Substance_id Substance_name Substance_category Substance_subcategory cas_no id_drugbank id_pharmgkb id_kegg id_ttd id_pubchem id_chemspider id_npass synonyms Molecular_formula inchikey iupacname Product_company Therapeutic_class s2m m2s s2probio probio2s diet_rxn drug_rxn diet_rxn_id drug_rxn_id PMDBD16 Acetaminophen "Therapeutic Substance; Herbal Substance" analgesics 103-90-2 DB00316 PA448015 D00217 DAP001436 1983 1906 NPC76327 "acetaminophen; Paracetamol; 4-Acetamidophenol; 103-90-2; N-(4-Hydroxyphenyl)acetamide; Tylenol; APAP; Panadol; Acetaminofen; Datril; N-Acetyl-p-aminophenol; p-Hydroxyacetanilide; 4''-Hydroxyacetanilide; p-Acetamidophenol; Naprinol; Lonarid; Algotropyl; Anelix; Multin; Acenol; Acamol; p-Acetaminophenol; Pyrinazine; Injectapap; Clixodyne; Liquagesic; Acetagesic; Gelocatil; Servigesic; Acetalgin; Abensanil; Valadol; Tralgon; Tabalgin; Lestemp; Alvedon; Valgesic; Tussapap; Finimal; Paracet; Homoolan; Febrolin; Febrilix; Febridol; Dymadon; Anaflon; Apamide" C8H9NO2 RZVAJINKPMORJF-UHFFFAOYSA-N N-(4-hydroxyphenyl)acetamide Beximco Pharma Analgesics No Yes No No No Yes ACMP_GLC_GLCAASE,ACMP_GLC_GLCAASEe,ACMP_GLC_GLCAASEepp,ACMPGLU_GLCAASE,ACMPGLU_GLCAASEe,ACMPGLU_GLCAASEepp,ACMPte,ACMPtepp,ACMPtex,EX_acmp(e) PMDBD135 Butyric Acid Therapeutic Substance Investigational Drug 107-92-6 DB03568 n.a. n.a. n.a. 264 259 n.a. "butyric acid; butanoic acid; n-Butyric acid; 107-92-6; n-Butanoic acid; propylformic acid; ethylacetic acid; Butanic acid; 1-propanecarboxylic acid; butyrate; 1-Butyric acid; Buttersaeure; butanoate; Kyselina maselna; Butyric acid (natural); Propanecarboxylic acid; Buttersaeure [German]; 1-butanoic acid; FEMA Number 2221; Kyselina maselna [Czech]; FEMA No. 2221; HSDB 940; CCRIS 6552; butoic acid; 2-butanoate; NSC 8415; UNII-40UIR9Q29H; UN2820; AI3-15306; EINECS 203-532-3; MFCD00002814; BRN 0906770; CH3-[CH2]2-COOH; 40UIR9Q29H; CHEBI:30772" C4H8O2 FERIUCNNQQJTOY-UHFFFAOYSA-N butanoic acid n.a. n.a. No Yes No Yes No No PMDBD189 Choline "Therapeutic Substance; Herbal Substance" compound 62-49-7 DB00122 PA448976 D07690 n.a. 305 299 NPC136014 "choline; Choline ion; Bilineurine; Choline cation; Cholinum; 2-Hydroxy-N,N,N-trimethylethanaminium; 62-49-7; (2-Hydroxyethyl)trimethylammonium; trimethylethanolamine; N-trimethylethanolamine; CCRIS 5847; AI3-24208; UNII-N91BDP6H0X; BRN 1736748; N,N,N-trimethylethanol-ammonium; CHEBI:15354; (beta-hydroxyethyl)trimethylammonium; EINECS 200-535-1; CHEMBL920; N91BDP6H0X; (2-hydroxyethyl)trimethylazanium; 2-hydroxy-N,N,N-trimethyl-ethanaminium; vitamin J; CHT; NSC402838; NCGC00015219-03; C5H14NO" C5H14NO+ OEYIOHPDSNJKLS-UHFFFAOYSA-N 2-hydroxyethyl(trimethyl)azanium n.a. n.a. No Yes No No Yes No rxnAGORA2600,rxnAGORA2601,rxnAGORA2735,rxnAGORA3737,rxnAGORA3772,rxnAGORA3815,rxnAGORA4555 PMDBD378 Gallic acid Herbal Substance Medicinal Herbal Compounds n.a. n.a. n.a. n.a. n.a. 370 n.a. NPC225710 "Gallic acid; 3,4,5-Trihydroxybenzoic acid; 149-91-7; gallate; Gallic acid, tech.; GALOP; Pyrogallol-5-carboxylic acid; Kyselina gallova; HSDB 2117; 3,4,5-Trihydroxybenzoate; CCRIS 5523; Kyselina gallova [Czech]; Gallic acid polymer; UNII-632XD903SP; NSC 674319; Gallicum acidum; CHEBI:30778; AI3-16412; Kyselina 3,4,5-trihydroxybenzoova; EINECS 205-749-9; NSC 20103; MFCD00002510; BRN 2050274; Kyselina 3,4,5-trihydroxybenzoova [Czech]; CHEMBL288114; 3,4,5-trihydroxy-Benzoic acid; 632XD903SP; NSC20103; NSC6" C7H6O5 LNTHITQWFMADLM-UHFFFAOYSA-N 3,4,5-trihydroxybenzoic acid n.a. n.a. Yes No Yes No No No PMDBD130 Bupropion Therapeutic Substance Approved Drug 34911-55-2 DB01156 PA448687 D07591 DAP000052 444 431 n.a. "bupropion; Amfebutamone; 34911-55-2; 2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one; Amfebutamon; Wellbutrin; (+-)-Bupropion; amfebutamonum; Amfebutamona; 34841-39-9; Bupropion [INN:BAN]; Wellbatrin; Elontril; Amfebutamonum [INN-Latin]; Zyban; Amfebutamona [INN-Spanish]; Bupropion SR; Bupropion hydrocloride; AMFEBUTAMONE HCl; alpha-(tert-butylamino)-m-chloropropiophenone; CHEMBL894; BRN 2101062; (+-)-1-(3-chlorophenyl)-2-((1,1-dimethylethyl)amino)-1-propanone; CHEBI:3219; 1-(3-chlorophenyl)-2-[(1,1-dimethylethyl)amino]propan-1" C13H18ClNO SNPPWIUOZRMYNY-UHFFFAOYSA-N 2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one GlaxoSmithKline plc n.a. No Yes No No No No PMDBD430 Hippuric acid Environmental Chemicals Environmental Substance n.a. n.a. n.a. n.a. n.a. 464 n.a. NPC3371 "Hippuric acid; 2-Benzamidoacetic acid; 495-69-2; N-Benzoylglycine; Benzoylglycine; Benzamidoacetic acid; hippurate; Benzoylaminoacetic acid; Hippursaeure; Phenylcarbonylaminoacetic acid; Benzamidoessigsaeure; Benzoylaminoessigsaeure; N-Benzoyl-glycin; (benzoylamino)acetic acid; Bz-Gly-OH; Acido ippurico; Acido ippurico [Italian]; 2-(Phenylformamido)Acetic Acid; NSC 9982; UNII-TE0865N2ET; 66407-11-2; Hippuric acid, 98%; N-(phenylcarbonyl)glycine; EINECS 207-806-3; MFCD00002692; CHEMBL" C9H9NO3 QIAFMBKCNZACKA-UHFFFAOYSA-N 2-benzamidoacetic acid n.a. n.a. No Yes No No No No PMDBD445 Indole "Therapeutic Substance; Herbal Substance" Investigational Drug 120-72-9 DB04532 n.a. n.a. n.a. 798 776 NPC82295 "indole; 1H-Indole; 120-72-9; Indol; 2,3-Benzopyrrole; 1-Benzazole; Ketole; 1-Azaindene; Benzopyrrole; 2,3-Benzopyrole; Caswell No. 498B; Indole (natural); Indol [German]; 1-Benzo(b)pyrrole; 1H-Benzo[b]pyrrole; FEMA No. 2593; CCRIS 4421; HSDB 599; EPA Pesticide Chemical Code 025000; Benzo[b]pyrrole; UNII-8724FJW4M5; AI3-01540; NSC 1964; EINECS 204-420-7; CHEMBL15844; CHEBI:16881; 8724FJW4M5; MFCD00005607; NCGC00167539-01; Indole, 99+%; DSSTox_CID_737; DSSTox_RID_75761; DSSTox_GSID_20737; IND; CAS-120-72-9; benzazole; mono-indole; Indole.; 1-H-in" C8H7N SIKJAQJRHWYJAI-UHFFFAOYSA-N 1H-indole n.a. n.a. No Yes No No No No PMDBD1392 Pyrazinamide Therapeutic substance Drug 98-96-4 DB00339 PA451182 D00144 DAP000660 1046 1017 n.a. "pyrazinamide; pyrazinecarboxamide; 98-96-4; pyrazine-2-carboxamide; pyrazinoic acid amide; Zinamide; 2-Pyrazinecarboxamide; Aldinamide; Aldinamid; Pirazinamid; Pyrazineamide; Tebrazid; Pyrafat; Unipyranamide; pyrazine carboxylamide; Pirazimida; Farmizina; Eprazin; Novamid; 2-Carbamylpyrazine; Pyrazinecarboxylic acid amide; Pirazinamida; Pyrazinamidum; Tisamid; Isopas; Pirazinamide; Pyrazine carboxamide; Pezetamid; Piraldina; D-50; Pirazinamide [DCIT]; MK 56; PZA; Pyrazinamidum [INN-Latin]; NCI-C01785; Pirazinamida [INN-Spanish]; C5H5N3O; D-50 " C5H5N3O IPEHBUMCGVEMRF-UHFFFAOYSA-N pyrazine-2-carboxamide n.a. n.a. No Yes No No No No PMDBD1363 Phenytoin Therapeutic substance Drug 57-41-0 DB00252 PA450947 D00512 DAP000130 1775 1710 n.a. "phenytoin; 5,5-DIPHENYLHYDANTOIN; 57-41-0; Diphenylhydantoin; Dilantin; 5,5-diphenylimidazolidine-2,4-dione; Phenytoine; Dihydantoin; Zentropil; Diphenylan; Diphantoin; Dilabid; Aleviatin; Epamin; Lepitoin; Fenylepsin; Diphedan; Sodanton; Phentytoin; Lehydan; Dihycon; Difenin; Diphenylhydatanoin; Sylantoic; Hidantomin; Hidantilo; Diphenine; Thilophenyl; Fenytoine; Elepsindon; Dantoinal; Zentronal; Phenatoine; Hidantina; Diphentyn; Dillantin; Dilantine; Sodantoin; Phanatine; Phanantin; Kessodanten; Hydantoinal; Fenitoina; Epilantin; Ditoinate; Di-Hydan" C15H12N2O2 CXOFVDLJLONNDW-UHFFFAOYSA-N 5,5-diphenylimidazolidine-2,4-dione n.a. n.a. No Yes No No No No PMDBD1432 Tacrine Therapeutic substance Drug 321-64-2 DB00382 PA451576 D08555 DAP000558 1935 1859 n.a. "Tacrine; 1,2,3,4-tetrahydroacridin-9-amine; 321-64-2; Tetrahydroaminacrine; 1,2,3,4-TETRAHYDRO-9-ACRIDINAMINE; Tetrahydroaminoacridine; Cognex; Tetrahydroaminocrin; Tetrahydroaminocrine; 9-amino-1,2,3,4-tetrahydroacridine; Tacrine [INN:BAN]; Tacrinum [INN-Latin]; Tacrina [INN-Spanish]; CS 12602; UNII-4VX7YNB537; 1,2,3,4-Tetrahydro-9-aminoacridine; CHEMBL95; EINECS 206-291-2; 5-Amino-6,7,8,9-tetrahydroacridine (European); 5-Amino-6,7,8,9-tetrahydroacridi" C13H14N2 YLJREFDVOIBQDA-UHFFFAOYSA-N 1,2,3,4-tetrahydroacridin-9-amine n.a. n.a. No Yes No No No No PMDBD1010 Acebutolol Therapeutic substance Drug 37517-30-9 DB01193 PA448011 D02338 DAP000484 1978 1901 n.a. "acebutolol; Acetobutolol; 37517-30-9; Neptal; dl-Acebutolol; Acebutololo; Prent; Acebutololum; Sectral; (+-)-Acebutolol; N-(3-Acetyl-4-(2-hydroxy-3-(isopropylamino)propoxy)phenyl)butyramide; Acebutololum [INN-Latin]; Acebrutololum [INN-Latin]; Acetobutolol [INN-Spanish]; Acebutolol [USAN:INN:BAN]; 5''-Butyramido-2''-(2-hydroxy-3-isopropylaminopropoxy)acetophenone; CHEBI:2379; CCRIS 9214; RP 21823; EINECS 253-539-0; 3''-Acetyl-4''-(2-hydroxy-3-(isopropylamino)propoxy)butyranilide; BRN 2162244; 1-(2-Acetyl-4-n-butyramidophenoxy)-2-hyd" C18H28N2O4 GOEMGAFJFRBGGG-UHFFFAOYSA-N N-[3-acetyl-4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]butanamide n.a. n.a. No Yes No No No No PMDBD1012 Acetohexamide Therapeutic substance Drug 968-81-0 DB00414 PA164777011 D00219 DAP000922 1989 1912 n.a. "acetohexamide; 968-81-0; Dymelor; Acetohexamid; Gamadiabet; Dimelor; Metaglucina; Tsiklamid; Hypoglicil; Dimelin; Ordimel; Minoral; Acetohexamida; Acetohexamidum; 1-(4-acetylphenyl)sulfonyl-3-cyclohexylurea; N-(p-Acetylphenylsulfonyl)-N''-cyclohexylurea; Acetohexamidum [INN-Latin]; Acetohexamida [INN-Spanish]; 1-((p-Acetylphenyl)sulfonyl)-3-cyclohexylurea; CCRIS 4; NCI-C03247; UNII-QGC8W08I6I; 1-(p-Acetylbenzenesulfonyl)-3-cyclohexylurea; 4-Acetyl-N-((cyclohexylamino)carbonyl)benzenesulfonamide; Benzenesulfonamide, 4-acetyl-N-[(cyc" C15H20N2O4S VGZSUPCWNCWDAN-UHFFFAOYSA-N 1-(4-acetylphenyl)sulfonyl-3-cyclohexylurea n.a. n.a. No Yes No No No No PMDBD22 Albendazole Therapeutic Substance Approved Drug 54965-21-8 DB00518 PA164746058 D00134 DAP000951 2082 1998 n.a. "albendazole; 54965-21-8; Albenza; Eskazole; Valbazen; Zentel; Proftril; Albendazol; Bilutac; Albendazolum; Zental; SK&F 62979; SKF 62979; Methyl 5-(propylthio)-2-benzimidazolecarbamate; SK&F-62979; Albendazolum [INN-Latin]; Albendazol [INN-Spanish]; 5-(Propylthio)-2-carbomethoxyaminobenzimidazole; Methyl [5-(Propylthio)benzimidazol-2-yl]carbamate; SKF-62979; methyl N-[6-(propylsulfanyl)-1H-1,3-benzodiazol-2-yl]carbamate; (5-(Propylthio)-1H-benzimidazol-2-yl)carbamic acid methyl ester; methyl N-(6-propylsulfanyl-1H-benzim" C12H15N3O2S HXHWSAZORRCQMX-UHFFFAOYSA-N methyl N-(6-propylsulfanyl-1H-benzimidazol-2-yl)carbamate GlaxoSmithKline Antiprotozoal Agents Yes Yes Yes No No No PMDBD26 Alfuzosin Therapeutic Substance Approved Drug 81403-80-7 DB00346 PA164774795 D07124 DCL000664 2092 2008 n.a. "alfuzosin; 81403-80-7; Alfuzosinum; Alfuzosina; Alfuzosine; Alfuzosinum [Latin]; Alfuzosine [French]; Alfuzosina [Spanish]; Alfuzosin [INN:BAN]; Uroxatral; ALFLUZOCIN; SL 77499; SL 77-499; HSDB 7290; CHEMBL709; N-[3-[(4-amino-6,7-dimethoxyquinazolin-2-yl)-methylamino]propyl]oxolane-2-carboxamide; CHEBI:51141; N-{3-[(4-amino-6,7-dimethoxyquinazolin-2-yl)(methyl)amino]propyl}tetrahydrofuran-2-carboxamide; N-(3-((4-Amino-6,7-dimethoxy-2-quinazolinyl)methylamino)propyl)tetrahydro-2-furancarboxamide; Alfusosine; C19H27N5O4; alphuzos" C19H27N5O4 WNMJYKCGWZFFKR-UHFFFAOYSA-N N-[3-[(4-amino-6,7-dimethoxyquinazolin-2-yl)-methylamino]propyl]oxolane-2-carboxamide Sanofi-Aventis Antihypertensive Agents No Yes No No No No PMDBD1021 Allopurinol Therapeutic substance Drug 315-30-0 DB00437 PA448320 D00224 DAP000773 135401907 2010 n.a. "allopurinol; 315-30-0; 1H-Pyrazolo[3,4-d]pyrimidin-4-ol; Zyloprim; Zyloric; Lopurin; Caplenal; Bleminol; Atisuril; Uripurinol; Milurit; Embarin; Progout; Foligan; Urosin; Suspendol; Epidropal; Cellidrin; Anoprolin; Uriprim; Hamarin; Allural; Ailural; Bloxanth; Allopur; Lysuron; Alositol; Xanturat; Uricemil; Ledopur; Cosuric; Urtias; Apurin; Remid; Apurol; Urolit; Gotax; Geapur; Urbol; Anzief; Aloral; Ketobun-A; Urobenyl; Apulonga; Takanarumin; Miniplanor; Ketanrift; Dabrosin; Dabroson; Nektrohan; Riball; Aluline; Adenock; Monarch; Gichtex; Allozym; Hexanuret; Epu" C5H4N4O OFCNXPDARWKPPY-UHFFFAOYSA-N 1,5-dihydropyrazolo[3,4-d]pyrimidin-4-one n.a. n.a. No Yes No No No No PMDBD1022 Alosetron Therapeutic substance Drug 122852-42-0 DB00969 PA164745502 D07129 DAP000369 2099 2015 n.a. "alosetron; 122852-42-0; Lotronex; UNII-13Z9HTH115; Alosetron [INN:BAN]; GR68755; CHEBI:253342; 5-methyl-2-[(5-methyl-1H-imidazol-4-yl)methyl]-3,4-dihydropyrido[4,3-b]indol-1-one; 2,3,4,5-Tetrahydro-5-methyl-2-((5-methyl-1H-imidazol-4-yl)methyl)-1H-pyrido(4,3-b)indol-1-one; 13Z9HTH115; Q-200612; C17H18N4O; MLS001401464; Alosetron (INN); 5-methyl-2-[(5-methyl-1H-imidazol-4-yl)methyl]-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indol-1-one; 5-Methyl-2-[(4-methyl-1H-imidazol-5-yl)methyl]-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indol-1-one" C17H18N4O JSWZEAMFRNKZNL-UHFFFAOYSA-N 5-methyl-2-[(5-methyl-1H-imidazol-4-yl)methyl]-3,4-dihydropyrido[4,3-b]indol-1-one n.a. n.a. No Yes No No No No PMDBD29 Alprenolol "Therapeutic Substance; Herbal Substance" "Approved Drug; Medicinal Herbal Compounds" 13655-52-2 DB00866 PA164750541 D07156 DAP000941 2119 2035 NPC141739 "alprenolol; Alpheprol; Alfeprol; 13655-52-2; Alprenololum; Alfeprol [Russian]; Alprenololum [INN-Latin]; Alprenolol [INN:BAN]; 1-(o-Allylphenoxy)-3-(isopropylamino)-2-propanol; 1-(2-Allylphenoxy)-3-isopropylamino-2-propanol; EINECS 237-140-9; CHEMBL266195; (RS)-Alprenolol;dl-Alprenolol; CHEBI:51211; NCGC00015099-05; DSSTox_CID_25127; DSSTox_RID_80" C15H23NO2 PAZJSJFMUHDSTF-UHFFFAOYSA-N 1-(propan-2-ylamino)-3-(2-prop-2-enylphenoxy)propan-2-ol AstraZeneca Antiarrhythmic Agents No Yes No No No No PMDBD30 Altretamine Therapeutic Substance Therapeutic Substance 645-05-6 DB00488 PA164743136 n.a. DAP000989 2123 2038 n.a. "altretamine; 645-05-6; HEXAMETHYLMELAMINE; Hexalen; Hexastat; Hemel; 2,4,6-Tris(dimethylamino)-1,3,5-triazine; Altretaminum; Altretamina; Altretaminum [INN-Latin]; ENT 50852; NC 195; 2,4,6-Tris(dimethylamino)-s-triazine; NCI-C50259; HMM; Altretamina [INN-Spanish]; N2,N2,N4,N4,N6,N6-hexamethyl-1,3,5-triazine-2,4,6-triamine; Altretamine (Hexalen); NSC 13875; HTM; HXM; UNII-Q8BIH59O7H; CCRIS 5492; MLS000069621" C9H18N6 UUVWYPNAQBNQJQ-UHFFFAOYSA-N 2-N,2-N,4-N,4-N,6-N,6-N-hexamethyl-1,3,5-triazine-2,4,6-triamine n.a. Anticancer Agents No Yes No No No No PMDBD32 Amantadine Therapeutic Substance Approved Drug 768-94-5 DB00915 PA448360 n.a. DAP000781 2130 2045 n.a. "amantadine; 1-Adamantanamine; 768-94-5; adamantan-1-amine; 1-Adamantylamine; 1-Aminoadamantane; Adamantylamine; Adamantanamine; Aminoadamantane; Symmetrel; Amantidine; Pk-merz; Adamantamine; Symadine; 1-Adamantamine; Amantadinum; Amantadina; Amantadine [INN:BAN]; Amantadinum [INN-Latin]; Amantadina [INN-Spanish]; adamantan-1-ylamine; Gocovri; TCMDC-125869; 1-adamantaneamine; UNII-BF4C9Z1J53; 1-Aminotricyclo(3.3.1.1(sup 3,7))decane; NSC 341865; Tricyclo(3.3.1.13,7)decan-1-amine; tricyclo[3.3.1.1~3,7~]decan-1-amine; HSDB 3202; Tricyclo[3." C10H17N DKNWSYNQZKUICI-UHFFFAOYSA-N adamantan-1-amine n.a. Antiviral Agents No Yes No No No No PMDBD1448 Theophylline Therapeutic substance Drug 58-55-9 DB00277 PA451647 D00371 DAP000002 2153 2068 n.a. "theophylline; 58-55-9; 1,3-Dimethylxanthine; Theophyllin; Elixophyllin; Theolair; Nuelin; Theophylline anhydrous; Theocin; Respbid; Theo-dur; Elixophylline; Pseudotheophylline; Lanophyllin; Theovent; Uniphyl; Slo-phyllin; Teofyllamin; Parkophyllin; Bronkodyl; Xantivent; Theocontin; Uniphyllin; Optiphyllin; Maphylline; Liquophylline; Doraphyllin; Armophylline; Accurbron; Theacitin; Synophylate; Medaphyllin; Theofol; Theobid; Teolair; Solosin; Aerolate; Theolix; Theograd; Elixicon; Elixex; Acet-theocin; Theophyl-225; Slo-bid; Aerolate III; Xanthium; Sust" C7H8N4O2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 1,3-dimethyl-7H-purine-2,6-dione n.a. n.a. No Yes No No No No PMDBD36 Amiodarone Therapeutic Substance anti-arrhythmic 1951-25-3 DB01118 PA448383 D02910 DAP000496 2157 2072 n.a. "amiodarone; 1951-25-3; Cordarone; Amiodarona; Amiodaronum; Amjodaronum; Amiodaronum [INN-Latin]; Amiodarona [INN-Spanish]; Pacerone; L 3428; L-3428; UNII-N3RQ532IUT; 2-Butyl-3-(3,5-diiodo-4-(2-diethylaminoethoxy)benzoyl)benzofuran; 2-n-Butyl-3'',5''-diiodo-4''-N-diethylaminoethoxy-3-benzoylbenzofuran; (2-butyl-1-benzofuran-3-yl){4-[2-(diethylamino)ethoxy]-3,5-diiodophenyl}methanone; C25H29I2NO3; 2-Butyl-3-benzofuranyl 4-(2-(diethylamino)ethoxy)-3,5-diiodophenyl ketone; SKF 33134-A; EINECS 217-772-1; CHEMBL633; BRN 1271711; N3RQ532" C25H29I2NO3 IYIKLHRQXLHMJQ-UHFFFAOYSA-N (2-butyl-1-benzofuran-3-yl)-[4-[2-(diethylamino)ethoxy]-3,5-diiodophenyl]methanone Wyeth-Ayerst Laboratories Antiarrhythmic Agents No Yes No Yes No Yes AMIO_GLC_GLCAASE,AMIO_GLC_GLCAASEe,AMIO_GLC_GLCAASEepp,AMIOte,AMIOtepp,AMIOtex,EX_amio(e) PMDBD1028 Amitriptyline Therapeutic substance Drug 50-48-6 DB00321 PA448385 D07448 DNC001466 2160 2075 n.a. "amitriptyline; Amitriptylin; Elavil; 50-48-6; Triptanol; Damitriptyline; Lantron; Seroten; Damilen; Flavyl; Proheptadiene; Amitryptiline; Triptisol; Adepress; Tryptanol; Adepril; Amitriprolidine; Triptilin; Redomex; Amytriptylin; Damilan; Ro 4-1575; Amitriptylin [German]; Amitriptilina [Italian]; Amitriptyline [INN:BAN]; Amitril; Sarotex; Amitriptylinum [INN-Latin]; Amitriptilina [INN-Spanish]; MK 230; 5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,d)cycloheptene; 3-(10,11-dihydro-5H-dibenzo[a,d][7]annulen-5-ylidene)-N,N-dimet" C20H23N KRMDCWKBEZIMAB-UHFFFAOYSA-N N,N-dimethyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,11,13-hexaenylidene)propan-1-amine n.a. n.a. No Yes No No No No PMDBD39 Amlodipine Therapeutic Substance antihypertensive 88150-42-9 DB00381 PA448388 D07450 DAP000139 2162 2077 n.a. "amlodipine; 88150-42-9; Norvasc; Amlodis; Coroval; Amlocard; Lipinox; AMLODIPINE BASE; Amlodipinum; Amlodipino; Caduet; Istin; Amlodipine Free Base; Amlodipinum [Latin]; Amlodipino [Spanish]; Amlodipine [INN:BAN]; Amlodipine besilate; CHEBI:2668; Norvasc (TN); 3-ethyl 5-methyl 2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate; 3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate; UK-4834011; Amlor; 3-O-ethyl 5-O-methyl 2-(2-aminoetho" C20H25ClN2O5 HTIQEAQVCYTUBX-UHFFFAOYSA-N 3-O-ethyl 5-O-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate Dainippon Sumitomo Antihypertensive Agents Yes Yes No No No No PMDBD41 Amoxapine Therapeutic Substance Approved Drug 14028-44-5 DB00543 PA448405 D00228 DAP001149 2170 2085 n.a. "amoxapine; 14028-44-5; Asendin; Demolox; Moxadil; Amoxan; Desmethylloxapin; Asendis; Amoxapina; Amoxepine; Amoxapinum; Amoxapinum [INN-Latin]; Amoxapina [INN-Spanish]; 2-Chloro-11-(1-piperazinyl)dibenz(b,f)(1,4)oxazepine; CL 67772; CL-67772; UNII-R63VQ857OT; 2-chloro-11-(piperazin-1-yl)dibenzo[b,f][1,4]oxazepine; EINECS 237-867-1; C17H16ClN3O; BRN 0832057; CHEMBL1113; 2-Chlor-11-(1-piperazinyl)dibenz(b,f)(1,4)oxazepin; 8-chloro-6-piperazin-1-ylbenzo[b][1,4]benzoxazepine; 2-Ch" C17H16ClN3O QWGDMFLQWFTERH-UHFFFAOYSA-N 8-chloro-6-piperazin-1-ylbenzo[b][1,4]benzoxazepine n.a. Antidepressants Yes Yes No No No No PMDBD45 Anagrelide Therapeutic Substance Approved Drug 68475-42-3 DB00261 PA164742986 D07455 DAP000612 135409400 2097 n.a. "anagrelide; 68475-42-3; Anagrelida; Anagrelidum; Xagrid; 6,7-Dichloro-5,10-dihydroimidazo[2,1-b]quinazolin-2(3H)-one; Anagrelide [INN:BAN]; Anagrelidum [INN-Latin]; Anagrelida [INN-Spanish]; C10H7Cl2N3O; UNII-K9X45X0051; BL 416201; HSDB 7325; CHEMBL760; BRN 0619582; 6,7-Dichloro-1,5-dihydroimidazo(2,1-b)quinazolin-2(3H)-one; 6,7-Dichlor-1,5-dihydroimidazo(2,1-b)chinazolin-2(3H)-on; CHEBI:142290; K9X45X0051; 6,7-Dichloro-1,5-dihydroimidazo[2,1-b]quinazolin-2(3H)-one" C10H7Cl2N3O OTBXOEAOVRKTNQ-UHFFFAOYSA-N 6,7-dichloro-3,5-dihydro-1H-imidazo[2,1-b]quinazolin-2-one Shire Phamaceuticals Antithrombotic Agents No Yes No Yes No No PMDBD46 Anastrozole Therapeutic Substance Approved Drug 120511-73-1 DB01217 PA448432 D00960 DAP000627 2187 2102 n.a. "anastrozole; 120511-73-1; Arimidex; anastrazole; Anastrozol; 2,2''-(5-((1H-1,2,4-triazol-1-yl)methyl)-1,3-phenylene)bis(2-methylpropanenitrile); ZD-1033; ZD1033; ZD 1033; ICI D1033; UNII-2Z07MYW1AZ; 2-[3-(2-cyanopropan-2-yl)-5-(1,2,4-triazol-1-ylmethyl)phenyl]-2-methylpropanenitrile; ICI-D1033; HSDB 7462; ICI-D 1033; alpha,alpha,alpha'',alpha''-Tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-m-benzenediacetonitrile; 2Z07MYW1AZ; CHEMBL1399; 2,2''-[5-(1H-1,2,4-triazol-1-ylmethyl)benzene-1,3-diyl]bis(2-methylpropanenitrile); CHEBI:2704" C17H19N5 YBBLVLTVTVSKRW-UHFFFAOYSA-N 2-[3-(2-cyanopropan-2-yl)-5-(1,2,4-triazol-1-ylmethyl)phenyl]-2-methylpropanenitrile AstraZeneca Anticancer Agents No Yes No Yes No No PMDBD49 Anthralin Therapeutic Substance Approved Drug 1143-38-0 DB11157 n.a. n.a. n.a. 2202 2117 n.a. "anthralin; Dithranol; 1143-38-0; 1,8-Dihydroxyanthrone; 1,8-Dihydroxy-9-anthrone; Cignolin; Chrysodermol; Cigthranol; 1,8-Dihydroxyanthracen-9(10H)-one; Batridol; Psoriacid-Stift; Anthra-Derm; 1,8-dihydroxy-10H-anthracen-9-one; Drithoscalp; DrithoCreme; 1,8-DIHYDROXY-9(10H)-ANTHRACENONE; NSC 43970; Anthraline; NSC 629313; UNII-U8CJK0JH5M; Dithranolum [INN-Latin]; Anthralin [USP]; CCRIS 628; CHEBI:37510; EINECS 214-538-0; U8CJK0JH5M; BRN 2054360; CHEMBL46469; Dithranol [INN]" C14H10O3 NUZWLKWWNNJHPT-UHFFFAOYSA-N 1,8-dihydroxy-10H-anthracen-9-one n.a. n.a. Yes No No No No No PMDBD18 Acetylsalicylic acid Therapeutic Substance Therapeutic Substance 50-78-2 DB00945 PA448497 D00109 DAP000843 2244 2157 n.a. "aspirin; ACETYLSALICYLIC ACID; 50-78-2; 2-Acetoxybenzoic acid; 2-(Acetyloxy)benzoic acid; o-Acetoxybenzoic acid; Acylpyrin; O-Acetylsalicylic acid; Ecotrin; Easprin; Acetophen; Acenterine; Polopiryna; Acetosal; Acetylsalicylate; Colfarit; Salicylic acid acetate; o-Carboxyphenyl acetate; Enterosarein; Temperal; Acetylin; Aspergum; Salcetogen; Pharmacin; Acetosalin; Premaspin; Micristin; Benaspir; Aspirdrops; Acetonyl; Aceticyl; Empirin; Ecolen; Rhodine; Endydol; Saletin; Rheumintabletten; Solprin acid; Enterosarine; Bialpirinia; Globentyl; Enterici" C9H8O4 BSYNRYMUTXBXSQ-UHFFFAOYSA-N 2-acetyloxybenzoic acid Bayer Pharmaceuticals Corporation Analgesics No Yes No No No No PMDBD76 Astemizole Therapeutic Substance Approved Drug 68844-77-9 DB00637 PA448498 D00234 DAP000326 2247 2160 n.a. "astemizole; 68844-77-9; Hismanal; Histaminos; Paralergin; Laridal; Retolen; Alermizol; Histamen; Astemison; Kelp; Astemizol; Wareezol; Hestazol; Astemizolum; Metodih; Novo-mastizol A; Astemizol [German]; Astemizol [INN-Spanish]; Astemizolum [INN-Latin]; C28H31FN4O; CCRIS 7595; R 42512; 1-[(4-Fluorophenyl)methyl]-N-[1-[2-(4-methoxyphenyl)ethyl]-4-piperidinyl]-1H-benzimidazol-2-amine; GNF-PF-2461; HSDB 6799; UNII-7HU6337315; 1-(p-Fluorobenzyl)-2-((1-(2-(p-methoxyphenyl)ethyl)piperid-4-yl)amino)benzimidazole" C28H31FN4O GXDALQBWZGODGZ-UHFFFAOYSA-N 1-[(4-fluorophenyl)methyl]-N-[1-[2-(4-methoxyphenyl)ethyl]piperidin-4-yl]benzimidazol-2-amine Janssen Pharmaceutica Antiallergic Agents Yes No Yes No No No PMDBD1047 Atrazine Environmental Chemicals Pesticides 1912-24-9 DB07392 n.a. n.a. n.a. 2256 2169 n.a. "atrazine; 1912-24-9; Gesaprim; Atrazin; Oleogesaprim; Chromozin; Primaze; Gesoprim; Fenatrol; Radazin; Fenamin; Atrasine; Zeazine; Strazine; Pitezin; Hungazin; Atranex; Argezin; Primatol; Atazinax; Aktikon; Zeazin; Wonuk; Cyazin; Candex; Vectal; Inakor; Aatrex; Cekuzina-T; Aktinit A; Actinite PK; Atratol A; Aktinit PK; Aktikon PK; Weedex A; Crisazine; Fenamine; Crisatrina; Radizin; Atrataf; Akticon; Aatram; Zeapos; Griffex; Atratol; Atrex; Atred; Primatol A; Hungazin PK; Aatrex nine-O; Vectal SC; Herbatoxol; Zeopos; Triazine A 1294; Gesaprim 50; Farmco atrazine" C8H14ClN5 MXWJVTOOROXGIU-UHFFFAOYSA-N 6-chloro-4-N-ethyl-2-N-propan-2-yl-1,3,5-triazine-2,4-diamine n.a. n.a. Yes No No No No No PMDBD85 Azathioprine Therapeutic Substance Approved Drug 446-86-6 DB00993 PA448515 D00238 DAP000782 2265 2178 n.a. "azathioprine; 446-86-6; Imuran; Azothioprine; Azathioprin; Azatioprin; Azamun; Imurel; Azanin; Azathiopurine; Ccucol; Muran; Imurek; Azasan; Rorasul; Azamun [Czech]; BW 57-322; NSC-39084; BW-57-322; NCI-C03474; 6-[(1-methyl-4-nitro-1H-imidazol-5-yl)sulfanyl]-7H-purine; 6-(1-Methyl-4-nitroimidazol-5-yl)thiopurine; Azatioprina [INN-Spanish]; Azathioprinum [INN-Latin]; Imuran (TN); NSC 39084; 6-(1-Methyl-p-nitro-5-imidazolyl)-thiopurine; Methylnitroimidazolylmercaptopurine; 6-((1-Methyl-4-nitro-1H-imidazol-5-yl)thio)-1H-purine; UNII-MRK24" C9H7N7O2S LMEKQMALGUDUQG-UHFFFAOYSA-N 6-(3-methyl-5-nitroimidazol-4-yl)sulfanyl-7H-purine GlaxoSmithKline Immunosuppressive Agents Yes Yes No No No No PMDBD101 Benzbromarone Therapeutic Substance Approved Drug 3562-84-3 DB12319 n.a. D01056 n.a. 2333 2243 n.a. "benzbromarone; 3562-84-3; Benzbromaron; Desuric; Urinorm; Normurat; Uricovac; Minuric; Exurate; Hipurik; Narcaricin; Azubromaron; L 2214-Labaz; Uroleap (TN); Harolan; MJ 10061; 3,5-Dibromo-4-hydroxyphenyl-2-ethyl-3-benzofuranyl ketone; 2-Ethyl-3-(3,5-dibrom-4-hydroxybenzoyl)benzofuran; L 2214; Benzbromaronum [INN-Latin]; (3,5-Dibromo-4-hydroxyphenyl)(2-ethyl-1-benzofuran-3-yl)methanone; Benzobromarona [INN-Spanish]; NSC 85433; Benzbromarone [USAN:INN:BAN]; L2214-Lab" C17H12Br2O3 WHQCHUCQKNIQEC-UHFFFAOYSA-N (3,5-dibromo-4-hydroxyphenyl)-(2-ethyl-1-benzofuran-3-yl)methanone Labaz Laboratories n.a. Yes Yes Yes No No No PMDBD103 Benzthiazide Therapeutic Substance Approved Drug 91-33-8 DB00562 PA164776841 D00651 DAP000603 2343 2253 n.a. "benzthiazide; Benzothiazide; 91-33-8; Aquatag; Lemazide; Dihydrex; Fovane; Freeuril; Exosalt; Edemex; Proaqua; Diucen; Urese; Exna; Regulon; Diucene; Pfizer 1393; Benzthiazidum; Benzotiazida; Aquapres; Urazide; Aquasec; Fouane; Hy-drine; Pro-aqua; Aqua-Scrip; Rid-ema; S-Aqua; Benztiazide [DCIT]; Benzthiazidum [INN-Latin]; Benzotiazida [INN-Spanish]; C15H14ClN3O4S3; 3-Benzylthiomethyl-6-chloro-7-sulfamoyl-1,2,4-benzothiadiazine 1,1-dioxide; P 1393; UNII-1TD8J48L61; HSDB 3296" C15H14ClN3O4S3 NDTSRXAMMQDVSW-UHFFFAOYSA-N 3-(benzylsulfanylmethyl)-6-chloro-1,1-dioxo-4H-1lambda6,2,4-benzothiadiazine-7-sulfonamide n.a. Antihypertensive Agents No Yes No Yes No No PMDBD107 Berberine Herbal Substance antifungal infections and as antidiarrheal 2086-83-1 DB04115 PA165860812 D00092 DNC000385 2353 2263 NPC53069 "berberine; 2086-83-1; Umbellatine; Berberin; UNII-0I8Y3P32UF; 0I8Y3P32UF; C20H18NO4; CHEBI:16118; Berberal; EINECS 218-229-1; BRN 3570374; ST055798; 9,10-Dimethoxy-2,3-(methylenedioxy)-7,8,13,13a-tetrahydroberbinium; 9,10-dimethoxy-5,6-dihydro[1,3]dioxolo[4,5-g]isoquino[3,2-a]isoquinolin-7-ium; Berbamine sulphate acid; CHEMBL12089; 7,8,13,13a-tetradehydro-9,10-dimethoxy-2,3-(" C20H18NO4+ YBHILYKTIRIUTE-UHFFFAOYSA-N 16,17-dimethoxy-5,7-dioxa-13-azoniapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-1(13),2,4(8),9,14,16,18,20-octaene n.a. n.a. No Yes No Yes No No PMDBD112 Bicalutamide Therapeutic Substance Approved Drug 90357-06-5 DB01128 PA164746255 D00961 DAP000092 2375 2284 n.a. "bicalutamide; 90357-06-5; Casodex; Cosudex; Calutide; ICI-176334; ICI 176334; Bicalutamide (CDX); N-[4-cyano-3-(trifluoromethyl)phenyl]-3-(4-fluorophenyl)sulfonyl-2-hydroxy-2-methylpropanamide; Bicalutamide (Casodex); CHEMBL409; BRN 5364666; N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methylpropanamide; (+-)-4''-Cyano-alpha,alpha,alpha-trifluoro-3-((p-fluorophenyl)sulfonyl)-2-methyl-m-lactotoluidide; C18H14F4N2O4S; ICI 176,334; Propanamide, N-(4-cyano-3-(trifluoromethyl)phenyl)-3-((4-fluor" C18H14F4N2O4S LKJPYSCBVHEWIU-UHFFFAOYSA-N N-[4-cyano-3-(trifluoromethyl)phenyl]-3-(4-fluorophenyl)sulfonyl-2-hydroxy-2-methylpropanamide AstraZeneca plc Anticancer Agents No Yes No No No No PMDBD113 Bifonazole Therapeutic Substance Approved Drug 60628-96-8 DB04794 PA164746464 n.a. DAP000877 2378 2287 n.a. "bifonazole; 60628-96-8; Mycospor; Bifonazol; Trifonazole; BAY H 4502; Amycor; Azolmen; Bifonazolum [INN-Latin]; Bifonazol [INN-Spanish]; 1-((4-Biphenylyl)phenylmethyl)-1H-imidazole; 1-(alpha-(4-Biphenylyl)benzyl)imidazole; 1-[phenyl-(4-phenylphenyl)methyl]imidazole; (+-)-1-(p,alpha-Diphenylbenzyl)imidazole; Bay H-4502; 1-(p,alpha-Diphenylbenzyl)imidazole; Bay-h-4502; EINECS 262-336-6; BRN 0618427; MLS000028576; CHEMBL277535; Bifonazolum; CHEBI:78692; 1-[biphenyl-4-yl(phenyl)meth" C22H18N2 OCAPBUJLXMYKEJ-UHFFFAOYSA-N 1-[phenyl-(4-phenylphenyl)methyl]imidazole Bayer Pharmaceuticals Corporation Antifungal Agents Yes No Yes No No No PMDBD115 Biperiden Therapeutic Substance Approved Drug 514-65-8 DB00810 PA448626 D00779 DAP001125 2381 2289 n.a. "biperiden; 514-65-8; Biperidene; Akineton; Biperidine; Beperiden; Bipariden; Biperideno; Biperidenum; Biperidenum [INN-Latin]; Biperidene [INN-French]; Biperideno [INN-Spanish]; KL 373; alpha-5-Norbornen-2-yl-alpha-phenyl-1-piperidinepropanol; UNII-0FRP6G56LD; Biperiden HCl; 3-Piperidino-1-phenyl-1-bicycloheptenyl-1-propanol; 1-Bicycloheptenyl-1-phenyl-3-piperidino-propanol-1; EINECS 208-184-6; BRN 0290038; alpha-bicyclo[2.2.1]hept-5-en-2-yl-alpha-phenyl-1-piperidinepropanol; CHEMBL1101; 0FRP6G56LD; CHEBI:3112; 3-Piperidino-1-phen" C21H29NO YSXKPIUOCJLQIE-UHFFFAOYSA-N 1-(2-bicyclo[2.2.1]hept-5-enyl)-1-phenyl-3-piperidin-1-ylpropan-1-ol Knoll Pharma Antiparkinson Agents No Yes No Yes No No PMDBD116 Bisacodyl Therapeutic Substance Approved Drug 603-50-9 DB09020 n.a. D00245 n.a. 2391 2299 n.a. "bisacodyl; 603-50-9; Dulcolax; Brocalax; Bicol; Sanvacual; Durolax; Fenilaxan; Stadalax; Hillcolax; Endokolat; Theralax; Dulcolan; Ulcolax; Telemin; Laxans; Godalax; Neolax; Laxine; Ivilax; Eulaxan; Nigalax; Laxorex; Laxadin; Zetrax; Pyrilax; Sk-bisacodyl; Laxanin N; Deficol; LACO; Phenol, 4,4''-(2-pyridinylmethylene)bis-, diacetate (ester); LA96a; HalfLytely; Bisacodylum [INN-Latin]; Bisacodilo [INN-Spanish]; Bis(p-acetoxyphenyl)-2-pyridylmethane; Di-(p-acetoxyphenyl)-2-pyridylmethane; Di-(4-acetoxyphenyl)-2-pyridylmethane; MLS000069729; UNII-10" C22H19NO4 KHOITXIGCFIULA-UHFFFAOYSA-N [4-[(4-acetyloxyphenyl)-pyridin-2-ylmethyl]phenyl] acetate n.a. n.a. No Yes No Yes No No PMDBD124 Bromazepam Therapeutic Substance anti-anxiety disorders 1812-30-2 DB01558 PA10035 D01245 DAP001035 2441 2347 n.a. "bromazepam; Lexotanil; Durazanil; Compedium; Lexilium; Creosedin; Lexaurin; Lectopam; Lexotan; Lekotam; Lexomil; Compendium; Calmepam; Normoc; 1812-30-2; Ultramidol; LA Xvii; Bromazepamum [INN-Latin]; Bromazepamum [Latin]; Ro 5-3350; 7-Bromo-5-(2-pyridyl)-3H-1,4-benzodiazepin-2(1H)-one; KL-001; KL 001; Bromazepam [USAN:INN:BAN:JAN]; 7-Bromo-1,3-dihydro-5-(2-pyridyl)-2H-1,4-benzodiazepin-2-one; UNII-X015L14V0O; NSC 140669; EINECS 217-322-4; 7-bromo-5-pyridin-2-y" C14H10BrN3O VMIYHDSEFNYJSL-UHFFFAOYSA-N 7-bromo-5-pyridin-2-yl-1,3-dihydro-1,4-benzodiazepin-2-one Hoffmann-La Roche pharmaceutical company Hypnotics and Sedatives No Yes No No No No PMDBD126 Bromperidol Therapeutic Substance Approved Drug 10457-90-6 DB12401 n.a. n.a. n.a. 2448 2354 n.a. "bromperidol; 10457-90-6; Impromen; Bromoperidol; 4-(4-(4-bromophenyl)-4-hydroxypiperidin-1-yl)-1-(4-fluorophenyl)butan-1-one; UNII-LYH6F7I22E; Bromperidolum [INN-Latin]; R 11333; EINECS 233-943-3; 4-(4-(4-Bromophenyl)-4-hydroxypiperidino)-4''-fluorobutyrophenone; CC 2489; BRN 1552256; LYH6F7I22E; 4-[4-(4-bromophenyl)-4-hydroxypiperidin-1-yl]-1-(4-fluorophenyl)butan-1-one; Tesoprel; 4-(4-(p-Bromophenyl)-4-hydroxypiperidino)-4''-fluorobutyrophenone; 4-(4-(4-Bromophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)-1-butanone" C21H23BrFNO2 RKLNONIVDFXQRX-UHFFFAOYSA-N 4-[4-(4-bromophenyl)-4-hydroxypiperidin-1-yl]-1-(4-fluorophenyl)butan-1-one n.a. n.a. Yes No Yes No No No PMDBD129 Bufexamac Therapeutic Substance Approved Drug 2438-72-4 DB13346 n.a. D01271 n.a. 2466 2372 n.a. "bufexamac; 2438-72-4; Bufexamic acid; 2-(4-Butoxyphenyl)-N-hydroxyacetamide; Parfenac; Malipuran; Droxaryl; Parfenal; Feximac; Mofenar; 4-Butoxy-N-hydroxybenzeneacetamide; Paraderm; Norfemac; Bufexamacum; Flogicid; p-Butoxyphenylacetohydroxamic acid; Bufexamaco; 4-Butoxyphenylacetohydroxamic acid; Anderm; Flogocid N plastigel; 2-(p-Butoxyphenyl)-acetohydroxamic acid; Acide p-butoxyphenylacethydroxamique; Bufessamac [DCIT]; Bufexamacum [INN-Latin]; Bufexamaco [INN-Spanish]; CP 1044 J3; UNII-4T3C38J78L; Benzeneacetamide, 4-butoxy-N-hyd" C12H17NO3 MXJWRABVEGLYDG-UHFFFAOYSA-N 2-(4-butoxyphenyl)-N-hydroxyacetamide n.a. n.a. Yes No No No No No PMDBD1064 Bumetanide Therapeutic substance Drug 28395-03-1 DB00887 PA448682 D00247 DAP000361 2471 2377 n.a. "bumetanide; 28395-03-1; 3-(Butylamino)-4-phenoxy-5-sulfamoylbenzoic acid; Bumex; Burinex; Fordiuran; Lunetoron; Segurex; Fontego; Ro 10-6338; Bumetanida; Aquazone; Bumetanidum; Diurama; Butinat; Yurinex; Cambiex; Bumetanidum [INN-Latin]; Bumetanida [INN-Spanish]; Lixil-Leo; PF 1593; 3-(Aminosulfonyl)-5-(butylamino)-4-phenoxybenzoic acid; UNII-0Y2S3XUQ5H; EINECS 249-004-6; BRN 2185351; 0Y2S3XUQ5H; MLS000028457; CHEBI:3213; Bumethanide; C17H20N2O5S; Burine; BENZOIC ACID, 3-(BUTYLAMI" C17H20N2O5S MAEIEVLCKWDQJH-UHFFFAOYSA-N 3-(butylamino)-4-phenoxy-5-sulfamoylbenzoic acid n.a. n.a. No Yes No No No No PMDBD1065 Buspirone Therapeutic substance Drug 36505-84-7 DB00490 PA448689 D07593 DAP000031 2477 2383 n.a. "buspirone; 36505-84-7; Ansial; Buspironum; Buspirona; Buspironum [INN-Latin]; Buspirona [INN-Spanish]; Buspirone [INN:BAN]; UNII-TK65WKS8HL; MJ-9022-1; 8-(4-(4-(2-Pyrimidinyl)-1-piperizinyl)butyl)-8-azaspiro(4,5)decane-7,9-dione; 8-[4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl]-8-azaspiro[4.5]decane-7,9-dione; CHEMBL49; EINECS 253-072-2; TK65WKS8HL; BRN 0964904; CHEBI:3223; C21H31N5O2; 8-(4-(4-(Pyrimidin-2-yl)piperazin-1-yl)butyl)-8-azaspiro[4.5]decane-7,9-dione" C21H31N5O2 QWCRAEMEVRGPNT-UHFFFAOYSA-N 8-[4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl]-8-azaspiro[4.5]decane-7,9-dione n.a. n.a. No Yes No No No No PMDBD131 Butamben Therapeutic Substance Approved Drug 94-25-7 DB11148 n.a. n.a. n.a. 2482 2388 n.a. "Butyl 4-aminobenzoate; butamben; 94-25-7; Butesin; Butylcaine; Butyl aminobenzoate; Butoform; Butesine; Scuroform; Planoform; Scuroforme; Butyl keloform; BUTYL P-AMINOBENZOATE; 4-(Butoxycarbonyl)aniline; Benzoic acid, 4-amino-, butyl ester; N-Butyl p-aminobenzoate; n-Butyl-p-aminobenzoate; 4-Aminobenzoic Acid n-Butyl Ester; 4-Aminobenzoic acid butyl ester; Benzoic acid, p-amino-, butyl ester; p-Aminobenzoic acid butyl ester; Butyl PABA; NSC 128464; UNII-EFW857872Q; CCRIS 5891; 4-amino butylbenzoate; p-Aminobenzoic acid, butyl ester" C11H15NO2 IUWVALYLNVXWKX-UHFFFAOYSA-N butyl 4-aminobenzoate n.a. n.a. Yes No No No No No PMDBD1069 Caffeine Therapeutic substance Drug 2/8/1958 DB00201 PA448710 D00528 DAP000099 2519 2424 n.a. "caffeine; 58-08-2; 1,3,7-Trimethylxanthine; Guaranine; Thein; Methyltheobromine; Cafeina; Theine; Koffein; Mateina; Alert-pep; Coffeine; Caffein; Cafipel; Refresh''n; Caffedrine; Stim; Nodaca; Dexitac; Caffine; Cafecon; Cafamil; Anhydrous caffeine; No-Doz; Eldiatric C; 7-Methyltheophylline; Vivarin; Organex; Hycomine; Nix Nap; Methyltheobromide; 3,7-Dihydro-1,3,7-trimethyl-1H-purine-2,6-dione; Phensal; Coffein; Caffeine, synthetic; Quick-Pep; Coffeinum; Tirend; 1,3,7-Trimethyl-2,6-dioxopurine; 1,3,7-Trimethylpurine-2,6-dione; Theophylline, 7-methy" C8H10N4O2 RYYVLZVUVIJVGH-UHFFFAOYSA-N 1,3,7-trimethylpurine-2,6-dione n.a. n.a. No Yes No No Yes No rxn07729,rxnDiet37 PMDBD893 Verapamil "Therapeutic Substance; Herbal Substance" "Approved Drug; Medicinal Herbal Compounds" 52-53-9 DB00661 PA451868 D02356 DAP000040 2520 2425 NPC42793 "VERAPAMIL; Iproveratril; 52-53-9; Vasolan; Dilacoran; Isoptin; Isoptine; Falicard; Finoptin; Isoptimo; Calan; Verapamilum; Verapamilo; Verapamilum [INN-Latin]; Lekoptin; Verapamilo [INN-Spanish]; Isotopin; Calcan; Tarka; D-365; Verelan; Izoptin; Securon; Verapamil [USAN:INN:BAN]; CP-16533-1; Covera-HS; 5-((3,4-Dimethoxyphenethyl)methylamino)-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile; 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile; Verpamil; CCRIS 6749; Verelan PM; Isoptin SR" C27H38N2O4 SGTNSNPWRIOYBX-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]-2-propan-2-ylpentanenitrile Pfizer Inc Analgesics No Yes No No No No PMDBD1073 Candesartan Therapeutic substance Drug 139481-59-7 DB13919 PA448765 D00522 n.a. 2541 2445 n.a. "candesartan; 139481-59-7; Blopress; CV-11974; 1-((2''-(1H-Tetrazol-5-yl)-[1,1''-biphenyl]-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylic acid; CV 11974; UNII-S8Q36MD2XX; 2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylic acid; CHEMBL1016; S8Q36MD2XX; 2-Ethoxy-1-(p-(o-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxylic acid; CHEBI:3347; C24H20N6O3; 2-ethoxy-3-[[4-[2-(1h-tetrazol-5-yl)phenyl]phenyl]methyl]-3h-benzoimidazole-4-carboxylic acid; NCGC00167474-01; AK-57139; DSSTox_CID_" C24H20N6O3 HTQMVQVXFRQIKW-UHFFFAOYSA-N 2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylic acid n.a. n.a. No Yes No No No No PMDBD1075 Carbamazepine Therapeutic substance Drug 298-46-4 DB00564 PA448785 D00252 DAP000129 2554 2457 n.a. "carbamazepine; 298-46-4; Tegretol; Carbamazepen; 5H-Dibenzo[b,f]azepine-5-carboxamide; Finlepsin; Carbazepine; Biston; Equetro; 5H-Dibenz[b,f]azepine-5-carboxamide; Carbamezepine; Tegretal; Epitol; Karbamazepin; Neurotol; Carbatrol; Timonil; Telesmin; Stazepine; Carbamazepin; Lexin; Tegretol-Xr; benzo[b][1]benzazepine-11-carboxamide; Carbamazepinum; Carbamazepina; Bipotrol; Amizepin; Teril; Geigy 32883; 5-Carbamyl-5H-dibenzo(b,f)azepine; 5-Carbamoyl-5H-dibenzo(b,f)azepine; 5H-Dibenz(b,f)azepine-5-carboxamide; Carnexiv; Calepsin; 5-Carbamoyl" C15H12N2O FFGPTBGBLSHEPO-UHFFFAOYSA-N benzo[b][1]benzazepine-11-carboxamide n.a. n.a. No Yes No No No No PMDBD148 Carisoprodol Therapeutic Substance Approved Drug 78-44-4 DB00395 PA448809 D00768 n.a. 2576 2478 n.a. "carisoprodol; 78-44-4; Isomeprobamate; Carisoprodate; Carisoprodatum; SOMA; Isoprotane; Isoprothane; Carisoma; Isobamate; Sanoma; Isopropyl meprobamate; Skutamil; Miolisodal; Somalgit; Atonalyt; Flexartal; Mioratrina; Somanil; Mioril; Relasom; Nospasm; Flexal; Arusal; Apesan; Carlsoprol; Diolene; Carlsoma; Carlsodol; Brianil; Domarax; Mioriodol; Mediquil; Izoprotan; Isoprotan; Carisol; Caprodat; Calenfa; Stialgin; Somadril; Carsodal; Carisoprodolum; Meprodat; Listaflex; Flexagit; Fibrosona; Chinchen; Carsodol; Flexidon; Flexagilt; Caridolin; Neotica; Artifar" C12H24N2O4 OFZCIYFFPZCNJE-UHFFFAOYSA-N [2-(carbamoyloxymethyl)-2-methylpentyl] N-propan-2-ylcarbamate n.a. n.a. No Yes No Yes No No PMDBD1080 carmustine Therapeutic substance Drug 154-93-8 DB00262 PA448810 D00254 DAP000041 2578 2480 n.a. "carmustine; 154-93-8; 1,3-Bis(2-chloroethyl)-1-nitrosourea; BCNU; Carmustin; Nitrumon; Carmubris; Gliadel; BiCNU; Bi CNU; Carmustinum; Bischloroethyl nitrosourea; Bischlorethylnitrosurea; Bischlorethylnitrosourea; Carmustina; Becenum; N,N''-BIS(2-CHLOROETHYL)-N-NITROSOUREA; 1,3-Bis(2-chloroethyl)nitrosourea; Bis(2-chloroethyl)nitrosourea; NSC-409962; SRI 1720; FDA 0345; Bischloroethylnitrosourea; BiCNU (TN); Carmustinum [INN-Latin]; Carmustina [INN-Spanish]; DTI 015; NCI-C04773; SK 27702; Bis(2-c" C5H9Cl2N3O2 DLGOEMSEDOSKAD-UHFFFAOYSA-N 1,3-bis(2-chloroethyl)-1-nitrosourea n.a. n.a. Yes No No No No No PMDBD150 Carvedilol Therapeutic Substance Approved Drug 72956-09-3 DB01136 PA448817 D00255 DAP000135 2585 2487 n.a. "carvedilol; 72956-09-3; Coreg; Dilatrend; Eucardic; Carvedilolum [Latin]; BM 14190; Carvedilolum; 1-(9H-Carbazol-4-yloxy)-3-[[2-(2-methoxyphenoxy)ethyl]amino]-2-propanol; SKF 105517; BM-14190; 1-((9H-Carbazol-4-yl)oxy)-3-((2-(2-methoxyphenoxy)ethyl)amino)propan-2-ol; Coreg CR; DQ 2466; HSDB 7044; 1-(9H-carbazol-4-yloxy)-3-[2-(2-methoxyphenoxy)ethylamino]propan-2-ol; (+-)-1-(Carbazol-4-yloxy)-3-((2-(o-methoxyphenoxy)ethyl)amino)-2-propanol; Carvedilol phosphate; CHEMBL723; DQ-2466; CHEBI:3441; C24H26N2O4" C24H26N2O4 OGHNVEJMJSYVRP-UHFFFAOYSA-N 1-(9H-carbazol-4-yloxy)-3-[2-(2-methoxyphenoxy)ethylamino]propan-2-ol GlaxoSmithKline plc Vasodilator Agents Yes Yes Yes No No No PMDBD170 Celecoxib "Therapeutic Substance; Herbal Substance" "Approved Drug; Medicinal Herbal Compounds" 169590-42-5 DB00482 PA448871 D00567 DAP000737 2662 2562 NPC316910 "celecoxib; 169590-42-5; Celebrex; Celebra; Onsenal; Celocoxib; Celecox; SC 58635; SC-58635; 4-[5-(4-METHYLPHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-1-YL]BENZENESULFONAMIDE; YM177; 4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide; YM 177; 184007-95-2; HSDB 7038; UNII-JCX84Q7J1L; p-(5-p-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide; SC58635; C17H14F3N3O2S; 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzene-1-sulfonamide; 4-(5-(4-Methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benz" C17H14F3N3O2S RZEKVGVHFLEQIL-UHFFFAOYSA-N 4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide Pfizer Analgesics No Yes No No No Yes CLCXB_GLC_GLCAASE,CLCXB_GLC_GLCAASEe,CLCXB_GLC_GLCAASEepp,CLCXBte,CLCXBtepp,CLCXBtex,EX_clcxb(e) PMDBD175 Cetirizine Therapeutic Substance Approved Drug 83881-51-0 DB00341 PA448905 n.a. DAP000323 2678 2577 n.a. "cetirizine; 83881-51-0; Virlix; Cetirizina; Cetirizin; Setir; Cetryn; Ziptek; Cetirizinum; Zirtek; Cetirizinum [Latin]; Hitrizin Film Tablet; Cetirizina [Spanish]; 2-(2-{4-[(4-chlorophenyl)(phenyl)methyl]piperazin-1-yl}ethoxy)acetic acid; Cetirizine [INN:BAN]; CETIRIZINE HYDROCHLORIDE; CHEMBL1000; C21H25ClN2O3; CHEBI:3561; AC-170; 2-[2-[4-[(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]acetic acid; (2-(4-((4-Chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)acetic acid; (2-{4-[(4-chlorophenyl)(phenyl)methyl]piperazin-1-yl}eth" C21H25ClN2O3 ZKLPARSLTMPFCP-UHFFFAOYSA-N 2-[2-[4-[(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]acetic acid Pfizer Pharmaceuticals Antiallergic Agents No Yes No No No No PMDBD181 Chlormezanone Therapeutic Substance Approved Drug 80-77-3 DB01178 PA448939 D00268 DAP001252 2717 2616 n.a. "chlormezanone; 80-77-3; Chlormethazanone; Trancopal; Chlormethazone; Clormetazon; Chlormezanon; Clormetazanone; Phenarol; dl-Chlormezanone; Trancote; Supotran; Miorilax; Rilaquil; Rilansyl; Clorilax; Rilassol; Myolespen; Tanafol; Bisina; Banabin; Alinam; Rilax; Rexan; Banabin-sintyal; Muskel-Trancopal; Mio-sed; Banabil-sintyal; 2-(4-Chlorophenyl)-3-methyl-1,3-thiazinan-4-one 1,1-dioxide; Chlormezanonum; Tranrilax; Dichloromezanone; Clormezanone [DCIT]; Suprotan; Chlomedinon; Rillasol; Muskel; Lobak; (+-)-Chlormezanone; Clormezanona [INN-Spanish]" C11H12ClNO3S WEQAYVWKMWHEJO-UHFFFAOYSA-N 2-(4-chlorophenyl)-3-methyl-1,1-dioxo-1,3-thiazinan-4-one n.a. Analgesics No Yes No Yes No No PMDBD1108 Chlorothiazide Therapeutic substance Drug 58-94-6 DB00880 PA448953 D00519 DAP000605 2720 2619 n.a. "chlorothiazide; 58-94-6; Chlorthiazide; Diuril; Chlorothiazid; Chlotride; Chlortiazid; Thiazide; Saluretil; Chlorurit; Warduzide; Chlorosal; Yadalan; Salunil; Alurene; Diutrid; Diurilix; Clotride; Salisan; Diuresal; Saluric; Diurite; Urinex; Flumen; Minzil; Neo-Dema; Sk-chlorothiazide; Chlorothiazidum; Chlorthiazidum; Clorotiazida; Chlorthiazid; Aldoclor; 6-Chloro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide; Clorotiazide [DCIT]; 2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-, 1,1-dioxide; Diuril Boluses, Veterinary; Clorotiazida [" C7H6ClN3O4S2 JBMKAUGHUNFTOL-UHFFFAOYSA-N 6-chloro-1,1-dioxo-4H-1lambda6,2,4-benzothiadiazine-7-sulfonamide n.a. n.a. No Yes No No No No PMDBD183 Chloroxine Therapeutic Substance Approved Drug 773-76-2 DB01243 PA164754879 D03472 n.a. 2722 2621 n.a. "chloroxine; 5,7-Dichloroquinolin-8-ol; 773-76-2; 5,7-Dichloro-8-hydroxyquinoline; Chlorquinol; Capitrol; 5,7-Dichloro-8-quinolinol; Dichloroxin; Quixalin; Chloroxyquinoline; Dichloroquinolinol; Dikhloroskin; Quinolor; Endiaron; Clofuzid; Dichlorohydroxyquinoline; Chlofucid; Quesyl; 5,7-Dichlorooxine; 5,7-Dichloroxine; Chlorohydroxyquinoline; 5,7-Dichloro-8-oxyquinoline; Chloroxine [USAN]; 5,7-Dichlor-8-hydroxychinolin; C9H5Cl2NO; NSC 3904; CHQ; UNII-2I8BD50I8B; CCRIS 5751; Capitrol Cream Shampoo; EINECS 212-2" C9H5Cl2NO WDFKMLRRRCGAKS-UHFFFAOYSA-N 5,7-dichloroquinolin-8-ol n.a. n.a. Yes No Yes No No No PMDBD1110 Chlorpropamide Therapeutic substance Drug 94-20-2 DB00672 PA448966 D00271 DAP000923 2727 2626 n.a. "chlorpropamide; 94-20-2; Chloropropamide; Diabinese; Chlorpropamid; Diabenese; Glucamide; Meldian; Diabetoral; Chlorodiabina; Diabeneza; Chloronase; Adiaben; Diabaril; Melitase; Insulase; Dynalase; Catanil; Millinese; Mellinese; Diabenal; Diabechlor; Glisema; Oradian; Asucrol; Diabet-Pages; Diamel Ex; Clorpropamide; Clorpropamid; Prodiaben; Diabexan; 4-chloro-N-(propylcarbamoyl)benzenesulfonamide; 1-(4-Chlorophenylsulfonyl)-3-propylurea; Chlorpropamidum; Clorpropamida; Bioglumin; 1-(p-Chlorobenzenesulfonyl)-3-propylurea; 1-Propyl-3-(p-chlorobe" C10H13ClN2O3S RKWGIWYCVPQPMF-UHFFFAOYSA-N 1-(4-chlorophenyl)sulfonyl-3-propylurea n.a. n.a. No Yes No No No No PMDBD1112 Chlorthalidone Therapeutic substance Drug 77-36-1 DB00310 PA448970 D00272 DAP000521 2732 2631 n.a. "chlorthalidone; Chlortalidone; 77-36-1; Phthalamudine; Chlorphthalidolone; Chlorthalidon; Hygroton; Phthalamodine; Chlorothalidone; Chlorphthalidone; Zambesil; Thalitone; Saluretin; Natriuran; Oradil; Isoren; Igroton; Renon; Hydro-Long; Oxodolin; Chlortalidonum; Famolin; Urolin; Oksodolin (oxodolin); Racemic chlorthalidone; 2-Chloro-5-(1-hydroxy-3-oxoisoindolin-1-yl)benzenesulfonamide; (+-)-Hygroton; Clortalidone [DCIT]; (+-)-Chlorthalidone; Demi-Regroton; Clortalidona [INN-Spanish]; Chlortalidonum [INN-Latin]; G-33182; 1-Keto-3-(3''-sulfam" C14H11ClN2O4S JIVPVXMEBJLZRO-UHFFFAOYSA-N 2-chloro-5-(1-hydroxy-3-oxo-2H-isoindol-1-yl)benzenesulfonamide n.a. n.a. No Yes No No No No PMDBD1113 Chlorzoxazone Therapeutic substance Drug 95-25-0 DB00356 PA448971 D00771 DAP000952 2733 2632 n.a. "chlorzoxazone; 95-25-0; Paraflex; Chlorzoxazon; Chloroxazone; 5-Chloro-2-benzoxazolone; 5-Chloro-2-benzoxazolinone; Biomioran; Myoflexine; Myoflexin; Escoflex; Pathorysin; Solaxin; Miotran; Neoflex; Mioran; 5-Chloro-2-hydroxybenzoxazole; Parafon Forte DSC; 5-Chlorobenzoxazolidone; Chlorzoxane; 5-Chloro-2(3H)-benzoxazolone; 5-Chloro-2-benzoxazolol; Usaf ma-10; 5-Chlorobenzoxazol-2-one; Strifon Forte Dsc; 5-Chloro-1,3-benzoxazol-2(3H)-one; 5-Chlorobenzoxazolone; 2-Hydroxy-5-chlorobenzoxazole; 5-Chlorobenzo" C7H4ClNO2 TZFWDZFKRBELIQ-UHFFFAOYSA-N 5-chloro-3H-1,3-benzoxazol-2-one n.a. n.a. No Yes No No No No PMDBD1116 Cilostazol Therapeutic substance Drug 73963-72-1 DB01166 PA164746334 D01896 DAP000191 2754 2652 n.a. "cilostazol; 73963-72-1; Pletal; Cilostazole; Pletaal; OPC-13013; Cilostazolum; Cilostazolum [INN-Latin]; OPC 13013; OPC 21; OPC-21; 6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydro-2(1H)-quinolinone; UNII-N7Z035406B; CHEBI:31401; C20H27N5O2; 3,4-Dihydro-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-2(1H)-quinolinone; 6-[4-(1-cyclohexyltetrazol-5-yl)butoxy]-3,4-dihydro-1H-quinolin-2-one; 6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one; 6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydrocarbo" C20H27N5O2 RRGUKTPIGVIEKM-UHFFFAOYSA-N 6-[4-(1-cyclohexyltetrazol-5-yl)butoxy]-3,4-dihydro-1H-quinolin-2-one n.a. n.a. No Yes No No No No PMDBD194 Cimetidine Therapeutic Substance Approved Drug 51481-61-9 DB00501 PA449001 D00295 DAP000338 2756 2654 n.a. "cimetidine; 51481-61-9; Tagamet; Eureceptor; Tametin; Ulcedine; Dyspamet; Cimetag; Acinil; Ulcedin; Tratul; Gastromet; Acibilin; Edalene; Cimetum; Ulcomet; Ulcimet; Cimal; Ulhys; Tagamet Hb; Tagamet Hb 200; Cimetidine Hcl; Ulcomedina; Cimetidina; Valmagen; Metracin; SKF-92334; Ulcofalk; Ulcestop; Cimetidinum; Gastrobitan; Evicer; Peptol; SKF 92334; Cimetidinum [INN-Latin]; Cimetidina [INN-Spanish]; 2-Cyano-1-methyl-3-(2-(((5-methylimidazol-4-yl)methyl)thio)ethyl)guanidine; N-Cyano-N''-methyl-N''''-[2-[[(4-methyl-1H-imidazol-5-yl)methyl]thio]ethyl" C10H16N6S AQIXAKUUQRKLND-UHFFFAOYSA-N 1-cyano-2-methyl-3-[2-[(5-methyl-1H-imidazol-4-yl)methylsulfanyl]ethyl]guanidine GlaxoSmithKline Antiulcer Agents No Yes No No No No PMDBD196 Cinnarizine Therapeutic Substance Approved Drug 298-57-7 DB00568 PA164749342 D01295 DAP000325 2761 1264793 n.a. "1-(diphenylmethyl)-4-(3-phenylprop-2-enyl)piperazine; 1-Cinnamyl-4-diphenylmethylpiperazine; Prestwick1_000278; Prestwick0_000278; 1-(Diphenylmethyl)-4-(3-phenyl-2-propen-1-yl)piperazine; Oprea1_696883; SPBio_002375; CTK4D2521; HMS3372L16; KS-000048IA; DB00568; MCULE-5586055809; DB-047662; C3459; FT-0665055; FT-0623849; FT-0665054; Q27224950; 1-(diphenylmethyl)-4-(3-phenyl-2-propenyl) piperazine" C26H28N2 DERZBLKQOCDDDZ-UHFFFAOYSA-N 1-benzhydryl-4-(3-phenylprop-2-enyl)piperazine n.a. n.a. Yes No No No No No PMDBD197 Cinoxacin Therapeutic Substance Approved Drug 28657-80-9 DB00827 PA449007 D00872 DAP000999 2762 2660 n.a. "cinoxacin; 28657-80-9; Cinobac; Compound 64716; Cinoxacino; Cinoxacine; Cinoxacinum; Cinobactin; Uronorm; Cinx; Cinoxacine [INN-French]; Cinoxacinum [INN-Latin]; Cinoxacino [INN-Spanish]; UNII-LMK22VUH23; 1-Ethyl-6,7-methylenedioxy-4(1H)-oxocinnoline-3-carboxylic acid; NSC 304467; MLS000069630; EINECS 249-133-8; 1-ethyl-4-oxo-[1,3]dioxolo[4,5-g]cinnoline-3-carboxylic acid; BRN 1084304; LMK22VUH23; SMR000058232; 1-Ethyl-1,4-dihydro-4-oxo(1,3)dioxolo(4,5-g)cinnoline-3-carboxylic acid; CHEBI:3716; C12H10N2O5; [1,3]Dioxolo[4,5-g]cinnol" C12H10N2O5 VDUWPHTZYNWKRN-UHFFFAOYSA-N 1-ethyl-4-oxo-[1,3]dioxolo[4,5-g]cinnoline-3-carboxylic acid n.a. Antiinfective Agents Yes No No No No No PMDBD1118 Ciprofloxacin Therapeutic substance Antibiotics 85721-33-1 DB00537 PA449009 D00186 DAP001360 2764 2662 n.a. "ciprofloxacin; 85721-33-1; Ciprofloxacine; Ciprobay; Ciproxan; Cipro; Ciprofloxacina; Cipro IV; Ciprofloxacinum; Ciprofloxacino; Ciproquinol; Cipromycin; Ciproflox; Ciprocinol; Ciprodar; Cifloxin; Ciproxina; Ciprinol; Bernoflox; Septicide; Bacquinor; Cipro XR; Ciloxan; 1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid; Cetraxal; 1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid; Spitacin; Quintor; Quinolid; Proflaxin; Probiox; Ipiflox; Roxytal; Italnik; Fimoflox; Corsac" C17H18FN3O3 MYSWGUAQZAJSOK-UHFFFAOYSA-N 1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid n.a. n.a. Yes Yes No No No No PMDBD1120 Citalopram Therapeutic substance Drug 59729-33-8 DB00215 PA449015 D07704 DAP000118 2771 2669 n.a. "citalopram; 59729-33-8; Nitalapram; Celexa; Cipram; Citalopramum [INN-Latin]; Bonitrile; [3H]Citalopram; 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile; Lu-10-171; Lu 10-171; C20H21FN2O; EINECS 261-891-1; CHEMBL549; 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile; 1-(3-(Dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile; CHEBI:77397; 1-(3-(Dimethylamino)propyl)-1-(p-fluorophenyl)-5-phthalancarbonitrile; 1,3-Dihydro-1-(3-(dimet" C20H21FN2O WSEQXVZVJXJVFP-UHFFFAOYSA-N 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile n.a. n.a. No Yes No No No No PMDBD209 Clioquinol Therapeutic Substance Approved Drug 130-26-7 DB04815 PA449039 n.a. n.a. 2788 2686 n.a. "clioquinol; 130-26-7; 5-Chloro-7-iodoquinolin-8-ol; Iodochlorhydroxyquin; Chinoform; Chloroiodoquin; Chloroiodoquine; 5-Chloro-8-hydroxy-7-iodoquinoline; Iodochloroxyquinoline; Cliquinol; Vioform; Iodochlorohydroxyquinoline; Chlorojodochin; Iodochloroxine; Iodochloroquine; Enteroquinol; Iodoenterol; 7-Iodo-5-chloroxine; Entero-Vioform; 5-Chloro-7-iodo-8-quinolinol; Iodochlorhydroxyquinoline; Iodoxyquinoline; Iodenterol; Entrokin; Enteroseptol; Domeform; Barquinol; Rheaform; Quinoform; Quinambicide; Lekosept; Dioquinol; Dermaform; Entersept" C9H5ClINO QCDFBFJGMNKBDO-UHFFFAOYSA-N 5-chloro-7-iodoquinolin-8-ol n.a. n.a. Yes No Yes No No No PMDBD1123 Clobazam Therapeutic substance Drug 22316-47-8 DB00349 PA10888 D01253 DAP000672 2789 2687 n.a. "Clobazam; Urbanyl; Frisium; Chlorepin; Clorepin; 22316-47-8; Urbadan; Onfi; LM-2717; Clobazamum; HR 376; RU-4723; H-4723; Clobazamum [INN-Latin]; LM 2717; 7-Chloro-1-methyl-5-phenyl-1H-1,5-benzodiazepine-2,4(3H,5H)-dione; H 4723; UNII-2MRO291B4U; 7-chloro-1-methyl-5-phenyl-1,5-benzodiazepine-2,4-dione; NSC 336279; 1-Phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1,5-benzodiazepine; CCRIS 7506; CHEBI:31413; EINECS 244-908-7; HR-376; BRN 0758410" C16H13ClN2O2 CXOXHMZGEKVPMT-UHFFFAOYSA-N 7-chloro-1-methyl-5-phenyl-1,5-benzodiazepine-2,4-dione n.a. n.a. No Yes No No No No PMDBD210 Clofazimine "Therapeutic Substance; Herbal Substance" antimicrobial 2030-63-9 DB00845 PA164748759 D00278 DAP000789 2794 2692 NPC469949 "clofazimine; 2030-63-9; Lamprene; Lampren; Chlofazimine; Clofazimina; Clofaziminum; Clofaziminum [INN-Latin]; B 663 (Pharmaceutical); Clofazimina [INN-Spanish]; NSC-141046; B-663; G 30320; N,5-bis(4-chlorophenyl)-3-propan-2-yliminophenazin-2-amine; UNII-D959AE5USF; B 663 (VAN); C27H22Cl2N4; 3-(p-Chloranilino)-10-(p-chlorphenyl)-2,10-dihydro-2-(isopropylimino)-phenazin; B 663; 3-(p-Chloroanilino)-10-(p-chlorophenyl)-2,10-dihydro-2-(isopropylimino)phenazine" C27H22Cl2N4 WDQPAMHFFCXSNU-UHFFFAOYSA-N N,5-bis(4-chlorophenyl)-3-propan-2-yliminophenazin-2-amine Norvatis Phamaceuticals Corporation Antiinflammatory Agents Yes Yes Yes No No No PMDBD1126 Clomipramine Therapeutic substance Drug 303-49-1 DB01242 PA449048 D00811 DAP000742 2801 2699 n.a. "clomipramine; Chlorimipramine; 303-49-1; Monochlorimipramine; 3-Chloroimipramine; Hydiphen; Anafranil base; Anafranil (free base); 3-(3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine; Clomipraminum [INN-Latin]; Clomipramina [INN-Spanish]; Clomipramine [INN:BAN]; Clomicalm; NSC 169865; UNII-NUV44L116D; 3-Chloro-5-(3-(dimethylamino)propyl)-10,11-dihydro-5H-dibenz(b,f)azepine; Anafranil (TN); EINECS 206-144-2; G 34586; BRN 1323" C19H23ClN2 GDLIGKIOYRNHDA-UHFFFAOYSA-N 3-(2-chloro-5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethylpropan-1-amine n.a. n.a. No Yes No No No No PMDBD214 Clonazepam Therapeutic Substance Central nervous system agents 1622-61-3 DB01068 PA449050 D00280 DAP000259 2802 2700 n.a. "clonazepam; Klonopin; Rivotril; Chlonazepam; Iktorivil; Cloazepam; Antelepsin; 1622-61-3; Clonazepamum; Clonopin; Landsen; Antilepsin; Lonazep; Kenoket; Paxam; Clonex; Solfidin; Lktorivil; Alti-Clonazepam; Ro 4-8180; Ro 5-4023; Klonopin Rapidly Disintegrating; Clonazepamum [INN-Latin]; 5-(2-chlorophenyl)-7-nitro-1,3-dihydro-1,4-benzodiazepin-2-one; 1,3-Dihydro-7-nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one; UNII-5PE9FDE8GB; 5-(2-Chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one; 2H-1,4-Benzodiazepin-2-one, 5-(2-chlo" C15H10ClN3O3 DGBIGWXXNGSACT-UHFFFAOYSA-N 5-(2-chlorophenyl)-7-nitro-1,3-dihydro-1,4-benzodiazepin-2-one Roche Pharmaceuticals Anticonvulsants No Yes No No No Yes CZP_NR,CZP_NRe,EX_czp(e),tCZPpp PMDBD215 Clonidine Therapeutic Substance Approved Drug 4205-90-7 DB00575 PA449051 D00281 DAP000231 2803 2701 n.a. "clonidine; 4205-90-7; Clonidin; Catapres; Duraclon; Chlornidinum; Catapres-TTS; Catarpresan; Catarpres; Adesipress; Catapressan; ST 155BS; N-(2,6-Dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine; ST-155-BS; Catapresan; Clonidinum [INN-Latin]; Clonidinhydrochlorid; CATAPRES-TTS-3; CATAPRES-TTS-1; CATAPRES-TTS-2; 2-(2,6-Dichloroanilino)-2-imidazoline; SKF 34427; Catapres- TTS; Clonidina [INN-Spanish]; M-5041T; Hemiton; CLORPRES; 2-((2,6-Dichlorophenyl)imino)imidazolidine; clonidine (amino form); 2-(2,6-Dichloroanilino)-1,3-diazacyclopente" C9H9Cl2N3 GJSURZIOUXUGAL-UHFFFAOYSA-N N-(2,6-dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine Intas Pharmaceuticals Antihypertensive Agents No Yes No No No No PMDBD218 Clotrimazole Therapeutic Substance Approved Drug 23593-75-1 DB00257 PA449057 D00282 DAP000138 2812 2710 n.a. "clotrimazole; 23593-75-1; Lotrimin; Canesten; Mycelex; Mycosporin; Clotrimazol; Empecid; Mykosporin; Gyne lotrimin; Trimysten; Chlotrimazole; 1-(o-Chlorotrityl)imidazole; Mycelex G; Rimazole; Tibatin; Mycelex 7; Mono-baycuten; Mycelex Troches; Lotrimin AF Cream; Gyne-Lotrimin; Mycelex OTC; Lotrimin AF Solution; Pedisafe; Canestine; Veltrim; Gynix; Lotrimin Af; Trivagizole 3; Desamix F; Mycelex-G; Fem Care; Gyne-Lotrimin 3; Mycelex-7; Monobaycuten; Clotrimazolum; Canifug; 1-((2-Chlorophenyl)diphenylmethyl)-1H-imidazole; (Chlorotrityl)imidazole" C22H17ClN2 VNFPBHJOKIVQEB-UHFFFAOYSA-N 1-[(2-chlorophenyl)-diphenylmethyl]imidazole Bayer Pharmaceuticals Corporation Antifungal Agents Yes No Yes No No No PMDBD1128 Clozapine Therapeutic substance Drug 5786-21-0 DB00363 PA449061 D00283 DAP000029 135398737 10442628 n.a. "clozapine; 5786-21-0; Leponex; Clozapin; Fazaclo; CLOZARIL; Clorazil; Iprox; Clozapina; Clozapinum; HF-1854; Clozapinum [INN-Latin]; W-801; Clozapina [INN-Spanish]; HF 1854; 8-Chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo[b,e][1,4]diazepine; 8-chloro-11-(4-methylpiperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine; UNII-J60AR2IKIC; CCRIS 9171; HSDB 6478; 8-Chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo(b,e)(1,4)diazepine; CHEMBL42; EINECS 227-313-7; J60AR2IKIC; BRN 07649" C18H19ClN4 QZUDBNBUXVUHMW-UHFFFAOYSA-N 3-chloro-6-(4-methylpiperazin-1-yl)-11H-benzo[b][1,4]benzodiazepine n.a. n.a. No Yes No No No No PMDBD223 Colchicine "Therapeutic Substance; Herbal Substance" "Approved Drug; Medicinal Herbal Compounds" 64-86-8 DB01394 PA449092 D00570 DAP001254 2833 2731 NPC226941 "Colchine; 64-86-8; (R/S)-Colchicine; 209810-38-8; CHEBI:23359; (S)-(-)-colchicine; 54192-66-4; N-(1,2,3,10-Tetramethoxy-9-oxo-5,6,7,9-tetrahydrobenzo[a]heptalen-7-yl)acetamide; (+)-Colchicine; MFCD00078484; Colchicine;colchicine; CHEMBL87; (S)-Colchicine >95%; Epitope ID:141498; (+-)-COLCHICINE; Neuro_000002; KSC621O9T; MLS001181527; SCHEMBL675246; CTK5C1799; DTXSID20274387; HMS3414L21; HMS3678L19; HMS3267B14; HMS2875H17; BCP09065; CC0177; AC-2" C22H25NO6 IAKHMKGGTNLKSZ-UHFFFAOYSA-N N-(1,2,3,10-tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl)acetamide n.a. n.a. No Yes No Yes No No PMDBD234 Cyclobenzaprine Therapeutic Substance Approved Drug 303-53-7 DB00924 PA449160 D07758 DAP000891 2895 2792 n.a. "cyclobenzaprine; Proheptatriene; 303-53-7; Proheptatrien; Proeptatriene; Lisseril; Ciclobenzaprina; Fexmid; Cyclobenzaprinum; 10,11-Dehydroamitriptyline; Cyclobenzaprine [INN]; Proeptatriene [Italian]; Yurelax; Cyclobenzaprinum [INN-Latin]; MK 130; Ciclobenzaprina [INN-Spanish]; Ro 4-1577; UNII-69O5WQQ5TI; Cyclobenzaprine (INN); EINECS 206-145-8; Flexeril hydrochloride; 3-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine; 69O5WQQ5TI; 9715 R.P; CHEBI:3996; 5-(3-Dimetilaminopropiliden)-5H-dibenzo-(a,d)-ciclopentene" C20H21N JURKNVYFZMSNLP-UHFFFAOYSA-N N,N-dimethyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenylidene)propan-1-amine Janssen Research And Development Llc Antidepressants No Yes No Yes No No PMDBD236 Cyclopenthiazide Therapeutic Substance Approved Drug 742-20-1 DB13532 n.a. n.a. n.a. 2904 2801 n.a. "cyclopenthiazide; Cyclomethiazide; 742-20-1; Benesal; Cyclopentiazid; Cyclometiazid; Navidreks; Navidrex; Salimid; Salimed; Ultra-Minzil; Salurilo-C; Navidrix; Tsiklometiazid; Ciba 8341-Su; SU 8341; Su-8341; 3-Cyclopentylmethyl hydrochlorothiazide deriv; UNII-866GEV195O; UNII-T7817XC41U; MLS000737270; 2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3-(cyclopentylmethyl)-3,4-dihydro-, 1,1-dioxide; 6-Chloro-3-(cyclopentylmethyl)-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide; T7817XC41U; 866GEV195O; NSC107679; NSC-1" C13H18ClN3O4S2 BKYKPTRYDKTTJY-UHFFFAOYSA-N 6-chloro-3-(cyclopentylmethyl)-1,1-dioxo-3,4-dihydro-2H-1lambda6,2,4-benzothiadiazine-7-sulfonamide n.a. n.a. Yes No Yes No No No PMDBD237 Cyclophosphamide Therapeutic Substance lymphoma and leukemia 50-18-0 DB00531 PA449165 D07760 DAP000532 2907 2804 n.a. "cyclophosphamide; 50-18-0; Cyclophosphamid; Cyclophosphane; Neosar; Cytoxan; Cytophosphan; Procytox; Clafen; Endoxan; Cyclophosphan; Cyclostin; Sendoxan; Cyclophosphamidum; Cytophosphane; Endoxana; Endoxanal; Claphene; Genoxal; Endoxan-Asta; Endoxan R; Zyklophosphamid; Mitoxan; (RS)-Cyclophosphamide; (+-)-Cyclophosphamide; Cyclophosphoramide; Cyklofosfamid; Cyclofosphamide; Senduxan; Enduxan; Endoxane; Semdoxan; Cyclophosphanum; Ciclophosphamide; Cyclophosphamide anhydrous; Rcra waste number U058; Asta B 518; D,L-Cyclophosphamide; Cycloblastin" C7H15Cl2N2O2P CMSMOCZEIVJLDB-UHFFFAOYSA-N N,N-bis(2-chloroethyl)-2-oxo-1,3,2lambda5-oxazaphosphinan-2-amine Baxter International Inc Anticancer Agents Yes Yes Yes Yes No No PMDBD1135 Cyproheptadine Therapeutic substance Drug 129-03-3 DB00434 PA164749366 n.a. DAP000103 2913 2810 n.a. "CYPROHEPTADINE; Periactin; 129-03-3; Eiproheptadine; Periactinol; Dronactin; 4-(5H-dibenzo[a,d][7]annulen-5-ylidene)-1-methylpiperidine; Cyproheptadinum; Ciproheptadina; MK 141; Cyproheptadine [INN:BAN]; Cyproheptadinum [INN-Latin]; Ciproheptadina [INN-Spanish]; 4-(5H-Dibenzo(a,d)cyclohepten-5-ylidene)-1-methylpiperidine; 1-Methyl-4-(5H-dibenzo(a,d)cycloheptenylidene)piperidine; 5-(1-Methylpiperidylidene-4)-5H-dibenzo(a,d)cyclopheptene; 1-Methyl-4-(5-dibenzo(a,e)cycloheptatrienylidene)piperidine; 4-(5-Dibenzo(a,d)cyclohepte" C21H21N JJCFRYNCJDLXIK-UHFFFAOYSA-N 1-methyl-4-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenylidene)piperidine n.a. n.a. No Yes No No No No PMDBD1139 Dapsone Therapeutic substance Drug 80-08-0 DB00250 PA449211 D00592 DAP000637 2955 2849 n.a. "dapsone; 80-08-0; Diaphenylsulfone; 4,4''-Sulfonyldianiline; Dapson; 4-Aminophenyl sulfone; 4,4''-Diaminodiphenyl sulfone; 4,4''-Diaminodiphenylsulfone; Diaphenylsulfon; Sulfona; DADPS; Sulphadione; Avlosulfone; Sulfadione; Diphenasone; Disulone; Udolac; p-Aminophenyl sulfone; Bis(4-aminophenyl) sulfone; Croysulfone; Novophone; Dapsonum; Dumitone; Avlosulfon; Aczone; Eporal; Diphone; Diaphenylsulphon; Metabolite C; Diaphenylsulphone; Sulfonyldianiline; Sumicure S; Sulphonyldianiline; Bis(p-aminophenyl) sulfone; p,p-Sulphonylbisbenzamine; Sulfon" C12H12N2O2S MQJKPEGWNLWLTK-UHFFFAOYSA-N 4-(4-aminophenyl)sulfonylaniline n.a. n.a. No Yes No No No No PMDBD1148 Desipramine Therapeutic substance Drug 50-47-5 DB01151 PA449233 D07791 DAP001151 2995 2888 n.a. "desipramine; Norimipramine; Desmethylimipramine; Desipramin; 50-47-5; Demethylimipramine; Monodemethylimipramine; Desimipramine; Dimethylimipramine; Dezipramine; 3-(10,11-DIHYDRO-5H-DIBENZO[B,F]AZEPIN-5-YL)-N-METHYLPROPAN-1-AMINE; Methylaminopropyliminodibenzyl; desipraminum; Desimpramine; Sertofran; Norpramine; Desipramina; DMI (pharmaceutical); N-(3-Methylaminopropyl)iminobibenzyl; 5-(gamma-Methylaminopropyl)iminodibenzyl; Desipramine (D4); DMI 50475; Desipramine [INN:BAN]; Desipraminum [INN-Latin]; Desipra" C18H22N2 HCYAFALTSJYZDH-UHFFFAOYSA-N 3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N-methylpropan-1-amine n.a. n.a. No Yes No No No No PMDBD1154 Diazepam Therapeutic substance Drug 439-14-5 DB00829 PA449283 D00293 DNC000549 3016 2908 n.a. "diazepam; Valium; 439-14-5; Diazemuls; Ansiolisina; Stesolid; Seduxen; Sibazon; Relanium; Faustan; Apaurin; Methyldiazepinone; Unisedil; Stesolin; Serenamin; Ruhsitus; Renborin; Quievita; Valitran; Tranqdyn; Seduksen; Relaminal; Quiatril; Quetinil; Dipezona; Diazetard; Diazepan; Calmpose; Tranimul; Tensopam; Serenack; Paranten; Kiatrium; Domalium; Condition; Bialzepam; Ansiolin; Tranquirit; Serenzin; Neurolytril; Liberetas; Diacepan; Ceregulart; Calmocitene; Bensedin; Atensine; Apozepam; Velium; Plidan; Paxate; Morosan; Umbrium; Sonacon; Sedipam; Levium; Diapam" C16H13ClN2O AAOVKJBEBIDNHE-UHFFFAOYSA-N 7-chloro-1-methyl-5-phenyl-3H-1,4-benzodiazepin-2-one n.a. n.a. No Yes No No No No PMDBD1156 Diazoxide Therapeutic substance Drug 364-98-7 DB01119 PA449285 D00294 DAP000956 3019 2911 n.a. "diazoxide; 364-98-7; Proglycem; Hyperstat; Eudemine; Hypertonalum; Proglicem; Dizoxide; Mutabase; 7-Chloro-3-methyl-2H-1,2,4-benzothiadiazine 1,1-dioxide; Diazossido; Sch-6783; Diazoxidum; Diazoxido; Sch 6783; Diazossido [Italian]; SRG-95213; Diazossido [DCIT]; SRG 95213; 2H-1,2,4-Benzothiadiazine, 7-chloro-3-methyl-, 1,1-dioxide; Diazoxidum [INN-Latin]; Diazoxido [INN-Spanish]; C8H7ClN2O2S; UNII-O5CB12L4FN; NSC-64198; NSC 76130; CHEBI:4495; EINECS 206-668-1; NSC 64198; O5CB12L4FN; MLS000028459; 7-Cloro-3-metil-2H-1,2,4-benzotiodiazina-1" C8H7ClN2O2S GDLBFKVLRPITMI-UHFFFAOYSA-N 7-chloro-3-methyl-4H-1lambda6,2,4-benzothiadiazine 1,1-dioxide n.a. n.a. No Yes No No No No PMDBD263 Diclofenac Therapeutic Substance anti-inflammatory 15307-86-5 DB00586 PA449293 D07816 DAP000620 3033 2925 n.a. "diclofenac; 15307-86-5; Diclofenac acid; dichlofenac; Voltaren; Diclofenacum; Diclophenac; 2-(2-((2,6-Dichlorophenyl)amino)phenyl)acetic acid; Diclofenaco; ProSorb-D; Voltarol; Diclofenac resinate; Pennsaid; 2-((2,6-Dichlorophenyl)amino)benzeneacetic acid; 2-(2,6-Dichloroanilino)phenylacetic Acid; Diclofenacum [INN-Latin]; Diclofenaco [INN-Spanish]; Solaraze; 2-[2-(2,6-dichloroanilino)phenyl]acetic acid; UNII-144O8QL0L1; {2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid; CHEBI:4" C14H11Cl2NO2 DCOPUUMXTXDBNB-UHFFFAOYSA-N 2-[2-(2,6-dichloroanilino)phenyl]acetic acid Novartis Pharmaceuticals Corp Neurology Agents No Yes No Yes No Yes DCF_GLC_GLCAASE,DCF_GLC_GLCAASEe,DCF_GLC_GLCAASEepp,DCFte,DCFtepp,DCFtex,EX_dcf(e) PMDBD266 Dicyclomine Therapeutic Substance Approved Drug 77-19-0 DB00804 PA164744928 n.a. DAP001118 3042 2934 n.a. "dicyclomine; Dicycloverin; Dicycloverine; Bentyl; Bentylol; Wyovin; Diocyl; Di-syntramine; Dicicloverina; 77-19-0; Dicycloverinum; Merbentyl; Dicycloverinum [INN-Latin]; Dicicloverina [INN-Spanish]; Bentyl hydrochloride; Dicycloverine [INN:BAN]; UNII-4KV4X8IF6V; Bentylol hydrochloride; Dicycloverin hydrochloride; HSDB 3058; [1,1''-Bicyclohexyl]-1-carboxylic acid, 2-(diethylamino)ethyl ester; EINECS 201-009-4; Bicyclohexyl-1-carbonsaeure-2''diethylaminoethylester; (1,1''-Bicyclohexyl)-1-carboxylic acid, 2-(diethylamino)ethyl ester; 4K" C19H35NO2 CURUTKGFNZGFSE-UHFFFAOYSA-N 2-(diethylamino)ethyl 1-cyclohexylcyclohexane-1-carboxylate Peckforton Pharmaceuticals Anticholinergic Agents No Yes No No No No PMDBD273 Diethylstilbestrol Therapeutic Substance Approved Drug 56-53-1 DB00255 PA449307 D00577 DAP001011 3054 395306 n.a. "cis-Diethyl Stilbestrol; 6898-97-1; 4-[4-(4-hydroxyphenyl)hex-3-en-3-yl]phenol; (Z,E)-Diethylstilbestrol; 4,4''-hex-3-ene-3,4-diyldiphenol; cis-Diethylstilbestrol; DSSTox_RID_79594; DSSTox_CID_20770; DSSTox_GSID_40770; CCRIS 9140; 22610-99-7; CAS-6898-97-1; AI3-17297; C18H20O2; Stilbestrol;DES; NCGC00090749-04; Diethylstilbestrol BP; Spectrum_000940; Diethylstilbestrol,(S); Spectrum3_000391; Spectrum2_000148; Spectrum4_000512; Prestwick0_000756; Prestwick1_000756; ACMC-209o5h; Oprea1_042" C18H20O2 RGLYKWWBQGJZGM-UHFFFAOYSA-N 4-[4-(4-hydroxyphenyl)hex-3-en-3-yl]phenol n.a. n.a. Yes No Yes No No No PMDBD1160 Diflunisal Therapeutic substance Drug 22494-42-4 DB00861 PA449313 D00130 DAP000152 3059 2951 n.a. "diflunisal; 22494-42-4; Dolobid; Fluniget; Dolobis; Flovacil; Fluodonil; Flustar; Adomal; 5-(2,4-Difluorophenyl)salicylic acid; Citidol; Noaldol; Algobid; Unisal; Reuflos; 5-(2,4-difluorophenyl)-2-hydroxybenzoic acid; MK-647; Diflusinal; MK 647; Diflunisalum [INN-Latin]; 2-(Hydroxy)-5-(2,4-difluorophenyl)benzoic acid; 2'',4''-Difluoro-4-hydroxy-3-biphenylcarboxylic acid; 5-[2,4-Difluorophenyl]salicylic acid; UNII-7C546U4DEN; 5-(2,4-DIFLUOROPHENYL)-2-HYDROXY-BENZOIC ACID; 2''" C13H8F2O3 HUPFGZXOMWLGNK-UHFFFAOYSA-N 5-(2,4-difluorophenyl)-2-hydroxybenzoic acid n.a. n.a. No Yes No No No No PMDBD1162 Diphenhydramine Therapeutic substance Drug 58-73-1 DB01075 PA449349 D00300 DAP000490 3100 2989 n.a. "diphenhydramine; 58-73-1; Benadryl; Benzhydramine; Probedryl; Alledryl; Dihidral; 2-(Benzhydryloxy)-N,N-dimethylethanamine; Antistominum; Benzhydroamina; Benzhydraminum; Diphantine; Difenhydramin; Ibiodral; Difedryl; Dibondrin; Debendrin; Benadrin; Syntedril; Novamina; Medidryl; Hyadrine; Histaxin; Drylistan; Diabylen; Diabenyl; Dermodrin; Benodine; Baramine; Allergical; Mephadryl; Desentol; Dermistina; Betramin; Benzhydril; Benzantine; Benachlor; Bagodryl; Dabylen; Antomin; Dylamon; Benylin; Benylan; Benodin; Amidryl; Benapon; Nausen; Diphenylhydramine" C17H21NO ZZVUWRFHKOJYTH-UHFFFAOYSA-N 2-benzhydryloxy-N,N-dimethylethanamine n.a. n.a. No Yes No No No No PMDBD285 Diphenylpyraline Therapeutic Substance Approved Drug 147-20-6 DB01146 PA164746377 D07862 DAP001071 3103 2992 n.a. "diphenylpyraline; Hispril; Diphenylpyrilene; Allergen; Diphenylpyralamine; 147-20-6; Lyssipoll; Histyn; Mepiben; Histryl; Dayfen; Neargal; Belfene; 4-(Diphenylmethoxy)-1-methylpiperidine; Difenilpiralina; Diphenylpyralinum; 4-(Benzhydryloxy)-1-methylpiperidine; 1-Methyl-4-piperidyl benzhydryl ether; AN 1041; Diphenylpyraline [INN:BAN]; Difenilpiralina [INN-Spanish]; Diphenylpyralinum [INN-Latin]; 4-benzhydryloxy-1-methylpiperidine; UNII-33361OE3AV; EINECS 205-686-7; 4-(benzhydryloxy)-N-methylpiperidine; PIPERIDINE, 4-(DIPHENYLMETHOX" C19H23NO OWQUZNMMYNAXSL-UHFFFAOYSA-N 4-benzhydryloxy-1-methylpiperidine n.a. Antihistamines No Yes No No No No PMDBD286 Dipyridamole Therapeutic Substance Approved Drug 58-32-2 DB00975 PA449367 D00302 DNC001625 3108 2997 n.a. "dipyridamole; 58-32-2; Dipyridamol; Persantin; Dipyridamine; Dipyudamine; Persantine; Curantyl; Stimolcardio; Kurantil; Stenocardil; Cardoxin; Dipyridan; Dipiridamol; Cardioflux; Peridamol; Coroxin; Apricor; Anginal; Corosan; Coribon; Stenocardiol; Permiltin; Justpertin; Chilcolan; Agilease; Piroan; Cleridium 150; Prandiol; Gulliostin; Coronarine; Natyl; Prandiol 75; Usaf Ge-12; Dypyridamol; Iv Persantine; Dipyridamolum; RA 8; 2,2'',2'''',2''''''-((4,8-Di(piperidin-1-yl)pyrimido[5,4-d]pyrimidine-2,6-diyl)bis(azanetriyl))tetraethanol; RA-8; Dipiridamol " C24H40N8O4 IZEKFCXSFNUWAM-UHFFFAOYSA-N 2-[[2-[bis(2-hydroxyethyl)amino]-4,8-di(piperidin-1-yl)pyrimido[5,4-d]pyrimidin-6-yl]-(2-hydroxyethyl)amino]ethanol FISCHER and ROCH Vasodilator Agents No Yes No Yes No No PMDBD1163 Disopyramide Therapeutic substance Drug 5/9/3737 DB00280 PA449373 D00303 DAP000504 3114 3002 n.a. "disopyramide; 3737-09-5; Dicorantil; Rythmodan; Ritmodan; Disopiramida; Searle 703; Disopyramidum; Disopyramidum [INN-Latin]; Disopiramida [INN-Spanish]; SC 7031; alpha-Diisopropylaminoethyl-alpha-phenylpyridine-2-acetamide; SC-7031; gamma-Diisopropylamino-alpha-phenyl-alpha-(2-pyridyl)butyramide; H 3292; CHEMBL517; alpha-(2-(Diisopropylamino)ethyl)-alpha-phenyl-2-pyridineacetamide; CHEBI:4657; EINECS 223-110-2; 4-(diisopropylamino)-2-phenyl-2-pyridin-2-ylbutanamide; NCGC00015358-18; Lispine" C21H29N3O UVTNFZQICZKOEM-UHFFFAOYSA-N 4-[di(propan-2-yl)amino]-2-phenyl-2-pyridin-2-ylbutanamide n.a. n.a. No Yes No No No No PMDBD288 Disulfiram Therapeutic Substance Approved Drug 97-77-8 DB00822 PA449376 D00131 DAP000012 3117 3005 n.a. "disulfiram; Tetraethylthiuram disulfide; 97-77-8; Antabuse; Antabus; Bis(diethylthiocarbamoyl) disulfide; Esperal; Anticol; Alcophobin; Teturam; TETD; Exhorran; Dicupral; Hoca; Ethyldithiurame; Antietanol; Antaethyl; Tetradine; Antivitium; Abstensil; Teturamin; Tetraetil; Contralin; Antalcol; Antadix; Cronetal; Antikol; Antietil; Refusal; Krotenal; Averzan; Antetil; Antetan; Abstinyl; Aversan; Abstinil; Etabus; Ethyl tuads; Ethyl Thiram; Ethyl Thiurad; Ethyl Tuex; Thiuranide; Ephorran; Antaetil; Disulfan; Antaenyl; Stopetyl; Disulfuram; Contrapot; Antiaet" C10H20N2S4 AUZONCFQVSMFAP-UHFFFAOYSA-N diethylcarbamothioylsulfanyl N,N-diethylcarbamodithioate Odyssey Pharmaceuticals Alcohol Deterrents Yes No No No No No PMDBD1167 Donepezil Therapeutic substance Drug 120014-06-4 DB00843 PA449394 D00670 DAP000560 3152 3040 n.a. "donepezil; 120014-06-4; Aricept; 2-((1-Benzylpiperidin-4-yl)methyl)-5,6-dimethoxy-2,3-dihydro-1H-inden-1-one; Donepezil [INN:BAN]; 2-[(1-benzyl-4-piperidyl)methyl]-5,6-dimethoxy-2,3-dihydroinden-1-one; HSDB 7743; 2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxy-2,3-dihydro-1H-inden-1-one; CHEMBL502; CHEBI:53289; C24H29NO3; donepezilo; 2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxy-2,3-dihydroinden-1-one; 1H-Inden-1-one, 2,3-dihydro-5" C24H29NO3 ADEBPBSSDYVVLD-UHFFFAOYSA-N 2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxy-2,3-dihydroinden-1-one n.a. n.a. No Yes No No No No PMDBD295 Ebselen Therapeutic Substance Investigational Drug 60940-34-3 DB12610 n.a. n.a. n.a. 3194 3082 n.a. "ebselen; 60940-34-3; 2-Phenyl-1,2-benzisoselenazol-3(2H)-one; 2-phenyl-1,2-benzoselenazol-3-one; Ebseleno; Ebselenum; Ebselene; SPI-1005; Ebselene [French]; Ebselenum [Latin]; Ebseleno [Spanish]; Ebselen [INN]; 2-phenylbenzo[d][1,2]selenazol-3(2H)-one; PZ 51; Harmokisane; PZ-51; C13H9NOSe; DR-3305; UNII-40X2P7DPGH; MLS000028488; CCRIS 3714; PZ51; 2-Phenyl-1,2-benzisoselenazolin-3-one; SMR000058445; 2-phenyl-1,2-benzoisoselenazol-3(2H)-one; CHEMBL51085; NSC 639762; DR 3305; Prestwick_1057; RP 60" C13H9NOSe DYEFUKCXAQOFHX-UHFFFAOYSA-N 2-phenyl-1,2-benzoselenazol-3-one n.a. Fibrinolytic Agents Yes No Yes No No No PMDBD304 Enoxacin Therapeutic Substance Approved Drug 74011-58-8 DB00467 PA449462 D00310 DAP001000 3229 3116 n.a. "enoxacin; 74011-58-8; Penetrex; Enoxacine; Comprecin; Flumark; AT-2266; Enoxacino; Enoxacinum; Bactidan; 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8-naphthyridine-3-carboxylic acid; Enoxor; Almitil; Enoram; CI-919; Enoxacine [French]; Enoxacinum [Latin]; enofloxacin; CI 919; Enoxacino [Spanish]; Enoxacin (Penetrex); PD 107779; 1-ethyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid; PD-107779; UNII-325OGW249P; NSC 629661; CCRIS 5242; C15H17FN4O3; CHEBI:157175; 1-ethyl-6-fluoro-4-oxo-7-pipe" C15H17FN4O3 IDYZIJYBMGIQMJ-UHFFFAOYSA-N 1-ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,8-naphthyridine-3-carboxylic acid n.a. Antiinfective Agents Yes No Yes No No No PMDBD310 Epirizole Therapeutic Substance Approved Drug 18694-40-1 DB08991 n.a. D01394 n.a. 3242 3129 n.a. "epirizole; Mepirizole; 18694-40-1; Methopyrimazole; Mebron; Mepirizol; 4-Methoxy-2-(5-methoxy-3-methyl-1H-pyrazol-1-yl)-6-methylpyrimidine; Epirizolum [INN-Latin]; DA-398; Mepirizol [German]; 4-Methoxy-2-(5-methoxy-3-methylpyrazol-1-yl)-6-methylpyrimidine; Epirizol [INN-Spanish]; UNII-3B46O2FH8I; Epirizole [USAN:INN:JAN]; EINECS 242-507-1; BRN 0751084; MLS000028844; 3B46O2FH8I; 1-(4-Methoxy-6-methyl-2-pyrimidinyl)-3-methyl-5-methoxypyrazole; 2-(3-Methyl-5-methoxy-1-pyrazolyl)-4-methoxy-6-methylpyrimidine; 2-(3-Methoxy-5-methyl" C11H14N4O2 RHAXSHUQNIEUEY-UHFFFAOYSA-N 4-methoxy-2-(5-methoxy-3-methylpyrazol-1-yl)-6-methylpyrimidine n.a. n.a. Yes No No No No No PMDBD319 Ethacrynic acid "Therapeutic Substance; Herbal Substance" "Approved Drug; Medicinal Herbal Compounds" n.a. n.a. n.a. n.a. n.a. 3278 n.a. NPC282294 "ETHACRYNIC ACID; Etacrynic Acid; 58-54-8; ethacrynate; Etacrinic acid; Hydromedin; Edecrin; Taladren; Otacril; Hidromedin; Edecrina; Endecril; Edecril; Crinuryl; Uregit; Reomax; Mingit; Etakrinic acid; Methylenebutyrylphenoxyacetic acid; MK-595; Ethacrinique (acide); Acido etacrinico; Acide etacrynique; Acidum etacrynicum; Kyselina ethakrynova; Kyselina ethakrynova [Czech]; Acidum etacrynicum [INN-Latin]; Acide etacrynique [INN-French]; Acido etacrinico [INN-Spanish]; (2,3-Dichloro-4-(2-methylene-1-oxobutyl)phenoxy)acetic acid; Methylen" C13H12Cl2O4 AVOLMBLBETYQHX-UHFFFAOYSA-N 2-[2,3-dichloro-4-(2-methylidenebutanoyl)phenoxy]acetic acid n.a. Diuretics Yes Yes No No No No PMDBD323 Ethoxzolamide Therapeutic Substance Approved Drug 452-35-7 DB00311 PA164754743 D02441 DAP000598 3295 3179 n.a. "ethoxzolamide; Ethoxyzolamide; Ethoxazolamide; 452-35-7; Ethamide; 6-Ethoxy-2-benzothiazolesulfonamide; Etoxzolamide; Cardrase; Glaucotensil; Diuretic C; 6-Ethoxy-1,3-benzothiazole-2-sulfonamide; Mingoral; 6-Ethoxybenzo[d]thiazole-2-sulfonamide; 6-Ethoxyzolamide; 6-Ethoxybenzothiazole-2-sulfonamide; 6-Ethoxybenzothiazole-2-sulphonamide; U-4191; NSC 10679; UNII-Z52H4811WX; C9H10N2O3S2; HSDB 3268; CHEMBL18; EINECS 207-199-5; BRN 0212240; MLS000028637; AI3-50805; Redupresin; 6-Ethoxy-benzothiazole-2" C9H10N2O3S2 OUZWUKMCLIBBOG-UHFFFAOYSA-N 6-ethoxy-1,3-benzothiazole-2-sulfonamide n.a. Diuretics No Yes No No No No PMDBD324 Etodolac Therapeutic Substance Approved Drug 41340-25-4 DB00749 PA449550 D00315 DAP000778 3308 3192 n.a. "etodolac; 41340-25-4; Etodolic acid; Lodine; Ultradol; Lodine XL; Ramodar; Etodolaco; Etodolacum; AY 24236; AY-24236; Etodolacum [INN-Latin]; Etodolaco [INN-Spanish]; AY-24,236; Edolan; CCRIS 3923; 1,3,4,9-Tetrahydro-1,8-diethylpyrano(3,4-b)indole-1-acetic acid; 1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid; 2-(1,8-diethyl-4,9-dihydro-3H-pyrano[3,4-b]indol-1-yl)acetic acid; 2-(1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl)acetic acid" C17H21NO3 NNYBQONXHNTVIJ-UHFFFAOYSA-N 2-(1,8-diethyl-4,9-dihydro-3H-pyrano[3,4-b]indol-1-yl)acetic acid Meda Pharmaceuticals Analgesics No Yes No No No No PMDBD328 Etretinate Therapeutic Substance Approved Drug 54350-48-0 DB00926 PA449554 D00316 n.a. 3312 4445538 n.a. "9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenoic acid ethyl ester; CTK8F9698; BCP31125; AKOS030228516; VZ20178; DB00926; KS-0000017G; FT-0653621; Q27166420; ethyl 9-(4-methoxy-2,3,6-trimethyl-phenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoate; 9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic acid ethyl ester; 9-(4-methoxy-2,3,6-trimethyl-phenyl)-3,7-dimethyl-nona-2,4,6,8-tetraen-1-oic acid ethyl ester" C23H30O3 HQMNCQVAMBCHCO-UHFFFAOYSA-N ethyl 9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenoate n.a. n.a. Yes No No No No No PMDBD331 Famciclovir Therapeutic Substance Approved Drug 104227-87-4 DB00426 PA449585 D00317 DAP000489 3324 3207 n.a. "famciclovir; 104227-87-4; Famvir; BRL-42810; Famciclovirum; 2-(2-(2-Amino-9H-purin-9-yl)ethyl)propane-1,3-diyl diacetate; Famciclovirum [INN-Latin]; BRL 42810; Famciclovir (Famvir); UNII-QIC03ANI02; [2-(acetyloxymethyl)-4-(2-aminopurin-9-yl)butyl] acetate; CHEBI:4974; FCV; 9-[4-acetoxy-3-(acetoxymethyl)but-1-yl]-2-aminopurine; 2-[(acetyloxy)methyl]-4-(2-amino-9H-purin-9-yl)butyl acetate; QIC03ANI02; C14H19N5O4; 2-(2-(2-Amino-9H-purin-9-yl)ethyl)-1,3-propanediol diacetate (ester); 1,3-Propanediol, 2-(2-(2-amino-9H-purin-9-yl)" C14H19N5O4 GGXKWVWZWMLJEH-UHFFFAOYSA-N [2-(acetyloxymethyl)-4-(2-aminopurin-9-yl)butyl] acetate Schering-Plough Antiviral Agents No Yes No No No No PMDBD332 Famotidine "Therapeutic Substance; Herbal Substance" "Approved Drug; Medicinal Herbal Compounds" 76824-35-6 DB00927 PA449586 D00318 DAP000341 3325 3208 NPC323937 "famotidine; 76824-35-6; Famotidinum; Famotidina; PEPCID; Brolin; Gastro; Gastrosidin; Apogastine; Gastrodomina; Ulceprax; Ulcatif; Rubacina; Purifam; Nevofam; Neocidine; Invigan; Ingastri; Gastrofam; Vagostal; Ulcofam; Rogasti; Renapepsa; Quamtel; Peptidin; Nulcerin; Nulceran; Notidin; Huberdina; Famowal; Famotin; Famonit; Famodar; Famocid; Cuantin; Blocacid; Ulgarine; Tipodex; Pepfamin; Panalba; Mensoma; Lecedil; Gastridan; Famotal; Famodin; Confobos; Bestidine; Ulfinol; Ulfamid; Ulfagel; Restadin; Quamatel; Pepdine; Pepcidin; Midefam; Gastropen; Gastrion; Gastr" C8H15N7O2S3 XUFQPHANEAPEMJ-UHFFFAOYSA-N 3-[[2-(diaminomethylideneamino)-1,3-thiazol-4-yl]methylsulfanyl]-N''-sulfamoylpropanimidamide n.a. n.a. Yes Yes No No No No PMDBD1190 Felbamate Therapeutic substance Drug 25451-15-4 DB00949 PA449590 D00536 DAP000093 3331 3214 n.a. "felbamate; 25451-15-4; Felbatol; 2-Phenylpropane-1,3-diyl dicarbamate; 2-Phenyl-1,3-propanediol dicarbamate; Felbamyl; Taloxa; Felbamato; Felbamatum; W-554; Felbamatum [Latin]; Felbamato [Spanish]; 1,3-Propanediol, 2-phenyl-, dicarbamate; ADD-03055; Felbamate [USAN:INN]; W 554; UNII-X72RBB02N8; carbamic acid 2-phenyltrimethylene ester; CHEBI:4995; Carbamic acid, 2-phenyltrimethylene ester; EINECS 247-001-4; BRN 3345236; 3-(carbamoyloxy)-2-phenylpropyl carbamate; MLS000028465; X72RBB02N8; NCGC00015429-08; SMR000058448; (3-carbamoyloxy" C11H14N2O4 WKGXYQFOCVYPAC-UHFFFAOYSA-N (3-carbamoyloxy-2-phenylpropyl) carbamate n.a. n.a. No Yes No No No No PMDBD335 Felodipine Therapeutic Substance Approved Drug 72509-76-3 DB01023 PA449591 D00319 DAP000487 3333 3216 n.a. "felodipine; 72509-76-3; Plendil; Renedil; Flodil; Munobal; Splendil; Feloday; dl-Felodipine; Perfudal; Prevex; Modip; Hydac; Agon; Plendil ER; Felodipina; Penedil; Preslow; Felogard; Plendil Retard; Munobal Retard; Plendil Depottab; Felodipinum; Felodipinum [INN-Latin]; Felodipina [INN-Spanish]; Felodur ER; AGON SR; 3-ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate; C18H19Cl2NO4; Felodipine (Plendil); H 154/82; 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid ethyl met" C18H19Cl2NO4 RZTAMFZIAATZDJ-UHFFFAOYSA-N 5-O-ethyl 3-O-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate AstraZeneca Antihypertensive Agents Yes Yes Yes No No No PMDBD337 Fenbufen Therapeutic Substance Approved Drug 36330-85-5 DB08981 PA166049176 D01344 n.a. 3335 3218 n.a. "fenbufen; 36330-85-5; Lederfen; Cinopal; Napanol; Bufemid; 4-(4-Biphenylyl)-4-oxobutyric acid; 3-(4-Phenylbenzoyl)propionic acid; 3-(4-Biphenylylcarbonyl)propionic acid; 4-(biphenyl-4-yl)-4-oxobutanoic acid; gamma-Oxo(1,1''-biphenyl)-4-butanoic acid; CL-82204; 4-([1,1''-biphenyl]-4-yl)-4-oxobutanoic acid; 3-(4-Biphenylcarbonyl)propionic acid; Fenbufenum [INN-Latin]; Fenbufene [INN-French]; CL 82204; 4-biphenyl-4-yl-4-oxobutanoic acid; UNII-9815R1WR9B; 4-oxo-4-(4-phenylphenyl)butanoic acid; MLS0" C16H14O3 ZPAKPRAICRBAOD-UHFFFAOYSA-N 4-oxo-4-(4-phenylphenyl)butanoic acid n.a. n.a. Yes No No No No No PMDBD339 Fenfluramine Therapeutic Substance Approved Drug 458-24-2 DB00574 PA449592 n.a. DAP001478 3337 3220 n.a. "fenfluramine; Obedrex; Rotondin; Pesos; Ponderax PA; Fenfluraminum; Fenfluramina; Adifax; (+-)-Fenfluramine; DL-Fenfluramine; Fenfluramina [DCIT]; 458-24-2; Fenfluraminum [INN-Latin]; Fenfluramine [INN:BAN]; N-ethyl-1-[3-(trifluoromethyl)phenyl]propan-2-amine; 2-Ethylamino-1-(3-trifluoromethylphenyl)propane; 1-(meta-Trifluoromethyl-phenyl)-2 ethylaminopropane; N-Ethyl-alpha-methyl-3-trifluoromethylphenethylamine; HSDB 3080; 3-(Trifluoromethyl)-N-ethyl-alpha-methylphenethylamine; S 768; EINECS 207-276-3; DEA No. 1670; BRN 4783711" C12H16F3N DBGIVFWFUFKIQN-UHFFFAOYSA-N N-ethyl-1-[3-(trifluoromethyl)phenyl]propan-2-amine n.a. n.a. No Yes No No No No PMDBD340 Fenofibrate Therapeutic Substance Approved Drug 49562-28-9 DB01039 PA449594 D00565 DAP000270 3339 3222 n.a. "fenofibrate; 49562-28-9; Procetofen; Lipantil; Lipanthyl; Tricor; Fenobrate; Secalip; Lipidil; Antara; Proctofene; Triglide; Lipoclar; Finofibrate; Lipofene; Sedufen; Lipirex; Fenogal; Fenoglide; Elasterin; Protolipan; Fenotard; Lipsin; Liposit; Lipofen; Lipidex; Nolipax; Ankebin; Lipifen; Elasterate; Procetofene; Luxacor; Fenofibratum [INN-Latin]; Fenofibrato [INN-Spanish]; Lipantil (TN); Tricor (TN); propan-2-yl 2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoate; LF-178; TRICOR (MICRONIZED); Isopropyl 2-(4-(4-chlorobenzoyl)phenoxy)-2-methylprop" C20H21ClO4 YMTINGFKWWXKFG-UHFFFAOYSA-N propan-2-yl 2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoate Abbott Laboratories Antilipemic Agents No Yes No No No No PMDBD341 Fenspiride Therapeutic Substance Approved Drug n.a. DB08979 n.a. n.a. n.a. 3344 3227 n.a. "fenspiride; 5053-06-5; Respiride; Fenspirid; Viarespan; Fenspiride [INN]; 8-Phenethyl-1-oxa-3,8-diazaspiro[4.5]decan-2-one; 8-(2-phenylethyl)-1-oxa-3,8-diazaspiro[4.5]decan-2-one; Fenspiridum [INN-Latin]; Fenspirida [INN-Spanish]; UNII-S983QC7HKM; S983QC7HKM; 8-Phenethyl-1-oxa-3,8-diaza-spiro[4.5]decan-2-one; C15H20N2O2; Fenspiride (INN); EINECS 225-751-3; BRN 0533332; Fenspiridum; Fenspirida; 1-Oxa-3,8-diazaspiro" C15H20N2O2 FVNFBBAOMBJTST-UHFFFAOYSA-N 8-(2-phenylethyl)-1-oxa-3,8-diazaspiro[4.5]decan-2-one n.a. n.a. No Yes No No No No PMDBD1192 Fexofenadine Therapeutic substance Drug 83799-24-0 DB00950 PA449621 D07958 DAP000330 3348 3231 n.a. "fexofenadine; 83799-24-0; Carboxyterfenadine; Terfenadine carboxylate; Terfenadine-COOH; Terfenadine acid metabolite; Allegra; Fexofenadine [INN:BAN]; HSDB 7486; MDL 16455; 2-(4-(1-Hydroxy-4-(4-(hydroxydiphenylmethyl)piperidin-1-yl)butyl)phenyl)-2-methylpropanoic acid; 4-(1-Hydroxy-4-(4-(hydroxydiphenylmethyl)-1-piperidinyl)butyl)-alpha,alpha-dimethylbenzeneacetic acid; CHEMBL914; CHEBI:5050; 2-[4-(1-hydroxy-4-{4-[hydroxy(diphenyl)methyl]piperidin-1-yl}butyl)phenyl]-2-methylpropanoic acid; Fexofendine; AK-75768; 139965-10-9" C32H39NO4 RWTNPBWLLIMQHL-UHFFFAOYSA-N 2-[4-[1-hydroxy-4-[4-[hydroxy(diphenyl)methyl]piperidin-1-yl]butyl]phenyl]-2-methylpropanoic acid n.a. n.a. No Yes No No No No PMDBD1195 Flavoxate Therapeutic substance Drug 15301-69-6 DB01148 PA164781386 n.a. DAP001114 3354 3237 n.a. "flavoxate; 15301-69-6; Flavoxatum; Flavoxato; 2-(piperidin-1-yl)ethyl 3-methyl-4-oxo-2-phenyl-4H-chromene-8-carboxylate; Flavossato [DCIT]; Flavoxate [INN:BAN]; Flavoxatum [INN-Latin]; Flavoxato [INN-Spanish]; UNII-3E74Y80MEY; 4H-1-Benzopyran-8-carboxylic acid, 3-methyl-4-oxo-2-phenyl-, 2-(1-piperidinyl)ethyl ester; EINECS 239-337-5; 2-piperidinoethyl 3-methylflavone-8-carboxylate; Spasuret hydrochloride; CHEBI:5088; 3E74Y80MEY; 2-piperidin-1-ylethyl 3-methyl-4-oxo-2-phenylchromene-8-carboxylate; beta-piperidinoethyl 3-meth" C24H25NO4 SPIUTQOUKAMGCX-UHFFFAOYSA-N 2-piperidin-1-ylethyl 3-methyl-4-oxo-2-phenylchromene-8-carboxylate n.a. n.a. No Yes No No No No PMDBD353 Fleroxacin Therapeutic Substance Approved Drug 79660-72-3 DB04576 PA164774762 D01716 DAP000928 3357 3240 n.a. "fleroxacin; 79660-72-3; Megalone; Fleroxicin; Quinodis; Megalocin; Fleroxacinum; Fleroxacino; 6,8-Difluoro-1-(2-fluoroethyl)-1,4-dihydro-7-(4-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid; Fleroxacine; AM-833; Fleroxacinum [Latin]; Fleroxacine [French]; Fleroxacino [Spanish]; Ro 23-6240; AM 833; FLRX; Fleroxacin (Quinodis); Ro 23-6240/000; UNII-N804LDH51K; Ro-236240; CCRIS 3972; CHEBI:31810; C17H18F3N3O3; BRN 4300996; 6,8-difluoro-1-(2-fluoroethyl)-7-(4-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid; N804LDH51K" C17H18F3N3O3 XBJBPGROQZJDOJ-UHFFFAOYSA-N 6,8-difluoro-1-(2-fluoroethyl)-7-(4-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid n.a. Antiinfective Agents Yes No No No No No PMDBD357 Fluconazole Therapeutic Substance Approved Drug 86386-73-4 DB00196 PA449653 D00322 DAP000628 3365 3248 n.a. "fluconazole; 86386-73-4; Diflucan; Triflucan; Biozolene; Elazor; Biocanol; Fluconazol; Fungata; Fluconazolum; Pritenzol; Flucazol; Flunizol; Flukezol; Flucostat; Zonal; UK 49858; Alflucoz; Oxifugol; Syscan; 2-(2,4-DIFLUOROPHENYL)-1,3-DI(1H-1,2,4-TRIAZOL-1-YL)PROPAN-2-OL; Forcan; Flusol; Cryptal; Canzol; Zoltec; Dimycon; Zemyc; Baten; Mutum; 2-(2,4-Difluorophenyl)-1,3-bis(1H-1,2,4-triazol-1-yl)propan-2-ol; Fluconazol [Spanish]; Fluconazolum [Latin]; UK-49858; DRG-0005; UNII-8VZV102JFY; 2-(2,4-difluorophenyl)-1,3-bis(1,2,4-triazol-1-yl)propan-2" C13H12F2N6O RFHAOTPXVQNOHP-UHFFFAOYSA-N 2-(2,4-difluorophenyl)-1,3-bis(1,2,4-triazol-1-yl)propan-2-ol Pfizer Antifungal Agents No Yes No Yes No No PMDBD358 Flucytosine Therapeutic Substance antifungals 2022-85-7 DB01099 PA449654 D00323 DAP001542 3366 3249 n.a. "5-Fluorocytosine; flucytosine; 2022-85-7; Ancotil; Ancobon; 5-Fluorocystosine; Fluocytosine; 5-FC; Flucytosin; 5-Fluorocytosin; Fluorcytosine; Alcobon; 4-Amino-5-fluoropyrimidin-2(1H)-one; Flucytosinum; Ro 2-9915; 4-Amino-5-fluoro-2(1H)-pyrimidinone; 5-Flurocytosine; 5-Flucytosine; 2-Hydroxy-4-amino-5-fluoropyrimidine; 5-fluoro cytosine; Ancobon (TN); Flucitosina [DCIT]; Ro 29915 E/265601; NSC 103805; Flucytosinum [INN-Latin]; 117969-88-7; Flucytosine (Ancobon); Flucytosine (5" C4H4FN3O XRECTZIEBJDKEO-UHFFFAOYSA-N 6-amino-5-fluoro-1H-pyrimidin-2-one n.a. Antifungal Agents Yes Yes Yes Yes No No PMDBD360 Flufenamic acid Therapeutic Substance Approved Drug 530-78-9 DB02266 PA166049190 D01581 n.a. 3371 3254 n.a. "flufenamic acid; 530-78-9; Arlef; Fluphenamic acid; Nichisedan; Achless; Tecramine; Paraflu; Lanceat; Flufacid; Plostene; Fullsafe; Parlef; Surika; Parlif; Flufenaminsaeure; N-(3-Trifluoromethylphenyl)anthranilic acid; Reumajust A; Acido flufenamico; 2-{[3-(trifluoromethyl)phenyl]amino}benzoic acid; Ristogen; Sastridex; Meralen; Ansatin; 2-((3-(Trifluoromethyl)phenyl)amino)benzoic acid; Fluore-200; ANT-1; NSC-82699; Acide flufenamique; Acidum flufenamicum; TVX 916; INF 1837; 3''-Trifluoro" C14H10F3NO2 LPEPZBJOKDYZAD-UHFFFAOYSA-N 2-[3-(trifluoromethyl)anilino]benzoic acid n.a. n.a. Yes No No No No No PMDBD367 Fluphenazine Therapeutic Substance Approved Drug 69-23-8 DB00623 PA449676 D07977 DCL000806 3372 3255 n.a. "FLUPHENAZINE; Triflumethazine; Fluorophenazine; Fluorphenazine; Fluorfenazine; 69-23-8; Siqualon; Elinol; Phthorphenazine; Vespazine; Ftorphenazine; Siqualine; Sevinol; Pacinol; Prolixin; Fluphenazinum; Flufenazina; Flufenazin; Valamina; Dapotum; Flufenazina [DCIT]; SQ 4918; 2-(4-(3-(2-(trifluoromethyl)-10H-phenothiazin-10-yl)propyl)piperazin-1-yl)ethanol; Fluphenazine [INN:BAN]; Moditen (Tabl or elixir); Fluphenazinum [INN-Latin]; 10-(3-(2-Hydroxyethyl)piperazinopropyl)-2-(trifluoromethyl)phenothiazine; 4-(3-(2-Trifluoromethyl-10-ph" C22H26F3N3OS PLDUPXSUYLZYBN-UHFFFAOYSA-N 2-[4-[3-[2-(trifluoromethyl)phenothiazin-10-yl]propyl]piperazin-1-yl]ethanol Bristol-Myers Squibb Antipsychotic Agents No Yes No No No No PMDBD361 Flumequine Therapeutic Substance Approved Drug 42835-25-6 DB08972 n.a. n.a. n.a. 3374 3257 n.a. "flumequine; 42835-25-6; Flumigal; Apurone; Imequyl; Flumisol; Flumiquil; Flumix; 9-Fluoro-5-methyl-1-oxo-1,5,6,7-tetrahydropyrido[3,2,1-ij]quinoline-2-carboxylic acid; R 802 (bactericide); Flumequinum [INN-Latin]; Flumequino [INN-Spanish]; HSDB 7034; R 802; EINECS 255-962-6; MLS000069546; R-802; CHEBI:85269; 9-fluoro-6,7-dihydro-5-methyl-1-oxo-1h,5h-benzo[ij]quinolizine-2-carboxylic acid; NCGC00018211-03; Flumequinum; SMR000058826; AK-27078; Flumequino; DSSTox_CID_25623; DSSTox_RID_81008; 9-Fluoro-5-methyl-1-oxo-6,7-dihydro-1H,5H-py" C14H12FNO3 DPSPPJIUMHPXMA-UHFFFAOYSA-N 7-fluoro-12-methyl-4-oxo-1-azatricyclo[7.3.1.05,13]trideca-2,5,7,9(13)-tetraene-3-carboxylic acid n.a. n.a. Yes No Yes No No No PMDBD1200 Fluorouracil Therapeutic substance Drug 51-21-8 DB00544 PA128406956 D00584 DAP000829 3385 3268 n.a. "5-Fluorouracil; fluorouracil; 51-21-8; 5-FU; Fluoroplex; Efudex; Adrucil; Carac; Fluracil; 5-fluoropyrimidine-2,4(1H,3H)-dione; Fluoroblastin; Kecimeton; Carzonal; Timazin; Efudix; Arumel; Fluril; 5-Fluoracil; Queroplex; Fluracilum; Ulup; Phthoruracil; Fluro Uracil; 5-fluoro-1H-pyrimidine-2,4-dione; 5-Fluoro-2,4(1H,3H)-pyrimidinedione; Fluorouracilum; Ftoruracil; Efurix; Fluri; 5 Fluorouracil; 5-Fluoropyrimidine-2,4-dione; Effluderm (free base); Fluorouracilo; Fluroblastin; 2,4-Dihydroxy-5-fluoropyrimidine; 2,4(1H,3H)-Pyrimidinedione, 5-fluo" C4H3FN2O2 GHASVSINZRGABV-UHFFFAOYSA-N 5-fluoro-1H-pyrimidine-2,4-dione n.a. n.a. Yes No No No No No PMDBD366 Fluoxetine "Therapeutic Substance; Herbal Substance" inhibitor 54910-89-3 DB00472 PA449673 D00823 DAP000186 3386 3269 NPC328267 "fluoxetine; 54910-89-3; Prozac; Pulvules; Fluoxetin; Portal; Eufor; Animex-On; Fluoxetina; Fluoxetina [Spanish]; Fluoxetinum; Fluoxetinum [INN-Latin]; Fluoxetina [INN-Spanish]; Reconcile; N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine; Fluoxetine [USAN:INN:BAN]; (+-)-N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine; N-Methyl-3-(p-trifluoromethylphenoxy)-3-phenylpropylamine; (+-)-N-Methyl-3-phenyl-3-((alpha,alpha,alpha-trifluoro-p-tolyl)oxy)propylamine; CHEMBL41; dl-3-(p-Trifluoromethylphenoxy)-N-me" C17H18F3NO RTHCYVBBDHJXIQ-UHFFFAOYSA-N N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine Eli Lilly Antidepressants No Yes No Yes No No PMDBD1201 Flurbiprofen Therapeutic substance Drug 5104-49-4 DB00712 PA449683 D00330 DAP000621 3394 3277 n.a. "flurbiprofen; 5104-49-4; Ansaid; Froben; Antadys; Flurofen; Cebutid; Anside; 2-(2-fluorobiphenyl-4-yl)propanoic acid; 3-Fluoro-4-phenylhydratropic acid; Flugalin; Flubiprofen; Ocufen; Flurbiprofene [INN-French]; Flurbiprofenum [INN-Latin]; Flurbiprofeno [INN-Spanish]; BTS 18322; 2-(3-fluoro-4-phenylphenyl)propanoic acid; FP 70; BTS-18322; 2-Fluoro-alpha-methyl-(1,1''-biphenyl)-4-acetic acid; C15H13FO2; U-27182; (+-)-2-Fluoro-alpha-methyl-4-biphenylacetic acid; Stayban; Zepolas; Adfeed; FLURBIPROPHEN; CCRIS 3708; U 27182; 2-(2-Fluorobiphe" C15H13FO2 SYTBZMRGLBWNTM-UHFFFAOYSA-N 2-(3-fluoro-4-phenylphenyl)propanoic acid n.a. n.a. No Yes No No No No PMDBD1202 Flutamide Therapeutic substance Drug 13311-84-7 DB00499 PA449685 D00586 DAP000301 3397 3280 n.a. "flutamide; 13311-84-7; Niftolide; Eulexin; Niftholide; 2-Methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide; NFBA; niftolid; Drogenil; Flutamin; Sch 13521; Cebatrol, veterinary; Flutamida; Flutamidum; Sch-13521; 4''-Nitro-3''-trifluoromethylisobutyranilide; Ham''s F-12 medium; Flutamidum [INN-Latin]; Flutamida [INN-Spanish]; 2-Methyl-N-(4-nitro-3-[trifluoromethyl]phenyl)propanamide; NSC 215876; Flutamide (Eulexin); CCRIS 7246; UNII-76W6J0943E; alpha,alpha,alpha-Trifluo" C11H11F3N2O3 MKXKFYHWDHIYRV-UHFFFAOYSA-N 2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide n.a. n.a. No Yes No No No No PMDBD1205 Formoterol Therapeutic substance Drug 73573-87-2 DB00983 PA134687907 D07990 DAP000247 3410 3292 n.a. "formoterol; 73573-87-2; Foradil; Formoterolum [INN-Latin]; n-[2-hydroxy-5-(1-hydroxy-2-{[1-(4-methoxyphenyl)propan-2-yl]amino}ethyl)phenyl]formamide; FORMOTEROL FUMARATE; CHEBI:63082; 2''-hydroxy-5''-(1-hydroxy-2-((p-methoxy-alpha-methylphenethyl)amino)ethyl)formanilide; N-[2-hydroxy-5-(1-hydroxy-2-{[2-(4-methoxyphenyl)-1-methylethyl]amino}ethyl)phenyl]formamide; 2''-hydroxy-5''-{1-hydroxy-2-[(p-methoxy-alpha-methylphenethyl)amino]ethyl}formanilide; Formoterol (INN); Oxis (TN); Oxeze/Oxis; BD-40A; CGP-25827A; NCGC00181126-01" C19H24N2O4 BPZSYCZIITTYBL-UHFFFAOYSA-N N-[2-hydroxy-5-[1-hydroxy-2-[1-(4-methoxyphenyl)propan-2-ylamino]ethyl]phenyl]formamide n.a. n.a. No Yes No No No No PMDBD375 Furazolidone Therapeutic Substance Approved Drug 67-45-8 DB00614 PA164746760 D00830 DAP000993 3435 3317 n.a. "furazolidone; 67-45-8; Furazolidona; Furazolidonum; Nifurazolidonum; Furazolum; UNII-5J9CPU3RE0; Furazolidonum [INN-Latin]; Furazolidona [INN-Spanish]; 5J9CPU3RE0; CHEBI:5195; CCRIS 1540; HSDB 7036; Furox Aerosol Powder (Veterinary); NSC 6469; EINECS 200-653-3; NF-180; Prestwick_1067; AI3-50103; Spectrum_001098; Spectrum3_000436; Prestwick0_000808; Prestwick1_000808; Spectrum4_000559; Spectrum2_001015; Oprea1_494195; SCHEMBL64995; KBioGR_001257; KBioSS_001578; 2-Oxazolidinone, 3" C8H7N3O5 PLHJDBGFXBMTGZ-UHFFFAOYSA-N 3-[(5-nitrofuran-2-yl)methylideneamino]-1,3-oxazolidin-2-one n.a. n.a. Yes No Yes No No No PMDBD1209 Furosemide Therapeutic substance Drug 54-31-9 DB00695 PA449719 D00331 DAP000043 3440 3322 n.a. "furosemide; 54-31-9; Frusemide; Lasix; Furosemid; Furanthril; Errolon; Fusid; Frusemin; Macasirool; Fursemide; Furantril; Furanthryl; Beronald; Prefemin; Lowpstron; Aisemide; Trofurit; Rosemide; Fuluvamide; Desdemin; Radonna; Fulsix; Seguril; Furesis; Lasilix; Transit; Katlex; Lasex; Salix; Urex; Frusetic; Promedes; Fursemid; Eutensin; Lazix; Frusid; Urosemide; Profemin; Furosedon; Furanturil; Frusemid; Frusenex; Rusyde; Dryptal; Impugan; Uresix; Aluzine; Yidoli; Uremide; Nicorol; Diural; Laxur; Disal; Urian; Hydro-rapid; Apo-Frusemide; Synephron; Spirofur; Selecto" C12H11ClN2O5S ZZUFCTLCJUWOSV-UHFFFAOYSA-N 4-chloro-2-(furan-2-ylmethylamino)-5-sulfamoylbenzoic acid n.a. n.a. No Yes No No No No PMDBD1210 Gabapentin Therapeutic substance Drug 60142-96-3 DB00996 PA449720 D00332 DNC000670 3446 3328 n.a. "gabapentin; 60142-96-3; Neurontin; 1-(Aminomethyl)cyclohexaneacetic acid; Gabapentine; Aclonium; 2-[1-(aminomethyl)cyclohexyl]acetic acid; Gabapetin; Gabapentinum; Fanatrex; Gabapentino; Serada; Gabapentino [Spanish]; [1-(AMINOMETHYL)CYCLOHEXYL]ACETIC ACID; gabapentina; Gabapentinum [INN-Latin]; Gabapentine [INN-French]; Gralise; Gabapentino [INN-Spanish]; Go 3450; Goe-3450; 2-(1-(aminomethyl)cyclohexyl)acetic acid; GOE 2450; CI-945; CI 945; gabapentin (Neurontin); DM-1796; (1-Aminomethyl-cycl" C9H17NO2 UGJMXCAKCUNAIE-UHFFFAOYSA-N 2-[1-(aminomethyl)cyclohexyl]acetic acid n.a. n.a. No Yes No No No No PMDBD1212 Gemfibrozil Therapeutic substance Drug 25812-30-0 DB01241 PA449750 D00334 DAP000210 3463 3345 n.a. "gemfibrozil; 25812-30-0; 5-(2,5-Dimethylphenoxy)-2,2-dimethylpentanoic acid; Lopid; Decrelip; Jezil; Lipur; Bolutol; Apo-Gemfibrozil; Gemfibromax; Lipazil; Fibratol; Gemlipid; Gemfibril; Trialmin; Litarek; Hipolixan; Fibrocit; Cholespid; Ausgem; Pilder; CI-719; Gemfibrozilo; Gemfibrozilum; Renabrazin; Progemzal; Synbrozil; Lifibron; Ipolipid; Taborcil; Normolip; Lanaterom; Regulip; Reducel; Polyxit; Micolip; Tentroc; Lipira; Gemnpid; Elmogan; Clearol; Sinelip; Lipizyl; Lipigem; Innogen; Fetinor; Brozil; Gozid; Hidil; Gemd; WL-Gemfibrozil; Gevilon Uno; Gen-Fi" C15H22O3 HEMJJKBWTPKOJG-UHFFFAOYSA-N 5-(2,5-dimethylphenoxy)-2,2-dimethylpentanoic acid n.a. n.a. No Yes No No No Yes EX_gmfl(e),GMFL_GLC_GLCAASE,GMFL_GLC_GLCAASEe,GMFL_GLC_GLCAASEepp,GMFLte,GMFLtepp,GMFLtex PMDBD399 Gliclazide Therapeutic Substance Approved Drug 21187-98-4 DB01120 PA10892 D01599 DAP000522 3475 3356 n.a. "gliclazide; 21187-98-4; Glimicron; Gliclazidum [INN-Latin]; Gliclazida [INN-Spanish]; Diamicron; Nordialex; 1-(3-Azabicyclo(3.3.0)oct-3-yl)-3-(p-tolylsulfonyl)urea; CHEBI:31654; C15H21N3O3S; 1-(Hexahydrocyclopenta(c)pyrrol-2(1H)-yl)-3-(p-tolylsulfonyl)urea; S-852; S-1702; Gliclazida; 1-(3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl)-3-(4-methylphenyl)sulfonylurea; N-(4-Methylbenzenesulfonyl)-N''-(3-azabicyclo(3.3.0)oct-3-yl)urea; Gliclazide-d4; N-(hexahydrocyclopenta[c]pyrrol-2(1H)-ylcarbamoyl)-4-methylbenzenesulfonami" C15H21N3O3S BOVGTQGAOIONJV-UHFFFAOYSA-N 1-(3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl)-3-(4-methylphenyl)sulfonylurea n.a. Hypoglycemic Agents No Yes No No No No PMDBD1215 Glimepiride Therapeutic substance Drug 93479-97-1 DB00222 PA449761 D00593 DAP000132 3476 16740595 n.a. "glimepiride; 93479-97-1; Amaryl; Glimepirid; Amarel; Glimepirida; Glimepiridum; Endial; Hoe-490; Glimepride; cis-Glimepiride; Glimepiridum [Latin]; HOE 490; Glimepirida [Spanish]; UNII-24T6XIR2MZ; CCRIS 7083; CHEBI:5383; UNII-6KY687524K; 684286-46-2; 1-((p-(2-(3-Ethyl-4-methyl-2-oxo-3-pyrroline-1-carboxamido)ethyl)phenyl)sulfonyl)-3-(trans-4-methylcyclohexyl)urea; 4-ethyl-3-methyl-N-[2-[4-[(4-methylcyclohexyl)carbamoylsulfamoyl]phenyl]ethyl]-5-oxo-2H-pyrrole-1-carboxamide; BRN 5365754; 24T6XIR2MZ; 6KY687524K; NCGC00016960-03; Ronam" C24H34N4O5S WIGIZIANZCJQQY-UHFFFAOYSA-N 4-ethyl-3-methyl-N-[2-[4-[(4-methylcyclohexyl)carbamoylsulfamoyl]phenyl]ethyl]-5-oxo-2H-pyrrole-1-carboxamide n.a. n.a. No Yes No No No No PMDBD400 Glipizide Therapeutic Substance Approved Drug 29094-61-9 DB01067 PA449762 D00335 DAP000920 3478 3359 n.a. "glipizide; 29094-61-9; Glucotrol; Glydiazinamide; Melizide; Sucrazide; Glupizide; Glucozide; Glibenese; Napizide; Mindiab; Minidiab; Glupitel; Dipazide; Minodiab; Ozidia; Glucotrol XL; Glucolip; Glibetin; Aldiab; Minidab; Glipid; Glican; Digrin; Glidiab; Glyde; Gluco-Rite; Glide; Glipizida; Glipizidum; Glipizidum [INN-Latin]; Glipizida [INN-Spanish]; Metaglip; CP 28720; K 4024; K-4024; CP-28720; TK 1320; C21H27N5O4S; UNII-X7WDT95N5C; CP 28,720; Glipizide (Glucotrol); EINECS 249-427-6; BRN 0903495; CHEMBL1073; X7WDT95N5C; 1-Cyclohexyl-3-((p-(2-(5-methyl" C21H27N5O4S ZJJXGWJIGJFDTL-UHFFFAOYSA-N N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-5-methylpyrazine-2-carboxamide Pfizer Pharmaceuticals Hypoglycemic Agents No Yes No No No No PMDBD1217 Glyburide Therapeutic substance Drug 10238-21-8 DB01016 PA449782 D00336 DAP000037 3488 3368 n.a. "Glibenclamide; glyburide; 10238-21-8; Glybenclamide; Micronase; Diabeta; Glynase; Daonil; Euglucon; Maninil; Semi-daonil; Apo-Glibenclamide; Euglucon 5; Neogluconin; Bastiverit; Azuglucon; Orabetic; Euglykon; Euglucan; Renabetic; Prodiabet; Glucolon; Duraglucon; Yuglucon; Glibenil; Betanase; Benclamin; Tiabet; Libanil; Glibil; Glibens; Dibelet; Glimide; Gilemal; Suraben; Humedia; Glimel; Glybenzcyclamide; Melix; Adiab; Pira; Med-Glionil; Normoglucon; Hexaglucon; Glucohexal; Glibenbeta; Glucoremed; Praeciglucon; Lisaglucon; Gewaglucon; Lederglib; Glucobene" C23H28ClN3O5S ZNNLBTZKUZBEKO-UHFFFAOYSA-N 5-chloro-N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-2-methoxybenzamide n.a. n.a. No Yes No No No No PMDBD1222 Guanfacine Therapeutic substance Drug 29110-47-2 DB01018 PA449825 D08031 DAP000900 3519 3399 n.a. "GUANFACINE; 29110-47-2; Guanfacinum [INN-Latin]; Guanfacina [INN-Spanish]; Guanfacine [INN:BAN]; UNII-30OMY4G3MK; N-(diaminomethylidene)-2-(2,6-dichlorophenyl)acetamide; EINECS 249-442-8; 30OMY4G3MK; N-amidino-2-(2,6-dichlorophenyl)acetamide; CHEBI:5558; N-carbamimidoyl-2-(2,6-dichlorophenyl)acetamide; SPD 503; C9H9Cl2N3O; Guanfacinum; Guanfacina; Guanfacine Monohydrochloride; NCGC00015469-05; Lon798; Guanfacine (INN); Estulic (TN); Tenex (Salt/Mix); Estulic (Salt/Mix)" C9H9Cl2N3O INJOMKTZOLKMBF-UHFFFAOYSA-N N-(diaminomethylidene)-2-(2,6-dichlorophenyl)acetamide n.a. n.a. No Yes No No No No PMDBD418 Haloperidol Therapeutic Substance Approved Drug 52-86-8 DB00502 PA449841 D00136 DAP000313 3559 3438 n.a. "haloperidol; 52-86-8; Haldol; Serenace; Aloperidin; Aloperidol; Brotopon; Eukystol; Einalon S; Ulcolind; Serenase; Uliolind; Serenelfi; Aloperidolo; Halojust; Vesalium; Halopoidol; Galoperidol; Pernox; Mixidol; Halopal; Sernel; Sernas; Linton; Dozic; Aldo; Lealgin compositum; Keselan; Peluces; Bioperidolo; Haldol Solutab; McN-JR-1625; Haloperidolum; Aloperidon; Fortunan; 4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-1-(4-fluorophenyl)butan-1-one; Aloperidolo [DCIT]; Aloperidolo [Italian]; Haloperidolum [INN-Latin]; NSC 170973; R-1625; R 1625; C21H" C21H23ClFNO2 LNEPOXFFQSENCJ-UHFFFAOYSA-N 4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-1-(4-fluorophenyl)butan-1-one Janssen Pharmaceutica Antipsychotic Agents Yes Yes Yes No No No PMDBD419 Haloprogin Therapeutic Substance Approved Drug 777-11-7 DB00793 PA164768737 D00339 DAP001332 3561 3440 n.a. "haloprogin; Mycanden; 777-11-7; Halotex; Mycilan; Polik; M-1028 (Meiji); Haloproginum [INN-Latin]; Haloprogine [INN-French]; Haloprogina [INN-Spanish]; M 1028; C9H4Cl3IO; 2,4,5-Trichlorophenyl iodopropargyl ether; UNII-AIU7053OWL; 3-Iodo-2-propynyl 2,4,5-trichlorophenyl ether; Ether, 3-iodo-2-propynyl 2,4,5-trichlorophenyl; EINECS 212-286-6; Haloprogine; 2,4,5-Trichlorophenyl-gamma-iodopropargyl ether; 2,4,5-Trichlorophenyl gamma-iodopropargil ether; NSC 100071; (3-Iod-2-propinyl)-(2,4,5-trichlorphenyl)ether; BRN 1976771; CHEMBL1" C9H4Cl3IO CTETYYAZBPJBHE-UHFFFAOYSA-N 1,2,4-trichloro-5-(3-iodoprop-2-ynoxy)benzene n.a. Antifungal Agents Yes No No No No No PMDBD423 Hexachlorophene Therapeutic Substance Approved Drug 70-30-4 DB00756 PA449871 D00859 DAP001050 3598 3472 n.a. "hexachlorophene; 70-30-4; Hexachlorophen; Hexachlorofen; Nabac; Almederm; Fostril; Exofene; pHisoHex; Tersaseptic; Steraskin; Hexophene; Gamophene; Phisodan; Dermadex; Septisol; Distodin; Hexafen; Gamophen; Surofene; Septofen; Hexabalm; Acigena; Turgex; Steral; Hexide; Germa-Medica; Surgi-Cen; Surgi-Cin; Cotofilm; Ritosept; Hexosan; Fomac; Fesia-sin; Ster-zac; Soy-dome; Neosept V; G-Eleven; Hexachlorophane; Hexascrub; Bilevon; Phiso-Scrub; Septi-Soft; TRICHLOROPHENE; Hexa-Germ; 6,6''-Methylenebis(2,4,5-trichlorophenol); Hexaclorofeno; Armohex; Hexachlorop" C13H6Cl6O2 ACGUYXCXAPNIKK-UHFFFAOYSA-N 3,4,6-trichloro-2-[(2,3,5-trichloro-6-hydroxyphenyl)methyl]phenol n.a. Antiinfective Agents Yes No Yes No No No PMDBD425 Hexetidine Therapeutic Substance Approved Drug 141-94-6 DB08958 n.a. D07068 n.a. 3607 3481 n.a. "hexetidine; 141-94-6; Oraldene; Hexoral; Glypesin; Hextril; Elsix; Collu hextril; Triocil; Triscol; Sterisil; Sterilate; Duranil Aerosol; Hexetidinum; Collu-Hextril; Steri/Sol; Drossadin; Paradenyl; Oraseptic; Steri/Sol (VAN); Caswell No. 033BB; Hexetidinum [INN-Latin]; Hexetidina [INN-Spanish]; NSC-17764; NSC 17764; 1,3-bis(2-ethylhexyl)-5-methyl-1,3-diazinan-5-amine; UNII-852A84Y8LS; C21H45N3; 5-Amino-1,3-bis(2-ethylhexyl)hexahydro-5-methylpyrimidine; EINECS 205-513-5; MLS0022" C21H45N3 DTOUUUZOYKYHEP-UHFFFAOYSA-N 1,3-bis(2-ethylhexyl)-5-methyl-1,3-diazinan-5-amine n.a. n.a. Yes No No No No No PMDBD1225 Hydralazine Therapeutic substance Drug 86-54-4 DB01275 PA449894 D08044 DAP000728 3637 3511 n.a. "hydralazine; 1-Hydrazinophthalazine; Hydralazin; 1-Hydrazinylphthalazine; Hypophthalin; 86-54-4; Hydrazinophthalazine; Apresoline; Apressin; Apresolin; Idralazina; 6-Hydralazine; 1(2H)-Phthalazinone, hydrazone; Hydrallazine; Hidralazina; Aprezolin; Hidralazin; Hipoftalin; 1-Phthalazinylhydrazine; phthalazin-1-ylhydrazine; Hydralazinum; Hydrazone 1(2H)-phthalazinone; Ciba 5968; 59275-69-3; Apressin (pharmaceutical); (E)-1-Hydrazono-1,2-dihydrophthalazine; Idralazina [DCIT]; Idralazina [Italian]; Hidralazina [Spanish]; Hydralazine [INN:B" C8H8N4 RPTUSVTUFVMDQK-UHFFFAOYSA-N phthalazin-1-ylhydrazine n.a. n.a. No Yes No No No No PMDBD1226 Hydrochlorothiazide Therapeutic substance Drug 58-93-5 DB00999 PA449899 D00340 DAP000750 3639 3513 n.a. "hydrochlorothiazide; 58-93-5; HCTZ; Hypothiazide; Esidrix; Oretic; Hydrodiuretic; Servithiazid; Hydrosaluric; Hidrotiazida; Dichlotiazid; Hydrochlorthiazide; Hydrochlorothiazid; Vetidrex; Idrotiazide; Thiuretic; Maschitt; Aquarills; Newtolide; Disalunil; Diclotride; Dichlotride; Megadiuril; Hypothiazid; Aquarius; Nefrix; Hidril; Drenol; Esidrex; Hydril; Chlorosulthiadil; Hidrochlortiazid; Hydro-Diuril; Hydro-Aquil; Jen-Diril; Dihydrochlorothiazide; HydroDIURIL; Dihydrochlorothiazid; Dihydrochlorothiazidum; Moduretic; Apresazide; Urodiazin; Neoflume" C7H8ClN3O4S2 JZUFKLXOESDKRF-UHFFFAOYSA-N 6-chloro-1,1-dioxo-3,4-dihydro-2H-1lambda6,2,4-benzothiadiazine-7-sulfonamide n.a. n.a. No Yes No No No No PMDBD1228 Hydroflumethiazide Therapeutic substance Drug 135-09-1 DB00774 PA164752557 D00654 DAP000747 3647 3521 n.a. "hydroflumethiazide; 135-09-1; Glomerulin; Diuredemina; Hidroflumetiazid; Hydroflumethizide; Hidroalogen; Flutizide; Diurometon; Spandiuril; Robezon; Saluron; Enjit; Trifluoromethylhydrothiazide; Leodrine; Vergonil; Hydrenox; Diucardin; Bristurin; Rodiuran; Olmagran; Elodrine; Finuret; Bristab; Sisuril; Rontyl; Hydol; Trifluoromethylhydrazide; NaClex; Di-ademil; Dihydroflumethazide; Dihydroflumethiazide; Hydroflumethazide; Elodrin; Metforylthiadiazin; Methforylthiazidine; Metflorylthiazidine; Rivosil; Idroflumetiazide; Hidroflumetiazida; Metforylt" C8H8F3N3O4S2 DMDGGSIALPNSEE-UHFFFAOYSA-N 1,1-dioxo-6-(trifluoromethyl)-3,4-dihydro-2H-1lambda6,2,4-benzothiadiazine-7-sulfonamide n.a. n.a. No Yes No No No No PMDBD1231 Ibuprofen Therapeutic substance Drug 15687-27-1 DB01050 PA449957 D00126 DAP000780 3672 3544 n.a. "ibuprofen; 15687-27-1; 2-(4-Isobutylphenyl)propanoic acid; Brufen; Motrin; Advil; Nurofen; Nuprin; Liptan; Dolgit; Ibuprocin; Buburone; Ibumetin; Anflagen; Medipren; Butylenin; Lamidon; Ebufac; Mynosedin; Haltran; Epobron; Trendar; Roidenin; Apsifen; Nobfen; Bluton; Rufen; PediaProfen; Andran; Nobgen; Adran; 2-[4-(2-methylpropyl)phenyl]propanoic acid; Nobfelon; Tabalon; Inabrin; Suspren; Rebugen; Pantrop; Brufort; (RS)-Ibuprofen; Urem; Anco; Ibu-slo; Brufanic; Ibuprohm; Napacetin; Ibufen; Ibren; 4-Isobutylhydratropic acid; p-Isobutylhydratropic acid; Proar" C13H18O2 HEFNNWSXXWATRW-UHFFFAOYSA-N 2-[4-(2-methylpropyl)phenyl]propanoic acid n.a. n.a. No Yes No No No No PMDBD1235 Imipramine Therapeutic substance Drug 50-49-7 DB00458 PA449969 D08070 DAP001154 3696 3568 n.a. "imipramine; Melipramine; Imidobenzyle; 50-49-7; Antideprin; Melipramin; Berkomine; Dimipressin; Tofranil; Intalpram; Nelipramin; Timolet; Dynaprin; Janimine; Irmin; Dpid; Dyna-zina; Impramine; Promiben; Iramil; Imiprin; Censtin; Censtim; Imipramina; Declomipramine; Imipraminum; Imipramin; Imizin; Tofranil, base; 3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine; Psychoforin; Imavate; Imizine; Eupramin; Surplix; Imipramina [Italian]; Imipramine [INN:BAN]; Imipraminum [INN-Latin]; Imipramina [INN-Spanish]; N-(gamma-Dimethylam" C19H24N2 BCGWQEUPMDMJNV-UHFFFAOYSA-N 3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethylpropan-1-amine n.a. n.a. No Yes No No No No PMDBD1236 Indapamide Therapeutic substance Drug 26807-65-8 DB00808 PA449975 D00345 DAP000498 3702 3574 n.a. "indapamide; 26807-65-8; Noranat; Tertensif; Veroxil; Lozol; Indaflex; Indamol; Fludex; Arifon; Natrilix; Pressurai; Tandix; Ipamix; Bajaten; Indapamida; Metindamide; Cormil; Damide; Indapamidum; Indapamidum [INN-Latin]; Indapamida [INN-Spanish]; SE-1520; 1-(4-Chloro-3-sulfamoylbenzamido)-2-methylindoline; SE 1520; RHC 2555; USV 2555; Indapamide (Lozol); S-1520; 4-chloro-N-(2-methyl-2,3-dihydroindol-1-yl)-3-sulfamoylbenzamide; 4-chloro-N-(2-methyl-2,3-dihydro-1H-indol-1-yl)-3-sulfamoylbenzamide; 4-Chloro-N-(2-methyl-1-indolinyl)-3-sulfamo" C16H16ClN3O3S NDDAHWYSQHTHNT-UHFFFAOYSA-N 4-chloro-N-(2-methyl-2,3-dihydroindol-1-yl)-3-sulfamoylbenzamide n.a. n.a. No Yes No No No No PMDBD446 Indomethacin Therapeutic Substance NSAID 53-86-1 DB00328 PA449982 D00141 DAP000617 3715 3584 n.a. "indomethacin; 53-86-1; indometacin; Indocin; Indometacine; Indomethacine; Indocid; Metindol; Amuno; Indomethazine; Imbrilon; Tannex; Indomethacinum; Metartril; Infrocin; Indoptic; Artrivia; Inflazon; Indomecol; Mikametan; Methazine; Indoptol; Confortid; Artracin; Sadoreum; Reumacide; Idomethine; Artrinovo; Indomed; Metacen; Indomee; Inacid; Lausit; Indacin; Dolovin; Mobilan; Indo-tablinen; Indo-rectolmin; Inteban sp; Indometicina; Indometacyna; Mezolin; Indo-Lemmon; Indocin Sr; Indometa" C19H16ClNO4 CGIGDMFJXJATDK-UHFFFAOYSA-N 2-[1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]acetic acid Recordati Rare Diseases Inc Antiinflammatory Agents No Yes No No No Yes EX_imn(e),IMN_GLC_GLCAASE,IMN_GLC_GLCAASEe,IMN_GLC_GLCAASEepp,IMNte,IMNtepp,IMNtex PMDBD450 Iohexol Therapeutic Substance Approved Drug 66108-95-0 DB01362 PA450061 D01817 n.a. 3730 3599 n.a. "iohexol; 66108-95-0; Nycodenz; Omnipaque; Exypaque; Iohexolum; Omnipaque 240; Omnipaque 70; Omnipaque 140; Omnipaque 350; Omnipaque 300; Omnipaque 210; Omnipaque 180; Iohexolum [INN-Latin]; UNII-4419T9MX03; CHEBI:31709; EINECS 266-164-2; WIN 39424; BRN 2406632; N,N''-Bis(2,3-dihydroxypropyl)-5-(N-(2,3-dihydroxypropyl)acetamido)-2,4,6-triiodoisophthalamide; 5-[acetyl(2,3-dihydroxypropyl)amino]-1-N,3-N-bis(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide; WIN-39424; 4419T9MX03; NCGC00166000-01; DSSTox_CID_3157; 5-(N-2,3-Dih" C19H26I3N3O9 NTHXOOBQLCIOLC-UHFFFAOYSA-N 5-[acetyl(2,3-dihydroxypropyl)amino]-1-N,3-N-bis(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide n.a. n.a. Yes No No No No No PMDBD451 Iopanoic acid Therapeutic Substance Approved Drug 96-83-3 DB08946 n.a. n.a. n.a. 3735 3604 n.a. "IOPANOIC ACID; Iodopanoic acid; 96-83-3; Telepaque; Cholevid; Polognost; Iopagnost; Iopanoicum; iopanic acid; Jopanoic acid; Copanoic; Colepax; Cistobil; Jopagnost; Choladine; Bilijodon; 2-(3-Amino-2,4,6-triiodobenzyl)butanoic acid; 2-(3-Amino-2,4,6-triiodobenzyl)butyric acid; Teletrast; Acidum iopanoicum; Iodopanic acid; NSC 41706; Acide iopanoique [French]; Acidum iopanoicum [INN-Latin]; Acido iopanoico [INN-Spanish]; Acide iopanoique [INN-French]; Acido iopanoico [Latin,Spanish]; HSDB 3345; 2-[(3-amino-2,4,6-triiodophenyl)methyl]bu" C11H12I3NO2 OIRFJRBSRORBCM-UHFFFAOYSA-N 2-[(3-amino-2,4,6-triiodophenyl)methyl]butanoic acid n.a. n.a. Yes No No No No No PMDBD454 Irbesartan Therapeutic Substance Approved Drug 138402-11-6 DB01029 PA450084 D00523 DAP000364 3749 3618 n.a. "irbesartan; 138402-11-6; Aprovel; Avapro; Karvea; SR-47436; BMS-186295; BMS 186295; SR 47436; UNII-J0E2756Z7N; CHEMBL1513; 8-butyl-7-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-7,9-diazaspiro[4.4]non-8-en-6-one; 2-butyl-3-{[2''-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one; CHEBI:5959; C25H28N6O; J0E2756Z7N; NCGC00095122-01; AK-57149; DSSTox_CID_3169; DSSTox_RID_76900; 2-Butyl-3-[2''-(1H-tetrazol-5-yl)" C25H28N6O YOSHYTLCDANDAN-UHFFFAOYSA-N 2-butyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one Bristol-Myers Squibb Antihypertensive Agents No Yes No No No No PMDBD1240 Isocarboxazid Therapeutic substance Drug 59-63-2 DB01247 PA450101 D02580 DAP000577 3759 3628 n.a. "isocarboxazid; 59-63-2; Isocarboxazide; Marplan; Isocarbonazid; Enerzer; Benazide; N''-Benzyl-5-methylisoxazole-3-carbohydrazide; Isocarboxyzid; Isocarbossazide; Marplon; Isocarbossazide [DCIT]; Maraplan; Isocarboxazidum [INN-Latin]; Isocarboxazide [INN-French]; Isocarboxazida [INN-Spanish]; BMIH; N''-benzyl-5-methyl-1,2-oxazole-3-carbohydrazide; Ro 5-0831; Ro 5-0831/1; N''-Benzyl N-methyl-5-isoxazolecarboxylhydrazide-3; 3-Isoxazolecarboxylic acid, 5-methyl-, 2-(phenylmethyl)hydrazide; 5-Methyl-3-isoxazolecarboxylic acid 2-benzylhy" C12H13N3O2 XKFPYPQQHFEXRZ-UHFFFAOYSA-N N''-benzyl-5-methyl-1,2-oxazole-3-carbohydrazide n.a. n.a. No Yes No No No No PMDBD459 Isoconazole Therapeutic Substance Approved Drug 27523-40-6 DB08943 n.a. D04624 n.a. 3760 3629 n.a. "Isoconazole; 27523-40-6; Travogen; Isoconazol [INN-Spanish]; Isoconazolum [INN-Latin]; EINECS 248-508-3; CHEBI:83667; 1-[2-(2,4-dichlorophenyl)-2-[(2,6-dichlorophenyl)methoxy]ethyl]imidazole; Isoconazolum; Isoconazol; 1-(2,4-Dichloro-beta-((2,6-dichlorobenzyl)oxy)phenethyl)imidazole; 1-(2-(2,4-Dichlorophenyl)-2-((2,6-dichlorophenyl)methoxy)ethyl)1H-imidazole; DSSTox_CID_25447; DSSTox_RID_80886; DSSTox_GSID_45447; 1-(2-(2,4-Dichlorophenyl)-2-((2,6-dichlorophenyl)methoxy)ethyl)-1H-imidazole; 1H-Imidazole, 1-(2-(2,4-dichlorop" C18H14Cl4N2O MPIPASJGOJYODL-UHFFFAOYSA-N 1-[2-(2,4-dichlorophenyl)-2-[(2,6-dichlorophenyl)methoxy]ethyl]imidazole n.a. n.a. Yes No Yes No No No PMDBD1241 Isradipine Therapeutic substance Drug 75695-93-1 DB00270 PA450131 D00349 DAP000134 3784 3652 n.a. "isradipine; 75695-93-1; DynaCirc; Isradipin; Lomir; Isrodipine; Prescal; Esradin; Dynacirc CR; Clivoten; Dynacrine; Isradipinum [Latin]; Isradipino [Spanish]; Rebriden; DynaCire; PN 200-110; PN-200-110; DynaCire CR; (+-)-Isradipine; (+/-)-Isradipine; Isradipine (Dynacirc); PN 200; C19H21N3O5; 3,5-Pyridinedicarboxylic acid, 4-(4-benzofurazanyl)-1,4-dihydro-2,6-dimethyl-, methyl 1-methylethyl ester; 3,5-Pyridinedicarboxylic acid, 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-2,6-dimethyl-, methyl 1-methylethyl ester; Isopropyl methyl (+-)" C19H21N3O5 HMJIYCCIJYRONP-UHFFFAOYSA-N 3-O-methyl 5-O-propan-2-yl 4-(2,1,3-benzoxadiazol-4-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate n.a. n.a. No Yes No No No No PMDBD467 Ketoconazole "Therapeutic Substance; Herbal Substance" fungal infections 65277-42-1 DB01026 PA450146 D00351 DAP000630 3823 3691 NPC471614 "ketoconazole; Nizoral; 79156-75-5; 1-[4-[4-[[2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone; 65277-42-1; NSC317629; Ketozole; CHEBI:48339; NSC-317629; R-41400; 1-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]ethanone; Ketokonazol; fungarest;fungoral; SCHEMBL8408; Oprea1_683648; US8987315, Ketoconazole; CHEMBL157101; GTPL2568; SCHEMBL18258319; CTK5E6507; J02AB02; DTXSID20273956; BDBM151585; HMS3267K04; Piperazine, (+" C26H28Cl2N4O4 XMAYWYJOQHXEEK-UHFFFAOYSA-N 1-[4-[4-[[2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone Johnson & Johnson Antifungal Agents Yes Yes Yes No No No PMDBD468 Ketoprofen "Therapeutic Substance; Herbal Substance" anti-inflammatory 22071-15-4 DB01009 PA450149 D00132 DAP000623 3825 3693 NPC329556 "ketoprofen; 22071-15-4; 2-(3-Benzoylphenyl)propanoic acid; Orudis; 2-(3-Benzoylphenyl)propionic acid; Ketoprofene; m-Benzoylhydratropic acid; Profenid; Oruvail; 3-Benzoylhydratropic acid; Capisten; Alrheumat; Alrheumun; Epatec; Actron; Aneol; Orudis (TN); Orudis KT; Ketoprophene; Ketoprofeno; RP-19583; racemic-Ketoprofen; 2-[3-(phenylcarbonyl)phenyl]propanoic acid; RP 19583; 2-(m-Benzoylphenyl)propionic acid; Ketoprofenum [INN-Latin]; Ketoprofene [INN-French]; Racemic ketoprofen; Ketoprofeno [INN-Spanish]; 3-BENZOYL-ALPHA-METHYLBENZENE" C16H14O3 DKYWVDODHFEZIM-UHFFFAOYSA-N 2-(3-benzoylphenyl)propanoic acid ProEthic Pharmaceuticals Analgesics No Yes No No No No PMDBD1244 Labetalol Therapeutic substance Drug 36894-69-6 DB00598 PA164743150 D08106 DAP000038 3869 3734 n.a. "labetalol; 36894-69-6; Labetolol; Albetol; Ibidomide; Normodyne; Labetalolum; Trandate; Labetalolum [INN-Latin]; 2-Hydroxy-5-(1-hydroxy-2-((4-phenylbutan-2-yl)amino)ethyl)benzamide; Labetalol [INN:BAN]; AH 5158; 5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide; 2-hydroxy-5-[1-hydroxy-2-(4-phenylbutan-2-ylamino)ethyl]benzamide; ScH 15719W; UNII-R5H8897N95; HSDB 6537; 3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol; EINECS 253-258-3; CHEBI:6343; AH-5158; 2-Hydroxy-5-(1-hydroxy-2-(" C19H24N2O3 SGUAFYQXFOLMHL-UHFFFAOYSA-N 2-hydroxy-5-[1-hydroxy-2-(4-phenylbutan-2-ylamino)ethyl]benzamide n.a. n.a. No Yes No No No No PMDBD1247 Lamotrigine Therapeutic substance Drug 84057-84-1 DB00555 PA450164 D00354 DAP000039 3878 3741 n.a. "lamotrigine; 84057-84-1; 6-(2,3-Dichlorophenyl)-1,2,4-triazine-3,5-diamine; Lamictal; Lamictal Cd; Lamotriginum [Latin]; Lamictal XR; Lamotrigina [Spanish]; Lamotriginum; Lamotrigina; BW-430C; Lamictal ODT; BW 430C; 3,5-Diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine; 3,5-Diamino-6-(2,3-dichlorophenyl)-as-triazine; UNII-U3H27498KS; EINECS 281-901-8; CHEMBL741; C9H7Cl2N5; LTG;BW430C; MLS000069685; CHEBI:6367; U3H27498KS; Lamotrigine, 98%; NCGC00015605-06; Labileno; SMR000058464; Lamito" C9H7Cl2N5 PYZRQGJRPPTADH-UHFFFAOYSA-N 6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine n.a. n.a. No Yes No No No No PMDBD472 Lansoprazole Therapeutic Substance Approved Drug 103577-45-3 DB00448 PA450180 D00355 DAP000725 3883 3746 n.a. "lansoprazole; 103577-45-3; Prevacid; Bamalite; Monolitum; Ogastro; Lansoprazol; Limpidex; Agopton; Lanzor; Opiren; Prevacid SoluTab; Takepron; Lanzopral; Zoton; Lansopep; Lanproton; Mesactol; Lasoprol; Lancid; Ketian; Blason; Prezal; Lanston; Aprazol; Ulpax; Lanz; Pro Ulco; AG-1749; Lansoprazolum; Compraz; Prosogan; Ilsatec; Suprecid; Zoprol; Dakar; Promp; Prevacid Iv; Lanzol-30; AG 1749; Lansoprazol [INN-Spanish]; Lansox; Lansoprazolum [INN-Latin]; Lanzo; A-65006; Prevacid 24HR; CHEBI:6375; HSDB 7204; 2-[[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]m" C16H14F3N3O2S MJIHNNLFOKEZEW-UHFFFAOYSA-N 2-[[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl]-1H-benzimidazole n.a. n.a. Yes Yes Yes No No No PMDBD473 Leflunomide Therapeutic Substance Approved Drug 75706-12-6 DB01097 PA450192 D00749 DAP000636 3899 3762 n.a. "leflunomide; 75706-12-6; Arava; lefunamide; Leflunomidum; Leflunomida; HWA 486; 5-methyl-N-[4-(trifluoromethyl)phenyl]-1,2-oxazole-4-carboxamide; Leflunomidum [INN-Latin]; HWA-486; SU 101 (pharmaceutical); Leflunomida [INN-Spanish]; SU101; Arava (TN); 5-Methylisoxazole-4-carboxylic acid (4-trifluoromethyl)anilide; 5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide; alpha,alpha,alpha-Trifluoro-5-methyl-4-isoxazolecarboxy-p-toluidide; UNII-G162GK9U4W" C12H9F3N2O2 VHOGYURTWQBHIL-UHFFFAOYSA-N 5-methyl-N-[4-(trifluoromethyl)phenyl]-1,2-oxazole-4-carboxamide Sanofi-Aventis Antiinflammatory Agents Yes Yes No No No No PMDBD1255 Letrozole Therapeutic substance Drug 112809-51-5 DB01006 PA450196 D00964 DAP000626 3902 3765 n.a. "letrozole; 112809-51-5; Femara; 4,4''-((1h-1,2,4-triazol-1-yl)methylene)dibenzonitrile; Letrozol; CGS 20267; CGS-20267; LETRAZOLE; Femera; 4-[(4-cyanophenyl)-(1,2,4-triazol-1-yl)methyl]benzonitrile; UNII-7LKK855W8I; 4,4''-(1H-1,2,4-triazol-1-ylmethanediyl)dibenzonitrile; HSDB 7461; 4,4''-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile; C17H11N5; CHEMBL1444; 4-[(4-CYANOPHENYL)(1H-1,2,4-TRIAZOL-1-YL)METHYL]BENZONITRILE; 4,4''-(1h-1,2,4-triazol-1-ylmethylene)bisbenzonitrile; 7L" C17H11N5 HPJKCIUCZWXJDR-UHFFFAOYSA-N 4-[(4-cyanophenyl)-(1,2,4-triazol-1-yl)methyl]benzonitrile n.a. n.a. No Yes No No No No PMDBD490 Loperamide "Therapeutic Substance; Herbal Substance" "Approved Drug; Medicinal Herbal Compounds" 53179-11-6 DB00836 PA450262 D08144 DAP000425 3955 3818 NPC316906 "loperamide; 53179-11-6; Imodium; Ioperamide; Loperamidum; Loperamida; Loperamidum [INN-Latin]; Loperamida [INN-Spanish]; Loperamide [INN:BAN]; 4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-N,N-dimethyl-2,2-diphenylbutanamide; UNII-6X9OC3H4II; Maalox Anti-Diarrheal; C29H33ClN2O2; EINECS 258-416-5; R-18553; CHEMBL841; BRN 1558273; 6X9OC3H4II; 4-(4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl)-N,N-dimethyl-2,2-diphenylbutanamide; CHEBI:6532; 4-(4" C29H33ClN2O2 RDOIQAHITMMDAJ-UHFFFAOYSA-N 4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-N,N-dimethyl-2,2-diphenylbutanamide Janssen Pharmaceutica Antidiarrheals No Yes No Yes No No PMDBD494 Loratadine "Therapeutic Substance; Herbal Substance" "Approved Drug; Medicinal Herbal Compounds" 79794-75-5 DB00455 PA450266 D00364 DAP000101 3957 3820 NPC116961 "loratadine; 79794-75-5; Claritin; Loratidine; Clarityn; Alavert; Lisino; Clarityne; Loracert; Loradex; Loratyne; Fristamin; Claritine; Lorastine; Lertamine; Histaloran; Bonalerg; Civeran; Versal; Loranox; Allertidin; Polaratyne; Rinomex; Rhinase; Nularef; Claratyne; Optimin; Loritine; Anhissen; Sohotin; Sensibit; Restamine; Lorfast; Loraver; Lesidas; Clarinase; Biloina; Aerotina; Velodan; Sanelor; Lowadina; Lorantis; Loradif; Alerpriv; Lergy; Alarin; Tadine; Pylor; Zeos; Sch 29851; Sinhistan Dy; Talorat Dy; Bedix Loratadina; Claritin Reditabs; Clarinase Repera" C22H23ClN2O2 JCCNYMKQOSZNPW-UHFFFAOYSA-N ethyl 4-(13-chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-ylidene)piperidine-1-carboxylate Schering-Plough Corporation Antihistamines Yes Yes Yes No No No PMDBD1260 Lorazepam Therapeutic substance Drug 846-49-1 DB00186 PA450267 D00365 DAP000237 3958 3821 n.a. "lorazepam; Ativan; o-Chloroxazepam; 846-49-1; o-Chlorooxazepam; Temesta; Tavor; Delormetazepam; Sedatival; Duralozam; Bonatranquan; Anxiedin; Almazine; Lorabenz; Idalprem; Emotival; Punktyl; Orfidal; Laubeel; Wypax; Quait; Lorax; Loraz; Apo-Lorazepam; Lorazepam Intensol; Norlormetazepam; Aplacassee; Sidenar; Novhepar; Lozepam; Lorazin; Larpose; Kalmalin; Efasedan; Azurogen; Tranqipam; Sinestron; Sedizepan; Rocosgen; Lorapam; Lorsedal; Lorazep; Lorazene; Equitam; Aplacasse; Silence; Renaquil; Loridem; Lorenin; Anzepam; Tolid; Merlit; Lorat; Loram; Bonton; Trapax" C15H10Cl2N2O2 DIWRORZWFLOCLC-UHFFFAOYSA-N 7-chloro-5-(2-chlorophenyl)-3-hydroxy-1,3-dihydro-1,4-benzodiazepin-2-one n.a. n.a. No Yes No No No No PMDBD495 Losartan Therapeutic Substance Approved Drug 114798-26-4 DB00678 PA450268 D08146 DAP000523 3961 3824 n.a. "losartan; 114798-26-4; DUP 89; Lortaan; LOSARTAN POTASSIUM; Cozaar; Hyzaar; Losartan [INN:BAN]; Losartan monopotassium salt; UNII-JMS50MPO89; C22H23ClN6O; MK-954; DuP-753; CHEBI:6541; JMS50MPO89; 2-n-butyl-4-chloro-5-hydroxymethyl-1-[(2''-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]imidazole; (2-butyl-4-chloro-1-{[2''-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazol-5-yl)methanol; 2-Butyl-4-chloro-1-((2''-(1H-etrazol-5-yl) (1,1''-biphenyl)-4-yl)methyl)-1H-imidazole-5-methanol; [2-butyl-5-chloro-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]ph" C22H23ClN6O PSIFNNKUMBGKDQ-UHFFFAOYSA-N [2-butyl-5-chloro-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Merck & Co Antihypertensive Agents No Yes No No No Yes EX_lstn(e),LSTN1GLUC_GLCAASE,LSTN1GLUC_GLCAASEe,LSTN1GLUC_GLCAASEepp,LSTNM7_GLCAASE,LSTNM7_GLCAASEe,LSTNM7_GLCAASEepp,LSTNte,LSTNtepp,LSTNtex PMDBD1264 Malathion Environmental Chemicals Pesticides 121-75-5 DB00772 PA164748092 D00534 DAP000895 4004 3864 n.a. "malathion; Carbophos; 121-75-5; Carbofos; Mercaptothion; Karbofos; Phosphothion; Prioderm; Maldison; Carbetox; Ethiolacar; Sadophos; Cythion; Oleophosphothion; Chemathion; Sadofos; Malagran; Fosfotion; Carbetovur; Moscarda; Malakill; Malathon; Malaspray; Malaphos; Fosfothion; Malphos; Fyfanon; Malatox; Taskil; Sumitox; Malafor; Cimexan; Malatol; Malamar; Etiol; Ovide; Emmatos extra; Ortho Malathion; Siptox I; Hilthion; Mercaptotion; Malacide; Malation; Forthion; Extermathion; Malathion E50; Malasol; Malmed; Kypfos; Malamar 50; Carbethoxy malathion; Kop-thio" C10H19O6PS2 JXSJBGJIGXNWCI-UHFFFAOYSA-N diethyl 2-dimethoxyphosphinothioylsulfanylbutanedioate n.a. n.a. Yes No No No No No PMDBD1266 Maprotiline Therapeutic substance Drug 10262-69-8 DB00934 PA450322 D02566 DAP001150 4011 3871 n.a. "maprotiline; 10262-69-8; Maprotylina [Polish]; Maprotilin; Maprotylina; Maprotilinum [INN-Latin]; Maprotilina [INN-Spanish]; 276-Ba; UNII-2U1W68TROF; N-Methyl-9,10-ethanoanthracene-9(10H)-propylamine; CHEBI:6690; EINECS 233-599-4; 3-(9,10-Dihydro-9,10-ethanoanthracen-9-yl)propylmethylamine; BRN 2385493; 3-(9,10-Dihydro-9,10-ethanoanthracen-9-yl)-N-methylpropan-1-amine; 2U1W68TROF; BA-34276; BA-34276 [As Hydrochloride]; NCG" C20H23N QSLMDECMDJKHMQ-UHFFFAOYSA-N N-methyl-3-(1-tetracyclo[6.6.2.02,7.09,14]hexadeca-2,4,6,9,11,13-hexaenyl)propan-1-amine n.a. n.a. No Yes No No No No PMDBD511 Mebendazole Therapeutic Substance Approved Drug 31431-39-7 DB00643 PA164776669 D00368 DAP000950 4030 3890 n.a. "mebendazole; 31431-39-7; Vermox; Telmin; Mebenvet; Pantelmin; Vermirax; Ovitelmin; Mebenoazole; Mebutar; Bantenol; Lomper; MBDZ; Vermicidin; Verpanyl; Besantin; Noverme; Mebendazol; Sufil; Methyl (5-benzoyl-1H-benzo[d]imidazol-2-yl)carbamate; Mebendazolum; Versid; Carbamic acid, (5-benzoyl-1H-benzimidazol-2-yl)-, methyl ester; 5-Benzoyl-2-benzimidazolecarbamic acid methyl ester; Methyl 5-benzoyl-2-benzimidazolecarbamate; Methyl 5-benzoyl-2-benzimidazolylcarbamate; Mebendazolum [INN-Latin]; Mebendazol [INN-Spanish]; R 17635; Methyl 5-be" C16H13N3O3 OPXLLQIJSORQAM-UHFFFAOYSA-N methyl N-(6-benzoyl-1H-benzimidazol-2-yl)carbamate Janssen Pharmaceutica Antinematodal Agents No Yes No Yes No No PMDBD1271 Mefenamic Acid Therapeutic substance NSAID 61-68-7 DB00784 PA450347 D00151 DAP000779 4044 3904 n.a. "mefenamic acid; 61-68-7; Ponstel; 2-[(2,3-dimethylphenyl)amino]benzoic acid; Ponstan; Mephenamic acid; Parkemed; Coslan; Ponalar; Mefacit; Methenamic acid; 2-((2,3-Dimethylphenyl)amino)benzoic acid; Mephenaminic acid; Mefenaminsaeure; Vialidon; Lysalgo; Tanston; Bonabol; Bafameritin-M; Tamany Bonsan; Ponstan forte; Acide mefenamique; Pontal; Namphen; Mefanamic acid; Bafhameritin-M; Ponstyl; CN-35355; Mefenacid; Ponstil; N-2,3-Xylylanthranilic acid; 2-(2,3-Dimethylanilino)benzoic acid; HL 1; Mefedolo; Mycasaal; Rolan; INF-3355; INF 3355; Acido m" C15H15NO2 HYYBABOKPJLUIN-UHFFFAOYSA-N 2-(2,3-dimethylanilino)benzoic acid n.a. n.a. No Yes No No No No PMDBD517 Mefloquine Therapeutic Substance Approved Drug 53230-10-7 DB00358 PA450348 D04895 DAP001310 4046 3906 n.a. "mefloquine; Lariam; GNF-Pf-5544; 49752-90-1; 53230-10-7; alpha-2-Piperidinyl-2,8-bis(trifluoromethyl)-4-quinolinemethanol; WR-142490; CHEMBL416956; CHEBI:63681; Mefloquinone; [2,8-bis(trifluoromethyl)quinolin-4-yl]-(2-piperidyl)methanol; melfoquine; Mefaquin; Meflokin; rac-mefloquine; [2,8-bis(trifluoromethyl)quinolin-4-yl](piperidin-2-yl)methanol; (2,8-bis(trifluoromethyl)quinolin-4-yl)(piperidin-2-yl)methanol; EINECS 256-468-3; Ro-21-5998-001; Spectrum_001312; Spectrum5_001122; Spectrum3_000953; Prestwick3_000126; Spectrum2_001" C17H16F6N2O XEEQGYMUWCZPDN-UHFFFAOYSA-N [2,8-bis(trifluoromethyl)quinolin-4-yl]-piperidin-2-ylmethanol n.a. n.a. No Yes No No No No PMDBD521 Memantine Therapeutic Substance Approved Drug 19982-08-2 DB01043 PA10364 D08174 DAP000493 4054 3914 n.a. "memantine; 19982-08-2; 3,5-dimethyladamantan-1-amine; 1-Amino-3,5-dimethyladamantane; Namenda; Ebixa; 3,5-Dimethyl-1-adamantanamine; Memantina; Memantinum [INN-Latin]; Memantina [INN-Spanish]; Memantin; Memantinum; 1,3-Dimethyl-5-adamantanamine; Memantine [INN]; 3,5-Dimethyl-1-aminoadamantane; Memantine [INN:BAN]; 3,5-Dimethyl-1-adamantylamine; UNII-W8O17SJF3T; HSDB 7327; 3,5-Dimethyltricyclo(3.3.1.1(3,7))decan-1-amine; CHEMBL807; 3,5-dimethyladamantanylamine; W8O17SJF3T; D-145; CHE" C12H21N BUGYDGFZZOZRHP-UHFFFAOYSA-N 3,5-dimethyladamantan-1-amine Merz & Co GmbH n.a. No Yes No No No No PMDBD1275 Menadione Therapeutic substance chemotherapeutic 58-27-5 DB00170 PA450358 D02335 DNC001501 4055 3915 n.a. "menadione; 58-27-5; Vitamin K3; 2-Methyl-1,4-naphthoquinone; Menaphthone; 2-methylnaphthalene-1,4-dione; 2-Methylnaphthoquinone; Thyloquinone; 2-Methyl-1,4-naphthalenedione; Panosine; Klottone; Kayquinone; Kappaxin; Kayklot; Kolklot; Menaphthon; Menadion; Kipca; Kanone; Prokayvit; Kaergona; Aquinone; Mitenone; Kativ-G; Aquakay; Mitenon; Koaxin; Kaykot; Kareon; Hemodal; Synkay; Karcon; K-Thrombyl; K-Vitan; Kipca-Oil Soluble; Juva-K; Vitamin K2(0); Vitamin K0; Vitamin K 3; 2-Methyl-1,4-naphthochinon; Menaquinone 0; Menaphtone; Menadionum; Usaf ek-5185" C11H8O2 MJVAVZPDRWSRRC-UHFFFAOYSA-N 2-methylnaphthalene-1,4-dione n.a. n.a. No Yes No No No No PMDBD1277 Meprobamate Therapeutic substance Drug 57-53-4 DB00371 PA450377 D00376 DAP001507 4064 3924 n.a. "meprobamate; Meprobamat; Meprospan; Equanil; Miltown; Meprocompren; Amepromat; Meprobam; Tranmep; Meproban; Dapaz; Neuramate; Metranquil; Meprocon; Mepantin; Lepetown; Ipsotian; Equilium; Equatrate; Carbaxin; Biobamate; Ansiatan; Anastress; Holbamate; Despasmol; Cirponyl; Biobamat; Miltamato; Meprotil; Meprotan; Meprosan; Meproleaf; Meprindon; Mepranil; Mepavlon; Margonil; Harmonin; Dicandiol; Calmadin; Auxietil; Anxietil; Ansiowas; Metractyl; Meprotabs; Meprosin; Meprodil; Mepiosine; Libiolan; Crestanil; Calmiren; Ayeramate; Andaksin; Anatimon; Anathylmon; Mi" C9H18N2O4 NPPQSCRMBWNHMW-UHFFFAOYSA-N [2-(carbamoyloxymethyl)-2-methylpentyl] carbamate n.a. n.a. No Yes No No No No PMDBD525 Mesalazine Therapeutic Substance anti-inflammatory 89-57-6 DB00244 PA450384 D00377 DAP000729 4075 3933 n.a. "5-Aminosalicylic acid; mesalamine; Mesalazine; 5-Amino-2-hydroxybenzoic acid; 89-57-6; Asacol; Pentasa; Claversal; Canasa; 5-ASA; Salofalk; Rowasa; m-Aminosalicylic acid; Mesasal; Lialda; Fisalamine; Lixacol; Apriso; p-Aminosalicylsaeure; sfRowasa; Mesalazinum; Asacolitin; Mesalazina; 5-amino-2-hydroxy-benzoic acid; Asacol HD; Mesalazinum [Latin]; 5-Amino Salicylic Acid; Mesalamine [USAN]; Mesalazina [Spanish]; p-Aminosalicylsaeure [German]; 2-Hydroxy-5-aminobenzoic acid; 3-carbox" C7H7NO3 KBOPZPXVLCULAV-UHFFFAOYSA-N 5-amino-2-hydroxybenzoic acid n.a. n.a. No Yes No Yes No No PMDBD530 Metformin "Therapeutic Substance; Herbal Substance" Cardiac drugs 657-24-9 DB00331 PA450395 D04966 DAP000205 4091 3949 NPC230775 "metformin; 657-24-9; 1,1-Dimethylbiguanide; N,N-dimethylimidodicarbonimidic diamide; Metiguanide; Metformine; Dimethylbiguanide; Haurymelin; Gliguanid; Fluamine; Flumamine; Melbin; Diabex; N,N-Dimethylbiguanide; Glumetza; Islotin; Glifage; Siofor; N1,N1-Dimethylbiguanide; DMGG; NNDG; Dimethyldiguanide; N,N-Dimethyldiguanide; Metformina [DCIT]; Metformina [Spanish]; Metforminum [INN-Latin]; Metformine [INN-French]; Metformin [USAN:INN:BAN]; 1,1-Dimethyl biguanide; LA-6023; BIGUANIDE, 1,1-DIMETHY" C4H11N5 XZWYZXLIPXDOLR-UHFFFAOYSA-N 3-(diaminomethylidene)-1,1-dimethylguanidine Bristol-Myers Squibb Hypoglycemic Agents Yes Yes Yes Yes No No PMDBD1283 Methazolamide Therapeutic substance Drug 554-57-4 DB00703 PA450413 D00655 DAP000599 4100 21122102 n.a. "methazolamide; 554-57-4; Neptazane; Methenamide; Neptazaneat; Naptazane; Metazolamide [DCIT]; N-(3-methyl-5-sulfamoyl-1,3,4-thiadiazol-2-ylidene)acetamide; Methazolamidum [INN-Latin]; Metazolamida [INN-Spanish]; UNII-W733B0S9SD; (Z)-methazolamide; CHEBI:6822; C5H8N4O3S2; HSDB 3269; EINECS 209-066-7; L584601; BRN 0232387; UNII-DA43GW06P1; MLS000028532; CHEMBL288100; W733B0S9SD; DA43GW06P1; Acetamide, N-[5-(aminosulfonyl)-3-methyl-1,3,4-thiadiazol-2(3H)-ylide" C5H8N4O3S2 FLOSMHQXBMRNHR-UHFFFAOYSA-N N-(3-methyl-5-sulfamoyl-1,3,4-thiadiazol-2-ylidene)acetamide n.a. n.a. No Yes No No No No PMDBD1286 Methocarbamol Therapeutic substance Drug 532-03-6 DB00423 PA164749506 D00402 n.a. 4107 3964 n.a. "methocarbamol; 532-03-6; Robaxin; Lumirelax; Parabaxin; Metocarbamolo; Relestrid; Myolaxene; Miolaxene; Metofenia; Tresortil; Romethocarb; Etroflex; Surquetil; Reflexyn; Neuraxin; Methocal; Miorilas; Metocarbamol; Miowas; Robinax; Delaxin; Avetil; Perilax; Metofenina; Guaiacol glyceryl ether carbamate; Guaiphenesin carbamate; Guaiphenesine carbamate; Glycerylguaiacolate carbamate; Glycerylguajacol-carbamat; Forbaxin; AHR 85; 2-Hydroxy-3-(2-methoxyphenoxy)propyl carbamate; Methocarbamolum; Robaxine; Robaxan; Robaxon; 1,2-Propanediol, 3-(2-metho" C11H15NO5 GNXFOGHNGIVQEH-UHFFFAOYSA-N [2-hydroxy-3-(2-methoxyphenoxy)propyl] carbamate n.a. n.a. No Yes No No No No PMDBD537 Methoxsalen "Therapeutic Substance; Herbal Substance" "Approved Drug; Medicinal Herbal Compounds" 298-81-7 DB00553 PA450433 D00139 DAP000996 4114 3971 NPC33320 "methoxsalen; 8-Methoxypsoralen; 298-81-7; XANTHOTOXIN; Ammoidin; Meladinine; Xanthotoxine; 8-MOP; Oxsoralen; Meloxine; Meladinin; Oxypsoralen; Puvalen; 9-Methoxy-7H-furo[3,2-g]chromen-7-one; Meladoxen; Ammodin; Uvadex; Methoxa-Dome; 8-Methoxypsoralene; Oxsoralen-ultra; New-Meladinin; Methoxalen; Geroxalen; Puvamet; Oxsoralen lotion; Zanthotoxin; Oxsoralen Ultra; 9-methoxyfuro[3,2-g]chromen-7-one; Psoralon-MOP; 9-Methoxypsoralen; 8-MP; 8-Methoxyfuranocoumarin; Proralone-mop; 9-Methoxy-7H-furo[3,2-g][1]benzopyran-7-one; O-methylxanthotoxol; Me" C12H8O4 QXKHYNVANLEOEG-UHFFFAOYSA-N 9-methoxyfuro[3,2-g]chromen-7-one n.a. Anticancer Agents No Yes No No No No PMDBD541 Methylphenidate Therapeutic Substance Approved Drug 113-45-1 DB00422 PA450464 D04999 DAP000024 4158 4015 n.a. "methylphenidate; Methylphenidan; Phenidylate; Concerta; Calocain; Plimasine; Meridil; Methyl phenidate; Methyl phenidylacetate; 113-45-1; Ritalin; Metilfenidato [Italian]; Methylfenidan; Methylphenidatum; Metilfenidato [INN-Spanish]; Methylphenidatum [INN-Latin]; 4311/B Ciba; Methyl phenidyl acetate; methyl phenyl(piperidin-2-yl)acetate; Methyl alpha-phenyl-alpha-(2-piperidyl)acetate; alpha-Phenyl-2-piperidineacetic acid methyl ester; NCI-C56280; HSDB 3126; 2-Piperidineacetic acid, alpha-phenyl-, methyl ester; Methyl (2-phenyl-2-(" C14H19NO2 DUGOZIWVEXMGBE-UHFFFAOYSA-N methyl 2-phenyl-2-piperidin-2-ylacetate Novartis Central Nervous System Stimulants No Yes No Yes No No PMDBD1289 Metoclopramide Therapeutic substance Drug 364-62-5 DB01233 PA450475 D00726 DAP000530 4168 4024 n.a. "metoclopramide; 364-62-5; Methochlopramide; Metochlopramide; Primperan; Reliveran; Metaclopramide; Reglan; Metaclopromide; Moriperan; Metoclol; Plasil; Maxolon; 2-Methoxy-5-chloroprocainamide; Metoclopramida; 4-Amino-5-chloro-N-(2-(diethylamino)ethyl)-2-methoxybenzamide; Methoclopramide; Metoclopramidum; Elieten; Plasil (pharmaceutical); Metoclopramidum [INN-Latin]; Metoclopramida [INN-Spanish]; Cerucal; 5-Chloro-2-methoxyprocainamide; Clopra; 4-amino-5-chloro-N-[2-(diethylamino)ethyl]-2-methoxybenzamide; Metocobil; Maxeran; Gastromax" C14H22ClN3O2 TTWJBBZEZQICBI-UHFFFAOYSA-N 4-amino-5-chloro-N-[2-(diethylamino)ethyl]-2-methoxybenzamide n.a. n.a. No Yes No No No No PMDBD1290 Metolazone Therapeutic substance Drug 17560-51-9 DB00524 PA164781022 D00431 DAP000749 4170 4026 n.a. "metolazone; 17560-51-9; Zaroxolyn; Diulo; Mykrox; Microx; Metalozone; Oldren; Metenix; 7-Chloro-2-methyl-4-oxo-3-(o-tolyl)-1,2,3,4-tetrahydroquinazoline-6-sulfonamide; Metolazonum; Metolazona; Metolazonum [INN-Latin]; Metolazona [INN-Spanish]; 7-Chloro-1,2,3,4-tetrahydro-2-methyl-3-(2-methylphenyl)-4-oxo-6-quinazolinesulfonamide; SR-720-22; SR 720-22; Metolazone (Zaroxolyn); 2-Methyl-3-o-tolyl-6-sulfamyl-7-chloro-1,2,3,4-tetrahydro-4-quinazolinone; 7-Chloro-1,2,3,4-tetrahydro-2-methyl-4-oxo-3-o-tolyl-6-quinazolinesulfonamide" C16H16ClN3O3S AQCHWTWZEMGIFD-UHFFFAOYSA-N 7-chloro-2-methyl-3-(2-methylphenyl)-4-oxo-1,2-dihydroquinazoline-6-sulfonamide n.a. n.a. No Yes No No No No PMDBD546 Metronidazole "Therapeutic Substance; Herbal Substance" antibiotic 443-48-1 DB00916 PA450484 D00409 DAP000534 4173 4029 NPC332382 "metronidazole; 443-48-1; Flagyl; Metronidazol; 2-Methyl-5-nitroimidazole-1-ethanol; Anagiardil; Trichazol; MetroGel; Novonidazol; Metronidaz; Gineflavir; Trivazol; Trichopol; Meronidal; Danizol; Mexibol; Vagilen; Clont; Bayer 5360; Giatricol; 2-(2-Methyl-5-nitro-1H-imidazol-1-yl)ethanol; Trikacide; Trichomol; Sanatrichom; Flagemona; Trichocide; Takimetol; Metronidazolo; Tricocet; Efloran; Acromona; Trimeks; Trikamon; Monasin; Monagyl; Wagitran; Vagimid; Trikozol; Orvagil; Entizol; Deflamon; Atrivyl; Vertisal; Trikojol; Trichex; Flagesol; Tricom; Nalox" C6H9N3O3 VAOCPAMSLUNLGC-UHFFFAOYSA-N 2-(2-methyl-5-nitroimidazol-1-yl)ethanol Pfizer Pharmaceuticals Antiinfective Agents Yes Yes Yes Yes No Yes EX_mtz(e),MTZ_GLC_GLCAASE,MTZ_GLC_GLCAASEe,MTZ_GLC_GLCAASEepp,MTZte,MTZtepp,MTZtex PMDBD1292 Metyrapone Therapeutic substance Drug 54-36-4 DB01011 PA450486 D00410 DAP000424 4174 4030 n.a. "metyrapone; 54-36-4; 2-Methyl-1,2-di-3-pyridyl-1-propanone; Metopirone; Methopyrapone; Metopiron; Methopyrinine; Methopirapone; Methapyrapone; Metyrapon; Methopyrone; Methbipyranone; Metopyrone; Mepyrapone; Metroprione; Metapyron; Metirapona; Metyraponum; Metapirone; Su 4885; 2-methyl-1,2-dipyridin-3-ylpropan-1-one; Metyraponum [INN-Latin]; Metirapona [INN-Spanish]; 2-Methyl-1,2-di-3-pyridinyl-1-propanone; UNII-ZS9KD92H6V; 2-Methyl-1,2-bis(3-pyridyl)-1-propanone; NSC 25265; 1,2-Di-3-pyridyl-2" C14H14N2O FJLBFSROUSIWMA-UHFFFAOYSA-N 2-methyl-1,2-dipyridin-3-ylpropan-1-one n.a. n.a. No Yes No No No No PMDBD1293 Mexiletine Therapeutic substance Drug 31828-71-4 DB00379 PA450488 n.a. DAP000505 4178 4034 n.a. "Mexiletine; 31828-71-4; 1-(2,6-dimethylphenoxy)propan-2-amine; Mexitil; Mexiletina; Mexilitine; Mexiletinum; Mexiletinum [INN-Latin]; Mexiletina [INN-Spanish]; 1-(2,6-Dimethylphenoxy)-2-propanamine; Mexiletine [INN:BAN]; 1-Methyl-2-(2,6-xylyloxy)ethylamine; 2-(2-aminopropoxy)-1,3-dimethylbenzene; 1-(2'',6''-Dimethylphenoxy)-2-aminopropane; EINECS 250-825-7; CHEMBL558; 1-methyl-2-(2,6-xylyloxy)ethanamine; BRN 2092205; 1-(2,6-Dimethylphenoxy)-2-aminop" C11H17NO VLPIATFUUWWMKC-UHFFFAOYSA-N 1-(2,6-dimethylphenoxy)propan-2-amine n.a. n.a. No Yes No No No No PMDBD548 Miconazole Therapeutic Substance Approved Drug 22916-47-8 DB01110 PA450494 D00882 DAP000154 4189 4044 n.a. "miconazole; 22916-47-8; Monistat; Monistat IV; Daktarin IV; Miconazol; Miconazolum; Miconazolo; Minostate; Dactarin; MJR 1762; Miconazolum [INN-Latin]; Vusion; Miconazolo [DCIT]; Monistat-Derm; Florid(nitrate); 1-[2-(2,4-Dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-1H-imidazole; Miconazol [INN-Spanish]; Brentan; R 18134; 1-(2-((2,4-Dichlorobenzyl)oxy)-2-(2,4-dichlorophenyl)ethyl)-1H-imidazole; Miconazole 3; NSC 170986; C18H14Cl4N2O; 1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole; CCRIS 7924; Micona" C18H14Cl4N2O BYBLEWFAAKGYCD-UHFFFAOYSA-N 1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole Janssen Pharmaceutica Antifungal Agents Yes Yes Yes No No No PMDBD1297 Mirtazapine Therapeutic substance Drug 85650-52-8 DB00370 PA450522 D00563 DAP000010 4205 4060 n.a. "mirtazapine; 85650-52-8; Remeron; Remergil; Mepirzepine; Zispin; 61337-67-5; Remergon; Mirtazepine; Rexer; 6-Azamianserin; Remeron SolTab; Mirtazipine; Mepirzapin; Promyrtil; Norset; Mirtazapina; Avanza; ORG 3770; Mirtazapinum; Mirtazapinum [INN-Latin]; Mirtazapina [INN-Spanish]; 2-Methyl-1,2,3,4,10,14b-hexahydropyrazino[2,1-a]pyrido[2,3-c][2]benzazepine; Org-3770; Mirtazapine [USAN:INN:BAN]; 1,2,3,4,10,14b-Hexahydro-2-methylpyrazino[2,1-a]pyrido[2,3-c][2]benzazepine; EINECS 288-060-6; CHEMBL654; 1,2,3,4,10,14b-Hexahydro-2-methylpyraz" C17H19N3 RONZAEMNMFQXRA-UHFFFAOYSA-N 5-methyl-2,5,19-triazatetracyclo[13.4.0.02,7.08,13]nonadeca-1(15),8,10,12,16,18-hexaene n.a. n.a. No Yes No No No No PMDBD554 Mitotane Therapeutic Substance Approved Drug 53-19-0 DB00648 PA164746157 D00420 DAP000033 4211 4066 n.a. "mitotane; 53-19-0; Mitotan; Lysodren; o,p''-DDD; Chlodithane; Chloditan; Khlodithan; Chlodithan; 1-(2-Chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane; 2,4''-Ddd; Mitotano; 1-Chloro-2-[2,2-dichloro-1-(4-chlorophenyl)ethyl]benzene; NCI-C04933; Mitotanum [INN-Latin]; o,p''-TDE; 2,4''-Dichlorodiphenyldichloroethane; o,p-Tde; o,p''-Dichlorodiphenyldichloroethane; Mitotano [INN-Spanish]; 2,4''-Dichlorophenyldichlorethane; CB313; 1-Chloro-2-(2,2-dichloro-1-(4-chlorophenyl)ethyl)" C14H10Cl4 JWBOIMRXGHLCPP-UHFFFAOYSA-N 1-chloro-2-[2,2-dichloro-1-(4-chlorophenyl)ethyl]benzene Bristol Myers Squibb Anticancer Agents Yes Yes No No No No PMDBD1300 Mitoxantrone Therapeutic substance chemotherapeutic 65271-80-9 DB01204 PA450526 D08224 DAP000057 4212 4067 n.a. "mitoxantrone; 65271-80-9; Mitozantrone; Mitoxanthrone; DHAQ; Dihydroxyanthraquinone; Mitoxantron; Novantrone; Mitoxantrona; Mitoxantronum; Mitoxantronum [INN-Latin]; Mitoxantrona [INN-Spanish]; Mitoxantrone [INN]; NSC 279836; UNII-BZ114NVM5P; DHAD; NSC279836; NSC-279836; Mitoxantrone (INN); CCRIS 7604; 1,4-Bis(2-(2-hydroxyethylamino)ethyl)amino)-5,8-dihydroxyanthraquinone; C22H28N4O6; 1,4-Dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione; BRN 2795126; BZ114NVM5P; 5,8-Bis((2-((2-hydroxyethyl)amino)ethyl)amino" C22H28N4O6 KKZJGLLVHKMTCM-UHFFFAOYSA-N 1,4-dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione n.a. n.a. No Yes No No No No PMDBD1302 Modafinil Therapeutic substance Drug 68693-11-8 DB00745 PA450530 D01832 n.a. 4236 4088 n.a. "modafinil; 68693-11-8; Provigil; Modiodal; 2-[(diphenylmethyl)sulfinyl]acetamide; Modafinilum [Latin]; 2-(Benzhydrylsulfinyl)acetamide; Modafinilo [Spanish]; Alertec; CRL 40476; Modafinil [USAN:INN]; (+-)-Modafinil; 2-benzhydrylsulfinylacetamide; CRL-40476; 2-((Diphenylmethyl)sulfinyl)acetamide; Modavigil; CEP 1538; CHEMBL1373; C15H15NO2S; DEA No. 1680; CHEBI:77585; 2-(diphenylmethyl)sulfinylacetamide; CEP-1538; 2-(Diphenyl-methanesulfinyl)-acetamide; NCGC00095176-03; Sparlon; DSSTox_CID_3329" C15H15NO2S YFGHCGITMMYXAQ-UHFFFAOYSA-N 2-benzhydrylsulfinylacetamide n.a. n.a. No Yes No No No No PMDBD565 Nabumetone Therapeutic Substance NSAID 42924-53-8 DB00461 PA450572 D00425 DAP000735 4409 4256 n.a. "nabumetone; 42924-53-8; Relafen; 4-(6-methoxynaphthalen-2-yl)butan-2-one; Arthaxan; Nabumetona; Relifex; Relifen; Listran; 4-(6-Methoxy-2-naphthyl)-2-butanone; nabumeton; Mebutan; Consolan; Balmox; Relif; Flambate; Unimetone; Dolsinal; Prodac; Nabumetonum [INN-Latin]; Nabumetonum; Nabuser; 4-(6-Methoxy-2-naphthalenyl)-2-butanone; BRL-14777; UNII-LW0TIW155Z; BRL 14777; MLS000069541; 4-(2-Methoxynaphthalen-6-yl)butan-2-one; BRL14777; BRN 2103472; LW0TIW155Z; SMR000058835; CHEBI:7443; NCGC00016853-01" C15H16O2 BLXXJMDCKKHMKV-UHFFFAOYSA-N 4-(6-methoxynaphthalen-2-yl)butan-2-one Nobex Corp n.a. No Yes No No No No PMDBD566 Nadifloxacin Therapeutic Substance Approved Drug 124858-35-1 DB12447 n.a. n.a. n.a. 4410 4257 n.a. "nadifloxacin; 124858-35-1; OPC-7251; Nadixa; Acuatim; S-Nadifloxacin; Opc 7251; Nadifloxacine [INN-French]; Nadifloxacinum [INN-Latin]; Nadifloxacino [INN-Spanish]; jinofloxacin; NDFX; CCRIS 4066; C19H21FN2O4; CHEBI:31889; NCGC00164620-01; Nadifloxacino; Nadifloxacinum; Nadifloxacine; DSSTox_RID_81654; DSSTox_CID_26483; DSSTox_GSID_46483; 9-fluoro-8-(4-hydroxypiperidin-1-yl)-5-methyl-1-oxo-1,5,6,7-tetrahydropyrido[3,2,1-ij]quinoline-2-carboxylic acid; 1H,5H-Benzo[ij]quinolizine-2-carboxylic acid, 9-fluoro-6,7-dihydro-8-(4-hydroxy" C19H21FN2O4 JYJTVFIEFKZWCJ-UHFFFAOYSA-N 7-fluoro-8-(4-hydroxypiperidin-1-yl)-12-methyl-4-oxo-1-azatricyclo[7.3.1.05,13]trideca-2,5,7,9(13)-tetraene-3-carboxylic acid n.a. n.a. Yes No Yes No No No PMDBD569 Naftopidil Therapeutic Substance Approved Drug 57149-07-2 DB12092 n.a. n.a. n.a. 4418 4265 n.a. "naftopidil; 57149-07-2; KT-611; Flivas; Naftopidil [INN]; Avishot; Naftopidilum [Latin]; Naftopidil (Flivas); BM-15275; Naftopidil (unspecified); BRN 0629965; 1-(4-(2-methoxyphenyl)piperazin-1-yl)-3-(naphthalen-1-yloxy)propan-2-ol; CHEMBL142635; C24H28N2O3; 4-(2-methoxyphenyl)-alpha-[(1-naphthalenyloxy)methyl]-1-piperazineethanol; NCGC00015718-06; (+-)-1-(4-(2-Methoxyphenyl)piperazinyl)-3-(1-naphthyloxy)propan-2-ol; (RS)-1-(4-(2-methoxyphenyl)-1-piperazinyl)-3-(1-naphthyloxy)-2-propanol; 4-(2-Methoxyphenyl)-alpha-((1-naphtha" C24H28N2O3 HRRBJVNMSRJFHQ-UHFFFAOYSA-N 1-[4-(2-methoxyphenyl)piperazin-1-yl]-3-naphthalen-1-yloxypropan-2-ol n.a. n.a. No Yes No No No No PMDBD1308 Nalidixic acid Therapeutic substance Antibiotics 389-08-2 DB00779 PA164746384 D00183 DAP000817 4421 4268 n.a. "nalidixic acid; 389-08-2; Nalidixin; Nalidixate; Nevigramon; Uronidix; Nalidixan; Innoxalon; Nalitucsan; Unaserus; Sicmylon; NegGram; Nalidic acid; Nalidixinic acid; Wintomylon; Nogram; Naxuril; Jicsron; Urisal; Dixinal; Dixiben; Nalurin; Cybis; Nalix; 1-Ethyl-7-methyl-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid; Nalidicron; Urodixin; Uriclar; Uralgin; Kusnarin; Betaxina; Nicelate; Narigix; Specifin; Specifen; Negram; Uroman; Uriben; Uropan; Uroneg; Poleon; Naldixic acid; Acide nalidixique; Eucistin; Acido nalidixico; Acide nalidixico; Acidum" C12H12N2O3 MHWLWQUZZRMNGJ-UHFFFAOYSA-N 1-ethyl-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylic acid n.a. n.a. Yes No No No No No PMDBD1311 Naratriptan Therapeutic substance Drug 121679-13-8 DB00952 PA450597 D08255 DAP000890 4440 4287 n.a. "naratriptan; 121679-13-8; N-methyl-2-[3-(1-methylpiperidin-4-yl)-1H-indol-5-yl]ethanesulfonamide; UNII-QX3KXL1ZA2; N-methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide; QX3KXL1ZA2; CHEMBL1278; N-methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide; CHEBI:7478; Colatan; naratriptanum; Naramig (TN); Naratriptan (INN); NCGC00181786-01; Naratriptan [INN:BAN]; PubChem2191; GTPL45; SCHEMBL68753; BIDD:GT0312; ZINC4076; DTXSID7023354; HY-B" C17H25N3O2S AMKVXSZCKVJAGH-UHFFFAOYSA-N N-methyl-2-[3-(1-methylpiperidin-4-yl)-1H-indol-5-yl]ethanesulfonamide n.a. n.a. No Yes No No No No PMDBD1313 Nefazodone Therapeutic substance Drug 83366-66-9 DB01149 PA450603 D08257 DAP000042 4449 4294 n.a. "nefazodone; 83366-66-9; Nefazodonum [Latin]; Nefazodona [Spanish]; Nefazodona; Nefazodonum; Nefazodone [INN:BAN]; UNII-59H4FCV1TF; 1-(3-(4-(m-Chlorophenyl)-1-piperazinyl)propyl)-3-ethyl-4-(2-phenoxyethyl)-delta2-1,2,4-triazolin-5-one; CHEMBL623; 59H4FCV1TF; CHEBI:7494; Nefadar; 2-{3-[4-(3-chlorophenyl)piperazin-1-yl]propyl}-5-ethyl-4-(2-phenoxyethyl)-2,4-dihydro-3H-1,2,4-triazol-3-one; 1-(3-(4-(3-Chlorpheyl-1-piperazinylpropyl)-3-ethyl-4,5-dihydro-4-(2-phenoxyethyl)-1,2,4-triazol-5-on" C25H32ClN5O2 VRBKIVRKKCLPHA-UHFFFAOYSA-N 2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-5-ethyl-4-(2-phenoxyethyl)-1,2,4-triazol-3-one n.a. n.a. No Yes No No No No PMDBD582 Nevirapine Therapeutic Substance Approved Drug 129618-40-2 DB00238 PA450616 D00435 DAP000184 4463 4308 n.a. "nevirapine; 129618-40-2; Viramune; BI-RG-587; Nevirapine anhydrous; Viramune XR; NVP; BIRG 0587; 11-Cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[3,2-b:2'',3''-e][1,4]diazepin-6-one; UNII-99DK7FVK1H; 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL-6H-DIPYRIDO[3,2-B:2'',3''-E][1,4]DIAZEPIN-6-ONE; 11-Cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido(3,2-b:2'',3''-e)(1,4)diazepin-6-one; Nevirapine (Viramune); BIRG-0587; HSDB 7164; CHEMBL57; NEV; NSC 641530; 99DK7FVK1H; 11-CYCLOPROPYL-4-METHYL-5H-DIPYRIDO[3,2-B:2'',3''-E][1,4]DIAZEPIN-6(11H)-ONE; 11-Cyc" C15H14N4O NQDJXKOVJZTUJA-UHFFFAOYSA-N 2-cyclopropyl-7-methyl-2,4,9,15-tetrazatricyclo[9.4.0.03,8]pentadeca-1(11),3,5,7,12,14-hexaen-10-one Boehringer Ingelheim Anti-HIV Agents No Yes No Yes No No PMDBD1318 Nicardipine Therapeutic substance effective in the treatment of angina and coronary spasms without showing cardiodepressant effects 55985-32-5 DB00622 PA450620 n.a. DAP000486 4474 4319 n.a. "nicardipine; 55985-32-5; Nicardipinum; Nicardipinum [INN-Latin]; Nicardipino [INN-Spanish]; Nicardipine [INN:BAN]; Cardene; CHEBI:7550; C26H29N3O6; EINECS 259-932-3; Cardene (TN); BRN 0504321; 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 2-(benzylmethylamino)ethyl methyl ester; 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, methyl 2-(methyl(phenylmethyl)amino)ethyl ester; 2-(Benzylmethylamino)ethyl methyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)pyridine-3,5-di" C26H29N3O6 ZBBHBTPTTSWHBA-UHFFFAOYSA-N 5-O-[2-[benzyl(methyl)amino]ethyl] 3-O-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate n.a. n.a. No Yes No No No No PMDBD586 Niclosamide Therapeutic Substance Approved Drug 50-65-7 DB06803 PA165958408 D00436 n.a. 4477 4322 n.a. "niclosamide; 50-65-7; Niclocide; 5-Chloro-N-(2-chloro-4-nitrophenyl)-2-hydroxybenzamide; Tredemine; Phenasal; Bayluscid; Fenasal; Yomesan; Helmiantin; Dichlosale; Atenase; Devermin; Cestocid; Vermitid; Radeverm; Mansonil; Iomesan; Sagimid; Iomezan; Devermine; Nasemo; Sulqui; Lintex; 2'',5-Dichloro-4''-nitrosalicylanilide; Mato; Fedal-Telmin; Bayer 73; Zestocarp; Radewerm; Bayer 2353; Chemagro 2353; BAY 2353; C13H8Cl2N2O4; 5-Chloro-2''-chloro-4''-nitrosalicylanilide; nicolsamide; HL 2447; WR" C13H8Cl2N2O4 RJMUSRYZPJIFPJ-UHFFFAOYSA-N 5-chloro-N-(2-chloro-4-nitrophenyl)-2-hydroxybenzamide n.a. n.a. Yes No Yes No No No PMDBD588 Nifedipine "Therapeutic Substance; Herbal Substance" calcium channel blocker 21829-25-4 DB01115 PA450631 D00437 DAP000529 4485 4330 NPC190945 "nifedipine; 21829-25-4; Adalat; Procardia; Procardia XL; Cordipin; Corinfar; Adalat CC; Fenihidine; Oxcord; Citilat; Fenihidin; dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate; Nifediac; Adalate; Bay-a-1040; Afeditab CR; Hexadilat; Nifedical; Introcar; Coracten; Tibricol; Kordafen; Pidilat; Sepamit; Anifed; Adapine; Zenusin; Orix; Adalat LA; Nifedipinum; Afeditab; Nifedipino; 1,4-Dihydro-2,6-dimethyl-4-(2-nitrophenyl)-3,5-pyridinedicarboxylic acid dimethyl ester; Adipine XL; 3,5-Pyridinedicarboxylic acid, 1,4-di" C17H18N2O6 HYIMSNHJOBLJNT-UHFFFAOYSA-N dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate Bayer Analgesics No Yes No No No No PMDBD591 Nilutamide Therapeutic Substance Approved Drug 63612-50-0 DB00665 PA450632 D00965 DAP000302 4493 4337 n.a. "nilutamide; 63612-50-0; Anandron; Nilandron; Nilandrone; 5,5-dimethyl-3-(4-nitro-3-(trifluoromethyl)phenyl)imidazolidine-2,4-dione; Nilutamidum; Nilutamida; 5,5-dimethyl-3-[4-nitro-3-(trifluoromethyl)phenyl]imidazolidine-2,4-dione; Nilutamidum [Latin]; Nilutamida [Spanish]; RU-23908; Nilutamide [USAN:INN:BAN]; RU 23908; RU 23908-10; 5,5-Dimethyl-3-(alpha,alpha,alpha-trifluoro-4-nitro-m-tolyl)hydantoin; UNII-51G6I8B902; C12H10F3N3O4; BRN 0841906; CHEMBL1274; CHEBI:7573; 5,5-Dimethyl-3-[4-nitro-3-(trifluoromethyl)phenyl]-2,4-imid" C12H10F3N3O4 XWXYUMMDTVBTOU-UHFFFAOYSA-N 5,5-dimethyl-3-[4-nitro-3-(trifluoromethyl)phenyl]imidazolidine-2,4-dione Aventis Pharmaceuticals Inc. Anticancer Agents Yes Yes No No No No PMDBD592 Nimesulide Therapeutic Substance Approved Drug 51803-78-2 DB04743 PA137179528 D01049 DPR000079 4495 4339 n.a. "nimesulide; 51803-78-2; N-(4-Nitro-2-phenoxyphenyl)methanesulfonamide; Mesulid; Aulin; Flogovital; Sulidene; Nimed; R-805; 4-NITRO-2-PHENOXYMETHANESULFONANILIDE; Nisulid; Nimesulidum [INN-Latin]; Nimesulida [INN-Spanish]; R 805; UNII-V4TKW1454M; 4-Nitro-2-phenoxy-methanesulfonanilide; 4''-Nitro-2''-phenoxymethanesulfonanilide; EINECS 257-431-4; 4''-Nitro-2''-phenoxymethansulfonanilid; BRN 2421175; CHEMBL56367; MLS000069680; V4TKW1454M; CHEBI:4" C13H12N2O5S HYWYRSMBCFDLJT-UHFFFAOYSA-N N-(4-nitro-2-phenoxyphenyl)methanesulfonamide n.a. n.a. Yes No No No No No PMDBD593 Nimodipine Therapeutic Substance Approved Drug 66085-59-4 DB00393 PA450633 D00438 DAP000306 4497 4341 n.a. "nimodipine; 66085-59-4; Nimotop; Periplum; Nimodipino; Nimodipinum; Admon; Nimodipinum [INN-Latin]; Nimodipino [INN-Spanish]; BAY e 9736; Bay-e-9736; Bay-E 9736; Nimodipine-d7; Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate; DRG-0139; CHEBI:7575; Nimodipine (Nimotop); 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 2-methoxyethyl 1-methylethyl ester; EINECS 266-127-0; BRN 0459792; MLS000863294; 3-isopropyl 5-(2-methoxyethyl) 2,6-dimethyl-4-(3-nitrophenyl" C21H26N2O7 UIAGMCDKSXEBJQ-UHFFFAOYSA-N 3-O-(2-methoxyethyl) 5-O-propan-2-yl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate Bayer Pharmaceuticals Corporation Vasodilator Agents Yes Yes No No No No PMDBD1321 Nisoldipine Therapeutic substance Drug 63675-72-9 DB00401 PA450634 D00618 DAP000595 4499 4343 n.a. "nisoldipine; 63675-72-9; Sular; Nisocor; Zadipina; Nisoldipinum; Baymycard; Syscor; Nisoldipinum [INN-Latin]; Nisoldipino [INN-Spanish]; Bay k 5552; 3-Isobutyl 5-methyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate; Bay-k-5552; BAY-k 5552; CHEBI:76917; methyl 2-methylpropyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate; EINECS 264-407-7; BRN 0454188; CHEMBL441428; Nisoldipin; Nisoldipino; C20H24N2O6; (+-)-Isobutyl methyl 1,4-dihydro-2,6-dimethyl-4-(o-nitrophenyl)-3,5-pyridinedicarbox" C20H24N2O6 VKQFCGNPDRICFG-UHFFFAOYSA-N 3-O-methyl 5-O-(2-methylpropyl) 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate n.a. n.a. No Yes No No No No PMDBD595 Nitrazepam Therapeutic Substance anticonvulsant and hypnotic 146-22-5 DB01595 PA10242 D00531 DAP000691 4506 4350 n.a. "nitrazepam; 146-22-5; Benzalin; Neozepam; Remnos; Mogadon; Imeson; Neuchlonic; Nitrados; Eunoctin; Apodorm; Imesont; Calsmin; Trazenin; Sonebon; Radedorm; Surem; Hipsal; Nelmat; Hipnax; Epibenzalin; Unisomnia; Epinelbon; Sonnolin; Somitran; Nitrenpax; Pelson; Paxisyn; Nelbon; Dumolid; Relact; Cerson; N-Desmethylnimetazepam; Persopit; Ibrovek; Gerson; Eatan; Dormo-Puren; Dormin-5; Mitidin; Eatan N; 1,3-Dihydro-7-nitro-5-phenyl-2H-1,4-benzodiazepin-2-one; Nitrazepamum; Mogadone; Megadon; Magadon; Mogadan; Nitrazepamum [INN-Latin]; Ro 4-5360; LA 1" C15H11N3O3 KJONHKAYOJNZEC-UHFFFAOYSA-N 7-nitro-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one n.a. Antianxiety Agents No Yes No No No No PMDBD596 Nitrendipine Therapeutic Substance Approved Drug 39562-70-4 DB01054 PA146096020 D00629 DAP001263 4507 4351 n.a. "nitrendipine; 39562-70-4; Baypress; Bayotensin; Nidrel; Nitrendipin; Nitrendipinum; Nitrendipino; Bylotensin; Deiten; Bay-e-5009; BAY e 5009; Nitrendipinum [INN-Latin]; Nitrendipino [INN-Spanish]; 3-ethyl 5-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate; 1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid ethyl methyl ester; CHEBI:7582; EINECS 254-513-1; BRN 0498823; MLS000069349; C18H20N2O6; MFCD00082255" C18H20N2O6 PVHUJELLJLJGLN-UHFFFAOYSA-N 5-O-ethyl 3-O-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate n.a. Antihypertensive Agents No Yes No Yes No No PMDBD600 Nitroglycerin Therapeutic Substance Therapeutic Substance 55-63-0 DB00727 PA450644 D00515 DNC001024 4510 4354 n.a. "nitroglycerin; Glyceryl trinitrate; Trinitroglycerin; Nitroglycerol; Nitroglycerine; Nitrostat; Trinitroglycerol; Glycerol trinitrate; Nitro-dur; 55-63-0; Minitran; Nitroderm; Nitroglyn; Nitrospan; Nitronet; Tridil; Transderm-nitro; Transderm Nitro; Sustonit; Nitrocine; Epinitril; Susadrin; Perlinganit; Nitrolingual; Nitrolan; Trinitrin; Natispray; Lenitral; Nitrong; Niong; Nitro-Bid; Nitroderm TTS; Nitroretard; Nitroplast; Corditrine; Trinitrosan; Rectogesic; Nitroglicerina; Cordipatch; Perglottal; Nitrorectal; Gilustenon; Trinitrolong; Temponitrin" C3H5N3O9 SNIOPGDIGTZGOP-UHFFFAOYSA-N 1,3-dinitrooxypropan-2-yl nitrate n.a. Vasodilator Agents No Yes No No No No PMDBD607 Norfloxacin Therapeutic Substance Approved Drug 70458-96-7 DB01059 PA450654 D00210 DAP000654 4539 4380 n.a. "norfloxacin; 70458-96-7; Norfloxacine; Noroxin; Chibroxin; Baccidal; Sebercim; MK-366; Norfloxacinum; Norfloxacino; Barazan; Fulgram; NFLX; AM-715; 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid; Lexinor; Zoroxin; 1-ethyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid; Norfloxacine [INN-French]; Norfloxacinum [INN-Latin]; Norfloxacino [INN-Spanish]; AM 715; MK-0366; MK 0366; 1-Ethyl-6-fluoro-4-oxo-7-(1-piperazinyl)-1,4-dihydro-3-quinolinecarboxylic acid; 1,4-Dihydro-1-ethyl" C16H18FN3O3 OGJPXUAPXNRGGI-UHFFFAOYSA-N 1-ethyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid n.a. Antibiotics Yes No Yes No No No PMDBD1323 Nortriptyline Therapeutic substance Drug 72-69-5 DB00540 PA450657 D08288 DAP001152 4543 4384 n.a. "nortriptyline; Aventyl; Desmethylamitriptyline; Desitriptilina; Sensaval; Noritren; 72-69-5; Ateben; Avantyl; Noramitriptyline; Demethylamitriptyline; Lumbeck; Pamelor; Nortryptiline; Nortryptyline; Demethylamitryptyline; Nortriptylinum; Psychostyl; Nortriptilina [DCIT]; Nortriptyline [INN:BAN]; Vividyl; Acetexa; Nortriptylinum [INN-Latin]; UNII-BL03SY4LXB; CCRIS 9175; 3-(10,11-Dihydro-5H-dibenzo[a,d]cyclohepten-5-ylidene)-N-methyl-1-propanamine; 3-(10,11-dihydro-5H-dibenzo[a,d][7]annulen-5-ylidene)-N-methyl" C19H21N PHVGLTMQBUFIQQ-UHFFFAOYSA-N N-methyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,11,13-hexaenylidene)propan-1-amine n.a. n.a. No Yes No No No No PMDBD611 Ofloxacin "Therapeutic Substance; Herbal Substance" "Approved Drug; Medicinal Herbal Compounds" 82419-36-1 DB01165 PA450684 D00453 DAP000655 4583 4422 NPC330683 "ofloxacin; 82419-36-1; Floxin; Ofloxacine; Tarivid; Oxaldin; Oflocet; Visiren; Ocuflox; OFLX; Ofloxacino; Ofloxacinum; Exocin; Hoe-280; DL-8280; Ofloxacin Otic; Floxin otic; Ofloxacina [DCIT]; Ofloxacinum [Latin]; Ofloxacine [French]; Ofloxacino [Spanish]; HOE 280; FLOXIN IN DEXTROSE 5%; DL 8280; 9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid; DL-ofloxacin; PT 01; ORF 18489; CHEBI:7731; CCRIS 5233" C18H20FN3O4 GSDSWSVVBLHKDQ-UHFFFAOYSA-N 7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid Janssen Pharmaceutica Antibiotics Yes Yes Yes No No No PMDBD614 Olanzapine Therapeutic Substance Approved Drug 132539-06-1 DB00334 PA450688 D00454 DAP000022 135398745 10442212 n.a. "olanzapine; 132539-06-1; Zyprexa; Zyprexa Zydis; Olansek; Zalasta; Zyprexa Intramuscular; Zyprexa Velotab; LY-170053; 2-Methyl-4-(4-methylpiperazin-1-yl)-10H-benzo[b]thieno[2,3-e][1,4]diazepine; Zypadhera; Lanzac; LY 170053; 2-methyl-4-(4-methylpiperazin-1-yl)-10H-thieno[2,3-b][1,5]benzodiazepine; 2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine; Olanzapin; UNII-N7U69T4SZR; LY170053; C17H20N4S; 2-methyl-4-(4-methylpiperazin-1-yl" C17H20N4S KVWDHTXUZHCGIO-UHFFFAOYSA-N 2-methyl-4-(4-methylpiperazin-1-yl)-10H-thieno[2,3-b][1,5]benzodiazepine Eli Lilly Antipsychotic Agents No Yes No No No No PMDBD619 Omeprazole Therapeutic Substance gastric acid-related disorders 73590-58-6 DB00338 PA450704 D00455 DAP000180 4594 4433 n.a. "omeprazole; 73590-58-6; Losec; Prilosec; Antra; Esomeprazole; Omeprazon; Audazol; Zegerid; Parizac; Omepral; Omapren; Mopral; Miol; Logastric; Indurgan; Gastroloc; Epirazole; Emeproton; Ceprandal; Sanamidol; Prazidec; Secrepina; Peptilcer; Inhibitron; Gibancer; Dudencer; Dizprazol; Ulcometion; Pepticum; Inhipump; Gastrimut; Belmazol; Zefxon; Ompanyt; Omeprol; Miracid; Mepral; Ulcozol; Ulcesep; Omizac; Zoltum; Ramezol; Prysma; Omisec; Omezol; Ulceral; Ozoken; Ultop; Ulsen; Lomac; Elgam; Zimor; Desec; Omid; Omed; Ocid; OMEP; Prazolit; Pepticus; Paprazol; Omezolan; Nopra" C17H19N3O3S SUBDBMMJDZJVOS-UHFFFAOYSA-N 6-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]-1H-benzimidazole AstraZeneca Antiulcer Agents Yes Yes Yes Yes No No PMDBD1331 Ondansetron Therapeutic substance Drug 99614-02-5 DB00904 PA450705 D00456 DAP000221 4595 4434 n.a. "ondansetron; 99614-02-5; Zofran; Zudan; Zophren; 9-Methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)-2,3-dihydro-1H-carbazol-4(9H)-one; Zofran ODT; Zuplenz; ondansetron (Zofran); 116002-70-1; GR 38032X; GR-38032F; 9-methyl-3-[(2-methylimidazol-1-yl)methyl]-2,3-dihydro-1H-carbazol-4-one; GR 38032; BRN 3622981; CHEBI:7773; C18H19N3O; 9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-2,3,4,9-tetrahydro-1H-carbazol-4-one; 9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-1,2,3,9-tetrahydro-4H-carbazol-4-one; 1,2,3,9-Tetrahydro-9-methyl-3-((" C18H19N3O FELGMEQIXOGIFQ-UHFFFAOYSA-N 9-methyl-3-[(2-methylimidazol-1-yl)methyl]-2,3-dihydro-1H-carbazol-4-one n.a. n.a. No Yes No No No No PMDBD628 Oxaprozin Therapeutic Substance Approved Drug 21256-18-8 DB00991 PA450730 D00463 DAP000622 4614 4453 n.a. "oxaprozin; 21256-18-8; Daypro; 3-(4,5-Diphenyl-1,3-oxazol-2-yl)propanoic acid; Alvo; 3-(4,5-Diphenyloxazol-2-yl)propanoic acid; Oxaprozinum; Oxaprozine; Deflam; Voir; Oxaprozine [INN-French]; Oxaprozinum [INN-Latin]; WY-21743; Oxaprozina [INN-Spanish]; Oxaprozina; 4,5-Diphenyl-2-oxazolepropionic acid; WY-21,743; 4,5-Diphenyl-2-oxazolepropanoic acid; WY 21743; NSC310839; Oxaprozinum;Wy21743; 3-(4,5-Diphenyl-2-oxazolyl)propenoic acid; beta-(4,5-Diphenyloxazol-2-yl)propionic acid; UNII-MHJ80W9L" C18H15NO3 OFPXSFXSNFPTHF-UHFFFAOYSA-N 3-(4,5-diphenyl-1,3-oxazol-2-yl)propanoic acid Gd Searle Llc Antiinflammatory Agents Yes Yes No Yes No No PMDBD1336 Oxazepam Therapeutic substance Drug 604-75-1 DB00842 PA450731 D00464 DAP000243 4616 4455 n.a. "oxazepam; Tazepam; Serax; Adumbran; 604-75-1; Droxacepam; Ansioxacepam; Praxiten; Noctazepam; Quilibrex; Anxiolit; Durazepam; Psiquiwas; Nesontil; Zaxopam; Drimuel; Serpax; Sobril; Seresta; Serenal; Sedigoa; Rondar; Pacienx; Murelax; Limbial; Isodin; Bonare; Aplakil; Serepax; Serenid; Propax; Astress; Vaben; Hi-Long; Nortemazepam; Azutranquil; Sigacalm; Psicopax; Uskan; (RS)-Oxazepam; Tarchomin; Nozepam; (+-)-Oxazepam; Serenid-D; Lederpam; Oxazepamum; Abboxapam; Oxozepam; Tacepam; Oxanid; Alepam; Anxiolit retard; QUEN; Tranquo-buscopan-wirkstoff; Oxa-puren; Z10" C15H11ClN2O2 ADIMAYPTOBDMTL-UHFFFAOYSA-N 7-chloro-3-hydroxy-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one n.a. n.a. No Yes No No No No PMDBD639 Pantoprazole "Therapeutic Substance; Herbal Substance" "Approved Drug; Medicinal Herbal Compounds" 102625-70-7 DB00213 PA450774 D05353 DAP000724 4679 4517 NPC316756 "pantoprazole; 102625-70-7; Protonix; Pantozol; Pantoprazol; Pantoprazolum; BY-1023; Pantoloc; Pantoprazolum [INN-Latin]; Pantoprazol [INN-Spanish]; SK&F-96022; BY 1023; SK&F 96022; Protonix I.V.; SKF-96022; Pantozol Control; SK-96022; C16H15F2N3O4S; HSDB 7292; CHEMBL1502; 6-(difluoromethoxy)-2-[(3,4-dimethoxypyridin-2-yl)methylsulfinyl]-1H-benzimidazole; CHEBI:7915; Pantoprazole sodium hydrate; 5-(Difluoromethoxy)-2-(((3,4-dimethoxy-2-pyridyl)methyl)sulfinyl)benzimidazole; 5-(difluoromethoxy)-2-{[(3,4-dimethoxypyridin-2-yl" C16H15F2N3O4S IQPSEEYGBUAQFF-UHFFFAOYSA-N 6-(difluoromethoxy)-2-[(3,4-dimethoxypyridin-2-yl)methylsulfinyl]-1H-benzimidazole "Wyeth; Altana; Solvay" Antiulcer Agents No Yes No Yes No No PMDBD640 Papaverine "Therapeutic Substance; Herbal Substance" "Approved Drug; Medicinal Herbal Compounds" 58-74-2 DB01113 PA164745550 D07425 DAP000959 4680 4518 NPC195268 "papaverine; Papaverin; Papanerine; Robaxapap; 58-74-2; Papanerin; Pavabid; 1-(3,4-Dimethoxybenzyl)-6,7-dimethoxyisoquinoline; Papaverina; Papaverine [BAN]; 6,7-Dimethoxy-1-veratrylisoquinoline; Papaverina [Italian]; NSC 136630; UNII-DAA13NKG2Q; S-M-R; Papaverine (BAN); 1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxyisoquinoline; 1-((3,4-Dimethoxyphenyl)methyl)-6,7-dimethoxyisoquinoline; EINECS 200-397-2; DAA13NKG2Q; BRN 0312930" C20H21NO4 XQYZDYMELSJDRZ-UHFFFAOYSA-N 1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxyisoquinoline n.a. Vasodilator Agents No Yes No No No No PMDBD650 Pentobarbital Therapeutic Substance Approved Drug 76-74-4 DB00312 PA450859 D00499 DAP000671 4737 4575 n.a. "pentobarbital; Pentobarbitone; Nembutal; Mebubarbital; Ethaminal; Mebumal; Pentobarbituric acid; Neodorm; Rivadorm; Dorsital; Nebralin; Pentobarbiturate; 76-74-4; Pentabarbitone; Neodorm (new); Pentabarbital; Pentobarbitalum; Aethaminalum; 5-Ethyl-5-(sec-pentyl)barbituric acid; 5-Ethyl-5-(1-methylbutyl)barbituric acid; Nembutal (VAN); Neodorm (VAN); Pentobarbital (VAN); Pentobarbitone (VAN); Pentobarbitale [DCIT]; 5-Ethyl-5-(1-methylbutyl)malonylurea; 5-Ethyl-5-(1-methylbu" C11H18N2O3 WEXRUCMBJFQVBZ-UHFFFAOYSA-N 5-ethyl-5-pentan-2-yl-1,3-diazinane-2,4,6-trione Oak Pharmaceuticals Inc Hypnotics and Sedatives No Yes No No No No PMDBD1355 Pentoxifylline Therapeutic substance Drug 6/5/6493 DB00806 PA450864 D00501 DAP000048 4740 4578 n.a. "pentoxifylline; Trental; Oxpentifylline; 6493-05-6; Pentoxifyllin; Torental; Pentoxyphylline; Dimethyloxohexylxanthine; Pentoxiphyllium; Vazofirin; Pentoxiphylline; Pentoxyfylline; Rentylin; 3,7-Dimethyl-1-(5-oxohexyl)xanthine; Pentoxyphyllin; 1-(5-Oxohexyl)theobromine; 3,7-dimethyl-1-(5-oxohexyl)purine-2,6-dione; 3,7-Dihydro-3,7-dimethyl-1-(5-oxohexyl)-1H-purine-2,6-dione; BL-191; BL 191; 3,7-Dimethyl-1-(5-oxohexyl)-3,7-dihydro-1H-purine-2,6-dione; Pentoxyfilline; Pe" C13H18N4O3 BYPFEZZEUUWMEJ-UHFFFAOYSA-N 3,7-dimethyl-1-(5-oxohexyl)purine-2,6-dione n.a. n.a. No Yes No No No No PMDBD655 Perphenazine Therapeutic Substance Approved Drug 58-39-9 DB00850 PA450882 D00503 DAP000100 4748 4586 n.a. "perphenazine; 58-39-9; Perphenazin; Trilafon; Perfenazine; Etaperazine; Ethaperazine; Etaperazin; Fentazin; Thilatazin; Perphenan; Chlorpiprazine; Decentan; Chlorperphenazine; Triphenot; Trilifan; Emesinal; Trifaron; Tranquisan; Perfenazina; F-mon; Perphenazinum; Sch 3940; Perfenazina [Italian]; 2-(4-(3-(2-Chloro-10H-phenothiazin-10-yl)propyl)piperazin-1-yl)ethanol; Perphenazinum [INN-Latin]; Perfenazina [INN-Spanish]; 4-[3-(2-Chlorophenothiazin-10-yl)propyl]-1-piperazineethanol; UNII-FTA7XXY4EZ; C21H26ClN3OS; PZC; 2-[4-[3-(2-Chloropheno" C21H26ClN3OS RGCVKNLCSQQDEP-UHFFFAOYSA-N 2-[4-[3-(2-chlorophenothiazin-10-yl)propyl]piperazin-1-yl]ethanol Schering-Plough Corporation Antipsychotic Agents Yes Yes Yes No No No PMDBD657 Phenacetin Therapeutic Substance analgesic 62-44-2 DB03783 PA450897 D00569 DNC001117 4754 4590 n.a. "phenacetin; 62-44-2; Acetophenetidin; N-(4-Ethoxyphenyl)acetamide; Acetphenetidin; Acetophenetidine; Acetophenetin; Phenacetine; p-Acetophenetidide; 4''-Ethoxyacetanilide; Contradouleur; Phenazetin; Contradol; Codempiral; Achrocidin; Commotional; 4-Ethoxyacetanilide; p-Acetophenetidine; Phenedina; Phenacet; Pertonal; Pyraphen; Phenacitin; Phenacetinum; Fenidina; Phenidin; Fenacetina; p-Ethoxyacetanilide; Kalmin; Phenin; Fenina; p-Acetophenetide; p-Acetphenetidin; Tetracydin; Phenazetina; Veganine; Sinutab; Edrisal" C10H13NO2 CPJSUEIXXCENMM-UHFFFAOYSA-N N-(4-ethoxyphenyl)acetamide n.a. n.a. No Yes No No No No PMDBD658 Phenazopyridine Therapeutic Substance Approved Drug 94-78-0 DB01438 PA164746899 D08346 n.a. 4756 4592 n.a. "phenazopyridine; 94-78-0; Gastracid; 3-(Phenylazo)-2,6-pyridinediamine; Urogesic; Pyrazofen; Baridium; Pyridiate; Viridium; Geridium; Gastrotest; 2,6-Diamino-3-phenylazopyridine; Fenazopiridina; Eridium; Phenazopyridinum; 2,6-Diamino-3-(phenylazo)pyridine; Phenazopyridine [INN:BAN]; UNII-K2J09EMJ52; Fenazopiridina [INN-Spanish]; Phenazopyridinum [INN-Latin]; NSC 145895; 3-(phenyldiazenyl)pyridine-2,6-diamine; HSDB 3153; EINECS 202-363-2; BRN 0184497; K2J09EMJ5" C11H11N5 QPFYXYFORQJZEC-UHFFFAOYSA-N 3-phenyldiazenylpyridine-2,6-diamine n.a. n.a. No Yes No Yes No No PMDBD661 Phenindione Therapeutic Substance Approved Drug n.a. DB00498 PA164784031 D08354 DAP000769 4760 4596 n.a. "phenindione; 83-12-5; 2-Phenyl-1,3-indandione; 2-Phenyl-1H-indene-1,3(2H)-dione; Dindevan; Rectadione; Phenylindanedione; Phenylindione; Phenyline; Fenhydren; Phenillin; Phenhydren; Emandione; Athrombon; Theradione; Diophindane; Pindione; Fenilin; Danedion; Fenindion; Emandion; Tromazal; Phenylin; Diadilan; Phenylen; Hemolidione; Eridione; Danilone; Hedulin; Trombol; Indema; Bindan; Dineval; Indon; Thrombasal; Cronodione; Indion; 2-Phenylindandione; 2-Phenyl-1,3-diketohydrindene; Phenindionum; Phenyllin; Fenindio" C15H10O2 NFBAXHOPROOJAW-UHFFFAOYSA-N 2-phenylindene-1,3-dione n.a. Anticoagulants Yes No No No No No PMDBD1361 Phenoxybenzamine Therapeutic substance Drug 59-96-1 DB00925 PA450919 n.a. DAP000478 4768 4604 n.a. "phenoxybenzamine; Dibenyline; Dibenzyline; Dibenylin; Bensylyt; Benzylyt; 59-96-1; Dibenylene; Dibenzyran; Fenoxibenzamina; Fenossibenzamina [DCIT]; Fenossibenzamina; Phenoxybenzaminum [INN-Latin]; Fenoxibenzamina [INN-Spanish]; Phenoxybenzamine [INN:BAN]; N-benzyl-N-(2-chloroethyl)-1-phenoxypropan-2-amine; 688A; A 688; NSC 37448; CCRIS 505; 2-(N-Benzyl-2-chloroethylamino)-1-phenoxypropane; N-(2-Chloroethyl)-N-(1-methyl-2-phenoxyethyl)benzenemethanamine; HSDB 400" C18H22ClNO QZVCTJOXCFMACW-UHFFFAOYSA-N N-benzyl-N-(2-chloroethyl)-1-phenoxypropan-2-amine n.a. n.a. No Yes No No No No PMDBD674 Pioglitazone Therapeutic Substance Approved Drug 111025-46-8 DB01132 PA450970 D08378 DAP000272 4829 4663 n.a. "Pioglitazone; 111025-46-8; Actos; 105355-27-9; Pioglitazonum; Pioglitazona; Glustin; Zactos; Pioglitazonum [INN-Latin]; Pioglitazona [INN-Spanish]; Duetact; U 72107; Pioglitazone [INN:BAN]; AD-4833; 5-(4-(2-(5-ethylpyridin-2-yl)ethoxy)benzyl)thiazolidine-2,4-dione; CHEBI:8228; Pioglitazone (Actos); HSDB 7322; 5-{4-[2-(5-ethylpyridin-2-yl)ethoxy]benzyl}-1,3-thiazolidine-2,4-dione; Actos (TN); 5-[[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione; C19H20N2O3S; 105390-47-4; AD 4833; 5-[4-[2-(5-ETHYL-2-PYRIDYL" C19H20N2O3S HYAFETHFCAUJAY-UHFFFAOYSA-N 5-[[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione Takeda Pharmaceuticals Hypoglycemic Agents Yes Yes Yes No No No PMDBD698 Pranlukast Therapeutic Substance Approved Drug 103177-37-3 DB01411 PA134698661 n.a. DAP000977 4887 4718 n.a. "Pranlukast; 103177-37-3; Ono-1078; pranlukast hydrate; N-[4-oxo-2-(2H-tetrazol-5-yl)chromen-8-yl]-4-(4-phenylbutoxy)benzamide; UNII-TB8Z891092; CCN 00401; RS 411; CHEMBL21333; Azlaire; 150821-03-7; 4-Oxo-8-(4-(4-phenylbutoxy)benzoylamino)-2-(tetrazol-5-yl)-4H-1-benzopyran; TB8Z891092; NCGC00181765-01; N-(4-OXO-2-(1H-TETRAZOL-5-YL)-4H-CHROMEN-8-YL)-4-(4-PHENYLBUTOXY)BENZAMIDE; N-(4-oxo-2-(2H-tetrazol-5-yl)-4H-chromen-8-yl)-4-(4-phenylbutoxy)benzamide; 8-[4(4-phenylbutoxy)benzoyl]amino-2-(5-tetrazolyl)-4-oxo-4H-1-benzopyran;" C27H23N5O4 NBQKINXMPLXUET-UHFFFAOYSA-N N-[4-oxo-2-(2H-tetrazol-5-yl)chromen-8-yl]-4-(4-phenylbutoxy)benzamide n.a. Antiasthmatic Agents Yes No Yes No No No PMDBD1376 Praziquantel Therapeutic substance Anti-infection 55268-74-1 DB01058 PA164764583 D00471 DAP000695 4891 4722 n.a. "praziquantel; 55268-74-1; Droncit; Biltricide; Pyquiton; Cesol; Embay 8440; Azinox; Cutter Tape Tabs; Praziquantelum [INN-Latin]; 2-(cyclohexylcarbonyl)-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isoquinolin-4-one; CCRIS 4114; MLS000038419; 2-(cyclohexanecarbonyl)-3,6,7,11b-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4-one; Praziquantel (Biltricide); EINECS 259-559-6; BRN 0761557; SMR000037139; 2-cyclohexanecarbonyl-1H,2H,3H,4H,6H,7H,11bH-piperazino[2,1-a]isoquinolin-4-one; 2-(cyclohexanecarbonyl)-1,2,3,6,7,11b-hexahydro-4H-pyraz" C19H24N2O2 FSVJFNAIGNNGKK-UHFFFAOYSA-N 2-(cyclohexanecarbonyl)-3,6,7,11b-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4-one n.a. n.a. No Yes No No No No PMDBD1377 Prazosin Therapeutic substance Drug 19216-56-9 DB00457 PA451093 D08411 DAP000300 4893 4724 n.a. "prazosin; 19216-56-9; Furazosin; Prazosine; Prazocin; Prazosinum; Prazosina; Prazosinum [INN-Latin]; Prazosine [INN-French]; Prazosina [INN-Spanish]; Prazosin [INN:BAN]; [3H]-Prazosin; 2-(4-(2-Furoyl)piperazin-1-yl)-4-amino-6,7-dimethoxyquinazoline; 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)piperazine; UNII-XM03YJ541D; (4-(4-Amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl)(furan-2-yl)methanone; HSDB 3298; CHEMBL2; C19H21N5O4; Min" C19H21N5O4 IENZQIKPVFGBNW-UHFFFAOYSA-N [4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(furan-2-yl)methanone n.a. n.a. No Yes No No No No PMDBD1381 Primidone Therapeutic substance Drug 125-33-7 DB00794 PA451105 D00474 DAP000678 4909 4740 n.a. "primidone; 125-33-7; Primaclone; Mysoline; Liskantin; 2-Deoxyphenobarbital; Lepimidin; Mylepsinum; Misodine; Primidon; Neurosyn; Mylepsin; Mizodin; Lepsiral; Sertan; Primoline; Milepsin; Hexadiona; Majsolin; Prysoline; Primakton; Prilepsin; Misolyne; 2-Desoxyphenobarbital; Midone; Mysedon; Mizolin; Cyral; Medi-Pets; Primacone; Desoxyphenobarbitone; Pyrimidone Medi-pets; Resimatil; Primidonum; Primidona; Primacione; 5-ethyl-5-phenyl-1,3-diazinane-4,6-dione; Roe 101; 5-Phenyl-5-ethyl-hexahydropyrimidine-4,6-dione; 4,6(1H,5H)-Pyrimidinedione, 5-eth" C12H14N2O2 DQMZLTXERSFNPB-UHFFFAOYSA-N 5-ethyl-5-phenyl-1,3-diazinane-4,6-dione n.a. n.a. No Yes No No No No PMDBD1382 Probenecid Therapeutic substance Drug 57-66-9 DB01032 PA451106 D00475 DAP001292 4911 4742 n.a. "probenecid; 57-66-9; 4-(Dipropylsulfamoyl)benzoic acid; Probenecid acid; Benemid; Probecid; Benecid; Probalan; Benuryl; Tubophan; Probexin; Uricosid; Prolongine; Probenemid; Apurina; Proben; Synergid R; p-(Dipropylsulfamoyl)benzoic acid; 4-[(dipropylamino)sulfonyl]benzoic acid; Probenecidum; Probenecida; Probenecide; Robenecid; Benemide; Probenid; 4-((Dipropylamino)sulfonyl)benzoic acid; Polycillin-BRB; 4-(Di-n-propylsulfamoyl)benzoesaeure; 4-(N,N-Dipropylsulfamoyl)benzoesaeure; Probenecidum [" C13H19NO4S DBABZHXKTCFAPX-UHFFFAOYSA-N 4-(dipropylsulfamoyl)benzoic acid n.a. n.a. No Yes No No No Yes EX_prob(e),PROB_GLC_GLCAASE,PROB_GLC_GLCAASEe,PROB_GLC_GLCAASEepp,PROBte,PROBtepp,PROBtex PMDBD1383 Procainamide Therapeutic substance Drug 9/6/1951 DB01035 PA451108 n.a. DAP000516 4913 4744 n.a. "PROCAINAMIDE; 51-06-9; Novocainamide; Biocoryl; Novocamid; 4-amino-N-(2-diethylaminoethyl)benzamide; Procaine amide; Pronestyl; Procamide; Novocainamid; Novocaine amide; 4-Amino-N-[2-(diethylamino)ethyl]benzamide; Procainamida; Procainamidum; Procan; Procapan (free base); p-Aminobenzoic diethylaminoethylamide; p-Amino-N-(2-diethylaminoethyl)benzamide; Procainamide [INN:BAN]; Procainamidum [INN-Latin]; Procainamida [INN-Spanish]; 4-Amino-N-(2-(diethylamino)ethyl)benzamide; UNII-L39WTC366D; NSC 27461; CHEBI:8428; HSDB 3170; EINECS 200" C13H21N3O REQCZEXYDRLIBE-UHFFFAOYSA-N 4-amino-N-[2-(diethylamino)ethyl]benzamide n.a. n.a. No Yes No No No No PMDBD707 Procarbazine Therapeutic Substance Approved Drug 671-16-9 DB01168 PA451112 D08423 DAP000986 4915 4746 n.a. "procarbazine; 671-16-9; Procarbazin; Ibenzmethyzin; Natulan; Ibenzmethyzine; Procarbazin [German]; Procarbazinum; Procarbazina; Procarbazinum [INN-Latin]; Procarbazina [INN-Spanish]; N-Isopropyl-4-((2-methylhydrazinyl)methyl)benzamide; Procarbazine [INN:BAN]; 2-(p-Isopropylcarbamoylbenzyl)-1-methylhydrazine; p-(2-Methylhydrazinomethyl)-N-isopropylbenzamide; 1-Methyl-2-(p-(isopropylcarbamoyl)benzyl)hydrazine; 4-((2-Methylhydrazino)methyl)-N-isopropylbenzamide" C12H19N3O CPTBDICYNRMXFX-UHFFFAOYSA-N 4-[(2-methylhydrazinyl)methyl]-N-propan-2-ylbenzamide Sigma-Tau Pharmaceuticals Anticancer Agents No Yes No Yes No No PMDBD1385 Promethazine Therapeutic substance Drug 60-87-7 DB01069 PA451128 D00494 DAP000334 4927 4758 n.a. "promethazine; Proazamine; Diphergan; 60-87-7; Promethazin; Phensedyl; Phenargan; Promezathine; Protazine; Promazinamide; Isophenergan; Prothazin; Histargan; Thiergan; Provigan; Diprozin; Prometazin; Diprazine; Vallergine; Fenetazina; Hiberna; Fenazil; Dimapp; Avomine; Prorex; Aprobit; Phargan; Fargan; Tanidil; Procit; Pyrethiazine; Promethacon; Promethegan; Lilly 1516; Prometazina; Atosil; Promethiazine; Promethazinum; Antiallersin; Promesan; Proazaimine; Prometasin; Pilpophen; Pilothia; Iergigan; Fenetazine; Camergan; Promacot; Pipolphene; Lercigan; Prome" C17H20N2S PWWVAXIEGOYWEE-UHFFFAOYSA-N N,N-dimethyl-1-phenothiazin-10-ylpropan-2-amine n.a. n.a. No Yes No No No No PMDBD1386 Propafenone Therapeutic substance Drug 54063-53-5 DB01182 PA451131 D08435 DAP000497 4932 4763 n.a. "propafenone; 54063-53-5; Rythmol; Propafenona; Propafenonum; Propafenonum [INN-Latin]; Propafenona [INN-Spanish]; Propafenone [INN:BAN]; GNF-Pf-4594; 1-(2-(2-Hydroxy-3-(propylamino)propoxy)phenyl)-3-phenyl-1-propanone; EINECS 258-955-6; CHEMBL631; 1-(2-(2-hydroxy-3-(propylamino)propoxy)phenyl)-3-phenylpropan-1-one; CHEBI:63619; 1-{2-[2-hydroxy-3-(propylamino)propoxy]phenyl}-3-phenylpropan-1-one; 1-[2-[2-hydroxy-3-(propylamino)propoxy]phenyl]-3-phenylpropan-1-one; NCGC00015819-06; 1-(2-(2-Hydroxy-3-propylaminopropoxy)phenyl)" C21H27NO3 JWHAUXFOSRPERK-UHFFFAOYSA-N 1-[2-[2-hydroxy-3-(propylamino)propoxy]phenyl]-3-phenylpropan-1-one n.a. n.a. No Yes No No No No PMDBD1388 Propranolol Therapeutic substance Drug 525-66-6 DB00571 PA451145 D08443 DAP000089 4946 4777 n.a. "propranolol; Propanolol; beta-Propranolol; 525-66-6; Betalong; Propanalol; Euprovasin; Anapriline; Dociton; Avlocardyl; Proprasylyt; Reducor; Propanix; Inderal; propranololo; Corpendol; Betadren; Sumial; Sawatal; Racemic propranolol; Propranololum; D,L-Propranolol; (+-)-Propranolol; Propranololo [DCIT]; Propranolol [INN:BAN]; Propanolol [INN-Spanish]; Propranololum [INN-Latin]; CCRIS 3082; 1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol; AY-20694; 1-naphthalen-1-yloxy-3-(propan-2-ylamino)propan-2-ol; CHEMBL27; EINECS 208-378-0" C16H21NO2 AQHHHDLHHXJYJD-UHFFFAOYSA-N 1-naphthalen-1-yloxy-3-(propan-2-ylamino)propan-2-ol n.a. n.a. No Yes No No No Yes EX_propl(e),PROPL_GLC_GLCAASE,PROPL_GLC_GLCAASEe,PROPL_GLC_GLCAASEepp,PROPLte,PROPLtepp,PROPLtex PMDBD1391 Protriptyline Therapeutic substance Drug 438-60-8 DB00344 PA451168 D08447 DAP000863 4976 4805 n.a. "protriptyline; Protryptyline; Amimetilina; Triptil; 438-60-8; Vivactil; Protriptyline [INN:BAN]; Protriptylinum [INN-Latin]; 7-(3-Methylaminopropyl)-1,2:5,6-dibenzocycloheptatriene; Protriptilina [INN-Spanish]; 3-(5H-dibenzo[a,d][7]annulen-5-yl)-N-methylpropan-1-amine; N-Methyl-5H-dibenzo[a,d]cycloheptene-5-propanamine; 5-(3-Methylaminopropyl)-5H-Dibenzo[a,d]cycloheptene; Vivactyl; Triptyl; Maximed; UNII-4NDU154T12; N-Methyl-5H-dibenzo[a,d]cycloheptene-5-propylamine; HSDB 3391; N-3-(5H-Dibenzo(a,d)cyclohepten-5-yl)propyl-N-me" C19H21N BWPIARFWQZKAIA-UHFFFAOYSA-N N-methyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenyl)propan-1-amine n.a. n.a. No Yes No No No No PMDBD715 Pyrimethamine Therapeutic Substance Approved Drug 58-14-0 DB00205 PA451193 D00488 DAP000633 4993 4819 n.a. "pyrimethamine; 58-14-0; Daraprim; 5-(4-chlorophenyl)-6-ethylpyrimidine-2,4-diamine; Chloridine; Diaminopyritamin; Ethylpyrimidine; Pirimetamin; Chloridin; Pirimecidan; Chloridyn; Pyrimethamin; Pirimetamina; Malocide; Primethamine; Erbaprelina; Khloridin; Darachlor; Tindurin; Malocid; Maloprim; 5-(4-CHLOROPHENYL)-6-ETHYL-2,4-PYRIMIDINEDIAMINE; Malacid; Darapram; Daraprime; Pyremethamine; Pyrimethaminum; Daraclor; 2,4-Diamino-5-(p-chlorophenyl)-6-ethylpyrimidine; RP 4753; 2,4-Diamino-5-ch" C12H13ClN4 WKSAUQYGYAYLPV-UHFFFAOYSA-N 5-(4-chlorophenyl)-6-ethylpyrimidine-2,4-diamine n.a. Antimalarials Yes Yes Yes No No No PMDBD1397 Rabeprazole Therapeutic substance Drug 117976-89-3 DB01129 PA451216 D08463 DAP000727 5029 4853 n.a. "rabeprazole; 117976-89-3; Aciphex; Habeprazole; Pariets; Rabeprazole [INN:BAN]; CHEBI:8768; LY307640; HSDB 7321; Sodium rabeprazole; 2-(((4-(3-Methoxypropoxy)-3-methylpyridin-2-yl)methyl)sulfinyl)-1H-benzo[d]imidazole; 2-({[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methyl}sulfinyl)-1H-benzimidazole; 2-[[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methylsulfinyl]-1H-benzimidazole; 2-(((4-(3-Methoxypropoxy)-3-methyl-2-pyridinyl)methyl)sulfinyl)-1H-benzimidazole; AK-55871; 1H-Benzimidazole, 2-[[[4-(3-methoxypropoxy)-3-methyl-2" C18H21N3O3S YREYEVIYCVEVJK-UHFFFAOYSA-N 2-[[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methylsulfinyl]-1H-benzimidazole n.a. n.a. No Yes No No No No PMDBD1398 Raloxifene Therapeutic substance Drug 84449-90-1 DB00481 PA451221 n.a. DAP000792 5035 4859 n.a. "raloxifene; 84449-90-1; Keoxifene; Raloxifenum [Latin]; Raloxifeno [Spanish]; Raloxifenum; Raloxifeno; Raloxifene [INN:BAN]; LY 139481; LY-139481; UNII-YX9162EO3I; Optruma; CCRIS 7129; HSDB 7460; CHEMBL81; (6-hydroxy-2-(4-hydroxyphenyl)benzo[b]thiophen-3-yl)(4-(2-(piperidin-1-yl)ethoxy)phenyl)methanone; (2-(4-Hydroxyphenyl)-6-hydroxybenzo(b)thien-3-yl)(4-(2-(1-piperidinyl)ethoxy)phenyl)methanone; YX9162EO3I; C28H27NO4S; CHEBI:8772; RAL; [6-hydroxy-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl]-[4-(2-piperidin-1-ylethoxy)phenyl]metha" C28H27NO4S GZUITABIAKMVPG-UHFFFAOYSA-N [6-hydroxy-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl]-[4-(2-piperidin-1-ylethoxy)phenyl]methanone n.a. n.a. No Yes No No No No PMDBD732 Rebamipide Therapeutic Substance Approved Drug 90098-04-7 DB11656 n.a. n.a. n.a. 5042 4866 n.a. "rebamipide; 90098-04-7; Proamipide; Mucosta; 111911-87-6; OPC-12759; Pramipide; Rebamipide [INN:JAN]; Rebamipidum [INN-Latin]; Rebamipide hydrate; OPC 12759; CCRIS 3585; 2-(4-Chlorobenzoylamino)-3-(1,2-dihydro-2-oxo-4-quinolyl)propionic acid; 2-[(4-chlorobenzoyl)amino]-3-(2-oxo-1H-quinolin-4-yl)propanoic acid; 139344-42-6; NCGC00095161-01; 2-(4-Chlorobenzamido)-3-[2(1H)-quinolinon-4-yl]propionic Acid; 2-(4-chlorobenzamido)-3-(2-oxo-1,2-dihydroquinolin-4-yl)propanoic acid; (+-)-2-(4-Chlorobenzoylamino)-3-(2(1H)-quinolinon-4-y" C19H15ClN2O4 ALLWOAVDORUJLA-UHFFFAOYSA-N 2-[(4-chlorobenzoyl)amino]-3-(2-oxo-1H-quinolin-4-yl)propanoic acid n.a. n.a. No Yes No No No No PMDBD748 Riluzole Therapeutic Substance Approved Drug 1744-22-5 DB00740 PA451251 D00775 DAP000527 5070 4892 n.a. "riluzole; 1744-22-5; Rilutek; 2-Amino-6-(trifluoromethoxy)benzothiazole; 6-(trifluoromethoxy)benzo[d]thiazol-2-amine; 6-(trifluoromethoxy)-1,3-benzothiazol-2-amine; RP-54274; Riluzol; 2-amino-6-trifluoromethoxybenzothiazole; 2-amino-6-(trifluoromethoxy)benzo[d]thiazole; PK-26124; Riluzolum [INN-Latin]; Riluzol [INN-Spanish]; RP 54274; UNII-7LJ087RS6F; C8H5F3N2OS; Riluzole (Rilutek); MLS000069369; Amino-2 trifluoromethoxy-6 benzothiazole; 6-Trifluoromethoxy-benzothiazol-2-ylamine; 2-Be" C8H5F3N2OS FTALBRSUTCGOEG-UHFFFAOYSA-N 6-(trifluoromethoxy)-1,3-benzothiazol-2-amine Sanofi-Aventis Anticonvulsants No Yes No Yes No No PMDBD1403 Rimantadine Therapeutic substance Drug 13392-28-4 DB00478 PA164748038 D08483 DAP001087 5071 4893 n.a. "rimantadine; 13392-28-4; 1-(1-Adamantyl)ethanamine; 1-(Adamantan-1-yl)ethanamine; 1-(adamantan-1-yl)ethan-1-amine; alpha-Methyl-1-adamantanemethylamine; Rimantadine [INN:BAN]; alpha-Methyladamantanemethylamine; Rimantadinum [INN-Latin]; Remantadine; 1-(1-Adamantyl)ethylamin; Rimantadina [INN-Spanish]; 1-Adamantan-1-yl-ethylamine; RIMANTADIN; HSDB 7438; CHEMBL959; BRN 2715740; .alpha.-Methyladamantanemethylamine; 1-(1-adamantyl)-ethylamine; 1-(tricyclo[3.3.1.1~3,7~]dec-1-yl)ethanamine" C12H21N UBCHPRBFMUDMNC-UHFFFAOYSA-N 1-(1-adamantyl)ethanamine n.a. n.a. No Yes No No No No PMDBD750 Risperidone Therapeutic Substance second-generation antipsychotic (SGA) 106266-06-2 DB00734 PA451257 D00426 DAP000003 5073 4895 n.a. "risperidone; 106266-06-2; Risperidal; Risperdal; Rispolept; Risperdal Consta; Sequinan; Risperin; Rispolin; Apexidone; Risperidal M-Tab; Risperidonum; Risperidona; Risperidonum [Latin]; Risperidona [Spanish]; Risperdal M-Tab; Psychodal; Belivon; Spiron; R 64 766; C23H27FN4O2; UNII-L6UH7ZF8HC; R-64766; R 64766; R 64,766; CHEMBL85; L6UH7ZF8HC; 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one; BRN 4891881; CHEBI:8871" C23H27FN4O2 RAPZEAPATHNIPO-UHFFFAOYSA-N 3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one Janssen-Cilag Antipsychotic Agents No Yes No Yes No No PMDBD1406 Ropinirole Therapeutic substance Parkinson''s? 91374-21-9 DB00268 PA164749035 D08489 DAP001515 5095 4916 n.a. "ropinirole; 91374-21-9; ropinirol; ReQuip; Ropinirolum; Ropinirolum [INN-Latin]; Ropinirol [INN-Spanish]; SKF 101468; 4-[2-(dipropylamino)ethyl]-1,3-dihydro-2H-indol-2-one; SK&F 101468; UNII-030PYR8953; 4-(2-(dipropylamino)ethyl)indolin-2-one; CHEMBL589; CHEBI:8888; 030PYR8953; NCGC00015893-02; DSSTox_RID_80742; DSSTox_CID_25195; DSSTox_GSID_45195; Ropinirole [INN:BAN]; Ropitor (TN); CAS-91374-21-9; SK&F-101468-A; 4-(2-(Dipropylamino)ethyl)-1,3-dihydro-2H-indol-2-one" C16H24N2O UHSKFQJFRQCDBE-UHFFFAOYSA-N 4-[2-(dipropylamino)ethyl]-1,3-dihydroindol-2-one n.a. n.a. No Yes No No No No PMDBD757 Roxatidine acetate Therapeutic Substance Approved Drug 78628-28-1 DB08806 PA165958424 D08495 n.a. 5105 4926 n.a. "ROXATIDINE ACETATE; 78628-28-1; Aceroxatidine; Pifatidine; Roxatidinum; Roxatidina; Roxane; Roxatidinum [Latin]; Roxatidina [Spanish]; UNII-ZUP3LSD0DO; ZUP3LSD0DO; BRN 5829308; C19H28N2O4; 2-Oxo-2-((3-(3-(piperidin-1-ylmethyl)phenoxy)propyl)amino)ethyl acetate; 2-(Acetyloxy)-N-(3-(3-(1-piperidinylmethyl)phenoxy)propyl)acetamide; [2-oxo-2-[3-[3-(piperidin-1-ylmethyl)phenoxy]propylamino]ethyl] acetate; Acetamide, 2-(acetyloxy)-N-(3-(3-(1-piperidinylmethyl" C19H28N2O4 SMTZFNFIKUPEJC-UHFFFAOYSA-N [2-oxo-2-[3-[3-(piperidin-1-ylmethyl)phenoxy]propylamino]ethyl] acetate n.a. n.a. No Yes No No No No PMDBD761 Saccharin "Therapeutic Substance; Dietary Substance; Herbal Substance" "Investigational Drug; Dietary Compounds; Artificial Sweetener; Medicinal Herbal Compounds" n.a. DB12418 n.a. n.a. n.a. 5143 4959 NPC328793 "saccharin; 81-07-2; o-Benzoic sulfimide; o-Sulfobenzimide; Saccharine; Saccharimide; Benzosulfimide; Benzoic sulfimide; o-Benzosulfimide; Saccharinose; Benzosulphimide; Garantose; Saccharinol; Gluside; Benzosulfinide; Hermesetas; Saccharol; Sweeta; Saccharin insoluble; Glucid; Saccharin acid; 1,2-Benzisothiazol-3(2H)-one, 1,1-dioxide; Benzoic sulphimide; Saccharina; Zaharina; Kandiset; Sucrette; Sacarina; Sykose; Saxin; Benzo-2-sulphimide; o-Benzoyl sulfimide; Sucre edulcor; o-Benzoic sulphimide; Benzoylsulfonic Imide; o-Sulfobenzoic acid im" C7H5NO3S CVHZOJJKTDOEJC-UHFFFAOYSA-N 1,1-dioxo-1,2-benzothiazol-3-one n.a. n.a. Yes Yes No No No No PMDBD762 Salmeterol Therapeutic Substance Approved Drug 89365-50-4 DB00938 PA451300 D05792 DAP000947 5152 4968 n.a. "Salmeterol; 89365-50-4; Serevent; Aeromax; Astmerole; Salmeterolum [Latin]; GR 33343X; SALMATEROL; 2-(hydroxymethyl)-4-[1-hydroxy-2-[6-(4-phenylbutoxy)hexylamino]ethyl]phenol; SN408D; HSDB 7315; 2-(hydroxymethyl)-4-(1-hydroxy-2-{[6-(4-phenylbutoxy)hexyl]amino}ethyl)phenol; 136112-01-1; Salmeterol-fluticasone propionate mixt.; CHEBI:64064; (+-)-4-Hydroxy-alpha''-(((6-(4-phenylbutoxy)hexyl)amino)methyl)-m-xylene-alpha,alpha''-diol; (+-)-4-Hydroxy-alpha1-(((6-(4-phenylbutoxy)hexyl)amino)methyl)-1,3-benzenedimethanol; Salmeterol " C25H37NO4 GIIZNNXWQWCKIB-UHFFFAOYSA-N 2-(hydroxymethyl)-4-[1-hydroxy-2-[6-(4-phenylbutoxy)hexylamino]ethyl]phenol GlaxoSmithKline Bronchodilator Agents Yes No No No No No PMDBD808 Sulfadiazine Therapeutic Substance antibiotic 68-35-9 DB00359 PA451539 D00587 DAP001238 5215 5026 n.a. "sulfadiazine; 68-35-9; Sulphadiazine; Sulfapyrimidine; Sulfadiazin; Sulfazine; Sulfadiazene; Adiazine; Debenal; Adiazin; Sulfapyrimidin; Liquadiazine; Pyrimal; 2-Sulfanilamidopyrimidine; Theradiazine; Spofadrizine; Cremodiazine; Terfonyl; Quadramoid; Quadetts; Neotrizine; Microsulfon; Cremotres; Sulfonsol; Sulfolex; Sterazine; Piridisir; Truozine; Trifonamide; Sulfatryl; Sanodiazine; Palatrize; Eskadiazine; Diazolone; Deltazina; Neazine; Pirimal; Trisem; Sulfose; Diazin; Sulfanilamidopyrimidine; Honey diazine; Triple Sulfas; Tri-Sulfameth; Lipo-Levaz" C10H10N4O2S SEEPANYCNGTZFQ-UHFFFAOYSA-N 4-amino-N-pyrimidin-2-ylbenzenesulfonamide Lilly Antiinfective Agents No Yes No No No No PMDBD668 Picosulfuric acid Therapeutic Substance compound 10040-34-3 DB09268 n.a. n.a. n.a. 5243 5053 n.a. "Picosulfuric acid; Picosulfate; UNII-95D580798S; 10040-34-3; 95D580798S; Picosulphate; CHEMBL1741134; SCHEMBL18552552; CTK8A7124; DTXSID70143251; ZINC3873921; Phenol, 4,4''-(2-pyridinylmethylene)bis-, 1,1''-bis(hydrogen sulfate); DB09268; LS-187202; NS00004849; picosulfuric acid;sodium picosulfate;Picosulfate sodium; Bis(sulfuric acid)2-pyridinylmethylenebis(1,4-phenylene) ester; (pyridin-2-ylmethanediyl)dibenzene-4,1-diyl bis(hydrogen sulfate)" C18H15NO8S2 UJIDKYTZIQTXPM-UHFFFAOYSA-N [4-[pyridin-2-yl-(4-sulfooxyphenyl)methyl]phenyl] hydrogen sulfate n.a. n.a. No Yes No No No No PMDBD789 Sotalol Therapeutic Substance Approved Drug 3930-20-9 DB00489 PA451457 n.a. DAP000372 5253 5063 n.a. "sotalol; 3930-20-9; beta-Cardone; Sotalolum; DL-Sotalol; Sotalol [INN:BAN]; Sotalolum [INN-Latin]; MJ-1999; N-(4-(1-Hydroxy-2-(isopropylamino)ethyl)phenyl)methanesulfonamide; .beta.-Cardone; 4''-(1-Hydroxy-2-(isopropylamino)ethyl)methane sulfonanilide; CCRIS 4204; CHEMBL471; 4''-(1-Hydroxy-2-isopropylaminoethyl)methanesulfonanilid; CHEBI:63622; N-{4-[1-hydroxy-2-(propan-2-ylamino)ethyl]phenyl}methanesulfonamide; N-[4-[1-hydroxy-2-(propan-2-ylamino)ethyl]phenyl]met" C12H20N2O3S ZBMZVLHSJCTVON-UHFFFAOYSA-N N-[4-[1-hydroxy-2-(propan-2-ylamino)ethyl]phenyl]methanesulfonamide Bristol-Myers Squibb Antiarrhythmic Agents No Yes No No No No PMDBD439 Imatinib Therapeutic Substance Therapeutic Substance 152459-95-5 DB00619 PA10804 D01441 DNC001383 5291 5101 n.a. "Imatinib; 152459-95-5; STI571; Glivec; Imatinib (STI571); sti-571; Cgp 57148; Imatinib [INN:BAN]; Imatinib free base; STI 571; N-(4-Methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide; UNII-BKJ8M8G5HI; Imatinib Methansulfonate; CCRIS 9076; CGP 57148B; CGP-57148; BKJ8M8G5HI; 4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide; 4-(4-METHYL-PIPERAZIN-1-YLMETHYL)-N-[4-METHYL-3-(4-PYRIDIN-3-YL-PYRIMIDIN-2-YLAMINO)-PHENYL]-BENZAMIDE" C29H31N7O KTUFNOKKBVMGRW-UHFFFAOYSA-N 4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide Novartis AG Anticancer Agents No Yes No No No No PMDBD1493 Vorinostat Therapeutic substance Anti-cancer 149647-78-9 DB02546 PA164748224 D06320 DAP001082 5311 5120 n.a. "Vorinostat; 149647-78-9; SAHA; suberoylanilide hydroxamic acid; Zolinza; N-hydroxy-N''-phenyloctanediamide; Suberanilohydroxamic acid; N1-hydroxy-N8-phenyloctanediamide; MK-0683; MK0683; Vorinostat (SAHA, MK0683); SAHA cpd; N''-hydroxy-N-phenyloctanediamide; CCRIS 8456; OCTANEDIOIC ACID HYDROXYAMIDE PHENYLAMIDE; N-Hyrdroxy-N''-phenyloctanediamide; UNII-58IFB293JI; Vorinostat (SAHA); SHH; CHEMBL98; 58IFB293JI; CHEBI:45716; WIN64652; NSC701852; MFCD00945317; NSC-701852; NCGC00168085-02; NCGC00168085-01" C14H20N2O3 WAEXFXRVDQXREF-UHFFFAOYSA-N N''-hydroxy-N-phenyloctanediamide n.a. n.a. No Yes No No No No PMDBD1427 Sulfamethoxazole Therapeutic substance Drug 723-46-6 DB01015 PA451544 D00447 DNC001393 5329 5138 n.a. "sulfamethoxazole; 723-46-6; Sulphamethoxazole; Gantanol; Sulfisomezole; Sulfamethoxazol; Metoxal; Sulfamethylisoxazole; 4-Amino-N-(5-methyl-3-isoxazolyl)benzenesulfonamide; Simsinomin; Radonil; Sinomin; Sulphamethoxazol; Sulpha-methoxizole; Bactrim; Sulfamethalazole; Azo-gantanol; Sulphamethylisoxazole; Urobak; Sulfamethoxizole; 3-Sulfanilamido-5-methylisoxazole; Gantanol-DS; 4-amino-N-(5-methylisoxazol-3-yl)benzenesulfonamide; Bactrimel; Gamazole; Ro 4-2130; 4-amino-N-(5-methyl-1,2-oxazol-3-yl)benzenesulfonamide; Sulphisomezole; 5-Me" C10H11N3O3S JLKIGFTWXXRPMT-UHFFFAOYSA-N 4-amino-N-(5-methyl-1,2-oxazol-3-yl)benzenesulfonamide n.a. n.a. No Yes No No No No PMDBD810 Sulfanilamide "Therapeutic Substance; Herbal Substance" anti-infective 63-74-1 DB00259 PA451545 D08543 DNC001391 5333 5142 NPC315403 "sulfanilamide; 4-Aminobenzenesulfonamide; 63-74-1; Sulphanilamide; Sulphonamide; Sulfamine; Sulfonylamide; p-Aminobenzenesulfonamide; Prontosil Album; Streptasol; Bacteramid; p-Sulfamoylaniline; Sulfonamide P; p-Aminobenzenesulfamide; Streptoclase; Estreptocida; Exoseptoplix; Sulfanidyl; p-Sulfamidoaniline; Sulfocidine; Sulfamidyl; Sulfanil; Sulfanalone; Sulfana; Sulfanilimidic acid; p-Anilinesulfonamide; p-Aminophenylsulfonamide; 4-Aminobenzene-1-Sulfonamide; Therapol; Streptagol; Strepamide; Septoplex; Pysoc" C6H8N2O2S FDDDEECHVMSUSB-UHFFFAOYSA-N 4-aminobenzenesulfonamide n.a. n.a. No Yes No No No Yes EX_sanilamide(e),SANILAMIDEt2r,SANILAMIDEt2rpp,SANILAMIDEtex PMDBD811 Sulfapyridine Therapeutic Substance Approved Drug 144-83-2 DB00891 PA164779050 D02434 DAP001200 5336 5145 n.a. "sulfapyridine; 144-83-2; Sulphapyridine; 2-Sulfapyridine; Sulfidin; 2-Sulfanilamidopyridine; Sulfidine; 2-Sulfanilylaminopyridine; Streptosilpyridine; Piridazol; Pyridazol; Eubasinum; Coccoclase; Haptocil; Eubasin; Plurazol; Relbapiridina; Thioseptal; Septipulmon; Pyriamid; Adiplon; Trianon; Dagenan; Ronin; 2-Sulfanilamidopyridin; Solfapiridina; N-2-Pyridylsulfanilamide; Sulfapyridinum; Sulfapiridina; 4-amino-N-pyridin-2-ylbenzenesulfonamide; N1-2-Pyridylsulfanilamide; 2-(p-Aminobenzenesulphonamido)pyridine" C11H11N3O2S GECHUMIMRBOMGK-UHFFFAOYSA-N 4-amino-N-pyridin-2-ylbenzenesulfonamide n.a. Dermatologic Agents No Yes No No No Yes EX_sulfp(e),SULFPt2r,SULFPt2rpp,SULFPtex PMDBD813 Sulfinpyrazone Therapeutic Substance anti-inflammatory 57-96-5 DB01138 PA451550 D00449 DAP000794 5342 5149 n.a. "sulfinpyrazone; 57-96-5; Sulphinpyrazone; (+/-)-SULFINPYRAZONE; Anturane; Sulfinpyrazon; Anturan; Diphenylpyrazone; Sulfoxyphenylpyrazolidine; Anturanil; Anturidin; Enturen; Anturano; Sulfinpyrazine; 1,2-Diphenyl-4-(2-(phenylsulfinyl)ethyl)pyrazolidine-3,5-dione; USAF GE-13; Sulfinpyrazonum; Enturan; Anturen; NSC 75925; Anturane (TN); Sulfinpyrazonum [INN-Latin]; G 28315; Sulfinpirazona [INN-Spanish]; 4-[2-(benzenesulfinyl)ethyl]-1,2-diphenylpyrazolidine-3,5-dione; 4-(Phenylsulfoxyethyl)-1,2-diphenyl-3,5-pyrazolidinedione; 1,2-Diphe" C23H20N2O3S MBGGBVCUIVRRBF-UHFFFAOYSA-N 4-[2-(benzenesulfinyl)ethyl]-1,2-diphenylpyrazolidine-3,5-dione n.a. Uricosuric Agents No Yes No No No Yes EX_spz(e),SPZ_GLC_GLCAASE,SPZ_GLC_GLCAASEe,SPZ_GLC_GLCAASEepp,SPZte,SPZtepp,SPZtex PMDBD819 Sulpiride Therapeutic Substance Approved Drug 15676-16-1 DB00391 PA164745485 D01226 DAP000310 5355 5162 n.a. "sulpiride; 15676-16-1; Sulpyrid; Sulpirid; Dolmatil; Aiglonyl; Dogmatil; Guastil; Dobren; (RS)-(+/-)-sulpiride; (+/-)-Sulpiride; Sursumid; Mirbanil; Misulvan; Splotin; Abilit; Neogama; Miradol; Meresa; Omperan; Eglonyl; Sernevin; Dogmatyl; Psicocen; Pyrkappl; Coolspan; Calmoflorine; Zemorcon; Stamonevrol; Lisopiride; Isnamide; Darleton; Alimoral; Kylistro; Fardalan; Championyl; Ozoderpin; Norestran; Mariastel; Eusulpid; Desmenat; Suprium; Omiryl; Normum; Eglonil; Valirem; Restful; Dresent; Fidelan; Equilid; Nufarol; Enimon; N-[(1-ethylpyrrolidin-2-yl)methyl]" C15H23N3O4S BGRJTUBHPOOWDU-UHFFFAOYSA-N N-[(1-ethylpyrrolidin-2-yl)methyl]-2-methoxy-5-sulfamoylbenzamide n.a. n.a. No Yes No No No No PMDBD380 Gatifloxacin Therapeutic Substance Approved Drug 112811-59-3 DB01044 PA449738 D08011 DAP001387 5379 5186 n.a. "Gatifloxacin; 112811-59-3; Tequin; Zymar; Gatiflo; AM-1155; Gatispan; Gatiquin; Zymaxid; Gatilox; Gaity; AM 1155; CG 5501; BMS-206584; Gatifloxacine; Gatifloxacin [USAN:INN]; 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid; gatifloxacin anhydrous; GTFX; BMS 206584-01; 1-Cyclopropyl-1,4-dihydro-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid; 1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic a" C19H22FN3O4 XUBOMFCQGDBHNK-UHFFFAOYSA-N 1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid Bristol-Myers Squibb Antiinfective Agents Yes Yes Yes No No No PMDBD1436 Tegafur Therapeutic substance chemotherapeutic 17902-23-7 DB09256 n.a. D01244 n.a. 5386 5193 n.a. "tegafur; Ftorafur; 17902-23-7; Futraful; Fluorofur; Sinoflurol; Citofur; Florafur; Neberk; Fental; Furafluor; Nitobanil; Furofutran; Furflucil; Franroze; Coparogin; Fulfeel; Exonal; Sunfral; Lifril; Lamar; Riol; Tefsiel C; FT-207; Phthorafur; 1-(2-Tetrahydrofuryl)-5-fluorouracil; 5-Fluoro-1-(tetrahydro-2-furyl)uracil; Racemic Ftorafur; Phthorafur [Czech]; MJF-12264; 5-fluoro-1-(tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione; NSC-148958; Tegafurum [INN-Latin]; 5-Fluoro-1-(tetr" C8H9FN2O3 WFWLQNSHRPWKFK-UHFFFAOYSA-N 5-fluoro-1-(oxolan-2-yl)pyrimidine-2,4-dione n.a. n.a. No Yes No No No No PMDBD1441 Temazepam Therapeutic substance Drug 846-50-4 DB00231 PA451608 D00370 DAP000238 5391 5198 n.a. "temazepam; Restoril; Hydroxydiazepam; Methyloxazepam; Oxydiazepam; Levanxol; Levanxene; Euhypnos; Crisonar; Signopam; N-Methyloxazepam; Normison; Remestan; Mabertin; Planum; 3-Hydroxydiazepam; 846-50-4; Euipnos; Cerepax; Tenox; Temaz; Normitab; Nocturne; Temtabs; Nortem; Dasuen; Norkotral Tema; temazep von ct; Pronervon T; Temazepamum; Temador; Nomapam; Lenal; Uvamin Retard; Wy-3917; Neodorm SP; ER 115; Temazepamum [INN-Latin]; Ro 5-5345; WY 3917; K-3917; NSC 246303; Tema" C16H13ClN2O2 SEQDDYPDSLOBDC-UHFFFAOYSA-N 7-chloro-3-hydroxy-1-methyl-5-phenyl-3H-1,4-benzodiazepin-2-one n.a. n.a. No Yes No No No No PMDBD829 Temozolomide Therapeutic Substance antitumor? 85622-93-1 DB00853 PA451609 D06067 DAP000987 5394 5201 n.a. "temozolomide; 85622-93-1; Methazolastone; Temodar; Temodal; Temozolamide; 3-methyl-4-oxo-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide; Temozolomidum [Latin]; Temozolodida [Spanish]; Temozolomidum; CCRG-81045; CCRG 81045; Sch 52365; NSC 362856; Sch-52365; M&B-39831; CCRIS 8996; NSC-362856; MB 39831; M&B 39831; 8-Carbamoyl-3-methylimidazo(5,1-d)-1,2,3,5-tetrazin-4(3H)-one; UNII-YF1K15M17Y; M & B 39831; BRN 5547136; 3-Methyl-4-oxo-3,4-dihydroimidazo(5,1-d)(1,2,3,5)tetrazine-8-carboxamide" C6H6N6O2 BPEGJWRSRHCHSN-UHFFFAOYSA-N 3-methyl-4-oxoimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide Schering-Plough Anticancer Agents Yes Yes No Yes No No PMDBD1442 Terazosin Therapeutic substance Drug 63590-64-7 DB01162 PA451612 D08569 DAP000371 5401 5208 n.a. "terazosin; Terazosine; 63590-64-7; Fosfomic; Flumarc; Vasomet; Blavin; Hytrin; Terazosinum; Terazosina; Terazosinum [INN-Latin]; Terazosine [INN-French]; Terazosina [INN-Spanish]; Terazosin HCl; Terazosin [INN:BAN]; 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-((tetrahydro-2-furanyl)carbonyl)piperazine; CHEMBL611; MLS000069703; Abbott-45975; CHEBI:9445; C19H25N5O4; SMR000058309; 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(tetrahydro-2-furoyl)piperazine; 6,7-dimethoxy-2-[4-(oxolane-2-carbonyl)piperazin-1-yl]quinazolin-4-amine; 6,7-di" C19H25N5O4 VCKUSRYTPJJLNI-UHFFFAOYSA-N [4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(oxolan-2-yl)methanone n.a. n.a. No Yes No No No No PMDBD1444 Terbutaline Therapeutic substance Drug 23031-25-6 DB00871 PA451616 n.a. DAP000246 5403 5210 n.a. "terbutaline; Terbutalin; 23031-25-6; Brican; Bricanyl; Bricaril; Brethine; Brethaire; Bricar; Bricyn; Terbutalinum; Terbutalina [DCIT]; Terbutaline sulfate; Terbutalina; 5-[2-(tert-butylamino)-1-hydroxyethyl]benzene-1,3-diol; Terbutalinum [INN-Latin]; Terbutalino [INN-Spanish]; (+-)-Terbutaline; Terbutaline [INN:BAN]; KWD 2019; KWD-2019; TERBUTALINE HEMISULFATE; 5-(2-(tert-Butylamino)-1-hydroxyethyl)benzene-1,3-diol; EINECS 245-385-8; BRN 2370513; 5-(2-((1,1-DIMETHYLETHYL)AMINO)-1-HYDROXYETHYL)-1,3-BENZENEDIOL; CHEBI:9449" C12H19NO3 XWTYSIMOBUGWOL-UHFFFAOYSA-N 5-[2-(tert-butylamino)-1-hydroxyethyl]benzene-1,3-diol n.a. n.a. No Yes No No No No PMDBD834 Terfenadine Therapeutic Substance Approved Drug 50679-08-8 DB00342 PA451619 D00521 DAP000102 5405 5212 n.a. "terfenadine; 50679-08-8; Seldane; Triludan; Ternadin; Teldane; Allerplus; Teldanex; Terdin; Aldaban; Terfenadina; Terfen; RMI-9918; RMI 9918; Terfenadinum [INN-Latin]; Terfenadina [INN-Spanish]; MDL 9918; HSDB 6508; C32H41NO2; MDL-9918; EINECS 256-710-8; BRN 5857899; 1-(4-tert-butylphenyl)-4-[4-[hydroxy(diphenyl)methyl]piperidin-1-yl]butan-1-ol; CHEMBL17157; alpha-[4-(1,1-Dimethylethyl)phenyl]-4-(hydroxydiphenylmethyl)-1-piperidinebutanol; MLS000028499; CHEBI:9453; Cyater; alpha-(p-tert-Butylphenyl)-4-(hydroxydiphenylmethyl)-1-piperid" C32H41NO2 GUGOEEXESWIERI-UHFFFAOYSA-N 1-(4-tert-butylphenyl)-4-[4-[hydroxy(diphenyl)methyl]piperidin-1-yl]butan-1-ol Marion Merrell. Dow, Inc. Antihistamines Yes No Yes No No No PMDBD1447 Thalidomide Therapeutic substance Drug 50-35-1 DB01041 PA451644 D00754 DAP000865 5426 5233 n.a. "thalidomide; 50-35-1; Thalomid; Sedoval; 2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione; (+/-)-THALIDOMIDE; Psychotablets; Corronarobetin; Theophilcholine; Psycholiquid; Telargean; Talargan; Profarmil; Neosydyn; Hippuzon; Ectiluran; Thalinette; Softenon; Shinnibrol; Sedisperil; Polygripan; Pantosediv; Neufatin; Neosedyn; Tensival; Talismol; Softenil; Quetimid; Nevrodyn; Neurosedin; Nerosedyn; Glutanon; Gastrinide; Enterosediv; Contergan; Calmorex; Asmadion; Algosediv; Valgraine; Sedimide; Sandormin; Quietoplex; Noctosediv; Neurosedym; Neurodyn; Dist" C13H10N2O4 UEJJHQNACJXSKW-UHFFFAOYSA-N 2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione n.a. n.a. No Yes No No No No PMDBD1452 Thioridazine Therapeutic substance Drug 50-52-2 DB00679 PA451666 D00373 DAP000476 5452 5253 n.a. "thioridazine; Mellaril; Thioridazin; 50-52-2; Melleril; Meleril; Malloryl; Sonapax; Mellaril-S; Melleretten; Mellerette; Mellerets; Mallorol; dl-Thioridazine; Tioridazina; Melleryl; TP-21; Melleril (liquid); Thioridazinum; (+-)-Thioridazine; Thioridazine prolongatum; 10-(2-(1-Methylpiperidin-2-yl)ethyl)-2-(methylthio)-10H-phenothiazine; Orsanil; Tioridazina [INN-Spanish]; Thioridazinum [INN-Latin]; 2-Methylmercapto-10-(2-(N-methyl-2-piperidyl)ethyl)phenothiazine; 3-Methylmercapto-N-(2''-(N-methyl-2-piperidyl)ethyl)phenothiazine; HSDB " C21H26N2S2 KLBQZWRITKRQQV-UHFFFAOYSA-N 10-[2-(1-methylpiperidin-2-yl)ethyl]-2-methylsulfanylphenothiazine n.a. n.a. No Yes No No No No PMDBD1456 Ticlopidine Therapeutic substance Drug 55142-85-3 DB00208 PA451686 D08594 DAP000723 5472 5273 n.a. "ticlopidine; 55142-85-3; 5-(2-Chlorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine; Ticlid; Ticlopidinum; Ticlopidina; PCR 5332; Ticlopidine [INN:BAN]; Ticlopidinum [INN-Latin]; Ticlopidina [INN-Spanish]; UNII-OM90ZUW7M1; 5-[(2-chlorophenyl)methyl]-4,5,6,7-tetrahydrothieno[3,2-c]pyridine; EINECS 259-498-5; C14H14ClNS; BRN 1216802; 5-((2-Chlorophenyl)methyl)-4,5,6,7-tetrahydrothieno(3,2-c)pyridine; OM90ZUW7M1; CHEBI:9588; 5-[(2-chlorophenyl)methyl]-4H,5H,6H,7H-thieno[3,2-c]pyridine; Ticlopidine-d4; Thieno(3,2-c)pyridine, 4,5,6" C14H14ClNS PHWBOXQYWZNQIN-UHFFFAOYSA-N 5-[(2-chlorophenyl)methyl]-6,7-dihydro-4H-thieno[3,2-c]pyridine n.a. n.a. No Yes No No No No PMDBD849 Tinidazole Therapeutic Substance Approved Drug 19387-91-8 DB00911 PA10813 D01426 n.a. 5479 5279 n.a. "tinidazole; 19387-91-8; Tindamax; Tinidazol; Fasigyn; Trimonase; 1-(2-(Ethylsulfonyl)ethyl)-2-methyl-5-nitro-1H-imidazole; Simplotan; Tricolam; Fasigin; Bioshik; Sorquetan; Pletil; timidazole; 1-[2-(Ethylsulfonyl)ethyl]-2-methyl-5-nitro-1H-imidazole; Tinidazol [INN-Spanish]; Tinidazolum [INN-Latin]; CP 12574; 1-(2-ethylsulfonylethyl)-2-methyl-5-nitroimidazole; UNII-033KF7V46H; CCRIS 7621; C8H13N3O4S; CP-12574; CHEBI:63627; HSDB 7362; 1-(2-(Ethylsulfonyl)ethyl)-2-methyl-5-ni" C8H13N3O4S HJLSLZFTEKNLFI-UHFFFAOYSA-N 1-(2-ethylsulfonylethyl)-2-methyl-5-nitroimidazole Presutti Laboratories n.a. Yes Yes Yes Yes No No PMDBD850 Tioconazole Therapeutic Substance Approved Drug 65899-73-2 DB01007 PA164746156 D00890 DAP001268 5482 5282 n.a. "tioconazole; 65899-73-2; Trosyl; Vagistat-1; Vagistat; Trosyd; Gyno-trosyd; Fungibacid; Tioconazolum; Zoniden; Tioconazolum [INN-Latin]; Tioconazol [INN-Spanish]; Tz-3; UK-20349; C16H13Cl3N2OS; UK 20349; EINECS 265-973-8; BRN 0573867; Tioconazol; CHEBI:77898; 1-(2,4-Dichloro-beta-((2-chloro-3-thenyl)-oxy)phenethyl)imidazole; (+-)-1-(2,4-Dichloro-beta-((2-chloro-3-ethenyl)oxy)phenethyl)imidazole; 1-[2-[(2-chlorothiophen-3-yl)methoxy]-2-(2,4-dichlorophenyl)ethyl]imidazole; NCGC00167430-01; 1-(2,4-Dichloro-(beta-(2-chloro-3-thenyl)ox" C16H13Cl3N2OS QXHHHPZILQDDPS-UHFFFAOYSA-N 1-[2-[(2-chlorothiophen-3-yl)methoxy]-2-(2,4-dichlorophenyl)ethyl]imidazole n.a. Antifungal Agents Yes No Yes No No No PMDBD1458 Tizanidine Therapeutic substance Drug 51322-75-9 DB00697 PA451701 n.a. DAP000234 5487 5287 n.a. "tizanidine; 51322-75-9; Sirdalud; Ternelin; Zanaflex; Tizanidinum; Tizanidina; Tizanidinum [INN-Latin]; Tizanidina [INN-Spanish]; 5-chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-2,1,3-benzothiadiazol-4-amine; Tizanidine [INN:BAN]; 5-Chloro-4-(2-imidazolin-2-ylamino)-2,1,3-benzothiadiazole; UNII-6AI06C00GW; BRN 0618691; CHEMBL1079; 6AI06C00GW; CHEBI:63629; NCGC00160529-01; 2,1,3-Benzot" C9H8ClN5S XFYDIVBRZNQMJC-UHFFFAOYSA-N 5-chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-2,1,3-benzothiadiazol-4-amine n.a. n.a. No Yes No No No No PMDBD855 Tolazamide Therapeutic Substance Approved Drug 1156-19-0 DB00839 PA164774902 D00379 DAP000919 5503 5302 n.a. "tolazamide; 1156-19-0; Tolinase; Norglycin; Tolanase; Tolazolamide; Diabewas; Tolazamidum; Tolazamida; 1-(Hexahydro-1-azepinyl)-3-p-tolylsulfonylurea; N-(p-Toluenesulfonyl)-N''-hexamethyleniminourea; U-17835; 4-(p-Tolylsulfonyl)-1,1-hexamethylenesemicarbazide; NCI-C03327; 1-(Hexahydro-1H-azepin-1-yl)-3-(p-tolylsulfonyl)urea; Tolazamidum [INN-Latin]; Tolazamida [INN-Spanish]; U 17835; CCRIS 591; NSC-70762; UNII-9LT1BRO48Q; EINECS 214-588-3; Benzenesulfonamide, N-[[(hexahydro-1H-aze" C14H21N3O3S OUDSBRTVNLOZBN-UHFFFAOYSA-N 1-(azepan-1-yl)-3-(4-methylphenyl)sulfonylurea n.a. Hypoglycemic Agents No Yes No Yes No No PMDBD1459 Tolbutamide Therapeutic substance Drug 64-77-7 DB01124 PA451718 D00380 DAP000136 5505 5304 n.a. "tolbutamide; 64-77-7; Orinase; Artosin; Tolbutamid; Diabetol; Tolumid; Dolipol; Arkozal; Rastinon; Aglicid; Diaben; Orabet; 1-Butyl-3-tosylurea; Willbutamide; Tolylsulfonylbutylurea; Diasulfon; Butamide; Tolbusal; Pramidex; Ipoglicone; Dirastan; Diabuton; Glyconon; Diabetamid; Orezan; Oralin; Toluina; Oterben; Drabet; Toluvan; Orinaz; Mobenol; Butamid; Artozin; 1-Butyl-3-(p-tolylsulfonyl)urea; Sk-tolbutamide; N-n-Butyl-N''-tosylurea; Tolbutamida; Tolbutamidum; 1-p-Toluenesulfonyl-3-butylurea; 1-Butyl-3-(p-methylphenylsulfonyl)urea; N-Butyl-N''-(p-tol" C12H18N2O3S JLRGJRBPOGGCBT-UHFFFAOYSA-N 1-butyl-3-(4-methylphenyl)sulfonylurea n.a. n.a. No Yes No No No No PMDBD857 Tolnaftate Therapeutic Substance Approved Drug 2398-96-1 DB00525 PA164752438 D00381 DAP001237 5510 5309 n.a. "tolnaftate; 2398-96-1; Tolnaphthate; Tonoftal; Tinactin; Sporiline; Tolsanil; Tinaderm; Aftate; Chinofungin; Focusan; Tinavet; Dermoxin; Pitrex; Naphthiomate T; Phytoderm; Tritin; Timoped; HI-Alazin; Fungistop; Tolnaftatum; Tolnaftato; Sorgoa; Tniaderm; Dungistop; Separin; Tolnaftato [DCIT]; Naphthiomate-T; Hi-alarzin; O-2-Naphthyl m,N-dimethylthiocarbanilate; Tolnaftatum [INN-Latin]; Sch 10144; Tolnaftato [INN-Spanish]; 2-Naphthyl N-methyl-N-(3-tolyl)thionocarbamate; Tinavet (Veterinary); m,N-Dimethylthiocarbanilic acid O-2-naphthyl ester" C19H17NOS FUSNMLFNXJSCDI-UHFFFAOYSA-N O-naphthalen-2-yl N-methyl-N-(3-methylphenyl)carbamothioate Schering-Plough Antifungal Agents Yes No Yes No No No PMDBD1472 Trazodone Therapeutic substance Drug 19794-93-5 DB00656 PA451744 D08626 DAP000104 5533 5332 n.a. "trazodone; Trazodon; 19794-93-5; Trazonil; Trazalon; Desirel; Beneficat; Trazodil; Sideril; Trazodona; Trazodonum; Trazodonum [INN-Latin]; Trazodona [INN-Spanish]; Trazodonum [Latin]; Trazodona [Spanish]; Trazodone [INN:BAN]; UNII-YBK48BXK30; C19H22ClN5O; EINECS 243-317-1; CHEMBL621; BRN 0628010; YBK48BXK30; CHEBI:9654; Oleptro; 2-{3-[4-(3-chlorophenyl)piperazin-1-yl]propyl}[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one; 2-(3-[4-(3-Chlorophenyl)-1-piperazi" C19H22ClN5O PHLBKPHSAVXXEF-UHFFFAOYSA-N 2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-[1,2,4]triazolo[4,3-a]pyridin-3-one n.a. n.a. No Yes No No No No PMDBD1474 Triamterene Therapeutic substance Drug 396-01-0 DB00384 PA451752 D00386 DAP000575 5546 5345 n.a. "triamterene; 396-01-0; 6-phenylpteridine-2,4,7-triamine; 2,4,7-Triamino-6-phenylpteridine; Dyrenium; Dytac; Pterophene; Triteren; Triamteril; Triamteren; Pterofen; Teridin; Taturil; Diurene; Ademine; Noridil; Ademin; Urocaudal; Triampur; Noridyl; Jatropur; Dyren; Teriam; Diren; Ditak; Tri-Span; Triamteril complex; Trispan; 6-Phenyl-2,4,7-pteridinetriamine; Diucelpin; Triamthiazid; Triurene; Tricilone; Triamizide; Esiteren; Diuteren; Dinazide; Masuharmin; Jenateren; Diutensat; Renezide; Kalspare; Hypertorr; Hidiurese; Dytenzide; Dyberzide; Isobar; Amtere" C12H11N7 FNYLWPVRPXGIIP-UHFFFAOYSA-N 6-phenylpteridine-2,4,7-triamine n.a. n.a. No Yes No No No No PMDBD1475 Triazolam Therapeutic substance Drug 28911-01-5 DB00897 PA451753 D00387 DAP000244 5556 5355 n.a. "triazolam; Halcion; 28911-01-5; Songar; Clorazolam; Novidorm; Triazolamum [INN-Latin]; 8-Chloro-6-(2-chlorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine; U-33,030; DEA No. 2887; CCRIS 1932; U 33030; UNII-1HM943223R; HSDB 6759; EINECS 249-307-3; CHEMBL646; U-33030; BRN 1226643; 8-Chloro-6-(o-chlorophenyl)-1-methyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine; C17H12Cl2N4; CHEBI:9674; 8-Chloro-6-(2-chlorophenyl)-1-methyl-4H-(1,2,4)triazolo(4,3-a)(1,4)benzodiazepine; 4H-[1,2,4]Triazolo[4,3-a][1,4]benzodiazepine, 8-chloro" C17H12Cl2N4 JOFWLTCLBGQGBO-UHFFFAOYSA-N 8-chloro-6-(2-chlorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine n.a. n.a. No Yes No No No No PMDBD869 Triclosan "Therapeutic Substance; Herbal Substance" "Approved Drug; Medicinal Herbal Compounds" 3380-34-5 DB08604 n.a. D06226 n.a. 5564 5363 NPC205213 "triclosan; 3380-34-5; 5-CHLORO-2-(2,4-DICHLOROPHENOXY)PHENOL; 2,4,4''-Trichloro-2''-hydroxydiphenyl ether; Irgasan; Cloxifenolum; Triclosanum; Irgasan DP300; Stri-Dex Face Wash; Lexol 300; Stri-Dex Cleansing Bar; 5-Chloro-2-(2,4-dichloro-phenoxy)-phenol; Triclosanum [INN-Latin]; CH 3565; DP-300; Caswell No. 186A; C12H7Cl3O2; UNII-4NM5039Y5X; HSDB 7194; CHEBI:164200; Ether, 2''-hydroxy-2,4,4''-trichlorodiphenyl; EINECS 222-182-2; CHEMBL849; EPA Pestic" C12H7Cl3O2 XEFQLINVKFYRCS-UHFFFAOYSA-N 5-chloro-2-(2,4-dichlorophenoxy)phenol n.a. Antibiotics Yes No Yes No No No PMDBD1478 Trifluoperazine Therapeutic substance Drug 117-89-5 DB00831 PA451771 D08636 DAP000034 5566 5365 n.a. "trifluoperazine; Trifluperazine; Trifluoroperazine; 117-89-5; Triperazine; Triflurin; Trifluoperazin; Trifluoperazina; Trifluoromethylperazine; Flurazine; Stelazine; Triphthasine; Trifluroperizine; Trifluoperazinum; Trifluoperazine hydrochloride; Trifluoperazina [Italian]; RP 7623; Fluoperazine; Trifluoperazine [INN:BAN]; TFP; Trifluoperazinum [INN-Latin]; Trifluoperazina [INN-Spanish]; Trifluoromethyl-10-(3''-(1-methyl-4-piperazinyl)propyl)phenothiazine; 10-[3-(4-methylpiperazin-1-yl)propyl]-2-(trifluoromethyl)-10H-phenothiazine" C21H24F3N3S ZEWQUBUPAILYHI-UHFFFAOYSA-N 10-[3-(4-methylpiperazin-1-yl)propyl]-2-(trifluoromethyl)phenothiazine n.a. n.a. No Yes No No No No PMDBD873 Trihexyphenidyl Therapeutic Substance Approved Drug 144-11-6 DB00376 PA164747026 D08638 DAP001532 5572 5371 n.a. "trihexyphenidyl; Benzhexol; Triphenidyl; Parkinane retard; 144-11-6; Trihexyphenidyle; Benzhexolum; Sedrena (free base); Trihexyphenidylum; Trihexyphenidyle [INN-French]; Trihexyphenidylum [INN-Latin]; Trihexifenidilo [INN-Spanish]; Trihexyphenidyl [INN:BAN]; 1-cyclohexyl-1-phenyl-3-(piperidin-1-yl)propan-1-ol; HSDB 3196; EINECS 205-614-4; NSC 12268; 1-cyclohexyl-1-phenyl-3-piperidin-1-ylpropan-1-ol; BRN 0088959; CHEB" C20H31NO HWHLPVGTWGOCJO-UHFFFAOYSA-N 1-cyclohexyl-1-phenyl-3-piperidin-1-ylpropan-1-ol Lederle Laboratories Div American Cyanamid Co Antiparkinson Agents No Yes No Yes No No PMDBD1479 Trimethobenzamide Therapeutic substance Drug 138-56-7 DB00662 PA164764516 D08643 n.a. 5577 5375 n.a. "trimethobenzamide; 138-56-7; Tigan; N-(4-(2-(Dimethylamino)ethoxy)benzyl)-3,4,5-trimethoxybenzamide; Trimetobenzamida; Trimethobenzamidum; Trimetobenzamida [INN-Spanish]; Trimethobenzamidum [INN-Latin]; Trimethobenzamide [INN]; UNII-W2X096QY97; HSDB 3198; EINECS 205-332-1; CHEBI:27796; 4-(2-Dimethylaminoethoxy)-N-(3,4,5-trimethoxybenzoyl)benzylamine; W2X096QY97; Tribenzagan; Stemetic; N-((2-Dimethylaminoethoxy)benzyl)-3,4,5-trimethoxybenzamide; Benzacot; Trimethobenzamide (INN)" C21H28N2O5 FEZBIKUBAYAZIU-UHFFFAOYSA-N N-[[4-[2-(dimethylamino)ethoxy]phenyl]methyl]-3,4,5-trimethoxybenzamide n.a. n.a. No Yes No No No No PMDBD877 Trimethoprim Therapeutic Substance Approved Drug 738-70-5 DB00440 PA451788 D00145 DAP000927 5578 5376 n.a. "trimethoprim; 738-70-5; Proloprim; Trimpex; Trimetoprim; Monotrimin; Monotrim; Trimopan; Bactramin; 2,4-Diamino-5-(3,4,5-trimethoxybenzyl)pyrimidine; Wellcoprim; Monoprim; Trimanyl; Syraprim; Uretrim; Triprim; 5-(3,4,5-trimethoxybenzyl)pyrimidine-2,4-diamine; Trimethoprime; Trimethoprimum; Abaprim; Apo-Sulfatrim; Zamboprim; Sulfoxaprim; Sulfamar; Sinotrim; Pancidim; NIH 204; Bacticel; Wellcoprin; Urobactrim; Streptoplus; Kombinax; Colizole; Briscotrim; Biosulten; Bethaprim; Antrimox; Trisulfam; Trisulcom; Sugaprim; Novotrimel; Lagatrim; Fermagex; Es" C14H18N4O3 IEDVJHCEMCRBQM-UHFFFAOYSA-N 5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine GlaxoSmithKline Antiinfective Agents Yes Yes Yes No No No PMDBD878 Troglitazone Therapeutic Substance Approved Drug 97322-87-7 DB00197 PA451799 D00395 DAP001337 5591 5389 n.a. "troglitazone; 97322-87-7; Rezulin; Romglizone; Prelay; CS-045; Romozin; Noscal; CS 045; Rezulin (TN); GR 92132X; CCRIS 8969; GR92132X; CI-991; GR-92132X; CI 991; CHEBI:9753; C24H27NO5S; (+-)-all-rac-5-(p-((6-Hydroxy-2,5,7,8-tetramethyl-2-chromanyl)methoxy)benzyl)-2,4-thiazolidinedione; 5-(4-(6-Hydroxy-2,5,7,8-tetramethylchroman-2-ylmethoxy)benzyl)thiazolidine-2,4-dione; Troglitazone (CS-045); BRN 4338399; NCGC00164445-01; DSSTox_CID_3719; DSSTox_RID_77162; DSSTox_GSID_23719; 2,4-Thiazolidinedione, 5-((4-((3,4-dihydro-6-hydroxy-2,5,7" C24H27NO5S GXPHKUHSUJUWKP-UHFFFAOYSA-N 5-[[4-[(6-hydroxy-2,5,7,8-tetramethyl-3,4-dihydrochromen-2-yl)methoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione Daiichi Sankyo Pharma Development Antiinflammatory Agents Yes No Yes No No Yes EX_tgz(e),TGZ_GLC_GLCAASE,TGZ_GLC_GLCAASEe,TGZ_GLC_GLCAASEepp,TGZte,TGZtepp,TGZtex PMDBD1488 Venlafaxine Therapeutic substance Drug 93413-69-5 DB00285 PA451866 D08670 DAP000054 5656 5454 n.a. "venlafaxine; 93413-69-5; Elafax; D,L-Venlafaxine; Venlafaxina; Venlafaxinum; 1-(2-(dimethylamino)-1-(4-methoxyphenyl)ethyl)cyclohexanol; Venlafaxine [INN:BAN]; Venlafaxinum [INN-Latin]; Venlafaxin; Venlafaxina [INN-Spanish]; 1-[2-(Dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexanol; 1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexan-1-ol; Efectin; CHEBI:9943; HSDB 6699; NCGC00095109-01; DSSTox_CID_3737; DSSTox_RID_77175; DSSTox_GSID_23737; Venlafexine; Venlafa" C17H27NO2 PNVNVHUZROJLTJ-UHFFFAOYSA-N 1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexan-1-ol n.a. n.a. No Yes No No No No PMDBD907 Zafirlukast Therapeutic Substance Approved Drug 107753-78-6 DB00549 PA451949 D00411 DAP000091 5717 5515 n.a. "zafirlukast; 107753-78-6; Accolate; Olmoran; ICI-204219; Cyclopentyl (3-(2-methoxy-4-((o-tolylsulfonyl)carbamoyl)benzyl)-1-methyl-1H-indol-5-yl)carbamate; Accoleit; ICI 204219; C31H33N3O6S; ICI 204,219; UNII-XZ629S5L50; Cyclopentyl 3-(2-methoxy-4-((o-tolylsulfonyl)carbamoyl)benzyl)-1-methylindole-5-carbamate; Zafirlukast (Accolate); CHEMBL603; Aeronix; CHEBI:10100; XZ629S5L50; 4-(5-cyclopentyloxycarbonylamino-1-methyl-1H-indol-3-ylmethyl)-3-methoxy-N-o-tolylsulfonylbenzamide; NCGC00164547-06; NCGC00164547-01; Vanticon; DSSTox_C" C31H33N3O6S YEEZWCHGZNKEEK-UHFFFAOYSA-N cyclopentyl N-[3-[[2-methoxy-4-[(2-methylphenyl)sulfonylcarbamoyl]phenyl]methyl]-1-methylindol-5-yl]carbamate AstraZeneca plc Antiasthmatic Agents Yes Yes Yes No No No PMDBD908 Zaleplon Therapeutic Substance Approved Drug 151319-34-5 DB00962 PA451952 D00530 DAP000266 5719 5517 n.a. "zaleplon; 151319-34-5; Sonata; Zerene; CL-284846; SKP-1041; N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethylacetamide; ZAL-846; CL 284846; LJC 10846; CL 284,846; DEA No. 2781; ZAL 846; L846; L-846; UNII-S62U433RMH; LJC-10846; 3''-(3-Cyanopyrazolo(1,5-a)pyrimidin-7-yl)-N-ethylacetanilide; N-(3-(3-Cyanopyrazolo(1,5-a)pyrimidin-7-yl)phenyl)-N-ethylacetamide; S62U433RMH; CHEBI:10102; 3''-(3-Cyanopyrazolo(1,5-alpha)pyrimidin-7-yl)-N-ethylacetanilide; N-(3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl)-N-ethylacetamide; NCGC0016" C17H15N5O HUNXMJYCHXQEGX-UHFFFAOYSA-N N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethylacetamide King Pharm Hypnotics and Sedatives No Yes No Yes No No PMDBD915 Zonisamide Therapeutic Substance ?anticonvulsant 68291-97-4 DB00909 PA451978 D00538 DAP000500 5734 5532 n.a. "zonisamide; 68291-97-4; Zonegran; 1,2-Benzisoxazole-3-methanesulfonamide; Excegram; Exceglan; 1,2-benzoxazol-3-ylmethanesulfonamide; Zonisamidum [Latin]; Zonisamida [Spanish]; AD-810; Zonisamidum; Zonisamida; CI-912; 3-(Sulfamoylmethyl)-1,2-benzisoxazole; CI 912; AD 810; benzo[d]isoxazol-3-ylmethanesulfonamide; PD 110843; 1-(1,2-Benzoxazol-3-Yl)methanesulfonamide; Benzo[d]isoxazol-3-yl-methanesulfonamide; PD-110843; HSDB 7293; UNII-459384H98V; BRN 1077076; SPR_2; C8H8N2O3S; 1-(1,2-benzisoxazol-3-yl)methanesulfonamide; Excegran; NCGC00" C8H8N2O3S UBQNRHZMVUUOMG-UHFFFAOYSA-N 1,2-benzoxazol-3-ylmethanesulfonamide Eisai Analgesics No Yes No Yes No No PMDBD916 Zotepine Therapeutic Substance Approved Drug 26615-21-4 DB09225 n.a. D01321 n.a. 5736 5534 n.a. "zotepine; 26615-21-4; Nipolept; Lodopin; Zoleptil; Zotepina; Zotepinum; Compound-4; Zotepina [Spanish]; Zotepinum [INN-Latin]; Zotepina [INN-Spanish]; C18H18ClNOS; UNII-U29O83JAZW; 2-Chloro-11-(2-(dimethylamino)ethoxy)dibenzo(b,f)thiepin; 2-Chlor-11-(2-dimethylaminoaethoxy)-dibenzo(b,f)-thiepin; BRN 1435710; U29O83JAZW; CHEMBL285802; CHEBI:32316; 2-[(8-chlorodibenzo[b,f]thiepin-10-yl)oxy]-N,N-dimethylethanamine; 2-Chloro-11-(2-dimethylaminoethoxy)-dibenzo(b,f)thiepine; NCGC00182081-02; 2-Chlor-11-(2-dimethylaminoaethoxy)-dibenzo" C18H18ClNOS HDOZVRUNCMBHFH-UHFFFAOYSA-N 2-(3-chlorobenzo[b][1]benzothiepin-5-yl)oxy-N,N-dimethylethanamine n.a. n.a. Yes No Yes No No No PMDBD259 Dexamethasone Therapeutic Substance Therapeutic Substance n.a. DB01234 PA449247 D00292 DAP000007 5743 5541 n.a. "dexamethasone; 50-02-2; Decadron; Maxidex; Dexamethazone; Dexasone; Hexadrol; Oradexon; Prednisolone F; Hexadecadrol; Millicorten; Desametasone; Cortisumman; Decaspray; Calonat; Dexacort; Auxiron; Dexason; Azium; Fluormethylprednisolone; Aeroseb-Dex; Visumetazone; Mediamethasone; Desamethasone; Superprednol; Deltafluorene; Turbinaire; Dextelan; Dexameth; Decaderm; Gammacorten; Fortecortin; Dexadeltone; Dexacortal; Dekacort; Dectancyl; Decasone; Mymethasone; Dinormon; Dexapolcort; Dexalona; Dexacortin; Desameton; Desadrene; Aphtasolon; Dergramin; Dexone" C22H29FO5 UREBDLICKHMUKA-CXSFZGCWSA-N (8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one Swiss Pharma Antiinflammatory Agents No Yes No Yes No No PMDBD1130 Cortisone Acetate Therapeutic substance Drug 4/4/1950 DB01380 PA449130 D00973 n.a. 5745 5543 n.a. "CORTISONE ACETATE; Cortisone 21-acetate; 50-04-4; Cortone acetate; Incortin; Biocort acetate; Scheroson; Artriona; Cortadren; Cortisyl; Adreson; Irisone acetate; Cortelan; Cortistab; Ricortex; Corlin; Cortogen acetate; Compound E acetate; Cortisone (acetate); Cortisone monoacetate; NSC 49420; Cortisone, 21-acetate; Cortilen; UNII-883WKN7W8X; 11-Dehydro-17-hydroxycorticosterone-21-acetate; CCRIS 3661; 11-Dehydro-17-hydroxycorticosterone acetate; EINECS 200-006-5; 17-Hydroxy-3,11,20" C23H30O6 ITRJWOMZKQRYTA-RFZYENFJSA-N [2-[(8S,9S,10R,13S,14S,17R)-17-hydroxy-10,13-dimethyl-3,11-dioxo-1,2,6,7,8,9,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate n.a. n.a. No Yes No No No No PMDBD1227 Hydrocortisone Therapeutic substance immune, inflammatory, and neoplastic conditions 50-23-7 DB00741 PA449905 D00088 DAP000718 5754 5551 n.a. "hydrocortisone; Cortisol; 50-23-7; Cetacort; Acticort; Hydrocortisyl; Hydrasson; Cobadex; Signef; Hytone; Cortef; Hycort; Optef; 17-Hydroxycorticosterone; Kendall''s compound F; Hydrocortone; Hycortol; Efcorbin; Cortiment; Cortifan; Corticreme; Cortanal; Traumaide; Permicort; Ficortril; Dermacort; Tarcortin; Hycortole; Cortispray; Proctocort; Genacort; Efcortelan; Dermolate; Cortonema; Cortenema; Cleiton; Alacort; Cortril; Dihydrocostisone; Hytone lotion; Hydro-Adreson; Hidro-Colisona; Scheroson F; Reichstein''s substance M; Incortin-H; Polcort H; Esider" C21H30O5 JYGXADMDTFJGBT-VWUMJDOOSA-N (8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one n.a. n.a. No Yes No No No No PMDBD1378 Prednisolone Therapeutic substance Drug 50-24-8 DB00860 PA451096 D00472 DAP000419 5755 5552 n.a. "prednisolone; 50-24-8; Metacortandralone; Hydroretrocortine; Predonine; Meticortelone; Deltacortril; Deltahydrocortisone; Prenolone; Hydroretrocortin; Delta-Cortef; PRDL; Hydrodeltalone; Hydrodeltisone; Deltacortenol; Prednelan; Precortancyl; Paracotol; Lentosone; Dydeltrone; Dicortol; Delcortol; Decaprednil; Sterolone; Predonin; Predniliderm; Fernisolone; Donisolone; Cortalone; Scherisolon; Rolisone; Hydeltrone; Estilsona; Codelcortone; Prednicen; Precortisyl; Precortilon; Paracortol; Hydeltra; Erbasona; Erbacort; Deltisilone; Cotogesic; Prelone; St" C21H28O5 OIGNJSKKLXVSLS-VWUMJDOOSA-N (8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one n.a. n.a. No Yes No No No No PMDBD315 Estradiol "Therapeutic Substance; Herbal Substance" Herbal 50-28-2 DB00783 PA449503 D00105 DAP000854 5757 5554 NPC48342 "estradiol; beta-Estradiol; 17beta-Estradiol; 50-28-2; Oestradiol; Dihydrofolliculin; Estrace; Ovocyclin; progynon; Dihydrotheelin; Dihydroxyestrin; Vivelle; Gynoestryl; Gynergon; Diogynets; Aquadiol; Diogyn; Oestroglandol; Ovahormon; Femestral; Estrovite; Primofol; Follicyclin; Profoliol; Ginosedol; Corpagen; Aerodiol; Perlatanol; Ovastevol; Ovasterol; Oestergon; Macrodiol; Dimenformon; Lamdiol; Femogen; Evorel; Divigel; Vagifem; Altrad; Climara; Bardiol; Syndiol; Dihydromenformon; estradiol-17beta; cis-Estradiol; Estraderm TTS; Trocosone; Estroclim; Est" C18H24O2 VOXZDWNPVJITMN-ZBRFXRBCSA-N (8R,9S,13S,14S,17S)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol n.a. Estrogens No Yes No No No Yes ESTRADIOLGLC_GLCAASE,ESTRADIOLGLC_GLCAASEe,ESTRADIOLGLC_GLCAASEepp,ESTRADIOLte,ESTRADIOLtepp,ESTRADIOLtex,EX_estradiol(e) PMDBD739 Reserpine "Therapeutic Substance; Herbal Substance" "Approved Drug; Medicinal Herbal Compounds" 50-55-5 DB00206 PA451236 D00197 DAP000755 5770 5566 NPC88923 "reserpine; 50-55-5; Serpalan; Serpasil; Serpivite; Apoplon; Hypersil; Alserin; Rausedil; Raupasil; Elserpine; Deserpine; Serpanray; Reserpin; Rauwasedin; Raunervil; Rausedyl; Hiserpia; Sandril; Resine; Serpate; Rivasin; (-)-Reserpine; Rau-Sed; Reserpamed; Helfoserpin; Eskaserpine; Reserpanca; Maviserpin; Bioserpine; Austrapine; Ascoserpina; Mayserpine; Hiposerpil; Enipresser; Rauserpine; Purserpine; Mephaserpin; Restran; Resercen; Rauwilid; Rausingle; Raurine; Raupoid; Rauloydin; Raudiford; Quiescin; Eskaserp; Benazyl; Reserpina; Reserpil; Reserpene; Reserba" C33H40N2O9 QEVHRUUCFGRFIF-MDEJGZGSSA-N methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate n.a. Antihypertensive Agents Yes Yes No No No No PMDBD355 Floxuridine Therapeutic Substance Therapeutic Substance 50-91-9 DB00322 PA449652 D04197 DAP001245 5790 5586 n.a. "floxuridine; 50-91-9; 5-Fluorodeoxyuridine; 2''-Deoxy-5-fluorouridine; Fluorodeoxyuridine; FUDR; Floxuridin; Deoxyfluorouridine; 5-Fluoro-2''-deoxyuridine; Fluoruridine deoxyribose; 5FdU; Floxuridinum; Floxiridina; 5-Fluoro-2-desoxyuridine; FdUrd; beta-5-Fluoro-2''-deoxyuridine; 5 Fluorodeoxyuridine; Floxuridinum [INN-Latin]; 5-Fluorouracil 2''-deoxyriboside; Floxiridina [INN-Spanish]; 5-fluoro-1-((2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1h,3h)-dione; 5-Fluoro-2-deoxyuridine; 5-Fluorouracil deoxyribo" C9H11FN2O5 ODKNJVUHOIMIIZ-RRKCRQDMSA-N 5-fluoro-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione Heidelberger n.a. Yes Yes Yes No No No PMDBD1421 Spironolactone Therapeutic substance diuretic and also antihypertensive effects 7/1/1952 DB00421 PA451483 D00443 DAP000297 5833 5628 n.a. "spironolactone; 52-01-7; Aldactone; Spirolactone; Verospiron; Spirolang; Verospirone; Euteberol; Spiroctan; Acelat; Aldactone A; Spironocompren; Uractone; Spiresis; Spiridon; Urusonin; Melarcon; Xenalon; Spirone; Alderon; Dira; Spiro-Tablinen; Spironolactone A; spironolattone; Aquareduct; Aldopur; Spironolactonum; Espironolactona; Deverol; Almatol; Aldace; Altex; Spironolattone [DCIT]; Berlactone; SC 9420; Spironolactonum [INN-Latin]; Espironolactona [INN-Spanish]; SC-9420; UNII-27O7W4T232; C24H32O4S; HSDB 3184; EINECS 200-133-6; NSC 150399; BRN 005" C24H32O4S LXMSZDCAJNLERA-ZHYRCANASA-N S-[(7R,8R,9S,10R,13S,14S,17R)-10,13-dimethyl-3,5''-dioxospiro[2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-17,2''-oxolane]-7-yl] ethanethioate n.a. n.a. No Yes No No No No PMDBD505 Lynestrenol Therapeutic Substance Approved Drug 52-76-6 DB12474 n.a. n.a. n.a. 5857 5648 n.a. "LYNESTRENOL; 52-76-6; Linestrenol; Ethynylestrenol; Ethinylestrenol; Orgametrol; Orgametril; Lynoestrenol; Exluton; Endometril; Exlution; Exlutona; Orgametil; 3-Desoxynorlutin; Ethynloestrenol; Lynenol; Lynstranol; Exluten; Ethinyloestranol; Ethinyl oestrenol; NSC-37725; Org 485-50; IND 1006; Linestrenolo [DCIT]; 17alpha-Ethynylestrenol; 17-alpha-Ethynylestrenol; 17-alpha-Ethynyloestrenol; UNII-N2Z8ALG4U5; Lynestrenolum [INN-Latin]; Linestrenol [INN-Spanish]; CCRIS 9093; EINECS 200-151-4; Lynoestrenol [Progestins]; NSC 37725; Estr-4-en-17be" C20H28O YNVGQYHLRCDXFQ-XGXHKTLJSA-N (8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-2,3,6,7,8,9,10,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ol n.a. n.a. Yes No Yes No No No PMDBD1379 Prednisone Therapeutic substance Drug 2/3/1953 DB00635 PA451100 D00473 DAP001041 5865 5656 n.a. "prednisone; 53-03-2; Dehydrocortisone; Deltasone; Decortin; Meticorten; Orasone; Ultracorten; Rectodelt; Dacortin; Encorton; Deltacortone; Deltacortisone; Sterapred; Decortisyl; Colisone; Encortone; Decortancyl; Deltison; Prednison; Prednilonga; Paracort; Ancortone; Cortan; 1,2-Dehydrocortisone; Liquid Pred; Di-Adreson; Zenadrid; Ultracortene; Prednisonum; Hostacortin; Dekortin; Bicortone; Supercortil; Servisone; Prednidib; Panafcort; Lisacort; Cortidelt; Pronison; Prednizon; Enkorton; Diadreson; Winpred; Cotone; Nurison; Lodotra; Juvason; Wojtab; Panasol" C21H26O5 XOFYZVNMUHMLCC-ZPOLXVRWSA-N (8S,9S,10R,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione n.a. n.a. No Yes No No No No PMDBD1183 Estrone Therapeutic substance Drug 53-16-7 DB00655 PA449512 D00067 DAP001020 5870 5660 n.a. "estrone; 53-16-7; folliculin; OESTRONE; Theelin; estrovarin; follicular hormone; Estrugenone; Kestrone; Estron; Follicunodis; Hormestrin; Thelykinin; Oestronum; Aquacrine; Disynformon; Destrone; Oestroperos; Oestroform; Hiestrone; Glandubolin; Folliculine; Kolpon; Oestrin; Folisan; Folipex; Femidyn; Menagen; Unden; Ketohydroxyestrin; Ketohydroxyoestrin; Estrone-A; Endofolliculina; Thelestrin; Hormofollin; Crinovaryl; Wynestron; Thynestron; Solliculin; Menformon; Hormovarine; Follestrol; Folikrin; Estrusol; Crystogen; Cristallovar; Ovifollin; Ketodestrin" C18H22O2 DNXHEGUUPJUMQT-CBZIJGRNSA-N (8R,9S,13S,14S)-3-hydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-one n.a. n.a. No Yes No No No Yes ESTRONEGLC_GLCAASE,ESTRONEGLC_GLCAASEe,ESTRONEGLC_GLCAASEepp,ESTRONEt,ESTRONEtex,ESTRONEtpp,EX_estrone(e) PMDBD438 Idoxuridine Therapeutic Substance Approved Drug 54-42-2 DB00249 PA164781019 D00342 DAP000997 5905 5694 n.a. "idoxuridine; 5-Iodo-2''-deoxyuridine; 54-42-2; 5-Iododeoxyuridine; Idoxuridin; Iododeoxyridine; Iodoxuridine; (+)-5-Iodo-2''-deoxyuridine; IUDR; Joddeoxiuridin; 2''-Deoxy-5-iodouridine; Stoxil; Herplex; Dendrid; Idoxene; Allergan 211; IDUR; Kerecid; Virudox; Iduridin; 5IUDR; Idoxuridinum; Antizona; Idoxuridina; Heratil; Allergan 201; IDU; 5-Iodouracil deoxyriboside; Idossuridina [DCIT]; IdUrd; 5-IUDR; Iduoculos; 1-(2-Deoxy-beta-D-ribofuranosyl)-5-iodouracil; Herplex liquifilm; Idoxuridinum [INN-Latin]; Idoxuridina [INN-Spanish]; Ophthalmadine; Sp" C9H11IN2O5 XQFRJNBWHJMXHO-RRKCRQDMSA-N 1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-iodopyrimidine-2,4-dione n.a. n.a. Yes No No No No No PMDBD1364 Pilocarpine Therapeutic substance Drug 92-13-7 DB01085 PA450962 D00525 DAP001113 5910 5699 n.a. "pilocarpine; Pilokarpin; 92-13-7; Pilocarpol; Syncarpine; Pilocarpin; Salagen; Pilokarpol; (+)-Pilocarpine; Isoptocarpine; Ocusert pilo; Ocusert pilo-20; Ocusert Pilo-40; Ocusert P 20; Pilocarpine chloride; UNII-01MI4Q9DI3; (3S,4R)-3-Ethyl-4-((1-methyl-1H-imidazol-5-yl)methyl)dihydrofuran-2(3H)-one; (3S,4R)-3-ethyl-4-[(1-methyl-1H-imidazol-5-yl)methyl]dihydrofuran-2(3H)-one; HSDB 3163; Pilocarpine monohydrochloride; EINECS 202-128-4; CHEMBL550; AI3-50523; CHEBI:8207; 01MI4Q9DI3; (3S-cis)-3-Ethyldihydro-4-((1-methyl-1H-imidazol-5-yl" C11H16N2O2 QCHFTSOMWOSFHM-WPRPVWTQSA-N (3S,4R)-3-ethyl-4-[(3-methylimidazol-4-yl)methyl]oxolan-2-one n.a. n.a. No Yes No No No No PMDBD178 Chloramphenicol "Therapeutic Substance; Herbal Substance" bacteriostatic 56-75-7 DB00446 PA448927 D00104 DAP001356 5959 5744 NPC159589 "chloramphenicol; 56-75-7; Chloromycetin; Chlornitromycin; Levomycetin; Halomycetin; Levomicetina; Globenicol; Chlorocid; Chloroamphenicol; Oleomycetin; Detreomycin; Chlorocol; Chloramex; Alficetyn; Fenicol; Leukomycin; Enteromycetin; Sificetina; Juvamycetin; Cloramicol; Chloramficin; Aquamycetin; D-Chloramphenicol; Chloramfilin; Amphenicol; Novophenicol; Intramycetin; Stanomycetin; Levomitsetin; Laevomycetinum; Dextromycetin; Micochlorine; Ciplamycetin; Mediamycetine; Detreomycine; Chloronitrin; Loromisin; Leukomyan; Isicetin; Embacetin; Econochlo" C11H12Cl2N2O5 WIIZWVCIJKGZOK-RKDXNWHRSA-N 2,2-dichloro-N-[(1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]acetamide Aventis Pharmaceuticals Inc. Antibiotics Yes Yes Yes No No Yes CAP_NR,CAP_NRe,CHLPHNCL_GLC_GLCAASE,CHLPHNCL_GLC_GLCAASEe,CHLPHNCL_GLC_GLCAASEepp,CHLPHNCLte,CHLPHNCLtepp,CHLPHNCLtex,EX_chlphncl(e),tCAPpp PMDBD1384 Progesterone Therapeutic substance hormone 57-83-0 DB00396 PA451123 D00066 DAP000549 5994 5773 n.a. "progesterone; 57-83-0; Pregn-4-ene-3,20-dione; Agolutin; Luteohormone; Crinone; 4-Pregnene-3,20-dione; Utrogestan; Syngesterone; Progestin; Luteol; Corpus luteum hormone; Progesterol; Pregnenedione; Glanducorpin; Progestron; Gestormone; Prometrium; Corlutin; Cyclogest; Progestone; Gestone; Methylpregnone; Progesteronum; Progestasert; Progestronol; Hormoflaveine; Piaponon; Lutocylin; Lutociclina; Luteovis; Luteosan; Luteopur; Luteogan; Hormoluton; Flavolutan; Syngestrets; Proluton; Progekan; Nalutron; Lutoform; Gynlutin; Gesterol; Fologenon; Corporin" C21H30O2 RJKFOVLPORLFTN-LEKSSAKUSA-N (8S,9S,10R,13S,14S,17S)-17-acetyl-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one n.a. n.a. No Yes No No No No PMDBD836 Testosterone propionate Therapeutic Substance Approved Drug 57-85-2 DB01420 PA164751373 D00959 n.a. 5995 5774 n.a. "testosterone propionate; 57-85-2; Agovirin; Androteston; Aquaviron; Hormoteston; Androlon; Enarmon; Bio-testiculina; Androtest P; Testonique; Androsteston; Sterandryl; Testolets; Synerone; Solvotest; Pantestin; Orchistin; Masenate; Uniteston; Tostrin; Testormol; Synandrol; Testoxyl; Testosid; Testogen; Testodrin; Telipex; Propiokan; Andronate; Testrex; Testodet; Testaform; Orchiol; Nasdol; Vulvan; Enarmon-oil; Okasa-Mascul; Neo-Hombreol; Andrusol-P; Oreton propionate; Recthormone testosterone; NSC 9166; Testosteroni propionas; Testosteron propionate" C22H32O3 PDMMFKSKQVNJMI-BLQWBTBKSA-N [(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] propanoate n.a. n.a. Yes No Yes No No No PMDBD1037 Apomorphine Therapeutic substance Drug 58-00-4 DB00714 PA164781163 D07460 DAP000281 6005 5783 n.a. "apomorphine; L-Apomorphine; Apomorphin; Apomorfin; Apokyn; Uprima; R-(-)-Apomorphine; Ixense; 58-00-4; Apomorphine hydrochloride; (-)-10,11-Dihydroxyaporphine; 6abeta-Aporphine-10,11-diol; UNII-N21FAR7B4S; Apomorphine [BAN]; HSDB 3289; C17H17NO2; 6a-beta-Aporphine-10,11-diol; Apomorphine hydrochloride hemihydrate; CHEMBL53; EINECS 200-360-0; VR-040; N21FAR7B4S; Apormorphine; CHEBI:48538; Apomorphine (BAN); (6aR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol; NCGC00025349-02; Apomorphinium chloride hemihydrate; DSST" C17H17NO2 VMWNQDUVQKEIOC-CYBMUJFWSA-N (6aR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol n.a. n.a. No Yes No No No No PMDBD1445 Tetrabenazine Therapeutic substance Drug 58-46-8 DB04844 PA140222719 D08575 DAP000756 6018 5796 n.a. "TETRABENAZINE; 58-46-8; Nitoman; Tetrabenzaine; 718635-93-9; Rubigen; Tetrabenzine; tetra Benazin; Xenazine; Tetrabenazine Racemate; Tetrabenazinum [INN-Latin]; Tetrabenazina [INN-Spanish]; Tetrabenazine (Racemate); Ro 1-9569; 3-isobutyl-9,10-dimethoxy-3,4,6,7-tetrahydro-1H-pyrido[2,1-a]isoquinolin-2(11bH)-one; Tetrabenazinum; 9,10-dimethoxy-3-(2-methylpropyl)-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinolin-2-one; NSC 169886; Ro 1-9569/12; MLS003106727; CHEMBL117785; Tetrabenazine [INN:BAN]; CHEBI:64028; (-)-tetrabenazine; 1,3" C19H27NO3 MKJIEFSOBYUXJB-UHFFFAOYSA-N 9,10-dimethoxy-3-(2-methylpropyl)-1,3,4,6,7,11b-hexahydrobenzo[a]quinolizin-2-one n.a. n.a. No Yes No No No No PMDBD466 Kanamycin "Therapeutic Substance; Herbal Substance" "Approved Drug; Medicinal Herbal Compounds" n.a. DB01172 PA450137 n.a. DNC000201 6032 5810 NPC43850 "kanamycin; KANAMYCIN A; Kanamycin Base; 59-01-8; Kanamycine; Kanamicina [Italian]; KM (the Antibiotic); Kanamycin [INN:BAN]; Kanamycine [INN-French]; Kanamycinum [INN-Latin]; UNII-EQK9Q303C5; CHEBI:17630; HSDB 3107; C18H36N4O11; EINECS 200-411-7; BRN 0061647; 4,6-Diamino-2-hydroxy-1,3-cyclohexane 3,6''diamino-3,6''-dideoxydi-alpha-D-glucoside; EQK9Q303C5; KAN; 8063-07-8; Kanamycinum; Kanamicina; D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucop" C18H36N4O11 SBUJHOSQTJFQJX-NOAMYHISSA-N (2R,3S,4S,5R,6R)-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-3-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4,5-triol n.a. n.a. No Yes No No No No PMDBD371 Folic acid "Therapeutic Substance; Herbal Substance" "Approved Drug; Medicinal Herbal Compounds" 59-30-3 DB00158 PA449692 D00070 DAP001309 6037 5815 NPC147983 C19H19N7O6 OVBPIULPVIDEAO-LBPRGKRZSA-N (2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid n.a. n.a. Yes No No No No No PMDBD1362 Phenylephrine Therapeutic substance Drug 59-42-7 DB00388 PA450935 D08365 DAP000224 6041 5818 n.a. "phenylephrine; L-Phenylephrine; 59-42-7; Metasympatol; Mezaton; Neosynephrine; Metasynephrine; Metaoxedrin; m-Oxedrine; Metaoxedrine; Visadron; Mesatone; Mesaton; m-Sympatol; Isophrin; m-Synephrine; m-Sympathol; R(-)-Phenylephrine; Metaoxedrinum; Mesatonum; Phenylephrinum; Fenilefrina; m-Methylaminoethanolphenol; Neo-Synephrine; Isophrim; 3-[(1R)-1-hydroxy-2-(methylamino)ethyl]phenol; Ak-dilate; Ah-Chew; Mydfrin; Cyclomydril; Fenilefrina [INN-Spanish]; Phenylephrinum [INN-Latin]; l-(3-Hydroxyphenyl)-N-methylethanolamine" C9H13NO2 SONNWYBIRXJNDC-VIFPVBQESA-N 3-[(1R)-1-hydroxy-2-(methylamino)ethyl]phenol n.a. n.a. No Yes No No No No PMDBD476 Levodopa "Therapeutic Substance; Herbal Substance" Parkinson''s 59-92-7 DB01235 PA450213 D00059 DAP000209 6047 5824 NPC161593 "levodopa; L-dopa; 59-92-7; 3,4-dihydroxy-L-phenylalanine; 3-Hydroxy-L-tyrosine; Dopar; Larodopa; Bendopa; Levopa; 3-(3,4-Dihydroxyphenyl)-L-alanine; Cidandopa; Insulamina; Maipedopa; Eldopal; Dopasol; Dopaidan; Prodopa; Pardopa; Eldopar; Syndopa; Dopalina; 3,4-Dihydroxyphenylalanine; Dihydroxy-L-phenylalanine; (-)-Dopa; Helfo-Dopa; Dopaflex; Brocadopa; Deadopa; Dopal-fher; Dopastral; Dopaston; Doparkine; Eurodopa; Eldopatec; Veldopa; Doprin; Doparl; (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid; L-3,4-Dihydroxyphenylalanine; Dopa; Levedopa" C9H11NO4 WTDRDQBEARUVNC-LURJTMIESA-N (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid Orion Corp n.a. No Yes No Yes No No PMDBD1031 Ampicillin Therapeutic substance Antibiotics 69-53-4 DB00415 PA448419 D00204 DAP000432 6249 6013 n.a. "ampicillin; 69-53-4; Aminobenzylpenicillin; Ampicillin acid; Amcill; Polycillin; Principen; Penbritin; Ampicilline; Omnipen; Totacillin; Synpenin; Tokiocillin; Pentrexyl; Novo-ampicillin; anhydrous ampicillin; D-Ampicillin; D-(-)-Ampicillin; Ultrabion; Sumipanto; Semicillin; Rosampline; Penicline; Divercillin; Campicillin; Ultrabron; Totalciclina; Racenacillin; Pentrexl; Orbicilina; Grampenil; Delcillin; Copharcilin; Austrapen; Amplital; Ampifarm; Ampichel; Princillin; Penbrock; Guicitrina; Duphacillin; Britacil; Bonapicillin; Amplipenyl; Ampipenin" C16H19N3O4S AVKUERGKIZMTKX-NJBDSQKTSA-N (2S,5R,6R)-6-[[(2R)-2-amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid n.a. n.a. Yes No No No No No PMDBD1136 Cytarabine Therapeutic substance Drug 147-94-4 DB00987 PA449177 D00168 DNC001551 6253 6017 n.a. "cytarabine; 147-94-4; Cytosine arabinoside; Ara-C; Arabinocytidine; Cytosar; Tarabine; Udicil; Alexan; Cytosar-U; 1-beta-D-Arabinofuranosylcytosine; Cytarabina; Aracytin; Arabitin; Erpalfa; Arafcyt; Depocyt; DepoCyte; Arabinofuranosylcytosine; Cytarabin; Arabinosylcytosine; Aracytidine; Cytosine beta-D-arabinofuranoside; Cytosinearabinoside; Cytosine-beta-D-arabinofuranoside; Cytarabinoside; Cytarabinum; Citarabina; Cytonal; beta-D-Arabinosylcytosine; Depocyt (liposomal); Cytosine arabinofuranoside; Cytarabinum [INN-Latin]; Citarabina [INN" C9H13N3O5 UHDGCWIWMRVCDJ-CCXZUQQUSA-N 4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one n.a. n.a. No Yes No No No No PMDBD872 Trifluridine Therapeutic Substance deglycosylation 70-00-8 DB00432 PA451775 D00391 DAP000760 6256 6020 n.a. "Trifluridine; TRIFLUOROTHYMIDINE; 70-00-8; Viroptic; 5-Trifluorothymidine; Trifluoromethyldeoxyuridine; Trifluridina; Virophta; Trifluridinum; F3TDR; F3DThd; TFDU; 5-(Trifluoromethyl)deoxyuridine; 5-Trifluoromethyl-2-deoxyuridine; Trifluridinum [INN-Latin]; Trifluridina [INN-Spanish]; Trifluorothymine deoxyriboside; 2''-Deoxy-5-(trifluoromethyl)uridine; 5-Trifluoro-2''-deoxythymidine; 1-((2R,4S,5R)-4-Hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-(trifluoromethyl)pyrimidine-2,4(1H,3H)-dione; 2''-Deoxy-5-trifluoromethyluridine" C10H11F3N2O5 VSQQQLOSPVPRAZ-RRKCRQDMSA-N 1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-(trifluoromethyl)pyrimidine-2,4-dione Monarch Pharmaceuticals Antiviral Agents Yes Yes Yes No No No PMDBD1281 Mestranol Therapeutic substance Drug 72-33-3 DB01357 PA450388 D00575 DAP001014 6291 6054 n.a. "mestranol; 72-33-3; Norquen; Menophase; Devocin; Ovastol; Ethynylestradiol 3-methyl ether; Mestranolum; 3-Methoxyethynylestradiol; EE(sub3)ME; delta-MVE; Ethynylestradiol methyl ether; 3-Methylethynylestradiol; EE3ME; Inostral (steroid); Mestranolo [DCIT]; 3-O-Methylethynylestradiol; Compound 33355; Inostral; 3-Methylethynyloestradiol; 3-Methoxyethynyloestradiol; Mestranolum [INN-Latin]; 3-Methoxy-17alpha-ethynylestradiol; Caswell No. 547A; Ethinylestradiol 3-methyl ether; Ethinyloestradiol 3-methyl ether; SC 4725; Ethynyloestradiol " C21H26O2 IMSSROKUHAOUJS-MJCUULBUSA-N (8R,9S,13S,14S,17R)-17-ethynyl-3-methoxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ol n.a. n.a. No Yes No No No No PMDBD880 Tryptophan "Therapeutic Substance; Herbal Substance" amino acid commonly found? 73-22-3 DB00150 PA10323 D00020 DAP001316 6305 6066 NPC203468 "L-tryptophan; 73-22-3; tryptophan; L-Tryptophane; h-Trp-oh; (S)-Tryptophan; Tryptophane; Optimax; tryptacin; trofan; Ardeytropin; (2S)-2-amino-3-(1H-indol-3-yl)propanoic acid; Pacitron; Indole-3-alanine; L-beta-3-Indolylalanine; Kalma; L-Tryptofan; L-Trp; L-(-)-Tryptophan; 3-Indol-3-ylalanine; Tryptan; Lyphan; Tryptophan (VAN); Tryptophan (H-3); 1-beta-3-Indolylalanine; Tryptophanum [Latin]; Triptofano [Spanish]; 1H-Indole-3-alanine; 1beta-3-Indolylalanine; triptofano; 2-Amino-3-indolylpropanoic acid; Tryptophanum; Tryptophane [French]; (S" C11H12N2O2 QIVBCDIJIAJPQS-VIFPVBQESA-N (2S)-2-amino-3-(1H-indol-3-yl)propanoic acid n.a. Antidepressants No Yes No No No No PMDBD538 Methsuximide Therapeutic Substance Approved Drug 77-41-8 DB05246 PA164743145 D00404 DAP001253 6476 6231 n.a. "METHSUXIMIDE; Mesuximide; 77-41-8; Celontin; Petinutin; Methsuximid; Metsuccimide; 1,3-dimethyl-3-phenylpyrrolidine-2,5-dione; Mesuximidum; mesuximid; alpha-Methylphensuximide; N,2-Dimethyl-2-phenylsuccinimide; 1,3-Dimethyl-3-phenylsuccinimide; Metosuccimmide [DCIT]; Mesuximidum [INN-Latin]; Mesuximida [INN-Spanish]; 1,3-Dimethyl-3-phenyl-2,5-dioxopyrrolidine; 1,3-Dimethyl-3-phenyl-pyrrolidin-2,5-dione; PM 396; 1,3-Dimethyl-3-phenyl-2,5-pyrrolidinedione" C12H13NO2 AJXPJJZHWIXJCJ-UHFFFAOYSA-N 1,3-dimethyl-3-phenylpyrrolidine-2,5-dione Pfizer Pharmaceuticals Anticonvulsants No Yes No Yes No No PMDBD1060 Bisphenol A Environmental Chemicals Bisphenols 7/5/1980 DB06973 n.a. n.a. n.a. 6623 6371 n.a. "Bisphenol A; 80-05-7; 2,2-Bis(4-hydroxyphenyl)propane; 4,4''-Isopropylidenediphenol; Bisphenol; Diphenylolpropane; 4,4''-Bisphenol A; Diano; 4,4''-(propane-2,2-diyl)diphenol; 2,2-Bis(p-hydroxyphenyl)propane; Biphenol A; Parabis A; DIAN; Rikabanol; p,p''-Bisphenol A; p,p''-Isopropylidenebisphenol; Bisphenol-A; Bisferol A; 2,2-Di(4-phenylol)propane; p,p''-Dihydroxydiphenylpropane; Ipognox 88; Pluracol 245; 4,4''-Dihydroxydiphenylpropane; 4-[2-(4-hydroxyphenyl)propan-2-yl]phenol" C15H16O2 IISBACLAFKSPIT-UHFFFAOYSA-N 4-[2-(4-hydroxyphenyl)propan-2-yl]phenol n.a. n.a. Yes No No No No No PMDBD1288 Methylprednisolone Therapeutic substance Drug 83-43-2 DB00959 PA450466 D00407 DAP001040 6741 6485 n.a. "methylprednisolone; 83-43-2; Medrol; Metilprednisolone; Medrone; Urbason; 6alpha-Methylprednisolone; Metilbetasone; Medrate; Dopomedrol; Promacortine; Besonia; Metastab; Mesopren; Solomet; Noretona; Moderin; Wyacort; Urbasone; Metrisone; Medesone; Methylprednisolon; Suprametil; Sieropresol; Metysolon; Esametone; Reactenol; Firmacort; Metrocort; Methyleneprednisolone; Nirypan; Medixon; Lemod; Artisone-wyeth; Medrol dosepak; 6-alpha-Methylprednisolone; Medrol adt pak; Predni N Tablinen; Medlone 21; Metilprednisolone [DCIT]; Summicort;; Metilpredniso" C22H30O5 VHRSUDSXCMQTMA-PJHHCJLFSA-N (6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one n.a. n.a. No Yes No No No No PMDBD461 Isosorbide dinitrate "Therapeutic Substance; Herbal Substance" organic nitrates for the treatment of angina pec-toris 87-33-2 DB00883 PA450125 D00516 DAP001057 6883 6619 NPC85078 "ISOSORBIDE DINITRATE; 87-33-2; Sorbide nitrate; Isordil; Sorbidnitrate; Nitrosorbide; Dinitrosorbide; Isoket; Vascardin; Sorbitrate; Sorbidilat; Sorbonit; Isotrate; Isorbid; Flindix; Carvasin; Dilatrate-SR; Sorbislo; Sorbangil; Nitrosorbid; Myorexon; Iso-Bid; ISDN; Cedocard; Nitrosorbon; Cornilat; Vasodilat; Corosorbide; Claodical; Vasorbate; Resoidan; Harrical; Difutrat; Carvanil; Emoper; Tinidil; Sorquad; Rigedal; Cardis; Korodil; Maycor; Lomilan; Coronex; Xanyl; Nosim; Sorbide, dinitrate; Isordil Tembids; Rifloc Retard; Dilatrate; Dinitroisosorbide; Car" C6H8N2O8 MOYKHGMNXAOIAT-JGWLITMVSA-N [(3S,3aS,6R,6aS)-3-nitrooxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-6-yl] nitrate Biovail Corporation Vasodilator Agents Yes Yes Yes No No No PMDBD1360 Phenformin Therapeutic substance Drug 114-86-3 DB00914 PA1000 D08351 DAP000206 8249 7953 n.a. "PHENFORMIN; 114-86-3; N-Phenethylbiguanide; Fenformin; Phenformine; Phenethyldiguanide; Fenformina; Phenylethylbiguanide; Pedg; Glukopostin; Cronoformin; Phenformix; Fenormin; Fenfoduron; Retardo; Dibiraf; Glyphen; Dibotin; Diabis; Debeone; Db-retard; beta-PEBG; Normoglucina; Lentobetic; Insoral; Azucaps; Feguanide; Debinyl; DB Comb; Dibein; 1-Phenethylbiguanide; D Bretard; beta-Phenethylbiguanide; Phenforminum; Fenformina [INN-Spanish]; Phenformine [INN-French]; Phenforminum [INN-Latin]; N-(2-Ph" C10H15N5 ICFJFFQQTFMIBG-UHFFFAOYSA-N 1-(diaminomethylidene)-2-(2-phenylethyl)guanidine n.a. n.a. Yes No No No No No PMDBD579 Neomycin "Therapeutic Substance; Herbal Substance" "Approved Drug; Medicinal Herbal Compounds" 1404-04-2 DB00994 PA450608 D08260 DAP000036 8378 n.a. NPC176381 "Framycetin; neomycin; NEOMYCIN B; Soframycin; Mycifradin; Fradiomycin; Actiline; Soframycine; Neomas; Framycetinum; Framycetine; Framicetina; Antibiotique; Fradiomycinum; Myacyne; Framygen; Neolate; Nivemycin; Actilin; Enterfram; Caswell No. 595; Vonamycin powder V; Neomcin; Neomycin B sulfate; Neomin; Fradiomycin B; Neo-Rx; Neomicina [DCIT]; 119-04-0; Framycetinum [INN-Latin]; Neomycine [INN-French]; Neomycinum [INN-Latin]; Framycetine [INN-French]; Framicetina [INN-Spanish]; Framycetin [INN:BAN:DCF]; 1404-04-2; NEOMYCIN SULFATE; CCRIS 5462" C23H46N6O13 PGBHMTALBVVCIT-VCIWKGPPSA-N (2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol n.a. Antibiotics No Yes No No No No PMDBD191 Cianidanol "Therapeutic Substance; Herbal Substance" "Approved Drug; Medicinal Herbal Compounds" 154-23-4 DB14086 n.a. n.a. n.a. 9064 8711 NPC219876 "(+)-catechin; Cianidanol; CATECHIN; 154-23-4; Catechuic acid; Cyanidanol; Catechinic acid; D-Catechin; Catergen; (+)-Cyanidanol; (+)-Catechol; Cianidol; (+)-Cyanidan-3-ol; (+)-Catechin Hydrate; Biocatechin; D-(+)-Catechin; D-Catechol; Dexcyanidanol; Catechin (flavan); Catechol (flavan); (2R,3S)-Catechin; (2R,3S)-2-(3,4-Dihydroxyphenyl)chroman-3,5,7-triol; Gambier; (2R,3S)-(+)-Catechin; Cianidanolum; Catechu; Transepar; Katha; Cutch (dye); (+)-Cianidanol; 3,3'',4'',5,7-Flavanpentol; KB-53; (+)-Cyanidanol-3; CCRIS 6855; Ciani" C15H14O6 PFTAWBLQPZVEMU-DZGCQCFKSA-N (2R,3S)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol n.a. n.a. No Yes No No Yes No rxnDiet57,rxnAdd49 PMDBD1027 Aminophylline Therapeutic substance Drug 317-34-0 DB01223 PA164781029 D00227 DAP000613 9433 9062 n.a. "aminophylline; 317-34-0; Aminophyllin; Phyllocontin; Theophyllamine; Somophyllin; Cardophyllin; Aminodur; Truphylline; Theophylline ethylenediamine; Phyllindon; Peterphyllin; Methophylline; Metaphylline; Inophylline; Diuxanthine; Variaphylline; Thephyldine; Metaphyllin; Eurphyllin; Diaphylline; Theophyldine; Theolamine; Syntophyllin; Stenovasan; Phylcardin; Linampheta; Genophyllin; Aminocardol; Vasofilina; Theophyllaminum; Norofilina; Neophyiline; Ethophylline; Cardophylin; Cardiofilina; Theolone; Theodrox; Euufillin; Minaphil; Diophllin; Grifomin" C16H24N10O4 FQPFAHBPWDRTLU-UHFFFAOYSA-N "1,3-dimethyl-7H-purine-2,6-dione;ethane-1,2-diamine" n.a. n.a. No Yes No No No No PMDBD377 Galantamine "Therapeutic Substance; Herbal Substance" "Approved Drug; Medicinal Herbal Compounds" 357-70-0 DB00674 PA449726 D04292 DAP000559 9651 9272 NPC78359 "galanthamine; Galantamine; 357-70-0; (-)-Galanthamine; Lycoremine; Lycoremin; Jilkon; Reminyl; Razadyne; Galanthaminum; Nivalin; Razadyne ER; Galantaminum [INN-Latin]; Galantamina [INN-Spanish]; UNII-0D3Q044KCA; NSC 100058; BRN 0093736; HSDB 7361; Reminyl (TN); Galantamina; CHEMBL659; 0D3Q044KCA; (4aS,6R,8aS)-4a,5,9,10,11,12-Hexahydro-3-methoxy-11-methyl-6H-benzofuro(3a,3,2-ef)(2)benzazepin-6-ol; CHEBI:42944; Galanthamine base; NCGC00017256-04; Galantaminum; (-)-Galantamine; GNT; Galantamine [USAN:INN]; Galanthamine HBr; (1S,12S,14R)-9-m" C17H21NO3 ASUTZQLVASHGKV-JDFRZJQESA-N (1S,12S,14R)-9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol Janssen Pharmaceutica Parasympathomimetics No Yes No No No Yes EX_gltmn(e),GLTMN_GLC_GLCAASE,GLTMN_GLC_GLCAASEe,GLTMN_GLC_GLCAASEepp,GLTMNte,GLTMNtepp,GLTMNtex PMDBD1056 Betamethasone Therapeutic substance Drug 378-44-9 DB00443 PA164754818 D00244 DAP001043 9782 9399 n.a. "betamethasone; 378-44-9; Betadexamethasone; Flubenisolone; Betamethazone; Visubeta; Rinderon; Betapredol; Betacortril; Betacorlan; Betasolon; Betametasone; Celestene; Betnelan; Methazon; Betsolan; Betamamallet; Cidoten; Bebate; Becort; Bedifos; beta-Methasone; Desacort-Beta; Rinderon A; beta-Methasone alcohol; Betafluorene; Celestone; Betamethasone cream; Betametasona; Betamethasonum; Betamethasone alcohol; Betametasone [DCIT]; Hormezon; 9alpha-Fluoro-16beta-methylprednisolone; Betamethasonum [INN-Latin]; Celestone Syrup and Tablets; Betameta" C22H29FO5 UREBDLICKHMUKA-DVTGEIKXSA-N (8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one n.a. n.a. No Yes No No No No PMDBD364 Fluorometholone Therapeutic Substance Approved Drug 426-13-1 DB00324 PA164781355 D01367 DAP001047 9878 9494 n.a. "fluorometholone; 426-13-1; Oxylone; Fluormetholone; Flumetholon; Delmeson; Cortilet; FML Liquifilm; Fluor-Op; Trilcin; Fluoromethalone; FML Forte; Fluormetholonum; Fluorometolona; Fluorometholonum; Neo-Oxylone; Fluorometolone [DCIT]; FML-S Liquifilm; Fluormetholon; Fluorometolona [INN-Spanish]; Fluorometholonum [INN-Latin]; NSC 33001; component of Neo-Oxylone; UNII-SV0CSG527L; FML; U 8614; (6S,8S,9R,10S,11S,13S,14S,17R)-17-acetyl-9-fluoro-11,17-dihydroxy-6,10,13-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one" C22H29FO4 FAOZLTXFLGPHNG-KNAQIMQKSA-N (6S,8S,9R,10S,11S,13S,14S,17R)-17-acetyl-9-fluoro-11,17-dihydroxy-6,10,13-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one Alcon Laboratories Antiallergic Agents Yes No No No No No PMDBD240 Cyproterone acetate Therapeutic Substance Approved Drug 427-51-0 DB04839 PA10049 D01368 DAP000906 9880 9496 n.a. "CYPROTERONE ACETATE; 427-51-0; Androcur; Cyproterone 17-O-acetate; Cyproteroneacetate; Cyproteron acetate; Cyproteron-R acetate; Cyprosterone acetate; NSC-81430; SH 714; UNII-4KM2BN5JHF; SH 80714; Cyproterone 17alpha-acetate; SH-714; CCRIS 4385; HSDB 3592; Cyproterone acetate [USAN:JAN]; EINECS 207-048-3; NSC 81430; 4KM2BN5JHF; C24H29ClO4; MLS000859908; Cyproterone 17.alpha.-acetate; CHEMBL139835; (1R,3aS,3bR,7aR,8aS,8bS,8cS,10a" C24H29ClO4 UWFYSQMTEOIJJG-FDTZYFLXSA-N [(1S,2S,3S,5R,11R,12S,15R,16S)-15-acetyl-9-chloro-2,16-dimethyl-6-oxo-15-pentacyclo[9.7.0.02,8.03,5.012,16]octadeca-7,9-dienyl] acetate n.a. n.a. No Yes No Yes No No PMDBD177 Chenodeoxycholic acid Herbal Substance Medicinal Herbal Compounds 474-25-9 DB06777 PA165958403 D00163 n.a. 10133 9728 n.a. "chenodeoxycholic acid; Chenodiol; Chenic acid; Chenix; Cdca; Chenodeoxycholate; 474-25-9; Chenodesoxycholic acid; Gallodesoxycholic acid; Chendol; Anthropodeoxycholic acid; Anthropodesoxycholic acid; Chenofalk; Anthropododesoxycholic acid; Chenodesoxycholsaeure; Henohol; Xenbilox; Chenique Acid; Chenocholic acid; Chenodiol [USAN]; 3alpha,7alpha-Dihydroxy-5beta-cholan-24-oic acid; Sodium chenodeoxycholate; Acido chenodeoxicholico; Chenodesoxycholsaeure [German]; 3alpha,7alpha-Dihydroxy-5beta-cholanic acid; Acide chenodeoxycholique" C24H40O4 RUDATBOHQWOJDD-BSWAIDMHSA-N (4R)-4-[(3R,5S,7R,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid Sigma Tau Pharmaceuticals Inc n.a. No Yes No No No No PMDBD420 Hesperidin "Therapeutic Substance; Herbal Substance" anti-allergy 520-26-3 DB04703 PA449867 D01038 n.a. 10621 10176 NPC79056 "hesperidin; 520-26-3; Cirantin; Hesperidoside; Hesper bitabs; Hesperetin-rutinosid; Hesperetin 7-rhamnoglucoside; Hesperidine; Ciratin; (S)-(-)-Hesperidin; NSC 44184; UNII-E750O06Y6O; CCRIS 3940; Hesperitin-7-rutinoside; EINECS 208-288-1; BRN 0075140; Hesperetin 7-rutinoside; MLS001304066; (2S)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxy-2,3-dihydrochromen-4-one; CHEBI:28775; USAF CF-3; Hesperidin, " C28H34O15 QUQPHWDTPGMPEX-QJBIFVCTSA-N (2S)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxy-2,3-dihydrochromen-4-one n.a. n.a. No Yes No No No No PMDBD527 Metamfetamine Therapeutic Substance psychostimulant and sympathomimetic 537-46-2 DB01577 PA450403 n.a. DAP001496 10836 10379 n.a. "METHAMPHETAMINE; Metamfetamine; d-Methamphetamine; d-Deoxyephedrine; d-Desoxyephedrine; d-N-Methylamphetamine; Metamphetamine; d-Methylamphetamine; Methylamphetamine; d-Phenylisopropylmethylamine; N-Methylamphetamine; (S)-Methamphetamine; Norodin; (+)-Methylamphetamine; d-(S)-Methamphetamine; D-1-Phenyl-2-methylaminopropane; Desyphed; (+)-N-Methylamphetamine; (S)-Methylamphetamine; (+)-(S)-Deoxyephedrine; Methyl-beta-phenylisopropylamine; 1-Phenyl-2-methylaminopropane; (S)-(+)-Deoxyephedrine; Metamfetamina; Metamfetaminum; Stimulex" C10H15N MYWUZJCMWCOHBA-VIFPVBQESA-N (2S)-N-methyl-1-phenylpropan-2-amine Ovation Pharma Central Nervous System Stimulants No Yes No No No No PMDBD475 Levocarnitine "Therapeutic Substance; Herbal Substance" Herbal 541-15-1 DB00583 PA450154 D02176 DAP000958 10917 10455 NPC295832 "L-carnitine; Levocarnitine; 541-15-1; vitamin BT; (R)-Carnitine; Carnitor; Carnitine; (-)-Carnitine; Karnitin; (-)-L-Carnitine; L-(-)-Carnitine; Carnitene; Levocarnitina; Metina; L-Carnitine inner salt; Levocarnitinum; Carniking; Carnovis; Carnitolo; Carnilean; Carrier; Lefcar; L(-)-Carnitine; Levocarnitinum [Latin]; Levocarnitina [Spanish]; Carniking 50; (3R)-3-hydroxy-4-(trimethylammonio)butanoate; Levocarnitine [USAN:INN]; gamma-Trimethyl-beta-hydroxybutyrobetaine; bicarnesine; gamma-Trimethyl-ammonium-beta-hydroxybut" C7H15NO3 PHIQHXFUZVPYII-ZCFIWIBFSA-N (3R)-3-hydroxy-4-(trimethylazaniumyl)butanoate n.a. n.a. No Yes No No No No PMDBD182 Chlorotrianisene Therapeutic Substance Approved Drug 569-57-3 DB00269 PA164768822 D00269 DAP001012 11289 10815 n.a. "chlorotrianisene; 569-57-3; Chlortrianizen; Chlortrianisestrol; TACE; Chlorotrianisine; Chlortrianisen; Chlorotrianizen; Chlorestrolo; Chloortrianisestrol; Khlortrianizen; Hormonisene; Clorotrisin; Merbentul; Clorestrolo; Metace; Anisene; Rianil; Chlortrianisoestrolum; Chlortrianisene; Chlorotrisin; Tri-p-anisylchloroethylene; Chlortrianisenum; Tace-fn; Tris(p-methoxyphenyl)chloroethylene; Clorotrianiseno; Trianisestrol; Triagen; Chlorotrianisenum [INN-Latin]; Chlorotrianisenum; Tace (pharmaceutical); Clorotrianiseno [INN-Spanish]; Chloro" C23H21ClO3 BFPSDSIWYFKGBC-UHFFFAOYSA-N 1-[1-chloro-2,2-bis(4-methoxyphenyl)ethenyl]-4-methoxybenzene n.a. Anticancer Agents Yes No Yes No No No PMDBD471 Lactulose Therapeutic Substance laxative? 4618-18-2 DB00581 PA164748762 D00352 n.a. 11333 10856 n.a. "lactulose; Duphalac; D-Lactulose; Chronulac; Bifiteral; Constilac; Cephulac; Cholac; Lactulosa; Isolactose; Constulose; Laevolac; Heptalac; Portalac; Laxilose; Lactulosum; Generlac; Enulose; Acilac; Lactulosum [Latin]; Lactulosa [Spanish]; Lattulosio [Italian]; Lactulosum [INN-Latin]; Lactulosa [INN-Spanish]; UNII-9XH2P2N8EP; 4-O-beta-D-Galactopyranosyl-D-fructose; EINECS 225-027-7; BRN 6278818; BRN 0093773; 9XH2P2N8EP; 4-O-beta-D-Galactopyranosyl-D-fructofuranose; 4-beta-D-Galactosido-(1,4)-D-fructose; D-Fructose, 4-O-beta-D-galactopyran" C12H22O11 JCQLYHFGKNRPGE-FCVZTGTOSA-N (2S,3R,4S,5R,6R)-2-[(2R,3S,4S,5R)-4,5-dihydroxy-2,5-bis(hydroxymethyl)oxolan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol n.a. n.a. No Yes No Yes No Yes EX_lactl(e),GALASE_LACTL,GALASE_LACTLe,LACTLt PMDBD519 Megestrol acetate Therapeutic Substance Approved Drug 595-33-5 DB00351 PA450351 D00952 DAP000861 11683 11192 n.a. "MEGESTROL ACETATE; 595-33-5; Megace; Megestryl acetate; Megace ES; Niagestin; Magestin; Megeron; Ovarid; Ovaban; Pallace; Ovaban (Veterinary); Megestat; Megestrol-17-acetate; NSC-71423; UNII-TJ2M0FR8ES; BDH 1298; Maygace; CCRIS 372; SC10363; 17alpha-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate; SC 10363; EINECS 209-864-5; 6-Dehydro-6-methyl-17alpha-acetoxyprogesterone; 17alpha-Acetoxy-6-dehydro-6-methylprogesterone; 6-Methyl-6-dehydro-17alpha-acetoxyprogesterone; 17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione 17-acetate; TJ2M0" C24H32O4 RQZAXGRLVPAYTJ-GQFGMJRRSA-N [(8R,9S,10R,13S,14S,17R)-17-acetyl-6,10,13-trimethyl-3-oxo-2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate n.a. n.a. No Yes No Yes No No PMDBD314 Erythromycin "Therapeutic Substance; Herbal Substance" "Approved Drug; Medicinal Herbal Compounds" 114-07-8 DB00199 PA449493 D00140 DAP000111 12560 12041 NPC227622 "erythromycin; Erythromycin A; 114-07-8; E-Mycin; Abomacetin; Erythrocin; Erythromycinum; Erymax; Emgel; Erythromycine; Eritromicina; Erythro-Statin; Ilotycin; E-Glades; Eryacne; (-)-ERYTHROMYCIN; Erythromycin base; Torlamicina; Robimycin; Abboticin; Erycette; Ery-Tab; E-Base; erythro; Erythroguent; Propiocine; Erythromid; Erycinum; Mephamycin; Dumotrycin; Eritrocina; Stiemycin; Pantomicina; Erythrogran; Ilocaps; Erygel; Ermycin; Sansac; Eryderm; Erycin; Erycen; Dotycin; Wemid; Aknin; ERYC; Eryc Sprinkles; Theramycin Z; Erythra-Derm; Kesso-Mycin" C37H67NO13 ULGZDMOVFRHVEP-RWJQBGPGSA-N (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione Eli Lilly Antibiotics Yes No Yes No No No PMDBD477 Levonorgestrel Therapeutic Substance contraception and hormone 797-63-7 DB00367 PA450218 D00950 DAP001207 13109 12560 n.a. "Levonorgestrel; norgestrel; 797-63-7; D-Norgestrel; (-)-Norgestrel; Microval; Postinor; Levonova; Mirena; Jadelle; Neogest; Ovrette; Plan B; NORPLANT; Norplant 2; Microlution; Follistrel; Triciclor; Microgyn; Triagynon; Microlut; Ovranette; Monovar; Nordet; Trigoa; 18-Methylnorethisterone; Microgynon CD; Microgest ED; Norplant II; Ovral-Lo; Logynon ED; Levlen ED; Trinordiol 28; Trinordiol 21; Microgynon 28; Microgynon 21; d(-)-Norgestrel; Monofeme 28; Stediril 30; Nordette 21; Nordette 28; Minivlar 30; Neogynon 21; Levonelle; Trifeme 28; Preven; Tri-Le" C21H28O2 WWYNJERNGUHSAO-XUDSTZEESA-N (8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one n.a. n.a. No Yes No Yes No No PMDBD1490 Vinblastine Therapeutic substance Drug 865-21-4 DB00570 PA451877 n.a. DAP000785 13342 12773 n.a. "vinblastine; Vinblastin; Vincaleucoblastin; Vincaleukoblastine; Vincoblastine; Rozevin; Nincaluicolflastine; Vinblastina [DCIT]; 865-21-4; Vinblastine [INN:BAN]; Vinblastinum [INN-Latin]; Velbe; VR-8; UNII-5V9KLZ54CY; CCRIS 9002; HSDB 3263; NCI-C04842; C46H58N4O9; NDC 0002-1452-01; EINECS 212-734-0; NSC 47842; Velban; CHEMBL159; 29060-LE; 5V9KLZ54CY; Vinblastinum; Vinblastina; VLB; (3aR-(3aalpha,4beta,5beta,5abeta,9(3R*,5S*,7R*,9S*),10bR*,13aalpha))-methyl 4-(acetyloxy)-3a-ethyl-9-(5-ethyl-1,4,5,6,7,8,9,10-octahydro-5-hydroxy-9-(metho" C46H58N4O9 JXLYSJRDGCGARV-CFWMRBGOSA-N methyl (1R,9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-4-[(13S,15R,17S)-17-ethyl-17-hydroxy-13-methoxycarbonyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-13-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate n.a. n.a. No Yes No No No No PMDBD316 Estradiol Valerate Therapeutic Substance Approved Drug 979-32-8 DB13956 n.a. n.a. n.a. 13791 13194 n.a. "estradiol valerate; 979-32-8; Delestrogen; Estradiol 17-valerate; Estradiol valerianate; Neofollin; Estraval; Progynova; Femogex; Progynon-Depot; Oestradiol valerate; Climaval; Atladiol; Pharlon; Duratrad; Deladiol; Estate; Dura-estradiol; Exten strone; Repo-Estra; Depo estro med; Delestrogen 4X; Estraval PA; Estraval 2X; Estroval-10; Delahormone unimatic; Depo-Estro-Med; Femogen-L.A.; Primogyna; Gynokadin; Ronfase; Pelanin; Merimono; Cyclocur; Postoval; Nuvelle; Estradiol Depot; Primogyn-Depot; Gynogen L.A. 20; Gynogen L.A. 40; Gynogen L.A. 10" C23H32O3 RSEPBGGWRJCQGY-RBRWEJTLSA-N [(8R,9S,13S,14S,17S)-3-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] pentanoate n.a. n.a. Yes No Yes No No No PMDBD888 Vancomycin "Therapeutic Substance; Herbal Substance" "Approved Drug; Medicinal Herbal Compounds" 1404-90-6 DB00512 PA451850 D00212 DAP001330 14969 14253 NPC314743 "VANCOMYCIN; Vancocin; Vancoled; Vancomycinum; Vancomycine; Vancomicina; 1404-90-6; VANCOR; Vancomycinum [INN-Latin]; Vancomycine [INN-French]; Vancomicina [INN-Spanish]; UNII-6Q205EH1VU; HSDB 3262; EINECS 215-772-6; CHEMBL262777; 6Q205EH1VU; CHEBI:28001; Vancomycin (USP); vancomicin; vanomycin; Vancomycin [USP:INN:BAN]; Vancomycin [USAN:INN:BAN]; Vancomycin hydrochloride from Streptomyces orientalis; C66H75Cl2N9O24; Viomycin derivative; [(2S,3R,4S,5S,6R)-3-[(2S,4S,5S,6S)-4-amino-5-hydroxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-4,5-d" C66H75Cl2N9O24 MYPYJXKWCTUITO-LYRMYLQWSA-N (1S,2R,18R,19R,22S,25R,28R,40S)-48-[(2S,3R,4S,5S,6R)-3-[(2S,4S,5S,6S)-4-amino-5-hydroxy-4,6-dimethyloxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-22-(2-amino-2-oxoethyl)-5,15-dichloro-2,18,32,35,37-pentahydroxy-19-[[(2R)-4-methyl-2-(methylamino)pentanoyl]amino]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentazaoctacyclo[26.14.2.23,6.214,17.18,12.129,33.010,25.034,39]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34(39),35,37,46,49-pentadecaene-40-carboxylic acid n.a. n.a. Yes Yes No No No No PMDBD408 Glycyrrhizin Herbal Substance hepatoprotective n.a. n.a. n.a. n.a. n.a. 14982 n.a. NPC202666 "Glycyrrhizic acid; glycyrrhizin; Glycyrrhizinic acid; 1405-86-3; Glycyron; Glycyrrhetinic acid glycoside; glyzyrrhizin; Glizigen; 18-beta-Glycyrrhizic acid; Glycyrrizin; Liquorice; UNII-6FO62043WK; Rizinsan K2 A2 (free acid); HSDB 496; CHEBI:15939; EINECS 215-785-7; C42H62O16; Glycyrrhizin [JAN]; NSC 167409; NSC 234419; BRN 0077922; CHEMBL441687; NSC 2800; beta-Glycyrrhizin; Dipotassium glycyrrhizinate; 6FO62043WK; NSC-234419; NSC-167409; DSSTox_RID_82047; DSSTox_CID_27006; DSSTox_GSID_47006; Glycyram" C42H62O16 LPLVUJXQOOQHMX-QWBHMCJMSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4S,5S,6S)-2-[[(3S,4aR,6aR,6bS,8aS,11S,12aR,14aR,14bS)-11-carboxy-4,4,6a,6b,8a,11,14b-heptamethyl-14-oxo-2,3,4a,5,6,7,8,9,10,12,12a,14a-dodecahydro-1H-picen-3-yl]oxy]-6-carboxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid n.a. n.a. No Yes No No No No PMDBD528 Metaxalone Therapeutic Substance Approved Drug 1665-48-1 DB00660 PA164747189 D00773 n.a. 15459 14709 n.a. "METAXALONE; 1665-48-1; Skelaxin; Methaxalonum; Zorane; Metaxalon; Methoxolone; 5-((3,5-Dimethylphenoxy)methyl)oxazolidin-2-one; Metazolone; Metazalone; Metaxolone; AHR-438; Metaxalonum [Latin]; Metassalone [DCIT]; Metaxalonum [INN-Latin]; Metaxalona [INN-Spanish]; AHR 438; 5-[(3,5-Dimethylphenoxy)methyl]-1,3-oxazolidin-2-one; 5-(3,5-Xyloloxymethyl)oxazolidin-2-one; Metaxalona [Spanish]; CL 39,148; NSC 170959; Metaxalone [USAN:INN:BAN]" C12H15NO3 IMWZZHHPURKASS-UHFFFAOYSA-N 5-[(3,5-dimethylphenoxy)methyl]-1,3-oxazolidin-2-one Elan Corp plc n.a. No Yes No Yes No No PMDBD1025 Amiloride Therapeutic substance Drug 2609-46-3 DB00594 PA448368 D07447 DAP000187 16231 15403 n.a. "AMILORIDE; Amipramidin; 2609-46-3; Midamor; Guanamprazine; Amipramizide; Amipramizid; Guanamprazin; Amilorida; Amiloridum; Amyloride; Amiloridum [INN-Latin]; Amilorida [INN-Spanish]; 3,5-diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide; Amiloride [INN:BAN]; N-Amidino-3,5-diamino-6-chloropyrazinecarboxamide; C6H8ClN7O; UNII-7DZO8EB0Z3; CCRIS 6545; EINECS 220-024-7; 3,5-Diamino-N-(aminoiminomethyl)-6-chloropyrazinecarboxamide; N-Amidino-3,5-diamino-6-chlorpyrazincarboxamid; Amiloride hydrochloride hydrate; Pyrazinecarboxamide" C6H8ClN7O XSDQTOBWRPYKKA-UHFFFAOYSA-N 3,5-diamino-6-chloro-N-(diaminomethylidene)pyrazine-2-carboxamide n.a. n.a. No Yes No No No No PMDBD671 Pimozide Therapeutic Substance Approved Drug 2062-78-4 DB01100 PA450965 D00560 DAP000316 16362 15520 n.a. "pimozide; 2062-78-4; Orap; Opiran; Pimozidum; Pimozidum [INN-Latin]; McN-JR-6238; R-6238; Primozida [INN-Spanish]; R 6238; UNII-1HIZ4DL86F; R6238; NSC 170984; McN-JR 6238; CCRIS 9172; C28H29F2N3O; EINECS 218-171-7; BRN 0729089; 1-[1-[4,4-Bis(p-fluorophenyl)butyl]-4-piperidyl]-2-benzimidazolinone; 1-(1-(4,4-Bis(p-fluorophenyl)butyl)-4-piperidyl)-2-benzimidazolinone; 1HIZ4DL86F; CHEMBL1423; 1-(4,4-Bis(p-fluorophenyl)butyl)-4-(2-oxo-1-benzimidazolinyl)piperidine; 3-[1-[4,4-bis(4-fluorophenyl)butyl]piperidin-4-yl]-1H-benzimidazol-2-o" C28H29F2N3O YVUQSNJEYSNKRX-UHFFFAOYSA-N 3-[1-[4,4-bis(4-fluorophenyl)butyl]piperidin-4-yl]-1H-benzimidazol-2-one Janssen Pharmaceutica Antipsychotic Agents Yes Yes No Yes No No PMDBD804 Streptomycin "Therapeutic Substance; Herbal Substance" "Approved Drug; Medicinal Herbal Compounds" 57-92-1 DB01082 PA451512 n.a. DAP000144 19649 18508 NPC94319 "streptomycin; 57-92-1; Strepcen; Streptomycin A; Gerox; Streptomycine; Streptomycin sulphate; Agrimycin; Chemform; Streptomycin sulfate; CHEBI:17076; UNII-Y45QSO73OB; Agrept; Neodiestreptopab; NSC-14083; Y45QSO73OB; Streptomycin A sulfate; Streptomycinum; Hokko-mycin; 2,4-Diguanidino-3,5,6-trihydroxycyclohexyl 5-deoxy-2-O-(2-deoxy-2-methylamino-alpha-L-glucopyranosyl)-3-C-formyl-beta-L-lyxopentanofuranoside; Caswell No. 804; Streptomyzin [German]; Streptomicina [Italian]; Streptomycin [INN:BAN]; Estreptomicina [INN-Spanish]; CCRIS " C21H39N7O12 UCSJYZPVAKXKNQ-HZYVHMACSA-N 2-[(1R,2R,3S,4R,5R,6S)-3-(diaminomethylideneamino)-4-[(2R,3R,4R,5S)-3-[(2S,3S,4S,5R,6S)-4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy-4-formyl-4-hydroxy-5-methyloxolan-2-yl]oxy-2,5,6-trihydroxycyclohexyl]guanidine n.a. n.a. Yes Yes No No No No PMDBD200 Cladribine "Therapeutic Substance; Herbal Substance" chemotherapeutic 4291-63-8 DB00242 PA449027 D01370 DAP000565 20279 19105 NPC314152 "Cladribine; 2-Chloro-2''-deoxyadenosine; 4291-63-8; Leustatin; 2-Chlorodeoxyadenosine; 2-CdA; Cladarabine; Chlorodeoxyadenosine; CldAdo; Litak; 2-Chloro-2''-deoxy-beta-adenosine; Cladaribine; 2-chloro-deoxyadenosine; 2ClAdo; RWJ 26251; UNII-47M74X9YT5; MLS000028377; NSC 105014-F; RWJ-26251; NSC 105014; BRN 0624220; (2R,3S,5R)-5-(6-amino-2-chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol; SMR000058553; Leustat; 2-Chloro-6-amino-9-(2-deoxy-beta-D-erythropentofuranosyl)purine; 2-chloro-6-amino-9-(2-deoxy-beta" C10H12ClN5O3 PTOAARAWEBMLNO-KVQBGUIXSA-N (2R,3S,5R)-5-(6-amino-2-chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol n.a. Anticancer Agents Yes Yes No Yes No No PMDBD1197 Flucloxacillin Therapeutic substance Antibiotics 5250-39-5 DB00301 PA164781042 D04196 DAP001163 21319 20037 n.a. "Flucloxacillin; FLOXACILLIN; Floxapen; 5250-39-5; flucloxacilina; Flucloxacilline; Flucloxacillinum; flucloxacillin sodium; Flucloxacilline [INN-French]; Flucloxacilina [INN-Spanish]; Flucloxacillinum [INN-Latin]; Floxacillin [USAN]; BRL 2039; 3-(2-Chloro-6-fluorophenyl)-5-methyl-4-isoxazolylpenicillin; Flucloxacillin-Sodium; C19H17ClFN3O5S; UNII-43B2M34G2V; Floxacillin (USAN); CHEBI:5098; Flucloxacillin (INN); Floxapen (TN); EINECS 226-051-0; Floxacillin sodium salt; 43B2M34G2V; BRL-2039; Flucloxacillin [INN]" C19H17ClFN3O5S UIOFUWFRIANQPC-JKIFEVAISA-N (2S,5R,6R)-6-[[3-(2-chloro-6-fluorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid n.a. n.a. Yes No No No No No PMDBD278 Dihydrostreptomycin sulfate "Therapeutic Substance; Herbal Substance" "Approved Drug; Medicinal Herbal Compounds" n.a. n.a. n.a. n.a. n.a. 21653 n.a. NPC121479 "Dihydrostreptomycin sulfate; Didromycin; Didromycine; Panstreptin; 5490-27-7; UNII-T7D4876IUE; Abiocine; Dihydrostreptomycin 3/2 sulfate; Dihydrostreptomycin Sulfate [USP]; DIHYDROSTREPTOMYCIN SESQUISULFATE; EINECS 226-823-7; AI3-50133; T7D4876IUE; Dihydrostreptomycin sequisulphate; Dihydrostreptomycin sulfate (2:3)(salt); Dihydrostreptomycin sulfate (USP); D-Streptamine, O-2-deoxy-2-(methylamino)-alpha-L-glucopyranosyl-(1-2)-O-5-deoxy-3-C-(hydroxymethyl)-alpha-L-lyxofuranosyl-(1-4)-N,N''-bis(aminoiminomethyl)-, sulfate (2:" C42H88N14O36S3 CZWJCQXZZJHHRH-YCRXJPFRSA-N "2-[(1R,2R,3S,4R,5R,6S)-3-(diaminomethylideneamino)-4-[(2R,3R,4R,5S)-3-[(2S,3S,4S,5R,6S)-4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy-4-hydroxy-4-(hydroxymethyl)-5-methyloxolan-2-yl]oxy-2,5,6-trihydroxycyclohexyl]guanidine;sulfuric acid" n.a. n.a. Yes No Yes No No No PMDBD1489 Vidarabine Therapeutic substance antiviral 24356-66-9 DB00194 PA451876 D00406 DAP000642 21704 20400 n.a. "Vidarabine; Adenine arabinoside; Ara-A; 5536-17-4; Arabinosyladenine; Vira-A; Spongoadenosine; Araadenosine; 9-beta-D-Arabinofuranosyladenine; Arabinosyl adenine; Arabinoside adenine; Arasena-A; Vidarabine anhydrous; Vidarabin; Vira ATM; Vidarabina [DCIT]; (2R,3S,4S,5R)-2-(6-Amino-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol; 9-BETA-D-ARABINOFURANOSYL-ADENINE; 9beta-D-Arabinofuranosyladenine; 9-beta-Arabinoadenosine; beta-D-Arabinosyladenine; araA; Adenine-beta-D-arabinofuranoside; Vidarabinum [INN-Latin]; UNII-3XQD2ME" C10H13N5O4 OIRDTQYFTABQOQ-UHTZMRCNSA-N (2R,3S,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol n.a. n.a. No Yes No No No No PMDBD1114 Chromium Environmental Chemicals Heavy Metals 7440-47-3 DB11136 n.a. n.a. n.a. 23976 22412 n.a. "Cr; Chromium; 7440-47-3; Chrome; Chrom; Chromium compounds; Chromium, elemental; cromo; Chromium metal; Chrome [French]; Chrom [German]; chromide(1-); chromium atom; Chromium, metal; CCRIS 159; UNII-0R0008Q3JB; HSDB 910; EINECS 231-157-5; 24Cr; CHEBI:28073; Chromium, metal and insol. salts; 0R0008Q3JB; Chromium, metal and chromium(III) compounds; Chromium metal [Chromium and chromium compounds]; Chromium, 99+%, pure, powder; MFCD00010944; Dinakrome; chromium anion; BioChrome; chromide(-I); Chromium Yeast Dark; Chromium Trituration; Chromi" Cr VYZAMTAEIAYCRO-UHFFFAOYSA-N chromium n.a. n.a. Yes No No No No No PMDBD1072 Camptothecin Therapeutic substance Therapeutic Substance 4/3/7689 DB04690 PA153590860 n.a. n.a. 24360 22775 n.a. "camptothecin; Camptothecine; 7689-03-4; (S)-(+)-Camptothecin; Campathecin; d-Camptothecin; (+)-Camptothecine; (+)-Camptothecin; 20(S)-Camptothecine; 21,22-Secocamptothecin-21-oic acid lactone; NSC94600; Camptothecine (8CI); Camptothecine (S,+); CHEMBL65; (4S)-4-ethyl-4-hydroxy-1H-pyrano[3'',4'':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; UNII-XT3Z54Z28A; MLS000766223; XT3Z54Z28A; CHEBI:27656; NSC-94600; AK-39842; (+)-Camptothecin, 98%; Q-200785; (S)-4-ethyl-4-hydroxy-1H-Pyrano[3'',4'':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H" C20H16N2O4 VSJKWCGYPAHWDS-FQEVSTJZSA-N (19S)-19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione n.a. n.a. No Yes No No No No PMDBD803 Stanozolol Therapeutic Substance Approved Drug 10418-03-8 DB06718 PA165958391 D00444 n.a. 25249 23582 n.a. "stanozolol; Winstrol; Androstanazole; 10418-03-8; Androstanazol; Stromba; Tevabolin; Stanazolol; Winstrol Depot; Strombaject; Estazol; Winstroid; Anabol; Winstrol V; Estanozolol; Stanozololum; Stanozolo [DCIT]; Androstanazole (VAN); WIN 14833; Stanozolol (1''H form); Winstrol-V; Stanozololum [INN-Latin]; Estanozolol [INN-Spanish]; UNII-4R1VB9P8V3; Androstanazolestanazol; HSDB 3185; Stanozolol (2''H form); EINECS 233-894-8; NSC 43193; NSC 233046; 4R1VB9P8V3; CHEBI:9249" C21H32N2O LKAJKIOFIWVMDJ-IYRCEVNGSA-N (1S,2S,10S,13R,14S,17S,18S)-2,17,18-trimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5-dien-17-ol n.a. n.a. Yes No Yes No No No PMDBD1076 Carbendazim Environmental Chemicals Pesticides 10605-21-7 DB13009 n.a. n.a. n.a. 25429 23741 n.a. "Carbendazim; 10605-21-7; Carbendazole; Mecarzole; Bavistin; Carbendazime; Carbendazol; Thicoper; Derosal; Bavistan; Medamine; Funaben; Methyl 2-benzimidazolecarbamate; Garbenda; BMK (fungicide); Kemdazin; Carbendazym; Supercarb; Equitdazin; Agrizim; Kolfugo; Karben; Delsene; Custos; Stempor; Bitosen; Bengard; Battal; Myco; Bavistin 3460; carbendazine; Methyl benzimidazol-2-ylcarbamate; Pillarstin; Falicarben; Fungisol; Triticol; Stein; Spin; Bercema-Bitosen; Kolfugo Extra; Preventol BCM; Antibac MF; Carben VL; Funaben 3; BCM (fungicide); METHYL 1H-BEN" C9H9N3O2 TWFZGCMQGLPBSX-UHFFFAOYSA-N methyl N-(1H-benzimidazol-2-yl)carbamate n.a. n.a. Yes No No No No No PMDBD553 Misonidazole Therapeutic Substance Tumor Hypoxia 13551-87-6 DB11716 n.a. n.a. n.a. 26105 24317 n.a. "Misonidazole; 13551-87-6; Ro 7-0582; SRI 1354; Misonidazolum [INN-Latin]; Misonidazol [INN-Spanish]; CCRIS 1160; 1-methoxy-3-(2-nitro-1H-imidazol-1-yl)propan-2-ol; EINECS 236-931-6; 1-(2-Hydroxy-3-methoxypropyl)-2-nitroimidazole; 1-methoxy-3-(2-nitroimidazol-1-yl)propan-2-ol; SR 1354; BRN 0613655; NSC-261,037; alpha-(Methoxymethyl)-2-nitro-1H-imidazole-1-ethanol; 1-(2-NITRO-1-IMIDAZOLYL)-3-METHOXY-2-PROPANOL; MLS003115361; 1-(2''-hydroxy-3''-methoxypropyl)-2-nitroimidazole; NSC261037; NSC-261037; 1H-Imidazole-1-ethanol, alpha-(m" C7H11N3O4 OBBCSXFCDPPXOL-UHFFFAOYSA-N 1-methoxy-3-(2-nitroimidazol-1-yl)propan-2-ol n.a. n.a. No Yes No No No Yes EX_miso(e),MISO_GLC_GLCAASE,MISO_GLC_GLCAASEe,MISO_GLC_GLCAASEepp,MISOte,MISOtepp,MISOtex PMDBD260 Diacerein Therapeutic Substance Approved Drug 13739-02-1 DB11994 n.a. n.a. n.a. 26248 24456 n.a. "Diacerein; 13739-02-1; Diacetylrhein; Diacerhein; Fisiodar; Artrodar; 1,8-DIACETOXY-3-CARBOXYANTHRAQUINONE; DIACERIN; 4,5-Diacetylrhein; Diacereine [French]; Diacereinum [Latin]; Diacereina [Spanish]; SF-277; 4,5-diacetyloxy-9,10-dioxoanthracene-2-carboxylic acid; UNII-4HU6J11EL5; C19H12O8; EINECS 237-310-2; BRN 2184909; MLS000028577; 4HU6J11EL5; 1,8-Diacetoxyanthraquinone-3-carboxylic acid; M01AX21; AC-201; 4,5-diacetyloxy-9,10-dioxo-2-anthracenecarboxylic " C19H12O8 TYNLGDBUJLVSMA-UHFFFAOYSA-N 4,5-diacetyloxy-9,10-dioxoanthracene-2-carboxylic acid n.a. n.a. Yes No Yes No No No PMDBD1414 Selegiline Therapeutic substance Drug 14611-51-9 DB01037 PA451316 D03731 DAP000579 26757 24930 n.a. "selegiline; L-Deprenalin; Emsam; Eldepryl; L-Deprenyl; (-)-selegiline; Jumex; 14611-51-9; Carbex; Zelapar; Deprenyl; (-)-Deprenil; Selegilinum; Selegilina; Selegilinum [INN-Latin]; Selegilina [INN-Spanish]; UNII-2K1V7GP655; l-E 250; N-methyl-N-[(2R)-1-phenylpropan-2-yl]prop-2-yn-1-amine; CHEMBL972; CHEBI:9086; 2K1V7GP655; Otrasel; (R)-(-)-N,alpha-Dimethyl-N-2-propinylphenethylamine; (R)-(-)-N-Methyl-N-(1-phenyl-2-propyl)-2-propinylamin; selgene; Anipryl; Selegyline; Benzeneethana" C13H17N MEZLKOACVSPNER-GFCCVEGCSA-N (2R)-N-methyl-1-phenyl-N-prop-2-ynylpropan-2-amine n.a. n.a. No Yes No No No No PMDBD474 Levamisole "Therapeutic Substance; Herbal Substance" "Therapeutic Substance; Herbal Substance" 14769-73-4 DB00848 PA450205 D08114 DAP000570 26879 25037 NPC469974 "levamisole; 14769-73-4; Levamisol; L-Tetramisole; Wormicid; Lepuron; Ketrax; LEVOMYSOL; Ergamisol; Levamisolum; (S)-(-)-Levamisole; Vermisol 150; Levamisol [INN-Spanish]; Levamisolum [INN-Latin]; (-)-Tetramisole; (S)-6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole; Levamisole [INN:BAN]; (6S)-6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazole; TCMDC-125847; dl-Tetramisole; UNII-2880D3468G; EINECS 238-836-5; CHEMBL1454; L-2,3,5,6-Tetrahyro-6-phenylimidazo(2,1-b)thiaz" C11H12N2S HLFSDGLLUJUHTE-SNVBAGLBSA-N (6S)-6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazole Janssen Pharmaceutica Anticancer Agents No Yes No Yes No No PMDBD838 Thiamphenicol Therapeutic Substance Approved Drug 15318-45-3 DB08621 n.a. n.a. n.a. 27200 25315 n.a. "thiamphenicol; 15318-45-3; Thiophenicol; (+)-Thiamphenicol; Dextrosulphenidol; Raceophenidol; D-Thiocymetin; D-Thiophenicol; Thiamcol; Thiocymetin (TN); Armai (TN); Thiocymetin; Tiamfenicolo [DCIT]; UNII-FLQ7571NPM; Tiamfenicol [INN-Spanish]; Thiamphenicol (Thiophenicol); Macphenicol; C12H15Cl2NO5S; Urfamicina; Thiamphenicolum [INN-Latin]; Descocin; Urfamycine; Igralin; Hyrazin; Dexawin; Rincrol; Neomyson; Masatirin; Efnicol; WIN-5063-2; Unaseran-D; Thiamphenicol [USAN:INN:BAN:JAN]; EINECS 239-355-3; RACEPHENICOL; NSC 522822; FLQ7571NPM; MLS0" C12H15Cl2NO5S OTVAEFIXJLOWRX-NXEZZACHSA-N 2,2-dichloro-N-[(1R,2R)-1,3-dihydroxy-1-(4-methylsulfonylphenyl)propan-2-yl]acetamide n.a. n.a. Yes No Yes No No No PMDBD1265 Manganese Environmental Chemicals Heavy Metals 7439-96-5 DB06757 n.a. D04854 n.a. 27854 25916 n.a. "Manganese(2+); Manganese(II); Manganous ion; Manganese (Mn2+); Mn2+; Manganese ion(2+); Manganese cation; MANGANESE(II) ION; Manganese, ion (Mn2+); Manganese(2+)ions; Manganese cation (2+); UNII-H6EP7W5457; 16397-91-4; Mn(II); Mn++; Mn(2+); H6EP7W5457; 15365-82-9; manganese ion; Manganous cation; Manganous dication; Manganese dication; manganese (II); MnII; Manganese(2+) ion; Mn(II) (incorrect); ion (Mn2+); Manganese cation (Mn2+); Hexaaquamanganese(2+) ion; at. no. 25; Manganese(2+), hexaaqua-, ion; CTK4C7940; CHEBI:29035; DTXSID00167687" Mn+2 WAEMQWOKJMHJLA-UHFFFAOYSA-N manganese(2+) n.a. n.a. Yes No No No No No PMDBD624 Ornidazole Therapeutic Substance Approved Drug 16773-42-5 DB13026 n.a. n.a. n.a. 28061 26102 n.a. "Ornidazole; 16773-42-5; Tiberal; Ornidazolum; Madelen; Ro 7-0207; Ornidazol; 1-chloro-3-(2-methyl-5-nitro-1H-imidazol-1-yl)propan-2-ol; 1-(3-Chloro-2-hydroxypropyl)-2-methyl-5-nitroimidazole; 1-Chloro-3-(2-methyl-5-nitro-1H-imidazol-1-yl)-2-propanol; NSC 95075; 1-(2-Hydroxy-3-chloropropyl)-2-methyl-5-nitroimidazole; Ornidazole [USAN:INN]; Ornidazolum [INN-Latin]; Ornidazol [INN-Spanish]; Ro-70207; CCRIS 9030; CHEBI:75176; EINECS 240-826-0; C7H10ClN3O3; BRN 0614299" C7H10ClN3O3 IPWKIXLWTCNBKN-UHFFFAOYSA-N 1-chloro-3-(2-methyl-5-nitroimidazol-1-yl)propan-2-ol n.a. n.a. Yes No Yes No No No PMDBD246 Danazol Therapeutic Substance Approved Drug 17230-88-5 DB01406 PA164749056 D00289 DAP001017 28417 26436 n.a. "danazol; Danocrine; 17230-88-5; Chronogyn; Danol; Winobanin; Danazole; Cyclomen; Danazolum; Ladogal; Danzol; Danokrin; Danatrol; Danazolum [INN-Latin]; WIN 17757; UNII-N29QWW3BUO; WIN-17757; CCRIS 6747; EINECS 241-270-1; N29QWW3BUO; NSC 270916; Danovaol; 17-alpha-Pregn-4-en-20-yno(2,3-d)isoxazol-17-ol; 17alpha-Pregna-2,4-dien-20-yno(2,3-d)isoxazol-17-ol; 17-alpha-2,4-Pregnadien-20-yno(2,3-d)isoxazol-17-ol; CHEBI:4315; anatrol; NCGC00164400-01; Panacrine; Danoval; Danogen; DSSTox_CID" C22H27NO2 POZRVZJJTULAOH-LHZXLZLDSA-N (1S,2R,13R,14S,17R,18S)-17-ethynyl-2,18-dimethyl-7-oxa-6-azapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-ol n.a. Fertility Agents No Yes No Yes No No PMDBD529 Metergoline Therapeutic Substance Approved Drug 17692-51-2 DB13520 n.a. D07218 n.a. 28693 26687 n.a. "metergoline; Liserdol; Metergolin; Methergoline; Metergolina; 17692-51-2; Metergolinum; Metergolinum [Latin]; Metergolina [DCIT]; Metergolina [Spanish]; Metergoline [INN:BAN]; Substance 355/255; C25H29N3O2; Metergolinum [INN-Latin]; 1-Methyl-N-carbobenzyloxydihydro-D-lysergamin; FI-6337; MLS000069437; UNII-1501393LY5; AHR 3009; 1-Methyl-8-beta-carbobenzyloxyaminomethyl-10-alpha-ergoline; EINECS 241-686-3; 1,6-Dimethyl-8-beta-carbobenzyloxaminomethyl-10-alpha-ergoline; FI 6337" C25H29N3O2 WZHJKEUHNJHDLS-QTGUNEKASA-N benzyl N-[[(6aR,9S,10aR)-4,7-dimethyl-6,6a,8,9,10,10a-hexahydroindolo[4,3-fg]quinolin-9-yl]methyl]carbamate n.a. n.a. Yes No No No No No PMDBD1142 Daunorubicin Therapeutic substance chemotherapeutic 20830-81-3 DB00694 PA449212 D07776 DNC000517 30323 28163 n.a. "daunorubicin; Daunomycin; 20830-81-3; Acetyladriamycin; Leukaemomycin C; Rubidomycin; Cerubidine; Daunorubicine; Daunorrubicina; Daunamycin; Daunarubicinum; (+)-Daunomycin; Cerubidin; DaunoXome; Rubomycin C; Daunorubicinum; Daunoblastin; Rubomycin; Daunorubicinum [INN-Latin]; RP 13057; Daunorubicin [INN:BAN]; RCRA waste no. U059; FI6339; NSC-82151; DaunoXome (TN); FI 6339; UNII-ZS7284E0ZP; CCRIS 914; ZS7284E0ZP; (8S-cis)-8-Acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyrannosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methox" C27H29NO10 STQGQHZAVUOBTE-VGBVRHCVSA-N (7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione n.a. n.a. No Yes No No No No PMDBD488 Lofexidine Therapeutic Substance Approved Drug 31036-80-3 DB04948 PA164744510 n.a. DAP000064 30668 28460 n.a. "Lofexidine; 31036-80-3; Lofexidinum; Lofexidina; Lofexidinum [INN-Latin]; Lofexidina [INN-Spanish]; 2-[1-(2,6-dichlorophenoxy)ethyl]-4,5-dihydro-1H-imidazole; Britlofex; 2-[1-(2,6-dichlorophenoxy)ethyl]-2-imidazoline; 2-(alpha-(2,6-Dichlorophenoxy)ethyl)2-imidazoline; Lofexidine [INN:BAN]; 2-(1-(2,6-Dichlorophenoxy)ethyl)-4,5-dihydro-1H-imidazole; CHEMBL17860; CHEBI:51368; Lucemyra; 1H-Imidazole, 2-(1-(2,6-dichlorop" C11H12Cl2N2O KSMAGQUYOIHWFS-UHFFFAOYSA-N 2-[1-(2,6-dichlorophenoxy)ethyl]-4,5-dihydro-1H-imidazole US WorldMeds Antihypertensive Agents No Yes No No No No PMDBD662 Phenoxyethanol Therapeutic Substance Therapeutic Substance 122-99-6 DB11304 n.a. n.a. n.a. 31236 13848467 n.a. "2-PHENOXYETHANOL; 122-99-6; Phenoxyethanol; Ethylene glycol monophenyl ether; Phenyl cellosolve; Phenoxytol; Phenoxethol; Phenoxetol; Ethylene glycol phenyl ether; Phenoxyethyl alcohol; 2-Phenoxyethan-1-Ol; 1-Hydroxy-2-phenoxyethane; Rose ether; Phenylmonoglycol ether; Arosol; Dowanol EP; 2-Phenoxyethyl alcohol; Glycol monophenyl ether; 2-Hydroxyethyl phenyl ether; Phenylglycol; Fenyl-cellosolve; 2-Fenoxyethanol; Dowanol EPH; 2-Phenoxy-ethanol; Emery 6705; Emeressence 1160; Fenylcelosolv; Marlophen P; beta-Hydroxye" C8H10O2 QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol n.a. n.a. No Yes No No No No PMDBD290 Doxorubicin "Therapeutic Substance; Herbal Substance" chemotherapeutic 23214-92-8 DB00997 PA449412 D03899 DNC000163 31703 29400 NPC261012 "doxorubicin; Adriamycin; 23214-92-8; Doxil; Doxorubicine; Adriablastin; Adriblastina; Doxorubicinum; 14-Hydroxydaunomycin; 14-Hydroxydaunorubicine; Adriamycin semiquinone; Doxorubicinum [INN-Latin]; Doxorubicine [INN-French]; Doxorubicina [INN-Spanish]; FI 106; Doxorubicin [USAN:INN:BAN]; Hydroxydaunorubicin; CCRIS 739; HSDB 3070; NDC 38242-874; UNII-80168379AG; NCI-C01514; EINECS 245-495-6; CHEMBL53463; Doxorubicina; CHEBI:28748; NSC 123127" C27H29NO11 AOJJSUZBOXZQNB-TZSSRYMLSA-N (7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione Sequus Pharmaceuticals Inc Anticancer Agents No Yes No Yes No No PMDBD677 Pivampicillin Therapeutic Substance Approved Drug 33817-20-8 DB01604 PA164776912 n.a. DAP001171 33478 30899 n.a. "Pivampicillin; Pivaloylampicillin; Pivaloyloxymethyl ampicillinate; Pivampicilina; Pivampicillinum; Pivampicilline; Ampicillin pivaloyloxymethyl ester; 33817-20-8; Pivampicillinum [INN-Latin]; Pivampicilline [INN-French]; Pivampicilina [INN-Spanish]; Pivampicillin [INN:BAN]; MK 191; UNII-0HLM346LL7; EINECS 251-688-6; 0HLM346LL7; CHEBI:8255; C22H29N3O6S; DSSTox_RID_80890; DSSTox_CID_25459; DSSTox_GSID_45459; 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((aminophenylacetyl)amino)-3,3-dimethyl-7-oxo-, (2,2-dimethyl-1-oxo" C22H29N3O6S ZEMIJUDPLILVNQ-ZXFNITATSA-N 2,2-dimethylpropanoyloxymethyl (2S,5R,6R)-6-[[(2R)-2-amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate n.a. Antibiotics Yes No Yes No No No PMDBD42 Amoxicillin Therapeutic Substance Approved Drug 26787-78-0 DB01060 PA448406 D07452 DAP000443 33613 31006 n.a. "amoxicillin; Amoxycillin; 26787-78-0; Amoxicillin anhydrous; Amoxicilline; p-Hydroxyampicillin; Amopenixin; Amolin; Moxal; D-Amoxicillin; Clamoxyl; Amoxicillinum; Amoxicilina; Amoxil; Delacillin; Histocillin; Piramox; Aspenil; Amoxivet; Vetramox; Unicillin; Flemoxin; Efpenix; Cemoxin; Bristamox; Anemolin; AMPC; Amoxiden; Amoclen; Amoxi; Sumox; Amoxi-Mast; Sawamox PM; Metafarma capsules; Metifarma capsules; Imacillin; Moxatag; Moxacin; Ibiamox; Amopen; Robamox; Hiconcil; DisperMox; Amoxicillin trihydrate; Amoxicillinum [INN-Latin]; Amoxicilline [INN-Fr" C16H19N3O5S LSQZJLSUYDQPKJ-NJBDSQKTSA-N (2S,5R,6R)-6-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid AstraZeneca Antibiotics Yes Yes Yes No No No PMDBD1469 Tramadol Therapeutic substance Drug 27203-92-5 DB00193 PA451735 D08623 DAP000140 33741 31105 n.a. "Tramadol; (+)-Tramadol; 27203-92-5; cis-Tramadol; Ralivia flashtab; Ralivia ER; Tramadolum [INN-Latin]; Tramadol [INN:BAN]; 123154-38-1; (R,R) tramadol; Tramal; EINECS 248-319-6; UNII-0NG5TTM63P; 0NG5TTM63P; CHEBI:75725; (1R,2R)-2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol; Ryzolt; 181289-58-7; NCGC00159343-02; Tramadon; (+)-trans-2-(Dimethylaminomethyl)-1-(m-methoxyphenyl)cyclohexanol; Racemic tramadol; DSSTox_CID_3691; DSSTox_RID_77150; DSSTox_GSID_23691" C16H25NO2 TVYLLZQTGLZFBW-ZBFHGGJFSA-N (1R,2R)-2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexan-1-ol n.a. n.a. No Yes No No No No PMDBD585 Nicergoline Therapeutic Substance Approved Drug 27848-84-6 DB00699 PA164743014 D01290 DAP000902 34040 31373 n.a. "nicergoline; 27848-84-6; Nimergoline; Nimergoline base; Nicotergoline; Nicergolin [German]; Nicergolina [DCIT]; Nicergolinum [INN-Latin]; UNII-JCV8365FWN; C24H26BrN3O3; FI 6714; RP 19651; EINECS 248-694-6; Sermion (TN); NSC 150531; 10-Methoxy-1,6-dimethylergoline-8beta-methanol 5-bromonicotinate; BRN 4828393; JCV8365FWN; Nicergolinum; CHEBI:31902; 1-Methyl-lumilysergol 8-(5-bromonicotinate) 10-methyl ether; 10-Methoxy-1,6-dimethylergoline-8beta-methanol 5-bromonicotinate (ester); (+)-10-Methoxy-1,6-dimethylergoline-8-beta-methan" C24H26BrN3O3 YSEXMKHXIOCEJA-FVFQAYNVSA-N [(6aR,9R,10aS)-10a-methoxy-4,7-dimethyl-6a,8,9,10-tetrahydro-6H-indolo[4,3-fg]quinolin-9-yl]methyl 5-bromopyridine-3-carboxylate n.a. Vasodilator Agents No Yes No Yes No No PMDBD629 Oxcarbazepine Therapeutic Substance Approved Drug 28721-07-5 DB00776 PA450732 D00533 DAP000528 34312 31608 n.a. "OXCARBAZEPINE; 28721-07-5; Trileptal; Oxcarbamazepine; Oxcarbazepinum; Oxcarbazepina; GP 47680; 10-Oxo-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide; KIN-493; GP-47680; Oxcarbazepinum [INN-Latin]; 5-oxo-6H-benzo[b][1]benzazepine-11-carboxamide; Oxcarbazepina [INN-Spanish]; 10,11-Dihydro-10-oxo-5H-dibenz(b,f)azepine-5-carboxamide; 10,11-Dihydro-10-oxo-5H-dibenz[b,f]azepine-5-carboxamide; UNII-VZI5B1W380; MLS000084586; SPN-804; EINECS 249-188-8; CHEMBL1068; SMR00004" C15H12N2O2 CTRLABGOLIVAIY-UHFFFAOYSA-N 5-oxo-6H-benzo[b][1]benzazepine-11-carboxamide Norvatis Phamaceuticals Corporation Anticonvulsants No Yes No No No No PMDBD1077 Carbidopa Therapeutic substance Drug 28860-95-9 DB00190 PA448794 D00558 DAP000592 34359 31640 n.a. "carbidopa; 28860-95-9; Lodosyn; (S)-(-)-carbidopa; Carbidopa anhydrous; N-Aminomethyldopa; alpha-Methyldopahydrazine; L-alpha-Methyldopahydrazine; S-(-)-Carbidopa; (S)-carbidopa; Carbidopum; Carbidopum [INN-Latin]; Carbidopa (anhydrous); Hadrazino-alpha-methyldopa; S(-)-CARBIDOPA; L-3-(3,4-Dihydroxyphenyl)-2-methyl-2-hydrazinopropionic acid; UNII-KR87B45RGH; MK 486; CCRIS 5093; (2S)-3-(3,4-dihydroxyphenyl)-2-hydrazino-2-methylpropanoic acid; (-)-L-alpha-Hydrazino-3,4-dihydroxy-alpha-methylhydrocinnamic acid; (2S)-3-(3,4-dihydro" C10H14N2O4 TZFNLOMSOLWIDK-JTQLQIEISA-N (2S)-3-(3,4-dihydroxyphenyl)-2-hydrazinyl-2-methylpropanoic acid n.a. n.a. No Yes No No No No PMDBD909 Zidovudine Therapeutic Substance Approved Drug 30516-87-1 DB00495 PA451954 D00413 DAP000701 35370 32555 n.a. "zidovudine; Azidothymidine; 30516-87-1; 3''-Azido-3''-deoxythymidine; Retrovir; AZT; Zidovudinum; Compound S; Zidovudina; ZIDOVUDINE [AZT]; zidovudin; BW A509U; Zidovudinum [Latin]; Zidovudina [Spanish]; BWA509U; ZDV; DRG-0004; 3''-Azido-2'',3''-Dideoxythymidine; UNII-4B9XT59T7S; 3''-Deoxy-3''-azidothymidine; CCRIS 105; Aztec; NSC 602670; BW-A509U; HSDB 6515; BW-A-509U; 3''-Azido-3''-deoxythymidine (AIDS); CHEMBL129; BW-A 509U; MLS000028548; 4B9XT59T7S; 1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-1,2" C10H13N5O4 HBOMLICNUCNMMY-XLPZGREQSA-N 1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione GlaxoSmithKline Anti-HIV Agents Yes Yes Yes No No No PMDBD325 Etofenamate Therapeutic Substance Approved Drug 30544-47-9 DB08984 n.a. D04102 n.a. 35375 32560 n.a. "ETOFENAMATE; 30544-47-9; Rheumon; Bayrogel; Rheumon gel; UNII-KZF0XM66JC; Etofenamatum [INN-Latin]; Etofenamato [INN-Spanish]; Bay d 1107; 2-(2-hydroxyethoxy)ethyl 2-[3-(trifluoromethyl)anilino]benzoate; C18H18F3NO4; TVX 485; 2-(2-Hydroxyethoxy)ethyl 2-((3-(trifluoromethyl)phenyl)amino)benzoate; WHR 5020; EINECS 250-231-8; KZF0XM66JC; BRN 2953263; 2-(2-hydroxyethoxy)ethyl 2-{[3-(trifluoromethyl)phenyl]amino}benzoate; WHR-5020; Benzoic acid, 2-[[3-(trifluoromethyl)phenyl]amino]-, 2-(2-hydroxyethoxy)ethyl ester; NCGC00016804-01" C18H18F3NO4 XILVEPYQJIOVNB-UHFFFAOYSA-N 2-(2-hydroxyethoxy)ethyl 2-[3-(trifluoromethyl)anilino]benzoate n.a. n.a. Yes No No No No No PMDBD853 Tobramycin "Therapeutic Substance; Herbal Substance" "Approved Drug; Medicinal Herbal Compounds" 32986-56-4 DB00684 PA451704 D00063 DAP000110 36294 33377 NPC314408 "tobramycin; 32986-56-4; Nebramycin 6; Nebramycin factor 6; Nebramycin VI; 3''-Deoxykanamycin B; Tobramicin; Nebcin; Tobradistin; Tobrex; Aktob; Tobi; Deoxykanamycin B; NEBRAMYCIN; Tobralex; Tobramycin Base; Tobi Podhaler; 1-Epitobramycin; Tobramycetin; Tobracin; Nebicin; Gotabiotic; Tobacin; Tobrased; Bethkis; Tobramaxin; Tenebrimycin; Tobramitsetin; Tenemycin; TOBRAMYCIN SULFATE; UNII-VZ8RRZ51VK; C18H37N5O9; Tobramycine [INN-French]; Tobramycinum [INN-Latin]; Tobramicina [INN-Spanish]; Tobracin (TN); NSC 180514; Tobrex (TN); HSDB 3259; Lilly 476" C18H37N5O9 NLVFBUXFDBBNBW-PBSUHMDJSA-N (2S,3R,4S,5S,6R)-4-amino-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol n.a. n.a. Yes No Yes No No No PMDBD636 Paclitaxel "Therapeutic Substance; Herbal Substance" chemotherapeutic agent 33069-62-4 DB01229 PA450761 D00491 DNC001411 36314 10368587 NPC208553 "paclitaxel; TAXOL; 33069-62-4; Taxol A; Abraxane; Paxene; Yewtaxan; Plaxicel; Paxceed; Onxol; Ebetaxel; ABI-007; Genaxol; Capxol; LipoPac; Paclitaxel (Taxol); Genetaxyl; Genexol; Intaxel; TaxAlbin; Zisu; OncoGel; NSC-125973; EmPAC; ABI 007; UNII-P88XT4IS4D; MBT 0206; NSC125973; Mitotax; HSDB 6839; DHP 107; DRG-0190; NK 105; QW 8184; P88XT4IS4D; BMS-181339-01; CHEMBL428647; 5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine; CHEBI:45863; nab-paclit" C47H51NO14 RCINICONZNJXQF-MZXODVADSA-N [(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-diacetyloxy-15-[(2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl]oxy-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate Celgene Summit, NJ n.a. Yes Yes No Yes No No PMDBD327 Etoposide "Therapeutic Substance; Herbal Substance" Therapeutic Substance 33419-42-0 DB00773 PA449552 D00125 DAP000786 36462 33510 NPC185498 "etoposide; 33419-42-0; VePesid; Toposar; trans-Etoposide; Lastet; (-)-Etoposide; Zuyeyidal; Etoposidum; Etoposido; Etoposidum [INN-Latin]; VP-16; Etoposide (VP16); VP 16-213; Vepesid J; VP 16 (pharmaceutical); Etoposido [INN-Spanish]; Etopophos (phosphate salt); VP 16; VP-16-213; 4-Demethylepipodophyllotoxin beta-D-ethylideneglucoside; VP 16213; UNII-6PLQ3CP4P3; NK 171; NSC 141540; NSC-141540; CCRIS 2392; HSDB 6517; 4''-Demethylepipodophyllotoxin 9-(4,6-O-(R)-ethylidene-beta-D-glucopyranoside); EINECS 251-509-1; Epipodophyllotoxin VP-162" C29H32O13 VJJPUSNTGOMMGY-MRVIYFEKSA-N (5S,5aR,8aR,9R)-5-[[(2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-methyl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-9-(4-hydroxy-3,5-dimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[6,5-f][1,3]benzodioxol-8-one Bristol Myers Squibb Co Pharmaceutical Research Institute Anticancer Agents Yes Yes Yes Yes No No PMDBD1454 Ticarcillin Therapeutic substance Antibiotics 34787-01-4 DB01607 PA451684 n.a. DAP000458 36921 33876 n.a. "TICARCILLIN; 34787-01-4; Ticarcillinum; Ticarcilina; Ticarcilline; Ticarcilina [INN-Spanish]; Ticarcillinum [INN-Latin]; Ticarcilline [INN-French]; Ticar; CHEBI:9587; Ticarcillin [INN:BAN]; UNII-F93UJX4SWT; C15H16N2O6S2; EINECS 252-213-5; F93UJX4SWT; alpha-carboxy-3-thienylmethylpenicillin; BRL-2288; (2S,5R,6R)-6-{[(2R)-2-carboxy-2-thiophen-3-ylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1" C15H16N2O6S2 OHKOGUYZJXTSFX-KZFFXBSXSA-N (2S,5R,6R)-6-[[(2R)-2-carboxy-2-thiophen-3-ylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid n.a. n.a. Yes No No No No No PMDBD742 Ribavirin Therapeutic Substance Approved Drug 36791-04-5 DB00811 PA451241 D00423 DNC001210 37542 34439 n.a. "ribavirin; 36791-04-5; Tribavirin; Rebetol; Virazole; Copegus; Vilona; Ribavirine; Ribamide; Ribasphere; Ribamidil; Viramid; Ribamidyl; Rebetron; Varazid; RTCA; Ribavirin Capsules; Ribavirinum; Ribavirina; Ribavirinum [INN-Latin]; Ribavirine [INN-French]; ICN-1229; Ribavirina [INN-Spanish]; 1-beta-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide; 1-beta-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide; DRG-0028; SCH 18908; UNII-49717AWG6K; Ribavirin (Copegus)" C8H12N4O5 IWUCXVSUMQZMFG-AFCXAGJDSA-N 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,4-triazole-3-carboxamide Hoffmann-La Roche pharmaceutical company Antiviral Agents Yes No Yes No No No PMDBD111 Bezafibrate Therapeutic Substance Approved Drug 41859-67-0 DB01393 PA162364313 D01366 DAP001182 39042 35728 n.a. "bezafibrate; 41859-67-0; Bezalip; Cedur; Bezafibrat; Befizal; Sklerofibrat; Bezatol; Azufibrat; Bezafibratum; Bezafibrato; Bezafibratum [INN-Latin]; Bezafibrato [INN-Spanish]; Bezafibrato [Spanish]; Bezatol SR (TN); BM-15.075; BM 15075; LO 44; BF-759; 2-[4-[2-[(4-chlorobenzoyl)amino]ethyl]phenoxy]-2-methylpropanoic acid; UNII-Y9449Q51XH; Difaterol; CCRIS 9085; 2-(p-(2-(p-Chlorobenzamido)ethyl)phenoxy)-2-methylpropionic acid; BM 15.075; EINECS 255-567-9; C19H20ClNO4; BRN 4267656; BM-15075; MLS000028533; durabezur; CHEMBL264374; Reducterol" C19H20ClNO4 IIBYAHWJQTYFKB-UHFFFAOYSA-N 2-[4-[2-[(4-chlorobenzoyl)amino]ethyl]phenoxy]-2-methylpropanoic acid n.a. Antilipemic Agents No Yes No No No No PMDBD1307 Nadolol Therapeutic substance Drug 42200-33-9 DB01203 PA450573 D00432 DAP000122 39147 35815 n.a. "nadolol; 42200-33-9; Corgard; Solgol; (2R,3S)-5-(3-(tert-Butylamino)-2-hydroxypropoxy)-1,2,3,4-tetrahydronaphthalene-2,3-diol; Anabet; SQ-11725; (2R,3S)-5-[3-(tert-butylamino)-2-hydroxypropoxy]-1,2,3,4-tetrahydronaphthalene-2,3-diol; CHEMBL649; Nadololum [INN-Latin]; MLS000028580; SMR000058975; DSSTox_CID_3342; EN300-50860; DSSTox_RID_76983; DSSTox_GSID_23342; CCRIS 1048; HSDB 6532; EINECS 255-706-3; SR-01000000251; 2,3-Naphthalenediol, " C17H27NO4 VWPOSFSPZNDTMJ-UCWKZMIHSA-N (2R,3S)-5-[3-(tert-butylamino)-2-hydroxypropoxy]-1,2,3,4-tetrahydronaphthalene-2,3-diol n.a. n.a. No Yes No No No No PMDBD281 Diltiazem Therapeutic Substance Approved Drug 42399-41-7 DB00343 PA449334 D07845 DAP001262 39186 35850 n.a. "diltiazem; 42399-41-7; Cardizem; d-cis-Diltiazem; Endrydil; Anoheal; Dilticard; Dilcontin; Acalix; Dilzen; Dilta-Hexal; Dilt-cd; Incoril AP; Diltiazemum; Diltzac; Dilren; Cardil; Tiazac; (+)-diltiazem; Tiamate; Diltiazem [INN:BAN]; Diltiazemum [INN-Latin]; (+)-cis-diltiazem; Diltiazen; UNII-EE92BBP03H; HSDB 6528; CHEMBL23; EINECS 255-796-4; BRN 3573079; EE92BBP03H; (2S,3S)-5-(2-(dimethylamino)ethyl)-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]thiazepin-3-yl acetate; CHEBI:101278; (2S,3S)-5-[2-(dimethylamino)ethyl]-2-(4-methox" C22H26N2O4S HSUGRBWQSSZJOP-RTWAWAEBSA-N [(2S,3S)-5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-3-yl] acetate Valeant International Barbados Srl Antihypertensive Agents No Yes No Yes No No PMDBD1358 Permethrin Environmental Chemicals Pesticides 52645-53-1 DB04930 PA164743137 D05443 DAP001235 40326 36845 n.a. "Permethrin; 52645-53-1; Transpermethrin; Ambush; 1RS,cis-Permethrin; 1RS-trans-Permethrin; Transpermethrin [ISO]; Pounce; (+-)-cis-Permethrin; trans-(+-)-Permethrin; NRDC 148; NRDC 146; (+-)-trans-Permethrin; (+-)-cis-Fmc 33297; FMC 35171; Elimite; Kudos; UNII-509F88P9SZ; (3-phenoxyphenyl)methyl 3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropane-1-carboxylate; BRN 4153590; Permethrine; (+)-trans-Permethrin; Permetrina; Perthrine; Perigen; Dragnet; Ambushfog; Stomoxin; Stomoxi; Permasect; Kaleait; Ectiban; Corsair; Chinetrin; Acticin; Stomozan" C21H20Cl2O3 RLLPVAHGXHCWKJ-UHFFFAOYSA-N (3-phenoxyphenyl)methyl 3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropane-1-carboxylate n.a. n.a. Yes No No No No No PMDBD584 Nicardipine hydrochloride "Therapeutic Substance; Herbal Substance" "Approved Drug; Medicinal Herbal Compounds" n.a. n.a. n.a. n.a. n.a. 41114 n.a. NPC63370 "NICARDIPINE HYDROCHLORIDE; 54527-84-3; Nicardipine HCl; Cardene; Perdipine; Nicodel; Loxen; YC-93; Angioglebil; Bionicard; Nicardil; Perdipina; Lincil; Dagan; Nicardipine (Hydrochloride); Dafil; Cardene SR; YC-93 hydrochloride; RS-69216; RS-69216-XX-07-0; YC 93; EINECS 259-198-4; Nicardipine hydrochloride [USAN:JAN]; MLS000069782; 69441-18-5; SMR000058487; Cardene (TN); 3-{2-[benzyl(methyl)amino]ethyl} 5-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate hydrochloride; 2-(Benzylmethylamino)ethyl methyl 1,4-dih" C26H30ClN3O6 AIKVCUNQWYTVTO-UHFFFAOYSA-N "5-O-[2-[benzyl(methyl)amino]ethyl] 3-O-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate;hydrochloride" n.a. n.a. Yes No No No No No PMDBD1232 Idarubicin Therapeutic substance chemotherapeutic 58957-92-9 DB01177 PA449961 n.a. DAP000050 42890 39117 n.a. "IDARUBICIN; 58957-92-9; 4-Demethoxydaunorubicin; 4-Demethoxydaunomycin; Idarubicin Hcl; Idarubicina; Idamycin; Idarubicine [INN-French]; Idarubicinum [INN-Latin]; Idarubicina [INN-Spanish]; Idarubicin [INN:BAN]; IMI 30; UNII-ZRP63D75JW; IMI-30; CCRIS 5083; NSC 256439; NSC-256439; ZRP63D75JW; CHEBI:42068" C26H27NO9 XDXDZDZNSLXDNA-TZNDIEGXSA-N (7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione n.a. n.a. No Yes No No No No PMDBD162 Ceforanide Therapeutic Substance Approved Drug 60925-61-3 DB00923 PA164746057 D00259 DAP001175 43507 39656 n.a. "CEFORANIDE; 60925-61-3; Precef; Ceforanidum; Ceforanido; Ceforanidum [INN-Latin]; Ceforanido [INN-Spanish]; BL-S786; BL-S 786; Radacef; UNII-8M1YF8951V; C20H21N7O6S2; (6R,7R)-7-[[2-[2-(aminomethyl)phenyl]acetyl]amino]-3-[[1-(carboxymethyl)tetrazol-5-yl]sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; CHEBI:3495; 8M1YF8951V; 7-(o-(Aminomethyl)phenylacetamido)-3-(((1-(carboxymethyl)-1H-tetrazol-5-yl)thio)methyl)-3-cephem-4-carboxylic acid; (6R,7R)-7-(2-(alpha-Amino-o-tolyl)acetamido)-3-(((1-(carbo" C20H21N7O6S2 SLAYUXIURFNXPG-CRAIPNDOSA-N (6R,7R)-7-[[2-[2-(aminomethyl)phenyl]acetyl]amino]-3-[[1-(carboxymethyl)tetrazol-5-yl]sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid n.a. Antibiotics Yes No Yes No No No PMDBD1365 Piperacillin Therapeutic substance Antibiotics 66258-76-2 DB00319 PA450975 D00466 DAP001164 43672 39798 n.a. "piperacillin; Pipracil; 61477-96-1; Piperacillin anhydrous; Piperacilline; PIPERACILLIN SODIUM; PIPC; Piperacillin hydrate; Pipril; Cl-227193; Piperacillin [INN]; Piperacillin (INN); CHEBI:8232; CCRIS 7362; UNII-9I628532GX; (2S,5R,6R)-6-{[(2R)-2-{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; C23H27N5O7S; EINECS 262-811-8; CHEMBL702; T-1220; 9I628532GX; (2S,5R,6R)-6-[[(2R)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-phenylac" C23H27N5O7S IVBHGBMCVLDMKU-GXNBUGAJSA-N (2S,5R,6R)-6-[[(2R)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid n.a. n.a. Yes No No No No No PMDBD642 Paroxetine Therapeutic Substance Approved Drug 61869-08-7 DB00715 PA450801 D02362 DAP001428 43815 39888 n.a. "paroxetine; 61869-08-7; Paxil; Paxil CR; Paxetil; Seroxat; Frosinor; Paroxetinum; Paroxetina; Motivan; Casbol; Aropax; Paroxetinum [INN-Latin]; PaxPar; Paroxetina [INN-Spanish]; BRL 29060; FG 7051; Pexeva; Paroxetine [USAN:INN:BAN]; BRL-29060; (3S,4R)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine; UNII-41VRH5220H; (-)-(3S,4R)-4-(p-Fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine; (3s,4r)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine; [3H]Paroxetine; C19H20FNO3" C19H20FNO3 AHOUBRCZNHFOSL-YOEHRIQHSA-N (3S,4R)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine GlaxoSmithKline Antidepressants No Yes No Yes No No PMDBD143 Captopril Therapeutic Substance Approved Drug 62571-86-2 DB01197 PA448780 D00251 DAP000589 44093 40130 n.a. "captopril; 62571-86-2; Capoten; L-Captopril; Lopirin; Captopryl; Cesplon; Tensoprel; Captolane; Captoril; Dilabar; Acepress; Garranil; Tenosbon; Hypertil; Alopresin; Acepril; Lopril; Captoprilum; Aceplus; Acediur; (2S)-1-[(2S)-2-methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid; Tensobon; Isopresol; Apopril; Asisten; Captoprilum [INN-Latin]; SQ-14225; SQ 14225; D-2-Methyl-3-mercaptopropanoyl-L-proline; D-3-Mercapto-2-methylpropanoyl-L-proline; Lopirin [Switzerland]; SQ 14,225; 1-((2S)-3-Mercapto-2-methylpropionyl)-L-proline; SA 333" C9H15NO3S FAKRSMQSSFJEIM-RQJHMYQMSA-N (2S)-1-[(2S)-2-methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid Bristol-Myers Squibb Antihypertensive Agents No Yes No No No No PMDBD160 Cefoperazone Therapeutic Substance Approved Drug 62893-19-0 DB01329 PA448849 n.a. DAP000450 44185 40206 n.a. "Cefoperazonum [INN-Latin]; Cefoperazono [INN-Spanish]; Cefoperazon; Cefoperazone [INN:BAN]; C25H27N9O8S2; EINECS 263-749-4; BRN 0603333; (6R,7R)-7-((R)-2-(4-Ethyl-2,3-dioxo-1-piperazinylcarboxamido)-2-(4-hydroxyphenyl)acetamido)-3-((1-methyl-1H-tetrazol-5-yl)thiomethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-2-carbonsaeure; CP 52640; Epitope ID:174845; SCHEMBL16091123; BCP24490" C25H27N9O8S2 GCFBRXLSHGKWDP-WTKTZPJXSA-N (6R,7R)-7-[[2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid n.a. n.a. Yes Yes No No No No PMDBD1249 Latamoxef Therapeutic substance Antibiotics 64952-97-2 DB04570 PA164743144 D08109 DAP001181 47499 43215 n.a. "Latamoxef; moxalactam; Lamoxactam; 64952-97-2; Latamoxefum; Oxa-cephem; Festamoxin; LMOX; Latamoxefum [INN-Latin]; Moxam; Listeria mox supplement; Latamoxef [INN:BAN]; Shiomarin; CHEBI:599928; EINECS 265-287-9; S-6059; 1-Oxacephalosporin; Disodium Moxalactam; Lilly 127935; Latamoxef (INN); Ly127935; C20H20N6O9S; Spectrum_000971; Prestwick0_000819; Spectrum4_000064; Prestwick1_0" C20H20N6O9S JWCSIUVGFCSJCK-CAVRMKNVSA-N (6R,7R)-7-[[2-carboxy-2-(4-hydroxyphenyl)acetyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid n.a. n.a. Yes No No No No No PMDBD587 Nicorandil Therapeutic Substance Approved Drug 65141-46-0 DB09220 n.a. D01810 n.a. 47528 43240 n.a. "NICORANDIL; 65141-46-0; Ikorel; SG-75; Dancor; 2-Nicotinamidoethyl nitrate; Sigmart; Adancor; Nicorandilum; SG 75; 2-(nicotinamido)ethyl nitrate; N-(2-Hydroxyethyl)nicotinamide nitrate; Nicorandilum [INN-Latin]; 2-(pyridine-3-carbonylamino)ethyl nitrate; 2-(Nicotinamido)ethyl nitrat; N-(2-Hydroxyethyl)nicotinamide nitrate (ester); Nicorandil (Ikorel); UNII-260456HAM0; CHEBI:31905; EINECS 265-514-1; N-[2-(NITROOXY)ETHYL]-3-PYRIDINECARBOXAMIDE; BRN 0481451" C8H9N3O4 LBHIOVVIQHSOQN-UHFFFAOYSA-N 2-(pyridine-3-carbonylamino)ethyl nitrate "Chugai; Roche; Sanofi-Aventis; Merk KGaA; Pfizer; 3M Pharmaceutical" Vasodilator Agents Yes No Yes No No No PMDBD154 Cefadroxil Therapeutic Substance Approved Drug 50370-12-2 DB01140 PA448835 D00257 DAP000446 47965 43630 n.a. "cefadroxil; 50370-12-2; Cephadroxil; Cefadroxil anhydrous; D-Cefadroxil; Cefadroxilum; Cefadroxilo; Duricef; BL-S578; UNII-Q525PA8JJB; CHEBI:3479; (6R,7R)-7-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; CDX; Q525PA8JJB; Oracefal; Cefadroxilum [INN-Latin]; Cefadroxilo [INN-Spanish]; BL-S 578; S-578; S 578; DSSTox_CID_2749; Cefadroxil, 95-105%; DSSTox_RID_76714; DSSTox_GSID_22749" C16H17N3O5S BOEGTKLJZSQCCD-UEKVPHQBSA-N (6R,7R)-7-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Pharco B international Antibiotics Yes No No No No No PMDBD1083 Cefaclor Therapeutic substance Antibiotics 53994-73-3 DB00833 PA164749137 D00256 DAP000442 51039 46260 n.a. "cefaclor; 53994-73-3; Cephaclor; Ceclor; Cefaclor anhydrous; Cefaclorum; Kefral; Panoral; Raniclor; Cefaclorum [INN-Latin]; UNII-3Z6FS3IK0K; 3-Chloro-7-D-(2-phenylglycinamido)-3-cephem-4-carboxylic acid; Lilly 99638; S 6472; CHEBI:3478; CCL; Ceclor CD; 3Z6FS3IK0K; MLS000069617; Cefaclor, 96%; (6R,7R)-7-{[(2R)-2-amino-2-phenylacetyl]amino}-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; NCGC00022612-04; Alfacet; SMR000058250; DSSTox_CID_2748; DSSTox_RID_76713; DSSTox_GSID_22748; (6R,7R)-7-((R)-2-amino-2-phenylace" C15H14ClN3O4S QYIYFLOTGYLRGG-GPCCPHFNSA-N (6R,7R)-7-[[(2R)-2-amino-2-phenylacetyl]amino]-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid n.a. n.a. Yes No No No No No PMDBD1349 Pefloxacin Therapeutic substance Antibiotics 70458-92-3 DB00487 PA164742856 D02306 DAP001001 51081 46291 n.a. "Pefloxacin; 70458-92-3; Pefloxacine; Pefloxacino; Pefloxacinum; PFLX; Pefloxacin [INN-French]; Pefloxacinum [INN-Latin]; Pefloxacino [INN-Spanish]; 1-ethyl-6-fluoro-7-(4-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid; AM-725; 1584RB; UNII-2H52Z9F2Q5; EU-5306; EU 5306; C17H20FN3O3; EINECS 274-611-8; 1-ethyl-6-fluoro-7-(4-methylpiperazin-1-yl)-4-oxo-quinoline-3-carboxylic acid; 1589 RB; BRN 0567618; CHEBI:50199; 2H52Z9F2Q5; 1-Ethyl-6-fluoro-1,4-dihydro-7-(4-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid" C17H20FN3O3 FHFYDNQZQSQIAI-UHFFFAOYSA-N 1-ethyl-6-fluoro-7-(4-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid n.a. n.a. Yes No No No No No PMDBD164 Cefotetan Therapeutic Substance Approved Drug 69712-56-7 DB01330 PA164784033 D00260 DAP000451 53025 47904 n.a. "cefotetan; 69712-56-7; Cefotetanum; Cefotan; Cefotetanum [INN-Latin]; ICI 156834; MLS002153829; CHEBI:3499; ICI-156834; YM 09330; (6R,7S)-7-({[4-(2-amino-1-carboxy-2-oxoethylidene)-1,3-dithietan-2-yl]carbonyl}amino)-7-methoxy-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; SMR001233197; Cefotetan, 95-103%; 7beta-({[4-(2-amino-1-carboxy-2-oxoethylidene)-1,3-dithietan-2-yl]carbonyl}amino)-7alpha-methoxy-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-3,4-didehyd" C17H17N7O8S4 SRZNHPXWXCNNDU-RHBCBLIFSA-N (6R,7S)-7-[[4-(2-amino-1-carboxy-2-oxoethylidene)-1,3-dithietane-2-carbonyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid AstraZeneca Antibiotics Yes No Yes No No No PMDBD496 Lovastatin "Therapeutic Substance; Herbal Substance" lower the risk of cardiovascular disease 75330-75-5 DB00227 PA450272 D00359 DAP000551 53232 48085 NPC97577 "lovastatin; 75330-75-5; mevinolin; Mevacor; MK-803; Lovalord; Nergadan; Mevinacor; Altoprev; Artein; Lovalip; 6alpha-Methylcompactin; Hipovastin; Lovasterol; Paschol; Closterol; Teroltrat; Tecnolip; Rovacor; Cholestra; Rodatin; Lozutin; Lovastin; Lipofren; Lestatin; Hipolip; Colevix; Taucor; Lipdip; Belvas; Monacolin K; Lovastatine [French]; Lovastatinum [Latin]; Lovastatina [Spanish]; 6-alpha-Methylcompactin; Lovastatine; Altocor; Lipivas; Mevlor; Sivlor; MSD 803; MK 803; UNII-9LHU78OQFD; MLS000069585; HSDB 6534; 9LHU78OQFD; BRN 3631989; 2beta,6alpha-D" C24H36O5 PCZOHLXUXFIOCF-BXMDZJJMSA-N [(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate Atos Pharma Anticholesteremic Agents No Yes No Yes No No PMDBD783 Simvastatin "Therapeutic Substance; Herbal Substance" Cardiac drugs 79902-63-9 DB00641 PA451363 D00434 DAP001519 54454 49179 NPC36491 "simvastatin; 79902-63-9; Zocor; Synvinolin; Sinvacor; Denan; Lipex; MK-733; Sivastin; Lodales; Simvastatine; Simovil; Colemin; Cholestat; Medipo; Pantok; Simvastatina; Simvastatinum; Nivelipol; Labistatin; Rendapid; Velostatin; Vasotenal; Zocord; Corolin; Zorced; Coledis; Simvastatin lactone; Simvastatin (Zocor); Lipovas; Simvoget; Simvacor; Simcard; Simlup; Rechol; Simvastatinum [Latin]; Simvastatine [French]; Simvastatina [Spanish]; MK-0733; (1S,3R,7S,8S,8aR)-8-(2-((2R,4R)-4-Hydroxy-6-oxotetrahydro-2H-pyran-2-yl)ethyl)-3,7-dimethyl-1,2,3,7,8,8" C25H38O5 RYMZZMVNJRMUDD-HGQWONQESA-N [(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] 2,2-dimethylbutanoate Merck & Co Anticholesteremic Agents Yes Yes No No No No PMDBD1375 Pravastatin Therapeutic substance Drug 81093-37-0 DB00175 PA451089 D08410 DAP000550 54687 49398 n.a. "pravastatin; 81093-37-0; Pravastatinum; Pravastatine; Pravastatina; Pravachol; Eptastatin; PRAVASTATIN SODIUM; Pravastatin acid; Pravastatinum [Latin]; Pravastatine [French]; Pravastatina [Spanish]; Pravastatin [INN:BAN]; UNII-KXO2KT9N0G; CCRIS 7557; KXO2KT9N0G; CHEMBL1144; (3R,5R)-3,5-dihydroxy-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-{[(2S)-2-methylbutanoyl]oxy}-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid; (3R,5R)-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-[(2S)-2-methylbutanoyl]oxy-1,2,6,7,8,8a-hexahydronaphthale" C23H36O7 TUZYXOIXSAXUGO-PZAWKZKUSA-N (3R,5R)-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-[(2S)-2-methylbutanoyl]oxy-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid n.a. n.a. No Yes No No No No PMDBD1067 Cabergoline Therapeutic substance Drug 81409-90-7 DB00248 PA448708 D00987 DAP000251 54746 49452 n.a. "cabergoline; 81409-90-7; Dostinex; Cabaser; Cabaseril; Cabergolinum [Latin]; Cabergolina [Spanish]; Cabergolinum; Cabergolina; FCE-21336; UNII-LL60K9J05T; C26H37N5O2; 1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea; FCE 21336; BRN 6020775; LL60K9J05T; CHEBI:3286; Galastop; DSSTox_CID_2719; 1-ethyl-3-(3''-dimethylamionpropyl)-2-(6''-allylergoline-8''beta-carbonyl)urea; 1-[(6-allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea; (8R)-6-allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbam" C26H37N5O2 KORNTPPJEAJQIU-KJXAQDMKSA-N (6aR,9R,10aR)-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)-7-prop-2-enyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide n.a. n.a. No Yes No No No No PMDBD721 Quinapril Therapeutic Substance Approved Drug 85441-61-8 DB00881 PA451205 D03752 DAP000588 54892 49565 n.a. "quinapril; 85441-61-8; Quinaprilum [Latin]; Quinaprilum; Accupril; UNII-RJ84Y44811; CHEBI:8713; Accuretic; RJ84Y44811; (3S)-2-{N-((S)-1-Ethoxycarbonyl-3-phenylpropyl)-L-alanyl}-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid; Quinapril [INN:BAN]; Quinapril [USP:INN:BAN]; Quinapril (INN); Quinapril (Korec); Spectrum_001597; Spectrum3_001551; Spectrum2_000825; Spectrum5_001075; Spectrum4_00072" C25H30N2O5 JSDRRTOADPPCHY-HSQYWUDLSA-N (3S)-2-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-3,4-dihydro-1H-isoquinoline-3-carboxylic acid Pfizer Pharmaceuticals Antihypertensive Agents No Yes No Yes No No PMDBD549 Mifepristone Therapeutic Substance Approved Drug 84371-65-3 DB00834 PA450500 D00585 DAP000090 55245 49889 n.a. "mifepristone; 84371-65-3; Mifegyne; Mifeprex; RU-486; Korlym; Corlux; RU486; RU 486; Mifepriston; Mifepristonum [Latin]; Mifepristona [Spanish]; RU 38486; RU-38486; UNII-320T6RNW1F; Mifepristone [USAN:INN:BAN]; HSDB 6841; R 38486; BRN 5779404; RU 486-6; MLS000069785; 320T6RNW1F; VGX-410C; CHEBI:50692; VGX-410; Mifepristone, 98%; (8S,11R,13S,14S,17S)-11-(4-(dimethylamino)phenyl)-17-hydroxy-13-methyl-17-(prop-1-yn-1-yl)-1,2,6,7,8,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one; NCGC00025179-05; SMR000058481; DSSTox_CID" C29H35NO2 VKHAHZOOUSRJNA-GCNJZUOMSA-N (8S,11R,13S,14S,17S)-11-[4-(dimethylamino)phenyl]-17-hydroxy-13-methyl-17-prop-1-ynyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one HRA Pharma n.a. Yes Yes No Yes No No PMDBD463 Itraconazole Therapeutic Substance Approved Drug 84625-61-6 DB01167 PA450132 D00350 DAP000631 55283 49927 n.a. "itraconazole; 84625-61-6; Oriconazole; Sporanox; Sporanox (TN); Itrizole (TN); ITCZ; Itraconazole (Sporanox); Itraconazol [Spanish]; Itraconazolum [Latin]; cis-Itraconazole; 84604-65-9; DSSTox_CID_3180; DSSTox_RID_76908; DSSTox_GSID_23180; ITZ; A1-01739; C35H38Cl2N8O4; 1-(butan-2-yl)-4-{4-[4-(4-{[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-4,5-dihydro-1H-1,2,4-triazol-5-one; 2-butan-2-yl-4-[4-[4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-yl" C35H38Cl2N8O4 VHVPQPYKVGDNFY-ZPGVKDDISA-N 2-butan-2-yl-4-[4-[4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1,2,4-triazol-3-one n.a. n.a. Yes Yes No Yes No No PMDBD1207 Fosinopril Therapeutic substance Drug 98048-97-6 DB00492 PA449710 D00622 DAP000582 55891 7875352 n.a. "fosinopril; 98048-97-6; CHEBI:5163; (2S,4S)-4-cyclohexyl-1-(2-{[2-methyl-1-(propanoyloxy)propoxy](4-phenylbutyl)phosphoryl}acetyl)pyrrolidine-2-carboxylic acid; 474519-28-3; (2S,4S)-4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid; C30H46NO7P; (4S)-4-cyclohexyl-1-({[2-methyl-1-(propanoyloxy)propoxy](4-phenylbutyl)phosphoryl}acetyl)-L-proline; SR-05000001490; SCHEMBL15626; CHEMBL3306578; DTXSID1023079; HMS2089P08; HMS3715N21; (2S,4S)-4-cyclohexyl-1-[2-[[(1S" C30H46NO7P BIDNLKIUORFRQP-FKDWWROVSA-N (2S,4S)-4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid n.a. n.a. No Yes No No No No PMDBD765 Sarafloxacin Therapeutic Substance Approved Drug 98105-99-8 DB11491 n.a. n.a. n.a. 56208 50727 n.a. "Sarafloxacin; 98105-99-8; Sarafloxacinum; Sarafloxacino; Difloxacino; Sarafloxacine; Difloxacinum; Difloxacine; 6-fluoro-1-(4-fluorophenyl)-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid; Sarafloxacin [INN:BAN]; Difloxacinum [Latin]; Difloxacine [French]; Difloxacino [Spanish]; Abbott 57135; UNII-RC3WJ907XY; Sarafloxacine [INN-French]; Sarafloxacinum [INN-Latin]; Sarafloxacino [INN-Spanish]; HSDB 7035; RC3WJ907XY; Saraflox; 3-Quinolinecarboxylic acid, 6-fluoro-1-(4-fluorophenyl)-1,4-dihydro-4-oxo-7-(1-piperazin" C20H17F2N3O3 XBHBWNFJWIASRO-UHFFFAOYSA-N 6-fluoro-1-(4-fluorophenyl)-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid n.a. n.a. Yes No Yes No No No PMDBD1400 Ranolazine Therapeutic substance Drug 95635-55-5 DB00243 PA164746007 n.a. DAP000875 56959 51354 n.a. "RANOLAZINE; 95635-55-5; Ranexa; N-(2,6-dimethylphenyl)-2-(4-(2-hydroxy-3-(2-methoxyphenoxy)propyl)piperazin-1-yl)acetamide; CVT-303; Ranolazine (Ranexa); N-(2,6-dimethylphenyl)-2-[4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl]acetamide; 142387-99-3; RS-43285-003; CHEBI:87690; N-(2,6-dimethylphenyl)-2-{4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl}acetamide; CVT 303; C24H33N3O4; NCGC00015897-02; DSSTox_RID_80743; DSSTox_CID_25196; DSSTox_GSID_45196; (-)-Ranolazine; Ran4; Latixa; RAN D" C24H33N3O4 XKLMZUWKNUAPSZ-UHFFFAOYSA-N N-(2,6-dimethylphenyl)-2-[4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl]acetamide n.a. n.a. No Yes No No No No PMDBD352 Finasteride Therapeutic Substance Approved Drug 98319-26-7 DB01216 PA449627 D00321 DAP000045 57363 51714 n.a. "finasteride; 98319-26-7; Proscar; Propecia; Finastid; Prostide; Chibro-Proscar; MK-906; Finpecia; Finasteridum; Finasterida; Finasteridum [INN-Latin]; Finasterida [INN-Spanish]; MK 906; UNII-57GNO57U7G; MK-0906; MK 0906; CCRIS 7438; HSDB 6793; (5alpha,17beta)-(1,1-Dimethylethyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide; (1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-tert-butyl-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide; CHEMBL710; N-tert-Butyl-3-oxo-4-aza-5alpha-androst-1-en-17beta-carbox" C23H36N2O2 DBEPLOCGEIEOCV-WSBQPABSSA-N (1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-tert-butyl-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide Merck Antihyperplasia Agents No Yes No No No No PMDBD441 Imiquimod Therapeutic Substance Approved Drug 99011-02-6 DB00724 PA449972 D02500 DAP000278 57469 51809 n.a. "IMIQUIMOD; 99011-02-6; Aldara; Zyclara; 1-(2-methylpropyl)-1H-imidazo[4,5-c]quinolin-4-amine; Beselna; 1-isobutyl-1H-imidazo[4,5-c]quinolin-4-amine; 4-Amino-1-isobutyl-1H-imidazo[4,5-c]quinoline; R 837; 4-Amino-1-isobutyl-1H-imidazo(4,5-c)quinoline; R-837; 1-(2-methylpropyl)imidazo[4,5-c]quinolin-4-amine; S-26308; UNII-P1QW714R7M; S 26308; 9050-31-1; C14H16N4; MFCD00866946; CHEMBL1282; 1-isobutylimidazo[4,5-c]quinolin-4-amine; P1QW714R7M; 1-(2-Methylpropyl)-1H-imidazole[4,5" C14H16N4 DOUYETYNHWVLEO-UHFFFAOYSA-N 1-(2-methylpropyl)imidazo[4,5-c]quinolin-4-amine INova Pharmaceuticals Antiviral Agents Yes No No No No No PMDBD778 Sertindole Therapeutic Substance Approved Drug 106516-24-9 DB06144 PA164784002 D00561 DAP000832 60149 54229 n.a. "SERTINDOLE; 106516-24-9; SerLect; Serdolect; Sertindol; Lu 23-174; Sertindolum; Sertindolum [INN-Latin]; Sertindol [INN-Spanish]; Lu-23-174; UNII-GVV4Z879SP; 1-(2-{4-[5-chloro-1-(4-fluorophenyl)-1H-indol-3-yl]piperidin-1-yl}ethyl)imidazolidin-2-one; GVV4Z879SP; CHEMBL12713; CHEBI:9122; 1-[2-[4-[5-chloro-1-(4-fluorophenyl)-indol-3-yl]-1-piperidyl]ethyl]imidazolidin-2-one; 1-(2-(4-(5-Chloro-1-(p-fluorophenyl)indol-3-yl)piperidino)ethyl)-2-imidazolidinone; 1-(2-(4-(5-Chloro-1-(4-fluorophenyl)-1H-indole-3-yl)-1-piperidinyl)ethy" C24H26ClFN4O GZKLJWGUPQBVJQ-UHFFFAOYSA-N 1-[2-[4-[5-chloro-1-(4-fluorophenyl)indol-3-yl]piperidin-1-yl]ethyl]imidazolidin-2-one n.a. Antipsychotic Agents Yes No No No No No PMDBD1189 Exemestane Therapeutic substance Drug 107868-30-4 DB00990 PA449563 D00963 DAP000625 60198 54278 n.a. "EXEMESTANE; 107868-30-4; Aromasin; 6-Methyleneandrosta-1,4-diene-3,17-dione; Fce 24304; Exemestanum; Exemestano; Exemestanum [INN-Latin]; Exemestano [INN-Spanish]; FCE-24304; 6-Methylene-androsta-1,4-diene-3,17-dione; Exemestane [USAN:INN:BAN]; UNII-NY22HMQ4BX; HSDB 7463; FCE24304; 6-methylideneandrosta-1,4-diene-3,17-dione; Aromasine; NY22HMQ4BX; PNU-155971; CHEBI:4953; (8R,9S,10R,13S,14S)-10,13-dimethyl-6-methylene-7,8,9,10,11,12,13,14,15,16-decahydro-3H-cyclopenta[a]phenanthrene-3" C20H24O2 BFYIZQONLCFLEV-DAELLWKTSA-N (8R,9S,10R,13S,14S)-10,13-dimethyl-6-methylidene-7,8,9,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,17-dione n.a. n.a. No Yes No No No No PMDBD798 Sparfloxacin Therapeutic Substance Approved Drug 110871-86-8 DB01208 PA451472 D00590 DAP000161 60464 54517 n.a. "sparfloxacin; 110871-86-8; Zagam; AT-4140; CI-978; Spara; SPFX; CI 978; PD-131501; AT 4140; Sparfloxacinum [INN-Latin]; Sparfloxacine [INN-French]; DRG-0143; PD 131501; Esparfloxacino [INN-Spanish]; UNII-Q90AGA787L; CHEBI:9212; CP 103826; 111542-93-9; BRN 3658018; Q90AGA787L; Sparfloxacine; cis-5-Amino-1-cyclopropyl-7-(3,5-dimethyl-1-piperazinyl)-6,8-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid; 5-Amino-1-cyclopropyl-7-(cis-3,5-dimethyl-1-piperazinyl)-6,8-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid; Sparfloxacin" C19H22F2N4O3 DZZWHBIBMUVIIW-DTORHVGOSA-N 5-amino-1-cyclopropyl-7-[(3R,5S)-3,5-dimethylpiperazin-1-yl]-6,8-difluoro-4-oxoquinoline-3-carboxylic acid Square pharma Antibiotics Yes No Yes No No No PMDBD910 Zileuton Therapeutic Substance Approved Drug 111406-87-2 DB00744 PA451955 D00414 DAP000591 60490 54531 n.a. "ZILEUTON; 111406-87-2; Zyflo; Leutrol; 1-(1-(Benzo[b]thiophen-2-yl)ethyl)-1-hydroxyurea; Zyflo CR; Zileutonum; Abbott 64077; Zileutonum [INN-Latin]; N-(1-Benzo(b)thien-2-ylethyl)-N-hydroxyurea; A-64077; A 64077; 1-[1-(1-benzothiophen-2-yl)ethyl]-1-hydroxyurea; Zyflo (TN); ABBOTT-64077; CHEMBL93; 1-[1-(1-benzothien-2-yl)ethyl]-1-hydroxyurea; N-[1-(benzo[b]thiophen-2-yl)ethyl]-N-hydroxyurea; (+-)-1-(1-Benzo(b)thien-2-ylethyl)-1-hydroxyurea; (+/-)-1-(1-Benzo[b]thien-2-ylethyl)-1-hyd" C11H12N2O2S MWLSOWXNZPKENC-UHFFFAOYSA-N 1-[1-(1-benzothiophen-2-yl)ethyl]-1-hydroxyurea Cornerstone Therapeutics Inc Antiinflammatory Agents Yes Yes No No No No PMDBD1453 Tiagabine Therapeutic substance Drug 115103-54-3 DB00906 PA451682 n.a. DAP000164 60648 54661 n.a. "tiagabine; 115103-54-3; Gabitril; (R)-Tiagabine; Tiagabinum; Tiagabina; Tiagabinum [INN-Latin]; Tiagabina [INN-Spanish]; Tiagabine [INN:BAN]; Tiagabine [INN]; Abbott-70569; UNII-Z80I64HMNP; Tiagabine (INN); ABBOTT-70569-1; Gabitril (TN); CHEMBL1027; Z80I64HMNP; ABT-569; CHEBI:9586; NO-328; (-)-(R)-1-(4,4-Bis(3-methyl-2-thienyl)-3-butenyl)nipecotic acid; A-70569-1; Gabatril; NO 329; (3R)-1-[4,4-bis(3-methyl-2-thienyl)but-3-en-1-yl]piperidine-3-carboxylic acid; (3R)-1-[4,4-bis(3-methylthiophen-2-yl)but-3-en-1-yl]piperidine-3-carboxyl" C20H25NO2S2 PBJUNZJWGZTSKL-MRXNPFEDSA-N (3R)-1-[4,4-bis(3-methylthiophen-2-yl)but-3-enyl]piperidine-3-carboxylic acid n.a. n.a. No Yes No No No No PMDBD1465 Topotecan Therapeutic substance Drug 123948-87-8 DB01030 PA451729 D08618 DAP000648 60700 54705 n.a. "topotecan; 123948-87-8; Hycamtin; Topotecan lactone; Hycamptamine; Topotecane; Hycamtamine; Topotecanum; Topotecane [INN-French]; Topotecanum [INN-Latin]; (S)-Topotecan; Topotecan [INN:BAN]; SKF-104864-A; SK&F-104864-A; 9-Dimethylaminomethyl-10-hydroxycamptothecin; UNII-7M7YKX2N15; C23H23N3O5; NSC609699; CHEMBL84; Hycamtin (TN); 7M7YKX2N15; CHEBI:63632; SK-S-104864-A; (S)-10-[(DIMETHYLAMINO)METHYL]-4-ETH" C23H23N3O5 UCFGDBYHRUNTLO-QHCPKHFHSA-N (19S)-8-[(dimethylamino)methyl]-19-ethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione n.a. n.a. No Yes No No No No PMDBD384 Gemcitabine Therapeutic Substance chemotherapy 95058-81-4 DB00441 PA449748 D02368 DAP001246 60750 54753 n.a. "gemcitabine; 95058-81-4; 2''-Deoxy-2'',2''-difluorocytidine; 2'',2''-Difluorodeoxycytidine; GEMCITABINE HYDROCHLORIDE; Gamcitabine; DFdCyd; dFdC; UNII-B76N6SBZ8R; LY188011; Gemcitabinum [INN-Latin]; Gemcitabina [INN-Spanish]; 4-amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydropyrimidin-2-one; DDFC; 103882-84-4; B76N6SBZ8R; 2'',2''-difluoro-2''-deoxycytidine; 4-Amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one; CHEBI:175901; Gem" C9H11F2N3O4 SDUQYLNIPVEERB-QPPQHZFASA-N 4-amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one Eli Lilly Anticancer Agents Yes Yes Yes Yes No No PMDBD69 Aripiprazole Therapeutic Substance Approved Drug 129722-12-9 DB01238 PA10026 D01164 DAP000076 60795 54790 n.a. "Aripiprazole; 129722-12-9; Abilify; Abilitat; Abilify Discmelt; OPC-14597; aripiprazol; Discmelt; Opc 14597; OPC 31; OPC-31; 7-[4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butoxy]-3,4-dihydrocarbostyril; UNII-82VFR53I78; C23H27Cl2N3O2; 7-(4-(4-(2,3-DICHLOROPHENYL)PIPERAZIN-1-YL)BUTOXY)-3,4-DIHYDROQUINOLIN-2(1H)-ONE; HSDB 7320; CHEMBL1112; 7-(4-(4-(2,3-Dichlorophenyl)-1-piperazinyl)butyloxy)-3,4-dihydro-2(1H)-quinolinone; 7-(4-(4-(2,3-Dichlorophenyl)-1-piperazinyl)butoxy)-3,4-dihydro-2(1H)-quinolinone; 2(1H)-Quinolinone, 7-[4-[4-(" C23H27Cl2N3O2 CEUORZQYGODEFX-UHFFFAOYSA-N 7-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-3,4-dihydro-1H-quinolin-2-one "Bristol-Myers Squibb; Otsuka Pharmaceutical Co., Ltd" Antipsychotic Agents Yes Yes No No No No PMDBD78 Atorvastatin "Therapeutic Substance; Herbal Substance" "Approved Drug; Medicinal Herbal Compounds" 134523-00-5 DB01076 PA448500 D07474 DAP000553 60823 54810 NPC102008 "atorvastatin; 134523-00-5; Cardyl; Tozalip; Xavator; Lipitor; Torvast; Sotis; ATORVASTATIN CALCIUM; Atorvastatin [INN:BAN]; 110862-48-1; UNII-A0JWA85V8F; CCRIS 7159; C33H35FN2O5; HSDB 7039; Lipitor (TN); (3R,5R)-7-(2-(4-Fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoic acid; A0JWA85V8F; CHEMBL1487; (R-(R*,R*))-2-(4-Fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoic acid; CI 981; CHEBI:39548; (betaR,deltaR)-2-(p-Fluorophenyl)-b" C33H35FN2O5 XUKUURHRXDUEBC-KAYWLYCHSA-N (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid Pfizer Pharmaceuticals Anticholesteremic Agents No Yes No No No No PMDBD1246 Lamivudine Therapeutic substance Drug 134678-17-4 DB00709 PA450163 D00353 DAP000167 60825 54812 n.a. "lamivudine; 134678-17-4; Epivir; Zeffix; Heptovir; Epivir-HBV; Hepitec; Heptodin; 3TC; BCH-189; (-)-2''-Deoxy-3''-thiacytidine; 2'',3''-Dideoxy-3''-thiacytidine; 3''-Thia-2'',3''-dideoxycytidine; 4-amino-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one; GR109714X; GR-109714X; (-)-BCH-189; beta-L-2'',3''-Dideoxy-3''-thiacytidine; beta-L-3''-Thia-2'',3''-dideoxycytidine; (-)NGPB-21; (-)-BCH 189; 136891-12-8; UNII-2T8Q726O95; HSDB 7155; GR 109714X; (-)-1-((2R,5S)-2-(Hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine; 4-ami" C8H11N3O3S JTEGQNOMFQHVDC-NKWVEPMBSA-N 4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one n.a. n.a. No Yes No No No No PMDBD294 Duloxetine Therapeutic Substance Major Depressive Disorder. 116539-59-4 DB00476 PA10066 D01179 DAP000494 60835 54822 n.a. "duloxetine; 116539-59-4; (S)-Duloxetine; Cymbalta; Yentreve; DULOXETINE HYDROCHLORIDE; Duloxetine [INN:BAN]; (S)-N-Methyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propan-1-amine; LY 248686; UNII-O5TNM5N07U; Ariclaim; Xeristar; LY248686; HSDB 7368; Yentreve (TN); O5TNM5N07U; (S)-N-Methyl-gamma-(1-naphthalenyloxy)-2-thiophenepropanamine; CHEBI:36795; (3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine; (3S)-N-methyl-3-naphthalen-1-yloxy-3-thiophen-2-ylpropan-1-amine; LY-248686; methyl[(3S)-3-(naphthalen-1-yloxy)-3-(thiophe" C18H19NOS ZEUITGRIYCTCEM-KRWDZBQOSA-N (3S)-N-methyl-3-naphthalen-1-yloxy-3-thiophen-2-ylpropan-1-amine Eli Lilly Antidepressants No Yes No Yes No No PMDBD455 Irinotecan Therapeutic Substance antineoplastic enzyme inhibitor? 97682-44-5 DB00762 PA450085 D08086 DAP001339 60838 54825 n.a. "irinotecan; 97682-44-5; (+)-Irinotecan; Camptosar; Irinotecanum; Irinotecanum [INN-Latin]; Irinotecan lactone; Irinotecan mylan; Irinophore C; Irinotecan [INN:BAN]; CPT-11; Onivyde; HSDB 7607; CHEMBL481; UNII-7673326042; (S)-4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3'',4'':6,7]indolizino[1,2-b]quinolin-9-yl [1,4''-bipiperidine]-1''-carboxylate; CHEBI:80630; C33H38N4O6; (4S)-4,11-DIETHYL-4-HYDROXY-3,14-DIOXO-3,4,12,14-TETRAHYDRO-1H-PYRANO[3'',4'':6,7]INDOLIZINO[1,2-B]QUINOLIN-9-YL 1,4''-BIPIPERIDINE-1''-CARBOX" C33H38N4O6 UWKQSNNFCGGAFS-XIFFEERXSA-N [(19S)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl] 4-piperidin-1-ylpiperidine-1-carboxylate Pfizer Pharmaceuticals Anticancer Agents Yes Yes No Yes No No PMDBD887 Valsartan Therapeutic Substance Approved Drug 137862-53-4 DB00177 PA451848 D00400 DAP000363 60846 54833 n.a. "valsartan; 137862-53-4; Diovan; Tareg; Provas; CGP 48933; CGP-48933; Exforge; (S)-2-(N-((2''-(1H-Tetrazol-5-yl)-[1,1''-biphenyl]-4-yl)methyl)pentanamido)-3-methylbutanoic acid; UNII-80M03YXJ7I; N-(p-(o-1H-Tetrazol-5-ylphenyl)benzyl)-N-valeryl-L-valine; CHEMBL1069; (2S)-3-methyl-2-[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid; 80M03YXJ7I; CHEBI:9927; 137863-60-6; C24H29N5O3; N-(1-oxopentyl)-N-[[2''-(1H-tetrazol-5-yl)[1,1''-biphenyl]-4-yl]methyl]-L-valine; L-Valine, N-(1-oxopentyl)-N-[[2''-(2H-tetrazo" C24H29N5O3 ACWBQPMHZXGDFX-QFIPXVFZSA-N (2S)-3-methyl-2-[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid Norvatis Phamaceuticals Corporation Antihypertensive Agents No Yes No No No No PMDBD1495 Zolmitriptan Therapeutic substance Drug 139264-17-8 DB00315 PA451975 D00415 DAP000077 60857 54844 n.a. "zolmitriptan; 139264-17-8; Zomig; Zomigoro; Zomigon; Flezol; 311C90; Zomig-ZMT; Zomig ZMT; Zomig Nasal Spray; UNII-2FS66TH3YW; Zolmitriptan (Zomig); C16H21N3O2; (S)-4-[3-(2-Dimethylamino-ethyl)-1H-indol-5-ylmethyl]-oxazolidin-2-one; CHEMBL1185; 2FS66TH3YW; 4-((3-(2-(Dimethylamino)ethyl)-1H-indol-5-yl)methyl)-2-oxazolidinone; CHEBI:10124; (S)-4-((3-(2-(Dimethylamino)ethyl)indol-5-yl)methyl)-2-oxazolidinone; (S)-4-((3-(2-(dimethylamino)ethyl)-1H-indol-5-yl)methyl)oxazolidin-2-one; (S)-4-((3-(2-(Dimethylamino)ethyl)-1H-indol-5-yl" C16H21N3O2 ULSDMUVEXKOYBU-ZDUSSCGKSA-N (4S)-4-[[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl]-1,3-oxazolidin-2-one n.a. n.a. No Yes No No No No PMDBD1018 Adefovir Dipivoxil Therapeutic substance Drug 142340-99-6 DB00718 PA10005 D01655 DNC001135 60871 54855 n.a. "ADEFOVIR DIPIVOXIL; 142340-99-6; Hepsera; Preveon; Adefovir pivoxil; bis-POM PMEA; GS-0840; GS 840; GS 0840; GS-840; Adefovir dipivoxyl; [2-(6-aminopurin-9-yl)ethoxymethyl-(2,2-dimethylpropanoyloxymethoxy)phosphoryl]oxymethyl 2,2-dimethylpropanoate; UNII-U6Q8Z01514; C20H32N5O8P; Adefovir dipivoxil [USAN]; Adefovir dipivoxil (USAN); Adefovir di(pivaloyloxymethyl) ester; U6Q8Z01514; Adefovir Dipivoxil (Preveon, Hepsera); (((2-(6-Amino-9H-purin-9-yl)ethoxy)methyl)phosphinylidene)bis(oxymethylene) 2,2-dimethylpropanoate; NCGC00164" C20H32N5O8P WOZSCQDILHKSGG-UHFFFAOYSA-N [2-(6-aminopurin-9-yl)ethoxymethyl-(2,2-dimethylpropanoyloxymethoxy)phosphoryl]oxymethyl 2,2-dimethylpropanoate n.a. n.a. No Yes No No No No PMDBD1172 Emtricitabine Therapeutic substance Drug 143491-57-0 DB00879 PA10069 D01199 DAP001084 60877 54859 n.a. "Emtricitabine; 143491-57-0; Emtriva; Coviracil; (-)-FTC; 4-amino-5-fluoro-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one; 524W91; Racivir; dOTFC; BW-524W91; BW524W91; 2-FTC; (-)-2''-Deoxy-5-fluoro-3''-thiacytidine; FTC; BW 524W91; 2'',3'',5-FTC; 143491-54-7; UNII-G70B4ETF4S; DRG-0208; 2''-Deoxy-5-fluoro-3''-thiacytidine; BW 1592; CHEBI:31536; 3''-Thia-2''.3''-dideoxy-5-fluorocytidine; HSDB 7337; FTC-(-); 2''-Deoxy-5-fluoro-3''-oxa-4''-thiocytidine; 1-(2-(Hydroxymethyl)oxathiolan-5-yl)-5-fluorocytosine; 4-amino-5-fluoro-1-[(" C8H10FN3O3S XQSPYNMVSIKCOC-NTSWFWBYSA-N 4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one n.a. n.a. No Yes No No No No PMDBD141 Capecitabine Therapeutic Substance chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers.? 154361-50-9 DB01101 PA448771 D01223 DAP000761 60953 54916 n.a. "CAPECITABINE; 154361-50-9; Xeloda; Capecitabin; Captabin; 5''-deoxy-5-fluoro-N-[(pentyloxy)carbonyl]cytidine; Ro 09-1978; Ro 09-1978/000; UNII-6804DJ8Z9U; N(4)-Pentyloxycarbonyl-5''-deoxy-5-fluorocytidine; 5''-Deoxy-5-fluoro-N-((pentyloxy)carbonyl)cytidine; C15H22FN3O6; Pentyl 1-(5-deoxy-beta-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinecarbamate; Capiibine; Pentyl (1-((2R,3R,4S,5R)-3,4-dihydroxy-5-methyltetrahydrofuran-2-yl)-5-fluoro-2-oxo-1,2-dihydropyrimidin" C15H22FN3O6 GAGWJHPBXLXJQN-UORFTKCHSA-N pentyl N-[1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyloxolan-2-yl]-5-fluoro-2-oxopyrimidin-4-yl]carbamate Roche Anticancer Agents No Yes No Yes No No PMDBD434 Hypochlorite Therapeutic Substance Approved Drug 14380-61-1 DB11123 n.a. n.a. n.a. 61739 55632 n.a. "Hypochlorite; Hypochlorite ion; 14380-61-1; UNII-T5UM7HB19N; T5UM7HB19N; Hypochlorites; hypochloride; hypochorite; hypochiorite; Hypochlorit; oxidochlorate(1-); UN3212; Hypochlorous acidanion; Hypochlorite (8CI,9CI); ClO(-); DTXSID8073136; [ClO](-); CHEBI:29222; CTK0H5052; DB11123; HYPOCHLORITES, INORGANIC, N.O.S.; Q409049; Hypochlorites, inorganic, n.o.s. [UN3212] [Oxidizer]" ClO- WQYVRQLZKVEZGA-UHFFFAOYSA-N hypochlorite n.a. n.a. No Yes No No No No PMDBD1483 Trovafloxacin Therapeutic substance Antibiotics 147059-72-1 DB00685 PA164749184 n.a. DAP000652 62959 16736478 n.a. "Trovafloxacin; 147059-72-1; TVFX; Trovafloxacin [INN]; UNII-9F388J00UK; Trovafloxacin (INN); 7-[(1R,5S,6s)-6-amino-3-azabicyclo[3.1.0]hex-3-yl]-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid; CP-99219; CHEBI:9763; C20H15F3N4O3; 9F388J00UK; Trovan (oral); 7-[(1S,5R)-6-amino-3-azabicyclo[3.1.0]hexan-3-yl]-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid; Fluorinated quinolone; CP-99,219; trovafloxacine; trovafloxacinum; trovafloxacino; TR6" C20H15F3N4O3 WVPSKSLAZQPAKQ-SOSAQKQKSA-N 7-[(1R,5S)-6-amino-3-azabicyclo[3.1.0]hexan-3-yl]-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid n.a. n.a. Yes No No No No No PMDBD298 Efavirenz Therapeutic Substance Approved Drug 154598-52-4 DB00625 PA449441 D00896 DAP000709 64139 57715 n.a. "efavirenz; 154598-52-4; Sustiva; Stocrin; DMP-266; DMP 266; EFV; (4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one; UNII-JE6H2O27P8; L 743726; HSDB 7163; (4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-1H-3,1-benzoxazin-2-one; (4S)-6-Chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one; L-743,726; (-)-6-CHLORO-4-CYCLOPROPYLETHYNYL-4-TRIFLUOROMETHYL-1,4-DIHYDRO-2H-3,1-BENZOXAZIN-2-ONE" C14H9ClF3NO2 XPOQHMRABVBWPR-ZDUSSCGKSA-N (4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-1H-3,1-benzoxazin-2-one n.a. Anti-HIV Agents Yes Yes Yes No No Yes EFV_GLC_GLCAASE,EFV_GLC_GLCAASEe,EFV_GLC_GLCAASEepp,EFVte,EFVtepp,EFVtex,EX_efv(e) PMDBD547 Mevastatin Therapeutic Substance Approved Drug 73573-88-3 DB06693 n.a. n.a. n.a. 64715 58262 n.a. "Mevastatin; compactin; 73573-88-3; ML-236B; Mevastatine; Mevastatinum; Mevastatina; Mevastatinum [INN-Latin]; Antibiotic ML 236B; Mevastatin [INN]; CS 500; Compactin (penicillium); Mevastatine [INN-French]; UNII-1UQM1K0W9X; ML 236 B; Mevastatina [INN-Spanish]; CCRIS 4505; Mevastatin (Compactin); [(1S,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-7-methyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate; 1UQM1K0W9X; CHEMBL54440; CHEBI:34848; Compactin, Mevastatinum, Mevastatina; ML236B; Compactin;ML236B; 7-(1" C23H34O5 AJLFOPYRIVGYMJ-INTXDZFKSA-N [(1S,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-7-methyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate n.a. n.a. No Yes No No No No PMDBD95 Baicalin Herbal Substance anti-inflammatory n.a. n.a. n.a. n.a. n.a. 64982 n.a. NPC237435 "Baicalin; 21967-41-9; Baicalein 7-O-glucuronide; 7-D-Glucuronic acid-5,6-dihydroxyflavone; Baicalein-7-O-glucuronide; CHEMBL485818; CHEBI:2981; UNII-347Q89U4M5; 5,6-dihydroxy-4-oxo-2-phenyl-4H-chromen-7-yl beta-D-glucopyranosiduronic acid; 347Q89U4M5; (2S,3S,4S,5R,6S)-6-((5,6-dihydroxy-4-oxo-2-phenyl-4H-chromen-7-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid; 5,6,7-trihydroxyflavone 7-O-beta-D-glucuronide; BAICAILIN; beta-D-Glucopyranosiduronic acid, 5,6-dihydroxy-4-oxo-2-phenyl-4H-1-benzopyran-7-yl; 3156" C21H18O11 IKIIZLYTISPENI-ZFORQUDYSA-N (2S,3S,4S,5R,6S)-6-(5,6-dihydroxy-4-oxo-2-phenylchromen-7-yl)oxy-3,4,5-trihydroxyoxane-2-carboxylic acid n.a. n.a. No Yes No No No No PMDBD772 Secoisolariciresinol Therapeutic Substance anticancer 29388-59-8 DB12179 n.a. n.a. n.a. 65373 58845 n.a. "Secoisolariciresinol; 29388-59-8; (-)-Secoisolariciresinol; UNII-M8QRJ7JEJH; CCRIS 7790; M8QRJ7JEJH; EINECS 249-599-2; CHEMBL368347; CHEBI:65004; (2R,3R)-2,3-bis[(4-hydroxy-3-methoxyphenyl)methyl]butane-1,4-diol; (2R,3R)-2,3-bis(4-hydroxy-3-methoxybenzyl)butane-1,4-diol; (R-(R*,R*))-2,3-Bis((4-hydroxy-3-methoxyphenyl)methyl)butane-1,4-diol; RR-secoisolariciresinol; (-) secoisolariciresinol; (+/-)-Secoisolariciresinol; 8R,8''R-secoisolariciresinol; MLS001424213; BIDF1039; SCHEMBL12427083; CTK4C5737; DTXSID50183615; HMS2052G03; HMS" C20H26O6 PUETUDUXMCLALY-HOTGVXAUSA-N (2R,3R)-2,3-bis[(4-hydroxy-3-methoxyphenyl)methyl]butane-1,4-diol n.a. n.a. No Yes No Yes Yes No rxn25065,rxnDiet204,rxnAdd200,rxnAdd201 PMDBD1295 Milnacipran Therapeutic substance Drug 92623-85-3 DB04896 PA164752812 D08222 DAP001155 65833 9797657 n.a. "Milnacipran; 92623-85-3; Milnacipranum [Latin]; Midalcipran; Ixel; UNII-ES1O38J3C4; Milnacipran [INN]; F 2207; (1R,2S)-2-(aminomethyl)-N,N-diethyl-1-phenylcyclopropane-1-carboxamide; ES1O38J3C4; Milnacipran (INN); Dalcipran; (+-)-Milnacipran; Milnacipran HCl; 96847-55-1; F2207; Milnacipranum; Milnace; Dextromilnacipran; (1R,2S)-2-(aminomethyl)-N,N-diethyl-1-phenylcyclopropanecarboxamide; (+-)-cis-2-(Aminomethyl)-N,N-diethyl-1-phenylcyclopropanecarboxamid" C15H22N2O GJJFMKBJSRMPLA-HIFRSBDPSA-N (1R,2S)-2-(aminomethyl)-N,N-diethyl-1-phenylcyclopropane-1-carboxamide n.a. n.a. No Yes No No No No PMDBD669 Pidotimod Therapeutic Substance Approved Drug 121808-62-6 DB11364 n.a. D07261 n.a. 65944 59348 n.a. "Pidotimod; 121808-62-6; (R)-3-((S)-5-Oxopyrrolidine-2-carbonyl)thiazolidine-4-carboxylic acid; PGT/1A; Pidotomod; Pidotimod [INN]; Pidotimodum [INN-Latin]; CCRIS 7271; UNII-785363R681; BRN 6636310; Pidotimod (INN); NCGC00160516-01; (R-(R*,S*))-3-((5-Oxo-2-pyrrolidinyl)carbonyl)-4-thiazolidinecarboxylic acid; (R)-3-((S)-(5-Oxo-2-pyrrolidinyl)carbonyl)-thiazolidin-4-carbonsaeure [German]; 785363R681; C9H12N2O4S; (R)-3-((S)-5-Oxoprolyl)-4-thiazolidinecarboxylic acid; Pidotimodum; Polimod; Pigitil; (4R)-3-[oxo-[(2S)-5-oxo-2-pyrrol" C9H12N2O4S UUTKICFRNVKFRG-WDSKDSINSA-N (4R)-3-[(2S)-5-oxopyrrolidine-2-carbonyl]-1,3-thiazolidine-4-carboxylic acid n.a. n.a. No Yes No Yes No No PMDBD738 Repaglinide Therapeutic Substance Approved Drug 135062-02-1 DB00912 PA451234 D00594 DAP000133 65981 59377 n.a. "Repaglinide; 135062-02-1; Prandin; NovoNorm; GlucoNorm; AG-EE 623 ZW; Repaglinidum [INN-Latin]; Repaglinida [INN-Spanish]; AG-EE 388 ZW; (S)-2-Ethoxy-4-(2-((3-methyl-1-(2-(piperidin-1-yl)phenyl)butyl)amino)-2-oxoethyl)benzoic acid; AGEE-623ZW; UNII-668Z8C33LU; C27H36N2O4; (S)-(+)-2-Ethoxy-4-[N-[1-(2-piperidinophenyl)-3-methyl-1-butyl]aminocarbonylmethyl]benzoic acid; CHEMBL1272; 2-ethoxy-4-[2-[[(1S)-3-methyl-1-(2-piperidin-1-ylphenyl)butyl]amino]-2-oxoethyl]benzoic acid; CHEBI:8805; 668Z8C33LU" C27H36N2O4 FAEKWTJYAYMJKF-QHCPKHFHSA-N 2-ethoxy-4-[2-[[(1S)-3-methyl-1-(2-piperidin-1-ylphenyl)butyl]amino]-2-oxoethyl]benzoic acid Novo Nordisk Hypoglycemic Agents No Yes No No No Yes EX_rep(e),REP_GLC_GLCAASE,REP_GLC_GLCAASEe,REP_GLC_GLCAASEepp,REPte,REPtepp,REPtex PMDBD828 Telmisartan Therapeutic Substance Approved Drug 144701-48-4 DB00966 PA451605 D00627 DAP000766 65999 59391 n.a. "Telmisartan; 144701-48-4; Micardis; Pritor; BIBR 277; Kinzalmono; BIBR-277; 4''-((1,7''-Dimethyl-2''-propyl-1H,3''H-[2,5''-bibenzo[d]imidazol]-3''-yl)methyl)-[1,1''-biphenyl]-2-carboxylic acid; BIBR 277SE; Telmisattan; Telmisartan [INN]; UNII-U5SYW473RQ; 4''-[(1,7''-dimethyl-2''-propyl-1H,3''H-2,5''-bibenzimidazol-3''-yl)methyl]biphenyl-2-carboxylic acid; BIBR-277SE; BIBR-277-SE; 2-[4-[[4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propylbenzimidazol-1-yl]methyl]phenyl]benzoic acid; CHEMBL1017; U5SYW473RQ; CHEBI:9434; 4''-((4-Methyl-6-(1-methyl" C33H30N4O2 RMMXLENWKUUMAY-UHFFFAOYSA-N 2-[4-[[4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propylbenzimidazol-1-yl]methyl]phenyl]benzoic acid Boehringer Ingelheim Antihypertensive Agents Yes Yes Yes No No Yes EX_tlms(e),TLMS_GLC_GLCAASE,TLMS_GLC_GLCAASEe,TLMS_GLC_GLCAASEepp,TLMSte,TLMStepp,TLMStex PMDBD779 Sertraline "Therapeutic Substance; Herbal Substance" "Approved Drug; Medicinal Herbal Compounds" 79617-96-2 DB01104 PA451333 D02360 DAP000051 68617 61881 NPC320656 "sertraline; 79617-96-2; (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine; (+)-Sertraline; Sertralina; Sertralinum; Sertralinum [Latin]; Sertralina [Spanish]; Zoloft; Sertraline [INN:BAN]; Lustral; Cp 51974; UNII-QUC7NX6WMB; sertraline (Zoloft); Sertraline [Zoloft]; (1S-cis)-1,2,3,4-Tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine; cis-(+)-sertraline; HSDB 7037; (1S,4S)-sertraline; QUC7NX6WMB; CHEMBL809; BRN 5753709; CHEBI:9123; TBA-2010_Sertraline_1; 1-Naphthalenamine, 4-(3,4-dichlorophenyl)" C17H17Cl2N VGKDLMBJGBXTGI-SJCJKPOMSA-N (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine Pfizer Inc Antidepressants Yes Yes No No No No PMDBD71 Artemisinin "Therapeutic Substance; Herbal Substance" "Approved Drug; Medicinal Herbal Compounds" 63968-64-9 DB13132 PA165111696 n.a. n.a. 68827 62060 NPC260977 "artemisinin; Qinghaosu; 63968-64-9; Artemisinine; Arteannuin; Artemisine; (+)-Artemisinin; Huanghuahaosu; Artemisinina; Artemisininum; Qinghosu; Quing Hau Sau; Qing Hau SU; Artemisinin [INN]; Qinghaosu [Chinese]; Artemisinine [French]; Artemisininum [Latin]; Artemisinina [Spanish]; Qing Hau Sau [Chinese]; UNII-9RMU91N5K2; Artemisia annua L., extract; NSC 369397; Qing Hau Sau; CHEBI:223316; BRN 4194670; Octahydro-3,6,9-trimethyl-3,12-epoxy-12H-pyrano(4,3-j)-1,2-benzodioxepin-10(3H)-one; 9RMU91N5K2; C15H22O5; Astemisinin" C15H22O5 BLUAFEHZUWYNDE-NNWCWBAJSA-N (1R,4S,5R,8S,9R,12S,13R)-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadecan-10-one n.a. n.a. Yes Yes No Yes No No PMDBD1158 Dienogest Therapeutic substance Drug 65928-58-7 DB09123 n.a. n.a. n.a. 68861 62093 n.a. "Dienogest; 65928-58-7; Dienogestrel; Dienogestril; Dinagest; Dienogestum; Endometrion; Natazia; STS 557; Visanne; STS-557; Dienogestum [Latin]; UNII-46M3EV8HHE; MJR-35; 17alpha-17-Hydroxy-3-oxo-19-norpregna-4,9-diene-21-nitrile; BAY86-5258; BAY 86-5258; 46M3EV8HHE; 2-[(8S,13S,14S,17R)-17-hydroxy-13-methyl-3-oxo-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl]acetonitrile; CHEBI:70708; 17-alpha-Cyanomethyl-17-beta-hydroxy-estra-4,9(10)-dien-3-one; 17-alpha-Cyanomethyl-17-beta-hydroxyestra-4,9(10)-diene-3-one" C20H25NO2 AZFLJNIPTRTECV-FUMNGEBKSA-N 2-[(8S,13S,14S,17R)-17-hydroxy-13-methyl-3-oxo-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl]acetonitrile n.a. n.a. No Yes No No No No PMDBD293 Drospirenone Therapeutic Substance Approved Drug 67392-87-4 DB01395 PA164749409 D03917 DAP001206 68873 62105 n.a. "Drospirenone; 67392-87-4; Dihydrospirorenone; Dehydrospirorenone; Drospirenona; 1,2-Dihydrospirorenone; Drospirenonum; DRSP; Drospirenonum [INN-Latin]; Drospirenona [INN-Spanish]; ZK 30595; ZK30595; CCRIS 6523; UNII-N295J34A25; EINECS 266-679-2; BRN 4765500; ZK-30595; CHEBI:50838; N295J34A25; DSSTox_RID_81639; 6-beta,7-beta;15-beta,16-beta-Dimethylene-3-oxo-17-alpha-pregn-4-ene-21,17-carbolactone; DSSTox_CID_26465; DSSTox_GSID_46465; (6R,7R,8R,9S,10R,13S,14S,15S,16S,17S)-1,3'',4'',6,6a,7,8,9,10,11,12,13,14,15,15a,16-Hexadecahydro-1" C24H30O3 METQSPRSQINEEU-HXCATZOESA-N (1R,2R,4R,10R,11S,14S,15S,16S,18S,19S)-10,14-dimethylspiro[hexacyclo[9.8.0.02,4.05,10.014,19.016,18]nonadec-5-ene-15,5''-oxolane]-2'',7-dione n.a. Contraceptive Agents No Yes No No No No PMDBD1042 Artemether Therapeutic substance Drug 71963-77-4 DB06697 PA165111698 D02483 n.a. 68911 62138 n.a. "Artemether; beta-Artemether; 71963-77-4; Dihydroartemisinin methyl ether; Artemisininelactol methyl ether; Methyl-dihydroartemisinine; Artemetherum; Artemetero; beta-Dihydroartemisinin methyl ether; SM 224; Artemetheri; Artemetherum [INN-Latin]; Artemetero [INN-Spanish]; Dihydroquinghaosu methyl ether; HSDB 7456; CHEBI:195280; NSC 665970; Artenam; CPD000469218; Artemos; Artemether Labeled d3; SM-224; (1R,4S,5R,8S,9R,10S,12R,13R)-10-methoxy-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.0^{4,13}.0^{8,13}]hexadecane; C16H26O" C16H26O5 SXYIRMFQILZOAM-HVNFFKDJSA-N (1R,4S,5R,8S,9R,10S,12R,13R)-10-methoxy-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadecane n.a. n.a. No Yes No No No No PMDBD1312 Nebivolol Therapeutic substance Drug 118457-14-0 DB04861 PA151958426 D05127 DAP000942 71301 64421 n.a. "Nebivolol; 99200-09-6; Nebivololum [Latin]; 2,2''-Azanediylbis(1-(6-fluorochroman-2-yl)ethanol); Dexnebivolol; CHEBI:64019; 2,2''-iminobis[1-(6-fluoro-3,4-dihydro-2H-chromen-2-yl)ethanol]; Nebivolol [USAN:INN:BAN]; 118457-14-0; R-65824; C22H25F2NO4; R65,824; 118457-16-2; alpha,alpha''-(Iminobis(methylene))bis(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol); (1R)-1-[(2S)-6-fluoro-3,4-dihydro-2H-chromen-2-yl]-2-[[(2R)-2-[(2S)-6-fluoro-3,4" C22H25F2NO4 KOHIRBRYDXPAMZ-UHFFFAOYSA-N 1-(6-fluoro-3,4-dihydro-2H-chromen-2-yl)-2-[[2-(6-fluoro-3,4-dihydro-2H-chromen-2-yl)-2-hydroxyethyl]amino]ethanol n.a. n.a. No Yes No No No No PMDBD1165 Dofetilide Therapeutic substance Drug 115256-11-6 DB00204 PA449389 D00647 DAP000495 71329 64435 n.a. "Dofetilide; 115256-11-6; Tikosyn; Dofetilida; Dofetilidum; Dofetilidum [INN-Latin]; Dofetilida [INN-Spanish]; UK 68798; UK-68798; Dofetilide (Tikosyn); UK-68,798; UNII-R4Z9X1N2ND; UK 68,798; C19H27N3O5S2; beta-((p-Methanesulfonamidophenethyl)methylamino)methanesulfono-p-phenetidide; 1-(4-Methanesulphonamidophenoxy)-2-[N-(4-methanesulphonamidophenethyl)-N-methylamino]ethane; CHEMBL473; R4Z9X1N2ND; CHEBI:4681; N-[4-[2-[Methyl[2-[4-[(methylsulfonyl)amino]phenoxy]ethyl]amino]ethyl]phenyl]methanesulfonamide; NCGC00164549-01; DSSTox_" C19H27N3O5S2 IXTMWRCNAAVVAI-UHFFFAOYSA-N N-[4-[2-[2-[4-(methanesulfonamido)phenoxy]ethyl-methylamino]ethyl]phenyl]methanesulfonamide n.a. n.a. No Yes No No No No PMDBD1233 Iloperidone Therapeutic substance Drug 133454-47-4 DB04946 PA161199368 D02666 n.a. 71360 64459 n.a. "Iloperidone; 133454-47-4; Zomaril; Fanapt; Fanapta; HP 873; HP-873; Iloperidone (Fanapt); UNII-VPO7KJ050N; 4''-(3-(4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidino)propoxy)-3''-methoxyacetophenone; C24H27FN2O4; VPO7KJ050N; CHEMBL14376; 1-(4-(3-(4-(6-Fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl)propoxy)-3-methoxyphenyl)ethanone; CHEBI:65173; 1-[4-[3-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]propoxy]-3-methoxyphenyl]ethanone; NCGC00188864-01; 1-[4-[3-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]propoxy]-3-methoxyphenyl]eth" C24H27FN2O4 XMXHEBAFVSFQEX-UHFFFAOYSA-N 1-[4-[3-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]propoxy]-3-methoxyphenyl]ethanone n.a. n.a. No Yes No No No No PMDBD899 Voriconazole Therapeutic Substance Approved Drug 137234-62-9 DB00582 PA10233 D00578 DAP001271 71616 64684 n.a. "Voriconazole; 137234-62-9; Vfend; (2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol; UK-109496; UK 109496; Voriconazole [USAN:INN:BAN]; UNII-JFU09I87TR; DRG-0301; UK-109,496; (2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1,2,4-triazol-1-yl)butan-2-ol; VCZ; CHEMBL638; JFU09I87TR; CPD000466350; (R-(R*,S*))-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol; CHEBI:10023; C16H14F3N5O; 4-Pyrimidineethanol, alpha-(2,4-di" C16H14F3N5O BCEHBSKCWLPMDN-MGPLVRAMSA-N (2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1,2,4-triazol-1-yl)butan-2-ol Pfizer Antifungal Agents Yes Yes No No No No PMDBD771 Secnidazole Therapeutic Substance Approved Drug 3366-95-8 DB12834 n.a. n.a. n.a. 71815 64839 n.a. "Secnidazole; 3366-95-8; Secnidazol; Flagentyl; Secnidazolum; Secnidazolum [INN-Latin]; RP 14539; PM 185184; Secnidazol [INN-Spanish]; 1-(2-methyl-5-nitro-1H-imidazol-1-yl)propan-2-ol; 1-(2-Methyl-5-nitro-1-imidazolyl)-2-propanol; 1-(2-Methyl-5-nitro-imidazol-1-yl)-propan-2-ol; PM-185184; Secnidazole (Flagentyl); SYM-1219; EINECS 222-134-0; RP-14539; MLS000559043; 1-(2-Hydroxypropyl)-2-methyl-5-nitroimidazol; 1-(2-methyl-5-nitroimidazol-1-yl)propan-2-ol; NCGC00095158-01; SMR000149359; alpha,2-Dimethyl-5-nitroimidazole-1-ethanol" C7H11N3O3 KPQZUUQMTUIKBP-UHFFFAOYSA-N 1-(2-methyl-5-nitroimidazol-1-yl)propan-2-ol Lupin n.a. Yes No Yes No No No PMDBD308 Epicatechin Therapeutic Substance Investigational Drug 490-46-0 DB12039 n.a. n.a. n.a. 72276 65230 n.a. "(-)-Epicatechin; Epicatechin; 490-46-0; L-Epicatechin; (-)-Epicatechol; l-Acacatechin; epi-Catechin; Epicatechol; (2R,3R)-2-(3,4-Dihydroxyphenyl)chroman-3,5,7-triol; l-Epicatechol; (2R,3R)-(-)-Epicatechin; UNII-34PHS7TU43; epi-Catechol; CCRIS 7097; EINECS 207-710-1; NSC 81161; CHEBI:90; (-)epicatechin; 34PHS7TU43; 2-(3,4-Dihydroxyphenyl)-2,3,4-trihydro-3,5,7-trihydroxychromene; (2R,3R)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol; NSC81161; (2R,3R)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-1-benzopy" C15H14O6 PFTAWBLQPZVEMU-UKRRQHHQSA-N (2R,3R)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol n.a. n.a. No Yes No No No No PMDBD775 Sennoside A Herbal Substance Medicinal Herbal Compounds n.a. n.a. n.a. n.a. n.a. 73111 n.a. NPC76112 "Sennoside A; 81-27-6; Senna extract; Senokot; UNII-2F1O30GVXH; NSC 112929; EINECS 201-339-9; 2F1O30GVXH; CHEBI:9112; 8013-11-4; C42H38O20; sennoside; Sennoside-A; SENNA; Glaxenna; Sennalax; Gentlax; Senolax; Dosaflex; Moivat; Exprep; Amyran; Senan; Sennae folium; Black Draught; NSC112929; Tisasen A; Senna (powdered); Sennoside A, G; NCGC00095095-01; GLYSENNIDE; Sennoside A;sennoside A; DSSTox_CID_3576; Se" C42H38O20 IPQVTOJGNYVQEO-KGFNBKMBSA-N (9R)-9-[(9R)-2-carboxy-4-hydroxy-10-oxo-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-9H-anthracen-9-yl]-4-hydroxy-10-oxo-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-9H-anthracene-2-carboxylic acid n.a. n.a. No Yes No No No No PMDBD79 Atovaquone Therapeutic Substance Approved Drug 95233-18-4 DB01117 PA448502 D00236 DAP000156 74989 10482034 n.a. "ATOVAQUONE; 95233-18-4; Mepron; Wellvone; Acuvel; Atavaquone; 566C80; Mepron (antipneumocystic); cis-Atovaquone; BW 566C; 566C; 94015-53-9; Atovaquone (Atavaquone); DRG-0084; 137732-39-9; 2-(trans-4-(p-Chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone; UNII-Y883P1Z2LT; C22H19ClO3; BW 566C-80; HSDB 7083; 3-[4-(4-chlorophenyl)cyclohexyl]-4-hydroxynaphthalene-1,2-dione; 2-[trans-4-(4-chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthoquinone; 2-(TRANS-4-(4-CHLOROPHENYL)CYCLOHEXYL)-3-HYDROXY-1,4-NAPHTHALENEDIONE; Y883P1Z2LT; CHEBI:5755" C22H19ClO3 BSJMWHQBCZFXBR-UHFFFAOYSA-N 3-[4-(4-chlorophenyl)cyclohexyl]-4-hydroxynaphthalene-1,2-dione GlaxoSmithKline Antifungal Agents Yes Yes No No No No PMDBD1407 Rosiglitazone Therapeutic substance Anti-diabetics 122320-73-4 DB00412 PA451283 D00596 DAP000271 77999 70383 n.a. "rosiglitazone; 122320-73-4; Avandia; Brl-49653; 5-(4-(2-(Methyl(pyridin-2-yl)amino)ethoxy)benzyl)thiazolidine-2,4-dione; Rosiglizole; Brl 49653; rosiglitazone (Avandia); BRL49653; Avandaryl; TDZ 01; Rosiglitazone [INN:BAN]; Avandamet; C18H19N3O3S; CHEBI:50122; Rosigilitazone; 5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]phenyl]methyl]-2,4-thiazolidinedione; 5-((4-(2-Methyl-2-(pyridinylamino)ethoxy)phenyl)methyl)-2,4-thiazolidinedione-2-butenedioate" C18H19N3O3S YASAKCUCGLMORW-UHFFFAOYSA-N 5-[[4-[2-[methyl(pyridin-2-yl)amino]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione n.a. n.a. No Yes No No No No PMDBD1057 Bexarotene Therapeutic substance Drug 153559-49-0 DB00307 PA164752250 D03106 DAP000276 82146 74139 n.a. "Bexarotene; 153559-49-0; Targretin; Targrexin; Targretyn; LGD 1069; LGD1069; Bexaroten; LG100069; LGD-1069; UNII-A61RXM4375; LG 1069; HSDB 7453; p-(1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl)benzoic acid; 4-[1-(3,5,5,8,8-pentamethyl-6,7-dihydronaphthalen-2-yl)ethenyl]benzoic acid; 4-[1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)ethenyl]benzoic acid; 166175-31-1; CHEMBL1023; LG-100069; LG 100069; Targret; CHEBI:50859; A61RXM4375; 4-[1-(5,6,7,8-tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)ethenyl]" C24H28O2 NAVMQTYZDKMPEU-UHFFFAOYSA-N 4-[1-(3,5,5,8,8-pentamethyl-6,7-dihydronaphthalen-2-yl)ethenyl]benzoic acid n.a. n.a. No Yes No No No No PMDBD201 Clarithromycin Therapeutic Substance Approved Drug 81103-11-9 DB01211 PA449028 D00276 DAP000410 84029 10342604 n.a. "clarithromycin; 81103-11-9; Biaxin; 6-O-Methylerythromycin; Klaricid; 6-O-Methylerythromycin a; Clarithromycine; Clathromycin; Abbott-56268; A-56268; Macladin; Veclam; Kofron; Klacid; Clarith; Clarithromycinum; Naxy; TE-031; Biaxin XL; Mabicrol; Clambiotic; Bicrolid; Astromen; Claricide; Clacine; Abbotic; Klaciped; Heliclar; Claribid; Klarin; Cyllid; Zeclar; Maclar; Klarid; Mavid; Helas; Biaxin filmtab; Adel; Klax; Biaxin HP; Biaxin xl filmtab; Klaricid Pediatric; DRG-0099; UNII-H1250JIK0A; Claritromicina [INN-Spanish]; Clari" C38H69NO13 AGOYDEPGAOXOCK-KCBOHYOISA-N (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-12,13-dihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-7-methoxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione n.a. n.a. Yes Yes Yes No No No PMDBD1234 Imidacloprid Environmental Chemicals Pesticides 105827-78-9 DB11421 n.a. n.a. n.a. 86418 77934 n.a. "1-((6-Chloro-3-pyridinyl)methyl)-4,5-dihydro-N-nitro-imidazol-2-amine; 1-((6-chloro-3-pyridinyl)methyl)-n-nitro-4,5-dihydro-1h-imidazol-2-amine; MLS001304087; HMS3373H06; HMS2231F05; BDBM50212288; AKOS015895351; SMR000718777; SC-18937; DB-042420; FT-0656073; 292-EP2308857A1; 292-EP2305658A1; 292-EP2298076A1; 292-EP2280009A1; 292-EP2275422A1; 292-EP2274983A1; 292-EP2377845A1; 292-EP2308858A1; 292-EP2298077A1; 292-EP2281812A1; FT-0631157; 292-EP2314583A1; 292-EP2311816A1; 292-EP2292608A1; NS00000361; 292-EP2311817A1; 292-EP2305662A1; 29" C9H10ClN5O2 YWTYJOPNNQFBPC-UHFFFAOYSA-N N-[1-[(6-chloropyridin-3-yl)methyl]-4,5-dihydroimidazol-2-yl]nitramide n.a. n.a. Yes No No No No No PMDBD866 Tretazicar Therapeutic Substance Therapeutic Substance 21919-05-1 DB04253 n.a. n.a. n.a. 89105 80403 n.a. "Tretazicar; 21919-05-1; CB 1954; CB1954; 5-(1-Aziridinyl)-2,4-dinitrobenzamide; 5-(AZIRIDIN-1-YL)-2,4-DINITROBENZAMIDE; 5-Aziridino-2,4-dinitrobenzamide; CB-1954; 5-Aziridinyl-2,4-dinitrobenzamide; Tretazicar [INN]; 2,4-Dinitroethyleneiminobenzamide; 2,4-Dinitro-5-ethyleneiminobenzamide; NSC 115829; CHEMBL23330; CCRIS 1631; UNII-7865D5D01M; NSC-115829; 7865D5D01M; BRN 5825582; CB1; C9H8N4O5; SMR000326847; 5-[aziridin-1-yl]-2,4-dinitrobenzamide; aziri" C9H8N4O5 WOCXQMCIOTUMJV-UHFFFAOYSA-N 5-(aziridin-1-yl)-2,4-dinitrobenzamide n.a. n.a. No Yes No Yes No No PMDBD1320 Nicotine Environmental Chemicals Other 5/11/1954 DB00184 PA450626 D03365 DAP000175 89594 80863 n.a. "nicotine; L-Nicotine; 54-11-5; (-)-Nicotine; (S)-Nicotine; (S)-3-(1-methylpyrrolidin-2-yl)pyridine; Habitrol; 3-[(2S)-1-methylpyrrolidin-2-yl]pyridine; (S)-(-)-Nicotine; Nicotrol; Nicoderm; Nicocide; Fumetobac; Micotine; Tendust; Nico-dust; Nicoderm Cq; Nicotine alkaloid; Nico-Fume; Emo-nik; Mach-Nic; Nic-Sal; Nikotin [German]; Nicotine polacrilex; Nikotyna [Polish]; Flux MAAG; XL All Insecticide; Ortho N-5 dust; Ortho N-4 dust; Nicotina [Italian]; Niagara P.A. dust; Prostep; Nicotina; Nicorette; Nikotyna; Destruxol orchid spray; Nicotrol Inh" C10H14N2 SNICXCGAKADSCV-JTQLQIEISA-N 3-[(2S)-1-methylpyrrolidin-2-yl]pyridine n.a. n.a. Yes No No No No No PMDBD1303 Moexipril Therapeutic substance Drug 103775-10-6 DB00691 PA164769059 n.a. DAP000586 91270 82418 n.a. "MOEXIPRIL; Univasc; 103775-10-6; Uniretic; Moexiprilum [INN-Latin]; UNII-WT87C52TJZ; WT87C52TJZ; CHEMBL1165; Moexipril [INN:BAN]; CHEBI:6960; RS-10085; (3S)-2-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline-3-carboxylic acid; Moexiprilum; Moexipril (INN); (S)-2-((S)-2-((S)-1-ethoxy-1-oxo-4-phenylbutan-2-ylamino)propanoyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid; C27H34N2O7; PubChem18219; SCHEMBL34030; 109715-88-0; BIDD:GT0007; GTPL6571; DTXSID902" C27H34N2O7 UWWDHYUMIORJTA-HSQYWUDLSA-N (3S)-2-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline-3-carboxylic acid n.a. n.a. No Yes No No No No PMDBD401 Gliquidone Therapeutic Substance Approved Drug 33342-05-1 DB01251 PA164744895 D02430 DAP000924 91610 82719 n.a. "Gliquidone; 33342-05-1; Glurenorm; Beglynor; Gliquidonum; Gliquidonum [INN-Latin]; Gliquidona [INN-Spanish]; ARDF 26 SE; ARDF 26; C27H33N3O6S; UNII-C7C2QDD75P; EINECS 251-463-2; BRN 1559726; C7C2QDD75P; ARDF-26; 3-Cyclohexyl-1-[4-[2-(7-methoxy-4,4-dimethyl-1,3-dioxo-isoquinolin-2-yl)ethyl]phenyl]sulfonyl-urea; MFCD00631870; 1-cyclohexyl-3-[4-[2-(7-methoxy-4,4-dimethyl-1,3-dioxoisoquinolin-2-yl)ethyl]phenyl]sulfonylurea; glycvidon; glikvidon; NCGC00016819-01; Beglynora; Gliquidona; CAS-33342-05-1; DSSTox_CID_3096; DSSTox_RID_76873" C27H33N3O6S LLJFMFZYVVLQKT-UHFFFAOYSA-N 1-cyclohexyl-3-[4-[2-(7-methoxy-4,4-dimethyl-1,3-dioxoisoquinolin-2-yl)ethyl]phenyl]sulfonylurea Boehriger Ingelheim Hypoglycemic Agents Yes No No No No No PMDBD1259 Lopinavir Therapeutic substance Drug 192725-17-0 DB01601 PA450264 D01425 DAP000708 92727 83706 n.a. "Lopinavir; 192725-17-0; ABT-378; Aluviran; ABT 378; A 157378.0; A-157378.0; RS-346; UNII-2494G1JF75; CHEBI:31781; Lopinavir (ABT-378); LPV; (alphaS)-Tetrahydro-N-((alphaS)-alpha-((2S,3S)-2-hydroxy-4-phenyl-3-(2-(2,6-xylyloxy)acetamido)butyl)phenethyl)-alpha-isopropyl-2-oxo-1(2H)-pyrimidineacetamide; Koletra; A 157378; A-157378-0; 2494G1JF75; N-{1-BENZYL-4-[2-(2,6-DIMETHYL-PHENOXY)-ACETYLAMINO]-3-HYDROXY-5-PHENYL-PENTYL}-3-METHYL-2-(2-OXO-TETRAHYDRO-PYRIMIDIN-1-YL)-BUTYRAMIDE; (2S)-N-[(2S,4S,5S)-5-[[2-(2,6-dimethylphenoxy)ace" C37H48N4O5 KJHKTHWMRKYKJE-SUGCFTRWSA-N (2S)-N-[(2S,4S,5S)-5-[[2-(2,6-dimethylphenoxy)acetyl]amino]-4-hydroxy-1,6-diphenylhexan-2-yl]-3-methyl-2-(2-oxo-1,3-diazinan-1-yl)butanamide n.a. n.a. No Yes No No No No PMDBD440 Imipenem Therapeutic Substance Approved Drug 64221-86-9 DB01598 PA449968 n.a. DAP000459 104838 94631 n.a. "imipenem; Imipemide; 64221-86-9; N-Formimidoylthienamycin; Tienamycin; Imipenem anhydrous; Imipenemum; N-formimidoyl thienamycin; Imipenem hydrate; imipen; MK 0787; CHEBI:471744; Imipenem, N-Formimidoyl thienamycin; 74431-23-5; UNII-Q20IM7HE75; Imipenem (INN); Primaxin; (5R,6S)-6-((R)-1-Hydroxyethyl)-3-(2-(iminomethylamino)ethylthio)-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carbonsaeure; MK-0787; CHEMBL148; Q20IM7HE75; (5R,6S)-3-((2-(Formimidoylamino)ethyl)thio)-6-((R)-1-hydroxyethyl)-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxyl" C12H17N3O4S ZSKVGTPCRGIANV-ZXFLCMHBSA-N (5R,6S)-3-[2-(aminomethylideneamino)ethylsulfanyl]-6-[(1R)-1-hydroxyethyl]-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid Merck & Co Antibiotics Yes No Yes No No No PMDBD9 7-ethyl-10-hydroxycamptothecin Therapeutic Substance Therapeutic Substance 86639-52-3 DB05482 n.a. n.a. n.a. 104842 94634 n.a. "7-Ethyl-10-hydroxycamptothecin; 86639-52-3; SN-38; SN 38 lactone; SN 38; 7-Ethyl-10-hydroxy-camptothecin; 10-Hydroxy-7-ethylcamptothecin; SN38; 7-Ethyl-10-hydroxy-20(S)-camptothecin; UNII-0H43101T0J; (S)-4,11-Diethyl-4,9-dihydroxy-1H-pyrano[3'',4'':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; NK012; NK-012; NK 012; CHEBI:8988; 7-Ethyl-10-hydroxy camptothecin; NSC673596; 0H43101T0J; (4S)-4,11-diethyl-4,9-dihydroxy-1H-pyrano[3'',4'':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; (+)-7-ETHY" C22H20N2O5 FJHBVJOVLFPMQE-QFIPXVFZSA-N (19S)-10,19-diethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione NeoPharm n.a. No Yes No No No No PMDBD122 Bosentan Therapeutic Substance Approved Drug 147536-97-8 DB00559 PA10034 D01227 DNC000341 104865 94651 n.a. "Bosentan; 147536-97-8; Tracleer; Ro 47-0203; Ro-47-0203; Bosentan [USAN:INN:BAN]; C27H29N5O6S; UNII-XUL93R30K2; p-tert-Butyl-N-(6-(2-hydroxyethoxy)-5-(o-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl)benzenesulfonamide; Ro 47-0203/039; 4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]benzenesulfonamide; CHEMBL957; XUL93R30K2; Actelion; CHEBI:51450; 4-(1,1-Dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2''-bipyrimidin)-4-yl)benzenesulfornamide; NCGC00167440-01; bosentan a" C27H29N5O6S GJPICJJJRGTNOD-UHFFFAOYSA-N 4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]benzenesulfonamide Actelion Pharmaceuticals Antihypertensive Agents Yes Yes No No No Yes BSN_GLC_GLCAASE,BSN_GLC_GLCAASEe,BSN_GLC_GLCAASEepp,BSNte,BSNtepp,BSNtex,EX_bsn(e) PMDBD725 Racecadotril Therapeutic Substance Approved Drug 81110-73-8 DB11696 n.a. n.a. n.a. 107751 96913 n.a. "Racecadotril; 81110-73-8; Acetorphan; Benzyl 2-(3-(acetylthio)-2-benzylpropanamido)acetate; Racecadotril [INN]; Racecadotril (Acetorphan); Racecadotril (INN); AK-72817; 112573-73-6; Glycine, N-(2-((acetylthio)methyl)-1-oxo-3-phenylpropyl)-, phenylmethyl ester; (+-)-N-(2-((Acetylthio)methyl)-1-oxo-3-phenylpropyl)glycine phenylmethyl ester; Glycine, N-[2-[(acetylthio)methyl]-1-oxo-3-phenylpropyl]-,phenylmethyl ester [CAS]; C21H23NO4S; benzyl 2-[[2-(acetylsulfanylmethyl)-3-phenylpropanoyl]amino]acetate; Glycine, N-(2-((acet" C21H23NO4S ODUOJXZPIYUATO-UHFFFAOYSA-N benzyl 2-[[2-(acetylsulfanylmethyl)-3-phenylpropanoyl]amino]acetate n.a. n.a. No Yes No Yes No No PMDBD385 Geniposide Herbal Substance Geniposide has significant effects on digestive system, cardiovascular system and central nervous system diseases. Geniposide also has certain anti-inflammatory and soft tissue injury effects. n.a. n.a. n.a. n.a. n.a. 107848 n.a. NPC255677 "Geniposide; 24512-63-8; UNII-145295QLXY; Jasminoidin; CHEBI:5299; 145295QLXY; Cyclopenta[c]py" C17H24O10 IBFYXTRXDNAPMM-BVTMAQQCSA-N methyl (1S,4aS,7aS)-7-(hydroxymethyl)-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,4a,5,7a-tetrahydrocyclopenta[c]pyran-4-carboxylate n.a. n.a. No Yes No Yes No No PMDBD1193 Fingolimod Therapeutic substance Drug 162359-55-9 DB08868 n.a. D10001 n.a. 107970 97087 n.a. "Fingolimod; 162359-55-9; 2-Amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol; 2-Amino-2-[2-(4-octylphenyl)ethyl]-1,3-propanediol; 2-Amino-2-(4-octylphenethyl)propane-1,3-diol; UNII-3QN8BYN5QF; 2-Amino-2-[2-(4-octylphenyl)ethyl]-1,3-propandiol; Fingolimod [INN]; Gilenya (TN); 3QN8BYN5QF; CHEMBL314854; CHEBI:63115; Fingolimod (INN); FTY720 free base; C19H33NO2; 2-amino-2-(2-(4-octylphenyl)ethyl)propane-1,3-diol; 2-amino-2-(2-(4-octylphenyl)ethyl)-1,3-propanediol; 1,3-Propane" C19H33NO2 KKGQTZUTZRNORY-UHFFFAOYSA-N 2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol n.a. n.a. No Yes No No No No PMDBD245 Daidzin "Therapeutic Substance; Herbal Substance" "Therapeutic Substance; Herbal Substance" 552-66-9 DB02115 n.a. n.a. n.a. 107971 97088 NPC161749 "Daidzin; 552-66-9; Daidzoside; Daidzein 7-O-glucoside; Daidzein 7-glucoside; Daidzein-7-glucoside; daidzein-7-o-glucoside; daidzein 7-O-beta-D-glucoside; UNII-4R2X91A5M5; 7-(beta-D-Glucopyranosyloxy)-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one; BRN 0059741; CHEBI:42202; 4R2X91A5M5; Daidzein-7-O-beta-D-glucopyranoside; Daidzin, 98%; DZN; 3-(4-hydroxyphenyl)-4-oxo-4H-chromen-7-yl beta-D-glucopyranoside; Dadzin; NPI 031D; 2vle; Daidzin (Daidzein-7-O-?-D-glucopyranoside); Daidzin, analytical standard; MLS006010640; 4-18-00-01808 (Beils" C21H20O9 KYQZWONCHDNPDP-QNDFHXLGSA-N 3-(4-hydroxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one n.a. n.a. No Yes No Yes Yes No rxn23865,rxn41390,rxnDiet111 PMDBD890 Vardenafil Therapeutic Substance Approved Drug 224785-90-4 DB00862 PA10229 D08668 DAP000414 135400189 99300 n.a. "Vardenafil; Levitra; 224785-90-4; Vivanza; UNII-UCE6F4125H; HSDB 7304; Levitra (TN); BAY38-9456; CHEMBL1520; UCE6F4125H; 2-{2-ETHOXY-5-[(4-ETHYLPIPERAZIN-1-YL)SULFONYL]PHENYL}-5-METHYL-7-PROPYLIMIDAZO[5,1-F][1,2,4]TRIAZIN-4(1H)-ONE; VDN; CHEBI:46295; Vardenafil-d5; BAY 38-9456; 2-(2-Ethoxy-5-(4-ethylpiperazin-1-yl-1-sulfonyl)phenyl)-5-methyl-7-propyl-3H-imidazo(5,1-f)(1,2,4)triazin-4-one; 224789-15-5; 1-((3-(3,4-Dihydro-5-methyl-4-oxo-7-propylimidazo(5,1-f)-as-triazin-2-yl)-4-ethoxyphenyl)sulfonyl)-4-ethylpiperazine; 2-(2-et" C23H32N6O4S SECKRCOLJRRGGV-UHFFFAOYSA-N 2-[2-ethoxy-5-(4-ethylpiperazin-1-yl)sulfonylphenyl]-5-methyl-7-propyl-3H-imidazo[5,1-f][1,2,4]triazin-4-one Bayer Pharmaceuticals Corporation Antiimpotence Agents Yes Yes No No No No PMDBD822 Tadalafil Therapeutic Substance Approved Drug 171596-29-5 DB00820 PA10333 D02008 DAP000615 110635 99301 n.a. "Tadalafil; Cialis; 171596-29-5; Ic351; Tadanafil; ADCIRCA; IC 351; ICOS 351; GF 196960; IC-351; UNII-742SXX0ICT; HSDB 7303; (6R,12aR)-6-(Benzo[d][1,3]dioxol-5-yl)-2-methyl-2,3,12,12a-tetrahydropyrazino[1'',2'':1,6]pyrido[3,4-b]indole-1,4(6H,7H)-dione; CHEMBL779; 742SXX0ICT; GF-196960; (6R-trans)-6-(1,3-Benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-pyrazino(1'',2'':1,6)pyrido(3,4-b)indole-1,4-dione; (6R,12aR)-2,3,6,7,12,12a-Hexahydro-2-methyl-6-(3,4-(methylenedioxy)phenyl) pyrazino(1'',2'':1,6)pyrido(3,4-b)indole-1,4-dione" C22H19N3O4 WOXKDUGGOYFFRN-IIBYNOLFSA-N (2R,8R)-2-(1,3-benzodioxol-5-yl)-6-methyl-3,6,17-triazatetracyclo[8.7.0.03,8.011,16]heptadeca-1(10),11,13,15-tetraene-4,7-dione Eli Lilly Antiimpotence Agents No Yes No No No No PMDBD1368 Pivmecillinam Therapeutic substance Antibiotics 32886-97-8 DB01605 PA164750167 D02889 DAP001174 115163 16735658 n.a. "Pivmecillinam; Amdinocillin Pivoxil; 32886-97-8; Pivmecilinamo; Pivmecillinamum; Pivamdinocillin; Selexid; Pivmecillinamum [INN-Latin]; Pivmecilinamo [INN-Spanish]; UNII-1WAM1OQ30B; amdinocillin, pivaloyloxymethyl ester; Coactabs; Amdinocillin pivoxil [USAN]; Pivmecillinam (INN); 1WAM1OQ30B; Amdinocillin pivoxil (USAN); CHEBI:51210; Pivmecillinam [INN]; Ro-109071; RO-10-9071; Ro 10-9071; [(2,2-dimethylpropanoyl)oxy]methyl (2S,5R,6R)-6-[(azepan-1-ylmethylidene)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxy" C21H33N3O5S NPGNOVNWUSPMDP-HLLBOEOZSA-N 2,2-dimethylpropanoyloxymethyl (2S,5R,6R)-6-(azepan-1-ylmethylideneamino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate n.a. n.a. Yes No No No No No PMDBD638 Paliperidone Therapeutic Substance Approved Drug 144598-75-4 DB01267 PA163518919 D05339 DAP000847 115237 103109 n.a. "Paliperidone; 144598-75-4; 9-Hydroxyrisperidone; Invega; PALLIPERIDONE; R-76477; 9-hydroxy risperidone; C23H27FN4O3; 3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one; 3-(2-(4-(6-fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl)ethyl)-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one; R 76477; CHEMBL1621; RO-76477; 4H-Pyrido[1,2-a]pyrimidin-4-one, 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydr" C23H27FN4O3 PMXMIIMHBWHSKN-UHFFFAOYSA-N 3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-9-hydroxy-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one Johnson & Johnson n.a. No Yes No No No No PMDBD1322 Nitisinone Therapeutic substance Drug 104206-65-7 DB00348 PA164777037 n.a. DAP000774 115355 103195 n.a. "Nitisinone; 104206-65-7; Orfadin; Nitisone; NTBC; 2-(2-nitro-4-(trifluoromethyl)benzoyl)cyclohexane-1,3-dione; 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione; Nitisinone [USAN:INN]; 2-[2-nitro-4-(trifluoromethyl)benzoyl]cyclohexane-1,3-dione; SC 0735; 2-(2-Nitro-4-trifluoromethylbenzoyl)cyclohexane-1,3-dione; Nitisinone-13C6; UNII-K5BN214699; C14H10F3NO5; 2-(Alpha,alpha,alpha-trifluoro-2-nitro-p-tuluoyl)-1,3-cyclohexanedione; SC-0735; CHEMBL1337; CHEBI:50378; 1,3-Cyclohexanedione, 2-[2-nitro-4-(trifluoromethyl)ben" C14H10F3NO5 OUBCNLGXQFSTLU-UHFFFAOYSA-N 2-[2-nitro-4-(trifluoromethyl)benzoyl]cyclohexane-1,3-dione n.a. n.a. No Yes No No No No PMDBD1124 Clofarabine Therapeutic substance Drug 123318-82-1 DB00631 PA164754863 n.a. DAP000849 119182 106472 n.a. "Clofarabine; 123318-82-1; Clolar; Evoltra; Clofarex; CAFdA; Cl-F-Ara-A; C1-F-Ara-A; UNII-762RDY0Y2H; 2-Chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-9H-purin-6-amine; 2-Chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine; CHEBI:681569; (2R,3R,4S,5R)-5-(6-amino-2-chloropurin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol; 762RDY0Y2H; (2R,3R,4S,5R)-5-(6-amino-2-chloro-9H-purin-9-yl)-4-fluoro-2-(hydroxymethyl)tetrahydrofuran-3-ol; 2-chloro-9-(" C10H11ClFN5O3 WDDPHFBMKLOVOX-AYQXTPAHSA-N (2R,3R,4S,5R)-5-(6-amino-2-chloropurin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol n.a. n.a. No Yes No No No No PMDBD826 Tazobactam Therapeutic Substance Approved Drug 89786-04-9 DB01606 PA164764504 D00660 DAP000926 123630 110216 n.a. "Tazobactam; 89786-04-9; Tazobactam acid; Tazobactamum; YTR-830H; YTR 830H; Zosyn; UNII-SE10G96M8W; CHEMBL404; CL-298741; YTR 830; SE10G96M8W; CHEBI:9421; YTR 830 H; (2S,3S,5R)-3-methyl-7-oxo-3-(1H-1,2,3-triazol-1-ylmethyl)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 4,4-dioxide; Tazobactamum [INN-Latin]; CCRIS 2203; Cl 298741; BRN 4787943; (2S,3S,5R)-3-Methyl-7-oxo-3-(1H-1,2,3-triazol-1-ylmeth" C10H12N4O5S LPQZKKCYTLCDGQ-WEDXCCLWSA-N (2S,3S,5R)-3-methyl-4,4,7-trioxo-3-(triazol-1-ylmethyl)-4lambda6-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid Gepach International Antiinfective Agents Yes No Yes No No No PMDBD382 Gefitinib "Therapeutic Substance; Herbal Substance" "Approved Drug; Medicinal Herbal Compounds" 184475-35-2 DB00317 PA131301952 D01977 DAP000657 123631 110217 NPC56271 "Gefitinib; 184475-35-2; Iressa; ZD1839; Irressat; gefitinib (zd1839); N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-amine; ZD 1839; ZD-1839; N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(morpholin-4-yl)propoxy]quinazolin-4-amine; N-(3-Chloro-4-fluoro-phenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine; UNII-S65743JHBS; CCRIS 9011; 4-(3''-Chloro-4''-fluoroanilino)-7-methoxy-6-(3-morpholinopropoxy)quinazoline; N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(4-morpholinyl)propoxy]-4-quinazoli" C22H24ClFN4O3 XGALLCVXEZPNRQ-UHFFFAOYSA-N N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine AstraZeneca Anticancer Agents Yes Yes Yes No No No PMDBD1149 Desloratadine Therapeutic substance Drug 100643-71-8 DB00967 PA164776964 D03693 DAP000331 124087 110575 n.a. "Desloratadine; 100643-71-8; Clarinex; Descarboethoxyloratadine; Neoclarityn; Sch-34117; Aerius; Azomyr; Desloratidine; Denosin; 8-Chloro-11-piperidin-4-ylidene-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine; Sch 34117; Descarboethoxyoratidine; UNII-FVF865388R; CHEMBL1172; 8-chloro-11-(piperidin-4-ylidene)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine; 8-Chloro-6,11-dihydro-11-(4-piperidinylidene)-5H-benzo(5,6)cyclohepta(1,2-b)pyridine; MLS000559042; CHEBI:291342; FVF865388R; 5H-Benzo[5,6]cyclohepta[1,2-b]pyridine, 8" C19H19ClN2 JAUOIFJMECXRGI-UHFFFAOYSA-N 13-chloro-2-piperidin-4-ylidene-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaene n.a. n.a. No Yes No No No No PMDBD535 Methotrexate Therapeutic Substance chemotherapeutic n.a. DB00563 PA450428 D00142 DNC000933 126941 112728 n.a. "methotrexate; 59-05-2; Rheumatrex; Amethopterin; Trexall; Metatrexan; Hdmtx; Abitrexate; Methylaminopterinum; (S)-2-(4-(((2,4-Diaminopteridin-6-yl)methyl)(methyl)amino)benzamido)pentanedioic acid; Methylaminopterin; MTX; 4-Amino-10-methylfolic acid; Methotrexate hydrate; Metotrexato; Methotrexatum; Maxtrex; Rasuvo; A-Methopterin; A-Methpterin; Folex-Pfs; Methotrexat-Ebewe; N-Bismethylpteroylglutamic acid; NSC-740; NCI-C04671; Antifolan; Metotressato [DCIT]; Mexate-Aq; CL-14377; UNII-YL5FZ2Y5U1; Methotrex" C20H22N8O5 FBOZXECLQNJBKD-ZDUSSCGKSA-N (2S)-2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methylamino]benzoyl]amino]pentanedioic acid n.a. n.a. Yes Yes Yes Yes No No PMDBD1434 Tamsulosin Therapeutic substance Drug 106133-20-4 DB00706 PA451583 n.a. DAP000086 129211 114457 n.a. "TAMSULOSIN; 106133-20-4; (R)-5-(2-((2-(2-Ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide; Tamsulosinum; Tamsulosine; Tamsulosina; (-)-Tamsulosin; Tamsulosine [INN-French]; Tamsulosinum [INN-Latin]; Tamsulosina [INN-Spanish]; Tamsulosin [INN:BAN]; UNII-G3P28OML5I; (r)-(-)-tamsulosin; Flomax (TN); CHEMBL836; G3P28OML5I; CHEBI:9398; 5-[(2R)-2-{[2-(2-ethoxyphenoxy)ethyl]amino}propyl]-2-methoxybenzenesulfonamide; 5-[(2R)-2-[2-(2-ethoxyphenoxy)ethylamino]propyl]-2-methoxybenzenesulfonamide; Flowmax; Amsulosin; Q-101875" C20H28N2O5S DRHKJLXJIQTDTD-OAHLLOKOSA-N 5-[(2R)-2-[2-(2-ethoxyphenoxy)ethylamino]propyl]-2-methoxybenzenesulfonamide n.a. n.a. No Yes No No No No PMDBD1409 Rufinamide Therapeutic substance Drug 106308-44-5 DB06201 PA166131606 D05775 n.a. 129228 114471 n.a. "Rufinamide; 106308-44-5; Inovelon; Banzel; 1-(2,6-Difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide; Cgp 33101; CGP-33101; 1-[(2,6-difluorophenyl)methyl]-1H-1,2,3-Triazole-4-carboxamide; Xilep; RUF-331; RUF 331; UNII-WFW942PR79; C10H8F2N4O; 1-[(2,6-difluorophenyl)methyl]triazole-4-carboxamide; E 2080; WFW942PR79; E-2080; NCGC00165883-02; E2080; DSSTox_CID_26506; DSSTox_RID_81675; DSSTox_GSID_46506; 1-[(2,6-difluorophenyl)methyl]-1H-1,2,3-triazole-4 carboxamide; 1H-1,2" C10H8F2N4O POGQSBRIGCQNEG-UHFFFAOYSA-N 1-[(2,6-difluorophenyl)methyl]triazole-4-carboxamide n.a. n.a. No Yes No No No No PMDBD806 Sulbactam Therapeutic Substance Approved Drug 68373-14-8 DB09324 n.a. D02223 n.a. 130313 115306 n.a. "SULBACTAM; 68373-14-8; sulbactam acid; Betamaze; Penicillanic Acid Sulfone; Sulbactamum; (2S,5R)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 4,4-dioxide; penicillanic acid 1,1-dioxide; UNII-S4TF6I2330; CP 45899; CHEMBL403; CP-45899; (2S,5R)-3,3-Dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid 4,4-dioxide; CP-45,899; CHEBI:9321; S4TF6I2330; Sulbactam;Penicillanic acid sulfone; Sulbactam [INN:BAN]; Sulbactamum [INN-Latin]; DSSTox_CID_3605; MFCD00867005; DSSTox_RID_77104; (2S,5R)-3,3-dim" C8H11NO5S FKENQMMABCRJMK-RITPCOANSA-N (2S,5R)-3,3-dimethyl-4,4,7-trioxo-4lambda6-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid Kowa Pharmaceuticals America n.a. Yes No No No No No PMDBD334 Febuxostat Therapeutic Substance Approved Drug 144060-53-7 DB04854 PA165958521 D01206 n.a. 134018 118173 n.a. "Febuxostat; 144060-53-7; Adenuric; Uloric; 2-(3-cyano-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylic acid; Tei-6720; Tei 6720; Feburic; TMX 67; TMX-67; Zurig; 2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methyl-1,3-thiazole-5-carboxylic acid; UNII-101V0R1N2E; Febuxostat (Uloric); C16H16N2O3S; 2-(3-Cyano-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylic acid; 2-(3-CYANO-4-ISOBUTOXY-PHENYL)-4-METHYL-5-THIAZOLE-CARBOXYLIC ACID; CHEMBL1164729; 101V0R1N2E; NCGC00182059-02; 5-Thiazolecarboxylic acid, 2-(3-cyano-4-(2-methylpropoxy)phenyl" C16H16N2O3S BQSJTQLCZDPROO-UHFFFAOYSA-N 2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methyl-1,3-thiazole-5-carboxylic acid Takeda n.a. No Yes No Yes No No PMDBD75 Aspartame "Therapeutic Substance; Dietary Substance; Herbal Substance" "Dietary Compounds; Artificial Sweetener; Medicinal Herbal Compounds" 22839-47-0 DB00168 PA448493 D02381 n.a. 134601 118630 NPC197470 "aspartame; 22839-47-0; Nutrasweet; Asp-phe-ome; Asp-Phe methyl ester; Aspartam; Canderel; L-Aspartyl-L-phenylalanine methyl ester; Aspartamum; Aspartylphenylalanine methyl ester; Aspartamo; Sweet dipeptide; Tri-sweet; Dipeptide sweetener; Equal; Methyl aspartylphenylalanate; H-Asp-Phe-OMe; 1-Methyl N-L-alpha-aspartyl-L-phenylalanate; Aspartam [INN-French]; Aspartamum [INN-Latin]; methyl L-alpha-aspartyl-L-phenylalaninate; Aspartamo [INN-Spanish]; UNII-Z0H242BBR1; 3-Amino-N-(alpha-methoxycarbonylphenethyl) su" C14H18N2O5 IAOZJIPTCAWIRG-QWRGUYRKSA-N (3S)-3-amino-4-[[(2S)-1-methoxy-1-oxo-3-phenylpropan-2-yl]amino]-4-oxobutanoic acid n.a. n.a. Yes Yes No No No No PMDBD830 Tempol Therapeutic Substance Investigational Drug 2226-96-2 DB12449 n.a. n.a. n.a. 137994 121639 n.a. "tempol; TMPN; HyTEMPO; 4-hydroxy-2,2,6,6-tetramethyl-piperidinooxy; 4-Oxypiperidol; Nitroxyl 2; 4-hydroxy-2,2,6,6-tetramethyl piperidinyloxy; 4-Hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl; 4-Hydroxy-2,2,6,6-tetramethylpiperidine 1-oxyl; Tetramethylpiperidino-N-oxyl; UNII-U78ZX2F65X; Tetramethylpiperidinol N-oxyl; U78ZX2F65X; CCRIS 4555; NR 1; 4-Hydroxy Tempo, Free Radical; 2,2,6,6-Tetramethyl-4-piperidinol-N-oxyl; 4-Hydroxy-2,2,6,6-tetramethylpiperidinooxy; 2,2,6,6-Tetramethyl-4-piperidinol 1-oxyl; 4-Hydroxy-TEMPO, free radi" C9H18NO2 UZFMOKQJFYMBGY-UHFFFAOYSA-N "Georgetown University; Mitos Pharmaceuticals Inc" n.a. No Yes No No No No PMDBD1180 Escitalopram Therapeutic substance Drug 128196-01-0 DB01175 PA10074 n.a. DAP000741 146570 129277 n.a. "Escitalopram; (S)-Citalopram; 128196-01-0; S(+)-Citalopram; (+)-Citalopram; Seroplex; S-(+)-Citalopram; Cipralex; Escitalopram [INN]; (1S)-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile; UNII-4O4S742ANY; Esertia; Escitalopram (INN); CHEMBL1508; R-Citalopram; 4O4S742ANY; CHEBI:36791; (+)-(S)-1-(3-(Dimethylamino)propyl)-1-(p-fluorophenyl)-5-phthalancarbonitrile" C20H21FN2O WSEQXVZVJXJVFP-FQEVSTJZSA-N (1S)-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile n.a. n.a. No Yes No No No No PMDBD1045 Atazanavir Therapeutic substance Drug 198904-31-3 DB01072 PA10251 D07471 DNC000332 148192 130642 n.a. "Atazanavir; 198904-31-3; Latazanavir; Zrivada; BMS-232632; BMS 232632; Atazanavir [INN:BAN]; CGP 73547; Atazanavir Base; UNII-QZU4H47A3S; CGP-73547; ATV; HSDB 7339; Reyataz (TN); QZU4H47A3S; CHEMBL1163; CHEBI:37924; NCGC00182552-01; DSSTox_RID_82887; DSSTox_CID_28617; DSSTox_GSID_48691; DR7; (3S,8S,9S,12S)-3,12-BIS(1,1-DIMETHYLETHYL)-8-HYDROXY-4,11-DIOXO-9-(PHENYLMETHYL)-6-[[4-(2-PYRIDINYL)PHENYL]METHYL]-2,5,6,10,13-PENTAAZATETRADECANEDIOIC ACID DIMETHYL ESTER; atazanavirum" C38H52N6O7 AXRYRYVKAWYZBR-GASGPIRDSA-N methyl N-[(2S)-1-[2-[(2S,3S)-2-hydroxy-3-[[(2S)-2-(methoxycarbonylamino)-3,3-dimethylbutanoyl]amino]-4-phenylbutyl]-2-[(4-pyridin-2-ylphenyl)methyl]hydrazinyl]-3,3-dimethyl-1-oxobutan-2-yl]carbamate n.a. n.a. No Yes No No No No PMDBD1257 Levofloxacin Therapeutic substance Antibiotics 100986-85-4 DB01137 PA450214 D08120 DAP000160 149096 131410 n.a. "LEVOFLOXACIN; 100986-85-4; Levaquin; Quixin; Cravit; Iquix; (-)-Ofloxacin; Ofloxacin S-(-)-form; Levofloxacine; (S)-Ofloxacin; Tavanic; Levofloxacino; Levofloxacinum; Elequine; Oftaquix; L-Ofloxacin; Floxacin; DR-3355; (S)-(-)-Ofloxacin; Levofloxacin hydrate; Levofloxacine [INN-French]; Levofloxacinum [INN-Latin]; Levofloxacino [INN-Spanish]; HR 355; DR3355; Levofloxacin [USAN:INN:JAN]; RWJ 25213-097; UNII-RIX4E89Y14; RWJ-25213; MP-376; CCRIS 4074; Levofloxacin (Levaquin); Levaquin (TN); (S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-pip" C18H20FN3O4 GSDSWSVVBLHKDQ-JTQLQIEISA-N (2S)-7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid n.a. n.a. Yes Yes No No No No PMDBD329 Ezetimibe Therapeutic Substance Lipid modifying agents 163222-33-1 DB00973 PA10816 D01966 DAP000717 150311 132493 n.a. "Ezetimibe; 163222-33-1; Zetia; Ezetrol; Ezedoc; Sch 58235; SCH-58235; (3R,4S)-1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)azetidin-2-one; UNII-EOR26LQQ24; (-)-Sch 58235; Ezetimibe (Zetia); EOR26LQQ24; CHEBI:49040; 1-(4-fluorophenyl)-3(R)-[3-(4-fluorophenyl)-3(S)-hydroxypropyl]-4(S)-(4-hydroxyphenyl)-2-azetidinone; (3R,4S)-1-(4-fluorophenyl)-3-((S)-3-(4-fluorophenyl)-3-hydroxypropyl)-4-(4-hydroxyphenyl)azetidin-2-one; DSSTox_CID_24223; DSSTox_RID_80127; DSSTox_GSID_44223; (3R,4S)-1-(p-Flu" C24H21F2NO3 OLNTVTPDXPETLC-XPWALMASSA-N (3R,4S)-1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)azetidin-2-one Schering-Plough Anticholesteremic Agents No Yes No Yes No Yes EX_eztmb(e),EZTMB_GLC_GLCAASE,EZTMB_GLC_GLCAASEe,EZTMB_GLC_GLCAASEepp,EZTMBte,EZTMBtepp,EZTMBtex,SCH_488128_GLCAASE,SCH_488128_GLCAASEe,SCH_488128_GLCAASEepp PMDBD1179 Ertapenem Therapeutic substance Antibiotics 153832-46-3 DB00303 PA164777032 D07908 DAP000431 150610 132758 n.a. "Ertapenem; 153832-46-3; Ertapenem [INN]; UNII-G32F6EID2H; Ertapenem (INN); Ertapenem sodium; Invanz (TN); G32F6EID2H; (4R,5S,6S)-3-[(3S,5S)-5-[(3-carboxyphenyl)carbamoyl]pyrrolidin-3-yl]sulfanyl-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid; C22H25N3O7S; CHEBI:404903; (4R,5S,6S)-3-((3S,5S)-5-((3-carboxyphenyl)carbamoyl)pyrrolidin-3-ylthio)-6-((R)-1-hydroxyethyl)-4-methyl-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid; (1R,5S,6S,8R,2''S,4''S)-2-(2-(3-carboxyphenylcarbamoyl)" C22H25N3O7S JUZNIMUFDBIJCM-ANEDZVCMSA-N (4R,5S,6S)-3-[(3S,5S)-5-[(3-carboxyphenyl)carbamoyl]pyrrolidin-3-yl]sulfanyl-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid n.a. n.a. Yes No No No No No PMDBD562 Moxifloxacin Therapeutic Substance Approved Drug 151096-09-2 DB00218 PA450555 D08237 DAP000158 152946 134802 n.a. "moxifloxacin; 151096-09-2; Moxifloxacin [INN:BAN]; Moxeza; 1-Cyclopropyl-6-fluoro-7-((4aS,7aS)-hexahydro-1H-pyrrolo[3,4-b]pyridin-6(2H)-yl)-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid; UNII-U188XYD42P; U188XYD42P; 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-((4aS,7aS)-octahydro-6H-pyrrolo(3,4-b)pyridin-6-yl)-4-oxo-3-quinolinecarboxylic acid; CHEBI:63611; BAY 12-8039; Izilox; 1-Cyclopropyl-6-Fluoro-8-Methoxy-7-[(4as,7as)-Octahydro-6h-Pyrrolo[3,4-B]pyridin-6-Yl]-4-Oxo-1,4-Dihydroquinoline-3-Carboxylic Acid" C21H24FN3O4 FABPRXSRWADJSP-MEDUHNTESA-N 7-[(4aS,7aS)-1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxoquinoline-3-carboxylic acid Bayer AG Antibiotics Yes Yes Yes No No No PMDBD1310 Naproxen Therapeutic substance Drug 22204-53-1 DB00788 PA450595 D00118 DAP000968 156391 137720 n.a. "NAPROXEN; 22204-53-1; (S)-Naproxen; (+)-Naproxen; Naprosyn; Naproxene; Equiproxen; Aleve; (S)-(+)-Naproxen; Laraflex; d-Naproxen; (S)-(+)-2-(6-Methoxy-2-naphthyl)propionic acid; Naproxenum; Calosen; Nycopren; Naproxeno; Naprosyne; Bonyl; Naixan; Reuxen; Axer; (+)-(S)-Naproxen; Ec-Naprosyn; (S)-2-(6-methoxynaphthalen-2-yl)propanoic acid; (2S)-2-(6-methoxynaphthalen-2-yl)propanoic acid; Flexipen; Clinosyn; Artrixen; Anexopen; Acusprain; Leniartil; Danaprox; Bipronyl; Artroxen; Novonaprox; Arthrisil; Napren; Naposin; Napflam; Genoxen; Daprox; Atiflan" C14H14O3 CMWTZPSULFXXJA-VIFPVBQESA-N (2S)-2-(6-methoxynaphthalen-2-yl)propanoic acid n.a. n.a. No Yes No No No No PMDBD1117 Cinacalcet Therapeutic substance Drug 226256-56-0 DB01012 PA164776671 D03504 DAP000256 156419 137743 n.a. "Cinacalcet; 226256-56-0; AMG073; AMG-073; AMG 073; UNII-UAZ6V7728S; Parareg; (R)-N-(1-(Naphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)propan-1-amine; UAZ6V7728S; CHEBI:48390; N-((1R)-1-(Naphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)propan-1-amine; N-[(1R)-1-(1-naphthyl)ethyl]-3-[3-(trifluoromethyl)phenyl]propan-1-amine; N-((1R)-1-(1-Naphthyl)ethyl)-3-(3-(trifluoromethyl)phenyl)propan-1-amine; (R)-alpha-methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-1-naphthalenemethane amine; CNC; Cinacalcet (USAN); KRN-1493; N-[" C22H22F3N VDHAWDNDOKGFTD-MRXNPFEDSA-N N-[(1R)-1-naphthalen-1-ylethyl]-3-[3-(trifluoromethyl)phenyl]propan-1-amine n.a. n.a. No Yes No No No No PMDBD1328 Olmesartan Therapeutic substance Drug 144689-24-7 DB00275 PA164742950 D01204 DAP001412 158781 139674 n.a. "Olmesartan; 144689-24-7; Olmesartan Acid; Votum; Olme sartan; RNH-6270; UNII-8W1IQP3U10; CHEMBL1516; 8W1IQP3U10; CHEBI:48416; 4-(2-hydroxypropan-2-yl)-2-propyl-1-{[2''-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid; 1-((2''-(1H-tetrazol-5-yl)-[1,1''-biphenyl]-4-yl)methyl)-4-(2-hydroxypropan-2-yl)-2-propyl-1H-imidazole-5-carboxylic acid" C24H26N6O3 VTRAEEWXHOVJFV-UHFFFAOYSA-N 5-(2-hydroxypropan-2-yl)-2-propyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylic acid n.a. n.a. No Yes No No No No PMDBD1439 Telbivudine Therapeutic substance Drug 3424-98-4 DB01265 PA164760861 D06675 DAP000698 159269 140081 n.a. "Telbivudine; Epavudine; 2''-Deoxy-L-thymidine; L-Thymidine; beta-L-Thymidine; Telbivudin; Tyzeka; L-dT; L-Deoxythymidine; 3424-98-4; Sebivo; NV-02B; LDT600; beta-L-2''-Deoxythymidine; LdT; NV 02B; UNII-2OC4HKD3SF; CHEBI:63624; LDT-600; 1-(2-Deoxy-beta-L-erythro-pentofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione; 2OC4HKD3SF; 26879-47-0; 1-(2-deoxy-beta-L-ribofuranosyl)-5-methyluracil; 1-((2S,4R,5S)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione; Thymine, 1-(2-deoxy-beta-L-erythro-pentofuranosyl)" C10H14N2O5 IQFYYKKMVGJFEH-CSMHCCOUSA-N 1-[(2S,4R,5S)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione n.a. n.a. No Yes No No No No PMDBD1343 Paromomycin Therapeutic substance Antibiotics 7542-37-2 DB01421 PA164784023 n.a. DAP000407 165580 145115 n.a. "paromomycin; Aminosidin; AMINOSIDINE; Hydroxymycin; Paucimycin; Crestomycin; Estomycin; Monomycin A; catenulin; Paromomycin I; Neomycin E; 7542-37-2; Paramomycin Sulfate; Humatin; Paucimycinum; Paromomycinum; Paromomicina; Zygomycin A1; Paromomycine; UNII-61JJC8N5ZK; Gabbromycin; Paromomycin [INN]; Paromomycin (INN); R 400; (1R,2R,3S,4R,6S)-4,6-diamino-2-{[3-O-(2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl)-beta-D-ribofuranosyl]oxy}-3-hydroxycyclohexyl 2-amino-2-deoxy-alpha-D-glucopyranoside; Antibiotic 503-3; 61JJC8N5ZK; Gabromycin; Am" C23H45N5O14 UOZODPSAJZTQNH-LSWIJEOBSA-N (2S,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(2R,3S,4R,5S)-5-[(1R,2R,3S,5R,6S)-3,5-diamino-2-[(2S,3R,4R,5S,6R)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-hydroxycyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxyoxane-3,4-diol n.a. n.a. Yes No No No No No PMDBD313 Erlotinib Therapeutic Substance Approved Drug 183321-74-6 DB00530 PA134687924 D07907 DAP001010 176870 154044 n.a. "Erlotinib; 183321-74-6; N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine; 4-[(3-Ethynylphenyl)amino]-6,7-bis(2-methoxyethoxy)quinazoline; OSI-774; UNII-J4T82NDH7E; NSC 718781; CHEMBL553; J4T82NDH7E; [6,7-BIS(2-METHOXY-ETHOXY)QUINAZOLINE-4-YL]-(3-ETHYNYLPHENYL)AMINE; N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine; CHEBI:114785; NCGC00164574-01; AK142763; [6,7-Bis-(2-methoxy-ethoxy)-quinazolin-4-yl]-(3-ethynyl-phenyl)-amine; DSSTo" C22H23N3O4 AAKJLRGGTJKAMG-UHFFFAOYSA-N N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine OSI Pharma Anticancer Agents Yes Yes Yes No No No PMDBD252 Deflazacort Therapeutic Substance Approved Drug 14484-47-0 DB11921 n.a. D03671 n.a. 189821 164861 n.a. "DEFLAZACORT; 14484-47-0; Oxazacort; Calcort; Azacort; Flantadin; Emflaza; Deflan; Cortax; MDL 458; UNII-KR5YZ6AE4B; Lantadin; DL-458-IT; L-5458; KR5YZ6AE4B; C25H31NO6; MDL-458; Dezacor; DSSTox_CID_378; Deflazacortum [INN-Latin]; DSSTox_RID_75552; DSSTox_GSID_20378; Deflazacortum; Enzocort; Decortil; Deflanil; EINECS 238-483-7; Deflazacort (Calcort); 2-[(4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)-5-hydroxy-4a,6a,8-trimethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphtho[2'',1'':4,5]indeno[1,2-d][1,3]oxazol-6b-yl]-2-oxoethyl acet" C25H31NO6 FBHSPRKOSMHSIF-GRMWVWQJSA-N [2-[(1S,2S,4R,8S,9S,11S,12S,13R)-11-hydroxy-6,9,13-trimethyl-16-oxo-5-oxa-7-azapentacyclo[10.8.0.02,9.04,8.013,18]icosa-6,14,17-trien-8-yl]-2-oxoethyl] acetate n.a. n.a. No Yes No Yes No No PMDBD424 Hexestrol Therapeutic Substance Approved Drug 84-16-2 DB07931 n.a. n.a. n.a. 192197 166848 n.a. "hexestrol; meso-Hexestrol; 84-16-2; Hexoestrol; Hexanoestrol; Hexestrofen; Estra-Plex; Hormoestrol; Mesohexestrol; Synestrol; Erythrohexestrol; Cycloestrol; Estronal; Estrifar; Syntrogene; Synthovo; Extra-plex; Hexron; Threo-hexestrol; Erythro-hexestrol; Hexestrol (VAN); Sinestrol; meso hexestrol; meso-3,4-Di(p-hydroxyphenyl)-n-hexane; UNII-10BI795R7D; CCRIS 9073; meso-3,4-Bis(p-hydroxyphenyl)-n-hexane; Dihydrostilbestrol; HSDB 2149; 4-[(1R,2S)-1-ethyl-2-(4-hydroxyphenyl)butyl]phenol; EINECS 201-518-1; gamma,delta-Di(p-hydroxyphenyl)-hex" C18H22O2 PBBGSZCBWVPOOL-HDICACEKSA-N 4-[(3S,4R)-4-(4-hydroxyphenyl)hexan-3-yl]phenol n.a. n.a. Yes No Yes No No No PMDBD879 Troleandomycin Therapeutic Substance Approved Drug n.a. DB13179 PA127840611 D01322 DAP000411 202225 16707 n.a. "TROLEANDOMYCIN; Triacetyloleandomycin; Oleandomycin triacetate; Oleandocetine; Tribiocillina; Oleandomycin triacetyl ester; Evramicina; Cyclamycin; Troleandomycine; Troleandomicina; Triocetin; Troleandomycinum; Triacetyloleandomycinum; 2751-09-9; Treolmicina; Matromicina; UNII-C4DZ64560D; Oleandomycin, triacetate (ester); CHEBI:45735; C4DZ64560D; TAO; Wytrion; Viamicina; Triolan; Aovine; Treis-Micina; Matromycin T; Tao (VAN); Troleandomycine [INN-French]; Troleandomycinum [INN-Latin]; Troleandomicina [INN-Spanis" C41H67NO15 LQCLVBQBTUVCEQ-QTFUVMRISA-N [(3R,5S,6S,7R,8S,9R,12R,13S,14S,15R)-6-[(2S,3R,4S,6R)-3-acetyloxy-4-(dimethylamino)-6-methyloxan-2-yl]oxy-8-[(2R,4S,5S,6S)-5-acetyloxy-4-methoxy-6-methyloxan-2-yl]oxy-5,7,9,12,13,15-hexamethyl-10,16-dioxo-1,11-dioxaspiro[2.13]hexadecan-14-yl] acetate n.a. n.a. Yes No Yes No No No PMDBD729 Ramelteon Therapeutic Substance Approved Drug 196597-26-9 DB00980 PA164744896 n.a. DAP000070 208902 181000 n.a. "Ramelteon; 196597-26-9; Rozerem; TAK-375; (S)-N-[2-(1,6,7,8-tetrahydro-2H-indeno-[5,4-b]furan-8-yl)ethyl]propionamide; UNII-901AS54I69; CHEMBL1218; (S)-N-(2-(1,6,7,8-tetrahydro-2H-indeno-(5,4)furan-8-yl)ethyl)propionamide; N-[2-[(8S)-2,6,7,8-tetrahydro-1H-cyclopenta[e][1]benzofuran-8-yl]ethyl]propanamide; TAK375; (S)-N-(2-(1,6,7,8-tetrahydro-2H-indeno[5,4-b]furan-8-yl)ethyl)propionamide; 901AS54I69; (-)-N-(2-(((8S)-1,6,7,8-Tetrahydro-2H-indeno(5,4-b)furan-8-yl)ethyl)propanamide; Ramelteon [USAN]; N-{2-[(8S)-1,6,7,8-tetra" C16H21NO2 YLXDSYKOBKBWJQ-LBPRGKRZSA-N N-[2-[(8S)-2,6,7,8-tetrahydro-1H-cyclopenta[e][1]benzofuran-8-yl]ethyl]propanamide Takeda Hypnotics and Sedatives No Yes No No No No PMDBD1141 Darunavir Therapeutic substance Drug 206361-99-1 DB01264 PA163522472 D03656 DAP001086 213039 184733 n.a. "Darunavir; 206361-99-1; Prezista; TMC114; TMC-114; UIC-94017; Darunavirum; TMC 114; Darunavirum [INN-Latin]; UNII-YO603Y8113; CHEMBL1323; (3R,3AS,6AR)-HEXAHYDROFURO[2,3-B]FURAN-3-YL(1S,2R)-3-[[(4-AMINOPHENYL)SULFONYL](ISOBUTYL)AMINO]-1-BENZYL-2-HYDROXYPROPYLCARBAMATE; CHEBI:367163; Darunavir-d9; YO603Y8113; N-((1S,2R)-3-(((4-Aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-benzylpropyl)((1S,2R,5R)-4,6-dioxabicyclo(3.3.0)oct-2-yloxy)carboxamide; NCGC00168773-01" C27H37N3O7S CJBJHOAVZSMMDJ-HEXNFIEUSA-N [(3aS,4R,6aR)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamate n.a. n.a. No Yes No No No No PMDBD1253 Lenalidomide Therapeutic substance Drug 191732-72-6 DB00480 PA162363968 D04687 DAP001255 216326 187515 n.a. "Lenalidomide; 191732-72-6; Revlimid; Revimid; CC-5013; 3-(4-Amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione; Lenalidomide (CC-5013); CDC 501; IMiD3; CC 5013; CDC-501; 3-(4-Amino-1-oxo-1,3-dihydro-2H-isoindol-2-yl)piperidine-2,6-dione; 3-(7-amino-3-oxo-1H-isoindol-2-yl)piperidine-2,6-dione; Revlimid (TN); CHEBI:63791; 1-oxo-2-(2,6-dioxopiperidin-3-yl)-4-aminoisoindoline; NCGC00167491-01; AK-47482" C13H13N3O3 GOTYRUGSSMKFNF-UHFFFAOYSA-N 3-(7-amino-3-oxo-1H-isoindol-2-yl)piperidine-2,6-dione n.a. n.a. No Yes No No No No PMDBD1245 Lacosamide Therapeutic substance Drug 175481-36-4 DB06218 PA166160048 D07299 n.a. 219078 189902 n.a. "Lacosamide; 175481-36-4; Erlosamide; (R)-2-acetamido-N-benzyl-3-methoxypropanamide; Harkoseride; Vimpat; Erlosamide [INN]; SPM 927; SPM-927; UNII-563KS2PQY5; (2R)-2-acetamido-N-benzyl-3-methoxypropanamide; ADD 234037; CHEMBL58323; 563KS2PQY5; (2R)-2-(Acetylamino)-N-benzyl-3-methoxypropanamide; NCGC00253740-01; (2R)-N-benzyl-2-acetamido-3-methoxypropanamide; (R)-2-Acetylamino-N-benzyl-3-methoxy-propionamide; 175481-26-2; 2-(acetylamino)-N-benzyl-3-methoxypropanami" C13H18N2O3 VPPJLAIAVCUEMN-GFCCVEGCSA-N (2R)-2-acetamido-N-benzyl-3-methoxypropanamide n.a. n.a. No Yes No No No No PMDBD188 Cholic acid Herbal Substance Medicinal Herbal Compounds 81-25-4 DB02659 PA166160055 D10699 n.a. 221493 192176 NPC80089 "cholic acid; 81-25-4; Colalin; Cholalic acid; Cholalin; cholate; Cholsaeure; Cholbam; NSC-6135; 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholanic acid; 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholan-24-oic acid; UNII-G1JO7801AE; HSDB 982; (R)-4-((3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-Trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid; Cholic acid [USAN]; 3,7,12-Trihydroxycholanic acid; MFCD00003672; G1JO7801AE" C24H40O5 BHQCQFFYRZLCQQ-OELDTZBJSA-N (4R)-4-[(3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid n.a. n.a. No Yes No No No No PMDBD1182 Estramustine Therapeutic substance Drug 2998-57-4 DB01196 PA449507 D04066 DAP001307 259331 227635 n.a. "estramustine; 2998-57-4; Estramustinum; Estramustina; Estramustinum [INN-Latin]; Estramustina [INN-Spanish]; UNII-35LT29625A; Estradiol 3-(N,N-bis(2-chloroethyl)carbamate); 17beta-Estradiol 3-(bis(2-chloroethyl)carbamate); CHEMBL1575; CHEBI:4868; NSC-89201; 35LT29625A; [(8R,9S,13S,14S,17S)-17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl] N,N-bis(2-chloroethyl)carbamate; NCGC00164581-01; estramustin; DSSTox_CID_26458; DSSTox_RID_81632; DSSTox_GSID_46458; C23H31Cl2NO3; Estradiol 3-[bis(2-chl" C23H31Cl2NO3 FRPJXPJMRWBBIH-RBRWEJTLSA-N [(8R,9S,13S,14S,17S)-17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl] N,N-bis(2-chloroethyl)carbamate n.a. n.a. No Yes No No No No PMDBD751 Ritonavir Therapeutic Substance Approved Drug 155213-67-5 DB00503 PA451260 D00427 DAP000169 392622 347980 n.a. "ritonavir; 155213-67-5; Norvir; ABT-538; Abbott 84538; A-84538; ABBOTT-84538; DRG-0244; UNII-O3J8G9O825; CHEBI:45409; HSDB 7160; RTV; O3J8G9O825; Ritonavir, 98%; NSC693184; NSC-693184; 5-Thiazolylmethyl ((alphaS)-alpha-((1S,3S-1-hydroxy-3-((2S)-2-(3-((2-isopropyl-4-thiazolyl)methyl)-3-methylureido)-3-methylbutyramido)-4-phenylbutyl)phenethyl)carbamate; 1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[[(2S)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1,6-diphenylhexan-2-yl]car" C37H48N6O5S2 NCDNCNXCDXHOMX-XGKFQTDJSA-N 1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[[(2S)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1,6-diphenylhexan-2-yl]carbamate Abbott Laboratories Anti-HIV Agents No Yes No Yes No No PMDBD574 Naringenin "Therapeutic Substance; Herbal Substance" "Investigational Drug; Medicinal Herbal Compounds" 480-41-1 DB03467 PA151958361 n.a. n.a. 439246 388383 NPC32441 "naringenin; 480-41-1; (S)-5,7-Dihydroxy-2-(4-hydroxyphenyl)chroman-4-one; pelargidanon; naringetol; (2S)-Naringenin; salipurpol; Asahina; (S)-Naringenin; Naringenine; Salipurol; UNII-HN5425SBF2; CCRIS 5839; C15H12O5; YSO1; (-)-(2S)-Naringenin; CHEMBL9352; (S)-2,3-Dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one; AI3-23355; HN5425SBF2; CHEBI:17846; NSC 11855; (-)-Naringenin; Flavanone, 4'',5,7-trihydroxy- (8CI); (2S)-5,7-dihydroxy-2-(4-hydrox" C15H12O5 FTVWIRXFELQLPI-ZDUSSCGKSA-N (2S)-5,7-dihydroxy-2-(4-hydroxyphenyl)-2,3-dihydrochromen-4-one n.a. n.a. No Yes No No Yes No rxn02074,rxn16633,rxnDiet162,rxnAdd78 PMDBD1354 Pentostatin Therapeutic substance Drug 53910-25-1 DB00552 PA450863 D00155 DAP000566 439693 388759 n.a. "pentostatin; Deoxycoformycin; Nipent; 53910-25-1; 2''-Deoxycoformycin; CO-Vidarabine; Covidarabine; Vidarbine; NSC-218321; 2''-DCF; YK-176; Co-V; PD-ADI; UNII-395575MZO7; Vira A deaminase inhibitor; 2''-Dexoycoformycin; CI-825; PD-81565; (R)-Deoxycoformycin; 395575MZO7; (8R)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H,6H,7H,8H-imidazo[4,5-d][1,3]diazepin-8-ol; NCGC00182045-01; 8R-2''-Deoxycoformycin; (R)-2''-Deoxycoformycin; Deaminase inhibitor (PD); dCF; NSC 218321; Pentostatinum [INN-Latin]; Pentostatine [INN-French]; Pentost" C11H16N4O4 FPVKHBSQESCIEP-JQCXWYLXSA-N (8R)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7,8-dihydro-4H-imidazo[4,5-d][1,3]diazepin-8-ol n.a. n.a. No Yes No No No No PMDBD1394 Quinidine Therapeutic substance Drug 56-54-2 DB00908 PA451209 D08458 DAP000515 441074 389880 n.a. "quinidine; 56-54-2; (+)-Quinidine; Pitayine; beta-Quinine; (8R,9S)-Quinidine; (9S)-6''-Methoxycinchonan-9-ol; Cin-Quin; Conquinine; Conchinin; Quinidex; Chinidin; Kinidin; Conchinine; chinidinum; quinidina; Quiniduran; Chinidine; UNII-ITX08688JL; Quinaglute; Quinidine sulfate; CHEBI:28593; (S)-[(2R,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl](6-methoxyquinolin-4-yl)methanol; alpha-(6-Methoxy-4-quinolyl)-5-vinyl-2-quinuclidinemethanol; Quinicardine; CHEMBL1294; (1S)-(6-Methoxyquinolin-4-yl)((2R,4S,5R)-5-vinylquinuclidin-2-yl)methan" C20H24N2O2 LOUPRKONTZGTKE-LHHVKLHASA-N (S)-[(2R,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol n.a. n.a. No Yes No No No No PMDBD524 Meropenem Therapeutic Substance Approved Drug 96036-03-2 DB00760 PA164764445 D02222 DAP000441 441130 389924 n.a. "meropenem; 96036-03-2; Merrem; Meropenem anhydrous; Meropenemum; Antibiotic SM 7338; MERONEM; SM-7338; 119478-56-7; MEPM; UNII-YOP6PX0BAO; CHEBI:43968; Meropenemum [INN-Latin]; Meropenem [INN]; Meropenem (INN); Meropenem Hydrate; YOP6PX0BAO; (4R,5S,6S)-3-[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid; Merrem I.V.; ICI-194660" C17H25N3O5S DMJNNHOOLUXYBV-PQTSNVLCSA-N (4R,5S,6S)-3-[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid AstraZeneca Antibiotics Yes No Yes No No No PMDBD415 Griseofulvin "Therapeutic Substance; Herbal Substance" "Approved Drug; Medicinal Herbal Compounds" 126-07-8 DB00400 PA449814 D00209 DAP000539 441140 389934 NPC234053 "griseofulvin; 126-07-8; (+)-Griseofulvin; Amudane; Fulvicin; Grisactin; Grisefuline; Griseofulvina; Grizeofulvin; Griseofulvinum; Grisovin; Grifulvin; Spirofulvin; Grisofulvin; Fulcin; Likuden; Lamoryl; Grysio; Griseofulvine; Poncyl; Curling factor; Griscofulvin; Fulvistatin; Delmofulvina; Greosin; Fulvinil; Fulvina; Fulcine; Murfulvin; Grisetin; Grifulin; Gresfeed; Fungivin; Guservin; Griseomix; Grisactin Ultra; Neo-Fulcin; Biogrisin-FP; Fulvican grisactin; Griseofulvin-forte; Griseofulvin forte; Fulvicin-U/F; Fulvicin P/G; Fulvicin-P/G; Griseofulvi" C17H17ClO6 DDUHZTYCFQRHIY-RBHXEPJQSA-N (2S,5''R)-7-chloro-3'',4,6-trimethoxy-5''-methylspiro[1-benzofuran-2,4''-cyclohex-2-ene]-1'',3-dione n.a. Antifungal Agents No Yes No No No No PMDBD1088 Cefoxitin Therapeutic substance Antibiotics 35607-66-0 DB01331 PA448856 D02345 DAP000452 441199 389981 n.a. "cefoxitin; 35607-66-0; Mefoxin; CEPHOXITIN; Cefoxitinum; Cefoxitina; Rephoxitin; Cefoxitine; Mefoxitin; ceftoxitin; UNII-6OEV9DX57Y; Cenomycin; CFX; CHEBI:209807; CHEMBL996; 6OEV9DX57Y; AK118716; DSSTox_CID_2764; DSSTox_RID_76721; DSSTox_GSID_22764; CA" C16H17N3O7S2 WZOZEZRFJCJXNZ-ZBFHGGJFSA-N (6R,7S)-3-(carbamoyloxymethyl)-7-methoxy-8-oxo-7-[(2-thiophen-2-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid n.a. n.a. Yes No No No No No PMDBD275 Digitoxin "Therapeutic Substance; Herbal Substance" "Approved Drug; Medicinal Herbal Compounds" 71-63-6 DB01396 PA449316 D00297 DAP000120 441207 389987 NPC72260 "digitoxin; Digitoxoside; 71-63-6; Digitoxinum; Unidigin; Crystodigin; Digitoksin; Crystodigin (TN); Cardidigin; Carditoxin; Cardigin; Coramedan; Digitophyllin; Digipural; Tardigal; Digisidin; Acedoxin; Purpurid; Cristapurat; Myodigin; Digimerck; Digicor; UNII-E90NZP2L9U; Digitaline nativelle; DigitoXin, USP; Asthenthilo; Digitoxosidum; Lanatoxin; Digitrin; Natigal; Glucodigin; Digilong; Carditalin; Purodigin; Ditaven; Digitoksim; Monodigitoxoside; Mono-glycocard; De-Tone; Digitoxigenin tridigitoxoside; Crystalline digitalin; Digitossina [DCIT]; Pur" C41H64O13 WDJUZGPOPHTGOT-XUDUSOBPSA-N 3-[(3S,5R,8R,9S,10S,13R,14S,17R)-3-[(2R,4S,5S,6R)-5-[(2S,4S,5S,6R)-5-[(2S,4S,5S,6R)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-14-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one n.a. Antiarrhythmic Agents No Yes No Yes No Yes DIGITOXINt2r,DIHYDRO_DIGITOXINc,EX_digitoxin(e) PMDBD1161 Dimenhydrinate Therapeutic substance Drug 523-87-5 DB00985 PA449338 D00520 DAP000333 441281 10210 n.a. "Prestwick_892; CHEBI:4604; SCHEMBL1249592; HMS1568F12; NCGC00017026-01; 2-(diphenylmethoxy)-N,N-dimethylethanaminium 8-chloro-1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydropurin-7-ide; A829056; 8-chloro-1,3-dimethyl-2-oxo-6-purinolate; 2-(diphenylmethyl)oxyethyl-dimethylammonium; 8-chloranyl-1,3-dimethyl-2-oxidanylidene-purin-6-olate; 2-(diphenylmethyl)oxyethyl-dimethyl-azanium" C24H28ClN5O3 KKRAMGIVRBZVCD-UHFFFAOYSA-N "2-benzhydryloxyethyl(dimethyl)azanium;8-chloro-1,3-dimethyl-2-oxopurin-6-olate" n.a. n.a. No Yes No No No No PMDBD550 Miglitol Therapeutic Substance Approved Drug 72432-03-2 DB00491 PA164776726 D00625 DAP000712 441314 390074 n.a. "MIGLITOL; 72432-03-2; Glyset; (2R,3R,4R,5S)-1-(2-hydroxyethyl)-2-(hydroxymethyl)piperidine-3,4,5-triol; Bay-m-1099; UNII-0V5436JAQW; Miglitol (Glyset); Seibule; CHEMBL1561; CHEBI:6935; 0V5436JAQW; Diastabol; Bay m 1099; Miglitolum [Latin]; 1,5-dideoxy-1,5-[(2-hydroxyethyl)imino]-D-glucitol; Plumarol; DSSTox_CID_3323; (2R,3R,4R,5S)-1-(2-Hydroxyethyl)-2-(hydroxymethyl)-3,4,5-piperidinetriol; DSSTox_RID_76977; DSSTox_GSID_23323; Bay 1099; C8H17NO5; Miglitolum; EINECS 276-661-6; SMR000466381; Glyset (TN); CAS-72432-03-2" C8H17NO5 IBAQFPQHRJAVAV-ULAWRXDQSA-N (2R,3R,4R,5S)-1-(2-hydroxyethyl)-2-(hydroxymethyl)piperidine-3,4,5-triol n.a. Hypoglycemic Agents No Yes No No No No PMDBD1051 Bacampicillin Therapeutic substance Antibiotics 50972-17-3 DB01602 PA164745461 n.a. DAP001162 441397 390135 n.a. "bacampicillin; Bacampicilline; 50972-17-3; bacampicillinum; Bacampicilina; CHEBI:2968; 1''-Ethoxycarbonyloxyethyl-(6-D-alpha-aminophenylacetamido)penicillanate; Bacampicillin [INN:BAN]; BAPC; Bacampicilline [INN-French]; Bacampicilina [INN-Spanish]; Bacampicillinum [INN-Latin]; 1-[(ethoxycarbonyl)oxy]ethyl (2S,5R,6R)-6-{[(2R)-2-amino-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate; UNII-8GM2J22278; 6-((R)-2-Amino-2-phenylacetamido)penicillansaeure-(1-(ethoxycarbonyloxy)ethylester" C21H27N3O7S PFOLLRNADZZWEX-FFGRCDKISA-N 1-ethoxycarbonyloxyethyl (2S,5R,6R)-6-[[(2R)-2-amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate n.a. n.a. Yes No No No No No PMDBD484 Linezolid Therapeutic Substance Approved Drug 165800-03-3 DB00601 PA450233 D00947 DAP000398 441401 390139 n.a. "linezolid; 165800-03-3; Zyvox; (S)-N-((3-(3-fluoro-4-morpholinophenyl)-2-oxooxazolidin-5-yl)methyl)acetamide; Zyvoxid; PNU-100766; Zyvoxam; U-100766; PNU 100766; U 100766; UNII-ISQ9I6J12J; C16H20FN3O4; HSDB 7478; N-(((S)-3-(3-Fluoro-4-morpholinophenyl)-2-oxo-5-oxazolidinyl)methyl)acetamide; CHEMBL126; ISQ9I6J12J; N-[[(5S)-3-[3-fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide; N-[[(5S)-3-(3-fluoro-4-morpholin-4-ylphenyl)-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide; CHEBI:63607; Linezolid, 98%; Acetamide, N-[" C16H20FN3O4 TYZROVQLWOKYKF-ZDUSSCGKSA-N N-[[(5S)-3-(3-fluoro-4-morpholin-4-ylphenyl)-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide Pfizer Pharmaceuticals Antibiotics Yes Yes Yes No No No PMDBD392 Ginsenoside Re Herbal Substance Medicinal Herbal Compounds n.a. n.a. n.a. n.a. n.a. 441921 n.a. NPC208594 "Ginsenoside Re; 52286-59-6; Ginsenoside B2; Panaxoside RE; ginsenoside-Re; UNII-46F3R0BL3I; Chikusetsusaponin IVc; 51542-56-4; NSC 308877; CHEMBL510095; 46F3R0BL3I; CHEBI:77148; EINECS 257-814-6; NSC-308877; 2-O-(6-Deoxy-alpha-L-mannopyranosyl)-(3beta,6alpha,12beta)-20-(beta-D-glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl-beta-D-glucopyranoside; (20S)-ginsenoside Re; SCHEMBL669738; CTK8F0918; HY-N" C48H82O18 PWAOOJDMFUQOKB-WCZZMFLVSA-N (2S,3R,4R,5R,6S)-2-[(2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-[(2S)-6-methyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-6-methyloxane-3,4,5-triol n.a. n.a. No Yes No No No No PMDBD393 Ginsenoside Rf Herbal Substance Medicinal Herbal Compounds n.a. n.a. n.a. n.a. n.a. 441922 n.a. NPC245280 "Ginsenoside Rf; 52286-58-5; ginsenoside-rf; UNII-JOS8BON5YW; Panaxoside RF; JOS8BON5YW; CHEBI:67986; GINSENOSIDE- RF; CHEMBL1773987; DTXSID90904205; Ginsenoside Rf, analytical standard; HY-N0601; MFCD00210509; AKOS027251120; ZINC238809500; CS-3841; SC-46561; AS-56543; X1153; N1917; C08945; 286G585; Q-100589; Q27104950; Ginsenoside Rf, primary pharmaceutical reference standard; (beta,6alpha,12beta)-3,12,20-trihydroxydammar-24-en-6-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside; (3beta,6alpha,12beta)-3,12,20-Trihydroxydammar-24-e" C42H72O14 UZIOUZHBUYLDHW-XUBRWZAZSA-N (2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-17-[(2S)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol n.a. n.a. No Yes No No No No PMDBD394 Ginsenoside Rg1 Herbal Substance Medicinal Herbal Compounds 22427-39-0 DB06750 n.a. n.a. n.a. 441923 390498 NPC114874 "Ginsenoside RG1; 22427-39-0; Panaxoside A; Sanchinoside C1; Panaxoside Rg1; Ginsenoside A2; Sanchinoside Rg1; UNII-PJ788634QY; (20S)-ginsenoside Rg1; CHEBI:67987; PJ788634QY; (3beta,6alpha,12beta)-3,12-Dihydroxydammar-24-ene-6,20-diyl bis-beta-D-Glucopyranoside; Ginsenoside g1; CHEMBL501637; Panaxoside A;; Ginsenoside A2;; Ginsenoside Rg1;; EINECS 244-989-9; Panax ginseng extract; Dammarane, -D-glucopyranoside; BIDD:ER0075; SCHEMBL19875635" C42H72O14 YURJSTAIMNSZAE-HHNZYBFYSA-N (2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-[(2S)-6-methyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol n.a. n.a. No Yes No No No No PMDBD665 Phorbol Herbal Substance Medicinal Herbal Compounds n.a. n.a. n.a. n.a. n.a. 442070 n.a. NPC163004 "PHORBOL; 17673-25-5; UNII-XUZ76S9127; CHEBI:8116; 4beta-Phorbol; 4-beta-Phorbol; XUZ76S9127; (1aR,1bS,4aR,7aS,7bS,8R,9R,9aS)-4a,7b,9,9a-tetrahydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-1,1a,1b,4,4a,7a,7b,8,9,9a-decahydro-5H-cyclopropa[3,4]benzo[1,2-e]azulen-5-one; 4,9,12-beta,13,20-Pentahydroxy-1,6-tigliadien-3-on; CCRIS 694; 4,9,12beta,13,20-pentahydroxy-1,6-tigliadien-3-on; 4,9,12beta,13,20-pentahydroxytiglia-1,6-dien-3-one; HSDB 4328; 4-.beta.-Phorbol; NSC 154778" C20H28O6 QGVLYPPODPLXMB-UBTYZVCOSA-N (1S,2S,6R,10S,11R,13S,14R,15R)-1,6,13,14-tetrahydroxy-8-(hydroxymethyl)-4,12,12,15-tetramethyltetracyclo[8.5.0.02,6.011,13]pentadeca-3,8-dien-5-one n.a. n.a. No Yes No Yes No No PMDBD575 Naringin Herbal Substance Anti-oxidant, anti-cancer and blood cholesterol lowering effect n.a. n.a. n.a. n.a. n.a. 442428 n.a. NPC142860 "naringin; 10236-47-2; Naringoside; Naringin hydrate; UNII-N7TD9J649B; Naringenin 7-O-neohesperidoside; Naringenine-7-rhamnosidoglucoside; 4''5-diOH-Flavone-7-rhgluc; N7TD9J649B; CHEMBL451532; CHEBI:28819; C27H32O14; aurantiin; Naringenin 7-Rhamnoglucoside; Naringenin-7-beta-neohesperidoside; Naringenin 7-O-[alpha-L-rhamnosyl-(1->2)-beta-D-glucoside]; EINECS 233-566-4; 7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)-2,3-d" C27H32O14 DFPMSGMNTNDNHN-ZPHOTFPESA-N (2S)-7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)-2,3-dihydrochromen-4-one n.a. n.a. No Yes No No No No PMDBD645 Pedunculagin Herbal Substance Medicinal Herbal Compounds n.a. n.a. n.a. n.a. n.a. 442688 n.a. NPC31034 "Pedunculagin; CHEMBL506204; CHEBI:7948; 7045-42-3; C10236; DTXSID20990656; BDBM50242262; Q7160092; 2,3,4,5,6,7,11,17,18,19,20,21,22-Tridecahydroxy-10a,11,12a,13,25a,25b-hexahydrodibenzo[g,i]dibenzo[6'',7'':8'',9''][1,4]dioxecino[2'',3'':4,5]pyrano[3,2-b][1,5]dioxacycloundecine-9,15,24,27-tetrone" C34H24O22 IYMHVUYNBVWXKH-ZITZVVOASA-N (1R,2S,19R,22R)-7,8,9,12,13,14,20,28,29,30,33,34,35-tridecahydroxy-3,18,21,24,39-pentaoxaheptacyclo[20.17.0.02,19.05,10.011,16.026,31.032,37]nonatriaconta-5,7,9,11,13,15,26,28,30,32,34,36-dodecaene-4,17,25,38-tetrone n.a. n.a. No Yes No No No No PMDBD1463 Tolvaptan Therapeutic substance Drug 150683-30-0 DB06212 n.a. D01213 n.a. 443894 391976 n.a. "(R)-(+)-Tolvaptan; 331947-66-1; UNII-1E2497LPNY; 1E2497LPNY; (R)-N-(4-(7-chloro-5-hydroxy-2,3,4,5-tetrahydro-1H-benzo[b]azepine-1-carbonyl)-3-methylphenyl)-2-methylbenzamide; N-[4-[[(5R)-7-chloro-5-hydroxy-2,3,4,5-tetrahydro-1-benzazepin-1-yl]-oxomethyl]-3-methylphenyl]-2-methylbenzamide; Samsca (TN); Tolvaptan (JAN/USAN/INN); MLS006011965; SCHEMBL1650272; CHEMBL4303142; QCR-237; DTXSID00332136; ZINC538658; N-[4-[(7-Chloro-2,3,4,5-tetrahydro-5-hydroxy-1H-1-benzazepin-1-yl)carbonyl]-3-methylphenyl]-2-methy" C26H25ClN2O3 GYHCTFXIZSNGJT-XMMPIXPASA-N N-[4-[(5R)-7-chloro-5-hydroxy-2,3,4,5-tetrahydro-1-benzazepine-1-carbonyl]-3-methylphenyl]-2-methylbenzamide n.a. n.a. No Yes No No No No PMDBD897 Vinpocetine Therapeutic Substance Approved Drug 42971-09-5 DB12131 n.a. n.a. n.a. 443955 392007 n.a. "vinpocetine; 42971-09-5; Cavinton; Ceractin; Apovincaminic acid ethyl ester; Ethyl apovincamin-22-oate; TCV-3B; Ethyl (+)-apovincaminate; RGH-4405; Vinpocetinum [INN-Latin]; cis-Apovincaminic acid ethyl ester; RGH 4405; (+)-Apovincaminic acid ethyl ester; Ethyl (+)-cis-apovincaminate; (+)-cis-Apovincaminic acid ethyl ester; Apovincaminate d''ethyle [French]; AY 27,255; UNII-543512OBTC; 3-alpha,16-alpha-Apovincaminic acid ethyl ester; Eburnamenine-14-carboxylic acid ethyl ester; Ethyl apovincaminate; EINECS 256-028-0; BRN 0900803" C22H26N2O2 DDNCQMVWWZOMLN-IRLDBZIGSA-N ethyl (15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaene-17-carboxylate n.a. Vasodilator Agents No Yes No Yes No No PMDBD898 Voglibose Therapeutic Substance Investigational Drug 83480-29-9 DB04878 PA164752433 D01665 DAP001104 444020 392046 n.a. "voglibose; 83480-29-9; Glustat; Basen; AO-128; UNII-S77P977AG8; A-71100; CHEMBL476960; S77P977AG8; Voglibose [USAN:INN]; Voglibosum [INN-Latin]; Voglibosa [INN-Spanish]; DSSTox_CID_1442; DSSTox_RID_76161; DSSTox_GSID_21442; (1S,2S,3R,4S,5S)-5-[(1,3-dihydroxypropan-2-yl)amino]-1-(hydroxymethyl)cyclohexane-1,2,3,4-tetrol; (1S,2S,3R,4S,5S)-5-((1,3-dihydroxypropan-2-yl)amino)-1-(hydroxymethyl)cyclohexane-1,2,3,4-tetraol; CCRIS 4540; Voglibosum; Voglibosa; Basen OD; 3,4-Dideoxy-4-((2-hydroxy-1-(hydroxymethyl)ethyl)amino)-2-C-(hydrox" C10H21NO7 FZNCGRZWXLXZSZ-CIQUZCHMSA-N (1S,2S,3R,4S,5S)-5-(1,3-dihydroxypropan-2-ylamino)-1-(hydroxymethyl)cyclohexane-1,2,3,4-tetrol Takeda Hypoglycemic Agents No Yes No No No No PMDBD1140 Darifenacin Therapeutic substance Drug 133099-04-4 DB00496 PA164774901 D01699 DAP001131 444031 392054 n.a. "Darifenacin; Enablex; Emselex; 133099-04-4; UNII-APG9819VLM; UK-88525; APG9819VLM; CHEMBL1346; (S)-1-(2-(2,3-Dihydro-5-benzofuranyl)ethyl)-alpha,alpha-diphenyl-3-pyrrolidineacetamide; CHEBI:391960; 2-[(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl]-2,2-diphenylacetamide; [3H]darifenacin; 2-{(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide; NCGC00168775-01; Darifenacin (USAN/INN); Darifenacin [USAN:INN:BAN]; 2-[(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-y" C28H30N2O2 HXGBXQDTNZMWGS-RUZDIDTESA-N 2-[(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl]-2,2-diphenylacetamide n.a. n.a. No Yes No No No No PMDBD740 Resveratrol "Therapeutic Substance; Herbal Substance" "Approved Drug; Medicinal Herbal Compounds" 501-36-0 DB02709 PA165291838 n.a. DNC001205 445154 392875 NPC161571 "resveratrol; 501-36-0; trans-resveratrol; 3,4'',5-Trihydroxystilbene; 3,5,4''-Trihydroxystilbene; (E)-5-(4-Hydroxystyryl)benzene-1,3-diol; (E)-resveratrol; 3,4'',5-Stilbenetriol; 5-[(E)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol; Resvida; 3,4'',5-Trihydroxy-trans-stilbene; SRT-501; SRT501; 5-[(1E)-2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol; 3,5,4''-Trihydroxy-trans-stilbene; Resveratol; trans-3,4'',5-trihydroxystilbene; 5-[(E)-2-(4-hydroxyphenyl)vinyl]benzene-1,3-diol; Resveratrol, natural; UNII-Q369O8926L; CHEBI:45713; C14H12O3; tr" C14H12O3 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 5-[(E)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol Sirtris Pharma n.a. Yes Yes Yes Yes Yes No rxn02968,rxnDiet197,rxnAdd218,rxnAdd219 PMDBD821 Tacrolimus "Therapeutic Substance; Herbal Substance" reduce the activity of the patient''s immune system 104987-11-3 DB00864 PA451578 D00107 DAP000162 445643 393220 NPC99864 "tacrolimus; 104987-11-3; Prograf; Protopic; Fujimycin; FK506; Tacrolimus anhydrous; Advagraf; Modigraf; Protopy; Fk-506; Anhydrous Tacrolimus; tacrolimus (fk506); Tsukubaenolide; FR-900506; LCP-Tacro; FK 506; 8-DEETHYL-8-[BUT-3-ENYL]-ASCOMYCIN; UNII-Y5L2157C4J; Astagraf XL; Tacrolimus hydrate; (-)-FK 506; Prograf (TN); FR900506; CHEMBL269732; CHEBI:61049; Y5L2157C4J; TACROLIMUS MONOHYDRATE; K506; Tacrolimus (anhydrous); NCGC00163470-03; Prograft; Tacrolimus [USAN]; CCRIS 7124; Graceptor; Envarsus; Avagraf; L 679934; Envarsus XR" C44H69NO12 QJJXYPPXXYFBGM-LFZNUXCKSA-N (1R,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-1,14-dihydroxy-12-[(E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-17-prop-2-enyl-11,28-dioxa-4-azatricyclo[22.3.1.04,9]octacos-18-ene-2,3,10,16-tetrone "Fujisawa; Sucampo" Immunosuppressive Agents No Yes No Yes No No PMDBD755 Rosuvastatin Therapeutic Substance lipid-lowering drug 287714-41-4 DB01098 PA134308647 D08492 DAP000555 446157 393589 n.a. "Rosuvastatin; 287714-41-4; ZD4522; UNII-413KH5ZJ73; CHEMBL1496; CHEBI:38545; 413KH5ZJ73; ZD-4522; (3R,5S,6E)-7-[4-(4-fluorophenyl)-2-(N-methylmethanesulfonamido)-6-(propan-2-yl)pyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid; (3R,5S,6E)-7-{4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl}-3,5-dihydroxyhept-6-enoic acid; (3R,5S,6E)-7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(ethyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid; (E)-7-[4-(4-Fluorophenyl)-6-isopropyl-2-[meth" C22H28FN3O6S BPRHUIZQVSMCRT-VEUZHWNKSA-N (E,3R,5S)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid AstraZeneca Anticholesteremic Agents No Yes No Yes No No PMDBD1306 Mycophenolic Acid Therapeutic substance Drug 24280-93-1 DB01024 PA164748728 n.a. DAP000784 446541 393865 n.a. "mycophenolic acid; 24280-93-1; Mycophenolate; Myfortic; Melbex; Mycophenolsaeure; Lilly-68618; 6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoic acid; Acido micofenolico; Micofenolico acido; NSC-129185; Acide mycophenolique; Acidum mycophenolicum; CCRIS 5565; NSC 129185; UNII-HU9DX48N0T; (4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydro-2-benzofuran-5-yl)-4-methylhex-4-enoic acid; 483-60-3; Ly 68618; Micofenolico acido [Spanish]; Acido micofenolico [INN-Spanish]; Acidum mycophenolicum [INN-Latin]; Acid" C17H20O6 HPNSFSBZBAHARI-RUDMXATFSA-N (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-5-yl)-4-methylhex-4-enoic acid n.a. n.a. No Yes No No No No PMDBD1122 Clindamycin Therapeutic substance Antibiotics 18323-44-9 DB01190 PA449035 D00277 DAP000409 446598 27005 n.a. "clindamycin; 18323-44-9; Dalacine; Chlolincocin; Clinimycin; Dalacin C; Sobelin; Cleocin; UNII-3U02EL437C; 7-Chlorolincomycin; 7-Chloro-7-deoxylincomycin; Clindamycine; Antirobe; Klimicin; ClindaDerm; 3U02EL437C; U 21251; Klindan 300; 7-Deoxy-7(S)-chlorolincomycin; 7(S)-Chloro-7-deoxylincomycin; C18H33ClN2O5S; methyl 7-chloro-6,7,8-trideoxy-6-{[(4R)-1-methyl-4-propyl-L-prolyl]amino}-1-thio-L-threo-alpha-D-galacto-octopyranoside; HSDB 3037; Clindamycinum; Clindamicina; U-21251; EINECS 242-209-1; (2S,4R)-N-((1S,2S)-2-chloro-1-((2R,3R,4" C18H33ClN2O5S KDLRVYVGXIQJDK-AWPVFWJPSA-N (2S,4R)-N-[(1S,2S)-2-chloro-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide n.a. n.a. Yes Yes No No No No PMDBD123 Brivudine Therapeutic Substance Therapeutic Substance 69304-47-8 DB03312 n.a. n.a. n.a. 446727 394011 n.a. "Brivudine; 69304-47-8; BVDU; Brivudin; Helpin; (E)-5-(2-Bromovinyl)-2''-deoxyuridine; Bromovinyldeoxyuridine; Zostex; Brivudine [INN]; 5-BROMOVINYLDEOXYURIDINE; Brivudinum [INN-Latin]; Brivudina [INN-Spanish]; (E)-5-(2-Bromovinyl)-deoxyuridine; C11H13BrN2O5; CCRIS 2831; UNII-2M3055079H; 5-(2-bromovinyl)-2''-deoxyuridine; NSC 633770; trans-5-(2-Bromovinyl)-2''-deoxyuridine; Brivudine (INN); RP-101; MFCD00058585; NCGC00093656-01; 2M3055079H" C11H13BrN2O5 ODZBBRURCPAEIQ-PIXDULNESA-N 5-[(E)-2-bromoethenyl]-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione n.a. n.a. No Yes No No No Yes BRVt2,BRVt2pp,BRVtex,EX_brv(e),PYNP_BRV PMDBD1206 Fosfomycin Therapeutic substance Antibiotics 23155-02-4 DB00828 PA164748039 D04253 DAP000767 446987 394204 n.a. "FOSFOMYCIN; phosphomycin; Phosphonomycin; 23155-02-4; Fosfonomycin; Fosfocina; Veramina; Fosfomicina; Fosfomycinum; Fosfomycine; Antibiotic 833A; Phosphonemycin; [(2R,3S)-3-methyloxiran-2-yl]phosphonic acid; UNII-2N81MY12TE; (2R-cis)-(3-Methyloxiranyl)phosphonic acid; (1R,2S)-epoxypropylphosphonic acid; L-cis-1,2-epoxypropylphosphonic acid; (-)-(1R,2S)-(1,2-Epoxypropyl)phosphonic acid; CHEMBL1757; 2N81MY12TE; CHEBI:28915; FCM; (1R,2" C3H7O4P YMDXZJFXQJVXBF-STHAYSLISA-N [(2R,3S)-3-methyloxiran-2-yl]phosphonic acid n.a. n.a. Yes No No No No No PMDBD88 Azithromycin Therapeutic Substance Approved Drug 83905-01-5 DB00207 PA448519 n.a. DNC001539 447043 10482163 n.a. "azithromycin; Zithromax; 83905-01-5; Sumamed; Zitromax; Zmax; Azithromycinum; Azithromycine; Hemomycin; Azitrocin; Azasite; Azenil; Zitrotek; Misultina; Zithrax; Azitromax; Mixoterin; Setron; Aziwok; Zitrim; Tromix; Aztrin; Zifin; Tobil; Zmas; Zeto; Azithromycinum [Latin]; Azithromycine [French]; Zithromax IV; AZITHROMYCIN DIHYDRATE; CP-62993; Z-Pak; Aritromicina [Spanish]; CP 62993; UNII-J2KLZ20U1M; DRG-0104; C38H72N2O12; CCRIS 1961; HSDB 7205; Azithromycin (anhydrous); BRN 5387583; J2KLZ20U1M; Azythromycin; CHEBI:2955; Azithromycin (AIDS Initiative" C38H72N2O12 MQTOSJVFKKJCRP-BICOPXKESA-N (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,6,8,10,12,14-heptamethyl-1-oxa-6-azacyclopentadecan-15-one n.a. n.a. Yes Yes Yes No No No PMDBD520 Melphalan Therapeutic Substance Approved Drug 148-82-3 DB01042 PA450354 D00369 DAP000791 460612 405297 n.a. "melphalan; 148-82-3; Alkeran; Melfalan; L-PAM; Phenylalanine mustard; L-Sarcolysine; L-Sarcolysin; L-Phenylalanine mustard; p-L-Sarcolysin; Levofalan; Melphalanum; Levopholan; Melfalano; Levofolan; L-Sarkolysin; 4-[Bis(2-chloroethyl)amino]-L-phenylalanine; Phenylalanine nitrogen mustard; p-Di-(2-chloroethyl)amino-L-phenylalanine; p-Bis(beta-chloroethyl)aminophenylalanine; 3-(p-(Bis(2-chloroethyl)amino)phenyl)-L-alanine; Melphalanum [INN-Latin]; p-N-Bis(2-chloroethyl)amino-L-phenylalanine; Melfalano [INN-Spanish]; 4-(Bis(2-chloroet" C13H18Cl2N2O2 SGDBTWWWUNNDEQ-LBPRGKRZSA-N (2S)-2-amino-3-[4-[bis(2-chloroethyl)amino]phenyl]propanoic acid n.a. Anticancer Agents Yes Yes No Yes No No PMDBD1372 Posaconazole Therapeutic substance Drug 171228-49-2 DB01263 PA151958574 D02555 DAP001101 468595 411709 n.a. "Posaconazole; 171228-49-2; Noxafil; Sch 56592; Posaconazole SP; SCH56592; SCH-56592; UNII-6TK1G07BHZ; Schering 56592; CHEMBL1397; 6TK1G07BHZ; 4-[4-[4-[4-[[(3R,5R)-5-(2,4-difluorophenyl)-5-(1,2,4-triazol-1-ylmethyl)oxolan-3-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-2-[(2S,3S)-2-hydroxypentan-3-yl]-1,2,4-triazol-3-one; 4-(4-(4-(4-(((3R,5R)-5-((1H-1,2,4-TRIAZOL-1-YL)METHYL)-5-(2,4-DIFLUOROPHENYL)TETRAHYDROFURAN-3-YL)METHOXY)PHENYL)PIPERAZIN-1-YL)PHENYL)-1-((2S,3S)-2-HYDROXYPENTAN-3-YL)-1H-1,2,4-TRIAZOL-5(4H)-ONE; CHEBI:6435" C37H42F2N8O4 RAGOYPUPXAKGKH-XAKZXMRKSA-N 4-[4-[4-[4-[[(3R,5R)-5-(2,4-difluorophenyl)-5-(1,2,4-triazol-1-ylmethyl)oxolan-3-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-2-[(2S,3S)-2-hydroxypentan-3-yl]-1,2,4-triazol-3-one n.a. n.a. Yes Yes No No No No PMDBD780 Shikonin Herbal Substance Medicinal Herbal Compounds n.a. n.a. n.a. n.a. n.a. 479503 n.a. NPC246693 "shikonin; 517-89-5; Isoarnebin 4; (R)-5,8-Dihydroxy-2-(1-hydroxy-4-methylpent-3-en-1-yl)naphthalene-1,4-dione; (-)-Shikonin; (+)-Shikonin; 5,8-Dihydroxy-2-[(1R)-1-hydroxy-4-methyl-pent-3-enyl]naphthalene-1,4-dione; Tokyo Violet; CHEBI:81068; NSC 252844; CCRIS 6492; Shikonin S; 5,8-dihydroxy-2-[(1R)-1-hydroxy-4-methylpent-3-en-1-yl]-1,4-dihydronaphthalene-1,4-dione; BRN 2058010; (R)-(+)-Shikonin; SR-05000001466; HSDB 8100; (+)-5,8-Dihydroxy-2-(1-hydroxy-4-methyl-3-pentenyl)-1,4-naphthoquinone; 1,4-Naphthalenedione, 5,8-dihydr" C16H16O5 NEZONWMXZKDMKF-SNVBAGLBSA-N 5,8-dihydroxy-2-[(1R)-1-hydroxy-4-methylpent-3-enyl]naphthalene-1,4-dione n.a. n.a. No Yes No No No No PMDBD856 Tolfenamic acid Therapeutic Substance Approved Drug 13710-19-5 DB09216 PA166049189 D01183 n.a. 610479 530683 n.a. "tolfenamic acid; 13710-19-5; Clotam; Tolfedine; 2-[(3-Chloro-2-methylphenyl)amino]benzoic Acid; N-(3-Chloro-2-methylphenyl)anthranilic acid; Acido tolfenamico; Acide tolfenamique; Acidum tolfenamicum; GEA 6414; 2-(3-Chloro-2-methylanilino)benzoic acid; N-(2-Methyl-3-chlorophenyl)anthranilic acid; UNII-3G943U18KM; N-(3-Chloro-o-tolyl)-anthranilic acid; N-(3-Chloro-ortho-tolyl) anthranilic acid; CHEBI:32243; 3G943U18KM; NCGC00016705-05" C14H12ClNO2 YEZNLOUZAIOMLT-UHFFFAOYSA-N 2-(3-chloro-2-methylanilino)benzoic acid n.a. n.a. Yes No Yes No No Yes EX_tlf_a(e),TAT_GLCAASE,TAT_GLCAASEe,TAT_GLCAASEepp,TLF_Ate,TLF_Atepp,TLF_Atex PMDBD1327 Oleic acid Dietary Substances a naturally occurring fatty acid 112-80-1 DB04224 n.a. D02315 n.a. 637517 553123 n.a. "Elaidic acid; 112-79-8; trans-Oleic acid; 9-octadecenoic acid; trans-9-Octadecenoic acid; (E)-octadec-9-enoic acid; (E)-Oleic acid; trans-Octadec-9-enoic acid; (9E)-octadec-9-enoic acid; Elaidinsaeure; Elaidinsaure; acide elaidique; 9-elaidic acid; trans-Elaidic acid; Octadec-9-enoic acid; 9E-octadecenoic acid; UNII-4837010H8C; trans-.DELTA.9-Octadecenoic acid; (9E)-Octadecenoic acid; EINECS 204-006-6; MFCD00063954; NSC 26988; 9-trans-Octadecenoic acid; trans-delta(sup 9)-Octad" C18H34O2 ZQPPMHVWECSIRJ-MDZDMXLPSA-N (E)-octadec-9-enoic acid n.a. n.a. No Yes No No No No PMDBD5 2-chloro-5-nitro-N-phenylbenzamide Therapeutic Substance Investigational Drug n.a. DB07863 n.a. n.a. n.a. 644213 559235 n.a. "GW9662; 22978-25-2; 2-Chloro-5-nitro-N-phenylbenzamide; GW 9662; 2-Chloro-5-nitrobenzanilide; GW-9662; MLS001056751; CHEBI:79993; MFCD01215270; 2-Chloro-5-nitro-N-phenyl-benzamide; 2-Chloro-5-nitro-N-4-phenylbenzamide; SMR000326735; (2-chloro-5-nitrophenyl)-N-benzamide; SR-01000075999; Tocris-1508; Spectrum5_001989; Lopac-M-6191; DSSTox_RID_79570; DSSTox_CID_20723; Lopac0_000798; DSSTox_GSID_40723; KBioSS_000361; BSPBio_001021; KBioGR_000361; SCHEMBL420231; CHEMBL375270; GTPL3442; cid_644213; DTXS" C13H9ClN2O3 DNTSIBUQMRRYIU-UHFFFAOYSA-N 2-chloro-5-nitro-N-phenylbenzamide n.a. n.a. No Yes No No No No PMDBD1294 Mezlocillin Therapeutic substance Antibiotics 51481-65-3 DB00948 PA164750540 D05021 DAP001180 656511 570894 n.a. "MEZLOCILLIN; 51481-65-3; Mezlin; Mezlocillinum; Mezlocilline; Mezlocilina; MEZLOCILLIN SODIUM; Multocillin; Mezlocillin acid; UNII-OH2O403D1G; CHEBI:6919; OH2O403D1G; (2S,5R,6R)-3,3-dimethyl-6-{[(2R)-2-({[3-(methylsulfonyl)-2-oxoimidazolidin-1-yl]carbonyl}amino)-2-phenylacetyl]amino}-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; 6beta-{(2R)-2-[3-(methanesulfonyl)-2-oxoimidazolidine-1-carboxamido]-2-phenylacetamido}penicillanic acid; NCGC00167470-01; Mezlocillinum [INN-Latin]; Mezlocilline [INN-French]; Mezlocil" C21H25N5O8S2 YPBATNHYBCGSSN-VWPFQQQWSA-N (2S,5R,6R)-3,3-dimethyl-6-[[(2R)-2-[(3-methylsulfonyl-2-oxoimidazolidine-1-carbonyl)amino]-2-phenylacetyl]amino]-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid n.a. n.a. Yes No No No No No PMDBD44 Amygdalin "Herbal Substance; Dietary Substance" Herbal Substance n.a. n.a. n.a. n.a. n.a. 656516 n.a. NPC266389 "amygdalin; 29883-15-6; (R)-Amygdalin; D-Amygdalin; (R)-Laenitrile; (R)-Amygdaloside; UNII-214UUQ9N0H; D(-)-Mandelonitrile-beta-D-gentiobioside; D-Mandelonitrile-beta-D-glucosido-6-beta-D-glucoside; Amygdaloside; 214UUQ9N0H; R-Amygdalin; CHEBI:17019; Vitamin B17; Mandelonitrile-beta-gentiobioside; 6-O-BETA-D-GLUCOSIDO-BETA-D-GLUCOSIDE; (2R)-[(6-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)oxy](phenyl)acetonitrile; HSDB 3559; EINECS 249-925-3; NSC-15780; NSC 15780; BRN 0066856; Benzeneacetonitrile, alpha-((6-O-beta-D-glucopyranos" C20H27NO11 XUCIJNAGGSZNQT-JHSLDZJXSA-N (2R)-2-phenyl-2-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyacetonitrile n.a. n.a. No Yes No No No No PMDBD1337 Oxtriphylline Therapeutic substance Drug 4499-40-5 DB01303 PA164748137 D02017 DAP000868 656652 25044543 n.a. "OXTRIPHYLLINE; Choline theophyllinate; 4499-40-5; Choline theophylline; UNII-3K045XR58X; Oxtriphylline [USP]; Choline salt with theophylline (1:1); 3K045XR58X; Oxtriphylline (USP); Choline theophyllinate (INN); Choline theophyllinate [INN]; Theocolin; Colina teofillinato; Cholini theophyllinas; Teofilinato de colina; Oxtriphylline pediatric; Theophyllinate de choline; cholintheophyllinat; Theocolin (TN); Choline thieophyllinate; Theophyline and choline; Choline theophylline (JAN); SCHEMBL4629; SCHEMBL152854; CHEMBL1200434; DTXSID20" C12H21N5O3 SOELXOBIIIBLRJ-UHFFFAOYSA-M "1,3-dimethyl-2-oxopurin-6-olate;2-hydroxyethyl(trimethyl)azanium" n.a. n.a. No Yes No No No No PMDBD359 Fludarabine Therapeutic Substance Approved Drug 21679-14-1 DB01073 PA449655 D01907 DAP000567 657237 571392 n.a. "Fludarabine; 21679-14-1; F-Ara-A; 2-Fluoro Ara-A; 9-beta-D-Arabinofuranosyl-2-fluoroadenine; (2R,3S,4S,5R)-2-(6-Amino-2-fluoro-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol; Fludarabine [INN]; Fludarabinum [Latin]; Fludarabina [Spanish]; 2-F-ara-A; Fludarabine (INN); NSC 118218; CCRIS 3382; Fludarabine (Fludara); (2R,3S,4S,5R)-2-(6-amino-2-fluoro-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol; 2-Fluoro-9-beta-D-arabinofuranosyladenine; (2R,3S,4S,5R)-2-(6-amino-2-fluoropurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-d" C10H12FN5O4 HBUBKKRHXORPQB-FJFJXFQQSA-N (2R,3S,4S,5R)-2-(6-amino-2-fluoropurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol Genzyme Corp Anticancer Agents Yes Yes No Yes No No PMDBD1389 Propylthiouracil Therapeutic substance Drug 51-52-5 DB00550 PA451156 D00562 DAP001247 657298 571424 n.a. "propylthiouracil; 51-52-5; 6-Propyl-2-thiouracil; Propacil; Procasil; Prothiurone; Prothyran; 2-Mercapto-6-propylpyrimidin-4-ol; Propycil; Thiuragyl; Protiural; Prothiucil; Prothycil; Propyl-Thiorist; Propyl-Thyracil; 6-N-Propylthiouracil; Propythiouracil; Propilthiouracil; 6-Propylthiouracil; Propyl-Thiorit; Propylthiorit; Thyreostat II; 6-Thio-4-propyluracil; 6-propyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one; 6-N-Propyl-2-thiouracil; Propylthiouracile; PTU (thyreostatic); Propiltiouracilo; 4-Propyl-2-thiouracil; Propylthiouracilum; 2-M" C7H10N2OS KNAHARQHSZJURB-UHFFFAOYSA-N 6-propyl-2-sulfanylidene-1H-pyrimidin-4-one n.a. n.a. No Yes No No No No PMDBD1169 Doxepin Therapeutic substance Drug 1668-19-5 DB01142 PA449409 D07875 DAP000177 667468 3046 n.a. "doxepin; Cidoxepin; cis-doxepin; Doxepine; (Z)-Doxepin; UNII-F96TTB8728; 1668-19-5; Cidoxepinum; Cidoxepina; CHEMBL101740; 3607-18-9; CHEBI:36691; F96TTB8728; Cidoxepin [INN]; 3-Dibenz[b,e]oxepin-11(6H)-ylidene-N,N-dimethyl-1-propanamine; (3Z)-3-dibenzo[b,e]oxepin-11(6H)-ylidene-N,N-dimethylpropan-1-amine; (3z)-3-(Dibenzo[b,E]oxepin-11(6h)-Ylidene)-N,N-Dimethylpropan-1-Amine; Doxepin (Z)-isomer" C19H21NO ODQWQRRAPPTVAG-BOPFTXTBSA-N (3Z)-3-(6H-benzo[c][1]benzoxepin-11-ylidene)-N,N-dimethylpropan-1-amine n.a. n.a. No Yes No No No No PMDBD268 Dienestrol "Therapeutic Substance; Herbal Substance" "Approved Drug; Medicinal Herbal Compounds" 13029-44-2 DB00890 PA164745534 D00898 DAP001015 667476 580857 NPC26244 "dienestrol; Dehydrostilbestrol; Dienoestrol; 84-17-3; (E,E)-Dienestrol; Cycladiene; Dienol; Estraguard; Dehydrostilboestrol; Oestrodienol; Willnestrol; Hormofemin; Estragard; Dienesterol; Oestrovis; para-Dien; alpha-Dienestrol; E,E-Dienestrol; Dienestrol (E,E); Dienoestrol bp; Follidiene; Estrodienol; Oestrodiene; Restrol; 13029-44-2; Oestrasid; p,p''-(Diethylideneethylene)diphenol; Di(p-oxyphenyl)-2,4-hexadiene; Oestroral; Dinestrol; Follormon; Teserene; Sexadien; Gynefollin; Estroral; Agaldog; Retalon; Dinovex; 3,4-Bis(4-hydroxyphenyl)-2,4-hex" C18H18O2 NFDFQCUYFHCNBW-SCGPFSFSSA-N 4-[(2E,4E)-4-(4-hydroxyphenyl)hexa-2,4-dien-3-yl]phenol n.a. Estrogens Yes No Yes No No No PMDBD326 Etomidate Therapeutic Substance Approved Drug 33125-97-2 DB00292 PA164743987 D00548 DAP000669 667484 580864 n.a. "Etomidate; 33125-97-2; (+)-Etomidate; Amidate; Etomidatum; Etomidato; (R)-ETHYL 1-(1-PHENYLETHYL)-1H-IMIDAZOLE-5-CARBOXYLATE; Hypnomidate; D-Etomidate; (d)-Etomidate; UNII-Z22628B598; (+)-Ethyl 1-(alpha-methylbenzyl)imidazole-5-carboxylate; R-(+)-Ethyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate; ethyl 1-[(1R)-1-phenylethyl]-1H-imidazole-5-carboxylate; CHEMBL681; (R)-(+)-1-(alpha-Methylbenzyl)imidazole-5-carboxylic acid ethyl ester; ethyl 3-[(1R)-1-phenylethyl]imidazole-4-carboxylate; Etomidatum [INN-Latin]; CHEBI:4910; Etom" C14H16N2O2 NPUKDXXFDDZOKR-LLVKDONJSA-N ethyl 3-[(1R)-1-phenylethyl]imidazole-4-carboxylate Janssen Pharmaceutica Analgesics Yes No Yes No No No PMDBD523 Mercaptopurine "Therapeutic Substance; Herbal Substance" "Approved Drug; Medicinal Herbal Compounds" 50-44-2 DB01033 PA450379 D04931 DAP000147 667490 580869 NPC189314 "6-Mercaptopurine; mercaptopurine; 50-44-2; Purinethol; Mercapurin; 6-Thiopurine; Leukerin; Mercaleukin; Leupurin; 6-Thioxopurine; Puri-Nethol; Ismipur; 7H-purine-6-thiol; Mern; 6-Thiohypoxanthine; 6-Mercaptopurin; 6-Purinethiol; Purimethol; Purinethiol; 6-MP; Purine-6-thiol; 9H-Purine-6-thiol; 6 MP; 3H-Purine-6-thiol; 1,9-dihydro-6H-purine-6-thione; Mercaleukim; 1,7-Dihydro-6H-purine-6-thione; 1H-Purine-6(9H)-thione; Mercaptopurine (6-MP); 3,7-dihydropurine-6-thione; Merkaptopuryna; Me" C5H4N4S GLVAUDGFNGKCSF-UHFFFAOYSA-N 3,7-dihydropurine-6-thione Novopharm Anticancer Agents Yes No No No No No PMDBD136 Caffeic acid Herbal Substance compound n.a. n.a. n.a. n.a. n.a. 689043 n.a. NPC294902 "caffeic acid; 3,4-Dihydroxycinnamic acid; 331-39-5; 3-(3,4-dihydroxyphenyl)acrylic acid; (E)-3-(3,4-dihydroxyphenyl)acrylic acid; (2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid; 3,4-Dihydroxybenzeneacrylic acid; trans-caffeic acid; trans-Caffeate; 3,4-Dihydroxy-trans-cinnamate; 501-16-6; 3-(3,4-Dihydroxyphenyl)propenoic acid; UNII-U2S3A33KVM; 4-(2''-Carboxyvinyl)-1,2-dihydroxybenzene; 4-(2-Carboxyethenyl)-1,2-dihydroxybenzene; 3-(3,4-Dihydroxyphenyl)-2" C9H8O4 QAIPRVGONGVQAS-DUXPYHPUSA-N (E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid n.a. n.a. Yes Yes No No No No PMDBD845 Thiothixene Therapeutic Substance Approved Drug 3313-26-6 DB01623 PA451669 D00374 DAP000318 941651 819430 n.a. "thiothixene; cis-Thiothixene; Tiotixene; Navane; (Z)-Thiothixene; 3313-26-6; Thiothixine; Tiotixenum [INN-Latin]; Tiotixeno [INN-Spanish]; Thiothixene (Z); Orbinamon; Navaron; Navan; Thiothixene hydrochloride; UNII-7318FJ13YJ; NSC-108165; MLS000028463; (9Z)-N,N-dimethyl-9-[3-(4-methylpiperazin-1-yl)propylidene]thioxanthene-2-sulfonamide; SMR000058396; 5591-45-7; 7318FJ13YJ; CP-12,252-1 base; cis-N,N-Dimethyl-9-(3-(4-methyl-1-piperazinyl)propylidene)thioxanthene-2-sulfonamide; Tiotixenum; Tiotixeno; CP-12,252-1; P-4657-B; CP 12252-1" C23H29N3O2S2 GFBKORZTTCHDGY-UWVJOHFNSA-N (9Z)-N,N-dimethyl-9-[3-(4-methylpiperazin-1-yl)propylidene]thioxanthene-2-sulfonamide Pfizer Pharmaceuticals Antipsychotic Agents No Yes No Yes No No PMDBD318 Eszopiclone Therapeutic Substance Approved Drug 138729-47-2 DB00402 PA162630444 n.a. DAP000933 969472 839530 n.a. "Eszopiclone; 138729-47-2; (S)-Zopiclone; Lunesta; Estorra; Esopiclone; (+)-Zopiclone; Eszopiclone [USAN:INN]; ( )-Zopiclone; SEP-190; UNII-UZX80K71OE; CHEBI:53760; HSDB 7472; SEP-225441; UZX80K71OE; (5S)-6-(5-CHLOROPYRID-2-YL)-5-(4-METHYLPIPERAZIN-1-YL)CARBONYLOXY-7-OXO-6,7-DIHYDRO-5H-PYRROLO[3,4-B]PYRAZINE; (+)-(5S)-6-(5-Chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo(3,4-b)pyrazin-5-yl 4-methylpiperazine-1-carboxylate; [(7S)-6-(5-chloropyridin-2-yl)-5-oxo-7H-pyrrolo[3,4-b]pyrazin-7-yl] 4-methylpiperazine-1-carboxylate; (5" C17H17ClN6O3 GBBSUAFBMRNDJC-INIZCTEOSA-N [(7S)-6-(5-chloropyridin-2-yl)-5-oxo-7H-pyrrolo[3,4-b]pyrazin-7-yl] 4-methylpiperazine-1-carboxylate GSK Hypnotics and Sedatives No Yes No Yes No No PMDBD233 Curcumin "Therapeutic Substance; Herbal Substance" "Investigational Drug; Medicinal Herbal Compounds" 458-37-7 DB11672 n.a. n.a. n.a. 969516 839564 NPC109083 "curcumin; 458-37-7; Diferuloylmethane; Natural yellow 3; Turmeric yellow; Curcuma; Indian saffron; Turmeric; Kacha haldi; Gelbwurz; Curcumin I; Souchet; Haldar; Haidr; Halud; Halad; Merita earth; Yellow Ginger; Terra Merita; Yellow Root; Safran d''Inde; Yo-Kin; Golden seal; Curcuma oil; Orange Root; Oils, curcuma; C.I. Natural Yellow 3; Curcumine; (1E,6E)-1,7-Bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione; Hydrastis; Indian turmeric; Yellow puccoon; Diferaloylmethane; Turmeric extract; Kurkumin [Czech]; Tumeric yellow; Turmeric oil; Oi" C21H20O6 VFLDPWHFBUODDF-FCXRPNKRSA-N (1E,6E)-1,7-bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione n.a. n.a. Yes Yes No Yes Yes No rxnDiet98,rxnAdd41 PMDBD1285 Methimazole Therapeutic substance Drug 60-56-0 DB00763 PA450422 D00401 DNC001429 1349907 1131173 n.a. "methimazole; 60-56-0; thiamazole; Tapazole; 2-Mercapto-1-methylimidazole; Methimazol; 1-Methylimidazole-2-thiol; Thymidazol; Metazolo; Thymidazole; Mercazolyl; Mercazole; Thycapzol; Metothyrine; Metothyrin; Merkazolil; Mercaptazole; Thiamazol; Strumazol; Favistan; Basolan; 1-Methyl-1H-imidazole-2-thiol; Thycapsol; Metotirin; Danantizol; Frentirox; Thacapzol; Merkastan; Metizol; Mercasolyl; Methylmercaptoimidazole; 1-Methyl-2-mercaptoimidazole; Methiamazole; Tiamazol; Usaf el-30; Mercazolylum; 3-met" C4H6N2S PMRYVIKBURPHAH-UHFFFAOYSA-N 3-methyl-1H-imidazole-2-thione n.a. n.a. No Yes No No No No PMDBD816 Sulindac Therapeutic Substance anti-inflammatory 38194-50-2 DB00605 PA451565 D00120 DAP000569 1548887 1265915 n.a. "sulindac; Clinoril; 38194-50-2; Arthrocine; Sulindac sulfoxide; Sulindacum; Sulindaco; Mobilin; Aflodac; Sulreuma; MK 231; Sulindacum [INN-Latin]; Sulindaco [INN-Spanish]; MK-231; cis-5-Fluoro-2-methyl-1-((p-methylsulfinyl)benzylidene)indene-3-acetic acid; CHEBI:9352; CCRIS 3305; C20H17FO3S; cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid; (Z)-5-Fluoro-2-methyl-1-((p-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid; EINECS 253-819-2; BRN 2951842; Reumofil; Citireuma; Clisundac; Algocet" C20H17FO3S MLKXDPUZXIRXEP-MFOYZWKCSA-N 2-[(3Z)-6-fluoro-2-methyl-3-[(4-methylsulfinylphenyl)methylidene]inden-1-yl]acetic acid Merck & Co Antiinflammatory Agents No Yes No No No No PMDBD142 Capsaicin Dietary Substance Dietary Compounds 404-86-4 DB06774 n.a. D00250 n.a. 1548943 1265957 NPC255550 "Capsaicin; 404-86-4; Zostrix; CAPSAICINE; (E)-Capsaicin; Qutenza; E-CAPSAICIN; Styptysat; Axsain; Isodecenoic acid vanillylamide; trans-8-Methyl-N-vanillyl-6-nonenamide; NGX-4010; Capsaicin [USAN]; Caswell No. 158; FEMA No. 3404; Transacin; (E)-8-Methyl-N-vanillyl-6-nonenamide; trans-Capsaicin; NCI-C56564; UNII-S07O44R1ZM; NSC 56353; CCRIS 1588; CHEBI:3374; HSDB 954; ALGRX 4975; C18H27NO3; Capsaicin (JAN/USP); ZOSTRIX (TN); N-(4-Hydroxy-3-methoxybenzyl)-8-methylnon-trans-6-enamide; EINECS 206-96" C18H27NO3 YKPUWZUDDOIDPM-SOFGYWHQSA-N (E)-N-[(4-hydroxy-3-methoxyphenyl)methyl]-8-methylnon-6-enamide Samyang Corp n.a. Yes Yes No No No No PMDBD1203 Fluvastatin Therapeutic substance Drug 93957-54-1 DB01095 PA449688 D07983 DAP000554 1548972 1265982 n.a. "fluvastatin; Fluvastatine; Fluvastatinum; Fluvastatina; Fluvastatine [INN-French]; Fluvastatinum [INN-Latin]; Fluvastatina [INN-Spanish]; Cranoc; 93957-54-1; Fluindostatin; CHEBI:5136; CHEMBL350239; Fluvastatin [INN:BAN]; 155229-76-8; C24H26FNO4; XU 62320; XU-62320; (3S,5R,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; Fluvastatin (INN); (+-)-fluvastatin; Fluvas (TN); (3S,5R)-FLUVASTATIN SODIUM SALT; (3S,5R)-fluvastatin; Prestwick3_000859; rac-(3R,5S)-fluvastatin; SCHEMBL2847; SCHEMBL2849; BS" C24H26FNO4 FJLGEFLZQAZZCD-JUFISIKESA-N (E,3S,5R)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid n.a. n.a. No Yes No No No No PMDBD1443 Terbinafine Therapeutic substance Drug 91161-71-6 DB00857 PA451614 D02375 DAP000753 1549008 1266005 n.a. "terbinafine; 91161-71-6; Lamisil; Lamasil; Lamisil Tablet; Lamisil AT; SF-86-327; (E)-N,6,6-trimethyl-N-(naphthalen-1-ylmethyl)hept-2-en-4-yn-1-amine; SF 86-327; terbinafin; UNII-G7RIW8S0XP; (E)-N-(6,6-Dimethyl-2-hepten-4-ynyl)-N-methyl-1-naphthalenemethylamine; Terbinafina; (E)-N-(6,6-Dimethyl-2-hepten-4-ynyl)-N-methyl-1-naphthalene methanamine; G7RIW8S0XP; CHEMBL822; BRN 4256376; CHEBI:9448; Terbinafinum; Zabel; NCGC00159346-02; (2E)-N,6,6-trimethyl-N-(1-naphthylmethyl)hept-2-en-4-yn-1-amine; (2E)-N,6,6-trimethyl-N-(naphthalen" C21H25N DOMXUEMWDBAQBQ-WEVVVXLNSA-N (E)-N,6,6-trimethyl-N-(naphthalen-1-ylmethyl)hept-2-en-4-yn-1-amine n.a. n.a. No Yes No No No No PMDBD522 Merbromin Therapeutic Substance Approved Drug 129-16-8 DB13392 n.a. D00861 n.a. 2724062 8029248 n.a. C20H9Br2HgNa2O6 KQSRXDXJGUJRKE-UHFFFAOYSA-L "disodium;[2,7-dibromo-9-(2-carboxylatophenyl)-3-oxido-6-oxoxanthen-4-yl]mercury;hydrate" n.a. n.a. Yes No Yes No No No PMDBD276 Digoxin "Therapeutic Substance; Herbal Substance" cardiac glycoside 20830-75-5 DB00390 PA449319 D00298 DAP000744 2724385 2006532 NPC173555 "digoxin; 20830-75-5; 12beta-Hydroxydigitoxin; Lanoxicaps; Lanoxin; Digosin; Digoxin Pediatric; Lanicor; Digacin; Dilanacin; CHEBI:4551; MLS000069819; Lanacordin; Cardiogoxin; SMR000059217; Rougoxin; Mapluxin; Lenoxin; Lanacrist; Dynamos; Eudigox; Davoxin; Vanoxin; Digoxine; Neo-Lanicor; (3beta,5beta,12beta)-3-{[2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide; Lanoxin PG; Digoxin Nativelle; SK-Digoxin; UNII-73K41" C41H64O14 LTMHDMANZUZIPE-PUGKRICDSA-N 3-[(3S,5R,8R,9S,10S,12R,13S,14S,17R)-3-[(2R,4S,5S,6R)-5-[(2S,4S,5S,6R)-5-[(2S,4S,5S,6R)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-12,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one GlaxoSmithKline Antiarrhythmic Agents Yes Yes No Yes No Yes DIGOXIN_GLC_GLCAASE,DIGOXIN_GLC_GLCAASEe,DIGOXIN_GLC_GLCAASEepp,DIGOXINt2r,DIGOXINte,DIGOXINtepp,DIGOXINtex,DIHYDRO_DIGOXINc,EX_digoxin(e) PMDBD1433 Tamoxifen Therapeutic substance Therapeutic Substance 10540-29-1 DB00675 PA451581 D08559 DAP000108 2733526 2015313 n.a. "tamoxifen; 10540-29-1; trans-Tamoxifen; Soltamox; Crisafeno; Diemon; Tamoxifene; Tamoxen; Citofen; Oncomox; Valodex; Retaxim; Tamizam; Istubol; Tamoxifeno; Tamoxifenum; Tamoxifene [INN-French]; Tamoxifenum [INN-Latin]; Tamoxifeno [INN-Spanish]; Tamoxifen (Z); Tamoxifen [INN:BAN]; Tamoxifen and its salts; ICI-46474; ICI 47699; CCRIS 3275; 1-p-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene; UNII-094ZI81Y45; 1-para-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene; HSDB 6782" C26H29NO NKANXQFJJICGDU-QPLCGJKRSA-N 2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine n.a. n.a. No Yes No No No No PMDBD1187 Ethionamide Therapeutic substance Drug 536-33-4 DB00609 PA164768738 D00591 DAP001141 2761171 2041901 n.a. "ethionamide; 536-33-4; 2-ethylpyridine-4-carbothioamide; Ethioniamide; Ethyonomide; Ethinamide; Thioamide; Etioniamid; Etionamid; Amidazine; Ethylisothiamide; Trecator; 2-Ethylthioisonicotinamide; Trecator-SC; Tubenamide; Iridocin; Etionizine; Etionizin; Etiocidan; Ethimide; Amidazin; Tubermin; Thianide; Tuberoid; Trekator; Thioniden; Sertinon; Rigenicid; Isotiamida; Iridozin; Tuberoson; Trescazide; Trescatyl; Nicotion; Itiocide; Fatoliamid; Etionizina; Aetina; Tianid; Etionid; Isothin; Ethina; Aetiva; Thianid; Tebe" C8H10N2S AEOCXXJPGCBFJA-UHFFFAOYSA-N 2-ethylpyridine-4-carbothioamide n.a. n.a. No Yes No No No No PMDBD1413 Scopolamine Therapeutic substance Drug 51-34-3 DB00747 PA451308 D00138 DNC000757 3000322 10194106 n.a. "scopolamine; Hyoscine; (-)-Hyoscine; Scopine (-)-tropate; 51-34-3; Hyosol; l-Scopolamine; (-)-Scopolamine; Transderm-Scop; 6,7-Epoxytropine tropate; Scopine tropate; Atrochin; Atroquin; Isopto Hyoscine; Epoxytropine tropate; Scopolamine hydrobromide; 6-beta,7-beta-Epoxy-3-alpha-tropanyl S-(-)-tropate; UNII-DL48G20X8X; Oscine; Scopamin; Beldavrin; Transderm scop; alpha-(Hydroxymethyl)benzeneacetic acid 9-methyl-3-oxa-9-azatricyclo(3.3.1.0(2.4))non-7-yl ester; Skopolamin; Hyosceine; Scop; DL48G20X8X; CHEMBL3084722; CHEBI:16794; LSM-4015" C17H21NO4 STECJAGHUSJQJN-USLFZFAMSA-N [(1R,2R,4S,5S)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl] (2S)-3-hydroxy-2-phenylpropanoate n.a. n.a. No Yes No No No No PMDBD1258 Lincomycin Therapeutic substance Drug 154-21-2 DB01627 PA164749212 D00223 DAP000839 3000540 2272112 n.a. "lincomycin; 154-21-2; Lincomycinum; Cillimycin; Lincomicina; Lincomycin A; UNII-BOD072YW0F; CHEMBL1447; Lincomycine; Lincolnensin; Jiemycin; Lincocin; Lincomycin, (2S-cis)-Isomer; C18H34N2O6S; Lincomycin (USAN/INN); BOD072YW0F; Lincolcina; CHEBI:6472; Lincomycine [French]; Lincomycinum [INN-Latin]; Lincomycine [INN-French]; Lincomicina [INN-Spanish]; U-10149; Methyl 6,8-dideoxy-6-trans-(1-methyl-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-D-erythro-alpha-D-galacto-octopyranoside" C18H34N2O6S OJMMVQQUTAEWLP-KIDUDLJLSA-N (2S,4R)-N-[(1R,2R)-2-hydroxy-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide n.a. n.a. No Yes No No No No PMDBD731 Ranitidine "Therapeutic Substance; Herbal Substance" Drugs for acid related disorders 66357-35-5 DB00863 PA451224 D00422 DAP000340 3001055 4863 NPC320751 "ranitidine; 66357-35-5; Raticina; ZANTAC; Gastrosedol; Rantacid; Ptinolin; Quantor; Ranitiget; Ranisen; Raniogas; Ranidine; Microtid; Taural; Ulceranin; Ranitidina; Zantadin; Xanidine; Weichilin; Ranitidinum; Duractin; Zantab; Weidos; Verlost; Urantac; Raniter; Radinat; Logast; Istomar; Atural; Acidex; Achedos; Randin; Mauran; Ezopta; Vesyca; Sampep; Gastrial; Coralen; Vizerul; Quicran; Axoban; Ratic; Ranin; Ul-Pep; Zantic; Rantidine; Ranitidine HCL; Ranitidinum [INN-Latin]; Ranitidina [INN-Spanish]; Ranitidine [USAN:BAN:INN]; Ranitidine Base; (E)-ranitidine" C13H22N4O3S VMXUWOKSQNHOCA-UKTHLTGXSA-N (E)-1-N''-[2-[[5-[(dimethylamino)methyl]furan-2-yl]methylsulfanyl]ethyl]-1-N-methyl-2-nitroethene-1,1-diamine GlaxoSmithKline Antiulcer Agents No Yes No No No No PMDBD1440 Telithromycin Therapeutic substance Antibiotics 191114-48-4 DB00976 PA10202 D01078 DAP000109 3002190 2273373 n.a. "Telithromycin; Ketek; 191114-48-4; HMR3647; UNII-KI8H7H19WL; HMR-3647; Levviax; HMR 3647; RU 66647; RU-66647; KI8H7H19WL; RU66647; DSSTox_RID_81629; DSSTox_CID_26455; DSSTox_GSID_46455; HSDB 7359; CAS-191114-48-4; HMR3647;RU66647; Telithromycin [USAN:INN:BAN]; NCGC00164575-01; SCHEMBL5100; CHEMBL1136; DTXSID3046455; CHEBI:29688; HY-A0062; ZINC9574770; Erythromycin, 3-de((2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-11,12-dideoxy-6-O-methyl-3-oxo-12,11-(oxycarbonyl((4-(4-(3-pyridinyl)-1H-imidazol-1-yl)butyl)imino" C43H65N5O10 LJVAJPDWBABPEJ-PNUFFHFMSA-N (1S,2R,5R,7R,8R,9R,11R,13R,14R)-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-15-[4-(4-pyridin-3-ylimidazol-1-yl)butyl]-3,17-dioxa-15-azabicyclo[12.3.0]heptadecane-4,6,12,16-tetrone n.a. n.a. Yes Yes No No No No PMDBD1267 Maraviroc Therapeutic substance Drug 376348-65-1 DB04835 PA164768835 n.a. DNC001487 3002977 20078004 n.a. "Maraviroc; 376348-65-1; Selzentry; Celsentri; UK-427857; UK-427,857; UK 427857; UNII-MD6P741W8A; MD6P741W8A; MVC; 4,4-difluoro-N-[(1S)-3-[(1R,5S)-3-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octan-8-yl]-1-phenylpropyl]cyclohexane-1-carboxamide; CHEMBL1201187; CHEBI:63608; NCGC00183109-02; 4,4-difluoro-N-((1S)-3-((1R,5S)-3-(3-isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octan-8-yl)-1-phenylpropyl)cyclohexane-1-carboxamide; Cyclohexanecarboxamide, 4,4-difluoro-N-((1S)-3-((3-exo)-3-(3-meth" C29H41F2N5O GSNHKUDZZFZSJB-HLMSNRGBSA-N 4,4-difluoro-N-[(1S)-3-[(1S,5R)-3-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octan-8-yl]-1-phenylpropyl]cyclohexane-1-carboxamide n.a. n.a. No Yes No No No No PMDBD859 Toremifene Therapeutic Substance Approved Drug 89778-26-7 DB00539 PA451731 n.a. DAP000793 3005573 2275722 n.a. "toremifene; Acapodene; Farestone; Z-Toremifene; 89778-26-7; Toremifeno; Toremifenum; Toremifenum [Latin]; Toremifeno [Spanish]; FC-1157a; GTx 006; Toremifene [INN:BAN]; UNII-7NFE54O27T; GTx-006; C26H28ClNO; {2-[4-(4-Chloro-1,2-diphenyl-but-1-enyl)-phenoxy]-ethyl}-dimethyl-amine; CHEBI:9635; 7NFE54O27T; (Z)-2-(4-(4-Chloro-1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine; 2-{4-[(1Z)-4-chloro-1,2-diphenylbut-1-en-1-yl]phenoxy}-N,N-dimethylethanamine; 2-(para-((Z)-4-Chloro-1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylethylami" C26H28ClNO XFCLJVABOIYOMF-QPLCGJKRSA-N 2-[4-[(Z)-4-chloro-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine Prostrakan Inc Anticancer Agents Yes No No No No No PMDBD1314 Nelarabine Therapeutic substance Drug 121032-29-9 DB01280 PA164752425 D05134 DAP000985 3011155 2280207 n.a. "Nelarabine; Nelzarabine; 121032-29-9; Arranon; Atriance; 506U78; GW 506U78; GW-506U78; 506U; 2-Amino-9-beta-D-arabinofuranosyl-6-methoxy-9H-purine; NSC-686673; Nelarabine (Arranon); CHEBI:63612; UNII-60158CV180; 9-beta-D-Arabinofuranosyl-6-methoxy-9H-purin-2-amine; Nelzarabine (USAN); MAY; NCGC00181098-01; S1213; 60158CV180; (2R,3S,4S,5R)-2-(2-amino-6-methoxy-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol; DSSTox_RID_81952; DSSTox_CID_26842; DSSTox_GSID_46842; ArranonG; 9beta-D-Arabinofuranosyl-6-methoxy-9H-purin-2-amine; GW506U78" C11H15N5O5 IXOXBSCIXZEQEQ-UHTZMRCNSA-N (2R,3S,4S,5R)-2-(2-amino-6-methoxypurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol n.a. n.a. No Yes No No No No PMDBD602 Nizatidine Therapeutic Substance antiulcerotics 76963-41-2 DB00585 PA164752234 D00440 DAP000339 3033637 4356 n.a. "nizatidine; 76963-41-2; Axid; Acinon; Zanizal; Nizax; Naxidine; Distaxid; Cronizat; Calmaxid; Galitidin; Gastrax; Ulcosol; Panaxid; Nizaxid; Antizid; Ulxid; Tazac; Zinga; LY-139037; Niaztidine; Splendil ER; Axid Ar; ZE-101; Nizatidinum; ZL-101; Nizatidinum [Latin]; Nizatidine-d3; Nizatidina; Nizatidina [Spanish]; N-(2-(((2-((Dimethylamino)methyl)-4-thiazolyl)methyl)thio)ethyl)-N''-methyl-2-nitro-1,1-ethenediamine; (E)-N-(2-(((2-((dimethylamino)methyl)thiazol-4-yl)methyl)thio)ethyl)-N''-methyl-2-nitroethene-1,1-diamine; HSDB 3574; C12H21N5O2S" C12H21N5O2S2 SGXXNSQHWDMGGP-IZZDOVSWSA-N (E)-1-N''-[2-[[2-[(dimethylamino)methyl]-1,3-thiazol-4-yl]methylsulfanyl]ethyl]-1-N-methyl-2-nitroethene-1,1-diamine Eli Lilly Antiulcer Agents No Yes No No No No PMDBD1166 Dolasetron Therapeutic substance antinauseant and antiemetic 115956-12-2 DB00757 PA449390 n.a. DAP000368 3033818 30845229 n.a. "dolasetron; 115956-12-2; LSM-5418; Anzemet Cinv; 1H-Indole-3-carboxylic acid, octahydro-3-oxo-2,6-methano-2H-quinolizin-8-yl ester, stereoisomer; SCHEMBL42064; SCHEMBL42063; BIDD:GT0287; ZINC2688; DTXSID4048276; CHEMBL2368925; CHEBI:94561; HY-B0750; s5326; 3594AH; BDBM50451546; ZINC100019093; ZINC103105084; AKOS025404537; ZINC100038399; AKOS022184758; DB00757; CS-3747; CCG-267749; AS-74586; (2alpha,6alpha,8alpha,9abeta)-octahydro-3-oxo-2,6-methano-2h-quinolizin-8-yl-1h-indole-3-carboxylate; 115956-13-3; AB00698337-03; SR-05000001488" C19H20N2O3 UKTAZPQNNNJVKR-AKJUYKBHSA-N [(3S,7R)-10-oxo-8-azatricyclo[5.3.1.03,8]undecan-5-yl] 1H-indole-3-carboxylate n.a. n.a. No Yes No No No No PMDBD478 Levosimendan Therapeutic Substance Levosimendan is used to manage acutely decompensated congestive heart failur 141505-33-1 DB00922 PA164749138 D04720 DAP000797 3033825 2298414 n.a. "LEVOSIMENDAN; 141505-33-1; Simdax; (-)-OR-1259; UNII-C6T4514L4E; OR-1259; CHEBI:50567; C6T4514L4E; ((4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl)hydrazono)propanedinitrile; Levosimedan; OR 1259; Mesoxalonitrile (-)-(p((R)-1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl)hydrazone; DSSTox_RID_81620; DSSTox_CID_26445; (R)-((4-(1,4,5,6-Tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl)hydrazono) propanedintrile; DSSTox_GSID_46445; (R)-Simendan; Levosimendan [INN]; levosimendanum" C14H12N6O WHXMKTBCFHIYNQ-SECBINFHSA-N 2-[[4-[(4R)-4-methyl-6-oxo-4,5-dihydro-1H-pyridazin-3-yl]phenyl]hydrazinylidene]propanedinitrile Abbott Laboratories Cardiotonic Agents No Yes No No No No PMDBD1395 Quinine Therapeutic substance Drug 130-95-0 DB00468 PA451213 n.a. DAP000491 3034034 84989 n.a. "Quinine; 130-95-0; Chinin; Chinine; (8S,9R)-Quinine; 6''-Methoxycinchonidine; (-)-Quinine; (R)-(-)-quinine; chininum; quinina; Quinoline alkaloid; Quinine, Anhydrous; Qualaquin; UNII-A7V27PHC7A; quinine bisulphate; quinine sulfate; Quinine anhydrous; CHEBI:15854; Quinine HCl; Chinin [German]; 6-Methoxycinchonine; A7V27PHC7A; Quinine sulphate; (R)-(6-methoxyquinolin-4-yl)((2S,4S,8R)-8-vinylquinuclidin-2-yl)methanol; Aflukin; Quinine, tannate; 6''-Methoxycinchonan-9-ol; NSC 192949; 130-89-2; (R)-(-)-Qu" C20H24N2O2 LOUPRKONTZGTKE-WZBLMQSHSA-N (R)-[(2S,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol n.a. n.a. No Yes No No No No PMDBD1050 Azoxystrobin Environmental Chemicals Pesticides 131860-33-8 DB07401 n.a. n.a. n.a. 3034285 2298772 n.a. "Azoxystrobin; 131860-33-8; Amistar; Bankit; Heritage; Quadris; Icia-5504; UNII-NYH7Y08IPM; HSDB 7017; TCMDC-125883; ICI-A 5504; NYH7Y08IPM; EINECS Annex I Index 607-256-00-X; CHEBI:40909; C22H17N3O5; methyl (2E)-2-(2-{[6-(2-cyanophenoxy)pyrimidin-4-yl]oxy}phenyl)-3-methoxyprop-2-enoate; NCGC00163818-04; methyl (E)-2-[2-[6-(2-cyanophenoxy)pyrimidin-4-yloxy]phenyl]-3-methoxyacrylate; Methyl (E)-2-(2-(6-(2-cyanopheoxy)pyrimidin-4-yloxy)phenyl)-3-methoxypropenoate; methyl (E)-2-[2-[6-(2-cyanophenoxy)pyrimidin-4-yl]oxyphenyl]-3-me" C22H17N3O5 WFDXOXNFNRHQEC-GHRIWEEISA-N methyl (E)-2-[2-[6-(2-cyanophenoxy)pyrimidin-4-yl]oxyphenyl]-3-methoxyprop-2-enoate n.a. n.a. Yes No No No No No PMDBD249 Dasatinib Therapeutic Substance Therapeutic Substance 302962-49-8 DB01254 PA162372878 D03658 DAP000004 3062316 2323020 n.a. "Dasatinib; 302962-49-8; Sprycel; BMS-354825; BMS 354825; BMS354825; Dasatinib anhydrous; Dasatinib (anhydrous); Dasatinib (BMS-354825); N-(2-CHLORO-6-METHYLPHENYL)-2-({6-[4-(2-HYDROXYETHYL)PIPERAZIN-1-YL]-2-METHYLPYRIMIDIN-4-YL}AMINO)-1,3-THIAZOLE-5-CARBOXAMIDE; N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide; anh. dasatinib; Dasatinib [USAN]; UNII-X78UG0A0RN; anhydrous dasatinib; dasatinib (anh.); N-(2-chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)pi" C22H26ClN7O2S ZBNZXTGUTAYRHI-UHFFFAOYSA-N N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide Bristol Myers Squibb Anticancer Agents No Yes No Yes No No PMDBD1438 Telavancin Therapeutic substance Antibiotics 372151-71-8 DB06402 n.a. n.a. n.a. 3081362 2338980 n.a. "Telavancin; Vibativ; UNII-XK134822Z0; 372151-71-8; TD-6424; CHEBI:71229; XK134822Z0; Telavancin [INN]; telavancinum; telavancina; telavancine; HSDB 8194; TD6424; SCHEMBL8287015; CHEMBL507870; GTPL10925; DTXSID10873383; DB06402; LS-192933; T-1455; Telavancin, Antibiotic for Culture Media Use Only; Q7695658; N(3'''')-[2-(decylamino)ethyl]-29-{[(phosphonomethyl)amino]methyl}vancomycin" C80H106Cl2N11O27P ONUMZHGUFYIKPM-MXNFEBESSA-N (1S,2R,18R,19R,22S,25R,28R,40S)-22-(2-amino-2-oxoethyl)-5,15-dichloro-48-[(2S,3R,4S,5S,6R)-3-[(2S,4S,5S,6S)-4-[2-(decylamino)ethylamino]-5-hydroxy-4,6-dimethyloxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,18,32,35,37-pentahydroxy-19-[[(2R)-4-methyl-2-(methylamino)pentanoyl]amino]-20,23,26,42,44-pentaoxo-36-[(phosphonomethylamino)methyl]-7,13-dioxa-21,24,27,41,43-pentazaoctacyclo[26.14.2.23,6.214,17.18,12.129,33.010,25.034,39]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34,36,38,46,49-pentadec n.a. n.a. Yes No No No No No PMDBD62 Apramycin "Therapeutic Substance; Herbal Substance" "Approved Drug (veterinary medicine); Medicinal Herbal Compounds" 37321-09-8 DB04626 n.a. D02322 DNC000243 3081545 2339128 NPC315036 "apramycin; Nebramycin II; Nebramycin factor 2; Apramycinum; Apramycine; Apramicina; 37321-09-8; UNII-388K3TR36Z; Ambylan; Apralan; CHEBI:2790; 4-O-(3alpha-Amino-6alpha-((4-amino-4-deoxy-alpha-D-glucopyranosyl)oxy)-2,3,4,5abeta,6,7,8,8aalpha-octahydro-8beta-hydroxy-7beta-(methylamino)pyrano(3,2-b)pyran-2alpha-yl)-2-deoxy-D-streptamine; 4-O-((8R)-2-Amino-8-O-(4-amino-4-deoxy-alpha-D-glucopyranosyl)-2,3,7-trideoxy-7-(methylamino)-D-glycero-alpha-D-allo-octodialdo-1,5:8,4-dipyranos-1-yl)-2-deoxy-D-streptamine; 388K3TR36Z; Ap" C21H41N5O11 XZNUGFQTQHRASN-XQENGBIVSA-N (2R,3R,4S,5S,6S)-2-[[(2R,3S,4R,4aR,6S,7R,8aS)-7-amino-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2,3-dihydroxycyclohexyl]oxy-4-hydroxy-3-(methylamino)-2,3,4,4a,6,7,8,8a-octahydropyrano[3,2-b]pyran-2-yl]oxy]-5-amino-6-(hydroxymethyl)oxane-3,4-diol n.a. n.a. Yes No Yes No No No PMDBD785 Sitagliptin Therapeutic Substance Approved Drug 486460-32-6 DB01261 PA164748978 D08516 DAP000639 4369359 3571948 n.a. "Sitagliptin; 486460-32-6; Januvia; MK-0431; Xelevia; Sitagliptin phosphate; UNII-QFP0P1DV7Z; Tesavel; LEZ763; QFP0P1DV7Z; Sitagliptan; (R)-3-AMINO-1-(3-(TRIFLUOROMETHYL)-5,6-DIHYDRO-[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL)-4-(2,4,5-TRIFLUOROPHENYL)BUTAN-1-ONE; (2R)-4-OXO-4-[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE; (3R)-3-amino-1-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one; CHEBI:40237; (3R)" C16H15F6N5O MFFMDFFZMYYVKS-SECBINFHSA-N (3R)-3-amino-1-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one Merck & Co Hypoglycemic Agents No Yes No No No Yes EX_stg(e),STG_M3_GLCAASE,STG_M3_GLCAASEe,STG_M3_GLCAASEepp,STG_M4_GLCAASE,STG_M4_GLCAASEe,STG_M4_GLCAASEepp,STGte,STGtepp,STGtex PMDBD1460 Tolcapone Therapeutic substance Parkinson''s? 134308-13-7 DB00323 PA451720 D00786 DAP000607 4659569 3848682 n.a. "Tolcapone; 134308-13-7; Tasmar; Ro 40-7592; (3,4-Dihydroxy-5-nitrophenyl)(4-methylphenyl)methanone; 3,4-Dihydroxy-4''-methyl-5-nitrobenzophenone; Ro-40-7592; (3,4-dihydroxy-5-nitrophenyl)(p-tolyl)methanone; (3,4-dihydroxy-5-nitrophenyl)-(4-methylphenyl)methanone; UNII-CIF6334OLY; CCRIS 7904; CIF6334OLY; CHEMBL1324; C14H11NO5; CHEBI:63630; Ro-407592; NCGC00181767-01; 4''-methyl-3,4-dihydroxy-5-nitrobenzophenone; 3,4-dihydroxy-5-nitro-4''-methylbenzophenone; DSSTox_CID_3685" C14H11NO5 MIQPIUSUKVNLNT-UHFFFAOYSA-N (3,4-dihydroxy-5-nitrophenyl)-(4-methylphenyl)methanone n.a. n.a. No Yes No No No No PMDBD717 Quercetin Herbal Substance Medicinal Herbal Compounds 117-39-5 DB04216 n.a. n.a. DAP001419 5280343 4444051 NPC20791 "quercetin; 117-39-5; Meletin; Sophoretin; Xanthaurine; Quercetine; Quercetol; Quertine; 3,3'',4'',5,7-Pentahydroxyflavone; Quercitin; 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one; Flavin meletin; 3,5,7,3'',4''-Pentahydroxyflavone; Cyanidelonon 1522; T-Gelb bzw. grun 1; C.I. Natural Yellow 10; Quercetin content; Kvercetin; Quertin; 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one; C.I. Natural red 1; Kvercetin [Czech]; Natural Yellow 10; C.I. 75670; CI Natural Yellow 10; 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxy" C15H10O7 REFJWTPEDVJJIY-UHFFFAOYSA-N 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxychromen-4-one n.a. Hypoglycemic Agents Yes No Yes No Yes No rxn16644,rxn21124,rxn24726,rxn40107,rxn41435,rxn45587,rxnDiet189,rxnAdd137,rxnAdd138,rxnAdd140 PMDBD881 Tylosin "Therapeutic Substance; Herbal Substance" "Approved Drug (veterinary medicine); Medicinal Herbal Compounds" 1401-69-0 DB11475 n.a. D02490 n.a. 5280440 4444097 NPC316205 "Tylosin; Tylosine; Tylocine; tylosin tartrate; Tilosina; Tylosinum; 1401-69-0; Tylosin A; Fradizine; Tylan; UNII-YEF4JXN031; YEF4JXN031; CHEBI:17658; Vubityl 200; Tylosinum [INN-Latin]; Tylosine [INN-French]; Tilosina [INN-Spanish]; HSDB 7022; EINECS 215-754-8; AI3-29799; SR-05000002057; Tylosin [USP:INN:BAN]; Tylan (TN); Tylosin (USP/INN); SCHEMBL3081; BSPBio_003548; SPECTRUM1505312; CHEMBL42743; SCHEMBL16931534; HY-B0519A; HMS1922B22; Pharmakon1600-01505312; HMS2093B11; Antibiotic obtained from cultures of Streptomyces fradiae, or the sa" C46H77NO17 WBPYTXDJUQJLPQ-VMXQISHHSA-N 2-[(4R,5S,6S,7R,9R,11E,13E,15R,16R)-6-[(2R,3R,4R,5S,6R)-5-[(2S,4R,5S,6S)-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-16-ethyl-4-hydroxy-15-[[(2R,3R,4R,5R,6R)-5-hydroxy-3,4-dimethoxy-6-methyloxan-2-yl]oxymethyl]-5,9,13-trimethyl-2,10-dioxo-1-oxacyclohexadeca-11,13-dien-7-yl]acetaldehyde n.a. n.a. Yes No Yes No No No PMDBD485 Linoleic acid Herbal Substance unknown 60-33-3 DB14104 n.a. n.a. n.a. 5280450 4444105 NPC85813 "linoleic acid; 60-33-3; Linolic acid; (9Z,12Z)-octadeca-9,12-dienoic acid; Telfairic acid; cis,cis-Linoleic acid; Grape seed oil; cis,cis-9,12-Octadecadienoic acid; Linoleate; Emersol 315; cis-9,cis-12-Octadecadienoic acid; 9,12-Linoleic acid; Unifac 6550; 9Z,12Z-octadecadienoic acid; 9Z,12Z-Linoleic acid; Extra Linoleic 90; 9-cis,12-cis-Linoleic acid; Polylin 515; Emersol 310; all-cis-9,12-Octadecadienoic acid; (Z,Z)-9,12-Octadecadienoic acid; Polylin No. 515; Oils, grape; alpha-Linoleic acid; Linoleic; acide linoleique; 9,12-Octad" C18H32O2 OYHQOLUKZRVURQ-HZJYTTRNSA-N (9Z,12Z)-octadeca-9,12-dienoic acid n.a. n.a. No Yes No Yes No No PMDBD1070 Calcitriol Therapeutic substance Drug 32222-06-3 DB00136 PA448717 D00129 DAP000289 5280453 4444108 n.a. "calcitriol; Rocaltrol; Calcijex; Topitriol; 32222-06-3; 1alpha,25-Dihydroxyvitamin D3; Silkis; Soltriol; 1alpha,25-Dihydroxycholecalciferol; Dihydroxyvitamin D3; 1,25-DHCC; Calcitriolum; 1,25-Dihydroxyvitamin D; Vectical; 1,25-DIHYDROXYCHOLECALCIFEROL; 1alpha,25(OH)2D3; 1,25-Dihydroxyvitamin D3; 1alpha,25-Dihydroxyvitamin D; 1-alpha,25-Dihydroxyvitamin D3; Calcitriolum [INN-Latin]; UNII-FXC9231JVH; DN-101; 1,25-Dihydroxycholecaliferol; CCRIS 5522; Ro 21-5535; HSDB 3482; 1-alpha,25-Dihydroxycholecalciferol; EINECS 250-963-8; DN 101; CHE" C27H44O3 GMRQFYUYWCNGIN-NKMMMXOESA-N (1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol n.a. n.a. No Yes No No No No PMDBD760 Rutin "Therapeutic Substance; Herbal Substance" ?decrease capillary fragility 153-18-4 DB01698 PA451291 n.a. n.a. 5280805 4444362 NPC176740 "RUTIN; 153-18-4; rutoside; Phytomelin; Quercetin 3-rutinoside; Birutan; Eldrin; Rutin trihydrate; Myrticolorin; Rutabion; Venoruton; 3-Rutinosyl quercetin; Bioflavonoid; Paliuroside; Tanrutin; Osyritrin; Rutine; Rutozyd; 3-Rhamnoglucosylquercetin; Melin; Quercetin-3-rutinoside; Quercetin 3-O-rutinoside; Rutinum; Rutosido; Rutosidum; Globularicitrin; Violaquercitrin; Globulariacitrin; Rutinic acid; Birutan Forte; Birutin; Quercetin rhamnoglucosine; Vitamin P; Quercetin-3beta-rutinoside; UNII-5G06TVY3R7; Rutosid; Ilixanthin; Oxyritin; Rutinion ac" C27H30O16 IKGXIBQEEMLURG-NVPNHPEKSA-N 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-4-one n.a. n.a. No Yes No Yes Yes No rxn42983,rxnDiet194 PMDBD386 Genistein "Therapeutic Substance; Herbal Substance" antineoplastic and antitumor 446-72-0 DB01645 PA165109660 n.a. DCL000330 5280961 4444448 NPC39426 "genistein; 446-72-0; Prunetol; Genisteol; 4'',5,7-Trihydroxyisoflavone; Genisterin; Sophoricol; 5,7-dihydroxy-3-(4-hydroxyphenyl)-4H-chromen-4-one; 5,7,4''-Trihydroxyisoflavone; Bonistein; Differenol A; Genestein; NPI 031L; 5,7-dihydroxy-3-(4-hydroxyphenyl)chromen-4-one; 5,7-Dihydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one; C.I. 75610; SIPI 807-1; 5,7-Dihydroxy-3-(4-hydroxyphenyl)-4-benzopyrone; UNII-DH2M523P0H; NSC 36586; CCRIS 7675; NSC36586; CHEMBL44; EINECS 207-174-9" C15H10O5 TZBJGXHYKVUXJN-UHFFFAOYSA-N 5,7-dihydroxy-3-(4-hydroxyphenyl)chromen-4-one DSM Nutritional Products n.a. No Yes No Yes Yes No rxn02099,rxnDiet132,rxnAdd180 PMDBD128 Budesonide Therapeutic Substance Approved Drug 51333-22-3 DB01222 PA448681 D00246 DAP000320 5281004 4444479 n.a. "budesonide; Rhinocort; Entocort; 51333-22-3; Preferid; Budeson; Rhinocort Aqua; Pulmicort; Micronyl; Cortivent; Spirocort; Respules; Bidien; Entocort EC; Pulmicort Respules; Budesonidum; Uceris; Rhinocort alpha; Pulmicort Flexhaler; Budesonidum [INN-Latin]; Budesonido [INN-Spanish]; Budesonide [USAN:INN:BAN:JAN]; S 1320; CCRIS 5230; CHEBI:3207; MAP-0010; EINECS 257-139-7; MLS000028507; Budesonide MMX; 51372-29-3; 16,17-Butylidenebis(oxy)-11,21-dihydroxypregna-1,4-diene-3,20-dione; S-1320" C25H34O6 VOVIALXJUBGFJZ-KWVAZRHASA-N (1S,2S,4R,8S,9S,11S,12S,13R)-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-propyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one AstraZeneca Antiinflammatory Agents No Yes No Yes No No PMDBD1091 Cefprozil Therapeutic substance Antibiotics 92665-29-7 DB01150 PA164746342 n.a. DAP000447 5281006 4444481 n.a. "cefprozil; Cefprozil anhydrous; Cefzil; Arzimol; Procef; Cefprozilum; Cefprozilo; Serozil; Cronocef; Cefprozilum [INN-Latin]; 92665-29-7; Cefprozilo [INN-Spanish]; Brisoral; BMY 28100; trans-Cefprozil; (E)-cefprozil; Cefprozil hydrate; S1SDI2FJIY; UNII-S1SDI2FJIY; Cefzil (TN); 92676-86-3; Cefprozil hydrate (Cefzil); Cefprozil (INN); Cefprozil (TN); 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carb" C18H19N3O5S WDLWHQDACQUCJR-ZAMMOSSLSA-N (6R,7R)-7-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-8-oxo-3-[(E)-prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid n.a. n.a. Yes No No No No No PMDBD558 Montelukast Therapeutic Substance Drugs for obstructive airway disease 158966-92-8 DB00471 PA450546 D08229 DAP000309 5281040 4444507 n.a. "montelukast; 158966-92-8; Singulair; Montelukast [INN:BAN]; UNII-MHM278SD3E; (R-(E))-1-(((1-(3-(2-(7-Chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropaneacetic acid; MK 0476; CHEMBL787; MHM278SD3E; CHEBI:50730; 1-((((1R)-1-(3-((1E)-2-(7-Chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropaneacetic acid; {1-[({(1R)-1-{3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl}-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl}sulfanyl)me" C35H36ClNO3S UCHDWCPVSPXUMX-TZIWLTJVSA-N 2-[1-[[(1R)-1-[3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl]-3-[2-(2-hydroxypropan-2-yl)phenyl]propyl]sulfanylmethyl]cyclopropyl]acetic acid Schering-Plough Corporation Antiasthmatic Agents Yes Yes Yes No No No PMDBD1151 Dexchlorpheniramine Maleate Therapeutic substance Drug 2438-32-6 DB09555 n.a. n.a. n.a. 5281070 4444527 n.a. "Dexchlorpheniramine maleate; 2438-32-6; (+)-Chlorpheniramine maleate; Polaramine; d-Chlorpheniramine maleate; Mylaramine; Dexchlorpheniramine (maleate); UNII-B10YD955QW; Dextrochlorpheniramine maleate; Dexchloropheniramine maleate; Chlorpheniramine d-form maleate; CHEBI:4465; S-(+)-Chlorpheniramine maleate salt; B10YD955QW; Dexchlorpheniramine maleate [USP]; S-(+)-Chlorpheniramine maleate; Dexchlorpheniramine maleate (USP); EINECS 219-450-6; SR-01000075763; polar amine; DeXchlorpheniramine Maleate, USP; (+)-2-(p-Chloro-alpha-(2" C20H23ClN2O4 DBAKFASWICGISY-DASCVMRKSA-N "(Z)-but-2-enedioic acid;(3S)-3-(4-chlorophenyl)-N,N-dimethyl-3-pyridin-2-ylpropan-1-amine" n.a. n.a. No Yes No No No No PMDBD1329 Olopatadine Therapeutic substance Drug 113806-05-6 DB00768 PA450698 n.a. DAP001062 5281071 4444528 n.a. "Olopatadine; Patanol; 113806-05-6; OLOPATADINE HYDROCHLORIDE; Olopatadine [INN:BAN]; UNII-D27V6190PM; Pazeo; KW-4679; ALO-4943A; (Z)-2-(11-(3-(Dimethylamino)propylidene)-6,11-dihydrodibenzo[b,e]oxepin-2-yl)acetic acid; 2-[(11Z)-11-[3-(dimethylamino)propylidene]-6H-benzo[c][1]benzoxepin-2-yl]acetic acid; D27V6190PM; 140462-76-6; {(11Z)-11-[3-(dimethylamino)propylidene]-6,11-dihydrodibenzo[b,e]oxepin-2-yl}acetic acid; 11-((Z)-3-(Dimeth" C21H23NO3 JBIMVDZLSHOPLA-LSCVHKIXSA-N 2-[(11Z)-11-[3-(dimethylamino)propylidene]-6H-benzo[c][1]benzoxepin-2-yl]acetic acid n.a. n.a. No Yes No No No No PMDBD563 Mycophenolate mofetil Therapeutic Substance inosine monophosphate dehydrogenase inhibitor? 128794-94-5 DB00688 PA450566 D00752 DNC000397 5281078 4444535 n.a. "mycophenolate mofetil; 128794-94-5; CellCept; RS 61443; RS-61443; TM-MMF; Myfenax; 115007-34-6; Mycophenolic acid morpholinoethyl ester; UNII-9242ECW6R0; CHEBI:8764; HSDB 7436; Cellcept (TN); 2-Morpholinoethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate; 2-(morpholin-4-yl)ethyl (4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydro-2-benzofuran-5-yl)-4-methylhex-4-enoate; (E)-2-Morpholinoethyl 6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydroisobenzofuran-5-yl)-4-methylhex-4-enoate; C23H31N" C23H31NO7 RTGDFNSFWBGLEC-SYZQJQIISA-N 2-morpholin-4-ylethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-5-yl)-4-methylhex-4-enoate Roche Immunosuppressive Agents No Yes No Yes No No PMDBD306 Entacapone Therapeutic Substance Approved Drug 130929-57-6 DB00494 PA164748726 D00781 DAP000608 5281081 4444537 n.a. "ENTACAPONE; 130929-57-6; Comtan; Comtess; Entacaponum; OR-611; Entacapona; Entacaponum [INN-Latin]; Entacapona [INN-Spanish]; OR 611; (E)-alpha-Cyano-N,N-diethyl-3,4-dihydroxy-5-nitrocinnamamide; 2-Cyano-N,N-diethyl-3-(3,4-dihydroxy-5-nitrophenyl)propenamide; UNII-4975G9NM6T; CHEMBL953; (2E)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylprop-2-enamide; CHEBI:4798; N,N-diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl) acrylamide; C14H15N3O5; 4975G9NM6T; (E)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide; (E)-2" C14H15N3O5 JRURYQJSLYLRLN-BJMVGYQFSA-N (E)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylprop-2-enamide Norvatis Phamaceuticals Corporation Antiparkinson Agents Yes Yes Yes Yes No No PMDBD284 Diosmin "Therapeutic Substance; Herbal Substance" "Approved Drug; Medicinal Herbal Compounds" 520-27-4 DB08995 n.a. D07858 n.a. 5281613 4444932 NPC209296 "diosmin; 520-27-4; Diosimin; Barosmin; Venosmine; Diosmil; Diosmine; Flebosten; Daflon; Diovenor; Tovene; Ven-Detrex; Veno-V; Diosminum; Rioven; Diosmetin 7-O-rutinoside; UNII-7QM776WJ5N; 7QM776WJ5N; CHEBI:4631; 3'',5,7-trihydroxy-4''-methoxyflavone-7-rutinoside; C28H32O15; 5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-4-one; Buchu Resin; Diosmin, analytical standard; DSSTox_CID_25892; DSSTox_RID_81206; DSSTox_GSID_458" C28H32O15 GZSOSUNBTXMUFQ-YFAPSIMESA-N 5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-4-one n.a. n.a. No Yes No No Yes No rxnAddEX6,rxnAdd88 PMDBD244 Daidzein "Therapeutic Substance; Herbal Substance" a weakly estrogenic compound with potential health 486-66-8 DB13182 n.a. n.a. n.a. 5281708 4445025 NPC234560 "daidzein; 486-66-8; 4'',7-Dihydroxyisoflavone; Daidzeol; 7,4''-Dihydroxyisoflavone; 7-hydroxy-3-(4-hydroxyphenyl)-4H-chromen-4-one; 7-Hydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one; 7-hydroxy-3-(4-hydroxyphenyl)chromen-4-one; 7-Hydroxy-3-(4-hydroxyphenyl)-4-benzopyrone; UNII-6287WC5J2L; CCRIS 7600; K 251b; EINECS 207-635-4; MFCD00016954; BRN 0231523; CHEMBL8145; 4'',7-Dihydroxy-iso-flavone; d-(+)-alpha-methylbenzylamine; CHEBI:28197; 6287WC5J2L; Daidzein,(S); Daidzein, 98%" C15H10O4 ZQSIJRDFPHDXIC-UHFFFAOYSA-N 7-hydroxy-3-(4-hydroxyphenyl)chromen-4-one n.a. n.a. No Yes No Yes Yes No rxnDiet110,rxnAdd176,rxnAdd177 PMDBD714 Puerarin "Therapeutic Substance; Herbal Substance" Herbal 3681-99-0 DB12290 n.a. n.a. n.a. 5281807 4445119 NPC124478 "Puerarin; 3681-99-0; Kakonein; CHEBI:8633; UNII-Z9W8997416; Daidzein-8-C-glucoside; NPI 031G; Z9W8997416; Puerarin, analytical standard; 7-hydroxy-3-(4-hydroxyphenyl)-8-((2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)-4H-chromen-4-one; Q63408673; NSC 380711; BRN 0064198; AC1NQZ4N; 8-beta-D-Glucopyranosyl-7-hydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one; NSC-380711; Kudzu Root Extract; 7,4''-Dihydroxy-8-C-glucosylisoflavone; SureCN8581666; 4-19-00-03200 (Beilstein Handbook Reference); MLS002473178" C21H20O9 HKEAFJYKMMKDOR-VPRICQMDSA-N 7-hydroxy-3-(4-hydroxyphenyl)-8-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-4-one n.a. n.a. No Yes No No No No PMDBD299 Ellagic acid "Therapeutic Substance; Herbal Substance" compound 476-66-4 DB08846 n.a. n.a. n.a. 5281855 4445149 NPC178134 "ellagic acid; 476-66-4; Benzoaric acid; Elagostasine; Lagistase; Eleagic acid; Alizarine Yellow; 2,3,7,8-Tetrahydroxychromeno[5,4,3-cde]chromene-5,10-dione; Ellagic acid dihydrate; Llagic acid; Acide ellagique; Acido elagico; Acidum ellagicum; C.I. 55005; Gallogen (VAN); Gallogen (astringent); C.I. 75270; Ellagate; UNII-19YRN3ZS9P; Ellagic acid [INN:DCF]; CCRIS 774; Acido elagico [INN-Spanish]; Gallogen, astringent; Acide ellagique [INN-French]; Acidum ellagicum [INN-Latin]; MLS000069632; C14H6O8; EINECS 207-508-3; MFCD00006914; NSC407" C14H6O8 AFSDNFLWKVMVRB-UHFFFAOYSA-N 6,7,13,14-tetrahydroxy-2,9-dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(15),4,6,8(16),11,13-hexaene-3,10-dione n.a. n.a. No Yes No No Yes No rxnDiet119,rxnAdd43,rxnAdd44,rxnAdd45 PMDBD193 Cilnidipine Therapeutic Substance Approved Drug 132203-70-4 DB09232 n.a. D01173 n.a. 5282138 4445338 n.a. "cilnidipine; 132203-70-4; Cinalong; FRC-8653; Siscard; Atelec; FRC 8653; 3-cinnamyl 5-(2-methoxyethyl) 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate; Cilnidipine [INN]; CHEBI:31399; (+-)-(E)-Cinnamyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate; Cilnidipine, 99%; 2-methoxyethyl (2E)-3-phenylprop-2-en-1-yl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate; NCGC00162150-01; Cinaldipine; DSSTox_RID_81530; DSSTox_CID_26309; DSSTox_GSID_46309; 1,4-Di" C27H28N2O7 KJEBULYHNRNJTE-DHZHZOJOSA-N 3-O-(2-methoxyethyl) 5-O-[(E)-3-phenylprop-2-enyl] 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate Fuji Viscera Pharmaceutical n.a. Yes No No No No No PMDBD465 Josamycin "Therapeutic Substance; Herbal Substance" "Approved Drug; Medicinal Herbal Compounds" 16846-24-5 DB01321 PA164749133 D01235 DAP000887 5282165 4445361 NPC314451 "josamycin; Leucomycin A3; Turimycin A5; Kitasamycin A3; Josamycine; Antibiotic yl-704 A3; Josamicina; Josamycinum; Josamycinum [INN-Latin]; Josamycine [INN-French]; Josamicina [INN-Spanish]; 16846-24-5; Yl-704 A3; Leucomycin V, 3-acetate 4B-(3-methylbutanoate); UNII-HV13HFS217; EN-141; Josacine; EINECS 240-871-6; Leucomycin V 3-acetate 4b-(3-methylbutanoate); Leucomycin V, 3-acetate 4(sup B)-(3-methylbutanoate); HV13HFS217; Leucomycin V, 3-acetate 4(sup beta)-(3-methylbutanoate); JM; CHEBI:31739; ST075007; Stereoisomer of 4-(acetyl" C42H69NO15 XJSFLOJWULLJQS-NGVXBBESSA-N [(2S,3S,4R,6S)-6-[(2R,3S,4R,5R,6S)-6-[[(4R,5S,6S,7R,9R,10R,11E,13E,16R)-4-acetyloxy-10-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)-1-oxacyclohexadeca-11,13-dien-6-yl]oxy]-4-(dimethylamino)-5-hydroxy-2-methyloxan-3-yl]oxy-4-hydroxy-2,4-dimethyloxan-3-yl] 3-methylbutanoate n.a. n.a. Yes No Yes No No No PMDBD25 Alfacalcidol Therapeutic Substance Approved Drug 41294-56-8 DB01436 PA164746469 D01518 n.a. 5282181 4445376 n.a. "alfacalcidol; 1-Hydroxycholecalciferol; 1alpha-Hydroxyvitamin D3; 41294-56-8; 1alpha-Hydroxycholecalciferol; Alphacalcidol; Alfarol; alpha-Calcidol; One-Alpha; Alfacalcidolum; 1-Hydroxyvitamin D3; Un-Alpha; 1alpha-Hydroxy-vitamin D3; Etalpha; Oxydevit; UNII-URQ2517572; Sinovul; CHEBI:31186; EinsAlpha; (5Z,7E)-9,10-Seco-5,7,10(19)-cholestatrien-1alpha,3beta-diol; Alpha D 3; URQ2517572; Bondiol; 1 alpha-hydroxyvitamin D3; Alfacalcidolum [INN-Latin]; Alfacalcidol [INN:BAN:JAN]; CCRIS 3341; 1alpha-hydroxyvitam" C27H44O2 OFHCOWSQAMBJIW-AVJTYSNKSA-N (1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol n.a. n.a. Yes No Yes No No No PMDBD788 Sorivudine Therapeutic Substance antiviral 77181-69-2 DB11998 n.a. n.a. n.a. 5282192 4445384 n.a. "SORIVUDINE; Bravavir; Usevir; Brovavir; 77181-69-2; BVAU; BV-Ara-U; YN-72; Bromovinyluridine; 5-Bromovinyl-araU; BV-araU; SQ-32756; Sorivudinum [INN-Latin]; Sorivudina [INN-Spanish]; UNII-C7VOZ162LV; ARYS-01; CCRIS 5285; (E)-5-(2-Bromovinyl)uridine; DRU-0136; C7VOZ162LV; (E)-5-(2-Bromovinyl)-1-beta-D-arabinofuranosyluracil; CHEMBL70046; 1-beta-D-Arabinofuranosyl-(E)-5-(2-bromovinyl)uracil; (+)-1-beta-D-Arabinofuranosyl-5-((E)-2-bromovinyl)uracil; SQ 32,756; (E)-1-beta-D-Arabinofuranosyl-5-(2-bromoethenyl)-2,4(1H,3H)-pyrimidinedione" C11H13BrN2O6 GCQYYIHYQMVWLT-HQNLTJAPSA-N 5-[(E)-2-bromoethenyl]-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione n.a. n.a. No Yes No Yes No Yes EX_srv(e),PYNP_SRV,SRVt2,SRVt2pp,SRVtex PMDBD864 Tranilast Therapeutic Substance Approved Drug 53902-12-8 DB07615 n.a. D02027 n.a. 5282230 4445411 n.a. "tranilast; 53902-12-8; Rizaben; trans-Tranilast; Tranilastum; 70806-55-2; MK 341; N-(3,4-Dimethoxycinnamoyl)anthranilic acid; Tranilastum [INN-Latin]; Tranilast [USAN:INN:JAN]; UNII-HVF50SMY6E; SB-252218; MK-341; Tranilast (SB 252218); 3,4-DAA; n-(3'',4''-dimethoxycinnamoyl) anthranilic acid; HVF50SMY6E; MLS000028468; CHEBI:77572; 2-((3-(3,4-Dimethoxyphenyl)-1-oxo-2-propenyl)amino)benzoic acid; Tranilast (trans-); (E)-2-(3-(3,4-dimethoxyphenyl)acrylamido)benzoic acid; NCGC00018185-05" C18H17NO5 NZHGWWWHIYHZNX-CSKARUKUSA-N 2-[[(E)-3-(3,4-dimethoxyphenyl)prop-2-enoyl]amino]benzoic acid Kissei n.a. No Yes No No No No PMDBD1095 Ceftibuten Therapeutic substance Antibiotics 97519-39-6 DB01415 PA164744555 D00922 DAP000456 5282242 4445419 n.a. "ceftibuten; 97519-39-6; Ceftibuteno; Ceftibutenum; Ceftibutene; Cedax; cis-ceftibuten; UNII-IW71N46B4Y; Cephem; cis-Ceftibutin; Sch-39720; 7432-S; Antibiotic 7432S; Sch 39720; Cephalosporin 7432-S; CHEBI:3510; IW71N46B4Y; Isocef; (+)-(6R,7R)-7-((Z)-2-(2-Amino-4-thiazolyl)-4-carboxycrotonamido)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; Ceftibuten hydrate; Ceftibutene [INN-French]; Ceftibutenum [INN-Latin]; CETB; Ceftibuteno [INN-Spanish]; Ceftibuten [USAN:INN:BAN]; S 7432; (6R,7R)-7-((Z)-2-(2-Aminothiazol-4-yl)-4-c" C15H14N4O6S2 UNJFKXSSGBWRBZ-BJCIPQKHSA-N (6R,7R)-7-[[(Z)-2-(2-amino-1,3-thiazol-4-yl)-4-carboxybut-2-enoyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid n.a. n.a. Yes No No No No No PMDBD1298 Misoprostol Therapeutic substance reduce the risk of NSAID induced gastric ulcers 59122-46-2 DB00929 PA450523 D00419 DAP000358 5282381 4445541 n.a. "misoprostol; 59122-46-2; Cytotec; Isprelor; Misoprostolum [INN-Latin]; SC-29333; Misodel; SC 29333; CCRIS 6859; HSDB 3573; BRN 4155643; NCGC00162445-02; Misoprostolum; Misotol; Misoprost; methyl 7-[(1R,2R,3R)-3-hydroxy-2-[(E)-4-hydroxy-4-methyloct-1-enyl]-5-oxocyclopentyl]heptanoate; Misotac; Misogon; Misopess; GyMiso; Cytotec (TN); Methyl (+-)-11-alpha,16-dihydroxy-16-methyl-9-oxoprost-13-en-1-oate; misoprostol (methyl ester); (11-alpha,13E)-(+-)-1" C22H38O5 OJLOPKGSLYJEMD-URPKTTJQSA-N methyl 7-[(1R,2R,3R)-3-hydroxy-2-[(E)-4-hydroxy-4-methyloct-1-enyl]-5-oxocyclopentyl]heptanoate n.a. n.a. No Yes No No No No PMDBD221 Codeine "Therapeutic Substance; Herbal Substance" "Therapeutic Substance; Herbal Substance" 76-57-3 DB00318 PA449088 D03580 DAP000213 5284371 4447447 NPC43069 "codeine; Methylmorphine; Codeine anhydrous; Codicept; l-Codeine; Coducept; Morphine monomethyl ether; 76-57-3; Morphine 3-methyl ether; (-)-Codeine; O3-Methylmorphine; codeinum; Morphine-3-methyl ether; Codein; Norcodine, N-methyl; Norcodeine, N-methyl; CODEINE BASE; Codeine polistirex; codeina; CCRIS 7555; Morphine-3-methyl ester; HSDB 3043; UNII-UX6OWY2V7J; O(3)-methylmorphine; CHEBI:16714; EINECS 200-969-1; UX6OWY2V7J; Codeine Anhydrate" C18H21NO3 OROGSEYTTFOCAN-DNJOTXNNSA-N (4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-ol Forest Pharmaceuticals Analgesics No Yes No No No No PMDBD1013 Acitretin Therapeutic substance Drug 55079-83-9 DB00459 PA448039 D02754 DAP000743 5284513 4447573 n.a. "Acitretin; 55079-83-9; Etretin; Soriatane; Neotigason; Acitretine; all-trans-Acitretin; Retinoid etretin; Acitretinum; Acitretina; TMMP; Ro 10-1670; Acitretinum [Latin]; Acitretine [French]; Acitretina [Spanish]; (2E,4E,6E,8E)-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenoic acid; UNII-LCH760E9T7; Ro 10-1670/000; CCRIS 5534; Ro-10-1670; all-trans-3,7-Dimethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-2,4,6,8-nonatetraenoic acid; (all-E)-9-(4-Methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic aci" C21H26O3 IHUNBGSDBOWDMA-AQFIFDHZSA-N (2E,4E,6E,8E)-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenoic acid n.a. n.a. No Yes No No No No PMDBD1014 Acrivastine Therapeutic substance Drug 87848-99-5 DB09488 n.a. D02760 n.a. 5284514 4447574 n.a. "ACRIVASTINE; 87848-99-5; Semprex; Acrivastin; Acrivastinum; Acrivastina; Acrivastinum [Latin]; BW-825C; BW 825C; Acrivastina [Spanish]; BW A825C; Acrivastine [USAN:INN:BAN]; UNII-A20F9XAI7W; A20F9XAI7W; (E)-6-((E)-3-(1-Pyrrolidinyl)-1-p-tolylpropenyl)-2-pyridineacrylic acid; CHEBI:83168; C22H24N2O2; (E)-6-((E)-3-(1-Pyrrolidinyl-1-p-tolylpropenyl)-2-pyridinacrylsaeure; BW825C; NCGC00182053-02; 2-Propenoic acid,3-[6-[(1E)-1-(4-methylp" C22H24N2O2 PWACSDKDOHSSQD-IUTFFREVSA-N (E)-3-[6-[(E)-1-(4-methylphenyl)-3-pyrrolidin-1-ylprop-1-enyl]pyridin-2-yl]prop-2-enoic acid n.a. n.a. No Yes No No No No PMDBD1220 Granisetron Therapeutic substance Drug 109889-09-0 DB00889 PA449809 D04370 DAP000295 5284566 10482033 n.a. "granisetron; 109889-09-0; Sustol; Sancuso; Granisetronum; Kevatril; APF530; UNII-WZG3J2MCOL; CHEBI:5537; APF 530; WZG3J2MCOL; 1-methyl-N-[(3-endo)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-1H-indazole-3-carboxamide; CHEMBL1290003; BRL 43694; BRL-43694; 1-Methyl-N-(9-methyl-endo-9-azabicyclo(3.3.1)non-3-yl)-1H-indazole-3-carboxamide; BRL 43964; 1-methyl-N-[(1S,5R)-9-methyl-9-azabicyclo[3.3.1]nonan-3-yl]indazole-3-carboxamide; 1-Methyl-N-[(1r,5s)-9-Methyl-9-Azabicyclo[3.3.1]nonan-3-Yl]indazole-3-Carboxamide; SR-05000001492; BIDD:GT0" C18H24N4O MFWNKCLOYSRHCJ-AGUYFDCRSA-N 1-methyl-N-[(1S,5R)-9-methyl-9-azabicyclo[3.3.1]nonan-3-yl]indazole-3-carboxamide n.a. n.a. No Yes No No No No PMDBD493 Loracarbef Therapeutic Substance Approved Drug 76470-66-1 DB00447 PA164754806 D00916 DAP000434 5284585 4447635 n.a. "loracarbef; Lorabid; Loracarbefum; 76470-66-1; loracarbef anhydrous; UNII-W72I5ZT78Z; Loribid; W72I5ZT78Z; Loracarbefum [INN-Latin]; CHEBI:47544; KT 3777; LY-163892; LY163892; LY 163892; Loracarbef [USAN:INN:BAN]; Anhydrous loracarbef; Loracarbef (INN); Lorbef (TN); LORACABEF; CHEMBL1013; LORACARBEF, ANHYDROUS; SCHEMBL34153; BIDD:GT0753; DTXSID7023223; CTK2H7568; HMS3713L04; HY-B1682; ZINC1530993; 1-Azabicyclo(4.2.0)o" C16H16ClN3O4 JAPHQRWPEGVNBT-UTUOFQBUSA-N (6R,7S)-7-[[(2R)-2-amino-2-phenylacetyl]amino]-3-chloro-8-oxo-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Eli Lilly Antibiotics Yes No Yes No No No PMDBD572 Naloxone "Therapeutic Substance; Herbal Substance" "Approved Drug; Medicinal Herbal Compounds" 465-65-6 DB01183 PA450586 D08249 DAP000097 5284596 4447644 NPC201055 "naloxone; l-Naloxone; 465-65-6; Narcan; n-Allylnoroxymorphone; (-)-Naloxone; Nalossone [DCIT]; EN 1530 base; Naloxonum [INN-Latin]; Naloxonum; Naloxona; Naloxona [INN-Spanish]; Narcanti; N-Allyl-noroxymorphone; 1-N-Allyl-14-hydroxynordihydromorphinone; Naloxone [INN:BAN]; HSDB 3279; UNII-36B82AMQ7N; 1-N-Allyl-7,8-dihydro-14-hydroxynormorphinone; l-N-Allyl-14-hydroxynordihydromorphinone; 17-Allyl-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one; 17-Allyl-4,5-alpha-epoxy-3,14-dihydroxymorphinan-6-one; EINECS 207-365-7; NSC 70413; l-N-Al" C19H21NO4 UZHSEJADLWPNLE-GRGSLBFTSA-N (4R,4aS,7aR,12bS)-4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one n.a. n.a. No Yes No No No No PMDBD1464 Topiramate Therapeutic substance Drug 97240-79-4 DB00273 PA451728 D00537 DAP000137 5284627 4447672 n.a. "topiramate; 97240-79-4; Topamax; Epitomax; Topamax Sprinkle; Topiramatum; Tipiramate; McN-4853; Tipiramato; Topiramato; Tipiramate [French]; Tipiramato [Spanish]; McN 4853; Topiramatum [INN-Latin]; topiramatum [Latin]; Topiramato [INN-Spanish]; RWJ-17021-000; RWJ-17021; C12H21NO8S; 2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate; 2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulfamate; UNII-0H73WJJ391; USL255; USL-255; BRN 5988957" C12H21NO8S KJADKKWYZYXHBB-XBWDGYHZSA-N [(1R,2S,6S,9R)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.02,6]dodecan-6-yl]methyl sulfamate n.a. n.a. No Yes No No No No PMDBD1218 Glyphosate Environmental Chemicals Pesticides 1071-83-6 DB04539 n.a. n.a. DNC000698 5288464 4450646 n.a. "DB04539; carboxy-N-(phosphonomethyl)methanaminium; (Carboxylatomethyl)aminiomethylphosphonic acid dianion" C3H9NO5P+ XDDAORKBJWWYJS-UHFFFAOYSA-O carboxymethyl(phosphonomethyl)azanium n.a. n.a. Yes No Yes No No No PMDBD560 Morphine "Therapeutic Substance; Herbal Substance" opioid agonist 57-27-2 DB00295 PA450550 D08233 DAP000071 5288826 4450907 NPC232533 "morphine; Morphia; Morphinum; Morphium; Morphin; (-)-Morphine; Morphina; DepoDur; Ospalivina; Meconium; Moscontin; Morphinism; Duromorph; MS Contin; l-Morphine; 57-27-2; Roxanol; Morfina; Dulcontin; MORPHINE SULFATE; Infumorph; Nepenthe; Dreamer; Morpho; Kadian; Unkie; Avinza; Hocus; Hard stuff; Cube juice; Oramorph SR; Statex SR; Ms Emma; Morphin [German]; Morfina [Italian]; Duramorph; Morphina [Italian]; M-Eslon; Morphine [BAN]; CCRIS 5762; HSDB 2134; (5R,6S,9R,13S,14R)-4,5-Epoxy-N-methyl-7-morphinen-3,6-diol; UNII-76I7G6D29C; CHEBI:17303; CHEMBL70" C17H19NO3 BQJCRHHNABKAKU-KBQPJGBKSA-N (4R,4aR,7S,7aR,12bS)-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7,9-diol Eurohealth International Sarl Analgesics No Yes No Yes No Yes EX_mrphn(e),MRPHN_3GLC_GLCAASE,MRPHN_3GLC_GLCAASEe,MRPHN_3GLC_GLCAASEepp,MRPHN_6GLC_GLCAASE,MRPHN_6GLC_GLCAASEe,MRPHN_6GLC_GLCAASEepp,MRPHNte,MRPHNtepp,MRPHNtex PMDBD470 Lacidipine Therapeutic Substance Approved Drug 103890-78-4 DB09236 n.a. D04657 n.a. 5311217 4470736 n.a. "Lacidipine; 103890-78-4; Lacipil; Motens; GR-43659X; Lacidipinum [Latin]; Lacidipino [Spanish]; Lacidipine (Lacipil, Motens); UNII-260080034N; GR 43659X; GR 43659 X; C26H33NO6; Lacimen; DSSTox_CID_26429; DSSTox_RID_81607; DSSTox_GSID_46429; 4-(o-((E)-2-Carboxyvinyl)phenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid, 4-tert-butyl diethyl ester; diethyl 2,6-dimethyl-4-[2-[(E)-3-[(2-methylpropan-2-yl)oxy]-3-oxoprop-1-enyl]phenyl]-1,4-dihydropyridine-3,5-dicarboxylate; 260080034N; Lacidipinum; Lacidipino; Lacirex; trans " C26H33NO6 GKQPCPXONLDCMU-CCEZHUSRSA-N diethyl 2,6-dimethyl-4-[2-[(E)-3-[(2-methylpropan-2-yl)oxy]-3-oxoprop-1-enyl]phenyl]-1,4-dihydropyridine-3,5-dicarboxylate n.a. n.a. Yes No Yes No No No PMDBD576 Nateglinide Therapeutic Substance Approved Drug 105816-04-4 DB00731 PA450600 D01111 DAP000918 5311309 10482084 n.a. "nateglinide; 105816-04-4; Starlix; Starsis; Fastic; Trazec; A-4166; AY-4166; SDZ-DJN-608; DJN-608; DJN 608; Nateglinide [INN]; UNII-41X3PWK4O2; SDZ-DJN 608; AY 4166; AY4166; A 4166; CHEMBL783; SDZ DJN 608; N-[(trans-4-Isopropylcyclohexyl)carbonyl]-D-phenylalanine; 41X3PWK4O2; senaglinide; CHEBI:31897; 105816-06-6; (-)-N-(trans-4-Isopropylcyclohexanecarbonyl)-D-phenylalanine; N-{[trans-4-(propan-2-yl)cyclohexyl]carbonyl}-D-phenylalanine; (2R)-2-[[oxo-(4-propan-2-ylcycl" C19H27NO3 OELFLUMRDSZNSF-OFLPRAFFSA-N (2R)-3-phenyl-2-[(4-propan-2-ylcyclohexanecarbonyl)amino]propanoic acid Norvatis Phamaceuticals Corporation Hypoglycemic Agents No Yes No Yes No No PMDBD1431 Sunitinib Therapeutic substance multi-targeted receptor tyrosine kinase (RTK) inhibitor 557795-19-4 DB01268 PA162372840 D06402 DCL000646 5329102 4486264 n.a. "Sunitinib; 557795-19-4; Sutent; Sunitinib malate; SU11248; SU-11248; Su-011248; Sunitinib Base; SU 11248; 342641-94-5; UNII-V99T50803M; N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide; CHEMBL535; N-[2-(diethylamino)ethyl]-5-{[(3Z)-5-fluoro-2-oxo-2,3-dihydro-1H-indol-3-ylidene]methyl}-2,4-dimethyl-1H-pyrrole-3-carboxamide; CHEBI:38940; 341031-54-7; NSC750690; V99T50803M; (Z)-N-(2-(Diethylamino)ethyl)-5-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-d" C22H27FN4O2 WINHZLLDWRZWRT-ATVHPVEESA-N N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide n.a. n.a. No Yes No No No No PMDBD243 Dacarbazine Therapeutic Substance Approved Drug n.a. DB00851 PA449197 D00288 DAP000533 135398738 10481959 n.a. "dacarbazine; DTIC; Deticene; 4342-03-4; Biocarbazine; DTIC-Dome; Biocarbazine R; ICDMT; Decarbazine; ICDT; DTIE; 4-(Dimethyltriazeno)imidazole-5-carboxamide; Dacarbazinum [INN-Latin]; Dacarbazino [INN-Spanish]; NSC-45388; 5-(3,3-Dimethyl-1-triazeno)imidazole-4-carboxamide; 5-(3,3-Dimethyltriazeno)imidazole-4-carboxamide; Di-me-triazenoimidazolecarboxamide; NSC45388; 5-(Dimethyltriazeno)imidazole-4-carboxamide; (Dimethyltriazeno)imidazolecarboxamide; NSC 45388; 4-(3,3-Dimethyl-1-triazeno)imidazole-5-carboxamide; NCI-C04717; 4-(5)-(" C6H10N6O FDKXTQMXEQVLRF-ZHACJKMWSA-N 4-[(E)-dimethylaminodiazenyl]-1H-imidazole-5-carboxamide n.a. n.a. Yes No No No No No PMDBD812 Sulfasalazine Therapeutic Substance anti-inflammatory 599-79-1 DB00795 PA451547 D00448 DAP000153 5339 10605946 n.a. "sulfasalazine; 599-79-1; Salicylazosulfapyridine; Azulfidine; Salazosulfapyridine; Sulphasalazine; Salazopyrin; Asulfidine; Salazopyridin; Sulcolon; Azopyrin; Accucol; Colo-Pleon; Salazopiridazin; Salisulf; Reupirin; Benzosulfa; Azopyrine; Salazosulfapyridin; w-t Sasp oral; Sulfasalazin; Azulfidine EN; Sulfazalazine; Sulfasalazinum; Sulfasalazina; Azulfidine EN-tabs; Salazosulfapiridina; Sas-500; Salazosulfapyridinum; Azosulfidin; SASP; 5-(p-(2-Pyridylsulfamyl)phenylazo)salicylic acid; Salazo-sulfapyridinum; S.A.S.-500; 5-(4-(2-Pyridylsulfa" C18H14N4O5S NCEXYHBECQHGNR-UHFFFAOYSA-N 2-hydroxy-5-[[4-(pyridin-2-ylsulfamoyl)phenyl]diazenyl]benzoic acid n.a. n.a. No Yes No Yes No Yes EX_ssz(e),SSZ_AR_NADi,SSZ_AR_NADPi,SSZt2r,SSZt2rpp,SSZtex PMDBD1309 Naltrexone Therapeutic substance Drug 16590-41-3 DB00704 PA450588 D05113 DAP000379 5360515 4514524 n.a. "naltrexone; 16590-41-3; ReVia; Vivitrol; N-Cyclopropylmethylnoroxymorphone; Vivitrex; Celupan; Naltrexonum [INN-Latin]; Naltrexona [INN-Spanish]; UNII-5S6W795CQM; N-Cyclopropylmethyl-14-hydroxydihydromorphinone; Naltrexone [USAN:INN:BAN]; CCRIS 3506; HSDB 6750; 17-(Cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one; EINECS 240-649-9; UM-792; 17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one; BRN 3596648; 5S6W795CQM; CHEBI:7465; (-)-Naltrexone; Nemexin; EN-1639A [AS HYDROCHLORIDE]; DSSTox_RID_81532; DSSTox_" C20H23NO4 DQCKKXVULJGBQN-XFWGSAIBSA-N (4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one n.a. n.a. No Yes No No No No PMDBD1152 Dextromethorphan Therapeutic substance Drug 125-71-3 DB00514 PA449273 D03742 DNC000541 5360696 13109865 n.a. "dextromethorphan; d-Methorphan; delta-Methorphan; Dextromorphan; 125-71-3; Dextromethorfan; Delsym; Dextrometorfano; Destrometerfano; Albutussin; Dextromethorphane; Dextromethorphanum; Dextromethorfan [Czech]; Destrometerfano [DCIT]; BA 2666; Dextrometorfano [INN-Spanish]; Benylin DM; Dextromethorphanum [INN-Latin]; Dextromethorphane [INN-French]; HSDB 3056; Dextromethorphan [USP:INN:BAN]; UNII-7355X3ROTS; 3-Methoxy-17-methyl-9alpha,13alpha,14alpha-morphinan; Dextrometorphan; Romilar; Morphinan, 3-methoxy-17-methyl-, (9alpha,13alph" C18H25NO MKXZASYAUGDDCJ-NJAFHUGGSA-N (1S,9S,10S)-4-methoxy-17-methyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene n.a. n.a. No Yes No No No No PMDBD158 Cefixime Therapeutic Substance Approved Drug 79350-37-1 DB00671 PA164768821 D00258 DAP000439 5362065 4514923 n.a. "CEFIXIME; 79350-37-1; Cephoral; Cefixima; Cefiximum; Cefspan; Cefiximum [Latin]; (-)-Cefixim; Cefixima [Spanish]; Oroken; Cefixoral; Cefixim; FK-027; UNII-XZ7BG04GJX; CL-284635; (E)-Cefixime; Unixime; Suprax; FR-17027; XZ7BG04GJX; MLS002222332; CHEBI:472657; Cefixime Anhydrous; CFIX; Cefixime, 98%; Cefixime hydrate; (6R,7R)-7-({(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(carboxymethoxy)imino]acetyl}amino)-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; SMR001307271; Necopen; Tricef; Denvar; FK 027; BRN 6025058; FR 17027; CL" C16H15N5O7S2 OKBVVJOGVLARMR-QSWIMTSFSA-N (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(carboxymethoxyimino)acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Wyeth Pharmaceuticals Antibiotics Yes No Yes No No No PMDBD98 Benazepril Therapeutic Substance Approved Drug 86541-75-5 DB00542 PA448561 D07499 DAP000584 5362124 4514935 n.a. "benazepril; 86541-75-5; Benazeprilum [Latin]; Benazeprilum; Lotrel; Benazepril [INN:BAN]; CGS-14824-A; UNII-UDM7Q7QWP8; CGS-14824A; UDM7Q7QWP8; CHEMBL838; CHEBI:3011; 2-[(3S)-3-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]-2-oxo-4,5-dihydro-3H-1-benzazepin-1-yl]acetic acid; [(3S)-3-{[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino}-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]acetic acid; benazapril; benzaz" C24H28N2O5 XPCFTKFZXHTYIP-PMACEKPBSA-N 2-[(3S)-3-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]-2-oxo-4,5-dihydro-3H-1-benzazepin-1-yl]acetic acid Norvatis Phamaceuticals Corporation Antihypertensive Agents No Yes No No No No PMDBD730 Ramipril Therapeutic Substance Approved Drug 87333-19-5 DB00178 PA451223 D00421 DAP000581 5362129 4514937 n.a. "ramipril; 87333-19-5; Tritace; Altace; Carasel; Triatec; Ramace; Delix; Vesdil; Acovil; Cardace; Lostapres; Quark; Hytren; Ramiprilum [Latin]; Hoe-498; Ramiprilum; Pramace; HOE 498; Altace (TN); UNII-L35JN3I7SJ; L35JN3I7SJ; CHEMBL1168; CHEBI:8774; C23H32N2O5; (2S,3aS,6aS)-1-[(2S)-2-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}propanoyl]-octahydrocyclopenta[b]pyrrole-2-carboxylic acid; (2S,3aS,6aS)-1-((S)-N-((S)-1-Ethoxycarbonyl-3-phenylpropyl)alanyl)octahydrocyclopenta(b)pyrrol-2-carbonsaeure; (2S,3aS,6aS)-1-((S)-N-((S)-1-Carboxy-3" C23H32N2O5 HDACQVRGBOVJII-JBDAPHQKSA-N (2S,3aS,6aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrole-2-carboxylic acid Sanofi-Aventis Antihypertensive Agents No Yes No No No No PMDBD1238 Indinavir Therapeutic substance Drug 150378-17-9 DB00224 PA449977 n.a. DAP000168 5362440 4515036 n.a. "indinavir; 150378-17-9; Compound J; MK-639; UNII-9MG78X43ZT; CHEBI:44032; Indinavir [USAN]; (1(1S,2R),5(S))-2,3,5-Trideoxy-N-(2,3-dihydro-2-hydroxy-1H-inden-1-yl)-5-(2-(((1,1-dimethylethyl)amino)carbonyl)-4-(3-pyridinylmethyl)-1-piperazinyl)-2-(phenylmethyl)-D-erythro-Pentonamide; 9MG78X43ZT; C36H47N5O4; L-735524; Indinavir [USAN:INN:BAN]; Indinavir monohydrate; L-735,524; D-erythro-Pentonamide, 2,3,5-trideoxy-N-(2,3-dihydro-2-hydroxy-1H-inden-1-yl)-5-(2-(((1,1-dimethylethyl)amino)carbonyl)-4-(3-pyridinylmethyl)-1-pipera" C36H47N5O4 CBVCZFGXHXORBI-PXQQMZJSSA-N (2S)-1-[(2S,4R)-4-benzyl-2-hydroxy-5-[[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]amino]-5-oxopentyl]-N-tert-butyl-4-(pyridin-3-ylmethyl)piperazine-2-carboxamide n.a. n.a. No Yes No No No Yes EX_inv(e),INV_M1_GLCAASE,INV_M1_GLCAASEe,INVte,INVtepp,INVtex PMDBD745 Rifampicin "Therapeutic Substance; Herbal Substance" "Approved Drug; Medicinal Herbal Compounds" 13292-46-1 DB01045 PA451250 D00211 DNC000965 135398735 10468813 NPC317567 "Rifampicin; rifampin; Rifadin; Rimactane; Rimactan; Rifamycin AMP; 13292-46-1; Rifaldazine; Rifaprodin; Tubocin; Riforal; Rifa; Rifampicinum; Archidyn; Rifoldine; Rifoldin; Rimactizid; Rimazid; Rifagen; Rifampicin SV; R/AMP; Rimactazid; Rifobac; Fenampicin; Doloresum; Sinerdol; Rifaldin; Rifadine; Rifinah; Rifamor; Benemicin; Rifaldazin; Eremfat; Arficin; Arzide; Rifcin; Rifam; L-5103 Lepetit; Dione 21-acetate; Rifampicine [French]; Rifampicina; Abrifam; Rifampicinum [INN-Latin]; Rifampicina [INN-Spanish]; Ba 41166/E; 3-(((4-Methyl-1-piperazinyl)imino" C43H58N4O12 JQXXHWHPUNPDRT-WLSIYKJHSA-N [(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-[(E)-(4-methylpiperazin-1-yl)iminomethyl]-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate n.a. n.a. Yes No Yes No No No PMDBD1174 Enalapril Therapeutic substance Drug 75847-73-3 DB00584 PA449456 D07892 DAP001374 5388962 4534998 n.a. "enalapril; 75847-73-3; Vasotec; Enalaprilum; Enalaprila; Lexxel; Enalaprilum [INN-Latin]; Enalaprila [INN-Spanish]; UNII-69PN84IO1A; Enalapril Richet; CHEMBL578; Gadopril; 69PN84IO1A; CHEBI:4784; C20H28N2O5; (S)-1-(N-(1-(Ethoxycarbonyl)-3-phenylpropyl)-L-alanyl)-L-proline; 1-(N-((S)-1-Carboxy-3-phenylpropyl)-L-alanyl)-L-proline 1''-ethyl ester; NCGC00021569-04; Enalapril [INN:BAN]; N-[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]-L-alanyl-L-proline; DSSTox_CID_2982; DSSTox_RID_76817; DSSTox_GSID_22982; (S)-1-{(S)-2-[1-((S)-Ethoxycarbony" C20H28N2O5 GBXSMTUPTTWBMN-XIRDDKMYSA-N (2S)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid n.a. n.a. No Yes No No No No PMDBD598 Nitrofural Therapeutic Substance Approved Drug 59-87-0 DB00336 PA164754877 D00862 n.a. 5447130 4566720 n.a. "nitrofurazone; Nitrofural; Furacilin; 59-87-0; Furacin; Furacillin; Furaldon; Furacine; Aldomycin; Nifuzon; 5-Nitro-2-furaldehyde semicarbazone; Actin-N; Nitrozone; Mastofuran; Furazone; Chemofuran; Furacycline; Furacoccid; Furaziline; Furacinetten; Babrocid; Otofuran; Nitrofurazan; Monafuracin; Furesol; Mammex; Amifur; Alfucin; Furazol W; 5-Nitrofurfural semicarbazone; Nitrofurol; Fuvacillin; Furametral; Biofuracina; Becafurazone; Monofuracin; Dermofural; Furatsilin; Monafuracis; Furaseptyl; Yatrocin; Otofural; Nifurid; Furfurin; Furaderm; Fracine; Co" C6H6N4O4 IAIWVQXQOWNYOU-FPYGCLRLSA-N [(E)-(5-nitrofuran-2-yl)methylideneamino]urea n.a. n.a. Yes No Yes No No No PMDBD1071 Calcium Therapeutic substance Drug 7440-70-2 DB01373 PA164712582 n.a. n.a. 5460341 4573905 n.a. "Ca; 7440-70-2; Calcium; Elemental calcium; Calcium, elemental; UNII-SY7Q814VUP; HSDB 273; EINECS 231-179-5; UN1401; SY7Q814VUP; MFCD00085314; Calcium, 99%, granular; Calcium, 99%, turnings; Calcium compounds; Kalzium; calcium atom; Calcium ingot; Calcium Chelate; Calcium standard solution, for AAS, 1 mg-ml Ca in 2 to 5% HNO3; Bio Lacta Cal; calcium(0); Calcium, Natural Milk; Calcium, granular, 99%; 20Ca; EC 231-179-5; Calcium Milk Calcium 28%; Calcium Krebs 21% 40M; Calcium Sweet Chelate 20%; Calcium Oratate 11% 40M; KSC377C8L; Ca(0); Ca" Ca OYPRJOBELJOOCE-UHFFFAOYSA-N calcium n.a. n.a. Yes No No No No No PMDBD1098 Cefuroxime Therapeutic substance Antibiotics 55268-75-2 DB01112 PA448868 D00262 DAP000445 5479529 4586393 n.a. "cefuroxime; Cephuroxime; Cefuroxim; Cefuroximo; 55268-75-2; Cefuroximum; Sharox; Zinacef Danmark; Zinacef; Biofuroksym; Cefuril; Cefuroximum [INN-Latin]; Cefuroximo [INN-Spanish]; UNII-O1R9FJ93ED; Cefuroxime [USAN:INN:BAN]; C16H16N4O8S; EINECS 259-560-1; BRN 5783190; O1R9FJ93ED; CHEBI:3515; Kefurox; (6R,7R)-7-(2-(2-Furyl)glyoxylamido)-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid 7(sup 2)-(Z)-(O-methyloxime) carbamate (ester); 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-(((aminocarbon" C16H16N4O8S JFPVXVDWJQMJEE-IZRZKJBUSA-N (6R,7R)-3-(carbamoyloxymethyl)-7-[[(2Z)-2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid n.a. n.a. Yes No No No No No PMDBD1097 Ceftriaxone Therapeutic substance Antibiotics 73384-59-5 DB01212 PA448866 D07659 DAP000145 5479530 4586394 n.a. "ceftriaxone; Biotrakson; Rocephin; Rocefin; 73384-59-5; Ceftriazone; Ceftriaxonum [INN-Latin]; Ceftriaxona [INN-Spanish]; Ceftriaxona; Ceftriaxonum; Rocephine; CEFTRIAXONE SODIUM; Ro 139904; DRG-0071; Ceftriaxon; Rocephalin; CHEBI:29007; C18H18N8O7S3; UNII-75J73V1629; EINECS 277-405-6; CTRX; CHEMBL161; Ro 13-9904; Ro-13-9904; Longacef; 75J73V1629; 78384-59-5; 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-8-oxo-3-(((1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-1,2,4-triazin-3-yl)t" C18H18N8O7S3 VAAUVRVFOQPIGI-SPQHTLEESA-N (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-5,6-dioxo-1H-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid n.a. n.a. Yes No No No No No PMDBD1085 Cefepime Therapeutic substance Antibiotics 88040-23-7 DB01413 PA164754876 D02376 DAP000455 5479537 4586395 n.a. "cefepime; Maxipime; Cefepima; Cefepimum [Latin]; Cefepima [Spanish]; Cefepimum; 88040-23-7; Axepim; BMY 28142; BMY-28142; E-Cefepime; CFPM; UNII-807PW4VQE3; 807PW4VQE3; CHEBI:478164; 1-(((6R,7R)-7-(2-(2-Amino-4-thiazolyl)glyoxylamido)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-1-methylpyrrolidinium hydroxide, inner salt, 7(sup 2)-(Z)-(O-methyloxime); Pyrrolidinium, 1-((7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-1-methyl-, hydroxi" C19H24N6O5S2 HVFLCNVBZFFHBT-ZKDACBOMSA-N (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(1-methylpyrrolidin-1-ium-1-yl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate n.a. n.a. Yes No No No No No PMDBD863 Trandolapril Therapeutic Substance Approved Drug 87679-37-6 DB00519 PA451737 D00383 DAP000583 5484727 4588590 n.a. "trandolapril; 87679-37-6; Mavik; Gopten; Odrik; Trandolaprilum [Latin]; RU-44570; RU44570; RU 44570; UNII-1T0N3G9CRC; CCRIS 6594; 1T0N3G9CRC; C24H34N2O5; (2S,3aR,7aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acid; NCGC00182079-02; Trandolaprilum; Udrik; DSSTox_CID_3692; DSSTox_RID_77151; DSSTox_GSID_23692; (2S,3aR,7aS)-1-((S)-N-((S)-1-Carboxy-3-phenylpropyl)alanyl)hexahydro-2-indolinecarboxylic acid, 1-ethyl ester; Odric; Preran; Trandolapril [INN:BAN]; 1H-I" C24H34N2O5 VXFJYXUZANRPDJ-WTNASJBWSA-N (2S,3aR,7aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acid Abbott Laboratories Antihypertensive Agents No Yes No No No No PMDBD1143 Deferasirox Therapeutic substance Drug 201530-41-8 DB01609 PA164760843 D03669 n.a. 214348 10770206 n.a. "Deferasirox; 201530-41-8; Exjade; ICL 670; ICL670A; ICL 670A; ICL-670A; Deferasiroxum; Deferasiroxum [INN-Latin]; ICL-670; ICL670; UNII-V8G4MOF2V9; CGP-72670; Deferasirox (Exjade); CHEBI:49005; 4-[3,5-bis(2-hydroxyphenyl)-1H-1,2,4-triazol-1-yl]benzoic acid; 4-(3,5-Bis(2-hydroxyphenyl)-1H-1,2,4-triazol-1-yl)benzoic acid; V8G4MOF2V9; C21H15N3O4; NCGC00181754-01; DSSTox_CID_28522; DSSTox_RID_82794; DSSTox_GSID_48596; 1044764-54-6; Jadenu; Benzoic acid, 4-(3,5-bis(2-hydr" C21H15N3O4 BOFQWVMAQOTZIW-UHFFFAOYSA-N 4-[3,5-bis(2-hydroxyphenyl)-1,2,4-triazol-1-yl]benzoic acid n.a. n.a. No Yes No No No No PMDBD1087 Cefotaxime Therapeutic substance Antibiotics 63527-52-6 DB00493 PA448852 D07647 DAP000146 5742673 4674877 n.a. "cefotaxime; Cephotaxime; 63527-52-6; Cefotaxime acid; E-cefotaxime; UNII-N2GI8B1GK7; Cefotaximum; Claforan; Cefotaxima; N2GI8B1GK7; CHEBI:204928; Cefotaxime [INN:BAN]; Cefotaximum [INN-Latin]; HR 756; Cefotaxima [INN-Spanish]; 60846-21-1; RU 24756; C16H17N5O7S2; Omnatax; Taxim; EINECS 264-299-1; RU 24662; 4kot; (6R,7R)-3-(Acetoxymethyl)-7-(()-2-(2-amino-4-thiazolyl)-2-methoxyimino" C16H17N5O7S2 GPRBEKHLDVQUJE-QSWIMTSFSA-N (6R,7R)-3-(acetyloxymethyl)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid n.a. n.a. Yes No No No No No PMDBD618 Olsalazine Therapeutic Substance anti-inflammatory 15722-48-2 DB01250 PA450700 D00727 n.a. 22419 10642377 n.a. "Olsalazine; 15722-48-2; Olsalazina; Azodisal; Olsalazinum; 5,5''-Azobis(salicylic acid); Olsalazinum [Latin]; Olsalazina [Spanish]; 3,3''-Azobis(6-hydroxybenzoic acid); Olsalazine [INN:BAN]; C.I. Mordant Yellow 5; UNII-ULS5I8J03O; ULS5I8J03O; CHEBI:7770; C14H10N2O6; mordant yellow 5; Rasal; 3,3''-diazene-1,2-diylbis(6-hydroxybenzoic acid); (E)-5,5''-(diazene-1,2-diyl)bis(2-hydroxybenzoic acid); Mirtazanine; Dipentium; Olsalazin; Olsalazine (INN); 5,5''-azodisalicylic aci" C14H10N2O6 QQBDLJCYGRGAKP-UHFFFAOYSA-N 5-[(3-carboxy-4-hydroxyphenyl)diazenyl]-2-hydroxybenzoic acid n.a. n.a. No Yes No Yes No Yes EX_olsa(e),OLSA_AR_NADi,OLSA_AR_NADPi,OLSAt2r,OLSAt2rpp,OLSAtex PMDBD744 Rifabutin "Therapeutic Substance; Herbal Substance" "Approved Drug; Medicinal Herbal Compounds" 72559-06-9 DB00615 PA451249 D00424 DAP000656 135398743 10482168 NPC314987 "RIFABUTIN; Ansamycin; Mycobutin; Rifabutine; Ansatipine; Ansatipin; Alfacid; 72559-06-9; LM-427; Rifabutinum [Latin]; Rifabutine [French]; Rifabutina [Spanish]; Antibiotic LM 427; 4-N-isobutylspiropiperidylrifamycin S; LM 427; HSDB 3577; DRG-0085; 1,4-Dihydro-1-deoxy-1'',4-didehydro-5''-(2-methylpropyl)-1-oxorifamycin XIV; 4-Deoxo-3,4-(2-spiro(N-isobutyl-4-piperidyl)-2,5-dihydro-1H-imidazo)-rifamycin S; BRN 3584778; NCGC00090762-01; DSSTox_CID_10773; DSSTox_RID_79103; DSSTox_GSID_33960; RBT" C46H62N4O11 ZWBTYMGEBZUQTK-PVLSIAFMSA-N [(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,32-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-1''-(2-methylpropyl)-6,23-dioxospiro[8,33-dioxa-24,27,29-triazapentacyclo[23.6.1.14,7.05,31.026,30]tritriaconta-1(32),2,4,9,19,21,24,26,30-nonaene-28,4''-piperidine]-13-yl] acetate Adria Laboratories Antibiotics Yes Yes Yes No No No PMDBD746 Rifapentine Therapeutic Substance Approved Drug 61379-65-5 DB01201 PA164783809 D00879 DAP000426 135403821 10482075 n.a. "RIFAPENTINE; Priftin; 61379-65-5; Cyclopentylrifampicin; Rifapentin; Priftin (TN); Rifamycin AF/ACPP; CHEBI:45304; MDL-473; MDL 473; 3-(((4-Cyclopentyl-1-piperazinyl)imino)methyl)rifamycin; DL 473; UNII-XJM390A33U; KTC 1; XJM390A33U; Cyclopentyl rifampin; DL-473; R-773; R 77-3; Rifapentinum [Latin]; Rifapentina [Spanish]; (2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-8-{(E)-[(4-cyclopentylpiperazin-1-yl)imino]methyl}-5,6,9,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca" C47H64N4O12 WDZCUPBHRAEYDL-GZAUEHORSA-N [(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-26-[(E)-(4-cyclopentylpiperazin-1-yl)iminomethyl]-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate n.a. n.a. Yes Yes Yes No No No PMDBD96 Balsalazide Therapeutic Substance anti-inflammatory 80573-04-2 DB01014 PA448536 D07488 DAP000733 54585 10662422 n.a. "BALSALAZIDE; 80573-04-2; Balsalazido; Balsalazidum; Balsalazida; Balsalazidum [Latin]; Balsalazido [Spanish]; Balsalazida [Spanish]; Balsalazide Disodium; Balsalazide [INN:BAN]; (E)-5-((4-((2-Carboxyethyl)carbamoyl)phenyl)diazenyl)-2-hydroxybenzoic acid; UNII-P80AL8J7ZP; Colazide; (E)-5-((4-(((2-Carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acid; P80AL8J7ZP; CHEBI:267413; C17H15N3O6; (E)-5-({p-[(2-carboxyethyl)carbamoyl]phenyl}azo)-2-salicylic acid; 5-[4-(2-carboxy-ethylcarbamoyl)-phenylazo]-2-hydroxy-benzoic acid" C17H15N3O6 IPOKCKJONYRRHP-UHFFFAOYSA-N 5-[[4-(2-carboxyethylcarbamoyl)phenyl]diazenyl]-2-hydroxybenzoic acid n.a. Antiinflammatory Agents No Yes No Yes No No PMDBD1341 Palonosetron Therapeutic substance Drug 135729-56-5 DB00377 PA10352 D07175 DAP000367 6337614 4892289 n.a. "Palonosetron; 135729-61-2; Aloxi; Palonosetron [INN]; 2-Qhbiqo; UNII-5D06587D6R; Aloxi (TN); CHEBI:85161; Palonosetron (INN); 2-(1-Azabicyclo(2.2.2)oct-3-yl)-2,3,3a,4,5,6-hexahydro-1H-benz(de)isoquinolin-1-one; 5D06587D6R; (-)-Palonosetron; (3aS)-2-[(3S)-1-azabicyclo[2.2.2]octan-3-yl]-2,3,3a,4,5,6-hexahydro-1H-benzo[de]isoquinolin-1-one; (3~{a}~{S})-2-[(3~{S})-1-azabicyclo[2.2.2]octan-3-yl]-3~{a},4,5,6-tetrahydro-3~{H}-benzo[de]isoquinolin-1-one; (S-(R*,R*))-2-(1-Azabicyclo(2.2.2)oct-3-yl)-2,3,3a,4,5,6-hexahydro-1H-benz(" C19H24N2O CPZBLNMUGSZIPR-NVXWUHKLSA-N (3aS)-2-[(3S)-1-azabicyclo[2.2.2]octan-3-yl]-3a,4,5,6-tetrahydro-3H-benzo[de]isoquinolin-1-one n.a. n.a. No Yes No No No No PMDBD747 Rifaximin Therapeutic Substance Approved Drug 80621-81-4 DB01220 PA164752443 D02554 DAP001006 6436173 10482302 n.a. "Rifaximin; Rifaxidin; Rifacol; Xifaxan; 80621-81-4; Rifaximine; Rifamycin L 105; Rifamycin L 105SV; Fatroximin; Normix; Rifaximina; Rifamixin; Ritacol; Rifaximine [French]; Rifaximinum [Latin]; Rifaximina [Spanish]; C43H51N3O11; UNII-L36O5T016N; L 105SV; L 105 (Ansamacrolide antibiotic); L 105; BRN 3584528; Rifaximin [USAN:INN]; CHEBI:75246; L36O5T016N; Rifaximin, 98%; Rifaximin (Xifaxan); Rifaximinum; 4-Deoxy-4''-methylpyrido(1'',2''-1,2)imidazo(5,4-c)rifamycin SV; (2S,16Z,18E,20S,21S,22R,23R,24R,25S,26S,27S,28E)-5,6,21,23,25 Pentahydrox" C43H51N3O11 NZCRJKRKKOLAOJ-XRCRFVBUSA-N [(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,36-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22,30-octamethyl-6,23-dioxo-8,37-dioxa-24,27,33-triazahexacyclo[23.10.1.14,7.05,35.026,34.027,32]heptatriaconta-1(35),2,4,9,19,21,25(36),26(34),28,30,32-undecaen-13-yl] acetate n.a. n.a. Yes Yes Yes No No No PMDBD801 Spiramycin Therapeutic Substance Approved Drug 24916-50-5 DB06145 n.a. n.a. n.a. 6440717 4944970 n.a. "Foromacidine A; Demycarosylturimycin H; Spiramycin I; Spiramycin A; Spiramycin 1; spiramycin; Foromacidin; Foromacidin A; C43H74N2O14; 8025-81-8; 24916-50-5; NSC55926; Rovamycinetrade mark; NSC64393; IC 5902; CHEBI:85260; DB06145; LS-145761; J-015730; UNII-71ODY0V87H component ACTOXUHEUCPTEW-KWBWCIJSSA-N; [(4R,5S,6S,7R,9R,10R,11E,13E,16R)-6-{[(2S,3R,4R,5S,6R)" C43H74N2O14 ACTOXUHEUCPTEW-KWBWCIJSSA-N 2-[(4R,5S,6S,7R,9R,10R,11E,13E,16R)-6-[(2S,3R,4R,5S,6R)-5-[(2S,4R,5S,6S)-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-10-[(2R,5S,6S)-5-(dimethylamino)-6-methyloxan-2-yl]oxy-4-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-1-oxacyclohexadeca-11,13-dien-7-yl]acetaldehyde n.a. n.a. Yes No Yes No No No PMDBD1188 Everolimus Therapeutic substance Drug 159351-69-6 DB01590 PA164746311 D02714 DAP001223 6442177 21106307 n.a. "Zortress; SDZ-RAD; SDZ RAD; RAD; Everolimus; 40-O-(2-hydroxyethyl)-rapamycin; RAD001; RAD, SDZ; 40-O-(2-Hydroxyethyl)rapamycin; RAD 001; Certican; Afinitor; 001, RAD; 42-O-(2-Hydroxyethyl)rapamycin; 159351-69-6; Votubia; Afinitor Disperz; CHEBI:68478; RAD-001; UNII-9HW64Q8G6G; 9HW64Q8G6G; NCGC00167512-01; (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(2R)-1-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]propan-2-yl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9" C53H83NO14 HKVAMNSJSFKALM-GKUWKFKPSA-N (1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-[(2R)-1-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]propan-2-yl]-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone n.a. n.a. No Yes No No No No PMDBD287 Dirithromycin Therapeutic Substance Approved Drug 62013-04-1 DB00954 PA449368 D03865 DAP000888 6473883 4976073 n.a. "Dirithromycin; Diritromicina; Dirithromycinum; Dirithromycine; 62013-04-1; Dynabac; LY 237216; LY-237216; UNII-1801D76STL; MLS000028564; (9S)-9-Deoxo-11-deoxy-9,11-(imino((1R)-2-(2-methoxyethoxy)ethylidene)oxy)erythromycin; SMR000058954; MLS001074061; CHEBI:474014; 1801D76STL; Diritromicina [Spanish]; Dirithromycine [French]; Dirithromycinum [Latin]; (1R,2R,3R,6R,7S,8S,9R,10R,12R,13S,15R,17S)-3-ethyl-2,10-dihydroxy-15-[(2-methoxyethoxy)methyl]-2,6,8,10,12,17-hexamethyl-5-oxo-9-{[3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-h" C42H78N2O14 WLOHNSSYAXHWNR-DWIOZXRMSA-N (1R,2R,3R,6R,7S,8S,9R,10R,12R,13S,15R,17S)-9-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-3-ethyl-2,10-dihydroxy-7-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-15-(2-methoxyethoxymethyl)-2,6,8,10,12,17-hexamethyl-4,16-dioxa-14-azabicyclo[11.3.1]heptadecan-5-one n.a. n.a. Yes No Yes No No No PMDBD1049 Azlocillin Therapeutic substance Antibiotics 37091-66-0 DB01061 PA164749135 D02339 DAP001169 6479523 4980416 n.a. "azlocillin; 37091-66-0; Azlocillinum; Azlocilline; Azlocilina; Azlocillinum [INN-Latin]; Azlocilline [INN-French]; Azlocilina [INN-Spanish]; UNII-HUM6H389W0; CHEBI:2956; HUM6H389W0; (2S,5R,6R)-3,3-dimethyl-7-oxo-6-{[(2R)-2-{[(2-oxoimidazolidin-1-yl)carbonyl]amino}-2-phenylacetyl]amino}-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; EINECS 253-348-2; 6-((R)-2" C20H23N5O6S JTWOMNBEOCYFNV-NFFDBFGFSA-N (2S,5R,6R)-3,3-dimethyl-7-oxo-6-[[(2R)-2-[(2-oxoimidazolidine-1-carbonyl)amino]-2-phenylacetyl]amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid n.a. n.a. Yes No No No No No PMDBD608 Norgestimate Therapeutic Substance Approved Drug 35189-28-7 DB00957 PA164744346 D05209 DAP001210 6540478 5022837 n.a. "NORGESTIMATE; Dexnorgestrel acetime; 35189-28-7; Norgestimato; Norgestimatum; Norgestimatum [INN-Latin]; Norgestimato [INN-Spanish]; UNII-C291HFX4DY; RWJ 10131; ORF 10131; D 138; (+)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one oxime acetate (ester); ORF-10131; C291HFX4DY; CHEBI:50815; d-13-beta-Ethyl-17-alpha-ethynyl-17-beta-acetoxygon-4-en-3-one oxime; (17-alpha)-17-(Acetyloxy)-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one 3-oxime; 20799-27-3; NCGC00181353-01; norgestrel oxime acetate; DSSTox_RID_82018; DSSTox_" C23H31NO3 KIQQMECNKUGGKA-NMYWJIRASA-N [(3E,8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-3-hydroxyimino-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate n.a. Contraceptive Agents Yes No No No No No PMDBD599 Nitrofurantoin Therapeutic Substance Approved Drug 67-20-9 DB00698 PA450640 D00439 DAP000998 6604200 5036498 n.a. "nitrofurantoin; 67-20-9; Macrodantin; 5-Nitrofurantoin; Furadantin; Furadonine; Furadantoin; Furadontin; Furadoine; Furadantine; Nifurantin; Furantoin; Nitrofuradantin; Nitrofurantoine; Welfurin; Furatoin; Furachel; Berkfurin; Urofurin; Urantoin; Novofuran; Furadonin; Parfuran; Zoofurin; Trantoin; Orafuran; Macrobid; Furobactina; Chemiofuran; Urodin; Nitoin; Furalan; Urizept; Ituran; Furina; Cystit; Urolong; Cyantin; Furadantine mc; Uro-Tablinen; Fur-ren; Macrofuran; Nitrofurantoina; Furadoninum; Furaloid; Nierofu; Benkfuran; Dantafur; Nitrex; Macpac; Nitr" C8H6N4O5 NXFQHRVNIOXGAQ-YCRREMRBSA-N 1-[(E)-(5-nitrofuran-2-yl)methylideneamino]imidazolidine-2,4-dione Procter And Gamble Pharmaceuticals Inc Sub Procter And Gamble Co Antiinfective Agents Yes Yes Yes No No No PMDBD590 Nifurtimox Therapeutic Substance Approved Drug 23256-30-6 DB11820 n.a. n.a. n.a. 6842999 5246596 n.a. "NIFURTIMOX; Lampit; Bayer 2502; 23256-30-6; BAY 2502; Nifurtimox [INN:BAN]; Nifurtimoxum [INN-Latin]; CCRIS 2201; CHEBI:7566; EINECS 245-531-0; BAYER-2502; BAY-A2502; C10H13N3O5S; BAY-2502; DNDI1613515; 4-Thiomorpholinamine, 3-methyl-N-((5-nitro-2-furanyl)methylene)-, 1,1-dioxide; 4-((5-Nitrofurfurylidene)amino)-3-methylthiomorpholine-1,1-dioxide; 1-((5-Nitrofurfurylidene)amino)-2-methyltetrahydro-1,4-thiazine-4,4-dioxide; 4-Thiomorpholinamine, 3-methyl-N-[(5-nitro-2-furanyl)methylene]-, 1,1-dioxide; 3-Methyl-4-(5''-nitrofuryl" C10H13N3O5S ARFHIAQFJWUCFH-IZZDOVSWSA-N (E)-N-(3-methyl-1,1-dioxo-1,4-thiazinan-4-yl)-1-(5-nitrofuran-2-yl)methanimine Bayer healthcare pharmaceuticals n.a. Yes No Yes No No No PMDBD627 Oxaliplatin Therapeutic Substance chemotherapy agent 61825-94-3 DB00526 PA131285527 D01790 DAP000062 6857599 8062727 n.a. "oxaliplatine; CHEBI:31941; Diaminocyclohexane Oxalatoplatinum; DB00526; (SP-4-2)[(1R,2R)-cyclohexane-1,2-diamine-kappa(2)N,N''][ethanedioato(2-)-kappa(2)O(1),O(2)]platinum" C8H16N2O4Pt+2 ZROHGHOFXNOHSO-BNTLRKBRSA-N "(1R,2R)-cyclohexane-1,2-diamine;oxalic acid;platinum(2+)" n.a. n.a. No Yes No No No No PMDBD1138 Dantrolene Therapeutic substance Drug 7261-97-4 DB01219 PA449208 D02347 DNC001623 6914273 5290202 n.a. "dantrolene; Dantrolenum [INN-Latin]; Dantroleno [INN-Spanish]; 7261-97-4; Dantroleno; UNII-F64QU97QCR; F-368; Dantrolenum; Ryanodex; 1-((5-(p-Nitrophenyl)furfurylidene)amino)hydantoin; HSDB 3050; C14H10N4O5; EINECS 230-684-8; BRN 0705189; F64QU97QCR; 1-(((5-(4-Nitrophenyl)-2-furanyl)methylene)amino)-2,4-imidazolidinedione; 833480-90-3; 1-[[5-(p-Nitrophenyl)furfurylidene]amino]hydantoin; 2,4-Imidazo" C14H10N4O5 OZOMQRBLCMDCEG-VIZOYTHASA-N 1-[(E)-[5-(4-nitrophenyl)furan-2-yl]methylideneamino]imidazolidine-2,4-dione n.a. n.a. No Yes No No No No PMDBD758 Roxithromycin Therapeutic Substance Approved Drug 80214-83-1 DB00778 PA164750505 D01710 DAP000885 6915744 5291557 n.a. "roxithromycin; Rulide; Roxitromicina; Roxithromycinum; Roxithromycine; 80214-83-1; RU 965; RU 28965; UNII-21KOF230FA; Rulid; CHEBI:48935; Roxithromycinum [Latin]; Roxithromycine [French]; Roxitromicina [Spanish]; 21KOF230FA; RU-965; RU-28965; 9-(O-((2-Methoxyethoxy)methyl)oxime)erythromycin; CCRIS 3461; (9E)-erythromycin 9-(O-((2-methoxyethoxy)methyl)oxime); (E)-roxithromycin; Erythromycin 9-(O-((2-methoxyethoxy)methyl)oxime); BRN 4286925; Rulide (TN); 9-[O-[(2-Methoxyethoxy)methyl]oxime]erythromycin; SR-05000001850; Erythromycin, 9" C41H76N2O15 RXZBMPWDPOLZGW-XMRMVWPWSA-N (3R,4S,5S,6R,7R,9R,10E,11S,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-10-(2-methoxyethoxymethoxyimino)-3,5,7,9,11,13-hexamethyl-oxacyclotetradecan-2-one Sanofi-Aventis Antibiotics Yes No Yes No No No PMDBD156 Cefdinir Therapeutic Substance Approved Drug 91832-40-5 DB00535 PA164768739 D00917 DAP000436 6915944 5291705 n.a. "cefdinir; 91832-40-5; Omnicef; CFDN; Cefdinirum; Cefdinyl; Cefzon; FK-482; CI-983; FK 482; Cefdinirum [INN-Latin]; UNII-CI0FAO63WC; (E)-Cefdinir; BMY 28488; CI 983; Cefdinir (Omnicef); CHEBI:3485; PD-134393; PD 134393; BMY-28488; CI0FAO63WC; (-)-(6R,7R)-7-(2-(2-Amino-4-thiazolyl)glyoxylamido)-8-oxo-3-vinyl-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7(sup 2)-(Z)-oxime; Cefdirnir; C14H13N5O5S2; Ceftinex; Cefdinir [USAN:INN]; 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl) (hydroxyimino)acet" C14H13N5O5S2 RTXOFQZKPXMALH-GHXIOONMSA-N (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-hydroxyiminoacetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Abbott Laboratories Antibiotics Yes No Yes No No No PMDBD390 Ginsenoside Rb2 Herbal Substance Medicinal Herbal Compounds n.a. n.a. n.a. n.a. n.a. 6917976 n.a. NPC63368 "Ginsenoside Rb2; Ginsenoside C; 11021-13-9; UNII-N219O0L31C; NSC 308878; Ginsenoside-Rb2; CHEBI:77152; N219O0L31C; EINECS 234-251-4; (20S)-ginsenoside Rb2; CHEMBL449303; HY-N0040; 20-[(6-O-a-L-arabinopyranosyl-ss-D-glucopyranosyl)oxy]-12ss-hydroxydammar-24-en-3ss-yl 2-O-ss-D-glucopyranosyl-ss-D-glucopyranoside; 20-((6-O-alpha-L-Arabinopyranosyl-beta-D-glucopyranosyl" C53H90O22 NODILNFGTFIURN-GZPRDHCNSA-N (2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-[[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-4,4,8,10,14-pentamethyl-17-[(2S)-6-methyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5S)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxan-2-yl]oxyhept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol n.a. n.a. No Yes No No No No PMDBD1171 Dutasteride Therapeutic substance Drug 164656-23-9 DB01126 PA164749300 D03820 DAP000044 6918296 5293502 n.a. "Dutasteride; 164656-23-9; Avodart; GG-745; GI-198745; GI 198745; UNII-O0J6XJN02I; GG 745; O0J6XJN02I; (5alpha,17beta)-N-(2,5-Bis(trifluoromethyl)phenyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide; alpha,alpha,alpha,alpha'',alpha'',alpha''-Hexafluoro-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxy-2'',5''-xylidide; CHEMBL1200969; Avolve; CHEBI:521033; Dutasteride, 99%" C27H30F6N2O2 JWJOTENAMICLJG-QWBYCMEYSA-N (1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-[2,5-bis(trifluoromethyl)phenyl]-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide n.a. n.a. No Yes No No No No PMDBD895 Vilazodone Therapeutic Substance Approved Drug 163521-12-8 DB06684 n.a. D09698 n.a. 6918314 5293518 n.a. "Vilazodone; 163521-12-8; 5-(4-(4-(5-Cyano-1H-indol-3-yl)butyl)piperazin-1-yl)benzofuran-2-carboxamide; UNII-S239O2OOV3; EMD 515259; CHEMBL439849; S239O2OOV3; CHEBI:70707; 5-[4-[4-(5-cyano-1H-indol-3-yl)butyl]piperazin-1-yl]-1-benzofuran-2-carboxamide; 5-{4-[4-(5-cyano-1H-indol-3-yl)butyl]piperazin-1-yl}-1-benzofuran-2-carboxamide; EMD-68-843; EMD-515259; SB 659746A; SB-659746-A; Vilazodone [USAN:INN]; vilazodona; vilazodonum; HSDB 8197; Vilazodone" C26H27N5O2 SGEGOXDYSFKCPT-UHFFFAOYSA-N 5-[4-[4-(5-cyano-1H-indol-3-yl)butyl]piperazin-1-yl]-1-benzofuran-2-carboxamide Genaissance and Merck KGaA n.a. No Yes No No No No PMDBD63 Aprepitant Therapeutic Substance Approved Drug 170729-80-3 DB00673 PA164747039 D02968 DNC000952 135413536 5293568 n.a. "Aprepitant; 170729-80-3; Emend; MK-0869; MK-869; L-754030; UNII-1NF15YR6UY; C23H21F7N4O3; 1NF15YR6UY; CHEMBL1471; CHEBI:499361; MK 869; MK 0869; 5-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl]-1,2-dihydro-1,2,4-triazol-3-one; MK0869; L 754030; 5-[[(2R,3S)-2-[(1R)-1-[3,5-BIS(Trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3H-1,2,4-triazol-3-one; 3-(((2R,3S)-2-((R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)morpholino)m" C23H21F7N4O3 ATALOFNDEOCMKK-OITMNORJSA-N 3-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl]-1,4-dihydro-1,2,4-triazol-5-one Merck & Co Antiemetics Yes Yes Yes No No No PMDBD1374 Prasugrel Therapeutic substance Drug 150322-43-3 DB06209 PA154410481 D05597 n.a. 6918456 5293653 n.a. "Prasugrel; 150322-43-3; Effient; Efient; CS-747; Prasugrel (Effient); 5-(2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetate; LY640315; LY-640315; CS 747; CHEBI:87723; Prasugrel, 98%; 5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetate; 2-[2-(Acetyloxy)-6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl]-1-cyclopropyl-2-(2-fluorophenyl)e" C20H20FNO3S DTGLZDAWLRGWQN-UHFFFAOYSA-N [5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-6,7-dihydro-4H-thieno[3,2-c]pyridin-2-yl] acetate n.a. n.a. No Yes No No No No PMDBD1024 Ambrisentan Therapeutic substance Drug 177036-94-1 DB06403 PA165860521 n.a. n.a. 6918493 5293690 n.a. "Ambrisentan; 177036-94-1; Letairis; Volibris; BSF 208075; LU-208075; (S)-2-(4,6-Dimethylpyrimidin-2-yloxy)-3-methoxy-3,3-diphenylpropanoic acid; UNII-HW6NV07QEC; HW6NV07QEC; LU 208075; CHEMBL1111; (S)-2-((4,6-Dimethylpyrimidin-2-yl)oxy)-3-methoxy-3,3-diphenylpropanoic acid; BSF-208075; (2S)-2-(4,6-dimethylpyrimidin-2-yl)oxy-3-methoxy-3,3-diphenylpropanoic acid; DSSTox_CID_26282; DSSTox_RID_81508; DSSTox_GSID_46282; LU208075" C22H22N2O4 OUJTZYPIHDYQMC-LJQANCHMSA-N (2S)-2-(4,6-dimethylpyrimidin-2-yl)oxy-3-methoxy-3,3-diphenylpropanoic acid n.a. n.a. No Yes No No No No PMDBD180 Chlorhexidine "Therapeutic Substance; Herbal Substance" "Approved Drug; Medicinal Herbal Compounds" 55-56-1 DB00878 PA164776863 D07668 DAP001326 9552079 2612 NPC125416 "chlorhexidine; 55-56-1; Tubulicid; Rotersept; Fimeil; Soretol; Hexadol; Chlorohexidine; Chlorhexidinum; Chlorhexidin; Sterilon; Nolvasan; Cloresidina [DCIT]; Chlorhexidin [Czech]; Chlorhexidinum [INN-Latin]; Clorhexidina [INN-Spanish]; Hibistat; Chlorhexidine [INN:BAN]; 1,6-Bis(p-chlorophenyldiguanido)hexane; 1,6-Di(4''-chlorophenyldiguanido)hexane; UNII-R4KO0DY52L; 1,6-Bis(5-(p-chlorophenyl)biguandino)hexane; Exidine; CCRIS 9230; C22H30Cl2N10; 1,1''-Hexamethylenebis(5-(p-chlorophenyl)biguanide); 1,1''-Hexamethylene bis(5-(p-chlorophen" C22H30Cl2N10 GHXZTYHSJHQHIJ-UHFFFAOYSA-N (1E)-2-[6-[[amino-[(E)-[amino-(4-chloroanilino)methylidene]amino]methylidene]amino]hexyl]-1-[amino-(4-chloroanilino)methylidene]guanidine G. D. Pharmaceuticals Antibiotics Yes No Yes No No No PMDBD91 Aztreonam Therapeutic Substance Approved Drug 78110-38-0 DB00355 PA448523 D00240 DAP000117 5742832 4674940 n.a. "aztreonam; Azactam; 78110-38-0; Primbactam; SQ-26776; NSC646279; CHEMBL158; SQ 26776; Azthreonam; UNII-G2B4VE5GH8; NSC-646279; 2-[[(Z)-[1-(2-Amino-4-thiazolyl)-2-[[(2S,3S)-2-methyl-4-oxo-1-sulfo-3-azetidinyl]amino]-2-oxoethylidene]amino]oxy]-2-methylpropionic Acid; rel-Aztreonam; G2B4VE5GH8; MFCD00072145; SQ-28429; CHEBI:161680; SR-01000841814; Squibb 26776; Aztreonam (Azactam, Cayston); Azetreonam; E-Aztreonam; Prestwick_914; PubChem13620; Prestwick2_000185; Prestwick3_000185; BSPBio_000109" C13H17N5O8S2 WZPBZJONDBGPKJ-VEHQQRBSSA-N 2-[(Z)-[1-(2-amino-1,3-thiazol-4-yl)-2-[[(2S,3S)-2-methyl-4-oxo-1-sulfoazetidin-3-yl]amino]-2-oxoethylidene]amino]oxy-2-methylpropanoic acid n.a. n.a. Yes No No No No No PMDBD1213 Gemifloxacin Therapeutic substance Antibiotics 175463-14-6 DB01155 PA10088 D08012 DAP000851 9571107 7845573 n.a. "Gemifloxacin; 175463-14-6; Gemifloxacin [INN]; Gemifloxacin mesylate; Factive; Gemifioxacin; LB-20304; SB 265805; Gemifloxacin (INN); LB 20304; CHEMBL430; 7-(3-Aminomethyl-4-methoxyimino-pyrrolidine-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-(1,8)-naphthyridine-3-carboxylic acid; CHEBI:101853; SB-265805; LB 20304a; 7-[(4Z)-3-(aminomethyl)-4-methoxyimino-pyrrolidin-1-yl]-1-cyclopropyl-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid" C18H20FN5O4 ZRCVYEYHRGVLOC-HYARGMPZSA-N 7-[(4Z)-3-(aminomethyl)-4-methoxyiminopyrrolidin-1-yl]-1-cyclopropyl-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid n.a. n.a. Yes Yes No No No No PMDBD12 Acarbose "Therapeutic Substance; Herbal Substance" "Approved Drug; Medicinal Herbal Compounds" 56180-94-0 DB00284 PA448010 D00216 DCL000309 9811704 23264314 NPC314306 "UNII-T58MSI464G; T58MSI464G; BIDD:GT0622; BAYG5421; SCHEMBL4606191; HSDB 7984; HY-B0089; ZINC96309558; Acarbose [USAN:USP:INN:BAN:JAN]; DS-3277; CS-1787; DB00284; (2R,3R,4R,5R)-4-(((2R,3R,4R,5S,6R)-5-(((2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-(((1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl)amino)tetrahydro-2H-pyran-2-yl)oxy)-3,4-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-2,3,5,6-tetrahydroxyhexanal; D-Glucose,O-4,6-dideoxy-4-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohe" C25H43NO18 CEMXHAPUFJOOSV-XGWNLRGSSA-N (2R,3R,4R,5R)-4-[(2R,3R,4R,5S,6R)-5-[(2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino]oxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3,5,6-tetrahydroxyhexanal n.a. n.a. Yes Yes Yes Yes No No PMDBD300 Eltrombopag Therapeutic Substance Eltrombopag is a thrombopoietin receptor agonist used to treat thrombocytopenia or aplastic anemia associated with various etiologies. 496775-61-2 DB06210 n.a. D03978 n.a. 135449332 19879943 n.a. "Eltrombopag; 496775-61-2; Promacta; Revolade; (Z)-3''-(2-(1-(3,4-Dimethylphenyl)-3-methyl-5-oxo-1H-pyrazol-4(5H)-ylidene)hydrazinyl)-2''-hydroxy-[1,1''-biphenyl]-3-carboxylic acid; SB497115; UNII-S56D65XJ9G; Eltrombopag-Isomer; (ZE)-Eltrombopag; SB-497115; S56D65XJ9G; CHEMBL461101; 1807882-48-9; CHEBI:85010; Eltrombopag (SB-497115-GR); NCGC00274067-01; 376591-99-0; Eltrombopag [INN]; SB 497115; Eltrombopag/; HSDB 8212" C25H22N4O4 SVOQIEJWJCQGDQ-UHFFFAOYSA-N 3-[3-[[2-(3,4-dimethylphenyl)-5-methyl-3-oxo-1H-pyrazol-4-yl]diazenyl]-2-hydroxyphenyl]benzoic acid GlaxoSmithKline n.a. No Yes No No No Yes ELTR_GLC_GLCAASE,ELTR_GLC_GLCAASEe,ELTR_GLC_GLCAASEepp,ELTRte,ELTRtepp,ELTRtex,EX_eltr(e) PMDBD28 Aloin Herbal Substance Medicinal Herbal Compounds n.a. n.a. n.a. n.a. n.a. 9866696 n.a. NPC48130 "aloin; Alloin; Aloin A; Aloin, curaco; Aloin, Cape; Aloin(mixture of A&B); CHEMBL497001; CHEBI:73222; 10-beta-D-glucopyranosyl-1,8-dihydroxy-3-(hydroxymethyl)anthracen-9(10H)-one; (1S)-1,5-anhydro-1-[4,5-dihydroxy-2-(hydroxymethyl)-10-oxo-9,10-dihydroanthracen-9-yl]-D-glucitol; 8015-61-0; 10-(1'',5''-Anhydroglucosyl)aloe-emodin-9-anthrone; 10-beta-D-Glucopyranosyl-1,8-dihydroxy-3-hydroxymethyl-9(10H)-anthrone; 10-(1,5''-Anhydroglucosyl)aloe-emodin-9-anthrone; SCHEMBL4974144; 10-beta-D-Glucopyranosyl-1,8-dihydroxy-3-(hydr" C21H22O9 AFHJQYHRLPMKHU-CGISPIQUSA-N 1,8-dihydroxy-3-(hydroxymethyl)-10-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-10H-anthracen-9-one n.a. n.a. Yes No No No No No PMDBD773 Secoisolariciresinol diglucoside Herbal Substance Medicinal Herbal Compounds n.a. n.a. n.a. n.a. n.a. 9917980 n.a. NPC278961 "Secoisolariciresinol diglucoside; 158932-33-3; Secoisolarisiresinol diglucoside; Seco-isolariciresinol diglucoside; (R,R)-Secoisolariciresinol diglucoside; UNII-T9281L29MV; T9281L29MV; SDG; Secoisolariciresinol diglycoside; C32H46O16; Secoisolariciresinol-Diglucoside; SCHEMBL16307898; CHEMBL2425486; DTXSID40432760; HY-N6937; s3780; ZINC67940726; CCG-270376; EBD2202224; Y0185; X1171; CS-0100998; 244S820; Q4161320; beta-D-Glucopyranose, diglycoside with 2,3-bis[(4-hydroxy-3-methoxyphenyl)methyl]-1,4-butanediol, [R-(R*,R*)]- (9CI); (2" C32H46O16 SBVBJPHMDABKJV-PGCJWIIOSA-N (2R,3R,4S,5S,6R)-2-[(2R,3R)-2,3-bis[(4-hydroxy-3-methoxyphenyl)methyl]-4-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybutoxy]-6-(hydroxymethyl)oxane-3,4,5-triol n.a. n.a. No Yes No No No No PMDBD482 Linagliptin Therapeutic Substance Approved Drug 668270-12-0 DB08882 n.a. D09566 n.a. 10096344 8271879 n.a. "Linagliptin; 668270-12-0; Tradjenta; BI 1356; Ondero; BI-1356; Linagliptin (BI-1356); UNII-3X29ZEJ4R2; BI-1356-BS; ione; 3X29ZEJ4R2; CHEMBL237500; CHEBI:68610; C25H28N8O2; (R)-8-(3-aminopiperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methylquinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione; 8-[(3r)-3-Aminopiperidin-1-Yl]-7-But-2-Yn-1-Yl-3-Methyl-1-[(4-Methylquinazolin-2-Yl)methyl]-3,7-Dihydro-1h-Purine-2,6-Dione; (R)-8-(3-aminopiperidin-1-yl)-7-(but-2-ynyl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dion" C25H28N8O2 LTXREWYXXSTFRX-QGZVFWFLSA-N 8-[(3R)-3-aminopiperidin-1-yl]-7-but-2-ynyl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]purine-2,6-dione Boehringer Ingelheim n.a. No Yes No No No No PMDBD1344 Pazopanib Therapeutic substance Drug 444731-52-6 DB06589 n.a. D05380 n.a. 10113978 8289501 n.a. "Pazopanib; 444731-52-6; GW786034; UNII-7RN5DR86CK; Pazopanib (GW-786034); 790713-33-6; 7RN5DR86CK; GW 78603; 5-((4-((2,3-dimethyl-2H-indazol-6-yl)(methyl)amino)pyrimidin-2-yl)amino)-2-methylbenzenesulfonamide; CHEBI:71219; 5-({4-[(2,3-dimethyl-2H-indazol-6-yl)(methyl)amino]pyrimidin-2-yl}amino)-2-methylbenzene-1-sulfonamide; NCGC00188865-01; DSSTox_RID_82929; DSSTox_CID_28659; DSSTox_GSID_48733; 5-[4-[(2,3-Dimethyl-2H-indazol-6-yl)-methyl-amino]-pyrimidin-2-ylamino]-2-methyl-benzenesulfonamide; 5-(4-((2,3-dimethyl-2H-indaz" C21H23N7O2S CUIHSIWYWATEQL-UHFFFAOYSA-N 5-[[4-[(2,3-dimethylindazol-6-yl)-methylamino]pyrimidin-2-yl]amino]-2-methylbenzenesulfonamide n.a. n.a. No Yes No No No No PMDBD94 Bacitracin Therapeutic Substance Approved Drug 1405-87-4 DB00626 PA448531 D00128 DAP000710 10909430 9084687 n.a. "Bacitracin A; Bacitracin A2a; UNII-DDA3RRX0P7; Fortracin; DDA3RRX0P7; Mycitracin; Altracin; 22601-59-8; CHEBI:35862; Topitracin; Penitracin; Zutracin; Ayfivin; EINECS 245-115-9; NSC 45737; Parentracin; Bacitracine; Topitrasin; Bacitracina; Baciliquin; Baciim; Septa; Spectrocin Plus; Bacitek ointment; Ak-Tracin; Baci-rx; Baci-Jel; Bacitracinum [Latin]; Bacitracine [French]; Bacitracina [Spanish]; Bactine Triple Antibiotic; Bacitracin A (B015); USAF" C66H103N17O16S CLKOFPXJLQSYAH-ABRJDSQDSA-N (4R)-4-[[(2S)-2-[[(4R)-2-[(1S,2S)-1-amino-2-methylbutyl]-4,5-dihydro-1,3-thiazole-4-carbonyl]amino]-4-methylpentanoyl]amino]-5-[[(2S,3S)-1-[[(3S,6R,9S,12R,15S,18R,21S)-3-(2-amino-2-oxoethyl)-18-(3-aminopropyl)-12-benzyl-15-[(2S)-butan-2-yl]-6-(carboxymethyl)-9-(1H-imidazol-5-ylmethyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclopentacos-21-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-5-oxopentanoic acid n.a. Antibiotics Yes No Yes No No No PMDBD769 Saxagliptin Therapeutic Substance Approved Drug 361442-04-8 DB06335 PA165958362 D08996 n.a. 11243969 9419005 n.a. "Saxagliptin; Onglyza; 361442-04-8; BMS-477118; BMS 477118; OPC-262; UNII-8I7IO46IVQ; 8I7IO46IVQ; CHEMBL385517; CHEBI:71272; BMS-477118-11; axagliptin; (1S,3S,5S)-2-[(2S)-2-amino-2-(3-hydroxyadamantan-1-yl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile; (1S,3S,5S)-2-((2S)-Amino(3-hydroxytricyclo(3.3.1.13,7)dec-1-yl)acetyl)-2-azabicyclo(3.1.0)hexane-3-carbonitrile; BMS477118; (1S,3S,5S)-2-[(2S)-2-amino-2-(3-hydroxy-1-adamantyl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile; Saxagliptin [INN]; Saxagliptine; Saxagliptin (BMS" C18H25N3O2 QGJUIPDUBHWZPV-SGTAVMJGSA-N (1S,3S,5S)-2-[(2S)-2-amino-2-(3-hydroxy-1-adamantyl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile "Bristol-Myers Squibb; AstraZeneca" n.a. No Yes No No No No PMDBD396 Ginsenoside Rg5 Herbal Substance Medicinal Herbal Compounds n.a. n.a. n.a. n.a. n.a. 11550001 n.a. NPC159036 "Ginsenoside Rg5; 186763-78-0; Ginsenoside-Rg5; CHEBI:67992; CHEMBL400244; HY-N0908; ZINC95613310; CS-3850; Q27136475" C42H70O12 NJUXRKMKOFXMRX-RNCAKNGISA-N (2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-[[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-4,4,8,10,14-pentamethyl-17-[(2E)-6-methylhepta-2,5-dien-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol n.a. n.a. No Yes No No No No PMDBD372 Fostamatinib Therapeutic Substance Approved Drug 901119-35-5 DB12010 n.a. n.a. n.a. 11671467 9846198 n.a. "Fostamatinib; 901119-35-5; Fostamatinib (R788); R788; Fostamatinib(R788); Tavalisse; UNII-SQ8A3S5101; R-788 Free acid; R 788; R-788; R-935788 Free acid; SQ8A3S5101; R7935788; [6-[[5-fluoro-2-(3,4,5-trimethoxyanilino)pyrimidin-4-yl]amino]-2,2-dimethyl-3-oxopyrido[3,2-b][1,4]oxazin-4-yl]methyl dihydrogen phosphate; Fostamatinib/R788; [6-({5-Fluoro-2-[(3,4,5-Trimethoxyphenyl)amino]pyrimidin-4-Yl}amino)-2,2-Dimethyl-3-Oxo-2,3-Dihydro-4h-Pyrido[3,2-B][1,4]oxazin-4-Yl]methyl Dihydrogen Phosphate; 2H-Pyrido(3,2-b)-1,4-oxazin-3(4H" C23H26FN6O9P GKDRMWXFWHEQQT-UHFFFAOYSA-N [6-[[5-fluoro-2-(3,4,5-trimethoxyanilino)pyrimidin-4-yl]amino]-2,2-dimethyl-3-oxopyrido[3,2-b][1,4]oxazin-4-yl]methyl dihydrogen phosphate Rigel Pharmaceuticals n.a. No Yes No No No No PMDBD1325 Nystatin Therapeutic substance Drug 1400-61-9 DB00646 PA450666 D00202 DAP000879 11953884 10468627 n.a. "Mycostatin (TN); SCHEMBL3232; Nystatin (JP17/USP/INN); CHEBI:7660; LMPK06000001; D00202; C06572; (21E,23E,25E,27E,31E,33E)-20-[(3-amino-3,6-dideoxy-D-mannopyranosyl)oxy]-4,6,8,11,12,16,18,36-octahydroxy-35,37,38-trimethyl-2,14-dioxooxacyclooctatriaconta-21,23,25,27,31,33-hexaene-17-carboxylic acid" C47H75NO17 ZDFDJJJGIRGMBE-AFARJNEBSA-N (21E,23E,25E,27E,31E,33E)-20-[(3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-4,6,8,11,12,16,18,36-octahydroxy-35,37,38-trimethyl-2,14-dioxo-1-oxacyclooctatriaconta-21,23,25,27,31,33-hexaene-17-carboxylic acid n.a. n.a. No Yes No No No No PMDBD457 Isoaminile Therapeutic Substance Approved Drug 77-51-0 DB08944 n.a. D08088 n.a. 12162152 64873333 n.a. "DB08944; (2R,4S)-2-Phenyl-2-isopropyl-4-(dimethylamino)pentanenitrile" C16H24N2 WFLSCFISQHLEED-GOEBONIOSA-N (2R,4S)-4-(dimethylamino)-2-phenyl-2-propan-2-ylpentanenitrile n.a. n.a. No Yes No No No No PMDBD391 Ginsenoside Rc Herbal Substance Medicinal Herbal Compounds n.a. n.a. n.a. n.a. n.a. 12855889 n.a. NPC220427 "Ginsenoside Rc; 11021-14-0; ginsenoside-Rc; Panaxoside RC; UNII-0K83B0L786; NSC 310104; CHEBI:77154; 0K83B0L786; EINECS 234-253-5; BRN 1677618; CHEMBL451702; HY-N0042; 20-[(6-O-a-L-arabinofuranosyl-ss-D-glucopyranosyl)oxy]-12ss-hydroxydammar-24-en-3ss-yl 2-O-ss-D-glucopyranosyl-ss-D-glucopyranoside; 20-((6-O-alpha-L-Arabinofuranosyl-beta-D-glucopyranosyl)oxy)-12beta-hydroxydammar-24-en-3beta-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside; MFCD00133368; s9266; AKOS037514670; CCG-270633; CS-3837; NCGC00485983-01; AS-56539" C53H90O22 JDCPEKQWFDWQLI-LUQKBWBOSA-N (2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-2-[[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-17-[(2S)-2-[(2S,3R,4S,5S,6R)-6-[[(2R,3R,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4,5-trihydroxyoxan-2-yl]oxy-6-methylhept-5-en-2-yl]-12-hydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol n.a. n.a. No Yes No No No No PMDBD437 Idebenone Therapeutic Substance Approved Drug 58186-27-9 DB09081 n.a. D01750 n.a. 12881464 14944546 n.a. "SCHEMBL7407419; DB09081; NS00073405; 6-(12-hydroxydodecyl)-2,3-dimethoxy-5-methyl-1,4-benzoquinone; 2-(12-hydroxydodecyl)-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione" C21H34O5 VMHWZDULLBLUMS-UHFFFAOYSA-N 2-(12-hydroxydodecyl)-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione n.a. n.a. Yes Yes No Yes No No PMDBD1096 Ceftobiprole Therapeutic substance Antibiotics 209467-52-7 DB04918 n.a. D08885 n.a. 135413542 23350302 n.a. "Ceftobiprole; 209467-52-7; UNII-5T97333YZK; 5T97333YZK; BAL9141-000; Ro-63-9141; ceftobiprol; Zeftera; ceftobiprolum; BAL-9141; Ro-639141; Ceftobiprole [USAN:INN]; Ceftobiprole (USAN/INN); SCHEMBL158871; SCHEMBL2671901; CHEMBL520642; SCHEMBL19236292; DTXSID40870229; CHEBI:140407; DB04918; BAL-9141000; Ro 63-9141; BAL 9141-000; BAL-9141-000; HY-112579; CS-0047547; Ro-63-9141/000; D08885; Ceftobiprole, Antibiotic for Culture Media Use Only" C20H22N8O6S2 VOAZJEPQLGBXGO-SDAWRPRTSA-N (6R,7R)-7-[[(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-hydroxyiminoacetyl]amino]-8-oxo-3-[(E)-[2-oxo-1-[(3R)-pyrrolidin-3-yl]pyrrolidin-3-ylidene]methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid n.a. n.a. Yes No No No No No PMDBD841 Thimerosal Therapeutic Substance Approved Drug 54-64-8 DB11590 n.a. D00864 n.a. 16684434 5697 n.a. "thimerosal; Thiomersal; 54-64-8; Thiomersalate; Mercurothiolate; Sodium merthiolate; Sodium ethylmercurithiosalicylate; MERTHIOLATE; Thiomersalat; Thimersalate; Thimerosalum; Thimerosalate; Thimerosol; Ethylmercurithiosalicylate sodium; Ethylmercurithiosalicylic acid sodium salt; Thiomersalum; Mertorgan; Merphol; Tiomersal; Merzonin; Merfamin; Nosemack; Estivin; Elicide; Mercurothiolatum; Merzonin sodium; Aeroaid spray; Merthiolate salt; Merthiolate sodium; Vitaseptol Loesung; Merseptyl (VAN); Ethyl(2-mercaptobenzoato-S)mercury sodium sa" C9H9HgNaO2S RTKIYNMVFMVABJ-UHFFFAOYSA-L "sodium;(2-carboxylatophenyl)sulfanyl-ethylmercury" n.a. n.a. Yes No Yes No No No PMDBD1137 Dalbavancin Therapeutic substance Antibiotics 171500-79-1 DB06219 n.a. D03640 n.a. 23724878 30791917 n.a. "Dalvance; Zeven; Xydalba; BI-397; Dalvance (TN); Zeven (TN); Dalbavancin (USAN/INN); a a-1; GTPL10876; D03640" C88H100Cl2N10O28 KGPGQDLTDHGEGT-VBZOGQDBSA-N (2S,3S,4R,5R,6S)-6-[[(1S,2R,19R,22R,34S,37R,40R)-5,32-dichloro-52-[3-(dimethylamino)propylcarbamoyl]-2,26,31,44,49-pentahydroxy-22-(methylamino)-21,35,38,54,56,59-hexaoxo-47-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-7,13,28-trioxa-20,36,39,53,55,58-hexazaundecacyclo[38.14.2.23,6.214,17.219,34.18,12.123,27.129,33.141,45.010,37.046,51]hexahexaconta-3,5,8,10,12(64),14(63),15,17(62),23(61),24,26,29(60),30,32,41(57),42,44,46(51),47,49,65-henicosaen-64-yl]oxy]-3,4-dihydroxy-5-(10-methylund n.a. n.a. Yes No No No No No PMDBD1419 Solithromycin Therapeutic substance Antibiotics 760981-83-7 DB09308 n.a. n.a. n.a. 25242512 25056854 n.a. "Solithromycin; CEM-101; Solithera; OP-1068; CEM 101; 760981-83-7; UNII-9U1ETH79CK; OP 1068; 9U1ETH79CK; Solithromycin [USAN:INN]; CEM101; SCHEMBL19114493; CHEMBL1232510; GTPL10859; OPT-1068; EX-A2272; OP1068; ZINC95627834; AKOS032947334; Solithromycin; CEM-101; OP-1068; DB09308; compound 3 [PMID: 30258539]; CS-5053; HY-17593; T4288; T-4288; Q7558263; 2H-Oxacyclotetradecino(4,3-d)oxazole-2,6,8,14(1H,7H,9H)-tetrone, 1-(4-(4-(3-aminophenyl)-1H-1,2,3-triazol-1-yl)butyl)-4-ethyl-7- fluorooctahydro-11-methoxy-3a,7,9,11,13,15-hexamethyl" C43H65FN6O10 IXXFZUPTQVDPPK-ZAWHAJPISA-N (1S,2R,5S,7R,8R,9R,11R,13R,14R)-15-[4-[4-(3-aminophenyl)triazol-1-yl]butyl]-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-5-fluoro-9-methoxy-1,5,7,9,11,13-hexamethyl-3,17-dioxa-15-azabicyclo[12.3.0]heptadecane-4,6,12,16-tetrone n.a. n.a. Yes No No No No No PMDBD1491 Vinorelbine Therapeutic substance Drug 71486-22-1 DB00361 PA451881 D08680 DAP000765 44424639 4470974 n.a. "vinorelbine; Vinorelbine Ditartarate; Vinorelbin; Vinorelbinum [Latin]; Vinorelbina [Spanish]; methyl (1R,9R,10R,11R,12R,19R)-11-(acetyloxy)-12-ethyl-4-[(12S,14R)-16-ethyl-12-(methoxycarbonyl)-1,10-diazatetracyclo[12.3.1.0^{3,11}.0^{4,9}]octadeca-3(11),4,6,8,15-pentaen-12-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.0^{1,9}.0^{2,7}.0^{16,19}]nonadeca-2,4,6,13-tetraene-10-carboxylate" C45H54N4O8 GBABOYUKABKIAF-GHYRFKGUSA-N methyl (1R,9R,10R,11R,12R,19R)-11-acetyloxy-12-ethyl-4-[(12S,14R)-16-ethyl-12-methoxycarbonyl-1,10-diazatetracyclo[12.3.1.03,11.04,9]octadeca-3(11),4,6,8,15-pentaen-12-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate n.a. n.a. No Yes No No No No PMDBD464 Ivermectin "Therapeutic Substance; Herbal Substance" "Approved Drug; Medicinal Herbal Compounds" 70288-86-7 DB00602 PA450133 D00804 DAP000261 46936176 30776735 NPC469812 "SCHEMBL44295; DB00602; W-5275" C95H146O28 SPBDXSGPUHCETR-CVSKBELMSA-N "(1R,4S,5''S,6R,6''R,8R,10E,12S,13S,14E,16E,20R,21R,24S)-6''-[(2R)-butan-2-yl]-21,24-dihydroxy-12-[(2R,4S,5S,6S)-5-[(2S,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-5'',11,13,22-tetramethylspiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2''-oxane]-2-one;(1R,4S,5''S,6R,6''R,8R,10E,12S,13S,14E,16E,20R,21R,24S)-21,24-dihydroxy-12-[(2R,4S,5S,6S)-5-[(2S,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-5'',11,13,22-" n.a. n.a. Yes No Yes No No No PMDBD389 Ginsenoside Rb1 "Therapeutic Substance; Herbal Substance" "Therapeutic Substance; Herbal Substance" 41753-43-9 DB06749 n.a. n.a. n.a. 46937026 8073937 NPC208650 Q27095725 C54H92O23 JRZQHNRYHFRTFZ-MHMDWUMYSA-N (2R,3R,4S,5S,6R)-2-[[(2R,3S,4S,5R,6S)-6-[(2S)-2-[(1R,3S,5R,8R,9R,12R,13R,14R,17S)-3-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-12-hydroxy-1,4,4,8,14-pentamethyl-1,2,3,5,6,7,9,10,11,12,13,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-6-methylhept-5-en-2-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol n.a. n.a. No Yes No No No No PMDBD1399 Raltegravir Therapeutic substance Drug 518048-05-0 DB06817 n.a. D06676 n.a. 54671008 16445111 n.a. "Raltegravir; 518048-05-0; Raltegravir (MK-0518); MK-0518; MK0518; UNII-22VKV8053U; N-(2-(4-((4-fluorobenzyl)carbamoyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)propan-2-yl)-5-methyl-1,3,4-oxadiazole-2-carboxamide; MK 0518; 22VKV8053U; NCGC00184997-01; AK326327; DSSTox_CID_28586; DSSTox_RID_82857; DSSTox_GSID_48660; Isentress(TM); N-[2-[4-[(4-fluorophenyl)methylcarbamoyl]-5-hydroxy-1-methyl-6-oxopyrimidin-2-yl]propan-2-yl]-5-methyl-1,3,4-oxadiazole-2-carboxamide; Raltegravir (INN); CAS-518048-05-0; Raltegravir [USAN" C20H21FN6O5 CZFFBEXEKNGXKS-UHFFFAOYSA-N N-[2-[4-[(4-fluorophenyl)methylcarbamoyl]-5-hydroxy-1-methyl-6-oxopyrimidin-2-yl]propan-2-yl]-5-methyl-1,3,4-oxadiazole-2-carboxamide n.a. n.a. No Yes No No No No PMDBD1170 Doxycycline Therapeutic substance Antibiotics 564-25-0 DB00254 PA449415 D07876 DAP001371 54671203 10469369 n.a. "doxycycline; Vibramycin; 564-25-0; Doxytetracycline; Doxiciclina; Doxycyclinum; Oracea; Monodox; Doxy-Caps; Vibravenos; Doxycycline (anhydrous); Vibra-tabs; 6-Deoxytetracycline; Doxycycline hyclate; Vibramycine; Deoxymykoin; Investin; Doxivetin; Doxitard; Liviatin; Azudoxat; Spanor; Ronaxan; Doxycen; 6alpha-Deoxy-5-oxytetracycline; Doxy-Puren; Doxy-Tabs; alpha-Doxycycline; alpha-6-Deoxyoxytetracycline; 5-Hydroxy-alpha-6-deoxytetracycline; Doxycyclin; 6-alpha-Deoxy-5-oxytetracycline; Dossiciclina [DCIT]; 6-Deoxyoxytetracycline; Doxiciclina [" C22H24N2O8 SGKRLCUYIXIAHR-AKNGSSGZSA-N (4S,4aR,5S,5aR,6R,12aR)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide n.a. n.a. Yes Yes No No No No PMDBD1339 Oxytetracycline Therapeutic substance Drug 79-57-2 DB00595 PA450757 n.a. DAP000401 54675779 10482174 n.a. "oxytetracycline; Terramycin; 79-57-2; Oxyterracine; Oxyterracin; Oxytetracyclin; Oxymycin; Terrafungine; Oxitetracyclin; Oxitetraciclina; Ryomycin; Biostat; Adamycin; Geomycin; Oxytetracyclinum; Oxitetracyclinum; 5-Hydroxytetracycline; Oxytetracycline (anhydrous); Solkaciclina; Oxyterracyne; Ursocycline; Terramitsin; Riomitsin; Oksisyklin; Lenocycline; Imperacin; Ursocyclin; Berkmycen; Proteroxyna; Geotilin; Fanterrin; Dabicycline; Tarocyn; Oxypam; Macocyn; Teravit; Tarosin; Tetran; Antibiotic TM 25; Oxytetracycline amphoteric; Liquamycin LA 200" C22H24N2O9 OWFJMIVZYSDULZ-PXOLEDIWSA-N (4S,4aR,5S,5aR,6S,12aR)-4-(dimethylamino)-1,5,6,10,11,12a-hexahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide n.a. n.a. No Yes No No No No PMDBD1296 Minocycline Therapeutic substance Antibiotics 10118-90-8 DB01017 PA450519 D05045 DAP000405 54675783 16735907 n.a. "minocycline; 10118-90-8; Minocyclin; Minociclina; Minocin; Minomycin; Minocyn; Dynacin; Minocyclinum [INN-Latin]; Minociclina [INN-Spanish]; CL 59806; MINO; 7-Dimethylamino-6-demethyl-6-deoxytetracycline; UNII-FYY3R43WGO; Tri-minocycline; (4S,4AS,5AR,12AS)-4,7-BIS(DIMETHYLAMINO)-3,10,12,12A-TETRAHYDROXY-1,11-DIOXO-1,4,4A,5,5A,6,11,12A-OCTAHYDROTETRACENE-2-CARBOXAMIDE; CHEBI:50694; HSDB 3130; FYY3R43WGO; BRN 3077644; Minocyclinum; C23H27N3O7; 4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-diox" C23H27N3O7 FFTVPQUHLQBXQZ-KVUCHLLUSA-N (4S,4aS,5aR,12aR)-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide n.a. n.a. Yes Yes No No No No PMDBD265 Dicumarol "Therapeutic Substance; Herbal Substance" "Approved Drug; Medicinal Herbal Compounds" n.a. n.a. n.a. n.a. n.a. 54676038 n.a. NPC229113 "dicumarol; dicoumarol; 66-76-2; Bishydroxycoumarin; dicoumarin; melitoxin; bis-hydroxycoumarin; Antitrombosin; Dicumarine; Dicoumal; Baracoumin; Acavyl; Dicuman; Acadyl; Trombosan; Kumoran; Dufalone; Dicumol; Temparin; Cumid; Cuma; Dicumaol R; 3,3''-Methylenebis(4-hydroxycoumarin); Bis(4-hydroxycoumarin-3-yl)methane; Dicoumarolum; Anathrombase; Dicumarolum; Apekumarol; Dicumarinum; Dicoumerol; Bis-3,3''-(4-hydroxycoumarinyl)methane; Di-(4-hydroxy-3-coumarinyl)methane; Dicumarolo [DCIT]; Dwukumarol [Polish]; 3,3''-methylenebis(4-hydroxy-2H-chro" C19H12O6 DOBMPNYZJYQDGZ-UHFFFAOYSA-N 4-hydroxy-3-[(4-hydroxy-2-oxochromen-3-yl)methyl]chromen-2-one n.a. Anticoagulants Yes No Yes No No No PMDBD1366 Piroxicam Therapeutic substance Drug 36322-90-4 DB00554 PA450985 D00127 DAP000181 54676228 10442653 n.a. "piroxicam; 36322-90-4; Feldene; Piroxicamum; Pyroxycam; Roxicam; Piroftal; BAXO; CP-16171; CP 16171; Piroxicamum [INN-Latin]; CHF 1251; UNII-13T4O6VMAM; 4-Hydroxy-2-methyl-N-(pyridin-2-yl)-2H-benzo[e][1,2]thiazine-3-carboxamide 1,1-dioxide; NSC 666076; 2H-1,2-Benzothiazine-3-carboxamide, 4-hydroxy-2-methyl-N-2-pyridinyl-, 1,1-dioxide; Piroxicam (Feldene); CCRIS 3719; C15H13N3O4S; 4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazine-3-carboxamide-1,1-dioxide; EINECS 252-974-3; BRN 0627692; 13T4O6VMAM; 4-Hydroxy-2-methyl-N-2-pyrid" C15H13N3O4S QYSPLQLAKJAUJT-UHFFFAOYSA-N 4-hydroxy-2-methyl-1,1-dioxo-N-pyridin-2-yl-1lambda6,2-benzothiazine-3-carboxamide n.a. n.a. No Yes No No No No PMDBD14 Acenocoumarol Therapeutic Substance Approved Drug 152-72-7 DB01418 PA452632 D07064 DAP000772 54676537 10443441 n.a. "ACENOCOUMAROL; Acenocoumarin; Nicoumalone; 152-72-7; Nitrowarfarin; Nitrovarfarian; Nicumalon; Sinthrome; Sintrom; Acenocumarol; Syncoumar; Sinkumar; Syncumar; Acenocumarolo; Sincoumar; Sinthrom; Acenokumarin; Ascumar; Syntrom; Zotil; Acenocoumarolum; Neositron; Sintroma; Acenocumarolum; Nitrophenylacetylethyl-4-hydroxycoumarine; Acenocoumarolum [INN-Latin]; Trombostop; Acitrom; Acenokumarin [Czech]; Acenocumarolo [DCIT]; Acenocoumarol [INN]; 3-(alpha-Acetonyl-4-nitrobenzyl)-4-hydroxycoumarin; G-23350; 3-(alpha-Acetonyl-p-nitrobenzyl)-4-hy" C19H15NO6 VABCILAOYCMVPS-UHFFFAOYSA-N 4-hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]chromen-2-one n.a. n.a. Yes No Yes No No No PMDBD1274 Meloxicam Therapeutic substance Drug 71125-38-7 DB00814 PA450353 D00969 DAP000971 54677470 10442740 n.a. "meloxicam; 71125-38-7; Mobic; Movalis; Metacam; Mobicox; Mobec; Meloxicam (Mobic); Parocin; Movatec; Meloxicamum [Latin]; UH-AC 62XX; 4-hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide; Meloxicamum; 4-Hydroxy-2-methyl-N-(5-methylthiazol-2-yl)-2H-benzo[e][1,2]thiazine-3-carboxamide 1,1-dioxide; UNII-VG2QF83CGL; UHAC-62XX; CCRIS 9139; C14H13N3O4S2; VG2QF83CGL; CHEMBL599; 4-Hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide; MLS000028587; CHEBI:6741" C14H13N3O4S2 ZRVUJXDFFKFLMG-UHFFFAOYSA-N 4-hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-1,1-dioxo-1lambda6,2-benzothiazine-3-carboxamide n.a. n.a. No Yes No No No No PMDBD900 Warfarin "Therapeutic Substance; Herbal Substance" "Approved Drug; Medicinal Herbal Compounds" 81-81-2 DB00682 PA451906 n.a. DAP000770 54678486 10442445 NPC2989 "warfarin; 81-81-2; Coumadin; Coumafene; Coumafen; Prothromadin; Zoocoumarin; Coumarins; Vampirinip II; Panwarfin; Warfarine; Coumefene; Solfarin; Maveran; Kumader; Dethnel; Dethmor; Brumolin; Kypfarin; Kumadu; Rosex; Frass-Ratron; Athrombine-K; Mar-Frin; Rattentraenke; Temus W; Rodafarin; Warfarat; Rattunal; Ratorex; Kumatox; Ratron; Vampirinip iii; D-Con; Tox-hid; Rats-no-more; Ratten-Koederrohr; Rat-Trol; Rat-Gard; Rat-Kill; Rat-Ola; Rat-Mix; Ro-Deth; Rat-a-way; Coumaphene; Ratoxin; Rat & mice bait; Martin''s mar-frin; Rat-B-gon; Maag Rattentod Cum" C19H16O4 PJVWKTKQMONHTI-UHFFFAOYSA-N 4-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-2-one Pharmaceutical Research Assoc Inc Anticoagulants No Yes No No No No PMDBD1145 Demeclocycline Therapeutic substance Drug 127-33-3 DB00618 PA164745513 D00290 DAP000402 54680690 10482117 n.a. "demeclocycline; Demethylchlortetracycline; DMCT; Ledermycin; Demethylchlortetracyclin; Declomycin; 6-Demethyl-7-chlorotetracycline; 127-33-3; 7-Chloro-6-demethyltetracycline; Novotriclina; Demeclocyclinum; Demeclociclina; Sumaclina; Diuciclin; Demetraclin; Demeclor; Perciclina; Demethylchlortetracyclinum; Demethylchlorotetracycline; Deganol; 6-Demethylchlorotetracycline; Tri-demethylchlortetracycline; Clortetrin; Mexocine; DMCT (antibiotic); DMCTC; Demeclocyclinum [INN-Latin]; Demeclociclina [INN-Spanish]; 6-Demethylchlortetracycline" C21H21ClN2O8 GUXHBMASAHGULD-SEYHBJAFSA-N (4S,4aS,5aS,6S,12aR)-7-chloro-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide n.a. n.a. No Yes No No No No PMDBD1457 Tigecycline Therapeutic substance Antibiotics 220620-09-7 DB00560 PA164746412 D01079 DAP000880 54686904 10482314 n.a. "Tigecycline; 220620-09-7; Tygacil; WAY-GAR-936; GAR-936; TBG-MINO; GAR 936; CHEBI:149836; Tigecycline hydrate; (4S,4aS,5aR,12aS)-9-(2-(tert-butylamino)acetamido)-4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide; UNII-70JE2N95KR; 70JE2N95KR; Tigecyclin; (4S,4aS,5aR,12aS)-9-(2-(tert-Butylamino)acetamido)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1; (4S,4aS,5aR,12aS)-9-[(N-tert-butylglycyl)amino]-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-diox" C29H39N5O8 SOVUOXKZCCAWOJ-HJYUBDRYSA-N (4S,4aS,5aR,12aR)-9-[[2-(tert-butylamino)acetyl]amino]-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide n.a. n.a. Yes No No No No No PMDBD504 Lymecycline Therapeutic Substance Approved Drug 992-21-2 DB00256 PA164747190 D06884 DAP000881 54707177 20121315 n.a. "Lymecycline; N-Lysinomethyltetracycline; Lymecyclinum; Limeciclina; Tetralysal; Tetracycline-L-methylenelysine; Tetracycline-L-methylene lysine; 992-21-2; Mucomycin; UNII-7D6EM3S13P; Infaciclina; Ciclolysal; Vebicyclysal; Tetralisal; Lisinbiotic; Ciclisin; Armyl; 7D6EM3S13P; N6-((4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamido)methyl)lysine; (+)-N-(5-Amino-5-carboxypentylaminomethyl)-4-dimethylamino-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydro" C29H38N4O10 PZTCVADFMACKLU-UEPZRUIBSA-N (2S)-6-[[[(4S,4aS,5aS,6S,12aR)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carbonyl]amino]methylamino]-2-aminohexanoic acid n.a. n.a. Yes No Yes No No No PMDBD80 Auranofin Therapeutic Substance Approved Drug 34031-32-8 DB00995 PA448510 D00237 DAP000757 70788951 5293650 n.a. "Ridaura; AURANOFIN; Triethylphosphine gold; SK&F-39162; SK-39162; 2,3,4,6-Tetra-O-acetyl-1-thio-beta-D-glucopyranosato-S (triethylphosphine)gold; Auranofina; Auranofinum; Auranofine; Auroafen; CHEMBL1366; GTPL6306; CHEBI:2922; BDBM50153291; DB00995; (1-Thio-beta-D-glucopyranosato)(triethylphosphine)gold2,3,4,6-tetraacetate; (2,3,4,6-tetra-O-acetyl-1-thio-beta-D-glucopyranosato-kappaS(1))(triethylphosphine)gold; gold(+1) cation; (2S,3R,4S,5R,6R)-3,4,5-triacetyloxy-6-(acetyloxymethyl)oxane-2-thiolate; triethylphosphane" C20H35AuO9PS IRPYFWIZKIOHQN-XTZHGVARSA-N "gold;(2S,3R,4S,5R,6R)-3,4,5-triacetyloxy-6-(acetyloxymethyl)oxane-2-thiolate;triethylphosphanium" n.a. n.a. Yes No Yes No No No PMDBD307 Epacadostat Therapeutic Substance Epacadostat has been used in trials studying the treatment of HL, Melanoma, Glioblastoma, Mucosal Melanoma, and Ovarian Carcinoma, among others. 1204669-58-8 DB11717 n.a. n.a. n.a. 135564890 34448418 n.a. "Epacadostat; 1204669-58-8; IDO inhibitor 1; 1204669-37-3; INCB 024360; Epacadostat (INCB024360); Epacadostat(INCB 024360); INCB-024360; UNII-71596A9R13; N-(3-bromo-4-fluorophenyl)-N''-hydroxy-4-{[2-(sulfamoylamino)ethyl]amino}-1,2,5-oxadiazole-3-carboximidamide; AK174791; 71596A9R13; (Z)-N-(3-bromo-4-fluorophenyl)-N''-hydroxy-4-[2-(sulfamoylamino)ethylamino]-1,2,5-oxadiazole-3-carboxamidine; N-(3-bromo-4-fluorophenyl)-N''-hydroxy-4-[[2-(sulfamoylamino)ethyl]amino]-1,2,5-oxadiazole-3-carboximidamide; BBJ; Epacadostat [USAN:IN" C11H13BrFN7O4S FBKMWOJEPMPVTQ-UHFFFAOYSA-N N''-(3-bromo-4-fluorophenyl)-N-hydroxy-4-[2-(sulfamoylamino)ethylamino]-1,2,5-oxadiazole-3-carboximidamide n.a. n.a. No Yes No No No No PMDBD447 Insulin human Therapeutic Substance Approved Drug 11061-68-0 DB00030 PA164744571 D03230 DAP000802 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD452 Ipilimumab Therapeutic Substance a human cytotoxic T-lymphocyte antigen 4 (CTLA-4) blocking antibody used to treat metastatic or unresectable melanoma 477202-00-9 DB06186 n.a. D04603 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD487 Liraglutide Therapeutic Substance Approved Drug 204656-20-2 DB06655 PA165958364 D06404 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD449 Iocetamic acid Therapeutic Substance Approved Drug 16034-77-8 DB09403 n.a. n.a. n.a. n.a. 25724 n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No Yes No No No PMDBD796 Soybean oil Dietary Substance Foods 8001-22-7 DB09422 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No Yes No No No PMDBD147 Carboxymethylcellulose Therapeutic Substance Approved Drug n.a. DB11059 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD690 Polysorbate 80 Therapeutic Substance Approved Drug 9005-65-6 DB11063 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD644 Pectin Herbal Substance Medicinal Herbal Compounds 9000-69-5 DB11158 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD906 Xylitol "Therapeutic Substance; Herbal Substance" n.a. 87-99-0 DB11195 n.a. D00061 n.a. n.a. 6646 NPC197207 n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No Yes No rxnAGORA3761,rxnAGORA5323,rxnAGORA5324 PMDBD776 Sennosides Therapeutic Substance Therapeutic Substance 517-43-1 DB11365 n.a. n.a. n.a. n.a. 5010 n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD262 Diclazuril Therapeutic Substance Approved Drug (veterinary medicine) 101831-37-2 DB11398 n.a. D03794 n.a. n.a. 401855 n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD305 Enrofloxacin Therapeutic Substance Investigational Drug 93106-60-6 DB11404 n.a. D02473 n.a. n.a. 64326 n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD336 Fenbendazole Therapeutic Substance Approved Drug 43210-67-9 DB11410 n.a. D04140 n.a. n.a. 3217 n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD354 Florfenicol Therapeutic Substance Approved Drug (veterinary medicine) 73231-34-2 DB11413 n.a. D04194 n.a. n.a. 102776 n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No Yes No No No PMDBD844 Thiostrepton Therapeutic Substance Approved Drug (veterinary medicine) n.a. DB11467 n.a. n.a. n.a. n.a. 10469505 n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No Yes No No No PMDBD342 Fentiazac Therapeutic Substance Approved Drug 18046-21-4 DB13217 n.a. D01975 n.a. n.a. 26854 n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD867 Tribenoside Therapeutic Substance Approved Drug 10310-32-4 DB13227 n.a. n.a. n.a. n.a. 169970 n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD818 Suloctidil Therapeutic Substance Approved Drug 54767-75-8 DB13340 n.a. n.a. n.a. n.a. 5036698 n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD699 Pranoprofen Therapeutic Substance Approved Drug 52549-17-4 DB13514 n.a. n.a. n.a. n.a. 4719 n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No Yes No No PMDBD633 Oxolinic acid Therapeutic Substance Approved Drug 14698-29-4 DB13627 n.a. D02301 n.a. n.a. 4467 n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No Yes No No No PMDBD594 Niridazole Therapeutic Substance Approved Drug 61-57-4 DB13661 n.a. n.a. n.a. n.a. 5868 n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No Yes No No No PMDBD407 Glycyrrhizic acid Therapeutic Substance Approved Drug 1405-86-3 DB13751 n.a. D00157 n.a. n.a. 14263 n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD479 Lidoflazine Therapeutic Substance Approved Drug 3416-26-0 DB13766 PA165818137 n.a. n.a. n.a. 3789 n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD759 Rufloxacin Therapeutic Substance Approved Drug 101363-10-4 DB13772 n.a. D02474 n.a. n.a. 52489 n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No Yes No No No PMDBD675 Pipemidic acid Therapeutic Substance Approved Drug 51940-44-4 DB13823 n.a. n.a. n.a. n.a. 4665 n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD589 Nifuroxazide Therapeutic Substance Approved Drug 965-52-6 DB13855 n.a. n.a. n.a. n.a. 4495115 n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No Yes No No No PMDBD206 Clinafloxacin Therapeutic Substance Approved Drug 105956-97-6 DB14025 n.a. D02539 n.a. n.a. 54184 n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No Yes No No No PMDBD431 Hycanthone Therapeutic Substance Approved Drug 3105-97-3 DB14061 n.a. D00541 n.a. n.a. 3508 n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD134 Butylparaben Environmental Chemicals Unclassified Substance 94-26-8 DB14084 n.a. D01420 n.a. n.a. 6916 n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD790 Soy isoflavones Dietary Substance Dietary Compounds n.a. DB14101 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD832 Tenofovir Therapeutic Substance Investigational Drug 147127-20-6 DB14126 PA10204 n.a. n.a. n.a. 408154 n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD397 Ginsenosides Therapeutic Substance Investigational Drug 74749-74-9 DB14152 n.a. n.a. n.a. n.a. 2342730 n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD405 Glycyrrhiza glabra Herbal Substance Medicinal Herb 84775-66-6 DB14312 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No Yes No No No PMDBD770 Scutellaria baicalensis root Therapeutic Substance Investigational Drug n.a. DB14364 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No Yes No No PMDBD555 Mometasone furoate Therapeutic Substance Approved Drug 83919-23-7 DB14512 n.a. D00690 n.a. n.a. 390091 n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD280 Diloxanide furoate Therapeutic Substance Approved Drug 3736-81-0 DB14638 n.a. D02480 n.a. n.a. 18400 n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No Yes No No No PMDBD492 Loperamide oxide Therapeutic Substance Anti-diarrheal medication 106900-12-3 DB14661 n.a. n.a. n.a. n.a. 64511 n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD253 Deleobuvir Therapeutic Substance under investigation in clinical trial 863884-77-9 DB14850 PA166128130 n.a. n.a. n.a. 29773345 n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No Yes DLB_GLC_GLCAASE,DLB_GLC_GLCAASEe,DLB_GLC_GLCAASEepp,DLBte,DLBtepp,DLBtex,EX_dlb(e) PMDBD2 1-b-D-arabinofuranosyl-5-(E)-(2-bromovinyl)uracil Environmental Chemicals Unclassified Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD3 2,8-DHQ (including 2,4-DHQ) Environmental Chemicals Environmental Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No Yes No No PMDBD4 2-amino-3,6-dihydro-3H-imidazo[4,5-f]quinoline Environmental Chemicals Unclassified Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD6 3,3-dimethyl-1-butanol Environmental Chemicals Unclassified Substance n.a. n.a. n.a. n.a. n.a. 12233 n.a. n.a. "3,3-Dimethylbutan-1-ol; 3,3-DIMETHYL-1-BUTANOL; 624-95-3; 3,3-Dimethylbutanol; Neohexanol; UNII-543OYD666T; tert-HEXYL ALCOHOL; 3,3-Dimethyl-butan-1-ol; EINECS 210-872-6; NSC 54158; CHEMBL25029; 543OYD666T; tert-Hexanol; NSC54158; PubChem3096; 3,3dimethyl-1-butanol; 3,3-dimethyl butan-1-ol; 1-Butanol, 3,3-dimethyl; ACMC-1B71I; SCHEMBL13695; KSC495S2N; DTXSID3060796; CTK3J5926; 3,3-Dimethyl-1-butanol, 98%; ACT02969; ZINC1685024; BCP21756; KS-000000BZ; BDBM50026474; ANW-34234; NSC-54158; BBL10" C6H14O DUXCSEISVMREAX-UHFFFAOYSA-N 3,3-dimethylbutan-1-ol n.a. n.a. No Yes No No No No PMDBD7 3,4-Dihydro-5-Methyl-Isoquinolinone Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. n.a. 148140 n.a. n.a. "129075-56-5; 5-methyl-3,4-dihydroisoquinolin-1(2H)-one; 3,4-Dihydro-5-methyl-1(2H)-isoquinolinone; 3,4-DIHYDRO-5-METHYL-ISOQUINOLINONE; PD-128763; CHEBI:41928; PD128763; CHEMBL125200; 3,4-dihydro-5-methylisoquinolinone; 5-Methyl-3,4-dihydro-1(2H)-isoquinolinone; 5-methyl-1,2,3,4-tetrahydroisoquinolin-1-one; PD 128763; dihydroisoquinolinone, 1; 5-methyl- 3,4-dihydroisoquinolin-1(2H)-one; ACMC-1C7L4; SCHEMBL831538; AMBZ0075; CTK4B6146; BDBM2" C10H11NO RLLZPXDJYADIEU-UHFFFAOYSA-N 5-methyl-3,4-dihydro-2H-isoquinolin-1-one n.a. n.a. No Yes No No No No PMDBD8 5-fluorouracil Therapeutic Substance antineoplastic antimetabolite n.a. n.a. n.a. n.a. n.a. 3385 n.a. n.a. "5-Fluorouracil; fluorouracil; 51-21-8; 5-FU; Fluoroplex; Efudex; Adrucil; Carac; Fluracil; 5-fluoropyrimidine-2,4(1H,3H)-dione; Fluoroblastin; Kecimeton; Carzonal; Timazin; Efudix; Arumel; Fluril; 5-Fluoracil; Queroplex; Fluracilum; Ulup; Phthoruracil; Fluro Uracil; 5-fluoro-1H-pyrimidine-2,4-dione; 5-Fluoro-2,4(1H,3H)-pyrimidinedione; Fluorouracilum; Ftoruracil; Efurix; Fluri; 5 Fluorouracil; 5-Fluoropyrimidine-2,4-dione; Effluderm (free base); Fluorouracilo; Fluroblastin; 2,4-Dihydroxy-5-fluoropyrimidine; 2,4(1H,3H)-Pyrimidinedione, 5-fluo" C4H3FN2O2 GHASVSINZRGABV-UHFFFAOYSA-N 5-fluoro-1H-pyrimidine-2,4-dione n.a. n.a. Yes Yes Yes Yes No Yes 56DFURADH,56DFURADHe,56DFURADHepp,5FURADH,5FURAt,5FURAtex,5FURAtpp,EX_5fura(e),FCSND,FCSNDe PMDBD10 Abacavir Sulfate Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 441384 n.a. n.a. "Abacavir sulfate; 188062-50-2; Ziagen; Abacavir sulphate; Abacavir (sulfate); 1592U89 sulfate; UNII-J220T4J9Q2; Abacavir Hemisulfate; J220T4J9Q2; 136777-48-5; 2-Cyclopentene-1-methanol, 4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-, (1S,4R)-, sulfate (2:1); bis([(1S,4R)-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]cyclopent-2-en-1-yl]methanol); sulfuric acid; HSDB 7154; Abacavir sulfate [USAN:USP]; bis({(1S,4R)-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]cyclopent-2-en-1-yl}methanol) sulfate" C28H38N12O6S WMHSRBZIJNQHKT-FFKFEZPRSA-N "[(1S,4R)-4-[2-amino-6-(cyclopropylamino)purin-9-yl]cyclopent-2-en-1-yl]methanol;sulfuric acid" n.a. n.a. Yes Yes No No No No PMDBD11 Acacia catechu Herbal Substance Medicinal Herb n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No Yes No No No PMDBD13 Acecainide Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 4342 n.a. n.a. "N-Acetylprocainamide; Acecainide; 32795-44-1; Acekainid; NAPA; Acecainida; Acecainidum; N-Acetyloprokainamid; Acecainide [INN]; Acekainid [Polish]; 4''-((2-(Diethylamino)ethyl)carbamoyl)acetanilide; Acecainidum [INN-Latin]; Acecainida [INN-Spanish]; N-Acetyloprokainamid [Polish]; UNII-910Q707V6F; CHEBI:60728; BRN 2868559; CHEMBL1097; MLS000069490; 4-acetamido-N-[2-(diethylamino)ethyl]benzamide; 910Q707V6F; SMR000059070" C15H23N3O2 KEECCEWTUVWFCV-UHFFFAOYSA-N 4-acetamido-N-[2-(diethylamino)ethyl]benzamide n.a. n.a. No Yes No No No No PMDBD15 Acesulfame-potassium Dietary Substance "Dietary Compounds; Artificial Sweetener" n.a. n.a. n.a. n.a. n.a. 23683747 n.a. n.a. "Acesulfame potassium; Acesulfam-K; Potassium acesulfame; Hoe 095; UNII-23OV73Q5G9; CCRIS 1032; 23OV73Q5G9; EINECS 259-715-3; Acesulfame-K; H733293; Acesulfame potassium salt; 1,2,3-Oxathiazin-4(3H)-one, 6-methyl-, 2,2-dioxide, potassium salt; Acesulfame potassium [NF]; Potassium 6-methyl-1,2,3-oxathiazin-4(3H)-one 2,2-dioxide; 6-Methyl-1,2,3-oxathiazin-4(3H)-one 2,2-dioxide, potassium salt; Acesulfame-potassium; Acesulfam K; SCHEMBL17454392; LS-1366; EC 259-715-3; potassium 6-methyl-2,2-dioxo-4-oxathiazinolate; Q132037; A830716" C4H4KNO4S WBZFUFAFFUEMEI-UHFFFAOYSA-M "potassium;6-methyl-2,2-dioxooxathiazin-4-olate" n.a. n.a. Yes No No No No No PMDBD17 Acetopromazine maleate salt Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 6420038 n.a. n.a. "Acepromazine maleate; 3598-37-6; Anatran; Acetopromazine maleate; Acetopromazine maleate salt; UNII-37862HP2OM; Notensil maleate; NSC 264522; 37862HP2OM; EINECS 222-748-9; DSSTox_CID_27763; DSSTox_RID_82540; DSSTox_GSID_47783; A 23051; Phenothiazine, 2-acetyl-10-(3-(dimethylamino)propyl)-, maleate; Maleate acide de l''acetyl 3-dimethylamino 3-propyl-10-phenothiazine; Maleate acide de l''acetyl 3-dimethylamino 3-propyl-10-phenothiazine [French]; SR-05000001648; NCGC00016634-01; Ethanone, 1-(10-(3-(dimethylamino)propyl)-10H-pheno" C23H26N2O5S FQRHOOHLUYHMGG-BTJKTKAUSA-N "(Z)-but-2-enedioic acid;1-[10-[3-(dimethylamino)propyl]phenothiazin-2-yl]ethanone" n.a. n.a. Yes No No No No No PMDBD20 Activated soy pod fiber Dietary Substance Dietary Compounds n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD21 Agaricus bisporus Dietary Substance Foods n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD24 Alexidine dihydrochloride Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 102678 n.a. n.a. "Alexidine dihydrochloride; 1715-30-6; Alexidine HCl; ALEXIDINE HYDROCHLORIDE; Alexidine (dihydrochloride); UNII-I2A7616PY1; I2A7616PY1; N,N''''-Bis(2-ethylhexyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediamidine dihydrochloride; NCGC00094996-01; 1,1''-Hexamethylenebis(5-(2-ethylhex-1-yl))biguanide dihydrochloride; DSSTox_CID_25881; DSSTox_RID_81197; DSSTox_GSID_45881; 2,4,11,13-Tetraazatetradecanediimidamide, N1,N14-bis(2-ethylhexyl)-3,12-diimino-, hydrochloride (1:2); 2,4,11,13-Tetraazatetradecanediimidamide, N,N''''-bis(2" C26H58Cl2N10 BRJJFBHTDVWTCJ-UHFFFAOYSA-N "1-[N''-[6-[[amino-[[N''-(2-ethylhexyl)carbamimidoyl]amino]methylidene]amino]hexyl]carbamimidoyl]-2-(2-ethylhexyl)guanidine;dihydrochloride" n.a. n.a. Yes No Yes No No No PMDBD27 Aloe vera Herbal Substance Medicinal Herb n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD31 Alverine citrate salt Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 21718 n.a. n.a. "ALVERINE CITRATE; 5560-59-8; Alverine (citrate); Antispasmin; Spacolin; ALVERINE CITRATE SALT; Gamatran citrate; NSC 35459; Alverine dihydrogen citrate; UNII-9JFB58YK1E; NCI 85x; 9JFB58YK1E; MLS000069524; CHEBI:53785; N-Ethyl-3,3''-diphenyldipropylamine citrate (1:1); NSC-35459; NCGC00017047-01; SMR000058631; CAS-5560-59-8; DSSTox_CID_25562; DSSTox_RID_80959; DSSTox_GSID_45562; N-ethyl-3-phenyl-N-(3-phenylpropyl)propan-1-amine 2-hydroxypropane-1,2,3-tricarboxylate; SR-01000003029; Alverine citrate [USAN:NF]; Alverrine citrate; Alveri" C26H35NO7 RYHCACJBKCOBTJ-UHFFFAOYSA-N "N-ethyl-3-phenyl-N-(3-phenylpropyl)propan-1-amine;2-hydroxypropane-1,2,3-tricarboxylic acid" n.a. n.a. Yes No No No No No PMDBD33 Amethopterin (R,S) Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 4112 n.a. n.a. "Amethopterin; DL-Amethopterin; 60388-53-6; (+)-Amethopterin; Mexate; DL-Methotrexate; Methylaminopterin; (+/-)Amethopterin; Abitrexate; Ledertrexate; TCMDC-123832; 6-Mtx (DL); METHOTREXATE(+/-); Amethopterin (R,S); EINECS 262-213-7; Antifolan; MLS002701970; N-(4-(((2,4-Diamino-6-pteridinyl)methyl)methylamino)benzoyl)-DL-glutamic acid; N-(p-(((2,4-Diamino-6-pteridinyl)methyl)methylamino)benzoyl)-DL-glutamic acid; NSC 117356" C20H22N8O5 FBOZXECLQNJBKD-UHFFFAOYSA-N 2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methylamino]benzoyl]amino]pentanedioic acid n.a. n.a. Yes No Yes No No No PMDBD34 Amikacin hydrate Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 16218899 n.a. n.a. "Amikacin hydrate; MLS002207279; 1257517-67-1; SMR001306795; SCHEMBL2172496; CHEMBL1879513; BDBM91426; cid_16218899; C22H43N5O13.H2O; 2212AH; Amikacin hydrate, aminoglycoside antibiotic; 1257517-67-1,37517-28-5(freebase)" C22H45N5O14 DTSOZYYWEZJFSS-XTHCGPPUSA-N "(2S)-4-amino-N-[(1R,2S,3S,4R,5S)-5-amino-2-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-[(2R,3R,4S,5S,6R)-6-(aminomethyl)-3,4,5-trihydroxyoxan-2-yl]oxy-3-hydroxycyclohexyl]-2-hydroxybutanamide;hydrate" n.a. n.a. Yes No Yes No No No PMDBD37 Amiodarone hydrochloride Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 441325 n.a. n.a. "Amiodarone hydrochloride; 19774-82-4; Amiodarone HCL; Nexterone; Amiodar; Uro-Septra; Amiodarone (hydrochloride); Pacerone; Rythmarone; Ritmocardyl; Trangorex; Miodrone; Atlansil; Renodoron; Cordarex; Angoron; Amiodaronum hydrochloride; UNII-976728SY6Z; 51087 N HCl; (2-Butylbenzofuran-3-yl)(4-(2-(diethylamino)ethoxy)-3,5-diiodophenyl)methanone hydrochloride; MLS000028520; L 3428 labaz; NSC-85442; 976728SY6Z; HSDB 6525; SMR000058296; SKF 33134-A; SKF 33134 A; EINECS 243-293-2; NSC 85442; DSSTox_CID_17185; DSSTox_RID_79304; DSSTox_GSID_3718" C25H30ClI2NO3 ITPDYQOUSLNIHG-UHFFFAOYSA-N "(2-butyl-1-benzofuran-3-yl)-[4-[2-(diethylamino)ethoxy]-3,5-diiodophenyl]methanone;hydrochloride" n.a. n.a. Yes No Yes No No No PMDBD38 Amiprilose hydrochloride Environmental Chemicals Unclassified Substance n.a. n.a. n.a. n.a. n.a. 9798098 n.a. n.a. "amiprilose; Therafectin; AMIPRILOSE HYDROCHLORIDE; Amiprilose HCl; 60414-06-4; UNII-546994B3VA; SM-1213 (Free base); Amiprilose hydrochloride [USAN]; 56824-20-5; 546994B3VA; Amiprilose hydrochloride (USAN); Therafectin (TN); MLS002154029; CHEMBL1256946; AKOS016010143; AKOS015845775; CCG-220845; 3-O-(3-(Dimethylamino)propyl)-1,2-O-isopropylidene-alpha-D-glucofuranose hydrochloride; AK115821; SMR001233356; AX8053495; D02911; 414A064; Q27261179; alpha-D-Glucofuranose, 3-O-(3-(dimethylamino)propyl)-1,2-O-(1-methylethylidene)-, hydroch" C14H28ClNO6 RJNRORZRFGUAKL-ADMBVFOFSA-N "(1R)-1-[(3aR,5R,6S,6aR)-6-[3-(dimethylamino)propoxy]-2,2-dimethyl-3a,5,6,6a-tetrahydrofuro[2,3-d][1,3]dioxol-5-yl]ethane-1,2-diol;hydrochloride" n.a. n.a. Yes No No No No No PMDBD40 Amodiaquin dihydrochloride dihydrate Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 64646 n.a. n.a. "Amodiaquin dihydrochloride dihydrate; 6398-98-7; Amodiaquine dihydrochloride dihydrate; Amodiaquine hydrochloride; UNII-K6PW2S574L; Amodiaquin (dihydrochloride dihydrate); 4-((7-Chloroquinolin-4-yl)amino)-2-((diethylamino)methyl)phenol dihydrochloride dihydrate; K6PW2S574L; Amodiaquine hydrochloride [USP]; NCGC00017063-01; AK164307; CAS-6398-98-7; Amodiaquine hydrochloride (USP); 4-[(7-chloroquinolin-4-yl)amino]-2-(diethylaminomethyl)phenol;dihydrate;dihydrochloride; CHEBI:50652; CAM-AQ 1; Amodiaquin dihydrochlorid-2-wasse" C20H28Cl3N3O3 YVNAYSHNIILOJS-UHFFFAOYSA-N "4-[(7-chloroquinolin-4-yl)amino]-2-(diethylaminomethyl)phenol;dihydrate;dihydrochloride" n.a. n.a. Yes No No No No No PMDBD43 Ampicillin trihydrate Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 23565 n.a. n.a. "AMPICILLIN TRIHYDRATE; 7177-48-2; Aminobenzylpenicillin trihydrate; Trafarbiot; Amperil; Ampinova; Cymbi; Amcap; Ampicillin 3-wasser; UNII-HXQ6A1N7R6; alpha-Aminobenzylpenicillin trihydrate; CCRIS 267; NCI-C56086; HXQ6A1N7R6; CHEBI:31209; (D-(-)-alpha-Aminobenzyl)penicillin trihydrate; vidopen; Principen ''125''; AMPICILLIN/AMPICILLIN TRIHYDRATE; Principen ''250''; Principen ''500''; (2S,5R,6R)-6-{[(2R)-2-amino-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid trihydrate; C16H25N3O7S; OMNIPEN " C16H25N3O7S RXDALBZNGVATNY-CWLIKTDRSA-N "(2S,5R,6R)-6-[[(2R)-2-amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid;trihydrate" n.a. n.a. Yes No Yes No No No PMDBD47 Anethole-trithione Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 637563 n.a. n.a. "ANETHOLE; trans-Anethole; 4180-23-8; 104-46-1; (E)-Anethole; p-Propenylanisole; Anise camphor; cis-Anethol; Isoestragole; Anethol; trans-Anethol; p-Anethole; Oil of aniseed; Monasirup; (E)-Anethol; 4-Propenylanisole; Aniskampfer; trans-p-Propenylanisole; (E)-p-Propenylanisole; p-1-Propenylanisole; (E)-1-Methoxy-4-(prop-1-en-1-yl)benzene; (E)-1-(4-Methoxyphenyl)propene; Nauli gum; trans-4-(1-Propenyl)anisole; trans-p-Anethole; 1-methoxy-4-[(1E)-prop-1-en-1-yl]benzene; (E)-1-Methoxy-4-(1-propenyl)benzene; trans-p-Metho" C10H12O RUVINXPYWBROJD-ONEGZZNKSA-N 1-methoxy-4-[(E)-prop-1-enyl]benzene n.a. n.a. Yes No Yes No No No PMDBD48 Anthocyanidins Herbal Substance Plant Compounds n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD50 Anti-PD-L1 therapy Therapeutic Substance Drug Class n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No Yes No No PMDBD51 Anti-TNF antibobies Therapeutic Substance Drug Class n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD52 Antibiotic Therapeutic Substance Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD53 Antibiotic (extensive treatment) Therapeutic Substance Drug Class n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD54 Anticancer drugs Therapeutic Substance Drug Class n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No Yes No No PMDBD55 Antidiabetic drugs Therapeutic Substance Drug Class n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD56 Antiobiotics Therapeutic Substance Drug Class n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD57 Anti?PD1 therapy Therapeutic Substance Drug Class n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No Yes No No PMDBD58 Antrodia cinnamomea Herbal Substance Medicinal Herb n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No Yes No No No PMDBD60 Apple juice Dietary Substance Drinks n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD61 Apple juice colloid Dietary Substance Drinks n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD64 Aqueous soy extract Dietary Substance Dietary Compounds n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD65 Aqueous soy extract (fermented soy product) Dietary Substance Dietary Compounds n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD66 Aqueous soy extract (hypecholesterolemic plus unfermented soy product) Dietary Substance Dietary Compounds n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD67 Aqueous soy extract (hypercholesterolemic plus isoflavone-supplemented fermented soy product) Dietary Substance Dietary Compounds n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD68 Arabinoxylan-oligosaccharides Environmental Chemicals Unclassified Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD70 Arsenic Environmental Chemicals Environmental Substance n.a. n.a. n.a. n.a. n.a. 5359596 n.a. n.a. "7440-38-2; As; Arsenic; Arsenicals; Arsenic compounds; Arsenic, inorganic; Arsenic-75; Arsen; Grey arsenic; Gray arsenic; Arsenic Black; Metallic arsenic; Colloidal arsenic; Agent SA; Arsenic, elemental; Arsenowodor [Polish]; Arsen [German,Polish]; Arsenic hydride (AsH3); Arsenwasserstoff [German]; UNII-V1I29R0RJQ; CCRIS 55; Arsenic and arsenic compounds; UNII-N712M78A8G; HSDB 510; HSDB 509; EINECS 232-066-3; EINECS 231-148-6; UN2188; UN1558; Arsenic, organic compounds; UN 2188; V1I29R0RJQ; N712M78A8G; Arsenic and certain arsenic compounds" As RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic n.a. n.a. Yes Yes No No No No PMDBD72 Artificial sweetener cyclamate Dietary Substance Dietary Compounds n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD73 Aryl hydrocarbon receptor activator Environmental Chemicals "Industrial Chemicals and Pollutants; Toxic Agents" n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD74 Asenapine maleate Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 6917875 n.a. n.a. "Asenapine maleate; 85650-56-2; Saphris; Asenapine (maleate); Org 5222; Sycrest; Org-5222; 1H-Dibenz[2,3:6,7]oxepino[4,5-c]pyrrole, 5-chloro-2,3,3a,12b-tetrahydro-2-methyl-, trans-, (Z)-2-butenedioate (1:1); trans-5-chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-dibenz[2,3:6,7]oxepino[4,5-c]pyrrole maleate; Asenapine maleate [USAN]; Asenapine/; C17H16ClNO.C4H4O4; Saphris (TN); EINECS 288-064-8; trans-5-Chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-dibenz(2,3:6,7)oxepino(4,5-c)pyrrole maleate; (S,S)-Asenapine Maleate; SCHEMBL175228; Ase" C21H20ClNO5 GMDCDXMAFMEDAG-CHHFXETESA-N "(Z)-but-2-enedioic acid;(2S,6S)-9-chloro-4-methyl-13-oxa-4-azatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),7(12),8,10,14,16-hexaene" n.a. n.a. Yes Yes Yes No No No PMDBD77 Astragali radix Herbal Substance Medicinal Herb n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD81 Avermectin B1a Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 6434889 n.a. n.a. "AVERMECTIN B1A; 65195-55-3; abamectin component B1a; Abamectin B1a; Avermectin B(1)a; Abamectine [French]; Abamectinum [Latin]; Abamectina [Spanish]; Caswell No. 063AB; Antibiotic C 076B1a; Abamectin komponente B1a; 5-O-Demethylavermectin A1a; UNII-K54ZMM929K; Avermectin; EINECS 265-610-3; K54ZMM929K; CHEBI:29534; DSSTox_CID_3892; DSSTox_RID_77221; DSSTox_GSID_23892; Abamectina; Abamectine; C48H72O14; Abamectin / Avermectin B1A; Ab" C48H72O14 RRZXIRBKKLTSOM-XPNPUAGNSA-N (1''R,2R,3S,4''S,6S,8''R,10''E,12''S,13''S,14''E,16''E,20''R,21''R,24''S)-2-[(2S)-butan-2-yl]-21'',24''-dihydroxy-12''-[(2R,4S,5S,6S)-5-[(2S,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-3,11'',13'',22''-tetramethylspiro[2,3-dihydropyran-6,6''-3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene]-2''-one n.a. n.a. Yes No Yes No No No PMDBD82 Azacytidine-5 Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 6420049 n.a. n.a. "Azacytidine-5; Prestwick_972; Prestwick1_000866; Prestwick2_000866; Prestwick0_000866; SPBio_002832; SCHEMBL16187746; HMS1570N13" C8H12N4O5 NMUSYJAQQFHJEW-OEXCPVAWSA-N 4-amino-1-[(3S,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3,5-triazin-2-one n.a. n.a. Yes No No No No No PMDBD83 Azaguanine-8 Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 135403646 n.a. n.a. "8-AZAGUANINE; 134-58-7; Azaguanine-8; Guanazolo; Azaguanine; Pathocidine; Pathocidin; Guanazol; Triazologuanine; Azan; 8 AG; NSC-749; SK 1150; 5-Amino-1H-v-triazolo(d)pyrimidin-7-ol; AZG; 5-Amino-7-hydroxy-1H-v-triazolo(d)pyrimidine; 5-Amino-1H-[1,2,3]triazolo[4,5-d]pyrimidin-7(6H)-one; SF-337; 5-Amino-1,6-dihydro-7H-v-triazolo(4,5-d)pyrimidin-7-one; 5-amino-1H-triazolo[4,5-d]pyrimidin-7-ol; 5-Amino-1,4-dihydro-7H-1,2,3-triazolo(4,5-d)pyrimidin-7-one; 5-Amino-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-ol; 7H-1,2,3-Triazolo[4,5-d]pyrim" C4H4N6O LPXQRXLUHJKZIE-UHFFFAOYSA-N 5-amino-2,6-dihydrotriazolo[4,5-d]pyrimidin-7-one n.a. n.a. Yes No No No No No PMDBD86 Azelastine HCl Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 54360 n.a. n.a. "AZELASTINE HYDROCHLORIDE; AZELASTINE HCl; 79307-93-0; Astelin; Optivar; Allergodil; Rhinolast; Azeptin; Azelastine (hydrochloride); Astepro; Optilast; W-2979M; E-0659; CHEBI:2951; 37932-96-0; A-5610; A 5610; 4-(4-chlorobenzyl)-2-(1-methylazepan-4-yl)phthalazin-1(2H)-one hydrochloride; Azelastine hydrochloride [USAN:JAN]; NCGC00095173-01; DSSTox_RID_81243; 4-(p-Chlorobenzyl)-2-(hexahydro-1-methyl-1H-azepin-4-yl)-1(2H)-phthalazinone monohydrochloride; DSSTox_CID_25945" C22H25Cl2N3O YEJAJYAHJQIWNU-UHFFFAOYSA-N "4-[(4-chlorophenyl)methyl]-2-(1-methylazepan-4-yl)phthalazin-1-one;hydrochloride" n.a. n.a. Yes No Yes No No No PMDBD87 Azetirelin Therapeutic Substance thyrotropin-releasing hormone (TRH) ana-logue n.a. n.a. n.a. n.a. n.a. 65841 n.a. n.a. "Azetirelin; 95729-65-0; UNII-70J5AWG54Q; 70J5AWG54Q; Azetirelinum; Azetireline; Azetirelina; Azetirelin [INN]; YM-14673; Azetirelinum [INN-Latin]; Azetireline [INN-French]; Azetirelina [INN-Spanish]; SCHEMBL195158; CHEMBL2104559; DTXSID20241938; Q27265867; (-)-N-(((2S)-4-Oxo-2-azetidinyl)carbonyl)-L-histidyl-L-prolinamide; Nalpha-[(S)-4-OXO-AZETIDINE-2-CARBONYL]-L-HISTIDYL-L-PROLINAMIDE" C15H20N6O4 WBGUMUGCONUXFK-DCAQKATOSA-N (2S)-1-[(2S)-3-(1H-imidazol-5-yl)-2-[[(2S)-4-oxoazetidine-2-carbonyl]amino]propanoyl]pyrrolidine-2-carboxamide n.a. n.a. No Yes No No No No PMDBD89 Azlocillin sodium salt Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 23685176 n.a. n.a. "AZLOCILLIN SODIUM; Azlocillin sodium salt; Securopen; Azlin; 37091-65-9; Monosodium azlocillin; Azlocillin (sodium salt); UNII-DWV1EFW947; Sodium azlocillin; CHEBI:51864; DWV1EFW947; C20H22N5O6SNa; EINECS 253-347-7; Azlocillin sodium [USP]; Sodium (2S,5R,6R)-3,3-dimethyl-7-oxo-6-((R)-2-(2-oxo-1-imidazolidinecarboxamido)-2-phenylacetamido)-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate; Azlin (TN); SCHEMBL192700; CHEMBL1201041; HY-B0529A; HMS3714F03; HMS2097F03" C20H22N5NaO6S UVOCNBWUHNCKJM-XFAPPKAWSA-M "sodium;(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[[(2R)-2-[(2-oxoimidazolidine-1-carbonyl)amino]-2-phenylacetyl]amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate" n.a. n.a. Yes No Yes No No No PMDBD90 Azo dyes Environmental Chemicals Environmental Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD92 B-GOSr (prebiotic oligosaccharide) Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD93 Bacampicillin hydrochloride Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 441398 n.a. n.a. "Bacampicillin hydrochloride; 37661-08-8; bacampicillin HCl; Spectrobid; Bacampicillin (hydrochloride); Bacampicillin hydrochoride; BAPC; Ambaxin; Velbacil; Penglobe; Bacacil; Ambacamp; CHEBI:2969; DSSTox_CID_25466; DSSTox_RID_80897; DSSTox_GSID_45466; EINECS 253-580-4; UNII-PM034U953T; C21H27N3O7S.HCl; Spectrobid (TN)" C21H28ClN3O7S IWVTXAGTHUECPN-ANBBSHPLSA-N "1-ethoxycarbonyloxyethyl (2S,5R,6R)-6-[[(2R)-2-amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate;hydrochloride" n.a. n.a. Yes No Yes No No No PMDBD97 Bawei Xileisan Herbal Substance TCM Formula n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD99 Benfluorex hydrochloride Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 198015 n.a. n.a. "Benfluorex hydrochloride; 23642-66-2; Mediaxal; Lipophoral; Balans; Benfluorex (hydrochloride); EINECS 245-801-8; NCGC00094832-01; 2-(alpha-Methyl-3-(trifluoromethyl)phenylethylamino)ethyl benzoat; DSSTox_CID_25854; DSSTox_RID_81175; 2-[[1-Methyl-2-[3-(trifluoromethyl)phenyl]ethyl]amino]ethyl benzoate hydrochloride; DSSTox_GSID_45854; W-110575; 2-((alpha-Methyl-m-(trifluoromethyl)phenethyl)amino)ethanol benzoate (ester); Benfluorex HCl; 2-{(1-METHYL-2-[3-(TRIFLUOROMETHYL)PHENYL]ETHYL}AMINO)ETHYL BENZOATE HYDROCHLORIDE; 2-((" C19H21ClF3NO2 NLOALSPYZIIXEO-UHFFFAOYSA-N "2-[1-[3-(trifluoromethyl)phenyl]propan-2-ylamino]ethyl benzoate;hydrochloride" n.a. n.a. Yes No Yes No No No PMDBD100 Benzathine benzylpenicillin Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 15232 n.a. n.a. "1538-09-6; Benzathine benzylpenicillin; Penduran; Pendepon; Debecillin; BENZATHINE PENICILLIN G; Dibencillin; Diaminocillina; Benzethacil; Lentocillin; Extenicilline; Benzacillin; Longacilina; Penidure; Penditan; Duropenin; Wycillina; Longicil; Leomypen; Benzapen; Moldamin; Durabiotic; Debecylina; Penadur; Dibencil; Cillenta; Neolin; Bica-penicillin; Dura-penita; Bicillin I; Diamine penicillin; Bicillin 1; Penadur L-A; Pen-Di-Ben; Megacillin suspension; Benzathin penicillin G; Penicillin G, benzathine; UNII-SSZ1S4I0US; Benzylpenicillinum benzat" C48H56N6O8S2 BVGLIYRKPOITBQ-ANPZCEIESA-N "N,N''-dibenzylethane-1,2-diamine;(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid" n.a. n.a. Yes No Yes No No No PMDBD102 Benzethonium chloride Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 8478 n.a. n.a. "benzethonium chloride; 121-54-0; Quatrachlor; Phemeride; Hyamine; Benzethoniumchloride; Phemerol Chloride; Hyamine 1622; Phemithyn; Kylacol; Disilyn; Solamin; Diapp; Polymine D; Benzetonium chloride; Anti-germ 77; Benzethonii chloridum; Antiseptol; Cloruro de benzetonio; Banagerm; Chlorure de benzethonium; Inactisol; Benzethonium chloride 1622; Microklenz; Benzethoni chloridum; UNII-PH41D05744; p-tert-Octylphenoxyethoxyethyldimethylbenzylammonium chloride; MFCD00011742; Formula 144; Benzethonium chloride, 97%; Phemerol chloride monohydr" C27H42ClNO2 UREZNYTWGJKWBI-UHFFFAOYSA-M "benzyl-dimethyl-[2-[2-[4-(2,4,4-trimethylpentan-2-yl)phenoxy]ethoxy]ethyl]azanium;chloride" n.a. n.a. Yes No Yes No No No PMDBD104 Benzydamine hydrochloride Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 65464 n.a. n.a. "Benzydamine hydrochloride; 132-69-4; Benzydamine HCl; Benzindamine hydrochloride; Benzidamine hydrochloride; Benalgin; Epirotin; Enzamin; Dorinamin; Difflam; Benzidan; Salyzoron; Ririlim; Oxinazin; Imotryl; Benzyrin; Riripen; Indolin; Flogaton; Tantum; Tamas; Verax; Benzydamine (hydrochloride); UNII-K2GI407R4Q; EINECS 205-076-0; AF 864; Benzydamine hydrochloride [USAN:JAN]; K2GI407R4Q; AF-864; 1-Benzyl-3-gamma-dimethylaminopropoxy-1H-indazole hydrochloride; 1-benzyl-3-(3-[dimethylamino]propoxy)-1h-indazole hydrochloride; 1-Benzyl-3-(3-(d" C19H24ClN3O HNNIWKQLJSNAEQ-UHFFFAOYSA-N "3-(1-benzylindazol-3-yl)oxy-N,N-dimethylpropan-1-amine;hydrochloride" n.a. n.a. Yes No Yes No No No PMDBD105 Benzylpenicillin sodium Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 23668834 n.a. n.a. "Penicillin G sodium; Penicillin G sodium salt; 69-57-8; Benzylpenicillin sodium; Crystapen; American penicillin; Pencillin G sodium; Sodium penicillin G; BENZYLPENICILLIN SODIUM SALT; Sodium benzylpenicillinate; Sodium penicillin II; Veticillin; Penilaryn; Mycofarm; Novocillin; Sodium penicillin; Kesso-Pen; Pen-A-Brasive; Sodium benzylpenicillin G; Monosodium benzylpenicillin; Benzylpenicillinic acid sodium salt; Sodium benzylpenicillin; Penicillin G, sodium; Sugracillin sodium salt; Penicillin G Sodium, Crystalline; Sodium benzylp" C16H17N2NaO4S FCPVYOBCFFNJFS-LQDWTQKMSA-M "sodium;(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate" n.a. n.a. Yes No Yes No No No PMDBD106 Bepridil hydrochloride Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 50088 n.a. n.a. "BEPRIDIL HYDROCHLORIDE; Bepridil HCl; 68099-86-5; Vascor; 74764-40-2; 1978CERM; EINECS 268-472-2; MLS000028456; 1-Isobutoxy-2-pyrrolidino-3-(N-benzylanilino)propane hydrochloride; CERM 1978; SMR000058419; 1-Pyrrolidineethanamine, beta-((2-methylpropoxy)methyl)-N-phenyl-N-(phenylmethyl)-, monohydrochloride; Bepridil hydrochloride hydrate; N-Benzyl-beta-((2-methylpropoxy)methyl)-N-phenylpyrrolidine-1-ethylamine monohydrochloride; CHEBI:52712; SR-01000075304; Prestwick_697; Opera_ID_594; Bepridil Monohydrochloride; C24H34N2O.HCl" C24H35ClN2O JXBBWYGMTNAYNM-UHFFFAOYSA-N "N-benzyl-N-[3-(2-methylpropoxy)-2-pyrrolidin-1-ylpropyl]aniline;hydrochloride" n.a. n.a. Yes No Yes No No No PMDBD108 Betamethasone acetate Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 443967 n.a. n.a. "BETAMETHASONE ACETATE; 987-24-6; Betamethasone 21-acetate; beta-Methasone acetate; UNII-TI05AO53L7; TI05AO53L7; CHEBI:31275; 9-Fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 21-acetate; (11beta,16beta)-9-fluoro-11,17-dihydroxy-16-methyl-3,20-dioxopregna-1,4-dien-21-yl acetate; [2-[(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate; EINECS 213-578-6; 9-fluoro-11beta,17-dihydroxy-16be" C24H31FO6 AKUJBENLRBOFTD-QZIXMDIESA-N [2-[(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate n.a. n.a. No Yes No Yes No No PMDBD109 Betamethasone valerate Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 16533 n.a. n.a. "BETAMETHASONE VALERATE; Betnovate; Betamethasone 17-valerate; 2152-44-5; Betaderm; Luxiq; beta-Val; Celestoderm; Bextasol; Betatrex; Bedermin; Valnac; Dermovaleas; Betnovateat; Betneval; Tokuderm; Dermosol; beta-Methasone 17-valerate; Betamethasone-17-valerate; Ecoval 70; Topagen (Veterinary); Gentocin (Veterinary); UNII-9IFA5XM7R2; 9IFA5XM7R2; CHEBI:31277; C27H37FO6; Betamethasone valerate (Betnovate); EINECS 218-439-3; [(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,1" C27H37FO6 SNHRLVCMMWUAJD-SUYDQAKGSA-N [(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] pentanoate n.a. n.a. No Yes No Yes No No PMDBD110 Betaxolol hydrochloride Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 107952 n.a. n.a. "Betaxolol hydrochloride; 63659-19-8; Betaxolol HCL; Betoptima; Lokren; Kerlone; Betaxolol (hydrochloride); Betoptic; Kerlon; Betaxolo Hydrochloride; Betoptic S; Betaxolol hydrochloride (Betoptic); EINECS 264-384-3; alo 1401-02; MLS000863279; SL 75 212-10; 1-(isopropylamino)-3-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]propan-2-ol hydrochloride; SMR000058420; SL 75.212-10; 1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-(propan-2-ylamino)propan-2-ol;hydrochloride; 1-(4-(2-(Cyclopropylmethoxy)ethyl)phenoxy)-3-isopropylaminopropan-2-ol" C18H30ClNO3 CHDPSNLJFOQTRK-UHFFFAOYSA-N "1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-(propan-2-ylamino)propan-2-ol;hydrochloride" n.a. n.a. Yes No Yes No No No PMDBD114 BILR355 Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. n.a. 3010663 n.a. n.a. "BILR 355; 380378-81-4; CHEMBL1630842; BILR-355; UNII-V7T28EEE1C; BILR355; V7T28EEE1C; BILR 355 BS; DIP007; SCHEMBL5080040; CTK4H9172; DTXSID30191455; ZINC593585; BDBM50058303; 11-ethyl-5-methyl-8-[2-(1-oxidoquinolin-1-ium-4-yl)oxyethyl]dipyrido[[?],[?]][1,4]diazepin-6-one; 5,11-Dihydro-11-e" C25H23N5O3 BEMBRAMZGVDPMH-UHFFFAOYSA-N 2-ethyl-9-methyl-13-[2-(1-oxidoquinolin-1-ium-4-yl)oxyethyl]-2,4,9,15-tetrazatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-10-one n.a. n.a. No Yes No No No No PMDBD119 Black tea Dietary Substance Drinks n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD120 Black tea extract Dietary Substance Dietary Compounds n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD125 Bromocriptine mesylate Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 31100 n.a. n.a. "BROMOCRIPTINE MESYLATE; Bromocriptine mesilate; Bromocryptine mesylate; Pravidel; Parlodel; 22260-51-1; Bagren; Bromergon; CB-154 mesylate; Bromocriptine methanesulfonate; (+)-Bromocriptine methanesulfonate; UNII-FFP983J3OD; 2-Bromo-alpha-ergocryptine mesylate; Bromocryptine methanesulfonate; CB 154; Bromocriptine (mesylate); EINECS 244-881-1; FFP983J3OD; 2-Bromo-alpha-ergocryptine methanesulfonate; CHEBI:3182; 2-Bromine-alpha-ergocryptine methanesulfonate; 2-Bromo-alpha-ergokryptine-mesilate [German]; CB-154; 2-Bromoergocryptine" C33H44BrN5O8S NOJMTMIRQRDZMT-GSPXQYRGSA-N "(6aR,9R)-5-bromo-N-[(1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide;methanesulfonic acid" n.a. n.a. No Yes No Yes No No PMDBD132 Butenafine Hydrochloride Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 443867 n.a. n.a. "Butenafine hydrochloride; 101827-46-7; Butenafine HCL; Mentax; KP-363; Butenafine (Hydrochloride); UNII-R8XA2029ZI; CHEBI:31325; N-(p-tert-Butylbenzyl)-N-methyl-1-naphthalenemethylamine hydrochloride; Mentax-TC; R8XA2029ZI; 1-(4-tert-butylphenyl)-N-methyl-N-(naphthalen-1-ylmethyl)methanamine hydrochloride; 1-Naphthalenemethanamine, N-[[4-(1,1-dimethylethyl)phenyl]methyl]-N-methyl-, hydrochloride (1:1); N-[[4-(1,1-Dimethylethyl)phenyl]methyl]-N-methyl-1-naphthalenemethanamine hydrochloride; N-(4-(tert-butyl)benzyl)-N-meth" C23H28ClN LJBSAUIFGPSHCN-UHFFFAOYSA-N "1-(4-tert-butylphenyl)-N-methyl-N-(naphthalen-1-ylmethyl)methanamine;hydrochloride" n.a. n.a. Yes No No No No No PMDBD133 Butoconazole nitrate Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 47471 n.a. n.a. "BUTOCONAZOLE NITRATE; 64872-77-1; Femstat; Gynomyk; Gynazole-1; Mycelex-3; Exelgyn; Femstat One; Femstat 3; RS-35887; Butoconazole (nitrate); Butaconazole nitrate; RS 35887; CHEBI:3241; C19H17Cl3N2S.HNO3; RS-35887-00-10-3; (+-)-1-(4-(p-Chlorophenyl)-2-((2,6-dichlorophenyl)thio)butyl)imidazole mononitrate; (+-)-1-(4-(4-Chlorophenyl)-2-((2,6-dichlorophenyl)thio)butyl)-1H-imidazole mononitrate; AK164492; DSSTox_RID_80888; DSSTox_CID_25452; 1-[4-(4-chlorophenyl)-2-(2,6-dichlorophenyl)sulfanylbutyl]imidazole;nitric acid; DSSTox_GSID_" C19H18Cl3N3O3S ZHPWRQIPPNZNML-UHFFFAOYSA-N "1-[4-(4-chlorophenyl)-2-(2,6-dichlorophenyl)sulfanylbutyl]imidazole;nitric acid" n.a. n.a. Yes No Yes No No No PMDBD137 Calcitonin Therapeutic Substance calcitonin n.a. n.a. n.a. n.a. n.a. 16220016 n.a. n.a. "Calcitonin-salmon; Thyrocalcitonin (salmon); Cibacalcin; Salmon calcitonin; Tonocalcin; Salcatonin; Calcimonta; Salmocalcin; Porostenina; Osseocalcina; Miracalcic; Cibacalcine; Calcitoran; Ostostabil; Calcihexal; Bionocalcin; Rulicalcin; Prontocalcin; Eptacalcin; Staporos; Stalcin; Salcatyn; Ostosalm; Osteobion; Miacalcin; Citonina; Riostin; Oseototal; Catonin; Calcinil; Biocalcin; Salmofar; Quosten; Osteovis; Kalsimin; Ipocalcin; Calsynar; Calogen; Calcioton; Astronin; Steocin; Caltine; Calciben; Salcat; Ucecal; Casalm; Cadens; Karil; Sical; Calco; Isi-ca" C145H240N44O48S2 BBBFJLBPOGFECG-VJVYQDLKSA-N (4S)-4-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[2-[[(2S)-2-[[(2S)-2-[[(4R,7S,10S,13S,16S,19S,22R)-22-amino-16-(2-amino-2-oxoethyl)-7-[(1R)-1-hydroxyethyl]-10,19-bis(hydroxymethyl)-13-(2-methylpropyl)-6,9,12,15,18,21-hexaoxo-1,2-dithia-5,8,11,14,17,20-hexazacyclotricosane-4-carbonyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]acetyl]amino]hexanoyl]amino]-4-methylpentanoyl]amino]-3-hydroxypropanoyl]amino]-5-oxopentanoyl]amino]-5-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-5-amin n.a. n.a. No Yes No No No No PMDBD138 Calycosin-7-O-b-D-glucoside Herbal Substance Medicinal Herbal Compounds n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD139 Camellia sinensis Herbal Substance Medicinal Herb n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD140 Camylofine dihydrochloride Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 23724817 n.a. n.a. "5892-41-1; camylofin dihydrochloride; Camylofin hydrochloride; Camylofine dihydrochloride; W-110066; Acamylophenine hydrochloride (JAN); Camylofin Chlorhydrate; Camylophenine dihydrochloride; C19H34Cl2N2O2; SCHEMBL12481408; CHEMBL4303602; CTK8J4872; CHEBI:31158; DTXSID70974421; ZX-AT013334; 3-Methylbutyl {[2-(diethylamino)ethyl]amino}(phenyl)acetate dihydrochloride; OR60053; CCG-213987; W0021; SW220091-1; D01759; SR-01000872770; SR-01000872770-1; Q23766546; Camylofine dihydrochloride, analytical standard, for drug analysis; Isopent" C19H34Cl2N2O2 ZHRVNCCPAKIGRH-UHFFFAOYSA-N "3-methylbutyl 2-[2-(diethylamino)ethylamino]-2-phenylacetate;dihydrochloride" n.a. n.a. No Yes No No No No PMDBD144 Carbadox Therapeutic Substance Approved Drug (veterinary medicine) n.a. n.a. n.a. n.a. n.a. 135511839 n.a. n.a. "CARBADOX; 6804-07-5; Mecadox; Getroxel; MLS001333201; SMR000857182; (E)-2-((2-(methoxycarbonyl)hydrazono)methyl)quinoxaline 1,4-dioxide; Hydrazinecarboxylic acid, [(1,4-dioxido-2-quinoxalinyl)methylene]-,methyl ester; DSSTox_CID_23913; DSSTox_RID_80088; DSSTox_GSID_43913; Fortigro; W-104691; C11H10N4O4; Fortrigo; Karbadox [Czech]; N-[(E)-(1-hydroxy-4-oxido-quinoxalin-4-ium-2-ylidene)methyl]iminocarbamic acid methyl ester; CAS-6804-07-5; Carbadoxum [INN-Latin]; SR-05000001715; Carbadox [USAN:INN:BAN]; CCRIS 3002; HSDB 7028; EINECS" C11H10N4O4 OVGGLBAWFMIPPY-WUXMJOGZSA-N methyl N-[(E)-(1,4-dioxidoquinoxaline-1,4-diium-2-yl)methylideneamino]carbamate n.a. n.a. Yes No Yes No No No PMDBD145 Carbenoxolone disodium salt Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 636402 n.a. n.a. "CARBENOXOLONE SODIUM; Biogastrone; Carbenoxolone disodium; Bioral; Duogastrone; Sanodin; 7421-40-1; UNII-F1MP7242Z5; Gastrausil; Neogel; Berkobiogastrone; Ulcus-tablinen; Carbenoxolone disodium salt; Terulcon tabletten; F1MP7242Z5; Sodium carbenoxolone; Carbenoxolon dinatrium; Carbenoxolon-dinatrium; Carbenoxolone, disodium salt; DSSTox_RID_80969; DSSTox_CID_25572; DSSTox_GSID_45572; Disodium glycyrrhetinyl succina; Carbenoxolone sodium [USAN:JAN]; EINECS 231-044-0; Glycyrrhetinic acid hydrogen succinate, disodium salt; Bioplex; 18-b" C34H48Na2O7 BQENDLAVTKRQMS-SBBGFIFASA-L "disodium;(2S,4aS,6aR,6aS,6bR,8aR,10S,12aS,14bR)-10-(3-carboxylatopropanoyloxy)-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1H-picene-2-carboxylate" n.a. n.a. Yes No No No No No PMDBD146 Carbetapentane citrate Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 90010 n.a. n.a. "Carbetapentane citrate; Pentoxyverine citrate; 23142-01-0; Loucarbate; Pentoxiverine citrate; Carbetapentane citrate salt; Toclase; Toclase citrate; Carbetapentane (citrate); Carbetapentone citrate; UNII-4SH0MFJ5HJ; Carbetapentane citrate [NF]; EINECS 245-449-5; 4SH0MFJ5HJ; 2-(2-diethylaminoethoxy)ethyl 1-phenylcyclopentanecarboxylate citrate; 2-(2(Diethylamino)ethoxy)ethyl 1-phenyl-cyclopentanecarboxylate citrate (1:1); Ethanol, 2-(2-(diethylamino)ethoxy)-, 1-phenylcyclopentanecarboxylate (ester) citrate; 2-(2-(Diethylamin" C26H39NO10 AKJDEXBCRLOVTH-UHFFFAOYSA-N "2-[2-(diethylamino)ethoxy]ethyl 1-phenylcyclopentane-1-carboxylate;2-hydroxypropane-1,2,3-tricarboxylic acid" n.a. n.a. No Yes No Yes No No PMDBD149 Carmustine, Etoposide, Cytarabine and melphalan combination Therapeutic Substance Drug Combination n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD152 CB954 Environmental Chemicals Unclassified Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No Yes No No PMDBD153 Cefaclor hydrate Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 51038 n.a. n.a. "Cefaclor monohydrate; 70356-03-5; Cefaclor hydrate; Distaclor; Ceclor; Panacef; Kefolor; Alfatil; Alfatil Kapseln; Compound 99638; Muco Panoral; Kefolor Suspension; Cefaclor-1-wasser; Panoral; Lilly 99638 hydrate; Raniclor; UNII-69K7K19H4L; Cefaclor (monohydrate); 69K7K19H4L; Ceclor CD; 3-Chloro-7-D-(2-phenylglycinamido)-3-cephem-4-carboxylic acid monohydrate; (6R,7R)-7-((R)-2-Amino-2-phenylacetamido)-3-chloro-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid monohydrate; Cefachlor; 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2" C15H16ClN3O5S WKJGTOYAEQDNIA-IOOZKYRYSA-N "(6R,7R)-7-[[(2R)-2-amino-2-phenylacetyl]amino]-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;hydrate" n.a. n.a. Yes No Yes No No No PMDBD155 Cefazolin sodium salt Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 23675322 n.a. n.a. "CEFAZOLIN SODIUM; 27164-46-1; Cefazoline sodium; Cefazolin sodium salt; Ancef; Zolicef; Kefzol; Sodium cefazolin; Sodium cephazolin; Cefazil; Monosodium cefazolin; Cefazolin (sodium); Totacef; Cefamedin; Gramaxin; Biazolina; CEFAZOLIN AND DEXTROSE; CHEBI:3483; UNII-P380M0454Z; Cephazolin Sodium; Sodium CEZ; Cefalomicina; Cefabiozim; Zolisint; Neofazol; Cefacidal; Lampocef; Zolin; Recef; MLS000028706; Bor-Cefazol; CEZ sodium; Firmacef; Cefazina; Liviclina; Atirin; P380M0454Z; SMR000058708; Lilly 46083; SKF 41558; SK&F-41558; ANCEF IN PLASTIC CO" C14H13N8NaO4S3 FLKYBGKDCCEQQM-WYUVZMMLSA-M "sodium;(6R,7R)-3-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]-8-oxo-7-[[2-(tetrazol-1-yl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate" n.a. n.a. Yes No Yes No No No PMDBD157 Cefepime hydrochloride Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 9571075 n.a. n.a. "Cefepime HCl; Cefepime hydrochloride; 123171-59-5; Cefepime hydrochloride monohydrate; Cefepime (Dihydrochloride Monohydrate); Cefepime chloride hydrochloride hydrate; Cefepime dihydrochloride hydrate; CHEBI:31368; BMY-28142 2HCl.H2O; UNII-I8X1O0607P; CFPM; cefepime dihydrochloride; cefepime dihydrochloride monohydrate; I8X1O0607P; BMY 28142 2HCl.H2O; cefepime hydrochloride hydrate; Cefepime In Plastic Container; Cefepime hydrochloride [USAN:USP]; Maxipime (TN); NCGC00017147-01; DSSTox_RID_80996; DSSTox_CID_25603; DSSTox_GSID_45" C19H28Cl2N6O6S2 LRAJHPGSGBRUJN-OMIVUECESA-N "(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(1-methylpyrrolidin-1-ium-1-yl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;chloride;hydrate;hydrochloride" n.a. n.a. Yes No Yes No No No PMDBD159 Cefmetazole sodium salt Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 23666711 n.a. n.a. "CEFMETAZOLE SODIUM; 56796-39-5; Zefazone; Cefmetazon; CEFMETAZOLE SODIUM SALT; CMZ sodium; CS 1170 sodium; SKF 83088 sodium; Cefmetazole (sodium); cefmetazone; UNII-37Y9VR4W7A; Zefazone In Plastic Container; CHEBI:3490; U 72791A; Metafar; 37Y9VR4W7A; Sodium cefmetazole; U-72791A; DSSTox_RID_80985; DSSTox_CID_25590; DSSTox_GSID_45590; Sodium (6R,7S)-7-(2-((cyanomethyl)thio)acetamido)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate; CMZ; 5-Thia-1-azabicyclo(4.2.0)oct-2-e" C15H16N7NaO5S3 BITQGIOJQWZUPL-PBCQUBLHSA-M "sodium;(6R,7S)-7-[[2-(cyanomethylsulfanyl)acetyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate" n.a. n.a. Yes No Yes No No No PMDBD161 Cefoperazone dihydrate Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 6420003 n.a. n.a. "Cefoperazone dihydrate; 113826-44-1; Prestwick_735; SCHEMBL3758644; CHEMBL1697715; DTXSID70423565; HMS2096A15; HMS3713A15; HMS1569A15; CCG-220327; Cefoperazone dihydrate, VETRANAL(TM), analytical standard; Cefoperazone dihydrate, United States Pharmacopeia (USP) Reference Standard; Cefoperazone dihydrate, European Pharmacopoeia (EP) Reference Standard" C25H31N9O10S2 OMYIZCZQILAOGB-BYLXUVCXSA-N "(6R,7R)-7-[[(2R)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;dihydrate" n.a. n.a. Yes No Yes No No No PMDBD163 Cefotaxime sodium salt Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 10695961 n.a. n.a. "CEFOTAXIME SODIUM; CEFOTAXIME SODIUM SALT; 64485-93-4; (+)-Cefotaxime sodium salt; Sodium cefotaxime; Cefotaxime (sodium salt); Tolycar; Claforan; Pretor; UNII-258J72S7TZ; HR 756; Tolycor; Zariviz; Ralopar; C16H16N5NaO7S2; Claforan sodium; MLS000028559; CHEBI:3498; 258J72S7TZ; RU 24756; Sodium 7-(2-(2-amino-4-thiazolyl)-2-methoxyiminoacetamido)cephalosporanate; HR-756; Cefotax; SMR000058812; Cefotaxime sodium salt (syn-isomer); EINECS 264-915-9; MLS002222330; CEFOTAXIME NA-SALT; Cefotaxim sodium salt; SMR001307269; CLAFORAN IN DEXTROSE " C16H16N5NaO7S2 AZZMGZXNTDTSME-JUZDKLSSSA-M "sodium;(6R,7R)-3-(acetyloxymethyl)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate" n.a. n.a. Yes No Yes No No No PMDBD165 Cefotiam hydrochloride Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 47896 n.a. n.a. "Cefotiam dihydrochloride; CEFOTIAM HYDROCHLORIDE; 66309-69-1; Halospor; Pansporin; Pansporine; Ceradon; Spizef; Cefotiam (hydrochloride); Pansporin Ampullen; Abbott 48999; UNII-H7V12WDZ93; SCE 963; EINECS 266-312-6; H7V12WDZ93; Abbott-48999; C18H23N9O4S3.2HCl; CGP-14221/E; 7(R)-(2-(2-Amino-4-thiazolyl)acetamido)-3-(((1-(2-(dimethylamino)ethyl)-1H-tetrazol-5-yl)thio)methyl)-3-cephem-4-carboxylic acid dihydrochloride; (6R,7R)-7-(2-(2-Amino-4-thiazolyl)acetamido)-3-(((1-(2-(dimethylamino)ethyl)-1H-tetrazol-5-yl)thio)methyl)-8-ox" C18H25Cl2N9O4S3 BWRRTAXZCKVRON-DGPOFWGLSA-N "(6R,7R)-7-[[2-(2-amino-1,3-thiazol-4-yl)acetyl]amino]-3-[[1-[2-(dimethylamino)ethyl]tetrazol-5-yl]sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;dihydrochloride" n.a. n.a. Yes No Yes No No No PMDBD166 Cefoxitin sodium salt Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 23667300 n.a. n.a. "CEFOXITIN SODIUM; Cefoxitin sodium salt; 33564-30-6; Cenomycin; Cefoxitin (sodium); Mefoxitin; Merxin; Betacef; UNII-Q68050H03T; Monosodium cefoxitin; Cefoxil; MLS000028557; Cefoxotin sodium; CHEBI:3501; Q68050H03T; SMR000058809; Cefoxitin sodium salt, 94%; Mefoxithin; Farmoxin; MEFOXIN IN PLASTIC CONTAINER; EINECS 251-574-6; MK 206; MEFOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER; NCGC00183034-01; L 620388; MEFOXIN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER; C16H16N3NaO7S2; Prestwick_12; Sodium (6R-cis)-3-((carbamoyloxy)methyl)-7-metho" C16H16N3NaO7S2 GNWUOVJNSFPWDD-XMZRARIVSA-M "sodium;(6R,7S)-3-(carbamoyloxymethyl)-7-methoxy-8-oxo-7-[(2-thiophen-2-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate" n.a. n.a. Yes No Yes No No No PMDBD167 Cefsulodin sodium salt Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 656644 n.a. n.a. "cefsulodin sodium; 52152-93-9; Sulcephalosporin; Cefsulodin sodium salt hydrate; Cefsulodine sodium; CEFSULODIN SODIUM SALT; Cefsulodin Sodium Salt, Hydrate; Pseudomonil; UNII-2D087186PY; Abbott 46811; Abbott-46811; Cefsulodin (sodium); Cefomonil; Tilmapor; Takesulin; Pseudocef; Monaspor; CHEBI:31380; Pyocefal; Ulfaret; 2D087186PY; Abbott-468 11; CGP 7174E; SCE 129; Takesulin (TN); Cefsulodin sodium [USAN:JAN]; EINECS 257-692-4; CGP-7174/E; Prestwick_977; C22H20N4O8S2; 4-Carbamoyl-1-(((6R,7R)-2-carboxy-8-oxo-7-((2R)-2-phenyl-2-sulfoacet" C22H19N4NaO8S2 REACMANCWHKJSM-DWBVFMGKSA-M "sodium;(6R,7R)-3-[(4-carbamoylpyridin-1-ium-1-yl)methyl]-8-oxo-7-[[(2R)-2-phenyl-2-sulfonatoacetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate" n.a. n.a. Yes No Yes No No No PMDBD168 Ceftazidime pentahydrate Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 6536864 n.a. n.a. "Ceftazidime pentahydrate; Tazidime; Fortaz; Ceftazidime hydrate; Tazicef; Pentacef; Fortum; Ceptaz; 78439-06-2; SN 401 pentahydrate; CHEBI:3509; Modacin; GR-20263; GR 20263; Tazidime In Plastic Container; Fortam; LY-139381; LY 139381; Fortaz (TN); 1-(((6R,7R)-7-(2-(2-Amino-4-thiazolyl)glyoxylamido)-2-carboxy-8-oxo-5-thia-1-az" C22H32N6O12S2 NMVPEQXCMGEDNH-TZVUEUGBSA-N "(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(2-carboxypropan-2-yloxyimino)acetyl]amino]-8-oxo-3-(pyridin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate;pentahydrate" n.a. n.a. Yes No Yes No No No PMDBD169 Cefuroxime sodium salt Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 23670318 n.a. n.a. "CEFUROXIME SODIUM; Cefuroxime sodium salt; Biociclin; Anaptivan; Sodium cefuroxime; Zinacef; 56238-63-2; Ultroxim; Spectrazolr; Colifossim; Curoxime; Curoxima; Medoxim; Lifurox; Kesint; Furoxil; Cefumax; Cefofix; Bioxima; Ketocef; Cefurex; Curoxim; Curocef; Cefuroxim Lilly; Cefuroxim Hexal; Cefuroxima Fabra; Cefuroxim MN; Cefuroxim AJ; Cefuroxim curasan; Cefuroxima Richet; Cetroxil [inj.]; Cefuroxim Genericsn; Cefuroxim Fresenius; Sharox [inj.]; Zinnat [inj.]; Froxal [inj.]; Cefuroxim Norcox [inj.]; Kefurox; Cefuroxime (sodium); KEFUROX IN PLAST" C16H15N4NaO8S URDOHUPGIOGTKV-JTBFTWTJSA-M "sodium;(6R,7R)-3-(carbamoyloxymethyl)-7-[[(2Z)-2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate" n.a. n.a. Yes No Yes No No No PMDBD171 Centurion cultivar blueberry extract Dietary Substance Dietary Compounds n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD172 Cephalosporanic acid, 7-amino Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 441328 n.a. n.a. "7-Aminocephalosporanic acid; 957-68-6; 7-ACA; 7-Aminocephalosporinic acid; 7beta-Aminocephalosporanic acid; 7-ACS; UNII-9XI67897RG; CHEBI:2255; (7R)-7-aminocephalosporanic acid; Cephalosporanic acid, 7-amino; (7R)-7-Aminocephalosporanate; (6R,7R)-3-(acetoxymethyl)-7-amino-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 9XI67897RG; MFCD00005177; (6R,7R)-3-[(acetyloxy)methyl]-7-amino-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; DSSTox_CID_25342; DSSTox_RID_80810; DSSTox_GSID_45342; 3-acetoxymethyle" C10H12N2O5S HSHGZXNAXBPPDL-HZGVNTEJSA-N (6R,7R)-3-(acetyloxymethyl)-7-amino-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid n.a. n.a. Yes No No No No No PMDBD173 Cephalosporins Therapeutic Substance Drug Class n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD174 Cephalothin sodium salt Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 23675321 n.a. n.a. "CEPHALOTHIN SODIUM; 58-71-9; cefalotin sodium; Sodium cephalothin; Cephalothin sodium salt; Sodium cefalotin; Sodium cephalotin; Cefalotina sodica; Seffin; Keflin; Toricelocin; Cefalothine; Cepovenin; Synclotin; Ceporacin; Cefalotin sodium salt; Microtin; Lospoven; Cet Injektionsfl; Tokiosarl Ampullen; Keflin In Plastic Container; Cephalothin (sodium); Cephalotin sodium salt; Lovvalline Injektionsfl; Lilly 38253; UNII-C22G6EYP8B; Keflin N Injektionsflaschen; Cefalotina sodica [Spanish]; Cefalothin sodium; EINECS 200-394-6; C22G6EYP8B; CH" C16H15N2NaO6S2 VUFGUVLLDPOSBC-XRZFDKQNSA-M "sodium;(6R,7R)-3-(acetyloxymethyl)-8-oxo-7-[(2-thiophen-2-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate" n.a. n.a. Yes No Yes No No No PMDBD176 Checkpoint inhibitor therapy Therapeutic Substance Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD179 Chlorcyclizine hydrochloride Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 62413 n.a. n.a. "CHLORCYCLIZINE HYDROCHLORIDE; CHLORCYCLIZINE HCl; Eramide; Perazil; 1620-21-9; 14362-31-3; Di-Paralene; Chlorcyclizinium chloride; Chlorcyclizine chloride; Chlorcyclizine (hydrochloride); Chlorcyclizine monohydrochloride; EINECS 238-335-1; NSC 169496; NSC-169496; 1-(p-Chlorobenzhydryl)-4-methylpiperazine monohydrochloride; 1-((4-Chlorophenyl)(phenyl)methyl)-4-methylpiperazine hydrochloride; 1-(p-Chloro-alpha-phenylbenzyl)-4-methylpiperazine monohydrochloride; Piperazine, 1-((4-chlorophenyl)phenylmethyl)-4-methyl-, monohydro" C18H22Cl2N2 MSIJLVMSKDXAQN-UHFFFAOYSA-N "1-[(4-chlorophenyl)-phenylmethyl]-4-methylpiperazine;hydrochloride" n.a. n.a. Yes No Yes No No No PMDBD184 Chlorpheniramine maleate Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 5281068 n.a. n.a. "Chlorpheniramine maleate; 113-92-8; Piriton; Chlorphenamine Maleate; Neorestamin; Lorphen; Allerclor; Synistamin; Kloromin; Ibioton; Antagonate; Chlormene; Allergin; Piriex; Alunex; Dehist; Chlor-tripolon; C-Meton; Histadur dura-tabs; Chlor-Trimeton OD; Pyridamal 100; Pyridamal-100; Polaronil [German]; Carbinoxamide maleate; Chlor-Trimeton Allergy; Chlor-Trimeton Injection; Histaspan-Plus; Histaspan-D; NCI-C55265; Chlorpheniramine (maleate); dl-Chlorpheniramine maleate; Ru-Tuss Capsules; Polaronil; Chloroprophenpyridamine maleate; CCRIS 141" C20H23ClN2O4 DBAKFASWICGISY-BTJKTKAUSA-N "(Z)-but-2-enedioic acid;3-(4-chlorophenyl)-N,N-dimethyl-3-pyridin-2-ylpropan-1-amine" n.a. n.a. Yes Yes Yes No No No PMDBD185 Chlorpromazine hydrochloride Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 6240 n.a. n.a. "Chlorpromazine hydrochloride; 69-09-0; Chlorpromazine Hcl; Sonazine; Promacid; Klorpromex; Chloractil; Plegomazin; Hebanil; Propaphenin; Taroctyl; Promapar; Marazine; Klorproman; Hybernal; Tranzine; Promachel; Hibernal; Promexin; Norcozine; Neurazine; Lomazine; Unitensen; Megatil; Aminazinum; Chlorpromazinium chloride; Fenactil monohydrochloride; Aminazin monohydrochloride; Chloropromazine monohydrochloride; Ampliactil monohydrochloride; Hibanil; Megaphen hydrochloride; Contomin hydrochloride; Chlorpromazine (hydrochloride); Chlorpromazine " C17H20Cl2N2S FBSMERQALIEGJT-UHFFFAOYSA-N "3-(2-chlorophenothiazin-10-yl)-N,N-dimethylpropan-1-amine;hydrochloride" n.a. n.a. Yes No Yes No No No PMDBD186 Chlorprothixene hydrochloride Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 5282478 n.a. n.a. "Chlorprothixene hydrochloride; Chlorprothixene HCl; Minithixen; 6469-93-8; UNII-268KCR965N; cis-Chlorprothixene hydrochloride; trans-N714; (Z)-Chlorprothixene hydrochloride; C18H18ClNS.HCl; EINECS 229-289-3; NSC 78193; NSC 56379; NSC 169899; (E)-Chlorprothixene hydrochloride; trans-Chlorprothixene hydrochloride; 268KCR965N; Truxal hydrochloride; NSC 78192; NSC 56378; NSC 64084; cis-2-Chloro-9-(3-(dimethylamino)propylidene)thioxanthene, hydrochloride; (Z)-2-Chloro-9-(3-dimethylaminopropylidene)thioxanthene hydrochloride; Thioxant" C18H19Cl2NS YWKRLOSRDGPEJR-KIUKIJHYSA-N "(3Z)-3-(2-chlorothioxanthen-9-ylidene)-N,N-dimethylpropan-1-amine;hydrochloride" n.a. n.a. Yes No Yes No No No PMDBD187 Chlortetracycline hydrochloride Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 54682468 n.a. n.a. "Chlortetracycline hydrochloride; Isphamycin; Aureociclina; Chlorotetracycline hydrochloride; 64-72-2; Aureocycline; Aureocarmyl; Clorocipan; Auxeomycin; Aureomycin hydrochloride; B-Aureo; Tetra 5; CLTC; AUREOMYCIN; Biomycin hydrochloride; Psittacin hydrochloride; Biomitsin hydrochloride; Fermycin Soluble; Chlortetracycline HCl; Aureomycin monohydrochloride; Chlortetracyclinium chloride; 7-Chlorotetracycline hydrochloride; Aurofac 100; Aureovit 12C80; Chlortetracycline (hydrochloride); UNII-O1GX33ON8R; Chlortetracycline, monohydrochl" C22H24Cl2N2O8 QYAPHLRPFNSDNH-MRFRVZCGSA-N "(4S,4aS,5aS,6S,12aR)-7-chloro-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;hydrochloride" n.a. n.a. Yes No Yes No No No PMDBD190 Choline-containing compounds Environmental Chemicals Unclassified Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD192 Cichorium intybus Herbal Substance Medicinal Herb n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD195 Cinnamon essential oil Environmental Chemicals Unclassified Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No Yes No No No PMDBD199 Ciprofloxacin hydrochloride monohydrate Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 62998 n.a. n.a. "86393-32-0; Ciprofloxacin hydrochloride hydrate; Ciprofloxacin hydrochloride monohydrate; Ciloxan; Oftacilox; Ceprimax; Proquin XR; Cipro; Floxacipron; Supraflox; Sophixin; Plenolyt; Phaproxin; Globuce; Flociprin; Felixene; Disfabac; Cunesin; Citeral; Ophaflox; Novoquin; Novidat; Microgan; Loxacid; Keefloxin; Cipronex; Ciflosin; Siprogut; Roflazin; Proxacin; Cipropol; Ciprofur; Belmacina; Suiflox; Renator; Quinoflox; Megaflox; Inkamil; Ciproktan; Ciprocinal; Piprol; Flunas; Sepcen; Quipro; Ofitin; Ciflan; Strox; Lypro; Cilox; Cipad; Cenin; Catex; Nixin; Bay o" C17H21ClFN3O4 ARPUHYJMCVWYCZ-UHFFFAOYSA-N "1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid;hydrate;hydrochloride" n.a. n.a. Yes No Yes No No No PMDBD202 Clavulanate potassium salt Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No Yes No No No PMDBD203 Clemastine fumarate Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 5281069 n.a. n.a. "CLEMASTINE FUMARATE; 14976-57-9; Tavist; Agasten; Mecloprodine; Aloginan; Xolamin; Trabest; Marsthine; Maikohis; Reconin; Kinotomin; Inbestan; Masletine; Lacretin; Anhistan; Alphamin; Tavegyl; Tavegil; Piloral; Lecasol; Fuluminol; Clemanil; Clemastine hydrogen fumarate; Mallermin-F; Telgin-G; Meclastine fumarate; Tavist-1; Clemastine (fumarate); Meclastine hydrogen fumarate; UNII-19259EGQ3D; HSDB 6507; Contac 12 Hour Allergy; EINECS 239-055-2; CHEBI:3739; 19259EGQ3D; C21H26ClNO.C4H4O4; (+)-(2R)-2-(2-(((R)-p-Chloro-alpha-methyl-alpha-phenylbenz" C25H30ClNO5 PMGQWSIVQFOFOQ-YKVZVUFRSA-N "(E)-but-2-enedioic acid;(2R)-2-[2-[(1R)-1-(4-chlorophenyl)-1-phenylethoxy]ethyl]-1-methylpyrrolidine" n.a. n.a. No Yes No Yes No No PMDBD204 Clemizole Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 2782 n.a. n.a. "Clemizole; 442-52-4; Histacur; Clemizol; Histakool; Lergopenin; Clemizolum; 1-(4-Chlorobenzyl)-2-(pyrrolidin-1-ylmethyl)-1H-benzo[d]imidazole; Depocural; 1-(p-Chlorobenzyl)-2-pyrrolidylmethylenebenzimidazole; UNII-T97CB3796L; NSC 46261; CHEBI:52140; T97CB3796L; 1-[(4-chlorophenyl)methyl]-2-(pyrrolidin-1-ylmethyl)benzimidazole; NSC-46261; 1-(4-chlorobenzyl)-2-(pyrrolidin-1-ylmethyl)-1H-benzimidazole; 1H-Benzimidazole, 1-((4-chlorophenyl)methyl)-2-(1-pyrro" C19H20ClN3 CJXAEXPPLWQRFR-UHFFFAOYSA-N 1-[(4-chlorophenyl)methyl]-2-(pyrrolidin-1-ylmethyl)benzimidazole n.a. n.a. No Yes No No No No PMDBD205 Clemizole hydrochloride Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 5309446 n.a. n.a. "Clemizole hydrochloride; 1163-36-6; Clemizole HCl; Clemizole (hydrochloride); Allercur; Reactrol; UNII-85W6I13D8M; Allercure hydrochloride; Clemizole hydrochloride [JAN]; MLS000120342; 85W6I13D8M; SMR000058430; AL 20; EINECS 214-605-4; DSSTox_RID_80695; DSSTox_CID_25136; DSSTox_GSID_45136; P 48; Clemizole hydrochloride (JAN); Clemizole.HCl; 1H-Benzimidazole, 1-[(4-chlorophenyl)methyl]-2-(1-pyrrolidinylmethyl)-, hydrochloride (1:1); 1-[(4-Chlorophenyl)methyl]-2-(1-pyrrolidinylmethyl)-1H-benzimidazole hydrochloride; 1-p-Chlorobenz" C19H21Cl2N3 DNFMJYXRIMLMBZ-UHFFFAOYSA-N "1-[(4-chlorophenyl)methyl]-2-(pyrrolidin-1-ylmethyl)benzimidazole;hydrochloride" n.a. n.a. Yes No Yes No No No PMDBD208 Clindamycin hydrochloride Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 16051951 n.a. n.a. "Clindamycin hydrochloride; Clindamycin Hcl; 21462-39-5; Cleocin; Clindamycin (hydrochloride); Cleocin hydrochloride; UNII-T20OQ1YN1W; T20OQ1YN1W; Cleocin HCl; C18H33ClN2O5S.HCl; BenzaClin; 58207-19-5; CLINDAMYCIN ALCOHOLATE; Dalacin (TN); Methyl-7-chloro-6,7,8-trideoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-thio-L-threo-?-D-galacto-octopyranoside hydrochloride; Clinsol; Clintabs; MFCD07793327; Antirobe vet.; (2S,4R)-N-[(1S,2S)-2-chloro-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]pro" C18H34Cl2N2O5S AUODDLQVRAJAJM-XJQDNNTCSA-N "(2S,4R)-N-[(1S,2S)-2-chloro-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide;hydrochloride" n.a. n.a. Yes No Yes No No No PMDBD211 Clofilium tosylate Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 175533 n.a. n.a. "Clofilium tosylate; 92953-10-1; UNII-13ZVF1051K; N-(4-(4-Chlorophenyl)butyl)-N,N-diethylheptan-1-aminium 4-methylbenzenesulfonate; 13ZVF1051K; NCGC00017142-01; CAS-92953-10-1; DSSTox_RID_80994; DSSTox_CID_25601; DSSTox_GSID_45601; Benzenebutanaminium, 4-chloro-N,N-diethyl-N-heptyl-, salt with 4-methylbenzenesulfonicacid (1:1); A1-01947; MLS002154263; GNF-Pf-3889; 4-Chloro-N,N-Diethyl-N-Heptyl-Benzenebutanaminiusaltwith4-Methylbenzenes; clofilium tosylateclofilium tosylate; SMR001233522; Prestwick_682" C28H44ClNO3S MOQZYUUHIWPDQC-UHFFFAOYSA-M "4-(4-chlorophenyl)butyl-diethyl-heptylazanium;4-methylbenzenesulfonate" n.a. n.a. Yes No No No No No PMDBD212 Clomiphene citrate (Z,E) Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No Yes No No No PMDBD213 Clomipramine hydrochloride Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 68539 n.a. n.a. "Clomipramine hydrochloride; 17321-77-6; Clomipramine HCL; Anafranil; 3-(3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine hydrochloride; Anaphranil; 3-Chloroimipramine hydrochloride; Chloroimipramine monohydrochloride; Chlorimipramine hydrochloride; UNII-2LXW0L6GWJ; Clomipramine (hydrochloride); Clomipramine Monohydrochloride; Clomicalm; EINECS 241-344-3; 2LXW0L6GWJ; MLS000028511; CHEBI:3755; SMR000058295; I615; Anafranil (TN); C19H23ClN2.HCl; 3-Chloro-5-(3-(dimethylamino)propyl)-10,11-dihydro-5H-dib" C19H24Cl2N2 WIMWMKZEIBHDTH-UHFFFAOYSA-N "3-(2-chloro-5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethylpropan-1-amine;hydrochloride" n.a. n.a. Yes No No No No No PMDBD216 Clopidogrel sulfate Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 115366 n.a. n.a. "Clopidogrel bisulfate; 120202-66-6; Clopidogrel hydrogen sulfate; Iscover; Plavix; 135046-48-9; Clopidogrel bisulphate; (S)-methyl 2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetate sulfate; Clopidogrel hemisulfate; CLOPIDOGREL SULFATE; Clopidogrel sulphate; clopidogrel hydrogen sulphate; Clopidogrel (hydrogen sulfate); UNII-08I79HTP27; 113665-84-2; Clopidogrel (Plavix); SR 25990C; (S)-(+)-Clopidogrel Sulfate; SR-25990C; 08I79HTP27; PM-103; MFCD05865229; Myogrel; SR-25990; Clopidogrel hydrogensulfate; Plavix (TN" C16H18ClNO6S2 FDEODCTUSIWGLK-RSAXXLAASA-N "methyl (2S)-2-(2-chlorophenyl)-2-(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)acetate;sulfuric acid" n.a. n.a. No Yes No Yes No No PMDBD217 Closantel Therapeutic Substance Approved Drug (veterinary medicine) n.a. n.a. n.a. n.a. n.a. 42574 n.a. n.a. "Closantel; 57808-65-8; N-(5-chloro-4-((4-chlorophenyl)(cyano)methyl)-2-methylphenyl)-2-hydroxy-3,5-diiodobenzamide; Closantelum [INN-Latin]; C22H14Cl2I2N2O2; EINECS 260-967-1; NSC 335306; CHEMBL12131; MLS001332593; N-{5-chloro-4-[(4-chlorophenyl)(cyano)methyl]-2-methylphenyl}-2-hydroxy-3,5-diiodobenzamide; CHEBI:77054; R 31520; NCGC00166312-01; SMR000857079; N-(5-Chloro-4-((4-chlorophenyl)cyanomethyl)-2-methylphenyl)-2-hydroxy-3,5-diiodobenzamide; DSSTox_CID_20662; 5''-Chloro-alpha(sup 4)-(p-chlorophenyl)-alpha(sup 4)-cyano" C22H14Cl2I2N2O2 JMPFSEBWVLAJKM-UHFFFAOYSA-N N-[5-chloro-4-[(4-chlorophenyl)-cyanomethyl]-2-methylphenyl]-2-hydroxy-3,5-diiodobenzamide n.a. n.a. Yes No Yes No No No PMDBD219 Cloxacillin sodium salt Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 23675320 n.a. n.a. "Cloxacillin sodium; Cloxacillin sodium salt; 642-78-4; Cloxacillin sodium anhydrous; Sodium cloxacillin; Sodium orbenin; Monosodium cloxacillin; Sodium syntarpen; Austrastaph; Staphybiotic; Gelstaph; Ekvacillin; Ankerbin; Orbenin sodium; Prevencilina P; Prostaphlin A; Prostaphilin A; BRL 1621 sodium salt; Tegopen; Syntarpen sodium salt; UNII-MWQ645MKMF; BRL-1621 sodium salt; Cloxacillin (sodium); EINECS 211-390-9; MWQ645MKMF; 3-o-Chlorophenyl-5-methyl-4-isoxazolylpenicillin sodium; Sodium 3-(o-chlorophenyl)-5-methyl-4-isoxazolylpeni" C19H17ClN3NaO5S SCLZRKVZRBKZCR-SLINCCQESA-M "sodium;(2S,5R,6R)-6-[[3-(2-chlorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate" n.a. n.a. Yes No Yes No No No PMDBD220 Cocoa drink Dietary Substance Drinks n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD224 Colistin sulfate Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No Yes No No No PMDBD226 Common azole treatment Therapeutic Substance Drug Class n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD227 Conventional soy milk Dietary Substance Drinks n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD228 Conventional soy milk (26.5% beta-conglycinin/38.7% glycinin) Dietary Substance Drinks n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD229 CpG oligodeoxynucleotides Therapeutic Substance oligodeoxynucleotides n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD230 CpG-oligonucleotide immunotherapy Therapeutic Substance Drug Class n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD231 CTLA-4 blockade Therapeutic Substance Drug Class n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No Yes No No PMDBD232 Curcuma longa Herbal Substance Medicinal Herb n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD235 Cyclobenzaprine hydrochloride Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 22576 n.a. n.a. "Cyclobenzaprine hydrochloride; 6202-23-9; Cyclobenzaprine HCL; Flexeril; Flexiban; Amrix; Lisseril; Tensodox; Cycloflex; Cloben; Cyben; Novo-Cycloprine; MK 130 hydrochloride; 3-(5H-dibenzo[a,d][7]annulen-5-ylidene)-N,N-dimethylpropan-1-amine hydrochloride; Cyclobenzaprine (hydrochloride); Proheptatriene hydrochloride; Proheptatriene monohydrochloride; TNX-102; UNII-0VE05JYS2P; Yurelax; Proheptatrien monohydrochloride; EINECS 228-264-4; NSC 78206; NSC 173379; NSC 169900; 10,11delta-Amitriptyline hydrochloride; 0VE05JYS2P; CHEBI:3997" C20H22ClN VXEAYBOGHINOKW-UHFFFAOYSA-N "N,N-dimethyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenylidene)propan-1-amine;hydrochloride" n.a. n.a. Yes No Yes No No No PMDBD238 Cyclosporin A Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 5284373 n.a. n.a. "cyclosporin A; cyclosporine; Ciclosporin; 59865-13-3; Cyclosporine A; Cyclosporin; Neoral; Ciclosporine; Sandimmun; Sang-35; Sandimmune; Ciclosporinum; Ciclosporina; Equoral; Neoplanta; Gengraf; Sandimmun Neoral; UNII-83HN0GTJ6D; Antibiotic S 7481F1; Consupren; Restasis; Ramihyphin A; SangCyA; 83HN0GTJ6D; MLS001333756; CHEBI:4031; CSA; S-Neoral; Cipol N; Sigmasporin Microoral; Sang 35; DSSTox_CID_365; Ciclosporinum [INN-Latin]; Ciclosporine [INN-French]; Ciclosporina [INN-Spanish]; DSSTox_RID_75541; Ciclosporin (Ciclosporin A); DSSTox_GSID_203" C62H111N11O12 PMATZTZNYRCHOR-CGLBZJNRSA-N (3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone n.a. n.a. Yes No Yes No No No PMDBD239 Cyproheptadine hydrochloride Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 13770 n.a. n.a. "cyproheptadine hydrochloride; 969-33-5; Cyproheptadine Hcl; Cipractin; Anarexol; Nuran; Periactin hydrochloride; Antegan; Peritol; Periactin syrup; Cycloheptadine hydrochloride; component of Dronactin; Periactinol (VAN); Cyproheptadiene hydrochloride; Cyproheptadine (hydrochloride); Periactinol hydrochloride; 41354-29-4; Cyproheptadine chlorhydrate; Cyproheptadine hydrochloride anhydrous; UNII-0S9323MCT0; VUFB3511; EINECS 213-535-1; NSC 169911; Cyproheptadine Hydrochloride (anhydrous); C21H21N.HCl; CPD000058431; MLS000028462; AI3-269" C21H22ClN ZPMVNZLARAEGHB-UHFFFAOYSA-N "1-methyl-4-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenylidene)piperidine;hydrochloride" n.a. n.a. Yes No No No No No PMDBD241 Cysteine-S-conjugates of xenobiotics Environmental Chemicals Unclassified Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD247 Dantrolene sodium salt Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 6604100 n.a. n.a. "DANTROLENE SODIUM; Dantrolene sodium salt; Dantrium; Sodium dantrolene; Dantrolene (sodium); 14663-23-1; Dantrolene, Sodium Salt; UNII-28F0G1E0VF; Dantamacrin; Dantrix; Dantrolene Sodium (anhydrous); Dantrolene sodium [USAN:BAN:JAN]; EINECS 238-706-8; Dantrolene sodium anhydrous; 28F0G1E0VF; 1-((5-(p-Nitrophenyl)furfurylidene)amino)hydantoin sodium; Ryanodex; F 440; Dantrolene sodium hemiheptahydrate; 2,4-Imidazolidinedione, 1-(((5-(4-nitrophenyl)-2-furanyl)methylene)amino)-, sodium salt; 24868-20-0; Dantrolene Sodium Hydrate" C14H9N4NaO5 KSRLIXGNPXAZHD-HAZZGOGXSA-M "sodium;3-[(E)-[5-(4-nitrophenyl)furan-2-yl]methylideneamino]-2-oxo-4H-imidazol-5-olate" n.a. n.a. Yes No No No No No PMDBD248 Darifenacin hydrobromide Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 444030 n.a. n.a. "Darifenacin hydrobromide; darifenacin HBr; 133099-07-7; Darifenacin (hydrobromide); Emselex; UNII-CR02EYQ8GV; UK 88525-04 hydrobromide; CR02EYQ8GV; CHEBI:31455; UK-88525-04; DSSTox_RID_81899; DSSTox_CID_26780; DSSTox_GSID_46780; (S)-2-{1-(2-(2,3-Dihydrobenzofuran-5-yl)ethyl)-3-pyrrolidnyl}-2,2-diphenylacetamide hydrobromide; (S)-2-(1-(2-(2,3-dihydrobenzofuran-5-yl)ethyl)pyrrolidin-3-yl)-2,2-diphenylacetamide h" C28H31BrN2O2 UQAVIASOPREUIT-VQIWEWKSSA-N "2-[(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl]-2,2-diphenylacetamide;hydrobromide" n.a. n.a. Yes No No No No No PMDBD250 Daunorubicin hydrochloride Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 62770 n.a. n.a. "23541-50-6; DAUNORUBICIN HCL; DAUNORUBICIN HYDROCHLORIDE; Daunomycin hydrochloride; Cerubidine; Daunoblastina; Ondena; Daunomycin HCL; Rubidomycin hydrochloride; daunorubicinol hydrochloride; RP 13057 hydrochloride; Daunoblastin; Rubomycin; Daunomycin chlorohydrate; Daunomycin, hydrochloride; UNII-UD984I04LZ; Daunorubicin (Hydrochloride); CCRIS 915; EINECS 245-723-4; C27H29NO10.HCl; AI3-44887; UD984I04LZ; NDC 0082-4155; (1S,3S)-3-Acetyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1-naphthacenyl 3-amino-2,3,6-tr" C27H30ClNO10 GUGHGUXZJWAIAS-QQYBVWGSSA-N "(7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride" n.a. n.a. Yes No Yes No No No PMDBD251 Dealcoholized red wine Dietary Substance Drinks n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD254 Demecarium bromide Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 5965 n.a. n.a. "DEMECARIUM BROMIDE; 56-94-0; Humorsol; Visumatic; Tosmilen; Frumtosnil; Tosmilene; Visumiotic; Tosmicil; Tonilen; Demekastigmine bromide; Demekarium bromide; Demecarii bromidum; Bromuro de demecario; Bromure de demecarium; Demecarii bromidum [INN-Latin]; BC 48; UNII-61D5V4OKTP; Bromuro de demecario [INN-Spanish]; Bromure de demecarium [INN-French]; HSDB 2168; EINECS 200-301-9; 3,3''-(((Decane-1,10-diylbis(methylazanediyl))bis(carbonyl))bis(oxy))bis(N,N,N-trimethylbenzenaminium) bromide; 61D5V4OKTP; (m-Hydroxyphenyl)trimethylammoniu" C32H52Br2N4O4 YHKBUDZECQDYBR-UHFFFAOYSA-L "trimethyl-[3-[methyl-[10-[methyl-[3-(trimethylazaniumyl)phenoxy]carbonylamino]decyl]carbamoyl]oxyphenyl]azanium;dibromide" n.a. n.a. Yes No No No No No PMDBD255 Demeclocycline hydrochloride Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 54686764 n.a. n.a. "DEMECLOCYCLINE HYDROCHLORIDE; 64-73-3; Demeclocycline HCL; Detravis; Clortetrin; Ledermycine; Ledermicina; Veraciclina; Elkamicina; Detracin; Demeplus; 7-Chloro-6-demethyltetracycline hydrochloride; Declomycin hydrochloride; Ledermycin; Demeclocycline (hydrochloride); Demethylchlortetracycline hydrochloride; UNII-29O079NTYT; 6-Demethyl-7-chlorotetracycline hydrochloride; Demethylchlorotetracycline hydrochloride; Mexocine; EINECS 200-592-2; MLS000028422; Demeclocycline hydrochloride (internal use); 29O079NTYT; CHEBI:59725" C21H22Cl2N2O8 OAPVUSSHCBRCOL-KBHRXELFSA-N "(4S,4aS,5aS,6S,12aR)-7-chloro-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide;hydrochloride" n.a. n.a. Yes No Yes No No No PMDBD256 Deptropine citrate Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 6604492 n.a. n.a. "Deptropine citrate; Deptropine dihydrogen citrate; UNII-05LW13XKKR; 05LW13XKKR; Deptrin; Brontina; CHEBI:50190; NCGC00017039-01; CAS-2169-75-7; DIBENZHEPTROPINE CITRATE; 2169-75-7; EINECS 218-516-1; Deptropine FNA; NSC 169431; DSSTox_RID_80954; DSSTox_CID_25557; DSSTox_GSID_45557; SCHEMBL466848; CHEMBL1475191; 3-alpha-(10,11-Dihydro-5H-dibenzo(a,d)cyclohepten-5-yloxy)tropane citrate; DTXSID4045557; CHEMBL2107603; 3-(10,11-Dihydro-5H-dibenzo(a,d)cyclohepten-5-yloxy)tropane citrate; Tropane, 3alpha-((10,11-dihydro-5H-dibenzo(a,d)cy" C29H35NO8 CHQGYMXXKZPWOI-IIPFOPBBSA-N "2-hydroxypropane-1,2,3-tricarboxylic acid;(1R,5S)-8-methyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,11,13-hexaenyloxy)-8-azabicyclo[3.2.1]octane" n.a. n.a. Yes No No No No No PMDBD257 Dequalinium dichloride Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 10649 n.a. n.a. "dequalinium chloride; 522-51-0; Dequalinium Dichloride; Dequafungan; Decabis; Danical; Gorgine; Decosan; Dekuarin; Optipect; Grocreme; Erosept; Eriosept; Decaminum; Phylletten; Vaster; Evazol; Efisol; Angils; Dequalinium (Chloride); Dequalinii chloridum; Rumilet; Labosept; Dekamin; Sentril; Sanoral; Polycidine; Dequavet; Dequavagyn; Dekadin; Decamine; Oralgol; Dequadin; Ivazil; Cloruro de decalinio; Sorot; BAQD 10; Dequalin chloride; Chlorure de dequalinium; Dynexan-mhp; Dequalinum Chloride; Decamine (pharmaceutical); UNII-XYS8INN1I6; Dequalinio clo" C30H40Cl2N4 LTNZEXKYNRNOGT-UHFFFAOYSA-N "1-[10-(4-amino-2-methylquinolin-1-ium-1-yl)decyl]-2-methylquinolin-1-ium-4-amine;dichloride" n.a. n.a. Yes No Yes No No No PMDBD258 Deshipu stachyose granules Dietary Substance Dietary Compounds n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD261 Diacetamate Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 17499 n.a. n.a. "Diacetamate; 2623-33-8; 4-Acetamidophenyl acetate; 4''-Acetoxyacetanilide; Acetaminophen acetate; 4-Acetoxyacetanilide; P-ACETOXYACETANILIDE; N,O-Diacetyl-4-aminophenol; Diacetamat; 4-(Acetylamino)phenyl acetate; N-Acetyl-4-aminophenyl acetate; UNII-BFG1TY61BG; NSC 6083; (4-acetamidophenyl) acetate; NSC 33893; N-[4-(Acetyloxy)phenyl]acetamide; BFG1TY61BG; Acetaminophen Acetate (Acetaminophen Impurity); NCGC00160605-01; Acetanilide, acetate (ester); Diacetam" C10H11NO3 UJAOSPFULOFZRR-UHFFFAOYSA-N (4-acetamidophenyl) acetate n.a. n.a. No Yes No No No No PMDBD264 Dicloxacillin sodium salt hydrate Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 23675786 n.a. n.a. "Dicloxacillin sodium; DICLOXACILLIN SODIUM MONOHYDRATE; Dicloxacillin sodium hydrate; 13412-64-1; Dicloxacillin sodium salt hydrate; Pathocil; Diclocil; Dycill; Brispen; Dicloxacillin sodium salt monohydrate; Dynapen; Digloxilline; Stampen; Noxaben; Biocloxin; Constaphyl; Novapen; Diflor; Clocil; Ciclex; BRL-1702; Pen-Sint; Sodium dicloxacillin monohydrate; Staphcillin A banyu; Sodium dicloxacillin hydrate; Dichlorstapenor sodium; MDI-PC; Bayer 5488; UNII-4HZT2V9KX0; BLP-1011; Dicloxacillin (Sodium hydrate); CHEBI:52019; 4HZT2V9KX0; P-1011" C19H18Cl2N3NaO6S SIGZQNJITOWQEF-VICXVTCVSA-M "sodium;(2S,5R,6R)-6-[[3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate;hydrate" n.a. n.a. Yes No Yes No No No PMDBD267 Dicyclomine hydrochloride Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 441344 n.a. n.a. "Dicyclomine hydrochloride; Dicyclomine Hcl; 67-92-5; Dicycloverine hydrochloride; Procyclomin; Stannitol; Spasmoject; Icramin; Bentomine; Sawamin; Mamiesan; Benacol; Antispas; Dyspas; Atumin; Dibent; Ametil; Oxityl-P; Wyovin hydrochloride; Diocyl hydrochloride; Merbentyl; Kolantyl hydrochloride; Dicyclomine (hydrochloride); UNII-CQ903KQA31; BENTYL PRESERVATIVE FREE; Dicycloverin hydrochloride; 2-Diethylaminoethyl bicyclohexyl-1-carboxylate hydrochloride; Bentyl hydrochloride; EINECS 200-671-1; NSC 404381; Bentylol hydrochloride; MLS00002" C19H36ClNO2 GUBNMFJOJGDCEL-UHFFFAOYSA-N "2-(diethylamino)ethyl 1-cyclohexylcyclohexane-1-carboxylate;hydrochloride" n.a. n.a. Yes No No No No No PMDBD269 Diet rich in fiber Dietary Substance Foods n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD270 Dietary choline Dietary Substance Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD271 Dietary fiber Dietary Substance Dietary Compounds n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD272 Dietary phosphatidylcholine Dietary Substance Dietary Compounds n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD274 Diflorasone diacetate Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 71414 n.a. n.a. "Diflorasone diacetate; 33564-31-7; Florone E; Apexicon e; Psorcon; Diflorasone di(acetate); UNII-7W2J09SCWX; EINECS 251-575-1; BRN 2318163; 7W2J09SCWX; MLS001076548; MLS000069559; CHEBI:31483; 6alpha,9-Difluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17,21-diacetate; NCGC00022003-03; SMR000058814; 6alpha-Fluorobetamethasone-17,21 diacetate; DSSTox_RID_81024; DSSTox_CID_25646; U-34865; DSSTox_GSID_45646" C26H32F2O7 BOBLHFUVNSFZPJ-JOYXJVLSSA-N [2-[(6S,8S,9R,10S,11S,13S,14S,16S,17R)-17-acetyloxy-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate n.a. n.a. No Yes No Yes No No PMDBD277 Dihydrodaidzein Herbal Substance Medicinal Herbal Compounds n.a. n.a. n.a. n.a. n.a. 176907 n.a. n.a. "dihydrodaidzein; 17238-05-0; 7-hydroxy-3-(4-hydroxyphenyl)chroman-4-one; Dihydrodaidzein (keto); Dihydrodazein; (+/-)-Dihydrodaidzein; 7,4''-Dihydroxyisoflavanone; 2,3-dihydro-7-hydroxy-3-(4-hydroxyphenyl)-4H-1-Benzopyran-4-one; 7-hydroxy-3-(4-hydroxyphenyl)-2,3-dihydro-4H-chromen-4-one; 4'',7-dihydroxy-Isoflavanone; SCHEMBL131543; (R,S)-2,3-Dihydrodaidzein; SCHEMBL16152440; CHEBI:75842; CTK8C3008; DTXSID70912308; BID0517; ZX-AFC001619; HY-N1461; ANW-69504; LMPK12050447; ACM17238050; AK-61048; LS-19336" C15H12O4 JHYXBPPMXZIHKG-UHFFFAOYSA-N 7-hydroxy-3-(4-hydroxyphenyl)-2,3-dihydrochromen-4-one n.a. n.a. No Yes No No No No PMDBD279 Dihydroxyphenylalanine (DOPA) Therapeutic Substance Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD282 Dimethisoquin hydrochloride Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 176907 n.a. n.a. "dihydrodaidzein; 17238-05-0; 7-hydroxy-3-(4-hydroxyphenyl)chroman-4-one; Dihydrodaidzein (keto); Dihydrodazein; (+/-)-Dihydrodaidzein; 7,4''-Dihydroxyisoflavanone; 2,3-dihydro-7-hydroxy-3-(4-hydroxyphenyl)-4H-1-Benzopyran-4-one; 7-hydroxy-3-(4-hydroxyphenyl)-2,3-dihydro-4H-chromen-4-one; 4'',7-dihydroxy-Isoflavanone; SCHEMBL131543; (R,S)-2,3-Dihydrodaidzein; SCHEMBL16152440; CHEBI:75842; CTK8C3008; DTXSID70912308; BID0517; ZX-AFC001619; HY-N1461; ANW-69504; LMPK12050447; ACM17238050; AK-61048; LS-19336" C15H12O4 JHYXBPPMXZIHKG-UHFFFAOYSA-N 7-hydroxy-3-(4-hydroxyphenyl)-2,3-dihydrochromen-4-one n.a. n.a. Yes No No No No No PMDBD289 Doxazosin mesylate Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 62978 n.a. n.a. "Doxazosin mesylate; 77883-43-3; Cardura; Carduran; Cardular; Cardura XL; Tensiobas; Doxazomerck; Dedralen; Cardenalin; Progandol; Diblocin; Doxazosin AZU; Prostadilat; Kaltensif; Doxolbran; Cardoxan; Cardoral; Alfadil; Normathen; Doxazosin (mesylate); Tonocardin; Doxaben; Doksura; Supressin; Benur; Diblocin Uro; Cardular Uro; Diblocin PP; Cardular PP; Doxazosin mesilate; HSDB 7082; MLS000028455; UK 33,274-27; (4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl)(2,3-dihydrobenzo[b][1,4]dioxin-2-yl)methanone methanesulfonate; SMR000058441" C24H29N5O8S VJECBOKJABCYMF-UHFFFAOYSA-N "[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(2,3-dihydro-1,4-benzodioxin-3-yl)methanone;methanesulfonic acid" n.a. n.a. Yes Yes No Yes No No PMDBD291 Doxorubicin hydrochloride Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 443939 n.a. n.a. "Doxorubicin Hydrochloride; 25316-40-9; Doxorubicin HCl; ADRIAMYCIN HYDROCHLORIDE; Adriblastina; Adriacin; Rubex; Doxorubicin (Adriamycin) HCl; Adriamycin PFS; Adriamycin RDF; Doxorubicin (hydrochloride); UNII-82F2G7BL4E; Hydroxydaunorubicin hydrochloride; Adriblastin; ADRIAMYCIN, HYDROCHLORIDE; Lipodox; MLS001401460; 82F2G7BL4E; NSC 123127; Hydroxydaunorubicin; SMR000058570; KW-125; DSSTox_RID_78854; DSSTox_RID_80678; DSSTox_CID_10636; DSSTox_GSID_30636; DSSTox_GSID_45111; CCRIS 740; Duxocin; Adrosal; EINECS 246-818-3; Adriamycin hydroch" C27H30ClNO11 MWWSFMDVAYGXBV-RUELKSSGSA-N "(7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride" n.a. n.a. Yes No Yes No No No PMDBD292 Doxycycline hydrochloride Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 54685920 n.a. n.a. "Doxycycline hydrochloride; Doxycycline HCl; 10592-13-9; Doxigalumicina; Doxylin; Doxycycline hyclate; Doxycycline (hydrochloride); Biocamycin; Tecacin; Samecin; Roximycin; Novadox; Midoxin; Mespafin; Liomycin; Tetradox; Nivocilin; Vibradox; Tanamicin; Idocyklin; Ecodox; UNII-4182Z6T2ET; Doxy-tablinen; Vibra-tabs; Vibramycin hyclate; Doxy-II; RETENS; Vibramycin hydrochloride; CHEBI:652992; 4182Z6T2ET; 24390-14-5; Doxycycline Hydrochloride [JAN]; Deoxyoxytetracycline hydrochloride; EINECS 234-198-7; Doxycycline, Hyclate; DSSTox_CID_25405; DSSTo" C22H25ClN2O8 PTNZGHXUZDHMIQ-CVHRZJFOSA-N "(4S,4aR,5S,5aR,6R,12aR)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide;hydrochloride" n.a. n.a. Yes No Yes No No No PMDBD296 Eburnamonine (-) Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 71203 n.a. n.a. "Vinburnine; (-)-Eburnamonine; Vincamone; eburnamonine; 4880-88-0; Eburnal; l-Eburnamonine; Eburnamonine (-); Eburnal ritardo; cis-Vincamone; Vinburnine [INN]; Vincamona [Spanish]; Vinburninum [INN-Latin]; Vinburnina [INN-Spanish]; UNII-G54D0HMY25; CH-846; (-)-Eburnamonina [Spanish]; 3-alpha,16-alpha-Eburnamonine; Eburnamonine (-)-form; EINECS 225-490-5; CH 846; NSC 322920; 3alpha,16alpha-Eburnamonine; G54D0HMY25; CHEBI:4740; (3alpha,16alpha)-Eburnamenin-14(15H)-one; (3-alpha,16-alpha)-Eburnamin-14(15H)-one; Vinburnine (INN); NSC322920" C19H22N2O WYJAPUKIYAZSEM-MOPGFXCFSA-N (15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18)-tetraen-17-one n.a. n.a. Yes No No No No No PMDBD297 Econazole nitrate Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 68589 n.a. n.a. "Econazole nitrate; 24169-02-6; Ifenec; Pevaryl; Gyno-pevaryl; Epi-pevaryl; Spectazole; Econazole (nitrate); Econazole nitrate salt; 68797-31-9; (+-)-Econazole nitrate; Gyno-Pevaryl 150; Palavale; NSC 243115; CCRIS 6031; R 14827; EINECS 246-053-5; MLS000028626; Econazole nitrate (Spectazole); SQ 13050; R 14,827; NSC-243115; SMR000058732; DSSTox_CID_5226; 1-(2,4-Dichloro-beta-((p-chlorobenzyl)oxy)phenethyl)imidazole nitrate; Imidazole, 1-(2,4-dichloro-beta-((p-chlorobenzyl)oxy)phenethyl)-, mononitrate; 1-(2-((4-Chlorophenyl)methoxy)-2" C18H16Cl3N3O4 DDXORDQKGIZAME-UHFFFAOYSA-N "1-[2-[(4-chlorophenyl)methoxy]-2-(2,4-dichlorophenyl)ethyl]imidazole;nitric acid" n.a. n.a. Yes No Yes No No No PMDBD301 Emulsifiers (P80 and CMC) Dietary Substance Dietary Compounds n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD302 Enalapril maleate Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 5388961 n.a. n.a. "Enalapril maleate; 76095-16-4; Renitec; Glioten; Crinoren; Benalapril; Renivace; Innovace; Naprilene; Baripril; Enapren; Dabonal; Vasotec; Xanef; Vapresan; Prilenap; Konveril; Inoprilat; Hipoartel; Enaprin; Enapril; Elfonal; Analept; Amprace; Repantril; Pressotec; Minipril; Lotrial; Vasopril; Tensazol; Ristalen; Regomed; Norpril; Neotensin; Naritec; Lipraken; Kenopril; Feliberal; Enalasyn; Enaladil; Enacard; Ecapril; Defluin; Coprilor; Converten; Controlvas; Biocronil; Alphrin; Acetensil; Reniten; Renavace; Invoril; Innovade; Eupressin; Enarenal; Enapres; Denapr" C24H32N2O9 OYFJQPXVCSSHAI-QFPUQLAESA-N "(Z)-but-2-enedioic acid;(2S)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid" n.a. n.a. No Yes No No No No PMDBD303 Enilconazole Therapeutic Substance Approved Drug (veterinary medicine) n.a. n.a. n.a. n.a. n.a. 37175 n.a. n.a. "IMAZALIL; Enilconazole; 35554-44-0; Deccozil; Chloramizol; Imaverol; Fungaflor; Eniloconazol (SP); Deccozil S 75; Enilconazole (BPC); Magnate; Fungazil; Florasan; Clinafarm; R 23979; 1-(2-(Allyloxy)-2-(2,4-dichlorophenyl)ethyl)-1H-imidazole; Enilconazol; Caswell No. 497AB; CGA 41333; Imazalil [ANSI:BSI:ISO]; C14H14Cl2N2O; 1-[2-(2,4-dichlorophenyl)-2-prop-2-enoxyethyl]imidazole; Enilconazole [USAN:BAN:INN]; CHEBI:83829; HSDB 6672; EINECS 252-615-0" C14H14Cl2N2O PZBPKYOVPCNPJY-UHFFFAOYSA-N 1-[2-(2,4-dichlorophenyl)-2-prop-2-enoxyethyl]imidazole n.a. n.a. Yes No Yes No No No PMDBD309 Epimedium grandiflorum top (flavonoids) Herbal Substance Medicinal Herb n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD311 Ergonovine maleate Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 6437065 n.a. n.a. "Ergonovine maleate; ergometrine maleate; Metriclavin; Cornocentin; Ermetrin; Ergomet; Oxytocic; Ergometrine hydrogen maleate; Crude ergot; Ergometrine maleate (1:1); Ergotocin maleate; Ergometrin maleate; 129-51-1; Ergonovine hydrogen maleate; Ergotrate; D-Ergonovine maleate; Ergonovine, maleate (1:1); Ergometrine acid maleate; UNII-YMH3D0ZJWV; YMH3D0ZJWV; EINECS 204-953-5; Ergonovine, maleate (1:1) (salt); NSC 93752; Ergonovine maleate [USP]; CHEBI:31554; Ergotrate Maleate; Ergonovine maleate (USP); 9,10-Didehydro-N-((S)-2-hydroxy-1" C23H27N3O6 YREISLCRUMOYAY-IIPCNOPRSA-N "(6aR,9R)-N-[(2S)-1-hydroxypropan-2-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide;(Z)-but-2-enedioic acid" n.a. n.a. No Yes No No No No PMDBD312 Ergotamine tartrate Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 9787 n.a. n.a. "ergotamine tartrate; Ergotamine D-tartrate; Ergotamine bitartrate; UNII-MRU5XH3B48; 379-79-3; Gynergen; MRU5XH3B48; Cornutamin; Migretamine; Ergotartrate; Wigrettes; Secupan; Exmigra; Lingran; Lingraine; Secagyn; Femergin; Ergate; Avetol; Ergam; Neo-ergotin; Gotamine tartrate; Medihaler ergotamine; Rigetamin; Ergomar; Ergostat; Ergotamine hemitartrate; DSSTox_CID_5253; Ergotamine tartrate (VAN); ETIN; DSSTox_RID_77717; DSSTox_GSID_25253; CCRIS 487; Ergotamine, tartrate (2:1); Ergotamine tartrate (2:1) (salt); EINECS 206-835-9; NSC 41869; CAS-3" C70H76N10O16 CJMJLDQKTOJACI-BGQAIRJTSA-N "(6aR,9R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide;(2R,3R)-2,3-dihydroxybutanedioic acid" n.a. n.a. No Yes No No No No PMDBD317 Estropipate Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 5284555 n.a. n.a. "Estropipate; 7280-37-7; Piperazine estrone sulfate; Piperazine estronesulfate; Ogen; Harmogen; UNII-SVI38UY019; Ortho-Est; Sulestrex; SVI38UY019; Estra-1,3,5(10)-trien-17-one, 3-(sulfooxy)-, compd. with piperazine (1:1); OGEN 5; OGEN 2.5; OGEN 1.25; OGEN .625; EINECS 230-696-3; piperazine (8R,9S,13S,14S)-13-methyl-17-oxo-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-3-yl sulfate; Piperazine oestrone sulphate; Conjugated estrogens: piperazine estrone sulfate; Estrone hydrogen sulfate compound with piperazine" C22H32N2O5S HZEQBCVBILBTEP-ZFINNJDLSA-N "[(8R,9S,13S,14S)-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate;piperazine" n.a. n.a. Yes Yes No No No No PMDBD320 Ethaverine hydrochloride Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 5702159 n.a. n.a. "Ethaverine hydrochloride; 985-13-7; Ethaquin; Consenil; Papetherine; Laverin; Neopavrin; Paveroid; Isovex; Cebral; ETHAVERINE HCl; Perperine; Perparine; Perparin; Barbonin hydrochloride; UNII-6Z6T599E49; Perparin hydrochloride; Perperine hydrochloride; Perparine hydrochloride; Papetherine hydrochloride; 1-(3,4-Diethoxybenzyl)-6,7-diethoxyisoquinoline hydrochloride; 6Z6T599E49; EINECS 213-573-9; NSC 525044; DSSTox_RID_82536; DSSTox_CID_27759; DSSTox_GSID_47779; 6,7-Diethoxy-1-(3,4-diethoxybenzyl)isoquinoline hydrochloride; ISOQUINOLINE" C24H30ClNO4 UPUDVKWQBVIKBG-UHFFFAOYSA-N "1-[(3,4-diethoxyphenyl)methyl]-6,7-diethoxyisoquinoline;hydrochloride" n.a. n.a. Yes No No No No No PMDBD321 Ethopropazine Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 3290 n.a. n.a. "ethopropazine; Profenamine; Parsidol; Isothiazine; Ethopromazine; Isothazine; Prophenaminum; Prophenamine; Phenopropazine; Parsitan; Parkin; Profenaminum; Parsotil; Parfezine; Rodipal; Isopthazine; Profenamina; Ethapropazine; Profenamina [Italian]; Fempropazine; Isotazin; Profenaminum [INN-Latin]; Profenamina [INN-Spanish]; 522-00-9; 10-(2-Diethylaminopropyl)phenothiazine; Profenamine [INN:BAN]; 2-Diethylamino-1-propyl-N-dibenzoparathiazine; SKF 2538; RP 3356; SC 2538; N,N-Diethyl-alpha-methyl-10H-phenothiazine-10-ethanamine; 10-[2-(Diet" C19H24N2S CDOZDBSBBXSXLB-UHFFFAOYSA-N N,N-diethyl-1-phenothiazin-10-ylpropan-2-amine n.a. n.a. No Yes No Yes No No PMDBD322 Ethopropazine hydrochloride Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 122824 n.a. n.a. "Ethopropazine hydrochloride; Profenamine hydrochloride; 1094-08-2; Profenamine HCl; Ethopropazine HCl; Pardisol; Lysivane; Parphezein; Parfezin; Dibutil; Profenamine monohydrochloride; Parphezin; Isothazine hydrochloride; Parsidol (VAN); Lysivane hydrochloride; Parsidol hydrochloride; Parsidol monohydrochloride; 10-(2-(Diethylamino)propyl)phenothiazine monohydrochloride; EINECS 214-134-4; NSC 64074; NSC 169467; N,N-Diethyl-alpha-methyl-10H-phenothiazine-10-ethylamine monohydrochloride; ethopropazine monohydrochloride; CHEMBL12009" C19H25ClN2S VXPCQISYVPFYRK-UHFFFAOYSA-N "N,N-diethyl-1-phenothiazin-10-ylpropan-2-amine;hydrochloride" n.a. n.a. Yes No Yes No No No PMDBD330 Fadrozole hydrochloride Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 59694 n.a. n.a. "FADROZOLE HYDROCHLORIDE; 102676-31-3; Afema; Fadrozole HCl; CGS 16949A; Fadrozole.HCl; CGS 16949; 4-(5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl)benzonitrile hydrochloride; CCRIS 4597; Fadrozole hydrochloride [USAN]; CHEMBL468419; 4-(5,6,7,8-Tetrahydroimidazo(1,5-a)pyridin-5-yl)benzonitrile monohydrochloride; Fadrozole hydrochloride (USAN); Benzonitrile, 4-(5,6,7,8-tetrahydroimidazo(1,5-a)pyridin-5-yl)-, monohydrochloride; Fadrozole monohydrochloride; Arensin; 4-(5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl)-Benzonitrile" C14H14ClN3 UKCVAQGKEOJTSR-UHFFFAOYSA-N "4-(5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl)benzonitrile;hydrochloride" n.a. n.a. Yes No Yes No No No PMDBD333 Famprofazone Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 3326 n.a. n.a. "Famprofazone; 22881-35-2; Famprofazonum; Famprofazon; Famprofazone [INN:BAN]; Famprofazonum [INN-Latin]; Famprofazona [INN-Spanish]; EINECS 245-284-9; BRN 5768367; C24H31N3O; DSSTox_RID_80877; DSSTox_CID_25435; 3-(N-Methyl-(alpha-methyl-beta-phenyl)-e" C24H31N3O GNUXVOXXWGNPIV-UHFFFAOYSA-N 1-methyl-5-[[methyl(1-phenylpropan-2-yl)amino]methyl]-2-phenyl-4-propan-2-ylpyrazol-3-one n.a. n.a. Yes Yes No No No No PMDBD338 Fendiline hydrochloride Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 5702162 n.a. n.a. "Fendiline hydrochloride; 13636-18-5; Fendiline HCl; Fendiline (hydrochloride); MLS000069570; 3,3-diphenyl-N-(1-phenylethyl)propan-1-amine hydrochloride; NCGC00094891-01; SMR000058827; DSSTox_CID_25860; DSSTox_RID_81180; DSSTox_GSID_45860; SR-01000003123; NCGC00018223-06; 3,3-diphenyl-N-(1-phenylethyl)propan-1-amine;hydrochloride; Prestwick_568; Sensit (TN); Fendiline(hydrochloride); Opera_ID_555; CAS-13636-18-5; MLS002222223; MLS001076126; SPECTRUM1501026; SCHEMBL666530; CHEMBL1405922; DTXSID2045860; CTK8F9736; REGID_for_CID_5702162" C23H26ClN NJXWZWXCHBNOOG-UHFFFAOYSA-N "3,3-diphenyl-N-(1-phenylethyl)propan-1-amine;hydrochloride" n.a. n.a. Yes No No No No No PMDBD343 Fermentable fibre (inulin) Dietary Substance Dietary Compounds n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD344 Fermented aqueous soy extract (by Enterococcus faecium and Lactobacillus helveticus) Dietary Substance Dietary Compounds n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD345 Fermented soy milk Dietary Substance Drinks n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD346 Fermented soy milk (by Enterococcus faecium) Dietary Substance Drinks n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD347 Fermented soy milk (by Lactobacillus plantarum) Dietary Substance Drinks n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD348 Fermented soy product Dietary Substance Drinks n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD349 Fermented soybean milk Dietary Substance Drinks n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD350 Fexofenadine HCl Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 63002 n.a. n.a. "FEXOFENADINE HYDROCHLORIDE; 153439-40-8; FEXOFENADINE HCL; Allegra; Telfast; 2-(4-(1-Hydroxy-4-(4-(hydroxydiphenylmethyl)piperidin-1-yl)butyl)phenyl)-2-methylpropanoic acid hydrochloride; MDL 16,455A; Fexofenadine (hydrochloride); 138452-21-8; Fexofenidine hydrochloride; Terfenadine carboxylate hydrochloride; MDL 16455; MDL-16455A; MDL-16455; DSSTox_CID_28642; C32H40ClNO4; DSSTox_RID_82912; DSSTox_GSID_48716; 2-(4-{1-hydroxy-4-[4-(hydroxydiphenylmethyl)piperidin-1-yl]butyl}phenyl)-2-methylpropanoic acid hydrochloride; 2-[4-[1" C32H40ClNO4 RRJFVPUCXDGFJB-UHFFFAOYSA-N "2-[4-[1-hydroxy-4-[4-[hydroxy(diphenyl)methyl]piperidin-1-yl]butyl]phenyl]-2-methylpropanoic acid;hydrochloride" n.a. n.a. Yes No No No No No PMDBD351 Fibre Dietary Substance Dietary Compounds n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD356 Flucloxacillin sodium Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 23667629 n.a. n.a. "flucloxacillin sodium; 1847-24-1; Floxacillin sodium; Floxapen sodium; Flucloxacillin sodium salt; Floxacillin Na salt; Sodium flucloxacillin; Monosodium flucloxacillin; Stafopen sodium salt; Staphylex Sodium salt; MFI-PC; UNII-05F65O42VK; EINECS 217-428-0; Flucloxacillin-Sodium; NSC 277175; Floxacillin sodium salt; CHEBI:31615; 05F65O42VK; Floxapen (TN); 5-Methyl-3-(2-chloro-6-fluorophenyl)-4-isoxazolylpenicillin sodium; 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(((3-(2-chloro-6-fluorophenyl)-5-methyl-4-isoxazoly" C19H16ClFN3NaO5S OTEANHMVDHZOPB-SLINCCQESA-M "sodium;(2S,5R,6R)-6-[[3-(2-chloro-6-fluorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate" n.a. n.a. Yes No Yes No No No PMDBD362 Flunarizine dihydrochloride Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 5282407 n.a. n.a. "Flunarizine dihydrochloride; 30484-77-6; flunarizine hydrochloride; Flunarizine 2HCl; Flunarizine HCl; Flunarizine diHCl; Flunarizine (dihydrochloride); KW-3149; UNII-C11102TO53; 1-(Bis(4-fluorophenyl)methyl)-4-cinnamylpiperazine dihydrochloride; EINECS 250-216-6; Flunarizine hydrochloride [USAN:JAN]; R 14950; C11102TO53; 27064-95-5; (E)-1-(Bis-(p-fluorophenyl)methyl)-4-cinnamylpiperazine dihydrochloride; 1-[Bis(4-fluorophenyl)methyl]-4-(3-phenyl-2-propenyl)piperazine dihydrochloride" C26H28Cl2F2N2 RXKMOPXNWTYEHI-RDRKJGRWSA-N "1-[bis(4-fluorophenyl)methyl]-4-[(E)-3-phenylprop-2-enyl]piperazine;dihydrochloride" n.a. n.a. Yes No No No No No PMDBD363 Flunixin meglumine Therapeutic Substance Approved Drug (veterinary medicine) n.a. n.a. n.a. n.a. n.a. 39212 n.a. n.a. "FLUNIXIN MEGLUMINE; 42461-84-7; Flunixin meglumin; Banamine; Flumeglumine; Flunixin-S; Sch 14714 meglumine; Flunixin N-methylglucanine; Flunixin (meglumine); Banamine (Veterinary); UNII-8Y3JK0JW3U; Sch-14714 meglumine; EINECS 255-836-0; 8Y3JK0JW3U; finadyne; CHEBI:76144; 2-[[2-Methyl-3-(trifluoromethyl)phenyl]amino]-3-pyridinecarboxylic acid meglumine salt; 1-Deoxy-1-(methylamino)-D-glucitol 2-(2-methyl-3-(perfluoromethyl)anilino)nicotinate; 2-(alpha(sup 3),alpha(sup 3),alpha(sup 3)-Trifluoro-2,3-xylidino)nicotinic acid comp" C21H28F3N3O7 MGCCHNLNRBULBU-WZTVWXICSA-N "(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol;2-[2-methyl-3-(trifluoromethyl)anilino]pyridine-3-carboxylic acid" n.a. n.a. Yes No No No No No PMDBD368 Fluphenazine dihydrochloride Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 67356 n.a. n.a. "Fluphenazine dihydrochloride; Fluphenazine hydrochloride; 146-56-5; Prolixin; Anatensol; Permitil; Moditen; Tensofin; Fluphenazine (dihydrochloride); OMCA; Lyorodin; Mirenil; Trancin; Liogen; FLUPHENAZINE HCL; Squibb 4918; Flufenazin; Calmansial; Fluphenazine chloride; Permitil hydrochloride; UNII-ZOU145W1XL; Fluorophenazine dihydrochloride; Dapotum; CCRIS 4032; EINECS 205-674-1; NSC 179197; ZOU145W1XL; Valamina; MFCD00055212; 1-(2-Hydroxyethyl)-4-(3-(2-trifluoromethyl-10-phenothiazinylpropyl)piperazine dihydrochloride; A 4077" C22H28Cl2F3N3OS MBHNWCYEGXQEIT-UHFFFAOYSA-N "2-[4-[3-[2-(trifluoromethyl)phenothiazin-10-yl]propyl]piperazin-1-yl]ethanol;dihydrochloride" n.a. n.a. Yes No No No No No PMDBD369 Fluspirilen Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 3396 n.a. n.a. "Fluspirilene; Redeptin; Imap; 1841-19-6; Fluspirilen; Fluspirilenum [INN-Latin]; Fluspirileno [INN-Spanish]; McN-JR-6218; Fluspiriline; R 6218; 8-[4,4-bis(4-fluorophenyl)butyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one; Fluspirilene [USAN:INN:BAN]; UNII-C5QA4GLR9M; EINECS 217-418-6; C5QA4GLR9M; BRN 0633853; 1-Phenyl-4-oxo-8-(4,4-bis(4-fluorophenyl)butyl)-1,3,8-triazaspiro(4,5)decane; CHEMBL46516; R-6218; 8-(4,4-Bis(p-fluorophenyl)butyl)-1-phenyl-1,3,8-triazaspiro-(4.5)decan-4-one; NCGC00015424-11; NCGC00015424-04; Fluspirilenum" C29H31F2N3O QOYHHIBFXOOADH-UHFFFAOYSA-N 8-[4,4-bis(4-fluorophenyl)butyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one n.a. n.a. Yes No No No No No PMDBD370 Fluvoxamine maleate Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 9560989 n.a. n.a. "FLUVOXAMINE MALEATE; Luvox; 61718-82-9; Fevarin; Luvox CR; Fluvoxamine (maleate); UNII-5LGN83G74V; DU23000; SME 3110; DU-23000; 5LGN83G74V; 54739-18-3; Floxyfral; Faverin; (E)-5-Methoxy-1-(4-(trifluoromethyl)phenyl)pentan-1-one O-(2-aminoethyl) oxime maleate; 5-Methoxy-4''-trifluoromethylvalerophenone (E)-O-2-aminoethyloxime monomaleate; 5-Methoxy-4''-(trifluoromethyl)valerophenone (E)-O-(2-aminoethyl)oxime, maleate (1:1); 54739-20-7; 1-Pentanone, 5-methoxy-1-(4-(trifluoromethyl)phenyl)-, O-(2-aminoethyl)oxime, (E)-, (Z)-2-but" C19H25F3N2O6 LFMYNZPAVPMEGP-PIDGMYBPSA-N "(Z)-but-2-enedioic acid;2-[(E)-[5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene]amino]oxyethanamine" n.a. n.a. No Yes No Yes No No PMDBD373 Freeze-dried doenjang Dietary Substance Foods n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD374 Furaltadone hydrochloride Therapeutic Substance Approved Drug (veterinary medicine) n.a. n.a. n.a. n.a. n.a. 9576185 n.a. n.a. "Furaltadone hydrochloride; Furaltadone HCl; 3759-92-0; Furasol hydrochloride; Furaltadone (hydrochloride); NF-260; NF-902 hydrochloride; NSC 53270; levo-5-(Morpholinomethyl)-3-((5-nitrofurfurylidene)amino)-2-oxazolidinone hydrochloride; 2-Oxazolidinone, 5-(morpholinomethyl)-3-((5-nitrofurfurylidene)amino)-, L-, monohydrochloride; CCRIS 1041; EINECS 223-169-4; NF-269; 2-Oxazolidinone,5-(4-morpholinylmethyl)-3-[[(5-nitro-2-furanyl)methylene]amino]-,monohydrochloride; 3031-51-4; 2818-22-6; C13H16N4O6.HCl; C13H16N4O6.ClH; SR-010" C13H17ClN4O6 PPSVFZXMDMUIGB-FJUODKGNSA-N "5-(morpholin-4-ylmethyl)-3-[(E)-(5-nitrofuran-2-yl)methylideneamino]-1,3-oxazolidin-2-one;hydrochloride" n.a. n.a. Yes No Yes No No No PMDBD376 Fusidic acid sodium salt Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 23672955 n.a. n.a. "Fusidate sodium; Sodium fusidate; 751-94-0; FUSIDIC ACID SODIUM SALT; Sodium fusidin; Fucidine; Fucidina; Intertulle fucidin; Fusidic acid sodium; ZN 6-NA; Fusidin; Fusidate Sodium [USAN]; Fusidic acid, sodium salt; Fusidic acid (sodium salt); UNII-J7P3696BCQ; SQ-16360; SQ 16360; EINECS 212-030-3; J7P3696BCQ; Fusidate sodium (USAN); Sodium 3alpha,11alpha,16beta-trihydroxy-29-nor-8alpha,9beta,13alpha,14beta-dammara-17(20),24-dien-21-oate 16-acetate; Fusin; SMR000326707; 29-Nordammara-17(20),24-dien-21-oic acid, 16-(acetyloxy)-3,11" C31H47NaO6 HJHVQCXHVMGZNC-JCJNLNMISA-M "sodium;(2Z)-2-[(3R,4S,5S,8S,9S,10S,11R,13R,14S,16S)-16-acetyloxy-3,11-dihydroxy-4,8,10,14-tetramethyl-2,3,4,5,6,7,9,11,12,13,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ylidene]-6-methylhept-5-enoate" n.a. n.a. Yes No Yes No No No PMDBD379 Ganoderma lucidum Herbal Substance Medicinal Herb n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD381 GBR 12909 dihydrochloride Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 104920 n.a. n.a. "67469-78-7; Vanoxerine dihydrochloride; GBR 12909 dihydrochloride; Vanoxeamine; Vanoxerine hydrochloride; GBR-12909 dihydrochloride; GBR-12909; Vanoxerine dihydrochloride(GBR12909); UNII-MWO1IP03EV; Vanoxerine 2HCl; I 893; I-893; 1-(2-(bis(4-fluorophenyl)methoxy)ethyl)-4-(3-phenylpropyl)piperazine dihydrochloride; MWO1IP03EV; GBR12909 dihydrochloride; 1-{2-[bis(4-fluorophenyl)methoxy]ethyl}-4-(3-phenylpropyl)piperazine dihydrochloride; 1-(2-[bis(4-Fluorophenyl)methoxy]ethyl)-4-(3-phenylpropyl)piperazine dihydrochloride; CHE" C28H34Cl2F2N2O MIBSKSYCRFWIRU-UHFFFAOYSA-N "1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine;dihydrochloride" n.a. n.a. Yes No No No No No PMDBD383 Gegen Qilian decoction Herbal Substance TCM Formula n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No Yes No No No PMDBD388 Gentamicine sulfate Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 6419933 n.a. n.a. "Gentamicine sulfate; Gentamicin, sulfate (salt); Gentamicin sulfate salt; GENTAMICIN SULPHATE; Prestwick_240; CHEMBL1200643; EBD9010; HMS1568O22; HMS3712O22; HMS2095O22; AKOS026750085; CCG-220160; gentamicin sulfate (water content 10%); AS-35221; AB0089061; J10041; SR-01000872641; 405G410; SR-01000872641-1; Gentamicin sulfate, meets EP, USP testing specifications; Gentamicin sulfate, meets USP testing specifications, powder; Gentamicin sulfate, European Pharmacopoeia (EP) Reference Standard; Gentamicin sulfate salt, potency: >" C60H125N15O25S RDEIXVOBVLKYNT-HDZPSJEVSA-N "(2R,3R,4R,5R)-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,6S)-3-amino-6-[(1R)-1-aminoethyl]oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol;(2R,3R,4R,5R)-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,6S)-3-amino-6-(aminomethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol;(2R,3R,4R,5R)-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,6S)-3-amino-6-[(1R)-1-(methylamino)ethyl]oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol;sulfuric aci" n.a. n.a. Yes No No No No No PMDBD395 Ginsenoside Rg3 Herbal Substance Medicinal Herbal Compounds n.a. n.a. n.a. n.a. n.a. 9918693 n.a. n.a. "Ginsenoside Rg3; 14197-60-5; (20S)-Propanaxadiol; 20S-propanaxadiol; (20S)-ginsenoside Rg3; 20(S)-Propanaxidiol; UNII-227D367Y57; 20(S)-Ginsenoside Rg3; CHEMBL398412; CHEBI:67991; 227D367Y57; 20(S)-Ginsenoside-Rg3; 20s-ginsenoside rg3; (R)Ginsenoside-Rg3; (3beta,12beta)-12,20-dihydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside; Rg3; Ginsenoside Rg3,(S); 2''(R)-Ginsenoside-Rg3; GTPL7658; (2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-2-[[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-17-[(2S)-2-hydroxy" C42H72O13 RWXIFXNRCLMQCD-JBVRGBGGSA-N (2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-2-[[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-17-[(2S)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-6-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol n.a. n.a. No Yes No No No No PMDBD398 Glafenine hydrochloride Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 3085326 n.a. n.a. "Glafenine hydrochloride; 65513-72-6; Glafenin hydrochloride; glafenine HCl; Glafenine (hydrochloride); DSSTox_CID_25497; DSSTox_RID_80916; DSSTox_GSID_45497; SR-01000473478; C19H17ClN2O4.ClH; Prestwick_628; Glafenine(hydrochloride); NCGC00016909-01; CAS-65513-72-6; MLS002154254; SCHEMBL970807; CHEMBL1572751; DTXSID7045497; KS-00001FBC; HY-B1153A; CTK8G0041; HMS1568L08; Tox21_110678; 2430AH; Tox21_110678_1; AKOS024374941; MCULE-3160845237; CCG-220293; CS-6517; Benzoic acid, 2-((7-chloro-4-quinolinyl)amino)-, 2,3-dihydroxypropyl ester, m" C19H18Cl2N2O4 CEUMONXVSJOJIH-UHFFFAOYSA-N "2,3-dihydroxypropyl 2-[(7-chloroquinolin-4-yl)amino]benzoate;hydrochloride" n.a. n.a. Yes No Yes No No No PMDBD402 Glucuronidated compound Environmental Chemicals Unclassified Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No Yes No No PMDBD403 Glucuronides Environmental Chemicals Environmental Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No Yes No No PMDBD404 Gluten Dietary Substance Dietary Compounds n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No Yes No No PMDBD406 Glycyrrhiza uralensis Herbal Substance Medicinal Herb n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD409 Grape antioxidant dietary fiber Dietary Substance Dietary Compounds n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD410 Grape pomace cocentrate and grape seed extract Dietary Substance Dietary Compounds n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD411 Grape-derived polyphenols Dietary Substance Dietary Compounds n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD412 Green tea Dietary Substance Drinks n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD413 Green tea extracts Dietary Substance Dietary Compounds n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD414 Green tea leaves powder Dietary Substance Dietary Compounds n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD416 Guanadrel sulfate Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 68552 n.a. n.a. "Guanadrel sulfate; Hylorel; 22195-34-2; Hyloride; CL-1388R; CL 1388R; U 28288D; Guanadrel sulfate [USAN]; HSDB 6536; Hylorel (TN); Guanadrel Hemisulfate; U-28288D; U 28,288D; CHEBI:5556; (1,4-Dioxaspiro(4.5)dec-2-ylmethyl)guanidine sulfate (2:1); N-(1,4-dioxaspiro[4.5]dec-2-ylmethyl)guanidine sulfate(2:1); U-28,288D; Guanidine (1,4-dioxaspiro(4.5)dec-2-ylmethyl)-, sulfate (2:1); Guanadrel sulfate (USAN); guanadrel sulfate (2:1); Anarel; Guanadrel sulfate [USAN:USP]; NCGC00016758-01; CAS-22195-34-2; DSSTox_CID_25432; DSSTox_RID_8087" C20H40N6O8S RTEVGQJRTFFMLL-UHFFFAOYSA-N "2-(1,4-dioxaspiro[4.5]decan-3-ylmethyl)guanidine;sulfuric acid" n.a. n.a. Yes No No No No No PMDBD417 Halofantrine hydrochloride Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 37392 n.a. n.a. "HALOFANTRINE HYDROCHLORIDE; 36167-63-2; Halfan; Halofantrino [Spanish]; (+-)-Halofantrine hydrochloride; WR 171669; Halofantrine Hydrochloride [USAN]; WR-171,669; EINECS 252-895-4; UNII-2B7ENL644K; C26H30Cl2F3NO.HCl; WR-171669; 2B7ENL644K; NCGC00016833-01; DSSTox_CID_25464; 9-(3-(dibutylamino)-1-hydroxypropyl)-1,3-dichloro-6-(trifluoromethyl)phenanthrene hydrochloride; 1,3-Dichloro-6-trifluoromethyl-9-(3-(dibutylamino)-1-hydroxypropyl)phenanthrene HCl; DSSTox_RID_80895" C26H31Cl3F3NO WANGFTDWOFGECH-UHFFFAOYSA-N "3-(dibutylamino)-1-[1,3-dichloro-6-(trifluoromethyl)phenanthren-9-yl]propan-1-ol;hydrochloride" n.a. n.a. Yes No No No No No PMDBD421 Heterocyclic amine 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) Environmental Chemicals Unclassified Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD422 Heterocyclic amines Environmental Chemicals Unclassified Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD426 High-fat (saturated and unsaturated) Dietary Substance Dietary Compounds n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD427 High-fat and high-sugar diet Dietary Substance Foods n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD428 High-fiber diets Dietary Substance Dietary Compounds n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD429 High-flavanol cocoa powder extract Dietary Substance Dietary Compounds n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD432 Hydrazine Environmental Chemicals "Industrial Chemicals; Medicinal chemicals" n.a. n.a. n.a. n.a. n.a. 9321 n.a. n.a. "HYDRAZINE; Diamine; 302-01-2; Levoxine; Diazane; Hydrazine base; Nitrogen hydride; Oxytreat 35; Hydrazyna; Hydrazines; Hydrazin; Hydrazyna [Polish]; Hydrazine, anhydrous; Hydrazine (anhydrous); RCRA waste number U133; hydrazinyl; UNII-27RFH0GB4R; CCRIS 335; HSDB 544; EINECS 206-114-9; UN3293; UN2029; H2NNH2; RCRA waste no. U133; 27RFH0GB4R; N2H4; CHEBI:15571; HYDRAZINE (HYDRAZINE SULFATE); Hydrazine solution; HDZ; Hydrazine/Hydrazine sulfate; Amerzine; amino nitrogen; Zerox; Catalyzed hydrazine; Scav-Ox II; Zerox (Salt/Mix); Amerzine (Salt/Mix" H4N2 OAKJQQAXSVQMHS-UHFFFAOYSA-N hydrazine n.a. n.a. No Yes No No No No PMDBD433 Hydrocortisone base Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 5754 n.a. n.a. "hydrocortisone; Cortisol; 50-23-7; Cetacort; Acticort; Hydrocortisyl; Hydrasson; Cobadex; Signef; Hytone; Cortef; Hycort; Optef; 17-Hydroxycorticosterone; Kendall''s compound F; Hydrocortone; Hycortol; Efcorbin; Cortiment; Cortifan; Corticreme; Cortanal; Traumaide; Permicort; Ficortril; Dermacort; Tarcortin; Hycortole; Cortispray; Proctocort; Genacort; Efcortelan; Dermolate; Cortonema; Cortenema; Cleiton; Alacort; Cortril; Dihydrocostisone; Hytone lotion; Hydro-Adreson; Hidro-Colisona; Scheroson F; Reichstein''s substance M; Incortin-H; Polcort H; Esider" C21H30O5 JYGXADMDTFJGBT-VWUMJDOOSA-N (8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one n.a. n.a. Yes No No No No No PMDBD436 Ibutilide fumarate Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 5281065 n.a. n.a. "IBUTILIDE FUMARATE; 122647-32-9; Corvert; Ibutilide hemifumarate; Ibutilide Fumarate [USAN]; U-70226E; U 70226E; MFCD01715410; Methanesulfonamide, N-[4-[4-(ethylheptylamino)-1-hydroxybutyl]phenyl]-, (2E)-2-butenedioate (2:1); Ibutilide (fumarate); U70226E; (+-)-4''-(4-(Ethylheptylamino)-1-hydroxybutyl)methanesulfonanilide fumarate (2:1) (salt); (+-)-N-(4-(4-(Ethylheptylamino)-1-hydroxybutyl)phenyl)methanesulfonamide (E)-butenedioate; (+-)-4''-(4-(Ethylheptylamino)-1-hydroxybutyl)methanesulfoanilide (E)-2-butenedioate (2:1" C44H76N4O10S2 PCIOHQNIRPWFMV-WXXKFALUSA-N "(E)-but-2-enedioic acid;N-[4-[4-[ethyl(heptyl)amino]-1-hydroxybutyl]phenyl]methanesulfonamide" n.a. n.a. Yes No No No No No PMDBD442 Incretin Environmental Chemicals Human Metabolite n.a. n.a. n.a. n.a. n.a. 16140499 n.a. n.a. "Incretin; Incretins; Insulin-releasing polypeptide; Glucose-Dependent Insulin-Releasing Hormone; 54241-84-8; Gastric Inhibitory Polypeptide human, >=95% (HPLC); gastric inhibitory polypeptide (human)-Asn-Ile-Thr-Gln-OH" C226H338N60O66S MGXWVYUBJRZYPE-YUGYIWNOSA-N (2S)-5-amino-2-[[(2S,3R)-2-[[(2S,3S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-6-amino-2-[[(2S)-6-amino-2-[[2-[[(2S)-6-amino-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S,3R)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propano n.a. n.a. No Yes No No No No PMDBD444 Indatraline hydrochloride Environmental Chemicals Unclassified Substance n.a. n.a. n.a. n.a. n.a. 10314472 n.a. n.a. "Indatraline hydrochloride; 96850-13-4; CPD000449273; NCGC00094042-01; Lu 19-005; SMR000449273; SR-01000075409; 86939-10-8; Indatraline HCl; DSSTox_CID_22631; DSSTox_RID_80062; DSSTox_GSID_42631; MLS001423997; MLS000758200; Indatraline hydrochloride, solid; DTXSID3042631; CHEMBL1256749; CTK8G0299; (1r,3s)-indatraline hydrochloride; REGID_for_CID_10314472; Tox21_500684; Tox21_111238; BN0274; AKOS024456685; CCG-100795; NC00045; LP00684; NCGC00261369-01; CAS-96850-13-4; I-119; EU-0100684; B6799; SR-01000075409-1; SR-01000075409-3; (1R,3S)-rel-3" C16H16Cl3N QICQDZXGZOVTEF-MELYUZJYSA-N "(1R,3S)-3-(3,4-dichlorophenyl)-N-methyl-2,3-dihydro-1H-inden-1-amine;hydrochloride" n.a. n.a. Yes No No No No No PMDBD448 Intact soy protein isolate Dietary Substance Dietary Compounds n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD453 Ipsalazide Therapeutic Substance unknown n.a. n.a. n.a. n.a. n.a. 72003 n.a. n.a. "Ipsalazide; Ipsalazidum [Latin]; Ipsalazida [Spanish]; Ipsalazido [Spanish]; 80573-03-1; UNII-499H4332KZ; BX 650 A; BX-650A; 499H4332KZ; (E)-5-((4-(((Carboxymethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acid; (E)-p-((3-Carboxy-4-hydroxyphenyl)azo)hippuric acid; Ipsalazidum; Ipsalazida; Ipsalazido; Ipsalazide [INN:BAN]; Ipsalazide [BAN:INN]; Ipsalazide (free base); SCHEMBL596652; SCHEMBL11165440; CHEMBL2104872; ZINC4216628; LS-36378; Q27259264" C16H13N3O6 CQSRTOJJBONKMC-UHFFFAOYSA-N 5-[[4-(carboxymethylcarbamoyl)phenyl]diazenyl]-2-hydroxybenzoic acid n.a. n.a. No Yes No No No No PMDBD456 Irsogladine maleate Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 5282435 n.a. n.a. "irsogladine maleate; 84504-69-8; Gaslon; Irsogladine (maleate); MN-1695; UNII-66GVU60EPQ; 66GVU60EPQ; 57381-28-9; Irsogladine HBr; 6-(2,5-DICHLOROPHENYL)-1,3,5-TRIAZINE-2,4-DIAMINE MALEATE; DSSTox_RID_79454; 1,3,5-Triazine-2,4-diamine, 6-(2,5-dichlorophenyl)-, (Z)-2-butenedioate (1:1); DSSTox_CID_20234; DSSTox_GSID_40234; s-Triazine, 2,4-diamino-6-(2,5-dichlorophenyl)-, maleate; Gaslon N; CAS-84504-69-8; Dicloguamine maleate;MN1695; Irsogladine maleate [JAN]; CCRIS 8107; C9H7Cl2N5.C4H4O4; Iosogladine maleate; NCGC00160397-01; Dic" C13H11Cl2N5O4 PJLVTVAIERNDEQ-BTJKTKAUSA-N "(Z)-but-2-enedioic acid;6-(2,5-dichlorophenyl)-1,3,5-triazine-2,4-diamine" n.a. n.a. No Yes No No No No PMDBD460 Isoflavones Dietary Substance Dietary Compounds n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD469 Ketorolac tromethamine Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 84003 n.a. n.a. "Ketorolac tromethamine; Ketorolac tris salt; 74103-07-4; Toradol; Acular; Ketorolac tromethamine salt; Acular LS; Ketorolac (tromethamine salt); Acular PF; Acuvail; Syntex; Ketorolac trometamol; SPRIX; Acular Preservative Free; Ketorolac (Toradol); Lixidol; Dolac; 2-amino-2-(hydroxymethyl)propane-1,3-diol 5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylate; Toradol (TN); (+/-)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid tris salt; (+-)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid, compound with 2-amino-2-(h" C19H24N2O6 BWHLPLXXIDYSNW-UHFFFAOYSA-N "2-amino-2-(hydroxymethyl)propane-1,3-diol;5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid" n.a. n.a. No Yes No Yes No No PMDBD480 Lignans "Herbal Substance; Dietary Substance" "Medicinal Herbal Compounds; Dietary Compounds" n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD483 Lincomycin hydrochloride Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 64710 n.a. n.a. "Lincomycin hydrochloride; LINCOMYCIN HCL; 859-18-7; Frademicina; Lincomycin (hydrochloride); 7179-49-9; UNII-GCW8Y9936L; C18H34N2O6S.HCl; Mycivin; Lincomix; Lincogap; GCW8Y9936L; Lincomix 20; Pura Ject 100; NCGC00159326-02; Lincolnensin, hydrochloride; DSSTox_RID_82556; DSSTox_CID_27780; DSSTox_GSID_47803; Antibiotic 124a, hydrochloride; Lincomycin hydrochloride anhydrous; EINECS 212-726-7; U 10149a; Lincocin Hydrochloride; (2S,4R)-N-((1R,2R)-2-hydroxy-1-((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(methylthio)tetrahydro-2H-pyran-2-yl)pro" C18H35ClN2O6S POUMFISTNHIPTI-BOMBIWCESA-N "(2S,4R)-N-[(1R,2R)-2-hydroxy-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide;hydrochloride" n.a. n.a. Yes No Yes No No No PMDBD486 Linum usitatissimum Herbal Substance Medicinal Herb n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No Yes No No No PMDBD489 Lomefloxacin hydrochloride Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 68624 n.a. n.a. "Lomefloxacin hydrochloride; 98079-52-8; Lomefloxacin HCl; Maxaquin; Okacyn; Uniquin; Bareon; Ny-198; Mazaquin; SC-47111; Lomefloxacin (hydrochloride); NY 198; CCRIS 2581; 1-ethyl-6,8-difluoro-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride; Lomefloxacin hydrochloride [USAN:JAN]; CHEBI:6518; MFCD00214312; Lomefloxacin hydrochloride (Maxaquin); L-6500; DSSTox_RID_80931; DSSTox_CID_25527; DSSTox_GSID_45527; (+-)-1-Ethyl-6,8-difluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarbox" C17H20ClF2N3O3 KXEBLAPZMOQCKO-UHFFFAOYSA-N "1-ethyl-6,8-difluoro-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid;hydrochloride" n.a. n.a. Yes No Yes No No No PMDBD491 Loperamide hydrochloride Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 71420 n.a. n.a. "Loperamide hydrochloride; 34552-83-5; Loperamide HCl; Imodium; Suprasec; Loperyl; Lopemin; Fortasec; Lopemid; Dissenten; Tebloc; Imosec; Imodium A-D; Maalox Antidiarrheal; BREK; BLOX; Loperamide (hydrochloride); UNII-77TI35393C; PJ185; EINECS 252-082-4; Maalox Anti-Diarrheal; C29H33ClN2O2.HCl; MLS000069779; 4-(4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl)-N,N-dimethyl-2,2-diphenylbutanamide hydrochloride; CHEBI:6533; R 18553; 4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-N,N-dimethyl-2,2-diphenylbutanamide hydrochloride; 4-(p-Chloroph" C29H34Cl2N2O2 PGYPOBZJRVSMDS-UHFFFAOYSA-N "4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-N,N-dimethyl-2,2-diphenylbutanamide;hydrochloride" n.a. n.a. Yes No No No No No PMDBD497 Lovastatin related compounds Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD498 Low glycinin soy milk Dietary Substance Drinks n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD499 Low glycinin soy milk (49.5% beta-conglycinin/6% glycinin) Dietary Substance Drinks n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD500 Low-fiber diet Dietary Substance Foods n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD501 Low-fibre diet Dietary Substance Foods n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD502 Loxapine succinate Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 71399 n.a. n.a. "Loxapine succinate; 27833-64-3; Loxapine succinate salt; Loxapac; Cloxazepin; Daxolin; Loxapine (succinate); Lederle; UNII-X59SG0MRYU; Loxapine,succinate; CCRIS 1917; EINECS 248-682-0; X59SG0MRYU; CL 71563; CPD000058470; MLS000069383; Butanedioic acid, compd. with 2-chloro-11-(4-methyl-1-piperazinyl)dibenz[b,f][1,4]oxazepine (1:1); NCGC00016160-02; SMR000058470; CAS-27833-64-3; DSSTox_RID_80764; DSSTox_CID_25227; 2-Chloro-11-(4-methyl-1-piperazinyl)dibenz(b,f)(1,4)oxazepine succinate (1:1); DSSTox_GSID_45227; C22H24ClN3O5; CL-71563" C22H24ClN3O5 YQZBAXDVDZTKEQ-UHFFFAOYSA-N "butanedioic acid;8-chloro-6-(4-methylpiperazin-1-yl)benzo[b][1,4]benzoxazepine" n.a. n.a. Yes Yes No No No No PMDBD506 Mafenide hydrochloride Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 67313 n.a. n.a. "Mafenide hydrochloride; 138-37-4; 4-Aminomethylbenzenesulfonamide hydrochloride; 4-(Aminomethyl)benzenesulfonamide hydrochloride; Marfanil; Masudin; Morfanil; Homosulfamine; Homosulfamine hydrochloride; Mafenide HCl; Emilene hydrochloride; Sulfamylon hydrochloride; Sulfbenzamine hydrochloride; 4-Homosulfanilamide hydrochloride; Mesudin hydrochloride; Ambamide hydrochloride; Mesudrin hydrochloride; Neofamid hydrochloride; Homosulfanilamide hydrochloride; Maphenide hydrochloride; Mafenide (hydrochloride); p-Aminomethylphenylsulfo" C7H11ClN2O2S SIACJRVYIPXFKS-UHFFFAOYSA-N "4-(aminomethyl)benzenesulfonamide;hydrochloride" n.a. n.a. Yes No Yes No No No PMDBD507 Magnoloside A Herbal Substance Medicinal Herbal Compounds n.a. n.a. n.a. n.a. n.a. 21629882 n.a. n.a. "Magnoloside A; 113557-95-2; ZINC252586492; W1954" C29H36O15 QLZWUGOYBODRLF-QQLYGORSSA-N [(2R,3R,4R,5R,6R)-2-[2-(3,4-dihydroxyphenyl)ethoxy]-5-hydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-4-yl] (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate n.a. n.a. Yes No No No No No PMDBD509 Marine oil Dietary Substance Nutrient Supplement n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD510 Maru cultivar blueberry extract Dietary Substance Dietary Compounds n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD513 Mebhydroline 1,5-naphtalenedisulfonate Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 22529 n.a. n.a. "Mebhydrolin napadisylate; 6153-33-9; Diazoline; Mebhydrolin napadisilate; Diazolin; Incidal; Mebhydroline Napadisylate; Omeril; Diazolinum; Mebhydrolin (napadisylate); Mebhydroline 1,5-naphthalenedisulfonate salt; UNII-O5G04RB25M; EINECS 228-170-3; mebhydroline 1,5-naphthalenedisulfonate; O5G04RB25M; Mebhydrolin 1,5-naphtalenedisulfonate; Mebhydroline 1,5-naphtalenedisulfonate; NCGC00017059-01; CAS-6153-33-9; 1,5-Naphthalenedisulfonic acid, compd. with 2,3,4,5-tetrahydro-2-methyl-5-(phenylmethyl)-1H-pyrido(4,3-b)indole (1:2)" C48H48N4O6S2 CJUOSBUQOWKEKJ-UHFFFAOYSA-N "5-benzyl-2-methyl-3,4-dihydro-1H-pyrido[4,3-b]indole;naphthalene-1,5-disulfonic acid" n.a. n.a. Yes No Yes No No No PMDBD514 Meclocycline sulfosalicylate Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 54676538 n.a. n.a. "Meclocycline sulfosalicylate; Mecloderm; Meclutin; Meclan; Meclan Cream; 73816-42-9; UNII-46VZA7RX2B; Meclocycline sulfosalicylate salt; Meclocycline 5-sulfosalicylate; EINECS 277-614-2; 46VZA7RX2B; Meclocycline (Sulfosalicylate Salt); (4S,4aR,5S,5aR,12aS)-7-Chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methylene-1,11-dioxo-2-naphthacenecarboxamide mono(5-sulfosalicylate) (salt); C22H21ClN2O8.C7H6O6S; Benzoic acid, 2-hydroxy-5-sulfo-, compd. with (4S-(4alpha,4aalpha,5alpha,5aalpha,1" C29H27ClN2O14S WVJKUGVVYXCLFV-CCHMMTNSSA-N "(4S,4aR,5S,5aR,12aR)-7-chloro-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methylidene-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;2-hydroxy-5-sulfobenzoic acid" n.a. n.a. Yes No Yes No No No PMDBD515 Meclofenamic acid sodium salt monohydrate Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 23663959 n.a. n.a. "Meclomen; Meclodol; Lenidolor; meclofenamate sodium hydrate; UNII-94NJ818U2W; 67254-91-5; Meclofenamic acid sodium salt monohydrate; Meclofenamate sodium monohydrate; CHEBI:76232; 94NJ818U2W; NCGC00017062-01; CAS-6385-02-0; Meclomen (TN); DSSTox_RID_80964; DSSTox_CID_25567; DSSTox_GSID_45567; CL-583.NA SALT; Meclofenamate Sodium [USAN]; 2-[(2,6-Dichloro-3-methylphenyl)amino]benzoic acid sodium salt monohydrate; Prestwick_829; SCHEMBL3504; Meclofenamate sodium (USP); MLS002222266; sodium meclofenamate monohydrate; C14H10Cl2NO2.Na.H" C14H12Cl2NNaO3 QHJLLDJTVQAFAN-UHFFFAOYSA-M "sodium;2-(2,6-dichloro-3-methylanilino)benzoate;hydrate" n.a. n.a. Yes No No No No No PMDBD516 Meclozine dihydrochloride Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 64713 n.a. n.a. "Meclizine dihydrochloride; 1104-22-9; Meclozine dihydrochloride; Bonamine; Meclizine hydrochloride; 1-((4-Chlorophenyl)(phenyl)methyl)-4-(3-methylbenzyl)piperazine dihydrochloride; Postafen; Vertizine; Diadril; Taizer; V-Cline; Duremesin; Ancolan dihydrochloride; Postafene dihydrochloride; meclizine diHCl; Meclizine (dihydrochloride); NSC 28728; Parachloramine dihydrochloride; Meclizine hydrochloride anhydrous; EINECS 214-164-8; UNII-V5604WJ3XP; UNII-408UZ554UD; V5604WJ3XP; Meclizine 2HCl; 408UZ554UD; 1-[(4-chlorophenyl)(phenyl)met" C25H29Cl3N2 VCTHNOIYJIXQLV-UHFFFAOYSA-N "1-[(4-chlorophenyl)-phenylmethyl]-4-[(3-methylphenyl)methyl]piperazine;dihydrochloride" n.a. n.a. Yes No Yes No No No PMDBD518 Mefloquine hydrochloride Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 65329 n.a. n.a. "Mefloquine hydrochloride; Mefloquine HCL; 51773-92-3; Mephaquin; Mefloquine (hydrochloride); WR 142490 hydrochloride; NSC 157387; UNII-326VC85GV6; Ro 21-5998/001; EINECS 257-412-0; 326VC85GV6; DSSTox_RID_82568; DSSTox_CID_27796; DL-erythro-alpha-2-Piperidyl-2,8-bis(trifluoromethyl)-4-quinolinemethanol monohydrochloride; DSSTox_GSID_47819; Loriam; MLS001332559; (S)-[2,8-bis(trifluoromethyl)quinolin-4-yl][(2R)-piperidin-2-yl]methanol hydrochloride; (R*,S*)-(1)-alpha-2-Piperidyl-2,8-bis(trifluoromethyl)quinoline-4-methanol mono" C17H17ClF6N2O WESWYMRNZNDGBX-YLCXCWDSSA-N "(S)-[2,8-bis(trifluoromethyl)quinolin-4-yl]-[(2R)-piperidin-2-yl]methanol;hydrochloride" n.a. n.a. Yes No No No No No PMDBD526 Mesoridazine besylate Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 36207 n.a. n.a. "MESORIDAZINE BESYLATE; 32672-69-8; Mesoridazine benzenesulfonate; NC 123; UNII-T4G2I958J2; C21H26N2OS2.C6H6O3S; Mesoridazine besylate [USP]; CHEBI:6781; T4G2I958J2; mesoridazine besilate; 10-(2-(1-Methyl-2-piperidyl)ethyl)-2-(methylsulfinyl)phenothiazine monobenzenesulfonate; benzenesulfonic acid;10-[2-(1-methylpiperidin-2-yl)ethyl]-2-methylsulfinylphenothiazine; (+-)-10-(2-(1-Methyl-2-piperidyl)ethyl)-2-(methylsulfinyl)phenothiazine monobenzenesulfonate; Mesoridazine besylate (USP)" C27H32N2O4S3 CRJHBCPQHRVYBS-UHFFFAOYSA-N "benzenesulfonic acid;10-[2-(1-methylpiperidin-2-yl)ethyl]-2-methylsulfinylphenothiazine" n.a. n.a. Yes No No No No No PMDBD531 Methacycline hydrochloride Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 54685047 n.a. n.a. "METHACYCLINE HYDROCHLORIDE; 3963-95-9; Methacycline HCl; Metacycline hydrochloride; Rondomycin; Ciclobiotic; Germiciclin; Adriamicina; Metadomus; Metilenbiotic; Physiomycine; Globociclina; Optimycin; Megamycine; Londomycin; Rindex; UNII-9GJ0N7ZAP0; Methacycline (hydrochloride); Methacycline monohydrochloride; EINECS 223-568-3; NSC 356465; 9GJ0N7ZAP0; C22H23ClN2O8; CHEBI:6806; NSC-356465; DSSTox_RID_80840; DSSTox_CID_25382; DSSTox_GSID_45382; 4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methylene-1,11-d" C22H23ClN2O8 VXPSARQTYDZXAO-CCHMMTNSSA-N "(4S,4aR,5S,5aR,12aR)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methylidene-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;hydrochloride" n.a. n.a. Yes No Yes No No No PMDBD532 Methantheline bromide Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 5883 n.a. n.a. "METHANTHELINE BROMIDE; Banthine; Methanthelinium bromide; Dixamone bromide; Ulcudexter; Frenogastrico; Gastrosedan; Resobantin; Vagantin; Doladene; Vagamin; Metantyl; Gastron; Methelina; Metaxan; Xanteline; Banthin; Asabaine; Ulcine; Avagal; 53-46-3; MTB 51; Metantelinio bromuro [DCIT]; UNII-090519SAPF; SC 2910; Banthine bromide; Methanthine bromide; Methanthelinii bromidum [INN-Latin]; EINECS 200-176-0; NSC 32145; Bromuro de metantelinio [INN-Spanish]; Bromure de methanthelinum [INN-French]; 090519SAPF; Xanthene-9-carboxylic acid, ester w" C21H26BrNO3 PQMWYJDJHJQZDE-UHFFFAOYSA-M "diethyl-methyl-[2-(9H-xanthene-9-carbonyloxy)ethyl]azanium;bromide" n.a. n.a. Yes No No No No No PMDBD533 Methiazole Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 6604471 n.a. n.a. "Methiazole; 74239-55-7; N-[6-(propan-2-ylthio)-1H-benzimidazol-2-yl]carbamic acid methyl ester; Prestwick-14D11; Prestwick3_001080; Prestwick0_001080; Prestwick2_001080; Prestwick1_001080; Methiazole, 98% (TLC); BSPBio_001100; MLS002154145; SPBio_003000; SCHEMBL9882802; BPBio1_001210; CHEMBL1354363; CTK8G0826; CHEBI:94268; DTXSID50424979; HMS3715G22; HMS3370O02; HMS2231A21; HMS2098G22; HMS1571G22; ZINC4245701; CCG-221080; NCGC00017007-01; NCGC00017007-02; SMR001233449; AB00514034; SR-01000841828; SR-01000841828-2; BRD-K02764365-001-05-2" C12H15N3O2S SXJIZQPZESTWLD-UHFFFAOYSA-N methyl N-(6-propan-2-ylsulfanyl-1H-benzimidazol-2-yl)carbamate n.a. n.a. Yes No No No No No PMDBD534 Methiothepin maleate Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 5358812 n.a. n.a. "Methiothepin maleate; METITEPINE MALEATE; 19728-88-2; CHEBI:64202; NSC281816; 8-Methylthio-10-(4-methylpiperazino)-10,11-dihydrodibenzo(b,f)thiepin maleate; 1-(10,11-Dihydro-8-(methylthio)dibenzo(b,f)thiepin-10-yl)-4-methylpiperazine maleate; MLS000756636; 1-methyl-4-[8-(methylsulfanyl)-10,11-dihydrodibenzo[b,f]thiepin-10-yl]piperazine (2Z)-but-2-enedioate; 20229-30-5; SR-01000075560; Prestwick_739; Piperazine, 1-[10,11-dihydro-8-(methylthio)dibenzo[b,f]thiepin-10-yl]-4-methyl-, (2Z)-2-butenedioate (1:1); SPECTRUM150363" C24H28N2O4S2 IWDBEHWZGDSFHR-BTJKTKAUSA-N "(Z)-but-2-enedioic acid;1-methyl-4-(3-methylsulfanyl-5,6-dihydrobenzo[b][1]benzothiepin-5-yl)piperazine" n.a. n.a. Yes No Yes No No No PMDBD536 Methotrimeprazine maleat salt Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 5282484 n.a. n.a. "levomepromazine maleate; Methotrimeprazine maleate; 7104-38-3; Levo Mepromazine Maleate; UNII-5KN5Y9V01K; 5KN5Y9V01K; Methoprazine; Methotrimeprazine maleat salt; Levomepromazinmaleat; Hirnamin (TN); [(2R)-3-(2-methoxyphenothiazin-10-yl)-2-methylpropyl]dimethylamine, (2Z)but-2- enedioic acid; (Z)-but-2-enedioic acid;(2R)-3-(2-methoxyphenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine; Levomepromazine maleate [USAN:JAN]; EINECS 230-412-8; NCGC00016681-01; CAS-7104-38-3; DSSTox_RID_80853; DSSTox_CID_25399; DSSTox_GSID_45399; SCHE" C23H28N2O5S IFLZPECPTYCEBR-VIEYUMQNSA-N "(Z)-but-2-enedioic acid;(2R)-3-(2-methoxyphenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine" n.a. n.a. Yes No No No No No PMDBD539 Methyl benzethonium chloride Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 5702238 n.a. n.a. "Methylbenzethonium chloride; 25155-18-4; Methyl benzethonium chloride; UNII-NN7590IUQX; NN7590IUQX; Benzyldimethyl(2-(2-((4-(1,1,3,3-tetramethylbutyl)-o-tolyl)oxy)ethoxy)ethyl)ammonium chloride; MLS002153966; Quat20; Quat 20; SR-05000002081; benzyl-dimethyl-[2-[2-[2-methyl-4-(2,4,4-trimethylpentan-2-yl)phenoxy]ethoxy]ethyl]azanium;chloride; SMR001233305; Prestwick_9; C28H44ClNO2; SPECTRUM1503253; SCHEMBL136062; METHYLBENZTHONIUM CHLORIDE; CHEMBL1321398; HMS502B21; HMS2235G10; HMS1570M11; Pharmakon1600-01503253; HMS3371P01; HMS209" C28H44ClNO2 QWZLBLDNRUUYQI-UHFFFAOYSA-M "benzyl-dimethyl-[2-[2-[2-methyl-4-(2,4,4-trimethylpentan-2-yl)phenoxy]ethoxy]ethyl]azanium;chloride" n.a. n.a. Yes No Yes No No No PMDBD540 Methylmercury Environmental Chemicals compound n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes Yes No No No No PMDBD542 Methysergide maleate Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 5281073 n.a. n.a. "Methysergide maleate; 129-49-7; Deseril-retard; Methysergide hydrogen maleate; Desernil bismaleate; Deseril; Methysergide bimaleate; Methysergide maleate salt; UNII-2U7H1466GH; EINECS 204-950-9; NSC 186061; Methysergide maleate [USP]; 1-Methyl-D-lysergic acid butanolamide dimaleate; 2U7H1466GH; Lysergamide, N-((1-hydroxymethyl)propyl)-1-methyl-, maleate; (+)-N-((1-Hydroxymethyl)propyl)-1-methyl-D-lysergamide bimaleate; 1-(Hydroxymethyl)propylamide of 1-methyl-(+)-lysergic acid hydrogen maleate; Methysergide maleate (USP)" C25H31N3O6 LWYXFDXUMVEZKS-ZVFOLQIPSA-N "(6aR,9R)-N-[(2S)-1-hydroxybutan-2-yl]-4,7-dimethyl-6,6a,8,9-tetrahydroindolo[4,3-fg]quinoline-9-carboxamide;(Z)-but-2-enedioic acid" n.a. n.a. No Yes No No No No PMDBD543 Metitepine maleate Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 5358812 n.a. n.a. "Methiothepin maleate; METITEPINE MALEATE; 19728-88-2; CHEBI:64202; NSC281816; 8-Methylthio-10-(4-methylpiperazino)-10,11-dihydrodibenzo(b,f)thiepin maleate; 1-(10,11-Dihydro-8-(methylthio)dibenzo(b,f)thiepin-10-yl)-4-methylpiperazine maleate; MLS000756636; 1-methyl-4-[8-(methylsulfanyl)-10,11-dihydrodibenzo[b,f]thiepin-10-yl]piperazine (2Z)-but-2-enedioate; 20229-30-5; SR-01000075560; Prestwick_739; Piperazine, 1-[10,11-dihydro-8-(methylthio)dibenzo[b,f]thiepin-10-yl]-4-methyl-, (2Z)-2-butenedioate (1:1); SPECTRUM150363" C24H28N2O4S2 IWDBEHWZGDSFHR-BTJKTKAUSA-N "(Z)-but-2-enedioic acid;1-methyl-4-(3-methylsulfanyl-5,6-dihydrobenzo[b][1]benzothiepin-5-yl)piperazine" n.a. n.a. No Yes No No No No PMDBD544 Metixene hydrochloride Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 64722 n.a. n.a. "metixene hydrochloride; Contalyl; Methixene hydrochloride; Tremaril hydrochloride; 1553-34-0; Methixart; Tremaril wonder; Methixene HCl; Methixene hydrochloride anhydrous; N 715; EINECS 216-300-1; 9-(1-Methyl-3-piperidylmethyl)thiaxanthene hydrochloride; 9-(1''-Methylpiperidine-3''-methyl)thioxanthene hydrochloride; NSC 78194; 1-Methyl-3-(thioxanthen-9-ylmethyl)-1-piperidine hydrochloride; 1-Pipecoline, 3-(thioxanthen-9-yl)methyl-, hydrochloride; Thioxanthene, 9-(1-methyl-3-piperidylmethyl)-, hydrochloride; Piperidine, 1-meth" C20H24ClNS RSXZRFHNNTTWCB-UHFFFAOYSA-N "1-methyl-3-(9H-thioxanthen-9-ylmethyl)piperidine;hydrochloride" n.a. n.a. Yes No No No No No PMDBD545 Metoprolol tartrate Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 441308 n.a. n.a. "56392-17-7; Selectadril; Metoproferm; Metocard; Jeprolol; Cardoxone; Arbralene; Topromel; Prolaken; Metomerck; Mepolol; Sigaprolol; Selopral; Metoberag; Bloksan; Vasocardin; Selokeen; Ritmolol; Metoprolin; Metolol; Metoberta; Kapodine; Beprolo; Azumetop; Prelis; Bloxan; Minax; Metoprolol acis; Metop; Lanoc; Beloc; Metoprolol-rpm; Metoprolol-Wolf; Slow lopresor; Metoprolol Atid; Slow-Lopresor; Apo-Metoprolol; Metoprolol Verla; Metoprolol PB; Metoprolol AL; Metoprolol Stada; Metoprolol-GRY; Meto-Isis; Metoprolol Basics; Proken M; Metoprolol Heumann; Meto" C34H56N2O12 YGULWPYYGQCFMP-CEAXSRTFSA-N "(2R,3R)-2,3-dihydroxybutanedioic acid;1-[4-(2-methoxyethyl)phenoxy]-3-(propan-2-ylamino)propan-2-ol" n.a. n.a. No Yes No No No No PMDBD552 Minocycline hydrochloride Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 54685925 n.a. n.a. "MINOCYCLINE HYDROCHLORIDE; 13614-98-7; Minocycline HCl; Arestin; Minomycin; Vectrin; Minocycline chloride; Minocin; Minomax; Periocline; Solodyn; Tri-mino; Minocycline (hydrochloride); Dynacin; Mynocine hydrochloride; Tri-minocycline; UNII-0020414E5U; EINECS 237-099-7; Minocycline hydrochloride (internal use); C23H27N3O7.HCl; Minocycline, Hydrochloride; 0020414E5U; (4S,4aS,5aR,12aS)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide hydrochloride; DSSTox_RID_80306; DSST" C23H28ClN3O7 WTJXVDPDEQKTCV-VQAITOIOSA-N "(4S,4aS,5aR,12aR)-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide;hydrochloride" n.a. n.a. Yes No Yes No No No PMDBD556 Monensin sodium salt Therapeutic Substance Approved Drug (veterinary medicine) n.a. n.a. n.a. n.a. n.a. 23667299 n.a. n.a. "Monensin sodium salt; Monensin sodium; Sodium monensin; 22373-78-0; DSSTox_RID_80970; DSSTox_CID_25573; DSSTox_GSID_45573; Monensin A sodium salt; NSC343257; C36H61NaO11; NCGC00017089-01; CAS-22373-78-0; MLS002153986; SCHEMBL4057708; DTXSID2045573; CHEMBL1908308; HMS2097E18; HMS3714E18; HY-N0150; Tox21_110771; Tox21_113191; s2324; AKOS025147337; CCG-220748; AM84797; SMR001233320; CS-0007881; dioxaspiro[4.5]decan-9-yl]-3-methoxy-2-methylpentanoate" C36H61NaO11 XOIQMTLWECTKJL-FBZUZRIGSA-M "sodium;(2S,3R,4S)-4-[(2S,5R,7S,8R,9S)-2-[(2R,5S)-5-ethyl-5-[(2R,3S,5R)-5-[(2S,3S,5R,6R)-6-hydroxy-6-(hydroxymethyl)-3,5-dimethyloxan-2-yl]-3-methyloxolan-2-yl]oxolan-2-yl]-7-hydroxy-2,8-dimethyl-1,10-dioxaspiro[4.5]decan-9-yl]-3-methoxy-2-methylpentanoate" n.a. n.a. Yes No Yes No No No PMDBD557 Monomeric-rich fraction grape seed extract Dietary Substance Dietary Compounds n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD559 Moricizine hydrochloride Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 34632 n.a. n.a. "MORICIZINE HYDROCHLORIDE; Moracizine hydrochloride; 29560-58-5; Ethmozine; Ethmosine; Moricizine HCl; Etmozin; Ethmozin; UNII-71OK3Z1ESP; 71OK3Z1ESP; MLS000830274; Moricizine hydrochloride [USP]; EN 313; moracizine HCl; SMR000036736; Ethyl 10-(3-morpholinopropionyl)phenothiazine-2-carbamate hydrochloride; Ethyl 10-(beta-N-morpholinylpropionyl)phenothiazine-2-carbamate hydrochloride; Ethyl ether of 10-(beta-morpholylpropionyl)phenthiazinecarbamino acid hydrochloride; DSSTox_RID_82543; DSSTox_CID_27766; DSSTox_GSID_47786" C22H26ClN3O4S GAQAKFHSULJNAK-UHFFFAOYSA-N "ethyl N-[10-(3-morpholin-4-ylpropanoyl)phenothiazin-2-yl]carbamate;hydrochloride" n.a. n.a. Yes No No No No No PMDBD561 Moxalactam disodium salt Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 441242 n.a. n.a. "MOXALACTAM DISODIUM; Moxam; latamoxef sodium; latamoxef disodium; Disodium latamoxef; 64953-12-4; Shiomarin; Moxalactam disodium salt; Shionogi 6059S; Antibiotic 6059-S; 6059-S; LY-127935; DSSTox_RID_80988; DSSTox_CID_25595; DSSTox_GSID_45595; LY 127935; EINECS 265-288-4; 6059S; Moxalactam disodium (USAN); S-6059; Moxalactam disodium [USAN:USP]; Shiomarin (TN); Prestwick_33; NCGC00017130-01; N-((6R,7R)-2-Carboxy-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-oxa-1-azabicyclo(4.2.0)oct-2-en-7-yl)-2-(p-hydroxyphenyl)m" C20H18N6Na2O9S GRIXGZQULWMCLU-HUTAOCTPSA-L "disodium;(6R,7R)-7-[[2-carboxylato-2-(4-hydroxyphenyl)acetyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate" n.a. n.a. Yes No Yes No No No PMDBD564 N6-methyladenosine Environmental Chemicals Unclassified Substance n.a. n.a. n.a. n.a. n.a. 102175 n.a. n.a. "N6-Methyladenosine; N-Methyladenosine; 1867-73-8; 6-Methyladenosine; N(6)-Methyladenosine; 6-Methylaminopurinosine; 6-Methylaminopurine riboside; 6-Methylaminopurine D-riboside; N6-methyladenosine (m6A); 6-Methylaminopurine ribonucleoside; (2R,3S,4R,5R)-2-(Hydroxymethyl)-5-(6-(methylamino)-9H-purin-9-yl)tetrahydrofuran-3,4-diol; UNII-CLE6G00625; CHEBI:21891; (N-6)-Methyladenosine; N(6)-monomethyladenosine; CHEMBL383144; CLE6G00625; NSC 29409; M6A; NSC-29409; (2R,3S,4R,5R)-2-Hydroxymethyl-5-(6-methylamino-p" C11H15N5O4 VQAYFKKCNSOZKM-IOSLPCCCSA-N (2R,3S,4R,5R)-2-(hydroxymethyl)-5-[6-(methylamino)purin-9-yl]oxolane-3,4-diol n.a. n.a. Yes No No No No No PMDBD567 Nafcillin sodium salt monohydrate Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 23704143 n.a. n.a. "Nafcillin sodium salt monohydrate; NAFCILLIN SODIUM; Nafcillin sodium monohydrate; 7177-50-6; Nafcillin sodium hydrate; Nafcil; UNII-49G3001BCK; Nafcillin (sodium monohydrate); Wy 3277; CHEBI:51919; 49G3001BCK; WY-3277; NCGC00017070-01; CAS-7177-50-6; DSSTox_RID_80967; DSSTox_CID_25570; DSSTox_GSID_45570; Nafcillin natrium-1-wasser; SMR000653476; Naphthicillin; Nafcillin sodium [USAN:USP]; Unipen (TN); Nafcillin sodium (USP); Monosodium (2S,5R,6R)-6-(2-ethoxy-1-naphthamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-c" C21H23N2NaO6S OCXSDHJRMYFTMA-KMFBOIRUSA-M "sodium;(2S,5R,6R)-6-[(2-ethoxynaphthalene-1-carbonyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate;hydrate" n.a. n.a. Yes No Yes No No No PMDBD568 Nafronyl oxalate Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 312915 n.a. n.a. "Nafronyl oxalate; 3200-06-4; Naftidrofuryl oxalate; Nafronyl oxalate salt; Naftidrofuryl (oxalate); 2-(Diethylamino)ethyl 3-(naphthalen-1-yl)-2-((tetrahydrofuran-2-yl)methyl)propanoate oxalate; Dusodril; Dubimax; Praxilene; Iridus; LS-121; EU-1806; DSSTox_RID_80935; DSSTox_CID_25533; DSSTox_GSID_45533; naftidrofuryl hydrogen oxalate; UNII-5ADB8D9388; CHEMBL1439099; SMR000539007; 2-Furanpropanoic acid, tetrahydro-a-(1-naphthalenylmethyl)-,2-(diethylamino)ethyl ester, ethanedioate (1:1); Nafronyl oxalate salt, analytical standar" C26H35NO7 SSAJNPNVUYMUCI-UHFFFAOYSA-N "2-(diethylamino)ethyl 2-(naphthalen-1-ylmethyl)-3-(oxolan-2-yl)propanoate;oxalic acid" n.a. n.a. No Yes No No No No PMDBD570 Naftopidil dihydrochloride Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 11957660 n.a. n.a. "NAFTOPIDIL DIHYDROCHLORIDE; 57149-08-3; Naftopidil DiHCl; Avishot; Flivas; 1-(4-(2-methoxyphenyl)piperazin-1-yl)-3-(naphthalen-1-yloxy)propan-2-ol dihydrochloride; C24H30Cl2N2O3; 1-[4-(2-methoxyphenyl)-1-piperazinyl]-3-(1-naphthoxy)-2-propanol dihydrochloride; SR-01000002977; Naftopidil dihydrochloride [MI]; Naftopidil 2HCl; KT-611 dihydrochloride; Naftopidil.Dihydrochloride; EU-0100941; Naftopidil (dihydrochloride); SCHEMBL1322047; CHEMBL1593765; HMS1571C11; KS-00000GR4; Tox21_500941; s1387" C24H30Cl2N2O3 HZVCEQMJXMUXJF-UHFFFAOYSA-N "1-[4-(2-methoxyphenyl)piperazin-1-yl]-3-naphthalen-1-yloxypropan-2-ol;dihydrochloride" n.a. n.a. Yes No Yes No No No PMDBD571 Nalidixic acid sodium salt Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 3864541 n.a. n.a. "Nalidixic acid sodium salt; Baktogram; 3374-05-8; Nalidixic acid sodium; Sodium nalidixate; NALIDIXATE SODIUM; Dixilina; Chemiurin; Nalidixic acid (sodium salt); UNII-Y7NU182221; Nalidixate sodium anhydrous [USAN]; EINECS 222-159-7; Y7NU182221; Win 18320; sodium 1-ethyl-7-methyl-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylate; Sodium 1-ethyl-1,4-dihydro-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylate; 1-Ethyl-1,4-dihydro-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylic acid sodium salt; Nalidixate sodium anhydrous; 1,8-Naphthy" C12H11N2NaO3 ROKRAUFZFDQWLE-UHFFFAOYSA-M "sodium;1-ethyl-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylate" n.a. n.a. Yes No Yes No No No PMDBD573 Naproxen(+) Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 156391 n.a. n.a. "NAPROXEN; 22204-53-1; (S)-Naproxen; (+)-Naproxen; Naprosyn; Naproxene; Equiproxen; Aleve; (S)-(+)-Naproxen; Laraflex; d-Naproxen; (S)-(+)-2-(6-Methoxy-2-naphthyl)propionic acid; Naproxenum; Calosen; Nycopren; Naproxeno; Naprosyne; Bonyl; Naixan; Reuxen; Axer; (+)-(S)-Naproxen; Ec-Naprosyn; (S)-2-(6-methoxynaphthalen-2-yl)propanoic acid; (2S)-2-(6-methoxynaphthalen-2-yl)propanoic acid; Flexipen; Clinosyn; Artrixen; Anexopen; Acusprain; Leniartil; Danaprox; Bipronyl; Artroxen; Novonaprox; Arthrisil; Napren; Naposin; Napflam; Genoxen; Daprox; Atiflan" C14H14O3 CMWTZPSULFXXJA-VIFPVBQESA-N (2S)-2-(6-methoxynaphthalen-2-yl)propanoic acid n.a. n.a. No Yes No No No No PMDBD578 Nefazodone HCl Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 54911 n.a. n.a. "NEFAZODONE HYDROCHLORIDE; 82752-99-6; Nefazodone Hcl; Dutonin; Serzone; Menfazona; Rulivan; Reseril; Nefazodone (hydrochloride); 1-(3-(4-(3-Chlorophenyl)piperazin-1-yl)propyl)-3-ethyl-4-(2-phenoxyethyl)-1H-1,2,4-triazol-5(4H)-one hydrochloride; BMY 13754; 2-[3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl]-5-ethyl-2,4-dihydro-4-(2-phenoxyethyl)-3H-1,2,4-triazol-3-one hydrochloride; BMY-13754; Nefadar; UNII-27X63J94GR; MJ-13754-1; CHEBI:7495; MJ 13,754-1; 27X63J94GR; 1-(3-(4-(m-Chlorophenyl)-1-piperazinyl)propyl)-3-ethyl-4-(2-pheno" C25H33Cl2N5O2 DYCKFEBIOUQECE-UHFFFAOYSA-N "2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-5-ethyl-4-(2-phenoxyethyl)-1,2,4-triazol-3-one;hydrochloride" n.a. n.a. Yes No No No No No PMDBD580 Neoprontosil Therapeutic Substance anti-infective n.a. n.a. n.a. n.a. n.a. 8625 n.a. n.a. "Neoprontosil; AZOSULFAMIDE; 132-38-7; CHEMBL237251; PRONTOCIL; Neoprontosil, disodium salt; Neoprontsil; AABSSN; 2,7-Naphthalenedisulfonic acid, 6-(acetylamino)-3-[[4-(aminosulfonyl)phenyl]azo]-4-hydroxy-, disodium salt; DTXSID0074500; CTK0H9987; ZINC28863804; BDBM50221406; ZINC261161909; NS00041391; 6-acetamido-4-hydroxy-3-((4-sulfamoylphen" C18H16N4O10S3 RALNLQYPLYWQRT-UHFFFAOYSA-N 6-acetamido-4-hydroxy-3-[(4-sulfamoylphenyl)diazenyl]naphthalene-2,7-disulfonic acid n.a. n.a. No Yes No No No No PMDBD581 Neostigmine bromide Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 8246 n.a. n.a. "neostigmine bromide; 114-80-7; Neoserine bromide; Eustigmin bromide; neo-Proserin; Proserine bromide; Stigmanol bromide; Synstigmin bromide; Leostigmine bromide; Prostigmin; Philostigmin bromide; Kirkstigmine bromide; Stigmosan bromide; Prostigmin bromide; Neostigmine methyl bromide; Prostigmine bromide; Vagostigmine bromide; Syntostigmin bromide; Neostigmini bromidum; Synstigmini bromidum; Vagostigmin; 3-((Dimethylcarbamoyl)oxy)-N,N,N-trimethylbenzenaminium bromide; Syntostigmine bromide; Synthostigmine bromide; Syntostigmin (tab" C12H19BrN2O2 LULNWZDBKTWDGK-UHFFFAOYSA-M "[3-(dimethylcarbamoyloxy)phenyl]-trimethylazanium;bromide" n.a. n.a. No Yes No No No No PMDBD597 Nitrobenzodiazepine Therapeutic Substance Drug Class n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No Yes No No PMDBD604 Nonfermented soybean milk Dietary Substance Drinks n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD605 Nopal Herbal Substance Medicinal Herb n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No Yes No No No PMDBD606 Norcyclobenzaprine Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD609 Novobiocin sodium salt Therapeutic Substance Approved Drug (veterinary medicine) n.a. n.a. n.a. n.a. n.a. 54730021 n.a. n.a. "Novobiocin sodium salt; 1476-53-5; Albamycin;Cathomycin; CHEMBL2079809; HMS3374H11; HMS3656A08; VA11981; MCULE-6200351849; AK163556; SC-20129; AS-57689; FT-0673157; Z1583387385; sodium 4-[(7-{[4-(carbamoyloxy)-3-hydroxy-5-methoxy-6,6-dimethyloxan-2-yl]oxy}-4-hydroxy-8-methyl-2-oxo-2H-chromen-3-yl)carbamoyl]-2-(3-methylbut-2-en-1-yl)benzen-1-olate; Benzamide,N-[7-[[3-O-(aminocarbonyl)-6-deoxy-5-C-methyl-4-O-methyl-a-L-lyxo-hexopyranosyl]oxy]-4-hydroxy-8-methyl-2-oxo-2H-1-benzopyran-3-yl]-4-hydroxy-3-(3-methyl-2-buten-1-yl" C31H35N2NaO11 WWPRGAYLRGSOSU-UHFFFAOYSA-M "sodium;4-[[7-(4-carbamoyloxy-3-hydroxy-5-methoxy-6,6-dimethyloxan-2-yl)oxy-4-hydroxy-8-methyl-2-oxochromen-3-yl]carbamoyl]-2-(3-methylbut-2-enyl)phenolate" n.a. n.a. Yes No Yes No No No PMDBD610 NSAIDs Therapeutic Substance compound n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No Yes No No PMDBD612 Oil tea Herbal Substance Medicinal Herb n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD613 Okara (soy pulp/soy fiber) Dietary Substance Dietary Compounds n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No Yes No No No PMDBD615 Oligofructose Herbal Substance Medicinal Herbal Compounds n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD616 Oligomeric-rich fraction grape seed extract Dietary Substance Dietary Compounds n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD617 Olmesartan medoxomil Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 130881 n.a. n.a. "Olmesartan medoxomil; 144689-63-4; Benicar; Olmetec; CS-866; Cs 866; UNII-6M97XTV3HD; 6M97XTV3HD; C29H30N6O6; NCGC00095136-01; 1H-Imidazole-5-carboxylic acid, 4-(1-hydroxy-1-methylethyl)-2-propyl-1-((2''-(1H-tetrazol-5-yl)(1,1''-biphenyl)-4-yl)methyl)-, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester; 1H-Imidazole-5-carboxylic acid, 4-(1-hydroxy-1-methylethyl)-2-propyl-1-((2''-(1H-tetrazol-5-yl) (1,1''-biphenyl)-4-yl)methyl)-, (5-methyl-2-oxo-1,3-dioxol-4-yl) methyl ester; Olvance; Olsertain; Benevas" C29H30N6O6 UQGKUQLKSCSZGY-UHFFFAOYSA-N (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 5-(2-hydroxypropan-2-yl)-2-propyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylate n.a. n.a. No Yes No No No No PMDBD620 Oorethindrone acetate Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No Yes No No PMDBD621 Oorgestimate Therapeutic Substance Approved Drug 35189-28-7 DB00957 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No Yes No No PMDBD622 Ooscapine Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD625 Orphenadrine citrate Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 83823 n.a. n.a. "Orphenadrine citrate; 4682-36-4; Banflex; Flexon; Flexoject; Orphenadrine dihydrogen citrate; Orphenadrine (Citrate); X-Otag; Plenactol; Flexor; Euflex; Tega-Flex; Norflex (pharmaceutical); 2-hydroxypropane-1,2,3-tricarboxylic acid; dimethyl({2-[(2-methylphenyl)(phenyl)methoxy]ethyl})amine; Orphenadrine citrate salt; EINECS 225-137-5; Orphenadrine citrate [USP]; Orphenadrine citrate (Norflex); CHEBI:7790; 4596-23-0; NCGC00094745-01; N,N-Dimethyl-2-((o-methyl-alpha-phenylbenzyl)oxy)ethylamine citrate (1:1); Orphenadrine citrate (" C24H31NO8 MMMNTDFSPSQXJP-UHFFFAOYSA-N "N,N-dimethyl-2-[(2-methylphenyl)-phenylmethoxy]ethanamine;2-hydroxypropane-1,2,3-tricarboxylic acid" n.a. n.a. No Yes No No No No PMDBD626 Oxacillin sodium Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 23667631 n.a. n.a. "Oxacillin sodium salt; OXACILLIN SODIUM; Oxabel; 1173-88-2; Prostaphlin; Staphcillin V; Oxabel Sodium salt; Monosodium oxacillin; Bristopen; Stapenor; Resistopen; Micropenin; Sodium oxacillin; Oxacillin (sodium salt); Oxacillin sodium (VAN); Oxacillin sodium anhydrous; UNII-4TWD2995UP; Cryptocillin; CHEBI:52134; BRL 1400; EINECS 214-636-3; Bactocill; Sodium methylphenylisoaxazolylpenicillin; NSC 527712; 4TWD2995UP; 5-Methyl-3-phenyl-4-isoxazolyl penicillin, sodium; SQ-16423; Bactocill In Plastic Container; 4-Thia-1-azabicyclo[3.2.0]he" C19H18N3NaO5S VDUVBBMAXXHEQP-SLINCCQESA-M "sodium;(2S,5R,6R)-3,3-dimethyl-6-[(5-methyl-3-phenyl-1,2-oxazole-4-carbonyl)amino]-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate" n.a. n.a. Yes No Yes No No No PMDBD630 Oxethazaine Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 4621 n.a. n.a. "Oxethazaine; Oxetacaine; 126-27-2; Oxethacaine; Mucaine; Oxaethacainum; Oxaine; Stomacain; Muthesa; Betalgil; Topicain; Oxethacaina [Italian]; oxethazine; Tepilta; Oxetacainum [INN-Latin]; Oxetacaina [INN-Spanish]; UNII-IP8QT76V17; CCRIS 4692; EINECS 204-780-5; WY 806; FH 099; BRN 2404063; CHEMBL127592; IP8QT76V17; CHEBI:31947; Wy-806; Oxetacaine (INN); Oxetacaine [INN]; 2,2''-((2-Hydroxyethyl)imino)bis(N-(1,1-dimethyl-2-phenylethyl)-N-methylacetamide); NCGC00016382-01; CAS-126-27-2; 2-Di(N-methyl-N-phenyl-tert-butyl-carbamoylmethyl)amino" C28H41N3O3 FTLDJPRFCGDUFH-UHFFFAOYSA-N 2-[2-hydroxyethyl-[2-[methyl-(2-methyl-1-phenylpropan-2-yl)amino]-2-oxoethyl]amino]-N-methyl-N-(2-methyl-1-phenylpropan-2-yl)acetamide n.a. n.a. Yes No Yes No No No PMDBD631 Oxibendazol Therapeutic Substance Approved Drug (veterinary medicine) n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD632 Oxiconazole Nitrate Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 9556529 n.a. n.a. "Oxiconazole nitrate; Oxistat; Myfungar; Oceral; 64211-46-7; oxiconazole; Sgd 301-76; ST 813; UNII-RQ8UL4C17S; EINECS 264-730-3; Oxiconazole nitrate [USAN:JAN]; ST-813; RQ8UL4C17S; CHEBI:7826; 2'',4''-Dichloro-2-imidazol-1-ylacetophenone (Z)-(O-(2,4-dichlorobenzyl)oxime), mononitrate; RO-13-8996; NCGC00095170-01; DSSTox_RID_81241; 2'',4''-Dichloro-2-imidazol-1-ylacetophenone (Z)-(o-(2,4-dichlorobenzyl))oxime nitrate; DSSTox_CID_25943; DSSTox_GSID_45943; Ro 13-8996; Ethanone, 1-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl)-, O-((2,4-dichl" C18H14Cl4N4O4 WVNOAGNOIPTWPT-NDUABGMUSA-N "(Z)-1-(2,4-dichlorophenyl)-N-[(2,4-dichlorophenyl)methoxy]-2-imidazol-1-ylethanimine;nitric acid" n.a. n.a. Yes No Yes No No No PMDBD634 Oxybutynin chloride Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 91505 n.a. n.a. "Oxybutynin chloride; Oxybutynin hydrochloride; 1508-65-2; Oxybutynin HCl; Dridase; Tropax; Oxybutynin (chloride); Ditropan Xl; Oxibutinina hydrochloride; EINECS 216-139-7; 4-(Diethylamino)but-2-ynyl cyclohexylphenylglycolate hydrochloride; alpha-Phenylcyclohexaneglycolic acid 4-(diethylamino)-2-butynyl ester hydrochloride; MLS000069688; MJ 4309-1; SMR000058490; 4-Diethylamino-2-butynyl phenyl(cyclohexyl)glycolate hydrochloride; 4-(Diethylamino)-2-butynyl alpha-phenylcyclohexaneglycolate hydrochloride" C22H32ClNO3 SWIJYDAEGSIQPZ-UHFFFAOYSA-N "4-(diethylamino)but-2-ynyl 2-cyclohexyl-2-hydroxy-2-phenylacetate;hydrochloride" n.a. n.a. No Yes No Yes No No PMDBD635 Oxytetracycline dihydrate Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 54680691 n.a. n.a. "Oxytetracycline dihydrate; 6153-64-6; OXTC; Oxytetracyclini dihydras; Hydroxytetrazyklindihydrat; Oxytetracyclinium dihydricum; UNII-X20I9EN955; CCRIS 9079; Oxytetracycline (dihydrate); X20I9EN955; (4S,4aR,5S,5aR,6S,12aS)-4-(dimethylamino)-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide dihydrate; Terramycin (TN); Oxytetracycline base; DSSTox_CID_3412; DSSTox_RID_77015; DSSTox_GSID_23412; 4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-met" C22H28N2O11 IMLJLCJZQLGHJS-JEKSYDDFSA-N "(4S,4aR,5S,5aR,6S,12aR)-4-(dimethylamino)-1,5,6,10,11,12a-hexahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;dihydrate" n.a. n.a. Yes No Yes No No No PMDBD641 Parbendazole Therapeutic Substance Approved Drug (veterinary medicine) n.a. n.a. n.a. n.a. n.a. 26596 n.a. n.a. "Parbendazole; 14255-87-9; Helmatac; Methyl (5-butyl-1H-benzo[d]imidazol-2-yl)carbamate; Worm Guard; Verminum; Parbendazol; Helatac; PBDZ; SKF 29044; UNII-N4X8WVX2UG; Carbamic acid, (5-butyl-1H-benzimidazol-2-yl)-, methyl ester; Parbendazol [INN-Spanish]; Parbendazolum [INN-Latin]; METHYL 5-BUTYL-2-BENZIMIDAZOLECARBAMATE; SK&F 29044; 5-Butyl-2-(carbomethoxyamino)benzimidazole; TCMDC-131798; EINECS 238-133-3; SKF-29044; N4X8WVX2UG; 5-Butyl-2-benzimidazolecarbamic acid methyl ester; methyl N-(6-butyl-1H-benzimidazol-2-yl)carbam" C13H17N3O2 YRWLZFXJFBZBEY-UHFFFAOYSA-N methyl N-(6-butyl-1H-benzimidazol-2-yl)carbamate n.a. n.a. Yes No No No No No PMDBD643 Partially hydrolyzed soy protein isolate Dietary Substance Dietary Compounds n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD646 Pefloxacine Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 51081 n.a. n.a. "Pefloxacin; 70458-92-3; Pefloxacine; Pefloxacino; Pefloxacinum; PFLX; Pefloxacin [INN-French]; Pefloxacinum [INN-Latin]; Pefloxacino [INN-Spanish]; 1-ethyl-6-fluoro-7-(4-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid; AM-725; 1584RB; UNII-2H52Z9F2Q5; EU-5306; EU 5306; C17H20FN3O3; EINECS 274-611-8; 1-ethyl-6-fluoro-7-(4-methylpiperazin-1-yl)-4-oxo-quinoline-3-carboxylic acid; 1589 RB; BRN 0567618; CHEBI:50199; 2H52Z9F2Q5; 1-Ethyl-6-fluoro-1,4-dihydro-7-(4-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid" C17H20FN3O3 FHFYDNQZQSQIAI-UHFFFAOYSA-N 1-ethyl-6-fluoro-7-(4-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid n.a. n.a. Yes No Yes No No No PMDBD647 Pemirolast potassium Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 443866 n.a. n.a. "PEMIROLAST POTASSIUM; 100299-08-9; Alamast; Pemilaston; Pemirolast potassium salt; BMY 26517; UNII-497A17OUUE; BMY-26517; Alegysal; CCRIS 3562; Pemirolast potassium [USAN:JAN]; TWT-8152; 497A17OUUE; TBX; DSSTox_RID_81773; DSSTox_CID_26623; 9-Methyl-3-(1H-tetrazol-5-yl)-4H-pyrido(1,2-a)pyrimidin-4-one, potassium salt; DSSTox_GSID_46623; potassium 5-(9-methyl-4-oxo-4H-pyrido[1,2-a]pyrimidin-3-yl)tetrazol-1-ide; 9-Methyl-3-(1H-tetrazol-5-yl)-4H-pyrido[1,2-a]pyrimidin-4-one Potassium Salt; 4H-Pyrido(1,2-a)pyrimidin-4-one, 9-methyl" C10H7KN6O NMMVKSMGBDRONO-UHFFFAOYSA-N "potassium;9-methyl-3-(1,2,3-triaza-4-azanidacyclopenta-2,5-dien-5-yl)pyrido[1,2-a]pyrimidin-4-one" n.a. n.a. Yes Yes No No No No PMDBD648 Penbutolol sulfate Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 38010 n.a. n.a. "PENBUTOLOL SULFATE; 38363-32-5; Levatol; Penbutolol sulfato [Spanish]; CCRIS 1108; HOE 39-893d; UNII-US71433228; HOE 893d; EINECS 253-906-5; (-)-Terbuclomine; US71433228; (-)-1-(tert-Butylamino)-3-(o-cyclopentylphenoxyl)-2-propanol sulfate; (S)-1-(tert-Butylamino)-3-(o-cyclopentylphenoxy)-2-propanol sulfate (2:1) (salt); (S)-1-(2-Cyclopentylphenoxy)-3-((1,1-dimethylethyl)amino)-2-propanol sulfate (2:1) (salt); Hoe-893d; Penbutolol sulfato; (S)-Bis(di-tert-butyl(3-(2-cyclopentylphenoxy)-2-hydroxypropyl)ammonium) sulphate; C1" C36H60N2O8S FEDSNBHHWZEYTP-ZFQYHYQMSA-N "(2S)-1-(tert-butylamino)-3-(2-cyclopentylphenoxy)propan-2-ol;sulfuric acid" n.a. n.a. No Yes No Yes No No PMDBD649 Pentamidine isethionate Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 8813 n.a. n.a. "PENTAMIDINE ISETHIONATE; 140-64-7; Pentamidine isethionate salt; Pentamidine diisethionate; 4,4''-(Pentane-1,5-diylbis(oxy))dibenzimidamide bis(2-hydroxyethanesulfonate); Pentamidine isetionate; Pentamidine (isethionate); Pentacarinat; Lomidine; Diamidine; UNII-V2P3K60DA2; Pneumopent; Lomidin; Pentamidine isothionate; Lomidine isoethionate; PENTAM; RP 2512; V2P3K60DA2; CHEBI:7977; 4,4''-(Pentamethylenedioxy)dibenzamidine bis(2-hydroxyethanesulfonate); 1,5-Bis(p-amidinophenoxy)pentane bis(2-hydroxyethanesulfonate salt); USAF XR-10" C23H36N4O10S2 YBVNFKZSMZGRAD-UHFFFAOYSA-N "4-[5-(4-carbamimidoylphenoxy)pentoxy]benzenecarboximidamide;2-hydroxyethanesulfonic acid" n.a. n.a. Yes No Yes No No No PMDBD652 Perhexiline maleate Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 5284439 n.a. n.a. "Perhexiline maleate; 6724-53-4; Perhexiline maleate salt; Pexid; 2-(2,2-Dicyclohexylethyl)piperidine maleate; Perhexiline maleate [USAN]; CCRIS 5491; C19H35N.C4H4O4; EINECS 229-775-5; MLS000028601; MLS001077289; 2-(2,2-Dicyclohexylethyl)piperidine acid maleate; 2-(2,2-Dicyclohexylethyl)piperidine maleate (1:1); 2-(2,2-Dicyclohexylethyl)piperidinium hydrogen maleate; Piperidine, 2-(2,2-dicyclohexylethyl)-, maleate (1:1); NCGC00095025-01; SMR000058713; Piperidine, 2-(2,2-dicyclohexylethyl)-, (Z)-2-butenedioate (1:1); DSSTox_CI" C23H39NO4 JDZOTSLZMQDFLG-BTJKTKAUSA-N "(Z)-but-2-enedioic acid;2-(2,2-dicyclohexylethyl)piperidine" n.a. n.a. Yes No No No No No PMDBD653 Pericyazine Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 4747 n.a. n.a. "periciazine; Propericiazine; PERICYAZINE; Piperocyanomazine; Neuleptil; 2622-26-6; Periciazinum; Nemactil; Neulactil; Aolept; propericyazine; Periciazina; Bayer 1409; Periciazine [INN]; Periciazinum [INN-Latin]; Periciazina [INN-Spanish]; 2-Cyano-10-(3-(4-hydroxy-1-piperidyl)propyl)phenothiazine; 10-(3-(4-Hydroxypiperidino)propyl)phenothiazine-2-carbonitrile; SKF 20,716; IC 6002; 6909 RP; WH 7508; RP 8908; 2-Cyano-10-(3-(4-hydroxypiperidino)propyl)phenothiazine; UNII-3405M6FD73; F.I. 6145; EINECS 220-071-3; Cyano-3 ((hydroxy-4 piperi" C21H23N3OS LUALIOATIOESLM-UHFFFAOYSA-N 10-[3-(4-hydroxypiperidin-1-yl)propyl]phenothiazine-2-carbonitrile n.a. n.a. No Yes No No No No PMDBD656 Persistent organic pollutant Environmental Chemicals Industrial Chemicals and Pollutants n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD660 Phenethicillin potassium salt Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 23675317 n.a. n.a. "phenethicillin potassium; Pheneticillin potassium; Penicillin-152 potassium; Phenethicillin potassium salt; Synthecillin; Alfacillin; Synthecilline; Feneticilline; Synerpenin; Astracillin; Synapen; Semopen; Peniplus; Oralopen; Maxipen; Bendralan; Alticina; Priospen; Chemipen; Triospen; Syncillin; Penemve; Optipen; Brocsil; Pensig; Penova; Broxil; Darcil; alpha-Oracillin; Synthepen tabl; Penicillin mv; Dramcillin-S; K Phenethicillin; Chemipen-C; Ro-Cillin; A-Phenoxyethylpenicillinic acid potassium salt; CHEBI:31987; 132-93-4; Pheno-M-penicillin" C17H19KN2O5S ORMNNUPLFAPCFD-DVLYDCSHSA-M "potassium;(2S,5R,6R)-3,3-dimethyl-7-oxo-6-(2-phenoxypropanoylamino)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate" n.a. n.a. Yes No Yes No No No PMDBD663 Phenytoin sodium Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 657302 n.a. n.a. "PHENYTOIN SODIUM; 630-93-3; Dilantin sodium; Diphenylhydantoin Sodium; 5,5-Diphenylhydantoin sodium salt; Diphantoine; Fenidantoin; Novodiphenyl; Citrullamon; Epsolin; Epdantoin; Ditomed; Fenytoin; Fenigramon; Enkefal; Derizene; Phenilep; Hidantin; Dihydan; Alepsin; Tacosal; Fenitron; Eptolin; Epileptin; Decatona; Cumatil; Aladdin; Episar; Muldis; Ditoin; Lepitoin sodium; Hidantal sodium; Fenitoin sodium; Denyl sodium; Sodium phenytoin; Diphenine sodium; Aleviatin sodium; Fenitoina Sodica; Epilantin-E; Soluble phenytoin; Diphenylan sodium; Metinal" C15H11N2NaO2 FJPYVLNWWICYDW-UHFFFAOYSA-M "sodium;5,5-diphenylimidazolidin-3-ide-2,4-dione" n.a. n.a. No Yes No No No No PMDBD666 Phosphate or sulfate ester prodrugs Therapeutic Substance Drug Class n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD667 Physical activity Others Others n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD670 Pimethixene maleate Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 5702167 n.a. n.a. "PIMETHIXENE MALEATE; 13187-06-9; UNII-U22U244M9X; EINECS 236-141-1; BP-400; 9-(N-Methyl-piperidyliden-4)thioxane maleate; U22U244M9X; 9-(1-Methyl-4-piperidylene)thioxanthene maleate; Thioxanthene, 9-(1-methyl-4-piperidylene)-, maleate; NCGC00094897-01; 1-Methyl-4-(9H-thioxanthen-9-ylidene)piperidinium hydrogen maleate; DSSTox_RID_81183; DSSTox_CID_25863; DSSTox_GSID_45863; Pimethixen maleate salt; SR-01000872656; CAS-13187-06-9; Prestwick_656; Pimethixene maleate salt; SCHEMBL301225; SPECTRUM1501114; DTXSID7045863; CHEMBL1523827" C23H23NO4S IPANUAHQWFDVAG-BTJKTKAUSA-N "(Z)-but-2-enedioic acid;1-methyl-4-thioxanthen-9-ylidenepiperidine" n.a. n.a. Yes No No No No No PMDBD672 Pinaverium bromide Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 40703 n.a. n.a. "PINAVERIUM BROMIDE; 53251-94-8; Dicetel; Pinaverium bromide [INN]; Pinaverii bromidum [INN-Latin]; LAT 1717; Bromuro de pinaverio [INN-Spanish]; Bromure de pinaverium [INN-French]; EINECS 258-450-0; Pinaverium bromide (INN); Morpholinium, 4-[(2-bromo-4,5-dimethoxyphenyl)methyl]-4-[2-[2-(6,6-dimethylbicyclo[3.1.1]hept-2-yl)ethoxy]ethyl]-, bromide (1:1); Pinaverii bromidum; UNII-7SCF54H12J; 4-(6-Bromoveratryl)-4-(2-(2-(6,6-dimethyl-2-norpinyl)ethoxy)ethyl)morpholinium bromide" C26H41Br2NO4 IKGXLCMLVINENI-UHFFFAOYSA-M "4-[(2-bromo-4,5-dimethoxyphenyl)methyl]-4-[2-[2-(6,6-dimethyl-2-bicyclo[3.1.1]heptanyl)ethoxy]ethyl]morpholin-4-ium;bromide" n.a. n.a. Yes No Yes No No No PMDBD676 Piperacillin sodium salt Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 23666879 n.a. n.a. "PIPERACILLIN SODIUM; 59703-84-3; Pipracil; Sodium piperacillin; PIPERACILLIN SODIUM SALT; Piperacillin (sodium); UNII-M98T69Q7HP; Pentcillin; MLS000069533; CHEBI:8233; M98T69Q7HP; Pipracil Sterile; SMR000058579; Zosyn Sterile; CCRIS 2591; T 1220; T-1220; EINECS 261-868-6; CL 227193; CL 227,193; Pentcillin (TN); Pipracil (TN); Sodium (2S,5R,6R)-6-((R)-2-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)-2-phenylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate" C23H26N5NaO7S WCMIIGXFCMNQDS-IDYPWDAWSA-M "sodium;(2S,5R,6R)-6-[[(2R)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate" n.a. n.a. Yes No Yes No No No PMDBD678 Pivmecillinam hydrochloride Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 115162 n.a. n.a. "pivmecillinam hydrochloride; 32887-03-9; Melysin; Pivmecillinam (hydrochloride); amdinocillin pivoxil hydrochloride; Selexid; Pivmecillinam HCl; UNII-48FX7N21H2; Pivmecilinamo clorhidrato [Spanish]; EINECS 251-278-7; pivmecilinamo clorhidrato; MLS002154128; 48FX7N21H2; FL-1039; CHEBI:51213; 4-Thia-1-azabicyclo[3.2.0]" C21H34ClN3O5S UHPXMYLONAGUPC-WKLLBTDKSA-N "2,2-dimethylpropanoyloxymethyl (2S,5R,6R)-6-(azepan-1-ylmethylideneamino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate;hydrochloride" n.a. n.a. Yes No No No No No PMDBD679 Pizotifen malate Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 168993 n.a. n.a. "Pizotifen malate; Pizotyline malate; 5189-11-7; Pizotifen (malate); Sanomtgran; Mosegor; Pizotifen hydrogen malate; Litec malate; Sandomygran malate; Sandomigran malate; BC 105 malate; C19H21NS.C4H6O5; CHEBI:50213; EINECS 225-970-4; 4-(9,10-dihydro-4H-benzo[4,5]cyclohepta[1,2-b]thiophen-4-ylidene)-1-methylpiperidine 2-hydroxysuccinate; Pizotifen maleate; Sandomigran (TN); Q-201591; Piperidine, 4-(9,10-dihydro-4H-benzo(4,5)cyclohepta(1,2-b)thien-4-ylidene)-1-methyl-, malate (1:1); Malic acid, compound with 4-(9,10-dihydro-4H-b" C23H27NO5S IWAWCPZVTXCFKD-UHFFFAOYSA-N "2-hydroxybutanedioic acid;1-methyl-4-(6-thiatricyclo[8.4.0.03,7]tetradeca-1(14),3(7),4,10,12-pentaen-2-ylidene)piperidine" n.a. n.a. Yes No No No No No PMDBD680 Plant-derived glycosides(amygdalin) Herbal Substance Medicinal Herbal Compounds n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD681 Plantago asiatica L. Herbal Substance Medicinal Herb n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No Yes No No No PMDBD682 Platinum chemotherapy Therapeutic Substance Drug Class n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD683 Polyaromatic compounds Environmental Chemicals Unclassified Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No Yes No No PMDBD684 Polyphenols "Herbal Substance; Dietary Substance" "Medicinal Herbal Compounds; Dietary Compounds" n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No Yes No No PMDBD685 Polyphenols (caffeic acid) Dietary Substance Dietary Compounds n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD686 Polyphenols (grape and/or cranberry extract) Dietary Substance Dietary Compounds n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD687 Polyphenols (resveratrol) Dietary Substance Dietary Compounds n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD688 Polysaccharide Herbal Substance Medicinal Herbal Compounds n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No Yes No No No PMDBD689 Polysaccharides (after cyclophosphamide administration) Dietary Substance Dietary Compounds n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD691 Polysorbate 81 Environmental Chemicals Industrial Chemicals and Pollutants n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD692 Pomegranate byproduct Dietary Substance Dietary Compounds n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD693 Pomegranate extract "Herbal Substance; Dietary Substance" "Herbal Substance; Dietary Substance" n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD694 Pomegranate peel extract Dietary Substance Dietary Compounds n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD695 Potassium oxonate Environmental Chemicals unknown n.a. n.a. n.a. n.a. n.a. 2723920 n.a. n.a. "Potassium oxonate; 2207-75-2; Oteracil potassium; Oxonic acid potassium salt; Allantoxanic acid potassium salt; Oxonic acid, potassium salt; Oxonate, potassium; potassium 4,6-dioxo-1,4,5,6-tetrahydro-1,3,5-triazine-2-carboxylate; Potassium azaorotate; Oxonate; Potassium 2,6-dihydroxytriazinecarboxylate; Potassium 4,6-Dihydroxy-1,3,5-triazine-2-carboxylate; UNII-4R7FFA00RX; 4R7FFA00RX; CHEBI:80230; Allantoxanic acid, potassium salt; 5-Azaorotic acid, potassium salt; Potassium 1,4,5,6-tetrahydro-4,6-dioxo-1,3,5-triazine-2-car" C4H2KN3O4 IAPCTXZQXAVYNG-UHFFFAOYSA-M "potassium;4,6-dioxo-1H-1,3,5-triazine-2-carboxylate" n.a. n.a. No Yes No No No No PMDBD696 Potentilla discolor Bunge Herbal Substance Medicinal Herb n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD697 PPIs Therapeutic Substance Drug Class n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD701 Prenylamine lactate Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 65557 n.a. n.a. "Prenylamine lactate; Angormin; Sedolatan; Irrorin; Incoran; Coredamin; Plactamin; Corontin; Reocorin; Crepasin; Seccidin; Roinin; Agozol; UNII-6J3J6SXI7V; 69-43-2; EINECS 200-705-5; Prenylamine lactate [JAN]; 6J3J6SXI7V; N-(3,3-Diphenylpropyl)-alpha-methylphenethylamine lactate; Prenylamine lactate (JAN); Phenethylamine, N-(3,3-diphenylpropyl)-alpha-methyl-, lactate; 3,3-diphenyl-N-(1-phenylpropan-2-yl)propan-1-amine;2-hydroxypropanoic acid; C24H27N.C3H6O3; Segontin (TN); Prestwick_878; MLS002153874; CHEMBL1367944; SCHEMBL10614915; HM" C27H33NO3 QPOFIDVRLWJICD-UHFFFAOYSA-N "3,3-diphenyl-N-(1-phenylpropan-2-yl)propan-1-amine;2-hydroxypropanoic acid" n.a. n.a. Yes No No No No No PMDBD702 Pridinol methanesulfonate salt Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 165542 n.a. n.a. "Pridinol methanesulfonate; 6856-31-1; Pridinol methanesulfonate salt; UNII-AQ4K0AJT6G; Prestwick_138; AQ4K0AJT6G; MLS000069569; SMR000058822; Loxeen; 1,1-diphenyl-3-piperidin-1-ylpropan-1-ol;methanesulfonic acid; SR-01000000125; C20H25NO.CH4O3S; EINECS 229-953-2; Pridinol (mesylate); Konlax (TN); Opera_ID_274; MLS002222172; MLS001074110; SPECTRUM1503077; SCHEMBL195084; REGID_for_CID_165542; CHEMBL1528011; HMS502E08; DTXSID40218667; HMS3370K22; HMS2233N07; Pharmakon1600-01503077; HMS1922C17; HMS3714O20; HMS2097O20; HMS1570O20; CCG-39523" C21H29NO4S VNJHUUNVDMYCRH-UHFFFAOYSA-N "1,1-diphenyl-3-piperidin-1-ylpropan-1-ol;methanesulfonic acid" n.a. n.a. Yes No No No No No PMDBD703 Prilocaine hydrochloride Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 92163 n.a. n.a. "Prilocaine hydrochloride; 1786-81-8; Propitocaine hydrochloride; Prilocaine HCl; Xylonest; Prilocaine chloride; Citanest hydrochloride; Citanest plain; Prilocaine (hydrochloride); Astra 1512; N-(2-Methylphenyl)-2-(propylamino)propanamide hydrochloride; 2-(Propylamino)-o-propionotoluidide hydrochloride; L-67; EINECS 217-244-0; MFCD00079279; MLS000069690; Propanamide, N-(2-methylphenyl)-2-(propylamino)-, hydrochloride (1:1); 2-(Propylamino)-o-propionotoluidide monohydrochloride; alpha-Propylamine-2-methyl-prop" C13H21ClN2O BJPJNTKRKALCPP-UHFFFAOYSA-N "N-(2-methylphenyl)-2-(propylamino)propanamide;hydrochloride" n.a. n.a. Yes No No No No No PMDBD704 Primaquine phosphate Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 6135 n.a. n.a. "primaquine diphosphate; 63-45-6; PRIMAQUINE PHOSPHATE; Primaquine bisphosphate; Primaquine (Diphosphate); Primaquine bis(phosphate); 1,4-Pentanediamine, N4-(6-methoxy-8-quinolinyl)-, phosphate (1:2); CCRIS 1946; EINECS 200-560-8; NSC 149765; Primaquine phosphate;Primaquine bisphosphate; 8-((4-Amino-1-methylbutyl)amino)-6-methoxyquinoline diphosphate; 8-((4-Amino-1-methylbutyl)amino)-6-methoxyquinoline phosphate (1:2); DSSTox_RID_80773; DSSTox_CID_25248; DSSTox_GSID_45248; Primaquine diphosphate, 98%" C15H27N3O9P2 GJOHLWZHWQUKAU-UHFFFAOYSA-N "4-N-(6-methoxyquinolin-8-yl)pentane-1,4-diamine;phosphoric acid" n.a. n.a. No Yes No No No No PMDBD705 Proadifen hydrochloride Environmental Chemicals Unclassified Substance n.a. n.a. n.a. n.a. n.a. 65341 n.a. n.a. "Proadifen hydrochloride; 62-68-0; Proadifen HCl; Propyladiphenin; SKF-525A hydrochloride; Proadifen (hydrochloride); SKF 525A; SK&F 525-A; RP 5171; Proadifen hydrochloride [USAN]; UNII-30624AA6X2; SKF 525-A; U 5446; NSC 39690; NSC 170997; 5171 RP; 2-Diethylaminoethyl 2,2-diphenylvalerate hydrochloride; 2-(Diethylamino)ethyl-2,2-diphenylvalerate hydrochloride; AI3-22677; 2''-Diethylaminoethyl 2,2-diphenylpentanoate hydrochloride; 5171 R. P.; Diethylaminoethanol ester of diphenylpropylacetic acid hydrochloride; 30624AA6X2" C23H32ClNO2 FHIKZROVIDCMJA-UHFFFAOYSA-N "2-(diethylamino)ethyl 2,2-diphenylpentanoate;hydrochloride" n.a. n.a. Yes No No No No No PMDBD706 Proanthocyanidin-rich grape seed extract Dietary Substance Dietary Compounds n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD708 Prochlorperazine dimaleate Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 5281032 n.a. n.a. "Prochlorperazine dimaleate; Prochlorperazine maleate; 84-02-6; Prochlorperazine dimaleate salt; UNII-I1T8O1JTL6; Buccastem; Emetiral; Vertigon; Pasotomin; Nibromin A; Meterazin maleate; Stemetil dimaleate; I1T8O1JTL6; Proclorperazine maleate; Prochlorperazinu dimaleat; Prochlorperazine bimaleate; C20H24ClN3S.2C4H4O4; Prochlorperazine hydrogen maleate; Prochloroproazine hydrogen maleate; Prochlorperazinu dimaleat [Czech]; EINECS 201-511-3; DSSTox_RID_83206; DSSTox_CID_28941; DSSTox_GSID_49015; CHEBI:8436" C28H32ClN3O8S DSKIOWHQLUWFLG-SPIKMXEPSA-N "(Z)-but-2-enedioic acid;2-chloro-10-[3-(4-methylpiperazin-1-yl)propyl]phenothiazine" n.a. n.a. Yes No No No No No PMDBD709 Promazine hydrochloride Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 5887 n.a. n.a. "PROMAZINE HYDROCHLORIDE; 53-60-1; Promazine Hcl; Starazin; Sparine; Talofen; Promazine (hydrochloride); Promazine monohydrochloride; UNII-U16EOR79U4; RP 4560; Chlorowodorek promazyny [Polish]; N,N-dimethyl-3-(10H-phenothiazin-10-yl)propan-1-amine hydrochloride; EINECS 200-179-7; NSC 17468; Promazine hydrochloride [USP]; AI3-28022; MLS000069671; U16EOR79U4; N-(3-(Dimethylamino)propyl)phenothiazine hydrochloride; 10-(3-(Dimethylamino)propyl)phenothiazine hydrochloride; Phenothiazine, 10-(3-(dimethylamino)propyl)-, hydrochloride" C17H21ClN2S JIVSXRLRGOICGA-UHFFFAOYSA-N "N,N-dimethyl-3-phenothiazin-10-ylpropan-1-amine;hydrochloride" n.a. n.a. Yes No Yes No No No PMDBD710 Promethazine hydrochloride Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 6014 n.a. n.a. "PROMETHAZINE HYDROCHLORIDE; 58-33-3; Promethazine Hcl; Phenergan; N,N-dimethyl-1-(10H-phenothiazin-10-yl)propan-2-amine hydrochloride; Fenergan; Farganesse; Diprazin; Pipolphen; Fellozine; Pipolfen; Romergan; Diprasine; Ganphen; Plletia; Remsed; Atosil; Promethazine (hydrochloride); Promethazine chloride; Promethiazin; Soporil; Proneurin; Primine; Kinetosin; Allerfen; Promine; Promantine; Lergigan; Histantil; Duplamin; Phencen; Phenadoz; Hibechin; Goodnight; Frinova; Closin; Bonnox; Dorme; Prome; Prometh Plain; Prometh Fortis; Eusedon Mono; Phenerg" C17H21ClN2S XXPDBLUZJRXNNZ-UHFFFAOYSA-N "N,N-dimethyl-1-phenothiazin-10-ylpropan-2-amine;hydrochloride" n.a. n.a. Yes No Yes No No No PMDBD711 Prontosil Therapeutic Substance antibacterial n.a. n.a. n.a. n.a. n.a. 66895 n.a. n.a. "prontosil; Sulfamidochrysoidine; Rubiazol; Prontosil rubrum; 103-12-8; UNII-Q64Q9N6Q6O; Q64Q9N6Q6O; CHEBI:8464; P-[(2,4-diaminophenyl)azo]benzenesulphonamide; p-((2,4-Diaminophenyl)azo)benzenesulphonamide; 4-[(2,4-diaminophenyl)diazenyl]benzenesulfonamide; p-[(2,4-diaminophenyl)azo]benzenesulphonamide;sulfamidochrysoidine; ulfamidochrysoidine; EINECS 203-081-2; Aseptil rojo (TN); AI3-09088; SCHEMBL155099; SCHEMBL155098; CHEMBL488279; CTK4A1757; DTXSID60145608; Relbazon; Streptocid" C12H13N5O2S ABBQGOCHXSPKHJ-UHFFFAOYSA-N 4-[(2,4-diaminophenyl)diazenyl]benzenesulfonamide n.a. n.a. No Yes No No No Yes EX_pront(e),PRONT_AR_NADi,PRONT_AR_NADPi,PRONT_GLC_GLCAASE,PRONT_GLC_GLCAASEe,PRONT_GLC_GLCAASEepp,PRONTt2r,PRONTt2rpp,PRONTte,PRONTtepp,PRONTtex PMDBD712 Propidium iodide Environmental Chemicals Unclassified Substance n.a. n.a. n.a. n.a. n.a. 104981 n.a. n.a. "propidium iodide; 25535-16-4; Propidium diiodide; 3,8-Diamino-5-(3-(diethyl(methyl)ammonio)propyl)-6-phenylphenanthridin-5-ium iodide; Propidium Iodine; Propidium (Iodide); UNII-TP416O228T; CHEBI:51240; EINECS 247-081-0; NSC 169541; 3,8-Diamino-5-[3-(diethylmethylammonio)propyl]-6-phenylphenanthridinium diiodide; 3,8-Diamino-5-(3-(diethylmethylammonio)propyl)-6-phenylphenanthridinium diiodide; TP416O228T; C27H34I2N4; 3,8-Diamino-5-(3-diethylaminopropyl)-6-phenylphenanthridinium iodide methiodide; Phenanthridinium, 3,8-dia" C27H34I2N4 XJMOSONTPMZWPB-UHFFFAOYSA-M "3-(3,8-diamino-6-phenylphenanthridin-5-ium-5-yl)propyl-diethyl-methylazanium;diiodide" n.a. n.a. Yes No Yes No No No PMDBD713 Protriptyline hydrochloride Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 6603149 n.a. n.a. "Protriptyline hydrochloride; 1225-55-4; Protriptyline HCl; Maximed; Vivactil; Concordin; Protriptyline (hydrochloride); Triptyl; Triptil hydrochloride; Normethyl EX4442; MK-240; UNII-44665V00O8; Triptil (VAN); MLS000069697; Vivactyl; MK-240 (VAN); SMR000058503; EINECS 214-956-3; 44665V00O8; 5H-Dibenzo[a,d]cycloheptene-5-propanamine, N-methyl-, hydrochloride (1:1); NSC 169912; DSSTox_RID_82027; DSSTox_CID_26951; DSSTox_GSID_46951; N-Methyl-5H-dibenzo(a,d)cycloheptene-5-propylamine hydrochloride; CHEBI:8598; 5-(3-Methylaminopropyl)-5H" C19H22ClN OGQDIIKRQRZXJH-UHFFFAOYSA-N "N-methyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenyl)propan-1-amine;hydrochloride" n.a. n.a. Yes No No No No No PMDBD716 Pyrvinium pamoate Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 54680693 n.a. n.a. "Pyrvinium pamoate; 3546-41-6; Pyrvinium embonate; Viprynium embonate; Vanquin; Pyrvinium pamoate salt hydrate; NSC 223622; Vermitibier; Vanquil; NCGC00017042-01; 4-[(3-carboxylato-2-hydroxynaphthalen-1-yl)methyl]-3-hydroxynaphthalene-2-carboxylate;2-[(E)-2-(2,5-dimethyl-1-phenylpyrrol-3-yl)ethenyl]-N,N,1-trimethylquinolin-1-ium-6-amine; Vipyrvinium embonate; Dipyrivinium Pamoate; CAS-3546-41-6; Povan (TN); DSSTox_CID_3545; DSSTox_RID_77072; DSSTox_GSID_23545; SCHEMBL62130; Pyrvinium pamoate (JAN/USP); CHEBI:8688; DTXSID4023545" C75H70N6O6 OOPDAHSJBRZRPH-UHFFFAOYSA-L "3-carboxy-1-[(3-carboxy-2-oxidonaphthalen-1-yl)methyl]naphthalen-2-olate;2-[(E)-2-(2,5-dimethyl-1-phenylpyrrol-3-yl)ethenyl]-N,N,1-trimethylquinolin-1-ium-6-amine" n.a. n.a. Yes No Yes No No No PMDBD718 Quercetin-3-glucoside "Herbal Substance; Dietary Substance" compound n.a. n.a. n.a. n.a. n.a. 5280804 n.a. n.a. "Isoquercitrin; Isoquercetin; 482-35-9; Quercetin 3-o-glucopyranoside; Quercetin 3-glucoside; 3-Glucosylquercetin; Glucosyl 3-quercetin; Quercetol 3-glucoside; Hirsutrin; Quercetin 3-O-glucoside; Quercetin 3-D-glucoside; Isotrifoliin; Quercetol 3-monoglucoside; Quercetin 3-monoglucoside; Quercetin 3-beta-glucoside; quercetin-3-glucoside; Quercetin-3-O-glucopyranoside; Quercetin 3-beta-O-glucoside; quercetin-3-O-glucoside; 3-beta-D-Glucosylquercetin; UNII-6HN2PC637T; NSC 115918; BRN 0100989; CHEMBL250450; 6HN2PC637T; CHEBI:68352; quer" C21H20O12 OVSQVDMCBVZWGM-QSOFNFLRSA-N 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one n.a. n.a. No Yes No No No No PMDBD719 Quetiapine hemifumarate Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 5281025 n.a. n.a. "Quetiapine fumarate; 111974-72-2; Quetiapine hemifumarate; Seroquel XR; Seroquel; ICI-204636; ICI 204,636; ZM 204636; UNII-2S3PL1B6UJ; Quetiapine fumarate [USAN]; ZD5077; 2S3PL1B6UJ; ZM 204,636; ICI 204636; 2-(2-(4-Dibenzo(b,f)(1,4)thiazepine-11-yl-1-piperazinyl)ethoxy)ethanol; 2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol hemifumarate; Ethanol, 2-(2-(4-dibenzo(b,f)(1,4)thiazepin-11-yl-1-piperazinyl)ethoxy)-, (E)-2-butenedioate (2:1) (salt); CHEBI:8708; FK949E" C46H54N6O8S2 ZTHJULTYCAQOIJ-WXXKFALUSA-N "2-[2-(4-benzo[b][1,4]benzothiazepin-6-ylpiperazin-1-yl)ethoxy]ethanol;(E)-but-2-enedioic acid" n.a. n.a. Yes No No No No No PMDBD720 Quinacrine dihydrochloride dihydrate Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 2725002 n.a. n.a. "Quinacrine dihydrochloride dihydrate; 6151-30-0; Quinacrine HCl; Quinacrine hydrochloride; Mepacrine hydrochloride; Atabrine hydrochloride dihydrate; Mepacrine hydrochloride dihydrate; Quinacrine hydrochloride dihydrate; Quinacrine 2HCl 2H2O; Quinacrine hydrochloride hydrate; Mepacrine HCl; DSSTox_RID_80962; DSSTox_CID_25565; 6-Chloro-9-((4-(diethylamino)-1-methylbutyl)amino)-2-methoxyacridine dihydrochloride dihydrate; DSSTox_GSID_45565; Acridine, 6-chloro-9-((4-(diethylamino)-1-methylbutyl)amino)-2-methoxy-, dihydrochlo" C23H36Cl3N3O3 RZFNKJVCPDLQQA-UHFFFAOYSA-N "4-N-(6-chloro-2-methoxyacridin-9-yl)-1-N,1-N-diethylpentane-1,4-diamine;dihydrate;dihydrochloride" n.a. n.a. Yes No No No No No PMDBD722 Qushi Huayu Fang Herbal Substance TCM Formula n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD723 R(-) Apomorphine hydrochloride hemihydrate Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 6852399 n.a. n.a. "MLS000069811; Apomorphine hydrochloride hemihydrate; 41372-20-7; SMR000059235; R-(-)-Apomorphine hydrochloride hemihydrate; SMR000653528; (R)-Apomorphine Hydrochloride Hemihydrate; Opera_ID_1132; MLS002153277; MLS002222153; MLS001074112; SCHEMBL5429071; C17H17NO2.ClH.H2O; CHEMBL1256708; HW2A207; 2223AH; AKOS030526144; NCGC00180984-01; SMR001307246; R(-) Apomorphine hydrochloride hemihydrate; MLS-0235817.0001; (R)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol hydrochloride hydrate" C17H20ClNO3 DQQCJDBYNZMPOA-FFXKMJQXSA-N "(6aR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol;hydrate;hydrochloride" n.a. n.a. Yes No No No No No PMDBD724 Rabeprazole Sodium salt Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 14720269 n.a. n.a. "RABEPRAZOLE SODIUM; 117976-90-6; Rebeprazole sodium; Pariet; Aciphex; Rabeprazole sodium salt; Rabeprazole (sodium); Aciphex Sprinkle; LY 307640 sodium; LY-307640; Rabeprazole sodium [USAN]; CHEBI:8769; LY307640 sodium; E 3810; E3810; Sodium rabeprazole; AK-94764; DSSTox_CID_24205; 2-(((4-(3-Methoxypropoxy)-3-methyl-2-pyridyl)methyl)sulfinyl)benzimidazole sodium salt; DSSTox_RID_80118; C18H20N3NaO3S; DSSTox_GSID_44205; 1H-Benzimidazole, 2-(((4-(3-methoxypropoxy)-3-methyl-2-pyridinyl)methyl)sulfinyl)-, sodium salt; Q-201655; Rabici" C18H20N3NaO3S KRCQSTCYZUOBHN-UHFFFAOYSA-N "sodium;2-[[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methylsulfinyl]benzimidazol-1-ide" n.a. n.a. Yes No Yes No No No PMDBD726 Racepinephrine HCl Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 5924 n.a. n.a. "329-63-5; DL-ADRENALINE HYDROCHLORIDE; (+/-)-Epinephrine hydrochloride; Racepinephrine hydrochloride; 4-(1-Hydroxy-2-(methylamino)ethyl)benzene-1,2-diol hydrochloride; DL-Epinephrine (hydrochloride); (+-)-Epinephrine hydrochloride; 1,2-Benzenediol, 4-[1-hydroxy-2-(methylamino)ethyl]-, hydrochloride; Asthmanefrin; (+-)-Adrenaline hydrochloride; (+/-)-ADRENALIN HYDROCHLORIDE; EINECS 206-346-0; Racepinephrine hydrochloride (USP); Racepinephrine hydrochloride [USP]; 4-[1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol, chlorid" C9H14ClNO3 ATADHKWKHYVBTJ-UHFFFAOYSA-N "4-[1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol;hydrochloride" n.a. n.a. Yes No No No No No PMDBD727 Radiation sensitizer misonidazole Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD728 Raloxifene hydrochloride Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 54900 n.a. n.a. "RALOXIFENE HYDROCHLORIDE; 82640-04-8; Raloxifene Hcl; Evista; Keoxifene hydrochloride; Keoxifene; (6-Hydroxy-2-(4-hydroxyphenyl)benzo[b]thiophen-3-yl)(4-(2-(piperidin-1-yl)ethoxy)phenyl)methanone hydrochloride; LY 156758; Raloxifene (hydrochloride); UNII-4F86W47BR6; C28H27NO4S.HCl; LY156758; CHEBI:50740; Evista (Raloxifene Hydrochloride); 4F86W47BR6; Optruma; LY-156758; 6-Hydroxy-2-(p-hydroxyphenyl)benzo(b)thien-3-yl-p-(2-piperidinoethoxy)phenyl ketone, hydrochloride; C28H28ClNO4S; DSSTox_RID_79119; DSSTox_CID_14181; DSSTox_GSI" C28H28ClNO4S BKXVVCILCIUCLG-UHFFFAOYSA-N "[6-hydroxy-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl]-[4-(2-piperidin-1-ylethoxy)phenyl]methanone;hydrochloride" n.a. n.a. Yes No No No No No PMDBD733 Red Ginseng Herbal Substance Medicinal Herb n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD734 Red meat (haem) Dietary Substance Foods n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD735 Red wine Dietary Substance Drinks n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD736 Red wine grape extract Dietary Substance Dietary Compounds n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD737 Regular soy milk Dietary Substance Drinks n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD743 Ribostamycin sulfate salt Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 6419922 n.a. n.a. "Ribostamycin sulfate salt; 53797-35-6; Prestwick_190; HMS1570G18" C17H36N4O14S RTCDDYYZMGGHOE-SAQGLUNGSA-N "5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[(2S,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol;sulfuric acid" n.a. n.a. Yes No No No No No PMDBD749 Riluzole hydrochloride Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 6419992 n.a. n.a. "Riluzole hydrochloride; 850608-87-6; 2-Amino-6-trifluoromethoxybenzothiazole hydrochloride; SMR000449311; SR-01000002997; Prestwick_644; CPD000449311; Riluzole (hydrochloride); MLS001424008; MLS000758261; SCHEMBL1394245; CHEMBL1531817; HY-B0211A; 2-Benzothiazolamine, 6-(trifluoromethoxy)-, monohydrochloride; HMS1568B15; AKOS024458639; CCG-100788; NC00038; NCGC00180988-01; CS-0020981; SR-01000002997-9; SR-01000002997-4; 2-Amino-6-(trifluoromethoxy)-benzothiazole hydrochloride; 6-(Trifluoromethoxy)benzo[d]thiazol-2-amine hydrochlor" C8H6ClF3N2OS QEAOELIJQRYJJS-UHFFFAOYSA-N "6-(trifluoromethoxy)-1,3-benzothiazol-2-amine;hydrochloride" n.a. n.a. Yes No No No No No PMDBD752 Rizatriptan benzoate Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 77997 n.a. n.a. "Rizatriptan benzoate; 145202-66-0; Maxalt; Maxalt-MLT; MK-462; Rizatriptan (benzoate); MK 462; MK-0462; UNII-WR978S7QHH; MK 0462; 2-(5-((1H-1,2,4-TRIAZOL-1-YL)METHYL)-1H-INDOL-3-YL)-N,N-DIMETHYLETHANAMINE BENZOATE; Rizatriptan benzoate [USAN:USP]; L 705126; L-705126; WR978S7QHH; L-705,126; L 705,126; Rizatriptan Benzoate (Maxalt); N,N-Dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethylamine benzoate; AK163196; 3-(2-(Dimethylamino)ethyl)-5-(1H-1,2,4-triazol-1-ylmethyl)indole monobenzoate; 1H-Indole-3-ethanamine, N,N-dim" C22H25N5O2 JPRXYLQNJJVCMZ-UHFFFAOYSA-N "benzoic acid;N,N-dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethanamine" n.a. n.a. No Yes No No No No PMDBD753 Ronidazole Therapeutic Substance Approved Drug (veterinary medicine) n.a. n.a. n.a. n.a. n.a. 5094 n.a. n.a. "ronidazole; 7681-76-7; Ronidazol; Ridzol; Ridzol P; Ridazole; Dugro; (1-Methyl-5-nitro-1H-imidazol-2-yl)methyl carbamate; (1-Methyl-5-nitroimidazol-2-yl)methyl carbamate; Ronidazolum; Ronidazol-pharmachim; Ronidazol [INN-Spanish]; Ronidazolum [INN-Latin]; UNII-E01R4M1063; 1H-Imidazole-2-methanol, 1-methyl-5-nitro-, carbamate (ester); Ronidazol-pharmachim [Bulgarian]; EINECS 231-675-1; BRN 0886221; 1-Methyl-5-nitroimidazole-2-methanol carbamate ester; AI3-27430; MLS000028665; C6H8N4O4; E01R4M1063; 1-Methyl-5-nitro-1H-imidazole-2-m" C6H8N4O4 PQFRTXSWDXZRRS-UHFFFAOYSA-N (1-methyl-5-nitroimidazol-2-yl)methyl carbamate n.a. n.a. Yes No Yes No No No PMDBD754 Rosmarinus officinals Herbal Substance Medicinal Herb n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD763 Salvia officinalis Herbal Substance Medicinal Herb n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD764 Saquinavir mesylate Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 60934 n.a. n.a. "Saquinavir mesylate; 149845-06-7; Invirase; Fortovase; Saquinavir mesilate; Saquinavir, Mesylate; Ro 31-8959/003; UNII-UHB9Z3841A; Saquinavir monomethanesulfonate salt; UHB9Z3841A; CHEBI:32121; Saquinavir mesylate (AIDS Initiative); NCGC00091469-01; DSSTox_CID_3835; DSSTox_RID_77202; DSSTox_GSID_23835; Ro 31-8959; (S)-N-((alphaS)-alpha-((1R)-2-((3S,4aS,8aS)-3-(tert-Butylcarbamoyl)octahydro-2(1H)-isoquinolyl)-1-hydroxyethyl)phenethyl)-2-quinaldamidosuccinamide monomethanesulfonate (salt); Butanediamide, N1-[(1S,2R)-3-[(3S,4aS" C39H54N6O8S IRHXGOXEBNJUSN-YOXDLBRISA-N "(2S)-N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]-2-(quinoline-2-carbonylamino)butanediamide;methanesulfonic acid" n.a. n.a. Yes Yes No No No No PMDBD766 Saturated fat Dietary Substance Dietary Compounds n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD767 Saturated fat (palmitate) Dietary Substance Dietary Compounds n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD768 Saturated fats Dietary Substance Dietary Compounds n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD774 Semen Coicis Herbal Substance Medicinal Herb n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD777 Sertaconazole nitrate Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 200103 n.a. n.a. "Sertaconazole nitrate; 99592-39-9; Dermofix; Ertaczo; Zalain; Sertaconazole (nitrate); FI 7056; FI-7045; Ginedermofix; Dermoseptic; Sertaconazole mononitrate; 1-[2-[(7-Chloro-1-benzothien-3-yl)methoxy]-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole nitrate; 1H-Imidazole, 1-(2-((7-chlorobenzo(b)thien-3-yl)methoxy)-2-(2,4-dichlorophenyl)ethyl)-, mononitrate; Fisderm; Onabet; Extens; SR-05000001439; 1-[2-[(7-chloro-1-benzothiophen-3-yl)methoxy]-2-(2,4-dichlorophenyl)ethyl]imidazole;nitric acid; Ertaczo (TN); Zalain (TN); 1-(2-((7-Chlo" C20H16Cl3N3O4S HAAITRDZHUANGT-UHFFFAOYSA-N "1-[2-[(7-chloro-1-benzothiophen-3-yl)methoxy]-2-(2,4-dichlorophenyl)ethyl]imidazole;nitric acid" n.a. n.a. Yes No Yes No No No PMDBD781 Sildenafil citrate Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 135413523 n.a. n.a. "Sildenafil citrate; 171599-83-0; Revatio; VIAGRA; Sildenafil (citrate); Caverta; Sildenafil citrate [USAN]; UNII-BW9B0ZE037; Sildenafil citrate salt; BW9B0ZE037; CHEBI:58987; 5-(2-ethoxy-5-((4-methylpiperazin-1-yl)sulfonyl)phenyl)-1-methyl-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-one 2-hydroxypropane-1,2,3-tricarboxylate; UK 92480-10; UK 92480; sildenafilcitrate; UK-92480-10; DSSTox_RID_81321; DSSTox_CID_26076; DSSTox_GSID_46076; 1-((3-(6,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo(4,3-d)pyrimidin-5-yl)-4-ethoxyphenyl)sul" C28H38N6O11S DEIYFTQMQPDXOT-UHFFFAOYSA-N "5-[2-ethoxy-5-(4-methylpiperazin-1-yl)sulfonylphenyl]-1-methyl-3-propyl-6H-pyrazolo[4,3-d]pyrimidin-7-one;2-hydroxypropane-1,2,3-tricarboxylic acid" n.a. n.a. No Yes No Yes No No PMDBD782 Silybum marianum Herbal Substance Medicinal Herb n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD784 Sisomicin sulfate Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 439243 n.a. n.a. "Sisomicin sulfate; Extramycin; Pathomycin; 53179-09-2; Siseptin; Baymicine; Sisomin; Mensiso; Sisomycin sulfate; UNII-K14444371C; Sch 13475 sulfate; Antibiotic 66-40 sulfate; Disisomicin pentakis(sulphate); EINECS 258-414-4; K14444371C; Sisomicin (sulfate); O-3-Deoxy-4-C-methyl-3-(methylamino)-beta-L-arabinopyranosyl-(1->4)-O-(2,6-diamino-2,3,4,6-tetradeoxy-alpha-D-glycero-hex-4-enopyranosyl-(1->6))-2-deoxy-L-streptamine sulfate (2:5) (salt); Siseptin (TN); Sisomicin sulfate [USAN:USP:JAN]" C38H84N10O34S5 CIKNYWFPGZCHDL-ZHFUJENKSA-N "(2R,3R,4R,5R)-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[[(2S,3R)-3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yl]oxy]-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol;sulfuric acid" n.a. n.a. Yes No No No No No PMDBD786 Sodium butyrate Environmental Chemicals Microbiota metabolite n.a. n.a. n.a. n.a. n.a. 5222465 n.a. n.a. "SODIUM BUTYRATE; 156-54-7; Sodium butanoate; Butyric acid sodium salt; Butanoic acid, sodium salt; Butyrate sodium; Sodium n-butyrate; Butyric acid, sodium salt; Sodium propanecarboxylate; Butanoic acid, sodium salt (1:1); Butanoic acid sodium salt; UNII-8RAS91C36W; CCRIS 7068; HSDB 5655; Sodium butyrate (USP); TPA/BA; Sodium butyrate [USP]; EINECS 205-857-6; C4H7NaO2; MFCD00002816; NSC 174280; 8RAS91C36W; CHEBI:64103; Butyric Acid, Na; Butyric acid sodium salt, 98%; CHEMBL62381; NSC174280; NSC-174280; NCGC00167555-01; Sodiumbutanoate" C4H7NaO2 MFBOGIVSZKQAPD-UHFFFAOYSA-M "sodium;butanoate" n.a. n.a. Yes No No No No No PMDBD787 Sodium cyclamate Dietary Substance "Dietary Compounds; Artificial Sweetener" n.a. n.a. n.a. n.a. n.a. 23665706 n.a. n.a. "SODIUM CYCLAMATE; 139-05-9; Sodium cyclohexylsulfamate; Sodium N-cyclohexylsulfamate; Cyclamate sodium; Sulfamic acid, cyclohexyl-, monosodium salt; Cyclamic acid sodium salt; Suestamin; Assugrin; Sugaron; Suessette; Ibiosuc; Sugarin; Natrii cyclamas; Sucaryl sodium; Sodium sucaryl; Ciclamato sodico; Hachi-Sugar; Dulzor-Etas; Natrium cyclamicum; Assurgrin feinsuss; Assurgrin vollsuss; Sodium cyclohexanesulfamate; Sucrum 7; Cyclamate de sodium; Asugryn; Natrium cyclohexylsulfamat; Cyclohexylsulfamate sodium; Natriumzyklamate [German]" C6H12NNaO3S UDIPTWFVPPPURJ-UHFFFAOYSA-M "sodium;N-cyclohexylsulfamate" n.a. n.a. No Yes No No No No PMDBD791 Soy isoflavones (daidzein, genistein, glycitein) Dietary Substance Dietary Compounds n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD792 Soy milk Dietary Substance Drinks n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No Yes No No No PMDBD793 Soy milk (powder) Dietary Substance Drinks n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD794 Soy protein Dietary Substance Dietary Compounds n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD795 Soy protein concentrate (SPC) Dietary Substance Dietary Compounds n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD797 Soygerm powder Dietary Substance Dietary Compounds n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD799 Spectinomycin dihydrochloride Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 64740 n.a. n.a. "Spectinomycin dihydrochloride; 21736-83-4; Spectinomycin hydrochloride; actinospectacin; Spectinomycin 2HCl; Spectinomycin HCl; Spectinomycin (dihydrochloride); Spectinomycin dihydrochloride pentahydrate; CHEBI:9216; EN300-74585; DSSTox_RID_80873; DSSTox_CID_25429; DSSTox_GSID_45429; 22189-32-8; UNII-296JEI210Z" C14H26Cl2N2O7 FOGDPGQSHLLYIK-XYQGXRRISA-N "(1R,3S,5R,8R,10R,11S,12S,13R,14S)-8,12,14-trihydroxy-5-methyl-11,13-bis(methylamino)-2,4,9-trioxatricyclo[8.4.0.03,8]tetradecan-7-one;dihydrochloride" n.a. n.a. Yes No Yes No No No PMDBD800 Spiperone Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 5265 n.a. n.a. "spiperone; Spiropitan; Spiroperidol; 749-02-0; Spiperonum; Espiperona; [3H]spiperone; [3H]-spiperone; R 5147; Spiperonum [INN-Latin]; Espiperona [INN-Spanish]; E 525; UNII-4X6E73CJ0Q; NSC 170983; 8-[4-(4-fluorophenyl)-4-oxobutyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one; MLS000028615; Spiperone [USAN:INN:BAN:JAN]; 8-(3-(p-Fluorobenzoyl)propyl)-1-phenyl-1,3,8-triazaspiro(4.5)decan-4-one; 8-(3-p-Fluorobenzoyl-1-propyl)-4-oxo-1-phenyl-1,3,8-triazaspiro(4,5)decane; EINECS 212-024-0; BRN 0632204; SMR000058674; 1,3,8-Triazaspiro(4.5" C23H26FN3O2 DKGZKTPJOSAWFA-UHFFFAOYSA-N 8-[4-(4-fluorophenyl)-4-oxobutyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one n.a. n.a. Yes No No No No No PMDBD802 Stachyose Dietary Substance Dietary Compounds n.a. n.a. n.a. n.a. n.a. 439531 n.a. n.a. "Stachyose; 470-55-3; Lupeose; CHEBI:17164; stachyose hydrate; Manneotetrose; alpha-D-Galp-(1->6)-alpha-D-Galp-(1->6)-alpha-D-Glcp-(1<->2)-beta-D-Fruf; 54261-98-2; O-alpha-D-galactopyranosyl-(1->6)o-alpha-D-galactopyranosyl-(1->6)O-alpha-D-galactopyranosyl-beta-D-fructofuranoside; Stachyose hydrate from Stachys tuberifera; 10094-58-3; tachyose; Stachyose n-Hydrate; MFCD00149457; Stachyose - 70%; bmse000240; Epitope ID:150068; C01613; SCHEMBL32922; CHEMBL1625803; ZINC85544384; AKOS016009597; NCGC00246978-01; AK111" C24H42O21 UQZIYBXSHAGNOE-XNSRJBNMSA-N (2S,3R,4S,5R,6R)-2-[[(2R,3R,4S,5R,6S)-6-[[(2R,3S,4S,5R,6R)-6-[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methoxy]-3,4,5-trihydroxyoxan-2-yl]methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol n.a. n.a. Yes No No No No No PMDBD805 Streptozotocin Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 29327 n.a. n.a. "streptozocin; STREPTOZOTOCIN; 18883-66-4; streptozosin; Streptozocinium; Streptozocine; Estreptozocina; Streptozocinum; alpha-Streptozocin; streptozotocin (stz); N-D-Glucosyl-(2)-N''-nitrosomethylurea; CHEBI:9288; C8H15N3O7; N-D-Glucosyl-(2)-N''-nitrosomethylharnstoff; 2-Deoxy-2-(((methylnitrosoamino)carbonyl)amino)-D-glucopyranose; UNII-8H27GUR065; 8H27GUR065; 2-Deoxy-2-(3-methyl-3-nitrosoureido)-D-glucopyranose; 2-deoxy-2-{[methyl(nitroso)carbamoyl]amino}-alpha-D-glucopyranose; DSSTox_CID_1282; DSSTox_RID_76055; DSSTox_GSID_212" C8H15N3O7 ZSJLQEPLLKMAKR-GKHCUFPYSA-N 1-methyl-1-nitroso-3-[(2S,3R,4R,5S,6R)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]urea n.a. n.a. Yes No No No No No PMDBD807 Sulconazole nitrate Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 65495 n.a. n.a. "Sulconazole nitrate; 61318-91-0; Exelderm; 82382-23-8; Sulconazole nitrate salt; Sulconazole mononitrate; Sulconazolenitrate; 1-[2-(4-Chlorobenzylthio)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole nitrate; RS 44872; RS-44872; MLS000028611; RS-44872-00-10-3; SMR000058734; 1-(2-[p-Chlorobenzylthio]-2-[2,4-dichlorophenyl]ethyl)-1H-imidazole; (+-)-1-(2,4-Dichloro-beta-((4-chlorobenzyl)thio)phenethyl)imidazole nitrate; DSSTox_RID_80911; DSSTox_CID_25490; (+-)-1-(2,4-Dichloro-beta-((p-chlorobenzyl)thio)phenethyl)imidazole mononitrat" C18H16Cl3N3O3S CRKGMGQUHDNAPB-UHFFFAOYSA-N "1-[2-[(4-chlorophenyl)methylsulfanyl]-2-(2,4-dichlorophenyl)ethyl]imidazole;nitric acid" n.a. n.a. Yes No Yes No No No PMDBD809 Sulfamonomethoxine Therapeutic Substance Approved Drug (veterinary medicine) n.a. n.a. n.a. n.a. n.a. 5332 n.a. n.a. "sulfamonomethoxine; 1220-83-3; Sulfamonomethoxin; Daimeton; Sulfamonometoxina; 4-amino-N-(6-methoxypyrimidin-4-yl)benzenesulfonamide; Sulfamonomethoxinum; 4-Amino-N-(6-methoxy-4-pyrimidinyl)benzenesulfonamide; DS-36; DJ-1550; N1-(6-Methoxy-4-pyrimidinyl)sulfanilamide; ICI 32525; Ro 4-3476; UNII-U700P169W2; Sulfamonometoxina [INN-Spanish]; Sulfamonomethoxinum [INN-Latin]; 4-METHOXY-6-SULFANILAMIDOPYRIMIDINE; 4-amino-N-(6-methoxypyrimidin-4-yl)benzene-1-sulfonamide; BRN " C11H12N4O3S WMPXPUYPYQKQCX-UHFFFAOYSA-N 4-amino-N-(6-methoxypyrimidin-4-yl)benzenesulfonamide n.a. n.a. Yes No No No No No PMDBD814 Sulfonamide antibiotics Therapeutic Substance Drug Class n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD815 Sulfoxide Environmental Chemicals Unclassified Substance n.a. n.a. n.a. n.a. n.a. 8442 n.a. n.a. "Sulfoxide; PIPERONYL SULFOXIDE; Sulfoxyl; Sulphoxide; Sulfox-cide; Sulfocide; 120-62-7; n-Octylisosafrole sulfoxide; Isosafrole n-octylsulfoxide; Sulfoxide (synergist); n-Octylsulfoxide of isosafrole; Isosafrole octyl sulfoxide; Piperonyl sulfoxide (insecticide); Isosafrole, octyl sulfoxide; NCI-C02824; Caswell No. 615; ENT 16,634; Isofrol-n-octyl sulfoxide; UNII-WOR3CS513R; Piperonyl sulfoxide (VAN); NSC 8400; CCRIS 523; 5-[2-(Octylsulfinyl)propyl]-1,3-benzodioxole; n-Octyl sulfoxide of isosafrole; HSDB 1746; 1-Methyl-2-(3,4-methy" C18H28O3S ATTZFSUZZUNHBP-UHFFFAOYSA-N 5-(2-octylsulfinylpropyl)-1,3-benzodioxole n.a. n.a. No Yes No No No No PMDBD817 Sulindac sulfide Environmental Chemicals Active Metabolite of Prodrug n.a. n.a. n.a. n.a. n.a. 5352624 n.a. n.a. "Sulindac sulfide; 49627-27-2; (Z)-Sulindac sulfide; UNII-6UVA8S2DEY; 32004-67-4; 6UVA8S2DEY; CHEMBL18797; CHEBI:75408; (Z)-5-Fluoro-2-methyl-1-[p-(methylthio)benzylidene]indene-3-acetic acid; NCGC00161601-01; DSSTox_CID_29004; DSSTox_RID_83269; DSSTox_GSID_49078; Sulindac sulphide; {(1Z)-5-fluoro-2-methyl-1-[4-(methylsulfanyl)benzylidene]-1H-inden-3-yl}acetic acid; (Z)-5-Fluoro-2-methyl-1-((4-(methylthio)phenyl)methylene)-1H-indene-3-acetic acid; (Z)-2-(3-(4-(methylthio)benzylidene)-6-fluoro-2-methyl-3H-inden-1-yl)acetic a" C20H17FO2S LFWHFZJPXXOYNR-MFOYZWKCSA-N 2-[(3Z)-6-fluoro-2-methyl-3-[(4-methylsulfanylphenyl)methylidene]inden-1-yl]acetic acid n.a. n.a. No Yes No No No No PMDBD820 Sumatriptan succinate Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 59772 n.a. n.a. "SUMATRIPTAN SUCCINATE; 103628-48-4; Imitrex; Imigran; Suminat; Migratriptan; Sumadol; Sumigrene; Novelian; Migratan; Antibet; Permicran; Diletan; Sumatrin; Micralgin; Imijekt; Arcoiran; Migmax; Sumavel DosePro; 1-(3-(2-(Dimethylamino)ethyl)-1H-indol-5-yl)-N-methylmethanesulfonamide succinate; Alsuma; Sumatriptan (succinate); Sumatriptan succinate [USAN]; UNII-J8BDZ68989; C14H21N3O2S.C4H6O4; GR 43175C; GR 43175; sumatriptan hydrogen succinate; CHEBI:64359; J8BDZ68989; GR-43175C; Onzetra Xsail; mitrex; Zembrace SymTouch; Sumitrex; Imitrex (TN)" C18H27N3O6S PORMUFZNYQJOEI-UHFFFAOYSA-N "butanedioic acid;1-[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]-N-methylmethanesulfonamide" n.a. n.a. Yes Yes Yes No No No PMDBD823 Talampicillin hydrochloride Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 71446 n.a. n.a. "talampicillin hydrochloride; Yamacillin; Talampicillin HCl; Talpen; BRL 8988; Talampicillin hydrochloride [USAN:JAN]; 39878-70-1; (2S,5R,6R)-6-((R)-2-Amino-2-phenylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid ester with 3-hydroxyphthalide, monohydrochloride; CHEBI:34993; Aseocillin (TN)" C24H24ClN3O6S PAZSYTCTHYSIAO-WVFSJLEKSA-N "(3-oxo-1H-2-benzofuran-1-yl) (2S,5R,6R)-6-[[(2R)-2-amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate;hydrochloride" n.a. n.a. Yes No Yes No No No PMDBD824 Tamoxifen citrate Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 2733525 n.a. n.a. "Tamoxifen citrate; 54965-24-1; Istubal; Tamoxifen (Citrate); Zitazonium; UNII-7FRV7310N6; Tamoxifen citrate salt; ICI 46474; Zynoplex; Tamoxifen Citrate (Nolvadex); Tamoplex; Noxitem; Ledertam; Ginarsan; Tamoxasta; Oncotam; Terimon; Tafoxen; Jenoxifen; Tamofen; Nourytan; Farmifeno; Nolgen; Emblon; Noltam; Zemide; Kessar; Tamax; Taxus; Genox; Tamox-Puren; Apo-Tamox; C32H37NO8; 7FRV7310N6; Z-Tamoxifen citrate; NSC180973; NCGC00024928-06; Tamoxifen citrate, 98%; CAS-54965-24-1; DSSTox_CID_1301; DSSTox_RID_76068; DSSTox_GSID_21301; CCRIS 6718; Caditam" C32H37NO8 FQZYTYWMLGAPFJ-OQKDUQJOSA-N "2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylic acid" n.a. n.a. Yes No Yes No No No PMDBD825 Taurine conjugated bile acid Environmental Chemicals Environmental Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD827 Tea polyphenols Dietary Substance Dietary Compounds n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD831 Tenatoprazole Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 636411 n.a. n.a. "Tenatoprazole; 113712-98-4; Ulsacare; Protop; TU-199; TU 199; C16H18N4O3S; NCGC00167521-01; DSSTox_CID_26687; DSSTox_RID_81821; DSSTox_GSID_46687; Tenatoprazole [INN]; CAS-113712-98-4; Benatoprazole; Tenatoprazole (JAN/INN); SCHEMBL323288; sTU-199; DTXSID1046687; CHEMBL1475252; CHEBI:94379; CTK8E8964; Tenatoprazole, >=98% (HPLC); HMS3713D12; HMS2090B06; BCP09130; Tox21_112518; BDBM50402289; s4212; Tox21_112518_1; AKOS015969750; AKOS01589516" C16H18N4O3S ZBFDAUIVDSSISP-UHFFFAOYSA-N 5-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]-1H-imidazo[4,5-b]pyridine n.a. n.a. Yes Yes No Yes No No PMDBD835 Terminalia arjuna Herbal Substance Medicinal Herb n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD837 Tetracycline hydrochloride Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 54704426 n.a. n.a. "TETRACYCLINE HYDROCHLORIDE; 64-75-5; Tetracycline HCl; Achromycin hydrochloride; Tetracycline (hydrochloride); Topicycline; Tetrabid; Supramycin; Sustamycin; Telotrex; Sumycin; UNII-P6R62377KV; MFCD00078142; Triphacyclin; Tetramavan; Tetrabakat; Dumocyclin; Tetracompren; Stilciclina; Remicyclin; Hostacycline; Bristacycline; Tetralution; Quadracycline; Mephacyclin; Tetrablet; Tetrakap; Tetracaps; Actisite; Tetrosol; Tetramed; Ricycline; Piracaps; Partrex; Diacycine; Artomycin; Tefilin; Subamycin; Unicin; Teline; Qidtet; Paltet; Retet; Tetra-wedel; Neo" C22H25ClN2O8 YCIHPQHVWDULOY-FMZCEJRJSA-N "(4S,4aS,5aS,6S,12aR)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;hydrochloride" n.a. n.a. Yes No Yes No No No PMDBD839 Thiazolidinediones Therapeutic Substance Drug Class n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD840 Thiethylperazine dimalate Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 11954258 n.a. n.a. "Thiethylperazine malate; Norzine Ampuls; Thietylperazine malate; 52239-63-1; Thiethylperazine dimalate; EINECS 257-780-2; 2-(Ethylthio)-10-(3-(4-methyl-1-piperazinyl)propyl)phenothiazine malate (1:2); NCGC00017115-01; CAS-52239-63-1; Thiethylperazine malate [USP]; Torecan (TN); Butanedioic acid, hydroxy-, compd. with 2-(ethylthio)-10-(3-(4-methyl-1-piperazinyl)propyl)-10H-phenothiazine (2:1); 10H-Phenothiazine, 2-(ethylthio)-10-(3-(4-methyl-1-piperazinyl)propyl)-, 2-hydroxy-1,4-butanedioate (1:2); Malic acid, compound w" C30H41N3O10S2 GTHHLZDYRHLACN-UHFFFAOYSA-N "2-ethylsulfanyl-10-[3-(4-methylpiperazin-1-yl)propyl]phenothiazine;2-hydroxybutanedioic acid" n.a. n.a. Yes No No No No No PMDBD842 Thioguanosine Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 2724387 n.a. n.a. "6-Thioguanosine; 85-31-4; THIOGUANOSINE; 2-Amino-6-mercaptopurin-9-ylriboside; 6-Thioguanosine (VAN); 2-Amino-6-mercaptopurine riboside; 6-Mercaptoguanosine; UNII-C558LI0K8P; Ribosylthioguanine; C10H13N5O4S; Thioguanine riboside; EINECS 201-597-2; 6-Thiodeoxyguanosine; 6-Thioguanine riboside; MLS002153781; AI3-50278; C558LI0K8P; 6-Thioguanine ribonucleoside; 2-Amino-9-(beta-D-ribofuranosyl)purine-6-thiol; 2-Amino-6-mercapto-9(beta-D-ribofuranosyl)purine; 2-Amino-9beta-D-ribofuranosyl-9H-purine-6-thiol; 2-Amin" C10H13N5O4S OTDJAMXESTUWLO-UUOKFMHZSA-N 2-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H-purine-6-thione n.a. n.a. Yes No No No No No PMDBD843 Thioridazine hydrochloride Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 66062 n.a. n.a. "Thioridazine hydrochloride; 130-61-0; Thioridazine Hcl; Sonapax hydrochloride; Thioridazine chloride; Mellaril hydrochloride; Thioridazine.HCl; Aldazine; USAF SZ-B; Melleril (tablet); USAF SZ-3; Thioridazine (hydrochloride); EINECS 204-992-8; NSC 186060; MLS000028408; Thioridazine-d3 Hydrochloride; CHEBI:48566; Orsanil; 2-Methylmercapto-10-(2-(N-methyl-2-piperidyl)ethyl)phenothiazine hydrochloride; 10-[2-(1-methylpiperidin-2-yl)ethyl]-2-(methylsulfanyl)-10H-phenothiazine hydrochloride; SMR000058380; 10-(2-(1-Methyl-2-piperidyl)" C21H27ClN2S2 NZFNXWQNBYZDAQ-UHFFFAOYSA-N "10-[2-(1-methylpiperidin-2-yl)ethyl]-2-methylsulfanylphenothiazine;hydrochloride" n.a. n.a. Yes No No No No No PMDBD846 Thonzonium bromide Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 11102 n.a. n.a. "THONZONIUM BROMIDE; 553-08-2; Tonzonium bromide; Thonzonium (bromide); Thonzide; UNII-JI2B19CR0R; NC 1264; JI2B19CR0R; MLS002154065; SMR001233380; Tonzonium bromide [INN]; Tonzonium bromide (INN); DSSTox_CID_25326; DSSTox_RID_80805; DSSTox_GSID_45326; Tonzonii bromidum; Hexadecyl(2-[(p-methoxybenzyl)-2-pyrimidinylamino]ethyl)dimethylammonium bromide; Hexadecyl(2-((p-methoxybenzyl)-2-pyrimidinylamino)ethyl)dimethylammonium bromide; Bromuro de tonzonio; Bromure de tonzonium; SR-01000841261; NCGC00016507-01; CAS-553-08-2; Tonzoniumb" C32H55BrN4O WBWDWFZTSDZAIG-UHFFFAOYSA-M "hexadecyl-[2-[(4-methoxyphenyl)methyl-pyrimidin-2-ylamino]ethyl]-dimethylazanium;bromide" n.a. n.a. Yes No Yes No No No PMDBD847 Thyroxine (L) Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 5819 n.a. n.a. "L-thyroxine; levothyroxine; 51-48-9; thyroxine; thyroxin; Tetraiodothyronine; Thyrax; 3,3'',5,5''-Tetraiodo-L-thyronine; Thyroxinal; Thyreoideum; Thyratabs; Thyroxine iodine; synthroid; Levothyroxin; (-)-Thyroxine; L-Thyroxin; 3,5,3'',5''-Tetraiodo-L-thyronine; L-T4; Thyroxine (l); DL-Thyroxin; Levothyroxine sodium; levothroid; t4; Thyroxine (VAN); 3,5,3'',5''-Tetraiodothyronine; O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-L-tyrosine; Laevothyroxinum; T4 (Hormone); L-3,5,3'',5''-Tetraiodothyronine; Levothyroxinum (acid); Laevothyroxinum (acid); Th" C15H11I4NO4 XUIIKFGFIJCVMT-LBPRGKRZSA-N (2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoic acid n.a. n.a. Yes No Yes No No No PMDBD848 Ticarcillin sodium Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 470375 n.a. n.a. "TICARCILLIN DISODIUM; ticarcillin sodium; Ticarpen; Aerugipen; Ticar; Ticarcillin disodium salt; 4697-14-7; UNII-G8TVV6DSYG; G8TVV6DSYG; CHEBI:35017; 29457-07-6; NCGC00017046-01; Monapen; CAS-4697-14-7; BRL 2288; 74682-62-5; Disodium Ticarcillin; BRL-2288; N-(2-Carboxy-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)hept-6-yl)-3-thiophenemalonamic acid disodium salt; disodium (2S,5R,6R)-3,3-dimethyl-6-[[(2R)-3-oxidanidyl-3-oxidanylidene-2-thiophen-3-yl-propanoyl]amino]-7-oxidanylidene-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxyl" C15H14N2Na2O6S2 ZBBCUBMBMZNEME-QBGWIPKPSA-L "disodium;(2S,5R,6R)-6-[[(2R)-2-carboxylato-2-thiophen-3-ylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate" n.a. n.a. Yes No Yes No No No PMDBD851 Tiratricol, 3,3'',5-triiodothyroacetic acid Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 5803 n.a. n.a. "Tiratricol; 51-24-1; Triac; 3,3'',5-TRIIODOTHYROACETIC ACID; Triiodothyroacetic acid; 2-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]acetic acid; UNII-29OQ9EU4R1; Tiratricol [INN]; 3'',3,5-Triiodothyroacetic acid; CHEMBL41632; 29OQ9EU4R1; Triacana; Tiratricol (INN); CAS-51-24-1; NCGC00016227-01; Teatrois; Tiratricol, 3,3'',5-triiodothyroacetic acid; [4-(4-HYDROXY-3-IODO-PHENOXY)-3,5-DIIODO-PHENYL]-ACETIC ACID; DSSTox_RID_80767; DSSTox_CID_25232; DSSTox_GSID_45232; Tiratr" C14H9I3O4 UOWZUVNAGUAEQC-UHFFFAOYSA-N 2-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]acetic acid n.a. n.a. Yes No Yes No No No PMDBD852 TMAO Environmental Chemicals Human Metabolite n.a. n.a. n.a. n.a. n.a. 1145 n.a. n.a. "TRIMETHYLAMINE N-OXIDE; Trimethylamine oxide; 1184-78-7; Triox; N,N-dimethylmethanamine oxide; TMAO; Trimethyloxamine; Methanamine, N,N-dimethyl-, N-oxide; trimethylamine-N-oxide; Trimethylamine, N-oxide; N,N-Dimethylmethanamine N-oxide; TMANO; (CH3)3NO; Trimethylaminoxid; UNII-FLD0K1SJ1A; EINECS 214-675-6; FLD0K1SJ1A; NSC 408426; TRIMETHYLAMINE N-OXIDE HYDROCHLORIDE; AI3-60110; N(CH3)3O; Trimethylamine, N-oxide (8CI); N,N-Dimethyl-methanamine-N-oxide; N,N-dimethylmethanamine oxide (IUPAC); TMAe; trimethylaminoxide; trimethylamineox" C3H9NO UYPYRKYUKCHHIB-UHFFFAOYSA-N N,N-dimethylmethanamine oxide n.a. n.a. No Yes No No No No PMDBD854 Tofu diet Dietary Substance Foods n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD858 Toltrazuril Therapeutic Substance Approved Drug (veterinary medicine) n.a. n.a. n.a. n.a. n.a. 68591 n.a. n.a. "Toltrazuril; 69004-03-1; Baycox; Toltrazurilum [Latin]; Toltrazurilo [Spanish]; UNII-QVZ3IAR3JS; Bay-i 9142; 1-methyl-3-[3-methyl-4-[4-(trifluoromethylsulfanyl)phenoxy]phenyl]-1,3,5-triazinane-2,4,6-trione; QVZ3IAR3JS; Toltrazurilum; Toltrazurilo; 1-Methyl-3-(4-(p-((trifluoromethyl)thio)phenoxy)-m-tolyl)-s-triazine-2,4,6(1H,3H,5H)-trione; C18H16F3N3O4S; bay vi 9142; 1,3,5-Triazine-2,4,6(1H,3H,5H)-trione, 1-methyl-3-[3" C18H14F3N3O4S OCINXEZVIIVXFU-UHFFFAOYSA-N 1-methyl-3-[3-methyl-4-[4-(trifluoromethylsulfanyl)phenoxy]phenyl]-1,3,5-triazinane-2,4,6-trione n.a. n.a. Yes No No No No No PMDBD860 Tosufloxacin hydrochloride Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 10433396 n.a. n.a. "Tosufloxacin hydrochloride; A 60969; 104051-69-6; Tosufloxacin HCl; SR-01000763339; SCHEMBL3754459; CHEMBL542832; CCG-220465; SR-01000763339-4; Q27283349; 7-(3-amino-1-pyrrolidinyl)-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid hydrochloride; 1,8-Naphthyridine-3-carboxylic acid, 1,4-dihydro-7-(3-amino-1-pyrrolidinyl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-, hydrochloride(1:1)" C19H16ClF3N4O3 CIHZSSCESOLBRQ-UHFFFAOYSA-N "7-(3-aminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid;hydrochloride" n.a. n.a. Yes No Yes No No No PMDBD861 Tracazolate hydrochloride Environmental Chemicals Unclassified Substance n.a. n.a. n.a. n.a. n.a. 24871267 n.a. n.a. "Tracazolate hydrochloride; 1135210-68-2; DSSTox_RID_80751; DSSTox_CID_25208; DSSTox_GSID_45208; ethyl 4-(butylamino)-1-ethyl-6-methyl-1H-pyrazolo[3,4-b]pyridine-5-carboxylate hydrochloride; ICI 136753; SR-01000075239; NCGC00015985-03; 4-(Butylamino)-1-ethyl-6-methyl 1H-pyrazolo[3,4b]pyridine-5-ethylcarboxylate hydrochloride; SCHEMBL1061780; DTXSID0045208; CHEMBL2356666; HMS1571C13; Tox21_110273; Tox21_110273_1; AKOS024456664; CCG-220976; NCGC00015985-08; NCGC00180921-01; T-230; B6790; SR-01000075239-6; SR-01000075239-3; J-002976" C16H25ClN4O2 TUIXDPUEMQXVHO-UHFFFAOYSA-N "ethyl 4-(butylamino)-1-ethyl-6-methylpyrazolo[3,4-b]pyridine-5-carboxylate;hydrochloride" n.a. n.a. Yes No No No No No PMDBD865 Trazodone hydrochloride Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 62935 n.a. n.a. "Trazodone hydrochloride; 25332-39-2; Trazodone Hcl; Desyrel; Molipaxin; Bimaran; Thombran; Trittico; Apo-Trazodone; Trazodone (hydrochloride); Pragmazone; Triticum; Tritico; Tombran; Devidon; Trialodine; Azona; AF-1161; UNII-6E8ZO8LRNM; KB-831; Oleptro; AF 1161; EINECS 246-855-5; 6E8ZO8LRNM; NSC 292811; MLS000069698; CHEBI:9655; Trazodone hydrochloride (Desyrel); NSC-292811; 2-(3-(4-(m-Chlorophenyl)-1-piperazinyl)propyl)-s-triazolo(4,3-a)pyridin-3(2H)-one monohydrochloride; 1,2,4-Triazolo[4,3-a]pyridin-3(2H)-one,2-[3-[4-(3-chlorophenyl)" C19H23Cl2N5O OHHDIOKRWWOXMT-UHFFFAOYSA-N "2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-[1,2,4]triazolo[4,3-a]pyridin-3-one;hydrochloride" n.a. n.a. Yes No Yes No No No PMDBD870 Trifluoperazine dihydrochloride Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 66064 n.a. n.a. "Trifluoperazine dihydrochloride; 440-17-5; Trifluoperazine hydrochloride; Trifluoperazine 2HCl; Terfluzine; Stelazine; Trifluoperazine HCl; Triphthazine; Jatroneural; Eskazinyl; Eskazine; Tryptazine; Triftazin; Trazine; Fluoperazine; Trifluoroperazine hydrochloride; Tryptazine dihydrochloride; Triphthazine dihydrochloride; Calmazine; Stalazine hydrochloride; Modalina; Stelazine dihydrochloride; UNII-6P1Y2SNF5V; Fluoperazine dihydrochloride; Trifluoroperazine dihydrochloride; Trifluoperazine (dihydrochloride); SKF 5019; Trifluoperazin" C21H26Cl2F3N3S BXDAOUXDMHXPDI-UHFFFAOYSA-N "10-[3-(4-methylpiperazin-1-yl)propyl]-2-(trifluoromethyl)phenothiazine;dihydrochloride" n.a. n.a. Yes No No No No No PMDBD871 Triflupromazine hydrochloride Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 66069 n.a. n.a. "Triflupromazine hydrochloride; 1098-60-8; Fluorofen; Neoprin; Flumazin; Triflupromazine HCl; Nivoman; Psyquil; Siquil; Vesprin hydrochloride; Triflupromazine (hydrochloride); Trifluopromazine hydrochloride; Fluopromazine monohydrochloride; Triflupromazine monohydrochloride; UNII-9E75N4A5HM; MC 4703; Trifluopromazine hydrochloride (VAN); EINECS 214-149-6; NSC 14959; NSC 17473; MLS000069672; 9E75N4A5HM; NCGC00094410-02; SMR000058517; Vesprin (TN); 10-(3-(Dimethylamino)propyl)-2-(trifluoromethyl)phenothiazine monohydrochloride; 10-(3-D" C18H20ClF3N2S FTNWXGFYRHWUKG-UHFFFAOYSA-N "N,N-dimethyl-3-[2-(trifluoromethyl)phenothiazin-10-yl]propan-1-amine;hydrochloride" n.a. n.a. Yes No Yes No No No PMDBD874 Trimebutine maleate Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 5388977 n.a. n.a. "Trimebutine maleate; 34140-59-5; Debridat; Polibutin; Trimebutine (maleate); Dromostat; Trimedat; Trimebutine maleate salt; Ibutin; Digerent polifarma; SMR000058893; MLS000028659; 2-(Dimethylamino)-2-phenylbutyl 3,4,5-trimethoxybenzoate maleate; NCGC00096059-01; EINECS 251-845-9; TM 906; DSSTox_RID_81292; DSSTox_CID_26017; 3,4,5-Trimethoxybenzoic Acid 2-(Dimethylamino)-2-phenylbutyl Ester Maleate Salt; DSSTox_GSID_46017; Q-201885; MLS001401430; SMR000653473; CAS-34140-59-5; SMR000471622; Trimebutine maleate [JAN]; Cerekinon (TN); EIN" C26H33NO9 FSRLGULMGJGKGI-BTJKTKAUSA-N "(Z)-but-2-enedioic acid;[2-(dimethylamino)-2-phenylbutyl] 3,4,5-trimethoxybenzoate" n.a. n.a. No Yes No Yes No No PMDBD875 Trimeprazine tartrate Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 441236 n.a. n.a. "Trimeprazine tartrate; Alimemazine hemitartrate; Alimemazine tartrate; 4330-99-8; Trimeprazine tartrate [USP]; Trimeprazine tartrate (USP); (2R,3R)-2,3-dihydroxybutanedioic acid;N,N,2-trimethyl-3-phenothiazin-10-ylpropan-1-amine; Alimezine (TN); Alimemazine tartrate (JP17); SCHEMBL719590; s5730; CCG-270431; SC-78545; D02245; Q27256512; Trimeprazine Tartrate 1.0 mg/ml in Methanol (as free base); 10-[3-(Dimethylamino)-2-methylpropyl]phenothiazine Tartrate" C40H50N4O6S2 AJZJIYUOOJLBAU-CEAXSRTFSA-N "(2R,3R)-2,3-dihydroxybutanedioic acid;N,N,2-trimethyl-3-phenothiazin-10-ylpropan-1-amine" n.a. n.a. Yes No No No No No PMDBD876 Trimetazidine dihydrochloride Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 83201 n.a. n.a. "Trimetazidine dihydrochloride; 13171-25-0; 1-(2,3,4-Trimethoxybenzyl)piperazine dihydrochloride; Kyurinett; Trimetazidine HCl; Trimetazidine hydrochloride; Trimetajust; Lubomail; Yosimilon; Vastarel; Trimetazidine (dihydrochloride); 1-[(2,3,4-trimethoxyphenyl)methyl]piperazine dihydrochloride; Trimetazidine DiHCl; UNII-48V6723Z1P; EINECS 236-117-0; S 4004; Piperazine, 1-[(2,3,4-trimethoxyphenyl)methyl]-, dihydrochloride; 48V6723Z1P; DSSTox_RID_80858; DSSTox_CID_25407; DSSTox_GSID_45407; W-108326; Piperazine, 1-(2,3,4-trimethoxyb" C14H24Cl2N2O3 VYFLPFGUVGMBEP-UHFFFAOYSA-N "1-[(2,3,4-trimethoxyphenyl)methyl]piperazine;dihydrochloride" n.a. n.a. No Yes No No No No PMDBD882 Unfermented soy product Dietary Substance Foods n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD883 Unsaturated fat Dietary Substance Dietary Compounds n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD884 Unspecified antibiotic Therapeutic Substance Drug Class n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD885 Urolithin-A Herbal Substance Medicinal Herbal Compounds n.a. n.a. n.a. n.a. n.a. 5488186 n.a. n.a. "urolithin A; 1143-70-0; 3,8-dihydroxy-6H-benzo[c]chromen-6-one; 3,8-Dihydroxy-6H-dibenzo(b,d)pyran-6-one; 3,8-Dihydroxyurolithin; 3,8-Hydroxydibenzo-alpha-pyrone; 3,8-dihydroxy-6h-dibenzo[b,d]pyran-6-one; 3,8-dihydroxybenzo[c]chromen-6-one; 3,8-dihydroxy-urolithin; SCHEMBL803408; CHEMBL1836264; CTK4A8707; KS-00000TQI; DTXSID40150694; Urolithin A, >=97% (HPLC); s5312; ZINC13484727; AKOS028108778; CCG-266776; DB15464; CS-6305; DS-19328; AK5445" C13H8O4 RIUPLDUFZCXCHM-UHFFFAOYSA-N 3,8-dihydroxybenzo[c]chromen-6-one n.a. n.a. Yes No No No No No PMDBD886 Vaccinium myrtillus Herbal Substance Medicinal Herb n.a. n.a. n.a. n.a. n.a. n.a. 84540227 n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No Yes No No No PMDBD889 Vancomycin hydrochloride Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 6420023 n.a. n.a. "Vancomycin HCL; VANCOMYCIN HYDROCHLORIDE; Vancomycin monohydrochloride; 1404-93-9; Vancomycin (hydrochloride); UNII-71WO621TJD; Vancocine hydrochloride; Vancomycin, hydrochloride; 71WO621TJD; Vancomycin hydrochloride from Streptomyces orientalis; Vancocin hydrochloride; AeroVanc; Vancomycin, monohydrochloride; SR-01000076194; Prestwick_816; Vancomycin hydrochloride [USP:JAN]; Cancocin hydrochloride; Vancocin hydrochloride in plastic container; Vancomycin HCl (Vancocin); CHEMBL3747636; CHEMBL1200628; DTXSID90891868; HMS1569D15; Va" C66H76Cl3N9O24 LCTORFDMHNKUSG-XTTLPDOESA-N "(1S,2R,18R,19R,22S,25R,28R,40S)-48-[(2S,3R,4S,5S,6R)-3-[(2S,4S,5S,6S)-4-amino-5-hydroxy-4,6-dimethyloxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-22-(2-amino-2-oxoethyl)-5,15-dichloro-2,18,32,35,37-pentahydroxy-19-[[(2R)-4-methyl-2-(methylamino)pentanoyl]amino]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentazaoctacyclo[26.14.2.23,6.214,17.18,12.129,33.010,25.034,39]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34(39),35,37,46,49-pentadecaene-40-carboxylic acid;hydrochloride" n.a. n.a. Yes No Yes No No No PMDBD891 Vecuronium bromide Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 39764 n.a. n.a. "VECURONIUM BROMIDE; 50700-72-6; Norcuron; ORG NC 45; Vecuronii bromidum; Bromuro de vecuronio; Vecuronium (bromide); Bromure de vecuronium; Org-NC-45; NC-45; UNII-7E4PHP5N1D; ORG-NC 45; Vecuronii bromidum [INN-Latin]; Bromure de vecuronium [INN-French]; Bromuro de vecuronio [INN-Spanish]; EINECS 256-723-9; 7E4PHP5N1D; acetate;bromide; CHEBI:9940; 1-(3alpha,17beta-Dihydroxy-2beta-piperidino-5alpha-androstan-16beta,5alpha-yl)-1-methylpiperidinium bromide, diacetate; DSSTox_CID_3736; DSSTox_RID_77174; 5alpha-Androstan-3alpha,17beta" C34H57BrN2O4 VEPSYABRBFXYIB-PWXDFCLTSA-M "[(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-acetyloxy-10,13-dimethyl-16-(1-methylpiperidin-1-ium-1-yl)-2-piperidin-1-yl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate;bromide" n.a. n.a. Yes No No No No No PMDBD901 Western high-fat diets Dietary Substance Foods n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD902 Wild blueberry Dietary Substance Foods n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No Yes No No No PMDBD903 Wine polyphenols Dietary Substance Dietary Compounds n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD904 Wognoside Herbal Substance Medicinal Herbal Compounds n.a. n.a. n.a. n.a. n.a. 12004622 n.a. n.a. "Wogonoside; 51059-44-0; (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(5-hydroxy-8-methoxy-4-oxo-2-phenylchromen-7-yl)oxyoxane-2-carboxylic acid; Oprea1_259997; Wogonin 7-O-b-D-glucuronide; MLS000563432; SCHEMBL13223530; CHEMBL1508816; HMS3332D12; HMS2212B09; BCP31664; Oroxindin; Wogonin 7-O-glucuronide; SMR000232282; DB-050213; FT-0689337" C22H20O11 LNOHXHDWGCMVCO-UHFFFAOYSA-N 3,4,5-trihydroxy-6-(5-hydroxy-8-methoxy-4-oxo-2-phenylchromen-7-yl)oxyoxane-2-carboxylic acid n.a. n.a. No Yes No No No No PMDBD994 AMC formula Herbal Substance TCM Formula n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD905 Xiao-Qing-Long Tang Herbal Substance TCM Formula n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD911 Zingiber officinale Herbal Substance Medicinal Herb n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD912 Ziprasidone Hydrochloride Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 219099 n.a. n.a. "Ziprasidone hydrochloride; 122883-93-6; Ziprasidone HCl; Geodon; Zeldox; 5-(2-(4-(Benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-6-chloroindolin-2-one hydrochloride; Ziprasidone (hydrochloride); UNII-JAL53626GG; 5-[2-[4-(1,2-Benzisothiazol-3yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2H-indol-2-one hydrochloride; Ziprasidone hydrochloride [USAN]; 5-[2-[4-(1,2-Benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2H-indol-2-one hydrochloride; C21H21ClN4OS.HCl; JAL53626GG; C21H22Cl2N4OS; CP 88059; 2H-Indol-2-one, " C21H22Cl2N4OS NZDBKBRIBJLNNT-UHFFFAOYSA-N "5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-1,3-dihydroindol-2-one;hydrochloride" n.a. n.a. Yes No No No No No PMDBD913 Ziprasidone mesylate Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 656685 n.a. n.a. "Ziprasidone mesylate; 199191-69-0; Ziprasidone mesylate trihydrate; Ziprasidone mesilate; Geodon; UNII-3X6SAX83JZ; Ziprasidone mesylate hydrate; 3X6SAX83JZ; Ziprasidone mesylate [USAN]; Geodon (TN); CP-88, 059-27; Ziprasidone mesylate (USAN); CP-8805927; 5-(2-(4-(1,2-Benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-2-indolinone monomethanesulfonate, trihydrate; 2H-Indol-2-one, 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-, monomethanesulfonate, trihydrate; Ziprasidone (mesylate hydrate); CH" C22H31ClN4O7S2 WLQZEFFFIUHSJB-UHFFFAOYSA-N "5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-1,3-dihydroindol-2-one;methanesulfonic acid;trihydrate" n.a. n.a. No Yes No No No No PMDBD914 Zn(ii)-curcumin Environmental Chemicals Nutrient Supplement n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD917 Zuclopenthixol dihydrochloride Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. n.a. 6433208 n.a. n.a. "Zuclopenthixol dihydrochloride; Zuclopenthixol hydrochloride; Clopixol; Cisordinol; Sordenac; Ciatyl; cis-Clopenthixol hydrochloride; UNII-7042692VYN; alpha-Clopenthixol dihydrochloride; EINECS 261-080-2; 58045-23-1; Clopenthixol cis(Z)-form dihydrochloride; Chlorpenthixol dihydrochloride; N 789; FDA 0199; EINECS 211-194-3; NSC 78203; NSC 169185; 7042692VYN; Clopixol (TN); Clopenthixol dihydrochloride; W 2304; 1-Piperazineethanol, 4-(3-(2-chlorothioxanthen-9-yl)propyl)-, dihydrochloride; Thioxanthene, 2-chloro-9-(3-(4-(2-hydroxye" C22H27Cl3N2OS LPWNZMIBFHMYMX-MHKBYHAFSA-N "2-[4-[(3Z)-3-(2-chlorothioxanthen-9-ylidene)propyl]piperazin-1-yl]ethanol;dihydrochloride" n.a. n.a. Yes No Yes No No No PMDBD1184 Etanercept Therapeutic substance Drug 185243-69-0 DB00005 PA449515 D00742 DNC000605 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD1017 Adalimumab Therapeutic substance Drug 331731-18-1 DB00051 PA10004 D02597 DAP000392 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD1239 Infliximab Therapeutic substance Drug 170277-31-3 DB00065 PA452639 D02598 DAP000107 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD1485 Ustekinumab Therapeutic substance Drug 815610-63-0 DB05679 n.a. D09214 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD1437 Teicoplanin Therapeutic substance Antibiotics 61036-62-2 DB06149 PA164746244 D02142 n.a. 133065662 n.a. n.a. "Targocid; Antibiotic 8327A; Teichomycin; MDL 507; Teicoplanina; Teicoplanine; Teicoplaninum; Tecoplaninum; Tecoplanina; Tecoplanine; Teicoplaninum [Latin]; Teicoplanine [French]; Teicoplanina [Spanish]; Tecoplaninum [INN-Latin]; Tecoplanine [INN-French]; Teicoplanine [INN-French]; Teicoplaninum [INN-Latin]; Tecoplanina [INN-Spanish]; Teicoplanina [INN-Spanish]; UNII-4U3D3YY81M; Teicoplanin [USAN:INN:BAN]; 4U3D3YY81M; GTPL10924; MDL-507; 61036-62-2; 8327A" C88H97Cl2N9O33 BJNLLBUOHPVGFT-CAYRISATSA-N (1S,2R,19R,22R,34S,37R,40R,52S)-2-[(2R,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-22-amino-5,15-dichloro-64-[(2S,3R,4R,5S,6R)-3-(decanoylamino)-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-26,31,44,49-tetrahydroxy-21,35,38,54,56,59-hexaoxo-47-[(3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-7,13,28-trioxa-20,36,39,53,55,58-hexazaundecacyclo[38.14.2.23,6.214,17.219,34.18,12.123,27.129,33.141,45.010,37.046,51]hexahexaconta-3,5,8,10,12(64),14,16,23(61),24,26,29(60),30,3 n.a. n.a. Yes No No No No No PMDBD1211 Garenoxacin Therapeutic substance Antibiotics 194804-75-6 DB06160 n.a. n.a. n.a. 124093 110579 n.a. "Garenoxacin; 194804-75-6; Ganefloxacin; T-3811; T 3811; UNII-V72H9867WB; (R)-1-Cyclopropyl-8-(difluoromethoxy)-7-(1-methylisoindolin-5-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid; V72H9867WB; BMS-284756; Garenfloxacin; 194804-75-6 pound not223652-90-2; NCGC00181770-01; Garenoxacin [INN:BAN]; BMS 284756 (*Mesylate salt*); garenoxacinum; garenoxacino; garenoxacine; T-3811MEa; C23H20F2N2O4; BMS-284756 (*Mesylate salt*); BMS284756" C23H20F2N2O4 NJDRXTDGYFKORP-LLVKDONJSA-N 1-cyclopropyl-8-(difluoromethoxy)-7-[(1R)-1-methyl-2,3-dihydro-1H-isoindol-5-yl]-4-oxoquinoline-3-carboxylic acid n.a. n.a. Yes No No No No No PMDBD1487 Vedolizumab Therapeutic substance Approved Drug 943609-66-3 DB09033 n.a. D08083 n.a. n.a. 943609663 n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD1026 Amino acids Dietary Substances Amino acids 65072-01-7 DB09393 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD1492 Vitamin D Therapeutic substance Drug 1406-16-2 DB11094 n.a. n.a. n.a. 5280795 n.a. n.a. "Vitamin D3; cholecalciferol; 67-97-0; Calciol; Colecalciferol; VITAMIN D; Oleovitamin D3; Trivitan; Arachitol; Ricketon; Vigorsan; Deparal; Activated 7-dehydrocholesterol; Colecalcipherol; Delsterol; Quintox; Ebivit; Cholecalciferolum; (+)-Vitamin D3; D3-Vigantol; D3-Vicotrat; vitamin d-3; Vi-de-3-hydrosol; NEO Dohyfral D3; Vitinc Dan-Dee-3; Rampage; Colecalciferolum; Cholecalciferol, D3; Vi-De3; Colecalciferolo [DCIT]; FeraCol; Duphafral D3 1000; 1406-16-2; Colecalciferolum [INN-Latin]; 7-Dehydrocholestrol, activated; Irradiated 7-dehydroch" C27H44O QYSXJUFSXHHAJI-YRZJJWOYSA-N (1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol n.a. n.a. Yes No No No No No PMDBD1417 Sitafloxacin Therapeutic substance Antibiotics 163253-35-8 DB13261 n.a. n.a. n.a. 461399 27471522 n.a. "Sitafloxacin; Gracevit; 127254-12-0; Sitafloxacin Sesquihydrate; UNII-3GJC60U4Q8; DU-6859a; 163253-35-8; Sitafloxacin isomer II; C19H18ClF2N3O3; DU 6859; CHEBI:4304; 3GJC60U4Q8; 7-((S)-7-AMINO-5-AZASPIRO[2.4]HEPTAN-5-YL)-8-CHLORO-6-FLUORO-1-((1R,2S)-2-FLUOROCYCLOPROPYL)-4-OXO-1,4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID; STFX; DU-6859; 127254-10-8; 7-(7-Amino-5-azaspiro(2.4)heptan-5-yl)-8-chloro-6-fluoro-1-(2-fluorocyclopropyl)-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid sesquihydrate; 7-((7S)-Amino-5-azaspiro(2,4)heptan-5-yl)-8" C19H18ClF2N3O3 PNUZDKCDAWUEGK-CYZMBNFOSA-N 7-[(7S)-7-amino-5-azaspiro[2.4]heptan-5-yl]-8-chloro-6-fluoro-1-[(1R,2S)-2-fluorocyclopropyl]-4-oxoquinoline-3-carboxylic acid n.a. n.a. Yes No No No No No PMDBD1089 Cefpirome Therapeutic substance Antibiotics 84957-29-9 DB13682 n.a. D07649 n.a. 5479539 4586396 n.a. "CEFPIROME; 84957-29-9; Cefpiromum; Cefpiroma; Cefrom; HR 810; UNII-S72Q2F09HY; cefpirome sulfate; S72Q2F09HY; CHEBI:3503; Cefpiromum [Latin]; Cefpiroma [Spanish]; Cefpirome [INN:BAN]; HR-810; (6R,7R)-7-{[(2Z)-2-(2-Amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-(6,7-dihydro-5H-cyclopenta[b]pyridinium-1-ylmethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate; cefpirome sulphate; NCGC00181339-01; Cerfpirome; C22H22N6O5S2; Broact; Keiten; Cefpirome (INN); 5H-1-Pyrindinium, 1-((7-(((2-amino-4-thiazolyl)(methoxyimin" C22H22N6O5S2 DKOQGJHPHLTOJR-WHRDSVKCSA-N (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-(6,7-dihydro-5H-cyclopenta[b]pyridin-1-ium-1-ylmethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate n.a. n.a. Yes No No No No No PMDBD1278 Mercuric chloride Environmental Chemicals Heavy Metals 7487-94-7 DB13765 n.a. D01905 n.a. 24085 22517 n.a. "MERCURIC CHLORIDE; Mercury(II) chloride; Dichloromercury; Sublimate; Mercury dichloride; Mercury bichloride; Corrosive sublimate; Mercury perchloride; Mercuric bichloride; 7487-94-7; Sublimat; Sulema; HgCl2; Perchloride of mercury; Corrosive mercury chloride; Chlorure mercurique; Calochlor; Fungchex; Sulem; Bichlorure de mercure; Abavit B; Mercury chloride (HgCl2); Bichloride of mercury; Chlorid rtutnaty; Mercury(2+) chloride; Quecksilber chlorid; Calocure; Sublimat [Czech]; Sulema [Russian]; Cloruro di mercurio; mercury(II)chloride; dic" Cl2Hg LWJROJCJINYWOX-UHFFFAOYSA-L dichloromercury n.a. n.a. Yes No No No No No PMDBD1068 Cadmium Environmental Chemicals Heavy Metals 7440-43-9 DB14085 n.a. n.a. n.a. 23973 22410 n.a. "7440-43-9; Cadmium; Cd; Colloidal cadmium; Cadmium compounds; Cadmium, elemental; Kadmium; Kadmium [German]; UNII-00BH33GNGH; CCRIS 112; HSDB 282; EINECS 231-152-8; MFCD00010914; 00BH33GNGH; C I 77180; C.I. 77180; Cadmium [Cadmium and cadmium compounds]; Cadmium [Cadmium and certain cadmium compounds]; cadmio; Cadmium, Reference Standard Solution; Cadmium, mass of 135; Cadmium metal; Elemental cadmium; CD135; Cadmium, p.a.; Cadmium powder 325 mesh; 48Cd; Cadmium, >=99.9%; EC 231-152-8; Cadmium powder - 100mesh; Cadmium, thermovacuum " Cd BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium n.a. n.a. Yes No Yes No Yes No rxnAGORA534,rxnAGORA2596 PMDBD1000 4-Aminosalicylic Acid Therapeutic substance Drug n.a. n.a. n.a. n.a. n.a. 4649 n.a. n.a. "4-Aminosalicylic acid; 4-Amino-2-hydroxybenzoic acid; 65-49-6; Aminosalicylic acid; P-AMINOSALICYLIC ACID; Rezipas; Aminopar; Pamisyl; Parasalindon; Deapasil; Apacil; Parasal; Paser; Para-aminosalicylic acid; Paramycin; Gabbropas; Pasnodia; Parasalicil; Osacyl; Aminox; Pasolac; Pasmed; Pasdium; Pasara; Pamacyl; Propasa; Pasalon; Entepas; Pasem; Pasa; 2-Hydroxy-4-aminobenzoic acid; PASK; APAS; Para-Pas; Sanipirol-4; para-Amino salicylic acid; Hellipidyl; Pascorbic; 4-Aminosalicylate; PAS-C; PAS (acid); Kyselina p-am" C7H7NO3 WUBBRNOQWQTFEX-UHFFFAOYSA-N 4-amino-2-hydroxybenzoic acid n.a. n.a. No Yes No No No No PMDBD1001 2,2'',4,4''-Tetrabromodiphenyl ether Environmental Chemicals Persistent Organic Pollutants n.a. n.a. n.a. n.a. n.a. 95170 n.a. n.a. "5436-43-1; 2,2'',4,4''-Tetrabromodiphenyl ether; 4,4''-Oxybis(1,3-dibromobenzene); BDE-47; PBDE 47; DIBROMOPHENYL ETHER; 2,2''4,4''-Tetrabromodiphenyl ether; 2,4-dibromo-1-(2,4-dibromophenoxy)benzene; BDE 47; C12H6Br4O; PBDE-47; UNII-0N97R5X10X; 1,1''-oxybis(2,4-dibromobenzene); NSC 21724; bis(2,4-dibromophenyl) ether; CHEBI:81584; 0N97R5X10X; NSC21724; 1,1''-Oxybis[2,4-dibromobenzene]; AK121881; PBDE 47 (2,2'',4,4''-Tetrabromodiphenyl ether); DSSTox_CID_10056; PBDE No. " C12H6Br4O XYBSIYMGXVUVGY-UHFFFAOYSA-N 2,4-dibromo-1-(2,4-dibromophenoxy)benzene n.a. n.a. Yes No No No No No PMDBD1002 2,3,7,8-tetrachlorodibenzofuran Environmental Chemicals Persistent Organic Pollutants n.a. n.a. n.a. n.a. n.a. 39929 n.a. n.a. "2,3,7,8-TETRACHLORODIBENZOFURAN; Tcdbf; TCDF; 51207-31-9; 2,3,7,8-TCDF; UNII-XZJ41GQI5D; NCI-C56611; HSDB 4306; 2,3,7,8-Tetrapolychlorinated dibenzofuran; 2,3,7,8-Tetrachloro-dibenzofuran; XZJ41GQI5D; BRN 1430934; CHEMBL136710; CHEBI:81506; 2,3,7,8-Tetrachlorodibenzo[b,d]furan; 2,3,7,8-Tetrachlorodibenzofuran [Dioxin and dioxin-like compounds]; PCDF 83; SCHEMBL548471; ACMC-1B053; DTXSID3052147; CTK3F0526; ZINC5784249; 2,3,7,8-TCDF (and congeners); BDBM50408308; LS-162; 2,3,7,8-Tetrachlorodibenzo[b" C12H4Cl4O KSMVNVHUTQZITP-UHFFFAOYSA-N 2,3,7,8-tetrachlorodibenzofuran n.a. n.a. Yes No No No No No PMDBD1003 2,3,7,8-tetrachlorodibenzo-p-dioxin Environmental Chemicals Persistent Organic Pollutants n.a. n.a. n.a. n.a. n.a. 15625 n.a. n.a. "2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN; TCDD; Dioxin; Tetradioxin; Tetrachlorodibenzodioxin; 1746-01-6; Dioxine; TCDBD; 2,3,7,8-Tetrachlorooxanthrene; 2,3,7,8-TCDD; 2,3,7,8-Tetrachlorodibenzodioxin; Dioksyny; Dioksyny [Polish]; Dioxin (herbicide contaminant); 2,3,7,8-Tetrachlorodibenzo-1,4-dioxin; NCI-C03714; UNII-DO80M48B6O; PCDD 48; CCRIS 576; HSDB 4151; EINECS 217-122-7; 2,3,7,8-Tetrachlorodibenzo[b,e][1,4]dioxin; 2,3,7,8-tetrachloro-dibenzo-p-dioxin; Dibenzo(b,e)(1,4)dioxin, 2,3,7,8-tetrach" C12H4Cl4O2 HGUFODBRKLSHSI-UHFFFAOYSA-N 2,3,7,8-tetrachlorodibenzo-p-dioxin n.a. n.a. Yes No No No No No PMDBD1004 5-aminosalicylic acid Therapeutic substance Drug n.a. n.a. n.a. n.a. n.a. 4075 n.a. n.a. "5-Aminosalicylic acid; mesalamine; Mesalazine; 5-Amino-2-hydroxybenzoic acid; 89-57-6; Asacol; Pentasa; Claversal; Canasa; 5-ASA; Salofalk; Rowasa; m-Aminosalicylic acid; Mesasal; Lialda; Fisalamine; Lixacol; Apriso; p-Aminosalicylsaeure; sfRowasa; Mesalazinum; Asacolitin; Mesalazina; 5-amino-2-hydroxy-benzoic acid; Asacol HD; Mesalazinum [Latin]; 5-Amino Salicylic Acid; Mesalamine [USAN]; Mesalazina [Spanish]; p-Aminosalicylsaeure [German]; 2-Hydroxy-5-aminobenzoic acid; 3-carbox" C7H7NO3 KBOPZPXVLCULAV-UHFFFAOYSA-N 5-amino-2-hydroxybenzoic acid n.a. n.a. Yes No No No No No PMDBD1005 5-fluoro-2''-deoxyuridine Therapeutic substance Therapeutic Substance n.a. n.a. n.a. n.a. n.a. 5790 n.a. n.a. "floxuridine; 50-91-9; 5-Fluorodeoxyuridine; 2''-Deoxy-5-fluorouridine; Fluorodeoxyuridine; FUDR; Floxuridin; Deoxyfluorouridine; 5-Fluoro-2''-deoxyuridine; Fluoruridine deoxyribose; 5FdU; Floxuridinum; Floxiridina; 5-Fluoro-2-desoxyuridine; FdUrd; beta-5-Fluoro-2''-deoxyuridine; 5 Fluorodeoxyuridine; Floxuridinum [INN-Latin]; 5-Fluorouracil 2''-deoxyriboside; Floxiridina [INN-Spanish]; 5-fluoro-1-((2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1h,3h)-dione; 5-Fluoro-2-deoxyuridine; 5-Fluorouracil deoxyribo" C9H11FN2O5 ODKNJVUHOIMIIZ-RRKCRQDMSA-N 5-fluoro-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione n.a. n.a. No Yes No No No No PMDBD1006 5-fluorocytosine Therapeutic substance chemotherapeutic n.a. n.a. n.a. n.a. n.a. 3366 n.a. n.a. "5-Fluorocytosine; flucytosine; 2022-85-7; Ancotil; Ancobon; 5-Fluorocystosine; Fluocytosine; 5-FC; Flucytosin; 5-Fluorocytosin; Fluorcytosine; Alcobon; 4-Amino-5-fluoropyrimidin-2(1H)-one; Flucytosinum; Ro 2-9915; 4-Amino-5-fluoro-2(1H)-pyrimidinone; 5-Flurocytosine; 5-Flucytosine; 2-Hydroxy-4-amino-5-fluoropyrimidine; 5-fluoro cytosine; Ancobon (TN); Flucitosina [DCIT]; Ro 29915 E/265601; NSC 103805; Flucytosinum [INN-Latin]; 117969-88-7; Flucytosine (Ancobon); Flucytosine (5" C4H4FN3O XRECTZIEBJDKEO-UHFFFAOYSA-N 6-amino-5-fluoro-1H-pyrimidin-2-one n.a. n.a. No Yes No No No Yes EX_fcsn(e),FCSND,FCSNDe,FCSNt PMDBD1007 5-fluorodeoxyuridine Therapeutic substance Drug n.a. n.a. n.a. n.a. n.a. 5790 n.a. n.a. "floxuridine; 50-91-9; 5-Fluorodeoxyuridine; 2''-Deoxy-5-fluorouridine; Fluorodeoxyuridine; FUDR; Floxuridin; Deoxyfluorouridine; 5-Fluoro-2''-deoxyuridine; Fluoruridine deoxyribose; 5FdU; Floxuridinum; Floxiridina; 5-Fluoro-2-desoxyuridine; FdUrd; beta-5-Fluoro-2''-deoxyuridine; 5 Fluorodeoxyuridine; Floxuridinum [INN-Latin]; 5-Fluorouracil 2''-deoxyriboside; Floxiridina [INN-Spanish]; 5-fluoro-1-((2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1h,3h)-dione; 5-Fluoro-2-deoxyuridine; 5-Fluorouracil deoxyribo" C9H11FN2O5 ODKNJVUHOIMIIZ-RRKCRQDMSA-N 5-fluoro-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione n.a. n.a. No Yes No No No No PMDBD1008 6-Mercaptopurine-2'-deoxyriboside Therapeutic substance chemotherapeutic n.a. n.a. n.a. n.a. n.a. 3037127 n.a. n.a. "2''-Deoxy-6-thioinosine; NSC 90557; 6-Mercaptopurine deoxyriboside; NSC 409366; 6-Mercaptopurine-2''-deoxyribonucleoside; 2239-64-7; 9-(2-Deoxy-beta-D-erythro-pentofuranosyl)-9H-purine-6(1H)-thiol; Inosine, 2''-deoxy-6-thio- (9CI); dI6S; 6-Mercapto-9-(2''-deoxy-b-D-ribofuranosyl)purine; 6-thio-2'' -deoxyinosine; SCHEMBL16216743; 6-Mercaptopurine-2-deoxyriboside; MFCD00056001; ZINC17163387; LS-127175; (2R,3S,5R)-2-(Hydroxymethyl)-5-(6-me" C10H12N4O3S WACLJMMBCDNRJE-RRKCRQDMSA-N 9-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H-purine-6-thione n.a. n.a. No Yes No No No No PMDBD1009 ACE inhibitors Therapeutic substance Drug category n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD1011 Acesulfame potassium Environmental Chemicals Artificial Sweeteners n.a. n.a. n.a. n.a. n.a. 11074431 n.a. n.a. "Acesulfame potassium; 55589-62-3; Acesulfame K; potassium 6-methyl-4-oxo-4H-1,2,3-oxathiazin-3-ide 2,2-dioxide; 6-Methyl-1,2,3-oxathiazin-4(3H)-one 2,2-dioxide potassium salt; Acesulfame (potassium); Acesulfame potassium salt; Acesulfame-K; NCGC00090729-01; AK128967; C4H4KNO4S; DSSTox_CID_10606; DSSTox_RID_78852; DSSTox_GSID_30606; Acesulfame potassium (NF); CAS-55589-62-3; E950; E 950; potassium;6-methyl-2,2-dioxo-1-oxa-2?^{6}-thia-3-azanidacyclohex-5-en-4-one; MLS006010910; INS NO.950; CHEMBL1351474; DTXSID1030606; KS-00000JHP" C4H4KNO4S WBZFUFAFFUEMEI-UHFFFAOYSA-M "potassium;6-methyl-2,2-dioxo-1-oxa-2lambda6-thia-3-azanidacyclohex-5-en-4-one" n.a. n.a. Yes No No No No No PMDBD1015 Actinomycin Therapeutic substance Drug n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD1016 Acyclovir Zovirax Therapeutic substance Drug n.a. n.a. n.a. n.a. n.a. 135398513 n.a. n.a. "acyclovir; Aciclovir; Acycloguanosine; 59277-89-3; Zovirax; Vipral; Virorax; Wellcome-248U; 9-[(2-Hydroxyethoxy)methyl]guanine; Aciclovirum; Zovir; Aciclovirum [Latin]; Sitavig; 9-HYROXYETHOXYMETHYLGUANINE; Aciclovirum [INN-Latin]; W-248-U; 9-(2-Hydroxyethoxy)methylguanine; Acyclovir-side chain-2-3H; 2-Amino-9-((2-hydroxyethoxy)methyl)-1H-purin-6(9H)-one; 9-((2-Hydroxyethoxy)methyl)guanine; BW-248U; UNII-X4HES1O11F; 2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one; DRG-0008; 2-Amino-9-[(2-hydroxyethoxy)methyl]-1,9-dihydro-6H-purin" C8H11N5O3 MKUXAQIIEYXACX-UHFFFAOYSA-N 2-amino-9-(2-hydroxyethoxymethyl)-1H-purin-6-one n.a. n.a. No Yes No No No No PMDBD1019 Aflatoxin B1 Environmental Chemicals Carcinogenic mycotoxins n.a. n.a. n.a. n.a. n.a. 186907 n.a. n.a. "AFLATOXIN B1; 1162-65-8; Aflatoxin B; NSC 529592; HSDB 3453; CCRIS 12; UNII-9N2N2Y55MH; NSC-529592; AFB1; EINECS 214-603-3; Aflatoxin B1, crystalline; BRN 1269174; CHEBI:2504; 9N2N2Y55MH; (6aR,9aS)-4-methoxy-2,3,6a,9a-tetrahydrocyclopenta[c]furo[3'',2'':4,5]furo[2,3-h]chromene-1,11-dione; 2,3,6aalpha,9aalpha-Tetrahydro-4-methoxycyclopenta(c)furo(3'',2'':4,5)furo(2,3-h)(1)benzopyran-1,11-dione; Cyclopenta(c)furo(3''" C17H12O6 OQIQSTLJSLGHID-WNWIJWBNSA-N (3S,7R)-11-methoxy-6,8,19-trioxapentacyclo[10.7.0.02,9.03,7.013,17]nonadeca-1,4,9,11,13(17)-pentaene-16,18-dione n.a. n.a. Yes Yes No No No No PMDBD1020 Aldicarb Environmental Chemicals Pesticides n.a. n.a. n.a. n.a. n.a. 9570071 n.a. n.a. "aldicarb; Temik; Aldicarbe; 116-06-3; Temik 10 G; NSC 379586; Z-isomeraldicarb; UC-21149; 2-Methyl-2-(methylthio)propionaldehyde O-(methylcarbamoyl)oxime; OMS-771; 2-Methyl-2-(methylthio)propanal, O-((methylamino)carbonyl)oxime; Propanal, 2-methyl-2-(methylthio)-, O-((methylamino)carbonyl)oxime; Carbamyl; Sulfone aldoxycarb; 2-Methyl-2-(methylthio)propanal O-[(methylamino)carbonyl]oxime; Propanal, 2-methyl-2-(methylthio)-, O-[(methylamino)carbonyl]oxime; Aldicarb [ISO]; Aldicarbe [French]; Temik G10; TEMIK G; Caswell No. 011A" C7H14N2O2S QGLZXHRNAYXIBU-WEVVVXLNSA-N [(E)-(2-methyl-2-methylsulfanylpropylidene)amino] N-methylcarbamate n.a. n.a. Yes No No No No No PMDBD1023 Alpha blockers Therapeutic substance Drug category n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD1029 Amoxicillin plus metronidazole Therapeutic substance Antibiotics n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD1030 Amoxicillin/clavulanate Therapeutic substance Antibiotics n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD1032 Anti PD-1 therapy Therapeutic substance Drug category n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD1033 Antibiotics (previous month antibiotics) Therapeutic substance Drug category n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD1034 Antihistamines (H1 inhibitor) Therapeutic substance Drug category n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD1035 Antihistamines (H2 inhibitor) Therapeutic substance Drug category n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD1036 Antihistamines (H3 inhibitor) Therapeutic substance Drug category n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD1038 AQ4N Therapeutic substance Therapeutic Substance n.a. n.a. n.a. n.a. n.a. 9955116 n.a. n.a. "Banoxantrone; AQ4N; 136470-65-0; UNII-W5H7E45YT3; W5H7E45YT3; AQ 4N; Banoxantrone [INN:BAN]; AQ-4N; SCHEMBL3676563; CHEMBL117391; ZINC3776950; DB04975; 1,4-Bis((2-(dimethylamino)ethyl)amino)-5,8-dihydroxy-9,10-anthracenedione N,N''-dioxide; NCGC00346890-01; DS-016089; NS00069174; Q27292332; 1,4-Bis(2-(dimethylazinoyl)ethylamino)-5,8-dihydroxy-9,10-anthraquinone; 1,4-Bis[2-(dimethylamino-n-oxide)ethylamino]-5,8-dihydroxyanthracene-9,10-dione" C22H28N4O6 YZBAXVICWUUHGG-UHFFFAOYSA-N 2-[[4-[2-[dimethyl(oxido)azaniumyl]ethylamino]-5,8-dihydroxy-9,10-dioxoanthracen-1-yl]amino]-N,N-dimethylethanamine oxide n.a. n.a. No Yes No No No No PMDBD1039 Ara G hydrate Therapeutic substance Investigational Drug n.a. n.a. n.a. n.a. n.a. 135499520 n.a. n.a. "38819-10-2; 9-(beta-D-Arabinofuranosyl)guanine; Arabinosylguanine; Ara-G hydrate; 9-Arabinofuranosylguanine; 9-beta-d-Arabinofuranosylguanine; Ara-G; Guanine arabinoside; 9-(b-d-arabinofuranosyl)guanine; 9-beta-Arabinosylguanine; NSC 76352; UNII-0Z99WX0GPF; 0Z99WX0GPF; CHEMBL240933; CHEBI:73141; 9-(BETA-D-ARABINOFURANOSYL)-GUANINE; C10H13N5O5; 2-amino-9-(beta-D-arabinofuranosyl)-1,9-dihydro-6H-purin-6-one; 2-Amino-9-((2R,3S,4" C10H13N5O5 NYHBQMYGNKIUIF-FJFJXFQQSA-N 2-amino-9-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one n.a. n.a. No Yes No No No No PMDBD1040 aracytine Therapeutic substance Drug n.a. n.a. n.a. n.a. n.a. 114682 n.a. n.a. "Arabinofuranosylcytosine; Cytarabinoside; Spongocytidine; Aracytidine; Aracytine; Cytarabin; Iretin; 3083-52-1; Arabinoside C; Arabinosylcytosine; Cytosine arabinose; 1-Arabinofuranosylcytosine; 1-beta-D-Arabinosylcytosine; Cytosine b-D-arabinofuranoside; Cyclocide; Citozar; ara-Cytosine; Cytosar U; Tarabine PFS; AC-1075; U 19920A; Spectrum_000331; Spectrum3_000373; Spectrum2_000159; U-19,920; Spectrum5_000821; Spectrum4_000307; (Arabinofuranosyl)cytosine; 4-Amino-1-arabinofuranosyl-2(1H)-pyrimidinone" C9H13N3O5 UHDGCWIWMRVCDJ-STUHELBRSA-N 4-amino-1-[(3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one n.a. n.a. Yes No No No No No PMDBD1041 Arsenic and zinc Environmental Chemicals Heavy Metals n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD1044 Aspirin Therapeutic substance pain and fever due to various causes n.a. n.a. n.a. n.a. n.a. 2244 n.a. n.a. "aspirin; ACETYLSALICYLIC ACID; 50-78-2; 2-Acetoxybenzoic acid; 2-(Acetyloxy)benzoic acid; o-Acetoxybenzoic acid; Acylpyrin; O-Acetylsalicylic acid; Ecotrin; Easprin; Acetophen; Acenterine; Polopiryna; Acetosal; Acetylsalicylate; Colfarit; Salicylic acid acetate; o-Carboxyphenyl acetate; Enterosarein; Temperal; Acetylin; Aspergum; Salcetogen; Pharmacin; Acetosalin; Premaspin; Micristin; Benaspir; Aspirdrops; Acetonyl; Aceticyl; Empirin; Ecolen; Rhodine; Endydol; Saletin; Rheumintabletten; Solprin acid; Enterosarine; Bialpirinia; Globentyl; Enterici" C9H8O4 BSYNRYMUTXBXSQ-UHFFFAOYSA-N 2-acetyloxybenzoic acid n.a. n.a. Yes Yes No No No No PMDBD1046 Atorvastatin Calcium Therapeutic substance Approved Drug n.a. n.a. n.a. n.a. n.a. 60822 n.a. n.a. "ATORVASTATIN CALCIUM; 134523-03-8; Lipitor; Sortis; Tahor; Atorvastatin Hemicalcium; CI-981; Atorvastatin hemicalcium salt; Atorvastatin calcium salt; UNII-C0GEJ5QCSO; Torvast; C0GEJ5QCSO; DRG-0321; CI 981; PD 134298-38A; CHEBI:50686; Atorvastatin calcium hydrate; Atorvastatin calcium [USAN]; Sotis; Calcium (betaR,deltaR)-2-(p-fluorophenyl)-beta,delta-dihydroxy-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrole-1-heptanoate (1:2); Lipitor (TN); 110862-48-1; DSSTox_RID_80143; DSSTox_CID_24303; DSSTox_GSID_44303; Storvas; Rotacor; CHEMBL3" C66H68CaF2N4O10 FQCKMBLVYCEXJB-MNSAWQCASA-L "calcium;(3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoate" n.a. n.a. No Yes No No No No PMDBD1048 "Atrazine; estradiol; PCB126; PCB153" Environmental Chemicals Persistent Organic Pollutants n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD1052 Benzo[a]pyrene Environmental Chemicals Persistent Organic Pollutants n.a. n.a. n.a. n.a. n.a. 2336 n.a. n.a. "benzo[a]pyrene; 50-32-8; benzo[pqr]tetraphene; 3,4-Benzopyrene; BENZO(A)PYRENE; 3,4-Benzpyrene; benzo[def]chrysene; Benzpyrene; 6,7-Benzopyrene; Benz[a]pyrene; 3,4-BP; 3,4-Benz[a]pyrene; 3,4-Benzopirene; 3,4-Benzpyren; Benzo[d,e,f]chrysene; Benz(a)pyrene; (B(a)P); B(a)P; BP; 3,4 Benzpyrene; RCRA waste number U022; Benzo(d,e,f)chrysene; 3,4-Benz(a)pyrene; NSC 21914; 3,4-Benzo(a)pyrene; B[a]p; 3,4-Benzpyren [German]; CCRIS 76; Benzo[A]-Pyrene; Benzo(def)chrysene; 3,4-benzylpyrene; 3,4-Benzopirene [Italian]; UNII-3417WMA06D; CHEBI:29865; HSDB " C20H12 FMMWHPNWAFZXNH-UHFFFAOYSA-N benzo[a]pyrene n.a. n.a. Yes No No No No No PMDBD1053 Benztropine Mesylate Therapeutic substance Drug n.a. n.a. n.a. n.a. n.a. 238053 n.a. n.a. "BENZTROPINE MESYLATE; Cogentin mesylate; 132-17-2; Benztropine (mesylate); MLS000737056; NSC42199; SMR000394012; Cobrentin methanesulfonate; EN300-51031; 3-(diphenylmethoxy)-8-methyl-8-azabicyclo[3.2.1]octane, methanesulfonic acid; Benzatropine methanesulfonate; Q-200693; 3-Diphenylmethoxytropane mesylate; MK 02; 3-(Benzhydryloxy)-8-methyl-8-azabicyclo[3.2.1]octane methanesulfonate; 3-Diphenylmethoxytropane methanesulfonate; Tropine benzohydryl ether methanesulfonate; 102701-02-0; Cogentin methanesulfonate; SR-01000075303; Ben" C22H29NO4S CPFJLLXFNPCTDW-UHFFFAOYSA-N "3-benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane;methanesulfonic acid" n.a. n.a. No Yes No No No No PMDBD1054 "Berry fruits(cranberries; raspberries)" Environmental Chemicals Food n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No Yes No No No PMDBD1055 Beta blockers Therapeutic substance Drug category n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD1058 Bile acids Dietary Substances compound n.a. n.a. n.a. n.a. n.a. 439520 n.a. n.a. "Bile salt; Bile acid; Bile Salts; CHEBI:22868; C01558" C24H40O5 BHQCQFFYRZLCQQ-UMZBRFQRSA-N 4-[(3R,5S,7R,12S)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid n.a. n.a. No Yes No No No No PMDBD1059 Bisoprolol Fumarate Therapeutic substance Drug n.a. n.a. n.a. n.a. n.a. 6917733 n.a. n.a. "Bisoprolol fumarate; 104344-23-2; Bisoprolol hemifumarate; Zebeta; Bisoprolol monofumarate; Monocor; Maintate; Fondril; Emcor; Concor; Soprol; TA-4708; Euradal; SMR000471619; 105878-43-1; MFCD00792743; Bisocard; Congescor; Cardicor; SR-01000597980; Concor COR; 66722-45-0; Bisoprolol fumarate (1:x); SCHEMBL41419; MLS001401436; MLS001076669; ARONIS24282; CHEMBL1200708; C18H31NO4.C4H4O4; Pharmakon1600-01505704; HMS2233F12; HMS1569A21; BCPP000331; HMS2051I16; HMS2094O19; EMD33512; SBB080729; s1206; RW2574; NSC759181; AKOS005267174; CCG-213520; AC-5016" C22H35NO8 RZPZLFIUFMNCLY-WLHGVMLRSA-N "(E)-but-2-enedioic acid;1-(propan-2-ylamino)-3-[4-(2-propan-2-yloxyethoxymethyl)phenoxy]propan-2-ol" n.a. n.a. No Yes No No No No PMDBD1061 "bisphenol A; ethinyl estradiol" Environmental Chemicals Others n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD1063 Brompheniramine Maleate Therapeutic substance Approved Drug n.a. n.a. n.a. n.a. n.a. 5281067 n.a. n.a. "Brompheniramine maleate; 980-71-2; Brompheniramine hydrogen maleate; Rolabromophen; Dimotane; Veltane; Spentane; Gammistin; Drauxin; Nagemid; Ebalin; Allent; Dimetane-ten; Parabromdylamine maleate; Drixoral Syrup; Brompheniramine (maleate); Dimetapp Allergy; Dimetane Extentabs; Lodrane; Brompheniramine maleate [USP]; EINECS 213-562-9; MLS000028423; CHEBI:3184; (+/-)-Brompheniramine maleate; (+/-)-Brompheniramine maleate salt; SMR000058417; 2-(p-Bromo-alpha-(2-(dimethylamino)ethyl)benzyl)pyridine maleate; 2-(p-Bromo-alpha-(2-(dimethyl" C20H23BrN2O4 SRGKFVAASLQVBO-BTJKTKAUSA-N "3-(4-bromophenyl)-N,N-dimethyl-3-pyridin-2-ylpropan-1-amine;(Z)-but-2-enedioic acid" n.a. n.a. No Yes No No No No PMDBD1066 Butorphanol-(+)-Tartrate Therapeutic substance Approved Drug n.a. n.a. n.a. n.a. n.a. 24840146 n.a. n.a. "Butorphanol tartrate; levo-BC-2627 tartrate; Torbutrol; Torate; Stadol NS; Torbutrol (Veterinary); Stadol Preservative Free; DEA No. 9720; EINECS 261-443-5; Butorphanol Tartrate Preservative Free; 58786-99-5; Butorphanol tartrate civ; (-)-17-(Cyclobutylmethyl)morphinan-3,14-diol D-(-)-tartrate (1:1) (salt); Morphinan-3,14-diol, 17-(cyclobutylmethyl)-, (S-(R*,R*))-2,3-dihydroxybutanedioate (1:1) (salt); Morphinan-3,14-diol, 17-(cyclobutylmethyl)-, (-)-, (S-(R*,R*))-2,3-dihydroxybutanedioate (1:1) (salt); SCHEMBL443889; CHEM" C25H35NO8 GMTYREVWZXJPLF-SXWPHCFWSA-N "(1S,9R,10S)-17-(cyclobutylmethyl)-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene-4,10-diol;2,3-dihydroxybutanedioic acid" n.a. n.a. No Yes No No No No PMDBD1074 Carbamate aldicarb Environmental Chemicals Pesticides n.a. n.a. n.a. n.a. n.a. 9570071 n.a. n.a. "aldicarb; Temik; Aldicarbe; 116-06-3; Temik 10 G; NSC 379586; Z-isomeraldicarb; UC-21149; 2-Methyl-2-(methylthio)propionaldehyde O-(methylcarbamoyl)oxime; OMS-771; 2-Methyl-2-(methylthio)propanal, O-((methylamino)carbonyl)oxime; Propanal, 2-methyl-2-(methylthio)-, O-((methylamino)carbonyl)oxime; Carbamyl; Sulfone aldoxycarb; 2-Methyl-2-(methylthio)propanal O-[(methylamino)carbonyl]oxime; Propanal, 2-methyl-2-(methylthio)-, O-[(methylamino)carbonyl]oxime; Aldicarb [ISO]; Aldicarbe [French]; Temik G10; TEMIK G; Caswell No. 011A" C7H14N2O2S QGLZXHRNAYXIBU-WEVVVXLNSA-N [(E)-(2-methyl-2-methylsulfanylpropylidene)amino] N-methylcarbamate n.a. n.a. Yes No No No No No PMDBD1078 Carbinoxamine Maleate Therapeutic substance Approved Drug n.a. n.a. n.a. n.a. n.a. 5282409 n.a. n.a. "CARBINOXAMINE MALEATE; 3505-38-2; Lergefin; Carbinoxamine maleate salt; Ciberon; Cliston; Clistin; p-Carbinoxamine maleate; Allergefon maleate; Paracarbinoxamine maleate; Hislosine; Ziriton; Histine sirup; Polistin T-caps; Polistine T-caps; Carbinoxamine hydrogen maleate; Clistin-D; EINECS 222-498-0; NSC 62362; CHEBI:31353; 2-(p-Chloro-alpha-(2-(dimethylamino)ethoxy)benzyl)pyridine maleate; 2-(p-Chloro-alpha-(2-(dimethylamino)ethoxy)benzyl)pyridine bimaleate; 2-(p-Chloro-alpha-(2-(dimethylamino)ethoxy)benzyl)pyridine maleate (1:" C20H23ClN2O5 GVNWHCVWDRNXAZ-BTJKTKAUSA-N "(Z)-but-2-enedioic acid;2-[(4-chlorophenyl)-pyridin-2-ylmethoxy]-N,N-dimethylethanamine" n.a. n.a. No Yes No No No No PMDBD1079 carboxymethylcellulose or polysorbate-80 Environmental Chemicals Food additives n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD1081 Carnitine Dietary Substances quaternary ammonium compound n.a. n.a. n.a. n.a. n.a. 288 n.a. n.a. "DL-Carnitine; Carnitine; 406-76-8; Carnitine DL-form; Carnitine [INN]; 3-hydroxy-4-(trimethylammonio)butanoate; (+-)-Carnitine; 461-06-3; L(-)-Carnitine; D,L-carnitine; Levocarnitine;Vitamin B(T); d(+)-carnitine; 3-hydroxy-4-(trimethylazaniumyl)butanoate; EINECS 206-976-6; Carnicor; Carnitinum [INN-Latin]; Carnitina [INN-Spanish]; CHEBI:17126; MFCD00038747; AK113129; Carnitina; (S)-3-Hydroxy-4-(trimethylammonio)butanoate; (1)-(3-Carboxy-2-hydroxypropyl)trimethylammonium hydroxide; Novaine; Excitine; Vitacarn; Miotonal; Miocor; Novain" C7H15NO3 PHIQHXFUZVPYII-UHFFFAOYSA-N 3-hydroxy-4-(trimethylazaniumyl)butanoate n.a. n.a. No Yes No No No No PMDBD1082 CB1954 Therapeutic substance "Drug; Prodrug" n.a. n.a. n.a. n.a. n.a. 89105 n.a. n.a. "Tretazicar; 21919-05-1; CB 1954; CB1954; 5-(1-Aziridinyl)-2,4-dinitrobenzamide; 5-(AZIRIDIN-1-YL)-2,4-DINITROBENZAMIDE; 5-Aziridino-2,4-dinitrobenzamide; CB-1954; 5-Aziridinyl-2,4-dinitrobenzamide; Tretazicar [INN]; 2,4-Dinitroethyleneiminobenzamide; 2,4-Dinitro-5-ethyleneiminobenzamide; NSC 115829; CHEMBL23330; CCRIS 1631; UNII-7865D5D01M; NSC-115829; 7865D5D01M; BRN 5825582; CB1; C9H8N4O5; SMR000326847; 5-[aziridin-1-yl]-2,4-dinitrobenzamide; aziri" C9H8N4O5 WOCXQMCIOTUMJV-UHFFFAOYSA-N 5-(aziridin-1-yl)-2,4-dinitrobenzamide n.a. n.a. No Yes No No No No PMDBD1084 Cefditoren Pivoxil Therapeutic substance Drug n.a. n.a. n.a. n.a. n.a. 6437877 n.a. n.a. "cefditoren pivoxil; 117467-28-4; Spectracef; Cefditoren pivaloyloxymethyl ester; CDTR-PI; Cefditorin; Meiact; Cefditoren (pivoxil); Cefditoren PI voxil; Cefditoren Pivoxil [JAN]; UNII-78THA212DH; ME 1207; ME-1207; CCRIS 7768; CEFDITORIN PIVOXIL; C25H28N6O7S3; ME1207; 78THA212DH; CHEBI:560555; [(2,2-dimethylpropanoyl)oxy]methyl (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-[(Z)-2-(4-methyl-1,3-thiazol-5-yl)ethenyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate; [(2,2-dimethylpropanoyl)o" C25H28N6O7S3 AFZFFLVORLEPPO-UVYJNCLZSA-N 2,2-dimethylpropanoyloxymethyl (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(Z)-2-(4-methyl-1,3-thiazol-5-yl)ethenyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate n.a. n.a. No Yes No No No No PMDBD1086 Cefetamet-pivoxil Therapeutic substance Antibiotics n.a. n.a. n.a. n.a. n.a. 5486182 n.a. n.a. "Cefetamet pivoxil; Cefetamet pivoxyl; 65243-33-6; Globocef; UNII-F6XA85N260; F6XA85N260; Cefetamet pivaloyloxymethyl ester; 7-(2 (2-Aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-desacetoxyceph-3-em-4-carboxylic acid pivaloyloxymethyl ester; Cefditoren impurity 3, Cefetamet Pivoxil; PubChem20563; NCGC00181788-01; SCHEMBL74256; CHEMBL4303443; DTXSID40110016; CHEBI:135812; 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2Z)-(2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-3-methyl-8-o" C20H25N5O7S2 DASYMCLQENWCJG-XUKDPADISA-N 2,2-dimethylpropanoyloxymethyl (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate n.a. n.a. Yes No No No No No PMDBD1090 Cefpodoxime Proxetil Therapeutic substance Antibiotics n.a. n.a. n.a. n.a. n.a. 6526396 n.a. n.a. "cefpodoxime proxetil; Vantin; Banan; 87239-81-4; Orelox; Doxef; CS-807; U-76252; CHEBI:3505; Cefodox; Cepodem; Cefoprox; DSSTox_CID_2766; DSSTox_RID_76722; DSSTox_GSID_22766; cefpodoxime 1-(isopropyloxycarbonyloxy)ethyl ester; (RS)-1-((Isopropoxycarbonyl)oxy)ethyl (+)-(6R,7R)-7-(2-(2-amino-4-thiazolyl)-2-((Z)-methoxyimino)acetamido)-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate; Cephpodoxime Proxetil; Simplicef; Otreon; CS 807; Xtum-O" C21H27N5O9S2 LTINZAODLRIQIX-FBXRGJNPSA-N 1-propan-2-yloxycarbonyloxyethyl (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate n.a. n.a. Yes Yes No No No No PMDBD1092 Ceftaroline Therapeutic substance "Approved Drug; Antibiotics" n.a. n.a. n.a. n.a. n.a. 9852981 n.a. n.a. "Ceftaroline fosamil; Ceftaroline inner salt; 229016-73-3; PPI-0903; CHEBI:70718; UNII-7P6FQA5D21; 7P6FQA5D21; (6R,7R)-7-({(2Z)-2-(ethoxyimino)-2-[5-(phosphonoamino)-1,2,4-thiadiazol-3-yl]acetyl}amino)-3-{[4-(1-methylpyridinium-4-yl)-1,3-thiazol-2-yl]sulfanyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate; ceftarolina fosamilo; Ceftaroline fosamil [USAN:INN:BAN]; ceftarolinum fosamilum; SCHEMBL1464037; CHEMBL501122; DTXSID60177444; DB06590" C22H21N8O8PS4 ZCCUWMICIWSJIX-NQJJCJBVSA-N (6R,7R)-7-[[(2Z)-2-ethoxyimino-2-[5-(phosphonoamino)-1,2,4-thiadiazol-3-yl]acetyl]amino]-3-[[4-(1-methylpyridin-1-ium-4-yl)-1,3-thiazol-2-yl]sulfanyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate n.a. n.a. Yes No No No No No PMDBD1093 Ceftaroline/avibactam Therapeutic substance Antibiotics n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD1094 Ceftazidime/avibactam Therapeutic substance Antibiotics n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD1099 Cefuroxime axetil Therapeutic substance Antibiotics n.a. n.a. n.a. n.a. n.a. 6321416 n.a. n.a. "cefuroxime axetil; Ceftin; Zinnat; Cefuroxime 1-acetoxyethyl ester; Elobact; Zinat; Bioracef; CXM-AX; Coliofossim; 64544-07-6; Furoxime; Cethixim; Cepazine; Cetoxil; Celocid; Nivador; Medoxm; Kalcef; Zoref; Sharox-500; CCI-15641; UNII-Z49QDT0J8Z; DRG-0157; SN 407; CCI 15641; CHEBI:3516; (E)-Cefuroxime Axetil; BRN 6854419; Z49QDT0J8Z; (RS)-1-Hydroxyethyl (6R,7R)-7-(2-(2-furyl)glyoxylamido)-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate, 7(sup 2)-(Z)-(O-methyloxime), 1-acetate 3-carbamate; C20H22N4O10S" C20H22N4O10S KEJCWVGMRLCZQQ-YJBYXUATSA-N 1-acetyloxyethyl (6R,7R)-3-(carbamoyloxymethyl)-7-[[(2Z)-2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate n.a. n.a. Yes No No No No No PMDBD1100 Cefuroxime axetil followed vancomycin Therapeutic substance Antibiotics n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD1101 Cefuroxime axetil than vancomycIn Therapeutic substance Antibiotics n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD1102 Cephaloridine Therapeutic substance Antibiotics n.a. n.a. n.a. n.a. n.a. 5773 n.a. n.a. "cephaloridine; cefaloridine; Cephaloridin; Cephaloridinum; Cefaloridin; Cepaloridin; Cefalorizin; Cephalomycine; Cepalorin; Ceflorin; Loridine; 50-59-9; Cefaloridina; Kefloridin; Cefaloridinum; Glaxoridin; Ceporin; Intrasporin; Vioviantine; Sefacin; Keflordin; Deflorin; Cilifor; Ceporan; Verolgin; Lloncefal; Kefspor; Ampligram; Sasperin; Faredina; Ceporine; Keflodin; Betaine cephaloridine; CHEBI:3537; UNII-LVZ1VC61HB; Cefaloridinum [INN-Latin]; Cefaloridina [INN-Spanish]; N-(7-(2''-Thienylacetamidoceph-3-ylmethyl))-pyridinium-2-carboxylate; SCH " C19H17N3O4S2 CZTQZXZIADLWOZ-CRAIPNDOSA-N (6R,7R)-8-oxo-3-(pyridin-1-ium-1-ylmethyl)-7-[(2-thiophen-2-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate n.a. n.a. Yes No No No No No PMDBD1103 Cephazolin Therapeutic substance Antibiotics n.a. n.a. n.a. n.a. n.a. 33255 n.a. n.a. "cefazolin; Cephazolin; Cephamezine; 25953-19-9; Cefazoline; Cefamezin; Cephazoline; Cephazolidin; Cefazolina; Cefazolinum; Cefazolin acid; Elzogram; Kefzol; Cefazolinum [INN-Latin]; CEZ; Cefazoline [INN-French]; Cefazolina [INN-Spanish]; Totacef; Cephazolin Sodium; UNII-IHS69L0Y4T; HSDB 3213; CHEBI:474053; EINECS 247-362-8; Cefazolin sodium salt; BRN 4169371; IHS69L0Y4T; (6R,7R)-3-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]-8-oxo-7-[[2-(tetrazol-1-yl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; Cefazil" C14H14N8O4S3 MLYYVTUWGNIJIB-BXKDBHETSA-N (6R,7R)-3-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]-8-oxo-7-[[2-(tetrazol-1-yl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid n.a. n.a. Yes No No No No No PMDBD1104 Chemotherapy Therapeutic substance Drug category n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD1105 Chenodiol Therapeutic substance Drug n.a. n.a. n.a. n.a. n.a. 10133 n.a. n.a. "chenodeoxycholic acid; Chenodiol; Chenic acid; Chenix; Cdca; Chenodeoxycholate; 474-25-9; Chenodesoxycholic acid; Gallodesoxycholic acid; Chendol; Anthropodeoxycholic acid; Anthropodesoxycholic acid; Chenofalk; Anthropododesoxycholic acid; Chenodesoxycholsaeure; Henohol; Xenbilox; Chenique Acid; Chenocholic acid; Chenodiol [USAN]; 3alpha,7alpha-Dihydroxy-5beta-cholan-24-oic acid; Sodium chenodeoxycholate; Acido chenodeoxicholico; Chenodesoxycholsaeure [German]; 3alpha,7alpha-Dihydroxy-5beta-cholanic acid; Acide chenodeoxycholique" C24H40O4 RUDATBOHQWOJDD-BSWAIDMHSA-N (4R)-4-[(3R,5S,7R,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid n.a. n.a. No Yes No No No No PMDBD1106 Chloroquine Diphosphate Therapeutic substance Drug n.a. n.a. n.a. n.a. n.a. 64927 n.a. n.a. "Chloroquine diphosphate; Chloroquine phosphate; 50-63-5; Aralen phosphate; Tanakan; Delagil; Arechin; Chloroquine bis(phosphate); Chingamin phosphate; Resochin; Chingaminum; Alermine; H-Stadur; Aralen diphosphate; Quingamine; Miniquine; Tanakene; Avloclor; Khingamin; Chloroquin diphosphate; Chlorochin diphosphate; Tanakan (antimalarial); Chloroquine (phosphate); Gontochin phosphate; dl-Chloroquine diphosphate; Chloroquine diphosphate salt; NSC 14050; Ipsen 225; CCRIS 1554; EINECS 200-055-2; WR 1522; 3377 RP; Chloroquine dihydrogen phospha" C18H32ClN3O8P2 QKICWELGRMTQCR-UHFFFAOYSA-N "4-N-(7-chloroquinolin-4-yl)-1-N,1-N-diethylpentane-1,4-diamine;phosphoric acid" n.a. n.a. No Yes No No No No PMDBD1107 Chlorothalonil Environmental Chemicals Pesticides n.a. n.a. n.a. n.a. n.a. 15910 n.a. n.a. "CHLOROTHALONIL; Tetrachloroisophthalonitrile; 1897-45-6; Daconil; Bravo; m-Tcpn; Nopcocide; 1,3-Dicyanotetrachlorobenzene; 2,4,5,6-Tetrachloroisophthalonitrile; meta-TCPN; Chloroalonil; Dacosoil; Exotherm; Clortosip; Termil; Repulse; Forturf; Faber; Sweep; Exotherm termil; m-Tetrachlorophthalonitrile; Daconil M; Tpn (pesticide); meta-Tetrachlorophthalodinitrile; Bravo 6F; Terraclactyl; Chlorthalonil; Daconil 2787; Clortocaf ramato; Daconil Flowable; Bravo-W-75; Bravo 500; 2,4,5,6-tetrachloro" C8Cl4N2 CRQQGFGUEAVUIL-UHFFFAOYSA-N 2,4,5,6-tetrachlorobenzene-1,3-dicarbonitrile n.a. n.a. Yes No No No No No PMDBD1111 Chlorpyrifos Environmental Chemicals Pesticides n.a. n.a. n.a. n.a. n.a. 2730 n.a. n.a. "chlorpyrifos; 2921-88-2; Chlorpyriphos; Dursban; Lorsban; Trichlorpyrphos; Brodan; Chlorpyrifos-ethyl; Piridane; Pyrinex; Coroban; Stipend; Equity; Lentrek; Lock-On; Killmaster; Danusban; Spannit; Tafaban; Bonidel; Geodinfos; Zidil; Terial; Durmet; Radar; Dowco 179; Suscon green; Suscon blue; suSCon; Dursban R; Dursban F; Chlorpyrifos ethyl; Dursban 4E; Chlorpyriphos-ethyl; Ethyl chlorpyriphos; Chloropyrifos; Dursban 10CR; Phosphorothioic acid, O,O-diethyl O-(3,5,6-trichloro-2-pyridinyl) ester; Chlorpyrifos (Dursban); Detmol U.A.; Dhanusban; Grofo" C9H11Cl3NO3PS SBPBAQFWLVIOKP-UHFFFAOYSA-N diethoxy-sulfanylidene-(3,5,6-trichloropyridin-2-yl)oxy-lambda5-phosphane n.a. n.a. Yes No No No No No PMDBD1115 Chromium (VI) Environmental Chemicals Heavy Metals n.a. n.a. n.a. n.a. n.a. 29131 n.a. n.a. "Chromium(6+); Chromium(VI); Chromium hexavalent ion; Hexavalent chromium; Chromium(6+) ion; 18540-29-9; Chromium(6+)ion; Chromium(6+)ions; Chromium(VI) ions; Chromium, hexavalent; Chromium(6+) ions; CHROMIUM (VI); Chromium (cr(sup 6+)); Chromium compounds, hexavalent; Chromium ion (6+); Chromium(VI) compounds; NCI-C04273; Chromium, ion(Cr6+); Chromium, ion (Cr 6+); Chromium (hexavalent compounds); Chromium, hexavalent (Cr(VI)); Chromium, ion (Cr6+); Cr(VI); Chromium(VI) compounds, n.o.s.; Chromium (VI) ion; chromium(VI) cation; Cr6+" Cr+6 JOPOVCBBYLSVDA-UHFFFAOYSA-N chromium(6+) n.a. n.a. Yes No No No No No PMDBD1119 Ciprofloxacin plus clindamycin Therapeutic substance Antibiotics n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD1121 Clarithromycin plus metronidazole Therapeutic substance Antibiotics n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD1125 Clomiphene Citrate Therapeutic substance Drug n.a. n.a. n.a. n.a. n.a. 3033832 n.a. n.a. "Clomifene citrate; CLOMIPHENE CITRATE; 50-41-9; Zuclomiphene citrate; Clomid; cis-Clomiphene citrate; Clomiphene A citrate; Zuclomid; Clomiphene citrate salt; Milophene; Serophene; Chloramiphene; Omifin; Clomifene citrate (Serophene); (Z)-Clomiphene citrate; UNII-UY5X264QZV; Clostilbegyt; RMI 16289; Ikaclomin; Genozym; Clomphid; Clomivid; Dyneric; 2-(4-(2-Chloro-1,2-diphenylvinyl)phenoxy)-N,N-diethylethanamine 2-hydroxypropane-1,2,3-tricarboxylate; Zuclomiphene (citrate); NSC 35770; 7619-53-6; NSC 151466; UY5X264QZV; Fertivet; Fertyl; Cl" C32H36ClNO8 PYTMYKVIJXPNBD-OQKDUQJOSA-N "2-[4-[(Z)-2-chloro-1,2-diphenylethenyl]phenoxy]-N,N-diethylethanamine;2-hydroxypropane-1,2,3-tricarboxylic acid" n.a. n.a. No Yes No No No No PMDBD1127 Clopidogrel Hydrogen Sulfate Therapeutic substance Drug n.a. n.a. n.a. n.a. n.a. 115366 n.a. n.a. "Clopidogrel bisulfate; 120202-66-6; Clopidogrel hydrogen sulfate; Iscover; Plavix; 135046-48-9; Clopidogrel bisulphate; (S)-methyl 2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetate sulfate; Clopidogrel hemisulfate; CLOPIDOGREL SULFATE; Clopidogrel sulphate; clopidogrel hydrogen sulphate; Clopidogrel (hydrogen sulfate); UNII-08I79HTP27; 113665-84-2; Clopidogrel (Plavix); SR 25990C; (S)-(+)-Clopidogrel Sulfate; SR-25990C; 08I79HTP27; PM-103; MFCD05865229; Myogrel; SR-25990; Clopidogrel hydrogensulfate; Plavix (TN" C16H18ClNO6S2 FDEODCTUSIWGLK-RSAXXLAASA-N "methyl (2S)-2-(2-chlorophenyl)-2-(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)acetate;sulfuric acid" n.a. n.a. No Yes No No No No PMDBD1129 Corticosteroids Therapeutic substance Drug n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD1131 Cromolyn Therapeutic substance Drug n.a. n.a. n.a. n.a. n.a. 2882 n.a. n.a. "cromolyn; Cromoglicic acid; 16110-51-3; Cromoglycate; Cromoglycic acid; Intal; Cromoglicate; Acido cromoglicico; Acide cromoglicique; Acidum cromoglicicum; 5,5''-((2-Hydroxypropane-1,3-diyl)bis(oxy))bis(4-oxo-4H-chromene-2-carboxylic acid); UNII-Y0TK0FS77W; Aarane; Acidum cromoglicicum [INN-Latin]; Acido cromoglicico [INN-Spanish]; Acide cromoglicique [INN-French]; Sodium Chromoglycate; Y0TK0FS77W; CHEBI:59773; Rynacrom; Lomudas; Frenasma; Nalcrom; Lomusol; Lomudal; Aararre; Nebulasma; Nasmil; Cromo asma aerosol; 1,3-Bis(2-carboxychromo" C23H16O11 IMZMKUWMOSJXDT-UHFFFAOYSA-N 5-[3-(2-carboxy-4-oxochromen-5-yl)oxy-2-hydroxypropoxy]-4-oxochromene-2-carboxylic acid n.a. n.a. No Yes No No No No PMDBD1132 Crude extracts of metabolites from Microcystis aeruginosa Environmental Chemicals Biological Contaminants n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD1133 Cyclamate Environmental Chemicals Artificial Sweeteners n.a. n.a. n.a. n.a. n.a. 7533 n.a. n.a. "Cyclamic acid; Cyclohexylsulfamic acid; 100-88-9; CYCLAMATE; N-Cyclohexylsulfamic acid; Cyclohexanesulfamic acid; Hexamic acid; Sucaryl; Sucaryl acid; Cyclohexylaminesulphonic acid; N-Cyclohexylsulphamic acid; Polycat 200; Cyclohexylaminesulfonic acid; Cyclohexylamidosulfuric acid; Cylamic acid; Cyclohexylsulphamic acid; Cyclohexanesulphamic acid; Zyklamat; Cyclohexylamidosulphuric acid; Cyclohexylamide sulfate; Cyclohexylamine sulfamic acid; NSC 220327; UNII-HN3OFO5036; Cyc" C6H13NO3S HCAJEUSONLESMK-UHFFFAOYSA-N cyclohexylsulfamic acid n.a. n.a. Yes No No No No No PMDBD1134 Cyclosporine A Therapeutic substance Drug n.a. n.a. n.a. n.a. n.a. 5284373 n.a. n.a. "cyclosporin A; cyclosporine; Ciclosporin; 59865-13-3; Cyclosporine A; Cyclosporin; Neoral; Ciclosporine; Sandimmun; Sang-35; Sandimmune; Ciclosporinum; Ciclosporina; Equoral; Neoplanta; Gengraf; Sandimmun Neoral; UNII-83HN0GTJ6D; Antibiotic S 7481F1; Consupren; Restasis; Ramihyphin A; SangCyA; 83HN0GTJ6D; MLS001333756; CHEBI:4031; CSA; S-Neoral; Cipol N; Sigmasporin Microoral; Sang 35; DSSTox_CID_365; Ciclosporinum [INN-Latin]; Ciclosporine [INN-French]; Ciclosporina [INN-Spanish]; DSSTox_RID_75541; Ciclosporin (Ciclosporin A); DSSTox_GSID_203" C62H111N11O12 PMATZTZNYRCHOR-CGLBZJNRSA-N (3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone n.a. n.a. No Yes No No No No PMDBD1144 Delavirdine Mesylate Therapeutic substance Drug n.a. n.a. n.a. n.a. n.a. 441386 n.a. n.a. "DELAVIRDINE MESYLATE; 147221-93-0; Delavirdine (mesylate); Delavirdine mesilate; Rescriptor; U-90152S; UNII-421105KRQE; Delavirdine monomethanesulfonate; delavirdine methanesulfonate; Delavirdine mesylate [USAN]; CHEBI:4379; 421105KRQE; Delavirdine mesylate (USAN); 1-(3-(Isopropylamino)-2-pyridyl)-4-((5-methanesulfonamidoindol-2-yl)carbonyl)piperazine monomethanesulfonate; Methanesulfonamide, N-[2-[[4-[3-[(1-methylethyl)amino]-2-pyridinyl]-1-piperazinyl]carbonyl]-1H-indol-5-yl]-, methanesulfonate (1:1); SR-05000001471; Res" C23H32N6O6S2 MEPNHSOMXMALDZ-UHFFFAOYSA-N "methanesulfonic acid;N-[2-[4-[3-(propan-2-ylamino)pyridin-2-yl]piperazine-1-carbonyl]-1H-indol-5-yl]methanesulfonamide" n.a. n.a. No Yes No No No No PMDBD1146 Deoxynivalenol Environmental Chemicals Biological Contaminants n.a. n.a. n.a. n.a. n.a. 40024 n.a. n.a. "DEOXYNIVALENOL; 51481-10-8; Vomitoxin; Dehydronivalenol; 4-Deoxynivalenol; 4-Desoxynivalenol; Desoxynivalenol; UNII-JT37HYP23V; NSC 269144; CCRIS 7801; Rd toxin; HSDB 7245; 12,13-Epoxy-3-alpha,7-alpha,15-trihydroxy-9-trichothecen-8-one; JT37HYP23V; Deoxynivalenol 100 microg/mL in Acetonitrile; 3alpha,7alpha,15-Trihydroxy-12,13-epoxytrichothec-9-en-8-one; SCHEMBL2694361; CHEMBL513300; (3alp" C15H20O6 LINOMUASTDIRTM-QGRHZQQGSA-N (1R,2R,3S,7R,9R,10R,12S)-3,10-dihydroxy-2-(hydroxymethyl)-1,5-dimethylspiro[8-oxatricyclo[7.2.1.02,7]dodec-5-ene-12,2''-oxirane]-4-one n.a. n.a. Yes No Yes No No No PMDBD1147 "DEP; methylparaben; triclosan" Environmental Chemicals Phthalates n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD1150 Desvenlafaxine Succinate Hydrate Therapeutic substance Drug n.a. n.a. n.a. n.a. n.a. 6918664 n.a. n.a. "386750-22-7; Pristiq; Desvenlafaxine succinate hydrate; Desvenlafaxine (succinate hydrate); Desvenlafaxine Succinate [USAN]; DVS-233; butanedioic acid;4-[2-(dimethylamino)-1-(1-hydroxycyclohexyl)ethyl]phenol;hydrate; Desvenlafaxine succinate (USAN); O-desmethylvenlafaxine Succinate Monohydrate; Desvenlafaxine Succinate Monohydrate (O-Desmethylvenlafaxine Succinate Monohydrate); Pristiq (TN); SCHEMBL1278407; Desvenlafaxine(succinatehydrate); Desvenlafaxinesuccinatemonohydrate; HY-B0602A; CTK8E8387; DTXSID70959511; HMS3747G15" C20H33NO7 PWPDEXVGKDEKTE-UHFFFAOYSA-N "butanedioic acid;4-[2-(dimethylamino)-1-(1-hydroxycyclohexyl)ethyl]phenol;hydrate" n.a. n.a. No Yes No No No No PMDBD1153 Di(2-ethylhexyl) phthlate Environmental Chemicals Phthalates n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No Yes No No No PMDBD1155 Diazinon Environmental Chemicals Pesticides n.a. n.a. n.a. n.a. n.a. 3017 n.a. n.a. "diazinon; Dimpylate; 333-41-5; Diazinone; Oleodiazinon; Neocidol; Spectracide; Diazitol; Dassitox; Ciazinon; Ektoband; Nedcidol; Nucidol; Flytrol; Exodin; Diazol; Diazide; Sarolex; Dazzel; Dacutox; Basudin; Antigal; Galesan; Bazuden; Dicid; Alfa-tox; Diazajet; Dimpylat; Garden Tox; Neocidol (oil); Terminator; Bassadinon; Kayazol; Dizinon; Meodinon; Kayazinon; Drawizon; Disonex; Compass; Nipsan; Dyzol; Diazinon ag 500; Knox-out; Neodinon; Optimizer; Dimpylatum; Delzinon; Dizictol; Dipofene; Srolex; Dizinil; Bazudin; Basudin 10 G; Geigy 24480; Basudin S; Knox Out" C12H21N2O3PS FHIVAFMUCKRCQO-UHFFFAOYSA-N diethoxy-(6-methyl-2-propan-2-ylpyrimidin-4-yl)oxy-sulfanylidene-lambda5-phosphane n.a. n.a. Yes No No No No No PMDBD1157 Dichlorodiphenyl-dichloroethylene Environmental Chemicals Pesticides n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD1159 Diethyl phosphate (metabolite of CPF+ others)(I) Environmental Chemicals Pesticides n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD1164 DMP, DEP, and DBP combined Environmental Chemicals Phthalates n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD1173 Emulsi?ers (P80 and CMC) Environmental Chemicals Other n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD1175 Enalaprilat Maleate Therapeutic substance "Approved Drug; Prodrug" n.a. n.a. n.a. n.a. n.a. 5388962 n.a. n.a. "enalapril; 75847-73-3; Vasotec; Enalaprilum; Enalaprila; Lexxel; Enalaprilum [INN-Latin]; Enalaprila [INN-Spanish]; UNII-69PN84IO1A; Enalapril Richet; CHEMBL578; Gadopril; 69PN84IO1A; CHEBI:4784; C20H28N2O5; (S)-1-(N-(1-(Ethoxycarbonyl)-3-phenylpropyl)-L-alanyl)-L-proline; 1-(N-((S)-1-Carboxy-3-phenylpropyl)-L-alanyl)-L-proline 1''-ethyl ester; NCGC00021569-04; Enalapril [INN:BAN]; N-[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]-L-alanyl-L-proline; DSSTox_CID_2982; DSSTox_RID_76817; DSSTox_GSID_22982; (S)-1-{(S)-2-[1-((S)-Ethoxycarbony" C20H28N2O5 GBXSMTUPTTWBMN-XIRDDKMYSA-N (2S)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid n.a. n.a. No Yes No No No No PMDBD1176 Epoxiconazole Environmental Chemicals Pesticides n.a. n.a. n.a. n.a. n.a. 3317081 n.a. n.a. "Epoxiconazole; 135319-73-2; CHEBI:83758; 1-[[3-(2-chlorophenyl)-2-(4-fluorophenyl)oxiran-2-yl]methyl]-1,2,4-triazole; 1-{[3-(2-chlorophenyl)-2-(4-fluorophenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazole; 133855-98-8; 106325-08-0; 1-((3-(2-Chlorophenyl)-2-(4-fluorophenyl)oxiran-2-yl)methyl)-1H-1,2,4-triazole; Epoxyconazol; DSSTox_CID_20372; DSSTox_RID_79488; SCHEMBL21976; DSSTox_GSID_40372; Epoxiconazole (BAS 480F); cc-169; CHEMBL3184033" C17H13ClFN3O ZMYFCFLJBGAQRS-UHFFFAOYSA-N 1-[[3-(2-chlorophenyl)-2-(4-fluorophenyl)oxiran-2-yl]methyl]-1,2,4-triazole n.a. n.a. Yes No No No No No PMDBD1177 Eprosartan Mesylate Therapeutic substance Drug n.a. n.a. n.a. n.a. n.a. 5282474 n.a. n.a. "EPROSARTAN MESYLATE; 144143-96-4; Teveten; Eprosartan mesilate; eprosartan methanesulfonate; Eprosartan (mesylate); UNII-8N2L1NX8S3; Eprosartan mesylate [USAN:BAN]; SK&F 108566-J; 8N2L1NX8S3; CHEBI:48409; (E)-2-Butyl-1-(p-carboxybenzyl)-alpha-2-thenylimidazole-5-acrylic acid, monomethanesulfonate; SK&F-108566-J; DSSTox_CID_24217; DSSTox_RID_80124; DSSTox_GSID_44217; Eprosartan Monomethanesulfonate; 2-Thiophenepropanoic acid, alpha-[[2-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazol-5-yl]methylene]-, (alphaE)-, methane" C24H28N2O7S2 DJSLTDBPKHORNY-XMMWENQYSA-N "4-[[2-butyl-5-[(E)-2-carboxy-3-thiophen-2-ylprop-1-enyl]imidazol-1-yl]methyl]benzoic acid;methanesulfonic acid" n.a. n.a. No Yes No No No No PMDBD1181 Esomeprazole Potassium Therapeutic substance Drug n.a. n.a. n.a. n.a. n.a. 23672364 n.a. n.a. "Esomeprazole potassium; UNII-F37S7G37O2; Esomeprazole potassium [USAN]; F37S7G37O2; Esomeprazole potassium (USAN); 161796-84-5; CHEMBL2105642; DTXSID20167240; D09339; Q27277571; Potassium 5-methoxy-2-[(S)-(4-methoxy-3,5-dimethylpyridin-2-yl)methanesulfinyl]benzimidazol-1-ide; 1H-Benzimidazole, 6-methoxy-2-((S)-((4-methoxy-3,5-dimethyl-2-pyridinyl)methyl)sulfinyl)-, potassium salt (1:1); (-)-5-Methoxy-2-((S)-((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)-1H-benzimidazole potassium salt" C17H18KN3O3S FOFFPEFVSRGLOZ-JIDHJSLPSA-N "potassium;5-methoxy-2-[(S)-(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]benzimidazol-1-ide" n.a. n.a. No Yes No No No No PMDBD1186 Ethinyl Estradiol Therapeutic substance Drug n.a. n.a. n.a. n.a. n.a. 5991 n.a. n.a. "ethinyl estradiol; Ethynylestradiol; Ethynyl estradiol; ETHINYLESTRADIOL; 57-63-6; Ethinyloestradiol; Ginestrene; 17-Ethinylestradiol; 17alpha-Ethynylestradiol; Progynon C; Novestrol; Etistradiol; Etinoestryl; Ethinoral; Orestralyn; Etinestryl; Eticyclin; Spanestrin; Follicoral; Etinestrol; Eticyclol; Primogyn; Menolyn; Amenoron; Lynoral; Ethidol; Estorals; Oradiol; Estinyl; Estigyn; Linoral; Inestra; Estoral; Ertonyl; Dyloform; Esteed; Neo-Estrone; Primogyn M; Primogyn C; Nogest-S; Eston-E; Feminone; Palonyl; Perovex; 17-Ethynylestradiol; Diogyn E; Mi" C20H24O2 BFPYWIDHMRZLRN-SLHNCBLASA-N (8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol n.a. n.a. No Yes No No No No PMDBD1191 Fenoprofen Calcium Therapeutic substance Drug n.a. n.a. n.a. n.a. n.a. 64746 n.a. n.a. "Fenoprofen calcium; 34597-40-5; Calcium 2-(3-phenoxyphenyl)propionate; Fenprofen calcium; Calcium fenoprofen; Fenoprofen calcium anhydrous; 56367-29-4; 2-(3-Phenoxyphenyl)propionic acid calcium salt; EINECS 252-107-9; Calcium (1)-bis(2-(3-phenoxyphenyl)propionate); Fenoprofen Calcium Salt; dl-2-(3-Phenoxyphenyl)propionic acid calcium salt; (+-)-alpha-Methyl-3-phenoxybenzeneacetic acid calcium salt; 53746-45-5; 71720-56-4; Nalfon 200; anhydrous fenoprofen calc" C30H26CaO6 VHUXSAWXWSTUOD-UHFFFAOYSA-L "calcium;2-(3-phenoxyphenyl)propanoate" n.a. n.a. No Yes No No No No PMDBD1194 Fipronil Environmental Chemicals Pesticides n.a. n.a. n.a. n.a. n.a. 3352 n.a. n.a. "fipronil; 120068-37-3; Fipronil [ISO]; C12H4Cl2F6N4OS; HSDB 7051; RM 1601; MB 46030; CHEMBL101326; 5-amino-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-[(trifluoromethyl)sulfinyl]-1H-pyrazole-3-carbonitrile; 5-amino-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-(trifluoromethylsulfinyl)pyrazole-3-carbonitrile; M & B 46030; CHEBI:83394; 5-amino-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-4-((trifluoromethyl)sulfinyl)-1h-pyrazole-3-carbonitrile; NCGC00094574-06; DSSTox_CID_14609; DSSTox_RID_79176; 5-Amino-3-cyano-1-(2,6-di" C12H4Cl2F6N4OS ZOCSXAVNDGMNBV-UHFFFAOYSA-N 5-amino-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-(trifluoromethylsulfinyl)pyrazole-3-carbonitrile n.a. n.a. Yes No No No No No PMDBD1196 Flecainide Acetate Therapeutic substance Drug n.a. n.a. n.a. n.a. n.a. 41022 n.a. n.a. "Flecainide acetate; 54143-56-5; Flecainide (acetate); Tambocor; FLECAINIDE MONOACETATE; R-818; Flecainide acetate salt; R 818; EINECS 258-997-5; N-(Piperidin-2-ylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide monoacetate; MLS000069675; CHEBI:5091; N-(2-Piperidinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide monoacetate; SMR000058451; EN300-51344; n-(piperidin-2-ylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide acetate; 2,5-Bis-(2,2,2-trifluoroethoxy)-N-(2-piperidinylmethyl)benzamide acetate; N-(2-Piperidylmethyl)-2,5-bi" C19H24F6N2O5 RKXNZRPQSOPPRN-UHFFFAOYSA-N "acetic acid;N-(piperidin-2-ylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide" n.a. n.a. No Yes No No No No PMDBD1198 Fludarabine de phosphate Therapeutic substance chemotherapeutic n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD1199 Fludrocortisone Acetate Therapeutic substance Drug n.a. n.a. n.a. n.a. n.a. 225609 n.a. n.a. "FLUDROCORTISONE ACETATE; 514-36-3; Scherofluron; Cortineff; Fludrocortisone 21-acetate; Florinef acetate; Alflorone acetate; F-Cortef acetate; Cortef-F; Fluohydrocortisone acetate; Fludrocortisone (acetate); UNII-V47IF0PVH4; Fluorocortisone acetate; 9alpha-Fluorohydrocortisone acetate; U 4845; 9alpha-Fluorohydrocortisone 21-acetate; V47IF0PVH4; CHEBI:5102; NSC-15186; (11beta)-9-fluoro-11,17-dihydroxy-3,20-dioxopregn-4-en-21-yl acetate" C23H31FO6 SYWHXTATXSMDSB-GSLJADNHSA-N [2-[(8S,9R,10S,11S,13S,14S,17R)-9-fluoro-11,17-dihydroxy-10,13-dimethyl-3-oxo-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate n.a. n.a. No Yes No No No No PMDBD1208 Fox River mixture (PCBs mixture) Environmental Chemicals Persistent Organic Pollutants n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No Yes No No No PMDBD1214 Genistin Dietary Substances Anti-cancer, estrogenic and antiatherosclerotic n.a. n.a. n.a. n.a. n.a. 5281377 n.a. n.a. "Genistin; 529-59-9; Genistine; Genistein 7-glucoside; Genistoside; Genistein glucoside; Genisteol 7-monoglucoside; Genistein 7-O-beta-D-glucoside; UNII-1POG3SCN5T; NSC 5112; Glucosyl-7-genistein; CHEBI:27514; Genistein, 7-O-beta-D-glucoside; Genistein, 7-beta-D-glucopyranoside; 1POG3SCN5T; Isoflavone, 4'',5,7-trihydroxy-, 7-D-glucoside; BRN 0064479; C21H20O10; 4'',5,7-Trihydroxyisoflavone 7-glucoside; genistein 7-O-glucoside; 4'',5,7-trihydroxyisoflavone 7-D-glucoside; 5-hydroxy-3-(4-hydroxyph" C21H20O10 ZCOLJUOHXJRHDI-CMWLGVBASA-N 5-hydroxy-3-(4-hydroxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one n.a. n.a. No Yes No No No No PMDBD1216 Glucocorticoids Therapeutic substance Drug category n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD1219 Glyphosate-based herbicide Environmental Chemicals Pesticides n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD1221 Guanabenz Acetate Therapeutic substance Drug n.a. n.a. n.a. n.a. n.a. 5702062 n.a. n.a. "Guanabenz acetate; 23256-50-0; Wytensin; WY-8678 acetate; Guanabenz (Acetate); Wy-8678; UNII-443O19GK1A; WY 8678 acetate; MLS000028717; Guanabenz (WY-8678) Acetate; 443O19GK1A; C8H8Cl2N4.C2H4O2; HSDB 6535; SMR000058454; EINECS 245-534-7; Guanabenz monoacetate; BR 750; ((2,6-Dichlorobenzylidene)amino)guanidine acetate; ((2,6-Dichlorobenzylidene)amino)guanidine monoacetate; Guanabenz acetate salt; SR-01000075268; [(2,6-Dichlorobenzylidene)amino]guanidine acetate; 3-((2,6-Dichlorophenyl)methylene)carbazamidine monoacetate; Wytensin " C10H12Cl2N4O2 MCSPBPXATWBACD-GAYQJXMFSA-N "acetic acid;2-[(E)-(2,6-dichlorophenyl)methylideneamino]guanidine" n.a. n.a. No Yes No No No No PMDBD1223 Hexachlorocyclohexane Environmental Chemicals "Pesticides; Persistent Organic Pollutants" n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD1224 High-fat diet (HFD) Dietary Substances Diet n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD1229 Hydroxychloroquine Sulfate Therapeutic substance Drug n.a. n.a. n.a. n.a. n.a. 12947 n.a. n.a. "HYDROXYCHLOROQUINE SULFATE; 747-36-4; Hydroxychloroquine sulphate; Ercoquin; 2-((4-((7-Chloroquinolin-4-yl)amino)pentyl)(ethyl)amino)ethanol sulfate; Plaquinol; Toremonil; TCMDC-123987; NSC 4375; Oxichlorochine Sulfate; Hydroxychloroquine sulfate [USP]; EINECS 212-019-3; AI3-52706; NSC-4375; Quensyl; AK-72909; Ethanol, 2-((4-((7-chloro-4-quinolyl)amino)pentyl)ethylamino)-, sulfate (1:1) (salt); DSSTox_CID_27788; 2-((4-((7-Chloro-4-quinolyl)amino)pentyl)ethylamino)ethanol sulfate (1:1) (salt); 2-((4-((7-Chloro-4-quinolinyl)ami" C18H28ClN3O5S JCBIVZZPXRZKTI-UHFFFAOYSA-N "2-[4-[(7-chloroquinolin-4-yl)amino]pentyl-ethylamino]ethanol;sulfuric acid" n.a. n.a. No Yes No No No No PMDBD1230 Hydroxyzine Dihydrochloride Therapeutic substance Drug n.a. n.a. n.a. n.a. n.a. 91513 n.a. n.a. "Hydroxyzine dihydrochloride; 2192-20-3; Hydroxyzine hydrochloride; Hydroxyzine 2HCl; 2-(2-(4-((4-Chlorophenyl)(phenyl)methyl)piperazin-1-yl)ethoxy)ethanol dihydrochloride; Orgatrax; Vistaject; Vistazine; Neurolax; Vistarex; Arcanax; Alamon; Durrax; Disron; Quiess; Marax; Atranine A; Vistaril steraject; Vistaril Parenteral; Hydroxyzine (dihydrochloride); Tran-Q dihydrochloride; Ataraxoid dihydrochloride; Tranquizine dihydrochloride; EINECS 218-586-3; AK-54930; AI3-50162; W-107513; CHEBI:5819; Ethanol, 2-[2-[4-[(4-chlorophenyl)phenylmet" C21H29Cl3N2O2 ANOMHKZSQFYSBR-UHFFFAOYSA-N "2-[2-[4-[(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]ethanol;dihydrochloride" n.a. n.a. No Yes No No No No PMDBD1237 Indigestible polysaccharides Dietary Substances unknown n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD1243 Ketotifen Fumarate Therapeutic substance Drug n.a. n.a. n.a. n.a. n.a. 5282408 n.a. n.a. "KETOTIFEN FUMARATE; 34580-14-8; Zaditen; Zaditor; Ketotifen hydrogen fumarate; Alaway; Ketotifen (fumarate); UNII-HBD503WORO; HC 20,511 fumarate; Ketotifen fumarate (Zaditor); Ketotifen fumarate [USAN:JAN]; Ketotifen fumarate salt; EINECS 252-100-0; HBD503WORO; MLS000069701; SMR000058462; 4,9-Dihydro-4-(1-methyl-4-piperidylidene)-10H-benzo(4,5)cyclohepta(1,2-b)thiophen-10-one fumarate (1:1); C23H23NO5S; 4,9-dihydro-4-(1-methylpiperidin-4-ylidene)-10H-benzo[4,5]cyclohepta[1,2-b]thiophene-10-one fumarate; 4,9-Dihydro-4-(1-methy" C23H23NO5S YNQQEYBLVYAWNX-WLHGVMLRSA-N "(E)-but-2-enedioic acid;2-(1-methylpiperidin-4-ylidene)-6-thiatricyclo[8.4.0.03,7]tetradeca-1(14),3(7),4,10,12-pentaen-8-one" n.a. n.a. No Yes No No No No PMDBD1248 Lapatinib Ditosylate Therapeutic substance Drug n.a. n.a. n.a. n.a. n.a. 9941095 n.a. n.a. "Lapatinib Ditosylate; 388082-77-7; Tykerb; Tyverb; Lapatinib (GW-572016) Ditosylate; Lapatinib (ditosylate); N-(3-CHLORO-4-((3-FLUOROBENZYL)OXY)PHENYL)-6-(5-(((2-(METHYLSULFONYL)ETHYL)AMINO)METHYL)FURAN-2-YL)QUINAZOLIN-4-AMINE BIS(4-METHYLBENZENESULFONATE); 388082-78-8; UNII-4WK72K94MC; 4WK72K94MC; AK-47669; bis(4-methylbenzene-1-sulfonic acid); N-{3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}-6-(5-{[(2-methanesulfonylethyl)amino]methyl}furan-2-yl)quinazolin-4-amine; Tykerb Ditosylate; SR-05000001472; GW-572016; Lapatinib d" C43H42ClFN4O10S3 UWYXLGUQQFPJRI-UHFFFAOYSA-N "N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]furan-2-yl]quinazolin-4-amine;4-methylbenzenesulfonic acid" n.a. n.a. No Yes No No No No PMDBD1250 Laxatives Therapeutic substance Drug category n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD1251 Lead Environmental Chemicals Heavy Metals n.a. n.a. n.a. n.a. n.a. 5352425 n.a. n.a. "Lead; 7439-92-1; Pb; Plumbum; Blei; Lead metal; Lead cation Pb4+; Glover; Lead element; Lead flake; Lead, elemental; Omaha & grant; C.I. Pigment Metal 4; Rough lead bullion; Olow [Polish]; Lead S2; CI pigment metal 4; Lead S 2; Lead ion (1 ); Lead, ion (Pb4+); Lead, inorganic; UNII-7Y62STE4M2; SSO 1; KS-4; HSDB 231; CCRIS 1581; lead(0); Pb-S 100; UNII-2P299V784P; C.I. 77575; EINECS 231-100-4; CI 77575; 7Y62STE4M2; Trimethyl Lead Ion; MFCD00134050; 2P299V784P; Lead, elemental and inorganic compounds; plomo; Lead, 99+%, powder; Lead, 99+%, gra" Pb WABPQHHGFIMREM-UHFFFAOYSA-N lead n.a. n.a. Yes No No No No No PMDBD1252 Lemofloxacin Therapeutic substance Antibiotics n.a. n.a. n.a. n.a. n.a. 45357079 n.a. n.a. "Lemofloxacin; AKOS015960855; AS-14325; AC-12466; K763" C17H21F2N3O3 YZGAZHWDQGGMJN-UHFFFAOYSA-N 1-ethyl-6,8-difluoro-7-(3-methylpiperazin-1-yl)-4-oxo-2,3-dihydroquinoline-3-carboxylic acid n.a. n.a. Yes No No No No No PMDBD1254 Lenapenem Therapeutic substance Antibiotics n.a. n.a. n.a. n.a. n.a. 216262 n.a. n.a. "Lenapenem; UNII-D6NBQ3H12U; 149951-16-6; D6NBQ3H12U; BO-2727; (4R,5S,6S)-6-[(1R)-1-hydroxyethyl]-3-[(3S,5S)-5-[(1R)-1-hydroxy-3-(methylamino)propyl]pyrrolidin-3-yl]sulfanyl-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid; Lenapenem [INN]; L-739428; 149882-71-3; SCHEMBL75702; CHEMBL3989459; GTPL10825; CTK4C6450; BO2727; Q27276182; L-739,4" C18H29N3O5S PZLOCBSBEUDCPF-YJIVIRPOSA-N (4R,5S,6S)-6-[(1R)-1-hydroxyethyl]-3-[(3S,5S)-5-[(1R)-1-hydroxy-3-(methylamino)propyl]pyrrolidin-3-yl]sulfanyl-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid n.a. n.a. Yes No No No No No PMDBD1256 Levocetirizine Dihydrochloride Therapeutic substance Drug n.a. n.a. n.a. n.a. n.a. 9955977 n.a. n.a. "Levocetirizine dihydrochloride; 130018-87-0; Xusal; Levocetirizine 2HCl; Xyzal; UNII-SOD6A38AGA; SOD6A38AGA; Levocetirizine dihydrochloride [USAN]; (R)-Cetirizine dihydrochloride; Levocetirizine HCl; Levocetirizine (dihydrochloride); Acetic acid, (2-(4-((R)-(4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-, dihydrochloride; (2-(4-((R)-(4-Chlorophenyl)phenylmethyl)piperazin-1-yl)ethoxy)acetic acid dihydrochloride; Acetic acid, 2-[2-[4-[(R)-(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]-, hydrochloride (1:2); [2-[4" C21H27Cl3N2O3 PGLIUCLTXOYQMV-GHVWMZMZSA-N "2-[2-[4-[(R)-(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]acetic acid;dihydrochloride" n.a. n.a. No Yes No No No No PMDBD1261 Losartan Potassium Therapeutic substance Drug n.a. n.a. n.a. n.a. n.a. 11751549 n.a. n.a. "LOSARTAN POTASSIUM; 124750-99-8; Cozaar; Lorzaar; Losaprex; losartan potassium salt; Hyzaar; ERYTHROPOIETIN; losartanpotassium; MK 954; Tenopres; Losacor; Lorzaan; Lortaan; Losacar; Ocsaar; Lotim; UNII-3ST302B24A; Niten; Losartan Potassium (DuP 753); Neo Lotan; Du Pont 753; 11096-26-7; MK-0954; 3ST302B24A; DuP 753; L-158086; MK0954; MK 0954; Lifezar; C22H22CIKN6OK; DuP-753; 2-Butyl-4-chloro-1-(2''-(tetrazol-5-yl)biphenyl-4-ylmethyl)-1H-imidazole-5-methanol potassium; 2-Butyl-4-chloro-1-(p-(o-1H-tetrazol-5-ylphenyl)benzyl)imidazole-5-methano" C22H22ClKN6O OXCMYAYHXIHQOA-UHFFFAOYSA-N "potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,3-triaza-4-azanidacyclopenta-2,5-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol" n.a. n.a. No Yes No No No No PMDBD1263 L-tyrosine Dietary Substances amino acid n.a. n.a. n.a. n.a. n.a. 6057 n.a. n.a. "L-tyrosine; tyrosine; 60-18-4; (S)-Tyrosine; p-Tyrosine; H-Tyr-OH; L-p-Tyrosine; (2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid; 4-Hydroxy-L-phenylalanine; Tyrosinum [Latin]; Tyrosine (VAN); Tirosina [Spanish]; L-(-)-Tyrosine; (-)-alpha-Amino-p-hydroxyhydrocinnamic acid; Tyrosine [USAN:INN]; beta-(p-Hydroxyphenyl)alanine; (S)-alpha-Amino-4-hydroxybenzenepropanoic acid; 3-(4-Hydroxyphenyl)-L-alanine; L-Tyrosin; FEMA No. 3736; L-2-Amino-3-p-hydroxyphenylpropanoic acid; (S)-3-(p-Hydroxyphen" C9H11NO3 OUYCCCASQSFEME-QMMMGPOBSA-N (2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid n.a. n.a. No Yes No No Yes Yes rxnAGORA1373,rxnAGORA2354,rxnAGORA2374,rxnAGORA2375,rxnAGORA3160,rxnAGORA3808,rxnAGORA3809,rxnAGORA3856,rxnAGORA4809,rxnAGORA4971 EX_tyr_L(e) PMDBD1268 MCB3837 Therapeutic substance Antibiotics n.a. n.a. n.a. n.a. n.a. 44201350 n.a. n.a. "Oxaquin; MCB-3837; UNII-1221R21ZRQ; 1221R21ZRQ; SCHEMBL2109002; GTPL10997; DNV3837; MCB3837; MCB 3837; DNV-3837; HY-100435; CS-0018921; Q27251356; 7-(4-{4-[(5S)-5-(Acetylamino-methyl)-2-oxo-oxazolidin-3-yl]-2-fluoro-phenoxymethyl}-4-phosphonooxy-piperidin-1-yl) -1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid; 7-(4-((4-((5S)-5-(Acetamidomethyl)-2-oxo-oxazolidin-3-yl)-2-fluoro-phenoxy)methyl)-4-phosphonooxy-1-piperidyl)-1-cyclopropyl-6-fluoro-4-oxo-quinoline-3-carboxylic acid; 3-Quinolinecarboxylic aci" C31H33F2N4O11P MNABRWLVTSGIMU-FQEVSTJZSA-N 7-[4-[[4-[(5S)-5-(acetamidomethyl)-2-oxo-1,3-oxazolidin-3-yl]-2-fluorophenoxy]methyl]-4-phosphonooxypiperidin-1-yl]-1-cyclopropyl-6-fluoro-4-oxoquinoline-3-carboxylic acid n.a. n.a. Yes No No No No No PMDBD1269 Meclizine Dihydrochloride Therapeutic substance Drug n.a. n.a. n.a. n.a. n.a. 64713 n.a. n.a. "Meclizine dihydrochloride; 1104-22-9; Meclozine dihydrochloride; Bonamine; Meclizine hydrochloride; 1-((4-Chlorophenyl)(phenyl)methyl)-4-(3-methylbenzyl)piperazine dihydrochloride; Postafen; Vertizine; Diadril; Taizer; V-Cline; Duremesin; Ancolan dihydrochloride; Postafene dihydrochloride; meclizine diHCl; Meclizine (dihydrochloride); NSC 28728; Parachloramine dihydrochloride; Meclizine hydrochloride anhydrous; EINECS 214-164-8; UNII-V5604WJ3XP; UNII-408UZ554UD; V5604WJ3XP; Meclizine 2HCl; 408UZ554UD; 1-[(4-chlorophenyl)(phenyl)met" C25H29Cl3N2 VCTHNOIYJIXQLV-UHFFFAOYSA-N "1-[(4-chlorophenyl)-phenylmethyl]-4-[(3-methylphenyl)methyl]piperazine;dihydrochloride" n.a. n.a. No Yes No No No No PMDBD1270 Meclofenamate Therapeutic substance Drug n.a. n.a. n.a. n.a. n.a. 4037 n.a. n.a. "meclofenamic acid; meclofenamate; 644-62-2; Meclophenamic acid; Arquel; Meclomen (free acid); 2-[(2,6-dichloro-3-methylphenyl)amino]benzoic acid; Meclomen; Acido meclofenamico; Acide meclofenamique; Acidum meclofenamicum; Acidum meclofenamicum [INN-Latin]; Acido meclofenamico [INN-Spanish]; Acide meclofenamique [INN-French]; INF 4668; N-(2,6-Dichloro-m-tolyl)anthranilic acid; CI-583; N-(3-Methyl-2,6-dichlorophenyl)anthranilic acid; 2-(2,6-dichloro-3-methylanilino)benzoic acid; N-(2,6-Dichloro-3-methylphenyl)anthranilic acid" C14H11Cl2NO2 SBDNJUWAMKYJOX-UHFFFAOYSA-N 2-(2,6-dichloro-3-methylanilino)benzoic acid n.a. n.a. No Yes No No No No PMDBD1273 Melamine Dietary Substances compound n.a. n.a. n.a. n.a. n.a. 7955 n.a. n.a. "MELAMINE; 1,3,5-Triazine-2,4,6-triamine; 108-78-1; Cyanuramide; Cyanurotriamine; Cyanurotriamide; Isomelamine; Theoharn; Teoharn; Triaminotriazine; Cyanuric triamide; Hicophor PR; s-Triazinetriamine; Aero; 2,4,6-Triamino-1,3,5-triazine; Yukamelamine; Pluragard; Cymel; Virset 656-4; 2,4,6-Triamino-s-triazine; Spinflam ML 94M; 2,4,6-Triaminotriazine; Pluragard C 133; ADK Stab ZS 27; Mark ZS 27; DG 002 (amine); NCI-C50715; Cyanurtriamide; 1,3,5-Triazine-2,4,6(1H,3H,5H)-triimine; ZS 27; UNII-N3GP2YSD88; s-triamino" C3H6N6 JDSHMPZPIAZGSV-UHFFFAOYSA-N 1,3,5-triazine-2,4,6-triamine n.a. n.a. No Yes No No No No PMDBD1276 Mepenzolate Bromide Therapeutic substance Drug n.a. n.a. n.a. n.a. n.a. 6461 n.a. n.a. "MEPENZOLATE BROMIDE; 76-90-4; Cantil; Colibantil; Cantilaque; Gastropidil; Trancolon; Delevil; Colopiril; Tralanta; Eftoron; Cantilon; Colum; Trokonil; Mepenzolate (Bromide); JB 340; Mepenzolati bromidum [INN-Latin]; N-Methyl-3-piperidyl benzilate methobromide; Bromure de mepenzolate [INN-French]; N-Methyl-3-piperidyl benzilate methyl bromide; Bromuro de mepenzolato [INN-Spanish]; 3-(2-Hydroxy-2,2-diphenylacetoxy)-1,1-dimethylpiperidin-1-ium bromide; Cantril; N-Methyl-3-piperidyldiphenylglycolate methobromide; 3-Hydroxy-1,1-dimeth" C21H26BrNO3 JRRNZNSGDSFFIR-UHFFFAOYSA-M "(1,1-dimethylpiperidin-1-ium-3-yl) 2-hydroxy-2,2-diphenylacetate;bromide" n.a. n.a. No Yes No No No No PMDBD1279 Mercury Environmental Chemicals Heavy Metals n.a. n.a. n.a. n.a. n.a. 23931 n.a. n.a. "Mercury; Hg; 7439-97-6; Quicksilver; Hydrargyrum; Metallic mercury; Liquid silver; Quecksilber; Mercurio; Mercure; Quick silver; Colloidal mercury; Mercury, elemental; Rtec; Kwik; Mercury vapor; elemental mercury; Mercury, metallic; Mercure [French]; RCRA waste number U151; Mercurio [Italian]; RTEC [Polish]; Quecksilber [German]; KWIK [Dutch]; Caswell No. 546; UNII-FXS1BY2PGL; Mercury, vapor; NCI-C60399; CCRIS 1578; UN 2024 (liquid compounds); HSDB 1208; Mercury vapor (as Hg); FXS1BY2PGL; EINECS 231-106-7; UN2809; RCRA waste no. U151; EPA Pes" Hg QSHDDOUJBYECFT-UHFFFAOYSA-N mercury n.a. n.a. Yes No No No No No PMDBD1280 Mesalazines Therapeutic substance Drug n.a. n.a. n.a. n.a. n.a. 4075 n.a. n.a. "5-Aminosalicylic acid; mesalamine; Mesalazine; 5-Amino-2-hydroxybenzoic acid; 89-57-6; Asacol; Pentasa; Claversal; Canasa; 5-ASA; Salofalk; Rowasa; m-Aminosalicylic acid; Mesasal; Lialda; Fisalamine; Lixacol; Apriso; p-Aminosalicylsaeure; sfRowasa; Mesalazinum; Asacolitin; Mesalazina; 5-amino-2-hydroxy-benzoic acid; Asacol HD; Mesalazinum [Latin]; 5-Amino Salicylic Acid; Mesalamine [USAN]; Mesalazina [Spanish]; p-Aminosalicylsaeure [German]; 2-Hydroxy-5-aminobenzoic acid; 3-carbox" C7H7NO3 KBOPZPXVLCULAV-UHFFFAOYSA-N 5-amino-2-hydroxybenzoic acid n.a. n.a. No Yes No No No No PMDBD1282 Metaproterenol Hemisulfate Therapeutic substance Drug n.a. n.a. n.a. n.a. n.a. 441333 n.a. n.a. "Metaproterenol sulfate; Orciprenaline sulfate; 5874-97-5; Metaproterenol hemisulfate; Metaproterenol hemisulfate salt; Metaproterenol sulfate, orciprenaline sulfate; TH-152; EN300-50867; DSSTox_RID_80848; DSSTox_CID_25391; DSSTox_GSID_45391; 5-[1-hydroxy-2-(propan-2-ylamino)ethyl]benzene-1,3-diol;sulfuric acid; Metaproterenol sulphate; Prestwick_845; Alupent (TN); MFCD00058303; NCGC00016662-01; CAS-5874-97-5; Orciprenaline (hemisulfate); Metaproterenol (hemisulfate); SCHEMBL41815; Metaproterenol sulfate (USP); Orciprenaline sulf" C22H36N2O10S MKFFGUZYVNDHIH-UHFFFAOYSA-N "5-[1-hydroxy-2-(propan-2-ylamino)ethyl]benzene-1,3-diol;sulfuric acid" n.a. n.a. No Yes No No No No PMDBD1284 Methenamine Hippurate Therapeutic substance Drug n.a. n.a. n.a. n.a. n.a. 21945 n.a. n.a. "Methenamine hippurate; 5714-73-8; Hiprex; Hippramine; Haiprex; Viapta; hexamine hippurate; Hexamethylenetetramine hippurate; Hexamethylenetetramine monohippurate; UNII-M329791L57; Methenamine (hippurate); R-657; EINECS 227-206-5; Hexamethylene tetramine hippurate; HIPPURIC ACID, compd. with HEXAMETHYLENETETRAMINE (1:1); M329791L57; Hexamethylenetetramine monohippurate;Hexamethylenetetramine monohippurate; N-Benzoylglycine, compound with 1,3,5,7-tetraazatricyclo(3.3.1.13,7)decane (1:1); Glycine, N-benzoyl, compd. with 1,3,5,7" C15H21N5O3 ROAIXOJGRFKICW-UHFFFAOYSA-N "2-benzamidoacetic acid;1,3,5,7-tetrazatricyclo[3.3.1.13,7]decane" n.a. n.a. No Yes No No No No PMDBD1287 Methylergonovine Maleate Therapeutic substance Drug n.a. n.a. n.a. n.a. n.a. 5281072 n.a. n.a. "Methylergonovine maleate; Methylergometrine maleate; 57432-61-8; Methergine; Erezingen; Methylergobasine maleate; USAF uctl-8; UNII-IR84JPZ1RK; Maleic acid, methyl ergonovine; Methylergonovine maleate salt; EINECS 260-734-4; IR84JPZ1RK; Ergonovine, methyl-, maleate (1:1); Methylergometrine (maleate); Methylergonovine maleate [USP]; 9,10-Didehydro-N-((S)-1-(hydroxymethyl)propyl)-6-methylergoline-8beta-carboxamide maleate (1:1) (salt); Methylergonovine maleate (USP); Ergoline-8-carboxamide, 9,10-didehydro-N-(1-(hydroxymethyl)" C24H29N3O6 NOFOWWRHEPHDCY-DAUURJMHSA-N "(6aR,9R)-N-[(2S)-1-hydroxybutan-2-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide;(Z)-but-2-enedioic acid" n.a. n.a. No Yes No No No No PMDBD1299 Mitomycin C Therapeutic substance Drug n.a. n.a. n.a. n.a. n.a. 5746 n.a. n.a. "mitomycin C; Mitomycin; 50-07-7; Mutamycin; Ametycine; Mitocin-C; Mitomycin-C; Ametycin; Mytozytrex; Mitomycinum; Mytomycin; Mitozytrex; Mitomycinum C; Mitocin C; Mitomycins; Mitamycin; MMC; Mitosol; 7-Amino-9alpha-methoxymitosane; NSC-26980; Mitomycyna C [Polish]; Mito-C; Mit-C; Mitomycinum [INN-Latin]; Mitomycine [INN-French]; Mitomicina [INN-Spanish]; NSC 26980; Mitomycyna C; NCI-C04706; C15H18N4O5; RCRA waste number U010; NSC26980; Mitomycine; CCRIS 414; UNII-50SG953SK6; HSDB 3239; EINECS 200-008-6; RCRA waste no. U010; AI3-26199; CHEBI:2750" C15H18N4O5 NWIBSHFKIJFRCO-WUDYKRTCSA-N [(4S,6S,7R,8S)-11-amino-7-methoxy-12-methyl-10,13-dioxo-2,5-diazatetracyclo[7.4.0.02,7.04,6]trideca-1(9),11-dien-8-yl]methyl carbamate n.a. n.a. No Yes No No No No PMDBD1301 Mixture Environmental Chemicals Antibiotics n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No Yes No No No PMDBD1304 Monoethylhexyl phthalate Environmental Chemicals Phthalates n.a. n.a. n.a. n.a. n.a. 20393 n.a. n.a. "4376-20-9; 2-(((2-Ethylhexyl)oxy)carbonyl)benzoic acid; Mehp; Mono(2-ethylhexyl) phthalate; Mono(2-ethylhexyl)phthalate; PHTHALIC ACID MONO-2-ETHYLHEXYL ESTER; 2-Ethylhexyl hydrogen phthalate; Monoethylhexyl phthalate; MONO-2-ETHYLHEXYL PHTHALATE; Mono-(2-ethylhexyl)phthalate; (2-Ethylhexyl) hydrogen phthalate; 1,2-Benzenedicarboxylic acid, mono(2-ethylhexyl) ester; mono(ethylhexyl) phthalate; BAR 1; Phthalate, mono(2-ethylhexyl); CCRIS 1742; EINECS 224-477-1; 2-(2-ethylhexoxycarbonyl)benzoic acid; Monoethylhexyl phthalic ac" C16H22O4 DJDSLBVSSOQSLW-UHFFFAOYSA-N 2-(2-ethylhexoxycarbonyl)benzoic acid n.a. n.a. Yes No No No No No PMDBD1315 Nelfinavir Mesylate Therapeutic substance Drug n.a. n.a. n.a. n.a. n.a. 64142 n.a. n.a. "Nelfinavir mesylate; 159989-65-8; Viracept; Nelfinavir mesilate; Nelfinavir Mesylate [USAN]; UNII-98D603VP8V; Nelfinavir mesylate hydrate; HSDB 7159; C32H45N3O4S.CH4O3S; Nelfinavir Methanesulfonate; AG-1343; CHEBI:7497; AG1343; 98D603VP8V; AG 1343; Viracept (TN); NFV; DSSTox_RID_79093; DSSTox_CID_10777; DSSTox_GSID_33736; CHEMBL1205; 3-Isoquinolinecarboxamide, N-(1,1-dimethylethyl)decahydro-2-(2-hydroxy-3-((3-hydroxy-2-methylbenzoyl)amino)-4-(phenylthio)butyl)-, (3S-(2(2,S*,3S*),3-alpha,4a-beta,8a-beta))-, monomethanesulfonate " C33H49N3O7S2 NQHXCOAXSHGTIA-SKXNDZRYSA-N "(3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-phenylsulfanylbutyl]-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinoline-3-carboxamide;methanesulfonic acid" n.a. n.a. No Yes No No No No PMDBD1316 Neocarzinostatin Therapeutic substance compound n.a. n.a. n.a. n.a. n.a. 5282473 n.a. n.a. "ZINOSTATIN; Neocarzinostatin (JAN); Zinostatin (USAN/INN); SCHEMBL1347615; D02046; 33862-EP2311808A1; 33862-EP2298768A1; 33862-EP2295416A2; 33862-EP2298764A1; 33862-EP2298748A2; 33862-EP2295427A1; 33862-EP2295055A2; 33862-EP2272832A1; 33862-EP2311453A1; 33862-EP2298765A1; 33862-EP2295426A1; 33862-EP2311829A1; 33862-EP2305642A2; 33862-EP2275420A1; 120130-EP2298778A1; 120130-EP2272832A1" C35H35NO12 BLXZMHNVKCEIJX-PNKAXBHOSA-N [(4S,6R,11R,12R)-11-[(2R,3R,4R,5R,6R)-4,5-dihydroxy-6-methyl-3-(methylamino)oxan-2-yl]oxy-4-[(4R)-2-oxo-1,3-dioxolan-4-yl]-5-oxatricyclo[8.3.0.04,6]tridec-1(13)-en-2,7-diyn-12-yl] 2-hydroxy-7-methoxy-5-methylnaphthalene-1-carboxylate n.a. n.a. No Yes No No No No PMDBD1317 Neotame Environmental Chemicals Artificial Sweeteners n.a. n.a. n.a. n.a. n.a. 9810996 n.a. n.a. "Neotame; 165450-17-9; Neotame [NF]; (S)-3-((3,3-Dimethylbutyl)amino)-4-(((S)-1-methoxy-1-oxo-3-phenylpropan-2-yl)amino)-4-oxobutanoic acid; UNII-VJ597D52EX; N-(N-(3,3-dimethylbutyl)-L-alpha-aspartyl)-L-phenylalanine 1-methyl ester; VJ597D52EX; Neotame-d5; L-Phenylalanine, N-(3,3-dimethylbutyl)-L-alpha-aspartyl-, 2-methyl ester; (S)-3-((3,3-Dimethylbutyl)amino)-4-(((S)-1-methoxy-1-oxo-3-phenylpropan-2-yl)amino)-4-oxobutanoic ac; (3S)-3-(3,3-dimethylbutylamino)-4-[[(2S)-1-methoxy-1-oxo-3-phenylpropan-2-yl]amino]-4-oxob" C20H30N2O5 HLIAVLHNDJUHFG-HOTGVXAUSA-N (3S)-3-(3,3-dimethylbutylamino)-4-[[(2S)-1-methoxy-1-oxo-3-phenylpropan-2-yl]amino]-4-oxobutanoic acid n.a. n.a. Yes No No No No No PMDBD1319 Nickel Environmental Chemicals Heavy Metals n.a. n.a. n.a. n.a. n.a. 935 n.a. n.a. "Ni; 7440-02-0; Nickel; Raney alloy; Fibrex; Nickel catalyst; Nickel, soluble salts; Nickel ion; Nickel particles; Fibrex P; Nickel, elemental; Nichel [Italian]; nickel(1+); Nickel 205; Nickel 270; Nickel 207; Nickel 201; Nickel 200; niquel; niccolum; Alcan 756; Metallic nickel; Nickel, ion (Ni1+); NI 0901-S (harshaw); CCRIS 427; UNII-7OV03QG267; Nickel,Raney Nickel; NP 2; EL12; Ni 4303T; Ni 270; HSDB 1096; Nickel, elemental/metal; Ni 0901-S; RCH 55/5; Nickel, soluble compounds; EINECS 231-111-4; Nickel [Nickel and nickel compounds]; 28Ni; CI 777" Ni PXHVJJICTQNCMI-UHFFFAOYSA-N nickel n.a. n.a. Yes No Yes No No No PMDBD1324 NSAIDs and sulfasalazine therapy Therapeutic substance Drug category n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD1326 Ochratoxin A Environmental Chemicals compound n.a. n.a. n.a. n.a. n.a. 442530 n.a. n.a. "OCHRATOXIN A; 303-47-9; Antibiotic 9663; Phenylalanine - ochratoxin A; NCI-C56586; (-)-N-((5-Chloro-8-hydroxy-3-methyl-1-oxo-7-isochromanyl)carbonyl)-3-phenylalanine; NSC 201422; C20H18ClNO6; CHEBI:7719; OTA; Ochratoxin A, aspergillus ochraceus; Ochratoxin A-BSA conjugate from Aspergillus ochraceus; N-(((3R)-5-Chloro-8-hydroxy-3-methyl-1-oxo-7-isochromanyl)carbonyl)-3-phenyl-L-alanine; UNII-1779SX6LUY; N-{[(3R)-5-chloro-8-hydroxy-3-methyl-1-oxo-3,4-dihydro-1H-isochromen-7-yl]carbonyl}-L-phenylalanine; L-Phenylalanine, N-(" C20H18ClNO6 RWQKHEORZBHNRI-BMIGLBTASA-N (2S)-2-[[(3R)-5-chloro-8-hydroxy-3-methyl-1-oxo-3,4-dihydroisochromene-7-carbonyl]amino]-3-phenylpropanoic acid n.a. n.a. Yes Yes No No No No PMDBD1330 Omega-3 PUFA supplementation Dietary Substances Dietary Compounds n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD1332 Opiates (opioid) Therapeutic substance Drug category n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD1334 Oseltamivir Phosphate Therapeutic substance Drug n.a. n.a. n.a. n.a. n.a. 78000 n.a. n.a. "Oseltamivir phosphate; 204255-11-8; Tamiflu; Oseltamivir (phosphate); UNII-4A3O49NGEZ; Oseltamir Phosphate; GS 4104; 4A3O49NGEZ; ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylate phosphate; CHEBI:7799; Ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate phosphate (1:1); GS4104; Ro 64-0796/002; Osteltamivir phosphate; 1-Cyclohexene-1-carboxylic acid, 4-(acetylamino)-5-amino-3-(1-ethylpropoxy)-, ethyl ester, (3R,4R,5S)-, phosphate (1:1); (3R-(3alpha,4beta,5al" C16H31N2O8P PGZUMBJQJWIWGJ-ONAKXNSWSA-N "ethyl (3R,4R,5S)-4-acetamido-5-amino-3-pentan-3-yloxycyclohexene-1-carboxylate;phosphoric acid" n.a. n.a. No Yes No No No No PMDBD1335 Other bisphenols Environmental Chemicals Bisphenols n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD1340 p,p''-Dichlorodiphenyldichloroethylene Environmental Chemicals Pesticides n.a. n.a. n.a. n.a. n.a. 3035 n.a. n.a. "p,p''-DDE; 72-55-9; 4,4''-DDE; dichlorodiphenyldichloroethylene; DDT dehydrochloride; 2,2-Bis(4-chlorophenyl)-1,1-dichloroethylene; 1,1-Dichloro-2,2-bis(4-chlorophenyl)ethene; DDE; NCI-C00555; p,p''-Dichlorodiphenyldichloroethylene; p,p''-Dichlorodiphenyl dichloroethylene; p,p''-(Dichlorodiphenyl)-2,2-dichloroethylene; 1,1-Dichloro-2,2-bis(p-chlorophenyl)ethylene; DDE (VAN); NSC 1153; para,para''-DDE; 2,2-Bis(p-chlorophenyl)-1,1-dichloroethylene; CCRIS 193; Dichlorodipheny" C14H8Cl4 UCNVFOCBFJOQAL-UHFFFAOYSA-N 1-chloro-4-[2,2-dichloro-1-(4-chlorophenyl)ethenyl]benzene n.a. n.a. Yes No No No No No PMDBD1342 Paracetamol Therapeutic substance first-line therapy in pain n.a. n.a. n.a. n.a. n.a. 1983 n.a. n.a. "acetaminophen; Paracetamol; 4-Acetamidophenol; 103-90-2; N-(4-Hydroxyphenyl)acetamide; Tylenol; APAP; Panadol; Acetaminofen; Datril; N-Acetyl-p-aminophenol; p-Hydroxyacetanilide; 4''-Hydroxyacetanilide; p-Acetamidophenol; Naprinol; Lonarid; Algotropyl; Anelix; Multin; Acenol; Acamol; p-Acetaminophenol; Pyrinazine; Injectapap; Clixodyne; Liquagesic; Acetagesic; Gelocatil; Servigesic; Acetalgin; Abensanil; Valadol; Tralgon; Tabalgin; Lestemp; Alvedon; Valgesic; Tussapap; Finimal; Paracet; Homoolan; Febrolin; Febrilix; Febridol; Dymadon; Anaflon; Apamide" C8H9NO2 RZVAJINKPMORJF-UHFFFAOYSA-N N-(4-hydroxyphenyl)acetamide n.a. n.a. Yes Yes No No No No PMDBD1345 PCB congeners Environmental Chemicals Persistent Organic Pollutants n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD1346 PCB congeners (PCB153, PCB138, PCB180) Environmental Chemicals Persistent Organic Pollutants n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD1347 PCB mixture Environmental Chemicals Persistent Organic Pollutants n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD1348 PCB-126 Environmental Chemicals Persistent Organic Pollutants n.a. n.a. n.a. n.a. n.a. n.a. 56775 n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD1351 Penicillin Therapeutic substance Antibiotics n.a. n.a. n.a. n.a. n.a. 2349 n.a. n.a. "Penicillin; Cillin; 61-33-6; Benzopenicillin; Galofak; 7005-30-3; Compocillin G; 3,3-Dimethyl-7-oxo-6-[(phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; (Phenylmethyl)penicillin; NSC131815; (Phenylmethyl)penicillinic acid; NSC-193396; 3,3-dimethyl-7-oxo-6-((phenylacetyl)amino)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; Penicilline G sodium salt; Oprea1_713794; Oprea1_861345; CHEMBL300052; SCHEMBL2109546; CTK2H5530; DTXSID20274362; NSC11964; NSC193396; NSC-11964; STL453455; AKOS030242685; MCULE-3899" C16H18N2O4S JGSARLDLIJGVTE-UHFFFAOYSA-N 3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid n.a. n.a. Yes No No No No No PMDBD1352 "Penicillin G; erythromycin, or both" Environmental Chemicals Antibiotics n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD1353 Pentachlorophenol Environmental Chemicals Pesticides n.a. n.a. n.a. n.a. n.a. 992 n.a. n.a. "pentachlorophenol; 2,3,4,5,6-Pentachlorophenol; 87-86-5; Chlorophen; Lauxtol; Permite; Pentachlorophenate; Dowicide 7; Santophen; Permasan; Sinituho; Permagard; Pentacon; Penchlorol; Fungifen; Liroprem; Permacide; Peratox; Penwar; Durotox; Glazd penta; Grundier arbezol; Penta-Kil; Term-i-trol; PENTA; Chem-Tol; Santophen 20; Pentachlorphenol; Thompson''s wood fix; Preventol P; PCP (pesticide); Chlon; Pentachlorofenol; Permatox penta; Lauxtol A; Dowicide EC-7; Santobrite; Pentaclorofenolo; Penta ready; Woodtreat A; Penta wr; Chem" C6HCl5O IZUPBVBPLAPZRR-UHFFFAOYSA-N 2,3,4,5,6-pentachlorophenol n.a. n.a. Yes No No No No No PMDBD1356 Perfluorobutanesulfonic acid Environmental Chemicals Persistent Organic Pollutants n.a. n.a. n.a. n.a. n.a. 67815 n.a. n.a. "375-73-5; perfluorobutanesulfonic acid; Nonafluorobutanesulfonic acid; Nonafluoro-1-butanesulfonic acid; 1-Perfluorobutanesulfonic acid; 1,1,2,2,3,3,4,4,4-nonafluorobutane-1-sulfonic acid; Nonafluorobutane-1-sulfonic acid; PFBS; 1,1,2,2,3,3,4,4,4-Nonafluoro-1-butanesulfonic acid; perfluorobutane sulfonic acid; 1,1,2,2,3,3,4,4,4-Nonafluorobutane-1-sulphonic acid; EINECS 206-793-1; UNII-1FV02N6NVO; 1FV02N6NVO; 59933-66-3; Perfluorobutane s" C4HF9O3S JGTNAGYHADQMCM-UHFFFAOYSA-N 1,1,2,2,3,3,4,4,4-nonafluorobutane-1-sulfonic acid n.a. n.a. Yes No No No No No PMDBD1357 Perindopril Erbumine Therapeutic substance Drug n.a. n.a. n.a. n.a. n.a. 441313 n.a. n.a. "PERINDOPRIL ERBUMINE; 107133-36-8; ACEON; Perindopril tert-butylamine; McN-A-2833-109; Perindopril (erbumine); Perindopril erbumine [USAN]; CHEBI:8025; S-9490-3; UNII-1964X464OJ; 1964X464OJ; (2S,3aS,7aS)-1-((S)-N-((S)-1-Carboxybutyl)alanyl)hexahydro-2-indolinecarboxylic acid, 1-ethyl ester, compound with tert-butylamine (1:1); Covapril; Coversyl" C23H43N3O5 IYNMDWMQHSMDDE-MHXJNQAMSA-N "(2S,3aS,7aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxopentan-2-yl]amino]propanoyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acid;2-methylpropan-2-amine" n.a. n.a. No Yes No No No No PMDBD1359 PFAS: F-53B Environmental Chemicals Persistent Organic Pollutants n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD1367 Pitavastatin Calcium Therapeutic substance Drug n.a. n.a. n.a. n.a. n.a. 5282451 n.a. n.a. "Pitavastatin calcium; 147526-32-7; Livalo; Pitavastatin hemicalcium; NK-104; Nisvastatin; UNII-IYD54XEG3W; Pitavastatin calcium salt; NK 104; IYD54XEG3W; 2C25H23FNO4.Ca; CHEBI:71258; Itavastatin calcium; Bis((3R,5S,6E)-7-(2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl)-3,5-dihydroxy-6-heptenoate), monocalcium salt; Pitavastatin calcium (JAN); Livazo; Flovas; Alipza; P-872441; P 872441" C50H46CaF2N2O8 RHGYHLPFVJEAOC-FFNUKLMVSA-L "calcium;(E,3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoate" n.a. n.a. No Yes No No No No PMDBD1369 Polychemotherapy Therapeutic substance Drug category n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD1370 Polycyclic aromatic hydrocarbon Environmental Chemicals Persistent Organic Pollutants n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD1371 Polymyxin E Therapeutic substance Antibiotics n.a. n.a. n.a. n.a. n.a. 5311054 n.a. n.a. "colistin; Polymyxin E; 1066-17-7; Colobreathe; Promixin; Colistin,(S); N-[(2S)-4-amino-1-[[(2S,3R)-1-[[(2S)-4-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18S,21S)-6,9,18-tris(2-aminoethyl)-3-[(1R)-1-hydroxyethyl]-12,15-bis(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxobutan-2-yl]-5-methylheptanamide; SCHEMBL1979092; CHEMBL499783; GTPL10794; Colistin sulfate, >19000 IU/mg; AB01566924_01; SR-01000872582; 066C177; Q418946; SR-0100" C52H98N16O13 YKQOSKADJPQZHB-QNPLFGSASA-N N-[(2S)-4-amino-1-[[(2S,3R)-1-[[(2S)-4-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18S,21S)-6,9,18-tris(2-aminoethyl)-3-[(1R)-1-hydroxyethyl]-12,15-bis(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxobutan-2-yl]-5-methylheptanamide n.a. n.a. Yes No No No No No PMDBD1373 Pramipexole Dihydrochloride Monohydrate Therapeutic substance Drug n.a. n.a. n.a. n.a. n.a. 166589 n.a. n.a. "Pramipexole dihydrochloride monohydrate; 191217-81-9; Mirapex; Pramipexole 2HCl Monohydrate; Pramipexole dihydrochloride hydrate; (S)-N6-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine dihydrochloride hydrate; UNII-3D867NP06J; PRAMIPEXOLE HYDROCHLORIDE; Pramipexole hydrochloride hydrate; BI-Sifrol; SND919CL2Y; CHEBI:51147; C10H17N3S.2HCl.H2O; PNU-98528E; 3D867NP06J; (S)-2-Amino-4,5,6,7-tetrahydro-6-(propylamino)benzothiazole dihydrochloride monohydrate; 191712-81-9; Pramipexole dihydrochloride [USAN]; SND-919CL2Y; 2,6-B" C10H21Cl2N3OS APVQOOKHDZVJEX-QTPLPEIMSA-N "(6S)-6-N-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine;hydrate;dihydrochloride" n.a. n.a. No Yes No No No No PMDBD1387 Propamocarb Environmental Chemicals Pesticides n.a. n.a. n.a. n.a. n.a. 32490 n.a. n.a. "PROPAMOCARB; 24579-73-5; Propamocarbe; Propyl (3-(dimethylamino)propyl)carbamate; Carbamic acid, [3-(dimethylamino)propyl]-, propyl ester; UNII-8HLL7N9UWO; Propamocarbe [ISO-French]; propyl N-[3-(dimethylamino)propyl]carbamate; Nor-AM 39744; Propamocarb [ANSI:BSI:ISO]; 8HLL7N9UWO; Propyl 3-(dimethylamino)propylcarbamate; BRN 2080745; SN 39744; CHEBI:82033; EPA Pesticide Chemical Code 119302; Propamocarb free base; propyl [3-(dimethylamino)propyl]carbamate; Carbamic acid, (3-(dimethylamino)propyl)-, propyl ester; propamocarbe " C9H20N2O2 WZZLDXDUQPOXNW-UHFFFAOYSA-N propyl N-[3-(dimethylamino)propyl]carbamate n.a. n.a. Yes No No No No No PMDBD1390 Proton pump inhibitors Therapeutic substance Drug category n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD1393 Quetiapine Fumarate Therapeutic substance Drug n.a. n.a. n.a. n.a. n.a. 5281025 n.a. n.a. "Quetiapine fumarate; 111974-72-2; Quetiapine hemifumarate; Seroquel XR; Seroquel; ICI-204636; ICI 204,636; ZM 204636; UNII-2S3PL1B6UJ; Quetiapine fumarate [USAN]; ZD5077; 2S3PL1B6UJ; ZM 204,636; ICI 204636; 2-(2-(4-Dibenzo(b,f)(1,4)thiazepine-11-yl-1-piperazinyl)ethoxy)ethanol; 2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol hemifumarate; Ethanol, 2-(2-(4-dibenzo(b,f)(1,4)thiazepin-11-yl-1-piperazinyl)ethoxy)-, (E)-2-butenedioate (2:1) (salt); CHEBI:8708; FK949E" C46H54N6O8S2 ZTHJULTYCAQOIJ-WXXKFALUSA-N "2-[2-(4-benzo[b][1,4]benzothiazepin-6-ylpiperazin-1-yl)ethoxy]ethanol;(E)-but-2-enedioic acid" n.a. n.a. No Yes No No No No PMDBD1396 Quinupristin/dalfopristin Therapeutic substance Antibiotics n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD1401 Rasagiline Mesylate Therapeutic substance Drug n.a. n.a. n.a. n.a. n.a. 3052775 n.a. n.a. "Rasagiline mesylate; 161735-79-1; Rasagiline mesilate; Azilect; TVP-1012; (R)-N-(Prop-2-yn-1-yl)-2,3-dihydro-1H-inden-1-amine methanesulfonate; Rasagiline (mesylate); Rasagiline methanesulfonate; Rasagiline mesylate [USAN]; UNII-LH8C2JI290; TVP 1012; LH8C2JI290; MFCD08460604; TV 1012; NCGC00168774-01; Azilect (TN); 1H-Inden-1-amine, 2,3-dihydro-N-2-propynyl-, (R)-, methanesulfonate; 1H-Inden-1-amine, 2,3-dihydro-N-2-propynyl-, (1R)-, methanesulfonate; (R)-N-2-Propynyl-1-indanamine methanesulfonate; Rasagiline mesylate (USAN)" C13H17NO3S JDBJJCWRXSVHOQ-UTONKHPSSA-N "methanesulfonic acid;(1R)-N-prop-2-ynyl-2,3-dihydro-1H-inden-1-amine" n.a. n.a. No Yes No No No No PMDBD1402 Rifampin Therapeutic substance Drug n.a. n.a. n.a. n.a. n.a. 135398735 n.a. n.a. "Rifampicin; rifampin; Rifadin; Rimactane; Rimactan; Rifamycin AMP; 13292-46-1; Rifaldazine; Rifaprodin; Tubocin; Riforal; Rifa; Rifampicinum; Archidyn; Rifoldine; Rifoldin; Rimactizid; Rimazid; Rifagen; Rifampicin SV; R/AMP; Rimactazid; Rifobac; Fenampicin; Doloresum; Sinerdol; Rifaldin; Rifadine; Rifinah; Rifamor; Benemicin; Rifaldazin; Eremfat; Arficin; Arzide; Rifcin; Rifam; L-5103 Lepetit; Dione 21-acetate; Rifampicine [French]; Rifampicina; Abrifam; Rifampicinum [INN-Latin]; Rifampicina [INN-Spanish]; Ba 41166/E; 3-(((4-Methyl-1-piperazinyl)imino" C43H58N4O12 JQXXHWHPUNPDRT-WLSIYKJHSA-N [(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-[(E)-(4-methylpiperazin-1-yl)iminomethyl]-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate n.a. n.a. No Yes No No No No PMDBD1404 Ritipenem acoxil Therapeutic substance Antibiotics n.a. n.a. n.a. n.a. n.a. 6918147 n.a. n.a. "Ritipenem Acoxil; UNII-F975H7YQX9; F975H7YQX9; Ritipenem acetoxymethyl ester; FCE-22891; Fce 22891; Penemac; BRN 4723315; 87238-52-6; Rtipenem acoxil; Acetoxymethyl (5R,6S)-2-carbamoyloxymethyl-6-((1R)-hydroxyethyl)-2-penem-3-carboxylate; FC/TA-891; fce22891; SCHEMBL9799600; ZINC3934758; Q27277840" C13H16N2O8S FZKGLCPKPZBGLX-ROXVQFJHSA-N acetyloxymethyl (5R,6S)-3-(carbamoyloxymethyl)-6-[(1R)-1-hydroxyethyl]-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate n.a. n.a. Yes No No No No No PMDBD1405 Rivastigmine Tartrate Therapeutic substance Drug n.a. n.a. n.a. n.a. n.a. 6918078 n.a. n.a. "Rivastigmine tartrate; 129101-54-8; SDZ-ENA 713; Rivastigmine Hydrogen Tartrate; Rivastigmine (tartrate); UNII-9IY2357JPE; ENA 713; Rivastigmine tartrate (Exelon); (S)-3-(1-(Dimethylamino)ethyl)phenyl ethyl(methyl)carbamate (2R,3R)-2,3-dihydroxysuccinate; 9IY2357JPE; Carbamic acid, N-ethyl-N-methyl-, 3-[(1S)-1-(dimethylamino)ethyl]phenyl ester, (2R,3R)-2,3-dihydroxybutanedioate (1:1); Rivastigmine bitartrate; Rivastigmine hydrogentartrate; Carbamic acid, ethylmethyl-, 3-((1S)-1-(dimethylamino)ethyl)phenyl ester, (2R,3R)" C18H28N2O8 GWHQHAUAXRMMOT-MBANBULQSA-N "(2R,3R)-2,3-dihydroxybutanedioic acid;[3-[(1S)-1-(dimethylamino)ethyl]phenyl] N-ethyl-N-methylcarbamate" n.a. n.a. No Yes No No No No PMDBD1408 Rosuvastatin Calcium Therapeutic substance Drug n.a. n.a. n.a. n.a. n.a. 5282455 n.a. n.a. "Rosuvastatin calcium; Crestor; 147098-20-2; Rosuvastatin Calcium Salt; Rosuvastatin hemicalcium; ZD 4522; Rosuvastatin; ZD4522; ZD 4522, calcium salt; UNII-83MVU38M7Q; Rosuvastatin calcium [USAN]; S-4522; S 4522; 83MVU38M7Q; CHEBI:77249; calcium (3R,5S,E)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl)-3,5-dihydroxyhept-6-enoate; Crestor (TN); ZD-4522; Rovista; (S-(R*,S*-(E)))-7-(4-(4-Fluorophenyl)-6-(1-methylethyl)-2-(methyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid, c" C44H54CaF2N6O12S2 LALFOYNTGMUKGG-BGRFNVSISA-L "calcium;(E,3R,5S)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoate" n.a. n.a. No Yes No No No No PMDBD1410 Rulfoxacin Therapeutic substance Antibiotics n.a. n.a. n.a. n.a. n.a. 58258 n.a. n.a. "Rufloxacin; 101363-10-4; MF 934; RUFLOXACIN HCl; UNII-Y521XM2900; C17H18FN3O3S; CHEBI:8909; Y521XM2900; Rufloxacine; Rufloxacino; Rufloxacinum; 9-fluoro-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7h-[1,4]thiazino[2,3,4-ij]quinoline-6-carboxylic acid; 9-Fluoro-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]thiazino[2,3,4-ij]quinoline-6-carboxylic acid;9-Fluoro-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]thiazino[2,3,4-ij]quinoline-6-carboxylic acid; 8-Fluoro-9-(4-methyl-piperazin-1-yl)-6-oxo-2,3-dihyd" C17H18FN3O3S NJCJBUHJQLFDSW-UHFFFAOYSA-N 7-fluoro-6-(4-methylpiperazin-1-yl)-10-oxo-4-thia-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid n.a. n.a. Yes No No No No No PMDBD1411 "saccharin; sucralose; aspartame" Environmental Chemicals Artificial Sweeteners n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD1416 Silver nanoparticles Environmental Chemicals Nanoparticles n.a. n.a. n.a. n.a. n.a. 23954 n.a. n.a. "Silver; Ag; 7440-22-4; Argentum; Silver metal; Silver atom; Colloidal silver; Silver, colloidal; Algaedyn; Epinall; Amalgum; Silber; Shell silver; Astroflake 5; Carey Lea silver; Silver, elemental; Silber [German]; Silpowder 130; Degussa 67; Degussa 80; Silflake 135; KS (metal); Jelcon SH 1; L-3 (element); Caswell No. 735; Metz 25B; FA 2 (metal); Dotite XA 208; Germany: C-Pigment 2; D 25 (metal); TCG 7r; G 12 (metal); Lead refinery silver bullion; Silver nanoparticles; Metz 3000-1; UNII-3M4G523W1G; HSDB 5034; EINECS 231-131-3; SR 999; LS 500; LA " Ag BQCADISMDOOEFD-UHFFFAOYSA-N silver n.a. n.a. Yes No No No No No PMDBD1418 Sitagliptin Phosphate Therapeutic substance Drug n.a. n.a. n.a. n.a. n.a. 6451150 n.a. n.a. "Sitagliptin phosphate; 654671-78-0; Januvia; Sitagliptin (phosphate); MK-0431; UNII-494P4635I6; MK 0431; CHEMBL393336; 494P4635I6; MK0431; (2R)-4-Oxo-4-(3-(trifluoromethyl)-5,6-dihydro(1,2,4)triazolo(4,3-a)pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-amine phosphate salt; 7-(3R)-3-Amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl-5,6,7,8-tetrahydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazine phosphate" C16H18F6N5O5P IQFYVLUXQXSJJN-SBSPUUFOSA-N "(3R)-3-amino-1-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one;phosphoric acid" n.a. n.a. No Yes No No No No PMDBD1420 Sorafenib Tosylate Therapeutic substance Drug n.a. n.a. n.a. n.a. n.a. 406563 n.a. n.a. "Sorafenib tosylate; 475207-59-1; Nexavar; BAY 43-9006; Nexavar(R); Sorafenib (Tosylate); Sorafenib tosylate [USAN]; UNII-5T62Q3B36J; CHEBI:50928; 5T62Q3B36J; BAY 54-9085; AK162385; Sorafenib (Nexavar); Sorafenib tosylate (USAN); DSSTox_CID_27817; DSSTox_RID_82581; DSSTox_GSID_47839; 4-(4-(3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido)phenoxy)-N2-methylpyridine-2-carboxamide mono (4-methylbenzenesulfonate); 1-(4-Chloro-3-(trifluoromethyl)phenyl)-3-(4-((2-(methylcarbamoyl)pyridin-4-yl)oxy)phenyl)urea mono(4-methylbenzenesulfona" C28H24ClF3N4O6S IVDHYUQIDRJSTI-UHFFFAOYSA-N "4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide;4-methylbenzenesulfonic acid" n.a. n.a. No Yes No No No No PMDBD1422 Splenda Environmental Chemicals Artificial Sweeteners n.a. n.a. n.a. n.a. n.a. 71485 n.a. n.a. "Sucralose; 56038-13-2; Trichlorosucrose; Splenda; Aspasvit; Acucar Light; Trichlorogalacto-sucrose; 1'',4,6''-Trichlorogalactosucrose; UNII-96K6UQ3ZD4; EINECS 259-952-2; 1,6-Dichloro-1,6-dideoxy-beta-D-fructofuranosyl 4-chloro-4-deoxy-alpha-D-galactopyranoside; BRN 3654410; 96K6UQ3ZD4; Trichlorogalactosucrose; 1,6-Dichloro-1,6-dideoxy-beta-D-fructofuranosyl-4-chloro-4-deoxy-alpha-D-galactopyranoside; CHEBI:32159; Sucralose [BAN]; 4,1'',6''-Trichloro-4,1'',6''-trideoxy-galacto-sucrose; DSSTox_CID_20245; 1,6-Dichloro-1,6-dideoxy-beta" C12H19Cl3O8 BAQAVOSOZGMPRM-QBMZZYIRSA-N (2R,3R,4R,5R,6R)-2-[(2R,3S,4S,5S)-2,5-bis(chloromethyl)-3,4-dihydroxyoxolan-2-yl]oxy-5-chloro-6-(hydroxymethyl)oxane-3,4-diol n.a. n.a. Yes No No No No No PMDBD1423 SSRI antidepressants Therapeutic substance Drug category n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD1424 Statins Therapeutic substance Drug category n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD1425 Streptonegrin Therapeutic substance Drug n.a. n.a. n.a. n.a. n.a. 5298 n.a. n.a. "streptonigrin; Rufocromomycin; Bruneomycin; Nigrin; Streptonigran; Valacidin; Rufocromomycine; 3930-19-6; Rufocromomicina; NSC-45383; Rufocromomycinum; Abbott Crystalline antibiotic; NSC 45383; NSC45383; Streptonigrin [USAN]; Antibiotic from Streptomyces flocculus; Rufochromomycin; A 050165L302; AO50165L302; NSC83950; SN (VAN); Rufocromomycinum [INN-Latin]; Rufocromomycine [INN-French]; Rufocromomicina [INN-Spanish]; CCRIS 1264; CHEBI:9287; MLS000028827; UNII-261Q3JB310; 5278 R. P.; EINECS 223-501-8; NSC 83950; 5-Amino-6-(7-amino-5,8-dih" C25H22N4O8 PVYJZLYGTZKPJE-UHFFFAOYSA-N 5-amino-6-(7-amino-6-methoxy-5,8-dioxoquinolin-2-yl)-4-(2-hydroxy-3,4-dimethoxyphenyl)-3-methylpyridine-2-carboxylic acid n.a. n.a. No Yes No No No No PMDBD1426 Sucralose Environmental Chemicals Artificial Sweeteners n.a. n.a. n.a. n.a. n.a. 71485 n.a. n.a. "Sucralose; 56038-13-2; Trichlorosucrose; Splenda; Aspasvit; Acucar Light; Trichlorogalacto-sucrose; 1'',4,6''-Trichlorogalactosucrose; UNII-96K6UQ3ZD4; EINECS 259-952-2; 1,6-Dichloro-1,6-dideoxy-beta-D-fructofuranosyl 4-chloro-4-deoxy-alpha-D-galactopyranoside; BRN 3654410; 96K6UQ3ZD4; Trichlorogalactosucrose; 1,6-Dichloro-1,6-dideoxy-beta-D-fructofuranosyl-4-chloro-4-deoxy-alpha-D-galactopyranoside; CHEBI:32159; Sucralose [BAN]; 4,1'',6''-Trichloro-4,1'',6''-trideoxy-galacto-sucrose; DSSTox_CID_20245; 1,6-Dichloro-1,6-dideoxy-beta" C12H19Cl3O8 BAQAVOSOZGMPRM-QBMZZYIRSA-N (2R,3R,4R,5R,6R)-2-[(2R,3S,4S,5S)-2,5-bis(chloromethyl)-3,4-dihydroxyoxolan-2-yl]oxy-5-chloro-6-(hydroxymethyl)oxane-3,4-diol n.a. n.a. Yes No No No No No PMDBD1428 Sulphalene Therapeutic substance Antibiotics n.a. n.a. n.a. n.a. n.a. 9047 n.a. n.a. "SULFALENE; 152-47-6; Sulfamethoxypyrazine; Sulfametopyrazine; Sulfalen; Sulfamethopyrazine; 4-amino-N-(3-methoxypyrazin-2-yl)benzenesulfonamide; Kelfizine; Longum; Sulfapyrazinemethoxyne; Sulfapyrazinemethoxine; Kelfizina; Polycidal; Kelfizin; Dalysep; Sulfapyrazinemethoxyine; Kelfizine W; SMP2; 3-Methoxy-2-sulfapyrazine; 2-Sulfanilamido-3-methoxypyrazine; 3-Methoxy-2-sulfanilamidopyrazine; Farmitalia 204/122; 3-Methoxypyrazine sulfanilamide; 2-Methoxy-3-sulfanilamidopyrazine; Sulfalene [USAN:INN]; Sulfalenum [INN-Latin]; Solfametop" C11H12N4O3S KXRZBTAEDBELFD-UHFFFAOYSA-N 4-amino-N-(3-methoxypyrazin-2-yl)benzenesulfonamide n.a. n.a. Yes No No No No No PMDBD1429 Sulphasomidine Therapeutic substance Antibiotics n.a. n.a. n.a. n.a. n.a. 5343 n.a. n.a. "SULFISOMIDINE; Sulfaisodimidine; sulfisomidin; 515-64-0; Sulphasomidine; Sulfasomidine; Sulfadimetine; 4-amino-N-(2,6-dimethylpyrimidin-4-yl)benzenesulfonamide; Sulfamethin; Sulfaisodimerazine; Elkosin; Domian; Sulfaisodimidinum; Solfisomidina; Sulfaisomidine; Elkosine; Elcosine; Aristogyn; Aristamid; Mefenal; Erycon; Elkosil; Isosulf; 4-Sulfa-2,6-dimethylpyrimidine; 4-Sulfanilamido-2,6-dimethylpyrimidine; 2,4-Dimethyl-6-sulfanilamidopyrimidine; 6-Sulfanilamido-2,4-dimethylpyrimidine; 2,6-Dimethyl-4-sulfanilamidopyrimidine; Solfisomid" C12H14N4O2S YZMCKZRAOLZXAZ-UHFFFAOYSA-N 4-amino-N-(2,6-dimethylpyrimidin-4-yl)benzenesulfonamide n.a. n.a. Yes No No No No No PMDBD1435 Tau-fluvalinate Environmental Chemicals Pesticides n.a. n.a. n.a. n.a. n.a. 91768 n.a. n.a. "Tau-fluvalinate; 102851-06-9; CHEBI:39367; Fluwarol; Fluvarol; Mavrik EW; D-Valine, N-[2-chloro-4-(trifluoromethyl)phenyl]-,cyano(3-phenoxyphenyl)methyl ester; N-[2-chloro-4-(trifluoromethyl)phenyl]-D-valine cyano(3-phenoxyphenyl)methyl ester; cyano(3-phenoxyphenyl)methyl N-[2-chloro-4-(trifluoromethyl)phenyl]-D-valinate; Tau-fluvalinate [ISO]; (a-RS,2R)-Fluvalinate; (RS)-alpha-Cyano-3-phenoxybenzyl N-(2-chloro-alpha,alpha,alpha-trifluoro-p-tolyl)-D-valinate; [cyano-(3-phenoxyphenyl)methyl] (2R)-2-[2-chloro-4-(trifluor" C26H22ClF3N2O3 INISTDXBRIBGOC-XMMISQBUSA-N [cyano-(3-phenoxyphenyl)methyl] (2R)-2-[2-chloro-4-(trifluoromethyl)anilino]-3-methylbutanoate n.a. n.a. Yes No No No No No PMDBD1446 Tetrachlorodibenzo-p-dioxin Environmental Chemicals Persistent Organic Pollutants n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No Yes No No No PMDBD1449 Thiamethoxam Environmental Chemicals Pesticides n.a. n.a. n.a. n.a. n.a. 5821911 n.a. n.a. "Thiamethoxam; 153719-23-4; Actara; Diacloden; Cruiser; Adage; Actara 2GR; Actara 25WG; Adage 5FS; Thiamethoxam [ISO]; (E)-thiamethoxam; CGA 293343; CCRIS 9026; UNII-747IC8B487; n-(3-((2-chlorothiazol-5-yl)methyl)-5-methyl-1,3,5-oxadiazinan-4-ylidene)nitramide; 747IC8B487; AK405352; 3-((2-Chloro-5-thiazolyl)methyl)tetrahydro-5-methyl-N-nitro-4H-1,3,5-oxadiazin-4-imine; C8H10CLN5O3S; 4H-1,3,5-Oxadiazin-4-imine, 3-[(2-chloro-5-thiazolyl)meth" C8H10ClN5O3S NWWZPOKUUAIXIW-DHZHZOJOSA-N (NE)-N-[3-[(2-chloro-1,3-thiazol-5-yl)methyl]-5-methyl-1,3,5-oxadiazinan-4-ylidene]nitramide n.a. n.a. Yes No No No No No PMDBD1450 Thioguanine Therapeutic substance Drug n.a. n.a. n.a. n.a. n.a. 2723601 n.a. n.a. "6-Thioguanine; thioguanine; 154-42-7; Tioguanine; 2-Amino-6-mercaptopurine; 6-Mercaptoguanine; Tioguanin; Tabloid; Lanvis; 2-Amino-6-purinethiol; 2-Aminopurin-6-thiol; 2-Amino 6MP; 2-Aminopurine-6-thiol; Wellcome U3B; 2-Aminopurine-6(1H)-thione; 6-Mercapto-2-aminopurine; 2-Amino-9H-purine-6-thiol; 6-TG; 2-Amino-6-merkaptopurin; Tioguaninum; Tioguanina; 2-Thioguanine; 2-Amino-1,7-dihydro-6H-purine-6-thione; BW 5071; 2-Amin" C5H5N5S WYWHKKSPHMUBEB-UHFFFAOYSA-N 2-amino-3,7-dihydropurine-6-thione n.a. n.a. No Yes No No No No PMDBD1451 Thiopurines Therapeutic substance compound n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes Yes No No No No PMDBD1455 Ticarcillin/clavulanate Therapeutic substance Antibiotics n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD1461 Tolmetin sodium dihydrate Therapeutic substance Drug n.a. n.a. n.a. n.a. n.a. 23677829 n.a. n.a. "Tolmetin sodium dihydrate; 64490-92-2; Sodium tolmetin dihydrate; Tolumetin sodium dihydrate; Tolmetin (sodium dihydrate); UNII-02N1TZF99F; 02N1TZF99F; CHEBI:72014; Sodium 1-methyl-5-p-toluoylpyrrole-2-acetate dihydrate; NCGC00017129-01; CAS-64490-92-2; DSSTox_CID_25594; DSSTox_RID_80987; DSSTox_GSID_45594; Tolmetin sodium salt dihydrate; Sodium 2-(1-methyl-5-(4-methylbenzoyl)-1H-pyrrol-2-yl)acetate dihydrate; 1H-Pyrrole-2-acetic acid, 1-methyl-5-(4-methylbenzoyl)-, sodium salt, dihydrate; McN-2559-21-98; Tolectin sdoium; 1-M" C15H18NNaO5 QQILXENAYPUNEA-UHFFFAOYSA-M "sodium;2-[1-methyl-5-(4-methylbenzoyl)pyrrol-2-yl]acetate;dihydrate" n.a. n.a. No Yes No No No No PMDBD1462 Tolterodine Tartrate Therapeutic substance Drug n.a. n.a. n.a. n.a. n.a. 443878 n.a. n.a. "Tolterodine tartrate; 124937-52-6; Detrol LA; Detrusitol; Detrol; PNU-200583E; UNII-5T619TQR3R; Tolterodine L-Tartrate; Tolterodine tartrate [USAN]; (R)-2-(3-(Diisopropylamino)-1-phenylpropyl)-4-methylphenol (2R,3R)-2,3-dihydroxysuccinate; Tolterodine (tartrate); Kabi-2234; PNU 200583E; 5T619TQR3R; Tolterodine tartrate (Detrol LA); Urotrol; (R)-2-(3-Diisopropylamino-1-phenyl-propyl)-p-cresol L-tartrate; C26H37NO7; (+)-(R)-2-(I-(2-(Diisopropylamino)ethyl)benzyl)-p-cresol L-tartrate (1:1) (salt); Phenol, 2-((1R)-3-(bis(1-methyl" C26H37NO7 TWHNMSJGYKMTRB-KXYUELECSA-N "(2R,3R)-2,3-dihydroxybutanedioic acid;2-[(1R)-3-[di(propan-2-yl)amino]-1-phenylpropyl]-4-methylphenol" n.a. n.a. No Yes No No No No PMDBD1466 Toremifene Base Therapeutic substance Drug n.a. n.a. n.a. n.a. n.a. 3005573 n.a. n.a. "toremifene; Acapodene; Farestone; Z-Toremifene; 89778-26-7; Toremifeno; Toremifenum; Toremifenum [Latin]; Toremifeno [Spanish]; FC-1157a; GTx 006; Toremifene [INN:BAN]; UNII-7NFE54O27T; GTx-006; C26H28ClNO; {2-[4-(4-Chloro-1,2-diphenyl-but-1-enyl)-phenoxy]-ethyl}-dimethyl-amine; CHEBI:9635; 7NFE54O27T; (Z)-2-(4-(4-Chloro-1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine; 2-{4-[(1Z)-4-chloro-1,2-diphenylbut-1-en-1-yl]phenoxy}-N,N-dimethylethanamine; 2-(para-((Z)-4-Chloro-1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylethylami" C26H28ClNO XFCLJVABOIYOMF-QPLCGJKRSA-N 2-[4-[(Z)-4-chloro-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine n.a. n.a. No Yes No No No No PMDBD1467 Torsemide Therapeutic substance ?loop diuretic n.a. n.a. n.a. n.a. n.a. 41781 n.a. n.a. "Torasemide; TORSEMIDE; 56211-40-6; Demadex; Torasemidum; Torasemida; Luprac; Torasemidum [INN-Latin]; Torasemida [INN-Spanish]; Torem; Unat; JDL 464; AC 4464; AC-4464; 1-Isopropyl-3-((4-m-toluidino-3-pyridyl)sulfonyl)urea; JDL-464; BM-02015; BM 02015; N-(Isopropylcarbamoyl)-4-(m-tolylamino)pyridine-3-sulfonamide; UNII-W31X2H97FB; AC4464; Torsemide (Demadex); CCRIS 6736; N-(((1-Methylethyl)amino)carbonyl)-4-((3-methylphenyl)amino)-3-pyridinesulfonamide; BRN 0498515; MLS001165687; CHEBI:9637; W31X2H97FB; Torasemide, Anhydrous; NCGC000168" C16H20N4O3S NGBFQHCMQULJNZ-UHFFFAOYSA-N 1-[4-(3-methylanilino)pyridin-3-yl]sulfonyl-3-propan-2-ylurea n.a. n.a. No Yes No No No No PMDBD1468 Traffic-related air Environmental Chemicals Others n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD1470 Trans-resveratrol Therapeutic substance Drug n.a. n.a. n.a. n.a. n.a. 445154 n.a. n.a. "resveratrol; 501-36-0; trans-resveratrol; 3,4'',5-Trihydroxystilbene; 3,5,4''-Trihydroxystilbene; (E)-5-(4-Hydroxystyryl)benzene-1,3-diol; (E)-resveratrol; 3,4'',5-Stilbenetriol; 5-[(E)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol; Resvida; 3,4'',5-Trihydroxy-trans-stilbene; SRT-501; SRT501; 5-[(1E)-2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol; 3,5,4''-Trihydroxy-trans-stilbene; Resveratol; trans-3,4'',5-trihydroxystilbene; 5-[(E)-2-(4-hydroxyphenyl)vinyl]benzene-1,3-diol; Resveratrol, natural; UNII-Q369O8926L; CHEBI:45713; C14H12O3; tr" C14H12O3 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 5-[(E)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol n.a. n.a. No Yes No No No No PMDBD1471 Tranylcypromine Hemisulfate Therapeutic substance Drug n.a. n.a. n.a. n.a. n.a. 25267092 n.a. n.a. "Tranylcypromine hemisulfate; 13492-01-8; Tranylcypromine sulfate; TRANS-2-PHENYLCYCLOPROPYLAMINE HEMISULFATE SALT; (1R,2S)-2-phenylcyclopropan-1-amine;sulfuric acid; Cyclopropanamine, 2-phenyl-, (1R,2S)-rel-, sulfate (2:1); Tranylcypromine sulfate [USAN:USP]; s9464; API0009012; Tranylcypromine sulfate; Tranylcypromine; AS-16857; (1R,2S)-2-phenylcyclopropanamine hemisulfate; C-20989; trans-2-phenyl-cyclo-propyl-amine hemisulfate salt; UNII-7ZAT6ES870 component BKPRVQDIOGQWTG-FKXFVUDVSA-N" C18H24N2O4S BKPRVQDIOGQWTG-FKXFVUDVSA-N "(1R,2S)-2-phenylcyclopropan-1-amine;sulfuric acid" n.a. n.a. No Yes No No No No PMDBD1473 Triamcinolone Acetonide Therapeutic substance Drug n.a. n.a. n.a. n.a. n.a. 6436 n.a. n.a. "TRIAMCINOLONE ACETONIDE; 76-25-5; Azmacort; Aristogel; Aristoderm; Nasacort; Vetalog; Kenalog; Nasacort AQ; Tricinolon; Triaceton; Tramacin; Zilretta; Triacort; Solodelf; Kenalone; Triacet; Rineton; Flutone; Trymex; Triderm; Oracort; Flutex; Triatex; Oralone; AllerNaze; Triam-Injekt; Aristocort A; Adcortyl A; Tri-Nasal; Omcilon A; Kenalog-H; Nasacort HFA; Volon A; Coupe-A; Kenalog in Orabase; Kenalog-10; Aristocort acetonide; Kenalog 40; Tricort-40; Triamcinolone (acetonide); Kenalog-40; Triamcinolone 16,17-acetonide; Trivaris; Triesence; Acetospan; Vo" C24H31FO6 YNDXUCZADRHECN-JNQJZLCISA-N (1S,2S,4R,8S,9S,11S,12R,13S)-12-fluoro-11-hydroxy-8-(2-hydroxyacetyl)-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one n.a. n.a. No Yes No No No No PMDBD1476 Trichlorfon Environmental Chemicals Pesticides n.a. n.a. n.a. n.a. n.a. 5853 n.a. n.a. "Metrifonate; TRICHLORFON; Chlorophos; Trichlorphon; Metriphonate; Methyl chlorophos; 52-68-6; Chlorofos; Bilarcil; Foschlor; Dipterex; Chloroftalm; Chloroxyphos; Ricifon; Neguvon; Dylox; Trichlorophon; Khloroftalm; Agroforotox; Trichlorofon; Polfoschlor; Fliegenteller; Chlorophthalm; Hypodermacid; Wotexit; Phoschlor; Mazoten; Forotox; Masoten; Diptevur; Bovinox; Votexit; Volfartol; Sotipox; Ritsifon; Ditrifon; Cekufon; Dyvon; Briton; Tugon; Trinex; Loisol; Combot; Anthon; Danex; Soldep; Proxol; Dyrex; Briten; Trichlorphon FN; (+-)-Trichlorfon; Foschlor R; DE" C4H8Cl3O4P NFACJZMKEDPNKN-UHFFFAOYSA-N 2,2,2-trichloro-1-dimethoxyphosphorylethanol n.a. n.a. Yes No No No No No PMDBD1477 Tricyclic antidepressants Therapeutic substance Drug category n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD1480 Trimethoprim/sulfamethoxazole Therapeutic substance Antibiotics n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD1481 Trimipramine Maleate Therapeutic substance Drug n.a. n.a. n.a. n.a. n.a. 5282318 n.a. n.a. "Trimipramine maleate; 521-78-8; Surmontil maleate; Trimipramine maleate salt; Trimeprimine maleate; Trimipramine (maleate); Trimeprimine monomaleate; Trimipramini maleas; Trimipramine hydrogen maleate; Trimipramium maleinicum; Trimipramine acid maleate; Trimipramine Maleate, BP; C20H26N2.C4H4O4; EINECS 208-318-3; UNII-D28E1043W5; UNII-I412286V22; D28E1043W5; I412286V22; DSSTox_RID_80796; DSSTox_CID_25315; 5-(3-(Dimethylamino)-2-methylpropyl)-10,11-dihydro-5H-dibenz(b,f)azepine maleate (1:1); DSSTox_GSID_45315; 5H-Dibenz(b,f)azep" C24H30N2O4 YDGHCKHAXOUQOS-BTJKTKAUSA-N "(Z)-but-2-enedioic acid;3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N,2-trimethylpropan-1-amine" n.a. n.a. No Yes No No No No PMDBD1482 Trospium Chloride Therapeutic substance Drug n.a. n.a. n.a. n.a. n.a. 5284631 n.a. n.a. "trospium chloride; Sanctura; 10405-02-4; Spasmex; Spasmo-lyt; Uraplex; Santura; Relaspium; Trospium Cl; Sanctura XR; Trospii chloridum; Cloruro de trospio; Spasmo 3; Trospium (chloride); Chlorure de trospium; IP631; UNII-1E6682427E; Trospium chloride (Sanctura); Keptan; Azoniaspiro Compound XVII; AS Xvii; IP-631; 1E6682427E; DSSTox_CID_3724; DSSTox_RID_77166; DSSTox_GSID_23724; Trospii chloridum [INN-Latin]; Cloruro de trospio [INN-Spanish]; Chlorure de trospium [INN-French]; EINECS 233-875-4; Regurin; CAS-10405-02-4; NCGC00167438-02; NCGC" C25H30ClNO3 RVCSYOQWLPPAOA-DHWZJIOFSA-M "[(1R,5S)-spiro[8-azoniabicyclo[3.2.1]octane-8,1''-azolidin-1-ium]-3-yl] 2-hydroxy-2,2-diphenylacetate;chloride" n.a. n.a. No Yes No No No No PMDBD1484 Ursodiol Therapeutic substance Drug n.a. n.a. n.a. n.a. n.a. 31401 n.a. n.a. "URSODEOXYCHOLIC ACID; ursodiol; 128-13-2; Actigall; UDCA; Ursofalk; Ursolvan; ursodeoxycholate; Delursan; UrSO; Urso Forte; Ursodesoxycholic acid; Destolit; Ursochol; Cholit-ursan; Ursodamor; Ursobilin; Litursol; Solutrat; Deursil; Ursacol; Lyeton; Arsacol; Urso DS; Peptarom; UDCS; 3alpha,7beta-Dihydroxy-5beta-cholan-24-oic acid; Ursosan; Ursodexycholic Acid; Urso 250; 3-alpha,7-beta-Dioxycholanic acid; 7-beta-Hydroxylithocholic acid; 3-alpha,7-beta-Dihydroxycholanic acid; Acido ursodeossicolico [Italian]; Acido urso" C24H40O4 RUDATBOHQWOJDD-UZVSRGJWSA-N (4R)-4-[(3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid n.a. n.a. No Yes No No No No PMDBD1486 Valacyclovir Therapeutic substance Drug n.a. n.a. n.a. n.a. n.a. 135398742 n.a. n.a. "valacyclovir; Valaciclovir; 124832-26-4; Valtrex; Zelitrex; ValACV; Valcyclovir; Valaciclovir [INN:BAN]; Val-ACV; UNII-MZ1IW7Q79D; L-Valine ester with 9-((2-hydroxyethoxy)methyl)guanine; L-Valine, 2-((2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy)ethyl ester; Valtrex (TN); MZ1IW7Q79D; CHEMBL1349; 2-[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl L-valinate; BW256U87; CHEBI:35854; 124832-27-5; Valcivir; (S)-2-[(2-Amino-6-oxo-6,9-dihydro-3H-purin-9-yl)methoxy]ethyl-2-amino-3-methylbutanoate; W-200980; Talavir; Virval; Vala" C13H20N6O4 HDOVUKNUBWVHOX-QMMMGPOBSA-N 2-[(2-amino-6-oxo-1H-purin-9-yl)methoxy]ethyl (2S)-2-amino-3-methylbutanoate n.a. n.a. No Yes No No No No PMDBD1494 Ziprasidone hydrochloride Therapeutic substance Drug n.a. n.a. n.a. n.a. n.a. 219099 n.a. n.a. "Ziprasidone hydrochloride; 122883-93-6; Ziprasidone HCl; Geodon; Zeldox; 5-(2-(4-(Benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-6-chloroindolin-2-one hydrochloride; Ziprasidone (hydrochloride); UNII-JAL53626GG; 5-[2-[4-(1,2-Benzisothiazol-3yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2H-indol-2-one hydrochloride; Ziprasidone hydrochloride [USAN]; 5-[2-[4-(1,2-Benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2H-indol-2-one hydrochloride; C21H21ClN4OS.HCl; JAL53626GG; C21H22Cl2N4OS; CP 88059; 2H-Indol-2-one, " C21H22Cl2N4OS NZDBKBRIBJLNNT-UHFFFAOYSA-N "5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-1,3-dihydroindol-2-one;hydrochloride" n.a. n.a. No Yes No No No No PMDBD1496 beta-Hexachlorocyclo hexane Environmental Chemicals Pesticides n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD1497 beta-lactam Environmental Chemicals Antibiotics n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Yes No No No No No PMDBD1498 beta-Lapachone Therapeutic substance chemotherapeutic n.a. n.a. n.a. n.a. n.a. 3885 n.a. n.a. "beta-Lapachone; 4707-32-8; lapachone; ARQ 501; 2,2-Dimethyl-3,4-dihydro-2H-benzo[h]chromene-5,6-dione; .beta.-Lapachone; ARQ-501; 3,4-Dihydro-2,2-dimethyl-2H-naphtho[1,2-B]pyran-5,6-dione; UNII-6N4FA2QQ6A; NSC 26326; 3,4-Dihydro-2,2-dimethyl-2H-naphtho(1,2-b)pyran-5,6-dione; SL 11001; 2,2-dimethyl-3,4-dihydrobenzo[h]chromene-5,6-dione; NSC-26326; NSC 629749; BRN 0181499; 6N4FA2QQ6A; CHEBI:10429; 3,4-Dihydro-2,2-dimethyl-2H-naphthol[1,2-b]pyran-5,6-d" C15H14O3 QZPQTZZNNJUOLS-UHFFFAOYSA-N 2,2-dimethyl-3,4-dihydrobenzo[h]chromene-5,6-dione n.a. n.a. No Yes No No No No PMDBD2000001 Ginsenoside n.a. reproductive system in animal testicles n.a. n.a. n.a. n.a. n.a. 3086007 n.a. NPC275618 Ginsenosides, GINSENOSIDE, 74749-74-9, UNII-3K198YD54P, (3S,5R,8R,9R,10R,14R,17S)-17-(2-hydroxy-6-methylhept-5-en-2-yl)-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol, 3K198YD54P, Panaxosides, DB14152 C30H52O2 NLHQJXWYMZLQJY-SWIZOJJJSA-N (3S,5R,8R,9R,10R,14R,17S)-17-(2-hydroxy-6-methylhept-5-en-2-yl)-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol n.a. n.a. No Yes No No No No PMDBD2000002 Poncirin n.a. unknown n.a. n.a. n.a. n.a. n.a. 442456 n.a. NPC97285 Poncirin, 14941-08-3, Isosakuranetin-7-O-neohesperidoside, Citrifolioside, CHEBI:66773, 8MUY4P95B4, Isosakuranetin 7-O-neohesperidoside, (2S)-7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-methoxyphenyl)-2,3-dihydrochromen-4-one, (2S)-poncirin, UNII-8MUY4P95B4, EINECS 239-020-1, Isosakuranetin-7-O-beta-D-neohesperidoside, PoncirinCitrifolioside, SureCN123069, Poncirin, analytical standard, SCHEMBL123069, CHEMBL451050, DTXSID00933642, NLAWPKPYBMEWIR-SKYQDXIQSA-N, HY-N2258, s9165, AKOS037514792, CCG-270181, NCGC00163611-01, (S)-7-((2-O-(6-Deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl)oxy)-2,3-dihydro-5-hydroxy-2-(4-methoxyphenyl)-4H-benzopyran-4-one, 1ST40169, AC-34235, CS-0019587, C09830, Q3388129, (2S)-5-hydroxy-2-(4-methoxyphenyl)-4-oxo-3,4-dihydro-2H-chromen-7-yl 2-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoside, (2S)-7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-tetrahydropyran-2-yl]oxy-5-hydroxy-2-(4-methoxyphenyl)chroman-4-one, (2s)-7-[(2s,3r,4s,5s,6r)-4,5-dihydroxy6-(hydroxymethyl)-3-[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2(4-methoxyphenyl)-2,3-dihydrochromen-4-one, (S)-7-((2-O-(6-DEOXY-.ALPHA.-L-MANNOPYRANOSYL)-.BETA.-D-GLUCOPYRANOSYL)OXY)-2,3-DIHYDRO-5-HYDROXY-2-(4-METHOXYPHENYL)-4H-BENZOPYRAN-4-ONE, 4H-1-Benzopyran-4-one, 7-[[2-O-(6-deoxy-.alpha.-L-mannopyranosyl)-.beta.-D-glucopyranosyl]oxy]-2,3-dihydro-5-hydroxy-2-(4-methoxyphenyl)-, (2S)-, 5,7-Dihydroxy-4''-methoxyflavanone, 7-(2-O-.alpha.-L-rhamnopyranosyl-.beta.-D-glucopyranoside), 7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-methoxyphenyl)-2,3-dihydrochromen-4-one C28H34O14 NLAWPKPYBMEWIR-SKYQDXIQSA-N (2S)-7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-methoxyphenyl)-2,3-dihydrochromen-4-one n.a. n.a. No Yes No No No No PMDBD2000003 Steviol glycosides Therapeutic Substance unknown n.a. n.a. n.a. n.a. D04MRG 442089 n.a. NPC272056 Stevioside, Steviosin, 57817-89-7, CHEBI:9271, Rebaudin, UNII-0YON5MXJ9P, 0YON5MXJ9P, Diterpene glycoside, STEVIBIOSIDE, CCRIS 6116, EINECS 260-975-5, (-)-STEVIOSIDE, STEVIAN 50, BRN 0077427, INS NO.960, DTXSID7021281, FEMA NO. 4763, INS-960, 4-17-00-03618 (Beilstein Handbook Reference), E-960, STEVIOSIDE (MART.), STEVIOSIDE [MART.], STEVIOSIDE (USP-RS), STEVIOSIDE [USP-RS], 13-[(2-O-.beta.-D-Glucopyranosyl-.alpha.-D-glucopyranosyl)oxy]kaur-16-en-18-oic acid .beta.-D-glucopyranosyl ester, Kaur-16-en-18-oic acid, 13-((2-O-beta-D-glucopyranosyl-alpha-D-glucopyranosyl)oxy)-, beta-D-glucopyranosyl ester, C09189, CHEMBL444122, Eupatorin?, Stevin?, Steviol glycosides, 1-O-(13alpha-((2-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)oxy)-18-oxo-5beta,8alpha,9beta,10alpha-kaur-16-en-18-yl)-beta-D-glucopyranose, 1-O-{13alpha-[(2-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)oxy]-18-oxo-5beta,8alpha,9beta,10alpha-kaur-16-en-18-yl}-beta-D-glucopyranose, 13-((2-O-.beta.-D-Glucopyranosyl-.alpha.-D-glucopyranosyl)oxy)kaur-16-en-18-oic acid .beta.-D-glucopyranosyl ester, 13-((2-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)oxy)kaur-16-en-18-oic acid beta-D-glucopyranosyl ester, 13-[(2-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)oxy]kaur-16-en-18-oic acid beta-D-glucopyranosyl ester, alpha-G-SWEET, STEVIOSIDE [MI], .ALPHA.-G-SWEET, STEVIOSIDE [INCI], SCHEMBL33428, DTXCID301281, GTPL12423, HY-N0669, BDBM50480264, AKOS015895872, CS-W019786, DS-6711, Q415043, (4.ALPHA.)-13-((2-O-.BETA.-D-GLUCOPYRANOSYL-.BETA.-D-GLUCOPYRANOSYL)OXY)KAUR-16-EN-18-OIC ACID .BETA.-D-GLUCOPYRANOSYL ESTER, (4alpha)-13-((2-O-beta-D-GLUCOPYRANOSYL-beta-D-GLUCOPYRANOSYL)OXY)KAUR-16-EN-18-OIC ACID beta-D-GLUCOPYRANOSYL ESTER, (4alpha)-beta-D-Glucopyranosyl 13-((2-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)oxy)kaur-16-en-18-oate, [(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl] [(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-tetrahydropyran-2-yl]oxy-dimethyl-methylene-[?]carboxylate, 1-O-{(5beta,8alpha,9beta,10alpha,13alpha)-13-[(2-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)oxy]-18-oxokaur-16-en-18-yl}-beta-D-glucopyranose, KAUR-16-EN-18-OIC ACID, 13-((2-O-.BETA.-D-GLUCOPYRANOSYL-.BETA.-D-GLUCOPYRANOSYL)OXY)-, .BETA.-D-GLUCOPYRANOSYL ESTER, (4.ALPHA.)-, KAUR-16-EN-18-OIC ACID, 13-((2-O-beta-D-GLUCOPYRANOSYL-beta-D-GLUCOPYRANOSYL)OXY)-, beta-D-GLUCOPYRANOSYL ESTER, (4alpha)-, Kaur-16-en-18-oic acid,13-[(2-O-b-D-glucopyranosyl-b-D-glucopyranosyl)oxy]-,b-D-glucopyranosyl ester, (4a)- C38H60O18 UEDUENGHJMELGK-HYDKPPNVSA-N [(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1R,4S,5R,9S,10R,13S)-13-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-5,9-dimethyl-14-methylidenetetracyclo[11.2.1.01,10.04,9]hexadecane-5-carboxylate n.a. n.a. No Yes No No No No PMDBD2000004 Rebaudioside A Therapeutic Substance compound 58543-16-1 DB15136 n.a. n.a. n.a. 6918840 5294031 NPC162791 Rebaudioside A, 58543-16-1, Stevioside A3, Rebaudioside-A, Truvia, Sweetener 4G-S, Reb A, Rebiana, Rebaudiana a, Sooolite!-Pure, Reb-A 97, Reb-A, REBAUDIOSIDEA, Glycoside X, Pure Via, Chrysanta AR-P, B3FUD0528F, DTXSID8047898, UNII-B3FUD0528F, INS NO.960A, CCRIS 6119, INS-960A, 19-O-beta-glucopyranosyl-13-O-(beta-glucopyranosyl(1-2)-beta-glucopyranosyl(1-3))-beta-glucopyranosyl-13-hydroxykaur-16-en-19-oic acid, FEMA NO. 4601, SG 95RA50, CHEBI:145012, DTXCID50819922, RA 95, E-960A, Glycoside A3, from Stevia rebaudiana, 19-O-beta-glucopyranosyl-13-O-(beta-glucopyranosyl(1-2)-beta-glucopyranosyl(1-3))-beta-glucopyranosylsteviol, REBAUDIOSIDE A (USP-RS), REBAUDIOSIDE A [USP-RS], Stevia, [(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1R,4S,5R,9S,10R,13S)-13-[(2S,3R,4S,5R,6R)-5-hydroxy-6-(hydroxymethyl)-3,4-bis[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy]oxan-2-yl]oxy-5,9-dimethyl-14-methylidenetetracyclo[11.2.1.01,10.04,9]hexadecane-5-carboxylate, MFCD02183463, Glycoside A3, 1-O-(13alpha-((beta-D-glucopyranosyl-(1->2)-(beta-D-glucopyranosyl-(1->3))-beta-D-glucopyranosyl)oxy)-18-oxo-5beta,8alpha,9beta,10alpha-kaur-16-en-18-yl)-beta-D-glucopyranose, 1-O-(13alpha-{[beta-D-glucopyranosyl-(1->2)-[beta-D-glucopyranosyl-(1->3)]-beta-D-glucopyranosyl]oxy}-18-oxo-5beta,8alpha,9beta,10alpha-kaur-16-en-18-yl)-beta-D-glucopyranose, 13-((2-O-beta-D-glucopyranosyl-3-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)oxy)-ent-kaur-16-en-19-oic acid beta-D-glucopyranosyl ester, 13-[(2-O-beta-D-glucopyranosyl-3-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)oxy]-ent-kaur-16-en-19-oic acid beta-D-glucopyranosyl ester, REBAUDIOSIDE A [MI], REBAUDIOSIDE A [FCC], 92332-31-5, REBAUDIOSIDE A [INCI], 522 - Stevia (Soft Drink), SCHEMBL19769999, HELXLJCILKEWJH-NCGAPWICSA-N, HY-N0466, Rebaudioside A, >=96% (HPLC), Tox21_200565, s3796, AKOS037748820, CCG-270597, CS-5793, DB15136, NCGC00258119-01, 1ST40200, AS-18742, CAS-58543-16-1, Rebaudioside A, analytical reference material, Q63408635, Rebaudioside A, United States Pharmacopeia (USP) Reference Standard, (4.ALPHA.)-13-((O-.BETA.-D-GLUCOPYRANOSYL-(1->2)-O-(.BETA.-D-GLUCOPYRANOSYL-(1->3))-.BETA.-D-GLUCOPYRANOSYL)OXY)KAUR-16-EN-18-OIC ACID .BETA.-D-GLUCOPYRANOSYL ESTER, (4alpha)-13-((O-beta-D-GLUCOPYRANOSYL-(1->2)-O-(beta-D-GLUCOPYRANOSYL-(1->3))-beta-D-GLUCOPYRANOSYL)OXY)KAUR-16-EN-18-OIC ACID beta-D-GLUCOPYRANOSYL ESTER, [(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl](1R,4S,5R,9S,10R,13S)-13-[(2S,3R,4S,5R,6R)-5-hydroxy-6-(hydroxymethyl)-3,4-bis[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy]oxan-2-yl]oxy-5,9-dimethyl-14-methylidenetetracyclo[11.2.1.01,10.04,9]hexadecane-5-carboxylate C44H70O23 HELXLJCILKEWJH-NCGAPWICSA-N [(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1R,4S,5R,9S,10R,13S)-13-[(2S,3R,4S,5R,6R)-5-hydroxy-6-(hydroxymethyl)-3,4-bis[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy]oxan-2-yl]oxy-5,9-dimethyl-14-methylidenetetracyclo[11.2.1.01,10.04,9]hexadecane-5-carboxylate n.a. n.a. No Yes No No No No PMDBD2000005 Stevioside Therapeutic Substance compound 57817-89-7 DB16882 n.a. n.a. D04MRG 442089 390625 NPC272056 Stevioside, Steviosin, 57817-89-7, CHEBI:9271, Rebaudin, UNII-0YON5MXJ9P, 0YON5MXJ9P, Diterpene glycoside, STEVIBIOSIDE, CCRIS 6116, EINECS 260-975-5, (-)-STEVIOSIDE, STEVIAN 50, BRN 0077427, INS NO.960, DTXSID7021281, FEMA NO. 4763, INS-960, 4-17-00-03618 (Beilstein Handbook Reference), E-960, STEVIOSIDE (MART.), STEVIOSIDE [MART.], STEVIOSIDE (USP-RS), STEVIOSIDE [USP-RS], 13-[(2-O-.beta.-D-Glucopyranosyl-.alpha.-D-glucopyranosyl)oxy]kaur-16-en-18-oic acid .beta.-D-glucopyranosyl ester, Kaur-16-en-18-oic acid, 13-((2-O-beta-D-glucopyranosyl-alpha-D-glucopyranosyl)oxy)-, beta-D-glucopyranosyl ester, C09189, CHEMBL444122, Eupatorin?, Stevin?, Steviol glycosides, 1-O-(13alpha-((2-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)oxy)-18-oxo-5beta,8alpha,9beta,10alpha-kaur-16-en-18-yl)-beta-D-glucopyranose, 1-O-{13alpha-[(2-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)oxy]-18-oxo-5beta,8alpha,9beta,10alpha-kaur-16-en-18-yl}-beta-D-glucopyranose, 13-((2-O-.beta.-D-Glucopyranosyl-.alpha.-D-glucopyranosyl)oxy)kaur-16-en-18-oic acid .beta.-D-glucopyranosyl ester, 13-((2-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)oxy)kaur-16-en-18-oic acid beta-D-glucopyranosyl ester, 13-[(2-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)oxy]kaur-16-en-18-oic acid beta-D-glucopyranosyl ester, alpha-G-SWEET, STEVIOSIDE [MI], .ALPHA.-G-SWEET, STEVIOSIDE [INCI], SCHEMBL33428, DTXCID301281, GTPL12423, HY-N0669, BDBM50480264, AKOS015895872, CS-W019786, DS-6711, Q415043, (4.ALPHA.)-13-((2-O-.BETA.-D-GLUCOPYRANOSYL-.BETA.-D-GLUCOPYRANOSYL)OXY)KAUR-16-EN-18-OIC ACID .BETA.-D-GLUCOPYRANOSYL ESTER, (4alpha)-13-((2-O-beta-D-GLUCOPYRANOSYL-beta-D-GLUCOPYRANOSYL)OXY)KAUR-16-EN-18-OIC ACID beta-D-GLUCOPYRANOSYL ESTER, (4alpha)-beta-D-Glucopyranosyl 13-((2-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)oxy)kaur-16-en-18-oate, [(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl] [(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-tetrahydropyran-2-yl]oxy-dimethyl-methylene-[?]carboxylate, 1-O-{(5beta,8alpha,9beta,10alpha,13alpha)-13-[(2-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)oxy]-18-oxokaur-16-en-18-yl}-beta-D-glucopyranose, KAUR-16-EN-18-OIC ACID, 13-((2-O-.BETA.-D-GLUCOPYRANOSYL-.BETA.-D-GLUCOPYRANOSYL)OXY)-, .BETA.-D-GLUCOPYRANOSYL ESTER, (4.ALPHA.)-, KAUR-16-EN-18-OIC ACID, 13-((2-O-beta-D-GLUCOPYRANOSYL-beta-D-GLUCOPYRANOSYL)OXY)-, beta-D-GLUCOPYRANOSYL ESTER, (4alpha)-, Kaur-16-en-18-oic acid,13-[(2-O-b-D-glucopyranosyl-b-D-glucopyranosyl)oxy]-,b-D-glucopyranosyl ester, (4a)- C38H60O18 UEDUENGHJMELGK-HYDKPPNVSA-N [(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1R,4S,5R,9S,10R,13S)-13-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-5,9-dimethyl-14-methylidenetetracyclo[11.2.1.01,10.04,9]hexadecane-5-carboxylate n.a. n.a. No Yes No No No No PMDBD2000006 Isoquercetin(Quercitin-3-glucoside) n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD2000007 Anthocyanins n.a. Potential anticancer, anti-oxidant and anti-inflammatory n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD2000008 Genistin n.a. Anti-cancer, estrogenic and antiatherosclerotic n.a. n.a. n.a. n.a. n.a. 5281377 n.a. NPC313163 "Genistin, 529-59-9, Genistoside, Genistine, Genistein 7-glucoside, Genistein glucoside, Genisteol 7-monoglucoside, Genistein 7-O-beta-D-glucoside, Glucosyl-7-genistein, CHEBI:27514, genistein 7-O-glucoside, 1POG3SCN5T, MFCD00016883, Genistein, 7-O-beta-D-glucoside, 4'',5,7-trihydroxyisoflavone 7-D-glucoside, Genistein, 7-beta-D-glucopyranoside, 5-hydroxy-3-(4-hydroxyphenyl)-4-oxo-4H-chromen-7-yl beta-D-glucopyranoside, 5-hydroxy-3-(4-hydroxyphenyl)-7-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-4H-chromen-4-one, 5-hydroxy-3-(4-hydroxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one, 4'',5,7-Trihydroxyisoflavone 7-.beta.-D-glucopyranoside, NSC 5112, UNII-1POG3SCN5T, Glucopyranoside, genistein-7, beta-D-, BRN 0064479, NSC-5112, Genistin?, Genistein-7-O-beta-D-glucopyranoside, 7-O-.beta.-D-glucopyranosyl genistein, Genistin,(S), 4'',5,7-Trihydroxyisoflavone 7-glucoside, 5-hydroxy-3-(4-hydroxyphenyl)-7-((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)-4H-chromen-4-one, GENISTIN [USP-RS], SCHEMBL62148, Genistin, analytical standard, 4-18-00-02732 (Beilstein Handbook Reference), MLS006010735, BIDD:ER0520, CHEMBL486625, MEGxp0_000436, GENISTEIN GENISTIN [MI], DTXSID3022324, ACon1_001495, Genistin - CAS 529-59-9, Genistin, >=97.5% (TLC), Genistein 7-O-b-D-glucopyranoside, HY-N0595, BDBM50025609, AKOS025146960, CCG-208377, CS-4240, 4H-1-Benzopyran-4-one, 7-(beta-D-glucopyranosyloxy)-5-hydroxy-3-(4-hydroxyphenyl)-, NCGC00163559-01, NCGC00163559-02, NCGC00180447-01, 1ST40177, AS-11684, SMR003929926, G0358, C09126, GENISTEIN 7-O-.BETA.-D-GLUCOPYRANOSIDE, Genistin, primary pharmaceutical reference standard, Q-100603, Q5533221, BRD-K51391729-001-01-4, GENISTIN (CONSTITUENT OF SOY ISOFLAVONES) [DSC], Genistin, from Glycine max (soybean), >=95% (HPLC), 5,4''-DI-HYDROXYISOFLAVONE-7-O-.BETA.-D-GLUCOPYRANOSIDE, Genistin, United States Pharmacopeia (USP) Reference Standard, GenistinGenistine; Genistein 7-glucoside; Genistein glucoside" C21H20O10 ZCOLJUOHXJRHDI-CMWLGVBASA-N 5-hydroxy-3-(4-hydroxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one n.a. n.a. No Yes No No Yes No rxn23868,rxnDiet133,rxnAdd181 PMDBD2000009 Naringin Therapeutic Substance Anti-oxidant, anti-cancer and blood cholesterol lowering effect n.a. n.a. n.a. n.a. D09VQM 442428 n.a. NPC142860 naringin, 10236-47-2, aurantiin, Naringoside, Naringenin 7-Rhamnoglucoside, (2S)-Naringin, Naringenin 7-O-neohesperidoside, UNII-N7TD9J649B, N7TD9J649B, CHEBI:28819, Naringenine-7-rhamnosidoglucoside, Naringenin-7-beta-neohesperidoside, EINECS 233-566-4, 4''5-diOH-Flavone-7-rhgluc, AI3-19008, CHEMBL451532, DTXSID6022478, NARINGENIN-7-RHAMNOGLUCOSIDE, (2S)-7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)-2,3-dihydrochromen-4-one, (S)-7-(((2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-(((2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)-5-hydroxy-2-(4-hydroxyphenyl)chroman-4-one, 7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)-2,3-dihydrochromen-4-one, 4'',5,7-Trihydroxyflavanone-7-rhamnoglucoside, NARINGIN (USP-RS), NARINGIN [USP-RS], 5-Hydroxy-2-(4-hydroxyphenyl)-7-(2-O-alpha-L-rhamnopyranosyl-beta-D-glucopyranosyloxy)-4-chromanon, 7-(2-O-(6-Deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyloxy)-2,3-dihydro-4'',5,7-trihydroxyflavone, 4'',5,7-trihydroxyflavanone 7-rhamnoglucoside, Naringenin 7-O-alpha-L-rhamnosyl-(1->2)-beta-D-glucoside, naringenin 7-O-(alpha-L-rhamnosyl-(1,2)-beta-D-glucoside), Naringenin 7-O-[alpha-L-rhamnosyl-(1->2)-beta-D-glucoside], MFCD00148888, (2S)-5-hydroxy-2-(4-hydroxyphenyl)-4-oxo-3,4-dihydro-2H-1-benzopyran-7-yl 2-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoside, (2S)-5-hydroxy-2-(4-hydroxyphenyl)-4-oxo-3,4-dihydro-2H-chromen-7-yl 2-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoside, 4H-1-Benzopyran-4-one, 7-((2-O-(6-deoxy-alpha-L-mannapyranosyl)-beta-D-glucopyranosyl)oxy)-2,3-dihydro-5-hydroxy-2-(4-hydroxyphenyl), (S)-, SR-01000736681, naringenin-7-hesperidoside, Naringenin 7-O-(alpha-L-rhamnosyl-(1->2)-beta-D-glucoside), Naringin extract, Naringenin,(S), (S)-7-((2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-((2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yloxy)tetrahydro-2H-pyran-2-yloxy)-5-hydroxy-2-(4-hydroxyphenyl)chroman-4-one, Naringenin Glycoside, Naringin (Naringoside), NARINGIN [INCI], NARINGIN [MI], Prestwick0_000467, Prestwick1_000467, Prestwick2_000467, Prestwick3_000467, AURANTIIN [WHO-DD], SCHEMBL23432, BSPBio_000574, cid_25075, MLS000069459, BIDD:ER0262, DivK1c_000247, SPBio_002513, BPBio1_000632, cid_442428, DTXCID302478, GTPL4738, MEGxp0_001877, ACon1_000139, HMS500M09, KBio1_000247, NINDS_000247, CITRUS NARINGININE [VANDF], HMS2231M18, HY-N0153, BDBM50241582, s2329, AKOS016034302, CCG-208591, CS-5632, IDI1_000247, NCGC00142617-01, NCGC00142617-02, NCGC00142617-03, 1ST40036, AS-12929, SMR000059108, XN167836, NS00014639, C09789, A800566, Q418469, SR-01000736681-4, SR-01000736681-5, BRD-K02953697-001-09-2, BRD-K02953697-002-03-3, (2S)-5-hydroxy-2-(4-hydroxyphenyl)-4-oxo-3,4-dihydro-2H-chromen-7-yl 2-O-(6-deoxy-alpha-L-mannopyranosyl)-betaD-glucopyranoside, (2S)-7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-tetrahydropyran-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)chroman-4-one, (2S)-7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)chroman-4-one, (2S)-7-[(2S,4S,5S,3R,6R)-3-((2S,6S,3R,4R,5R)-3,4,5-trihydroxy-6-methyl(2H-3,4, 5,6-tetrahydropyran-2-yloxy))-4,5-dihydroxy-6-(hydroxymethyl)(2H-3,4,5,6-tetra hydropyran-2-yloxy)]-5-hydroxy-2-(4-hydroxyphenyl)chroman-4-one, (2S)-7-{[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-5-hydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-4-one, (S)-7-((2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-((2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-tetrahydro-2H-pyran-2-yloxy)-tetrahydro-2H-pyran-2-yloxy)-5-hydroxy-2-(4-hydroxyphenyl)chroman-4-one, 4H-1-Benzopyran-4-one, 7-((2-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl)oxy)-2,3-dihydro-5-hydroxy-2-(4-hydroxyphenyl)-, (2S)-, 4H-1-Benzopyran-4-one,7-[[2-O-(6-deoxy-.alpha.-L-mannopyranosyl)-.beta.-D-glucopyranosyl]oxy]-2,3-dihydro-5-hydroxy-2-(4-hydroxyphenyl)-,(S)-, 7-((2-O-(6-DEOXY-.ALPHA.-L-MANNOPYRANOSYL)-.BETA.-D-GLUCOPYRANOSYL)OXY)-2,3-DIHYDRO-5-HYDROXY-2-(4-HYDROXYPHENYL)-4H-1-BENZOPYRAN-4-ONE, 7-[[2-O-(6-Deoxy-.alpha.-L-mannopyranosyl)-.beta.-D-glucopyranosyl]oxy]-5-hydroxy-2(S)-(4-hydroxyphenyl)-4H-1-benzopyran-4-one, ZWN C27H32O14 DFPMSGMNTNDNHN-ZPHOTFPESA-N (2S)-7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)-2,3-dihydrochromen-4-one n.a. n.a. No Yes No No Yes No rxn41673,rxnDiet164,rxnAdd80 PMDBD2000010 Serotonin dopamine n.a. compound n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD2000011 Nitrotoluene n.a. compound n.a. n.a. n.a. n.a. n.a. 6944 n.a. n.a. 2-Nitrotoluene, 1-Methyl-2-nitrobenzene, 88-72-2, O-NITROTOLUENE, NITROTOLUENE, o-Nitrotoluol, o-Methylnitrobenzene, Toluene, o-nitro-, 2-Methyl-1-nitrobenzene, 2-Methylnitrobenzene, 2-Nitrotoluol, ortho-Nitrotoluol, Benzene, 1-methyl-2-nitro-, 1321-12-6, 1-methyl-2-nitro-benzene, NSC 9577, ONT, 6Q9N88YIAY, MLS001055384, DTXSID4025791, CHEBI:33098, 2-NITROTOLUENE-A,A,A-D3, NSC-9577, o-NT, SMR000677946, ortho-nitrotoluene, Nitrotoluene, o-, 2-Nitrotoluene, >=99%, DTXCID005791, CAS-88-72-2, CCRIS 1224, HSDB 2189, Nitrotoluene, o-isomer, EINECS 201-853-3, UNII-6Q9N88YIAY, AI3-16311, 2-nitro toluene, 2-nitro-toluene, o-mononitrotoluene, Benzene,methylnitro-, o-methyl nitrobenzene, 2-methyl-nitrobenzene, o-Nitrotoluene, liquid, TOLUENE,2-NITRO, ORTHO NITROTOLUENE, NITROTOLUENE, 2-, EC 201-853-3, cid_6944, WLN: WNR B1, O-NITROTOLUENE [MI], SCHEMBL26788, CHEMBL47047, 2-NITROTOLUENE [HSDB], 2-NITROTOLUENE [IARC], SCHEMBL8008054, BDBM91068, NSC9577, HMS3039E06, 2-Nitrotoluene, analytical standard, AMY40779, Tox21_202393, Tox21_300032, MFCD00007157, AKOS000120143, UN-1664, NCGC00090723-01, NCGC00090723-02, NCGC00090723-03, NCGC00254124-01, NCGC00259942-01, BS-43806, N0275, NS00005656, EN300-19370, o-Nitrotoluene, liquid [UN1664] [Poison], C19597, Q2533785, F9995-1659, InChI=1/C7H7NO2/c1-6-4-2-3-5-7(6)8(9)10/h2-5H,1H C7H7NO2 PLAZTCDQAHEYBI-UHFFFAOYSA-N 1-methyl-2-nitrobenzene n.a. n.a. No Yes No No No No PMDBD2000012 Amphetamine Therapeutic Substance attention-deficit/hyperactivity disorders (ADHD) 300-62-9 DB00182 PA448408 D07445 D05BMG 3007 n.a. NPC112609 AMPHETAMINE, Amfetamine, 1-phenylpropan-2-amine, dl-Amphetamine, 300-62-9, Desoxynorephedrine, Norephedrane, 1-Phenyl-2-aminopropane, Elastonon, Fenopromin, Phenedrine, alpha-Methylphenethylamine, beta-Aminopropylbenzene, Propisamine, Psychedrine, Raphetamine, Rhinalator, Simpatedrin, Sympatedrine, Actedron, Allodene, Anorexide, Anorexine, Benzebar, Benzolone, Isoamyne, Mecodrin, Novydrine, Oktedrin, Ortedrine, Percomon, Profamina, Simpatina, Sympamine, Weckamine, Adipan, Finam, Isomyn, 1-Methyl-2-phenylethylamine, 1-Phenyl-2-propylamine, Protioamphetamine, amfetaminum, alpha-Methylbenzeneethaneamine, 3-Phenyl-2-propylamine, Fenylo-izopropylaminyl, (Phenylisopropyl)amine, dl-alpha-Methylphenethylamine, 1-Phenyl-2-propanamine, 2-Amino-1-phenylpropane, (+-)-Benzedrine, racemic-Desoxynor-ephedrine, Amfetamin, Amfetamina, Amphetamin, Anfetamina, Dyanavel, dl-Benzedrine, beta-Phenylisopropylamin, Adzenys ER, Amphetamine, dl-, 1-Phenyl-2-amino-propan, (+-)-alpha-Methylphenylethylamine, beta-Phenylisopropylamine, 60-15-1, rac-Amphetamine, (+-)-alpha-Methylphenethylamine, HSDB 3287, .beta.-Aminopropylbenzene, Amfetaminum [INN-Latin], Benzeneethanamine, alpha-methyl-, (+-)-, Amfetamina [INN-Spanish], (+-)-alpha-Methylbenzeneethanamine, (+/-)-Desoxynorephedrine, Benzeneethanamine, .alpha.-methyl-, UNII-CK833KGX7E, EINECS 200-458-3, EINECS 206-096-2, CK833KGX7E, dl-1-Phenyl-2-aminopropane, Adzenys XR-ODT, NSC 27159, NSC-27159, Phenethylamine, alpha-methyl-, .alpha.-Methylbenzeneethanamine, Phenethylamine, alpha-methyl-, (+-)-, Norephedrine, deoxy-, 3-AMINO-1-PROPYLBENZENE, AI3-02438, 1-Phenylpropan-2-amin, alpha-Methylphenylethylamine, Dexedrine, CHEBI:2679, DTXSID4022600, Amfetamine (INN), NSC27159, Dexacaps, NT-0201, AMFETAMINE [INN], Amfetaminum (INN-Latin), Desoxynorephedrin, Amfetamina (INN-Spanish), Phenethylamine, .alpha.-methyl-, (.+/-.)-, AMFETAMINE (MART.), AMFETAMINE [MART.], Benzeneethanamine, .alpha.-methyl-, (.+/-.)-, Amfetamina [Italian], Anfetamina [Spanish], DEA No. 1100, Amfetamine [INN:BAN], Adderall XR, Dyanavel XR, beta-Aminopropylbenzene (VAN), DELCOBESE, Fenylo-izopropylaminyl [Polish], Benzeneethanamine, alpha-methyl-, 1-Phenyl-2-aminopropane (VAN), beta-Phenylisopropylamin [German], 1-Phenyl-2-amino-propan [German], beta-phenyl-isopropylamine, alpha-Methylbenzeneethanamine, amphetaminium, (+)-.alpha.-Methylphenethylamine, Adderal, Adzenys, Isoamycin, amphetamine-, NSC73713, Amfetamin (TN), Dyanavel (TN), component of Amodex, Phenethylamine, d-, S(+)-Amphetamine, (+-)-amphetamine, Adzenys (TN), (plusmn)-amphetamine, Benzeneethanamine, .alpha.-methyl-, (S)-, Noclon (Salt/Mix), ACETEDRON, Fenamin (Salt/Mix), Ortenal (Salt/Mix), Zedrine (Salt/Mix), (+/-)-Benzedrine, Euphodyn (Salt/Mix), Stimulan (Salt/Mix), Fabedrine (Salt/Mix), Oraldrina (Salt/Mix), Vapedrine (Salt/Mix), Sympametin (Salt/Mix), component of Biphetamine, Phenethylamine, (+)-, 3-phenylpropan-2-amine, AMPHETAMINE [MI], (.+/-.)-Benzedrine, Benzeneethanamine, (S)-, RACEMIC AMPHETAMINE, .beta.-Phenylisopropylamin, alpha-methyl phenethylamine, AMPHETAMINE, (D), AMPHETAMINE [HSDB], CHEMBL405, .beta.-Phenylisopropylamine, AMPHETAMINE [VANDF], SCHEMBL8858, .alpha.-Methylphenethylamine, AMFETAMINE [WHO-DD], Oprea1_447423, d/l-Amphetamine hydrochloride, (.+/-.)-Desoxynorephedrine, .alpha.-Methylphenylethylamine, DivK1c_000991, WLN: ZY1&1R, (S)-.alpha.-Phenylethylamine, d-.alpha.-Methylphenethylamine, DTXCID402600, GTPL4804, WLN: ZY1&1R -D, .alpha.-Methylbenzeneethaneamine, DL-.alpha.-Methylphenethylamine, (+-)-DESOXYNOREPHEDRINE, HMS503G03, KBio1_000991, Phenethylamine, .alpha.-methyl-, (+/-)-beta-Phenylisopropylamine, alpha-methyl-beta-phenylethylamine, AMPHETAMINE [ORANGE BOOK], N06BA01, (+-)-alpha-methyl phenethylamine, (+-)-PHENYLISOPROPYLAMINE, (+/-)-alpha-Methylphenethylamine, CHEBI:132233, NINDS_000991, rac-(2R)-1-phenylpropan-2-amine, (+)-.alpha.-Methylphenylethylamine, PHENETHYLAMINE, ALPHA-METHYL, RACEMIC DESOXY-NOR-EPHEDRINE, .alpha.-Methylphenethylamine, d-form, BDBM50005246, (S)-(+)-.beta.-Phenylisopropylamine, (+-)-BETA-PHENYLISOPROPYLAMINE, (.+/-.)-.beta.-Phenylisopropylamine, AB07478, DB00182, (+-)-1-PHENYL-2-AMINOPROPANE, (.+/-.)-.alpha.-Methylphenethylamine, IDI1_000991, rac-Amphetamine 1.0 mg/ml in Methanol, (.+/-.)-.alpha.-Methylphenylethylamine, (+-)-ALPHA-METHYLBENZENE-ETHANAMINE, (+-)-ALPHA-METHYLPHENYL ETHYLAMINE, Benzeneethanamine, alpha-methyl-, (+/-)-, (+/-)-.ALPHA.-METHYLPHENETHYLAMINE, NS00000406, BENZENEETHANAMINE, ALPHA-METHYL-,(+-), C07514, D03740, D07445, L000864, Q179452, BENZENEETHANAMINE, .ALPHA.-METHYL-, (+/-)-, SELEGILINE HYDROCHLORIDE IMPURITY B [EP IMPURITY] C9H13N KWTSXDURSIMDCE-UHFFFAOYSA-N 1-phenylpropan-2-amine PharmacoFore Inc n.a. No Yes No No No No PMDBD2000013 Abiraterone Therapeutic Substance prostate cancer 154229-19-3 DB05812 PA166123407 D09701 D02STN 132971 117349 n.a. "Abiraterone, 154229-19-3, CB 7598, CB-7598, (3beta)-17-(3-pyridinyl)-androsta-5,16-dien-3-ol, 17-(3-Pyridyl)androsta-5,16-dien-3beta-ol, Abiraterone (CB-7598), CB7598, UNII-G819A456D0, CHEBI:68642, (3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-(pyridin-3-yl)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol, G819A456D0, NSC-741232, (3beta)-17-(pyridin-3-yl)androsta-5,16-dien-3-ol, CHEMBL254328, Androsta-5,16-dien-3-ol, 17-(3-pyridinyl)-, (3beta)-, DTXSID80879993, 17-(pyridin-3-yl)androsta-5,16-dien-3beta-ol, 154229-19-3 (Abiraterone), MFCD00924100, NSC 741232, 17-(3-Pyridyl)androsta-5,16-dien-3.beta.-ol, (1S,2R,5S,10R,11S,15S)-2,15-dimethyl-14-(pyridin-3-yl)tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-7,13-dien-5-ol, (3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-pyridin-3-yl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-ol, ABIRATERONE (USP IMPURITY), ABIRATERONE [USP IMPURITY], (3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-(pyridin-3-yl)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol., Abiraterone [INN:BAN], abirateronum, Abiraterona, Abiraterone- Bio-X, Androsta-5,16-dien-3-ol, 17-(3-pyridinyl)-, (3b)-, ABIRATERONE [MI], ABIRATERONE [INN], ABIRATERONE [VANDF], CB 7630 [as acetate], SCHEMBL61108, ABIRATERONE [WHO-DD], MLS006010235, GTPL6745, BDBM25458, EX-A106, L02BX03, GZOSMCIZMLWJML-VJLLXTKPSA-N, DTXCID501021626, NSC749226, s1123, AKOS005146525, AM84498, CS-0156, DB05812, ES-0045, NSC-749226, AC-25764, BA164060, HY-70013, SMR002530050, 17-(3-Pyridyl)androsta-5.16-dien-3beta-ol, A24884, EN300-311691, AB01274738-01, AB01274738_02, Q321431, SR-01000941584, (3b)-17-(3-Pyridinyl)androsta-5,16-dien-3-ol, J-519524, SR-01000941584-1, BRD-K50071428-001-01-7, BRD-K50071428-001-03-3, CB-7598;17-(3-Pyridyl)androsta-5,16-dien-3beta-ol, Z2301684603, 17-(PYRIDIN-3-YL)ANDROSTA-5,16-DIEN-3.BETA.-OL, ANDROSTA-5,16-DIEN-3-OL, 17-(3-PYRIDINYL)-(3beta)-, ANDROSTA-5,16-DIEN-3-OL, 17-(3-PYRIDINYL)-(3.BETA.)-, (3aS,3bR,7S,9aR,9bS,11aS)-9a,11a-dimethyl-1-(pyridin-3-yl)-3H,3aH,3bH,4H,6H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-ol, Abiraterone; CB 7598; (3beta)-17-(3-Pyridinyl)androsta-5,16-dien-3-ol; 17-(3-Pyridinyl)-androsta-5,16-dien-3beta-ol" C24H31NO GZOSMCIZMLWJML-VJLLXTKPSA-N (3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-pyridin-3-yl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-ol n.a. n.a. No Yes No No No No PMDBD2000014 Sulphinpyrazone Therapeutic Substance anti-inflammatory n.a. n.a. n.a. n.a. D03DEI 5342 n.a. n.a. "sulfinpyrazone, 57-96-5, Sulphinpyrazone, Anturane, (+/-)-SULFINPYRAZONE, Sulfinpyrazon, Anturan, Diphenylpyrazone, Sulfoxyphenylpyrazolidine, Anturanil, Anturidin, Enturen, Anturano, 1,2-Diphenyl-4-(2-(phenylsulfinyl)ethyl)pyrazolidine-3,5-dione, USAF GE-13, Sulfinpyrazine, Sulfinpyrazonum, Anturen, Enturan, NSC 75925, Sulfinpirazona, 4-[2-(benzenesulfinyl)ethyl]-1,2-diphenylpyrazolidine-3,5-dione, G 28315, Anturane (TN), Sulfinpyrazonum [INN-Latin], 4-(Phenylsulfoxyethyl)-1,2-diphenyl-3,5-pyrazolidinedione, Sulfinpirazona [INN-Spanish], 1,2-Diphenyl-4-(2''-phenylsulfinethyl)-3,5-pyrazolidinedione, sufinpyrazone, suphinpyrazone, CHEBI:9342, HSDB 3396, 1,2-Diphenyl-3,5-dioxo-4-(2-phenylsulfinylethyl)pyrazolidine, UNII-V6OFU47K3W, 4-(2-Benzenesulfinylethyl)-1,2-diphenylpyrazolidine-3,5-dione, 3,5-Pyrazolidinedione, 1,2-diphenyl-4-(2-(phenylsulfinyl)ethyl)-, EINECS 200-357-4, V6OFU47K3W, NSC-75925, BRN 0713597, G-28315, DTXSID0023618, G 28,315, NSC75925, 1,2-Diphenyl-4-(2-(phenylsulfinyl)ethyl)-3,5-pyrazolidinedione, 1,2-Diphenyl-4-[2-(phenylsulfinyl)ethyl]-3,5-pyrazolidinedione, 1,2-Diphenyl-3,5-dioxo-4-(2''-phenyl-sulfinyl-aethyl)-pyrazolidin, Diphenylpyrazone;G-28315, DTXCID003618, 3,5-Pyrazolidinedione, 1,2-diphenyl-4-[2-(phenylsulfinyl)ethyl]-, Sulfoxyphenylpyrazolidin, Sulfinpyrazone [USP:INN:BAN:JAN], Apo-Sulfinpyrazone, CAS-57-96-5, NCGC00016255-01, 1,2-diphenyl-4-[2-(phenylsulfinyl)ethyl]pyrazolidine-3,5-dione, Sulfinpyrazonum (INN-Latin), Sulfinpirazona (INN-Spanish), SULFINPYRAZONE (MART.), SULFINPYRAZONE [MART.], SULFINPYRAZONE (USP-RS), SULFINPYRAZONE [USP-RS], SULFINPYRAZONE (EP IMPURITY), Sulfinpyrazone (USP:INN:BAN:JAN), SULFINPYRAZONE [EP IMPURITY], SULFINPYRAZONE (EP MONOGRAPH), SULFINPYRAZONE (USP IMPURITY), SULFINPYRAZONE [EP MONOGRAPH], SULFINPYRAZONE [USP IMPURITY], SMR000058991, sulfinpyrazone (SPZ), SR-01000003152, sulfinpirazone, Prestwick_455, 1,2-Diphenyl-3,5-dioxo-4-(2''-phenyl-sulfinyl-aethyl)-pyrazolidin [German], (-+)-sulfinpyrazone, Spectrum_001022, Prestwick0_000290, Prestwick1_000290, Prestwick2_000290, Prestwick3_000290, Spectrum2_001324, Spectrum3_000590, Spectrum4_000845, Spectrum5_000984, SULFINPYRAZONE [MI], SULFINPYRAZONE [INN], SULFINPYRAZONE [JAN], BIDD:PXR0096, SCHEMBL34421, BSPBio_000200, BSPBio_002040, KBioGR_001449, KBioSS_001502, MLS000028565, MLS001074941, DivK1c_000090, SPECTRUM1500554, SULFINPYRAZONE [VANDF], SPBio_001447, SPBio_002419, BPBio1_000220, GTPL5826, Sulfinpyrazone (JAN/USP/INN), SULFINPYRAZONE [WHO-DD], HMS500E12, KBio1_000090, KBio2_001502, KBio2_004070, KBio2_006638, KBio3_001540, M04AB02, NINDS_000090, 1,2-Diphenyl-4-(phenylsulfinylethyl)-3,5-pyrazolidinedione, HMS1568J22, HMS1921C09, HMS2092K11, HMS2095J22, HMS2233H11, HMS3259I06, HMS3371B22, HMS3712J22, HMS3885F12, Pharmakon1600-01500554, BCP05344, HY-B1271, SULFINPYRAZONE [ORANGE BOOK], Sulfinpyrazone for system suitability, Tox21_110331, 4-[2-(benzenesulfinyl)ethyl]-1,2-diphenyl-pyrazolidine-3,5-dione, BDBM50237626, CCG-39262, MFCD00057279, NSC757332, s4628, AKOS015913283, Tox21_110331_1, DB01138, DS-6609, NC00539, NSC-757332, IDI1_000090, (invertedexclamationmarkA)-Sulfinpyrazone, NCGC00016255-02, NCGC00016255-03, NCGC00016255-04, NCGC00016255-05, NCGC00016255-06, NCGC00016255-07, NCGC00016255-10, NCGC00018267-01, NCGC00023932-03, NCGC00023932-04, AC-13602, AC-32767, (+/-)-Sulfinpyrazone, analytical standard, SBI-0051528.P003, WLN: T5VNNV EHJ BR& CR& E2SO&R, AB00052103, CS-0013052, NS00004052, U0114, 4-(Phenylsulfoxyethyl)-1,5-pyrazolidinedione, C07317, D00449, EN300-124005, H10364, 3, 1,2-diphenyl-4-[2-(phenylsulfinyl)ethyl]-, AB00052103_13, A869550, Q3790542, SR-01000003152-2, SR-01000003152-4, W-105427, BRD-A36217750-001-05-6, BRD-A36217750-001-09-8, Z1557407327, Sulfinpyrazone, European Pharmacopoeia (EP) Reference Standard, 1,2-di(phenyl)-4-(2-phenylsulfinylethyl)pyrazolidine-3,5-dione, 1,2-diphenyl-4-[2-(phenylsulfinyl)-ethyl]-pyrazolidine-3,5-dione, Sulfinpyrazone, United States Pharmacopeia (USP) Reference Standard, Sulfinpyrazone for system suitability, European Pharmacopoeia (EP) Reference Standard, Sulfinpyrazone; 1,2-diphenyl-4-(2-phenylsulphinylethyl)pyrazolidine-3,5-dione;(+/-)-Sulfinpyrazone" C23H20N2O3S MBGGBVCUIVRRBF-UHFFFAOYSA-N 4-[2-(benzenesulfinyl)ethyl]-1,2-diphenylpyrazolidine-3,5-dione n.a. Uricosuric Agents No Yes No No No No PMDBD2000015 Anti-cytotoxic T-lymphocyte-associated antigen 4(CTLA-4) n.a. negative regulators of T cell proliferation and functions n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD2000016 PD-1 inhibitors n.a. unknown n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD2000017 Anti-axis programmed cell death protein 1 (PD-1) and its ligand (PD-L1) n.a. immune checkpoint repressing T cell response n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD2000018 Gliadin n.a. compound n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD2000019 Methamphetamine Therapeutic Substance psychostimulant and sympathomimetic n.a. n.a. n.a. n.a. D0P6UB 10836 n.a. n.a. METHAMPHETAMINE, Metamfetamine, d-Deoxyephedrine, d-Desoxyephedrine, d-Methamphetamine, Methylamphetamine, d-N-Methylamphetamine, Metamphetamine, d-Methylamphetamine, N-Methylamphetamine, d-Phenylisopropylmethylamine, (S)-Methamphetamine, D-1-Phenyl-2-methylaminopropane, Norodin, (S)-Methylamphetamine, (+)-Methylamphetamine, d-(S)-Methamphetamine, Metamfetamina, Metamfetaminum, Methyl-beta-phenylisopropylamine, (+)-N-Methylamphetamine, 537-46-2, (+)-(S)-Deoxyephedrine, (S)-(+)-Deoxyephedrine, 1-Phenyl-2-methylaminopropane, Metanfetamina, Desyphed, S-(+)-Methamphetamine, (2S)-N-methyl-1-phenylpropan-2-amine, (+)-methamphetamine, (S)-N,alpha-Dimethylbenzeneethanamine, D-N,alpha-dimethylphenethylamine, Crank, Methamphetaminum, Meth, Crystal Meth, Metamfetamine [INN], (+)-2-(N-Methylamino)-1-phenylpropane, Metamfetaminum [INN-Latin], Metamfetamina [INN-Spanish], Metanfetamina [INN-Spanish], Methamphetaminum [INN-Latin], (+)-N,alpha-Dimethylphenethylamine, dextromethamphetamine, D-1-Phenyl-2-methylaminopropan, (+)-N,alpha-Dimethyl-beta-phenylethylamine, Meth (Street Name), N-Methyl-beta-phenylisopropylamine, 1-Phenyl-2-methylamino-propan [German], (+)-(S)-N-alpha-Dimethylphenethylamine, Metamfetaminum [Latin], d-1-Phenyl-2-methylaminopropan [German], 2S-(+)-Methamphetamine, (S)-(+)-Methamphetamine, (alphaS)-N,alpha-dimethylbenzeneethanamine, ICE [Street Name], N-Methyl-beta-phenylisopropylamin [German], Crank [Street Name], Speed [Street Name], NSC 25115, CHEBI:6809, HSDB 3359, (s)-phenylmethylaminopropane, EINECS 208-668-7, Crystal Meth [Street Name], NSC-25115, (S)-N,alpha-Dimethylbenzeneethanoamine, UNII-44RAL3456C, (S)-(+)-N,alpha,dimethylphenethylamine, Metamfetamine (INN), Phenethylamine, N,alpha-dimethyl-, (+)-, 44RAL3456C, Benzeneethanamine, N,alpha-dimethyl-, (S)-, Methyl-.beta.-phenylisopropylamine, d-N,.alpha.-Dimethylphenethylamine, Stimulex, Speed, Benzeneethanamine, N,alpha-dimethyl-, (alphaS)-, J6.362B, DTXSID8037128, Desoxyephedrine hydrochloride, 1-Phenyl-2-methylamino-propan, Crank (Street Name), ICE (Street Name), Speed (Street Name), N-Methyl-beta-phenylisopropylamin, Metamfetaminum (Latin), Methamphetaminum [JP], Metanfetamina [Spanish], Metamfetaminum (INN-Latin), Crystal Meth (Street Name), Metamfetamina (INN-Spanish), Metanfetamina (INN-Spanish), Methamphetaminum (INN-Latin), N Methylamphetamine, N-Methyl-1-phenyl-2-propanamine, (+ )-Methylamphetamine, Benzeneethanamine, N,alpha-dimethyl-, (+)-, DEA No. 1105, B40, metamfetamine racemate, Methamphetamine (MA), Benzeneethanamine, N,.alpha.-dimethyl-, (S)-, Phenethylamine, N,.alpha.-dimethyl-, (S)-(+)-, Epitope ID:178090, intra-venous methamphetamine, Phenethylamine, N,alpha-dimethyl-, (S)-(+)-, Benzeneethanamine,.alpha.-dimethyl-, (S)-, d-N,a-dimethylphenethylamine, METHAMPHETAMINE [MI], SCHEMBL42615, Phenethylamine,.alpha.-dimethyl-, (S)-(+)-, METHAMPHETAMINE [HSDB], METAMFETAMINE [WHO-DD], METHAMPHETAMINE [VANDF], CHEMBL1201201, DTXCID6017128, WLN: 1MY1&1R -D, N06BA03, N,I+/--Dimethyl-phenethyl amine, Desyphed hydrochloride (Salt/Mix), NSC25115, N-Methyl-1-phenyl-2-propanamine #, BDBM50359499, PDSP1_001404, PDSP1_001405, PDSP2_001388, PDSP2_001389, (+)-N,.alpha.-Dimethylphenethylamine, (S)-N-methyl-1-phenylpropan-2-amine, DB01577, Desoxyephedrine hydrochloride (Salt/Mix), methyl[(2S)-1-phenylpropan-2-yl]amine, Phenethylamine,.alpha.-dimethyl-, (+)-, (+)-(S)-N-.alpha.-Dimethylphenethylamine, Benzeneethanamine,.alpha.-dimethyl-, (+)-, NS00000412, Phenethylamine, N,.alpha.-dimethyl-, (+)-, Benzeneethanamine, N,.alpha.-dimethyl-, (+)-, C07164, D08187, (+)-N,.alpha.-Dimethyl-.beta.-phenylethylamine, Q191924, Phenethylamine, N,alpha-dimethyl-, (S)-(+)- (8CI), Benzeneethanamine, N,alpha-dimethyl-, (alphaS)- (9CI), (+)-N,.alpha.-Dimethylphenethylamine hydrochloride (Salt/Mix) C10H15N MYWUZJCMWCOHBA-VIFPVBQESA-N (2S)-N-methyl-1-phenylpropan-2-amine Ovation Pharma Central Nervous System Stimulants No Yes No No No No PMDBD2000020 Hydrocortisone acetate Therapeutic Substance immune, inflammatory, and neoplastic conditions 3/3/1950 DB14539 n.a. D00165 n.a. 5744 n.a. n.a. "hydrocortisone acetate, 50-03-3, Cortisol 21-acetate, Hydrocortisone 21-acetate, Cortell, Cortifoam, Cortef acetate, Cortisol acetate, Lanacort, Hydrocortisat, Hydrocortistab, Abbocort, Bambicort, Biocortar, Chemysone, Cortacream, Hydrosone, Pabracort, Resicort, Cortaid, Cortes, Dricort, Mysone, Cortril acetate, Aceto-cort, Micort-hc, Berlison F, Hycortole acetate, Collusul-HC, Hysone-A, Carmol HC, Hemsol-HC, Orabase HCA, Hydrin-2, Compound F acetate, Epifoam, Lenirit, Sintotrat, Velopural, Cortril acetate-AS, Wycort, Isopto-Hydrocortisone, Acetate-AS, Eye-Cort, Hydroxycorticosterone acetate, Glycocortison, Hydrocortison, Hydrocortone acetate, Idrocortigamma, Sagittacortin, Alfacorton, Allocort, Berlison, Cortiderm, Cortidro, Cortiform, Cortimycine, Cortioftal, Derminovag, Fenitral, Hipokort, Hydrison, Idrocort, Iracetisone, Medithane, Ophticor, Pannocort, Sanadermil, Supralef, Urecortyn, Cortic, Ebenol, Hyderm, Latimit, Corti, Efzem, Korti, Paro, Posterine Corte, Siguent Hycor, Acepolcort-H, Crema transcutan, Ekzemsalbe F, Corti Selbe, Hydrosone-A, Cortisol, 21-acetate, Anusol-HC, Hydriocort von ct, Squibb-HC, Hycor Eye Oitment, Soenol Hydrocortison, Hydrocortison Streuli, Idrocortisone Acetano, Colifoam, Hydrocal, Dermosa hidrocortisona, Ala scalp, Oft Cusi Hidrocortisona, U-CORT, 17-Hydroxycorticosterone-21-acetate, NSC 741, NSC-741, 21-O-acetylcortisol, 17-alpha-Hydroxycorticosterone acetate, Hydro-Adreson [inj.], CHEBI:17609, Corticosterone, 17-hydroxy-, 21-acetate, EINECS 200-004-4, Hydrocortisoni acetas, UNII-3X7931PO74, AI3-26389, MFCD00037714, 3X7931PO74, 11-beta,17-alpha-Dihydroxy-21-acetoxypregesterone, MLS000069734, 17-Hydroxycorticosterone acetate, 21-Acetoxy-11-beta,17-alpha-dihydroxypregn-4-ene-3,20-dione, Pregn-4-ene-3,20-dione, 11beta,17,21-trihydroxy-, 21-acetate, EC 200-004-4, Pregn-4-ene-3,20-dione, 11-beta,17,21-trihydroxy-, 21-acetate, Pregn-4-ene-3,20-dione, 21-(acetoxy)-11,17-dihydroxy-, (11-beta)-, Hydrocortisone acetate [USP:BAN:JAN], 17.alpha.-Hydroxycorticosterone acetate, Hydro-Adreson (inj.), SMR000058178, 17.alpha.-Hydrocorticosterone-21-acetate, Pregn-4-ene-3,20-dione, 21-(acetyloxy)-11,17-dihydroxy-, (11beta)-, U-CORT COMPONENT HYDROCORTISONE ACETATE, EPIFOAM COMPONENT HYDROCORTISONE ACETATE, Pregn-4-ene-3,20-dione, 21-(acetyloxy)-11,17-dihydroxy-, (11.beta.)-, PRAMOSONE COMPONENT HYDROCORTISONE ACETATE, CARMOL HC COMPONENT HYDROCORTISONE ACETATE, COR-OTICIN COMPONENT HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE COMPONENT OF EPIFOAM, HYDROCORTISONE ACETATE COMPONENT OF U-CORT, NEO-CORTEF COMPONENT HYDROCORTISONE ACETATE, OPHTHOCORT COMPONENT HYDROCORTISONE ACETATE, COLY-MYCIN S COMPONENT HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE COMPONENT OF CARMOL HC, HYDROCORTISONE ACETATE COMPONENT OF COR-OTICIN, HYDROCORTISONE ACETATE COMPONENT OF NEO-CORTEF, HYDROCORTISONE ACETATE COMPONENT OF OPHTHOCORT, HYDROCORTISONE ACETATE COMPONENT OF PRAMOSONE, PROCTOFOAM HC COMPONENT HYDROCORTISONE ACETATE, TERRA-CORTRIL COMPONENT HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE COMPONENT OF COLY-MYCIN S, HYDROCORTISONE ACETATE COMPONENT OF PROCTOFOAM HC, HYDROCORTISONE ACETATE COMPONENT OF TERRA-CORTRIL, 11beta,17-dihydroxy-3,20-dioxopregn-4-en-21-yl acetate, Bacicoline, 11beta,17,21-trihydroxypregn-4-ene-3,20-dione, 21-acetate, 11beta,17alpha,21-Trihydroxy-4-pregnene-3,20-dione 21-acetate, CHLOROMYCETIN HYDROCORTISONE COMPONENT HYDROCORTISONE ACETATE, Corticaine Cream, HYDROCORTISONE ACETATE COMPONENT OF CHLOROMYCETIN HYDROCORTISONE, Clear-Aid, Cortisporin Cream, HYDROCORTISONE ACETATE (MART.), HYDROCORTISONE ACETATE [MART.], 53187-58-9, HYDROCORTISONE ACETATE (USP-RS), Hydrocortisone acetate (USP:BAN:JAN), HYDROCORTISONE ACETATE [USP-RS], SMR000653536, HYDROCORTISONE ACETATE (EP IMPURITY), HYDROCORTISONE ACETATE [EP IMPURITY], HYDROCORTISONE ACETATE (EP MONOGRAPH), HYDROCORTISONE ACETATE [EP MONOGRAPH], HYDROCORTISONE ACETATE (USP MONOGRAPH), HYDROCORTISONE ACETATE [USP MONOGRAPH], HYDROCORTISONE IMPURITY C (EP IMPURITY), HYDROCORTISONE IMPURITY C [EP IMPURITY], Hydrocortisone-21-acetate, DTXCID0028612, 21-(Acetyloxy)-11,17-dihydroxypregn-4-ene-3,20-dione, Colofoam, Cortucid, Efcolin, Cordes, Nucort, Roosin, Pregn-4-ene-3,20-dione, 11,17,21-trihydroxy-, 21-acetate, ZCortUltra, Zee Hydrocream, Cortisil Mdx, Hepacort Plus, ZCort, Hair Sanity, Barquinol HC, Gentisone HC, Rectacort-HC, Fucidin H, Genticin HC, Hemmorex-HC, CaldeCORT, Gppe Foam Aero, Gppe Ear Susp, Gppe Eye Crm, Hc45 Hydrocort, Cortifoam (TN), Poli-A, component of Protef, HairSanity Step 1, Xpect Hydrocortisone, Neomed Pharmaceutical, Protef (Salt/Mix), hydrocortisone-acetate, Epifoam (Salt/Mix), Chloromycetin Hydrocortisone Ophthalmic, Genuine Hydrocortisone, Mantadil (Salt/Mix), Chloromycetin Hydrocort, Gadaderm Hydrocortisone, U-cort (TN), CAREALL Hydrocortisone, Cortisol- 21-acetate, Bacicoline (Salt/Mix), Neobacimyx (Salt/Mix), component of Neo-Cortef, Clear-Aid (Salt/Mix), Opera_ID_774, Vanicream HC Anti-Itch, Hydrocortisone (acetate), Neo-Cortef (Salt/Mix), Hydrocortisone Acetate 1%, Aftate Hydrocortisone Cream, Hc45, Terra-Cortril (Salt/Mix), Immediate ComfortBioelements, Lidamantle-HC (Salt/Mix), Thompson Hydrocortisone 1%, ProctoFoam-HC (Salt/Mix), SCHEMBL7419, Proctocream-HC (Salt/Mix), CHEMBL1091, DOG MX-HYDROCORTISONE, Ancalima Hydrocortisone Cream, Corticaine Cream (Salt/Mix), MLS001076491, MLS002207225, MLS002548890, Cortisporin Cream (Salt/Mix), Medi-First 1% Hydrocortisone, Medi-First Hydrocortisone 1%, American Safety and First Aid, Green Guard Hydrocortisone 1%, Hair SanityHair Sanity Part I, MEGxm0_000464, NSC741, Coly-Mycin S Otic (Salt/Mix), MySimplePetLab Itchy Ear Relief, ACon0_000402, ACon1_000363, ADVANCED ANTI-ITCH THERAPY, DTXSID20962156, HMS2090M06, HMS2230H03, HMS2235G21, HMS3259E05, HMS3714D04, Medi-First Plus Hydrocortisone 1%, 42016-02-4, HY-B1183, Hydrocortisone acetate (JP17/USP), HYDROCORTISONE ACETATE [JAN], 17-Hydroxycorticosterone 21-acetate, BDBM50474607, HYDROCORTISONE ACETATE [INCI], LMST02030093, s5501, HYDROCORTISONE ACETATE [VANDF], 17-Hydroxycorticosterone, 21-acetate, AKOS015919714, CAREALL HydrocortisoneMaximum Strength, PREDNISOLONE ACETATE IMPURITY A, CCG-220891, CS-4792, DB14539, HYDROCORTISONE ACETATE [WHO-DD], HYDROCORTISONE ACETATE [WHO-IP], KS-1070, NC00457, HYDROCORTISONE 21-ACETATE [MI], NCGC00021277-03, [2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate, HYDROCORTISONE ACETATE [GREEN BOOK], HYDROCORTISONE ACETATE [ORANGE BOOK], Hydrocortisone 21-acetate, >=98% (HPLC), HYDROCORTISONI ACETAS [WHO-IP LATIN], NS00008477, PREDNISOLONE ACETATE IMPURITY A [EP], EN300-50291, Hydrocortisone acetate for peak identification, Hydrocortisone AcetateAntipruritic (Anti-Itch), Anti-Itch Vulva Cream 1 Hydrocortisone Acetate, C02821, D00165, D97703, AB00430024-17, A827940, Biocorneum HC Advanced Scar Supervision Anti-itch, Chloromycetin Hydrocortisone Ophthalmic (Salt/Mix), SR-01000000170, 11.beta.17.alpha.-Dihydroxy-21-acetoxypregesterone, BIOCORNEUM ADVANCED SCAR TREATMENT ANTI-ITCH, Hydrocortisone 21-acetate, Sigma Reference Standard, Q-201212, SR-01000000170-3, 11.beta.,17.alpha.-Dihydroxy-21-acetoxypregesterone, BRD-K11612998-001-01-6, Q27102474, 21-Acetoxy-4-pregnene-11beta,17alpha-diol-3,20-dione, Hydrocortisone 21-acetate, tested according to Ph.Eur., PROMIKA ANTI-ITCH HYDROCORTISONEFOR CATS AND DOGS, Z600425184, 21-Acetoxy-11.beta.,17-dihydroxypregn-4-en-3,20-dione, 21-Acetoxy-11.beta.,17-dihydroxypregn-4-ene-3,20-dione, Hydrocortisone 21-acetate, meets USP testing specifications, Pregn-4-ene-3, 11.beta.,17,21-trihydroxy-, 21-acetate, Well and Good Relieve Itching and Soothe Skin Irritations, 11beta,17,21-Trihydroxypregn-4-ene-3,20-dione 21-acetate, 4-Pregnene-11beta,17alpha,21-triol-3,20-dione 21-acetate, Hydrocortisone 21-acetate, VETRANAL(TM), analytical standard, HYDROCORTISONE SODIUM SUCCINATE IMPURITY B [EP IMPURITY], Vagisil Anti-itch Creme Maximum Strength Sensitive Skin Formula, WLN: L E5 B666 OV MUTJ A CQ E FV1OV1 FQ -B&ACEF, (11beta)-21-Acetyloxy)-11,17-dihydroxypregn-4-ene-3,20-dione, 21-Acetoxy-11.beta.,17.alpha.-dihydroxypregn-4-ene-3,20-dione, 21-Acetoxy-11.beta.17.alpha.-dihydroxypregn-4-ene-3,20-dione, Hydrocortisone 21-acetate, Antibiotic for Culture Media Use Only, HYDROCORTISONE HYDROGEN SUCCINATE IMPURITY B [EP IMPURITY], Pregn-4-ene-3, 21-(acetyloxy)-11,17-dihydroxy-, (11.beta.)-, Pregn-4-ene-3,20-dione, 11.beta.,17,21-trihydroxy-, 21-acetate, 11,17-Dihydroxy-3,20-dioxopregn-4-en-21-yl acetate, (11.beta.)-, 11.beta.,17.alpha.,21-Trihydroxypregn-4-ene-3,20-dione 21-acetate, Hydrocortisone acetate, British Pharmacopoeia (BP) Reference Standard, Hydrocortisone acetate, European Pharmacopoeia (EP) Reference Standard, Hydrocortisone acetate, United States Pharmacopeia (USP) Reference Standard, Pregn-4-ene-3,20-dione, 21-(acetoxy)-11,17-dihydroxy-, (11-.beta.)-, Hydrocortisone Acetate, Pharmaceutical Secondary Standard; Certified Reference Material, [2-[(8S,9S,10R,11S,13S,14S,17R)-10,13-dimethyl-11,17-bis(oxidanyl)-3-oxidanylidene-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxidanylidene-ethyl] ethanoate, 2-[(1R,3aS,3bS,9aR,9bS,10S,11aS)-1,10-dihydroxy-9a,11a-dimethyl-7-oxo-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-1-yl]-2-oxoethyl acetate, acetic acid [2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] ester, Hydrocortisone acetate for peak identification, European Pharmacopoeia (EP) Reference Standard" C23H32O6 ALEXXDVDDISNDU-JZYPGELDSA-N [2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate n.a. n.a. No Yes No No No No PMDBD2000021 Chloroacetic acid n.a. Antioxidant n.a. n.a. n.a. n.a. n.a. 300 n.a. NPC158994 chloroacetic acid, Monochloroacetic acid, 79-11-8, 2-chloroacetic acid, Chloracetic acid, Chloroethanoic acid, Acetic acid, chloro-, Acide chloracetique, Monochloroethanoic acid, Monochloracetic acid, Monochloorazijnzuur, Monochloressigsaeure, Acidomonocloroacetico, 2-chloro-acetic acid, Acide monochloracetique, Chloroacetic acid, solid, Acide chloroacetique, Kyselina chloroctova, Acetocaustin, Chloroacetic, 2-chloro-ethanoic acid, Caswell No. 179B, Chloroacetic acid [BSI:ISO], Acetic acid, 2-chloro-, .alpha.-Chloroacetic acid, NSC 142, Monochloorazijnzuur [Dutch], NCI-C60231, Acide chloracetique [French], Kyselina chloroctova [Czech], monochloro acetic acid, Monochloressigsaeure [German], Acide chloroacetique [French], alpha-Chloroacetic acid, Acidomonocloroacetico [Italian], CCRIS 2117, HSDB 939, Acide monochloracetique [French], Chloroacetic acid, molten, Monochloroacetic acid [BSI:ISO], Acide chloracetique [ISO-French], Chloroacetic acid (80% or less), chloro-acetic acid, EINECS 201-178-4, Acetocaustin (TN), EPA Pesticide Chemical Code 279400, UNII-5GD84Y125G, BRN 0605438, CH2ClCOOH, DTXSID4020901, CHEBI:27869, AI3-25035, NSC-142, 5GD84Y125G, CHLOROACETIC-ACID, alpha-chloro-acetic acid, DTXCID20901, Monochloracetic acidacide monochloracetique, Chloroacetic acid, liquid, EC 201-178-4, 4-02-00-00474 (Beilstein Handbook Reference), MFCD00002683, CHLOROACETIC ACID CRYSTALLINE, Chloroacetic acid, molten [UN3250] [Poison], Chloroacetic acid, solid [UN1751] [Poison], Acide chloracetique (ISO-French), MONOCHLOROACETIC ACID (MART.), MONOCHLOROACETIC ACID [MART.], sJPhLQDIKTp@, MCAA, UN1750, UN1751, UN3250, Chloressigsauer, Chlorethansauere, CHLOROACETIC ACID, ACS, cloroacetic acid, chloro acetic acid, Monochloor azijnzuur, R3W, ClCH2COOH, monochloro-acetic acid, Acidomono chloroacetico, Acide monochloroacetique, Chloroacetic acid, 99%, Chloroacetic acid, solid [UN1751] [Poison], bmse000367, WLN: QV1G, Chloroacetic acid, molten [UN3250] [Poison], Chloroacetic acid, >=99%, NCIOpen2_002217, Chloroacetic acid, ACS grade, MLS001065621, BIDD:ER0630, CHEMBL14090, CHLOROACETIC ACID [MI], NSC142, CHLOROACETIC ACID [ISO], Chloroacetic acid, solid (dot), CHLOROACETIC ACID [HSDB], CHLOROACETIC ACID [INCI], FOCAUTSVDIKZOP-UHFFFAOYSA-, CHLOROACETIC ACID [VANDF], BCP20585, NSC42970, STR00326, Tox21_201114, LMFA01090068, MONOCHLOROACETIC ACID [VANDF], NSC-42970, Chloroacetic acid, analytical standard, AKOS000118920, MONOCHLOROACETIC ACID [WHO-DD], UN 1751, CAS-79-11-8, NCGC00091473-01, NCGC00091473-02, NCGC00091473-03, NCGC00258666-01, SMR000568484, Chloroacetic acid, for synthesis, 99.0%, Chloroacetic acid, ACS reagent, >=99.0%, Chloroacetic acid, purum, >=97.0% (T), C2123, NS00003112, Chloroacetic acid, puriss., >=99.0% (T), EN300-16767, C06755, D07677, Chloroacetic acid, JIS special grade, >=99.0%, Q409013, J-520023, Chloroacetic acid, PESTANAL(R), analytical standard, F2190-0289, InChI=1/C2H3ClO2/c3-1-2(4)5/h1H2,(H,4,5), Chloroacetic acid 1000 microg/mL in Methyl-tert-butyl ether C2H3ClO2 FOCAUTSVDIKZOP-UHFFFAOYSA-N 2-chloroacetic acid n.a. n.a. No Yes No No No No PMDBD2000022 Doxifluridine Therapeutic Substance deglycosylation 5/9/3094 DB12947 n.a. D01309 D03KXY 18343 17322 n.a. doxifluridine, 5''-Deoxy-5-fluorouridine, 5-fluoro-5''-deoxyuridine, Furtulon, 3094-09-5, 5''-Dfur, Flutron, Uridine, 5''-deoxy-5-fluoro-, Doxifluridina, Doxifluridinum, Fulturon, Ro 219738, Ro 21-9738, 5''dFUrd, 1-((2R,3R,4S,5R)-3,4-dihydroxy-5-methyltetrahydrofuran-2-yl)-5-fluoropyrimidine-2,4(1H,3H)-dione, 1-(beta-D-5-Desoxyribofuranoxyl)-5-fluoruracil, CHEMBL1130, V1JK16Y2JP, DTXSID2022967, CHEBI:31521, NSC-758890, NCGC00093926-03, RO-219738, 5''FDUR, DTXCID602967, AMC 0101, 5''-Doxifluridine, 5''-dFUrd, Furtulon (TN), 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyl-tetrahydrofuran-2-yl]-5-fluoro-pyrimidine-2,4-dione, SMR000326811, CAS-3094-09-5, Uridine-5''-deoxy-5-fluoro-, SR-01000075886, Doxifluridine [INN:JAN], 5-DFUR, Doxifluridinum [INN-Latin], Doxifluridina [INN-Spanish], MFCD00866530, EINECS 221-440-1, Doxifluridine (5-Fluoro-5''-deoxyuridine), DOXIFLURIDINE [MI], 5-Deoxy-5''-fluorouridine, 5-Fluoro-5`-deoxyuridine, UNII-V1JK16Y2JP, DOXIFLURIDINE [INN], DOXIFLURIDINE [JAN], SCHEMBL8094, Doxifluridine (JP17/INN), Lopac0_000537, MLS001332579, MLS001332580, MLS002172440, MLS002207077, DOXIFLURIDINE [MART.], DOXIFLURIDINE [WHO-DD], HMS2090C22, HMS2231I05, HMS3261L15, AMY13408, HY-B0021, Tox21_111231, Tox21_500537, BDBM50132295, s2045, CAPECITABINE IMPURITY B (USP), AKOS015852921, AKOS015896821, Tox21_111231_1, CCG-204627, CS-1270, DB12947, KS-5065, LP00537, NSC 758890, SDCCGSBI-0050520.P002, NCGC00093926-01, NCGC00093926-02, NCGC00093926-05, NCGC00093926-11, NCGC00261222-01, Ro-21-9738, BP-58654, SRI-11552-08, SRI-11552_09, 5''''-Deoxy-5-Fluorouridine (5''''-Dfur), EU-0100537, NS00046999, D01309, F 8791, Q1253473, SR-01000075886-1, SR-01000075886-5, BRD-K58262659-001-09-7, 1-(.BETA.-D-5-DESOXYRIBOFURANOXYL)-5-FLUORURACIL, Capecitabine impurity B, European Pharmacopoeia (EP) Reference Standard, 1-((2R,3R,4S,5R)-3,4-dihydroxy-5-methyl-tetrahydrofuran-2-yl)-5-fluoropyrimidine-2,4(1H,3H)-dione, 1-((2R,5R)-3,4-Dihydroxy-5-methyl-tetrahydro-furan-2-yl)-5-fluoro-1H-pyrimidine-2,4-dione, 1-((4S,2R,3R,5R)-3,4-Dihydroxy-5-methyloxolan-2-yl)-5-fluoro-1,3-dihydropyrimidine-2,4-dione, 1-(5-Deoxy-beta-D-ribofuranosyl)-5-fluoropyrimidine-2,4(1H,3H)-dione (5''-Deoxy-5-fluorouridine), Furtulon, Flutron, doxyfluridine, Doxifluridina, Doxifluridinum 5''-Doxifluridine, 5''dFUrd, 5-fluoro-5''-deoxyuridine C9H11FN2O5 ZWAOHEXOSAUJHY-ZIYNGMLESA-N 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyloxolan-2-yl]-5-fluoropyrimidine-2,4-dione n.a. n.a. No Yes No No No No PMDBD2000023 Tretazicar(CB1954) n.a. chemotherapeutic n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD2000024 Banoxantrone(AQ4N) n.a. chemotherapeutic n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD2000025 Etoposide phosphate n.a. chemotherapeutic n.a. n.a. n.a. n.a. n.a. 6918092 n.a. n.a. "ETOPOSIDE PHOSPHATE, 117091-64-2, Etopofos, Etophos, Etopophos, Vepeside, Etopophos Preservative Free, BMY 40481, BMY-40481, Etoposide 4''-Phosphate, Etoposide phosphate [USAN], UNII-528XYJ8L1N, 528XYJ8L1N, VP16, Etoposide phosphate (USAN), 4''-Demethylepipodophyllotoxin 9-(4,6-O-(R)-ethylidene-beta-D-glucopyranoside), 4''-(dihydrogen phosphate), ETOPOSIDE PHOSPHATE (MART.), ETOPOSIDE PHOSPHATE [MART.], ETOPOSIDE PHOSPHATE (USP-RS), ETOPOSIDE PHOSPHATE [USP-RS], Furo(3'',4'':6,7)naphtho(2,3-d)-1,3-dioxol-6(5aH)-one, 5-(3,5-dimethoxy-4-(phosphonooxy)phenyl)-9-((4,6-O-ethylidene-beta-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-, (5R-(5alpha,5abeta,8aalpha,9beta(R*)))-, ETOPOSIDE PHOSPHATE (USP MONOGRAPH), ETOPOSIDE PHOSPHATE [USP MONOGRAPH], DTXCID6028571, etoposide-phosphate, Etopophos (TN), NCGC00185753-01, Eposin Etopophos Vepesid VP16, Etoposide Phosphate (Etopophos), CHEMBL1200645, ETOPOSIDE PHOSPHATE [MI], SCHEMBL13318053, CHEBI:135867, ETOPOSIDE PHOSPHATE [VANDF], EX-A3595, BDBM50247889, ETOPOSIDE PHOSPHATE [WHO-DD], AKOS025311200, ETOPOSIDE PHOSPHATE [ORANGE BOOK], NCGC00185753-04, AS-12896, HY-13630, CS-0007496, D04107, G12559, J-003505, Q27260984, 4''-DEMETHYLEPIPODOPHYLLOTOXIN 9-(4,6-O-(R)-ETHYLIDENE-.BETA.-D-GLUCOPYRANOSIDE), 4''-(DIHYDROGEN PHOSPHATE), FURO(3'',4'':6,7)NAPHTHO(2,3-D)-1,3-DIOXOL-6(5AH)-ONE, 5-(3,5-DIMETHOXY-4-(PHOSPHONOOXY)PHENYL)-9-((4,6-O-ETHYLIDENE-.BETA.-D-GLUCOPYRANOSYL)OXY)-5,8,8A,9-TETRAHYDRO-, (5R-(5.ALPHA.,5A.BETA.,8A.ALPHA.,9.BETA.(R*)))-, Furo[3'',4'':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 5-[3,5-dimethoxy-4-(phosphonooxy)phenyl]-9-[[4,6-O-(1R)-ethylidene-?-D-glucopyranosyl]oxy]-5,8,8a,9-tetrahydro-, (5R,5aR,8aR,9S)-; Etoposide Phosphate; Etopofos; Etopophos" C29H33O16P LIQODXNTTZAGID-OCBXBXKTSA-N [4-[(5S,5aR,8aR,9R)-5-[[(2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-methyl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-8-oxo-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[5,6-f][1,3]benzodioxol-9-yl]-2,6-dimethoxyphenyl] dihydrogen phosphate n.a. n.a. No Yes No No No No PMDBD2000026 Saponins n.a. compound n.a. n.a. n.a. n.a. n.a. 6540709 n.a. NPC490504 Saponins, beta-Aescinu, beta-Aescusan, beta-Reparil, beta Escin, beta-Aescinu [Czech], Flogencyl, Escin, beta-Aescin, beta-Escin, NSC 758653, Aescin, 11072-93-8, (2S,3S,4S,5R,6R)-6-[[(3S,4S,6aR,6bS,8R,8aR,9R,10R,14bR)-9-acetyloxy-8-hydroxy-4,8a-bis(hydroxymethyl)-4,6a,6b,11,11,14b-hexamethyl-10-[(Z)-2-methylbut-2-enoyl]oxy-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-4-hydroxy-3,5-bis[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy]oxane-2-carboxylic acid, (2S,3S,4S,5R,6R)-6-[[(3S,4S,6aR,6bS,8R,8aR,9R,10S,14bR)-9-acetyloxy-8-hydroxy-4,8a-bis(hydroxymethyl)-4,6a,6b,11,11,14b-hexamethyl-10-[(Z)-2-methylbut-2-enoyl]oxy-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-4-hydroxy-3,5-bis[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy]oxane-2-carboxylic acid, 6805-41-0, AXNVHPCVMSNXNP-ZELRDNAQSA-N, s4690, AKOS037514636, CCG-270645 C55H86O24 AXNVHPCVMSNXNP-ZELRDNAQSA-N (2S,3S,4S,5R,6R)-6-[[(3S,4S,6aR,6bS,8R,8aR,9R,10R,14bR)-9-acetyloxy-8-hydroxy-4,8a-bis(hydroxymethyl)-4,6a,6b,11,11,14b-hexamethyl-10-[(Z)-2-methylbut-2-enoyl]oxy-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-4-hydroxy-3,5-bis[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy]oxane-2-carboxylic acid n.a. n.a. No Yes No No No No PMDBD2000027 Ethanol Therapeutic Substance compound 64-17-5 DB00898 PA448073 D00068 D00AMQ 702 n.a. NPC2724 "ethanol, ethyl alcohol, alcohol, 64-17-5, grain alcohol, Methylcarbinol, Ethyl hydrate, Tecsol, Ethyl hydroxide, Algrain, Anhydrol, EtOH, Hydroxyethane, Alkohol, Jaysol S, Potato alcohol, 1-Hydroxyethane, Ethanol 200 proof, Aethylalkohol, Aethanol, Absolute ethanol, Alcool ethylique, etanol, Denatured alcohol, Denatured ethanol, Fermentation alcohol, Tecsol C, Dehydrated ethanol, Alcool etilico, Alcohol, ethyl, Alcohol, diluted, Etanolo, Jaysol, Etylowy alkohol, Alcohol dehydrated, Alkoholu etylowego, Ethyl alcohol usp, Synasol, Alcohol, anhydrous, absolute alcohol, Ethyl alcohol anhydrous, Alcohol anhydrous, Dehydrated alcohol, Ethylalcohol, Alcohol, dehydrated, Denatured alcohol CD-5, Denatured alcohol SD-1, Denatured alcohol CD-5a, Denatured alcohol SD-3a, Denatured alcohol CD-10, Denatured alcohol SD-17, Denatured alcohol SD-28, Denatured alcohol SD-30, Denatured alcohol SD-13a, Denatured alcohol SD-23a, Denatured alcohol SD-39b, Denatured alcohol SD-39c, Denatured alcohol SD-40m, Spirt, Ethanol, undenatured, SD Alchol 23-hydrogen, Alcare Hand Degermer, Alkohol [German], Aethanol [German], Etanolo [Italian], Alcohol (ethyl alcohol), Ethyl alcohol & water, 5%, Hinetoless, Ethicap, Thanol, NCI-C03134, Ethyl alcohol & water, 10%, Ethyl alcohol & water, 20%, Ethyl alcohol & water, 30%, Ethyl alcohol & water, 40%, Ethyl alcohol & water, 50%, Ethyl alcohol & water, 60%, Ethyl alcohol & water, 70%, Ethyl alcohol & water, 80%, Ethyl alcohol & water, 95%, Ethyl alcohol & water, 96%, Desinfektol EL, Ethyl alc, Ethylalcohol [Dutch], Anhydrous ethanol, Ethyl alcohol and water, Alcohol, Absolute, FEMA Number 2419, Alcohol [USP], Ethanol [JAN], Ethyl alcohol, undenatured, C2H5OH, Ethylicum, alcohol etilico, Edible alcohol, Alcohol,ethyl, Caswell No. 430, Infinity Pure, Aethylalkohol [German], HSDB 82, CCRIS 945, Anhydrous alcohol, Ethyl alcohol in alcoholic beverages, Alcohol,dehydrated, FEMA No. 2419, AI3-01706, Alcool etilico [Italian], Etylowy alkohol [Polish], Alcool ethylique [French], Ethanol, dehydrated, SY Fresh M, Alkoholu etylowego [Polish], Esumiru WK 88, SDM No. 37, NSC 85228, ALCOHOL DENAT., Anhydrol PM 4085, Alcoholum, Ethanolum, Ethyl alcohol, absolute, Ethyl alcohol, anhydrous, Ethyl alcohol (Ethanol), Ethanol Vapor, Sd alcohol, SD alcohol 23-hydrogen, Ethyl alcohol, dehydrated, Alcohol denatured, Alcohol (ethyl), SDA 3A, Ru-Tuss Hydrocodone Liquid, Alcohol, denatured, EINECS 200-578-6, Alcohol (USP), Alcohol determination--alcohol, EPA Pesticide Chemical Code 001501, ABLYSINOL, 100C.NPA, IMS 99, Absolute ethyl alcohol, DTXSID9020584, UNII-3K9958V90M, CHEBI:16236, Punctilious ethyl alcohol, 3K9958V90M, Ethanol Absolute, Ethanol-1-13C (9CI), DTXCID30584, HBN-1 COMPONENT ETHANOL, AVAGARD COMPONENT ALCOHOL, UNII-7528N5H79B, PM-6193-200, EC 200-578-6, ETHANOL COMPONENT OF HBN-1, ALCOHOL COMPONENT OF AVAGARD, NSC85228, NSC-85228, Ethylol, ALCOHOL (II), ALCOHOL [II], B3324, ALCOHOL (USP-RS), ALCOHOL [USP-RS], Alcohol, Grain, Ethanol Anhydrous, Ethanol; Dehydrated Alcohol, 68475-56-9, EOH, ALCOHOL, DEHYDRATED (II), ALCOHOL, DEHYDRATED [II], Sekundasprit, Ethylic alcohol, DEHYDRATED ALCOHOL (USP-RS), DEHYDRATED ALCOHOL [USP-RS], MFCD00003568, Ethanol denatured, Ethanol, Anhydrous, 42845-45-4, DEHYDRATED ALCOHOL (USP MONOGRAPH), DEHYDRATED ALCOHOL [USP MONOGRAPH], ETHANOL, ANHYDROUS (EP MONOGRAPH), ETHANOL, ANHYDROUS [EP MONOGRAPH], Lux, Ethanol (9CI), ETHANOL IN ALCOHOLIC BEVERAGES (IARC), ETHANOL IN ALCOHOLIC BEVERAGES [IARC], Ethyl Alcohol 70%, Ethyl Alcohol 75%, Ethyl Alcohol 80%, ALCOHOL 5% IN DEXTROSE 5%, dicolor, frida, handsanttizer, Activessence, Antiseptique, Applelicious, Athylalkohol, Baishichen, Cleansified, Cleanslate, Dentovations, Enovatizer, Enviropure, Freshorize, Germstarcitrus, germstarGel, germstarLuxe, Gingerbread, Handsanitizer, Handzitizer, Hygienigel, Instafresh, Kingspoint, Margaritaville, Microsilver, Professional, Sanitizetek, Sanitizing, Santotizer, Spatheraphy, Advanced, AdvancedPurell, Alchohol, Alcochol, Alcogel, Alochol, Alvaclean, Applause, Athanol, Biorell, Claires, Clensil, Cupcake, Dermokil, EcolabFacilipro, Equaline, Foamahol, Fressly, Gelclor, Gelrite, Hygenize, Hygiene, Instant, Kandesn, Kanechom, Kleanops, Livpure, livWell, Lollipop, Medisoft, Medpanol, Mermaid, Mixline, Novagel, Novogel, Novospray, Oilogic, Prosanca, Purador, Puretize, Quiclean, Rainwater, Refresher, Regimen, Rejuviel, Rubbing, SafeshaLavender, Safeway, Sanetto, Sanibeads, Sanifoam, Sanigen, Sanikit, Sanilso, Sanimep, Sanitaxe, Sanitizer, SanitizerSpray, Sanizen, Santigel, Santihand, Savvycare, SimpliSanitized, Skinact, Skininc, Softsan, Terragel, Uberliss, Unicorn, Unscented, UnscentedRefill, Vfender, Virocene, Vitalsail, Walgreens, Xanitize, 10 mg/dL Aq. Ethanol Standard Solution " C2H6O LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol n.a. Analgesics No Yes No No Yes No rxnAGORA241,rxnAGORA852,rxnAGORA1285,rxnAGORA5011,rxnAGORA5015 PMDBD2000028 L-carnitine Therapeutic Substance compound n.a. n.a. n.a. n.a. D0G8SQ 10917 n.a. NPC295832 "L-carnitine, Levocarnitine, 541-15-1, (R)-Carnitine, Carnitor, vitamin BT, (-)-Carnitine, Karnitin, (-)-L-Carnitine, L-(-)-Carnitine, Carnitene, Levocarnitina, Metina, Carnitine, (-)-, Levocarnitinum, Carnitolo, Carnovis, L-Carnitine inner salt, Lefcar, L(-)-Carnitine, Carniking, Carnilean, Carnitor SF, Levocarnitinum [Latin], Levocarnitina [Spanish], gamma-Trimethyl-beta-hydroxybutyrobetaine, (3R)-3-hydroxy-4-(trimethylammonio)butanoate, vitamin B T, Carniking 50, Carnitine, L-, gamma-Trimethyl-ammonium-beta-hydroxybutirate, bicarnesine, 1-CARNITINE, (3R)-3-hydroxy-4-(trimethylazaniumyl)butanoate, 3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt, L-gamma-trimethyl-beta-hydroxybutyrobetaine, R-(-)-3-hydroxy-4-trimethylaminobutyrate, DRG-0211, 3-carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium, 44985-71-9, EINECS 208-768-0, (R)-3-hydroxy-4-(trimethylammonio)butanoate, UNII-0G389FZZ9M, (R)-(3-Carboxy-2-hydroxypropyl)trimethylammonium hydroxide, NSC-759132, 0G389FZZ9M, CHEBI:16347, (L-3-Carboxy-2-hydroxypropyl)trimethylammonium hydroxide, inner salt, HSDB 7588, levocarnitine HCl, 1-Propanaminium, 3-carboxy-2-hydroxy-N,N,N-trimethyl-, inner salt, (R)-, 1-Propanaminium, 3-carboxy-2-hydroxy-N,N,N-trimethyl-, hydroxide, inner salt, (R)-, (3-Carboxy-2-hydroxypropyl)trimethyl-ammonium hydroxide, inner salt, CHEMBL1149, Ammonium, (3-carboxy-2-hydroxypropyl)trimethyl-, hydroxide, inner salt, L-, Carnicor, Carrier, DTXSID4023208, (-)-(R)-3-Hydroxy-4-(trimethylammonio)butyrate, L-carnitine Base, 1-Propanaminium, 3-carboxy-2-hydroxy-N,N,N-trimethyl-, hydroxide, inner salt, 1-Propanaminium, 3-carboxy-2-hydroxy-N,N,N-trimethyl-, inner salt, (2R)-, Levocarnitine [USAN:USP:INN:BAN], Oristar lch, NSC 759132, Carnitine HCl, Levocarnitinum (Latin), gamma-L-trimethyl-beta-hydroxybutyrobetaine, (2r)-3-carboxy-2-hydroxy-n,n,n-trimethyl-1-propanaminium inner salt, LEVOCARNITINE (MART.), LEVOCARNITINE [MART.], (3R)-(-)-3-Hydroxy-4-(trimethylammonio)butanoate, Levocarnitine [USAN:INN], LEVOCARNITINE (USP-RS), LEVOCARNITINE [USP-RS], LEVOCARNITINE (EP MONOGRAPH), LEVOCARNITINE [EP MONOGRAPH], L Carnitine, Levocarnitine (USAN:USP:INN:BAN), LEVOCARNITINE (USP MONOGRAPH), LEVOCARNITINE [USP MONOGRAPH], Carnitor (TN), SMR000112475, carnitine (L-form), gamma-Trimethyl-hydroxybutyrobetaine, Levocarnitine;Vitamin B(T), 3-hydroxy-4-trimethylammoniobutanoate, Levocarnil, Levocarnitin, Nefrocarnit, Carnipass, delta-carnitine, Levocarnitine (JAN/USP/INN), L-Carnitin, Carnipass 20, L-Carn, L-Carnitine,(S), 1-Propanaminium,3-carboxy-2-hydroxy-N,N,N-trimethyl-, CARNITINE HYDROCHLORIDE, DL-, LEVOCARNITINE SF, (R)-3-Hydroxy-4-trimethylammoniobutyrate, CARNITINE [MI], (R)-3-Hydroxy-4-(trimethylammonio)butyrate, bmse000211, L-CARNITINE [FCC], Levocarnitine Oral Solution, C-1985, L-Carnitin 100 microg/mL in Acetonitrile, LEVOCARNITINE [INN], LEVOCARNITINE [JAN], L-carnitine (Levocarnitine), L-CARNITINE [VANDF], LEVOCARNITINE [HSDB], LEVOCARNITINE [USAN], SCHEMBL21970, LEVOCARNITINE [VANDF], MLS001332549, MLS001332550, BIDD:GT0603, Carnitine dl-form hydrochloride, LEVOCARNITINE [WHO-DD], DTXCID903208, GTPL4780, A16AA01, HMS2093J13, HMS2267H24, Pharmakon1600-01505437, LEVOCARNITINE [ORANGE BOOK], HY-B0399, (R)-(3-Carboxy-2-hydroxypropyl)trimethylammonium hydroxide, inner salt, Ammonium, (3-carboxy-2-hydroxypropyl)trimethyl-, hydroxide,inner salt, BDBM50037268, c0049, NSC741806, NSC759132, s2388, AKOS005267245, BCP9000830, CCG-213241, DB00583, KS-1422, NSC-741806, 6-CHLORO-3-HYDROXY(1H)INDAZOLE, 3-Hydroxy-4-(trimethylammonio) butanoate, 3-hydroxy-4-trimethylammoniobutanoic acid, AS-11974, (R)-3-Hydroxy-4-trimethylammoniobutanoate, L-Carnitine inner salt, synthetic, >=98%, NS00076300, C00318, D02176, AB00919083_05, AB00919083_06, EN300-6495783, A829968, beta-Hydroxy-gamma-N,N,N-trimethylammoniobutyrate, Levocarnitine Oral Solution (Suguar Free) 1 g/10 mL, Q20735709, (3R)-3-hydroxy-4-(trimethylammonio)butanoate;L-Carnitine, R(-)-beta-Hydroxy-gamma-(N,N,N-trimethylammonio)butyrate, (-)-(R)-3-Hydroxy-4-(trimethylammonio)butyrate, Vitamin BT, Levocarnitine, European Pharmacopoeia (EP) Reference Standard, Levocarnitine, United States Pharmacopeia (USP) Reference Standard, 1-Propanaminium, 3-carboxy-2-hydroxy-N,N,N-trimethyl-, inner salt, (2R)- (9CI), Ammonium, (3-carboxy-2-hydroxypropyl)trimethyl-, hydroxide, inner salt, L- (8CI), Levocarnitine, Pharmaceutical Secondary Standard; Certified Reference Material" C7H15NO3 PHIQHXFUZVPYII-ZCFIWIBFSA-N (3R)-3-hydroxy-4-(trimethylazaniumyl)butanoate n.a. n.a. No Yes No No No No PMDBD2000029 Indicine N-oxide n.a. compound n.a. n.a. n.a. n.a. n.a. 280564 n.a. n.a. "Indicine N-oxide, 41708-76-3, INDICINE-N-OXIDE, [(7R,8R)-7-hydroxy-4-oxido-5,6,7,8-tetrahydro-3H-pyrrolizin-4-ium-1-yl]methyl (2R)-2-hydroxy-2-[(1S)-1-hydroxyethyl]-3-methylbutanoate, NSC132319, NSC 132319, NSC-132319, (+)-Indicine N-oxide, Indicin-N-oxid, Indicine, N-oxide, Indicine N-oxide (7CI); (+)-Indicine N-oxide, Indicine N-oxide, HPLC Grade, CHEMBL512655, DTXSID101315334, BDBM50480295, MFCD00866484, AKOS040758123, 1ST14184, NCI60_000712, HY-105529, CS-0026202, [(7R,8R)-7-hydroxy-4-oxido-5,6,7,8-tetrahydro-3H-pyrrolizin-4-ium-1-yl]methyl (2R)-2-hydroxy-2-[(1S)-1-hydroxyethyl]-3-methyl-butanoate, Butanoic acid, (2R,3S)-dihydroxy-2-(1-methylethyl)-(2,3,5,7a-tetrahydro-(1R)-hydroxy-1H-pyrrolizin-7-yl)methyl ester, N-oxide, Butanoic acid,3-dihydroxy-2-(1-methylethyl)- (2,3,5,7a-tetrahydro-1-hydroxy-1H-pyrrolizin-7-yl) methyl ester, N-oxide, (1R-(1.alpha.,7(2R*,3S*),7a.beta))-" C15H25NO6 DNAWGBOKUFFVMB-PZIGJSDBSA-N [(7R,8R)-7-hydroxy-4-oxido-5,6,7,8-tetrahydro-3H-pyrrolizin-4-ium-1-yl]methyl (2R)-2-hydroxy-2-[(1S)-1-hydroxyethyl]-3-methylbutanoate n.a. n.a. No Yes No No No No PMDBD2000030 L-tryptophan Therapeutic Substance amino acid n.a. n.a. n.a. n.a. D05EJG 6305 n.a. n.a. L-tryptophan, tryptophan, 73-22-3, h-Trp-oh, L-Tryptophane, (S)-Tryptophan, Tryptophane, trofan, tryptacin, Ardeytropin, Optimax, Pacitron, (2S)-2-amino-3-(1H-indol-3-yl)propanoic acid, Indole-3-alanine, Kalma, L-beta-3-Indolylalanine, L-Tryptofan, L-Trp, L-(-)-Tryptophan, 3-Indol-3-ylalanine, (-)-Tryptophan, Tryptophan (H-3), 1-beta-3-Indolylalanine, triptofano, Tryptophanum, Tryptan, Lyphan, 1beta-3-Indolylalanine, Tryptophan (VAN), Triptofano [Spanish], Tryptophanum [Latin], 1H-Indole-3-alanine, Tryptophan, L-, 2-Amino-3-indolylpropanoic acid, L(-)-Tryptophan, (L)-TRYPTOPHAN, (S)-alpha-Amino-1H-indole-3-propanoic acid, Tryptophane [French], alpha''-Amino-3-indolepropionic acid, Tryptophan [USAN:INN], L-alpha-amino-3-indolepropionic acid, EH 121, L-alpha-Aminoindole-3-propionic acid, trp, Sedanoct, (S)-alpha-Aminoindole-3-propionic acid, Trytophan-, CCRIS 617, 1H-Indole-3-alanine (VAN), HSDB 4142, Alanine, 3-indol-3-yl-, NCI-C01729, AI3-18478, L-Alanine, 3-(1H-indol-3-yl)-, 1H-Indole-3-alanine, (S)-, alpha-Amino-3-indolepropionic acid, L-, CHEBI:16828, (S)-alpha-amino-beta-(3-indolyl)-propionic acid, UNII-8DUH1N11BX, (S)-2-Amino-3-(3-indolyl)propionic acid, EINECS 200-795-6, 8DUH1N11BX, NSC 13119, Indole-3-propionic acid, alpha-amino-, 1H-Indole-3-propanoic acid, alpha-amino-, (S)-, Propionic acid, 2-amino-3-indol-3-yl-, DTXSID5021419, Lopac-T-0254, MFCD00064340, NSC-13119, Tryptophan ((-),l,s), (S)-alpha-Amino-beta-indolepropionic acid, CHEMBL54976, DTXCID801419, EC 200-795-6, (S)-2-Amino-3-(1H-indol-3-yl)propanoic acid, Tryptophanum (Latin), TRYPTOPHAN (II), TRYPTOPHAN [II], TRYPTOPHAN (MART.), TRYPTOPHAN [MART.], Htrp, l-b-3-Indolylalanine, TRYPTOPHAN (EP MONOGRAPH), TRYPTOPHAN [EP MONOGRAPH], Levotryptophan, TRYPTOPHAN (USP MONOGRAPH), TRYPTOPHAN [USP MONOGRAPH], beta-3-indolylalanine, CAS-73-22-3, Propionic acid, 2-amino-3-indol-3-yl, L-Tryptophan (9CI), Tryptophan (USP/INN), (S)-a-Amino-b-indolepropionic acid, N-ACETYLTRYPTOPHAN IMPURITY A (EP IMPURITY), N-ACETYLTRYPTOPHAN IMPURITY A [EP IMPURITY], (S)-a-Aminoindole-3-propionic acid, Alanine, 3-indol-3-yl, L-Tryptophan-13C11,15N2, (2S)-2-amino-3-(1H-indol-3-yl)propanoate, trytophan, (S)-a-Amino-1H-indole-3-propanoic acid, TRP-01, L-Trytophan, 1qaw, 80206-30-0, L-Tryptophan,(S), L-Trp-OH, 2a4m, H-L-Trp-OH, TRYPTOPHAN [MI], L-Tryptophan (JP17), TRYPTOPHAN [INN], S(-)-1-alpha-Aminoindole-3-propionic acid, TRYPTOPHAN [HSDB], TRYPTOPHAN [INCI], TRYPTOPHAN [USAN], Tryptophan (L-Tryptophan), TRYPTOPHAN [VANDF], Tryptophan, L- (8CI), bmse000050, bmse000868, bmse001017, Epitope ID:136043, T 0254, L-TRYPTOPHAN [FCC], L-TRYPTOPHAN [JAN], SCHEMBL7328, 2-Amino-3-indolylpropanoate, (S)-(-)-2-Amino-3-(3-indolyl)propionic Acid, (S)-1H-Indole-3-alanine, Lopac0_001183, GTPL717, L-TRYPTOPHAN [VANDF], MLS001056750, DivK1c_000457, L-TRYPTOPHAN [USP-RS], (s)-a-amino-b-indolepropionate, 151A3008-4CFE-40C9-AC0B-467EF0CB50EA, (S)-a-Aminoindole-3-propionate, BDBM21974, HMS501G19, KBio1_000457, N06AX02, 3-(1H-indol-3-yl)-L-Alanine, L-a-Amino-3-indolepropionic acid, NINDS_000457, alpha-Aminoindole-3-propionic acid, HMS3263N07, Pharmakon1600-01500600, 202406-50-6, HY-N0623, STR02722, (S)-alpha-Aminoindole-3-propionate, Tox21_201246, Tox21_300359, Tox21_501183, NSC757373, s3987, (s)-alpha-amino-beta-indolepropionate, L-Tryptophan, Vetec(TM), 98.5%, (S)-a-Amino-1H-indole-3-propanoate, AKOS015854052, Indoe-3-propionic acid, alpha-amino-, AM82273, CCG-205257, CS-W020011, DB00150, LP01183, NSC-757373, SDCCGSBI-0051150.P002, IDI1_000457, NCGC00015994-01, NCGC00094437-01, NCGC00094437-02, NCGC00094437-03, NCGC00094437-04, NCGC00094437-08, NCGC00254424-01, NCGC00258798-01, NCGC00261868-01, (S)-alpha-Amino-1H-indole-3-propanoate, AC-17050, BP-13286, IS_TRYPTOPHAN-2,4,5,6,7-D5, SMR000326686, TS-04426, L-Tryptophan, BioUltra, >=99.5% (NT), EU-0101183, NS00003513, T0541, (S)-Tryptophan 1H-Indole-3-alanine, (S)-, EN300-52634, C00078, D00020, L-.ALPHA.-AMINO-3-INDOLEPROPIONIC ACID, L-Tryptophan, reagent grade, >=98% (HPLC), M02943, P16427, AB00373874_05, L-Tryptophan, Vetec(TM) reagent grade, >=98%, (S)-2-amino-3-(1H-Indol-3-yl)-propionic acid, A837752, L-Tryptophan, Cell Culture Reagent (H-L-Trp-OH), Q181003, SR-01000075590, 4-(3-METHOXYANILINO)-4-OXOBUT-2-ENOICACID, SR-01000075590-1, F0001-2364, Z756440056, 1H-INDOLE-3-PROPANOIC ACID, .ALPHA.-AMINO-, (S)-, L-Tryptophan, certified reference material, TraceCERT(R), Tryptophan, European Pharmacopoeia (EP) Reference Standard, L-Tryptophan, United States Pharmacopeia (USP) Reference Standard, L-Tryptophan, from non-animal source, meets EP, JP, USP testing specifications, suitable for cell culture, 99.0-101.0% C11H12N2O2 QIVBCDIJIAJPQS-VIFPVBQESA-N (2S)-2-amino-3-(1H-indol-3-yl)propanoic acid n.a. Antidepressants No Yes No No Yes No rxnAGORA1372,rxnAGORA2367,rxnAGORA2368,rxnAGORA2370,rxnAGORA2371,rxnAGORA2934,rxnAGORA3152,rxnAGORA3811,rxnAGORA3925,rxnAGORA4745 PMDBD2000031 Methylmercuric chloride n.a. compound n.a. n.a. n.a. n.a. n.a. 409301 n.a. n.a. METHYLMERCURY CHLORIDE, 115-09-3, Methylmercuric chloride, Chloromethylmercury, Caspan, chloro(methyl)mercury, Mercury, chloromethyl-, Methylmercury(II) chloride, Mercury methyl chloride, Methyl mercuric chloride, Methyl meruric chloride, Monomethyl mercury chloride, Methylmercury monochloride, Methylmerkurichlorid, Mercurymethyl chloride, NSC 19998, CH3HgCl, Monomethylmercury chloride, Methylmercuric(II) chloride, DTXSID5020813, monomethylmercuric chloride, Chloromethyl mercury, Mercurymethylchloride, Caspan (VAN), MeHgCl, Methylmerkurichlorid [Czech], Methyl mercuric(II) chloride, Methyl mercury (II) chloride, CCRIS 3968, methyl mercury chloride, EINECS 204-064-2, UNII-RWZ4L3O1X0, BRN 3600218, HSDB 7785, [HgClMe], Mercury methylchloride, Methyl mercury, chloro, monomethymercuric chloride, Methylmercury(2) chloride, 4-04-00-04436 (Beilstein Handbook Reference), DTXCID90813, SCHEMBL565953, WLN: G-HG-1, Methyl mercuric (II) chloride, CHEBI:28216, NSC19998, Tox21_202524, MFCD00013592, AKOS015903736, Methylmercury(II) chloride, Cl ~13 %, NCGC00090848-01, NCGC00090848-02, NCGC00260073-01, CAS-115-09-3, Q21010649, Methylmercury(II) chloride, PESTANAL(R), analytical standard CH3ClHg BABMCXWQNSQAOC-UHFFFAOYSA-M chloro(methyl)mercury n.a. n.a. No Yes No No No No PMDBD2000032 Metoprolol Therapeutic Substance beta-blocker 51384-51-1 DB00264 PA450480 D02358 D0I2MK 4171 4027 NPC320242 "metoprolol, 51384-51-1, (RS)-Metoprolol, Beatrolol, dl-Metoprolol, 37350-58-6, Seroken, Spesicor, Metohexal, Preblok, Toprol, Meijoprolol, Metoprololum, Selo-Zok, Presolol, Loresor, Neobloc, Metrol, rac Metoprolol-d7, TOPROL-XL, 1-(Isopropylamino)-3-(4-(2-methoxyethyl)phenoxy)propan-2-ol, CGP 2175, Metoprololum [INN-Latin], 1-[4-(2-methoxyethyl)phenoxy]-3-(propan-2-ylamino)propan-2-ol, CGP-2175, (+/-)-Metoprolol, Metoprolol slow release, CCRIS 4198, HSDB 6531, UNII-GEB06NHM23, GEB06NHM23, CHEBI:6904, 1-[4-(2-methoxyethyl)phenoxy]-3-propan-2-ylamino-propan-2-ol, DTXSID2023309, CHEMBL13, EINECS 257-166-4, 1-(isopropylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol, 2-Propanol, 1-(4-(2-methoxyethyl)phenoxy)-3-((1-methylethyl)amino)-, DTXCID503309, Betalok, Spesikor, METOPROLOL, (+/-)-, 51384-51-1 (free base), GP-2175E, H-93/26, Lopresoretic, 2-Propanol, 1-[4-(2-methoxyethyl)phenoxy]-3-[(1-methylethyl)amino]-, Metoprololum (INN-Latin), METOPROLOL (MART.), METOPROLOL [MART.], Metoprolol [USAN:INN:BAN], 1-(4-(2-methoxyethyl)phenoxy)-3-(propan-2-ylamino)propan-2-ol, {2-hydroxy-3-[4-(2-methoxyethyl)phenoxy]propyl}(propan-2-yl)amine, 1-(4-(2-Methoxyethyl)-phenoxy)-3-((1-methylethyl)amino)-2-propanol, 1-[4-(2-methoxyethyl)phenoxy]-3-[(propan-2-yl)amino]propan-2-ol, (+/-)-1-(Isopropylamino)-3-(p-(beta-methoxyethyl)phenoxy)-2-propanol, 1-(4-(2-METHOXYETHYL)PHENOXY)-3-((1-METHYLETHYL)AMINO)-2-PROPANOL, 1-[(1-methylethyl)amino]-3-({4-[2-(methyloxy)ethyl]phenyl}oxy)propan-2-ol, 2-Propanol, 1-[4-(2-methoxyethyl)phenoxy]-3-[(1-methylethyl)amino]-, (.+/-.)-, LOPRESSIDONE, CGP2175, Metoprolol (USAN/INN), metoprololo, rac Metoprolol, Lopresol (Salt/Mix), METOPROLOL [MI], Lopresoretic (Salt/Mix), METOPROLOL [INN], (.+/-.)-Metoprolol, METOPROLOL [HSDB], METOPROLOL [USAN], METOPROLOL [VANDF], 2-Propanol, 1-(4-(2-methoxyethyl)phenoxy)-3-((1-methylethyl)amino)-, (+-)-, SCHEMBL4093, METOPROLOL [WHO-DD], GTPL553, 1-(Isopropylamino)-3-[4-(2-methoxyethyl)phenoxy]-2-propanol, H 93/26 (Salt/Mix), BDBM25756, C07AB02, HMS2090B15, HMS3886O04, BCA38451, BCP09038, Tox21_303972, MFCD00599534, s5430, AKOS005927923, BG-0006, CCG-204813, CS-3159, DB00264, SDCCGSBI-0050706.P005, NCGC00021148-03, NCGC00021148-04, NCGC00021148-05, NCGC00021148-21, NCGC00356981-01, 54163-88-1, AC-19022, HY-17503, SBI-0050706.P004, 3-BROMO-4,5-DIHYDROXYBENZYLALCOHOL, CAS-51384-51-1, A2878, AB00053499, NS00000197, C07202, D02358, EN300-317058, AB00053499-21, AB00053499_22, AB00053499_23, A823609, A871296, L000669, Q409468, Q-201400, SR-01000003148-2, BRD-A03623303-045-02-0, BRD-A03623303-045-05-3, Z398538014, 1-(Isopropylamino)-3-[p-(2-methoxyethyl)phenoxy]-2-propanol, 1-Isopropylamino-3-[4-(2-methoxy-ethyl)-phenoxy]-propan-2-ol, (2R,3R)-2,3-dihydroxysuccinic acid;1-(isopropylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol" C15H25NO3 IUBSYMUCCVWXPE-UHFFFAOYSA-N 1-[4-(2-methoxyethyl)phenoxy]-3-(propan-2-ylamino)propan-2-ol AstraZeneca Antihypertensive Agents No Yes No No No No PMDBD2000033 Phosphatidylcholine n.a. compound n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD2000034 Phospholipase A2 n.a. unknown n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD2000035 Xylose Therapeutic Substance nutritional usage 58-86-6 DB09419 n.a. n.a. D07HZY 135191 559198 NPC86191 D-Xyl, D-Xylopyranose, D-Xylopyranoside, D-Xylose, Xyl, Xylopyranose, Xylopyranoside, Xylose, d-(+)-Xylose, Xyloside, (3R,4S,5R)-oxane-2,3,4,5-tetrol, Wood sugar, 7261-26-9, D-xylopentose, 10257-31-5, CHEBI:53455, D(+)-XYLOSE, Xylopyranose (6CI,7CI,8CI,9CI), 50855-32-8, Xylomed, DTXCID903745, DTXSID0023745, Xylo-Pfan, (3R,4S,5R)-tetrahydro-2H-pyran-2,3,4,5-tetrol, rel-(3R,4S,5R)-Tetrahydro-2H-pyran-2,3,4,5-tetraol, Xylose, pure, D-(+)-Xylose, >=99%, (3R,4S,5R)-Tetrahydro-2H-pyran-2,3,4,5-tetraol, D Xylose, xylo-pentose, BRN 1562108, AI3-19010, Xylose (USP), Xylo-Pfan (TN), Epitope ID:114701, SCHEMBL39891, MLS001361339, CHEMBL502135, cid_135191, BDBM16234, CHEBI:18222, CHEBI:65327, SRBFZHDQGSBBOR-IOVATXLUSA-N, D-(+)-Xylose, analytical standard, Tox21_302055, MFCD00064360, AKOS025401342, D-(+)-Xylose, BioXtra, >=99%, D-(+)-Xylose, puriss., 98.5%, CAS-58-86-6, D-(+)-Xylose, 99%, natural sourced, NCGC00165998-01, NCGC00255319-01, AC-11300, AS-11757, SMR000857378, CS-0083551, C00181, D06346, EN300-118961, G72648, D-(+)-Xylose, SAJ special grade, 98.0-101.0%, F8887-9207, WURCS=2.0/1,1,0/(a212h-1x_1-5)/1/, Xylose, European Pharmacopoeia (EP) Reference Standard, Z1255356270, Xylose, United States Pharmacopeia (USP) Reference Standard, D-(+)-Xylose, BioUltra, >=99.0% (sum of enantiomers, HPLC) C5H10O5 SRBFZHDQGSBBOR-IOVATXLUSA-N (3R,4S,5R)-oxane-2,3,4,5-tetrol n.a. n.a. No Yes No No No No PMDBD2000036 Insulin Therapeutic Substance Blood glucose control n.a. n.a. n.a. n.a. D06SVW 70678557 n.a. NPC322805 Endopancrine, Decurvon, Dermulin, Humilin, Insular, Insulyl, Iszilin, Musulin, 9004-10-8, Dal-insulinum, Intesulin B, AERx, INSULIN INJECTION, Injectable insulini neutrale, Iletin, CCRIS 5464, HSDB 3102, HMR 4006, EINECS 232-672-8, Insulinum dalanatum (INN-Latin), Insulinum dalanatum [INN-Latin], AERx (Insulin management system), AERx [Insulin management system], Insulina dalanatada (INN-Spanish), Insulina dalanatada [INN-Spanish], Soluble Insulin, Insulin, Soluble, Insulini injectio neutralis (INN-Latin), Insulini injectio neutralis [INN-Latin], Inyectable neutro de insulina (INN-Spanish), Inyectable neutro de insulina [INN-Spanish], Solute neutre injectable d''insuline (INN-French), Solute neutre injectable d''insuline [INN-French], insulin-human, Insulin, dalanated, Insulina dalanatada, Insulinum dalanatum, Imusay-131, DALANATED INSULIN, Dalanated insulin [INN], Insulina iniettabile neutra, Insulini injectio neutralis, Inyectable neutro de insulina, DTXSID9037664, Insulin, dalanated [USAN:INN], CHEBI:145810, Solute neutre injectable d''insuline, Insulina iniettabile neutra [DCIT], 12584-58-6 , Insulin, Pork, S.N. 44 C256H381N65O77S6 YAJCHEVQCOHZDC-QMMNLEPNSA-N (4S)-4-[[2-[[(1R,6R,12S,15S,18S,21S,24S,27S,30S,33S,36S,39S,42R,47R,50S,53S,56S,59S,62S,65S,68S,71S,74S,77S,80S,83S,88R)-88-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[(2-aminoacetyl)amino]-3-methylpentanoyl]amino]-3-methylbutanoyl]amino]-4-carboxybutanoyl]amino]-5-oxopentanoyl]amino]-6-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-3-amino-2-[[(2S)-2-[[(2S)-2-amino-3-phenylpropanoyl]amino]-3-methylbutanoyl]amino]-3-oxopropanoyl]amino]-5-oxopentanoyl]amino]-3-(1H-imidazol-4-yl)propanoyl]amino]-4-methylpentanoyl]amino]-47-[[(1S)-3-amino-1-carboxy-3-oxopropyl]carbamoyl]-53-(2-amino-2-oxoethyl)-62-(3-amino-3-oxopropyl)-77-[(2R)-butan-2-yl]-24,56-bis(2-carboxyethyl)-83-[(1S)-1-hydroxyethyl]-12,71,80-tris(hydroxymethyl)-33,50,65-tris[(4-hydroxyphenyl)methyl]-15-(1H-imidazol-4-ylmethyl)-27-methyl-18,30,36,59,68-pentakis(2-methylpropyl)-7,10,13,16,19,22,25,28,31,34,37,40,49,52,55,58,61,64,67,70,73,76,79,82,85,87-hexacosaoxo-21,39-di(propan-2-yl)-3,4,44,45,90,91-hexathia-8,11,14,17,20,23,26,29,32,35,38,41,48,51,54,57,60,63,66,69,72,75,78,81,84,86-hexacosazabicyclo[72.11.7]dononacontane-42-carbonyl]amino]acetyl]amino]-5-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S,3S)-1-[(2S)-2-[[(2S)-6-amino-1-[[(1S,2S)-1-carboxy-2-hydroxypropyl]amino]-1-oxohexan-2-yl]carbamoyl]pyrrolidin-1-yl]-3-hydroxy-1-oxobutan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-2-oxoethyl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-5-oxopentanoic acid n.a. Hypoglycemic Agents No Yes No No No No PMDBD2000037 Hespesidin n.a. "Therapeutic Substance; Herbal Substance" n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD2000038 Glyceryl trinitrate Therapeutic Substance angina pectoris n.a. n.a. n.a. n.a. D07YDE 4510 n.a. n.a. nitroglycerin, Glyceryl trinitrate, Trinitroglycerin, Nitrostat, 55-63-0, Nitroglycerine, Nitroglycerol, Trinitroglycerol, Nitro-dur, Minitran, Transderm-nitro, Glycerol trinitrate, Nitrolingual, Trinitrin, Nitronet, Nitora, Tridil, Lenitral, Nitroderm, Nitroglyn, Nitrospan, Niong, NitroMist, Transderm Nitro, Nitro-Bid, Nitroglicerina, Nitrostabilin, Angiolingual, Cardamist, Epinitril, Klavikordal, Myoglycerin, Natispray, Niglycon, Nitrocine, Nitrolan, Nitroletten, Nitrolowe, Nitromel, Nitronal, Nitrorectal, Nitroretard, Nysconitrine, Perglottal, Perlinganit, Rectogesic, Susadrin, Sustonit, Temponitrin, Trinalgon, Trinitrol, Vasoglyn, Angibid, Angorin, Glonoin, Niglin, Nitrong, propane-1,2,3-triyl trinitrate, Soup, Gilucor nitro, Blasting gelatin, Nitro-lent, Nitrozell retard, Nitro-Span, Nitroderm TTS, Nitrine-TDC, Cordipatch, Corditrine, Glycerin trinitrate, Nitrogliceryna, Nitroplast, Trinitrosan, Adesitrin, Chitamite, Deponit, Glonoinum, Glytrin, Millisrol, Nitrodisc, Nitrogard, Nitroglin, Nitromex, Nitromint, Percutol, Suscard, Triniplas, Myocon, Rectiv, NitroCor, Glyceryl nitrate, Transiderm-nitro, 1,2,3-Propanetriol, trinitrate, Coro-Nitro, Nitro-Time, Glyceroltrinitraat, Propanetriol Trinitrate, Nitrolingual Spray, NITRO IV, Gonitro, Transderm-Nitro TTS, Glycerintrinitrate, 1,2,3-Propanetriyl nitrate, Glycerol, nitric acid triester, Trinitrine, SK-106N, Glycerol(trinitrate de), Nitrol (pharmaceutical), Trinitrin Tablets, NG, Rcra waste number P081, IMX-150, Diluted nitroglycerin, 1,3-dinitrooxypropan-2-yl nitrate, NITROLINGUAL PUMPSPRAY, NTG, 1,2,3-propanetrioltrinitrate, Nitroglycerin in Dextrose 5%, NK-843, Nitromed, 1,2,3-Propanetriol trinitrate, Glycerol Nitric Acid Triester, G59M7S0WS3, GTN, CHEBI:28787, C01DA02, Gilustenon, Trinitrolong, Sustak, 1,2,3-trinitrooxypropane, TNG, NitroBid, 1,2,3-Propanetriol, 1,2,3-trinitrate, Aldonitrin, Cardiodisco, Colenitral, Discotrine, Glycerylnitrat, Lentonitrina, Nitrobukal, Nitrocerin, Nitrocontin, Nitropatch, Nitropercuten, Nitroperlinit, Nitropront, Nitroprontan, Plastranit, Ratiopharm, Trinipatch, Angiplex, Angonist, Buccard, Cardabid, Cardinit, Dauxona, Diafusor, DTXSID1021407, Glyceryl, Herwicard, Minitram, Mionitrat, Nitradisc, Nitroard, Nitrobaat, Nitroclyn, Nitrocot, Nitrodyl, Nitrolin, Nitropen, Nitroprol, Nitrorex, Nitrovis, Perganit, Polnitrin, Trinitron, Turicard, Vasolator, Vernies, Willong, Anglix, Herzer, Myovin, Nirmin, Nitrek, Sustac, Nitrol Ointment, Trinitrina Erba, Nitradisc Pad, Nitro-Pflaster, Nitrobid Oint, Nitrong Retard, Niong Retard, Nitro Retard, Aquo-Trimitrosan, Nitro Rorer, Nitromack Retard, Nitromint Retard, Nitronal Aqueous, Nitrogard-SR, Mi-Trates, Nitradisc TTS, Nitriderm TTS, Nitro-Par, Top-Nitro, Nitrocine 5, Nitrodyl TTS, Nitromint Aerosol, Nitrong-SR, Deponit 5, Deponit-5, Neos nitro OPT, Nit-Ret, Nitroglycerin-ACC, Transderm-N TTS, Nitro Mack Retard, Nitro-M-Bid, Nitro-Mack Retard, Gepan Nitroglicerin, Nitro Dur TTS, Nitroderm TTS-5, GTN-Pohl, Nitroderm TTS Ext, Nitro-Dur 5, Nitrocontin Continus, Deponit TTS 5, Nitro-Gesanit Retard, Cellegesic, Deponit TTS 10, Nitro-Dur 10, Nitrocap, NitroQuick, NitroQuik, Percutol Oint., Nitrong parenteral, NitrocapT.D., Glycerine trinitrate, Nitroglycerin (NG), Trinitrate, Glyceryl, Corangin Nitrokapseln, Trinitroglicerina Fabra, Anogesic, Minitro, Nitriderm, Nitroject, Vascana, Buccal, Nitrogliceryna [Polish], Nitroglycerine [French], GLYCERYL TRINITRATE (MART.), GLYCERYL TRINITRATE [MART.], Tridil sublin, Trinitrine Simple Laleuf, Nitroglicerina [Italian], Nitroglicerina [Spanish], Aquo-trinitrosan, NITROGLYCERIN (USP IMPURITY), NITROGLYCERIN [USP IMPURITY], DILUTED NITROGLYCERIN (USP-RS), DILUTED NITROGLYCERIN [USP-RS], Glycerintrinitrate [Czech], Glyceroltrinitraat [Dutch], Nitromist (TN), Minitran (TN), HSDB 30, SDM No. 17, Nitro-bid (TN), Nitro-dur (TN), CCRIS 4089, nitroglycerin ointment, DILUTED NITROGLYCERIN (USP MONOGRAPH), DILUTED NITROGLYCERIN [USP MONOGRAPH], Nitric acid triester of gylcerol, Transderm-nitro (TN), Glycerol(trinitrate de) [French], Glycerol (trinitrate de) [French], Glycerol (trinitrate de), EINECS 200-240-8, UN0143, UN1204, UN3064, UN3319, Nitroglycerin [USP:JAN], RCRA waste no. P081, BRN 1802063, UNII-G59M7S0WS3, 2,3-dinitrooxypropyl nitrate, Nitrofortin, Nitrolande, Nitrosigma, Reminitrol, Solinitrina, Corangil, Nitrolar, Sutonit, Myocor, trans-nitro, Glyceroltrinitrat, Nitro mack, S.N.G., 2,3-bis(nitrooxy)propyl nitrate, MQX-503, Nitro-PRN, MED-2002, Glyceroli trinitratis, Nitroglycerin tablets, Nitroglycerin Lingual, Nitroglycerin Slocaps, SK-866, SK-878, UN0144, Glonoinum Kit Refill, Nitroglycerin Injection, GLONOINUM [HPUS], Nitroglycerin In Dextrose, NITROGLYCERIN [MI], CHEMBL730, EC 200-240-8, Nitroglycerin (JP17/USP), NITROGLYCERIN [HSDB], S.N.G, SCHEMBL15421, NITROGLYCERIN [VANDF], 4-01-00-02762 (Beilstein Handbook Reference), UN 0143 (Salt/Mix), UN 0144 (Salt/Mix), UN 1204 (Salt/Mix), (Component of) SDM No 17, (Component of) SDM No 37, BIDD:GT0142, NITROGLYCERIN, DEXTROSE, Nitroglycerin, liquid, not desensitized [Forbidden], SDM No. 17 (Salt/Mix), SDM No. 27 (Salt/Mix), 1,2,3-Propanetriol trinatrate, 1,2,3-tris-nitryloxy-propane, GTPL7053, Trinitrate 1,2,3-propanetriol, Nitroglycerin Transdermal System, Nitric acid triester of glycerol, HMS2094M15, NITROGLYCERIN [ORANGE BOOK], NITROGLYCERIN TABLETS [JAN], c0061, GLYCERYL TRINITRATE [WHO-DD], NK 843, AKOS030254238, 1,3-bis(nitrooxy)propan-2-yl nitrate, DB00727, Nitroglycerin, liquid, not desensitized, Nitroglycerin Sustained-release capsules, Nitroglycerin Transdermal Delivery System, Nitroglycerin Transdermal Infusion System, NS00004622, C07455, D00515, EN300-7352804, Q162867, SR-01000944510, SR-01000944510-1, Nitroglycerin, desensitized with not <40% non-volatile water insoluble phlegmatizer, by mass, Nitroglycerin, desensitized with not <40% non-volatile water insoluble phlegmatizer, by mass [UN0143] [Explosive 1.1D, Poison] C3H5N3O9 SNIOPGDIGTZGOP-UHFFFAOYSA-N 1,3-dinitrooxypropan-2-yl nitrate n.a. Vasodilator Agents No Yes No No No No PMDBD2000039 2-Amino-3-methylimidazo(4,5-f)quinoline(IQ) n.a. chemical?compounds? n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD2000040 Arbutin Therapeutic Substance anti-infective 497-76-7 DB11217 n.a. n.a. n.a. 440936 389765 NPC142319 "arbutin, 497-76-7, Arbutoside, Ursin, Uvasol, p-Arbutin, beta-Arbutin, 4-Hydroxyphenyl beta-D-glucopyranoside, p-Hydroxyphenyl beta-D-glucoside, Arbutine, Arbutinum, Arbutyne, 4-Hydroxyphenyl-beta-D-glucopyranoside, p-Hydroxyphenyl beta-D-glucopyranoside, Hydroquinone-O-beta-D-glucopyranoside, Hydroquinone beta-D-glucopyranoside, Hydroquinone glucose, Hydroquinone-beta-D-glucopyranoside, hydroquinone O-beta-D-glucopyranoside, Ericolin, UNII-C5INA23HXF, C5INA23HXF, Hydroquinone-glucose, (2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-(4-hydroxyphenoxy)oxane-3,4,5-triol, CCRIS 9273, (2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-(4-hydroxyphenoxy)tetrahydro-2H-pyran-3,4,5-triol, DTXSID7040152, CHEBI:18305, HSDB 7661, NSC 4036, NSC-4036, EINECS 207-850-3, beta-D-Glucopyranoside, 4-hydroxyphenyl, BRN 0089673, 4-Hydroxyphenyl-.beta.-D-glucopyranoside, CHEMBL232202, DTXCID5020152, 5-17-07-00110 (Beilstein Handbook Reference), MFCD00016915, beta-D-Glucopyranoside, 4-hydroxyphenyl-, Ursi, ARBUTIN (MART.), ARBUTIN [MART.], (2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-(4-oxidanylphenoxy)oxane-3,4,5-triol, CAS-497-76-7, Hydroquinone |A-D-glucopyranoside, SR-05000002157, b-Arbutin, -Arbutin, Uva,p-Arbutin, NCGC00095599-01, b-D-Glucopyranoside, 4-hydroxyphenyl, HYDRO H, Spectrum_000786, Hydroquinone-D-glucoside, SpecPlus_000314, ARBUTIN [HSDB], ARBUTIN [INCI], Arbutin, >=98%, ARBUTIN [MI], ARBUTINUM [HPUS], Prestwick3_001026, Spectrum2_000662, Spectrum3_001233, Spectrum4_001474, Spectrum5_000147, ARBUTIN [WHO-DD], bmse000365, Arbutin (Uva, p-Arbutin), Arbutin, analytical standard, SCHEMBL36351, BSPBio_001211, BSPBio_002706, Hydroquinone-beta-D-glucoside, KBioGR_002047, KBioSS_001266, SPECTRUM300539, MLS002207046, DivK1c_006410, 4-hydroxyphenyl-glucopyranoside, SPBio_000723, BPBio1_001333, MEGxp0_001504, KBio1_001354, KBio2_001266, KBio2_003834, KBio2_006402, KBio3_002206, HMS2098M13, HMS3715M13, P-Hydroxyphenyl beta -D-glucoside, Tosowoong Mens Booster Repair Skin, HY-N0192, 4-Hydroxyphenyl-beta-glucopyranoside, Hydroquinone beta -D-glucopyranoside, Tox21_111509, Tox21_302428, BDBM50219502, CCG-38565, s2263, AKOS015965305, Tox21_111509_1, DB11217, KS-5252, SDCCGMLS-0066538.P001, (2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-(4-hydroxyphenoxy)tetrahydropyran-3,4,5-triol, P-Hydroxyphenyl beta -D-glucopyranoside, SMP1_000028, NCGC00166076-02, NCGC00166076-03, NCGC00166076-04, NCGC00166076-07, NCGC00166076-09, NCGC00255705-01, AC-20183, beta -D-Glucopyranoside, 4-hydroxyphenyl, I(2)-D-Glucopyranoside, 4-hydroxyphenyl, SMR001233417, ICEKING Freckle Removing Whitening Masque, Sooryehan Pure-Whitening Essential Starter, ICEKING Whitening Freckle Removing Essence, A0522, AB00443586, HYDROQUINONE-.BETA.-D-GLUCOPYRANOSIDE, SW199492-2, C06186, 4-Hydroxyphenyl b-D-glucopyranoside, 9CI, 8CI, EN300-7388350, A827849, Arbutin, primary pharmaceutical reference standard, ISAKNOX WHITE SYMPHONY BRIGHTENING EMULSION, Q416446, ICEKING Freckle Removing Whitening Facial Cleanser, SR-05000002157-2, SR-05000002157-4, alpha-Arbutin; 4-Hydroquinone-alpha-D-glucopyranoside, Arbutin, European Pharmacopoeia (EP) Reference Standard, 4E19B706-2013-4401-A1FC-A154DADF42B4, (2S,3R,4S,5S,6R)-2-(4-hydroxyphenoxy)-6-methylol-tetrahydropyran-3,4,5-triol, 7OQ" C12H16O7 BJRNKVDFDLYUGJ-RMPHRYRLSA-N (2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-(4-hydroxyphenoxy)oxane-3,4,5-triol n.a. n.a. No Yes No No Yes No rxnAGORA2570,rxnAGORA2731 PMDBD2000041 Butyl paraben n.a. compound n.a. n.a. n.a. n.a. n.a. 7184 n.a. n.a. Butyl 4-hydroxybenzoate, BUTYLPARABEN, 94-26-8, Butyl paraben, Butyl p-hydroxybenzoate, Butyl parahydroxybenzoate, Nipabutyl, Butoben, Butyl chemosept, Butyl parasept, Tegosept B, Butyl tegosept, Butyl butex, Tegosept Butyl, Aseptoform butyl, Preserval B, Solbrol B, n-Butyl p-hydroxybenzoate, Butyl-Parasept, Benzoic acid, 4-hydroxy-, butyl ester, butyl p-hydroxy benzoate, 4-(Butoxycarbonyl)phenol, n-butyl 4-hydroxybenzoate, n-Butyl parahydroxybenzoate, n-Butyl hydroxybenzoate, FEMA No. 2203, n-Butyl-p-hydroxybenzoate, 4-Hydroxybenzoic acid butyl ester, Benzoic acid, p-hydroxy-, butyl ester, n-Butyl-paraben, p-Hydroxybenzoic acid butyl ester, Lexgard B, n-Butyl-4-hydroxybenzoate, NSC 8475, p-Hydroxybenzoic acid n-butyl ester, Butylparaben (NF), Butylparaben (TN), Butylparaben [NF], SPF, p-Hydroxybenzoic acid, butyl ester, 4-Hydroxybenzoic acid, butyl ester, MFCD00016478, p-Hydroxybenzoic butyl ester, 3QPI1U3FV8, Butyl parahydroxybenzoate (TN), DTXSID3020209, CHEBI:88542, 4-Hydroxybenzoic acid-n-butyl ester, NSC-13164, CAS-94-26-8, NCGC00016354-03, DTXCID90209, Butylparaben [USAN], butyl-p-hydroxybenzoate, Caswell No. 130A, FEMA Number 2203, n-Butyl paraben, 4-Hydroxybenzoic acid-n-butyl ester 1000 microg/mL in Acetonitrile, Butyl Par asept, SMR000462402, CCRIS 2462, HSDB 286, p-Hydroxy butyl benzoate, SR-01000389296, EINECS 202-318-7, UNII-3QPI1U3FV8, EPA Pesticide Chemical Code 061205, BRN 1103741, butyl-paraben, AI3-02930, 27K, Butyl 4-?Hydroxybenzoate(Butyl Paraben), 4mg9, Prestwick0_000894, Prestwick1_000894, Prestwick2_000894, Prestwick3_000894, BUTYLPARABEN [II], BUTYLPARABEN [MI], WLN: QR DVO4, BUTYLPARABEN [HSDB], BUTYLPARABEN [INCI], cid_7184, SCHEMBL3647, BUTYLPARABEN [VANDF], BSPBio_000708, Butyl //p//-Hydroxybenzoate, MLS000575004, MLS002154054, MLS002303045, BIDD:ER0231, BUTYLPARABEN [USP-RS], SPBio_002917, BPBio1_000780, CHEMBL459008, F0266-0124, N-Butyl-P-Hydroxybenzoate,(S), BDBM23448, FEMA 2203, NSC8475, Butyl parahydroxybenzoate (JP15), Butyl parahydroxybenzoate (JP17), Butyl 4-hydroxybenzoate, >=99%, HMS1570D10, HMS2094A21, HMS2097D10, HMS2220G15, HMS3327P04, HMS3714D10, Pharmakon1600-01505995, HY-B1431, NSC-8475, Tox21_110393, Tox21_201785, Tox21_300332, NSC759303, p-Hydroxybenzoic acid, n-butyl ester, s4584, BUTYL HYDROXYBENZOATE [MART.], AKOS000121421, BUTYL HYDROXYBENZOATE [WHO-DD], Tox21_110393_1, BUTYL PARAHYDROXYBENZOATE [JAN], CCG-213596, CS-4783, DB14084, NSC-759303, BUTYL P-HYDROXY BENZOATE [FHFI], Butyl 4-Hydroxybenzoate (Butyl Paraben), NCGC00016354-01, NCGC00016354-02, NCGC00016354-04, NCGC00016354-05, NCGC00016354-06, NCGC00016354-07, NCGC00016354-11, NCGC00091142-01, NCGC00091142-02, NCGC00254294-01, NCGC00259334-01, AC-34535, AS-14309, SY032891, SBI-0206946.P001, Butyl 4-hydroxybenzoate, >=99.0% (GC), AB00513951, B3771, H0210, NS00010637, EN300-21566, BUTYL PARAHYDROXYBENZOATE [EP IMPURITY], BUTYL PARAHYDROXYBENZOATE [EP MONOGRAPH], D01420, AB00513951_09, A844895, Q3302873, SR-01000389296-1, SR-01000389296-3, W-100204, BRD-K08287586-001-03-6, BRD-K08287586-001-08-5, Butyl 4-hydroxybenzoate, SAJ first grade, >=99.0%, PROPYL HYDROXYBENZOATE IMPURITY D [EP IMPURITY], Z291799028, METHYL PARAHYDROXYBENZOATE IMPURITY D [EP IMPURITY], InChI=1/C11H14O3/c1-2-3-8-14-11(13)9-4-6-10(12)7-5-9/h4-7,12H,2-3,8H2,1H C11H14O3 QFOHBWFCKVYLES-UHFFFAOYSA-N butyl 4-hydroxybenzoate n.a. n.a. No Yes No No No No PMDBD2000042 Zearalenone n.a. compound n.a. n.a. n.a. n.a. n.a. 5281576 n.a. NPC33144 "ZEARALENONE, 17924-92-4, trans-Zearalenone, (-)-Zearalenone, Mycotoxin F2, (S)-Zearalenone, Zenone, (S)-(-)-Zearalenone, F-2 toxin, (10S)-Zearalenone, C18H22O5, (3S,11E)-14,16-dihydroxy-3-methyl-3,4,5,6,9,10-hexahydro-1H-2-benzoxacyclotetradecine-1,7(8H)-dione, CHEBI:10106, Compound F-2, Mycotoxin F2;Toxin F2, F2 Toxin, MFCD00133085, 6-(10-Hydroxy-6-oxo-trans-1-undecenyl)-beta-resorcylic acid lactone, MLS000097901, CHEMBL454173, 1H-2-Benzoxacyclotetradecin-1,7(8H)-dione, 3,4,5,6,9,10-hexahydro-14,16-dihydroxy-3-methyl-, (3S,11E)-, DTXSID0021460, 5W827M159J, (S-(E))-3,4,5,6,9,10-Hexahydro-14,16-dihydroxy-3-methyl-1H-2-benzoxacyclotetradecin-1,7(8H)-dione, SMR000058177, DTXCID701460, Mycotoxin F-2, ZEA, CCRIS 623, Zearalenone 100 microg/mL in Acetonitrile, CAS-17924-92-4, HSDB 4208, NCI-C50226, (S,E)-14,16-Dihydroxy-3-methyl-3,4,5,6,9,10-hexahydro-1H-benzo[c][1]oxacyclotetradecine-1,7(8H)-dione, 1H-2-Benzoxacyclotetradecin-1,7(8H)-dione, 3,4,5,6,9,10-hexahydro-14,16-dihydroxy-3-methyl-, (S)-(-)-, EINECS 241-864-0, BRN 1350216, UNII-5W827M159J, benzoxacyclotetradecin-1,7(8H)-dione, ZEARALENONE [MI], Opera_ID_1608, ZEARALENONE [HSDB], COMPD F-2, Epitope ID:146094, Benzoxacyclotetradec-11-en-1-one, 14,16-dihydroxy-3-methyl-7-oxo-, trans-, Resorcylic acid, 6-(10-hydroxy-6-oxo-1-undecenyl)-, mu-lactone, trans-, SCHEMBL33754, SCHEMBL33755, BSPBio_003581, Zearalenone, fungal mycotoxin, MLS000028817, MLS000888273, MLS001174881, BIDD:ER0058, SPECTRUM1505290, Zearalenone, reference material, 6-(10-Hydroxy-6-oxo-trans-1-undecenyl)-.beta.-resorcylic acid lactone, REGID_for_CID_657988, REGID_for_CID_5281576, BCP06062, EX-A3324, ZON, Tox21_201153, Tox21_303510, BDBM50247676, CCG-40041, HB2517, LMPK04000016, s5676, Zearalenone 50 microg/mL in Methanol, AKOS001577898, 1ST7204, SDCCGMLS-0066858.P001, NCGC00038520-03, NCGC00090809-01, NCGC00090809-02, NCGC00090809-11, NCGC00257246-01, NCGC00258705-01, (2E,11S)-15,17-dihydroxy-11-methyl-12-oxabicyclo[12.4.0]octadeca-1(18),2,14,16-tetraene-7,13-dione, (3S,11E)-3,4,5,6,9,10-Hexahydro-14,16-dihydroxy-3-methyl-1H-2-benzoxacyclotetradecin-1,7(8H)-dione, (S-(Z))-3,4,5,6,9,10-Hexahydro-14,16-dihydroxy-3-methyl-1H-2-benzoxacyclotetradecin-1,7(8H)-dione, 1H-2-Benzoxacyclotetradecin-1,7(8H)-dione, 3,4,5,6,9,10-hexahydro-14,16-dihydroxy-3-methyl-, (S-(Z))-, 1ST7204-100A, AC-35060, VS-02573, HY-103447, CS-0027914, NS00005531, Z0047, C09981, Zearalenone Solution in Acetonitrile, 100ug/mL, Q169326, J-011439, BRD-K42017082-001-02-6, Zearalenone(-)-Zearalenone; Mycotoxin F2; (S)-Zearalenone, 6-(10-HYDROXY-6-OXO-TRANS-1-UNDECENYL) BETA RESORCYCLIC ACID-MU-LACTONE, (11E)-14,16-DIHYDROXY-3-METHYL-3,4,5,6,7,8,9,10-OCTAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,7-DIONE, (2E,11S)-15,17-dihydroxy-11-methyl-12-oxabicyclo[12.4.0]octadeca-1(14),2,15,17-tetraene-7,13-dione, (3S,11E)-14,16-dihydroxy-3-methyl-3,4,5,6,7,8,9,10-octahydro-1H-2-benzoxacyclotetradecine-1,7-dione, (3S,11E)-3,4,5,6,9,10-Hexahydro-14, 16-dihydroxy-3-methyl-1H-2-benzoxacyclotetradecin- 1,7(8H)-dione, (4S,12E)-16,18-dihydroxy-4-methyl-3-oxabicyclo[12.4.0]octadeca-1(14),12,15,17-tetraene-2,8-dione, (S,E)-14,16-Dihydroxy-3-methyl-3,4,5,6,9,10-hexahydro-1H-2-benzoxacyclotetradecine-1,7(8H)-dione, 1H-2-Benzoxacyclotetradecin-1,7(8H)-dione, 3,4,5,6,9,10-hexahydro-14,16-dihydroxy-3-methyl-, (3S)-, 3,4,5,6,9,10-Hexahydro-14,16-dihydroxy-3-methyl-1H-2- benzoxacyclotetradecin-1,7(8H)-dione" C18H22O5 MBMQEIFVQACCCH-QBODLPLBSA-N (4S,12E)-16,18-dihydroxy-4-methyl-3-oxabicyclo[12.4.0]octadeca-1(14),12,15,17-tetraene-2,8-dione n.a. n.a. No Yes No No No No PMDBD2000043 Sulfotransferase n.a. enzyme n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD2000044 succinylsulfathiazole n.a. antibacterial n.a. n.a. n.a. n.a. n.a. 5315 n.a. n.a. succinylsulfathiazole, 116-43-8, Colistatin, Cremosuxidine, Sulfasuxidine, Sulfadigesin, Sulfasuccidine, Sulfasuccithiazole, Succinylsulphathiazole, Sulfasuccinil, Kaoxidin, Kaoxidine, 4''-(2-Thiazolylsulfamoyl)succinanilic acid, Sulfasuccidin, Sulfenterone, Thiacyl, Rolsul, Butanoic acid, 4-oxo-4-[[4-[(2-thiazolylamino)sulfonyl]phenyl]amino]-, Succinyl sulfathiazole, p-2-Thiazolylsulfamylsuccinanilic acid, 4-oxo-4-[4-(1,3-thiazol-2-ylsulfamoyl)anilino]butanoic acid, NSC 14193, NSC 163939, Succinylsulfathiazole [INN], 4-oxo-4-((4-(N-(thiazol-2-yl)sulfamoyl)phenyl)amino)butanoic acid, Anhydrous Succinylsulfathiazole, 2-(N(sup4)-Succinylsulfanilamido)thiazole, CHEBI:9309, RSS8647O4S, DTXSID7045281, Succinanilic acid, 4''-(2-thiazolylsulfamoyl)-, NSC14193, MFCD00022437, NSC-14193, NSC163939, NSC-163939, 4-oxo-4-[4-(thiazol-2-ylsulfamoyl)anilino]butanoic acid, NCGC00016367-01, CAS-116-43-8, Succinilsulfatiazol, Succinylsulfathiazole (INN), Succinilsolfatiazolo, Succinylsulfathiazol, 4''-(1,3-Thiazol-2-ylsulphamoyl)succinanilic acid, Succinylsulfathiazolum, DTXCID5025281, Butanoic acid, 4-oxo-4-((4-((2-thiazolylamino)sulfonyl)phenyl)amino)-, N4-Succinyl-N-(2-thiazolyl)sulfanilamide, SR-01000000176, 4-(Succinylamino)-N-(2-thiazolyl)benzenesulfonamide, Succinilsolfatiazolo [DCIT], UNII-RSS8647O4S, Succinilsulfatiazol [INN-Spanish], Succinylsulfathiazol [INN-French], 4-(Succinylamino)-N-(2-thiazolyl)benzenesulfonamide hydrate, Succinylsulfathiazolum [INN-Latin], EINECS 204-141-0, 2-(N4-Succinylsulfanilamido)thiazole, Prestwick_1016, Succinylsulfathiazole [USP:INN:BAN], GUANICAR, N-succinylsulfathiazole, BRN 0349989, Spectrum_001389, AI3-26816, Maybridge1_006038, Prestwick0_000702, Prestwick1_000702, Prestwick2_000702, Prestwick3_000702, Spectrum2_001946, Spectrum3_001488, Spectrum4_000045, Tharap cat: antimicrobial, Oprea1_335927, REGID_for_CID_5315, BSPBio_000883, BSPBio_003075, KBioGR_000509, KBioSS_001869, 4-27-00-04637 (Beilstein Handbook Reference), MLS000069715, DivK1c_001028, SCHEMBL151873, SPECTRUM1502025, SPBio_002011, SPBio_002804, Succinylsulfathiazole, >=98%, BPBio1_000973, CHEMBL1484857, HMS503M17, HMS558K10, KBio1_001028, KBio2_001869, KBio2_004437, KBio2_007005, KBio3_002575, Succinylsulfathiazole plymorph II, CCG-439, SUCCINYLSULFATHIAZOLE [MI], NINDS_001028, HMS1570M05, HMS1921F06, HMS2092N21, HMS2097M05, HMS2230P18, HMS3373O12, HMS3714M05, Pharmakon1600-01502025, HY-B0921, Tox21_110400, 4-oxo-4-((4-((2-thiazolylamino)sulfonyl)phenyl)amino)butanoic acid, NSC758161, s4585, SUCCINYLSULFATHIAZOLE [MART.], Succinylsulfathiazole, ~95% (TLC), SUCCINYLSULFATHIAZOLE [WHO-DD], AKOS002161889, Tox21_110400_1, DB13580, NSC-758161, p-2-Thiazolylsulfamoylsuccinanilic acid, IDI1_001028, NCGC00016367-02, NCGC00016367-03, NCGC00016367-04, NCGC00016367-05, NCGC00016367-06, NCGC00016367-08, NCGC00022723-03, NCGC00022723-04, AS-15960, SMR000058172, SBI-0051704.P002, SUCCINYLSULFATHIAZOLE [EP IMPURITY], AB00052259, EU-0083314, NS00004809, S0581, S0991, C71535, D07060, AB00052259_13, A927102, N4-Succinyl-N-(2-thiazolyl)sulfanilamide hydrate, J-003439, Q3976577, SR-01000000176-2, SR-01000000176-3, SR-01000000176-4, BRD-K01950558-001-05-5, BRD-K01950558-001-09-7, F0856-0033, 4-oxo-4-(4-(N-thiazol-2-ylsulfamoyl)phenylamino)butanoic acid, 4-Oxo-4-[[4-[(2-thiazolylamino)sulfonyl]phenyl]amio]-butanoic acid, 4-Oxo-4-(4-[(1,3-thiazol-2-ylamino)sulfonyl]anilino)butanoic acid #, 4-Oxo-4-[[4-(thiazol-2-ylsulfamoyl)phenyl]amino]butanoic acid monohydrate C13H13N3O5S2 SKVLYVHULOWXTD-UHFFFAOYSA-N 4-oxo-4-[4-(1,3-thiazol-2-ylsulfamoyl)anilino]butanoic acid n.a. n.a. No Yes No No No No PMDBD2000045 Nitroglycerin(glyceryl trinitrate) n.a. angina pectoris n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD2000046 Benzodiazepines n.a. unknown n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD2000047 Sodium picosulfate Therapeutic Substance laxative n.a. n.a. n.a. n.a. D00TGR 68654 n.a. n.a. "sodium picosulfate, 10040-45-6, Picosulfate sodium, Laxoberal, Laxoberon, Sodium picosulphate, Evacuol, Picolax, Neopax, Guttalax-Fher, Pico-Salax, DA-1773, 4,4''-(2-Picolylidene)bis(phenylsulfuric acid) disodium salt, LA 391, Picosulfate sodium anhydrous, Sodium picosulfate anhydrous, Anhydrous Sodium Picosulfate, DA 1773, Sodium picosulphate anhydrous, Picosulfol, DTXSID7048663, Guttalax, Rapilax, CHEBI:32147, 4,4''-(2-Pyridylmethylene)diphenol bis(hydrogen sulfate) disodium salt, VW106606Y8, Laxidogol, Evanol, Sodium picosulfate 100 microg/mL in Acetonitrile, Picosulfate sodium hydrate, C18H13NNa2O8S2, Picoprep, Natrii picosulfas, Sodium picosulphate monohydrate, Picosulfato sodico, Disodium 4,4''-(2-pyridylmethylene)-di(phenyl sulphate);Disodium 4,4''-(2-pyridylmethylene)-di(phenyl sulphate);Sodium picosulfate, Natrii picosulfas [INN-Latin], Picosulfate de sodium, LA-391, Picosulfato sodico [INN-Spanish], NCGC00182711-01, Picosulfate de sodium [INN-French], Sodium Picosulfate [INN:BAN:JAN], EINECS 233-120-9, 2-Picolylidenebis(p-phenyl sodium sulfate), Natriumpicosulfat, UNII-VW106606Y8, Guttalax;Laxoberon, Disodium 4,4''-disulfoxydiphenyl-(2-pyridyl)methane, Picosulfate sodium salt, 4-methyl-2-pentenoicacid, 4,4''-(2-Pyridylmethylene)diphenolbis(hydrogen sulfate) (ester) disodium salt, 4,4''-(2-Pyridinylmethylene)bisphenol bis(hydrogen sulfate) (ester) disodium salt, SCHEMBL346436, PICOSULFATE SODIUM [MI], 1ST11192Na, CHEMBL1697768, DTXCID0028589, SODIUM PICOSULFATE [INN], Picosulfate for system suitability, HMS3652K17, BCP11522, Tox21_113026, MFCD00867640, s4020, 4,4''-(2-Pyridinylmethylene)bisphenol 1,1''-Bis(hydrogen sulfate) Sodium Salt, AKOS030632777, disodium;[4-[pyridin-2-yl-(4-sulfonatooxyphenyl)methyl]phenyl] sulfate, Phenol, 4,4''-(2-pyridylmethylene)bis-, bis(hydrogen sulfate), disodium salt, CCG-269559, AC-31735, AS-15785, CAS-10040-45-6, NS00078064, S0936, SW219183-1, C71029, Q410265, sodium (pyridin-2-ylmethylene)bis(4,1-phenylene) bis(sulfate), Sodium 4,4''-(pyridin-2-ylmethylene)bis(4,1-phenylene) disulfate, 4,4''-(2-PYRIDYLMETHYLENE)DIPHENOL BIS(HYDROGEN SULPHATE) DISODIUM SALT" C18H13NNa2O8S2 GOZDTZWAMGHLDY-UHFFFAOYSA-L "disodium;[4-[pyridin-2-yl-(4-sulfonatooxyphenyl)methyl]phenyl] sulfate" Ferring Pharmaceuticals n.a. No Yes No No No No PMDBD2000048 Grape Seed Polyphenol Extract (GPSE) n.a. unknown n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD2000049 Cycasin n.a. compound n.a. n.a. n.a. n.a. n.a. 5459896 n.a. n.a. Cykazine, CYCASIN, 14901-08-7, beta-D-Glucosyloxyazoxymethase, CCRIS 185, HSDB 5096, beta-D-Glucosyloxyazoxymethane, Cycas revoluta glucoside, 9H51HL0E1D, Methylazoxymethanol glucoside, (Methyl-ONN-azoxy)methyl beta-D-glucopyranoside, Methylazoxymethanolbeta-D-glucoside, Methylazoxymethanol-beta-D-glucoside, NSC 15190, BRN 0025396, UNII-9H51HL0E1D, NSC-15190, (Methyl-ONN-azoxy)-methyl-beta-D-glucopyranoside, beta-D-Glucopyranoside, (methyl-ONN-azoxy)methyl, CYCASIN [HSDB], CYCASIN [IARC], CYCASIN [MI], 4-17-00-03009 (Beilstein Handbook Reference), beta-D-Glucopyranoside, (methyl-ONN-azoxy)methyl-, DTXSID2057574, Cycasin and methylazoxymethanol acetate, (Z)-methyl-oxido-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethylimino]azanium, C01418, beta-D-Glucopyranoside, ((Z)-methyl-ONN-azoxy) methyl, ((1Z)-2-METHYL-2-OXIDODIAZENYL)METHYL .BETA.-D-GLUCOPYRANOSIDE, (Z)-methyl-oxido-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxymethylimino]ammonium C8H16N2O7 YHLRMABUJXBLCK-LBCXAKKBSA-N (Z)-methyl-oxido-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethylimino]azanium n.a. n.a. No Yes No No No No PMDBD2000050 2-methoxy esterone n.a. Anti-angiogenic n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD2000051 Chlorogenic acid Therapeutic Substance Antioxidant n.a. n.a. n.a. n.a. D02HCQ 1794427 n.a. NPC302857 CHLOROGENIC ACID, 327-97-9, 3-O-Caffeoylquinic acid, Heriguard, Chlorogenate, 3-(3,4-Dihydroxycinnamoyl)quinic acid, 3-Caffeoylquinic acid, Hlorogenic acid, trans-Chlorogenic acid, CP chlorogenic acid, Caffeoyl quinic acid, Chlorogenicacid, NSC-407296, 5-CQA, (+)-Chlorogenic acid, CCRIS 1400, Chlorogenic acid [MI], 5-O-(3,4-Dihydroxycinnamoyl)-L-quinic acid, trans-Caffeic acid 5-o-D-quinate, 202650-88-2, EINECS 206-325-6, Chlorogenic acid [WHO-DD], UNII-318ADP12RI, NSC 70861, NSC-70861, NSC 407296, 318ADP12RI, CHEBI:16112, trans-5-O-Caffeoylquinic acid, MFCD00003862, (1S,3R,4R,5R)-3-[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy-1,4,5-trihydroxycyclohexane-1-carboxylic acid, CHEMBL284616, DTXCID604786, Cyclohexanecarboxylic acid, 3-((3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl)oxy)-1,4,5-trihydroxy-, (1S-(1-alpha,3-beta,4-alpha,5-alpha))-, DTXSID3024786, 1,3,4,5-tetrahydroxycyclohexanecarboxylic acid 3-(3,4-dihydroxycinnamate), (1S,3R,4R,5R)-3-{[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-1,4,5-trihydroxycyclohexane-1-carboxylic acid, Cyclohexanecarboxylic acid, 3-(((2E)-3-(3,4-dihydroxyphenyl)-1-oxo-2-propen-1-yl)oxy)-1,4,5-trihydroxy-, (1S,3R,4R,5R)-, Cyclohexanecarboxylic acid, 3-((3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl)oxy)-1,4,5-trihydroxy-, (1S,3R,4R,5R)-, Chlorogenic acid (constituent of st. john''s wort) [DSC], 3-O-(3,4-Dihydroxycinnamoyl)-D-quinic acid, (1S,3R,4R,5R)-3-(((E)-3-(3,4-dihydroxyphenyl)acryloyl)oxy)-1,4,5-trihydroxycyclohexane-1-carboxylic acid, Cyclohexanecarboxylic acid, 3-((3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl)oxy)-1,4,5-trihydroxy-, (1S-(1alpha,3beta,4alpha,5alpha))-, Cyclohexanecarboxylic acid, 3-[[3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl]oxy]-1,4,5-trihydroxy-, (1S,3R,4R,5R)-, caffeoylquinic acid, CHLOROGENIC ACID (USP-RS), CHLOROGENIC ACID [USP-RS], Chlorogenic acid hemihydrate, 3-O-caffeoyl-D-quinic acid, Caffetannic acid, 1,3,4,5-Tetrahydroxycyclohexanecarboxylic acid 3-(3,4-dihydroxycinnamate, 3-Caffeoylquinate, Acid, Chlorogenic, 3-[[3-(3,4-Dihydroxyphenyl)-1-oxo-2-propenyl]oxy] 1,4,5-trihydroxycyclohexanecarboxylic acid, (1S,3R,4R,5R)-3-(((3-(3,4-dihydroxyphenyl)acryloyl)oxy)-1,4,5-trihydroxycyclohexanecarboxylic acid, [1S-(1alpha,3beta,4alpha,5alpha)]-3-[[3-(3,4-Dihydroxyphenyl)-1-oxo-2-propenyl]oxy]-1,4,5-trihydroxycyclohexanecarboxylic acid, [1S-(1alpha,3beta,4alpha,5alpha)]3-[[3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl]oxy]-1,4,5-trihydroxycyclohexanecarboxylic acid, cyclohexanecarboxylic acid, 3-[[(2E)-3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl]oxy]-1,4,5-trihydroxy-, (1S,3R,4R,5R)-, Cyclohexanecarboxylic acid, 3-[[3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl]oxy]-1,4,5-trihydroxy-, [1S-(1alpha,3beta,4alpha,5alpha)]-, 3 Caffeoylquinic Acid, Acid, 3-Caffeoylquinic, 3-trans-Caffeoylquinic acid, Hlorogenate, Helianthic acid, Igasuric acid, NSC70861, Chlorogenic-acid, NSC407296, Caffeylquinic acid, Chlorogenic acid,, (1S-(1alpha,3beta,4alpha,5alpha))3-((3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl)oxy)-1,4,5-trihydroxycyclohexanecarboxylic acid, 3-(3,4-Dihydroxycinnamoyl)quinate, CAS-327-97-9, edit(1S,3R,4R,5R)-3-(((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl)oxy)-1,4,5-trihydroxycyclohexane-1-carboxylic acid, edit(1S,3R,4R,5R)-3-{[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-1,4,5-trihydroxycyclohexane-1-carboxylic acid, Prestwick_112, (E)-chlorogenic acid, 5-caffeoyl quinic acid, Chlorogenic Acid1510, Chlorogenic acid (8CI), Prestwick2_000427, Prestwick3_000427, Spectrum5_000733, bmse000387, Quinic acid, 5-caffeoyl-, SCHEMBL19466, BSPBio_000414, BSPBio_003353, SPECTRUM210800, MLS002153805, BIDD:ER0453, BPBio1_000456, Quinic acid, 3-caffeoyl-, E-, ACon1_000581, CHEBI:95271, GTPL12477, BDBM513080, DTXSID101318952, HMS1569E16, HMS1923C11, HMS2096E16, HMS2235F03, HMS3649E06, HY-N0055, Tox21_202495, BDBM50327036, CCG-38471, s2280, AKOS015955866, AC-6032, Chlorogenic acid, >=95% (titration), CS-3766, DB12029, SDCCGMLS-0066467.P001, NCGC00168941-01, NCGC00168941-02, NCGC00168941-03, NCGC00168941-05, NCGC00260044-01, (1S,3R,4R,5R)-3-[(E)-3-(3,4-DIHYDROXY-PHENYL)-ACRYLOYLOXY]-1,4,5-TRIHYDROXY-CYCLOHEXANECARBOXYLIC ACID, (1S,3R,4R,5R)-3-[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy-1,4,5-trihydroxycyclohexane-1-carboxylicacid, 1ST40089, AS-12284, SMR000857273, Chlorogenic acid 1000 microg/mL in Acetone, NS00015066, Chlorogenic acid 10 microg/mL in Acetonitrile, C00852, F16266, Chlorogenic acid (constituent of st. john''s wort), Q421964, SR-01000841185, SR-01000946600, D54CAE3D-CDDA-455D-A28E-77FC9EFE4A43, SR-01000841185-4, SR-01000946600-1, BRD-K47114202-001-06-2, 32CF6D13-8F08-485F-B79E-F8A6AC318E07, Chlorogenic acid, primary pharmaceutical reference standard, Chlorogenic acid, European Pharmacopoeia (EP) Reference Standard, Chlorogenic acid, United States Pharmacopeia (USP) Reference Standard, 3-[(E)-3-(3,4-Dihydroxy-phenyl)-acryloyloxy]-1,4,5-trihydroxy-cyclohexanecarboxylic acid, 3-[3-(3,4-Dihydroxy-phenyl)-acryloyloxy]-1,4,5-trihydroxy-cyclohexanecarboxylic acid, (1R,3S,4S,5S)-3-[(E)-3-(3,4-Dihydroxy-phenyl)-acryloyloxy]-1,4,5-trihydroxy-cyclohexanecarboxylic acid, (1S,3R,4R,5R)-3-(((3-(3,4-dihydroxyphenyl)acryloyl)oxy)-1,4,5-trihydroxycyclohexanecarboxylicacid, (1S,3R,4R,5R)-3-((E)-3-(3,4-dihydroxyphenyl)acryloyloxy)-1,4,5-trihydroxycyclohexanecarboxylic acid, (1S,3R,4R,5R)-3-[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy-1,4,5-trihydroxy-cyclohexanecarboxylic acid, (1S,3R,4R,5R)-3-[3-(3,4-dihydroxyphenyl)prop-2-enoyloxy]-1,4,5-trihydroxycyclohexanecarboxylic acid, (1S,3R,4R,5R,E)-3-(3-(3,4-dihydroxyphenyl)acryloyloxy)-1,4,5-trihydroxycyclohexanecarboxylic acid, Chlorogenic acid (constituent of echinacea angustifolia root, echinacea pallida root, echinacea purpurea root and echinacea purpurea aerial parts), CYCLOHEXANECARBOXYLIC ACID, 3-((3-(3,4-DIHYDROXYPHENYL)-1-OXO-2-PROPENYL)OXY)-1,4,5-TRIHYDROXY-, (1S-(1-.ALPHA.,3-.BETA.,4-.ALPHA.,5-.ALPHA.))-, Cyclohexanecarboxylic acid,3-[[3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl]oxy]-1,4,5-trihydroxy-,(1S,3R,4R,5R)- C16H18O9 CWVRJTMFETXNAD-JUHZACGLSA-N (1S,3R,4R,5R)-3-[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy-1,4,5-trihydroxycyclohexane-1-carboxylic acid n.a. n.a. No Yes No No No No PMDBD2000052 Soy-derived phytoestrogens n.a. Xeno-estrogens n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD2000053 Heterocyclic aromaticamines (HAAs) n.a. Carcinogenic agents n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD2000054 7-ethyl-10-hydroxycamptothecin(SN-38) n.a. antineoplastic n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD2000055 NaringNnin n.a. compound n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD2000056 Lovastatine Therapeutic Substance Hypolipidemics n.a. n.a. n.a. n.a. D06WTZ 53232 n.a. NPC97577 "lovastatin, 75330-75-5, mevinolin, Lovalip, Mevacor, Altoprev, Mevlor, Sivlor, Lovalord, Nergadan, Altocor, Artein, MK-803, Monacolin K, Cholestra, Closterol, Hipovastin, Lestatin, Lipofren, Lovasterol, Lovastin, Tecnolip, Teroltrat, 6alpha-Methylcompactin, Belvas, Colevix, Hipolip, Lipdip, Lipivas, Lozutin, Paschol, Rodatin, Rovacor, Taucor, Lovastatine, 6-alpha-Methylcompactin, Mevinacor, Lovastatine [French], Lovastatinum [Latin], Lovastatina [Spanish], Lovastatinum, Lovastatina, MSD 803, HSDB 6534, UNII-9LHU78OQFD, 9LHU78OQFD, (+)-mevinolin, NSC-758662, Lovastatin [USAN], BRN 3631989, CCRIS 8092, MLS000069585, DTXSID5020784, L-154803, CHEBI:40303, Lovastatin (Standard), C10AA02, ML-530B, 6.alpha.-Methylcompactin, Lovastatin (MK-803), MK 803, 2beta,6alpha-Dimethyl-8alpha-(2-methyl-1-oxobutoxy)-mevinic acid lactone, SMR000058779, DTXCID50784, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-Hexahydro-3,7-dimethyl-8-(2-(2R,4R)-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl (S)-2-methyl-butyrate, (1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (2S)-2-methylbutanoate, (1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (2S)-2-methylbutanoate, [(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate, EC 616-212-7, ADVICOR COMPONENT LOVASTATIN, Lovastatin [USAN:USP:INN:BAN], 6-Methylcompactin, MFCD00072164, NSC633781, LOVASTATIN COMPONENT OF ADVICOR, Lovastatin (Mevacor), Lovastatinum (Latin), NSC 758662, NCGC00023509-03, 6 Methylcompactin, LOVASTATIN (MART.), LOVASTATIN [MART.], LOVASTATIN (USP-RS), LOVASTATIN [USP-RS], butanoic acid, 2-methyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester, (2S)-, LOVASTATIN (EP MONOGRAPH), LOVASTATIN [EP MONOGRAPH], Liposcler, LOVASTATIN (USP MONOGRAPH), LOVASTATIN [USP MONOGRAPH], 6 alpha-Methylcompactin, Rextat, Lovastatin (USAN:USP:INN:BAN), Monakolin K, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-Hexahydro-8-(2-((4R,6R)-4-hydroxy-2-oxo-2H-pyran-6-yl)ethyl)-3,7-dimethylnaphtyl(S)-2-methylbutyrat, (1S,3R,7S,8S,8aR)-8-(2-((2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl)ethyl)-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (S)-2-methylbutanoate, (S)-(1S,3R,7S,8S,8aR)-8-(2-((2R,4R)-4-Hydroxy-6-oxotetrahydro-2H-pyran-2-yl)ethyl)-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2-methylbutanoate, Mevacor (TN), SIMVASTATIN IMPURITY E (EP IMPURITY), SIMVASTATIN IMPURITY E [EP IMPURITY], CHEMBL503, Lovastatin & Primycin, Lovastatin (USP/INN), SR-05000001880, (1S-(1alpha(R*),3alpha,7beta,8beta(2S*,4S*),8abeta))-2-Methylbutanoic acid 1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester, (S)-2-Methylbutyric acid, 8-ester with (4R,6R)-6-(2-((1S,2S,6R,8S,8aR)-1,2,6,7,8,8a-hexahydro-8-hydroxy-2,6-dimethyl-1-naphthyl)ethyl)tetrahydro-4-hydroxy-2H-pyran-2-one, 1,2,6,7,8,8a-Hexahydro-beta,delta-dihydroxy-2,6-dimethyl-8-(2-methyl-1-oxobutyoxy)-1-naphthaleneheptanoic acid delta-lactone, Mevinolin from Aspergillus sp., 1cqp, Lovastatin,(S), (1S,3R,7S,8S,8aR)-8-(2-((2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl)ethyl)-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (2S)-2-methylbutanoate, (2S)-2-METHYLBUTANOIC ACID (1S,3R,7S,8S,8AR)-1,2,3,7,8,8A-HEXAHYDRO-3,7-DIMETHYL-8-(2-((2R,4R)-TETRAHYDRO-4-HYDROXY-6-OXO-2H-PYRAN-2-YL)ETHYL)-1-NAPHTHALENYL ESTER, (2S)-2-Methylbutanoic acid (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester, (S)-((1S,3R,7S,8S,8aR)-8-(2-((2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl)ethyl)-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl) 2-methylbutanoate, [(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxo-tetrahydropyran-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate, Lovastatin- Bio-X, Prestwick_819, CAS-75330-75-5, Mevinolin (lovastatin), LOVASTATIN [MI], LOVASTATIN [INN], Opera_ID_1578, Prestwick0_000516, Prestwick1_000516, Prestwick2_000516, Prestwick3_000516, Spectrum3_001873, Spectrum5_001294, LOVASTATIN [HSDB], LOVASTATIN [VANDF], SCHEMBL3136, LOVASTATIN [WHO-DD], US9115116, lovastatin, BIDD:PXR0113, BSPBio_000471, BSPBio_001265, BSPBio_003346, 74133-25-8, Butanoic acid, 2-methyl-, 1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester, (1S-(1alpha(R*),3alpha,7beta,8beta(2S*,4S*),8abeta))-, cid_53232, MLS001055358, MLS006011867, US9353061, Lovastatina, BIDD:GT0749, DivK1c_001032, SPECTRUM1503977, SPBio_002392, BPBio1_000519, GTPL2739, MEGxm0_000398, LOVASTATIN [ORANGE BOOK], SCHEMBL14227102, ACon0_000534, ACon1_000390, BDBM34168, HMS503O05, HY-N0504R, KBio1_001032, KBio3_002848, Simvastatin impurity, lovastatin-, Lovastatin for peak identification, NINDS_001032, HMS1569H13, HMS1792O07, HMS1923O13, HMS1990O07, HMS2089M06, HMS2093O03, HMS2096H13, HMS2236F07, HMS3039N16, HMS3259F10, HMS3268C03, HMS3403O07, HMS3412H19, HMS3676H19, HMS3713H13, HMS3884B03, Pharmakon1600-01503977, (S)-2-Methylbutyric acid, 8-ester with (4R,6R)-6-[2-[(1S,2S,6R,8S,8aR)-1,2,6,7,8,8a-hexahydro-8-hydroxy-2,6-dimethyl-1-naphthyl]ethyl]tetrahydro-4-hydroxy-2H-pyran-2-one, 2-Methyl-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-1-naphthalenyl ester butanoic acid, Butanoic acid, 2-methyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-((2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester, (2S)-, HY-N0504, MK-803; LOVALIP; MEVACOR, Tox21_110888, Tox21_201475, Tox21_300268, CCG-39627, NSC758662, NSC779704, s2061, AKOS005267139, Tox21_110888_1, CS-1990, DB00227, KS-1082, Mevinolin from Aspergillus sp., powder, NC00713, NSC-633781, NSC-779704, IDI1_001032, NCGC00023509-04, NCGC00023509-05, NCGC00023509-06, NCGC00023509-07, NCGC00023509-08, NCGC00023509-09, NCGC00023509-10, NCGC00023509-11, NCGC00023509-13, NCGC00023509-14, NCGC00023509-16, NCGC00254157-01, NCGC00259026-01, AC-13961, BL164644, Butanoic acid, 2-methyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester, (2S)-, G226, SMR000673570, SBI-0051881.P002, CS-0694830, L0214, NS00000544, EN300-52515, C07074, D00359, AB00052400-17, AB00052400_18, AB00052400_19, Mevinolin from Aspergillus sp., >=98% (HPLC), A838030, A838383, Q417740, SR-01000000123, SR-01000000123-3, SR-05000001880-1, SR-05000001880-2, BRD-K09416995-001-06-8, BRD-K09416995-001-21-7, Mevacor;Monacolin K;mevinolin;6-alpha-Methylcompactin, SIMVASTATIN IMPURITY, LOVASTATIN-(USP IMPURITY), SIMVASTATIN IMPURITY, LOVASTATIN- [USP IMPURITY], Z754931258, (2S)-(1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-Hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl-2-methyl butanoate, (2S)-2-methylbutanoic acid [(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxo-2-oxanyl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] ester, (S)-2-Methyl-butyric acid (1S,3R,7S,8S,8aR)-8-[2-((3R,5R)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl ester, [(1S,3R,7S,8S,8aR)-3,7-dimethyl-8-[2-[(2R,4R)-4-oxidanyl-6-oxidanylidene-oxan-2-yl]ethyl]-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate, [(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-Hydroxy-6-oxo-tetrahydropyran-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] 2-methylbutanoate, 1S,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (2S)-2-methylbutanoate, 8-[2-(4-Hydroxy-6-oxotetrahydro-2H-pyran-2-yl)ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydro-1-naphthale, Butanoic acid, 2-methyl-, 1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(tetrahydro-4-hydroxy-6-- oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester, (1S-(1alpha(R*),3alpha,7beta,8beta(2S*,4S*),8abeta))-, BUTANOIC ACID, 2-METHYL-, 1,2,3,7,8,8A-HEXAHYDRO-3,7-DIMETHYL-8-(2-(TETRAHYDRO-4-HYDROXY-6-OXO-2H-PYRAN-2-YL)ETHYL)-1-NAPHTHALENYL ESTER, (1S-(1.ALPHA.(R*),3.ALPHA.,7.BETA.,8.BETA.(2S*,4S*),8.ALPHA..BETA.))-" C24H36O5 PCZOHLXUXFIOCF-BXMDZJJMSA-N [(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate Atos Pharma Anticholesteremic Agents No Yes No No No No PMDBD2000057 Cisplatin Therapeutic Substance Antitumor 15663-27-1 DB00515 PA449014 D00275 D0U5HU 5702198 76401 n.a. "cisplatin, 14913-33-8, trans-Dichlorodiamineplatinum(II), azane;dichloroplatinum, Platinum, diamminedichloro-, (SP-4-1)-, trans-Diamminedichloro platinum(II), MFCD00011623, trans-Platinum(II)diammine dichloride, CACP, trans-Dichlorodiamineplatinum(II);Transplatin, SR-05000001586, IA call, Trans-Platinum diammine dichloride, Cisplatin in water, Cisplatin,(S), Cisplatin in DMSO, CPDC, DDP-H, PLATINOL (TN), SPECTRUM1502107, Cisplatin (JP17/USP/INN), cis-Diaminodichloroplatinum(II), cis-Dichlorodiamine platinum(II), HMS502M12, HMS1921J18, HMS2092D04, BCP01792, BCP18182, CCG-39901, AKOS005137969, NCGC00094962-01, NCGC00094962-02, NCGC00094962-03, NS00134107, C06911, D00275, cis-Diammineplatinum(II) dichloride, crystalline, Q412415, SR-01000076254, SR-01000076254-1, SR-05000001586-1, SR-05000001586-3, Z3182781436, Cisplatin, European Pharmacopoeia (EP) Reference Standard, Cisplatin, United States Pharmacopeia (USP) Reference Standard, cis-Diamineplatinum(II) dichloride, >=99.9% trace metals basis, Cisplatin impurity A, European Pharmacopoeia (EP) Reference Standard, Transplatin, United States Pharmacopeia (USP) Reference Standard, Cisplatin, Pharmaceutical Secondary Standard; Certified Reference Material" Cl2H6N2Pt LXZZYRPGZAFOLE-UHFFFAOYSA-L "azane;dichloroplatinum" Bristol-Myers Squibb Anticancer Agents No Yes No No No No PMDBD2000058 Salicin Therapeutic Substance compound n.a. n.a. n.a. n.a. D06BQU 439503 n.a. NPC226712 "salicin, 138-52-3, Salicoside, D-(-)-Salicin, Salicine, D(-)-Salicin, Salicyl alcohol glucoside, D-Salicin, (2R,3S,4S,5R,6S)-2-(Hydroxymethyl)-6-(2-(hydroxymethyl)phenoxy)tetrahydro-2H-pyran-3,4,5-triol, 2-(Hydroxymethyl)phenyl beta-D-glucopyranoside, Saligenin beta-D-glucopyranoside, Saligenin-beta-D-glucopyranoside, 2-(Hydroxymethyl)phenyl-beta-d-glucopyranoside, alpha-Hydroxy-o-tolyl beta-D-glucopyranoside, Salicinum, beta-D-Glucopyranoside, 2-(hydroxymethyl)phenyl, C13H18O7, o-(Hydroxymethyl)phenyl beta-D-glucopyranoside, Benzyl alcohol, o-hydroxy-, o-glucoside, AI3-19099, MFCD00006590, SPECTRUM1502255, (2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[2-(hydroxymethyl)phenoxy]oxane-3,4,5-triol, B-D-Glucopyranoside, 2-(hydroxymethyl)phenyl, CHEBI:17814, NSC-5751, D-()-Salicin, 4649620TBZ, SDCCGMLS-0066698.P001, NCGC00142605-01, NSC 5751, (2R,3S,4S,5R,6S)-2-(Hydroxymethyl)-6-(2-(hydroxymethyl)-phenoxy)tetrahydro-2H-pyran-3,4,5-triol, SMR000112301, Salicin [USP], SR-05000001594, Salicin (6CI,8CI), EINECS 205-331-6, delta-Salicin, UNII-4649620TBZ, Saligenin glucoside, SA0, D-(?)-Salicin, Spectrum_001230, 2-(Hydroxymethyl)phenyl-.beta.-d-glucopyranoside, SALICIN [INCI], SALICIN [MI], SALICINUM [HPUS], Spectrum2_000756, Spectrum3_000948, Spectrum4_001058, Spectrum5_000971, D-()-Salicin;Salicoside, bmse000315, D-SALICIN [USP-RS], SCHEMBL24936, KBioGR_001356, KBioSS_001710, Saligenin-b-D-glucopyranoside, MLS000563050, MLS001306490, DivK1c_000030, S0625_SIGMA, SPBio_000772, CHEMBL462997, MEGxp0_000685, Salicin (Salicoside, Salicine), ACon1_000373, GTPL12454, HMS500B12, KBio1_000030, KBio2_001710, KBio2_004278, KBio2_006846, KBio3_002016, DTXSID10883326, NINDS_000030, GLXC-13826, HMS1921P08, HMS2092F14, HMS2268J11, HMS3884B15, Pharmakon1600-01502255, HY-N0149, Saligenin beta-delta-glucopyranoside, Saligenin-beta-delta-glucopyranoside, D-(-)-Salicin, analytical standard, CCG-40332, NSC758201, s2351, ZINC03847505, 2-(Hydroxymethyl)phenyl hexopyranoside, AKOS004907439, AC-8042, CS-8027, D-(-)-Salicin, >=99% (GC), NSC-758201, IDI1_000030, NCGC00142605-02, NCGC00142605-04, (2S,4S,5S,3R,6R)-6-(hydroxymethyl)-2-[2-(hydroxymethyl)phenoxy]-2H-3,4,5,6-tet rahydropyran-3,4,5-triol, 1ST40324, SALICYL ALCOHOL GLUCOSIDE [WHO-DD], SBI-0051746.P002, 2(hydroxymethyl)phenyl-beta-D-glucopyranoside, NS00015239, S0003, SW219123-1, C01451, 2-(Hydroxymethyl)-phenyl-beta-D-glucopyranoside, 2-(hydroxymethyl)phenyl-O-beta-D-glucopyranoside, AB00052296_07, Q419173, SR-05000001594-1, SR-05000001594-2, BRD-K64614248-001-02-4, BRD-K64614248-001-06-5, EAD32BE1-198E-432C-9F44-DC0DC9A3305B, Salicin, European Pharmacopoeia (EP) Reference Standard, D-Salicin, United States Pharmacopeia (USP) Reference Standard, WURCS=2.0/1,1,0/[a2122h-1b_1-5_1*O(C^ZC^ZC^ZC^ZC^ZC^E$3)/4CO]/1/, 2-(Hydroxymethyl)phenyl-beta-D-glucopyranoside, Salicoside, Salicyl alcohol glucoside, Saligenin beta-D-glucoside" C13H18O7 NGFMICBWJRZIBI-UJPOAAIJSA-N (2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[2-(hydroxymethyl)phenoxy]oxane-3,4,5-triol n.a. n.a. No Yes No No No No PMDBD2000059 Roflumilast Therapeutic Substance Drugs for obstructive airway disease 162401-32-3 DB01656 PA165948052 D05744 D0R4UW 449193 395793 n.a. Roflumilast, 162401-32-3, DAXAS, 3-(CYCLOPROPYLMETHOXY)-N-(3,5-DICHLOROPYRIDIN-4-YL)-4-(DIFLUOROMETHOXY)BENZAMIDE, Daliresp, BY217, BYK20869, BY-217, B9302-107, ZORYVE, BY 217, roflumilastum, Benzamide, 3-(cyclopropylmethoxy)-N-(3,5-dichloro-4-pyridinyl)-4-(difluoromethoxy)-, 3-(Cyclopropylmethoxy)-N-(3,5-dichloro-4-pyridinyl)-4-(difluoromethoxy)benzamide, UNII-0P6C6ZOP5U, 0P6C6ZOP5U, BYK-20869, Roflumilast (Daxas), CHEBI:47657, B 9302-107, CHEMBL193240, DTXSID8044123, ARQ-151, 3-cyclopropylmethoxy-4-difluoromethoxy-N-(3,5-di-chloropyrid-4-yl)benzamide, 3-Cyclopropylmethoxy-N-(3,5-dichloropyridin-4-yl)-4-(difluoromethoxy)benzamide, BYK 20869, MFCD00938270, B-9302-107, ROF, Libertek, Roflumilast [USAN], ROFLUMILAST (MART.), ROFLUMILAST [MART.], C17H14Cl2F2N2O3, Roflumilast [USAN:INN], Roflumilast (JAN/USAN/INN), APTA-2217, 1xmu, 1xoq, Daliresp (TN), Roflumilast- Bio-X, 3g4l, ROFLUMILAST [MI], ROFLUMILAST [INN], ROFLUMILAST [JAN], ROFLUMILAST [VANDF], SCHEMBL19158, ROFLUMILAST [WHO-DD], MLS006010074, ARQ-154 (Roflumilast foam), ROFLUMILAST [EMA EPAR], ARQ-151 (roflumilast cream), GTPL6962, DTXCID6024123, APTA 2217, BDBM14774, Roflumilast, >=98% (HPLC), AMY4219, EX-A059, R03DX07, ROFLUMILAST [ORANGE BOOK], HMS3655P21, HMS3748C19, HMS3884F09, BCP03736, s2131, ARQ-151/Zoryve (roflumilast cream), AKOS005146309, AM84550, CCG-268678, CS-0963, DB01656, PB29130, NCGC00346566-01, NCGC00346566-09, AC-23383, AS-14120, BR164364, HY-15455, SMR002530074, SY008710, BCP0726000146, NS00040687, R0193, SW220196-1, A24672, D05744, AB01565852_02, EN300-7365610, Q693482, J-510858, BRD-K03194791-001-02-2, 3- cyclo-propylmethoxy-4-difluoromethoxy-N- [3, 5-di-chloropyrid-4-yl]- benzamid, Benzamide, 3-(cyclopropylmethoxy)-N-(3,5-dichloro-4-pyridinyl)-4-(difluoromethoxy)-, n-(3,5-dichloropyridin-4-yl)-4-difluoromethoxy-3-cyclopropylmethoxybenzamide C17H14Cl2F2N2O3 MNDBXUUTURYVHR-UHFFFAOYSA-N 3-(cyclopropylmethoxy)-N-(3,5-dichloropyridin-4-yl)-4-(difluoromethoxy)benzamide Nycomed US Inc n.a. No Yes No No No No PMDBD2000060 Nivolumab Therapeutic Substance Anticancer 946414-94-4 DB09035 n.a. D10316 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD2000061 Carboplatin Therapeutic Substance antineoplastic alkylating? 41575-94-4 DB00958 PA448803 D01363 D0X7HM 426756 8514637 n.a. "41575-94-4, Carboplatin, Paraplatin, Cbdca, Carboplatinum, MFCD00070464, NSC-241240, cis-(1,1-Cyclobutanedicarboxylato)diammineplatinum(II), cis-Diammine(1,1-cyclobutanedicarboxylato)platinum(II), 1,1-Cyclobutanedicarboxylate diammine platinum(II), cis-Diammine(1,1-cyclobutanedicarboxylato)platinum, DTXSID3046742, CHEBI:31355, DTXCID201476080, NSC201345, NSC241240, Platinum(II),1-cyclobutanedicarboxylato)diammine-, cis-, Platinum,1-cyclobutanedicarboxylato(2-)-O,O'')-, (SP-4-2)-, Platinum,1-cyclobutanedicarboxylato(2-)-O,O'']-, (SP-4-2)-, Epitope ID:194801, SCHEMBL4964, 1,1-Cyclobutanedicarboxylatodiammineplatinum(II), Paraplatin (Bristol Meyers), Lopac0_000230, HMS3269H03, Pharmakon1600-01502106, NSC758182, Tox21_112586_1, NSC-758182, NCGC00167800-01, NCGC00263858-02, BP-25385, SY075575, CAS-41575-94-4, NS00076275, EN300-123065, AB01273939-01, azanide;cyclobutane-1,1-dicarboxylic acid;platinum(2+), 7,7-diamino-6,8-dioxa-7-platinaspiro[3.5]nonane-5,9-dione, Platinum, diammine[1,1-cyclobutanedicarboxylato(2-)-.kappa.O,.kappa.O'''']-, (SP-4-2)-" C6H12N2O4Pt VSRXQHXAPYXROS-UHFFFAOYSA-N "azanide;cyclobutane-1,1-dicarboxylic acid;platinum(2+)" Bristol-Myers Squibb Anticancer Agents No Yes No No No No PMDBD2000062 Medroxyprogesterone Acetate n.a. hormone n.a. n.a. n.a. n.a. n.a. 6279 n.a. n.a. "Medroxyprogesterone acetate, Medroxyprogesterone 17-acetate, 71-58-9, Provera, Metigestrona, Depo-Provera, Farlutin, Gestapuran, Perlutex, Veramix, Methylacetoxyprogesterone, Amen, Medroxyacetate progesterone, Clinovir, Depcorlutin, Deporone, Lutopolar, Nadigest, Prodasone, Progestalfa, Progevera, Proverone, Repromix, Sirprogen, Supprestral, Nidaxin, Oragest, Depo-Promone, Promone-E, NSC-26386, Depot-medroxyprogesterone acetate, 6-alpha-Methyl-17-alpha-acetoxyprogesterone, Cycrin, Medroxyprogesteroneacetate, Depo-Subq Provera 104, 6-alpha-Methyl-17-alpha-hydroxyprogesterone acetate, 17alpha-Hydroxy-6alpha-methylprogesterone acetate, 6alpha-Methyl-17alpha-hydroxyprogesterone acetate, 6alpha-Methyl-4-pregnene-3,20-dion-17alpha-ol acetate, Depot medroxyprogesterone acetate, DP150, Pregn-4-ene-3,20-dione, 17-(acetyloxy)-6-methyl-, (6alpha)-, 17-Acetoxy-6alpha-methylprogesterone, Aragest, Ralovera, 6alpha-Methyl-17-acetoxy progesterone, Hysron, Provera dosepak, Depo-clinovir, Depo-Ralovera, NSC-21171, U 8839, C2QI4IOI2G, Medroxyprogesterone (acetate), MLS000069442, MLS001148217, (6alpha)-17-(Acetyloxy)-6-methylpreg-4-ene-3,20-dione, (6alpha)-6-methyl-3,20-dioxopregn-4-en-17-yl acetate, 17-Hydroxy-6alpha-methylpregn-4-ene-3,20-dione acetate, CHEBI:6716, DTXSID0025527, ONCO-Provera, Medroxyprogesterone acetate (Standard), Medrosterona, Clinofem, Cykrina, Depocon, Indivina, Mepastat, Meprate, Repromap, SMR000059125, Sumiferm, Suprestral, TV-46046, Veraplex, Dugen, Depo-progestin, Depo-Prodasone, Depo-Progevera, Perlutex Leo, Depo-Map, Aragest 5, Med-Pro, MPA-beta, MPA Hexal, MPA-Noury, MAP (steroid), 17alpha-Acetoxy-6alpha-methylprogesterone, Depomedroxyprogesterone acetate, DTXCID905527, MPA GYM, Depo-Medroxyprogesterone acetate, Depo-subq provera, CAS-71-58-9, Medroxy Progesterone 17-Acetate, CCRIS 371, 17.alpha.-Acetoxy-6.alpha.-methylprogesterone, Medroxyprogesterone acetate [JAN], EINECS 200-757-9, UNII-C2QI4IOI2G, 6alpha-Methyl-17-acetoxyprogesterone, NSC 21171, Depo-Provera Contraceptive, 17-Acetoxy-6-alpha-methylprogesterone, (6.alpha.-Pregn-4-ene-3, 17-(acetyloxy)-6-methyl-, 17.alpha.-Hydroxy-6-.alpha.-methylprogesterone acetate, Pregn-4-ene-3, 17-hydroxy-6.alpha.-methyl-, acetate, 6-alpha-Methyl-17-acetoxy progesterone, BRN 2066112, Pregn-4-ene-3, 17-(acetyloxy)-6-methyl-, (6.alpha.)-, Medroxyprogesterone 17 Acetate, AI3-60127, Pregn-4-ene-3,20-dione, 17-(acetyloxy)-6-methyl-, (6.alpha.)-, 17-Acetoxy-6.alpha.-methylprogesterone, 6.alpha.-Methyl-17-acetoxyprogesterone, NCGC00094713-01, 17alpha-Hydroxy-6-alpha-methylprogesterone acetate, Progesterone, 17-hydroxy-6alpha-methyl-, acetate, 17-alpha-Hydroxy-6-alpha-methylprogesterone acetate, Provera (TN), Depo-provera (TN), 6alpha-Methyl-17alpha-acetoxypregn-4-ene-3,20-dione, Medroxyprogesterone acetate [USP:JAN], 17-alpha-Acetoxy-6-alpha-methylpregn-4-ene-3,20-dione, 17alpha-Acetoxy-6-alpha-methylpregn-4-ene-3,20-dione, 6-alpha-Methyl-17-alpha-acetoxypregn-4-ene-3,20-dione, Progesterone, 17-alpha-hydroxy-6-alpha-methyl-, acetate, Medroxyprogesterone acetate [Progestins], 6-alpha-Methyl-4-pregnene-3,20-dion-17-alpha-ol acetate, 6.alpha.-Methyl-17.alpha.-acetoxyprogesterone, (6-alpha)-17-(Acetyloxy)-6-methylpreg-4-ene-3,20-dione, 17alpha-Hydroxy-6alpha-methylpregn-4-ene-3,20-dione acetate, 6alpha-Pregn-4-ene-3,20-dione, 17-(acetyloxy)-6-methyl-, CPD000653524, 17-alpha-Hydroxy-6-alpha-methylpregn-4-ene-3,20-dione acetate, Pregn-4-ene-3,20-dione, 17-(acetyloxy)-6-methyl-, (6a)-, Medroxyprogesteroni acetas, Opera_ID_1110, medroxyprogesterone-acetate, 17.alpha.-Hydroxy-6.alpha.-methylprogesterone acetate, 6.alpha.-Methyl-17.alpha.-hydroxyprogesterone acetate, Medroxiprogesterone Acetate, CHEMBL717, SCHEMBL4276, 6.alpha.-Methyl-17.alpha.-acetoxypregn-4-ene-3,20-dione, 17.alpha.-Acetoxy-6-.alpha.-methylpregn-4-ene-3,20-dione, 4-08-00-02212 (Beilstein Handbook Reference), 6.alpha.-Methyl-4-pregnene-3,20-dion-17.alpha.-ol acetate, MLS002207115, 17.alpha.-Hydroxy-6.alpha.-methylpregn-4-ene-3,20-dione acetate, Depo-subq provera 104 (TN), HY-B0469R, HMS2233O07, HMS2235E05, HMS3259O14, HMS3884B10, Pregn-4-ene-3,20-dione, 17-hydroxy-6alpha-methyl-, acetate, (6-alpha)-Pregn-4-ene-3,20-dione, 17-(acetyloxy)-6-methyl-, (6S,8R,9S,10R,13S,14S,17R)-17-Acetyl-6,10,13-trimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl acetate, CBP-1011, HY-B0469, NSC21171, NSC26386, Tox21_111319, Tox21_200141, BDBM50067678, s2567, AKOS015894870, Tox21_111319_1, AC-2174, CCG-264965, DB00603, NC00574, Medroxyprogesterone acetate (JP17/USP), MRF-0000023, NCGC00022037-03, NCGC00022037-04, NCGC00022037-05, NCGC00022037-07, NCGC00257695-01, NCGC00263480-01, AS-13981, MEDROXYPROGESTERONE ACETATE [IARC], SMR000653524, MEDROXYPROGESTERONE ACETATE [MART.], MEDROXYPROGESTERONE ACETATE [VANDF], MEDROXYPROGESTERONE 17-ACETATE [MI], MEDROXYPROGESTERONE ACETATE [USP-RS], MEDROXYPROGESTERONE ACETATE [WHO-DD], MEDROXYPROGESTERONE ACETATE [WHO-IP], CS-0694837, NS00006415, C08150, C76275, D00951, AB00384270-14, AB00384270_15, EN300-7480751, Medroxyprogesterone 17-acetate, >=97% (HPLC), MEDROXYPROGESTERONE ACETATE [ORANGE BOOK], MEDROXYPROGESTERONI ACETAS [WHO-IP LATIN], MEDROXYPROGESTERONE ACETATE [EP MONOGRAPH], MEDROXYPROGESTERONE ACETATE [USP MONOGRAPH], MEGESTROL ACETATE IMPURITY A [EP IMPURITY], LUNELLE COMPONENT MEDROXYPROGESTERONE ACETATE, PREMPRO COMPONENT MEDROXYPROGESTERONE ACETATE, Q2823834, (6?)-6-Methyl-3,20-dioxopregn-4-en-17-yl acetate, 6.alpha.-Pregn-4-ene-3, 17-(acetyloxy)-6-methyl-, MEDROXYPROGESTERONE ACETATE COMPONENT OF LUNELLE, MEDROXYPROGESTERONE ACETATE COMPONENT OF PREMPRO, PREMPHASE COMPONENT MEDROXYPROGESTERONE ACETATE, MEDROXYPROGESTERONE ACETATE COMPONENT OF PREMPHASE, Medroxyprogesterone-17-acetate 100 microg/mL in Acetonitrile, Medroxyprogesterone 17-acetate, VETRANAL(TM), analytical standard, Medroxyprogesterone acetate, European Pharmacopoeia (EP) Reference Standard, Medroxyprogesterone Acetate, Pharmaceutical Secondary Standard; Certified Reference Material, Medroxyprogesterone acetate, United States Pharmacopeia (USP) Reference Standard, (1R,3aS,3bR,5S,9aR,9bS,11aS)-1-acetyl-5,9a,11a-trimethyl-7-oxo-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-1-yl acetate, Medroxyprogesterone acetate for peak identification, European Pharmacopoeia (EP) Reference Standard, Medroxyprogesterone acetate for system suitability, European Pharmacopoeia (EP) Reference Standard, Medroxyprogesterone acetate, for performance test, European Pharmacopoeia (EP) Reference Standard" C24H34O4 PSGAAPLEWMOORI-PEINSRQWSA-N [(6S,8R,9S,10R,13S,14S,17R)-17-acetyl-6,10,13-trimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate n.a. n.a. No Yes No No No No PMDBD2000063 Irinotecan (CPT-11) n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000064 Anti-CTLA-4 mAbs n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000065 Anti-PD-1/PD-L1 mAbs n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000066 Tolmetin Therapeutic Substance Approved Drug 26171-23-3 DB00500 PA451721 n.a. D09BHB 5509 5308 n.a. tolmetin, 26171-23-3, 1-Methyl-5-p-toluoylpyrrole-2-acetic acid, Tolectin, Tolmetine, Tolmetinum, Tolmetina, Tolmetino, Tolmetina [DCIT], McN-2559, 1H-Pyrrole-2-acetic acid, 1-methyl-5-(4-methylbenzoyl)-, Tolmetine [INN-French], Tolmetinum [INN-Latin], Tolmetino [INN-Spanish], 2-(1-METHYL-5-(4-METHYLBENZOYL)-1H-PYRROL-2-YL)ACETIC ACID, MCN 2559, 1-Methyl-5-(4-methylbenzoyl)-pyrrole-2-acetic acid, 5-(p-Toluoyl)-1-methylpyrrole-2-acetic acid, 2-[1-methyl-5-(4-methylbenzoyl)pyrrol-2-yl]acetic acid, HSDB 3403, UNII-D8K2JPN18B, EINECS 247-497-2, D8K2JPN18B, Acido 1-metil-5-(p-tolnil)-pirrol-2-acetico, Pyrrole-2-acetic acid, 1-methyl-5-p-toluoyl-, BRN 0485305, 2-[1-methyl-5-(4-methylbenzoyl)-1H-pyrrol-2-yl]acetic acid, CHEBI:71941, 1-Methyl-5-(4-methylbenzoyl)-1H-pyrrole-2-acetic acid, CHEMBL1020, DTXSID2043951, 2-{1-methyl-5-[(4-methylphenyl)carbonyl]-1H-pyrrol-2-yl}acetic acid, 5-22-06-00392 (Beilstein Handbook Reference), [1-Methyl-5-(4-methylbenzoyl)-1H-pyrrol-2-yl]acetic acid, Tolmetine (INN-French), Tolmetinum (INN-Latin), Tolmetino (INN-Spanish), 1-Methyl-5-p-toluoyl-pyrrole-2-acetic acid, Tolmetin (USAN/INN), McN-2559-21-98, (1-methyl-5-(4-methylbenzoyl)-1H-pyrrol-2-yl)acetic acid, Tolmetin [USAN:INN:BAN], Acido 1-metil-5-(p-tolnil)-pirrol-2-acetico [Spanish], Spectrum_000935, TOLMETIN [HSDB], TOLMETIN [USAN], TOLMETIN [INN], TOLMETIN [JAN], TOLMETIN [MI], TOLMETIN [VANDF], Prestwick0_000856, Prestwick1_000856, Prestwick2_000856, Prestwick3_000856, Spectrum2_001205, Spectrum3_000603, Spectrum4_000359, Spectrum5_001194, TOLMETIN [WHO-DD], SCHEMBL3150, Oprea1_869397, BSPBio_000871, BSPBio_002106, KBioGR_000797, KBioSS_001415, BIDD:GT0468, DivK1c_000213, SPBio_000990, SPBio_002792, BPBio1_000959, GTPL7311, DTXCID0023951, KBio1_000213, KBio2_001415, KBio2_003983, KBio2_006551, KBio3_001606, M01AB03, M02AA21, NINDS_000213, HMS2090D06, HMS3886I03, BCP09085, HY-B1799, BDBM50295287, MFCD00599595, s4832, AKOS015850645, CCG-267033, CS-W008734, DB00500, GS-6529, SB63879, IDI1_000213, NCGC00094796-03, 1-Methyl-5-p-toluoylpyrrole-2-aceticacid, SBI-0051537.P002, NS00008120, 1-methyl- 5-(p-toluoyl)pyrrole-2-acetic acid, C07149, D02355, EN300-6482019, A818238, 1-Methyl-5-(4-methylbenzoyl)pyrrole-2-acetic acid, J-504975, Q3992411, BRD-K82562631-236-02-0, BRD-K82562631-325-03-9, F6782-4251, Z1741975772, [1-Methyl-5-(4-methyl-benzoyl)-1H-pyrrol-2-yl]-acetic acid, [1-Methyl-5-(4-methylbenzoyl)-1H-pyrrol-2-yl]acetic acid #, [1-Methyl-5-(4-methyl-benzoyl)-1H-pyrrol-2-yl]-acetic acid(tolmetin), TLT C15H15NO3 UPSPUYADGBWSHF-UHFFFAOYSA-N 2-[1-methyl-5-(4-methylbenzoyl)pyrrol-2-yl]acetic acid Ortho Mcneil Janssen Pharmaceuticals Inc Antiinflammatory Agents No No No No No No PMDBD2000067 Amphotericin B Therapeutic Substance Approved Drug 1397-89-3 DB00681 PA448415 D00203 D02DWM 5280965 10237579 n.a. "amphotericin b, 1397-89-3, Amphotericin, Amphotericine B, Halizon, Fungizone, Ampho-Moronal, Amphotericinum B, Amphocin, Amphotec, Fungilin, Amfotericina B, AMPH-B, Amphozone, Liposomal Amphotericin B, Ambisome, Abelcet, Amphotocerin, Abelecet, ABLC, Ambil, Amphotericin-B, Anfotericine B, Amphotericin B liposome, Mysteclin-F, UNII-7XU7A7DROE, 7XU7A7DROE, NSC 527017, CCRIS 5963, CHEBI:2682, HSDB 3008, amphotericin B liposomal, Amphotericin B (85%), EINECS 215-742-2, MFCD00877763, NS 718, BRN 0078342, ABELCET, LIPOSOMAL AMPHOTERICIN B, Fungisone, AI3-26528, Amfotericina B [INN-Spanish], Amphotericine B [INN-French], Amphotericinum B [INN-Latin], DTXSID9022601, Amphotericin B [USP:INN:JAN], 5-18-10-00525 (Beilstein Handbook Reference), NSC-527017, (1R-(1R*,3S*,5R*,6R*,9R*,11R*,15S*,16R*,17R*,18S*,19E,21E,23E,25E,27E,29E,31E,33R*,35S*,36R*,37S*))-33-((3-Amino-3,6-dideoxy-beta-D-mannopyranosyl)oxy)-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo(33.3.1)nonatriaconta-19,21,23,25,27,29,31-heptaene-36-carboxylic acid, 14,39-Dioxabicyclo(33.3.1)nonatriaconta-19,21,23,25,2 7,29,31-heptaene-36-carboxylic acid, 33-((3-amino-3,6-dideoxy-beta-D-mannopyranosyl)oxy)-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-(1R-(1R*,3S*,5R*,6R*,9R*,11R*,15S*,16R*,17R*,18S*,19E,21E,23E, 25E-27E,29E,31E,33R*,35S*,36R*,37S*))-, Amfotericina B (INN-Spanish), Amphotericine B (INN-French), Amphotericinum B (INN-Latin), AMPHOTERICIN B (MART.), AMPHOTERICIN B [MART.], AMPHOTERICIN B (USP-RS), AMPHOTERICIN B [USP-RS], Amphotericin B (USP:INN:JAN), Amphomoronal, Amphortericin B, AMPHOTERICIN B (EP MONOGRAPH), AMPHOTERICIN B [EP MONOGRAPH], NSC527017, AMPHOTERICIN B (USP MONOGRAPH), AMPHOTERICIN B [USP MONOGRAPH], IAB, (1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,19E,21E,23E,25E,27E,29E,31E,33R,35S,36R,37S)-33-(((2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaene-36-carboxylic acid, (1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,19E,21E,23E,25E,27E,29E,31E,33R,35S,36R,37S)-33-[(3-amino-3,6-dideoxy-beta-D-mannopyranosyl)oxy]-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaene-36-carboxylic acid, Amphotericin B trihydrate, DTXCID802601, Funganiline, Fungisome, Amphotericin BETA, Fungizone (TN), NCGC00090808-01, Amphotec (TN), (1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,19E,21E,23E,25E,27E,29E,31E,33R,35S,36R,37S)-33-((3-amino-3,6-dideoxy-beta-D-mannopyranosyl)oxy)-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo(33.3.1)nonatriaconta-19,21,23,25,27,29,31-heptaene-36-carboxylic acid, (1S,3R,4E,6E,8E,10E,12E,14E,16E,18S,19R,20R,21S,25R,27R,30R,31R,33S,35R,37S,38R)-3-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-19,25,27,30,31,33,35,37-octahydroxy-18,20,21-trimethyl-23-oxo-22,39-dioxabicyclo[33.3.1]nonatriaconta-4,6,8,10,12,14,16-heptaene-38-carboxylic acid, AmBisome (TN), Amp B, AMPHOTERACIN B, Amphotericin b, liposome, Prestwick3_000410, Amphotericin B solubilized, Amphotericin B (~80%), AMPHOTERICIN B [MI], SCHEMBL17973, AMPHOTERICIN B [INN], AMPHOTERICIN B [JAN], BSPBio_000340, AMPHOTERICIN B [HSDB], BIDD:GT0351, AMPHOTERICIN B [VANDF], BPBio1_000374, CHEMBL267345, NKTR-024, AMPHOTERICIN B [WHO-DD], AMPHOTERICIN B [WHO-IP], A01AB04, A07AA07, G01AA03, J02AA01, HMS2096A22, HMS3713A22, Amphotericin B (JP17/USP/INN), HY-B0221, Amphotericin b, liposome [WHO-DD], Amphotericin B, Streptomyces nodosus, AMPHOTERICIN B [ORANGE BOOK], Amphotericin B from Streptomyces sp., LMPK06000002, s1636, AKOS024464746, AMPHOTERICIN B LIPOSOME [VANDF], CCG-220410, DB00681, AMPHOTERICINUM B [WHO-IP LATIN], 14,39-Dioxabicyclo(33.3.1)nonatriaconta-19,21,23,25,27,29,31-heptaene-36-carboxylic acid, 33-((3-amino-3,6-dideoxy-beta-D-mannopyranosyl)oxy)-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-, (1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,19E,21E,23E,25E,27E,29E,31E,33R,35S,36R,37S)-, AB00513832, C06573, D00203, AB00513832_02, Q412223, 1397-89-3, C47H73NO17, Amphotericin B from Streptomyces sp., ~80% (HPLC), powder, Amphotericin B from Streptomyces sp., BioReagent, suitable for cell culture, ~80% (HPLC), Amphotericin B solubilized, powder, gamma-irradiated, BioXtra, suitable for cell culture, (1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,19E,21E,23E,25E,27E,29E,31E,33R,35S,36R,37S)-33-(3-Amino-3,6-dideoxy-beta-D-mannopyranosyloxy)-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo(33.3.1)nonatriaconta-19,21,23,25,27,29,31-heptaene-36-carboxylic acid, (1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,19E,21E,23E,25E,27E,29E,31E,33R,35S,36R,37S)-33-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,, (1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,19E,21E,23E,25E,27E,29E,31E,33R,35S,36R,37S)-33-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaene-36-carboxylic acid, (1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,19E,21E,23E,25E,27E,29E,31E,33R,35S,36R,37S)-33-[(3-Amino-3,6-dideoxy-?-D-mannopyranosyl)oxy]-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaene-36-carboxylic acid, (1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,19E,21E,23E,25E,27E,29E,31E,33R,35S,36R,37S)-33-[(3-amino-3,6-dideoxy-beta-D-mannopyranosyl)oxy]-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-he, (1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,19E,21E,23E,25E,27E,29E,31E,33R,35S,36R,37S)-33-[(3-amino-3,6-dideoxy-beta-D-mannopyranosyl)oxy]-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-hept, (1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,19E,21E,23E,25E,27E,29E,31E,33R,35S,36S,37S)-33-(3-Amino-3,6-dideoxy-beta-D-mannopyranosyloxy)-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo(33.3.1)nonatriaconta-19,21,23,25,27,29,31-heptaene-36-carboxylic acid, (1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,19Z,21Z,23Z,25Z,27Z,29Z,31Z,33R,35S,36R,37S)-33-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaene-36-carboxylic acid, (1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,33R,35S,36R,37S)-33-{[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy}-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaene-36-carbo, 14,39-DIOXABICYCLO(33.3.1)NONATRIACONTA-19,21,23,25,2 7,29,31-HEPTAENE-36-CARBOXYLIC ACID, 33-((3-AMINO-3,6-DIDEOXY-BETA-D- MANNOPYRANOSYL)OXY)-1,3,5,6,9,11,-17,37-OCTAHYDROXY-15,16,18-TRIMETHYL- 13-OXO-(1R-(1R*,3S*,5R*,6R*,9R*,11R*,15S*,16R*,17R*,18S*,19E,21E,23E, 25E-27E,29E,31E,33R*,35S*,36R*,37S*))-, 14,39-DIOXABICYCLO(33.3.1)NONATRIACONTA-19,21,23,25,27,29,31-HEPTAENE-36-CARBOXYLIC ACID, 33-((3-AMINO-3,6-DIDEOXY-BETA-D-MANNOPYRANOSYL)OXY)-1,3,5,6,9,11,17,37-OCTAHYDROXY-15,16,18-TRIMETHYL-13-OXO-, (1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,19E,21E,23E,25E,27E,29E,31E,33R,35S,36R,37S, 14,39-DIOXABICYCLO(33.3.1)NONATRIACONTA-19,21,23,25,27,29,31-HEPTAENE-36-CARBOXYLIC ACID, 33-((3-AMINO-3,6-DIDEOXY-BETA-D-MANNOPYRANOSYL)OXY)-1,3,5,6,9,11,17,37-OCTAHYDROXY-15,16,18-TRIMETHYL-13-OXO-, (1R-(1R*,3S*,5R*,6R*,9R*,11R*,15S*,16R*,17R*,18S*,19E,21E,23E,25E,27E,29E,31E,33R*,35S*,36R*,37S*))-, Amphotericin B from Streptomyces sp., Vetec(TM) reagent grade, BioReagent, suitable for cell culture, ~80%, Amphotericin B; (1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,19E,21E,23E,25E,27E,29E,31E,33R,35S,36R,37S)-33-[(3-amino-3,6-dideoxy-?-D-mannopyranosyl)oxy]-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaene-36-carboxylic acid" C47H73NO17 APKFDSVGJQXUKY-INPOYWNPSA-N (1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,19E,21E,23E,25E,27E,29E,31E,33R,35S,36R,37S)-33-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaene-36-carboxylic acid n.a. Antifungal Agents Yes No No No No No PMDBD2000068 Anidulafungin (LY303366) Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. D0F9BY 166548 n.a. n.a. Anidulafungin, Eraxis, 166663-25-8, Ecalta, V-Echinocandin, LY303366, VER-002, LY-303366, Anidulafungina, Anidulafungine, Anidulafunginum, UNII-9HLM53094I, VER002, CHEBI:55346, 9HLM53094I, Anidulafungin (LY303366), D70013, D-70013, N-[(3S,6S,9S,11R,15S,18S,20R,21R,24S,25S,26S)-6-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-11,20,21,25-tetrahydroxy-3,15-bis[(1R)-1-hydroxyethyl]-26-methyl-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosan-18-yl]-4-[4-(4-pentoxyphenyl)phenyl]benzamide, ANIDULAFUNGIN (MART.), ANIDULAFUNGIN [MART.], (4R,5R)-4,5-DIHYDROXY-N(SUP 2)-((4''''-(PENTYLOXY)-P-TERPHENYL-4-YL)CARBONYL)-L-ORNITHYL-L-THREONYL-TRANS-4-HYDROXY-L-PROLYL-(S)-4-HYDROXY-4-(P-HYDROXYPHENYL)-L-THREONYL-L-THREONYL-(3S,4S)-3-HYDROXY-4-METHYL-L-PROLINE CYCLIC (6->1)-PEPTIDE, ECHINOCANDIN B, 1-((4R,5R)-4,5-DIHYDROXY-N(SUP 2)-((4''''-(PENTYLOXY)(1,1'':4'',1''''-TERPHENYL)-4-YL)CARBONYL)-L-ORNITHINE)-, ANIDULAFUNGIN [USAN], DTXSID50873201, Anidulafungin [USAN:INN:BAN], 1-((4R,5R)-4,5-Dihydroxy-N2-((4''''-(pentyloxy)(1,1'':4'',1''''-terphenyl)-4-yl)carbonyl)-L-ornithine)-echinocandin B, Echinocandin B, 1-[(4R,5R)-4,5-dihydroxy-N2-[[4''''-(pentyloxy)[1,1'':4'',1''''-terphenyl]-4-yl]carbonyl]-L-ornithine]-, N-((2R,6S,9S,11R,12R,14aS,15S,16S,20S,23S,25aS)-23-((1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl)-2,11,12,15-tetrahydroxy-6,20-bis((1R)-1-hydroxyethyl)-16-methyl-5,8,14,19,22,25-hexaoxotetracosahydro-1H-dipyrrolo(2,1-c:2'',1''-l)(1,4,7,10,13,16)hexaazacyclohenicosin-9-yl)-4''''-(pentyloxy)-1,1'':4'',1''''-terphenyl-4-carboxamide, N-{(2R,6S,9S,11R,12R,14aS,15S,16S,20S,23S,25aS)-23-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-2,11,12,15-tetrahydroxy-6,20-bis[(1R)-1-hydroxyethyl]-16-methyl-5,8,14,19,22,25-hexaoxotetracosahydro-1H-dipyrrolo[2,1-c:2'',1''-l][1,4,7,10,13,16]hexaazacyclohenicosin-9-yl}-4''''-(pentyloxy)-1,1'':4'',1''''-terphenyl-4-carboxamide, ANIDULAFUNGIN [MI], ANIDULAFUNGIN [INN], SCHEMBL38292, ANIDULAFUNGIN [VANDF], (4R,5R)-4,5-Dihydroxy-N(sup 2)-((4''-(pentyloxy)-p-terphenyl-4-yl)carbonyl)-L-ornithyl-L-threonyl-trans-4-hydroxy-L-prolyl-(S)-4-hydroxy-4-(p-hydroxyphenyl)-L-threonyl-L-threonyl-(3S,4S)-3-hydroxy-4-methyl-L-proline cyclic (6-1)-peptide, ANIDULAFUNGIN [WHO-DD], CHEMBL264241, ANIDULAFUNGIN [EMA EPAR], DTXCID90820698, J02AX06, JHVAMHSQVVQIOT-MFAJLEFUSA-N, ANIDULAFUNGIN [ORANGE BOOK], BDBM50417554, MFCD00917070, s4286, AKOS030526640, CCG-270647, CS-1824, DB00362, NCGC00386349-01, HY-13553, NS00007722, SW222238-1, EN300-19769052, J-010304, Q4764531, Echinocandin B, 1-((4R,5R)-4,5-dihydroxy-N2-((4''''-(pentyloxy)(1,1'':4'',1''''-terphenyl)-4-yl)carbonyl)-L-ornithine), N-[(3S,6S,9S,11R,15S,18S,20R,21R,24S,25S,26S)-6-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-11,20,21,25-tetrahydroxy-3,15-bis[(1R)-1-hydroxyethyl]-26-methyl-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexaazatricyclo[22.3.0.0,9,13]heptacosan-18-yl]-4''-[4-(pentyloxy)phenyl]-[1,1''-biphenyl]-4-carboxamide, N-[(3S,6S,9S,11R,15S,18S,20R,21R,24S,25S,26S)-6-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-11,20,21,25-tetrahydroxy-3,15-bis[(1R)-1-hydroxyethyl]-26-methyl-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexaazatricyclo[22.3.0.0^{9,13}]heptacosan-18-yl]-4-{4-[4-(pentyloxy)phenyl]phenyl}benzamide, N-[[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-tetrahydroxy-bis[(1R)-1-hydroxyethyl]-methyl-hexaoxo-[?]yl]-4-[4-(4-pentoxyphenyl)phenyl]benzamide C58H73N7O17 JHVAMHSQVVQIOT-MFAJLEFUSA-N N-[(3S,6S,9S,11R,15S,18S,20R,21R,24S,25S,26S)-6-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-11,20,21,25-tetrahydroxy-3,15-bis[(1R)-1-hydroxyethyl]-26-methyl-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosan-18-yl]-4-[4-(4-pentoxyphenyl)phenyl]benzamide Pfizer Pharmaceuticals Antifungal Agents Yes No No No No No PMDBD2000069 Broxyquinoline Therapeutic Substance n.a. 521-74-4 DB13536 n.a. n.a. n.a. 2453 2359 n.a. broxyquinoline, 5,7-Dibromoquinolin-8-ol, 521-74-4, 5,7-Dibromo-8-hydroxyquinoline, 5,7-Dibromo-8-quinolinol, Dibromoxin, Broxyquinolin, Dibromoxine, Dibromoxyquinoline, Broxiquinoline, Dibromoquin, Fenilor, Broxykinolin, Dibromoksin, Paramiba, Brodiar, Colepur, Colipar, 5,7-Dibromooxine, Paramibe, Broxichinolinum, 8-QUINOLINOL, 5,7-DIBROMO-, Dibromohydroxyquinoline, Bromoxine, Starogyn, NSC 1810, NSC-1810, MFCD00006785, MLS002207288, UK4C618C8T, DTXSID9045849, NSC1810, Broxyquinoline (INN), NCGC00094815-01, Brossichinolina, Broxyquinolinum, SMR000054336, Broxyquinoline 100 microg/mL in Acetonitrile, BROXYQUINOLINE [INN], DTXCID7025849, Broxiquinolina, Brossichinolina [DCIT], Broxyquinoline [INN:DCF], Broxyquinolinum [INN-Latin], CAS-521-74-4, Broxiquinolina [INN-Spanish], UCB 5055, EINECS 208-317-8, BRN 0153624, UNII-UK4C618C8T, Intensopan, AI3-19529, Starogyn (TN), 5,7-Dibromo-oxine, Spectrum_000760, Spectrum2_000944, Spectrum3_000575, Spectrum4_000387, Spectrum5_001463, 8-Quinolinol,7-dibromo-, Probes1_000369, Probes2_000040, BROXYQUINOLINE [MI], cid_2453, NCIOpen2_009022, 5,7-dibromo-quinolin-8-ol, Oprea1_209922, BSPBio_001990, KBioGR_000913, KBioSS_001240, 5-21-03-00290 (Beilstein Handbook Reference), DivK1c_000776, SCHEMBL115293, SPECTRUM1500623, SPBio_000908, BROXYQUINOLINE [MART.], CHEMBL223448, BROXYQUINOLINE [WHO-DD], BDBM76301, HMS502G18, KBio1_000776, KBio2_001240, KBio2_003808, KBio2_006376, KBio3_001490, 5,7-bis(bromanyl)quinolin-8-ol, CHEBI:109543, NINDS_000776, HMS1921K19, HMS3652L09, Pharmakon1600-01500623, AMY18082, HY-B1212, Tox21_111338, AC7858, CCG-40333, NSC757389, s4195, AKOS000119895, AKOS005489208, Tox21_111338_1, AC-4821, CS-4839, DB13536, NSC-757389, 5,7-Dibromo-8-hydroxyquinoline, 98%, IDI1_000776, NCGC00094815-02, NCGC00094815-03, NCGC00094815-05, AS-58136, SY036132, SBI-0051561.P002, A7662, D0208, NS00001604, SW219614-1, EN300-21309, D07109, AB00052129-04, AB00052129_07, AB00052129_08, AG-690/03055006, SR-01000872768, Q4976946, SR-01000872768-1, W-105847, Z104495270 C9H5Br2NO ZDASUJMDVPTNTF-UHFFFAOYSA-N 5,7-dibromoquinolin-8-ol n.a. n.a. Yes No No No No No PMDBD2000070 Butoconazole Therapeutic Substance Approved Drug 64872-76-0 DB00639 PA164781353 D07598 D0N3SP 47472 43192 n.a. Butoconazole, 64872-76-0, Butaconazole, Butoconazolum, Butoconazol, Gynofort, Butoconazol [INN-Spanish], Butoconazolum [INN-Latin], RS 35887-10-3, NSC-758658, Butoconazole (INN), CHEBI:3240, UNII-0Q771797PH, 0Q771797PH, NSC 758658, (+-)-1-((4-(p-Chlorophenyl)-2-((2,6-dichlorophenyl)thio)imidazole, BUTOCONAZOLE [INN], Butoconazol (INN-Spanish), Butoconazolum (INN-Latin), 1H-Imidazole, 1-(4-(4-chlorophenyl)-2-((2,6-dichlorophenyl)thio)butyl)-, (+-)-, Butoconazole [INN:BAN], MLS002153798, 1-(4-(4-chlorophenyl)-2-((2,6-dichlorophenyl)thio)butyl)-1H-imidazole, 1-[4-(4-Chloro-phenyl)-2-(2,6-dichloro-phenylsulfanyl)-butyl]-1H-imidazole, 1-[4-(4-Chlorophenyl)-2-[(2,6-dichlorophenyl)thio]butyl]-1H-imidazole, 1-{4-(4-chlorophenyl)-2-[(2,6-dichlorophenyl)sulfanyl]butyl}-1H-imidazole, 1H-Imidazole, 1-[4-(4-chlorophenyl)-2-[(2,6-dichlorophenyl)thio]butyl]-, (+-)-1-[4-(4-Chlorophenyl)-2-[(2,6-dichlorophenyl)thio]butyl]-1H-imidazole, (+/-)-1-(4-(P-CHLOROPHENYL)-2-((2,6-DICHLOROPHENYL)THIO)BUTYL)IMIDAZOLE, 1H-Imidazole, 1-(4-(4-chlorophenyl)-2-((2,6-dichlorophenyl)thio)butyl)-, (+/-)-, Gynofort (TN), 67085-13-6, SMR001233176, 1-(4-(4-chlorophenyl)-2-((2,6-dichlorophenyl)sulfanyl)butyl)-1H-imidazole, 1-[4-(4-chlorophenyl)-2-[(2,6-dichlorophenyl)sulfanyl]butyl]-1H-imidazole, (+-)-1-(4-(4-Chlorophenyl)-2-((2,6-dichlorophenyl)thio)butyl)-1H-imidazole, 1-(4-(4-Chloro-phenyl)-2-(2,6-dichloro-phenylsulfanyl)-butyl)-1H-imidazole, 1-(4-(4-Chlorophenyl)-2-(2,6-dichlorophenylthio)-n-butyl)-1H-imidazole, Prestwick0_000408, Prestwick1_000408, Prestwick2_000408, Prestwick3_000408, BUTOCONAZOLE [MI], 1-[4-(4-chlorophenyl)-2-(2,6-dichlorophenyl)sulfanyl-butyl]imidazole, 1-[4-(4-chlorophenyl)-2-(2,6-dichlorophenyl)sulfanylbutyl]imidazole, BUTOCONAZOLE [VANDF], CHEMBL1295, SCHEMBL44237, BSPBio_000336, cid_47471, MLS006010743, BUTOCONAZOLE [WHO-DD], SPBio_002275, BPBio1_000370, 1-[(2S)-4-(4-chlorophenyl)-2-(2,6-dichlorophenyl)sulfanyl-butyl]imidazole, DTXSID2048537, BDBM79206, HY-B0293A, G01AF15, HMS3264E14, Pharmakon1600-01504140, AMY32540, BUTOCONAZOLE, Butoconazole Nitrate, NSC758658, s5359, AKOS015900067, CCG-213264, DB00639, NCGC00179596-01, NCGC00179596-04, AC-15961, SMR001550002, AB00513831, CS-0013455, NS00010194, C08065, D07598, AB00513831-07, AB00513831_08, AB00513831_09, Butoconazole, VETRANAL(TM), analytical standard, A834909, EN300-18563887, Q2928948, BRD-A16665823-001-01-2, BRD-A16665823-008-03-3, 1-(4-(4-chlorophenyl)-2-(2,6-dichlorophenylthio)butyl)-1H-imidazole, 1-[4-(4-chlorophenyl)-2-(2,6-dichlorophenyl)sulfanylbutyl]imid-azole, 1-[4-(4-chlorophenyl)-2-(2,6-dichlorophenylthio)-n-butyl]-imidazole, (.+/-.)-1-[4-(p-Chlorophenyl)-2-[(2,6-dichlorophenyl)thio]butyl]imidazole, 1-(4-(4-Chlorophenyl)-2-[(2,6-dichlorophenyl)sulfanyl]butyl)-1H-imidazole #, 1H-Imidazole, 1-[4-(4-chlorophenyl)-2-[(2,6-dichlorophenyl)thio]butyl]-, (1)- C19H17Cl3N2S SWLMUYACZKCSHZ-UHFFFAOYSA-N 1-[4-(4-chlorophenyl)-2-(2,6-dichlorophenyl)sulfanylbutyl]imidazole Roche Palo Alto Llc Antifungal Agents Yes No No No No No PMDBD2000071 Caspofungin Acetate n.a. n.a. n.a. n.a. n.a. n.a. n.a. 6850808 n.a. n.a. "Caspofungin acetate, 179463-17-3, Cancidas, caspofungin diacetate, MK 0991, L 743872, Cancidas (TN), MK-0991, MK-0991 (Acetate);L-743872 (Acetate), Caspofungin acetate- Bio-X, SCHEMBL149293, Caspofungin Acetate (>90%), L 743873, CHEMBL4297142, Caspofungin acetate (JAN/USAN), MFCD08141839, AKOS025401982, AC-27763, BC164293, D02501, F20901" C56H96N10O19 OGUJBRYAAJYXQP-LLXMLGLCSA-N "acetic acid;N-[(3S,6S,9S,11R,15S,18S,20R,21S,24S,25S)-21-(2-aminoethylamino)-3-[(1R)-3-amino-1-hydroxypropyl]-6-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-11,20,25-trihydroxy-15-[(1R)-1-hydroxyethyl]-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosan-18-yl]-10,12-dimethyltetradecanamide" n.a. n.a. Yes No No No No No PMDBD2000072 Cetrimonium Bromide (CTAB) Therapeutic Substance Phase 2 n.a. n.a. n.a. n.a. DM5T2B 5974 n.a. n.a. "Cetrimonium bromide, 57-09-0, Cetyltrimethylammonium bromide, Hexadecyltrimethylammonium bromide, CTAB, Bromat, CETAB, Centimide, Ctmab, Cee dee, Acetoquat CTAB, Cetyl trimethyl ammonium bromide, Hexadecyl trimethyl ammonium bromide, Trimethylcetylammonium bromide, Lauroseptol, Lissolamine, Cetaflon, Cetarol, Pollacid, Quamonium, Micol, Cetrimide bp, Cetavlon bromide, Lissolamine A, Lissolamin V, Cycloton V, Cirrasol OD, Softex KW, N-Cetyltrimethylammonium bromide, Cetrimonii bromidum, Cetavlon, Suticide, Mical, N,N,N-trimethylhexadecan-1-aminium bromide, Bromuro de cetrimonio, Hexadecyltrimethylammoniumbromide, Bromure de cetrimonium, Cetrimonium (bromide), Cirrasol-OD, Trimethylhexadecylammonium bromide, N-HEXADECYLTRIMETHYLAMMONIUM BROMIDE, (1-Hexadecyl)trimethylammonium bromide, Palmityltrimethyl ammonium bromide, Caswell No. 167, Cetrimonio bromuro, N,N,N-Trimethylcetylammonium bromide, N,N,N-Trimethyl-1-hexadecanaminium bromide, 1-Hexadecanaminium, N,N,N-trimethyl-, bromide, Sumquat 6030, N-Hexadecyl-N,N,N-trimethylammonium bromide, CHEBI:3567, hexadecyltrimethylazanium bromide, cetrimoniumbromide, UNII-L64N7M9BWR, EINECS 200-311-3, L64N7M9BWR, NSC 32927, NSC-32927, EPA Pesticide Chemical Code 069117, Palmityltrimethylammonium bromide, AI3-12209, Cetrimonii bromidum [INN-Latin], Hexadecanyltrimethylammonium bromide, Bromure de cetrimonium [INN-French], Bromuro de cetrimonio [INN-Spanish], Hexadecyl-trimethyl-ammonium; bromide, MFCD00011772, Ammonium, hexadecyltrimethyl-, bromide, cetyl trimethylammonium bromide, CHEMBL307346, DTXSID5037028, RHODAQUAT M-242B/99, EC 200-311-3, RONACARE CETRIMONIUM BROMIDE, NCGC00164283-01, Cetrimida, Cetrimidum, n-HexadecyltriMethyl-d3-aMMoniuM BroMide, n-HexadecyltriMethylaMMoniuM-d42 BroMide, HEXADECYL-D33 TRIMETHYLAMMONIUM BROMIDE, Bromat (VAN), 1-Hexadecanaminium, N,N,N-tri(methyl-d3)-, bromide, Micol (VAN), DTXCID3017028, Cetrimonii bromidum (INN-Latin), Lissolamine V (VAN), Cetavlex, Cradocap, Zetrimid, Cetrimide [INN:BAN:JAN], CETRIMONIUM BROMIDE (MART.), CETRIMONIUM BROMIDE [MART.], Bromure de cetrimonium (INN-French), Bromuro de cetrimonio (INN-Spanish), CETRIMONIUM BROMIDE (USP-RS), CETRIMONIUM BROMIDE [USP-RS], Cetyltrimethylammonium (bromide);Hexadecyltrimethylammonium (bromide);CTAB, Cetrimonio bromuro [DCIT], Cetrimonium bromide [INN], C19H42BrN, CAS-57-09-0, CTABR, SR-05000001830, cetyltrimethylammoniumbromide, Cetrimonium Bromide (CTAB), Lissolamine V, cetyl N, hexadecyl(trimethyl)azanium bromide, HTAB cpd, Cetrimonium bromide [INN:BAN:NF], hexadecyl(trimethyl)ammonium bromide, cAtrimonium (cation), Epitope ID:116869, UNII-24QSH2NL8N, SCHEMBL4377, 24QSH2NL8N, cetyltrimethyl ammonium bromide, cetyltrimethyl-ammonium bromide, SPECTRUM1503200, Cetrimonium bromide (NF/INN), cetyl trimethyl-ammonium bromide, CETRIMONIUM BROMIDE [MI], HMS500K11, D08AJ02, Dr. Zheng bacteriostatic solution, R02AA17, hexadecyl-trimethylammonium bromide, N,N-Trimethylcetylammonium bromide, CETRIMONIUM BROMIDE [INCI], HMS1922G21, HMS2092L22, HMS3652J19, Pharmakon1600-01503200, CETRIMONIUM BROMIDE [VANDF], hexadecyl-trimethyl ammonium bromide, HY-B1260, NSC32927, Tox21_112096, Tox21_300853, CCG-39968, CETRIMONIUM BROMIDE [WHO-DD], NSC758401, s4242, AKOS015915119, Tox21_112096_1, CS-4893, NSC-758401, SB40734, Hexadecyltrimethylammonium bromide, 99%, inverted exclamation markY96.0% (AT), N,N-Trimethyl-1-hexadecanaminium bromide, NCGC00095012-01, NCGC00095012-02, NCGC00164283-07, NCGC00254756-01, AS-11739, BP-30064, N-Hexadecyl-N,N-trimethylammonium bromide, WLN: 16K1&1&1 &Q &E, Hexadecyltrimethylammonium bromide, >=98%, 1-Hexadecanaminium,N,N-trimethyl-, bromide, Hexadecyl trimethyl ammonium bromide (CTAB), H0081, NS00077218, SW220088-1, EN300-99610, D03454, Hexadecyltrimethylammonium bromide, AR, >=99%, A831309, Q416077, Hexadecyltrimethylammonium bromide, >=96.0% (AT), Hexadecyltrimethylammonium bromide, BioXtra, >=99%, Q-200821, SR-05000001830-1, SR-05000001830-3, Hexadecyltrimethylammonium bromide, analytical standard, 1-Hexadecanaminium, N,N,N-trimethyl-, bromide (1:1), Z2417556873, Hexadecyltrimethylammonium bromide, BioUltra, >=99.0% (AT), Hexadecyltrimethylammonium bromide, for ion pair chromatography, Hexadecyltrimethylammonium bromide, for molecular biology, >=99%, Hexadecyltrimethylammonium bromide, Vetec(TM) reagent grade, 96%, Cetrimonium bromide, United States Pharmacopeia (USP) Reference Standard, Hexadecyltrimethylammonium bromide, BioUltra, for molecular biology, >=99.0% (AT), Hexadecyltrimethylammonium bromide, puriss. p.a., matrix substance for MALDI-MS" C19H42BrN LZZYPRNAOMGNLH-UHFFFAOYSA-M "hexadecyl(trimethyl)azanium;bromide" Crescita Therapeutics n.a. Yes No No No No No PMDBD2000073 Cetylpyridinium Chloride n.a. n.a. n.a. n.a. n.a. n.a. n.a. 31239 n.a. n.a. cetylpyridinium chloride, 123-03-5, 1-hexadecylpyridin-1-ium chloride, hexadecylpyridinium chloride, 1-Hexadecylpyridinium chloride, Pristacin, Ceprim, Cetamium, Aktivex, Cepacol, 1-Cetylpyridinium chloride, Biosept, Dobendan, Pyrisept, Tserigel, Cepacol chloride, Quaternario CPC, Acetoquat CPC, Intexsan CPC, Swabettes Hoechst, Ammonyx CPC, Medilave, Cetyl pyridinium chloride, Merocet, N-Hexadecylpyridinium chloride, N-Cetylpyridinium chloride, Ceeprin chloride, Ceepryn chloride, Pyridinium, 1-hexadecyl-, chloride, Cetylpyridini chloridum, 1-Palmitylpyridinium chloride, Cetylpyridinii chloridum, CETYLPYRIDINIUM CHLORIDE ANHYDROUS, Caswell No. 166A, Cloruro de cetilpiridinio, Chlorure de cetylpyridinium, Cetilpiridinio cloruro, HSDB 38, hexadecyl pyridinium chloride, EINECS 204-593-9, UNII-6BR7T22E2S, NSC 14864, EPA Pesticide Chemical Code 069160, 6BR7T22E2S, Cetylpyridinium chloride [INN], DTXSID6041761, CHEBI:32915, AI3-15070, Cetylpyridinii chloridum [INN-Latin], NB 002, NSC-14864, Cetylpyridinium (chloride), Cloruro de cetilpiridinio [INN-Spanish], Chlorure de cetylpyridinium [INN-French], DTXCID4021761, Ceepryn, NSC-756673, Cetylpyridinii chloridum (INN-Latin), Cloruro de cetilpiridinio (INN-Spanish), Chlorure de cetylpyridinium (INN-French), Cetilpiridinio cloruro [DCIT], CETYLPYRIDINIUM CHLORIDE (II), CETYLPYRIDINIUM CHLORIDE (MART.), CETYLPYRIDINIUM CHLORIDE (USP-RS), CETYLPYRIDINIUM CHLORIDE (EP MONOGRAPH), CETYLPYRIDINIUM CHLORIDE (USP MONOGRAPH), Corinz, Health, BreathAway, CleanZing, mouth fresh, Sprol, TheraStom, BioShell, Advanced Guard, QCare, CrestGum Care, CVS Antiseptic, Dr. Protector, E-zen Gargle, Crest Pro Health, CETYLPYRIDINIUM CHLORIDE MONOHYDRATE (EP IMPURITY), FreshMax Mouthwash, Antiplaque solution, Reach Anti Plaque, CepacolAntibacterial, SmartMouth Mouthwash, Suction Toothbrushes, Zestymint Antiseptic, cetylpyridium chloride, SARINA, Mastikis fresh gargle, Oral B Gum Detoxify, Oral-BAnti-Bacterial, 1-Hexadecylpyridinium chloride (1:1), Antiseptic Oral Rinse, Kalaya Breath Refresh, SARINAANTISEPTIC, Cetylpyridinium cloride, Cetylpridinium Chloride, Oral B Plaque Defense, Multi-Action Antiseptic, Hello Peace Out Plaque, cetylpyridinium chloratum, Killfire mouth freshener, Antigingivitis/Antiplaque, cAtylpyridinium (cation), Colgate Swish Mild Mint, Cetyl-pyridinium chloride, Crest Pro-HealthClinical, TheraBreath Healthy Gums, Breath mellow Water Lily, Chloride, Cetylpyridinium, Crest Pro-HealthAdvantage, Crest Pro-HealthGum Care, Double X CONCENTRATED, Colgate Simply Fresh Mint, Colgate Total Ultra Fresh, Therabreath Plaque Control, PerCara Oral Health Rinse, QUALITY CHOICE MINT, Breath mellow Azalea Peach, Crest Pro-HealthGerm Guard, Family WellnessTotal Health, SCHEMBL4763, CloSYS Silver Healthy Gums, DuoCare Clinical Oral Rinse, Pesticide Code: 069160, ReddyPort Antiplaque Solution, Colgate Swish Refreshing Mint, AssuredOral Health Fresh Mint, CHEMBL34833, SPECTRUM1500169, CETYLPRYIDINIUM CHLORIDE, COOL SENSE STICK GARGLE, Crest Pro-HealthBacteria Guard, Colgate Swish Invigorating Mint, 1-Hexadecyl-Pyridinium Chloride, CPH Anti-bacterial Breath Mist, HYVEEPRO CLEAN BLUE MINT, Roccos Old SchoolPeircing Armor, Equaline Multi-Action Antiseptic, 1-hexadecylpyridin-1-iumchloride, BreathAwayMouth Rinse Fresh Mint, HMS501B08, ParodontaxActive Gum Health Mint, B05CA01, D08AJ03, D09AA07, R02AA06, Total Advanced Health Fresh Mint, Crest Pro-Health Multi-Protection, Kimvent Oral Care Toothbrush pack, HMS1920M13, HMS2091A20, HMS3652F05, Pharmakon1600-01500169, Anhydrous, Cetylpyridinium Chloride, Chloride Anhydrous, Cetylpyridinium, Crest Pro-HealthIntense Clean Mint, Crest Pro-HealthIntense Fresh Mint, FreshMax MouthwashFresh Mint Flavor, HY-B1464, NSC14864, antigingivitis/antiplaque mouth rinse, CPC 1000 Pre and Post Teat Dip, PerCara Oral Health RinseFresh Mint, Suction Swab with Corinz Oral Rinse, TheraBreath Healthy Gums Oral Rinse, Tox21_301296, 1-Cetylpyridinium chloride 1-hydrate, CCG-39719, CETYLPYRIDINIUM CHLORIDE [MI], Hellopeace out, plaque antigingivitis, MFCD00011731, NSC756673, s4172, Denti Whoo Bubble Concentrated Gargle, AKOS005267197, Crest Pro-HealthGum and Breath Purify, Oral B Gum DetoxifySpecial Care Rinse, CETYLPYRIDINIUM CHLORIDE [HSDB], DISCOUNT DRUG MARTMINT MOUTHWASH, KS-5309, ParodontaxActive Gum Health Clear Mint, WLN: T6KJ A16 & Q & G, Crest Pro HealthGum plus Bacteria Guard, CETYLPYRIDINIUM CHLORIDE [WHO-DD], NCGC00094618-01, NCGC00094618-02, NCGC00257543-01, SmartMouth MouthwashClinical DDS Formula, AC-32490, CAS-123-03-5, SmartMouthClinical Gum and Plaque Formula, Suction Toothbrush with Corinz Oral Rinse, Colgate Total Advanced Gum Health Mouthwash, Crest Pro-HealthBreath Purify and Gum Care, Pyridinium, 1-hexadecyl-, chloride (1:1), A5161, CS-0013168, H0078, NS00093500, SmartMouth Advance Clinical DDS Formula Mint, SW222237-1, EN300-23845, Orajle Anti-Bacterial Rinse for Bleeding Gums, Oral B Plaque DefenseSpecial Care Oral Rinse, QCare Rx Oral Cleansing and Suctioning System, F20369, Colgate Total 12 Hr Pro-Shield Spearmint Surge, A832584, A890863, Colgate Total Advanced Pro-Shield Peppermint Blast, Colgate Total Advanced Pro-Shield Spearmint Surge, Q418318, QCARE ORAL CLEANSING AND SUCTIONING SYSTEM, SR-05000001582, SR-05000001582-1, W-105282, Crest Pro-Health Multi-ProtectionRefreshing Clean Mint, Crest Pro-HealthPro Active Defense Whole Mouth Clean, QCare Petite Size Oral Cleansing and Suctioning System, Scope All Day CPC Antigingivitis/Antiplaque Mouthwash, ScopeGet Fresh CPC Antigingivitis/Antiplaque Mouthwash, Z89264780, Scope All Day CPC Antigingivitis/Antiplaque MouthwashAll Day, Toothette Oral Care Single Use System with Antiseptic Oral Rinse, QCare Oral Cleansing and Suctioning System compatible with 0.12% Chlorhexidine Gluconate (CHG) Oral Rinse C21H38ClN YMKDRGPMQRFJGP-UHFFFAOYSA-M "1-hexadecylpyridin-1-ium;chloride" n.a. n.a. Yes No No No No No PMDBD2000074 Chlorquinaldol Therapeutic Substance n.a. 72-80-0 DB13306 n.a. D07208 n.a. 6301 6062 n.a. Chlorquinaldol, 72-80-0, 5,7-Dichloro-8-hydroxyquinaldine, 5,7-dichloro-2-methylquinolin-8-ol, 5,7-Dichloro-8-hydroxy-2-methylquinoline, Chloroquinaldol, 5,7-Dichloro-2-methyl-8-quinolinol, Clorquinaldol, Sterosan, 5,7-Dichloro-8-quinaldinol, Siasteran, Siosteran, Steroxin, Siogene, Chlorquinaldolum, Gyno-sterosan, 5,7-Dichloro-2-methyl-8-hydroxyquinoline, 8-QUINOLINOL, 5,7-DICHLORO-2-METHYL-, Chloquinan, Hydroxydichloroquinaldine, 5,7-Dichloro-2-methyl-quinolin-8-ol, MFCD00023984, D6VHC87LLS, NSC-755830, MLS002695929, Chlorchinaldol, DTXSID3048998, CHEBI:74500, Chlorchinaldolum, Chlorquinaldol (INN), NCGC00095795-04, Clorchinaldolo, SMR001549973, 2-methyl-5,7-dichloro-8-hydroxyquinoline, CHLORQUINALDOL [INN], DTXCID3028924, Chlorchinaldin, Chlorguinaldon, Clorchinaldolo [DCIT], Siogen, CHLORQUINALDOL, Chlorquinaldol (5,7-Dichloro-2-methyl-8-quinolinol), CAS-72-80-0, Clorquinaldol [INN-Spanish], Chlorquinaldolum [INN-Latin], Chlorquinaldol [INN:BAN:DCF], EINECS 200-789-3, UNII-D6VHC87LLS, BRN 0156683, Gynotherax, Vagisteran, Florabina, Saprosan, Siogenal, Siogeno, Siogenon, Siosept, Sterozan, Quesil, Hydroxydichloroquinaldinol, Spectrum2_000524, Spectrum3_001092, Spectrum4_001263, CHLORQUINALDOL [MI], cid_6301, Oprea1_721210, BSPBio_002764, KBioGR_001846, SPECTRUM212151, 5-21-03-00346 (Beilstein Handbook Reference), SCHEMBL301405, SPBio_000507, CHLORQUINALDOL [MART.], CHEMBL224325, CHLORQUINALDOL [WHO-DD], BDBM76302, KBio3_001984, 5-bromo 2-isobutoxy benzonitirle, HMS3089A18, HMS3264I07, HMS3652H09, Pharmakon1600-00212151, BCP11865, HY-B1360, Tox21_113490, CCG-39580, NSC755830, s4192, AKOS000119838, Tox21_113490_1, CS-4899, DB13306, NSC 755830, PS-7753, s10253, NCGC00095795-01, NCGC00095795-02, NCGC00095795-03, NCGC00095795-06, AC-29743, Quinolin-8-ol, 5,7-dichloro-2-methyl-, SY015325, SBI-0207012.P001, 5,7-bis(chloranyl)-2-methyl-quinolin-8-ol, NS00021341, SW220230-1, EN300-19748, D07208, 5,7-Dichloro-8-hydroxy-2-methylquinoline, 98%, AB00443827_06, AB00443827_07, A837624, SR-01000872737, Q1645622, SR-01000872737-1, W-104478, Z104475058, 5,7-Dichloro-8-hydroxyquinaldine 5,7-Dichloro-2-methyl-8-hydroxyquinoline C10H7Cl2NO GPTXWRGISTZRIO-UHFFFAOYSA-N 5,7-dichloro-2-methylquinolin-8-ol n.a. n.a. Yes No No No No No PMDBD2000075 Cloxiquine n.a. n.a. n.a. n.a. n.a. n.a. n.a. 2817 n.a. n.a. 5-CHLORO-8-HYDROXYQUINOLINE, 130-16-5, 5-Chloroquinolin-8-ol, Cloxiquine, cloxyquin, 5-Chloro-8-quinolinol, 8-Quinolinol, 5-chloro-, Dermofongin, 5-Chlorooxine, Dermofungin, Chlorisept, 5-Chloro-8-oxyquinoline, Chloroxychinolin, Dermofongin A, 8-Hydroxy-5-chloroquinoline, Monochlorohydroxyquinoline, Cloxyquin [USAN], 5-Chloro-quinolin-8-ol, 5-chloranylquinolin-8-ol, MFCD00006788, NSC 35083, Cloxiquine [INN], NSC-35083, BPF36H1G6S, MLS002695956, DTXSID4045973, Cloxiquine (INN), NSC35083, Cloxyquin (USAN), NCGC00095303-02, Cloxiquina, SMR000274338, Cloxiquine 100 microg/mL in Acetonitrile, DTXCID2025973, 5-Chlor-8-chinolinol, Cloxiquinum, Cloxiquinum [INN-Latin], Cloxiquina [INN-Spanish], CAS-130-16-5, EINECS 204-978-1, UNII-BPF36H1G6S, BRN 0005289, Dermofungin|, 5-Chloroquinophenol, HZQ, 5-Chloro-8-quinolol, Spectrum_000820, CLOXYQUIN [MI], Spectrum2_001131, Spectrum3_000361, Spectrum4_000297, Spectrum5_000785, 5-Chloro-quinoline-8-ol, 5Chloro-8-hydroxyquinoline, cid_2817, CLOXIQUINE [MART.], CLOXIQUINE [WHO-DD], NCIOpen2_004102, Oprea1_189008, BSPBio_002081, KBioGR_000854, KBioSS_001300, 5-21-03-00279 (Beilstein Handbook Reference), 5-chloro-8-hydroxy-quinoline, DivK1c_000163, SCHEMBL115838, SPECTRUM1500202, SPBio_001021, CHEMBL225164, 5-Chloro-8-quinolinol, 95%, BCBcMAP01_000058, BDBM76305, HMS500I05, KBio1_000163, KBio2_001300, KBio2_003868, KBio2_006436, KBio3_001301, CHEBI:134818, NINDS_000163, HMS1920A06, HMS2091G14, HMS3091A16, Pharmakon1600-01500202, AMY23287, HY-B0963, NSC53182, STR00716, Tox21_111501, AC8858, CCG-39556, NSC-53182, NSC756701, s4559, AKOS000121487, Tox21_111501_1, AC-4776, CS-4448, NSC-756701, PS-3329, IDI1_000163, QTL1_000025, NCGC00095303-01, NCGC00095303-03, NCGC00095303-04, SY047042, SBI-0051320.P003, NS00009640, EN300-21587, D03572, AB00051952_05, SR-05000002034, SR-05000002034-1, W-108352, BRD-K46982791-001-02-9, BRD-K46982791-001-04-5, Q27274791, F0001-0401, Z1954804579, InChI=1/C9H6ClNO/c10-7-3-4-8(12)9-6(7)2-1-5-11-9/h1-5,12 C9H6ClNO CTQMJYWDVABFRZ-UHFFFAOYSA-N 5-chloroquinolin-8-ol n.a. n.a. Yes No No No No No PMDBD2000076 Evans Blue Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. D0P2CS 9409 n.a. n.a. "evans blue, 314-13-6, Direct Blue 53, Evan''s Blue, Azovan Blue, C.I. DIRECT BLUE 53, C.I. 23860, Dye Evans Blue, Evablin, Diazobleu, MFCD00004021, Geigy-blau 536, C.I. direct blue 53 tetrasodium salt, Diamine Sky Blue FF, Diazol Pure Blue BF, Geigy Blue 536, med, DTXSID9022815, Direct blue 53 tetrasodium salt, 45PG892GO1, NSC-8680, 1,3-Naphthalenedisulfonic acid, 6,6''-((3,3''-dimethyl(1,1''-biphenyl)-4,4''-diyl)bis(azo))bis(4-amino-5-hydroxy)-, tetrasodium salt, Evansblue, NSC 8680, AZOVAN SODIUM, 4,4''-Bis(1-amino-8-hydroxy-2,4-disulfo-7-naphthylazo)-3,3''-bitolyl, tetrasodium salt, 4,4''-Bis(1-amino-8-hydroxy-2,4-disulpho-7-naphthylazo)-3,3''-bitolyl, tetrasodium salt, 4,4''-Bis(7-(1-amino-8-hydroxy-2,4-disulfo)naphthylazo)-3,3''-bitolyl, tetrasodium salt, 4,4''-Bis(7-(1-amino-8-hydroxy-2,4-disulpho)naphthylazo)-3,3''-bitolyl, tetrasodium salt, C.I. Direct Blue 53, tetrasodium salt, DTXCID102815, T1824, T 1824, T-1824, CAS-314-13-6, Sodium 6,6''-((3,3''-dimethyl-[1,1''-biphenyl]-4,4''-diyl)bis(diazene-2,1-diyl))bis(4-amino-5-hydroxynaphthalene-1,3-disulfonate), Modr Evansova [Czech], Blekit evansa [Polish], Evans blue, sodium salt, NCGC00024822-02, NCGC00181162-01, Modr Prima 53 [Czech], CCRIS 167, Blekit evansa, Modr Evansova, C34H24N6Na4O14S4, tetrasodium 6,6''-[(3,3''-dimethylbiphenyl-4,4''-diyl)di(E)diazene-2,1-diyl]bis(4-amino-5-hydroxynaphthalene-1,3-disulfonate), EINECS 206-242-5, Modr Prima 53, Evans blue [USP], CI Direct Blue 53, EVANS BLUE [IARC], EVAN''S BLUE [MI], EVANS BLUE [VANDF], AZOVAN BLUE [MART.], EVANS BLUE [WHO-DD], Evans blue (Technical Grade), UNII-45PG892GO1, DYE EVANS BLUE [VANDF], CHEMBL1200712, CHEBI:82467, EVANS BLUE [ORANGE BOOK], Evans Blue (C.I. 23860), HMS3264P03, AMY22387, Tox21_110929, Tox21_113237, HB0280, s4716, Direct Blue 53; C.I. 23860, AKOS005287327, AKOS015903001, CCG-213687, GS-6076, 1,3-Naphthalenedisulfonic acid, 6,6''-((3,3''-dimethyl(1,1''-biphenyl)-4,4''-diyl)bis(azo))bis(4-amino-5-hydroxy-, tetrasodium salt, 1,3-Naphthalenedisulfonic acid, 6,6''-((3,3''-dimethyl-4,4''-biphenylylene)bis(azo))bis(4-amino-5-hydroxy-, tetrasodium salt, Tetrasodium 6,6''-(3,3''-dimethyl-(1,1''-biphenyl)-4,4''diyl)bis(azo)bis(4-amino-5-hydroxy-1,3-naphthalenedisulphonate), tetrasodium 6,6''-[(3,3''-dimethyl-4,4''-biphenyldiyl)bis(2,1-diazenediyl)]bis(4-amino-5-hydroxy-1,3-naphthalenedisulfonate), E0197, C19422, H10520, A875909, 1,3-Naphthalenedisulfonic acid, 6,6''-((3,3''-dimethyl(1,1''-biphenyl)-4,4''-diyl)bis(2,1-diazenediyl))bis(4-amino-5-hydroxy-, sodium salt (1:4), 6,6-[(3,3''-Dimethyl[1,1''-biphenyl]-4, 4''-diyl)bis(azo)bis[4-amino-5-hydroxy-1,3-naphthalenedisulphonic acid] tetrasodium salt, 6,6-[(3,3''-Dimethyl[1,1''-biphenyl]-4,4''-diyl)bis(azo)bis[4-amino- 5-hydroxy-1,3-naphthalenedisulphonic acid] tetrasodium salt, sodium 6,6''-(1E,1''E)-(3,3''-dimethylbiphenyl-4,4''-diyl)bis(diazene-2,1-diyl)bis(4-amino-5-hydroxynaphthalene-1,3-disulfonate), tetrasodium 4-amino-6-[(1E)-2-{4''-[(1E)-2-(8-amino-1-hydroxy-5,7-disulfonatonaphthalen-2-yl)diazen-1-yl]-3,3''-dimethyl-[1,1''-biphenyl]-4-yl}diazen-1-yl]-5-hydroxynaphthalene-1,3-disulfonate, tetrasodium 4-amino-6-[(E)-2-{4''-[(E)-2-(8-amino-1-hydroxy-5,7-disulfonaphthalen-2-yl)diazen-1-yl]-3,3''-dimethyl-[1,1''-biphenyl]-4-yl}diazen-1-yl]-5-hydroxynaphthalene-1,3-disulfonate, tetrasodium 6,6''-{(3,3''-dimethyl[1,1''-biphenyl]-4,4''-diyl)bis[diazene-2,1-diyl]}bis(4-amino-5-hydroxynaphthalene-1,3-disulfonate)" C34H24N6Na4O14S4 ATNOAWAQFYGAOY-UHFFFAOYSA-J "tetrasodium;4-amino-6-[[4-[4-[(8-amino-1-hydroxy-5,7-disulfonatonaphthalen-2-yl)diazenyl]-3-methylphenyl]-2-methylphenyl]diazenyl]-5-hydroxynaphthalene-1,3-disulfonate" n.a. n.a. Yes No No No No No PMDBD2000077 Everolimus (RAD001) Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. D0K3QS 6442177 n.a. n.a. "001, RAD, 40-O-(2-hydroxyethyl)-rapamycin, 40-O-(2-Hydroxyethyl)rapamycin, Afinitor, Certican, Everolimus, RAD, RAD 001, RAD, SDZ, RAD001, SDZ RAD, SDZ-RAD, Zortress, 159351-69-6, Votubia, 42-O-(2-Hydroxyethyl)rapamycin, RAD-001, everolimusum, CHEBI:68478, Afinitor Disperz, Rapamycin, 42-O-(2-hydroxyethyl)-, 9HW64Q8G6G, DTXSID0040599, XIENCE V, RAD 666, RAD-666, UNII-9HW64Q8G6G, DTXCID8020599, HSDB 8255, Everolimus (INN), NSC733504, NCGC00167512-01, Everolimus (RAD001), EVEROLIMUS [INN], EVEROLIMUS (MART.), EVEROLIMUS [MART.], EVEROLIMUS (USP-RS), EVEROLIMUS [USP-RS], (1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.0(sup 4,9))hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone, (1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.04,9)hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone, (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-23,27-epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone, (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(2R)-1-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]propan-2-yl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone, EVEROLIMUS (EP MONOGRAPH), EVEROLIMUS [EP MONOGRAPH], (1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,35R)-1,18-dihydroxy-12-{(2R)-1-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]propan-2-yl}-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.0(4,9)]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone, Everolimus [USAN], AfinitorDisperz, 42-O-(2-Hydroxy)ethyl rapamycin, Everolimus tablets, (1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,35R)-1,18-dihydroxy-12-((2R)-1-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)propan-2-yl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.0(4,9))hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone, (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-((2R)-1-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)propan-2-yl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido(2,1-c)(1,4)oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone, EVE - Everolimus, EVEROLIMUS [MI], EVEROLIMUS [JAN], EVEROLIMUS [VANDF], SCHEMBL4378, EVEROLIMUS [WHO-DD], EVEROLIMUS [EMA EPAR], Everolimus [USAN:INN:BAN], NVP-RAD-001, Everolimus, analytical standard, GTPL5889, RAD-001C, CHEMBL1908360, EVEROLIMUS [ORANGE BOOK], L01XE10, L04AA18, Everolimus; RAD001; SDZ-RAD, 42-O-(2-Hydroxyethyl)-rapamycin, EX-A2057, Tox21_112510, BDBM50088378, AKOS015850977, CS-0064, DB01590, AS-16971, HY-10218, CAS-159351-69-6, Q421052, Q-101413, BRD-K13514097-001-01-2, BRD-K13514097-001-05-3, dihydroxy-[(1R)-2-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxy-cyclohexyl]-1-methyl-ethyl]-dimethoxy-hexamethyl-[?]pentone" C53H83NO14 HKVAMNSJSFKALM-GKUWKFKPSA-N (1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-[(2R)-1-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]propan-2-yl]-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone Novartis Anticancer Agents Yes No No No No No PMDBD2000078 Fenticonazole Nitrate n.a. n.a. n.a. n.a. n.a. n.a. n.a. 51754 n.a. n.a. "FENTICONAZOLE NITRATE, 73151-29-8, Lomexin, Falvin, Fenticonazole mononitrate, Fenticonazole (Nitrate), REC 15/1476, Fenticonazole nitrate [USAN], Rec 15-1476, 8V4JGC8YRF, CHEBI:83606, alpha-(2,4-Dichlorophenyl)-beta,N-imidazolylethyl-4-phenylthiobenzyl ether nitrate, (+-)-1-(2,4-Dichloro-beta-((p-(phenylthio)benzyl)oxy)phenethyl)imidazole mononitrate, 1-[2-(2,4-dichlorophenyl)-2-[(4-phenylsulfanylphenyl)methoxy]ethyl]imidazole;nitric acid, 1-(2-(2,4-dichlorophenyl)-2-((4-(phenylthio)benzyl)oxy)ethyl)-1H-imidazole nitrate, Fenticonazole nitrate (USAN), Fenticonazole nitrate 100 microg/mL in Acetonitrile, Lomexin Nitrate, EINECS 277-302-6, UNII-8V4JGC8YRF, Gynoxin, Fenticonazolnitrat, Lomexin (TN), TX 15338, 1-[2-(2,4-dichlorophenyl)-2-[(4-phenylsulfanylphenyl)methoxy]ethyl]imidazole; nitric acid, Rec-151476B free base, SCHEMBL362708, CHEMBL2107703, DTXSID30993890, Rec-151476, FJNRUWDGCVDXLU-UHFFFAOYSA-N, BCPP000232, HMS3655J11, BCP26349, HY-B0359, AC-426, MFCD00941391, s2031, FENTICONAZOLE MONONITRATE [MI], FENTICONAZOLE NITRATE [MART.], AKOS015855521, FENTICONAZOLE NITRATE [WHO-DD], BCP9000681, CCG-269839, 1-(2-(2,4-Dichlorophenyl)-2-((4-(phenylthio)phenyl)methoxy)ethyl)-1H-imidazolium nitrate, 1-(2-(2,4-dichlorophenyl)-2-((4-phenylsulfanylphenyl)methoxy)ethyl)imidazole nitrate, Imidazole, 1-(2,4-dichloro-beta-(p-(phenylthio)benzyloxy)phenethyl)-, nitrate, REC-15/1476, 1H-Imidazole, 1-(2-(2,4-dichlorophenyl)-2-((4-(phenylthio)phenyl)methoxy)ethyl)-, (+-)-, mononitrate, AS-18687, 2,2,3,3,4,5-HEXACHLOROBIPHENYL, FENTICONAZOLE NITRATE [EP MONOGRAPH], F1008, SW219219-1, D02583, A837734, Q27157007, 1-(2-(2,4-dichlorophenyl)-2-(4-(phenylthio)benzyloxy)ethyl)-1H-imidazole nitrate, 1-[2-(2,4-dichlorophenyl)-2-[[4-(phenylthio)phenyl]methoxy]ethyl]imidazole; nitric acid, (+/-)-1-(2,4-DICHLORO-.BETA.-((P-(PHENYLTHIO)BENZYL)OXY)PHENETHYL)IMIDAZOLE MONONITRATE, 1H-IMIDAZOLE, 1-(2-(2,4-DICHLOROPHENYL)-2-((4-(PHENYLTHIO)PHENYL)METHOXY)ETHYL)-, (+/-)-, MONONITRATE, Nitric acid--1-[2-(2,4-dichlorophenyl)-2-{[4-(phenylsulfanyl)phenyl]methoxy}ethyl]-1H-imidazole (1/1), rac-1-[2-(2,4-dichlorophenyl)-2-{[4-(phenylsulfanyl)benzyl]oxy}ethyl]-1H-imidazole nitrate" C24H21Cl2N3O4S FJNRUWDGCVDXLU-UHFFFAOYSA-N "1-[2-(2,4-dichlorophenyl)-2-[(4-phenylsulfanylphenyl)methoxy]ethyl]imidazole;nitric acid" n.a. n.a. Yes No No No No No PMDBD2000079 Fluorouracil (5-Fluoracil, 5-FU) Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. D05LEO 3385 n.a. NPC75844 "5-Fluorouracil, fluorouracil, 51-21-8, 5-FU, Fluoroplex, Efudex, Adrucil, Carac, Fluracil, Fluoroblastin, Queroplex, 5-fluoropyrimidine-2,4(1H,3H)-dione, Phthoruracil, Carzonal, Kecimeton, Fluril, 5-Fluoracil, Fluracilum, Timazin, Arumel, Efudix, Ulup, Fluorouracilum, Fluro Uracil, 5 Fluorouracil, 5-Fluoruracil, Ftoruracil, Fluri, 5-fluoro-1H-pyrimidine-2,4-dione, 5-Fluoro-2,4(1H,3H)-pyrimidinedione, Effluderm (free base), Fluorouracilo, Fluroblastin, 5-Fluoropyrimidine-2,4-dione, Efurix, Fluoro-uracile, Fluoro-uracilo, Uracil, 5-fluoro-, Ro 2-9757, 5-Faracil, Cinco FU, Fluorouracile, 2,4(1H,3H)-Pyrimidinedione, 5-fluoro-, 2,4-Dihydroxy-5-fluoropyrimidine, 5-fluoro-uracil, 5-Fluor-2,4-pyrimidindiol, 5-fluoropyrimidine-2,4-diol, 2,4-Dioxo-5-fluoropyrimidine, Fluorouricil, NSC 19893, NSC-19893, 5-Fluoropyrimidin-2,4-diol, 5-fluoro uracil, 5-Ftouracyl, 5-Fluoro-2,4-pyrimidinedione, Fluorouracil Cream, 5-Fluor-2,4-dihydroxypyrimidin, Fluorouracil, 5-, Ro-2-9757, U-8953, Fluorouracilum [INN-Latin], Fluorouracilo [INN-Spanish], Fluouracil, CCRIS 2582, Tolak, Fluoro Uracil, HSDB 3228, 5-Fluracil, 191047-65-1, EINECS 200-085-6, FU, 5-Fluor-2,4(1H,3H)-pyrimidindion, UNII-U3P01618RT, 5 FU, DTXSID2020634, CHEBI:46345, AI3-25297, U3P01618RT, NSC19893, Ro-29757, 5FU, CHEMBL185, 5-fluoro-1,2,3,4-tetrahydropyrimidine-2,4-dione, 2,4-Pyrimidinediol, 5-fluoro- (9CI), DTXCID40634, MLS000069498, Phtoruracil, EC 200-085-6, MFCD00006018, 191047-64-0, 191115-88-5, URF, Fluorouracil [USAN:USP:INN:BAN:JAN], NCGC00015442-02, Effluderm, SMR000038082, Fluorouracile [DCIT], 5-Fluoracil [German], 5-Fluoracyl, 5-Fluoruracil [German], Fluorouracilum (INN-Latin), Fluorouracilo (INN-Spanish), FLUOROURACIL (MART.), FLUOROURACIL [MART.], 1004-03-1, FLUOROURACIL (USP-RS), FLUOROURACIL [USP-RS], 5-FLUOROURACIL (IARC), 5-FLUOROURACIL [IARC], Flurablastin, FLUOROURACIL (EP MONOGRAPH), FLUOROURACIL [EP MONOGRAPH], FLUOROURACIL (USP MONOGRAPH), FLUOROURACIL [USP MONOGRAPH], CAS-51-21-8, Fluoroplex (TN), 5-Fluor-2,4-pyrimidindiol [Czech], Fluorouracil (USAN:USP:INN:BAN:JAN), Adrucil (TN), Carac (TN), FLUCYTOSINE IMPURITY A (EP IMPURITY), FLUCYTOSINE IMPURITY A [EP IMPURITY], 5-Fluor-2,4-dihydroxypyrimidin [Czech], SR-01000075881, 5-Fluor-2,4(1H,3H)-pyrimidindion [Czech], inhibits thymilidate synthetase, AccuSite, 2,4-Dioxo-5-fluoropryimidine, 5-fluorourasil, 5-florouracil, 5-fluorouacil, 5 Fluorouracilum, 5-FU (TN), 1upf, 5F-uracil, U 8953, Fluorouracil; 5-Fluoropyrimidine-2,4(1H,3H)-dione; Flucytosine Imp. A (EP); Flucytosine Impurity A, Adrucil (ICN), Adrucil (Fluorouracil), Spectrum_000841, Opera_ID_134, 5-Fluorouracil, 99%, Spectrum2_000076, Spectrum3_000434, Spectrum4_000557, Spectrum5_000718, WLN: T6MVMVJ EF, FLUOROURACIL [MI], Lopac-F-6627, F0151, 5-Fluorouracil (5-FU), FLUOROURACIL [INN], FLUOROURACIL [JAN], UPCMLD-DP130, F 6627, FLUOROURACIL [HSDB], FLUOROURACIL [USAN], SCHEMBL3646, 5-fluorpyrimidin-2,4-diol, FLUOROURACIL [VANDF], Folfox component fluorouracil, Lopac0_000536, BSPBio_002048, FLUCYTOSINE IMPURITY A, KBioGR_001253, KBioSS_001321, 2(1H)-Pyrimidinone, 5-fluoro-4-hydroxy- (9CI), 4(3H)-Pyrimidinone, 5-fluoro-2-hydroxy- (9CI), MLS002415705, DivK1c_000054, FLUOROURACIL [WHO-DD], FLUOROURACIL [WHO-IP], SPECTRUM1500305, SPBio_000291, EMTRICITABINE IMPURITY F, 5-fluoro-2,4-dioxo-pyrimidin, 5-fluoro-pyrimidine-2,4-diol, GTPL4789, UPCMLD-DP130:001, Fluorouracil (JP17/USP/INN), HMS500C16, KBio1_000054, KBio2_001321, KBio2_003889, KBio2_006457, KBio3_001268, 5-Fluoro-2,3H)-pyrimidinedione, 5-FLUOROURACIL [WHO-IP], L01BC02, 2,4-Pyrimidinedione, 5-fluoro-, NINDS_000054, BCPP000428, FLUOROURACIL [ORANGE BOOK], HMS1920O18, HMS2090I04, HMS2091F19, HMS3259O03, HMS3261L13, HMS3654K22, HMS3715H03, HMS3865L03, Pharmakon1600-01500305, 5-Fluorouracil, analytical standard, BCP02083, 2,3H)-Pyrimidinedione, 5-fluoro-, Fluorouracil (5-Fluoracil, 5-FU), Fluorouracil (5-Fluoracil; 5-FU), Tox21_110150, Tox21_202335, Tox21_300112, Tox21_500536, BDBM50340677, CCG-39879, DL-399, NSC757036, NSC816997, s1209, FLUOROURACILUM [WHO-IP LATIN], AKOS000119162, AKOS003237897, AKOS008044307, Tox21_110150_1, BCP9000239, CS-0993, DB00544, KS-5129, LP00536, NC00454, NSC-757036, NSC-816997, SDCCGSBI-0050519.P005, FLUCYTOSINE IMPURITY A [WHO-IP], IDI1_000054, NCGC00015442-01, NCGC00015442-03, NCGC00015442-04, NCGC00015442-05, NCGC00015442-06, NCGC00015442-07, NCGC00015442-08, NCGC00015442-09, NCGC00015442-10, NCGC00015442-11, NCGC00015442-12, NCGC00015442-15, NCGC00015442-16, NCGC00015442-24, NCGC00015442-30, NCGC00091349-01, NCGC00091349-02, NCGC00091349-03, NCGC00091349-04, NCGC00091349-05, NCGC00091349-07, NCGC00091349-08, NCGC00254023-01, NCGC00259884-01, NCGC00261221-01, 5-Fluoro-2,4(1H, 3H)-pyrimidinedione, 5-Fluoro-2,4-(1H,3H)-pyrimidinedione, 5-Fluoropyrimidine-2,4-(1H,3H)-dione, AC-11201, BF166014, EMTRICITABINE IMPURITY F [WHO-IP], HY-90006, NCI60_001652, SRI-10792-04, SRI-10792-05, SRI-10792-06, SRI-10792_07, SRI-10792_08, 5-Fluoro-1H-pyrimidine-2,4-dione(5FU), 5-Fluorouracil, >=99% (HPLC), powder, SBI-0050519.P004, 5-Fluoro-1H-pyrimidine-2,4-dione(5-FU), 5-Fluoro-1H-pyrimidine-2,4-dione (5-FU), A7567, AM20100252, EU-0100536, NS00000337, SW199617-3, 5-Fluoro-1H-pyrimidine-2,4-dione(5-FUra), 5-FLUOROPYRIMIDIN-2,4(1H,3H)-DIONE, EN300-33909, Fluorouracil, meets USP testing specifications, C07649, D00584, 5-Fluorouracil, Vetec(TM) reagent grade, >=99%, Q238512, W-60379, (5-fluorouracil)5-Fluoro-1H-pyrimidine-2,4-dione, 5-Fluoro-1H-pyrimidine-2,4-dione(5-fluoro uracil), SR-01000075881-1, SR-01000075881-3, SR-01000075881-5, W-202929, 5-Fluoro-1H-pyrimidine-2,4-dione (5-Fluorouracil), BRD-K24844714-001-02-1, 5-FLUOROPYRIMIDIN-2,4(1H,3H)-DIONE [WHO-IP], Z275128052, 5-Fluoro-1H-pyrimidine-2,4-dione(5-fluorouracil)(5-FU), 5-Fluorouracil, certified reference material, TraceCERT(R), Fluorouracil, British Pharmacopoeia (BP) Reference Standard, Fluorouracil, European Pharmacopoeia (EP) Reference Standard, Fluorouracil, United States Pharmacopeia (USP) Reference Standard, pyrimidine antimetabolite: inhibits nucleic acid replication; tetratogen, Fluorouracil, Pharmaceutical Secondary Standard; Certified Reference Material, InChI=1/C4H3FN2O2/c5-2-1-6-4(9)7-3(2)8/h1H,(H2,6,7,8,9" C4H3FN2O2 GHASVSINZRGABV-UHFFFAOYSA-N 5-fluoro-1H-pyrimidine-2,4-dione Hoffmann-La Roche pharmaceutical company Immunosuppressive Agents Yes No No No No No PMDBD2000080 Isavuconazole Therapeutic Substance Phase 3 241479-67-4 DB11633 n.a. n.a. D07VHS 6918485 5293682 n.a. "Isavuconazole, 241479-67-4, BAL-4815, isavuconazol, BAL 4815, Isavuconazole [INN], isavuconazolum, 1286730-05-9, CHEBI:85979, UNII-60UTO373KE, 60UTO373KE, RO 0094815, 4-[2-[(1R,2R)-2-(2,5-Difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]-4-thiazolyl]benzonitrile, 4-[2-[(2R,3R)-3-(2,5-difluorophenyl)-3-hydroxy-4-(1,2,4-triazol-1-yl)butan-2-yl]-1,3-thiazol-4-yl]benzonitrile, DTXSID2058251, RO-0094815, Isavuconazole (INN), 4-(2-((2R,3R)-3-(2,5-difluorophenyl)-3-hydroxy-4-(1H-1,2,4-triazol-1-yl)butan-2-yl)thiazol-4-yl)benzonitrile, 4-{2-[(2R,3R)-3-(2,5-difluorophenyl)-3-hydroxy-4-(1H-1,2,4-triazol-1-yl)butan-2-yl]-1,3-thiazol-4-yl}benzonitrile, Bal4815, 4-(2-((2R,3R)-3-(2,5-DIFLUOROPHENYL)-3-HYDROXY-4-(1H-1,2,4-TRIAZOL-1-YL)BUTAN-2-YL)-1,3-THIAZOL-4-YL)BENZONITRILE, 4-(2-((2R,3R)-Rel-3-(2,5-difluorophenyl)-3-hydroxy-4-(1H-1,2,4-triazol-1-yl)butan-2-yl)thiazol-4-yl)benzonitrile, ISAVUCONAZOLE [MI], BAL-8557(pro-drug), SCHEMBL939038, ISAVUCONAZOLE [WHO-DD], CHEMBL409153, DTXCID6032069, ASP9766, J02AC05, DDFOUSQFMYRUQK-RCDICMHDSA-N, BCP07587, EX-A1785, BDBM50595118, MFCD06407745, s3722, AKOS027250772, CCG-269093, CS-3492, DB11633, NCGC00390646-01, NCGC00390646-02, 4-[2-[(1R,2R)-2-(2,5-difluorophenyl)-2-hydroxy-1-methyl-3-(1,2,4-triazol-1-yl)propyl]thiazol-4-yl]benzonitrile, AC-31076, AS-30128, HY-14273, BAL-4815;RO-0094815, Isavuconazole; BAL-4815; RO-0094815, NS00066825, D10750, EN300-7401534, A899541, J-015363, Q6079042, BAL-4815;BAL4815;BAL 4815;RO-0094815;RO0094815;RO 0094815, (2R,3R)-3-[4-(4-cyanophenyl)thiazol-2-yl]-1-(1H-1,2,4-triazol-1-yl)-2-(2,5-difluorophenyl)-butan-2-ol, 2R,3R)-3-[4-(4-Cyanophenyl)thiazol-2-yl]-2-(2,5- difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol, 4-{2-[(1R,2R)-2-(2,5-Difluoro-phenyl)-2-hydroxy-1-methyl -3-[1,2,4]triazol-1-yl-propyl]-thiazol-4-yl}-benzonitrile, 4-{2-[(1R,2R)-2-(2,5-Difluoro-phenyl)-2-hydroxy-1-methyl-3-[1,2,4]triazol-1-yl-propyl]-thiazol-4-yl }-benzonitrile, Benzonitrile, 4-[2-[(1R,2R)-2-(2,5-difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]-4-thiazolyl]-" C22H17F2N5OS DDFOUSQFMYRUQK-RCDICMHDSA-N 4-[2-[(2R,3R)-3-(2,5-difluorophenyl)-3-hydroxy-4-(1,2,4-triazol-1-yl)butan-2-yl]-1,3-thiazol-4-yl]benzonitrile Astellas n.a. Yes No No No No No PMDBD2000081 Micafungin Sodium n.a. n.a. n.a. n.a. n.a. n.a. n.a. 23666118 n.a. n.a. "Micafungin sodium, 208538-73-2, Funguard, Mycamine, FK463 Sodium, FK463, Micafungin Na, Micafungin sodium salt, FK-463, MCFG, IS1UP79R56, FK 463, Micafungin sodium [USAN], UNII-IS1UP79R56, CHEBI:80105, sodium;[5-[(1S,2S)-2-[(3S,6S,9S,11R,15S,18S,20R,21R,24S,25S,26S)-3-[(1R)-3-amino-1-hydroxy-3-oxopropyl]-11,20,21,25-tetrahydroxy-15-[(1R)-1-hydroxyethyl]-26-methyl-2,5,8,14,17,23-hexaoxo-18-[[4-[5-(4-pentoxyphenyl)-1,2-oxazol-3-yl]benzoyl]amino]-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosan-6-yl]-1,2-dihydroxyethyl]-2-hydroxyphenyl] sulfate, MICAFUNGIN SODIUM (MART.), MICAFUNGIN SODIUM [MART.], FK 463 (sodium), C56H70N9NaO23S, Mycamine Sodium, Micafungin sodium?, Funguard (TN), Mycamine (TN), Micafungin sodium- Bio-X, MICAFUNGIN NA [VANDF], Micafungin sodium (JAN/USAN), MICAFUNGIN SODIUM [JAN], CHEMBL1237070, EX-A4114A, MICAFUNGIN SODIUM [WHO-DD], MICAFUNGIN SODIUM SALT [MI], s4287, CCG-270668, MICAFUNGIN SODIUM [ORANGE BOOK], AC-30600, BM164667, D02465, Q27149252, Pneumocandin A0, 1-((4R,5R)-4,5-dihydroxy-N2-(4-(5-(5-(pentyloxy)phenyl)-3-isoxazolyl)benzoyl)-L-ornithine)-4-((4S)-4-hydroxy-4-(4-hydroxy-3-(sulfooxy)phenyl)-L-threonine)-, monosodium salt, Sodium 5-((1S,2S)-2-((3S,6S,9S,11R,15S,18S,20R,21R,24S,25S,26S)-3-((R)-2-carbamoyl-1-hydroxyethyl)-11,20,21,25-tetrahydroxy-15-((R)-1-hydroxyethyl)-26-methyl-2,5,8,14,17,23-hexaoxo-18-(4-(5-(4-pentyloxyphenyl)isoxazol-3-yl)benzoylamino)-1,4,7,13,16,22-hexaazatricyclo(22.3.0.09,13)heptacos-6-yl)-1,2-dihydroxyethyl)-2-hydroxyphenyl sulfate" C56H70N9NaO23S KOOAFHGJVIVFMZ-WZPXRXMFSA-M "sodium;[5-[(1S,2S)-2-[(3S,6S,9S,11R,15S,18S,20R,21R,24S,25S,26S)-3-[(1R)-3-amino-1-hydroxy-3-oxopropyl]-11,20,21,25-tetrahydroxy-15-[(1R)-1-hydroxyethyl]-26-methyl-2,5,8,14,17,23-hexaoxo-18-[[4-[5-(4-pentoxyphenyl)-1,2-oxazol-3-yl]benzoyl]amino]-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosan-6-yl]-1,2-dihydroxyethyl]-2-hydroxyphenyl] sulfate" n.a. n.a. Yes No No No No No PMDBD2000082 Miconazole Nitrate n.a. n.a. n.a. n.a. n.a. n.a. n.a. 68553 n.a. NPC489306 "Miconazole nitrate, 22832-87-7, Andergin, Albistat, Conofite, Aflorix, Florid, Dermonistat, Micatin, Gyno-Monistat, Epi-Monistat, Gyno-Daktar, Daktarin, Deralbine, Mezolitan, Crimak, Micotef, Daktarin talc, Gyno-Daktarin, Miconal Ecobi, Miconazole 7, M-zole 7 Dual Pack, Monistat 3, Monistat 5, Monistat 7, Priconazole, Miconazole (nitrate), Monistat-Derm, M-zole 3 Combination Pack, Miconazole 1, Miconazole 3, Monistat Dual-pak, Brentan, Vusion, Monistat 3 Combination Pack, Monistat 7 Combination Pack, Monistat-3 Combination Pack, Baza cream antifungal, NSC 169434, Baza cream, UNII-VW4H1CYW1K, VW4H1CYW1K, (+/-)-MICONAZOLE NITRATE, 1-(2-((2,4-dichlorobenzyl)oxy)-2-(2,4-dichlorophenyl)ethyl)-1H-imidazole nitrate, Miconazole Nitrate Combination Pack, R 14,889, EINECS 245-256-6, Monistat 1 Combination Pack, Miconazole 3 Combination Pack, Miconazole 7 Combination Pack, NSC-169434, R 14889, MFCD00058161, Monistat 3 combination pack (prefilled), R18134 nitrate, Miconazole nitrate salt, 1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-1H-imidazole; nitric acid, 1H-Imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)-, mononitrate, MLS000028674, 1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole mononitrate, Miconazole nitrate [USAN:USP:JAN], ( inverted exclamation markA)-Miconazole nitrate salt, NSC169434, (+/-)-Miconazole nitrate salt, SMR000058733, VUSION COMPONENT MICONAZOLE NITRATE, EASOTIC COMPONENT MICONAZOLE NITRATE, Monistat (TN), MICONAZOLE NITRATE COMPONENT OF VUSION, MICONAZOLE NITRATE COMPONENT OF EASOTIC, Imidazole, 1-(2,4-dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)-, mononitrate, (+-)-Miconazole nitrate, R-14889, Lotrimin AF Powder, Fungisdin, MICONAZOLE NITRATE (MART.), MICONAZOLE NITRATE [MART.], MICONAZOLE NITRATE (USP-RS), MICONAZOLE NITRATE [USP-RS], Antifungal Cream, Lotrimin AF Spray Liquid, Miconazole nitrate (USAN:USP:JAN), Lotrimin AF Powder Aerosol, 1-[2-(2,4-Dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole Nitrate, 1-[2-(2,4-Dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-1H-imidazole Nitrate, 75319-48-1, MICONAZOLE NITRATE (EP MONOGRAPH), MICONAZOLE NITRATE [EP MONOGRAPH], MICONAZOLE NITRATE (USP MONOGRAPH), MICONAZOLE NITRATE [USP MONOGRAPH], Monistat Cream & Suppositories, MICONAZOLE NITRATE (EMA EPAR VETERINARY), MICONAZOLE NITRATE [EMA EPAR VETERINARY], MCZ, Lotrimin AF Jock-Itch Powder Aerosol, Micaonazole, Conazol, Lagicam, Miconole, Miconosol, Freds, BioTrisFlush, MicaVed, Anti-fungal, Antifungal Body, Baza Antifungal, Green Tetterine, ZeasorbAF, Lagicamantifungal, Monistat nitrate, SR-01000000271, Davis Miconazole, Leader Medicated, Macerrx Web, Selan Antifungal, Miconazoli nitras, Micotrin AP, Jock Itch Spray, Miconasil Nitrate, Mycozyl AP, Remedy Antifungal, Secura Antifungal, Triple Antifungal, Vagistat-3, 1-(2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl)-1H-imidazole nitrate, FredsMiconazole 3, Kendall Antifungal, 7 Day Vaginal, meijerMiconazole 3, Miconazole 3 Day, Micro-Guard(AF), Nitrate, Miconasil, DB Antifungal foot, Nitrate, Miconazole, Athletes Foot Spray, Micatin (TN), Tineacide Antifungal, Topco Miconazole 3, Conofite Cream 2%, Antifungal Miconazole, careone miconazole 1, Conzol1 %, Equate Miconazole 1, HERS Miconazole 3, PiYanPing Antifungal, topcare miconazole 3, Conofite Lotion 1%, DERMAFUNGAL, Dg Health Miconazole, TINEACIDEAntifungal, TRIPLEAF, Careone miconazole 7, Miconazole nitrate1%, Careone Miconazole 3, Lotrimin AFAntifungal, Miconazole 1Walgreens, Miconazorb AF Powder, Remedy with Phytoplex, Sunmark Miconazole 3, Sunmark Miconazole 7, Topcare Miconazole 1, Topcare Miconazole 7, Aloe Vesta Antifungal, Basic Care Miconazole, Bengama-MICONAZOLE, Critic Aid Clear AF, Nail Fungus Treatment, rac-miconazole nitrate, Thera Antifungal Body, Up and Up Miconazole, vagisil brand vagistat, BOA VIDA Antifungal, Equaline Miconazole 3, Equaline Miconazole 7, Miconazole Foot Powder, Soothe and Cool Treat, Miconazole Nitrate 2%, NAIL RENU Antifungal, Warrior Antifungal Foot, Care One Miconazole 1, CPD000058733, FemmesilMaximum Strength, Jock Itch Powder Spray, basic care miconazole 3, Dg Health Miconazole 3, Miconazole Nitrate,(S), VAGISTAT 3, VAGISTEN-V7 DAY, Antifungal Athletes Foot, (RS)-miconazole nitrate, Basic Care miconazole 1, A2A Anti-Fungal Powder, Basic Care Miconazole 7, caring mill miconazole 3, Good Sense Miconazole 3, Good Sense Miconazole 7, miconazole 1feminine care, Up and Up Miconazole 1, Up and Up Miconazole 3, Up and Up Miconazole 7, Dynarex Antifungal Powder, Opera_ID_1059, Touchless Care Antifungal, Astonea Miconazole nitrate, DCH Labs Antifungal Jock, Premier ValueMiconazole 3, Secura AntifungalGreaseless, Relispray Antifungal Powder, component of Monistat cream, Jock Itch Spray Talc Free, BAZA CREAM [VANDF], CAREALL Miconazole Nitrate, Harris Teeter Miconazole 3, Harris Teeter Miconazole 7, NSC 169434 Nitrate, Secura AntifungalExtra Thick, CHEMBL1559, Miconazole 3Walgreen Company, Signature Care Miconazole 1, Signature Care Miconazole 3, Signature Care Miconazole 7, Quality Choice3 Day Vaginal, SCHEMBL15799, Viniferamine Antifungal Cream, 2% Miconazole Nitrate Cream, CVS Feminine Intimate Powder, Exchange Select Miconazole 1, Family Wellness Miconazole 3, Miconazole Nitrate Cream 2%, Molecular AF Molecular Cream, MLS001148223, MLS002548903, Femmesil CremeMaximum Strength, Miconazole 1 Combination Pack, SPECTRUM1500413, Anti-Fungal Miconazole Nitrate, REGID_for_CID_68553, Remedy AntifungalWith Olivamine, CHEBI:6924, Treatonic Nail Fungus Treatment, MICONAZOLE NITRATE [MI], MICONAZOLE NITRATE [JAN], HMS500H18, HY-B0454A, Miconazole nitrate (JP17/USP), SUNMARK MICONAZOLE NITRATE, Aloe Vesta Clear Antifungal 56g, DTXSID50996767, MICONAZOLE NITRATE [INCI], MICONAZOLE NITRATE [USAN], ANTIMICROBIAL DRUG PRODUCTS, miconazole 1yeast infection relief, Antifungal Liquid Continuous Spray, Antifungal Miconazole Powder Spray, Fungus Master Antifungal Treatment, HMS1920N21, HMS2091F16, HMS2233O22, HMS3259M05, HMS3655D05, MICONAZOLE NITRATE [VANDF], Monistat 7with Reusable Applicator, Pharmakon1600-01500413, Aloe Vesta Clear Antifungal 141g, Meijer Jock Itch Relief Antifungal, Miconazole Nitrate Cream USP, 2%, AMY11000, BCP13696, MICONAZOLE NITRATE [WHO-DD], MICONAZOLE NITRATE [WHO-IP], topcare miconazole 3combination pack, Budpak Antifungal Miconazole Nitrate, Good Neighbor Pharmacy Miconazole 1, Good Neighbor Pharmacy Miconazole 7, Miconazole Nitrate Antifungal Powder, CCG-39756, NSC757119, s1956, Anti-fungal Powder Miconazole Nitrate, Athletes Foot Powder Spray Talc Free, Priconazole Lotion 1% and Spray 1%, AKOS015895065, AKOS015962190, Miconazorb Antifungal Powder Talc Free, Private Label Antifungal Barrier Cream, AB02339, Antifungal Miconazole Liquid Continuous, MICONAZOLE NITRATE [GREEN BOOK], NC00461, NSC-757119, 1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole;nitric acid, MICONAZOLE NITRATE [ORANGE BOOK], Monistat 33-Day Pre-filled Applicators, SUNMARK MICONAZOLE NITRATEantifungal, MICONAZOLI NITRAS [WHO-IP LATIN], NCGC00094728-01, NCGC00094728-02, NCGC00094728-03, AS-13575, BM166180, Good Neighbor Pharmacy Miconazole Nitrate, Novana Antifungal Barrier With Miconazole, Antifungal Miconazorb AF Powder Talc Free, Miconazole Nitrate Antifungal Powder Spray, TINEACIDE ANTIFUNGALMAXIMUM STRENGTH, TopCareMiconazole 3 Yeast Infection Relief, MICONAZOLE Nitrate 2% Cream ANTIFUNGAL, Monistat 3 Combination Pack3 Ovule Inserts, Antifungal Miconazole Liquid Continuous Spray, M1769, NS00082586, SKIN PROTECTOR WITH BREATHABLE BARRIER, STIX 3 DAY YEAST INFECTION TREATMENT, SW196614-3, Aluminum hydroxideoxide(al(oh)o),hydrate(9ci), MONISTAT 77-DAY DISPOSABLE APPLICATORS, Anti-fungal Powder Miconazole Nitrate Talc Free, C08070, D00882, Quinsana Anti-Fungal Powder 2 Miconazole Nitrate, [2,4-dichlorobenzyloxy)phenethyl]imidazole nitrate, Good Neighbor Pharmacy Jock Itch Relief Antifungal, (+/-)-Miconazole nitrate salt, imidazole antibiotic, Evercare Antifungal Treatment Super Absorbent Powder, J-014876, SR-01000000271-2, Anti-fungal Miconazole Athletes Foot Spray Talc Free, Good Neighbor Pharmacy Athletes foot Relief Antifungal, Q27292045, Monistat 7 Combination Pack7-Day Pre-Filled Applicators, 1-[2,4-dichlorobenzyl)oxy]phenethyl]imidazole mononitrate, 1-(2,4-Dichloro-ss-[(2,4-dichlorobenzyl)oxy]phenethyl)imidazole, Miconazole nitrate, British Pharmacopoeia (BP) Reference Standard, Miconazole nitrate, European Pharmacopoeia (EP) Reference Standard, Miconazole nitrate, United States Pharmacopeia (USP) Reference Standard, 1-((2RS)-2-(2,4-Dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl)-1H-imidazole mononitrate, 1-(2,4-DICHLORO-.BETA.-((2,4-DICHLOROBENEZYL)OXY)PHENETHYL)IMIDAZOLE MONONITRATE, 1-(2,4-DICHLORO-beta-((2,4-DICHLOROBENEZYL)OXY)PHENETHYL)IMIDAZOLE MONONITRATE, 1-(2-(2,4-Dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)-1H-imidazole Mononitrate, 1H-Imidazole,1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-,mononitrate, 1H-Imidazole,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-, mononitrate, Imidazole,4-dichloro-.beta.-[(2,4-dichlorobenzyl)oxy]phenethyl]-, mononitrate, (+/-)-Miconazole nitrate salt, Pharmaceutical Secondary Standard; Certified Reference Material, 1H-Imidazole, 1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-, nitrate (1:1)" C18H15Cl4N3O4 MCCACAIVAXEFAL-UHFFFAOYSA-N "1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole;nitric acid" n.a. n.a. Yes No No No No No PMDBD2000083 Miltefosine Therapeutic Substance Approved Drug 58066-85-6 DB09031 n.a. D02494 D00FGR 3599 3473 NPC478931 "Miltefosine, 58066-85-6, Hexadecylphosphocholine, Miltex, Impavido, HDPC, Hexadecylphosphorylcholine, Miltefosina, Miltefosinum, n-Hexadecylphosphorylcholine, n-hexadecylphosphocholine, Miltefos, 1-Hexadecylphosphorylcholine, hexadecyl 2-(trimethylazaniumyl)ethyl phosphate, miltefosin, D-18506, hexadecyl 2-(trimethylammonio)ethyl phosphate, hexadecyl phosphocholine, Miltefosin C, Fos-choline 16, Miltefosinum [INN-Latin], Miltefosina [INN-Spanish], hexadecyl (2-(trimethylAmmonio)ethyl) phosphate, monohexadecylphosphocholine, D 18506, monohexadecylphosphorylcholine, UNII-53EY29W7EC, NSC605583, Miltefosine (INN), NSC-605583, NSC-758968, BRN 3690495, 53EY29W7EC, DTXSID7045942, CHEBI:75283, D18506, CHEMBL125, NSC 605583, HePC;Hexadecyl phosphocholine, 2-(((Hexadecyloxy)hydroxyphosphinyl)oxy)-N,N,N-trimethylethanaminium hydroxide, inner salt, Choline phosphate, hexadecyl ester, hydroxide, inner salt, DTXCID5025942, 4-04-00-01460 (Beilstein Handbook Reference), MFCD00133396, MMV688990, Ethanaminium, 2-(((hexadecyloxy)hydroxyphosphinyl)oxy)-N,N,N-trimethyl-, hydroxide, inner salt, NCGC00095169-01, MILTEFOSINE [INN], Miltefosinum (INN-Latin), Miltefosina (INN-Spanish), MILTEFOSINE (MART.), MILTEFOSINE [MART.], C21H46NO4P, Miltefosine [INN:BAN], CAS-58066-85-6, Choline hexadecyl phosphate, ?Miltefosine, Miltefosine?, Miltextrade mark, HePC Hydrate, Impavidotrade mark, Impavido (TN), Choline, inner salt, TF-002, Ethanaminium, 2-(((hexadecyloxy)hydroxyphosphinyl)oxy)-N,N,N-trimethyl-, hydroxide, innner salt, Choline hydroxide, hexadecyl hydrogen phosphate, inner salt, MILTEFOSINE [MI], Hexadecyl Phosphorylcholine, H-1850, M-7200, SCHEMBL26215, MILTEFOSINE [WHO-DD], SPECTRUM1505329, choline phosphate hexadecyl ester, hydroxide, inner salt, GTPL11355, MILTEFOSINE [ORANGE BOOK], P01CX04, Hexadecyl Phosphorylcholine Hydrate, HMS1922D16, HMS2089J15, HMS3649I09, Pharmakon1600-01505329, hexadecylphosphocholine, miltefosine, BCP04506, miltefosine (hexadecylphosphocholine), Tox21_111466, BDBM50034220, CCG-35584, CCG-36097, CCG-40025, DL-131, HB0412, Hexadecyl 2-(trimethyl-.lambda.~5~-azanyl)ethyl hydrogen phosphate, NSC758968, s3056, 1-N-HEXADECYLPHOSPHORYLCHOLINE, AKOS015914886, Tox21_111466_1, BCP9000927, DB09031, NCGC00095169-02, NCGC00095169-03, NCGC00095169-05, NCGC00095169-07, HY-13685, BCP0726000071, M2445, NS00004313, hexadecyloxy-2-trimethylammonioethylphosphorate, D02494, AB00642217-03, AB00642217_04, EN300-7397728, Miltefosine, >=98% (perchloric acid titration), A831718, Hexadecyl 2-(N,N,N-trimethylamino)ethyl Phosphate, Q411787, Hexadecyl 2-(Trimethylammonio)ethyl Phosphate Hydrate, 2-[hexadecoxy(hydroxy)phosphoryl]oxyethyl-trimethyl-ammonium, Phosphoric Acid Hexadecyl 2-(Trimethylammonio)ethyl Ester, [2-(Hexadecyloxy-hydroxy-phosphoryloxy)-ethyl]-trimethyl-ammonium, 3, 4-hydroxy-N,N,N-trimethyl-, hydroxide, inner salt, 4-oxide, hexadecyl 2-(trimethyl-lambda~5~-azanyl)ethyl hydrogen phosphate, Phosphoric Acid Hexadecyl 2-(Trimethylammonio)ethyl Ester Hydrate, 2-(((Hexadecycloxy)hydroxyphosphinyl)oxy)-N,N,N-trimethylethanaminium Inner Salt, 2-(((Hexadecyloxy)hydroxyphosphinyl)oxy)-N,N,N-trimethylethanaminium hydroxide" C21H46NO4P PQLXHQMOHUQAKB-UHFFFAOYSA-N hexadecyl 2-(trimethylazaniumyl)ethyl phosphate Aeterna Zentaris Antifungal Agents Yes No No No No No PMDBD2000084 Mitoxantrone 2HCl n.a. n.a. n.a. n.a. n.a. n.a. n.a. 51082 n.a. n.a. "Mitoxantrone hydrochloride, 70476-82-3, Mitoxantrone dihydrochloride, Mitoxantrone HCl, Novantrone, Novantron, Mitoxantrone 2HCl, Mitoxantrone (dihydrochloride), DHAD, CL-232315, Ralenova, 1,4-Dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino)anthracene-9,10-dione dihydrochloride, NSC-301739, MITOXANTHRONE HYDROCHLORIDE, Mitozantrone hydrochloride, mitozantrone dihydrochloride, DHAQ, CL 232,315, U6USW86RD0, CHEBI:50727, CL 232315, DTXSID0045173, MFCD00242943, Immunex, 70476-82-3 (HCl), 1,4-Dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino)anthraquinone dihydrochloride, 1,4-Dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]anthraquinone dihydrochloride, 1,4-dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione;dihydrochloride, 1,4-Dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]-9,10-anthracenedione dihydrochloride, 9,10-Anthracenedione, 1,4-dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino)-, dihydrochloride, DTXCID8025173, Bisantrone, MITOXANTRONE HYDROCHLORIDE (MART.), MITOXANTRONE HYDROCHLORIDE [MART.], MITOXANTRONE HYDROCHLORIDE (USP-RS), MITOXANTRONE HYDROCHLORIDE [USP-RS], CCRIS 2592, HSDB 6543, MITOXANTRONE HYDROCHLORIDE (EP IMPURITY), MITOXANTRONE HYDROCHLORIDE [EP IMPURITY], MITOXANTRONE HYDROCHLORIDE (EP MONOGRAPH), MITOXANTRONE HYDROCHLORIDE [EP MONOGRAPH], MITOXANTRONE HYDROCHLORIDE (USP MONOGRAPH), MITOXANTRONE HYDROCHLORIDE [USP MONOGRAPH], NCGC00015693-02, EINECS 274-619-1, CAS-70476-82-3, UNII-U6USW86RD0, NSC 301739, Neotalem, Onkotrone, Eslep, SR-01000076001, mitoxanthrone hcl, Mitoxantrone Dihcl, Novantron (TN), 1,4-dihydroxy-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)anthracene-9,10-dione dihydrochloride, Mitoxantrone hydrochloride; 1,4-Dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]anthracene-9,10-dione dihydrochloride, Prestwick_571, 1,4-dihydroxy-5,8-bis-[2-(2-hydroxyethylamino)ethylamino]anthraquinone 2hcl, 1,4-dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione hydrochloride, Mitoxantrone hydrochloride [USAN:USP:JAN], Mitoxantroni Hydrochloridum, Hydrochloride, Mitoxantrone, SCHEMBL3928, SPECTRUM1503278, MITOXANTRONEHYDROCHLORIDE, CHEMBL1417019, HMS1569M11, HMS1922O21, BCP23424, dhaq dihydrochloride 65271-80-9, Tox21_110197, Tox21_500779, CCG-39938, HY-13502A, s2485, Mitoxantrone hydrochloride (JAN/USP), AKOS015895228, Tox21_110197_1, AC-1591, BCP9000932, Dihydroxyanthracenedione Dihydrochloride, LP00779, 1,4-Dihydroxy-5,8-bis-[2-(2-hydroxyethylamino)ethylamino]anthraquinone dihydrochloride, MITOXANTRONE HYDROCHLORIDE [JAN], MITOXANTRONE DIHYDROCHLORIDE [MI], MITOXANTRONE HYDROCHLORIDE [HSDB], MITOXANTRONE HYDROCHLORIDE [USAN], NCGC00015693-09, NCGC00094116-01, NCGC00094116-02, NCGC00094116-03, NCGC00094116-04, NCGC00261464-01, AS-13162, MITOXANTRONE HYDROCHLORIDE [VANDF], BCP0726000265, MITOXANTRONE HYDROCHLORIDE [WHO-DD], EU-0100779, M3110, NS00091303, SW196745-5, Mitoxantrone dihydrochloride, >=97% (HPLC), D02166, EN300-268139, M 6545, MITOXANTRONE HYDROCHLORIDE [ORANGE BOOK], SR-01000076001-1, SR-01000076001-8, W-104553, Q27122209, Z2569867923, Mitoxantrone dihydrochloride pound>>Mitozantrone dihydrochloride, Mitoxantrone hydrochloride, European Pharmacopoeia (EP) Reference Standard, 1,4-dihydroxy-5,8-bis-[[2-(2-hydroxyethylamino)ethyl]amino]-anthraquinone dihydrochloride, 1,4-Dihydroxy-5,8-bis-[2-(2-hydroxy-ethylamino)-ethylamino]-anthraquinone dihydrochloride, 1,4-dihydroxy-5,8-bis-[2-(2-hydroxyethylamino)ethylamino]anthraquinonedihydrochloride, 1,4-dihydroxy-5,8-bis[[2-(2-hydroxyethylamino)ethyl]amino]anthraquinone dihydrochloride, Mitoxantrone hydrochloride, United States Pharmacopeia (USP) Reference Standard, 1,4-dihydroxy-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)-9,10-dihydroanthracene-9,10-dione dihydrochloride, 1,4-dihydroxy-5,8-bis(2-(2-hydroxyethylamino)ethylamino)anthracene-9,10-dione dihydrochloride" C22H30Cl2N4O6 ZAHQPTJLOCWVPG-UHFFFAOYSA-N "1,4-dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione;dihydrochloride" n.a. n.a. Yes No No No No No PMDBD2000085 Natamycin Therapeutic Substance Approved Drug 7681-93-8 DB00826 PA164744325 D00884 D02FEM 5284447 10468784 NPC315783 "NATAMYCIN, pimaricin, Tennecetin, Delvocid, Mycophyt, Synogil, Myprozine, 7681-93-8, Pimafucin, Pimaracin, Natacyn, Antibiotic A-5283, Natamycinum, Delvolan, Natamicina, Natamycine, CL 12,625, 8O0C852CPO, INS NO.235, INS-235, NSC-759167, Pimaricine, CL 12625, CL-12625, Delvopos, Natafucin, DTXCID301163, DTXSID6021163, E-235, Natamycin(Pimaricin), MFCD00135085, Antibiotic A 5283, E 235, NATAMYCIN (MART.), NATAMYCIN [MART.], NATAMYCIN (USP-RS), NATAMYCIN [USP-RS], 16-(3-Amino-3,6-didesoxy-beta-D-mannopyranosyloxy)-5,6-epoxy-8,12,14-trihydroxy-26-methyl-2,10-dioxo-1-oxacyclohexacosa-3,17,19,21,23-pentaen-13-carbonsaeure, myuprozine, NATAMYCIN (USP MONOGRAPH), NATAMYCIN [USP MONOGRAPH], Pimarizin, 6,11,28-Trioxatricyclo[22.3.1.05,7]octacosa-8,14,16,18,20-pentaene-25-carboxylic acid, 22-[(3-amino-3,6-dideoxy-.beta.-D-mannopyranosyl)oxy]-1,3,26-trihydroxy-12-methyl-10-oxo-, (1R,3S,5R,7R,8E,12R,14E,16E,18E,20E,22R,24S,25R,26S)-, Pimarizin [German], Natamycine [INN-French], Natamycinum [INN-Latin], CHEBI:7488, Natamicina [INN-Spanish], UNII-8O0C852CPO, Natamatrix, Natajen, Natamax, Natamycin [USAN:USP:INN:BAN], NCGC00016686-01, (1R,3S,5R,7R,8E,12R,14E,16E,18E,20E,22R,24S,25R,26S)-22-[(3-amino-3,6-dideoxy-beta-D-mannopyranosyl)oxy]-1,3,26-trihydroxy-12-methyl-10-oxo-6,11,28-trioxatricyclo[22.3.1.0~5,7~]octacosa-8,14,16,18,20-pentaene-25-carboxylic acid, 6,11,28-TRIOXATRICYCLO(22.3.1.05,7)OCTACOSA-8,14,16,18,20-PENTAENE-25-CARBOXYLIC ACID, 22-((3-AMINO-3,6-DIDEOXY-.BETA.-D-MANNOPYRANOSYL)OXY)-1,3,26-TRIHYDROXY-12-METHYL-10-OXO-, (1R,3S,5R,7R,8E,12R,14E,16E,18E,20E,22R,24S,25R,26S)-, CAS-7681-93-8, EINECS 231-683-5, Pimaricin; Natamycin, NATAMYCIN [FCC], NATAMYCIN [INN], PIMARICIN [JAN], NATAMYCIN [MI], NATAMYCIN [INCI], NATAMYCIN [USAN], NATAMYCIN [VANDF], NATAMYCIN [WHO-DD], SCHEMBL18140, NATAMYCIN [ORANGE BOOK], CHEMBL1200656, NCXMLFZGDNKEPB-FFPOYIOWSA-N, DTXCID501473823, EX-A1989, HY-B0133, PMR, Tox21_110561, BDBM50370755, AKOS030485970, 73 - Natamycin (pimaricin) in cheese, CS-1909, DB00826, NSC 759167, NICOTINAMIDE_ADENINE_DINUCLEOTIDE, Stereoisomer of 22-((3-amino-3,6-dideoxy-beta-D-mannopyranosyl)oxy)-1,3,26-trihydroxy-12-methyl-10-oxo-6,11,28-trioxatricyclo(22.3.1.0(sup 5,7))octacosa-8,14,16,18,20-pentaene-25-carboxylic acid, NS00003340, Natamycin, VETRANAL(TM), analytical standard, NCGC00373238-02_C33H47NO13_Delvocid, EN300-22411493, Pimaricin preparation, ~2.5%, aqueous suspension, Q248466, Natamycin, United States Pharmacopeia (USP) Reference Standard, Pimaricin, from Streptomyces chattanoogensis, >=95% (HPLC), Natamycin, Pharmaceutical Secondary Standard; Certified Reference Material, (1R*,3S*,5R*,7R*,8E,12R*,14E,16E,18E,20E,22R*,24S*,25R*,26S*)-22-(3-Amino-3,6-dideoxy-beta-D-mannopyranosyloxy)-1,3,26-trihydroxy-12-methyl-10-oxo-6,11,28-trioxatricyclo(22.3.1.05,7)octacosa- 8,14,16,18,20-pentaene-25-carboxylic acid, (1R,3S,5R,7R,8E,12R,14E,16E,18E,20E,22R,24S,25R,26S)-22-((3-amino-3,6-dideoxy-beta-D-mannopyranosyl)oxy)-1,3,26-trihydroxy-12-methyl-10-oxo-6,11,28-trioxatricyclo(22.3.1.0(5,7))octacosa-8,14,16,18,20-pentaene-25-carboxylic acid, (1R,3S,5R,7R,8E,12R,14E,16E,18E,20E,22R,24S,25R,26S)-22-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,26-trihydroxy-12-methyl-10-oxo-6,11,28-trioxatricyclo[22.3.1.05,7]octacosa-8,14,16,18,20-pentaene-25-carboxylic acid, (1R,3S,5R,7R,8E,12R,14E,16E,18E,20E,22R,24S,25R,26S)-22-{[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy}-1,3,26-trihydroxy-12-methyl-10-oxo-6,11,28-trioxatricyclo[22.3.1.0,5,7]octacosa-8,14,16,18,20-pentaene-25-carboxylic acid, (5R,7R,24S)-22R-[(3S-amino-3,6-dideoxy-beta-D-mannopyranosyl)oxy]-1R,3S,26S-trihydroxy-12R-methyl-10-oxo-6,11,28-trioxatricyclo[22.3.1.05,7]octacosa-8E,14E,16E,18E,20E-pentaene-25R-carboxylic acid" C33H47NO13 NCXMLFZGDNKEPB-FFPOYIOWSA-N (1R,3S,5R,7R,8E,12R,14E,16E,18E,20E,22R,24S,25R,26S)-22-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,26-trihydroxy-12-methyl-10-oxo-6,11,28-trioxatricyclo[22.3.1.05,7]octacosa-8,14,16,18,20-pentaene-25-carboxylic acid n.a. Antifungal Agents Yes No No No No No PMDBD2000086 Nitroxoline Therapeutic Substance Patented 4008-48-4 DB01422 PA164754993 n.a. D0KG9M 19910 18756 n.a. NITROXOLINE, 5-nitroquinolin-8-ol, 8-Hydroxy-5-nitroquinoline, 4008-48-4, 5-Nitro-8-hydroxyquinoline, 5-Nitro-8-quinolinol, Nitroxolin, 5-Nitrox, Noxibiol, Nibiol, Noxin, 8-Quinolinol, 5-nitro-, 5-Nitroxine, 5-Nitroks, 5-NOK, 5-Nitro-8-oxyquinoline, 5NOK, Nitroxolinum, 5-Nitro-8-oxychinoline, Nitroxolina, Nitroxolinum [INN-Latin], Nitroxolina [INN-Spanish], A-82, BAS 58, NSC 74947, MLS000069750, NSC-74947, SMR000059036, DTXSID4046284, Galinok, CHEBI:67121, Isinok, Nicene Forte, Nitroxoline (INN), MFCD00006791, A8M33244M6, NCGC00160664-01, NITROXOLINE [INN], Uro-Coli, DTXCID2026284, CAS-4008-48-4, Nitroxoline [INN:BAN:DCF], EINECS 223-662-4, BRN 0166146, Nitroxlina, UNII-A8M33244M6, Nitroxoline (TN), HNQ, Nitrohydroxyquinoline, 3ai8, Opera_ID_204, 5-Nitro-quinolin-8-ol, NITROXOLINE [MI], 5-Nitro-8hydroxyquinoline, Quinolin-8-ol, 5-nitro-, NITROXOLINE [MART.], Oprea1_594857, 8-Hydroxy-5-nitro-chinoline, NITROXOLINE [WHO-DD], 5-21-03-00297 (Beilstein Handbook Reference), cid_19910, MLS001148594, SCHEMBL151248, REGID_for_CID_19910, 5-Nitroquinolin-8-ol, 96%, WLN: T66 BNJ GNW JQ, CHEMBL1454910, BDBM64987, HMS2230I14, HMS3264C05, HMS3374D08, KUC105356N, Pharmakon1600-01506173, 8-Hydroxy-5-nitroquinoline, 96%, AMY23308, HY-B1159, NSC74947, Tox21_111969, KSC-8-140, NSC760393, s4591, AKOS001053242, Tox21_111969_1, AC-7828, CCG-213981, CS-4761, DB01422, NSC-760393, PS-5547, NCGC00160664-03, A6696, H0805, NS00004195, EN300-17364, D07245, 5-Nitro-8-quinolinol|5-Nitro-8-hydroxyquinoline, AB00572598_14, AG-205/04556035, Q304570, SR-01000721863, SR-01000721863-4, W-106391, Z56922155, InChI=1/C9H6N2O3/c12-8-4-3-7(11(13)14)6-2-1-5-10-9(6)8/h1-5,12 C9H6N2O3 RJIWZDNTCBHXAL-UHFFFAOYSA-N 5-nitroquinolin-8-ol n.a. n.a. Yes No No No No No PMDBD2000087 Nystatin (Fungicidin) n.a. n.a. n.a. n.a. n.a. n.a. n.a. 44424838 n.a. NPC477515 Nystatin (Fungicidin), nystatin, SCHEMBL10073781, VQOXZBDYSJBXMA-VHFLTRTASA-N, 1400-61-9, s1934, AKOS024464748, CCG-270578, NCGC00386193-01, Q251005, (1S,3R,4R,7R,9R,11R,15S,16R,17R,18S,19E,21E,25E,27E,29E,31E,33R,35S,36R,37S)-33-[(2S,3R,4R,5R,6S)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,4,7,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,25,27,29,31-hexaene-36-carboxylic acid C47H75NO17 VQOXZBDYSJBXMA-VHFLTRTASA-N (1S,3R,4R,7R,9R,11R,15S,16R,17R,18S,19E,21E,25E,27E,29E,31E,33R,35S,36R,37S)-33-[(2S,3R,4R,5R,6S)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,4,7,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,25,27,29,31-hexaene-36-carboxylic acid n.a. n.a. Yes No No No No No PMDBD2000088 Octenidine Dihydrochloride n.a. n.a. n.a. n.a. n.a. n.a. n.a. 51166 n.a. NPC479575 "Octenidine dihydrochloride, OCTENIDINE HYDROCHLORIDE, 70775-75-6, Octenidine HCl, Sensidin do, Win 41464-2, Octenidine hydrochloride [USAN], U84956NU4B, LAS189962, LAS-189962, WIN-41464-2, 1,1''-(Decane-1,10-diyl)bis(N-octylpyridin-4(1H)-imine) dihydrochloride, N-octyl-1-[10-(4-octyliminopyridin-1-yl)decyl]pyridin-4-imine;dihydrochloride, Octenidine hydrochloride (USAN), 1,1''-Decamethylenebis(1,4-dihydro-4-(octylimino)pyridine) dihydrochloride, 1-Octanamine, N,N''-(1,10-decanediyldi-1(4H)-pyridinyl-4-ylidene)bis-, dihydrochloride, N,N''-(1,10-Decanediyldi-1(4H)-pyridinyl-4-ylidene)bis(1-octanamine) dihydrochloride, CHEMBL36342, OCTENIDINE HCL [INCI], SCHEMBL126065, UNII-U84956NU4B, HY-B2170A, DTXSID90221025, Win-414642, SMGTYJPMKXNQFY-UHFFFAOYSA-N, BCP22785, EINECS 274-861-8, MFCD01938808, s5012, CCG-270262, CS-6224, OCTENIDINE DIHYDROCHLORIDE [MI], OCTENIDINE HYDROCHLORIDE [MART.], OCTENIDINE HYDROCHLORIDE [WHO-DD], O0388, D05222, D86682, A847887, Q1409243" C36H64Cl2N4 SMGTYJPMKXNQFY-UHFFFAOYSA-N "N-octyl-1-[10-(4-octyliminopyridin-1-yl)decyl]pyridin-4-imine;dihydrochloride" n.a. n.a. Yes No No No No No PMDBD2000089 Olanexidine Hydrochloride semihydrate Therapeutic Substance Registered Drug n.a. n.a. n.a. n.a. D0Q2ZV 6918362 n.a. n.a. "Olanexidine hydrochloride, Olanexidine HCl, 146509-94-6, Olanexidine (hydrochloride), C8DA6Y6X6K, Olanexidine hydrochloride anhydrous, 146509-94-6 (HCl), 1-[N''-[(3,4-dichlorophenyl)methyl]carbamimidoyl]-2-octylguanidine;hydrochloride, Olanexidine Hydrochloride semihydrate, 218282-71-4, Olanexidinehydrochloride, UNII-C8DA6Y6X6K, SCHEMBL918821, CHEMBL540531, GVBQOBUYEOFFLD-UHFFFAOYSA-N, OPB 2045, AKOS040749062, HY-125654A, MS-27032, CS-0092622, Q27275320, 1-(3,4-DICHLOROBENZYL)-5-OCTYLBIGUANIDE HYDROCHLORIDE, N1 -(3,4-dichlorobenzyl)-N5 -octyl-biguanide hydrochloride, N1-(3'',4''-dichlorobenzyl)-N5-octyl-biguanide hydrochloride, Imidodicarbonimidic diamide, N-((3,4-dichlorophenyl)methyl)-N''-octyl-, monohydrochloride, N-((3,4-Dichlorophenyl)methyl)-N''-octylimidodicarbonimidic diamide monohydrochloride" C17H28Cl3N5 GVBQOBUYEOFFLD-UHFFFAOYSA-N "1-[N''-[(3,4-dichlorophenyl)methyl]carbamimidoyl]-2-octylguanidine;hydrochloride" n.a. n.a. Yes No No No No No PMDBD2000090 Perifosine (KRX-0401) Therapeutic Substance Phase 1 n.a. n.a. n.a. n.a. D0R1VU 148177 n.a. n.a. "Perifosine, 157716-52-4, KRX-0401, 1,1-Dimethylpiperidin-1-ium-4-yl octadecyl phosphate, Perifosine (KRX-0401), (1,1-dimethylpiperidin-1-ium-4-yl) octadecyl phosphate, D 21266, NSC 639966, Perifosine [INN], NSC-639966, 1,1-dimethylpiperidinium-4-yl octadecyl phosphate, KRX 0401, NSC639966, D-21266, DTXSID3048946, CHEBI:67272, Piperidinium, 4-[[hydroxy(octadecyloxy)phosphinyl]oxy]-1,1-dimethyl-, inner salt, 2GWV496552, NCGC00187909-01, 1,1-dimethylpiperidin-1-ium-4-yl octadecyl phosphate., Piperidinium, 4-((hydroxy(octadecyloxy)phosphinyl)oxy)-1,1-dimethyl-, inner salt, C25H52NO4P, NKA17, UNII-2GWV496552, octadecyl-(1,1-dimethyl-4-piperidylio)phosphate, 4-((Hydroxy(octadecyloxy)phosphinyl)oxy)-1,1-dimethylpiperidinium inner salt, PERIFOSINE [MI], PERIFOSINE [WHO-DD], SCHEMBL93872, CHEMBL372764, GTPL7424, DTXCID0028872, BCP00245, EX-A2229, YHI-1003, Tox21_113365, BDBM50431630, MFCD00927554, NSC800842, s1037, Piperidinium,1-dimethyl-, inner salt, AKOS005146344, CCG-269358, CS-0209, DB06641, EX-3388, GS-3834, NSC-800842, NCGC00187909-02, NCGC00187909-13, AC-25019, AM808092, HY-50909, CAS-157716-52-4, P2831, A23834, D21266, Octadecyl-(1,1-dimethyl-4-piperidylio) phosphate, J-500086, Q3411917, Perifosine; KRX-0401; NSC 639966; D21266, 1,1-DIMETHYLPIPERIDINIUM-4-YL OCTADECYL PHOSPHATE, INNER SALT, 4-Hydroxy-1,1-dimethylpiperidinium hydroxide, octadecyl hydrogen phosphate, inner salt" C25H52NO4P SZFPYBIJACMNJV-UHFFFAOYSA-N (1,1-dimethylpiperidin-1-ium-4-yl) octadecyl phosphate AEterna Zentaris Anticancer Agents Yes No No No No No PMDBD2000091 Piroctone Olamine n.a. n.a. n.a. n.a. n.a. n.a. n.a. 50258 n.a. n.a. "PIROCTONE OLAMINE, 68890-66-4, Octopirox, Piroctone ethanolamine, Kopirox, Octopyrox, Piroctoneolamine, Piroctone ethanolamine salt, Piroctone olamine [USAN], UNII-A4V5C6R9FB, EINECS 272-574-2, A4V5C6R9FB, 2-aminoethanol;1-hydroxy-4-methyl-6-(2,4,4-trimethylpentyl)pyridin-2-one, NSC-759894, PIROCTONE ETHANOLAMINE SALT (1:1), EC 272-574-2, NSC 759894, Piroctone olamine (USAN), 1-Hydroxy-4-methyl-6-(2,4,4-trimethylpentyl)-2-(1H)pyridinone, 2-aminoethanol salt, PIROCTONE OLAMINE (MART.), PIROCTONE OLAMINE [MART.], PIROCTONE OLAMINE (USP-RS), PIROCTONE OLAMINE [USP-RS], 1-hydroxy-4-methyl-6-(2,4,4-trimethylpentyl)-2-pyridone monoethanolamine salt, 1-HYDROXY-4-METHYL-6-(2,4,4-TRIMETHYLPENTYL)-2-PYRIDONE MONOETHANOLAMINE, (+/-)-, 1-Hydroxy-4-methyl-6-(2,4,4-trimethylpentyl)pyridin-2(1H)-one 2-aminoethanol salt, DTXCID2026735, 1-hydroxy-4-methyl-6-(2,4,4-trimethylpentyl)pyridin-2(1H)-one compound with 2-aminoethan-1-ol (1:1), Allermyl, Keratolux, Octopirox (TN), SCHEMBL2843, 1-Hydroxy-4-methyl-6-(2,4,4-trimethylpentyl)-2(1H)-pyridone compound with 2-aminoethanol (1:1), 1-Hydroxy-4-methyl-6-(2,4,4-trimethylpentyl)pyridin-2(1H)-one compound with 2-aminoethanol (1:1), 1-Hydroxy-4-methyl-6-(2,4,4-trimethylpentyl)pyridin-2(1H)-one, compound with 2-aminoethanol (1:1), 2(1H)-Pyridinone, 1-hydroxy-4-methyl-6-(2,4,4-trimethylpentyl)-, compound with 2-aminoethanol (1:1), CHEMBL2107154, PIROCTONE OLAMINE [INCI], BTSZTGGZJQFALU-UHFFFAOYSA-N, AMY40819, BCP29912, HY-B1345, MFCD01690792, s5213, Piroctone olamine, analytical standard, AKOS025149526, CCG-267454, CS-7659, PIROCTONE ETHANOLAMINE [WHO-DD], AS-15254, P2178, D05505, Piroctone ethanolamine salt; Octopirox; Kopirox, PIROCTONE ETHANOLAMINE SALT (1:1) [MI], A836281, Q412572, W-104652, 4-methyl-1-oxido-6-(2,4,4-trimethylpentyl)-2-pyridinone, 1-Hydroxy-4-methyl-6-(2,4,4-trimethylpentyl)-2(1H)-pyridone Ethanolamine, Piroctone olamine, United States Pharmacopeia (USP) Reference Standard, 1-hydroxy-4-methyl-6-(2,4,4-trimethylpentyl)-1,2-dihydropyridin-2-one; 2-aminoethan-1-ol, Ethanol, 2-amino-, compd. with 1-hydroxy-4-methyl-6-(2,4,4-trimethylpentyl)-2(1H)-pyridinone (1:1) (9CI); 1-Hydroxy-4-methyl-6-(2,4,4-trimethylpentyl)-2-pyridone monoethanolamine salt; Octopirox; Octopyrox; Piroctone ethanolamine salt; Piroctone olamine" C16H30N2O3 BTSZTGGZJQFALU-UHFFFAOYSA-N "2-aminoethanol;1-hydroxy-4-methyl-6-(2,4,4-trimethylpentyl)pyridin-2-one" n.a. n.a. Yes No No No No No PMDBD2000092 Rapamycin (Sirolimus) Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. D03LJR 5284616 n.a. NPC213222 (-)-Rapamycin, 53123-88-9, AY 22989, AY-22989, I 2190A, I-2190A, I2190A, NSC 226080, RAPA, Rapammune, Rapamune, Rapamycin, SIIA 9268A, Sirolimus, Wy 090217, rapalimus, Supralimus, WY-090217, Rapamycin (Sirolimus), HYFTOR, sirolimusum, Cypher, Antibiotic AY 22989, Rapamycin (GMP), FYARRO, CCRIS 9024, CHEBI:9168, SILA 9268A, W36ZG6FT64, HSDB 7284, L04AA10, Npc-12g, SM-88 COMPONENT SIROLIMUS, DE-109, NSC-226080, UNII-W36ZG6FT64, DTXSID5023582, MFCD00867594, Rapamycin Immunosuppressant Drug, NAB-RAPAMYCIN COMPONENT RAPAMYCIN, SIROLIMUS (MART.), SIROLIMUS [MART.], EC 610-965-5, SIROLIMUS (USP-RS), SIROLIMUS [USP-RS], NSC226080, (1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-{(2S)-1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl}-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.0(4,9)]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone, (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(2R)-1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone, EVEROLIMUS IMPURITY A (EP IMPURITY), EVEROLIMUS IMPURITY A [EP IMPURITY], (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-23,27-epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone, DTXCID503582, Perceiva, 1fkb, 1pbk, NCGC00021305-05, Rapamycin/Sirolimus, LCP-Siro, (1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-((2S)-1-((1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl)propan-2-yl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.0(4,9))hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone, (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-((2R)-1-((1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl)propan-2-yl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido(2,1-c)(1,4)oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone, (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(1R)-2-[(1S,3R,4R)-4-hydroxy-3-(methyloxy)cyclohexyl]-1-methylethyl}-6,8,12,14,20,26-hexamethyl-10,21-bis(methyloxy)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(6H,31H)-pentone, RAP, RPM, S1039, Rapamycin (>85%), SIROLIMUS [INN], SIROLIMUS [JAN], RAPAMYCIN [MI], Human Blood - Sirolimus, SIROLIMUS [HSDB], SIROLIMUS [USAN], SIROLIMUS [VANDF], BiomolKI2_000084, SCHEMBL3463, SIROLIMUS [WHO-DD], Rapamycin,Sirolimus,Rapamune, BIDD:PXR0165, SIROLIMUS [EMA EPAR], 23,27-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine, MLS006010168, Sirolimus [USAN:INN:BAN], GTPL6031, SIROLIMUS [ORANGE BOOK], BDBM36609, MS-R001, S01XA23, HMS2089A21, HMS3403F11, HMS3884C03, (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hexadecahydro-9,27-dihydroxy-3-[(1R)-2-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethyl]-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-23,27-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone, (9S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-{(2R)-1-[(3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl}-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone, EX-A1044, AC-722, BDBM50064359, HY-10219G, AKOS015850976, AKOS015961618, CCG-100684, CS-0063, DB00877, NSC-2260804, NCGC00021305-06, NCGC00021305-07, Rapamycin from Streptomyces hygroscopicus, AS-11687, HY-10219, SMR004701276, Fyarro (sirolimus albumin-bound particles), UNM-0000358684, A-275, CS-0626126, R0097, Rapamycin, VETRANAL(TM), analytical standard, M02444, Q32089, Q-201659, BRD-K84937637-001-04-0, BRD-K84937637-001-06-5, BRD-K89626439-001-01-0, Z2568665260, Rapamycin from Streptomyces hygroscopicus, >=95% (HPLC), powder, Rapamycin from Streptomyces hygroscopicus, Vetec(TM) reagent grade, >=95%, (1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.04,9)hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone, (1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-{(2S)-1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl}-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone, (3 S ,6 R ,7 E ,9 R ,10 R ,12 R ,14 S ,15 E ,17 E , 19 E ,21 S ,23 S ,26 R ,27 R ,34a S )-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34, 34a-hexadecahydro-9,27-dihydroxy-3-, (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34 aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hex adecahydro-9,27-dihydroxy-3-[(1R)-2-[(1S,3R,4R)-4-hydro xy-3-methoxycyclohexyl]-1-methylethyl]-10,21-dimethoxy- 6,8,12,14,20,26-hexamethyl-23,27-ep, (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-4,9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-heptadecahydro-9,27-dihydroxy-3-[(1R)-2-[(1S,3,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethyl]-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-223,27-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine-1,5,11,28,29(6H,31H)-pentone, (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hexadecahydro-9,27-dihydroxy-3-[(1R)-2-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethyl]-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-23,27-ep, (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(1R)-2-[(1S,3R,4R)-4-hydroxy-3-(methyloxy)cyclohexyl]-1-methylethyl}-6,8,12,14,20,26-hexamethyl-10,21-bis(methyloxy)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro, (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(1R)-2-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethyl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone, 1,18-Dihydroxy-12-[2-(4-hydroxy-3-methoxy-cyclohexyl)-1-methyl-ethyl]-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-aza-tricyclo[30.3.1.0*4,9*]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone (Rapamycin), 9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-23,27-epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,2 C51H79NO13 QFJCIRLUMZQUOT-HPLJOQBZSA-N (1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-[(2R)-1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl]-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone Wyeth Immunosuppressive Agents Yes No No No No No PMDBD2000093 Ridaforolimus (Deforolimus, MK-8669) n.a. n.a. n.a. n.a. n.a. n.a. n.a. 129010049 n.a. n.a. Ridaforolimus (Deforolimus, MK-8669), SW222224-1, BRD-K09078998-001-01-4 C53H84NO14P BUROJSBIWGDYCN-HSPIJORXSA-N (1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32R,35R)-12-[(2R)-1-[(1S,3R,4S)-4-dimethylphosphoryloxy-3-methoxycyclohexyl]propan-2-yl]-1,18-dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone n.a. n.a. Yes No No No No No PMDBD2000094 Tavaborole (AN-2690) Therapeutic Substance n.a. n.a. n.a. n.a. n.a. D05VGL 11499245 n.a. n.a. Tavaborole, 174671-46-6, AN-2690, 5-FLUOROBENZO[C][1,2]OXABOROL-1(3H)-OL, Kerydin, AN2690, 2,1-Benzoxaborole, 5-fluoro-1,3-dihydro-1-hydroxy-, AN 2690, 5-fluoro-1-hydroxy-3H-2,1-benzoxaborole, 5-Fluoro-1,3-dihydro-1-hydroxy-2,1-benzoxaborole, UNII-K124A4EUQ3, 5-fluoro-2,1-benzoxaborol-1(3H)-ol, Tavaborole [USAN], K124A4EUQ3, CHEBI:77942, 5-fluoro-1,3-dihydro-2,1-benzoxaborol-1-ol, HSDB 8342, DTXSID00169888, Tavaborole (USAN), MFCD10699483, 5-Fluoro-3H-benzo[c][1,2)oxaborol-1-ol, 5-fluoro-3H-benzo[c][1,2]oxaborol-1-ol, Tavaborole [USAN:INN], tavaborol, tavaborolum, p-fluorbenzoxaborole, Kerydin (TN), SCH-900340, Tavaborole (>90%), TAVABOROLE [MI], TAVABOROLE [INN], AN-2690(Tavaborole), TAVABOROLE [VANDF], Tavaborole (AN-2690), TAVABOROLE [WHO-DD], SCHEMBL500016, CHEMBL443052, DTXCID5092379, TAVABOROLE [ORANGE BOOK], D01AE24, LFQDNHWZDQTITF-UHFFFAOYSA-N, TAVABOROLE topical solution, 5%, BCP08730, EX-A1086, BDBM50370987, s4996, AKOS006303927, CCG-266215, CS-1058, DB09041, DS-8392, MB08883, 5-Fluoro-1-hydroxy-2,1-benzoxaborolane, NCGC00264110-01, NCGC00264110-02, AC-30887, HY-10980, SY038332, NS00073562, T3775, D10169, EN300-125084, F11396, 1,3-dihydro-5-fluoro-1-hydroxy-2,1-benzoxaborole, Q21011226, Z1198279578 C7H6BFO2 LFQDNHWZDQTITF-UHFFFAOYSA-N 5-fluoro-1-hydroxy-3H-2,1-benzoxaborole Anacor n.a. Yes No No No No No PMDBD2000095 Temsirolimus (CCI-779, NSC 683864) Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. D0ES1Q 6918289 n.a. n.a. Temsirolimus, Torisel, CCI-779, 162635-04-3, 624KN6GM2T, DTXSID2040945, UNII-624KN6GM2T, WAY-CCI 779, CHEMBL1201182, DTXCID0020945, HSDB 7931, Cci 779, Rapamycin 42-(2,2-bis(hydroxymethyl)propionate), MFCD00934421, NCGC00167518-01, Rapamycin, 42-(3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate), TEMSIROLIMUS (MART.), TEMSIROLIMUS [MART.], 42-(3-Hydroxy-2-(hydroxymethyl)-2-methylpropanoate)rapamycin, Rapamycin 42-[3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate], (1R,2R,4S)-4-{(2R)-2-[(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,30S,34aS)-9,27-dihydroxy-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-1,5,11,28,29-pentaoxo-1,4,5,6,9,10,11,12,13,14,21,22,23,24,25,26,27,28,29,31,32,33,34,34a-tetracosahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontin-3-yl]propyl}-2-methoxycyclohexyl 3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate, CHEBI:79699, temsirolimusum, Temserolimus, NSC-683864, Rapamycin 42-, Temsirolimus (CCI-779, NSC 683864), Temsirolimus [USAN], Temsirolimus (>80%), TEMSIROLIMUS [MI], TEMSIROLIMUS [INN], TEMSIROLIMUS [JAN], TEMSIROLIMUS [VANDF], SCHEMBL18792, TEMSIROLIMUS [WHO-DD], GTPL5892, TEMSIROLIMUS [EMA EPAR], L01XE09, Temsirolimus, >=98% (HPLC), CBPNZQVSJQDFBE-FUXHJELOSA-N, TEMSIROLIMUS [ORANGE BOOK], 42-[3-Hydroxy-2-methylpropanoate, 42-[3-Hydroxy-2-(hydroxymethyl)-2-methylpropanoate]-rapamycin, Temsirolimus [USAN:INN:BAN:JAN], Tox21_112515, BDBM50343413, s1044, AKOS025142069, AM84554, CCG-264790, CS-0129, NCGC00167518-02, NCGC00167518-05, NCGC00167518-09, HY-50910, CAS-162635-04-3, T3574, AB01274736-01, AB01274736_02, SR-01000898799, J-009958, Q7699074, SR-01000898799-3, BRD-K08177763-001-02-6, Rapamycin 42-ester with 2,2-bis-(hydroxymethyl)propionic acid, A4I C56H87NO16 CBPNZQVSJQDFBE-FUXHJELOSA-N [(1R,2R,4S)-4-[(2R)-2-[(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-2,3,10,14,20-pentaoxo-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraen-12-yl]propyl]-2-methoxycyclohexyl] 3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate Wyeth n.a. Yes No No No No No PMDBD2000096 Zinc Pyrithione Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D07FTI 26041 n.a. n.a. "Zinc pyrithione, OM-1563, DTXSID7026314, DTXCID90820451, Bis((1-oxidopyridin-2-yl)thio)zinc, zinc;1-oxidopyridin-1-ium-2-thiolate, NCGC00091933-01, NCGC00183121-01, Zinc pt, Zinci pyrithionum, Finecide ZPT, Hokucide ZPT, Niccanon SKT, Biocut ZP, zinc bis(2-thioxopyridin-1(2H)-olate), 1698050-37-1, Tomicide Z 50, Tomicide ZPT 50, CAS-13463-41-7, Evafine P 50, Caswell No. 923, Zinc Pyrithione Powder, BC-J, biokera, shampoo, Balancing, Chevance, Dandrene, Elementz, Medaclear, Treatment, Vanicream, Zincopan, Zolidyne, classic control, LuckyClassic, pyrthione zinc, DermaZinc, Zinc 2-pyridinethiol-1-oxide, Bioxsine Series, Dandruff Detox, Everyday Clean, Pyrithion-Zink, Pyrithionr Zinc, Pyrithions Zinc, Pyritione Zinc, Royal Dandruff, Zinc-pyrion, American Crew, CCRIS 4894, Classic Clean, Zinc Therapy, HairQ, Zinc soap, Zn-pyrion, Clean Apple, CyzoneBe Sexy, Four Season, Happy Cappy, Head Remedy, Itchy Scalp, LuckyDry Hair, piritiona cincica, Pyrithizone Zinc, Zinc pyridine-2-thiol 1-oxide, Shiny and Sleek, Dry Scalp, Free and Clear, Blue Cap, Crawford Dandruff, HSDB 4498, Vanicream Z-Bar, Zinc 1-hydroxy-2-pyridinethione, Blue Cap Cream, Dry Scalp Care, Smooth and glossy, Zinc bis(2-pyridylthio)-N-oxide, Bis(2-pyridinethiol-1-oxide)zinc, pyrithione (base), Piritionato cincico, Pyrithione zincique, LIFECELL Womens, Dry Scalp Dandruff, Lucky2in1 Classic, FSB 8332, Pyrithionum zincicum, EpochAva Puhi Moni, 2 in 1 Dandruff, 2-Pyridinethiol-1-oxide, zinc salt, Antidandruff Shampoo, Dandruff 2 in 1, EINECS 236-671-3, EquateEveryday Clean, Fresh Mint Dandruff, LIFECELL Mens, Vegetability Natural, 2-Mercaptopyridine 1-oxide zinc salt, 2-mercaptopyridine-1-oxide zinc salt, HEAD AND SHOULDERS CONDITIONER, Aloe Coal 01, ANTIDANDRUFF, Divine Dandrene 1%, Divine Dandrene 2%, FRUITOPIA, HEBDANDRUFF, Pyrithione Zinc 1%, REVOX, SAFEWAYDANDRUFF, AxeFeeze AntiDandruff, GKhair Anti-Dandruff, MOJELIM Dr, Sulfur 8 Aqua Blue, WeCare Anti-Dandruff, Anti-Dandruff Shampoo, Bis(2-pyridylthio)zinc 1,1''-dioxide, Control Anti-Dandruff, EPA Pesticide Chemical Code 088002, LEudine Anti-dandruff, Nioxin Scalp Recovery, NSC 290409, Simply Clean Dandruff, AxeFreeze AntiDandruff, DAMOAE THERAPY, PYRITHIONE ZINE, SHIKATRI CLASS, Vancide ZP Dispersion, 2 in 1 Antidandruff, BALLVIC SEBO, REBIRTH HAIR, Pert Plus 2 in 1, pyrithione zinc shampoo, SELEX DNA, X FOLATE, AxeAntiDandruff Styling, bis(N-oxopyridine-2-thionato)zinc (II), Everyday Clean Dandruff, Satinique Anti Dandruff, dandruff therapy shampoo, Equaline DandruffRefresh, HAIRJOY MSM HAIR, Personal CAREDry Scalp, Shampoo plus Conditioner, Control Dandruff Therapy, Pert Plus Dandruff Plus, AffirmCare Scalp Therapy, AI3-62421, HEAD AND SHOULDER, MEDECEAN SEBORRHEA, DR. SCALP ACTIVE, modesa 2 in 1 dandruff, Shelo NABEL Anti Caspa, Apex Crown Anti Dandruff, Daylogic Refresh Dandruff, Dermaharmony Zinc Therapy, Royal Dandruff Dry Scalp, Sereve Professional Scalp, Zincon Medicated Dandruff, Head and Shoulders 2in1, MSM HAIR SIGNATURE, Personal CAREDaily Clean, ZENOTRI Scalp Shampoo., Balmers Cooling Zone 31, Pyrithione Zinc 0.22%, Dermaharmony Tea Tree Bar, Dermaharmony Unscented Bar, Equate Dry Scalp Dandruff, Aloe Coal 02 Conditioner, BYE-BYE CRADLE CAP, CVS PHARMACYDANDRUFF, DG BODYSIMPLY CLEAN, Natural 17 Anti-Dandruff, P.O.V. Classic Dandruff, SAFEWAY CAREDANDRUFF, URBAN WASH DANDRUFF, Dermaharmony Face and Body, Dry Scalp CareDandruff MD, Head and Shoulders Coconut, Daylogic 2 in 1 Dandruff, Zinc, bis(1-hydroxy-2(1H)-pyridinethionato)-, EQUALINECLASSIC CLEAN, ESIKAMen Effective Control, Head and Shoulders Grooming, Head and Shoulders Scalp X, MOISTURIZING DANDRUFF, OREAD BLUE Anti-Dandruff, SuaveMen 2 in 1 Dandruff, ZENOTRI Follicle Shampoo., Classic Control Antidandruff, Daylogic Dry Scalp Dandruff, Dermaharmony Pyrithione Zinc, LBELHOMME ANTIDANDRUFF, UNII-R953O2RHZ5, 2in1Dandruff and Conditioner, Australian Gold Defense Zone, Hair and Scalp anti-dandruff, Marcs Everyday Care Dandruff, Sebastian Purist Antidandruff, Selsun Blue Itchy Dry Scalp, P.O.V. Dry Scalp Dandruff, Sulfur 8 Kids Anti-Dandruff, 2 in 1, Head and Shoulders Dual Pack, Head and ShouldersGreen Apple, Head and ShouldersItchy Scalp, BLADE HOWLANTI-DANDRUFF, Equaline DandruffClassic Clean, Equate Everyday Clean Dandruff, Halsa Pyrithione Zinc Dandruff, Head and ShouldersVolume Boost, Hyvee Care Dry Scalp Dandruff, Leader Dandruff Everyday Clean, Marcs Dry Scalp Care Dandruff, Mizani Scalp Care Antidandruff, Modesa Dandruff Everyday Clean, Royal Dandruff Dry Scalp Care, AxeArmor AntiDandruff 2 in 1, Head and Shouldersmenthol fresh, SIMPLY BODYCARE DANDRUFF, ClearComplete Care AntiDandruff, Daylogic Dandruff Classic Clean, First Aid Beauty Anti-Dandruff, Head and Shoulders Coconut Kit, Head and Shoulders Shea Butter, Head and Shoulders Styling Gel, Head and ShouldersClassic Clean, Topcare Everyday Clean Dandruff, Alberto VO5 2 in 1 Dandruff, DG BODY2 IN 1 CLASSIC, ESIKAMEN MAXIMUM STRENGTH, Head and Shouldersrenewing clean, SAFEWAYDANDRUFF DRY SCALP, (T-4)-Bis(1-hydroxy-2(1H)-pyridinethionato-O,S)zinc, Cremo Anti-Dandruff Fresh blend, Dermaharmony 1% Pyrithione Zinc, Flakes Cedar Mint Anti Dandruff, Head and Shoulders Ginger 2in1, Head and Shoulders Molding Clay, Head Remedy Dandruff Conditioner, Pert Plus 2 in 1Anti-Dandruff, ALEVAI Stem Cell Anti-Dandruff, ESIKAMen Multi-Action 2-in-1, Head and Shoulders Coconut 2in1, Head and Shoulders Coconut Daily, Head and Shoulders Deep Moisture, Head and Shoulders Scalp Restore, jm5b01461, Compound 171, TopCareGentle Dandruff Dry Scalp, Zinc 1-hydroxypyridine-2-thione, basic essentials dandruffdry scalp, D11AX12, Dermaharmony Seborrheic Dermatitis, Head and ShouldersDry Scalp Care, As I AmDry and Itchy Scalp Care, BEING WELL BODYDry Scalp Care, bis(1-oxidopyridin-2-ylthio)zinc, EQUALINEDRY SCALP 2 IN 1, Equate Beauty Color Safe Dandruff, Head and Shoulders Charcoal Daily, Head and Shoulders Styling Pomade, Hyvee Care Classic Clean Dandruff, Pert Plus for Men Daily Dandruff, Pyrithione zincique (INN-French), Pyrithionum zincicum (INN-Latin), Urban Wash Everday Clean Dandruff, BDBM429354, CONTROL Dandruff-Free Beard Wash, Dandrene Anti-Dandruff Conditioner, Esika Men DandruffMaximum Strength, Head and Shoulders Dry Scalp Care, Mercaptopyridine N-oxide zinc salt, Piritionato cincico (INN-Spanish), TopCare Dry Scalp Gentle Dandruff, XtraCare Anti-Dandruff Conditioner, Epoch Ava Puhi Moni Anti-Dandruff, Head and ShouldersSmooth and Silky, SuaveProfessionals Men AntiDandruff, TopCare Beauty Pure Sport Dandruff, TopCare2 in 1 Dandruff Dry Scalp, Art of Sport Anti Dandruff Compete, Art of Sport Anti Dandruff Victory, ClearMen Ocean Mineral AntiDandruff, DG BODY2 IN 1 GREEN APPLE, Equaline DandruffDry Scalp 2 in 1, Equate 2 in 1 Dry Scalp Dandruff, Equate Dry Scalp 2 in 1 Dandruff, GLOBAL KERATIN-ANTI-DANDRUFF, Head and Shoulders Aloe Vera 2in1, Head and Shoulders Calming Lavender, Head and Shoulders Lemon Oil 2in1, Head and ShouldersGreen Apple 2in1, Head and ShouldersItchy Scalp 2in1, MEMBERS MARK GENTLE DANDRUFF, Nioxin Scalp RecoverySoothing Serum, P.O.V. Classic 2 in 1 Dandruff, SAFEWAYDANDRUFF CLASSIC CLEAN, DG BODY2 IN 1 SIMPLY CLEAN, HEAD AND SHOULDERS OLD SPICE, Head and Shoulders Scalp X for Men, TopCare 2 in 1 Dry Scalp Dandruff, Tox21_111182, Tox21_113399, Tox21_202180, Tox21_303205, XtraCare Anti-Dandruff Hair Cleanse, Anti-Dandruff Juniper and Eucalyptus, ClearComplete Scalp Care Antidandruff, Equate Everyday Clean 2in1 Dandruff, Equate Green Apple 2 in 1 Dandruff, Head and Shoulders Texturizing Putty, Head and Shouldersbreakage prevention, Kerastase Paris Symbiose Antidandruff, Matrix Biolage ScalpSync Antidandruff, MFCD00067336, Modesa 2 in 1 Dandruff Green Apple, Nioxin Scalp Recovery Soothing Serum, TopCare2 in 1 Dandruff Green Apple, ALEVAI-STEM CELL ANTI DANDRUFF, ClearMen Strong and Full AntiDandruff, Daylogic 2in1 Dandruff Classic Clean, EQUALINECLASSIC CLEAN 2 IN 1, Equate Everyday Clean Gentle Dandruff, HEAD AND SHOULDERMEN OLD SPICE, Head and Shoulders 2in1Classic Clean, HEAD AND SHOULDERS APPLE FRESH, Head and Shoulders Cleansing Cucumber, Marcs 2 in 1 Everyday Care Dandruff, REVAGAIN Hair and Scalp revitalizing, Salon Designs Everyday Clean Dandruff, Shopko Beauty Everyday Clean Dandruff, SPAI-SONSALKALINE DRY-DANDRUFF, TopCareGentle Dandruff Everyday Clean, AKOS040732194, basic essentials dandruffeveryday clean, ClearMen Cool Sport Mint AntiDandruff, Equate Classic Spice 2 in 1 Dandruff, Head and Shouldershair loss prevention, Oily Hair DandruffZerran International, P.O.V. 2 in 1 Dry Scalp Dandruff, Personal Care Pyrithione Zinc Dandruff, Daylogic 2 in 1 DandruffClassic Scent, Daylogic 2in1 Dandruff Dry Scalp Care, DG BODY2 IN 1 DRY SCALP CARE, DOVEMEN PLUS CARE ANTI DANDRUFF, Head and Shoulders Apple Cider Vinegar, Head and Shoulders Deep Moisture 2in1, Head and Shoulders Deep Moisture Daily, Head and Shoulders Scalp X Conditioner, Head and Shoulders Tea Tree Oil 2in1, Head and Shoulders Tea Tree Oil Daily, Head and ShouldersDry Scalp Care 2in1, Just For Men Control GX Anti-Dandruff, OM 1563, SAFEWAY CARENORMAL TO OILY HAIR, TopCare2 in 1 Dandruff Everyday Clean, ZINC PYRIDINE-2-THIONE-N-OXIDE, ALEVAI-ANTI DANDRUFF SCALP SERUM, Axe2 in 1 Armor AntiDandruff 2 in 1, Clear2 in 1 Scalp Comfort AntiDandruff, ClearMen Clean and Refresh AntiDandruff, Equate Everyday Clean 2 in 1 Dandruff, HEAD AND SHOULDERS 3 IN 1 MEN, Nioxin Scalp RecoveryMedicating Cleanser, P.O.V. Green Apple 2 in 1 Dandruff, Rite Aid Dandruff2 in 1 Classic Clean, SAFEYWAY CARENORMAL TO OILY HAIR, Sulfur 8 Oil Moisturizer Anti-Dandruff, USEPA/OPP Pesticide Code: 088002, DANDRUFF SHAMPOODRY SCALP RECOVERY, Head and Shoulders Supreme Color Protect, Head and ShouldersSmooth and Silky 2in1, Jason Dandruff Relief Treatment 2 in 1, Mane n Tail Daily Control Anti-Dandruff, NCGC00257089-01, NCGC00259729-01, Topcare 2 in 1 Everyday Clean Dandruff, TOPCAREGENTLE DANDRUFF GREEN APPLE, 1ST10354, 2-PYRIDINETHIOL N-OXIDE ZINC SALT, BIS(2-PYRIDINETHIOL 1-OXIDE)ZINC, ClearComplete Care Nourishing AntiDandruff, Head and Shoulders Calming Lavender Daily, Head and Shoulders Classic Clean Dandruff, Head and Shoulders Dual Pack Green Apple, Marcs Everyday Care DandruffAnti-Dandruff, Nioxin Scalp Recovery Medicating Cleanser, P.O.V. Timeless Spice 2 in 1 Dandruff, Rite Aid Dandruff2 in 1 Dry Scalp Care, SuaveMen 2 in 1 Pure Power Antidandruff, Sulfur 8 Light Moisturizer Anti-Dandruff, Vitale Sensitive Scalp Daily Scalp Healer, ZINC 1-HYDROXY-2-PYRIDINE-THIONE, As I AmDry and Itchy Scalp Care Co Wash, ClearMen Deep Clean Hydration AntiDandruff, Halsa anti Dandruffmoisturizes and restores, HEAD AND SHOULDERS RENEWING CLEANSE, Head and Shoulders Royal Oils Frizz Tamer, Hyvee Care Classic Clean 2 in 1 Dandruff, Marcs Dry Scalp Care DandruffAnti-Dandruff, Nioxin Scalp Recovery Anti-Dandruff System, Sulfur 8 Fresh Anti-Dandruff Moisturizing, Walgreens Dandruff Itchy Dry Scalp Defense, ALEVAI Stem Cell Anti-Dandruff Conditioner, Equate Everyday Clean DandruffAnti-Dandruff, Head and Shoulders Bare Minimal Ingredients, Head and Shoulders Deep Scalp Cleanse 2in1, Head and Shoulders Moisturizing Avocado Oil, HEAD AND SHOULDERS REFRESHING RELIEF, Head And Shoulders2 in 1 Smooth and silky, HEAD AND SHOULDERSBREAKEGE PREVENTION, KeraCare Dry and Itchy Scalp Anti-Dandruff, Leader Dandruff Everyday CleanAnti-Dandruff, MOISTURIZING DANDRUFF1% Pyrithione Zinc, Shopko Beauty Green Apple 2 in 1 Dandruff, Walgreens Dandruff Plus Conditioner 2 in 1, Advanced Herbal Carefor thinning-damaged hair, ADVANCED SEBORRHEIC DERMATITIS THERAPY, As I AmDry and Itchy Scalp Care Conditioner, AT ONE WITH NATUREDRY AND ITCHY SCALP, Bis(1-hydroxy-2-(1H)-pyridinethionato)zinc, CLASSIC CLEAN 2 IN 1FOR NORMAL HAIR, ClearMen 2 in 1 Complete Care AntiDandruff, ClearMen Citrus Fresh Hydration AntiDandruff, DANDRUFF CONDITIONERDRY SCALP RECOVERY, Dermaharmony Pyrithione Zincwith Shea Butter, EVERY MAN JACK 2-IN-1 ANTI-DANDRUFF, Head and Shoulders Apple Cider Vinegar 2in1, Head and Shoulders Complete Scalp Care 2in1, Head and Shoulders Deep Scalp Cleanse Daily, Head and Shoulders Dual PackSmooth and Silky, Head and Shoulders Dual SachetsClassic Clean, Head and Shoulders Headstrong Daily Dandruff, Head and Shoulders MEN Old Spice Pure Sport, Head and Shoulders Royal Oils Moisture Boost, Head and Shoulders Supreme Detox and Hydrate, maxxam dermaCare Pre-Shampoo Scalp Treatment, SHILLS ACNE Purifying Peel Off Black Mask, Sulfur 8 Five Star Anti-Dandruff Hair Groom, XtraCare 2 in 1 Hair Cleanse and Condition, 1-HYDROXY-2-PYRIDINETHIONE, ZINC SALT, BIS(2-PYRIDYLTHIO)ZINC, N,N''-DIOXIDE, Equate beauty Color Safe Dandruff Conditioner, Halsa Pyrithione Zinc Dandruff-Dry Scalp Care, Head and Shoulders Clinical Moisturizing Scalp, Head and Shoulders ConditionerSmooth and Silky, Head and Shoulders Deep Scalp Hydration 2in1, Head and Shoulders Deep Scalp Hydration Daily, Head and Shoulders Hair and Scalp Conditioner, Head and Shoulders Supreme Nourish and Smooth, Modesa 2 in 1 Dandruff Almond Oil Dry Scalp, Nioxin Scalp Recovery Moisturizing Conditioner, Panrosa FRESH CLEAN Pyrithione Zinc Dandruff, Shopko Beauty Classic Spice 2 in 1 Dandruff, SuaveMen Deep Clean Mint Refresh AntiDandruff, Sulfur 8 Fresh Anti-Dandruff Oil Moisturizing, AffirmCare Scalp TherapyHydrating Anti-Dandruff, American Crew Anti-Dandruff plus Sebum Control, BEING WELL BODY2in1 Dandruff and Conditioner, BIS(2-PYRIDYLTHIO)ZINC, 1,1''-DIOXIDE, EC 236-671-3, Equate Dry Scalp 2 in 1 DandruffAnti-Dandruff, F16428, Head and Shoulders Dual SachetsSmooth and Silky, Head and Shoulders Supreme Clarify and Volumize, J1002901Jason Dandruff Relief 2in1Treatment, ANTI-DANDRUFF SHAMPOO AND CONDITIONERHOWL, Australian Gold Defense ZoneAnti-Dandruff Step 2, ClearComplete Scalp Care AntiDandruff Conditioner, ClearMen 2 in 1 Clean and Refresh AntiDandruff, Equate Dry Scalp 2 in 1 Dandruff SH and COND, Equate Green Apple 2 in 1 DandruffAnti-Dandruff, HEAD AND SHOULDERS 2 IN RENEWING CLEANSE, Head and Shoulders 2in1 MEN Eucalyptus and Neem, Head and Shoulders Classic Clean with Vitamin E, Head and Shoulders Supreme Hydrating Scalp Serum, Head and Shoulders Supreme Soothe and Strengthen, Advance Techniques Keep Clear2-in-1 Anti-Dandruff, ALEVAI-STEM CELL ANTI-DANDRUFF CONDITIONER, AxeSignature Daily Dandruff Defense Anti-Dandruff, ClearMen 2 in 1 Dry Scalp Hydration AntiDandruff, DANDRUFF SHAMPOODAILY CLEAN FOR NORMAL HAIR, Dial For Men Dandruff Control Hair and Body Wash, DoveDermacare Scalp Pure Daily Care Anti-Dandruff, Dual Senses Scalp Regulation AntiDandruff Shampoo, Head and Shoulders Headstrong Daily Dandruff 2in1, Head and Shoulders MEN Advanced Series Sandalwood, J1002902 Jason Dandruff Relief 2in1 Treatment, Marcs 2 in 1 Everyday Care DandruffAnti-Dandruff, SuaveRevitalizing Mint and Eucalyptus AntiDandruff, Walgreens Dandruff Conditioner 2 in 1 Itchy Scalp, XtraCare Anti-Dandruff Hair Cleansefor normal hair, Advance Techniques Keep ClearAnti-Dandruff Treatment, bis(pyridine-2-thiolato-kappaS 1(oxide-kappaO))zinc, CyzoneBe Sexy BS Tech Zinc Pyrithione And Silicones, DoveDermacare Scalp Coconut Hydration Anti-Dandruff, DoveDermacare Scalp Invigorating Mint Anti-Dandruff, Equate Everyday Clean 2 in 1 Dandruff SH and COND, Equate Everyday Clean 2 in 1 DandruffAnti-Dandruff, ESIKA MEN 2 EN 1 ANTIDANDRUFF MULTI-ACTION, ESIKAVital With Active Z 2-in-1 Dandruff Control, ETERNAL SPIRIT BEAUTY HAIR PRO ANTI-DANDRUFF, HEAD AND SHOULDERS 2 IN SOFT AND MANAGEABLE, Head and Shoulders Clinical Itch Relief Scalp Mist, Head and Shoulders Clinical Scalp Calming Treatment, Head and Shoulders Royal Oils Daily Moisture Scalp, Head and Shoulders Royal Oils Deep Moisture Masque, Head and Shoulders Royal Oils Instant Soothe Scalp, Head and Shoulders Royal Oils Nighttime Scalp Tonic, Head and Shoulders Supreme Color Protect Conditioner, LOreal Paris Men Expert Antidandruff Conditioner and, Q-201649, Redken 5th Avenue NYC Scalp Relief Dandruff Control, SuaveNourishing Coconut and Shea Butter AntiDandruff, DANDRUFF CONDITIONERDAILY CLEAN FOR NORMAL HAIR, DESIGN ESSENTIALS PEPPERMINT-ALOE THERAPEUTICS, Equate Mens Bold Scent 2 in 1 Dandruff SH and COND, Equate Mens Ultra Sport 2 in 1 Dandruff SH and COND, Equate Soft and Smooth 2 in 1 Dandruff SH and COND, Head and Shoulders 2in1 Men Advanced Series Charcoal, Head and Shoulders Deep Moisture Scalp and Hair Mask, Head and Shoulders MEN Advanced Series Bourbon 2in1, Head and Shoulders Supreme Detoxifying Pre-Wash Mask, LOreal Paris Ever Pure Dandruff Scalp Care and Detox, Mizani Scalp Care Conditioner Antidandruff Conditioner, My Black is Beautiful Scalp Care Cooling Scalp Serum, OCEAN BREEZE 2 IN 1 DANDRUFFSEA MINERAL SCENT, Pert Plus 2 in 1 Shampoo and ConditionerAnti-Dandruff, Royal Oils by Head and Shoulders Moisture Boost 2in1, The Original Mane n Tail Daily Control Anti Dandruff, Walgreens Dandruff Plus Conditioner 2 in 1 Dry Scalp, XtraCare 2 in 1 Hair Cleanse and ConditionGreen Apple, XtraCare Anti-Dandruff Conditionermint and eucalyptus, XtraCare Anti-Dandruff Hair Cleansefor sensitive hair, XtraCare Anti-Dandruff Hair Cleansemint and eucalyptus, AffirmCare Scalp TherapyAnti-Dandruff Exfoliating Masque, Glovers Clinical Care Seborrheic Dermatitis Antidandruff, HEAD AND SHOULDERS 2 IN 1 INSTANT MOISTURIZATION, Head and Shoulders Hair and Scalp ConditionerGreen Apple, Head and Shoulders MEN Advanced Series Sandalwood 2in1, Head and Shoulders Men Advanced Series Swagger Old Spice, Head and Shoulders Supreme Detox and Hydrate Conditioner, My Black is Beautiful Scalp Care Calming Scalp and Hair, Pert Plus 2 in 1 Shampoo and ConditionerDry Scalp Care, SuaveProfessionals Men 2 in 1 Classic Clean AntiDandruff, Walgreens Dandruff Itchy Dry Scalp DefenseAnti-dandruff, Walgreens Dandruff Plus Conditioner 2 in 1Anti-dandruff, XtraCare 2 in 1 Hair Cleanse and ConditionCoconut Water, XtraCare Anti-Dandruff ConditionerCoconut and Shea Butter, XtraCare Anti-Dandruff Hair CleanseCocoa and Shea Butter, AffirmCare Scalp TherapyHydrating Anti-Dandruff Conditioner, Australian GoldMetro 365 Medicated 2 in 1 Anti-Dandruff, DANDRUFF 2 IN 1 SHAMPOO AND CONDITIONERSHINY SMOOTH, DoveDermacare Scalp Dryness and Itch Relief Anti-Dandruff, DoveDermacare Scalp Invigorating Mint 2 In 1 Anti-Dandruff, DoveDermacare Scalp Pure Daily Care 2 In 1 Anti-Dandruff, Equate Dry Scalp 2 in 1 Dandruff SH and CONDAnti-Dandruff, Head and Shoulders 2in1 Men Advanced Series Full and Thick, Head and Shoulders CoconutDaily Hair and Scalp Conditioner, Head and Shoulders Deep Moisture Hair and Scalp Conditioner, Head and Shoulders Dry Scalp CareHair and Scalp Conditioner, Head and Shoulders Hair and Scalp ConditionerClassic Clean, Head and Shoulders MEN Advanced Series Lavender Mint 2in1, Head and Shoulders MEN Advanced Series Sage and Mint 2in1, Head and Shoulders Shea Butter Hair and Scalp Conditioner, Head and Shoulders Supreme Nourish and Smooth Conditioner, Head and Shoulders Supreme Scalp Moisturizer with Hemp Seed, Head and Shoulders Supreme Soothe and Strengthen Conditioner, Head and ShouldersVolume Boost Hair and Scalp Conditioner, Royal Oils by Head and Shoulders Moisture Boost Scalp Care, Royal Oils by Head and Shoulders Sulfate Free Scalp Care, SuaveInvigorating Ocean Minerals and Aloe Vera AntiDandruff, XtraCare Anti-Dandruff Hair CleanseCoconut and Shea Butter, Australian Gold Defense ZoneAnti-dandruff Leave-in Treatment, Australian GoldMetro 365 Medicated Leave-In Treatment Step 3, DoveDermacare Scalp Coconut Hydration Anti-Dandruff Conditioner, Head and Shoulders 2in1 Men Advanced Series Swagger Old Spice, Head and Shoulders Bare Minimal Ingredients Soothing Hydration, Head and Shoulders Clinical Dandruff Defense Dry Scalp Rescue, Neutrogena Daily Control TGel 2 in 1 Dandruff Plus Conditioner, SuaveNourishing Coconut and Shea Butter AntiDandruff Conditioner, SuaveRevitalizing Mint and Eucalyptus AntiDandruff Conditioner, The Original Mane n Tail Daily Control 2 in 1 Anti Dandruff, Walgreens Dandruff Conditioner 2 in 1 Itchy ScalpAnti-dandruff, Zinc, bis(1-hydroxy-2(1H)-pyridinethionato-O,S)-, (T-4)-, DANDRUFF 2 IN 1 SHAMPOO AND CONDITIONERDRY SCALP RECOVERY, Equate Everyday Clean 2 in 1 Dandruff SH and CONDAnti-Dandruff, Equate Mens Bold Scent 2 in 1 Dandruff SH and CONDAnti-Dandruff, Equate Mens Ultra Sport 2 in 1 Dandruff SH and CONDAnti-Dandruff, Equate Soft and Smooth 2 in 1 Dandruff SH and CONDAnti-Dandruff, Head and Shoulders 2in1 Dry Scalp Care with Almond and Coconut Oil, Head and Shoulders 2in1 Men Advanced Series Pure Sport Old Spice, Head and Shoulders Calming LavenderDaily Hair and Scalp Conditioner, Head and Shoulders White Charcoal Daily Hair and Scalp Conditioner, Mane n Tail Daily Control 2 in 1 Anti Dandruff Shampoo Conditioner, Walgreens Dandruff Plus Conditioner 2 in 1 Dry ScalpAnti-dandruff, basic essentials dandruff (clean and conditioner)2 in 1 everyday clean, DANDRUFF 2 IN 1 SHAMPOO AND CONDITIONERDAILY CLEAN FOR NORMAL HAIR, DANDRUFF SHAMPOO AND CONDITIONERWITH CUCUMBER AND LEMONGRASS EXTRACTS, DoveDermacare Scalp Dryness and Itch Relief Anti-Dandruff Conditioner, Essentials Scalp Control Anti-Dandruff 2 IN 1 Shampoo plus Conditioner, Head and Shoulders Supreme Clarify and Volumize Scalp and Hair Conditioner, LANCELL HUITOMO HAIR LOSS PREVENTION HAIR GROWER CLEAN FORMULA, Royal Oils by Head and Shoulders Moisturizing Hair and Scalp Co-Wash, Essentials Scalp Control Deep Clean with Invigorating Mint Anti-Dandruff Shampoo, Royal Oils by head and shoulders Moisture Renewal Scalp Balancing Conditioner, 3590-23-6" C10H8N2O2S2Zn OTPSWLRZXRHDNX-UHFFFAOYSA-L "zinc;1-oxidopyridin-1-ium-2-thiolate" n.a. n.a. Yes No No No No No PMDBD2000097 Zotarolimus(ABT-578) n.a. n.a. n.a. n.a. n.a. n.a. n.a. 23375907 n.a. n.a. Zotarolimus, Zotarolimus(ABT-578), 221877-54-9, zotarilumus, ABT-578, UNII-H4GXR80IZE, Zotarolimus [USAN:INN], Endeavor, (1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-19,30-dimethoxy-12-[(2R)-1-[(1S,3R,4S)-3-methoxy-4-(tetrazol-1-yl)cyclohexyl]propan-2-yl]-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone C52H79N5O12 CGTADGCBEXYWNE-GTTQIJKGSA-N (1R,9S,12S,15R,16E,18R,19R,21R,23S,24Z,26E,28E,30S,32S,35R)-1,18-dihydroxy-19,30-dimethoxy-12-[(2R)-1-[(1S,3R,4S)-3-methoxy-4-(tetrazol-1-yl)cyclohexyl]propan-2-yl]-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone n.a. n.a. Yes No No No No No PMDBD2000098 (1-(4-chlorophenoxy)-3-[(4, 6-dimethyl-2-pyrimidinyl) thio]-2- propanol) n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000099 (10R,11R)-Hydnocarpin n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000100 (10R,11R)-Hydnocarpin D n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000101 (10S,11S)-Hydnocarpin D n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000102 (1E)-1-{[(1E)-prop-1-ene-1-sulfinyl]sulfanyl}prop-1-ene n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000103 (1R,2S,7R,3E,11E)-2,18-diacetoxycembra-3,8(19),11,15(17)-tetraen-7-ol n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000104 (1R,2S,7R,3E,8E,11E)-2,18-diacetoxycembra-3,8,11,15(17)-tetraen-7-ol n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000105 (1R,2S,7R,8R)-2,18-diacetoxyasperdiol n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000106 (1R,3S,7R,8S,11S,12R)-3-hydroxy-1,4,8-trimethyl-12-(propan-2-yl)tricyclo[9.3.0.0]tetradec-4-en-6-one n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000107 (1R,4R,8S,11S,12R)-4-hydroxy-1,4,8-trimethyl-12-(propan-2-yl)tricyclo[9.3.0.0]tetradec-3(7)-en-6-one n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000108 (1Z)-(2-phenylethylidene)-lambda4-sulfanyliumolate n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000109 (1Z)-(prop-2-en-1-ylidene)-lambda4-sulfanyliumolate n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000110 (1Z)-ethylidene-lambda4-sulfanyliumolate n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000111 (2-(4-chlorophenyl)- 4-{[(6-methyl-2-pyridinyl)amino]methylene}-1,3-oxazol- 5(4H)-one) n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000112 (2-{[(2-phenylethyl)sulfanyl]sulfinyl}ethyl)benzene n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000113 (2E)-1-(1 ,3 -benzodioxol-5-yl)-3-(2-naphthyl)-2-propen-1-one n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000114 (2E)-1-(1,3-benzodioxol-5-yl)-3-(2-chloro-quinolin-3-yl)-2-propen-1-one n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000115 (2E)-1-(1,3-benzodioxol-5-yl)-3-[5-(2-nitro-phenyl)-furan-2-yl]-2-propen-1-one n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000116 (2E)-1-(2 ,4 ,5 -trimethoxyphenyl)-3-(2-chloro-6-methoxy-quinolin-3-yl)-2-propen-1-one n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000117 (2E)-1-(2 ,4 ,5 -trimethoxyphenyl)-3-(2-chloro-quinolin-3-yl)-2-propen-1-one n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000118 (2E)-1-(2 ,4 ,5 -trimethoxyphenyl)-3-(2-naphthyl)-2-propen-1-one n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000119 (2E)-1-(2 ,5 -dimethoxyphenyl)-3-(2-naphthyl)-2-propen-1-one n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000120 (2E)-1-(2 ,5 -dimethoxyphenyl)-3-[2,5-dimethyl-1-(3-trifluoromethyl-phenyl)-1H-pirrol-3-yl]-2-propen-1-one n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000121 (2E)-1-(3 ,4 ,5 -trimethoxyphenyl)-3-(2-naphthyl)-2-propen-1-one n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000122 (2E)-1-(3 ,4 -dimethoxyphenyl)-3-(2-naphthyl)-2-propen-1-one n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000123 (2E)-1-(3 ,5 -dimethoxyphenyl)-3-(2-naphthyl)-2-propen-1-one n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000124 (2E)-1-(3 -methoxyphenyl)-3-(2-naphthyl)-2-propen-1-one n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000125 (2E)-1-(4 -methoxyphenyl)-3-(2-naphthyl)-2-propen-1-one n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000126 (2E)-1-(5-clorotiophen-2-yl)-3-(3-methoxy-4-benzyloxi-phenyl)-2-propen-1-one n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000127 (2E)-1-[4 -(1H-imidazol-1-yl)phenyl]-3-(2-naphthyl)-2-propen-1-one n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000128 (2E)-1-[4 -(1H-imidazol-1-yl)phenyl]-3-(3-methoxy-4-benzyloxi-phenyl)-2-propen-1-one n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000129 (2E)-1-[4-(3-nitropyridin-2-yl)piperazin-1-yl]-3-phenylprop-2-en-1-one n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000130 (2E)-1-[4-(4-nitrophenyl)piperazin-1-yl]-3-phenylprop-2-en-1-one n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000131 (2E)-3-(3-hydroxy-4-methoxyphenyl)-1-phenylprop-2-en-1-one n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000132 (2E)-3-(4-Hydroxy-3-methoxyphenyl)-1-phenyl-2-propen-1-one n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000133 (2E)-5-[(1S,2R,4aR,8aR)-1,2,4a,5-tetramethyl-1,2,3,4,4a,7,8,8a-octahydronaphthalen-1-yl]-3-formylpent-2-enoic acid n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000134 (2E)-N -(2 -hydroxy-5 -bromo-benzilidene)-3,4,5-trimethoxybenzohydrazide n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000135 (2E)-N-(6-nitro-1,3-benzothiazol-2-yl)-3-phenylprop-2-enamide n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000136 (2E)-N-[3-(1H-imidazol-1-yl)propyl]-3-phenylprop-2-enamide n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000137 (2E)-N-[3-(1H-indol-3-yl)propyl]-3-phenylprop-2-enamide n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000138 (2-methyl-5-nitro-1H-imidazol-1-yl)methyl (2E)-3-phenylprop-2-enoate n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000139 (2R)-2-amino-3-(2,3-dihydro-1H-inden-2-yl)propanoic acid n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000140 (2R)-2-amino-3-(2-phenylethanesulfinyl)propanoic acid n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000141 (2R)-2-amino-3-(benzenesulfinyl)propanoic acid n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000142 (2R)-2-amino-3-(thiophene-2-sulfinyl)propanoic acid n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000143 (2R)-2-amino-3-[(4-chlorophenyl)methanesulfinyl]propanoic acid n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000144 (2R)-2-amino-3-[(4-methylphenyl)methanesulfinyl]propanoic acid n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000145 (2R)-2-amino-3-phenylmethanesulfinylpropanoic acid n.a. n.a. n.a. n.a. n.a. n.a. n.a. 335443 n.a. n.a. S-Benzyl-L-cystein-S-oxide, 60668-81-7, 2-amino-3-benzylsulfinylpropanoic acid, 2-amino-3-(phenylmethyl)sulfinylpropanoic acid, NSC344840, S-Benzylcysteine sulfoxide, (2R)-2-AMINO-3-PHENYLMETHANESULFINYLPROPANOIC ACID, 3-(Benzylsulfinyl)alanine #, 3-(Phenylmethanesulfinyl)alanine, DTXSID00976099, OBQBHBOGTLPNJM-UHFFFAOYSA-N, AKOS014810677, NSC-344840 C10H13NO3S OBQBHBOGTLPNJM-UHFFFAOYSA-N 2-amino-3-benzylsulfinylpropanoic acid n.a. n.a. No No No No No No PMDBD2000146 (2R)-2-amino-4-phenylbutanoic acid n.a. n.a. n.a. n.a. n.a. n.a. n.a. 6950302 n.a. n.a. D-Homophenylalanine, 82795-51-5, (2R)-2-amino-4-phenylbutanoic acid, h-d-hophe-oh, (R)-2-amino-4-phenylbutanoic acid, (r)-homophenylalanine, Homophenylalanine, D-, h-d-homophe-oh, Homophenylalanine, (-)-, D-2-amino-4-phenylbutanoic acid, (R)-2-Amino-4-phenylbutyric acid, UNII-5847ZW3PEP, 5847ZW3PEP, Benzenebutanoic acid, alpha-amino-, (alphaR)-, (2R)-2-azaniumyl-4-phenylbutanoate, (-)-2-Amino-4-phenylbutyric acid, d-homophe, d-homophenyl-ala, MFCD00063091, 2-amino-4-phenyl-butyric acid, (r)-2-amino-4-phenyl-butyric acid, d-homophenyl alanine, SCHEMBL44312, JTTHKOPSMAVJFE-SECBINFHSA-N, AKOS015853803, AC-9968, CS-W017272, D-Homophenylalanine, >=98.0% (HPLC), DS-14385, AM20041216, H0984, EN300-144880, J-640375, Q27261551, Z1255399095, BENZENEBUTANOIC ACID, .ALPHA.-AMINO-, (.ALPHA.R)- C10H13NO2 JTTHKOPSMAVJFE-SECBINFHSA-N (2R)-2-amino-4-phenylbutanoic acid n.a. n.a. No No No No No No PMDBD2000147 (2R)-2-amino-5-(1-nitrocarbamimidamido)pentanoic acid n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000148 (2R)-2-amino-6-acetamidohexanoic acid n.a. n.a. n.a. n.a. n.a. n.a. n.a. 6994067 n.a. n.a. H-D-LYS(AC)-OH, 51621-57-9, (2R)-6-acetamido-2-aminohexanoic acid, (R)-6-Acetamido-2-aminohexanoic acid, (2R)-6-acetamido-2-azaniumylhexanoate, Nepsilon-Acetyl-D-lysine, D-Lys(Ac)-OH, N6-acetyl-D-lysine, N~6~-Acetyl-D-lysine, SCHEMBL919222, DTXSID70426374, MFCD00237141, (R)-6-Acetamido-2-aminohexanoicacid, AKOS006274205, AS-56573, (2R)-2-AMINO-6-ACETAMIDOHEXANOIC ACID, F10914, EN300-7360978 C8H16N2O3 DTERQYGMUDWYAZ-SSDOTTSWSA-N (2R)-6-acetamido-2-aminohexanoic acid n.a. n.a. No No No No No No PMDBD2000149 (2R,3E)-2-Amino-4-phenyl-3-butenoic acid n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000150 (2S)-2-amino-3-(1,3-thiazol-4-yl)propanoic acid n.a. n.a. n.a. n.a. n.a. n.a. n.a. 2761495 n.a. n.a. 119433-80-6, L-4-Thiazolylalanine, Thiazolylalanine, (S)-2-Amino-3-(thiazol-4-yl)propanoic acid, 3-(4-Thiazolyl)-L-alanine, 3-(4-Thiazoyl)-L-alanine, l-Thiazolylalanine, Thiazolylalanine, l, (2S)-2-amino-3-(1,3-thiazol-4-yl)propanoic acid, 136010-41-8, VTL1Y3S44B, 4-Thiazolepropanoic acid, alpha-amino-, (alphaS)-, UNII-VTL1Y3S44B, (s)-3-(4-thiazolyl)alanine, MFCD00079677, H-Ala(4-Thz)-OH, 3-(4-thiazolyl)alanine, 4-Thiazolepropanoic acid, alpha-amino-, (S)-, SCHEMBL990477, THIAZOLYLALANINE [INCI], DTXSID90152461, l-4-thiazolylalanine, AldrichCPR, 3-(1,3-thiazol-4-yl)-L-alanine, AKOS006283464, AKOS015856630, PS-12172, (S)-2-(thiazol-4-ylamino)propanoic acid, CS-0107874, NS00126234, A15155, EN300-1300650, (2S)-2-azaniumyl-3-(1,3-thiazol-4-yl)propanoate, Q27292016, 4-THIAZOLEPROPANOIC ACID, .ALPHA.-AMINO-, (S)- C6H8N2O2S WBZIGVCQRXJYQD-YFKPBYRVSA-N (2S)-2-amino-3-(1,3-thiazol-4-yl)propanoic acid n.a. n.a. No No No No No No PMDBD2000151 (2S)-2-amino-3-(4-tert-butylphenyl)propanoic acid n.a. n.a. n.a. n.a. n.a. n.a. n.a. 2761795 n.a. n.a. 82372-74-5, L-4-TERT-BUTYL-PHE, H-PHE(4-TBU)-OH, 4-tert-Butyl-L-phenylalanine, (S)-2-Amino-3-(4-(tert-butyl)phenyl)propanoic acid, (2S)-2-amino-3-(4-tert-butylphenyl)propanoic acid, p-tert-Butylphenylalanine, 4-(1,1-dimethylethyl)-L-phenylalanine, L-Phenylalanine, 4-(1,1-dimethylethyl)-, 10YZ0R5GQ0, (2S)-2-azaniumyl-3-(4-tert-butylphenyl)propanoate, MFCD02259528, 4-t-butyl-l-phenylalanine, UNII-10YZ0R5GQ0, SCHEMBL383814, DTXSID60375923, AKOS012010563, AM82723, AC-25343, AS-20122, CS-0154903, EN300-267465, A864423, L-4-tert-Butyl-phenylalanine (H-L-Phe(4-tBu)-OH) C13H19NO2 CSJZKSXYLTYFPU-NSHDSACASA-N (2S)-2-amino-3-(4-tert-butylphenyl)propanoic acid n.a. n.a. No No No No No No PMDBD2000152 (2S)-2-amino-3-(tert-butylsulfanyl)propanoic acid n.a. n.a. n.a. n.a. n.a. n.a. n.a. 6951060 n.a. n.a. (S)-tert-Butyl-D-Cys, H-D-Cys(tBu)-OH, 300583-35-1, (2S)-2-amino-3-tert-butylsulfanylpropanoic acid, D-S-tert-Butylcysteine, (S)-2-Amino-3-(S-t-Butylthio)propanoic Acid, SCHEMBL622880, (S)-2-amino-3-(tert-butylthio)propanoic acid, EN300-1720468, (2S)-2-AMINO-3-(TERT-BUTYLSULFANYL)PROPANOIC ACID C7H15NO2S VADVRIAPCDFQJU-RXMQYKEDSA-N (2S)-2-amino-3-tert-butylsulfanylpropanoic acid n.a. n.a. No No No No No No PMDBD2000153 (2S)-2-amino-4-bromopent-4-enoic acid n.a. n.a. n.a. n.a. n.a. n.a. n.a. 2762282 n.a. n.a. 151144-96-6, (S)-2-Amino-4-bromopent-4-enoic acid, L-2-Amino-4-bromo-4-pentenoic acid, (2S)-2-amino-4-bromopent-4-enoic acid, 4-Pentenoic acid, 2-amino-4-bromo-, (S)- (9CI), (2S)-2-azaniumyl-4-bromopent-4-enoate, DTXSID20376138, MFCD06659115, AKOS016843807, PS-12806, CS-0196813, D97319, A884105, Q27457158 C5H8BrNO2 YTCSGBSYHNQHFD-BYPYZUCNSA-N (2S)-2-amino-4-bromopent-4-enoic acid n.a. n.a. No No No No No No PMDBD2000154 (2S,3R,4S,5S,6R)-3-(2-(1H-Indol-3-yl)acetamido)-6-(acetoxymethyl)tetrahydro-2H-pyran-2,4,5-triyl triacetate n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000155 (2S,3R,4S,5S,6R)-6-(Acetoxymethyl)-3-(2-(4-(trifluoromethyl)phenyl)acetamido)tetrahydro-2H-pyran-2,4,5-triyltriacetate n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000156 (2S,3R,4S,5S,6R)-6-(Acetoxymethyl)-3-(2-(4-bromophenyl)acetamido)tetrahydro-2H-pyran-2,4,5-triyl triacetate n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000157 (2S,3R,4S,5S,6R)-6-(Acetoxymethyl)-3-(2-(4-chlorophenyl)acetamido)tetrahydro-2H-pyran-2,4,5-triyl triacetate n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000158 (2S,3R,4S,5S,6R)-6-(Acetoxymethyl)-3-(2-(4-fluorophenyl)acetamido)tetrahydro-2H-pyran-2,4,5-triyl triacetate n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000159 (2S,3R,4S,5S,6R)-6-(Acetoxymethyl)-3-(2-(4-methoxyphenyl)acetamido)tetrahydro-2H-pyran-2,4,5-triyl triacetate n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000160 (2S,3R,4S,5S,6R)-6-(Acetoxymethyl)-3-(3-oxohexanamido)tetrahydro-2H-pyran-2,4,5-triyl triacetate n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000161 (2S,3R,4S,5S,6R)-6-(Acetoxymethyl)-3-(3-oxooctanamido)tetrahydro-2H-pyran-2,4,5-triyl triacetate n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000162 (2S,3R,4S,5S,6R)-6-(Acetoxymethyl)-3-butyramidotetrahydro-2H-pyran-2,4,5-triyl triacetate n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000163 (2S,3R,4S,5S,6R)-6-(Acetoxymethyl)-3-decanamidotetrahydro-2H-pyran-2,4,5-triyl triacetate n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000164 (2S,3R,4S,5S,6R)-6-(Acetoxymethyl)-3-dodecanamidotetrahydro-2H-pyran-2,4,5-triyl triacetate n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000165 (2S,3R,4S,5S,6R)-6-(Acetoxymethyl)-3-octanamidotetrahydro-2H-pyran-2,4,5-triyl triacetate n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000166 (2Z)-N-hexyl-2-hydroxy-3-[4-(trifluoromethyl)phenyl]prop-2-enamide n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000167 (3R)-4-(4-acetylphenyl)-3-aminobutan-2-one n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000168 (3R)-7-hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid n.a. n.a. n.a. n.a. n.a. n.a. n.a. 7015746 n.a. n.a. 152286-30-1, (R)-7-Hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid, (3R)-7-hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid, D-7-HYDROXY-1,2,3,4-TETRAHYDROISOQUINOLINE-3-CARBOXYLIC ACID, D-7-Hydroxy-Tic, H-7-Hydroxy-D-Tic-OH, D-7-Hydroxy-1,2,3,4-tetrahydro-3-isoquinolinecarboxylic acid, (R)-1,2,3,4-Tetrahydro-7-hydroxyisoquinoline-3-carboxylic acid, SCHEMBL1280052, DTXSID10426757, BCP14133, CS-M1263, h-7-hydroxy-D-tic-oh, AldrichCPR, MFCD00171281, AKOS006275194, AKOS015856356, AC-24263, PS-12438, EN300-2008859, A809282, J-008911, Z1198151614, (R)-7-Hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylicacid, (3R)-7-oxidanyl-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid, 3-Isoquinolinecarboxylicacid,1,2,3,4-tetrahydro-7-hydroxy-,(3R)-, D-7-Hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid (H-D-Tic(7-OH)-OH) C10H11NO3 HIKCRLDSCSWXML-SECBINFHSA-N (3R)-7-hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid n.a. n.a. No No No No No No PMDBD2000169 (5E)-5-decylidene-1,3-thiazolidine-2,4-dione n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000170 (5E)-5-dodecylidene-1,3-thiazolidine-2,4-dione n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000171 (5E)-5-hexylidene-1,3-thiazolidine-2,4-dione n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000172 (5E)-5-octylidene-1,3-thiazolidine-2,4-dione n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000173 (5E)-5-undecylidene-1,3-thiazolidine-2,4-dione n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000174 (5-nitrofuran-2-yl)methyl (2E)-3-phenylprop-2-enoate n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000175 (5S)-1,7-bis(4-hydroxyphenyl)-5-O-_-D- apiofuranosyl(1 _ 6)-_-D-glucopyranosyloxyheptan-3-one n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000176 (5Z)-2-(1,1-dichloro-2-phenylethyl)-5-{[4-(trifluoromethyl)phenyl]methylidene}-1,3-oxazolidin-4-one n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000177 (5Z)-2-(1,1-dichloro-3,3-dimethylbutyl)-5-(phenylmethylidene)-1,3-oxazolidin-4-one n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000178 (5Z)-2-(1,1-dichloro-3,3-dimethylbutyl)-5-[(3-methoxyphenyl)methylidene]-1,3-oxazolidin-4-one n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000179 (5Z)-2-(1,1-dichloro-3,3-dimethylbutyl)-5-{[4-(trifluoromethyl)phenyl]methylidene}-1,3-oxazolidin-4-one n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000180 (5Z)-2-(1,1-dichloro-7-methyloctyl)-5-{[4-(trifluoromethyl)phenyl]methylidene}-1,3-oxazolidin-4-one n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000181 (5Z)-2-(1,1-dichlorobut-3-yn-1-yl)-5-{[4-(trifluoromethyl)phenyl]methylidene}-1,3-oxazolidin-4-one n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000182 (5Z)-2-(1,1-dichloropropyl)-5-{[4-(trifluoromethyl)phenyl]methylidene}-1,3-oxazolidin-4-one n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000183 (5Z)-2-(2,2-dimethylpropyl)-5-{[3-(trifluoromethyl)phenyl]methylidene}-1,3-oxazolidin-4-one n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000184 (5Z)-2-tert-butyl-5-{[3-(trifluoromethyl)phenyl]methylidene}-1,3-oxazolidin-4-one n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000185 (5Z)-4-Bromo-5-(bromomethylene)-3-butyl-2(5H)-furanone n.a. n.a. n.a. n.a. n.a. n.a. n.a. 9839657 n.a. NPC53136 (5Z)-4-bromo-5-(bromomethylene)-3-butyl-2(5H)-furanone, (5Z)-4-BROMO-5-(BROMOMETHYLIDENE)-3-BUTYLFURAN-2-ONE, 4-bromo-5-(bromomethylene)-3-butyl-2(5h)-furanone, CHEMBL448241, SCHEMBL1049932, UVJAGAXWVHGYRW-ALCCZGGFSA-, UVJAGAXWVHGYRW-ALCCZGGFSA-N, 4-bromo-5Z-(bromomethylene)-3-butylfuran-2-one, (5Z)-4-bromo-5-(bromomethylene)-3-butyl-furan-2-one, InChI=1/C9H10Br2O2/c1-2-3-4-6-8(11)7(5-10)13-9(6)12/h5H,2-4H2,1H3/b7-5- C9H10Br2O2 UVJAGAXWVHGYRW-ALCCZGGFSA-N (5Z)-4-bromo-5-(bromomethylidene)-3-butylfuran-2-one n.a. n.a. No No No No No No PMDBD2000186 (E)-1-[6-[(3-acetyl-2,4,6-trihydroxy-5-methylphenyl)methyl]-5,7-dihydroxy-2,2-dimethyl-2H-1-benzopyran-8-yl]-3-phenyl-2-propen-1-one n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000187 (E)-3-Decen-2-one n.a. n.a. n.a. n.a. n.a. n.a. n.a. 5363233 n.a. NPC217923 "3-Decen-2-one, 10519-33-2, dec-3-en-2-one, Heptylidene acetone, (E)-dec-3-en-2-one, Oenanthylidene acetone, 18402-84-1, Trans-3-decen-2-one, (E)-3-Decen-2-one, (3E)-Dec-3-en-2-one, 3-Decen-2-one, (E)-, FEMA No. 3532, 3-Decen-2-one, (3E)-, Z22804BQXD, EINECS 234-059-0, Enanthylidene acetone, (3E)-3-Decen-2-one, UNII-Z22804BQXD, trans-Decen-2-al, SCHEMBL120780, CHEMBL206566, 3-DECEN-2-ONE [FHFI], DTXSID201315551, MFCD00015700, AKOS027320081, (3E)-3-DECEN-2-ONE [MI], AS-40174, CS-0440272, D1933, A905941, Q27294888, 3-Decen-2-one, predominantly trans, >=97%, stabilized, FG, Heptylidene acetone; Oenanthylidene acetone; SmartBlock; 3-Decen-2-one" C10H18O JRPDANVNRUIUAB-CMDGGOBGSA-N (E)-dec-3-en-2-one n.a. n.a. No No No No No No PMDBD2000188 (E)-Chalcone Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D06ERH 637760 n.a. NPC71664 Chalcone, trans-Chalcone, 614-47-1, (E)-Chalcone, 94-41-7, Benzalacetophenone, Benzylideneacetophenone, Chalkone, Phenyl styryl ketone, Cinnamophenone, 2-Benzalacetophenone, 1,3-DIPHENYL-2-PROPEN-1-ONE, 1,3-Diphenylpropenone, (2E)-1,3-diphenylprop-2-en-1-one, 2-Benzylideneacetophenone, 3-Phenylacrylophenone, (E)-1,3-diphenylprop-2-en-1-one, Styryl phenyl ketone, 2-Propen-1-one, 1,3-diphenyl-, 1-Benzoyl-2-phenylethene, beta-Benzoylstyrene, Benzylidenecetophenone, 1-Benzoyl-1-phenylethene, Phenyl trans-styryl ketone, 1,3-Diphenyl-2-propenone, 1-Phenyl-2-benzoylethylene, Benzylidene acetophenone, beta-Phenylacrylophenone, Phenyl 2-phenylvinyl ketone, trans-Benzalacetophenone, Acrylophenone, 3-phenyl-, 1,3-Diphenyl-1-propen-3-one, alpha-Benzylideneacetophenone, trans-Benzylideneacetophenone, 1,3-diphenylprop-2-en-1-one, (E)-Benzylideneacetophenone, 2-Propen-1-one, 1,3-diphenyl-, (2E)-, Phenyl (E)-2-phenylethenyl ketone, NSC 26612, (E)-1,3-Diphenyl-2-propen-1-one, CCRIS 2213, CCRIS 3778, Chalkon, 2-Propen-1-one, 1,3-diphenyl-, (E)-, EINECS 202-330-2, EINECS 210-383-8, UNII-5S5A2Q39HX, b-Phenylacrylophenone, (2E)-1,3-Diphenyl-2-propen-1-one, 5S5A2Q39HX, .beta.-Benzoylstyrene, 1,3 Diphenyl 2 Propen 1 One, AI3-00946, NSC-4523, substituted chalcone, 5j, (E)-1,3-DIPHENYL-PROPENONE, MFCD00003082, NSC-26612, .beta.-Phenylacrylophenone, CHALCONE, (E)-, NSC-167107, 1-Benzoyl-2-phenylethylene, CHEMBL7976, .alpha.-Benzylideneacetophenone, MLS000069600, CHEBI:27618, CHEBI:48965, PHENYL (E)-STYRYL KETONE, phenyl (E)--2-phenylethenyl ketone, benzylidenacetophenone, NSC 167107, SMR000059029, TRANS-CHALCONE-D12, 98 ATOM % D, WLN: RV1U1R, Cinnamoylbenzene, .omega.-Benzylideneacetophenone, Chalcone methoxyamine, DTXSID8022531, b-Benzoylstyrene, Chalcone 1, phenylstyryl ketone, Chalcedony8108, Chalcone, 13, 3-phenyl-Acrylophenone, trans-Chalcone, 97%, a-Benzylideneacetophenone, CHALCONE [MI], Opera_ID_1389, bmse000704, CHALCONE (E)-FORM, SCHEMBL27580, chalcone (ACD/Name 4.0), BIDD:ER0232, cid_637760, BDBM29143, CHALCONE (E)-FORM [MI], DTXCID80809654, DTXSID20873536, NSC4523, 1, 3-Diphenyl-1-propen-3-one, HMS2235P17, AMY37401, BCP14123, NSC26612, STR06550, AC7897, NSC167107, s5845, AKOS001041518, AKOS025310645, (E)-1,3-diphenyl-prop-2-en-1-one, 2-Propen-1-one,3-diphenyl-, (E)-, NCGC00018232-03, (E)-3-phenyl-1-phenylprop-2-en-1-one, AC-16892, HY-121054, CS-0079373, NS00015146, EN300-16057, 1,3-Diphenyl-2-propenone, >=98.0% (GC), C01484, D70211, A833233, A852077, AE-641/00372002, Q899416, SR-01000000156, J-200119, SR-01000000156-2, Z46028346, 5173133B-0B1C-46FB-8DFF-976669EE9D5B C15H12O DQFBYFPFKXHELB-VAWYXSNFSA-N (E)-1,3-diphenylprop-2-en-1-one n.a. n.a. No No No No No No PMDBD2000189 (furan-2-yl)methyl (2E)-3-phenylprop-2-enoate n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000190 (R)-2,3-Diaminopropanoic acid n.a. n.a. n.a. n.a. n.a. n.a. n.a. 638152 n.a. NPC4347 (R)-2,3-Diaminopropanoic acid, 1915-96-4, (2R)-2,3-diaminopropanoic acid, D-2,3-Diaminopropionic acid, D-Alanine, 3-amino-, 3-Amino-D-Alanine, D-2,3-diaminopropanoic acid, (r)-2,3-diaminopropionic acid, D-Dap, 2RA, D-Dap-OH, SCHEMBL417811, d-2,3-diamino propionic acid, (R)-2,3-Diaminopropanoicacid, CHEMBL420464, (-)-2,3-diaminopropionic acid, DTXSID70348547, (2R)-2,3-diaminopropionic acid, CHEBI:136598, 0649QNM7H6, D-2-AMINO-.BETA.-ALANINE, MFCD08461011, (2R)-2,3-bis(azanyl)propanoic acid, AKOS016843237, BS-49962, 2,3-DIAMINOPROPIONIC ACID, (-)-, CS-0311806, EN300-262543, G72876, Q27236170 C3H8N2O2 PECYZEOJVXMISF-UWTATZPHSA-N (2R)-2,3-diaminopropanoic acid n.a. n.a. No No No No No No PMDBD2000191 (R)-2-Amino-3-biphenyl-3-yl-propionic acid n.a. n.a. n.a. n.a. n.a. n.a. n.a. 10263728 n.a. n.a. (R)-2-Amino-3-biphenyl-3-yl-propionic acid, 164172-95-6, (2R)-2-amino-3-(3-phenylphenyl)propanoic Acid, CHEMBL291538, SCHEMBL22190023, (R)-2-Amino-3-biphenyl-3-yl-propionic aci, (R)-2-Amino-3-biphenyl-3-yl-propionicacid, A50412 C15H15NO2 XXPHIHDDXCFWMS-CQSZACIVSA-N (2R)-2-amino-3-(3-phenylphenyl)propanoic acid n.a. n.a. No No No No No No PMDBD2000192 (R)-2-amino-3-cyclohexylpropanoic acid n.a. n.a. n.a. n.a. n.a. n.a. n.a. 736026 n.a. n.a. 58717-02-5, (R)-2-amino-3-cyclohexylpropanoic acid, H-D-CHA-OH, 3-Cyclohexyl-D-alanine, (2R)-2-amino-3-cyclohexylpropanoic acid, D-Cyclohexylalanine, D-3-Cyclohexylalanine, (R)-D-CYCLOHEXYLALANINE, (R)-2-AMINO-3-CYCLOHEXYL-PROPIONIC ACID, 3-Cyclohexylalanine, D-, CX76B5H6YN, CHEMBL441123, (R)-3-Cyclohexylalanine, MFCD00153485, BETA-CYCLOHEXYL-D-ALANINE, H-D-Cha-OH HCl, h-D-cha-oh, AldrichCPR, UNII-CX76B5H6YN, SCHEMBL503347, H--Cyclohexyl-D-Ala-OH HCl, ORQXBVXKBGUSBA-MRVPVSSYSA-N, .BETA.-CYCLOHEXYL-D-ALANINE, CS-B1050, BDBM50179724, AKOS016842822, (R)-2-amino-3-cyclohexylpropanoicacid, DS-2120, (R)-alpha-aminocyclohexanepropionic acid, AC-25313, HY-60040, (2R)-2-azanyl-3-cyclohexyl-propanoic acid, C2659, EN300-199910, A831989, Q27467924, Z995228686, CYCLOHEXANEPROPANOIC ACID, ALPHA-AMINO-, (ALPHAR)-, CYCLOHEXANEPROPANOIC ACID, .ALPHA.-AMINO-, (.ALPHA.R)- C9H17NO2 ORQXBVXKBGUSBA-MRVPVSSYSA-N (2R)-2-amino-3-cyclohexylpropanoic acid n.a. n.a. No No No No No No PMDBD2000193 (R)-2-amino-3-cyclopentylpropanoic acid n.a. n.a. n.a. n.a. n.a. n.a. n.a. 6993046 n.a. n.a. 99295-81-5, (R)-2-amino-3-cyclopentylpropanoic acid, 3-CYCLOPENTANE-D-ALANINE, D-3-Cyclopentylalanine, (2R)-2-AMINO-3-CYCLOPENTYLPROPANOIC ACID, H-D-CYCPENTALA-OH, (R)-3-CYCLOPENTYLALANINE, 3-cyclopentyl-D-alanine, SCHEMBL288281, DTXSID80426345, KDYAKYRBGLKMAK-SSDOTTSWSA-N, ZBA60710, MFCD03788182, AKOS016843877, AC-1677, AC-4449, CS-0043572, EN300-716191, D-beta-Cyclopentylalanine (H-D-Ala(cPent)-OH) C8H15NO2 KDYAKYRBGLKMAK-SSDOTTSWSA-N (2R)-2-amino-3-cyclopentylpropanoic acid n.a. n.a. No No No No No No PMDBD2000194 (RW)2-NH2 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000195 (RW)3-NH2 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000196 (RW)4D n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000197 (RW)4-NH2 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000198 (Z)-3-(bromomethylene) isobenzofuran-1(3H)-one n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000199 (Z)-3-bromo-5-(bromomethylene) furan-2(5H)-one n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000200 (Z)-4-bromo-5-(bromomethylene)-3-(1-bromobutyl)-2(5H)-furanone n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000201 (Z)-4-bromo-5-(bromomethylene)-3-(1-bromoethyl)-2(5H)-furanone n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000202 (Z)-4-bromo-5-(bromomethylene)-3-(1-bromohexyl)-2(5H)-furanone n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000203 (Z)-4-bromo-5-(bromomethylene)-3-butyl-2(5H)-furanone n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000204 (Z)-4-bromo-5-(bromomethylene)-3-ethyl-2(5H)-furanone n.a. n.a. n.a. n.a. n.a. n.a. n.a. 12051732 n.a. n.a. CHEMBL1253275, PXUWFYUVVGVIKU-HYXAFXHYSA-, (z)-4-bromo-5-(bromomethylene)-3-ethyl-2(5h)-furanone, InChI=1/C7H6Br2O2/c1-2-4-6(9)5(3-8)11-7(4)10/h3H,2H2,1H3/b5-3- C7H6Br2O2 PXUWFYUVVGVIKU-HYXAFXHYSA-N (5Z)-4-bromo-5-(bromomethylidene)-3-ethylfuran-2-one n.a. n.a. No No No No No No PMDBD2000205 (Z)-4-bromo-5-(bromomethylene)-3-hexyl-2(5H)-furanone n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000206 (Z)-4-bromo-5-(bromomethylene)-3-methylfuran-2(5H)-one n.a. n.a. n.a. n.a. n.a. n.a. n.a. 9900052 n.a. n.a. CHEMBL254466, SCHEMBL2235446, (5Z)-4-bromo-5-(bromomethylene)-3-methyl-furan-2-one, (Z)-4-bromo-5-(bromomethylene)-3-methylfuran-2(5H)-one C6H4Br2O2 DWBIFKKMTVAYDE-RQOWECAXSA-N (5Z)-4-bromo-5-(bromomethylidene)-3-methylfuran-2-one n.a. n.a. No No No No No No PMDBD2000207 (Z)-5-(bromomethylene)-3-(hydroxymethyl]thiophen-2(5H)- one n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000208 (Z)-5-(chloromethylene) furan-2(5H)-one n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000209 (Z)-5-decylidenethiazolidine-2,4-dione n.a. n.a. n.a. n.a. n.a. n.a. n.a. 46196601 n.a. n.a. (Z)-5-decylidenethiazolidine-2,4-dione, SCHEMBL679831, WXOBRTHZPRIKRH-KHPPLWFESA-N C13H21NO2S WXOBRTHZPRIKRH-KHPPLWFESA-N (5Z)-5-decylidene-1,3-thiazolidine-2,4-dione n.a. n.a. No No No No No No PMDBD2000210 (Z)-5-octylidenethiazolidine-2,4-dione n.a. n.a. n.a. n.a. n.a. n.a. n.a. 46220260 n.a. n.a. SCHEMBL679787, CHEMBL4281032, (z)-5-octylidenethiazolidine-2,4-dione C11H17NO2S VVEOYZHPLYMRHY-HJWRWDBZSA-N (5Z)-5-octylidene-1,3-thiazolidine-2,4-dione n.a. n.a. No No No No No No PMDBD2000211 [(ethanesulfinyl)sulfanyl]ethane n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000212 1-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl)ethyl (2E)-3-phenylprop-2-enoate n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000213 1-(2-Chloroacetyl)-5-methylindoline-2,3-dione n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000214 1-(2-Chloroacetyl)indoline-2,3-dione n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000215 1-(3,5-dinitrophenyl)ethan-1-one n.a. n.a. n.a. n.a. n.a. n.a. n.a. 258569 n.a. n.a. 14401-75-3, 1-(3,5-dinitrophenyl)ethanone, 3'',5''-Dinitroacetophenone, 3,5-DINITROACETOPHENONE, 1-(3,5-DINITROPHENYL)ETHAN-1-ONE, Ethanone, 1-(3,5-dinitrophenyl)-, C8H6N2O5, NSC87635, NCIOpen2_005176, SCHEMBL3291219, DTXSID80293175, WGJQPJOLPLYFJH-UHFFFAOYSA-N, 3'',5''-Dinitroacetophenone, 97%, CK2561, MFCD00631987, NSC 87635, NSC-87635, AKOS003239997, AKOS015916237, AB06607, AS-45926, CS-0328720, A808158, J-007897 C8H6N2O5 WGJQPJOLPLYFJH-UHFFFAOYSA-N 1-(3,5-dinitrophenyl)ethanone n.a. n.a. No No No No No No PMDBD2000216 1-(4-amino-2-hydroxyphenyl)ethan-1-one n.a. n.a. n.a. n.a. n.a. n.a. n.a. 459296 n.a. n.a. "1-(4-amino-2-hydroxyphenyl)ethanone, 2476-29-1, 1-(4-AMINO-2-HYDROXYPHENYL)ETHAN-1-ONE, 4''-Amino-2''-hydroxyacetophenone, 1-(4-Amino-2-hydroxyphenyl)ethane-1-one, Ethanone, 1-(4-amino-2-hydroxyphenyl)-, 2-acetyl-5-aminophenol, MFCD00100636, 1-(4-amino-2-hydroxy-phenyl)ethanone, 4 inverted exclamation mark -Amino-2 inverted exclamation mark -hydroxyacetophenone, DSJ, SCHEMBL615576, Amino-2-hydroxyphenyl)ethanone, DTXSID30332629, CHEBI:194597, QQZFVONVJPXCSQ-UHFFFAOYSA-N, AMY12170, AKOS005659177, CS-W005109, DS-0851, PS-4191, SB75739, SY009074, A848118, W-206910, 1-(4-amino-2-hydroxyphenyl)ethan-1-one, AldrichCPR, F0001-0837, 4''-Amino-2''-hydroxyacetophenone;1-(4-Amino-2-hydroxyphenyl)ethane-1-one" C8H9NO2 QQZFVONVJPXCSQ-UHFFFAOYSA-N 1-(4-amino-2-hydroxyphenyl)ethanone n.a. n.a. No No No No No No PMDBD2000217 1-(4-chlorophenyl)-3-m-tolyurea n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000218 1-(4-chlorophenyl)-3-p-tolyurea n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000219 1-(4-methoxyphenyl)-3-m-tolyurea n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000220 1-(4-methoxyphenyl)-3-p-tolyurea n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000221 1-(6-aminopyridin-3-yl)ethan-1-one n.a. n.a. n.a. n.a. n.a. n.a. n.a. 21113396 n.a. n.a. 19828-20-7, 2-Amino-5-acetylpyridine, 1-(6-aminopyridin-3-yl)ethanone, 1-(6-aminopyridin-3-yl)ethan-1-one, 1-(6-AMINO-PYRIDIN-3-YL)-ETHANONE, ETHANONE, 1-(6-AMINO-3-PYRIDINYL)-, Ethanone,1-(6-amino-3-pyridinyl)-, MFCD09038484, 1-(2-AMINOPYRIDIN-5-YL)ETHANONE, 5-Acetyl-2-aminopyridine, 1-(6-amino-3-pyridinyl)-Ethanone, SCHEMBL1105486, CHEMBL4566135, 1-(6-aminopyrid-3-yl)ethanone, DTXSID90610854, ZVXNDGKDTCTEBW-UHFFFAOYSA-N, BCP27196, 1-(6-Aminopyridin-3-yl)-ethanone, AB8078, AKOS006330216, AB49552, AM85654, DS-16689, SY008087, CS-0044041, A15353, EN300-120456, J-507900 C7H8N2O ZVXNDGKDTCTEBW-UHFFFAOYSA-N 1-(6-aminopyridin-3-yl)ethanone n.a. n.a. No No No No No No PMDBD2000222 1-(pyrazin-2-yl)ethan-1-one n.a. n.a. n.a. n.a. n.a. n.a. n.a. 30914 n.a. n.a. Acetylpyrazine, 2-ACETYLPYRAZINE, 22047-25-2, Ethanone, 1-pyrazinyl-, Methyl pyrazinyl ketone, 1-pyrazin-2-ylethanone, 1-(pyrazin-2-yl)ethanone, 1-(pyrazin-2-yl)ethan-1-one, 1-Pyrazinylethanone, Ketone, methyl pyrazinyl, Pyrazin-1-ylethan-1-one, Ethanone, 1-(2-pyrazinyl)-, 1-pyrazin-2-yl-ethanone, MFCD00006134, Ethanone, l-pyrazinyl-, Pyrazine der., 1-Pyrazin-2-ylethan-1-one, FEMA No. 3126, 1-(2-Pyrazinyl)ethanone, GR391IBU5C, DTXSID5047085, NSC-72374, 2-acetyl pyrazine, EINECS 244-753-5, 1-pyrazinyl-ethanone, NSC 72374, L-Pyrazinyl-Ethanone, Acetylpyrazine, 97%, 2-acetyl-1,4-diazine, AI3-34445, 1-Pyrazin-2-ylmethanone, UNII-GR391IBU5C, 1-(2-pyrazinyl)-ethanone, 1-(pyrazin-2-yl)-ethanone, SCHEMBL78340, 1-(2-Pyrazinyl)ethanone #, ACETYLPYRAZINE [FHFI], 1-(2-pyrazinyl)-1-ethanone, 2-ACETYLPYRAZINE [FCC], CHEMBL3188662, DTXCID3027085, FEMA 3126, METHYL 2-PYRAZINYL KETONE, CHEBI:145236, BCP29214, NSC72374, Tox21_302309, AC7524, s6261, AKOS000265506, AB00602, AC-3203, CS-W007692, HY-W007692, PS-5458, 2-Acetylpyrazine, >=99%, FCC, FG, NCGC00256085-01, SY004986, CAS-22047-25-2, A0988, AM20070441, NS00012989, EN300-67311, A19555, Q-100279, Q15726062, F2158-1508, Z513735920, 2-Acetylpyrazine pound>>1-Pyrazinylethanone pound>>1-pyrazin-2-yl-ethanone C6H6N2O DBZAKQWXICEWNW-UHFFFAOYSA-N 1-pyrazin-2-ylethanone n.a. n.a. No No No No No No PMDBD2000223 1-(pyridin-4-yl)ethan-1-one n.a. n.a. n.a. n.a. n.a. n.a. n.a. 14282 n.a. n.a. "4-Acetylpyridine, 1122-54-9, 1-pyridin-4-ylethanone, Ethanone, 1-(4-pyridinyl)-, Methyl 4-pyridyl ketone, 4-Acetyl pyridine, Ketone, methyl 4-pyridyl, 4-Pyridyl methyl ketone, Pyridine, 4-acetyl-, 1-(pyridin-4-yl)ethanone, 1-(pyridin-4-yl)ethan-1-one, MFCD00006433, 1-Pyridin-4-yl-ethanone, 1-(4-PYRIDINYL)ETHANONE, NSC-111, G47437IOW7, CCRIS 5954, NSC 111, 1-(4-pyridyl)ethanone, EINECS 214-350-9, BRN 0107629, UNII-G47437IOW7, AI3-26822, 4-Acetyl-pyridine, .gamma.-Acetylpyridine, 4-Acetylpyridine, 97%, PYRIDINE,4-ACETYL, WLN: T6NJ DV1, 1-(pyridin-4-yl)-ethanone, SCHEMBL55235, 1-(4-Pyridinyl)ethanone #, ACETYL PYRIDINE, 4-, 5-21-07-00400 (Beilstein Handbook Reference), METHYL 4-PYRIDYLKETONE, CHEMBL445953, NSC111, DTXSID0022147, HY-Y0179, AKOS000119796, AB00760, AC-8358, CS-W008727, FG-0441, 1-(4-pyridyl)ethanone;4-Acetylpyridine, SY005519, A0113, AM20050673, NS00021527, EN300-17993, 4-Acetylpyridine, Vetec(TM) reagent grade, 97%, A802523, Q-100066, Q27278737, F0001-0269, InChI=1/C7H7NO/c1-6(9)7-2-4-8-5-3-7/h2-5H,1H" C7H7NO WMQUKDQWMMOHSA-UHFFFAOYSA-N 1-pyridin-4-ylethanone n.a. n.a. No No No No No No PMDBD2000224 1,1,6,6,7,7-hexahydroxy-5,5-diisopropyl-3,3-dimethyl-2,2-binaphthalene-8,8-dicarbaldehyde n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000225 1,2,3,4-Tetrahydroisoquinoline-3-carboxylic acid n.a. n.a. n.a. n.a. n.a. n.a. n.a. 95489 n.a. n.a. 1,2,3,4-Tetrahydroisoquinoline-3-carboxylic acid, 67123-97-1, 35186-99-3, H-DL-TIC-OH, H-TIC-OH, 3-Isoquinolinecarboxylic acid, 1,2,3,4-tetrahydro-, rac 1,2,3,4-Tetrahydroisoquinoline-3-carboxylic Acid, 1,2,3,4-Tetrahydro-3-isoquinolinecarboxylic acid, 1,2,3,4-Tetrahydro-isoquinoline-3-carboxylic acid, C0KDL86B2L, CHEMBL11912, MFCD00191496, DL-1,2,3,4-TETRAHYDROISOQUINOLINE-3-CARBOXYLIC ACID, 3-carboxy-1,2,3,4-tetrahydroisoquinoline, Tic-AA, 1,2,3,4-Tetrahydroisoquinoline-3(s)-carboxylic acid, Tetrahydro-3-isoquinoline carboxylic acid, NSC14794, EINECS 266-580-4, NSC 14794, 1,2,3,4-TETRAHYDRO-3-ISOQUINOLINE CARBOXYLIC ACID, UNII-C0KDL86B2L, SCHEMBL43168, IFLab1_006055, (1)-1,2,3,4-Tetrahydroisoquinoline-3-carboxylic acid, AMY6545, DTXSID80868286, BCP28792, BCP34435, BDBM50023454, NSC-14794, AKOS001025539, AKOS016050695, CCG-256428, CS-W004987, FS-3738, SB30316, SB38229, SB38527, tetrahydroisoquinoline 3-carboxylic acid, tetrahydroisoquinoline-3-carboxylic acid, NCGC00326402-01, SY017250, SY017614, SY039779, EU-0099971, NS00015789, NS00096459, EN300-54023, 3,4-dihydro-1H-isoquinoline-3-carboxylic Acid, AB01321347-02, 1,2,3.4-tetrahydroisoquinoline-3-carboxylic acid, A822632, A835639, A855757, SR-01000446756, 1,2,3,4 -tetrahydro-3-isoquinolinecarboxylic acid, 1,2,3,4-tetra-hydroisoquinoline-3-carboxylic acid, 1,2,3,4-tetrahydro-3-isoquinoline-carboxylic acid, J-503765, SR-01000446756-1, (-)1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid, 1,2,3,4-Tetrahydroisoquinoline-3(R)-carboxylic acid, Z56822177, DL-1,2,3,4-TETRAHYDROISOQUINOLINE-3-CARBOXYLIC, F0896-0181, (R)-(+)-1,2,3,4-Tetrahydroisoquinoline-3-Carboxylic Acid, 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid, AldrichCPR, 1,2,3,4-TETRAHYDROISOQUINOLINE-3-CARBOXYLIC ACID, (+/-)- C10H11NO2 BWKMGYQJPOAASG-UHFFFAOYSA-N 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid n.a. n.a. No No No No No No PMDBD2000226 1,3-bis[3-chloro-5-(1,3-dichloropropane-2-yloxy)-2(5H)-furanone-4-ylsulfonyl]propane n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000227 1,3-dimethyl-6-(4-methylphenyl)-5-[3-(4-methylphenyl)-1-phenyl-1H-pyrazol-4-yl]-1H,2H,3H,4H,5H,6H-pyrimido[4,5-d][1,3]diazine-2,4-dione n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000228 1,3-dimethyl-6-(4-methylphenyl)-5-[3-(4-nitrophenyl)-1-phenyl-1H-pyrazol-4-yl]-1H,2H,3H,4H,5H,6H-pyrimido[4,5-d][1,3]diazine-2,4-dione n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000229 1,3-dim-tolyurea n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000230 1-[2-(2,4-dichlorophenyl)-5-(3,4,5-trimethoxyphenyl)-1,3,4-oxadiazol-3(2H)-yl]ethanone n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000231 1-[2-(2-nitrophenyl)-5-phenyl-1,3,4-oxadiazol-3(2H)-yl]ethanone n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000232 1-[2-(3,5-dichlorophenyl)-5-(3,4,5-trimethoxyphenyl)-1,3,4-oxadiazol-3(2H)-yl]ethanone n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000233 1-[2-(3-bromo-4-hydroxy-5-methoxyphenyl)-5-(3,4,5-trimethoxyphenyl)-1,3,4-oxadiazol-3(2H)-yl]ethanone n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000234 1-[2-(naphthalen-1-yl)-5-(3,4,5-trimethoxyphenyl)-1,3,4-oxadiazol-3(2H)-yl]ethanone n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000235 1-{2-[(E)-2-(4-chlorophenyl)ethenyl]-4-phenylquinolin-3-yl}ethan-1-one n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000236 1-{2-[(E)-2-(4-hydroxy-3-methoxyphenyl)ethenyl]-4-phenylquinolin-3-yl}ethan-1-one n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000237 1-{2-[(E)-2-(4-methoxyphenyl)ethenyl]-4-phenylquinolin-3-yl}ethan-1-one n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000238 1-{2-[(E)-2-[3,5-bis(trifluoromethyl)phenyl]ethenyl]-4-phenylquinolin-3-yl}ethan-1-one n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000239 1-{4-phenyl-2-[(E)-2-[4-(trifluoromethoxy)phenyl]ethenyl]quinolin-3-yl}ethan-1-one n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000240 1-{6-nitro-4-phenyl-2-[(E)-2-(3,4,5-trimethoxyphenyl)ethenyl]quinolin-3-yl}ethan-1-one n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000241 1-{6-nitro-4-phenyl-2-[(E)-2-[4-(trifluoromethoxy)phenyl]ethenyl]quinolin-3-yl}ethan-1-one n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000242 1010cys n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000243 11(R)-hydroxy-12(20)-en-knightal n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000244 11(R)-hydroxy-12(20)-en-knightol acetate n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000245 12-hydroxy decyl beta-maltose n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000246 12-methyltetradecanoic acid n.a. n.a. n.a. n.a. n.a. n.a. n.a. 21672 n.a. NPC314679 "12-Methyltetradecanoic acid, 5502-94-3, Sarcinic acid, Aseanostatin P5, ANTEISOPENTADECANOIC ACID, 12-methyl myristic acid, 12-methyl-tetradecanoic acid, methyl myristic acid, 12-MTA, anteiso-C15:0, Tetradecanoic acid, 12-methyl-, (S)-Aseanostatin P5, TP0OL0Z8US, CHEBI:39251, anteiso-15:0, UNII-TP0OL0Z8US, 12-Methyl tetradecanoic acid, anteiso-C15, 15:0 anteiso, 12-methylmyristic acid, 12-Methyltetradecansaeure, 12-Methyl-tetradecansaeure, Compound NP-024794, C15:0ai, AI-PENTADECANOIC ACID, 15:0ai, MLS000517264, SCHEMBL397325, (+)-12-methyl myristic acid, CHEMBL495852, aC15:0, DTXSID10970381, XKLJLHAPJBUBNL-UHFFFAOYSA-N, HMS2267L13, METHYL MYRISTIC ACID [INCI], a15:0, LMFA01020008, MFCD00083664, AKOS040736981, NCGC00247048-01, PD077349, SMR000127417, (+/-)-12-METHYLTETRADECANOIC ACID, HY-121943, CS-0083723, Q27119789, 12-Methyltetradecanoic acid; Sarcinic acid; Aseanostatin P5" C15H30O2 XKLJLHAPJBUBNL-UHFFFAOYSA-N 12-methyltetradecanoic acid n.a. n.a. No No No No No No PMDBD2000247 13-(2-chloro-6-methoxyquinolin-3-yl)-3,3-dimethyl-1H,2H,3H,4H,4aH,6H,11H,13H,13aH-indazolo[1,2-b]phthalazine-1,6,11-trione n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000248 13-(2-chloro-6-methylquinolin-3-yl)-3,3-dimethyl-1H,2H,3H,4H,6H,11H,13H-indazolo[1,2-b]phthalazine-1,6,11-trione n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000249 13-(2-chloro-7-methoxyquinolin-3-yl)-3,3-dimethyl-1H,2H,3H,4H,6H,11H,13H-indazolo[1,2-b]phthalazine-1,6,11-trione n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000250 13-(2-chloro-7-methylquinolin-3-yl)-3,3-dimethyl-1H,2H,3H,4H,6H,11H,13H-indazolo[1,2-b]phthalazine-1,6,11-trione n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000251 13-(2-chloro-8a-methyl-4a,8a-dihydroquinolin-3-yl)-3,3-dimethyl-1H,2H,3H,4H,6H,11H,13H-indazolo[1,2-b]phthalazine-1,6,11-trione n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000252 13-(2-chloroquinolin-3-yl)-3,3-dimethyl-1H,2H,3H,4H,6H,11H,13H-indazolo[1,2-b]phthalazine-1,6,11-trione n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000253 13-{7-methoxy-[1,2,3,4]tetrazolo[1,5-a]quinolin-4-yl}-3,3-dimethyl-1H,2H,3H,4H,6H,11H,13H-indazolo[1,2-b]phthalazine-1,6,11-trione n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000254 13-{8-methoxy-[1,2,3,4]tetrazolo[1,5-a]quinolin-4-yl}-3,3-dimethyl-1H,2H,3H,4H,6H,11H,13H-indazolo[1,2-b]phthalazine-1,6,11-trione n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000255 13-methyltetradecanoic acid n.a. n.a. n.a. n.a. n.a. n.a. n.a. 151014 n.a. NPC55023 13-Methyltetradecanoic acid, 2485-71-4, 13-methylmyristic acid, Isopentadecanoic acid, Isopentadecylic acid, Subtilopentadecanoic acid, 13-Mtd, LeDSF3, 13-METHYLTETRADECANOICACID, M09T9M1LTY, 13-methyl-tetradecanoic acid, 13-Methyl tetradecanoic acid, Tetradecanoic acid, 13-methyl-, CHEBI:39250, 13-Methylmyristate, UNII-M09T9M1LTY, iso-pentadecanoic acid, iso-C15, 13-Methyl-tetradecansaeure, iso-C15:0, 15:0 iso, SCHEMBL366393, CHEMBL495851, DTXSID90179552, i-C15:0, LMFA01020009, MFCD00083431, AKOS040748729, i-15:0, MS-23435, PD078182, HY-131503, CS-0136053, NS00056584, G12313, 13-Methylmyristic acid, >=98% (capillary GC), A928069, J-015704, Q20179071 C15H30O2 ZOCYQVNGROEVLU-UHFFFAOYSA-N 13-methyltetradecanoic acid n.a. n.a. No No No No No No PMDBD2000256 14,15,29,30-Tetrahydro-5H,20H-dibenzo[h,s]bis([1,2,3]triazolo)[5,1-c:5_,1_-n][1,4,7,12,15,18]hexaazacyclodocosine-6,12,13,21,27,28(7H,22H)-hexaone n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000257 14-alpha-lipoyl andrographolide n.a. n.a. n.a. n.a. n.a. n.a. n.a. 25154345 n.a. n.a. CHEMBL560980, 14-Alpha-lipoyl andrographolide C28H42O6S2 RNSASHBZNLJPDG-MCLZGWMTSA-N [(3S,4E)-4-[2-[(1R,4aS,5R,6R,8aS)-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylidene-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl]ethylidene]-5-oxooxolan-3-yl] 5-(dithiolan-3-yl)pentanoate n.a. n.a. No No No No No No PMDBD2000258 14-dehydroxy-11,12-didehydroandrographolide- 3,19-bis(succinic acid) potasium sodium salt n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000259 14-Glycinyl andrographolide hydrochloride n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000260 16P n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000261 16P-AC n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000262 17-Deacetyl norgestimate n.a. n.a. n.a. n.a. n.a. n.a. n.a. 62930 n.a. n.a. Norelgestromin, Levonorgestrel oxime, 17-Deacetylnorgestimate, Norplant 3-oxime, D-Norgestrel 3-oxime, 18-Methylnorethindrone oxime, 17-Deacylnorgestimate, 53016-31-2, Ortho Evra, (8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-3-hydroxyimino-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-ol, Deacetylnorgestimate, Norgestimate metabolite Norelgestromin, Norelgestromin (17-Deacetylnorgestimate), DTXSID9046788, (3Z)-17-Desacetyl Norgestimate, BRN 4202099, UNII-R0TAY3X631, Norelgestromin [USAN:INN:BAN], RWJ 10553, Levonorgestrel 3-Oxime, 17-Deacetyl norgestimate, 18,19-Dinorpregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-, oxime, (17alpha)-, R0TAY3X631, CHEMBL4791392, 74183-54-3, 13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one oxime, DB06713, 18,19-Dinorpregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-, oxime, (8-alpha,9-beta,10-alpha,13-alpha,14-beta)-, 17-Deacylnorgestimate17-Deacetyl norgestimate C21H29NO2 ISHXLNHNDMZNMC-XUDSTZEESA-N (8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-3-hydroxyimino-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-ol n.a. n.a. No No No No No No PMDBD2000263 1-mesityl-3(4-nitrophenyl)urea n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000264 1-methanesulfonyl-4-methylbenzene n.a. n.a. n.a. n.a. n.a. n.a. n.a. 18521 n.a. n.a. "3185-99-7, Methyl p-tolyl sulfone, 1-Methyl-4-(methylsulfonyl)benzene, 4-(Methylsulfonyl)toluene, p-Tolyl methyl sulfone, Benzene, 1-methyl-4-(methylsulfonyl)-, Sulfone, methyl p-tolyl, 1-methyl-4-methylsulfonylbenzene, Methylp-TolylSulfone, p-(methylsulfonyl)toluene, p-(Methylsulphonyl)toluene, 1-Methanesulfonyl-4-methyl-benzene, 59203-01-9, 1-methanesulfonyl-4-methylbenzene, Methyl 4-tolyl sulfone, NSC 2722, NSC 29038, TG77SM513A, NSC-2722, MFCD00014742, NSC-29038, 4-(methylsulphonyl)toluene, UNII-TG77SM513A, P-METHYLSULFONYLTOLUENE, EINECS 221-682-8, p-tolylmethylsulphone, Ts-Me, Methyl p-tolylsulfone, 4-methylsulfonyltoluene, Methyl p-tolyl sulphone, (p-Tolylsulfonyl)methane, Maybridge4_002299, methyl-p-toluene sulfonate, SCHEMBL12807, METHYL 4-TOLYLSULFONE, Methyl (S)-p-toluenesulfinate, SCHEMBL9541106, methyl-(4-methylphenyl)sulphone, CHEMBL1088935, DTXSID6075229, 1-Methansulfonyl-4-methylbenzene, NSC2722, 4-(Methylsulfonyl)toluene, 97%, HMS1527I11, 4-methanesulfonyl-1-methyl-benzene, NSC29038, 2-Benzoxazolemethanaminehydrochloride, 4-METHYLPHENYL METHYL SULFONE, CCG-49782, 1-Methyl-4-(methyl-sulphonyl)benzene, 1-Methyl-4-(methylsulfonyl)benzene #, AKOS000352549, FS-1023, NCGC00176705-01, AC-18789, SY002922, CS-0117038, M0842, NS00029185, D70958, EN300-295475, A821032, AE-095/31500059, J-521718, SR-01000639213-1, W-106873, BRD-K92730216-001-01-4, Q27289950, 1-methyl-4-methylsulfonyl-benzene;Methyl p-Tolyl Sulfone, InChI=1/C8H10O2S/c1-7-3-5-8(6-4-7)11(2,9)10/h3-6H,1-2H" C8H10O2S YYDNBUBMBZRNQQ-UHFFFAOYSA-N 1-methyl-4-methylsulfonylbenzene n.a. n.a. No No No No No No PMDBD2000265 1-methyl-4-({[(4-methylphenyl)methyl]disulfanyl}methyl)benzene n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000266 2- geranyloxy-1-(2-methylbutanoyl)phloroglucinol n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000267 2-((3,4-dichlorophenyl)sulfonyl)-4-(1H-tetrazol-1-yl)pyrimidine n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000268 2-(2-(2-Azidoacetamido)-5-bromophenyl)-2-oxo-N-(prop-2-yn-1-yl)acetamide n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000269 2-(2-(2-Azidoacetamido)-5-fluorophenyl)-2-oxo-N-( prop-2-yn-1-yl)acetamide n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000270 2-(2-(2-Azidoacetamido)-5-methylphenyl)-2-oxo-N-(prop-2-yn-1-yl)acetamide n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000271 2-(2-(2-Azidoacetamido)-5-nitrophenyl)-2-oxo-N-(prop-2-yn-1-yl)acetamide n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000272 2-(2-(2-Azidoacetamido)phenyl)-2-oxo-N-(prop-2-yn-1-yl)acetamide n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000273 2-(2-(2-Chloroacetamido)-5-fluorophenyl)-2-oxo-N-( prop-2-yn-1-yl)acetamide n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000274 2-(2-(2-Chloroacetamido)-5-methylphenyl)-2-oxo-N-( prop-2-yn- 1-yl)acetamide n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000275 2-(2-(2-Chloroacetamido)-5-nitrophenyl)-2-oxo-N-( prop-2-yn-1-yl)acetamide n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000276 2-(2-(2-Chloroacetamido)phenyl )-2-oxo-N-( prop-2-yn-1-yl )acetamide n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000277 2-(2,4-difluorophenyl)-1,3-bis(1H-1,2,4-triazol-1-yl)propan-2-yl (2E)-3-phenylprop-2-enoate n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000278 2-(2-chloro-5-fluorophenyl)-5-(4,5-dibromo-1-methyl-1H-pyrrol-2-yl)-1,3,4-oxadiazole n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000279 2-(2-Thienylsulfonyl)ethanethioamide n.a. n.a. n.a. n.a. n.a. n.a. n.a. 2778709 n.a. n.a. 2-(2-Thienylsulfonyl)ethanethioamide, 175202-34-3, 2-thiophen-2-ylsulfonylethanethioamide, Ethanethioamide, 2-(2-thienylsulfonyl)-, Maybridge1_004617, 2-(thiophene-2-sulfonyl)ethanethioamide, Ethanethioamide,2-(2-thienylsulfonyl)-, Oprea1_480214, SCHEMBL5464840, CHEMBL1824159, HMS554J19, DTXSID60381089, CHEBI:195138, YNPIRUTXXLFXRU-UHFFFAOYSA-N, 2-thiophen-2-ylsulonylethanethioamide, AKOS015908822, CCG-238789, 2-(Thiophen-2-ylsulfonyl)ethanethioamide, MS-22230, 2-(2-thienylsulfonyl)ethanethioamide, AldrichCPR, W-206168, BRD-K51403107-001-01-9 C6H7NO2S3 YNPIRUTXXLFXRU-UHFFFAOYSA-N 2-thiophen-2-ylsulfonylethanethioamide n.a. n.a. No No No No No No PMDBD2000280 2-(4-(Trifluoromethyl)phenyl)-N-((2R,3R,4S,5S,6R)-2,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)acetamide n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000281 2-(4,5-dibromo-1-methyl-1H-pyrrol-2-yl)-5-(2,4-dichlorophenyl)-1,3,4-oxadiazole n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000282 2-(4,5-dibromo-1-methyl-1H-pyrrol-2-yl)-5-(4-methoxyphenyl)-1,3,4-oxadiazole n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000283 2-(4,5-dibromo-1-methyl-1H-pyrrol-2yl)-5-(4-nitrophenyl)-1,3,4-oxadiazole n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000284 2-(4,5-dibromo-1-methyl-1H-pyrrol-2-yl)-5-(ethylthio)-1,3,4-oxadiazole n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000285 2-(4,5-dibromo-1-methyl-1H-pyrrol-2-yl)-5-(methylthio)-1,3,4-oxadiazole n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000286 2-(4,5-dibromo-1-methyl-1H-pyrrol-2-yl)-5-(phenylthio)-1,3,4-oxadiazole n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000287 2-(4,5-dibromo-1-methyl-1H-pyrrol-2-yl)-5-(pyridin-4-yl)-1,3,4-oxadiazole n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000288 2-(4,5-dibromo-1-methyl-1H-pyrrol-2-yl)-5-phenyl-1,3,4-oxadiazole n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000289 2-(4,5-dibromo-1-methyl-1H-pyrrol-2-yl)-5-styryl-1,3,4-oxadiazole n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000290 2-(4-Bromophenyl)-N-((2R,3R,4S,5S,6R)-2,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)acetamide n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000291 2-(4-Chlorophenyl)-5-(4,5-dibromo-1-methyl-1H-pyrrol-2-yl)-1,3,4-oxadiazole n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000292 2-(4-Chlorophenyl)-N-((2R,3R,4S,5S,6R)-2,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)acetamide n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000293 2-(4-Fluorophenyl)-N-((2R,3R,4S,5S,6R)-2,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)acetamide n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000294 2-(4-Methoxyphenyl)-N-((2R,3R,4S,5S,6R)-2,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)acetamide n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000295 2-(4-methoxyphenyl)-N-(3-{[2-(4-methoxyphenyl)ethyl]imino}-1,4-dihydro-2-quinox alinylidene)ethanamine n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000296 2-(5-(4,5-dibromo-1-methyl-1H-pyrrol-2-yl)-1,3,4-oxadiazole-2-yl)phenol n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000297 2-(5-Bromo-2-(2-chloroacetamido)phenyl )-2-oxo-N-( prop-2-yn-1-yl)acetamide n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000298 2-(5-Chloro-2-(2-chloroacetamido)phenyl )-2-oxo-N-( prop-2-yn-1-yl)acetamide n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000299 2(5H)-furanone n.a. n.a. n.a. n.a. n.a. n.a. n.a. 10341 n.a. NPC147824 2(5H)-Furanone, 497-23-4, Furan-2(5H)-one, BUTENOLIDE, Isocrotonolactone, 2-Buten-4-olide, 2-Butenolide, gamma-Crotonolactone, 2H-furan-5-one, 2-Oxo-2,5-dihydrofuran, Crotonolactone, 4-Hydroxy-2-butenoic acid lactone, gamma-Crotolactone, alpha,beta-Crotonolactone, delta,alpha,beta-Butenolide, gamma-Hydroxycrotonic acid lactone, 5H-furan-2-one, 2-Butenoic acid gamma-lactone, 2-Butenoic acid-gamma-lactone, .gamma.-Crotonolactone, 2-Buten-1,4-olide, 2,5-dihydrofuran-2-one, 4-Hydroxycrotonic acid gamma-lactone, NSC 197009, 2,5-Dihydrofuranone, 2-Butenoic acid, 4-hydroxy-, gamma-lactone, MFCD00005376, 4-Hydroxy-2-butenoic acid gamma-lactone, CHEMBL166223, CHEBI:38118, 2-Butenoic acid-.gamma.-lactone, 8KXK25H388, .delta.,.alpha.,.beta.-Butenolide, .gamma.-Hydroxycrotonic acid lactone, NSC-197009, 2-(5H)-furanone, 4-Hydroxy-2-butenoic acid .gamma.-lactone, Crotonic acid, 4-hydroxy-, .gamma.-lactone, 2-Butenoic acid, 4-hydroxy-, .gamma.-lactone, but-2-en-4-olide, .DELTA..alpha.,.beta.-Butolide, 2-Butenoic acid, .gamma.-lactone, .DELTA..alpha.,.beta.-Butenolide, CCRIS 5722, EINECS 207-839-3, BRN 0383585, UNII-8KXK25H388, g-Crotonolactone, ?-Crotonolactone, 5H-furanone, HSDB 8151, 2_5H_furanone, CRATONE, .gamma.-Crotolactone, 5 H-Furan-2-one, (5H)-furan-2-one, alpha,alpha,beta-Butolide, 2(5H)FURANONE, .BETA.-CROTONOLACTONE, 2(5H)-Furanone, 98%, 5-17-09-00112 (Beilstein Handbook Reference), laquo gammaRaquo -crotolactone, .alpha.,.beta.-Crotonolactone, Crotonic acid, 4-hydroxy-, gamma-lactone (6CI,7CI), laquo gammaRaquo -crotonolactone, DTXSID7075422, FEMA NO. 4138, VIHAEDVKXSOUAT-UHFFFAOYSA-, BCP15247, NSC51296, BDBM50360798, NSC-51296, NSC197009, AKOS000268618, CS-W008270, HY-W008270, laquo deltaRaquo ,alpha,beta-butenolide, SB60895, Crotonic acid, 4-hydroxy-, gamma-lactone, SY017893, 2-Butenoic acid-laquo gammaRaquo -lactone, 2-Oxo-2,5-dihydrofuran(2-[5H]-furanone), 5-OXO-2,5-DIHYDROFURAN-3-YL ESTER, A7404, AM20100212, NS00021175, EN300-80159, laquo gammaRaquo -hydroxycrotonic acid lactone, C17601, 2(5H)-Furanone (laquo gammaRaquo -crotonolactone), 4-Hydroxy-2-butenoic acid laquo gammaRaquo -lactone, J-506134, Q4596886, Crotonic acid, 4-hydroxy-, laquo gammaRaquo -lactone, 2-Butenoic acid, 4-hydroxy-, laquo gammaRaquo -lactone, Z1219048777, 4-HYDROXY-2-BUTENOIC ACID .GAMMA.-LACTONE [FHFI], InChI=1/C4H4O2/c5-4-2-1-3-6-4/h1-2H,3H2 C4H4O2 VIHAEDVKXSOUAT-UHFFFAOYSA-N 2H-furan-5-one n.a. n.a. No No No No No No PMDBD2000300 2-(Aminomethyl)-L-phenylalanine n.a. n.a. n.a. n.a. n.a. n.a. n.a. 2762275 n.a. n.a. L-2-Aminomethylphenylalanine, 959580-92-8, (2S)-2-amino-3-[2-(aminomethyl)phenyl]propanoic acid, 158149-99-6, (S)-2-Amino-3-(2-(aminomethyl)phenyl)propanoic acid, L-2-Aminomethylphe, starbld0017864, o-aminomethylphenylalanine, SCHEMBL1818794, 2-(aminomethyl)-L-phenylalanine, DTXSID80376134, MFCD06659114, AKOS026670281, AS-84331, L-2-Aminomethylphenylalanine (H-L-Phe(2MeNH2)-OH) C10H14N2O2 RDAKEAJYLGZEEA-VIFPVBQESA-N (2S)-2-amino-3-[2-(aminomethyl)phenyl]propanoic acid n.a. n.a. No No No No No No PMDBD2000301 2-(hexylsulfonyl)-4-(1H-1,2,3-triazol-1-yl)pyrimidine n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000302 2-(Trifluoromethyl)-D-phenylalanine n.a. n.a. n.a. n.a. n.a. n.a. n.a. 7005100 n.a. n.a. 130930-49-3, 2-(Trifluoromethyl)-D-phenylalanine, (R)-2-AMINO-3-(2-(TRIFLUOROMETHYL)PHENYL)PROPANOIC ACID, (2R)-2-amino-3-[2-(trifluoromethyl)phenyl]propanoic acid, 2-Trifluoromethyl-D-Phenylalanine, D-2-TRIFLUOROMETHYLPHE, D-Phenylalanine, 2-(trifluoromethyl)-, (2R)-2-azaniumyl-3-[2-(trifluoromethyl)phenyl]propanoate, MFCD01860877, SCHEMBL503201, DTXSID30426491, IOABLDGLYOGEHY-MRVPVSSYSA-N, AKOS016843045, AC-5861, AM83481, CS-W010345, HY-W009629, PS-12174, 2-(Trifluoromethyl)-D-phenylalanine, >=98.0%, A850818, J-005904, 2-(Trifluoromethyl)-D-phenyalanine (H-D-Phe(2-CF3)-OH) C10H10F3NO2 IOABLDGLYOGEHY-MRVPVSSYSA-N (2R)-2-amino-3-[2-(trifluoromethyl)phenyl]propanoic acid n.a. n.a. No No No No No No PMDBD2000303 2,2 -Dipyridyl n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000304 2,3,4,5,6-Pentafluoro-L-phenylalanine n.a. n.a. n.a. n.a. n.a. n.a. n.a. 2761496 n.a. n.a. 34702-59-5, (S)-2-Amino-3-(perfluorophenyl)propanoic acid, L-PENTAFLUOROPHE, 2,3,4,5,6-PENTAFLUORO-L-PHENYLALANINE, (2S)-2-amino-3-(2,3,4,5,6-pentafluorophenyl)propanoic acid, 138109-65-6, L-Phenylalanine, 2,3,4,5,6-pentafluoro-, Pentafluorophenylalanine, L-, VJJ37GCZ42, L-Pentafluorophenylalanine, (2S)-2-Azaniumyl-3-(2,3,4,5,6-pentafluorophenyl)propanoate, D-Pentafluorophenylalanine, L-2,3,4,5,6-Pentafluorophenylalanine, H-PHE(F5)-OH, MFCD01860881, D-2,3,4,5,6-Pentafluorophenylalanine, L-Phenylalanine,2,3,4,5,6-pentafluoro-, hydrochloride (9CI), (S)-2-Amino-3-(perfluorophenyl)propanoicacid, UNII-VJJ37GCZ42, SCHEMBL158168, FLUORINATED PHENYLALANINE, DTXSID00375801, AKOS015890220, AC-5835, DS-3939, CS-0158433, P2085, C74787, A822352, Q27464395 C9H6F5NO2 YYTDJPUFAVPHQA-VKHMYHEASA-N (2S)-2-amino-3-(2,3,4,5,6-pentafluorophenyl)propanoic acid n.a. n.a. No No No No No No PMDBD2000305 2,3-Dehydrosilybin n.a. n.a. n.a. n.a. n.a. n.a. n.a. 5467200 n.a. n.a. 2,3-dehydrosilybin, 25166-14-7, Dehydrosilybin, DEHYDROSILYLBIN, 3,5,7-trihydroxy-2-[3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-2,3-dihydro-1,4-benzodioxin-6-yl]chromen-4-one, CHEMBL38464, NSC648334, quercetin 3'',4''-coniferyl, SCHEMBL936621, CHEBI:172705, BDBM50084979, NSC-648334, NCI60_016767, 3, 5, 7-trihydroxy-2-[3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-2, 3-dihydro-1, 4-benzodioxin-6-yl]chromen-4-one, 3,5,7-Trihydroxy-2-[3-(4-hydroxy-3-methoxy-phenyl)-2-hydroxymethyl-2,3-dihydro-benzo[1,4]dioxin-6-yl]-chromen-4-one, 3,5,7-trihydroxy-2-[3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-2,3-dihydro-1,4-benzodioxin-6-yl]-4H-chromen-4-one C25H20O10 BVKQRAYKLBRNIK-UHFFFAOYSA-N 3,5,7-trihydroxy-2-[3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-2,3-dihydro-1,4-benzodioxin-6-yl]chromen-4-one n.a. n.a. No No No No No No PMDBD2000306 2,3-dihydroxybenzoic acid n.a. n.a. n.a. n.a. n.a. n.a. n.a. 19 n.a. NPC260837 "2,3-Dihydroxybenzoic acid, 303-38-8, Pyrocatechuic acid, o-Pyrocatechuic acid, 2-Pyrocatechuic acid, 3-Hydroxysalicylic acid, Benzoic acid, 2,3-dihydroxy-, DOBK, Catecholcarboxylic acid, 2,3-Dihydroxybenzoicacid, DHBA, dihydroxybenzoic acid, 2,3 DHB, 2,3-DIHYDROXY-BENZOIC ACID, MFCD00002446, Catechol-3-carboxylic acid, 2,3-dihydroxy benzoic acid, 27138-57-4, NSC 27435, 2,3-DIHDROXYBENZOIC ACID, CHEBI:18026, 70D5FBB392, NSC-27435, Resorcylic acid, Benzoic acid, dihydroxy-, EINECS 206-139-5, BRN 2209117, Pyrocatechuate, UNII-70D5FBB392, o-Pyrocatechuate, Catecholcarboxylate, 1l6m, 3tf6, 3u0d, Spectrum2_001086, Spectrum3_001819, Benzoic acid,3-dihydroxy-, 2,3 Dihydroxy-benzoic acid, 2,3-Dihydroxybenzoate, IV, CHEMBL1432, SCHEMBL37458, BSPBio_003437, 4-10-00-01414 (Beilstein Handbook Reference), MLS001066375, SPBio_001132, Pyrocatechol-3-carboxylic Acid, BDBM92456, KBio3_002940, DTXSID70858712, 2,3-Dihydroxybenzoic acid, 99%, HMS2231J14, HMS3369A12, KUC106698N, AMY17988, HY-Y0202, NSC27435, CCG-40337, AKOS009156763, AC-2985, CS-W019844, DB01672, PS-3013, SDCCGMLS-0066859.P001, NCGC00178064-01, BP-12659, KSC-11-207-9, SMR000471836, SY003494, NS00009040, S4946, 1,2-DIHYDROXYBENZENE-3-CARBOXYLIC ACID, C00196, EN300-112276, A820329, SR-01000761414, Q-200170, Q2823200, SR-01000761414-2, Z367679198, 2,3-Dihydroxybenzoic acid;Catecholcarboxylic acid;NSC 27435, FF124556-A828-490B-B324-9AE859B695FA, InChI=1/C7H6O4/c8-5-3-1-2-4(6(5)9)7(10)11/h1-3,8-9H,(H,10,11" C7H6O4 GLDQAMYCGOIJDV-UHFFFAOYSA-N 2,3-dihydroxybenzoic acid n.a. n.a. No No No No No No PMDBD2000307 2,4,5-Trifluorophenylalanine n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000308 2,4-Dichlorophenylalanine n.a. n.a. n.a. n.a. n.a. n.a. n.a. 225440 n.a. n.a. 5472-68-4, 2-amino-3-(2,4-dichlorophenyl)propanoic acid, 2,4-Dichloro-DL-phenylalanine, MFCD05227922, MFCD01860882, NSC14790, 2,4-dichlorophenylalanine, 2-Amino-3-(2,4-dichlorophenyl)propanoicacid, SCHEMBL44904, beta-(2,4-Dichlorophenyl)alanine, NSC29445, NSC-14790, NSC-29445, AKOS000171119, AKOS016843204, CS-15676, SY031008, SY044843, SY096734, A924130, 2-Amino-3-(2,4-dichloro-phenyl)-propionic acid (H-DL-Phe(2,4-diCl)-OH) C9H9Cl2NO2 GWHQTNKPTXDNRM-UHFFFAOYSA-N 2-amino-3-(2,4-dichlorophenyl)propanoic acid n.a. n.a. No No No No No No PMDBD2000309 2,4-Difluorophenylalanine n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000310 2,4-Dimethylphenylalanine n.a. n.a. n.a. n.a. n.a. n.a. n.a. 2762260 n.a. n.a. 259726-56-2, L-2,4-Dimethylphenylalanine, (S)-2-Amino-3-(2,4-dimethylphenyl)propanoic acid, 2,4-Dimethyl-L-Phenylalanine, L-2,4-Dimethylphe, H-Phe(2,4-DiMe)-OH, (2S)-2-amino-3-(2,4-dimethylphenyl)propanoic acid, L-Phenylalanine, 2,4-dimethyl-, 2,4-dimethylphenylalanine, H-Phe(2,4-Me2)-OH, l-2,4-dimethyl phenylalanine, SCHEMBL668469, AMY7657, MFCD06659111, AKOS012010562, PS-12772, CS-0450170, A50115, L-2,4-Dimethylphenylalanine (H-L-Phe(2,4-diMe)-OH) C11H15NO2 ZEWXVRJSLTXWON-JTQLQIEISA-N (2S)-2-amino-3-(2,4-dimethylphenyl)propanoic acid n.a. n.a. No No No No No No PMDBD2000311 2,4-Dinitro-D-phenylalanine n.a. n.a. n.a. n.a. n.a. n.a. n.a. 40787457 n.a. n.a. 1217849-53-0, (R)-2-Amino-3-(2,4-dinitrophenyl)propanoic acid, D-2,4-DINITROPHENYLALANINE, D-2,4-Dinitrophe, (2R)-2-AMINO-3-(2,4-DINITROPHENYL)PROPANOIC ACID, (R)-2-Amino-3-(2,4-dinitrophenyl)propanoicacid, 2,4-Dinitro-D-phenylalanine, DTXSID40654627, MFCD08061613, AKOS016844167, PS-12877, CS-0338612, D-2,4-Dinitrophenylalanine (H-D-Phe(2,4-diNO2)-OH) C9H9N3O6 LLVUHQYJZJUDAM-SSDOTTSWSA-N (2R)-2-amino-3-(2,4-dinitrophenyl)propanoic acid n.a. n.a. No No No No No No PMDBD2000312 2,5-bis(4,5-dibromo-1-methyl-1H-pyrrol-2-yl)-1,3,4-oxadiazole n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000313 2-amino-3-(2-nitrophenyl)propanoic acid n.a. n.a. n.a. n.a. n.a. n.a. n.a. 228815 n.a. n.a. 2-amino-3-(2-nitrophenyl)propanoic acid, 35378-63-3, 2-Nitro-DL-Phenylalanine, 2-Amino-3-(2-nitrophenyl)propanoicacid, NSC-21949, NSC21949, SCHEMBL43104, MFCD00508172, AKOS000176603, AKOS016843212, AM83438, AS-49495, 2-azanyl-3-(2-nitrophenyl)propanoic acid, CS-0156661, (2S)-2-azaniumyl-3-(2-nitrophenyl)propanoate, EN300-296063, I10931, A811097, 2-AMINO-5-FLUORO-4-METHYL-3-NITROPYRIDINE, METHYL5-CYANO-2-(DIMETHOXYMETHYL)-6-MERCAPTONICOTINATE, 2-Amino-3-(2-nitrophenyl)propanoic acid (H-DL-Phe(2-NO2)-OH) C9H10N2O4 SDZGVFSSLGTJAJ-UHFFFAOYSA-N 2-amino-3-(2-nitrophenyl)propanoic acid n.a. n.a. No No No No No No PMDBD2000314 2-amino-3-(3-chlorophenyl)propanoic acid n.a. n.a. n.a. n.a. n.a. n.a. n.a. 85680 n.a. n.a. 1956-15-6, 3-CHLORO-DL-PHENYLALANINE, 2-amino-3-(3-chlorophenyl)propanoic acid, h-dl-phe(3-cl)-oh, 14091-12-4, 3-Chlorophenylalanine, 3-Chloro-3-phenylalanine, 3-Chloro-3-phenyl-DL-alanine, MFCD01631984, EINECS 217-797-8, EINECS 237-940-8, DLPhe(3Cl)OH, dl-3-chlorophenylalanine, 3-Chlorophenylalanine #, SCHEMBL42993, BCP11546, MFCD05227933, AKOS000170084, AKOS016843193, AB08125, AB09412, AB21649, AM82743, SY035271, SY035277, 2-Amino-3-(3-chlorophenyl)propionic acid, 2-azanyl-3-(3-chlorophenyl)propanoic acid, (S)-2-Amino-3-(3-chlorophenyl)propionic acid, EN300-147660, A805013, A839845, A924699, 2-AMINO-3-(3-CHLORO-PHENYL)-PROPIONIC ACID, DL-2-AMINO-3-(3-CHLORO-PHENYL)-PROPIONIC ACID, F8887-3973, DL-2-Amino-3-(3-chloro-phenyl)-propionic acid (H-DL-Phe(3-Cl)-OH) C9H10ClNO2 JJDJLFDGCUYZMN-UHFFFAOYSA-N 2-amino-3-(3-chlorophenyl)propanoic acid n.a. n.a. No No No No No No PMDBD2000315 2-amino-3-(3-nitrophenyl)propanoic acid n.a. n.a. n.a. n.a. n.a. n.a. n.a. 228814 n.a. n.a. 2-amino-3-(3-nitrophenyl)propanoic acid, 22888-56-8, 3-Nitro-DL-Phenylalanine, NSC21948, 2-Amino-3-(3-nitrophenyl)propanoicacid, MFCD01860661, MFCD04117829, SCHEMBL44004, CHEMBL1995504, XAA88856, 3-(hydroxy(oxido)amino)phenylalanine, MFCD00069003, AKOS000175276, AKOS016843178, AM83447, AS-64002, NCI60_001825, PD197212, SY035321, SY239468, CS-0156977, EN300-1846538, A878399, 3-Nitro-DL-phenylalanine (H-DL-Phe(3-NO2)-OH) C9H10N2O4 YTHDRUZHNYKZGF-UHFFFAOYSA-N 2-amino-3-(3-nitrophenyl)propanoic acid n.a. n.a. No No No No No No PMDBD2000316 2-amino-3-(4-methylbenzenesulfinyl)propanoic acid n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000317 2-amino-3-(prop-2-ene-1-sulfinyl)propanoic acid n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000318 2-amino-3-(propane-1-sulfinyl)propanoic acid n.a. n.a. n.a. n.a. n.a. n.a. n.a. 350625 n.a. n.a. (R)C(R)S-S-Propylcysteine sulfoxide, 2-amino-3-propylsulfinylpropanoic acid, 17935-27-2, NSC-513365, NSC513365, 3-(Propane-1-sulfinyl)alanine, SCHEMBL17789223, DTXSID50939013, CHEBI:173840, JZKMSAGUCSIIAH-UHFFFAOYSA-N, 2-amino-3-propylsulinylpropanoic acid, AKOS014774604, 2-AMINO-3-(PROPANE-1-SULFINYL)PROPANOIC ACID C6H13NO3S JZKMSAGUCSIIAH-UHFFFAOYSA-N 2-amino-3-propylsulfinylpropanoic acid n.a. n.a. No No No No No No PMDBD2000319 2-amino-4-chlorobenzoic acid n.a. n.a. n.a. n.a. n.a. n.a. n.a. 66646 n.a. n.a. "2-Amino-4-chlorobenzoic acid, 89-77-0, 4-Chloroanthranilic acid, Benzoic acid, 2-amino-4-chloro-, Anthranilic acid, 4-chloro-, 4-Chloro anthranilic acid, MFCD00007778, G55K85R12H, NSC-17188, 4-chloro-2-aminobenzoic acid, 4-Chloroanthranil acid, EINECS 201-938-5, BRN 0743349, UNII-G55K85R12H, 2-amino-4-chloro-benzoic acid, AI3-52450, 2-amino-4-chlorobenzoic, 2-amino-4chlorobenzoic acid, 4-14-00-01072 (Beilstein Handbook Reference), BIDD:GT0812, SCHEMBL128885, 2-amino-4-chloro benzoic acid, 4-chloro-2-amino-benzoic acid, DTXSID80237473, CHEBI:194581, 2-azanyl-4-chloranyl-benzoic acid, BCP30811, CS-D1675, NSC17188, STR01923, NSC 17188, 2-Amino-4-chlorobenzoic acid, 98%, AKOS000119774, AC-2458, PS-4144, SY001306, A0661, AM20060807, NS00039342, EN300-19514, A-5331, A811726, Q27278774, F2121-0038, Z104474094, 4-Chloroanthranilic acid;Benzoic acid, 2-amino-4-chloro-;4-chloro-2-aminobenzoic acid, InChI=1/C7H6ClNO2/c8-4-1-2-5(7(10)11)6(9)3-4/h1-3H,9H2,(H,10,11" C7H6ClNO2 JYYLQSCZISREGY-UHFFFAOYSA-N 2-amino-4-chlorobenzoic acid n.a. n.a. No No No No No No PMDBD2000320 2-amino-5-methoxy-5-oxopentanoic acid n.a. n.a. n.a. n.a. n.a. n.a. n.a. 73913 n.a. n.a. 14487-45-7, H-DL-GLU(OME)-OH, 5-Methyl DL-glutamate, 2-amino-5-methoxy-5-oxopentanoic acid, DL-Glutamic acid gamma-methyl ester, C6H11NO4, L-Glutamic acid, 5-methyl ester, glutamic acid, 5-methyl ester, MFCD00063110, 28677-37-4, glutamic acid 5-methyl ester, SR-01000945158, MFCD00237069, 5-methyl glutamate, EINECS 238-494-7, gamma-methyl glutamate, glutamate, gamma-methyl ester, SCHEMBL1983229, Glutamic acid gamma methyl ester, D-Glutamic acid IU-methyl ester, (5)-Methyl L-hydrogen glutamate, DTXSID20859653, CHEBI:165860, CHEBI:193556, DL-Glutamic Acid 5-Methyl Ester, Glutamic acid, gamma-methyl ester, 2-amino-5-methoxy-5-oxopentanoic acid (non-preferred name), NSC12959, amino-5-methoxy-5-oxopentanoic acid, EINECS 216-110-9, NSC 12959, NSC-12959, AKOS006230277, HY-W098060, PB48199, 2-amino-5-keto-5-methoxy-valeric acid, 2-aminopentanedioic acid 5-methyl ester, 2-amino-pentanedioic acid 5-methyl ester, 2-azanyl-5-methoxy-5-oxo-pentanoic acid, DS-13910, SY003851, SY066550, SY083470, AI3-52387, CS-0150702, (2R)-2-amino-5-methoxy-5-oxo-pentanoic acid, (2S)-2-azaniumyl-5-methoxy-5-oxo-pentanoate, EN300-122021, A808986, SR-01000945158-1, SR-01000945158-2 C6H11NO4 ZGEYCCHDTIDZAE-UHFFFAOYSA-N 2-amino-5-methoxy-5-oxopentanoic acid n.a. n.a. No No No No No No PMDBD2000321 2-amino-6-chlorobenzoic acid n.a. n.a. n.a. n.a. n.a. n.a. n.a. 75071 n.a. n.a. 2-Amino-6-chlorobenzoic acid, 2148-56-3, 6-Chloroanthranilic acid, Benzoic acid, 2-amino-6-chloro-, MFCD00051530, 2-amino-6-chloro-benzoic acid, NSC17189, 6-Chloranthranilsaure, 6-chloro anthranilic acid, 2Amino-6-chlorobenzoic acid, SCHEMBL147437, 2-amino-6-chloro benzoic acid, DTXSID40175761, CS-D1462, EINECS 218-416-8, NSC 17189, NSC-17189, 2-Amino-6-chlorobenzoic acid, 98%, AKOS001741281, AC-1745, AM84753, PS-4143, SY001857, C2048, NS00026877, EN300-65916, A-5352, A815413, Z995132230, InChI=1/C7H6ClNO2/c8-4-2-1-3-5(9)6(4)7(10)11/h1-3H,9H2,(H,10,11 C7H6ClNO2 SZCPTRGBOVXVCA-UHFFFAOYSA-N 2-amino-6-chlorobenzoic acid n.a. n.a. No No No No No No PMDBD2000322 2-amino-6-fluorobenzoic acid n.a. n.a. n.a. n.a. n.a. n.a. n.a. 521142 n.a. n.a. 2-Amino-6-fluorobenzoic acid, 434-76-4, 6-Fluoroanthranilic acid, benzoic acid, 2-amino-6-fluoro-, Anthralic acid, 6-fluoro-, 2-Azanyl-6-Fluoranyl-Benzoic Acid, MFCD00067781, 2,amino-6-fluorobenzoic acid, 2-amino-6-fluoro-benzoic acid, 4owo, 6-fluoroanthranilate, amino-6-fluorobenzoic acid, 6-FABA, 2-Amino-6-fluorobenzoicacid, 2-amino-6-luorobenzoic acid, Oprea1_302702, SCHEMBL283962, CHEMBL4453722, DTXSID60963006, CHEBI:194591, BCP16598, 2-Amino-6-fluorobenzoic acid, 98%, AKOS005064108, AC-3438, BS-3856, CS-W001131, HY-W001131, BP-20086, SY005291, A1692, AM20061163, F0475, EN300-41610, W-202763, Q27456372, Z424764636, InChI=1/C7H6FNO2/c8-4-2-1-3-5(9)6(4)7(10)11/h1-3H,9H2,(H,10,11, 6F0 C7H6FNO2 RWSFZKWMVWPDGZ-UHFFFAOYSA-N 2-amino-6-fluorobenzoic acid n.a. n.a. No No No No No No PMDBD2000323 2-amino-imidazole/ triazole conjugate n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000324 2-Benzyl-5-(4,5-dibromo-1-methyl-1H-pyrrol-2-yl)-1,3,4-oxadiazole n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000325 2-bromo-4-methyl-6-(3,4,5-tribromo-1H-pyrrole-2-carbonyl)phenol n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000326 2-bromodecanoic acid n.a. n.a. n.a. n.a. n.a. n.a. n.a. 98310 n.a. n.a. 2-Bromodecanoic acid, 2623-95-2, Decanoic acid, 2-bromo-, 2-Bromocapric acid, 2-bromo-decanoic acid, 2-Bromocapricacid, EINECS 220-086-5, NSC 99841, alpha-Bromocapric acid, alpha-bromodecanoic acid, Decanoic acid,2-bromo-, .alpha.-Bromocapric acid, SCHEMBL2718852, CHEBI:72820, DTXSID20870989, NSC99841, LMFA01090003, NSC-99841, 2-Bromodecanoic acid, >=96.0% (AT), AS-80772, NS00049339, E85155, A818339, J-016342, Q27140167 C10H19BrO2 KNLOTZNPRIFUAR-UHFFFAOYSA-N 2-bromodecanoic acid n.a. n.a. No No No No No No PMDBD2000327 2-bromohexanoic acid n.a. n.a. n.a. n.a. n.a. n.a. n.a. 12013 n.a. n.a. 2-BROMOHEXANOIC ACID, 616-05-7, DL-2-Bromohexanoic acid, 2-Bromocaproic acid, Hexanoic acid, 2-bromo-, .alpha.-Bromo-n-caproic acid, alpha-Bromohexanoic acid, .alpha.-Bromohexanoic acid, 2-bromo-hexanoic acid, .alpha.-Bromocaproic acid, 99GKX2FXIB, NSC-73987, DL-2-Bromohexanoicacid, alpha-Bromo-n-caproic acid, alpha-Bromocaproic acid, UNII-99GKX2FXIB, bromohexanoic acid, EINECS 210-461-1, NSC 73987, DL-2-Bromocaproic acid, hexanoic acid, 2-bromo, AI3-11171, WLN: QVYE4, NCIOpen2_000344, 2-Bromohexanoic acid, 97%, SCHEMBL140785, DTXSID50883244, NSC73987, DL-.ALPHA.-BROMOCAPROIC ACID, MFCD00004218, (+/-)-2-BROMOCAPRONIC ACID, (+/-)-2-BROMOHEXANOIC ACID, AKOS000119458, AKOS016358018, 2-BROMOCAPRONIC ACID, (+/-)-, AS-15504, .ALPHA.-BROMO-N-CAPROIC ACID [MI], B0601, CS-0152387, NS00042117, EN300-20411, H11951, J-520409, Q27272208, F2191-0204, InChI=1/C6H11BrO2/c1-2-3-4-5(7)6(8)9/h5H,2-4H2,1H3,(H,8,9 C6H11BrO2 HZTPKMIMXLTOSK-UHFFFAOYSA-N 2-bromohexanoic acid n.a. n.a. No No No No No No PMDBD2000328 2-bromooctanoic acid n.a. n.a. n.a. n.a. n.a. n.a. n.a. 552003 n.a. n.a. 2-Bromooctanoic acid, 2623-82-7, Octanoic acid, 2-bromo-, 2-Bromo-n-octanoic Acid, 2-BROMOOCTANOICACID, 2-Bromocaprylic acid, 70610-87-6, Octanoic acid, 2-bromo-, (A+/-)-, 2-bromo-octanoic acid, 2-Bromooctanoic acid #, Octanoic acid,2-bromo-, 2-Bromooctanoic acid, 97%, SCHEMBL375050, MFCD00004219, AKOS015893911, BS-43962, B0627, CS-0328199, NS00047992, EN300-7721254, J-016340, InChI=1/C8H15BrO2/c1-2-3-4-5-6-7(9)8(10)11/h7H,2-6H2,1H3,(H,10,11 C8H15BrO2 GTGTXZRPJHDASG-UHFFFAOYSA-N 2-bromooctanoic acid n.a. n.a. No No No No No No PMDBD2000329 2C-4 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000330 2-Carbamoylphenylalanine n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000331 2-Chloro-DL-Phenylalanine n.a. n.a. n.a. n.a. n.a. n.a. n.a. 85679 n.a. n.a. "14091-11-3, 2-amino-3-(2-chlorophenyl)propanoic acid, 2-Chloro-DL-Phenylalanine, 2-chlorophenylalanine, o-Chloro-dl-phenylalanine, DL-Phenylalanine, 2-chloro-, 2-Amino-3-(2-chloro-phenyl)-propionic acid, MFCD00037774, D-2-chlorophenylalanine, 1991-77-1, O-Chlorophenylalanine, L-2-Chloro phenylalanine, H-D-Phe(2-Cl)-OH.HCl, 2-Chloro-3-phenyl-DL-alanine, MFCD00077920, MFCD00077921, NSC28185, EINECS 237-939-2, NSC 233876, 2-Amino-3-(2-chlorophenyl)propanoicacid, (R)-2-AMINO-3-(2-CHLOROPHENYL)PROPANOIC ACID, SCHEMBL43976, DL-beta-(o-Chlorophenyl)alanine, NSC-28185, NSC154946, NSC233876, AKOS000185911, AKOS016842352, AB01662, AB02989, AM82734, CS-W002170, DS-1249, FS-3217, HY-W002170, NSC-154946, NSC-233876, (S)-(-)-3,7-Dimethyl-6-octenoicacid, SY030197, SY035311, SY035312, NS00052241, EN300-140883, A885717, DL-2-AMINO-3-(2-CHLORO-PHENYL)-PROPIONIC ACID, F2147-6557, 2-Amino-3-(2-chlorophenyl)propanoic acid (H-DL-Phe(2-Cl)-OH), 2-Chloro-DL-phenylalanine; 2-Amino-3-(2-chlorophenyl)propanoic acid;2-Chloro-DL-phenylalanine" C9H10ClNO2 CVZZNRXMDCOHBG-UHFFFAOYSA-N 2-amino-3-(2-chlorophenyl)propanoic acid n.a. n.a. No No No No No No PMDBD2000332 2-Cyano-D-phenylalanine n.a. n.a. n.a. n.a. n.a. n.a. n.a. 7009695 n.a. n.a. "263396-41-4, D-2-Cyanophenylalanine, 2-Cyano-D-phenylalanine, (R)-2-Amino-3-(2-cyanophenyl)propanoic acid, (2R)-2-amino-3-(2-cyanophenyl)propanoic Acid, D-2-Cyanophenylalarine, D-Phenylalanine, 2-cyano-, D-2-Cyanophe, AC-5871, -;D-2-Cyanophenylalanine, SCHEMBL2030783, DTXSID30426572, MFCD01860878, AKOS006345216, AM82757, AS-14699, CS-0450282, A50112, D-2-Cyanophenylalanine (H-D-Phe(2-CN)-OH), A877256" C10H10N2O2 OCDHPLVCNWBKJN-SECBINFHSA-N (2R)-2-amino-3-(2-cyanophenyl)propanoic acid n.a. n.a. No No No No No No PMDBD2000333 2-Fluoro-L-phenylalanine n.a. n.a. n.a. n.a. n.a. n.a. n.a. 716319 n.a. n.a. "2-Fluoro-L-phenylalanine, 19883-78-4, H-Phe(2-F)-OH, L-2-Fluorophenylalanine, (2S)-2-amino-3-(2-fluorophenyl)propanoic acid, (S)-2-AMINO-3-(2-FLUOROPHENYL)PROPANOIC ACID, o-Fluoro-L-phenylalanine, 2-FLUORO-L-PHE, 2-Fluorophenylalanine, L-Phenylalanine, 2-fluoro-, Phenylalanine, 2-fluoro-, MFCD00066448, L-2-FLUOROPHE, L-2-F-PHE-OH, L-2-Fluoro phenylalanine, H-O-FLUORO-PHE-OH, (S)-2-Amino-3-(2-fluorophenyl)propionic Acid, L-(2-Fluorophenyl)alanine, SCHEMBL44127, CHEBI:155831, DTXSID301313089, AKOS010396266, AC-5821, AM83327, CS-W017052, HY-W016336, AS-12158, F0273, NS00049340, (S)-3-(2-fluorophenyl)-2-aminopropanoic acid, 2-Fluoro-L-phenylalanine (H-L-Phe(2-F)-OH), EN300-1300765, A814035, A851587, J-300397, (2S)-2-amino-3-(2-fluorophenyl)propanoic acid;2-Fluoro-L-phenylalanine" C9H10FNO2 NYCRCTMDYITATC-QMMMGPOBSA-N (2S)-2-amino-3-(2-fluorophenyl)propanoic acid n.a. n.a. No No No No No No PMDBD2000334 2-geranyloxy-1-(2-methylpropanoyl)phloroglucinol n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000335 2-geranyloxy-4,6-dihydroxybenzophenone n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000336 2-Hexylmaleic anhydride n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000337 2-Hydroxychalcone n.a. n.a. n.a. n.a. n.a. n.a. n.a. 5367146 n.a. NPC141523 2-Hydroxychalcone, 644-78-0, 42224-53-3, 3-(2-hydroxyphenyl)-1-phenylprop-2-en-1-one, (E)-3-(2-hydroxyphenyl)-1-phenylprop-2-en-1-one, (2E)-3-(2-hydroxyphenyl)-1-phenylprop-2-en-1-one, (E)-2-Hydroxychalcone, 2-(2-Hydroxybenzal)acetophenone, Salicylalacetophenone, 2-Propen-1-one, 3-(2-hydroxyphenyl)-1-phenyl-, MLS002608038, NSC640539, 3-(2-hydroxyphenyl)-1-phenyl-2-propen-1-one, (E)-3-(2-hydroxyphenyl)-1-phenyl-prop-2-en-1-one, 2-Hydroxybenzylidene acetophenone, Chalcone, 1, EINECS 211-422-1, NSC 640539, AI3-00855, 2-Hydroxychalcone, 95%, SCHEMBL626785, SCHEMBL626787, CHEMBL147067, BDBM86002, HMS3078L22, NSC37432, 2-(2-Hydroxybenzylidene)acetophenone, MFCD00016449, NSC-37432, NSC170281, AKOS000486194, AKOS025309995, NSC-170281, NSC-640539, MS-10592, SMR001526790, HY-119931, CS-0078796, CS-0311212, H0234, NS00042209, A834764, AB-016/30005051, SR-01000078236, SR-01000078236-1, trans-3-(O-Hydroxyphenyl)-1-phenyl-2-propen-1-one, W-104837, (2E)-3-(2-Hydroxyphenyl)-1-phenyl-2-propen-1-one #, 6-[(1Z,2Z)-3-Hydroxy-3-phenyl-2-propene-1-ylidene]-2,4-cyclohexadiene-1-one C15H12O2 UDOOPSJCRMKSGL-ZHACJKMWSA-N (E)-3-(2-hydroxyphenyl)-1-phenylprop-2-en-1-one n.a. n.a. No No No No No No PMDBD2000338 2-Methoxy-4-propylphenol n.a. n.a. n.a. n.a. n.a. n.a. n.a. 17739 n.a. NPC8547 "2-METHOXY-4-PROPYLPHENOL, Dihydroeugenol, 2785-87-7, 4-Propylguaiacol, Coerulignol, Phenol, 2-methoxy-4-propyl-, Guaiacylpropane, Cerulignol, p-Propylguaiacol, 4-Propyl-2-methoxyphenol, p-n-Propylguaiacol, (4-Hydroxy-3-methoxyphenyl)propane, 4-Hydroxy-3-methoxypropylbenzene, Eugenol dihydro, Guaiacol, 4-propyl-, 1-Propyl-3-methoxy-4-hydroxybenzene, 4-Propyl-O-methoxyphenol, 1-(4-Hydroxy-3-methoxyphenyl)propane, 5-Propyl-O-hydroxyanisole, NSC 53043, FEMA No. 3598, 2-Methoxy-4-(1-propyl)phenol, 2-methoxy-4-propyl phenol, 2-methoxy-4-propyl-phenol, 2-Methoxy-4-n-propylphenol, Phenol, 4-propyl, 2-methoxy, DTXSID2047199, NSC-53043, A3XE712277, Propylguaiacol, p-, EINECS 220-499-0, BRN 1866292, dehydroeugenol,, di hydroeugenol, dihydro eugenol, eugenyl dihydro, Oracle, cerulignol,, Coerulignol,, dihydro,, guaiacyl propane, AI3-18037, di hydro eugenol, UNII-A3XE712277, 4-propyl guaicol, 4-propyl guaiacol, di hydro eugenol,, 4-Propylguaiacol;, 4-Propyl-Guaiacol, EOL, H7Y, para-propyl guaiacol, para-n-propyl guaiacol, 5-Propyl-o-hydroxyanisole,, DIHYDROEUGENOL 909, 4-propyl-ortho-methoxyphenol, 5-propyl-ortho-hydroxyanisole, WLN: QR D3 BO1, 4-06-00-05976 (Beilstein Handbook Reference), SCHEMBL267532, CHEMBL3186884, DTXCID0027199, 2-Methoxy-4-propylphenol, 9CI, 4-hydroxy-3-methoxypropyl benzene, CHEBI:167417, CAA78587, NSC53043, Tox21_302722, (4-hydroxy-3-methoxyphenyl) propane, MFCD00037196, 1-(3-Methoxy-4-hydroxyphenyl)propane, AKOS005608362, 1-(4-hydroxy-3-methoxyphenyl) propane, 2-METHOXY-4-PROPYLPHENOL [FHFI], NCGC00256773-01, 2-Methoxy-4-propylphenol, >=99%, FG, VS-02191, CAS-2785-87-7, 2-Methoxy-4-propylphenol (p-propylguaiacol), 4-Propyl-2-methoxyphenol (4-propylguaiacol), CS-0199387, NS00012234, EN300-1267410, A819218, Q27273589" C10H14O2 PXIKRTCSSLJURC-UHFFFAOYSA-N 2-methoxy-4-propylphenol n.a. n.a. No No No No No No PMDBD2000339 2-methoxy-cinnamaldehyde n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000340 2-Methoxy-D-Phenylalanine n.a. n.a. n.a. n.a. n.a. n.a. n.a. 10631698 n.a. n.a. 2-Methoxy-D-Phenylalanine, 170642-31-6, (R)-2-Amino-3-(2-methoxyphenyl)propanoic acid, (2R)-2-AMINO-3-(2-METHOXYPHENYL)PROPANOIC ACID, (S)-2-Amino-3-(2-methoxyphenyl)propanoic acid, SCHEMBL4595466, DTXSID70442716, MFCD03788081, AKOS016843679, AM83384, AS-58553, N12455, A882007 C10H13NO3 SEUPQWHWULSGJC-MRVPVSSYSA-N (2R)-2-amino-3-(2-methoxyphenyl)propanoic acid n.a. n.a. No No No No No No PMDBD2000341 2-Methoxyhydroquinone n.a. n.a. n.a. n.a. n.a. n.a. n.a. 69988 n.a. NPC124712 2-Methoxyhydroquinone, 2-methoxybenzene-1,4-diol, 824-46-4, Methoxyhydroquinone, o-Methoxyhydroquinone, 1,4-Benzenediol, 2-methoxy-, 1,4-Dihydroxy-2-methoxybenzene, 2HI6HNR5U1, CHEMBL551075, MFCD00013971, UNII-2HI6HNR5U1, EINECS 212-530-1, 2-MOHYDROP, SCHEMBL62784, 2-Methoxyhydroquinone, 98%, METHOXYHYDROQUINONE, O-, 2-Methoxy-1,4-benzenediol #, DTXSID00231716, CHEBI:176649, BDBM50297425, AKOS015856224, CS-W014391, PS-6133, AM808228, PD166897, SY048447, M0539, NS00022821, EN300-184406, Q-101987, Q27254754, InChI=1/C7H8O3/c1-10-7-4-5(8)2-3-6(7)9/h2-4,8-9H,1H C7H8O3 LAQYHRQFABOIFD-UHFFFAOYSA-N 2-methoxybenzene-1,4-diol n.a. n.a. No No No No No No PMDBD2000342 2-Nitro-cinnamaldehyde n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000343 2-oxindole n.a. n.a. n.a. n.a. n.a. n.a. n.a. 321710 n.a. NPC178681 Oxindole, 59-48-3, Indolin-2-one, 2-Oxindole, 2-Indolinone, 1,3-Dihydro-2H-indol-2-one, 1,3-Dihydroindol-2-one, Oxindol, Indol-2(3H)-one, 2H-Indol-2-one, 1,3-dihydro-, 2-Oxoindoline, 2-Oxindoline, Indoline-2-one, MFCD00005711, 2-OXOINDOLE, 2,3-dihydro-1H-indol-2-one, 1,3-dihydro-indol-2-one, DICLOFENAC IMPURITY E, Oxindole (2-Indolone), NSC 274863, CHEBI:31697, 0S9338U62H, NSC-274863, 2,3-Dihydroindol-2-one, indol-2-ol, 2Oxindole, 2-Ketoindoline, UNII-0S9338U62H, indolin 2-one, EINECS 200-429-5, INDOLINONE, indolin-2(1H)-one, 2(1H,3H)indolone, BRN 0114692, 2-Oxindole, 97%, 2(1H,3H)-indolone, Oxindole (2-Indolinone), 2,3-Dihydroindole-2-one, SCHEMBL19504, 5-21-08-00007 (Beilstein Handbook Reference), CHEMBL40823, 1,3-dihydro-2H-indol-2-on, SCHEMBL4096312, SCHEMBL4787144, SCHEMBL4787148, SCHEMBL9305641, DTXSID80870389, HMS1647D16, 1,3-dihydro-(2H)-indol-2-One, 1,3-Dihydro-2H-indol-2-one #, o-(Aminophenyl)-acetic acid lactam, BCP21784, CS-M2997, HY-Y0061, STR01316, AB7349, BDBM50434120, CX1001, NSC274863, s4861, AKOS000119409, 1,3-DIHYDRO-INDOL-2-ONE-D4, AB00523, AC-3269, CCG-266121, CG-0513, 2-Oxindole pound>>Diclofenac Impurity E, NCGC00382195-02, AM807053, BP-12514, SY004718, 2-Oxindole, purum, >=97.0% (HPLC), NS00014928, O0272, EN300-20422, A24270, AH-034/32845032, DICLOFENAC SODIUM IMPURITY E [EP IMPURITY], J-400304, Q2018788, DICLOFENAC POTASSIUM IMPURITY E [EP IMPURITY], DICLOFENAC POTASSIUM IMPURITY I [EP IMPURITY], F0918-7910, Z104478112, InChI=1/C8H7NO/c10-8-5-6-3-1-2-4-7(6)9-8/h1-4H,5H2,(H,9,10 C8H7NO JYGFTBXVXVMTGB-UHFFFAOYSA-N 1,3-dihydroindol-2-one n.a. n.a. No No No No No No PMDBD2000344 2-phenylethane-1-SO-thioperoxol n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000345 3-(1-Naphthyl)-D-Alanine n.a. n.a. n.a. n.a. n.a. n.a. n.a. 6950505 n.a. n.a. 78306-92-0, 3-(1-Naphthyl)-D-alanine, D-1-Naphthylalanine, H-D-1-Nal-OH, (R)-2-AMINO-3-(NAPHTHALEN-1-YL)PROPANOIC ACID, (2R)-2-amino-3-naphthalen-1-ylpropanoic acid, 3-(1-NAPHTHYL)-D-ALA, (2R)-2-azaniumyl-3-naphthalen-1-ylpropanoate, (2R)-2-amino-3-(naphthalen-1-yl)propanoic acid, MFCD00038544, SCHEMBL660499, D-3-(1-Naphthyl )-alanine, (2R)-2-AMINO-3-(NAPHTH-1-YL)PROPANOIC ACID, H-D-ALA(1-NAPH)-OH, AKOS017482146, D-1-Naphthylalanine (H-D-1Nal-OH), AC-5877, PS-3747, CS-0146968, F12291, EN300-1692426 C13H13NO2 OFYAYGJCPXRNBL-GFCCVEGCSA-N (2R)-2-amino-3-naphthalen-1-ylpropanoic acid n.a. n.a. No No No No No No PMDBD2000346 3-(2-Furyl)-D-alanine n.a. n.a. n.a. n.a. n.a. n.a. n.a. 7009697 n.a. n.a. D-2-Furylalanine, 110772-46-8, (R)-2-Amino-3-(furan-2-yl)propanoic acid, 3-(2-Furyl)-D-alanine, (2R)-2-amino-3-(furan-2-yl)propanoic acid, (R)-2-Amino-3-(furan-2-yl)propanoicacid, D-2-furylalanine, AldrichCPR, SCHEMBL1663153, RXZQHZDTHUUJQJ-ZCFIWIBFSA-N, MFCD01860879, AKOS012010223, AC-5884, AM83673, DS-6043, HY-W051568, PD197221, (R)-2-Amino-3-furan-2-yl-propionic acid, CS-0043946, EN300-312233 C7H9NO3 RXZQHZDTHUUJQJ-ZCFIWIBFSA-N (2R)-2-amino-3-(furan-2-yl)propanoic acid n.a. n.a. No No No No No No PMDBD2000347 3-(2-Furylmethyl)-2-{[(5-hydroxy-1H-pyrazol-3-yl)methyl]sulfanyl}-3,5,6,7-tetrahydro-4H-cyclopenta[4,5]thieno[2,3-d]pyrimidin-4-one n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000348 3-(2-Naphthyl)alanine n.a. n.a. n.a. n.a. n.a. n.a. n.a. 250399 n.a. n.a. "14108-60-2, H-DL-2-NAL-OH, 2-Amino-3-(naphthalen-2-yl)propanoic acid, 3-(2-Naphthyl)-DL-alanine, 2-amino-3-naphthalen-2-ylpropanoic acid, 6960-34-5, 3-(2-Naphthyl)alanine, 2-AMINO-3-NAPHTHALEN-2-YL-PROPIONIC ACID, MFCD00070216, 2-Naphthalenepropanoic acid, alpha-amino-, 2-naphthylalanine, 2-Naphthalenealanine, 3-Naphthalen-2-ylalanine, MFCD00038546, beta-naphtyl alanine, DL-2-Naphthylalanine, 3-(2-naphthyl)-alanine, 3-(2-Naphthyl)alanine #, SCHEMBL93304, H-DL-Ala(2-naphthyl)-OH, H-DL-ALA(2-NAPH)-OH, CHEMBL3272605, DTXSID50290595, CHEBI:229533, NSC69865, DL-3-(2-NAPHTHYL)-ALANINE, NSC-69865, AKOS000191768, AKOS016843550, AB01739, AB02815, alpha-Amino-2-naphthalenepropanoic acid, 2-Amino-3-naphthalen-2-ylpropionic acid, AS-63072, SY031901, SY035315, SY035605, CS-0146966, EN300-57632, (R)-2-amino-3-(naphthalen-2-yl)propanoicacid, A50367, DL-2-Amino-3-(naphthalen-2-yl)propanoic acid, A831878, J-007457, (2S)-2-azaniumyl-3-(2-naphthyl)propanoate;3-(2-Naphthyl)-L-alanine" C13H13NO2 JPZXHKDZASGCLU-UHFFFAOYSA-N 2-amino-3-naphthalen-2-ylpropanoic acid n.a. n.a. No No No No No No PMDBD2000349 3-(2-Naphthyl)-D-alanine n.a. n.a. n.a. n.a. n.a. n.a. n.a. 2733661 n.a. n.a. 3-(2-Naphthyl)-D-alanine, 76985-09-6, H-D-2-NAL-OH, (R)-2-AMINO-3-(NAPHTHALEN-2-YL)PROPANOIC ACID, (2R)-2-amino-3-naphthalen-2-ylpropanoic acid, 2-D-NAPHTHYLALANINE, beta-Naphthyl-D-ala, beta-2-Naphthyl-D-alanine, UNII-571V312YMY, 571V312YMY, (2R)-2-amino-3-(naphthalen-2-yl)propanoic acid, (2R)-2-azaniumyl-3-naphthalen-2-ylpropanoate, D-2-NAPHTHYLALANINE, D-3-(2-Naphthyl)-alanine, (R)-2-Amino-3-Naphthalene-2-yl-Propionic Acid, H-D-2Nal-OH, MFCD00038546, D-2Nal, D-2-Nal, (2R)-2-Amino-3-(2-naphthyl)propionic acid, d-3-(2-naphthyl)alanine, (R)-3-(2-naphthyl)alanine, SCHEMBL210104, D-3-(2-Naphthyl )-alanine, .BETA.-NAPHTHYL-D-ALA, H-D-ALA(2-NAPH)-OH, CHEBI:183401, DTXSID601313769, AMY22802, .BETA.-2-NAPHTHYL-D-ALANINE, AKOS010400402, AC-7945, CS-W008269, DS-7835, HY-W008269, (R)-alpha-Amino-2-naphthalenepropionic Acid, N0665, 3-(2-Naphthyl)-D-alanine (H-D-2Nal-OH), EN300-199905, F16403, M03141, A838926, Q27261451, 2-NAPHTHALENEPROPANOIC ACID, .ALPHA.-AMINO-, (R)-, (2R)-2-amino-3-(naphthalen-2-yl)propanoic acid (non-preferred name) C13H13NO2 JPZXHKDZASGCLU-GFCCVEGCSA-N (2R)-2-amino-3-naphthalen-2-ylpropanoic acid n.a. n.a. No No No No No No PMDBD2000350 3-(2-Pyridinyl)alanine n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000351 3-(2-Thienyl)alanine n.a. n.a. n.a. n.a. n.a. n.a. n.a. 91444 n.a. n.a. 2021-58-1, 3-(2-Thienyl)-dl-alanine, 2-Amino-3-(thiophen-2-yl)propanoic acid, 3-(2-Thienyl)alanine, 2-Thiophenealanine, Thienylalanine, 2-Thienylalanine, 139-86-6, 2-amino-3-thiophen-2-ylpropanoic acid, 2-Thiophenepropanoic acid, alpha-amino-, H-Beta-(2-Thienyl)-Dl-Ala-Oh, X 151, 6ZK0RDK1XB, b-(2-Thienyl)-D-alanine, NSC-754, MFCD00005459, 2-amino-3-thiophen-2-yl-propionic acid, H-beta-(2-Thienyl)-D-Ala-OH, beta-(2-THIENYL)-DL-ALANINE, beta-2-thienylalanine, NSC 754, beta-2-dl-Thienylalanine, EINECS 205-378-2, alpha-Amino-2-thiophenepropanoic acid, 2-amino-3-(2-thienyl)propanoic acid, beta-2-Thienyl-DL-alanine, h-3-dl-ala(2-thienyl)-oh, MFCD00064335, MFCD00077166, EINECS 217-967-1, 2-Amino-3-(2-thienyl)propionic acid, 2-Thiophenepropionic acid, alpha-amino-, 2-Amino-3-(thiophen-2-yl)propanoicacid, .beta.-2-Thienylalanine, UNII-6ZK0RDK1XB, beta-thienyl-D,L-alanine, 3-(2-Thienyl)alanine #, 3-(2-Thienyl)dL-alanine, SCHEMBL43293, .beta.-2-Thieny-dl-alanine, 3-(2-thienyl)-D,L-alanine, 3-(2-thienyl)-d,l -alanine, NSC754, 4-ETHYL-2-OCTENOICACID, H--(2-Thienyl)-DL-Ala-OH, DTXSID10862813, DL-3-(2-THIENYL)ALANINE, 3-Fluoro-4-methoxyphenethylAlcohol, 22574-47-6, BCP11711, .BETA.-2-THIENYL-DL-ALANINE, AKOS000180445, AKOS016843095, dl-2-.beta.-Thienyl-.alpha.-alanine, AM83778, HY-W141842, 2-aMino-3-(thien-2-yl)propanoic acid, 3-(2-Thienyl)-DL-alanine, >=98%, AS-12162, SY035273, SY035318, 2-Thiophenepropanoic acid, .alpha.-amino-, 2-Thiophenepropionic acid, .alpha.-amino-, CS-0201638, NS00041625, EN300-95840, A50245, T-3500, 2-Thiophenepropanoic acid, alpha-amino-, (+/-)-, A920255, Q4897173, 3-(2-Thienyl)-DL-alanine, purum, >=98.0% (NT), 2-Thiophenepropanoic acid, .alpha.-amino-, (.+/-.)-, F0918-0381, 2-THIOPHENEPROPANOIC ACID, .ALPHA.-AMINO-, (+/-)- C7H9NO2S WTOFYLAWDLQMBZ-UHFFFAOYSA-N 2-amino-3-thiophen-2-ylpropanoic acid n.a. n.a. No No No No No No PMDBD2000352 3-(2-Thienyl)-D-alanine n.a. n.a. n.a. n.a. n.a. n.a. n.a. 7111750 n.a. n.a. 62561-76-6, 3-(2-Thienyl)-D-alanine, D-2-THIENYLALANINE, (R)-2-amino-3-(thiophen-2-yl)propanoic acid, (2R)-2-amino-3-thiophen-2-ylpropanoic acid, beta-(2-Thienyl)-D-alanine, d-3-(2-thienyl)alanine, 2-amino isobutyric acid, beta-2-thienyl-D-alanine, PJ4EM0CL5E, (2R)-2-azanyl-3-thiophen-2-yl-propanoic acid, MFCD00077166, UNII-PJ4EM0CL5E, (2R)-2-amino-3-(2-thienyl)propanoic acid, (2R)-2-Amino-3-(2-thienyl)propionic acid, a-(2-thienyl)-D-alanine, (2R)-2-amino-3-(thiophen-2-yl)propanoic acid, H-D-Ala(2-Thienyl)-OH, 3-(2-thiophenyl)-D-alanine, BIDD:GT0430, SCHEMBL288244, beta-(2-thiophenyl)-D-alanine, H--(2-Thienyl)-D-Ala-OH, H-D-3-(2-thienyl)-Ala-OH, CHEBI:77819, WTOFYLAWDLQMBZ-ZCFIWIBFSA-N, CS-M2655, HY-I0423, .BETA.-2-THIENYL-D-ALANINE, D-2-Thienylalanine (H-D-2Thi-OH), AKOS012010222, AKOS015854101, AC-9985, AM83777, .BETA.-(2-THIENYL)-D-ALANINE, PS-12177, (2R)-2-Amino-3-(2-thienyl) propionic acid, (R)-2-amino-3-(thiophen-2-yl)propanoicacid, EN300-77292, F52519, A809328, A814337, 2-Thiophenepropanoic acid, alpha-amino-, (alphaR)-, Q27147425, 2-THIOPHENEPROPANOIC ACID, .ALPHA.-AMINO-, (.ALPHA.R)- C7H9NO2S WTOFYLAWDLQMBZ-ZCFIWIBFSA-N (2R)-2-amino-3-thiophen-2-ylpropanoic acid n.a. n.a. No No No No No No PMDBD2000353 3-(3-fluorophenyl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one n.a. n.a. n.a. n.a. n.a. n.a. n.a. 3821570 n.a. n.a. WAY-272494, JODHEPSOPJRJBT-UHFFFAOYSA-N, 3-(3-fluorophenyl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one C18H14FNO3S2 JODHEPSOPJRJBT-UHFFFAOYSA-N 5-[(3-ethoxy-4-hydroxyphenyl)methylidene]-3-(3-fluorophenyl)-2-sulfanylidene-1,3-thiazolidin-4-one n.a. n.a. No No No No No No PMDBD2000354 3-(3-Pyridinyl)alanine n.a. n.a. n.a. n.a. n.a. n.a. n.a. 314100 n.a. n.a. "17470-24-5, 2-Amino-3-(pyridin-3-yl)propanoic acid, 3-(3-Pyridyl)-DL-alanine, H-DL-3-PAL-OH, 3-(3''-PYRIDYL)-DL-ALANINE, 2-amino-3-pyridin-3-ylpropanoic acid, NSC-230426, 3-Pyridinepropanoic acid, alpha-amino-, 82667X5OWF, BETA-(3-PYRIDYL)-DL-ALANINE, MFCD02259525, H-BETA-(3-PYRIDYL)-ALA-OH, 3-(3-pyridinyl)alanine, MFCD00079673, MFCD00079676, DL-ALA(3''-PYRIDYL)-OH, NSC230426, NoName_146, H-Ala(3-pyridyl)-OH.HCl, 3-Pyridylalanine, AldrichCPR, SCHEMBL124364, UNII-82667X5OWF, H-DL-ALA(3-PYRI)-OH, beta-(3-Pyridyl)alanine, DL-, DTXSID60901089, DFZVZEMNPGABKO-UHFFFAOYSA-N, H-3-Pal-OH;(S)-2-Amino-3-pyridin-3-yl-propionic acid;C3-(3-Pyridyl)-L-alanine, AKOS000180443, AKOS016842370, AB03057, AB11720, AM83724, .BETA.-(3-PYRIDYL)-DL-ALANINE, .BETA.-(3-PYRIDYL)ALANINE, DL-, AS-33079, SY030064, SY033040, SY057601, CS-0156817, DL-2-Amino-3-(pyridin-3-yl)propanoic acid, 2-AMINO-3-PYRIDIN-3-YL-PROPIONIC ACID, EN300-118570, 3-PYRIDINEPROPANOIC ACID, .ALPHA.-AMINO-, A881671, J-011028" C8H10N2O2 DFZVZEMNPGABKO-UHFFFAOYSA-N 2-amino-3-pyridin-3-ylpropanoic acid n.a. n.a. No No No No No No PMDBD2000355 3-(4-fluorophenyl)-5-(3-(allyloxy)-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000356 3-(4-fluorophenyl)-5-(3-ethoxy- 4-hydroxybenzylidene)-2-thioxothiazolidin-4-one n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000357 3-(4-Pyridinyl)alanine n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000358 3-(Aminomethyl)-D-phenylalanine n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000359 3-(pyridin-3-yl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one n.a. n.a. n.a. n.a. n.a. n.a. n.a. 72036004 n.a. n.a. HHFWJJJBGTTZGL-UHFFFAOYSA-N, AKOS030745001, 3-(pyridin-3-yl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one C17H14N2O3S2 HHFWJJJBGTTZGL-UHFFFAOYSA-N 5-[(3-ethoxy-4-hydroxyphenyl)methylidene]-3-pyridin-3-yl-2-sulfanylidene-1,3-thiazolidin-4-one n.a. n.a. No No No No No No PMDBD2000360 3-(Trifluoromethyl)phenylalanine n.a. n.a. n.a. n.a. n.a. n.a. n.a. 2777602 n.a. n.a. 63701-37-1, 3-(Trifluoromethyl)-dl-phenylalanine, 2-amino-3-(3-(trifluoromethyl)phenyl)propanoic acid, 2-amino-3-[3-(trifluoromethyl)phenyl]propanoic Acid, 3-trifluoromethyl-dl-phenylalanine, L-3-Trifluoromethylphenylalanine, DL-Phenylalanine, 3-(trifluoromethyl)-, ammoniumsalicylate, SCHEMBL44155, 2-Amino-3-(3-(trifluoromethyl)phenyl)propanoicacid, 3-(Trifluoromethyl)phenylalanine, (2R)-2-amino-3-[3-(trifluoromethyl)phenyl]propanoic acid, DTXSID90980024, BURBNIPKSRJAIQ-UHFFFAOYSA-N, DL-3-(Trifluoromethyl)phenylalanine, AKOS000189408, AKOS016843215, AB01999, AB02797, AM83491, FS-5780, PD196697, CS-0454403, A50214, EN300-1930818, A834479, 2-azanyl-3-[3-(trifluoromethyl)phenyl]propanoic acid C10H10F3NO2 BURBNIPKSRJAIQ-UHFFFAOYSA-N 2-amino-3-[3-(trifluoromethyl)phenyl]propanoic acid n.a. n.a. No No No No No No PMDBD2000361 3,3-dimethyl-13-{[1,2,3,4]tetrazolo[1,5-a]quinolin-4-yl}-2H,4H,13H-indazolo[1,2-b]phthalazine-1,6,11-trione n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000362 3,3-dimethyl-13-{7-methyl-[1,2,3,4]tetrazolo[1,5-a]quinolin-4-yl}-1H,2H,3H,4H,6H,11H,13H-indazolo[1,2-b]phthalazine-1,6,11-trione n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000363 3,3-dimethyl-13-{8-methyl-[1,2,3,4]tetrazolo[1,5-a]quinolin-4-yl}-1H,2H,3H,4H,6H,11H,13H-indazolo[1,2-b]phthalazine-1,6,11-trione n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000364 3,3-dimethyl-13-{9-methyl-[1,2,3,4]tetrazolo[1,5-a]quinolin-4-yl}-1H,2H,3H,4H,6H,11H,13H-indazolo[1,2-b]phthalazine-1,6,11-trione n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000365 3,3-Diphenyl-D-alanine n.a. n.a. n.a. n.a. n.a. n.a. n.a. 1520861 n.a. n.a. 149597-91-1, 3,3-Diphenyl-D-alanine, (R)-2-amino-3,3-diphenylpropanoic acid, D-3,3-Diphenylalanine, (2R)-2-amino-3,3-diphenylpropanoic acid, D-Phenylalanine, beta-phenyl-, beta-Phenyl-D-phenylalanine, H2JAP020MP, L-3,3''-Biphenylalanine, MFCD01631990, (R)-Diphenylalanine, (R)-2-Amino-3,3-diphenylpropanoicacid, L-3,3-Diphenyl Alanine, UNII-H2JAP020MP, SCHEMBL502830, .BETA.-PHENYL-D-PHENYLALANINE, AKOS015912122, AC-4456, CS-W010282, DS-5145, D-PHENYLALANINE, .BETA.-PHENYL-, 3,3-Diphenyl-D-alanine, >=98.0% (HPLC), EN300-6473070, Q27447765 C15H15NO2 PECGVEGMRUZOML-CQSZACIVSA-N (2R)-2-amino-3,3-diphenylpropanoic acid n.a. n.a. No No No No No No PMDBD2000366 3,4-Dichloro-5-[(1,3-dichloropropan-2-yloxy)]-2(5H)-furanone n.a. n.a. n.a. n.a. n.a. n.a. n.a. 122208470 n.a. n.a. 3,4-dichloro-5-[(1,3-dichloropropan-2-yloxy)]-2(5h)-furanone C7H6Cl4O3 DVKDIZGFLORAJA-UHFFFAOYSA-N 3,4-dichloro-2-(1,3-dichloropropan-2-yloxy)-2H-furan-5-one n.a. n.a. No No No No No No PMDBD2000367 3,4-Dichloro-5-[(4-methylphenylsulfonyl)]-2(5H)-furanone n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000368 3,4-Dichloro-cinnamaldehyde n.a. n.a. n.a. n.a. n.a. n.a. n.a. 13186065 n.a. n.a. 3-(3,4-Dichlorophenyl)prop-2-enal, 62374-02-1, (E)-3-(3,4-dichlorophenyl)prop-2-enal, (2E)-3-(3,4-DICHLOROPHENYL)PROP-2-ENAL, 3,4-dichloro-cinnamaldehyde, KRIZSOUMJXQNGU-OWOJBTEDSA-N, (E)-3-(3,4-Dichlorophenyl)acrylaldehyde, (trans)-3-(3,4-Dichlorophenyl)-2-propenal, EN300-192925, G54399, EN300-6486198, Z1269224361 C9H6Cl2O KRIZSOUMJXQNGU-OWOJBTEDSA-N (E)-3-(3,4-dichlorophenyl)prop-2-enal n.a. n.a. No No No No No No PMDBD2000369 3,4-Dichlorophenylalanine n.a. n.a. n.a. n.a. n.a. n.a. n.a. 2761498 n.a. n.a. 52794-99-7, (S)-2-Amino-3-(3,4-dichlorophenyl)propanoic acid, L-3,4-Dichlorophenylalanine, 3,4-Dichloro-L-phenylalanine, 3,4-dichlorophenylalanine, (2S)-2-amino-3-(3,4-dichlorophenyl)propanoic acid, H-Phe(3,4-DiCl)-OH, L-3,4-Dichlorophenlalanine, (2S)-2-azaniumyl-3-(3,4-dichlorophenyl)propanoate, L-3,4-DICHLOROPHE, L-3,4-Dichloro phenylalanine, 3,4-di chlorophenylalanine, SCHEMBL43915, (2S)-2-azanyl-3-(3,4-dichlorophenyl)propanoic acid, CHEMBL4866247, DTXSID90967254, H-Phe(3 pound not4-DiCl)-OH, H-PHE(3,4-CL2)-OH, H-L-PHE(3,4-CL2)-OH, MFCD00191203, AKOS012010566, AC-5850, AM82040, CS-W022751, HY-W042011, DS-15296, F12351, EN300-1168597, A829255, Q27467945 C9H9Cl2NO2 NRCSJHVDTAAISV-QMMMGPOBSA-N (2S)-2-amino-3-(3,4-dichlorophenyl)propanoic acid n.a. n.a. No No No No No No PMDBD2000370 3,4-Dimethoxychalcone n.a. n.a. n.a. n.a. n.a. n.a. n.a. 5354494 n.a. n.a. 3,4-Dimethoxychalcone, 5416-71-7, 3-(3,4-dimethoxyphenyl)-1-phenylprop-2-en-1-one, 53744-28-8, 53744-27-7, (E)-3-(3,4-dimethoxyphenyl)-1-phenylprop-2-en-1-one, NSC643172, (2E)-3-(3,4-dimethoxyphenyl)-1-phenylprop-2-en-1-one, 2-Propen-1-one, 3-(3,4-dimethoxyphenyl)-1-phenyl-, (2E)-, 2-Propen-1-one, 3-(3,4-dimethoxyphenyl)-1-phenyl-, Chalcone, 5, Chalcone,4-dimethoxy-, CHEMBL33943, SCHEMBL3133053, BDBM86006, LSHZPTCZLWATBZ-CSKARUKUSA-N, HY-W083373A, NSC11868, MFCD00041327, NSC-11868, NSC204995, NSC237973, AKOS000277526, 3,4-Dimethoxy benzylidene acetophenone, MS-9831, NSC-204995, NSC-237973, NSC-643172, CS-0159082, 2-Propen-1-one,4-dimethoxyphenyl)-1-phenyl-, D85665, (2E)-3-(3,4-dimethoxyphenyl)-1-phenyl-2-propen-1-one, (E)-3-(3,4-dimethoxyphenyl)-1-phenyl-prop-2-en-1-one, 2-Propen-1-one,3-(3,4-dimethoxyphenyl)-1-phenyl-, (2E)- C17H16O3 LSHZPTCZLWATBZ-CSKARUKUSA-N (E)-3-(3,4-dimethoxyphenyl)-1-phenylprop-2-en-1-one n.a. n.a. No No No No No No PMDBD2000371 3,5-dibromotyrosined n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000372 3,5-Difluoro-dl-phenylalanine n.a. n.a. n.a. n.a. n.a. n.a. n.a. 2737045 n.a. n.a. 3,5-difluoro-dl-phenylalanine, 32133-37-2, DL-3,5-Difluorophenylalanine, 2-amino-3-(3,5-difluorophenyl)propanoic Acid, 3,5-difluorophenylalanine, 3,5-Difluoro-D-Phenylalanine, MFCD00061308, 2-Amino-3-(3,5-difluorophenyl)propionic acid, 3,5-Difluoro-L-phenylaniline, MFCD01631988, 2-amino-3-(3,5-difluoro-phenyl)-propionic acid, D-3,5-Difluorophenylalanine, SCHEMBL188320, DTXSID10371798, QFGMPXZFCIHYIR-UHFFFAOYSA-N, CCG-47323, DL-3,5-Difluorophenylalanine, 97%, AKOS015915736, AKOS032963164, AB02433, AB09417, AB09419, AC-9902, CS-W021816, HY-W041076, PS-6487, 3 pound not5-Difluoro-DL-phenylalanine, ACETOPHENONE-2,3,4,5,6-D5, SY044825, SY064472, A50353, EN300-1858212, A818536, A821165, J-018644, SR-01000636947-1, 1(S)-2-amino-3-(3,5-difluorophenyl)propanoic acid, 2-azanyl-3-[3,5-bis(fluoranyl)phenyl]propanoic acid, 2-Amino-3-(3,5-difluorophenyl)propanoic acid, 2-Amino-3-(3,5-difluorophenyl)propionic acid, C9H9F2NO2 QFGMPXZFCIHYIR-UHFFFAOYSA-N 2-amino-3-(3,5-difluorophenyl)propanoic acid n.a. n.a. No No No No No No PMDBD2000373 3,5-Diiodotyrosine Therapeutic Substance Investigational Drug 300-39-0 DB03374 n.a. n.a. D0Z0EF 9305 8946 n.a. 3,5-Diiodo-L-tyrosine, 300-39-0, Diiodotyrosine, L-3,5-Diiodotyrosine, L-Diiodotyrosine, 3,5-DIIODOTYROSINE, (S)-2-Amino-3-(4-hydroxy-3,5-diiodophenyl)propanoic acid, (2S)-2-amino-3-(4-hydroxy-3,5-diiodophenyl)propanoic acid, H-Tyr(3,5-I2)-OH, L-Tyrosine, 3,5-diiodo-, 3,5-L-Diiodotyrosine, 3,5-Iodo-L-tyrosine, DIT (amino acid), H-3,5-Diiodo-Tyr-OH, DiIY, 3,5-Diiodotyrocine, Tyrosine, 3,5-diiodo-, L-, CHEBI:15768, NSC 4143, MFCD00016542, 6L57Q44ZWW, DTXSID0048680, NCGC00163111-01, C9H9I2NO3, DTXCID6028606, Diiodotyrosine, dl-, NSC-208959, CAS-300-39-0, DIOTYROSINE, 3,5-diiodotyrosine dl-form, UNII-6L57Q44ZWW, Dijodtyrosin, NSC-4143, NSC208959, NSC 208959, TYI, EINECS 206-092-0, 3-5-Diiodo-L-tyrosine, Spectrum5_001996, DIIODOTYROSINE, L-, bmse000327, Epitope ID:122959, MLS000028503, SCHEMBL147579, DIIODOTYROSINE [MART.], GTPL6651, CHEMBL1236469, TRYOSINE, 3,5-DIIODO-, 3,5-DIIODOTYROSINE, L-, HMS2230P17, 3,5-DIIODOTYROSINE L-FORM, 4-Hydroxy-3,5-diiodophenylalanine, DIIODOTYROSINE [EP IMPURITY], Tox21_113061, AKOS002276212, Tox21_113061_1, AM83562, DB03374, 3,5-DIIODOTYROSINE L-FORM [MI], NCGC00163111-02, SMR000058274, HY-113214, CS-0059327, D0612, NS00009267, 3,5-Diiodo-L-tyrosine dihydrate, crystalline, C01060, D87842, EN300-155423, Q410521, J-300288, J-300435, LIOTHYRONINE SODIUM IMPURITY B [EP IMPURITY], Z1509614134, (S)-2-Amino-3-(4-hydroxy-3,5-diiodophenyl)propanoicacid, E33DC826-4246-4751-B348-4B31BFB6F996 C9H9I2NO3 NYPYHUZRZVSYKL-ZETCQYMHSA-N (2S)-2-amino-3-(4-hydroxy-3,5-diiodophenyl)propanoic acid n.a. n.a. No No No No No No PMDBD2000374 3,5-Dimethyl benzyl dodecyl beta-maltoside n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000375 3,5-dimethylaniline n.a. n.a. n.a. n.a. n.a. n.a. n.a. 7949 n.a. n.a. 3,5-Dimethylaniline, 108-69-0, 3,5-XYLIDINE, Benzenamine, 3,5-dimethyl-, 1-Amino-3,5-dimethylbenzene, 3,5-Xylylamine, 3,5-Dimethylphenylamine, 3,5-Xylidene, 5-Amino-1,3-xylene, 3,5-Dimethylbenzenamine, 3,5-Dimethylbenzeneamine, 5-Amino-1,3-dimethylbenzene, 3,5-dimethyl aniline, NSC 26880, 3,5-dimethyl-aniline, MFCD00007813, DTXSID8026309, 1418BR6T2H, NSC-26880, 5-Amino-m-xylene, CCRIS 4742, HSDB 2096, Benzene, 1-amino-3,5-dimethyl-, EINECS 203-607-0, m-xylidin, UNII-1418BR6T2H, 3,5dimethylaniline, NSC26880, 3,5 dimethylaniline, 3.5-dimethylaniline, 3, 5-dimethylaniline, 3,5-dimethyl-phenylamine, EC 203-607-0, 3,5-XYLIDENE-, SCHEMBL33318, XYLIDENE, 3,5-, 3,5-Dimethylaniline, 98%, MLS002302997, WLN: ZR C1 E1, DTXCID806309, 3,5-XYLIDINE [HSDB], CHEMBL1603782, HMS3039G12, STR00834, Tox21_200232, AKOS000119347, AM61282, CS-W001076, PS-3011, XYLIDINE 3,5-DIMETHYLBENZENAMINE, NCGC00091402-01, NCGC00091402-02, NCGC00257786-01, AC-10848, CAS-108-69-0, SMR001307312, D0671, NS00008073, EN300-20193, XYLIDINE 3,5-DIMETHYLBENZENAMINE [MI], 3,5-Dimethylaniline, technical, >=97.0% (GC), J-511355, Q27251562, F2190-0467, Z104477214, InChI=1/C8H11N/c1-6-3-7(2)5-8(9)4-6/h3-5H,9H2,1-2H C8H11N MKARNSWMMBGSHX-UHFFFAOYSA-N 3,5-dimethylaniline n.a. n.a. No No No No No No PMDBD2000376 3-[(prop-2-ene-1-sulfinyl)sulfanyl]prop-1-ene Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D0X9YD 65036 n.a. NPC2088 "Allicin, 539-86-6, Diallyl thiosulfinate, S-allyl prop-2-ene-1-sulfinothioate, Diallyldisulfid-S-oxid, Thio-2-propene-1-sulfinic acid S-allyl ester, Allylthiosulphinic acid allyl ester, 2-Propene-1-sulfinothioic acid, S-2-propenyl ester, DADSO, S-Allyl acrylo-1-sulphinothioate, CCRIS 9053, S-allyl 2-propene-1-sulfinothioate, EINECS 208-727-7, UNII-3C39BY17Y6, BRN 1752823, 3-prop-2-enylsulfinylsulfanylprop-1-ene, 2-Propene-1-sulfinothioic acid S-2-propenyl ester, CHEBI:28411, 3C39BY17Y6, 2-Propene-1-sulfinic acid, thio-, S-allyl ester, CHEMBL359965, DTXSID6043707, 3-[(prop-2-ene-1-sulfinyl)sulfanyl]prop-1-ene, 4-04-00-00007 (Beilstein Handbook Reference), S-prop-2-en-1-yl prop-2-ene-1-sulfinothioate, S-2-PROPEN-1-YL 2-PROPENE-1-SULFINOTHIOATE, allimin, diallyl disulfide-oxide, C6H10OS2, allylthiosulfinate, allitridi, Allicin kit, 3-allylsulfinylsulfanylprop-1-ene, Allicin, tech. grade, Diallyldisulfid-S-oxide, Allicin (not validated), Dianyctrsnlgide;Allisatin, ALLICIN [MI], ALLICIN [WHO-DD], ALLICIN(TECH GRADE), SCHEMBL2920, 2-propene-1-sulfinothioic acid, Allicin (Allyl-S(O)S-Allyl), GTPL2419, DTXCID4023707, 3-allylsulfinylsulfanyl-prop-1-ene, BCP08391, HY-N0315, BDBM50240948, MFCD00468100, NSC707388, s3860, AKOS006282482, ALLICIN (CONSTITUENT OF GARLIC), CCG-266298, DB11780, FD10435, NSC-707388, 3-(prop-2-enylsulfinylthio)-1-propene, AC-34150, XA162045, XA176305, CS-0008813, NS00032908, NS00115953, ALLICIN (CONSTITUENT OF GARLIC) [DSC], C07600, EN300-217463, S-2-Propenyl 2-propene-1-sulfinothioate, 9CI, A829889, Q409641, Q-200609, 2-Propene-1-sulfinothioic acid, S-2-propenyl ester (9CI), Diallyl thiosulfinate and Allylthiosulphinic acid allyl ester, Diallyldisulfid-S-oxid, 3-prop-2-enylsulfinylsulfanylprop-1-ene" C6H10OS2 JDLKFOPOAOFWQN-UHFFFAOYSA-N 3-prop-2-enylsulfinylsulfanylprop-1-ene n.a. n.a. No No No No No No PMDBD2000377 3-{2-[(1S,2R,4aR,8aR)-1,2,4a,5-tetramethyl-1,2,3,4,4a,7,8,8a-octahydronaphthalen-1-yl]ethyl}-5-methylidene-N-phenyl-2,5-dihydrofuran-2-amine n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000378 3-{2-[(1S,2R,4aR,8aR)-1,2,4a,5-tetramethyl-1,2,3,4,4a,7,8,8a-octahydronaphthalen-1-yl]ethyl}-N-(2-fluorophenyl)-5-methylidene-2,5-dihydrofuran-2-amine n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000379 3-{2-[(1S,2R,4aR,8aR)-1,2,4a,5-tetramethyl-1,2,3,4,4a,7,8,8a-octahydronaphthalen-1-yl]ethyl}-N-(3-fluorophenyl)-5-methylidene-2,5-dihydrofuran-2-amine n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000380 3-Amino-4-(2,4-difluorophenyl)-2-butanone n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000381 3beta-Hydroxyolean-12-en-28-al 3-p-coumarate n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000382 3-bromo-5-methoxy-4-[(4-methylphenylsulfanyl)]-2(5H)-furanone n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000383 3-Bromophenylalanine n.a. n.a. n.a. n.a. n.a. n.a. n.a. 554078 n.a. n.a. 30163-20-3, 2-amino-3-(3-bromophenyl)propanoic acid, 3-Bromo-DL-phenylalanine, H-DL-Phe(3-Br)-OH, dl-3-Bromophenylalanine, (S)-2-amino-3-(3''-bromophenyl)propanoic acid, MFCD05227935, 3-Bromophenylalanine, DL-3-BR-PHE-OH, MFCD06659100, MFCD06659110, 3-Bromophenylalanine #, SCHEMBL44026, 2-AMINO-3-(3-BROMO-PHENYL)-PROPIONIC ACID, DTXSID20339142, AKOS000193022, AKOS016843197, AKOS025213184, AB21654, AB25926, AB25927, AM82710, CS-W003225, DS-2410, HY-W003225, 5-ACETYLAMINO-3-NITRO1,2-XYLIN, PD196410, SY023878, SY023879, SY026457, 2-azanyl-3-(3-bromophenyl)propanoic acid, EN300-156472, A820229, A840298, Q-101730, F2147-6547 C9H10BrNO2 GDMOHOYNMWWBAU-UHFFFAOYSA-N 2-amino-3-(3-bromophenyl)propanoic acid n.a. n.a. No No No No No No PMDBD2000384 3-Carbamoylphenylalanine n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000385 3-Chloro-5-[(2-chloroethoxy)]-4-[(4-methylphenylsulfanyl)]-2(5H)-furanone n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000386 3-chloro-5-hydroxy-4-[(4-methylphenylsulfanyl)]-2(5H)-furanone n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000387 3-chloro-5-hydroxy-4-[(4-methylphenylsulfonyl)]-2(5H)-furanone n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000388 3-Chlorotyrosine Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D0X6LZ 110992 n.a. n.a. 3-Chloro-L-tyrosine, 3-Chlorotyrosine, 7423-93-0, 3-Cl-Tyr-OH, (S)-2-Amino-3-(3-chloro-4-hydroxyphenyl)propanoic acid, (2S)-2-amino-3-(3-chloro-4-hydroxyphenyl)propanoic acid, SY44C9MINA, 3-chloro-4-hydroxy-L-phenylalanine, MFCD00045865, chlorotyrosine, (2S)-2-azaniumyl-3-(3-chloro-4-hydroxyphenyl)propanoate, Tyrosine, 3-chloro-, CLY, 3-Chloro-DL-tyrosine, L-Tyrosine, 2-chloro-, L-Tyrosine, 3-chloro-, UNII-SY44C9MINA, Tyrosine, 3-chloro-, L-, m-chlorotyrosine, meta-chlorotyrosine, EINECS 231-050-3, H-Tyr(3-Cl)-OH, SCHEMBL28512, 3-Chloro-L-tyrosine, 97%, 3-chloro-4-hydroxyphenylalanine, CHEMBL3808682, CHEBI:53678, DTXSID801315678, 3-chloro-4-hydroxy-1-phenylalanine, s6106, AKOS010366957, AM83547, CS-W021911, HY-W041171, AC-14498, DS-15329, PD099448, J278.826H, NS00047775, M03243, Q27124161, S-7423-93-0 C9H10ClNO3 ACWBBAGYTKWBCD-ZETCQYMHSA-N (2S)-2-amino-3-(3-chloro-4-hydroxyphenyl)propanoic acid n.a. n.a. No No No No No No PMDBD2000389 3-fluoroaniline n.a. n.a. n.a. n.a. n.a. n.a. n.a. 9742 n.a. n.a. "3-FLUOROANILINE, 372-19-0, m-Fluoroaniline, 1-Amino-3-fluorobenzene, Benzenamine, 3-fluoro-, 3-Fluoranilin, 3-Fluorobenzenamine, 3-Fluoro-phenylamine, Aniline, 3-fluoro-, Aniline, m-fluoro-, m-fluorophenylamine, m-aminofluorobenzene, NSC 10300, MFCD00007758, TLL4X88AZP, CHEBI:27873, NSC-10300, 3-fluorophenylamine, 3-Fluoranilin [Czech], EINECS 206-747-0, BRN 1305471, 3-flouroaniline, 5-fluoroaniline, 3-fluoraniline, AI3-28559, meta-fluoroaniline, 3-fluoro aniline, 3-fluoro-aniline, 3-fluro-phenylamine, m-Fluoro phenylamine, 3-fluorophenyl amine, 3-fluorobenzenaminium, 1,3-fluorobenzenamine, 3-Fluoroaniline, 99%, UNII-TLL4X88AZP, WLN: ZR CF, SCHEMBL33929, 4-12-00-01101 (Beilstein Handbook Reference), CHEMBL58888, 4-AMINO-2-FLUOROBENZENE, DTXSID10190683, BCP13758, NSC10300, AKOS000119146, AM86913, CS-W020419, PS-9262, F0101, NS00042187, 3-Fluoroaniline, technical, >=97.0% (GC), 3-Fluorobenzenamine; 1-Amino-3-fluorobenzene, EN300-19094, A19472, m-Fluoroaniline [UN2941] [Keep away from food], W-106560, Q27103382, F2190-0426, InChI=1/C6H6FN/c7-5-2-1-3-6(8)4-5/h1-4H,8H" C6H6FN QZVQQUVWFIZUBQ-UHFFFAOYSA-N 3-fluoroaniline n.a. n.a. No No No No No No PMDBD2000390 3-Fluoro-DL-phenylalanine n.a. n.a. n.a. n.a. n.a. n.a. n.a. 9976 n.a. n.a. 3-Fluoro-dl-phenylalanine, 456-88-2, 2629-54-1, H-DL-PHE(3-F)-OH, 3-Fluorophenylalanine, 2-amino-3-(3-fluorophenyl)propanoic acid, m-Fluorophenylalanine, DL-3-Fluorophenylalanine, m-Fluoro-dl-phenylalanine, DL-Phenylalanine, 3-fluoro-, Alanine, (3-fluorophenyl)-, Phenylalanine, 3-fluoro-, DL-3-(3-Fluorophenyl)alanine, MFCD00004273, ALANINE, 3-(m-FLUOROPHENYL)-, NSC 208960, 2-Amino-3-(3-fluoro-phenyl)-propionic acid, 3-Fluoro-3-phenylalanine, m-Fluorophenylalanine (VAN), Alanine, 3-(m-fluorophenyl)-, DL-, 3-fluoro phenylalanine, EINECS 207-272-1, MFCD00066449, MFCD00066450, EINECS 220-104-1, NSC 41871, 2-Amino-3-(3-fluorophenyl)propionic Acid, 2-Cyclopentylacetophenone, WLN: QVYZ1R CF, H-DL-3-F-Phe-OH, URSOLICACIDMETHYLESTER, SCHEMBL42948, CHEMBL50636, FLUORO-DL-PHENYLALANINE, (3-FLUOROPHENYL)ALANINE, NSC41871, NSC-41871, NSC208960, AKOS000168457, AKOS016843009, AB00349, AB02698, AB02699, AC-9898, AM83338, CS-W017055, HY-W016339, NSC-208960, PS-6600, SY035269, SY035324, SY046381, F0169, EN300-142283, A872345, J-300400, F2147-6669 C9H10FNO2 VWHRYODZTDMVSS-UHFFFAOYSA-N 2-amino-3-(3-fluorophenyl)propanoic acid n.a. n.a. No No No No No No PMDBD2000391 3-geranyl-1-(2-methylbutanoyl)phloroglucinol n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000392 3-geranyl-1-(2-methylpropanoyl)phloroglucinol n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000393 3-hexyl-4-bromo-5-methylene-2(5H)-furanone n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000394 3-hexyl-5-bromomethylene-2(5H)-furanone n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000395 3-hydroxychalcone n.a. n.a. n.a. n.a. n.a. n.a. n.a. 5358381 n.a. n.a. 3-(3-hydroxyphenyl)-1-phenylprop-2-en-1-one, (E)-3-(3-hydroxyphenyl)-1-phenylprop-2-en-1-one, 81226-95-1, 20426-49-7, 3-Hydroxychalcone, Chalcone, 2, 3-hydroxy chalcone, NSC247056, CHEMBL388322, SCHEMBL1524799, BDBM86003, FGLRWHNZUBAWJK-MDZDMXLPSA-N, MFCD00205550, 1-Phenyl-3-m-hydroxyphenyl-propenone, AKOS002719605, NSC-247056, 2-Propen-1-one, 3-(3-hydroxyphenyl)-1-phenyl-, (E)-3-(3-hydroxyphenyl)-1-phenyl-prop-2-en-1-one, (2E)-3-(3-Hydroxyphenyl)-1-phenyl-2-propen-1-one # C15H12O2 FGLRWHNZUBAWJK-MDZDMXLPSA-N (E)-3-(3-hydroxyphenyl)-1-phenylprop-2-en-1-one n.a. n.a. No No No No No No PMDBD2000396 3-Hydroxyphenylalanine Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D05XGI 6950578 n.a. NPC30324 L-m-Tyrosine, 587-33-7, 3-HYDROXY-L-PHENYLALANINE, Meta-Tyrosine, (S)-2-amino-3-(3-hydroxyphenyl)propanoic acid, 3-tyrosine, 3-Hydroxyphenylalanine, m-Tyrosine, L-META-TYROSINE, m-L-Tyrosine, (2S)-2-amino-3-(3-hydroxyphenyl)propanoic acid, 3-(m-Hydroxyphenyl)alanine, L-(-)-m-Tyrosine, L-mTyr, L-Phenylalanine, 3-hydroxy-, m-Tyrosine, L-, CHEBI:44303, L-M-TYR, MFCD00063059, D5YF57V4QW, CHEMBL1232501, L-3-hydroxyphenylalanine, UNII-D5YF57V4QW, (2S)-2-azaniumyl-3-(3-hydroxyphenyl)propanoate, Tyrosine, meta-, MTY, M-TYROSINE [MI], 3-TYROSINE L-, M-L-TYR-OH, H-PHE(3-OH)-OH, SCHEMBL147042, DTXSID60871778, BDBM50463214, AKOS005259649, AKOS012010213, AM83354, CS-W017159, DB03552, HY-W016443, AS-16026, NS00042619, A13202, A26752, C20807, EN300-247349, AU-004/43509530, Q27096325, 65FEA9F8-AC27-4B7E-9E2A-F5D485E5839E, Z995228186, (S)-2-Amino-3-(3-hydroxyphenyl)propanoic acid m-L-Tyr-OH C9H11NO3 JZKXXXDKRQWDET-QMMMGPOBSA-N (2S)-2-amino-3-(3-hydroxyphenyl)propanoic acid n.a. n.a. No No No No No No PMDBD2000397 3-Hydroxytyrosine n.a. n.a. n.a. n.a. n.a. n.a. n.a. 836 n.a. n.a. "DL-DOPA, 63-84-3, 3,4-Dihydroxy-DL-phenylalanine, 2-Amino-3-(3,4-dihydroxyphenyl)propanoic acid, 3-(3,4-Dihydroxyphenyl)-DL-alanine, dihydroxyphenylalanine, 3-Hydroxytyrosine, DL-Dioxyphenylalanine, Dopa, DL-Dihydroxyphenylalanine, DL-Tyrosine, 3-hydroxy-, 3-Hydroxy-DL-tyrosine, DL-3,4-Dopa, DL-3-Hydroxytyrosine, (R,S)-Dopa, (+-)-Dopa, DL-beta-(3,4-Dihydroxyphenyl)alanine, 3'',4''-Dihydroxyphenylalanine, (+-)-3-(3,4-Dihydroxyphenyl)alanine, MFCD00063060, 2-amino-3-(3,4-dihydroxy-phenyl)-propionic acid, D-B-3,4-Dihydroxyphenylalanine, CHEBI:49168, QI9C343R60, ALANINE, 3-(3,4-DIHYDROXYPHENYL)-, DL-, NSC-16940, D-Tyrosine, 3-hydroxy-, D-3-Hydroxytyrosine, dl-3,4-Dihydroxyphenylalanine, WLN: QVYZ1R CQ DQ, EINECS 200-566-0, NSC 16940, UNII-QI9C343R60, AI3-23874, 3-(3,4-Dihydroxyphenyl)-D-alanine, NSC-118368, beta-(3,4-Dihydroxyphenyl)-alpha-alanine, Alanine, 3-(3,4-dihydroxyphenyl)-, D-, Tyrosine, 3-hydroxy-, DOPA DL-FORM, DOPA, DL-, DOPA DL-FORM [MI], SCHEMBL24360, alpha-amino-Hydrocaffeic acid, (.+-.)-Dopa, 3,4-Dihydroxyphenylalanine #, DL-4,5-Dihydroxyphenylalanine, BDBM4377, CHEMBL351042, DL-DOPA; DL-Dioxyphenylalanine, DTXSID8020549, Alanine,4-dihydroxyphenyl)-, D-, DL-3'',4''-Dihydroxyphenylalanine, 3(3,4-Dihydroxyphenyl)dl-alanine, Alanine,4-dihydroxyphenyl)-, DL-, BCP25747, NSC16940, b-(3,4-Dihydroxyphenyl)-a-alanine, DL-b-(3,4-Dihydroxyphenyl)alanine, NSC118368, (.+-.)-3,4-Dihydroxyphenylalanine, AKOS001132704, AKOS016843592, 3,4-Dihydroxy-DL-phenylalanine, 97%, GS-6861, PB43103, a-amino-3,4-dihydroxy-Benzenepropanoate, L-dopa; 3,4-Dihydroxy-L-phenylalanine, NCGC00015384-02, NCGC00015384-03, NCGC00095195-01, NCGC00095195-02, (+/-) 3-(3,4-Dihydroxyphenyl)alanine, AS-81574, BP-12841, DL-.beta.-(3,4-Dihydroxyphenyl)alanine, SY010977, SY343921, (.+-.)-3-(3,4-Dihydroxyphenyl)alanine, DL-Alanine, 3-(3,4-dihydroxy-phenyl)-, (+/-)-3,4-DIHYDROXYPHENYLALANINE, 2-Amino-3-(3,4-dihydroxyphenyl)propanoate, alpha-amino-3,4-dihydroxy-Benzenepropanoate, HY-113404, a-amino-3,4-dihydroxy-Benzenepropanoic acid, CS-0059346, D0599, D9503, dl-beta-(3,4-Dihydroxyphenyl)-alpha-alanine, NS00006424, S6083, beta-(3,4-Dihydroxyphenyl)-DL-alpha-alanine, EN300-52489, alpha-amino-3,4-dihydroxy-Benzenepropanoic acid, H11952, .beta.-(3,4-Dihydroxyphenyl)-DL-.alpha.-alanine, A834552, L001274, Q27121510, DD916368-6635-446F-AF55-7B416FD65026, IM3" C9H11NO4 WTDRDQBEARUVNC-UHFFFAOYSA-N 2-amino-3-(3,4-dihydroxyphenyl)propanoic acid n.a. n.a. No No No No No No PMDBD2000398 3-indolylacetonitrile n.a. n.a. n.a. n.a. n.a. n.a. n.a. 351795 n.a. NPC279081 3-Indoleacetonitrile, 771-51-7, Indole-3-acetonitrile, 2-(1H-indol-3-yl)acetonitrile, 3-Indolylacetonitrile, 1H-Indole-3-acetonitrile, 3-(Cyanomethyl)indole, Indolylacetonitrile, Indoleacetonitrile, Indolylacetonitril, 3-Indolacetonitrile, Acetonitrile, 3-indolyl-, 1H-Indol-3-ylacetonitrile, Indol-3-ylacetonitrile, (3-Indolyl)acetonitrile, USAF CB-29, (indol-3-yl)acetonitrile, 3-Cyanomethyl-1H-indole, (1H-indol-3-yl)-acetonitrile, NSC 523272, Indolyl-3-acetonitrile, AG97OFW8JW, (Indole-3-yl)acetonitrile, (1H-Indol-3-yl)acetonitrile, CHEMBL1812654, CHEBI:17566, MFCD00005628, NSC-523272, IAN, CCRIS 5807, EINECS 212-232-1, BRN 0125488, AI3-50105, 3-cyanomethylindole, b-Indoleacetonitrile, beta-Indoleacetonitrile, 3-indolyl-Acetonitrile, indole-3-ylacetonitrile, .beta.-Indoleacetonitrile, UNII-AG97OFW8JW, beta-indole-3-acetonitrile, bmse000488, 1H-indole-3-ylacetonitrile, 3-Indoleacetonitrile, 98%, 5-22-03-00074 (Beilstein Handbook Reference), 1H-Indol-3-ylacetonitrile #, BIDD:GT0196, SCHEMBL149254, WLN: T56 BMJ D1CN, 2(1H-indol-3-yl)acetonitrile, AMY871, DTXSID5061118, DMCPFOBLJMLSNX-UHFFFAOYSA-, 2-(1H-indol-3-yl)ethanenitrile, 2-(1H-indol-3-yl)-acetonitrile, GLXC-26570, HY-Y0136, BDBM50350241, NSC523272, s6043, AKOS000120379, CS-W008768, MB00159, PS-3276, AC-10572, PD124092, I0024, NS00014724, EN300-20368, 3-Indoleacetonitrile, purum, >=96.0% (GC), C02938, I-5650, A838975, BRD-K65452854-001-01-5, Q27102461, Z104477894, 71C17B3A-CA19-4822-A4E7-D424F7074B4C, InChI=1/C10H8N2/c11-6-5-8-7-12-10-4-2-1-3-9(8)10/h1-4,7,12H,5H2, 3BO C10H8N2 DMCPFOBLJMLSNX-UHFFFAOYSA-N 2-(1H-indol-3-yl)acetonitrile n.a. n.a. No No No No No No PMDBD2000399 3-Iodotyrosine Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D0CI3A 439744 n.a. n.a. 3-Iodo-L-tyrosine, 70-78-0, H-Tyr(3-I)-OH, 3-IODOTYROSINE, Monoiodotyrosine, L-Tyrosine, 3-iodo-, (S)-2-Amino-3-(4-hydroxy-3-iodophenyl)propanoic acid, 3-IODO-TYROSINE, IODOTYROSINE, (2S)-2-amino-3-(4-hydroxy-3-iodophenyl)propanoic acid, 3-Monoiodo-L-tyrosine, 3-Iodo-4-hydroxyphenylalanine, Tyrosine, 3-iodo-, L-, Tyrosine, 3-iodo-, MLS000069664, FRQ98U4U27, CHEBI:27847, MFCD00002608, H-3-Iodo-Tyr-OH, SMR000059143, IYR, UNII-FRQ98U4U27, NSC-210787, EINECS 200-744-8, L-Tyrosine-3-iodo, IOTYROSINE, NSC 210787, bmse000337, Lopac0_000673, 3-IODOTYROSINE [MI], 4-Hydroxy-3-iodophenylalanine, SCHEMBL159412, 3-Iodo-L-tyrosine (I-Tyr), CHEMBL479789, cid_439744, DTXSID1075353, BDBM37633, 4-Hydroxy-3-iodophenylalanine #, HMS3262G07, Tox21_500673, S(-)-3-Iodo-4-hydroxyphenylalanine, s6044, H-Tyr(3-l)-OH 3-Iodo-L-tyrosine, AKOS015919312, AC-7495, AM83577, CCG-204759, CS-W008452, DB01758, HY-W008452, LP00673, SDCCGSBI-0050652.P002, NCGC00022269-03, NCGC00022269-04, NCGC00022269-05, NCGC00022269-06, NCGC00261358-01, AS-18515, 3-Iodo-L-tyrosine, >=99.0% (HPLC), EU-0100673, I0075, NS00015014, C02515, I 8250, I-7700, M06129, EN300-6495864, Q410703, SR-01000075606, SR-01000075606-1, (2S)-2-amino-3-(4-hydroxy-3-iodophenyl)propanoate, Z1269198907, (2S)-2-amino-3-(4-hydroxy-3-iodo-phenyl)propionic acid, (2S)-2-azanyl-3-(3-iodanyl-4-oxidanyl-phenyl)propanoic acid, 1E933C28-2631-4076-821D-3F47E9A1B023 C9H10INO3 UQTZMGFTRHFAAM-ZETCQYMHSA-N (2S)-2-amino-3-(4-hydroxy-3-iodophenyl)propanoic acid n.a. n.a. No No No No No No PMDBD2000400 3-Methoxychalcone n.a. n.a. n.a. n.a. n.a. n.a. n.a. 5367166 n.a. n.a. 3-Methoxychalcone, 3-(3-methoxyphenyl)-1-phenylprop-2-en-1-one, (E)-3-(3-methoxyphenyl)-1-phenylprop-2-en-1-one, CHEMBL318170, NSC636919, m-Methoxychalcone, Chalcone, 3-methoxy-, 3-Methoxystyryl phenyl ketone, SCHEMBL8987297, IWFHVAAFIDSBRL-ZHACJKMWSA-N, 5470-91-7, BDBM50440653, MFCD00205551, AKOS008685409, NSC-636919, 3-(3-methoxyphenyl)-1-phenyl-2-propen-1-one, AD-276/30562005, (E)-3-(3-methoxyphenyl)-1-phenyl-prop-2-en-1-one, (2E)-3-(3-Methoxyphenyl)-1-phenyl-2-propen-1-one # C16H14O2 IWFHVAAFIDSBRL-ZHACJKMWSA-N (E)-3-(3-methoxyphenyl)-1-phenylprop-2-en-1-one n.a. n.a. No No No No No No PMDBD2000401 3-Methoxy-D-Phenylalanine n.a. n.a. n.a. n.a. n.a. n.a. n.a. 10420176 n.a. n.a. 3-Methoxy-D-Phenylalanine, 145306-65-6, D-Phenylalanine, 3-methoxy-, (2R)-2-amino-3-(3-methoxyphenyl)propanoic acid, (R)-2-Amino-3-(3-methoxy-phenyl)-propionic acid, (R)-2-AMINO-3-(3-METHOXYPHENYL)PROPANOIC ACID, H-D-PHE(3-OME)-OH, SCHEMBL4596077, DTXSID80439576, MFCD03788082, AKOS015995150, AM83393, AC-24594, DS-13844, CS-0172616, (R)-2-Amino-3-(3-methoxyphenyl)propanoicacid, J-512790 C10H13NO3 XTXGLOBWOMUGQB-SECBINFHSA-N (2R)-2-amino-3-(3-methoxyphenyl)propanoic acid n.a. n.a. No No No No No No PMDBD2000402 3-Methyl-D-phenylalanine n.a. n.a. n.a. n.a. n.a. n.a. n.a. 6993650 n.a. n.a. 114926-39-5, (R)-2-Amino-3-(m-tolyl)propanoic acid, 3-Methyl-D-phenylalanine, D-3-Methylphenylalanine, (2R)-2-amino-3-(3-methylphenyl)propanoic acid, D-3-METHYLPHE, D-PHENYLALANINE, 3-METHYL-, 3-Methy-D-Phenylalanine, (R)-2-Amino-3-(m-tolyl)propanoicacid, MFCD01860871, (R)-2-amino-3-m-tolylpropanoic acid, D-3-Methyl Phenylalanine, SCHEMBL1795728, JZRBSTONIYRNRI-SECBINFHSA-N, DTXSID601312961, AKOS016843520, AC-9922, AM83419, CS-W017263, HY-W016547, PS-12171, A13012, D-3-Methylphenylalanine (H-D-Phe(3-Me)-OH), EN300-199890, F12207 C10H13NO2 JZRBSTONIYRNRI-SECBINFHSA-N (2R)-2-amino-3-(3-methylphenyl)propanoic acid n.a. n.a. No No No No No No PMDBD2000403 3-Nitro-D-tyrosine n.a. n.a. n.a. n.a. n.a. n.a. n.a. 759471 n.a. n.a. 3-nitro-d-tyrosine, 32988-39-9, (R)-2-Amino-3-(4-hydroxy-3-nitrophenyl)propanoic acid, (2R)-2-amino-3-(4-hydroxy-3-nitrophenyl)propanoic acid, SCHEMBL4502044, (R)-2-Amino-3-(4-hydroxy-3-nitrophenyl)propanoicacid, CHEBI:86270, DTXSID70353959, MFCD02684446, AKOS015955703, AS-57429, CS-0210257, N-8190, Q27159043 C9H10N2O5 FBTSQILOGYXGMD-ZCFIWIBFSA-N (2R)-2-amino-3-(4-hydroxy-3-nitrophenyl)propanoic acid n.a. n.a. No No No No No No PMDBD2000404 3-Nitrophenylalanine n.a. n.a. n.a. n.a. n.a. n.a. n.a. 2761812 n.a. n.a. 19883-74-0, (S)-2-amino-3-(3-nitrophenyl)propanoic acid, 3-Nitro-L-phenylalanine, L-3-NITROPHENYLALANINE, L-Phenylalanine, 3-nitro-, (2S)-2-amino-3-(3-nitrophenyl)propanoic acid, NSC-21948, L-3-Nitrophe, 3-nitrophenylalanine, MFCD01860661, 3-Nitrophenylalanine, L-, Q9MP3V7QQV, (S)-2-Amino-3-(3-nitrophenyl)propanoicacid, H-Phe(3-NO2)-OH, NCIStruc1_000602, NCIStruc2_000493, SCHEMBL44005, CHEMBL1449772, DTXSID601313707, BCP11570, NCI21948, Alanine, 3-(m-nitrophenyl)-, L-, CCG-37980, NCGC00013280, AKOS015891099, AC-7951, AM83445, HY-W050494, NCGC00013280-02, NCGC00096399-01, AS-19756, PD197213, CS-0042825, (2S)-2-azaniumyl-3-(3-nitrophenyl)propanoate, (S)-2-Amino-3-(3-nitrophenyl)propionic acid, EN300-316583, A814032, J-012842 C9H10N2O4 YTHDRUZHNYKZGF-QMMMGPOBSA-N (2S)-2-amino-3-(3-nitrophenyl)propanoic acid n.a. n.a. No No No No No No PMDBD2000405 3-oxo-C6-HSL n.a. n.a. n.a. n.a. n.a. n.a. n.a. 688505 n.a. NPC145658 N-(3-Oxohexanoyl)-L-homoserine lactone, 143537-62-6, N-(beta-Ketocaproyl)-L-homoserine lactone, N-(Ketocaproyl)-L-homoserine Lactone, (S)-3-oxo-N-(2-oxotetrahydrofuran-3-yl)hexanamide, CHEBI:63789, 3-oxo-N-[(3S)-2-oxooxolan-3-yl]hexanamide, 3-oxo-N-[(3S)-2-oxotetrahydrofuran-3-yl]hexanamide, CHEMBL458201, (S)-3-(3-oxohexanamido)butyrolactone, (S)-3-(3-ketohexanamido)butyrolactone, N-(3-ketocaproyl)-L-homoserine lactone, N-(3-ketohexanoyl)-L-homoserine lactone, (S)-3-(3-oxohexanamido)-2-oxotetrahydrofuran, (S)-3-(3-ketohexanamido)-2-oxotetrahydrofuran, VAI-1, AI-1 (Vibrio fischeri), Autoinducer I, OHHL, 3-Oxo-C6-HSL, SCHEMBL136646, 3-Oxohexanoyl-homoserine lactone, autoinducer 1 (Vibrio fischeri), autoinducer 1 (Aliivibrio fischeri), L-3-Oxo-hexanoyl-homoserine lactone, BDBM50526999, MFCD00171363, AKOS040745056, CS-W009522, HY-W008806, N-( beta -ketocaproyl)-L-Homoserine lactone, N-(.beta.-Ketocaproyl)-L-homoserine lactone, C21198, Y13555, N-3-oxohexanoyl)-3-aminodihydro-2(3H)-furanone, N-(beta-Ketocaproyl)-L-homoserine lactone, >=98%, Q27132806, Hexanamide, 3-oxo-N-[(3S)-tetrahydro-2-oxo-3-furanyl]- C10H15NO4 YRYOXRMDHALAFL-QMMMGPOBSA-N 3-oxo-N-[(3S)-2-oxooxolan-3-yl]hexanamide n.a. n.a. No No No No No No PMDBD2000406 3-oxo-C8-HSL n.a. n.a. n.a. n.a. n.a. n.a. n.a. 127293 n.a. n.a. 147795-39-9, N-(3-Oxooctanoyl)-L-homoserine lactone, N-3-oxo-octanoyl-L-Homoserine lactone, 3-oxo-N-[(3S)-2-oxooxolan-3-yl]octanamide, 3-OXO-OCTANOIC ACID (2-OXO-TETRAHYDRO-FURAN-3-YL)-AMIDE, N-(3-Oxooctanoyl)homoserine lactone, Octanamide, 3-oxo-N-[(3S)-tetrahydro-2-oxo-3-furanyl]-, N-(beta-Oxooctan-1-oyl)homoserine lactone, CHEMBL463321, MFCD08277025, N-(3-oxo-octanoyl)-homoserine lactone, OOHL, Aai-OOHL, CF1, A. Tumefaciens, N-(beta-Ketooctanoyl)-L-hsl, Conjugation factor 1, agrobacterium, N-(3-Oxo-octanoyl)-L-homoserine lactone, 3-oxo-C8-HSL, AI-1 (A. tumefaciens), N-(beta-Oxooctan-1-oyl)-L-homoserine lactone, AAI-1, N-(3-OXO-OCTANAL-1-YL)-HOMOSERINE LACTONE, SCHEMBL1080050, autoinducer 1 (A. tumefaciens), DTXSID60163802, FXCMGCFNLNFLSH-JTQLQIEISA-N, N-(beta-Ketooctanoyl)-L-homoserine, BDBM50351511, LMFA08030004, DB08081, N-beta-oxo-octanoyl-L-Homoserine lactone, PD004806, TS-08991, HY-108700, CS-0030129, NS00069825, G76771, J-008413, 3-oxo-N-[(3S)-2-oxotetrahydrofuran-3-yl]octanamide, Q27097310, 3-Oxo-N-[(3S)-tetrahydro-2-oxo-3-furanyl]octanamide, Z3301590447, Octanamide, 3-oxo-N-(tetrahydro-2-oxo-3-furanyl)-, (S)-, N-(3-Oxooctanoyl)-L-homoserine lactone, >=97% (HPLC), white powder C12H19NO4 FXCMGCFNLNFLSH-JTQLQIEISA-N 3-oxo-N-[(3S)-2-oxooxolan-3-yl]octanamide n.a. n.a. No No No No No No PMDBD2000407 3-tetra- decanoyltetronic n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000408 3-tetradecanoylthiotetronic n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000409 4 alpha, 5 alpha-epoxy-10 alpha, 14H-1-epi-inuviscolide n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000410 4-(2-(5-(4,5-dibromo-1-methyl-1H-pyrrol-2-yl)-1,3,4-oxadiazol-2-yl)vinyl)-2-methoxyphenol n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000411 4-(2-methybutyryl)-4H-tomentosin n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000412 4-(5-(4,5-dibromo-1-methyl-1H-pyrrol-2-yl)-1,3,4-oxadiazole-2-yl)aniline n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000413 4-(Aminomethyl)-D-phenylalanine n.a. n.a. n.a. n.a. n.a. n.a. n.a. 7018015 n.a. n.a. 1217662-97-9, (R)-2-Amino-3-(4-(aminomethyl)phenyl)propanoic acid, D-4-Aminomethylphe, (2R)-2-amino-3-[4-(aminomethyl)phenyl]propanoic acid, SCHEMBL662103, (R)-2-Amino-3-(4-(aminomethyl)phenyl)propanoicacid, 4-(aminomethyl)-D-phenylalanine, DTXSID10426934, D-Phenylalanine, 4-(aminomethyl)-, MFCD06659099, AKOS016844004, PS-12804, D-4-Aminomethylphenylalanine (H-D-Phe(4-MeNH2)-OH), Q27452038 C10H14N2O2 GNVNKFUEUXUWDV-SECBINFHSA-N (2R)-2-amino-3-[4-(aminomethyl)phenyl]propanoic acid n.a. n.a. No No No No No No PMDBD2000414 4-(Trifluoromethyl)-D-phenylalanine n.a. n.a. n.a. n.a. n.a. n.a. n.a. 7004189 n.a. n.a. 114872-99-0, 4-(Trifluoromethyl)-D-phenylalanine, 4-Trifluoromethyl-D-Phenylalanine, D-4-Trifluoromethylphenylalanine, D-Phenylalanine, 4-(trifluoromethyl)-, (R)-2-AMINO-3-(4-(TRIFLUOROMETHYL)PHENYL)PROPANOIC ACID, H-D-PHE(4-CF3)-OH, MFCD01860876, D-4-TRIFLUOROMETHYLPHE, SCHEMBL148122, H-D-Phe(4-CF3)-OHHCl, CRFFPDBJLGAGQL-MRVPVSSYSA-N, AKOS015853779, AC-5865, AM83499, HY-W141809, AS-20111, CS-0201606, F52518, Q27466070, 4-(Trifluoromethyl)-D-phenylalanine, >=98.5% (HPLC), 4-(Trifluoromethyl)-D-phenylalanine (H-D-Phe(4-CF3)-OH) C10H10F3NO2 CRFFPDBJLGAGQL-MRVPVSSYSA-N (2R)-2-amino-3-[4-(trifluoromethyl)phenyl]propanoic acid n.a. n.a. No No No No No No PMDBD2000415 4,5-dihydroxy-2,3-pentanedione n.a. n.a. n.a. n.a. n.a. n.a. n.a. 443434 n.a. n.a. 4,5-dihydroxypentane-2,3-dione, 142937-55-1, 4,5-Dihydroxy-2,3-pentanedione, 1-Deoxypentosone, 2,3-Pentanedione, 4,5-dihydroxy- (9CI), KZE5WQK34F, 1-Deoxypento-2,4-diulose, 2,3-Pentanedione, 4,5-dihydroxy-, 2,3-Pentanedione, 4,5-dihydroxy-, (4S)- (9CI), UNII-KZE5WQK34F, SCHEMBL355798, CHEMBL247773, DTXSID801306744, 2,3-Pentanedione,4,5-dihydroxy-(9ci), HY-156043, CS-0891560 C5H8O4 UYTRITJAZOPLCZ-UHFFFAOYSA-N 4,5-dihydroxypentane-2,3-dione n.a. n.a. No No No No No No PMDBD2000416 4-Acetamido-D-phenylalanine n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000417 4-Amino-D-phenylalanine n.a. n.a. n.a. n.a. n.a. n.a. n.a. 1268124 n.a. n.a. 102281-45-8, (R)-2-Amino-3-(4-aminophenyl)propanoic acid, 4-Amino-D-phenylalanine, D-4-Aminophenylalanine, (2R)-2-amino-3-(4-aminophenyl)propanoic acid, D-Phenylalanine, 4-amino-, (2R)-3-(4-aminophenyl)-2-ammoniopropanoate, D-4-aminophe, p-Amino-D-phenylalanine acid, (2R)-2-Amino-3-(4-aminophenyl)propanoic acid hydrate, MFCD00069926, p-amino-D-phenylalanine, para-amino-D-phenylalanine, SCHEMBL288375, CHEBI:143083, CEA28145, AKOS016843484, AC-5869, AM82696, DS-3403, CS-0157504, (R)-2-Amino-3-(4-aminophenyl)propanoicacid, F12222, D-4-Aminophenylalanine (H-D-Phe(4-NH2)-OH) C9H12N2O2 CMUHFUGDYMFHEI-MRVPVSSYSA-N (2R)-2-amino-3-(4-aminophenyl)propanoic acid n.a. n.a. No No No No No No PMDBD2000418 4-Benzoylphenylalanine Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D08AHA 7020128 n.a. n.a. "104504-45-2, L-4-Benzoylphenylalanine, 4-benzoyl-l-phenylalanine, (S)-2-Amino-3-(4-benzoylphenyl)propanoic acid, Para-(Benzoyl)-Phenylalanine, p-benzoyl-l-phenylalanine, 4-benzoylphenylalanine, 9RU6KQ9WYD, L-Phenylalanine, 4-benzoyl-, L-p-Benzoylphenylalanine, H-L-Bpa-OH, H-Bpa-OH, H-p-Bz-Phe-OH, H-Bpa-OH H-Phe(4-Bz)-OH, (2S)-2-amino-3-(4-benzoylphenyl)propanoic acid, UNII-9RU6KQ9WYD, para-Benzoyl-L-phenylalanine, SCHEMBL44097, H-Phe(4-Bzo)-OH.nH2O, DTXSID20909021, 4-(phenylcarbonyl)-L-phenylalanine, MFCD00238102, AKOS015891140, CS-W000795, DB08371, DS-4812, HY-W000795, NS00069050, A26763, H11625, (2S)-2-Azaniumyl-3-(4-benzoylphenyl)propanoate, L-P-Benzoylphenylalanine; 4-Benzoyl-l-phenylalanine, Q27097586, PBF" C16H15NO3 TVIDEEHSOPHZBR-AWEZNQCLSA-N (2S)-2-amino-3-(4-benzoylphenyl)propanoic acid n.a. n.a. No No No No No No PMDBD2000419 4-Benzyl-sulfonyl-5-hydroxy-3-chloro-2(5H)-furanone n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000420 4-bromo-5-(bromomethylene)-3-(1-( 2-propynyloxy)butyl)-2(5H)-furanone n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000421 4-bromo-5-(bromomethylene)-3-(1-(2-(2-(2-azidoethoxy)ethoxy)ethoxy)butyl)-2(5H)-furanone n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000422 4-bromo-5-(bromomethylene)-3-(1-acetoxybutyl)-2(5H)-furanone n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000423 4-bromo-5-(bromomethylene)-3-(1-bromobutyl)-2(5H)-furanone n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000424 4-bromo-5-(bromomethylene)-3-butyl-2(5H)- furanone n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000425 4-bromo-5-(dibromomethylene)-3-(1-acetoxyoethyl)-2(5H)-furanone n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000426 4-bromo-5-(dibromomethylene)-3-(1-bromoethyl)-2(5H)-furanone n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000427 4-bromo-5-(dibromomethylene)-3-ethyl-2(5H)-furanone n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000428 4-bromoaniline n.a. n.a. n.a. n.a. n.a. n.a. n.a. 7807 n.a. n.a. "4-Bromoaniline, 106-40-1, P-BROMOANILINE, Benzenamine, 4-bromo-, 4-Bromobenzenamine, p-Bromophenylamine, Aniline, p-bromo-, 4-Bromo-aniline, 4-Bromobenzeneamine, p-bromo aniline, 4-Bromanilinu, 4-Bromo-phenylamine, MFCD00007822, DTXSID7021867, 0RR61TC330, NSC-7085, DTXCID301867, 4-Bromanilinu [Czech], 4-bromophenylamine, CAS-106-40-1, CCRIS 4591, HSDB 2194, NSC 7085, EINECS 203-393-9, BRN 0742031, parabromoaniline, UNII-0RR61TC330, 4-brornoaniline, p-bromo-aniline, AI3-17277, 4-bromo aniline, Aniline, p-bromo, 4-aminobromobenzene, R4 4-bromoaniline, 4-bromo-phenyl-amine, (4-bromophenyl)-amine, ANILINE,4-BROMO, 4-Bromoaniline, 97%, BROMOANILINE, P-, P-BROMOANILINE [MI], SCHEMBL45481, 4-12-00-01497 (Beilstein Handbook Reference), MLS002454431, BIDD:GT0258, CHEMBL57376, 4-BROMOANILINE [HSDB], NSC7085, HMS3050B09, STR00728, Tox21_202459, Tox21_302910, 4-Bromoaniline, >=99.0% (GC), 4-Bromoaniline, for synthesis, 98%, 4-Bromobenzenamine; p-bromophenylamine, AKOS000119091, AM10670, PS-3352, NCGC00091730-01, NCGC00091730-02, NCGC00256346-01, NCGC00260008-01, AC-13468, SMR001252237, B1393, NS00021481, EN300-19060, D95300, AC-907/25014110, Q412773, J-001585, J-514801, F2190-0431, InChI=1/C6H6BrN/c7-5-1-3-6(8)4-2-5/h1-4H,8H" C6H6BrN WDFQBORIUYODSI-UHFFFAOYSA-N 4-bromoaniline n.a. n.a. No No No No No No PMDBD2000429 4-Bromo-D-phenylalanine n.a. n.a. n.a. n.a. n.a. n.a. n.a. 671215 n.a. n.a. 4-Bromo-D-phenylalanine, 62561-74-4, (r)-2-amino-3-(4-bromophenyl)propanoic acid, H-D-Phe(4-Br)-OH, 4-Bromo-D-Phe-OH, P-BROMO-D-PHENYLALANINE, d-4-Bromophenylalanine, (2R)-2-amino-3-(4-bromophenyl)propanoic acid, D-4-Bromophe, D-Phenylalanine, 4-bromo-, D-4-Br-Phe-OH, D-4-Bromo phenylalanine, MFCD01075126, (R)-2-AMINO-3-(4-BROMO-PHENYL)-PROPIONIC ACID, 2-AMINO-3-(4-BROMO-PHENYL)-PROPIONIC ACID, SCHEMBL244718, PEMUHKUIQHFMTH-MRVPVSSYSA-N, AKOS016842809, AC-5857, AM82717, AS-11800, CS-0119906, D-4-Bromophenylalanine (H-D-Phe(4-Br)-OH), (R)-2-amino-3-(4-bromophenyl)propionic acid, EN300-217283, M03236, A847886, J-300376, Q-101614 C9H10BrNO2 PEMUHKUIQHFMTH-MRVPVSSYSA-N (2R)-2-amino-3-(4-bromophenyl)propanoic acid n.a. n.a. No No No No No No PMDBD2000430 4-Br-PHL n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000431 4-Chloro-2-fluoro-DL-phenylalanine n.a. n.a. n.a. n.a. n.a. n.a. n.a. 3745699 n.a. n.a. 4-Chloro-2-fluoro-DL-phenylalanine, 754944-16-6, 2-amino-3-(4-chloro-2-fluorophenyl)propanoic acid, SCHEMBL4469853, MFCD04115957, AKOS015956919, 4-CHLORO-2-FLUORO-DI-PHENYLALANINE, CS-0269266, A50345, EN300-1968670, 2-amino-3-(4-chloro-2-fluorophenyl)propanoicacid, 4-Chloro-2-fluoro-DL-phenylalanine (H-DL-Phe(4-Cl,2-F)-OH) C9H9ClFNO2 ZPMGQOHZMMWUAT-UHFFFAOYSA-N 2-amino-3-(4-chloro-2-fluorophenyl)propanoic acid n.a. n.a. No No No No No No PMDBD2000432 4-chloro-7-(trifluoromethyl)quinoline n.a. n.a. n.a. n.a. n.a. n.a. n.a. 67668 n.a. n.a. 4-Chloro-7-(trifluoromethyl)quinoline, 346-55-4, 4-chloro-7-trifluoromethylquinoline, Quinoline, 4-chloro-7-(trifluoromethyl)-, MFCD00006775, NSC91883, EINECS 206-471-0, 4-chloro-7-trifluoromethyl quinoline, TimTec1_005248, SCHEMBL317413, CHEMBL567057, DTXSID00188170, HMS1548O12, 7-trifluoromethyl-4-chloroquinoline, AMY18109, BCP32445, 4-Chloro-7-trifluoromethyl-quinoline, GEO-00824, NSC 91883, NSC-91883, AKOS002671341, CS-W001856, GS-6796, SB71497, 4-chloro-7-(trifluoromethyl) quinoline, 4-chloro-7-(trifluoromethyl)-quinoline, 4-chloranyl-7-(trifluoromethyl)quinoline, BP-12401, SY109502, 4-Chloro-7-(trifluoromethyl)quinoline, 98%, NS00041663, EN300-115631, A822333, W-200317, Z1492205960 C10H5ClF3N LLRQVSZVVAKRJA-UHFFFAOYSA-N 4-chloro-7-(trifluoromethyl)quinoline n.a. n.a. No No No No No No PMDBD2000433 4-chloroaniline n.a. n.a. n.a. n.a. n.a. n.a. n.a. 7812 n.a. n.a. "4-CHLOROANILINE, 106-47-8, p-Chloroaniline, 4-Chlorobenzenamine, Benzenamine, 4-chloro-, para-Chloroaniline, p-Chloraniline, p-Chlorophenylamine, 1-Amino-4-chlorobenzene, 4-Chlorophenylamine, 4-Aminochlorobenzene, p-Aminochlorobenzene, Aniline, p-chloro-, 4-Amino-1-chlorobenzene, 4-Chloro-1-aminobenzene, 4-Chloro-phenylamine, Aniline, 4-chloro-, 4-Chloranilin, p-CA, 4-Chlorobenzeneamine, Benzeneamine, 4-chloro, 4-chloro aniline, RCRA waste number P024, NCI-C02039, NSC 36941, CHEBI:20331, 4-CHLORO-ANILINE, DTXSID9020295, Z553SGH315, MFCD00007835, NSC-36941, 4-CHLOROANILINE-2,3,5,6-D4, NCGC00091468-02, 4-Chlorobenzamine, 35749-94-1, Caswell No. 182, 4-Chloranilin [Czech], CCRIS 131, HSDB 2047, EINECS 203-401-0, RCRA waste no. P024, EPA Pesticide Chemical Code 017203, 4chloroaniline, UNII-Z553SGH315, 4-chioroaniline, monochloroaniline, parachloroaniline, 4-chloraniline, AI3-14908, para-choroaniline, 4-Choraniline, p-chloro-aniline, para-chioroaniline, 4- chloroaniline, (4-chlorophenyl)amine, 4-Chloro-phenyl amine, 4-Chloro-phenyl-amine, (4-chlorophenyl)-amine, 4-Chloroaniline, 98%, WLN: ZR DG, EC 203-401-0, SCHEMBL27544, P-CHLOROANILINE [MI], MLS001065589, BIDD:ER0279, BIDD:GT0259, CHEMBL15888, DTXCID50295, 4-CHLOROANILINE [HSDB], SULOFENUR METABOLITE VIII, Aniline, 4-chloro-4-chloranilin, P-CHLOROANILINE [USP-RS], PARA-CHLOROANILINE [IARC], NSC36941, 4-Chloroaniline, analytical standard, Tox21_400030, 4-Chloroaniline(4-Chlorophenylamine), BDBM50235880, 4-?Chloroaniline(4-Chlorophenylamine), AKOS000119173, AM10490, PS-6272, RP10019, NCGC00091468-01, NCGC00091468-03, CAS-106-47-8, SMR000568489, NS00010861, 4-Chloroaniline, technical, >=97.0% (GC), EN300-19099, 4-Chloroaniline 100 microg/mL in Acetonitrile, 4-Chloroaniline, purified by sublimation, >=99%, Q413515, 4-Chloroaniline, PESTANAL(R), analytical standard, W-109393, F2190-0430, PROGUANIL HYDROCHLORIDE IMPURITY B [EP IMPURITY], Z104472774, 4-Chloroaniline, European Pharmacopoeia (EP) Reference Standard, CHLORHEXIDINE DIHYDROCHLORIDE IMPURITY P [EP IMPURITY], InChI=1/C6H6ClN/c7-5-1-3-6(8)4-2-5/h1-4H,8H, 1,4-aminochlorobenzene;4-amino-1-chlorobenzene;4-aminochlorobenzene, p-Chloroaniline, United States Pharmacopeia (USP) Reference Standard, p-Chloroaniline, Pharmaceutical Secondary Standard; Certified Reference Material" C6H6ClN QSNSCYSYFYORTR-UHFFFAOYSA-N 4-chloroaniline n.a. n.a. No No No No No No PMDBD2000434 4-Chlorochalcone n.a. n.a. n.a. n.a. n.a. n.a. n.a. 5377022 n.a. n.a. 4-Chlorochalcone, 956-04-7, p-Chlorochalcone, (E)-3-(4-chlorophenyl)-1-phenylprop-2-en-1-one, 3-(4-chlorophenyl)-1-phenylprop-2-en-1-one, 22252-16-0, (2E)-3-(4-chlorophenyl)-1-phenylprop-2-en-1-one, 3-(4-Chlorophenyl)-1-phenyl-2-propen-1-one, 2-Propen-1-one, 3-(4-chlorophenyl)-1-phenyl-, trans-4-Chlorochalcone, (E)-4-Chlorochalcone, 4-Chlorochalcone, trans-, 4-Chlorochalcone, (E)-, NSC-237974, NSC-636920, FLU6LN357N, CHEMBL227560, Chalcone, 4-chloro-, (E)-, CHEBI:34398, (E)-p-Chlorostyryl phenyl ketone, CMLDBU00003474, (E)-3-(4-chlorophenyl)-1-phenyl-2-propen-1-one, (E)-3-(4-chlorophenyl)-1-phenyl-prop-2-en-1-one, NSC636920, (2E)-3-(4-Chlorophenyl)-1-phenyl-2-propenone, (2E)-3-(4-Chlorophenyl)-1-phenyl-2-propen-1-one, p-Chlorostyryl phenyl ketone, 2-Propen-1-one, 3-(4-chlorophenyl)-1-phenyl-, (E)-, 2-Propen-1-one, 3-(4-chlorophenyl)-1-phenyl-, (2E)-, NSC 2643, MFCD00016345, 4-Chlorostyryl phenyl ketone, (4-Chlorobenzylidene)acetophenone, EINECS 213-476-1, NSC 636920, BRN 1105953, NSC-2643, AI3-19969, Chalcone, 4-chloro-, 4-Chlorochalcone, 97%, UNII-FLU6LN357N, 2-07-00-00427 (Beilstein Handbook Reference), SCHEMBL197310, BDBM50440657, NSC237974, AKOS001377258, AKOS025310572, s12306, MS-11493, CS-0370920, NS00042011, A845348, Q27116041, Z46028359 C15H11ClO ABGIIXRNMHUKII-DHZHZOJOSA-N (E)-3-(4-chlorophenyl)-1-phenylprop-2-en-1-one n.a. n.a. No No No No No No PMDBD2000435 4-chloroquinoline n.a. n.a. n.a. n.a. n.a. n.a. n.a. 69140 n.a. n.a. 4-Chloroquinoline, 611-35-8, Quinoline, 4-chloro-, MFCD00006773, 4-chloro-quinoline, FXK6W2A3GT, NSC 96902, NSC-96902, CCRIS 3979, EINECS 210-267-7, 4-chioroquinoline, UNII-FXK6W2A3GT, 4-Chloroquinoline, 99%, SCHEMBL201545, KNDOFJFSHZCKGT-UHFFFAOYSA-, DTXSID40209979, AMY37085, BCP26812, NSC96902, STR08502, AKOS002680474, CS-W007603, HY-W007603, SB15637, AC-23128, BP-12079, SY003930, C2284, NS00034581, EN300-53992, A15688, SR-01000523978, J-650262, SR-01000523978-1, W-203282, F0907-4178, Z431511604, InChI=1/C9H6ClN/c10-8-5-6-11-9-4-2-1-3-7(8)9/h1-6H C9H6ClN KNDOFJFSHZCKGT-UHFFFAOYSA-N 4-chloroquinoline n.a. n.a. No No No No No No PMDBD2000436 4-Cyanophenylalanine n.a. n.a. n.a. n.a. n.a. n.a. n.a. 1501865 n.a. n.a. 4-Cyano-L-Phenylalanine, 167479-78-9, L-4-Cyanophenylalanine, H-Phe(4-CN)-OH, (S)-2-amino-3-(4-cyanophenyl)propanoic acid, (2S)-2-amino-3-(4-cyanophenyl)propanoic acid, 4-Cyanophenylalanine, 104531-20-6, (s)-2-amino-3-(4-cyanophenyl)propionic acid, (L)-4-Cyanophenylalanine, l-4-cyanophe, L-4- Cyanophenylalanine, MFCD00270363, p-cyanophenylalanine, para-Cyano-L-phenylalanine, SCHEMBL43594, DTXSID30937335, KWIPUXXIFQQMKN-VIFPVBQESA-N, STR03229, AKOS006342996, AC-7943, AM82773, CS-W022752, A50120, EN300-1167130, J-001192, Q27454596 C10H10N2O2 KWIPUXXIFQQMKN-VIFPVBQESA-N (2S)-2-amino-3-(4-cyanophenyl)propanoic acid n.a. n.a. No No No No No No PMDBD2000437 4-dimethyl-amino-cinnamaldehyde n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000438 4-Ethylcatechol n.a. n.a. n.a. n.a. n.a. n.a. n.a. 70761 n.a. n.a. 4-Ethylcatechol, 4-ethylbenzene-1,2-diol, 1124-39-6, 4-Ethylpyrocatechol, 4-Ethyl-1,2-benzenediol, 1,2-Benzenediol, 4-ethyl-, 574JV8BYR2, CHEMBL1276241, Benzenediol, 4-ethyl-, 3,4-Dihydroxyethylbenzene, UNII-574JV8BYR2, 4-EthylC atechol, EINECS 214-397-5, P-ETHYLCATECHOL, 4-Ethylcatechol, 95%, 4-Ethylpyrocatechol, 8CI, 1,2-Benzenediol,4-ethyl-, SCHEMBL56556, 4-Ethyl-1,2-benzenediol #, ETHYLPYROCATECHOL, 4-, HFLGBNBLMBSXEM-UHFFFAOYSA-, DTXSID50150029, CHEBI:179260, AMY19655, BDBM50483042, MFCD00015847, AKOS016008639, AS-39285, CS-0309130, NS00023642, EN300-1599490, A802581, J-002778, Q27261467, InChI=1/C8H10O2/c1-2-6-3-4-7(9)8(10)5-6/h3-5,9-10H,2H2,1H3, 8RU C8H10O2 HFLGBNBLMBSXEM-UHFFFAOYSA-N 4-ethylbenzene-1,2-diol n.a. n.a. No No No No No No PMDBD2000439 4-Ethylguaiacol n.a. n.a. n.a. n.a. n.a. n.a. n.a. 62465 n.a. NPC156840 4-Ethyl-2-methoxyphenol, 2785-89-9, 4-Ethylguaiacol, p-Ethylguaiacol, 2-Methoxy-4-ethylphenol, PHENOL, 4-ETHYL-2-METHOXY-, Guaiacyl ethane, Homocresol, 4-ethyl guaiacol, 4-ethyl-2-methoxy-phenol, 4-Hydroxy-3-methoxy ethylbenzene, Guaiacol, 4-ethyl-, 4-Hydroxy-3-methoxyethylbenzene, Guaiacol, 4-ethyl, FEMA No. 2436, 4-Hydroxy-3-methoxyphenylethane, p-Ethyl-2-methoxyphenol, 1-Hydroxy-2-methoxy-4-ethylbenzene, 4-Ethyl-2-metoxy phenol, Phenol, 2-methoxy-4-ethyl, C9NFD83BJ5, CHEMBL3186900, DTXSID0047038, MFCD00038714, NSC-82313, 4-Ethyl-2-methoxyphenol (4-ethylguaiacol), NSC 82313, UNII-C9NFD83BJ5, 4-Ethyl guiacol, 4-ethyl-guaiacol, EINECS 220-500-4, UNII-BX3THX8LT4, BX3THX8LT4, 4-Ethyl-2-methoxy phenol, 4-Ethyl-d5-2-methoxyphenol, SCHEMBL109504, 4-Ethylguaiacol, natural, FG, 4-ETHYLGUAIACOL [FHFI], 4-ETHYL GUAIACOL [FCC], DTXCID8027038, FEMA 2436, CHEBI:179252, BCP19091, NSC82313, 4-Ethylguaiacol, analytical standard, Tox21_302308, BDBM50548721, AKOS015851764, 4-Ethylguaiacol, >=98%, FCC, FG, CCG-356437, CS-W018090, DS-4664, Ethylguiacol (4-ethyl-2-methoxyphenol), NCGC00256287-01, AC-15463, SY001597, CAS-2785-89-9, 4-Ethylguaiacol 1000 microg/mL in Methanol, E0353, NS00012404, D90493, EN300-120486, 2-PHENYL-PYRAZOLO[1,5-A]PYRIMIDIN-5-OL, Q229953, Q-100353, Z57234301, InChI=1/C9H12O2/c1-3-7-4-5-8(10)9(6-7)11-2/h4-6,10H,3H2,1-2H C9H12O2 CHWNEIVBYREQRF-UHFFFAOYSA-N 4-ethyl-2-methoxyphenol n.a. n.a. No No No No Yes No rxn25875,rxnDiet68,rxnAdd226 PMDBD2000440 4-Fluoro-(S)-4,5-Dihydroxypentane-2,3-dione n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000441 4-Fluoro-2-methyl-D-phenylalanine n.a. n.a. n.a. n.a. n.a. n.a. n.a. 56971782 n.a. n.a. D-2-Methyl-4-fluorophe, 1213186-81-2, (R)-2-Amino-3-(4-fluoro-2-methylphenyl)propanoic acid, (2R)-2-amino-3-(4-fluoro-2-methylphenyl)propanoic acid, 4-Fluoro-2-methyl-D-phenylalanine, starbld0017867, MFCD12198173, AKOS017482112, PS-12418, CS-0455074, D-2-Methyl-4-fluorophenylalanine (H-D-Phe(2-Me,4-F)-OH) C10H12FNO2 WDSUDTPFZZINJC-SECBINFHSA-N (2R)-2-amino-3-(4-fluoro-2-methylphenyl)propanoic acid n.a. n.a. No No No No No No PMDBD2000442 4-Fluoro-D-phenylalanine n.a. n.a. n.a. n.a. n.a. n.a. n.a. 716314 n.a. n.a. 4-Fluoro-D-phenylalanine, 18125-46-7, D-4-Fluorophenylalanine, (R)-2-Amino-3-(4-fluorophenyl)propanoic acid, D-PHENYLALANINE, 4-FLUORO-, H-D-Phe(4-F)-OH, p-Fluoro-D-phenylalanine, (2R)-2-amino-3-(4-fluorophenyl)propanoic acid, 4-Fluorophenylalanine, D-, R-(+)-4-Fluorophenylalanine, (R)-4-FLUOROPHENYLALANINE, UNII-963G7O1PVE, 963G7O1PVE, D-4-FLUOROPHE, (2R)-2-azaniumyl-3-(4-fluorophenyl)propanoate, MFCD00063063, H-D-Phe(4-F)-OH.HCl, D-4-Fluoro phenylalanine, MFCD00063064, Lopac-F-4646, SCHEMBL72793, 3-(4-fluorophenyl)-l-alanine, CHEMBL1434241, XWHHYOYVRVGJJY-MRVPVSSYSA-N, AKOS016842810, AC-5834, AM83344, CS-W015995, HY-W015279, NCGC00015435-01, AS-14702, F0901, 4-Fluoro-D-phenylalanine (H-D-Phe(4-F)-OH), EN300-199904, A812599, Q-101536, Q27271856, Z995228438, p-Fluoro-D-phenylalanine, >=99.0% (sum of enantiomers, HPLC) C9H10FNO2 XWHHYOYVRVGJJY-MRVPVSSYSA-N (2R)-2-amino-3-(4-fluorophenyl)propanoic acid n.a. n.a. No No No No No No PMDBD2000443 4-fluoroindole n.a. n.a. n.a. n.a. n.a. n.a. n.a. 2774502 n.a. n.a. 4-Fluoroindole, 4-Fluoro-1H-indole, 387-43-9, 1H-Indole, 4-fluoro-, MFCD00055992, 4-fluoro-indole, 4-Fluoroindole, 97%, BIDD:GT0103, SCHEMBL680718, ZWKIJOPJWWZLDI-UHFFFAOYSA-, DTXSID00379061, ZWKIJOPJWWZLDI-UHFFFAOYSA-N, AM959, BCP27160, AKOS005063960, CS-W001557, PB20892, PS-9127, AC-23424, SY012837, A5696, F0556, EN300-85406, A15545, F-4500, Z1203161966, InChI=1/C8H6FN/c9-7-2-1-3-8-6(7)4-5-10-8/h1-5,10H C8H6FN ZWKIJOPJWWZLDI-UHFFFAOYSA-N 4-fluoro-1H-indole n.a. n.a. No No No No No No PMDBD2000444 4H-tomentosin n.a. n.a. n.a. n.a. n.a. n.a. n.a. 15109105 n.a. NPC470244 4H-Tomentosin, CHEMBL1912056 C15H22O3 KQEADOUDJYBGFC-AIHGEPKZSA-N (3aR,7S,8aR)-6-(3-hydroxybutyl)-7-methyl-3-methylidene-4,7,8,8a-tetrahydro-3aH-cyclohepta[b]furan-2-one n.a. n.a. No No No No No No PMDBD2000445 4-Hydroxy benzoate n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000446 4-hydroxy coumarin n.a. n.a. n.a. n.a. n.a. n.a. n.a. 54682930 n.a. NPC141068 "4-Hydroxycoumarin, 1076-38-6, 4-Coumarinol, Benzotetronic acid, 4-Hydroxy-2H-chromen-2-one, 4-hydroxychromen-2-one, Coumarin, 4-hydroxy-, 2H-1-BENZOPYRAN-2-ONE, 4-HYDROXY-, 4-Hydroxy-2H-1-benzopyran-2-one, 4-Hydroxy coumarin, 4-Hydroxy-chromen-2-one, 4-hydroxy-2-chromenone, MFCD00006856, 4-HYDROXY-1-BENZOPYRAN-2-ONE, 4-hydroxy-2H-benzo[b]pyran-2-one, 22105-09-5, X954ZLL2RD, CHEMBL301141, CHEBI:40070, NSC11889, NSC-11889, 4-Hydroxy-2H-1-benzopyran-2-one (4-Hydroxycoumarin), 2-Hydroxychromone, 4-hydroxy-coumarin, 4- Hydroxycoumarin, 4HC, EINECS 214-060-2, NSC 11889, 4H-1-Benzopyran-4-one, 2-hydroxy-, UNII-X954ZLL2RD, BRN 0129768, hydroxychromone, 4hydroxycoumarin, AI3-52393, 4-hyroxycoumarin, 4-hydroxyl coumarin, 4-Monohydroxycoumarin, 4-Hydroxycoumarin, 98%, CBiol_000838, WLN: T66 BOVJ EQ, 5-18-01-00378 (Beilstein Handbook Reference), MLS004491719, SCHEMBL131312, MEGxm0_000452, SCHEMBL1961365, DTXSID8061472, ACon1_001952, 4-Hydroxy-2H-chromen-2-one #, DTXSID50944748, HMS1607G02, 4-hydroxy-2-oxo-2H-1-benzopyran, 2-Hydroxy-4H-1-benzopyran-4-one, BCP31120, HY-N6856, STR01861, BDBM50055710, ICCB4_000134, AKOS000119142, AKOS037515220, AM84328, DB03410, 4-HYDROXYCOUMARIN [USP IMPURITY], NCGC00179970-01, AC-13227, NCI60_000453, PD016118, SMR000112320, SY001614, CS-0015925, EU-0066799, H0235, NS00014742, EN300-17333, C20414, D71127, WARFARIN SODIUM IMPURITY B [EP IMPURITY], 4-Hydroxycoumarin, Vetec(TM) reagent grade, 98%, SR-01000389319, 4-Hydroxy-1-benzopyran-2-one; 4-Coumarinyl alcohol, J-515519, J-620003, SR-01000389319-1, BRD-K48844111-001-01-4, Q25323691, Z56922074, 4-HYDROXY-1-BENZOPYRAN-2-ONE; 4-HYDROXYCOUMARIN, F0266-2972, 4-Hydroxy Coumarin;4-Coumarinol;4-Hydroxy-2H-chromen-2-one, InChI=1/C9H6O3/c10-7-5-9(11)12-8-4-2-1-3-6(7)8/h1-5,10" C9H6O3 VXIXUWQIVKSKSA-UHFFFAOYSA-N 4-hydroxychromen-2-one n.a. n.a. No No No No No No PMDBD2000447 4-Hydroxy-2,5-dimethyl-3(2H)-furanone Therapeutic Substance Patented Drug n.a. n.a. n.a. n.a. D03ZOH 19309 n.a. NPC107703 Furaneol, 3658-77-3, 4-hydroxy-2,5-dimethylfuran-3(2H)-one, 4-Hydroxy-2,5-dimethyl-3(2H)-furanone, 4-Hydroxy-2,5-dimethyl-3(2H)furanone, 2,5-Dimethyl-4-hydroxy-3(2H)-furanone, Pineapple ketone, Dimethylhydroxy furanone, Alletone, 3(2H)-Furanone, 4-hydroxy-2,5-dimethyl-, 4-hydroxy-2,5-dimethylfuran-3-one, Strawberry furanone, 4-hydroxy-2,5-dimethyl-3-furanone, Coe 536, FEMA No. 3174, FEMA 3174, 2,5-Dimethyl-4-hydroxy-2,3-dihydrofuran-3-one, 2,5-Dimethyl-3-hydroxy-4-oxo-4,5-dihydrofuran, 4-Hydroxy-2,5-dimethylfuran-2(3H)-one, 4-hydroxy-2,5-dimethyl-2,3-dihydrofuran-3-one, 3(2H)-FURANONE, 2,5-DIMETHYL-4-HYDROXY-, 20PI8YZP7A, 192466-95-8, DTXSID0041517, CHEBI:76247, MFCD00010706, EINECS 222-908-8, UNII-20PI8YZP7A, BRN 1281357, CCRIS 8102, 4-Hydroxy-2,5-dimethyl-3(2H)-furanone (natural), ALNOSE, HDMF, dimethylhydroxyfuranone, (+/-)-Furaneol, SCHEMBL57008, CHEMBL3186302, DIMETHYL DIHYDROFURANOLONE, DTXCID8021517, HSDB 8322, HY-N7093, Tox21_300823, 2,5-DIMETHYLDIHYDROFURANOLONE, AC8010, s5178, AKOS015900499, CS-W013470, DIMETHYLHYDROXY FURANONE [INCI], SB60884, NCGC00248185-01, NCGC00254727-01, 2,5-dimethyl-4-hydroxy-2h-furan-3-one, 2,5-dimethyl-4-hydroxy-3[2H] furanone, 4-hydroxy-2,5-dimethyl-3-oxo-2H-furan, AC-14027, AS-15673, SY035594, CAS-3658-77-3, 2,5-dimethyl-4-hydroxy-3-(2H)-furanone, 2.5-dimethyl-4-hydroxy-3-(2H)-furanone, 4-hydroxy-2,5-dimethyl-furan-3(2H)-one, 2,5-dimethyl-4-hydroxy-(2h)-furan-3-one, 2,5-dimethyl-4-hydroxy-3-oxo-(2H)-furan, D1569, D1884, NS00012307, C20717, EN300-175904, 2,3-Dihydro-4-hydroxy-2,5-dimethyl-3-furanone, 4-oxo-3-hydroxy-2,5-dimethyl-4,5-dihydrofuran, A823300, Q250455, Q-100434, 4-HYDROXY-2,5-DIMETHYL-3(2H)-FURANONE [FCC], 4-HYDROXY-2,5-DIMETHYL-3(2H)-FURANONE [FHFI], Z1255395050, 2,5-Dimethyl-4-hydroxy-3(2H)-furanone (Technical Grade), 4-Hydroxy-2,5-dimethyl-3(2H)-furanone, >=99.0% (GC), 4-Hydroxy-2,5-dimethyl-3(2H)-furanone, >=98%, FCC, FG, 4-Hydroxy-2,5-dimethyl-3(2H)-furanone, analytical standard, 4-Hydroxy-2,5-dimethyl-3(2H)-furanone, natural, >=98%, FG, InChI=1/C6H8O3/c1-3-5(7)6(8)4(2)9-3/h3,8H,1-2H, 4-Hydroxy-2,5-dimethyl-3(2H)-furanone, 15 wt. % (in propylene glycol), FG C6H8O3 INAXVXBDKKUCGI-UHFFFAOYSA-N 4-hydroxy-2,5-dimethylfuran-3-one UNILEVER PLC UNILEVER N.V. CONOPCO, INC., D/B/A UNILEVER n.a. No No No No No No PMDBD2000448 4-Hydroxychalcone n.a. n.a. n.a. n.a. n.a. n.a. n.a. 5282361 n.a. n.a. 4-Hydroxychalcone, 20426-12-4, 4-hydroxy chalcone, 38239-55-3, 2-Propen-1-one, 3-(4-hydroxyphenyl)-1-phenyl-, (E)-3-(4-hydroxyphenyl)-1-phenylprop-2-en-1-one, (2E)-3-(4-hydroxyphenyl)-1-phenylprop-2-en-1-one, 3-(4-hydroxyphenyl)-1-phenylprop-2-en-1-one, (E)-3-(4-hydroxyphenyl)-1-phenyl-prop-2-en-1-one, 4-hydroxy-chalcone, 2-(4-Hydroxybenzal)acetophenone, Chalcone, 4-hydroxy-, (E)-4-Hydroxychalcone, 3-(4-hydroxyphenyl)-1-phenyl-2-propen-1-one, JO97Q47VBU, (4-Hydroxybenzal)acetophenone, CHEBI:34423, 2-(4-Hydroxybenzylidene)acetophenone, NSC-170282, MFCD00016488, UNII-JO97Q47VBU, CCRIS 2228, NSC-60593, 4-Hydroxybenzylidene acetophenone, Chalcone 2, Chalcone, 3, NSC 60593, YISI, (E)-3-(4-Hydroxy-phenyl)-1-phenyl-propenone, starbld0019043, 3-(4-hydroxy-phenyl)-1-phenyl-prop-2-en-1-one, CHEMBL7747, MLS000777850, BIDD:ER0068, 4-Hydroxystyryl phenyll ketone, TRANS-4-HYDROXYCHALCONE, SCHEMBL1375837, DTXSID3022453, N-a-Boc-L-Tryptophanbenzylester, BDBM86004, HMS2766F17, (4-Hydroxybenzylidene) acetophenone, NSC170282, AKOS001325512, CCG-214736, NSC 170282, NCGC00246413-01, (4-HYDROXYBENZYLIDENE)ACETOPHENONE, LS-14375, MS-11494, SMR000414187, HY-107818, CS-0030695, CS-0369633, H0955, NS00116308, S4763, 1-phenyl-3-(4-hydroxyphenyl)-2-propen-1-one, A814543, AE-641/00204063, (E)-3-(4-hydroxyphenyl)-1-phenyl-2-propen-1-one, T5763121, Q27116057, Z46028347, (2E)-3-(4-Hydroxyphenyl)-1-phenyl-2-propen-1-one #, 2-Propen-1-one, 3-(4-hydroxyphenyl)-1-phenyl-, (2E)-, 2-PROPEN-1-ONE, 3-(4-HYDROXYPHENYL)-1-PHENYL-, (E)-, IPJ C15H12O2 PWWCDTYUYPOAIU-DHZHZOJOSA-N (E)-3-(4-hydroxyphenyl)-1-phenylprop-2-en-1-one n.a. n.a. No No No No No No PMDBD2000449 4-Iodo-d-phenylalanine n.a. n.a. n.a. n.a. n.a. n.a. n.a. 2733279 n.a. n.a. "4-iodo-d-phenylalanine, 62561-75-5, h-d-phe(4-i)-oh, D-4-Iodophenylalanine, P-IODO-D-PHENYLALANINE, (2R)-2-amino-3-(4-iodophenyl)propanoic acid, d-phe(4-i)-oh, d-4-iodophe, (R)-2-amino-3-(4-iodophenyl)propanoic acid, D-p-Iodophenylalanine, (d)-4-iodophenyl alanine, (2R)-2-azaniumyl-3-(4-bromophenyl)propanoate, D-Phenylalanine, 4-iodo-, d-4-iodo phenylalanine, MFCD00063067, D-4-Iodophenylalanine;H-D-Phe(4-I)-OH, h-p-iodo-d-phe-oh, para-iodo-d-phenylalanine, SCHEMBL44620, p-Iodo-D-phenylalanine, 97%, CHEMBL1233638, CHEBI:43422, PZNQZSRPDOEBMS-MRVPVSSYSA-N, AKOS016842993, AC-5859, AM83377, CS-W012188, DB04713, HY-W011472, DS-16181, IOY, (r)-2-amino-3-(4-iodo-phenyl)-propionic acid, EN300-1168710, SR-01000883987, J-300410, SR-01000883987-1, BRD-K66664625-001-01-2, Q27095455, Z1269112635" C9H10INO2 PZNQZSRPDOEBMS-MRVPVSSYSA-N (2R)-2-amino-3-(4-iodophenyl)propanoic acid n.a. n.a. No No No No No No PMDBD2000450 4-methanesulfonylaniline n.a. n.a. n.a. n.a. n.a. n.a. n.a. 79617 n.a. n.a. 4-(Methylsulfonyl)aniline, 5470-49-5, 4-methylsulfonylaniline, 4-(methylsulphonyl)aniline, 4-Mesylaniline, Benzenamine, 4-(methylsulfonyl)-, 4-(methylsulfonyl)benzenamine, 4-methanesulfonylaniline, p-(Methylsulfonyl)aniline, (4-Methylsulfonyl)aniline, 4-AMINOPHENYL METHYL SULFONE, p-aminophenyl methyl sulfone, 4-Aminophenyl methyl sufhone, UZ65E6P9TF, Aniline, p-(methylsulfonyl)-, AI3-08088, NSC-27552, NSC-229035, NSC27552, EINECS 226-803-8, p-Methylsulfonylaniline, 4-methyl sulfonylaniline, 4-methanesulphonylaniline, 4-methanesulfonyl-aniline, UNII-UZ65E6P9TF, 4-methanesulfonylphenylamine, 4-methanesulphonylphenylamine, SCHEMBL55092, 4-Methanesulfonyl-phenylamine, 4-methanesulphonyl-phenylamine, MLS000100546, 4-(methylsulfonyl)-phenylamine, IFLab1_000204, (4-methylsulfonyl-phenyl)-amine, CHEMBL1329603, DTXSID50203165, HMS1412J06, HMS2258O15, MFCD00025353, NSC 27552, NSC229035, AKOS000206762, AB01467, AC-1924, CS-W005110, NSC 229035, SDCCGMLS-0061734.P002, IDI1_008423, 4-aminophenyl methyl sulfone, AldrichCPR, BP-21471, SMR000017438, AM20061075, NS00033181, EN300-14448, D70950, 9X-0815, J-501447, Z85926241, F0051-0005, InChI=1/C7H9NO2S/c1-11(9,10)7-4-2-6(8)3-5-7/h2-5H,8H2,1H C7H9NO2S XJEVFFNOMKXBLU-UHFFFAOYSA-N 4-methylsulfonylaniline n.a. n.a. No No No No No No PMDBD2000451 4-Methoxycarbonylphenylboronic acid n.a. n.a. n.a. n.a. n.a. n.a. n.a. 2734369 n.a. n.a. "99768-12-4, 4-Methoxycarbonylphenylboronic acid, Methyl 4-boronobenzoate, 4-(Methoxycarbonyl)phenylboronic acid, (4-(Methoxycarbonyl)phenyl)boronic acid, (4-Methoxycarbonylphenyl)boronic acid, 4-(Methoxycarbonyl)benzeneboronic Acid, [4-(methoxycarbonyl)phenyl]boronic acid, 4-Methoxycarbonylbenzeneboronic acid, 4-(methoxycabonyl)phenylboronic acid, p-(methoxycarbonyl)phenylboronic acid, 4-carbomethoxyphenylboronic acid, 4-methoxycarbonyl phenyl boronic acid, MFCD01632203, Methyl 4-(Dihydroxyboranyl)Benzoate, SCHEMBL140644, CHEMBL1824169, p-carbomethoxyphenyl boronic acid, DTXSID40370259, p-methoxycarbonylphenylboronic acid, 4-(carbomethoxy)phenylboronic acid, 4-methoxycarbonyl phenylboronic acid, 4-methoxycarbonyl-phenylboronic acid, 4-methoxycarbonylphenyl boronic acid, 4-methoxycarbonylphenyl-boronic acid, BCP03529, 4-methoxycarbonyl-phenyl boronic acid, 4-methoxycarbonyl-phenyl-boronic acid, (4-methoxycarbonylphenyl)-boronic acid, 4-(methoxycarbonyl) phenylboronic acid, 4-(methoxycarbonyl)-phenylboronic acid, 4-(methoxycarbonyl)phenyl-boronic acid, AKOS000264853, (4-(Methoxycarbonyl)phenyl)boronicacid, 4-(Methoxycarbonyl)phenyl boronic acid, AB09470, AC-2895, AM62784, AS-2263, CS-W003977, HY-W003977, (4-methoxycarbonyl-phenyl) boronic acid, 4-(methoxycarbonyl) phenyl boronic acid, NCGC00249475-01, (4-(methoxycarbonyl)phenyl) boronic acid, [4-(methoxy carbonyl)phenyl]boronic acid, [4-(methoxycarbonyl)-phenyl]boronic acid, BP-11412, SY003283, Benzoic acid, 4-borono-, 1-methyl ester, {4-[(methyloxy)carbonyl]phenyl}boronic acid, A6989, M1907, EN300-68541, J-515664, Z1095162714, 4-Methoxycarbonylphenylboronic(contains varying amounts of Anhydride), 4-(methoxycarbonyl)phenylboronic acid;4-Methoxycarbonylphenylboronic Acid" C8H9BO4 PQCXFUXRTRESBD-UHFFFAOYSA-N (4-methoxycarbonylphenyl)boronic acid n.a. n.a. No No No No No No PMDBD2000452 4-Methoxychalcone n.a. n.a. n.a. n.a. n.a. n.a. n.a. 641819 n.a. n.a. 4-Methoxychalcone, 959-33-1, (E)-3-(4-methoxyphenyl)-1-phenylprop-2-en-1-one, 22252-15-9, (2E)-3-(4-methoxyphenyl)-1-phenylprop-2-en-1-one, Chalcone, 4-methoxy-, 2-Propen-1-one, 3-(4-methoxyphenyl)-1-phenyl-, 3-(4-Methoxyphenyl)-1-phenyl-2-propen-1-one, 2-(4-Methoxybenzal)acetophenone, 4''-Methoxybenzylideneacetophenone, (E)-3-(4-methoxyphenyl)-1-phenyl-prop-2-en-1-one, 2-propen-1-one, 3-(4-methoxyphenyl)-1-phenyl-, (2E)-, MFCD00017179, Phenyl p-methoxystyryl ketone, 3-(4-methoxyphenyl)-1-phenylprop-2-en-1-one, 2-(4-Methoxybenzylidene)acetophenone, NSC636917, p-Methoxyphenyl styryl ketone, NSC 11866, Chalcone, 4, 3-(4-Methoxy-phenyl)-1-phenyl-propenone, trans-4-Methoxychalcone, 2-(p-Anisal)acetophenone, p-Methoxystyryl phenyl ketone, 4-Methoxystyryl phenyl ketone, 2-(p-Anisylidene)acetophenone, SCHEMBL521906, (2E)-3-(4-Methoxyphenyl)-1-phenyl-2-propen-1-one, CHEMBL105496, SCHEMBL1566431, BDBM86005, (p-Methoxybenzylidene)acetophenone, (4-Methoxybenzylidene)acetophenone, DTXSID601313945, NSC11866, XAA25215, NSC-11866, NSC170287, AKOS000447894, NSC-170287, NSC-636917, LS-14472, CS-0181937, M1409, NS00015322, EN300-16058, 1-Phenyl-3-(4-methoxyphenyl)-2-propen-1-one, A23188, S10243, 1-Phenyl-3-(4-methoxyphenyl)-2-propen- 1-one, 2-Propen-1-one,3-(4-methoxyphenyl)-1-phenyl-, 10L-722, A878641, AE-641/00576037, W-100150, Q63395979, Z46028374, InChI=1/C16H14O2/c1-18-15-10-7-13(8-11-15)9-12-16(17)14-5-3-2-4-6-14/h2-12H,1H3/b12-9 C16H14O2 XUFXKBJMCRJATM-FMIVXFBMSA-N (E)-3-(4-methoxyphenyl)-1-phenylprop-2-en-1-one n.a. n.a. No No No No No No PMDBD2000453 4-methoxy-cinnamaldehyde n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000454 4-Methyl benzyl dodecyl beta-maltoside n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000455 4-Methylphenylalanine n.a. n.a. n.a. n.a. n.a. n.a. n.a. 151513 n.a. n.a. 1991-87-3, 4-Methyl-L-phenylalanine, L-4-Methylphenylalanine, H-Phe(4-Me)-OH, 4-Methylphenylalanine, Phenylalanine, 4-methyl-, (2S)-2-amino-3-(4-methylphenyl)propanoic acid, (S)-2-Amino-3-(p-tolyl)propanoic acid, L-Phenylalanine, 4-methyl-, 7758-37-4, (2S)-2-azaniumyl-3-(4-methylphenyl)propanoate, MFCD00038575, (S)-2-amino-3-p-tolylpropanoic acid, L-4-METHYLPHE, H-p-Me-D-Phe-OH, H-P-ME-PHE-OH, 4-Methy-L-Phenylalanine, 4-METHYL-L-PHE-OH, L-4-ME-PHE-OH, P-methylphenylalanine, L-4-Methyl Phenylalanine, (S)-4-Methylphenylalanine, SCHEMBL44872, CHEMBL1230319, DTXSID20228249, DQLHSFUMICQIMB-VIFPVBQESA-N, BCP11552, AKOS012010209, AC-9926, AM83427, AS-14585, CS-0128883, M2743, (S)-2-AMINO-3-P-TOLYL-PROPIONIC ACID, EN300-267467, F12350, A814071, J-300418, Q27454875 C10H13NO2 DQLHSFUMICQIMB-VIFPVBQESA-N (2S)-2-amino-3-(4-methylphenyl)propanoic acid n.a. n.a. No No No No No No PMDBD2000456 4-nitro-cinnamaldehyde n.a. n.a. n.a. n.a. n.a. n.a. n.a. 5354135 n.a. n.a. 4-Nitrocinnamaldehyde, 1734-79-8, 3-(4-nitrophenyl)acrylaldehyde, 49678-08-2, p-Nitrocinnamaldehyde, (E)-3-(4-nitrophenyl)acrylaldehyde, trans-4-Nitrocinnamaldehyde, CINNAMALDEHYDE, p-NITRO-, 2-Propenal, 3-(4-nitrophenyl)-, (E)-3-(4-nitrophenyl)prop-2-enal, 3-(4-Nitrophenyl)-2-propenal, (2E)-3-(4-nitrophenyl)prop-2-enal, 3-(4-nitrophenyl)prop-2-enal, 48R8LAM7YX, NSC-1318, CCRIS 3774, NSC 1318, EINECS 217-076-8, 3-(4-NITRO-PHENYL)-PROPENAL, UNII-48R8LAM7YX, BRN 1565424, MFCD00007379, 4-nitro-cinnamaldehyde, 4-Nitrocinnamaldehyde, predominantly trans, (E)-4-Nitrocinnamaldehyde, WLN: WNR D1U1VH, 4-NITROCINNAMALDAHYDE, 0-07-00-00358 (Beilstein Handbook Reference), SCHEMBL565867, 4-NITROCINNAMIC ALDEHYDE, NSC1318, (E)-3-(4-nitrophenyl)-acrylaldehyde, AKOS005384588, CS-W017374, NCGC00341285-01, AS-60096, AS-61816, CS-0369308, N0541, NS00025695, EN300-313698, 4-Nitrocinnamaldehyde, predominantly trans, 98%, AB01332726-02, A913872, J-010912, Q27259167, trans-4-Nitrocinnamaldehyde, technical, >=97.0% (T), Z1255430997, InChI=1/C9H7NO3/c11-7-1-2-8-3-5-9(6-4-8)10(12)13/h1-7H/b2-1 C9H7NO3 ALGQVMMYDWQDEC-OWOJBTEDSA-N (E)-3-(4-nitrophenyl)prop-2-enal n.a. n.a. No No No No No No PMDBD2000457 4-Nitro-D-phenylalanine n.a. n.a. n.a. n.a. n.a. n.a. n.a. 679497 n.a. n.a. 56613-61-7, 4-Nitro-D-phenylalanine, H-D-Phe(4-NO2)-OH, p-Nitro-D-Phenylalanine, 4-Nitro-D-phenylalanine hydrate, (2R)-2-amino-3-(4-nitrophenyl)propanoic acid, (R)-2-amino-3-(4-nitrophenyl)propanoic acid, MFCD00066016, D-4-Nitrophe, D-Phenylalanine, 4-nitro-, 4-nitro-phenylalanine, D-Phe(4-NO2)-OH, SCHEMBL503312, SCHEMBL12463780, DTXSID60350452, GTVVZTAFGPQSPC-MRVPVSSYSA-N, H-D-Phe(4-NO2)-OH.nH2O, AKOS015854093, AM83455, CS-W015122, GS-0036, HY-W014406, PD196948, N0849, EN300-344157 C9H10N2O4 GTVVZTAFGPQSPC-MRVPVSSYSA-N (2R)-2-amino-3-(4-nitrophenyl)propanoic acid n.a. n.a. No No No No No No PMDBD2000458 4-nitropyridine N -oxide n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000459 4-Phenyl-N-((2R,3R,4S,5S,6R)-2,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)butanamide n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000460 4-tertiary butyl benzyl decyl beta-maltoside n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000461 4-tertiary butyl benzyl dodecyl beta-maltoside n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000462 5 alpha-Epoxyalantolactone n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000463 5- hydroxyethyl-3-tetradecanoyltetramic acid n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000464 5-(4,5-dibromo-1-methyl-1H-pyrrol-2-yl)-1,3,4-oxadiazole-2-thiol n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000465 5-(dibromomethylene)-3-(1-acetoxyethyl)-2(5H)-furanone n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000466 5-(dibromomethylene)-3-(1-bromobutyl)-2(5H)-furanone n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000467 5-(dibromomethylene)-3-(1-bromoethyl)-2(5H)-furanone n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000468 5-(dibromomethylene)-3-butyl-2(5H)-furanone n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000469 5-(dibromomethylene)-3-ethyl-2(5H)-furanone n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000470 5-(dibromomethylene)-3-hexyl-2(5H)-furanone n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000471 5,7,8,4-Tetramethoxyflavone n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000472 5,8,11,14-Eicosatetraynoic acid Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D0G9IP 1780 n.a. NPC158179 "ETYA, 5,8,11,14-eicosatetraynoic acid, 1191-85-1, Eicosatetraynoic acid, icosa-5,8,11,14-tetraynoic acid, eicosatetranoic acid, Ro 3-1428, Octadehydroarachidonic acid, 5FEJ8J06DR, MLS000069514, MFCD00036967, SMR000058640, MLS-0002886.0001, Ro 31428, ITY, Opera_ID_402, Spectrum5_001952, UNII-5FEJ8J06DR, cid_1780, CBiol_001864, SCHEMBL68751, BSPBio_001449, KBioGR_000169, KBioSS_000169, BML2-F04, CHEMBL458328, GTPL2669, BDBM31752, CHEBI:94483, KBio2_000169, KBio2_002737, KBio2_005305, KBio3_000337, KBio3_000338, DTXSID20152318, Bio1_000150, Bio1_000639, Bio1_001128, Bio2_000169, Bio2_000649, HMS1361I11, HMS1791I11, HMS1989I11, HMS3402I11, HMS3649D21, BAA19185, HSCI1_000035, LMFA01030691, 5,8,11,14-Icosatetraynoic acid #, AKOS040733080, CCG-207933, IDI1_033919, NCGC00018135-01, NCGC00018135-02, NCGC00018135-03, NCGC00018135-04, NCGC00018135-05, NCGC00018135-06, NCGC00021784-03, NCGC00021784-04, NCGC00021784-05, ETYA - CAS 1191-85-1, MS-24251, HY-124108, CS-0084220, EICOSA-5,8,11,14-TETRAYNOIC ACID, NS00096692, 5,8,11,14-Eicosatetraynoic acid, >=97%, G12095, SR-01000000036, J-004079, SR-01000000036-3, SR-01000000036-4, Q27077167, Icosa‐5,8,11,14‐tetraynoic acid (D3)" C20H24O2 MGLDCXPLYOWQRP-UHFFFAOYSA-N icosa-5,8,11,14-tetraynoic acid n.a. n.a. No No No No No No PMDBD2000473 5-Bicyclic brominated furanones n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000474 5-Bromo-1-(2-chloroacetyl)indoline-2,3-dione n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000475 5-Bromoindole n.a. n.a. n.a. n.a. n.a. n.a. n.a. 24905 n.a. n.a. 5-BROMOINDOLE, 10075-50-0, 5-Bromo-1H-indole, 1H-Indole, 5-bromo-, 5-bromo indole, MFCD00005670, 5-bromo-indole, 5-bromanyl-1~{H}-indole, R8FGF42R4A, CHEMBL325917, NSC-75581, 220310-64-5, 5bromoindole, H4N, NSC75581, EINECS 233-208-7, NSC 75581, 5-bromo 1H indole, 5-Bromoindole, 99%, 5-Bromo-1H-indole #, Maybridge1_006195, UNII-R8FGF42R4A, NCIOpen2_000472, SCHEMBL74304, BIDD:GT0232, DTXSID6073996, HMS559B13, BCP26677, CS-D0617, BDBM50358747, CCG-42502, GEO-00480, s5439, AKOS000120596, AB00482, AC-1348, FS-1805, SB40564, HY-30236, PD088081, SY005268, AM20060209, B1738, NS00022999, EN300-21081, A16225, B-8420, B-8424, SR-01000632498-1, F8881-6102, Z104489174, InChI=1/C8H6BrN/c9-7-1-2-8-6(5-7)3-4-10-8/h1-5,10 C8H6BrN VXWVFZFZYXOBTA-UHFFFAOYSA-N 5-bromo-1H-indole n.a. n.a. No No No No No No PMDBD2000476 5-bromomethylene-2 (5H)-furanone n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000477 5-Chloro-1-(2-chloroacetyl)indoline-2,3-dione n.a. n.a. n.a. n.a. n.a. n.a. n.a. 11368908 n.a. n.a. 62888-31-7, 5-chloro-1-(2-chloroacetyl)indoline-2,3-dione, 1H-Indole-2,3-dione, 5-chloro-1-(chloroacetyl)-, DTXSID10463809 C10H5Cl2NO3 PEZJZULQBSQJSV-UHFFFAOYSA-N 5-chloro-1-(2-chloroacetyl)indole-2,3-dione n.a. n.a. No No No No No No PMDBD2000478 5-Chloroindole n.a. n.a. n.a. n.a. n.a. n.a. n.a. 87110 n.a. n.a. 5-Chloroindole, 17422-32-1, 5-Chloro-1H-indole, 1H-Indole, 5-chloro-, Indole, 5-chloro-, MFCD00005672, FMJ30GB9J6, CHEMBL555013, NSC-89562, 5-Chloro indole, 5-chloroindol, 5-chloro-indole, 3fue, NSC89562, EINECS 241-448-9, NSC 89562, 5-chlor-1H-indole, 5-chloranyl-1H-indole, 5-Chloroindole, 98%, UNII-FMJ30GB9J6, SCHEMBL405311, DTXSID10169793, BCP22790, STR01849, BDBM50294169, AKOS000266642, AB00485, AC-2477, BCP9000183, CG-0504, CS-W007384, HY-W007384, SY001555, AM20061192, NS00025728, EN300-68660, A22088, C-4218, C-4220, A811622, Q27451623, Z1095352660, InChI=1/C8H6ClN/c9-7-1-2-8-6(5-7)3-4-10-8/h1-5,10, 11S C8H6ClN MYTGFBZJLDLWQG-UHFFFAOYSA-N 5-chloro-1H-indole n.a. n.a. No No No No No No PMDBD2000479 5-decyl-1,3-thiazolidine-2,4-dione n.a. n.a. n.a. n.a. n.a. n.a. n.a. 71523933 n.a. n.a. n, ., a, . C13H23NO2S HYVBSAHBLNHMJI-UHFFFAOYSA-N 5-decyl-1,3-thiazolidine-2,4-dione n.a. n.a. No No No No No No PMDBD2000480 5-fluoroindole n.a. n.a. n.a. n.a. n.a. n.a. n.a. 67861 n.a. n.a. "5-Fluoroindole, 5-Fluoro-1H-indole, 399-52-0, 1H-Indole, 5-fluoro-, Indole, 5-fluoro-, MFCD00005671, ZL8W3FGT5K, CHEMBL555457, CHEBI:72818, NSC 88613, NSC-88613, 5-Fluoro indole, 5-fluoroindol, 5-fluoro-indole, 5-fluoro-indol, 3fuf, 14O, EINECS 206-917-4, 5-Fluoroindole, 98%, UNII-ZL8W3FGT5K, 5-Fluoro-1H-indole #, BIDD:GT0536, SCHEMBL228554, DTXSID10192940, AM972, BCP09868, CS-D0680, NSC88613, BDBM50294170, AKOS004117075, AB00483, AC-2259, 5-Fluoro-1H-indole;Indole, 5-fluoro-, AS-12602, HY-40156, SY003931, 5-Fluoroindole, purum, >=97.0% (GC), 1-(3-nitro-phenyl)-piperazinedihydrochloride, F0369, NS00043687, EN300-73560, A22152, F-4520, F-4525, Q27140165, Z1160902020, InChI=1/C8H6FN/c9-7-1-2-8-6(5-7)3-4-10-8/h1-5,10" C8H6FN ODFFPRGJZRXNHZ-UHFFFAOYSA-N 5-fluoro-1H-indole n.a. n.a. No No No No No No PMDBD2000481 5-fluorooxiindole n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000482 5-Hydroxy-4-[(4-methylphenyl)sulfonyl]-3-chloro-2(5H)-furanone n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000483 5-octyl-1,3-thiazolidine-2,4-dione n.a. n.a. n.a. n.a. n.a. n.a. n.a. 16058685 n.a. n.a. SCHEMBL23641349 C11H19NO2S ZCRBNUCQSVGDLG-UHFFFAOYSA-N 5-octyl-1,3-thiazolidine-2,4-dione n.a. n.a. No No No No No No PMDBD2000484 6-(4-chlorophenyl)-1,3-dimethyl-5-[3-(4-methylphenyl)-1-phenyl-1H-pyrazol-4-yl]-1H,2H,3H,4H,5H,6H-pyrimido[4,5-d][1,3]diazine-2,4-dione n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000485 6-Amino Penicillinic acid n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000486 6-Aminoflavone n.a. n.a. n.a. n.a. n.a. n.a. n.a. 16217320 n.a. n.a. 6-Aminoflavone, 4613-53-0, 6-amino-2-phenyl-4H-chromen-4-one, 6-amino-2-phenylchromen-4-one, 6-Aminoflavone 97, 6-Aminoflavone, 97%, SCHEMBL926716, CHEMBL1215529, 6-amino-2-phenyl-chromen-4-one, DTXSID00584330, YWHKBWPNCFDUPQ-UHFFFAOYSA-N, MFCD05664254, AKOS002292628, BS-28729, 6-Amino-2-phenyl-4H-1-benzopyran-4-one, CS-0204306, F2211-0001 C15H11NO2 YWHKBWPNCFDUPQ-UHFFFAOYSA-N 6-amino-2-phenylchromen-4-one n.a. n.a. No No No No No No PMDBD2000487 6-Bicyclic brominated furanones n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000488 6-Chloroindole n.a. n.a. n.a. n.a. n.a. n.a. n.a. 87111 n.a. n.a. 6-Chloroindole, 6-Chloro-1H-indole, 17422-33-2, 1H-Indole, 6-chloro-, MFCD00005681, CHEMBL511085, CHEBI:80918, NSC-58083, 6-chloro indole, 6-chloro-indole, NSC58083, EINECS 241-449-4, 6-chlor-1H-indole, Indole, 6-chloro-, 6-chloro-1-H-indole, 6-Chloroindole, 99%, 6-Chloro-1H-indole #, M4E7MR63DA, SCHEMBL75475, YTYIMDRWPTUAHP-UHFFFAOYSA-, DTXSID70169794, BCP00061, BDBM50434114, GEO-02877, NSC 58083, AKOS000265598, 6-chloro-1h-indole aka 6-chloroindole, AC-6211, CS-W001973, FS-1732, HY-W001973, SB34263, AM803344, SY002338, NS00025729, EN300-39394, A15299, C-4240, C17089, Q27151419, Z382723678, InChI=1/C8H6ClN/c9-7-2-1-6-3-4-10-8(6)5-7/h1-5,10H C8H6ClN YTYIMDRWPTUAHP-UHFFFAOYSA-N 6-chloro-1H-indole n.a. n.a. No No No No No No PMDBD2000489 6-Chlorooxindole n.a. n.a. n.a. n.a. n.a. n.a. n.a. 736344 n.a. n.a. 6-Chlorooxindole, 56341-37-8, 6-chloroindolin-2-one, 6-Chloro-2-oxindole, 6-Chloro-1,3-dihydro-2H-indol-2-one, 6-chloro-1,3-dihydroindol-2-one, 6-Chloro-2-indolinone, 6-Chloro 2-oxindole, 6-chloro-2,3-dihydro-1H-indol-2-one, 6-chloro-1,3-dihydro-indol-2-one, MFCD00209962, CHEMBL1232568, 6-chloroindole-2(3h)-one, 2H-Indol-2-one, 6-chloro-1,3-dihydro-, 6-chloro-oxindol, 6-chloro oxindole, 6-chloro-oxindole, 4k2y, 6-chloroindol-2(3h)-one, SCHEMBL221280, 6-Chloro-2-oxindole, 97%, CENVPIZOTHULGJ-UHFFFAOYSA-, AMY4028, DTXSID00353003, WLZ3259, CHEBI:194669, STR08222, BDBM50434122, AKOS000119599, AB04797, AC-2683, CS-W008657, 6-chloroindole-1,3-dihydro(2h)-2-one, 6-chloro- 1,3-dihydro-2H-indol-2-one, AC-22698, SY002545, C2024, NS00008023, EN300-17337, C-5242, 5W-0082, Q27460049, Z56922083, F0001-1479, InChI=1/C8H6ClNO/c9-6-2-1-5-3-8(11)10-7(5)4-6/h1-2,4H,3H2,(H,10,11) C8H6ClNO CENVPIZOTHULGJ-UHFFFAOYSA-N 6-chloro-1,3-dihydroindol-2-one n.a. n.a. No No No No No No PMDBD2000490 6-fluoroindole n.a. n.a. n.a. n.a. n.a. n.a. n.a. 351278 n.a. n.a. 6-Fluoroindole, 6-fluoro-1H-indole, 399-51-9, 1H-indole, 6-fluoro-, 6-fluoro indole, MFCD00056933, 6-fluoroindol, 6-fluoro-indole, NSC520436, 6-Fluoroindole, 98%, SCHEMBL444450, CHEMBL107324, DTXSID10325857, AM971, BCP26890, AKOS005146262, AC-3155, BH-0438, CS-W002271, HY-W002271, NSC 520436, NSC-520436, PB12993, SY004098, F0352, EN300-39393, A15555, F-4540, Z382723676, InChI=1/C8H6FN/c9-7-2-1-6-3-4-10-8(6)5-7/h1-5,10 C8H6FN YYFFEPUCAKVRJX-UHFFFAOYSA-N 6-fluoro-1H-indole n.a. n.a. No No No No No No PMDBD2000491 6-Gingerol Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D0Y1YR 442793 n.a. NPC20287 "6-Gingerol, gingerol, 23513-14-6, [6]-Gingerol, (6)-Gingerol, (S)-(+)-[6]Gingerol, (S)-(6)-Gingerol, (S)-5-Hydroxy-1-(4-hydroxy-3-methoxyphenyl)decan-3-one, (5S)-5-hydroxy-1-(4-hydroxy-3-methoxyphenyl)decan-3-one, 1391-73-7, 3-Decanone, 5-hydroxy-1-(4-hydroxy-3-methoxyphenyl)-, (5S)-, (5S)-5-hydroxy-1-(4-hydroxy-3-methoxyphenyl)-3-decanone, UNII-925QK2Z900, CHEBI:10136, (+)-[6]-Gingerol, (+)-5-Hydroxy-1-(4-hydroxy-3-methoxyphenyl)-3-decanone, (S)-5-Hydroxy-1-(4-hydroxy-3-methoxyphenyl)-3-decanone, 925QK2Z900, C17-H26-O4, CHEMBL402978, (5S)-5-Hydroxy-1-(4-hydroxy-3-methoxy-phenyl)decan-3-one, 3-Decanone, 5-hydroxy-1-(4-hydroxy-3-methoxyphenyl)-, (S)-, MFCD00210507, 3-Decanone, 5-hydroxy-1-(4-hydroxy-3-methoxyphenyl)-, (S)-(+)-, 5-Hydroxy-1-(4''-hydroxy-3''-methoxyphenyl)-3-decanone, BDBM50317427, (S)-(+)-[6]Gingerol;6-Gingerol, 5-Hydroxy-1-(4-hydroxy-3-methoxyphenyl)-3-decanone, CBiol_001786, SCHEMBL32102, BSPBio_001347, KBioGR_000067, KBioSS_000067, (6)-GINGEROL [MI], CHEMBL446043, GTPL2428, DTXSID3041035, KBio2_000067, KBio2_002635, KBio2_005203, KBio3_000133, KBio3_000134, NLDDIKRKFXEWBK-AWEZNQCLSA-N, Bio1_000072, Bio1_000561, Bio1_001050, Bio2_000067, Bio2_000547, HMS1361D09, HMS1791D09, HMS1989D09, HMS3402D09, SRCG-00265, [6]-Gingerol, analytical standard, BDBM50275147, CA-422, s3836, [6]-Gingerol, >=98% (HPLC), AKOS015888215, CCG-208033, CCG-208214, CS-6333, IDI1_033817, NCGC00163131-01, NCGC00163131-02, NCGC00163131-03, AC-33934, DS-12369, HY-14615, 1ST000358, 6-GINGEROL (CONSTITUENT OF GINGER), NS00027445, C10462, 6-GINGEROL (CONSTITUENT OF GINGER) [DSC], A816759, Q421081, SR-05000002341, Q-100300, SR-05000002341-2, W-205525, BRD-K26117720-001-02-2, (S)-5-Hydroxy-1-(4-hydroxy-3-methoxy-phenyl-3-decanone, [1-(4''''-hydroxy-3''''-methoxyphenyl)-5-hydroxy-3-decanone]" C17H26O4 NLDDIKRKFXEWBK-AWEZNQCLSA-N (5S)-5-hydroxy-1-(4-hydroxy-3-methoxyphenyl)decan-3-one n.a. n.a. No No No No No No PMDBD2000492 6-hydroxyflavone n.a. n.a. n.a. n.a. n.a. n.a. n.a. 72279 n.a. n.a. 6-Hydroxyflavone, 6665-83-4, 6-hydroxy-2-phenylchromen-4-one, 6-Hydroxy-2-phenyl-4-benzopyrone, 6-Hydroxy-2-phenyl-4H-chromen-4-one, 6-Monohydroxyflavone, 6-Hydroxy-2-phenyl-chromen-4-one, NSC-26744, MLS000738065, 4H-1-Benzopyran-4-one, 6-hydroxy-2-phenyl-, CHEMBL138649, CHEBI:34472, NSC26744, MFCD00017329, 148S6Z78H6, EINECS 229-704-8, NSC 26744, Diisononyladipate, UNII-148S6Z78H6, 6-hydroxy-flavone, 6-Hydroxyflavone, 10, 6-Hydroxyflavone, 98%, 6-Hydroxyflavone (6-HF), HYDROXYFLAVONE, 6-, FLAVONE, 6-HYDROXY-, BIDD:ER0190, SCHEMBL676594, 6-HF, MEGxp0_001697, DTXSID8022327, ACon1_002026, HMS2764K07, HMS3885I17, HY-N7110, BDBM50081950, s3634, AKOS002670169, CCG-214625, NCGC00179903-01, NCGC00179903-03, 6-Hydroxy-2-phenyl-4H-chromen-4-one #, AS-57550, PD001907, SMR000393737, 6-hydroxy-2-phenyl-4-oxo-4H-1-benzopyran, CS-0030698, H0851, NS00046378, 4H-1-Benzopyran-4-one,6-hydroxy-2-phenyl-, D90962, Q2817908, BRD-K04253610-001-01-6 C15H10O3 GPZYYYGYCRFPBU-UHFFFAOYSA-N 6-hydroxy-2-phenylchromen-4-one n.a. n.a. No No No No No No PMDBD2000493 6-MO-LF11-215 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000494 6-MO-LF11-227 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000495 6-MO-LF11-322 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000496 7-Bicyclic brominated furanones n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000497 7-bromoindole n.a. n.a. n.a. n.a. n.a. n.a. n.a. 2757020 n.a. n.a. 7-Bromoindole, 7-bromo-1H-indole, 51417-51-7, MFCD00799492, 1H-INDOLE, 7-BROMO-, 7-bromoindol, 7-bromo-indole, 7-brom-1H-indole, 7-Bromoindole, 96%, BIDD:GT0121, SCHEMBL445281, DTXSID30373698, BCP00953, AKOS005206885, AC-5107, CS-W002687, HY-W002687, MS-1993, PB29115, SY013868, A7581, AM20060208, B2873, EN300-98387, B-8450, F1905-7199 C8H6BrN RDSVSEFWZUWZHW-UHFFFAOYSA-N 7-bromo-1H-indole n.a. n.a. No No No No No No PMDBD2000498 7-chloroindole n.a. n.a. n.a. n.a. n.a. n.a. n.a. 104644 n.a. n.a. 7-Chloroindole, 53924-05-3, 7-Chloro-1H-indole, 1H-Indole, 7-chloro-, MFCD01321301, 7-chloro-indole, Indole, 7-chloro, EINECS 258-865-7, 3,5-xylyloxyaceticacid, 7-Chloroindole, 97%, TP2MHC8CJ2, BIDD:GT0137, SCHEMBL443938, CHEMBL111579, DTXSID80202207, BCP26628, AKOS005174238, CS-W020039, FS-2241, SB14992, AC-24620, SY029004, A7832, AM20060937, C2436, NS00032876, C-4250, EN300-117693, 7-Chloro-1H-indole pound>>1H-Indole, 7-chloro-, Z1255488512 C8H6ClN WMYQAKANKREQLM-UHFFFAOYSA-N 7-chloro-1H-indole n.a. n.a. No No No No No No PMDBD2000499 7-chloroquinolin-4-ol n.a. n.a. n.a. n.a. n.a. n.a. n.a. 66593 n.a. n.a. 7-Chloroquinolin-4-ol, 7-Chloro-4-hydroxyquinoline, 86-99-7, 7-chloroquinolin-4(1H)-one, 23833-97-8, 7-Chloro-4-quinolinol, 7-chloro-1H-quinolin-4-one, chloroxoquinoline, 4-Quinolinol, 7-chloro-, 7-chloro-quinolin-4-ol, 7-Chloro-4-keto-quinoline, 23FWH4CH0U, MLS000517803, CHEMBL1409793, KUC100209, MFCD00006778, NSC-38928, 4(1H)-Quinolinone, 7-chloro-, 7-chloro-4(1H)-quinolinone, 4mrw, NSC38928, EINECS 201-715-2, NSC 38928, 7-Chloro4-quinolinol, UNII-23FWH4CH0U, SCHEMBL409748, AMY340, DTXSID90235344, CHLOROXOQUINOLINE [WHO-DD], HMS2203H11, HMS3349G17, KUC100209N, BDBM50532260, MFCD20542777, AKOS002683703, AKOS015998208, CCG-321470, CS-W017251, SB67538, SB67621, NCGC00247321-01, AS-47497, PD063051, SMR000129049, SY016725, SY296663, CS-0166875, NS00039162, E76575, EN300-223987, F13945, A841908, AE-641/13516197, W-104048, Q27463509, Z1255464975, MRW C9H6ClNO XMFXTXKSWIDMER-UHFFFAOYSA-N 7-chloro-1H-quinolin-4-one n.a. n.a. No No No No No No PMDBD2000500 7-fluoroindole n.a. n.a. n.a. n.a. n.a. n.a. n.a. 2774504 n.a. n.a. 7-fluoroindole, 7-fluoro-1H-indole, 387-44-0, MFCD01074502, 1H-INDOLE, 7-FLUORO-, PHENYLZINCBROMIDE, 7-fluoranyl-1H-indole, SCHEMBL446638, 7-Fluoro-1H-indole, 97%, AMY3673, DTXSID60379062, 7-Fluoro-1H-indole, AldrichCPR, XONKJZDHGCMRRF-UHFFFAOYSA-N, BCP26708, AKOS005063961, AC-1891, CS-W007613, HY-W007613, PB18526, PS-9128, SY003992, A6536, F0555, EN300-96231, F-4550, A824264 C8H6FN XONKJZDHGCMRRF-UHFFFAOYSA-N 7-fluoro-1H-indole n.a. n.a. No No No No No No PMDBD2000501 7-fluoroindoline-2,3-dione n.a. n.a. n.a. n.a. n.a. n.a. n.a. 586418 n.a. n.a. "7-Fluoroisatin, 317-20-4, 7-fluoroindoline-2,3-dione, 7-Fluoro-1H-indole-2,3-dione, 1H-Indole-2,3-dione, 7-fluoro-, 7-Fluoroindole-1H-2,3-dione, 7-fluoro-2,3-dihydro-1H-indole-2,3-dione, 7-Fluoro-2,3-dihydro-1H-indol-2,3-dione, MFCD01569508, 7-fluoro-2,3-indolinedione, 7-Fluoroindole-2,3-dione, 7-Fluoroisatin Form I, 7-Fluoroisatin, 96%, Isatin-based compound, 42, SCHEMBL281604, CHEMBL224988, 7-Fluoro-1H-indol-2,3-dione, BDBM22822, HGBGVEOXPHGSOS-UHFFFAOYSA-, DTXSID90342986, 7-fluoro- 1H-indole-2,3-dione, 7-fluoro-1 H-indole-2,3-dione, BCP21682, 7-Fluoro-1H-indole-2,3-dione #, AC-439, AKOS000142982, AB09245, CS-W009274, FS-1261, SY009282, AM20060261, F0551, EN300-73880, 7-Fluoro-1H-indole-2,3-dione;7-Fluoroisatin, F-5610, InChI=1/C8H4FNO2/c9-5-3-1-2-4-6(5)10-8(12)7(4)11/h1-3H,(H,10,11,12)" C8H4FNO2 HGBGVEOXPHGSOS-UHFFFAOYSA-N 7-fluoro-1H-indole-2,3-dione n.a. n.a. No No No No No No PMDBD2000502 7-formylindole n.a. n.a. n.a. n.a. n.a. n.a. n.a. 2734629 n.a. n.a. Indole-7-carboxaldehyde, 1H-indole-7-carbaldehyde, 1074-88-0, 7-Formylindole, 7-formyl indole, 1H-INDOLE-7-CARBOXALDEHYDE, MFCD01318152, indole-7-carbaldehyde, 7-Formyl-1H-indole, 7-indolcarboxaldehyde, 7-Indolecarboxaldehyde, 7-indole carboxaldehyde, Indole-7-carboxaldehyde (7-Formylindole), 1H-indole-7-carbaldehyd, Indole -7-carboxaldehyde, SCHEMBL97592, Indole-7-carboxaldehyde, 97%, AMY6754, DTXSID50370407, CHEBI:151092, AKOS005254735, AB08653, CS-W008013, HY-W008013, PS-3330, AC-22444, SY007723, EN300-66980, I-2206, Z1065768468 C9H7NO XQVZDADGTFJAFM-UHFFFAOYSA-N 1H-indole-7-carbaldehyde n.a. n.a. No No No No No No PMDBD2000503 7-hydroxyindole n.a. n.a. n.a. n.a. n.a. n.a. n.a. 2737651 n.a. n.a. 7-hydroxyindole, 1H-indol-7-ol, 2380-84-9, 7-HYDROXY-1H-INDOLE, INDOL-7-OL, OR3V96LY5G, J467.723D, 7-hydroxy indole, 7-hydroxy-indole, UNII-OR3V96LY5G, 7-hydroxyindole, AldrichCPR, SCHEMBL109665, CHEMBL3634136, DTXSID5042669, ORVPXPKEZLTMNW-UHFFFAOYSA-N, AMY18001, MFCD00152102, AKOS006230012, AB04040, CS-W005047, PS-3281, AC-19417, A4966, H-6080, A816916 C8H7NO ORVPXPKEZLTMNW-UHFFFAOYSA-N 1H-indol-7-ol n.a. n.a. No No No No No No PMDBD2000504 7-methoxyindole n.a. n.a. n.a. n.a. n.a. n.a. n.a. 76660 n.a. n.a. "7-Methoxyindole, 7-Methoxy-1H-indole, 3189-22-8, 7-methoxy indole, 1H-Indole, 7-methoxy-, Indole, 7-methoxy-, MFCD00047203, 9R05QK9RP4, NSC 100739, NSC-100739, 7-methoxy-indole, EINECS 221-690-1, NSC100739, 7-Methoxyindole, 97%, 7-(methyloxy)-1H-indole, UNII-9R05QK9RP4, 1H-Indol-7-yl methyl ether, SCHEMBL594125, 1H-Indol-7-yl methyl ether #, CHEMBL2018156, DTXSID90185739, BCP26417, GEO-01685, AKOS005257650, AB02030, AC-4545, CS-W001536, PS-3733, SY009284, A5745, AM20060359, M1751, NS00029192, 7-Methoxy-1H-indole;1H-Indole, 7-methoxy-, EN300-77222, M-3464, A875773, Q27896707, Z1192378717, InChI=1/C9H9NO/c1-11-8-4-2-3-7-5-6-10-9(7)8/h2-6,10H,1H" C9H9NO FSOPPXYMWZOKRM-UHFFFAOYSA-N 7-methoxy-1H-indole n.a. n.a. No No No No No No PMDBD2000505 7-methylindole n.a. n.a. n.a. n.a. n.a. n.a. n.a. 70275 n.a. n.a. "7-Methylindole, 933-67-5, 7-Methyl-1H-indole, 1H-Indole, 7-methyl-, 7-Methylindol, Indole, 7-methyl-, MFCD00005684, 7Z1E6HIT9S, CHEMBL326430, NSC-618, 7-methyl-indole, 7-methyindole, UNII-7Z1E6HIT9S, NSC 618, EINECS 213-270-1, 7-Methylindole, 97%, 7-Methyl-1H-indole #, BIDD:GT0219, SCHEMBL129649, NSC618, DTXSID60239374, BCP26569, AB2914, BDBM50232879, AKOS005202960, AB00504, CG-0508, CS-W007670, HY-W007670, Indole, 7-methyl-;7-Methyl-1H-indole, SY005774, AM20061183, M1702, NS00039551, EN300-74873, M-3944, Q4642877, F0001-2248, Z1171217428, InChI=1/C9H9N/c1-7-3-2-4-8-5-6-10-9(7)8/h2-6,10H,1H" C9H9N KGWPHCDTOLQQEP-UHFFFAOYSA-N 7-methyl-1H-indole n.a. n.a. No No No No No No PMDBD2000506 7-nitroindole n.a. n.a. n.a. n.a. n.a. n.a. n.a. 23396 n.a. n.a. 7-Nitroindole, 7-Nitro-1H-indole, 6960-42-5, 1H-Indole, 7-nitro-, INDOLE, 7-NITRO-, NSC 69874, MFCD00005683, BRN 0130874, 7-nitro indole, NSC69874, 7-Nitroindole, 97%, 5-20-07-00044 (Beilstein Handbook Reference), SCHEMBL259909, CHEMBL164632, DTXSID20219879, NSC-69874, AKOS005207160, AB00500, AC-3141, CS-W001974, HY-W001974, PS-5704, SY004017, A9204, AM20060938, N0685, EN300-118948, N-3040, Z1255382963 C8H6N2O2 LZJGQIVWUKFTRD-UHFFFAOYSA-N 7-nitro-1H-indole n.a. n.a. No No No No No No PMDBD2000507 7P-AC n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000508 8-fluoroquinoline n.a. n.a. n.a. n.a. n.a. n.a. n.a. 67856 n.a. n.a. 8-Fluoroquinoline, 394-68-3, Quinoline, 8-fluoro-, MFCD01685514, WC3ZS5FY7R, NSC-51786, CCRIS 2891, BRN 0114548, NSC51786, 8-Fluoro-quinolinium, UNII-WC3ZS5FY7R, FLUOROQUINOLINE, 8-, 8-Fluoroquinoline, AldrichCPR, SCHEMBL1538341, CHEMBL1162366, DTXSID60192591, RNAAXKYOTPSFGV-UHFFFAOYSA-N, BCP19389, NSC 51786, AKOS005259248, AC-3295, CS-W001560, PS-6513, R)-(+)-methyl(R)-2-chloropropionate, SB67539, SY004608, F1185, NS00125050, EN300-27706, A824560, W-200551, Z243277338 C9H6FN RNAAXKYOTPSFGV-UHFFFAOYSA-N 8-fluoroquinoline n.a. n.a. No No No No No No PMDBD2000509 9-hydroxy-2-propyl-4H-pyrido[1,2-a]pyrimidin-4-one n.a. n.a. n.a. n.a. n.a. n.a. n.a. 12219996 n.a. n.a. SCHEMBL2906516, TXFWVAQBEGQXIX-UHFFFAOYSA-N, AKOS015971183, 9-hydroxy-2-propyl-4H-pyrido[1,2-a]pyrimidin-4-one C11H12N2O2 TXFWVAQBEGQXIX-UHFFFAOYSA-N 9-hydroxy-2-propylpyrido[1,2-a]pyrimidin-4-one n.a. n.a. No No No No No No PMDBD2000510 A-3 n.a. n.a. n.a. n.a. n.a. n.a. n.a. 1960 n.a. n.a. N-(2-Aminoethyl)-5-chloronaphthalene-1-sulfonamide, 83298-75-3, CHEMBL219301, Tocris-0366, CBiol_002054, BSPBio_001382, A-3, SCHEMBL2739414, DTXSID00274345, CHEBI:107666, Bio1_000340, Bio1_000829, Bio1_001318, HMS1791F04, HMS1989F04, HMS3402F04, N-(2-AMINOETHYL)-5-CHLORO-NAPHTHALENE-1-SULFONAMIDE, BDBM50375645, SDCCGSBI-0633780.P001, NCGC00024555-01, NCGC00024555-02, NCGC00024555-03, NCGC00024555-04, NCGC00024555-05, NCGC00024555-06, N-(2-aminoethyl)-5-chloro-1-naphthalenesulfonamide, BRD-K51215422-001-02-3, BRD-K51215422-003-01-1, Q27185988, 5-Chloro-naphthalene-1-sulfonic acid, (2-amino-ethyl)-amide C12H13ClN2O2S ACIMRXKJKQGBGL-UHFFFAOYSA-N N-(2-aminoethyl)-5-chloronaphthalene-1-sulfonamide n.a. n.a. No No No No No No PMDBD2000511 AAP2 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000512 Abacavir Therapeutic Substance Approved Drug 136470-78-5 DB01048 PA448004 D07057 D0A4IJ 441300 390063 n.a. "abacavir, 136470-78-5, Ziagen, Abacavir sulfate, 1592U89, Abacavir [INN], (1S,4R)-4-[2-Amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol, Abacavir (INN), CHEBI:421707, WR2TIP26VS, ((1S,4R)-4-(2-amino-6-(cyclopropylamino)-9H-purin-9-yl)cyclopent-2-en-1-yl)methanol, MFCD00903850, [(1S,4R)-4-[2-amino-6-(cyclopropylamino)purin-9-yl]cyclopent-2-en-1-yl]methanol, {(1S-cis)-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]cyclopent-2-en-1-yl}methanol, 2-Cyclopentene-1-methanol, 4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-, (1S,4R)-, NSC-742406, [(1S,4R)-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]cyclopent-2-en-1-yl]methanol, [(1s,4r)-4-[2-amino-6-(cyclopropylamino)purin-9-yl]-1-cyclopent-2-enyl]methanol, Avacavir, ABC, 136777-48-5, (1S,4R)-4-(2-amino-6-(cyclopropylamino)-9H-purin-9-yl)-2-cyclopentene-1-methanol, 2-Cyclopentene-1-methanol, 4-(2-amino-6-(cyclopropylamino)-9H-purin-9-yl)-, (1S-cis)-, (+/-)-Abacavir, Abacavir [INN:BAN], UNII-WR2TIP26VS, DTXSID4046444, NSC742406, Ziagen (TM)(*Succinate salt*), {(1S,4R)-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]cyclopent-2-en-1-yl}methanol, 2-Cyclopentene-1-methanol, 4-(2-amino-6-(cyclopropylamino)-9H-purin-9-yl)-, (1S,4R)-, NCGC00164560-01, ABACAVIR [MI], ABACAVIR [VANDF], AVACAVIR [VANDF], ABACAVIR [MART.], ABACAVIR [WHO-DD], Epitope ID:137341, ABACAVIR [EMA EPAR], CHEMBL1380, SCHEMBL38632, MLS006010117, GTPL11152, MCGSCOLBFJQGHM-SCZZXKLOSA-N, SRCA-00004, BCP07728, Abacavir (1.0 mg/mL in Methanol), BDBM50366816, s5215, AKOS024464970, AC-1299, CCG-267342, CS-1354, DB01048, DT-0030, NSC 742406, (+/-)-4-[2-Amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol, (-)-CIS-4-(2-AMINO-6-(CYCLOPROPYLAMINO)-9H-PURIN-9-YL)-2-CYCLOPENTENE-1-METHANOL, NCGC00164560-02, NCGC00164560-05, NCGC00164560-17, BA166801, HY-17423, SMR004701251, NS00007385, C07624, D07057, EN300-258000, AB01566826_01, A807079, A905952, Q304330, J-700136, ((1s,4r)-4-(2-amino-6-(cyclopropylamino)-9h-purin-9-yl)cyclopent-2-enyl)methanol, (+/-)-cis-4-[2-Amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol, [(1S,4R)-4-[2-amino-6-(cyclopropylamino)purin-9-yl]cyclopent-2-en-1-yl]methanol;Abacavir" C14H18N6O MCGSCOLBFJQGHM-SCZZXKLOSA-N [(1S,4R)-4-[2-amino-6-(cyclopropylamino)purin-9-yl]cyclopent-2-en-1-yl]methanol GlaxoSmithKline Anti-HIV Agents No No No No No No PMDBD2000513 Aceroside VIII n.a. n.a. n.a. n.a. n.a. n.a. n.a. 21637600 n.a. NPC178449 Aceroside VIII, (2R,3R,4S,5S,6R)-2-[(3R)-1,7-bis(4-hydroxyphenyl)heptan-3-yl]oxy-6-[[(2R,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxymethyl]oxane-3,4,5-triol, CHEMBL1774773, CHEBI:184017, Aceroside VIII, >=95% (LC/MS-ELSD), (2R,3R,4S,5S,6R)-2-(((R)-1,7-Bis(4-hydroxyphenyl)heptan-3-yl)oxy)-6-((((2R,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)tetrahydrofuran-2-yl)oxy)methyl)tetrahydro-2H-pyran-3,4,5-triol C30H42O12 JLMGCBFIPZDHLZ-GYOMMSMMSA-N (2R,3R,4S,5S,6R)-2-[(3R)-1,7-bis(4-hydroxyphenyl)heptan-3-yl]oxy-6-[[(2R,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxymethyl]oxane-3,4,5-triol n.a. n.a. No No No No No No PMDBD2000514 Acetohydroxamic Acid Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. D0R9BG 1990 n.a. NPC319972 acetohydroxamic acid, N-Hydroxyacetamide, 546-88-3, Lithostat, Methylhydroxamic acid, Acetic acid, oxime, Acetylhydroxamic acid, Acetohydroximic acid, N-Acetylhydroxylamine, Acetamide, N-hydroxy-, Acethydroxamsaeure, cetohyroxamic acid, N-Acetyl hydroxyacetamide, Acethydroxamsaure, Acethydroxamic acid, Acetohydroxamate, Hydroxylamine, N-acetyl-, Acido acetohidroxamico, AHA, Acide acetohydroxamique, Acidum acetohydroxamicum, Acetyl hydroxyamino, ACETOHYDROXAMICACID, n-hydroxy-acetamide, CCRIS 1730, NSC 176136, Acidum acetohydroxamicum [Latin], HSDB 3585, EINECS 208-913-8, UNII-4RZ82L2GY5, NSC-176136, 4RZ82L2GY5, DTXSID7022546, CHEBI:27777, AI3-62232, MFCD00009994, DTXCID802546, Acetamide, N-hydroxy- (9CI), NSC176136, Acetohydroxamic acid [USAN:USP:INN], NCGC00094576-01, WLN: QMV1, Acethydroxamsaeure [German], Acidum acetohydroxamicum (Latin), oxime, Acide acetohydroxamique [French], Acido acetohidroxamico [Spanish], ACETOHYDROXAMIC ACID (MART.), ACETOHYDROXAMIC ACID [MART.], ACETOHYDROXAMIC ACID (USP-RS), ACETOHYDROXAMIC ACID [USP-RS], Acetohydroxamic acid (USAN:USP:INN), Lithostat (TN), CAS-546-88-3, ACETOHYDROXAMIC ACID (USP MONOGRAPH), ACETOHYDROXAMIC ACID [USP MONOGRAPH], N-hydroxyacetimidic acid, N-hydroxyethanimidic acid, acetohydroxamsaure, Acetohydroxamic acid (USP/INN), Acetic acid|oxime, acethydroximic acid, Acetohyroxamic acid, Acetyl hydroxyamine, Prestwick_38, acetohydroxamic-acid, N-oxidanylethanamide, acetohydroxarnic acid, methyl hydroximic acid, Spectrum_000020, Spectrum2_000109, Spectrum3_000285, Spectrum4_000138, Spectrum5_000812, CH3C(O)NHOH, 2-Hydroxyamino-2-ethanal, CHEMBL734, Acetohydroxamic acid, 98%, BSPBio_001790, KBioGR_000556, KBioSS_000360, MLS001076662, DivK1c_000821, SPECTRUM1500103, SPBio_000098, CHEBI:49029, HMS502J03, KBio1_000821, KBio2_000360, KBio2_002928, KBio2_005496, KBio3_001290, ACETOHYDROXAMIC ACID [MI], G04BX03, NSC5073, NINDS_000821, ACETOHYDROXAMIC ACID (AHA), ACETOHYDROXAMIC ACID [INN], HMS1920A07, HMS2091G07, HMS2231M17, Pharmakon1600-01500103, ACETOHYDROXAMIC ACID [HSDB], ACETOHYDROXAMIC ACID [USAN], HY-B1235, NSC-5073, STR08084, ACETOHYDROXAMIC ACID [VANDF], Tox21_111301, BDBM50099857, CCG-38927, GEO-00010, NSC755855, s4602, ACETOHYDROXAMIC ACID [WHO-DD], AKOS000172340, Tox21_111301_1, AB01014, CS-4881, DB00551, NSC-755855, IDI1_000821, NCGC00094576-02, NCGC00094576-03, NCGC00094576-05, ACETOHYDROXAMIC ACID [ORANGE BOOK], BP-13320, SMR000499570, SBI-0051270.P003, A0051, AM20100343, NS00018656, EN300-36948, C06808, D00220, AB00051907_07, A830321, Q481822, SR-01000763642, SR-01000763642-2, W-105609, Z59181917, Acetohydroxamic acid, United States Pharmacopeia (USP) Reference Standard C2H5NO2 RRUDCFGSUDOHDG-UHFFFAOYSA-N N-hydroxyacetamide n.a. Antiinfective Agents No No No No No No PMDBD2000515 Acetycholine n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000516 Aciclovir Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. D0B5MP 135398513 n.a. n.a. "acyclovir, Aciclovir, Acycloguanosine, 59277-89-3, Zovirax, Virorax, Vipral, Wellcome-248U, Aciclovirum, 9-[(2-Hydroxyethoxy)methyl]guanine, Sitavig, Zovir, 2-Amino-9-((2-hydroxyethoxy)methyl)-1H-purin-6(9H)-one, Gerpevir, Hascovir, Acyclovir-side chain-2-3H, Aciclovirum [Latin], Acicloftal, Cargosil, Novirus, 9-(2-Hydroxyethoxy)methylguanine, 9-HYROXYETHOXYMETHYLGUANINE, W-248-U, 9-((2-Hydroxyethoxy)methyl)guanine, Aciclovirum [INN-Latin], BW-248U, DRG-0008, CCRIS 1953, CHEBI:2453, NSC 645011, 141294-79-3, HSDB 6511, UNII-X4HES1O11F, 2-Amino-1,9-dihydro-9-((2-hydroxyethoxy)methyl)-6H-purin-6-one, EINECS 261-685-1, X4HES1O11F, Aciclovir [INN], MFCD00057880, NSC-645011, NSC-758477, AVACLYR, 2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one, DTXSID1022556, Acyclovir (Aciclovir), 2-Amino-1,9-dihydro-9-[(2-hydroxyethoxy)methyl]-6H-purin-6-one, 2-Amino-9-[(2-hydroxyethoxy)methyl]-1,9-dihydro-6H-purin-6-one, 6H-Purin-6-one, 2-amino-1,9-dihydro-9-[(2-hydroxyethoxy)methyl]-, ACYCLOVIR-SIDECHAIN-2-3H, Acyclovir [USAN:USP], Zovirax (TN), NSC645011, 9-[(2-Hydroxyethoxy)-methyl]guanine, 2-amino-9-(2-hydroxyethoxymethyl)-1H-purin-6-one, MLS000069633, DTXCID102556, Activir, 9-(2-Hydroxyethoxymethyl)guanine, 6H-Purin-6-one, 2-amino-1,9-dihydro-9-((2-hydroxyethoxy)methyl)-, Aciclovirum (Latin), AC2, Acyclovir [USAN], 2-amino-9-((2-hydroxyethoxy)methyl)-3H-purin-6(9H)-one, NCGC00015061-02, Aciclovier, SMR000058225, Genvir, Maynar, Zyclir, Acyclovir (USAN:USP), ACICLOVIR (IARC), ACICLOVIR [IARC], 2-amino-9-[(2-hydroxyethoxy)methyl]-6,9-dihydro-3H-purin-6-one, CAS-59277-89-3, Aciclovirum (INN-Latin), 6H-Purin-6-one, 1,9-dihydro-2-amino-9-((2-hydroxyethoxy)methyl)-, 2-amino-9-(2-hydroxyethoxymethyl)purin-6-ol, ACICLOVIR (MART.), ACICLOVIR [MART.], ACYCLOVIR (USP-RS), ACYCLOVIR [USP-RS], ACICLOVIR (EP MONOGRAPH), ACICLOVIR [EP MONOGRAPH], ACYCLOVIR (USP MONOGRAPH), ACYCLOVIR [USP MONOGRAPH], Viropump, AcycloFoam, 2-amino-9-((2-hydroxyethoxy)methyl)-1,9-dihydro-6H-purin-6-one, Acic, C8H11N5O3, 2-amino-9-{[(2-hydroxyethyl)oxy]methyl}-1,9-dihydro-6H-purin-6-one, Acyclo-V, Acyclovir Lauriad, Acyclovir (USP), 88713-38-6, SR-01000075540, ACV & Pluronic F-68, VALACICLOVIR HYDROCHLORIDE IMPURITY B (EP IMPURITY), VALACICLOVIR HYDROCHLORIDE IMPURITY B [EP IMPURITY], Aclovir, Acyclovir & Pluronic F-68, Cyclovir, Poviral, Sitavir, VALACICLOVIR HYDROCHLORIDE HYDRATE IMPURITY B (EP IMPURITY), VALACICLOVIR HYDROCHLORIDE HYDRATE IMPURITY B [EP IMPURITY], Prestwick_6, 1pwy, BW-248-U, Sitavig (TN), Spectrum_001739, ACICLOVIR [JAN], ACYCLOVIR [MI], ACYCLOVIR [HSDB], Opera_ID_1674, Prestwick0_000086, Prestwick1_000086, Prestwick2_000086, Prestwick3_000086, Spectrum2_001563, Spectrum3_001874, Spectrum4_000225, Spectrum5_001093, ACYCLOVIR [VANDF], Lopac-A-4669, Aciclovir (JP17/INN), CHEMBL184, A 4669, ACICLOVIR [WHO-DD], ACICLOVIR [WHO-IP], SCHEMBL3175, Lopac0_000037, ACICLOVIRUM [WHO-IP], BSPBio_000012, BSPBio_003348, KBioGR_000889, KBioSS_002219, BIDD:GT0646, DivK1c_000185, SPECTRUM1503603, SPBio_001466, SPBio_001951, 2-amino-9-[(2-hydroxyethoxy)methyl]hydropurin-6-one, BPBio1_000014, GTPL4829, SCHEMBL9828560, 9(2-hydroxyethoxymethyl)guanine, ACYCLOVIR [ORANGE BOOK], HMS500J07, KBio1_000185, KBio2_002219, KBio2_004787, KBio2_007355, KBio3_002850, D06BB03, J05AB01, S01AD03, NINDS_000185, HMS1568A14, HMS1922E08, HMS2090G09, HMS2095A14, HMS2234K21, HMS3259N10, HMS3260G15, HMS3269M15, HMS3372K02, HMS3413D21, HMS3655C14, HMS3677D21, HMS3712A14, Pharmakon1600-01503603, BCP11036, 9-(2-hydroxyethoxy methyl) guanine, Tox21_110075, Tox21_500037, 69657-51-8 (Na salt), BDBM50021776, BDBM50103518, CCG-39909, NSC335752, NSC758477, NSC780378, s1807, AKOS000656213, AKOS015995680, AKOS022135433, Tox21_110075_1, AC-8068, CS-1353, DB00787, KS-1027, LP00037, NC00717, NSC-780378, SDCCGSBI-0050026.P003, IDI1_000185, SMP1_000007, NCGC00015061-01, NCGC00015061-03, NCGC00015061-04, NCGC00015061-05, NCGC00015061-06, NCGC00015061-07, NCGC00015061-08, NCGC00015061-09, NCGC00015061-10, NCGC00015061-12, NCGC00015061-13, NCGC00015061-28, NCGC00015061-29, NCGC00022426-03, NCGC00093555-01, NCGC00093555-02, NCGC00093555-03, NCGC00093555-04, NCGC00167756-01, NCGC00167756-02, NCGC00260722-01, NCGC00381719-03, HY-17422, SY051130, Acycloguanosine, >=99% (HPLC), powder, Aciclovir 1.0 mg/ml in Dimethyl Sulfoxide, AM20100442, EU-0100037, NS00009000, SW196324-3, C06810, D00222, EN300-123010, A832236, A935190, Q147101, Q-200591, SR-01000075540-1, SR-01000075540-3, SR-01000075540-5, 2-azanyl-9-(2-hydroxyethyloxymethyl)-3H-purin-6-one, BRD-K32318651-001-17-9, Aciclovir, British Pharmacopoeia (BP) Reference Standard, F2173-0946, Z1546610471, Aciclovir, European Pharmacopoeia (EP) Reference Standard, 2-Amino-9-(2-hydroxy-ethoxymethyl)-5,9-dihydro-purin-6-one, Acyclovir, United States Pharmacopeia (USP) Reference Standard, 2-amino-9-((2-hydroxyethoxy)methyl)-3,9-dihydro-6H-purin-6-one, 2-Amino-9-(2-hydroxy-ethoxymethyl)-5,9-dihydro-purin-6-one (ACV), 2-Amino-9-[(2-hydroxyethoxy)methyl]-1,9-dihydro-6H-purin-6-one #, ACV; Acycloguanosine; Acyclovir; NSC 645011; NSC-645011; NSC645011, Acyclovir, Pharmaceutical Secondary Standard; Certified Reference Material, Aciclovir for peak identification 1, European Pharmacopoeia (EP) Reference Standard, Aciclovir for peak identification 2, European Pharmacopoeia (EP) Reference Standard, Aciclovir for system suitability, European Pharmacopoeia (EP) Reference Standard, InChI=1/C8H11N5O3/c9-8-11-6-5(7(15)12-8)10-3-13(6)4-16-2-1-14/h3,14H,1-2,4H2,(H3,9,11,12,15" C8H11N5O3 MKUXAQIIEYXACX-UHFFFAOYSA-N 2-amino-9-(2-hydroxyethoxymethyl)-1H-purin-6-one GlaxoSmithKline Antiviral Agents No No No No No No PMDBD2000517 Adamantane dodecyl beta-maltoside n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000518 AFP1 n.a. n.a. n.a. n.a. n.a. n.a. n.a. 5484726 n.a. n.a. Aflatoxin P1, 32215-02-4, (3S,7R)-11-hydroxy-6,8,19-trioxapentacyclo[10.7.0.02,9.03,7.013,17]nonadeca-1(12),2(9),4,10,13(17)-pentaene-16,18-dione, 11-Hydroxy-6,8,19-trioxapentacyclo[10.7.0.02,9.03,7.013,17]nonadeca-1(12),2(9),4,10,13(17)-pentaene-16,18-dione, AFP1, CHEBI:82579, DTXSID50185977, NRCXNPKDOMYPPJ-HYORBCNSSA-N, (6aR,9aS)-2,3,6a,9a-Tetrahydro-4-hydroxycyclopenta[c]furo[3'',2'':4,5]furo[2,3-h][1]benzopyran-1,11-dione, Cyclopenta(c)furo(3'',2'':4,5)furo(2,3-h)(1)-benzopyran-1,11-dione, 2,3,6a,9a-tetrahydro-4-hydroxy-, (6aR,9aS)-, Cyclopenta(c)furo(3'',2'':4,5)furo(2,3-h)(1)-benzopyran-1,11-dione, 2,3,6a,9a-tetrahydro-4-hydroxy-, (6aR-cis)-, C19587, Q27156098, (3S,7R)-11-hydroxy-6,8,19-trioxapentacyclo[10.7.0.0?,?.0?,?.0??,??]nonadeca-1(12),2(9),4,10,13(17)-pentaene-16,18-dione C16H10O6 NRCXNPKDOMYPPJ-HYORBCNSSA-N (3S,7R)-11-hydroxy-6,8,19-trioxapentacyclo[10.7.0.02,9.03,7.013,17]nonadeca-1(12),2(9),4,10,13(17)-pentaene-16,18-dione n.a. n.a. No No No No No No PMDBD2000519 Ajoene Therapeutic Substance n.a. 92285-01-3 DB17735 n.a. n.a. n.a. 5386591 n.a. NPC204251 Ajoene, (E)-Ajoene, 92285-01-3, 92284-99-6, Ajoene, (E)-, E-Ajoene, NSC614554, (E)-1-(prop-2-enyldisulfanyl)-3-prop-2-enylsulfinylprop-1-ene, NSC-614554, W36UK64JYA, Disulfide, 2-propen-1-yl (1E)-3-(2-propen-1-ylsulfinyl)-1-propen-1-yl, CHEMBL122890, CHEBI:80708, 4,5,9-Trithiadodeca-1,6,11-triene 9-oxide, Disulfide, 2-propenyl 3-(2-propenylsulfinyl)-1-propenyl, Ajoene (not validated), Disulfide, 2-propenyl (1E)-3-(2-propenylsulfinyl)-1-propenyl, Disulfide, 2-propenyl 3-(2-propenylsulfinyl)-1-propenyl, (E)-, E/Z Ajoene (~20per cent in Ethyl Acetate), trans-Ajoene, 2-Propen-1-yl[3-(2-propen-1-ylsulfinyl)-1-propen-1-yl] disulfide, Disulfide, 2-propen-1-yl [3-(2-propen-1-ylsulfinyl)-1-propen-1-yl], UNII-W36UK64JYA, NSC 614554, UNII-99A0041VG8, Ajoene, trans-, 2-Propenyl-3-(2-propenylsulfinyl)-1-propenyl disulfide, SCHEMBL465526, AJOENE (E)-FORM [MI], IXELFRRANAOWSF-FNORWQNLSA-N, DTXSID501318485, BDBM50240785, AKOS040754739, AKOS040755267, 99A0041VG8, E- Ajoene (~20% in Ethyl Acetate), HY-106784A, HY-106784, CS-0026551, CS-0173650, Q338762, (E)-1-(allyldisulfanyl)-3-allylsulfinyl-prop-1-ene, (e,z)-4,5,9-trithiadodeca-1,6,11-triene 9-oxide, (E)-1-allyl-2-(3-(allylsulfinyl)prop-1-enyl)disulfane, (E)-1-Allyldisulfanyl-3-(prop-2-ene-1-sulfinyl)-propene, (E)-1-Allyl-2-(3-(allylsulfinyl)prop-1-en-1-yl)disulfane C9H14OS3 IXELFRRANAOWSF-FNORWQNLSA-N (E)-1-(prop-2-enyldisulfanyl)-3-prop-2-enylsulfinylprop-1-ene n.a. n.a. No No No No No No PMDBD2000520 Allicin Therapeutic Substance Investigational Drug 539-86-6 DB11780 n.a. n.a. D0X9YD 65036 58548 NPC2088 "Allicin, 539-86-6, Diallyl thiosulfinate, S-allyl prop-2-ene-1-sulfinothioate, Diallyldisulfid-S-oxid, Thio-2-propene-1-sulfinic acid S-allyl ester, Allylthiosulphinic acid allyl ester, 2-Propene-1-sulfinothioic acid, S-2-propenyl ester, DADSO, S-Allyl acrylo-1-sulphinothioate, CCRIS 9053, S-allyl 2-propene-1-sulfinothioate, EINECS 208-727-7, UNII-3C39BY17Y6, BRN 1752823, 3-prop-2-enylsulfinylsulfanylprop-1-ene, 2-Propene-1-sulfinothioic acid S-2-propenyl ester, CHEBI:28411, 3C39BY17Y6, 2-Propene-1-sulfinic acid, thio-, S-allyl ester, CHEMBL359965, DTXSID6043707, 3-[(prop-2-ene-1-sulfinyl)sulfanyl]prop-1-ene, 4-04-00-00007 (Beilstein Handbook Reference), S-prop-2-en-1-yl prop-2-ene-1-sulfinothioate, S-2-PROPEN-1-YL 2-PROPENE-1-SULFINOTHIOATE, allimin, diallyl disulfide-oxide, C6H10OS2, allylthiosulfinate, allitridi, Allicin kit, 3-allylsulfinylsulfanylprop-1-ene, Allicin, tech. grade, Diallyldisulfid-S-oxide, Allicin (not validated), Dianyctrsnlgide;Allisatin, ALLICIN [MI], ALLICIN [WHO-DD], ALLICIN(TECH GRADE), SCHEMBL2920, 2-propene-1-sulfinothioic acid, Allicin (Allyl-S(O)S-Allyl), GTPL2419, DTXCID4023707, 3-allylsulfinylsulfanyl-prop-1-ene, BCP08391, HY-N0315, BDBM50240948, MFCD00468100, NSC707388, s3860, AKOS006282482, ALLICIN (CONSTITUENT OF GARLIC), CCG-266298, DB11780, FD10435, NSC-707388, 3-(prop-2-enylsulfinylthio)-1-propene, AC-34150, XA162045, XA176305, CS-0008813, NS00032908, NS00115953, ALLICIN (CONSTITUENT OF GARLIC) [DSC], C07600, EN300-217463, S-2-Propenyl 2-propene-1-sulfinothioate, 9CI, A829889, Q409641, Q-200609, 2-Propene-1-sulfinothioic acid, S-2-propenyl ester (9CI), Diallyl thiosulfinate and Allylthiosulphinic acid allyl ester, Diallyldisulfid-S-oxid, 3-prop-2-enylsulfinylsulfanylprop-1-ene" C6H10OS2 JDLKFOPOAOFWQN-UHFFFAOYSA-N 3-prop-2-enylsulfinylsulfanylprop-1-ene n.a. n.a. No No No No No No PMDBD2000521 Aloe Vera Gel n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000522 Aloe-emodin Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D09BUG 10207 n.a. NPC70622 Aloe-emodin, Aloe emodin, 481-72-1, Aloeemodin, Aloe-emodine, Rhabarberone, 3-Hydroxymethylchrysazine, 1,8-dihydroxy-3-(hydroxymethyl)anthracene-9,10-dione, 3-Hydroxymethylchrysazin, EMODINE, 1,8-Dihydroxy-3-(hydroxymethyl)anthraquinone, 1,8-Dihydroxy-3-hydroxymethylanthraquinone, NSC 38628, 1,8-Dihydroxy-3-(hydroxymethyl)-9,10-anthracenedione, 9,10-Anthracenedione, 1,8-dihydroxy-3-(hydroxymethyl)-, CCRIS 3526, UNII-C8IYT9CR7C, C8IYT9CR7C, 3-(Hydroxymethyl)chrysazin, EINECS 207-571-7, BRN 2059062, CHEBI:2607, DTXSID2030695, NSC-38628, CHEMBL40275, 1,8-dihydroxy-3-hydroxymethyl-anthraquinone, DTXCID0010695, Anthraquinone, 1,8-dihydroxy-3-(hydroxymethyl)-, 4-08-00-03578 (Beilstein Handbook Reference), NSC38628, 1,8-Dihydroxy-3-(hydroxymethyl)anthra-9,10-quinone, MFCD00017373, ANTHRAQUINONE, 1,8-DIHYDROXY-3-HYDROXYMETHYL-, DIHYDROXY-3-HYDROXYMETHYLANTHRAQUINONE, 1,8-, 1,8-Dihydroxy-3-(hydroxymethyl)-anthracene-9,10-dione (Aloe-Emodin), SMR000470920, AloeEmodine, Aloe-emodol, Rottlerin?, Aloe-Emodine,(S), ALOE-EMODIN [MI], cid_10207, MLS000697563, MLS006011799, SCHEMBL309756, Aloe-emodin, analytical standard, Aloe-emodin, >=95% (HPLC), HMS3655N16, BCP28272, EX-A6788, HY-N0189, Tox21_302400, AC-020, BDBM50085551, LMPK13040002, s2259, AKOS005720864, CCG-208456, CS-3709, 9, 1,8-dihydroxy-3-(hydroxymethyl)-, SMP2_000291, NCGC00163510-01, NCGC00163510-02, NCGC00163510-03, NCGC00255349-01, AS-11638, CAS-481-72-1, NCI60_003685, NS00018020, SW219916-1, Anthraquinone,8-dihydroxy-3-(hydroxymethyl)-, SR-01000765772, Q-100526, Q3533249, SR-01000765772-3, 1,8-Dihydroxy-3-(hydroxymethyl)anthra-9,10-quinone #, 1,8-Dihydroxy-3-hydroxymethyl-9,10-anthracenedione, 9CI, 9,10-Dihydro-4,5-dihydroxy-9,10-dioxo-2-hydroxymethyl-anthracene, Diacerein impurity B, European Pharmacopoeia (EP) Reference Standard, 1,8-DIHYDROXY-3-(HYDROXYMETHYL)-9,10-DIHYDROANTHRACENE-9,10-DIONE, InChI=1/C15H10O5/c16-6-7-4-9-13(11(18)5-7)15(20)12-8(14(9)19)2-1-3-10(12)17/h1-5,16-18H,6H C15H10O5 YDQWDHRMZQUTBA-UHFFFAOYSA-N 1,8-dihydroxy-3-(hydroxymethyl)anthracene-9,10-dione n.a. n.a. No No No No No No PMDBD2000523 alpha-costic acid n.a. n.a. n.a. n.a. n.a. n.a. n.a. 89043384 n.a. NPC476795 alpha-Costic acid, CHEMBL3628849, SCHEMBL13250881, FS-8405 C15H22O2 UTXMCYDEIZPGME-ILWWEHDPSA-N 2-[(2R,4aR)-4a,8-dimethyl-2,3,4,5,6,8a-hexahydro-1H-naphthalen-2-yl]prop-2-enoic acid n.a. n.a. No No No No No No PMDBD2000524 alpha-Defensin-3 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000525 alpha-Humulene n.a. n.a. n.a. n.a. n.a. n.a. n.a. 5281520 n.a. NPC66577 "Humulene, alpha-Humulene, ALPHA-CARYOPHYLLENE, 6753-98-6, 3,7,10-Humulatriene, .alpha.-Caryophyllene, a-humulene, alpha -humulene, 1,4,8-Cycloundecatriene, 2,6,6,9-tetramethyl-, (E,E,E)-, .alpha.-Humulene, EINECS 229-816-7, UNII-54W56MD2WD, (1E,4E,8E)-alpha-humulene, BRN 3240075, 54W56MD2WD, CHEBI:5768, 2,6,6,9-Tetramethyl-1,4,8-cycloundecatriene (E,E,E)-, HUMULENE, ALPHA-, (1E,4E,8E)-2,6,6,9-tetramethyl-1,4,8-cycloundecatriene, (1E,4E,8E)-humula-1(11),4,8-triene, 4-05-00-01171 (Beilstein Handbook Reference), (1E,4E,8E)-2,6,6,9-tetramethylcycloundeca-1,4,8-triene, MFCD00042689, (E,E,E)-2,6,6,9-tetramethyl-1,4,8-cycloundecatriene, 1,4,8-Cycloundecatriene, 2,6,6,9-tetramethyl-, (1E,4E,8E)-, 2,6,6,9-Tetramethyl-1,4,8-cycloundecatriene, Alpha-humulene alpha-humulene, (1E,4E,8E)-2,6,6,9-Tetramethyl-1,4-8-cycloundecatriene, trans,trans,trans-2,6,6,9-Tetramethyl-1,4,8-cycloundecatriene, 2,6,6,9-tetramethyl-cycloundeca-1,4,8-triene, Humulen, alpha-Humalene, Alpha-humulol, Caryophyllene:, Hemp, Weed, alpha -humulen, -Humulene, alpha -humulenen, Alpha caryophyllene, CANNABIS, HUMULENE [MI], Humulene; -Caryophyllene, a-Caryophyllene (obsol.), minyak fraksi daun cengkeh, (+/-)-alpha-HUMULENE, CHEMBL251280, CHEBI:49289, DTXSID30858793, Alpha-caryophylla-2,8(14)-diene, alpha-Humulene, analytical standard, (+/-)-.ALPHA.-HUMULENE, HY-N6968, alpha-Humulene, >=96.0% (GC), AKOS015965488, alpha -humulene (alpha -caryophyllene), LMPR0103110001, AS-35296, CS-0031813, NS00020870, C09684, Cycloundeca-1,4,8-triene,2,6,6,9-tetramethyl-, Q1995108, 2,6,6,9-Tetramethyl-(E,E,E)-1,4,8-Cycloundecatriene, 2,6,6,9-Tetramethyl-(1E,4E,8E)-1,4,8-Cycloundecatriene, Cycloundeca-1,4,8-triene,2,6,6,9-tetramethyl-, (E,E,E)-, 2,6,6,9-Tetramethyl-1,4,8-cycloundecatriene-, (1E,4E,8E)-, V8Z" C15H24 FAMPSKZZVDUYOS-HRGUGZIWSA-N (1E,4E,8E)-2,6,6,9-tetramethylcycloundeca-1,4,8-triene n.a. n.a. No No No No No No PMDBD2000526 alpha-Longipinene n.a. n.a. n.a. n.a. n.a. n.a. n.a. 12311396 n.a. NPC18672 Longipinene, alpha-Longipinene, (+)-alpha-Longipinene, 5989-08-2, 104AN9V5Q1, UNII-104AN9V5Q1, (1R,2S,7R,8R)-2,6,6,9-tetramethyltricyclo[5.4.0.02,8]undec-9-ene, 3,3,7,9-Tetramethyltricyclo(5.4.0.0(2,8))undec-9-ene, Tricyclo(5.4.0.0(2,8))undec-9-ene, 3,3,7,9-tetramethyl-, (1R,2S,7R,8R)-2,6,6,9-tetramethyltricyclo[5.4.0.0(2,8)]undec-9-ene, TRICYCLO(5.4.0.02,8)UNDEC-9-ENE, 2,6,6,9-TETRAMETHYL-, (1R,2S,7R,8R)-, (+)-.alpha.-Longipinene, CHEBI:62753, Longipinene (~75%), 2,6,6,9-tetramethyltricyclo(5.4.0.0(2,8))undec-9-ene, CHEBI:62752, DTXSID30975297, HICYDYJTCDBHMZ-COMQUAJESA-N, Q27132143, (1R,2S,7R,8R)-2,6,6,9-tetramethyltricyclo[5.4.0.0?,?]undec-9-ene C15H24 HICYDYJTCDBHMZ-COMQUAJESA-N (1R,2S,7R,8R)-2,6,6,9-tetramethyltricyclo[5.4.0.02,8]undec-9-ene n.a. n.a. No No No No No No PMDBD2000527 alpha-mangostin Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D06PRC 5281650 n.a. NPC228785 "alpha-Mangostin, Mangostin, 6147-11-1, 1,3,6-Trihydroxy-7-methoxy-2,8-bis(3-methylbut-2-en-1-yl)-9H-xanthen-9-one, Mangostine, NSC-30552, Alpha-Mangostin, 95%, a-Mangostin, U6RIV93RU1, 7-o-methyl-4-desprenylcostatin, CHEBI:67547, NSC27593, NSC30552, NSC 27593, NSC 30552, NSC-27593, 1,3,6-Trihydroxy-7-methoxy-2,8-bis(3,3-dimethylallyl)xanthone, UNII-U6RIV93RU1, NSC 139154, NSC-139154, 1,3,6-trihydroxy-7-methoxy-2,8-diprenylxanthone, 1,3,6-trihydroxy-7-methoxy-2,8-bis(3-methylbut-2-enyl)xanthen-9-one, 1,3,6-Trihydroxy-7-methoxy-2,8-bis(3-methyl-2-butenyl)-9H-xanthen-9-one, CHEMBL323197, HSDB 8103, DTXSID00210420, TNP00140, 9H-Xanthen-9-one, 1,3,6-trihydroxy-7-methoxy-2,8-bis(3-methyl-2-butenyl)-, MFCD00135200, 1,3,6-Trihydroxy-7-methoxy-2,8-di(3-methyl-2-butenyl)xanthone, 1,3,6-trihydroxy-7-methoxy-2,8-bis(3-methylbut-2-enyl)-9H-xanthen-9-one, Xanthen-9-one, 1,3,6-trihydroxy-7-methoxy-2,8-bis(3-methyl-2-butenyl)-, alpha-mangosten, 3,6,8-trihydroxy-2-methoxy-1,7-bis(3-methylbut-2-enyl)xanthen-9-one, 1,3,6-TRIHYDROXY-7-METHOXY-2,8-BIS-(3-METHYL-2-BUTEN-1-YL)-9H-XANTHEN-9-ONE, 7-O-methyl-gamma-mangostin, delta-mangostin, alpha-mangostin?, 9H-Xanthen-9-one,3,6-trihydroxy-7-methoxy-2,8-bis(3-methyl-2-butenyl)-, Xanthen-9-one,3,6-trihydroxy-7-methoxy-2,8-bis(3-methyl-2-butenyl)-, .Alpha.-mangosten, .Alpha.-mangostin, Spectrum_001726, SpecPlus_000574, MANGOSTIN [MI], MANGOSTIN [INCI], Spectrum2_001620, Spectrum3_001297, Spectrum4_001911, Spectrum5_000622, BSPBio_002933, KBioGR_002529, KBioSS_002206, BIDD:ER0576, DivK1c_006670, SCHEMBL354735, SPECTRUM1504015, SPECTRUM1505128, 7-o-methyl-.gamma.-mangostin, SPBio_001659, KBio1_001614, KBio2_002206, KBio2_004774, KBio2_007342, KBio3_002153, DTXCID00132911, BCP13253, HY-N0328, alpha-Mangostin, >=98% (HPLC), 1,7-bis(3-methylbut-2-enyl)-3,6,8-trihydroxy-2-methoxyxanthen-9-one, BDBM50214969, CCG-36465, NSC139154, s3804, 9H-Xanthen-9-one,1,3,6-trihydroxy-7-methoxy-2,8-bis(3-methyl-2-butenyl)-, AKOS015912806, AC-6089, CS-6435, DS-3359, SDCCGMLS-0066796.P001, 1,3,6-Trihydroxy-7-methoxy-2,8-bis(3-methyl-2-buten-1-yl)-9H-xanthen-9-one, NCGC00017251-01, NCGC00017251-02, NCGC00017251-03, NCGC00017251-04, NCGC00017251-05, NCGC00095730-01, NCGC00095730-02, NCGC00095730-03, NCGC00178385-01, 1ST181798, M2793, A833244, Q909638, SR-05000002649, Q-100010, SR-05000002649-1, BRD-K11991978-001-02-6, BRD-K11991978-001-03-4, 1,3,6-trihydroxy-7-methoxy-2,8-bis(3-methylbut-2-enyl)-9-xanthenone, 1,3,6-Trihydroxy-7-methoxy-2,8-bis-(3-methyl-but-2-enyl)-xanthen-9-one, 2-methoxy-1,7-bis(3-methylbut-2-enyl)-3,6,8-tris(oxidanyl)xanthen-9-one, (c) paragraph sign-mangostin pound>>alpha-Mangostin; NSC 139154; NSC 27593; NSC 30552, 9H-Xanthen-9-one, 1,3,6-trihydroxy-7-methoxy-2,8-bis(3-methyl-2-buten-1-yl)-, alpha-Mangostin1,3,6-Trihydroxy-7-methoxy-2,8-bis(3-methylbut-2-en-1-yl)-9H-xanthen-9-one; Mangostine" C24H26O6 GNRIZKKCNOBBMO-UHFFFAOYSA-N 1,3,6-trihydroxy-7-methoxy-2,8-bis(3-methylbut-2-enyl)xanthen-9-one n.a. n.a. No No No No No No PMDBD2000528 alpha-Pinene Therapeutic Substance n.a. 80-56-8 DB15573 n.a. n.a. n.a. 6654 6402 NPC13991 ALPHA-PINENE, 80-56-8, 2-Pinene, Acintene A, .alpha.-Pinene, 2,6,6-Trimethylbicyclo[3.1.1]hept-2-ene, Pinene isomer, pin-2(3)-ene, alfa-Pinene, Sylvapine A, PINENE, ALPHA, (+/-)-alpha-Pinene, (+/-)-2-Pinene, NSC 7727, pin-2-ene, Bicyclo[3.1.1]hept-2-ene, 2,6,6-trimethyl-, Leavo-95, DTXSID4026501, CHEBI:36740, (+-)-2-pinene, NSC-7727, 2,6,6-Trimethylbicyclo(3.1.1)-2-hept-2-ene, PC-500(TERPENE), FEMA No. 2902, alpha-Pinene (natural), FEMA Number 2902, DTXCID006501, 4,6,6-Trimethylbicyklo(3,1,1)hept-3-en, 2,6,6-Trimethylbicyclo(3.1.1)hept-2-ene, 2437-95-8, (1R)-(+)-alpha-Pinene, NSC94522, NSC94523, CCRIS 697, PC-500, HSDB 720, NCGC00090682-01, DL-Pin-2(3)-ene, EINECS 201-291-9, EINECS 219-445-9, UNII-JPF3YI7O34, BRN 3194807, (1R)-2,6,6-Trimethylbicyclo[3.1.1]hept-2-ene, 25766-18-1, AI3-24594, Bicyclo(3.1.1)hept-2-ene, 2,6,6-trimethyl, 1S-.alpha.-Pinene, CAS-80-56-8, 2,6,6-Trimethylbicyclo(3.1.1)-2-heptene, 2,6,6-Trimethylbicyclo[3.1.1]-2-heptene, EC 201-291-9, 4-05-00-00456 (Beilstein Handbook Reference), alphapinene, alpha pinene, an alpha-pinene, Cyclic dexadiene, alpha -pinene, alpha.-pinene, 4,6,6-trimethylbicyclo[3.1.1]hept-3-ene, Acitene A, (-)alpha-pinene, Pinene, .alpha., alpha [D] Pinene, alpha [L] Pinene, AUSTRALENE, (+-)-alpha-pinene, 1R-.alpha.-Pinene, 2,6,6-trimethyl-bicyclo[3.1.1]hept-2-ene, (R)-.alpha.-Pinene, PINENE (ALPHA), (-)-?-Pinene, (1S)-2,6,6-Trimethylbicyclo[3.1.1]hept-2-ene, PINENE, ALPHA (D), PINENE, ALPHA (L), Pesticide Code: 067004., (.+/-.)-.alpha.-Pinene, alpha-PINENE, (+/-)-, CHEMBL442565, NSC7727, alpha-Pinene (+/-)-alpha-Pinene, AMY22338, Tox21_110996, Tox21_200108, Tox21_303385, NSC-94522, NSC-94523, PC 500, AKOS000121239, AB86235, AB86464, AB93066, DB15573, UN 2368, NCGC00090682-02, NCGC00257379-01, NCGC00257662-01, LS-13835, Trimethyl Bicyclo (3.1.1) hept-2-ene, 2,6-Trimethylbicyclo[3.1.1]-2-heptene, Bicyclo[3.1.1]hept-2-ene,6,6-trimethyl-, NS00067073, 2,6-Trimethylbicyclo[3.1.1]-2-hept-2-ene, EN300-21685, C09880, A839247, Q-201582, (3Z)-5-METHYL-1H-INDOLE-2,3-DIONE3-OXIME, Q27104380, 2,6,6-TRIMETHYLBICYCLO (3.1.1)HEPT-2-ENE, 9CL, BICYCLO(3.1.1)HEPT-2-ENE,2,6,6-TRIMETHYL-2-PINENE, Bicyclo[3.1.1]hept-2-ene, 2,6,6-trimethyl-, (.+/-.)-, (+/-)-2-Pinene, 2,6,6-Trimethylbicyclo[3.1.1]hept-2-ene, alpha-Pinene C10H16 GRWFGVWFFZKLTI-UHFFFAOYSA-N 2,6,6-trimethylbicyclo[3.1.1]hept-2-ene n.a. n.a. No No No No No No PMDBD2000529 alpha-tocopherol Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. D02TQO 14985 n.a. NPC242580 "VITAMIN E, alpha-Tocopherol, D-alpha-Tocopherol, 59-02-9, 5,7,8-Trimethyltocol, (+)-alpha-Tocopherol, alpha Tocopherol, TOCOPHEROL, 2074-53-5, Phytogermine, Aquasol E, (R,R,R)-alpha-Tocopherol, Syntopherol, Viteolin, Eprolin, Esorb, (2R,4''R,8''R)-alpha-Tocopherol, Tocopherol alpha, dl-a-Tocopherol, alpha-Vitamin E, Profecundin, Denamone, Epsilan, Tokopharm, Vascuals, Viprimol, Etavit, alpha-Tokoferol, Evion, alpha-Tocopherol, D-, d-a-tocopherol, Eprolin S, Viterra E, E Prolin, E-Vimin, D-alpha tocopherol, Lan-E, Med-E, Tenox GT 1, Vi-E, Rhenogran Ronotec 50, a-Tocopherol, (2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL, Covitol F 1000, E 307 (tocopherol), (R)-2,5,7,8-Tetramethyl-2-((4R,8R)-4,8,12-trimethyltridecyl)chroman-6-ol, Vitamin Ea, a-D-Tocopherol, Tocopherol (R,S), (+)-a-Tocopherol, CCRIS 3588, CHEBI:18145, Vitamin-E, 2,5,7,8-Tetramethyl-2-(4'',8'',12''-trimethyltridecyl)-6-chromanol, HSDB 2556, EINECS 200-412-2, NSC 20812, (+/-)-alpha-Tocopherol, 1406-18-4, Evitaminum, Waynecomycin, Almefrol, E307, Emipherol, Etamican, Vitayonon, Ilitia, (2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydro-2H-chromen-6-ol, H4N855PNZ1, BPBio1_000362, 18920-62-2, Vitaplex E, DTXSID0026339, E 307, Spavit E, EC 200-412-2, ido-E, Endo E, N9PR3490H9, Vita E, Antisterility vitamin, a-Vitamin E, MFCD00072045, (2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-ol, 2H-1-Benzopyran-6-ol, 3,4-dihydro-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-, (2R)-, rel-alpha-Vitamin E, 2H-1-Benzopyran-6-ol, 3,4-dihydro-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-, (2R)-rel-, DTXCID706339, RRR-alpha-tocopherol, Vitamin E alpha, CAS-59-02-9, 2H-1-Benzopyran-6-ol, 3,4-dihydro-2,5,7,8-tetramethyl-2-((4R,8R)-4,8,12-trimethyltridecyl)-, (2R)-, 2H-1-Benzopyran-6-ol, 3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-, (2R-(2R*(4R*,8R*)))-, 2H-1-Benzopyran-6-ol, 3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-, [2R-[2R*(4R*,8R*)]]-, SMR000471844, VIV, alpha-Tocopherol acid, 3,4-Dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-benzopyran-6-ol, (all-R)-alpha-Tocopherol, DTXSID8021355, Phytogermin, Palmvtee, alpha-Tocoferol, (+-)-Med-E, UNII-N9PR3490H9, Vitamin Ealpha, NSC-20812, Alpha-tocopherols, .ALPHA.-TOCOPHEROL, D-, Pheryl-E, DL--Tocopherol, Vita plus E, Acne C-Patch, rel--Vitamin E, -Vitamin E, Vitamin e d-alpha, NCGC00016688-02, Vitamin E, liquid, Prestwick_653, EINECS 215-798-8, EINECS 218-197-9, .alpha.-Vitamin E, Envirose 100, NSC 82623, COVIREL, RRR-alpha-tocopheryl, Vitamin E [USP], ()-alpha-Tocopherol, delta-alpha-tocopherol, alpha-delta-Tocopherol, Tocopherol, d-alpha-, CONTROX VP, EPROLIN-S, Vitamin E (D-form), TENOX GT, CHEMBL47, (R,R,R)-a-Tocopherol, Prestwick3_000404, (+)- alpha -Tocopherol, (+)-.alpha.-Tocopherol, all-rac-alpha-Tocopherolum, bmse000600, R,r,r-.alpha.-tocopherol, alpha-TOCOPHEROL (II), SCHEMBL3097, COVI-OX T 30P, DL-all-rac-alpha-Tocopherol, RIKKI N 70, UNII-H4N855PNZ1, BIDD:PXR0174, COVI-OX T 50, Vita-Jec Essential E-300, BSPBio_000328, E-MIX 40A, MLS001066396, MLS001335981, MLS001335982, BIDD:ER0562, INS NO.307A, T1539_SIGMA, DTXCID201355, INS-307A, (+)-ALPHA-TOCOPHEROL-, ALPHA-TOCOPHEROL [HSDB], (2R,4''R,8''R)-a-Tocopherol, .ALPHA.-TOCOPHEROL [MI], ALPHA TOCOPHEROL (USP-RS), (+)--Tocopherol; D--Tocopherol, HMS2096A10, HMS2231G08, C29H50O2 (D-alpha-tocopherol), D-ALPHA TOCOPHEROL [MART.], HY-N0683, Tox21_110563, Tox21_113208, Tox21_202081, BDBM50458513, E-307A, LMPR02020001, MFCD00006848, AKOS004910417, CS-8161, DB00163, (2R)-2-((4R,8R)-4,8,12-trimethyltridecyl)-2,5,7,8-tetramethylchroman-6-ol, NCGC00142625-01, NCGC00142625-04, NCGC00142625-05, NCGC00142625-06, NCGC00142625-07, NCGC00142625-10, NCGC00142625-17, NCGC00259630-01, (2R)-3,4-Dihydro-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-2H-1-benzopyran-6-ol, (2R*(4R*,8R*))-(1)-3,4-Dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-benzopyran-6-ol, ALPHA-TOCOPHEROL, UNSPECIFIED FORM, AS-13990, J24.260H, rel-(+)--Tocopherol; rel-D--Tocopherol, J203.513H, E-307, NS00069772, T2309, C02477, F82497, EN300-7417123, Q158348, Q-201932, W-107596, W-109164, Z2235811339, 07AA93F0-3339-4EEC-B50B-ADB70F657087, (2R,4''R,8''R)-2,5,7,8-Tetramethyl-2-(4'',8'',12''-trimethyltridecyl)-6-chromanol, 3,4-Dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-1- -benzopyran-6-ol, 3,4-Dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-1--benzopyran-6-ol, (2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydro-2H-1-benzopyran-6-ol, (R)-2,5,7,8-tetramethyl-2-((4R,8R)-4,8,12-trimethyltridecyl)-3,4-dihydro-2H-chromen-6-ol, 2H-1-Benzopyran-6-ol, 3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-, 2R- 2R*(4R*,8R*) -, 2H-1-Benzopyran-6-ol, 3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-, (2R*(4R*,8R*))-(+-)-, rel-(2R)-2,5,7,8-tetramethyl-2-((4R,8R)-4,8,12-trimethyltridecyl)-3,4-dihydro-2H-chromen-6-ol" C29H50O2 GVJHHUAWPYXKBD-IEOSBIPESA-N (2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-ol n.a. n.a. No No No No No No PMDBD2000530 Amikacin Therapeutic Substance Approved Drug 37517-28-5 DB00479 PA164744372 D02543 D0Y3MO 37768 n.a. NPC330590 "amikacin, 37517-28-5, Amikacinum, Amicacin, Lukadin, amikacine, Amikacina, Amikavet, Amikin, Arikace, Amikacillin, Mikavir, Potentox, Antibiotic BB-K 8, Amukin, Amikacine [INN-French], Amikacinum [INN-Latin], Amikacina [INN-Spanish], Amikacin Base, BB-K8, Kaminax, Amikozit, 1-N-(L(-)-gamma-Amino-alpha-hydroxybutyryl)kanamycin A, CHEBI:2637, BAY 41-6551, HSDB 3583, Arikayce liposomal, Amikacin free base, EINECS 253-538-5, Briclin, NSC 177001, UNII-84319SGC3C, DTXSID3022586, Amiglyde-V, 84319SGC3C, NSC-177001, Amikacin [USP:INN:BAN], ANTIBIOTIC BB-K8, DTXCID002586, (2S)-4-amino-N-[(1R,2S,3S,4R,5S)-5-amino-2-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-[(2R,3R,4S,5S,6R)-6-(aminomethyl)-3,4,5-trihydroxyoxan-2-yl]oxy-3-hydroxycyclohexyl]-2-hydroxybutanamide, O-3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1-4)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1-6))-N(sup 3)-(4-amino-L-2-hydroxybutyryl)-2-deoxy-L-streptamine, MAT2501, N1-[(S)-4-Amino-2-hydroxybutyryl]kanamycin A, 37517-28-5 (free base), Amikacin Dihydrate, NSC177001, (2S)-4-amino-N-{(1R,2S,3S,4R,5S)-5-amino-2-[(3-amino-3-deoxy-alpha-D-glucopyranosyl)oxy]-4-[(6-amino-6-deoxy-alpha-D-glucopyranosyl)oxy]-3-hydroxycyclohexyl}-2-hydroxybutanamide, AMK, BB-K 8, NCGC00093350-02, Amikacine (INN-French), Amikacinum (INN-Latin), Amikacina (INN-Spanish), AMIKACIN (MART.), AMIKACIN [MART.], AMIKACIN (USP-RS), AMIKACIN [USP-RS], Amikacin (USP:INN:BAN), (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-2-(((2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-4-(((2R,3R,4S,5S,6R)-6-(aminomethyl)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1->4)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1->6))-N(3)-(4-amino-L-2-hydroxybutyryl)-2-deoxy-L-streptamine, AMIKACIN (EP MONOGRAPH), AMIKACIN [EP MONOGRAPH], AMIKACIN (USP MONOGRAPH), AMIKACIN [USP MONOGRAPH], (2S)-4-amino-N-[(1R,2S,3S,4R,5S)-5-amino-2-{[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4-{[(2R,3R,4S,5S,6R)-6-(aminomethyl)-3,4,5-trihydroxyoxan-2-yl]oxy}-3-hydroxycyclohexyl]-2-hydroxybutanamide, Amikacin (USP/INN), SR-01000722004, NCGC00093350-05, Amikacin,(S), (2S)-N-[(1R,2S,3S,4R,5S)-4-[(2R,3R,4S,5S,6R)-6-(aminomethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-5-azanyl-2-[(2S,3R,4S,5S ,6R)-4-azanyl-6-(hydroxymethyl)-3,5-bis(oxidanyl)oxan-2-yl]oxy-3-oxidanyl-cyclohexyl]-4-azanyl-2-oxidanyl-butanamide, AKN, Amikacin; 6-O-(3-Amino-3-deoxy-?-d-glucopyranosyl)-4-O-(6-amino-6-deoxy-?-d-glucopyranosyl)-1-N-[(2S)-4-amino-2-hydroxybutanoyl]-2-deoxy-d-streptamine, Amikacinum (Latin), Amikin (Disulfate), MFCD00883675, AT03 - Amikacin, BAY41-6551, Amikacin (free base), nktr-061, AMIKACIN [HSDB], AMIKACIN [INN], AMIKACIN [JAN], AMIKACIN [MI], AMIKACIN [VANDF], Prestwick3_000395, AMIKACIN [WHO-DD], AMIKACIN [WHO-IP], CHEMBL177, SCHEMBL2985, CAS-37517-28-5, BSPBio_000609, D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1-6)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1-4))-N1-(4-amino-2-hydroxy-1-oxobutyl)-2-deoxy-, (S)-, BPBio1_000671, TD1 - Therapeutic Drug mixture, GTPL10894, HY-B0509A, D06AX12, J01GB06, S01AA21, AMIKACINUM [WHO-IP LATIN], Tox21_111201, BDBM50237603, MFCD11045969, AKOS005383276, Tox21_111201_1, DB00479, NCGC00093350-03, (2S)-4-amino-N-[(1R,2S,3S,4R,5S)-5-amino-2-(3-amino-3-deoxy-alpha-D-glucopyranosyloxy)-4-(6-amino-6-deoxy-alpha-D-glucopyranosyloxy)-3-hydroxycyclohexyl]-2-hydroxybutanamide, AS-76985, D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1->6)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1->4))-N(sup 1)-(4-amino-2-hydroxy-1-oxobutyl)-2-deoxy-, (S)-, D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1-6)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1-4))-N(sup 1)-(4-amino-2-hydroxy-1-oxobutyl)-2-deoxy-, (S)-, O-3-Amino-3-deoxy-.alpha.-D-glucopyranosyl-(1->6)-O-[6-amino-6-deoxy-.alpha.-D-glucopyranosyl-(1->4)]-1-(4-amino-2-hydroxy-1-oxobutyl)-2-deoxy-D-streptamine, AB00513828, NS00006181, C06820, D02543, AB00513828_06, Amikacin, Antibiotic for Culture Media Use Only, EN300-7481440, A823716, Q408529, SR-01000722004-6, W-106531, (2S)-4-amino-N-[(1R,2S,3S,4R,5S)-5-amino-2-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-4-[(2R,3R,4S,5S,6R)-6-(aminomethyl)-3,4,5-trihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-cyclohexyl]-2-hydroxy-butanamide, (2S)-N-[(1R,2S,3S,4R,5S)-4-[(2R,3R,4S,5S,6R)-6-(aminomethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-5-azanyl-2-[(2S,3R,4S,5S, (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-2-((2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)-4-((2R,3R,4S,5S,6R)-6-(aminomethyl)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yloxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide, ,6R)-4-azanyl-6-(hydroxymethyl)-3,5-bis(oxidanyl)oxan-2-yl]oxy-3-oxidanyl-cyclohexyl]-4-azanyl-2-oxidanyl-butanamide, D-STREPTAMINE, O-3-AMINO-3-DEOXY-.ALPHA.-D-GLUCOPYRANOSYL-(1->6)-O-(6-AMINO-6-DEOXY-.ALPHA.-D-GLUCOPYRANOSYL-(1->4))-N(SUP 1)-(4-AMINO-2-HYDROXY-1-OXOBUTYL)-2-DEOXY-, (S)-, D-Streptamine, O-3-amino-3-deoxy-.alpha.-D-glucopyranosyl-(1->6)-O-[6-amino-6-deoxy-.alpha.-D-glucopyranosyl-(1->4)]-N1-[(2S)-4-amino-2-hydroxy-1-oxobutyl]-2-deoxy-, D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1.fwdarw.6)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1.fwdarw.4))-N1-((2S)-4-amino-2-hydroxy-1-oxobutyl)-2-deoxy-, O-3-AMINO-3-DEOXY-.ALPHA.-D-GLUCOPYRANOSYL-(1->4)-O-(6-AMINO-6-DEOXY-.ALPHA.-D-GLUCOPYRANOSYL-(1->6))-N(SUP 3)-(4-AMINO-L-2-HYDROXYBUTYRYL)-2-DEOXY-L-STREPTAMINE, O-3-AMINO-3-DEOXY-alpha-D-GLUCOPYRANOSYL-(1->4)-O-(6-AMINO-6-DEOXY-alpha-D-GLUCOPYRANOSYL-(1->6))-N(SUP 3)-(4-AMINO-L-2-HYDROXYBUTYRYL)-2-DEOXY-L-STREPTAMINE" C22H43N5O13 LKCWBDHBTVXHDL-RMDFUYIESA-N (2S)-4-amino-N-[(1R,2S,3S,4R,5S)-5-amino-2-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-[(2R,3R,4S,5S,6R)-6-(aminomethyl)-3,4,5-trihydroxyoxan-2-yl]oxy-3-hydroxycyclohexyl]-2-hydroxybutanamide Abbott Laboratories Antibiotics No No No No No No PMDBD2000531 Amikacin disulfate salt n.a. n.a. n.a. n.a. n.a. n.a. n.a. 38351 n.a. n.a. "Amikacin disulfate, AMIKACIN SULFATE, 39831-55-5, Pierami, Amikin, Amikacin bis(sulphate), BB-K8, Amikacin sulphate, Kaminax, Arikayce, amikacin disulphate, Biodacyn, Amikacin (disulfate), Amikacin disulfate salt, Amikacin (as sulfate), N6M33094FD, Amikacin sulfate salt(1:2), NSC-755846, Amikafur, Amitrex, Chemacin, Fabianol, Likacin, Biklin, Kancin-Gap, Antibiotic BB-K8 sulfate, (2S)-4-amino-N-[(1R,2S,3S,4R,5S)-5-amino-2-(3-amino-3-deoxy-alpha-D-glucopyranosyloxy)-4-(6-amino-6-deoxy-alpha-D-glucopyranosyloxy)-3-hydroxycyclohexyl]-2-hydroxybutanamide disulfate, (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-2-(((2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-4-(((2R,3R,4S,5S,6R)-6-(aminomethyl)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide bis(sulfate), Amikacin (sulfate), O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1->4)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1->6))-N(3)-(4-amino-L-2-hydroxybutyryl)-2-deoxy-L-streptamine sulfate (1:2), NN-K 8, EINECS 254-648-6, Amikan, UNII-N6M33094FD, Amikacini sulfas, MFCD00167475, Amikacin sulfate [USAN:USP:JAN], Amikin (TN), AMIKIN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, AMIKACIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, BAY-416651 sulfate, AMIKACIN SULFATE [MI], AMIKACIN SULFATE [JAN], Amikacin sulfate (JP17/USP), CHEBI:2638, SCHEMBL1649432, AMIKACIN SULFATE [USAN], AMIKACIN SULFATE [VANDF], CHEMBL4208954, HY-B0509B, AMIKACIN SULFATE [MART.], AMIKACIN SULFATE [USP-RS], AMIKACIN SULFATE [WHO-DD], AMIKACINI SULFAS [WHO-IP], FXKSEJFHKVNEFI-GCZBSULCSA-N, DTXSID601045247, s3065, AMIKACIN SULFATE [GREEN BOOK], AKOS025310105, AMIKACIN SULFATE [EP IMPURITY], AMIKACIN SULFATE [ORANGE BOOK], AMIKACIN SULFATE [EP MONOGRAPH], CCG-270466, CS-3493, NSC 755846, AMIKACIN SULFATE [USP MONOGRAPH], AS-13777, D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1-6)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1-4))-N(sup 1)-(4-amino-2-hydroxy-1-oxobutyl)-2-deoxy-, (S)-, sulfate (1:2)(salt), O-3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1-4)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1-6))-N(sup 3)-(4-amino-L-2-hydroxybutyryl)-2-deoxy-L-streptamine sulfate (1:2), NS00088998, D00865, Q27105754, Amikacin sulfate, European Pharmacopoeia (EP) Reference Standard, Amikacin disulfate salt, potency: 674-786 mug per mg (as amikacin base), Amikacin sulfate, United States Pharmacopeia (USP) Reference Standard, Amikacin for system suitability, European Pharmacopoeia (EP) Reference Standard, Amikacin Sulfate, Pharmaceutical Secondary Standard; Certified Reference Material, Amikacin sulfate; 6-O-(3-Amino-3-deoxy-a-d-glucopyranosyl)-4-O-(6-amino-6-deoxy-a-d-glucopyranosyl)-1-N-[(2S)-4-amino-2-hydroxybutanoyl]-2-deoxy-d-streptamine sulfate, D-STREPTAMINE, O-3-AMINO-3-DEOXY-.ALPHA.-D-GLUCOPYRANOSYL-(1->6)-O-(6-AMINO-6-DEOXY-.ALPHA.-D-GLUCOPYRANOSYL-(1->4))-N(SUP 1)-(4-AMINO-2-HYDROXY-1-OXOBUTYL)-2-DEOXY-, (S)-, SULFATE (1:2) (SALT), D-STREPTAMINE, O-3-AMINO-3-DEOXY-.ALPHA.-D-GLUCOPYRANOSYL-(1->6)-O-(6-AMINO-6-DEOXY-.ALPHA.-D-GLUCOPYRANOSYL-(1->4))-N(SUP 1)-(4-AMINO-2-HYDROXY-1-OXOBUTYL)-2-DEOXY-, (S)-, SULPHATE (1:2) (SALT), D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1.fwdarw.6)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1.fwdarw.4))-N1-((2S)-4-amino-2-hydroxy-1-oxobutyl)-2-deoxy-, sulfate (1:2) (salt), O-3-AMINO-3-DEOXY-.ALPHA.-D-GLUCOPYRANOSYL-(1->4)-O-(6-AMINO-6-DEOXY-.ALPHA.-D-GLUCOPYRANOSYL-(1->6))-N(SUP 3)-(4-AMINO-L-2-HYDROXYBUTYRYL)-2-DEOXY-L-STREPTAMINE SULFATE (1:2), O-3-AMINO-3-DEOXY-.ALPHA.-D-GLUCOPYRANOSYL-(1->4)-O-(6-AMINO-6-DEOXY-.ALPHA.-D-GLUCOPYRANOSYL-(1->6))-N(SUP 3)-(4-AMINO-L-2-HYDROXYBUTYRYL)-2-DEOXY-L-STREPTAMINE SULPHATE (1:2)" C22H47N5O21S2 FXKSEJFHKVNEFI-GCZBSULCSA-N "(2S)-4-amino-N-[(1R,2S,3S,4R,5S)-5-amino-2-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-[(2R,3R,4S,5S,6R)-6-(aminomethyl)-3,4,5-trihydroxyoxan-2-yl]oxy-3-hydroxycyclohexyl]-2-hydroxybutanamide;sulfuric acid" n.a. n.a. No No No No No No PMDBD2000532 Aminocyclopropane n.a. n.a. n.a. n.a. n.a. n.a. n.a. 69828 n.a. NPC319278 Cyclopropylamine, Cyclopropanamine, 765-30-0, Aminocyclopropane, cyclopropyl amine, Cyclopropyl--d4-aMine, 8PR8XTH1X1, MFCD00001301, NSC-56127, EINECS 212-142-2, NSC 56127, UNII-8PR8XTH1X1, cyclopropyamine, cyclopropylamin, cylopropylamine, Cycloproplyamine, cyclopropyl amin, Cyclopropaneamine, Cyclopropylarnine, cyclopropyl-amine, N-cyclopropylamine, 3-cyclopropylamine, Cyclopropanamine-d5, Cyclopropylamine, 98%, CYCLOPROPANE AMINE, EC 212-142-2, DTXSID9061099, CHEBI:34660, HTJDQJBWANPRPF-UHFFFAOYSA-, CS-D1450, NSC56127, STR00451, GEO-00889, MFCD28009728, AKOS000119334, PB47448, AM804333, BP-10575, SY344664, NS00004424, EN300-21353, P19977, J-520185, Q1147604, InChI=1/C3H7N/c4-3-1-2-3/h3H,1-2,4H2, F2190-0503 C3H7N HTJDQJBWANPRPF-UHFFFAOYSA-N cyclopropanamine n.a. n.a. No No No No No No PMDBD2000533 Aminosalicylic Acid Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. D01WJL 4649 n.a. NPC301702 "4-Aminosalicylic acid, 65-49-6, 4-Amino-2-hydroxybenzoic acid, Aminosalicylic acid, P-AMINOSALICYLIC ACID, Rezipas, Para-aminosalicylic acid, Paramycin, Aminopar, Pamisyl, Parasal, Paser, Parasalindon, Deapasil, Apacil, Gabbropas, Parasalicil, Pasnodia, Aminox, Benzoic acid, 4-amino-2-hydroxy-, Entepas, Osacyl, Pamacyl, Pasalon, Pasara, Pasdium, Pasmed, Pasolac, Propasa, Pasem, Pasa, 2-Hydroxy-4-aminobenzoic acid, APAS, PASK, Para-Pas, Sanipirol-4, para-Amino salicylic acid, Hellipidyl, Pascorbic, PAS-C, PAS (acid), 4-Aminosalicylate, PAS, Kyselina p-aminosalicylova, aminosalicylate, Salicylic acid, 4-amino-, 3-Hydroxy-4-carboxyaniline, Amino-pas, Sanipriol-4, NIH 2939, NSC 2083, MFCD00007789, 4-Asa, AMINOSALICYLATE SODIUM, Aminosalicylic Acid [USP], A 1909, 4-amino-2-hydroxy-benzoic acid, p-amino salicylic acid, NSC-2083, MLS000069418, CHEBI:27565, NSC2083, 5B2658E0N2, Aminosalyl, Helipidyl, SMR000059110, Paser Granules, Aminosalicylic acid (USP), MLS000069579, PAS (VAN), 4-Aminosalicylicacid, Benzoic acid, 4-aminohydroxy-, HSDB 3203, 4-amino salicylic acid, Kyselina p-aminosalicylova [Czech], SR-01000002990, SMR000058830, EINECS 200-613-5, BRN 0473071, P.A.S, Aminosalicylic, Granupas, AI3-50142, UNII-5B2658E0N2, ISONICOTINIC ACID HYDRAZIDE P-AMINOSALICYLATE SALT, Pamisyl (TN), Paser (TN), 4-Aminosalicyclic acid, Spectrum_000042, .gamma.-Aminosalicylate, Opera_ID_614, Spectrum2_000001, Spectrum3_000297, Spectrum4_000145, Spectrum5_000804, para-amino-salicyclic acid, WLN: ZR CQ DVQ, Salicyclic acid, 4-amino-, SCHEMBL2262, CHEMBL1169, BSPBio_001834, KBioGR_000590, KBioSS_000422, 4-14-00-01967 (Beilstein Handbook Reference), MLS001148121, 4-Aminosalicylic acid, 99%, BIDD:GT0175, DivK1c_000350, 4-amino-2-hydroxobenzoic acid, SPBio_000001, p-Aminosalicylic acid STANDARD, DTXSID2022591, BDBM48319, HMS501B12, KBio1_000350, KBio2_000422, KBio2_002990, KBio2_005558, KBio3_001334, 4-azanyl-2-oxidanyl-benzoic acid, cid_11988145, NINDS_000350, AMINOSALICYLIC ACID [HSDB], HMS2090I07, HMS2093L14, HMS2236I04, HMS3371A17, HMS3715M08, KUC106682N, AMINOSALICYLIC ACID [VANDF], P-AMINOSALICYLIC ACID [MI], AMINOSALICYLIC ACID [MART.], AMY31099, BCP18565, HY-I0447, AMINOSALICYLIC ACID [USP-RS], AMINOSALICYLIC ACID [WHO-DD], CCG-39969, s5211, AKOS000121200, CS-W023102, DB00233, PB47849, 4-AMINO,2-HYDROXY-BENZOIC ACID, IDI1_000350, AMINOSALICYLIC ACID [ORANGE BOOK], NCGC00018110-01, NCGC00018110-02, NCGC00018110-03, NCGC00018110-04, AC-12894, AS-11043, SY001079, AMINOSALICYLIC ACID [USP MONOGRAPH], KSC-11-207-13, SBI-0051279.P003, SBI-0051279.P004, MESALAZINE IMPURITY E [EP IMPURITY], A0420, NS00010608, EN300-18730, C02518, D00162, NEOPASALATE COMPONENT AMINOSALICYLIC ACID, P17508, AB00051913-20, AMINOSALICYLIC ACID COMPONENT OF NEOPASALATE, Q229924, Q-200437, SR-01000002990-4, SR-01000002990-6, 4-Aminosalicylic acid, Vetec(TM) reagent grade, 99%, Z90121065, F2191-0245, para-aminosalicylic acid;Aminosalicylic acid;4-aminosalicylate, Aminosalicylic acid, United States Pharmacopeia (USP) Reference Standard, 4-Aminosalicylic acid, Pharmaceutical Secondary Standard; Certified Reference Material, InChI=1/C7H7NO3/c8-4-1-2-5(7(10)11)6(9)3-4/h1-3,9H,8H2,(H,10,11" C7H7NO3 WUBBRNOQWQTFEX-UHFFFAOYSA-N 4-amino-2-hydroxybenzoic acid Panray Corp Sub Ormont Drug And Chemical Co Inc n.a. No No No No No No PMDBD2000534 Amprenavir Therapeutic Substance Approved Drug 161814-49-9 DB00701 PA448422 D00894 D0A0OO 65016 58532 n.a. amprenavir, 161814-49-9, Agenerase, Prozei, VX-478, 141W94, KVX-478, Vertex VX478, VX 478, DRG-0258, CHEBI:40050, HSDB 7157, UNII-5S0W860XNR, 5S0W860XNR, (3S)-Tetrahydro-3-furanyl ((1S,2R)-3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)carbamate, J05AE05, VX478, Tetrahydro-3-furyl N-(3-(4-amino-N-isobutylbenzenesulfonamido)-1-benzyl-2-hydroxypropyl)carbamate, (3S-(3R*(1R*,2S*)))-(3-(((4-Aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(phenylmethyl)propyl) tetrahydro-3-furanyl carbamate, AMV, Carbamic acid, ((1S,2R)-3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)-, (3S)-tetrahydro-3-furanyl ester, DTXSID5046061, 141 W94, (3S)-oxolan-3-yl N-[(2S,3R)-3-hydroxy-4-[N-(2-methylpropyl)(4-aminobenzene)sulfonamido]-1-phenylbutan-2-yl]carbamate, Amprenavir [USAN], Amprenavir (agenerase), AMPRENAVIR (MART.), AMPRENAVIR [MART.], (S)-tetrahydrofuran-3-yl ((2S,3R)-4-((4-amino-N-isobutylphenyl)sulfonamido)-3-hydroxy-1-phenylbutan-2-yl)carbamate, Carbamic acid, (3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)-, tetrahydro-3-furanyl ester, (3S-(3R*(1S*,2R*)))-, Carbamic acid, N-[(1S,2R)-3-[[(4-aminophenyl)sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]-, (3S)-tetrahydro-3-furanyl ester, [(3S)-oxolan-3-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamate, {3-[(4-AMINO-BENZENESULFONYL)-ISOBUTYL-AMINO]-1-BENZYL-2-HYDROXY-PROPYL}-CARBAMIC ACID TETRAHYDRO-FURAN-3-YL ESTER, Agenerase (TM), Agenerase (TN), (S)-tetrahydrofuran-3-yl (2S,3R)-4-(4-amino-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate, [(3S)-tetrahydrofuran-3-yl] N-[(1S,2R)-3-[(4-aminophenyl)sulfonyl-isobutyl-amino]-1-benzyl-2-hydroxy-propyl]carbamate, GNA & Amprenavir, HHA & Amprenavir, DTXCID3026061, Amprenavirum, Amprenavir (JAN/USAN/INN), Amprenavir [USAN:INN:BAN], 1hpv, 3ekp, 3ekv, 3nuj, 3nuo, NCGC00159461-02, (3S)-TETRAHYDRO-3-FURYL ((alphaS)-alpha-((1R-1-HYDROXY-2-(N1-ISOBUTYLSULFANILAMIDO)ETHYL)PHENETHYL)CARBAMATE, (3S)-Tetrahydro-3-furyl [(alphaS)-alpha-[(1R-1-hydroxy-2-(N1-isobutylsulfanilamido)ethyl]phenethyl]carbamate, (3S)-tetrahydrofuran-3-yl ((1S,2R)-3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-1-benzyl-2-hydroxypropyl)carbamate, (3S)-tetrahydrofuran-3-yl [(1S,2R)-3-{[(4-aminophenyl)sulfonyl](2-methylpropyl)amino}-1-benzyl-2-hydroxypropyl]carbamate, 1t7j, 3nu3, 3nu4, 3nu5, 3nu6, 3nu9, 3sm2, AMPRENAVIR [MI], AMPRENAVIR [INN], AMPRENAVIR [JAN], AMPRENAVIR [HSDB], AMPRENAVIR [VANDF], APV & AAG, APV & HSA, CHEMBL116, AMPRENAVIR [WHO-DD], SCHEMBL34151, (3S)-Tetrahydro-3-furyl ((alphaS)-alpha-((1R-1-hydroxy-2-(N(sup 1)-isobutylsulfanilamido)ethyl)phenethyl)carbamate, MLS006011492, AMPRENAVIR [EMA EPAR], BIDD:GT0398, AMPRENAVIR [ORANGE BOOK], EX-A6824B, GTPL12681, KVX 478, 3s43, 3s45, HMS2090N10, BDBM50215393, MFCD00934214, s1639, Amprenavir & alpha1-acid glycoprotein, AKOS000280844, AM84544, BCP9000297, CCG-269742, CS-1410, DB00701, NCGC00159461-07, NCGC00159461-08, 4-Amino-N-((2 syn,3S)-2-hydroxy-4-phenyl-3-((S)-tetrahydrofuran-3-yloxycarbonylamino)-butyl)-N-isobutyl-benzenesulfonamide, Amprenavir 100 microg/mL in Acetonitrile, AS-30915, Carbamic acid, ((1S,2R)-3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)-, (3S)-tetrahydro-3-furanyl ester & Galanthus nivalis agglutinin (GNA), HY-17430, SMR003885056, BCP0726000051, NS00004082, SW219687-1, C08086, D00894, EN300-123443, AB01275534-01, AB01275534_02, A810295, Q422198, SR-05000001530, SR-05000001530-1, Z1551900491, (3S)-oxolan-3-yl N-[(2S,3R)-3-hydroxy-4-[N-(2-methylpropyl)-4-aminobenzenesulfonamido]-1-phenylbutan-2-yl]carbamate, (3S)-Tetrahydrofuran-3-yl (1S,2R)-3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-1-benzyl-2-hydroxypropyl)carbamate, (3S)-tetrahydrofuran-3-yl [(2S,3R)-4-{[(4-aminophenyl)sulfonyl](2-methylpropyl)amino}-3-hydroxy-1-phenylbutan-2-yl]carbamate, [(3S)-oxolan-3-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-oxidanyl-1-phenyl-butan-2-yl]carbamate, 4-Amino-N-((2syn,3S)-2-hydroxy-4-phenyl-3-((S)-tetrahydrofuran-3-yloxycarbonylamino)-butyl)-N-isobuty lbenzene sulfonamide, Carbamic acid, ((1S,2R)-3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)-, (3S)-tetrahydro-3-furanyl ester & Hippeastrum hybrid agglutinin( HHA), Carbamic acid, (3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(-phenylmethyl)propyl)-, tetrahydro-3-furanyl ester, (3S-(3R*(1S*,2R*)))-, N-[(1S,2R)-3-[[(4-Aminophenyl)sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]carbamic Acid (3S)-Tetrahydro-3-furanyl Ester, N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamic acid [(3S)-3-oxolanyl] ester C25H35N3O6S YMARZQAQMVYCKC-OEMFJLHTSA-N [(3S)-oxolan-3-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamate GlaxoSmithKline Anti-HIV Agents No No No No No No PMDBD2000535 Anidulafungin Therapeutic Substance Approved Drug 166663-25-8 DB00362 PA164742938 D03211 D0F9BY 166548 145752 n.a. Anidulafungin, Eraxis, 166663-25-8, Ecalta, V-Echinocandin, LY303366, VER-002, LY-303366, Anidulafungina, Anidulafungine, Anidulafunginum, UNII-9HLM53094I, VER002, CHEBI:55346, 9HLM53094I, Anidulafungin (LY303366), D70013, D-70013, N-[(3S,6S,9S,11R,15S,18S,20R,21R,24S,25S,26S)-6-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-11,20,21,25-tetrahydroxy-3,15-bis[(1R)-1-hydroxyethyl]-26-methyl-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosan-18-yl]-4-[4-(4-pentoxyphenyl)phenyl]benzamide, ANIDULAFUNGIN (MART.), ANIDULAFUNGIN [MART.], (4R,5R)-4,5-DIHYDROXY-N(SUP 2)-((4''''-(PENTYLOXY)-P-TERPHENYL-4-YL)CARBONYL)-L-ORNITHYL-L-THREONYL-TRANS-4-HYDROXY-L-PROLYL-(S)-4-HYDROXY-4-(P-HYDROXYPHENYL)-L-THREONYL-L-THREONYL-(3S,4S)-3-HYDROXY-4-METHYL-L-PROLINE CYCLIC (6->1)-PEPTIDE, ECHINOCANDIN B, 1-((4R,5R)-4,5-DIHYDROXY-N(SUP 2)-((4''''-(PENTYLOXY)(1,1'':4'',1''''-TERPHENYL)-4-YL)CARBONYL)-L-ORNITHINE)-, ANIDULAFUNGIN [USAN], DTXSID50873201, Anidulafungin [USAN:INN:BAN], 1-((4R,5R)-4,5-Dihydroxy-N2-((4''''-(pentyloxy)(1,1'':4'',1''''-terphenyl)-4-yl)carbonyl)-L-ornithine)-echinocandin B, Echinocandin B, 1-[(4R,5R)-4,5-dihydroxy-N2-[[4''''-(pentyloxy)[1,1'':4'',1''''-terphenyl]-4-yl]carbonyl]-L-ornithine]-, N-((2R,6S,9S,11R,12R,14aS,15S,16S,20S,23S,25aS)-23-((1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl)-2,11,12,15-tetrahydroxy-6,20-bis((1R)-1-hydroxyethyl)-16-methyl-5,8,14,19,22,25-hexaoxotetracosahydro-1H-dipyrrolo(2,1-c:2'',1''-l)(1,4,7,10,13,16)hexaazacyclohenicosin-9-yl)-4''''-(pentyloxy)-1,1'':4'',1''''-terphenyl-4-carboxamide, N-{(2R,6S,9S,11R,12R,14aS,15S,16S,20S,23S,25aS)-23-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-2,11,12,15-tetrahydroxy-6,20-bis[(1R)-1-hydroxyethyl]-16-methyl-5,8,14,19,22,25-hexaoxotetracosahydro-1H-dipyrrolo[2,1-c:2'',1''-l][1,4,7,10,13,16]hexaazacyclohenicosin-9-yl}-4''''-(pentyloxy)-1,1'':4'',1''''-terphenyl-4-carboxamide, ANIDULAFUNGIN [MI], ANIDULAFUNGIN [INN], SCHEMBL38292, ANIDULAFUNGIN [VANDF], (4R,5R)-4,5-Dihydroxy-N(sup 2)-((4''-(pentyloxy)-p-terphenyl-4-yl)carbonyl)-L-ornithyl-L-threonyl-trans-4-hydroxy-L-prolyl-(S)-4-hydroxy-4-(p-hydroxyphenyl)-L-threonyl-L-threonyl-(3S,4S)-3-hydroxy-4-methyl-L-proline cyclic (6-1)-peptide, ANIDULAFUNGIN [WHO-DD], CHEMBL264241, ANIDULAFUNGIN [EMA EPAR], DTXCID90820698, J02AX06, JHVAMHSQVVQIOT-MFAJLEFUSA-N, ANIDULAFUNGIN [ORANGE BOOK], BDBM50417554, MFCD00917070, s4286, AKOS030526640, CCG-270647, CS-1824, DB00362, NCGC00386349-01, HY-13553, NS00007722, SW222238-1, EN300-19769052, J-010304, Q4764531, Echinocandin B, 1-((4R,5R)-4,5-dihydroxy-N2-((4''''-(pentyloxy)(1,1'':4'',1''''-terphenyl)-4-yl)carbonyl)-L-ornithine), N-[(3S,6S,9S,11R,15S,18S,20R,21R,24S,25S,26S)-6-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-11,20,21,25-tetrahydroxy-3,15-bis[(1R)-1-hydroxyethyl]-26-methyl-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexaazatricyclo[22.3.0.0,9,13]heptacosan-18-yl]-4''-[4-(pentyloxy)phenyl]-[1,1''-biphenyl]-4-carboxamide, N-[(3S,6S,9S,11R,15S,18S,20R,21R,24S,25S,26S)-6-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-11,20,21,25-tetrahydroxy-3,15-bis[(1R)-1-hydroxyethyl]-26-methyl-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexaazatricyclo[22.3.0.0^{9,13}]heptacosan-18-yl]-4-{4-[4-(pentyloxy)phenyl]phenyl}benzamide, N-[[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-tetrahydroxy-bis[(1R)-1-hydroxyethyl]-methyl-hexaoxo-[?]yl]-4-[4-(4-pentoxyphenyl)phenyl]benzamide C58H73N7O17 JHVAMHSQVVQIOT-MFAJLEFUSA-N N-[(3S,6S,9S,11R,15S,18S,20R,21R,24S,25S,26S)-6-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-11,20,21,25-tetrahydroxy-3,15-bis[(1R)-1-hydroxyethyl]-26-methyl-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosan-18-yl]-4-[4-(4-pentoxyphenyl)phenyl]benzamide Pfizer Pharmaceuticals Antifungal Agents No No No No No No PMDBD2000536 Aniline Therapeutic Substance n.a. 62-53-3 DB06728 n.a. n.a. n.a. 6115 5889 NPC271732 ANILINE, Benzenamine, Phenylamine, 62-53-3, Aminobenzene, Aminophen, Arylamine, Kyanol, Anilin, Cyanol, Benzeneamine, Krystallin, Benzidam, Anyvim, Anilina, Huile D''aniline, C.I. Oxidation Base 1, Rcra waste number U012, CI Oxidation Base 1, Caswell No. 051C, Anilinum, C.I. 76000, HSDB 43, CCRIS 44, NCI-C03736, Aniline and homologues, Aniline reagent, UN 1547, CHEBI:17296, UNII-SIR7XX2F1K, SIR7XX2F1K, EINECS 200-539-3, ANILINE-N,N-D2, EPA Pesticide Chemical Code 251400, Aniline-1-13C, CI 76000, DTXSID8020090, AI3-03053, MFCD00007629, DTXCID9090, EC 200-539-3, Benzene, amino, Anilin [Czech], ANILINE (IARC), ANILINE [IARC], ANILINE (MART.), ANILINE [MART.], ANILINE (USP-RS), ANILINE [USP-RS], Huile d''aniline [French], ANILINE (USP IMPURITY), ANILINE [USP IMPURITY], Phenyleneamine, D''aniline, RCRA waste no. U012, Anilina [Italian, Polish], FENTANYL IMPURITY F (EP IMPURITY), FENTANYL IMPURITY F [EP IMPURITY], Aniline and homologs, MESALAZINE IMPURITY K (EP IMPURITY), MESALAZINE IMPURITY K [EP IMPURITY], TRIMETHOPRIM IMPURITY K (EP IMPURITY), TRIMETHOPRIM IMPURITY K [EP IMPURITY], UN1547, benzenaminium, cyanole, BIDD:ER0581, phenyl amine, phenyl-amine, 8-aniline, Benzene, amino-, Fentanyl impurity F, 2-bromobenzylchloride, PhNH2, ANILINUM [HPUS], ANILINE [HSDB], ANILINE [INCI], ANILINE [MI], ANILINE [WHO-DD], CHEMBL538, Epitope ID:117704, Aniline, analytical standard, Aniline, AR, >=99%, Aniline, LR, >=99%, C6H5NH2, Discontinued, see H924510, BDBM92572, Trimethoprim specified impurity K, Aniline, ReagentPlus(R), 99%, BENZENE,AMINO (ANILINE), Aniline [UN1547] [Poison], AMY11081, STR00216, Aniline, ACS reagent, >=99.5%, Tox21_200345, AKOS000268796, DB06728, NCI 176889, Aniline, ASTM, ACS reagent, 99.5%, Aniline, SAJ first grade, >=99.0%, CAS-62-53-3, Aniline, JIS special grade, >=99.0%, Aniline, p.a., ACS reagent, 99.0%, NCGC00091297-01, NCGC00091297-02, NCGC00091297-03, NCGC00257899-01, BP-12047, Aniline, PESTANAL(R), analytical standard, A0463, NS00010656, EN300-33390, C00292, A833829, AMINOBENZOIC ACID IMPURITY C [EP IMPURITY], Q186414, SR-01000944923, J-519591, SR-01000944923-1, Q27121173, F2190-0417, InChI=1/C6H7N/c7-6-4-2-1-3-5-6/h1-5H,7H, Aniline, United States Pharmacopeia (USP) Reference Standard, 136260-71-4 C6H7N PAYRUJLWNCNPSJ-UHFFFAOYSA-N aniline n.a. n.a. No No No No No No PMDBD2000537 Anthraflavic acid n.a. n.a. n.a. n.a. n.a. n.a. n.a. 6776 n.a. NPC91478 "2,6-Dihydroxyanthraquinone, Anthraflavic acid, 84-60-6, 2,6-dihydroxyanthracene-9,10-dione, Anthraflavin, 9,10-Anthracenedione, 2,6-dihydroxy-, 2,6-Dihydroxyanthra-9,10-quinone, NSC-33531, Az-F, 2,6-dihydroxy-9,10-anthraquinone, 2,6-DIHYDROXY-ANTHRAQUINONE, 2,6-dihydroxy-9,10-anthracenedione, Anthraflavine, Anthraquinone, 2,6-dihydroxy-, MFCD00001228, CHEBI:34250, CHEMBL298398, 2,6-dihydroxy-9,10-dihydroanthracene-9,10-dione, W83883330W, Anthraflavic acid;2,6-Dihydroxyanthracene-9,10-dione, Anthrafravic acid, CCRIS 5593, EINECS 201-544-3, BRN 2054127, UNII-W83883330W, ANTHRAFLAVICACID, 9, 2,6-dihydroxy-, 2,6dihydroxyanthraquinone, 2,6-Dihdroxyanthraquinone, Anthraquinone,6-dihydroxy-, Epitope ID:116189, 2,6-dihydroxy anthraquinone, 4-08-00-03272 (Beilstein Handbook Reference), SCHEMBL124974, MEGxp0_001868, DTXSID6036546, ACon0_001479, ACon1_000002, AMY2560, 6,10-dihydroxy-2,9-anthraquinone, 9,10-dihydroxy-2,6-anthraquinone, NSC33531, BDBM50101979, s5169, 2,6-dihydroxyanthracene-9.10-dione, DIHYDROXYANTHRAQUINONE, 2,6-, AKOS001581115, 2,6-Dihydroxyanthra-9,10-quinone #, CCG-266870, CS-W006230, HY-W006230, Anthraflavic acid, technical grade, 90%, NCGC00168884-01, AS-14436, NCI60_002937, SY049293, EU-0066601, NS00014394, L10013, A864049, BRD-K65281664-001-01-8, Q27115942, 2,6-Dihydroxyanthracene-9,10-dione;2,6-Dihydroxyanthraquinone, InChI=1/C14H8O4/c15-7-1-3-9-11(5-7)14(18)10-4-2-8(16)6-12(10)13(9)17/h1-6,15-16" C14H8O4 APAJFZPFBHMFQR-UHFFFAOYSA-N 2,6-dihydroxyanthracene-9,10-dione n.a. n.a. No No No No No No PMDBD2000538 Anthranilate n.a. n.a. n.a. n.a. n.a. n.a. n.a. 227 n.a. n.a. anthranilic acid, 2-aminobenzoic acid, 118-92-3, o-aminobenzoic acid, o-Carboxyaniline, 2-Carboxyaniline, vitamin L1, o-Anthranilic acid, anthranilate, Benzoic acid, 2-amino-, 1-Amino-2-carboxybenzene, ortho-Aminobenzoic acid, Benzoic acid, o-amino-, Carboxyaniline, Kyselina anthranilova, NCI-C01730, Benzoic acid, amino-, Vitamin L, Caswell No. 033G, Kyselina o-aminobenzoova, 2-azaniumylbenzoate, 2-amino-Benzoic acid, NSC 144, CCRIS 49, 2-amino benzoic acid, Kyselina anthranilova [Czech], Antranilic Acid, BRN 0471803, HSDB 1321, Kyselina o-aminobenzoova [Czech], AI3-02408, EINECS 204-287-5, o-Aminobenzoesaeure, UNII-0YS975XI6W, 2-Aminobenzoesaeure, 0YS975XI6W, DTXSID8020094, CHEBI:30754, alpha-Aminobenzoic acid, Ortho-amidobenzoic acid, NSC-144, Anthranilic Acid-13C6, Cupric anthranilate, MFCD00007712, NSC-40929, DTXCID7094, Bis(anthranilato)copper, NSC 3937, Bis(o-aminobenzoato)copper, EC 204-287-5, Copper, bis(anthranilato)-, Anthranic acid, Copper, bis(2-aminobenzoato)-, NCGC00091175-01, Copper, bis(2-aminobenzoato-N,O)-, 1321-11-5, BE2, ANTHRANILIC ACID (IARC), ANTHRANILIC ACID [IARC], NSC3937, CAS-118-92-3, 15442-49-6, Anthranate, anthanilic acid, o-Anthranilate, o-amino-Benzoate, 4owv, 2-amino-Benzoate, Ortho-amidobenzoate, Ortho-aminobenzoate, 2-aminobezoic acid, anthranilic acid gr, EINECS 215-310-3, 2-Aminophenylacetate, 2-Carboxyphenylamine, o-amino-Benzoic acid, NSC 173996, 2-anilinecarboxylic acid, Anthranilic acid, 98%, H-2-Abz-OH, SCHEMBL675, bmse000067, bmse000917, H-(2)Abz-OH, NCIOpen2_001191, Oprea1_390012, 80206-34-4, 98072-80-1, CHEMBL14173, NSC144, ANTHRANILIC ACID [HSDB], 1-aminobenzene-2-carboxylic acid, O-AMINOBENZOIC ACID [MI], ANTHRANILIC ACID [WHO-DD], NSC40929, Tox21_111095, Tox21_200703, BDBM50376751, Anthranilic acid-ring-UL-14C, solid, AKOS002667021, Tox21_111095_1, DB04166, NCGC00091175-02, NCGC00091175-03, NCGC00258257-01, 50816-84-7, AC-11503, Anthranilic acid, reagent grade, >=98%, BP-30147, A0497, NS00009891, C00108, BENZOIC ACID,2-AMINO ANTHRANILIC ACID, Benzoic acid,2-amino-,labeled with tritium(9ci), Anthranilic acid, puriss. p.a., >=99.5% (T), Q385140, 3B851741-2A4D-440D-BB22-1A455121BA21, InChI=1/C7H7NO2/c8-6-4-2-1-3-5(6)7(9)10/h1-4H,8H2,(H,9,10, Benzoic acid,2-amino-,diazotized,coupled with 4-amino-5-hydroxy-2,7-naphthalenedisulfonic acid,diazotized 3,3''-dimethyl[1,1''-biphenyl]-4,4''-diamine and 5,5''-[oxybis[(5-hydroxy-3,1-phenylene)oxy]]b C7H7NO2 RWZYAGGXGHYGMB-UHFFFAOYSA-N 2-aminobenzoic acid n.a. n.a. No No No No No No PMDBD2000539 Apigenin Therapeutic Substance Investigational Drug 520-36-5 DB07352 n.a. n.a. D00RIX 5280443 4444100 NPC50898 "apigenin, 520-36-5, 5,7-Dihydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-one, Apigenol, Versulin, 4'',5,7-Trihydroxyflavone, Chamomile, Spigenin, Apigenine, C.I. Natural Yellow 1, Pelargidenon 1449, 5,7,4''-Trihydroxyflavone, 5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one, 5,7-Dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one, NSC 83244, 2-(p-Hydroxyphenyl)-5,7-dihydroxychromone, 4H-1-Benzopyran-4-one, 5,7-dihydroxy-2-(4-hydroxyphenyl)-, UCCF 031, 5,7-Dihydroxy-2-(4-hydroxyphenyl)-4-benzopyrone, CCRIS 3789, FLAVONE, 4'',5,7-TRIHYDROXY-, CHEBI:18388, 8002-66-2, EINECS 208-292-3, MFCD00006831, NSC-83244, UNII-7V515PI7F6, APEGENIN, BRN 0262620, Chamomile oil, german, DTXSID6022391, HSDB 7573, 7V515PI7F6, CHEMBL28, PELARGIDENON-1449, CI NATURAL YELLOW 1, DTXCID902391, UCCF-031, 5-18-04-00574 (Beilstein Handbook Reference), NSC83244, CAS-520-36-5, LY-080400, 4'',5,7-Trihydroxyflavone;Apigenol;C.I. Natural Yellow 1, SMR000326850, 4′,5,7-Trihydroxyflavone, SR-01000075663, Pelargidenone, 4der, 4dgm, 4hkk, Naringenin, 18, 5,7-Dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one; 4'',5,7-Trihydroxyflavone; Pelargidenon 1449;, Prestwick_719, Apigenin, 13, Tocris-1227, 3cf9, ST056301, APIGENIN [HSDB], APIGENIN [INCI], 4'',7-Trihydroxyflavone, APIGENIN [MI], BiomolKI_000078, Prestwick0_000414, Prestwick1_000414, Prestwick2_000414, Prestwick3_000414, Spectrum2_000428, Spectrum3_001882, Spectrum4_001999, Lopac-A-3145, APIGENIN [USP-RS], APIGENIN [WHO-DD], BiomolKI2_000082, 4,5, 7-Trihydroxyflavone, Lopac0_000065, Oprea1_622293, SCHEMBL19428, 4'',5,7-trihydroxy-Flavone, Apigenin, analytical standard, BSPBio_000368, BSPBio_003384, KBioGR_002565, SPECTRUM200846, MLS000697626, MLS000859991, MLS001074874, MLS006011839, BIDD:ER0135, DivK1c_000798, SCHEMBL222227, SPBio_000416, SPBio_002307, ghl.PD_Mitscher_leg0.1194, BDBM7458, BPBio1_000406, GTPL4136, MEGxp0_000176, ACon1_002450, cid_5280443, HMS502H20, KBio1_000798, KBio3_002887, NINDS_000798, Bio1_000376, Bio1_000865, Bio1_001354, HMS1569C10, HMS1922P22, HMS2096C10, HMS2230D17, HMS3260M11, HMS3267D21, HMS3373B18, HMS3412A08, HMS3561P09, HMS3655D18, HMS3676A08, HMS3866D03, Apigenin, >=95.0% (HPLC), BCP28288, HY-N1201, Tox21_201542, Tox21_302884, Tox21_500065, Apigenin; 4'',5,7-Trihydroxyflavone, CCG-40061, HB0117, HSCI1_000221, LMPK12110005, NSC815095, s2262, ZB1873, AKOS002140699, AC-8011, CS-5432, DB07352, LP00065, ND-9076, NSC-815095, SDCCGMLS-0066379.P001, SDCCGSBI-0050053.P003, IDI1_000798, SMP2_000338, Apigenin, >=97% (TLC), from citrus, NCGC00015049-01, NCGC00015049-02, NCGC00015049-03, NCGC00015049-04, NCGC00015049-05, NCGC00015049-06, NCGC00015049-07, NCGC00015049-08, NCGC00015049-09, NCGC00015049-10, NCGC00015049-11, NCGC00015049-12, NCGC00015049-13, NCGC00015049-14, NCGC00015049-15, NCGC00015049-16, NCGC00015049-18, NCGC00015049-22, NCGC00015049-28, NCGC00025057-01, NCGC00025057-02, NCGC00025057-03, NCGC00025057-04, NCGC00025057-05, NCGC00025057-06, NCGC00025057-07, NCGC00025057-08, NCGC00025057-09, NCGC00169835-01, NCGC00169835-02, NCGC00169835-03, NCGC00256419-01, NCGC00259092-01, NCGC00260750-01, LY080400, NCI60_041830, SY005957, TS-00897, APIGENIN (CONSTITUENT OF CHAMOMILE), LY 080400, EU-0100065, NS00007770, SW196866-2, A 3145, C01477, K00045, M01289, O11338, Apigenin 100 microg/mL in Acetonitrile:Methanol, Apigenin, >=97% (TLC), from parsley, powder, Biochem Biophys Res Comm 212: 767 (1997), EN300-7382221, 5,7-dihydroxy-2-(4-hydroxyphenyl)-chromen-4-one, A828903, APIGENIN (CONSTITUENT OF CHAMOMILE) [DSC], Apigenin, primary pharmaceutical reference standard, Q424567, 2-(P-HYDROXYPHENYL)-5,7-DIHYDROXY-CHROMONE, Q-100586, Q-200822, SR-01000075663-1, SR-01000075663-3, SR-01000075663-7, SR-01000075663-8, BRD-K01493881-001-10-4, BRD-K01493881-001-17-9, 5,7-Dihydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-one #, Z1741982550, 4H-1-Benzopyran-4-one,7-dihydroxy-2-(4-hydroxyphenyl)-, D50A2D8A-6D8B-4708-B21E-2DE9580D033F, Apigenin, United States Pharmacopeia (USP) Reference Standard, 4H-1BENZOPYRAN-4-ONE,5,7-DIHYDROXY-2-(4-HYDROXY-PHENYL)-" C15H10O5 KZNIFHPLKGYRTM-UHFFFAOYSA-N 5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one n.a. n.a. No No No No Yes No rxn02551,rxnDiet80,rxnAdd95,rxnAdd96,rxnAdd98 PMDBD2000540 Arbekacin Therapeutic Substance Approved Drug 51025-85-5 DB06696 PA165958370 D07462 D07JPC 68682 61936 n.a. "Arbekacin, Haberacin, Arbekacina, 51025-85-5, Arbekacine, Arbekacinum, Arbekacin [INN], ME1100, G7V6SLI20L, CHEBI:37922, Arbekacin (INN), 51025-85-5 (free base), (2S)-4-amino-N-[(1R,2S,3S,4R,5S)-5-amino-4-[(2R,3R,6S)-3-amino-6-(aminomethyl)oxan-2-yl]oxy-2-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxycyclohexyl]-2-hydroxybutanamide, ME-1100, Arbekacine [French], Arbekacinum [Latin], Arbekacin sulfate [JAN], Arbekacina [Spanish], NPC-14, (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-2-(((2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-4-(((2R,3R,6S)-3-amino-6-(aminomethyl)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide, NCGC00167530-01, UNII-G7V6SLI20L, 84G, DKB-AHB, 1665RB; AHB-DKB; Arbecacin;HABA-DKB; HBK, ARBEKACIN [MI], ARBEKACIN [WHO-DD], SCHEMBL18413, CHEMBL426926, GTPL7345, DTXSID8048319, MKKYBZZTJQGVCD-XTCKQBCOSA-N, AKOS025149466, DB06696, D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1-6)-O-(2,6-diamino-2,3,4,6-tetradeoxy-alpha-D-erythro-hexopyranosyl-(1-4))-N(sup 1)-(4-amino-2-hydroxy-1-oxobutyl)-2-deoxy-, (S)-, D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1-6)-O-(2,6-diamino-2,3,4,6-tetradeoxy-alpha-D-erythro-hexopyranosyl-(1-4))-N1-(4-amino-2-hydroxy-1-oxobutyl)-2-deoxy-, (S)-, O-3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1->4)-O-(2,6-diamino-2,3,4,6-tetradeoxy-alpha-D-erythro-hexopyranosyl-(1->6))-N''-((2S)-4-amino-2-hydroxybutyryl)-2-deoxy-L-streptamine, O-3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1-4)-O-(2,6-diamino-2,3,4,6-tetradeoxy-alpha-D-erythro-hexopyranosyl-(1-6))-N''-((2S)-4-amino-2-hydroxybutyryl)-2-deoxy-L-streptamine, D07462, Q4784668, (2S)-4-amino-N-[(1R,2S,3S,4R,5S)-5-amino-2-(3-amino-3-deoxy-alpha-D-glucopyranosyloxy)-4-(2,6-diamino-2,3,4,6-tetradeoxy-alpha-D-erythro-hexopyranosyloxy)-3-hydroxycyclohexyl]-2-hydroxybutanamide, (2S)-4-amino-N-[(1R,2S,3S,4R,5S)-5-amino-2-{[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4-{[(2R,3R,6S)-3-amino-6-(aminomethyl)oxan-2-yl]oxy}-3-hydroxycyclohexyl]-2-hydroxybutanamide, (2S)-4-amino-N-[(1R,2S,3S,4R,5S)-5-amino-4-[(2R,3R,6S)-3-amino-6-(aminomethyl)tetrahydropyran-2-yl]oxy-2-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-3-hydroxy-cyclohexyl]-2-hydroxy-butanamide, (2S)-4-amino-N-{(1R,2S,3S,4R,5S)-5-amino-2-[(3-amino-3-deoxy-alpha-D-glucopyranosyl)oxy]-4-[(2,6-diamino-2,3,4,6-tetradeoxy-alpha-D-erythro-hexopyranosyl)oxy]-3-hydroxycyclohexyl}-2-hydroxybutanamide, (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-2-((2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)-4-((2R,3R,6S)-3-amino-6-(aminomethyl)tetrahydro-2H-pyran-2-yloxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide, Butanamide, 4-amino-N-[(1R,2S,3S,4R,5S)-5-amino-2-[(3-amino-3-deoxy-.alpha.-D-glucopyranosyl)oxy]-4-[(2,6-diamino-2,3,4,6-tetradeoxy-.alpha.-D-erythro-hexopyranosyl)oxy]-3-hydroxycyclohexyl]-2-hydroxy-, (2S)-, D-STREPTAMINE, O-3-AMINO-3-DEOXY-.ALPHA.-D-GLUCOPYRANOSYL-(1->6)-O-(2,6-DIAMINO-2,3,4,6-TETRADEOXY-.ALPHA.-D-ERYTHRO-HEXOPYRANOSYL-(1->4))-N1-((2S)-4-AMINO-2-HYDROXY-1-OXOBUTYL)-2-DEOXY-, O-3-AMINO-3-DEOXY-.ALPHA.-D-GLUCOPYRANOSYL-(1->4)-O-(2,6-DIAMINO-2,3,4,6-TETRADEOXY-.ALPHA.-D-ERYTHRO-HEXOPYRANOSYL-(1->6))-N''-((2S)-4-AMINO-2-HYDROXYBUTYRYL)-2-DEOXY-L-STREPTAMINE" C22H44N6O10 MKKYBZZTJQGVCD-XTCKQBCOSA-N (2S)-4-amino-N-[(1R,2S,3S,4R,5S)-5-amino-4-[(2R,3R,6S)-3-amino-6-(aminomethyl)oxan-2-yl]oxy-2-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxycyclohexyl]-2-hydroxybutanamide Meiji Seika n.a. No No No No No No PMDBD2000541 Asperdiol n.a. n.a. n.a. n.a. n.a. n.a. n.a. 5358793 n.a. n.a. ASPERDIOL, 64180-67-2, NSC279559, CHEMBL1989490, DTXSID00418489, NSC-279559 C20H32O3 FLJAFHRJXPAASR-HOZOIBKHSA-N (4E,10E)-4-(hydroxymethyl)-10,14-dimethyl-7-prop-1-en-2-yl-15-oxabicyclo[12.1.0]pentadeca-4,10-dien-6-ol n.a. n.a. No No No No No No PMDBD2000542 Asperdiol acetate n.a. n.a. n.a. n.a. n.a. n.a. n.a. 6442232 n.a. n.a. asperdiol acetate, 198494-48-3, 15-Oxabicyclo(12.1.0)pentadeca-4,10-diene-4-methanol, 6-hydroxy-10,14-dimethyl-7-(1-methylethenyl)-, 4-acetate, (1S,4E,6S,7R,10E,14S)- C22H34O4 XHPIEOZMYVAMEY-IVQWWHATSA-N [(1S,4E,6S,7R,10E,14S)-6-hydroxy-10,14-dimethyl-7-prop-1-en-2-yl-15-oxabicyclo[12.1.0]pentadeca-4,10-dien-4-yl]methyl acetate n.a. n.a. No No No No No No PMDBD2000543 Autoinducer-2 n.a. n.a. n.a. n.a. n.a. n.a. n.a. 446576 n.a. NPC322233 Autoinducer-2, Autoinducer 2, AI-2, CHEBI:40646, (1R,2S,5S)-7,7-Dihydroxy-5-methyl-4,6,8-trioxa-7-boranuidabicyclo[3.3.0]octane-1,2-diol, (1R,5S,8S)-3,3-dihydroxy-5-methyl-2,4,6-trioxa-3-boranuidabicyclo[3.3.0]octane-1,8-diol, 3A-METHYL-5,6-DIHYDRO-FURO[2,3-D][1,3,2]DIOXABOROLE-2,2,6,6A-TETRAOL, AI2, Autoinducer II, AI-2 autoinducer, (S)-THMF-borate, AI-2 (vibrio), autoinducer-2 (vibrio), MolMap_000059, CHEMBL1230903, ACKRRKSNOOISSG-VPENINKCSA-N, Q4826351, (2S,4S)-2-methyl-2,3,4-tetrahydroxytetrahydrofuran-borate, (2S,4S)-2-methyl-2,3,3,4-tetrahydroxytetrahydrofuran-borate, (2S,3R,4S)-2,3,3,4-Tetrahydroxy-2-methyldihydrofuran-2,3-O borate, (2S,3R,4S)-2-METHYL-3,4-DIHYDROXY-OXOLAN-2,3-DIOXY-BORATE, (3aS,6S,6aR)-2,2,6,6a-tetrahydroxy-3a-methyltetrahydrofuro[3,2-d][1,3,2]dioxaborolan-2-uide, dihydroxy[(2S,3R,4S)-2-methyldihydrofuran-2,3,3,4(2H)-tetrolato(2-)-kappa(2)O(2),O(3)]borate(1-), dihydroxy[(2S,3R,4S)-2-methyldihydrofuran-2,3,3,4(2H)-tetrolato(2-)-kappa~2~O~2~,O~3~]borate(1-) (non-preferred name) C5H10BO7- ACKRRKSNOOISSG-VPENINKCSA-N (1R,5S,8S)-3,3-dihydroxy-5-methyl-2,4,6-trioxa-3-boranuidabicyclo[3.3.0]octane-1,8-diol n.a. n.a. No No No No No No PMDBD2000544 Avibactam Therapeutic Substance n.a. 1192500-31-4 DB09060 n.a. n.a. n.a. 9835049 8010770 n.a. Avibactam, 1192500-31-4, Avibactam free acid, NXL104, AVE-1330A free acid, Avibactam (free acid), Nxl-104 free acid, [(2S,5R)-2-carbamoyl-7-oxo-1,6-diazabicyclo[3.2.1]octan-6-yl] hydrogen sulfate, 396731-14-9, CHEMBL1689063, CHEBI:85984, 06MFO7817I, (2S,5R)-7-oxo-6-(sulfooxy)-1,6-diazabicyclo[3.2.1]octane-2-carboxamide, 1,6-Diazabicyclo(3.2.1)octane-2-carboxamide, 7-oxo-6-(sulfooxy)-, (1R,2S,5R)-rel-, (1R,2S,5R)-2-carbamoyl-7-oxo-1,6-diazabicyclo[3.2.1]octan-6-yl hydrogen sulfate, Avibactam [INN], Avibactam [USAN:INN], UNII-06MFO7817I, Avibactamfreeacid, SULFURIC ACID, MONO((1R,2S,5R)-2-(AMINOCARBONYL)-7-OXO-1,6-DIAZABICYCLO(3.2.1)OCT-6-YL) ESTER, SULFURIC ACID, MONO[(1R,2S,5R)-2-(AMINOCARBONYL)-7-OXO-1,6-DIAZABICYCLO[3.2.1]OCT-6-YL] ESTER, UNII-7352665165, AVIBACTAM [MI], AVIBACTAM [USAN], AVIBACTAM [WHO-DD], SCHEMBL1666807, AVIBACTAM, (+/-)-, GTPL10761, DTXSID901026066, AMY24028, AVI, ZAVICEFTA COMPONENT AVIBACTAM, BDBM50339145, AKOS030526076, AVIBACTAM COMPONENT OF ZAVICEFTA, CS-0593, DB09060, AC-35749, HY-14879, MS-23747, NS00070484, E80372, EN300-22179568, Q15410251, trans-7-oxo-6-(sulfooxy)-1,6-diazabicyclo[3.2.1]octan-2-carboxamide, (1R,2S,5R)-7-OXO-6-SULFOOXY-1,6-DIAZABICYCLO(3.2.1)OCTANE-2-CARBOXAMIDE, [(2S,5R)-2-CARBAMOYL-7-OXO-1,6-DIAZABICYCLO[3.2.1]OCTAN-6-YL]OXIDANESULFONIC ACID, 1416134-69-4, 794508-22-8 C7H11N3O6S NDCUAPJVLWFHHB-UHNVWZDZSA-N [(2S,5R)-2-carbamoyl-7-oxo-1,6-diazabicyclo[3.2.1]octan-6-yl] hydrogen sulfate n.a. n.a. No No No No No No PMDBD2000545 Azidocillin Therapeutic Substance n.a. 17243-38-8 DB08795 PA165958414 n.a. n.a. 15574941 16735689 n.a. "Azidocillin, 17243-38-8, azidocillinum, Azidocilina, Azidocilline, SPC 297 D, BRL 2534, D-(-)-(alpha-Azidobenzyl)penicillin, R8XDP7L3SL, (2S,5R,6R)-6-[[(2R)-2-azido-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, CHEBI:51758, SPC-297-D, BRL-2534, Azidocillina, (2S,5R,6R)-6-{[(2R)-2-azido-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, AZIDOCILLIN [INN], Azidocillina [DCIT], Azidocillin [INN:BAN], UNII-R8XDP7L3SL, Azidocilina [INN-Spanish], Azidocilline [INN-French], Azidocillinum [INN-Latin], EINECS 241-278-5, AZIDOCILLIN [MI], AZIDOCILLIN [WHO-DD], CHEMBL2105907, GTPL12291, DTXSID20938154, ODFHGIPNGIAMDK-NJBDSQKTSA-N, HY-B2091, DB08795, (2S,5R,6R)-6-((R)-2-Azido-2-phenylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptan-2-carbonsaeure, 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylicacid, 6-[[(2R)-azidophenylacetyl]amino]-3,3-dimethyl-7-oxo-, (2S,5R,6R)-, 6-(2-Azido-2-phenylacetamido)-3,3-dimethyl-7-oxo-4-thia-4-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(azido-2-phenylacetamido)penicillanic acid, CS-0017507, NS00008939, D-(-)-(.ALPHA.-AZIDOBENZYL)PENICILLIN, Q4832566, 2,2-dimethyl-6beta-[(2R)-2-azido-2-phenylacetamido]penam-3alpha-carboxylic acid, BRL 2351; BRL 2534; D-(-)--Azidobenzylpenicillin; DAN 10510; SPC 297D; SPC 97D, (2S,5R,6R)-6-((R)-2-AZIDO-2-PHENYLACETAMIDO)-3,3-DIMETHYL-7-OXO-4-THIA-1-AZABICYCLO(3.2.0)HEPTAN-2-CARBOXYLIC ACID, (2S,5R,6R)-6-((R)-2-azido-2-phenylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, (2S,5R,6R)-6-[(2R)-2-azido-2-phenylacetamido]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 6-(2-Azido-2-phenylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid" C16H17N5O4S ODFHGIPNGIAMDK-NJBDSQKTSA-N (2S,5R,6R)-6-[[(2R)-2-azido-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid n.a. n.a. No No No No No No PMDBD2000546 Bac8C n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000547 Bacalin hydrate n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000548 Bacampicillin Therapeutic Substance Approved Drug 50972-17-3 DB01602 PA164745461 n.a. D04CFW 441397 390135 n.a. "bacampicillin, 50972-17-3, Bacampicilline, Penglobe, bacampicillinum, Bacampicilina, CHEBI:2968, 1''-Ethoxycarbonyloxyethyl-(6-D-alpha-aminophenylacetamido)penicillanate, 1-ethoxycarbonyloxyethyl (2S,5R,6R)-6-[[(2R)-2-amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate, Bacampicillin (INN), 8GM2J22278, BAPC, BACAMPICILLIN [INN], 1-[(ethoxycarbonyl)oxy]ethyl (2S,5R,6R)-6-{[(2R)-2-amino-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate, 1-[(ethoxycarbonyl)oxy]ethyl (2S,5R,6R)-6-[(2R)-2-amino-2-phenylacetamido]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate, Bacampicillin [INN:BAN], Bacampicilina [INN-Spanish], Bacampicilline [INN-French], Bacampicillinum [INN-Latin], UNII-8GM2J22278, Penglobe (TN), Prestwick0_000416, Prestwick1_000416, Prestwick2_000416, Prestwick3_000416, BACAMPICILLIN [MI], Epitope ID:117129, C08122, CHEMBL1583, SCHEMBL33818, BACAMPICILLIN [VANDF], BSPBio_000372, SPBio_002311, BACAMPICILLIN [WHO-DD], BPBio1_000410, DTXSID2048030, GTPL12292, PFOLLRNADZZWEX-FFGRCDKISA-N, HY-B1149, AKOS030526153, CS-4753, DB01602, 6-((R)-2-Amino-2-phenylacetamido)penicillansaeure-(1-(ethoxycarbonyloxy)ethylester, NCGC00179582-01, (2S,5R,6R)-6((R)-(2-Amino-2-phenylacetamido))-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid ester with ethyl 1-hydroxyethylcarbonate, 1-Ethoxycarbonyloxyethyl (2S,5R,6R)-6((R)-(2-amino-2-phenylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptan-2-carboxylat, NS00009109, D07487, A828376, EN300-19766307, Q2878140, BRD-A41698174-003-03-9, (2S,5R,6R)-1-(ethoxycarbonyloxy)ethyl 6-((R)-2-amino-2-phenylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate, 1-[(ethoxycarbonyl)oxy]ethyl 6beta-[(2R)-2-amino-2-phenylacetamido]-2,2-dimethylpenam-3alpha-carboxylate, 1-ethoxycarbonyloxyethyl (2S,5R,6R)-6-[[(2R)-2-amino-2-phenyl-acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate;Bacampicillin, 4-THIA-1-AZABICYCLO(3.2.0)HEPTANE-2-CARBOXYLIC ACID, 6-((AMINOPHENYLACETYL)AMINO)-3,3-DIMETHYL-7-OXO-, 1-((ETHOXYCARBONYL)OXY)ETHYL ESTER, (2S-(2.ALPHA.,5.ALPHA.,6.BETA.(S*)))-, 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((aminophenylacetyl)amino)-3,3-dimethyl-7-oxo-, 1-((ethoxycarbonyl)oxy)ethyl ester, (2S-(2alpha,5alpha,6beta(S*)))-" C21H27N3O7S PFOLLRNADZZWEX-FFGRCDKISA-N 1-ethoxycarbonyloxyethyl (2S,5R,6R)-6-[[(2R)-2-amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate Pfizer Pharmaceuticals Antibiotics No No No No No No PMDBD2000549 Bactenecin n.a. n.a. n.a. n.a. n.a. n.a. n.a. 163998 n.a. n.a. Bactenecin, 116229-36-8, Bactenecin, bovine, Bac7, Arg-leu-cyclo(cys-arg-ile-val-val-ile-arg-val-cys)-arg, CHEBI:201834, 2-[[28-[[2-[[2-amino-5-(diaminomethylideneamino)pentanoyl]amino]-4-methylpentanoyl]amino]-13,22-di(butan-2-yl)-10,25-bis[3-(diaminomethylideneamino)propyl]-6,9,12,15,18,21,24,27-octaoxo-7,16,19-tri(propan-2-yl)-1,2-dithia-5,8,11,14,17,20,23,26-octazacyclononacosane-4-carbonyl]amino]-5-(diaminomethylideneamino)pentanoic acid, PD150815 C63H118N24O13S2 RHISNKCGUDDGEG-UHFFFAOYSA-N 2-[[28-[[2-[[2-amino-5-(diaminomethylideneamino)pentanoyl]amino]-4-methylpentanoyl]amino]-13,22-di(butan-2-yl)-10,25-bis[3-(diaminomethylideneamino)propyl]-6,9,12,15,18,21,24,27-octaoxo-7,16,19-tri(propan-2-yl)-1,2-dithia-5,8,11,14,17,20,23,26-octazacyclononacosane-4-carbonyl]amino]-5-(diaminomethylideneamino)pentanoic acid n.a. n.a. No No No No No No PMDBD2000550 Baicalein Therapeutic Substance Phase 2 491-67-8 DB16101 n.a. n.a. D00YEV 5281605 4444924 NPC239312 baicalein, 491-67-8, 5,6,7-Trihydroxyflavone, Noroxylin, 5,6,7-trihydroxy-2-phenyl-4H-chromen-4-one, Biacalein, BaiKalein, 5,6,7-trihydroxy-2-phenylchromen-4-one, 5,6,7-trihydroxy-2-phenyl-chromen-4-one, MFCD00017459, NSC 661431, NSC-661431, CHEBI:2979, UNII-49QAH60606, NSC661431, 49QAH60606, 5,6,7-Trihydroxy-2-phenyl-4H-1-benzopyran-4-one, CHEMBL8260, DTXSID2022389, 5,7-Trihydroxyflavone, BAICALEIN (USP-RS), BAICALEIN [USP-RS], Baicelein, Sho-saiko-to, SMR000112462, SR-01000597499, 4H-1-Benzopyran-4-one, 5,6,7-trihydroxy-2-phenyl-, Baicalein, 8, Baicalein,(S), 3WL, Baicalein, 14, Baicalein, 98%, Spectrum_000427, Tocris-1761, SpecPlus_000758, BAICALEIN [MI], BAICALEIN [INCI], Spectrum2_000466, Spectrum3_001608, Spectrum4_000537, Spectrum5_001418, BAICALEIN [WHO-DD], Oprea1_765614, BSPBio_003215, KBioGR_001173, KBioSS_000907, MLS002473007, MLS006011756, BIDD:ER0121, DivK1c_006854, SCHEMBL139617, SPECTRUM1504002, SPBio_000572, DTXCID802389, GTPL5144, KBio1_001798, KBio2_000907, KBio2_003475, KBio2_006043, KBio3_002435, HMS1922O22, HMS2267F15, HMS3268C22, HMS3412F14, HMS3649O19, HMS3655P18, HMS3676F14, BCP14393, HY-N0196, TNP00121, BDBM50009001, CCG-38705, LMPK12111095, NSC729192, s2268, AKOS005747014, AC-7991, CS-6159, NSC-729192, SDCCGMLS-0066744.P001, Baicalein, analytical reference material, SMP1_000037, NCGC00017236-01, NCGC00017236-02, NCGC00017236-03, NCGC00017236-04, NCGC00017236-05, NCGC00017236-06, NCGC00017236-07, NCGC00017236-08, NCGC00017236-10, NCGC00017236-11, NCGC00025282-01, NCGC00025282-02, NCGC00025282-03, NCGC00025282-04, NCGC00178204-01, AS-57923, PD132943, SY057137, 5,6,7-Trihydroxy-2-phenyl-chroman-4-one, NS00097437, SW219229-1, T2721, EN300-303171, S00113, 5,7-Trihydroxy-2-phenyl-4H-1-benzopyran-4-one, A827663, Q-100550, Q2879363, SR-01000597499-1, SR-01000597499-3, SR-01000597499-4, SR-01000597499-6, W-202870, 5,6,7-Trihydroxy-2-phenyl-(4H)-1-benzopyran-4-one, BRD-K72327355-001-02-2, BRD-K72327355-001-06-3, Z1824568302 C15H10O5 FXNFHKRTJBSTCS-UHFFFAOYSA-N 5,6,7-trihydroxy-2-phenylchromen-4-one n.a. n.a. No No No No Yes No rxnDiet85,rxnAdd101 PMDBD2000551 Bedaquiline Therapeutic Substance Approved Drug 843663-66-1 DB08903 n.a. D09872 D0Y4QG 5388906 4534966 n.a. "Bedaquiline, 843663-66-1, TMC207, TMC-207, R207910, TMC 207, AIDS-222089, bedaquilina, bedaquilinum, CHEBI:72292, HSDB 8217, 654653-93-7, Bedaquiline [USAN:INN], UNII-78846I289Y, R 207910, R-207910, (1R,2S)-1-(6-bromo-2-methoxyquinolin-3-yl)-4-(dimethylamino)-2-(naphthalen-1-yl)-1-phenylbutan-2-ol, AIDS 222089, (1R,2S)-1-(6-bromo-2-methoxyquinolin-3-yl)-4-(dimethylamino)-2-naphthalen-1-yl-1-phenylbutan-2-ol, 1-(6-Bromo-2-methoxy-quinolin-3-yl)-4-dimethylamino-2-naphthalen-1-yl-1-phenyl-butan-2-ol, 78846I289Y, DTXSID80903989, 843663-66-1 (free base), MMV689758, (alphaR,betaS)-rel-Bedaquiline, (1R,2S)-1-(6-bromo-2-methoxyquinolin-3-yl)-4-(dimethylamino)-2-(1-naphthyl)-1-phenylbutan-2-ol, (alphaS,betaR)-6-bromo-alpha-[2-(dimethylamino)ethyl]-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinolineethanol, BDQ, compound 1a (PMID: 17496888), compound 1a [PMID: 17496888], (1R,2S) 6-BROMO-ALPHA-(2-(DIMETHYLAMINO)ETHYL)-2-METHOXY-ALPHA-(1-NAPHTHYL)-BETA-PHENYL-3-QUINOLINEETHANOL, (1R,2S)-1-(6-Bromo-2-methoxy-3-quinolyl)-4-dimethylamino-2-(1-naphthyl)-1-phenyl-butan-2-ol, (1R,2S)-1-(6-Bromo-2-methoxy-quinolin-3-yl)-4-methyl-amino-2-naphthalen-1-yl-1-phenyl-butan-2-ol, 3-Quinolineethanol, 6-bromo-alpha-(2-(dimethylamino)ethyl)-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-, (alphaS,betaR)-, Bedaquiline [USAN], C32H31BrN2O2, (|AR,|AS)-rel-Bedaquiline, (1R,2S)-1-(6-bromo-2-methoxy-3-quinolyl)-4-(dimethylamino)-2-(1-naphthyl)-1-phenyl-butan-2-ol, BQ1, (aS,bR)-Bedaquiline, BEDAQUILINE [MI], BEDAQUILINE [INN], Bedaquiline (USAN/INN), (|AS,|AR)-Bedaquiline, BEDAQUILINE [VANDF], BEDAQUILINE [WHO-DD], SCHEMBL295482, CHEMBL376488, GTPL11171, J04AK05, DTXCID501331924, DTXSID101027810, cis-1-(6-Bromo-2-methoxyquinolin-3-yl)-4-(dimethylamino)-2-(naphthalen-1-yl)-1-phenylbutan-2-ol, EX-A4133, BDBM50063995, s5623, AKOS022186476, CCG-270030, DB08903, bromo-2-methoxy-quinolin-3-yl)-4-dimethylamino-2-naphthalen-1-yl-1-phenyl-butan-2-ol, NCGC00348215-01, NCGC00348215-03, NCGC00348215-04, (1R,2S)-1-(6-BROMO-2-METHOXY-QUINOLIN-3-YL)-4-DIMETHYLAMINO-2-(3-FLUOROPHENYL)-1-PHENYL-BUTAN-2-OL, 3-Quinolineethanol, 6-bromo-alpha-(2-(dimethylamino)ethyl)-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-, (alphaR,betaS)-rel-, AC-28385, HY-14881, NS00069910, D09872, SR-05000022473, J-500265, Q1257318, SR-05000022473-1, R403323; TMC207; R207910, (1R,2S)-1-(6-BROMO-2-METHOXYQUINOLIN-3-YL)-4-(DIMETHYLAMINO)-2-(NAPHTHALEN-1-YL)-1- PHENYLBUTAN-2-OL, 1-(1R)-(6-Bromo-2-methoxy-quinolin-3-yl)-4-dimethylamino-2-(2S)-(naphthalen-1-yl)-1-phenyl-butan-2-ol, 1-(6-bromo-2-methoxy-quinolin-3-yl)-4-dimethylamino-2-(3-fluorophenyl)-1-phenyl-butan-2-ol, 3-QUINOLINEETHANOL, 6-BROMO-.ALPHA.-(2-(DIMETHYLAMINO)ETHYL)-2-METHOXY-.ALPHA.-1-NAPHTHALENYL-.BETA.-PHENYL-, (.ALPHA.S,.BETA.R)-, 3-Quinolineethanol, 6-Bromo-Alpha-(2-(Dimethylamino)Ethyl)-2-Methoxy-Alpha-1-Naphthalenyl-Beta-Phenyl-, (Alpha-S,Beta-R)-, rel-(1R,2S)-1-(6-Bromo-2-methoxyquinolin-3-yl)-4-(dimethylamino)-2-(naphthalen-1-yl)-1-phenylbutan-2-ol" C32H31BrN2O2 QUIJNHUBAXPXFS-XLJNKUFUSA-N (1R,2S)-1-(6-bromo-2-methoxyquinolin-3-yl)-4-(dimethylamino)-2-naphthalen-1-yl-1-phenylbutan-2-ol Johnson & Johnson n.a. No No No No No No PMDBD2000552 Benzalacetone n.a. n.a. n.a. n.a. n.a. n.a. n.a. 637759 n.a. NPC311343 "Benzylideneacetone, Benzalacetone, 1896-62-4, 122-57-6, 4-Phenylbut-3-en-2-one, (E)-4-phenylbut-3-en-2-one, Methyl styryl ketone, 4-PHENYL-3-BUTEN-2-ONE, Acetocinnamone, trans-Benzylideneacetone, trans-4-Phenyl-3-buten-2-one, Benzylidene acetone, (E)-4-Phenyl-3-buten-2-one, trans-Benzalacetone, Styryl methyl ketone, Methyl trans-styryl ketone, Benzalaceton, 4-Phenylbutenone, 3-Buten-2-one, 4-phenyl-, Benzilideneacetone, Benzilidene acetone, 2-Phenylvinyl methyl ketone, TPBO, trans-Benzylidenacetone, Methyl 2-phenylvinyl ketone, trans-4-Phenyl-3-butene-2-one, Methyl beta-styryl ketone, Ketone, methyl styryl, 3-Buten-2-one, 4-phenyl-, (3E)-, trans-4-Phenylbut-3-en-2-one, 4-Phenyl-3-butene-2-one, (3E)-4-phenylbut-3-en-2-one, 3-BUTEN-2-ONE, 4-PHENYL-, (E)-, (3E)-4-Phenyl-3-buten-2-one, Benzalaceton [German], FEMA No. 2881, benzalacetone-d4, NSC 5605, BENZ, Methyl styryl acetone, 1-Buten-3-one-1-phenyl, Methyl .beta.-styryl ketone, ghl.PD_Mitscher_leg0.147, B03X40BMT5, DTXSID1031626, CHEBI:78399, CHEBI:217301, (3E)-4-Phenylbut-3-en-2-one (Benzalacetone), (E)-4-Phenyl-but-3-en-2-one, 4-Phenyl-but-3-en-2-one, NSC-5605, Benzalaceton (german), DTXCID305662, fema 2881, CAS-122-57-6, Benzylidene acetone (natural), CCRIS 5319, t-PBO, EINECS 204-555-1, EINECS 217-587-6, DTXSID4025662, BRN 0742046, BRN 0742047, UNII-B03X40BMT5, benzylidenacetone, AI3-00944, AI3-52291, benzylideneacetone, (E)-isomer, benzylideneacetone, (Z)-isomer, trans-Benzylideneacetone;Benzalacetone, trans-4-phenyl-but-3-en-2-one, (E)-1-Buten-3-one, 1-phenyl, (3E)-4-Phenylbut-3-en-2-one; Warfarin Sodium Imp. C (EP); Benzalacetone; Warfarin Sodium Impurity C; Warfarin Impurity C, cinnamyl methyl ketone, Epitope ID:120383, 1-Phenyl-1-buten-3-one, EC 204-555-1, Methyl beta -STYRYL ketone, SCHEMBL76632, 2-07-00-00287 (Beilstein Handbook Reference), 4-07-00-01003 (Beilstein Handbook Reference), E-4-phenyl-3-buten-2-one, MLS002454416, CHEMBL73639, SCHEMBL312972, WLN: 1V1U1R, BENZYLIDENEACETONE [MI], DTXCID9011626, 4-Phenyl-(E)-3-Buten-2-one, AMY6963, BENZYLIDENEACETONE, (E)-, Benzylideneacetone, >=98%, FG, NSC5605, Benzalacetone, analytical standard, HMS2268K18, 4-Phenyl-3-buten-2-one, 99%, BENZALACETONE [USP IMPURITY], Tox21_201502, Tox21_301598, Tox21_303222, MFCD00008779, s9478, AKOS000119902, CS-W013311, DS-4780, HY-W012595, 4-PHENYL-3-BUTEN-2-ONE, TRANS, NCGC00091356-01, NCGC00091356-02, NCGC00255323-01, NCGC00257166-01, NCGC00259053-01, 4-PHENYL-3-BUTEN-2-ONE [FHFI], LS-13761, SMR001252234, CAS-1896-62-4, trans-4-Phenyl-3-buten-2-one, >=99%, NS00003742, P0163, EN300-18891, D70186, D70528, EN300-366968, WARFARIN SODIUM IMPURITY C [EP IMPURITY], A804921, A813340, Q4380955, W-107746, W-109036, 3-BUTEN,2-ONE,4-PHENYL (TRANS) BENZALACETONE, 3-BUTEN,2-ONE,4-PHENYL (TRANS) BENZALACETONE, F0001-0357, Z2582847786, InChI=1/C10H10O/c1-9(11)7-8-10-5-3-2-4-6-10/h2-8H,1H3/b8-7" C10H10O BWHOZHOGCMHOBV-BQYQJAHWSA-N (E)-4-phenylbut-3-en-2-one n.a. n.a. No No No No No No PMDBD2000553 Benzenesul-fonamide,4-amino-N-methyl-N-[3-(3,4,7,8-tetrahydro-2,4-dioxo-2H-thiopyrano[4,3-d]pyrimidin-1(5H)-yl)propyl n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000554 Benzocaine Therapeutic Substance Approved Drug 7/9/1994 DB01086 PA448576 D00552 D0Q8ZX 2337 13854242 n.a. "benzocaine, Ethyl 4-aminobenzoate, 94-09-7, Ethyl aminobenzoate, Ethyl p-aminobenzoate, Parathesin, Norcaine, Americaine, Anaesthesin, Anesthesin, Parathesine, 4-Aminobenzoic acid ethyl ester, Amben ethyl ester, p-Carbethoxyaniline, Anaesthin, Anesthesine, Dermoplast, Ethoform, Hurricaine, Identhesin, Topcaine, Norcain, Baby Anbesol, Anaesthan-syngala, Ora-jel, Anestezin, Anesthone, Benzocainum, Keloform, Orthesin, Solu H, 4-Carbethoxyaniline, p-Ethoxycarboxylic aniline, 9011-18-1, p-(Ethoxycarbonyl)aniline, Ethyl p-aminophenylcarboxylate, Benzocaina, Benzoic acid, 4-amino-, ethyl ester, Dextran sulfate sodium, Ethyl PABA, 4-(Ethoxycarbonyl)aniline, Anaesthesinum, Ethoforme, Norcainum, Ethylis aminobenzoas, Aethoform, Otocain, Outgro, p-Aminobenzoic acid ethyl ester, Benzoic acid, p-amino-, ethyl ester, Aethylium paraminobenzoicum, Subcutin, ETHYL4-AMINOBENZOATE, 4-Aminobenzoic acid, ethyl ester, Caswell No. 430A, Benzocainum [INN-Latin], Benzocaina [INN-Spanish], Ethylester kyseliny p-aminobenzoove, Flavamed, HSDB 7225, p-Aminobenzoic acid, ethyl ester, 4-amino-benzoic acid ethyl ester, CHEBI:116735, UNII-U3RSY48JW5, NSC-4688, EINECS 202-303-5, ETHYL-P-AMINOBENZOATE, U3RSY48JW5, NSC 41531, NSC-41531, EPA Pesticide Chemical Code 097001, BRN 0638434, AR01, DTXSID8021804, AI3-02081, AR-01, MFCD00007892, Dextran, hydrogen sulfate, sodium salt, Benzocaine [USP:INN:BAN], DTXCID301804, 4-aminobenzoic acid-ethyl ester, Bensokain, 4-14-00-01129 (Beilstein Handbook Reference), NSC41531, CAS-94-09-7, NCGC00016352-01, Anestezin [Russian], Chloraseptic, Benzocainum (INN-Latin), Benzocaina (INN-Spanish), WLN: ZR DVO2, BENZOCAINE (MART.), BENZOCAINE [MART.], BENZOCAINE (USP-RS), BENZOCAINE [USP-RS], Benzocaine (USP:INN:BAN), Ethyl aminobenzoate (VAN), BENZOCAINE (EP MONOGRAPH), BENZOCAINE [EP MONOGRAPH], BENZOCAINE (USP MONOGRAPH), BENZOCAINE [USP MONOGRAPH], Finafta, Parathesin (TN), SMR000059025, Ethylester kyseliny p-aminobenzoove [Czech], Benzocaine (USP/INN), SR-05000001573, p-Aminobenzoic ethyl ester, Desensitizer, Anesgerm, Anestenka, Athoforme, Benzoak, Benzocain, Benzodent, Chiggerex, Goodwinol, Preboost, Stallion, TopexRaspberry, TopexStrawberry, Topicale, Vagisil, Defend, Ioline, Iolite, Rexall, TopexCherry, CaineTips, Opahl, TopexMint, UltraCare, NeuroMed, Baby Anestenka, Benzocaine Gel, benzocaine wipes, Chigger Relief, Climax Control, Lollicaine Mint, StingX, Benzo-JelCherry, Brace Relief, Dental Relief, FinaftaMultiOral, Intimate Wipe, Pleasure Balm, Prolong Plus, Roman Swipes, TopexBubble Gum, Topicale Xtra, Benzo-jel, GingiCaine Gel, NeuroMedFA, Allegenal-M, Alpha-Caine, Benzo-JelMint, Chigg Away, Delay Creme, Instant Erection, Nene Dente, Precaine B, Zilactin-B, TopexPina Colada, Benzo Jel, Boil Ease, Diet Ayds, Orabase-B, Prime-Gel, Sting and Bite, Anal Blu, FranklyNumb 1, Lollicaine Cherry, SalivaCAINE, Assist II, Benz O Sthetic, GingiCaine Fusion, Men Delay Wipe, NBE Anbesol, Blistex Kank-Eze, Hims Delay Wipes, Benzocaine 6%, Cream Desensitizer, Topical Anesthetic, Benzo-JelRaspberry, Kank-AMouth Pain, Anadent Kanka Gel, anal GLIDE, Kank-A, Mouth Sore Relief, Xpect Sting Wipes, Benzocaine 10%, Benzocaine 20%, BENZOCAINECherry, BENZOCAINEMint, Blistex Baby Kanka, Magic STAMINA, Oral Pain Reliever, OLP Baby Teething, EJECTDELAYGel, MyDerm Bite Relief, Prestwick_991, 4-carboethoxyaniline, aethylis aminobenzoas, Benzocaine 3.5%, Benzocaine 7.5%, Comfortox Benzocaine, Cvs Oral Anesthetic, ethyl 4aminobenzoate, ShungaSensation Balm, Anesgerm LA MUELA, Benzo-JelBubble Gum, ethyl 4-aminobenzate, ethyl 4-aminobezoate, McKesson Orasol Gel, Outgro (Salt/Mix), Mark 3, Precaine B Bubblegum, PROLONG, REALTREE, BENZOCAINERaspberry, Anbesol (Salt/Mix), Benzo-JelPina Colada, KY Duration for Him, KY Duration for Men, Vagisil (Salt/Mix), Benzocaine 10.0%, Benzocaine 5.00%, Benzocaine-5.00%, endless LoveFOR MEN, ethyl-4-aminobenzoate, Family wellnessRegular, Iodent Oral Analgesic, Leader Oral Analgesic, Lollicaine Bubble Gum, Mouth Sore Medication, Ms Topical Anesthetic, OrajelMaximum Strength, p-ethoxycarbonylaniline, RexallMaximum Strength, Sheffield Pain Relief, Topical AnestheticMint, Walgreens Pain Relief, BENZOCAINEStrawberry, Endless Love For Men, Oral Pain Relief Gel, 4-ethoxycarbonylaniline, Anestesico Topical Gel, Bite and Sting Relief, Desensitizing Lubricant, Dextransulfatesodiumsalt, ethyl p-amino-benzoate, ethyl-p-amino-benzoate, EZ ACCESS, Gps Topical Anesthetic, Lollicaine Pina Colada, Nrg Topical Anesthetic, Promescent Delay Wipes, STAY HARD, ANAL-ESE, AnbesolMaximum Strength, Benzo-JelSTRAWBERRY, Ethyl aminobenzoic acid, Red Cross Canker Sore, STA-HARD, Sting Relief Prep Pad, TopcareMaximum Strength, BENZOCAINEBubble Gum, Bite reliefScherer Labs, Chiggerex 2X Medicated, Cough-X (Salt/Mix), GingiCaine gel, Cherry, MAKESENSEPain Relief, Spectrum_000074, Climax ControlBenzocaine, Ethyl 4-amino-benzoate, Topical AnestheticBanana, Topical AnestheticCherry, Pleasure BalmKama Sutra, BENZOCAINE [MI], BENZOCAINEPina Colada, Equate Oral Pain Relief, Optimum Rock Hard Cream, Primo Topical Anesthetic, Trojan Extended Pleasure, WalgreensMaximum Strength, Warrior Chiggerex Relief, Chigger ReliefEvora Labs, ethyl 4-(amino)benzoate, Ombre Men overtime wipes, Oral GelMaximum Strength, UltraCare Anesthetic Gel, BENZOCAINE [INN], Atopalm Oral Pain Relief, Ethyl p-aminobenzoic acid, Gelato Topical Anesthetic, Gingicaine Gel Strawberry, Ismile Topical Anesthetic, Jianze Sting Relief Pads, Prestwick0_000712, Prestwick1_000712, Prestwick2_000712, Prestwick3_000712, Spectrum2_000117, Spectrum3_000314, Spectrum4_000249, Spectrum5_000860, BENZOCAINE [HSDB], ethyl 4-aminobenzoic acid, TokisanSore Throat Relief, TopCare Oral Pain Relief, Bite and Sting ReliefGNP, 20/20Topical Anesthetic, GingiCaine Liquid, Cherry, Good Neighbor Pain Relief, Gumnumb Topical Anesthetic, Precaine B Chocolate Mint, Terrasil Boil Pain Relief, Topical AnestheticRaspberry, Ultimate Erection Enhancer, BENZOCAINE [VANDF], Massage Men Gel Max Size, Massage Men Gel Max Time, TANAC Oral Pain Reliever, Burkhart Topical Anesthetic, Dentek Instant Pain Relief, Epitope ID:114084, ETHYL PABA [INCI], Gingicaine Gel Variety Pak, Goodsense Oral Pain Relief, Orajel Instant Pain Relief, Purelife Topical Anesthetic, Massage Men Gel Max Delay, Massage Men Gel Max Power, Topical AnestheticStrawberry, Bactimicina for Sore Throat, DZEUS Climax control wipes, Eclipse Topical AnalgesicFA, HurriCaineTopical Anesthetic, GingiCaine Gel, Mint Julep, Oral B Instant Pain Relief, Oralabs Cold Sore Treatment, Red Cross Oral Pain Relief, Topical AnestheticBubble Gum, BENZOCAINE [WHO-DD], BENZOCAINE [WHO-IP], BLT 1, SAMPL3, G4, Bencocaine Topical Anesthetic, Benzocaine Topical Anesthetic, Budpak Oral Maximum Strength, CVS PharmacyMaximum Strength, Ethyl aminobenzoate (JP17), GingiCaine Gel Banana flavor, GingiCaine Gel, Pina Colada, JO Prolonger with Benzocaine, Mouth Sore Relief Applicator, Oprea1_750694, Oprea1_827402, Precaine B Chocolate Vanilla, Quala Topical Anesthetic Gel, SCHEMBL25100, Alpha-CaineTopical Anesthetic, BSPBio_000923, BSPBio_001908, KBioGR_000658, KBioSS_000474, Rite AidProfessional Strength, Topical AnestheticPina Colada, VistaCaine Topical Anesthetic, 4-(Ethoxycarbonyl)phenylamine, AE-562/40377256, Certus Sting Relief Prep Pad, Gelato Anestesico Topical Gel, Health-tec Topical Anesthetic, MAKESENSEJunior Pain Relief, MLS001331704, MLS002153970, Sorbet Anestesico Topical Gel, DivK1c_000932, Ethyl 4-aminobenzoate, 98%, Family DollarOral Pain Relief, Gingicaine Gel, Cherry flavor, LubeLife Climax Control Delay, Male DesensitizerPleasure Balm, SPECTRUM1500139, (p-(Ethoxycarbonyl)phenylamine, Advance Topical Anesthetic Gel, Chloraseptic Warming Green Tea, Cvs Fast Acting Baby Teething, Dental City Topical Anesthetic, Ethyl p-aminobenzenecarboxylate, Ipana 20% Benzocaine Topical, SPBio_000134, SPBio_002844, Comfortcaine Topical Anesthetic, MINT RX ENDURANCE WIPES, ShungaMale Genital Desensitizer, BPBio1_001017, Candee Caine Topical Anesthetic, CHEMBL278172, GingiCaine Gel, Chocolate Mint, INTIMALE Benzocaine Delay Gel, LIGHTS Sting Relief Prep Pad, Benzocaine, 1mg/ml in Methanol, KOLORZ TOPICAL ANESTHETIC, MAGIC STAMINA Climax Control, Chloraseptic Warming Honey Lemon, Gingicaine Gel Strawberry Flavor, HurriCaineTopical Anesthetic Gel, Midway Select Topical Anesthetic, Scotts Select Topical Anesthetic, Zip Topical Anesthetic Gel Mint, Boy ButterDesensitizing Lubricant, Dextran sulfate sodium (DST-H), GingiCaine Liquid, Cherry flavor, HMS502O14, KBio1_000932, KBio2_000474, KBio2_003042, KBio2_005610, KBio3_001408, MandelayMale Genital Desensitizer, My Fair BabyInstant Pain Relief, p-amino benzoic acid ethyl ester, Sally Hansen Ouch-ReliefWax Kit, 4-amino benzoic acid ethyl ester, Baby Teething Oral Pain Reliever, C05AD03, Cvs Maximum Strength Boil Relief, D04AB04, ETHYL AMINOBENZOATE [JAN], Leader Oral Pain ReliefAnesthetic, N01BA05, NSC4688, Orajel Instant Pain ReliefRegular, R02AD01, Assist IIAnorectal (Hemorrhoidal), Astra-dent Topical Anesthetic Gel, Dextran sulfate sodium (KMDS-H), Monistat Care Instant Itch Relief, NINDS_000932, BDBM197282, Dextran sulfate sodium (DS-M-1), HMS1570O05, HMS1920G09, HMS2091M11, HMS2097O05, HMS2233H21, HMS3371D08, HMS3652H13, HMS3714O05, HMS3885B11, Pharmakon1600-01500139, WalgreensSevere Oral Pain Reliever, BENZOCAINUM [WHO-IP LATIN], HurriCaineTopical Anesthetic Liquid, Patterson Dental Topical Anesthetic, Walgreens Pain Relieving for Boils, Adventure Medical Kits Dental Medic, Anesgerm LA MUELAFast Pain Relief, Bite and Sting ReliefSignature Care, component of Tympagesic (Salt/Mix), CS-B0934, Dermawound Wound Care Venous Stasis, GingiCaine Gel, Mint Julep Flabvor, GingiCaine Gel, Pina Colada Flavor, HY-Y0258, STR01509, Tiger Supply Inc Topical Anesthetic, UltraCareOral Anesthetic Bubble Gum, UltraCareOral Anesthetic Walterberry, Goyescas 7 SyrupsSore Throat Relief, Orajel for ToothacheMaximum Strength, POWERECT Benzocaine Male Delay Gel, Rite Aid Tooth and Gum Pain Relief, Top Quality Mfg. Topical Anesthetic, Tox21_110391, Tox21_301149, CCG-38918, GingiCaine Gel, Cotton Candy Flavor, NSC755909, OneTouch RevolutionTopical Anesthetic, s4210, Sensicaine TM ExtraTopical Anesthetic, Signature Care Bite and Sting Relief, UltraCareOral Anesthetic Orange Cream, Zip Topical Anesthetic Gel Strawberry, AKOS000119763, Benzocaine 1.0 mg/ml in Acetonitrile, GingiCaine Gel, Chocolate Mint Flavor, Mouth Sore ReliefProfessional Strength, Sally Hansen Ouch-ReliefWax Strip Kit, Tox21_110391_1, AC-8127, Bite and Sting ReliefWell at Walgreens, DB01086, Goyescas Broncovac 5Sore Throat Relief, NSC-755909, Sally Hansen Ouch-relief Numbing Wipes, Budpak Baby Teething Oral Pain Reliever, IDI1_000932, Sally Hansen Ouch-relief Wax Strip Kit, SmartPractice topical anesthetic gelMint, Benzocaine, purum, >=99.0% (HPLC), Benzocaine, tested according to Ph.Eur., Bite and Sting Medicated Relief PadsCVS, Boy ButterExtreme Desensitizing Lubricant, NCGC00016352-02, NCGC00016352-03, NCGC00016352-04, NCGC00016352-07, NCGC00094598-01, NCGC00094598-02, NCGC00255047-01, TopCare Oral Pain ReliefMaximum Strength, BODY ACTION PRODUCTS Anal Glide Extra, Ethyl 4-aminobenzoate, 98.0-101.0%, Herbasoul Male Genital Desensitizer Cream, My Fair Baby oral gelInstant Pain Relief, SmartPractice topical anesthetic gelCherry, DenTek Instant Pain ReliefMaximum Strength, KOLORZ TOPICAL ANESTHETICPINA COLADA, KOLORZ TOPICAL ANESTHETICTRIPLE MINT, SBI-0051293.P003, 7 Select Oral Pain Maximum Strength Relief, BODY ACTION PRODUCTS Butt Eze Benzocaine, BODY ACTION PRODUCTS Climax Control Gel, BODY ACTION PRODUCTS Prolong Lubricating, component of Solarcaine aerosol (Salt/Mix), KOLORZ TOPICAL ANESTHETICCHERRY BURST, KOLORZ TOPICAL ANESTHETICCOTTON CANDY, Little Colds Sore Throat Relief Melt Aways, Rite Aid Tooth and Gum Pain ReliefCushions, SKINS DELAY Climax Control Benzocaine Gel, Winco Foods Maximum Strength Oral Analgesic, A0271, AB00051923, KOLORZ TOPICAL ANESTHETICBLUE RASBERRY, NS00001814, Rite Aid Liquid Anesthetic Oral Pain Relief, SmartPractice topical anesthetic gelRaspberry, SW197074-3, BODY ACTION PRODUCTS Endless Love for Men, Boy ButterExtreme H2O Desensitizing Lubricant, Carmex Cold Sore Treatment External Analgesic, EN300-16170, Safco Sensicaine Ultra Topical Anesthetic Gel, SmartPractice topical anesthetic gelBubble Gum, SmartPractice topical anesthetic gelStrawberry, C07527, D00552, SmartPractice topical anesthetic gelPina Colada, AB00051923_09, AB00051923_10, component of Anbesol maximum strength (Salt/Mix), HIGHER CONTROL Male Climax Control Lubricating, Sally Hansen Ouch-Relief Stripless Hard Wax Kit, A860898, A930377, AMINOBENZOIC ACID IMPURITY B [EP IMPURITY], BODY ACTION PRODUCTS Higher Control Male Climax, Q422745, Ethyl 4-aminobenzoate, SAJ first grade, >=99.0%, Q-200688, Quality Choice Maximum Strength Oral Pain Relieving, SR-05000001573-1, SR-05000001573-3, BRD-K75466013-001-05-2, BRD-K75466013-001-08-6, Ethyl 4-aminobenzoate, Vetec(TM) reagent grade, 98%, Z54178706, F2190-0448, Sally Hansen Microwavable Eybrow, Face and Lip Wax Kit, Benzocaine, European Pharmacopoeia (EP) Reference Standard, Orajel Severe ToothacheMaximum Strength Fast-Acting Formula, Benzocaine, United States Pharmacopeia (USP) Reference Standard, Benzocaine, Pharmaceutical Secondary Standard; Certified Reference Material" C9H11NO2 BLFLLBZGZJTVJG-UHFFFAOYSA-N ethyl 4-aminobenzoate Wyeth Pharmaceuticals Anesthetics No No No No No No PMDBD2000555 Benzophenonyl decyl beta-maltoside n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000556 Benzoylperoxide Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. D04DXN 7187 n.a. NPC261181 "BENZOYL PEROXIDE, 94-36-0, Peroxide, dibenzoyl, Dibenzoyl peroxide, Benzoyl superoxide, Benzoperoxide, Benoxyl, Lucidol, Acetoxyl, Oxylite, Panoxyl, Persadox, Benzol peroxide, Dibenzoylperoxid, Diphenylglyoxal peroxide, Benzoylperoxid, Luperco AST, Asidopan, Loroxide, Theraderm, Benzac, Eloxyl, Mytolac, benzoyl benzenecarboperoxoate, Resdan Akne, Epi-Clear, Persa-Gel, Akneroxid 5, Dry and Clear, Duresthin 5, Nayper BO, Benzoylperoxyde, Debroxide, Novadelox, Vanoxide, Acnegel, Incidol, Garox, Topex, Xerac, Dibenzoylperoxyde, Luperox fl, Peroxyde de benzoyle, Cadox bs, Quinolor compound, Lucidol B 50, Lucidol G 20, Perossido di benzoile, Luperco AA, Nayper B and bo, benzoylperoxide, Aztec BPO, Benzoic acid, peroxide, Benzaknen, Brevoxyl, Desanden, Akneroxide L, Norox bzp-250, Norox bzp-C-35, Desquam E, Benzac W, Clear By Design, Cadox B, Benzagel 10, Lucidol (peroxide), Benzagel, Benzashave, Superox 744, Cadox 40E, Desquam X, Desquam-X, Acne-Aid Cream, Benbel C, Oxy 5, Cadox B-CH 50, Cadat BPO, Lucidol-70, Aksil 5, Lucidol 50P, Benzaknew, Benzefoam, Lucidol KL 50, Oxy-10 Cover, Chaloxyd BP 50FT, Abcat 40, Benox 50, Cadet, Diphenylperoxyanhydride, benzoic peroxyanhydride, Cadox B 40E, Cadox B 50P, Cadox B 70W, Oxy-5, BZF-60, Fostex BPO, pHisoAc BP, Peroxide, Benzoyl, Xerac BP, Benzoyl peroxide [USAN], Lucidol 75FP, Superoxide, Benzoyl, Benoxyl (5&10) Lotion, Epi Clear Antiseptic Lotion, EPSOLAY, Stri-dex B.P., OXY WASH, Peroxyderm, Benzoyl, Dermoxyl, Luzidol, Nericur, OXY-10, Peroxydex, Preoxydex, Sanoxit, Superox, Benzoylperoxid [German], Bepio, benzoyl-peroxide, dibenzoylperoxide, Benzoyl peroxyde, Ins no.928, Diphenylglyoxal Superoxide, NSC-671, NSC-675, Akneroxid L, Anhydrous benzoyl peroxide, Benzoyl peroxide anhydrous, Dibenzoylperoxid [German], W9WZN9A0GM, Clearasil Antibacterial Acne Lotion, Superoxide, Diphenylglyoxal, Clearasil bp acne treatment, Nyper B, BPO, Ins-928, Nyper BMT, Cuticura acne cream, Lucidol 70, Lucidol 78, Oxy-L, component of Oxy-5, component of Vanoxide, NSC671, Xerac BP 5, DTXSID6024591, Clearasil benzoyl peroxide lotion, Cadet BPO 78W, Xerac BP 10, Hydrous benzoyl peroxide, Abcure S-40-25, Benzoylis peroxidum cum aqua, DTXCID001072, NSC675, E-928, CHEBI:82405, NSC 675, MFCD00003071, DUAC COMPONENT BENZOYL PEROXIDE, 2685-64-5, ACANYA COMPONENT BENZOYL PEROXIDE, EPIDUO COMPONENT BENZOYL PEROXIDE, TWYNEO COMPONENT BENZOYL PEROXIDE, NCGC00159380-02, NCGC00159380-05, BENZOYL PEROXIDE COMPONENT OF DUAC, Benzoylperoxid (german), W 75, WLN: RVOOVR, Benzoyl peroxide (usan), BENZACLIN COMPONENT BENZOYL PEROXIDE, BENZOYL PEROXIDE COMPONENT OF ACANYA, BENZOYL PEROXIDE COMPONENT OF EPIDUO, BENZOYL PEROXIDE COMPONENT OF TWYNEO, BENZAMYCIN COMPONENT BENZOYL PEROXIDE, Dibenzoylperoxid (german), BENZOYL PEROXIDE COMPONENT OF BENZACLIN, BENZOYL PEROXIDE COMPONENT OF BENZAMYCIN, Novadelox (18% benzoyl peroxide, 78% calcium sulphate, 4% magnesium carbonate), BENZOYL PEROXIDE (IARC), BENZOYL PEROXIDE [IARC], BENZOYL PEROXIDE (MART.), BENZOYL PEROXIDE [MART.], Benprox, Lavoclen, Benzoylperoxyde [Dutch], Pacnex, Neobenz micro, Androstan-17-one, 3-(acetyloxy)-5-bromo-6,19-epoxy-, (3b,5a,6b)-, Dibenzoylperoxyde [Dutch], BENZOYL PEROXIDE (USP IMPURITY), BENZOYL PEROXIDE [USP IMPURITY], CAS-94-36-0, CCRIS 630, Stri-dex B.P, Benzoyl peroxide gel, Peroxyde de benzoyle [French], HSDB 372, Perossido di benzoile [Italian], NSC 671, HYDROUS BENZOYL PEROXIDE (USP MONOGRAPH), HYDROUS BENZOYL PEROXIDE [USP MONOGRAPH], B 75W, Clearasil BP Acne Treatment Cream, EINECS 202-327-6, UNII-W9WZN9A0GM, Obliterate, Thermaderm, Benzepro, Bevoline, Blemish, Caraderma, G 20, Lucilite, Lucipal, Myhelper, Novadeiox, Periygel, Peroxyl, Presadox, Relovox, Unblemish, bezoyl peroxide, Florox, Benzoyl peroide, Triaz, Benzefoam Ultra, Benzoyl peroxide [USAN:USP], Lintera Wash, Replenix Acne, Benzoly Peroxide, Benzoyl Perozide, Breakout Control, Equate Repairing, Unblem Est, Zapzyt Acne, Luperco A, On Target, Oxy 5Vanishing, Acne Gel, Controlling Cream, di-benzoylperoxide, dibenzoy lperoxide, dibenzoyl peroxyde, dibenzoyl-peroxide, Lucidol GS, Lucidol RM, Luperco AC, Nighttime Control, Oc Eight, Skincoach TREAT, Luperco AFR, Equate Acne Wash, Humane Acne Wash, Oxy 10Vanishing, Oxy 5Tinted, Oxy Face Wash, Pca Skin Acne, Acne Tx Mask, Benzoazeline Forte, Bp Wash, BzOOBz, Dr Song Acne, Neutracure Restore, Terminator 10, bis benzoylperoxide, Vanishing AcneCVS, Bisbenzoyl peroxide, Cadox BTA, Kivoria Acne Wash, Spot On Treatment, BP Spot Treatment, HYR Acne Wash, Acne Cleansing Bar, Acne Control Serum, Advanced Acne Wash, All-IN-one, di-benzoyl peroxide, Gnp Acne Treatment, Oxy 10Tinted, Perkadox 20S, Sacheu Spot Eraser, Lucidol-78, Luperox A98, Acne Spot Corrector, Micronized Bpo Wash, ModesaAcne Treatment, Acne Face and Body, Peroxido de benzoilo, 5 Acne Med, DermisaCLEAR SKIN, Acne Treatment Serum, BBPO, Benzepro Creamy Wash, Micronized Bpo Scrub, Monat Acne Treatment, REFORM, RevitolAcne Treatment, Touch Acne Treatment, ZITFREE, SLMD Spot Treatment, Bepio (TN), 10 Acne Med, Acne Control Cleanser, Acne Med 5%, Benzoyl Peroxide 3%, Benzoyl Peroxide 4%, Benzoyl Peroxide Wash, Clenziderm Therapeutic, Maximum Strength Acne, Meijer Acne Treatment, Meijer Invisible Acne, Benzagel (Salt/Mix), Luperco AFR-250, SLMD BP Body Wash, Sulfoxyl (Salt/Mix), TheraSpecAcne Cleanser, ACNE THERAPY, Benzoyl Peroxide serum, SANPEROX BPO, 24 Hour Acne Serum, Asepxia Acne Treatment, benzoyl peroxide, 7%, CADET BPO, Cadet BPO-70W, Cadox BPO-W40, Cadox BTW-50, CLEAR MED, Davis Benzoyl Peroxide, Dermisa Acne Treatment, Dr. Throwers Bpo 5, Rugby Benzoyl Peroxide, Benzoyl peroxide(usan), Creamy Acne Face Wash, NYPER BO, NYPER BS, NYPER BW, NYPER FF, NYPER NS, 2.5 Acne Med, Acne Med 10%, Benzoyl Peroxide 10%, Bio-scriptives Repiderm, Neutrogena Acne Control, Oil-free Acne Cleanser, Anti Bac Acne Clearing, Foamimg Acne Face Wash, ACNE SPOT REPAIR, Dr. Lin Skincare Acne, O SKIN ACNE, Oxy 10 Acne Cleanser, Acne Med 2.5%, Benzoyl peroxide, USAN, BP Acne Spot Treatment, NYPER FF-K, Xerac BP (Salt/Mix), Acne Vanishing Gel-5%, Age Intervention Duality, Blemish Correcting Serum, CVS Acne Cleansing Bar, Healthy Skin Moisturizer, Neobenz Micro Plus Pack, Oxy Sensitive Face Wash, Special Clearing Booster, AcetOxyl 2.5 and 5, Benzoyl peroxide (USP), CRMY ACNE WASHCVS, Diphenylperoxyanhydride #, SCHEMBL63, Benzoyl Peroxide 2.5%, Benzoyl Peroxide 5.0%, Acne Face and Body Wash, Benzoyl Peroxide Cleanser, Dermaclear Spot Treatment, Equate Purifying Cleanser, Oxy Rapid Spot Treatment, Pr Benzoyl Peroxide Wash, TRIAZ;Dibenzoyl peroxide, Acne Foaming WashDaylodic, CLEAR MED5%, Fostex BPO (Salt/Mix), LUCIDOL 40E, Oxy 10, PCA SKIN BPO Cleanser, VeterGen Benzoyl Peroxide, Acne Vanishing Gel-10%, Benzoyl Peroxide 5% Gel, LUCIDOL BW 50T, Aztec benzoyl peroxide-dry, Breakout ControlBioelements, LUCIDOL 98, LUCIDOL BT 50, LUCIDOL CH 50, MEDPURA Benzoyl Peroxide, Proactiv Renewing Cleanser, Zapzyt Acne Treatment Gel, Benzoyl Peroxide 2.50%, Benzoyl Peroxide 4.00%, O SKIN ACNEMODERATE, Acnecare Dermacontrol Cream, Clear Cell Clarifying Acne, CLEAR MED10%, Clear Proof Acne Treatment, Family Care Acne Treatment, LUCIDOL S 50, LUCIDOL W 40, NYPER BMT 40, TC 1 (PEROXIDE), EC 202-327-6, Let Me Be Perfectly Clear, Benzoyl Peroxide 10% Gel, CADOX B 75W, Meijer 3 Step Acne System, Oxy On-The-Go Acne Stick, SAFEWAYACNE TREATMENT, SPOTLESS Daily Acne Wash, ZITFREEACNE TREATMENT, Age Intervention Duality Md, Benzoyl Peroxide Moisturizer, Clear Complexion Acne Serum, Daily Acne Control Cleanser, Oxy Face WashMaximum Aciton, Proactiv Repairing Treatment, Renewing Clarifying Cleanser, Rugby Benzoyl Peroxide Wash, Walgreens Acne Foaming Wash, BENZOYL PEROXIDE 5%, BPO-3, HUMANE Acne Spot Treatment, 111 Medco Benzoyl Peroxide, Family Dollar Acne Treatment, Meijer Acne Foaming Cleanser, Targeted Acne Spot Treatment, ACNE10%, CeraVe Acne Foaming Cleanser, DUAL-SHAVE 2 IN 1, MD-Acne Body Acne Treatment, ACNE SOLUTIONSEMERGENCY, Benzoyl peroxide (JAN/USP), Dr Acne Wash Facial Cleanser, MLS000028899, BENZOYL PEROXIDE [MI], BIDD:GT0840, Breakout ControlAcne Treatment, Walgreens 3 Step Acne System, Clarifying Face and Body Wash, BENZOYL PEROXIDE [FCC], BENZOYL PEROXIDE [JAN], Benzoyl PeroxideAcne Medication, BPT3.1 ACNE TREATMENT, CleanserAcne Clearing Treatment, CLEARX 3 BLEMISH CREME, TRIDERMA Acne Spot Treatment, VIE NATURELLE ACNE BODY, Aztec benzoyl peroxide-70-77, BPO 4%, BPO 6%, BPO 8%, Clean and Clear Persa-gel 10, Equate Acne WashAcne medication, Glytone Acne 3P Treatment Gel, SUPEROX 46-750, Walgreens Acne Control Cleanser, Walgreens Acne Foaming Cleanser, BENZOYL PEROXIDE [HSDB], BENZOYL PEROXIDE [INCI], Foaming Acne Face WashWalgreens, Pharmaskincare Acnecare Cleanser, Vanishing Acne Treatmentdaylogic, BENZOYL PEROXIDE [VANDF], BPT10.1 ACNE TREATMENT, CHEMBL1200370, Clear Cell Medicated Acne Scrub, O SKIN ACNE BENZOYL WASH, Targeted Acne Spot TreatmentCVS, AB Skincare Acne Spot Treatment, CA22 Benzoyl Peroxide Cleansing, Benzoyl peroxide, remainder water, Dermaharmony 5% Benzoyl Peroxide, Equate Beauty Acne Cleansing Bar, Fostex BPO Bar, Gel, and Wash, GLYTONE Acne BPO Treatment Gel, iBlanc Restora-BrightAcne Healing, Proactiv Emergency Blemish Relief, ACNE FORTE Acne Treatment Cream, BENZOYL PEROXIDE [WHO-DD], component of Vanoxide (Salt/Mix), CVS Health Acne Control Cleanser, SPOTLESS Acne Clearing Treatment, Cleargenix Advanced Acne Treatment, FACE VALUES ACNE MEDICATION, Glossier zit stick breakout eraser, HMS2092F22, Pharmakon1600-01503004, phenylcarbonyl benzenecarboperoxoate, SkinPharmacy Advanced Acne Therapy, SMART RELEASE BPO5 PERCENT, Acne defense Daily Treatment Serum, amazon basics acne foaming cleanser, Breakout Clearing Daytime Treatment, DermaClear Purity Cleanser Level I, Dermaharmony 10% Benzoyl Peroxide, DUAL-SHAVE 2 IN 1FOR HER, NA 2085 (DOT), UN 2085 (DOT), BENZOIL 12HR ACNE TREATMENT, Daily Leave on Acne Treatment Mask, Equate Beauty Acne Foaming Cleanser, Neutrogena Clear Pore Cleanser Mask, REPLENIX ACNE SOLUTIONS WASH, Skin Pharmacy Advanced Acne Therapy, SMART RELEASE BPO10 PERCENT, Walgreens Maximum Strength Acne Gel, 5 Percent Benzoyl Peroxide Cleanser, DermaClear Purity Cleanser Level II, IDP-126 component Benzoyl peroxide, Meijer Acne TreatmentAcne medication, Meijer Invisible AcneAcne medication, OxyTotal Care Clarifying Moisturizer, Touch Acne TreatmentBenzoyl Peroxide, Tox21_111619, 3 Step Acne SystemWell at Walgreens, Benzoyl peroxide (Luperox(R) A75), Benzoyl peroxide (Luperox(R) A98), BR1012, Breakout Clearing Emergency Spot Fix, GLYTONE Acne BPO Clearing Cleanser, Micronized Benzoyl Peroxide Treatment, NSC758205, Rugby Benzoyl PeroxideAcne Medication, 10% Benzoyl Peroxide acne medication, Advanced 3 in 1 Exfoliating Cleanser, Benzoyl peroxide (Luperox(R) A70S), Good Neighbor Pharmacy Acne Treatment, Neutrogena Stubborn Acne AM Treatment, OxyAdvanced Care Rapid Spot Treatment, SIGNATURE CARE ACNE MEDICATION, AKOS000120600, benzenecarboperoxoic acid benzoyl ester, BENZOYL PEROXIDE [ORANGE BOOK], BENZOYL PEROXIDE PLUS MEDICATED, Equate Maximum Strength Spot Treatment, Leader Maximum Strength Invisible Acne, Neutrogena On-the-Spot Acne Treatment, Proactiv Plus Pore Targeting Treatment, Proactivplus Skin Smoothing Exfoliator, Rugby Acne Medication Benzoyl Peroxide, Target Up and Up 3 Step Acne System, Tox21_111619_1, ACNE WIPEOUT CLINICAL ACNE System, AF Foam Clear Skin Acne Pore Cleanser, Benzoyl peroxide (Luperox(R) A75FP), CCG-213090, DB09096, Intensive Face and Body Acne Treatment, NSC-758205, Oxy Rapid Spot TreatmentMaximum Action, UN 2086, UN 2088, Benzoyl Peroxide - Contains 25% water, CVS Health Quick Action Spot Treatment, Equate Clear Complexion Facial Cleanser, Oxy Sensitive Face WashMaximum Soothing, ProactivExtra Strength Formula Treatment, TARGET UP AND UP ACNE MEDICATION, CABTREO COMPONENT BENZOYL PEROXIDE, Cetaphil Gentle Clear BPO Acne Cleanser, NCGC00159380-03, NCGC00159380-04, Rodan and FieldsUnblemish-Acne Medicated, SLMD AM Benzoyl Peroxide Acne Treatment, UNBLEMISH Dual Intensive Acne Treatment, Vanishing Acne Treatment CreamCVS Health, ACNE SPOT CORRECTORMAXIMUM STRENGTH, Benzoyl Acne Wash-2.5% Benzoyl Peroxide, BP-21236, Clear Proof Acne TreatmentAcne Medication, E928, HYDROUS BENZOYL PEROXIDE [WHO-IP], Neutrogena Rapid Clear Stubborn Acne Spot, Pharmaskincare Acnecare Dermacontrol Cream, Phisoderm Clear Confidence Spot Treatment, SMR000058568, Benzoyl-Plus Moisturizing Benzoyl Peroxide, ClearasilDaily Clear Tinted Acne Treatment, Meijer Acne Foaming CleanserAcne Treatment, Perrigo Benzoyl Peroxidehydroalcoholic base, Rugby Benzoyl Peroxide WashAcne Medication, SBI-0206719.P001, Walgreens Acne Foaming WashAcne Medication, CVS Health Maximum Strength Acne Treatment, glo SKIN BEAUTY Clear Skin Spot Treatment, MDacne Customized Cream (Benzoyl Peroxide), NeoBenz(R) MicroBenzoyl Peroxide Wash, 7%, TULA Skincare Go Away Acne Spot Treatment, Winco Foods Maximum Strength Acne Treatment, Acne Free Free 24 HR Acne Clearing System, ACNE WIPEOUT ALL DAY BREAKOUT CONTROL, B3152, Benzoyl Peroxide Deep Cleansing Foaming Wash, Benzoyl peroxide, blend in dibutyl phthalate, ClearasilDaily Clear Vanishing Acne Treatment, Complexion Clear Acne Treatment Rejuvenating, Naturium Benzoyl Peroxide Cream Cleanser 5%, NS00006130, Walgreens Acne Foaming CleanserAcne Treatment, Benzoyl peroxide, blend in tricresyl phosphate, Dermaharmony 5% Benzoyl PeroxideCleansing Bar, Neutrogena Rapid Clear Stubborn Acne Cleanser, OXYAdvanced Care Sensitive Skin Acne Cleanser, OXYAdvanced Care Soothing Cream Acne Cleanser, Pumice Cleansing Scrub-2.5% Benzoyl Peroxide, Solimo Renewing Cleanser For Acne Prone Skin, ZO Skin Health Acne Control Benzoyl Peroxide, Acne defense Daily Treatment SerumMerle Norman, C19346, Clean and Clear persa-gel 10 Maximum Strength, D03093, Dermaharmony 10% Benzoyl PeroxideCleansing Bar, Maximum Strength Acne Spot TreatmentCVS Health, Meijer Maximum Strength Foaming Acne Face Wash, Ocean Seas Dermatology Acne Treatment Cleanser, SERIOUS SKINCARE Continuously Clear Clearz It, Solimo Repairing Treatment For Acne Prone Skin, AB01562988_01, ACNE WIPEOUT CLEAR PORE oil-FREE CLEANSER, Avene Cleanance Acne Medicated Clearing Treatment, Benzoyl peroxide, for synthesis, 72.0-80.0%, Clean and Clear Continuous Control Acne Cleanser, CVS Health Acne Control CleanserAcne Medication, Differin Max Strength Acne Foaming BPO Cleanser, A844933, Paulas Choice Clear Daily Skin Clearing Treatment, Q411424, REPLENIX ACNE Solution BENZOYL PEROXIDE WASH, SkinPharmacy Advanced Acne Therapy Active Clearing, SkinPharmacy Advanced Acne Therapy Spot Treatment, SR-05000001817, Acne Free SEVERE ACNE 24 HR Acne Clearing System, BENZOYLIS PEROXIDUM CUM AQUA [WHO-IP LATIN], Clearasil Stubborn Acne Control 5in1 Spot Treatment, SPOTLESS Regimen for Acne, Blemishes and Breakouts, SR-05000001817-1, ACNE solutionsCLEARING MOISTURIZER ACNE MEDICATION, BRD-K59986511-001-02-3, Neutrogena On-the-Spot Acne TreatmentVanishing Formula, Acne Free Oil Free Acne Cleanser 2.5 Benzoyl Peroxide, Benzoyl peroxide, 97% (dry wt.), wet with 25% water, Benzoyl peroxide, SAJ first grade, >=98.0% dry basis, F0001-2260, La Roche-Posay Effaclar Duo Dual Action Acne Treatment, Luperox(R) A75, Benzoyl peroxide 75%, remainder water, Z104489074, Clearasil Stubborn Acne Control 5in1 Concealing Treatment, CVS Health Maximum Strength Acne TreatmentAcne Medication, Luperox(R) A70S, Benzoyl peroxide, 70%, remainder water, Luperox(R) A75, Benzoyl peroxide, 75%, remainder water, Luperox(R) A98, Benzoyl peroxide, reagent grade, >=98%, MEDPURA Benzoyl PeroxideAqueous Base, Acne Treatment Gel, Skin Pharmacy Advanced Acne TherapyTargeted Treatment Wipes, SkinPharmacy Advanced Acne TherapyTargeted Treatment Wipes, Walgreens Maximum Strength Tinted Acne Spot Treatment Cream, Meijer Maximum Strength Foaming Acne Face WashAcne Medication, Oil Free Deep Cleansing Duo Cleansing Brush Oil Free Acne Cleanser, Benzoyl peroxide blend with dicyclohexyl phthalate, technical, ~50% (T), CVS Health Concealing Acne Treatment Maximum Strength Adult Acne Treatment, La Roche Posay Laboratoire Dermatologique Effaclar Duo Acne Treatment, Luperox(R) ATC50, Benzoyl peroxide, ~50 wt. % in tricresyl phosphate, InChI=1/C14H10O4/c15-13(11-7-3-1-4-8-11)17-18-14(16)12-9-5-2-6-10-12/h1-10, Luperox(R) A75FP, Benzoyl peroxide, 75% remainder water, contains 25 wt. % water as stabilizer, 75%" C14H10O4 OMPJBNCRMGITSC-UHFFFAOYSA-N benzoyl benzenecarboperoxoate n.a. n.a. No No No No No No PMDBD2000557 Benzyl decyl beta-maltoside n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000558 Benzylpenicillin Therapeutic Substance Phase 3 61-33-6 DB01053 PA450842 D02336 D00QAR 5904 n.a. NPC90478 penicillin g, Benzylpenicillin, 61-33-6, Benzyl penicillin, Benzylpenicillinic acid, Free penicillin II, Pencillin G, Benzylpenicillin G, Dropcillin, Free penicillin G, Gelacillin, Liquacillin, Pharmacillin, Pradupen, Cilopen, Bencilpenicilina, Specilline G, Benzylpenicillinum, Cilloral, Cosmopen, Pfizerpen, Benzylpenicilline, Free benzylpenicillin, Benzopenicillin, bensylpenicillin, (5R,6R)-Benzylpenicillin, 6-(2-Phenylacetamido)penicillanic acid, Penicillin, (phenylmethyl)-, benzyl benicillin, Galofak, Compocillin G, Penicillin-G potassium, CHEBI:18208, HSDB 3166, Benzylpenicillinum [Latin], Penicillinic acid, (phenylmethyl)-, Phenylacetamidopenicillanic acid, (2S,5R,6R)-3,3-Dimethyl-7-oxo-6-(2-phenylacetamido)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, EINECS 200-506-3, UNII-Q42T66VG0C, NSC 193396, BRN 0044740, Q42T66VG0C, (Phenylmethyl)penicillin, Benzyl-6-aminopenicillinic acid, Penicillinic acid, benzyl-, NSC-193396, DTXSID5046934, Ursopen, J01CE01, 4-27-00-05861 (Beilstein Handbook Reference), (Phenylmethyl)penicillinic acid, 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-((phenylacetyl)amino)- (2S-(2alpha,5alpha,6beta))-, Benzylpenicillin (INN), Benzylpenicillinum (Latin), (2S,5R,6R)-3,3-Dimethyl-7-oxo-6-(2-phenylacetamido)-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, (2S,5R,6R)-3,3-dimethyl-7-oxo-6-(phenylacetamido)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-(2-phenylacetamido)-, BENZYLPENICILLIN [INN], BENZYLPENICILLIN (MART.), BENZYLPENICILLIN [MART.], Cillora, PenicillinG, Bencilpenicilina [Spanish], Benzylpenicilline [French], Benzylpenicillin [INN:BAN], 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-[(phenylacetyl)amino]- [2S-(2alpha,5alpha,6beta)]-, SMR000538912, PHENOXYMETHYLPENICILLIN IMPURITY A (EP IMPURITY), PHENOXYMETHYLPENICILLIN IMPURITY A [EP IMPURITY], NSC193396, Penicillin,(S), 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-(2-phenylacetamido)-, PENICILLIN-G, NSC131815, Spectrum_000933, CHEMBL29, Prestwick0_001078, Prestwick1_001078, Prestwick2_001078, Prestwick3_001078, Spectrum2_000518, Spectrum3_000542, Spectrum4_000471, Spectrum5_001108, Epitope ID:114070, PENICILLIN G [MI], SCHEMBL3783, PENICILLIN G [HSDB], BSPBio_001096, BSPBio_002183, KBioGR_000942, KBioSS_001413, PENICILLIN G [VANDF], (2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-((phenylacetyl)amino)-, (2S-(2alpha,5alpha,6beta))-, MLS000766897, MLS001032123, MLS001173382, DivK1c_000316, SPBio_000475, SPBio_002998, BPBio1_001206, GTPL4796, DTXCID3026934, KBio1_000316, KBio2_001413, KBio2_003981, KBio2_006549, KBio3_001683, BENZYLPENICILLIN [WHO-DD], NINDS_000316, GLXC-25718, HMS2875L09, (2S,6R)-3,3-Dimethyl-7-oxo-6-(2-phenylacetamido)-4-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylic acid, HY-N7139, BDBM50022787, Phenylacetyl-6-aminopenicillanic acid, AKOS005203091, DB01053, IDI1_000316, NCGC00159348-02, NCGC00159348-03, 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6- (2-phenylacetamido)-, 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-[(phenylacetyl)amino]- (2S,5R,6R)-, SBI-0051476.P003, (2S,5R,6R)-3,3-dimethyl-7-oxo-6-, Bicillin (*Benzathine Salt, Tetrahydrate*), CS-0013727, NS00068016, C05551, D02336, (2-phenylacetamido)-4-thia-1-azabicyclo[3.2.0], A833169, EN300-19631164, Q258450, W-109262, Benzylpenicillin 1000 microg/mL in Acetonitrile:Water, BRD-K55191674-236-03-7, BRD-K55191674-237-02-7, BRD-K55191674-237-12-6, Benzylpenicillin, Antibiotic for Culture Media Use Only, 2,2-dimethyl-6beta-(phenylacetamido)penam-3alpha-carboxylic acid, PHENOXYMETHYLPENICILLIN POTASSIUM IMPURITY A [EP IMPURITY], PHENOXYMETHYLPENICILLIN (BENZATHINE) TETRAHYDRATE IMPURITY A [EP IMPURITY], (+)-3,3-Dimethyl-7-oxo-6-phenylacetylamino-4-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylic acid(penicillin G), (2S,5R,6R)-3,3-dimethyl-7-oxo-6-(2-phenylacetamido)-4-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylic acid, (2S,5R,6R)-3,3-Dimethyl-7-oxo-6-(2-phenylacetamido)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylicacid, (2S,5R,6R)-3,3-DIMETHYL-7-OXO-6-[(PHENYLACETYL)AMINO]-4-THIA-1-AZABICYCLO[3.2.0]HEPTANE-2-CARBOXYLIC ACID, (2S,5R,6R)-3,3-Dimethyl-7-oxo-6-phenylacetylamino-4-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylic acid, 3,3-Dimethyl-7-oxo-6-phenylacetylamino-4-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylic acid, 3,3-Dimethyl-7-oxo-6-phenylacetylamino-4-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylic acid anion (Penicillin G), 3,3-Dimethyl-7-oxo-6-phenylacetylamino-4-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylic acid(penicillin G), 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]- (2S,5R,6R)-, 4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-[(phenylacetyl)amino]-, (2S,5R,6R)- C16H18N2O4S JGSARLDLIJGVTE-MBNYWOFBSA-N (2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid n.a. n.a. No No No No No No PMDBD2000559 Bergamottin n.a. n.a. n.a. n.a. n.a. n.a. n.a. 5471349 n.a. NPC191104 "Bergamottin, 7380-40-7, Bergamotine, Bergaptin, 5-Geranoxypsoralen, Bergamotin, 5-Geranyloxypsoralen, Bergomottin, 4-[(2E)-3,7-dimethylocta-2,6-dienoxy]furo[3,2-g]chromen-7-one, UNII-JMU611YFRB, JMU611YFRB, CCRIS 8085, CHEMBL1078442, CHEBI:70476, DTXSID50897528, MFCD00017409, 7H-furo(3,2-g)(1)benzopyran-7-one, 4-(((2E)-3,7-dimethyl-2,6-octadien-1-yl)oxy)-, 4-[(2Z)-3,7-dimethylocta-2,6-dienoxy]furo[3,2-g]chromen-7-one, 4-{[(2E)-3,7-dimethylocta-2,6-dien-1-yl]oxy}-7H-furo[3,2-g][1]benzopyran-7-one, 7H-Furo(3,2-g)(1)benzopyran-7-one, 4-((3,7-dimethyl-2,6-octadienyl)oxy)-, (E)-, Bergaptol geranyl ether, 4-(((2E)-3,7-dimethylocta-2,6-dien-1-yl)oxy)-7H-furo(3,2-g)chromen-7-one, 4-{[(2E)-3,7-Dimethylocta-2,6-dien-1-yl]oxy}-7H-furo[3,2-g]chromen-7-one, 7H-Furo[3,2-g][1]benzopyran-7-one, 4-[[(2E)-3,7-dimethyl-2,6-octadien-1-yl]oxy]-, BERGAMOTTIN [MI], SCHEMBL569529, SCHEMBL7183139, Bergamottin, analytical standard, DTXCID601326883, 482-46-2, HY-N2194, TNP00285, BDBM50310823, NSC710599, AKOS000277132, NSC-710599, 5-Geranoxypsoralen;Bergamotine;Bergaptin, NCGC00017345-01, NCGC00161832-01, AC-34220, 1ST175219, B3943, CS-0019502, C22152, Q568006, (E)-4-(3,7-dimethylocta-2,6-dienyloxy)-7H-furo[3,2-g]chromen-7-one, 4-([(2E)-3,7-dimethyl-2,6-octadienyl]oxy)-7h-furo[3,2-g]chromen-7-one, (E)-4-((3,7-Dimethylocta-2,6-dien-1-yl)oxy)-7H-furo[3,2-g]chromen-7-one" C21H22O4 DBMJZOMNXBSRED-OQLLNIDSSA-N 4-[(2E)-3,7-dimethylocta-2,6-dienoxy]furo[3,2-g]chromen-7-one n.a. n.a. No No No No No No PMDBD2000560 Besifloxacin Therapeutic Substance Approved Drug 141388-76-3 DB06771 n.a. D08872 D00TRV 10178705 8354210 n.a. Besifloxacin, 141388-76-3, Besivance, Besifloxacin [INN], BFE2NBZ7NX, UNII-BFE2NBZ7NX, ISV-403, BESIFLOXACINE, (R)-7-(3-aminohexahydro-1H-azepin-1-yl)-8-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid, 7-[(3R)-3-aminoazepan-1-yl]-8-chloro-1-cyclopropyl-6-fluoro-4-oxoquinoline-3-carboxylic acid, DTXSID00161706, BESIFLOXACIN (MART.), BESIFLOXACIN [MART.], 3-Quinolinecarboxylic acid, 7-(3-aminohexahydro-1H-azepin-1-yl)-8-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-, (R)-, 3-Quinolinecarboxylic acid, 7-[(3R)-3-aminohexahydro-1H-azepin-1-yl]-8-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-, (+)-7-((3R)-3-AMINOHEXAHYDRO-1H-AZEPIN-1-YL)-8-CHLORO-1-CYCLOPROPYL-6-FLUORO-4-OXO-1,4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID, 3-QUINOLINECARBOXYLIC ACID, 7-((3R)-3-AMINOHEXAHYDRO-1H-AZEPIN-1-YL)-8-CHLORO-1-CYCLOPROPYL-6-FLUORO-1,4-DIHYDRO-4-OXO-, besifloxacino, besifloxacinum, BESIFLOXACIN [MI], BESIFLOXACIN [VANDF], BESIFLOXACIN [WHO-DD], SCHEMBL725805, CHEMBL1201760, DTXCID0084197, GTPL12877, S01AE08, CHEBI:135622, s5941, AKOS005145882, AC-8867, DB06771, NCGC00386381-02, NCGC00386381-04, 7-[(3R)-3-aminoazepan-1-yl]-8-chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid, HY-14762, CS-0003546, NS00069194, A23458, AB01565807_02, EN300-19769057, Q3638978, Z2235811595, (R)-7-(3-Aminohexahydro-1H-azepin-1-yl)-8-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolin, 7-(3-aminohexahydro-1H-azepin-1-yl)-8-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid C19H21ClFN3O3 QFFGVLORLPOAEC-SNVBAGLBSA-N 7-[(3R)-3-aminoazepan-1-yl]-8-chloro-1-cyclopropyl-6-fluoro-4-oxoquinoline-3-carboxylic acid Bausch & Lomb n.a. No No No No No No PMDBD2000561 beta-6-20-G3K6 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000562 beta-Caryophyllene Therapeutic Substance Phase 2 n.a. n.a. n.a. n.a. D53QMP 5281515 n.a. NPC109813 BETA-CARYOPHYLLENE, Caryophyllene, trans-Caryophyllene, (-)-trans-Caryophyllene, 87-44-5, (-)-beta-caryophyllene, L-Caryophyllene, b-caryophyllene, (-)-(E)-Caryophyllene, (E)-Caryophyllene, .beta.-Caryophyllene, (E)-beta-caryophyllene, FEMA No. 2252, trans-beta-caryophyllene, CHEBI:10357, Beta-Caryophylene, trans-.beta.-Caryophyllene, (-)-Caryophyllene, .beta.-Caryophyllen, DTXSID8024739, (E)-beta-caryophylene, NSC 11906, NSC-11906, .beta.-(E)-Caryophyllene, BHW853AU9H, Cannabinoid, E-Caryophyllene, DTXCID304739, beta-Caryophyllen, MFCD00075925, (-)-E-Caryophyllene, 8-Methylene-4,11,11-(trimethyl)bicyclo(7.2.0)undec-4-ene, UNII-BHW853AU9H, (1R,4E,9S)-4,11,11-trimethyl-8-methylidenebicyclo[7.2.0]undec-4-ene, Bicyclo(7.2.0)undec-4-ene, 8-methylene-4,11,11-trimethyl-, (E)-(1R,9S)-(-)-, g-Caryophyllene, CCRIS 8094, clove terpenes, EINECS 201-746-1, (1R,4E,9S)-4,11,11-trimethyl-8-methylenebicyclo[7.2.0]undec-4-ene, trans-(1R,9S)-4,11,11-trimethyl-8-methylenebicyclo[7.2.0]undec-4-ene, (1R,4E,9S)-4,11,11-TRIMETHYL-8-METHYLENEBICYCLO(7.2.0)UNDEC-4-ENE, E-.beta.-caryophyllene, AI3-36121, .beta.-Caryophyllene, (-), CHEBI:63191, 2-Methylene-6,10,10-trimethylbicyclo(7.2.0)undec-5-ene, cariofileno, Tincturoid, Copaiba, 8-Methylene-4,11,11-(trimethyl)bicyclo[7.2.0]undec-4-ene, NSC11906, Caryophyllene B, Caryophyllene hg, beta-cariofillene, cb2 receptor, (1R,4E,9S)-4,11,11-trimethyl-8-methylene-bicyclo[7.2.0]undec-4-ene, (1R,4E,9S)-4,11,11-trimethyl-8-methylidenebicyclo(7.2.0)undec-4-ene, trans-(1R,9S)-4,11,11-trimethyl-8-methylenebicyclo(7.2.0)undec-4-ene, beta-caryophillene, BICYCLO(7.2.0)UNDEC-4-ENE, 4,11,11-TRIMETHYL-8-METHYLENE-, (E)-(1R,9S)-(-)-, Bicyclo[7.2.0]undec-4-ene, 4,11,11-trimethyl-8-methylene-, (E)-(1R,9S)-(-)-, Bicyclo[7.2.0]undec-4-ene, 8-methylene-4,11,11-trimethyl-, (E)-(1R,9S)-(-)-, 4,11,11-Trimethyl-8-methylenebicyclo(7.2.0)undec-4-ene, (1R-(1R*,4E,9S))-, Bicyclo(7.2.0)undec-4-ene, 4,11,11-trimethyl-8-methylene-, (1R-(1R*,4E,9S*))-, Bicyclo[7.2.0]undec-4-ene, 4,11,11-trimethyl-8-methylene-, [1R-(1R*,4E,9S*)]-, trans caryophyllene, caryophyllene 917, E-beta-caryophyllene, CAROPYLLENE, Caryophyllene, (E), 02 - Terpenes, (?)-b-caryophyllene, 1-CARYOPHYLLENE, beta-(e)-caryophyllene, beta-trans-caryophyllene, clove terpene derivative, (?)-trans-Caryophyllene, caryophyllene beta natural, CARYOPHYLLENE [MI], .beta.-trans-Caryophyllene, (-)-I(2)-caryophyllene, 12 - Analysis of terpenes, Bicyclo(7.2.0)undec-4-ene, 4,11,11-trimethyl-8-methylene-, CHEMBL445740, BETA-CARYOPHYLLENE [FCC], BETA-CARYOPHYLLENE [INCI], Bicyclo(7.2.0)undec-4-ene, 4,11,11-trimethyl-8-methylene-, (1R,4E,9S)-, HY-N1415, .BETA.-CARYOPHYLLENE [FHFI], Tox21_301497, (1S,9R)-6,10,10-trimethyl-2-methylenebicyclo[7.2.0]undec-5-ene, 11CAR7501, BDBM50529607, s6058, AKOS024283988, trans-(1R,9S)-8-Methylene-4,11,11-trimethylbicyclo[7.2.0]undec-4-ene, LMPR0103120001, beta-Caryophyllene, >=80%, FCC, FG, CAS-87-44-5, NCGC00142620-01, NCGC00255159-01, (-)-trans-Caryophyllene, analytical standard, CS-0016839, NS00079049, C09629, beta-Caryophyllene 2000 microg/mL in Acetonitrile, P198906, Q421614, W-109317, (-)-trans-Caryophyllene, >=98.5% (sum of enantiomers, GC), 8-Methylene-4,11,11-(trimethyl)bicyclo(7.2.0)undec-4-ene, (1R,4E,9S)-, BICYCLO(7.2.0)UNDEC-4-ENE, 4,11,11-TRIMETHYL-8-METHYLENE-, (1R-(1R*,4E,9S*)-, Bicyclo[7.2.0]undec-4-ene, 4,11,11-trimethyl-8-methylene-, [1R- (1R*,4E,9S*)]- C15H24 NPNUFJAVOOONJE-GFUGXAQUSA-N (1R,4E,9S)-4,11,11-trimethyl-8-methylidenebicyclo[7.2.0]undec-4-ene n.a. n.a. No No No No No No PMDBD2000563 beta-Defensin-1 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000564 beta-Defensin-3 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000565 beta-Pinene Therapeutic Substance n.a. 127-91-3 DB15574 n.a. n.a. n.a. 14896 14198 NPC78551 BETA-PINENE, 127-91-3, Pseudopinene, 2(10)-Pinene, Nopinene, 6,6-Dimethyl-2-methylenebicyclo[3.1.1]heptane, .beta.-Pinene, Terbenthene, Terebenthene, PINENE, BETA, 6,6-dimethyl-2-methylidenebicyclo[3.1.1]heptane, Pin-2(10)-ene, Pseudopinen, Nopinen, Bicyclo[3.1.1]heptane, 6,6-dimethyl-2-methylene-, Rosemarel, DTXSID7027049, CHEBI:50025, (-)-.beta.-Pinene, 25719-60-2, beta-Pinene (natural), DTXCID507049, 6,6-Dimethyl-2-methylenebicyclo(3.1.1)heptane, NSC21447, NSC59190, NSC-21447, NSC-59190, NSC-406265, HSDB 5615, 6,6-Dimethyl-2-methylenenorpinane, 2(10)-Pinene, (1S,5S)-(-)-, EINECS 204-872-5, EINECS 245-424-9, UNII-4MS8VHZ1HJ, NSC 21447, AI3-24483, 2,2,6-Trimethylbicyclo(3.1.1)hept-2-ene, 6,6-Dimethyl-2-methylene-bicyclo(3.1.1)heptane, Bicyclo[3.1.1]heptane, 6,6-dimethyl-2-methylene-, (1S)-, 2,6-Trimethylbicyclo[3.1.1]hept-2-ene, Bicyclo[3.1.1]heptane,6-dimethyl-2-methylene-, 6,6-dimethyl-2-methylidenebicyclo(3.1.1)heptane, (1)-6,6-Dimethyl-2-methylenebicyclo(3.1.1)heptane, (1S)-(-)-.beta.-Pinene, beta pinene, PC-600, -Pinene, ?-Pinene, L-.beta.-Pinene, Tributyl-tinhydroxide, beta-Pinene (pure), laevo-.beta.-Pinene, (+/-)-beta-PINENE, beta-PINENE, (+/-)-, CHEMBL501351, .beta.-Pinene-(1S)-(-), Tox21_200029, (1r)-(+)-pin-2(10)-ene, MFCD00063635, NSC406265, AKOS004119987, AKOS016843693, DB15574, NCGC00248498-01, NCGC00257583-01, CAS-127-91-3, LS-13836, beta-Pinene 1000 microg/mL in Isopropanol, NS00003251, P0441, Beta -Pinene 1000 microg/mL in Isopropanol, EN300-95729, C09882, Q300928, 6,6-Dimethyl-2-methylenebicyclo[3.1.1]heptane-, (S)- C10H16 WTARULDDTDQWMU-UHFFFAOYSA-N 6,6-dimethyl-2-methylidenebicyclo[3.1.1]heptane n.a. n.a. No No No No No No PMDBD2000566 beta-sitosterol glucoside n.a. n.a. n.a. n.a. n.a. n.a. n.a. 5742590 n.a. NPC243728 "Daucosterol, Sitogluside, Eleutheroside A, 474-58-8, Alexandrin, Daucosterin, Coriandrinol, beta-Sitosterol glucoside, BSSG, Doursterol, Sitoglusidum, Sterolin, Daucosterine, Sitoglusido, WA 184, beta-Daucosterol, EU-4906, Sitosteryl glycoside, AW 10, Sitosterol D-glucoside, NSC-165962, BSS-G, beta-Sitosteryl glucoside, Eleutheroside A, beta-Sitosterol monoglucoside, UNII-U45VN859W3, CHEBI:67554, AW-10, U45VN859W3, WA-184, Sitogluside (USAN/INN), 3-beta-(beta-D-Glucopyranosyloxy)stigmast-5-ene, beta-sitosteryl-beta-D-glucopyranoside, beta-Sitosterol D-glucoside, NSC 165962, .beta.-sitosterol-glucoside, BRN 4359450, CHEMBL506678, beta-Sitosterol beta-D-Glucoside, Sitosterol-3-O-beta-D-glucoside, (3beta)-stigmast-5-en-3-yl beta-D-glucopyranoside, .beta.-D-Glucopyranoside, (3.beta.)-stigmast-5-en-3-yl, beta-sitosterol 3-O-beta-D-glucopyranoside, (-)-beta-Sitosterol-beta-D-glucopyranoside, D05848, (2R,3R,4S,5S,6R)-2-[[(3S,8S,9S,10R,13R,14S,17R)-17-[(2R,5R)-5-ethyl-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol, NSC165962, (2R,3R,4S,5S,6R)-2-(((3S,8S,9S,10R,13R,14S,17R)-17-((2R,5R)-5-Ethyl-6-methylheptan-2-yl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol, sitosterol glucuronide, AC1NX3NW, beta-sitosterol glucutonide, Sitogluside [USAN:INN], Sitoglusidum [INN-Latin], Sitoglusido [INN-Spanish], beta-sitosterol-beta-D-glycoside, CID5742590, EU 4906, SITOGLUSIDE [INN], O-glucosyl-beta-sitosterol, SITOGLUSIDE [USAN], SureCN137210, 3beta-(beta-D-Glucopyranosyloxy)stigmast-5-ene, b-Sitosterol b-D-glucoside, Ambap474-58-8, C011015, SCHEMBL137210, sitosteryl 3-beta-D-glucoside, (3-beta)-Stigmast-5-en-3-yl-beta-D-glucopyranoside, beta-SITOSTEROL-GLUCOSIDE, DTXSID301045674, HY-N0410, 3-O-beta-D-glucosyl-beta-sitosterol, BDBM50257635, MFCD01683621, beta-sitosterol 3-O-beta-D-glucoside, beta-sitosterol-beta-D-glucopyranoside, AKOS032962016, CS-5421, Eleutheroside A;-Sitosterol -D-glucoside, MS-30381, FT-0686600, NS00123835, .BETA.-SITOSTEROL-.BETA.-D-GLUCOSIDE, C20785, SITOSTEROL 3-O-.BETA.-D-GLUCOPYRANOSIDE, Q-100502, Stigmast-5-ene, 3-beta-(beta-D-glucopyranosyloxy)-, beta-D-Glucopyranoside, (3beta)-stigmast-5-en-3-yl, Q15410900, 3.BETA.-(.BETA.-D-GLUCOPYRANOSYLOXY)STIGMAST-5-ENE, BETA-SITOSTEROL GLUCOSIDE (DAUCOSTEROL) (CONSTITUENT OF STINGING NETTLE), BETA-SITOSTEROL GLUCOSIDE (DAUCOSTEROL) (CONSTITUENT OF STINGING NETTLE) [DSC], (2R,3R,4S,5S,6R)-2-((3S,8S,9S,10R,13R,14S,17R)-17-((2R,5R)-5-ethyl-6-methylheptan-2-yl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yloxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol, (2R,3R,4S,5S,6R)-2-[[(3S,8S,9S,10R,13R,14S,17R)-17-[(1R,4R)-4-ethyl-1,5-dimethyl-hexyl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol" C35H60O6 NPJICTMALKLTFW-OFUAXYCQSA-N (2R,3R,4S,5S,6R)-2-[[(3S,8S,9S,10R,13R,14S,17R)-17-[(2R,5R)-5-ethyl-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol n.a. n.a. No No No No No No PMDBD2000567 Betulin Therapeutic Substance Investigational Drug 473-98-3 DB16890 n.a. n.a. D05KJY 72326 65272 NPC178383 "Betulin, 473-98-3, Betulinol, Betuline, Trochol, Betulol, Lup-20(29)-ene-3b,28-diol, Betulinic alcohol, Lup-20(29)-ene-3beta,28-diol, (+)-betulin, Lup-20(30)-ene-3beta,28-diol, NSC 4644, NSC-4644, 6W70HN7X7O, CHEBI:3086, (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3a-(Hydroxymethyl)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)icosahydro-1H-cyclopenta[a]chrysen-9-ol, MFCD00016802, (3beta)-lup-20(29)-ene-3,28-diol, Lup-20(29)-ene-3,28-diol, (3.beta.)-, (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3a-(hydroxymethyl)-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-ol, (1R,2R,5S,8R,9R,10R,13R,14R,17S,19R)-5-(hydroxymethyl)-1,2,14,18,18-pentamethyl-8-(prop-1-en-2-yl)pentacyclo[11.8.0.0^{2,10}.0^{5,9}.0^{14,19}]henicosan-17-ol, (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3a-(hydroxymethyl)-1-isopropenyl-5a,5b,8,8,11a-pentamethyl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-ol, SR-05000002167, EINECS 207-475-5, lup-20(29)-ene-3 beta,28-diol, NSC4644, UNII-6W70HN7X7O, AI3-62999, NSC692218, Lup-20(29)-ene-3,28-diol, (3beta)-, Lup-20(29)-ene-3.beta.,28-diol, Lup-20(30)-ene-3.beta.,28-diol, Betulinol (obsol.), Betulin, 23, ORISTRACT BTL, CP BETULIN, BETULIN [INCI], Betulin, >=98%, BETULIN [MI], Prestwick3_000990, Betulinol (obsol pound(c), Betulin, analytical standard, BSPBio_001059, CHEMBL23236, SCHEMBL131739, BPBio1_001165, MEGxp0_001726, ACon1_000091, BDBM23207, DTXSID101019934, HMS2098E21, EX-A3354, HY-N0083, s4754, Lup-20(29)-ene-3 ,28-diol, AKOS005267212, Lup-20(29)-ene-3beta ,28-diol, Lup-20(30)-ene-3beta ,28-diol, CCG-208619, CS-6156, GS-3254, LMPR0106140005, NSC-692218, NCGC00168803-01, NCGC00168803-02, NCGC00168803-04, AB00513988, B0803, NS00018049, (3.beta.)-Lup-20(29)-ene-3,28-diol, C08618, Lup-20(29)-ene-3,28-diol, (3beta )-, A827211, Q419726, Q-100501, SR-05000002167-2, SR-05000002167-3, BRD-K64874225-001-01-3, (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3 a-(hydroxymethyl)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)icosahydro-1H-cyclopenta[a]chrysen-9-ol, (3aS,5bR,9S,11aR)-3a-(hydroxymethyl)-1-isopropenyl-5a,5b,8,8,11a-pentamethyl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-ol;Betulin, 7372-31-8" C30H50O2 FVWJYYTZTCVBKE-ROUWMTJPSA-N (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3a-(hydroxymethyl)-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-ol n.a. n.a. No No No No No No PMDBD2000568 Betulinic acid Therapeutic Substance Phase 1 n.a. n.a. n.a. n.a. D0R9YR 64971 n.a. NPC264317 "betulinic acid, 472-15-1, Betulic acid, Mairin, Lupatic Acid, als-357, 3-Hydroxylup-20(29)-en-28-oic acid, 3beta-Hydroxy-20(29)-lupaene-28-oic acid, CCRIS 6748, NSC 113090, EINECS 207-448-8, beta-betulinic acid, NSC 677578, NSC-677578, CHEBI:3087, UNII-4G6A18707N, .beta.-betulinic acid, Lupatic acid;Betulic acid, NSC677578, 4G6A18707N, NSC-113090, Lup-20(29)-en-28-oic acid, 3-hydroxy-, (3beta)-, CHEMBL269277, 3beta-Hydroxy-lup-20(29)-en-28-oic acid, Lup-20(29)-en-28-oic acid, 3beta-hydroxy-, (3beta)-3-hydroxylup-20(29)-en-28-oic acid, MFCD00009619, 3beta-hydroxylup-20(29)-en-28-oic acid, (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-hydroxy-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)icosahydro-1H-cyclopenta[a]chrysene-3a-carboxylic acid, Betulinicacid, NSC113090, C30H48O3, (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-hydroxy-1-isopropenyl-5a,5b,8,8,11a-pentamethyl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-3a-carboxylic acid, SMR000445624, Gratiolone, Melaleucin, Platanol, betulinic-acid, Platanolic acid, Prestwick_95, (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-hydroxy-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-3a-carboxylic acid, Betulinic Acid, 24, Prestwick0_000417, Prestwick1_000417, Prestwick2_000417, Prestwick3_000417, BETULINIC ACID [MI], Lup-20(29)-en-28-oic acid, 3-hydroxy-, (3.beta.)-, SCHEMBL61767, BSPBio_000374, BSPBio_001587, cid_64971, MLS000728510, MLS006011257, BETULINIC ACID [INCI], SPBio_002313, BPBio1_000412, GTPL3945, BDBM23208, DTXSID80861974, HMS1569C16, HMS1791P09, HMS1989P09, HMS2096C16, HMS2232K03, HMS3402P09, Betulinic acid, analytical standard, Betulinic acid, >=98% (HPLC), HB3799, s3603, AKOS015920276, Betulinic acid, technical grade, 90%, CCG-208159, CS-1216, DB12480, LMPR0106140004, RL9-080, SMP2_000205, NCGC00163409-02, NCGC00163409-03, NCGC00163409-09, BP-25391, DS-15257, HY-10529, NS00042781, C08619, Lup-20(29)-en-28-oic acid, 3beta -hydroxy-, (3beta)-3-Hydroxy-lup-20(29)-en-28-oic Acid, 3-Hydroxy-(3beta)-Lup-20(29)-en-28-oic acid, Q384111, SR-01000779609, Q-100500, SR-01000779609-3, (+)-(3?)-3-Hydroxylup-20(29)-en-28-oic acid, BRD-K45401373-001-05-0, BRD-K45401373-001-22-5, (3.BETA.)-3-HYDROXYLUP-20(29)-EN-28-OIC ACID, (1R,2R,5S,8R,9R,10R,13R,14R,17S,19R)-17-hydroxy-1,2,14,18,18-pentamethyl-8-(prop-1-en-2-yl)pentacyclo[11.8.0.0^{2,10}.0^{5,9}.0^{14,19}]henicosane-5-carboxylic acid, (1R,3 aS,5aR,5bR,7aR,9S,11aR,11bR,13 aR,13bR)-9-hydroxy-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)icosahydro-1H-cyclopenta[a]chrysene-3a-carboxylic acid, (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-Hydroxy-1-isopropenyl-5a,5b,8,8,11a-pentamethyl-eicosahydro-cyclopenta[a]chrysene-3a-carboxylic acid, (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-hydroxy-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)icosahydro-1H-cyclopenta[a]chrysene-3a-carboxylicacid, (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-hydroxy-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-3a-carboxylicacid, 06L" C30H48O3 QGJZLNKBHJESQX-FZFNOLFKSA-N (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-hydroxy-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-3a-carboxylic acid n.a. n.a. No No No No No No PMDBD2000569 Bevirimat Therapeutic Substance Phase 2 174022-42-5 DB06581 n.a. n.a. D04MPB 457928 403003 NPC160506 "Bevirimat, 174022-42-5, PA-457, Bevirimat [INN], YK FH312, MPC-4326, 3-O-(3'',3''-Dimethylsuccinyl)betulinic acid, UNII-S125DW66N8, YK-FH312, S125DW66N8, PA 457, BVM, O-(3,3-Dimethylsuccinyl)betulinic acid, CHEMBL404519, CHEBI:65484, 3-O-(3'',3''-dimethylsuccinyl) betulinic acid, PA-103001, 3-O-(3'',3''-Dimethylsuccinyl)-betulinic acid, Lup-20(29)-en-28-oic acid, 3-(3-carboxy-3-methyl-1-oxobutoxy)-, (3beta)-, DSB, (3beta)-3-[(3-carboxy-3-methylbutanoyl)oxy]lup-20(29)-en-28-oic acid, (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-((3-carboxy-3-methylbutanoyl)oxy)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)icosahydro-3aH-cyclopenta[a]chrysene-3a-carboxylic acid, 3alpha-[(3-carboxy-3-methylbutanoyl)oxy]-8alpha,9beta,10alpha,13alpha,17alpha,19beta-lup-20(29)-en-28-oic acid, bevirimatum, (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-(4-hydroxy-3,3-dimethyl-4-oxo-butanoyl)oxy-1-isopropenyl-5a,5b,8,8,11a-pentamethyl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-3a-carboxylic acid, C36H56O6, bevirimat-dimeglumine, PA-457;MPC-4326;YK FH312, Bevirimat(PA-457), BEVIRIMAT [MI], SCHEMBL2612026, Bevirimat, >=98% (HPLC), DBS, PA-457, DTXSID20169749, YJEJKUQEXFSVCJ-WRFMNRASSA-N, (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-((3-carboxy-3-methylbutanoyl)oxy)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)icosahydro-1H-cyclopenta[a]chrysene-3a-carboxylic acid, EX-A2381, HY-N0842, ZGA02242, BDBM50050955, MFCD00954243, s9010, ZB1856, Bevirimat; PA-457; MPC-4326, AKOS030526656, CCG-270147, DB06581, NCGC00390568-02, AC-34026, MS-30468, NS00069609, 3-O-(3'''',3''''-dimethylsuccinyl)betulinic acid, 3-O-(3'''',3''''-dimethylsuccinyl)-betulinic acid, 3-O-(3'''',3''''-dimethyl-succinyl)-betulinic acid, Q851897, 3beta-(3-Carboxy-3-methylbutanoyloxy)lup-20(29)-en-28-oic acid, (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-(3-carboxy-3-methylbutanoyl)oxy-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-3a-carboxylic acid, (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13bR)-9-(3-carboxy-3-methylbutanoyloxy)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)icosahydro-1H-cyclopenta[a]chrysene-3a-carboxylic acid, 2,2-Dimethyl-succinic acid 4-((1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3a-carboxy-1-isopropenyl-5a,5b,8,8,11a-pentamethyl-icosahydro-cyclopenta[a]chrysen-9-yl) ester, 2,2-Dimethyl-succinic acid, 4-((1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3a-carboxy-1-isopropenyl-5a,5b,8,8,11a-pentamethyl-eicosahydro-cyclopenta[a]chrysen-9-yl) ester, 2I4" C36H56O6 YJEJKUQEXFSVCJ-WRFMNRASSA-N (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-(3-carboxy-3-methylbutanoyl)oxy-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-3a-carboxylic acid Panacos n.a. No No No No No No PMDBD2000570 Biphenyl n.a. n.a. n.a. n.a. n.a. n.a. n.a. 7095 n.a. NPC113670 Biphenyl, 1,1''-Biphenyl, 92-52-4, Phenylbenzene, DIPHENYL, Bibenzene, Xenene, 1,1''-Diphenyl, Lemonene, Phenador-X, Tetrosin LY, Carolid AL, PHPH, DIPHENYL-4-D1, Biphenyl [BSI:ISO], DIPHENYL-4,4''-D2, 1,1-Biphenyl, FEMA No. 3129, 6120-99-6, NSC 14916, 2L9GJK6MGN, 4819-98-1, E230, CHEMBL14092, DTXSID4020161, CHEBI:17097, MFCD00003054, NSC-14916, 68409-73-4, BNL, DTXCID60161, Caswell No. 087, CAS-92-52-4, CCRIS 935, HSDB 530, diphenyl, 14C-labeled, MCS 1572, EINECS 202-163-5, UNII-2L9GJK6MGN, CP 390, EPA Pesticide Chemical Code 017002, meta biphenyl, bi-phenyl, AI3-00036, 4-Biphenyl, Diphenyl,(S), Biphenyl-UL-14C, 4,4''-biphenyl, 1,1''''-biphenyl, 1, 1''-Diphenyl, Biphenyl, >=99%, BIPHENYL [FHFI], BIPHENYL [HSDB], BIPHENYL [ISO], DIPHENYL [MI], WLN: RR, DIPHENYL [MART.], 1,1''-Biphenyl, 9CI, BIPHENYL [USP-RS], bmse000506, EC 202-163-5, Biphenyl, analytical standard, BIDD:ER0669, INS NO.230, FEMA 3129, INS-230, NSC14916, Tox21_202108, Tox21_300167, BDBM50168002, Biphenyl 100 microg/mL in Methanol, Biphenyl, ReagentPlus(R), 99.5%, Biphenyl 10 microg/mL in Cyclohexane, AKOS000119944, NCGC00091836-01, NCGC00091836-02, NCGC00091836-03, NCGC00091836-04, NCGC00254175-01, NCGC00259657-01, Biphenyl, Vetec(TM) reagent grade, 99%, BS-42211, B0224, B0465, Biphenyl, PESTANAL(R), analytical standard, E-230, NS00010251, EN300-18009, C06588, Q410915, W-100283, Biphenyl, certified reference material, TraceCERT(R), F9995-1632, Biphenyl, United States Pharmacopeia (USP) Reference Standard, InChI=1/C12H10/c1-3-7-11(8-4-1)12-9-5-2-6-10-12/h1-10, 26008-28-6 C12H10 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 1,1''-biphenyl n.a. n.a. No No No No No No PMDBD2000571 Bis[(4-methylphenyl)methyl] disulfide n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000572 BisEDT-RIP n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000573 Bismuth oxide nanoparticle n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000574 Bis-O-acetyl-4,5-dihydroxy-2,3-pentanedione n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000575 BMAP-18 n.a. n.a. n.a. n.a. n.a. n.a. n.a. 168510728 n.a. n.a. BMAP-18, HY-P5446, CS-0883919 C113H188N34O20 YWAOJBTYFPBFPD-FNWPXSAPSA-N (2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[(2-aminoacetyl)amino]-5-carbamimidamidopentanoyl]amino]-3-phenylpropanoyl]amino]hexanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-phenylpropanoyl]amino]-5-carbamimidamidopentanoyl]amino]hexanoyl]amino]hexanoyl]amino]-3-phenylpropanoyl]amino]hexanoyl]amino]hexanoyl]amino]-4-methylpentanoyl]amino]-3-phenylpropanoyl]amino]hexanoyl]amino]hexanoyl]amino]-4-methylpentanoyl]amino]-3-hydroxypropanoic acid n.a. n.a. No No No No No No PMDBD2000576 BMAP-27 n.a. n.a. n.a. n.a. n.a. n.a. n.a. 16130511 n.a. n.a. BMAP-27, GRFKRFRKKFKKLFKKLSPVIPLLHL-NH2 C158H263N45O27 BRRSZIMJXSPBER-GPKCLSBHSA-N (2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[(2-aminoacetyl)amino]-5-carbamimidamidopentanoyl]amino]-3-phenylpropanoyl]amino]hexanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-phenylpropanoyl]amino]-5-carbamimidamidopentanoyl]amino]hexanoyl]amino]hexanoyl]amino]-3-phenylpropanoyl]amino]hexanoyl]amino]hexanoyl]amino]-4-methylpentanoyl]amino]-3-phenylpropanoyl]amino]hexanoyl]amino]hexanoyl]amino]-4-methylpentanoyl]amino]-3-hydroxypropanoyl]-N-[(2S)-1-[[(2S,3S)-1-[(2S)-2-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-amino-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-3-methyl-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]pyrrolidine-2-carboxamide n.a. n.a. No No No No No No PMDBD2000577 BMAP-28 n.a. n.a. n.a. n.a. n.a. n.a. n.a. 16131512 n.a. n.a. GGLRSLGRKILRAWKKYGPIIVPIIRI-NH2, BMAP-28 C145H250N44O29 WMFBKFIMNMRQAY-MVPIGCMHSA-N (2S)-1-[2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[(2-aminoacetyl)amino]acetyl]amino]-4-methylpentanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]acetyl]amino]-5-carbamimidamidopentanoyl]amino]hexanoyl]amino]-3-methylpentanoyl]amino]-4-methylpentanoyl]amino]-5-carbamimidamidopentanoyl]amino]propanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]hexanoyl]amino]hexanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]acetyl]-N-[(2S,3S)-1-[[(2S,3S)-1-[[(2S)-1-[(2S)-2-[[(2S,3S)-1-[[(2S,3S)-1-[[(2S)-1-[[(2S,3S)-1-amino-3-methyl-1-oxopentan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]pyrrolidine-2-carboxamide n.a. n.a. No No No No No No PMDBD2000578 Brecanavir Therapeutic Substance Discontinued in Phase 2 313682-08-5 DB04887 n.a. D03253 D07FJM 5743186 4675192 n.a. Brecanavir, 313682-08-5, GW64085X, Brecanavir [USAN], GW640385, CHEMBL206031, E367I8C7FI, [(3aS,4R,6aR)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl] N-[(2S,3R)-4-[1,3-benzodioxol-5-ylsulfonyl(2-methylpropyl)amino]-3-hydroxy-1-[4-[(2-methyl-1,3-thiazol-4-yl)methoxy]phenyl]butan-2-yl]carbamate, Brecanavir (USAN), GW-64085X, GW0385, GW-640385X, GW-640385, (3R,3AS,6AR)-HEXAHYDROFURO[2,3-B]FURAN-3-YL [(1S,2R)-3-[(1,3-BENZODIOXOL-5-YLSULFONYL)(ISOBUTYL)AMINO]-2-HYDROXY-1-{4-[(2-METHYL-1,3-THIAZOL-4-YL)METHOXY]BENZYL}PROPYL]CARBAMATE, [3H]GW0385, Brecanavir [USAN:INN], UNII-E367I8C7FI, Proteinase inhibitor 640385, 2fdd, 2fde, CARBAMIC ACID, ((1S,2R)-3-((1,3-BENZODIOXOL-5-YLSULFONYL)(2-METHYLPROPYL)AMINO)-2-HYDROXY-1-((4-((2-METHYL-4-THIAZOLYL)METHOXY)PHENYL)METHYL)PROPYL)-, (3R,3AS,6AR)-HEXAHYDROFURO(2,3-B)FURAN-3-YL ESTER, Carbamic acid, [(1S,2R)-3-[(1,3-benzodioxol-5-ylsulfonyl)(2-methylpropyl)amino]-2-hydroxy-1-[[4-[(2-methyl-4-thiazolyl)methoxy]phenyl]methyl]propyl]-, (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl ester, VX-385, GSK 640385, GW 0385, BRECANAVIR [INN], BRECANAVIR [WHO-DD], BDBM4685, SCHEMBL1533991, DTXSID10185296, JORVRJNILJXMMG-OLNQLETPSA-N, AMY16475, VX 385, AKOS005145761, DB04887, AC-31378, HY-121240, CS-0081293, NS00069745, D03253, Q4959983, (3R,3aS,6aR)-hexahydrofuro(2,3-b)furan-3-yl ((1S,2R)-3-((1,3-benzodioxol-5-ylsulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(4-((2-methylthiazol-4-yl)methoxy)benzyl)propyl)carbamate, (3R,3AS,6AR)-HEXAHYDROFURO(2,3-B)FURAN-3-YL((1S,2R)-3-((1,3,BENZODIOXOL-5-YLSULFONYL)2-METHYLPROPYL)AMINO)-2-HYDROXY-1-(4-((2-METHYLTHIOZOL-5-YL)METHOXY)BENZYL)PROPYL)CARBAMATE, (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl [(1S,2R)-3-[(1,3-benzodioxol-5-ylsulfonyl)(2-methylpropyl)amino]-2-hydroxy-1-{4-[(2-methyl-1,3-thiazol-4-yl)methoxy]benzyl}propyl]carbamate, (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl N-[(2S,3R)-4-[2H-1,3-benzodioxole-5-(2-methylpropyl)sulfonamido]-3-hydroxy-1-{4-[(2-methyl-1,3-thiazol-4-yl)methoxy]phenyl}butan-2-yl]carbamate, (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl(1S,2R)-3-[(1,3-benzodioxol-5-ylsulfonyl)(isobutyl)amino]-2-hydroxy-1-{4-[(2-methyl-1,3-thiazol-4-yl)methoxy]benzyl}propylcarbamate, [(1R,5S,6R)-2,8-Dioxabicyclo[3.3.0]oct-6-yl]n-[(2S,3R)-4-(benzo[1,3]dioxol-5-ylsulfonyl-(2-methylpropyl)amino)-3-hydroxy-1-[4-[(2-methyl-1,3-thiazol-4-yl)methoxy]phenyl]butan-2-yl]carbamate, [(3aS,4R,6aR)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl] N-[(1S,2R)-3-[1,3-benzodioxol-5-ylsulfonyl(isobutyl)amino]-2-hydroxy-1-[[4-[(2-methylthiazol-4-yl)methoxy]phenyl]methyl]propyl]carbamate, Carbamic acid, ((1S,2R)-3-((1,3-benzodioxol-5-ylsulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-((4-((2-methyl-4-thiazolyl)methoxy)phenyl)methyl)propyl)-, (3R,3aS,6aR)-hexahydrofuro(2,3-b)furan-3-yl ester C33H41N3O10S2 JORVRJNILJXMMG-OLNQLETPSA-N [(3aS,4R,6aR)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl] N-[(2S,3R)-4-[1,3-benzodioxol-5-ylsulfonyl(2-methylpropyl)amino]-3-hydroxy-1-[4-[(2-methyl-1,3-thiazol-4-yl)methoxy]phenyl]butan-2-yl]carbamate n.a. n.a. No No No No No No PMDBD2000579 Bromohexylmaleic anhydride n.a. n.a. n.a. n.a. n.a. n.a. n.a. 52942342 n.a. n.a. Bromohexylmaleic Anhydride, CHEMBL1253346 C10H13BrO3 KUKZUPGSOPDBEA-UHFFFAOYSA-N 3-bromo-4-hexylfuran-2,5-dione n.a. n.a. No No No No No No PMDBD2000580 Bromophenyl AHL n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000581 BS-34 n.a. n.a. n.a. n.a. n.a. n.a. n.a. 29314 n.a. n.a. alpha-(1-(Veratrylamino)ethyl)benzyl alcohol hydrochloride, 18864-10-3, BS-34, F 1641, BENZYL ALCOHOL, alpha-(1-(VERATRYLAMINO)ETHYL)-, HYDROCHLORIDE, Benzenemethanol, alpha-(1-(((3,4-dimethoxyphenyl)methyl)amino)ethyl)-, hydrochloride C18H24ClNO3 BWZKVGKMUDJHQU-UHFFFAOYSA-N "(3,4-dimethoxyphenyl)methyl-(1-hydroxy-1-phenylpropan-2-yl)azanium;chloride" n.a. n.a. No No No No No No PMDBD2000582 Butane-1,4-diamine Therapeutic Substance Discontinued in Phase 2 n.a. n.a. n.a. n.a. D00FMV 1045 n.a. NPC309330 "1,4-diaminobutane, putrescine, 1,4-butanediamine, 110-60-1, butane-1,4-diamine, tetramethylenediamine, Butylenediamine, Putrescin, 1,4-Butylenediamine, Tetramethyldiamine, 1,4-Tetramethylenediamine, putrescina, Putreszin, Tetramethylendiamin, MFCD00008235, NSC 60545, BRN 0605282, H2N(CH2)4NH2, AI3-25444, 1,4-Diamino-n-butane, NSC-60545, Putrescine; NSC 60545; Putramine, CHEMBL46257, V10TVZ52E4, CHEBI:17148, 1,4-Butanediamine-13C4, Putrescine-13C4, PUT, CCRIS 6751, EINECS 203-782-3, UNII-V10TVZ52E4, butylene amine, HSDB 7865, tetramethylendiamine, 4-amino-butyl-amine, tetramethylene diamine, 1,4 diamino butane, 1,4-butane diamine, 1,4-diamino butane, Putrescine, free base, Spectrum_001646, 1i7c, 1i7m, PUTRESCINE [MI], Spectrum2_001935, Spectrum3_001198, Spectrum4_000237, Spectrum5_001005, Lopac-P-7505, bmse000109, bmse000814, bmse000862, EC 203-782-3, 1,4-Diaminobutane, 99%, BUTANE,1,4-DIAMINO, Lopac0_000972, BSPBio_002875, KBioGR_000933, KBioSS_002126, DivK1c_000716, SPBio_001969, .alpha.,.omega.-Butanediamine, Putrescine, analytical standard, GTPL2388, DTXSID4041107, KBio1_000716, KBio2_002126, KBio2_004694, KBio2_007262, KBio3_002375, 1a99, NINDS_000716, HY-N2407, NSC60545, BDBM50009385, s5825, AKOS000119071, CCG-205052, DB01917, SDCCGMLS-0066929.P001, SDCCGSBI-0050945.P003, IDI1_000716, NCGC00015837-01, NCGC00015837-02, NCGC00015837-03, NCGC00015837-07, NCGC00162302-01, BP-21408, NCI60_004431, CS-0022608, D0239, NS00009671, 1,4-Diaminobutane, purum, >=98.0% (GC), EN300-19074, C00134, C02896, F17678, P-7990, 1,4-Diaminobutane, puriss., >=99.0% (GC), Q410190, InChI=1/C4H12N2/c5-3-1-2-4-6/h1-6H, F1791-1258, Z104472592, A4738F6F-F1A1-4B30-BF38-866D5AC66C93, 58I" C4H12N2 KIDHWZJUCRJVML-UHFFFAOYSA-N butane-1,4-diamine n.a. n.a. No No No No No No PMDBD2000583 Butanol n.a. n.a. n.a. n.a. n.a. n.a. n.a. 263 n.a. NPC294703 "1-butanol, butanol, Butan-1-ol, n-butanol, Butyl alcohol, 71-36-3, n-butyl alcohol, 1-hydroxybutane, Propylcarbinol, Butyl hydroxide, Methylolpropane, Propylmethanol, Hemostyp, n-Butan-1-ol, Butyric alcohol, 1-Butyl alcohol, Butanolo, Propyl carbinol, Alcool butylique, Butylowy alkohol, BuOH, Butanolen, Normal primary butyl alcohol, RCRA waste number U031, CCS 203, n-Butylalkohol, Alcohol, Butyl, Butyl alcohol (natural), FEMA No. 2178, FEMA Number 2178, 1 Butanol, 35296-72-1, Butyric or normal primary butyl alcohol, n-BuOH, HSDB 48, NSC 62782, CCRIS 4321, butanol-1, n-Butyl-1,1-d2 Alcohol, EINECS 200-751-6, UNII-8PJ61P6TS3, 8PJ61P6TS3, Butyl alcohol (NF), Butyl alcohol [NF], ALCOHOL,BUTYL, DTXSID1021740, CHEBI:28885, AI3-00405, n-Butyl--d6 Alcohol, MFCD00002964, NSC-62782, 1219794-84-9, 64118-16-7, 1-Butanol-4,4,4-d3, CHEMBL14245, DTXCID701740, EC 200-751-6, NCGC00090961-02, Butanols, 1-BUTANOL-3,3,4,4,4-D5, BUTYL ALCOHOL (II), BUTYL ALCOHOL [II], n-Propyl carbinol, Butanol [French], Butanolen [Dutch], Butanolo [Italian], 1-Butanol, analytical standard, BUTYL ALCOHOL (MART.), BUTYL ALCOHOL [MART.], 1-BUTANOL-2,2,3,3,4,4,4-D7, VANADIUM TETRABUTOXIDE, n-Butanol, Butan-1-ol, 1-Butanol, 6167-45-9, n Butanol, n Butyl Alcohol, Alcool butylique [French], Butylowy alkohol [Polish], 1-Butanol, ACS reagent, >=99.4%, CAS-71-36-3, Alcohol, n-Butyl, 1BO, Butanol, 1-, TRIBUTYL ACETYLCITRATE IMPURITY D (EP IMPURITY), TRIBUTYL ACETYLCITRATE IMPURITY D [EP IMPURITY], RCRA waste no. U031, UNII-WB09NY83YA, butaneol, butylalcohol, butan-1-olate,vanadium(4+), butyl-alcohol, n-butylalcohol, normal butanol, 1-butylalcohol, n-Propylcarbinol, n-Butanolbutanolen, nBuOH, 1 -butanol, 1- butanol, 1-n-Butanol, 1-Butanol, anhydrous, N-Butyl Alcohol,(S), 1-Butanol, for HPLC, n-Butanol, HPLC grade, 1-Butanol, 99%, 1-Butanol, HPLC Grade, n-C4H9OH, bmse000447, 1-butanol (butyl alcohol), 1-Butanol, 99.9%, BUTYL ALCOHOL [FCC], WB09NY83YA, BUTYL ALCOHOL [FHFI], BUTYL ALCOHOL [HSDB], WLN: Q4, 1-butanol (n-butyl alcohol), 1-BUTANOL [USP-RS], ALCOHOL,BUTYL [VANDF], BIDD:ER0611, N-BUTYL ALCOHOL [MI], N-BUTYL ALCOHOL [INCI], 1-Butanol, LR, >=99%, BDBM36173, 1-Butanol, anhydrous, 99.8%, N-Butanol, ACS, 99.4+%, N-BUTYL ALCOHOL [WHO-DD], 1-Butanol, AR, >=99.5%, 1-Butanol, for HPLC, 99.8%, Butyl alcohol, >=99.9%, FCC, NSC62782, Tox21_111046, Tox21_200741, LMFA05000109, AKOS000249218, 1-Butanol 500 microg/mL in Methanol, 1-Butanol, for HPLC, >=99.7%, DB02145, Butyl alcohol, >=99.9%, FCC, FG, NCGC00090961-01, NCGC00090961-03, NCGC00258295-01, BP-30034, 1-Butanol, SAJ first grade, >=99.0%, 1-Butanol, for molecular biology, >=99%, 1-Butanol, JIS special grade, >=99.0%, 1-Butanol, p.a., ACS reagent, 99.4%, 1-Butanol, for HPLC, >=99.8% (GC), 1-Butanol, spectrophotometric grade, 99.5%, 1-Butanol, UV HPLC spectroscopic, 99.5%, B0228, B0704, B0944, NS00009227, 1-Butanol, anhydrous, ZerO2(TM), 99.8%, EN300-19305, 1-Butanol, Ultrapure, Spectrophotometric Grade, Butyl alcohol, natural, >=99.5%, FCC, FG, C06142, D03200, Q16391, F0001-1830, InChI=1/C4H10O/c1-2-3-4-5/h5H,2-4H2,1H, 1-Butanol, puriss. p.a., ACS reagent, >=99.5% (GC), BDBC6468-886D-4F6C-8746-734F2B63E6CE, 1-Butanol, ACS reagent, reag. ISO, reag. Ph. Eur., 99.5%, 1-Butanol, United States Pharmacopeia (USP) Reference Standard, 1-Butanol, Pharmaceutical Secondary Standard; Certified Reference Material, 1-Butanol, puriss. p.a., ACS reagent, reag. ISO, reag. Ph. Eur., >=99.5% (GC)" C4H10O LRHPLDYGYMQRHN-UHFFFAOYSA-N butan-1-ol n.a. n.a. No No No No No No PMDBD2000584 Butein Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D0EW3L 5281222 n.a. NPC26697 "butein, 487-52-5, 2'',3,4,4''-Tetrahydroxychalcone, 2'',4'',3,4-Tetrahydroxychalcone, 3,4,2'',4''-Tetrahydroxychalcone, AC1NQY7L, (E)-1-(2,4-dihydroxyphenyl)-3-(3,4-dihydroxyphenyl)prop-2-en-1-one, UNII-4WVS5M0LGF, 4WVS5M0LGF, EINECS 207-659-5, CHEBI:3237, NSC-652892, (2E)-1-(2,4-dihydroxyphenyl)-3-(3,4-dihydroxyphenyl)prop-2-en-1-one, CHEMBL128000, 2-Propen-1-one, 1-(2,4-dihydroxyphenyl)-3-(3,4-dihydroxyphenyl)-, ISOLIQUIRITIGENIN METABOLITE M4, (E)-2'',3,4,4''-terahydroxychalcone, Chalcone, 2'',3,4,4''-tetrahydroxy-, 21849-70-7, Acrylophenone, 2'',4''-dihydroxy-3-(3,4-dihydroxyphenyl)-, TETRAHYDROXYCHALCONE, 3,4,2'',4''-, 2-Propen-1-one, 1-(2,4-dihydroxyphenyl)-3-(3,4-dihydroxyphenyl)-, (2E)-, 1-(2,4-Dihydroxyphenyl)-3-(3,4-dihydroxyphenyl)-2-propen-1-one, 2-PROPEN-1-ONE, 1-(2,4-DIHYDROXYPHENYL)-3-(3,4-DIHYDROXYPHENYL)-, (E)-, Butein, solid, LAVENDUSTINC, 2-Propen-1-one,1-(2,4-dihydroxyphenyl)-3-(3,4-dihydroxyphenyl)-, (2E)-, Butein, analytical standard, SCHEMBL139243, 2,3,4,4-tetrahydroxy Chalcone, CHEBI:92312, 3,4,2'',4''-Tetrahydroxychalone, AYMYWHCQALZEGT-ORCRQEGFSA-N, DTXSID101025569, 2'',3,4,4''-Tetrahydroxy-chalcone, 3,4,2'''',4''''-tetrahydroxychalone, 2-Propen-1-one,1-(2,4-dihydroxyphenyl)-3-(3,4-dihydroxyphenyl)-, BDBM50042949, HSCI1_000162, LMPK12120111, NSC652892, s8036, (2E)-1-(2,4-Dihydroxyphenyl)-3-(3,4-dihydroxyphenyl)-2-propen-1-one, AKOS032948361, CCG-208298, CS-5675, 2 inverted exclamation mark ,3,4,4 inverted exclamation mark -tetrahydroxy Chalcone, NCGC00163519-01, AS-35311, HY-16558, 2'',3,4,4''-Tetrahydroxychalcone; Butein, B3803, SW219249-1, C08578, A871883, Chalcone, 2'',3,4,4''-tetrahydroxy-(7CI,8CI), SR-05000002316, Q5002498, SR-05000002316-2, BRD-K17497770-001-01-0, Z2312273638, 3-(3,4-Dihydroxy-phenyl)-1-(2,4-dihydroxy-phenyl)-propenone, (E)-3-(3,4-Dihydroxy-phenyl)-1-(2,4-dihydroxy-phenyl)-propenone, (E)-1-(2,4-Dihydroxyphenyl)-3-(3,4-dihydroxyphenyl)-2-propen-1-one" C15H12O5 AYMYWHCQALZEGT-ORCRQEGFSA-N (E)-1-(2,4-dihydroxyphenyl)-3-(3,4-dihydroxyphenyl)prop-2-en-1-one n.a. n.a. No No No No Yes No rxnDiet89 PMDBD2000585 Butyl gallate n.a. n.a. n.a. n.a. n.a. n.a. n.a. 14128 n.a. NPC156124 BUTYL GALLATE, Butyl 3,4,5-trihydroxybenzoate, 1083-41-6, Progallin butyl, n-Butyl gallate, Gallic acid, butyl ester, Gallic acid n-butyl ester, Benzoic acid, 3,4,5-trihydroxy-, butyl ester, Butylester kyseliny gallove, butyl 3,4,5-tris(oxidanyl)benzoate, NSC33956, NSC-33956, 67HZ41U710, Butylester kyseliny gallove [Czech], EINECS 214-107-7, NSC 33956, BRN 3032709, UNII-67HZ41U710, Gallicacidn-butylester, Gallic Acid Butyl Ester, SCHEMBL35913, CBDivE_013159, 4-10-00-02004 (Beilstein Handbook Reference), CHEMBL494005, DTXSID40148490, HMS1577L19, BDBM50280382, MFCD00016432, AKOS015914064, CCG-305745, 3,4,5-trihydroxybenzoic acid butyl ester, Benzoic acid,4,5-trihydroxy-, butyl ester, G0186, NS00023498, D90725, A801860, Q27264133, NF0 C11H14O5 XOPOEBVTQYAOSV-UHFFFAOYSA-N butyl 3,4,5-trihydroxybenzoate n.a. n.a. No No No No No No PMDBD2000586 C12HSL n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000587 C16-33 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000588 C16G2 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000589 C4-HSL n.a. n.a. n.a. n.a. n.a. n.a. n.a. 10130163 n.a. n.a. "67605-85-0, (S)-N-(2-Oxotetrahydrofuran-3-yl)butyramide, N-Butyryl-L-homoserine lactone, N-butanoyl-L-homoserine lactone, N-[(3s)-2-Oxotetrahydrofuran-3-Yl]butanamide, N-[(3S)-2-oxooxolan-3-yl]butanamide, C4-HSL, CHEMBL207316, C4-HSL;N-Butyryl-L-homoserine lactone, HL4, Butanamide, N-[(3S)-tetrahydro-2-oxo-3-furanyl]-, SureCN131906, Butyryl-L-homoserine lactone, N-(butyryl)homoserine lactone, SCHEMBL131906, DTXSID30435962, PAI-1-2, CHEBI:177513, N-(butyryl)-L-homoserine lactone, autoinducer 1-2 (P. aeruginosa), HMS3650K19, MFCD12912262, AKOS015899835, (+)-a(S)-butyr-amido-r-butyrolactone, HY-114816, N-Butanoyl-L-homoserine lactone (C4-HSL), CS-0064384, D82565, SR-01000946805, SR-01000946805-1, Q27461123, N-[(3S)-TETRAHYDRO-2-OXO-3-FURANYL]BUTANAMIDE, Z203805754" C8H13NO3 VFFNZZXXTGXBOG-LURJTMIESA-N N-[(3S)-2-oxooxolan-3-yl]butanamide n.a. n.a. No No No No No No PMDBD2000590 C6-HSL n.a. n.a. n.a. n.a. n.a. n.a. n.a. 10058590 n.a. n.a. N-hexanoyl-L-Homoserine lactone, 147852-83-3, N-[(3s)-2-Oxotetrahydrofuran-3-Yl]hexanamide, C6-HSL, N-[(3S)-2-oxooxolan-3-yl]hexanamide, (S)-N-(2-Oxotetrahydrofuran-3-yl)hexanamide, N-[(3S)-Tetrahydro-2-oxo-3-furanyl]-hexanamide, Hexanoyl-L-homoserine lactone, HL6, SCHEMBL1116025, CHEBI:181934, ZJFKKPDLNLCPNP-QMMMGPOBSA-N, DTXSID101346642, HMS3650K17, MFCD12912260, AKOS030603082, AS-60644, HY-133685, CS-0129209, C21197, D86946, N-[(3S)-Tetrahydro-2-oxo-3-furanyl]hexanamide, N-Hexanoyl-L-homoserine lactone, >=96% (HPLC), SR-01000946804, J-008418, SR-01000946804-1, Q27461124 C10H17NO3 ZJFKKPDLNLCPNP-QMMMGPOBSA-N N-[(3S)-2-oxooxolan-3-yl]hexanamide n.a. n.a. No No No No No No PMDBD2000591 C8-HSL n.a. n.a. n.a. n.a. n.a. n.a. n.a. 6914579 n.a. n.a. N-OCTANOYL-L-HOMOSERINE LACTONE, 147852-84-4, N-[(3S)-2-oxooxolan-3-yl]octanamide, N-(2-OXOTETRAHYDROFURAN-3-YL)OCTANAMIDE, C8-HSL, Octanoyl-L-homoserine lactone, Octanamide, N-[(3S)-tetrahydro-2-oxo-3-furanyl]-, CHEMBL259352, (S)-N-(2-Oxotetrahydrofuran-3-yl)octanamide, N-[(3S)-Tetrahydro-2-oxo-3-furanyl]octanamide, HTF, AI-1-2 (Vibrio fischeri), N-(octanoyl)homoserine lactone, SCHEMBL1652991, GTPL12447, VAI-1-2, CHEBI:195581, JKEJEOJPJVRHMQ-JTQLQIEISA-N, DTXSID301305072, N-(octanoyl)-L-homoserine lactone, BDBM50351508, MFCD11113139, AKOS037646298, DB07928, HY-124237A, Octanoyl-L-homoserine lactone,HPLC>99%, AS-67960, CS-0129193, NS00072589, C21199, F87698, N-[(3S)-2-oxotetrahydrofuran-3-yl]octanamide, N-Octanoyl-L-homoserine lactone, >=96% (HPLC), J-008419, Q27097162 C12H21NO3 JKEJEOJPJVRHMQ-JTQLQIEISA-N N-[(3S)-2-oxooxolan-3-yl]octanamide n.a. n.a. No No No No No No PMDBD2000592 Cadmium Ion n.a. n.a. n.a. n.a. n.a. n.a. n.a. 31193 n.a. NPC328826 Cadmium ion, Cadmium(2+), Cadmium cation, Cadmium ions, Cadmium(2+)ions, Cadmium, ion (Cd2+), Cadmium(2+) ion, 9032-08-0, Cadmium, ion(Cd2+), UNII-T494FZ4G8G, T494FZ4G8G, Cd(2+), 22537-48-0, DTXSID60177060, cadmium cations, Cadmium elemental, cadmium(II), CdII, cadmium(II) cation, Cadmium (II) ion, Cd++, Cd2+, DTXCID7099551, CHEBI:48775, CHEBI:63063, WLZRMCYVCSSEQC-UHFFFAOYSA-N, NCGC00090932-02, NCGC00090932-03, NCGC00090932-04, Amyloglucosidase from |Aspergillus| |niger|, Q26841251 Cd+2 WLZRMCYVCSSEQC-UHFFFAOYSA-N cadmium(2+) n.a. n.a. No No No No No No PMDBD2000593 Calanolide A Therapeutic Substance Phase 1 142632-32-4 DB04886 n.a. n.a. D0S6KA 64972 58497 NPC205797 "Calanolide A, (+)-Calanolide A, 142632-32-4, CALANOLIDEA, S5A9TQN46W, CHEMBL267447, CHEBI:65552, NSC650886, NSC675451, NSC-675451, (10R,11S,12S)-12-hydroxy-6,6,10,11-tetramethyl-4-propyl-11,12-dihydro-2H,6H,10H-dipyrano[2,3-f:2'',3''-h]chromen-2-one, (+)-(10R,11S,12S)-10,11-trans-dihydro-12-hydroxy-6,6,10,11-tetramethyl-4-propyl-2H,6H-benzo[1,2-b:3,4-b'':5,6-b'''']tripyran-2-one, (10R,11S,12S)-11,12-dihydro-12-hydroxy-6,6,10,11-tetramethyl-4-propyl-2H,6H,10H-benzo(1,2-b:3,4-b'':5,6-b'''')tripyran-2-one, 2H,6H,10H-Benzo(1,2-b:3,4-b'':5,6-b'''')tripyran-2-one, 11,12-dihydro-12-hydroxy-6,6,10,11-tetramethyl-4-propyl-, (10R,11S,12S)-, UNII-S5A9TQN46W, NSC 650886, NSC 675451, NSC-650886, NSC-664737, (+)-(10R,11S,12S)-10,11-TRANS-DIHYDRO-12-HYDROXY-6,6,10,11-TETRAMETHYL-4-PROPYL-2H,6H-BENZO(1,2-B:3,4-B'':5,6-B'''')TRIPYRAN-2-ONE, 2H,6H,10H-Benzo[1,2-b:3,4-b'':5,6-b'''']tripyran-2-one, 11,12-dihydro-12-hydroxy-6,6,10,11-tetramethyl-4-propyl-, (10R,11S,12S)-, (+)-calnolide A, (+/-) Calanolide A, cid_1201, 2H,6H,10H-Benzo(1,2-b:3,4-b'':5,6-b'''')tripyran-2-one, 11,12-dihydro-12-hydroxy-6,6,10,11-tetramethyl-4-propyl-, (10R-(10alpha,11beta,12alpha))-, SCHEMBL140017, (+)-Calanolide A (synthetic), NIDRYBLTWYFCFV-FMTVUPSXSA-N, DTXSID601316787, BDBM50002662, AKOS015962188, DB04886, AC-16067, NS00068706, C09147, Q5018528, (10R,11S,12S)-12-Hydroxy-6,6,10,11-tetramethyl-4-propyl-11,12-dihydro-6H,10H-dipyrano[2,3-f;2'''',3''''-h]chromen-2-one, (10R,11S,12S)-12-hydroxy-6,6,10,11-tetramethyl-4-propyl-6,10,11,12-tetrahydro-2H-dipyrano[2,3-f:2'',3''-h]chromen-2-one, (16R,17S,18S)-18-hydroxy-10,10,16,17-tetramethyl-6-propyl-3,9,15-trioxatetracyclo[12.4.0.02,7.08,13]octadeca-1(14),2(7),5,8(13),11-pentaen-4-one, 12-Hydroxy-6,6,10,11-tetramethyl-4-propyl-11,12-dihydro-6H,10H-dipyrano[2,3-f;2'''',3''''-h]chromen-2-one(Calanolide A), InChI=1/C22H26O5/c1-6-7-13-10-15(23)26-21-16(13)20-14(8-9-22(4,5)27-20)19-17(21)18(24)11(2)12(3)25-19/h8-12,18,24H,6-7H2,1-5H3/t11-,12-,18+/m1/s" C22H26O5 NIDRYBLTWYFCFV-FMTVUPSXSA-N (16R,17S,18S)-18-hydroxy-10,10,16,17-tetramethyl-6-propyl-3,9,15-trioxatetracyclo[12.4.0.02,7.08,13]octadeca-1(14),2(7),5,8(13),11-pentaen-4-one Sarawak MediChem Pharmaceuticals n.a. No No No No No No PMDBD2000594 Calcium chloride Therapeutic Substance n.a. 10043-52-4 DB01164 PA448729 n.a. n.a. 5284359 23237 n.a. 10043-52-4, Calcium chloride anhydrous, Calcium dichloride, Dowflake, Liquidow, Peladow, CaCl2, Bovikalc, Calcium Chloride, Anhydrous, Intergravin-orales, Calcium chloride (CaCl2), Cacl2 (anhydrous), Calcium(2+) chloride, CHEBI:3312, Calcarea muriatica, INS NO.509, Calcium-45 chloride, DTXSID5020235, INS-509, NSC-759598, DTXCID30235, OFM21057LP, E-509, Calciumchloride, Calcium(II) chloride, Calcio cloruro, Calcium Choride, Conclyte-Ca, CaCl, 856 - Pickles, E509, [CaCl2], Calcium chloride, Prilled, Calcium chloride ultra dry, CALCIUM CHLORIDE [MI], CALCIUM CHLORIDE 10%, CALCIUM CHLORIDE HYDRATES, CHEMBL1200668, CALCIUM CHLORIDE [WHO-DD], Tox21_202585, AKOS024437435, DB01164, USEPA/OPP Pesticide Code: 075605, CALCIUM CHLORIDE ANHYDROUS [HSDB], NCGC00260134-01, CAS-10043-52-4, NS00093589, C08130, Q208451, Calcium chloride, anhydrous, dessicant, ACS grade, granular, anhydrous, granular, inverted exclamation markU7.0?mm, inverted exclamation markY93.0% CaCl2 UXVMQQNJUSDDNG-UHFFFAOYSA-L "calcium;dichloride" n.a. n.a. No No No No No No PMDBD2000595 CAMA n.a. n.a. n.a. n.a. n.a. n.a. n.a. 73555192 n.a. n.a. "Calar, Calcium bis(hydrogen methylarsonate), Calcium acid methanearsonate, CAMA, 5902-95-4, Calcium methanearsonate, Super dal-E-rad-calar, Calcium hydrogen methanearsonate, Super crab-E-rad-calar, Calcium bis(methylarsonate), Calcium acid methyl arsonate, USAF AN-11, Methanearsonic acid, calcium salt (2:1), Arsonic acid, methyl-, calcium salt (2:1), O5A2M92125, Super dal-E-rad, Caswell No. 136D, Calcium hydrogen methylarsonate, UNII-O5A2M92125, EINECS 227-598-8, MSMA, CALCIUM SALT, calcium;hydroxy(methyl)arsinate, SCHEMBL3251829, DTXSID8034748, J8.663K, EPA PESTICIDE CHEMICAL CODE 013806, Q27285362" C2H8As2CaO6 PKOMXLRKGNITKG-UHFFFAOYSA-L "calcium;hydroxy(methyl)arsinate" n.a. n.a. No No No No No No PMDBD2000596 Camphene Therapeutic Substance n.a. 79-92-5 DB15917 n.a. n.a. n.a. 6616 6364 NPC166362 CAMPHENE, 79-92-5, Comphene, 2,2-Dimethyl-3-methylenenorbornane, (+/-)-Camphene, DL-Camphene, 3,3-Dimethyl-2-methylenenorbornane, 3,3-Dimethyl-2-methylenenorcamphane, 2,2-dimethyl-3-methylidenebicyclo[2.2.1]heptane, FEMA No. 2229, 2,2-Dimethyl-3-methylenebicyclo[2.2.1]heptane, 565-00-4, Bicyclo[2.2.1]heptane, 2,2-dimethyl-3-methylene-, CCRIS 3783, HSDB 900, NSC 4165, 3,3-Dimethyl-2-methylenenorcamphene, EINECS 201-234-8, EINECS 209-275-3, UNII-G3VG94Z26E, CHEBI:3830, G3VG94Z26E, DTXSID8026488, AI3-01775, CAMPHENE, DL-, NSC-4165, 2,2-Dimethyl-3-methylenebicyclo(2.2.1)heptane, Camphene (2,2-dimethyl-3-methylene-norbornane), Bicyclo(2.2.1)heptane, 2,2-dimethyl-3-methylene-, DTXCID006488, CAMPHENE, (+/-)-, Camphene, (1R,4S)-(+)-, EC 201-234-8, (1)-2,2-Dimethyl-3-methylenebicyclo(2.2.1)heptane, CAMPHENE (MART.), CAMPHENE [MART.], Bicyclo[2.2.1]heptane, 2,2-dimethyl-3-methylene-, (1R)-, CAS-79-92-5, 2,2-dimethyl-3-methylidenebicyclo(2.2.1)heptane, MFCD00066603, 2,2-dimethyl-3-methylene-norbornane, CAMPHENE [FHFI], CAMPHENE [HSDB], CAMPHENE [INCI], CAMPHENE [FCC], CAMPHENE [MI], 2,2-Dimethyl-3-methylenebicyclo[2.2.1]heptane #, CAMPHENE, D,L-, 3,3-Dimethylenenorcamphene, CAMPHENE [WHO-DD], Bicyclo-(2.2.1)heptane, 2,2-Dimethyl-3-methylene-, 3,3-dimethyl-2-methylidenebicyclo[2.2.1]heptane, CHEMBL2268550, 2,2-Dimethyl-3-methylenebicyclo, NSC4165, 2,2-Dimethyl-3-methylene-norborane, Tox21_202014, Tox21_303152, AKOS004119935, CCG-266137, NCGC00249149-01, NCGC00257126-01, NCGC00259563-01, WLN: L55 A CYTJ CU1 D1 D1, VS-12317, 2,2-DIMETHYL-3-METHYLENE NORBORANE, NS00006622, 3,3-DIMETHYL-2-METHYLENE NORCAMPHANE, EN300-20391, C06076, E87135, Bicyclo[2.2.1]heptane,2-dimethyl-3-methylene-, Q416775, SR-01000944833, Bicyclo(2.2.1)heptane, 2,2-dimethyl-3-methylene, SR-01000944833-1, CAMPHENE(2,2-DIMETHYL-3-METHYLENE-NORBORNANE), Z104478010 C10H16 CRPUJAZIXJMDBK-UHFFFAOYSA-N 2,2-dimethyl-3-methylidenebicyclo[2.2.1]heptane n.a. n.a. No No No No No No PMDBD2000597 Capreomycin Therapeutic Substance Approved Drug 11003-38-6 DB00314 PA164746226 D00135 D0E7MV 3000502 2272094 n.a. capreomycin, SCHEMBL3666, BETA-SITOSTEROLACETATE, Q415909 C50H88N28O15 VCOPTHOUUNAYKQ-WBTCAYNUSA-N "(3S)-3,6-diamino-N-[[(2S,5S,8E,11S,15S)-15-amino-11-[(6R)-2-amino-1,4,5,6-tetrahydropyrimidin-6-yl]-8-[(carbamoylamino)methylidene]-2-(hydroxymethyl)-3,6,9,12,16-pentaoxo-1,4,7,10,13-pentazacyclohexadec-5-yl]methyl]hexanamide;(3S)-3,6-diamino-N-[[(2S,5S,8E,11S,15S)-15-amino-11-[(6R)-2-amino-1,4,5,6-tetrahydropyrimidin-6-yl]-8-[(carbamoylamino)methylidene]-2-methyl-3,6,9,12,16-pentaoxo-1,4,7,10,13-pentazacyclohexadec-5-yl]methyl]hexanamide" n.a. Antibiotics No No No No No No PMDBD2000598 Carabrol n.a. n.a. n.a. n.a. n.a. n.a. n.a. 15690483 n.a. NPC477920 Carabrol, (3aR,4aS,5S,5aR,6aR)-5-(3-hydroxybutyl)-5a-methyl-3-methylidene-3a,4,4a,5,6,6a-hexahydrocyclopropa[f][1]benzofuran-2-one, 68776-20-5, CHEMBL3315227, AKOS040734516, NCGC00385020-01 C15H22O3 MTIXBBDFRVGBOQ-WQFFSLPPSA-N (3aR,4aS,5S,5aR,6aR)-5-(3-hydroxybutyl)-5a-methyl-3-methylidene-3a,4,4a,5,6,6a-hexahydrocyclopropa[f][1]benzofuran-2-one n.a. n.a. No No No No No No PMDBD2000599 Carabrone n.a. n.a. n.a. n.a. n.a. n.a. n.a. 164879 n.a. NPC194637 Carabrone, 1748-81-8, Carabron, (3aR,4aS,5S,5aR,6aR)-5a-methyl-3-methylidene-5-(3-oxobutyl)-3a,4,4a,5,6,6a-hexahydrocyclopropa[f][1]benzofuran-2-one, CCRIS 1880, grandicin, 2H-Cyclopropa(f)benzofuran-2-one, octahydro-5a-methyl-3-methylene-5-(3-oxobutyl)-, MEGxp0_001642, CHEMBL3315226, ACon0_000363, DTXSID90938585, HY-N5020, AKOS015998610, NCGC00385841-01, AC-34820, MS-23515, CS-0032087, A881657, 5a-Methyl-3-methylidene-5-(3-oxobutyl)octahydro-2H-cyclopropa[f][1]benzofuran-2-one, (1R,3S,4S,5R,7R)-5-methyl-10-methylidene-4-(3-oxobutyl)-8-oxatricyclo[5.3.0.0?,?]decan-9-one, (3aR,4aS,5S,5aR,6aR)-5a-Methyl-3-methylene-5-(3-oxobutyl)octahydro-2H-cyclopropa[f]benzofuran-2-one, 2H-Cyclopropa[f]benzofuran-2-one, octahydro-5a-methyl-3-methylene-5-(3-oxobutyl)-, (3aR,4aS,5S,5aR,6aR)-, NCGC00385841-01_C15H20O3_2H-Cyclopropa[f]benzofuran-2-one, octahydro-5a-methyl-3-methylene-5-(3-oxobutyl)-, (3aR,4aS,5S,5aR,6aR)- C15H20O3 AGIQIKMGJVLKMA-NLRWUALESA-N (3aR,4aS,5S,5aR,6aR)-5a-methyl-3-methylidene-5-(3-oxobutyl)-3a,4,4a,5,6,6a-hexahydrocyclopropa[f][1]benzofuran-2-one n.a. n.a. No No No No No No PMDBD2000600 Carbonyl cyanide m-chlorophenylhydrazone n.a. n.a. n.a. n.a. n.a. n.a. n.a. 2603 n.a. n.a. "cccp, 555-60-2, Carbonyl cyanide 3-chlorophenylhydrazone, (3-Chlorophenyl)hydrazonomalononitrile, Carbonyl cyanide m-chlorophenylhydrazone, Carbonylcyanide-3-chlorophenylhydrazone, Carbonyl cyanide m-chlorophenyl hydrazone, m-Chlorophenyl carbonylcyanide hydrazone, [(3-chlorophenyl)hydrazono]malononitrile, (3-Chlorophenyl)carbonohydrazonoyl dicyanide, Propanedinitrile, [(3-chlorophenyl)hydrazono]-, Mesoxalonitrile, (m-chlorophenyl)hydrazone, NSC 88124, Propanedinitrile, ((3-chlorophenyl)hydrazono)-, CHEBI:3259, ((3-Chlorophenyl)hydrazono)propanedinitrile, Carbonyl cyanide, (3-chlorophenyl)hydrazone, C9H5ClN4, Carbonyl cyanide Chlorophenylhydrazone, Mesoxalonitrile 3-chlorophenylhydrazone, 2-[(3-Chlorophenyl)hydrazinylidene]propanedinitrile, ((3-Chlorophenyl)hydrazono)malononitrile, Carbonyl cyanide (m-chlorophenyl)hydrazone, 4D4NW27CG5, DTXSID7040990, MFCD00001848, NSC-88124, Carbonylcyanide m-chlorophenylhydrazone, m-Cl-CCP [555-60-2], [(3-chlorophenyl)hydrazono]propanedinitrile, Carbonyl cyanide 3-chlorophenylhydrazone;Carbonyl Cyanide m-Chlorophenylhydrazone, N''-(3-chlorophenyl)carbonohydrazonoyl dicyanide, Propanedinitrile, 2-(2-(3-chlorophenyl)hydrazinylidene)-, 2-((3-chlorophenyl)hydrazono)malononitrile, 2-[(3-Chlorophenyl)hydrazono]malononitrile, m-Cl-CCP, EINECS 209-103-7, Carbonylcyanide-m-chlorophenylhydrazone, Carbonyl cyanide-m-chlorophenylhydrazone, BRN 1842102, Propanedinitrile, 2-[2-(3-chlorophenyl)hydrazinylidene]-, Carbonyl cyanide, 3-chlorophenylhydrazone, CCCP?, 2-[(3-chlorophenyl)-hydrazono]malononitrile, CARBONYLCYANIDE3-CHLOROPHENYLHYDRAZONE, MolMap_000008, WLN: NCYCN&NUNR CG, WLN: NCYCN&UNMR CG, UNII-4D4NW27CG5, SCHEMBL379195, CHEMBL224214, DTXCID5020990, UGTJLJZQQFGTJD-UHFFFAOYSA-, HMS3266A14, HMS3867E03, BCP31475, EX-A3338, NSC88124, Tox21_302066, BDBM50198893, HB5062, s6494, AKOS003238387, CS-7660, NCGC00092273-01, NCGC00092273-02, NCGC00255699-01, AS-75696, CAS-555-60-2, (3-Chlorophenyl)carbonohydrazonoyldicyanide, HY-100941, C2876, NS00033339, 2-[(3-Chlorophenyl)hydrazono]malononitrile #, 2-[(3-chlorophenyl)hydrazono]propanedinitrile, 3-CHLOROPHENYLHYDRAZONOPROPANEDINITRILE, N-(3-chlorophenyl)carbonohydrazonoyl dicyanide, C75608, CARBONYL CYANIDE (3-CHLOROPHENYL)HYDRAZONE, [2-(3-chlorophenyl)hydrazinylidene]propanedinitrile, Q2720515, BRD-K15616905-001-01-5, Carbonyl Cyanide m-Chlorophenylhydrazone - CAS 555-60-2, Carbonyl cyanide 3-chlorophenylhydrazone, >=97% (TLC), powder, InChI=1/C9H5ClN4/c10-7-2-1-3-8(4-7)13-14-9(5-11)6-12/h1-4,13H, CCCP;Carbonyl cyanide m-chlorophenylhydrazone;Carbonyl cyanide 3-chlorophenylhydrazone; Mesoxalonitrile 3-chlorophenylhydrazone" C9H5ClN4 UGTJLJZQQFGTJD-UHFFFAOYSA-N 2-[(3-chlorophenyl)hydrazinylidene]propanedinitrile n.a. n.a. No No No No No No PMDBD2000601 Carboxymethyl chitosan n.a. n.a. n.a. n.a. n.a. n.a. n.a. 71306969 n.a. n.a. Carboxymethyl chitosan, 83512-85-0, N-[(2S,3R,4R,6R)-5-[(2S,3R,4R,5S,6R)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-[(2R,4R,5R,6R)-5-amino-4,6-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4-hydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide, MFCD00677440, N-Acetylchitosan, YC29683 C20H37N3O14 HGNQXZLWHDQLRE-XADFZESNSA-N N-[(2S,3R,4R,6R)-5-[(2S,3R,4R,5S,6R)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-[(2R,4R,5R,6R)-5-amino-4,6-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4-hydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide n.a. n.a. No No No No No No PMDBD2000602 Carminic acid n.a. n.a. n.a. n.a. n.a. n.a. n.a. 10255083 n.a. n.a. CARMINIC ACID, 1260-17-9, Natural red 4, Carmine, Coccinellin, Cochineal, Sun Red No. 1, Cochineal tincture, Sanred 1, CI Natural Red 4, Sun Red 1, San-Ei Gen San Red 1, C.I. Natural red 4, 3,5,6,8-Tetrahydroxy-1-methyl-9,10-dioxo-7-((2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)-9,10-dihydroanthracene-2-carboxylic acid, 2-Anthracenecarboxylic acid, 7-beta-D-glucopyranosyl-9,10-dihydro-3,5,6,8-tetrahydroxy-1-methyl-9,10-dioxo-, CI 75470, E 120, Carminic acid (E120), MFCD00167028, C.I. 75470, CID8Z8N95N, DTXSID9022817, Carmine Red, DSSTox_CID_2817, DSSTox_RID_81084, DSSTox_GSID_45735, 3,5,6,8-tetrahydroxy-1-methyl-9,10-dioxo-7-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]anthracene-2-carboxylic acid, DTXCID902817, E120, (1S)-1,5-anhydro-1-(7-carboxy-1,3,4,6-tetrahydroxy-8-methyl-9,10-dioxo-9,10-dihydroanthracen-2-yl)-D-glucitol, 3,5,6,8-tetrahydroxy-1-methyl-9,10-dioxo-7-[(2S,3S,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]anthracene-2-carboxylic acid, CAS-1260-17-9, CAS-1343-78-8, E 120 (dye), CCRIS 1397, HSDB 912, NSC 6196, EINECS 215-023-3, UNII-CID8Z8N95N, Carminic acid, primary pharmaceutical reference standard, NSC 326224, CHEBI:78310, UNII-TZ8Z31B35M, Cochenille dye, AI3-18242, Cochineal, dye, NSC-326224, NCGC00091708-04, 2-Anthracenecarboxylic acid, 7-.beta.-D-glucopyranosyl-9,10-dihydro-3,5,6,8-tetrahydroxy-1-methyl-9,10-dioxo-, ENJI, COCHINEAL CARMINE, Cochineal Carmine Powder, COCHINEAL RED PWD, Carminic Acid, >70%, Carminic Acid Natural dye, CI-NATURAL RED 4, CARMINIC ACID [MI], 2-Anthroic acid, 7-D-glucopyrosyl-9,10-dihydro-3,5,6,8-tetrahydroxy-1-methyl-9,10-dioxo-, 7-D-Glucopyranosyl-9,10-dihydro-3,5,6,8-tetrahydroxy-1-methyl-9,10-dioxo-2-anthroic acid, CARMINE 5297, NATURAL RED 2180, CARMINIC ACID [HSDB], 7beta-D-Glucopyranosyl-9,10-dihydro-3,5,6,8-tetrahydroxy-1-methyl-9,10-dioxo-2-anthracenecarboxylic acid, MLS002472940, Carmine component carminic acid, Carminic acid, puriss., 95%, CCRIS 4511, CHEMBL263094, SCHEMBL1808534, TZ8Z31B35M, INS-120, Carminic acid, analytical standard, CI 75470 [INCI], HMS2205G17, 3,5,6,8-tetrahydroxy-1-methyl-9,10-dioxo-7-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-9,10-dihydroanthracene-2-carboxylic acid, CARMINIC ACID (NATURAL DYE), HY-N8407, EINECS 215-680-6, Tox21_111163, Tox21_201979, Tox21_300294, AKOS015894273, Tox21_111163_1, NCGC00247988-01, NCGC00247988-02, NCGC00247988-03, NCGC00254004-01, NCGC00259528-01, AS-76171, SMR001397048, CS-0144108, E-120, CI-(1975)-NO.75470, 10.14272/DGQLVPJVXFOQEV-JNVSTXMASA-N.1, Q416860, doi:10.14272/DGQLVPJVXFOQEV-JNVSTXMASA-N.1, W-108224, Carminic acid (E120) 100 microg/mL in Acetonitrile:Methanol, 2-Anthracenecarboxylic acid, 7-ss-D-glucopyranosyl-9,10-dihydro-3,5,6,8-tetrahydroxy-1-methyl-9,10-dioxo-, 3,5,6,8-Tetrahydroxy-1-methyl-9,10-dioxo-7-((2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)-9,10-dihydroanthracene-2-carboxylicacid C22H20O13 DGQLVPJVXFOQEV-JNVSTXMASA-N 3,5,6,8-tetrahydroxy-1-methyl-9,10-dioxo-7-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]anthracene-2-carboxylic acid n.a. n.a. No No No No No No PMDBD2000603 Carnitine hydrochloride n.a. n.a. n.a. n.a. n.a. n.a. n.a. 9794197 n.a. n.a. "DL-Carnitine hydrochloride, Carnitine hydrochloride, 16224-32-1, d,l-Carnitine hydrochloride, 3-Hydroxy-4-(trimethylammonio)butanoate hydrochloride, DTXSID8045850, 3-hydroxy-4-(trimethylazaniumyl)butanoate hydrochloride, DTXCID6025850, CAS-461-05-2, 1-Propanaminium, 3-carboxy-2-hydroxy-N,N,N-trimethyl-, chloride, L-Carnitine chloride, F64264D63N, NCGC00094816-01, (R)-Carnitine (hydrochloride), (S)-Carnitine (hydrochloride), DL-Carnitine Benzyl Ester Chloride, 3-carboxy-2-hydroxy-N,N,N-trimethylpropan-1-aminium chloride, CARNITINE HYDROCHLORIDE, DL-, MFCD00066100, L-Carnitin 100 microg/mL in Acetonitrile, Tox21_111339, AC8488, AKOS015899583, CARNITINE CHLORIDE, (+/-)-, Tox21_111339_1, CCG-208519, CARNITINE HYDROCHLORIDE [WHO-DD], NCGC00263894-02, AS-11627, CARNITINE DL-FORM HYDROCHLORIDE [MI], C-1990, (-)-beta-Hydroxy-gamma-(trimethylammonio)butyrate, A826989, 3-hydroxy-4-(trimethylazaniumyl)butanoate;hydrochloride, .GAMMA.-TRIMETHYL-.BETA.-HYDROXYBUTYROBETAINE (+/- ) HYDROCHLORIDE, DL-(3-CARBOXY-2-HYDROXYPROPYL)TRIMETHYLAMMONIUM HYDROXIDE INNER SALT HYDROCHLORIDE" C7H16ClNO3 JXXCENBLGFBQJM-UHFFFAOYSA-N "3-hydroxy-4-(trimethylazaniumyl)butanoate;hydrochloride" n.a. n.a. No No No No No No PMDBD2000604 Carolacton n.a. n.a. n.a. n.a. n.a. n.a. n.a. 56935649 n.a. n.a. carolacton, CHEMBL4571710, CHEBI:188515, (E,3R,4R,6R)-8-[(2S,3S,7R,8E,10R,11R)-10,11-dihydroxy-3,7-dimethyl-12-oxo-1-oxacyclododec-8-en-2-yl]-3-methoxy-4,6-dimethyl-5-oxonon-7-enoic acid, C3R C25H40O8 WCKOGWVWLFJJJX-ZCXGUVEESA-N (E,3R,4R,6R)-8-[(2S,3S,7R,8E,10R,11R)-10,11-dihydroxy-3,7-dimethyl-12-oxo-1-oxacyclododec-8-en-2-yl]-3-methoxy-4,6-dimethyl-5-oxonon-7-enoic acid n.a. n.a. No No No No No No PMDBD2000605 Carvacrol Therapeutic Substance Investigational Drug 499-75-2 DB16404 n.a. n.a. D07JDC 10364 21105867 NPC312132 CARVACROL, 5-Isopropyl-2-methylphenol, 499-75-2, Isopropyl-o-cresol, Antioxine, 2-p-Cymenol, o-Thymol, Karvakrol, 5-Isopropyl-o-cresol, Isothymol, 2-Hydroxy-p-cymene, p-Cymen-2-ol, Phenol, 2-methyl-5-(1-methylethyl)-, 2-Methyl-5-isopropylphenol, 3-Isopropyl-6-methylphenol, p-Cymene, 2-hydroxy-, 5-Isopropyl-2-methyl-phenol, o-Cresol, 5-isopropyl-, 2-Methyl-5-(1-methylethyl)phenol, 2-Methyl-5-(Propan-2-Yl)Phenol, 2-methyl-5-propan-2-ylphenol, 6-Methyl-3-isopropylphenol, 1-Hydroxy-2-methyl-5-isopropylbenzene, FEMA No. 2245, Phenol, 5-isopropyl-2-methyl-, Cymene-2-ol, p-, Caswell No. 511, Phenol, 3-isopropyl-6-methyl-, 1-Methyl-2-hydroxy-4-isopropylbenzene, CYMOPHENOL, DENTOL, NSC 6188, CCRIS 7450, HSDB 906, Oxycymol, 2-Hydroxycymene, NSC-6188, EINECS 207-889-6, EPA Pesticide Chemical Code 022104, UNII-9B1J4V995Q, BRN 1860514, CHEBI:3440, AI3-03438, 9B1J4V995Q, CHEMBL281202, DTXSID6042074, 2-methyl-5-propan-2-yl-phenol, 4-06-00-03331 (Beilstein Handbook Reference), 2-Methyl-5-(1-methylethyl)-Phenol, MFCD00002236, Cymenol, Hydroxy-p-cymene, Carvacrol,(S), p-Cymene-2-ol, Carvacrol, 98%, CARVACROL [FCC], CARVACROL [MI], CARVACROL [FHFI], CARVACROL [HSDB], CARVACROL [INCI], CARVACROL [WHO-DD], SCHEMBL24734, 3-Isopropyl-6-methyl phenol, 3-Isopropyl-6-methyl-Phenol, BIDD:ER0492, Carvacrol, analytical standard, O-CRESOL, 5-ISOPROPYL, GTPL2497, Carvacrol, natural, 99%, FG, DTXCID4022074, Methyl-5-(1-methylethyl)phenol, p-Mentha-1,3,5-trien-2-ol, WLN: QR B1 EY1&1, FEMA 2245, NSC6188, Carvacrol, >=98%, FCC, FG, HY-N0711, Tox21_301378, BDBM50240433, s3788, AKOS000120828, AC-2688, CCG-266210, FS-4199, LMPR0102090017, MB00118, NCGC00256001-01, 1ST40100, CAS-499-75-2, Isothymol (=2-Isopropyl-4-methyl phenol), Carvacrol Cymenol 5-Isopropyl-2-methylphenol, CS-0009729, NS00004666, 2-HYDROXY-4-ISOPROPYL-1-METHYLBENZENE, EN300-21426, C09840, F17722, A827907, Q225543, Carvacrol, primary pharmaceutical reference standard, W-105999, BENZENE,2-HYDROXY,4-ISOPROPYL,1-METHYL CARVACROL, F8889-1978, Z104496566, BENZENE,2-HYDROXY,4-ISOPROPYL,1-METHYL CARVACROL, InChI=1/C10H14O/c1-7(2)9-5-4-8(3)10(11)6-9/h4-7,11H,1-3H, S5V C10H14O RECUKUPTGUEGMW-UHFFFAOYSA-N 2-methyl-5-propan-2-ylphenol n.a. n.a. No No No No No No PMDBD2000606 Caspofungin Therapeutic Substance n.a. 162808-62-0 DB00520 PA164743013 D07626 n.a. 16119814 17277006 n.a. Caspofungin, caspofungine, 162808-62-0, F0XDI6ZL63, Cancidas, UNII-F0XDI6ZL63, HSDB 7476, (4R,5S)-5-((2-aminoethyl)amino)-n2-(10,12-dimethyltetradecanoyl)-4-hydroxy-l-ornithyl-l-threonyl-trans-4-hydroxy-l-prolyl-(s)-4-hydroxy-4-(p-hydroxyphenyl)-l-threonyl-threo-3-hydroxy-l-ornithyl-trans-3-hydroxy-l-proline cyclic (1->6) disulfide, pneumocandin b0, 1-((4R,5S)-5-((2-aminoethyl)amino)-n2-((10R,12S)-10,12-dimethyl-1-oxotetradecyl)-4-hydroxy-l-ornithine)-5-((3R)-3-hydroxy-l-ornithine)-, Caspofungin [INN], L 743,872, (4R,5S)-5-((2-Aminoethyl)amino)-N(sup 2)-(10,12-dimethyltetradecanoyl)-4-hydroxy-L-ornithyl-L-threonyl-trans-4-hydroxy-L-prolyl-(S)-4-hydroxy-4-(p-hydroxyphenyl)-L-threonyl-threo-3-hydroxy-L-ornithyl-trans-3-hydroxy-L-proline cyclic (6-1)-peptide, L-743872, L-743,872, caspofunginum, DTXSID30873204, Caspofungina, CHEBI:474180, Caspofungin [INN:BAN], CASPOFUNGIN [MI], CASPOFUNGIN [HSDB], (10R,12S)-caspofungin, CASPOFUNGIN [VANDF], CASPOFUNGIN [WHO-DD], CASPOFUNGIN [EMA EPAR], SCHEMBL7903583, DTXCID60820701, J02AX04, (10R,12S)-N-((2R,6S,9S,11R,12S,14aS,15S,20S,23S,25aS)-12-((2-aminoethyl)amino)-20-((1R)-3-amino-1-hydroxypropyl)-23-((1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl)-2,11,15-trihydroxy-6-((1R)-1-hydroxyethyl)-5,8,14,19,22,25-hexaoxotetracosahydro-1H-dipyrrolo(2,1-c:2'',1''-l)(1,4,7,10,13,16)hexaazacyclohenicosin-9-yl)-10,12-dimethyltetradecanamide, (4R,5S)-5-((2-aminoethyl)amino)-N(2)-(10,12-dimethyltetradecanoyl)-4-hydroxy-L-ornithyl-L-threonyl-trans-4-hydroxy-L-prolyl-(S)-4-hydroxy-4-(p-hydroxyphenyl)-L-threonyl-threo-3-hydroxy-L-ornithyl-trans-3-hydroxy-L-proline cyclic (6-1)-peptide, 1-((4R,5S)-5-((2-aminoethyl)amino)-N(2)-(10,12-dimethyl-1-oxotetradecyl)-4-hydroxy-L-ornithine)-5-((3R)-3-hydroxy-L-ornithine)-pneumocandin B0, HY-17006A, Tetradecanamide, N-((2R,6S,9S,11R,12S,14aS,15S,20S,23S,25aS)-12-((2-aminoethyl)amino)-20-((1R)-3-amino-1-hydroxypropyl)-23-((1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl)tetracosahydro-2,11,15-trihyd roxy-6-((1R)-1-hydroxyethyl)-5,8,14,19,22,25-hexaoxo-1H-dipyrrolo(2,1-c:2'',1''-l)(1,4,7,10,13,16)hexaazacycloheneicosin-9-yl)-10,12-dimethyl-, CS-0009545, EN300-22853765, Q63413125, (10R,12S)-N-[(3S,6S,9S,11R,15S,18S,20R,21S,24S,25S)-3-[(1R)-3-amino-1-hydroxypropyl]-21-[(2-aminoethyl)amino]-6-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-11,20,25-trihydroxy-15-[(1R)-1-hydroxyethyl]-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexaazatricyclo[22.3.0.0,9,13]heptacosan-18-yl]-10,12-dimethyltetradecanamide C52H88N10O15 JYIKNQVWKBUSNH-WVDDFWQHSA-N (10R,12S)-N-[(3S,6S,9S,11R,15S,18S,20R,21S,24S,25S)-21-(2-aminoethylamino)-3-[(1R)-3-amino-1-hydroxypropyl]-6-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-11,20,25-trihydroxy-15-[(1R)-1-hydroxyethyl]-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosan-18-yl]-10,12-dimethyltetradecanamide n.a. n.a. No No No No No No PMDBD2000607 cat-AGE-RK1 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000608 cat-AGE-RK2 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000609 Catechin Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D0V7AA 9064 n.a. NPC219876 "(+)-catechin, Cianidanol, CATECHIN, 154-23-4, Catechuic acid, Catechinic acid, Cyanidanol, D-Catechin, Catergen, Cianidol, (+)-Catechol, (+)-Cyanidanol, Biocatechin, (+)-Cyanidan-3-ol, D-Catechol, D-(+)-Catechin, Dexcyanidanol, Catechin (flavan), Catechol (flavan), (+)-Catechin Hydrate, (2R,3S)-Catechin, (2R,3S)-2-(3,4-Dihydroxyphenyl)chroman-3,5,7-triol, 3-Cyanidanol, (+)-, DL-Catechin, Cianidanolum, Transepar, (2R,3S)-(+)-Catechin, dl-Catechol, (2R,3S)-2-(3,4-dihydroxyphenyl)chromane-3,5,7-triol, CCRIS 6855, Catechin, d-, (+)-Cianidanol, 3,3'',4'',5,7-Flavanpentol, 7295-85-4, KB-53, (+)-3'',4'',5,7-Tetrahydroxy-2,3-trans-flavan-3-ol, NSC 2819, NSC-2819, 2,3-trans-catechin, (+)-Cyanidanol-3, 2,3-Dihydro-4-desoxoquercetin, CHEBI:15600, (2R,3S)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol, 2H-1-Benzopyran-3,5,7-triol, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-, (2R-trans)-, Cianidanolum [INN-Latin], AI3-22757, EINECS 205-825-1, (+)-(2R,3S)-5,7,3'',4''-Tetrahydroxyflavan-3-ol, UNII-8R1V1STN48, Catechol (+), (+/-)-Catechin, 8R1V1STN48, NSC2819, (2R,3S)-3,3'',4'',5,7-Flavanpentol, CATECHIN, D, 2H-1-benzopyran-3,5,7-triol, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-, (2R,3S)-, Catechu, (2R,3S)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3,5,7-triol, (2R-trans)-2-(3,4-Dihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3,5,7-triol, CHEMBL311498, DTXSID3022322, (+)-2-(3,4-Dihydroxyphenyl)-3,5,7-chromantriol, MFCD00075649, 5J4Y243W61, 100786-01-4, Gambier, Katha, trans-(+)-3,3'',4'',5,7-Flavanpentol, Zyma, Cianidanolum (INN-Latin), Cyanidanol-3, CIANIDANOL (MART.), CIANIDANOL [MART.], (+)-Cyanidol-3, Cutch (dye), (+)-(2R:3S)-5,7,3'',4''-Tetrahydroxyflavan-3-ol, (+)-CATECHIN (USP-RS), (+)-CATECHIN [USP-RS], Catechin-(+,-) hydrate, Epicatechin-(-), Catechin (hydrate), Cianidanol [INN:JAN], MLS001056745, (2R,3S)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-1H-chromene-3,5,7-triol, Catechine dl-form, (+-)-catechin, (+/-)-catechol, KB 53, SR-01000075742, 88191-48-4, SMR000326724, Catechinate, Catechuate, Drenoliver, rac-catechin, Tanningenic acid, DL-Catechine, UNII-5J4Y243W61, (+)-Catechin;Cianidanol;Catechuic acid, Z 7300, Teafuran 30A, KXN, Prestwick_998, Sunkatol No. 1, EINECS 230-731-2, Slim 2, 2-(3,4-Dihydroxyphenyl)chromane-3,5,7-triol, RACEMIC CATECHIN, Spectrum_000395, (+)-Catechin,(S), 2-(3,4-Dihydroxyphenyl)-3,5,7-chromanetriol #, CATECHIN [MI], CATECHIN, DL-, CATECHIN [VANDF], CIANIDANOL [INN], CIANIDANOL [JAN], Prestwick0_000642, Prestwick0_000817, Prestwick1_000642, Prestwick1_000817, Prestwick2_000642, Prestwick2_000817, Prestwick3_000642, Spectrum2_000167, Spectrum3_000242, Spectrum4_001763, Spectrum5_000345, Epitope ID:116872, (+/-)-Catechin xHydrate, CIANIDANOL [WHO-DD], Lopac0_000219, SCHEMBL19741, BSPBio_000643, BSPBio_001624, KBioGR_002245, KBioSS_000875, 8001-48-7, 154-23-4 , anhydride, BIDD:ER0378, DivK1c_000647, SPBio_000033, SPBio_002564, SPBio_002634, CATECHIN DL-FORM [MI], BPBio1_000709, cid_107957, DTXCID202322, (3S,2R)-2-(3,4-dihydroxyphenyl)chromane-3,5,7-triol, CATECHOL, (+/-)-, ACon1_001489, BDBM23416, BDBM60836, CIANIDANOL, (+/-)-, HMS502A09, KBio1_000647, KBio2_000875, KBio2_003443, KBio2_006011, KBio3_001124, YK-85 Light Yellow Powder 85, 4c94, NINDS_000647, DTXSID001349029, HMS1570A05, HMS1570D15, HMS2097A05, HMS3260L19, Pharmakon1600-00210205, (+)-Catechin, analytical standard, HY-N0898, TNP00270, Tox21_500219, CCG-40007, LMPK12020001, NSC755824, s3974, s4722, trans3,3,4,5,7 pentahydroxyflavane, AKOS015960546, trans-2-(3,4-Dihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3,5,7-triol, CS-3759, DB14086, LP00219, ND-0342, NSC-755824, SDCCGMLS-0066526.P001, SDCCGSBI-0050207.P004, IDI1_000647, NCGC00017331-01, NCGC00017331-02, NCGC00017331-03, NCGC00017331-04, NCGC00017331-05, NCGC00017331-19, NCGC00093689-01, NCGC00093689-02, NCGC00093689-03, NCGC00260904-01, AC-11608, AC-35859, AS-72772, NCI60_002303, (+)-Catechin 1000 microg/mL in Acetone, SBI-0050207.P003, 1ST000259, EU-0100219, NS00004541, ( inverted exclamation markA)-Catechin hydrate, (+)-Catechin 1000 microg/mL in Acetonitrile, C 1251, C06562, D95105, H10916, AB00051886_13, EN300-6498629, (+/-)-Catechin 1000 microg/mL in Acetonitrile, A809512, A878497, NATURAL BROWN 3 (CUTCH EXTRA OR GAMBIER), Q415007, (+)-CATECHIN (CONSTITUENT OF MARITIME PINE), Q-100183, SR-01000075742-1, SR-01000075742-7, SR-01000075742-8, SR-01000075742-9, BRD-K58736316-001-07-9, BRD-K58736316-001-08-7, SR-01000075742-10, SR-01000075742-12, SR-01000075742-14, (+)-CATECHIN (CONSTITUENT OF MARITIME PINE) [DSC], D4A04A57-7609-451F-A446-53F4DFAD15F5, (2R,3S)-2-(3,4-dihydroxyphenyl)chroman-3,5,7-triol;hydrate, (+)-Catechin, United States Pharmacopeia (USP) Reference Standard, (+)-CATECHIN (CONSTITUENT OF GRAPE SEEDS OLIGOMERIC PROANTHOCYANIDINS), (+)-CATECHIN (CONSTITUENT OF POWDERED DECAFFEINATED GREEN TEA EXTRACT), (+)-Catechin, Pharmaceutical Secondary Standard; Certified Reference Material, (2R,3S)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3,5,7-triol;hydrate, (2R,3S)-2-[3,4-bis(oxidanyl)phenyl]-3,4-dihydro-2H-chromene-3,5,7-triol;hydrate, (2R-trans)-2-(3,4-Dihydroxyphenyl)-3-4-dihydro-2H-1-benzopyran-3,5,7-triol, 2-(3,4-Dihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3,5,7-triol, (2R-trans), 2H-1-Benzopyran-3,7-triol, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-, (2R-trans)-, 2H-1-BENZOPYRAN-3,5,7-TRIOL, 2-(3,4-DIHYDROXYPHENYL)-3,4-DIHYDRO-, (2S,3R)-REL-, 321-01-7, InChI=1/C15H14O6/c16-8-4-11(18)9-6-13(20)15(21-14(9)5-8)7-1-2-10(17)12(19)3-7/h1-5,13,15-20H,6H2/t13-,15+/m0/s" C15H14O6 PFTAWBLQPZVEMU-DZGCQCFKSA-N (2R,3S)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol n.a. n.a. No No No No No No PMDBD2000610 Catechin gallate Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D0RB1V 6419835 n.a. NPC289322 "(-)-Catechin gallate, 130405-40-2, (2S,3R)-2-(3,4-Dihydroxyphenyl)-5,7-dihydroxychroman-3-yl 3,4,5-trihydroxybenzoate, catechin gallate, Catechin gallate, (-)-, UNII-0KT1FO6VO6, (-)-catechin 3-o-gallate, 0KT1FO6VO6, CCRIS 9303, (-)-Catechin 3-gallate, ent-Catechin 3-O-gallate, CHEMBL129451, CHEBI:76131, MFCD00214258, (2S,3R)-2-(3,4-Dihydroxyphenyl)-3,4-dihydro-1(2H)-benzopyran-3,5,7-triol 3-(3,4,5-trihydroxybenzoate), [(2S,3R)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3,4-dihydro-2H-chromen-3-yl] 3,4,5-trihydroxybenzoate, Benzoic acid, 3,4,5-trihydroxy-, (2S,3R)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-5,7-dihydroxy-2H-1-benzopyran-3-yl ester, (2S,3R)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3,4-dihydro-2H-chromen-3-yl 3,4,5-trihydroxybenzoate, Benzoic acid, 3,4,5-trihydroxy-, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-5,7-dihydroxy-2H-1-benzopyran-3-yl ester, (2S-trans)-, (-)-CG, C22H18O10, (?)-Catechin gallate, (-)-catechin-3-o-gallate, (-)-Catechin gallate(CG), SCHEMBL4639342, DTXSID70156528, LSHVYAFMTMFKBA-CTNGQTDRSA-N, HY-N0356, BDBM50135169, LMPK12020091, AKOS016002019, CS-3758, AC-34201, AS-76781, 1ST157574, S00277, Q-100119, (-)-Catechin gallate; 3-(3,4,5-trihydroxybenzoate), Q27145773, (-)-Catechin gallate, >=98% (HPLC), from green tea, [(2S,3R)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-chroman-3-yl] 3,4,5-trihydroxybenzoate, 3,4,5-Trihydroxy-benzoic acid (2S,3R)-2-(3,4-dihydroxy-phenyl)-5,7-dihydroxy-chroman-3-yl ester" C22H18O10 LSHVYAFMTMFKBA-CTNGQTDRSA-N [(2S,3R)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3,4-dihydro-2H-chromen-3-yl] 3,4,5-trihydroxybenzoate n.a. n.a. No No No No No No PMDBD2000611 Cathelicidin Therapeutic Substance Phase 2 n.a. n.a. n.a. n.a. DS5LI8 16198951 n.a. NPC489217 Cathelicidin, 154947-66-7, ropocamptide, LL 37, LL-37, Bac4, Cathelicidin LL 37, Cap-18, hCAP 18, All38 peptide, LL-37 acetate, LL-37(human), LL-37 (Human), LL-37/hCAP18, CAP18,, CHEMBL530345, EX-A7429A, Cathelicidin antimicrobial peptide 18, AKOS024458536, RS-2000, LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES, LL-37 (LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES-acid), NH2-Leu-Leu-Gly-Asp-Phe-Phe-Arg-Lys-Ser-Lys-Glu-Lys-Ile-Gly-Lys-Glu-Phe-Lys-Arg-Ile-Val-Gln-Arg-Ile-Lys-Asp-Phe-Leu-Arg-Asn-Leu-Val-Pro-Arg-Thr-Glu-Ser-COOH C205H340N60O53 POIUWJQBRNEFGX-XAMSXPGMSA-N (4S)-5-[[(2S)-6-amino-1-[[(2S,3S)-1-[[2-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S,3S)-1-[[(2S)-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S,3S)-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-4-amino-1-[[(2S)-1-[[(2S)-1-[(2S)-2-[[(2S)-5-carbamimidamido-1-[[(2S,3R)-1-[[(2S)-4-carboxy-1-[[(1S)-1-carboxy-2-hydroxyethyl]amino]-1-oxobutan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-1-oxohexan-2-yl]amino]-2-oxoethyl]amino]-3-methyl-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-4-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-amino-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]acetyl]amino]-3-carboxypropanoyl]amino]-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-5-carbamimidamidopentanoyl]amino]hexanoyl]amino]-3-hydroxypropanoyl]amino]hexanoyl]amino]-5-oxopentanoic acid Promore Pharma n.a. No No No No No No PMDBD2000612 Cecropin (1-7)-melittin A (2-9) amide n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000613 Cecropin B n.a. n.a. n.a. n.a. n.a. n.a. n.a. 16130488 n.a. n.a. Cecropin B, 80451-05-4, cecropin B protein, Insecta, P9B Protein, P9B protein, Insecta, P9B protein, Hyalophora cecropia, Cecropin B protein, Hyalophora cecropia, Cecropin B protein,Insecta, CHEMBL1673088, DTXSID90230334, EX-A7391 C176H302N52O41S YIQHNFUJWYYSEC-MQAAYMCRSA-N (4S)-4-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-1-[2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S,3S)-2-[[2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-6-amino-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2,6-diaminohexanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]hexanoyl]amino]-3-methylbutanoyl]amino]-3-phenylpropanoyl]amino]hexanoyl]amino]hexanoyl]amino]-3-methylpentanoyl]amino]-4-carboxybutanoyl]amino]hexanoyl]amino]-4-methylsulfanylbutanoyl]amino]acetyl]amino]-5-carbamimidamidopentanoyl]amino]-4-oxobutanoyl]amino]-3-methylpentanoyl]amino]-5-carbamimidamidopentanoyl]amino]-4-oxobutanoyl]amino]acetyl]amino]-3-methylpentanoyl]amino]-3-methylbutanoyl]amino]hexanoyl]amino]propanoyl]amino]acetyl]pyrrolidine-2-carbonyl]amino]propanoyl]amino]-3-methylpentanoyl]amino]propanoyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]acetyl]amino]-5-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-amino-4-methyl-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxohexan-2-yl]amino]-1-oxopropan-2-yl]amino]-5-oxopentanoic acid n.a. n.a. No No No No No No PMDBD2000614 Cefacetrile Therapeutic Substance Approved Drug 10206-21-0 DB01414 PA164776752 D07629 D01ZEC 91562 82675 n.a. Cefacetrile, Cephacetrile, 10206-21-0, Celospor, Cefacetrilum [INN-Latin], Cefacetrilo [INN-Spanish], Cefacetril, 7-Cyanacetylamino-cephalosporansaeure, Vetrimast, Cefacetrile (INN), (6R,7R)-3-(acetyloxymethyl)-7-[(2-cyanoacetyl)amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, FDM21QQ344, (6R,7R)-3-(Acetoxymethyl)-7-(2-cyanoacetamido)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, Cefacetrilo, Cefacetrilum, CEFACETRILE [INN], cephacetril, Cefacetrile [INN:BAN], EINECS 233-508-8, UNII-FDM21QQ344, Vetrimast [veterinary] (TN), (6R,7R)-3-Acetoxymethyl-7-(2-cyanacetamido)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-2-carbonsaeure, 7-(2-Cyanacetamido)-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-2-carboxylat acetat (ester), CEPHACETRILE [MI], CEFACETRILE [WHO-DD], SCHEMBL141792, CHEMBL2110602, DTXSID0022779, GTPL12192, CHEBI:135437, 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-(2-cyanoacetamido)-3-(hydroxymethyl)-8-oxo-,acetate, 7-Cyanoacetamidocephalosporanic Acid, HY-A0253, 2,4,6-TRIMETHOXYCINNAMICACID, AKOS030240997, AT37995, DB01414, NCGC00510891-01, (6R,7R)-3-[(acetyloxy)methyl]-7-[(cyanoacetyl)amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 1ST12017, Cefacetrile 100 microg/mL in Acetonitrile, CS-0017597, NS00080979, D07629, J-000558, Q4919176, (6R,7R)-3-(Acetoxymethyl)-7-(2-cyanoacetamido)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid, (6R,7R)-3-[(acetyloxy)methyl]-7-(2-cyanoacetamido)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid C13H13N3O6S RRYMAQUWDLIUPV-BXKDBHETSA-N (6R,7R)-3-(acetyloxymethyl)-7-[(2-cyanoacetyl)amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid n.a. Antibiotics No No No No No No PMDBD2000615 Cefalonium Therapeutic Substance n.a. 5575-21-3 DB11385 n.a. D07634 n.a. 21743 20438 NPC143325 CEFALONIUM, Cephalonium, 5575-21-3, Cefalonium hydrate, NSC-759292, DTXSID5045388, K2P920217W, Cefalonum, Cefalonium [INN], DTXCID3025388, Cefalonio, Cefalonium [INN-Latin], Cefalonio [INN-Spanish], Lilly 41071, (6R,7R)-3-((4-Carbamoylpyridin-1-ium-1-yl)methyl)-8-oxo-7-(2-(thiophen-2-yl)acetamido)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate, Cefalonium [INN:BAN], EINECS 226-948-7, BRN 4169337, UNII-K2P920217W, Cephalonium hydrate, NCGC00016657-01, Cefalonium (BAN), CAS-5575-21-3, (6R,7R)-3-[(4-carbamoylpyridin-1-ium-1-yl)methyl]-8-oxo-7-[(2-thiophen-2-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate, Cepravin dry cow (TN), CEFALONIUM [JAN], CEPHALONIUM [MI], CEFALONIUM [MART.], 7-(alpha-Thienylacetamido)-3-(4-carbamoylpyridinomethyl)-3-cephem-4-carboxylic acid, (6R,7R)-3-(4-(4-Carbamoyl-1-pyridiniomethyl)-8-oxo-7-(2-(2-thienyl)acetamido)-5-thia-1-azabicyclo(4.2.0)oct-2-en-2-carboxylat, 3-(4-Carbamoylpyridylmethyl)-8-oxo-7-(alpha-(thien-2-yl)acetamido)-5-thia-1-azabicyclo(4.2.0)oct-2-en-2carbonsaeure, SCHEMBL125252, 5575-21-3 (Anhydrous), CEPHALONIUM [GREEN BOOK], CHEMBL2105567, CHEBI:95345, FMZXNVLFJHCSAF-DNVCBOLYSA-N, HMS1571G13, HMS2098G13, Pharmakon1600-01505997, HY-B1252, Methyl3-isocyano-3-phenylpropionate, Tox21_110548, 1ST12008W, NSC759292, AKOS026749802, Tox21_110548_1, CCG-213999, DB11385, NSC 759292, NCGC00179310-01, NCGC00179310-03, Pyridinium, 4-carbamoyl-1-((2-carboxy-8-oxo-7-(2-(2-thienyl)acetamido)-5-thia-1-aza-bicyclo(4.2.0)oct-2-en-3-yl)methyl)- hydroxide, inner salt, TS-07629, AB00513991, CS-0013045, NS00006696, D07634, AB00513991_02, A830789, Q5057218, 3-(4-Carbamoylpyridylmethyl)-8-oxo-7-(a-(thien-2-yl)acetamido)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-[(4-carbamoylpyridin-1-ium-1-yl)methyl]-8-oxo-7-[[2-(2-thienyl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate C20H18N4O5S2 FMZXNVLFJHCSAF-DNVCBOLYSA-N (6R,7R)-3-[(4-carbamoylpyridin-1-ium-1-yl)methyl]-8-oxo-7-[(2-thiophen-2-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate n.a. n.a. No No No No No No PMDBD2000616 Cefalotin Therapeutic Substance Approved Drug 153-61-7 DB00456 PA448886 D07635 D01PLN 6024 n.a. NPC487959 cephalothin, Cefalotin, 153-61-7, Cephalotin, Cefalothin, Cephalothinum, Cefalotina, (6R,7R)-3-(Acetoxymethyl)-8-oxo-7-(2-(thiophen-2-yl)acetamido)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, Cefalotine, Cefalotinum, Cemastin, 7-(2-Thienylacetamido)cephalosporanic acid, Coaxin, Keflin, Cefalotine [INN-French], Cefalotinum [INN-Latin], Cefalotina [INN-Spanish], Averon-1, Cephalotin acid, 7-(Thiophene-2-acetamido)cephalosporin, 3-Acetoxymethyl-7-(2-thienylacetamido)-3-cephem-4-carboxylic acid, (6R,7R)-3-(acetyloxymethyl)-8-oxo-7-[(2-thiophen-2-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, Cefalotin [INN], (6R,7R)-3-[(acetyloxy)methyl]-8-oxo-7-[2-(thiophen-2-yl)acetamido]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, CHEBI:124991, MLS001048966, 7-(2''-thienylacetamido)cephalosporanic acid, DTXSID4022783, R72LW146E6, 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-((acetyloxy)methyl)-8-oxo-7-((2-thienylacetyl)amino)-, (6R-trans)-, NCGC00159332-02, SMR000386987, DTXCID202783, C16H16N2O6S2, Cefalotin (BAN), 7-(Thiophene-2-acetamido)cephalosporanic acid, (6R,7R)-3-(acetoxymethyl)-8-oxo-7-[[2-(2-thienyl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, CAS-153-61-7, 7-(2-(2-Thienyl)acetylamido)cephalosporanic acid, HSDB 3024, Cefalotina fabra (TN), EINECS 205-815-7, BRN 0945586, UNII-R72LW146E6, 6R-trans-3-((Acetyloxy)methyl)-8-oxo-7-((2-thienylacetyl)amino)-5-thia-1-azabicyclo(4.2.0)-oct-2-ene-2-carboxylic acid, 4kox, 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-((acetyloxy)methyl)-8-oxo-7-((2-thienylacetyl)amino)-, (6R,7R)-, 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[(acetyloxy)methyl]-8-oxo-7-[(2-thienylacetyl)amino]-, (6R,7R)-, (+-)-Cephalothin, 3-(Acetoxymethyl)-8-oxo-7-(2-(2-thienyl)acetamido)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-(Hydroxymethyl)-8-oxo-7-(2-(2-thienyl)acetamido)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid acetate, Spectrum_000110, CEPHALOTHIN [MI], Prestwick0_000719, Prestwick1_000719, Prestwick2_000719, Prestwick3_000719, Spectrum2_000121, Spectrum3_000332, Spectrum4_000269, Spectrum5_000669, CEPHALOTHIN [HSDB], CHEMBL617, Epitope ID:116207, CEPHALOTHIN [VANDF], CEFALOTIN [WHO-DD], cid_6024, SCHEMBL2990, Lopac0_000283, BSPBio_000937, BSPBio_001963, KBioGR_000738, KBioSS_000550, 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-(hydroxymethyl)-8-oxo-7-(2-(2-thienyl)acetamido)-, acetate (ester), DivK1c_000097, SPBio_000162, SPBio_002858, BPBio1_001031, GTPL8798, CEPHALOTHIN [GREEN BOOK], SCHEMBL20477170, BDBM82898, HY-B1275A, KBio1_000097, KBio2_000550, KBio2_003118, KBio2_005686, KBio3_001183, NINDS_000097, HMS2267P23, Tox21_111579, MFCD00242614, s5294, AKOS015920120, Tox21_111579_1, CCG-268605, CS-W008776, DB00456, GS-3577, SDCCGSBI-0050271.P005, 7beta-(thiophen-2-ylacetamido)-3-acetoxymethyl-3,4-didehydrocepham-4-carboxylic acid, IDI1_000097, NCGC00023699-09, (6R,7R)-3-(Acetoxymethyl)-8-oxo-7-(2-(thiophen-2-yl)acetamido)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid, (6R,7R)-3-[(acetyloxy)methyl]-8-oxo-7-[(2-thienylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, SBI-0050271.P004, 7-(2-thienylacetamido) cephalosporanic acid, 7-(2-thienylacetamido)-cephalosporanic acid, C2769, NS00126621, C-2484, C07761, D07635, EN300-267043, A809447, Cephalothin, Antibiotic for Culture Media Use Only, SR-01000003118, Q2736126, SR-01000003118-3, BRD-K28210218-236-05-7, Z1741977144, CEPHALOTHIN 7-(2-THIENYLACETAMIDO)CEPHALOSPORANIC ACID, 3-acetoxymethyl-7beta-(2-thienylacetamido) ceph-3-em-4-carboxylic acid, 3-acetoxymethyl-7beta-(2-thienylacetamido)-3-cephem-4-carboxylic acid, 3-Acetoxymethyl-7beta-(2-thienylacetamido)ceph-3-em-4-carboxylic acid, (6R,7R)-3-(acetoxymethyl)-8-keto-7-[[2-(2-thienyl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, (6R,7R)-3-(acetoxymethyl)-8-oxo-7-(2-(thiophen-2-yl)acetamido)-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid, (6R,7R)-3-(acetyloxymethyl)-8-oxidanylidene-7-(2-thiophen-2-ylethanoylamino)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, (6R,7R)-3-(acetyloxymethyl)-8-oxo-7-[(1-oxo-2-thiophen-2-ylethyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, (6R,7R)-3-[(acetyloxy)methyl]-8-oxo-7-[(thiophen-2-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 51098-29-4 C16H16N2O6S2 XIURVHNZVLADCM-IUODEOHRSA-N (6R,7R)-3-(acetyloxymethyl)-8-oxo-7-[(2-thiophen-2-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Eli Lilly Antibiotics No No No No No No PMDBD2000617 Cefamandole Therapeutic Substance Approved Drug 34444-01-4 DB01326 PA448837 D02344 D06YHL 456255 n.a. n.a. cefamandole, Cefadole, 34444-01-4, CEPHAMANDOLE, Cefamandol, Cephadole, Cefamandolum, L-Cefamandole, Compound 83405, CHEBI:3480, (6R,7R)-7-(R)-Mandelamido-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-carboxylic acid, 5CKP8C2LLI, (6R,7R)-7-{[(2R)-2-hydroxy-2-phenylacetyl]amino}-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, COMPOUND-83405, (6R,7R)-7-[[(2R)-2-hydroxy-2-phenylacetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, J01DC03, Kefdole, 7-D-Mandelamido-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-3-cephem-4-carboxylic acid, Kefamandol, Mancef, (6R,7R)-7-((R)-2-hydroxy-2-phenylacetamido)-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, (6R,7R)-7-[(2R)-2-hydroxy-2-phenylacetamido]-3-{[(1-methyl-1H-1,2,3,4-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[(2-hydroxy-2-phenylacetyl)amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 30034-03-8, UNII-5CKP8C2LLI, Cefamandol [INN-Spanish], Cefamandole (USAN/INN), Cefamandolum [INN-Latin], free form, Cefamandole [USAN:INN:BAN], (6R,7R)-7-(R)-Mandelamido-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-carboxylic acid, 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((hydroxyphenylacetyl)amino)-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-, (6R-(6alpha,7beta(R*)))-, EINECS 252-030-0, BRN 0598510, CEFAMANDOLE [MI], Prestwick0_000747, Prestwick1_000747, Prestwick2_000747, Prestwick3_000747, CEFAMANDOLE [INN], CEFAMANDOLE [USAN], Epitope ID:141490, CEFAMANDOLE [VANDF], CEFAMANDOLE [MART.], CHEMBL1146, SCHEMBL37287, BSPBio_000734, CEFAMANDOLE [WHO-DD], SPBio_002673, BPBio1_000808, DTXSID7022750, GTPL12210, HY-B1128, BDBM50350468, AKOS025401365, AC-1294, CS-4724, DB01326, (6R,7R)-7-[[(2R)-2-hydroxy-2-phenyl-acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, (6R,7R)-7-{[(2R)-2-hydroxy-2-phenylacetyl]amino}-3-{[(1-methyl-1H-tetrazol-5-yl)thio]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7beta-[(2R)-2-hydroxy-2-phenylacetamido]-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}ceph-3-em-4-carboxylic acid, NS00002796, C06879, D02344, Cefamandole, Antibiotic for Culture Media Use Only, EN300-19734690, Q2601530, W-106736, BRD-K27130738-236-03-4, (6R,7R)-7-((R)-2-hydroxy-2-phenylacetamido)-3-((1-methyl-1H-tetrazol-5-ylthio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 5-THIA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXYLIC ACID, 7-((HYDROXYPHENYLACETYL)AMINO)-3-(((1-METHYL-1H-TETRAZOL-5-YL)THIO)METHYL)-8-OXO-, (6R-(6.ALPHA.,7.BETA.(R*)))-, 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2R)-2-hydroxy-2-phenylacetyl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-, (6R,7R)-, 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2R)-2-hydroxy-2-phenylacetyl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-, 6R,7R)- C18H18N6O5S2 OLVCFLKTBJRLHI-AXAPSJFSSA-N (6R,7R)-7-[[(2R)-2-hydroxy-2-phenylacetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Eli Lilly Antibiotics No No No No No No PMDBD2000618 Cefapirin Therapeutic Substance Approved Drug 21593-23-7 DB01139 PA164749340 n.a. D01DSP 30699 n.a. NPC481259 cephapirin, Cefapirin, Cephapirine, Cefaprin, 21593-23-7, Cefadyl, Cefapirina, Cefapirine, Cefapirinum, CEPR, Cefapirine [INN-French], Cefapirinum [INN-Latin], Cefapirina [INN-Spanish], CHEBI:554446, Cefatrexyl, Ambrocef, Cefatrex, 7-(2-(4-Pyridylthio)acetamido)cephalosporanic acid, HSDB 3215, 89B59H32VN, EINECS 244-466-5, BRN 1095157, UNII-89B59H32VN, 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-((acetyloxy)methyl)-8-oxo-7-(((4-pyridinylthio)acetyl)amino)-, (6R-trans)-, DTXSID9022784, Cefa, Cefaprin sodium, (6R,7R)-3-(Acetoxymethyl)-8-oxo-7-(2-(4-pyridylthio)acetamido)-5-thia-1-azabicyclo(4.2.0)oct-2-en-2-carbonsaeure, (6R,7R)-3-(Acetoxymethyl)-8-oxo-7-(2-(pyridin-4-ylthio)acetamido)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, (6R,7R)-3-(acetyloxymethyl)-8-oxo-7-[(2-pyridin-4-ylsulfanylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-(Hydroxymethyl)-8-oxo-7-(2-(4-pyridylthio)acetamidol-5-thia-1-azabicyclo(4.2.0)oct-2-en-2carbonsaeure acetat, 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-(hydroxymethyl)-8-oxo-7-(2-(4-pyridylthio)acetamido)-, acetate (ester), Cephalosporanic acid, 7-(2-(4-pyridylthio)acetamido)-, Cefapirine (INN-French), Cefapirinum (INN-Latin), Cefapirina (INN-Spanish), Cefapirin [INN:BAN], ANTIBIOTIC BL-P1322, Cefapirin (BAN), Metricure (TN), (6R,7R)-3-(acetoxymethyl)-8-oxo-7-{[(pyridin-4-ylsulfanyl)acetyl]amino}-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, (6R,7R)-3-(HYDROXYMETHYL)-8-OXO-7-(2-(4-PYRIDYLTHIO)ACETAMIDO)-5-THIA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXYLATE ACETATE (ESTER), (6R,7R)-3-[(acetyloxy)methyl]-8-oxo-7-[2-(pyridin-4-ylsulfanyl)acetamido]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, (6R,7R)-3-acetoxymethyl-7-[(pyridin-4-ylsulfanyl)acetamido]-3,4-didehydrocepham-4-carboxylic acid, NSC179171, 24356-60-3, Cefa-Lak, Cefa -ak, (6R,7R)-3-(acetoxymethyl)-8-oxo-7-(((pyridin-4-ylsulfanyl)acetyl)amino)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, (6R,7R)-3-acetoxymethyl-7-((pyridin-4-ylsulfanyl)acetamido)-3,4-didehydrocepham-4-carboxylic acid, Spectrum_000112, CEFAPIRIN [INN], CEPHAPIRIN [MI], CEFAPIRIN [HSDB], Prestwick0_000851, Prestwick1_000851, Prestwick2_000851, Spectrum2_000103, Spectrum3_000333, Spectrum4_000270, Spectrum5_000671, CEPHAPIRIN [VANDF], Epitope ID:116226, CEFAPIRIN [WHO-DD], SCHEMBL3205, CHEMBL1599, Lopac0_000279, BSPBio_001965, KBioGR_000740, KBioSS_000552, DivK1c_000042, SPBio_000086, SPBio_002782, DTXCID602784, GTPL12191, KBio1_000042, KBio2_000552, KBio2_003120, KBio2_005688, KBio3_001185, NINDS_000042, HY-A0153, BDBM50370592, AKOS015896499, DB01139, IDI1_000042, (6R,7R)-3-[(acetyloxy)methyl]-8-oxo-7-{[(pyridin-4-ylthio)acetyl]amino}-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, SBI-0050267.P004, CS-0017478, NS00084098, C06896, D07636, EN300-25916814, Q549803, J-014163, 7-(alpha-(4-PYRIDYLTHIO)ACETAMIDO)CEPHALOSPORANIC ACID, 7-(.ALPHA.-(4-PYRIDYLTHIO)ACETAMIDO)CEPHALOSPORANIC ACID, (6R, 7R)-3-(acetyloxymethyl)-8-oxo-7-[(2-pyridin-4-ylsulfanylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, (6R,7R)-3-(Acetoxymethyl)-8-oxo-7-(2-(pyridin-4-ylthio)acetamido)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid, (6R,7R)-3-(acetoxymethyl)-8-oxo-7-[[2-(4-pyridylsulfanyl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[(acetyloxy)methyl]-8-oxo-7-[[(4-pyridinylthio)acetyl]amino]-, (6R,7R)- C17H17N3O6S2 UQLLWWBDSUHNEB-CZUORRHYSA-N (6R,7R)-3-(acetyloxymethyl)-8-oxo-7-[(2-pyridin-4-ylsulfanylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid n.a. Antibiotics No No No No No No PMDBD2000619 Cefazolin Therapeutic Substance Approved Drug 25953-19-9 DB01327 PA448839 D02299 D09KDN 33255 n.a. NPC484463 "cefazolin, 25953-19-9, Cephazolin, Cefazoline, Cephamezine, Cephazoline, Cefamezin, Cephazolidin, Cefazolin acid, Cefazolina, Cefazolinum, Elzogram, CEZ, Cefazoline [INN-French], Cefazolinum [INN-Latin], Cefazolina [INN-Spanish], Kefzol, HSDB 3213, CHEBI:474053, UNII-IHS69L0Y4T, EINECS 247-362-8, IHS69L0Y4T, BRN 4169371, (6R,7R)-3-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]-8-oxo-7-[[2-(tetrazol-1-yl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, DTXSID2022753, J01DB04, Cefazolin [USP:INN:BAN], DTXCID302753, EC 247-362-8, Cefazina, Firmacef, Liviclina, Atirin, Acef, (6R,7R)-3-{[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, NCGC00159465-02, Cefazoline (INN-French), Cefazolinum (INN-Latin), Cefazolina (INN-Spanish), CEFAZOLIN (MART.), CEFAZOLIN [MART.], CEFAZOLIN (USP-RS), CEFAZOLIN [USP-RS], SK&F-41558, Cefazolin (USP:INN:BAN), (6R,7R)-7-(2-(1H-tetrazol-1-yl)acetamido)-3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, CEFAZOLIN (USP MONOGRAPH), CEFAZOLIN [USP MONOGRAPH], Cephamezine;Cephazoline, Cefazolin (USP), (6R,7R)-3-{[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[2-(1H-1,2,3,4-tetrazol-1-yl)acetamido]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, (6R,7R)-7-(2-(1H-tetrazol-1-yl)acetamido)-3-((5-methyl-1,3,4-thiadiazol-2-ylthio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, SMR000387025, CAS-25953-19-9, NSC291561, Cefazolin acid,(S), (6R,7R)-3-(((5-Methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-(2-(1H-tetrazol-1-yl)acetamido)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, (6R-trans)-3-(((5-Methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-(((1H-tetrazol-1-yl)acetyl)-amino)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(1-(1H-)-Tetrazolylacetamido)-3-(2-(5-methyl-1,3,4-thiadiazolyl)thiomethyl)delta3-cephem-4-carboxylic acid, Spectrum_000106, CEFAZOLIN [INN], CEFAZOLIN [MI], CEFAZOLIN [HSDB], Prestwick0_000736, Prestwick1_000736, Prestwick2_000736, Prestwick3_000736, Spectrum2_001140, Spectrum3_000330, Spectrum4_000267, Spectrum5_000665, CEFAZOLIN [VANDF], Cefazolinfor culture media, Epitope ID:116197, CEFAZOLIN [WHO-DD], SCHEMBL2841, CHEMBL1435, Lopac0_000274, BSPBio_000692, BSPBio_001939, KBioGR_000734, KBioSS_000546, MLS001032060, MLS001049010, DivK1c_000014, SPBio_001039, SPBio_002631, BPBio1_000762, GTPL10935, KBio1_000014, KBio2_000546, KBio2_003114, KBio2_005682, KBio3_001159, NINDS_000014, HMS2268D15, 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[[(5-methyl-1,3,4-thiadiazol-2-yl)thio]methyl]-8-oxo-7-[[2-(1H-tetrazol-1-yl)acetyl]amino]-, (6R,7R)-, HY-B1892, Tox21_111691, BDBM50370587, s5936, AKOS015962265, Tox21_111691_1, DB01327, SDCCGSBI-0050262.P005, IDI1_000014, NCGC00022653-09, (6R,7R)-3-{[(5-methyl-1,3,4-thiadiazol-2-yl)thio]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-{[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-7beta-[(1H-tetrazol-1-ylacetyl)amino]-3,4-didehydrocepham-4-carboxylic acid, 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-(((1H-tetrazol-1-yl)acetyl)amino)-, (6R-trans)-, 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-(2-(1H-tetrazol-1-yl)acetamido)-, AC-16010, BS-52943, Cefazolin 1000 microg/mL in Acetonitrile, SBI-0050262.P004, CS-0013954, 7-(1-(1H-)-TETRAZOLYLACETAMIDO)-3-, C06880, D02299, F87674, EN300-6731073, A818105, Q415739, W-107209, (6R, 7R)-3-[[(5-Methyl-1,3,4-thiadiazol-2- yl)thio]methyl]-8-oxo-7-[[1H-tetrazol-1- yl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2- ene-2-carboxylic acid, (6R,7R)-3-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]-8-oxo-7-[[2-(tetrazol-1-yl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;Cefazolin acid, (6R,7R)-3-[[(5-Methyl-1,3,4-thiadiazol-2-yl)thio]methyl]-8-oxo-7-[2-(1H-tetrazol-1-yl)acetamido]5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 5-THIA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXYLIC ACID, 3-(((5-METHYL-1,3,4-THIADIAZOL-2-YL)THIO)METHYL)-8-OXO-7-(((1H-TETRAZOL-1-YL)ACETYL)AMINO)-(6R-TRANS), Cefazolin; (6R,7R)-3-[[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl]-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid; (6R,7R)-3-[[(5-Methyl-1,3,4-thiadiazol-2-yl)thio]methyl]-8-oxo-7-[[2-(1H-tetrazol-1-yl)acetyl]amino]-5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid" C14H14N8O4S3 MLYYVTUWGNIJIB-BXKDBHETSA-N (6R,7R)-3-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]-8-oxo-7-[[2-(tetrazol-1-yl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Fujisawa Pharmaceutical Co Antibiotics No No No No No No PMDBD2000620 Cefditoren Therapeutic Substance Approved Drug 104145-95-1 DB01066 PA164747187 D01628 D0E3RW 9870843 8046534 n.a. Cefditoren, 104145-95-1, UNII-81QS09V3YW, Cefditoren [INN], CDTR, 81QS09V3YW, CHEBI:59343, (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(Z)-2-(4-methyl-1,3-thiazol-5-yl)ethenyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, Cefditoren (INN), (6R-(3(Z),6alpha,7beta(Z)))-7-((2-Amino-4-thiazolyl)(methoxyimino)acetyl)amino-3-(2-(4-methyl-5-thiazolyl)ethenyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino-3-(2-(4-methyl-5-thiazolyl)ethenyl)-8-oxo-, (6R-(3(Z),6alpha,7beta(Z)))-, Cefditoren [USAN:INN], cefditorene, cefditorenum, Cefditoreno, (6R,7R)-7-(((2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl)amino)-3-((Z)-2-(4-methyl-1,3-thiazol-5-yl)ethenyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-[(Z)-2-(4-methyl-1,3-thiazol-5-yl)ethenyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7beta-(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido-3-((Z)-2-(4-methyl-1,3-thiazol-5-yl)ethenyl)-3,4-didehydrocepham-4-carboxylic acid, 7beta-(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido-3-[(Z)-2-(4-methyl-1,3-thiazol-5-yl)ethenyl]-3,4-didehydrocepham-4-carboxylic acid, CEFDITOREN [MI], CEFDITOREN [VANDF], CEFDITOREN [WHO-DD], CHEMBL1743, SCHEMBL37473, J01DD16, DTXSID501328012, DB01066, 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2Z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)-1-oxoethyl)amino)-3-((Z)-2-(4-methyl-5-thiazolyl)ethenyl)-8-oxo-, (6R,7R)-, 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-3-[(1Z)-2-(4-methyl-5-thiazolyl)ethenyl]-8-oxo-, (6R,7R)-, PD194305, C-2467, C21546, D07639, Cefditorene, Antibiotic for Culture Media Use Only, EN300-21702526, (+)-(6R,7R)-7-(2-(2-Amino-4-thiazolyl)glyoxylamido)-3-((Z)-2-(4-methyl-5-thiazolyl)vinyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7(sup 2)-(Z)-(O-methyloxime), (6R,7R)-7-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido]-3-[(1Z)-2-(4-methyl-1,3-thiazol-5-yl)ethenyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, (6R,7R)-7-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido]-3-[(Z)-2-(4-methyl-1,3-thiazol-5-yl)ethenyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid C19H18N6O5S3 KMIPKYQIOVAHOP-YLGJWRNMSA-N (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(Z)-2-(4-methyl-1,3-thiazol-5-yl)ethenyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Cornerstone BioPharma Antibiotics No No No No No No PMDBD2000621 Cefepime? n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000622 Cefmenoxime Therapeutic Substance Approved Drug 65085-01-0 DB00267 PA164750569 D01739 D06QCC 9570757 7845223 n.a. cefmenoxime, 65085-01-0, Cefmenoximum, Cefmenoxima, Cefmenoxime [INN], Tacef, Cefmenoximum [INN-Latin], Cefmenoxima [INN-Spanish], Cefmenoxime (INN), SCE-1365, KBZ4844CXN, (6R,7R)-7-((Z)-2-(2-Amino-4-thiazolyl)-2-methoxyiminoacetamido)-3-((1-methyl-1H-5-tetraazolylthio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-2-carbonsaeure, CHEBI:55490, (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, SCE 1365, CMX, (6R,7R)-7-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido]-3-{[(1-methyl-1H-1,2,3,4-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, A 50912, AB 50912, UNII-KBZ4844CXN, (6R,7R)-7-[[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid (IUPAC), (6R,7R)-(2-(2-Amino-4-thiazolyl)glyoxylamido)-3-(1-methyl-1H-tetrazol-5-yl)thiomethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-2-carbonsaeure-7-(Z)-(O-methyloxim), CEFMENOXIME [MI], CEFMENOXIME [JAN], CEFMENOXIME [WHO-DD], 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-, (6R-(6alpha,7beta(Z)))-, SCHEMBL152861, CHEMBL1201224, DTXSID2022755, HY-B0875A, AKOS030573275, DB00267, NCGC00373220-03, (6R,7R)-7-({(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(methyloxy)imino]acetyl}amino)-3-{[(1-methyl-1H-tetrazol-5-yl)thio]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, (6R,7R)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-methoxyimino-acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7beta-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-3,4-didehydrocepham-4-carboxylic acid, CS-0013516, D07641, EN300-1692907, A834966, Z2583154272 C16H17N9O5S3 HJJDBAOLQAWBMH-YCRCPZNHSA-N (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid n.a. Antibiotics No No No No No No PMDBD2000623 Cefmetazole Therapeutic Substance Approved Drug 56796-20-4 DB00274 PA164746819 D00910 D05UBX 42008 38311 n.a. "cefmetazole, 56796-20-4, Cefmetazolo, Cefmetazolum, Cefmetazolum [INN-Latin], Cefmetazolo [INN-Spanish], (6R,7S)-7-[[2-(cyanomethylsulfanyl)acetyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, CHEBI:3489, U-72791, 3J962UJT8H, (6R,7S)-7-({[(cyanomethyl)sulfanyl]acetyl}amino)-7-methoxy-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 56796-20-4 (free), (6R,7S)-7-(2-((Cyanomethyl)thio)acetamido)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,7-[[[(cyanomethyl)thio]acetyl]amino]-7-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-, (6R,7S)-, 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((((cyanomethyl)thio)acetyl)amino)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-, (6R-cis)-, SKF 83088, CS 1170, (6R,7S)-7-{2-[(cyanomethyl)sulfanyl]acetamido}-7-methoxy-3-{[(1-methyl-1H-1,2,3,4-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, U 72791, Cefmetazole (USP/INN), EINECS 260-384-2, BRN 0634647, UNII-3J962UJT8H, Cefmetazole [USAN:USP:INN], Cefmetazolesodium, (6R,7S)-7-[2-[(Cyanomethyl)thio]acetamido]-7-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, CefmetaZole, 95%, CEFMETAZOLE [MI], Prestwick0_000700, Prestwick1_000700, Prestwick2_000700, Prestwick3_000700, CEFMETAZOLE [INN], CEFMETAZOLE [USAN], Epitope ID:116204, CEFMETAZOLE [VANDF], CEFMETAZOLE [MART.], CS 1170;SKF 83088;U 72791;U 72791a, Lopac0_000266, BSPBio_000859, CEFMETAZOLE [USP-RS], CEFMETAZOLE [WHO-DD], SCHEMBL147832, SPBio_002780, BPBio1_000945, CEFMETAZOLE SODIUM [JAN], CHEMBL1201195, DTXSID7022756, GTPL12215, SNBUBQHDYVFSQF-HIFRSBDPSA-N, CEFMETAZOLE [USP IMPURITY], CEFMETAZOLE [USP MONOGRAPH], BCP11998, HY-B1595, BDBM50350471, MFCD00865068, AKOS015896219, DB00274, SDCCGSBI-0050254.P002, (6R,7S)-7-({[(cyanomethyl)thio]acetyl}amino)-7-(methyloxy)-3-{[(1-methyl-1H-tetrazol-5-yl)thio]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, (6R,7S)-7-(2-((Cyanomethyl)thio)acetamido)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thiomethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, sodium salt, AC-13154, BS-42476, 2,6-DIFLUORO-4-METHOXYACETOPHENONE, CS-0013513, NS00011557, C08103, D00910, A831178, EN300-19766367, -1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, J-700159, Q5057238, (6R,7S)-7-({[(cyanomethyl)sulfanyl]acetyl}amino)-7-methoxy-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia, (6R,7S)-7-(2-(cyanomethylthio)acetamido)-7-methoxy-3-((1-methyl-1H-tetrazol-5-ylthio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, (6R,7S)-7-[[2-(cyanomethylthio)-1-oxoethyl]amino]-7-methoxy-3-[[(1-methyl-5-tetrazolyl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, (6R,7S)-7-[2-(cyanomethylsulfanyl)ethanoylamino]-7-methoxy-3-[(1-methyl-1,2,3,4-tetrazol-5-yl)sulfanylmethyl]-8-oxidanylidene-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7beta-{[(cyanomethyl)sulfanyl]acetamido}-7alpha-methoxy-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}ceph-3-em-4-carboxylic acid" C15H17N7O5S3 SNBUBQHDYVFSQF-HIFRSBDPSA-N (6R,7S)-7-[[2-(cyanomethylsulfanyl)acetyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Pharmacia And Upjohn Co Antibiotics No No No No No No PMDBD2000624 Cefonicid Therapeutic Substance Approved Drug 61270-58-4 DB01328 PA164743021 D07644 D01BQC 43594 39734 n.a. CEFONICID, 61270-58-4, Cefonicido, Cefonicidum, Monocef, Cefonicidum [INN-Latin], Cefonicido [INN-Spanish], CHEBI:3491, (6R,7R)-7-[[(2R)-2-hydroxy-2-phenylacetyl]amino]-8-oxo-3-[[1-(sulfomethyl)tetrazol-5-yl]sulfanylmethyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 6532B86WFG, Cefonicid (INN), CEFONICID [INN], (6R,7R)-7-[(2R)-2-hydroxy-2-phenylacetamido]-8-oxo-3-({[1-(sulfomethyl)-1H-1,2,3,4-tetrazol-5-yl]sulfanyl}methyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, (6R,7R)-7-{[(2R)-2-hydroxy-2-phenylacetyl]amino}-8-oxo-3-({[1-(sulfomethyl)-1H-tetrazol-5-yl]sulfanyl}methyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, Cefonicid [INN:BAN], UNII-6532B86WFG, (6R,7R)-7-(((2R)-2-HYDROXY-2-PHENYLACETYL)AMINO)-8-OXO-3-(((1-(SULFOMETHYL)-1H-TETRAZOL-5-YL)THIO)METHYL)-5-THIA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXYLIC ACID, (6R,7R)-7-{[(2R)-2-hydroxy-2-phenylacetyl]amino}-8-oxo-3-({[1-(sulfomethyl)-1H-tetrazol-5-yl]thio}methyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, Monocef (TN), CEFONICIDE, SK&F 75073, BRN 1066181, CEFONICID [MI], CEFONICID [VANDF], CEFONICID [WHO-DD], CHEMBL1601, SCHEMBL60350, BIDD:GT0667, DTXSID7022758, GTPL12217, DYAIAHUQIPBDIP-AXAPSJFSSA-N, DB01328, NS00011568, EN300-92950, C06882, D07644, A833135, Q5057286, BRD-K34058848-304-03-1, (6R,7R)-7-((R)-2-hydroxy-2-phenylacetamido)-8-oxo-3-((1-(sulfomethyl)-1H-tetrazol-5-ylthio)methyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, (6R,7R)-7-[[(2R)-2-hydroxy-1-oxo-2-phenylethyl]amino]-8-oxo-3-[[[1-(sulfomethyl)-5-tetrazolyl]thio]methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, (6R,7R)-8-oxidanylidene-7-[[(2R)-2-oxidanyl-2-phenyl-ethanoyl]amino]-3-[[1-(sulfomethyl)-1,2,3,4-tetrazol-5-yl]sulfanylmethyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 5-THIA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXYLIC ACID, 7-(((2R)-2-HYDROXY-2-PHENYLACETYL)AMINO)-8-OXO-3-(((1-(SULFOMETHYL)-1H-TETRAZOL-5-YL)THIO)METHYL)-, (6R,7R)-, 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((hydroxyphenylacetyl)amino)-8-oxo-3-(((1-sulfomethyl)-1H-tetrazol-5-yl)thio)methyl)-, (6R-(6-alpha,7-beta(R*)))-, 6beta-[(2R)-2-hydroxy-2-phenylacetamido]-3-({[1-(sulfomethyl)-1H-tetrazol-5-yl]sulfanyl}methyl)ceph-3-em-4-carboxylic acid C18H18N6O8S3 DYAIAHUQIPBDIP-AXAPSJFSSA-N (6R,7R)-7-[[(2R)-2-hydroxy-2-phenylacetyl]amino]-8-oxo-3-[[1-(sulfomethyl)tetrazol-5-yl]sulfanylmethyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Glaxosmithkline Antibiotics No No No No No No PMDBD2000625 Cefotiam Therapeutic Substance Approved Drug 61622-34-2 DB00229 PA164749298 D07648 D0K3DQ 43708 39831 n.a. cefotiam, 61622-34-2, Cefotiamum, Cefotiamum [INN-Latin], Aspil, CTM, Cefotiam (INN), J01DC07, CHEBI:355510, 91W6Z2N718, SCE 963, CEFOTIAM [INN], Cefotiam [INN:BAN], (6R,7R)-7-[[2-(2-amino-1,3-thiazol-4-yl)acetyl]amino]-3-[[1-[2-(dimethylamino)ethyl]tetrazol-5-yl]sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, (6R,7R)-7-[2-(2-Amino-thiazol-4-yl)-acetylamino]-3-[1-(2-dimethylamino-ethyl)-1H-tetrazol-5-ylsulfanylmethyl]-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid, CGP 14221E, 66309-69-1, (6R,7R)-7-[2-(2-amino-1,3-thiazol-4-yl)acetamido]-3-[({1-[2-(dimethylamino)ethyl]-1H-1,2,3,4-tetrazol-5-yl}sulfanyl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,7-[[(2-amino-4-thiazolyl)acetyl]amino]-3-[[[1-[2-(dimethylamino)ethyl]-1H-tetrazol-5-yl]thio]methyl]-8-oxo-, (6R,7R)-, Aspil (TN), SR-01000841230, UNII-91W6Z2N718, Cefotiam,(S), (6R,7R)-7-(2-(2-aminothiazol-4-yl)acetamido)-3-((1-(2-(dimethylamino)ethyl)-1H-tetrazol-5-ylthio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, CEFOTIAM [JAN], CEFOTIAM [MI], Prestwick0_000482, Prestwick1_000482, Prestwick2_000482, Prestwick3_000482, CEFOTIAM [WHO-DD], CHEMBL1296, BSPBio_000343, (6R,7R)-7-[[2-(2-amino-1,3-thiazol-4-yl)acetyl]amino]-3-[[1-(2-dimethylaminoethyl)tetrazol-5-yl]sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, SCHEMBL149538, SPBio_002264, BPBio1_000379, DTXSID6022763, SCHEMBL11224134, GTPL12254, QYQDKDWGWDOFFU-IUODEOHRSA-N, HY-B0734, BDBM50485561, DB00229, NCGC00179594-01, (6R,7R)-7-{[(2-amino-1,3-thiazol-4-yl)acetyl]amino}-3-[({1-[2-(dimethylamino)ethyl]-1H-tetrazol-5-yl}sulfanyl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, (6R,7R)-7-{[(2-amino-1,3-thiazol-4-yl)acetyl]amino}-3-[({1-[2-(dimethylamino)ethyl]-1H-tetrazol-5-yl}thio)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl)acetyl)amino)-3-(((1-(2-(dimethylamino)ethyl)-1H-tetrazol-5-yl)thio)methyl)-8-oxo-, (6R-trans)-, 7beta-(2-amino-1,3-thiazol-4-yl)acetamido-3-[({1-[2-(dimethylamino)ethyl]-1H-tetrazol-5-yl}sulfanyl)methyl]-3,4-didehydrocepham-4-carboxylic acid, AB00514684, CS-0009630, NS00006913, C21544, D07648, EN300-19766378, J-700162, Q3009984, SR-01000841230-2, BRD-K02275692-003-03-4, 7beta-(2-imino-4-thiazolin-4-yl)acetamido-3-{1-[2-(N,N-dimethylamino)ethyl]-1H-tetrazol-5-yl}thiomethyl-3-cephem-4-carboxylic acid, 7beta-[ 2-(2-aminothiazol-4-yl) acetamido]-3-[1-(2-dimethylaminoethyl)-1H-tetrazol-5-yl]thiomethyl-3-cephem-4-carboxylic acid C18H23N9O4S3 QYQDKDWGWDOFFU-IUODEOHRSA-N (6R,7R)-7-[[2-(2-amino-1,3-thiazol-4-yl)acetyl]amino]-3-[[1-[2-(dimethylamino)ethyl]tetrazol-5-yl]sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Takeda Antibiotics No No No No No No PMDBD2000626 Cefpiramide Therapeutic Substance Approved Drug 70797-11-4 DB00430 PA164748136 D01904 D02MZY 636405 552192 n.a. "cefpiramide, 70797-11-4, Cefpiramide acid, Cefpiramido, Cefpiramidum, WY-44635, WY-44,635, (6R,7R)-7-[[(2R)-2-(4-hydroxyphenyl)-2-[(6-methyl-4-oxo-1H-pyridine-3-carbonyl)amino]acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, DTXSID6046630, CHEBI:59213, P936YA152N, NSC-759869, (7R)-7-[[(2R)-2-(4-hydroxyphenyl)-2-[(6-methyl-4-oxo-1H-pyridine-3-carbonyl)amino]acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, NCGC00167444-01, SM 1652, SM-1652, (6R,7R)-7-((R)-2-(4-Hydroxy-6-methylnicotinamido)-2-(4-hydroxyphenyl)acetamido)-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, (6R,7R)-7-[(2R)-2-[(4-hydroxy-6-methylpyridin-3-yl)formamido]-2-(4-hydroxyphenyl)acetamido]-3-{[(1-methyl-1H-1,2,3,4-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, WY 44,635, Cefpiramidum [INN-Latin], Cefpiramido [INN-Spanish], UNII-P936YA152N, Cefpiramide [USAN:USP:INN], WY 44635, Cefpiramide (USP/INN), CEFPIRAMIDE [MI], CEFPIRAMIDE [INN], CEFPIRAMIDE [USAN], CEFPIRAMIDE [MART.], SCHEMBL49253, CEFPIRAMIDE [USP-RS], CEFPIRAMIDE [WHO-DD], CHEMBL1201204, DTXCID4026630, GTPL12027, CEFPIRAMIDE [USP IMPURITY], HMS3715H12, HY-B1354, Tox21_112448, MFCD00864893, s5186, AKOS025311237, CCG-221235, DB00430, NSC 759869, NCGC00167444-04, (6R,7R)-7-((R)-2-(4-Hydroxy-6-methylnicotinamido)-2-(p-hydroxyphenyl)acetamido)-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, AS-14170, CAS-70797-11-4, CS-0013097, NS00011570, D03428, EN300-19766072, Q4921174, BRD-K92872987-001-02-9, Cefpiramide acid;Cefpiramido;Cefpiramidum;WY-44635;SM-1652, (6R,7R)-7-((R)-2-(4-hydroxy-6-methylnicotinamido)-2-(4-hydroxyphenyl)acetamido)-3-((1-methyl-1H-tetrazol-5-ylthio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, (6R,7R)-7-{[(2R)-2-{[(4-hydroxy-6-methylpyridin-3-yl)carbonyl]amino}-2-(4-hydroxyphenyl)acetyl]amino}-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, (7R)-7-((R)-2-(4-hydroxy-6-methylnicotinamido)-2-(4-hydroxyphenyl)acetamido)-3-((1-methyl-1H-tetrazol-5-ylthio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((((4-hydroxy-6-methyl-3-pyridinyl)carbonyl)amino)(4-hydroxyphenyl)acetyl)amino)-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-, (6R-(6alpha,7beta(R*)))-, 7beta-[(2R)-2-{[(4-hydroxy-6-methylpyridin-3-yl)carbonyl]amino}-2-(4-hydroxyphenyl)acetamido]-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-3,4-didehydrocepham-4-carboxylic acid" C25H24N8O7S2 PWAUCHMQEXVFJR-PMAPCBKXSA-N (6R,7R)-7-[[(2R)-2-(4-hydroxyphenyl)-2-[(6-methyl-4-oxo-1H-pyridine-3-carbonyl)amino]acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Wyeth Ayerst Laboratories Antibiotics No No No No No No PMDBD2000627 Cefpodoxime Therapeutic Substance Approved Drug 80210-62-4 DB01416 PA164746385 D07650 D0W6CA 6335986 4891496 n.a. CEFPODOXIME, Cefpodoximum, Cefpodoxima, 80210-62-4, Epoxim, CPDX, Cefpodoximum [Latin], UNII-7R4F94TVGY, 7R4F94TVGY, Cefpodoxime (INN), CHEBI:3504, (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, CHEMBL1672, DTXSID6022765, Cefpodoximum (Latin), CEFPODOXIME [INN], Cefpodoxima [Spanish], Cefpodoxime [INN:BAN], (+)-(6R,7R)-7-(2-(2-AMINO-4-THIAZOLYL)-2-((Z)-METHOXYIMINO)ACETAMIDO)-3-(METHOXYMETHYL)-8-OXO-5-THIA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXYLIC ACID, (+)-(6R,7R)-7-(2-(2-AMINO-4-THIAZOLYL)GLYOXYLAMIDO)-3-(METHOXYMETHYL)-8-OXO-5-THIA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXYLIC ACID, 7(SUP 2)-(Z)-(O-METHYLOXIME), (6R,7R)-7-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-3-(methoxymethyl)-8-oxo-, (6R-(6alpha,7beta(Z)))-, Epoxim (TN), RU 51807, (6R,7R)-7-(((2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl)amino)-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7beta-((2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido)-3-(methoxymethyl)-3,4-didehydrocepham-4-carboxylic acid, 7beta-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido]-3-(methoxymethyl)-3,4-didehydrocepham-4-carboxylic acid, RU-51746, Cefpodoxime, Free Acid, CEFPODOXIME [MI], CEFPODOXIME [JAN], C08114, SCHEMBL27072, CEFPODOXIME [WHO-DD], DTXCID402765, HY-A0251, BDBM50292251, MFCD00864906, AKOS016008786, DB01416, NCGC00532497-01, (6R,7R)-7-({(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(methyloxy)imino]acetyl}amino)-3-[(methyloxy)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 1ST12018, MS-27549, CS-0017595, D07650, Cefpodoxime, VETRANAL(TM), analytical standard, EN300-22411570, SR-01000872579, SR-01000872579-1, CEFPODOXIME PROXETIL IMPURITY A [EP IMPURITY], 4-{((R)-2-Carboxy-3-methoxymethyl-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-en-7-ylcarbamoyl)-[(Z)-methoxyimino]-methyl}-thiazol-2-yl-ammonium C15H17N5O6S2 WYUSVOMTXWRGEK-HBWVYFAYSA-N (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Pfizer Pharmaceuticals Antibiotics No No No No No No PMDBD2000628 Ceftazidime Therapeutic Substance Approved Drug 72558-82-8 DB00438 PA448861 D07654 D0PH5Z 5481173 4587145 NPC485036 ceftazidime, 72558-82-8, Tazidime, Fortaz, Ceftazidime anhydrous, Pentacef, Tazicef, Ceptaz, ceftazidima, ceftazidimum, GR 20263, CHEBI:3508, Fortaz (TN), (6R,7R)-7-[[2-(2-Amino-1,3-thiazol-4-yl)-2-(2-carboxypropan-2-yloxyimino)acetyl]amino]-8-oxo-3-(pyridin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate, 7-[[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-(2-carboxypropan-2-yloxyimino)acetyl]amino]-8-oxo-3-(pyridin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate, GR-20263, LY-139381, 78439-06-2, (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(2-carboxypropan-2-yloxyimino)acetyl]amino]-8-oxo-3-(pyridin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate, CAZ, J01DD07, 1-{[(6R,7R)-7-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(1-carboxy-1-methylethoxy)imino]acetamido]-2-carboxylato-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl}pyridin-1-ium, NSC-759260, E-Ceftazidime, Ceftazidime (TN), Ceptaz (TN), SCHEMBL36849, BIDD:GT0734, CHEMBL44354, DTXSID5022770, HMS2090M13, (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(2-carboxypropan-2-yl)oxy]imino}acetyl]amino}-8-oxo-3-(pyridinium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate, HY-B0593, BDBM50420259, AKOS015951273, CCG-269983, DB00438, NCGC00179584-05, CEFTAZIDIME (ARGININE FORMULATION), AB00513848, C06889, D07654, AB00513848-02, Cefprozil, Antibiotic for Culture Media Use Only, A839420, EN300-22411480, Q-200811, (6R,7R)-7-((Z)-2-(2-Aminothiazol-4-yl)-2-(((2-carboxypropan-2-yl)oxy)imino)acetamido)-8-oxo-3-(pyridin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate (contains ca. 10% Na2CO3), (6R,7R)-7-((Z)-2-(2-Aminothiazol-4-yl)-2-(((2-carboxypropan-2-yl)oxy)imino)acetamido)-8-oxo-3-(pyridin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate(containsca.10%Na2CO3), (6R,7R)-7-({(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(1-carboxy-1-methylethoxy)imino]acetyl}amino)-8-oxo-3-(pyridinium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate, 7beta-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(2-carboxypropan-2-yl)oxy]imino}acetyl]amino}-3-(pyridinium-1-ylmethyl)-3,4-didehydrocepham-4-carboxylate C22H22N6O7S2 ORFOPKXBNMVMKC-DWVKKRMSSA-N (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(2-carboxypropan-2-yloxyimino)acetyl]amino]-8-oxo-3-(pyridin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate GlaxoSmithKline Antibiotics No No No No No No PMDBD2000629 Ceftazidime hydrate n.a. n.a. n.a. n.a. n.a. n.a. n.a. 6536864 n.a. n.a. "Ceftazidime pentahydrate, Fortaz, Ceftazidime hydrate, Pentacef, Tazicef, Tazidime, Ceptaz, Fortum, CHEBI:3509, DTXSID0045599, 78439-06-2, biotum, Modacin, Fortam, Fortaz (TN), GR-20263, LY-139381, Glazidim, NCGC00017137-01, Ceftazidime (USP), Tazicef (TN), CAS-78439-06-2, Ceftazidime hydrate (JP17), CHEMBL3186392, DTXCID8025599, HMS2096B19, HMS3713B19, (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(2-carboxypropan-2-yloxyimino)acetyl]amino]-8-oxo-3-(pyridin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate;pentahydrate, Tox21_110797, AKOS027327285, CCG-220489, 1-[[(6R,7R)-7-[[(2Z)-2-(2-Amino-4-thiazolyl)-2-[(1-carboxy-1-methylethoxy)imino]acetyl]amino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]pyridinium Inner Salt Pentahydrate, D00921, Ceftazidime hydrate, >=90.0%, contains 10% sodium carbonate as stabilizer, (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(2-carboxypropan-2-yl)oxy]imino}acetyl]amino}-8-oxo-3-(pyridinium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate pentahydrate, 7beta-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(2-carboxypropan-2-yl)oxy]imino}acetyl]amino}-3-(pyridinium-1-ylmethyl)-3,4-didehydrocepham-4-carboxylate--water (1/5)" C22H32N6O12S2 NMVPEQXCMGEDNH-TZVUEUGBSA-N "(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(2-carboxypropan-2-yloxyimino)acetyl]amino]-8-oxo-3-(pyridin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate;pentahydrate" n.a. n.a. No No No No No No PMDBD2000630 Ceftizoxime Therapeutic Substance Approved Drug 68401-81-0 DB01332 PA164748758 n.a. D0Y7BD 6533629 5018818 n.a. ceftizoxime, 68401-81-0, Ceftizoxima, Ceftizoximum, Cefizox, Ceftizoximum [INN-Latin], Ceftizoxima [INN-Spanish], Epocelin, Ceftizoxime (INN), syn-7-(2-(2-Amino-4-thiazolyl)-2-methoxyiminoacetamido)-3-cephem-4-carboxylic acid, FK-749, C43C467DPE, (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, SKF-88373, CHEBI:553473, MFCD00072000, (6R,7R)-7-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, Ceftix, CEFTIZOXIME [INN], Ceftizoxime [INN:BAN], (E)-Ceftizoxime, UNII-C43C467DPE, (6R,7R)-7-(((2Z)-2-(2-AMINO-1,3-THIAZOL-4-YL)-2-METHOXYIMINOACETYL)AMINO)-8-OXO-5-THIA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXYLIC ACID, 68403-31-6, (6R,7R)-7-(2-(2-Amino-4-thiazolyl)-2Z-(methoxyimino)acetamido)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-2-carbonsaeure, (6R,7R)-7-(2-(2-Amino-4-thiazolyl)glyoxyamido)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-carbonsaeure-7-(Z)-(O-methyloxim), FR-13479, CEFTIZOXIME [MI], CEFTIZOXIME [JAN], CHEMBL528, CEFTIZOXIME [VANDF], SCHEMBL37504, CEFTIZOXIME [USP-RS], CEFTIZOXIME [WHO-DD], DTXSID5022772, BDBM237182, (6R,7R)-7-((Z)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, HY-B1596, s4812, AKOS025310621, CCG-268439, DB01332, (6R,7R)-7-({(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(methyloxy)imino]acetyl}amino)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 1ST12023, 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4- thiazolyl)(methoxyimino)acetyl)amino)-8-oxo-, (6R-(6-alpha,7-beta(Z)))-, 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-8-oxo-, (6R-(6alpha,7beta(Z)))-, 7beta-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-2,3-didehydropenam-2-carboxylic acid, C2622, CS-0013519, C06890, D07658, A836131, EN300-21584677, (6R,7R)-7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-methoxyimino-1-oxoethyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, (6R,7R)-7-[[(2Z)-2-(2-azanyl-1,3-thiazol-4-yl)-2-methoxyimino-ethanoyl]amino]-8-oxidanylidene-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, (6R,7R)-7-[[(2Z)-2-(2-imino-3H-thiazol-4-yl)-2-methoxyimino-acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2Z)-(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-8-oxo-, (6R,7R)- C13H13N5O5S2 NNULBSISHYWZJU-LLKWHZGFSA-N (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Fujisawa Pharmaceutical Co Antibiotics No No No No No No PMDBD2000631 Cephalexin Therapeutic Substance Approved Drug 15686-71-2 DB00567 PA448883 D00263 D0Z5EM 27447 25541 n.a. "cephalexin, Cefalexin, 15686-71-2, Cephacillin, Keflex, Ceporexin, Cepexin, Cephalexine, Cephalexinum, Ceporexine, Celexin, Cepastar, Ceporex, Keflet, Sinthecillin, Alcephin, Alsporin, Carnosporin, Cefablan, Cefaleksin, Cefalexina, Cefalexine, Cefalexinum, Cefaloto, Cephanasten, Durantel, Mamalexin, Uphalexin, Cefadin, Ceforal, Felexin, Pyassan, Tepaxin, Cefadina, Cefaseptin, Cephaxin, Cophalexin, Erocetin, Factagard, Inphalex, Kefalospes, Kekrinal, Lafarine, Lexibiotico, Lopilexin, Madlexin, Mamlexin, Medoxine, Neolexina, Ortisporina, Sartosona, Sencephalin, Servispor, Sialexin, Sporicef, Sporidex, Tokiolexin, Zozarine, Alexin, Cefadal, Cefalin, Cefovit, Cephin, Ibilex, Ibrexin, Kefolan, Kidolex, Larixin, Lenocef, Lonflex, Neokef, Oracef, Oriphex, Oroxin, Ospexin, Pectril, Roceph, Sanaxin, Sepexin, Syncle, Synecl, Voxxim, Winlex, Cefax, Cepol, Check, Fexin, Nufex, Syncl, Ceporex Forte, Cefa-iskia, Ceporexin-E, Durantel DS, L-Keflex, Cefalessina, Cephalexin anhydrous, Ed A-Ceph, Novolexin, Palitrex, Biocef, Keforal, Roceph Distab, Cefalessina [DCIT], Panixine Disperdose, Ceflax, Cefalexine [INN-French], Cefalexinum [INN-Latin], Lilly 66873, Cefalexina [INN-Spanish], Cerexin, Optocef, Cefalexin anhydrous, 7-(D-alpha-Aminophenylacetamido)desacetoxycephalosporanic acid, Anhydrous cephalexin, Taicelexin, Cerexins, CHEBI:3534, HSDB 3022, 7-beta-(D-alpha-Amino-alpha-phenylacetylamino)-3-methyl-3-cephem-4-carboxylic acid, Anhydrous cefalexin, EINECS 239-773-6, Cefalexin [INN], Ceffanex, UNII-5SFF1W6677, BRN 0965503, CEFADROS, CEPHAMASTEN, EFALEXIN, GARASIN, IWALEXIN, KEFLORIDINA, ORACOCIN, CEX, DTXSID9022780, 5SFF1W6677, 7-(D-2-Amino-2-phenylacetamido)-3-methyl-delta3-cephem-4-carboxylic acid, SQ 20248, CHEMBL1727, DTXCID002780, LILLY-66873, NSC 758162, (6R,7R)-7-{[(2R)-2-amino-2-phenylacetyl]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, NCGC00159522-02, NSC-758162, (6R,7R)-7-((R)-2-amino-2-phenylacetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, (6R,7R)-7-[[(2R)-2-amino-2-phenylacetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2R)-aminophenylacetyl)amino)-3-methyl-8-oxo-, (6R,7R)-, 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2R)-aminophenylacetyl]amino]-3-methyl-8-oxo-, (6R,7R)-, L-Cephalexin, Cephalexin 1-hydrate, CEPHALEXIN (USP-RS), 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((aminophenylacetyl)amino)-3-methyl-8-oxo-, (6R-(6alpha,7beta(R*)))-, Cephalexin [USAN:BAN], (6R,7R)-7-[(2R)-2-amino-2-phenylacetamido]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, SMR000338536, CEPHALEXIN (USP MONOGRAPH), S 6437, CAS-15686-71-2, Keflex (TN), CEFALEXIN MONOHYDRATE (EP IMPURITY), CEFALEXIN MONOHYDRATE (EP MONOGRAPH), Amplex, 7beta-((2R)-2-amino-2-phenylacetamido)-3-methyl-3,4-didehydrocepham-4-carboxylic acid, 7beta-[(2R)-2-amino-2-phenylacetamido]-3-methyl-3,4-didehydrocepham-4-carboxylic acid, Cefalexin,(S), (6R,7R)-7-(((2R)-2-amino-2-phenylacetyl)amino)-3-methyl-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, (6R,7R)-7-((R)-2-AMINO-2-PHENYLACETAMIDO)-3-METHYL-8-OXO-5-THIA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXYLIC ACID, 34632-04-7, Cefalexin (JP17), Cephalexin (Cefalexin), CEFALEXIN [JAN], CEPHALEXIN [MI], Prestwick0_000358, Prestwick1_000358, Prestwick2_000358, Prestwick3_000358, CEPHALEXIN [HSDB], Epitope ID:117132, CEFALEXIN [WHO-DD], SCHEMBL2961, 7-(D-2-Amino-2-phenylacetamido)-3-methyl-delta (sup 3)-cephem-4- carboxylic acid, BSPBio_000455, (6R,7R)-7-((R)-2-Amino-2-phenylacetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-2-carbonsaeure, MLS000759527, MLS001424036, SPBio_002376, BPBio1_000501, GTPL4832, BCPP000289, HMS2051A04, HY-B0200, Tox21_111740, BDBM50139896, MFCD00056877, AKOS004119846, Tox21_111740_1, BCP9000509, CCG-100831, CS-2137, DB00567, NC00081, 7-(D-2-Amino-2-phenylacetamido)-3-methyl-delta (sup 3)-cephem-4-carboxylic acid, NCGC00159522-03, NCGC00159522-05, (6R,7R)-7-[[(2R)-2-amino-2-phenyl-acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(2-amino-2-phenylacetamido)-3-methyl-8-oxo-, D-, DS-11971, NS00098606, Cefalexin, VETRANAL(TM), analytical standard, C-2660, C06895, D00263, H10995, S-6437, Cefalexin 1000 microg/mL in Acetonitrile:Water, Cephalexin, Antibiotic for Culture Media Use Only, Q411417, Q-200819, BRD-K90733503-002-03-6, Cefalexin, British Pharmacopoeia (BP) Reference Standard, Z1880962282, Cephalexin monohydrate, Antibiotic for Culture Media Use Only, 7-(D-alpha-amino-phenylacetamido)-3-methyl-3-cepheme-4-carboxylic acid, Cephalexin, Pharmaceutical Secondary Standard; Certified Reference Material, 7-(D-.ALPHA.-AMINO-.ALPHA.-PHENYLACETAMIDO)-3-METHYL-3-CEPHEM-4-CARBOXYLIC ACID, 7-(D-alpha-AMINO-alpha-PHENYLACETAMIDO)-3-METHYL-3-CEPHEM-4-CARBOXYLIC ACID, (6R,7R)-7-((2R)-2-Amino-2-phenylacetylamino)-3-methyl-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, (6R,7R)-7-((R)-2-Amino-2-phenyl-acetylamino)-3-methyl-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid, (6R,7R)-7-((R)-2-amino-2-phenylacetamido)-3-methyl-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 5-THIA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXYLIC ACID, 7-((AMINOPHENYLACETYL)AMINO)-3-METHYL-8-OXO-,(6R-(6.ALPHA.,7.BETA.(R*)))-" C16H17N3O4S ZAIPMKNFIOOWCQ-UEKVPHQBSA-N (6R,7R)-7-[[(2R)-2-amino-2-phenylacetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Eli Lilly Antibiotics No No No No No No PMDBD2000632 Cephaloglycin Therapeutic Substance Approved Drug 3/1/3577 DB00689 PA164781027 D01949 D07WZH 19150 18069 n.a. Cefaloglycin, CEPHALOGLYCIN, Cephaloglycine, D-Cephaloglycine, Cephaoglycin acid, Cephaloglycin anhydrous, Cefaloglycine, 3577-01-3, Cefaloglicina, Cefaloglycinum, Kefglycin, D-(-)-Cephaloglycin, Kafocin, Lilly 39435, 7-(D-alpha-Aminophenyl-acetamido)cephalosporanic acid, 7-(2-D-alpha-Aminophenylacetamido)cephalosporanic acid, Cefaloglycine [INN-French], Cefaloglycinum [INN-Latin], Cefaloglicina [INN-Spanish], Kefocin, CHEBI:34613, Cefaloglycin (JAN), Cefaloglycin [INN], HD2D469W6U, Cefaloglycin dihydrate, Cephaloglycin anhdyous, HSDB 3214, EINECS 222-696-7, (6R,7R)-3-(acetyloxymethyl)-7-[[(2R)-2-amino-2-phenylacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, CEG, Cephaloglycin dihydrate, UNII-HD2D469W6U, 7-(D-2-Amino-2-phenylacetamido)-3-acetoxymethyl-delta(sup3)-cephem-4-carboxylic acid, 7-(2-Amino-2-phenylacetamido)-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid acetate (ester), DTXSID4022781, 7-(D-2-Amino-2-phenylacetamido)-3-acetoxymethyl-delta(sup 3)-cephem-4-carboxylic acid, 3-((Acetyloxy)methyl)-7-((aminophenylacetyl)amino)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-((acetyloxy)methyl)-7-((aminophenylacetyl)amino)-8-oxo-, (6R-(6alpha,7beta(R*)))-, 7-(2-Amino-2-phenylacetamido)-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)octane-2-carboxylic acid, acetate inner salt, CEFALOGLYCIN [JAN], Cefaloglycine (INN-French), Cefaloglycinum (INN-Latin), Cefaloglicina (INN-Spanish), 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(2-amino-2-phenylacetamido)-3-(hydroxymethyl)-8-oxo-, acetate (ester), D-, 3-acetoxymethyl-7beta-[(2R)-2-amino-2-phenylacetamido]-3,4-didehydrocepham-4-carboxylic acid, (6R,7R)-3-(acetoxymethyl)-7-{[(2R)-2-amino-2-phenylacetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, (6R,7R)-3-[(acetyloxy)methyl]-7-[(2R)-2-amino-2-phenylacetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, (6R,7R)-7-((R)-2-AMINO-2-PHENYLACETAMIDO)-3-(HYDROXYMETHYL)-8-OXO-5-THIA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXYLIC ACID ACETATE (ESTER), 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,3-[(acetyloxy)methyl]-7-[[(2R)-aminophenylacetyl]amino]-8-oxo-,(6R,7R)-, (6R,7R)-3-(acetoxymethyl)-7-(((2R)-2-amino-2-phenylacetyl)amino)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-acetoxymethyl-7beta-((2R)-2-amino-2-phenylacetamido)-3,4-didehydrocepham-4-carboxylic acid, 7-(D-alpha-Aminophenylacetamido)-cephalosporanic acid dihydrate, 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-carboxylic acid, 3-((acetyloxy)methyl)-7-((aminophenylacetyl)amino)-8-oxo-, (6R-(6alpha,7beta(R*))), dihydrate, CEPHALOGLYCIN [MI], Epitope ID:174844, SCHEMBL2947, CEPHALOGLYCIN [HSDB], CEFALOGLYCIN [WHO-DD], DTXCID402781, CHEMBL1200971, GTPL12193, DB00689, NCGC00521078-02, (6R,7R)-3-[(acetyloxy)methyl]-7-{[(2R)-2-amino-2-phenylacetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, HY-16137, CS-0006156, NS00011574, D01949, EN300-19734691, Q5057214, 7-(D-ALPHA-AMINOPHENYLACETAMIDO)CEPHALOSPORANIC ACID, 7-(2-AMINO-2-PHENYLACETAMIDO)-3-(HYDROXYMETHYL)-8-OXO-5 -THIA-1-AZABICYCLO, 5-THIA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXYLIC ACID, 3-((ACETYLOXY)METHYL)-7-((AMINOPHENYLACETYL)AMINO)-8-OXO-, (6R-(6AL///, 5-THIA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXYLIC ACID, 7-(2-AMINO-2-PHENYLACETAMIDO)-3-(HYDROXYMETHYL)-8-OXO-, ACETATE (ES///, 5-THIA-1-AZABICYCLO(4.2.0)OCT-2-ENE-CARBOXYLIC ACID, 3-((ACETYLOXY)METHYL)-7-((AMINOPHENYLACETYL)AMINO)-8-OXO-, (6R-(6.ALPHA.,7.BETA.(R*))), 5-THIA-1-AZABICYCLO(4.2.0)OCT-2-ENE-CARBOXYLIC ACID, 3-((ACETYLOXY)METHYL)-7-((AMINOPHENYLACETYL)AMINO)-8-OXO-, (6R-(6alpha,7beta(R*))) C18H19N3O6S FUBBGQLTSCSAON-PBFPGSCMSA-N (6R,7R)-3-(acetyloxymethyl)-7-[[(2R)-2-amino-2-phenylacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid n.a. Antibiotics No No No No No No PMDBD2000633 Cerulenin Therapeutic Substance Approved Drug 17397-89-6 DB01034 PA164764551 n.a. D03ZFG 5282054 4445281 n.a. cerulenin, 17397-89-6, Helicocerin, (2R,3S)-3-((4E,7E)-nona-4,7-dienoyl)oxirane-2-carboxamide, 2,3-Epoxy-4-oxo-7,10-dodecadienamide, (2R,3S)-3-[(4E,7E)-nona-4,7-dienoyl]oxirane-2-carboxamide, (2R,3S)-2,3-Epoxy-4-oxo-7E,10E-dodecadienamide, CHEMBL45627, CHEBI:171741, MF286Y830Q, (2R,3S)-3-((4E,7E)-Nona-4,7-dienoyl)-oxirane-2-carboxylic acid amide, Cerulenin (synthetic), (+)-Cerulenin, SR-05000002362, EINECS 241-424-8, NSC 116069, UNII-MF286Y830Q, 3-(1-Oxo-4,7-nonadienyl)oxiranecarboxamide, 2-Oxiranecarboxamide, 3-[(4E,7E)-1-oxo-4,7-nonadien-1-yl]-, (2R,3S)-, NSC-116069, 2-OXIRANECARBOXAMIDE, 3-((4E,7E)-1-OXO-4,7-NONADIEN-1-YL)-, (2R,3S)-, 7,10-DODECADIENAMIDE, 2,3-EPOXY-4-OXO-, Oxiranecarboxamide, 3-(1-oxo-4,7-nonadienyl)-, (2R-(2alpha,3alpha(4E,7E)))-, (2S)(3R)-2,3-Epoxy-4-oxo-7,10-dodecadienoylamide, CERULENIN [MI], (2R,3S,E,E)-2,3-Epoxy-4-oxo-7,10-dodecadienamide, SCHEMBL41207, BSPBio_001276, MLS006010821, (2r,3s)-3-(nona-4,7-dienoyl)oxirane-2-carboxamide, DTXSID2040995, CHEBI:94649, GVEZIHKRYBHEFX-NQQPLRFYSA-N, HMS1362P17, HMS1792P17, HMS1990P17, HMS3403P17, HMS3649F20, HY-A0210, BDBM50009248, MFCD00077686, MFCD00083595, NSC764755, (2R,3S)-3-[(4E,7E)-1-Oxo-4,7-nonadien-1-yl]-2-oxiranecarboxamide, (2R-(2alpha,3alpha(4E,7E)))-3-(1-Oxonona-4,7-dienyl)oxirane-2-carboxamide, 2,3-Epoxy-4-oxo-10-dodecadienamide, Oxiranecarboxamide, 3-(1-oxo-4,7-nonadienyl)-, [2R-[2a,3a(4E,7E)]]-, CCG-208171, CS-6992, DB01034, NSC-764755, IDI1_002233, Oxiranecarboxamide, 3-(1-oxo-4,7-nonadienyl)-, (2R-(2-alpha,3-alpha(4E,7E)))-, NCGC00163492-01, NCGC00163492-02, G237, SMR000058786, NS00025714, F85539, 3-Nona-4,7-dienoyl-oxirane-2-carboxylic acid amide, J-010957, Q5065296, SR-05000002362-2, SR-05000002362-3, BRD-K52075040-001-02-2, BRD-K52075040-001-03-0, BRD-K52075040-001-04-8, Cerulenin, >=98% (HPLC), from Cephalosporium caerulens, Cerulenin, Cephalosporium caerulens - CAS 17397-89-6, Z2311575475, (2R,3S)-3-[(4E,7E)-4,7-Nonadienoyl]-2-oxiranecarboxamide, 2R,3S)-3-[(4E,7E)-Nona-4,7-dienoyl]oxirane-2-carboxamide, 3-Nona-4,7-dienoyl-oxirane-2-carboxylic acid amide(Cerulenin), Oxiranecarboxamide, 3-[(4E,7E)-1-Oxo-4,7-nonadienyl]-, (2R,3S)-, (2R-(2.ALPHA.,3.ALPHA.(4E,7E)))-3-(1-OXONONA-4,7-DIENYL)OXIRANE- 2-CARBOXAMIDE, 1X9, OXIRANECARBOXAMIDE, 3-(1-OXO-4,7-NONADIENYL)-, (2R-(2- .ALPHA.,3-.ALPHA.(4E,7E)))- C12H17NO3 GVEZIHKRYBHEFX-NQQPLRFYSA-N (2R,3S)-3-[(4E,7E)-nona-4,7-dienoyl]oxirane-2-carboxamide n.a. Antiinfective Agents No No No No No No PMDBD2000634 Cerulenin? n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000635 CGP-37157 n.a. n.a. n.a. n.a. n.a. n.a. n.a. 2688 n.a. n.a. 75450-34-9, CGP 37157, CGP37157, CGP-37157, 7-Chloro-5-(2-chlorophenyl)-1,5-dihydro-4,1-benzothiazepin-2(3H)-one, CHEMBL1495071, 7-chloro-5-(2-chlorophenyl)-1,5-dihydro-4,1-benzothiazepin-2-one, C15H11Cl2NOS, BSPBio_001556, KBioGR_000276, KBioSS_000276, SCHEMBL869274, 4,1-Benzothiazepin-2(3H)-one, 7-chloro-5-(2-chlorophenyl)-1,5-dihydro-, CHEBI:91650, GTPL11611, KBio2_000276, KBio2_002844, KBio2_005412, KBio3_000551, KBio3_000552, YSSJ00988, DTXSID60996899, Bio1_000408, Bio1_000897, Bio1_001386, Bio2_000276, Bio2_000756, HMS1361N18, HMS1791N18, HMS1989N18, HMS3267K16, HMS3402N18, HMS3412I15, HMS3676I15, HMS3867M03, BDBM50139422, CM-119, HB1132, HSCI1_000330, AKOS024456390, IDI1_034026, NCGC00025008-02, NCGC00025008-03, HY-15754, MS-24819, CS-0008572, E0002, CGP-37157, >=98% (HPLC), powder, G13547, SR-01000597388, SR-01000597388-1, BRD-A35623999-001-02-4, BRD-A35623999-001-03-2, BRD-A35623999-001-04-0, CGP-37157 - CAS 75450-34-9, Q27163475, 7-Chloro-5-(2-chlorophenyl)-3,5-dihydro-4,1-benzothiazepin-2-ol, 7-chloro-5-(2-chlorophenyl)-1,5-dihydrobenzo[e][1,4]thiazepin-2(3H)-2weeks C15H11Cl2NOS KQEPIRKXSUIUTH-UHFFFAOYSA-N 7-chloro-5-(2-chlorophenyl)-1,5-dihydro-4,1-benzothiazepin-2-one n.a. n.a. No No No No No No PMDBD2000636 Ch Dhvar5 ads n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000637 Ch_GG_Nt-Dhvar5 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000638 Chelerythrine Therapeutic Substance Investigational Drug 34316-15-9 DB17024 n.a. n.a. D0T9ZL 2703 2602 NPC100079 chelerythrine, 34316-15-9, Toddalin, cheleritrine, broussonpapyrine, Toddaline, EINECS 251-930-0, [1,3]Benzodioxolo[5,6-c]phenanthridinium, 1,2-dimethoxy-12-methyl-, UNII-E3B045W6X0, CHEBI:78373, 1,2-dimethoxy-12-methyl-[1,3]benzodioxolo[5,6-c]phenanthridin-12-ium, E3B045W6X0, CHEMBL13045, 1,2-Dimethoxy-12-methyl(1,3)benzodioxolo(5,6-c)phenanthridinium, 1,2-Dimethoxy-12-Methyl[1,3]benzodioxolo[5,6-C]phenanthridin-12-Ium, 1,2-Dimethoxy-12-methyl[1,3]benzodioxolo[5,6-c]phenanthridinium, 1,2-Dimethoxy-12-methyl-[1,3]dioxolo-[4'',5'':4,5]benzo[1,2-c]phenanthridin-12-ium, 1,2-Dimethoxy-12-methyl-[1,3]dioxolo[4'',5'':4,5]benzo[1,2-c]phenanthridin-12-ium, (1,3)BENZODIOXOLO(5,6-C)PHENANTHRIDINIUM, 1,2-DIMETHOXY-12-METHYL-, 1,2-DIMETHOXY-12-METHYL(1,3)DIOXOLO)4'',5'':4,5)BENZO(1,2-C)PHENANTHRIDINIUM, NSC646662, 1,2-Dimethoxy-N-methyl(1,3)benzodioxolo(5,6-c)phenanthridinium chloride, Chelerytherine, Chelerythrine?, SR-01000075750, 1,2-dimethoxy-12-methyl(1,3)benzodioxolo(5,6-c)phenanthridin-12-ium, CTI, Lopac-C-2932, CHELERYTHRINE [MI], Lopac0_000241, BSPBio_001558, SCHEMBL288915, CHELERYTHRINE [WHO-DD], GTPL5953, MEGxp0_001953, BDBM25524, DTXSID20861211, HMS1791N20, HMS1989N20, HMS3402N20, BCP02912, HY-N2359, CHELERYTHRINE(TODDALINE)(RG), AKOS028108433, CCG-204336, NCGC00015225-01, NCGC00015225-02, NCGC00015225-03, NCGC00015225-04, NCGC00015225-05, NCGC00015225-06, NCGC00015225-07, NCGC00162102-01, NCGC00162102-02, NCGC00162102-03, NCGC00162102-04, NCGC00162102-05, NCI60_003349, NCI60_041672, 1ST157280, CS-0022541, NS00089928, Q5089853, SR-01000075750-5, BRD-K87904882-001-02-3, 1,2-Dimethoxy-12-methyl-12lambda~5~-[1,3]benzodioxolo[5,6-c]phenanthridine hydrochloride, 17,18-dimethoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0^{2,10}.0^{4,8}.0^{14,19}]henicosa-1(13),2,4(8),9,11,14(19),15,17,20-nonaen-21-ium, 17,18-dimethoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0^{2,10}.0^{4,8}.0^{14,19}]henicosa-1(13),2,4(8),9,11,14,16,18,20-nonaen-21-ium C21H18NO4+ LLEJIEBFSOEYIV-UHFFFAOYSA-N 1,2-dimethoxy-12-methyl-[1,3]benzodioxolo[5,6-c]phenanthridin-12-ium n.a. n.a. No No No No No No PMDBD2000639 Chitosan n.a. n.a. n.a. n.a. n.a. n.a. n.a. 71853 n.a. n.a. Chitosan, Poliglusam, 9012-76-4, Chicol, Flonac C, Flonac N, Sea Cure Plus, Kytex H, Kytex M, Sea Cure F, Kimitsu Chitosan F, Kimitsu Chitosan H, Kimitsu Chitosan L, Kimitsu Chitosan M, Chitopearl 3510, Kimitsu Chitosan F 2, Chitopearl BC 3000, Chitopearl BCW 2500, Chitopearl BCW 3000, Chitopearl BCW 3500, Chitopearl BCW 3505, Chitopearl BCW 3507, CTA 4, Chitosan - Non-animal origin, YEA, SCHEMBL972215, SCHEMBL21304990, FLASNYPZGWUPSU-SICDJOISSA-N, AKOS015918343, AKOS037652919, FS-4075, PD087114, YC171030, C2395, C2396, NS00013452, A843451, A845562, Q408510, Chitosan high molecular weight,310000-375000Da, Chitosan low molecular weight,50,000-190,000Da, inverted exclamation markY95% (deacetylated) ,viscosity 100-200 mPa.s from shrimp shells, methyl N-[(2S,3R,4R,5S,6R)-5-[(2S,3R,4R,5S,6R)-3-azanyl-5-[(2S,3R,4R,5S,6R)-3-azanyl-5-[(2S,3R,4R,5S,6R)-3-azanyl-5-[(2S,3R,4R,5S,6R)-3-azanyl-5-[(2S,3R,4R,5S,6R)-3-azanyl-5-[(2S,3R,4R,5S,6R)-3-azanyl-6-(hydroxymethyl)-4,5-bis(oxidanyl)oxan-2-yl]oxy-6-(hy, methyl N-[5-[3-amino-5-[3-amino-5-[3-amino-5-[3-amino-5-[3-amino-5-[3-amino-4,5-dihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-4-hydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-4-hydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-4-hydroxy-6-(hydrox, N-[(2S,3R,4R,5S,6R)-5-[[(2S,3R,4R,5S,6R)-3-amino-5-[[(2S,3R,4R,5S,6R)-3-amino-5-[[(2S,3R,4R,5S,6R)-3-amino-5-[[(2S,3R,4R,5S,6R)-3-amino-5-[[(2S,3R,4R,5S,6R)-3-amino-5-[[(2S,3R,4R,5S,6R)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)-2-oxanyl]oxy]-4-hydroxy-6-(hy C56H103N9O39 FLASNYPZGWUPSU-SICDJOISSA-N methyl N-[(2S,3R,4R,5S,6R)-5-[(2S,3R,4R,5S,6R)-3-amino-5-[(2S,3R,4R,5S,6R)-3-amino-5-[(2S,3R,4R,5S,6R)-3-amino-5-[(2S,3R,4R,5S,6R)-3-amino-5-[(2S,3R,4R,5S,6R)-3-amino-5-[(2S,3R,4R,5S,6R)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-[(2R,3S,4R,5R,6S)-5-amino-6-[(2R,3S,4R,5R,6R)-5-amino-4,6-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4-hydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4-hydroxy-6-(hydroxymethyl)oxan-3-yl]carbamate n.a. n.a. No No No No No No PMDBD2000640 Chlorhexidine acetate n.a. n.a. n.a. n.a. n.a. n.a. n.a. 9562059 n.a. n.a. "Chlorhexidine diacetate, Chlorhexidine acetate, 56-95-1, Bactigras, Hibitane diacetate, Chlorhexidine (diacetate), Chlorhexidine acetate [USP], DTXSID7032345, 5908ZUF22Y, Chlorohexidine diacetate, NSC-526936, 1,1''-Hexamethylenebis(5-(p-chlorophenyl)biguanide) diacetate, 206986-79-0, Chlorhexidine acetate (USP), acetic acid;(1E)-2-[6-[[amino-[(E)-[amino-(4-chloroanilino)methylidene]amino]methylidene]amino]hexyl]-1-[amino-(4-chloroanilino)methylidene]guanidine, Caswell No. 481E, 1,1''-Hexamethylenebis[5-(4-chlorophenyl)biguanide] Diacetate, 10,040 Diacetate, Chlorhexidine di(acetate), Bis(p-chlorophenyldiguanidohexane) diacetate, Chlorhexidine acetate (VAN), Chlorhexidine diacetate salt hydrate, 1,6-Bis(p-chlorophenylbiguanido)hexane diacetate, 1,6-Bis(5-(p-chlorophenyl)biguandino)hexane diacetate, EINECS 200-302-4, 1,1''-Hexamethylenebis(5-(p-chlorophenyl)biguanide)diacetate, 1,1''-Hexamethylene bis(5-(p-chlorophenyl)biguanide) diacetate, chlorhexidine diacetate salt, EPA Pesticide Chemical Code 045502, NSC 526936, 1,1''-Hexamethylenebis[5-(p-chlorophenyl)biguanide] diacetate, UNII-5908ZUF22Y, 1,6-Bis(N5-[p-chlorophenyl]-N1-biguanido)hexane, 1,1''-HEXAMETHYLENEBIS(5-(4-CHLOROPHENYL)BIGUANIDE) DIACETATE, N'',N''''''''''-hexane-1,6-diylbis[N-(4-chlorophenyl)(imidodicarbonimidic diamide)] diacetate, Nolvasan (TN), 1,6-Di(4''-chlorophenyldiguanidino)hexane diacetate, Chlorhexidini diacetas, 2,4,11,13-Tetraazatetradecanediimidamide, N,N''''-bis(4-chlorophenyl)-3,12-diimino-, diacetate, SCHEMBL12043, CHEMBL486819, DTXCID5012345, CHEBI:81711, 1,1''-Hexamethylenebis(5-(p-chlorophenyl)biguanide), diacetate, CHLORHEXIDINE DIACETATE [MI], Tox21_302363, s6288, CHLORHEXIDINE ACETATE [MART.], CHLORHEXIDINE DIACETATE [INCI], AKOS007930358, BIGUANIDE, 1,1''-HEXAMETHYLENEBIS(5-(p-CHLOROPHENYL)-, DIACETATE, CHLORHEXIDINE ACETATE [USP-RS], CS-W014415, HY-W013699, 2,4,11,13-Tetraazatetradecanediimidamide, N,N''-bis(4-chlorophenyl)-3,12-diimino-, diacetate, CAS-56-95-1, CHLORHEXIDINE DIACETATE [WHO-DD], CHLORHEXIDINE DIACETATE [WHO-IP], NCGC00091025-03, NCGC00255277-01, AS-12655, CHLORHEXIDINE ACETATE [GREEN BOOK], C2511, CHLORHEXIDINE ACETATE [USP MONOGRAPH], CHLORHEXIDINI DIACETAS [WHO-IP LATIN], CHLORHEXIDINE DIACETATE [EP MONOGRAPH], C18372, D07669, A831251, W-109258, Chlorhexidine diacetate salt hydrate, bis(biguanide) antimicrobial, Chlorhexidine acetate, Pharmaceutical Secondary Standard; Certified Reference Material, (1E)-2-[6-[[azanyl-[(E)-[azanyl-[(4-chlorophenyl)amino]methylidene]amino]methylidene]amino]hexyl]-1-[azanyl-[(4-chlorophenyl)amino]methylidene]guanidine; ethanoic acid, acetic acid; 2-[amino-[6-[[amino-[(E)-[amino-(4-chloroanilino)methylidene]amino]methylidene]amino]hexylimino]methyl]-1-(4-chlorophenyl)guanidine, N,N''-Bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradeca-nediimidamide, diacetate" C26H38Cl2N10O4 WDRFFJWBUDTUCA-UHFFFAOYSA-N "acetic acid;(1E)-2-[6-[[amino-[(E)-[amino-(4-chloroanilino)methylidene]amino]methylidene]amino]hexyl]-1-[amino-(4-chloroanilino)methylidene]guanidine" n.a. n.a. No No No No No No PMDBD2000641 Chlorpromazine Therapeutic Substance Approved Drug 50-53-3 DB00477 PA448964 D00270 D01ZII 2726 n.a. NPC484525 "chlorpromazine, Thorazine, 50-53-3, Largactil, Chloropromazine, Aminazine, Contomin, Chlorderazin, Propaphenin, Chlorpromados, Fenactil, Sanopron, Wintermin, Esmind, Largactilothiazine, Megaphen, Novomazina, Chlorpromazinum, Chlorpromazin, Largactyl, Phenactyl, Promactil, Aminazin, Elmarin, Fenaktyl, Promazil, Torazina, 2-Chloropromazine, Proma, Prozil, Chlor-Promanyl, Clorpromazina, Ampliactil, Psychozine, Fraction AB, 3-(2-chloro-10H-phenothiazin-10-yl)-N,N-dimethylpropan-1-amine, Amplictil, Aminasine, SKF 2601-A, Chlor-PZ, HL 5746, BC 135, CPZ, Cromedazine, Plegomasine, Amplicitil, 10H-Phenothiazine-10-propanamine, 2-chloro-N,N-dimethyl-, 3-(2-chlorophenothiazin-10-yl)-N,N-dimethylpropan-1-amine, N-(3-Dimethylaminopropyl)-3-chlorophenothiazine, HSDB 3033, Chlorpromazinum [INN-Latin], Clorpromazina [INN-Spanish], Chlorpromazine Tannate, 4560 R.P., 3-(2-chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine, CCRIS 3711, CHEBI:3647, [3-(2-chloro-10H-phenothiazin-10-yl)propyl]dimethylamine, UNII-U42B7VYA4P, Hemoglobin kodaira, EINECS 200-045-8, U42B7VYA4P, 2-Cloro-10 (3-dimetilaminopropil)fenotiazina, 2-chloro-N,N-dimethyl-10H-Phenothiazine-10-propanamine, NSC 167745, NSC-167745, 3-(2-Chloro-10H-phenothiazin-10-yl)-N,N-dimethyl-1-propanamine, 34468-21-8, DTXSID0022808, 2-Chloro-10-(3-(dimethylamino)propyl)phenothiazine, 2-Chloro-10-[3-(dimethylamino)propyl]phenothiazine, Chloro-3 (dimethylamino-3 propyl)-10 phenothiazine, SKF-2601A, CHEMBL71, GG 407, NSC-226514, J2.794D, Phenothiazine, 2-chloro-10-(3-(dimethylamino)propyl)-, DTXCID002808, Chlorpromazine [USP:INN:BAN], Phenothiazine hydrochloride, Hibanil, Unitensen, NSC167745, Phenothiazine, 2-chloro-10-[3-(dimethylamino)propyl]-, NCGC00015273-11, Thorazine Suppositories, Clorpromazina [Italian], Chlorpromazinum (INN-Latin), Clorpromazina (INN-Spanish), 146702-01-4, CHLORPROMAZINE (MART.), CHLORPROMAZINE [MART.], Chlorpromazine (USP:INN:BAN), Prazilpromactil, Chlordelazin, Phenathyl, chlorpromethazine, CHLORPROMAZINE (USP MONOGRAPH), CHLORPROMAZINE [USP MONOGRAPH], CAS-50-53-3, Thorazine (TN), Z80, chlorpromazine cation, [3-(2-chloro-10H-phenothiazin-10-yl)propyl]dimethylamine hydrochloride, CAS-69-09-0, Chlorpromazine (USP/INN), Chlorpromazine cation radical, Amplicatil, Chlropromados, Fraction, 2-Cloro-10 (3-dimetilaminopropil)fenotiazina [Italian], JHICC02042, Chloro-3 (dimethylamino-3 propyl)-10 phenothiazine [French], SKF 2601A, SKF-2601, Hibernal (Salt/Mix), Lomazine (Salt/Mix), Tranzine (Salt/Mix), Norcozine (Salt/Mix), Spectrum_000142, Prestwick0_000064, Prestwick1_000064, Prestwick2_000064, Prestwick3_000064, Spectrum2_001156, Spectrum3_000346, Spectrum4_000283, Spectrum5_000717, Lopac-C-8138, Biomol-NT_000020, Epitope ID:136898, GTPL83, 10H-Phenothiazine-10-propanamine, 2-chloro-N,N-dimethyl-, radical ion(1+), CHLORPROMAZINE [MI], SCHEMBL8321, CHLORPROMAZINE [INN], 10-(3-Dimethylaminopropyl)-2-chlorophenothiazine, 2-Chloro-10-(3-dimethylaminopropyl)phenothiazine, Lopac0_000249, Oprea1_110255, BSPBio_000247, BSPBio_002011, CHLORPROMAZINE [HSDB], KBioGR_000806, KBioGR_002312, KBioSS_000622, KBioSS_002314, MLS003166901, CHLORPROMAZINE [VANDF], CHLORPROMAZINUM [HPUS], DivK1c_000624, SPECTRUM1500184, 2-chloro-10-(3-(dimethylamino)propyl)-phenothiazine, 6-(Dimethylamino)nicotinicacid, SPBio_001111, SPBio_002168, BPBio1_000273, BPBio1_001181, QSPL 401, CHLORPROMAZINE [WHO-DD], HMS501P06, KBio1_000624, KBio2_000622, KBio2_002312, KBio2_003190, KBio2_004880, KBio2_005758, KBio2_007448, KBio3_001231, KBio3_002792, A10BB02, N05AA01, N05AF03, cMAP_000017, NINDS_000624, Bio1_000457, Bio1_000946, Bio1_001435, HMS1920M03, HMS2089C12, HMS2091E06, HMS3430C19, HMS3886G22, KUC112482N, Pharmakon1600-01500184, BCP03610, CHLORPROMAZINE [ORANGE BOOK], Tox21_110120, BDBM50001888, CCG-40059, MFCD00133295, NSC756661, NSC756689, s5749, AKOS001490972, Tox21_110120_1, 4560 RP, DB00477, KS-5101, NSC-756661, NSC-756689, RP-4560, SDCCGSBI-0050237.P005, IDI1_000624, PS31 - Chlorpromazine/Norchlorpromazine, QTL1_000021, NCGC00015273-01, NCGC00015273-02, NCGC00015273-03, NCGC00015273-04, NCGC00015273-05, NCGC00015273-06, NCGC00015273-07, NCGC00015273-08, NCGC00015273-09, NCGC00015273-10, NCGC00015273-12, NCGC00015273-13, NCGC00015273-14, NCGC00015273-15, NCGC00015273-16, NCGC00015273-17, NCGC00015273-19, NCGC00015273-31, NCGC00024409-04, NCGC00024409-05, NCGC00024409-06, NCGC00024409-07, NCGC00024409-08, KSC-315-032-, SMR001453710, 2-chloro-10-[3-(dimethylamino)propyl]-, SBI-0050237.P004, WLN: T C666 BN ISJ B3N1&1 EG, 2601A, AB00051943, NS00001759, 2601-A, C06906, D00270, AB00051943-15, AB00051943-16, AB00051943_17, AB00051943_18, 3-Chloro-10-(3-dimethylaminopropyl)phenothiazine, L000182, Q407972, SR-01000000012-5, SR-01000000012-6, 2-Chloro-10-(N-dimethylamino-n-propyl)-phenothiazine, BRD-K89997465-001-05-3, 10h-phenothiazine-10-propanamine, 2-chloro-n,n-dimethyl, 1N,1N-dimethyl-3-(2-chloro-10H-10-phenothiazinyl)-1-propanamine, 3-(2-Chloro-10H-phenothiazin-10-yl)-N,N-dimethyl-1-propanamine #, (chloropromazine) [3-(2-Chloro-phenothiazin-10-yl)-propyl]-dimethyl-amine, (chlorpromazine)[3-(2-Chloro-phenothiazin-10-yl)-propyl]-dimethyl-amine, [3-(2-Chloro-phenothiazin-10-yl)-propyl]-dimethyl-amine (chlor-promazine), [3-(2-Chloro-phenothiazin-10-yl)-propyl]-dimethyl-amine( Chlorpromazine), [3-(2-Chloro-phenothiazin-10-yl)-propyl]-dimethyl-amine(clorpromazine), Chlorpromazine;[3-(2-Chloro-phenothiazin-10-yl)-propyl]-dimethyl-amine" C17H19ClN2S ZPEIMTDSQAKGNT-UHFFFAOYSA-N 3-(2-chlorophenothiazin-10-yl)-N,N-dimethylpropan-1-amine GlaxoSmithKline Antipsychotic Agents No No No No No No PMDBD2000642 Chromate n.a. n.a. n.a. n.a. n.a. n.a. n.a. 24461 n.a. n.a. CHROMATE, dioxido(dioxo)chromium, 11104-59-9, chromates, Chromate(VI), 13907-45-4, Chromate (CrO42-), 9S2Y101D6M, CrO42?, Chromate ions, Chromate ion, Chromate Standard: CrO4(-2) @ 1000 microg/mL in H2O, Chromate Standard: CrO4(-2) @ 10000 microg/mL in H2O, CCRIS 6173, chromate(2-), tetraoxochromate(VI), tetraoxochromate(2-), CHROMATE ANION, tetraoxidochromate(VI), diketo(dioxido)chromium, tetraoxidochromate(2-), Chromate, wood preservative, CrO42-, UNII-9S2Y101D6M, CrO4(2-), DTXSID7065675, CHEBI:35404, CHROMATE (CRO42-) ION, CHROMATE ANION (CRO42-), [CrO4](2-), NCGC00161828-01, Q26840817 CrO4-2 ZCDOYSPFYFSLEW-UHFFFAOYSA-N dioxido(dioxo)chromium n.a. n.a. No No No No No No PMDBD2000643 Chrysin Therapeutic Substance Investigational Drug 480-40-0 DB15581 n.a. n.a. D01UYI 5281607 4444926 NPC78540 chrysin, 480-40-0, 5,7-Dihydroxyflavone, 5,7-Dihydroxy-2-phenyl-4H-chromen-4-one, Chrysine, 5,7-dihydroxy-2-phenylchromen-4-one, Crysin, 4H-1-Benzopyran-4-one, 5,7-dihydroxy-2-phenyl-, NSC-407436, FLAVONE, 5,7-DIHYDROXY-, NSC 407436, Chrysinic acid, 5,7-Dihydroxy-2-phenyl-4H-1-benzopyran-4-one, EINECS 207-549-7, UNII-3CN01F5ZJ5, 5,7-Dihydroxy-2-phenyl-chromen-4-one, BRN 0233276, 3CN01F5ZJ5, DTXSID1022396, CHEBI:75095, MFCD00006834, NSC407436, 5,7-Dihydroxy-2-phenyl-4H-benzo(b)pyran-4-one, CHEMBL117, DTXCID902396, 5-18-04-00076 (Beilstein Handbook Reference), CAS-480-40-0, 5,7-dihydroxy-2-phenyl-4H-benzo[b]pyran-4-one, SMR000112318, 5,7-dihydroxy-flavone, SR-01000765660, 3ebo, 4des, 57D, Chrysin,(S), 5,7-diOH-Flavone, Flavone,7-dihydroxy-, Chrysin 99+%, Chrysin, 97%, Ois 3, Spectrum_000245, 5, 7-Dihydroxyflavone, CHRYSIN [INCI], CHRYSIN [MI], Prestwick0_000889, Prestwick1_000889, Prestwick2_000889, Prestwick3_000889, Spectrum2_000753, Spectrum3_001399, Spectrum4_000780, Spectrum5_001503, Chrysin, analytical standard, Oprea1_045160, SCHEMBL44474, BSPBio_000678, BSPBio_002514, BSPBio_003018, KBioGR_001200, KBioSS_000725, MLS000697728, MLS001074879, MLS006011841, BIDD:ER0484, DivK1c_000614, SPECTRUM1500709, SPECTRUM1505144, SPBio_000766, SPBio_002897, BDBM7461, BPBio1_000746, GTPL8789, MEGxp0_001416, ACon1_000087, cid_5281607, HMS501O16, KBio1_000614, KBio2_000725, KBio2_003293, KBio2_005861, KBio3_002238, NINDS_000614, HMS1570B20, HMS1921E20, HMS2097B20, HMS2268I23, HMS3468N08, HMS3655L20, BCP22863, Tox21_302335, CCG-40148, LMPK12110189, NSC818102, s2281, AKOS000275936, BCP9000172, CS-7531, DB15581, GS-0927, NSC-818102, SDCCGMLS-0066586.P001, IDI1_000614, SMP1_000070, NCGC00016456-01, NCGC00016456-02, NCGC00016456-03, NCGC00016456-04, NCGC00016456-05, NCGC00016456-06, NCGC00016456-07, NCGC00016456-08, NCGC00016456-09, NCGC00016456-10, NCGC00016456-12, NCGC00094842-01, NCGC00094842-02, NCGC00094842-03, NCGC00094842-04, NCGC00094842-05, NCGC00168807-01, NCGC00168807-02, NCGC00168807-03, NCGC00168807-04, NCGC00255307-01, AC-10052, HY-14589, NCI60_003886, SY050125, AB00513947, C1652, NS00008874, SW197197-2, 5,7-Dihydroxy-2-phenyl-4H-chromen-4-one #, 4H-1-Benzopyran-4-one,7-dihydroxy-2-phenyl-, C-5980, EN300-303044, S00112, Chrysin 1000 microg/mL in Acetonitrile:Methanol, A827426, Q973741, SR-01000765660-3, SR-01000765660-4, 34B3B4AD-EEDD-4943-A1C6-8857D2FAA8E0, 5,7-Dihydroxy-2-phenyl-4H-1-benzopyran-4-one, 9CI, BRD-K22861715-001-07-5, BRD-K22861715-001-12-5, Z1824566175 C15H10O4 RTIXKCRFFJGDFG-UHFFFAOYSA-N 5,7-dihydroxy-2-phenylchromen-4-one n.a. n.a. No No No No Yes No rxnDiet92,rxnAdd102 PMDBD2000644 Chrysophanol n.a. n.a. n.a. n.a. n.a. n.a. n.a. 10208 n.a. NPC282923 "Chrysophanol, 481-74-3, CHRYSOPHANIC ACID, 3-Methylchrysazin, 1,8-Dihydroxy-3-methylanthraquinone, 1,8-dihydroxy-3-methylanthracene-9,10-dione, Turkey rhubarb, C.I. Natural Yellow 23, NSC 37132, 1,8-Dihydroxy-3-methyl-9,10-anthracenedione, NSC 646567, 4,5-Dihydroxy-2-methylanthraquinone, Crysophanic acid, Crysophanol, 2-Methyl-4,5-dihydroxyanthraquinone, 3-Methyl-1,8-dihydroxyanthraquinone, C.I. 75400, 1,8-Dihydroxy-3-Methyl-Anthraquinone, CCRIS 3525, CHEBI:3687, Chrysophansaeure, UNII-N1ST8V8RR2, EINECS 207-572-2, N1ST8V8RR2, NSC-37132, NSC-646567, Anthraquinone, 1,8-dihydroxy-3-methyl-, DTXSID6024832, 1,8-dihydroxy-3-methyl-9,10-anthraquinone, 9,10-Anthracenedione, 1,8-dihydroxy-3-methyl-, Chrysophanic acid (1,8-dihydroxy-3-methylanthraquinone), DTXCID704832, 1,8-Dihydroxy-3-methylanthra-9,10-quinone, HSDB 8483, MFCD00001208, NSC646567, Archinin, Rumicin, TURKEY-RHUBARB, RHENIC ACID, Spectrum_000792, Chrysophanic Acid,(S), SpecPlus_000321, Spectrum2_000043, Spectrum3_001183, Spectrum4_001477, Spectrum5_000153, 1,8-dihydroxy-3-methyl-anthracene-9,10-dione, BSPBio_002825, KBioGR_002053, KBioSS_001272, SPECTRUM300545, MLS000574888, CHEMBL41092, DivK1c_006417, SCHEMBL308131, SPBio_000165, CHRYSOPHANIC ACID [MI], 9, 1,8-dihydroxy-3-methyl-, Chrysophanic acid (Chrysophanol), Chrysophanol, analytical standard, KBio1_001361, KBio2_001272, KBio2_003840, KBio2_006408, KBio3_002325, HMS3656G17, CHRYSOPHANIC ACID [WHO-DD], BCP23439, EX-A6777, NSC37132, Tox21_202499, Anthraquinone,8-dihydroxy-3-methyl-, BDBM50455992, CCG-38348, LMPK13040006, s2406, 3-Methyl-1, 8-dihydroxyanthraquinone, 4, 5-Dihydroxy-2-methylanthraquinone, AKOS015905000, AC-7980, BCP9000004, DS-9706, SDCCGMLS-0066504.P001, NCGC00091823-01, NCGC00091823-02, NCGC00091823-03, NCGC00091823-04, NCGC00091823-05, NCGC00260048-01, CAS-481-74-3, HY-13595, SMR000156239, 1,8-Dihydroxy-3-methylanthraquinone, 98%, 8,9-dihydroxy-6-methyl-1,10-anthraquinone, C2505, NS00021170, SW219732-1, 1,8-Dihydroxy-3-methylanthra-9,10-quinone #, EN300-7401332, A827496, N-(diaminomethylene)formamide;3-METHYLCHRYSAZIN, SR-01000712223, 1,8-Dihydroxy-3-methyl-9,10-anthracenedione, 9CI, Q-100527, SR-01000712223-2, BRD-K59284035-001-02-0, BRD-K59284035-001-03-8, Q15410875, 9,10-Anthracenedione, 1,8-dihydroxy-3-methyl- (9CI), 1,8-DIHYDROXY-3-METHYL-9,10-DIHYDROANTHRACENE-9,10-DIONE" C15H10O4 LQGUBLBATBMXHT-UHFFFAOYSA-N 1,8-dihydroxy-3-methylanthracene-9,10-dione n.a. n.a. No No No No No No PMDBD2000645 Chrysophsin-1 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000646 Ciclopirox ethanolamine n.a. n.a. n.a. n.a. n.a. n.a. n.a. 38911 n.a. n.a. "Ciclopirox olamine, 41621-49-2, Ciclopirox ethanolamine, ciclopiroxolamine, Batrafen, Micoxolamina, Brumixol, Mycoster, Ciclopiroxolamin, Ciclochem, Dafnegin, Ciclopirox (olamine), HOE 296, Ciclopirox ethanolamine salt (1:1), HOE-296, UNII-50MD4SB4AP, EINECS 255-464-9, 50MD4SB4AP, NSC 336278, NSC-336278, DTXSID6045583, RV4104A, MFCD00078997, 6-Cyclohexyl-1-hydroxy-4-methyl-2(1H)-pyridone ethanolamine salt, Ciclobirox Olamine, 6-Cyclohexyl-1-hydroxy-4-methylpyridin-2(1H)-one compound with 2-aminoethanol (1:1), MLS003170863, 2-aminoethanol;6-cyclohexyl-1-hydroxy-4-methylpyridin-2-one, DTXCID4025583, 6-Cyclohexyl-1-hydroxy-4-methyl-2(1H)-pyridone, 2-aminoethanol salt, Ciclopirox olamine [USAN:USP:JAN], NSC336278, 2(1H)-Pyridinone, 6-cyclohexyl-1-hydroxy-4-methyl-, compound with 2-aminoethanol (1:1), 6-Cyclohexyl-1-hydroxy-4-methyl-2(1H)-pyridone compound with 2-aminoethanol (1:1), NCGC00017112-01, CAS-41621-49-2, 6-Cyclohexyl-1-hydroxy-4-methyl-2(1H)-pyridon, 2-aminoethanol-salz, Loprox (TN), 2-aminoethan-1-ol; 6-cyclohexyl-1-hydroxy-4-methyl-1,2-dihydropyridin-2-one, CICLOPIROX OLAMINE (MART.), CICLOPIROX OLAMINE [MART.], CICLOPIROX OLAMINE (USP-RS), CICLOPIROX OLAMINE [USP-RS], cyclopyroxolamine, MLS002153867, 6-Cyclohexyl-1-hydroxy-4-methylpyridin-2(1H)-one 2-aminoethanol salt, Ciclopirox olamine (USAN:USP:JAN), 6-CYCLOHEXYL-1-HYDROXY-4-METHYL-2(1H)-PYRIDONE COMPOUND WITH 2-AMINOETHANOL, CICLOPIROX OLAMINE (EP IMPURITY), CICLOPIROX OLAMINE [EP IMPURITY], CICLOPIROX OLAMINE (EP MONOGRAPH), CICLOPIROX OLAMINE [EP MONOGRAPH], CICLOPIROX OLAMINE (USP MONOGRAPH), CICLOPIROX OLAMINE [USP MONOGRAPH], SR-05000001589, SMR001233223, Penlac nail lacquer, Prestwick_785, Spectrum_000150, Ciclopirox Olamine,(S), CICLOPIROX 3%, Ciclopirox olamine- Bio-X, 6-Cyclohexyl-1-hydroxy-4-methyl-2(1H)-pyridon, 2-aminoethanol-salz [German], 6-Cyclohexyl-1-hydroxy-4-methylpyridin-2(1H)-one, compound with 2-aminoethanol (1:1), SCHEMBL66960, KBioSS_000630, DivK1c_000705, SPECTRUM1500189, Ciclopirox olamine (JAN/USP), CHEMBL242580, CICLOPIROX OLAMINE [JAN], HMS502D07, HY-B0450A, KBio1_000705, KBio2_000630, KBio2_003198, KBio2_005766, CICLOPIROX OLAMINE [INCI], CICLOPIROX OLAMINE [USAN], NINDS_000705, CICLOPIROX OLAMINE [VANDF], HMS1569N03, HMS1920O09, HMS2091E16, HMS2096N03, HMS2232B06, HMS3656B16, HMS3713N03, Pharmakon1600-01500189, CICLOPIROX OLAMINE [WHO-DD], Tox21_110781, CCG-38945, NSC756694, s3019, AKOS015891685, Tox21_110781_1, Ciclopirox olamine, analytical standard, CS-4767, KS-5086, NSC-756694, IDI1_000705, NCGC00017112-02, NCGC00017112-03, NCGC00017112-10, NCGC00094623-01, NCGC00094623-02, AC-14469, BC164302, Ciclopirox ethanolamine;Ciclopirox olamine, NCI60_002954, SY102087, C3545, NS00088641, SW196923-4, D01364, EN300-7357052, A825610, CICLOPIROX ETHANOLAMINE SALT (1:1) [MI], SR-05000001589-1, SR-05000001589-3, 2-aminoethanol; 6-cyclohexyl-1-hydroxy-4-methyl-pyridin-2-one, Ciclopirox olamine, European Pharmacopoeia (EP) Reference Standard, 6-Cyclohexyl-1-hydroxy-4-methyl-2(1H)-pyridone ethanolamine salt (1:1), Ciclopirox olamine, United States Pharmacopeia (USP) Reference Standard" C14H24N2O3 MBRHNTMUYWQHMR-UHFFFAOYSA-N "2-aminoethanol;6-cyclohexyl-1-hydroxy-4-methylpyridin-2-one" n.a. n.a. No No No No No No PMDBD2000647 Cidofovir Therapeutic Substance Approved Drug 113852-37-2 DB00369 PA448997 n.a. D04AAW 60613 54636 n.a. "Cidofovir, 113852-37-2, Vistide, HPMPC, Cidofovir anhydrous, (S)-HPMPC, Cidofovir hydrate, GS-504, anhydrous cidofovir, Cidofovir [INN], Cidofovir (Vistide), GS 0504, (S)-1-(3-Hydroxy-2-phosphonomethoxypropyl)cytosine, CDV, [1-(4-amino-2-oxo-pyrimidin-1-yl)-3-hydroxy-propan-2-yl]oxymethylphosphonic acid, GS-0504, (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine, (S)-(((1-(4-amino-2-oxopyrimidin-1(2H)-yl)-3-hydroxypropan-2-yl)oxy)methyl)phosphonic acid, CHEBI:3696, DTXSID3043734, ({[(2S)-1-(4-amino-2-oxopyrimidin-1(2H)-yl)-3-hydroxypropan-2-yl]oxy}methyl)phosphonic acid, (S)-1-[3-hydroxy-2-(phosphonomethoxy)propyl]cytosine, 768M1V522C, NSC-742135, NCGC00184994-01, Phosphonic acid, ((2-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1-(hydroxymethyl)ethoxy)methyl)-, (S)-, ({[(2S)-1-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3-hydroxypropan-2-yl]oxy}methyl)phosphonic acid, 1-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]cytosine, 1-[(S)-3-hydroxy-2-(phosphonomethoxy)propyl]cytosine, Cidofovir (anhydrous), Cidofovir hydrate (1:2), Cidofovirum, Forvade, (S)-(3-(4-amino-2-oxopyrimidin-1(2H)-yl)-1-hydroxypropan-2-yloxy)methylphosphonic acid, [(S)-2-(4-Amino-2-oxo-2H-pyrimidin-1-yl)-1-hydroxymethyl-ethoxymethyl]-phosphonic acid, HSDB 7115, GS504, 1-((S)-3-HYDROXY-2-(PHOSPHONOMETHOXY)PROPYL)CYTOSINE, Cidofovir gel, UNII-768M1V522C, Cidofovir,Vistide, [[(S)-2-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1-(hydroxymethyl)ethoxy]methyl]phosphonic acid, Cidofovir(Vistide), (((S)-2-(4-AMINO-2-OXO-1(2H)-PYRIMIDINYL)-1-(HYDROXYMETHYL)ETHOXY)METHYL)PHOSPHONIC ACID, Cidofovir; P-[[(1S)-2-(4-Amino-2-oxo-1(2H)-pyrimidinyl)-1-(hydroxymethyl)ethoxy]methyl]phosphonic acid; (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine; (S)-HPMPC; GS-504; Vistide, Forvade (TM), CIDOFOVIR [MI], (S)-HPMPC; Cidovir, CIDOFOVIR [HSDB], CHEMBL152, CIDOFOVIR [WHO-DD], Cidofovir anhydrous- Bio-X, SCHEMBL3948, (2S)-3-Hydroxy-2-phosphonylmethoxypropyl-cytosine, MLS003915629, (S)-1-[3-hydroxy-2-(phosphonylmethoxy)-propyl]cytosine, DTXCID1023734, BDBM31915, 1-[(S)-3-Hydroxy-2-(phosphonomethoxy)propyl]-cytosine dihydrate, BCP03734, EX-A4209, Tox21_112994, MFCD00866936, MFCD17215968, NSC742135, s1516, AKOS005145721, AKOS015854828, AC-1666, BCP9000528, CCG-267235, CS-1669, DB00369, GS-6438, (S)-2-(4-Amino-2-oxo-1(2H)-pyrimidinyl-1-(hydroxymethyl)ethoxy)methyl phosphonic acid, [(1S)-1-[(4-amino-2-oxo-pyrimidin-1-yl)methyl]-2-hydroxy-ethoxy]methylphosphonic acid, NCGC00184994-02, NCGC00184994-03, BC164304, HY-17438, SMR002544687, BCP0726000147, CAS-113852-37-2, AB01566823_01, EN300-7479747, Q423445, SR-01000931969, J-502695, SR-01000931969-2, (S)-(((1-(4-amino-2-oxopyrimidin-1(2H)-yl)-3-hydroxypropan-2-yl)oxy)methyl)phosphonicacid, ({[(S)-1-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3-hydroxypropan-2-yl]oxy}methyl)phosphonic acid, L8P, Phosphonic acid, [[(1S)-2-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1-(hydroxymethyl)ethoxy]methyl]-" C8H14N3O6P VWFCHDSQECPREK-LURJTMIESA-N [(2S)-1-(4-amino-2-oxopyrimidin-1-yl)-3-hydroxypropan-2-yl]oxymethylphosphonic acid Pfizer Pharmaceuticals Anti-HIV Agents No No No No No No PMDBD2000648 Cinnamaldehyde Therapeutic Substance Investigational Drug 14371-10-9 DB14184 n.a. n.a. D0PJ3M 637511 553117 NPC235059 "cinnamaldehyde, trans-Cinnamaldehyde, 14371-10-9, 104-55-2, Cinnamic aldehyde, Cinnamal, 3-Phenylacrylaldehyde, (E)-Cinnamaldehyde, Zimtaldehyde, (2E)-3-phenylprop-2-enal, 2-Propenal, 3-phenyl-, 3-Phenylpropenal, Phenylacrolein, trans-Cinnamic aldehyde, Cinnamylaldehyde, (E)-3-phenylprop-2-enal, (E)-3-Phenylpropenal, (E)-3-Phenyl-2-propenal, Cassia aldehyde, 3-Phenylacrolein, 2-propenal, 3-phenyl-, (2E)-, 3-phenylprop-2-enal, Cinnemaldehyde, Cinnamyl aldehyde, Abion CA, Cinnamaldehyde, (E)-, trans-Cinnamylaldehyde, Benzylideneacetaldehyde, beta-Phenylcrolein, 3-Phenyl-2-propenal, 3-Phenyl-2-propenaldehyde, Acrolein, 3-phenyl-, 3-Fenylpropenal, FEMA No. 2286, 3-Phenyl-2-propen-1-al, trans-3-Phenyl-2-propenal, (E)-Cinnamic aldehyde, NCI-C56111, 2-Propenal, 3-phenyl-, (E)-, (2E)-3-phenylacrylaldehyde, .beta.-phenylacrolein, CHEBI:16731, Cinnamaldehyde, trans-, (E)-3-Phenyl-propenal, MFCD00007000, NSC-16935, NSC-40346, SR60A3XG0F, (3E)-3-phenylprop-2-enal, (2E)-3-Phenyl-2-propenal, CHEMBL293492, Aldehyd skoricovy, DTXSID6024834, XC-800, NCGC00091512-04, NSC 16935, WLN: VH1U1R, DTXCID504834, 3-phenyl-propenal, Caswell No. 221A, FEMA Number 2286, 3-Fenylpropenal [Czech], Aldehyd skoricovy [Czech], Cinnamic aldehyde (natural), Hefty Dog and Cat Repellent, CAS-14371-10-9, CCRIS 3189, CCRIS 6222, Cinnamaldehyde [NF], HSDB 209, EINECS 203-213-9, UNII-SR60A3XG0F, DTXSID1024835, EPA Pesticide Chemical Code 040506, BRN 0605737, BRN 1071571, e-cinnamaldehyde, AI3-00473, AI3-33275, transcinnamaldehyde, |A-Phenylacrolein, trans cinnamaldehyde, CNMA, (trans)-cinnamaldehyde, trans cinnamic aldehyde, trans-3-Phenylacrolein, CINNAMAL [INCI], trans-3-phenyl-propenal, (E)-phenylvinyl aldehyde, (E)-3-phenylacrylaldehyde, bmse010257, Epitope ID:150921, CINNAMALDEHYDE [II], CINNAMALDEHYDE [MI], EC 203-213-9, trans-3-Phenylacrylaldehyde, Trans-Cinnamaldehyde ,(S), SCHEMBL3441, trans-Cinnamaldehyde, 99%, (E)-3-phenyl-acrylaldehyde, CINNAMALDEHYDE [FCC], trans-Cinnamaldehyde; trans-3-Phenylacrylaldehyde, Cinnamaldehyde (trans), neat, CINNAMALDEHYDE [FHFI], CINNAMALDEHYDE [HSDB], 2-07-00-00273 (Beilstein Handbook Reference), 4-07-00-00984 (Beilstein Handbook Reference), MLS002454394, CINNAMALDEHYDE (TRANS), trans-Cinnamaldehyde, >=99%, DTXCID904835, GTPL2423, (E)-cinnamaldehyde (incorrect), CINNAMALDEHYDE [USP-RS], CINNAMALDEHYDE [WHO-DD], trans-cinnamaldehyde (incorrect), CHEBI:142921, HMS2268O08, HMS3885E04, HY-N0609, NSC16935, NSC40346, Tox21_111144, Tox21_200272, Tox21_201804, Tox21_303271, BDBM50203065, s3763, AKOS000119171, Cinnamaldehyde, natural, >=95%, FG, CCG-266119, DB14184, Cinnamaldehyde min. 98%, for synthesis, Cinnamaldehyde 100 microg/mL in Toluene, NCGC00091512-01, NCGC00091512-02, NCGC00091512-05, NCGC00091512-06, NCGC00091512-07, NCGC00257017-01, NCGC00257826-01, NCGC00259353-01, trans-Cinnamaldehyde, analytical standard, AS-12078, AS-75456, CAS-104-55-2, SMR000112334, trans-Cinnamaldehyde, >=98%, FCC, FG, (E)-3-phenyl-2-propenal(E)-cinnamaldehyde, AM20060482, CS-0009609, NS00003408, EN300-19160, C00903, Cinnamaldehyde, Vetec(TM) reagent grade, 93%, D72477, EN300-735819, A801001, Q204036, W-205597, B99DD6C7-1C6D-4FE3-A172-54BFDB987683, Z3219847383, CINNAMALDEHYDE (CONSTITUENT OF CINNAMOMUM VERUM BARK) [DSC], Cinnamaldehyde, United States Pharmacopeia (USP) Reference Standard, InChI=1/C9H8O/c10-8-4-7-9-5-2-1-3-6-9/h1-8H/b7-4, TRANS-CINNAMALDEHYDE (CONSTITUENT OF CINNAMOMUM CASSIA BARK) [DSC]" C9H8O KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-3-phenylprop-2-enal n.a. n.a. No No No No No No PMDBD2000649 Cinnamic acid Therapeutic Substance Investigational Drug 140-10-3 DB18313 n.a. n.a. D0T2QL 444539 392447 NPC206800 "CINNAMIC ACID, TRANS-CINNAMIC ACID, 140-10-3, 621-82-9, 3-Phenylacrylic acid, (E)-Cinnamic acid, trans-3-Phenylacrylic acid, Phenylacrylic acid, Zimtsaeure, (E)-3-phenylprop-2-enoic acid, E-Cinnamic Acid, 3-Phenylpropenoic acid, trans-Cinnamate, (2E)-3-phenylprop-2-enoic acid, 2-Propenoic acid, 3-phenyl-, (2E)-, 3-phenylprop-2-enoic acid, Cinnamic acid, (E)-, Cinnamylic acid, trans-beta-Carboxystyrene, (2E)-3-Phenyl-2-propenoic acid, beta-Phenylacrylic acid, (E)-cinnamate, Benzeneacrylic acid, trans-3-Phenyl-2-propenoic acid, 3-Phenyl-2-propenoic acid, Heparin, lithium salt, Benzenepropenoic acid, FEMA No. 2288, CCRIS 3190, 2-Propenoic acid, 3-phenyl-, (E)-, (E)-3-Phenyl-2-propenoic acid, t-Cinnamic acid, EINECS 205-398-1, MFCD00004369, NSC 44010, Benzylideneacetic acid, UNII-U14A832J8D, BRN 1905952, CINNAMIC ACIDUM, AI3-23709, Cinnamic acid, trans-, Kyselina skoricove, PhCH=CHCO2H, TRANS-CINNAMIC-D5 ACID, Acidum cinnamylicum, U14A832J8D, (2E)-2-Phenyl-2-propenoic acid, PHENYLETHYLENECARBOXYLIC ACID, NSC-9189, NSC-44010, Cinnamic acid(only trans), NSC-623441, (2E)-3-phenylacrylic acid, CHEMBL27246, Cinnamic acid (natural), DTXSID5022489, CHEBI:27386, CHEBI:35697, NSC 9189, cinnamate, 4-09-00-02002 (Beilstein Handbook Reference), NCGC00165979-01, 352431-48-2, EINECS 210-708-3, BRN 0507757, AI3-00891, CINNAMIC ACID (MART.), CINNAMIC ACID [MART.], DTXCID002489, CINNAMIC ACID (USP-RS), CINNAMIC ACID [USP-RS], (E)-3-phenylprop-2-enoate, (2E)-3-phenylprop-2-enoate, CAS-140-10-3, .beta.-Phenylacrylic acid, 343338-31-8, (E)-3-Phenylacrylic acid, DTXSID40110056, trans-Zimtsaeure, NSC 623441, trans cinnamic acid, cinnamic acid, (trans)-(E)-isomer, 5-Thiazolamine?HCl, b-Phenylacrylic acid, Cinnamic acid, E-, Cinnamic Acid Natural, Cinnamic Acid1511, trans-b-Carboxystyrene, Cinnamicacid(onlytrans), trans-3-Phenylacrylate, (E)-3-Phenylacrylate, E-3-phenylpropenoic acid, Trans-Cinnamic Acid,(S), bmse000124, CINNAMIC ACID [MI], SCHEMBL1332, trans-.beta.-Carboxystyrene, trans-Cinnamic acid, 97%, trans-Cinnamic acid, 99%, WLN: QV1U1R, (E)-3-phenyl-acrylic acid, 3-phenyl-2E-propenoic acid, CINNAMIC ACID [FCC], Zimtsaeure | trans-Cinnamate, CINNAMIC ACID [FHFI], CINNAMIC ACID [INCI], trans-3-Phenyl-2-propenoate, BIDD:ER0586, tert-.beta.-Phenylacrylic acid, trans-Cinnamic acid, >=99%, (2E)-2-Phenyl-2-propenoate, (2E)-3-Phenyl-2-propenoate, GTPL3203, CINNAMIC ACID [WHO-DD], DTXCID9065316, BDBM16430, HY-N0610A, NSC9189, NSC44010, STR00363, trans-Cinnamic acid, >=99%, FG, Tox21_112279, Tox21_302137, NSC623441, s3677, AKOS000118871, CCG-214473, CS-W020005, trans-Cinnamic acid, analytical standard, NCGC00165979-04, NCGC00165979-06, NCGC00255114-01, 1ST40140, AC-34658, AS-75479, BP-20203, 3-Phenylacrylic acid; -Phenylacrylic acid, C3412, NS00001286, EN300-19599, trans-Cinnamic acid, purum, >=99.0% (T), C00423, D70605, EN300-306004, AB00374254-03, trans-cinnamic acid (trans-3-phenylacrylic acid), trans-Cinnamic Acid [Matrix for MALDI-TOF/MS], A833631, Q164785, SR-05000002380, trans-Cinnamic acid, natural, >=99%, FCC, FG, Q-100150, SR-05000002380-1, W-105037, F2191-0134, trans-Cinnamic Acid Zone Refined (number of passes:40), trans-Cinnamic acid; Phenylacrylic acid;Cinnamylic acid, Z104474406, 1BE36587-A165-4142-9340-18FFE3E03426, CINNAMIC ACID (CONSTITUENT OF CINNAMOMUM VERUM BARK) [DSC], Cinnamic acid, United States Pharmacopeia (USP) Reference Standard, TRANS-CINNAMIC ACID (CONSTITUENT OF CINNAMOMUM CASSIA BARK) [DSC], InChI=1/C9H8O2/c10-9(11)7-6-8-4-2-1-3-5-8/h1-7H,(H,10,11)/b7-6" C9H8O2 WBYWAXJHAXSJNI-VOTSOKGWSA-N (E)-3-phenylprop-2-enoic acid n.a. n.a. No No No No No No PMDBD2000650 Cinnamon oil Therapeutic Substance n.a. 8007-80-5 DB15986 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000651 Ciprofloxacin lactate n.a. n.a. n.a. n.a. n.a. n.a. n.a. 149514 n.a. NPC487368 "Ciprofloxacin lactate, 97867-33-9, 1-Cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid compound with 2-hydroxypropanoic acid (1:1), Ciproxin, Flociprin, 857213-31-1, Ciprofloxacin (lactate), UEY6XFC224, Flunase [inj.], 96186-80-0, Cipobacter, 1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid;2-hydroxypropanoic acid, Ificipro, Ciproxin [inj.], Quintor Eye Drops, Ciproflox [inj.], Ciproxina [inj.], Flociprin [inj.], 3-Quinolinecarboxylic acid, 1,4-dihydro-1-cyclopropyl-6-fluoro-4-oxo-7-(1-piperazinyl)-, mono(2-hydroxypropanoate), Ciprobid Eye Drops, 1-Cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid 2-hydroxypropanoic acid salt, UNII-UEY6XFC224, Ciproxin (TN), CIPROFLOXACIN LACTAT, SCHEMBL667608, CHEMBL1077975, C20H24FN3O6, DTXSID20913608, CIPROFLOXACIN (AS LACTATE), (+/-)-CIPROFLOXACIN LACTATE, MFCD01759747, CIPROFLOXACIN LACTATE [MART.], AKOS015896304, CIPROFLOXACIN LACTATE [WHO-DD], CS-W021038, HY-W040298, CIPROFLOXACIN LACTATE, (+/-)-, 1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-quinoline-3-carboxylic acid; 2-hydroxypropanoic acid, DS-11431, D07702, D82460, A845757, Q27291047, 1-CycloPr-6-fluoro-4-oxo-7-(piperaZin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid comp with 2-hydroxypropanoic acid(1:1);95%, 1-cyclopropyl-6-fluoranyl-4-oxidanylidene-7-piperazin-1-yl-quinoline-3-carboxylic acid; 2-oxidanylpropanoic acid, 1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-Quinolinecarboxylic Acid Mono(2-hydroxypropanoate), 1-cyclopropyl-6-fluoro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid; 2-hydroxypropanoic acid, 1-Cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid--2-hydroxypropanoic acid (1/1), 1-Cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylicacidcompoundwith2-hydroxypropanoicacid(1:1), 3-QUINOLINECARBOXYLIC ACID, 1-CYCLOPROPYL-6-FLUORO-1,4-DIHYDRO-4-OXO-7-(1-PIPERAZINYL)-, 2-HYDROXYPROPANOATE (1:1)" C20H24FN3O6 NRBJWZSFNGZBFQ-UHFFFAOYSA-N "1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid;2-hydroxypropanoic acid" n.a. n.a. No No No No No No PMDBD2000652 Ciprofloxacin? n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000653 cis-2-dodecenoic acid n.a. n.a. n.a. n.a. n.a. n.a. n.a. 5312376 n.a. n.a. cis-2-Dodecenoic acid, 55928-65-9, (Z)-dodec-2-enoic acid, BDSF, (2Z)-dodec-2-enoic acid, (2Z)-2-Dodecenoic acid, 2Z-dodecenoic acid, cis-2-lauroleic acid, 2-Dodecenoic acid, C12:1n-10, (Z)-2-dodecenoic acid, 2c-Dodecensaeure, cis-Dodec-2-ensaeure, cis-dodec-2-enoic acid, C12:1, n-10 cis, SCHEMBL1470309, 12:1, n-10 cis, CHEMBL4293570, CHEBI:38372, PAWGRNGPMLVJQH-KHPPLWFESA-N, HY-N7788, NSC59856, Burkholderia diffusible signal factor, LMFA01030224, MFCD16661220, NSC-59856, WS-02157, cis-2-Dodecenoic acid, >=95.0% (HPLC), CS-0137857, C21202, D86951, A848791, Q27117638, GEY C12H22O2 PAWGRNGPMLVJQH-KHPPLWFESA-N (Z)-dodec-2-enoic acid n.a. n.a. No No No No No No PMDBD2000654 cis-4-Hydroxy-L-proline n.a. n.a. n.a. n.a. n.a. n.a. n.a. 440015 n.a. n.a. cis-4-Hydroxy-L-proline, 618-27-9, (2S,4S)-4-hydroxypyrrolidine-2-carboxylic acid, L-Proline, 4-hydroxy-, (4S)-, cis-4-hydroxyproline, (4S)-4-hydroxy-L-proline, L-cis-4-hydroxyproline, allo-4-Hydroxy-L-proline, L-allo-hydroxyproline, H-CIS-HYP-OH, L-Allohydroxyproline, cis-Hydroxyproline, 4-cis-L-hydroxyproline, CIS-L-4-HYDROXYPROLINE, allo-4-Hydroxyproline, 4-hydroxyproline, CHEMBL1233477, CHEBI:28397, 43V78B6A3B, L-Proline, 4-hydroxy-, cis-, cis-4-Hydroxypyrrolidine-2-carboxylic acid, L-Proline, allo-hydroxy-, (2S,4S)-4-hydroxy-2-pyrrolidinecarboxylic acid, rel-(2S,4S)-4-Hydroxypyrrolidine-2-carboxylic acid, Proline, 4-allo-hydroxy-, L-, MFCD21608679, NSC 206274, allo-hydroxy-L-Proline, 81666-01-5, Hydroxyproline, cis-, Hydroxyproline cis-form, UNII-43V78B6A3B, MFCD00064320, NSC-206274, EINECS 210-542-1, (4s)-hydroxyproline, L-CIS-HYDROXYPROLINE, SCHEMBL19307, DTXSID20883473, 4-HYDROXYPROLINE CIS-(-)-, BDBM50357209, HYDROXYPROLINE CIS-FORM [MI], AKOS016015787, AC-2250, AC-3101, CS-W009077, AM808165, AS-15085, HY-40136, A8558, CS-0526875, H1169, NS00079458, EN300-66089, C01015, Q-200862, cis-4-Hydroxy-L-proline, collagen synthesis inhibitor, Q27103674, cis-4-Hydroxy-L-proline, Vetec(TM) reagent grade, 98%, F8880-8952 C5H9NO3 PMMYEEVYMWASQN-IMJSIDKUSA-N (2S,4S)-4-hydroxypyrrolidine-2-carboxylic acid n.a. n.a. No No No No No No PMDBD2000655 cis-Stillbene n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000656 Citral Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D00VWN 638011 n.a. NPC18205 Citral, GERANIAL, 5392-40-5, trans-Citral, (2E)-3,7-dimethylocta-2,6-dienal, 141-27-5, 3,7-dimethylocta-2,6-dienal, Citral a, geranialdehyde, alpha-Citral, (E)-Citral, geranal, Geranaldehyde, Lemsyn GB, Genanial, (E)-Geranial, 2,6-Octadienal, 3,7-dimethyl-, beta-Geranial, (E)-3,7-Dimethylocta-2,6-dienal, 147060-73-9, Citral alpha, 3,7-Dimethyl-2,6-octadienal, (E)-Neral, Citral (natural), 2,6-Octadienal, 3,7-dimethyl-, (2E)-, Lemarome n, Caswell No. 221B, Citral-A, FEMA Number 2303, trans-3,7-Dimethyl-2,6-octadienal, NCI-C56348, 2,6-Octadienal, 3,7-dimethyl-, (E)-, 3,7-Dimethyl-trans-2,6-octadienal, (E)-3,7-Dimethyl-2,6-octadienal, FEMA No. 2303, CCRIS 1043, HSDB 993, UNII-T7EU0O9VPP, 2,6-Dimethyloctadien-2,6-al-8, 3,7-Dimethyl-1,2,6-octadienal, NSC 6170, EINECS 205-476-5, EINECS 226-394-6, (2e)-geranial, EPA Pesticide Chemical Code 040510, UNII-758ZMW724E, BRN 1721871, BRN 1721873, CITRAL GERANIAL, CHEBI:16980, AI3-01011, AI3-28519, 758ZMW724E, T7EU0O9VPP, cis/trans-3,7-Dimethyl-2,6-octadienal, NSC6170, EC 205-476-5, EC 226-394-6, 3-01-00-03053 (Beilstein Handbook Reference), 4-01-00-03569 (Beilstein Handbook Reference), NSC-6170, trans-Citral = trans-3,7-Dimethyl-octa-2,6-dien-1-al, Citral, analytical standard, lemonal, DTXCID304836, cis,trans-Citral, DTXSID6024836, CITRAL NATURAL, Z-Citral, Natural Citral, CAS-5392-40-5, LEMAROME, CITRAL SINTETICO, MFCD00006997, alpha -Citral, Citral N, .alpha.-Citral, 3,2,6-octadienal, (2E)-3,7-Dimethyl-2,6-octadienal, Citral, cis + trans, CITRAL PQ EXTRA, Citral, 95%, trans-Citral (Geranial), CITRAL (MART.), SCHEMBL23073, CITRAL GERANIAL [MI], CITRAL (E109), 3,7-Dimethyl-2,6 octadienal, GTPL6327, CHEMBL1080997, 2,6-Octadienal,3,7-dimethyl-, DTXSID20881217, CHEBI:137934, WLN: VH1UY1&3Y1&U1, HY-N7083, 3,7-dimethyl-(e)-2,6-octadienal, Tox21_202093, Tox21_300095, 3,7-dimethyl-(2e)-2,6-octadienal, trans-3,7-dimethyl-octa-2,6-dienal, AKOS000119519, CCG-266236, Citral, natural, >=96%, FCC, FG, CS-W010948, LMPR0102010003, (2E)-3,7-dimethyl-octa-2,6-dienal, Citral 1000 microg/mL in Acetonitrile, Citral, Vetec(TM) reagent grade, 94%, NCGC00091550-01, NCGC00091550-02, NCGC00091550-03, NCGC00091550-04, NCGC00254026-01, NCGC00259642-01, AS-35309, (2E)-3,7-dimethyl-2,6-octadien-1-al, 2,6- OCTADIENAL, 3,7-DIMETHYL-, NS00076551, S5138, 2,6-OCTADIENAL, 3,7-DIMETHYL-(E), EN300-20399, C01499, 2-CIS-3,7-DIMETHYL-2,6-OCTADIEN-1-AL, A829835, Q410888, Q-200867, F0001-1403, Z104478042, 2,6-Octadienal,3,7-dimethyl-,reaction products with et alc., GRQ C10H16O WTEVQBCEXWBHNA-JXMROGBWSA-N (2E)-3,7-dimethylocta-2,6-dienal n.a. n.a. No No No No No No PMDBD2000657 Citropin 1.1 n.a. n.a. n.a. n.a. n.a. n.a. n.a. 10351598 n.a. n.a. Citropin 1.1 C76H131N19O19 QRKMRMNJGSPMNX-SDCDTWBGSA-N (3S)-3-[[(2S)-2-[[(2S)-2-[(2-aminoacetyl)amino]-4-methylpentanoyl]amino]-3-phenylpropanoyl]amino]-4-[[(2S)-1-[[(2S,3S)-1-[[(2S)-6-amino-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S,3S)-1-[[2-[[2-[[(2S)-1-amino-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-2-oxoethyl]amino]-3-methyl-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxohexan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-4-oxobutanoic acid n.a. n.a. No No No No No No PMDBD2000658 Clary sage n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000659 Clary sage oil n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000660 Clavulanate n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000662 Clomocycline Therapeutic Substance Approved Drug 1181-54-0 DB00453 PA164771235 D06885 D02GAC 54680675 21251443 n.a. "Clomocycline, Chlormethylenecycline, 1181-54-0, Clomocyclinum, Clomocyclinum [INN-Latin], Clomociclina [INN-Spanish], Clomocycline (INN), clomocyclina, Clomociclina, CHEBI:59589, YP0241BU76, (4S,4aS,5aS,6S,12aR)-7-chloro-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-N-(hydroxymethyl)-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide, 7-Chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-N-(hydroxymethyl)-6-methyl-1,11-dioxo-2-naphthacenecarboxamide, CLOMOCYCLINE [INN], N''-Methylolo-chlortetracycline, Clomocycline [INN:BAN], (4S,4aS,5aS,6S,12aS)-7-chloro-4-(dimethylamino)-3,6,10,12,12a-pentahydroxy-N-(hydroxymethyl)-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide, N-2-Hydroxymethylchlortetracycline, BRN 2715004, UNII-YP0241BU76, CLOMOCYCLINE [MI], CHLORMETHYLENCYCLINE, SCHEMBL49191, CLOMOCYCLINE [WHO-DD], CHEMBL2106071, naphthacenecarboxamide; Chlormethylenecycline; Chlortetracycline, N-methylol-, DTXSID80905089, DB00453, 2-Naphthacenecarboxamide, 7-chloro-4-(dimethylamino)-1,2,3,4,4a,5,5a,6,11,12a-decahydro-1,11-dioxo-N-(hydroxymethyl)-6-methyl-3,6,10,12,12a-pentahydroxy-, NS00069836, D06885, Q4925524" C23H25ClN2O9 BXTHDFJCJQJHKD-KMVLDZISSA-N (4S,4aS,5aS,6S,12aR)-7-chloro-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-N-(hydroxymethyl)-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide n.a. Antibiotics No No No No No No PMDBD2000663 Clove oil Therapeutic Substance n.a. 8000-34-8 DB11338 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000664 Cloxacillin Therapeutic Substance Approved Drug 61-72-3 DB01147 PA449059 n.a. D04KTZ 6098 n.a. n.a. cloxacillin, 61-72-3, Cloxacillinum, Cloxacilline, Cloxacilina, Methocillin S, Syntarpen, Chloroxacillin, Clossacillina, Cloxacillin sodium, Tegopen, BRL 1621, Methylchlorphenylisoxazoryl-penicillin, Cloxapen, Cloxacilina [INN-Spanish], Cloxacilline [INN-French], Cloxacillinum [INN-Latin], MCIPC, Clossacillina [DCIT], (3-(o-Chlorophenyl)-5-methyl-4-isoxazolyl)penicillin, CHEBI:49566, HSDB 3042, UNII-O6X5QGC2VB, O6X5QGC2VB, EINECS 200-514-7, 6-(3-(o-Chlorophenyl)-5-methyl-4-isoxazolecarboxamido)penicillanic acid, Cloxacillin (INN), (2S,5R,6R)-6-[[3-(2-chlorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 6-(((3-(2-Chlorophenyl)-5-methyl-4-isoxazolyl)carbonyl)amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, CHEMBL891, 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(((3-(2-chlorophenyl)-5-methyl-4-isoxazolyl)carbonyl)amino)-3,3-dimethyl-7-oxo-, (2S-(2alpha,5alpha,6beta))-, 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(3-(O-chlorophenyl)-5-methyl-4-isoxazolecarboxamido)-3,3-dimethyl-7-oxo-, DTXSID5022853, BRL1621, (2S,5R,6R)-6-({[3-(2-chlorophenyl)-5-methylisoxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, CLOXACILLIN [INN], Cloxacilina (INN-Spanish), Cloxacilline (INN-French), Cloxacillinum (INN-Latin), Cloxacillin [INN:BAN], CLOXACILLIN (MART.), CLOXACILLIN [MART.], (2S,5R,6R)-6-[3-(2-chlorophenyl)-5-methyl-1,2-oxazole-4-amido]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(3-(o-chlorophenyl)-S-methyl-4-isoxazolecarboxamido)-3,3-dimethyl-7-oxo-, Spectrum 001345, Tegopen (sodium monohydrate), 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 6-[[[3-(2-chlorophenyl)-5-methyl-4-isoxazolyl]carbonyl]amino]-3,3-dimethyl-7-oxo-, (2S,5R,6R)-, Orbenin (TN), cloxacillina, P-25 (sodium monohydrate), CloxacillinNa, Cloxapen (sodium monohydrate), BRL-1621 (sodium monohydrate), (2S,5R,6R)-6-(((3-(2-chlorophenyl)-5-methylisoxazol-4-yl)carbonyl)amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, (2S,5R,6R)-6-(3-(2-chlorophenyl)-5-methylisoxazole-4-carboxamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, Cloxacillin ,(S), cloxacillinum natricum, Spectrum_001345, Cloxacillin, Antibiotic for Culture Media Use Only, CLOXACILLIN [MI], Prestwick0_000186, Prestwick1_000186, Prestwick2_000186, Prestwick3_000186, Spectrum2_001143, Spectrum3_000360, Spectrum4_000296, Spectrum5_000783, CLOXACILLIN [HSDB], Epitope ID:120363, CLOXACILLIN [VANDF], SCHEMBL2953, BSPBio_000111, BSPBio_002059, CLOXACILLIN [WHO-DD], KBioGR_000852, KBioSS_001825, DivK1c_000736, SPBio_001065, SPBio_002032, BPBio1_000123, DTXCID502853, GTPL11126, HY-B0466A, KBio1_000736, KBio2_001825, KBio2_004393, KBio2_006961, KBio3_001279, J01CF02, NINDS_000736, BCP24144, BDBM50022788, DB01147, IDI1_000736, (2S,5R,6R)-6-[[3-(2-chlorophenyl)-5-methyl-isoxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, SBI-0051319.P003, Cloxacillin 1000 microg/mL in Acetonitrile, CS-0028411, NS00000114, C06923, D07733, EN300-708784, Q422219, W-105105, BRD-K01244426-236-05-5, BRD-K01244426-236-08-9, OXACILLIN SODIUM MONOHYDRATE IMPURITY E [EP IMPURITY], 6-(3-o-Chlorophenyl-5-methylisoxazol-4-ylamido) penicillanic acid, 6-(3-o-Chlorophenyl-5-methylisoxazol-4-ylamido)penicillanic acid, (2S,5R,6R)-6-(3-(2-chlorophenyl)-5-methylisoxazole-4-carboxamido)-3,3-dimethyl-7-oxo-4-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylic acid, (2S,5R,6R)-6-{[3-(2-Chloro-phenyl)-5-methyl-isoxazole-4-carbonyl]-amino}-3,3-dimethyl-7-oxo-4-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylic acid, 2,2-dimethyl-6beta-(((5-methyl-3-(2-chlorophenyl)isoxazol-4-yl)carbonyl)amino)penam-3alpha-carboxylic acid, 6-{[3-(2-Chloro-phenyl)-5-methyl-isoxazole-4-carbonyl]-amino}-3,3-dimethyl-7-oxo-4-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylic acid C19H18ClN3O5S LQOLIRLGBULYKD-JKIFEVAISA-N (2S,5R,6R)-6-[[3-(2-chlorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid Beecham phamaceuticals Antibiotics No No No No No No PMDBD2000665 Cobalt Ion n.a. n.a. n.a. n.a. n.a. n.a. n.a. 104729 n.a. NPC329418 Cobalt(2+), Cobaltous cation, Cobaltous ion, Cobalt(II) ion, Cobalt, ion (Co2+), Cobalt(II) cation, Co2+, cobalt ion, Cobalt ions, Cobalt cation (Co2+), Cobalt(II)ions, Cobalt(2+)ions, Cobalt(2+) ions, 22541-53-3, Co(II), Co++, UNII-AI1MR454XG, cobalt(II), AI1MR454XG, cobalt(2+) ion, CHEBI:48828, Co(2+), DTXSID20177066, Cobalt, ion(Co2 ), Cobalt dication, CoII, cobalt (II), Cobalt 2+, Cobalt ion(2+), Cobalt, ion(Co2), Co+2, DTXCID7099557, XLJKHNWPARRRJB-UHFFFAOYSA-N, DB14205, NCGC00248605-01, C00175, Q27104633 Co+2 XLJKHNWPARRRJB-UHFFFAOYSA-N cobalt(2+) n.a. n.a. No No No No No No PMDBD2000666 Coladonin n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000667 Colistin Therapeutic Substance Approved Drug 1066-17-7 DB00803 PA164760862 D02138 D0K7NQ 5311054 n.a. n.a. colistin, 1066-17-7, N-[(2S)-4-amino-1-[[(2S,3R)-1-[[(2S)-4-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18S,21S)-6,9,18-tris(2-aminoethyl)-3-[(1R)-1-hydroxyethyl]-12,15-bis(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxobutan-2-yl]-5-methylheptanamide, Colobreathe, Promixin, Colistin,(S), CHEMBL499783, SCHEMBL1979092, GTPL10794, YKQOSKADJPQZHB-QNPLFGSASA-N, NS00006868, AB01566924_01, Q418946, SR-01000872582, SR-01000872582-1, N-[(1S)-3-amino-1-[[(1S,2R)-1-[[(1S)-3-amino-1-[[(3S,6S,9S,12S,15R,18S,21S)-6,9,18-tris(2-aminoethyl)-3-[(1R)-1-hydroxyethyl]-12,15-diisobutyl-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]carbamoyl]propyl]carbamoyl]-2-hydroxy-propyl]carbamoyl]propyl]-5-methyl-heptanamide, N-[(1S)-3-amino-1-{[(1S,2R)-1-{[(1S)-3-amino-1-{[(3S,6S,9S,12S,15R,18S,21S)-6,9,18-tris(2-aminoethyl)-3-[(1R)-1-hydroxyethyl]-12,15-bis(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptaazacyclotricosan-21-yl]carbamoyl}propyl]carbamoyl}-2-hydroxypropyl]carbamoyl}propyl]-5-methylheptanamide C52H98N16O13 YKQOSKADJPQZHB-QNPLFGSASA-N N-[(2S)-4-amino-1-[[(2S,3R)-1-[[(2S)-4-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18S,21S)-6,9,18-tris(2-aminoethyl)-3-[(1R)-1-hydroxyethyl]-12,15-bis(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxobutan-2-yl]-5-methylheptanamide Parkdale Pharmaceuticals Antibiotics No No No No No No PMDBD2000668 Colistin sodium methanesulfonate n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000669 Colostrum Hexasaccharide n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000670 Competence Stimulating Peptide n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000671 Copper sulfate Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. D0BG4W 24462 n.a. n.a. "Copper sulfate, 7758-98-7, Copper(II) sulfate, CUPRIC SULFATE, Cupric sulfate anhydrous, Copper sulphate, Copper(2+) sulfate, Copper monosulfate, Copper(ii) sulfate, anhydrous, Cupricsulfate, Blue stone, Copper II sulfate, Delcup, Hylinec, Copper sulfate (1:1), Cupric sulphate, COPPERSULFATE, CuSO4, Copper(2+) sulphate, Monocopper sulfate, Incracide 10A, Incracide E 51, copper(II) sulphate, copper;sulfate, copper (II) sulfate, Copper Sulfate Powder, Sulfuric acid copper(2+) salt (1:1), Copper sulfate, anhydrous, Copper(2+) sulfate (1:1), Copper monosulphate, Copper sulfate (CuSO4), 10124-44-4, Snow Crystal Copper Sulfate, Aqua Maid Permanent Algaecide, CCRIS 3665, HSDB 916, Granular Crystals Copper Sulfate, Cupric sulphate anhydrous, Cupric sulfate, anhydrous, MAC 570, UNII-KUW2Q3U1VV, Cupric sulphate, anhydrous, KUW2Q3U1VV, Tobacco States Brand Copper Sulfate, 18939-61-2, EINECS 231-847-6, Phelps Triangle Brand Copper Sulfate, NSC 57630, Copper (as sulfate), Sulfuric acid, copper(2+) salt (1:1), Copper (II) sulphate, Sulfuric acid, copper(2+) salt, Cupric sulfate,anhydrous, Sa-50 Brand Copper Sulfate Granular Crystals, Aquatronics Snail-A-Cide Dri-Pac Snail Powder, MFCD00010981, Copper(ii) tetraoxosulfate, 1332-14-5, DTXSID6034479, CHEBI:23414, COPPER SULPHATE (1:1), EC 231-847-6, NSC-57630, COPPER(2+) SULPHATE (1:1), Trinagle, BCS copper fungicide, Blue copper (VAN), Kupfersulfat [German], CUPRIC SULFATE ANHYDROUS (II), CUPRIC SULFATE ANHYDROUS [II], Sulfate, Copper, Sulfate, Cupric, Vitriol, Blue, Sulfate de cuivre [French], COPPER SULFATE, ANHYDROUS (EP IMPURITY), COPPER SULFATE, ANHYDROUS [EP IMPURITY], CUPRIC SULFATE ANHYDROUS (USP MONOGRAPH), CUPRIC SULFATE ANHYDROUS [USP MONOGRAPH], Bluestone copper sulfate, Sulfuric acid, copper salt, copper(II)sulphate, copper(II)-sulfate, EINECS 242-692-9, CuSO4 copper sulphate, Copper (11) sulfate, Copper( cento) sulfate, Sulfuric acid, copper(2+) salt (1:?), SULFATE OF COPPER, SULFURIC ACID, COPPERSALT (8CI,9CI), CUPRIC SULFATE [MI], COPPER SULFATE [INCI], CUPRIC SULFATE [HSDB], Sulfuric acid copper(2+)salt, COPPER SULFATE (anhydrous), COPPER SULFATE [WHO-DD], DTXCID4014479, AKOS015902901, DB06778, CUPRIC SULFATE,ANHYDROUS [VANDF], Sulfuric acid, copper(2+) salt(1:1), BP-20356, NS00074389, C18713, A923422, Q107184, SR-01000944582, SR-01000944582-1" CuO4S ARUVKPQLZAKDPS-UHFFFAOYSA-L "copper;sulfate" Abraxis Pharmaceutical Products Antiinfective Agents No No No No No No PMDBD2000672 Coprinuslactone n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000673 Coumarin Therapeutic Substance Investigational Drug 91-64-5 DB04665 PA134521193 n.a. D03ZMQ 323 13848793 NPC139891 "coumarin, 91-64-5, 2H-Chromen-2-one, 2H-1-Benzopyran-2-one, cumarin, 1,2-Benzopyrone, chromen-2-one, Rattex, Coumarinic anhydride, Tonka bean camphor, Coumarine, cis-o-Coumarinic acid lactone, Coumarinic lactone, o-Hydroxycinnamic acid lactone, Benzo-alpha-pyrone, o-Hydroxycinnamic lactone, 2-Oxo-1,2-benzopyran, Kumarin, Benzo-a-pyrone, 2H-Benzo(b)pyran-2-one, 5,6-Benzo-2-pyrone, 2H-1-Benzopyran, 2-oxo-, Kumarin [Czech], o-Hydroxyzimtsaure-lacton, 5,6-Benzo-alpha-pyrone, 2H-Benzo[b]pyran-2-one, Coumarinum, 1-Benzopyran-2-one, NCI C07103, Caswell No. 259C, o-Coumaric acid lactone, 103802-83-1, NSC 8774, CCRIS 181, cis-o-Coumaric acid anhydride, chromenone, EPA Pesticide Chemical Code 127301, DTXSID7020348, CHEBI:28794, BRN 0383644, HSDB 1623, 2-oxo-2H-1-benzopyran, o-Hydroxyzimtsaure-lacton [German], AI3-00753, UNII-A4VZ22K1WT, NSC-8774, EINECS 202-086-7, A4VZ22K1WT, Nci-c07103, 2-Propenoic acid, 3-(2-hydroxyphenyl)-, delta-lactone, 3-(2-Hydroxyphenyl)-2-propenoic delta-lactone, Benzo-.alpha.-pyrone, Cinnamic acid, o-hydroxy-, delta-lactone, Coumarin (prohibited), NSC8774, o-hydroxycinnamic acid delta-lactone, MFCD00006850, CHEMBL6466, 2-Propenoic acid, 3-(2-hydroxyphenyl)-delta-lactone, DTXCID50348, MLS000028741, EC 202-086-7, 5-17-10-00143 (Beilstein Handbook Reference), NCGC00091502-01, Coumarin, >=98%, SMR000059040, COUMARIN (IARC), COUMARIN [IARC], COUMARIN (MART.), COUMARIN [MART.], 2h-chromene-2-one, 2-Propenoic acid, 3-(2-hydroxyphenyl)-, d-lactone, 2-Propenoic acid, 3-(2-hydroxyphenyl)-, .delta.-lactone, benzopyranone, coumarinac lactone, CAS-91-64-5, Coumarin [NF], COU, 2H-Benzopyran-2-one, SR-01000721887, chromen-one, a coumarin, coumarin-, d-lactone, Venalot mono, alpha-benzopyrone, Coumarin Phenolic, Rattex Rodenticide, benzopyrylium olate, Coumarin (DCF), Coumarin1513, 1, 2-Benzopyrone, a 1,2-benzopyrone, Venalot mono (TN), Spectrum_001336, ST023509, COUMARIN [HSDB], COUMARIN [INCI], Opera_ID_268, 2H-Chromen-2-one #, 3-(2-hydroxyphenyl)-, COUMARIN [MI], 2H-1-benzopyran-2-on, Spectrum2_000303, Spectrum3_001772, Spectrum4_001818, Spectrum5_000555, COUMARINUM [HPUS], bmse000077, COUMARIN [WHO-DD], Epitope ID:114082, SCHEMBL6252, WLN: T66 BOVJ, BSPBio_003263, KBioGR_002460, KBioSS_001816, MLS001148422, MLS002454395, {2H-Benzo[b]pyran-2-one}, BIDD:ER0667, SPECTRUM1400208, SPBio_000266, Cinnamic acid, .delta.-lactone, Coumarin, >=99% (HPLC), BDBM12342, KBio2_001816, KBio2_004384, KBio2_006952, KBio3_002764, GLXC-19130, HMS1923M11, HMS2091E19, HMS2232H18, HMS3369L08, HMS3652B05, HMS3885D09, Pharmakon1600-01400208, AMY37188, HY-N0709, Tox21_111141, Tox21_202427, Tox21_300057, CCG-38580, NSC755852, s4170, COUMARIN (PROHIBITED) [FHFI], AKOS000120175, Tox21_111141_1, 2H-chromen-2-one (ACD/Name 4.0), CR-0048, CS-8148, DB04665, NSC-755852, SDCCGMLS-0066912.P001, USEPA/OPP Pesticide Code: 127301, NCGC00091502-02, NCGC00091502-03, NCGC00091502-04, NCGC00091502-05, NCGC00091502-06, NCGC00091502-07, NCGC00091502-08, NCGC00091502-09, NCGC00091502-11, NCGC00091502-12, NCGC00091502-16, NCGC00254092-01, NCGC00259976-01, Coumarin 1000 microg/mL in Acetonitrile, NCI60_041938, SBI-0061760.P002, Cinnamic acid, o-hydroxy-, .delta.-lactone, Coumarin, Vetec(TM) reagent grade, >=99%, NS00002381, SW220278-1, EN300-18115, BIM-0061760.0001, C05851, D07751, D81844, AB00375898_11, AB00375898_12, Coumarin, primary pharmaceutical reference standard, Q111812, CU-01000013121-2, Q-100890, SR-01000721887-2, SR-01000721887-3, BRD-K23913458-001-02-5, BRD-K23913458-001-13-2, Coumarin, certified reference material, TraceCERT(R), Z57169486, Coumarin, European Pharmacopoeia (EP) Reference Standard, F3096-1712, COUMARIN (CONSTITUENT OF CINNAMOMUM CASSIA BARK) [DSC], COUMARIN (CONSTITUENT OF CINNAMOMUM VERUM BARK) [DSC], D3E956C4-9541-4F57-9435-7D915C38E19E, InChI=1/C9H6O2/c10-9-6-5-7-3-1-2-4-8(7)11-9/h1-6, 2h-1-benzopyran-2-one;coumarin;2h-chromen-2-one;coumarin ;coumarin (2h-1-benzopyran-2-one) (chromen-2-one);2h-1-benzopyran-2-one coumarin 2h-chromen-2-one coumarin coumarin (2h-1-benzopyran-2-one) (chromen-2-one)" C9H6O2 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N chromen-2-one n.a. n.a. No No No No No No PMDBD2000674 Coumarin-3-carboxylic acid Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D0H3NS 10752 n.a. n.a. Coumarin-3-carboxylic acid, 531-81-7, 2-Oxo-2H-chromene-3-carboxylic acid, 3-Carboxycoumarin, 2-Oxochromene-3-carboxylic acid, G 1 (rodenticide), 2-Oxobenzopyran-3-carboxylic acid, 2-Oxo-2H-1-benzopyran-3-carboxylic acid, 2H-1-BENZOPYRAN-3-CARBOXYLIC ACID, 2-OXO-, MFCD00006852, CHEMBL83294, V85UOV8788, NSC53239, NSC-14797, NSC-53239, G 1 (The rodenticide), WLN: T66 BOVJ DVQ, Malonic acid, .delta.-lactone, G 1 (The rodenticide) (VAN), G 1 (VAN), EINECS 208-518-0, NSC 14797, NSC 53239, BRN 0154276, Malonic acid, salicylidene-, delta-lactone, UNII-V85UOV8788, AI3-36066, COUMARIN-3-CARBOXYLICACID, 3-carboxy-coumarin, 3-carboxy coumarine, 3-CARBOXYLCOUMARIN, Oprea1_710975, SCHEMBL93571, CBDivE_014214, MLS000100456, IFLab1_000764, DTXSID70201183, CHEBI:192605, Coumarin-3-carboxylic acid, 99%, HMS1414C16, HMS2250I22, NSC14797, NSC44926, STR04665, 2-Oxo-2H-chromene-3-carboxylicacid, BDBM50131066, CCG-42658, NSC-44926, s9361, AKOS000104806, HY-W027968, 2-Oxo-2H-chromene-3-carboxylic acid #, COUMARIN-3-CARBOXYLIC ACID [MI], BP-11788, NCI60_001013, NCI60_004309, SMR000015715, 1ST164479, C3129, CS-0071992, NS00032672, Benzopyran-3-carboxylic acid, 2H-1-, 2-oxo, EN300-16938, Malonic acid, salicylidene-, .delta.-lactone, 2H-1-BENZOPYRAN-2-ONE-3-CARBOXYLIC ACID, AE-641/00583032, SR-01000389273, 1,2-BENZOPYRAN-3-CARBOXYLIC ACID, 2-KETO-, SR-01000389273-1, SR-01000389273-3, Q27291656, Z56824632, F0266-1412 C10H6O4 ACMLKANOGIVEPB-UHFFFAOYSA-N 2-oxochromene-3-carboxylic acid n.a. n.a. No No No No No No PMDBD2000675 cov-GK7-NH2 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000676 cov-GL13K n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000677 CRAMP n.a. n.a. n.a. n.a. n.a. n.a. n.a. 155817495 n.a. n.a. CRAMP, GTPL6266 C197H338N56O50 QBSFTGGUOCPHDM-GDCSACRRSA-N (2S)-2-[[(2S)-1-[(2S)-5-amino-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-6-amino-2-[[(2S,3S)-2-[[(2S)-6-amino-2-[[(2S)-5-amino-2-[[2-[[(2S,3S)-2-[[(2S)-6-amino-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[2-[[(2S,3S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[2-[[2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-amino-3-methylpentanoyl]amino]-3-hydroxypropanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-4-methylpentanoyl]amino]propanoyl]amino]acetyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]hexanoyl]amino]acetyl]amino]acetyl]amino]-4-carboxybutanoyl]amino]hexanoyl]amino]-3-methylpentanoyl]amino]acetyl]amino]-4-carboxybutanoyl]amino]hexanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]amino]hexanoyl]amino]-3-methylpentanoyl]amino]acetyl]amino]-5-oxopentanoyl]amino]hexanoyl]amino]-3-methylpentanoyl]amino]hexanoyl]amino]-4-oxobutanoyl]amino]-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-5-oxopentanoyl]amino]hexanoyl]amino]-4-methylpentanoyl]amino]-3-methylbutanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]pyrrolidine-2-carbonyl]amino]pentanedioic acid n.a. n.a. No No No No No No PMDBD2000678 Crocin Therapeutic Substance n.a. 42553-65-1 DB11874 n.a. n.a. n.a. 5281233 4444645 NPC110072 Crocin, Gardenia Yellow, Crocin I, 42553-65-1, Crocine, 94238-00-3, alpha-Crocin, Crocin 1, crocin-1, Saffron, .alpha.-crocin, Crocetin digentiobiose ester, bis[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl] (2E,4E,6E,8E,10E,12E,14E)-2,6,11,15-tetramethylhexadeca-2,4,6,8,10,12,14-heptaenedioate, crocetin di-gentiobiose ester, CHEMBL446785, DTXSID7046172, CHEBI:79068, 877GWI46C2, 11012-59-2, Crocetin bis(gentiobiosyl) ester, NCGC00160471-01, Bis(6-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl) 8,8''-diapo-psi,psi-carotenedioate, 39465-00-4, all-trans-Crocetin di-beta-D-gentiobiosyl ester, Crocin A, bis(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl (2E,4E,6E,8E,10E,12E,14E)-2,6,11,15-tetramethylhexadeca-2,4,6,8,10,12,14-heptaenedioate, CCRIS 678, CCRIS 7705, crocetin digentiobiosyl ester, EINECS 255-881-6, BRN 6473367, UNII-F32BA2H92Z, UNII-877GWI46C2, Crocin-I, HSDB 8211, Natural red 1, EINECS 254-465-1, Natural yellow 19, crocetin digentiobioside, CROCIN [INCI], CROCIN [WHO-DD], trans-Crocetin di(beta-D-gentiobiosyl) ester, DTXCID201457, F32BA2H92Z, SCHEMBL1463936, bis(beta-D-gentiobiosyl) crocetin, SEBIKDIMAPSUBY-RTJKDTQDSA-N, HMS3887O07, Crocetin Di(Beta-Gentiobiosyl)Ester, HY-N0697, crocetin di-beta-D-gentiobiose ester, Tox21_111837, BDBM50260195, s9511, AKOS015896765, DB11874, NCGC00160471-02, 8,8''-Diapo-.psi.,.psi.-carotenedioic acid, bis(6-O-.beta.-D-glucopyranosyl-.beta.-D-glucopyranosyl) ester, 8,8''-Diapo-psi,psi-carotenedioic acid, bis(6-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl) ester, beta-D-Glucopyranose, 6-O-beta-D-glucopyranosyl-, 1,1''-((2E,4E,6E,8E,10E,12E,14E)-2,6,11,15-tetramethyl-2,4,6,8,10,12,14-hexadecaheptaenedioate), FS-10544, CROCETIN DI-GENTIOBIOSE ESTER [MI], CAS-42553-65-1, C.I. 75100, CS-0009714, trans-crocetin bis(beta-D-gentiobiosyl) ester, C08589, A872860, Q424767, TRANS-CROCETIN DI(.BETA.-D-GENTIOBIOSYL) ESTER, ALL-TRANS-CROCETIN DI-.BETA.-D-GENTIOBIOSYL ESTER, (2E,4E,6E,8E,10E,12E,14E)-Bis((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-((((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)methyl)tetrahydro-2H-pyran-2-yl) 2,6,11,15-tetramethylhexadeca-2,4,6,8,10,12,14-heptaenedioate, (2E,4E,6E,8E,10E,12E,14E)-Bis((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-((((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)methyl)tetrahydro-2H-pyran-2-yl)2,6,11,15-tetramethylhexadeca-2,4,6,8,10,12,14-heptaenedioate, .BETA.-D-GLUCOPYRANOSE, 6-O-.BETA.-D-GLUCOPYRANOSYL-, 1,1''-((2E,4E,6E,8E,10E,12E,14E)-2,6,11,15-TETRAMETHYL-2,4,6,8,10,12,14-HEXADECAHEPTAENEDIOATE), bis[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}methyl)tetrahydro-2H-pyran-2-yl] (2E,4E,6E,8E,10E,12E,14E)-2,6,11,15-tetramethylhexadeca-2,4,6,8,10,12,14-heptaenedioate C44H64O24 SEBIKDIMAPSUBY-RTJKDTQDSA-N bis[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl] (2E,4E,6E,8E,10E,12E,14E)-2,6,11,15-tetramethylhexadeca-2,4,6,8,10,12,14-heptaenedioate n.a. n.a. No No No No No No PMDBD2000679 CSP n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000680 CSP-C16 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000681 CWR11 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000682 Cyanidin Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D0V3PG 128861 n.a. NPC46274 Cyanidin, 13306-05-3, cyanidin cation, Cyanidol, 2-(3,4-dihydroxyphenyl)chromenylium-3,5,7-triol, 3,5,7,3'',4''-Pentahydroxyflavylium, Flavylium, 3,3'',4'',5,7-pentahydroxy-, CHEMBL404515, 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-1-Benzopyrylium, CHEBI:27843, 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxychromenylium, 7732ZHU564, 1-Benzopyrylium, 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-, cyanidin ion, 3,3'',4,5,7-Pentahydroxyflavylium chloride, UNII-7732ZHU564, cyanidin(1+), SCHEMBL20799, 2-(3,4-dihydroxyphenyl) chromenylium-3,5,7-triol, NIOSH/LK9820000, HY-N0499A, DTXSID10157933, VEVZSMAEJFVWIL-UHFFFAOYSA-O, 25%,Source Blueberry Anthocyanins, BDBM50241503, LMPK12010002, 3,3'''',4'''',5,7-pentahydroxyflavylium, 3,3'',4'',5,7-Pentahydroxyflavyliumchlorid, CS-0147017, LK98200000, NS00002029, 3,5,7,3'''''''',4''''''''-Pentahydroxyflavylium, 3,3'',4'',5,7-Pentahydroxyflavylium acid anion, C05905, S00118, chlorure de 3,3'',4'',5,7-pentahydroxyflavylium, Q417606, 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxychromenium, Flavylium, 3,3'',4'',5,7-pentahydroxy-, acid anion, Benzopyrylium, 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-, acid anion, InChI=1/C15H10O6/c16-8-4-11(18)9-6-13(20)15(21-14(9)5-8)7-1-2-10(17)12(19)3-7/h1-6H,(H4-,16,17,18,19,20)/p+ C15H11O6+ VEVZSMAEJFVWIL-UHFFFAOYSA-O 2-(3,4-dihydroxyphenyl)chromenylium-3,5,7-triol n.a. n.a. No No No No No No PMDBD2000683 Cyclacillin Therapeutic Substance Approved Drug 3485-14-1 DB01000 PA164743456 D01334 D00HWO 19003 17941 n.a. CYCLACILLIN, ciclacillin, Vastcillin, Ciclacillum, Cyclapen, Aminocyclohexylpenicillin, 3485-14-1, Bastcillin, Cyclapen-W, Citosarin, Syngacillin, Ultracillin, Calthor, Vipicil, Wyvital, Ciclacillinum, Ciclacilline, Orfilina, (1-Aminocyclohexyl)penicillin, Ciclacilina, Wy-4508, 6-(1-Aminocyclohexanecarboxamido)penicillanic acid, Ciclacilina [INN-Spanish], Ciclacilline [INN-French], Ciclacillinum [INN-Latin], Aminocyclohexyl penicillin, Cyclacillin [USAN], 6-(1-Aminocyclohexylcarboxamido)penicillanic acid, WY 4508, AC 98, Penicillin, (aminocyclohexyl)-, NSC88789, NSC-88789, Ciclacillin [INN], Cyclacillin (USAN), DTXSID9022861, CHEBI:31444, (2S,5R,6R)-6-[(1-aminocyclohexanecarbonyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 72ZJ154X86, DTXCID002861, (2S,5R,6R)-6-{[(1-aminocyclohexyl)carbonyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, Noblicil, Peamezin, 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(((1-aminocyclohexyl)carbonyl)amino)-3,3-dimethyl-7-oxo-, (2S-(2alpha,5alpha,6beta))-, 6-(1-Aminocyclohexanecarboxamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, NCGC00016629-01, CAS-3485-14-1, 6beta-(1-aminocyclohexanecarboxamido)-2,2-dimethylpenam-3alpha-carboxylic acid, CICLACILLIN (MART.), CICLACILLIN [MART.], (2S,5R,6R)-6-(1-aminocyclohexaneamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylicacid, 6-[[(1-aminocyclohexyl)carbonyl]amino]-3,3-dimethyl-7-oxo-, (2S,5R,6R)-, 6-(1-Aminocyclohexanecarboxamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, AC-PC, Vastcillin (TN), Cyclapen-W (TN), MLS002694856, EINECS 222-470-8, NSC 88789, WY4508, Cyclacillin [USAN:USP], BRN 0938663, UNII-72ZJ154X86, (2S,5R,6R)-6-(((1-aminocyclohexyl)carbonyl)amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, (2S,5R,6R)-6-((1-Aminocyclohexanecarbonyl)amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, CYCLACILLIN [MI], Prestwick0_001120, Prestwick1_001120, Prestwick2_001120, Prestwick3_001120, CICLACILLIN [JAN], Ciclacillin (JP17/INN), CYCLACILLIN [VANDF], C-12104, SCHEMBL33900, BSPBio_001260, CICLACILLIN [WHO-DD], SPBio_003120, BPBio1_001385, GTPL4817, CHEMBL1200356, CYCLACILLIN [ORANGE BOOK], HMS1571O22, Tox21_110534, BDBM50350474, DB01000, NCGC00179238-01, 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(1-aminocyclohexanecarboxamido)-3,3-dimethyl-7-oxo-, HY-16158, NCI60_041965, AB00514059, CS-0006169, D01334, EN300-19766309, Q5119441, BRD-K89046952-001-03-4, WLN: T45 ANV ESTJ F1 F1 GVQ CMV- AL6TJ AZ, (2S,5R,6R)-6-[(1-aminocyclohexane)amido]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic Acid, 6-(((1-aminocyclohexyl)carbonyl)amino)-3,3-dimethyl-7-oxo-,(2S-(2alpha,5alpha,6beta))- C15H23N3O4S HGBLNBBNRORJKI-WCABBAIRSA-N (2S,5R,6R)-6-[(1-aminocyclohexanecarbonyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid n.a. Antibiotics No No No No No No PMDBD2000684 cyclo(Trp-Ser) n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000685 Cyclobutanamine n.a. n.a. n.a. n.a. n.a. n.a. n.a. 75645 n.a. n.a. Cyclobutylamine, Cyclobutanamine, 2516-34-9, Aminocyclobutane, cyclobutyl amine, 1-Aminocyclobutane, MFCD00001328, HFH6FE5D4Y, cyclobutylamin, cyclobutaneamine, 1-amino cyclobutane, EINECS 219-736-0, Cyclobutylamine, 98%, UNII-HFH6FE5D4Y, KZZKOVLJUKWSKX-UHFFFAOYSA-, AMY2668, DTXSID00870982, NSC 4598, EINECS 228-540-4, AKOS005254902, PB42394, PS-9374, A1036, CS-0006656, NS00081755, EN300-62688, F10463, W-107258, Q31190376, F1791-1731, InChI=1/C4H9N/c5-4-2-1-3-4/h4H,1-3,5H2 C4H9N KZZKOVLJUKWSKX-UHFFFAOYSA-N cyclobutanamine n.a. n.a. No No No No No No PMDBD2000686 Cycloserine Therapeutic Substance Approved Drug 68-41-7 DB00260 PA164764600 n.a. D02WFK 6234 5998 n.a. "D-cycloserine, cycloserine, 68-41-7, Seromycin, orientomycin, Oxamycin, Cyclo-D-serine, Cyclorin, Cicloserina, Farmiserina, Miroseryn, Tisomycin, Wasserina, Closina, D-4-amino-3-isoxazolidinone, Cycloserinum, (+)-4-Amino-3-isoxazolidinone, alpha-Cycloserine, (R)-4-AMINOISOXAZOLIDIN-3-ONE, D-4-amino-3-isoxazolidone, Miroserina, Novoserin, Tebemicina, (4R)-4-amino-1,2-oxazolidin-3-one, Oxamicina, (+)-Cycloserine, Cycloserin, Micoserina, (4R)-4-aminoisoxazolidin-3-one, PA 94, D-(+)-Cycloserine, D-Oxamycin, PA-94, (R)-4-AMINO-ISOXAZOLIDIN-3-ONE, RO-1-9213, 3-Isoxazolidinone, 4-amino-, (R)-, E-733-A, D-4-Amino-3-isossazolidone, D-CS, Cycloserinum [INN-Latin], HSDB 3218, 3-Isoxazolidinone, 4-amino-, (4R)-, Cicloserina [INN-Spanish], 3-Isoxazolidinone, 4-amino-, d-, K-300, (R)-4-Amino-3-isoxazolidone, 3-Isoxazolidinone, 4-amino-, (+)-, NSC 154851, I-1431, CHEBI:40009, D-Oxamicina, AI3-50153, EINECS 200-688-4, UNII-95IK5KI84Z, BRN 0080798, 95IK5KI84Z, DTXSID8022870, D-Cycloserine, synthetic, D-Cycloserine (Standard), NSC-76029, CHEMBL771, NSC-154851, C3H6N2O2, SC-49088, DTXCID902870, DCS, Cycloserine [USP:INN:BAN:JAN], 4-27-00-05549 (Beilstein Handbook Reference), MFCD00005353, CAS-68-41-7, NCGC00016306-01, Oxamicina [Italian], Cicloserina [Italian], Cycloserinum (INN-Latin), Cicloserina (INN-Spanish), CYCLOSERINE (MART.), CYCLOSERINE [MART.], R-4-Amino-3-isoxazolidinone, Cycloserine, D-, Closerin, CYCLOSERINE (USP IMPURITY), Cycloserine (USP:INN:BAN:JAN), CYCLOSERINE [USP IMPURITY], CYCLOSERINE (USP MONOGRAPH), CYCLOSERINE [USP MONOGRAPH], .alpha.-Cycloserine, NSC154851, (R)-Cycloserine, Seromycin (TN), SMR000058313, D-4-Amino-3-isossazolidone [Italian], R-(+)-Cycloserine, (R)-4-Amino-3-isoxazolidinone, (4R)-4-Amino-3-isoxazolidinone, CYCLOSERINE (D), SR-01000075432, DRG-0195, (R)-(+)-Cycloserine, D-amino-3-isoxazolidinone, cycloserine-(d), Serine, cyclo-, 3-Isoxazolidinone, 4-amino-, D, R(+)-4-Amino-3-isoxazolidinone, 4AX, 3-Isoxazolidinone, 4-amino-, (R), (R)-(+)-4-Amino-3-isoxazolidinone, Cycloserine, D(+), D-Cycloserine, powder, Spectrum_000860, 1pb9, CYCLOSERINE [MI], Prestwick0_001089, Prestwick1_001089, Prestwick2_001089, Prestwick3_001089, Spectrum2_000084, Spectrum3_000371, Spectrum4_000305, Spectrum5_000797, CYCLOSERINE [INN], CYCLOSERINE [JAN], Lopac-C-1159, Lopac-C-3909, Lopac-C-7005, CYCLOSERINE [HSDB], 3-Isoxazolidinone, 4-amino-, (4R)- (9CI), C 3909, C-9390, C-9400, CYCLOSERINE [VANDF], Lopac0_000252, SCHEMBL34322, BSPBio_001138, BSPBio_002121, CYCLOSERINE [WHO-DD], CYCLOSERINE [WHO-IP], KBioGR_000890, KBioSS_001340, MLS000758215, MLS001423962, MLS002548887, BIDD:GT0707, D-Cycloserine synth. BP 88, DivK1c_000098, SPECTRUM1500215, SPBio_000008, SPBio_003029, BPBio1_001252, FA6C7F8B-D080-4EA3-978F-1ECFB5A29D09, GTPL9489, Cycloserine (JP17/USP/INN), 4-Amino-3-isoxazolidinone, D-, HMS500E20, HY-B0030R, KBio1_000098, KBio2_001340, KBio2_003908, KBio2_006476, KBio3_001341, CYCLOSERINE [ORANGE BOOK], J04AB01, NINDS_000098, HMS1571I20, HMS1920C06, HMS2051C15, HMS2091I14, HMS2098I20, HMS2232F03, HMS3259L19, HMS3260D06, HMS3715I14, NJ-21, Pharmakon1600-01500215, (R)-3-Isoxazolidinone, 4-amino-, 4-Amino-3-isoxazolidinone, (R)-, CYCLOSERINUM [WHO-IP LATIN], HY-B0030, Tox21_110361, Tox21_500252, BDBM50038178, BDBM50103516, CCG-39705, D-Cycloserine, >=96.0% (NT), LMPK14000007, NSC756712, s1998, 4-Isoxazolidinamine, 3-oxo-, (D)-, AKOS015994626, Tox21_110361_1, AC-4721, DB00260, HS-0079, LP00252, NC00050, NC00676, NSC-756712, SDCCGSBI-0050240.P005, IDI1_000098, SMP1_000167, NCGC00015213-01, NCGC00015213-02, NCGC00015213-03, NCGC00016306-02, NCGC00016306-03, NCGC00016306-04, NCGC00016306-05, NCGC00016306-07, NCGC00016306-08, NCGC00016306-17, NCGC00093713-01, NCGC00093713-02, NCGC00260937-01, CAS-339-72-0, SBI-0050240.P004, AB00443920, CS-0695020, EU-0100252, NS00009120, 3-Isoxazolidinone, 4-amino-, (+)- (8CI), EN300-97131, C08057, D00877, M01471, AB00443920_09, AB00443920_10, A836140, Q418508, SR-01000759389, SR-01000075432-1, SR-01000075432-2, SR-01000075432-5, SR-01000075432-9, SR-01000759389-4, SR-01000075432-10, F2173-1228, Z1198154206, Cycloserine, United States Pharmacopeia (USP) Reference Standard, Cycloserine, Pharmaceutical Secondary Standard; Certified Reference Material, (4R)-4-azaniumyl-4,5-dihydroisoxazol-3-olate;(R)-4-AMINOISOXAZOLIDIN-3-ONE" C3H6N2O2 DYDCUQKUCUHJBH-UWTATZPHSA-N (4R)-4-amino-1,2-oxazolidin-3-one n.a. Antiinfective Agents No No No No No No PMDBD2000687 Cycloserine? n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000688 Cynarin Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. D0KN2M 5281769 n.a. NPC284948 "Cynarine, Cynarin, 30964-13-7, Cinarine, Cinarin, 1,5-Dicaffeoylquinic acid, Plemocil, 1,3-Dicaffeoylquinic acid, Cynarine [INN], Listrocol, 1,3-Dicqa, 212891-05-9, 1,5-Dicaffeoylqunic acid, UNII-85D81U9JAV, Cynarine [MI], 85D81U9JAV, (1R,3R,4S,5R)-1,3-Bis((3-(3,4-dihydroxyphenyl)acryloyl)oxy)-4,5-dihydroxycyclohexanecarboxylic acid, Cynarine [MART.], Cynarine [WHO-DD], Quinic acid 1,5-dicaffeic ester, CHEBI:520, 1,5-di-O-Caffeoylquinic acid, 1884-23-7, Caffeic acid 1-carboxy-4,5-dihydroxy-1,3-cyclohexylene ester, 1-carboxy-4,5-dihydroxy-1,3-cyclohexylenebis-(3,4-dihydroxycinnamate), Cynarine (MART.), 3,4-Dihydroxycinnamic acid 1-carboxy-4,5-dihydroxy-1,3-cyclohexylene ester, 3,4-Dihydroxycinnamic acid, 1-carboxy-4,5-dihydroxy-1,3-cyclohexylene ester, (1R,3R,4S,5R)-1,3-Bis((3-(3,4-dihydroxyphenyl)-1-oxo-2-propen-1-yl)oxy)-4,5-dihydroxycyclohexanecarboxylic acid, (1R,3R,4S,5R)-1,3-bis[[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy]-4,5-dihydroxycyclohexane-1-carboxylic acid, Cyclohexanecarboxylic acid, 1,3-bis(((2E)-3-(3,4-dihydroxyphenyl)-1-oxo-2-propen-1-yl)oxy)-4,5-dihydroxy-, (1R,3R,4S,5R)-, DTXCID9029805, 1,5-DQA, Phemocil, (1R,3R,4S,5R)-1,3-bis(((E)-3-(3,4-dihydroxyphenyl)acryloyl)oxy)-4,5-dihydroxycyclohexane-1-carboxylic acid, (1R,3R,4S,5R)-1,3-bis({[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy})-4,5-dihydroxycyclohexane-1-carboxylic acid, (1R,3R,4S,5R)-1,3-Bis[[3-(3,4-dihydroxyphenyl)-1-oxo-2-propen-1-yl]oxy]-4,5-dihydroxycyclohexanecarboxylic acid, (1R-(1alpha,3alpha,4alpha,5beta))-1,3-Bis((3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl)oxy)-4,5-dihydroxycyclohexanecarboxylic acid, Cyclohexanecarboxylic acid, 1,3-bis((3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl)oxy)-4,5-dihydroxy-, CAS-30964-13-7, DTXSID0050423, cynarinum, Cynaricine, Chinasaeure-1,3-dikaffeesaeureester, Cynarin (1,3-Dicaffeoylquinic acid), 1-O,3-O-Bis(3,4-dihydroxycinnamoyl)chinasaeure, Cynarine [INN:WHO-DD], Cynarin, analytical standard, 1,5-Dicaffeoyl quinic acid, SCHEMBL42528, 1_5_dihydrocaffeoylquinic_acid, CHEMBL487258, YDDUMTOHNYZQPO-RVXRWRFUSA-N, DTXSID301309674, BCP29379, HY-N0359, Tox21_111176, BDBM50369484, MFCD11112054, s3301, AKOS015912727, Tox21_111176_1, AC-6022, CS-6280, NCGC00274085-01, AS-74959, NS00007039, 1,3-Dicaffeoylquinic acid, >=98% (HPLC), A820670, J-003723, Q-100389, Q1763092, Cynarine;1,3-Dicaffeoylquinic acid;1,5-DQA;1,5-Dicaffeoylquinic acid, (1R,3R,4S,5R)-1,3-Bis((3-(3,4-dihydroxyphenyl)acryloyl)oxy)-4,5-dihydroxycyclohexanecarboxylicacid, (1R,3R,4S,5R)-1,3-bis{[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-4,5-dihydroxycyclohexane-1-carboxylic acid, (1R-(1.ALPHA.,3.ALPHA.,4.ALPHA.,5.BETA.))-1,3-BIS((3-(3,4-DIHYDROXYPHENYL)-1-OXO-2-PROPENYL)OXY)-4,5-DIHYDROXYCYCLOHEXANECARBOXYLIC ACID, 1,3-Dicaffeoylquinic acid (constituent of echinacea angustifolia root, echinacea pallida root, echinacea purpurea root and echinacea purpurea aerial parts), Cyclohexanecarboxylic acid,1,3-bis[[3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl]oxy]-4,5-dihydroxy-,(1R,3R,4S,5R)-" C25H24O12 YDDUMTOHNYZQPO-RVXRWRFUSA-N (1R,3R,4S,5R)-1,3-bis[[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy]-4,5-dihydroxycyclohexane-1-carboxylic acid n.a. n.a. No No No No No No PMDBD2000689 D, L- K6L9 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000690 D/L-Aspartate n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000691 D-2-aminoadipic acid n.a. n.a. n.a. n.a. n.a. n.a. n.a. 165627 n.a. n.a. "D-2-aminoadipic acid, 7620-28-2, (R)-2-Aminohexanedioic acid, (2R)-2-aminohexanedioic acid, D-alpha-aminoadipic acid, CHEBI:37025, Hexanedioic acid, 2-amino-, (-)- and (+)-, D-a-Aminoadipic acid, D-Homoglutamic acid, (R)-2-Aminoadipic acid, H-D-Aad-OH, D-|A-Aminoadipic acid, alpha-Aminoadipate, D-, Hexanedioic acid, 2-amino-, (2R)-, (R)-2-Amino-hexanedioic acid, d-2-aminoadipate, 2-Aminohexanedioic acid (-)- and (+)-, Lopac-A-7275, (R)-2-Aminohexanedioicacid, SCHEMBL2022365, CHEMBL1169505, BDBM85356, DTXSID90227062, OYIFNHCXNCRBQI-SCSAIBSYSA-N, AKOS016842486, CS-W016142, NCGC00015087-01, AC-22381, AS-14204, CAS_542-32-5, EN300-86337, A838640, Q27117011, Z1255486317, D--Aminoadipic acid;(R)-2-Aminohexanedioic acid;H-D-Homoglu-OH" C6H11NO4 OYIFNHCXNCRBQI-SCSAIBSYSA-N (2R)-2-aminohexanedioic acid n.a. n.a. No No No No No No PMDBD2000692 D-2-Methylphenylalanine n.a. n.a. n.a. n.a. n.a. n.a. n.a. 6951464 n.a. n.a. 80126-54-1, (R)-2-Amino-3-(o-tolyl)propanoic acid, 2-Methyl-D-phenylalanine, D-2-Methylphenylalanine, (2R)-2-amino-3-(2-methylphenyl)propanoic acid, D-2-METHYLPHE, O-METHYL-D-PHENYLALANINE, (2R)-2-azaniumyl-3-(2-methylphenyl)propanoate, D-Phenylalanine, 2-methyl-, 2-Methy-D-Phenylalanine, H-D-PHE(2-ME)-OH, D-2-Methyl Phenylalanine, H-O-ME-D-PHE-OH, SCHEMBL383453, DTXSID301313334, MFCD01860870, AKOS016843584, AC-5867, AM83410, PS-12170, CS-0152968, (R)-2-AMINO-3-O-TOLYLPROPANOIC ACID, D-2-Methylphenylalanine (H-D-Phe(2-Me)-OH), EN300-1298518, A839847 C10H13NO2 NHBKDLSKDKUGSB-SECBINFHSA-N (2R)-2-amino-3-(2-methylphenyl)propanoic acid n.a. n.a. No No No No No No PMDBD2000693 Daclatasvir Therapeutic Substance Approved Drug 1009119-64-5 DB09102 PA166128167 D10105 D09SGV 25154714 24609522 n.a. Daclatasvir, 1009119-64-5, Daclatasvir (BMS-790052), BMS-790052, Daklinza, 1214735-16-6, EBP 883, BMS 790052, Daclatasvir [USAN], BMS790052, methyl N-[(2S)-1-[(2S)-2-[5-[4-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate, CHEBI:82977, EBP-883, Daclatasvir (USAN), Carbamic acid, N,N''-[[1,1''-biphenyl]-4,4''-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]bis-, C,C''-dimethyl ester, Carbamic acid, N,N''-((1,1''-biphenyl)-4,4''-diylbis(1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl((1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl)))bis-, C,C''-dimethyl ester, Dimethyl ((2S,2''S)-((2S,2''S)-2,2''-(5,5''-([1,1''-biphenyl]-4,4''-diyl)bis(1H-imidazole-5,2-diyl))bis(pyrrolidine-2,1-diyl))bis(3-methyl-1-oxobutane-2,1-diyl))dica, methyl ((S)-1-((S)-2-(5-(4''-(2-((S)-1-((methoxycarbonyl)-L-valyl)pyrrolidin-2-yl)-1H-imidazol-5-yl)-[1,1''-biphenyl]-4-yl)-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate, methyl N-[(2S)-1-[(2S)-2-[5-(4''-{2-[(2S)-1-[(2S)-2-[(methoxycarbonyl)amino]-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl}-[1,1''-biphenyl]-4-yl)-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate, LI2427F9CI, methyl N-[(1S)-1-[(2S)-2-[5-[4-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methyl-butanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidine-1-carbonyl]-2-methyl-propyl]carbamate, DACLATASVIR [MI], DACLATASVIR [INN], DACLATASVIR [WHO-DD], dimethyl (2S,2''S)-1,1''-((2S,2''S)-2,2''-(4,4''-(biphenyl-4,4''-diyl)bis(1H-imidazole-4,2-diyl))bis(pyrrolidine-2,1-diyl))bis(3-methyl-1-oxobutane-2,1-diyl)dicarbamate, MLS006011140, EBP883, SCHEMBL2756027, CHEMBL2023898, SCHEMBL17897804, GTPL11266, EX-A410, BDBM627982, DTXSID901026404, AMY36655, dimethyl ((2S,2''S)-((2S,2''S)-2,2''-(5,5''-([1,1''-biphenyl]-4,4''-diyl)bis(1H-imidazole-5,2-diyl))bis(pyrrolidine-2,1-diyl))bis(3-methyl-1-oxobutane-2,1-diyl))dicarbamate, Dimethyl N,N''-(biphenyl-4,4''-diylbis{1H-imidazole-5,2-diyl-((2S)-pyrrolidine-2,1- diyl)((1S)-1-(1-methylethyl)-2-oxoethane-2,1-diyl)})dicarbamate, BDBM50387084, MFCD17129086, s1482, AKOS030524262, CCG-270425, CS-0588, DB09102, CVD-0019437, NCGC00346533-07, NCGC00346533-09, AC-28958, AS-75298, HY-10466, SMR004702917, NS00072904, SW219754-1, D10065, EN300-27736661, J-520204, Q5207712, Dimethyl ((2S,2''S)-((2S,2''S)-([1,1''-biphenyl]-4,4''-diylbis(1H-imidazole-5,2-diyl))bis(pyrrolidine-2,1-diyl))bis(3-methyl-1-oxobutane-1,2-diyl))dicarbamate, DIMETHYL N,N''-((1,1''-BIPHENYL)-4,4''-DIYLBIS(1H-IMIDAZOLE-5,2-DIYL-((2S)-PYRROLIDINE-2,1-DIYL)((1S)-3-METHYL-1-OXOBUTANE-1,2-DIYL)))DICARBAMATE, methyl [(2s)-1-{(2s)-2-[4-(4''-{2-[(2s)-1-{(2s)-2-[(methoxycarbonyl)amino]-3-methylbutanoyl}-2-pyrrolidinyl]-1h-imidazol-4-yl}-4-biphenylyl)-1h-imidazol-2-yl]-1-pyrrolidinyl}-3-methyl-1-oxo-2-butanyl]carbamate, methyl [(2S)-1-{(2S)-2-[4-(4''-{2-[(2S)-1-{(2S)-2-[(methoxycarbonyl)amino]-3-methylbutanoyl}pyrrolidin-2-yl]-1H-imidazol-4-yl}biphenyl-4-yl)-1H-imidazol-2-yl]pyrrolidin-1-yl}-3-methyl-1-oxobutan-2-yl]carbamate, Methyl [(2S)-1-{(2S)-2-[5-(4''-{2-[(2S)-1-{(2S)-2-[(methoxycarbonyl)amino]-3-methylbutanoyl}pyrrolidin-2-yl]-1H-imidazol-5-yl}biphenyl-4-yl)-1H-imidazol-2-yl]pyrrolidin-1-yl}-3-methyl-1-oxobutan-2-yl]carbamate, methyl-N-[(2s)-1-[(2s)-2-[5-[4-[4-[2-[(2s)-1-[(2s)-2-(methoxycarbonylamino)-3-methylbutanoyl] pyrrolidin-2-yl]-1h-imidazol-5-yl]phenyl]phenyl]-1himidazol-2-yl]pyrrolidin-1-yl]3-methyl-1-oxobutan-2-yl]carbamate C40H50N8O6 FKRSSPOQAMALKA-CUPIEXAXSA-N methyl N-[(2S)-1-[(2S)-2-[5-[4-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate Bristol-Myers Squibb n.a. No No No No No No PMDBD2000694 D-Alanine Therapeutic Substance Investigational Drug 338-69-2 DB01786 n.a. n.a. D01BCI 71080 64234 n.a. D-alanine, 338-69-2, (2R)-2-aminopropanoic acid, (R)-Alanine, H-D-Ala-OH, (R)-2-aminopropanoic acid, D-2-Aminopropionic acid, D-Ala, D-alpha-Alanine, Alanine, D-, Alanine D-form, (R)-2-Aminopropionic acid, Ba 2776, D-(-)-Alanine, D-alpha-Aminopropionsaeure, (R)-2-Aminopropionsaeure, D-Alanin, D-alpha-aminopropionic acid, MFCD00008077, D-.alpha.-Alanine, (2R)-2-azaniumylpropanoate, CHEMBL66693, E3UDS4613U, DTXSID3045649, CHEBI:15570, DAL, NCGC00024493-02, DTXCID1025649, CAS-338-69-2, D(-)-.alpha.-Alanine, UNII-E3UDS4613U, delta-Alanine, d-a-alanine, R Alanine, NSC-158286, (D)-alanine, delta-alpha-Alanine, EINECS 206-418-1, 3h-d-ala, delta-(-)-Alanine, NSC 158286, D(-)-alpha-Alanine, D(-)-a -Alanine, Tocris-0204, D-Alanine, >=99%, bmse000236, delta-2-Aminopropionic acid, (R)-2-amino propionic acid, ALANINE D-FORM [MI], GTPL4678, (2R)-2-(amino)propanoic acid, D-Alanine, >=98% (HPLC), Tox21_110903, BDBM50000109, s3203, AKOS015840336, Tox21_110903_1, CS-W020127, DB01786, NCGC00024493-01, NCGC00024493-03, NCGC00024494-02, AS-56052, HY-41700, A0177, AM20090517, NS00069914, D-Alanine, Vetec(TM) reagent grade, >=98%, EN300-53665, A-4200, C00133, M02932, A847287, SR-01000597686, SR-01000597686-3, Q27076975, Z802692914, 0C450B43-C901-4435-9E74-051222D815EA C3H7NO2 QNAYBMKLOCPYGJ-UWTATZPHSA-N (2R)-2-aminopropanoic acid n.a. n.a. No No No No No No PMDBD2000695 Dalfopristin Therapeutic Substance Approved Drug 112362-50-2 DB01764 PA164746234 D00853 D05AFC 6323289 16736919 n.a. DALFOPRISTIN, Dalfopristine, Dalfopristina, Dalfopristinum, RP 54476, 112362-50-2, RP-54476, R9M4FJE48E, 5-(2-DIETHYLAMINO-ETHANESULFONYL)-21-HYDROXY-10-ISOPROPYL-11,19-DIMETHYL-9,26-DIOXA-3,15,28-TRIAZA-TRICYCLO[23.2.1.00,255]OCTACOSA-1(27),12,17,19,25(28)-PENTAENE-2,8,14,23-TETRAONE, Dalfopristine [INN-French], Dalfopristinum [INN-Latin], Dalfopristina [INN-Spanish], RP54476, Virginiamycin M1, 26-((2-(diethylamino)ethyl)sulfonyl)-26,27-dihydro-, (26R,27S)-, (3R,4R,5E,10E,12E,14S,26R,26aS)-26-((2-(Diethylamino)ethyl)sulfonyl)-8,9,14,15,24,25,26,26a-octahydro-14-hydroxy-3-isopropyl-4,12-dimethyl-3H-21,18-nitrilo-1H,22H-pyrrolo(2,1-c)(1,8,4,19)dioxadiazacyclotetracosine-1,7,16,22(4H,17H)-tetrone, UNII-R9M4FJE48E, Dalfopristin [USAN:INN:BAN], HSDB 8068, (3R,4R,5E,10E,12E,14S,26R,26aS)-26-[[2-(Diethylamino)ethyl]sulfonyl]-8,9,14,15,24,25,26,26a-octahydro-14-hydroxy-3-isopropyl-4,12-dimethyl-3H-21,18-nitrilo-1H,22H-pyrrolo[2,1-c][1,8,4,19]dioxadiazacyclotetracosine-1,7,16,22(4H,17H)-tetrone, DOL, DALFOPRISTIN [MI], DALFOPRISTIN [INN], DALFOPRISTIN [JAN], DALFOPRISTIN [USAN], DALFOPRISTIN [VANDF], SCHEMBL40993, DALFOPRISTIN [WHO-DD], CHEBI:4309, CHEMBL1200937, GTPL10797, DTXSID10869549, DALFOPRISTIN [ORANGE BOOK], (6R,7S,10R,11R,12E,17E,19E,21S)-6-[2-(diethylamino)ethylsulfonyl]-21-hydroxy-11,19-dimethyl-10-propan-2-yl-9,26-dioxa-3,15,28-triazatricyclo[23.2.1.03,7]octacosa-1(27),12,17,19,25(28)-pentaene-2,8,14,23-tetrone, SYNERCID COMPONENT DALFOPRISTIN, DB01764, DALFOPRISTIN COMPONENT OF SYNERCID, NCGC00508820-02, Q5210829, 2-diethylaminoethylsulfonyl-hydroxy-isopropyl-dimethyl-[?]tetrone, (3R,4R,5E,10E,12E,14S,26R,26aS)-26-{[2-(diethylamino)ethyl]sulfonyl}-14-hydroxy-4,12-dimethyl-3-(1-methylethyl)-8,9,14,15,24,25,26,26a-octahydro-1H,3H,22H-21,18-(azeno)pyrrolo[2,1-c][1,8,4,19]dioxadiazacyclotetracosine-1,7,16,22(4H,17H)-tetrone, (3R,4R,5E,10E,12E,14S,26R,26aS)-26-{[2-(diethylamino)ethyl]sulfonyl}-14-hydroxy-4,12-dimethyl-3-(propan-2-yl)-8,9,14,15,24,25,26,26a-octahydro-1H,3H,22H-21,18-(azeno)pyrrolo[2,1-c][1,8,4,19]dioxadiazacyclotetracosine-1,7,16,22(4H,17H)-tetrone C34H50N4O9S SUYRLXYYZQTJHF-VMBLUXKRSA-N (6R,7S,10R,11R,12E,17E,19E,21S)-6-[2-(diethylamino)ethylsulfonyl]-21-hydroxy-11,19-dimethyl-10-propan-2-yl-9,26-dioxa-3,15,28-triazatricyclo[23.2.1.03,7]octacosa-1(27),12,17,19,25(28)-pentaene-2,8,14,23-tetrone n.a. Antibiotics No No No No No No PMDBD2000696 Danthron Therapeutic Substance Withdrawn from market n.a. n.a. n.a. n.a. D0J0EL 2950 n.a. NPC103540 "danthron, 1,8-Dihydroxyanthraquinone, 117-10-2, Chrysazin, Dantron, Antrapurol, Dorbane, Istizin, Laxanthreen, Diaquone, Laxanorm, Altan, 1,8-Dihydroxyanthracene-9,10-dione, Laxipurin, Zwitsalax, Danivac, Dionone, Duolax, Laxipur, 9,10-Anthracenedione, 1,8-dihydroxy-, danthrone, Prugol, Roydan, 1,8-Dihydroxy-9,10-anthraquinone, 1,8-Dihydroxyanthrachinon, Usaf nd-59, Dioxyanthrachinonum, Chrysazine, Dantrone, Dorbanex, 1,8-Dihydroxyanthra-9,10-quinone, 1,8-Dihydroxy-9,10-anthracenedione, Criasazin, Dantrona, Dantronum, LTAN, Anthraquinone, 1,8-dihydroxy-, 1,8-Dihydroanthraquinone, 1,8-dihydroxy-anthraquinone, NSC 38626, Dantron [INN], NSC 646568, 1,8-dihydroxy-9,10-dihydroanthracene-9,10-dione, Pilules Vinchy N.F., NSC7210, MFCD00001211, NSC-38626, Z4XE6IBF3V, NSC-646568, CHEMBL53418, CHEBI:3682, DTXSID9020328, Pastomin, Bancon, Istan, component of Doxan, Neokutin S, component of Modane, Scatron D, Dantron (INN), component of Doxidan, NSC646568, component of Dorbantyl, NCGC00091367-01, NCGC00091367-05, 9, 1,8-dihydroxy-, Anthraquinone,8-dihydroxy-, Dantrone [INN-French], Dantronum [INN-Latin], Dantrona [INN-Spanish], DTXCID10328, 1,4,5,8-Tetroxyantraquinone, WLN: L C666 BV IVJ DQ NQ, 1,8-Dihydroxyanthrachinon [Czech], Danthron [USP], CAS-117-10-2, CCRIS 3529, EINECS 204-173-5, UNII-Z4XE6IBF3V, Istizine, Laxapur, AI3-38117, HSDB 7764, 3nsq, Danthron, BAN, Dantron, INN, Dorbanex (Salt/Mix), Dorbantyl (Salt/Mix), Spectrum_001750, dihyanthraquin_P41_LT, DANTHRON [HSDB], DANTRON [IARC], DANTHRON [MI], DANTHRON [VANDF], DANTRON [MART.], Spectrum2_000603, Spectrum3_000650, Spectrum4_001682, Spectrum5_000324, dihyanthraquin_P21/n_LT, DANTRON [WHO-DD], NCIMech_000114, 1,8-Dihydroxyanthracene-9,10-dione (Danthron), dihyanthraquin_P41212_RT, SCHEMBL83688, BSPBio_002259, KBioGR_001944, KBioSS_002230, SPECTRUM211468, MLS000069608, Pilules Vinchy N.F. (TN), DivK1c_000284, SPBio_000506, MEGxp0_001693, ACon1_000135, BDBM11316, HMS500O06, KBio1_000284, KBio2_002230, KBio2_004798, KBio2_007366, KBio3_001479, 1,8-Dihydroxyanthraquinone ,(S), NINDS_000284, 1,8-Dihydroxyanthraquinone, 96%, HMS2091A09, HMS3715F08, Pharmakon1600-00211468, 8,9-dihydroxy-1,10-anthraquinone, BCP31079, HY-B0923, NSC-7210, NSC38626, Tox21_111122, Tox21_200986, CCG-35470, NSC755828, s4561, AKOS001583216, Tox21_111122_1, 1,8-Dihydroxyanthra-9,10-quinone #, AM10629, CS-4392, DB04816, HS-1003, NSC-755828, IDI1_000284, NCGC00091367-02, NCGC00091367-03, NCGC00091367-04, NCGC00091367-06, NCGC00091367-07, NCGC00258539-01, 1,8-bis(oxidanyl)anthracene-9,10-dione, NCI60_041443, SMR000059018, SY011288, DITHRANOL IMPURITY B [EP IMPURITY], SBI-0051330.P003, 1,8-Dihydroxy-9,10-anthracenedione, 9CI, D0563, EU-0099935, NS00015698, D07107, F17670, AB00051961_09, Danthron (1,8-Dihydroxyanthracene-9,10-dione), EN300-1693514, A803710, SR-01000721864, Q5221244, SR-01000721864-2, W-108572, BRD-K10065684-001-02-5, BRD-K10065684-001-03-3, BRD-K10065684-001-06-6, 1,8-Dihydroxyanthraquinone, Vetec(TM) reagent grade, 96%, Dantron; Chrysazin;1,8-Dihydroxyanthraquinone;1,4,5,8-tetroxyantraquinone, CHZ, InChI=1/C14H8O4/c15-9-5-1-3-7-11(9)14(18)12-8(13(7)17)4-2-6-10(12)16/h1-6,15-16" C14H8O4 QBPFLULOKWLNNW-UHFFFAOYSA-N 1,8-dihydroxyanthracene-9,10-dione n.a. n.a. No No No No No No PMDBD2000697 Daptomycin Therapeutic Substance n.a. 103060-53-3 DB00080 PA164768820 D01080 n.a. 21585658 10200644 n.a. DAPTOMYCIN, Cidecin, 103060-53-3, Daptomycinum, Daptomicina, Daptomycine, Cubicin, Deptomycin, Dapcin, LY-146032, Daptomycin for injection, UNII-NWQ5N31VKK, Cubicin Rf, NWQ5N31VKK, Daptomycinum [Latin], DAPZURA RT, LY146032, DTXSID1041009, Daptomycine [French], Daptomycinum (Latin), Daptomicina [Spanish], LY 146032, LY-164032, DAPTOMYCIN (MART.), DAPTOMYCIN [MART.], N-Decanoyl-L-tryptophyl-L-asparaginyl-L-aspartyl-L-threonylglycyl-L-ornithyl-L-aspartyl-D-alanyl-L-aspartylglycyl-D-seryl-threo-3-methyl-L-glutamyl-3-anthraniloyl-L-alanine epsilon1-lactone, N-DECANOYL-L-TRYPTOPHYL-L-ASPARAGINYL-L-ASPARTYL-L-THREONYLGLYCYL-L-ORNITHYL-L-ASPARTYL-D-ALANYL-L-ASPARTYLGLYCYL-D-SERYL-THREO-3-METHYL-L-GLUTAMYL-3-ANTHRANILOYL-L-ALANINE E1-LACTONE, Daptomycin [USAN:INN:BAN], (2R)-daptomycin, Cubicin (TN), DAPTOMYCIN [MI], DAPTOMYCIN [INN], DAPTOMYCIN [JAN], DAPTOMYCIN [USAN], DAPTOMYCIN [VANDF], DAPTOMYCIN [WHO-DD], Daptomycin in Sodium Chloride, Daptomycin (JAN/USAN/INN), DAPTOMYCIN [EMA EPAR], CHEMBL4744444, DAPTOMYCIN [ORANGE BOOK], DTXCID9021009, SCHEMBL13491700, J01XX09, EX-A1967, HY-B0108, N-decanoyl-L-tryptophyl-L-asparaginyl-L-aspartyl-L-threonylglycyl-L-ornithyl-L-aspartyl-D-alanyl-L-aspartylglycyl-D-seryl-threo-3-methyl-L-glutamyl-3-anthraniloyl-L-alanine 1.13-3.4-lactone, N-decanoyl-L-tryptophyl-L-asparaginyl-L-aspartyl-L-threonylglycyl-L-ornithyl-L-aspartyl-D-alanyl-L-aspartylglycyl-D-seryl-threo-3-methyl-L-glutamyl-3-anthraniloyl-L-alanine epsilon(1)-lactone, CS-1857, DB00080, MK-3009, N-decanoyl-L-tryptophyl-L-asparaginyl-L-aspartyl-L-threonylglycyl-L-ornithyl-L-aspartyl-D-alanyl-L-aspartylglycyl-D-seryl-threo-3-methyl-L-glutamyl-3-anthraniloyl-L-alanine-epsilon1-lactone, DAPTOMYCIN IN 0.9% SODIUM CHLORIDE, D4229, D01080, Q418747, N-(Decanoyl)-L-tryptophyl-D-asparaginyl-L-aspartyl-L-threonylglycyl-L-ornithyl-L-aspartyl-D-alanyl-L-aspartylglycyl-D-seryl-(3R)-3-methyl-L-glutamyl-3-(2-aminobenzoyl)-L-alanine 1.13->3.4-lactone C72H101N17O26 DOAKLVKFURWEDJ-QCMAZARJSA-N (3S)-3-[[(2R)-4-amino-2-[[(2S)-2-(decanoylamino)-3-(1H-indol-3-yl)propanoyl]amino]-4-oxobutanoyl]amino]-4-[[(3S,6S,9R,15S,18R,21S,24S,30S,31R)-3-[2-(2-aminophenyl)-2-oxoethyl]-24-(3-aminopropyl)-15,21-bis(carboxymethyl)-6-[(2R)-1-carboxypropan-2-yl]-9-(hydroxymethyl)-18,31-dimethyl-2,5,8,11,14,17,20,23,26,29-decaoxo-1-oxa-4,7,10,13,16,19,22,25,28-nonazacyclohentriacont-30-yl]amino]-4-oxobutanoic acid n.a. n.a. No No No No No No PMDBD2000698 DASamP1 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000699 D-Asparagine Therapeutic Substance n.a. 2058-58-4 DB03943 n.a. n.a. n.a. 439600 388679 n.a. D-Asparagine, 2058-58-4, H-D-Asn-OH, Asparagine D-form, (R)-2,4-Diamino-4-oxobutanoic acid, (2R)-2,4-diamino-4-oxobutanoic acid, (2R)-2-amino-3-carbamoylpropanoic acid, D(-)-Asparagine monohydrate, H-D-Asn-OH.H2O, (R)-2-Aminosuccinic acid 4-amide, D-2-aminosuccinamic acid, D-aspartic acid beta-amide, (2R)-4-amino-2-ammonio-4-oxobutanoate, CHEBI:28159, T6QV1010K6, (R)-2-amino-3-carbamoylpropanoic acid, Asparagine #, Asparagine, D-, (R)-(-)-2-Aminosuccinamic acid, NCGC00163330-01, UNII-T6QV1010K6, D-Asparagin, MFCD00008036, D-Asn, EINECS 218-163-3, d-asn11, D-Asparagine anhydrous, D-Asparagine, 99%, starbld0005099, D-Asparagine, anhydrous, D-Aspartic acid 4-amide, (R)-2-Aminosuccinamic acid, SCHEMBL92738, ASPARAGINE D-FORM [MI], CHEMBL1232369, DTXSID30872479, AKOS022186061, AM81553, CS-W011094, DB03943, HY-W010378, AS-12167, A0543, NS00068513, EN300-72273, C01905, D-Asparagine, puriss., anhydrous, >=99.0% (NT), J-013442, 5794-24-1 (. H2O), Q27094804, Z1147451758, (R)-2-Aminosuccinamic acid (R)-2-Aminosuccinic acid 4-amide D-Aspartic acid 4-amide C4H8N2O3 DCXYFEDJOCDNAF-UWTATZPHSA-N (2R)-2,4-diamino-4-oxobutanoic acid n.a. n.a. No No No No No No PMDBD2000700 D-Aspartate Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D08CAB 83887 n.a. NPC285322 D-Aspartic acid, 1783-96-6, (R)-2-aminosuccinic acid, D-Aspartate, (-)-Aspartic acid, H-D-Asp-OH, (2R)-2-aminobutanedioic acid, (R)-Aspartic acid, D-(-)-Aspartic acid, Aspartic acid D-form, Aspartic acid, D-, NSC 97922, (R)-(-)-Aminosuccinic acid, D-Asparaginsaeure, D-Aminosuccinic acid, BRN 1723529, Tocris-0213, MFCD00063081, C4H7NO4, 4SR0Q8YD1X, (R)-2-aminobutanedioic acid, CHEMBL29757, DTXSID2045650, CHEBI:17364, NCGC00024498-02, Aminosuccinic acid, (2R)-2-aminobutanedioate, [3H]-D-aspartate, [3H]D-aspartic acid, 1-Amino-1,2-carboxyethane, [3H]-D-aspartic acid, 4-04-00-02998 (Beilstein Handbook Reference), EINECS 217-234-6, UNII-4SR0Q8YD1X, delta-aspartate, NSC-97922, D-Asparaginic Acid, delta-aspartic acid, D-Asp, delta-asparaginsaeure, Lopac-alpha-9256, [3h]-d-asp, (R)-Aminosuccinic Acid, (R)-2-aminosuccinicacid, (R)-2-Aminobutanedioate, Guanosine-5-Monophosphate, Lopac-A-9256, delta-(-)-Aspartic acid, Biomol-NT_000167, bmse000273, D-ASPARTIC ACID [MI], SCHEMBL145539, BPBio1_001126, GTPL4698, GTPL6511, DTXCID0025650, BDBM31174, D-ASPARTIC ACID [WHO-DD], Tox21_110904, HB0230, PDSP1_001545, PDSP2_001529, s5129, AKOS015854091, DB02655, D-Aspartic acid, ReagentPlus(R), 99%, NCGC00015104-01, NCGC00024498-01, NCGC00024498-03, NCGC00024498-04, AC-22382, AS-12792, BP-12717, HY-42068, SY009812, CAS-1783-96-6, A0545, AM20090057, CS-0020434, NS00074115, EN300-67412, A-9180, C00402, D-Aspartic acid, Vetec(TM) reagent grade, 99%, A812365, SR-01000597731, SR-01000597731-1, Q27076990, 0BBACB33-ED80-42B3-9F05-75E0E3E41D6D, F1905-7153, Z1079451886, 27881-01-2 C4H7NO4 CKLJMWTZIZZHCS-UWTATZPHSA-N (2R)-2-aminobutanedioic acid n.a. n.a. No No No No No No PMDBD2000701 D-Aspartic acid Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D08CAB 83887 n.a. NPC285322 D-Aspartic acid, 1783-96-6, (R)-2-aminosuccinic acid, D-Aspartate, (-)-Aspartic acid, H-D-Asp-OH, (2R)-2-aminobutanedioic acid, (R)-Aspartic acid, D-(-)-Aspartic acid, Aspartic acid D-form, Aspartic acid, D-, NSC 97922, (R)-(-)-Aminosuccinic acid, D-Asparaginsaeure, D-Aminosuccinic acid, BRN 1723529, Tocris-0213, MFCD00063081, C4H7NO4, 4SR0Q8YD1X, (R)-2-aminobutanedioic acid, CHEMBL29757, DTXSID2045650, CHEBI:17364, NCGC00024498-02, Aminosuccinic acid, (2R)-2-aminobutanedioate, [3H]-D-aspartate, [3H]D-aspartic acid, 1-Amino-1,2-carboxyethane, [3H]-D-aspartic acid, 4-04-00-02998 (Beilstein Handbook Reference), EINECS 217-234-6, UNII-4SR0Q8YD1X, delta-aspartate, NSC-97922, D-Asparaginic Acid, delta-aspartic acid, D-Asp, delta-asparaginsaeure, Lopac-alpha-9256, [3h]-d-asp, (R)-Aminosuccinic Acid, (R)-2-aminosuccinicacid, (R)-2-Aminobutanedioate, Guanosine-5-Monophosphate, Lopac-A-9256, delta-(-)-Aspartic acid, Biomol-NT_000167, bmse000273, D-ASPARTIC ACID [MI], SCHEMBL145539, BPBio1_001126, GTPL4698, GTPL6511, DTXCID0025650, BDBM31174, D-ASPARTIC ACID [WHO-DD], Tox21_110904, HB0230, PDSP1_001545, PDSP2_001529, s5129, AKOS015854091, DB02655, D-Aspartic acid, ReagentPlus(R), 99%, NCGC00015104-01, NCGC00024498-01, NCGC00024498-03, NCGC00024498-04, AC-22382, AS-12792, BP-12717, HY-42068, SY009812, CAS-1783-96-6, A0545, AM20090057, CS-0020434, NS00074115, EN300-67412, A-9180, C00402, D-Aspartic acid, Vetec(TM) reagent grade, 99%, A812365, SR-01000597731, SR-01000597731-1, Q27076990, 0BBACB33-ED80-42B3-9F05-75E0E3E41D6D, F1905-7153, Z1079451886, 27881-01-2 C4H7NO4 CKLJMWTZIZZHCS-UWTATZPHSA-N (2R)-2-aminobutanedioic acid n.a. n.a. No No No No No No PMDBD2000702 D-Citrulline Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D0V2DT 637599 n.a. n.a. D-Citrulline, 13594-51-9, H-D-Cit-OH, (R)-2-Amino-5-ureidopentanoic acid, (2R)-2-amino-5-(carbamoylamino)pentanoic acid, Citrulline, D-, KNS2VUH6P2, N(5)-carbamoyl-D-ornithine, N5-(Aminocarbonyl)-D-ornithine, (2R)-2-ammonio-5-(carbamoylamino)pentanoate, D-Ornithine, N5-(aminocarbonyl)-, NSC-206276, D-Citruline, H-D-Orn(carbamoyl)-OH, MFCD00216469, Z,D-CITRULLINE, UNII-KNS2VUH6P2, D-Citrulline, >=99.0%, SCHEMBL437142, GTPL4683, CHEBI:49007, DTXSID90348463, (R)-2-Amino-5-ureido-pentanoic acid, AKOS016843011, AM82460, CS-W017449, (2R)-2-amino-5-ureido-pentanoic acid, AS-12983, EN300-7358469, A807006, J-300336, W-204205, Q27077003, Z1255438848 C6H13N3O3 RHGKLRLOHDJJDR-SCSAIBSYSA-N (2R)-2-amino-5-(carbamoylamino)pentanoic acid n.a. n.a. No No No No No No PMDBD2000703 D-Cystine n.a. n.a. n.a. n.a. n.a. n.a. n.a. 6857538 n.a. n.a. D-Cystine, 349-46-2, Cystine D-form, (S)-Cystine, Cystine, D-, Cystine, DL-, MFCD00002610, KX1RHN0Y0B, cystine, (2S,2''S)-3,3''-disulfanediylbis(2-aminopropanoic acid), 06681CV9GH, C6H12N2O4S2, (2S)-2-amino-3-[[(2S)-2-amino-2-carboxyethyl]disulfanyl]propanoic acid, (2S,2''S)-3,3''-dithiobis(2-aminopropanoic acid), (2S)-2-ammonio-3-[[(2S)-2-ammonio-2-carboxylatoethyl]disulfanyl]propanoate, Cystine, d, UNII-KX1RHN0Y0B, (2S)-2-amino-3-{[(2S)-2-amino-2-carboxyethyl]disulfanyl}propanoic acid, Cystine DL-form, NSC-203781, EINECS 206-486-2, D-Cystine, free base, D-Cystine, 98%, D-CYSTINE [MI], CYSTINE DL-FORM [MI], UNII-06681CV9GH, beta,beta''-Dithioalanine, dl-, CCRIS 8599, SCHEMBL5018669, CHEBI:35494, DTXSID301031752, EINECS 213-094-5, FD3019, AKOS024257100, CS-W001941, HY-W001941, NSC 203781, NCGC00166007-01, AS-13542, BP-13238, NS00079379, 3,3''-Dithiobis(2-aminopropanoic acid), dl-, C-9760, EN300-254099, Q27116494, Z1269180278 C6H12N2O4S2 LEVWYRKDKASIDU-QWWZWVQMSA-N (2S)-2-amino-3-[[(2S)-2-amino-2-carboxyethyl]disulfanyl]propanoic acid n.a. n.a. No No No No No No PMDBD2000704 DD13 n.a. n.a. n.a. n.a. n.a. n.a. n.a. 134102 n.a. n.a. Mopyridone, 82822-14-8, DD-13, C9893ZRM3K, 1-Morpholinomethyl-tetrahydro-1(1H)-pyrimidinone, 1-Morpholinomethyl-tetrahydro-2(1H)-pyrimidinone, Dd 13, BRN 6058057, Dd13, 1-(morpholin-4-ylmethyl)-1,3-diazinan-2-one, UNII-C9893ZRM3K, 1-(4-Morpholinomethyl)-tetrahydro-2(1H)-pyrimidinone, SCHEMBL5608494, NIOSH/UW7586000, Tetrahydro-1-(4-morpholinylmethyl)-2(1H)-pyrimidinone, 2(1H)-Pyrimidinone, tetrahydro-1-(4-morpholinylmethyl)-, ZSWVOFMSMUXCLY-UHFFFAOYSA-N, DTXSID201002930, UW75860000, 1-Morpholinomethyltetrahydro-2(1H)-pyrimidinone, 2(1H)-Pyrimidinone, tetrahydro-1-morpholinomethyl-, Q27275348, 1-(4-Morpholinylmethyl)tetrahydro-2(1H)-pyrimidinone #, 1-[(Morpholin-4-yl)methyl]-1,4,5,6-tetrahydropyrimidin-2-ol C9H17N3O2 ZSWVOFMSMUXCLY-UHFFFAOYSA-N 1-(morpholin-4-ylmethyl)-1,3-diazinan-2-one n.a. n.a. No No No No No No PMDBD2000705 Decanediol n.a. n.a. n.a. n.a. n.a. n.a. n.a. 18934410 n.a. n.a. Decanediol, Decane-1,1-diol, 27030-32-6, SCHEMBL164448, DTXSID80596633, INSRQEMEVAMETL-UHFFFAOYSA-N C10H22O2 INSRQEMEVAMETL-UHFFFAOYSA-N decane-1,1-diol n.a. n.a. No No No No No No PMDBD2000706 Decyl beta-maltoside n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000707 Delavirdine Therapeutic Substance Approved Drug 136817-59-9 DB00705 PA449223 n.a. D0G6SD 5625 5423 n.a. "Delavirdine, 136817-59-9, Rescriptor, Delavirdine [INN], u-90152, N-(2-(4-(3-(Isopropylamino)pyridin-2-yl)piperazine-1-carbonyl)-1H-indol-5-yl)methanesulfonamide, U 90152, Delavirdine (INN), 2-(4-(5-Methanesulfonamido-1H-indol-2-ylcarbonyl)-1-piperazinyl)-N-(1-methylethyl)-3-pyridinamine, DLV, N-[2-[4-[3-(propan-2-ylamino)pyridin-2-yl]piperazine-1-carbonyl]-1H-indol-5-yl]methanesulfonamide, DOL5F9JD3E, 1-(3-((1-Methylethyl)amino)-2-pyridinyl)-4-((5-((methylsulfonyl)amino)-1H-indol-2-yl)carbonyl)piperazine, CHEMBL593, N-[2-({4-[3-(propan-2-ylamino)pyridin-2-yl]piperazin-1-yl}carbonyl)-1H-indol-5-yl]methanesulfonamide, DTXSID6022892, CHEBI:119573, (1-(5-METHANSULPHONAMIDO-1H-INDOL-2-YL-CARBONYL)4-[METHYLAMINO)PYRIDINYL]PIPERAZINE, NCGC00168776-01, BHAP-U 90152, U 90152;BHAP-U 90152, (N-[2-[4-[3-(1-methylethylamino)pyridin-2-yl]piperazin-1-yl]carbonyl-1H-indol-5-yl] methanesulfonamide), N-(2-(1-(3-(isopropylamino)pyridin-2-yl)piperazine-4-carbonyl)-1H-indol-5-yl)methanesulfonamide, N-[2-(4-{3-[(propan-2-yl)amino]pyridin-2-yl}piperazine-1-carbonyl)-1H-indol-5-yl]methanesulfonamide, N-{2-[4-(3-Isopropylamino-pyridin-2-yl)-piperazine-1-carbonyl]-1H-indol-5-yl}-methanesulfonamide, DTXCID302892, UNII-DOL5F9JD3E, Rescriptor (TM), N-[2-[4-[3-(isopropylamino)-2-pyridyl]piperazine-1-carbonyl]-1H-indol-5-yl]methanesulfonamide, CAS-136817-59-9, C22H28N6O3S, Delavirdine (*Mesylate salt*), SR-05000001471, U90152S (*Mesylate salt*), PNU-90152-T, Delavirdine(U-90152) & .a.IFN, DELAVIRDINE [MI], DELAVIRDINE [VANDF], U90152, SCHEMBL34420, DELAVIRDINE [WHO-DD], BDBM1944, GTPL12674, HMS2089F20, HMS3713A14, BCP08068, Tox21_112637, AKOS015965076, Tox21_112637_1, CS-1660, DB00705, DT-0031, NCGC00168776-02, NCGC00168776-03, NCGC00168776-10, HY-10571, N-{2-[(4-{3-[(1-methylethyl)amino]pyridin-2-yl}piperazin-1-yl)carbonyl]-1H-indol-5-yl}methanesulfonamide, NS00071587, C06941, D07782, AB01275468-01, EN300-7442125, Q370244, J-006916, SR-05000001471-1, N-{2-[(4-{3-[(propan-2-yl)amino]pyridin-2-yl}piperazin-1-yl)carbonyl]-1H-indol-5-yl}methanesulfonamide, Piperazine, 1-[3-[(1-methylethyl)amino]-2-pyridinyl]-4-[[5-[(methylsulfonyl)amino]-1H-indol-2-yl]carbonyl]- & alpha-Interferon" C22H28N6O3S WHBIGIKBNXZKFE-UHFFFAOYSA-N N-[2-[4-[3-(propan-2-ylamino)pyridin-2-yl]piperazine-1-carbonyl]-1H-indol-5-yl]methanesulfonamide Pfizer Pharmaceuticals Anti-HIV Agents No No No No No No PMDBD2000708 Delphinidin Therapeutic Substance Phase 2 n.a. n.a. n.a. n.a. D0ZN1R 68245 n.a. NPC250432 "Delphinidin chloride, Delphinidin, 528-53-0, Delphinidine, Delphinidol, Ephdine, 8012-95-1, PARAFFIN, Delfinidol chloride, 3,3'',4'',5,5'',7-Hexahydroxyflavylium chloride, Delphinidin (chloride), 1-Benzopyrylium, 3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)-, chloride, EM6MD4AEHE, 2-(3,4,5-trihydroxyphenyl)chromenylium-3,5,7-triol chloride, 3,5,7-Trihydroxy-2-(3,4,5-trihydroxyphenyl)-1-benzopyrylium chloride, IdB 1056, 2-(3,4,5-trihydroxyphenyl)chromenylium-3,5,7-triol;chloride, CHEBI:38701, 3,5,7-Trihydroxy-2-(3,4,5-trihydroxyphenyl)benzopyrylium chloride, MFCD00016663, 3,3'',4'',5,5'',7-Hexahydroxy-2-phenylbenzopyrylium chloride, 3,5,7-Trihydroxy-2-(3,4,5-trihydroxyphenyl)chromenylium chloride, Delphinidine; Delphinidol; Ephdine; IdB 1056;Delfinidol chloride; Delphinidin, CHEMBL590878, Delphinidin chloride, analytical standard, CCRIS 2518, UNII-EM6MD4AEHE, EINECS 208-437-0, Delphinidinchloride, 2-(3,4,5-trihydroxyphenyl)-1-benzopyrylium-3,5,7-triol, DELPHINIDIN [MI], suitable for IR spectroscopy, SCHEMBL22369, Flavylium 3,3'',4'',5,5'',7-hexahydroxy-, chloride, IdB-1056, DTXSID701019982, 3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)chromenium chloride, BCP15819, HY-N2409, Delphinidin Chloride (~80% purity), 3,5,7-Trihydroxy-2-(3,4,5-trihydroxyphenyl)-1-benzopyrylium chloride (1:1), AKOS027326494, 1ST40109, AC-35150, AS-78369, CS-0022610, E88811, Q367258, 3,5,7-Trihydroxy-2-(3,4,5-trihydroxyphenyl)chromenyliumchloride" C15H11ClO7 FFNDMZIBVDSQFI-UHFFFAOYSA-N "2-(3,4,5-trihydroxyphenyl)chromenylium-3,5,7-triol;chloride" n.a. n.a. No No No No No No PMDBD2000709 den-SB056 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000710 den-SB056-1 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000711 Dephnetin n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000712 Dezocine Therapeutic Substance Approved Drug 53648-55-8 DB01209 PA164746059 D00838 D0P6VV 3033053 2297867 n.a. DEZOCINE, Dalgan, 53648-55-8, Dezocina, Dezocinum, Docozine, Dozocine, Wy-16225, Dezocinum [INN-Latin], Dezocina [INN-Spanish], UNII-VHX8K5SV4X, VHX8K5SV4X, CHEBI:4474, Wy-16,225, CHEMBL1685, WY 16225, (-)-13beta-Amino-5,6,7,8,9,10,11alpha,12-octahydro-5alpha-methyl-5,11-methanobenzocyclodecen-3-ol, DTXSID2022911, Dezocine (USAN), (1R,9S,15S)-15-amino-1-methyltricyclo[7.5.1.02,7]pentadeca-2(7),3,5-trien-4-ol, DEZOCINE [USAN], Dezocinum (INN-Latin), Dezocina (INN-Spanish), DEZOCINE (MART.), DEZOCINE [MART.], 13-Amino-5,6,7,8,9,10,11,12-octahydro-5-methyl-5,11-methanobenzocyclodecenol, (5R,11S,13S)-13-amino-5-methyl-5,6,7,8,9,10,11,12-octahydro-5,11-methanobenzocyclodecen-3-ol, Dezocine [USAN:INN], Dalgan (TN), DEZOCINE [INN], DEZOCINE [MI], WY 16,225, DEZOCINE [VANDF], DEZOCINE [WHO-DD], SCHEMBL3072, DEZOCINE [ORANGE BOOK], DTXCID702911, N02AX03, (5R,11S,13S)-13-amino-5-methyl-5,6,7,8,9,10,11,12-octahydro-5,11-methanobenzo[10]annulen-3-ol, BDBM50276568, AKOS016014025, DB01209, NS00069349, C08010, D00838, EN300-27032797, Q1109018, (1R,9S,15S)-15-amino-1-methyltricyclo[7.5.1.0,2,7]pentadeca-2,4,6-trien-4-ol, (1R,9S,15S)-15-amino-1-methyltricyclo[7.5.1.0^{2,7}]pentadeca-2,4,6-trien-4-ol, 5,11-Methanobenzocyclodecen-3-ol, 5,6,7,8,9,10,11,12-octahydro-13-amino-5-methyl-, (-)-13.BETA.-AMINO-5,6,7,8,9,10,11.ALPHA.,12-OCTAHYDRO-5.ALPHA.-METHYL-5,11-METHANOBENZOCYCLODECEN-3-OL, (-5alpha, 11alpha,13s)-13-amino-5,6,7,8,9,10,11,12-octahydro-5-methyl-5,11-methanobenzocyclodecen-3-ol, 5,11-METHANOBENZOCYCLODECEN-3-OL, 13-AMINO-5,6,7,8,9,10,11,12-OCTAHYDRO-5-METHYL-, (5.ALPHA.,11.ALPHA.,13S*), 5,11-METHANOBENZOCYCLODECEN-3-OL, 13-AMINO-5,6,7,8,9,10,11,12-OCTAHYDRO-5-METHYL-, (5alpha,11alpha,13S*), 5,11-Methanobenzocyclodecen-3-ol, 13-amino-5,6,7,8,9,10,11,12-octahydro-5-methyl-, (5alpha,11alpha,13S*)-, (-)- C16H23NO VTMVHDZWSFQSQP-VBNZEHGJSA-N (1R,9S,15S)-15-amino-1-methyltricyclo[7.5.1.02,7]pentadeca-2(7),3,5-trien-4-ol n.a. Analgesics No No No No No No PMDBD2000713 dF17-6K n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000714 dF21-10K n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000715 D-galactose cluster n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000716 D-glutamine n.a. n.a. n.a. n.a. n.a. n.a. n.a. 145815 n.a. n.a. D-glutamine, 5959-95-5, H-D-Gln-OH, (R)-2,5-diamino-5-oxopentanoic acid, D-2-Aminoglutaramic acid, (2R)-2-amino-4-carbamoylbutanoic acid, Glutamine, D-, (2R)-2,5-diamino-5-oxopentanoic acid, D-Gln, D-Glutamic acid 5-amide, MFCD00065607, (r)-2-amino-4-carbamoyl-butyric acid, 63HB36CA2Y, DTXSID6046345, CHEBI:17061, NCGC00163333-01, DGN, DTXCID4026345, (R)-glutamine, d-(+)-glutamine, CAS-5959-95-5, GLUTAMINE (D), UNII-63HB36CA2Y, D-Glutamin, D-2-Aminoglutaramate, D-Glutaminsaeure-5-amid, Lopac-G-3126, SCHEMBL60360, US9138393, D-Glutamine, US9144538, D-Glutamine, CHEMBL1232207, 1b74, D-Glutamine, >=98% (TLC), BDBM181129, Tox21_112047, s1893, AKOS006240044, AKOS015854104, Tox21_112047_1, AM81758, CCG-266177, CS-6029, DB02174, NCGC00015472-01, NCGC00093936-08, NCGC00163333-02, AC-11673, AC-24107, AS-13541, HY-100587, A8372, G0278, C00819, EN300-136492, G-3892, M02933, Q27102193, Z1203578189, 7A3C313F-6D25-48E7-A302-221F8AE9DFF1 C5H10N2O3 ZDXPYRJPNDTMRX-GSVOUGTGSA-N (2R)-2,5-diamino-5-oxopentanoic acid n.a. n.a. No No No No No No PMDBD2000717 D-Histidine Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D0PG8L 71083 n.a. n.a. "D-Histidine, 351-50-8, H-D-His-OH, (R)-2-Amino-3-(1H-imidazol-4-yl)propanoic acid, D-His, D-Histamine, D-Histidin, (2R)-2-amino-3-(1H-imidazol-5-yl)propanoic acid, (2R)-2-amino-3-(1H-imidazol-4-yl)propanoic acid, CHEBI:27947, (R)-2-Amino-3-(4-imidazolyl)propionic acid, 4JE5HRM5CH, MFCD00065963, (R)-alpha-Amino-1H-imidazole-4-propionic acid, (2R)-2-ammonio-3-(1H-imidazol-4-yl)propanoate, D-Histidine hydrochloride, D-Histidine; D-His-OH, copper-histidine, (r)-histidine, EINECS 206-513-8, 2ez7, HISTIDINE, D-, UNII-4JE5HRM5CH, D-alpha-Amino-beta-(4-imidazolyl)propionic acid, SCHEMBL59365, D-Histidine (H-D-His-OH), CHEMBL104875, GTPL4679, NIOSH/MS3116000, DTXSID70889344, Histidine, monohydrochloride, D-, D-Histidine, >=98% (TLC), 7006-35-1, BDBM50463187, FD3017, AKOS005716904, AKOS015854102, AKOS032949750, AC-8655, AM81800, CS-W013288, HY-W012572, NCGC00142611-01, NCGC00142611-02, AS-13490, D-Histidine, puriss., >=99.0% (T), D-a-Amino-ss-(4-imidazolyl)propionic acid, D-Histidine, Vetec(TM) reagent grade, 98%, H0998, MS31160000, EN300-67346, C06419, M02972, 3-(1H-Imidazole-4-yl)-2-aminopropanoic acid;, A822610, A836759, (2R)-2-amino-3-(3H-imidazol-4-yl)propanoic acid, (2R)-2-azanyl-3-(1H-imidazol-5-yl)propanoic acid, Q-101530, Q27077043, Z1079168982, E13FF66C-6B46-4431-AE14-82A8D0C9DD56" C6H9N3O2 HNDVDQJCIGZPNO-RXMQYKEDSA-N (2R)-2-amino-3-(1H-imidazol-5-yl)propanoic acid n.a. n.a. No No No No No No PMDBD2000718 Dibenzyl disulphide n.a. n.a. n.a. n.a. n.a. n.a. n.a. 9012 n.a. NPC36440 Dibenzyl disulfide, 150-60-7, Benzyl disulfide, Disulfide, bis(phenylmethyl), 1,2-dibenzyldisulfane, Dibenzyl disulphide, Benzyl bisulfide, Dibenzyldisulfid, Di(phenylmethyl)disulfide, (benzyldisulfanyl)methylbenzene, DISULFIDE, DIBENZYL, Bis(phenylmethyl) disulfide, 1,4-Diphenyl-2,3-dithiabutane, Di(phenylmethyl) disulfide, Benzyldisulfide, alpha-(Benzyldithio)toluene, 1,4-Diphenyl-2,3-dithiobutane, [(Benzyldisulfanyl)methyl]benzene, Diphenylmethyl disulfide, FEMA No. 3617, NSC 6841, .alpha.-(Benzyldithio)toluene, NSC 677465, BDS, 4,4''-Biphenyldiglyoxal disodium bisulfite, 1,1''-[dithiobis(methylene)]dibenzene, NSC-677465, ghl.PD_Mitscher_leg0.312, CHEBI:72752, NSC-6841, NSC677465, BG7680605N, Dibenzyldisulfide, Dibenzyldisulfid [Czech], CCRIS 6924, EINECS 205-764-0, 1,1''-(disulfanediyldimethanediyl)dibenzene, benzyl disulphide, dibenzyldisulphide, UNII-BG7680605N, dibenzyl-disulfide, 1,3-dithiabutane, Benzyl disulfide, 8CI, Benzyl disulfide (8CI), Dibenzyl disulfide, 98%, WLN: R1SS1R, DAILUBE S 700, Benzyl disulfide, 98%, FG, benzyldisulfanyl-methyl-benzene, SCHEMBL160895, CHEMBL121047, BENZYL DISULFIDE [FHFI], DIBENZYL DISULFIDE [MI], DTXSID6059738, FEMA 3617, NSC6841, BENZYL DISULFIDE [USP-RS], Bis(phenylmethyl) disulfide, 9CI, [(Benzyldisulfanyl)methyl]benzene #, MFCD00004783, AKOS005177808, CS-W010232, Dibenzyl disulfide, analytical standard, HY-W009516, B0417, NS00020151, EN300-16500, D77707, A809057, Dibenzyl disulfide 2 microg/mL in Transformer Oil, Dibenzyl disulfide 10 microg/mL in Transformer Oil, J-008720, Q27140119, Z55949860, Benzyl disulfide, United States Pharmacopeia (USP) Reference Standard, InChI=1/C14H14S2/c1-3-7-13(8-4-1)11-15-16-12-14-9-5-2-6-10-14/h1-10H,11-12H C14H14S2 GVPWHKZIJBODOX-UHFFFAOYSA-N (benzyldisulfanyl)methylbenzene n.a. n.a. No No No No No No PMDBD2000719 Dibenzyl sulphide n.a. n.a. n.a. n.a. n.a. n.a. n.a. 10867 n.a. NPC5324 Dibenzyl sulfide, BENZYL SULFIDE, 538-74-9, Dibenzyl sulphide, dibenzylsulfane, benzylsulfanylmethylbenzene, Benzyl thioether, Benzyl monosulfide, Dibenzyl monosulfide, Dibenzyl thioether, dibenzylsulfide, 1,3-Diphenyl-2-thiapropane, Benzene, 1,1''-[thiobis(methylene)]bis-, benzyl sulphide, 1,1''-(Thiobis(methylene))bisbenzene, NSC 212544, Benzene, 1,1''-(thiobis(methylene))bis-, [(Benzylsulfanyl)methyl]benzene, DTXSID6024599, 1,1''-[thiobis(methylene)]dibenzene, Sulfide, dibenzyl, NSC-212544, Q08048624M, Benzene,1''-[thiobis(methylene)]bis-, CCRIS 5969, HSDB 2794, EINECS 208-703-6, Dibenzylsulfid, AI3-00842, UNII-Q08048624M, Sulfide, dibenzyl-, MFCD00004784, SULFIDE,DIBENZYL, SCHEMBL206, ((Benzylthio)methyl)benzene, 4-AMINOBENZOICACIDHCL, BENZYL SULFIDE [MI], MLS002152894, (phenylmethylthio)methylbenzene, BENZYL SULFIDE [HSDB], DTXCID704599, CHEMBL1369381, SCHEMBL11075647, (C6H5CH2)2S, NSC6648, (phenylmethylsulfanyl)methylbenzene, HMS2270O24, NSC-6648, Tox21_200326, NSC212544, AKOS003626437, Dibenzyl sulfide, >=95.0% (HPLC), NCGC00091191-01, NCGC00091191-02, NCGC00257880-01, AC-16469, CAS-538-74-9, SMR000112558, B0440, NS00042676, D88649, A829811, Q10374760, InChI=1/C14H14S/c1-3-7-13(8-4-1)11-15-12-14-9-5-2-6-10-14/h1-10H,11-12H C14H14S LUFPJJNWMYZRQE-UHFFFAOYSA-N benzylsulfanylmethylbenzene n.a. n.a. No No No No No No PMDBD2000720 Dichloromethane n.a. n.a. n.a. n.a. n.a. n.a. n.a. 6344 n.a. NPC128350 "DICHLOROMETHANE, Methylene chloride, 75-09-2, Methylene dichloride, Methane, dichloro-, Methylene bichloride, Methane dichloride, Solaesthin, Solmethine, Narkotil, Freon 30, Aerothene MM, Metylenu chlorek, Chlorure de methylene, Dichlormethan, Metaclen, Soleana VDA, Khladon 30, CH2Cl2, F 30 (chlorocarbon), Methylenum chloratum, R30 (refrigerant), RCRA waste number U080, Caswell No. 568, dichloro-methane, NCI-C50102, R 30, HCC 30, Chloride, Methylene, Bichloride, Methylene, Dichloride, Methylene, HSDB 66, CCRIS 392, dichlormethane, Methoklone, Methylenchlorid, Salesthin, NSC 406122, UN 1593, dichloro methane, Chlorodorm D, F 30, EINECS 200-838-9, UNII-588X2YUY0A, EPA Pesticide Chemical Code 042004, BRN 1730800, 588X2YUY0A, DTXSID0020868, CHEBI:15767, AI3-01773, Methylene chloride [NF], NSC-406122, Dichloromethane, HPLC Grade, DTXCID40868, EC 200-838-9, 4-01-00-00035 (Beilstein Handbook Reference), MFCD00000881, NSC406122, Methylene chloride (NF), DICHLOROMETHANE (IARC), DICHLOROMETHANE [IARC], DICHLOROMETHANE (MART.), DICHLOROMETHANE [MART.], METHYLENE CHLORIDE (II), METHYLENE CHLORIDE [II], Metylenu chlorek [Polish], METHYLENE CHLORIDE (EP MONOGRAPH), METHYLENE CHLORIDE [EP MONOGRAPH], Methylene chloride; Dichloromethane; DCM, MFCD00000882, Chlorure de methylene [French], Dichloromethane (Methylene Chloride), UN1593, DICHLOROMETHANE, NF, RCRA waste no. U080, DICHLOROMETHANE, ACS, dichioromethane, dichlormetane, dichloromeihane, dichlorometan, dichlorometane, dichloromethan, dichoromethane, dicloromethane, methylenchoride, metylenchloride, Aerothene, Driverit, Nevolin, dichlor-methane, dichlorometliane, dichlorornethane, dicliloromethane, methylenchloride, methylenechlorid, methYIenechlorid, di-chloromethane, dichloromethane-, methlyenechloride, methylenechloride, methlene chloride, methyene chloride, methylen chloride, methylene chlorie, methylene cloride, metylene chloride, Methylene choride, mehtylene chloride, methlyene chloride, methylene,chloride, methylene-chloride, dichloro -methane, dichloro- methane, methylenedichloride, Distillex DS3, Dichloromethane, ACS reagent, >=99.5%, contains 40-150 ppm amylene as stabilizer, M-clean D, methyl ene chloride, MeCl2, DCM,SP Grade, methylene di chloride, N,N-methylenechloride, Methylene chloride ACS, Cl2CH2, H2CCl2, Dichloromethane, anhydrous, Dichloromethane, for HPLC, NCIMech_000221, WLN: G1G, Dichloromethane (DOT:OSHA), Dichloromethane, >=99.9%, CHEMBL45967, R 30 (REFRIGERANT), Dichloromethane, AR, >=99%, Dichloromethane (Peptide Grade), METHYLENE CHLORIDE [MI], METHYLENE CHLORIDE [FCC], DTXSID60166893, METHYLENE CHLORIDE [HSDB], Dichloromethane, LR, >=99.5%, Dichloromethane, purification grade, dichloromethane; methylene chloride, METHYLENE CHLORIDE [VANDF], Dichloromethane(Methylene Chloride), Dichloromethane, analytical standard, Dichloromethane, Environmental Grade, METHYLENE CHLORIDE [USP-RS], Tox21_202526, AKOS009031498, InChI=1/CH2Cl2/c2-1-3/h1H, Dichloromethane [UN1593] [Poison], Dichloromethane, ACS reagent, 99.5%, CAS-75-09-2, Dichloromethane, for HPLC, >=99.7%, Dichloromethane, Spectrophotometric Grade, NCGC00091504-01, NCGC00260075-01, Dichloromethane, Guaranteed Reagent Grade, SY010434, Dichloromethane 100 microg/mL in Methanol, Dichloromethane, suitable for PCB analysis, DESFLURANE IMPURITY E [EP IMPURITY], Dichloromethane 1000 microg/mL in Methanol, D0529, D3478, M0629, NS00004151, Dichloromethane, 99%, stabilized with ethanol, Dichloromethane, for HPLC, >=99.8% (GC), Dichloromethane, SAJ first grade, >=99.0%, Dichloromethane, Selectophore(TM), >=99.5%, C02271, D02330, Dichloromethane, analytical standard, stabilized, Dichloromethane, JIS special grade, >=99.0%, L023970, Q421748, Q425210, J-610006, Dichloromethane, 99%, stab. with ca. 50ppm amylene, Methylene Chloride HPLC grade Stabilized with Amylene, Dichloromethane, glass distilled HRGC/HPLC trace grade, Dichloromethane, TLC high-purity grade, >=99.8% (GC), Dichloromethane HPLC, UV/IR, min. 99.8%, isocratic grade, Dichloromethane, special, 99.9%, contains 40-60 ppm Amylene, Dichloromethane, for HPLC, >=99.8%, contains amylene as stabilizer, Dichloromethane, Selectophore(TM), >=99.5% (GC), inhibitor-free, Dichloromethane, technical grade, 95%, contains 40-60 ppm Amylene, Methylene chloride, European Pharmacopoeia (EP) Reference Standard, Dichloromethane, puriss. p.a., ACS reagent, reag. ISO, >=99.9% (GC), Dichloromethane, UV HPLC spectroscopic, 99.9%, contains 40-60 ppm Amylene, Dichloromethane, ACS reagent, >=99.5%, contains 50 ppm amylene as stabilizer, Dichloromethane, anhydrous, >=99.8%, contains 40-150 ppm amylene as stabilizer, Dichloromethane, anhydrous, contains 40-150 ppm amylene as stabilizer, ZerO2(TM), >=99.8%, Dichloromethane, biotech. grade, 99.9%, contains 40-150 ppm amylene as stabilizer, Dichloromethane, contains 40-150 ppm amylene as stabilizer, ACS reagent, >=99.5%, Dichloromethane, for HPLC, >=99.9%, contains 40-150 ppm amylene as stabilizer, Dichloromethane, puriss., meets analytical specification of Ph.??Eur., NF, >=99% (GC), Methylene Chloride, Pharmaceutical Secondary Standard; Certified Reference Material, Dichloromethane, >=99.9%, capillary GC grade, suitable for environmental analysis, contains amylene as stabilizer, Dichloromethane, ACS spectrophotometric grade, >=99.5%, contains 50-150 ppm amylene as stabilizer, Dichloromethane, Laboratory Reagent, >=99.9% (without stabilizer, GC), contains 0.1-0.4% ethanol as stabilizer, Dichloromethane, p.a., ACS reagent, reag. ISO, reag. Ph. Eur., 99.8%, contains 40-60 ppm Amylene, Dichloromethane, puriss. p.a., ACS reagent, reag. ISO, dried, >=99.8% (GC), <=0.001% water, M.C, Residual Solvent Class 2 - Methylene chloride, United States Pharmacopeia (USP) Reference Standard" CH2Cl2 YMWUJEATGCHHMB-UHFFFAOYSA-N dichloromethane n.a. n.a. No No No No No No PMDBD2000721 Dicinnamyl n.a. n.a. n.a. n.a. n.a. n.a. n.a. 5376733 n.a. n.a. 1,6-Diphenyl-1,3,5-hexatriene, 1,6-Diphenylhexa-1,3,5-triene, 1720-32-7, Dicinnamyl, 1,6-Diphenylhexatriene, DIPHENYLHEXATRIENE, 1,3,5-Hexatriene, 1,6-diphenyl-, [(1E,3E,5E)-6-phenylhexa-1,3,5-trienyl]benzene, Z428QK7RTE, Diphenylhexatriene, all-trans, 17329-15-6, NSC 90479, Benzene, 1,1''-(1,3,5-hexatriene-1,6-diyl)bis-, 1,6-Diphenyl-1,3,5-hexatriene, all-trans-, [(1E,3E,5E)-6-phenylhexa-1,3,5-trien-1-yl]benzene, 1,1''-(1E,3E,5E)-hexa-1,3,5-triene-1,6-diyldibenzene, E,E,E-1,6-diphenyl-1,3,5-hexatriene, NSC-90479, EINECS 217-011-3, Dph (dye), a,w-Diphenylhexatriene, UNII-Z428QK7RTE, alpha,omega-Diphenylhexatriene, E,E,E-1,6-diphenylhexatriene, CHEBI:51594, DTXSID401336583, 1,6-Diphenyl-1,3,5-hexa-triene, MFCD00004793, AKOS015903834, (6-Phenyl-1,3,5-hexatrienyl)benzene, CS-W014683, HY-W013967, 1,6-Diphenyl-1,3,5-hexatriene, 98%, LS-14625, PD069837, .ALPHA.,.OMEGA.-DIPHENYLHEXATRIENE, all-trans-1,6-Diphenyl-1,3,5-hexatriene, (1E,3E,5E)-1,6-Diphenylhexa-1,3,5-triene, Q955946, [(1E,3E,5E)-6-Phenyl-1,3,5-hexatrienyl]benzene C18H16 BOBLSBAZCVBABY-WPWUJOAOSA-N [(1E,3E,5E)-6-phenylhexa-1,3,5-trienyl]benzene n.a. n.a. No No No No No No PMDBD2000722 Diclofenac sodium n.a. n.a. n.a. n.a. n.a. n.a. n.a. 5018304 n.a. NPC488169 "Diclofenac sodium, QTG126297Q, Voltaren, 15307-79-6, Diclofenac sodium salt, Sodium diclofenac, Prophenatin, Neriodin, Diclophenac sodium, GP 45840, Benfofen, Dyloject, Ecofenac, Abitren, Solaraze, Diclofenac (Sodium), Diclophlogont, Dealgic, Deflamat, Delphinac, Diclomax, Dicloreum, Duravolten, Effekton, Feloran, Lexobene, Pennsaid, Primofenac, Rewodina, Voldal, Xenid, Voltaren-XR, Orthophen, Voltarol, Novapirina, Rhumalgan, Sodium (o-(2,6-dichloroanilino)phenyl)acetate, Olfen, DICLOFLEX, CHEBI:4509, DTXSID3037208, Benzeneacetic acid, 2-((2,6-dichlorophenyl)amino)-, monosodium salt, sodium 2-(2-((2,6-dichlorophenyl)amino)phenyl)acetate, 2-[(2,6-Dichlorophenyl)amino]benzeneacetic acid sodium salt, NSC-756725, Sodium (o-((2,6-dichlorophenyl)amino)phenyl)acetate, sodium {2-[(2,6-dichlorophenyl)amino]phenyl}acetate, (o-(2,6-Dichloroanilino)phenyl)acetic acid sodium salt, MLS000028386, (o-(2,6-Dichloroanilino)phenyl)acetic acid monosodium salt, DTXCID1017208, 2-((2,6-Dichlorophenyl)amino)benzeneacetic acid monosodium salt, Benzeneacetic acid, 2-[(2,6-dichlorophenyl)amino]-, monosodium salt, MFCD00082251, NCGC00017082-02, Anthraxiton, Allvoran, Batafil, Delimon, Delphimix, Dichronic, GP-45840, Kriplex, Ortofen, SMR000058567, Tsudohmin, Valetan, Voltarene, Vonafec, Blesin, Urigon, Vurdon, Solaraze (TN), ARTHROTEC COMPONENT DICLOFENAC SODIUM, CAS-15307-79-6, DICLOFENAC SODIUM COMPONENT OF ARTHROTEC, Diclofenac sodium 100 microg/mL in Acetonitrile, Voltaren ophthalmic, diclofenac diethylammonium, Sodium (2-((2,6-dichlorophenyl)amino)phenyl)acetate, Sodium 2-[2-[(2,6-Dichlorophenyl)amino]phenyl]acetate, sodium 2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetate, DICLOFENAC SODIUM (MART.), DICLOFENAC SODIUM [MART.], Assaren, DICLOFENAC SODIUM (USP-RS), DICLOFENAC SODIUM [USP-RS], Voltaren Gel, Benzeneacetic acid, 2-[(2,6-dichlorophenyl)amino]-, monosodium salt [CAS], DICLOFENAC SODIUM (EP MONOGRAPH), DICLOFENAC SODIUM [EP MONOGRAPH], DICLOFENAC SODIUM (USP MONOGRAPH), DICLOFENAC SODIUM [USP MONOGRAPH], SMR000449318, CCRIS 1909, Sodium [O-(2,6-dichloroanilino)phenyl]acetate, EINECS 239-346-4, Ba 47210, Diclofenac sodium injection, Diclofenac sodium topical gel, Berifen, DIC075V, Diclofenac sod, UNII-QTG126297Q, sodium 2-(2-(2,6-dichlorophenylamino)phenyl)acetate, TDS 943, Sodium (o-(2,6-dichloroanilino)phenyl) acetate, Diclofenac, Sodium, Voltaren (TN), Diclofenac sodium [USAN:USP:JAN], Diclofenac Sodium,(S), Opera_ID_564, SODIUM DICHLOFENAC, Lopac-D-6899, EC 239-346-4, CHEMBL1034, SCHEMBL24009, sodium;2-[2-(2,6-dichloroanilino)phenyl]acetate, MLS000758255, MLS001148587, MLS001423970, MLS002222163, MLS003882590, SPECTRUM1500237, VOLTAREN ARTHRITIS PAIN, DICLOFENAC SODIUM [JAN], Diclofenac sodium (JP17/USP), DICLOFENAC SODIUM [USAN], Diclofenac for system suitability, HMS500N14, DICLOFENAC SODIUM [VANDF], REGID_for_CID_5018304, Acetic acid, o-(2,6-dichloroanilino)phenyl-, monosodium salt, HMS1569H10, HMS1920E16, HMS2051M05, HMS2091M06, HMS2096H10, HMS2235O06, HMS2236D03, HMS3261I04, HMS3369K11, HMS3371J05, HMS3393M05, HMS3650B13, HMS3655A22, HMS3713H10, HMS3884C16, KUC112363N, DICLOFENAC SODIUM [WHO-DD], BCP02915, DICLOFENAC SODIUM SALT [MI], Tox21_110770, Tox21_300265, Tox21_500441, CCG-39754, s1903, AKOS000310014, AKOS005267222, AKOS024278942, DICLOFENAC SODIUM [GREEN BOOK], Tox21_110770_1, AC-1487, BCP9000605, CCG-100765, DICLOFENAC SODIUM [ORANGE BOOK], KS-5038, LP00441, NC00015, NSC 756725, SDCCGSBI-0050426.P002, KSC-322-017, NCGC00015361-01, NCGC00015361-02, NCGC00015361-03, NCGC00015361-04, NCGC00017082-01, NCGC00017082-03, NCGC00021125-03, NCGC00093858-01, NCGC00093858-02, NCGC00094648-01, NCGC00094648-02, NCGC00253928-01, NCGC00261126-01, BD166162, CPD000449318, HY-15037, BCP0726000303, D2508, Diclofenac Sodium Salt (1mg/ml in Methanol), EU-0100441, NS00077139, Sodium 2-(2,6-Dichloroanilino)phenylacetate, SW196404-3, sodium 2-(2,6-dichloroanilino)-phenylacetate, BIM-0051341.0001, D 6899, D00904, D78205, A809387, sodium 2-[(2,6-dichlorophenyl)amino]phenylacetate, Monosodium 2-(2,6-dichlorophenylamino)phenylacetate, Q-200965, sodium 2-[(2,6-dichlorophenyl)-amino]phenylacetate, 2-(2,6-Dichloroanilino)phenylacetic Acid Sodium Salt, Q12430631, sodium 2-[(2,6-dichlorophenyl)-amino]-phenyl-acetate, sodium 2-[(2,6-dichlorophenyl)-amino]-phenylacetate, sodium;2-[2-(2,6-dichloroanilino)phenyl]acetic acid, 2-[(2,6-Dichlorophenyl)amino]benzeneacetic acid sodium, Diclofenac Sodium 1.0 mg/ml in Methanol (as free acid), Benzeneacetic acid, 2-[(2,6-dichlorophenyl)amino]-, sodium salt (1:1)" C14H10Cl2NNaO2 KPHWPUGNDIVLNH-UHFFFAOYSA-M "sodium;2-[2-(2,6-dichloroanilino)phenyl]acetate" n.a. n.a. No No No No No No PMDBD2000723 Dicloxacillin Therapeutic Substance Approved Drug 3116-76-5 DB00485 PA164749649 D02348 D0R2KJ 18381 17358 n.a. dicloxacillin, 3116-76-5, Dicloxacycline, Dicloxacilina, Dicloxacilin, Dicloxacilline, Dicloxacillinum, Diclossacillina, Dynapen, Diclossacillina [DCIT], Dicloxacilina [INN-Spanish], Dicloxacilline [INN-French], Dicloxacillinum [INN-Latin], Maclicine, BRL 1702, R-13423, Methyldichlorophenylisoxazolylpenicillin, BRL-1702, CHEBI:4511, HSDB 3222, UNII-COF19H7WBK, COF19H7WBK, EINECS 221-488-3, 3-(2,6-Dichlorophenyl)-5-methyl-4-isoxazolylpenicillin, 6-(3-(2,6-Dichlorophenyl)-5-methyl-4-isoxazolecarboxamido)penicillanic acid, (2S,5R,6R)-6-[[3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(((3-(2,6-dichlorophenyl)-5-methyl-4-isoxazolyl)carbonyl)amino)-3,3-dimethyl-7-oxo-, (2S-(2alpha,5alpha,6beta))-, 6-(3-(2,6-Dichlorophenyl)-5-methyl-4-isoxazolecarboxamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, Dicloxaciclin, DTXSID1022924, Dichloroxacillin, (2S,5R,6R)-6-({[3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, Dicloxacilina (INN-Spanish), Dicloxacilline (INN-French), Dicloxacillinum (INN-Latin), (2S,5R,6R)-6-[3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazole-4-amido]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, DICLOXACILLIN (MART.), DICLOXACILLIN [MART.], Dicloxacillin [USAN:INN:BAN], (2S,5R,6R)-6-(3-(2,6-DICHLOROPHENYL)-5-METHYL-4-ISOXAZOLECARBOXAMIDO)-3,3-DIMETHYL-7-OXO-4-THIA-1-AZABICYCLO(3.2.0)HEPTANE-2-CARBOXYLATE, 6beta-{[3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazol-4-yl]carboxamido}-2,2-dimethylpenam-3alpha-carboxylic acid, Dicloxacillin (USAN/INN), Dicloxacillina, (2S,5R,6R)-6-(((3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazol-4-yl)carbonyl)amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6beta-((3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazol-4-yl)carboxamido)-2,2-dimethylpenam-3alpha-carboxylic acid, Spectrum_000932, Prestwick0_000450, Prestwick1_000450, Prestwick2_000450, Prestwick3_000450, Spectrum2_000981, Spectrum3_000386, Spectrum4_000507, Spectrum5_000869, DICLOXACILLIN [MI], CHEMBL893, Epitope ID:181860, DICLOXACILLIN [INN], DICLOXACILLIN [HSDB], DICLOXACILLIN [USAN], SCHEMBL23955, BSPBio_000500, BSPBio_002171, DICLOXACILLIN [VANDF], KBioGR_001053, KBioSS_001412, DivK1c_000658, SPBio_001041, SPBio_002439, DICLOXACILLIN [WHO-DD], BPBio1_000550, DTXCID202924, GTPL12261, HY-B1459A, KBio1_000658, KBio2_001412, KBio2_003980, KBio2_006548, KBio3_001391, J01CF01, NINDS_000658, BDBM50350476, AKOS016010072, DB00485, IDI1_000658, (2S,5R,6R)-6-({[3-(2,6-dichlorophenyl)-5-methylisoxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, SBI-0051342.P003, CS-0013566, NS00126885, C06950, D02348, EN300-708779, 1-(4-Chloro-benzyl)-piperidine-4-carboxylicacid, Q2313471, BRD-K05673000-323-02-8, 3-(2,6-Dichlorophenyl)-5-methyl-4-isooxazolylpenicillin, 3-(2,6-dichlorophenyl)-5-methyl-4-isoxazolyl penicillin, (2S,5R,6R)-6-(3-(2,6-dichlorophenyl)-5-methylisoxazole-4-carboxamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, (2S,5R,6R)-6-[[3-(2,6-dichlorophenyl)-5-methyl1,2-oxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid C19H17Cl2N3O5S YFAGHNZHGGCZAX-JKIFEVAISA-N (2S,5R,6R)-6-[[3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid Sandoz Inc Antibiotics No No No No No No PMDBD2000724 Dicyclohexylamine n.a. n.a. n.a. n.a. n.a. n.a. n.a. 7582 n.a. n.a. "DICYCLOHEXYLAMINE, N-Cyclohexylcyclohexanamine, 101-83-7, Cyclohexanamine, N-cyclohexyl-, DCHA, Dicha, N,N-Dicyclohexylamine, Dodecahydrodiphenylamine, Dicyklohexylamin, N,N-Diclohexylamine, N-Cyclohexyl-cyclohexylamine, NSC 3399, MLS002174250, CHEBI:34694, 1A93RJW924, NCGC00090955-03, SMR001224510, DCH, DTXSID6025018, NSC-3399, Dicyklohexylamin [Czech], DTXCID005018, CCRIS 6228, HSDB 4018, EINECS 202-980-7, UN2565, CAS-101-83-7, UNII-1A93RJW924, BRN 0605923, AI3-15334, dicydohexylamine, dicylohexylamine, dicylcohexylamine, Aminodicyclohexane, di-cyclohexylamine, dicyclohexyl-amine, Dicyclohexyl amine, Sodium Cyclamate Imp. D (EP); N-Cyclohexylcyclohexanamine; Sodium Cyclamate Impurity D, bis-cyclohexylamine, Bis(cyclohexyl)amine, Cy2NH, Cyclohexylcyclohexanamine, Dicyclohexylamine, 99%, SCHEMBL500, EC 202-980-7, cid_7582, NCIOpen2_002862, Oprea1_024913, N,N-DICYCLOHXYL-AMINE, 4-12-00-00022 (Beilstein Handbook Reference), MLS002152900, BIDD:ER0258, DICYCLOHEXYLAMINE [MI], WLN: L6TJ AM-AL6TJ, DICYCLOHEXYLAMINE [HSDB], CHEMBL1451838, BDBM74256, NSC3399, HMS3741I15, STR04129, Tox21_111044, Tox21_201771, Tox21_303097, MFCD00011658, Dicyclohexylamine, analytical standard, AKOS000119059, Tox21_111044_1, UN 2565, NCGC00090955-01, NCGC00090955-02, NCGC00090955-04, NCGC00090955-05, NCGC00090955-06, NCGC00257081-01, NCGC00259320-01, Dicyclohexylamine Dodecahydro diphenylamine, Dicyclohexylamine [UN2565] [Corrosive], D0435, NS00011452, EN300-17273, A11830, AG-617/02036022, Q425368, J-000503, F2190-0312, InChI=1/C12H23N/c1-3-7-11(8-4-1)13-12-9-5-2-6-10-12/h11-13H,1-10H" C12H23N XBPCUCUWBYBCDP-UHFFFAOYSA-N N-cyclohexylcyclohexanamine n.a. n.a. No No No No No No PMDBD2000725 Didanosine Therapeutic Substance Approved Drug 69655-05-6 DB00900 PA449301 D00296 D06FDR 135398739 45864 n.a. "didanosine, 2'',3''-Dideoxyinosine, 69655-05-6, DIDEOXYINOSINE, Videx, Videx EC, ddIno, Inosine, 2'',3''-dideoxy-, Didanosinum, Didanosina, 2,3-dideoxyinosine, DDI, BMY-40900, (-)-didanosine, Didanosinum [INN-Latin], Didanosina [INN-Spanish], UNII-K3GDH6OH08, DRG-0016, K3GDH6OH08, BMY 40900, CCRIS 805, NSC-612049, DTXSID6022927, HSDB 6548, CHEBI:490877, BRN 3619529, 9-[(2R,5S)-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1,9-dihydro-6H-purin-6-one, DTXCID402927, 9-[(2R,5S)-5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one, 9-((2R,5S)-5-(hydroxymethyl)tetrahydrofuran-2-yl)-9H-purin-6-ol, Didanosine [USAN:USP:INN:BAN], 9-((2R,5S)-5-(hydroxymethyl)-tetrahydrofuran-2-yl)-1H-purin-6(9H)-one, 9-((2R,5S)-5-Hydroxymethyl-tetrahydro-furan-2-yl)-1,9-dihydro-purin-6-one, NSC 612049, MFCD00077728, 9-[(2R,5R)-5-(HYDROXYMETHYL)TETRAHYDROFURAN-2-YL]-1,9-DIHYDRO-6H-PURIN-6-ONE, NCGC00090691-03, NCGC00159514-02, Didanosine 100 microg/mL in Acetonitrile, Didanosinum (INN-Latin), Didanosina (INN-Spanish), 9-((2R,5S)-5-(hydroxymethyl)tetrahydrofuran-2-yl)-3,9-dihydro-6H-purin-6-one, DIDANOSINE (MART.), DIDANOSINE [MART.], DIDANOSINE (USP-RS), DIDANOSINE [USP-RS], 2'',3''-Dideoxyinosine (ddI), DIDANOSINE (EP IMPURITY), DIDANOSINE [EP IMPURITY], DIDANOSINE (EP MONOGRAPH), DIDANOSINE (USP IMPURITY), DIDANOSINE [EP MONOGRAPH], DIDANOSINE [USP IMPURITY], DIDANOSINE (USP MONOGRAPH), DIDANOSINE [USP MONOGRAPH], Didanosine (USAN:USP:INN:BAN), 9-((2S,5R)-5-Hydroxymethyl-tetrahydro-furan-2-yl)-9H-purin-6-ol, Hypoxanthine ddN, NSC612049, ddI (Antiviral), 9-[(2R,5S)-5-(HYDROXYMETHYL)OXOLAN-2-YL]-6,9-DIHYDRO-3H-PURIN-6-ONE, D2I, SMR000058576, Videx(TM), Intron A & Videx, CAS-69655-05-6, Videx (TN), PC-SOD+ddI, Dideoxyinosine (DDI), LOA & ddI, 2'',3'' Dideoxyinosine, ddI + d4T combination, ddI & GM-CSF, SR-05000001487, DDI and rIFN.alpha.2, ddI & sCD4(rsCD4), 9-[(2R,5S)-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1H-purin-6-one, Didanosine EC, DS-4152 & ddI, 9-((2R,5S)-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1,9-dihydro-6H-purin-6-one, Didanosine,(S), Didanosine; 2'',3''-dideoxyinosine; 9-(2,3-Dideoxy-beta-d-glycero-pentofuranosyl)-1,9-dihydro-6H-purin-6-one, 9-(2,3-Dideoxy-beta-D-ribofuranosyl)-6-oxopurine, Didanosine (Videx), Didanosine and Interferon-.alpha.-2, Videx EC(TM)(slow-release capsules), KS-1049, 2'',3''-didesoxyinosin, 2'',3''-Dideoxyinosine (AIDS Initiative), ddI & IFN-.alpha., DIDANOSINE [MI], DDI (NUCLEOSIDE), DIDANOSINE [INN], DIDANOSINE [JAN], 2'', 3''-dideoxyinosine, DIDANOSINE [HSDB], DIDANOSINE [USAN], DIDANOSINE [VANDF], SCHEMBL3363, CHEMBL1460, DIDANOSINE [WHO-DD], DIDANOSINE [WHO-IP], 9-(2,3-Dideoxy-beta-D-ribofuranosyl)hypoxanthine, Listera ovata agglutinin & 2'',3''-Dideoxyinosine, Didanosine (JAN/USP/INN), MLS000759469, MLS001055350, MLS001424118, MLS002154216, MLS006011561, 3''-Azido-3''-deoxythymidine + 2'',3''-Dideoxyinosine, GTPL4833, DIDANOSINE [ORANGE BOOK], Didanosine for system suitability, 2'',3''-Dideoxyinosine & sCD4(soluble recombinant protein), J05AF02, HMS2051J11, HMS2089N20, HMS2095O08, HMS2232P22, HMS3712O08, HMS3884M06, -2-yl)-1H-purin-6(9H)-one, DIDANOSINUM [WHO-IP LATIN], HY-B0249, Tox21_111732, Tox21_202333, Tox21_300575, 9-[(2R,5S)-5-(hydroxymethyl)tetrahydrofuran-2-yl]-3H-purin-6-one, BDBM50404252, 2'',3''-Dideoxyinosine & Granulocyte-macrophage colony-stimulating factor, 2'',3''-DIDEOXYINOSINE; Didanosine, AKOS015833088, AKOS015901454, AKOS015963259, AKOS026750545, Tox21_111732_1, CCG-100947, CCG-220153, DB00900, NC00197, SRI-7013-04, SRI-7013-05, SRI-7013_07, NCGC00090691-01, NCGC00090691-02, NCGC00090691-14, NCGC00159514-03, NCGC00159514-04, NCGC00164280-01, NCGC00188983-01, NCGC00254496-01, NCGC00259882-01, NCGC00390773-01, 2DI, AC-12026, AC-32186, BP-58651, SMR004703324, 2'',3''-Dideoxyinosine, >=98% (HPLC), 2'',3''-Dideoxyinosine & Interferon-.alpha., D3066, NS00000541, SW198619-2, 9-((2R,5S)-5-(hydroxymethyl)tetrahydrofuran, C06953, D00296, EN300-123032, T71244, Q422606, J-700356, SR-05000001487-1, SR-05000001487-2, W-203551, Z1546616193, Didanosine, European Pharmacopoeia (EP) Reference Standard, 9-[(2R,5S)-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one, Didanosine, United States Pharmacopeia (USP) Reference Standard, Inosine, 2'',3''-dideoxy- & Recombinant Interferon-.alpha.-2, Lecithinized superoxide dismutase & Inosine, 2'',3''-dideoxy-, 2 inverted exclamation mark ,3 inverted exclamation mark -Dideoxyinosine, 9-((2R,5S)-5-(HYDROXYMETHYL)TETRAHYDROFURAN-2-YL)-1H-PURIN-6(9H)-ONE, Didanosine for system suitability, European Pharmacopoeia (EP) Reference Standard" C10H12N4O3 BXZVVICBKDXVGW-NKWVEPMBSA-N 9-[(2R,5S)-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one Bristol-Myers Squibb Anti-HIV Agents No No No No No No PMDBD2000726 DiHydroxyBenzoFuran n.a. n.a. n.a. n.a. n.a. n.a. n.a. 22994886 n.a. n.a. 1-Benzofuran-2,3-diol, dihydroxybenzofuran, 163463-62-5, Benzofuran-2,3-diol, 2,3-Benzofurandiol, SCHEMBL578354, GTPL10992, DTXSID20629434 C8H6O3 DNDWXJDUTDZBNV-UHFFFAOYSA-N 1-benzofuran-2,3-diol n.a. n.a. No No No No No No PMDBD2000727 Dihydroxybenzoic Acid (2,3-DHBA) n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000728 Dihydroxybenzoic Acid (2,4-DHBA) n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000729 Dihydroxybenzoic Acid (3,4-DHBA) n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000730 Di-MB-LF11-215 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000731 Di-MB-LF11-322 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000732 Dimethyl Sulfoxide Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. D08HVE 679 n.a. NPC42017 "dimethyl sulfoxide, DMSO, 67-68-5, Methyl sulfoxide, Methylsulfinylmethane, Dimethylsulfoxide, Dimethyl sulphoxide, Methane, sulfinylbis-, Demasorb, Demsodrox, Demavet, Domoso, Infiltrina, Somipront, Dimexide, Dolicur, Dromisol, Durasorb, Syntexan, Deltan, Demeso, Hyadur, sulfinylbismethane, Dimethyl sulfur oxide, Doligur, Dipirartril-tropico, Gamasol 90, Sulfinylbis(methane), Dermasorb, Kemsol, Dimethylsulphoxide, Rimso-50, Topsym, Dimethylsulfoxid, Dimethylsulfoxyde, SQ 9453, NSC-763, Rimso 50, Dimetil sulfoxido, Sulfinylbis-methane, Dimethyli sulfoxidum, Dimexidum, Caswell No. 381, (methylsulfinyl)methane, Dimetilsolfossido, (CH3)2SO, DMS-90, Sulfoxide, dimethyl, methanesulfinylmethane, A 10846, CCRIS 943, M 176, DMS 70, DMS 90, DMS-70, DTXSID2021735, NSC 763, Methyl sulphoxide, dimethyl-sulfoxide, S(O)Me2, EPA Pesticide Chemical Code 000177, SQ-9453, NSC763, YOW8V9698H, CHEBI:28262, AI3-26477, (methanesulfinyl)methane, DMSO, sterile filtered, MFCD00002089, (DMSO), C2H6OS, CHEMBL504, METHYL-13C SULFOXIDE, Methane, 1,1''-sulfinylbis-, DTXCID401735, Dimethyl sulfoxide, HPLC Grade, Dimethylsulphinyl, Dimethyl sulfoxide, 99%, 103759-08-6, Topsym (rescinded), Rimso-5, Domoso (Veterinary), DIMETHYL SULFOXIDE (II), DIMETHYL SULFOXIDE [II], methylsulfoxide, DIMETHYL SULFOXIDE (MART.), DIMETHYL SULFOXIDE [MART.], DIMETHYL SULFOXIDE (USP-RS), DIMETHYL SULFOXIDE [USP-RS], sulfinyldimethane, Dimetilsolfossido [DCIT], Dimethyl sulpoxide, DIMETHYL SULFOXIDE (EP MONOGRAPH), DIMETHYL SULFOXIDE [EP MONOGRAPH], DIMETHYL SULFOXIDE (USP MONOGRAPH), DIMETHYL SULFOXIDE [USP MONOGRAPH], HSDB 80, Sulphoxide, Dimethyl, Dimethylsulfoxyde [INN-French], Dimetil sulfoxido [INN-Spanish], Dimethyli sulfoxidum [INN-Latin], EINECS 200-664-3, UNII-YOW8V9698H, dimethysulfoxide, dimethlysulfoxide, dimethvlsulfoxide, dimethyisulfoxide, dimethylsulphoxid, Domoso Solution, dimethy sulfoxide, dimetyl sulfoxide, Domoso Gel, dimethyisulphoxide, dimethyl sulfoxyde, dimethyl-sulfoxyde, dimethyl suiphoxide, dimethyl-sulphoxide, dirnethyl sulfoxide, Dimethyl sulfoxixde, methylsulfmylmethane, DMSO (anydrous), dimethyl sulf oxide, Dimethylis sulfoxidum, DIMEHTYLSULFOXYDE, Dimethyl sulfoxide [USAN:USP:INN:BAN], Methyl sulfoxide (8CI), Rimso-50 (TN), dimethyl sulfoxide (dmso), DMSO (Sterile-filtered), DMSO [INCI], DMSO (Dimethyl sulfoxide), EC 200-664-3, H3C-SO-CH3, BIDD:PXR0182, Dimethyl sulfoxide, >=99%, Dimethyl sulfoxide, anhydrous, Dimethyl sulfoxide, for HPLC, Methane, sulfinylbis- (9CI), WLN: OS1&1, DIMETHYL SULFOXIDE [MI], DIMETHYL SULFOXIDE [INN], DIMETHYL SULFOXIDE [JAN], Dimethyl sulfoxide, >=99.5%, Dimethyl sulfoxide, PCR Reagent, DIMETHYL SULFOXIDE [HSDB], DIMETHYL SULFOXIDE [USAN], Dimethyl sulfoxide, ACS reagent, G04BX13, M02AX03, Methyl sulfoxide, >=99%, FG, Dimethyl sulfoxide, p.a., 99%, DIMETHYL SULFOXIDE [VANDF], Dimethyl sulfoxide, LR, >=99%, Pharmakon1600-01506122, AMY14894, CS-B1637, Dimethyl sulfoxide (JAN/USP/INN), DIMETHYL SULFOXIDE [WHO-DD], HY-Y0320, METHYLSULFINYLMETHANE [FHFI], Tox21_300957, BDBM50026472, HB3262, HB8591, NSC760436, Dimethyl sulfoxide, AR, >=99.5%, AKOS000121107, CCG-213615, DB01093, DIMETHYL SULFOXIDE [GREEN BOOK], Dimethyl sulfoxide, analytical standard, NSC-760436, CAS-67-68-5, DIMETHYL SULFOXIDE [ORANGE BOOK], MRF-0000764, USEPA/OPP Pesticide Code: 000177, (methanesulfinyl)methanedimethyl sulfoxide, Dimethyl sulfoxide, for molecular biology, Dimethyl sulfoxide; AIF; CE0; MS2Dec, NCGC00163958-01, NCGC00163958-02, NCGC00163958-03, NCGC00254859-01, 8070-53-9, Dimethyl sulfoxide, anhydrous, >=99.9%, Dimethyl sulfoxide, HPLC grade, 99.9%, Dimethyl Sulfoxide [for Spectrophotometry], Dimethyl sulfoxide, for HPLC, >=99.5%, Dimethyl sulfoxide, for HPLC, >=99.7%, D0798, D1159, D5293, Dimethyl sulfoxide solution 50 wt.% in H2O, Dimethyl sulfoxide, ACS reagent, >=99.9%, Dimethyl sulfoxide, AldraSORB(TM), 99.8%, InChI=1/C2H6OS/c1-4(2)3/h1-2H, NS00001957, EN300-24544, D01043, Dimethyl sulfoxide, >=99.6%, ReagentPlus(R), Dimethyl sulfoxide, ReagentPlus(R), >=99.5%, AB01563146_01, Dimethyl Sulfoxide (DMSO), cell culture reagent, Dimethyl sulfoxide, p.a., ACS reagent, 99.9%, Dimethyl sulfoxide, SAJ first grade, >=99.0%, Dimethyl sulfoxide, JIS special grade, >=99.0%, Dimethyl sulfoxide, Vetec(TM) reagent grade, 99%, Q407927, Dimethyl sulfoxide, UV HPLC spectroscopic, 99.9%, Dimethyl sulfoxide solution 50 wt.% in distilled H2O, Dimethyl sulfoxide, anhydrous, ZerO2(TM), >=99.9%, Dimethyl sulfoxide, meets EP, USP testing specifications, Z199055774, Dimethyl sulfoxide, ACS spectrophotometric grade, >=99.9%, Dimethyl sulfoxide, puriss. p.a., dried, <=0.02% water, Dimethyl sulfoxide, >=99.5% (GC), plant cell culture tested, Dimethyl sulfoxide, BioUltra, for molecular biology, >=99.5% (GC), Dimethyl sulfoxide, European Pharmacopoeia (EP) Reference Standard, Dimethyl sulfoxide, puriss. p.a., ACS reagent, >=99.9% (GC), Dimethyl sulfoxide, Vetec(TM) reagent grade, anhydrous, >=99.7%, Dimethyl sulfoxide, >=99.0%, suitable for absorption spectrum analysis, Dimethyl sulfoxide, United States Pharmacopeia (USP) Reference Standard, Dimethyl sulfoxide, for inorganic trace analysis, >=99.99995% (metals basis), Dimethyl sulfoxide, meets EP testing specifications, meets USP testing specifications, Dimethyl sulfoxide, Hybri-Max(TM), sterile-filtered, BioReagent, suitable for hybridoma, >=99.7%, Dimethyl sulfoxide, puriss., absolute, over molecular sieve (H2O <=0.005%), >=99.5% (GC), Dimethyl sulfoxide, sterile-filtered, BioPerformance Certified, meets EP, USP testing specifications, suitable for hybridoma" C2H6OS IAZDPXIOMUYVGZ-UHFFFAOYSA-N methylsulfinylmethane Mylan Institutional Llc n.a. No No No No No No PMDBD2000733 Diphenyl diselenide n.a. n.a. n.a. n.a. n.a. n.a. n.a. 15460 n.a. n.a. Diphenyl diselenide, 1666-13-3, Diselenide, diphenyl, Phenyl diselenide, 1,2-Diphenyldiselane, Diphenyldiselenide, (phenyldiselanyl)benzene, Bis(phenylselenide), MFCD00003001, 9ATU3Z459Q, CHEMBL3122204, NSC-49763, C12H10Se2, CCRIS 9227, EINECS 216-780-2, NSC 49763, 1,2-Diphenyldiselane #, Diphenyl diselenide, 98%, UNII-9ATU3Z459Q, DISELENIDE, DIPHENYL-, DTXSID6061864, AMY31939, NSC49763, BDBM50028969, AKOS005192800, AC-11061, D2186, NS00076368, Diphenyl diselenide, purum, >=97.0% (GC), EN300-37568, D90009, A810750, J-200095, Q3538196, InChI=1/C12H10Se2/c1-3-7-11(8-4-1)13-14-12-9-5-2-6-10-12/h1-10 C12H10Se2 YWWZCHLUQSHMCL-UHFFFAOYSA-N (phenyldiselanyl)benzene n.a. n.a. No No No No No No PMDBD2000734 Diphenyl disulphide n.a. n.a. n.a. n.a. n.a. n.a. n.a. 13436 n.a. n.a. DIPHENYL DISULFIDE, Phenyl disulfide, 882-33-7, 1,2-diphenyldisulfane, (Phenyldisulfanyl)benzene, Disulfide, diphenyl, diphenyldisulfide, Diphenyl disulphide, Biphenyl disulfide, Phenyldithiobenzene, Disulfide diphenyl, USAF E-1, 1,1''-dithiodibenzene, FEMA No. 3225, Phenyldisulfide, diphenyldisulphide, MFCD00003065, MLS000069663, CHEMBL462861, DTXSID6022131, NSC2689, 7P54H519IJ, NSC-2689, SMR000059177, NSC 2689, EINECS 212-926-4, phenyidisulfide, phenyldisulphide, Dithiobisbenzene, UNII-7P54H519IJ, diphenyidisulfide, phenyl-disulfide, AI3-02911, phenyl disulphide, PhSSPh, bis-(phenyl)disulfide, phenyldisulfanyl-benzene, (phenyldisulanyl)benzene, Phenyl disulfide, 8CI, Ph-S-S-Ph, Opera_ID_773, Phenyl disulfide, 99%, WLN: RSSR, (Phenyldisulfanyl)benzene #, SCHEMBL5148, Phenyl disulfide, >=98%, DTXCID702131, DIPHENYL DISULFIDE [MI], FEMA 3225, DIPHENYL DISULFIDE [FHFI], CHEBI:174102, HMS2235I05, HY-Y1177, STR01628, Tox21_200728, BDBM50450778, NSC799311, Phenyl disulfide, analytical standard, AKOS000120953, NSC-799311, NCGC00093353-02, NCGC00258282-01, CAS-882-33-7, CS-0017165, NS00022864, P0167, EN300-20703, D72521, A842506, Diphenyl disulfide, technical, >=97.0% (HPLC), J-520380, Q2423101, F0001-2477, Z104480056, ENVIRONMENTALLY HAZARDOUS SUBSTANCE, SOLID, N.O.S. (DIPHENYL DISULPHIDE), InChI=1/C12H10S2/c1-3-7-11(8-4-1)13-14-12-9-5-2-6-10-12/h1-10, 93345-44-9 C12H10S2 GUUVPOWQJOLRAS-UHFFFAOYSA-N (phenyldisulfanyl)benzene n.a. n.a. No No No No No No PMDBD2000735 Diphenyl methane n.a. n.a. n.a. n.a. n.a. n.a. n.a. 7580 n.a. n.a. Diphenylmethane, 101-81-5, Benzylbenzene, Ditan, Ditane, Benzene, 1,1''-methylenebis-, Diphenyl methane, Benzene, benzyl-, Methane, diphenyl-, 1,1''-Dimethylenebis(benzene), Benzene, (phenylmethyl)-, 1,1''-METHYLENEBISBENZENE, 1,1''-methylenedibenzene, (phenylmethyl)benzene, Benzylphenyl, Diphenylmethan, Benzyl benzene, Toluene, alpha-phenyl-, alpha-phenyltoluene, NSC 4708, HSDB 5141, EINECS 202-978-6, UNII-K3E387I0BC, MFCD00004781, AI3-28021-X, K3E387I0BC, DTXSID1041891, CHEBI:38884, AI3-00748, NSC-4708, Toluene, .alpha.-phenyl-, CHEMBL1796022, DTXCID9021891, Methylenedibenzene, Diphenylmethyl, benzyl-benzene, Diphenylmethane, 99%, Benzene,1''-methylenebis-, Diphenylmethane, >=99%, WLN: R1R, DIPHENYLMETHANE [MI], BIDD:ER0257, DIPHENYL METHANE [INCI], NSC4708, 1,1''-METHYLENEBIS(BENZENE), Tox21_301147, BDBM50346811, AKOS000120567, CS-W009530, 1,1''-METHYLENEBISBENZENE [HSDB], NCGC00248307-01, NCGC00255045-01, CAS-101-81-5, LS-14188, SY001825, D0896, NS00012346, EN300-21054, E75810, A800459, Q412882, W-108901, F0001-0052, InChI=1/C13H12/c1-3-7-12(8-4-1)11-13-9-5-2-6-10-13/h1-10H,11H C13H12 CZZYITDELCSZES-UHFFFAOYSA-N benzylbenzene n.a. n.a. No No No No No No PMDBD2000736 DispersinB-KSL-W wound gel n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000737 Diterpene phytol n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000738 Djenkolic acid n.a. n.a. n.a. n.a. n.a. n.a. n.a. 68134 n.a. n.a. Djenkolic acid, 498-59-9, L-Djenkolic acid, Djenkolate, beta,beta''-Methylenedithiodialanine, L-Djenkolate, L-Cysteine thioacetal of formaldehyde, 3,3''-(Methylenedithio)dialanine, 3QHC9R0YFZ, CHEBI:6211, 3,3''-Methylenedithiobis(2-aminopropanoic acid), (2R)-2-amino-3-[[(2R)-2-amino-2-carboxyethyl]sulfanylmethylsulfanyl]propanoic acid, UNII-3QHC9R0YFZ, S,S''-Methylenebiscysteine, s,s''-methylenebis-l-cysteine, NSC-76076, EINECS 207-863-4, Alanine, 3,3''-(methylenedithio)di-, NSC 76076, DJENKOLIC ACID [MI], S,S''-methylenebis(cysteine), S,S''-Methylenedi-L-cysteine, SCHEMBL151396, S,S''-methylene-bis-L-cysteine, CHEMBL3138615, DTXSID80198075, L-Cysteine, S,S''-methylenebis-, JMQMNWIBUCGUDO-WHFBIAKZSA-N, s4954, AKOS030538008, Alanine, 3,3''-(methylenedithio)di-, L-, HY-125923, CS-0103073, D0961, NS00031975, C08275, T70966, Q4263761, (2R,2''R)-3,3''-(methylenedisulfanediyl)bis(2-aminopropanoic acid), (2R,2''R)-3,3''-methylenebis(sulfanediyl)bis(2-aminopropanoic acid) C7H14N2O4S2 JMQMNWIBUCGUDO-WHFBIAKZSA-N (2R)-2-amino-3-[[(2R)-2-amino-2-carboxyethyl]sulfanylmethylsulfanyl]propanoic acid n.a. n.a. No No No No No No PMDBD2000739 DJK5 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000740 DJK6 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000741 D-Leucine Therapeutic Substance n.a. 328-38-1 DB01746 n.a. n.a. n.a. 439524 388617 n.a. "D-LEUCINE, 328-38-1, H-D-Leu-OH, (2R)-2-amino-4-methylpentanoic acid, (R)-Leucine, Leucine, D-, (R)-(-)-Leucine, (R)-2-Amino-4-methylpentanoic acid, D-Homo-valine, D-2-Amino-4-methylvaleric acid, D-Leu, D-Leucin, D-Leuzin, CHEBI:28225, (2R)-2-azaniumyl-4-methylpentanoate, 965COD96YA, DTXSID6046347, MFCD00063088, NCGC00163335-01, DLE, DTXCID4026347, Leucine,d, CAS-328-38-1, D-2-Amino-4-methylpentanoic acid, UNII-965COD96YA, NSC-77687, (D)-leucine, EINECS 206-327-7, NSC 77687, d-leu42, AI3-52422, SCHEMBL42012, D-LEUCINELEUCINE, D-, CHEMBL1232258, (R)-2-Amino-4-methylvaleric acid, BCP30475, CS-D1369, D-Leucine, ReagentPlus(R), 99%, HY-Y0378, Tox21_112049, BDBM50463213, (R)-2-amino-4-methyl-pentanoic acid, AKOS015841823, Tox21_112049_1, AC-8658, AM81870, DB01746, (2R)-2-Amino-4-methyl-pentanoic acid, NCGC00013565-03, NCGC00163335-02, NCGC00163335-03, AS-12286, D-Leucine, Vetec(TM) reagent grade, 97%, (R)-4-METHYL-2-AMINOPENTANOIC ACID, L0027, NS00074125, EN300-56092, C01570, Q16081973, F1905-7150, Z850973972, D-2-Amino-4-methylpentanoic acid;(R)-Leucine;H-D-Leu-OH" C6H13NO2 ROHFNLRQFUQHCH-RXMQYKEDSA-N (2R)-2-amino-4-methylpentanoic acid n.a. n.a. No No No No No No PMDBD2000742 D-LL-37 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000743 D-Methionine Therapeutic Substance Phase 3 348-67-4 DB02893 n.a. n.a. D0N0KW 84815 76512 n.a. "D-Methionine, 348-67-4, H-D-Met-OH, (R)-Methionine, methionine, D-Methionin, D-Metionien, METHIONINE, D-, MRx-1024, (2R)-2-amino-4-(methylsulfanyl)butanoic acid, (R)-2-amino-4-(methylthio)butanoic acid, Methionine d-form, R-Methionine, CHEBI:16867, (2R)-2-amino-4-methylsulfanylbutanoic acid, D-2-Amino-4-(methylthio)butyric acid, D-2-Amino-4-(methylthio)butanoic acid, CHEMBL1234268, MFCD00002622, MED, (R)-2-Amino-4-(methylmercapto)butyric acid, 868496F25R, Methionine D-, D-Metionien [Australian], NSC-45689, L-Methionine;, UNII-868496F25R, D-Met, EINECS 206-483-6, NSC 45689, D-Met-OH, bmse000450, D-Methionine;MRX-1024, SCHEMBL126688, S-METHYL-D-HOMOCYSTEINE, METHIONINE D-FORM [MI], DTXSID90883369, D-Methionine, >=98% (HPLC), BDBM50463194, s4494, AKOS015852500, AC-8661, AM81977, CS-7880, DB02893, NCGC00163337-01, AC-12369, DS-15125, HY-13694, (R)-2-Amino-4-methylsulfanyl-butyric acid, D-Methionine, puriss., >=99.0% (NT), M0102, NS00079639, EN300-72154, C00855, A822453, J-300192, Q-101531, Q27093862, Z1147215595" C5H11NO2S FFEARJCKVFRZRR-SCSAIBSYSA-N (2R)-2-amino-4-methylsulfanylbutanoic acid n.a. n.a. No No No No No No PMDBD2000744 Dodecyl beta-maltoside n.a. n.a. n.a. n.a. n.a. n.a. n.a. 114880 n.a. n.a. 69227-93-6, n-DODECYL-beta-D-MALTOSIDE, Lauryl maltoside, Dodecyl maltoside, Dodecyl-beta-D-maltoside, N-Dodecyl b-D-maltoside, n-Dodecyl beta-D-maltoside, n-Dodecyl |A-D-maltoside, N-Dodecyl-|A-D-maltoside, dodecyl beta-maltoside, (2R,3R,4S,5S,6R)-2-(((2R,3S,4R,5R,6R)-6-(Dodecyloxy)-4,5-dihydroxy-2-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol, MFCD00043012, Lauryl-beta-D-maltoside, CHEBI:43769, DI107E57B4, Dodecyl b-D-maltopyranoside, dodecyl 4-O-alpha-D-glucopyranosyl-beta-D-glucopyranoside, n-Dodecyl-b-D-maltoside, n-Dodecyl ?-D-maltoside, Dodecyl beta-D-maltoside, UNII-DI107E57B4, lauryl beta-maltoside, lauryl beta-D-maltoside, n-Dodecyl-I(2)-D-maltoside, SCHEMBL411624, CHEMBL1234047, DTXSID30988948, LAURYL-.BETA.-D-MALTOSIDE, NLEBIOOXCVAHBD-QKMCSOCLSA-N, N-DODECYL .BETA.-D-MALTOSIDE, AKOS016011222, dodecyl 4-O-hexopyranosylhexopyranoside, DS-6568, (2R,3R,4S,5S,6R)-2-((2R,3S,4R,5R,6R)-6-(dodecyloxy)-4,5-dihydroxy-2-(hydroxymethyl)tetrahydro-2H-pyran-3-yloxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol, (2R,3R,4S,5S,6R)-2-[(2R,3S,4R,5R,6R)-6-dodecoxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol, HY-128974, n-Dodecyl beta-D-maltoside, >=98% (GC), CS-0102968, NS00123785, 1-O-N-DODECYL-.BETA.-DMALTOPYRANOSIDE, F14800, A866883, n-Dodecyl beta-D-maltoside, BioXtra, >=98% (GC), b-D-Glucopyranoside, dodecyl 4-O-a-D-glucopyranosyl-, Q27120527, beta-D-Glucopyranoside, dodecyl 4-O-alpha-D-glucopyranosyl-, dodecyl alpha-D-glucopyranosyl-9(1->4)-beta-D-glucopyranoside C24H46O11 NLEBIOOXCVAHBD-QKMCSOCLSA-N (2R,3R,4S,5S,6R)-2-[(2R,3S,4R,5R,6R)-6-dodecoxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol n.a. n.a. No No No No No No PMDBD2000745 Dolutegravir Therapeutic Substance Approved Drug 1051375-16-6 DB08930 PA166114961 D10066 D00YZD 54726191 25051637 n.a. Dolutegravir, 1051375-16-6, GSK1349572, S/GSK1349572, Tivicay, GSK-1349572, GSK 1349572, Dolutegravir (GSK1349572), S-349572, (4r,12as)-N-(2,4-Difluorobenzyl)-7-Hydroxy-4-Methyl-6,8-Dioxo-3,4,6,8,12,12a-Hexahydro-2h-Pyrido[1'',2'':4,5]pyrazino[2,1-B][1,3]oxazine-9-Carboxamide, CHEBI:76010, UNII-DKO1W9H7M1, DKO1W9H7M1, Dolutegravir DTG, S-GSK1349572, Dolutegravir [USAN], HSDB 8152, (4R,12aS)-N-[(2,4-Difluorophenyl)methyl]-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-2H-pyrido[1'',2'':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide, (3S,7R)-N-[(2,4-difluorophenyl)methyl]-11-hydroxy-7-methyl-9,12-dioxo-4-oxa-1,8-diazatricyclo[8.4.0.0^{3,8}]tetradeca-10,13-diene-13-carboxamide, Dolutegravir (USAN), 1051375-16-6 (free), Tivicay (TN), 2H-Pyrido(1'',2'':4,5)pyrazino(2,1-b)(1,3)oxazine-9-carboxamide, N-((2,4-difluorophenyl)methyl)-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-, (4R,12aS)-, (3S,7R)-N-[(2,4-difluorophenyl)methyl]-11-hydroxy-7-methyl-9,12-dioxo-4-oxa-1,8-diazatricyclo[8.4.0.03,8]tetradeca-10,13-diene-13-carboxamide, (4R,12aS)-N-((2,4-difluorophenyl)methyl)-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-2H-Pyrido(1'',2'':4,5)pyrazino(2,1-b)(1,3)oxazine-9-carboxamide, Dolutegravir [USAN:INN], dolutegravirum, Soltegravir, (4R,12aS)-N-(2,4-difluorobenzyl)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido(1'',2'':4,5)pyrazino(2,1-b)(1,3)oxazine-9-carboxamide, 3s3m, 3s3n, 3s3o, (4R,12aS)-N-[(2,4-difluorophenyl)methyl]-7-hydroxy-4-methyl-6,8-dioxo-3,4,12,12a-tetrahydro-2H-pyrido[[?]:[?]]pyrazino[[?]][1,3]oxazine-9-carboxamide, DOLUTEGRAVIR [MI], DOLUTEGRAVIR [INN], DOLUTEGRAVIR [VANDF], SCHEMBL82071, MLS006011137, DOLUTEGRAVIR [WHO-DD], GTPL7365, CHEMBL1229211, DTXSID90909356, J05AX12, RHWKPHLQXYSBKR-BMIGLBTASA-N, (4R,12aS)-N-, EX-A1695, BDBM50062551, MFCD20488027, s2667, AKOS025396657, S/GSK-1349572, BCP9000620, CCG-268876, CS-0454, DB08930, Dolutegravir (0.1 mg/mL in Methanol), NCGC00346629-01, NCGC00346629-02, NCGC00346629-11, AC-28371, AS-75277, HY-13238, SMR004702915, NS00099377, S/GSK1349572,GSK1349572, D10066, EN300-7409916, A854801, Q937224, J-501471, Z2235801952, (3S,7R)-N-[(2,4-difluorophenyl)methyl]-11-hydroxy-7-methyl-9,12-dioxo-4-oxa-1,8-diazatricyclo[8.4.0.0(3),?]tetradeca-10,13-diene-13-carboxamide, (3S,7R)-N-[(2,4-difluorophenyl)methyl]-11-hydroxy-7-methyl-9,12-dioxo-4-oxa-1,8-diazatricyclo[8.4.0.0,3,8]tetradeca-10,13-diene-13-carboxamide, (4R,12.ALPHA.S)-N-((2,4-DIFLUOROPHENYL)METHYL)-7-HYDROXY-4-METHYL-6,8-DIOXO-3,4,6,8,12,12.ALPHA.-HEXAHYDRO-2H-PYRIDO(1'',2'':4,5)PYRAZINO(2,1-.BETA.)(1,3)OXAZINE-9-CARBOXAMIDE, (4R,12alphaS)-N-((2,4-DIFLUOROPHENYL)METHYL)-7-HYDROXY-4-METHYL-6,8-DIOXO-3,4,6,8,12,12alpha-HEXAHYDRO-2H-PYRIDO(1'',2'':4,5)PYRAZINO(2,1-beta)(1,3)OXAZINE-9-CARBOXAMIDE, (4R,12aS)-N-(2,4-difluorobenzyl)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-[1,3]oxazino[3,2-a]pyrido[1,2-d]pyrazine-9-carboxamide, (4R,12aS)-N-(2,4-Difluorobenzyl)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-[1,3]oxazino[3,2-d]pyrido[1,2-a]pyrazine-9-carboxamide, (4R,12aS)-N-[(2,4-Difluorophenyl)methyl]-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-2H-pyrido[1'',2'':4,5]pyrazino[2,1-b][1 ,3]oxazine-9-carboxamide, (4R,12aS)-N-[(2,4-difluorophenyl)methyl]-7-hydroxy-4-methyl-6,8-dioxo-3,4,12,12a-tetrahydro-2H-pyrido[5,6]pyrazino[2,6-b][1,3]oxazine-9-carboxamide, (4R,9aS)-5-hydroxy-4-methyl-6,10-dioxo-3,4,6,9,9a,10-hexahydro-2H-1-oxa-4a,8a-diaza-anthracene-7-carboxylic acid-2,4 difluorobenzylamide, (4R,9aS)-5-Hydroxy-4-methyl-6,10-dioxo-3,4,6,9,9a,10-hexahydro-2H-1-oxa-4a,8a-diazaanthracene-7-carboxylic acid 2,4-difluorobenzylamide, 2H-Pyrido(1'',2'':4,5)pyrazino(2,1-b)(1,3)oxazine-9-carboxamide, N-((2,4-difluorophenyl)methyl)-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-, (4R,12aS) C20H19F2N3O5 RHWKPHLQXYSBKR-BMIGLBTASA-N (3S,7R)-N-[(2,4-difluorophenyl)methyl]-11-hydroxy-7-methyl-9,12-dioxo-4-oxa-1,8-diazatricyclo[8.4.0.03,8]tetradeca-10,13-diene-13-carboxamide GlaxoSmithKline n.a. No No No No No No PMDBD2000746 Doripenem Therapeutic Substance n.a. 148016-81-3 DB06211 n.a. D03895 D03QWT 73303 66040 n.a. Doripenem, 148016-81-3, Doribax, S-4661, Finibax, UNII-BHV525JOBH, BHV525JOBH, DTXSID2046678, (4R,5S,6S)-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-3-[(3S,5S)-5-[(sulfamoylamino)methyl]pyrrolidin-3-yl]sulfanyl-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid, DTXCID0026678, S 4661, (4R,5S,6S)-6-((R)-1-hydroxyethyl)-4-methyl-7-oxo-3-(((3S,5S)-5-((sulfamoylamino)methyl)pyrrolidin-3-yl)thio)-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid, 1-Azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, 3-(((3S,5S)-5-(((aminosulfonyl)amino)methyl)-3-pyrrolidinyl)thio)-6-((1R)-1-hydroxyethyl)-4-methyl-7-oxo-, (4R,5S,6S)-, NCGC00167510-01, DORIPENEM (MART.), DORIPENEM [MART.], (+)-(4R,5S,6S)-6-((1R)-1-Hydroxyethyl)-4-methyl-7-oxo-3-(((3S,5S)-5-((sulfamoylamino)methyl)-3-pyrrolidinyl)thio)-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, Doripenem [INN], (4R,5S,6S)-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-3-{[(3S,5S)-5-[(sulfamoylamino)methyl]pyrrolidin-3-yl]sulfanyl}-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid, 1-Azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, 3-((5-(((aminosulfonyl)amino)methyl)-3-pyrrolidinyl)thio)-6-(1-hydroxyethyl)-4-methyl-7-oxo-, (4R-(3(3S*,5S*),4alpha,5beta,6beta(R*)))-, CAS-148016-81-3, MFCD09749887, Doripenem (USAN/INN), Doripenem [USAN:INN], doripenemum, (4R,5S,6S)-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-3-({(3S,5S)-5-[(sulfamoylamino)methyl]pyrrolidin-3-yl}sulfanyl)-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid, DORIPENEM [MI], DORIPENEM [USAN], DORIPENEM [VANDF], DORIPENEM [WHO-DD], SCHEMBL37471, DORIPENEM [EMA EPAR], CHEMBL491571, DORIPENEM [ORANGE BOOK], GTPL12183, J01DH04, AVAACINZEOAHHE-VFZPANTDSA-N, CHEBI:135928, BCPP000252, HY-B0187, Tox21_112508, BDBM50088382, MFCD02092739, s5531, AKOS015918362, compound 1m [PMID: 8621362], Tox21_112508_1, AM84446, BCP9000623, CCG-268891, CS-2075, DB06211, NCGC00167510-02, NCGC00167510-09, D5249, NS00005919, D03895, EN300-18166989, Q411552, SR-01000872589, SR-01000872589-1, (4R,5S,6S)-3-[[(3S,5S)-5-[[(Aminosulfonyl)amino]methyl]-3-pyrrolidinyl]thio]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic Acid, (4R,5S,6S)-6-((R)-1-hydroxyethyl)-4-methyl-7-oxo-3-(((3S,5S)-5-((sulfamoylamino)methyl)pyrrolidin-3-yl)thio)-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylicacid, (4R,5S,6S)-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-3-[(3S,5S)-5-[(sulfamoylamino)methyl]pyrrolidin-3-yl]sulfanyl-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid hydrate, O6P C15H24N4O6S2 AVAACINZEOAHHE-VFZPANTDSA-N (4R,5S,6S)-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-3-[(3S,5S)-5-[(sulfamoylamino)methyl]pyrrolidin-3-yl]sulfanyl-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid Shionogi n.a. No No No No No No PMDBD2000747 D-Phenylalanine Therapeutic Substance Investigational Drug 673-06-3 DB02556 n.a. n.a. D0B3LN 71567 64639 n.a. "D-phenylalanine, 673-06-3, H-D-Phe-OH, (2R)-2-amino-3-phenylpropanoic acid, Phenylalanine D-form, Sabiden, D-Phe, (R)-2-AMINO-3-PHENYLPROPANOIC ACID, Alanine, phenyl-, D-, NCI-C60195, Phenylalanine,d-, (R)-2-Amino-3-phenylpropionic acid, D-alpha-Amino-beta-phenylpropionic acid, D-(+)-Phenylalanine, MFCD00004270, 032K16VRCU, CHEBI:16998, D-.beta.-Phenylalanine, CCRIS 6267, EINECS 211-603-5, NSC 25005, UNII-032K16VRCU, NSC-25005, DPhe, l-3-phenylalanine, HDPheOH, (D)-Phenylalanine, Phenylalanine,(S), (2R)-2-amino-3-phenyl-propanoic acid, Spectrum_001725, Spectrum2_001558, Spectrum4_000865, Spectrum5_001137, (R)-PHENYLALANINE, PHENYLALANINE, D-, D-Phenylalanine, >=99%, SCHEMBL92744, KBioGR_001529, KBioSS_002205, DivK1c_000453, SPECTRUM1503391, SPBio_001436, CHEMBL379630, GTPL5797, DTXSID4025876, BDBM36161, HMS501G15, KBio1_000453, KBio2_002205, KBio2_004773, KBio2_007341, D-PHENYLALANINE [WHO-DD], D-.beta.-Phenyl-.alpha.-alanine, NINDS_000453, PHENYLALANINE D-FORM [MI], HMS1922C08, Pharmakon1600-01503391, HY-Y0079, D-Phenylalanine, >=98% (HPLC), CCG-39336, NSC758460, s4153, AKOS007930513, AC-8664, AM83526, CS-W020009, DB02556, NSC-758460, IDI1_000453, NCGC00163338-01, NCGC00163338-03, AC-11292, AS-11997, SBI-0051820.P002, NS00068080, P0135, EN300-60166, A20666, C02265, M02934, AB00052351_02, AB00052351_03, SR-01000872765, D-Phenylalanine, Vetec(TM) reagent grade, >=98%, J-300203, Q-101646, SR-01000872765-1, Q26841253, Z933646062, 4C53B247-2FE4-4464-92C0-9F3782A08966, D-alpha-Amino-beta-phenylpropionic acid;D-beta-Phenyl-alpha-aminopropionic acid" C9H11NO2 COLNVLDHVKWLRT-MRVPVSSYSA-N (2R)-2-amino-3-phenylpropanoic acid n.a. n.a. No No No No No No PMDBD2000748 D-Proline Therapeutic Substance Investigational Drug 344-25-2 DB02853 n.a. n.a. D0TE9B 8988 8640 n.a. "D-proline, 344-25-2, (R)-pyrrolidine-2-carboxylic acid, (2R)-pyrrolidine-2-carboxylic acid, H-D-Pro-OH, D-(+)-Proline, D-Prolin, R-Proline, D-Pro, (R)-2-CARBOXYPYRROLIDINE, (R)-PROLINE, MFCD00064317, CHEBI:16313, L01Q4LGZ5L, 1331908-17-8, (2R)-pyrrolidine-2-carboxylate, d-2-pyrrolidinecarboxylic acid, H-Pros-OH, H-DPro-OH, EINECS 206-452-7, (D)-proline, D-D-Pro-OH, starbld0002768, R)-2-Carboxypyrrolidine, PROLINE, D-, UNII-L01Q4LGZ5L, NCIStruc1_001918, NCIStruc2_000132, SCHEMBL65555, (+)-(R)-PROLINE, CHEMBL80257, (R)-pyrrolidine-2-carboxylate, GTPL4676, DTXSID70883367, pyrrolidine-2-(R)-carboxylic acid, NCI97923, BDBM50357224, CCG-37784, s6016, AKOS015923206, D-Proline, ReagentPlus(R), >=99%, CS-W020557, DB02853, NCGC00163339-01, NCGC00163339-02, pyrrolidine-2-carboxylic acid;D-PROLINE, AC-24083, HY-75087, TS-01590, D-Proline, Vetec(TM) reagent grade, 98%, AM20090537, NS00079485, P0994, EN300-60161, A15501, C00763, P-7200, J-300218, Q20035962, F1905-6974, Z933632584, D2735F99-0D23-48C4-B266-5C7A7DA319A4" C5H9NO2 ONIBWKKTOPOVIA-SCSAIBSYSA-N (2R)-pyrrolidine-2-carboxylic acid n.a. n.a. No No No No No No PMDBD2000749 D-tert-Leucine n.a. n.a. n.a. n.a. n.a. n.a. n.a. 6950340 n.a. n.a. D-tert-Leucine, 26782-71-8, h-d-tle-oh, (2R)-2-amino-3,3-dimethylbutanoic acid, D-Valine, 3-methyl-, (r)-2-amino-3,3-dimethylbutanoic acid, D-a-tert-Butyl-Gly-OH, 3-methyl-d-valine, (r)-tert-butylglycine, (R)-2-Amino-3,3-dimethylbutyric acid, P3L3QZA16M, MFCD00004265, (2R)-2-amino-3,3-dimethyl-butanoic acid, d-t-leucine, 2-Amino-3,3-dimethylbutanoic acid #, D-t-Butylglycine, (r)-tert-leucine, D-a-tert-Butylglycine, D-tert-Leucine, 98%, UNII-P3L3QZA16M, SCHEMBL1183636, DTXSID30426193, 2(R)-amino-3,3-dimethylbutyric acid, AKOS006240276, CS-W001954, HY-W001954, (2R)-2-amino-3,3-dimethylbutyric acid, AC-24096, AS-12227, AM20090329, L0157, NS00074132, EN300-72303, Q27466064 C6H13NO2 NPDBDJFLKKQMCM-BYPYZUCNSA-N (2R)-2-amino-3,3-dimethylbutanoic acid n.a. n.a. No No No No No No PMDBD2000750 D-Tryptophan Therapeutic Substance Investigational Drug 153-94-6 DB03225 n.a. n.a. D08CBB 9060 8707 n.a. D-Tryptophan, 153-94-6, H-D-Trp-OH, (R)-Tryptophan, D(+)-Tryptophan, D-TRYPTOPHANE, (+)-Tryptophan, (2R)-2-amino-3-(1H-indol-3-yl)propanoic acid, D-Trytophane, Tryptophan, D-, H-D-Typ-OH, D-Trp, MFCD00005647, (R)-2-Amino-3-(3-indolyl)propionic acid, 7NS97N9H1G, CHEMBL292303, DTR, DTXSID0046989, CHEBI:16296, (R)-(+)-2-Amino-3-(3-indolyl)propionic Acid, D-Tryptophan-d5, D-alpha-Amino-3-indolepropionic acid, NSC-97942, NCGC00093372-02, D-(+)-Tryptophan, DTXCID8026989, CAS-153-94-6, D-Trp-OH, (R)-(+)-tryptophan, EINECS 205-819-9, NSC 97942, (2R)-2-amino-3-(1H-indol-3-yl)propanoate, UNII-7NS97N9H1G, delta-trytophane, D-Trypophan, delta-tryptophane, DTrp, HDTrpOH, H-delta-TRP-oh, 1202359-57-6, delta-(+)-tryptophan, (R)-2-amino-3-(1H-indol-3-yl)propanoic acid, SCHEMBL92677, MLS000069477, GTPL5798, BCP16808, NSC97942, Tox21_111205, Tox21_301300, 2-amino-3-indol-3-ylpropanoic acid, BDBM50043799, s6253, AKOS001426593, AKOS015924228, D-Tryptophan, >=98.0% (HPLC), Tox21_111205_1, CCG-231118, CS-W013195, DB03225, HY-W012479, delta-alpha-Amino-3-indolepropionic acid, NCGC00093372-03, NCGC00094437-05, NCGC00257553-01, AC-24064, CS-11234, SMR000059103, AM20050158, NS00068209, T0539, EN300-53346, C00525, T-8300, J-300262, Q-101644, Q27077125, Q27115085, AFA369F6-7A19-42E1-B9E9-0156A2BCE50B, Z256709618, InChI=1/C11H12N2O2/c12-9(11(14)15)5-7-6-13-10-4-2-1-3-8(7)10/h1-4,6,9,13H,5,12H2,(H,14,15)/t9-/m1/s C11H12N2O2 QIVBCDIJIAJPQS-SECBINFHSA-N (2R)-2-amino-3-(1H-indol-3-yl)propanoic acid n.a. n.a. No No No No No No PMDBD2000751 D-Tyrosine Therapeutic Substance n.a. 556-02-5 DB03839 n.a. n.a. n.a. 71098 64252 n.a. "D-tyrosine, 556-02-5, H-D-Tyr-OH, (R)-2-amino-3-(4-hydroxyphenyl)propanoic acid, D-Tyr, (2R)-2-amino-3-(4-hydroxyphenyl)propanoic acid, 3-(4-Hydroxyphenyl)-D-alanine, D-Tyrosin, CHEBI:28479, (R)-TYROSINE, MFCD00063073, WQ5G9JQ7GC, CHEMBL1076637, (R)-3-(p-Hydroxyphenyl)alanine, (R)-2-Amino-3-(p-hydroxyphenyl)propionic acid, DTY, D-(+)-Tyrosine, d-p-Tyrosine, DTyr, Tyrosine, d-, (D)-Tyrosine, EINECS 209-112-6, UNII-WQ5G9JQ7GC, SCHEMBL20787, D-4-HYDROXYPHENYLALANINE, DTXSID50883441, CS-D1377, HY-Y0444, D-Tyrosine, ReagentPlus(R), 99%, BDBM50463198, AKOS015854094, AC-8668, AM82303, DB03839, NCGC00142608-01, NCGC00142608-02, AS-11715, D-Tyrosine, puriss., >=99.0% (NT), D-Tyrosine, Vetec(TM) reagent grade, 99%, NS00080446, T1141, EN300-61693, C06420, M02937, T-9000, (R)-2-Amino-3-(4-hydroxyphenyl)propionic acid, A830718, J-300275, Q16082044, Q27115118, Z969739284, (2R)-2-amino-3-(4-hydroxyphenyl)propanoic acid;D-Tyrosine, 1168FFD2-192C-4DB4-9161-4BF71A6C98C9, (2R)-2-Amino-3-(4-hydroxyphenyl)propanoic acid; (R)-Tyrosine; D-p-Tyrosine" C9H11NO3 OUYCCCASQSFEME-MRVPVSSYSA-N (2R)-2-amino-3-(4-hydroxyphenyl)propanoic acid n.a. n.a. No No No No No No PMDBD2000752 Econazole Therapeutic Substance Approved Drug 27220-47-9 DB01127 PA164746010 D03936 D0EV8E 3198 3086 n.a. econazole, 27220-47-9, Ecostatin, Econazolum, Econazol, (+-)-Econazole, 1-[2-[(4-chlorophenyl)methoxy]-2-(2,4-dichlorophenyl)ethyl]imidazole, Spectazole, UNII-6Z1Y2V4A7M, NSC 187789, NSC-187789, 6Z1Y2V4A7M, CCRIS 9032, Econazol [INN-Spanish], EINECS 248-341-6, BRN 0964150, (+/-)-ECONAZOLE, 1-(2-((4-Chlorobenzyl)oxy)-2-(2,4-dichlorophenyl)ethyl)-1H-imidazole, 1H-Imidazole, 1-(2-((4-chlorophenyl)methoxy)-2-(2,4-dichlorophenyl)ethyl)-, DTXSID2029872, CHEBI:82873, SQ 13050, 1-[2-[(4-Chlorophenyl)methoxy]-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole, 1-{2-[(4-chlorophenyl)methoxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole, NSC187789, (+/-)-Econazol, 1-(2,4-Dichloro-beta-((p-chlorobenzyl)oxy)phenethyl)imidazole, Econazol (INN-Spanish), 1-{2-[(4-chlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole, ECONAZOLE (MART.), ECONAZOLE [MART.], ECONAZOLE (EP MONOGRAPH), ECONAZOLE [EP MONOGRAPH], Ekonazole, Imidazole, 1,2,4-dichloro-beta-(p-chlorobenzyl)oxyphenethyl-, 1-(2,4-Dichloro-.beta.-((p-chlorobenzyl)oxy)phenethyl)imidazole, 1-[2,4-Dichloro-.beta.-[(p-chlorobenzyl)oxy]phenethyl]imidazole, R-14827, 1-{2-(4-chlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole, Imidazole, 1-(2,4-dichloro-beta-((p-chlorobenzyl)oxy)phenethyl)-, 1H-Imidazole, 1-[2-[(4-chlorophenyl)methoxy]-2-(2,4-dichlorophenyl)ethyl]-, Econazole [USAN], MICONAZOLE IMPURITY B (EP IMPURITY), MICONAZOLE IMPURITY B [EP IMPURITY], Econazole (USAN/INN), NCGC00018258-03, econazolo, Econazole [USAN:INN:BAN], rac-econazole, 1-(2-(4-chlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl)-1H-imidazole, 1-[2-(4-Chlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole, (RS)-econazole, ()-Econazol, Spectrum_001223, ECONAZOLE [INN], ECONAZOLE [MI], (.+/-.)-Econazole, Prestwick0_000304, Prestwick1_000304, Prestwick2_000304, Prestwick3_000304, Spectrum2_001439, Spectrum3_001467, Spectrum4_000446, Spectrum5_001033, ECONAZOLE [VANDF], CHEMBL808, ECONAZOLE [WHO-DD], SCHEMBL34498, BSPBio_000268, BSPBio_002993, KBioGR_000832, KBioSS_001703, cid_68589, DivK1c_000113, SPBio_001578, SPBio_002487, BPBio1_000296, CHEBI:4754, DTXCID409872, GTPL2446, BDBM31773, KBio1_000113, KBio2_001703, KBio2_004271, KBio2_006839, KBio3_002493, D01AC03, G01AF05, NINDS_000113, HY-B0885, MFCD00800993, s5492, AKOS015889868, ( inverted exclamation markA)-Econazol, 1H-Imidazole,4-dichlorophenyl)ethyl]-, CCG-268426, DB01127, IDI1_000113, NCGC00018258-02, NCGC00018258-05, NCGC00018258-06, NCGC00018258-07, NCGC00018258-09, AS-13862, MFCD00058160 (.HNO3), NCI60_001564, NCI60_001947, SBI-0051682.P002, AB00053611, NS00005601, C08068, D03936, F14858, AB00053611-20, AB00053611_21, AB00053611_22, EN300-7371061, 68797-31-9 (.HNO3), A818963, Q417141, MICONAZOLE NITRATE IMPURITY B [EP IMPURITY], W-107123, BRD-A51820102-008-05-7, BRD-A51820102-008-16-4, 1-[2,4-Dichloro-b-[(p-chlorobenzyl)oxy]phenethyl]imidazole, Imidazole,4-dichloro-.beta.-[(p-chlorobenzyl)oxy]phenethyl]-, 1-{2-(4-chlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl}imidazole, 1-[2-(4-chloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole, Imidazole, 1-(2,4-dichloro-.beta.-((p-chlorobenzyl)oxy)phenethyl)-, rac-1-(2-(4-chlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl)-1H-imidazole, 1-[(2RS)-2-[(4-Chlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole C18H15Cl3N2O LEZWWPYKPKIXLL-UHFFFAOYSA-N 1-[2-[(4-chlorophenyl)methoxy]-2-(2,4-dichlorophenyl)ethyl]imidazole Merz Pharmaceuticals Llc Antifungal Agents No No No No No No PMDBD2000753 Elemental silver n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000754 Elliptophenone A n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000755 Emodin Therapeutic Substance Terminated 518-82-1 DB07715 n.a. n.a. D0U7OU 3220 3107 NPC254847 "emodin, 518-82-1, Emodol, Frangula emodin, Schuttgelb, 1,3,8-trihydroxy-6-methylanthracene-9,10-dione, Rheum emodin, Archin, Frangulic acid, 3-Methyl-1,6,8-trihydroxyanthraquinone, Persian Berry Lake, 6-Methyl-1,3,8-trihydroxyanthraquinone, C.I. Natural Yellow 14, 1,3,8-Trihydroxy-6-methyl-9,10-anthraquinone, 1,3,8-Trihydroxy-6-methyl-9,10-anthracenedione, 9,10-Anthracenedione, 1,3,8-trihydroxy-6-methyl-, 1,3,8-Trihydroxy-6-methylanthraquinone, 4,5,7-Trihydroxy-2-methylanthraquinone, C.I. 75440, Alatinone, CCRIS 3528, NSC 408120, NSC 622947, Rheum-emodin, Frangulinic acid, HSDB 7093, UNII-KA46RNI6HN, KA46RNI6HN, Anthraquinone, 1,3,8-trihydroxy-6-methyl-, EINECS 208-258-8, NSC408120, BRN 1888141, DTXSID5025231, CHEBI:42223, AI3-38286, Anthraquinone, 6-methyl-1,3,8-trihydroxy-, MFCD00001207, 1,3,8-Trihydroxy-6-methylanthra-9,10-quinone, NSC-408120, NSC-622947, CHEMBL289277, DTXCID205231, NSC622947, 1,3,8-trihydroxy-6-methyl-9,10-dihydroanthracene-9,10-dione, EMODIN (USP-RS), EMODIN [USP-RS], 6-Methyl-1,3,8-trihydroxy-9,10-anthracenedione, EMO, rheum emodium, 1,8-Trihydroxy-6-methylanthraquinone, Emodin, Rheum, Emodin, Frangula, CAS-518-82-1, SMR000326798, SR-01000075615, Emdoin, Frangula-emodin, 3bqc, Emodin,(S), Spectrum_001954, 1f0q, 3ed0, SpecPlus_000332, EMODIN [HSDB], EMODIN [INCI], 1,3,8-tri-hydroxy-6-methyl-anthra-quinone, Spectrum2_000895, Spectrum3_000742, Spectrum4_001757, Spectrum5_000614, EMODIN [MI], Lopac-E-7881, Emodin, analytical standard, NCIMech_000049, Lopac0_000552, BSPBio_002324, KBioGR_002234, KBioSS_002508, 1,3,8-trihydroxy-6-methyl-anthracene-9,10-dione, MLS000563068, MLS001066370, MLS004257392, MLS006011712, DivK1c_006428, SCHEMBL177689, SPBio_000710, MEGxp0_000460, ACon1_001939, BDBM11318, KBio1_001372, KBio2_002500, KBio2_005068, KBio2_007636, KBio3_001544, Emodin - CAS 518-82-1, HMS2230K22, HMS3261P05, HMS3373B16, HMS3655H22, BCP18372, EX-A6778, TNP00318, 9, 1,3,8-trihydroxy-6-methyl-, Tox21_202999, Tox21_303218, Tox21_500552, CCG-35263, LMPK13040008, s2295, 3-Methyl-1,8-trihydroxyanthraquinone, 4,7-Trihydroxy-2-methylanthraquinone, AKOS003348641, AC-1004, CS-1412, DB07715, KS-5189, LP00552, SDCCGSBI-0050535.P004, Anthraquinone,3,8-trihydroxy-6-methyl-, SMP2_000211, 3-Methyl-1,6,8-trihydroxy-antraquinone, NCGC00015420-01, NCGC00015420-02, NCGC00015420-03, NCGC00015420-04, NCGC00015420-05, NCGC00015420-06, NCGC00015420-07, NCGC00015420-08, NCGC00015420-09, NCGC00015420-12, NCGC00015420-22, NCGC00091540-01, NCGC00091540-02, NCGC00091540-03, NCGC00091540-04, NCGC00091540-05, NCGC00257090-01, NCGC00260544-01, NCGC00261237-01, 1,3,8-Trihydroxy-6-methyl-anthraquinone, HY-14393, NCI60_003906, SY050737, 1ST000574, 6-methyl-1,3,8-tri-hydroxy-anthra-quinone, E0500, EU-0100552, NS00014575, SW219906-1, 1,8-Trihydroxy-6-methyl-9,10-anthraquinone, Emodin, from Frangula bark, >=90% (HPLC), E 7881, EN300-179559, K00056, Emodin; 6-Methyl-1,3,8-trihydroxyanthraquinone, 1,3, 8-Trihydroxy-6-methyl-9,10-anthraquinone, 1,3,8-Trihydroxy-6-methylanthra-9,10-quinone #, A828825, Q-100581, Q4348178, SR-01000075615-1, SR-01000075615-6, BRD-K58685305-001-03-0, 1,3,8-Trihydroxy-6-methyl-9,10-anthracenedione, 9CI, 9,10-Anthracenedione, 1,3,8-trihydroxy-6-methyl- (9CI), Emodin, United States Pharmacopeia (USP) Reference Standard, 1,3,8-trihydroxy-6-methyl-anthracene-9,10-dione;3-METHYL-1,6,8-TRIHYDROXYANTHRAQUINONE" C15H10O5 RHMXXJGYXNZAPX-UHFFFAOYSA-N 1,3,8-trihydroxy-6-methylanthracene-9,10-dione n.a. n.a. No No No No No No PMDBD2000756 Enfuvirtide Therapeutic Substance n.a. 159519-65-0 DB00109 PA164744517 n.a. n.a. 16130199 16743716 n.a. Enfuvirtide, Pentafuside, Fuzeon, DP178, CHEBI:608828, T-20, DP-178, T 20 (peptide), Dp 178, UNII-19OWO1T3ZE, 19OWO1T3ZE, T 20, T20, HSDB 7341, DTXSID20166672, Ac-YTSLIHSLIEESQNQQEKNEQELLELDKWASLWNWF-NH2, AcTyrThrSerLeuIleHisSerLeuIleGluGluSerGlnAsnGlnGlnGluLysAsnGluGlnGluLeuLeuGluLeuAspLysTrpAlaSerLeuTrpAsnTrpPheNH2, enfuvirtidum, Enfuvirtida, Fuzeon (TM), Fuzeon T-20, Enfuvirtide+PRO 140, Enfuvirtide + T1144, TNX-355 & Efuvirtide, ENFUVIRTIDE (MART.), T20-LAI, Enfuvirtide [USAN:INN:BAN], CHEMBL525076, DTXCID8089163, J05AX07, GNA & G-20, HHA & T-20, PENTAFUSIDE (TRIVIAL NAME), BDBM50023615, T-20+PRO 140, AKOS040763974, GP41 127-162 AA, 5A8 & T-20, R-698, T20 + T1144, Ac-YTSLIHSLIEESQNQQEKNEQELLELDKWASLWNWF-NH2 & PRO 140 (Anti-CCR5 monoclonal antibody), Humanized monoclonal antibody to CD4 & Ac-YTSLIHSLIEESQNQQEKNEQELLELDKWASLWNWF-NH2, Ac-Tyr-Thr-Ser-Leu-Ile-His-Ser-Leu-Ile-Glu-Glu-Ser-Gln-Asn-Gln-Gln-Glu-Lys-Asn-Glu-Gln-Glu-Leu-Leu-Glu-Leu-Asp-Lys-Trp-Ala-Ser-Leu-Trp-Asn-Trp-Phe-NH2 & Galanthus nivalis agglutinin (GNA), Ac-Tyr-Thr-Ser-Leu-Ile-His-Ser-Leu-Ile-Glu-Glu-Ser-Gln-Asn-Gln-Gln-Glu-Lys-Asn-Glu-Gln-Glu-Leu-Leu-Glu-Leu-Asp-Lys-Trp-Ala-Ser-Leu-Trp-Asn-Trp-Phe-NH2 & Hippeastrum hybrid agglutinin( HHA), Acetyl-Tyr-Thr-Ser-Leu-Ile-His-Ser-Leu-Ile-Glu-Glu-Ser-Gln-Asn-Gln-Gln-Glu-Lys-Asn-Glu-Gln-Glu-Leu-Leu-Glu-Leu-Asp-Lys-Trp-Ala-Ser-Leu-Trp-Asn-Trp-Phe-NH2, T-20-LAI [Ac-Tyr-Thr-Ser-Leu-Ile-His-Ser-Leu-Ile-Glu-Glu-Ser-Gln-Asn-Gln-Gln-Glu-Lys-Asn-Glu-Gln-Glu-Leu-Leu-Glu-Leu-Asp-Lys-Trp-Ala-Ser-Leu-Trp-Asn-Trp-Phe-NH2] C204H301N51O64 PEASPLKKXBYDKL-FXEVSJAOSA-N (4S)-4-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-acetamido-3-(4-hydroxyphenyl)propanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]-3-methylpentanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]-3-methylpentanoyl]amino]-4-carboxybutanoyl]amino]-4-carboxybutanoyl]amino]-3-hydroxypropanoyl]amino]-5-amino-5-oxopentanoyl]amino]-4-amino-4-oxobutanoyl]amino]-5-amino-5-oxopentanoyl]amino]-5-amino-5-oxopentanoyl]amino]-5-[[(2S)-6-amino-1-[[(2S)-4-amino-1-[[(2S)-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-4-amino-1-[[(2S)-1-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-1-oxohexan-2-yl]amino]-5-oxopentanoic acid n.a. n.a. No No No No No No PMDBD2000757 Ephedrine Therapeutic Substance Approved Drug 299-42-3 DB01364 PA449466 D00124 D0LG8E 9294 n.a. NPC226778 Ephedrine, l-Ephedrine, (-)-Ephedrine, 299-42-3, Ephedrin, L(-)-Ephedrine, Lexofedrin, Ephedrol, Mandrin, Sanedrine, Fedrin, I-Sedrin, 1-Sedrin, Ephedrine l-form, (1R,2S)-2-(methylamino)-1-phenylpropan-1-ol, Xenadrine, Norephedrine, N-methyl-, Ephedrine, anhydrous, Ephedrital, Ephedrosan, Ephedrotal, Ephedsol, Ephendronal, Ephoxamin, Kratedyn, Manadrin, Vencipon, Efedrin, Zephrol, Nasol, Ephedrine, L-(-)-, HSDB 3072, l-2-Methylamino-1-phenylpropanol, l-alpha-(1-Methylaminoethyl)benzyl alcohol, NSC 8971, EINECS 206-080-5, racephedrine, UNII-GN83C131XS, l-Erythro-2-(methylamino)-1-phenylpropan-1-ol, NSC 170951, Ephedrinum, anhydrous, GN83C131XS, CHEBI:15407, AI3-02761, (-)-alpha-(1-Methylaminoethyl)benzyl alcohol, NSC-8971, NSC-170951, (1R,2S)-1-phenyl-1-hydroxy-2-methylaminopropane, Biophedrin, Ephedremal, DTXSID0022985, Eciphin, Ephedral, (1R,2S)-2-methylamino-1-phenylpropan-1-ol, Benzenemethanol, alpha-(1-(methylamino)ethyl)-, (R-(R*,S*))-, EC 206-080-5, (1R,2S)-2-(methylamino)-1-phenyl-propan-1-ol, 1-Phenyl-2-methylaminopropanol, Benzenemethanol, alpha-(1-(methylamino)ethyl)-, (-)-, Sal-Phedrine, EPHEDRINE (MART.), EPHEDRINE [MART.], Ephedrine [USAN:BAN], 1-Hydroxy-2-methylamino-1-phenylpropane, EPHEDRINE (EP MONOGRAPH), EPHEDRINE [EP MONOGRAPH], EPHEDRINE (USP MONOGRAPH), EPHEDRINE [USP MONOGRAPH], (-)-Ephedrine hemisulfate, NSC8971, (L)-EPHEDRINE, (-)-(1R,2S)-Ephedrine, Ephedrine (TN), Ephedrine (USP), 1-2-Methylamino-1-phenylpropanol, Ephedrine Erythro Isomer, 2-Methylamino-1-phenyl-1-propanol, Erythro Isomer of Ephedrine, 1-Phenyl-1-hydroxy-2-methylaminopropane, Efedrina, alpha-Hydroxy-beta-methylaminopropylbenzene, 1-alpha-(1-Methylaminoethyl)benzyl alcohol, alpha-(1-(Methylamino)ethyl)benzenemethanol, NSC170951, alpha-Hydroxy-beta-methyl amine propylbenzene, 1(-)ephedrine, EPHEDRINE [MI], EPHEDRINE [HSDB], EPHEDRINE [VANDF], (1R,2S)-2-methylamino-1-phenyl-propan-1-ol, EPHEDRINE [WHO-DD], SCHEMBL4785, Lopac0_000501, GTPL556, (1r, 2s)-(-)-ephedrine, CHEMBL211456, DTXCID402985, -(1R,2S)-(-)-ephedrine, Benzenemethanol, alpha-((1S)-1-(methylamino)ethyl)-, (alphaR)-, HY-B1195, Benzenemethanol, .alpha.-[(1S)-1-(methylamino)ethyl]-, (.alpha.R)-, PDSP2_001327, PDSP2_001330, (1R,2S)-(-)-Ephedrine, 98%, AKOS016011257, Emerphed (ephedrine sulfate injection), EPHEDRINE, ANHYDROUS [WHO-IP], CCG-204592, CS-4802, DB01364, NCGC00162174-01, NCGC00162174-02, SBI-0051362.P003, EPHEDRINUM, ANHYDROUS [WHO-IP LATIN], NS00000382, (1R,2S)-2-Methylamino-1-phenyl-1-propanol, C01575, D00124, (1R*,2S*)-2-methylamino-1-phenyl-1-propanol, (1R,2S)-2-(methylamino)-1-phenyl-1-propanol, AB00375843_06, A820118, Q219626, SR-01000075166, (1R,2S)-(-)-2-Methylamino-1-phenyl-1-propanol, J-500280, SR-01000075166-1, (1R,2S)-(-)-2-(N-methylamino)-1-phenylpropan-1-ol, (1R,2S)-(-)-alpha-(1-Methylaminoethyl)benzenemethanol, (R-(R*,S*))-alpha-(1-(Methylamino)ethyl)benzenemethanol, PSEUDOEPHEDRINE HYDROCHLORIDE IMPURITY A [EP IMPURITY], BENZENEMETHANOL, .ALPHA.-(1-(METHYLAMINO)ETHYL)-, (R-(R*,S*))-, (R-(R*,S*))-.ALPHA.-(1-(METHYLAMINO)ETHYL)BENZENEMETHANOL [WHO-IP] C10H15NO KWGRBVOPPLSCSI-WPRPVWTQSA-N (1R,2S)-2-(methylamino)-1-phenylpropan-1-ol Ben Venue Laboratories Inc Central Nervous System Stimulants No No No No No No PMDBD2000758 Epicatechin gallate n.a. n.a. n.a. n.a. n.a. n.a. n.a. 107905 n.a. NPC160512 (-)-Epicatechin gallate, 1257-08-5, Epicatechin gallate, (-)-epicatechingallate, (-)-Epicatechin-3-O-gallate, L-Epicatechin gallate, epicatechin monogallate, (-)-Epicatechin-3-gallate, Teatannin, (-)-Epicatechin 3-O-gallate, ECG, Epicatechol, gallate, 3-O-Galloylepicatechin, epicatechin-3-O-gallate, (-)-cis-3,3'',4'',5,7-Pentahydroxyflavane 3-gallate, 3-Gallate(-)-Epicatechol, CHEMBL36327, [(2R,3R)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3,4-dihydro-2H-chromen-3-yl] 3,4,5-trihydroxybenzoate, CHEBI:70255, 92587OVD8Z, MFCD00075936, (2R,3R)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxychroman-3-yl 3,4,5-trihydroxybenzoate, Epicatechin-3-galloyl ester, Benzoic acid, 3,4,5-trihydroxy-, (2R,3R)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-5,7-dihydroxy-2H-1-benzopyran-3-yl ester, Epicatechin 3-gallate, epi-Catechin 3-O-gallate, epicatechin gallate, (2R-cis)-isomer, NSC 636594, UNII-92587OVD8Z, NSC636594, (2R,3R)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3,4-dihydro-2H-chromen-3-yl 3,4,5-trihydroxybenzoate, Epicatechol, 3-gallate, (-)-, NSC-636594, (-)epicatechingallate, Spectrum_000314, L-ECG, SpecPlus_000275, (-) epicatechin gallate, epicatechin-gallate-(-), Spectrum2_000165, Spectrum3_000246, Spectrum4_001540, Spectrum5_000080, epicatechin gallate (ECG), (-)-Epicatechin 3-gallate, (?)-Epicatechin 3-gallate, SCHEMBL39047, BSPBio_001632, EPICATECHOL 3-GALLATE, KBioGR_001980, KBioSS_000794, SPECTRUM210238, Benzoic acid, 3,4,5-trihydroxy-, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-5,7-dihydroxy-2H-1-benzopyran-3-yl ester, (2R-cis)-, DivK1c_006371, EPICATECHINGALLATE, L-, SPBio_000029, (-)EPICATECHIN GALLATE, MEGxp0_000810, EPICATECHIN 3-O-GALLATE, GTPL12462, KBio1_001315, KBio2_000794, KBio2_003362, KBio2_005930, KBio3_001132, DTXSID70925231, 3,4,5-Trihydroxy-benzoic acid 2-(3,4-dihydroxy-phenyl)-5,7-dihydroxy-chroman-3-yl ester, HY-N0002, BDBM50153015, CCG-38376, LMPK12020090, s3925, AKOS015965216, AC-6037, AM84365, CS-3761, SDCCGMLS-0066549.P001, (-)-cis-2-(3,4-Dihydroxyphenyl)-3,4-dihydro-1(2H)-benzopyran-3,5,7-triol 3-gallate, (-)-EPI CATECHIN-3-O-GALLATE, [(2R,3R)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-chroman-3-yl] 3,4,5-trihydroxybenzoate, NCGC00179135-01, NCGC00179135-02, 1ST40120, AS-15722, E0890, NS00094557, SR-05000002675, Q-200002, Q5382492, SR-05000002675-1, BRD-K50660797-001-01-0, BRD-K50660797-001-03-6, (-)-Epicatechin gallate, >=98% (HPLC), from green tea, Epicatechin gallate, primary pharmaceutical reference standard, rel-(2R,3R)-2-(3,4-Dihydroxyphenyl)-5,7-dihydroxychroman-3-yl 3,4,5-trihydroxybenzoate, (2R,3R)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3,4-dihydro-2H-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate, 3,4,5-Trihydroxy-benzoic acid (2R,3R)-2-(3,4-dihydroxy-phenyl)-5,7-dihydroxy-chroman-3-yl ester, Benzoic acid, 3,4,5-trihydroxy-, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-5,7- dihydroxy-2H-1-benzopyran-3-yl ester, (-)-cis- C22H18O10 LSHVYAFMTMFKBA-TZIWHRDSSA-N [(2R,3R)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3,4-dihydro-2H-chromen-3-yl] 3,4,5-trihydroxybenzoate n.a. n.a. No No No No No No PMDBD2000759 Epicatechin-3-gallate n.a. n.a. n.a. n.a. n.a. n.a. n.a. 65056 n.a. NPC114179 Epicatechin-3-gallate, (+)-epicatechin-3-O-gallate, 863-03-6, ent-Epicatechin 3-O-gallate, CHEMBL126142, CHEBI:76126, [(2S,3S)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3,4-dihydro-2H-chromen-3-yl] 3,4,5-trihydroxybenzoate, Epicatechin-3-galloyl ester, CCRIS 9285, SCHEMBL4639313, BDBM50135164, LMPK12020092, Benzoic acid, 3,4,5-trihydroxy-, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-5,7-dihydroxy-2H-1-benzopyran-3-yl ester, cis-, Q27145772, 3,6,9,12,15,18,21-Tetracosaheptaynoic Acid Methyl-d3 Ester, (2S,3S)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3,4-dihydro-2H-chromen-3-yl 3,4,5-trihydroxybenzoate, 3,4,5-Trihydroxy-benzoic acid (2S,3S)-2-(3,4-dihydroxy-phenyl)-5,7-dihydroxy-chroman-3-yl ester C22H18O10 LSHVYAFMTMFKBA-FPOVZHCZSA-N [(2S,3S)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3,4-dihydro-2H-chromen-3-yl] 3,4,5-trihydroxybenzoate n.a. n.a. No No No No No No PMDBD2000760 Epigallocatechin Therapeutic Substance n.a. 970-74-1 DB03823 n.a. n.a. n.a. 72277 65231 NPC220825 "(-)-Epigallocatechin, Epigallocatechin, 970-74-1, Epigallocatechol, L-Epigallocatechin, epi-Gallocatechin, Antiscurvy factor C2, (-)-Epigallocatechol, l-Epigallocatechol, Galloepicatechin, 3,3'',4'',5,5'',7-Flavanhexol, (-)-epi-Gallocatechin, Sunphenon EGC, Factor C2 (antiscurvy), (-)-3,3'',4'',5,5'',7-Flavanhexol, 2,3-cis-epigallocatechin, Antiscurvy factor C(sub 2), EGC, (2R,3R)-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol, CCRIS 5441, UNII-7Z197MG6QL, 7Z197MG6QL, CHEBI:42255, 1-epi-3'',4'',5,5'',7-Pentahydroxy-3-Flavan, NSC 674039, NSC-674039, CHEMBL47386, (2R,3R)-2-(3,4,5-trihydroxyphenyl)chromane-3,5,7-triol, (-)-EGC, DTXSID40891550, (-)-cis-3,3'',4'',5,5'',7-Hexahydroxyflavane, MFCD00075939, 2H-1-Benzopyran-3,5,7-triol, 3,4-dihydro-2-(3,4,5-trihydroxyphenyl)-, (2R-cis)-, 2-(3,4,5-TRIHYDROXY-PHENYL)-CHROMAN-3,5,7-TRIOL, (-)-cis-2-(3,4,5-Trihydroxyphenyl)-3,4-dihydro-1(2H)-benzopyran-3,5,7-triol, (-)EPIGALLOCATECHIN, (2R,3R)-2-(3,4,5-trihydroxyphenyl)chroman-3,5,7-triol, 2H-1-BENZOPYRAN-3,5,7-TRIOL, 3,4-DIHYDRO-2-(3,4,5-TRIHYDROXYPHENYL)-, (2R,3R)-, Teacatechin II, NSC674039, Epigallocatechin;EGC;L-Epigallocatechin, (-) epigallocatechin, epigallocatechin-(-), epigallocatechin (egc), Spectrum_000806, SpecPlus_000269, Spectrum2_000703, Spectrum3_000248, Spectrum4_000950, Spectrum5_000889, (-)-Epigallocatechin/EGC, (-)-Epigallocatechin(EGC), SCHEMBL19553, BSPBio_001636, KBioGR_001540, KBioSS_001286, SPECTRUM205113, DivK1c_006365, SPBio_000885, BCBcMAP01_000207, GTPL12461, KBio1_001309, KBio2_001286, KBio2_003854, KBio2_006422, KBio3_001136, DTXCID501030643, GLXC-13576, EGC, (-)-EPIGALLOCATECHIN, HY-N0225, (-)-Epigallocatechin from green tea, AC-394, BDBM50187665, CCG-38353, LMPK12020004, s3922, AKOS015965244, CS-3762, DB03823, DS-5807, SDCCGMLS-0066479.P001, (2R,3R)-3,4-Dihydro-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3,5,7-triol, SMP1_000114, NCGC00179131-01, NCGC00179131-02, (-)-Epigallocatechin, analytical standard, 124107-38-6, 1ST40119, NCI60_026204, (3,3'',4'',5,5'',7-Hexahydroxyflavan), E1084, NS00014558, (-)-3,5,7,3'',4'',5''-Hexahydroxylflavan, (-)-cis-3,3'',4'',5,5'',7-Hexahydroxyflavan, Epigallocatechin 1000 microg/mL in Acetonitrile, A846754, SR-05000002564, Q-200003, Q3044728, SR-05000002564-1, Q51617505, (-)-Epigallocatechin, >=95% (HPLC), from green tea, 3beta-Hydroxy-5alpha-pregnan-20-one Sulfate Pyridine Salt, C24E9F59-8F06-44E2-B2DE-FF132A8774F3, Epigallocatechin, primary pharmaceutical reference standard, rel-(2R,3R)-2-(3,4,5-Trihydroxyphenyl)chromane-3,5,7-triol, cis-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-1(2H)-benzopyran-3,5,7-triol, (-)-EPIGALLOCATECHIN(EGC) (CONSTITUENT OF POWDERED DECAFFEINATED GREEN TEA EXTRACT), (-)cis-2-(3,4,5-Trihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3,5,7-triol, 2H-1-Benzopyran-3,7-triol, 3,4-dihydro-2-(3,4,5-trihydroxyphenyl)-, (2R-cis)-, 5,7-triol,3,4-dihydro-2-(3,4,5-trihydroxyphenyl)-2h-1-benzopyran-(2r-cis, (-)-epigallocatechol;3,3?,4?,5,5?,7-flavanhexol;5,7-triol,3,4-dihydro-2-(3,4,5-trihydroxyphenyl)-2h-1-benzopyran-(2r-cis, 188819-07-0" C15H14O7 XMOCLSLCDHWDHP-IUODEOHRSA-N (2R,3R)-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol n.a. n.a. No No No No No No PMDBD2000761 Epigallocatechin Gallate Therapeutic Substance n.a. n.a. n.a. n.a. n.a. D0U2BH 65064 n.a. NPC250436 "(-)-Epigallocatechin gallate, EGCG, 989-51-5, Epigallocatechin gallate, Epigallocatechin 3-gallate, Tea catechin, Epigallocatechin-3-gallate, Teavigo, Epigallocatechin-3-monogallate, (-)-Epigallocatechin-3-o-gallate, (-)-epigallocatechin 3-gallate, PF-EGCg 90, (-)-Epigallocatechol gallate, NVP-XAA 723, CCRIS 3729, (2R,3R)-5,7-Dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl 3,4,5-trihydroxybenzoate, Catechin deriv., UNII-BQM438CTEL, BQM438CTEL, epigallocatechin-3-O-gallate, CHEBI:4806, Epigallocatechingallate, Epigallocatechin-gallate, Epigallocatechol, 3-gallate, (-)-, (2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl 3,4,5-trihydroxybenzoate, CHEMBL297453, [(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl] 3,4,5-trihydroxybenzoate, DTXSID1029889, [(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl] 3,4,5-trihydroxybenzoate, Benzoic acid, 3,4,5-trihydroxy-, (2R,3R)-3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl ester, EGCG cpd, (-)-Epigallocatechin Gallate (Standard), (2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate, Gallic acid, 3-ester with epigallocatechol, (-)-, DTXCID80567, (-)-cis-3,3'',4'',5,5'',7-Hexahydroxy-flavane-3-gallate, epigallo-catechin gallate, (-)-cis-2-(3,4,5-Trihydroxyphenyl)-3,4-dihydro-1(2H)-benzopyran-3,5,7-triol 3-gallate, Benzoic acid, 3,4,5-trihydroxy-, 3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl ester, (2R-cis)-, CAS-989-51-5, SMR000449288, SR-01000759328, (-)-EPIGALLOCATECHIN-3-O-GALLATE (USP-RS), (-)-EPIGALLOCATECHIN-3-O-GALLATE [USP-RS], L-Epigallocatechin gallate, Epigallocate, Sunphenon, EPIGALOCATECHIN GALLATE, (-)-EGCG, Epigallocic acid, Teatannin II, 2kdh, 3oob, 4awm, (-)-epigallocatechin 3-O-gallate, KDH, Epigallocatcchin Gallate, Epigallocatechol Gallate, Spectrum_000316, SpecPlus_000277, Spectrum2_000168, Spectrum3_000244, Spectrum4_001541, Spectrum5_000102, Galloyl-L-epigallocatechol, EGCG [WHO-DD], EGCG [MI], 3-O-Galloylepigallocatechin, (-)-Epigallocatechin gallat, (-)-Epigallocatehin gallate, SCHEMBL35258, BSPBio_001628, epigallocatechin-gallate-(-), KBioGR_002002, KBioSS_000796, SPECTRUM210239, cid_65064, MLS000758300, MLS001424000, DivK1c_006373, SPBio_000035, Epigallocatechin monogallate, B, GTPL7002, MEGxp0_001166, (-)-Epigallocatechin-3-gallate, ACon1_001054, KBio1_001317, KBio2_000796, KBio2_003364, KBio2_005932, KBio3_001128, HMS2051K21, HMS3649E08, 3-O-Galloyl-(-)-epigallocatechin, EPIGALLOCATECHIN 3-O-GALLATE, Tox21_201468, Tox21_303457, BDBM50070942, CCG-38378, FR-109, HY-13653R, LMPK12030005, MFCD00075940, s2250, AKOS015918182, CS-1258, DB12116, DS-9030, EPIGALLOCATECHIN GALLATE [INCI], NC00078, SDCCGMLS-0066550.P001, (-)-Epigallocatechin gallate, >=95%, (-)-Epigallocatechin-3-gallate; EGCG, NCGC00164319-01, NCGC00164319-02, NCGC00164319-03, NCGC00164319-04, NCGC00164319-06, NCGC00257243-01, NCGC00259019-01, (-)-Epigallocatechin gallate (85% (-)-epigallocatechin gallate, 10% (-)-epigallocatechin, 5% (-)- epicatechin gallate), 1ST40118, AC-34075, BP-30205, HY-13653, CS-0694875, E0694, NS00015163, SW197458-3, C09731, M01719, (-)-Epigallocatechin gallate, >=97.0% (HPLC), (-)-Epigallocatechin gallate, analytical standard, A845931, Q393339, SR-01000946601, Q-100914, SR-01000759328-5, SR-01000759328-6, SR-01000946601-1, Epigallocatechin-3-gallate 1000 microg/mL in Acetonitrile, (-)-Epigallocatechin gallate, >=80% (HPLC), from green tea, Epigallocatechin gallate, primary pharmaceutical reference standard, ((2R,3R)-2-(3,4,5-trihydroxyphenyl)-5,7-dihydroxy-chroman-3-yl) 3,4,5-trihydroxybenzoate, (-)-Epigallocatechin-3-O-gallate, United States Pharmacopeia (USP) Reference Standard, (2R,3R)-5,7-Dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl3,4,5-trihydroxybenzoate, [5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl] 2,3,4-trihydroxybenzoate, Epigallocatechin gallate, Pharmaceutical Secondary Standard; Certified Reference Material, (-)-cis-3,4-Dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-1(2H)-benzopyran-3-yl Gallate, (-)-EPIGALLOCATECHIN GALLATE (85% (-)-EPIGALLOCATECHIN GALLATE, 10% (-)-EPIGALLOCATECHIN, 5% (-)-EPICATECHIN GALLATE), (-)-EPIGALLOCATECHIN-3-O-GALLATE (EGCG) (CONSTITUENT OF POWDERED DECAFFEINATED GREEN TEA EXTRACT), (2R,3R)-5,7-Dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl-3,4,5-trihydroxybenzoate, (2R-cis)-3,4-Dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl 3,4,5-Trihydroxybenzoate, [(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl]3,4,5-trihydroxybenzoate, 2041570-28-7, 3,4,5-Trihydroxybenzoic acid (2R,3R)-3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl ester, 3,4-Dihydro-5,7-dihydroxy-2R-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3R-yl-3,4,5-trihydroxybenzoate, Benzoic acid, 3,4,5-trihydroxy-,(2R,3R)-3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl ester" C22H18O11 WMBWREPUVVBILR-WIYYLYMNSA-N [(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl] 3,4,5-trihydroxybenzoate Anagen Therapeutics Inc n.a. No No No No No No PMDBD2000762 epsilon-Polylysine n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000763 epsilon-viniferin n.a. n.a. n.a. n.a. n.a. n.a. n.a. 5281728 n.a. NPC15109 Epsilon-viniferin, 62218-08-0, CHEBI:10556, 0K8Z2K6Y7O, CHEMBL1224875, epsilon-viniferine, (-)-.epsilon.-Viniferin, AC1NQYZ4, (-)-Trans-epsilon-viniferin, -iniferin, Resveratrol dimer, ??-?Viniferin, (-)-epsilon-Viniferin, W2075, .EPSILON.-VINIFERIN, VINIFERIN, EPSILON-, SureCN3041632, UNII-0K8Z2K6Y7O, SCHEMBL3041632, epsilon-Viniferin , HPLC Grade, (E)-.EPSILON.-VINIFERIN, 5-{(2R,3R)-6-hydroxy-2-(4-hydroxyphenyl)-4-[(E)-2-(4-hydroxyphenyl)ethenyl]-2,3-dihydro-1-benzofuran-3-yl}benzene-1,3-diol, HY-N3841, BDBM50531887, MFCD12964987, AKOS040733117, 5-(2,3-Dihydro-6-hydroxy-2(4-hydroxyphenyl)4-(2-(4-hydroxyphenyl)ethenyl)-3-benzofuranyl)-1,3-benzenediol, MS-28265, CS-0024314, G13814, Q5383943, 1,3-BENZENEDIOL, 5-((2R,3R)-2,3-DIHYDRO-6-HYDROXY-2-(4-HYDROXYPHENYL)-4-((1E)-2-(4-HYDROXYPHENYL)ETHENYL)-3-BENZOFURANYL)-, 1,3-Benzenediol, 5-(2,3-dihydro-6-hydroxy-2(4-hydroxyphenyl)4-(2-(4-hydroxyphenyl)ethenyl)-3-benzofuranyl)-, 1,3-BENZENEDIOL, 5-(2,3-DIHYDRO-6-HYDROXY-2-(4-HYDROXYPHENYL)-4-(2-(4-HYDROXYPHENYL)ETHENYL)-3-BENZOFURANYL)-, (2R-(2.ALPHA.,3.BETA.,4(E)))-, 5-((2R,3R)-2,3-DIHYDRO-6-HYDROXY-2-(4-HYDROXYPHENYL)-4-((1E)-2-(4-HYDROXYPHENYL)ETHENYL)-3-BENZOFURANYL)-1,3-BENZENEDIOL, 5-((2R,3R)-6-Hydroxy-2-(4-hydroxyphenyl)-4-((E)-4-hydroxystyryl)-2,3-dihydrobenzofuran-3-yl)benzene-1,3-diol, 5-[(2R,3R)-6-hydroxy-2-(4-hydroxyphenyl)-4-[(E)-2-(4-hydroxyphenyl)vinyl]-2,3-dihydrobenzofuran-3-yl]benzene-1,3-diol C28H22O6 FQWLMRXWKZGLFI-YVYUXZJTSA-N 5-[(2R,3R)-6-hydroxy-2-(4-hydroxyphenyl)-4-[(E)-2-(4-hydroxyphenyl)ethenyl]-2,3-dihydro-1-benzofuran-3-yl]benzene-1,3-diol n.a. n.a. No No No No No No PMDBD2000764 Erythritol Therapeutic Substance Phase 2/3 149-32-6 DB04481 n.a. n.a. D00HGF 222285 192963 NPC33415 "ERYTHRITOL, meso-Erythritol, 149-32-6, Phycitol, Erythrit, Mesoerythritol, Phycite, Erythrite, Erythrol, L-Erythritol, (2R,3S)-butane-1,2,3,4-tetrol, Antierythrite, erythro-tetritol, 1,2,3,4-Butanetetrol, (2R,3S)-rel-, Butanetetrol, Erythroglucin, Paycite, C*Eridex, 1,2,3,4-Butanetetrol, i-Erythritol, Tetrahydroxybutane, (2R,3S)-rel-Butane-1,2,3,4-tetraol, CHEBI:17113, NIK 242, Cargill Zerose 16957, Erythritol, meso-, Erythritol [NF], UNII-RA96B954X6, CCRIS 7901, 1,2,3,4-Butanetetrol, (R*,S*)-, DTXSID6043919, HSDB 7968, meso-1,2,3,4-Tetrahydroxybutane, RA96B954X6, NSC 8099, NSC-8099, EINECS 205-737-3, MFCD00004710, (2S,3R)-butane-1,2,3,4-tetrol, ZEROSE TM 16957, INS NO.968, 10030-58-7, DTXCID4023919, FEMA NO. 4819, INS-968, NSC8099, Erythritol (NF), F 8015, Erythrol (VAN), 1,2,3,4-Butanetetrol, (theta,S)-, rel-(2R,3S)-butane-1,2,3,4-tetraol, E-968, ERYTHRITOL (MART.), ERYTHRITOL [MART.], BUTANE-1,2,3,4-TETROL, (2R,3S)-, ERYTHRITOL (USP-RS), ERYTHRITOL [USP-RS], BUTANE 1,2,3,4-TETROL (MESO-ERYTHRITOL), Lichen sugar, ERYTHRITOL (EP IMPURITY), ERYTHRITOL [EP IMPURITY], ERYTHRITOL (EP MONOGRAPH), ERYTHRITOL [EP MONOGRAPH], C4H10O4, MRY, SMR000112220, Erythritol,meso-erythritol, meso-Eythritol, L-(-)-Threitol, (2r,3s)-butane-1,2,3,4-tetraol, D-ERYTHRITOL, (2R,3S)-rel-1,2,3,4-Butanetetrol, ERYTHRITOL [MI], ERYTHRITOL [FCC], ERYTHRITOL [INCI], WLN: Q1YQYQ1Q, ERYTHRITOL [VANDF], 1,3,4-Tetrahydroxybutane, Epitope ID:114707, meso-Erythritol, >=99%, SCHEMBL17062, MLS001332365, MLS001332366, CHEMBL349605, HMS2270M08, Pharmakon1600-01301025, meso-Erythritol, analytical standard, Tox21_200564, NSC760400, s4224, 1,3,4-Butanetetrol, (R*,S*)-, AKOS006339851, AM83963, CCG-266079, DB04481, DS-5851, NSC-760400, NCGC00247033-01, NCGC00258118-01, CAS-149-32-6, E968, E0021, SW219107-1, C00503, D08915, E70403, WURCS=2.0/1,1,0/[h22h]/1/, EN300-1273040, Q421873, F0001-2636, Z1203161930, BDF1567C-B08B-425A-B87F-15FF46328423, Erythritol, European Pharmacopoeia (EP) Reference Standard, Erythritol, United States Pharmacopeia (USP) Reference Standard, Erythritol, Pharmaceutical Secondary Standard; Certified Reference Material" C4H10O4 UNXHWFMMPAWVPI-ZXZARUISSA-N (2S,3R)-butane-1,2,3,4-tetrol n.a. n.a. No No No No No No PMDBD2000765 Esculentin n.a. n.a. n.a. n.a. n.a. n.a. n.a. 188404 n.a. n.a. Esculentin Steroid, Esculentin, 131889-89-9, 1-[3-[5-[5-(3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl)oxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-8,11,12,14,16-pentahydroxy-10,13-dimethyl-1,2,3,4,7,9,11,12,15,17-decahydrocyclopenta[a]phenanthren-16-yl]ethanone, DTXSID50927379, 16-acetyl-8,11,12,14,16-pentahydroxyandrost-5-en-3-yl 6-deoxy-3-o-methylhexopyranosyl-(1->4)-2,6-dideoxy-3-o-methylhexopyranosyl-(1->4)-2,6-dideoxy-3-o-methylhexopyranoside, A809397, 1-[3-[[5-[[5-[(3,5-dihydroxy-4-methoxy-6-methyl-2-oxanyl)oxy]-4-methoxy-6-methyl-2-oxanyl]oxy]-4-methoxy-6-methyl-2-oxanyl]oxy]-8,11,12,14,16-pentahydroxy-10,13-dimethyl-1,2,3,4,7,9,11,12,15,17-decahydrocyclopenta[a]phenanthren-16-yl]ethanone, 1-[3-[4-methoxy-5-[4-methoxy-5-[4-methoxy-6-methyl-3,5-bis(oxidanyl)oxan-2-yl]oxy-6-methyl-oxan-2-yl]oxy-6-methyl-oxan-2-yl]oxy-10,13-dimethyl-8,11,12,14,16-pentakis(oxidanyl)-1,2,3,4,7,9,11,12,15,17-decahydrocyclopenta[a]phenanthren-16-yl]ethanone, Pregn-5-en-20-one, 3-((O-6-deoxy-3-O-methyl-beta-D-glucopyranosyl-(1-4)-O-2,6-dideoxy-3-O-methyl-beta-D-ribo-hexopyranosyl-(1-4)-2,6-dideoxy-3-O-methyl-beta-D-arabino-hexopyranosyl)oxy)-8,11,12,14,17-pentahydroxy-, (3beta,11alpha,12beta,14beta,17alpha)- C42H68O17 DPMVYTYRMGJDQQ-UHFFFAOYSA-N 1-[3-[5-[5-(3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl)oxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-8,11,12,14,16-pentahydroxy-10,13-dimethyl-1,2,3,4,7,9,11,12,15,17-decahydrocyclopenta[a]phenanthren-16-yl]ethanone n.a. n.a. No No No No No No PMDBD2000766 Esculetin Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D0YZ5G 5281416 n.a. NPC137949 Esculetin, 305-01-1, 6,7-DIHYDROXYCOUMARIN, Aesculetin, 6,7-Dihydroxy-2H-chromen-2-one, Cichorigenin, Esculetol, Cichoriin aglucon, Esculatin, Esculin aglucon, Esculin aglycon, Cichoriin aglycon, 2H-1-Benzopyran-2-one, 6,7-dihydroxy-, Asculetine, 6,7-dihydroxychromen-2-one, 6,7-Dihydroxy-2H-1-benzopyran-2-one, 6,7-Dihydroxy-2-benzopyrone, 91753-33-2, Coumarin, 6,7-dihydroxy-, NSC 26428, 6,7-bis(oxidanyl)chromen-2-one, 2,6-Dihydroxy-7H-chromen-7-one, MFCD00006874, MLS000069479, CHEMBL244743, SM2XD6V944, CHEBI:490095, 6,7-dihydroxy-1-benzopyran-2-one, NSC26428, NSC-26428, SMR000059055, esculetine, CCRIS 7065, 6,7-Dihydroxycounmarin, EINECS 206-161-5, BRN 0152788, UNII-SM2XD6V944, Esculetol), Aesculetin ,(S), Cichorigenin|Aesculetin, Spectrum_001166, Aesculetin (cichorigenin, 6,7-dihydroxy-coumarin, SpecPlus_000334, ESCULETIN [MI], ESCULETIN [INCI], Prestwick0_000940, Prestwick1_000940, Prestwick2_000940, Prestwick3_000940, Spectrum2_000586, Spectrum3_000752, Spectrum4_001886, Spectrum5_000512, bmse000986, Oprea1_719746, SCHEMBL24641, 6,7-Dihydroxy-2-chromenone, BSPBio_000880, BSPBio_002364, KBioGR_002416, KBioSS_001646, 5-18-03-00202 (Beilstein Handbook Reference), 6,7-Dihydroxycoumarin, 8CI, DivK1c_006430, Esculetin, analytical standard, SPECTRUM1500899, SPBio_000432, SPBio_003049, 6,7-Dihydroxycoumarin, 98%, BPBio1_000968, GTPL5180, DTXSID3075383, BDBM34571, cid_5281416, KBio1_001374, KBio2_001646, KBio2_004214, KBio2_006782, KBio3_001584, DTXSID801293090, HMS1570L22, HMS1921M14, HMS2097L22, HMS2233G24, HMS3373K09, KUC108669N, 6,7-Dihydroxycoumarin (Esculetin), AMY25634, EX-A6796, HY-N0284, Coumarin, 6,7-dihydroxy- Esculetin, CCG-38509, s4711, 6,7-Dihydroxy-2H-chromen-2-one #, AKOS000276955, Esculetin [Matrix for MALDI-TOF/MS], SDCCGMLS-0066669.P001, 2,6-Dihydroxy-7H-1-benzopyran-7-one, SMP2_000093, NCGC00016425-01, NCGC00016425-02, NCGC00016425-03, NCGC00016425-04, NCGC00016425-05, NCGC00016425-06, NCGC00094873-01, NCGC00094873-02, AC-18400, AC-34573, AS-11863, CAS-305-01-1, KSC-11-243-1, NCI60_002119, SY036794, 1ST157072, AB00489955, CS-0008780, E0386, E1287, NS00004806, C09263, E-3400, E-3401, O11524, 2H-1-Benzopyran-2-one, 6,7-dihydroxy- (9CI), A820407, SR-01000721907, Q3058018, SR-01000721907-2, BRD-K58149231-001-06-9, BRD-K58149231-001-10-1, B0005-464319, Esculetin, European Pharmacopoeia (EP) Reference Standard, InChI=1/C9H6O4/c10-6-3-5-1-2-9(12)13-8(5)4-7(6)11/h1-4,10-11, HFC C9H6O4 ILEDWLMCKZNDJK-UHFFFAOYSA-N 6,7-dihydroxychromen-2-one n.a. n.a. No No No No Yes No rxn41347,rxnDiet121 PMDBD2000767 Esculin Therapeutic Substance n.a. 531-75-9 DB13155 n.a. n.a. n.a. 5281417 4444765 NPC206264 "Esculin, aesculin, 531-75-9, Esculoside, Bicolorin, Enallachrome, Escosyl, (-)-Esculin, 6,7-Dihydroxycoumarin 6-glucoside, Esculetin 6-O-glucoside, Aesculinum, Crataegin, Esculine, Esculetin 6-beta-D-glucoside, 6,7-Dihydroxycoumarin-6-O-glucoside, Vitamin C2, Aesculetin glukosid, CHEBI:4853, Esculina, 7-Hydroxy-6-cumarinyl-glucosid, 6-(beta-D-Glucopyranosyloxy)-7-hydroxy-cumarin, esculetin glukosid, UNII-1Y1L18LQAF, 1Y1L18LQAF, NSC-26665, CCRIS 5724, 6-(beta-D-Glucopyranosyloxy)-7-hydroxy-2H-1-benzopyran-2-one, DTXSID7045318, 7-Hydroxy-6-glucosyloxy-2H-chromen, EINECS 208-517-5, NSC 26665, Esculin sesquihydrate, 7-hydroxy-6-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-2H-chromen-2-one, 7-Hydroxy-6-glucosyloxy-2H-chromene, DTXCID5025318, 7-hydroxy-2-oxo-2H-chromen-6-yl beta-D-glucopyranoside, 66778-17-4, Venoplant, MFCD00149492, 7-hydroxy-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-2-one, 7-hydroxy-6-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2H-chromen-2-one, ESCULOSIDE [JAN], 6-(.beta.-D-Glucopyranosyloxy)-7-hydroxy-2H-1-benzopyran-2-one, 6-[(2S,3R,4S,5S,6R)-6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-7-oxidanyl-chromen-2-one, 7-hydroxy-6-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy- 6-(hydroxymethyl)-2-tetrahydropyranyl]oxy}-2-chromenone, Esculetin-6-beta-D-glucopyranoside, Schillerstoff, SR-01000633930, 2H-1-Benzopyran-2-one, 6-(.beta.-D-glucopyranosyloxy)-7-hydroxy-, NCGC00016491-01, CAS-531-75-9, Aesculin (Esculin), Aesculin sesquihydrate, Spectrum_000361, 6,7-Dihydroxycoumarine-6-glucopyranoside, ESCULIN [INCI], ESCULIN [MI], Spectrum2_000576, Spectrum3_000731, Spectrum4_001923, Spectrum5_000845, AESCULINUM [HPUS], Esculetin 6-b-D-glucoside, SCHEMBL2893, ESCULOSIDE [WHO-DD], BSPBio_002282, KBioGR_002266, KBioSS_000841, DivK1c_000956, SPECTRUM1500901, SPBio_000392, CHEMBL482581, Esculetin-6-b-D-glucopyranoside, BCBcMAP01_000202, Esculetin 6-.beta.-D-glucoside, HMS502P18, KBio1_000956, KBio2_000841, KBio2_003409, KBio2_005977, KBio3_001502, NINDS_000956, HMS1921M16, 2H-1-Benzopyran-2-one, 6-(beta-D-glucopyranosyloxy)-7-hydroxy-, EX-A6781, HY-N0188, Tox21_110453, BDBM50480261, CCG-38501, MFCD00006879, s2258, AKOS015895151, DB13155, SDCCGMLS-0066653.P001, IDI1_000956, SMP1_000008, NCGC00094874-04, CS-0007892, NS00009922, 7-Hydroxycoumarin-6-yl beta-D-Glucopyranoside, C09264, EN300-116211, 6-(.beta.-D-Glucopyranosyloxy)-7-hydroxy-cumarin, A829428, Q376432, SR-01000633930-1, SR-01000633930-3, BRD-K51742987-001-02-3, BRD-K51742987-002-02-1, Esculin, European Pharmacopoeia (EP) Reference Standard, Z1494829512, 7-hydroxy-6-((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)-2H-chromen-2-one, 7-hydroxy-6-[3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-chromen-2-one hydrate;Esculin Sesquihydrate, 7OU" C15H16O9 XHCADAYNFIFUHF-TVKJYDDYSA-N 7-hydroxy-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-2-one n.a. n.a. No No No No Yes No rxn41347,rxnDiet122 PMDBD2000768 Esculin hydrate n.a. n.a. n.a. n.a. n.a. n.a. n.a. 16211025 n.a. NPC212670 "Esculin hydrate, Esculin sesquihydrate, 66778-17-4, CHEBI:73111, 1217453-54-7, 7-hydroxy-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-2-one;hydrate, 7-hydroxy-2-oxo-2H-chromen-6-yl beta-D-glucopyranoside--water (1/1), Esculetin-6-beta-D-glucopyranoside, MFCD00149492, Aesculin hydrate, SR-01000633930, Esculin (hydrate), Esculinsesquihydrate, 7-hydroxy-6-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-2H-chromen-2-one hydrate, Esculin hydrate, >=98%, MLS002695944, SCHEMBL829959, CHEMBL1718108, DTXSID60583344, Esculin hydrate, analytical standard, Esculin sesquihydrate, p.a., 98%, AKOS025310104, Esculin hydrate, >=98.0% (HPLC), AS-11688, SMR001562115, Esculin sesquihydrate, tested according to DAB, SR-01000633930-4, Q27140313, Esculin Sesquihydrate min. 97.5%, DAB, for biochemistry, 7-Hydroxy-2-oxo-2H-1-benzopyran-6-yl beta-D-glucopyranoside--water (1/1), 7-hydroxy-6-((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)-2H-chromen-2-one hydrate" C15H18O10 CQYPGSKIFJFVDQ-QWFKVUSTSA-N "7-hydroxy-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-2-one;hydrate" n.a. n.a. No No No No No No PMDBD2000769 Esomeprazole Therapeutic Substance Approved Drug 119141-88-7 DB00736 PA10075 D07917 D0C6DT 9568614 7843323 n.a. Esomeprazole, (S)-Omeprazole, 119141-88-7, (S)-(-)-Omeprazole, (-)-Omeprazole, Inexium paranova, Alenia, Esofag, Nexiam, Escz, Omeprazole S-form, esomeprazol, esomeprazolum, Nexium, (S)-Esomeprazole, Omeprazole, (s)-, Esomeprazole Sodium, UNII-N3PA6559FT, IZRA 40, Perprazole, Esomeprazole (INN), N3PA6559FT, CHEBI:50275, HSDB 8158, A02BC05, (S)-6-Methoxy-2-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)-1H-benzo[d]imidazole, DTXSID4044292, Esomeprazole magnesium, 5-Methoxy-2-((S)-((4-methoxy-3,5-dimethyl-2-pyridyl)methyl)sulfinyl)benzimidazole, ESOMEPRAZOLE [INN], 1H-Benzimidazole, 5-methoxy-2-((S)-((4-methoxy-3,5-dimethyl-2- pyridinyl)methyl)sulfinyl)-, H199/18, ESOMEPRAZOLE (MART.), ESOMEPRAZOLE [MART.], Esomeprazole [INN:BAN], (S)-5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl]-1H-benzimidazole, 6-methoxy-2-[(S)-(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]-1H-benzimidazole, Inexium paranova (TN), r-(+)-omeprazole, ESOMEPRAZOLE [VANDF], SCHEMBL19535, BIDD:GT0020, ESOMEPRAZOLE [WHO-DD], USRE49340, Rank 8, GTPL5488, OMEPRAZOLE S-FORM [MI], CHEMBL1201320, DTXCID10196488, SUBDBMMJDZJVOS-DEOSSOPVSA-N, BDBM586486, berkley and jensen heartburn treatment, AKOS015900821, AKOS016001455, AM84543, DB00736, 5-methoxy-2-{(S)-[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole, AS-77669, HY-17021, CS-0003839, NS00098762, D07917, Q553223, BRD-K61443506-001-01-0, (5)6-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methyl]sulfinyl]-1H-benzimidazole, (5)6-methoxy-2-[[(4-methoxy-3,5dimethyl-2-pyridinyl)-methyl]sulfinyl]-1H-benzimidazole, (5)6-methoxy-2-[[(4methoxy-3,5-dimethyl-2-pyridinyl)-methyl]sulfinyl]-1H-benzimidazole, (5)6-methoxy-2[[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methyl]sulfinyl]-1H-benzimidazole, (5)6-methoxy-2[[(4methoxy-3,5-dimethyl-2-pyridinyl)-methyl]sulfinyl]-1H-benzimidazole, (5)6-methoxy-2[[(4methoxy-3,5-dimethyl-2-pyridinyl)-methyl]sulfinyl]1H-benzimidazole, (s)-5-methoxy-2-(4-methoxy-3,5-dimethylpyridin-2-ylmethane-sulfinyl)-1h-benzimidazole, (S)-5-Methoxy-2-[(3,5-dimethyl-4-methoxy-2-pyridyl) methylsulfinyl]1-H-benzimidazole, (S)-5-Methoxy-2-[(3,5-dimethyl-4-methoxy-2-pyridyl)methylsulfinyl]-1H-benzimidazole, (s)-5-methoxy-2-[(4-methoxy-3,5-dimethyl-pyridin-2-yl)methylsulfinyl]-3h-benzimidazole, (s)-5-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]-1h-benzimidazole, (S)-5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole, 6-methoxy-2-[(S)-(4-methoxy-3,5-dimethylpyridin-2-yl)methanesulfinyl]-1H-1,3-benzodiazole, (+)-(5)6-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole, (S)-5-Methoxy-2-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)-1H-benzo[d]imidazole, 1H-BENZIMIDAZOLE, 5-METHOXY-2-((S)-((4-METHOXY-3,5-DIMETHYL-2-PYRIDINYL)METHYL)SULFINYL)-, 5-methoxy-2-[(S)-[(4-methoxy-3,5-dimethylpyridin-2-yl)methane]sulfinyl]-1H-1,3-benzodiazole C17H19N3O3S SUBDBMMJDZJVOS-DEOSSOPVSA-N 6-methoxy-2-[(S)-(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]-1H-benzimidazole AstraZeneca Antiulcer Agents No No No No No No PMDBD2000770 Ethambutol Therapeutic Substance Approved Drug 74-55-5 DB00330 PA164784021 D07925 D08QME 14052 13433 NPC174123 ethambutol, 74-55-5, Myambutol, Ethambutolum, Aethambutolum, D-Ethambutol, Tibutol, (+)-S,S-Ethambutol, Ethambutol Hydrochloride, (+)-ethambutol, (S,S)-ethambutol, (2S,2''S)-2,2''-(Ethane-1,2-diylbis(azanediyl))bis(butan-1-ol), Etambutolo [DCIT], Etambutol [INN-Spanish], Ethambutolum [INN-Latin], S,S-Ethambutol, Diambutol, CHEBI:4877, (+)-2,2''-(Ethylenediimino)di-1-butanol, (2S)-2-[2-[[(2S)-1-hydroxybutan-2-yl]amino]ethylamino]butan-1-ol, Purderal, (+)-N,N''-Bis(1-(hydroxymethyl)propyl)ethylenediamine, 1-Butanol,2,2''-(1,2-ethanediyldiimino)bis-, (2S,2''S)-, EMB, Ethambutol (INN), 8G167061QZ, (2R)-2-[2-(1-hydroxybutan-2-ylamino)ethylamino]butan-1-ol, 1-Butanol, 2,2''-(1,2-ethanediyldiimino)bis-, (2S,2''S)-, ETHAMBUTOL [INN], (2S,7S)-2,7-diethyl-3,6-diazaoctane-1,8-diol, (2S,2''S)-2,2''-(ethane-1,2-diyldiimino)dibutan-1-ol, Etambutolo, (2S)-2-[(2-{[(2S)-1-hydroxybutan-2-yl]amino}ethyl)amino]butan-1-ol, D-2,2''-(Ethylenediimino)di-1-butanol, D-2,2''-(Ethylenediimino)bis(1-butanol), 1-Butanol, 2,2''-(1,2-ethanediyldiimino)bis-, (S-(R*,R*))-, 1-Butanol, 2,2''-(ethylenediimino)di-, (+)-, d,N,N''-Bis(1-hydroxymethylpropyl)ethylenediamine, D-N,N''-Bis(1-hydroxymethylpropyl)ethylenediamine, Ethambutol [INN:BAN], (R)-2,2''-(1,2-Ethanediyldiimino)bis-1-butanol, NCGC00178864-03, UNII-8G167061QZ, HSDB 3078, Servambutol (TN), 95E, EINECS 200-810-6, Spectrum_001058, ETHAMBUTOL [MI], Spectrum2_001014, Spectrum3_000426, Spectrum4_000545, Spectrum5_000702, ETHAMBUTOL [HSDB], ETHAMBUTOL [VANDF], 1-Butanol, 2,2''-(1,2-ethanediyldiimino)bis-, (R)-, Myambutol (dihydrochloride), SCHEMBL3399, ETHAMBUTOL [WHO-DD], BSPBio_002012, KBioGR_001209, KBioSS_001538, CHEMBL44884, DivK1c_000561, SPBio_001167, CL 40881 (dihydrochloride), DTXSID8023006, GTPL12996, KBio1_000561, KBio2_001538, KBio2_004106, KBio2_006674, KBio3_001232, NINDS_000561, DTXSID901028179, HY-B0535, BDBM50448407, DB00330, IDI1_000561, NCGC00178864-01, NCGC00178864-04, SBI-0051375.P003, NS00000393, C06984, D07925, D94801, E-3950, EN300-150035, AB00053473_04, AB00053473_05, Q412318, (S,S)-2,2''-(1,2-Ethanediyldiimino)bis-1-butanol, BRD-K93231391-300-03-1, (+)-(S,S)-2,2''-(1,2-Ethylenediimino)-di-1-butanol, (2R*,2''R*)-2,2''-(Ethane-1,2-diyldiimino)dibutan-1-ol, (2S,2S)-2,2-(ETHANE-1,2-DIYLDIIMINO)DIBUTAN-1-OL, Ethambutol dihydrochloride, Antibiotic for Culture Media Use Only, (2S)-2-[2-[[(1S)-1-(hydroxymethyl)propyl]amino]ethylamino]butan-1-ol C10H24N2O2 AEUTYOVWOVBAKS-UWVGGRQHSA-N (2S)-2-[2-[[(2S)-1-hydroxybutan-2-yl]amino]ethylamino]butan-1-ol Macleods Pharmaceutical. Ltd Antitubercular Agents No No No No No No PMDBD2000771 Ethane-1,2-diamine Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D0WT6A 3301 n.a. n.a. "ethylenediamine, Ethane-1,2-diamine, 107-15-3, 1,2-Ethanediamine, 1,2-Diaminoethane, Ethylene diamine, Ethylendiamine, edamine, Dimethylenediamine, 1,2-Ethylenediamine, Aethaldiamin, Aethylenediamin, Ethyleendiamine, Ethylene-diamine, beta-Aminoethylamine, 1,2-Diaminoaethan, Algicode 106L, Amerstat 274, 1,2-Diamino-ethaan, 1,2-Diamino-ethano, Caswell No. 437, Ethylenediamine [JAN], NCI-C60402, CCRIS 5224, HSDB 535, CHEBI:30347, 1,4-diazabutane, EINECS 203-468-6, UNII-60V9STC53F, Edamine [INN], EPA Pesticide Chemical Code 004205, BRN 0605263, 60V9STC53F, DTXSID5021881, AI3-24231, CHEMBL816, H2NCH2CH2NH2, ETHANE,1,2-DIAMINO, DTXCID501881, EC 203-468-6, 4-04-00-01166 (Beilstein Handbook Reference), 2-Aminoethylammonium chloride, MFCD00008204, EN, NCGC00091527-01, ETHYLENEDIAMINE (II), ETHYLENEDIAMINE [II], 1,2-diaminoethane phase II, ETHYLENEDIAMINE (MART.), ETHYLENEDIAMINE [MART.], 1,2-diaminoethane phase I beta, Aethaldiamin [German], 1,2-diaminoethane phase I alpha, ethyl diamine, Ethyleendiamine [Dutch], Aethylenediamin [German], ETHYLENEDIAMINE (EP MONOGRAPH), ETHYLENEDIAMINE [EP MONOGRAPH], Ethylene-diamine [French], Ethane-1,2-diammonium bromide, ETHYLENEDIAMINE (USP MONOGRAPH), ETHYLENEDIAMINE [USP MONOGRAPH], CAS-107-15-3, Ethylenediamine, ReagentPlus(R), >=99%, 1,2-Diaminoaethan [German], 1,2-Diamino-ethaan [Dutch], ETHYLENEDIAMINE ANHYDROUS, 1,2-Diamino-ethano [Italian], 27308-78-7, Aminophylline Injection, UN1604, Ethylenediamine (anhydrous), TIZANIDINE HYDROCHLORIDE IMPURITY H (EP IMPURITY), TIZANIDINE HYDROCHLORIDE IMPURITY H [EP IMPURITY], Ethylenediamine [USP:JAN], ethylenediarnine, 2-aminoethylamine, ethylene di amine, 1,2-diaminoethan, ethylene - diamine, EDN, 1,2-ethylendiamine, 1,2-diamino-ethane, ethane 1,2-diamine, Caswell No 437, N,N''-ethylenediamine, Ethylenediamine, 8CI, 1,2-ethylene diamine, 1,2-ethylene-diamine, Ethylenediamine [UN1604] [Corrosive], .beta.-Aminoethylamine, ethane-1, 2-diamine, N,N''-ethylene diamine, Ethylenediamine, BioXtra, ETHYLENEDIAMINE MOD, Epitope ID:117724, Pesticide Code 004205, ETHYLENEDIAMINE [MI], Ethylenediamine (USP/JP15), Ethylenediamine (USP/JP17), ETHYLENEDIAMINE [HSDB], ETHYLENEDIAMINE [INCI], BDBM7972, NH2(CH2)2NH2, ALPHA,OMEGA-ETHANEDIAMINE, ETHYLENEDIAMINE [WHO-DD], 624-59-9 (di-hydrobromide), 333-18-6 (di-hydrochloride), 5700-49-2 (di-hydriodide), Ethylenediamine, analytical standard, STR00309, Tox21_111145, Tox21_201202, Ethylenediamine; Ethane-1,2-diamine, AKOS000118850, DB14189, UN 1604, Ethylenediamine, for synthesis, 99.0%, NCGC00091527-02, NCGC00258754-01, BP-20367, Ethylenediamine [UN1604] [Corrosive], E0077, E0081, NS00003922, EN300-19398, InChI=1/C2H8N2/c3-1-2-4/h1-4H, D01114, Ethylenediamine, SAJ special grade, >=99.0%, Ethylenediamine, meets USP testing specifications, Ethylenediamine, Vetec(TM) reagent grade, >=98%, Q411362, J-001723, Ethylenediamine, purified by redistillation, >=99.5%, Z104473714, Ethylenediamine, puriss. p.a., absolute, >=99.5% (GC), QuadraPure(R) AEA, 100-400 mum particle size, extent of labeling: 1.3 mmol/g loading, 1 % cross-linked with divinylbenzene" C2H8N2 PIICEJLVQHRZGT-UHFFFAOYSA-N ethane-1,2-diamine n.a. n.a. No No No No No No PMDBD2000772 Ethyl acetate n.a. n.a. n.a. n.a. n.a. n.a. n.a. 8857 n.a. NPC23508 "ETHYL ACETATE, 141-78-6, Ethyl ethanoate, Acetic acid ethyl ester, Acetoxyethane, Vinegar naphtha, Acetic ether, Ethyl acetic ester, Acetic acid, ethyl ester, Ethylacetate, Acetidin, Essigester, EtOAc, Acetic ester, Aethylacetat, Ethylacetat, 1-acetoxyethane, AcOEt, RCRA waste number U112, Ethylacetaat, Octan etylu, FEMA No. 2414, Etile (acetato di), Ethylazetat, Caswell No. 429, Ethyle (acetate d''), Acetate d''ethyle, Acetato de etilo, Ethyl acetate (natural), Ethylester kyseliny octove, CHEBI:27750, Essigsaeureethylester, acetic-acid-ethylester, HSDB 83, NSC 70930, CCRIS 6036, acet-ethylester, acet-eth-ester, Ethyl ester of acetic acid, EINECS 205-500-4, MFCD00009171, NSC-70930, CH3-CO-O-CH3, EPA Pesticide Chemical Code 044003, UNII-76845O8NMZ, Ethyl acetate [NF], DTXSID1022001, Ethyl Acetate, HPLC, AI3-00404, 76845O8NMZ, DTXCID602001, EC 205-500-4, ETHYL ACETATE (1-13C), ETHYL ACETATE (2-13C), NSC70930, Ethyl acetate (NF), NCGC00091766-01, E1504, ETHYL ACETATE (II), ETHYL ACETATE [II], Ethyl acetate, ACS reagent, ETHYL ACETATE (MART.), ETHYL ACETATE [MART.], Ethyl acetate; Ethyl ethanoate, Essigester [German], Ethylacetaat [Dutch], Aethylacetat [German], Octan etylu [Polish], ethyl-acetate, ETHYL ACETATE (EP MONOGRAPH), ETHYL ACETATE [EP MONOGRAPH], acetic acid ethyl, Acetate d''ethyle [French], Acetato de etilo [Spanish], Ethyl acetate, ACS reagent, >=99.5%, CAS-141-78-6, Etile (acetato di) [Italian], Ethyle (acetate d'') [French], Ethylester kyseliny octove [Czech], UN1173, CH3COOC2H5, RCRA waste no. U112, ethylaceate, ethylactate, ethylacteate, Etylacetate, ehtyl acetate, ethanol acetate, ethly acetate, ethyl acteate, ethyl_acetate, ehyl acetate, ethl acetate, ethy acetate, ethyl aceate, ethyl actate, etyl acetate, Acetyl ester, 1-ethyl acetate, 2~ethyl acetate, acetic ethyl ester, Etile(acetato di), Et-OAc, Ethyle(acetate d''), Caswell No 429, acetic acid ethylester, CH3CO2Et, Ethyl acetate HPLC grade, Ethyl acetate, for HPLC, Ethyl acetate, 99.9%, Ethyl acetate, ACS grade, CH3CO2CH2CH3, Epitope ID:116868, for HPLC,99.9%, ETHYL ACETATE [MI], Ethyl acetate, HPLC Grade, CH3CO2C2H5, ETHYL ACETATE [FCC], ETHYL ACETATE [FHFI], ETHYL ACETATE [HSDB], ETHYL ACETATE [INCI], Ethyl acetate, >=99.5%, WLN: 2OV1, CHEMBL14152, ACETIC ACID,ETHYL ESTER, Ethyl acetate, AR, >=99%, Ethyl acetate, LR, >=99%, ETHYL ACETATE [USP-RS], ETHYL ACETATE [WHO-DD], Ethyl acetate, analytical standard, Ethyl acetate, Environmental Grade, Ethyl acetate, anhydrous, 99.8%, Ethyl acetate, 99.9% low benzene, Tox21_111166, Tox21_202512, BDBM50128823, c0036, Ethyl acetate, >=99%, FCC, FG, Ethyl acetate, HPLC grade, 99.8%, AKOS000121947, Ethyl acetate, Spectrophotometric Grade, UN 1173, Ethyl acetate, for HPLC, >=99.5%, Ethyl acetate, for HPLC, >=99.7%, Ethyl acetate, for HPLC, >=99.8%, Ethyl acetate, PRA grade, >=99.5%, NCGC00260061-01, Ethyl acetate, biotech. grade, >=99.8%, Ethyl acetate, ReagentPlus(R), >=99.5%, Ethyl acetate, ReagentPlus(R), >=99.8%, Ethyl acetate, tested according to Ph.Eur., A0030, Ethyl acetate 100 microg/mL in Acetonitrile, Ethyl acetate, natural, >=99%, FCC, FG, Ethyl acetate, SAJ first grade, >=99.0%, NS00004207, Q0040, EN300-31487, Ethyl acetate [UN1173] [Flammable liquid], Ethyl acetate, for HPLC, >=99.8% (GC), Ethyl acetate, JIS special grade, >=99.5%, C00849, D02319, Ethyl acetate, capillary GC grade, >=99.5%, A807811, Q407153, Ethyl acetate, Laboratory Reagent, >=99.0% (GC), Ethyl acetate, UV-IR min. 99.8%, isocratic grade, J-007556, J-521240, F0001-0489, InChI=1/C4H8O2/c1-3-6-4(2)5/h3H2,1-2H, Ethyl acetate, puriss. p.a., ACS reagent, >=99.5% (GC), Ethyl acetate, United States Pharmacopeia (USP) Reference Standard, Ethylacetate, pure, meets the analytical specifications of Ph. Eur., Ethyl Acetate, Pharmaceutical Secondary Standard; Certified Reference Material, Ethyl acetate, puriss. p.a., ACS reagent, reag. ISO, reag. Ph. Eur., >=99.5% (GC), Ethyl acetate, puriss. p.a., free of higher boiling impurities, >=99.9% (GC), Ethyl acetate, puriss., meets analytical specification of Ph. Eur., BP, NF, >=99.5% (GC)" C4H8O2 XEKOWRVHYACXOJ-UHFFFAOYSA-N ethyl acetate n.a. n.a. No No No No No No PMDBD2000773 Ethyl gallate Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D06CPD 13250 n.a. NPC1321 ETHYL GALLATE, 831-61-8, Ethyl 3,4,5-trihydroxybenzoate, Gallic acid ethyl ester, Phyllemblin, Nipagallin A, Ethylgallate, Progallin A, Nipa No. 48, Gallic acid, ethyl ester, Benzoic acid, 3,4,5-trihydroxy-, ethyl ester, NIPA 48, 3,4,5-Trihydroxybenzoic acid ethyl ester, Ethylester kyseliny gallove, NSC 402626, 235I6UDD3L, CHEMBL453196, CHEBI:87247, MFCD00016430, NSC402626, NSC-402626, Ethyl-3,4,5-trihydroxybenzoate, Ethylester kyseliny gallove [Czech], EINECS 212-608-5, BRN 2116014, UNII-235I6UDD3L, Gallic acid-ethyl ester, Ethyl Gallate(Ethyl 3,4,5-Trihydroxybenzoate), SCHEMBL39599, Ethyl 3,5-trihydroxybenzoate, ETHYL GALLATE [INCI], Ethyl-3,5-trihydroxybenzoate, ETHYL GALLATE [MART.], DTXSID2061195, BCP15872, HY-N0525, BDBM50244948, ethyl 3,4,5-tris(oxidanyl)benzoate, s5550, AKOS015838687, 3,5-Trihydroxybenzoic acid ethyl ester, CCG-266568, AC-11363, AC-34482, DS-17928, E313, SY033133, 3,4,5-Trihydroxy-benzoic acid ethyl ester, Benzoic acid,4,5-trihydroxy-, ethyl ester, CS-0009060, E0854, G0016, NS00020124, Ethyl gallate, antioxidant, >=96.0% (HPLC), EN300-8620672, A840515, Q-100846, Q4532976, 2-([(4-CHLOROPHENYL)SULFONYL]AMINO)PROPANOICACID, F1905-7042, Z1255434814, 6359F896-3057-40AA-81CD-5734DCE29C20 C9H10O5 VFPFQHQNJCMNBZ-UHFFFAOYSA-N ethyl 3,4,5-trihydroxybenzoate n.a. n.a. No No No No No No PMDBD2000774 Ethylene glycol tetraacetic acid Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D0O5VI 6207 n.a. n.a. "EGTA, 67-42-5, Egtazic acid, Ethylenebis(oxyethylenenitrilo)tetraacetic acid, Gedta, Ebonta, 6,9-Dioxa-3,12-diazatetradecanedioic acid, 3,12-bis(carboxymethyl)-, 1,2-Bis[2-[bis(carboxymethyl)amino]ethoxy]ethane, Ethylene Glycol Tetraacetic Acid, 3,12-bis(carboxymethyl)-6,9-dioxa-3,12-diazatetradecanedioic acid, Ethylene glycol bis(2-aminoethyl ether)-N,N,N'',N''-tetraacetic acid, C14H24N2O10, [Ethylenebis(oxyethylenenitrilo)]tetraacetic acid, H4egta, Ethylene glycol-bis(2-aminoethylether)-N,N,N'',N''-tetraacetic acid, MFCD00004291, NSC 615010, 1,2-Bis(2-dicarboxymethylaminoethoxy)ethane, Ethylenedioxybis(ethyleneamino)tetraacetic acid, 2-[2-[2-[2-[bis(carboxymethyl)amino]ethoxy]ethoxy]ethyl-(carboxymethyl)amino]acetic acid, Glycol ether diamine tetraacetic acid, (Ethylenebis(oxyethylenenitrilo))tetraacetic acid, ethylene glycol bis(2-aminoethyl)tetraacetic acid, NSC-615010, DTXSID2045151, CHEBI:30740, Glycoletherdiaminetetraacetic Acid, Ethylene glycol-O,O''-bis(2-aminoethyl)-N,N,N'',N''-tetraacetic acid, NSC615010, Egtazic acid (USAN), NCGC00015416-02, ACETIC ACID, (ETHYLENEBIS(OXYETHYLENENITRILO))TETRA-, 526U7A2651, EGTAZIC ACID [USAN], DTXCID0025151, Acide egtazique, Acido egtazico, Acidum egtazicum, ethylene glycol bis(beta-aminoethyl ether)-N,N,N'',N''-tetraacetic acid, 2,2'',2'''',2''''''-[ethane-1,2-diylbis(oxyethane-2,1-diylnitrilo)]tetraacetic acid, CAS-67-42-5, Egtazic acid [USAN:INN], Ethylene Glycol-bis(2-aminoethylether)-N,N,N inverted exclamation marka,N inverted exclamation marka-tetraacetic Acid, Acide egtazique [INN-French], Acido egtazico [INN-Spanish], Acidum egtazicum [INN-Latin], Ethylene glycol bis(2-aminoethyl ether)tetraacetic acid, Glycol-etherdiaminetetraacetic acid, EINECS 200-651-2, Ethylenebis(oxyethylenenitrilo)tetra(acetic acid), BRN 1717370, Glycoletherdiamine-N,N,N'',N''-tetraacetic Acid, 2-[2-[2-[2-(Bis(carboxymethyl)amino)ethoxy]ethoxy]ethyl-(carboxymethyl)amino]acetic acid, UNII-526U7A2651, Ethylene glycol bis(aminoethyl ether)tetraacetate, EDGA, EGTA; Egtazic acid, Ethylene glycol, di(2-(N,N-dicarboxylmethyl)amino)ethyl ether, Ethylene glycol bis(beta-aminoethyl ether)-N,N''-tetraacetic acid, Ethyleneglycol-bis(beta-aminoethyl ether)-N,N1-tetra-acetic acid, Lopac-E-4378, bmse001011, EGTA [MI], EGTAZIC ACID [INN], Lopac0_000512, SCHEMBL22901, MLS000069445, CHEMBL240390, Glycoletherdiamine-tetraacetic acid, HMS3261H05, HY-D0861, Tox21_110141, Tox21_500512, HB4708, AKOS004910388, Tox21_110141_1, CCG-204603, Ethylenebis(oxyethylenenitrilo)tetraacet, LP00512, SDCCGSBI-0050496.P002, NCGC00015416-01, NCGC00015416-03, NCGC00015416-04, NCGC00015416-05, NCGC00015416-06, NCGC00093909-01, NCGC00093909-02, NCGC00261197-01, AC-31252, AS-72032, SMR000059072, SY010980, CS-0015171, E0106, E0805, EU-0100512, NS00014959, D03967, E 4378, Ethylene-bis(oxyethylenenitrilo)tetraacetic acid, H10668, EGTA, Molecular Biology Grade - CAS 67-42-5, Q408437, SR-01000075861, SR-01000075861-1, W-104715, Ethylene glycol bis-(2-aminoethyl ether)tetraacetic acid, Ethyleneglycol bis-(2-aminoethyl)ether tetraacetic acid, 1,2-Bis(2-aminoethoxyethane)-N,N,N'',N''-tetraacetic acid, 3,6-Dioxaoctane-1,8-diamine-N,N,N'',N''-tetraacetic acid, 2,2''-Ethylenedioxybis(ethylamine)-N,N,N'',N''-tetraacetic acid, Ethylene glycol-bis(2-aminoethyl)-N,N,N'',N''-tetraacetic acid, ethylene glycol-bis(2-aminoethylether)-n,n,n,n-tetraacetic acid, Acetic acid, [ethylenebis(oxyethylenenitrilo)]tetra- (6CI,8CI), Ethylene glycol bis(b-aminoethyl ether)-N,N,N'',N''-tetraacetic acid, 3,12-Bis(carboxymethyl)-6,9-dioxa-3,12-diazatetradecane-1,14-dioic acid, Ethylene glycol bis(.beta.-aminoethyl ether)-N,N,N'',N''-tetraacetic acid, ethylene glycol-bis(.beta.-aminoethyl ether)-n,n,n'',n''-tetraacetic acid, Ethylene glycol-O,O''-bis(2-aminoethyl)-N,N,N'',N''-tetraacetic acid, EGTA, 2,11-bis(carboxymethyl)-5,8-dioxa-2,11-diazadodecane-1,12-dicarboxylic acid, 3,12-Bis(carboxymethyl)-6,9-dioxa-3,12-diazatetra-decane-1,14-dioic acid (EGTA), 3,12-Bis(carboxymethyl)-6,9-dioxa-3,12-diazatetradecane-1,14-dioic acid #, 6,9-Dioxa-3,12-diazatetradecanedioic acid, 3,12-bis(carboxymethyl)- (9CI), Ethylene glycol-bis(2-aminoethylether)-N,N,N'',N''-tetraacetic acid, >=97.0%, Ethylene glycol-bis(2-aminoethylether)-N,N,N'',N''-tetraacetic acid, >=98.0% (T), Ethylene glycol-bis(2-aminoethylether)-N,N,N'',N''-tetraacetic acid, BioXtra, >=97 .0%, 1,2-Bis[2-[bis(carboxymethyl)amino]ethoxy]ethane ; Ethylene glycol-bis(2-aminoethylether)-N,N,N??,N??-tetraacetic acid, Ethylene glycol-bis(2-aminoethylether)-N,N,N'',N''-tetraacetic acid, BioUltra, for molecular biology, >=99.0% (T), Ethylene glycol-bis(2-aminoethylether)-N,N,N'',N''-tetraacetic acid, for molecular biology, >=97.0%" C14H24N2O10 DEFVIWRASFVYLL-UHFFFAOYSA-N 2-[2-[2-[2-[bis(carboxymethyl)amino]ethoxy]ethoxy]ethyl-(carboxymethyl)amino]acetic acid n.a. n.a. No No No No No No PMDBD2000775 Ethylenediametetraacetic acid n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000776 Eucarobustol E n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000777 Eugenol Therapeutic Substance Patented Drug 97-53-0 DB09086 n.a. n.a. D0O4QB 3314 13876103 NPC257124 "eugenol, 97-53-0, 4-Allyl-2-methoxyphenol, 4-Allylguaiacol, Eugenic acid, Allylguaiacol, p-Eugenol, Caryophyllic acid, p-Allylguaiacol, 2-Methoxy-4-prop-2-enylphenol, 2-Methoxy-4-allylphenol, Engenol, Phenol, 2-methoxy-4-(2-propenyl)-, 1,3,4-Eugenol, 2-Methoxy-4-(2-propenyl)phenol, 5-Allylguaiacol, Synthetic eugenol, 1-Hydroxy-2-methoxy-4-allylbenzene, 4-Allylcatechol-2-methyl ether, 2-Methoxy-1-hydroxy-4-allylbenzene, 4-Allyl-1-hydroxy-2-methoxybenzene, bioxeda, 1-Hydroxy-2-methoxy-4-prop-2-enylbenzene, 2-methoxy-4-(prop-2-en-1-yl)phenol, 2-Hydroxy-5-allylanisole, FEMA No. 2467, 4-Hydroxy-3-methoxy-1-allylbenzene, 4-Hydroxy-3-methoxyallylbenzene, 2-Methoxy-4-(2-propen-1-yl)phenol, Eugenol (natural), Phenol, 4-allyl-2-methoxy-, 4-Allylcatechol 2-methyl ether, NCI-C50453, 1-allyl-4-hydroxy-3-methoxybenzene, 1-Allyl-3-methoxy-4-hydroxybenzene, Caswell No. 456BC, FEMA Number 2467, 2-Metoksy-4-allilofenol, CCRIS 306, FA 100, CHEBI:4917, HSDB 210, NSC 209525, Caryophillic acid, NSC-8895, EINECS 202-589-1, Eugenol (USP), Eugenol [USP], EPA Pesticide Chemical Code 102701, NSC-209525, UNII-3T8H1794QW, BRN 1366759, DTXSID9020617, Phenol, 2-methoxy-4-(2-propen-1-yl)-, AI3-00086, 3T8H1794QW, MFCD00008654, naturel, CHEMBL42710, DTXCID90617, 2-Methoxy-4-(3-propenyl)phenol, EC 202-589-1, 3-(3-methoxy-4-hydroxyphenyl)propene, NCGC00091449-05, EUGENOL (IARC), EUGENOL [IARC], EUGENOL (II), EUGENOL [II], EUGENOL (MART.), EUGENOL [MART.], EUGENOL (USP-RS), EUGENOL [USP-RS], Eugenol [USAN], WLN: 1U2R DQ CO1, EUGENOL (EP MONOGRAPH), EUGENOL [EP MONOGRAPH], EUGENOL (USP MONOGRAPH), EUGENOL [USP MONOGRAPH], CAS-97-53-0, 2-Metoksy-4-allilofenol [Polish], SR-05000002043, allylguaicol, natural, naturale, oogenol, phenylpropanoid, redistillation, Eugenolum, fractionation,, animal feed, water white, Dentek Eugenol, alim ue, fami qs, Teething Gel, ugenol,, eugenic acid,, clove,, Isolate,, US Pharmacopoeia, Eugenol BP, flash distillation, clove oil fraction, Nuby Teething Gel, Eugenol,(S), 1-hydroxy-4-allyl-2-methoxybenzene, Red Cross Toothache, British Pharmacopoeia, clove oil terpeneless, eugenol for synthesis, Eugenol1518, 4-allyl-2methoxyphenol, 3s0e, EFEUF,, EUGENOL [VANDF], EUGENOL [FHFI], EUGENOL [HSDB], EUGENOL [INCI], Marshall Toothache Drops, 4-allyl 2-methoxyphenol, EUGENOL [FCC], EUGENOL [MI], Spectrum2_001264, Spectrum3_000646, Spectrum4_001783, Spectrum5_000425, EUGENOL [WHO-DD], 4-allyl-2-methoxy-Phenol, bmse010053, Epitope ID:114091, Eugenol, puriss., 98%, AnaDent Childrens Kanka Gel, Eugenol Toothache Medication, SCHEMBL20361, BSPBio_002251, KBioGR_002327, MLS000028901, SEUGE0001, BIDD:ER0696, DivK1c_000692, SPECTRUM1500296, SPBio_001228, GTPL2425, HMS502C14, KBio1_000692, KBio3_001471, 2-methoxy-4-prop-2-enyl-phenol, Eugenol, ReagentPlus(R), 99%, NSC8895, 4-(2-Propenyl)-2-methoxyphenol, Eugenol, natural, >=98%, FG, NINDS_000692, Eugenol, >=98%, FCC, FG, HMS1920O08, HMS2091F09, Pharmakon1600-01500296, 2-methoxy-4-(2-propenyl)-phenol, HY-N0337, Tox21_111134, Tox21_202040, Tox21_300105, BDBM50164168, CCG-38827, NSC209525, NSC757030, s4706, Eugenol, tested according to Ph.Eur., AKOS000121354, Tox21_111134_1, CS-7807, DB09086, FS-2702, NSC-757030, SDCCGMLS-0066578.P001, IDI1_000692, USEPA/OPP Pesticide Code: 102701, Eugenol 1000 microg/mL in Acetonitrile, NCGC00091449-01, NCGC00091449-02, NCGC00091449-03, NCGC00091449-04, NCGC00091449-06, NCGC00091449-07, NCGC00091449-08, NCGC00091449-10, NCGC00253915-01, NCGC00259589-01, AC-34149, Eugenol, Vetec(TM) reagent grade, 98%, SMR000059114, 2-METHOXY-4-(2''-PROPENYL)PHENOL, SBI-0051381.P003, Eugenol, PESTANAL(R), analytical standard, A0232, NS00003629, EN300-16622, D04117, AB00051992_02, A845719, Eugenol, primary pharmaceutical reference standard, Q423357, Eugenol, certified reference material, TraceCERT(R), Q-201105, SR-05000002043-1, SR-05000002043-2, BRD-K32977963-001-01-9, BRD-K32977963-001-03-5, Z56347226, EUGENOL (CONSTITUENT OF HOLY BASIL LEAF) [DSC], Eugenol, European Pharmacopoeia (EP) Reference Standard, F0001-2306, 2-methoxy-4-(prop-2-en-1-yl)phenol4-allyl-2-methoxyphenol, EUGENOL (CONSTITUENT OF CINNAMOMUM CASSIA BARK) [DSC], EUGENOL (CONSTITUENT OF CINNAMOMUM VERUM BARK) [DSC], Eugenol, United States Pharmacopeia (USP) Reference Standard, Eugenol, Pharmaceutical Secondary Standard; Certified Reference Material, InChI=1/C10H12O2/c1-3-4-8-5-6-9(11)10(7-8)12-2/h3,5-7,11H,1,4H2,2H" C10H12O2 RRAFCDWBNXTKKO-UHFFFAOYSA-N 2-methoxy-4-prop-2-enylphenol n.a. n.a. No No No No No No PMDBD2000778 Evodiamine n.a. n.a. n.a. n.a. n.a. n.a. n.a. 442088 n.a. NPC141612 Evodiamine, 518-17-2, d-Evodiamine, (+)-Evodiamine, Evodiamine, (+)-, CHEBI:4948, C01825BVNL, CHEMBL463165, (S)-14-methyl-8,13,13b,14-tetrahydroindolo[2'',3'':3,4]pyrido[2,1-b]quinazolin-5(7H)-one, (S)-14-methyl-7,8,13b,14-tetrahydroindolo[2'',3'':3,4]pyrido[2,1-b]quinazolin-5(13H)-one, (1S)-21-methyl-3,13,21-triazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-2(10),4,6,8,15,17,19-heptaen-14-one, UNII-C01825BVNL, C19H17N3O, Evodiamine,(S), EVODIAMINE [MI], EVODIAMINE [WHO-DD], MLS006011787, SCHEMBL682158, DTXSID10966123, BCP02282, HY-N0114, BDBM50560847, AKOS005622478, CS-6161, SMR001934404, VS-12304, C09187, Q-100579, Q27894193, Evodiamine, European Pharmacopoeia (EP) Reference Standard, (1S)-21-METHYL-3,13,21-TRIAZAPENTACYCLO[11.8.0.0(2),(1)?.0?,?.0(1)?,(2)?]HENICOSA-2(10),4,6,8,15,17,19-HEPTAEN-14-ONE, Indol(2'',3'':3,4)pyrido(2,1-b)quinazolin-5(7H)-one, 8,13,13b,14-tetrahydro-14-methyl-, (13bS)-, Indol(2'',3'':3,4)pyrido(2,1-b)quinazolin-5(7H)-one, 8,13,13b,14-tetrahydro-14-methyl-, (S)-, INDOLO(2'',3'':3,4)PYRIDO(2,1-B)QUINAZOLIN-5(7H)-ONE, 8,13,13B,14-TETRAHYDRO-14-METHYL-, (13BS)- C19H17N3O TXDUTHBFYKGSAH-SFHVURJKSA-N (1S)-21-methyl-3,13,21-triazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-2(10),4,6,8,15,17,19-heptaen-14-one n.a. n.a. No No No No No No PMDBD2000779 F2,5,12W n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000780 Farnesol Therapeutic Substance Investigational Drug 4602-84-0 DB02509 n.a. n.a. D0M0CF 445070 1266073 NPC103213 "farnesol, trans,trans-Farnesol, 106-28-5, (E,E)-Farnesol, 4602-84-0, (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol, trans-Farnesol, (2E,6E)-Farnesol, 2-trans,6-trans-Farnesol, All-trans-Farnesol, Farnesyl alcohol, 3,7,11-Trimethyl-2,6,10-dodecatrien-1-ol, Inhibitor A2, FCI 119a, 2,6-Di-trans-Farnesol, (E)-farnesol, 2,6,10-Dodecatrien-1-ol, 3,7,11-trimethyl-, HSDB 445, 2,6,10-dodecatrien-1-ol, 3,7,11-trimethyl-, (2E,6E)-, 2E,6E-farnesol, 3,7,11-trimethyldodeca-2,6,10-trien-1-ol, 3,7,11-Trimethyl-2,6,10-dodecatrienol, CIS-TRANS-FARNESOL, CHEBI:16619, X23PI60R17, (2E,6E)-3,7,11-Trimethyl-2,6,10-dodecatrien-1-ol, Trimethyl dodecatrienol, 2,6,10-Dodecatrien-1-ol, 3,7,11-trimethyl-, (E,E)-, EINECS 225-004-1, UNII-EB41QIU6JL, NSC 60597, EPA Pesticide Chemical Code 128911, Nikkosome, AI3-44561, (E,E)-3,7,11-Trimethyl-2,6,10-dodecatrien-1-ol, (2-trans,6-trans)-farnesol, trans,trans-3,7,11-Trimethyl-2,6,10-dodecatrien-1-ol, MFCD00002918, FEMA No. 2478, EB41QIU6JL, DTXCID80196591, transfarnesol, UNII-X23PI60R17, trans- farnesol, trans,trans-Farnesol; trans-Farnesol, .beta.-Farnesol, E,E-farnesol, all-trans farnesol, (E,E)farnesol, FOF, trans,trans farnesol, (E,)-arnesol, Farnesol (6CI), (E,E,)-farnesol, Farnesol, 95%, trans, trans-Farnesol, ALL-E-FARNESOL, Farnesol (2E,6E), Farnesol, (E,E)-, Farnesol, trans, trans, ST072172, 2E,6E-Farnesyl alcohol, mixture of isomers,95%, Spectrum5_002027, trans,trans-alpha-farnesol, trans,trans-Farnesol, 96%, trans,trans-Farnesol, 97%, SCHEMBL58068, 2-trans-S-6-trans-farnesol, BSPBio_002660, Farnesol, analytical standard, CHEMBL25308, SPECTRUM1501022, (E)-.BETA.-FARNESOL, DTXSID2040789, (E,E)-2,6-FARNESOL, BDBM11021, CHEBI:26199, CHEBI:28600, FARNESOL, (2E,6E)-, HY-Y0248A, AMY33538, BCP22704, Tox21_302034, AC-422, CCG-38862, s4941, AKOS004907430, LMPR0103010001, NCGC00095654-01, NCGC00095654-02, NCGC00095654-03, NCGC00095654-04, NCGC00095654-05, NCGC00255293-01, trans,trans-Farnesol, analytical standard, AS-16107, LS-14447, CAS-4602-84-0, FARNESOL TRANS,TRANS-FARNESOL [MI], CS-0031456, FEMA NO. 2478, (2E,6E)-, NS00007807, T0608, C01126, EN300-1692687, A801411, Q420449, Q-201851, W-109985, BRD-K24656285-001-01-0, (2E, 6E)-3,7,11-trimethyl2,6,10-dodecatrien-1-ol, (E,E,)-3,7,11-Trimethyl-2,6,10-dodecatrien-1-ol, F1905-7040, Z2315575130, (2E,6E)-3,7,11-trimethyl-dodeca-2,6,10-trien-1-ol, (E,E)-3,7,11-TRIMETHYL-2,6,10-DODECATNEN-1-OL, 2,6,10-Dodecatrien-1-ol, 3,7,11-trimethyl- (8CI,9CI), A2865747-EC66-4B9C-A593-0A066A438904, (2-trans,6-trans)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol, 3,7,11-TRIMETHYLDODECA-2-TRANS,6-TRANS,10-TRIEN-1-OL, InChI=1/C15H26O/c1-13(2)7-5-8-14(3)9-6-10-15(4)11-12-16/h7,9,11,16H,5-6,8,10,12H2,1-4H3/b14-9+,15-11, trans,trans-3,7,11-Trimethyl-2,6,10-dodecatrien-1-ol, (E,E)-3,7,11-Trimethyl-2,6,10-dodecatrien-1-ol" C15H26O CRDAMVZIKSXKFV-YFVJMOTDSA-N (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol n.a. n.a. No No No No No No PMDBD2000781 faropenem medoxomil n.a. n.a. n.a. n.a. n.a. n.a. n.a. 6918218 n.a. n.a. Faropenem daloxate, 141702-36-5, Faropenem medoxomil, Faropenem medoxil, SUN-A0026, Fropenem daloxate, Faropenem medoxomil [USAN], BAY-56-6854, a-0026, 5OK523O4FU, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl (5R,6S)-6-[(1R)-1-hydroxyethyl]-7-oxo-3-[(2R)-oxolan-2-yl]-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate, A0026, SUN-208, Faropenem medoxomil (USAN), 4-Thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid, 6-[(1R)-1-hydroxyethyl]-7-oxo-3-[(2R)-tetrahydro-2-furanyl]-, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester, (5R,6S)-, Orapem, UNII-5OK523O4FU, faropenem-medoxomil, BAY 566854, BAY 56-6854, A 0026, SCHEMBL2334640, SUN208, FAROPENEM DALOXATE [MI], CHEMBL1257070, SUN A0026, SUN 208, CHEBI:134710, BAY566854, AKOS030526093, BAY-566854, BAY56-6854, CS-0390, DB05659, HY-10004, MS-26703, NS00069240, D08919, F83978, A911194, Q27095691, (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl (5R,6S)-6-((1R)-1-hydroxyethyl)-7-oxo-3-((2R)-tetrahydrofuran-2-yl)-4-thia-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylate, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl (5R,6S)-6-((R)-1-hydroxyethyl)-7-oxo-3-((R)-tetrahydrofuran-2-yl)-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate, (5-METHYL-2-OXO-1,3-DIOXOREN-4-YL)METHYL(5R,6S)-6-((R)-1-HYDROXYETHYL)-7-OXO-3-((R)-2-TETRAHYDROFURYL)-4-THIA-1-AZABICYCLO(3.2.0)HEPT-2-ENE-2-CARBOXYLATE, 4-Thia-1-azabicyclo(.32.0)hept-2-ene-2-carboxylic acid, 6-((1R)-1-hydroxyethyl)-7-oxo-3-((2R)-tetrahydro-2-furanyl)-, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester, (5R,6S)-, 4-THIA-1-AZABICYCLO(3.2.0)HEPT-2-ENE-2-CARBOXYLIC ACID, 6-((1R)-1-HYDROXYETHYL)-7-OXO-3-((2R)-TETRAHYDRO-2-FURANYL)-, (5-METHYL-2-OXO-1,3-DIOXOL-4-YL)METHYL ESTER, (5R,6S), 4-Thia-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, 6-(1-hydroxyethyl)-7-oxo-3-(tetrahydro-2-furanyl)-, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester, (5R-(3(R*),5alpha,6alpha(R*)))-, 4-Thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid, 6-[(1R)-1-hydroxyethyl]-7-oxo-3-[(2R)-tetrahydro-2-furanyl]-, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester C17H19NO8S JQBKWZPHJOEQAO-DVPVEWDBSA-N (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl (5R,6S)-6-[(1R)-1-hydroxyethyl]-7-oxo-3-[(2R)-oxolan-2-yl]-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate n.a. n.a. No No No No No No PMDBD2000782 Fenclonine Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D0F2GG 4652 n.a. n.a. "Fenclonine, 7424-00-2, 4-Chloro-DL-phenylalanine, DL-4-Chlorophenylalanine, 2-amino-3-(4-chlorophenyl)propanoic acid, p-chlorophenylalanine, Fenchlonine, 4-Chlorophenylalanine, Fenclonin, DL-p-Chlorophenylalanine, DL-PCPA, DL-3-(p-Chlorophenyl)alanine, C-Pal, para-Chlorophenylalanine, CP-10188, H-DL-PHE(4-CL)-OH, Phenylalanine, 4-chloro-, CP-10,188, DL-Phenylalanine, 4-chloro-, Alanine, 3-(4-chlorophenyl)-, DL-, p-Chloro-DL-phenylalanine, 2-Amino-3-(4-chlorophenyl)propionic acid, CP 10,188, NSC 77370, NSC-77370, P-chlorophenylalanine, dl-, R5J7E3L9SP, H-P-CHLORO-DL-PHE-OH, DTXSID4045139, MFCD00002601, NCGC00015255-04, CP 10188, DL-PHE(4-CL)-OH, DTXCID2025139, Fencloninum [INN-Latin], Fenclonina [INN-Spanish], (RS)-2-Amino-3-(4-chloro-phenyl)-propionic acid;H-4-Chloro-DL-Phe-OH;Fenclonine;PCPA, CAS-7424-00-2, SR-01000075543, EINECS 231-051-9, ALANINE, 3-(p-CHLOROPHENYL)-, UNII-R5J7E3L9SP, BRN 2805758, AI3-62057, ALANINE, 3-(p-CHLOROPHENYL)-, DL-, MFCD00079675, HSDB 7747, Parachlorophenylalanine, p-CPA, Spectrum_001188, 4-Chlorophenylalanine #, FENCLONINE [INN], Spectrum2_001479, Spectrum3_001766, Spectrum4_000863, Spectrum5_001312, FENCLONINE [HSDB], FENCLONINE [USAN], (y)-p-Chlorophenylalanine, (?)-p-Chlorophenylalanine, FENCLONINE [MART.], Lopac0_000286, SCHEMBL26382, BSPBio_003231, KBioGR_001525, KBioSS_001668, (+/-)-p-Chlorophenylalanine, DivK1c_000873, SPECTRUM1502162, SPBio_001437, (A+/-)-p-Chlorophenylalanine, (.+-.)-p-Chlorophenylalanine, GTPL5240, (.+/-.)-p-Chlorphenylalanine, CHEMBL1256351, (.+/-.)-p-Chlorophenylalanine, BDBM82270, HMS502L15, KBio1_000873, KBio2_001668, KBio2_004236, KBio2_006804, KBio3_002731, 4-Chloro-dl-.beta.-phenylalanine, CHEBI:110187, NINDS_000873, HMS3260J14, HY-B1368, NSC77370, Tox21_110114, Tox21_500286, CCG-39197, s4586, AKOS000183864, AKOS016050371, Tox21_110114_1, AB00241, AB02502, AB03058, AC-9879, CS-4900, LP00286, SDCCGSBI-0050274.P003, IDI1_000873, NCGC00015255-03, NCGC00015255-05, NCGC00015255-06, NCGC00015255-07, NCGC00015255-08, NCGC00015255-09, NCGC00015255-13, NCGC00024889-02, NCGC00024889-03, NCGC00024889-04, NCGC00024889-05, NCGC00260971-01, AS-49808, SY032852, SY035278, CAS_7424-00-2, AM20060839, EU-0100286, NS00081601, ( inverted question mark)-p-Chlorophenylalanine, C 6506, D04143, EN300-112373, N10776, AB00052283-03, AB00052283_04, J-300388, Q5443204, SR-01000075543-1, SR-01000075543-3, W-204245, BRD-A81615860-001-02-9, F2147-6563, Z317024982" C9H10ClNO2 NIGWMJHCCYYCSF-UHFFFAOYSA-N 2-amino-3-(4-chlorophenyl)propanoic acid n.a. n.a. No No No No No No PMDBD2000783 Ferric chloride Therapeutic Substance n.a. 7705-08-0 DB15536 n.a. n.a. n.a. 24380 22792 n.a. FERRIC CHLORIDE, Iron(III) chloride, 7705-08-0, trichloroiron, Iron trichloride, Iron perchloride, Flores martis, Chlorure perrique, Iron (III) chloride, Perchlorure de fer, Iron chloride (FeCl3), Natural molysite, Iron sesquichloride, Iron chloride (Fe2Cl3), FERRIC CHLORIDE, ANHYDROUS, FeCl3, Caswell No. 459, Chlorure ferrique, Iron sesquichloride (DOT), U38V3ZVV3V, iron(3+) chloride, Iron(III) chloride, anhydrous, CCRIS 2299, HSDB 449, EINECS 231-729-4, MFCD00011005, NSC 51150, UNII-U38V3ZVV3V, EPA Pesticide Chemical Code 034901, NSC 135798, AI3-51902, CHEBI:30808, Ferric trichloride, NSC-51150, Iron chloride, solid, NSC-135798, Ferric chloride, solid, (FeCl3), [FeCl3], EC 231-729-4, WLN: FE G3, Chlorure ferrique [French], Chlorure perrique [French], Perchlorure de fer [French], Iron(III)chloride, Fe(III) chloride, iron (III)chloride, UN1773, UN2582, iron (III) cloride, iron-(III) chloride, iron-(III)-chloride, iron (III) trichloride, IRON III CHLORIDE, Iron(III) chloride, CP, Iron(III) chloride anhydrous, TDA Reagent, for microbiology, FERRIC CHLORIDE (ANHYDROUS), NSC51150, Iron(III) chloride, p.a., 98%, Fe/ppm Pd for nitro group reductions, NSC135798, AKOS015902743, DB15536, USEPA/OPP Pesticide Code: 034901, Iron(III) chloride,reagent grade, 97%, NCGC00249131-01, Iron(III) chloride, reagent grade, 97%, FERRIC CHLORIDE, (SOLID, ANHYDROUS), Iron(III) chloride, technical grade, 58%, Iron(III) chloride, anhydrous for synthesis, NS00093572, EN300-19478, Iron(III) chloride, LR, anhydrous, >=97%, Iron (III) chloride, Trace metals grade, 99.9%, Q399771, Ferric chloride, anhydrous [UN1773] [Corrosive], Iron(III) chloride, sublimed grade, >/=99.9% trace metals basis, Iron(III) chloride, sublimed grade, >=99.9% trace metals basis, Iron(III) chloride, anhydrous, powder, >=99.99% trace metals basis, Iron(III) chloride on silica gel, powder, extent of labeling: 5 wt. % loading Cl3Fe RBTARNINKXHZNM-UHFFFAOYSA-K trichloroiron n.a. n.a. No No No No No No PMDBD2000784 Ferrous n.a. n.a. n.a. n.a. n.a. n.a. n.a. 27284 n.a. n.a. ferrous ion, Iron(2+), Ferrous cation, Fe2+, Ferrous ions, Iron divalent ion, Ferrous, Iron dication, 15438-31-0, Iron, ion (Fe2+), Iron (II) ion, Iron ion(2+), Iron (Fe 2+), Iron(II), iron(2+) ion, IRON, ION(Fe 2+), UNII-GW89581OWR, Iron(II) ion, GW89581OWR, Fe+2, Fe(2+), Limonite, Iron(2+)ions, Taconite, Infed, Malleable iron, Wrought iron, iron(II) cation, FeII, Iron(2+) ions, iron (II), Pyrite8137, Fe +2 ion, Iron ion (2+), Fe(II), Fe++, Fe +2, DTXSID4042672, CHEBI:29033, DB14510, NS00078787, Q428946 Fe+2 CWYNVVGOOAEACU-UHFFFAOYSA-N iron(2+) n.a. n.a. No No No No No No PMDBD2000785 Ferulic Acid Therapeutic Substance Patented Drug n.a. n.a. n.a. n.a. D03SLR 445858 n.a. NPC70744 "ferulic acid, trans-Ferulic Acid, 1135-24-6, 537-98-4, 4-Hydroxy-3-methoxycinnamic acid, trans-4-Hydroxy-3-methoxycinnamic acid, 3-(4-Hydroxy-3-methoxyphenyl)acrylic acid, (E)-Ferulic acid, Coniferic acid, ferulate, 2-Propenoic acid, 3-(4-hydroxy-3-methoxyphenyl)-, Ferulic acid, trans-, 3-(4-Hydroxy-3-methoxyphenyl)-2-propenoic acid, (E)-3-(4-Hydroxy-3-methoxyphenyl)-2-propenoic acid, (2E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoic acid, Cinnamic acid, 4-hydroxy-3-methoxy-, 3-methoxy-4-hydroxycinnamic acid, Fumalic acid, Cinnamic acid, 4-hydroxy-3-methoxy-, (E)-, (E)-4-Hydroxy-3-methoxycinnamic acid, UNII-AVM951ZWST, (E)-4''-Hydroxy-3''-methoxycinnamic acid, 2-Propenoic acid, 3-(4-hydroxy-3-methoxyphenyl)-, (2E)-, AVM951ZWST, 4-Hydroxy-3-methoxy cinnamic acid, EINECS 208-679-7, Cinnamic acid, 4-hydroxy-3-methoxy-, trans-, MFCD00004400, 2-Propenoic acid, 3-(4-hydroxy-3-methoxyphenyl)-, (E)-, (E)-3-(4-hydroxy-3-methoxyphenyl)acrylic acid, CCRIS 3256, CCRIS 7127, CIS-FERULICACID, CHEBI:17620, (E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoic acid, HSDB 7663, NSC 2821, NSC-2821, EINECS 214-490-0, NSC 51986, NSC-51986, (2E)-3-(4-Hydroxy-3-methoxyphenyl)acrylic acid, NSC 674320, Fumalic acid (Ferulic acid), 4-Hydroxy-3-methoxycinnamate, (2E)-3-(4-Hydroxy-3-methoxyphenyl)-2-propenoic acid, (E)-3-(4-hydroxy-3-methoxy-phenyl)prop-2-enoic acid, CHEMBL32749, 3-(4-Hydroxy-3-methoxyphenyl)propenoic acid, NSC2821, 3-Methoxy-4-hydroxy-trans-cinnamate, NSC-674320, 97274-61-8, 3-methoxy-4-hydroxy-trans-cinnamic acid, (E)-Ferulate, trans-Ferulic Acid (purified by sublimation), Trans-3-(4-hydroxy-3-methoxyphenyl)acrylic acid, 4-HYDROXY-3-METHOXY-D3-CINNAMIC ACID, FERULIC ACID (USP-RS), FERULIC ACID [USP-RS], CINNAMIC ACID,4-HYDROXY,3-METHOXY FERULIC ACID, caffeic acid 3-methyl ether, ferulic acid, (E)-isomer, SMR000112202, 3-(4-hydroxy-3-methoxyphenyl)prop-2-enoic acid, DTXSID5040673, ferulasaure, Ferulicacid, trans-Ferulate, (E)-3-(4-Hydroxy-3-methoxyphenyl)-2-propenoate, CCRIS 7575, trans-FerulicAcid, Ferulic acid, E-, (E)-Coniferic acid, trans-4-Hydroxy-3-methoxycinnamicacid, Ferulic acid (M5), Ferulic Acid ,(S), FERULIC-ACID, Spectrum5_000554, bmse000459, bmse000587, bmse010211, FERULIC ACID [MI], trans-Ferulic acid, 99%, FERULIC ACID [HSDB], FERULIC ACID [INCI], SCHEMBL15673, BSPBio_003168, MLS001066385, MLS001332483, MLS001332484, MLS002207079, MLS006011435, SPECTRUM1501017, trans-Ferulic acid, >=99%, FERULIC ACID [WHO-DD], DTXCID3020673, DTXSID70892035, HMS1921D05, HMS2269P04, (E)-4-Hydroxy-3-methoxycinnamate, trans-4-Hydroxy-3-methoxycinnamate, BCP21231, BCP21789, HY-N0060, NSC51986, STR00961, (E)-4-hydroxy-3-methoxy-Cinnamate, TRANS-FERULIC ACID [WHO-DD], (E)4-hydroxy-3-methoxycinnamic acid, AC7905, BDBM50214744, CCG-38860, s2300, AKOS000263735, AC-7965, BCP9000163, DB07767, PS-3435, SDCCGMLS-0066667.P001, trans-3-methoxy-4-hydroxycinnamic acid, (E)-4-hydroxy-3-methoxy-Cinnamic acid, 3-(4-Hydroxy-3-methoxyphenyl)propenoate, 4-Hydroxy-3-methoxycinnamic acid, trans, NCGC00094889-01, NCGC00094889-02, NCGC00094889-03, NCGC00094889-04, 1ST40035, AC-10321, BS-17543, SMR004703246, AM20060784, CS-0007108, F1257, H0267, NS00068201, SW219616-1, EN300-16798, C01494, F-2000, A829775, FERULIC ACID (CONSTITUENT OF BLACK COHOSH), Q417362, SR-01000765539, (2E)-3-(4-Hydroxy-3-methoxyphenyl)-2-propenoate, (E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoicacid, J-002980, SR-01000765539-3, Z56782558, (E)-3-(3-methoxy-4-oxidanyl-phenyl)prop-2-enoic acid, FERULIC ACID (CONSTITUENT OF BLACK COHOSH) [DSC], 055E203F-B305-4B7F-8CE7-F9C0C03AB609, 3986A1BE-A670-4B06-833B-E17253079FD8, Ferulic acid, European Pharmacopoeia (EP) Reference Standard, trans-Ferulic acid, certified reference material, TraceCERT(R), Diethyl2-(acetamido)-2-(2-(bromomethyl)-5-nitrobenzyl)malonate, Ferulic acid, United States Pharmacopeia (USP) Reference Standard, trans-Ferulic acid, matrix substance for MALDI-MS, >=99.0% (HPLC), Ferulic Acid, Pharmaceutical Secondary Standard; Certified Reference Material, InChI=1/C10H10O4/c1-14-9-6-7(2-4-8(9)11)3-5-10(12)13/h2-6,11H,1H3,(H,12,13" C10H10O4 KSEBMYQBYZTDHS-HWKANZROSA-N (E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoic acid n.a. n.a. No No No No No No PMDBD2000786 FK506 Therapeutic Substance n.a. n.a. n.a. n.a. n.a. D06OMK 445643 n.a. NPC99864 tacrolimus, Fujimycin, 104987-11-3, Prograf, Tsukubaenolide, Protopic, Tacrolimus anhydrous, FK506, Advagraf, Modigraf, Anhydrous Tacrolimus, Prograft, Fk-506, Protopy, tacrolimus (fk506), LCP-Tacro, FK 506, Avagraf, Envarsus, FR-900506, Astagraf XL, Envarsus XR, Tacrolimus, anhydrous, Tacrolimus (anhydrous), Hecoria, (-)-FK 506, 8-DEETHYL-8-[BUT-3-ENYL]-ASCOMYCIN, Tacrolimus (INN), UNII-Y5L2157C4J, PROGRAPH, TACRO, CCRIS 7124, DTXSID5046354, FR900506, CHEBI:61049, HSDB 8195, Y5L2157C4J, Prograf (TN), Tacrolimus [USAN], NSC-758659, L 679934, CHEMBL269732, DTXCID3026354, K506, NCGC00163470-03, TACROLIMUS [INN], TACROLIMUS (MART.), TACROLIMUS [MART.], UNII-WM0HAQ4WNM, Graceptor, TACROLIMUS (USP-RS), CHEBI:61057, (3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-Hexadecahydro-5,19-dihydroxy-3-[(1E)-2-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethenyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propen-1-yl)-15,19-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(4H,23H)tetrone, TACROLIMUS (USP MONOGRAPH), FK-506 (Tacrolimus), MFCD11045918, 8-DEETHYL-8-(BUT-3-ENYL)-ASCOMYCIN, NSC 758659, SR-05000001879, Tacrolimus [USAN:INN], TACROLIMUS MONOHYDRATE (EP MONOGRAPH), tacrolimusum, Talymus, MFCD00869853, NSC717865, ENVARSUS-XR, TACROLIMUS [MI], SCHEMBL3088, TACROLIMUS [WHO-DD], BSPBio_001279, CHEMBL66247, L-679934, GTPL6784, Tacrolimus in whole human blood, CHEBI:93221, HMS503O21, C44H69NO12.H2O, D11AH01, L04AD02, HMS1792O21, HMS1990O21, HMS2093M19, HMS3403O21, Pharmakon1600-01503968, EX-A1677, Tox21_112056, BDBM50030448, BDBM50079777, HB0289, LMPK04000003, NSC758659, s5003, AKOS005145901, AC-1182, AM81227, CCG-270494, CS-1507, DB00864, IDI1_001040, NCGC00163470-01, NCGC00163470-02, NCGC00163470-04, NCGC00163470-05, NCGC00163470-06, NCGC00163470-07, NCGC00163470-27, HY-13756, SBI-0052894.P002, CAS-104987-11-3, M2258, NS00008708, A11860, C01375, D08556, EN300-221601, AB01209746-01, AB01209746_03, Q411648, Q-201775, SR-05000001879-1, SR-05000001879-2, SR-05000001879-5, BRD-K35452788-001-02-1, BRD-K69608737-001-03-7, BRD-K69608737-001-10-2, Z2242006187, [(E)-2-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethenyl]-14,16-, 15,19-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(23H)-tetrone,, (1R,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-1,14-dihydroxy-12-[(E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-17-prop-2-enyl-11,28-dioxa-4-azatricyclo[22.3.1.04,9]octacos-18-ene-2,3,10,16-tetrone, (1R,9S,12S,13R,14S,17R,21S,23S,24R,25S,27R)-1,14-dihydroxy-12-{1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl}-23,25-dimethoxy-13,19,21,27-tetramethyl-17-(prop-2-en-1-yl)-11,28-dioxa-4-azatricyclo[22.3.1.0,4,9]octacos-18-ene-2,3,10,16-tetrone, (3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-5,19-dihydroxy-3-{(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl}-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(prop-2-en-1-yl)-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-3H-15,19-epoxypyrido[2,1-c][1,4]oxazacyclotricosine-1,7,20,21(4H,23H)-tetrone, (3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-5,19-dihydroxy-3-{(E)-2-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethenyl}-14,16-dimethoxy-4,10,12,18-tetramethyl-8-prop-2-en-1-yl-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-3H-15,19-epoxypyrido[2,1-c][1,4]oxazacyclotricosine-1,7,20,21(4H,23H)-tetrone, (3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26AS)-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26A-HEXADECAHYDRO-5,19-DIHYDROXY-3-[(1E)-2-[(1R,3R,4R)-4-HYDROXY-3-METHOXYCYCLOHEXYL]-1-METHYLETHENYL]-14,16-DIMETHOXY-4,10,12,18-TETRAMETHYL-8-(2-PROPEN-1-YL)-15,19, (3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-Hexadecahydro-5,19-dihydroxy-3-[(1E)-2-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethenyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propen-1-yl)-15,19-e, (E)-(1R,9S,12S,13R,14R,21S,23S,24R,25S,27R)-17-Allyl-1,14-dihydroxy-12-[(E)-2-((3R,4R)-4-hydroxy-3-methoxy-cyclohexyl)-1-methyl-vinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-aza-tricyclo[22.3.1.0*4,9*]octacos-18-ene-2,3,10,16-tetraone, 15,19-Epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone, 5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-5,19-dihydroxy-3-(2-(4-hydroxy-3-methoxycyclohexyl)-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propenyl)-, (3S-(3R*(E(1S*,3S*,4S*)),4S*,5R*,8S*,9E,12R*,14R*,15S*,16R*,18S*,19S*,26aR*))-, 15,19-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone, 5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-5,19-dihydroxy-3-[(1E)-2-[(1R,3R,4R)-4-hydroxy-3-methoxycyc, 15,19-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone, 5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-5,19-dihydroxy-3-[(1E)-2-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethenyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propen-1-yl)-, (3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-, 15,19-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone, 5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-5,19-dihydroxy-3-[(E)-2-[(1R,3R,4R)-4-hydroxy-3-methoxycycl ohexyl]-1-methylethenyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propen-1-yl)-, (3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-, 4,5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-heptadecahydro-5,19-dihydroxy-3-, dimethoxy-4,10,12,18-tetramethyl-8-(2-propenyl)-,(3S,4R,5S,8R,12S,14S,15R,16S,18R,19R,26aS)-, lohexyl]-1-methylethenyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propen-1-yl)-, (3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)- C44H69NO12 QJJXYPPXXYFBGM-LFZNUXCKSA-N (1R,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-1,14-dihydroxy-12-[(E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-17-prop-2-enyl-11,28-dioxa-4-azatricyclo[22.3.1.04,9]octacos-18-ene-2,3,10,16-tetrone Fujisawa n.a. No No No No No No PMDBD2000787 Flavone Therapeutic Substance Investigational Drug 525-82-6 DB07776 n.a. n.a. D0S0RK 10680 10230 NPC32298 FLAVONE, 525-82-6, 2-Phenyl-4H-chromen-4-one, 2-Phenylchromone, 2-Phenyl-4-chromone, Asmacoril, 2-phenylchromen-4-one, Chromocor, Cromaril, 2-Phenyl-4H-1-benzopyran-4-one, 2-Phenyl-4-benzopyron, 2-Phenyl-chromen-4-one, 4H-1-Benzopyran-4-one, 2-phenyl-, Phenylchromone, Cromarile, 2-Phenyl-gamma-benzopyrone, 2-Phenylbenzopyran-4-one, 2-Phenyl-4H-benzopyran-4-one, Flavon, 2-Phenyl-.gamma.-benzopyrone, MFCD00006825, NSC 19028, NSC-19028, NSC19028, 2-phenyl-1,4-benzopyrone, 2-phenyl-1-benzopyran-4-one, MLS002638647, CHEMBL275638, S2V45N7G3B, DTXSID2022048, CHEBI:42491, NCGC00090962-05, DTXCID602048, 2-Phenyl-4H-chromen-4-on, CAS-525-82-6, FLN, SMR000112315, Flavone (VAN), CCRIS 4288, EINECS 208-383-8, BRN 0157598, UNII-S2V45N7G3B, Flavone, Flavone, 4hki, 2-phenyl-4H-chromone, FLAVONE [MI], Maybridge3_005286, bmse000945, CBiol_000263, SCHEMBL18879, GTPL409, 5-17-10-00552 (Beilstein Handbook Reference), MLS002177804, MLS002473400, 2-Phenylbenzo[b]pyran-4-one, BIDD:ER0515, MEGxp0_001685, 2-Phenyl-4H-chromen-4-one #, ACon1_000055, HMS1446A06, HMS2269O06, HMS3604K19, HY-N2424, Tox21_202987, Tox21_400059, BDBM50028962, ICCB2_000263, LMPK12110097, s3967, AKOS000603572, CCG-214679, DB07776, IDI1_016673, NCGC00090962-01, NCGC00090962-02, NCGC00090962-03, NCGC00090962-04, NCGC00090962-06, NCGC00168837-01, NCGC00260532-01, AC-35144, AS-58464, SY012830, CS-0022637, F0015, NS00007856, C10043, F-2700, A829155, EN300-18246169, L001213, CU-00000000060-1, Q2742033, BRD-K86741145-001-01-5, 6CC153EB-39A6-42FC-BE96-C8BF1D585E27, 11091-19-3, InChI=1/C15H10O2/c16-13-10-15(11-6-2-1-3-7-11)17-14-9-5-4-8-12(13)14/h1-10 C15H10O2 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 2-phenylchromen-4-one n.a. n.a. No No No No No No PMDBD2000788 Flavonoids 3 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000789 Flavonoids 7 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000790 Floxacillin? n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000791 Fluperlapine Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D0F8TG 49381 n.a. n.a. FLUPERLAPINE, 67121-76-0, Fluperlapina, Fluperlapine [INN], Fluperlapinum, Fluperlapinum [INN-Latin], Fluperlapina [INN-Spanish], 3-fluoro-6-(4-methylpiperazin-1-yl)-11H-benzo[c][1]benzazepine, CHEMBL63756, CHEBI:5122, DTXSID2046123, C10967, EWG253M961, 3-Fluoro-6-(4-methyl-1-piperazinyl)morphanthridine, NCGC00160388-01, DTXCID0026123, SMR000449303, CAS-67121-76-0, UNII-EWG253M961, Biomol-NT_000093, FLUPERLAPINE [MART.], GTPL279, MLS000758217, MLS001424156, SCHEMBL142558, BPBio1_001099, OBWGMKKHCLHVIE-UHFFFAOYSA-N, HMS2052M07, HMS2090H12, HMS3394M07, Tox21_111780, BDBM50040241, PDSP1_000472, PDSP2_000470, Tox21_111780_1, CCG-101093, NC00343, NCGC00160388-02, NCGC00160388-03, NCGC00160388-04, NB-106689, NS00123973, AB00639914-06, L000256, Q855654, SR-01000759288, SR-01000759288-4, BRD-K15715913-001-01-5, 3-Fluoro-6-(4-methyl-piperazin-1-yl)-11H-dibenzo[b,e]azepine, 3-fluoro-6-(4-methyl-piperazinyl)-11h-dibenz-(b,e)-azepine, (E)-3-fluoro-6-(4-methylpiperazin-1-yl)-11H-dibenzo[b,e]azepine, 3-Fluoro-6-(4-methyl-piperazin-1-yl)-11H-dibenzo[b,e]azepine(fluperlapine) C19H20FN3 OBWGMKKHCLHVIE-UHFFFAOYSA-N 3-fluoro-6-(4-methylpiperazin-1-yl)-11H-benzo[c][1]benzazepine n.a. n.a. No No No No No No PMDBD2000792 Fluspiriline Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. D0U5FS 3396 n.a. n.a. "Fluspirilene, Redeptin, 1841-19-6, Imap, Fluspirilen, R 6218, McN-JR-6218, Fluspirilenum [INN-Latin], Fluspirileno [INN-Spanish], Fluspiriline, 8-[4,4-bis(4-fluorophenyl)butyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one, R 6218;Redeptin, R-6218, C5QA4GLR9M, 1-Phenyl-4-oxo-8-(4,4-bis(4-fluorophenyl)butyl)-1,3,8-triazaspiro(4,5)decane, 8-(4,4-Bis(p-fluorophenyl)butyl)-1-phenyl-1,3,8-triazaspiro-(4.5)decan-4-one, CHEMBL46516, DTXSID7045152, Fluspirilene (R 6218; Redeptin), 1,3,8-Triazaspiro(4.5)decan-4-one, 8-(4,4-bis(4-fluorophenyl)butyl)-1-phenyl-, NCGC00015424-04, NCGC00015424-11, Fluspirileno, Fluspirilenum, CAS-1841-19-6, 1,3,8-Triazaspiro[4.5]decan-4-one, 8-[4,4-bis(4-fluorophenyl)butyl]-1-phenyl-, DTXCID5025152, Fluspirilene [USAN:INN:BAN], SMR000058304, Imap (TN), Lopac-F-100, SR-01000075385, EINECS 217-418-6, UNII-C5QA4GLR9M, Fluspirilene (USAN/INN), BRN 0633853, 8-(4,4-bis(4-fluorophenyl)butyl)-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one, Prestwick0_000906, Prestwick1_000906, Prestwick2_000906, Prestwick3_000906, FLUSPIRILENE [MI], F-100, FLUSPIRILENE [INN], GTPL85, 8-[4,4-bis(4-fluorophenyl)butyl]-4-phenyl-2,4,8-triazaspiro[4.5]decan-1-one, FLUSPIRILENE [USAN], cid_3396, Lopac0_000518, Oprea1_804941, SCHEMBL42082, BSPBio_000752, BSPBio_001343, FLUSPIRILENE [MART.], 5-26-04-00097 (Beilstein Handbook Reference), MLS000069357, MLS001333730, FLUSPIRILENE [WHO-DD], SPBio_002951, McN-JR 6218, BPBio1_000828, BDBM26948, CHEBI:93369, TQP0727, HMS1570F14, HMS1791D05, HMS1989D05, HMS2089C15, HMS2097F14, HMS2233B20, HMS3261H17, HMS3372H20, HMS3402D05, HMS3714F14, FLUSPIRILENE [EP MONOGRAPH], BCP09254, HY-B1655, Tox21_110142, Tox21_500518, MFCD00055137, NSC772296, 8-[4,4-bis(p-Fluorophenyl)butyl]-1-phenyl-1,3,8-triazino[4.5]decan-4-one, AKOS015969747, Tox21_110142_1, CCG-204608, DB04842, LP00518, NSC-772296, SDCCGSBI-0050501.P002, 1,3,8-Triazaspiro[4.5]decan-4-one, 8-[4,4-bis(p-fluorophenyl)butyl]-1-phenyl-, NCGC00015424-01, NCGC00015424-02, NCGC00015424-03, NCGC00015424-05, NCGC00015424-06, NCGC00015424-07, NCGC00015424-08, NCGC00015424-09, NCGC00015424-10, NCGC00015424-15, NCGC00016595-01, NCGC00093913-01, NCGC00093913-02, NCGC00093913-03, NCGC00093913-04, NCGC00093913-05, NCGC00261203-01, AS-16749, AB00513956, CS-0013609, EU-0100518, NS00010091, D02629, G12130, AB00513956-10, EN300-18531108, L001195, Q408300, J-011797, SR-01000075385-1, SR-01000075385-5, BRD-K77947974-001-04-9, ETHYL1-(TERT-BUTYL)-4,5-DIOXOPYRROLIDINE-3-CARBOXYLATE, Fluspirilene, European Pharmacopoeia (EP) Reference Standard, 8-(4,4-Bis(p-fluorophenyl)butyl)-1-phenyl-1,3,8-triazaspiro(4,5)decan-4-one, Fluspirilene; 8-[4,4-bis(4-Fluorophenyl)butyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one" C29H31F2N3O QOYHHIBFXOOADH-UHFFFAOYSA-N 8-[4,4-bis(4-fluorophenyl)butyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one Janssen Pharmaceutica Antipsychotic Agents No No No No No No PMDBD2000793 Fosamprenavir Therapeutic Substance Approved Drug 226700-79-4 DB01319 PA10084 D02497 D0F5MT 131536 116245 n.a. Fosamprenavir, 226700-79-4, GW433908, Fosamprenavir [INN], FOS-APV, GW-433908, VX-175, VX 175, Fosamprenavir (INN), [(3S)-oxolan-3-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-1-phenyl-3-phosphonooxybutan-2-yl]carbamate, WOU1621EEG, CHEBI:82941, GW433908A, fos-amprenavir, Amprenavir phosphate, GW 433908, Telzir(TM), Lexiva (TM), HSDB 7340, UNII-WOU1621EEG, (3-(((4-Aminophenyl)sulfonyl)(2-methylpropyl)amino)-1-(phenylmethyl)-2-(phosphonooxy)propyl)carbamic acid C-(tetrahydro-3-furanyl) ester, GW433908A (*Sodium Salt*), GW433908G (*Calcium Salt*), GW 908, GW-908, GW908 cpd, VX175 cpd, FOSAMPRENAVIR [MI], CHEMBL1664, FOSAMPRENAVIR [HSDB], SCHEMBL34080, FOSAMPRENAVIR [VANDF], Carbamic acid, ((1S,2R)-3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-1-(phenylmethyl)-2-(phosphonooxy)propyl)-, C-((3S)-tetrahydro-3-furanyl) ester, FOSAMPRENAVIR [WHO-DD], DTXSID2048296, GTPL12682, DTXSID20861514, MLBVMOWEQCZNCC-OEMFJLHTSA-N, VX175, CS-M2417, EX-A6824, AKOS032960329, DB01319, ((3S)Oxolan-3-yloxy)-N-((1S,2R)-3-{[(4-aminophenyl)sulfonyl](2-methylpropyl)amino}-1-benzyl-2-(phosphonooxy)propyl)carboxamide, [(3S)-tetrahydrofuran-3-yl] N-[(1S,2R)-3-[(4-aminophenyl)sulfonyl-isobutyl-amino]-1-benzyl-2-phosphonooxy-propyl]carbamate, AS-56492, FPV, HY-78726, NS00007849, C12723, D02497, EN300-19659831, Q1385311, (3S)-TETRAHYDRO-3-FURYL ((.ALPHA.S)-.ALPHA.-((1R)-1-HYDROXY-2-(N1-ISOBUTYLSULFANILAMIDO)ETHYL)PHENETHYL)CARBAMATE PHOSPHATE (ESTER), (3S)-tetrahydrofuran-3-yl [(2S,3R)-4-{[(4-aminophenyl)sulfonyl](2-methylpropyl)amino}-1-phenyl-3-(phosphonooxy)butan-2-yl]carbamate, (S)-TETRAHYDROFURAN-3-YL ((2S,3R)-4-(4-AMINO-N-ISOBUTYLPHENYLSULFONAMIDO)-1-PHENYL-3-(PHOSPHONOOXY)BUTAN-2-YL)CARBAMATE, {[(2R,3S)-1-[N-(2-methylpropyl)(4-aminobenzene)sulfonamido]-3-({[(3S)-oxolan-3-yloxy]carbonyl}amino)-4-phenylbutan-2-yl]oxy}phosphonic acid, {[(2R,3S)-1-[N-(2-methylpropyl)-4-aminobenzenesulfonamido]-3-({[(3S)-oxolan-3-yloxy]carbonyl}amino)-4-phenylbutan-2-yl]oxy}phosphonic acid, 1257693-05-2, CARBAMIC ACID, ((1S,2R)-3-(((4-AMINOPHENYL)SULFONYL)(2-METHYLPROPYL)AMINO)-1-(PHENYLMETHYL)-2-(PHOSPHONOOXY)PROPYL)-, C-(3S)-TETRAHYDRO-3-FURANYL) ESTER, N-[3-[N-(4-aminophenylsulfonyl)-N-isobutylamino]-1(s)-benzyl-2(r)-(phosphonooxyl)propyl]carbamic acid tetrahydrofuran-3(s)-yl ester, rel-(3R)-Tetrahydro-3-furanyl N-[(1R,2S)-3-[[(4-aminophenyl)sulfonyl](2-methylpropyl)amino]-1-(phenylmethyl)-2-(phosphonooxy)propyl]carbamate C25H36N3O9PS MLBVMOWEQCZNCC-OEMFJLHTSA-N [(3S)-oxolan-3-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-1-phenyl-3-phosphonooxybutan-2-yl]carbamate GlaxoSmithKline Anti-HIV Agents No No No No No No PMDBD2000794 Fosaphenytoin n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000795 Framycetin Therapeutic Substance Approved Drug 119-04-0 DB00452 PA450608 D05140 D05JNI 8378 n.a. n.a. "Framycetin, neomycin, NEOMYCIN B, 119-04-0, Fradiomycin, Mycifradin, Soframycin, Fradiomycin B, Enterfram, Framygen, Actilin, Neomas, Fradiomycinum, Framicetina, Framycetine, Framycetinum, Neomycin B sulfate, Caswell No. 595, Nivemycin, NEOMYCIN SULFATE, Antibiotic 10676, 1404-04-2, Neobrettin, USAF CB-19, CCRIS 5462, Framidal, Framycin, Francetin, Dekamycin iii, HSDB 3242, Soframycine, Actiline, Framycetin (INN), (2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol, Neo-Rx, Antibiotique, Myacyne, Neolate, ANTIBIOTIQUE EF 185, Neomycin sulphate, CHEBI:7508, Vonamycin powder V, Neomcin, Neomin, 4BOC774388, (1R,2R,3S,4R,6S)-4,6-diamino-2-{[3-O-(2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl)-beta-D-ribofuranosyl]oxy}-3-hydroxycyclohexyl 2,6-diamino-2,6-dideoxy-alpha-D-glucopyranoside, Neomicina [DCIT], Framycetinum [INN-Latin], Neomicina, Neomycine, Neomycinum, PIMAVECORT, FRAMYCETIN [INN], Neomycine [INN-French], Neomycinum [INN-Latin], Framycetine [INN-French], NMY, Framicetina [INN-Spanish], Framycetin [INN:BAN:DCF], Bycomycin, Jernadex, 11004-65-2, Fradiomycin B;Neomycin B, Neomycin B Hexaacetate, Neomycin [INN:BAN], EINECS 204-292-2, EINECS 215-766-3, EPA Pesticide Chemical Code 006303, BRN 0101621, Mycerin, UNII-I16QD7X297, UNII-4BOC774388, Antibiotic 956, (2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]oxy-3-hydroxy-cyclohexoxy]tetrahydropyran-3,4-diol, NEOMYCINB, Neomycin Trisulfate Hydrate Deuterated, Antibiotic produced by Streptomyces decaris. Neomycin B, NEOMYCIN B [MI], Prestwick3_000158, Neomycin B; Fradiomycin B, SCHEMBL3279, FRAMYCETIN [WHO-DD], BSPBio_000296, GTPL709, NEOMYCIN B [USP-RS], 4-18-00-07476 (Beilstein Handbook Reference), D-Streptamine, O-2,6-diamino-2,6-dideoxy-alpha-D-glucopyranosyl-(1-4)-O-(O-2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl-(1-3)-beta-D-ribofuranosyl-(1-5))-2-deoxy-, BPBio1_000326, CHEMBL184618, DTXSID2023359, HMS2089P15, I16QD7X297, AKOS024284361, CS-6390, DB00452, NCGC00179612-01, D-Streptamine, O-2,6-diamino-2,6-dideoxy-.beta.-L-idopyranosyl-(1.->3)-O-.beta.-D-ribofuranosyl-(1->5)]-O-[2,6-diamino-2,6-dideoxy-.alpha.-D-glucopyranosyl-(1->4)]-2-deoxy, HY-17624, AB00443887, NS00072944, C01737, D05140, AB00443887-03, EN300-7480789, MYCIFRADIN; NEOMAS; PIMAVECORT; VONAMYCIN, ANTIBIOTIC PRODUCED BY STREPTOMYCES DECARIS, J-004060, Q4492348, BRD-K71013094-065-01-2, (2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-{[(1R,2R,3S,4R,6S)-4,6-diamino-2-{[(2S,3R,4S,5R)-4-{[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy}-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-3-hydroxycyclohexyl]oxy}oxane-3,4-diol, 6-(2-{(4S,2R,3R,5R)-4-[(5S,6S,2R,3R,4R)-3-amino-6-(aminomethyl)-4,5-dihydroxy( 2H-3,4,5,6-tetrahydropyran-2-yloxy)]-3-hydroxy-5-(hydroxymethyl)oxolan-2-yloxy }(3S,6S,1R,2R,4R)-4,6-diamino-3-hydroxycyclohexyloxy)(3S,2R,4R,5R,6R)-5-amino- 2-(aminomethyl)-2H, D-STREPTAMINE, O-2,6-DIAMINO-2,6-DIDEOXY-.ALPHA.-D-GLUCOPYRANOSYL-(1->4)-O-(O-2,6-DIAMINO-2,6-DIDEOXY-.BETA.-L-IDOPYRANOSYL-(1->3)-.BETA.-D-RIBOFURANOSYL-(1->5))-2-DEOXY-, D-STREPTAMINE, O-2,6-DIAMINO-2,6-DIDEOXY-.BETA.-L-IDOPYRANOSYL-(1->3)-O-.BETA.-D-RIBOFURANOSYL-(1->5)-O-(2,6-DIAMINO-2,6-DIDEOXY-.ALPHA.-D-GLUCOPYRANOSYL-(1->4))-2-DEOXY-" C23H46N6O13 PGBHMTALBVVCIT-VCIWKGPPSA-N (2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol n.a. Antibiotics No No No No No No PMDBD2000796 Fraxin n.a. n.a. n.a. n.a. n.a. n.a. n.a. 5273568 n.a. NPC213197 Fraxin, 524-30-1, paviin, Fraxetin-8-O-glucoside, Fraxoside, FRAXINE, 2H-1-Benzopyran-2-one, 8-(beta-D-glucopyranosyloxy)-7-hydroxy-6-methoxy-, V7M270Y072, 8-(beta-D-Glucopyranosyloxy)-7-hydroxy-6-methoxy-2H-1-benzopyran-2-one, MFCD00010093, 2H-1-Benzopyran-2-one, 8-(.beta.-D-glucopyranosyloxy)-7-hydroxy-6-methoxy-, 7-Hydroxy-6-methoxy-8-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-2H-chromen-2-one, UNII-V7M270Y072, 7-hydroxy-6-methoxy-8-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-2-one, EINECS 208-355-5, FRAXIN [MI], Fraxin, analytical standard, FRAXETOL 8-GLUCOSIDE, MLS002473090, fraxetin-8-O-beta-D-glucoside, CHEBI:5170, CHEMBL293864, MEGxp0_000484, SCHEMBL1227439, ACon1_000325, EX-A8002Y, DTXSID30200410, CRSFLLTWRCYNNX-QBNNUVSCSA-N, fraxetin-8-beta-D-glucopyranoside, HMS2225L24, HY-N0579, fraxetin-8-O-beta-D-glucopyranoside, BDBM50428429, s9296, AKOS037514646, CCG-268292, NCGC00169184-01, 7-hydroxy-6-methoxy-8-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-chromen-2-one, AC-34583, AS-77295, SMR001397192, FRAXETIN 8-.BETA.-D-GLUCOPYRANOSIDE, CS-0009114, NS00032506, Q-100594, Q1452081, BRD-K31984062-001-01-6, 8-(beta-d-glucopyranosyloxy)-7-hydroxy-6-methoxycoumarin, 7,8-DIHYDROXY-6-METHOXYCOUMARIN 8-.BETA.-D-GLUCOPYRANOSIDE, 7-hydroxy-6-methoxy-2-oxo-2H-chromen-8-yl beta-D-glucopyranoside, METHYL3,3,3-TRIFLUORO-2-[2,2,2-TRIFLUORO-ACETYLIMINO]PROPIONATE, 7-hydroxy-6-methoxy-8-((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)-2H-chromen-2-one, InChI=1/C16H18O10/c1-23-7-4-6-2-3-9(18)25-14(6)15(11(7)20)26-16-13(22)12(21)10(19)8(5-17)24-16/h2-4,8,10,12-13,16-17,19-22H,5H2,1H3/t8-,10-,12+,13-,16+/m1/s C16H18O10 CRSFLLTWRCYNNX-QBNNUVSCSA-N 7-hydroxy-6-methoxy-8-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-2-one n.a. n.a. No No No No No No PMDBD2000797 FS8 n.a. n.a. n.a. n.a. n.a. n.a. n.a. 70678406 n.a. n.a. CHEMBL4575052, N-{5-[(7-{[(2r)-2,3-Dihydroxypropyl]oxy}-5-Oxo-10,11-Dihydro-5h-Dibenzo[a,D][7]annulen-2-Yl)amino]-2-Fluorophenyl}benzamide, 3uvq, BDBM50509055, Q27460419, FS8 C31H27FN2O5 ZPBRNNLSMHDHFY-XMMPIXPASA-N N-[5-[[14-[(2R)-2,3-dihydroxypropoxy]-2-oxo-6-tricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaenyl]amino]-2-fluorophenyl]benzamide n.a. n.a. No No No No No No PMDBD2000798 Furanone n.a. n.a. n.a. n.a. n.a. n.a. n.a. 140765 n.a. NPC38177 2(3H)-Furanone, furanone, 3H-furan-2-one, 20825-71-2, furan-2(3H)-one, .alpha.-Crotonolactone, 2-furanone, 2-Oxo-2,3-dihydrofuran, alpha-Crotonolactone, but-3-en-4-olide, alpha-Furanone, .alpha.-Furanone, beta,gamma-Crotonolactone, F666POB3G4, .delta.,.beta.,.gamma.-Butenolide, 4-hydroxy-3-butenoic acid gamma-lactone, 3-Butenoic acid, 4-hydroxy-, .gamma.-lactone, furan-2-one, UNII-F666POB3G4, .beta.,.gamma.-Crotonolactone, CHEBI:38120, 2,3-DIHYDROFURAN-2-ONE, DTXSID50174942, 2-B4O, J82.327I, 3-Butenoic acid, 4-hydroxy-, gamma-lactone, C17602, 4-HYDROXY-3-BUTENOIC ACID .GAMMA.-LACTONE, Q27117381 C4H4O2 RHDGNLCLDBVESU-UHFFFAOYSA-N 3H-furan-2-one n.a. n.a. No No No No No No PMDBD2000799 Furanone 56 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000800 Furanone C-30 n.a. n.a. n.a. n.a. n.a. n.a. n.a. 10131246 n.a. NPC103560 Furanone C-30, 247167-54-0, 2(5H)-Furanone, 4-bromo-5-(bromomethylene)-, (5Z)-, Furanone C30, (5z)-4-bromo-5-(bromomethylene)-2(5h)-furanone, (Z)-4-bromo-5-(bromomethylene)furan-2(5H)-one, 32323-47-0, 4-Bromo-5-(bromomethylene)furan-2(5H)-one, 4-bromo-5-(bromomethylene)-2(5H)-furanone, (5Z)-4-bromo-5-(bromomethylidene)furan-2-one, SCHEMBL1960492, CHEMBL1253219, DPGLBHQUHFJRJS-RQOWECAXSA-N, XJA16754, MFCD16875408, AKOS037646413, AS-68636, HY-131011, CS-0120371, E89213, (5Z)-4-bromo-5-(bromomethylidene)-2,5-dihydrofuran-2-one, (Z-)-4-Bromo-5-(bromomethylene)-2(5H)-furanone, >=97.0% (GC) C5H2Br2O2 DPGLBHQUHFJRJS-RQOWECAXSA-N (5Z)-4-bromo-5-(bromomethylidene)furan-2-one n.a. n.a. No No No No No No PMDBD2000801 Furanone F202 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000802 Furanone-2 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000803 Furanone-3 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000804 Furanone-5 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000805 Furanone-6 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000806 Furanone-8 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000807 Furvina Therapeutic Substance n.a. 189935-72-6 DB16547 n.a. n.a. n.a. 5849412 4722053 n.a. Furvina, Furvina [WHO-DD], 2-Bromo-5-(2-bromo-2-nitrovinyl)furan, 7HFX5XQO7N, UNII-7HFX5XQO7N, 189935-72-6, 2-bromo-5-(2-bromo-2-nitrovinyl)-furan, CHEMBL2335230, 1-(5-bromofur-2-yl)-2-bromo-2-nitroethene, Furan, 2-bromo-5-(2-bromo-2-nitroethenyl)-, Furan, 2-bromo-5-((1Z)-2-bromo-2-nitroethenyl)-, 35950-55-1, Furan, 2-bromo-5-[(1Z)-2-bromo-2-nitroethenyl]-, G 1, 2-bromo-5-[(Z)-2-bromo-2-nitroethenyl]furan, MurA inhibitor (compound 7), BDBM50428795, EN300-6733026, Q27268300, Z1269211442 C6H3Br2NO3 MJPPGVVIDGQOQT-HWKANZROSA-N 2-bromo-5-[(Z)-2-bromo-2-nitroethenyl]furan n.a. n.a. No No No No No No PMDBD2000808 Fusidic Acid Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. D0X7XG 3000226 n.a. NPC251680 "fusidic acid, Fusidine, 6990-06-3, Ramycin, Fusidate, Fucithalmic, Fucidic acid, Fucidin acid, Flucidin, Fucidate, Taksta, Acide fusidique, Acido fusidico, Fusidinic Acid, Acidum fusidicum, Sodium fusidate, Anhydrous Fusidic Acid, CEM-102, SQ 16,603, NSC-56192, (-)-Fusidic acid, (2Z)-2-[(3R,4S,5S,8S,9S,10S,11R,13R,14S,16S)-16-acetyloxy-3,11-dihydroxy-4,8,10,14-tetramethyl-2,3,4,5,6,7,9,11,12,13,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ylidene]-6-methylhept-5-enoic acid, SQ 16603, CHEBI:29013, 59XE10C19C, SQ-16603, UNII-59XE10C19C, MLS001332649, CEM102, DTXSID0023086, EINECS 230-256-0, MFCD00865135, NSC 56192, SMR000857101, (2E)-2-[(3R,4S,5S,8S,10S,11R,13R,14S,16S)-16-acetyloxy-3,11-dihydroxy-4,8,10,14-tetramethyl-2,3,4,5,6,7,9,11,12,13,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ylidene]-6-methylhept-5-enoic acid, (Z)-2-((3R,4S,5S,8S,9S,10S,11R,13R,14S,16S)-16-acetoxy-3,11-dihydroxy-4,8,10,14-tetramethyldodecahydro-1H-cyclopenta[a]phenanthren-17(2H,10H,14H)-ylidene)-6-methylhept-5-enoic acid, 29-Nordammara-17(20),24-dien-21-oic acid, 16-(acetyloxy)-3,11-dihydroxy-, (3alpha,4alpha,8alpha,9beta,11alpha,13alpha,14beta,16beta,17Z)-, Acide fusidique (INN-French), Acide fusidique [INN-French], Acido fusidico (INN-Spanish), Acido fusidico [INN-Spanish], Acidum fusidicum (INN-Latin), Acidum fusidicum [INN-Latin], FUSIDIC ACID (EP IMPURITY), FUSIDIC ACID [EP IMPURITY], FUSIDIC ACID (EP MONOGRAPH), FUSIDIC ACID [EP MONOGRAPH], Acid, Fusidic, (-)-16beta-acetoxy-3alpha,11alpha-dihydroxyfusida-17(20)Z,24-diene-21-oic acid, (2Z)-2-[(17Z)-16beta-acetoxy-3alpha,11alpha-dihydroxy-4alpha,8alpha,10,14beta-tetramethyl-5alpha,9beta,13alpha-gonan-17-ylidene]-6-methylhept-5-enoic acid, (2Z)-2-[(3alpha,4alpha,5alpha,8alpha,9beta,11alpha,13alpha,14beta,16beta,17Z)-16-(acetyloxy)-3,11-dihydroxy-4,8,10,14-tetramethylgonan-17-ylidene]-6-methylhept-5-enoic acid, (2Z)-2-[(3R,4S,5S,8S,9S,10S,11R,13R,14S,16S)-16-acetoxy-3,11-dihydroxy-4,8,10,14-tetramethyl-2,3,4,5,6,7,9,11,12,13,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ylidene]-6-methyl-hept-5-enoic acid, (3alpha,4alpha,8alpha,9beta,11alpha,13alpha,14beta,16beta,17Z)-16-(Acetyloxy)-3,11-dihydroxy-29-nordammara-17(20),24-dien-21-oic acid, 29-Nor-8alpha,9beta,13alpha,14beta-dammara-17(20),24-dien-21-oic acid, 3alpha,11alpha,16beta-trihydroxy-, 16-acetate, (Z)-, 3alpha,11alpha,16beta-Trihydroxy-29-nor-8alpha,9beta,13alpha,14beta-dammara-17(20),24-dien-21-oic acid 16-acetate, Fusidic acid (USAN/INN), fusidic-acid, 1qca, (2Z)-2-((17Z)-16beta-acetoxy-3alpha,11alpha-dihydroxy-4alpha,8alpha,10,14beta-tetramethyl-5alpha,9beta,13alpha-gonan-17-ylidene)-6-methylhept-5-enoic acid, FUSIDICACID, C.A.S. 62,602, Prestwick2_000390, FUSIDIC ACID [MI], FUSIDIC ACID [INN], FUSIDIC ACID [USAN], SCHEMBL25646, MLS001332650, MLS002207094, FUSIDIC ACID [WHO-DD], CHEMBL374975, DTXCID103086, Fusidic acid [USAN:INN:BAN], BDBM58924, cid_3000226, GTPL10815, D06AX01, J01XC01, S01AA13, HMS2235B11, EX-A3797, HY-B1350, NSC56192, Fusidic acid for peak identification, s3971, 16-(Acetyloxy)-3,11-dihydroxy-29-nordammara-17(20),24-dien-21-oic acid, AKOS005146257, CCG-269829, DB02703, DS-3261, LMPR0106040001, NCGC00485232-01, C.A.S. 62,602; Diethanolamine fusidate, CS-0013095, F1007, NS00007426, C06694, D04281, EN300-22411576, Q259930, Q-201141, Fusidic acid, European Pharmacopoeia (EP) Reference Standard, Fusidic acid for peak identification, European Pharmacopoeia (EP) Reference Standard, (2Z)-2-[(3beta,4beta,5alpha,8alpha,9beta,11beta,13alpha,16beta,17Z)-16-(acetyloxy)-3,11-dihydroxy-4,8,10,14-tetramethylgonan-17-ylidene]-6-methylhept-5-enoic acid, (2Z)-2-[(3R,4S,5S,8S,9S,10S,11R,13R,14S,16S)-16-acetyloxy-3,11-dihydroxy-4,8,10,14-tetramethyl-2,3,4,5,6,7,9,11,12,13,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ylidene]-6-methyl-5-heptenoic acid, (2Z)-2-[(3R,4S,5S,8S,9S,10S,11R,13R,14S,16S)-16-acetyloxy-4,8,10,14-tetramethyl-3,11-bis(oxidanyl)-2,3,4,5,6,7,9,11,12,13,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ylidene]-6-methyl-hept-5-enoic acid, (3a,4a,8a,9b,11a,13a,147b,167b,17Z)-16-(Acetyloxy)-3,11-dihydroxy-29-nordammara-17(20),24-dien-21-oic acid, (3alpha,4alpha,8alpha,9beta,11alpha,13alpha,147beta,167beta,17Z)-16-(Acetyloxy)-3,11-dihydroxy-29-nordammara-17(20),24-dien-21-oic Acid, (Z)-ent-16alpha-(acetyloxy)-3beta,11beta-dihydroxy-4beta,8,14- trimethyl-18-nor-5beta,10alpha-cholesta-17(20),24-dien-21-oate, 2-[(1Z,2S,3aS,3bS,5aS,6S,7R,9aS,9bS,10R,11aR)-2-(acetyloxy)-7,10-dihydroxy-3a,3b,6,9a-tetramethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-1-ylidene]-6-methylhept-5-enoic acid, 29-Nor-8.alpha.,13.alpha.,14.beta.-dammara-17(20),24-dien-21-oic acid, 3.alpha.,11.alpha.,16.beta.-trihydroxy-, 16-acetate, (Z)-, 29-Nordammara-17(20), 16-(acetyloxy)-3,11-dihydroxy-, (3.alpha.,4.alpha.,8.alpha.,9.beta.,11.alpha.,13.alpha.,14.beta.,16.beta.,17Z)-, 29-NORDAMMARA-17(20),24-DIEN-21-OIC ACID, 16-(ACETYLOXY)-3,11-DIHYDROXY-, (3.ALPHA.,4.ALPHA.,8.ALPHA.,9.BETA.,11.ALPHA.,13.ALPHA.,14.BETA.,16.BETA.,17Z), 29-Nordammara-17(20),24-dien-21-oic acid, 16-(acetyloxy)-3,11-dihydroxy-, (3a,4a,8a,9b,11a,13a,14b,16b,17Z)-, 29-NORDAMMARA-17(20),24-DIEN-21-OIC ACID, 16-(ACETYLOXY)-3,11-DIHYDROXY-, (3alpha,4alpha,8alpha,9beta,11alpha,13alpha,14beta,16beta,17Z), 3.alpha.,16.beta.-Trihydroxy-29-nor-8.alpha.,9.beta.,13.alpha.,14.beta.-dammara-17(20),24-dien-21-oic acid 16-acetate, ent-(17Z)-16alpha-(Acetyloxy)-3beta,11beta-dihydroxy-4beta,8,14-trimethyl-18-nor-5beta,10alpha-cholesta-17(20),24-dien-21-oic acid hemihydrate" C31H48O6 IECPWNUMDGFDKC-MZJAQBGESA-N (2Z)-2-[(3R,4S,5S,8S,9S,10S,11R,13R,14S,16S)-16-acetyloxy-3,11-dihydroxy-4,8,10,14-tetramethyl-2,3,4,5,6,7,9,11,12,13,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ylidene]-6-methylhept-5-enoic acid Leo Laboratories Antibiotics No No No No No No PMDBD2000809 FV7 n.a. n.a. n.a. n.a. n.a. n.a. n.a. 134814239 n.a. n.a. CHEMBL4214176, 6-chloro-4-(2-chlorophenyl)-1-[(4-fluoro-3,5-dimethylphenyl)methyl]-2-(piperazin-1-yl)-1H-benzimidazole, BDBM50459427, FV7 C26H25Cl2FN4 YIYWIIQFTVKZTC-UHFFFAOYSA-N 6-chloro-4-(2-chlorophenyl)-1-[(4-fluoro-3,5-dimethylphenyl)methyl]-2-piperazin-1-ylbenzimidazole n.a. n.a. No No No No No No PMDBD2000810 G H12 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000811 G10KHc n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000812 G2 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000813 Gallium cation Therapeutic Substance n.a. 22537-33-3 DB14524 n.a. n.a. n.a. 105145 94859 n.a. Gallium cation, gallium(3+), gallium(III) cation, Gallium, ion(3+), Gallium ion(3+), Gallium (ga3+), 22537-33-3, Gallium (III) ion, Gallium(3+) cation, gallium ion, Gallium, ion (Ga3+), Ga3+, UNII-F7K5MP217W, F7K5MP217W, Ga(3+), Ga(III), CHEBI:84043, DTXSID90177058, DTXCID3099549, DB14524, Q27157431 Ga+3 CKHJYUSOUQDYEN-UHFFFAOYSA-N gallium(3+) n.a. n.a. No No No No No No PMDBD2000814 Gallium Nitrate n.a. n.a. n.a. n.a. n.a. n.a. n.a. 5282394 n.a. n.a. Gallium nitrate (USAN), Gallium nitrate [USAN], gallium trinitrate nonahydrate, Ganite (TN), GALLIUM NITRATE [VANDF], GALLIUM NITRATE [ORANGE BOOK], GALLIUM NITRATE NONAHYDRATE [MI], D00940 GaH18N3O18 GOMSPTBXILHTSG-UHFFFAOYSA-N "gallium;trinitrate;nonahydrate" n.a. n.a. No No No No No No PMDBD2000815 Gallocatechin n.a. n.a. n.a. n.a. n.a. n.a. n.a. 65084 n.a. NPC268342 (+)-Gallocatechin, Gallocatechin, 970-73-0, Gallocatechol, (+)-gallocatechol, d-Gallocatechin, 1617-55-6, (2R,3S)-gallocatechin, UNII-HEJ6575V1X, HEJ6575V1X, CHEBI:31018, (2R,3S)-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol, NSC 674038, NSC-674038, CHEMBL125743, (2R,3S)-(+)-gallocatechin, CHEBI:68330, (2R,3S)-2-(3,4,5-trihydroxyphenyl)chromane-3,5,7-triol, (2R,3S)-flavan-3,3'',4'',5,5'',7-hexol, (2R,3S)-flavan-3,5,7,3'',4'',5''-hexol, 2H-1-Benzopyran-3,5,7-triol, 3,4-dihydro-2-(3,4,5-trihydroxyphenyl)-, (2R-trans)-, dl-Gallocatechin, (2R*,3S*)-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol, (2R,3S)-3,4-dihydro-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3,5,7-triol, 2H-1-Benzopyran-3,5,7-triol, 3,4-dihydro-2-(3,4,5-trihydroxyphenyl)-, (2R,3S)-, 2H-1-Benzopyran-3,5,7-triol, 3,4-dihydro-2-(3,4,5-trihydroxyphenyl)-, (2R,3S)-rel-, 2H-1-Benzopyran-3,5,7-triol, 3,4-dihydro-2-(3,4,5-trihydroxyphenyl)-,(2R,3S)-, rel-(2R,3S)-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol, (+-)-Gallocatechin, (+-)-Gallocatechol, Gallocatechol, (+-)-, Casuarin, NSC674038, (2R,3S)-2-(3,4,5-Trihydroxyphenyl)chroman-3,5,7-triol, MEGxp0_000240, SCHEMBL3872234, ACon1_000994, HY-N0521A, DTXSID10914220, (2R,3S)-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3,5,7-triol, BDBM50135165, LMPK12020002, AKOS022180463, CCG-267530, NCGC00169777-01, AC-34513, AS-78230, NCI60_026203, XG171201, CS-0022247, NS00094555, S9048, E80664, (+)-trans-3,3'',4'',5,5'',7-Hexahydroxyflavan, (2R,3S)-2-(3,4,5-Trihydroxy-phenyl)-chroman-3,5,7-triol, (2R,3S)-2-(3,4,5-Trihydroxy-phenyl)-1-benzopyran-3,5,7-triol, (2R*,3S*)- 3,4-dihydro-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3,5,7-triol, (2R*,3S*)-3,4-dihydro-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3,5,7-triol, 2H-1-Benzopyran-3,5,7-triol, 3,4-dihydro-2-(3,4,5-trihydroxyphenyl)-, trans-(+-)-, 2H-1-Benzopyran-3,7-triol, 3,4-dihydro-2-(3,4,5-trihydroxyphenyl)-, (2R-trans-), 4-{1-Butyl-9-[1-(4,6-dimethyl-pyrimidine-5-carbonyl)-4-methyl-piperidin-4-yl]-2-oxo-3,0-diaza-spiro[5.5]undec-3-ylmethyl}-piperidine-1-carboxylic acid methyl ester C15H14O7 XMOCLSLCDHWDHP-SWLSCSKDSA-N (2R,3S)-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol n.a. n.a. No No No No No No PMDBD2000816 Gallocatechin gallate Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D07KXK 5276890 n.a. NPC104983 Gallocatechin gallate, 5127-64-0, (+)-Gallocatechin gallate, (+)-Gallocatechol gallate, (+)-Gallocatechin-3-o-gallate, UNII-0C056HB16M, gallocatechin-3-gallate, Gallocatechin 3-O-gallate, Gallic acid, ester with gallocatechol, 0C056HB16M, [(2R,3S)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl] 3,4,5-trihydroxybenzoate, Benzoic acid, 3,4,5-trihydroxy-, (2R,3S)-3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl ester, CHEMBL126079, CHEBI:156284, Benzoic acid, 3,4,5-trihydroxy-, 3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl ester, (2R-trans)-, (2R,3S)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate, (2R,3S)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl 3,4,5-trihydroxybenzoate, GALLOCATECHIN 3-GALLATE, 3-Galloylgallocatechin, Gallocatechin-3-O-gallate, (+)-Gallocatechin 3-O-gallate, SCHEMBL10198783, DTXSID701336201, GCG, BDBM50135168, LMPK12020120, AKOS026670211, FS-8798, NS00094558, Q5519120, [(2R,3S)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl] 3,4,5-trihydroxybenzoate, 3,4,5-Trihydroxy-benzoic acid (2R,3S)-5,7-dihydroxy-2-(3,4,5-trihydroxy-phenyl)-chroman-3-yl ester C22H18O11 WMBWREPUVVBILR-GHTZIAJQSA-N [(2R,3S)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl] 3,4,5-trihydroxybenzoate n.a. n.a. No No No No No No PMDBD2000817 Ganciclovir Therapeutic Substance Approved Drug 82410-32-0 DB01004 PA449733 D00333 D05ARP 135398740 n.a. n.a. "ganciclovir, 82410-32-0, Cytovene, Gancyclovir, Vitrasert, Zirgan, RS-21592, Ganciclovirum, 2-Amino-9-(((1,3-dihydroxypropan-2-yl)oxy)methyl)-1H-purin-6(9H)-one, BW-759U, Cymevene, BW 759U, Virgan, 2''-Nor-2''-deoxyguanosine, 2''-NDG, BW 759, 9-[(1,3-Dihydroxy-2-propoxy)methyl]guanine, 9-((2-Hydroxy-1-(hydroxymethyl)ethoxy)methyl)guanine, MFCD00870588, 9-(1,3-DIHYDROXY-PROPOXYMETHANE)GUANINE, CHEBI:465284, 2-amino-9-{[(1,3-dihydroxypropan-2-yl)oxy]methyl}-6,9-dihydro-3H-purin-6-one, 9-((1,3-Dihydroxy-2-propoxy)methyl)guanine, Hydroxyacyclovir, NSC-759656, 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-1H-purin-6(9H)-one, P9G3CKZ4P5, 6H-Purin-6-one, 2-amino-1,9-dihydro-9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)-, MLS000028481, Guanine, 9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)-, DTXSID8041032, 2-(6-Amino-purin-9-ylmethoxy)-propane-1,3-diol, 2-amino-9-{[(1,3-dihydroxypropan-2-yl)oxy]methyl}-1,9-dihydro-6H-purin-6-one, 9-[[2-Hydroxy-1-(hydroxymethyl)ethoxy]methyl]guanine, NCGC00015471-02, HHEMG, SMR000058324, Biolf 62, Ganciclovirum [Latin], 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-9H-purin-6-ol, CAS-82410-32-0, 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-3H-purin-6(9H)-one, 2-Amino-9-(2-hydroxy-1-hydroxymethyl-ethoxymethyl)-1,9-dihydro-purin-6-one, 2-amino-9-(2-hydroxy-1-hydroxymethylethoxymethyl)-6,9-dihydro-1H-6-purinone, Ganciclovir 100 microg/mL in Acetonitrile:Water, C9H13N5O4, GCV, BIOLF-62, DTXCID6021032, 2-[(2-amino-6-hydroxypurin-9-yl)methoxy]propane-1,3-diol, Citovirax, Cymevan, Cymeven, BW-B 759U, DRG-0018, 2-amino-9-(((1,3-dihydroxypropan-2-yl)oxy)methyl)-1,9-dihydro-6H-purin-6-one, Vitrasert (TN), Cytovene (TN), CCRIS 9212, HSDB 6512, SR-01000075894, GCV & MSL, UNII-P9G3CKZ4P5, Ganciclovir (JAN/USP/INN), 2-amino-9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]-1H-purin-6-one, Ganciclovir,(S), 2-Amino-1,9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)-6-H-purin-6-one, BW-795, MB3795, Prestwick_1068, ST-605, Zirgan (TN), GCV & 1110U81, 1189966-73-1, Ganciclovir [USAN:USP:INN:BAN:JAN], Opera_ID_284, 2-amino-9-(1,3-dihydroxypropan-2-yloxymethyl)-1H-purin-6-one, 2-amino-9-(1,3-dihydroxypropan-2-yloxymethyl)-3H-purin-6-one, GANCICLOVIR [MI], Prestwick0_000839, Prestwick1_000839, Prestwick2_000839, Prestwick3_000839, GANCICLOVIR [INN], GANCICLOVIR [JAN], Lopac-G-2536, BIOLF62, GANCICLOVIR [HSDB], GANCICLOVIR [USAN], CHEMBL182, EC 627-054-3, G 2536, GANCICLOVIR [VANDF], SCHEMBL3033, GANCICLOVIR [MART.], Lopac0_000539, BSPBio_000797, GANCICLOVIR [USP-RS], GANCICLOVIR [WHO-DD], MLS001077349, BIDD:GT0783, SPBio_002718, GANCICLOVIR [EMA EPAR], BPBio1_000877, methyl)-1H-purin-6(9H)-one, SCHEMBL14491348, BDBM85707, GANCICLOVIR [EP IMPURITY], GANCICLOVIR [ORANGE BOOK], IRSCQMHQWWYFCW-UHFFFAOYSA-N, GANCICLOVIR [EP MONOGRAPH], HMS1570H19, HMS2090K08, HMS2097H19, HMS2235C21, HMS3259B13, HMS3261L19, HMS3371H01, HMS3604L19, HMS3655M18, HMS3714H19, Pharmakon1600-01502362, GANCICLOVIR [USP MONOGRAPH], BCP12705, NSC_3454, Tox21_110160, Tox21_500539, 2-(2-Amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol, BDBM50237614, NSC759656, PDSP1_000816, PDSP2_000803, s1878, 2-amino-9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]-3H-purin-6-one, AKOS004119898, AKOS026749928, AKOS037492029, Tox21_110160_1, Valganciclovir hydrochloride impurity a, AC-8069, CCG-204629, CS-2014, DB01004, Ganciclovir, >=99% (HPLC), powder, KS-1065, LP00539, NC00647, NSC 759656, SDCCGSBI-0050522.P002, 2-Amino-1,9-dihydro-9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)-6H-purin-6-one, SMP2_000038, NCGC00015471-01, NCGC00015471-03, NCGC00015471-04, NCGC00015471-05, NCGC00015471-06, NCGC00015471-08, NCGC00015471-16, NCGC00093928-01, NCGC00093928-02, NCGC00168567-01, NCGC00188980-01, NCGC00261224-01, 9-(1,3-dihydroxy-2propoxymethyl)guanine, BG164496, HY-13637, SY027981, 9-(1,3-dihydroxy-2-propoxymethyl)guanine, CAS_82410-32-0, 2-amino-9-((1,3-dihydroxypropan-2-yloxy), 9-(1,3-dihydroxy-2-propoxymethyl)-guanine, EU-0100539, G0315, NS00003516, SW197135-3, EN300-49857, C07019, D00333, 9-[[(1,3-Dihydroxy-2-propyl)oxy]methyl]guanine, A840322, A935676, Ganciclovir, Antibiotic for Culture Media Use Only, Q417640, SR-01000721941, Q-201148, SR-01000075894-1, SR-01000075894-4, SR-01000721941-3, Z594284200, Ganciclovir, European Pharmacopoeia (EP) Reference Standard, VALGANCICLOVIR HYDROCHLORIDE IMPURITY A [USP IMPURITY], Ganciclovir, United States Pharmacopeia (USP) Reference Standard, Ganciclovir, Pharmaceutical Secondary Standard; Certified Reference Material, 2-((6-Hydroxy-2-imino-2,3-dihydro-9H-purin-9-yl)methoxy)propane-1,3-diol, 2-amino-9-{[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl}-1,9-dihydro-6H-purin-6-one, Ganciclovir, 1.0 mg/mL (1% 1M HCl in Methanol), certified reference material, Guanine, 9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)- and MSL, neutralizing monoclonal antibody" C9H13N5O4 IRSCQMHQWWYFCW-UHFFFAOYSA-N 2-amino-9-(1,3-dihydroxypropan-2-yloxymethyl)-1H-purin-6-one Bausch & Lomb Pharmaceuticals, Inc. Antiviral Agents No No No No No No PMDBD2000818 Garlic extract n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000819 Gentamicin Therapeutic Substance Approved Drug 1403-66-3 DB00798 PA449753 n.a. D0L9UU 3467 n.a. NPC56298 gentamicin, Cidomycin, Gentamicina, Gentamicinum, Gentamycinum, Refobacin TM, Gentamicine, Gentamicins, Gentamycin-creme, 1403-66-3, Gentamycins, GENTAMYCIN, Oksitselanim, Centicin, Gentacycol, Lyramycin, Septigen, Gentamicine [INN-French], Gentamicinum [INN-Latin], Gentamicina [INN-Spanish], HSDB 3087, UNII-T6Z9V48IKG, EINECS 215-765-8, Gentamycin C1, 2-[4,6-diamino-3-[3-amino-6-[1-(methylamino)ethyl]oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol, T6Z9V48IKG, Gentamicin sulfate, Gentamicine (INN-French), Gentamicinum (INN-Latin), Gentamicina (INN-Spanish), 2-[4,6-diamino-3-[3-amino-6-(1-methylaminoethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-methylaminooxane-3,5-diol, Gentamicin sulphate sterile, Gentamycin-creme [German], Genoptic S.O.P., Gentamicin (TN), Gentamicin (BAN), Gentamicin [INN], Gentamicin [INN:BAN], Garamicin, Gentamycin Complex, Gentamicinum (Latin), SCHEMBL537630, CHEMBL329592, GTPL2427, DTXSID5034642, SCHEMBL19996168, CHEBI:17833, AKOS015961211, DB00798, AC-13386, NS00002225, D08013, EN300-19875459, Q422482, 1294497-75-8, 2-{[4,6-diamino-3-({3-amino-6-[1-(methylamino)ethyl]oxan-2-yl}oxy)-2-hydroxycyclohexyl]oxy}-5-methyl-4-(methylamino)oxane-3,5-diol, 4,6-diamino-3-(3-deoxy-4-C-methyl-3-(methylamino)pentopyranosyloxy)-2-hydroxycyclohexyl 2-amino-2,3,4,6,7-pentadeoxy-6-(methylamino)heptopyranoside C21H43N5O7 CEAZRRDELHUEMR-UHFFFAOYSA-N 2-[4,6-diamino-3-[3-amino-6-[1-(methylamino)ethyl]oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol Sandoz Antibiotics No No No No No No PMDBD2000820 Ginger oil Therapeutic Substance n.a. 7/8/8007 DB14690 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000821 GL13K n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000822 Glucose Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D0C1FY 5793 n.a. NPC289758 D-Glc, D-Glucopyranose, D-Glucopyranoside, D-Glucose, Glc, Glucopyranose, Glucopyranoside, Glucose, dextrose, 2280-44-6, Grape sugar, (3R,4S,5S,6R)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol, D-Glcp, Traubenzucker, 54-17-1, Glucopyranose, D-, Glucosum, anhydrous, CHEBI:4167, GLUCOSE, ALPHA-D-, rel-(3R,4S,5S,6R)-6-(Hydroxymethyl)tetrahydro-2H-pyran-2,3,4,5-tetraol, Corn sugar, DTXSID901015217, (+)-Glucose, (3R,4S,5S,6R)-6-(Hydroxymethyl)tetrahydro-2H-pyran-2,3,4,5-tetraol, Glucodin, Goldsugar, Meritose, Vadex, Clintose L, D-gluco-hexose, CPC hydrate, Roferose ST, Clearsweet 95, a-D-Glucopyranose, Staleydex 95M, Staleydex 111, Cerelose 2001, Tabfine 097(HS), UNII-5J5I9EB41E, 2h-pyran-2,3,4,5-tetraol, D-Glucopyranose, anhydrous, DTXSID30197710, Liquid glucose, glc-ring, EINECS 207-757-8, Cartose Cerelose, D-glucose-ring, Glucose injection, Glucose 40, Staleydex 130, EINECS 218-914-5, Glc-OH, Meritose 200, nchembio867-comp4, Glucose (JP17), starbld0000491, 6-(hydroxymethyl)tetrahydropyran-2,3,4,5-tetraol, Anhydrous Glucose ,(S), Purified glucose (JP17), Epitope ID:142342, D-(+)-DEXTROSE, GTPL4536, CHEMBL1222250, BDBM34103, CHEBI:37661, DTXCID90120201, DTXCID201473543, DTXSID501015215, 26655-34-5, AKOS025147374, NSC 287045, NCGC00166293-01, BS-48662, G0048, (3R,4S,5S,6R)-6-(hydroxymethyl)tetrahydro-, C00031, D00009, F71542, Q37525, Q23905964, N_FULL/O_FULL_10000000000000_GS_656, D-glucose (closed ring structure, complete stereochemistry), WURCS=2.0/1,1,0/(a2122h-1a_1-5)/1/, 1023302-86-4 C6H12O6 WQZGKKKJIJFFOK-GASJEMHNSA-N (3R,4S,5S,6R)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol n.a. n.a. No No No No No No PMDBD2000823 Glycinamide hydrochloride n.a. n.a. n.a. n.a. n.a. n.a. n.a. 2723639 n.a. n.a. "Glycinamide hydrochloride, 1668-10-6, 2-Aminoacetamide hydrochloride, Glycine amide hydrochloride, H-Gly-NH2.HCl, Glycinamide HCl, Glycinamidehydrochloride, Glycinamide, HCl, Acetamide, 2-amino-, hydrochloride (1:1), Glycineamide hydrochloride, Acetamide, 2-amino-, monohydrochloride, 2-aminoacetamide;hydrochloride, MFCD00013008, (2-amino-2-oxoethyl)azanium;chloride, GLYCINEAMIDE HCL, Glycinamide, monohydrochloride, glycinamide.HCl, glycinamide HCI, glycine amide HCl, GlyNH2.HCl, 2-Aminoacetamide HCl, Gly- NH2.HCl, glycinamide, hydrochloride, 9SPG4KUG6A, aminoacetamide hydrochloride, glycinamide hydrochloride salt, 2-aminoacetamide.hydrochloride, SCHEMBL123980, 2-amino-acetamide hydrochloride, Glycinamide hydrochloride, 98%, CHEMBL1222057, DTXSID60937242, NSC9225, HY-Y1123, NSC-9225, AKOS015848110, AC-7069, CS-W019695, GS-6747, BP-11918, PD056429, SY003860, Glycinamide hydrochloride, >=99.0% (AT), AM20080473, G0193, G0253, NS00081781, EN300-16216, G-4300, 2-Aminoethanimidic acid--hydrogen chloride (1/1), A810771, Q39047138, F2190-0517, Z1262254285" C2H7ClN2O WKNMKGVLOWGGOU-UHFFFAOYSA-N "2-aminoacetamide;hydrochloride" n.a. n.a. No No No No No No PMDBD2000824 Glycomonoterpenes (G-citral) n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000825 Glycomonoterpenes (G-citron) n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000826 Gossypetin hexamethyl ether n.a. n.a. n.a. n.a. n.a. n.a. n.a. 146093 n.a. NPC140364 Gossypetin hexamethyl ether, 3,5,7,8,3'',4''-Hexamethoxyflavone, 2-(3,4-Dimethoxyphenyl)-3,5,7,8-tetramethoxy-4H-1-benzopyran-4-one, 7741-47-1, 3,3'',4'',5,7,8-Hexamethoxyflavone, 3,5,7,8,3 inverted exclamation marka,4 inverted exclamation marka-Hexamethoxyflavone, 2-(3,4-dimethoxyphenyl)-3,5,7,8-tetramethoxychromen-4-one, SCHEMBL988273, DTXSID60228122, CHEBI:175984, XBZIUXVIWRAJKB-UHFFFAOYSA-N, HY-N11166, LMPK12113255, 4H-1-Benzopyran-4-one, 2-(3,4-dimethoxyphenyl)-3,5,7,8-tetramethoxy-, CS-0639018 C21H22O8 XBZIUXVIWRAJKB-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-3,5,7,8-tetramethoxychromen-4-one n.a. n.a. No No No No No No PMDBD2000827 Grepafloxacin Therapeutic Substance Approved Drug 119914-60-2 DB00365 PA449812 n.a. D0JL2K 72474 65391 n.a. "Grepafloxacin, 119914-60-2, Raxar, 146863-02-7, 1-cyclopropyl-6-fluoro-5-methyl-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid, 1-Cyclopropyl-6-fluoro-1,4-dihydro-5-methyl-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-5-methyl-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid, CHEMBL583, Tomefloxacin; dl-Grepafloxacin, CHEBI:5543, L1M1U2HC31, 1-CYCLOPROPYL-6-FLUORO-5-METHYL-7-(3-METHYLPIPERAZIN-1-YL)-4-OXO-QUINO LINE-3-CARBOXYLIC ACID, 3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-5-methyl-7-(3-methyl-1-piperazinyl)-4-oxo-, Grepafloxacin [INN], 1-cyclopropyl-6-fluoro-5-methyl-7-(3-methylpiperazin-1-yl)-4-oxo-quinoline-3-carboxylicacid, CCRIS 7284, OPC 17116, NCGC00167527-01, Grepafloxacin [INN:BAN], UNII-L1M1U2HC31, dl-Grepafloxacin Hydrochloride, dl-Grepafloxacin, PC 17116, PC-17116, GREPAFLOXACIN [MI], SCHEMBL34155, GREPAFLOXACIN [VANDF], (+-)-1-Cyclopropyl-6-fluoro-1,4-dihydro-5-methyl-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid, GREPAFLOXACIN [WHO-DD], DTXSID2048321, GTPL10818, AIJTTZAVMXIJGM-UHFFFAOYSA-N, HMS3713L05, BCP23880, HY-A0147, OPC17116, RKL10071, BDBM50117924, AKOS016013941, DB00365, 3-Quinolinecarboxylic acid, 1,4-dihydro-1-cyclopropyl-6-fluoro-5-methyl-7-(3-methyl-1-piperazinyl)-4-oxo-, CS-0017472, NS00002650, EN300-19766404, Q414846, SR-01000872592, SR-01000872592-1, (+/-)-1-CYCLOPROPYL-6-FLUORO-1,4-DIHYDRO-5-METHYL-7-(3-METHYL-1-PIPERAZINYL)-4-OXO-3-QUINOLINECARBOXYLIC ACID, (+/-)-3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-5-methyl-7-(3-methyl-1-piperazinyl)-4-oxo-, 1-Cyclopropyl-6-fluoro-5-methyl-7-(3-methyl-piperazin-1-yl)-4-oxo-1,4,4a,8a-tetrahydro-quinoline-3-carboxylic acid (Grepafloxacin), 1-Cyclopropyl-6-fluoro-5-methyl-7-(3-methyl-piperazin-1-yl)-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid, 1-cyclopropyl-6-fluoro-5-methyl-7-(3-methylpiperazin-1-yl)-4-oxo-quinoline-3-carboxylic acid, 1-cyclopropyl-6-fluoro-7-(3-methyl-1-piperazinyl)-5-methyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acid, 1-Cyclopropyl-6-fluoro-7-(3-methyl-1-piperazinyl)5-methyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acid, 3-QUINOLINECARBOXYLIC ACID, 1-CYCLOPROPYL-6-FLUORO-1,4-DIHYDRO-5-METHYL-7-(3-METHYL-1-PIPERAZINYL)-4-OXO-, (+/-)-" C19H22FN3O3 AIJTTZAVMXIJGM-UHFFFAOYSA-N 1-cyclopropyl-6-fluoro-5-methyl-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid GlaxoSmithKline Antibiotics No No No No No No PMDBD2000828 Guaiacol Therapeutic Substance Phase 3 1/5/1990 DB11359 n.a. D00117 D02JUW 460 n.a. NPC114325 "guaiacol, 2-Methoxyphenol, 90-05-1, o-Methoxyphenol, 2-Hydroxyanisole, Guaiastil, Pyroguaiac acid, o-Guaiacol, o-Hydroxyanisole, Pyrocatechol monomethyl ether, Phenol, 2-methoxy-, 1-Hydroxy-2-methoxybenzene, Anastil, Guaicol, Phenol, o-methoxy-, Methylcatechol, Guaicolina, Guajol, Guasol, O-Methyl catechol, Catechol monomethyl ether, Creodon, Guajakol, 8021-39-4, 2-Methoxy-Phenol, Methoxyphenol, Guajacol, Wood creosote, CREOSOTE, WOOD, FEMA No. 2532, Guaiacol (natural), Pyrocatechol methyl ester, (mu)-methoxyphenol, Guaiacol [JAN], NSC 3815, Methylcatachol, CCRIS 2943, 9009-62-5, HSDB 4241, 2-methoxyl-4-vinylphenol, UNII-6JKA7MAH9C, o--methoxyphenol, 6JKA7MAH9C, 2-methoxy phenol, NSC-3815, EINECS 201-964-7, 2-Methoxyphenol-3,4,5,6-d4,OD, MFCD00002185, Guaiacol (JAN), Creodon (TN), CHEBI:28591, AI3-05615, Catechol mono methyl ether, 20189-11-1, 2-methoxyphenol (guaiacol), 2-Methoxy-d3-phenol--d4, CHEMBL13766, DTXSID0023113, EC 201-964-7, Phenol, methoxy-, NCGC00090827-02, NCGC00090827-04, GUAIACOL (MART.), GUAIACOL [MART.], GUAIACOL (USP-RS), GUAIACOL [USP-RS], Guajakol [Czech], DTXCID003113, GUAIACOL (EP MONOGRAPH), GUAIACOL (USP IMPURITY), GUAIACOL [EP MONOGRAPH], GUAIACOL [USP IMPURITY], ortho-Guaiacol, Catechol, Methyl, CAS-90-05-1, 2-Hydroxy-Anisole, GUAIFENESIN IMPURITY A (EP IMPURITY), GUAIFENESIN IMPURITY A [EP IMPURITY], Guaiacol [JAN:NF], SR-01000838056, Guaiacol (2-Methoxyphenol), guiacol, Creasote, methoxy phenol, 6-methoxyphenol, hydroxyl anisole, O-methylcatechol, o-Guiacol, orthomethoxyphenol, o-methoxy-Phenol, 2-Methyloxyphenol, ortho-methoxyphenol, Guaiacol,(S), JZ3, 2-(methyloxy)phenol, O-HYDROXYANIOSOLE, GUAIACOL [FHFI], GUAIACOL [HSDB], GUAIACOL [MI], GUAIACOL [VANDF], O-METHOXY CATECHOL, DSSTox_CID_3113, bmse000436, bmse010027, GUAIACOL [WHO-DD], Guaiacol, puriss., 99%, WLN: QR BO1, DSSTox_RID_77552, 3-methoxy-4-hydroxy benzene, DSSTox_GSID_24853, SCHEMBL21626, ghl.PD_Mitscher_leg0.900, guaiacol (liquid) extra pure, Guaiacol, oxidation indicator, FEMA No 2532, MLS001055375, NSC3815, Guaiacol, natural, >=99%, FG, HMS2089D18, HMS2233P04, HMS3372N11, HMS3715E11, Pharmakon1600-01506165, BCP27082, CS-D1347, HY-N1380, STR03604, Tox21_111031, Tox21_201136, Tox21_202990, Tox21_400004, BDBM50240369, NSC760376, s3872, AKOS000118831, CCG-214035, DB11359, NSC-760376, PB43791, PS-3252, Guaiacol, SAJ first grade, >=98.0%, NCGC00090827-01, NCGC00090827-03, NCGC00090827-05, NCGC00090827-06, NCGC00090827-07, NCGC00258688-01, NCGC00260535-01, AC-34997, Guaiacol, Vetec(TM) reagent grade, 98%, SMR000059155, SY048708, CAS-8021-39-4, M0121, NS00010812, EN300-19498, C01502, D00117, F70227, 2-Methoxyphenol;o-Methoxyphenol;2-Hydroxyanisole, AB00876226-06, AB00876226_07, A843426, Q412403, Q-100002, SR-01000838056-2, SR-01000838056-3, F2173-0425, Guaiacol, European Pharmacopoeia (EP) Reference Standard, Z104474028, Guaiacol, United States Pharmacopeia (USP) Reference Standard, InChI=1/C7H8O2/c1-9-7-5-3-2-4-6(7)8/h2-5,8H,1H, Guaiacol, Pharmaceutical Secondary Standard; Certified Reference Material" C7H8O2 LHGVFZTZFXWLCP-UHFFFAOYSA-N 2-methoxyphenol n.a. n.a. No No No No Yes No rxn00596,rxnDiet137 PMDBD2000829 GW 5074 Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D0Z5TQ 5924208 n.a. n.a. "gw5074, 220904-83-6, GW 5074, GW-5074, Raf1 Kinase Inhibitor I, 1233748-60-1, 5-Iodo-3-[(3,5-dibromo-4-hydroxyphenyl)methylene]-2-indolinone, (3Z)-3-[(3,5-dibromo-4-hydroxyphenyl)methylidene]-5-iodo-1H-indol-2-one, 3-(3,5-dibromo-4-hydroxybenzylidene)-5-iodoindolin-2-one, GW5074 Z-isomer, GW-5074 Z-isomer, (Z)-GW 5074, B7W8RS1GG2, 3-(3,5-Dibromo-4-hydroxy-benzylidene)-5-iodo-1,3-dihydro-indol-2-one, CHEMBL72365, (Z)-3-(3,5-Dibromo-4-hydroxybenzylidene)-5-iodoindolin-2-one, GW-5074, (Z)-, 5-iodo-3-((3,5-dibromo-4-hydroxyphenyl)methylene)-2-indolinone, 3-(3,5-Dibromo-4-hydroxybenzyliden)-5-iodo-1,3-dihydroindol-2-one, (3Z)-3-((3,5-Dibromo-4-hydroxyphenyl)methylene)-1,3-dihydro-5-iodo-2H-indol-2-one, 2H-Indol-2-one, 3-((3,5-dibromo-4-hydroxyphenyl)methylene)-1,3-dihydro-5-iodo-, (3Z)-, SR-01000075897, STO521, GW5074, powder, Tocris-1381, BiomolKI_000056, Lopac-G-6416, BiomolKI2_000062, UNII-B7W8RS1GG2, UNII-P0LE4QW0S6, P0LE4QW0S6, Lopac0_000510, BMK1-F8, BSPBio_001275, SCHEMBL149921, GTPL8072, BCBcMAP01_000125, DTXSID10421368, EX-A889, LMXYVLFTZRPNRV-KMKOMSMNSA-N, HMS1362O17, HMS1792O17, HMS1990O17, HMS3261F21, HMS3403O17, HMS3412K12, HMS3676K12, BCP06316, Tox21_500510, BDBM50085415, EI-307, HSCI1_000002, MFCD09971042, NSC755765, NSC756228, AKOS024456562, CCG-100660, CCG-221814, CS-0092, NSC-755765, NSC-756228, SDCCGSBI-0050494.P002, IDI1_002223, NCGC00015478-01, NCGC00015478-02, NCGC00015478-03, NCGC00015478-04, NCGC00015478-05, NCGC00015478-06, NCGC00015478-07, NCGC00015478-09, NCGC00015478-19, NCGC00025134-01, NCGC00025134-02, NCGC00025134-03, NCGC00025134-04, NCGC00025134-05, NCGC00025134-06, NCGC00261195-01, AC-32865, AS-55911, HY-10542, G6416 (GW5074), EU-0100510, S2872, G 6416, K00053, A900890, J-510576, SR-01000075897-1, SR-01000075897-3, BRD-K07859598-001-03-9, Q27077947, (3Z)-3-[(3,5-dibromo-4-hydroxy-phenyl)methylene]-5-iodo-indolin-2-one, 3-(3, 5-Dibromo-4-hydroxybenzylidine-5-iodo-1,3-dihydro-indol-2-one), 3-(3,5-Dibromo-4-hydroxy-benzylidene)-5-iodo-1,3-dihydr o-indol-2-one, 3-(3,5-dibromo-4-hydroxybenzylidene)-5-iodo-1,3-dihydroindol-2-one, 3-(3,5-Dibromo-4-hydroxy-benzylidene)-5-iodo-1,3-dihydro-indol-2-one;GW5074, 3-[1-(3,5-Dibromo-4-hydroxy-phenyl)-meth-(Z)-ylidene]-5-iodo-1,3-dihydro-indol-2-one" C15H8Br2INO2 LMXYVLFTZRPNRV-KMKOMSMNSA-N (3Z)-3-[(3,5-dibromo-4-hydroxyphenyl)methylidene]-5-iodo-1H-indol-2-one n.a. n.a. No No No No No No PMDBD2000830 GW-9662 Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D00ACX 644213 n.a. NPC481861 2-Chloro-5-nitro-N-phenylbenzamide, GW9662, 22978-25-2, GW 9662, 2-Chloro-5-nitrobenzanilide, GW-9662, 2-Chloro-5-nitro-N-4-phenylbenzamide, benzamide, 2-chloro-5-nitro-N-phenyl-, MFCD01215270, UM18UZV2YD, MLS001056751, DTXSID8040723, CHEBI:79993, 2-Chloro-5-nitro-N-phenyl-benzamide, 2-Chloro-5-nitro- N -phenylbenzamide, SMR000326735, SR-01000075999, Benzamide,2-chloro-5-nitro-N-phenyl-, Tocris-1508, Spectrum5_001989, UNII-UM18UZV2YD, Lopac-M-6191, Lopac0_000798, BSPBio_001021, KBioGR_000361, KBioSS_000361, SCHEMBL420231, CHEMBL375270, cid_644213, GTPL3442, DTXCID6020723, BCBcMAP01_000086, BDBM55936, KBio2_000361, KBio2_002929, KBio2_005497, KBio3_000701, KBio3_000702, TIMTEC-BB SBB006523, EX-A595, DNTSIBUQMRRYIU-UHFFFAOYSA-N, Bio2_000341, Bio2_000821, HMS1362C03, HMS1792C03, HMS1990C03, HMS2235C11, HMS3262O18, HMS3267P20, HMS3372P17, HMS3403C03, HMS3412F15, HMS3649C18, HMS3651L10, HMS3676F15, BCP06354, 2-Chloro-5-nitrobenzanilide, 97%, METHYL15-METHYLHEPTADECANOATE, Tox21_301993, Tox21_500798, s2915, AKOS000155195, CCG-204882, CS-1102, DB07863, LP00798, SDCCGSBI-0050775.P002, 2-chloranyl-5-nitro-N-phenyl-benzamide, IDI1_002096, s10613, Benzanilide, 2-chloro-5-nitro- (8CI), NCGC00015688-01, NCGC00015688-02, NCGC00015688-03, NCGC00015688-04, NCGC00015688-05, NCGC00015688-06, NCGC00015688-07, NCGC00015688-08, NCGC00015688-09, NCGC00015688-21, NCGC00025193-01, NCGC00025193-02, NCGC00025193-03, NCGC00025193-04, NCGC00025193-05, NCGC00025193-06, NCGC00025193-07, NCGC00255683-01, NCGC00261483-01, AC-31443, AS-14069, CID 53394428, GW9662, >98% (HPLC), HY-16578, SY040458, CAS-22978-25-2, EU-0100798, NS00068185, SW203813-2, EN300-54989, Benzamide, 2-chloro-5-nitro-N-phenyl- (9CI), M 6191, J-014928, SR-01000075999-1, SR-01000075999-3, SR-01000075999-6, SR-01000075999-9, BRD-K93258693-001-02-5, BRD-K93258693-001-05-8, Q27077962, Z27782632 C13H9ClN2O3 DNTSIBUQMRRYIU-UHFFFAOYSA-N 2-chloro-5-nitro-N-phenylbenzamide n.a. n.a. No No No No No No PMDBD2000831 HA14-1 n.a. n.a. n.a. n.a. n.a. n.a. n.a. 3549 n.a. n.a. ha14-1, 65673-63-4, Ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate, HA 14-1, Ethyl [2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)]-4H-chromene-3-carboxylate, MFCD00218213, HA-14-1, 927635-64-1, Ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-1-benzopyran-3-carboxylate, (alphaR,4R)-rel-2-amino-6-bromo-alpha-cyano-3-(ethoxycarbonyl)-4H-1-benzopyran-4-aceticacid,ethylester, SR-01000511000, Maybridge1_000786, BSPBio_001583, KBioGR_000303, KBioSS_000303, SCHEMBL1427458, CHEBI:94328, HMS543L16, KBio2_000303, KBio2_002871, KBio2_005439, KBio3_000605, KBio3_000606, DTXSID20274403, EX-A148, SXJDCULZDFWMJC-UHFFFAOYSA-N, Bio2_000303, Bio2_000783, HMS1361P05, HMS1791P05, HMS1989P05, HMS3268C09, HMS3414M05, HMS3678M05, BCP01804, BTB 02933, HA 141, HSCI1_000186, NSC720569, AKOS007930839, BCP9000758, CCG-233971, NSC-720569, 2-Amino-6-bromo-alpha-cyano-3-(ethoxycarbonyl)-4H-1-benzopyran-4-acetic acid ethyl ester, IDI1_034053, SMP2_000039, NCGC00025207-02, NCGC00025207-03, NCGC00025207-04, NCGC00025207-05, NCGC00025207-06, NCGC00025207-12, NCGC00025207-15, NCGC00025207-16, AC-32822, NCI60_041312, PS-10256, HA 14-1, >=95% (CHN/NMR), powder, J-520710, SR-01000511000-1, SR-01000511000-2, BRD-A13807286-001-03-9, Q27166151, 2-Amino-6-bromo-?-cyano-3-(ethoxycarbonyl)-4H-1-benzopyran-4-acetic acid ethyl ester, 2-Amino-6-bromo-alpha-cyano-3-(ethoxycarbonyl)-4H-1-benzopyran-4-acetic acidethyl ester, 2-AMino-6-broMo-alpha-cyano-3-(ethoxycarbonyl)-4H-1-benzopyran-4-aceticacidethylester, (| inverted exclamation markR,4R)-rel-2-amino-6-bromo-|A-cyano-3-(ethoxycarbonyl)-4H-1-benzopyran-4-acetic acid, ethyl ester, 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-1-benzopyran-3-carboxylic acid ethyl ester C17H17BrN2O5 SXJDCULZDFWMJC-UHFFFAOYSA-N ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate n.a. n.a. No No No No No No PMDBD2000832 Hamamelitannin n.a. n.a. n.a. n.a. n.a. n.a. n.a. 44584241 n.a. n.a. Hamamelitannin, 469-32-9, Hamamelofuranose2,5-digallate, Hamamelofuranose 2''5''-digallate, hamamelitanin, 2'',5-Digalloylhamamelofuranose, CHEMBL465414, CHEBI:191119, FEPAFOYQTIEEIS-WZKFEGCESA-N, MFCD33023081, FS-7252, Q15632711, ((2S,3S,4S)-3,4,5-trihydroxytetrahydrofuran-2,4-diyl)bis(methylene) bis(3,4,5-trihydroxybenzoate), [(2S,3S,4S)-3,4,5-trihydroxy-4-[(3,4,5-trihydroxybenzoyl)oxymethyl]oxolan-2-yl]methyl 3,4,5-trihydroxybenzoate C20H20O14 FEPAFOYQTIEEIS-WZKFEGCESA-N [(2S,3S,4S)-3,4,5-trihydroxy-4-[(3,4,5-trihydroxybenzoyl)oxymethyl]oxolan-2-yl]methyl 3,4,5-trihydroxybenzoate n.a. n.a. No No No No No No PMDBD2000833 HE10 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000834 HE12 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000835 HE4 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000836 Hepcidin 20 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000837 Heptadecanoic acid n.a. n.a. n.a. n.a. n.a. n.a. n.a. 10465 n.a. NPC196924 "HEPTADECANOIC ACID, 506-12-7, Margaric acid, n-Heptadecanoic acid, Margarinic acid, n-Heptadecylic acid, n-Heptadecoic acid, Heptadecylic acid, HEPTADECANOIC-D33 ACID, NSC 3743, C17:0, 352431-41-5, Normal-heptadecanoic acid, MFCD00002751, 68424-37-3, V987Y9OZ8L, CHEBI:32365, margarinate, margaroate, NSC-3743, n-heptadecoate, n-heptadecylate, 63399-94-0, EINECS 208-027-1, BRN 1781004, UNII-V987Y9OZ8L, Margarinsaeure, margaric''acid, margaroic acid, Daturinic acid, Daturic acid, heptadecoic acid, AI3-36481, Heptadecanoic acic, X90, EINECS 270-298-7, Normal-heptadecanoate, heptadecansäure, Lead(2+) heptadecanoate, Heptadecanoic acid, 98%, DSSTox_CID_1596, EC 270-298-7, MARGARIC ACID [MI], SCHEMBL5941, DSSTox_RID_78651, DSSTox_GSID_28306, Heptadecanoic acid, >=98%, 4-02-00-01193 (Beilstein Handbook Reference), WLN: QV16, CH3-[CH2]15-COOH, CHEMBL1172910, DTXSID5021596, FA 17:0a, AMY5932, NSC3743, EINECS 264-123-3, EINECS 266-928-5, Tox21_202550, LMFA01010017, s3336, AKOS005716689, CS-W004284, FA 17:0, HY-W004284, NSC 122836, NCGC00260099-01, AS-57021, BP-27918, BP-30092, SY010570, SDA 19-005-00, CAS-67701-03-5, H0019, NS00019727, EN300-19173, EC 266-928-5, H10748, A871505, Q902204, 8EBAABCC-09B2-43FB-945D-A70E5905BFBE, Z104473032" C17H34O2 KEMQGTRYUADPNZ-UHFFFAOYSA-N heptadecanoic acid n.a. n.a. No No No No No No PMDBD2000838 Heptamethoxyflavone n.a. n.a. n.a. n.a. n.a. n.a. n.a. 44229628 n.a. n.a. HEPTAMETHOXYFLAVONE, SCHEMBL775094 C22H24O9 DGPHAUBUAGDZCS-UHFFFAOYSA-N 2-(2,3-dimethoxyphenyl)-3,5,6,7,8-pentamethoxychromen-4-one n.a. n.a. No No No No No No PMDBD2000839 Hesperetin Therapeutic Substance Approved Drug 520-33-2 DB01094 PA164742902 n.a. D07MGA 72281 65234 NPC302950 "hesperetin, Hesperitin, 520-33-2, 3'',5,7-Trihydroxy-4''-methoxyflavanone, (-)-hesperetin, (S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one, YSO2, 41001-90-5, 5,7,3''-Trihydroxy-4''-methoxyflavanone, Cyanidanon 4''-methyl ether 1626, NSC 57654, Prestwick_908, (-)-(S)-hesperetin, (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-2,3-dihydrochromen-4-one, NSC-57654, 4H-1-Benzopyran-4-one, 2,3-dihydro-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-, (S)-, Eriodictyol 4''-monomethyl ether, CHEBI:28230, Q9Q3D557F1, (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-2,3-dihydro-4H-chromen-4-one, MFCD00075646, (2S)-hesperetin, (S)-2,3-dihydro-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-one, (2s)-5,7-Dihydroxy-2-(3-Hydroxy-4-Methoxyphenyl)-2,3-Dihydro-4h-1-Benzopyran-4-One, EINECS 208-290-2, Hesperitine, UNII-Q9Q3D557F1, (S)-Hesperetin, 4H-1-Benzopyran-4-one, 2,3-dihydro-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-, (2S)-, (2S)-5,7-Dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-2,3-dihydro-4H-1-benzopyran-4-one (Hesperetin), 6JP, TNP00238, (+-)-Hesperetin, (S)-2,3-Dihydro-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-4-benzopyrone, 4''-Methoxy-3'',5,7-trihydroxyflavanone, Spectrum_000181, HESPERETIN [MI], (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one, Prestwick0_000124, Prestwick1_000124, Prestwick2_000124, Prestwick3_000124, Spectrum2_001793, Spectrum3_001104, Spectrum4_001935, Spectrum5_000683, HESPERETIN [FHFI], HESPERETIN [INCI], 5,7-Dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-4-chromanone, Oprea1_828704, SCHEMBL39833, BSPBio_000168, BSPBio_002808, KBioGR_002311, KBioSS_000661, SPECTRUM310012, Flavanone, 3'',5,7-trihydroxy-4''-methoxy- (VAN), MLS002154205, BIDD:ER0512, DivK1c_001039, SPBio_001745, SPBio_002107, BPBio1_000186, CHEMBL399121, DTXSID4022319, FEMA NO. 4313, BCBcMAP01_000087, BDBM23418, GTPL10953, HMS503O19, KBio1_001039, KBio2_000661, KBio2_003229, KBio2_005797, KBio3_002028, NINDS_001039, HMS1568I10, HMS2095I10, HMS2230M09, HMS3649H22, HMS3884N11, NP-13, (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxy-phenyl)chroman-4-one, BCP28273, HY-N0168, CCG-38441, LMPK12140003, s2308, AKOS016339567, AC-7970, DB01094, KS-5307, SDCCGMLS-0066605.P001, IDI1_001039, SMP1_000148, NCGC00016482-01, NCGC00016482-02, NCGC00016482-03, NCGC00016482-04, NCGC00142415-01, NCGC00142415-02, 1ST40171, 5,7, 3''-Trihydroxy-4''-methoxyflavanone, CAS-520-33-2, SMR001233491, Flavanone, 3'',5,7-trihydroxy-4''-methoxy-, H0721, Hesperitin; Hesperin; YSO2; Prestwick_908, NS00014845, SW197026-2, C01709, H10029, A828900, Discontinued. Please see H289480 or H289501, Q411310, SR-01000946723, SR-01000946723-1, BRD-K30553453-001-05-8, BRD-K30553453-001-08-2, Flavanone, 3'',5, 7-trihydroxy-4''-methoxy- (VAN), Flavanone, 3'',5,7-trihydroxy-4''-methoxy- (VAN) (8CI), (S)-5,7-Dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one;Hesperetin, (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-3,4-dihydro-2H-1-benzopyran-4-one, 2,3-DIHYDRO-5,7-DIHYDROXY-2-(3-HYDROXY-4-METHOXYPHENYL)-4H-1-BENZOPYRAN-4-ONE, 4H-1-Benzopyran-4-one,2,3-dihydro-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-, (2S)-" C16H14O6 AIONOLUJZLIMTK-AWEZNQCLSA-N (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-2,3-dihydrochromen-4-one n.a. Anticholesteremic Agents No No No No Yes Yes rxn07811,rxnDiet138,rxnAdd74,rxnAdd75 EX_hst(e),HST_3_GLC_GLCAASE,HST_3_GLC_GLCAASEe,HST_3_GLC_GLCAASEepp,HST_7_GLC_GLCAASE,HST_7_GLC_GLCAASEe,HST_7_GLC_GLCAASEepp,HSTte,HSTtepp,HSTtex PMDBD2000840 Hetacillin Therapeutic Substance Approved Drug 3511-16-8 DB00739 PA164746559 D01074 D0W7RJ 443387 391616 n.a. hetacillin, 3511-16-8, Hetacillinum, Versapen, Hetacilina, Hetacilline, Phenazacillin, Etacillina, Hetacillin acid, BL-P 804, BRL-804, UNII-TN4JSC48CV, TN4JSC48CV, CHEBI:5683, (2S,5R,6R)-6-[(4R)-2,2-dimethyl-5-oxo-4-phenylimidazolidin-1-yl]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, BLP-804, BL-P-804, EINECS 222-512-5, Hetacilina [INN-Spanish], Hetacilline [INN-French], Hetacillinum [INN-Latin], DTXSID4023121, N,N''-Isopropylidene-A-amino-benzyl penicillin, Hetacillin [USAN:USP:INN:BAN], 6-(2,2-Dimethyl-5-oxo-4-phenyl-1-imidazolidinyl)penicillansaeure, Hetacilina (INN-Spanish), Hetacilline (INN-French), Hetacillinum (INN-Latin), HETACILLIN (MART.), HETACILLIN [MART.], (2S,%R,6R)-6-(2,2-Dimethyl-5-oxo-4-phenyl-1-imidazolidinyl)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptan-2-carbonsaeure, 6-(2,2-Dimethyl-5-oxo-4-phenyl-1-imidazolidinyl)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 7-(2,2-dimethyl-5-oxo-4-phenyl-imidazolidin-1-yl)-3,3-dimethyl-6-oxo-2-thia-5-azabicyclo[3.2.0]heptane-4-carboxylic acid, Hetacillin (USAN:USP:INN:BAN), 6beta-[(4R)-2,2-dimethyl-5-oxo-4-phenylimidazolidin-1-yl]penicillanic acid, 4-THIA-1-AZABICYCLO(3.2.0)HEPTANE-2-CARBOXYLIC ACID, 6-((4R)-2,2-DIMETHYL-5-OXO-4-PHENYL-1-IMIDAZOLIDINYL)-3,3-DIMETHYL-7-OXO-, (2S,5R,6R)-, 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(2,2-dimethyl-5-oxo-4-phenyl-1-imidazolidinyl)-3,3-dimethyl-7-oxo-, (2S-(2alpha,5alpha,6beta(S*)))-, Etacillina [DCIT], BRL 804, 6beta-((4R)-2,2-dimethyl-5-oxo-4-phenylimidazolidin-1-yl)penicillanic acid, Versapen (TN), (2S,5R,6R)-6-((4R)-2,2-dimethyl-5-oxo-4-phenylimidazolidin-1-yl)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(2,2-Dimethyl-5-oxo-4-phenyl-1-imidazolidinyl)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 6beta-((4R)-2,2-dimethyl-5-oxo-4-phenylimidazolidin-1-yl)-2,2-dimethylpenam-3alpha-carboxylic acid, 6beta-[(4R)-2,2-dimethyl-5-oxo-4-phenylimidazolidin-1-yl]-2,2-dimethylpenam-3alpha-carboxylic acid, HETACILLIN [MI], HETACILLIN [INN], Hetacillin (USAN/INN), HETACILLIN [USAN], HETACILLIN [WHO-DD], SCHEMBL34131, DTXCID503121, CHEMBL1201116, HETACILLIN [ORANGE BOOK], GTPL12263, HY-16251A, AKOS027381814, CS-4870, DB00739, D01074, EN300-19734686, Q5746710, (2S,5R,6R)-6-((R)-2,2-dimethyl-5-oxo-4-phenylimidazolidin-1-yl)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 4-THIA-1-AZABICYCLO(3.2.0)HEPTANE-2-CARBOXYLIC ACID, 6-(2,2-DIMETHYL-5-OXO-4-PHENYL-1-IMIDAZOLIDINYL)-3,3-DIMETHYL-7-OXO-, (2S-(2.ALPHA.,5.ALPHA.,6.BETA.(S*)))- C19H23N3O4S DXVUYOAEDJXBPY-NFFDBFGFSA-N (2S,5R,6R)-6-[(4R)-2,2-dimethyl-5-oxo-4-phenylimidazolidin-1-yl]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid Bristol Laboratories Inc Div Bristol Myers Co Antibiotics No No No No No No PMDBD2000841 Hexameric peptide n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000842 Hexyl gallate n.a. n.a. n.a. n.a. n.a. n.a. n.a. 9831030 n.a. n.a. Hexyl gallate, Hexyl 3,4,5-trihydroxybenzoate, 1087-26-9, P2FVT76J5V, SCHEMBL36232, Hexyl3,4,5-trihydroxybenzoate, CHEMBL273804, DTXSID20431397, DQHJNOHLEKVUHU-UHFFFAOYSA-N, AKOS040733376, MS-23580, HY-135652, CS-0113693, Benzoic acid, 3,4,5-trihydroxy-, hexyl este, G12124 C13H18O5 DQHJNOHLEKVUHU-UHFFFAOYSA-N hexyl 3,4,5-trihydroxybenzoate n.a. n.a. No No No No No No PMDBD2000843 Hinokitiol Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D0H4YW 3611 n.a. n.a. hinokitiol, 499-44-5, beta-Thujaplicin, 4-Isopropyltropolone, Hinokitol, beta-Thujaplicine, Isopropyltropolone, THUJAPLICIN, BETA, Tropolone, 4-isopropyl-, .beta.-Thujaplicin, beta-Isopropyltropolon, 2-Hydroxy-4-isopropyl-2,4,6-cycloheptatrien-1-one, 2,4,6-Cycloheptatrien-1-one, 2-hydroxy-4-(1-methylethyl)-, 2-Hydroxy-4-isopropylcyclohepta-2,4,6-trien-1-one, beta-Isopropyltropolone, .beta.-Isopropyltropolon, b-Thujaplicin, NSC 18804, .beta.-Thujaplicine, 2-Hydroxy-4-(1-methylethyl)-2,4,6-cycloheptatrien-1-one, 2-hydroxy-6-propan-2-ylcyclohepta-2,4,6-trien-1-one, NSC18804, CHEMBL48310, MLS001048906, 2-hydroxy-4-(propan-2-yl)cyclohepta-2,4,6-trien-1-one, Hinokitiol 4-Isopropyltropolone, U5335D6EBI, 2-Hydroxy-4-isopropyl-2,4,6-cyclohepta-2,4,6-trien-1-one, CHEBI:10447, MFCD00040180, NSC-18804, SMR000387099, 2,4,6-CYCLOHEPTATRIEN-1-ONE, 2-HYDROXY-4-ISOPROPYL-, |A-Thujaplicin, 2-Hydroxy-4-isopropyl-cyclohepta-2,4,6-trien-1-one, EINECS 207-880-7, BRN 2045206, UNII-U5335D6EBI, AI3-28398, |A-thujaplici, beta -thujaplicin, beta -thujaplicine, 6-Isopropyl-tropolon, Thujaplicin, .beta., 2-hydroxy-4-isopropyl- 2,4,6-cycloheptatriene-1-one, 4-isopropyl-tropolone, beta -isopropyltropolon, beta-Thujaplicin, 99%, 4(6)-Isopropyltropolone, HINOKITIOL [INCI], NCIMech_000141, cid_3611, HINOKITIOL [WHO-DD], BSPBio_001025, KBioGR_000365, KBioSS_000365, 4-08-00-00488 (Beilstein Handbook Reference), BIDD:ER0491, SCHEMBL158795, SPECTRUM1505160, 2-hydroxy-6-isopropyl-cyclohepta-2,4,6-trien-1-one, DTXSID6043911, BDBM79632, FUWUEFKEXZQKKA-UHFFFAOYSA-, KBio2_000365, KBio2_002933, KBio2_005501, KBio3_000709, KBio3_000710, WLN: L7VJ BQ DY1&1, .BETA.-THUJAPLICIN [MI], AMY3994, Bio2_000343, Bio2_000823, HMS1362C07, HMS1792C07, HMS1990C07, HMS2269D23, HMS3403C07, HY-B2230, BDBM50330794, CCG-35378, s4771, AKOS015895184, AKOS037515521, CS-7724, KS-5297, IDI1_002098, QTL1_000044, NCGC00094565-01, NCGC00094565-02, NCGC00094565-03, NCGC00094565-04, NCGC00094565-05, NCGC00179338-01, NCI60_001565, SY052139, H0142, NS00003151, C09904, C75327, D04876, EN300-222362, beta-Thujaplicin, SAJ special grade, >=99.0%, 2-Hydroxy-4-isopropyl-2,6-cycloheptatrien-1-one, 2-Hydroxy-4-isopropyl-cyclohepta-2,4,6-trienone, A923788, SR-01000737397, 2,6-Cycloheptatrien-1-one, 2-hydroxy-4-isopropyl-, 2-hydroxy-4-isopropyl-cyclohepta2,4,6-trien-1-one, J-521461, Q2705171, SR-01000737397-2, 2-Hydroxy-4-isopropyl-2,4, 6-cycloheptatrien-1-one, BRD-K37691127-001-02-2, 2-hydroxy-6-propan-2-yl-1-cyclohepta-2,4,6-trienone, 2-oxidanyl-6-propan-2-yl-cyclohepta-2,4,6-trien-1-one, Z1255485978, 2,6-Cycloheptatrien-1-one, 2-hydroxy-4-(1-methylethyl)-, (2E,4Z,6Z)-2-hydroxy-4-isopropylcyclohepta-2,4,6-trienone, 2-Hydroxy-4(6)-(1-methylethyl)-2,4,6-cycloheptatrien-1-one, 9CI, InChI=1/C10H12O2/c1-7(2)8-4-3-5-9(11)10(12)6-8/h3-7H,1-2H3,(H,11,12) C10H12O2 FUWUEFKEXZQKKA-UHFFFAOYSA-N 2-hydroxy-6-propan-2-ylcyclohepta-2,4,6-trien-1-one n.a. n.a. No No No No No No PMDBD2000844 Histatin 5 n.a. n.a. n.a. n.a. n.a. n.a. n.a. 16132417 n.a. n.a. HISTATIN 5, DSHAKRHHGYKRKFHEKHHSHRGY, Salivary histatin 5, 115966-68-2, UNII-4281SUF5M7, 4281SUF5M7, Peptide F-A (human parotid saliva), H-Asp-Ser-His-Ala-Lys-Arg-His-His-Gly-Tyr-Lys-Arg-Lys-Phe-His-Glu-Lys-His-His-Ser-His-Arg-Gly-Tyr-OH, Hsn-5, CHEMBL374426, GLXC-26159 C133H195N51O33 KSXBMTJGDUPBBN-VPKNIDFUSA-N (4S)-4-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-carboxypropanoyl]amino]-3-hydroxypropanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]propanoyl]amino]hexanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]acetyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]hexanoyl]amino]-5-carbamimidamidopentanoyl]amino]hexanoyl]amino]-3-phenylpropanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-5-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-5-carbamimidamido-1-[[2-[[(1S)-1-carboxy-2-(4-hydroxyphenyl)ethyl]amino]-2-oxoethyl]amino]-1-oxopentan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-1-oxohexan-2-yl]amino]-5-oxopentanoic acid n.a. n.a. No No No No No No PMDBD2000845 hLF1-11 n.a. n.a. n.a. n.a. n.a. n.a. n.a. 25087507 n.a. n.a. hLF1-11, CHEMBL1213342, EX-A7461, 183623-03-2 C56H95N25O14S QFKUCTWLKINAOY-SNOMRCCPSA-N (2S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[(2-aminoacetyl)amino]-5-(diaminomethylideneamino)pentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-3-hydroxypropanoyl]amino]-3-methylbutanoyl]amino]-5-oxopentanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-3-sulfanylpropanoyl]amino]propanoic acid n.a. n.a. No No No No No No PMDBD2000846 Holothuroidin 1 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000847 Holothuroidin 2 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000848 Hsn5 12-mer n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000849 Human beta-defensin 3 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000850 Hydnocarpin D n.a. n.a. n.a. n.a. n.a. n.a. n.a. 11431204 n.a. NPC113163 Hydnocarpin D, CHEMBL89401 C25H20O9 ZYWKQKQEAVWKHD-ILBGXUMGSA-N 5,7-dihydroxy-2-[(2R,3R)-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-2,3-dihydro-1,4-benzodioxin-6-yl]chromen-4-one n.a. n.a. No No No No No No PMDBD2000851 Hydrogen peroxide Therapeutic Substance Approved Drug 7722-84-1 DB11091 n.a. n.a. D03IDU 784 763 n.a. hydrogen peroxide, 7722-84-1, oxydol, perhydrol, Interox, Inhibine, Superoxol, Albone, Kastone, Hydrogen dioxide, Albone 35, hydroperoxide, T-Stuff, Peroxaan, Elawox, Hioxyl, Lensept, Perone, Albone 35CG, Albone 50, Albone 50CG, Albone 70, Albone 70CG, Perone 50, Albone DS, Dihydrogen dioxide, Peroxide, H2O2, Hydrogen peroxide, 30%, Peroxan, Perone 30, Perone 35, Hydrogen peroxide (H2O2), Hydrogen peroxide, 3%, Caswell No. 486AAA, Hydrogen peroxide, 90%, dioxidane, Oxyfull, Eskata, Hyrogen peroxide, Waterstofperoxyde, Wasserstoffperoxid, CCRIS 1060, HSDB 547, Astri-UC, High Test Peroxide, Peroxyde d''hydrogene, Teat dip HP 5, Perossido di idrogeno, Asepticper, Baquashock, Crystacide, Peroxclean, Pre milk HP 0.5, Pre milk HP 1.0, Dentasept, Hybrite, Metrokur, Mirasept, Oxigenal, Oxysept, Pegasyl, EPA Pesticide Chemical Code 000595, Hipox, Hydrogen peroxide, 8% to 20%, Select Bleach, Xtra White, Hydrogen peroxide (conc > 52%), Hydrogen peroxide, 20% to 60%, Oxysept I, Lensan A, Odosat D, UNII-BBX060AN9V, Adeka Super EL, dihydrogen peroxide, EINECS 231-765-0, BBX060AN9V, HTP [peroxide], Crestal Whitestrips, NSC 19892, NSC-19892, Pre milk HP 0.5 10, UN2014, UN2015, UN2984, dihydrogen(peroxide), Anti-Keim 50, HOOH, UN 2015 (>52%), CHEBI:16240, UN 2984 (8%-20%), UN 2014 (20%-52%), Hydrogen peroxide (> 52% conc.), Hydrogen peroxide (USP), Hydrogen peroxide [USP], MFCD00011333, bis(hydridooxygen)(O--O), DTXSID2020715, EC 231-765-0, HTP (peroxide), NSC19892, 8007-30-5, PEO, HYDROGEN PEROXIDE (II), HYDROGEN PEROXIDE [II], (OH(OH)), [OH(OH)], HYDROGEN PEROXIDE (IARC), HYDROGEN PEROXIDE [IARC], HYDROGEN PEROXIDE (MART.), HYDROGEN PEROXIDE [MART.], Puresept, hydrogenperoxide, Waterstofperoxyde [Dutch], Wasserstoffperoxid [German], HYDROGEN PEROXIDE (USP IMPURITY), HYDROGEN PEROXIDE [USP IMPURITY], Peroxide, Hydrogen, CIX, Peroxyde d''hydrogene [French], Perossido di idrogeno [Italian], Hydrogen peroxide 35%, Whitespeed, Oxymate, Periogel, CleanCleaner, PerioRestore, a peroxide, OxiStom, PODConcentrate, Magic Bleaching, Clarigel Gold, Eco Whitening, Lase Peroxide, Quasar Brite, Opalescence Xtra, Perio Armor, Perio Plus, White Labs, Whiteness HP, Deslime LP, Gil Peroxy-Plus, Premium Whitening, Hydrogen peroxide (conc >52%), Perio Max Plus, OROXID Sensitiv, Perio Armor-X, hydrogen per oxide, Hydrogern Peroxide, OxyBlend55, BioFilm Blast MD, Gil Sani-Ox, Tooth Whole White, Concentrate H2O2, ActiveOxy 55, Henry Schein Mouth, Blossom HP 3, Dynarex HP 3, Luzen Whitening Gel, Oral B Mouth Sore, Oral Wound Cleanser, Oxyfull (TN), Perio Daily Defense, Sore Mouth Cleanser, ActiveOxy 110, 3 Hydrogen Peroxide, Hydrogen Peroxide3%, Q2 Oral Care Kit, Resiclean Concentrate, hydrogen hydroperoxide, Medline Peroxi Fresh, OXYBLEND, OXYBLENDLE, PREOP, Nite White Excel 2, Prima HP10, TRIZ sanitizer wipes, Perox 50, Zee Hydrogen Peroxide, 35% Perox-Aid, 3% Hydrogen Peroxide, Hydrogen Peroxide 3%, OPTION ONE, Milkhouse BrandOxy Dip, OXY-PLEX, Perox-A-Mint Solution, Teat Dip HP 10, Humco Hydrogen Peroxide, maxim Hydrogen Peroxide, Oxydol (JP17), Perox 100, Perox 102, Perox 105, Perox-400, PRO-SYS, Xpect Hydrogen Peroxide, Hydrogen peroxide 50%, 16oz Hydrogen Peroxide, 32oz Hydrogen Peroxide, HYDORGEN PEROXIDE, HYDROGEN-PEROXIDE, Antiseptic Oral Cleanser, Multipurpose Disinfectant, CURAD Hydrogen Peroxide, MIRAPHA30, aramark Hydrogen Peroxide, OXYDOL [JAN], 1.5% Hydrogen Peroxide, 1.7% Hydrogen Peroxide, Hydrogen Peroxide 3.0%, ECOLAB Hydrogen Peroxide, Hydrogen peroxide (8CI), Aplicare Hydrogen Peroxide, Hydrogen Peroxide3 Percent, Medic Booster Peroxide Dip, MolMap_000025, DOP Hydrogen Peroxide 3%, HCS Hydrogen Peroxide 3%, MediFirst Hydrogen Peroxide, 100 toothpast e Afternoon, OROXID Forte Oral Hygiene, TDPL-12x5, TDPL-15x5, 3 percent Hydrogen Peroxide, 3% Hydrogen Peroxide Wipes, Hydrogen Peroxide Antiseptic, Water Jel Hydrogen Peroxide, Biopure 3 Hydrogen Peroxide, Maokang 3 Hydrogen Peroxide, Hydrogen Peroxide Oral Rinse, Medi-First Hydrogen Peroxide, OXY-PLEX 1-2, Short Term Oral Care System, Short Term Oral Swab System, TDP-12x5, TDP-15x5, Hydrogen Peroxide3% Solution, Medline Peroxi FreshMouthwash, TDPL-12, EVAXO 3% Hydrogen Peroxide, Green Guard Hydrogen Peroxide, Peroxyl Mouth Sore Mild Mint, CHEMBL71595, DTXCID40715, Hydrogen peroxide 32 wt. %, Crane Safety Hydrogen Peroxide, Pre-Treatment Antiseptic Rinse, 1%/10% Elite Peroxide Dip, 16OZ HYDORGEN PEROXIDE, HYDROGEN PEROXIDE [MI], TDP-12, HYDROGEN PEROXIDE [FCC], PEROXY SHIELD MOUTH SORE, ReddyPort Antiseptic Oral Rinse, SMART SENSE Hydrogen Peroxide, HYDROGEN PEROXIDE [HSDB], HYDROGEN PEROXIDE [INCI], Hydrogen peroxide, 6% in water, CHEBI:25940, Pro Brighten Tooth whitening Gel, First Aid Only Hydrogen Peroxide, GNP Hydrogen Peroxide 3 Percent, HYDROGEN PEROXIDE [VANDF], Hydrogen Peroxide Debriding Agent, 0.5% Hydrogen Peroxide Teat Dip, AST Inc. ASTI-OXY TEAT DIP, Topcare 3 Hydrogen Peroxide Wipes, USUALKLENZ DISINFECTANTSPRAY, HYDROGEN PEROXIDE [WHO-DD], CVS Health Hydrogen Peroxide Wipes, Hydrogen peroxide (H2O2) (9CI), DenMat Hydrogen Peroxide Oral Rinse, Kimvent Oral Care Suction Swab pack, OXTERIL? 350 SPRAY (Evonik), Prevent Hydrogen Peroxide 3 Percent, Sunmark Hydrogen Peroxide 3 Percent, WLN: H2 O2 90%, Good Hygiene Therapeutic Mouth Rinse, Hydrogen PeroxideFirst Aid Antiseptic, Oral B Mouth SoreSpecial Care Rinse, First Aid Only Hydrogen Peroxide 3%, LUCKY SUPER SOFT Hydrogen Peroxide, Up and Up 3 Hydrogen Peroxide Wipes, AKOS015856794, HYDROGEN PEROXIDE [GREEN BOOK], Hydrogen peroxide compound disinfectant, Quality Choice Hydrogen Peroxide Wipes, DB11091, HYDROGEN PEROXIDE [ORANGE BOOK], Hydrogen Peroxide3 Percent ReadyInCase, North Country Dairy Supply TD7810HP, Prima Sanitizing pre and post teat dip, American Red Cross 3 Hydrogen Peroxide, Pharmacys Prescription Hydrogen Peroxide, QTL1_000041, Yueliangyuan 3% Hydrogen Peroxide Wipes, Health Mart Hydrogen Peroxide 3 Percent, Hydrogen peroxide, 50% aqueous solution, Hydrogen PeroxideLil Drug Store Products, Hydrogen Peroxide Topical Solution U.S.P, HYR Hydrogen PeroxideFirst Aid Antiseptic, Multi Purpose Sanitizer and Cleaner Wipes, OxyCide AMS Peroxide Sanitizing Teat Dip, Pharma-C-Wipes 3 Hydrogen Peroxide Wipes, Suction Swabs with Perox-A-Mint Solution, Unpa Cha Cha Premium Whitening Toothpaste, H1222, Nobda Hydrogen peroxide compound disinfectant, NS00013746, OxyCide 5-AMS Peroxide Sanitizing Teat Dip, Your Label Here Hydrogen Peroxide First Aid, LUCKY SUPER SOFT Hydrogen Peroxide3 Percent, MediChoice of Hydrogen Peroxide 3 10 Volume, Suction Toothbrush with Perox-A-Mint Solution, C00027, D00008, SFP INC. OXY-TD SANITIZING PRE TEAT DIP, The Pharma-C Company 3 Hydrogen Peroxide Wipes, Q171877, Q1088474, New Life 3% Hydrogen Peroxide FIRST AID ANTISEPTIC, Salon Safety Furniture and Surface 1 Minute Sanitizer, Suction Swab System with Perox-A-Mint Solution-Suction Swab, Ultra-Concentrated, Premium, Moderate-Foam Teat Dip Concentrate, Hydrogen peroxide 30%, meets the analytical specifications of Ph. Eur., stabilized, Suction Swab System with Perox-A-Mint Solution-Suction Swab and Suction Toothbrush H2O2 MHAJPDPJQMAIIY-UHFFFAOYSA-N hydrogen peroxide n.a. n.a. No No No No No No PMDBD2000852 Hypericin Therapeutic Substance n.a. 548-04-9 DB13014 n.a. n.a. n.a. 3663 4444511 n.a. hypericin, 548-04-9, Hypericum red, hipericin, hipericina, hypericine, Hyperizin, Cyclo-Werol, Cyclosan, Mycoporphyrin, SGX301, 1,3,4,6,8,13-Hexahydroxy-10,11-dimethylphenanthro[1,10,9,8-opqra]perylene-7,14-dione, VIMRxyn, Hypericin [USAN], SGX-301, Hypericin (SGX301), 4,5,7,4'',5'',7''-Hexahydroxy-2,2''-dimethylnaphthodianthrone, NSC407313, Hypericin & Visible light, NSC-407313, CHEBI:5835, CHEMBL286494, 7V2F1075HD, MFCD00016683, NSC622946, Cyclo werrol, 1,3,4,6,8,13-Hexahydroxy-10,11-dimethylphenanthro(1,10,9,8-opqra)perylene-7,14-dione, Phenanthro[1,10,9,8-opqra]perylene-7,14-dione, 1,3,4,6,8,13-hexahydroxy-10,11-dimethyl-, 9,11,13,16,18,20-hexahydroxy-5,24-dimethyloctacyclo[13.11.1.12,10.03,8.04,25.019,27.021,26.014,28]octacosa-1(26),2,4(25),5,8,10,12,14(28),15(27),16,18,20,23-tridecaene-7,22-dione, hexahydroxy(dimethyl)[?]dione, 1:6:8:10:11:13-hexahydroxy-3:4-dimethyl-meso-naphthodianthrene-7:14-dione, C30H16O8, Phenanthro(1,10,9,8-opqra)perylene-7,14-dione, 1,3,4,6,8,13-hexahydroxy-10,11-dimethyl-, 5,7,11,18,22,24-hexahydroxy-13,16-dimethyloctacyclo[13.11.1.12,10.03,8.04,25.019,27.021,26.014,28]octacosa-1(27),2(28),3,5,7,10,12,14,16,18,21,23,25-tridecaene-9,20-dione, EINECS 208-941-0, NSC 407313, NSC 622946, UNII-7V2F1075HD, Cyclo werro, CCRIS 8166, hypericin [INN], (component of) Hypericum spp (st. John''s wort), BiomolKI_000032, 4,5,7,4'',5'',7''-Hexahydroxy-2,2''-dimethyl-mesonapthtodianthron, BiomolKI2_000040, HYPERICIN [WHO-DD], SCHEMBL3182, BIDD:PXR0084, BMK1-D8, CHEMBL5082596, SCHEMBL10262695, DTXSID40203270, YDOIFHVUBCIUHF-UHFFFAOYSA-N, Hypericin - CAS 548-04-9, Hypericin from Hypericum perforatum, HY-N0453, BDBM50060874, CCG-36081, HB3934, HSCI1_000202, LMPK13040001, WHO 11835, AKOS015895658, AC-6048, CS-5687, NSC-622946, NCGC00162454-01, NCGC00163378-01, NCGC00163378-02, AS-74733, NCI60_003879, NCI60_006799, NS00001496, C07606, M01850, A870351, SR-05000002344, Hypericin from Hypericum perforatum, ~95% (HPLC), Hypericin, primary pharmaceutical reference standard, Q-100618, SR-05000002344-2, BRD-K29673530-001-03-9, Z1736866019, Hypericin is known as an anthroquinone derivative found in St. John''s Wort., 1,3,4,6,8,13-Hexahydroxy-10,11-dimethylphenanthro[1,10,9,8-opqra]perylene-7,14-dione, 9CI, 1,4,6,8,13-Hexahydroxy-10,11-dimethylphenanthro [1,10,9,8-opqra]perylene-7,14-dione P-conformer, 5,7,11,18,22,24-HEXAHYDROXY-13,16-DIMETHYLOCTACYCLO[13.11.1.1(2),(1)?.0(3),?.0?,(2)?.0(1)?,(2)?.0(2)(1),(2)?.0(1)?,(2)?]OCTACOSA-1,3,5,7,10,12,14(28),15(27),16,18,21,23,25-TRIDECAENE-9,20-DIONE, InChI=1/C30H16O8/c1-7-3-9(31)19-23-15(7)16-8(2)4-10(32)20-24(16)28-26-18(12(34)6-14(36)22(26)30(20)38)17-11(33)5-13(35)21(29(19)37)25(17)27(23)28/h3-6,31-36H,1-2H, Phenanthro[1,10,9,8-opqra]perylene-7,14-dione,1,3,4,6,8,13-hexahydroxy-10,11-dimethyl-, stereoisomer, Phenanthro[1,9,8-opqra]perylene-7,14-dione,1,3,4,6,8,13-hexahydroxy-10,11-dimethyl-, stereoisomer, rac-(3aM,10aM)-1,3,4,6,8,13-hexahydroxy-10,11- dimethylphenanthro[1,10,9,8-opqra]perylene-7,14- dione C30H16O8 YDOIFHVUBCIUHF-UHFFFAOYSA-N 9,11,13,16,18,20-hexahydroxy-5,24-dimethyloctacyclo[13.11.1.12,10.03,8.04,25.019,27.021,26.014,28]octacosa-1(26),2,4(25),5,8,10,12,14(28),15(27),16,18,20,23-tridecaene-7,22-dione n.a. n.a. No No No No No No PMDBD2000853 Hyperoside n.a. n.a. n.a. n.a. n.a. n.a. n.a. 5281643 n.a. NPC281131 Hyperoside, 482-36-0, Hyperin, Hyperosid, Quercetin 3-galactoside, Hyperozide, Quercetin-3-O-galactoside, Quercetin-3-galactoside, quercetin galactoside, Quercetin 3-D-galactoside, Quercetin 3-O-beta-D-galactopyranoside, Hyperasid, Jyperin, quercetin 3-O-galactoside, QUERCETIN 3-B-D-GALACTOSIDE, Quercetin 3-beta-D-galactopyranoside, NSC 407304, UNII-8O1CR18L82, CCRIS 9339, CHEBI:67486, 8O1CR18L82, EINECS 207-580-6, MFCD00016933, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-(((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-4H-chromen-4-one, CHEMBL251254, Quercetin 3-O-beta-D-galactoside, 2-(3,4-Dihydroxyphenyl)-3-(beta-D-galactopyranosyloxy)-5,7-dihydroxy-4H-1-benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one, Quercetin 3-.beta.-D-galactopyranoside, HYPEROSIDE (USP-RS), HYPEROSIDE [USP-RS], Isoquercitrin, 3,3'',4'',5,7-Pentahydroxyflavone 3-D-galactoside, 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-3-(.beta.-D-galactopyranosyloxy)-5,7-dihydroxy-, NSC-407304, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4H-chromen-3-yl beta-D-galactopyranoside, 2-[3,4-bis(oxidanyl)phenyl]-3-[(2S,3R,4S,5R,6R)-6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-5,7-bis(oxidanyl)chromen-4-one, 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-3-(beta-D-galactopyranosyloxy)-5,7-dihydroxy-, p Hyperin, Quercetin 3-O-.beta.-D-galactopyranoside, Hyperin,(S), BIDD:PXR0057, MLS000759538, 2-yloxy)-4H-chromen-4-one, jm5b01461, Compound 84, MEGxp0_000392, SCHEMBL1250514, ACon1_000623, BDBM429266, DTXSID501028789, HMS2051H17, HY-N0452, BDBM50241367, s5453, AKOS015896780, 6-(hydroxymethyl)tetrahydro-2H-pyran-, CCG-100970, NC00220, NCGC00168902-03, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-chromen-4-one, AS-56199, SMR000466394, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-, 1ST000529, QUERCETIN 3-O-.BETA.-D-GALACTOSIDE, CS-0008982, NS00079301, Quercetin 3-D-galactoside, >=97.0% (HPLC), AB00639910-03, 3-((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-, HYPEROSIDE (CONSTITUENT OF ST. JOHN''S WORT), Hyperoside, primary pharmaceutical reference standard, Q-100530, Q5242815, BRD-K84955386-001-01-1, 3-O-b-D-Galactopyranosyloxy-3'',4'',5,7-tetrahydroxyflavone, HYPEROSIDE (CONSTITUENT OF ST. JOHN''S WORT) [DSC], HYPEROSIDE (CONSTITUENT OF HAWTHORN LEAF WITH FLOWER), Hyperoside, United States Pharmacopeia (USP) Reference Standard, 2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4H-chromen-3-yl hexopyranoside #, 2-(3,4-Dihydroxy-phenyl)-5,7-dihydroxy-3-((2S,4R,5R)-3,4,5-trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-chromen-4-one, 2-(3,4-DIHYDROXYPHENYL)-3-(.BETA.-D-GALACTOPYRANOSYLOXY)-5,7-DIHYDROXY-4H-1-BENZOPYRAN-4-ONE, 2-(3,4-dihydroxyphenyl)-3-(alpha-D-galactopyranosyloxy)-5,7-dihydroxy-4H-1-benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)-4H-chromen-4-one, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4H-chromen-4-one, J6O C21H20O12 OVSQVDMCBVZWGM-DTGCRPNFSA-N 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one n.a. n.a. No No No No No No PMDBD2000854 IDR-1018 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000855 IG-13 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000856 IG-19 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000857 IG-25 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000858 Imazalil n.a. n.a. n.a. n.a. n.a. n.a. n.a. 37175 n.a. n.a. "IMAZALIL, Enilconazole, 35554-44-0, Deccozil, Bromazil, Fungaflor, Imaverol, Clinafarm, Chloramizol, Florasan, Fungazil, Magnate, Eniloconazol (SP), Deccozil S 75, NuZone, Enilconazole (BPC), Deccosil, Freshgard, 1H-Imidazole, 1-[2-(2,4-dichlorophenyl)-2-(2-propenyloxy)ethyl]-, 1-(2-(Allyloxy)-2-(2,4-dichlorophenyl)ethyl)-1H-imidazole, FloPro IMZ, R 23979, Amolden MP 100, Enilconazol, 73790-28-0, CGA 41333, Imazalil [ANSI:BSI:ISO], 1-[2-(Allyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole, imazalil sulphate, CHEBI:83829, MFCD00055331, Enilconazole (USAN/INN), R-23979, NSC-759313, 6K0NOF3XQ6, Enilconazole for veterinary use, 1-[2-(2,4-dichlorophenyl)-2-prop-2-enoxyethyl]imidazole, Allyl-1-(2,4-dichlorophenyl)-2-imidazol-1-ylethyl ether, (+-)-1-(beta-(Allyloxy)-2,4-dichlorophenethyl)-imidazole, 1398065-91-2, DTXSID8024151, (+ or -)-1-(beta-allyloxy-2,4-dichlorophenylethyl)imidazole, 1-(2-(2,4-Dichlorophenyl)-2-(2-propenyloxy)ethyl)-1H-imidazole, R 23,979, CGA-41333, Imazalil 1000 microg/mL in Acetone, Imazalil 10 microg/mL in Acetonitrile, Imazalil 100 microg/mL in Acetonitrile, 1-(2-(2,4-Dichlorphenyl)-2-(2-propenyloxy)aethyl)-1H-imidazol, Imazalil-d5 100 Amicrog/mL in in Acetone, imazalil phosphate, imazalil mononitrate, DTXCID504151, chloramizole, Caswell No. 497AB, 1H-Imidazole, 1-(2-(2,4-dichlorophenyl)-2-(2-propenyloxy)ethyl)-, 1-[2-allyloxy-2-(2,4-dichlorophenyl)ethyl]imidazole, Enilconazole [USAN:BAN:INN], HSDB 6672, EINECS 252-615-0, imazalil sulfate (1:1), UNII-6K0NOF3XQ6, EPA Pesticide Chemical Code 111901, BRN 0545683, Eniloconazol, Freshguard, Fecundal, Imaversol, Rappor plus, Fung-azil, Enilconazole [USAN:INN:BAN], Deccozil S75, Flo Pro IMZ, CAS-35554-44-0, Fecundal (Salt/Mix), Imazalil (enilconazole), IMAZALIL [ISO], Rappor plus (Salt/Mix), (.+/-.)-Imazalil, 33586-66-2, Prestwick0_000963, Prestwick1_000963, Prestwick2_000963, Prestwick3_000963, ENILCONAZOLE [MI], ENILCONAZOLE [INN], Imazalil sulphate (1:1), (+ or -)-1-(2-(2,4-dichlorophenylethyl)-2-(2-propenyloxy)ethyl)-1H-imidazole, 1-(2-(2,4-Dichlorphenyl)-2-(2-propenyloxy)aethyl)-1H-imidazol [German], ENILCONAZOLE [HSDB], ENILCONAZOLE [USAN], SCHEMBL22498, BSPBio_000965, ENILCONAZOLE [MART.], Imazalil, analytical standard, MLS002154075, Imazalil, ANSI, BSI, ISO, SPBio_002886, BPBio1_001063, CHEMBL356918, 1-[2-(Allyloxy)-2-(2,4-dichlorophenyl)ethyl]imidazole, PZBPKYOVPCNPJY-UHFFFAOYSA-, HMS1571A07, HMS2094C13, HMS2098A07, HMS3041C20, HMS3715A07, Pharmakon1600-01506067, AMY22447, HY-B1134, Tox21_201551, Tox21_300720, BDBM50051843, NSC759313, s5053, Imazalil 10 microg/mL in Cyclohexane, 1H-Imidazole, 1-(2-(2,4-dichlorophenyl)-2-(2-propenyloxy)ethyl)-, (+-)-, AKOS015895066, CCG-220963, CS-4739, NSC 759313, NCGC00163778-01, NCGC00163778-03, NCGC00163778-04, NCGC00163778-05, NCGC00163778-06, NCGC00163778-07, NCGC00254626-01, NCGC00259100-01, AC-15959, AS-10962, SMR000777988, SY104743, AB00513978, Imazalil, PESTANAL(R), analytical standard, NS00009564, C18739, D03997, AB00513978_06, A822869, Q421576, SR-01000855376, SR-01000855376-2, BRD-A11776908-001-03-6, BRD-A11776908-001-06-9, ENILCONAZOLE FOR VETERINARY USE [EP MONOGRAPH], 1-[2-(Allyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole #, 1-[2-allyloxy-2-(2,4-dichlorophenyl)ethyl]imidazole;Imazalil, Enilconazole, European Pharmacopoeia (EP) Reference Standard, (.+/-.)-1-(.beta.-(Allyloxy)-2,4-dichlorophenethyl)imidazole, (RS)-1-(.BETA.-ALLYLOXY-2,4-DICHLOROPHENETHYL)IMIDAZOLE, (+/-)-1-(.BETA.-(ALLYLOXY)-2,4-DICHLOROPHENETHYL)-IMIDAZOLE, (.+/-.)-1-[2-(2,4-Dichlorophenyl)-2-(2-propenyloxy)ethyl]-1H-imidazole, 1-[2-(2,4-Dichlorophenyl)-2-(2-propenyloxy)ethyl]-1H-imidazole, 9CI, 1-[2-(2,4-dichlorophenyl)-2-(prop-2-en-1-yloxy)ethyl]-1H-imidazole, (R,S)-1-(2-(2,4-DICHLOROPHENYL)-2-(2-PROPENYLOXY)ETHYL)-1H-IMIDAZOLE, 1-(2-(2,4-DICHLOROPHENYL)-2-(2-PROPEN-1-YLOXY)ETHYL)-1H-IMIDAZOLE, 1H-IMIDAZOLE, 1-(2-(2,4-DICHLOROPHENYL)-2-(2-PROPEN-1-YLOXY)ETHYL)-, 1H-IMIDAZOLE, 1-(2-(2,4-DICHLOROPHENYL)-2-(2-PROPENYLOXY)ETHYL)-, (+/-)-, 1H-Imidazole, 1-[2-(2,4-dichlorophenyl)-2-(2-propenyloxy)ethyl]-, (.+/-.)-, InChI=1/C14H14Cl2N2O/c1-2-7-19-14(9-18-6-5-17-10-18)12-4-3-11(15)8-13(12)16/h2-6,8,10,14H,1,7,9H2" C14H14Cl2N2O PZBPKYOVPCNPJY-UHFFFAOYSA-N 1-[2-(2,4-dichlorophenyl)-2-prop-2-enoxyethyl]imidazole n.a. n.a. No No No No No No PMDBD2000859 IMB-2 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000860 Imperatorin Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D09ROW 10212 n.a. NPC243509 "IMPERATORIN, 482-44-0, Ammidin, Marmelosin, Pentosalen, 8-Isoamylenoxypsoralen, 8-Isopentenyloxypsoralene, Marmelide, NSC 402949, 9-(3-methylbut-2-enoxy)furo[3,2-g]chromen-7-one, CCRIS 4346, HSDB 3497, 9-(3-Methylbut-2-enyloxy)furo(3,2-g)chromen-7-one, EINECS 207-581-1, 7H-Furo[3,2-g][1]benzopyran-7-one, 9-[(3-methyl-2-butenyl)oxy]-, NSC-402949, CHEBI:5885, DTXSID8048737, UNII-K713N25C78, AI3-61725, 9-[(3-methyl-2-buten-1-yl)oxy]-7H-furo[3,2-g]chromen-7-one, K713N25C78, 9-((3-Methyl-2-butenyl)oxy)-7H-furo(3,2-g)(1)benzopyran-7-one, CHEMBL453805, DTXCID5028663, 9-((3-methylbut-2-en-1-yl)oxy)-7H-furo[3,2-g]chromen-7-one, 9-[(3-methylbut-2-en-1-yl)oxy]-7H-furo[3,2-g]chromen-7-one, 7H-Furo(3,2-g)(1)benzopyran-7-one, 9-((3-methyl-2-butenyl)oxy)-, 5-Benzofuranacrylic acid, 6-hydroxy-7-((3-methyl-2-butenyl)oxy)-, delta-lactone, 6-Hydroxy-7-(3-methyl-2-butenyloxy)-5-benzofuranacrylic acid omega-lactone, 9-[(3-METHYL-2-BUTEN-1-YL)OXY]-7H-FURO[3,2-G][1]BENZOPYRAN-7-ONE, MFCD00016881, 9-(3-Methylbut-2-enyloxy)furo[3,2-g]chromen-7-one, 9-(3-Methylbut-2-enyloxy)-7H-furo(3,2-g)chromen-7-one, NCGC00095209-01, MARMELOSIN (USP-RS), MARMELOSIN [USP-RS], 9-(3-methylbut-2-enyloxy)-7H-furo[3,2-g]chromen-7-one, 9-[(3-methyl-2-butenyl)oxy]-7H-furo[3,2-g]-1-benzopyran-7-one, CAS-482-44-0, Pentosalen [BAN], 9-((3-methyl-2-butenyl)oxy)-7H-furo(3,2-g)-1-benzopyran-7-one, 9-((3-methylbut-2-en-1-yl)oxy)-7H-furo(3,2-g)chromen-7-one, 7H-Furo[3,2-g][1]benzopyran-7-one, 9-((3-methyl-2-butenyl)oxy)-, Pentasalen, BAN, Imperatorin,(S), 8-Prenyloxypsoralen, Spectrum_000755, SpecPlus_000755, IMPERATORIN [MI], Spectrum2_000376, Spectrum3_000145, Spectrum4_001422, Spectrum5_000244, PENTOSALEN [HSDB], [3,2-g]chromen-7-one, PENTOSALEN [WHO-DD], Oprea1_407817, SCHEMBL50437, BSPBio_001850, KBioGR_001864, KBioSS_001235, SPECTRUM102076, MLS000574838, DivK1c_006851, SPBio_000531, Marmelosin, analytical standard, MEGxp0_000089, ACon1_001117, KBio1_001795, KBio2_001235, KBio2_003803, KBio2_006371, KBio3_001050, HMS1922N22, HMS2218G08, HMS3261C08, HMS3354E04, HMS3885G06, BCP28280, HY-N0285, 8-(3-Methyl-2-butenyloxy)psoralen, Tox21_113179, Tox21_500413, BDBM50308719, CCG-38649, NSC402949, s3809, 9-(3-methylbut-2-enyloxy)-7H-furo, AKOS000277029, Tox21_113179_1, AC-8046, CS-5800, Imperatorin, >=98% (HPLC), powder, LP00413, SDCCGMLS-0066373.P001, SDCCGSBI-0052715.P002, NCGC00095209-02, NCGC00095209-03, NCGC00095209-04, NCGC00095209-05, NCGC00095209-06, NCGC00095209-12, NCGC00169661-01, NCGC00169661-02, NCGC00261098-01, AS-71539, SMR000156241, WLN: T C566 DO LVOTJ BO2UY1&1, I0904, NS00031781, 7H-Furo[3, 9-[(3-methyl-2-butenyl)oxy]-, C09269, A827504, SR-01000721772, Q-100532, Q1649534, SR-01000721772-2, 9-(3-Methyl-2-butenyloxy)-7-oxofuro[3,2-g]chromene, 9-(3-Methyl-but-2-enyloxy)-furo[3,2-g]chromen-7-one, Imperatorin, European Pharmacopoeia (EP) Reference Standard, 9-(3-methylbut-2-enoxy)furo[3,2-g]chromen-7-one;Imperatorin, 9-[(3-Methyl-2-butenyl)oxy]-7H-furo[3,2-g]chromen-7-one #, 9-[(3-methylbut-2-en-1-yl)oxy]-2H-furo[3,2-g]chromen-2-one, 9-[(3-Methylbut-2-enyl)oxy]-7H-furo[3,2-g][1]benzopyran-7-one, (9-[(3-methyl-2-buten-1-yl)oxy]-7H-furo[3,2-g][1]benzopyran-7-one), 6-Hydroxy-7-(3-Methyl-2-Butenyloxy)-5-Benzofuranacrylic Acid Gamma-Lactone, 6-Hydroxy-7-(3-methyl-2butenyloxy)-5-benzofuranacrylic acid delta-lactone, 7H-Furo[3,2-g][1]benzopyran-7-one, 9-[(3-methyl-2-buten-1-yl)oxy]-, 9-[(3-Methyl-2-butenyl)oxy]-7H-furo[3,2-g][1]benzopyran-7-one, 9CI, 5-Benzofuranacrylic acid, 6-hydroxy-7-((3-methyl-2-butenyl)oxy)-, .delta.-lactone, 6-HYDROXY-7-(3-METHYL-2-BUTENYLOXY)-5-BENZOFURANACRYLIC ACID .GAMMA.-LACTONE, InChI=1/C16H14O4/c1-10(2)5-7-19-16-14-12(6-8-18-14)9-11-3-4-13(17)20-15(11)16/h3-6,8-9H,7H2,1-2H" C16H14O4 OLOOJGVNMBJLLR-UHFFFAOYSA-N 9-(3-methylbut-2-enoxy)furo[3,2-g]chromen-7-one n.a. n.a. No No No No No No PMDBD2000861 Indirubin Therapeutic Substance n.a. 479-41-4 DB12379 n.a. n.a. n.a. 10177 4514277 n.a. "Indirubin, 479-41-4, Indigo Red, Couroupitine B, Indigopurpurin, 906748-38-7, (Z)-[2,3''-biindolinylidene]-2'',3-dione, Isoindirubin, Isoindirubine, Isoindogotin, 397242-72-7, (E)-[2,3''-biindolinylidene]-2'',3-dione, Indirubin [MI], NSC 105327, NSC-105327, 2H-Indol-2-one, 3-(1,3-dihydro-3-oxo-2H-indol-2-ylidene)-1,3-dihydro-, C.I. 73200, Indirubin 3E-form [MI], 3-(3-oxo-1H-indol-2-ylidene)-1H-indol-2-one, 1LXW6D3W2Z, V86L8P74GI, 2-(2-hydroxy-1H-indol-3-yl)indol-3-one, C.I. 75790, 3-(1,3-dihydro-3-oxo-2h-indol-2-ylidene)-1,3-dihydro-2h-indol-2-one, MFCD00956441, (Z)-[2,3 inverted exclamation mark -Biindolinylidene]-2 inverted exclamation mark ,3-dione, [2,3''-Biindolinylidene]-2'',3-dione, 3-(1,3-dihydro-3-oxo-2h-indol-2-ylidene)-1,3-dihydro-2h-indol-2-on, (3Z)-3-(1,3-Dihydro-3-oxo-2H-indol-2-ylidene)-1,3-dihydro-2H-indol-2-one, 2H-Indol-2-one,3-(1,3-dihydro-3-oxo-2H-indol-2-ylidene)-1,3-dihydro-, (3E)-3-(1,3-Dihydro-3-oxo-2H-indol-2-ylidene)-1,3-dihydro-2H-indol-2-one, 2H-Indol-2-one, 3-(1,3-dihydro-3-oxo-2H-indol-2-ylidene)-1,3-dihydro-, (3E)-, SMR000466311, BRN 0088279, UNII-V86L8P74GI, Indirubin,(S), Indirubin- Bio-X, INDARUBICIN, (delta2,3''-Biindoline)-2'',3-dione, CPD000466311, Indirubin derivative, 1, BiomolKI_000069, EM-A05-INDIRUBIN, [.DELTA.2,3-dione, BiomolKI2_000073, UNII-1LXW6D3W2Z, INDIRUBIN [WHO-DD], (3Z)-3-(3-oxoindolin-2-ylidene)indolin-2-one, (delta(sup 2,3'')-BIINDOLINE)-2'',3-DIONE, SCHEMBL27678, BMK1-G9, BSPBio_001110, KBioGR_000450, KBioSS_000450, 5-24-08-00507 (Beilstein Handbook Reference), MLS000759416, MLS001424211, MLS002473308, MLS006010732, CHEMBL35349, BDBM7392, CHEMBL259664, SCHEMBL9899338, CHEMBL1276127, CHEMBL3185783, CHEBI:92322, cid_5318433, KBio2_000450, KBio2_003018, KBio2_005586, KBio3_000839, KBio3_000840, EX-A347, CRDNMYFJWFXOCH-UHFFFAOYSA-N, Bio2_000395, Bio2_000875, DTXSID201026053, DTXSID501026052, HMS1362H11, HMS1792H11, HMS1990H11, HMS2051H20, HMS2234G06, HMS3369O15, HMS3393H20, HMS3403H11, HMS3656O13, AMY39890, BCP28869, HY-N0117, AC1180, BDBM50023867, BDBM50349806, FD9058, MFCD00221745, NSC105327, NSC827101, s2386, AKOS015895136, AKOS028108775, AKOS032455876, AC-8003, BCP9000788, CCG-100673, CCG-101058, CCG-267073, CS-3682, DB12379, IndirubinCouroupitine B; Indigopurpurin, NC00308, NSC-827101, SB64698, IDI1_002150, (2''Z)-Indirubin, >=98% (HPLC), NCGC00163356-01, NCGC00163356-02, NCGC00163356-03, NCGC00163356-04, NCGC00179302-02, (Z)-[2,3-Biindolinylidene]-2,3-dione, AC-29931, BI164578, CS-12423, LS-14462, PD003207, SMR004701694, SY058396, 3-(3-oxoindolin-2-ylidene)indolin-2-one, 1ST157073, 3-(3-indolinone-2-ylidene)-indolin-2-one, UNM-0000305766, I0868, NS00011738, NS00101121, SW197688-2, AB00639939-06, 2-(2-oxo-1H-indol-3-ylidene)-1H-indol-3-one, A827403, A922429, SR-01000759396, Q-100514, Q1661452, SR-01000759396-5, BRD-K17894950-001-03-6, BRD-K17894950-001-04-4, Q27164070, 3-(3-oxidanylidene-1H-indol-2-ylidene)-1H-indol-2-one, 2H-Indol-2-one,3-dihydro-3-oxo-2H-indol-2-ylidene)-1,3-dihydro-, (3E)-3-(3-Oxo-1,3-dihydro-2H-indol-2-ylidene)-1,3-dihydro-2H-indo l-2-one, (3z)-3-(3-oxo-1,3-dihydro-2h-indol-2-ylidene)-1,3-dihydro-2h-indol-2-one, (Z)-[2,3invertedexclamationmark-Biindolinylidene]-2invertedexclamationmark,3-dione, 2-[(3Z)-2-oxo-2,3-dihydro-1H-indol-3-ylidene]-2,3-dihydro-1H-indol-3-one" C16H10N2O2 JNLNPCNGMHKCKO-UHFFFAOYSA-N 2-(2-hydroxy-1H-indol-3-yl)indol-3-one n.a. n.a. No No No No No No PMDBD2000862 Indol AHL n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000863 Indole-3-acetaldehyde n.a. n.a. n.a. n.a. n.a. n.a. n.a. 800 n.a. NPC126427 2-(1H-indol-3-yl)acetaldehyde, 2591-98-2, indole-3-acetaldehyde, Indoleacetaldehyde, 1H-indole-3-acetaldehyde, Tryptaldehyde, indol-3-ylacetaldehyde, 1H-Indol-3-ylacetaldehyde, 2-(indol-3-yl)acetaldehyde, 2-(3-Indolyl)acetaldehyde, A346H8E8WU, CCRIS 5808, indole acetaldehyde, (indol-3-yl)acetaldehyde, UNII-A346H8E8WU, 1H-Indol-3-ylacetaldehyde #, SCHEMBL107104, CHEBI:18086, DTXSID90180582, AKOS006237176, AB02302, C00637, EN300-1601797, 3AA2B26B-6E90-473F-AE5E-CBF2BB1ACB49, Q27102813 C10H9NO WHOOUMGHGSPMGR-UHFFFAOYSA-N 2-(1H-indol-3-yl)acetaldehyde n.a. n.a. No No No No No No PMDBD2000864 Indole-3-acetamide n.a. n.a. n.a. n.a. n.a. n.a. n.a. 397 n.a. NPC110223 "indole-3-acetamide, 879-37-8, 2-(1H-Indol-3-yl)acetamide, 3-Indoleacetamide, 1H-Indole-3-acetamide, Indoleacetamide, 3-Indolylacetamide, (indol-3-yl)acetamide, 1H-Indol-3-ylacetamide, 2-(3-Indolyl)acetamide, MFCD00005641, 1-Indole-3-acetamide, NSC 1969, Indole--d5-3-acetaMide, O9SEW65XW3, Indole-3-acetamide (6CI,8CI), NSC-1969, TSR, Auxin amide, 3-INDOLE ACETAMIDE, (1H-indol-3-yl)acetamide, EINECS 212-904-4, 1H-indol-3-yl-acetamide, bmse000696, UNII-O9SEW65XW3, Indole-3-acetamide, 98%, Indole-3-acetamide (8CI), Oprea1_704903, SCHEMBL40822, 879-06-1, 1H-Indole-3-ethanimidic acid, SCHEMBL8082815, 3-Indolylacetamide;NSC 1969, 2-(1H-indol-3-yl)-acetamide, CHEBI:16031, ZOAMBXDOGPRZLP-UHFFFAOYSA-, DTXSID60236686, NSC1969, 2-(1H-Indol-3-yl)acetamide #, HMS1740A02, HMS3604E11, BCP27037, AM1212, HB0341, s5610, AKOS001129741, CCG-266389, CS-W017500, DB08652, FS-2701, HY-W016784, SB15031, AC-23418, SY014237, I0668, NS00039231, EN300-74842, A15869, C02693, I-0900, Q27097844, Z33546521, 99FEA035-A073-4863-9F14-923310E3BC45, IAM, InChI=1/C10H10N2O/c11-10(13)5-7-6-12-9-4-2-1-3-8(7)9/h1-4,6,12H,5H2,(H2,11,13)" C10H10N2O ZOAMBXDOGPRZLP-UHFFFAOYSA-N 2-(1H-indol-3-yl)acetamide n.a. n.a. No No No No No No PMDBD2000865 Indole-3-acetic acid n.a. n.a. n.a. n.a. n.a. n.a. n.a. 802 n.a. NPC111275 "indole-3-acetic acid, 87-51-4, indoleacetic acid, 3-Indoleacetic acid, Heteroauxin, 1H-Indole-3-acetic acid, 1H-indol-3-ylacetic acid, 2-(1H-Indol-3-yl)acetic acid, Rhizopin, auxin, Rhizopon A, Indol-3-ylacetic acid, 3-Iaa, 3-(Carboxymethyl)indole, 3-Indolylacetic acid, Hexteroauxin, beta-Indoleacetic acid, IAA, indoleacetate, Acetic acid, indolyl-, Heteroauxinhexteroauxiniaa, Indolylacetic acid, beta-Indolylacetic acid, Indolyl-3-acetic acid, indole acetic acid, omega-Skatole carboxylic acid, Kyselina 3-indolyloctova, (1H-Indol-3-yl)-acetic acid, Indoleacetic acid (VAN), (indol-3-yl)acetate, CCRIS 1014, EPA Pesticide Chemical Code 128915, Kyselina 3-indolyloctova [Czech], (indol-3-yl)acetic acid, AI3-24131, 2-(3-Indolyl)acetic acid, NSC 3787, 2-(indol-3-yl)ethanoic acid, 3-Indolylessigsaeure, .alpha.-IAA, .beta.-IAA, 3-indole acetic acid, 3-Indole-Acetic acid, .beta.-Indoleacetic acid, MFCD00005636, .beta.-Indolylacetic acid, .beta.-Indole-3-acetic acid, CHEMBL82411, (1H-Indol-3-yl)acetic acid, .omega.-Skatole carboxylic acid, DTXSID5020738, CHEBI:16411, .alpha.-Indol-3-yl-acetic acid, Indole--d5-3-acetic--d2 Acid, NSC3787, 6U1S09C61L, NSC-3787, 3-indoleacetate, 1173020-21-7, 1H-indol-3-ylacetate, DTXCID70738, (1H-indol-3-yl)acetate, CAS-87-51-4, IES, SMR000471855, Indole 3-acetic acid, 3-indolyl acetic acid, EINECS 201-748-2, Indolylacetate, b-Indoleacetate, UNII-6U1S09C61L, b-Indolylacetate, 3-Indolylacetate, alpha-IAA, beta-Indoleacetate, beta-IAA, 1H-Indole-3-acetic acid (9CI), beta-Indolylacetate, Indol-3-ylacetate, Indolyl-3-acetate, Skatole carboxylate, b-Indoleacetic acid, IAC, b-Indolylacetic acid, Indole-3acetic acid, 3-indolyl-acetic acid, 1H-Indole-3-acetate, Skatole carboxylic acid, Acid, 6, 2-(3-Indolyl)acetate, Indole-3-acetic-t acid, 1H-indol-3-acetic acid, Maybridge1_006755, 1H-Indole 3-acetic acid, beta-Indole-3-acetic acid, bmse000177, (1H-Indol-3-yl)-acetate, 3-Indoleacetic acid, 98%, 3-Indoleacetic acid, 99%, Oprea1_602123, SCHEMBL26344, MLS001066408, MLS001331664, MLS001332399, MLS001332400, 3-Indolylmethylcarboxylic acid, alpha-Indol-3-yl-acetic acid, Indole-3-acetic acid (8CI), INDOLEACETIC ACID [MI], WLN: T56 BMJ D1VQ, [3H]-IAA, 3-Indolyl acetic acid 100 microg/mL in Acetonitrile, HMS560L01, AMY2736, INDOLE ACETIC ACID [INCI], 2-(1H-indol-3-yl)-acetic acid, HMS2269G24, HMS3604M04, BCP26623, Tox21_202284, Tox21_302731, BDBM50201883, CCG-51070, s4799, AKOS000119890, 1H-Indole-3-acetic-a-t acid (9CI), AC-2974, CG-0522, CS-6287, DB07950, SDCCGMLS-0066204.P001, 3-Indoleacetic acid, >=98.0% (T), NCGC00247039-01, NCGC00247039-02, NCGC00256391-01, NCGC00259833-01, HY-18569, SY003464, EU-0099905, I0022, NS00014849, 3-Indoleacetic acid, technical, >=95% (T), EN300-17303, C00954, I-1000, I-1040, Q411208, SR-01000596909, 2-(1H-indol-3-yl)acetic acid;Indole-3-acetic acid, 3-Indoleacetic acid, SAJ special grade, >=98.5%, IS_INDOLE-2,4,5,6,7-D5-3-ACETIC ACID, SR-01000596909-1, SR-01000596909-2, Z56913182, 2-(3-Indolyl)acetic acid 3-(Carboxymethyl)-1H-indole, 3-Indoleacetic acid, PESTANAL(R), analytical standard, F0722-8837, 0A0524AE-D755-4E91-A73A-2AD867FE676A, 3-Indoleacetic acid, plant cell culture tested, crystalline, InChI=1/C10H9NO2/c12-10(13)5-7-6-11-9-4-2-1-3-8(7)9/h1-4,6,11H,5H2,(H,12,13" C10H9NO2 SEOVTRFCIGRIMH-UHFFFAOYSA-N 2-(1H-indol-3-yl)acetic acid n.a. n.a. No No No No No No PMDBD2000866 Indole-3-carboxyaldehyde n.a. n.a. n.a. n.a. n.a. n.a. n.a. 10256 n.a. NPC42372 INDOLE-3-CARBOXALDEHYDE, 1H-Indole-3-carbaldehyde, 487-89-8, 3-Formylindole, 1H-Indole-3-carboxaldehyde, Indole-3-carbaldehyde, Indole-3-aldehyde, 3-Indolecarboxaldehyde, Indol-3-carboxaldehyde, beta-Indolylaldehyde, INDOLE-3-CARBOXYALDEHYDE, 3-Indolecarbaldehyde, 3-Indolealdehyde, Indol-3-carbaldehyde, 4877-89-8, MFCD00005622, NSC 10118, 3-indolylformaldehyde, .beta.-Indolylaldehyde, 1H-indole-3-aldehyde, 7FN04C32UO, CHEMBL147741, 1228547-52-1, NSC-10118, 3-Formylindol, 3-indolemethanal, Indol-3-carbaldehyd, 3-Formyl-1H-indole, EINECS 207-665-8, BRN 0114117, UNII-7FN04C32UO, AI3-52407, b-Indolylaldehyde, 3-formyl indole, 3-formyl-indole, A-Indolylaldehyde, Indol-3-aldehyde, 3-indole aldehyde, indole-3-carboaldehyde, indole 3-carboxaldehyde, Indole-3-carboxaldehyde (3-Formylindole), I3CHO, I3CA, 1H-indole-3-carbaldehyd, indole-3-carboxy-aldehyde, 1H-Indole-3-carboxaldehde, bmse000645, SCHEMBL56373, 5-21-08-00246 (Beilstein Handbook Reference), Indole-3-carboxaldehyde, 97%, DTXSID5060069, CHEBI:28238, OLNJUISKUQQNIM-UHFFFAOYSA-, BCP00081, NSC10118, AM1029, BDBM50182880, AKOS000119898, CS-W007376, HY-W007376, PS-5323, SB14957, NCGC00161738-01, NCGC00161738-02, AC-23425, A7354, I0027, NS00031825, EN300-16816, C08493, I-2200, AB00443651-03, Indole-3-carboxaldehyde, purum, >=98.0% (T), A827605, A871878, A897853, AG-205/01412034, CU-00000000108-1, Q27103575, Z56785575, F0918-0115, 3-Indolylformaldehyde, 3-Formylindole, Indole-3-carbaldehyde, InChI=1/C9H7NO/c11-6-7-5-10-9-4-2-1-3-8(7)9/h1-6,10H, 1H-indole-3-carbaldehyde1H-Indole-3-carboxaldehyde487-89-8246045-99-8.beta.-IndolylaldehydeIndole-3-carbaldehydeIndole-3-carboxaldehyde57210_FLUKA129445_ALDRICHZINC00087959SBB004120BAS 07339836C084933 C9H7NO OLNJUISKUQQNIM-UHFFFAOYSA-N 1H-indole-3-carbaldehyde n.a. n.a. No No No No No No PMDBD2000867 Indole-7-carboxylic acid n.a. n.a. n.a. n.a. n.a. n.a. n.a. 74281 n.a. n.a. Indole-7-carboxylic acid, 1H-Indole-7-carboxylic acid, 1670-83-3, MFCD00210442, 7-CARBOXYINDOLE, CHEMBL2018159, 1~{H}-indole-7-carboxylic acid, 7-Indolecarboxylic acid, EINECS 216-801-5, Indole-7-carboxlic acid, indole 7-carboxylic acid, 1H-indol-7-carboxylic acid, Oprea1_470510, Oprea1_510927, SCHEMBL336234, DTXSID1061869, HMS1676K22, K7YV38W955, BCP26405, BDBM50607375, AKOS000210867, AC-4496, CC-0741, CS-W016137, PB25992, BP-10137, SY018597, A3703, AM20060417, EU-0067136, I0606, NS00025470, EN300-86038, I-2360, SR-01000392072, Q-102577, SR-01000392072-1, Z274503298, KXQ C9H7NO2 IPDOBVFESNNYEE-UHFFFAOYSA-N 1H-indole-7-carboxylic acid n.a. n.a. No No No No No No PMDBD2000868 Indolicidin n.a. n.a. n.a. n.a. n.a. n.a. n.a. 16129733 n.a. n.a. Indolicidin, 140896-21-5, Tridecapeptide amide, AKOS040763967, NH2-Ile-Leu-Pro-Trp-Lys-Trp-Pro-Trp-Trp-Pro-Trp-Arg-Arg-CONH2 C100H132N26O13 USSYUMHVHQSYNA-SLDJZXPVSA-N (2S)-1-[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S,3S)-2-amino-3-methylpentanoyl]amino]-4-methylpentanoyl]pyrrolidine-2-carbonyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]hexanoyl]amino]-3-(1H-indol-3-yl)propanoyl]-N-[(2S)-1-[[(2S)-1-[(2S)-2-[[(2S)-1-[[(2S)-1-[[(2S)-1-amino-5-carbamimidamido-1-oxopentan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]carbamoyl]pyrrolidin-1-yl]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]pyrrolidine-2-carboxamide n.a. n.a. No No No No No No PMDBD2000869 Ionic silver n.a. n.a. n.a. n.a. n.a. n.a. n.a. 104755 n.a. n.a. Silver cation, SILVER ION, silver(1+), Silver, ion (Ag1+), 14701-21-4, Silver ion (1+), Silver, ion, Silver(I), UNII-57N7B0K90A, 57N7B0K90A, Ag(+), CHEBI:49468, silver(I) cation, Ag+, Silver elemental, Silver,ion, Collosol argentum, Col sil, Silver preparation, Argent. nit., Argentum colloidale, Dermazin Crm 1%, Flamazine Crm 1%, silver (I), Silver (I) ion, silver(1+) ion, NANOVER, IONIC SILVER, Silver ion antibacterial, Silver standard for AAS, Silver standard for ICP, Hand Sanitizer Gel(Ag), Pekana - argentum metallicum, Ancos Silver Ion Antibacterial, Silver Liquid (S#107)-Liq, CHEMBL1230866, CHEBI:60253, Argentum Metallicum 4ch - 30ch, DTXSID10892099, FOIXSVOLVBLSDH-UHFFFAOYSA-N, Argentum Mettallicum Gtte 4ch-30ch, DB14521, BP-13466, E174, SSD (1% Silver Sulfadiazine Cream USP), Argentum Metallicum (Silver Metallicum 6x), NANO SILVER ANTIBACTERIAL DISINFECTANT, NS00131574, Argentum Met.Praep.D8(D10 D12 D15 D20 D30), Q27104658 Ag+ FOIXSVOLVBLSDH-UHFFFAOYSA-N silver(1+) n.a. n.a. No No No No No No PMDBD2000870 Isatin Therapeutic Substance Investigational Drug 91-56-5 DB02095 n.a. n.a. D0SP2O 7054 6787 NPC254698 "Isatin, 91-56-5, 1H-Indole-2,3-dione, 2,3-Indolinedione, Indoline-2,3-dione, INDOLE-2,3-DIONE, Isatine, Tribulin, 2,3-Diketoindoline, Pseudoisatin, 2,3-Dioxoindoline, Isatic acid lactam, Isotin, Isatinic acid anhydride, 2,3-Ketoindoline, o-Aminobenzoylformic anhydride, 2,3-dihydro-1H-indole-2,3-dione, 2,3-Dioxo-2,3-dihydroindole, NSC 9262, 84788-92-1, MFCD00005718, 1186480-61-4, 2,3-dihydroindole-2,3-dione, CHEMBL326294, DTXSID3038694, CHEBI:27539, NSC-9262, 82X95S7M06, EINECS 202-077-8, BRN 0383659, AI3-03111, 3-Indolinedione, UNII-82X95S7M06, indol-2, Indole-2, hydroxy-3-indolone, Isatin, p.a., 3-hydroxy-2-indolone, Isatin (Compound 1), Isatin, technical grade, 2H-indole-2,3-dione, ISATIN [INCI], ISATIN [MI], EC 202-077-8, WLN: T56 BMVVJ, SCHEMBL34016, 5-21-10-00221 (Beilstein Handbook Reference), MLS001066355, DTXCID1018694, 2,3-Dihydro-indole-2,3-dione, BDBM11022, NSC9262, HMS2267D18, HMS3885P18, S00335a, BCP15996, HY-Y0265, 2,3-dihydro-1H-indol-2,3-dione, Tox21_202876, s4717, AKOS000119125, CCG-266182, CS-W020128, DB02095, SB64041, CAS-91-56-5, NCGC00246983-01, NCGC00260422-01, AC-10666, AS-10908, SMR000471835, SY005277, AM20050218, I0080, NS00005535, EN300-17956, D70304, I-7800, I-7801, A843979, Q421348, F9995-1662, Isatin, for spectrophotometric det. of proline and thiophene, >=99.0%, InChI=1/C8H5NO2/c10-7-5-3-1-2-4-6(5)9-8(7)11/h1-4H,(H,9,10,11, Indoline-2,3-dione;2,3-Dioxo-2,3-dihydroindole; Isatic acid lactam; Isotin" C8H5NO2 JXDYKVIHCLTXOP-UHFFFAOYSA-N 1H-indole-2,3-dione n.a. n.a. No No No No No No PMDBD2000871 Isobutanol n.a. n.a. n.a. n.a. n.a. n.a. n.a. 6560 n.a. NPC88839 2-Methyl-1-propanol, Isobutanol, ISOBUTYL ALCOHOL, 2-Methylpropan-1-ol, 78-83-1, 1-Propanol, 2-methyl-, 1-Hydroxymethylpropane, Isopropylcarbinol, Iso-butyl alcohol, 2-Methylpropyl alcohol, i-Butyl alcohol, Isobutylalkohol, 2-Methylpropanol, Alcool isobutylique, 2-Methyl propanol, Fermentation butyl alcohol, i-Butanol, RCRA waste number U140, 2-Methylpropanol-1, FEMA No. 2179, Isopropyl carbitol, NSC 5708, 2-Methylpropyl-d9 Alcohol, Methyl-2 propanol-1, iso-C4H9OH, MFCD00004740, 2-methyl-1-propanyl alcohol, 56F9Z98TEM, DTXSID0021759, CHEBI:46645, 2-Methyl-d3-propyl--d4 Alcohol, NSC-5708, 68989-27-5, Isobutylalkohol [Czech], iso-butanol, FEMA Number 2179, Isobutyl alcohol (natural), Isopropyl carbinol, Alcool isobutylique [French], HSDB 49, CCRIS 2300, EINECS 201-148-0, UN1212, RCRA waste no. U140, BRN 1730878, isobutylalcohol, UNII-56F9Z98TEM, iso butanol, Butanol-iso, AI3-01777, 2-methylpropanoI, iBuOH, 2-methyl-propanol, iso-BuOH, i-BuOH, 2-methyl-l-propanol, 2-methyl-n-propanol, Isobutanol ACS grade, Propanol, 2-methyl-, 2-methyl-propan-1-ol, Isobutanol, HPLC Grade, EC 201-148-0, Isobutanol, Isobutyl alcohol, 4-01-00-01588 (Beilstein Handbook Reference), BIDD:ER0628, Isobutanol or isobutyl alcohol, ISOBUTYL ALCOHOL [II], ISOBUTYL ALCOHOL [MI], 2-Methyl-1-propanol, 99%, ISOBUTYL ALCOHOL [FCC], CHEMBL269630, DTXCID601759, ISOBUTYL ALCOHOL [FHFI], ISOBUTYL ALCOHOL [HSDB], WLN: Q1Y1&1, ISOBUTYL ALCOHOL [MART.], NSC5708, 2-Methyl-1-propanol, 99.5%, 2-Methyl-1-propanol, AR, 99%, Isobutanol, Spectrophotometric Grade, Tox21_201214, ISOBUTYL ALCOHOL (ISOBUTANOL), LMFA05000100, 2-methyl-1-propanol(isobutyl alcohol), 2-Methyl-1-propanol, LR, >=99%, AKOS000118740, Isobutyl alcohol, >=99%, FCC, FG, UN 1212, 2-METHYL-1-PROPANOL [USP-RS], CAS-78-83-1, NCGC00091851-01, NCGC00091851-02, NCGC00258766-01, 2-Methyl-1-propanol, analytical standard, 2-Methyl-1-propanol, anhydrous, 99.5%, 2-?Methyl-?1-?propanol(Isobutyl Alcohol), 2-Methyl-1-propanol, for HPLC, 99.5%, Isobutyl alcohol, ACS reagent, >=99.0%, I0094, NS00008599, EN300-19336, Isobutyl alcohol 5000 microg/mL in Methanol, 2-Methyl-1-propanol 10 microg/mL in Methanol, Isobutyl alcohol, natural, >=99%, FCC, FG, 2-Methyl-1-propanol, ACS reagent, >=99.0%, Q151797, 2-Methyl-1-propanol, p.a., ACS reagent, 99.0%, 2-Methyl-1-propanol, SAJ first grade, >=99.0%, J-509912, 2-Methyl-1-propanol, JIS special grade, >=99.0%, F0001-2058, InChI=1/C4H10O/c1-4(2)3-5/h4-5H,3H2,1-2H, 2-Methyl-1-propanol, ACS spectrophotometric grade, >=99.0%, 2-Methyl-1-propanol, reag. ISO, 99%, UV HPLC spectroscopic, Isobutanol or isobutyl alcohol [UN1212] [Flammable liquid], 2-Methyl-1-propanol, puriss. p.a., ACS reagent, >=99.5% (GC), 2-Methyl-1-propanol, BioUltra, for molecular biology, >=99.5% (GC), 2-Methyl-1-propanol, United States Pharmacopeia (USP) Reference Standard, 2-Methyl-1-propanol, puriss. p.a., ACS reagent, reag. Ph. Eur., >=99% (GC), 5OZ C4H10O ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 2-methylpropan-1-ol n.a. n.a. No No No No No No PMDBD2000872 Isoeugenol Therapeutic Substance n.a. 97-54-1 DB14188 n.a. n.a. n.a. 853433 7061 NPC36108 Isoeugenol, 97-54-1, (E)-Isoeugenol, trans-Isoeugenol, 2-Methoxy-4-propenylphenol, 4-Propenylguaiacol, 2-methoxy-4-(prop-1-en-1-yl)phenol, 5932-68-3, 4-Hydroxy-3-methoxy-1-propenylbenzene, Isoeugenol trans-form, trans-p-Propenylquaiacol, 4-Hydroxy-3-methoxypropenylbenzene, 2-METHOXY-4-(1-PROPENYL)PHENOL, Phenol, 2-methoxy-4-propenyl-, 1-Hydroxy-2-methoxy-4-propenylbenzene, trans-2-Methoxy-4-propenylphenol, (E)-2-Methoxy-4-(prop-1-enyl)phenol, Propenylguaiacol, Isoeugenol (I), Phenol, 2-methoxy-4-(1-propenyl)-, 2-methoxy-4-[(1E)-prop-1-en-1-yl]phenol, 2-methoxy-4-[(E)-prop-1-enyl]phenol, 1-Hydroxy-2-methoxy-4-propen-1-ylbenzene, Propenylgualacol, Iso-eugenol, NCI-C60979, 3-Methoxy-4-hydroxypropenylbenzene, 3-Methoxy-4-hydroxy-1-propen-1-ylbenzene, NSC 6769, Phenol, 2-methoxy-4-propenyl-, (E)-, Isoeugenol and isomers, CHEBI:50545, 1-(3-Methoxy-4-hydroxyphenyl)-1-propene, 4-Hydroxy-3-methoxy-1-propen-1-ylbenzene, (E)-2-Methoxy-4-(prop-1-en-1-yl)phenol, Phenol, 2-methoxy-4-(1-propenyl)-, (E)-, trans-4-Propenylgualacol, 28FSR1NAY4, CHEMBL193598, Isoeugenol,c&t, NSC-209522, 2-Methoxy-4-[(1E)-1-propenyl]phenol, NCGC00091470-02, Phenol, 2-methoxy-4-(1-propen-1-yl)-, Isoeugenol,predominantly trans, DTXCID502413, 2-Methoxy-4-[1-propenyl]phenol, UIL135434, 3-Methoxy-4-hydroxy-1-propenylbenzene, CAS-97-54-1, CCRIS 744, FEMA No. 2468, 2-methoxy-4-propenyl-Phenol, 4-06-00-06324 (Beilstein Handbook Reference), EINECS 202-590-7, EINECS 227-678-2, UNII-28FSR1NAY4, DTXSID7022413, NSC 209522, BRN 1909602, BRN 2046156, isougenol, UNII-5M0MWY797U, isoeugenol fcc, isoeugenol tech, e-isoeugenol, 1-(3-Methoxy-4-hydroxyphenyl)-1-propane, Iso eugenol, AI3-15356, Isoeugenol E, Isoeugenol Z, HSDB 8044, iso-Eugenol 2, isoeugenol 916, CHISOEUG, iso eugenol 88%+, isoeugenol extra nat us, Phenol, (E)-, Phenol, 2-methoxy-4-(1E)-1-propenyl-, ISOEUGENOL, E-, Isoeugenol, cis + trans, ISOEUGENOL, TRANS-, bmse010052, ISOEUGENOL, (E)-, IE TRANS 92, SCHEMBL57986, 3-06-00-04993 (Beilstein Handbook Reference), MLS001065576, BIDD:ER0697, WLN: 2U1R DQ CO1, Isoeugenol, analytical standard, Isoeugenol, predominantly trans, 5M0MWY797U, (E)-4-PROPENYLGUAIACOL, Isoeugenol, natural, 99%, FG, DTXSID50872350, NSC6769, HMS2268O09, WLN: 2U1R DQ CO1 -E, (E)-2-methoxy-4-propenyl-Phenol, 2-methoxy-4-(1-propenyl)-Phenol, ISOEUGENOL TRANS-FORM [MI], HY-N1952, NSC-6769, Tox21_111138, Tox21_202433, Tox21_300303, BDBM50548724, MFCD00009285, NSC209522, s5757, AKOS000120575, Tox21_111138_1, DB14188, trans-2-methoxy-4-(1-propenyl)phenol, (E)-2-methoxy-4-(1-propenyl)-Phenol, 2-Methoxy-4-propenylphenol (isoeugenol), NCGC00091470-01, NCGC00091470-03, NCGC00091470-04, NCGC00091470-05, NCGC00254142-01, NCGC00259982-01, (E)-2-methoxy-4- (1-propenyl)-Phenol, AC-34996, AS-61702, SMR000112408, (E)-2-Methoxy-4-(1-propen-1-yl)phenol, Isoeugenol 2000 microg/mL in Acetonitrile, CS-0018270, I0132, NS00012699, (E)-2-METHOXY-4-(1-PROPENYL)PHENOL, EN300-18429, 2-methoxy-4-(1-propenyl)phenol (ACD/Name 4.0), Isoeugenol, predominantly trans, analytical standard, Q27889971, Z57953030, F1905-7039 C10H12O2 BJIOGJUNALELMI-ONEGZZNKSA-N 2-methoxy-4-[(E)-prop-1-enyl]phenol n.a. n.a. No No No No No No PMDBD2000873 Isohydnocarpin n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000874 Isoliquiritigenin Therapeutic Substance n.a. 961-29-5 DB03285 n.a. n.a. n.a. 638278 553829 NPC19174 isoliquiritigenin, 961-29-5, 2'',4,4''-Trihydroxychalcone, (E)-1-(2,4-dihydroxyphenyl)-3-(4-hydroxyphenyl)prop-2-en-1-one, 4,2'',4''-Trihydroxychalcone, 6''-deoxychalcone, Isoliquiritigen, GU 17, 2'',4'',4-Trihydroxychalcone, Chalcone, 2'',4,4''-trihydroxy-, GU-17, C15H12O4, CCRIS 7676, UNII-B9CTI9GB8F, trihydroxychalcone, B9CTI9GB8F, 42''4''-trihydroxychalcone, 2-Propen-1-one, 1-(2,4-dihydroxyphenyl)-3-(4-hydroxyphenyl)-, (2E)-, 13745-20-5, (2E)-1-(2,4-dihydroxyphenyl)-3-(4-hydroxyphenyl)prop-2-en-1-one, CHEBI:310312, trans-2'',4,4''-trihydroxychalcone, 1-(2,4-Dihydroxyphenyl)-3-(4-hydroxyphenyl)-2-propen-1-one, 1-(2,4-Dihydroxyphenyl)-3-(4-hydroxyphenyl)prop-2-en-1-one, (2E)-1-(2,4-Dihydroxyphenyl)-3-(4-hydroxyphenyl)-2-propen-1-one, 2-Propen-1-one, 1-(2,4-dihydroxyphenyl)-3-(4-hydroxyphenyl)-, (E)-, Acrylophenone, 2'',4''-dihydroxy-3-(p-hydroxyphenyl)-, CHEMBL129795, GU17, (E)-1-(2,4-Dihydroxy-phenyl)-3-(4-hydroxy-phenyl)-propenone, (E)-1-(2,4-Dihydroxyphenyl)-3-(4-hydroxyphenyl)-2-propen-1-one, 2-PROPEN-1-ONE, 1-(2,4-DIHYDROXYPHENYL)-3-(4-HYDROXYPHENYL)-, MFCD00075907, (E)-1-(2,4-dihydroxyphenyl)-3-(4-hydroxyphenyl)-2-propene-1-one, 1060-19-1, ILG, SMR000112969, SR-01000075499, EINECS 237-316-5, BRN 1914295, iso-Liquiritigenin, ILTG, ISLQ, Isoliquiritigenin, powder, Spectrum5_000612, Lopac0_000681, BSPBio_003411, 1-08-00-00707 (Beilstein Handbook Reference), MLS000438943, MLS002207240, MLS006010045, BIDD:ER0235, SCHEMBL161168, SPECTRUM1504200, cid_638278, MEGxp0_001326, 2'',4,4''-Trihydroxy-Chalcone, DTXSID2022466, 2'''',4'''',4-trihydroxychalcone, 2'''',4,4''''-trihydroxychalcone, ACon1_000047, CHEBI:94010, TRIHYDROXYCHALCONE [INCI], BCPP000201, HMS2233H18, HMS3262I03, 2,4''''-dihydroxy-4-hydroxychalcone, BCP02312, HY-N0102, Tox21_500681, BDBM50042944, CCG-40334, CMLD3_000056, HB4213, LMPK12120096, s2404, Isoliquiritigenin, analytical standard, AKOS001590146, BCP9000795, CS-1745, DB03285, KS-5256, LP00681, SDCCGMLS-0066751.P001, SDCCGSBI-0050660.P004, NCGC00090504-01, NCGC00090504-02, NCGC00090504-03, NCGC00090504-04, NCGC00090504-05, NCGC00090504-06, NCGC00090504-07, NCGC00090504-08, NCGC00090504-24, NCGC00261366-01, AC-33981, EU-0100681, I0822, SW219658-1, C08650, I 3766, I11575, A845551, 2'',4''-Dihydroxy-3-(p-hydroxyphenyl)-Acrylophenone, Q-100904, Q3155537, SR-01000075499-1, SR-01000075499-5, BRD-K33583600-001-03-9, BRD-K33583600-001-04-7, 1-(2,4-Dihydroxy-phenyl)-3-(4-hydroxy-phenyl)-propenone, 1-(2,4-Dihydroxyphenyl)-3-(4-hydroxyphenyl)-prop-2-en-1-one, (E)-1-[2,4-bis(oxidanyl)phenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one, InChI=1/C15H12O4/c16-11-4-1-10(2-5-11)3-8-14(18)13-7-6-12(17)9-15(13)19/h1-9,16-17,19H/b8-3 C15H12O4 DXDRHHKMWQZJHT-FPYGCLRLSA-N (E)-1-(2,4-dihydroxyphenyl)-3-(4-hydroxyphenyl)prop-2-en-1-one n.a. n.a. No No No No No No PMDBD2000875 Isoniazid? n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000876 Isopropanol Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D0W7LK 3776 n.a. NPC163707 "Isopropyl alcohol, isopropanol, 2-Propanol, Propan-2-ol, 67-63-0, 2-Hydroxypropane, Alkolave, Avantine, Hartosol, Dimethylcarbinol, i-Propanol, sec-Propyl alcohol, Takineocol, Alcojel, Avantin, Petrohol, 1-Methylethanol, 2-Propyl alcohol, Isohol, Lavacol, Lutosol, Propol, Alcosolve 2, Imsol A, Alcosolve, Arquad DMCB, Spectrar, 1-Methylethyl alcohol, Alcolo, i-Propylalkohol, Combi-schutz, n-Propan-2-ol, i-Propyl alcohol, Iso-propylalkohol, Isopropyl alcohol, rubbing, ISO-PROPANOL, Alcool isopropilico, Alcool isopropylique, Visco 1152, sec-Propanol, Sterisol hand disinfectant, Iso-propyl alcohol, i-Propanol [German], iso-propylalcohol, Alcohol,isopropyl, FEMA No. 2929, FEMA Number 2929, i-Propylalkohol [German], Alcohol, Isopropyl, Iso-propylalkohol [German], Alcool isopropilico [Italian], Alcool isopropylique [French], CCRIS 2308, HSDB 116, Isopropylalkohol, isopropy alcohol, 2-propanolum, propanol-2, EINECS 200-661-7, NSC 135801, NSC-135801, BRN 0635639, ZURAGARD, DTXSID7020762, UNII-ND2M416302, CHEBI:17824, AI3-01636, Isopropyl alcohol (USP), Isopropyl alcohol [USP], MFCD00011674, ND2M416302, IPS 1, DTXCID50762, EC 200-661-7, 4-01-00-01461 (Beilstein Handbook Reference), NSC135801, ISOPROPYL ALCOHOL (ISOPROPANOL), 2-Propanol, anhydrous, NCGC00090917-01, Rubbing alcohol, DURAPREP COMPONENT ISOPROPYL ALCOHOL, SOLUPREP COMPONENT ISOPROPYL ALCOHOL, CHLORAPREP COMPONENT ISOPROPYL ALCOHOL, ISOPROPYL ALCOHOL COMPONENT OF DURAPREP, ISOPROPYL ALCOHOL COMPONENT OF SOLUPREP, iPrOH, ISOPROPYL ALCOHOL COMPONENT OF CHLORAPREP, 2-PROPANOL (USP-RS), 2-PROPANOL [USP-RS], ISOPROPYL ALCOHOL (II), ISOPROPYL ALCOHOL [II], ISOPROPYL ALCOHOL (IARC), ISOPROPYL ALCOHOL [IARC], 2-Propanol, USP, 99.0%, Caswell No. 507, ISOPROPYL ALCOHOL (MART.), ISOPROPYL ALCOHOL [MART.], isopropylalcohol, ISOPROPYL ALCOHOL(2-D), 2 Propanol, 2-Propanol, ACS reagent, >=99.5%, CAS-67-63-0, ISOPROPYL ALCOHOL (EP MONOGRAPH), ISOPROPYL ALCOHOL [EP MONOGRAPH], ACETONE IMPURITY B (EP IMPURITY), ACETONE IMPURITY B [EP IMPURITY], ISOPROPYL ALCOHOL (USP MONOGRAPH), ISOPROPYL ALCOHOL [USP MONOGRAPH], Isopropyl alcohol; Propan-2-ol; 2-Propanol, 555-31-7, UN1219, ISOPROPYL ALCOHOL(1,1,1,3,3,3-D6), isopropyl, ISOPROPYL ALCOHOL(1,1,1,2,3,3,3-D7), isoproylalcohol, sparkle, Stanitizer, Umbiliclean, Aplicare, Cornells, Everclear, Handwipe, Hanitize, Medpride, Purifie, Sanacare, Septinol, Unichem, Virahol, i-propylalcohol, Isopro, Lavaco, Meijer, Purity, ChemBrite, Clean, Curad, Forto, Germstaroriginal, SaniClean, 2propanol, DivasWintergreen, Iris, Wish, 2-propylalcohol, Alcohol Sterile, isoproyl alcohol, Jianze Alcohol, Publix Alcohol, Rush Sanitizers, Sanitizing Wipe, Sterile Alcohol, Winner Alcohol, Wise shield, Alcohol Pads, Alcohol Prep, Alcohol Swab, Aurora Fresh, Curad Alcohol, Lens Cleaner, Protector Gel, School Health, Travel Wipes, TopCo, ZuraGard Clear, Derma Hands, Korkay Sanitizer, lsopropyl alcohol, Prime Collection, Sani-Spray, Simple Sanitizer, Swim-ear, Thompson Alcohol, Walgreen Alcohol, ZuraGard Blue, Isopropyl-alcohol, propane-2ol, United CleanPlus, Anti Germ, Germs Out" C3H8O KFZMGEQAYNKOFK-UHFFFAOYSA-N propan-2-ol n.a. n.a. No No No No No No PMDBD2000877 Isoriccardin C n.a. n.a. n.a. n.a. n.a. n.a. n.a. 13831041 n.a. NPC165430 Isoriccardin C, 15-oxapentacyclo[20.2.2.216,19.110,14.02,7]nonacosa-1(24),2(7),3,5,10(29),11,13,16,18,22,25,27-dodecaene-3,13,24-triol C28H24O4 ZKRAPLUKBRYFFL-UHFFFAOYSA-N 15-oxapentacyclo[20.2.2.216,19.110,14.02,7]nonacosa-1(24),2(7),3,5,10(29),11,13,16,18,22,25,27-dodecaene-3,13,24-triol n.a. n.a. No No No No No No PMDBD2000878 Isosilybin A n.a. n.a. n.a. n.a. n.a. n.a. n.a. 11059920 n.a. NPC72787 Isosilybin A, 142796-21-2, Isosilibinin A, Iso-silybin A, Silybin B2, UNII-HHN3Q9H3DK, HHN3Q9H3DK, (2R,3R)-3,5,7-trihydroxy-2-[(2R,3R)-2-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-2,3-dihydro-1,4-benzodioxin-6-yl]-2,3-dihydrochromen-4-one, 4H-1-Benzopyran-4-one, 2-((2R,3R)-2,3-dihydro-2-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-1,4-benzodioxin-6-yl)-2,3-dihydro-3,5,7-trihydroxy-, (2R,3R)-, (2R,3R)-3,5,7-Trihydroxy-2-((2R,3R)-2-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-2,3-dihydrobenzo[b][1,4]dioxin-6-yl)chroman-4-one, 7-(4-bromobenzoyl)isosilybin A, Isosilybin A + B, (+)-isosilybin A, ISOSILYBIN A [MI], CHEMBL592676, SCHEMBL20152105, DTXSID20453675, CHEBI:205528, HY-N7043, BDBM50526629, AKOS040760487, (2R,3R)-3,5,7-Trihydroxy-2-[(2R,3R)-2-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-2,3-dihydrobenzo[1,4]dioxin-6-yl]-4-chromanone, MS-28966, 1ST166036, CS-0101837, E88732, ISOSILYBIN A (CONSTITUENT OF MILK THISTLE), Q27279939, ISOSILYBIN A (CONSTITUENT OF MILK THISTLE) [DSC], (2R,3R)-3,5,7-trihydroxy-2-[(2R,3R)-2-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-2,3-dihydro-1,4-benzodioxin-6-yl]-2,3-dihydro-4H-1-benzopyran-4-one, (2R,3R)-3,5,7-trihydroxy-2-[(2R,3R)-2-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-2,3-dihydro-1,4-benzodioxin-6-yl]-2,3-dihydro-4H-chromen-4-one C25H22O10 FDQAOULAVFHKBX-HKTJVKLFSA-N (2R,3R)-3,5,7-trihydroxy-2-[(2R,3R)-2-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-2,3-dihydro-1,4-benzodioxin-6-yl]-2,3-dihydrochromen-4-one n.a. n.a. No No No No No No PMDBD2000879 Isosinensetin n.a. n.a. n.a. n.a. n.a. n.a. n.a. 632135 n.a. NPC110639 Isosinensetin, 17290-70-9, 6-Demethoxynobiletin, 6-Demethoxylnobiletin, 2-(3,4-Dimethoxyphenyl)-5,7,8-trimethoxy-4H-chromen-4-one, 5,7,8,3'',4''-pentamethoxyflavone, 2-(3,4-dimethoxyphenyl)-5,7,8-trimethoxychromen-4-one, UNII-63Z99S38LE, Flavone, 3'',4'',5,7,8-pentamethoxy-, 63Z99S38LE, 3'',4'',5,7,8-Pentamethoxyflavone, DTXSID80348199, 4H-1-Benzopyran-4-one, 2-(3,4-dimethoxyphenyl)-5,7,8-trimethoxy-, SCHEMBL987761, CHEMBL451707, DTXCID60299271, CHEBI:175779, UYCWETIUOAGWIL-UHFFFAOYSA-N, HY-N1941, LMPK12111403, AKOS016012041, AC-34952, AS-57493, XI161836, CS-0018252, Isosinensetin3'',4'' ,5,7,8-pentamethoxyflavone, A881826, Q27263667, 2-(3,4-Dimethoxyphenyl)-5,7,8-trimethoxy-4H-1-benzopyran-4-one, 2-(3,4-Dimethoxyphenyl)-5,7,8-trimethoxy-4H-chromen-4-one #, 2-(3,4-DimethoIsosinensetinxyphenyl)-5,7,8-trimethoxy-4H-chromen-4-one, Isosinensetin pound>>3 inverted exclamation mark ,4 inverted exclamation mark ,5,7,8-pentamethoxyflavone C20H20O7 UYCWETIUOAGWIL-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5,7,8-trimethoxychromen-4-one n.a. n.a. No No No No No No PMDBD2000880 Isothiocyanate n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000881 Ivalin n.a. n.a. n.a. n.a. n.a. n.a. n.a. 65156 n.a. NPC116620 Ivalin, CHEBI:6077, (3aR,4aS,7S,8aR,9aR)-7-hydroxy-8a-methyl-3,5-dimethylidene-3a,4,4a,6,7,8,9,9a-octahydrobenzo[f][1]benzofuran-2-one, 5938-03-4, NSC 85237, CHEMBL1644108, BDBM50433447, Eudesma-4(14),11(13)-dien-12-oic acid, 2,8-dihydroxy-, gamma-lactone, C09488, Q27107027 C15H20O3 OVIILQQKQPCQTF-GGAZOKNXSA-N (3aR,4aS,7S,8aR,9aR)-7-hydroxy-8a-methyl-3,5-dimethylidene-3a,4,4a,6,7,8,9,9a-octahydrobenzo[f][1]benzofuran-2-one n.a. n.a. No No No No No No PMDBD2000882 K4-S4 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000883 KABT-AMP n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000884 Kaempherol Therapeutic Substance Investigational Drug 520-18-3 DB01852 n.a. n.a. D0G3TK 5280863 4444395 NPC116775 "kaempferol, 520-18-3, Robigenin, Kaempherol, Kempferol, Populnetin, Rhamnolutein, Trifolitin, Swartziol, 3,4'',5,7-Tetrahydroxyflavone, Pelargidenolon, Rhamnolutin, Indigo Yellow, Kampherol, Campherol, Kampferol, Nimbecetin, 3,5,7-Trihydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-one, Kaemferol, 5,7,4''-Trihydroxyflavonol, Pelargidenolon 1497, 3,5,7-Trihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one, C.I. 75640, 3,5,7-trihydroxy-2-(4-hydroxyphenyl)chromen-4-one, Pelargidenon, Kampcetin, CCRIS 41, 4H-1-Benzopyran-4-one, 3,5,7-trihydroxy-2-(4-hydroxyphenyl)-, Flavone, 3,4'',5,7-tetrahydroxy-, NSC 407289, NSC 656277, EINECS 208-287-6, Kempferol;Robigenin, NSC-407289, NSC-656277, UNII-731P2LE49E, BRN 0304401, 3,5,7,4''-Tetrahydroxyflavone, DTXSID7020768, CHEBI:28499, AI3-36096, HSDB 7703, 731P2LE49E, 3''-DEOXYQUERCETIN, MFCD00016938, CHEMBL150, DTXCID30768, 5-18-05-00251 (Beilstein Handbook Reference), NSC656277, CAS-520-18-3, CI 75640, KAEMPFEROL (IARC), KAEMPFEROL [IARC], SMR000112585, 4det, Kaempferol,(S), KAEMPFEROL [MI], 5,4''-Trihydroxyflavonol, Prestwick0_001098, Prestwick1_001098, Prestwick2_001098, Prestwick3_001098, KAEMPFEROL [HSDB], KAEMPFEROL [INCI], 3,5,7-Tetrahydroxyflavone, KAEMPFEROL [USP-RS], BIDD:PXR0073, Oprea1_650954, SCHEMBL18817, BSPBio_001176, MLS000697730, MLS001055391, MLS001074884, MLS006010737, BIDD:ER0134, SPBio_003058, Kaempferol, analytical standard, BDBM7462, BPBio1_001294, MEGxp0_001283, Flavone,4'',5,7-tetrahydroxy-, ACon1_001867, cid_5280863, GTPL11052, CHEBI: 28499, HMS1571K18, HMS2098K18, HMS2267I09, HMS3414C03, HMS3656M03, HMS3678C03, HMS3884B13, 4H-1-Benzopyran-4-one,3,5,7-trihydroxy-2-(4-hydroxyphenyl)-, Kaempferol, >=97.0% (HPLC), TNP00039, Tox21_201165, Tox21_303363, AC-544, HSCI1_000027, LMPK12110003, NSC407289, s2314, AKOS015895240, Kaempferol, >=90% (HPLC), powder, CCG-202823, CS-1273, DB01852, GS-3570, NCGC00016480-01, NCGC00016480-02, NCGC00016480-03, NCGC00016480-04, NCGC00016480-05, NCGC00016480-06, NCGC00016480-07, NCGC00016480-08, NCGC00016480-09, NCGC00091036-01, NCGC00091036-02, NCGC00164322-01, NCGC00179275-01, NCGC00179275-02, NCGC00257464-01, NCGC00258717-01, BP-25390, HY-14590, KAEMPFEROL (CONSTITUENT OF GINKGO), Kaempferol 100 microg/mL in Acetonitrile, SY023424, AB00514046, K0018, NS00001605, SW197199-2, 3,4'',5,7-tetrahydroxy-Flavone (7CI,8CI), C05903, EN300-205764, H10428, S00111, Flavone, 3,4'',5,7-tetrahydroxy- (7CI,8CI), KAEMPFEROL (CONSTITUENT OF GINKGO) [DSC], A828886, Q393336, SR-01000765646, Kaempferol, primary pharmaceutical reference standard, Q-100584, SR-01000765646-3, 3,5,7-trihydroxy-2-(4-hydroxyphenyl)-chromen-4-one, BRD-K12807006-001-05-2, BRD-K12807006-001-10-2, Z57183373, 2-(4-hydroxyphenyl)-3,5,7-tris(oxidanyl)chromen-4-one, 3,5,7-trihydroxy-2-(4-hydroxyphenyl)chromen-4-one??, A91A6666-86C8-4B33-B3EF-F74CD3CD7F47, 3,5,7-trihydroxy-2-(4-hydroxyphenyl)-1-benzopyran-4-one, 3,5,7-Trihydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-one #, 4H-1-Benzopyran-4-one,5,7-trihydroxy-2-(4-hydroxyphenyl)-, Kaempferol, United States Pharmacopeia (USP) Reference Standard, 4H-1-Benzopyran-4-one, 3,5,7-trihydroxy-2-(4-hydroxyphenyl)- (9CI), 3,4'',5,7-Tetrahydroxyflavone, 3,5,7-Trihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one, 4H-1-Benzopyran-4-one, 3,5,7-trihydroxy-2-(4-hydroxyphenyl)-5,7,4''-Trihydroxyflavonol" C15H10O6 IYRMWMYZSQPJKC-UHFFFAOYSA-N 3,5,7-trihydroxy-2-(4-hydroxyphenyl)chromen-4-one n.a. n.a. No No No No No No PMDBD2000885 kappa-Pyrosulfite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000886 Kaurenoic acid n.a. n.a. n.a. n.a. n.a. n.a. n.a. 73062 n.a. NPC161187 Kaurenoic acid, Ent-kaurenoic acid, Kauren-19-oic acid, 6730-83-2, Kaurenic acid, Kaur-16-en-18-oic acid, CHEBI:15417, Kaur-16-en-18-oic acid, (4alpha)-, (-)-Kaur-16-en-19-oic acid, ent-Kaur-16-en-19-oic acid, (4R,4aS,6aS,9R,11aR,11bS)-4,11b-dimethyl-8-methylenetetradecahydro-6a,9-methanocyclohepta[a]naphthalene-4-carboxylic acid, Cunabic acid, (8alpha,9beta,10alpha,13alpha)-kaur-16-en-18-oic acid, (4R,4aS,6aS,9S,11aR,11bS)-4,11b-dimethyl-8-methylenetetradecahydro-6a,9-methanocyclohepta[a]naphthalene-4-carboxylic acid, D572D9R2TZ, NSC 339145, kaurenoate, kaurenoicacid, NSC339145, NSC-339145, NE4, 3beta-hydroxy-kaurenoic acid, UNII-D572D9R2TZ, CHEMBL489140, Ent-kaur-16-en-18-oic acid, SCHEMBL21803663, NIKHGUQULKYIGE-OTCXFQBHSA-N, HY-N1469, BDBM50466103, MFCD28978039, s9439, ent-Kaur-16(17)-en-19-oic acid, AKOS026674268, CCG-267494, AS-56534, Kaurenoic acid, >=95% (LC/MS-ELSD), CS-0016962, Q27089430, (5beta,8alpha,9beta,10alpha,13alpha)-kaur-16-en-18-oic acid, (1S,9S,5R,13R)-5,9-dimethyl-14-methylenetetracyclo[11.2.1.0<1,10>.0<4,9>]hexadecane-5-carboxylic acid C20H30O2 NIKHGUQULKYIGE-OTCXFQBHSA-N (1S,4S,5R,9S,10R,13R)-5,9-dimethyl-14-methylidenetetracyclo[11.2.1.01,10.04,9]hexadecane-5-carboxylic acid n.a. n.a. No No No No No No PMDBD2000887 KD-13 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000888 knightine n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000889 Kojic acid Therapeutic Substance Investigational Drug 501-30-4 DB01759 n.a. n.a. D0F3CO 3840 3708 NPC116366 kojic acid, 501-30-4, 5-Hydroxy-2-(hydroxymethyl)-4H-pyran-4-one, 5-Hydroxy-2-(hydroxymethyl)-4-pyrone, 5-hydroxy-2-(hydroxymethyl)pyran-4-one, 4H-PYRAN-4-ONE, 5-HYDROXY-2-(HYDROXYMETHYL)-, 5-Hydroxy-2-hydroxymethyl-4-pyrone, acido kojico, 2-Hydroxymethyl-5-hydroxy-gamma-pyrone, Kojisaeure, CCRIS 4131, 2-(Hydroxymethyl)-5-hydroxy-4H-pyran-4-one, NSC 1942, EINECS 207-922-4, MFCD00006580, UNII-6K23F1TT52, BRN 0120895, 5-Hydroxy-2-hydroxymethyl-4H-4-pyranone, DTXSID2040236, CHEBI:43572, AI3-02549, HSDB 7664, Pyran-4-one, 5-hydroxy-2-(hydroxymethyl), 6K23F1TT52, NSC-1942, 123712-78-7, 5-Hydroxy-2-hydroxymethyl-pyran-4-one, 5-Hydroxy-2-hydroxymethyl-4H-pyran-4-one, CHEMBL287556, DTXCID0020236, NSC1942, 5-18-02-00516 (Beilstein Handbook Reference), NCGC00017325-03, NCGC00017325-06, KOJIC ACID (IARC), KOJIC ACID [IARC], KOJIC ACID (MART.), KOJIC ACID [MART.], CAS-501-30-4, Spectrum_000191, KOJIC ACID [MI], Spectrum2_001828, Spectrum3_001704, Spectrum4_000571, Spectrum5_001085, Natural Kojic Acid Powder, KOJIC ACID [HSDB], KOJIC ACID [INCI], Oprea1_038773, SCHEMBL36895, BSPBio_003288, KBioGR_001002, KBioSS_000671, KOJIC ACID [WHO-DD], BIDD:ER0501, DivK1c_000923, SPBio_001875, Kojic acid, analytical standard, MEGxm0_000388, WLN: T6O DVJ B1Q EQ, ACon1_000622, BEJNERDRQOWKJM-UHFFFAOYSA-, HMS502O05, KBio1_000923, KBio2_000671, KBio2_003239, KBio2_005807, KBio3_002508, NINDS_000923, HMS3604L04, KUC106760N, TNP00261, 2-Hydroxymethyl-5-hydroxy-?-pyrone, Tox21_110814, Tox21_113449, BDBM50031467, CCG-38458, s5174, AKOS000120649, Tox21_110814_1, 5-Hydroxy-2-hydroxymethyl-I(3)-pyron, DB01759, HY-W050154, IDI1_000923, SMP1_000171, NCGC00017325-01, NCGC00017325-02, NCGC00017325-04, NCGC00017325-05, NCGC00017325-10, NCGC00142361-01, NCGC00168903-01, NCGC00168903-02, NCGC00181145-01, AC-11658, AS-11648, Kojic acid, purum, >=98.0% (HPLC), KSC-11-228-2, SY018009, 2-Hydroxymethyl-5-hydroxy-4H-pyran-4-one, CS-0032701, K0010, K0012, NS00013805, EN300-20919, C91105, K-7000, 2-HYDROXYMETHYL-5-HYDROXY-.GAMMA.-PYRONE, Q416285, SR-01000945134, SR-01000945134-1, C65A72E0-0E46-4AF4-AA68-178ECA2E5FCC, F0001-1307, Z104484860, InChI=1/C6H6O4/c7-2-4-1-5(8)6(9)3-10-4/h1,3,7,9H,2H2 C6H6O4 BEJNERDRQOWKJM-UHFFFAOYSA-N 5-hydroxy-2-(hydroxymethyl)pyran-4-one n.a. n.a. No No No No No No PMDBD2000890 KSL n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000891 KSL-W n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000892 KT2 n.a. n.a. n.a. n.a. n.a. n.a. n.a. 137102595 n.a. n.a. CHEMBL4578839, 2-azanyl-9-[(1~{R},6~{R},8~{R},9~{R},10~{S},15~{R},17~{R},18~{R})-8-(4-azanylpyrrolo[2,3-d]pyrimidin-7-yl)-3,9,12,18-tetrakis(oxidanyl)-3,12-bis(oxidanylidene)-2,4,7,11,13,16-hexaoxa-3$l^{5},12$l^{5}-diphosphatricyclo[13.2.1.0^{6,10}]octadecan-17-yl]-1~{H}-purin-6-one, SCHEMBL18490544, BDBM50509409, KT2 C21H25N9O13P2 UTYHBKZTJXGVRM-NFASUMMFSA-N 2-amino-9-[(1R,6R,8R,9R,10S,15R,17R,18R)-8-(4-aminopyrrolo[2,3-d]pyrimidin-7-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3lambda5,12lambda5-diphosphatricyclo[13.2.1.06,10]octadecan-17-yl]-1H-purin-6-one n.a. n.a. No No No No No No PMDBD2000893 L- K6L9 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000894 L-2-Bromophenylalanine n.a. n.a. n.a. n.a. n.a. n.a. n.a. 193338 n.a. n.a. 42538-40-9, L-2-Bromophenylalanine, 2-Bromo-L-Phenylalanine, (S)-2-Amino-3-(2-bromophenyl)propanoic acid, 2-Bromophenylalanine, (2S)-2-amino-3-(2-bromophenyl)propanoic acid, H-PHE(2-BR)-OH, (2S)-2-azaniumyl-3-(2-bromophenyl)propanoate, L-2-Bromo phenylalanine, L-2-BROMOPHE, o-Bromo-L-phenylalanine, MFCD03092958, (S)-2-BROMOPHENYLALANINE, 30163-16-7, 2-AMINO-3-(2-BROMO-PHENYL)-PROPIONIC ACID, SCHEMBL43302, DTXSID70173694, JFVLNTLXEZDFHW-QMMMGPOBSA-N, AKOS012010214, AC-5852, AM82699, AS-14789, CS-0059190, EN300-385827, A851588 C9H10BrNO2 JFVLNTLXEZDFHW-QMMMGPOBSA-N (2S)-2-amino-3-(2-bromophenyl)propanoic acid n.a. n.a. No No No No No No PMDBD2000895 L-4-Carbamoylphenylalanine n.a. n.a. n.a. n.a. n.a. n.a. n.a. 2762272 n.a. n.a. L-4-Carbamoylphenylalanine, 223593-04-2, (S)-2-Amino-3-(4-carbamoylphenyl)propanoic acid, L-4-Carbamoylphe, (2S)-2-amino-3-(4-carbamoylphenyl)propanoic acid, SCHEMBL668747, (2S)-3-(4-aminocarbonylphenyl)-2-azanyl-propanoic acid, DTXSID60376132, MFCD01860658, AKOS015949714, PS-12792, CS-0205148, A878572, J-014666 C10H12N2O3 OZVAXCWACWDNIQ-QMMMGPOBSA-N (2S)-2-amino-3-(4-carbamoylphenyl)propanoic acid n.a. n.a. No No No No No No PMDBD2000896 L-744,832 n.a. n.a. n.a. n.a. n.a. n.a. n.a. 6451153 n.a. n.a. 160141-09-3, L 744832, propan-2-yl (2S)-2-[[2-[(2S,3S)-2-[[(2R)-2-amino-3-sulfanylpropyl]amino]-3-methylpentoxy]-3-phenylpropanoyl]amino]-4-methylsulfonylbutanoate, L 744,832, L-744,832, 2-(2-(2-amino-3-mercapto)propylamino-3-methyl)pentyloxy-3-phenylpropionylmethionine sulfone isopropyl ester, L-744832, propan-2-yl (2S)-2-[[(2S)-2-[(2S,3S)-2-[[(2R)-2-amino-3-sulfanylpropyl]amino]-3-methylpentoxy]-3-phenylpropanoyl]amino]-4-methylsulfonylbutanoate, DTXSID90936228, CHEBI:125428, (2S)-2-[[2-[(2S,3S)-2-[[(2R)-2-amino-3-mercaptopropyl]amino]-3-methylpentoxy]-1-oxo-3-phenylpropyl]amino]-4-methylsulfonylbutanoic acid propan-2-yl ester, BRD-A66794241-001-01-3, Q27216045, 2-({2-[(2-Amino-3-sulfanylpropyl)amino]-3-methylpentyl}oxy)-N-{4-(methanesulfonyl)-1-oxo-1-[(propan-2-yl)oxy]butan-2-yl}-3-phenylpropanimidic acid C26H45N3O6S2 PGOKBMWPBDRDGN-SIPQYZPLSA-N propan-2-yl (2S)-2-[[2-[(2S,3S)-2-[[(2R)-2-amino-3-sulfanylpropyl]amino]-3-methylpentoxy]-3-phenylpropanoyl]amino]-4-methylsulfonylbutanoate n.a. n.a. No No No No No No PMDBD2000897 Lactoferricin B n.a. n.a. n.a. n.a. n.a. n.a. n.a. 16132444 n.a. n.a. Lactoferricin B, 146897-68-9, L-Phenylalanine, L-phenylalanyl-L-lysyl-L-cysteinyl-L-arginyl-L-arginyl-L-tryptophyl-L-glutaminyl-L-tryptophyl-L-arginyl-L-methionyl-L-lysyl-L-lysyl-L-leucylglycyl-L-alanyl-L-prolyl-L-seryl-L-isoleucyl-L-threonyl-L-cysteinyl-L-valyl-L-arginyl-L-arginyl-L-alanyl- C141H226N46O29S3 CSSYQJWUGATIHM-IKGCZBKSSA-N (2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S,3R)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S)-6-amino-2-[[(2S)-2-amino-3-phenylpropanoyl]amino]hexanoyl]amino]-3-sulfanylpropanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-5-oxopentanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-5-carbamimidamidopentanoyl]amino]-4-methylsulfanylbutanoyl]amino]hexanoyl]amino]hexanoyl]amino]-4-methylpentanoyl]amino]acetyl]amino]propanoyl]pyrrolidine-2-carbonyl]amino]-3-hydroxypropanoyl]amino]-3-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]-3-sulfanylpropanoyl]amino]-3-methylbutanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-carbamimidamidopentanoyl]amino]propanoyl]amino]-3-phenylpropanoic acid n.a. n.a. No No No No No No PMDBD2000898 Lanthanum chloride n.a. n.a. n.a. n.a. n.a. n.a. n.a. 64735 n.a. n.a. Lanthanum chloride, Lanthanum(III) chloride, 10099-58-8, Lanthanum trichloride, trichlorolanthanum, Lanthanum chloride (LaCl3), MFCD00011068, Lanthanum(III) chloride, anhydrous, LaCl3, Lanthanum chloride, anhydrous, Lanthanum chloride (La2Cl6), CCRIS 6887, EINECS 233-237-5, UNII-04M8624OXV, DTXSID2051502, Lanthanum(III) chloride, ultra dry, AKOS032963570, Lanthanum(III) chloride, anhydrous, beads, EC 233-237-5, Q421212, Lanthanum(III) chloride, anhydrous (99.9%-La) (REO), Lanthanum(III) chloride, anhydrous, beads, -10 mesh, >=99.99% trace metals basis, Lanthanum(III) chloride, anhydrous, beads, -10 mesh, 99.9% trace metals basis Cl3La ICAKDTKJOYSXGC-UHFFFAOYSA-K trichlorolanthanum n.a. n.a. No No No No No No PMDBD2000899 L-Aspartate Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D0OT9B 5960 n.a. n.a. "L-aspartic acid, aspartic acid, 56-84-8, H-Asp-OH, L-aspartate, Asparagic acid, (2S)-2-aminobutanedioic acid, aspartate, Aspatofort, (S)-2-Aminosuccinic acid, L-Aminosuccinic acid, L-Asparagic acid, Asparaginic acid, L-Asparaginic acid, (S)-Aspartic acid, Aspartic acid, L-, (2S)-Aspartic acid, (S)-Aminobutanedioic acid, L-Aspartinsaeure, L-Asparaginsaeure, L-Asparaginsyra, Acidum asparticum, L-(+)-Aspartic acid, L-2-Aminobutanedioic acid, Aspartate, L-, Asparaginsaeure, L-Asp, 25608-40-6, 2-aminosuccinic acid, Aminosuccinic acid, Butanedioic acid, amino-, (S)-, Asparaginsaeure [German], (+)-Aspartic acid, (L)-ASPARTIC ACID, Acido aspartico, Aspartic acid (VAN), Acide aspartique, Asparagic acid (VAN), (S)-(+)-Aminosuccinic acid, Asparaginic acid (VAN), Acide aspartique [INN-French], Acido aspartico [INN-Spanish], HSDB 1430, Deamidated asparagine, NSC 3973, AI3-04461, FEMA No. 3565, CCRIS 6181, Acidum asparticum [INN-Latin], 6899-03-2, CHEBI:17053, BRN 1723530, UNII-30KYC7MIAI, 30KYC7MIAI, L( )-Aminobernsteinsaeure, L(+)-Aminobernsteinsaeure, asp, EINECS 200-291-6, (S)-2-aminobutanedioic acid, C4H7NO4, Beta-L-Aspartic Acid, FEMA NO. 3656, MFCD00002616, (S)-(+)-Aspartic acid, CHEMBL274323, DTXSID7022621, EC 200-291-6, (S)-Aspartate, (+)-Aspartate, ASPARTIC ACID (II), ASPARTIC ACID [II], L-Aspartic acid-13C4, 1-Amino-1,2-carboxyethane, asparaginsaure, (S)-Aminobutanedioate, ASPARTIC ACID (MART.), ASPARTIC ACID [MART.], ASPARTIC ACID (USP-RS), ASPARTIC ACID [USP-RS], NSC3973, ASPARTIC ACID (EP IMPURITY), ASPARTIC ACID [EP IMPURITY], L-Asparticacid, l aspartic acid, ASPARTIC ACID (EP MONOGRAPH), ASPARTIC ACID [EP MONOGRAPH], ASPARTIC ACID (USP MONOGRAPH), ASPARTIC ACID [USP MONOGRAPH], L- Aspartic acid, ALANINE IMPURITY A (EP IMPURITY), ALANINE IMPURITY A [EP IMPURITY], Aspartic Acid [USAN:INN], LYSINE ACETATE IMPURITY A (EP IMPURITY), LYSINE ACETATE IMPURITY A [EP IMPURITY], 4-04-00-02998 (Beilstein Handbook Reference), 39162-75-9, CHEBI:22660, Aminosuccinate, Asparagate, Asparatate, NSC-3973, aspartic acid,l, l-aspartic-acid, L-Asparagate, L-Aminosuccinate, Aspartic acid [USAN:USP:INN], aspartate magnesium, (L)-Aspartate, alpha-Aminosuccinate, (2S)-Aspartate, L-(+)-Aspartate, [3H]-L-aspartate, L-[14C]aspartate, L-Aspartic acid, 2, [3H]L-aspartic acid, (R)-2-aminosuccinate, (S)-2-aminosuccinate, Tocris-0214, [3h]-l-asp, (S)-amino-Butanedioate, alpha-Aminosuccinic acid, (S)-Aminosuccinic Acid, (S)-(+)-Aspartate, [3H]-L-aspartic acid, L-Aspartic acid (9CI), 2-Amino-3-methylsuccinate, Biomol-NT_000168, bmse000031, bmse000875, Aspartic acid (USP/INN), ASPARTIC ACID [MI], L-Aspartic acid (JP17), SCHEMBL3231, (S)-amino-Butanedioic acid, ASPARTIC ACID [INN], L-Aspartic acid, >=98%, L-Aspartic acid, 99.0%, Lopac0_000133, ASPARTIC ACID [HSDB], ASPARTIC ACID [INCI], ASPARTIC ACID [USAN], Aspartic acid, L- (8CI), ASPARTIC ACID [VANDF], Aspartic Acid (Aspartic Acid), L-Aspartic acid (H-Asp-OH), L-ASPARTIC ACID [FCC], L-ASPARTIC ACID [JAN], (2S)-2-azanylbutanedioic acid, BPBio1_001128, DTXCID402621, GTPL3309, GTPL4534, ASPARTIC ACID [WHO-DD], L-ASPARTIC ACID [FHFI], BDBM18125, L-Aspartic acid, >=98%, FG, HMS3260K08, .alpha.-Aminosuccinic acid, (L)-, 55443-54-4, HY-N0666, STR04614, Tox21_500133, HB0374, PDSP1_000819, PDSP2_000806, AKOS006239578, AKOS015853957, AM81585, CCG-204228, DB00128, LP00133, SDCCGSBI-0050121.P002, potassium aspartate and magnesium aspart, L-Aspartic acid (H-Asp-OH) USP grade, NCGC00024499-01, NCGC00024499-02, NCGC00024499-03, NCGC00024499-04, NCGC00024499-05, NCGC00024499-06, NCGC00024499-10, NCGC00260818-01, BP-13291, L-Aspartic acid, Vetec(TM) reagent grade, A0546, CS-0009701, EU-0100133, L-Aspartic acid, BioXtra, >=99% (HPLC), NS00074191, S5632, EN300-64901, L-Aspartic acid, BioUltra, >=99.5% (T), A 9256, A-9220, C00049, D00013, D70832, M03000, L-Aspartic acid, SAJ special grade, >=99.0%, A817928, A824434, L-Aspartic acid, reagent grade, >=98% (HPLC), Q178450, SR-01000597734, SR-01000597734-3, F8889-8684, Z995084132, A4B5FB11-A4B6-4D75-9860-2ACF670700B9, Aspartic acid, European Pharmacopoeia (EP) Reference Standard, L-Aspartic acid, certified reference material, TraceCERT(R), Aspartic acid, United States Pharmacopeia (USP) Reference Standard, L-Aspartic acid, BioReagent, suitable for cell culture, suitable for insect cell culture, L-Aspartic acid, Pharmaceutical Secondary Standard; Certified Reference Material, L-Aspartic acid, from non-animal source, meets EP, USP testing specifications, suitable for cell culture, 98.5-101.0%" C4H7NO4 CKLJMWTZIZZHCS-REOHCLBHSA-N (2S)-2-aminobutanedioic acid n.a. n.a. No No No No No No PMDBD2000900 Latamoxef Therapeutic Substance Approved Drug 64952-97-2 DB04570 PA164743144 D08109 D0O5LU 47499 43215 n.a. Latamoxef, moxalactam, 64952-97-2, Lamoxactam, Latamoxefum, Oxa-cephem, Festamoxin, Moxam, LMOX, Latamoxef (INN), CHEBI:599928, VUF6C936Z3, (6R,7R)-7-[[2-carboxy-2-(4-hydroxyphenyl)acetyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, LATAMOXEF [INN], 64952-97-2 (FREE ACID), Latamoxefum [INN-Latin], Listeria mox supplement, 6059-S, Latamoxef [INN:BAN], (6R,7R)-7-[2-carboxy-2-(4-hydroxyphenyl)acetamido]-7-methoxy-3-{[(1-methyl-1H-1,2,3,4-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, EINECS 265-287-9, UNII-VUF6C936Z3, 79120-38-0, Spectrum_000971, LATAMOXEF [JAN], MOXALACTAM [MI], Prestwick0_000819, Prestwick1_000819, Prestwick2_000819, Spectrum2_001067, Spectrum3_000510, Spectrum4_000064, Spectrum5_001371, MOXALACTAMSUPPLEMENT, MOXALACTAM [VANDF], Epitope ID:180870, LATAMOXEF [WHO-DD], BSPBio_002039, KBioGR_000587, KBioSS_001451, (6R-(6alpha,7alpha,7(S*)))-7-((Carboxy(4-hydroxyphenyl)acetyl)amino)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-oxa-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7beta-(2-Carboxy-2-(4-hydroxyphenyl)acetamido)-7alpha-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-1-oxa-1-dethia-3-cephem-4-carboxylic acid, CHEMBL74632, DivK1c_000909, SCHEMBL194012, SPBio_001054, SPBio_002638, DTXSID9023338, GTPL12031, KBio1_000909, KBio2_001451, KBio2_004019, KBio2_006587, KBio3_001539, JWCSIUVGFCSJCK-CAVRMKNVSA-N, NINDS_000909, BCP12584, BDBM50370589, DB04570, Moxalactam Supplement, for microbiology, IDI1_000909, SMP1_000200, (6R,7R)-7-{[carboxy(4-hydroxyphenyl)acetyl]amino}-7-(methyloxy)-3-{[(1-methyl-1H-tetrazol-5-yl)thio]methyl}-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, (6R,7R)-7-{[carboxy(4-hydroxyphenyl)acetyl]amino}-7-methoxy-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 5-Oxa-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((carboxy(4-hydroxyphenyl)acetyl)amino)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-, 7-((Carboxy(4-hydroxyphenyl)acetyl)amino)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-oxa-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid (6R-(6alpha,7alpha,7(S*)))-, SBI-0051450.P003, NS00011558, C07231, D08109, A867780, EN300-19651960, Q3827439, (6R,7R)-7-((CARBOXY(4-HYDROXYPHENYL)ACETYL)AMINO)-7-METHOXY-3-(((1-METHYL-1H-TETRAZOL-5-YL)THIO)METHYL)-8-OXO-5-OXA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXYLIC ACID, (6R,7R)-7-(2-carboxy-2-(4-hydroxyphenyl)acetamido)-7-methoxy-3-((1-methyl-1H-tetrazol-5-ylthio)methyl)-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, (6R,7R)-7-[[3-hydroxy-2-(4-hydroxyphenyl)-3-oxo-propanoyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 5-OXA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXYLIC ACID, 7-((CARBOXY(4-HYDROXYPHENYL)ACETYL)AMINO)-7-METHOXY-3-(((1-METHYL-1H-TETRAZOL-5-YL)THIO)METHYL)-8-OXO-, (6R,7R)-, 5-Oxa-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((carboxy(4-hydroxyphenyl)acetyl)amino)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-, (6R-(6alpha,7alpha,7(S*)))-, 5-Oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[carboxy(4-hydroxyphenyl)acetyl]amino]-7methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo- C20H20N6O9S JWCSIUVGFCSJCK-CAVRMKNVSA-N (6R,7R)-7-[[2-carboxy-2-(4-hydroxyphenyl)acetyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid n.a. Antibiotics No No No No No No PMDBD2000901 L-Canavanine Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D0V9FZ 439202 n.a. n.a. "L-canavanine, canavanine, 543-38-4, Canavanin, 2-Amino-4-(guanidinooxy)butyric acid, O-((Aminoiminomethyl)amino)-L-homoserine, O-((Aminoiminomethyl)amino)homoserine, (2S)-2-amino-4-(diaminomethylideneamino)oxybutanoic acid, 3HZV514J4B, CHEMBL443732, L-Homoserine, O-((aminoiminomethyl)amino)-, Butyric acid, 2-amino-4-(guanidinooxy)-, L-, CHEBI:609827, 2-azaniumyl-4-(diaminomethylideneamino)oxybutanoate, O-[(Aminoiminomethyl)amino]-L-homoserine, (S)-2-Amino-4-(guanidinooxy)butanoic acid, (2S)-2-amino-4-(carbamimidamidooxy)butanoic acid, GGB, L-Alpha-amino-gamma-[guanidinooxy]-N-butyric acid, L-Cav;LDN 21810, L-2-AMINO-4-(GUANIDINOOXY)BUTYRIC ACID, AI3-52153, L-alpha-Amino-gamma-(guanidinooxy)-n-butyric acid, UNII-3HZV514J4B, HSDB 3471, L(+)-Canavanine, Spectrum_001137, Tocris-0673, CANAVANINE [MI], L-CAV, Prestwick3_000609, Spectrum2_000800, Spectrum3_001206, Spectrum4_000783, Spectrum5_001884, CANAVANINE [HSDB], Lopac-C-9758, (+)-CANAVANINE, bmse000073, CANAVANINE, (+)-, Lopac0_000320, BSPBio_000518, BSPBio_002592, KBioGR_001226, KBioSS_001617, DivK1c_000360, O-carbamimidamido-L-homoserine, SCHEMBL151097, SPECTRUM1500833, SPBio_000940, BPBio1_000570, DTXSID5045041, HMS501B22, KBio1_000360, KBio2_001617, KBio2_004185, KBio2_006753, KBio3_002092, FSBIGDSBMBYOPN-VKHMYHEASA-N, NINDS_000360, HMS1921K08, HY-B1581, BDBM50271982, BDBM50370459, CCG-40178, AKOS006240676, DB01833, SDCCGMLS-0066683.P001, SDCCGSBI-0050308.P003, IDI1_000360, SMP1_000062, NCGC00015287-01, NCGC00015287-18, NCGC00015287-19, NCGC00024722-01, NCGC00024722-02, NCGC00024722-03, NCGC00024722-04, (2S)-2-amino-4-guanidinooxy-butanoic acid, O-{[Amino(imino)methyl]amino}-L-homoserine, CS-0013477, NS00014863, Butyric acid, 2-amino-4-(guanidinooxy)-, L, C00308, Q418408, [Eur.J.Pharmacol. 269:269; 271:87 (1994)], (2s)-2-amino-4-(((diaminomethylidene)amino)oxy)butanoic acid, 56C22C33-8657-4884-BE16-CAF24BF61D77, L-Canavanine, >=98% (TLC), powder, from Canavalia ensiformis" C5H12N4O3 FSBIGDSBMBYOPN-VKHMYHEASA-N (2S)-2-amino-4-(diaminomethylideneamino)oxybutanoic acid n.a. n.a. No No No No No No PMDBD2000902 L-carnosine Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D0M9BA 439224 n.a. n.a. L-Carnosine, Carnosine, 305-84-0, beta-Alanyl-L-histidine, Ignotine, Karnozin, Karnozzn, L-Histidine, beta-alanyl-, (2S)-2-(3-aminopropanamido)-3-(1H-imidazol-4-yl)propanoic acid, L-Ignotine, N-2-M, Polaprezinc, (3-aminopropanoyl)-L-histidine, CHEBI:15727, Nalpha-(beta-alanyl)-L-histidine, .beta.-Alanyl-L-histidine, NSC 524045, BRN 0087671, 8HO6PVN24W, beta-Alanylhistidine, MFCD00005207, (S)-2-(3-Aminopropanamido)-3-(1H-imidazol-5-yl)propanoic acid, (2S)-2-(3-aminopropanoylamino)-3-(1H-imidazol-5-yl)propanoic acid, Z 103, Z-103, N-beta-alanyl-L-histidine, (2~{S})-2-(3-azanylpropanoylamino)-3-(1~{H}-imidazol-4-yl)propanoic acid, 1370422-07-3, UNII-8HO6PVN24W, L-Histidine, N-.beta.-alanyl-, Sevitin, betaAla-His, b-Alanylhistidine, NSC-524045, beta-Ala-His-OH, B-Ala-his-oh, EINECS 206-169-9, b-Alanyl-L-histidine, beta-alanyl-l-histidin, .beta.-Alanylhistidine, Spectrum_001178, N-b-alanyl-L-Histidine, SpecPlus_000374, CARNOSINE [MI], CARNOSINE [INCI], Spectrum2_000454, Spectrum3_001212, Spectrum4_001673, Spectrum5_000605, CARNOSINE [VANDF], 3-aminopropionyl-histidine, bmse000246, bmse001002, C00386, CARNOSINE [WHO-DD], N-(b-Alanyl)-L-histidine, SCHEMBL33769, BSPBio_002624, KBioGR_002225, KBioSS_001658, 4-25-00-04381 (Beilstein Handbook Reference), DivK1c_006470, SPECTRUM1500944, N-(3-Aminopropanoyl)histidine, SPBio_000528, CHEMBL242948, GTPL4559, SCHEMBL25425775, KBio1_001414, KBio2_001658, KBio2_004226, KBio2_006794, KBio3_002124, DTXSID80879594, L-Carnosine, ~99%, crystalline, (2S)-2-(3-aminopropanoylamino)-3-imidazol-4-ylpropanoic acid, TNP00340, N(alpha)-(beta-alanyl)-L-histidine, BDBM50485554, CCG-38696, AKOS010421481, AKOS015963345, CS-W014210, DB11695, HY-W013494, SDCCGMLS-0066726.P001, NCGC00017390-01, NCGC00017390-02, NCGC00142487-01, AC-17084, AC-19690, AC-31940, AS-12570, A0222, L-Carnosine, Vetec(TM) reagent grade, 98%, S5226, EN300-302338, H11980, Q413822, SR-05000002473, SR-05000002473-1, (2S)-2-(3-aminopropanamido)-3-(1H-imidazol-5-yl)propanoic acid, (S)-2-(3-aminopropanamido)-3-(1H-imidazol-4-yl)propanoic acid, 8V0 C9H14N4O3 CQOVPNPJLQNMDC-ZETCQYMHSA-N (2S)-2-(3-aminopropanoylamino)-3-(1H-imidazol-5-yl)propanoic acid n.a. n.a. No No No No No No PMDBD2000903 L-cysteic acid Therapeutic Substance Investigational Drug 498-40-8 DB03661 n.a. n.a. D05AMX 72886 65718 NPC265829 L-Cysteic acid, 498-40-8, Cysteinesulfonic acid, Cysteic acid, L-, (R)-2-Amino-3-sulfopropanoic acid, L-Alanine, 3-sulfo-, 3-sulfo-L-alanine, (2R)-2-amino-3-sulfopropanoic acid, Cysteric acid, Alanine, 3-sulfo-, L-, Cysteic acid (VAN), Cysteinic acid, Cepteic acid, Cipteic acid, 3-Sulfoalanine, sulfo-D-alanine, 2-Amino-3-sulfopropionic acid, M6W2DJ6N5K, L-Cysteate, alpha-amino-beta-sulfopropionic acid, (2R)-2-amino-3-sulfo-propanoic acid, (R)-cysteate, Cysteinesulfonate, H-Cys(O)2-OH.H2O, MFCD00007524, NSC 254030, C3H7NO5S, UNII-M6W2DJ6N5K, NSC-254030, EINECS 207-861-3, bmse000380, CYSTEIC ACID [INCI], SCHEMBL44031, L-CYSTEIC ACID [MI], CYSTEIC ACID, (+)-, DTXSID7075424, L-Alanine, 3-sulfo- (9CI), CHEBI:17285, Alanine, 3-sulfo-, L- (8CI), AKOS006281833, AKOS015854116, (2R)-2-amino-3-sulfo-propionic acid, DB03661, (2R)-2-azanyl-3-sulfo-propanoic acid, DS-12037, OCS, CS-0083859, NS00014864, C00506, D81957, EN300-302681, Q29743881 C3H7NO5S XVOYSCVBGLVSOL-REOHCLBHSA-N (2R)-2-amino-3-sulfopropanoic acid n.a. n.a. No No No No No No PMDBD2000904 Lemon Therapeutic Substance n.a. n.a. DB10538 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000905 Lemon oil n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000906 LF11-215 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000907 LF11-227 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000908 LF11-322 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000909 LF11-324 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000910 LFampin n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000911 Lfcin n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000912 L-fucose cluster n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000913 Limonene n.a. n.a. n.a. n.a. n.a. n.a. n.a. 22311 n.a. NPC34764 LIMONENE, Dipentene, 138-86-3, Cinene, Cajeputene, DL-Limonene, Kautschin, Dipenten, Eulimen, Nesol, p-Mentha-1,8-diene, 1,8-p-Menthadiene, Cajeputen, Limonen, Cinen, Inactive limonene, Acintene DP dipentene, (+/-)-Limonene, 1-Methyl-4-(1-methylethenyl)cyclohexene, Cyclohexene, 1-methyl-4-(1-methylethenyl)-, Unitene, alpha-Limonene, Flavor orange, Orange flavor, Goldflush II, 4-Isopropenyl-1-methylcyclohexene, Acintene DP, 4-Isopropenyl-1-methyl-1-cyclohexene, Dipanol, Di-p-mentha-1,8-diene, 1,8(9)-p-Menthadiene, d,l-Limonene, Limonene, dl-, 7705-14-8, Dipentene 200, (+-)-Dipentene, DL-4-Isopropenyl-1-methylcyclohexene, (+-)-Linonene, Caswell No. 526, delta-1,8-Terpodiene, p-Mentha-1,8-diene, dl-, (+-)-alpha-Limonene, Dipentene, crude, MENTHA-1,8-DIENE (DL), NSC 21446, PC 560, 1-Methyl-4-isopropenyl-1-cyclohexene, Terpodiene, 1-methyl-4-(prop-1-en-2-yl)cyclohex-1-ene, Ciene, 1-methyl-4-prop-1-en-2-ylcyclohexene, Cyclil decene, HSDB 1809, Limonene, (+/-)-, NSC 844, Orange x, Dipentene, technical grade, p-Mentha-1,8-diene, (+-)-, .alpha.-Limonene, DIPENTENE (+-), EINECS 205-341-0, EINECS 231-732-0, 1-Methyl-p-isopropenyl-1-cyclohexene, EPA Pesticide Chemical Code 079701, Mentha-1,8-diene, DTXSID2029612, UNII-9MC3I34447, CHEBI:15384, AI3-00739, NSC-844, NSC-21446, (+-)-(RS)-limonene, DL-p-mentha-1,8-diene, Mentha-1,8-diene, DL, .delta.-1,8-Terpodiene, 8016-20-4, 9MC3I34447, Terpenes and Terpenoids, limonene fraction, Methyl-4-isopropenylcyclohexene, DTXCID209612, NSC844, 65996-98-7, (1)-1-Methyl-4-(1-methylvinyl)cyclohexene, 1-Methyl-4-isopropenylcyclohexene, Methyl-4-isopropenyl-1-cyclohexene, NSC21446, Methyl-4-(1-methylethenyl)cyclohexene, NCGC00163742-03, 4-(1-methylethenyl)-1-methyl-cyclohexene, (+/-)-1-METHYL-4-(1-METHYLETHENYL)CYCLOHEXENE, Cyclohexene, 1-methyl-4-(1-methylethenyl)-, (.+/-.)-, Limonene 1000 microg/mL in Isopropanol, CAS-138-86-3, 4-mentha-1,8-diene, TERPIN MONOHYDRATE IMPURITY C (EP IMPURITY), TERPIN MONOHYDRATE IMPURITY C [EP IMPURITY], Cyclohexene, 1-methyl-4-(1-methylethenyl)-, (R)-, UN2052, Achilles dipentene, Dipentene, tech., 4-isopropenyl-1-methyl-cyclohexene, Nesol/from Table/, c0626, p-Mentha-1, dl-, d(R)-4-Isopropenyl-1-methylcyclohexene, limonene, (+-)-, (.+-.)-Limonene, (.+-.)-Dipentene, p-Menthane/from Table/, 4 Mentha 1,8 diene, LIMONENE [HSDB], LIMONENE [MI], (.+/-.)-Dipentene, (.+/-.)-Limonene, DIPENTENE [VANDF], DIPENTEN [WHO-DD], Cyclohexene, (.+-.)-, Dipentene, p.a., 95%, (+-)-LIMONENE, 1-METHYL-4-PROP-1-EN-2-YL-CYCLOHEXENE, p-Mentha-1,8(9)-diene, CHEMBL15799, (.+/-.)-.alpha.-Limonene, (+/-)-p-Mentha-1,8-diene, p-Mentha-1, (.+-.)-, HMS3264E05, Pharmakon1600-00307080, HY-N0544, LIMONENE, (+/-)-(II), Tox21_112068, Tox21_201818, Tox21_303409, MFCD00062992, NSC757069, 1-methyl-4-isopropenylcyclohex-1-ene, LIMONENE, (+/-)- [II], AKOS009031280, Cyclohexene, 4-Isopropenyl-1-methyl-, USEPA/OPP Pesticide Code 079701, WLN: L6UTJ A1 DY1 & U1, CCG-214016, FS-8076, p-Mentha-1,8-diene, (.+/-.)-, SB44847, UN 2052, NCGC00163742-01, NCGC00163742-02, NCGC00163742-04, NCGC00163742-05, NCGC00257291-01, NCGC00259367-01, 8050-32-6, NCI60_041856, 1-methyl-4-(1-methylethenyl) cylcohexene, Dipentene [UN2052] [Flammable liquid], Cyclohexene, 1-methyl-4-(1-methylethynyl), CS-0009072, L0046, NS00067923, EN300-21627, C06078, D00194, E88572, AB01563249_01, Q278809, SR-01000872759, CYCLOHEXENE 1-METHYL-4-(1-METHYLETHENYL)-, J-007186, J-520048, SR-01000872759-1, 4B4F06FC-8293-455D-8FD5-C970CDB001EE, Dipentene, mixt. of limonene, 56-64%, and terpinolene, 20-25%, 1-Methyl-4-(1-methylethenyl)-or 1-methyl-4-isopropenyl-cyclohex-1-ene, 555-08-8, 8022-90-0 C10H16 XMGQYMWWDOXHJM-UHFFFAOYSA-N 1-methyl-4-prop-1-en-2-ylcyclohexene n.a. n.a. No No No No No No PMDBD2000914 Linalool Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D0X5DC 6549 n.a. NPC180871 Linalool, 78-70-6, 3,7-Dimethylocta-1,6-dien-3-ol, Linalol, LINALYL ALCOHOL, 3,7-Dimethyl-1,6-octadien-3-ol, allo-Ocimenol, beta-Linalool, (+-)-Linalool, Phantol, 1,6-Octadien-3-ol, 3,7-dimethyl-, p-Linalool, Linanool, Linolool, (+/-)-linalool, 2,6-Dimethyl-2,7-octadien-6-ol, 2,6-Dimethylocta-2,7-dien-6-ol, .beta.-Linalool, 2,6-Dimethyl-2,7-octadiene-6-ol, FEMA No. 2635, NSC 3789, (RS)-Linalool, DIABEXALL, (1)-3,7-Dimethyl-1,6-octadien-3-ol, CHEBI:17580, LINALOOL, DL-, NSC-3789, 3,7-dimethyl-octa-1,6-dien-3-ol, D81QY6I88E, DTXSID7025502, LINALOOL, (+/-)-, NSC3789, L 260-2, MFCD00008906, Linalool 1000 microg/mL in Isopropanol, LINALOOL (USP-RS), LINALOOL [USP-RS], (+/-)-3,7-Dimethyl-3-hydroxy-1,6-octadiene, Licareol, 22564-99-4, Linalool (natural), DTXCID305502, Caswell No. 526A, (S)-Linalol, dl-Linalool, FEMA Number 2635, CAS-78-70-6, CCRIS 6557, HSDB 645, EINECS 201-134-4, EINECS 245-083-6, EPA Pesticide Chemical Code 128838, BRN 1721488, UNII-D81QY6I88E, AI3-00942, Linalool b, |A-Linalool, Linalool, .beta., Linalool,(S), ( )-linalool, Linalool, 97%, 2,7-Octadien-6-ol, 2,6-dimethyl-, LINALOOL OIL, 3,6-octadien-3-ol, 2,7-octadiene-6-ol, LINALOOL [FHFI], LINALOOL [HSDB], LINALOOL [INCI], LINALOOL [FCC], 2,7-dien-6-ol, 3,6-dien-3-ol, dl-3,7-Dimethyl-3-hydroxy-1,6-octadiene, LINALOOL [MI], LINOLOOL (D), (.+/-.)-Linalool, LINALOOL [WHO-DD], EC 201-134-4, SCHEMBL20316, Linalool, analytical standard, 0-01-00-00462 (Beilstein Handbook Reference), MLS002152908, CHEMBL25306, GTPL2469, NDI 595 [FDMS], FEMA 2635, NDI 595, HMS2268E18, HMS3886G07, Linalool, >=97%, FCC, FG, 1, 3,7-dimethyl-, (-)-, HY-N0368, WLN: 1U1XQ1&3UY1&1, Tox21_201658, Tox21_303037, AC-551, BDBM50459894, MFCD09025547, s4957, 3,7-Dimethyl-1, 6-octadien-3-ol, AKOS015901617, ( inverted exclamation markA)-Linalool, CCG-266253, NCGC00091688-01, NCGC00091688-02, NCGC00091688-03, NCGC00091688-04, NCGC00257060-01, NCGC00259207-01, AS-56047, SMR000112394, SY264412, WLN: 1Y1&U3XQ1&1U1 -,-, (+/-)-3,7-Dimethyl-1,6-octadien-3-ol, CS-0008916, L0048, NS00005142, C03985, EN300-174564, F17676, Linalool, primary pharmaceutical reference standard, Q410932, CU-01000013132-2, Q-201306, Linalool, certified reference material, TraceCERT(R), Z1255402668 C10H18O CDOSHBSSFJOMGT-UHFFFAOYSA-N 3,7-dimethylocta-1,6-dien-3-ol n.a. n.a. No No No No No No PMDBD2000915 lin-SB056 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000916 lin-SB056-1 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000917 Lipoic acid Therapeutic Substance Phase 2 1200-22-2 DB00166 PA164776929 D00086 D02EVF 6112 5886 NPC166287 "lipoic acid, 1200-22-2, (R)-lipoic acid, (R)-5-(1,2-Dithiolan-3-yl)pentanoic acid, (R)-(+)-1,2-Dithiolane-3-pentanoic acid, (R)-alpha-Lipoic acid, R-(+)-Thioctic acid, (+)-alpha-Lipoic acid, R-alpha-Lipoic acid, Thioctic acid d-form, D-Thioctic acid, 1,2-Dithiolane-3-pentanoic acid, (3R)-, Berlition, Thiogamma, Lipoec, Tiobec, (R)-1,2-Dithiolane-3-pentanoic acid, R-Lipoic acid, (R)-(+)-lipoic acid, (R)-6,8-thioctic acid, 5-[(3R)-1,2-dithiolan-3-yl]pentanoic acid, 5-[(3R)-dithiolan-3-yl]pentanoic acid, (R)-1,2-Dithiolane-3-valeric Acid, (R)-(+)-Lipoate, alpha-(+)-Lipoic acid, 1,2-Dithiolane-3R-pentanoic acid, (R)-(+)-a-Lipoic acid, (r)-(+)-alpha-lipoic acid, Tioctic Acid, R-(+)-Lipoic acid, Lipoic acid (Standard), R-LA, MFCD01631142, VLL71EBS9Z, (3R)-1,2-Dithiolane-3-pentanoic Acid, R-(+)-alpha-Lipoic acid, CHEMBL134342, Heparlipon, CHEBI:30314, C8H14O2S2, Thioderm, Tiobec Retard, R-Lipoate, Byodinoral 300, UNII-VLL71EBS9Z, Thioctanoic acid, (+)-thioctic acid, (R)-Thioctic Acid, R-alpha Lipoic acid, ARLIPOIC ACID, (+)-a-Lipoic acid, Thioctic acid, d form, (y)-alpha-Lipoic Acid, 1,2-Dithiolane-3-pentanoic acid, (R)-, (+)-|A-Lipoic acid, (?)-alpha-Lipoic Acid, (R)-5-(1,2-Dithiolan-3-yl)pentanoicacid, SCHEMBL7924, (+)- alpha -Lipoic acid, ARLIPOIC ACID [INN], Lopac0_001129, (R)-(+)-?-Lipoic Acid, GTPL4822, DTXSID20152651, D-THIOCTIC ACID [WHO-DD], .ALPHA.-LIPOIC ACID, D-, HMS3263B19, THIOCTIC ACID D-FORM [MI], Tox21_501129, BDBM50106731, HY-18733R, LMFA01130001, s3998, (+)-1,2-Dithiolane-3-valeric Acid, (R)-6,8-DITHIOOCTANOIC ACID, AKOS015892879, AC-8133, CCG-205204, CS-5076, DB00166, LP01129, SDCCGSBI-0051097.P002, 5-[(3R)-3-dithiolanyl]pentanoic acid, NCGC00094396-01, NCGC00094396-02, NCGC00094396-03, NCGC00094396-04, NCGC00094396-05, NCGC00094396-06, NCGC00261814-01, AC-11124, AS-11009, HY-18733, ( inverted question mark)-alpha-Lipoic Acid, CS-0694941, EU-0101129, L0207, NS00068623, (R)-(+)--Lipoic acid;R-(+)-Thioctic acid, T 5625, (R)-(+)-alpha-Lipoic acid, analytical standard, EN300-7352963, A804416, SR-01000076163, (R)-(+)-1,2-Dithiolane-3-pentanoic acid, 97%, (R)-(+)-alpha-Lipoic acid, >=98.0% (HPLC), J-004243, Q-201824, SR-01000076163-1, Q27887203, Z1269228108, ( inverted question mark)-1,2-Dithiolane-3-pentanoic acid" C8H14O2S2 AGBQKNBQESQNJD-SSDOTTSWSA-N 5-[(3R)-dithiolan-3-yl]pentanoic acid InVasc Therapeutics n.a. No No No No No No PMDBD2000918 Listerine n.a. n.a. n.a. n.a. n.a. n.a. n.a. 114959 n.a. n.a. "Listerine, 51273-66-6, 5-methyl-2-propan-2-ylcyclohexan-1-ol;5-methyl-2-propan-2-ylphenol;1,3,3-trimethyl-2-oxabicyclo[2.2.2]octane, Phenol, 5-methyl-2-(1-methylethyl)-, mixt. with 5-methyl-2-(1-methylethyl)cyclohexanol and 1,3,3-trimethyl-2-oxabicyclo(2.2.2)octane" C30H52O3 CSAVDNHVPJNKTC-UHFFFAOYSA-N "5-methyl-2-propan-2-ylcyclohexan-1-ol;5-methyl-2-propan-2-ylphenol;1,3,3-trimethyl-2-oxabicyclo[2.2.2]octane" n.a. n.a. No No No No No No PMDBD2000919 L-K6 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000920 LL-13 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000921 LL13-37 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000922 LL-19 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000923 LL-25 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000924 LL-31 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000925 LL-37 Therapeutic Substance Phase 2 n.a. DB16532 n.a. n.a. DS5LI8 16198951 n.a. NPC489217 Cathelicidin, 154947-66-7, ropocamptide, LL 37, LL-37, Bac4, Cathelicidin LL 37, Cap-18, hCAP 18, All38 peptide, LL-37 acetate, LL-37(human), LL-37 (Human), LL-37/hCAP18, CAP18,, CHEMBL530345, EX-A7429A, Cathelicidin antimicrobial peptide 18, AKOS024458536, RS-2000, LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES, LL-37 (LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES-acid), NH2-Leu-Leu-Gly-Asp-Phe-Phe-Arg-Lys-Ser-Lys-Glu-Lys-Ile-Gly-Lys-Glu-Phe-Lys-Arg-Ile-Val-Gln-Arg-Ile-Lys-Asp-Phe-Leu-Arg-Asn-Leu-Val-Pro-Arg-Thr-Glu-Ser-COOH C205H340N60O53 POIUWJQBRNEFGX-XAMSXPGMSA-N (4S)-5-[[(2S)-6-amino-1-[[(2S,3S)-1-[[2-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S,3S)-1-[[(2S)-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S,3S)-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-4-amino-1-[[(2S)-1-[[(2S)-1-[(2S)-2-[[(2S)-5-carbamimidamido-1-[[(2S,3R)-1-[[(2S)-4-carboxy-1-[[(1S)-1-carboxy-2-hydroxyethyl]amino]-1-oxobutan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-1-oxohexan-2-yl]amino]-2-oxoethyl]amino]-3-methyl-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-4-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-amino-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]acetyl]amino]-3-carboxypropanoyl]amino]-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-5-carbamimidamidopentanoyl]amino]hexanoyl]amino]-3-hydroxypropanoyl]amino]hexanoyl]amino]-5-oxopentanoic acid Promore Pharma n.a. No No No No No No PMDBD2000926 LL7-37 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000927 Lomefloxacin Therapeutic Substance Approved Drug 98079-51-7 DB00978 PA164749165 D02318 D02KOF 3948 3811 n.a. lomefloxacin, 98079-51-7, Lomefloxacine, Lomefloxacino, Lomefloxacinum, LFLX, Lomefloxacine [French], Lomefloxacino [Spanish], Lomefloxacinum [Latin], DM 10 (bactericide), DM-10, 1-ethyl-6,8-difluoro-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid, SC-47111A, 1,4-Dihydro-6,8-difluoro-1-ethyl-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid, Lomefloxacin (USAN), CHEBI:116278, 1-ethyl-6,8-difluoro-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid, (+-)-1-Ethyl-6,8-difluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid, L6BR2WJD8V, 1-ethyl-6-fluoranyl-8-fluoro-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid, SC47111A, LOMEFLOXACIN [USAN], SC 47111A, 3-Quinolinecarboxylic acid, 1-ethyl-6,8-difluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-oxo-, CCRIS 6305, Maxaquin (hydrochloride), UNII-L6BR2WJD8V, NY-198 (hydrochloride), BRN 4210041, SC-47111B (mesylate), SC-47111 (hydrochloride), Lomefloxacin [USAN:INN:BAN], Lomefloxacin,(S), Spectrum_001431, Prestwick0_000238, Prestwick1_000238, Prestwick2_000238, Prestwick3_000238, Spectrum2_000696, Spectrum3_001494, Spectrum4_000158, Spectrum5_001246, LOMEFLOXACIN [MI], LOMEFLOXACIN [INN], CHEMBL561, Epitope ID:119067, LOMEFLOXACIN [VANDF], Lopac0_000678, SCHEMBL34609, BSPBio_000315, BSPBio_003107, KBioGR_000636, KBioSS_001911, DivK1c_000365, LOMEFLOXACIN [WHO-DD], SPBio_000851, SPBio_002236, BPBio1_000347, DTXSID4040680, GTPL12407, HY-B0455A, KBio1_000365, KBio2_001911, KBio2_004479, KBio2_007047, KBio3_002607, NINDS_000365, HMS2090O16, BCP11730, RKL10067, BDBM50417952, s5491, AKOS015964770, CCG-204764, DB00978, KS-5014, SDCCGSBI-0050657.P004, 1-ethyl-6,8-difluoro-7-(3-methylpiperazin-1-yl)-4-oxo-quinoline-3-carboxylic acid, 1-ethyl-6,8-difluoro-7-(3-methylpiperazinyl)-4-oxohydroquinoline-3-carboxylic acid, IDI1_000365, SMP1_000287, NCGC00015603-02, NCGC00015603-03, NCGC00015603-04, NCGC00015603-05, NCGC00015603-07, NCGC00015603-16, NCGC00162221-01, NCGC00178293-01, NCGC00178293-02, 3-Quinolinecarboxylic acid, 1,4-dihydro-6,8-difluoro-1-ethyl-7-(3-methyl-1-piperazinyl)-4-oxo-, 3-Quinolinecarboxylic acid, 1-ethyl-6,8-difluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-oxo-, (+-)-, SBI-0050657.P003, Lomefloxacin 1000 microg/mL in Acetonitrile, NS00007577, C07078, D02318, AB00053622-04, AB00053622-05, AB00053622_06, AB00053622_07, EN300-18553898, Q203618, BRD-A75850590-003-05-6, BRD-A75850590-003-06-4, (+/-)-1-ETHYL-6,8-DIFLUORO-1,4-DIHYDRO-7-(3-METHYL-1-PIPERAZINYL)-4-, (+/-)-1-ethyl-6,8-difluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid, 1-Ethyl-6,8-difluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-oxoquinoline-3-carboxylic acid, 1-ethyl-6,8-difluoro-7-(3-methylpiperazin-1-yl)-4-oxo-quinoline-3-carboxylic acid hydrochloride, 3-Quinolinecarboxylic acid, 1-ethyl-6,8-difluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-oxo- (+/-), 3-QUINOLINECARBOXYLIC ACID, 1-ETHYL-6,8-DIFLUORO-1,4-DIHYDRO-7-(3-METHYL-1-PIPERAZINYL)-4-OXO-, (+/-)- C17H19F2N3O3 ZEKZLJVOYLTDKK-UHFFFAOYSA-N 1-ethyl-6,8-difluoro-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid Pharmacia Corp Antibiotics No No No No No No PMDBD2000928 L-ornithine hydrochloride n.a. n.a. n.a. n.a. n.a. n.a. n.a. 76654 n.a. n.a. "L-Ornithine hydrochloride, 3184-13-2, L(+)-Ornithine hydrochloride, L-Ornithine monohydrochloride, L-ORNITHINE HCl, H-Orn-OH.HCl, (S)-2,5-Diaminopentanoic acid hydrochloride, Ornithine hydrochloride, L-Ornithine, monohydrochloride, Ornithine monohydrochloride, MFCD00064562, H-Orn-OH Hydrochloride, H-Orn-OH xHydrochloride, L-Ornithine (hydrochloride), HBK84K66XH, (2S)-2,5-diaminopentanoic acid;hydrochloride, L-Ornithine, hydrochloride (1:1), 20724-48-5, (S)-2,5-Diaminovaleric Acid Monohydrochloride, (S)-2,5-Diaminopentanoic acid monohydrochloride, Ornithine Hydrochloride (L-Ornithine Hydrochloride), L-Ornithine hydrochloride, 99%, Ornithine hydrochloride (VAN), L-(+)-Ornithine-Hydrochloride, MFCD00166412, ORNITHINE HCL, Ornithine L monochlorohydrate, Ornithine L- HCl, L-2,5-Diaminopentanoic acid, Ornithine L- monohydrochloride, (2S)-2,5-diaminopentanoic acid hydrochloride, L-Ornithine hydrochloride (VAN), L-(+)-2,5-Diaminopentanoic acid, EINECS 221-678-6, UNII-HBK84K66XH, NSC 118360, L-Ornithine-OH hydrochloride, AI3-52601, Ornithine, monohydrochloride, L-, NSC-118360, L-Ornithine, monohydrochloride (9CI); Ornithine, monohydrochloride, L- (8CI); L-(+)-Ornithine monohydrochloride; L-Ornithine hydrochloride; Ornithine hydrochloride; Ornithine monohydrochloride, L-Ornithine-OH.HCl, nBu-POR(20)*HCl, nBu-POR(50)*HCl, NCGC00183365-01, L-ORNITHINE MONOCHLOROHYDRATE/ORNITHINE, nBu-POR(100)*HCl, nBu-POR(200)*HCl, (S)-ornithine hydrochloride, DSSTox_CID_28946, DSSTox_RID_83211, DSSTox_GSID_49020, ORNITHINE HCL [INCI], L-(+)-omithine hydrochloride, SCHEMBL296380, L(+)-Ornithine hydrochloride;, L-(+)-ornithine hydrochloride, CHEMBL3184113, FEMA NO. 4190, NIOSH/RM2985100, DTXSID50858851, CHEBI:195690, L-(+)-Ornithine Monohydrochloride, Tox21_113545, L-Ornithine hydrochloride, pyrolyzate, AKOS015924212, CCG-266353, CS-W017734, HY-W017018, L-Ornithine monohydrochloride, >=99%, ORNITHINE MONOHYDROCHLORIDE, L-, ORNITHINE HYDROCHLORIDE [WHO-DD], L-Ornithine monohydrochloride, pyrolyzate, AC-22378, AS-12277, SY005520, CAS-26982-21-8, AM20090455, O0064, Ornithine, monohydrochloride, L-, pyrolyzate, RM29851000, EN300-63956, L-Ornithine monohydrochloride, p.a., 98.5%, L-Ornithine monohydrochloride, BioXtra, >=99%, (2S)-2,5-Diaminopentanoic acid monohydrochloride, L-Ornithine monohydrochloride, analytical standard, Q-201320, L-ORNITHINE MONOCHLOROHYDRATE/ORNITHINE [FHFI], Q27279845, F1905-8527, L-Ornithine monohydrochloride, BioXtra, >=99.5% (AT), Z991547388, L-Ornithine monohydrochloride, Vetec(TM) reagent grade, 98%, L-Ornithine hydrochloride, Cell Culture Reagent (H-L-Orn-OH.HCl), L-Ornithine monohydrochloride, BioReagent, suitable for cell culture, >=99%" C5H13ClN2O2 GGTYBZJRPHEQDG-WCCKRBBISA-N "(2S)-2,5-diaminopentanoic acid;hydrochloride" n.a. n.a. No No No No No No PMDBD2000929 Losartran n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000930 L-Phenylalanine Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. D0R1CR 6140 n.a. n.a. "L-phenylalanine, phenylalanine, 63-91-2, 3-Phenyl-L-alanine, (S)-2-Amino-3-phenylpropanoic acid, (2S)-2-amino-3-phenylpropanoic acid, (S)-Phenylalanine, (L)-Phenylalanine, 3-Phenylalanine, (S)-2-Amino-3-phenylpropionic acid, beta-Phenyl-L-alanine, Antibiotic FN 1636, H-Phe-OH, L-Alanine, phenyl-, Alanine, 3-phenyl-, L-Antibiotic FN 1636, fenilalanina, Phenylalaninum, (S)-alpha-Amino-beta-phenylpropionic acid, L-Alanine, 3-phenyl-, (S)-(-)-Phenylalanine, FEMA No. 3585, Phenylalanine (VAN), beta-Phenylalnine, (-)-, Fenilalanina [Spanish], Phenylalaninum [Latin], (S)-alpha-Aminohydrocinnamic acid, Alanine, phenyl-, L-, endophenyl, phenylalanin, (S)-alpha-Amino-benzenepropanoic acid, Phenylalanine, L-, HSDB 1825, Hydrocinnamic acid, alpha-amino-, phe, 2-Amino-3-phenylpropionic acid, L-, NSC 79477, Phenylalamine, Phenylalanine [USAN:INN:JAN], alpha-Aminohydrocinnamic acid, L-, alpha-Amino-beta-phenylpropionic acid, L-, Benzenepropanoic acid, alpha-amino-, (S)-, EINECS 200-568-1, alpha-Aminohydrocinnamic acid, (-)-phenylalanine, L-Phe, laevo-phenyl alanine, UNII-47E5O17Y3R, CCRIS 4254, L-PHENYLALININE, CHEBI:17295, 47E5O17Y3R, (-)-beta-Phenylalanine, MFCD00064227, NSC-79477, CHEMBL301523, DTXSID4040763, Phenylalanine [USAN:USP:INN:JAN], Phenylalaninum (Latin), 67675-33-6, PHENYLALANINE (II), PHENYLALANINE [II], 2S-alpha-phenylalanine, PHENYLALANINE (MART.), PHENYLALANINE [MART.], Phenylalanine (L-Phenylalanine), Alanine, phenyl-, PHENYLALANINE (EP MONOGRAPH), PHENYLALANINE [EP MONOGRAPH], Phenylalanine (USAN:USP:INN:JAN), PHENYLALANINE (USP MONOGRAPH), PHENYLALANINE [USP MONOGRAPH], .beta.-Phenylalanine, Phenyl-.alpha.-alanine, L-.beta.-Phenylalanine, .beta.-Phenyl-L-alanine, (-)-.beta.-Phenylalanine, .alpha.-Aminohydrocinnamic acid, .beta.-Phenyl-.alpha.-alanine, Phenylalanine (USP/INN), L-phenylaniline, Hydrocinnamic acid, .alpha.-amino-, 1-phenylalanine, .beta.-Phenyl-.alpha.-alanine, l-, L-phenyl Alanine, PheOH, 1usi, NCI9959, .alpha.-Amino-.beta.-phenylpropionic acid, Phenylalanine1532, racemic phenylalanine, Phenylalanine Phenolic, 1f2p, alpha-Aminohydrocinnamate, L-Phenylalanine, 99%, beta-Phenyl-alpha-alanine, L-Phenylalanine (JP17), PHENYLALANINE [MI], bmse000045, bmse000900, bmse000921, bmse001016, PHENYLALANINE [INN], SCHEMBL8119, NCIStruc1_000204, NCIStruc2_000248, PHENYLALANINE [HSDB], PHENYLALANINE [INCI], PHENYLALANINE [USAN], PHENYLALANINE [VANDF], (S)-alpha-Aminohydrocinnamate, L-Phenylalanine (H-Phe-OH), L-PHENYLALANINE [FCC], L-PHENYLALANINE [JAN], L-2-Amino-3-phenylpropionate, L-PHENYLALANINE [FHFI], L-Phenylalanine, 99%, FCC, PHENYLALANINE [WHO-DD], GTPL3313, (S)-alpha-Aminobenzenepropanoate, DTXCID2020763, (S)-2-amino-3-phenylpropanoate, BDBM18073, (S)-2-Amino-3-phenylpropionate, 1F9436B3-8B0D-4AC6-A004-4249B0BDA436, L-PHENYLALANINE [USP-RS], L-Phenylalanine non-animal source, (S)-alpha-Amino-benzenepropanoate, L-2-Amino-3-phenylpropionic acid, 30394-07-1, HY-N0215, L-2-amino-3-phenyl-propionic acid, (S)-alpha-Aminobenzenepropanoic acid, AC8117, CCG-37572, NCGC00013103, L-[2,3,4,5,6-3H]phenylalanine, (S)-alpha-Amino-beta-phenylpropionate, AKOS010373257, AKOS015853585, (S)-.alpha.-Aminobenzenepropanoic acid, DB00120, L-Phenylalanine, Vetec(TM), 98.5%, L-Phenylalanine, reagent grade, >=98%, LEUCINE IMPURITY C [EP IMPURITY], NCGC00013103-02, NCGC00013103-03, NCGC00013103-04, NCGC00013103-05, NCGC00095047-01, NCGC00095047-02, NCGC00095047-03, NCGC00095047-04, AC-22417, AS-14129, BP-20538, TYROSINE IMPURITY A [EP IMPURITY], IS_PHENYLALANINE-2,3,4,5,6-D5, L-Phenylalanine, 99%, natural, FCC, FG, AM20060774, NATEGLINIDE IMPURITY D [EP IMPURITY], NS00068215, P0134, Benzenepropanoic acid, .alpha.-amino-, (S)-, EN300-52626, L-Phenylalanine, BioUltra, >=99.0% (NT), A20654, C00079, D00021, M02961, L-Phenylalanine, SAJ special grade, >=99.0%, Q170545, L-.ALPHA.-AMINO-.BETA.-PHENYLPROPIONIC ACID, L-Phenylalanine, Vetec(TM) reagent grade, >=98%, Q-201326, L-Phenylalanine, Cell Culture Reagent (H-L-Phe-OH), LYSINE HYDROCHLORIDE IMPURITY B [EP IMPURITY], F0001-2360, Z756430566, L-Phenylalanine, certified reference material, TraceCERT(R), Phenylalanine, European Pharmacopoeia (EP) Reference Standard, 3-(2-AMINOETHYL)-1,3-THIAZOLIDINE-2,4-DIONEHYDROCHLORIDE, L-Phenylalanine, United States Pharmacopeia (USP) Reference Standard, L(-)-phenylalanine; Beta-phenylalanine;Dl-2-amino-3-phenylpropanoic acid;, L-Phenylalanine, analytical standard, for Nitrogen Determination According to Kjeldahl Method, L-Phenylalanine, Pharmaceutical Secondary Standard; Certified Reference Material, L-Phenylalanine, from non-animal source, meets EP, JP, USP testing specifications, suitable for cell culture, 98.5-101.0%" C9H11NO2 COLNVLDHVKWLRT-QMMMGPOBSA-N (2S)-2-amino-3-phenylpropanoic acid n.a. Dietary supplement No No No No Yes No rxnAGORA1347,rxnAGORA2003,rxnAGORA2004,rxnAGORA3059,rxnAGORA3808,rxnAGORA3809,rxn00489 PMDBD2000931 L-Phenylalanine-D-Lysine n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000932 L-Phenylalanine-L-Lysine n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000933 L-pipecolic acid n.a. n.a. n.a. n.a. n.a. n.a. n.a. 439227 n.a. n.a. "l-Pipecolic acid, 3105-95-1, (S)-Piperidine-2-carboxylic acid, L-Homoproline, L-Pipecolinic acid, l(-)-pipecolinic acid, h-hopro-oh, (2S)-piperidine-2-carboxylic acid, L-pipecolate, 2-Piperidinecarboxylic acid, (2S)-, L-(-)-Pipecolinic acid, L-(-)-pipecolic acid, Pipecolic acid, (-)-, (l)-pipecolic acid, (S)-pipecolic acid, (-)-Pipecolic acid, l-piperidine-2-carboxylic acid, (S)-(-)-2-Piperidinecarboxylic acid, (S)-Pipecolinic acid, (S)-(-)-pipecolic acid, CHEBI:30913, 69374CKB33, (S)-pipecolate, Pipecolic acid, L-(-)-, MFCD00005981, (S)-2-Piperidinecarboxylic acid, EINECS 221-462-1, L-Pipecolinate, h-homopro-oh, NSC-93089, UNII-69374CKB33, (S)-Pipecolinate, (-)-Pipecolate, YCP, NSC 93089, L-(-)-Pipecolate, (l)-pipecolinic acid, (S)-(-)-Pipecolate, bmse000237, L-Piperidine-2-carboxylate, (S)-2-Piperidinecarboxylate, SCHEMBL40185, (-)-PIPECOLINIC ACID, (S)-piperidine-2-carboxylate, 2(S)-Piperidinecarboxylic acid, CHEMBL322883, S)-2-Piperidinecarboxylic acid, (S)-Piperidine-2-carboxylicacid, DTXSID401035840, (S)-(-)-2-Piperidinecarboxylate, (S)-Piperidine-2-carboxylic acid;, PIPECOLIC ACID L-FORM [MI], (S)(-)-2-piperidinecarboxylic acid, L-Pipecolic acid, 99% (titration), s6302, AKOS005258385, CS-W013450, HY-W012734, Piperidine-2-carboxylic acid;H-HoPro-OH, AM803674, DS-13286, L-Pipecolic acid, Proline homolog., 99%, A5640, NS00074200, P1404, EN300-66085, C00408, L-Pipecolic acid, puriss., >=99.0% (NT), Q-103016, Q27104171, 7C6A2DED-5E15-4DFB-BF48-F9D231169779, Z1033300646" C6H11NO2 HXEACLLIILLPRG-YFKPBYRVSA-N (2S)-piperidine-2-carboxylic acid n.a. n.a. No No No No No No PMDBD2000934 Luteolin Therapeutic Substance Approved Drug 491-70-3 DB15584 n.a. n.a. D04AIT 5280445 4444102 NPC279121 luteolin, 491-70-3, Digitoflavone, Luteolol, 2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-4H-chromen-4-one, 3'',4'',5,7-Tetrahydroxyflavone, Flacitran, Luteoline, Salifazide, Weld Lake, Yama kariyasu, Cyanidenon 1470, 5,7,3'',4''-Tetrahydroxyflavone, Bismite, C.I. Natural Yellow 2, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxychromen-4-one, Cyanidenon-1470, 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-, CCRIS 3790, 2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-4-benzopyrone, UNII-KUX1ZNC9J2, KUX1ZNC9J2, EINECS 207-741-0, BRN 0292084, Luteolin (Standard), CHEBI:15864, C.I. 75590, FLAVONE, 3'',4'',5,7-TETRAHYDROXY-, MFCD00017309, CHEMBL151, DTXSID4074988, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4H-1-benzopyran-4-one, 2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-4-chromenone, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-chromen-4-one, 1318-21-4, SMR000326896, 7-Tetrahydroxyflavone, SR-01000779333, Daphneflavonol, Flavopurpol, Lutl, Luteolin?, 4dew, 4dgn, 4hkn, Luteolin,(S), 3'',4'',5,7-Tetrahydroxy-Flavone, LU2, Prestwick_122, LUTEOLIN [INCI], LUTEOLIN [MI], Prestwick0_000870, Prestwick1_000870, Prestwick2_000870, Prestwick3_000870, LUTEOLIN [WHO-DD], BIDD:PXR0059, Lopac0_000660, Oprea1_849964, SCHEMBL20426, BSPBio_000919, Luteolin, analytical standard, MLS000697655, MLS000860038, MLS002154043, MLS006011917, BIDD:ER0122, SPBio_002840, BDBM7459, BPBio1_001011, GTPL5215, MEGxp0_000143, DTXCID6040668, ACon1_000223, cid_5280445, HY-N0162R, HMS1570N21, HMS2097N21, HMS2220C06, HMS3356L02, HMS3561N09, HMS3649N21, HMS3656A05, HMS3714N21, Luteolin, >=99.0% (TLC), BCP03511, HY-N0162, TNP00073, Luteolin, >=98% (TLC), powder, LMPK12110006, s2320, AKOS002140588, AC-1125, BCP9000865, CCG-208309, CS-4611, DB15584, KS-5202, Luteolin 100 microg/mL in Acetonitrile, SMP2_000042, NCGC00016467-01, NCGC00016467-02, NCGC00016467-03, NCGC00016467-04, NCGC00016467-05, NCGC00016467-06, NCGC00016467-07, NCGC00016467-08, NCGC00016467-12, NCGC00016467-21, NCGC00142375-01, NCGC00142375-02, NCGC00142375-03, NCGC00179375-01, NCGC00179375-02, 1ST40243, CAS-491-70-3, SY030155, BCP0726000198, CS-0694839, NS00015143, SW196433-3, T2682, C01514, L 9283, S00110, EN300-1659559, A827664, Luteolin, primary pharmaceutical reference standard, Q415011, Q-100551, SR-01000779333-4, SR-01000779333-5, SR-01000779333-7, BRD-K05236810-001-05-9, 23A002A4-B47B-46CD-848C-65042EACF3FF, Z1741977179, 2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-4H-benzopyrone-4-one, 2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-4H-chromen-4-one #, 4H-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy- C15H10O6 IQPNAANSBPBGFQ-UHFFFAOYSA-N 2-(3,4-dihydroxyphenyl)-5,7-dihydroxychromen-4-one n.a. n.a. No No No No Yes No rxn02562,rxn02563,rxn04463,rxnDiet154,rxnAdd107,rxnAdd108,rxnAdd110 PMDBD2000935 Lys-a1 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000936 Lysozyme Therapeutic Substance n.a. 12650-88-3 DB13260 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000937 M8-33 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000938 M8G2 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000939 Macromomycin B n.a. n.a. n.a. n.a. n.a. n.a. n.a. 5748693 n.a. n.a. Macromomycin B, Macromomycins, Auromomycin, Macromomycin I, Macromomycin I protein, 12634-34-3, methyl 7-methoxy-2-methylidene-3-oxo-4H-1,4-benzoxazine-5-carboxylate, H4AJ86QK46, NSC-170105, 70213-45-5, Macromomycin, 2H-1,4-Benzoxazine-5-carboxylic acid, 3,4-dihydro-7-methoxy-2-methylene-3-oxo-, methyl ester, Methyl 3,4-dihydro-7-methoxy-2-methylene-3-oxo-2H-1,4-benzoxazine-5-carboxylate, 85691-10-7, Macromomycin protein, NSC 289642, UNII-H4AJ86QK46, Macromycin apoprotein, Streptomyces macromomyceticus, SCHEMBL15989044, DTXSID90220477, Q15426211 C12H11NO5 HXKWEZFTHHFQMB-UHFFFAOYSA-N methyl 7-methoxy-2-methylidene-3-oxo-4H-1,4-benzoxazine-5-carboxylate n.a. n.a. No No No No No No PMDBD2000940 Magainin-I n.a. n.a. n.a. n.a. n.a. n.a. n.a. 56678013 n.a. n.a. Magainin I, CHEBI:201898 C112H177N29O28S OFIZOVDANLLTQD-UHFFFAOYSA-N n.a. n.a. n.a. No No No No No No PMDBD2000941 Magainin-II n.a. n.a. n.a. n.a. n.a. n.a. n.a. 155486971 n.a. n.a. Magainin II, CHEBI:201476, LS-15545 C114H180N30O29S MGIUUAHJVPPFEV-UHFFFAOYSA-N 4-[[2-[[2-[[2-[2-[[6-amino-2-[[2-[[2-[[6-amino-2-[[6-amino-2-[2-[[2-[[2-[[2-[[2-[[6-amino-2-[[2-[[2-[(2-aminoacetyl)amino]-3-methylpentanoyl]amino]acetyl]amino]hexanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-3-hydroxypropanoyl]amino]propanoylamino]hexanoyl]amino]hexanoyl]amino]-3-phenylpropanoyl]amino]acetyl]amino]hexanoyl]amino]propanoylamino]-3-phenylpropanoyl]amino]-3-methylbutanoyl]amino]acetyl]amino]-5-[[1-[[1-[[4-amino-1-[(1-carboxy-2-hydroxyethyl)amino]-1,4-dioxobutan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-5-oxopentanoic acid n.a. n.a. No No No No No No PMDBD2000942 Malabaricone C n.a. n.a. n.a. n.a. n.a. n.a. n.a. 100313 n.a. NPC244441 Malabaricone C, 63335-25-1, 1-(2,6-dihydroxyphenyl)-9-(3,4-dihydroxyphenyl)nonan-1-one, CHEBI:69015, C9K53R3PRN, NSC-287968, 1-(2,6-dihydroxyphenyl)-9-(3,4-dihydroxyphenyl)-1-nonanone, 1-Nonanone, 1-(2,6-dihydroxyphenyl)-9-(3,4-dihydroxyphenyl)-, UNII-C9K53R3PRN, CHEMBL524100, MEGxp0_000379, SCHEMBL7784918, DTXSID40212721, HY-N8518, BDBM50182491, NSC287968, AKOS040763675, NSC 287968, MS-25640, XM175848, CS-0145503, NS00121850, E88916, Q27137360, 1-(2,6-Bis(oxidanyl)phenyl)-9-(3,4-bis(oxidanyl)phenyl)nonan-1-one C21H26O5 HCOZRFYGIFMIEX-UHFFFAOYSA-N 1-(2,6-dihydroxyphenyl)-9-(3,4-dihydroxyphenyl)nonan-1-one n.a. n.a. No No No No No No PMDBD2000943 Melittin n.a. n.a. n.a. n.a. n.a. n.a. n.a. 16133648 n.a. n.a. Melittin, 20449-79-0, Honeybee melittin, Forapine, Melittin (honeybee), Bee venom melittin, Forapin, Melitten, GIGAVLKVLTTGLPALISWIKRKRQQ-NH2, CHEBI:6736, Melittin I, MFCD00076868, Melittin TFA, Melittin (major), Melittin (apis cerana), UNII-24VT8NVE75, L-Glutamamide, glycyl-L-isoleucylglycyl-L-alanyl-L-valyl-L-leucyl-L-lysyl-L-valyl-L-leucyl-L-threonyl-L-threonylglycyl-L-leucyl-L-prolyl-L-alanyl-L-Leucyl-L-isoleucyl-L-seryl-L-tryptophyl-L-isoleucyl-L-lysyl-L-arginyl-L-lysyl-L-arginyl-L-glutaminyl-, 24VT8NVE75, CHEMBL412927, DTXSID001046261, EX-A7430, AKOS024456456, Melittin, >=97% (HPLC), synthetic, RS-2008, NCGC00167171-01, AC-32561, XM176021, Melittin (GIGAVLKVLTTGLPALISWIKRKRQQ-amide), Melittin from honey bee venom, >=65% (HPLC), Melittin from honey bee venom, >=85% (HPLC), G-I-G-A-V-L-K-V-L-T-T-G-L-P-A-L-I-S-W-I-K-R-K-R-Q-Q-NH2, Gly-Ile-Gly-Ala-Val-Leu-Lys-Val-Leu-Thr-Thr-Gly-Leu-Pro-Ala-Leu-Ile-Ser-Trp-Ile-Lys-Arg-Lys-Arg-Gln-Gln-NH2, Gly-L-Ile-Gly-L-Ala-L-Val-L-Leu-L-Lys-L-Val-L-Leu-L-Thr-L-Thr-Gly-L-Leu-L-Pro-L-Ala-L-Leu-L-Ile-L-Ser-L-Trp-L-Ile-L-Lys-L-Arg-L-Lys-L-Arg-L-Gln-L-Gln-NH2, glycyl-L-isoleucylglycyl-L-alanyl-L-valyl-L-leucyl-L-lysyl-L-valyl-L-leucyl-L-threonyl-L-threonylglycyl-L-leucyl-L-prolyl-L-alanyl-L-leucyl-L-isoleucyl-L-seryl-L-tryptophyl-L-isoleucyl-L-lysyl-L-arginyl-L-lysyl-L-arginyl-L-glutaminyl-L-glutamamide C131H229N39O31 VDXZNPDIRNWWCW-JFTDCZMZSA-N (2S)-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[2-[[(2S,3R)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S,3S)-2-[(2-aminoacetyl)amino]-3-methylpentanoyl]amino]acetyl]amino]propanoyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxybutanoyl]amino]acetyl]amino]-4-methylpentanoyl]pyrrolidine-2-carbonyl]amino]propanoyl]amino]-4-methylpentanoyl]amino]-3-methylpentanoyl]amino]-3-hydroxypropanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-3-methylpentanoyl]amino]hexanoyl]amino]-5-carbamimidamidopentanoyl]amino]hexanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-oxopentanoyl]amino]pentanediamide n.a. n.a. No No No No No No PMDBD2000944 Melittin B n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000945 Menthol Therapeutic Substance Approved Drug 1490-04-6 DB14123 n.a. n.a. D04CSZ 1254 1216 NPC223468 "MENTHOL, dl-Menthol, 1490-04-6, 2-Isopropyl-5-methylcyclohexanol, 15356-70-4, 89-78-1, Cyclohexanol, 5-methyl-2-(1-methylethyl)-, Menthyl alcohol, p-Menthan-3-ol, Mentholum, Caswell No. 540, Mineral ice, Hexahydrothymol, 5-methyl-2-propan-2-ylcyclohexan-1-ol, 3-Hydroxy-p-menthane, CCRIS 9231, (+/-)-Menthol, EINECS 216-074-4, Neomenthol, Menthol [USP], EPA Pesticide Chemical Code 051601, rac-Menthol, HSDB 593, DTXSID8029650, AI3-08161, Therapeutic mineral ice, Menthol, dl-, 5-Methyl-2-(1-methylethyl)cyclohexanol, 2-Isopropyl-5-methylcyclohexan-1-ol, Fisherman''s friend lozenges, DTXCID30805, 5-methyl-2-(propan-2-yl)cyclohexan-1-ol, CHEBI:25187, (1R,2S,5R)-Menthol, EC 216-074-4, Menthol (USP), MFCD00001484, (1S, 2S, 5R)-(+)-Neomenthol, 491-01-0, Menthol 1000 microg/mL in Acetonitrile, (1R,2R,5R)-Isomenthol, Racemic menthol, FEMA No. 2665, 3-p-Menthanol, Menthol, cis-1,3,trans-1,4-, MEGGEZONE, MFCD00062983, 491-02-1, DL-ISOMENTHOL, Cyclohexanol, 5-methyl-2-(1-methylethyl)-, [1S-(1.alpha.,2.alpha.,5.beta.)]-, 3-p-Menthol, (+/-)-p-Menthan-3-ol, CAS-1490-04-6, L(-)-Menthol, Robitussin Cough Drops, UNII-L7T10EIP3A, (1R,2R,5R)-5-methyl-2-(propan-2-yl)cyclohexan-1-ol, 5-Methyl-2-(1-methylethyl)-cyclohexanol, Menthol racemate, MFCD00062980, Cyclohexanol, 5-methyl-2-(1-methylethyl)-, (1.alpha.,2.beta.,5.alpha.)-, 2-Isopropyl-5-methyl-cyclohexanol, (-)menthol, NCGC00159382-02, (-) menthol, 4-Isopropyl-1-methylcyclohexan-3-ol, BOHENAO, Menthol, 99%, dl-Menthol (JP17), 1-methyl-4-isopropyl-3-hydroxycyclohexane, MENTHOL (II), MENTHOL (MART.), MENTHOL, UNSPECIFIED, SCHEMBL4612, L7T10EIP3A, Menthol, (.+/-.)-, Menthol, puriss., 99.0%, CHEMBL256087, DL-Menthol, analytical standard, MENTHOL (USP MONOGRAPH), LEVOMENTHOL OR RACEMENTHOL, MENTHOL, UNSPECIFIED FORM, SALONPAS COMPONENT MENTHOL, AMY3077, Cyclohexanol, 5-methyl-2-(1-methylethyl)-, [1S-(1.alpha.,2.beta.,5.beta.)]-, Fisherman''s friend lozenges (TN), BDBM248162, HMS3744K19, 2-Isopropyl-5-methylcyclohexanol #, BCP27552, BCP31841, CS-M3737, HY-N1369, menthol crystals; 15356-70-4, MENTHOL COMPONENT OF SALONPAS, Tox21_200010, Tox21_303464, 1-Methyl-4-isopropyl-3-cyclohexanol, DL-Menthol, >=95%, FCC, FG, ( inverted exclamation markA)-Menthol, AKOS000119740, AKOS016843634, Cyclohexanol, 5-methyl-2-(1-methylethyl)-, (1.alpha.,2.alpha.,5.beta.)-, AM81446, SB35230, SB44308, SB44857, (2R)-2-isopropyl-5-methyl-cyclohexanol, Menthol, SAJ special grade, >=98.0%, NCGC00159382-03, NCGC00159382-04, NCGC00159382-05, NCGC00159382-06, NCGC00257403-01, NCGC00257564-01, 1ST40117, HY-75161, SY004225, SY010603, SY073200, SY157908, VS-02042, Levomenthol; D-(-)-Menthol; (-)-Menthol, CS-0016777, M0321, NS00001027, EN300-19914, LEVOROTATORY-MENTHOL OR RACEMIC-MENTHOL, (+/-)-Menthol, racemic, >=98.0% (GC), 2-Isopropy-5-methylcyclohexanol-1,2,6,6-d4, D04849, D04918, E80543, (1S,2R,5R)-2-isopropyl-5-methyl-cyclohexanol, A808833, A809442, J-500418, Q27109870, L-p-Menthan-3-ol; Menthol ,natural; (1R,2S,5R)-(-)-Menthol, Menthol-plus it inverted exclamation markas 3 isomers-1,2,6,6-d4, Cyclohexanol, 5-methyl-2-(1-methylethyl)-, (1.alpha.,2.beta.,5.alpha.)-(.+/-.)-, Cyclohexanol, 5-methyl-2-(1-methylethyl)-, [1R-(1.alpha.,2.alpha.,5.beta.)]-, L-Menthol; (-)-Menthol; Levomenthol; Menthomenthol;2-isopropyl-5-methyl-cyclohexanol;Menthol" C10H20O NOOLISFMXDJSKH-UHFFFAOYSA-N 5-methyl-2-propan-2-ylcyclohexan-1-ol n.a. Antipruritics No No No No No No PMDBD2000946 Merimepodib Therapeutic Substance Approved Drug 198821-22-6 DB04862 n.a. n.a. D0F0ZE 153241 135060 n.a. Merimepodib, 198821-22-6, VX-497, MMPD, VI-21497, (S)-tetrahydrofuran-3-yl 3-(3-(3-methoxy-4-(oxazol-5-yl)phenyl)ureido)benzylcarbamate, 2ZL2BA06FU, VI-21,497, CHEMBL304087, VX497, Carbamic acid, N-[[3-[[[[3-methoxy-4-(5-oxazolyl)phenyl]amino]carbonyl]amino]phenyl]methyl]-, (3S)-tetrahydro-3-furanyl ester, (S)-Tetrahydro-3-furyl (m-(3-(3-methoxy-4-(5-oxazolyl)phenyl)ureido)benzyl)carbamate, [(3S)-tetrahydrofuran-3-yl] N-[[3-[(3-methoxy-4-oxazol-5-yl-phenyl)carbamoylamino]phenyl]methyl]carbamate, Carbamic acid, ((3-((((3-methoxy-4-(5-oxazolyl)phenyl)amino)carbonyl)amino)phenyl)methyl)-, (3S)-tetrahydro-3-furanyl ester, Vx 497, Merimepodib [USAN:INN], UNII-2ZL2BA06FU, Merimebodib, [(3S)-oxolan-3-yl] N-[[3-[[3-methoxy-4-(1,3-oxazol-5-yl)phenyl]carbamoylamino]phenyl]methyl]carbamate, carbamic acid, [[3-[[[[3-methoxy-4-(5-oxazolyl)phenyl]amino]carbonyl]amino]phenyl]methyl]-, (3S)-tetrahydro-3-furanyl ester, Merimepodib [USAN], MERIMEPODIB [MI], MERIMEPODIB [INN], Merimepodib (USAN/INN), MERIMEPODIB, VI-21497, VX-497, MERIMEPODIB [WHO-DD], SCHEMBL329922, GTPL10741, DTXSID70173639, JBPUGFODGPKTDW-SFHVURJKSA-N, BCP28336, EX-A1201, YHA82122, BDBM50102249, FD5020, MFCD09837807, s6689, AKOS027338219, DB04862, N-3-(3-(3-Methoxy-4-oxazol-5-ylphenyl)ureido)benzylcarbamic acid tetrahydrofuran-3-yl ester, NCGC00378589-01, AC-35396, AS-75124, HY-13986, NS00069697, D04936, A919457, Q1727082, (3S)-oxolan-3-yl N-{[3-({[3-methoxy-4-(1,3-oxazol-5-yl)phenyl]carbamoyl}amino)phenyl]methyl}carbamate, [[3-[[[[3-Methoxy-4-(5-oxazolyl)phenyl]amino]carbonyl]amino]phenyl]methyl]carbamic acid (3S)-tetrahydro-3-furanyl ester, {3-[3-(3-Methoxy-4-oxazol-5-yl-phenyl)-ureido]-benzyl}-carbamic acid (S)-(tetrahydro-furan-3-yl) ester, {3-[3-(3-Methoxy-4-oxazol-5-yl-phenyl)-ureido]-benzyl}-carbamic acid tetrahydro-furan-3-yl ester, N-[3-3-[3-Methoxy-4-(5-oxazolyl)phenyl]ureido]benzyl]carbamic acid tetrahydrofuran-3-(S)-yl ester C23H24N4O6 JBPUGFODGPKTDW-SFHVURJKSA-N [(3S)-oxolan-3-yl] N-[[3-[[3-methoxy-4-(1,3-oxazol-5-yl)phenyl]carbamoylamino]phenyl]methyl]carbamate GSK n.a. No No No No No No PMDBD2000947 Meta-bromo-thiolactone n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000948 meta-toluidine n.a. n.a. n.a. n.a. n.a. n.a. n.a. 7934 n.a. n.a. m-Toluidine, 3-Methylaniline, 108-44-1, 3-Toluidine, 3-AMINOTOLUENE, Benzenamine, 3-methyl-, m-Methylaniline, m-Tolylamine, m-Toluidin, m-Aminotoluene, 3-Methylbenzenamine, 3-Aminophenylmethane, m-Methylbenzenamine, 1-Amino-3-methylbenzene, 3-Aminotoluen, Aniline, 3-methyl-, 3-Amino-1-methylbenzene, meta-toluidine, 3-methylphenylamine, NSC 15349, MFCD00007808, DTXSID1026792, 006FKQ96T3, NSC-15349, m-Toluidine, 99%, m-Toluidin [Czech], m-Toluidyna [Polish], DTXCID506792, 3-Aminotoluen [Czech], m-Toluidyna, CAS-108-44-1, CCRIS 4325, HSDB 2043, EINECS 203-583-1, BRN 0635944, metatoluidine, UNII-006FKQ96T3, AI3-19859, m-tolyl-amine, meta-methylaniline, 3-methyl aniline, 3-methyl-aniline, phenmedipham TP3, 3-methyl-benzamine, 3-(methyl)aniline, 3-methyl-phenylamine, M-TOLUIDINE [MI], EC 203-583-1, WLN: ZR C1, SCHEMBL11789, (M-METHYLPHENYL)AMINE, m-Toluidine, liquid or solid, 4-12-00-01813 (Beilstein Handbook Reference), 3-AMINOTOLUENE [HSDB], CHEMBL3182179, m-Toluidine, analytical standard, BCP15285, NSC15349, Tox21_201265, Tox21_300568, AKOS000119100, PS-9299, NCGC00091601-02, NCGC00091601-03, NCGC00254415-01, NCGC00258817-01, m-Toluidine 100 microg/mL in Cyclohexane, NS00008859, T0298, EN300-18342, m-Toluidine, liquid or solid [UN1708] [Poison], Q1880736, W-108717, Z57127904, F2190-0419, InChI=1/C7H9N/c1-6-3-2-4-7(8)5-6/h2-5H,8H2,1H C7H9N JJYPMNFTHPTTDI-UHFFFAOYSA-N 3-methylaniline n.a. n.a. No No No No No No PMDBD2000949 Methacycline Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. D0H1AR 54675785 n.a. n.a. methacycline, Metacycline, 914-00-1, Rondomycin, Methylenecycline, Tri-methacycline, Methacyclinum, 6-Methyleneoxytetracycline, Metacyclinum, Metaciclina, 6-Methylene-5-oxytetracycline, 6-Methylene-5-hydroxytetracycline, GS-2876, 6-Deoxy-6-demethyl-6-methylene-5-oxytetracycline, Bialatan, 6-Demethyl-6-deoxy-5-hydroxy-6-methylenetetracycline, Methacycline base, Metacycline (INN), Metacycline [INN], Methacycline amphoteric, MOTC, CHEBI:6805, Methacycline (USAN), IR235I7C5P, 4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methylene-1,11-dioxo-2-naphthacenecarboxamide, Oxytetracycline, 6-methylene-, METHACYCLINE [USAN], (4S,4aR,5S,5aR,12aR)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methylidene-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide, (4S,4aR,5S,5aR,12aS)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methylidene-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide, Metacyclinum [INN-Latin], Methacycline [USAN:BAN], Metaciclina [INN-Spanish], (4S,4aR,5S,5aR,12aS)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methylene-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide, 2-Naphthacenecarboxamide,4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methylene-1,11-dioxo-, (4S,4aR,5S,5aR,12aS)-, GS 2876, HSDB 3118, EINECS 213-017-5, UNII-IR235I7C5P, 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methylene-1,11-dioxo-, (4S-(4alpha,4aalpha,5alpha,5aalpha,12aalpha))-, Spectrum_000381, Prestwick0_000964, Prestwick1_000964, Prestwick2_000964, Prestwick3_000964, Spectrum2_001398, Spectrum3_000917, Spectrum4_001016, Spectrum5_001576, METHACYCLINE [MI], METHACYCLINE [HSDB], SCHEMBL4014, SCHEMBL4015, METHACYCLINE [VANDF], BSPBio_000967, DOXYCYCLINE IMPURITY B, KBioGR_001511, KBioSS_000861, METACYCLINE [WHO-DD], METHACYCLINE [MART.], DivK1c_000591, SPBio_001416, SPBio_002888, BPBio1_001065, CHEMBL249837, DTXSID2023272, SCHEMBL19555132, KBio1_000591, KBio2_000861, KBio2_003429, KBio2_005997, KBio3_001894, NINDS_000591, XIYOPDCBBDCGOE-IWVLMIASSA-N, KUC106428N, 2-NAPHTHACENECARBOXAMIDE, 4-(DIMETHYLAMINO)-1,4,4A,5,5A,6,11,12A-OCTAHYDRO-3,5,10,12,12A-PENTAHYDROXY-6-METHYLENE-1,11-DIOXO-, (4S-(4.ALPHA.,4A.ALPHA.,5.ALPHA.,5A.ALPHA.,12A.ALPHA.))-, BCP24961, KSC-12-231A, BDBM50103629, BDBM50565697, AKOS015961140, DB00931, IDI1_000591, NCGC00179358-01, NCGC00179358-03, NCGC00179358-05, AC-13213, SBI-0051637.P002, AB00514707, NS00011900, C07654, D04972, G76918, AB00053593-03, AB00053593_04, AB00053593_05, EN300-7481364, DOXYCYCLINE HYCLATE IMPURITY B [EP IMPURITY], Q2365033, DOXYCYCLINE MONOHYDRATE IMPURITY B [EP IMPURITY], (4S,4aR,5S,5aR,12aS)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methylene-1,11-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide C22H22N2O8 XIYOPDCBBDCGOE-IWVLMIASSA-N (4S,4aR,5S,5aR,12aR)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methylidene-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide n.a. Antibiotics No No No No No No PMDBD2000950 methanesulfonylbenzene n.a. n.a. n.a. n.a. n.a. n.a. n.a. 18369 n.a. n.a. METHYL PHENYL SULFONE, 3112-85-4, (Methylsulfonyl)benzene, methylsulfonylbenzene, Benzene, (methylsulfonyl)-, Phenyl methyl sulfone, Sulfone, methyl phenyl, (Phenylsulfonyl)methane, methylphenylsulfone, (Methylsulphonyl)benzene, Methyl phenyl sulphone, methanesulfonylbenzene, 1-(Methylsulfonyl)benzene-4-D, phenylmethylsulfone, NSC 41587, Methanesulfonyl-benzene, MFCD00014741, 150B65AI4O, NSC-41587, 2122800-11-5, methylphenyl sulfone, EINECS 221-476-8, BRN 1906914, UNII-150B65AI4O, methylphenyl sulphone, Phenyl(methyl)sulfon, methyl(phenyl)sulfone, methanesulphonylbenzene, Phenyl methyl sulphone, 1-(Methylsulfonyl)Benzene, Bionet2_000393, SCHEMBL78253, 4-06-00-01468 (Beilstein Handbook Reference), CHEMBL116841, DTXSID1075228, HMS1365B19, AMY27999, NSC41587, STR03539, MFCD31699939, AKOS000279256, AC-16482, Methyl phenyl sulfone, >=98.0% (GC), SY018221, SY246294, CS-0011576, M0401, NS00010769, EN300-102333, 2R-0703, J-620023, W-106915, Q27251665, InChI=1/C7H8O2S/c1-10(8,9)7-5-3-2-4-6-7/h2-6H,1H C7H8O2S JCDWETOKTFWTHA-UHFFFAOYSA-N methylsulfonylbenzene n.a. n.a. No No No No No No PMDBD2000951 Methanol n.a. n.a. n.a. n.a. n.a. n.a. n.a. 887 n.a. NPC234306 "methanol, methyl alcohol, 67-56-1, wood alcohol, carbinol, Wood naphtha, Methylol, Methyl hydroxide, Methylalkohol, Monohydroxymethane, Alcohol, methyl, Alcool methylique, MeOH, Methyl hydrate, CH3OH, Metanolo, Alcool metilico, Metylowy alkohol, Freers Elm Arrester, Surflo-B17, Rcra waste number U154, Hydroxymethane, Wilbur-Ellis Smut-Guard, Metanol, Coat-B1400, Caswell No. 552, Metanol [Spanish], Metanolo [Italian], Alcohol,methyl, HSDB 93, Methylalkohol [German], X-Cide 402 Industrial Bactericide, MetOH, NSC 85232, CCRIS 2301, Alcool metilico [Italian], Metylowy alkohol [Polish], Alcool methylique [French], AI3-00409, Methyl alcohol [NF], UN1230, CHEBI:17790, Pyro alcohol, Methanol cluster, RCRA waste no. U154, EINECS 200-659-6, UNII-Y4S76JWI15, NSC-85232, EPA Pesticide Chemical Code 053801, Y4S76JWI15, DTXSID2021731, 170082-17-4, DTXCID801731, METHYL ALCOHOL (METHANOL), EC 200-659-6, Methanol, anhydrous, NSC85232, MFCD00004595, Methyl alcohol (NF), Methyl-d1 Alcohol, NCGC00091172-01, Methanol; Methyl alcohol, METHYL ALCOHOL (MART.), METHYL ALCOHOL [MART.], CH4O, Methanol, for HPLC, >=99.9%, Methanol, ACS reagent, >=99.8%, Methanol, or methyl alcohol [UN1230] [Flammable liquid, Poison], Alcohol, Wood, CAS-67-56-1, ACETONE IMPURITY A (EP IMPURITY), ACETONE IMPURITY A [EP IMPURITY], MOH, Methylalcohol, methly alcohol, Primary alcohol, methanol-, Wood, Manhattan spirits, a primary alcohol, Methanol LC-MS, Methanol, for HPLC, Methanol-[17O], Methanol, ACS Grade, Methanol, HPLC grade, Methanol, LCMS grade, METHANOL [MI], 3''-Hydroxystanozolol-D3, methanol (methyl alcohol), Methanol, Histology Grade, bmse000294, Epitope ID:116865, METHANOL [USP-RS], METHANOL [WHO-DD], Methanol, or methyl alcohol, METHYL ALCOHOL [II], Methanol, LR, >=99%, Methanol, SAJ special grade, Methanol, analytical standard, Methyl alcohol (DOT:OSHA), METHYL ALCOHOL [FCC], WLN: Q1, Methanol HPLC Gradient Grade, Methanol, Environmental Grade, CHEMBL14688, METHYL ALCOHOL [HSDB], METHYL ALCOHOL [INCI], ALCOHOL,METHYL [VANDF], Methanol, anhydrous, 99.8%, Methanol, p.a., 99.8%, Methanol, p.a., 99.9%, METHANOL [EP MONOGRAPH], Methanol, AR, >=99.5%, METHYL ALCOHOL [USP-RS], CHEBI:15734, Methanol, NMR reference standard, Methanol, ultrapure, HPLC Grade, Methanol, 99.8%, ACS reagent, Methanol, anhydrous, >=99.5%, Methanol, low water for titration, Methanol, Absolute - Acetone free, Methanol, low benzene, HPLC grade, Methanol, HPLC gradient, 99.9%, Methanol, or methyl alcohol [UN1230] [Flammable liquid, Poison], Methanol, for HPLC, >=99.8%, Methanol, PRA grade, >=99.9%, Tox21_111094, Tox21_202523, InChI=1/CH4O/c1-2/h2H,1H, Methanol, HPLC Plus, >=99.9%, AKOS000269045, Methanol, purification grade, 99.8%, UN 1230, Methanol, UHPLC, for mass spectrometry, USEPA/OPP Pesticide Code: 053801, Methanol, >=99.8%, for chromatography, Methanol, SAJ first grade, >=99.5%, NCGC00260072-01, Methanol, JIS special grade, >=99.8%, Methanol, Laboratory Reagent, >=99.6%, Methanol, UV HPLC spectroscopic, 99.9%, Methanol, anhydrous, ZerO2(TM), 99.8%, Methanol, spectrophotometric grade, >=99%, M0097, M0628, Methanol, ultrapure, Spectrophotometric Grade, NS00001876, C00132, D02309, Methanol, for HPLC, gradient grade, 99.93%, Methanol, suitable for determination of dioxins, Q14982, Methanol, for HPLC, gradient grade, >=99.9%, Methanol, glass distilled HRGC/HPLC trace grade, Methanol, low benzene, ACS reagent, = 99.8%, Methanol, low benzene, ACS reagent, >=99.8%, Methanol, ACS spectrophotometric grade, >=99.9%, Methanol HPLC, UV-IR min. 99.9% isocratic grade, Methanol, BioReagent, suitable for protein sequencing, Methanol, for HPLC, gradient grade, >=99.8% (GC), Q27115113, Methanol, Vetec(TM) reagent grade, anhydrous, >=99.8%, Moisture in methanol, 325 mg/kg, NIST(R) SRM(R) 8510, Moisture in methanol, 93 mg/kg, NIST(R) SRM(R) 8509, 4-METHYL-2-(2-THIENYL)-1,3-THIAZOLE-5-CARBOXYLICACID, Methanol with 0.1% trifluoroacetic acid, tested for UHPLC-MS, Methanol, >=99.8%, suitable for absorption spectrum analysis, Methanol, semiconductor grade PURANAL(TM) (Honeywell 17824), Methanol, p.a., ACS reagent, reag. ISO, reag. Ph. Eur., 99.9%, Methanol, puriss. p.a., absolute, ACS reagent, >=99.8% (GC), Methanol, semiconductor grade VLSI PURANAL(TM) (Honeywell 17744), Methanol, suitable for protein sequencing, BioReagent, >=99.93%, Methyl alcohol, United States Pharmacopeia (USP) Reference Standard, Methanol, Pharmaceutical Secondary Standard; Certified Reference Material, Methanol, puriss., meets analytical specification of Ph Eur, >=99.7% (GC), Methanol, for HPLC, gradient grade, suitable as ACS-grade LC reagent, >=99.9%, Methanol, puriss. p.a., ACS reagent, reag. ISO, reag. Ph. Eur., >=99.8% (GC), Residual Solvent Class 2 - Methanol, United States Pharmacopeia (USP) Reference Standard, JandaJel(TM)-OH, 100-200 mesh, extent of labeling: 1.0 mmol/g OH loading, 2 % cross-linked, JandaJel(TM)-OH, 200-400 mesh, extent of labeling: 1.0 mmol/g OH loading, 2 % cross-linked, JandaJel(TM)-OH, 50-100 mesh, extent of labeling: 1.0 mmol/g OH loading, 2 % cross-linked" CH4O OKKJLVBELUTLKV-UHFFFAOYSA-N methanol n.a. n.a. No No No No No No PMDBD2000952 Methyl eugenol n.a. n.a. n.a. n.a. n.a. n.a. n.a. 7127 n.a. NPC292792 METHYLEUGENOL, Methyl eugenol, 93-15-2, 4-Allyl-1,2-dimethoxybenzene, Eugenol methyl ether, 4-Allylveratrole, O-Methyleugenol, Eugenyl methyl ether, Methyl eugenol ether, Veratrole methyl ether, Methyl eugenyl ether, 1,2-Dimethoxy-4-(2-propenyl)benzene, Benzene, 1,2-dimethoxy-4-(2-propenyl)-, 1-Allyl-3,4-dimethoxybenzene, 3,4-Dimethoxyallylbenzene, 1,2-dimethoxy-4-prop-2-enylbenzene, Benzene, 4-allyl-1,2-dimethoxy-, 1,3,4-Eugenol methyl ether, 1,2-Dimethoxy-4-allylbenzene, 1-(3,4-Dimethoxyphenyl)-2-propene, 3-(3,4-dimethoxyphenyl)-1-propene, ENT 21040, FEMA No. 2475, 4-allyl-1,2-dimethoxy-benzene, Eugenol methyl, NSC 209528, 4-Allyl-1,2-dimethyoxybenzene, 1,2-Dimethoxy-4-(2-propen-1-yl)benzene, 1,2-dimethoxy-4-(prop-2-en-1-yl)benzene, MFCD00008652, 29T9VA6R7M, CHEBI:4918, DTXSID5025607, Benzene, 1,2-dimethoxy-4-(2-propen-1-yl)-, NSC-8900, NSC-209528, Benzene, 4-(2-propenyl)-1,2-dimethoxy, 1,4-Eugenol methyl ether, O-Methyl eugenol, DTXCID505607, WLN: 1U2R CO1 DO1, TRIDEUTEROMETHYL EUGENOL, Allylveratrol, Caswell No. 579AB, FEMA Number 2475, Benzene,2-dimethoxy-4-(2-propenyl)-, CAS-93-15-2, SMR000112378, CCRIS 746, HSDB 4504, o-Methyl eugenol ether, EINECS 202-223-0, EPA Pesticide Chemical Code 203900, BRN 1910871, UNII-29T9VA6R7M, AI3-21040, Methyleugenol,(S), methyl ester eugenol, Eugenol-methyl ether, METHYLCHAVIBETOL, METHYLEUGENOL [MI], EC 202-223-0, Allyl-1,2-dimethoxybenzene, METHYLEUGENOL [HSDB], METHYLEUGENOL [IARC], METHYL EUGENOL [FCC], VERATROLE, 4-ALLYL-, MLS001065600, MLS001333205, MLS001333206, CHAVIBETOL METHYL ETHER, METHYL EUGENOL [INCI], SCHEMBL113794, CHEMBL108861, 1,2-Dimethoxy-4-allyl benzene, 4-Allyl-1, 2-dimethoxybenzene, SCHEMBL10108224, FEMA 2475, Methyl eugenol, >=98%, FCC, NSC8900, HMS2269M09, HMS3886M22, Methyl eugenol, analytical standard, EUGENYL METHYL ETHER [FHFI], HY-N6996, Tox21_202347, Tox21_300071, BDBM50379791, ENT-21040, NSC209528, 4-Allyl-1,2-dimethoxybenzene, 99%, AKOS015838877, 1-(3, 4-Dimethoxyphenyl)-2-propene, CS-W017325, Dimethoxy-4-(prop-2-en-1-yl)benzene, 1, 2-Dimethoxy-4-(2-propenyl)benzene, NCGC00091474-01, NCGC00091474-02, NCGC00091474-03, NCGC00091474-04, NCGC00254085-01, NCGC00259896-01, AC-34351, AS-14807, D1360, NS00009255, S5755, E80630, EN300-698375, Q419829, W-100251, Z1255398904, METHYLEUGENOL (CONSTITUENT OF HOLY BASIL LEAF) [DSC] C11H14O2 ZYEMGPIYFIJGTP-UHFFFAOYSA-N 1,2-dimethoxy-4-prop-2-enylbenzene n.a. n.a. No No No No No No PMDBD2000953 Methyl gallate n.a. n.a. n.a. n.a. n.a. n.a. n.a. 7428 n.a. NPC264145 "METHYL GALLATE, Methyl 3,4,5-trihydroxybenzoate, 99-24-1, Gallic acid methyl ester, Methylgallate, Benzoic acid, 3,4,5-trihydroxy-, methyl ester, Gallic acid, methyl ester, CCRIS 5567, Gallicin, methyl galloate, NSC 363001, AI3-00861, 3,4,5-Trihydroxy-benzoic acid methyl ester, EINECS 202-741-7, UNII-623D3XG80C, BRN 2113180, GALLINCIN, 3,4,5-Trihydroxybenzoic acid methyl ester, 623D3XG80C, MFCD00002194, NSC-363001, CHEMBL65675, CHEBI:145828, 4-10-00-01998 (Beilstein Handbook Reference), NSC363001, M G, Methyl gallate;, methyl-3,4,5-trihydroxybenzoate, Gallic acid-methyl ester, cid_7428, 6-methylthiomorpholin-3-one, SCHEMBL39513, MLS000574912, DTXSID3059189, HMS2210A23, HMS3346G16, HY-N2010, BDBM50187133, s3790, methyl 3,4,5-tris(oxidanyl)benzoate, AKOS000277450, GALLIC ACID METHYL ESTER [MI], CCG-266463, Methyl 3,4,5-trihydroxybenzoate, 98%, NCGC00247606-01, NCGC00247606-02, AC-11364, AC-34481, AS-14808, SMR000156263, SY011144, CS-0018330, G0017, NS00040545, EN300-393116, A845986, CS-008/03903045, W-100047, Q15425833, Gallincin;NSC 363001;Methyl-3,4,5-trihydroxybenzoate, Z1255434713, InChI=1/C8H8O5/c1-13-8(12)4-2-5(9)7(11)6(10)3-4/h2-3,9-11H,1H" C8H8O5 FBSFWRHWHYMIOG-UHFFFAOYSA-N methyl 3,4,5-trihydroxybenzoate n.a. n.a. No No No No No No PMDBD2000954 Methyl indole-7-carboxylate n.a. n.a. n.a. n.a. n.a. n.a. n.a. 676694 n.a. n.a. methyl 1H-indole-7-carboxylate, 93247-78-0, Methyl indole-7-carboxylate, 1H-Indole-7-carboxylic acid methyl ester, INDOLE-7-CARBOXYLIC ACID METHYL ESTER, METHYL-INDOLE-7-CARBOXYLATE, MFCD00211064, Methylindole-7-carboxylate, methyl 7-indolecarboxylate, 7-methoxycarbonylindole, methyl 7-indole carboxylate, SCHEMBL761721, DTXSID70918582, METHYL(7-INDOLECARBOXYLATE), BCP26795, CCG-42843, AKOS000631420, CC-0744, CS-W002517, METHYL-1H-INDOLE-7-CARBOXYLATE, PB27475, SB10371, SDCCGMLS-0065886.P001, methyl indole-7-carboxylate, AldrichCPR, AC-22445, SY020041, AM20060405, EN300-132047, I-2530, A829779, Q-102562, SR-01000632809-1, Z1201619795 C10H9NO2 FTLOEULOTNVCGF-UHFFFAOYSA-N methyl 1H-indole-7-carboxylate n.a. n.a. No No No No No No PMDBD2000955 Methylthiopropylamine n.a. n.a. n.a. n.a. n.a. n.a. n.a. 77743 n.a. n.a. 3-(Methylthio)propylamine, 4104-45-4, 3-Methylthiopropylamine, 1-Propanamine, 3-(methylthio)-, 3-(methylsulfanyl)propan-1-amine, 3-methylsulfanylpropan-1-amine, 3-Methylthiopropanamine, 3-(methylthio)-1-propanamine, 3-Methylmercaptopropylamine, Methylmercaptopropylamine, 3-Aminopropyl methyl sulfide, MFCD00041898, 1IAP0CGD5S, 3-(Methylmercapto)propylamine, C03354, UNII-1IAP0CGD5S, Propylamine, 3-(methylthio)-, methylthiopropylamine, EINECS 223-875-2, 3-methylthio-propylamine, 3-(methylthio)-propylamine, 3-methylsulfanyl-propylamine, S-METHYLHOMOCYSTEAMINE, [3-(methylthio)propyl]amine, SCHEMBL22662, 3-(methylsulfanyl)propylamine, 3-(methylthio)propan-1-amine, DTXSID1063300, FEMA NO. 4649, CHEBI:16696, 3-(Methylthio)propylamine, 97%, 3-(Methylsulfanyl)-1-propanamine #, 3-METHYLSULFANYL-1-PROPYLAMINE, AKOS005203380, 1-AMINO-3-(METHYLTHIO)PROPANE, MS-20419, SY050465, 6-Bromo-2-chloro-3-methylphenylboronicacid, CS-0204914, M0754, NS00022156, EN300-63965, Q21099103 C4H11NS KKYSBGWCYXYOHA-UHFFFAOYSA-N 3-methylsulfanylpropan-1-amine n.a. n.a. No No No No No No PMDBD2000956 Meticillin Therapeutic Substance Approved Drug 61-32-5 DB01603 PA164777034 n.a. D06TQZ 6087 5862 NPC478433 methicillin, Meticillin, Methycillin, 61-32-5, Methicillinum, Meticilina, Meticilline, Meticillinum, Metacillin, Dimocillin, Staphcillin, Meticilina [INN-Spanish], Meticilline [INN-French], Meticillinum [INN-Latin], (2,6-Dimethoxyphenyl)penicillin, 6-(2,6-Dimethoxybenzamido)penicillanic acid, CHEBI:6827, (2S,5R,6R)-6-[(2,6-dimethoxybenzoyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, BRL 1241, 6beta-(2,6-dimethoxybenzamido)penicillanic acid, 2,6-dimethoxyphenyl penicillin, Meticillina, Q91FH1328A, Celbenin, (2S,5R,6R)-6-(2,6-dimethoxybenzamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, Meticillina [DCIT], Methcillin, Meticillin [INN], Methicillin [USAN], HSDB 3121, Meticillin [INN:BAN], EINECS 200-505-8, Penicillin, (2,6-dimethoxyphenyl)-, UNII-Q91FH1328A, (2S,5R,6R)-6-(2,6-DIMETHOXYBENZAMIDO)-3,3-DIMETHYL-7-OXO-4-THIA-1-AZABICYCLO(3.2.0)HEPTANE-2-CARBOXYLIC ACID, 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((2,6-dimethoxybenzoyl)amino)-3,3-dimethyl-7-oxo-, (2S-(2alpha,5alpha,6beta))-, Spectrum_000993, Spectrum2_001965, Spectrum3_000494, Spectrum4_000878, Spectrum5_001600, METICILLIN [HSDB], CHEMBL575, Epitope ID:139649, METHICILLIN [VANDF], SCHEMBL4898, METICILLIN [WHO-DD], BSPBio_001987, KBioGR_001575, KBioSS_001473, 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(2,6-dimethoxybenzamido)-3,3-dimethyl-7-oxo-, 6-(2,3-Dimethoxybenzamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, DivK1c_000100, SPBio_002089, DTXSID6023284, GTPL12264, KBio1_000100, KBio2_001473, KBio2_004041, KBio2_006609, KBio3_001487, NINDS_000100, BDBM50103523, 6beta-(2,6-dimethoxybenzamido)-2,2-dimethylpenam-3alpha-carboxylic acid, AKOS030530774, DB01603, IDI1_000100, (2S,5R,6R)-6-{[(2,6-dimethoxyphenyl)carbonyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(2,6-dimethoxybenzamido)-3,3,-dimethyl-7-oxo-, MII, SBI-0051440.P003, HY-121544, MRSA Selective Supplement, for microbiology, CS-0082724, NS00005780, C07177, EN300-19748934, Q409262, BRD-K34388247-236-02-5, (2S,5R,6R)-6-[(2,6-dimethoxybenzene)amido]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid C17H20N2O6S RJQXTJLFIWVMTO-TYNCELHUSA-N (2S,5R,6R)-6-[(2,6-dimethoxybenzoyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid Beecham phamaceuticals Antibiotics No No No No No No PMDBD2000957 Micafungin Therapeutic Substance Approved Drug 235114-32-6 DB01141 PA164781026 D02465 D06TOE 477468 n.a. NPC483754 Micafungin, 235114-32-6, Mycamine, Micafungin [INN], UNII-R10H71BSWG, R10H71BSWG, CHEBI:600520, Micafungin (INN), PNEUMOCANDIN A0, 1-((4R,5R)-4,5-DIHYDROXY-N(SUP 2)-(4-(5-(4-(PENTYLOXY)PHENYL)-3-ISOXAZOLYL)BENZOYL)-L-ORNITHINE)-4-((4S)-4-HYDROXY-4-(4-HYDROXY-3-(SULFOOXY)PHENYL)-L-THREONINE)-, Pneumocandin A0, 1-((4R,5R)-4,5-dihydroxy-N2-(4-(5-(4-(pentyloxy)phenyl)-3-isoxazolyl)benzoyl]-L-ornithine)-4-((4S)-4-hydroxy-4-(4-hydroxy-3-(sulfooxy)phenyl)-L-threonine)-, DTXSID90873341, micafungine, micafunginum, Micafungina, Mycamine(TM), Pneumocandin A0, 1-((4R,5R)-4,5-dihydroxy-N2-(4-(5-(4-(pentyloxy)phenyl)-3-isoxazolyl)benzoyl)-L-ornithine)-4-((4S)-4-hydroxy-4-(4-hydroxy-3-(sulfooxy)phenyl)-L-threonine)-, Micafungin(free acid)?, MICAFUNGIN [MI], MICAFUNGIN [JAN], MICAFUNGIN [VANDF], MICAFUNGIN [WHO-DD], MICAFUNGIN [EMA EPAR], CHEMBL457547, SCHEMBL11893279, DTXCID20820848, J02AX05, PIEUQSKUWLMALL-YABMTYFHSA-N, BDBM50478216, DB01141, D08218, EN300-19634541, J-015136, Q6827850, [5-[(1S,2S)-2-[[(1R)-3-amino-1-hydroxy-3-oxo-propyl]-tetrahydroxy-[(1R)-1-hydroxyethyl]-methyl-hexaoxo-[[4-[5-(4-pentoxyphenyl)isoxazol-3-yl]benzoyl]amino][?]yl]-1,2-dihydroxy-ethyl]-2-hydroxy-phenyl] hydrogen sulfate, 5.1:6-anhydro{(4R,5R)-4,5-dihydroxy-N(2)-(4-{5-[4-(pentyloxy)phenyl]isoxazol-3-yl}benzoyl)-L-ornithyl-L-threonyl-(4R)-4-hydroxy-L-prolyl-(4S)-4-hydroxy-4-[4-hydroxy-3-(sulfooxy)phenyl]-L-threonyl-(3R)-3-hydroxy-L-glutaminyl-(3S,4S)-3-hydroxy-4-methyl-L-proline} C56H71N9O23S PIEUQSKUWLMALL-YABMTYFHSA-N [5-[(1S,2S)-2-[(3S,6S,9S,11R,15S,18S,20R,21R,24S,25S,26S)-3-[(1R)-3-amino-1-hydroxy-3-oxopropyl]-11,20,21,25-tetrahydroxy-15-[(1R)-1-hydroxyethyl]-26-methyl-2,5,8,14,17,23-hexaoxo-18-[[4-[5-(4-pentoxyphenyl)-1,2-oxazol-3-yl]benzoyl]amino]-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosan-6-yl]-1,2-dihydroxyethyl]-2-hydroxyphenyl] hydrogen sulfate Astellas Pharma Antifungal Agents No No No No No No PMDBD2000958 Midazolam Therapeutic Substance Approved Drug 59467-70-8 DB00683 PA450496 D00550 D0U6LM 4192 4047 n.a. midazolam, Dormicum, 59467-70-8, Buccolam, Midazolamum, Versed, mezolam, 8-Chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine, Midazolamum [INN-Latin], Midazolam Base, Nayzilam, Midazolam civ, USL261, Ro 21-3981, DEA No. 2884, UNII-R60L0SM5BC, EINECS 261-774-5, R60L0SM5BC, BRN 0625572, CHEBI:6931, USL-261, CHEMBL655, 8-Chlor-6-(2-fluorphenyl)-1-methyl-4H-imidazo(1,5-a)(1,4)benzodiazepin, 8-Chloro-6-(o-fluorophenyl)-1-methyl-4H-imidazo(1,5-a)(1,4)benzodiazepine, DTXSID5023320, HSDB 6751, Midazolam [USP:INN:BAN:JAN], USL261 (nasal spray formulation), 4H-Imidazo(1,5-a)(1,4)benzodiazepine, 8-chloro-6-(2-fluorophenyl)-1-methyl-, Midazolamum (INN-Latin), MIDAZOLAM (MART.), MIDAZOLAM [MART.], 4H-Imidazo[1,5-a][1,4]benzodiazepine, 8-chloro-6-(2-fluorophenyl)-1-methyl-, 8-Chloro-6-(O-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]-benzodiazepine, MIDAZOLAM CIV (USP-RS), MIDAZOLAM CIV [USP-RS], MIDAZOLAM (EP MONOGRAPH), MIDAZOLAM [EP MONOGRAPH], MIDAZOLAM (USP MONOGRAPH), Midazolam (USP:INN:BAN:JAN), MIDAZOLAM [USP MONOGRAPH], 8-chloro-6-(2-fluorophenyl)-1-methyl-4h-imidazo(1,5-a)(1,4)benzodiazepine, 4H-IMIDAZO(1,5-A)(1,4)BENZODIAZEPINE, 8-CHLORO-6-(2-FLUOROPHENYL)-1-METHYL, Dormicum (TN), 12-chloro-9-(2-fluorophenyl)-3-methyl-2,4,8-triazatricyclo[8.4.0.0^{2,6}]tetradeca-1(10),3,5,8,11,13-hexaene, NCGC00168254-01, Medazolam, Buccolam (TN), Nayzilam (TN), 08J, Midazolamum (Latin), Versed (Salt/Mix), Dormonid (Salt/Mix), Hypnovel (Salt/Mix), Flormidal (Salt/Mix), MIDAZOLAM [INN], MIDAZOLAM [JAN], MIDAZOLAM [MI], MIDAZOLAM [VANDF], MIDAZOLAM [WHO-DD], Midazolam (JAN/USP/INN), Midazolam Injection, 10 mg, SCHEMBL35061, BIDD:GT0647, Midazolam hydrochloride, solid, Midazolam, 1mg/ml in Methanol, DTXCID503320, GTPL3342, MIDAZOLAM [ORANGE BOOK], BDBM21363, N05CD08, Midazolam 0.1 mg/ml in Methanol, Midazolam 1.0 mg/ml in Methanol, BCP21296, HY-B0676, 59467-70-8 (free), Midazolam (1.0 mg/mL in methanol), AKOS015842580, DB00683, 4H-Imidazo[1,5-a][1,4]benzodiazepine, 8-chloro-6-(2-fluoro-phenyl)-1-methyl-, (Z)-2-butenedioate, MIDAZOLAM IN 0.8% SODIUM CHLORIDE, MIDAZOLAM IN 0.9% SODIUM CHLORIDE, NS00000476, C07524, D00550, A832332, Q423071, Midazolam hydrochloride, United States Pharmacopeia (USP) Reference Standard, 12-chloro-9-(2-fluorophenyl)-3-methyl-2,4,8-triazatricyclo[8.4.0.0^{2,6}]tetradeca-1(14),3,5,8,10,12-hexaene C18H13ClFN3 DDLIGBOFAVUZHB-UHFFFAOYSA-N 8-chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine Roche Pharmaceuticals Hypnotics and Sedatives No No No No No Yes EX_mdz(e),MDZ_GLC_GLCAASE,MDZ_GLC_GLCAASEe,MDZ_GLC_GLCAASEepp,MDZGLC_GLCAASE,MDZGLC_GLCAASEe,MDZGLC_GLCAASEepp,MDZte,MDZtepp,MDZtex PMDBD2000959 Moxifloxacin? n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000960 MUC7 12-mer-D n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000961 MUC7 12-mer-L n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000962 MUC7 12-mer-L4 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000963 MUC7 20-mer n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000964 Mucobromic acid n.a. n.a. n.a. n.a. n.a. n.a. n.a. 3033972 n.a. n.a. "Mucobromic acid, 488-11-9, Bromomucic acid, (Z)-2,3-dibromo-4-oxobut-2-enoic acid, 2-Butenoic acid, 2,3-dibromo-4-oxo-, (2Z)-, 2,3-Dibromo-4-oxo-2-butenoic acid, Malealdehydic acid, dibromo-, MFCD00063745, 2-Butenoic acid, 2,3-dibromo-4-oxo-, (Z)-, (2Z)-2,3-Dibromo-4-oxobut-2-enoic acid, 2,3-Dibromomalealdehydic acid, Mucobromicacid, CCRIS 6704, EINECS 207-670-5, NSC 12426, C4H2Br2O3, AI3-16061, (2Z)-2,3-Dibromo-4-oxo-2-butenoic acid, Mucobromic acid, 99%, (Z)-2,3-dibromo-4-oxo-but-2-enoic acid, SCHEMBL319076, Mucobromic acid;2,3-Dibromo-4-oxo-2-butenoic acid, DTXSID20883397, NSC12426, NSC-12426, AKOS003625055, 2-Butenoic acid, 2,3-dibromo-4-oxo-, (Z)-2,3-dibromo-4-oxobut-2-enoicacid, BP-10120, 2-Butenoic acid,3-dibromo-4-oxo-, (Z)-, M0471, D78114, A815495, A827609, J-610084, Mucobromic acid 2,3-Dibromo-4-oxo-2-butenoic acid, W-106039, F2191-0142" C4H2Br2O3 NCNYEGJDGNOYJX-IHWYPQMZSA-N (Z)-2,3-dibromo-4-oxobut-2-enoic acid n.a. n.a. No No No No No No PMDBD2000965 Mucochloric acid n.a. n.a. n.a. n.a. n.a. n.a. n.a. 2771871 n.a. n.a. Mucochloric acid, 87-56-9, 2,3-Dichloromaleic aldehyde acid, 2-Butenoic acid, 2,3-dichloro-4-oxo-, (2Z)-, (2Z)-2,3-dichloro-4-oxobut-2-enoic acid, Kyselina mukochlorova, Dichloromalealdehydic acid, 2,3-Dichloro-4-oxo-2-butenoic acid, alpha,beta-Dichloro-beta-formylacrylic acid, Malealdehydic acid, dichloro-, (Z)-2,3-dichloro-4-oxobut-2-enoic acid, 2,3-dichloro-4-oxobutenoic acid, 2-Butenoic acid, 2,3-dichloro-4-oxo-, (Z)-, 57697-64-0, 5I5877JHIW, Aldehydodichloromaleic acid, DTXSID7020423, 3,4-Dichloro-2-hydroxycrotonolactone, NSC-15905, WLN: VHYGUYGVQ, .alpha.,.beta.-Dichloro-.beta.-formylacrylic acid, DTXCID70423, 3,4-Dichloro-2-hydroxycrotonolactonic acid, Acrylic acid,3-dichloro-3-formyl-, C4H2Cl2O3, CAS-87-56-9, Kyselina mukochlorova [Czech], CCRIS 6597, 2-Butenoic acid,3-dichloro-4-oxo-, (Z)-, Malealdehydic acid, dichloro-4-oxo-, (Z)-, HSDB 7230, (Z)-2,3-Dichloro-4-oxo-2-butenoic acid, EINECS 201-752-4, NSC 15905, (Z)-Dichloro-4-oxomalealdehydic acid, BRN 1705641, UNII-5I5877JHIW, AI3-26601, alpha,beta-Dichloro-beta-formyl acrylic acid, (2Z)-2,3-Dichloro-4-oxo-2-butenoic acid, EC 201-752-4, 4-03-00-01720 (Beilstein Handbook Reference), MUCOCHLORIC ACID [MI], SCHEMBL202877, MUCOCHLORIC ACID [HSDB], CHEMBL1879926, NSC15905, NSC35058, NSC56325, Tox21_201305, Tox21_302857, 2-Butenoic acid,3-dichloro-4-oxo-, MFCD00135465, NSC-35058, NSC-56325, NSC244774, AKOS000269580, NSC-244774, NCGC00164222-01, NCGC00249023-01, NCGC00256418-01, NCGC00258857-01, AS-10985, M0472, VU0513135-1, D97737, Q1951666, F3202-0514 C4H2Cl2O3 LUMLZKVIXLWTCI-IHWYPQMZSA-N (Z)-2,3-dichloro-4-oxobut-2-enoic acid n.a. n.a. No No No No No No PMDBD2000966 Mustard oil n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000967 Myricetin Therapeutic Substance Investigational Drug 529-44-2 DB02375 n.a. n.a. D0T3PW 5281672 4444991 NPC169749 "myricetin, 529-44-2, Cannabiscetin, Myricetol, Myricitin, 3,5,7-Trihydroxy-2-(3,4,5-trihydroxyphenyl)-4H-chromen-4-one, 3,3'',4'',5,5'',7-Hexahydroxyflavone, 3,5,7,3'',4'',5''-Hexahydroxyflavone, delphidenolon 1575, 3,5,7-Trihydroxy-2-(3,4,5-trihydroxyphenyl)-4H-1-benzopyran-4-one, 3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one, CCRIS 5838, NSC 407290, NSC-407290, 4H-1-Benzopyran-4-one, 3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)-, UNII-76XC01FTOJ, EINECS 208-463-2, 76XC01FTOJ, 3,3'',4,4'',5'',7-Hexahydro-2-phenyl-4H-chromen-4-one, BRN 0332331, CHEBI:18152, HSDB 7682, MFCD00006827, NSC407290, CHEMBL164, FLAVONE, 3,3'',4'',5,5'',7-HEXAHYDROXY-, Myricetin from Myrica cerifera leaf and bark, SMR001233193, SR-01000076005, Myrc, 4gqr, C15H10O8, Prestwick_342, Spectrum_001501, SpecPlus_000531, MYRICETIN [MI], MYRICETIN [HSDB], MYRICETIN [INCI], Prestwick0_000465, Prestwick1_000465, Prestwick2_000465, Prestwick3_000465, Spectrum4_001272, Spectrum5_000692, Lopac-M-6760, Myricetin (Cannabiscetin), BIDD:PXR0079, Lopac0_000740, SCHEMBL19302, BSPBio_000570, KBioGR_001884, KBioSS_001981, MLS002153825, MLS006010718, BIDD:ER0142, DivK1c_006627, Myricetin, analytical standard, SPBio_002509, BPBio1_000628, MEGxp0_000357, DTXSID8022400, ACon1_000267, BDBM15236, cid_5281672, KBio1_001571, KBio2_001981, KBio2_004549, KBio2_007117, 2o63, CHEBI: 18152, REGID_for_CID_5281672, HMS1569M12, HMS2096M12, HMS2231L04, HMS3262C22, HMS3656I05, Myricetin - CAS 529-44-2, BCP28295, Myricetin, >=96.0% (HPLC), Myricetin, >=96.0%, crystalline, TNP00286, Tox21_500740, HB0434, LMPK12110001, s2326, 3,7,3'',4'',5''-Hexahydroxyflavone, AKOS015903103, AC-4533, CCG-204825, CS-6221, DB02375, KS-5268, LP00740, SDCCGSBI-0050718.P003, 3,3'',4'',5,5'',7-hexOH-Flavone, Flavone,3'',4'',5,5'',7-hexahydroxy-, NCGC00015697-01, NCGC00015697-02, NCGC00015697-03, NCGC00015697-04, NCGC00015697-05, NCGC00015697-06, NCGC00015697-07, NCGC00015697-08, NCGC00015697-09, NCGC00015697-10, NCGC00015697-11, NCGC00015697-12, NCGC00015697-13, NCGC00015697-14, NCGC00015697-25, NCGC00094083-01, NCGC00094083-02, NCGC00094083-03, NCGC00094083-04, NCGC00179517-01, NCGC00179517-02, NCGC00261425-01, CAS-529-44-2, HY-15097, NCI60_003870, SY051702, EU-0100740, M2131, NS00014642, SW196616-2, M 6760, S00115, 3,3'',4'',5,5'',7-hexahydroxy-(8CI)- flavone, A829320, Q951449, C07E0ED2-ABF6-4BD3-A2B2-A98CAEF20FD1, Myricetin, primary pharmaceutical reference standard, Q-100601, SR-01000076005-1, SR-01000076005-6, BRD-K43149758-001-04-5, 3,3′,4′,5,5′,7-Hexahydroxyflavone, Cannabiscetin; HSDB 7682; HSDB7682; HSDB-7682, 3,4,5-trihydroxy-2-(3,4,5-trihydroxyphenyl)chromen-7-one, 3,5,7-Trihydroxy-2-(3,4,5-trihydroxyphenyl)-4H-chromen-4-one #, 4H-1-Benzopyran-4-one,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)-" C15H10O8 IKMDFBPHZNJCSN-UHFFFAOYSA-N 3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one n.a. n.a. No No No No Yes No rxn40107,rxnDiet161,rxnAdd132,rxnAdd133,rxnAdd135 PMDBD2000968 Myricitrin n.a. n.a. n.a. n.a. n.a. n.a. n.a. 5281673 n.a. NPC73855 Myricitrin, 17912-87-7, Myricitroside, Myricetrin, Myricitrine, Myricetin 3-O-rhamnoside, Myricetol 3-rhamnoside, Myricetin 3-rhamnoside, Myricetin 3-O-alpha-L-rhamnopyranoside, 5Z0ZO61WPJ, MLS000574998, CHEBI:70082, NSC19803, NSC-19803, 5,7-dihydroxy-3-(((2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-2-(3,4,5-trihydroxyphenyl)-4H-chromen-4-one, 5,7-dihydroxy-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one, SMR000232363, Myricetin 3-O-alpha-L-rhamnoside, 3-((6-Deoxy-alpha-L-mannopyranosyl)oxy)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-4H-benzopyran-4-one, 3,3'',4'',5,5'',7-Hexahydroxyflavone, 3-rhamnoside, MFCD00016930, 3-[(6-deoxy-alpha-L-mannopyranosyl)oxy]-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-4H-1-benzopyran-4-one, 4H-1-Benzopyran-4-one, 3-[(6-deoxy-.alpha.-L-mannopyranosyl)oxy]-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-, 5,7-dihydroxy-4-oxo-2-(3,4,5-trihydroxyphenyl)-4H-chromen-3-yl 6-deoxy-alpha-L-mannopyranoside, Flavone,3,3'',4'',5,5'',7-hexahydroxy-,3-rhamnoside, UNII-5Z0ZO61WPJ, Myricitrin (7), 4H-1-BENZOPYRAN-4-ONE, 3-((6-DEOXY-.ALPHA.-L-MANNOPYRANOSYL)OXY)-5,7-DIHYDROXY-2-(3,4,5-TRIHYDROXYPHENYL)-, Myricetin 3-O-.alpha.-L-rhamnopyranoside, EINECS 241-856-7, NSC 19803, myricetin-3-rhamnoside, Myricetin 3- rhamnoside, Myricitrin (Myricitrine), MYRICITRIN [INCI], 5,7-Dihydroxy-3-((2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-tetrahydro-pyran-2-yloxy)-2-(3,4,5-trihydroxy-phenyl)-1-benzopyran-4-one, SCHEMBL226022, Myricitrin, analytical standard, CHEMBL522983, MEGxp0_000257, FEMA NO. 4491, ACon1_000103, BDBM34753, cid_5281673, DTXSID40170771, BDBM153266, HMS2218N08, HY-N0152, Myricitrin, >=99.0% (HPLC), AC-638, MYRICETIN 3-O-RHAMNOPYRANOSIDE, AKOS015896842, CCG-208406, NCGC00163596-01, NCGC00163596-02, 5,7-dihydroxy-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one, BS-16289, CS-0007883, NS00021765, S2327, (3-PHENYLAMINOCARBONYLPHENYL)BORONICACID, MYRICETIN 3-O-.ALPHA.-L-RHAMNPYRONOSIDE, SR-01000712005, Myricitrin, primary pharmaceutical reference standard, Q6948223, SR-01000712005-3, 3-[(2S,3R,4R,5R,6S)-6-methyl-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-5,7-bis(oxidanyl)-2-[3,4,5-tris(oxidanyl)phenyl]chromen-4-one, 3-[(6-deoxy-|A-L-mannopyranosyl)oxy]-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-4H-benzopyran-4-one, 5,7-dihydroxy-3-((2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yloxy)-2-(3,4,5-trihydroxyphenyl)-4H-chromen-4-one, 5,7-dihydroxy-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-2-(3,4,5-trihydroxyphenyl)chromone, 5,7-dihydroxy-3-[[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-2-oxanyl]oxy]-2-(3,4,5-trihydroxyphenyl)-1-benzopyran-4-one C21H20O12 DCYOADKBABEMIQ-OWMUPTOHSA-N 5,7-dihydroxy-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one n.a. n.a. No No No No Yes No rxnAddEX10,rxnAdd136 PMDBD2000969 Myristic acid Therapeutic Substance Investigational Drug 544-63-8 DB08231 n.a. n.a. D08OBF 11005 10539 NPC301585 "Tetradecanoic acid, MYRISTIC ACID, 544-63-8, n-Tetradecanoic acid, Crodacid, n-Tetradecan-1-oic acid, n-Tetradecoic acid, 1-Tridecanecarboxylic acid, Myristate, Hydrofol acid 1495, Myristinsaeure, Univol U 316S, Emery 655, tetradecoic acid, Hystrene 9014, Myristic acid, pure, FEMA No. 2764, Myristic acid (natural), acide tetradecanoique, n-Myristic acid, NSC 5028, CCRIS 4724, HSDB 5686, Philacid 1400, C14:0, Prifac 2942, CH3-[CH2]12-COOH, CHEBI:28875, AI3-15381, NSC-5028, 1-tetradecanecarboxylic acid, EINECS 208-875-2, PHILACID-1400, UNII-0I3V7S25AW, PRIFRAC-2942, BRN 0508624, 0I3V7S25AW, DTXSID6021666, Edenor C 14, Acid, Myristic, MyristicAcid-13C14, CHEMBL111077, DTXCID501666, MYRISTIC-14-13C ACID, NSC5028, 4-02-00-01126 (Beilstein Handbook Reference), MFCD00002744, FA 14:0, n-tetradecan-1-oate, MYRISTIC ACID (II), MYRISTIC ACID [II], 32112-52-0, MYRISTIC ACID (MART.), MYRISTIC ACID [MART.], MYRISTIC ACID (USP-RS), MYRISTIC ACID [USP-RS], CH3-(CH2)12-COOH, CAS-544-63-8, Acid, Tetradecanoic, Myristic acid [NF], 62217-70-3, myristoate, myristoic acid, n-Tetradecanoate, Tetradecanoicacid, 3usx, Myristic acid pure, fatty acid 14:0, Hystrene 9514, TETRADECANSAEURE, 1-Tridecanecarboxylate, ACIDO MYNISTICO, MAGNESIUMARSENATE, Myristic acid, 95%, Myristic acid, natural, tridecanecarboxylic acid, Myristic acid (8CI), Myristic Acid, Reagent, 3v2n, 3w9k, Myristic acid, puriss., Univol U 3165, Myristic acid, ?99%, Tetradecanoic acid (9CI), bmse000737, Epitope ID:176772, MYRISTIC ACID [MI], SCHEMBL6374, MYRISTIC ACID [FCC], MYRISTIC ACID [FHFI], MYRISTIC ACID [HSDB], MYRISTIC ACID [INCI], MLS002152942, WLN: QV13, Tetradecanoic (Myristic) acid, GTPL2806, NAA 104, NAA 142, IS_D27-TETRADECANOIC ACID, HMS3039E15, HMS3648O20, Myristic acid, analytical standard, HY-N2041, EINECS 250-924-5, Myristic acid, >=98.0% (GC), Tox21_201852, Tox21_302781, BDBM50147581, LMFA01010014, s5617, Myristic acid, >=95%, FCC, FG, Myristic acid, Sigma Grade, >=99%, AKOS009156714, CCG-266785, DB08231, DS-3833, NSC 122834, NCGC00091068-01, NCGC00091068-02, NCGC00091068-03, NCGC00256547-01, NCGC00259401-01, AC-34674, BP-27915, SMR001224536, CS-0018531, M0476, NS00010444, EN300-78099, C06424, G74510, Myristic acid, Vetec(TM) reagent grade, 98%, Q422658, SR-01000854525, MYRISTIC ACID (CONSTITUENT OF SAW PALMETTO), SR-01000854525-3, W-109088, F8889-5016, Z1954802504, EDAE4876-C383-4AD4-A419-10C0550931DB, MYRISTIC ACID (CONSTITUENT OF SAW PALMETTO) [DSC], Myristic acid, United States Pharmacopeia (USP) Reference Standard, Tetradecanoic acid; 1-Tridecanecarboxylic acid; n-Tetradecanoic acid, Myristic acid, Pharmaceutical Secondary Standard; Certified Reference Material" C14H28O2 TUNFSRHWOTWDNC-UHFFFAOYSA-N tetradecanoic acid n.a. n.a. No No No No No No PMDBD2000970 Myristoyl-DL-carnitine n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000971 Myrrh oil n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000972 Myxinidin n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000973 Myxinidin1 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000974 Myxinidin2 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000975 Myxinidin3 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000976 N -(3-nitro-4-hydroxy-benzylidene)benzohydrazide n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000977 N -(4-trifluoromethyl-benzylidene)benzohydrazide n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000978 N -(5-bromo-2-hydroxy-benzylidene)benzohydrazide n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000979 N -(pyridin-3-yl-methylene)benzohydrazide n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000980 N -[(3-chloro-isoquinolin-4-yl)methylene] benzohydrazide n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000981 N 3-(2-thienylcarbonyl)-4-bromo-1,5-dimethyl-1H-pyrazole-3-carbohydrazide n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000982 N-((1E)-{4-ethoxy-3-[(8-oxo-1,5,6,8-tetrahydro-2H-1,5-methanopyrido[1,2-a][1,5]diazocin-3(4H)-yl)methyl]phenyl}methylene)-3,4,5-trihydroxybenzohydrazide n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000983 N-((2R,3R,4S,5S,6R)-2,4,5-Trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)butyramide n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000984 N-((2R,3R,4S,5S,6R)-2,4,5-Trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)dodecanamide n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000985 N-((2R,3R,4S,5S,6R)-2,4,5-Trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)hexanamide n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000986 N-((2R,3R,4S,5S,6R)-2,4,5-Trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)octanamide n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000987 N-(1,3-benzothiazol-2-yl)butanamide n.a. n.a. n.a. n.a. n.a. n.a. n.a. 708614 n.a. n.a. N-(1,3-benzothiazol-2-yl)butanamide, 92316-70-6, N-(benzo[d]thiazol-2-yl)butyramide, IFLab1_001083, SCHEMBL19771114, N-(Benzothiazol-2-yl)butyramide, HMS1415B05, AKOS000654815, IDI1_008950, SR-01000458118, SR-01000458118-1, BRD-K11326442-001-01-5, Z30199674, F0336-0412 C11H12N2OS MHNSNMRNSXMPTD-UHFFFAOYSA-N N-(1,3-benzothiazol-2-yl)butanamide n.a. n.a. No No No No No No PMDBD2000988 N-(1,3-Thiazol-2-yl)butanamide n.a. n.a. n.a. n.a. n.a. n.a. n.a. 3621821 n.a. n.a. N-(1,3-thiazol-2-yl)butanamide, SCHEMBL4112093, AKOS002944460 C7H10N2OS WMTBSFLGTUVUTO-UHFFFAOYSA-N N-(1,3-thiazol-2-yl)butanamide n.a. n.a. No No No No No No PMDBD2000989 N-(2-oxothiolan-3-yl)butanamide n.a. n.a. n.a. n.a. n.a. n.a. n.a. 4428038 n.a. n.a. N-(2-oxothiolan-3-yl)butanamide, N-Butyryl-DL-homocysteine thiolactone, 39837-08-6, SCHEMBL804838, DTXSID20403190, HY-W141788, CS-0201585, EN300-6730516, N-Butyryl-DL-homocysteine thiolactone, >=97.0% (HPLC) C8H13NO2S IMJUOGHALGXOSS-UHFFFAOYSA-N N-(2-oxothiolan-3-yl)butanamide n.a. n.a. No No No No No No PMDBD2000990 N-(2-Pyridinyl)butanamide n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000991 N-(2-Pyrimidinyl)butanamide n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000992 N-(4,5-Dihydro-1,3-thiazol-2-yl)butanamide n.a. n.a. n.a. n.a. n.a. n.a. n.a. 5113558 n.a. n.a. SCHEMBL3996997, AKOS003873028 C7H12N2OS JWFSGEUBZYPHBO-UHFFFAOYSA-N N-(4,5-dihydro-1,3-thiazol-2-yl)butanamide n.a. n.a. No No No No No No PMDBD2000993 N-(4-Bromobenzylidene)benzohydrazide n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000994 N-(4-hydroxy-2-methylphenyl)-3-oxododecanamide n.a. n.a. n.a. n.a. n.a. n.a. n.a. 24901250 n.a. n.a. SCHEMBL3855724 C19H29NO3 KAXXVJGAWVBWCH-UHFFFAOYSA-N N-(4-hydroxy-2-methylphenyl)-3-oxododecanamide n.a. n.a. No No No No No No PMDBD2000995 N-(4-Hydroxyphenyl)butanamide n.a. n.a. n.a. n.a. n.a. n.a. n.a. 66874 n.a. n.a. 4''-Hydroxybutyranilide, 101-91-7, N-Butyryl-p-aminophenol, N-(4-Hydroxyphenyl)butanamide, 4-Butyramidophenol, Butanamide, N-(4-hydroxyphenyl)-, p-Butyramidophenol, Suconox-4, p-(Butyrylamino)phenol, N-Butyroyl-p-aminophenol, Butyranilide, 4''-hydroxy-, N-(4-hydroxyphenyl)butyramide, VLQ9M6ZONH, Butyranilide, p-hydroxy-, NSC 166351, NSC-166351, UNII-VLQ9M6ZONH, EINECS 202-988-0, NSC166351, SCHEMBL39058, 4''-Hydroxybutyranilide, 97%, DTXSID0059241, N-(4-Hydroxyphenyl)butanamide #, STR09215, 4''-HYDROXYBUTYRANILIDE [MI], MFCD00020150, AKOS002944458, N-(4-HYDROXYPHENYL) BUTYRAMIDE, CS-0329898, NS00023087, D86519, AN-652/41618192, J-000520, Q27291888 C10H13NO2 KESXDDATSRRGAH-UHFFFAOYSA-N N-(4-hydroxyphenyl)butanamide n.a. n.a. No No No No No No PMDBD2000996 N-(4-Morpholinyl)butanamide n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000997 N-(4-Pyridinyl)butanamide n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000998 N-(5-Methyl-1,2-oxazol-3-yl)butanamide n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2000999 N-(6-tert-butyl-2,3-dihydro- 2-methylpyridazin-4-yl)-5-chlorothiophene-2-carbohydrazide n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001000 N-(pyrrolidin-3-yl)dodecanamide n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001001 N-[(3-chloro-isoquinolin-4-yl)methylene]benzohydrazide n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001002 N-[5-(6-amino-9H-purin-9-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]-3-(4-methoxyphenyl)propanamide n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001003 N1-(7-chloroquinolin-4-yl)dodecane-1,12-diamine n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001004 N1-(7-chloroquinolin-4-yl)ethane-1,2-diamine n.a. n.a. n.a. n.a. n.a. n.a. n.a. 221208 n.a. n.a. 5407-57-8, N1-(7-Chloroquinolin-4-yl)ethane-1,2-diamine, N-(2-aminoethyl)-7-chloroquinolin-4-amine, TCMDC-125850, N''-(7-chloroquinolin-4-yl)ethane-1,2-diamine, 4-(2-Aminoethyl)amino-7-chloroquinoline, N-(7-Chloroquinolin-4-yl)ethane-1,2-diamine, 1,2-ETHANEDIAMINE,N1-(7-CHLORO-4-QUINOLINYL), NSC5447, 1-Boc-4-formylindole, CHEMBL99254, SCHEMBL1147519, BDBM23301, DTXSID20277974, XBDASFGJHWAFFE-UHFFFAOYSA-N, NSC-5447, MFCD02179802, AKOS000188989, SB71543, AS-40839, CS-0197273, N-(7-Chloro-4-quinolyl)-1,2-diaminoethane, N''-(7-chloro-4-quinolyl)ethane-1,2-diamine, n-(7-chloro-4-quinolinyl)-1,2-ethanediamine, 7-chloro-4-[N-(2-aminoethyl)amino]-quinoline, N~1~-(7-Chloroquinolin-4-yl)ethane-1,2-diamine, 4-amino-7-chloroquinoline (ACQ)-based compound, 6, J-522864 C11H12ClN3 XBDASFGJHWAFFE-UHFFFAOYSA-N N''-(7-chloroquinolin-4-yl)ethane-1,2-diamine n.a. n.a. No No No No No No PMDBD2001005 N1-(7-chloroquinolin-4-yl)octane-1,8-diamine n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001006 N1-[7-(trifluoromethyl)quinolin-4-yl]dodecane-1,12-diamine n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001007 N1-[7-(trifluoromethyl)quinolin-4-yl]ethane-1,2-diamine n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001008 N1-[7-(trifluoromethyl)quinolin-4-yl]octane-1,8-diamine n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001009 NA10 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001010 NA12 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001011 NA8 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001012 NA8H n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001013 Na-Benzoate n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001014 NA-CATH n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001015 NA-CATH-ATRA1-ATRA1 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001016 N-Acetylcysteine Therapeutic Substance n.a. n.a. n.a. n.a. n.a. D06XGW 12035 n.a. NPC248970 "N-Acetyl-L-cysteine, acetylcysteine, 616-91-1, N-Acetylcysteine, mercapturic acid, Acetadote, L-Acetylcysteine, Broncholysin, Mucomyst, Fluimucetin, N-Acetyl-cysteine, Fluimucil, Parvolex, Respaire, Acetein, Flumucetin, Fluprowit, Airbron, Brunac, Fabrol, Mucosil, L-Cysteine, N-acetyl-, Fluimicil Infantil, N-Acetyl cysteine, Acetilcisteina, Acetylcysteinum, Mucosolvin, Syntemucol, Lysomucil, Mucofilin, acetyl cysteine, Inspir, Tixair, Mucolyticum Lappe, Mucolytikum Lappe, N-Acetyl-3-mercaptoalanine, (R)-2-Acetamido-3-mercaptopropanoic acid, Mucolyticum, Cetylev, Exomuc, Neo-fluimucil, Ac-Cys-OH, Cysteine, N-acetyl-, L-, Mucolyticum-Lappe, N-Acetyl-L-(+)-cysteine, NAC-TB, Acetyl-L-cysteine, component of Naxid, Mercapturic acid, (R)-, Fluatox, Fluimicil, LNAC, Mucolator, Flumil, Mucret, (R)-mercapturic acid, Muco sanigen, Oristar nalc, (2R)-2-acetamido-3-sulfanylpropanoic acid, MUCOSIL-10, MUCOSIL-20, N-acetyi-l-cysteine, L-alpha-Acetamido-beta-mercaptopropionic acid, CCRIS 3764, Mucocedyl, N-acetyl-(R)-cysteine, NSC 111180, UNII-WYQ7N0BPYC, WYQ7N0BPYC, HSDB 3003, EINECS 210-498-3, (2R)-2-Acetamido-3-sulfanyl-propanoic acid, Acetylcysteinum [INN-Latin], Acetilcisteina [INN-Spanish], Ilube (eye drops), N-A-C Sustain, NSC-111180, (r)-n-acetylcysteine, DTXSID5020021, CHEBI:28939, MFCD00004880, cysteine, N-acetyl-, RK-0202, DTXCID4021, MLS000028419, (R)-2-acetylamino-3-mercaptopropanoic acid, (2R)-2-acetylamino-3-sulfanylpropanoic acid, NSC111180, NCGC00022304-05, N-Acetyl-L-cysteine hydrochloride, SMR000058377, Acetylcysteine [USAN:USP:INN:BAN:JAN], ACETYLCYSTEINE (II), ACETYLCYSTEINE [II], Acetylcysteinum (INN-Latin), Acetilcisteina (INN-Spanish), ACETYLCYSTEINE (MART.), ACETYLCYSTEINE [MART.], ACETYLCYSTEINE (USP-RS), ACETYLCYSTEINE [USP-RS], Ilube, N-acetylcystein, ACETYLCYSTEINE (EP MONOGRAPH), ACETYLCYSTEINE [EP MONOGRAPH], N Acetylcysteine, ACETYLCYSTEINE (USP MONOGRAPH), ACETYLCYSTEINE [USP MONOGRAPH], Acid, Mercapturic, Acetylcysteine (USAN:USP:INN:BAN:JAN), CAS-616-91-1, N Acetyl L cysteine, N-Acetyl-N-Cysteine, SR-01000075439, Acetylcysteine Ph. Eur., DTXSID8048105, AcCys, N-acetyl-l-cys, Sodium 2-acetamido-3-mercaptopropionate, Tris-NAC, SC2, N-acetyl-L-cystein, Naxid (Salt/Mix), N-Acety-L-Cysteine, Acetyl Cysteine,(S), Acetylcysteine Injection, Opera_ID_452, MUCOMYST (TN), Spectrum2_000086, Spectrum3_000287, Spectrum4_000137, Spectrum5_000764, CHEMBL600, NAC & TNF, ACETYLCYSTEINE [MI], SCHEMBL5292, (2R)-2-(acetylamino)-3-sulfanylpropanoic acid, ACETYLCYSTEINE [INN], ACETYLCYSTEINE [JAN], Lopac0_000081, ACETYLCYSTEINE [HSDB], ACETYLCYSTEINE [USAN], BSPBio_001794, KBioGR_000554, MLS001076125, MLS006011563, ACETYLCYSTEINE [VANDF], SPECTRUM1500105, SPBio_000012, ACETYL CYSTEINE [INCI], ACETYLCYSTEINE [WHO-DD], Acetylcysteine(N-acetylcysteine), BRONCHOLYSIN (MUCOLYTIC), DTXCID6028076, CHEBI:22198, GTPL10945, KBio3_001294, N-Acetyl-L-cysteine, USP grade, R05CB01, S01XA08, V03AB23, Acetylcysteine (JP17/USP/INN), HMS1920A11, HMS2091G11, HMS2234J22, HMS3260A04, HMS3655G11, HMS3715D03, HMS3884E04, HY-B0215, 2-Acetylamino-3-mercapto-propionate, ACETYLCYSTEINE [ORANGE BOOK], Tox21_110877, Tox21_201078, Tox21_500081, acetylcysteine (n-acetyl-l-cysteine), BDBM50420190, CCG-38902, s1623, AKOS015841009, Tox21_110877_1, CCG-204176, DB06151, GS-3121, LP00081, SDCCGSBI-0050069.P002, (R)-2-Acetamido-3-mercaptopropanoicacid, NCGC00015086-04, NCGC00022304-03, NCGC00022304-04, NCGC00022304-06, NCGC00022304-07, NCGC00022304-08, NCGC00022304-17, NCGC00022304-21, NCGC00022304-23, NCGC00258631-01, NCGC00260766-01, AC-16071, AC-24117, BP-12854, SBI-0051272.P003, A0905, AM20100502, EU-0100081, NS00069131, SW199597-2, (2R)-2-acetylamino-3-mercapto-propionic acid, EN300-72028, A 7250, A-1100, C06809, D00221, L-Cysteine, N-acetyl- & Tumor necrosis factor, N-Acetyl-L-cysteine, BioXtra, >=99% (TLC), AB00051908_02, AB00382974-12, AB00382974_13, L-.alpha.-Acetamido-.beta.-mercaptopropionic acid, Q375613, J-507685, N-Acetyl-L-cysteine & Tumor necrosis factor (TNF), N-Acetyl-L-cysteine 100 microg/mL in Acetonitrile, SR-01000075439-1, SR-01000075439-3, SR-01000075439-5, BRD-K59058747-001-20-9, N-Acetyl-L-cysteine, cell culture tested, BioReagent, N-Acetyl-L-cysteine, Vetec(TM) reagent grade, 98%, F1905-7178, Z1143441555, CABC898A-E48B-4E13-9F72-98D0609A1854, N-Acetyl-L-cysteine, SAJ special grade, 98.0-102.0%, N-Acetyl-L-cysteine, Sigma Grade, >=99% (TLC), powder, Acetylcysteine, British Pharmacopoeia (BP) Reference Standard, Acetylcysteine, European Pharmacopoeia (EP) Reference Standard, Acetylcysteine, United States Pharmacopeia (USP) Reference Standard, N-Acetyl-L-cysteine, Pharmaceutical Secondary Standard; Certified Reference Material" C5H9NO3S PWKSKIMOESPYIA-BYPYZUCNSA-N (2R)-2-acetamido-3-sulfanylpropanoic acid Cumberland Pharmaceuticals Inc n.a. No No No No No No PMDBD2001017 NaCl Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. D04YZL 5234 n.a. n.a. "sodium chloride, 7647-14-5, Salt, Table salt, Halite, Saline, Common salt, Rock salt, Dendritis, Purex, Sodium chloric, Sodium chloride (NaCl), Flexivial, Gingivyl, Hyposaline, Sodium monochloride, Iodized salt, Slow Sodium, Top flake, SS salt, Adsorbanac, Natriumchlorid, Hypersal, Sea salt, NaCl, H.G. blending, Salt (ingredient), sodiumchloride, sodium;chloride, Trisodium trichloride, White crystal, Sodium chloride (Na4Cl4), Natrum Muriaticum, Extra Fine 200 Salt, Extra Fine 325 Salt, Sodium chloride brine, purified, Colyte, Isotonic saline, Broncho saline, Dendritic salt, Caswell No. 754, Normal saline, CCRIS 982, Arm-A-Vial, HSDB 6368, Kochsalz, Mafiron, cloruro sodico, EPA Pesticide Chemical Code 013905, natrii chloridum, Watesal A, chlorure de sodium, EINECS 231-598-3, Brinewate Superfine, NSC 77364, NSC-77364, UNII-451W47IQ8X, LS-1700, 14762-51-7, CHEBI:26710, 451W47IQ8X, Sodium chloride in plastic container, UNII-VR5Y7PDT5W, MFCD00003477, Sodium chloride, hypertonic, Sodium chloride 3% in plastic container, Sodium chloride 5% in plastic container, Sodium chloride [USP:JAN], Sodium chloride 0.9% in plastic container, 10% Sodium Chloride Injection, Sodium chloride 0.45% in plastic container, Sodium chloride 23.4% in plastic container, Ayr, SODIUM CHLORIDE ANHYDROUS, DTXSID3021271, SODIUM CHLORIDE, ANHYDROUS, Sodium chloride, for cell culture, EC 231-598-3, NSC77364, Sodium chloride 0.9% in sterile plastic container, Sodium chloride, for molecular biology, sterling, B1655, Sodium chloride, United States Pharmacopeia (USP) Reference Standard, Sodium chloride, ultra dry, Sodium chloride (USP:JAN), SODIUM CHLORIDE (II), SODIUM CHLORIDE [II], Sodium chloride (Na36Cl), SODIUM CHLORIDE (USP-RS), SODIUM CHLORIDE [USP-RS], Natriumchlorid [German], SODIUM CHLORIDE (EP MONOGRAPH), SODIUM CHLORIDE [EP MONOGRAPH], SODIUM CHLORIDE (USP MONOGRAPH), SODIUM CHLORIDE [USP MONOGRAPH], Halite (NaCl), Sodium chloride, meets analytical specification of Ph. Eur. BP USP, inverted exclamation markU0.00002% Al, Sodium chloride, ACS reagent, >=99.0%, Sodium-36 chloride, Athomer, Cleanoz, Isotonic, Licefreee, Nebusal, Pulmosal, Titrisol, Entsol, NasoxinSpray, sodium-chloride, Solsel, Octiq, Ancient Secrets, for spectroscopy, Sterile Saline, Walgreen Saline, Athomer Baby, Athomer Mini, Mineral Metea, Saline Wipes, Sea water, Athomer Propolis, Beanguard Gargle, Clear Mist, Normal Salt, Saline Mist, Stat trak plus, Walgreens Saline, Saline Nasal2oz, Saline Nasal3oz, Na-zone, Sel Gemme, Bye Zero, Aqua Maris Daily, Uzushio Biryuu M, Cardiovascular Kit, CVS Saline, Licefreee Everyday, Nat Mur, Natrium Muriaticum, TID Clean Align, TID Clean Plant, Adsorbanac (TN), Aqua Maris Strong, MEIJER Saline, TID Clean Care, TID Clean Dent, Amphenol-40, Aquamarine8105, Normal Salt Tablets, sodium chloride salt, Sterile Saline Mist, Saline Nasal1.5oz, Corvatrol 0.9%, 3% Sodium Chloride, Canners 999, Sodium Chloride ACS, sodium chloride spray, NaCl Solution, 1M, Nat Mur 3X, Nat Mur 6X, Extrafine 200 salt, Extrafine 325 salt, Natrum Muriaticum 6C, Saline Nasal1 fl oz, Walgreens Saline Mist, 32343-72-9, Sel Gemme8146, 0.9% saline, AQUA MARINA, Bye Bye (Toc Toc), Natrium Muriaticum 6X, Nat Mur 12X, Nat Mur 30X, SUPRASEL NITRITE, Homeopathic Pediculicide, Natrum muriaticum 30C, Vamousse Lice Treatment, Aqua Maris Daily Clean, Cleansing Wipe / Tube, P-Care K40MX, P-Care K80MX, Saline, sodium chloride, Sodium chloride, tablet, Nat Mur 200X, Natrum Muriaticum8009, TONICPET 9, Aqua Maris Extra Strong, Sodium chloride (8CI), Vamousse Lice Prevention, API AQUARIUM SALT, mono-sodium chloride salt, Muro 128, 0.9% nacl, Sodium chloride, isotonic, Sterile Saline Kids Mist, 7.5% Hypertonic Saline, Hypertonic Saline 7.2%, Sodium chloride 2.65%, Salt (6CI,7CI), Sodium Chloride 0.65%, Sodium ChlorideNormal Salt, VR5Y7PDT5W, API POND POND SALT, Special Salt 100/95, USP SODIUM CHLORIDE, Extra Strenght Saline Mist, Nacl 0.9%, WLN: NA G, Hypertonic Saline 7.2 %, VetivexVeterinary Hypertonic, SDG high level disinfectant, Ancient SecretsBreathe Again, Cardiovascular Accessory Kit, Sterile Saline MistRite Aid, Sterile Saline MistWalgreens, Vamousse Pro Lice Treatment, Natrum Muriaticum Kit Refill, Sodium Chloride Hypertonicity, SODIUM CHLORIDE [MI], SODIUM CHLORIDE1 GRAM, NATRUM MURIATICUM200ck, Sodium chloride, ACS reagent, Sykes 0.9% Sodium Chloride, B1655 [LANGUAL], SODIUM CHLORIDE [JAN], Sodium Chloride for Irrigation, Sodium chloride, 99.999%, 0.9% SODIUM CHLORIDE, RNS60 COMPONENT SALINE, Sodium chloride (JP17/USP), SODIUM CHLORIDE [HSDB], SODIUM CHLORIDE [INCI], Sodium chloride, Optical Grade, Chlorine-containing disinfectant, DTXCID001271, Sykes Hypertonic Saline 7.2%, SinuCleanse Sterile Saline Mist, SODIUM CHLORIDE [VANDF], Bacteriostatic sodium chloride 0.9% in plastic container, CHEMBL1200574, NATRUM MURIATICUM [HPUS], RNS-60 COMPONENT SALINE, HY-Y0344D, HY-Y0344H, HY-Y0344I, HY-Y0344J, Isotonic sodium chloride solution, SODIUM CHLORIDE 23.4%, Sodium chloride biochemical grade, 7647-14-5 (solid), SODIUM CHLORIDE [WHO-DD], SODIUM CHLORIDE [WHO-IP], Sterile Saline Kids MistPediaMeds, Veterinary 0.9% Sodium Chloride, VETIVEXVeterinary Sodium Chloride, Extra Strenght Saline MistRite Aid, Sodium chloride, AR, >=99.9%, Sodium chloride, LR, >=99.5%, Sodium chloride, Spectroscopy Grade, STR02627, Walgreens Saline MistExtra Strength, Haemonetics 0.9 % Sodium Chloride, Sodium chloride, MANAC Incorporated, SODIUM CHLORIDE [GREEN BOOK], Sodium chloride, >=99%, AR grade, Vamousse Lice Treatment Complete Kit, SODIUM CHLORIDE [ORANGE BOOK], AKOS024438089, AKOS024457457, Alfa Veterinary 0.9% Sodium Chloride, SODIUM CHLORIDE, BACTERIOSTATIC, USEPA/OPP Pesticide Code: 13905, DB09153, Sodium chloride, technical grade, 95%, Sodium chloride, technical grade, 97%, Altachlore Sodium Chloride Hypertonicity, NATRII CHLORIDUM [WHO-IP LATIN], Sodium Chloride Hypertonicity Ophthalmic, Sodium chloride, Ph. Eur., USP grade, Sodium chloride, p.a., 99-100.5%, SinuCleanse Sterile Saline Mist Daily Care, Sodium chloride, NIST(R) SRM(R) 919b, Sodium chloride, ReagentPlus(R), >=99%, Sodium chloride, USP, 99.0-100.5%, Sodium chloride, USP, 99.0-101.0%, Sterile Saline Kids MistSinuCleanse Breathe, CS-0376163, CS-0909801, CS-0909802, CS-0909803, NS00076259, Q2314, S0572, Sodium chloride, BioXtra, >=99.5% (AT), Sodium chloride, SAJ first grade, >=99.0%, Sodium chloride, tested according to Ph.Eur., D02056, Sodium chloride, 99.999% trace metals basis, Sodium chloride, JIS special grade, >=99.5%, Sodium chloride, Trace metals grade, 99.99%, Isotopic standard for chlorine, NIST SRM 975a, Sodium chloride, Vetec(TM) reagent grade, 99%, Sodanylium and hydrochloric acid, ion(1-) (1:1), Sodium chloride, puriss. p.a., >=99.5% (AT), Sodium chloride, NIST(R) SRM(R) 2201, ion-selective, Sodium chloride crystal optic disc, 25mm x 5mm, unpolished, Sodium chloride crystal optic disc, 13mm x 1mm, polished both sides, Sodium chloride crystal optic disc, 13mm x 2mm, polished both sides, Sodium chloride crystal optic disc, 22mm x 4mm, polished both sides, Sodium chloride crystal optic disc, 25mm x 2mm, polished both sides, Sodium chloride crystal optic disc, 25mm x 4mm, polished both sides, Sodium chloride crystal optic disc, 32mm x 3mm, polished both sides, Sodium chloride, BioUltra, for molecular biology, >=99.5% (AT), Sodium chloride, puriss. p.a., >=99.5% (AT), powder or crystals, Sodium chloride, reagent grade, >=98%, +80 mesh particle size, Sodium standard for AAS, ready-to-use, traceable to BAM, in H2O, Sodium chloride crystal optic rectangle, 38.5mm x 19.5mm x 4mm, unpolished, Sodium chloride crystal optic rectangle, 41mm x 23mm x 6mm, unpolished, Sodium chloride, anhydrous, beads, -10 mesh, 99.99% trace metals basis, Sodium chloride, anhydrous, beads, -10 mesh, 99.999% trace metals basis, Sodium chloride, p.a., ACS reagent, reag. ISO, reag. Ph. Eur., 99.5%, Sodium chloride, random crystals, optical grade, 99.98% trace metals basis, SODIUM CHLORIDE 0.9% IN PLASTIC THERMOJECT KIT FOR CARDIAC OUTPUT USE, Sodium chloride crystal optic disc, 32mm x 3mm (drilled), polished both sides, Sodium chloride crystal optic rectangle, 30mm x 15mm x 4mm (drilled), polished both sides, Sodium chloride crystal optic rectangle, 30mm x 15mm x 4mm, polished both sides, Sodium chloride crystal optic rectangle, 38.5mm x 19.5mm x 4mm, polished both sides, Sodium chloride, anhydrous, free-flowing, Redi-Dri(TM), ReagentPlus(R), >=99%, Sodium chloride, anhydrous, Redi-Dri(TM), free-flowing, ACS reagent, >=99%, Sodium chloride, BioPerformance Certified, >=99% (titration), Cell Culture Tested, Sodium chloride, meets analytical specification of Ph. Eur., BP, USP, 99.0-100.5%, Sodium chloride, Pharmaceutical Secondary Standard; Certified Reference Material, Sodium chloride, puriss. p.a., ACS reagent, reag. ISO, reag. Ph. Eur., >=99.5%, Sodium chloride crystal optic rectangle, 38.5mm x 19.5mm x 4mm (drilled), polished both sides, Sodium chloride, BioReagent, suitable for cell culture, suitable for insect cell culture, suitable for plant cell culture, >=99%, Sodium chloride, certified reference material for titrimetry, certified by BAM, according to ISO 17025, >=99.5%, Sodium chloride, for molecular biology, DNase, RNase, and protease, none detected, >=98% (titration)" ClNa FAPWRFPIFSIZLT-UHFFFAOYSA-M "sodium;chloride" n.a. n.a. No No No No No No PMDBD2001018 Nafcillin Therapeutic Substance Approved Drug 147-52-4 DB00607 PA450576 D08242 D0A0JH 8982 8634 n.a. nafcillin, Naphcillin, 147-52-4, Nafcilina, Nafcilline, Nafcillinum, Nallpen, Nafcilin-1, Unipen, (2-Ethoxy-1-naphthyl)penicillin, Nafcilina [INN-Spanish], Nafcilline [INN-French], Nafcillinum [INN-Latin], (2-ethoxy-1-naphthalenyl)penicillin, CHEBI:7447, Nafcillin sodium salt, HSDB 3133, Penicillin, (2-ethoxy-1-naphthalenyl)-, UNII-4CNZ27M7RV, (2S,5R,6R)-6-[(2-ethoxynaphthalene-1-carbonyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, EINECS 205-690-9, 4CNZ27M7RV, 6-(2-ethoxy-1-naphthamido)penicillanic acid, Nafcillin (INN), Penicillin, (2-ethoxy-1-naphthyl)-, BRN 0862393, 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(((2-ethoxy-1-naphthalenyl)carbonyl)amino)-3,3-dimethyl-7-oxo-, (2S-(2alpha,5alpha,6beta))-, DTXSID8023343, Naphthamidopenicillin, 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(2-ethoxy-1-naphthamido)-3,3-dimethyl-7-oxo-, NAFCILLIN [INN], Nafcilina (INN-Spanish), Nafcilline (INN-French), Nafcillinum (INN-Latin), Nafcillin [INN:BAN], 6beta-(2-ethoxynaphthalene-1-carboxamido)-2,2-dimethylpenam-3alpha-carboxylic acid, (2S,5R,6R)-6-(2-ethoxynaphthalene-1-amido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, (2S,5R,6R)-6-{[(2-ethoxynaphthalen-1-yl)carbonyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, (2s,5r,6r)-6-[(2-ethoxy-1-naphthoyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 4-THIA-1-AZABICYCLO(3.2.0)HEPTANE-2-CARBOXYLIC ACID, 6-(((2-ETHOXY-1-NAPHTHALENYL)CARBONYL)AMINO)-3,3-DIMETHYL-7-OXO-, (2S,5R,6R)-, 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 6-[[(2-ethoxy-1-naphthalenyl)carbonyl]amino]-3,3-dimethyl-7-oxo-, (2S,5R,6R)-, nafcillina, (2S,5R,6R)-6-(((2-ethoxynaphthalen-1-yl)carbonyl)amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, (2S,5R,6R)-6-((2-ethoxy-1-naphthoyl)amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, (2S,5R,6R)-6-((2-ethoxynaphthalene-1-carbonyl)amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, Nafcillin, Antibiotic for Culture Media Use Only, NAFCILLIN [MI], NAFCILLIN [HSDB], Prestwick0_000843, Prestwick1_000843, Prestwick2_000843, Prestwick3_000843, NAFCILLIN [VANDF], Epitope ID:141583, NAFCILLIN [WHO-DD], CHEMBL1443, SCHEMBL47797, BSPBio_000825, SPBio_002746, BPBio1_000909, DTXCID303343, GTPL10942, J01CF06, Ethoxynaphthamido Penicillin Sodium, BCP17447, HY-B0555, BDBM50103525, AKOS040744845, DB00607, (2S,5R,6R)-6-({[2-(ethyloxy)naphthalen-1-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, CS-0009511, C07250, D08242, EN300-24433472, Q1638852, W-108115, BRD-K18574842-323-03-3, (2S,5R,6R)-6-(2-ethoxy-1-naphthamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, (2S-(2.ALPHA.,5.ALPHA.,6.BETA.))-6-(((2-ETHOXY-L-NAPHTHALENYL)CARBONYL)-AMINO)-3,3-DIMETHYL-7-OXO-4-THIA-1-AZABICYCLO(3.2.0)HEPTANE-2-CARBOXYLIC ACID, (2S-(2alpha,5alpha,6beta))-6-(((2-ETHOXY-L-NAPHTHALENYL)CARBONYL)-AMINO)-3,3-DIMETHYL-7-OXO-4-THIA-1-AZABICYCLO(3.2.0)HEPTANE-2-CARBOXYLIC ACID, 4-THIA-1-AZABICYCLO(3.2.0)HEPTANE-2-CARBOXYLIC ACID, 6-(((2-ETHOXY-1-NAPHTHALENYL)CARBONYL)AMINO)-3,3-DIMETHYL-7-OXO-, (2S/// C21H22N2O5S GPXLMGHLHQJAGZ-JTDSTZFVSA-N (2S,5R,6R)-6-[(2-ethoxynaphthalene-1-carbonyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid n.a. Antibiotics No No No No No No PMDBD2001019 Na-Propionate n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001020 Na-Pyrosulfite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001021 N-Decanoyl cyclopentylamide n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001022 N-decanoyl-L- homoserine benzyl ester n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001023 Nelfinavir Therapeutic Substance n.a. 159989-64-7 DB00220 PA450606 D08259 n.a. 64143 57718 n.a. "nelfinavir, 159989-64-7, Viracept, Viracept (TN), UNII-HO3OGH5D7I, HO3OGH5D7I, Nelfinavir (INN), NSC-747167, AG-1343, CHEBI:7496, (3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-phenylsulfanylbutyl]-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinoline-3-carboxamide, CHEMBL584, (3S-(2(2S*,3S*),3alpha,4abeta,8abeta))-N-(1,1-Dimethylethyl)decahydro-2-(2-hydroxy-3-((3-hydroxy-2-methylbenzoyl)amino)-4-(phenylthio)butyl)-3-isoquinolinecarboxamide, DTXSID5035080, NSC 747167, (3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylphenyl)formamido]-4-(phenylsulfanyl)butyl]-decahydroisoquinoline-3-carboxamide, 1UN, 2-[2-HYDROXY-3-(3-HYDROXY-2-METHYL-BENZOYLAMINO)-4-PHENYL SULFANYL-BUTYL]-DECAHYDRO-ISOQUINOLINE-3-CARBOXYLIC ACID TERT-BUTYLAMIDE, N-(1,1-Dimethylethyl)decahydro-2-(2-hydroxy-3-((3-hydroxy-2-methylbenzoyl)amino)-4-(phenylthio)butyl)-3-isoquinolinecarboxamide (3S-(2(2S*,3S*),3alpha,4abeta,8abeta))-, NLF, NELFINAVIR [INN], Nelfinavir [INN:BAN], NFV, (3S,4aS,8aS)-N-(tert-Butyl)-2-((2R,3R)-2-hydroxy-3-(3-hydroxy-2-methylbenzamido)-4-(phenylthio)butyl)decahydroisoquinoline-3-carboxamide, 3-Isoquinolinecarboxamide, N-(1,1-dimethylethyl)decahydro-2-((2R,3R)-2-hydroxy-3-((3-hydroxy-2-methylbenzoyl)amino)-4-(phenylthio)butyl)-, (3S,4aS,8aS)-, 3-Isoquinolinecarboxamide, N-(1,1-dimethylethyl)decahydro-2-(2-hydroxy-3-((3-hydroxy-2-methylbenzoyl)amino)-4-(phenylthio)butyl)-, (3S-(2-(2S*,3S*),3-alpha,4a-beta,8a-beta))-, CHEMBL1205, AG1341, (3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methyl-benzoyl)amino]-4-phenylsulfanyl-butyl]-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinoline-3-carboxamide, 3-Isoquinolinecarboxamide, N-(1,1-dimethylethyl)decahydro-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylthio)butyl]-, (3S,4aS,8aS)-, SMR000596515, NSC722664, NCGC00090782-03, NELFINAVIR MESYLATE AG1343, nelfinavirum, Nelfinavir?, Met-SDF-1.beta. & Nelfinavir, 1ohr, (3S,4aS,8aS)-N-tert-butyl-2-((2R,3R)-2-hydroxy-3-((3-hydroxy-2-methylbenzoyl)amino)-4-(phenylsulfanyl)butyl)decahydroisoquinoline-3-carboxamide, (3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylsulfanyl)butyl]decahydroisoquinoline-3-carboxamide, NELFINAVIR [MI], NELFINAVIR [VANDF], NELFINAVIR [WHO-DD], BIDD:PXR0143, SCHEMBL38218, BDBM518, MLS001195634, MLS001304729, BIDD:GT0395, NELFINAVIR [EMA EPAR], DTXCID3015080, GTPL11090, J05AE04, QAGYKUNXZHXKMR-HKWSIXNMSA-N, HMS2232I04, Met-Stromal Cell-derived Factor-1.beta. (Human) & Nelfinavir, BDBM50061306, MFCD01938163, NSC747167, AKOS000280862, AM84529, CS-0677, DB00220, MRF-0000208, NCGC00090782-04, NCGC00090782-05, NCGC00090782-17, AC-20032, AS-75258, HY-15287, NS00003195, C07257, C73027, D08259, AB00698259-15, A810095, A810096, EN300-18530973, Q423366, (3S, 4aS, 8aS)-2-[(2R, 3R)-2-Hydroxy-3-(3-hydroxy-2-methyl-benzoylamino)-4-phenylthiobutyl]decahydroisoquinoline-3-carboxylic acid t-butylamide, (3S, 4aS, 8aS)-2-[(2R, 3R)-2-hydroxy-3-(3-hydroxy-2-methylbenzoylamino)-4-phenylthiobutyl]decahydroisoquinoline-3-carboxylic acid t-butylamide, (3S,4aS,8aS)-2-[(2R,3R)-2-Hydroxy-3-(3-hydroxy-2-methyl-benzoylamino)-4-phenylsulfanyl-butyl]-decahydro-isoquinoline-3-carboxylic acid tert-butylamide; compound with methanesulfonic acid, (3S,4aS,8aS)-2-[(2R,3R)-2-hydroxy-3-(3-hydroxy-2-methylbenzoylamino)-4-phenylthiobutyl]decahydroisoquinoline-3-carboxylic acid t-butylamide, (3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-[[(3-hydroxy-2-methylphenyl)-oxomethyl]amino]-4-(phenylthio)butyl]-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinoline-3-carboxamide, (3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-{[(3-hydroxy-2-methylphenyl)carbonyl]amino}-4-(phenylsulfanyl)butyl]decahydroisoquinoline-3-carboxamide, (3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-3-[(2-methyl-3-oxidanyl-phenyl)carbonylamino]-2-oxidanyl-4-phenylsulfanyl-butyl]-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinoline-3-carboxamide, 3-Isoquinolinecarboxamide, N-(1,1-dimethylethyl)decahydro-2- [(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylthio)butyl]-, (3S,4aS,8aS)-, 3-Isoquinolinecarboxamide,1-dimethyl ethyl)decahydro-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylthio)butyl]-, (3S,4aS,8aS)-, 3-Isoquinolinecarboxamide,1-dimethylethyl)decahydro-2-[2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylthio)butyl]-, [3S-[2(2S*,3S*),3.alpha.,4a.beta.,8a.beta.]]-, N-(tert-Butyl)-2-(2-hydroxy-3-(3-hydroxy-2-methylbenzamido)-4-(phenylthio)butyl)decahydroisoquinoline-3-carboxamide" C32H45N3O4S QAGYKUNXZHXKMR-HKWSIXNMSA-N (3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-phenylsulfanylbutyl]-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinoline-3-carboxamide n.a. n.a. No No No No No No PMDBD2001024 Neoeriocitrin n.a. n.a. n.a. n.a. n.a. n.a. n.a. 114627 n.a. NPC291124 "Neoeriocitrin, 13241-32-2, Eriodictyol 7-O-neohesperidoside, eriodictyol-7-neohesperidoside, Eriodictyol 7-neohesperidoside, CHEMBL3609603, Eriodictyol-7-O-neohesperidoside, (S)-7-(((2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-(((2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)-2-(3,4-dihydroxyphenyl)-5-hydroxychroman-4-one, AC1L3FPQ, Isoeriocitrin, EINECS 236-215-3, SureCN7203878, (2S)-7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-2-(3,4-dihydroxyphenyl)-5-hydroxy-2,3-dihydrochromen-4-one, CHEBI:7502, MEGxp0_001062, SCHEMBL7203878, Neoeriocitrin, ~95% (HPLC), ACon1_000964, DTXSID70157530, (S)-3'',4'',5,7-Tetrahydroxyflavanone-7-[2-O-(alpha-L-rhamnopyranosyl)-beta-D-glucopyranoside], EX-A6775, HY-N4119, BDBM50597717, AKOS037514509, FS-7651, NCGC00169807-01, 1ST40164, Neoeriocitrin, analytical reference material, CS-0032132, NS00024212, C09805, J-006173, BRD-K49062828-001-01-6, Q13564785, Neoeriocitrineriodictyol-7-neohesperidoside; Eriodictyol 7-neohesperidoside, (2S)-2-(3,4-dihydroxyphenyl)-5-hydroxy-4-oxo-3,4-dihydro-2H-1-benzopyran-7-yl 2-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoside, (2S)-7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-tetrahydropyran-2-yl]oxy-2-(3,4-dihydroxyphenyl)-5-hydroxy-chroman-4-one, (S)-7-((2-O-(6-Deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl)oxy)-2-(3,4-dihydroxyphenyl)-2,3-dihydro-5-hydroxy-4H-benzopyran-4-one, 7-[4,5-dihydroxy-6-(hydroxymethyl)-3-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxy-2-(3,4-dihydroxyphenyl)-5-hydroxy-2,3-dihydrochromen-4-one" C27H32O15 OBKKEZLIABHSGY-DOYQYKRZSA-N (2S)-7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-2-(3,4-dihydroxyphenyl)-5-hydroxy-2,3-dihydrochromen-4-one n.a. n.a. No No No No Yes No rxnAddEX3 PMDBD2001025 Neohesperidin n.a. n.a. n.a. n.a. n.a. n.a. n.a. 442439 n.a. NPC105095 Neohesperidin, 13241-33-3, Hesperetin-7-neohesperidoside, Hesperetin 7-O-neohesperidoside, OA5C88H3L0, (S)-7-(((2-O-6-Deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl)oxy)-2,3-dihydro-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-one, CHEBI:59016, NSC 31048, (2S)-7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-2,3-dihydrochromen-4-one, (S)-7-(((2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-(((2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one, (2S)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4-oxo-3,4-dihydro-2H-chromen-7-yl 2-O-(alpha-L-rhamnopyranosyl)-beta-D-glucopyranoside, 4H-1-Benzopyran-4-one, 7-[[2-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl]oxy]-2,3-dihydro-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-, (2S)-, NSC-31048, Neohesperidin, >=90%, (2S)-NEOHESPERIDIN, NEOHESPERIDIN [INCI], UNII-OA5C88H3L0, SCHEMBL121675, NEOHESPERIDIN [USP-RS], CHEMBL506398, FEMA NO. 4799, DTXSID60927668, Neohesperidin, analytical standard, HY-N0101, EINECS 236-216-9, AKOS015899387, CS-6413, BRN 0074945, SMP1_000209, 1ST40166, AS-75238, XH161790, C09806, 5-18-05-00219 (Beilstein Handbook Reference), Q18609455, 8-HYDROXYQUINOLINE-2-CARBOXALDEHYDE8-QUINOLYLHYDRAZONE, Neohesperidin, United States Pharmacopeia (USP) Reference Standard, (2S)-7-{[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-3,4-dihydro-2H-1-benzopyran-4-one, 4H-1-Benzopyran-4-one, 2,3-dihydro-7-((2-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl)oxy)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-, (S)-, 4H-1-BENZOPYRAN-4-ONE, 7-((2-O-(6-DEOXY-.ALPHA.-L-MANNOPYRANOSYL)-.BETA.-D-GLUCOPYRANOSYL)OXY)-2,3-DIHYDRO-5-HYDROXY-2-(3-HYDROXY-4-METHOXYPHENYL)-, (2S)-, 4H-1-BENZOPYRAN-4-ONE, 7-((2-O-(6-DEOXY-.ALPHA.-L-MANNOPYRANOSYL)-.BETA.-D-GLUCOPYRANOSYL)OXY)-2,3-DIHYDRO-5-HYDROXY-2-(3-HYDROXY-4-METHOXYPHENYL)-, (S)-, 4H-1-Benzopyran-4-one, 7-((2-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl)oxy)-2,3-dihydro-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-, (S)-, FLAVANONE, 3'',5,7-TRIHYDROXY-4''-METHOXY-, 7-(2-O-.ALPHA.-L-RHAMNOPYRANOSYL-.BETA.-D-GLUCOPYRANOSIDE) C28H34O15 ARGKVCXINMKCAZ-UZRWAPQLSA-N (2S)-7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-2,3-dihydrochromen-4-one n.a. n.a. No No No No Yes No rxnDiet166 PMDBD2001026 Nerolidol n.a. n.a. n.a. n.a. n.a. n.a. n.a. 5284507 n.a. NPC51758 NEROLIDOL, trans-Nerolidol, 7212-44-4, 40716-66-3, 3,7,11-Trimethyldodeca-1,6,10-trien-3-ol, (6E)-3,7,11-trimethyldodeca-1,6,10-trien-3-ol, (E)-3,7,11-Trimethyldodeca-1,6,10-trien-3-ol, 3,7,11-Trimethyl-1,6,10-dodecatrien-3-ol, Nerolidol trans-form, FCI 119b, Peruviol, Stirrup, 1,6,10-Dodecatrien-3-ol, 3,7,11-trimethyl-, (6E)-, (+)-Nerolidol, (6E)-nerolidol, 3-Hydroxy-3,7,11-trimethyl-1,6,10-dodecatriene, (E)-nerolidol, FG5V0N8P2H, 1,6,10-Dodecatrien-3-ol, 3,7,11-trimethyl-, DTXSID2040783, Methylvinylhomogeranyl carbinol, (3s)-3,7,11-trimethyldodeca-1,6,10-trien-3-ol, FEMA No. 2772, NCGC00095837-01, (.+/-.)-Nerolidol, EINECS 230-597-5, EPA Pesticide Chemical Code 128910, BRN 1724135, UNII-QR6IP857S6, trans nerolidol, AI3-10519, CCRIS 7678, 1,6,10-Dodecatrien-3-ol, 3,7,11-trimethyl-, (E)-, MFCD00008911, Nerolidol (E), EC 230-597-5, 3,7,11-Trimethyl-1,6,10-dodecatriene-3-ol, 3-01-00-02042 (Beilstein Handbook Reference), CHEBI:7524, DTXCID602247, QR6IP857S6, UNII-FG5V0N8P2H, FEMA 2772, Humbertiol, E-Nerolidol, .beta.-Nerolidol, .alpha.-Nerolidol, EINECS 255-053-4, Spectrum5_000460, .+/-.-trans-Nerolidol, NEROLIDOL, TRANS-, Nerolidol (cis and trans), (6E)-(+/-)-nerolidol, BSPBio_002958, CHEMBL25424, SCHEMBL114136, SPECTRUM1502251, DTXCID0020783, CHEBI:141283, NEROLIDOL TRANS-FORM [MI], HY-N1944, HY-N6635, Tox21_111527, Tox21_301382, trans-Nerolidol, analytical standard, CCG-38883, s5345, AKOS015902890, AKOS025310880, SDCCGMLS-0066709.P001, NEROLIDOL, (6E)-(+/-)-, NCGC00095837-02, NCGC00095837-03, NCGC00255198-01, 1ST40226, 35944-21-9, AS-16074, AS-75500, CAS-7212-44-4, 1ST168607, CAS-40716-66-3, CS-0018255, CS-0044197, N0454, NS00004499, A917868, Q415421, SR-05000002467, Q-201460, SR-05000002467-1, W-110939, (6E)-3,7,11-Trimethyl-1,6,10-dodecatrien-3-ol, trans-3,7,11-trimethyl-dodeca-1,6,10-trien-3-ol, trans-Nerolidol, primary pharmaceutical reference standard, (E)-3,7,11-Trimethyl-1,6,10-dodecatrien-3-ol, trans-3,7,11-Trimethyl-1,6,10-dodecatrien-3-ol C15H26O FQTLCLSUCSAZDY-SDNWHVSQSA-N (6E)-3,7,11-trimethyldodeca-1,6,10-trien-3-ol n.a. n.a. No No No No No No PMDBD2001027 N-Ethylacetanilide n.a. n.a. n.a. n.a. n.a. n.a. n.a. 10727 n.a. n.a. N-Ethylacetanilide, N-Ethyl-N-phenylacetamide, 529-65-7, Mannol, Ethylacetanilide, Acetamide, N-ethyl-N-phenyl-, Acetethylanilide, ACETANILIDE, N-ETHYL-, ACETYL-N-ETHYLANILIDE, NSC 8737, EINECS 208-466-9, BRN 2208178, AI3-05523, N-ethyl-acetanilide, N-ethyl-N-phenyl-acetamide, WLN: 2NR&V1, SCHEMBL1333185, DTXSID1060186, FSSVIYSWRLKICW-UHFFFAOYSA-, NSC8737, NSC-8737, AKOS003277540, CS-0258619, NS00032627, EN300-706202, G32390, Z58324632, InChI=1/C10H13NO/c1-3-11(9(2)12)10-7-5-4-6-8-10/h4-8H,3H2,1-2H3 C10H13NO FSSVIYSWRLKICW-UHFFFAOYSA-N N-ethyl-N-phenylacetamide n.a. n.a. No No No No No No PMDBD2001028 Netilmicin Therapeutic Substance Approved Drug 56391-56-1 DB00955 PA164754913 D08268 D07JZF 441306 n.a. n.a. netilmicin, 1-N-Ethylsisomicin, 56391-56-1, Netira, NETILMICIN SULFATE, Nettacin, Netilmicin (INN), 4O5J85GJJB, Netilmicina, Netilmicine, Netilmicinum, NSC-759586, NTL, 1-N-Aethylsisomicin, Netilyn, Vectacin, NETILMICIN [INN], Netilmicin [INN:BAN], 56391-57-2, Netilmicine [INN-French], Netilmicinum [INN-Latin], Netilmicina [INN-Spanish], (2R,3R,4R,5R)-2-[(1S,2S,3R,4S,6R)-4-amino-3-[[(2S,3R)-3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yl]oxy]-6-(ethylamino)-2-hydroxy-cyclohexoxy]-5-methyl-4-(methylamino)tetrahydropyran-3,5-diol, Netira (TN), UNII-4O5J85GJJB, HSDB 3584, Netilmicin,(S), EINECS 260-146-8, BRN 5316582, NETILMICIN [MI], Prestwick3_001101, NETILMICIN [HSDB], NETILMICIN [VANDF], CHEMBL1572, NETILMICIN [WHO-DD], BSPBio_001202, (2R,3R,4R,5R)-2-[(1S,2S,3R,4S,6R)-4-amino-3-[[(2S,3R)-3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yl]oxy]-6-(ethylamino)-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol, O-(2,6-Diamino-2,3,4,6-tetradesoxy-alpha-glycero-4-hexenopyranosyl-(1-4)-O-(3-desoxy-4-C-methyl-3-methylamino-beta-L-arabinopyranosyl-(1-6)-2-desoxy-N1-ethyl-D-streptamin, BPBio1_001324, DTXSID1048542, SCHEMBL18763322, GTPL12159, BDBM50470664, 2-hydroxycyclohexyloxy)-5-methyl-4-, DB00955, NSC 759586, NCGC00179265-01, NCGC00179265-05, NCGC00179265-08, (methylamino)tetrahydro-2H-pyran-3,5-diol, AB00514048, NS00004708, C07657, D08268, amino-3-((2S,3R)-3-amino-6-(aminomethyl)-, EN300-7481433, 3,4-dihydro-2H-pyran-2-yloxy)-6-(ethylamino)-, Q2553496, (2R,3R,4R,5R)-2-((1S,2S,3R,4S,6R)-4-, (2R,3R,4R,5R)-2-{[(1S,2S,3R,4S,6R)-4-amino-3-{[(2S,3R)-3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yl]oxy}-6-(ethylamino)-2-hydroxycyclohexyl]oxy}-5-methyl-4-(methylamino)oxane-3,5-diol, D-STREPTAMINE, O-3-DEOXY-4-C-METHYL-3-(METHYLAMINO)- .BETA.-L-ARABINOPYRANOSYL-(1->6)-O-(2,6-DIAMINO-2,3,4,6-TETRADEOXY-.ALPHA.-D-GLYCERO-HEX-4-ENOPYRANOSYL-(1->4))-2-DEOXY-N(SUP 1)-ETHYL-, D-Streptamine, O-3-deoxy-4-C-methyl-3-(methylamino)-.beta.-L-arabinopyranosyl-(1->6)-O-[2,6-diamino-2,3,4,6-tetradeoxy-.alpha.-D-glycero-hex-4-enopyranosyl-(1->4)]-2-deoxy-N1-ethyl-, D-Streptamine, O-3-deoxy-4-C-methyl-3-(methylamino)-beta-L-arabinopyranosyl(1-6)-O-(2,6-diamino-2,3,4,6-tetradeoxy-alpha-D-glycero-hex-4-enopyranosyl(1-4))-2-deoxy-N(sup 1)-ethyl-, D-Streptamine, O-3-deoxy-4-C-methyl-3-(methylamino)-beta-L-arabinopyranosyl-(1-6)-O-(2,6-diamino-2,3,4,6-tetradeoxy-alpha-D-glycero-hex-4-enopyranosyl-(1-4))-2-deoxy-N1-ethyl-, O-3-DEOXY-4-C-METHYL-3-(METHYLAMINO)-.BETA.-L-ARABINOPYRANOSYL-(1->4)-O-(2,6-DIAMINO-2,3,4,6-TETRADEOXY-.ALPHA.-D-GLYCERO-HEX-4-ENOPYRANOSYL-(1->6))-2-DEOXY-N(SUP 3)-ETHYL-L-STREPTAMINE C21H41N5O7 CIDUJQMULVCIBT-MQDUPKMGSA-N (2R,3R,4R,5R)-2-[(1S,2S,3R,4S,6R)-4-amino-3-[[(2S,3R)-3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yl]oxy]-6-(ethylamino)-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol Abbott Laboratories Antibiotics No No No No No No PMDBD2001029 n-Hexane n.a. n.a. n.a. n.a. n.a. n.a. n.a. 8058 n.a. NPC150271 "HEXANE, n-Hexane, 110-54-3, Esani, Gettysolve-B, Skellysolve B, Hexyl hydride, hexan, Dipropyl, Hexanen, Heksan, 92112-69-1, normal-hexane, Normal hexane, NCI-C60571, HSDB 91, NSC 68472, CCRIS 6247, CHEBI:29021, EINECS 203-777-6, UNII-2DDG612ED8, 2DDG612ED8, DTXSID0021917, AI3-24253, NSC-68472, n-C6H14, DTXCID001917, CH3-[CH2]4-CH3, EC 203-777-6, NSC68472, HEXANE (II), HEXANE [II], n-Hexan, N-HEXANE (MART.), N-HEXANE [MART.], Butane, ethyl-, Esani [Italian], Heksan [Polish], Hexanen [Dutch], HEXANES, MIXTURE OF ISOMERS, FOR SPECTROSCOPY, Hexane, for HPLC, >=95%, CH3-(CH2)4-CH3, MFCD00009520, 1-hexane, Hexane; NSC 68472; Skellysolve B; n-Hexane, UN1208, Senofilcon C, HexH, Hexane, for HPLC, Hexane, p.a., n-Hexane, anhydrous, Hexane (DOT), n-Hexane, p.a., n-Hexane HPLC grade, 68476-44-8, n-Hexane, ACS grade, Hexane Fraction, purum, Hexane, technical grade, n-Hexane, HPLC Grade, HEXANE [INCI], HEXANE [USP-RS], N-HEXANE [HSDB], HEXANE (N), Hexane, anhydrous, 95%, N-HEXANE [MI], Epitope ID:116866, Exxsol Hexane (Salt/Mix), Hexane, analytical standard, Hexane, p.a., 95%, 2CE3AJR3M4, SENOFILCON C [USAN], Hexane, AR, >=99%, WLN: 6H, Hexane, ACS reagent, 99%, CHEMBL15939, n-Hexane, Environmental grade, Hexane, p.a., 95.0%, Hexane, for HPLC, >=99%, Hexane, purification grade, 95%, n-Hexane, Spectrophotometric Grade, AMY22305, Hexane, ReagentPlus(R), >=99%, Hexane, puriss., >=95% (GC), Tox21_200777, LMFA11000007, Hexane, Laboratory Reagent, >=95%, Hexane, purum, >=98.0% (GC), n-Hexane 100 microg/mL in Methanol, AKOS000269046, Hexane, UV HPLC spectroscopic, 97%, Hexane, SAJ first grade, >=95.0%, n-Hexane 1000 microg/mL in Methanol, Hexane, JIS special grade, >=96.0%, Hexanes [UN1208] [Flammable liquid], NCGC00248828-01, NCGC00258331-01, CAS-110-54-3, Hexane, for HPLC, >=97.0% (GC), Hexane, spectrophotometric grade, >=95%, H0394, H0405, H0490, H1197, Hexane, suitable for determination of dioxins, NS00003550, A802211, Q150440, J-002443, Hexane, Vetec(TM) reagent grade, anhydrous, >=95%, Hexane, puriss. p.a., ACS reagent, >=99.0% (GC), 680AF2EE-A7B6-479B-BFB3-0F5354069F72, Hexane, >=96.0%, suitable for residual phthalate analysis, InChI=1/C6H14/c1-3-5-6-4-2/h3-6H2,1-2H, n-Hexane, 95% min. glass distilled HRGC/HPLC trace grade, Hexane, puriss. p.a., ACS reagent, reag. Ph. Eur., >=99% (GC), Hexane, Pharmaceutical Secondary Standard; Certified Reference Material, Hexane, commercial grade (52% n-hexane, 16% 3-methylpentane, 16% methylcyclopentane), Hexane, puriss., absolute, over molecular sieve (H2O <=0.01%), >=99.0% (GC), 478799-92-7, 50981-41-4, HEXANE, COMMERCIAL GRADE (52% n-HEXANE, 16% 3-METHYLCYCLOPENTANE, 16% METHYLCYCLOPENTANE)" C6H14 VLKZOEOYAKHREP-UHFFFAOYSA-N hexane n.a. n.a. No No No No No No PMDBD2001030 Niacinamide Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. D06NVJ 936 n.a. NPC306397 "nicotinamide, niacinamide, 98-92-0, 3-Pyridinecarboxamide, pyridine-3-carboxamide, Nicotinic acid amide, vitamin PP, Aminicotin, Amixicotyn, Papulex, Nicotylamide, Endobion, Hansamid, Nicobion, Nikotinamid, Savacotyl, Benicot, Dipegyl, Pelmine, Nicotinic amide, Delonin amide, Pelonin amide, Austrovit PP, Vi-Nicotyl, Inovitan PP, Amnicotin, Nicamindon, Nicomidol, Nicosylamide, Nicotamide, Nicotilamide, Nicotililamido, Nicovitina, Nicovitol, Nicozymin, Niocinamide, Niacevit, Niamide, Nicamina, Nicasir, Nicofort, Nicogen, Nicotol, Nicovit, Niozymin, Nicota, Niko-tamin, 3-Carbamoylpyridine, Nandervit-N, Nicotinamidum, Niavit PP, Nicosan 2, Nicotine amide, Nicotine acid amide, Nikotinsaeureamid, Pyridine-3-carboxylic acid amide, Vitamin B, Nicotylamidum, Nicotinsaureamid, beta-Pyridinecarboxamide, Pyridine, 3-carbamoyl-, Mediatric, Factor pp, m-(Aminocarbonyl)pyridine, 3-Pyridinecarboxylic acid amide, Nicotinamida, Pelmin, Acid amide, Witamina PP, PP-Faktor, Amid kyseliny nikotinove, Amide PP, 3-(aminocarbonyl)pyridine, Dipigyl, Niacinamid, Nicovel, Vitamin B (VAN), CCRIS 1901, Nicotinsaureamid [German], NAM, HSDB 1237, Nikotinsaeureamid [German], Amid kyseliny nikotinove [Czech], Nicotinamidum [INN-Latin], Nicotinamida [INN-Spanish], AI3-02906, NSC 13128, Nicotinamid, Nictoamide, Nicotinsaeureamid, 3-Amidopyridine, Vi-noctyl, EINECS 202-713-4, NSC-13128, NSC-27452, b-Pyridinecarboxamide, Niacinamide (USP), Niacinamide [USP], UNII-25X51I8RD4, Nicotinamide [INN], DTXSID2020929, CHEBI:17154, 25X51I8RD4, Nicotinamide (Standard), NSC13128, MFCD00006395, .beta.-Pyridinecarboxamide, Nicotinamide-(amide-15N), Nicotinamide (Vitamin B3), CHEMBL1140, DTXCID00929, MLS000069714, TPN COMPONENT NIACINAMIDE, EC 202-713-4, NIACINAMIDE COMPONENT OF TPN, NSC27452, NCGC00093354-03, NCGC00093354-05, SMR000058212, Nicotinamide 10 microg/mL in Acetonitrile, NIACINAMIDE (II), NIACINAMIDE [II], Niacinamide;Nicotinic acid amide;Vitamin B3, WLN: T6NJ CVZ, Nicotinamidum (INN-Latin), Nicotinamida (INN-Spanish), NIACINAMIDE (USP-RS), NIACINAMIDE [USP-RS], NICOTINAMIDE (MART.), NICOTINAMIDE [MART.], 3 Pyridinecarboxamide, Niacinamide [USAN], NICOTINAMIDE (EP IMPURITY), NICOTINAMIDE [EP IMPURITY], NIACINAMIDE (USP MONOGRAPH), NIACINAMIDE [USP MONOGRAPH], NICOTINAMIDE (EP MONOGRAPH), NICOTINAMIDE [EP MONOGRAPH], CAS-98-92-0, SR-01000721872, Niacotinamide, Nicosedine, Nicamid, nicotin-amide, Pahaba Control, Ultra Whitening, CellExosome HR, CellExosome SB, DEA No. 1405, Celonia CM, Ginseng Whitening, Dr. Cellmo, Royal GinsengCream, TOAS Rejuvenation, Nicotinamide,(S), Vitamin B3 amide, Costem cell 5 N, Royal GinsengLotion, AAPE Skin Ampoule, CellExosome HE HR, Fantastic LightCream, Royal Ginseng Toner, Vita C Bright Serum, Vita C Bright Toner, Niacinamide Face Mask, Royal Ginseng Essence, Ultra Whitening Ample, 11032-50-1, TANIA PURECREAM, JUVEHEAL W Ampoule, Nicotinamidum (Latin), BREXTEM S, NI-NICOTYL, Mediatric (Salt/Mix), niacin - Vitamin B3, Dr. Color Effect Red, 1yc5, DPC Aura Booster Mask, Dr Cellinme Mask Sheet, Opera_ID_775, Vita C Bright EyeCream, Miracle Laser Skin Mist, Niacin (as niacinamide), Pyridine-3-carboxylamide, APLIN SPOT REMOVER, KARATICA I M CURE, NIACINAMIDE [FCC], NICOTINAMIDE [MI], TANIA PURE ESSENCE, VITA C BRIGHTCREAM, Pellagra-Preventing Factor, INTOMEDI HR PEPTIDE, NIACINAMIDE [HSDB], NIACINAMIDE [INCI], NICOTINAMIDE [JAN], NYAAM NYAAM Vita Serum, RGO HYDRATION TONER, bmse000281, Miracle Moisturizer Essence, MolMap_000061, APLIN SPOT ALL KILL, MOISTIE PURE ESSENCE, NIACINAMIDE [VANDF], DPC Whitening Booster Mask, SCHEMBL2926, AAPE Nutrient Facial Toner, Nicotinamide (JP17/INN), NICOTINAMIDUM [HPUS], NYAAM NYAAM Peptide Serum, Cellpium double essence toner, AAPE Continuous Renewal Mask, MLS001424246, Primerose Snail Hydro Essence, Shieldlife Whitening Ion Mask, Ultra V AQUA SHINE MASK, Ultra Whitening First Essence, NICOTINAMIDE [WHO-DD], NICOTINAMIDE [WHO-IP], by selected hyaluron day serum, Dr Cellinme Skin Care Ampoule, CELLPIUM REAL MASK PACK, Cellpium super richness ampoule, CAVIALL Wrinkle-Free PowerTox, Cellpium premiumEX hybrid toner, Revital Perfecting Dual Ampoule, SCHEMBL6278767, SGCUT00176, Daily Whitening Care Sheet Mask, Edge Cutimal Cat Whitening Mask, SCHEMBL19978192, BDBM27507, CELLBN MILKY TONE-UPCREAM, HY-B0150R, NYAAM NYAAM Skin Reborn Serum, A11HA01, Cellpium premiumEX hybrid essence, NIACINAMIDE [ORANGE BOOK], BRIGHTUNING PEPTIDE AMPOULE, Nicotinamide, niacin, vitamin B3, HMS2052M21, HMS2090B05, HMS2093H03, HMS2236J03, HMS3370F21, HMS3394M21, HMS3655M20, HMS3713B22, HMS3884A16, Pharmakon1600-01505397, Ala-C Snail Cell Reparing Essence, AROCELL TIME REVERSE K I T, DR. GLODERM TABRX WHITENING, BCP07322, COSMEPURE BRIGHTENING CALMING, HY-B0150, THE SKIN HOUSE Vital BrightCream, THE SKIN HOUSE Vital BrightSerum, to_000073, ARILAC Brightening Mask Sheet Pack, Nicotinamide 1.0 mg/ml in Methanol, Nicotinamide, >=98.5% (HPLC), Nicotinamide, >=99.5% (HPLC), Tox21_111202, Tox21_201716, Tox21_302776, NICOTINAMIDUM [WHO-IP LATIN], NSC759115, s1899, THE SKIN HOUSE Vital Bright Toner, SFERANGS VITA C CAPSULEBOOSTER, AKOS005715850, Niveola P.H.c 3d Festival Mask Pack, Skin Project Ya Cooling Celluven Mask, THE SKIN HOUSE Vital BrightEmulsion, Tox21_111202_1, CCG-101149, CS-1968, DB02701, NC00399, NSC-759115, SB74497, Bk Cell 5days Of Secret Snow Whitening, EVECODE THREAD LIFTING MASK PACK, Nicotinamide 100 microg/mL in Methanol, Nicotinamide, >=98% (HPLC), powder, THE SKIN HOUSE Vital Bright Emulsion, THE SKIN HOUSE Vital Bright EyeCream, NCGC00093354-04, NCGC00093354-06, NCGC00093354-09, NCGC00256432-01, NCGC00259265-01, NIACIN (AS NIACINAMIDE) [VANDF], AS-13845, BN166252, COSMEPURE BRIGHTENING CALMING TONER, DERLADIE HerbalExtract BodySolution MIST, Nicotinamide, puriss., 99.0-101.0%, SY024804, DR. GLODERM TIME TO WHITENING MASK, FRESH MANDARIN AROMATHERAPY MASK27g, Nicotinamide, tested according to Ph.Eur., SBI-0206826.P001, AN ADC SP INTENSIVE MOISTURE ESSENCE, CS-0694823, Derma Pella Facial Cleanser for Normal Skin, DR.ALTHEA POWER WHITENING GLUTATHIONE, MIZON ENJOY VITAL UP TIME Whitening Mask, N0078, NS00005364, SW197779-3, The Hayan Cherry Blossom Brightening Essence, EN300-15612, Niacinamide, meets USP testing specifications, C00153, D00036, DERMAHAN THE WHITENING MOISTURIZING MASK, Nicotinamide (Niacinamide), analytical standard, AB00373895-13, AB00373895_15, AB00373895_16, Derma Pella Cleanser for Sensitive and Dry Skin, Nicotinamide, Vetec(TM) reagent grade, >=98%, A845925, AC-907/25014114, AROCELL X BELLE J SUPER POWER CELL AMPOULE, J9 ULTRA ADVANCED INTENSIVE SCALP SERUM V2, Q192423, LEBODY LAB RENEWAL DUAL EFFECT PEPTIDE SERUM, Q-201470, SR-01000721872-3, SR-01000721872-4, SR-01000721872-5, LEBODY LAB RENEWAL DUAL EFFECT IDEBENONE SERUM, MUSTUS DAILY HARVEST SQUEEZE TONE UP MASK PACK, PAPA RECIPE BOMBEE BRIGHTENING HONEY MASK PACK, SISEUNDEUSI LUMINANT MASK PACK STEP2(WHITENING), Z33546463, F2173-0513, Niacinamide;Nicotinic acid amide;Vitamin B3; Vitamin PP, Nicotinamide, British Pharmacopoeia (BP) Reference Standard, A186B02E-6C70-4E54-9739-79398D439AAA, Nicotinamide, European Pharmacopoeia (EP) Reference Standard, Niacinamide, United States Pharmacopeia (USP) Reference Standard, InChI=1/C6H6N2O/c7-6(9)5-2-1-3-8-4-5/h1-4H,(H2,7,9, Niacinamide, Pharmaceutical Secondary Standard; Certified Reference Material, Nicotinamide, BioReagent, suitable for cell culture, suitable for insect cell culture" C6H6N2O DFPAKSUCGFBDDF-UHFFFAOYSA-N pyridine-3-carboxamide n.a. Antiinflammatory Agents No No No No No No PMDBD2001031 Nisin n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001032 Nitazoxanide? n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001033 Nitrofurantoin? n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001034 n-Methyl-D-valine n.a. n.a. n.a. n.a. n.a. n.a. n.a. 6951143 n.a. n.a. n-methyl-d-valine, 88930-14-7, D-Valine, N-methyl-, d-n-methylvaline, (R)-3-Methyl-2-(methylamino)butanoic acid, (2R)-3-methyl-2-(methylamino)butanoic acid, 1XK24U48VP, (2~{R})-3-methyl-2-(methylamino)butanoic acid, H-D-Me-Val-OH, UNII-1XK24U48VP, SCHEMBL161931, AMY22718, HY-20561A, AM82395, MS-22776, (R)-3-Methyl-2-(methylamino)butanoicacid, CS-0010220, E80857, A850898, Q27463584 C6H13NO2 AKCRVYNORCOYQT-RXMQYKEDSA-N (2R)-3-methyl-2-(methylamino)butanoic acid n.a. n.a. No No No No No No PMDBD2001035 N-Nonanoyl-cyclopentylamide n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001036 Nobiletin Therapeutic Substance Preclinical n.a. n.a. n.a. n.a. D4PG6A 72344 n.a. NPC85233 Nobiletin, 478-01-3, Hexamethoxyflavone, 3'',4'',5,6,7,8-Hexamethoxyflavone, 5,6,7,8,3'',4''-Hexamethoxyflavone, 2-(3,4-Dimethoxyphenyl)-5,6,7,8-tetramethoxy-4H-1-benzopyran-4-one, 2-(3,4-dimethoxyphenyl)-5,6,7,8-tetramethoxychromen-4-one, NSC-76751, CCRIS 9012, UNII-D65ILJ7WLY, D65ILJ7WLY, NSC 76751, CHEBI:7602, 2-(3,4-dimethoxyphenyl)-5,6,7,8-tetramethoxy-4H-chromen-4-one, 4H-1-Benzopyran-4-one, 2-(3,4-dimethoxyphenyl)-5,6,7,8-tetramethoxy-, NSC-618903, CHEMBL76447, Nobiletin (Hexamethoxyflavone), DTXSID30197275, NSC76751, MFCD03273560, Flavone, 5,6,7,8,3'',4''-hexamethoxy, NOBILETIN (USP-RS), NOBILETIN [USP-RS], FLAVONE, 3'',4'',5,6,7,8-HEXAMETHOXY-, SMR000156231, CPD000156231, Nobiletin, >=97%, NOBILETIN [INCI], Spectrum2_001697, Spectrum3_000921, Spectrum4_001020, KBioGR_001519, MLS000574877, MLS000759462, MLS000877030, MLS001424129, Nobiletin, analytical standard, SCHEMBL244029, SPECTRUM1505268, SPBio_001654, MEGxp0_000930, ACon1_000921, GTPL12446, KBio3_001922, DTXCID40119766, 2-(3,4-dimethoxyphenyl)-5,6,7,8-tetramethoxy-chromen-4-one, HMS2051D09, HMS2234A09, HMS3373C14, HMS3393D09, HMS3651G20, HEXAMETHOXYFLAVONE [WHO-DD], HY-N0155, 3''4''5,6,7,8-Hexamethoxyflavone, 3,4,5,6,7,8-Hexamethoxyflavone, BDBM50338976, CCG-38781, LMPK12111468, NSC618903, AKOS015965334, NOBILETIN, 20% (Technical Grade), AC-1023, CS-5518, NC00186, SDCCGMLS-0066776.P001, NCGC00095703-01, NCGC00095703-02, NCGC00095703-06, NCGC00169228-01, 1ST40173, 5,6,7,8,3'''',4''''-hexamethoxyflavone, AS-17452, NCI60_041691, N0871, NS00018303, S2333, SW197566-2, A827343, SR-01000712262, Q-100511, Q2402963, SR-01000712262-5, BRD-K06753942-001-02-0, 2-(3,4-Dimethoxy-phenyl)-5,6,7,8-tetramethoxy-chromen-4-one, 4,5,6,7,8,9,10,11,12,13-decahydrocyclododeca[d]oxazole, 4H-1-Benzopyran-4-one,4-dimethoxyphenyl)-5,6,7,8-tetramethoxy-, 2-(3,4-Dimethoxyphenyl)-5,6,7,8-tetramethoxy-4H-1-benzopyran-4-one, 9CI C21H22O8 MRIAQLRQZPPODS-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5,6,7,8-tetramethoxychromen-4-one n.a. n.a. No No No No Yes No rxnAddEX11,rxnAdd114 PMDBD2001037 Nodakenetin n.a. n.a. n.a. n.a. n.a. n.a. n.a. 26305 n.a. NPC253574 Nodakenetin, 495-32-9, (-)-Marmesin, Nodakenitin, Prangeferol, (2R)-2-(2-hydroxypropan-2-yl)-2,3-dihydrofuro[3,2-g]chromen-7-one, PKL4EW8LPQ, (R)-2-(1-Hydroxy-1-methylethyl)-2,3-dihydro-7H-furo(3,2-g)(1)benzopyran-7-one, (2R)-2-(1-hydroxy-1-methylethyl)-2,3-dihydro-7H-furo[3,2-g]chromen-7-one, (R)-2-(2-Hydroxypropan-2-yl)-2,3-dihydro-7H-furo[3,2-g]chromen-7-one, Nodakenetic, (-)-Prangeferol, NANI, NODAKATIN, UNII-PKL4EW8LPQ, MLS001163827, (R)-(-)-NODAKENETIN, CHEMBL1464240, CHEBI:49083, DTXSID00964239, CHEBI:132623, HMS2871G16, HY-N2276, s3245, (2R)-2-(1-hydroxy-1-methyl-ethyl)-2,3-dihydrofuro[3,2-g]chromen-7-one, AKOS016023681, AC-35120, MS-23485, SMR000539229, CS-0019605, C09278, Q27121472, 2-(2-Hydroxypropan-2-yl)-2,3-dihydro-7H-furo[3,2-g][1]benzopyran-7-one, (R,S)-2-(1-Hydroxy-1-methyl-ethyl)-2,3-dihydro-furo[3,2-g]chromen-7-one, 7H-Furo(3,2-g)(1)benzopyran-7-one, 2,3-dihydro-2-(1-hydroxy-1-methylethyl)-, (R)-, 7H-FURO(3,2-G)(1)BENZOPYRAN-7-ONE, 2,3-DIHYDRO-2-(1-HYDROXY-1-METHYLETHYL)-, (-)-, 7H-FURO(3,2-G)(1)BENZOPYRAN-7-ONE, 2,3-DIHYDRO-2-(1-HYDROXY-1-METHYLETHYL)-, (2R)-, 7H-Furo[3,2g][1]-benzopyran-7-one, (-2,3-dihydro-2-(1-hydroxy-1-hydroxymethylethyl)-, (R) C14H14O4 FWYSBEAFFPBAQU-GFCCVEGCSA-N (2R)-2-(2-hydroxypropan-2-yl)-2,3-dihydrofuro[3,2-g]chromen-7-one n.a. n.a. No No No No No No PMDBD2001038 Norbgugaine 12 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001039 Norpinguisone n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001040 Norspermidine n.a. n.a. n.a. n.a. n.a. n.a. n.a. 5942 n.a. NPC27675 Norspermidine, Bis(3-aminopropyl)amine, Dipropylenetriamine, 56-18-8, 3,3''-Diaminodipropylamine, 3,3''-Iminobispropylamine, Caldine, 3,3''-Iminobis(propylamine), 1,7-Diamino-4-azaheptane, 4-Azaheptane-1,7-diamine, N-(3-Aminopropyl)-1,3-propanediamine, 3,3-Diaminodipropylamine, Aminobis(propylamine), Iminobis(propylamine), 3,3''-Iminodi(propylamine), P 2 (hardener), Imino-bis(3-propylamine), Dipropylentriamin, N-3-Aminopropyl-1,3-diaminopropane, Dipropylene triamine, 1,3-Propanediamine, N-(3-aminopropyl)-, 4-Azaheptamethylenediamine, Dipropylenetriamine (VAN), N-(3-aminopropyl)propane-1,3-diamine, Propylamine, 3,3''-iminobis-, Dipropylamine, 3,3''-diamino-, N''-(3-aminopropyl)propane-1,3-diamine, 3,3''-Iminodipropylamine, 1-Propanamine, 3,3''-iminobis-, NSC 7773, 1,5,9-triazanonane, 3,3''-Iminopropylamine, 3,3''-iminobis-Propylamine, 3,3''-diamino-Dipropylamine, RN1144MGND, CHEMBL28743, 1,3-Propanediamine, N1-(3-aminopropyl)-, DTXSID0025440, CHEBI:16841, NSC-7773, Initiating explosive iminobispropylamine, 3,3''-Iminobis[propylamine], Bis-(3-aminopropyl)amine, Dipropylentriamin [German], CCRIS 4826, di(3-aminopropyl)amine, EINECS 200-261-2, UN2269, UNII-RN1144MGND, BRN 1071254, AI3-25361, Dipropylenetriame, N-3-Aminopropyl, NSD, -1,3-propanediamine, 3,3''-Diaminopropylamine, Propylamine,3''-iminobis-, Dipropylamine,3''-diamino-, EC 200-261-2, 1, N-(3-aminopropyl)-, 3, 3''-Diaminodipropylamine, WLN: Z3M3Z, SCHEMBL15387, 1-Propanamine,3''-iminobis-, Bis(3,3''-aminopropyl)amine, 3,3''''-iminodi(propylamine), 4-04-00-01278 (Beilstein Handbook Reference), N,N-bis(3-aminopropyl)amine, 3,3''''-iminobis(propylamine), 3,3''-iminobis-1-Propanamine, 3,3''-azanediyldi(propanamine), DTXCID505440, Bis(3-aminopropyl)amine, 98%, 3,3''''-azanediyldi(propanamine), DIPROPYLENETRIAMINE [INCI], NSC7773, 3, {3''-Iminobis[propylamine]}, N,N-bis-(3-amino-propyl)-amine, AMY14287, STR03128, Tox21_202847, BDBM50009367, MFCD00008214, AKOS006223909, UN 2269, CAS-56-18-8, n1-(3-aminopropyl)propane-1,3-diamine, N-(3-Aminopropyl)-1, 3-propanediamine, NCGC00260393-01, D0090, NS00005363, Initiating explosive iminobispropylamine (dot), 1,3-PROPANEDIAMINE,N-(3-AMINOPROPYL)-, C03375, EN300-113765, 3,3''-Iminodipropylamine [UN2269] [Corrosive], Bis(3-aminopropyl)amine, purum, >=97.0% (GC), Q3878510, W-109255, Z1203577926 C6H17N3 OTBHHUPVCYLGQO-UHFFFAOYSA-N N''-(3-aminopropyl)propane-1,3-diamine n.a. n.a. No No No No No No PMDBD2001041 Novobiocin Therapeutic Substance Approved Drug 303-81-1 DB01051 PA164768819 n.a. D0Q0PR 54675769 10226117 NPC257728 novobiocin, 303-81-1, Streptonivicin, Cardelmycin, Inamycin, Albamycin, Spheromycin, Cathomycin, Crystallinic acid, Antibiotic PA-93, Cathocin, Novobiocina, Novobiocine, Novobiocinum, Robiocina, Sirbiocina, Stilbiocina, Albamix, Novo-R, Novobiocine [INN-French], Novobiocinum [INN-Latin], Novobiocina [INN-Spanish], PA 93, U 6391, HSDB 7443, EINECS 206-146-3, Benzamide, N-(7-((3-O-(aminocarbonyl)-6-deoxy-5-C-methyl-4-O-methyl-beta-L-lyxo-hexopyranosyl)oxy)-4-hydroxy-8-methyl-2-oxo-2H-1-benzopyran-3-yl)-4-hydroxy-3-(3-methyl-2-butenyl)-, UNII-17EC19951N, CHEBI:28368, AI3-50148, 17EC19951N, CHEMBL36506, 7-(3-(O-Carbamoyl)-4-(O-methyl)-5,5-dimethyl-alpha-L-lyxopyranosyloxy)-4-hydroxy-3-(4-hydroxy-3-(3-methyl-2-butenyl)benzamidol)-8-methylcumarin, 7-(Carbamoyltetrahydro-3-hydroxy-5-methoxy-6,6-dimethylpyran-2-yloxy)-4-hydroxy-3-(4-hydroxy-3-(3-methylbut-2-enyl)benzamide)-8-methyl-2H-chromen-2-one, NOV, DTXSID3041083, Novobiocine (INN-French), Novobiocinum (INN-Latin), Novobiocin [INN:BAN], Novobiocina (INN-Spanish), NOVOBIOCIN (MART.), NOVOBIOCIN [MART.], NOVOBIOCIN (USP-RS), NOVOBIOCIN [USP-RS], (3R,4S,5R,6R)-5-Hydroxy-6-((4-hydroxy-3-(4-hydroxy-3-(3-methylbut-2-en-1-yl)benzamido)-8-methyl-2-oxo-2H-chromen-7-yl)oxy)-3-methoxy-2,2-dimethyltetrahydro-2H-pyran-4-yl carbamate, Coumarin, 7-(4-(carbamoyloxy)tetrahydro-3-hydroxy-5-methoxy-6,6-dimethylpyran-2-yloxy)-4-hydroxy-3-(4-hydroxy-3-(4-hydroxy-3-(3-methyl-2-butenyl)benzamido)-8-methyl-, N-{7-[(3-O-carbamoyl-6-deoxy-5-methyl-4-O-methyl-beta-D-gulopyranosyl)oxy]-4-hydroxy-8-methyl-2-oxo-2H-chromen-3-yl}-4-hydroxy-3-(3-methylbut-2-en-1-yl)benzamide, (3R,4S,5R,6R)-5-hydroxy-6-{[4-hydroxy-3-({[4-hydroxy-3-(3-methylbut-2-en-1-yl)phenyl]carbonyl}amino)-8-methyl-2-oxo-2H-chromen-7-yl]oxy}-3-methoxy-2,2-dimethyltetrahydro-2H-pyran-4-yl carbamate, [(3R,4S,5R,6R)-5-hydroxy-6-[4-hydroxy-3-[[4-hydroxy-3-(3-methylbut-2-enyl)benzoyl]amino]-8-methyl-2-oxochromen-7-yl]oxy-3-methoxy-2,2-dimethyloxan-4-yl] carbamate, NSC2382, Vulcamicina, Vulkamycin, Biotexin, Streptonivicin (*Sodium salt*), 1476-53-5, 4urn, 4uro, Albamix Feed Medication, Spectrum_001001, 1aj6, NOVOBIOCIN [MI], NOVOBIOCIN [INN], Spectrum2_000977, Spectrum3_000528, Spectrum4_000457, Spectrum5_001274, NOVOBIOCIN [HSDB], NOVOBIOCIN [VANDF], NOVOBIOCIN [WHO-DD], SCHEMBL24805, BDBM282, BSPBio_002115, KBioGR_000874, KBioGR_002402, KBioSS_001481, KBioSS_002407, MLS001032086, DivK1c_000260, SCHEMBL238345, SPBio_001013, MEGxm0_000273, NOVOBIOCIN [GREEN BOOK], DTXCID1021083, ACon0_000808, ACon1_001693, GTPL12021, KBio1_000260, KBio2_001481, KBio2_002402, KBio2_004049, KBio2_004970, KBio2_006617, KBio2_007538, KBio3_001615, KBio3_002881, cMAP_000043, NINDS_000260, YJQPYGGHQPGBLI-KGSXXDOSSA-N, HY-B0425, BDBM50226181, AKOS027295139, AT38053, DB01051, IDI1_000260, NCGC00188981-01, N-[7-[[3-O-(Aminocarbonyl)-6-deoxy-5-C-methyl-4-O-methyl-.beta.-L-lyxo-hexopyranosyl]oxy]-4-hydroxy-8-methyl-2-oxo-2H-1-benzopyran-3-yl]-4-hydroxy-3-(3-methyl-2-butenyl), SMR000718617, Novobiocin 1000 microg/mL in Acetonitrile, A-256, CS-0082991, NS00010563, C05080, EN300-19736048, Novobiocin, Antibiotic for Culture Media Use Only, Q1639291, W-204218, BRD-K85307935-236-02-0, (3R,4S,5R,6R)-5-hydroxy-6-({4-hydroxy-3-[4-hydroxy-3-(3-methylbut-2-en-1-yl)benzamido]-8-methyl-2-oxo-2H-chromen-7-yl}oxy)-3-methoxy-2,2-dimethyloxan-4-yl carbamate, (3R,4S,5R,6R)-5-hydroxy-6-(4-hydroxy-3-(4-hydroxy-3-(3-methylbut-2-enyl)benzamido)-2-oxo-2H-chromen-7-yloxy)-3-methoxy-2,2-dimethyl-tetrahydro-2H-pyran-4-yl carbamate, (3R,4S,5R,6R)-5-hydroxy-6-(4-hydroxy-3-(4-hydroxy-3-(3-methylbut-2-enyl)benzamido)-8-methyl-2-oxo-2H-chromen-7-yloxy)-3-methoxy-2,2-dimethyl-tetrahydro-2H-pyran-4-yl carbamate, (3R,4S,5R,6R)-5-hydroxy-6-(4-hydroxy-3-(4-hydroxy-3-(3-methylbut-2-enyl)benzamido)-8-methyl-2-oxo-2H-chromen-7-yloxy)-3-methoxy-2,2-dimethyltetrahydro-2H-pyran-4-yl carbamate, (3R,4S,5R,6R)-5-hydroxy-6-[(2-hydroxy-3-{[4-hydroxy-3-(3-methylbut-2-en-1-yl)benzene]amido}-8-methyl-4-oxo-4H-chromen-7-yl)oxy]-3-methoxy-2,2-dimethyloxan-4-yl carbamate, (3R,4S,5R,6R)-5-hydroxy-6-[(4-hydroxy-3-{[4-hydroxy-3-(3-methylbut-2-en-1-yl)benzene]amido}-8-methyl-2-oxo-2H-chromen-7-yl)oxy]-3-methoxy-2,2-dimethyloxan-4-yl carbamate, [(3R,4S,5R,6R)-5-hydroxy-6-[4-hydroxy-3-[[4-hydroxy-3-(3-methylbut-2-enyl)benzoyl]amino]-8-methyl-2-oxo-chromen-7-yl]oxy-3-methoxy-2,2-dimethyl-tetrahydropyran-4-yl] carbamate, BENZAMIDE, N-(7-((3-O-(AMINOCARBONYL)-6-DEOXY-5-C-METHYL-4-O-METHYL-.ALPHA.-L-LYXO-HEXOPYRANOSYL)OXY)-4-HYDROXY-8-METHYL-2-OXO-2H-1-BENZOPYRAN-3-YL)-4-HYDROXY-3-(3-METHYL-2-BUTEN-1-YL)-, BENZAMIDE, N-(7-((3-O-(AMINOCARBONYL)-6-DEOXY-5-C-METHYL-4-O-METHYL-.BETA.-L-LYXO-HEXOPYRANOSYL)OXY)-4-HYDROXY-8-METHYL-2-OXO-2H-1-BENZOPYRAN-3-YL)-4-HYDROXY-3-(3-METHYL-2-BUTENYL)-, BENZAMIDE, N-(7-((3-O-(AMINOCARBONYL)-6-DEOXY-5-C-METHYL-4-O-METHYL-alpha-L-LYXO-HEXOPYRANOSYL)OXY)-4-HYDROXY-8-METHYL-2-OXO-2H-1-BENZOPYRAN-3-YL)-4-HYDROXY-3-(3-METHYL-2-BUTEN-1-YL)-, Carbamic acid (3R,4S,5R,6R)-5-hydroxy-6-{4-hydroxy-3-[4-hydroxy-3-(3-methyl-but-2-enyl)-benzoylamino]-8-methyl-2-oxo-2H-chromen-7-yloxy}-3-methoxy-2,2-dimethyl-tetrahydro-pyran-4-yl ester, Carbamic acid (3R,4S,5R,6R)-5-hydroxy-6-{4-hydroxy-3-[4-hydroxy-3-(4-methyl-pent-3-enyl)-benzoylamino]-8-methyl-2-oxo-2H-chromen-7-yloxy}-3-methoxy-2,2-dimethyl-tetrahydro-pyran-4-yl ester, Carbamic acid 5-hydroxy-6-{4-hydroxy-3-[4-hydroxy-3-(3-methyl-but-2-enyl)-benzoylamino]-8-methyl-2-oxo-2H-chromen-7-yloxy}-3-methoxy-2,2-dimethyl-tetrahydro-pyran-4-yl ester, Carbamic acid 5-hydroxy-6-{4-hydroxy-3-[4-hydroxy-3-(3-methyl-but-2-enyl)-benzoylamino]-8-methyl-2-oxo-2H-chromen-7-yloxy}-3-methoxy-2,2-dimethyl-tetrahydro-pyran-4-yl ester(Novobiocin) C31H36N2O11 YJQPYGGHQPGBLI-KGSXXDOSSA-N [(3R,4S,5R,6R)-5-hydroxy-6-[4-hydroxy-3-[[4-hydroxy-3-(3-methylbut-2-enyl)benzoyl]amino]-8-methyl-2-oxochromen-7-yl]oxy-3-methoxy-2,2-dimethyloxan-4-yl] carbamate Pfizer Pharmaceuticals Antibiotics No No No No No No PMDBD2001042 NRC-16 n.a. n.a. n.a. n.a. n.a. n.a. n.a. 168510740 n.a. n.a. NRC-16, HY-P5468, CS-0884102 C102H167N33O20 BZXQEECUFNVKSD-HQTHDTPHSA-N (2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-6-amino-2-[[(2S)-2-[(2-aminoacetyl)amino]-3-(1H-indol-3-yl)propanoyl]amino]hexanoyl]amino]hexanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-4-methylpentanoyl]amino]-5-carbamimidamidopentanoyl]amino]hexanoyl]amino]acetyl]amino]propanoyl]amino]hexanoyl]amino]-3-(1H-imidazol-4-yl)propanoyl]amino]-4-methylpentanoyl]amino]acetyl]amino]-N-[(2S)-1-[[(2S)-1-[[(2S,3S)-1-[[(2S)-1,6-diamino-1-oxohexan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]pentanediamide n.a. n.a. No No No No No No PMDBD2001043 O-(2,6-Dichlorobenzyl)-D-tyrosine n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001044 Octadecyl gallate n.a. n.a. n.a. n.a. n.a. n.a. n.a. 473591 n.a. n.a. Stearyl gallate, 10361-12-3, Octadecyl 3,4,5-trihydroxybenzoate, Gallic Acid Stearyl Ester, Octadecyl gallate, 3,4,5-TRIHYDROXYBENZOIC ACID STEARYL ESTER, Nipagallin ST, Marupi gallate S, Stearyl gallate [INCI], Benzoic acid, 3,4,5-trihydroxy-, octadecyl ester, Gallic acid, octadecyl ester, M6740S6023, Stearyl-gallat, UNII-M6740S6023, 3,4,5-trihydroxy benzoic acid stearyl ester, 3,4,5-Trihydroxybenzoic acid octadecyl ester, SCHEMBL51646, CHEMBL471323, DTXSID80145943, Octadecyl3,4,5-trihydroxybenzoate, HY-N8082, MFCD00016429, AKOS015914504, Octadecyl 3,4,5-trihydroxybenzoate #, AC-19743, AS-56864, CS-0139920, G0019, D90706, A852230, Q27283545 C25H42O5 BRNPAEUKZMBRLQ-UHFFFAOYSA-N octadecyl 3,4,5-trihydroxybenzoate n.a. n.a. No No No No No No PMDBD2001045 Octameric peptide n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001046 octane-1,8-diamine n.a. n.a. n.a. n.a. n.a. n.a. n.a. 24250 n.a. n.a. "1,8-Diaminooctane, 373-44-4, octane-1,8-diamine, 1,8-Octanediamine, Octamethylenediamine, 1,8-Octylenediamine, 1,8-Octamethylenediamine, OCTANE 1,8-DIAMINE, Diaminooctane, octamethylene diamine, alpha,omega-diaminooctane, CHEMBL29392, CHEBI:73112, 53A6694PIE, EINECS 206-764-3, BRN 1735426, UNII-53A6694PIE, 1,8 diaminooctane, 1-8-diaminooctane, 1.8-diaminooctane, 1,4-Octanediamine, 1,8-diamino octane, 1,8-octane diamine, Octane, 1,8-diamino-, 7613-16-3, EC 206-764-3, 1,8-Diaminooctane, 98%, SCHEMBL35706, 3-04-00-00612 (Beilstein Handbook Reference), 1,8-DIAMINO-N-OCTANE, DTXSID9073173, BDBM50129716, MFCD00008248, .ALPHA.,.OMEGA.-OCTANEDIAMINE, AKOS006223685, CS-W016375, DB04333, SB75550, AS-14372, D0107, NS00003319, EN300-211827, F21311, W-106546, Q27095148, Z1203577927, 27ADC60C-8497-49F5-9025-5A855BA566E6, 1,8-DIAMINOOCTANE; OCTAMETHYLENEDIAMINE; 1,8-OCTANEDIAMINE" C8H20N2 PWGJDPKCLMLPJW-UHFFFAOYSA-N octane-1,8-diamine n.a. n.a. No No No No No No PMDBD2001047 Octyl gallate Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D02ZSX 61253 n.a. n.a. "Octyl gallate, 1034-01-1, Octyl 3,4,5-trihydroxybenzoate, n-Octyl gallate, Progallin O, Stabilizer GA 8, n-Octylgallate, Gallic acid, octyl ester, BENZOIC ACID, 3,4,5-TRIHYDROXY-, OCTYL ESTER, Gallic acid octyl ester, Gallic acid n-octyl ester, Oktylester kyseliny gallove, GA 8 (VAN), n-Octyl ester of 3,4,5-trihydroxybenzoic acid, NSC 97419, Gallic acid-octyl ester, E311, CHEMBL277346, GA 8, DTXSID4040713, CHEBI:83631, NSC-97419, 079IIA2811, Oktylester kyseliny gallove [Czech], EINECS 213-853-0, Octyl gallate; Octyl 3,4,5-trihydroxybenzoate; E311, BRN 2132305, UNII-079IIA2811, Stabilizer GA-8, Gallic acid n-octyl-ester, SCHEMBL36234, 4-10-00-02005 (Beilstein Handbook Reference), BIDD:ER0271, WLN: QR BQ CQ EVO8, OCTIL GALLATE [MART.], INS NO.311, Octyl-3,4,5-trihydroxybenzoat, PPC-17, OCTYL GALLATE [WHO-DD], DTXCID2020713, INS-311, OCTYL GALLATE (E 311), OCTYL ESTER OF GALLIC ACID, Octyl 3,4,5-trihydroxybenzoate #, BCP15873, HY-N2011, NSC97419, Tox21_300272, BDBM50240376, MFCD00002197, OCTYL GALLATE [EP MONOGRAPH], 3,4,5-Trihydroxy-benzoicacioctylester, AKOS009031297, CCG-267265, 6-(3-Methoxy-phenyl)-morpholin-3-one, NCGC00164126-01, NCGC00164126-02, NCGC00164126-03, NCGC00254030-01, AC-20128, AC-34483, AS-10960, CAS-1034-01-1, 3,4,5-Trihydroxy-benzoic acid octyl ester, Benzoic acid,4,5-trihydroxy-, octyl ester, Octyl gallate, analytical reference material, CS-0018331, E-311, G0206, n-Octyl ester of 3,5-trihydroxybenzoic acid, NS00015718, Progallin O;n-Octyl gallate;Stabilizer GA 8, S9338, octyl 3,4,5-trihydroxybenzoate;Octyl gallate, Octyl gallate, antioxidant, >=99.0% (HPLC), A800728, J-000952, Q2317929, Octyl gallate, European Pharmacopoeia (EP) Reference Standard, 65D" C15H22O5 NRPKURNSADTHLJ-UHFFFAOYSA-N octyl 3,4,5-trihydroxybenzoate n.a. n.a. No No No No No No PMDBD2001048 OHC10HL n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001049 OHC8HL n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001050 Oleanolic Acid Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D0SJ2Q 10494 n.a. NPC142415 OLEANOLIC ACID, 508-02-1, Oleanic acid, Caryophyllin, Astrantiagenin C, Giganteumgenin C, Virgaureagenin B, Oleanol, 3beta-Hydroxyolean-12-en-28-oic acid, oleonolic acid, 3-beta-Hydroxyolean-12-en-28-oic acid, CCRIS 6493, NSC-114945, UNII-6SMK8R7TGJ, 6SMK8R7TGJ, Gledigenin 1, EINECS 208-081-6, (3-beta)-3-Hydroxyolean-12-en-28-oic acid, OleanolicAcid, NSC 114945, (4aS,6aR,6aS,6bR,8aR,10S,12aR,14bS)-10-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid, CHEBI:37659, NSC114945, Olean-12-en-28-oic acid, 3-hydroxy-, (3beta)-, Olean-12-en-28-oic acid, 3beta-hydroxy-, Olean-12-en-28-oic acid, 3-beta-hydroxy-, DTXSID50858790, Olean-12-en-28-oic acid, 3-hydroxy-, (3-beta)-, (4aS,6aS,6bR,8aR,10S,12aR,12bR,14bS)-10-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-octadecahydropicene-4a(2H)-carboxylic acid, OLEANOLIC ACID (USP-RS), OLEANOLIC ACID [USP-RS], MFCD00064914, (4aS,5S,6aS,6bR,8R,8aR,10S,12aR,12bR,14bS)-10-Hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-octadecahydro-2H-picene-4a-carboxylic acid, SMR000445561, OLEANOLIC_ACID, CHEMBL168, (3.beta.)-3-Hydroxyolean-12-en-28-oic acid, Olean-12-en-28-oic acid, 3-hydroxy-, (3.beta.)-, oleanolic-acid, OleanolsA currencyure, Oleanoic Acid Hydrate, Olean-12-en-28-oic acid, 3.beta.-hydroxy-, Olean-12-en-28-oic acid, 3-hydroxy-, (3b)-, Oleanolic acid, >=97%, OLEANOLIC ACID [MI], SCHEMBL71070, MLS000697656, MLS002207133, OLEANOLIC ACID [INCI], GTPL3306, OLEANOLIC ACID [WHO-DD], DTXCID701474453, HMS2232D15, Oleanolic acid (OA)(Compound 1), Oleanolic acid, analytical standard, (4aS,6aS,6bR,8aR,10S,12aR,12bR,14bS)-10-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylic acid, EX-A1991, HY-N0156, BDBM50346601, 3-beta-Hydroxyolean-12-en-28-oate, 3beta-hydroxy-Olean-12-en-28-oate, AKOS015951416, AC-8026, CCG-208530, CS-3800, LMPR0106150004, 3.beta.-hydroxy-Olean-12-en-28-oate, 3beta-hydroxy-Olean-12-en-28-oic acid, NCGC00017222-10, NCGC00017222-13, (2S,5S,10S,18S,1R,14R,15R,20R)-18-hydroxy-1,2,8,8,15,19,19-heptamethylpentacyc lo[12.8.0.0<2,11>.0<5,10>.0<15,20>]docos-11-ene-5-carboxylic acid, 1ST40102, AS-35338, BP-25410, (3-beta)-3-Hydroxyolean-12-en-28-oate, (3?)-3-Hydroxyolean-12-en-28-oic acid, 3.beta.-hydroxy-Olean-12-en-28-oic acid, (3beta)-3-hydroxyolean-12-en-28-oic acid, NS00019728, (3.beta.)-3-hydroxy-Olean-12-en-28-oate, C17148, EN300-342251, (3.beta.)-3-hydroxy-Olean-12-en-28-oic acid, (3.beta.)-3-beta-hydroxy-Olean-12-en-28-oate, 3.BETA.-HYDROXYOLEAN-12-EN-28-OIC ACID, Q418628, OLEANOLIC ACID (CONSTITUENT OF BANABA LEAF), Q-100572, (3.beta.)-3-beta-hydroxy-Olean-12-en-28-oic acid, OLEANOLIC ACID (CONSTITUENT OF HOLY BASIL LEAF), Oleanolic acid, primary pharmaceutical reference standard, C7EE6ACC-7175-4947-B524-FF8479525DA1, OLEANOLIC ACID (CONSTITUENT OF BANABA LEAF) [DSC], OLEANOLIC ACID (CONSTITUENT OF HOLY BASIL LEAF) [DSC], Oleanolic acid, European Pharmacopoeia (EP) Reference Standard, Oleanolic acid, United States Pharmacopeia (USP) Reference Standard, (4aS,6aR,6aS,6bR,8aR,10S,12aR,14bS)-10-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylicacid C30H48O3 MIJYXULNPSFWEK-GTOFXWBISA-N (4aS,6aR,6aS,6bR,8aR,10S,12aR,14bS)-10-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid n.a. n.a. No No No No No No PMDBD2001051 O-LF11-215 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001052 O-LF11-227 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001053 Olive oil Therapeutic Substance n.a. 8001-25-0 DB09567 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001054 Olmesartran n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001055 O-Methyl-D-tyrosine n.a. n.a. n.a. n.a. n.a. n.a. n.a. 6950205 n.a. n.a. O-Methyl-D-tyrosine, 39878-65-4, 4-Methoxy-D-Phenylalanine, (R)-2-Amino-3-(4-methoxyphenyl)propanoic acid, D-Tyrosine, O-methyl-, H-D-Tyr(Me)-OH, (2R)-2-amino-3-(4-methoxyphenyl)propanoic acid, D-4-methoxyphenylalanine, (R)-2-amino-3-(4-methoxyphenyl)propionic acid, Q4LA7968UD, UNII-Q4LA7968UD, (2R)-2-azaniumyl-3-(4-methoxyphenyl)propanoate, D-4-Methoxyphe, H-4-Methoxy-D-Phe-OH, SCHEMBL597743, CHEBI:192378, GEYBMYRBIABFTA-SECBINFHSA-N, DTXSID801315511, MFCD00190961, AKOS015851868, 132574-59-5, AC-25338, AM808156, AS-19805, O-Methyl-D-tyrosine, >=99.0% (NT), HY-141526, CS-0179569, M2332, EN300-4226974 C10H13NO3 GEYBMYRBIABFTA-SECBINFHSA-N (2R)-2-amino-3-(4-methoxyphenyl)propanoic acid n.a. n.a. No No No No No No PMDBD2001056 Orange extract n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001057 Oregano oil n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001058 Oseltamivir Therapeutic Substance Approved Drug 196618-13-0 DB00198 PA450721 D00900 D0O5NK 65028 58540 NPC469895 "oseltamivir, 196618-13-0, Tamvir, Tamiflu-Free, (-)-oseltamivir, GS-4104, oseltamivirum, GS 4104, GS4104, HSDB 7433, Agucort, Ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate, Ro-640796, Ro-64-0796, (3R,4R,5S)-Ethyl 4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-enecarboxylate, Oseltamivir (INN), Ro 640796, UNII-20O93L6F9H, ethyl (3R,4R,5S)-4-acetamido-5-amino-3-pentan-3-yloxycyclohexene-1-carboxylate, CHEBI:7798, GS-4071 ETHYL ESTER, GOP-A-Flu, 20O93L6F9H, RO64-0796, 1-Cyclohexene-1-carboxylic acid, 4-(acetylamino)-5-amino-3-(1-ethylpropoxy)-, ethyl ester, (3R-(3alpha,4beta,5alpha))-, DTXSID9044291, ebilfumin, RO640796, Oseltamivir 100 microg/mL in Acetonitrile, OSELTAMIVIR [INN], Oseltamivir [INN:BAN], ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylate, ethyl (3R,4R,5S)-4-acetamido-5-amino-3-pentan-3-yloxy-cyclohexene-1-carboxylate, ethyl (3R,4R,5S)-5-amino-4-acetamido-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylate, Agucort (TN), Tamiflu (*Phosphate salt 1:1*), SR-05000001499, 1-Cyclohexene-1-carboxylic acid, 4-(acetylamino)-5-amino-3-(1-ethylpropoxy)-, ethyl ester, (3R,4R,5S)-, oseltamivir-phosphate, OSELTAMIVIR [MI], GS 4104;GOP-A-Flu;GS-4104;Tamiflu-Free;Tamvir, OSELTAMIVIR [HSDB], OSELTAMIVIR [VANDF], CHEMBL1229, SCHEMBL32035, OSELTAMIVIR [WHO-DD], BIDD:GT0426, OSELTAMIVIR [EMA EPAR], BDBM5025, DTXCID7024291, GTPL11427, J05AH02, VSZGPKBBMSAYNT-RRFJBIMHSA-N, HMS2090C11, EX-A3415, AKOS015843442, AKOS015960501, CS-0552, DB00198, DT-0013, ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(1-ethylpropoxy)cyclohexene-1-carboxylate, Ethyl (5S,3R,4R)-4-(acetylamino)-5-amino-3-(ethylpropoxy)cyclohex-1-enecarboxylate, NCGC00095191-06, NCGC00095191-12, NCGC00095191-14, NCGC00095191-16, NCGC00178698-01, NCGC00178698-02, NCGC00178698-04, HY-13317, NS00000301, O0591, C08092, D08306, E84533, AB00173476-02, AB00173476_04, Q211509, SR-05000001499-1, BRD-K76011241-045-01-5, Ethyl (3R, 4R, 5S)-4-acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate, ethyl (3r,4r,5s)-4-(acetylamino)-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate, rel-Ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylate, (3r,4r,5s)-4-acetylamino-5-amino-3(1-ethylpropoxy) -1-cyclohexene-1-carboxylic acid ethyl ester, (3R,4R,5S)-4-acetylamino-5-amino-3-(1-ethyl-propoxy)-cyclohex-1-enecarboxylic acid ethyl ester, (3R,4R,5S)-4-acetylamino-5-amino-3-(1-ethyl-propoxy)cyclohex-1-enecarboxylic acid ethyl ester, 182367-47-1" C16H28N2O4 VSZGPKBBMSAYNT-RRFJBIMHSA-N ethyl (3R,4R,5S)-4-acetamido-5-amino-3-pentan-3-yloxycyclohexene-1-carboxylate Hoffmann-La Roche pharmaceutical company Antiviral Agents No No No No No No PMDBD2001059 OSIP108 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001060 Oxacillin Therapeutic Substance Approved Drug 66-79-5 DB00713 PA450725 D08307 D0MB8I 6196 5961 NPC478578 "oxacillin, Oxazocillin, 66-79-5, Oxazocilline, MPI-penicillin, Oxacilina, Ossacillina, Oxacilline, Oxacillinum, Prostaphlyn, Bactocill, Prostaphlin, MPi-PC, OXACILLIN SODIUM, 5-Methyl-3-phenyl-4-isoxazolyl-penicillin, Oxacilina [INN-Spanish], Oxacilline [INN-French], Oxacillinum [INN-Latin], CHEBI:7809, (5-methyl-3-phenyl-4-isoxazolyl)penicillin, EINECS 200-635-5, UNII-UH95VD7V76, Oxacillin (INN), Penicillin, (5-methyl-3-phenyl-4-isoxazolyl)-, UH95VD7V76, (2S,5R,6R)-3,3-dimethyl-6-[(5-methyl-3-phenyl-1,2-oxazole-4-carbonyl)amino]-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 6beta-(5-methyl-3-phenylisoxazol-4-yl)penicillanic acid, (2S,5R,6R)-3,3-dimethyl-6-{[(5-methyl-3-phenylisoxazol-4-yl)carbonyl]amino}-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, DTXSID8023397, 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3,3-dimethyl-6-[[(5-methyl-3-phenyl-4-isoxazolyl)carbonyl]amino]-7-oxo-, (2S,5R,6R)-, Methylphenylisoxazolyl Penicillin, Ossacillina [DCIT], OXACILLIN [INN], Oxacilina (INN-Spanish), Oxacilline (INN-French), Oxacillinum (INN-Latin), Oxacillin [INN:BAN], OXACILLIN (MART.), OXACILLIN [MART.], (2S,5R,6R)-3,3-dimethyl-6-(5-methyl-3-phenyl-1,2-oxazole-4-amido)-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 1173-88-2, Penicillin, Methylphenylisoxazolyl, Oxacilina (TN), MPI-penicillin; MPi-PC, oxacillina, Oxacillin,(S), (2S,5R,6R)-3,3-dimethyl-6-[(5-methyl-3-phenyl-isoxazole-4-carbonyl)amino]-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-6-(((5-methyl-3-phenyl-4-isoxazolyl)carbonyl)amino)-7-oxo-, (2S-(2alpha,5alpha,6beta))-, OXACILLIN [MI], OXACILLIN [VANDF], CHEMBL819, Epitope ID:181859, OXACILLIN [WHO-DD], SCHEMBL3817, DTXCID403397, GTPL10943, HY-B0925A, J01CF04, phenylisoxazole-4-carboxamido)-7-, BDBM50350483, DB00713, 2,2-dimethyl-6beta-(5-methyl-3-phenyl-1,2-oxazole-4-carboxamido)penam-3alpha-carboxylic acid, 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-6-(5-methyl-3-phenyl-4-isoxazolecarboxamide)-7-oxo-, 5-Methyl-3-phenyl-4-isooxazolylpenicillin, oxo-4-thia-1-azabicyclo[3.2.0]heptane-, CS-0013715, NS00000572, C07334, D08307, (2S,5R,6R)-3,3-dimethyl-6-(5-methyl-3-, EN300-19766050, Q418725, BRD-K96786677-236-01-6, BRD-K96786677-236-02-4, 4-THIA-1-AZABICYCLO(3.2.0)HEPTANE-2-CARBOXYLIC ACID, 3,3-DIMETHYL-6-(((5-METHYL-3-PHENYL-4-ISOXAZOLYL)CARBONYL)AMINO)-7-OXO-,(2S,5R,6R)-, 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3,3-dimethyl-6-(((5-methyl-3-phenyl-4-isoxazolyl)carbonyl)amino)-7-oxo-, (2S-(2.alpha.,5.alpha.,6.beta.))-" C19H19N3O5S UWYHMGVUTGAWSP-JKIFEVAISA-N (2S,5R,6R)-3,3-dimethyl-6-[(5-methyl-3-phenyl-1,2-oxazole-4-carbonyl)amino]-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid Sandoz Inc Antibiotics No No No No No No PMDBD2001061 Oxantel Therapeutic Substance n.a. 36531-26-7 DB13670 n.a. n.a. n.a. 5281087 4444540 n.a. OXANTEL, 36531-26-7, (E)-3-(2-(1-Methyl-1,4,5,6-tetrahydropyrimidin-2-yl)vinyl)phenol, 3-[(E)-2-(1-methyl-5,6-dihydro-4H-pyrimidin-2-yl)ethenyl]phenol, 94AJJ30D9E, Oxantelum, Oxantel [INN:BAN], Oxantelum [INN-Latin], UNII-94AJJ30D9E, OXANTEL [INN], OXANTEL [MI], OXANTEL [WHO-DD], SCHEMBL43905, SCHEMBL555044, CHEMBL1240977, GTPL10840, CHEBI:135610, VRYKTHBAWRESFI-VOTSOKGWSA-N, DTXSID601016597, (E)-3-(2-(1,4,5,6-tetrahydro-1-methyl-2-pyrimidinyl)vinyl)phenol, (E)-m-(2-(1,4,5,6-Tetrahydro-1-methyl-2-pyrimidinyl)vinyl)phenol, AKOS015961005, DB13670, AC-12737, CP-14,445, HY-124498, CS-0086698, NS00126104, Q1227207, BRD-K66019333-096-01-2, PHENOL, 3-(2-(1,4,5,6-TETRAHYDRO-1-METHYL-2-PYRIMIDINYL)ETHENYL), (E)-, Phenol, 3-(2-(1,4,5,6-tetrahydro-1-methyl-2-pyrimidinyl)ethenyl)-, (E)- C13H16N2O VRYKTHBAWRESFI-VOTSOKGWSA-N 3-[(E)-2-(1-methyl-5,6-dihydro-4H-pyrimidin-2-yl)ethenyl]phenol n.a. n.a. No No No No No No PMDBD2001062 Oxyresveratrol Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D06ZRX 5281717 n.a. NPC292452 Oxyresveratrol, 29700-22-9, Hydroxyresveratrol, Tetrahydroxystilbene, trans-oxyresveratrol, (E)-4-(3,5-Dihydroxystyryl)benzene-1,3-diol, 4-[(E)-2-(3,5-dihydroxyphenyl)ethenyl]benzene-1,3-diol, 4721-07-7, 4-[2-(3,5-dihydroxyphenyl)ethenyl]benzene-1,3-diol, OXYLRESVERATROL, 1,3-Benzenediol, 4-[(1E)-2-(3,5-dihydroxyphenyl)ethenyl]-, 2,3'',4,5''-Tetrahydroxystilbene, CHEMBL43065, 6V071CP5CR, CHEBI:7870, trans-2,3'',4,5''-tetrahydroxystilbene, 1,3-Benzenediol, 4-(2-(3,5-dihydroxyphenyl)ethenyl)-, (E)-, 4-(3,5-Dihydroxystyryl)benzene-1,3-diol, Puag-haad, 4-(2-(3,5-dihydroxyphenyl)ethenyl)benzene-1,3-diol, UNII-6V071CP5CR, 1,3-BENZENEDIOL, 4-((1E)-2-(3,5-DIHYDROXYPHENYL)ETHENYL)-, 2,4,3'',5''-Tetrahydroxystilbene, O-RES cpd, OXYRESVENOX, MLS002473086, SCHEMBL501690, 3'' 4 5''-tetrahydroxystilbene, MEGxp0_001057, REGID_for_CID_658108, ACon1_001063, cid_5281717, HYDROXYRESVERATROL [INCI], 4-[(E)-2-(3,5-dihydroxyphenyl)vinyl]benzene-1,3-diol, PDHAOJSHSJQANO-OWOJBTEDSA-N, REGID_for_CID_5281717, DTXSID801030442, GLXC-19085, HMS2218H19, HMS3885N20, BCP24308, HY-N1430, BDBM50108046, LMPK13090011, MFCD11974969, NSC315550, s4739, Oxyresveratrol, >=97.0% (HPLC), AKOS015915071, AC-5279, CCG-266904, CS-5655, NSC 315550, NSC-315550, trans-2,4,3'',5''-tetrahydroxystilbene, 2,3'',4,5''-Tetrahydroxy-trans-stilbene, NCGC00169713-01, NCGC00169713-02, AS-35032, SMR001397189, trans-2,4,3'''',5''''-tetrahydroxystilbene, TRANS-STILBENE-2,4,3'',5''-TETROL, N.357, NS00124301, O0373, 2,3'',4,5''-STILBENETETROL, (E)-, EN300-7368059, A820013, EN300-18754447, J-501984, Q7116143, (E)-5,5''-(ethene-1,2-diyl)bis(benzene-1,3-diol), 1,3-Benzenediol, 4-(2-(3,5-dihydroxyphenyl)ethenyl)-, Z2311627398, (oxyresveratrol)4-[(E)-2-(3,5-dihydroxyphenyl)vinyl]benzene-1,3-diol, NCGC00169713-02!4-[(E)-2-(3,5-dihydroxyphenyl)ethenyl]benzene-1,3-diol C14H12O4 PDHAOJSHSJQANO-OWOJBTEDSA-N 4-[(E)-2-(3,5-dihydroxyphenyl)ethenyl]benzene-1,3-diol n.a. n.a. No No No No No No PMDBD2001063 P10 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001064 P15-CSP n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001065 P60.4Ac n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001066 Palivizumab Therapeutic Substance n.a. 188039-54-5 DB00110 PA164748781 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001067 Palmitic acid Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D02TVS 985 n.a. NPC216630 "palmitic acid, Hexadecanoic acid, 57-10-3, Cetylic acid, palmitate, n-Hexadecanoic acid, Hexadecylic acid, 1-Pentadecanecarboxylic acid, Hydrofol, n-Hexadecoic acid, Palmitinic acid, hexaectylic acid, Pentadecanecarboxylic acid, hexadecoic acid, 1-Hexyldecanoic Acid, Industrene 4516, Emersol 140, Emersol 143, Hystrene 8016, Hystrene 9016, Palmitinsaeure, Palmitic acid, pure, Palmitic acid 95%, Kortacid 1698, FEMA No. 2832, Loxiol EP 278, Palmitic acid (natural), Hydrofol Acid 1690, Cetyl acid, Prifac 2960, C16:0, HSDB 5001, Pristerene 4934, Pristerene-4934, Edenor C16, NSC 5030, AI3-01594, Lunac P 95KC, Lunac P 95, Lunac P 98, CCRIS 5443, Prifac-2960, CHEBI:15756, NSC5030, NSC-5030, EINECS 200-312-9, UNII-2V16EO95H1, FA 16:0, BRN 0607489, Palmitic acid (NF), DTXSID2021602, Glycon P-45, IMEX C 1498, 2V16EO95H1, Hexadecanoic acid (9CI), MFCD00002747, 67701-02-4, Palmitic acid (7CI,8CI), CHEMBL82293, DTXCID101602, CH3-[CH2]14-COOH, EC 200-312-9, 4-02-00-01157 (Beilstein Handbook Reference), n-hexadecoate, LMFA01010001, PA 900, EDENOR C 16-98-100, FA 1695, SURFAXIN COMPONENT PALMITIC ACID, 1-hexyldecanoate, NCGC00164358-01, LUCINACTANT COMPONENT PALMITIC ACID, 1219802-61-5, pentadecanecarboxylate, Hexadecanoic acid 10 microg/mL in Acetonitrile, HEXADECANOIC-11,11,12,12-D4 ACID, PALMITIC ACID (II), PALMITIC ACID [II], PALMITIC ACID (MART.), PALMITIC ACID [MART.], CH3-(CH2)14-COOH, Palmitic acid; Hexadecanoic acid, PLM, palmic acid, Hexadecanoate (n-C16:0), PALMITIC ACID (EP MONOGRAPH), PALMITIC ACID [EP MONOGRAPH], Acid, Palmitic, CAS-57-10-3, Acid, Hexadecanoic, SR-01000944716, Palmitic acid [USAN:NF], palmitoate, Hexadecoate, Palmitinate, Palmitinsaure, palmitic-acid, palmitoic acid, Hexadecanoicacid, Aethalic acid, Hexadecanoic acid Palmitic acid, 2hmb, 2hnx, Palmitic acid_jeyam, n-Hexadecyclic Acid, fatty acid 16:0, Palmitic Acid, FCC, Kortacid 1695, Palmitic acid_RaGuSa, Univol U332, Prifrac 2960, Hexadecanoic acid anion, Hexadecanoic--d5 Acid, 3v2q, Palmitic acid, >=99%, bmse000590, Epitope ID:141181, CETYL ACID [VANDF], PALMITIC ACID [MI], SCHEMBL6177, PALMITIC ACID [DSC], PALMITIC ACID [FCC], PALMITIC ACID [FHFI], PALMITIC ACID [HSDB], PALMITIC ACID [INCI], PALMITIC ACID [USAN], FAT, WLN: QV15, P5585_SIGMA, PALMITIC ACID [VANDF], GTPL1055, QSPL 166, PALMITIC ACID [USP-RS], PALMITIC ACID [WHO-DD], (1(1)(3)C)hexadecanoic acid, 1b56, HMS3649N08, Palmitic acid, analytical standard, Palmitic acid, BioXtra, >=99%, Palmitic acid, Grade II, ~95%, HY-N0830, Palmitic acid, natural, 98%, FG, Tox21_112105, Tox21_201671, Tox21_302966, AC9381, BDBM50152850, s3794, Palmitic acid, >=95%, FCC, FG, AKOS005720983, Tox21_112105_1, CCG-267027, CR-0047, DB03796, Palmitic acid, for synthesis, 98.0%, NCGC00164358-02, NCGC00164358-03, NCGC00256424-01, NCGC00259220-01, BP-27917, Palmitic acid, purum, >=98.0% (GC), SY006518, CS-0009861, NS00008548, P0002, P1145, Palmitic acid, SAJ first grade, >=95.0%, EN300-19603, C00249, D05341, Palmitic acid, Vetec(TM) reagent grade, 98%, PALMITIC ACID (CONSTITUENT OF SPIRULINA), Palmitic acid, >=98% palmitic acid basis (GC), A831313, Q209727, PALMITIC ACID (CONSTITUENT OF FLAX SEED OIL), PALMITIC ACID (CONSTITUENT OF SAW PALMETTO), SR-01000944716-1, SR-01000944716-2, BA71C79B-C9B1-451A-A5BE-B480B5CC7D0C, PALMITIC ACID (CONSTITUENT OF BORAGE SEED OIL), PALMITIC ACID (CONSTITUENT OF SPIRULINA) [DSC], F0001-1488, Z104474418, PALMITIC ACID (CONSTITUENT OF EVENING PRIMROSE OIL), PALMITIC ACID (CONSTITUENT OF SAW PALMETTO) [DSC], Palmitic acid, certified reference material, TraceCERT(R), Palmitic acid, European Pharmacopoeia (EP) Reference Standard, Palmitic acid, United States Pharmacopeia (USP) Reference Standard, Palmitic acid, Pharmaceutical Secondary Standard; Certified Reference Material, Sodium Palmitate, Palmitic acid sodium salt, Sodium hexadecanoate, Sodium pentadecanecarboxylate, HSDB 759" C16H32O2 IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid n.a. n.a. No No No No No No PMDBD2001068 Palmitoyl-DL-carnitine n.a. n.a. n.a. n.a. n.a. n.a. n.a. 461 n.a. n.a. PALMITOYLCARNITINE, 1935-18-8, O-palmitoylcarnitine, O-hexadecanoylcarnitine, Palmitylcarnitine, PALMITOYL-CARNITINE, 3-hexadecanoyloxy-4-(trimethylazaniumyl)butanoate, CHEBI:73067, (+/-)-palmitoyl carnitine, U8K6DKA8V2, 3-(hexadecanoyloxy)-4-(trimethylammonio)butanoate, 3-(hexadecanoyloxy)-4-(trimethylazaniumyl)butanoate, 1-Propanaminium,3-carboxy-N,N,N-trimethyl-2-[(1-oxohexadecyl)oxy]-, inner salt, 1-Propanaminium, 3-carboxy-N,N,N-trimethyl-2-((1-oxohexadecyl)oxy)-, inner salt, UNII-U8K6DKA8V2, carnitine palmitate, hexadecanoylcarnitines, palmitoyl-dl-carnitine, Acylcarnitine C16:0, DL-PALMITOYLCARNITINE, PALMITYL-DL-CARNITINE, PALMITOYL DL-CARNITINE, SCHEMBL115183, CHEMBL301722, DTXSID90895028, O-HEXADECANOYL-DL-CARNITINE, BDBM50230701, LMFA07070098, AKOS027326556, PALMITOYL CARNITINE, (+/-)-, AC(16:0), HY-126357, CS-0102941, P-1098, Q7128408, (+-)-3-Carboxy-N,N,N-trimethyl-2-((1-oxohexadecyl)oxy)-1-propanaminium inner salt, 1-Propanaminium, 3-carboxy-N,N,N-trimethyl-2-((1-oxohexadecyl)oxy)-, inner salt, (+-)-, AMMONIUM, (3-CARBOXY-2-HYDROXYPROPYL)TRIMETHYL-, HYDROXIDE, INNER SALT, PALMITATE, PALMITIC ACID, ESTER WITH (3-CARBOXY-2-HYDROXYPROPYL)TRIMETHYLAMMONIUM HYDROXIDE INNER SALT C23H45NO4 XOMRRQXKHMYMOC-UHFFFAOYSA-N 3-hexadecanoyloxy-4-(trimethylazaniumyl)butanoate n.a. n.a. No No No No No No PMDBD2001069 Pa-MAP n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001070 Pantaprazole n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001071 para-anisidine n.a. n.a. n.a. n.a. n.a. n.a. n.a. 7732 n.a. n.a. p-Anisidine, 4-Methoxyaniline, 104-94-9, 4-Methoxybenzenamine, 4-Anisidine, 4-Aminoanisole, p-Methoxyaniline, Benzenamine, 4-methoxy-, Anisidine, p-Aminoanisole, para-Anisidine, p-Anisylamine, 4-Methoxybenzeneamine, p-Methoxyphenylamine, 1-Amino-4-methoxybenzene, Anisole, p-amino-, p-Dianisidine, 4-Methoxy-1-aminobenzene, Aniline, p-methoxy-, 4-Methoxy-phenylamine, Aniline, 4-methoxy-, 4-METHOXY-ANILINE, NSC 7921, DTXSID7024532, (4-methoxyphenyl)-amine, 29191-52-4, CHEBI:82388, NSC-7921, 4-(Methoxy-d3)aniline hydrochloride, MFCD00007864, 575917SNR4, DTXCID104532, Anisidine, p-, CAS-104-94-9, CCRIS 917, 4-methoxyphenylamine, 4-methoxy-benzenamine, HSDB 1603, EINECS 203-254-2, paraanisidine, 4methoxyaniline, para anisidine, rho-anisidine, p-anisidin, beta -anisidine, AI3-02392, p-Amino-Anisole, UNII-575917SNR4, 4-Amino-anisole, p-methoxy aniline, p-methoxy-aniline, 4-methoxy aniline, para-methoxyaniline, 4methoxy-phenylamine, para-methoxy aniline, p-methoxyphenyl amine, p-Methoxy phenylamine, 4-(methyloxy)aniline, (4-methoxyphenyl)amine, 4-methoxy phenyl amine, 4-methoxy-phenyl amine, 4-amino-1-methoxybenzene, p-Anisidine, >=99%, P-ANISIDINE [HSDB], SCHEMBL5097, WLN: ZR DO1, BIDD:GT0008, CHEMBL295652, NSC7921, HMS1757G11, BCP26755, STR00220, Tox21_202437, Tox21_303039, AC-565, AKOS000100571, AM84313, 1-Methoxy-4-amino-benzen (p-anisidin), NCGC00091136-01, NCGC00091136-03, NCGC00091136-04, NCGC00257099-01, NCGC00259986-01, 1-Methoxy-4-amino-benzene / p-anisidine, BP-12035, A0487, A0802, CS-0015840, NS00020559, EN300-17444, A15088, C19326, A937237, AC-907/25014180, Q-200438, Q3333299, Z56938150, F2190-0441, InChI=1/C7H9NO/c1-9-7-4-2-6(8)3-5-7/h2-5H,8H2,1H, O8U C7H9NO BHAAPTBBJKJZER-UHFFFAOYSA-N 4-methoxyaniline n.a. n.a. No No No No No No PMDBD2001072 para-Benzoquinone Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D0M2EM 4650 n.a. NPC304788 "p-benzoquinone, 1,4-BENZOQUINONE, Benzoquinone, Quinone, 106-51-4, p-Quinone, cyclohexa-2,5-diene-1,4-dione, para-Benzoquinone, Chinone, 2,5-Cyclohexadiene-1,4-dione, para-Quinone, Cyclohexadienedione, 1,4-Benzoquine, 1,4-Cyclohexadienedione, 1,4-Dioxybenzene, Steara pbq, p-Chinon, Benzo-chinon, Benzo-1,4-quinone, 1,4-Diossibenzene, Chinon, 1,4-Dioxy-benzol, 1,4-Cyclohexadiene dioxide, Semiquinone anion, semiquinone radicals, RCRA waste number U197, NCI-C55845, USAF P-220, Cyclohexadiene-1,4-dione, 1,4-Benzochinon, NSC 36324, [1,4]benzoquinone, CHEBI:16509, Quinone1,4-Benzoquinone, MFCD00001591, NSC-36324, CHEMBL8320, DTXSID6020145, 3T006GV98U, 3225-29-4, 1,4-Benzoquinone, 99%, DTXCID40145, p-Chinon [German], Benzo-chinon [German], Caswell No. 719C, 1,4-Benzoquinone; SKF-21232, Chinon [Dutch, German], 1,4 benzoquinone, CAS-106-51-4, 1,4-Dioxy-benzol [German], CCRIS 933, 1,4-Diossibenzene [Italian], HSDB 1111, EINECS 203-405-2, UN2587, RCRA waste no. U197, EPA Pesticide Chemical Code 059805, parabenzochinon, UNII-3T006GV98U, p-benzo-quinone, AI3-09068, C6H4O2, Quinone; p-BQ, NSC36324, 2,4-dione, p-BQ, Benzo-1,4-quinone #, QUINONE [MI], Lopac-B-1266, QUINONE [WHO-DD], Benzoquinone [UN2587], Epitope ID:116219, WLN: L6V DVJ, Chinon(DUTCH, GERMAN), EC 203-405-2, cid_4650, PARA-QUINONE [IARC], Lopac0_000120, SCHEMBL18103, MLS002454445, GTPL6307, 2,5-cyclohexadiene-1-4-dione, BDBM22774, 1,4-BENZOQUINONE [HSDB], HMS2230N13, HMS3260G22, AMY21949, 1,4-BENZOQUINONE [USP-RS], Tox21_202020, Tox21_302970, Tox21_500120, Benzoquinone [UN2587] [Poison], c0261, AKOS000119965, AKOS025243267, CCG-204215, LP00120, SDCCGSBI-0050108.P002, UN 2587, 2,5-CYCLOHEXANDIEN-1,4-DIONE, p-Benzoquinone, reagent grade, >=98%, NCGC00015139-01, NCGC00015139-02, NCGC00015139-03, NCGC00015139-04, NCGC00015139-05, NCGC00015139-06, NCGC00015139-07, NCGC00015139-10, NCGC00091053-01, NCGC00091053-02, NCGC00091053-03, NCGC00256505-01, NCGC00259569-01, NCGC00260805-01, SMR000326659, VS-02448, B0089, B0887, EU-0100120, NS00003185, EN300-19699, B 1266, C00472, 2,5-Cyclohexadiene-1,4-dione, radical ion(1-), A801452, Q402719, SR-01000075705, J-503966, SR-01000075705-1, Z104474802, InChI=1/C6H4O2/c7-5-1-2-6(8)4-3-5/h1-4, 1,4-Benzoquinone, pharmaceutical secondary standard; traceable to USP, 1,4-Benzoquinone, United States Pharmacopeia (USP) Reference Standard, cyclohexa-2,5-diene-1,4-dione; QUINONE RING OF THE PLASTOQUINONE 9, 1,4-Benzoquinone, Pharmaceutical Secondary Standard; Certified Reference Material, 1,4-Benzoquinone;2,5-Cyclohexadiene-1,4-dione; Quinone; 2,5-Cyclohexadiene-1,4-dione" C6H4O2 AZQWKYJCGOJGHM-UHFFFAOYSA-N cyclohexa-2,5-diene-1,4-dione n.a. n.a. No No No No No No PMDBD2001073 para-ethoxyaniline n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001074 para-ethylaniline n.a. n.a. n.a. n.a. n.a. n.a. n.a. 11504 n.a. n.a. 4-ETHYLANILINE, 589-16-2, p-Ethylaniline, Benzenamine, 4-ethyl-, 4-Ethylphenylamine, Aniline, 4-ethyl-, 1-Amino-4-ethylbenzene, Aniline, p-ethyl-, 4-ethylbenzenamine, p-Ethylaminobenzene, 4-Aminoethylbenzene, 4-ethyl aniline, NSC 62015, MHX72W1ZQV, MFCD00007921, NSC-62015, 1219802-96-6, CCRIS 5060, EINECS 209-637-0, UNII-MHX72W1ZQV, BRN 0774319, p-ethyl aniline, 4-ethylanilin, para-Ethylaniline, 4- ethylaniline, 4-ethyl-aniline, p-Aminoethylbenzene, 4-ethyl-phenylamine, 4-(ethyl)-aniline, 4-Ethylaniline, 98%, PARA-ETHYL ANILINE, ETHYL ANILINE, P-, SCHEMBL4409, WLN: ZR D2, 4-12-00-02419 (Beilstein Handbook Reference), DTXSID0022066, NSC62015, STR02939, AC9511, AKOS000119392, CS-W020122, AM806842, SY012867, E0061, NS00005225, EN300-20347, Q27284036, F2190-0422, Z104477836, InChI=1/C8H11N/c1-2-7-3-5-8(9)6-4-7/h3-6H,2,9H2,1H C8H11N HRXZRAXKKNUKRF-UHFFFAOYSA-N 4-ethylaniline n.a. n.a. No No No No No No PMDBD2001075 para-toluidine n.a. n.a. n.a. n.a. n.a. n.a. n.a. 7813 n.a. n.a. p-Toluidine, 4-Methylaniline, 106-49-0, 4-Toluidine, 4-Methylbenzenamine, p-Tolylamine, 4-AMINOTOLUENE, Benzenamine, 4-methyl-, p-Methylaniline, p-Toluidin, p-Methylbenzenamine, p-Aminotoluene, 1-Amino-4-methylbenzene, Naphtol AS-KG, Naphtol AS-KGLL, Aniline, p-methyl-, 4-Aminotoluen, 4-Amino-1-methylbenzene, para-toluidine, RCRA waste number U353, C.I. Azoic Coupling Component 107, NSC 15350, 12221-03-3, C.I. 37107, 26915-12-8, AZOIC COUPLING COMPONENT 107, DTXSID6021872, I1D0KL7I4U, CHEMBL58521, CHEBI:37825, MFCD00007906, NSC-15350, Toluidine, p-, 4-methylphenylamine, DTXCID601872, p-Toluidin [Czech], p-Toluidyna [Polish], 4-Aminotoluen [Czech], p-Toluidyna, CAS-106-49-0, CCRIS 598, HSDB 2044, CI Azoic Coupling Component 107, EINECS 203-403-1, RCRA waste no. U353, UNII-I1D0KL7I4U, paratoluidine, CI 37107, 4methylaniline, AI3-19858, p-tolyl-amine, 4-tolylamine, 4-amino-toluene, para-methylaniline, 4-methyl aniline, 4-methyl-aniline, 4MN, 4-methyl-phenylamine, p-Toluidine, 99%, 4-METHYLBENZAMINE, p-Toluidine, 99.6%, P-TOLUIDINE [MI], EC 203-403-1, P-Toluidine/4-Aminotoluene, WLN: ZR D1, SCHEMBL11887, p-Toluidine, liquid or solid, P-TOLUIDINE [USP-RS], 4-AMINOTOLUENE [HSDB], p-Toluidine, for synthesis, 99%, P-TOLUIDINE [USP IMPURITY], NSC15350, Tox21_202142, Tox21_300168, BDBM50008562, AKOS000119134, AM10491, GS-6708, p-Toluidine 100 microg/mL in Methanol, NCGC00247917-01, NCGC00247917-02, NCGC00247917-03, NCGC00254002-01, NCGC00259691-01, BP-11946, NS00003075, p-Toluidine, SAJ special grade, >=99.0%, T0300, EN300-17941, AMINOBENZOIC ACID IMPURITY D [EP IMPURITY], J-001600, p-Toluidine, liquid or solid [UN1708] [Poison], Q2043499, Z57127875, F2190-0420, InChI=1/C7H9N/c1-6-2-4-7(8)5-3-6/h2-5H,8H2,1H, P-TOLUIDINE, United States Pharmacopeia (USP) Reference Standard, p-Toluidine, for spectrophotometric det. of Au, Tl(III), W, >=99.0% C7H9N RZXMPPFPUUCRFN-UHFFFAOYSA-N 4-methylaniline n.a. n.a. No No No No No No PMDBD2001076 Paromomycin? n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001077 Patulin Therapeutic Substance Investigational Drug 149-29-1 DB15586 n.a. n.a. D0LB4A 4696 4534 NPC471611 "patulin, 149-29-1, Clavacin, Clavatin, Expansin, Patuline, Expansine, Claviformin, Claviform, Clairformin, Leucopin, Terinin, Gigantin, Mycoin, Mycoin C3, Penicidin, Tercinin, Mycoine C3, Mycosin, Penatin, Mycoin C, 4-Hydroxy-4H-furo[3,2-c]pyran-2(6H)-one, 4H-Furo[3,2-c]pyran-2(6H)-one, 4-hydroxy-, 4-hydroxy-4,6-dihydrofuro[3,2-c]pyran-2-one, Sch-351633, NSC 8120, NSC 32951, 4-Hydroxy-4H-furo(3,2-C)pyran-2(6H)-one, 4H-Furo(3,2-c)pyran-2(6H)-one, 4-hydroxy-, (2,4-Dihydroxy-2H-pyran-3(6H)-ylidene)acetic acid, 3,4-lactone, 4,6-Dihydro-4-hydroxy-2H-furo(3,2-c)pyran-2-one, NSC8120, NSC32951, MFCD00005858, SCH 351633, (2,4-Dihydroxy-2H-pyran-3(6H)-ylidene)acetic acid-3,4-lactone, Acetic acid, (2,4-dihydroxy-2H-pyran-3(6H)-ylidene)-, 3,4-lactone, 95X2BV4W8R, CHEMBL294018, CHEBI:74926, NSC-8120, 4,6-dihydro-4-hydroxy-2H-furo[3,2-c]pyran-2-one, NSC-32951, Patulin 100 microg/mL in Acetonitrile, (2, 3,4-lactone, 4-Hydroxy-4,6-dihydrofuro[4,5-c]pyran-2-one, 4H-Furo[3, 4-hydroxy-, 4-hydroxy-4,6-dihydro-2H-furo[3,2-c]pyran-2-one, 2,.alpha.-acetic acid, 3,4-lactone, WLN: T56 BOV GO IU & TJ FQ, 247172-18-5, CCRIS 4940, HSDB 3522, SR-05000002238, EINECS 205-735-2, BRN 0149675, UNII-95X2BV4W8R, Clavicin, Clavitin, Expansion, 2H-Pyran-.delta.(sup 3(6H), 2,4-dihydroxy-, 3,4-lactone, Acetic acid,4-dihydroxy-2H-pyran-3(6H)-ylidene)-, 3,4-lactone, Gigantic acid?, 4H-Furo(3,3-c)pyran-2(6H)-one, 4-hydroxy-, Clavacin; Expansin, DL-PATULIN, 520 - Patulin, Spectrum_000015, starbld0009637, Antibiotic YS 1649, PATULIN [HSDB], PATULIN [IARC], PATULIN [MI], 2,4-Dihydroxy-2H-pyran-delta-3(6H),alpha-acetic acid-3,4-lactone, Spectrum3_000796, Spectrum4_000753, Spectrum5_001659, PATULIN 13C3, 2H-Pyran-delta(sup 3(6H),alpha)-acetic acid, 2,4-dihydroxy-, 3,4-lactone, Antibiotic Sch 351633, Patulin, reference material, Neuro_000008, Clairformin;Patuline;Clavatin, SCHEMBL29056, BSPBio_002532, KBioGR_001106, KBioSS_000355, 5-18-03-00005 (Beilstein Handbook Reference), DivK1c_000438, SPECTRUM1503904, MEGxm0_000442, DTXSID2021101, ACon1_002106, HMS501F20, KBio1_000438, KBio2_000355, KBio2_002923, KBio2_005491, KBio3_001752, NINDS_000438, HMS1923M19, Patulin, >=98.0% (HPLC), BCP29227, EX-A5478, HY-N6779, BDBM50158841, AKOS015904103, 1ST7008, BS-1260, CCG-208451, DB15586, YS 1649, IDI1_000438, SMP1_000230, NCGC00095272-01, NCGC00095272-02, NCGC00095272-03, NCGC00095272-04, NCGC00095272-05, 1ST7008-100A, NCI60_041782, 4-Hydroxy-4H,6H-furo[3,2-c]pyran-2-one, CS-0083018, NS00011821, Patulin Solution in Acetonitrile, 100ug/mL, 4-Hydroxy-4H-Furo(3,3-c)pyran-2(6H)-one, A12069, 4-hydroxy-2H,4H,6H-furo[3,2-c]pyran-2-one, Q414526, J-008576, SR-05000002238-2, SR-05000002238-3, 2,4-Dihydroxy-2H-pyran-alpha -acetic acid, 3, 4-lactone, 4-Hydroxy-4H-furo[3,2-c]pyran-2(6H)-one, 9CI, 8CI, (+/-)-4-HYDROXY-4H-FURO(3,2-C)PYRAN-2(6H)-ONE, 2H-Pyran-.delta.(sup 3(6H), 2,4-dihydroxy-,3,4-lactone, 2H-Pyran-alpha )-acetic acid, 2, 4-dihydroxy-,3,4-lactone, 2H-Pyran-alpha )-acetic acid, 2,4-dihydroxy-, 3,4-lactone, 2,4-Dihydroxy-2H-pyran-.delta.-3(6H),.alpha.-acetic acid, 3,4-lactone, 2H-Pyran-.delta.(3(6H),.alpha.)-acetic acid, 2,4-dihydroxy-,3,4-lactone" C7H6O4 ZRWPUFFVAOMMNM-UHFFFAOYSA-N 4-hydroxy-4,6-dihydrofuro[3,2-c]pyran-2-one n.a. n.a. No No No No No No PMDBD2001078 p-Coumaric acid Therapeutic Substance Investigational Drug 501-98-4 DB04066 n.a. n.a. D0AU0M 637542 553148 NPC81010 "p-coumaric acid, 4-Hydroxycinnamic acid, 501-98-4, p-Hydroxycinnamic acid, trans-4-Hydroxycinnamic acid, 4-Coumaric acid, 7400-08-0, trans-p-Coumaric acid, p-Cumaric acid, p-Hydroxy-cinnamic acid, Para-Coumaric acid, Naringeninic acid, Hydroxycinnamic acid, (E)-p-Coumaric acid, trans-4-coumaric acid, 3-(4-hydroxyphenyl)acrylic acid, trans-p-Coumarinic acid, (E)-3-(4-Hydroxyphenyl)acrylic acid, Cinnamic acid, p-hydroxy-, (E)-p-Hydroxycinnamic acid, 4''-hydroxycinnamic acid, trans-p-Hydroxycinnamic acid, 2-propenoic acid, 3-(4-hydroxyphenyl)-, (2E)-, p-Hydroxyphenylacrylic acid, (2E)-3-(4-hydroxyphenyl)prop-2-enoic acid, 3-(4-Hydroxyphenyl)-2-propenoic acid, 4-coumarate, Cinnamic acid, p-hydroxy-, (E)-, trans-p-Hydroxycinnamate, 2-Propenoic acid, 3-(4-hydroxyphenyl)-, (E)-3-(4-Hydroxyphenyl)-2-propenoic acid, (E)-3-(4-hydroxyphenyl)prop-2-enoic acid, 4-Hydroxycinnamate, (2E)-3-(4-hydroxyphenyl)acrylic acid, beta-(4-Hydroxyphenyl)acrylic acid, NSC 59260, trans-4-hydroxycinnamate, UNII-IBS9D1EU3J, IBS9D1EU3J, EINECS 231-000-0, Para coumaric acid, (E)-4-hydroxycinnamic acid, 3-(4-hydroxyphenyl)prop-2-enoic acid, NSC 674321, p-coumarate, 2-Propenoic acid, 3-(4-hydroxyphenyl)-, (E)-, BRN 2207381, BRN 2207383, CHEBI:32374, ORISTAR PCA, parahydroxycinnamic acid, MFCD00004399, NSC-59260, NSC-674321, 4-hydroxy cinnamic acid, CHEMBL66879, PARA HYDROXYCINNAMIC ACID, 1261170-80-2, beta-[4-Hydroxyphenyl]acrylic acid, 0-10-00-00297 (Beilstein Handbook Reference), 4-10-00-01005 (Beilstein Handbook Reference), NSC674321, trans-p-coumarate, Dehydroepiandrosterone-[D6] (CertiMass solution), 3-(4-hydroxyphenyl)acrylate, .beta.-[4-Hydroxyphenyl]acrylic acid, trans-HPPA, (E)-3-[4-hydroxyphenyl]-2-propenoic acid, 4-coumaric acid, (E)-isomer, 4-Hydroxycinnamicacid, trans-p-Cumaric Acid, 4-Hydroxycinamic acid, .BETA.-(4-HYDROXYPHENYL)ACRYLIC ACID, 2-Propenoic acid, 3-(4-hydroxyphenyl)-, (Z)-, CHEBI:36090, hydroxycinnamate, Para coumarate, p-coumaric-acid, Para-Coumarate, p-Cumarate, naringeninic-acid, p-Hydroxycinnamate, 4qem, Coumaric acid, p-, 4''-Hydroxycinnamate, 4-Hydroxy cinnamate, p-Coumaric acid,trans, p-Coumaric acid 98%, 4f8j, p-Coumaric acid, trans, 4-Hydroxyphenylpropenoate, (2E)-3-(4-Hydroxyphenyl)-2-propenoic acid, trans-3-(4''-hydroxyphenyl)-2-propenoic acid, bmse000150, bmse000591, bmse010208, trans-4-HydroxycinnamicAcid, b-[4-Hydroxyphenyl]acrylate, SCHEMBL39106, p-hydroxycinnamic acid (M4), MLS001066419, p-Hydroxycinnamic acid, trans, P-COUMARIC ACID [MI], beta-[4-Hydroxyphenyl]acrylate, BDBM4374, GTPL5787, SODIUM2,4-PENTANEDIONATE, b-[4-Hydroxyphenyl]acrylic acid, trans-p-HydroxyzimtsA currencyure, DTXSID30901076, P-COUMARIC ACID [WHO-DD], HMS1409E10, 3-(4-Hydroxyphenyl)-2-propenoate, HYDROXYCINNAMIC ACID [INCI], BCP22803, HY-N2391, NSC59260, STR06515, 4-HYDROXYPHENYLPROPENOIC ACID, Cinnamic acid, 4-hydroxy-, trans-, AC7957, CK2547, s4759, s9564, AKOS000120685, p-Coumaric acid;p-Hydroxycinnamic acid, BCP9001042, CCG-266309, CS-W020394, DB04066, p-Coumaric acid, >=98.0% (HPLC), (E)-3-(4-hydroxyphenyl)prop-2-enoate, NCGC00246974-01, 1ST40051, 50940-26-6, AC-10318, AC-34130, AC-34133, AS-12000, BP-13278, SMR000112201, (E)-3-(4-hydroxyphenyl)prop-2-enoicacid, trans-p-Coumaric acid, analytical standard, AM20050138, NS00068187, EN300-17292, A19490, C00811, Q99374, (2E)-3-(4-Hydroxyphenyl)-2-propenoic acid #, A828008, AE-562/40414679, trans-p-Coumaric acid 1000 microg/mL in Acetone, Q-100560, W-104438, Z56911963, 0C1BFF2D-2CF7-4FC1-9F76-3268C2C7F783, F2191-0188, p-Coumaric acid, primary pharmaceutical reference standard, (E)-3-(4-hydroxyphenyl)prop-2-enoate;Trans-4-Hydroxycinnamic Acid, InChI=1/C9H8O3/c10-8-4-1-7(2-5-8)3-6-9(11)12/h1-6,10H,(H,11,12)/b6-3" C9H8O3 NGSWKAQJJWESNS-ZZXKWVIFSA-N (E)-3-(4-hydroxyphenyl)prop-2-enoic acid n.a. n.a. No No No No No No PMDBD2001079 Pelargonidin n.a. n.a. n.a. n.a. n.a. n.a. n.a. 440832 n.a. NPC190454 Pelargonidin, Pelargonidol, 7690-51-9, CHEBI:25863, 2-(4-hydroxyphenyl)chromenylium-3,5,7-triol, 3,5,7-trihydroxy-2-(4-hydroxyphenyl)-1-benzopyrylium, 1-Benzopyrylium, 3,5,7-trihydroxy-2-(4-hydroxyphenyl)-, CHEMBL591036, 3,4'',5,7-Tetrahydroxyflavylium, SCHEMBL20592, CHEMBL1197905, DTXSID40861793, XVFMGWDSJLBXDZ-UHFFFAOYSA-O, 3,4'',5,7-tetrahydroxy-Flavylium, BDBM50121994, BDBM50326998, LMPK12010003, NS00004445, C05904, 3,5,7-trihydroxy-2-(4-hydroxyphenyl)chromenylium, Q2522451 C15H11O5+ XVFMGWDSJLBXDZ-UHFFFAOYSA-O 2-(4-hydroxyphenyl)chromenylium-3,5,7-triol n.a. n.a. No No No No Yes No rxn04389,rxnDiet168,rxnAdd21,rxnAdd22 PMDBD2001080 Penciclovir Therapeutic Substance Approved Drug 39809-25-1 DB00299 PA450839 D05407 D07BYK 135398748 4563 n.a. "penciclovir, 39809-25-1, Denavir, Penciclovirum, BRL-39123, BRL 39123, Vectavir, Penciclovirum [INN-Latin], Pencyclovir, 9-(4-Hydroxy-3-(hydroxymethyl)butyl)guanine, CCRIS 9213, PE2, 9-(4-HYDROXY-3-(HYDROXYMETHYL)BUT-1-YL)GUANINE, 2-amino-9-[4-hydroxy-3-(hydroxymethyl)butyl]-3H-purin-6-one, UNII-359HUE8FJC, 359HUE8FJC, 9-(4-hydroxy-3-hydroxymethylbut-1-yl)guanine, NSC-759624, 9-(4-hydroxy-3-hydroxymethylbut-1-yl)-guanine, CHEBI:7956, DTXSID9046491, HSDB 8123, 9-[4-Hydroxy-3-(hydroxymethyl)butyl]guanine, 9-[4-hydroxy-3-(hydroxymethyl)but-1-yl]guanine, CHEMBL1540, DTXCID7026491, 2-amino-9-(4-hydroxy-3-(hydroxymethyl)butyl)-1H-purin-6(9H)-one, 2-amino-9-(4-hydroxy-3-(hydroxymethyl)butyl)-1,9-dihydro-6H-purin-6-one, 6H-Purin-6-one, 2-amino-1,9-dihydro-9-(4-hydroxy-3-(hydroxymethyl)butyl)-, 9-[2-hydroxy-1-(hydroxymethyl)-ethoxymethyl]guanine, NSC 759624, PCV, NCGC00164630-01, 2-amino-9-[4-hydroxy-3-(hydroxymethyl)butyl]-1H-purin-6-one, 2-amino-9-[4-hydroxy-3-(hydroxymethyl)butyl]-1,9-dihydro-6H-purin-6-one, Penciclovirum (INN-Latin), PENCICLOVIR (MART.), PENCICLOVIR [MART.], Penciclovir [USAN:INN:BAN], 2-[2-(2-amino-6-hydroxypurin-9-yl)ethyl]propane-1,3-diol, Adenovir, PENCICLOVIR (USP IMPURITY), PENCICLOVIR [USP IMPURITY], 6H-Purin-6-one, 2-amino-1,9-dihydro-9-[4-hydroxy-3-(hydroxymethyl)butyl]-, 2-AMINO-1,9-DIHYDRO-9-(4-HYDROXY-3-(HYDROXYMETHYL)BUTYL)-6H-PURIN-6-ONE, 6H-Purin-6-one, 2-amino-1,9-dihydro-9-[4-hydroxy-3-(hydroxymethyl)butyl-3,3,4,4-d4]-, SMR000466317, Denavir (TN), CAS-39809-25-1, SR-05000001512, 9-(2-hydroxy-1-(hydroxymethyl)-ethoxymethyl)guanine, Penciclovir (USAN/INN), Penciclovir,(S), 2-amino-9-[4-hydroxy-3-(hydroxymethyl)butyl]-3,9-dihydropurin-6-one, Penciclovir- Bio-X, MB2488, Penciclovirum (Latin), PENCICLOVIR [MI], PENCICLOVIR [INN], PENCICLOVIR [USAN], PENCICLOVIR [VANDF], SCHEMBL3494, PENCICLOVIR [WHO-DD], 2-Amino-1,9-dihydro-9-, MLS000759422, MLS001424110, SCHEMBL19236307, D06BB06, J05AB13, PENCICLOVIR [ORANGE BOOK], JNTOCHDNEULJHD-UHFFFAOYSA-N, HMS2051D06, HMS2090H11, HMS2232A11, HMS3371P04, HMS3393D06, HMS3652H07, HMS3713P14, Pharmakon1600-01502320, BCP13112, BRL39123, Tox21_112248, 2-amino-9-(4-hydroxy-3-(hydroxymethyl)butyl)-3H-purin-6(9H)-one, BDBM50210804, MFCD00866931, NSC759624, s4184, AKOS007930676, AKOS026750166, BRL 39123;VSA 671, Tox21_112248_1, AC-8067, CCG-101000, CCG-213029, CCG-266987, CS-1355, DB00299, KS-5016, NC00250, NCGC00263533-01, NCGC00263533-12, NCGC00386270-02, BP164247, HY-17424, NS00000601, P2164, SW197630-2, C07417, D05407, AB00698242-05, AB01275514-01, AB01275514_02, AB01566918_01, EN300-1081992, A824740, Q420364, SR-01000763121, SR-01000763121-3, SR-05000001512-1, SR-05000001512-2, Z2025569265, 2-[2-(2-Amino-6-hydroxy-purin-9-yl)-ethyl]-propane-1,3-diol, 2-amino-9-(4-hydroxy-3-hydroxymethylbutyl)-1,9-dihydropurin-6-one, 2-amino-9-[4-hydroxy-3-(hydroxymethyl)butyl]-3H-purin- 6-one, 2-azanyl-9-[3-(hydroxymethyl)-4-oxidanyl-butyl]-3H-purin-6-one, 2-Amino-9-(4-hydroxy-3-hydroxymethyl-butyl)-1,9-dihydro-purin-6-one, 2-amino-9-[4-hydroxy-3-(hydroxymethyl)butyl]-6,9-dihydro-1H-purin-6-one, 2-amino-9-[4-hydroxy-3-(hydroxymethyl)butyl]-6,9-dihydro-3H-purin-6-one, 2-Amino-9-(4-hydroxy-3-hydroxymethyl-butyl)-1,9-dihydro-purin-6-one (PCV), 2-Amino-9-(4-hydroxy-3-hydroxymethyl-butyl)-1,9-dihydro-purin-6-one(PCV, Penciclovir)" C10H15N5O3 JNTOCHDNEULJHD-UHFFFAOYSA-N 2-amino-9-[4-hydroxy-3-(hydroxymethyl)butyl]-1H-purin-6-one n.a. Antiviral Agents No No No No No No PMDBD2001081 Penicillenol A1 n.a. n.a. n.a. n.a. n.a. n.a. n.a. 54720258 n.a. n.a. penicillenol A1, CHEBI:212639, (3Z,5S)-5-(1-hydroxyethyl)-3-(1-hydroxy-2-methyloctylidene)-1-methylpyrrolidine-2,4-dione C16H27NO4 KWUIFAHSOVLDLQ-QZDCTXLUSA-N (3Z,5S)-5-(1-hydroxyethyl)-3-(1-hydroxy-2-methyloctylidene)-1-methylpyrrolidine-2,4-dione n.a. n.a. No No No No No No PMDBD2001082 Penicillenol A2 n.a. n.a. n.a. n.a. n.a. n.a. n.a. 135017477 n.a. n.a. penicillenol A2, CHEBI:227185, (3Z,5R)-5-(1-hydroxyethyl)-3-(1-hydroxy-2-methyloctylidene)-1-methylpyrrolidine-2,4-dione C16H27NO4 KWUIFAHSOVLDLQ-PKLLGXBMSA-N (3Z,5R)-5-(1-hydroxyethyl)-3-(1-hydroxy-2-methyloctylidene)-1-methylpyrrolidine-2,4-dione n.a. n.a. No No No No No No PMDBD2001083 Penicillenol B1 n.a. n.a. n.a. n.a. n.a. n.a. n.a. 54685489 n.a. n.a. penicillenol B1, CHEMBL496099 C16H25NO3 FRKQEEBAWRDYCO-SDQBBNPISA-N (5Z)-5-ethylidene-4-hydroxy-1-methyl-3-(2-methyloctanoyl)pyrrol-2-one n.a. n.a. No No No No No No PMDBD2001084 Penicillenol B2 n.a. n.a. n.a. n.a. n.a. n.a. n.a. 54685487 n.a. n.a. penicillenol B2, CHEMBL497966 C16H25NO3 FRKQEEBAWRDYCO-WUXMJOGZSA-N (5E)-5-ethylidene-4-hydroxy-1-methyl-3-(2-methyloctanoyl)pyrrol-2-one n.a. n.a. No No No No No No PMDBD2001085 Penicillenol C1 n.a. n.a. n.a. n.a. n.a. n.a. n.a. 135550825 n.a. n.a. penicillenol C1, CHEBI:217066, (3Z,5S)-5-(1-hydroxyethyl)-3-[(E)-1-hydroxy-2-methyloct-6-enylidene]-1-methylpyrrolidine-2,4-dione C16H25NO4 DRDBTDHUTFJYHV-PZMARAHQSA-N (3Z,5S)-5-(1-hydroxyethyl)-3-[(E)-1-hydroxy-2-methyloct-6-enylidene]-1-methylpyrrolidine-2,4-dione n.a. n.a. No No No No No No PMDBD2001086 Penicillenol C2 n.a. n.a. n.a. n.a. n.a. n.a. n.a. 135550826 n.a. n.a. penicillenol C2, CHEBI:210467, (3Z,5R)-5-(1-hydroxyethyl)-3-[(E)-1-hydroxy-2-methyloct-6-enylidene]-1-methylpyrrolidine-2,4-dione C16H25NO4 DRDBTDHUTFJYHV-WSUZUZABSA-N (3Z,5R)-5-(1-hydroxyethyl)-3-[(E)-1-hydroxy-2-methyloct-6-enylidene]-1-methylpyrrolidine-2,4-dione n.a. n.a. No No No No No No PMDBD2001087 Penicillic acid n.a. n.a. n.a. n.a. n.a. n.a. n.a. 1268111 n.a. n.a. penicillic acid, 90-65-3, 2,5-Hexadienoic acid, 3-methoxy-5-methyl-4-oxo-, (2Z)-3-methoxy-5-methyl-4-oxohexa-2,5-dienoic acid, Pencillic acid, Kyselina penicilova, MFCD00004365, 3-Methoxy-5-methyl-4-oxohexa-2,5-dienoic acid, Penicillinsaure, SCHEMBL148669, SCHEMBL8050382, DTXSID1074830, VOUGEZYPVGAPBB-XQRVVYSFSA-N, HY-N6777, Penicillic acid, >=98% (HPLC), NSC-402844, CS-0034504, G12043, Q2546851, (2Z)-3-Methoxy-5-methyl-4-oxo-2,5-hexadienoic acid #, .gamma.-Keto-.beta.-methoxy-.delta.-methylene-.delta.(sup .alpha.)-hexenoic acid C8H10O4 VOUGEZYPVGAPBB-XQRVVYSFSA-N (2Z)-3-methoxy-5-methyl-4-oxohexa-2,5-dienoic acid n.a. n.a. No No No No No No PMDBD2001088 Penicillin G Therapeutic Substance Phase 3 n.a. n.a. n.a. n.a. D00QAR 5904 n.a. NPC90478 penicillin g, Benzylpenicillin, 61-33-6, Benzyl penicillin, Benzylpenicillinic acid, Free penicillin II, Pencillin G, Benzylpenicillin G, Dropcillin, Free penicillin G, Gelacillin, Liquacillin, Pharmacillin, Pradupen, Cilopen, Bencilpenicilina, Specilline G, Benzylpenicillinum, Cilloral, Cosmopen, Pfizerpen, Benzylpenicilline, Free benzylpenicillin, Benzopenicillin, bensylpenicillin, (5R,6R)-Benzylpenicillin, 6-(2-Phenylacetamido)penicillanic acid, Penicillin, (phenylmethyl)-, benzyl benicillin, Galofak, Compocillin G, Penicillin-G potassium, CHEBI:18208, HSDB 3166, Benzylpenicillinum [Latin], Penicillinic acid, (phenylmethyl)-, Phenylacetamidopenicillanic acid, (2S,5R,6R)-3,3-Dimethyl-7-oxo-6-(2-phenylacetamido)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, EINECS 200-506-3, UNII-Q42T66VG0C, NSC 193396, BRN 0044740, Q42T66VG0C, (Phenylmethyl)penicillin, Benzyl-6-aminopenicillinic acid, Penicillinic acid, benzyl-, NSC-193396, DTXSID5046934, Ursopen, J01CE01, 4-27-00-05861 (Beilstein Handbook Reference), (Phenylmethyl)penicillinic acid, 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-((phenylacetyl)amino)- (2S-(2alpha,5alpha,6beta))-, Benzylpenicillin (INN), Benzylpenicillinum (Latin), (2S,5R,6R)-3,3-Dimethyl-7-oxo-6-(2-phenylacetamido)-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, (2S,5R,6R)-3,3-dimethyl-7-oxo-6-(phenylacetamido)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-(2-phenylacetamido)-, BENZYLPENICILLIN [INN], BENZYLPENICILLIN (MART.), BENZYLPENICILLIN [MART.], Cillora, PenicillinG, Bencilpenicilina [Spanish], Benzylpenicilline [French], Benzylpenicillin [INN:BAN], 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-[(phenylacetyl)amino]- [2S-(2alpha,5alpha,6beta)]-, SMR000538912, PHENOXYMETHYLPENICILLIN IMPURITY A (EP IMPURITY), PHENOXYMETHYLPENICILLIN IMPURITY A [EP IMPURITY], NSC193396, Penicillin,(S), 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-(2-phenylacetamido)-, PENICILLIN-G, NSC131815, Spectrum_000933, CHEMBL29, Prestwick0_001078, Prestwick1_001078, Prestwick2_001078, Prestwick3_001078, Spectrum2_000518, Spectrum3_000542, Spectrum4_000471, Spectrum5_001108, Epitope ID:114070, PENICILLIN G [MI], SCHEMBL3783, PENICILLIN G [HSDB], BSPBio_001096, BSPBio_002183, KBioGR_000942, KBioSS_001413, PENICILLIN G [VANDF], (2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-((phenylacetyl)amino)-, (2S-(2alpha,5alpha,6beta))-, MLS000766897, MLS001032123, MLS001173382, DivK1c_000316, SPBio_000475, SPBio_002998, BPBio1_001206, GTPL4796, DTXCID3026934, KBio1_000316, KBio2_001413, KBio2_003981, KBio2_006549, KBio3_001683, BENZYLPENICILLIN [WHO-DD], NINDS_000316, GLXC-25718, HMS2875L09, (2S,6R)-3,3-Dimethyl-7-oxo-6-(2-phenylacetamido)-4-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylic acid, HY-N7139, BDBM50022787, Phenylacetyl-6-aminopenicillanic acid, AKOS005203091, DB01053, IDI1_000316, NCGC00159348-02, NCGC00159348-03, 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6- (2-phenylacetamido)-, 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-[(phenylacetyl)amino]- (2S,5R,6R)-, SBI-0051476.P003, (2S,5R,6R)-3,3-dimethyl-7-oxo-6-, Bicillin (*Benzathine Salt, Tetrahydrate*), CS-0013727, NS00068016, C05551, D02336, (2-phenylacetamido)-4-thia-1-azabicyclo[3.2.0], A833169, EN300-19631164, Q258450, W-109262, Benzylpenicillin 1000 microg/mL in Acetonitrile:Water, BRD-K55191674-236-03-7, BRD-K55191674-237-02-7, BRD-K55191674-237-12-6, Benzylpenicillin, Antibiotic for Culture Media Use Only, 2,2-dimethyl-6beta-(phenylacetamido)penam-3alpha-carboxylic acid, PHENOXYMETHYLPENICILLIN POTASSIUM IMPURITY A [EP IMPURITY], PHENOXYMETHYLPENICILLIN (BENZATHINE) TETRAHYDRATE IMPURITY A [EP IMPURITY], (+)-3,3-Dimethyl-7-oxo-6-phenylacetylamino-4-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylic acid(penicillin G), (2S,5R,6R)-3,3-dimethyl-7-oxo-6-(2-phenylacetamido)-4-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylic acid, (2S,5R,6R)-3,3-Dimethyl-7-oxo-6-(2-phenylacetamido)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylicacid, (2S,5R,6R)-3,3-DIMETHYL-7-OXO-6-[(PHENYLACETYL)AMINO]-4-THIA-1-AZABICYCLO[3.2.0]HEPTANE-2-CARBOXYLIC ACID, (2S,5R,6R)-3,3-Dimethyl-7-oxo-6-phenylacetylamino-4-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylic acid, 3,3-Dimethyl-7-oxo-6-phenylacetylamino-4-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylic acid, 3,3-Dimethyl-7-oxo-6-phenylacetylamino-4-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylic acid anion (Penicillin G), 3,3-Dimethyl-7-oxo-6-phenylacetylamino-4-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylic acid(penicillin G), 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]- (2S,5R,6R)-, 4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-[(phenylacetyl)amino]-, (2S,5R,6R)- C16H18N2O4S JGSARLDLIJGVTE-MBNYWOFBSA-N (2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid n.a. n.a. No No No No No No PMDBD2001089 Pentagalloylglucose Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D00QDR 65238 n.a. NPC104222 "Pentagalloylglucose, 14937-32-7, 1,2,3,4,6-penta-O-galloyl-beta-D-glucopyranose, Pentagalloyl glucose, 1,2,3,4,6-Pentagalloylglucose, 1,2,3,4,6-Penta-O-galloyl-beta-D-glucose, beta-Penta-O-galloyl-glucose, 1,2,3,4,6-Pgg, 1,2,3,4,6-Pentakis-O-galloyl-beta-D-glucose, GALLOTANNIN 15, beta-D-pentagalloylglucose, 1,2,3,4,6-Pentagalloyl glucose, Pentagalloyl-beta-D-glucose, UNII-3UI3K8W93I, 1,2,3,4,6-Penta-O-galloylglucose, beta-D-Glucopyranose pentakis(3,4,5-trihydroxybenzoate), 3UI3K8W93I, CHEBI:18082, 1,2,3,4,6-Penta-O-galloyl beta-glucopyranose, Beta-1,2,3,4,6-Pentagalloylglucose, CHEMBL382408, C04576, 1,2,3,4,6-pentakis-O-(3,4,5-trihydroxybenzoyl)-beta-D-glucopyranose, J277.746K, 1,2,3,4,6-penta-O-galloyl-D-glucopyranose, 5GG, PGG, (2S,3R,4S,5R,6R)-6-(((3,4,5-Trihydroxybenzoyl)oxy)methyl)tetrahydro-2H-pyran-2,3,4,5-tetrayl tetrakis(3,4,5-trihydroxybenzoate), penta-O-galloyl-beta-d-glucose hydrate, penta-O-galloyl-beta-D-glucoside, DB03208, [(2R,3R,4S,5R,6S)-3,4,5,6-tetrakis[(3,4,5-trihydroxybenzoyl)oxy]tetrahydropyran-2-yl]methyl 3,4,5-trihydroxybenzoate, 1,2,3,4,6-penta-o-galloyl-beta-glucose, Penta-O-galloyl-b-D-glucose, SCHEMBL640108, MEGxp0_001051, ACon1_000145, DTXSID901029765, GLXC-15029, HY-N0527, BDBM50241052, s9399, AKOS015896803, CCG-270584, CS-5018, NCGC00180839-01, NCGC00180839-02, 1,2,3,4,6-Pentagalloyl beta-D-glucose, 1,2,3,4,6-pentagalloyl-beta-d-glucose, AC-34850, BS-15460, PENTA-O-GALLOYL-beta-D-GLUCOPYRANOSE, 1ST161011, 1,2,3,4,6-penta-o-galloyl-beta-d-glucoside, PENTA-O-GALLOYL-.BETA.-D-GLUCOPYRANOSE, .BETA.-1,2,3,4,6-PENTAGALLOYLGLUCOSE, 1,2,3,4,6-pentagalloyl-beta-d-glucopyranoside, 1,2,3,4,6-penta-o-galloyl-beta-d-glucopyranoside, Q4545645, 1,2,3,4,6-Penta-O-galloyl- beta -D-glucopyranose, 1,2,3,4,6-PENTA-O-GALLOYL-.BETA.-GLUCOSE, 1,2,3,4,6-Penta-O-galloyl-b-D-glucopyranose >90%, 1,2,3,4,6-Penta-O-galloyl-?-D-glucopyranose >90%, 1,2,3,4,6-PENTAGALLOYL-.BETA.-D-GLUCOPYRANOSE, 1,2,3,4,6-PENTA-O-GALLOYL-.BETA.-D-GLUCOPYRANOSE, 1,2,3,4,6-PENTAGALLOYL-.BETA.-D-GLUCOPYRANOSIDE, 1,2,3,4,6-PENTAGALLOYL GLUCOSE (CONSTITUENT OF BANABA LEAF), 1,2,3,4,6-PENTAGALLOYL GLUCOSE (CONSTITUENT OF BANABA LEAF) [DSC], .BETA.-D-GLUCOPYRANOSE, 1,2,3,4,6-PENTAKIS(3,4,5-TRIHYDROXYBENZOATE), 1,2,3,4,6-PENTAKIS-O-(3,4,5-TRIHYDROXYBENZOYL)-.BETA.-D-GLUCOPYRANOSE, 1,2,3,4,6-O-PentagalloylglucosePentagalloyl glucose; 1,2,3,4,6-Penta-O-galloyl-beta-D-glucose; 1,2,3,4,6-Pentagalloylglucose" C41H32O26 QJYNZEYHSMRWBK-NIKIMHBISA-N [(2R,3R,4S,5R,6S)-3,4,5,6-tetrakis[(3,4,5-trihydroxybenzoyl)oxy]oxan-2-yl]methyl 3,4,5-trihydroxybenzoate n.a. n.a. No No No No No No PMDBD2001090 Pentamethoxyflavone n.a. n.a. n.a. n.a. n.a. n.a. n.a. 68077 n.a. NPC40818 "Tangeretin, 481-53-8, Tangeritin, Ponkanetin, Pentamethoxyflavone, 4'',5,6,7,8-Pentamethoxyflavone, 5,6,7,8,4''-Pentamethoxyflavone, 5,6,7,8-tetramethoxy-2-(4-methoxyphenyl)chromen-4-one, 4H-1-Benzopyran-4-one, 5,6,7,8-tetramethoxy-2-(4-methoxyphenyl)-, 5,6,7,8-tetramethoxy-2-(4-methoxyphenyl)-4H-chromen-4-one, UNII-I4TLA1DLX6, I4TLA1DLX6, NSC53909, EINECS 207-570-1, NSC 53909, NSC-53909, BRN 0351695, CHEBI:9400, AI3-23869, 5,6,7,8-Tetramethoxy-2-(4-methoxyphenyl)-4-benzopyrone, 4'',5,6,7,8-pentamethoxy-flavone, NSC618905, NSC-618905, 4H-1-Benzopyran-4-one, 5,6,7,8-tetramethoxy-2-(p-methoxyphenyl)-, Flavone, 4'',5,6,7,8-pentamethoxy-, CHEMBL73930, MLS002667634, DTXSID30197417, 2-(4-Methoxyphenyl)-5,6,7,8-tetramethoxy-4H-1-benzopyran-4-one, 5,6,7,8-tetramethoxy-2-(4-methoxyphenyl)-4H-1-benzopyran-4-one, 5-18-05-00491 (Beilstein Handbook Reference), MFCD00017438, Flavone, 5,6,7,8,4''-pentamethoxy, Tangeritin; NSC53909; NSC618905, 4H-1-Benzopyran-4-one, 2-(4-methoxyphenyl)-5,6,7,8-tetramethoxy-, Tangeretin (6CI), Tangeretin;Tangeratin, Tangeretin (Tangeritin), Spectrum2_001698, Spectrum3_000920, Spectrum4_001019, TANGERITIN [INCI], TANGERETIN [WHO-DD], SCHEMBL19740, KBioGR_001517, Flavone, 4'',5,6,7,8-pentamethoxy- (7CI,8CI), SPECTRUM1505269, SPBio_001656, Tangeretin, analytical standard, MEGxp0_001011, Tangeretin, >=95% (HPLC), ACon1_001263, KBio3_001900, 5,6,7,8,4-pentamethoxyflavone, DTXCID40119908, Flavone,5,6,7,8-pentamethoxy-, HMS3651A22, HY-N0133, 4'''',5,6,7,8-pentamethoxyflavone, 5,6,7,8,4''''-Pentamethoxyflavone, BDBM50209218, CCG-38782, LMPK12111443, s2363, AKOS015895209, AC-1699, CS-5484, SDCCGMLS-0066766.P001, NCGC00095850-01, NCGC00095850-02, NCGC00169520-01, 1ST40174, AS-11637, NCI60_004330, SMR001557394, NS00031773, SW219232-1, T2708, A827490, Flavone, 4'',5,6,7,8-pentamethoxy-(7CI,8CI), SR-05000002625, CU-01000013437-2, Q-100525, Q1748737, SR-05000002625-1, BRD-K25186396-001-02-1, BRD-K25186396-001-04-7, 4H-1-Benzopyran-4-one,6,7,8-tetramethoxy-2-(4-methoxyphenyl)-, 4H-1-Benzopyran-4-one,6,7,8-tetramethoxy-2-(p-methoxyphenyl)-, 4H-1-Benzopyran-4-one, 5,6,7,8-tetra-methoxy-2-(4-methoxyphenyl)-, 5,6,7,8-Tetramethoxy-2-(4-methoxyphenyl)-4H-1-benzopyran-4-one, 9CI, TangeretinPonkanetin; Pentamethoxyflavone; 4'',5,6,7,8-Pentamethoxyflavone" C20H20O7 ULSUXBXHSYSGDT-UHFFFAOYSA-N 5,6,7,8-tetramethoxy-2-(4-methoxyphenyl)chromen-4-one n.a. n.a. No No No No No No PMDBD2001091 Pentanol n.a. n.a. n.a. n.a. n.a. n.a. n.a. 6276 n.a. NPC52403 "1-Pentanol, Pentan-1-ol, 71-41-0, Amyl alcohol, N-Amyl alcohol, Pentanol, n-Pentanol, Pentyl alcohol, Butylcarbinol, 1-Pentyl alcohol, Amylol, n-Butylcarbinol, N-PENTYL ALCOHOL, Pentanol-1, Pentasol, Alcool amylique, Butyl carbinol, n-Amylalkohol, n-Pentan-1-ol, Primary amyl alcohol, Amylalkohol, Amyl alcohol, normal, Pentanol (VAN), Petan-1-ol, n-Amylalkohol [Czech], Amyl alcohol (natural), Alcool amylique [French], 30899-19-5, FEMA No. 2056, Pentylalkohol, pentyl-alcohol, amyl-alcohol, n-pentyl-alcohol, NSC 5707, 1-Pentol, UN1105, Amyl alcohol, n-, Primary-N-amyl alcohol, MFCD00002977, n-C5H11OH, Pentanols [UN1105] [Flammable liquid], DTXSID6021741, CHEBI:44884, M9L931X26Y, NSC-5707, N-amylalkohol (czech), Alcool amylique (french), n-butyl carbinol, Pentanols, FEMA Number 2056, HSDB 111, EINECS 200-752-1, amylalcohol, BRN 1730975, pentylalcohol, Pentalcohol, n-pentylalcohol, Valeric alcohol, l-pentanol, UNII-M9L931X26Y, AI3-01293, 1-amyl alcohol, C5 alcohol, Amyl alcohol normal, Amyl alcohol,primary, 1-PENTANOL [MI], EC 200-752-1, AMYL ALCOHOL [FHFI], WLN: Q5, 4-01-00-01640 (Beilstein Handbook Reference), MLS002415674, CHEMBL14568, 1-PENTANOL [USP-RS], 1-AMYL ALCOHOL [FCC], Amyl alcohol, >=99%, FG, DTXCID101741, 1-Pentanol, analytical standard, N-PENTYL ALCOHOL [HSDB], BDBM22603, NSC5707, 1-Pentanol, p.a., 98.0%, HMS3039G16, high-purity pound not>99.5%(GC), Tox21_201107, 1-Pentanol, ACS reagent, >=99%, LMFA05000112, AKOS009031407, 1-Pentanol, ReagentPlus(R), >=99%, CAS-71-41-0, NCGC00091726-01, NCGC00091726-02, NCGC00258659-01, PE9, SMR001370872, 1-Pentanol, SAJ first grade, >=97.0%, 1-Pentanol, SAJ special grade, >=99.0%, NS00002210, P0055, EN300-19332, Pentan-1-ol; 1-Pentanol; Pentanol; n-Pentanol, Q151733, F0001-1831, 1-Pentanol, puriss. p.a., ACS reagent, >=99.0% (GC), InChI=1/C5H12O/c1-2-3-4-5-6/h6H,2-5H2,1H, 1-Pentanol, United States Pharmacopeia (USP) Reference Standard, 1-Pentanol, Pharmaceutical Secondary Standard; Certified Reference Material" C5H12O AMQJEAYHLZJPGS-UHFFFAOYSA-N pentan-1-ol n.a. n.a. No No No No No No PMDBD2001092 Peppermint oil Therapeutic Substance n.a. 8006-90-4 DB11198 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001093 Peptide 1 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001094 Peptide 1037 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001095 PG-1 n.a. n.a. n.a. n.a. n.a. n.a. n.a. 16136437 n.a. n.a. RGGRLCYCRRRFCVCVGR, PG-1, CHEMBL3221603 C88H150N36O20S4 XVVTWELITATBSB-UEDJBKKJSA-N (2S)-2-[[2-[[(2S)-2-[[(2R)-2-[[(2S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[2-[[2-[[(2S)-2-amino-5-carbamimidamidopentanoyl]amino]acetyl]amino]acetyl]amino]-5-carbamimidamidopentanoyl]amino]-4-methylpentanoyl]amino]-3-sulfanylpropanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-sulfanylpropanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-phenylpropanoyl]amino]-3-sulfanylpropanoyl]amino]-3-methylbutanoyl]amino]-3-sulfanylpropanoyl]amino]-3-methylbutanoyl]amino]acetyl]amino]-5-carbamimidamidopentanoic acid n.a. n.a. No No No No No No PMDBD2001096 Phenanthrene n.a. n.a. n.a. n.a. n.a. n.a. n.a. 995 n.a. NPC96835 PHENANTHRENE, 85-01-8, Phenanthren, Phenanthracene, Phenanthrin, Ravatite, Phenantrin, Phenanthrene, pure, CCRIS 1233, HSDB 2166, EINECS 201-581-5, UNII-448J8E5BST, NSC 26256, NSC-26256, Phenanthrene-13C2, 448J8E5BST, DTXSID6024254, CHEBI:28851, AI3-00790, (3)HELICENE, CHEMBL46730, DTXCID904254, NSC26256, MFCD00001168, Phenanthrene 10 microg/mL in Cyclohexane, Phenanthrene 200 microg/mL in Isooctane, Phenanthrene 10 microg/mL in Acetonitrile, Phenanthrene 100 microg/mL in Acetonitrile, PHENANTHRENE (IARC), PHENANTHRENE [IARC], Phenanthren [German], CAS-85-01-8, PEY, 9-Phenanthrene, phenanthrene-ring, Phenanthrene, 98%, Coal tar pitch volatiles: phenanthrene, Phenanthrene Zone Refined, PHENANTHRENE [MI], 9,10-Dehydrophenanthrene, bmse000560, PHENANTHRENE [HSDB], MLS002454437, WLN: L B666J, HMS2268O22, HY-B1727, Tox21_201638, Tox21_300573, BDBM50159266, AKOS008967330, Phenanthrene (purified by sublimation), Phenanthrene, zone-refined, >=99.5%, NCGC00091177-01, NCGC00091177-02, NCGC00091177-03, NCGC00091177-04, NCGC00254398-01, NCGC00259187-01, Phenanthrene, sublimed grade, >=99.5%, AC-11346, AS-12847, SMR000112025, CS-0013733, NS00009484, P0079, P0331, P1310, P2877, EN300-18073, Phenanthrene Zone Refined (number of passes:30), A841054, Q422037, 5-Amino-6-chloro-3-pyridinecarboxylicacidmethylester, W-104097, Z57139327, Phenanthrene, certified reference material, TraceCERT(R), Phenanthrene, purum, for fluorescence, >=97.0% (HPLC), Phenanthrene, analytical standard, for environmental analysis, InChI=1/C14H10/c1-3-7-13-11(5-1)9-10-12-6-2-4-8-14(12)13/h1-10 C14H10 YNPNZTXNASCQKK-UHFFFAOYSA-N phenanthrene n.a. n.a. No No No No No No PMDBD2001097 Phenobarbitone Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. D0Y7RW 4763 n.a. n.a. phenobarbital, Phenobarbitone, Phenobarbitol, Luminal, Phenylethylbarbiturate, 50-06-6, Phenobarbituric acid, Phenylethylmalonylurea, Fenobarbital, Phenemal, Adonal, Nunol, Phenylethylbarbituric acid, Dormiral, Gardenal, Gardepanyl, Neurobarb, Phenaemal, Amylofene, Aphenylbarbit, Aphenyletten, Barbiphenyl, Barbophen, Bialminal, Calmetten, Codibarbita, Coronaletta, Dezibarbitur, Fenylettae, Glysoletten, Hennoletten, Hypnaletten, Hypnolone, Hypnoltol, Lepinaletten, Lumesettes, Lumofridetten, Pharmetten, Phenemalum, Phenobarbyl, Phenoluric, Phenolurio, Phenoturic, Phenyletten, Polcominal, Promptonal, Sedizorin, Sedonettes, Somnolens, Somnoletten, Spasepilin, Starilettae, Versomnal, Aephenal, Agrypnal, Barbenyl, Barbipil, Barbita, Barbivis, Barbonal, Bardorm, Cabronal, Calminal, Cardenal, Chinoin, Cratecil, Doscalun, Duneryl, Ensobarb, Ensodorm, Epidorm, Episedal, Epsylone, Eskabarb, Etilfen, Euneryl, Fenbital, Fenemal, Fenosed, Haplopan, Henotal, Hypnette, Hypnogen, Hysteps, Lepinal, Linasen, Liquital, Lixophen, Lubergal, Lubrokal, Lumesyn, Luphenil, Luramin, Molinal, Nirvonal, Parkotal, Phenobal, Phenomet, Phenonyl, Phenyral, Sedabar, Sedicat, Sedofen, Sedonal, Sedophen, Sevenal, Solfoton, Sombutol, Somnosan, Somonal, Starifen, Teolaxin, Bartol, Epanal, Epilol, Haplos, Leonal, Lumen, Noptil, Sedlyn, Seda-Tablinen, Blu-phen, Nova-Pheno, Solu-Barb, Hypno-Tablinetten, Phen-Bar, Stental Extentabs, Phenobarb, PHOB, Talpheno, Triabarb, Triphenatol, 5-Ethyl-5-phenylbarbituric acid, Phenobarbitalum, Tridezibarbitur, Barbinal, Barbiphen, Lephebar, Teoloxin, Theoloxin, Zadoletten, Damoral, Dormina, Lefebar, Stental, Zadonal, 5-Phenyl-5-ethylbarbituric acid, SK-Phenobarbital, Austrominal, Thenobarbital, 5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione, Fenobarbitale, Elixir of phenobarbital, Phenylethylbarbitursaeure, Phenylaethylbarbitursaeure, 2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-5-phenyl-, Phenylethyl barbituric acid, Barbinol, Dormital, Barbilehae (barbilettae), Fenobarbital [INN-Spanish], 5-ethyl-5-phenyl-1,3-diazinane-2,4,6-trione, Phenobarbitalum [INN-Latin], Barbituric acid, 5-ethyl-5-phenyl-, CCRIS 502, 5-Ethyl-5-phenyl-pyrimidine-2,4,6-trione, CHEBI:8069, Phenobar, PHENOBARBITAL CIV, 5-Ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione, Acido 5-fenil-5-etilbarbiturico, HSDB 3157, UNII-YQE403BP4D, NSC-9848, EINECS 200-007-0, YQE403BP4D, component of Tedral, Sedonal (sedative), component of Slowten, NSC 128143, NSC-128143, TEDRIGEN, THEOPHED, component of Antrocol, component of Hecadrol, DTXSID5021122, AI3-02726, component of Bronkotabs, 5-Ethyl-5-phenyl-2,4,6-(1H,3H,5H)pyrimidinetrione, TEDRAL SUSPENSION, component of Primatene P, CHEMBL40, component of Valpin 50-PB, DTXCID701122, Phenobarbitonum, NSC9848, Phenobarbital [USP:INN:BAN:JAN], NSC128143, NSC-128143-, barbapil, barbellen, barbellon, phenylral, theominal, NCGC00159493-02, Fenobarbitale [DCIT], Phenobarbitalum [INN], Chardonna-2, Fenobarbital (INN-Spanish), PHENOBARBITAL (IARC), PHENOBARBITAL [IARC], Phenobarbitalum (INN-Latin), PHENOBARBITAL (MART.), PHENOBARBITAL [MART.], Phenyl-ethyl-barbituric acid, WLN: T6VMVMV FHJ F2 FR, PHENOBARBITAL (EP IMPURITY), PHENOBARBITAL [EP IMPURITY], PHENOBARBITAL CIV (USP-RS), PHENOBARBITAL CIV [USP-RS], Fenemal recip, Phenobarbital (USP:INN:BAN:JAN), PHENOBARBITAL (EP MONOGRAPH), PHENOBARBITAL [EP MONOGRAPH], PHENOBARBITAL (USP MONOGRAPH), PHENOBARBITAL [USP MONOGRAPH], CAS-50-06-6, Levsin PB Drops and Tablets, Luminal (TN), phenobarbital (PB), PRIMIDONE IMPURITY B (EP IMPURITY), PRIMIDONE IMPURITY B [EP IMPURITY], Acido 5-fenil-5-etilbarbiturico [Italian], 5-Ethyl-5-phenyl-2,6(1H,3H,5H)-pyrimidinetrione, METHYLPHENOBARBITAL IMPURITY A (EP IMPURITY), METHYLPHENOBARBITAL IMPURITY A [EP IMPURITY], Acid, Phenylethylbarbituric, 2,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-5-phenyl-, pheno, Nobatol, Phenobarbital Oral, Tedral (Salt/Mix), Kinesed (Salt/Mix), Antrocol (Salt/Mix), Donnatal (Salt/Mix), Phenylathylbarbitursaure, Phenylethylbarbitursaure, Donnazyme (Salt/Mix), Quadrinal (Salt/Mix), Mephobarbital M (nor), Barbidonna (Salt/Mix), Bronkotabs (Salt/Mix), Chardonna-2 (Salt/Mix), PHENOBARBITAL [MI], Epitope ID:116048, Phenobarbital Oral Solution, PHENOBARBITAL [INN], PHENOBARBITAL [JAN], PHENOBARBITAL [HSDB], BIDD:PXR0061, Oprea1_384816, SCHEMBL16583, 5-ethyl-5-phenyl-hexahydropyrimidine-2,4,6-trione, Methylphenobarbital, M(nor-), MLS001240232, DivK1c_000987, PHENOBARBITALUM [HPUS], PHENOBARBITAL [WHO-DD], PHENOBARBITAL [WHO-IP], GTPL2804, SCHEMBL11114624, SCHEMBL25330743, Acido-5-fenil-5-etilbarbiturico, HMS503E15, KBio1_000987, Phenobarbital (JP17/USP/INN), NINDS_000987, HMS2272G06, Phenobarbital, 1mg/ml in Methanol, Phenobarbital (5.0mg/ml in DMSO), Tox21_111713, Tox21_200510, BDBM50021437, component of Primatene P (Salt/Mix), Phenobarbital 0.1 mg/ml in Methanol, Phenobarbital 1.0 mg/ml in Methanol, AKOS000605404, AKOS015964976, Barbituric acid, 5-ethyl-5-phenyl-,, PHENOBARBITALUM [WHO-IP LATIN], AB02704, DB01174, Phenobarbital (1.0mg/mL in Methanol), Phenobarbital (5.0mg/ml in Methanol), component of Valpin 50-PB (Salt/Mix), IDI1_000987, Levsin PB Drops and Tablets (Salt/Mix), NCGC00159493-03, NCGC00159493-04, NCGC00258064-01, SMR000058986, NS00010275, C07434, D00506, A827956, Q407241, SR-01000313151, SR-01000313151-1, Phenobarbital, United States Pharmacopeia (USP) Reference Standard, 11097-06-6, InChI=1/C12H12N2O3/c1-2-12(8-6-4-3-5-7-8)9(15)13-11(17)14-10(12)16/h3-7H,2H2,1H3,(H2,13,14,15,16,17, UQA C12H12N2O3 DDBREPKUVSBGFI-UHFFFAOYSA-N 5-ethyl-5-phenyl-1,3-diazinane-2,4,6-trione FISCHER and ROCH Anticonvulsants No No No No No No PMDBD2001098 Phenol,2,4-bis(1,1-dimethylethyl) n.a. n.a. n.a. n.a. n.a. n.a. n.a. 7311 n.a. NPC252821 2,4-Di-tert-butylphenol, 96-76-4, Antioxidant No. 33, 2,4-DI-T-BUTYLPHENOL, 1-Hydroxy-2,4-di-tert-butylbenzene, Prodox 146, Phenol, 2,4-bis(1,1-dimethylethyl)-, Phenol, 2,4-di-tert-butyl-, 2,4-bis(tert-butyl)phenol, 2,4-ditert-butylphenol, Prodox 146A-85X, 2,4-Bis(1,1-dimethylethyl)phenol, 2,4-tert-butylphenol, MFCD00008828, NSC 174502, 2,4-Di-tert-butylphenol-d18, FOB94G6HZT, 2,4-di-tert-butyl phenol, 2,4-Di-tert-butyl-phenol, 2,4-di~{tert}-butylphenol, CHEMBL29873, DTXSID2026602, 2,4-Di-tert-butylhydroxybenzene, 2,4-Bis(1,1''-dimethylethyl)phenol, 2,4-bis(1,1-dimethylethyl)-phenol, NSC-174502, DTXCID606602, 1246816-88-5, CAS-96-76-4, 2,4-ditert-butyl-phenol, EINECS 202-532-0, UNII-FOB94G6HZT, Phenol, 2,4-di(1,1-dimethylethyl)-, BRN 1910383, 2,4-DTBP, 2,4-ditertbutylphenol, 2,4-di-tertbutylphenol, 2,4di-tert-butylphenol, ,4-Di-tert-butylphenol, 2,4-di-t-butyl-phenol, 2,4-di-tert.butylphenol, 2,4-di-tertbutyl phenol, 2,4-ditert-butyl phenol, 2,4-ditertiarybutylphenol, Phenol,4-di-tert-butyl-, AGIDOL 10, EC 202-532-0, ?2,4-Di-tert-butylphenol, 2,4-Di-tert.-butylphenol, 2,4-ditertiary-butyl phenol, SCHEMBL109921, CHEBI:89188, HSDB 8453, 2,4-Di-tert-butylphenol, 99%, BCP24012, Phenol,4-bis(1,1-dimethylethyl)-, Tox21_202320, Tox21_300114, BDBM50409544, NSC174502, Phenol,2,4-Bis(1,1-dimethylethyl), 1-Hydroxy-2, 4-di-tert-butylbenzene, AKOS003669719, CS-W015305, HY-W014589, NCGC00164059-01, NCGC00164059-02, NCGC00164059-03, NCGC00254167-01, NCGC00259869-01, AS-13983, PD158314, 2,4-Ditert-butylphenol (ACD/Name 4.0), WLN: 1X1&1&R BQ CX1&1&1, D0229, NS00010683, EN300-20927, E76999, A845633, Q-200191, Q26840829, 2,4-Di-tert-butylphenol 100 microg/mL in Acetonitrile, F0001-2302, (2S)-N-[(1S)-2-[[(1S)-2-[[(1S)-2-[[(1S)-2-[[2-[[(1S)-1-[[(1S)-4-amino-1-[(2S)-2-[(2-amino-2-oxo-ethyl)carbamoyl]pyrrolidine-1-carbonyl]-4-oxo-butyl]carbamoyl]-3-methyl-butyl]amino]-2-oxo-ethyl]amino]-1-[(4-hydroxyphenyl)methyl]-2-oxo-ethyl]amino]-1-(hydro, InChI=1/C14H22O/c1-13(2,3)10-7-8-12(15)11(9-10)14(4,5)6/h7-9,15H,1-6H, UGW C14H22O ICKWICRCANNIBI-UHFFFAOYSA-N 2,4-ditert-butylphenol n.a. n.a. No No No No No No PMDBD2001099 Phenoxymethylpenicillin Therapeutic Substance Approved Drug 1/8/1987 DB00417 PA164745442 D05411 D09CPR 6869 n.a. n.a. penicillin v, Phenoxymethylpenicillin, Penicillin phenoxymethyl, Oracillin, 87-08-1, Phenopenicillin, Phenomycilline, V-Cillin, Vebecillin, Fenospen, Distaquaine V, Phenoxymethyl penicillin, Meropenin, Calcipen, Fenacilin, Phenocillin, Phenoxymethylenepenicillinic acid, Stabicillin, Apopen, Oratren, Rocilin, Ospen, Compocillin V, Eskacillian V, Fenoximetilpenicilina, Beromycin, Eskacillin V, Phenoximethylpenicillinum, Phenoxymethylpenicillinum, Crystapen V, Pen-V, V-Tablopen, Acipen V, Pen-Oral, phenoxymethylpenicillinic acid, V-Cylina, V-Cyline, Phenoxymethylpenicilline, V-Cil, P-Mega-Tablinen, 6-Phenoxyacetamidopenicillanic acid, phenoxomethylpenicillin, Fenossimetilpenicillina, Pen-vee, Fenossimetilpenicillina [DCIT], Fenoximetilpenicilina [INN-Spanish], CCRIS 752, CHEBI:27446, HSDB 6314, EINECS 201-722-0, Phenoxymethylpenicilline [INN-French], Phenoxymethylpenicillinum [INN-Latin], UNII-Z61I075U2W, BRN 0096259, (2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, PC Pen VK, Z61I075U2W, (2S,5R,6R)-3,3-Dimethyl-7-oxo-6-[(phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, Penicillanic acid, 6-phenoxyacetamido-, Penicillin V [USAN:USP], Phenoxymethylpenicillin (INN), Phenoxymethylpenicillin [INN], 3,3-Dimethyl-7-oxo-6-((phenyloxyacetyl)amino)-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, (2S,5R,6R)-3,3-DIMETHYL-7-OXO-6-(2-PHENOXYACETAMIDO)-4-THIA-1- AZABICYCLO(3.2.0)HEPTANE-2-CARBOXYLIC ACID, (2S,5R,6R)-3,3-Dimethyl-7-oxo-6-(2-phenoxyacetamido)-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, (2S,5R,6R)-3,3-Dimethyl-7-oxo-6-(2-phenoxyacetamido)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-((phenoxyacetyl)amino)-, (2S-(2alpha,5alpha,6beta))-, PNV, DTXSID3023429, acipen-v, 4-27-00-05884 (Beilstein Handbook Reference), 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-(2-phenoxyacetamido)-, PV, Fenoxymethylpenicillin, Penicillin V [USAN], Penicillin, Phenoxymethyl, Penicillin V (USAN:USP), Oracilline, Orocillin, PENICILLIN V (USP-RS), PENICILLIN V [USP-RS], Phenoxymethylpenicillin 100 microg/mL in Acetonitrile, Fenoximetilpenicilina (INN-Spanish), 2,2-dimethyl-6beta-[(phenoxyacetyl)amino]penam-3alpha-carboxylic acid, PENICILLIN V (USP MONOGRAPH), PENICILLIN V [USP MONOGRAPH], Phenoxymethylpenicilline (INN-French), Phenoxymethylpenicillinum (INN-Latin), 3,3-dimethyl-6beta-[(phenoxyacetyl)amino]penam-2alpha-carboxylic acid (PIN), PHENOXYMETHYLPENICILLIN (MART.), PHENOXYMETHYLPENICILLIN [MART.], (2S,5R,6R)-3,3-dimethyl-7-oxo-6-{[(phenyloxy)acetyl]amino}-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-((phenoxyacetyl)amino)-, (2S,5R,6R)-, PEN V, PHENOXYMETHYLPENICILLIN (EP MONOGRAPH), PHENOXYMETHYLPENICILLIN [EP MONOGRAPH], V-Cillin (TN), Penicillin V (USP), phenoxomethylpenicillanyl, phenoxymethylpenicillanyl, 2,2-dimethyl-6beta-((phenoxyacetyl)amino)penam-3alpha-carboxylic acid, 3,3-dimethyl-6beta-((phenoxyacetyl)amino)penam-2alpha-carboxylic acid (PIN), (2S,5R,6R)-3,3-dimethyl-7-oxo-6-((phenoxyacetyl)amino)-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, PENICILLINV, PHENOSPEN, penicillin-v-potassium, Spectrum_001007, PEN-VEE-ORAL, Spectrum2_000495, Spectrum3_000543, Spectrum4_000472, Spectrum5_001409, CHEMBL615, Epitope ID:115011, Epitope ID:116056, PENICILLIN V [MI], PENICILLIN V [HSDB], SCHEMBL49223, BSPBio_002185, KBioGR_000944, KBioSS_001487, MLS001304105, DivK1c_000779, SPBio_000389, DTXCID303429, SCHEMBL22099709, CHEBI:53706, GTPL10920, HY-B0975A, KBio1_000779, KBio2_001487, KBio2_004055, KBio2_006623, KBio3_001685, J01CE02, PENICILLIN, PHENOXYMETHYL-, NINDS_000779, GLXC-25717, PENICILLIN V [ORANGE BOOK], 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-((phenoxyacetyl)amino)-, (2S-(2.alpha.,5.alpha.,6.beta.))-, BDBM50370584, 6-(Phenoxyacetamido)penicillanic Acid, AKOS015969737, DB00417, IDI1_000779, PHENOXYMETHYLPENICILLIN [WHO-DD], PHENOXYMETHYLPENICILLIN [WHO-IP], phenoxymethyl penicillinic acid*free acid, SMR000539431, SBI-0051477.P003, AB00514745, CS-0013728, NS00078894, Phenoxymethylpenicillin for system suitability, C08126, D05411, PHENOXYMETHYLPENICILLINUM [WHO-IP LATIN], EN300-19735891, Q422215, W-109316, BRD-K43966364-237-02-2, BRD-K43966364-237-03-0, 6beta-Phenoxyacetamido-2,2-dimethylpenam-3alpha-carboxylic acid, Phenoxymethylpenicillin, Antibiotic for Culture Media Use Only, Penicillin V, United States Pharmacopeia (USP) Reference Standard, Phenoxymethylpenicillin, European Pharmacopoeia (EP) Reference Standard, 4-THIA-1-AZABICYCLO(3.2.0)HEPTANE-2-CARBOXYLIC ACID, 3,3-DIMETHYL-7-OXO-6-((PHENOXYACETYL)AMINO)-, (2S-(2ALPHA,5ALPHA,6.BETA)).- C16H18N2O5S BPLBGHOLXOTWMN-MBNYWOFBSA-N (2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid n.a. Antibiotics No No No No No No PMDBD2001100 Phenyl-arginine-b-naphthylamide n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001101 Phloretin Therapeutic Substance Investigational Drug 60-82-2 DB07810 n.a. n.a. D0HD2G 4788 4624 NPC242895 "phloretin, 60-82-2, Dihydronaringenin, 3-(4-Hydroxyphenyl)-1-(2,4,6-trihydroxyphenyl)propan-1-one, Phloretol, 3-(4-Hydroxyphenyl)-1-(2,4,6-trihydroxyphenyl)-1-propanone, NSC 407292, 1-Propanone, 3-(4-hydroxyphenyl)-1-(2,4,6-trihydroxyphenyl)-, MFCD00002288, beta-(p-Hydroxyphenyl)phloropropiophenone, 2'',4'',6''-Trihydroxy-3-(p-hydroxyphenyl)propiophenone, 2'',4'',6''-Trihydroxy-3-(4-Hydroxyphenyl)propiophenone, NSC407292, S5J5OE47MK, beta-(p-Hydroxyphenyl)-2,4,6-trihydroxypropiophenone, beta-(4-Hydroxyphenyl)-2,4,6-trihydroxypropiophenone, CHEMBL45068, 2'',4'',6''-Trihydroxy-3-(4-hydroxyphenyl)-propiophenone, Propiophenone, 2'',4'',6''-trihydroxy-3-(p-hydroxyphenyl)-, DTXSID6022393, CHEBI:17276, NSC-407292, 2'',4,4'',6''-Tetrahydroxydihydrochalcone, .beta.-(p-Hydroxyphenyl)phloropropiophenone, 2'',4,4'',6''-Tetrahydroxy-Dihydrochalcone, NSC 407292;RJC 02792, SMR000326783, CCRIS 7459, SR-01000076081, EINECS 200-488-7, UNII-S5J5OE47MK, Asebogenol, 2uxi, G50, Spectrum_001295, 4,2'',4'',6''-Tetrahydroxydihydrochalcone, Phloretin, >=99%, SpecPlus_000333, PHLORETIN [MI], PHLORETIN [INCI], Spectrum2_000681, Spectrum3_001036, Spectrum4_001172, Spectrum5_001698, Lopac-P-7912, cid_4788, Lopac0_001012, Oprea1_824722, REGID_for_CID_4788, SCHEMBL38131, BSPBio_002851, KBioGR_001803, KBioSS_001775, SPECTRUM300554, MLS000728507, MLS000859922, MLS006012024, BIDD:ER0174, DivK1c_006429, SPBio_000801, DTXCID702393, GTPL4285, FEMA NO. 4390, BCBcMAP01_000040, BDBM23446, KBio1_001373, KBio2_001775, KBio2_004343, KBio2_006911, KBio3_002071, Phloretin - CAS 60-82-2, BP_35, HMS2224N17, HMS3263K05, HMS3332J03, HMS3656I07, BCP28296, HY-N0142, TNP00255, Tox21_202854, Tox21_501012, CCG-38573, HB0500, LMPK12120525, RJC 02792, s2342, AKOS015856338, AC-7995, CS-1477, DB07810, LP01012, SDCCGMLS-0066637.P001, SDCCGSBI-0050985.P003, CAS-60-82-2, Phloretin, analytical reference material, SMP1_000238, NCGC00015840-01, NCGC00015840-02, NCGC00015840-03, NCGC00015840-04, NCGC00015840-05, NCGC00015840-06, NCGC00015840-07, NCGC00015840-08, NCGC00015840-09, NCGC00015840-18, NCGC00094304-01, NCGC00094304-02, NCGC00094304-03, NCGC00094304-04, NCGC00260400-01, NCGC00261697-01, AS-14100, SY017103, EU-0101012, NS00006825, P1966, SW219308-1, C00774, P 7912, 2'',6''-Trihydroxy-3-(p-hydroxyphenyl)propiophenone, Q-100701, Q2268463, SR-01000076081-1, SR-01000076081-7, SR-01000076081-8, .beta.-(p-Hydroxyphenyl)-2,6-trihydroxypropiophenone, BRD-K15563106-001-02-4, BRD-K15563106-001-10-7, Propiophenone,4'',6''-trihydroxy-3-(p-hydroxyphenyl)-, .beta.-(p-Hydroxyphenyl)-2,4,6-trihydroxypropiophenone, 1-(2,4,6-trihydroxyphenyl)-3-(4-hydroxyphenyl)-1-propanone, 3-(4-Hydroxyphenyl)-1-(2,4,6-trihydroxyphenyl)-1-propanon, 3-(4-Hydroxy-phenyl)-1-(2,4,6-trihydroxy-phenyl)-propan-1-one, 3-(4-HYDROXYPHENYL)-1-(2,4,6-TRIHYDROXYPHENYL)-PROPAN-1-ONE [FHFI], InChI=1/C15H14O5/c16-10-4-1-9(2-5-10)3-6-12(18)15-13(19)7-11(17)8-14(15)20/h1-2,4-5,7-8,16-17,19-20H,3,6H" C15H14O5 VGEREEWJJVICBM-UHFFFAOYSA-N 3-(4-hydroxyphenyl)-1-(2,4,6-trihydroxyphenyl)propan-1-one n.a. n.a. No No No No Yes No rxn02077,rxn21848,rxnDiet178 PMDBD2001102 Phloridzin Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D06WAL 6072 n.a. NPC259182 "Phlorizin, Phloridzin, 60-81-1, Phlorhizin, Phlorizoside, Floridzin, Phlorrhizin, Phloretin 2''-glucoside, Phloridzinum, Phloridzosid, Phlorrhizen, Phlorizine, NSC 2833, Phloretin-2''-O-beta-glucoside, AI3-19835, EINECS 200-487-1, UNII-CU9S17279X, CHEBI:8113, Phlorizin hydrate, CU9S17279X, NSC-2833, Phloridzin dihydrate, phloretin 2''-O-glucoside, 1-(2,4-dihydroxy-6-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)phenyl)-3-(4-hydroxyphenyl)propan-1-one, 7061-54-3, Phloretin-2''-beta-glucoside, 1-[2-(beta-D-Glucopyranosyloxy)-4,6-dihydroxyphenyl]-3-(4-hydroxyphenyl)-1-propanone, CHEMBL245067, DTXSID3075339, Phloretin-2''-O-.beta.-glucoside, 2''-(beta-D-Glucopyranosyloxy)-4'',6''-dihydroxy-3-(4-hydroxyphenyl)propiophenone, 1-Propanone, 1-(2-(beta-D-glucopyranosyloxy)-4,6-dihydroxyphenyl)-3-(4-hydroxyphenyl)-, 1-(2,4-dihydroxy-6-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)-3-(4-hydroxyphenyl)propan-1-one, Phlorizin (dihydrate), 1-Propanone, 1-[2-(beta-D-glucopyranosyloxy)-4,6-dihydroxyphenyl]-3-(4-hydroxyphenyl)-, 2''-(.beta.-D-glucopyranosyloxy)-4'',6''-dihydroxy-3-(4-hydroxyphenyl)propiophenone, 1-[2-[(2S,3R,4S,5S,6R)-6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-4,6-bis(oxidanyl)phenyl]-3-(4-hydroxyphenyl)propan-1-one, Phloretin-2''-O-glucoside, SR-01000781913, Lopin, 1-Propanone, 1-[2-(.beta.-D-glucopyranosyloxy)-4,6-dihydroxyphenyl]-3-(4-hydroxyphenyl)-, Phloridzin Phenolic, O-glucoside, 1, Phloridzin1535, 1-PROPANONE, 1-(2-(.BETA.-D-GLUCOPYRANOSYLOXY)-4,6-DIHYDROXYPHENYL)-3-(4-HYDROXYPHENYL)-, Phlorizin (Phloridzin), Spectrum_001291, PHLORIDZIN [MI], SpecPlus_000325, Spectrum2_000701, Spectrum3_001227, Spectrum4_001651, Spectrum5_000521, PHLORIDZIN [INCI], PHLORIDZINUM [HPUS], PHLORIDZIN [WHO-DD], SCHEMBL17290, BSPBio_002674, KBioGR_002141, KBioSS_001771, SPECTRUM300547, JMC511145 Compound 1, DivK1c_006421, SPBio_000881, GTPL4757, DTXCID1042738, BDBM20875, KBio1_001365, KBio2_001771, KBio2_004339, KBio2_006907, KBio3_002174, HMS2090P10, Phloretin 2''-ss-D-glucopyranoside, HY-N0143, CCG-38341, s2343, 4,6-dihydroxy-2-(beta-D-glucosido)-beta-(p-hydroxyphenyl)propiophenone, AKOS015920054, AC-7976, CS-2013, SDCCGMLS-0066626.P001, 1-Propanone,1-[2-(b-D-glucopyranosyloxy)-4,6-dihydroxyphenyl]-3-(4-hydroxyphenyl)-, NCGC00142423-01, NCGC00142423-02, NCGC00142423-06, 1-[2,4-dihydroxy-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-3-(4-hydroxyphenyl)propan-1-one, 1-[2,4-dihydroxy-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-phenyl]-3-(4-hydroxyphenyl)propan-1-one, 1-{6-[(2S,4S,5S,3R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)(2H-3,4,5,6-tetrahydr opyran-2-yloxy)]-2,4-dihydroxyphenyl}-3-(4-hydroxyphenyl)propan-1-one, 1ST40016, AS-15724, NS00002475, P0248, C01604, A836937, A868885, Q413105, Q-100699, SR-01000781913-2, SR-01000781913-4, SR-01000781913-5, BRD-K73756878-001-02-9, 1-[2-(.beta.-D-Glucopyranosyloxy)-4,6-dihydroxyphenyl]-3-(4-hydroxyphenyl)-1-propanone, 1-[2-(?-D-Glucopyranosyloxy)-4,6-dihydroxyphenyl]-3-(4-hydroxyphenyl)-1-propanone, 1-[2-(ss-D-Glucopyranosyloxy)-4,6-dihydroxyphenyl]-3-(4-hydroxyphenyl)-1-propanone, 3,5-dihydroxy-2-[3-(4-hydroxyphenyl)propanoyl]phenyl beta-D-glucopyranoside, 1-(2,4-dihydroxy-6-((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)phenyl)-3-(4-hydroxyphenyl)propan-1-one, 1-[2,4-dihydroxy-6-[3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-phenyl]-3-(4-hydroxyphenyl)propan-1-one dihydrate;Phlorizin dihydrate, 112318-65-7, LN9" C21H24O10 IOUVKUPGCMBWBT-QNDFHXLGSA-N 1-[2,4-dihydroxy-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-3-(4-hydroxyphenyl)propan-1-one n.a. n.a. No No No No No No PMDBD2001103 Phosphate Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. D08VYC 1061 n.a. n.a. "phosphate, Phosphate ion, orthophosphate, 14265-44-2, O-Phosphate, Phosphate ions, phosphate(3-), UNII-NK08V8K8HR, NK08V8K8HR, tetraoxophosphate(V), tetraoxophosphate(3-), tetraoxidophosphate(3-), CHEBI:18367, PO4(3-), Phosphate PO4-3 @ 10,000microg/mL, Phosphate as P @ 1000 microg/mL in H2O, Phosphate as P @ 10000 microg/mL in H2O, PHOSPHATE (MART.), PHOSPHATE [MART.], Phosphate Standard: PO4(-3) @ 1000 microg/mL in H2O, Phosphate Standard: PO4(-3) @ 10000 microg/mL in H2O, Phosphates, PO43?, (PO4)(3-), [PO4](3-), a phosphate group, phosphate(3-) ion, LIQUIDGUARD, Phosphate Anion Solution, CREATINE PHOSPHATE;N-PHOSPHOCREATINE, PHOSPHATE [VANDF], phosphoric acid, ion(3-), DTXSID7039672, CHEBI:35780, BDBM50155537, MFCD00145108, AKOS015903596, DB14523, Phosphate standard solution (5 ppm PO4), NS00114190, Q177811, SODIUM ALENDRONATE TRIHYDRATE IMPURITY B [EP IMPURITY]" O4P-3 NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate n.a. n.a. No No No No No No PMDBD2001104 Phosphorylserine n.a. n.a. n.a. n.a. n.a. n.a. n.a. 106 n.a. NPC326206 dl-O-Phosphoserine, 17885-08-4, O-Phospho-DL-serine, DL-Serine dihydrogen phosphate, Serophen, Energoserina, serine, O-phosphono-, o-Phosphonoserine, 2-amino-3-phosphonooxypropanoic acid, DL-O-Phosphorylserine, DL-Serine monophosphoric acid, DL-SOP, phosphorylserine, P-serine, DL-Phosphoserine, 3-phospho-serine, serine-3-phosphate, 2-amino-3-(phosphonooxy)propanoic acid, DL-2-Amino-3-hydroxypropanoic acid 3-phosphate, serine phosphate, 3-phospho-1-serine, DL-O-Serine phosphate, H-D-Ser(POH)-OH, 6GV29P6OZA, DL-Serine, dihydrogen phosphate (ester), H-DL-Ser(H2PO3)-OH, CHEBI:37712, NSC-90791, H-Ser(POH)-OH, PHOSPHOSERINE, DL-, UNII-6GV29P6OZA, o-phosphoserin, seryl phosphate, P-ser, serine-3-p, 3-P-serine, EINECS 241-834-7, NSC 90791, DL-Serine monophosphorate, SCHEMBL6847, 2-amino-3-(oxyphosphinyloxyphosphinyl)propanoic acid, CHEMBL180002, DTXSID00859358, SERINE PHOSPHATE [WHO-DD], NSC90791, MFCD00021723, AKOS015998288, HY-15130, O-Phospho-DL-serine, >=98.0% (NT), CS-0003781, NS00014359, Serine, dihydrogen phosphate (ester) (9CI), F82024, L000353, SERINE, DIHYDROGEN PHOSPHATE (ESTER), DL-, Serine, dihydrogen phosphate (ester), DL- (8CI), SR-01000075466, (RS)-2-AMINO-3-PHOSPHONOOXY PROPANOIC ACID, SR-01000075466-1 C3H8NO6P BZQFBWGGLXLEPQ-UHFFFAOYSA-N 2-amino-3-phosphonooxypropanoic acid n.a. n.a. No No No No No No PMDBD2001105 Phylloseptin-1 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001106 phys-GL13K n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001107 Picolinic acid Therapeutic Substance n.a. 98-98-6 DB05483 n.a. n.a. n.a. 1018 993 NPC302159 picolinic acid, 98-98-6, 2-Picolinic acid, Pyridine-2-carboxylic acid, 2-Pyridinecarboxylic acid, 2-Carboxypyridine, o-Pyridinecarboxylic acid, alpha-Picolinic acid, alpha-Pyridinecarboxylic acid, PYRIDINECARBOXYLIC ACID, Acide picolique, Pyridine-carboxylique-2, MFCD00006293, 2-pyridine carboxylic acid, NSC 171, 32075-31-3, AI3-19242, PCL 016, Pyridinecarboxylic acid-(2), QZV2W997JQ, CHEMBL72628, .alpha.-Pyridinecarboxylic acid, DTXSID7031903, CHEBI:28747, NSC 21209, NSC-171, NCGC00165993-01, Nicogamol, Nikogamol, 2-pyridinecarboxylate, 88161-53-9, PLA, DTXCID5011903, Acide picolique [French], CAS-98-98-6, SMR000814709, NSC21209, Pyridine-carboxylique-2 [French], EINECS 202-719-7, UNII-QZV2W997JQ, BRN 0109595, picolinicacid, picolinic-acid, picolic acid, CCRIS 8307, 2-picolic acid, TOS-BB-0927, 2-Picolate, A-Picolinic acid, 6PC, pyridine carboxylic acid, pyridine-carboxylic acid, 2-pyridincarboxylic acid, pyridinium 2-carboxylate, a-Pyridinecarboxylic acid, 2-pyridine carboxic acid, Pyridine-A-carboxylic acid, 2-pyridine-carboxylic Acid, PICOLINIC ACID [MI], Oprea1_485360, SCHEMBL36055, 5-22-02-00003 (Beilstein Handbook Reference), MLS001335931, MLS001335932, Picolinic acid (PCL 016), Phenyl-(2-pyridyl)acetonitrile, NSC171, SIOXPEMLGUPBBT-UHFFFAOYSA-, HMS2232K05, BCP26613, CS-D1196, HY-I0660, STR00111, Tox21_112282, Tox21_202953, BDBM50000407, s6249, AKOS000119032, Tox21_112282_1, AB00685, AC-2105, AM81303, PS-4253, NCGC00165993-02, NCGC00260499-01, 2-Picolinic acid, ReagentPlus(R), 99%, BP-13036, BP-21456, NCI60_001382, SY001169, NS00014903, P0421, EN300-18459, A15945, 2-Picolinic acid, Vetec(TM) reagent grade, 98%, Q416682, C9DF3EBC-98F0-4165-BE9A-92F8EE33CDBA, W-100058, Z57968195, F2191-0113, InChI=1/C6H5NO2/c8-6(9)5-3-1-2-4-7-5/h1-4H,(H,8,9) C6H5NO2 SIOXPEMLGUPBBT-UHFFFAOYSA-N pyridine-2-carboxylic acid n.a. n.a. No No No No No No PMDBD2001108 Pine needle oil n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001109 Pinguisenol n.a. n.a. n.a. n.a. n.a. n.a. n.a. 11031463 n.a. NPC95673 PINGUISENOL, CHEBI:67832, Q27136308, (1R,3aS,4S,5S,7aS)-5-ethenyl-1,3a,4,7a-tetramethyl-1,2,3,4,6,7-hexahydroinden-5-ol C15H26O TUCSIUBDOHTKKQ-CAEXGNQWSA-N (1R,3aS,4S,5S,7aS)-5-ethenyl-1,3a,4,7a-tetramethyl-1,2,3,4,6,7-hexahydroinden-5-ol n.a. n.a. No No No No No No PMDBD2001110 Piperacillin-Tazobactam n.a. n.a. n.a. n.a. n.a. n.a. n.a. 23724843 n.a. n.a. "Piperacillin-tazobactam, Tazocin (TN), Zosyn (TN), Piperacillin-tazobactam mixt., NIOSH/XI0191450, Piperacillin sodium and tazobactam, DTXSID001016418, Tazobactam and piperacillin (JP17), Piperacillin-tazobactam mixt. (4:1), Tazobactam-piperacillin mixt. (1:4), XI01914500, D02505, 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3-methyl-7-oxo-3-(1H-1,2,3-triazol-1-ylmethyl)-, 4,4-dioxide, (2S-(2-alpha,3-beta,5-alpha))-, mixt. with (2S-(2-alpha,5-alpha,6-beta(S*)))-6-(((((4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl)amino)phenylacetyl)amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid (1:4), sodium;(2S,5R,6R)-6-[[(2S)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate;(2S,3S,5R)-3-methyl-4,4,7-trioxo-3-(triazol-1-ylmethyl)-4lambda6-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid" C33H38N9NaO12S2 TUPFOYXHAYOHIB-WZGOVNIISA-M "sodium;(2S,5R,6R)-6-[[(2S)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate;(2S,3S,5R)-3-methyl-4,4,7-trioxo-3-(triazol-1-ylmethyl)-4lambda6-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid" n.a. n.a. No No No No No No PMDBD2001111 Platyphylloside n.a. n.a. n.a. n.a. n.a. n.a. n.a. 9826264 n.a. NPC17968 platyphylloside, 90803-80-8, 3-Heptanone, 5-(beta-D-glucopyranosyloxy)-1,7-bis(4-hydroxyphenyl)-, (5S)-, (5S)-1,7-bis(4-hydroxyphenyl)-5-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyheptan-3-one, CHEMBL228449, DTXSID501317051, NSC784874, NSC799730, NSC-784874, NSC-799730 C25H32O9 PVPDIJGSCANSAG-JSFAVJLPSA-N (5S)-1,7-bis(4-hydroxyphenyl)-5-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyheptan-3-one n.a. n.a. No No No No No No PMDBD2001112 Pleurocidin n.a. n.a. n.a. n.a. n.a. n.a. n.a. 16130552 n.a. n.a. GWGSFFKKAAHVGKHVGKAALTHYL, Pleurocidin C129H192N36O29 MZJIKFCSPTZIFT-UVKRQXBBSA-N (2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[(2-aminoacetyl)amino]-3-(1H-indol-3-yl)propanoyl]amino]acetyl]amino]-3-hydroxypropanoyl]amino]-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]hexanoyl]amino]hexanoyl]amino]propanoyl]amino]propanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-3-methylbutanoyl]amino]acetyl]amino]hexanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-3-methylbutanoyl]amino]acetyl]amino]hexanoyl]amino]propanoyl]amino]propanoyl]amino]-4-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-methylpentanoic acid n.a. n.a. No No No No No No PMDBD2001113 PLF n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001114 p-nitrophenyl glycerol n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001115 Polyethyleneimine n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001116 Polymyxin B Therapeutic Substance n.a. 1404-26-8 DB00781 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001117 Povidone Iodine Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. D03EXK 410087 n.a. n.a. "Povidone iodine, 25655-41-8, Povidone-iodine, Betadine, Isodine, PVP-I, PVP iodine, PVP-Iodine, Isobetadyne, Bridine, Disphex, Povadyne, Ultradine, Efo-dine, 1-ethenylpyrrolidin-2-one;molecular iodine, NSC26245, povidone.iodine, molecular iodine; 1-vinylpyrrolidin-2-one, 1-ethenylpyrrolidin-2-one; molecular iodine, SCHEMBL1652685, BCP28568, NSC28655, MFCD00084483, NSC-26245, NSC-28655, AKOS015898248, PD118263, 1-ethenyl-2-pyrrolidinone; molecular iodine, A817952, Q241516, 1-vinylpyrrolidin-2-one compound with diiodine (1:1), Povidone (iodinated), European Pharmacopoeia (EP) Reference Standard" C6H9I2NO CPKVUHPKYQGHMW-UHFFFAOYSA-N "1-ethenylpyrrolidin-2-one;molecular iodine" n.a. n.a. No No No No No No PMDBD2001118 Pro-Gly n.a. n.a. n.a. n.a. n.a. n.a. n.a. 6426709 n.a. n.a. H-PRO-GLY-OH, L-Prolylglycine, 2578-57-6, Prolylglycine, Pro-Gly, Glycine, N-L-prolyl-, Prolyl-glycine, (S)-Prolylglycine, NSC 89175, CHEMBL59426, L-Prolylgycine, CHEBI:61695, (S)-2-(pyrrolidine-2-carboxamido)acetic acid, 42521I3FYC, 2-[[(2S)-pyrrolidine-2-carbonyl]amino]acetic acid, L-Prolyl-glycine, 2-{[(2S)-pyrrolidin-2-yl]formamido}acetic acid, Pro-Gly-OH, n-prolylglycine, UNII-42521I3FYC, MFCD00022391, NSC-89175, Glycine,l-prolyl-, L-Pro-Gly, PROLYLGLYCINE, L-, SCHEMBL620067, CS-WAA0142, HY-WAA0142, DTXSID301317124, BDBM50188480, AKOS010404824, CS-W017602, AS-56392, [(Pyrrolidine-2-carbonyl)-amino]-acetic acid, EN300-312391, [((S)-Pyrrolidine-2-carbonyl)-amino]-acetic acid, A877477, Q27893792, 654E0B74-C991-4228-B739-3A3AB574E291 C7H12N2O3 RNKSNIBMTUYWSH-YFKPBYRVSA-N 2-[[(2S)-pyrrolidine-2-carbonyl]amino]acetic acid n.a. n.a. No No No No No No PMDBD2001119 Prolificin A n.a. n.a. n.a. n.a. n.a. n.a. n.a. 11995285 n.a. NPC477272 prolificin A, CHEMBL448374, 1-[(2R,3S)-2-[(3E)-4,8-dimethylnona-3,7-dienyl]-5,7-dihydroxy-2-methyl-3-(3-methylbut-2-enyl)-3,4-dihydrochromen-8-yl]-2-methylbutan-1-one C31H46O4 KNWRSKBHVUABNU-YIYKOETFSA-N 1-[(2R,3S)-2-[(3E)-4,8-dimethylnona-3,7-dienyl]-5,7-dihydroxy-2-methyl-3-(3-methylbut-2-enyl)-3,4-dihydrochromen-8-yl]-2-methylbutan-1-one n.a. n.a. No No No No No No PMDBD2001120 prop-2-ene-1-SO-thioperoxol n.a. n.a. n.a. n.a. n.a. n.a. n.a. 14917355 n.a. n.a. allylsulfenate, 2-propenesulfenic acid, 62965-27-9, 3-hydroxysulfanylprop-1-ene, Allylsulfensaure, allylsulfenic acid, S-allylsulfenic acid, Prop-2-ene-1-SO-thioperoxol, prop-2-ene-1-SO--thioperoxol, DTXSID40565365, CHEBI:138314 C3H6OS WLHNIAVMSNXYHO-UHFFFAOYSA-N 3-hydroxysulfanylprop-1-ene n.a. n.a. No No No No No No PMDBD2001121 Propanol n.a. n.a. n.a. n.a. n.a. n.a. n.a. 1031 n.a. NPC311000 "1-propanol, propanol, Propan-1-ol, Propyl alcohol, n-propanol, 71-23-8, n-Propyl alcohol, ethylcarbinol, Policosanol, optal, 1-hydroxypropane, osmosol extra, Propylic alcohol, Propanol-1, 1-Propyl alcohol, n-Propan-1-ol, Propanole, Propanolen, Alcohol, propyl, Propanoli, Ethyl carbinol, Alcool propilico, Alcool propylique, Propylowy alkohol, n-Propyl alkohol, 142583-61-7, Albacol, propane-1-ol, 1-PROPONOL, propylalcohol, Propyl alcohol, normal, Caswell No. 709A, FEMA No. 2928, FEMA Number 2928, Propyl alcohol (natural), Propyl alcohol, n-, Propyl-d7 alcohol, NSC 30300, CCRIS 3202, HSDB 115, n-Propylalkohol, EINECS 200-746-9, EPA Pesticide Chemical Code 047502, n-PrOH, UNII-96F264O9SV, BRN 1098242, DTXSID2021739, CHEBI:28831, AI3-16115, Propylan-propyl alcohol, 96F264O9SV, Propyl-1,1-d2 alcohol, MFCD00002941, NSC-30300, 62309-51-7, UN 1274, Propyl-3,3,3-d3 alcohol, DTXCID001739, PROPANOL-2,2-D2, PROPYL-2-D1 ALCOHOL, PROPYL ALCOHOL (PROPANOL), EC 200-746-9, 4-01-00-01413 (Beilstein Handbook Reference), 1-Propanol, anhydrous, 1-Propanol-D1, Propanol; Propan-1-ol, 188894-71-5, 89603-83-8, POL, Propanole [German], Propanolen [Dutch], Propanol, 1-, Propanoli [Italian], PROPANOL (EP MONOGRAPH), PROPANOL [EP MONOGRAPH], PROPYL ALCOHOL (MART.), PROPYL ALCOHOL [MART.], 70907-80-1, 1 Propanol, Alcool propilico [Italian], Alcool propylique [French], n-Propyl alkohol [German], PROPANOL-1,1,2,2-D4, Propylowy alkohol [Polish], UN1274, Hydroxypropane, ethyl methanol, n-propylalcohol, normal propanol, 3-propanol, ASTM Method D7059 Calibration Mixture 1 500-1200 microg/mL in Toluene, ASTM Method D7059 Calibration Mixture 2 500-600 microg/mL in Toluene, ASTM Method D7059 Calibration Mixture 3 300-500 microg/mL in Toluene, ASTM Method D7059 Calibration Mixture 4 150-500 microg/mL in Toluene, ASTM Method D7059 Calibration Mixture 5 100-500 microg/mL in Toluene, ASTM Method D7059 Calibration Mixture 6 25-500 microg/mL in Toluene, ASTM Method D7059 Calibration Mixture 7 5-500 microg/mL in Toluene, nPrOH, HOPr, PrOH, normal propyl alcohol, Caswell No 709A, N-Propanol ACS grade, PROPYL-1,1,3,3,3-D5 ALCOHOL, n-C3H7OH, 1-Propanol, HPLC Grade, bmse000446, N-PROPANOL [HSDB], PROPANOL [WHO-DD], 1-Propanol, >=99%, PROPYL ALCOHOL [MI], Pesticide Code: 047502, PROPYL ALCOHOL [FCC], WLN: Q3, CHEMBL14687, PROPYL ALCOHOL [FHFI], PROPYL ALCOHOL [INCI], 1-PROPANOL [USP-RS], 1-Propanol, analytical standard, 1-Propanol, JIS special grade, 1-Propanol, >=99%, FG, 1-Propanol, LR, >=99%, 1-Propanol, >=99.80%, BDBM36153, 1-Propanol, anhydrous, 99.7%, 1-Propanol, p.a., 99.5%, 1-Propanol, AR, >=99.5%, AMY11110, NSC30300, Tox21_302440, 1-Propanol, Spectrophotometric Grade, LMFA05000101, n-Propanol or propyl alcohol, normal, 1-Propanol, natural, >=98%, FG, Hydroxypropyl cellulose-SL (HPC-SL), 1-Propanol, >=99% (GC), purum, AKOS000249219, 1-Propanol, for HPLC, >=99.5%, 1-Propanol, for HPLC, >=99.9%, DB03175, 1-Propanol, ACS reagent, >=99.5%, 1-Propanol, HPLC grade, >=99.5%, CAS-71-23-8, 1-Propanol, purum, >=99.0% (GC), NCGC00255163-01, 1-Propanol 100 microg/mL in Acetonitrile, 1-Propanol, SAJ first grade, >=99.0%, NS00001811, P0491, 1-Propanol, UV HPLC spectroscopic, 99.0%, EN300-19337, C05979, Q14985, A837125, InChI=1/C3H8O/c1-2-3-4/h4H,2-3H2,1H, J-505102, 1-Propanol, for inorganic trace analysis, >=99.8%, F0001-1829, 1-Propanol, puriss. p.a., Reag. Ph. Eur., >=99.5% (GC), 1-Propanol, United States Pharmacopeia (USP) Reference Standard, n-Propanol or propyl alcohol, normal [UN1274] [Flammable liquid], 1-Propanol, Pharmaceutical Secondary Standard; Certified Reference Material, 5VQ" C3H8O BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol n.a. n.a. No No No No No No PMDBD2001122 Propyl gallate n.a. n.a. n.a. n.a. n.a. n.a. n.a. 4947 n.a. NPC304929 "propyl gallate, 121-79-9, Propyl 3,4,5-trihydroxybenzoate, N-Propyl gallate, Tenox PG, Progallin P, Gallic acid, propyl ester, Nipagallin P, Gallic acid propyl ester, 3,4,5-Trihydroxybenzoic acid propyl ester, NIPA 49, Benzoic acid, 3,4,5-trihydroxy-, propyl ester, n-Propyl 3,4,5-trihydroxybenzoate, FEMA No. 2947, 3,4,5-Trihydroxybenzene-1-propylcarboxylate, Gallic acid n-propyl ester, Propylester kyseliny gallove, n-Propyl ester of 3,4,5-trihydroxybenzoic acid, NSC 2626, 3,4,5-Trihydroxybenzoic acid, propyl ester, NCI-C505888, 3,4,5-Trihydroxybenzoic acid n-propyl ester, Nipanox S 1, Propyl gallate (NF), Propyl gallate [NF], Gallic acid-propyl ester, NSC-2626, Propyl gallate (e 310), CHEMBL7983, Gallic acid, n-propyl ester, E310, 8D4SNN7V92, INS NO.310, DTXSID5021201, CHEBI:10607, INS-310, NSC2626, Anhydrous propyl gallate (e 310), MFCD00002196, NCGC00164234-01, E-310, DTXCID901201, Gallate, Propyl, Pro gallin P, CAS-121-79-9, CCRIS 541, HSDB 591, n-Propyl-3,4,5-Trihydroxybenzoate, EINECS 204-498-2, Propylester kyseliny gallove [Czech], UNII-8D4SNN7V92, Propyl galiate, AI3-17136, l ester, n-propyl-gallate, Sustane PG, Propylgallate,(S), Propyl gallate, powder, Propyl gallate, 98%, 3,4,5-Trihydroxy-benzoic acid propyl ester, Gallic acid propyl esterZ, PROPYL GALLATE [II], PROPYL GALLATE [MI], Oprea1_580415, SCHEMBL22630, CBDivE_013134, PROPYL GALLATE [FCC], BIDD:ER0334, Propyl 3,5-trihydroxybenzoate, PROPYL GALLATE [FHFI], PROPYL GALLATE [HSDB], PROPYL GALLATE [INCI], WLN: QR BQ CQ EVO3, PROPYL GALLATE [VANDF], PROPYL GALLATE [MART.], PROPYL GALLATE [USP-RS], PROPYL GALLATE [WHO-DD], FEMA 2947, n-Propyl 3,5-trihydroxybenzoate, Propyl gallate, >=98%, FCC, NCI-C50588, BCP13340, HY-N0524, Tox21_113531, Tox21_202286, Tox21_300060, BDBM50032154, s5113, 3,4,5-Trihydroxy-benzoic acid propy, PROPYL GALLATE [EP MONOGRAPH], AKOS001603853, 5-Methyl-4,5-dihydrothiazole-2-thiol, CCG-207932, DB12450, NCGC00164234-02, NCGC00164234-03, NCGC00164234-04, NCGC00254138-01, NCGC00259835-01, 3,5-Trihydroxybenzene-1-propylcarboxylate, 3,5-Trihydroxybenzoic acid, propyl ester, AC-11365, AC-34485, AS-11986, NCI60_002094, Propyl gallate, USP, 98.0-102.0%, Benzoic acid,4,5-trihydroxy-, propyl ester, CS-0009059, EU-0036319, G0018, NS00013163, n-Propyl ester of 3,5-trihydroxybenzoic acid, A19435, D02382, E80666, Propyl gallate, antioxidant, >=98.0% (HPLC), Q608726, SR-01000944710, Propyl gallate, for microscopy, >=98.0% (HPLC), Q-201634, SR-01000944710-1, EFFF5FFA-651C-4DE3-A25F-D807C65D5537, N-PROPYL ESTER OF 3,4,5- TRIHYDROXYBENZOIC ACID, Propyl gallate, European Pharmacopoeia (EP) Reference Standard, Propyl gallate, United States Pharmacopeia (USP) Reference Standard, Propyl gallate, Pharmaceutical Secondary Standard; Certified Reference Material, InChI=1/C10H12O5/c1-2-3-15-10(14)6-4-7(11)9(13)8(12)5-6/h4-5,11-13H,2-3H2,1H" C10H12O5 ZTHYODDOHIVTJV-UHFFFAOYSA-N propyl 3,4,5-trihydroxybenzoate n.a. n.a. No No No No No No PMDBD2001123 Protamine sulphate n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001124 Protocatechuic acid n.a. n.a. n.a. n.a. n.a. n.a. n.a. 72 n.a. NPC156654 "3,4-DIHYDROXYBENZOIC ACID, protocatechuic acid, 99-50-3, Protocatehuic acid, 4-Carboxy-1,2-dihydroxybenzene, protocatechuate, 4,5-Dihydroxybenzoic acid, Benzoic acid, 3,4-dihydroxy-, 3,4-dihydroxybenzoate, CCRIS 6291, protocatechuicacid, EINECS 202-760-0, UNII-36R5QJ8L4B, MFCD00002509, NSC 16631, BRN 1448841, 36R5QJ8L4B, DTXSID4021212, CHEBI:36062, PROTOCATECHOIC ACID, NSC-16631, Catechol-4-carboxylic Acid, 3, 4-Dihydroxybenzoic acid, CHEMBL37537, MLS000737807, DTXCID601212, FEMA NO. 4430, PROTOCATECHUIC ACID (PCA), DIHYDROXYBENZOIC ACID, 3,4-, 1ykp, DROXIDOPA METABOLITE (PROTOCATECHOIC ACID), 3,4-Dihydroxy Benzoic Acid, NSC16631, DB03946, SMR000528167, C00230, D-3487, Hypogallic acid, b-Resorcylate, beta-Resorcylate, ProtocatechicAcid, b-resorcylic acid, 4fht, Protacatechuic Acid, ZINCSELENITE, Carbohydroquinonic acid, cid_72, Protocatechuic Acid,(S), Protocatechuic acid (M1), bmse000328, 3,4-dihydroxy-benzoic acid, 3,4-dihydroxybenzoic acid (protocatechuic acid), SCHEMBL39435, 3,4-Dihydroxybenzoate, VIII, Pyrocatechol-4-carboxylic Acid, PROTOCATECHUIC ACID [MI], HMS2270A17, KUC104409N, HY-N0294, Tox21_200167, BDBM50100861, s3975, AKOS000119632, AC-9617, CCG-207950, CS-6092, KSC-10-128, CAS-99-50-3, NCGC00246757-01, NCGC00246757-02, NCGC00257721-01, 3,4-DIHYDROXYBENZOIC ACID [INCI], AS-10808, SY014104, AM20060767, NS00014667, 3,4-Dihydroxybenzoic acid, >=97.0% (T), EN300-21544, 3,4-Dihydroxybenzoic acid, analytical standard, F11285, 3,4-dihydroxybenzoate;3,4-Dihydroxybenzoic acid, A846038, AE-562/40524392, Q418599, 976C8CCE-B25D-4E0A-9A6F-3CEEA7A6964F, Z104501142, 3,4-Dihydroxybenzoic acid, Vetec(TM) reagent grade, 97%, PROTOCATECHOIC ACID (CONSTITUENT OF MARITIME PINE), Protocatechuic acid, primary pharmaceutical reference standard, PROTOCATECHOIC ACID (CONSTITUENT OF MARITIME PINE) [DSC], Protocatechuic acid, United States Pharmacopeia (USP) Reference Standard, InChI=1/C7H6O4/c8-5-2-1-4(7(10)11)3-6(5)9/h1-3,8-9H,(H,10,11, 1225528-47-1" C7H6O4 YQUVCSBJEUQKSH-UHFFFAOYSA-N 3,4-dihydroxybenzoic acid n.a. n.a. No No No No No No PMDBD2001125 Pseudomonas Quinolone Signal n.a. n.a. n.a. n.a. n.a. n.a. n.a. 2763159 n.a. n.a. 2-HEPTYL-3-HYDROXY-4-QUINOLONE, Pseudomonas quinolone signal, 2-heptyl-3-hydroxy-4(1H)-quinolone, 2-heptyl-3-hydroxy-1H-quinolin-4-one, 521313-35-9, 2-Heptyl-3-hydroxy-quinolone, 2-Heptyl-3-hydroxyl-4-quinolone, 2-HEPTYLQUINOLINE-3,4-DIOL, PQS, CHEMBL2426244, CHEBI:29472, 4(1H)-Quinolinone, 2-heptyl-3-hydroxy-, 2-HEPTYL-3-HYDROXY-4(1H)-QUINOLINONE, SCHEMBL130919, 3,4-dihydroxy-2-heptylquinoline, DTXSID00376772, BDBM50440134, MFCD07437949, AKOS015897030, SB71720, PD096092, HY-128200, CS-0095454, F16823, J-002218, Q27110090, 2-Heptyl-3-hydroxy-4(1H)-quinolone, >=96.0% (HPLC), JWW C16H21NO2 CEIUIHOQDSVZJQ-UHFFFAOYSA-N 2-heptyl-3-hydroxy-1H-quinolin-4-one n.a. n.a. No No No No No No PMDBD2001126 Psoralen Therapeutic Substance Phase 3 66-97-7 DB18665 n.a. n.a. D00VUI 6199 5964 NPC51146 Psoralen, 66-97-7, Ficusin, 7H-Furo[3,2-g]chromen-7-one, Furocoumarin, Psoralene, 7H-Furo[3,2-g][1]benzopyran-7-one, Psorline-P, furo[3,2-g]chromen-7-one, 6,7-Furanocoumarin, Furo(3,2-g)-coumarin, Furo(2'',3'',7,6)coumarin, Furo(4'',5'',6,7)coumarin, Furo[3,2-g]coumarin, NSC 404562, CCRIS 4343, Manaderm, Furo[2'',3'':7,6]coumarin, Furo[4'',5'':6,7]coumarin, KTZ7ZCN2EX, UNII-KTZ7ZCN2EX, 7H-Furo(3,2-g)(1)benzopyran-7-one, HSDB 3528, 7H-Furo[3,2-g]benzopyran-7-one, EINECS 200-639-7, 6-Hydroxy-5-benzofuranacrylic acid beta-lactone, NSC-404562, BRN 0152784, Furo[2''.3'':7.6]coumarin, 5-Benzofuranacrylic acid, 6-hydroxy-, delta-lactone, CHEBI:27616, 6-hydroxy-5-benzofuranacrylic acid delta-lactone, CHEMBL164660, 2H-furo[3,2-g]chromen-2-one, 2-Propenoic acid, 3-(6-hydroxy-5-benzofuranyl)-, delta-lactone, DTXSID00216205, 6-hydroxy-5-benzofuranacrylic acid gamma-lactone, 5-19-04-00445 (Beilstein Handbook Reference), TNP00293, MFCD00010520, 3-(6-hydroxy-5-benzofuranyl)-2-propenoic acid delta-lactone, PSORALEN (USP-RS), PSORALEN [USP-RS], furo(2'',3'':7,6)coumarin, furo(4'',5'':6,7)coumarin, 7H-Furo(3,2-g)chromen-7-one, C11H6O3, furo, furano[3,2-g]chromen-2-one, Psoralene (DCF), Manaderm (TN), Psoralen,(S), Psoralen, 97%, Furo[4'',7]coumarin, PHYTOALEXIN-CMPD, PSORALEN [HSDB], PSORALEN [MI], PSORALEN [WHO-DD], Oprea1_841692, SCHEMBL17835, Psoralen, analytical standard, MLS001304059, MEGxp0_001172, Psoralen, >=99% (HPLC), ACon1_001579, pyrano[5,6-f]benzofuran-7-one, DTXCID60138696, 7-furo[3,2-g][1]benzopyranone, HMS2267L05, BCP04177, HY-N0053, 7H-Furo[3,2-g]chromen-7-one #, BDBM50331544, NSC404562, s4737, AKOS004110987, AC-7968, CCG-266472, CS-3756, FURO(2'',3'':7'',6)COUMARIN, NCGC00017351-01, NCGC00017351-02, NCGC00017351-03, NCGC00017351-07, NCGC00142529-01, AS-59034, SMR000112587, NS00015842, P2077, 7H-Furo[3,2-g][1]benzopyran-7-one, 9CI, 6-hydroxy-5-benzofuranacrylic Acid deta-lacton, C09305, D08450, P-7850, A835599, Q417788, BRD-K47264279-001-01-4, 5-Benzofuranacrylic acid, 6-hydroxy-, .delta.-lactone, Z1201617131, 6-HYDROXY-5-BENZOFURANACRYLIC ACID .DELTA.-LACTONE, 2-Propenoic acid, 3-(6-hydroxy-5-benzofuranyl)-, .delta.-lactone, InChI=1/C11H6O3/c12-11-2-1-7-5-8-3-4-13-9(8)6-10(7)14-11/h1-6 C11H6O3 ZCCUUQDIBDJBTK-UHFFFAOYSA-N furo[3,2-g]chromen-7-one n.a. n.a. No No No No No No PMDBD2001127 PTP-7 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001128 Pyrimidinedione n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001129 Pyrogallol Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D06TPF 1057 n.a. NPC280254 "pyrogallol, benzene-1,2,3-triol, 87-66-1, 1,2,3-trihydroxybenzene, pyrogallic acid, 1,2,3-benzenetriol, fourrine PG, Fouramine Brown AP, fourrine 85, Pyro, Piral, C.I. Oxidation Base 32, fouramine base ap, C.I. 76515, 1,2,3-Trihydroxybenzen, CI Oxidation Base 32, Benzene, 1,2,3-trihydroxy-, NSC 5035, 2,3-Dihydroxyphenol, CCRIS 1940, HSDB 794, NSC-5035, EINECS 201-762-9, UNII-01Y4A2QXY0, BRN 0907431, 01Y4A2QXY0, CI 76515, DTXSID6025983, CHEBI:16164, AI3-00709, 1,2,3-Trihydroxybenzen [Czech], 1,2,3-TRIHYDROXY-BENZENE, benzene-1,2-3-triol, CHEMBL307145, DTXCID905983, 4-06-00-07327 (Beilstein Handbook Reference), Benzene-1,2,3-triol (Pyrogallol), MFCD00002192, NCGC00091507-01, PYROGALLOL (MART.), PYROGALLOL [MART.], 1,2,3-Trihydroxybenzen (CZECH), acid, Pyrogallic, CAS-87-66-1, Pyrogallol [NF], PYG, PYROGALLOL, ACS, Pyrogallic, Pyrogallol;, trihydroxybenzene, 1,3-Benzenetriol, Pyrogallol, 98%, PYROP, Pyrogallol ACS grade, 1,3-Trihydroxybenzen, Pyrogallic Acid,(S), 1,3-Trihydroxybenzene, PYROGALLOL [MI], Pyrogallol, ACS reagent, PYROGALLOL [HSDB], PYROGALLOL [INCI], Benzene,2,3-trihydroxy-, WLN: QR BQ CQ, PYROGALLOL [VANDF], SCHEMBL3532, PYROGALLOL [WHO-DD], C.I. Oxidation Base 32, MLS001066376, Pyrogallol, analytical standard, 1,2,3-Trihydroxybenzene, XIV, Pyrogallol, >=98% (HPLC), Pyrogallol, p.a., ACS reagent, NSC5035, BCP15871, HY-N1579, Pyrogallol, ACS reagent, >=99%, STR08708, Tox21_111143, Tox21_202373, BDBM50031472, Pyrogallol, Vetec(TM) reagent grade, s3885, AKOS000120163, AM10660, CCG-266100, CS-W019928, 1,2,3-Benzenetriol (ACD/Name 4.0), NCGC00091507-02, NCGC00091507-03, NCGC00259922-01, Pyrogallol, purum, >=98.0% (HPLC), AC-11384, BP-12538, GMN, Pyrogallol, SAJ first grade, >=98.0%, SMR000471842, Pyrogallol, JIS special grade, >=99.0%, NS00014915, P0570, EN300-18055, A15863, C01108, AB-131/40221933, Q388692, W-104009, Z57127553, 2,3-Dihydroxyphenol; Benzene-1,2,3-triol; NSC 5035, F0001-2163, InChI=1/C6H6O3/c7-4-2-1-3-5(8)6(4)9/h1-3,7-9, 30813-84-4" C6H6O3 WQGWDDDVZFFDIG-UHFFFAOYSA-N benzene-1,2,3-triol n.a. n.a. No No No No Yes No rxnDiet188,rxnAdd232 PMDBD2001130 Quercetin Dihydrate n.a. n.a. n.a. n.a. n.a. n.a. n.a. 5284452 n.a. n.a. "Quercetin dihydrate, 6151-25-3, 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one dihydrate, MFCD00149487, Quercetine dihydrate, Quercetin (dihydrate), 3,3'',4'',5,7-Pentahydroxyflavone dihydrate, DTXSID9021219, Quercetin dihydrate (Sophoretin), 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one dihydrate, 53B03V78A6, NCGC00017056-01, CAS-6151-25-3, 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxychromen-4-one;dihydrate, DTXCID401219, Quercetindihydrate, 3'',4'',5,7-tetrahydroxyflavonol, CCRIS 3304, UNII-53B03V78A6, Quercetin,(S), C15H10O7.2H2O, Flavone, 3,3'',4'',5,7-pentahydroxy-, dihydrate, Prestwick_541, SCHEMBL22103, BMK1-G2, CHEMBL1520590, QUERCETIN DIHYDRATE [MI], GMGIWEZSKCNYSW-UHFFFAOYSA-N, HMS1569F15, HMS2096F15, HMS3403F09, HMS3656A09, HMS3884N13, BCP07318, HY-N0146, Tox21_110761, Tox21_201150, 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-onedihydrate, HB0543, QUERCETIN DIHYDRATE [WHO-DD], s2347, 2-(3,4-dihydroxyphenyl)-3,5,7-, AKOS004910448, Tox21_110761_1, trihydroxy-4H-chromen-4-one dihydrate, CCG-208320, NCGC00015870-27, NCGC00258702-01, AS-13663, SY061661, CS-0007880, SW148203-5, A833274, Q27261093, F0001-1629, 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one Dihydrate (Quercetin Dihydrate), 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one dihydrate; 3,3′,4′,5,7-Pentahydroxyflavone dihydrate" C15H14O9 GMGIWEZSKCNYSW-UHFFFAOYSA-N "2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxychromen-4-one;dihydrate" n.a. n.a. No No No No No No PMDBD2001131 Quercetin-3-O-glucuronide n.a. n.a. n.a. n.a. n.a. n.a. n.a. 5274585 n.a. NPC235260 quercetin 3-O-glucuronide, 22688-79-5, Miquelianin, Quercituron, Querciturone, QUERCETIN GLUCURONIDE, Mikwelianin, QUERCETIN-3-O-GLUCURONIDE, Quercetin-3-glucosiduronic acid, quercetin-3-O-beta-D-glucuronopyranoside, Quercetin 3-glucuronide, UNII-RY36PD0CQ2, CHEBI:66395, Quercetin-3-O-beta-D-glucuronide, quercetin-3-O-glucoronoside, RY36PD0CQ2, CHEMBL520546, quercetin 3-O-beta-D-glucuronide, HMDB29212, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4H-chromen-3-yl beta-D-glucopyranosiduronic acid, beta-D-Glucopyranosiduronic acid, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4H-1-benzopyran-3-yl, (2S,3S,4S,5R,6S)-6-((2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4H-chromen-3-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid, Quercetin 3-O-|A-D-glucuronide, MFCD09752939, quercetin 3-O-beta-glucopyranoside, 3,3'',4'',5,7-Pentahydroxyflavone 3-glucuronide, (2S,3S,4S,5R,6S)-6-[2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxochromen-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid, SCHEMBL578422, MEGxp0_000321, QUERCETIN beta-GLUCURONIDE, Quercetein-3-O-beta-glucuronide, ACon1_000029, DTXSID70945358, cid_12004528, QUERCETIN 3-beta-GLUCURONIDE, (2S,3S,4S,5R)-6-(2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4H-chromen-3-yloxy)-3,4,5-trihydroxy-tetrahydro-2H-pyran-2-carboxylic acid, QUERCETIN .BETA.-GLUCURONIDE, BDBM50242280, Quercetin 3-O-.beta.-D-glucuronide, QUERCETIN-3-beta-D-GLUCURONIDE, AKOS032946010, CS-6851, QUERCETIN 3-.BETA.-GLUCURONIDE, NCGC00168861-02, (2S,3S,4S,5R,6S)-6-[2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-chromen-3-yl]oxy-3,4,5-trihydroxy-tetrahydropyran-2-carboxylic acid, AS-79366, HY-13930, Miquelianin (Quercetin 3-O-glucuronide)?, QUERCETIN-3-.BETA.-D-GLUCURONIDE, QUERCETIN-3-O-.BETA.-D-GLUCURONIDE, Quercetin 3-glucuronide, analytical standard, F17687, Q-0100, QUERCETIN 3-O-beta-D-GLUCURONOPYRANOSIDE, Quercetin 3-glucuronideQuercetin 3-O-glucuronide, Quercetin 3-glucuronide, >=95% (LC/MS-ELSD), QUERCETIN 3-O-.BETA.-D-GLUCURONOPYRANOSIDE, Q6871627, Quercetin 3-glucuronide, primary pharmaceutical reference standard, (2S,3S,4S,5R,6S)-6-(2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4H-chromen-3-yloxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid, .beta.-D-Glucopyranosiduronic acid, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4H-1-benzopyran-3-yl, 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-3-(.beta.-D-glucopyranuronosyloxy)-5,7-dihydroxy-, GLUCOPYRANOSIDURONIC ACID, 2-(3,4-DIHYDROXYPHENYL)-5,7-DIHYDROXY-4-OXO-4H-1-BENZOPYRAN-3-YL, .BETA.-D-, GLUCOPYRANOSIDURONIC ACID, 2-(3,4-DIHYDROXYPHENYL)-5,7-DIHYDROXY-4-OXO-4H-1-BENZOPYRAN-3-YL, beta-D- C21H18O13 DUBCCGAQYVUYEU-ZUGPOPFOSA-N (2S,3S,4S,5R,6S)-6-[2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxochromen-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid n.a. n.a. No No No No No No PMDBD2001132 Quinizarin Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D0Y6OK 6688 n.a. NPC96915 "Quinizarin, 1,4-Dihydroxyanthraquinone, 81-64-1, 1,4-dihydroxyanthracene-9,10-dione, Quinizarine, Chinizarin, Solvent Orange 86, 1,4-Dihydroxyanthrachinon, Smoke Orange R, 1,4-Dihydroxy-9,10-anthraquinone, Macrolex Orange GG, 9,10-Anthracenedione, 1,4-dihydroxy-, Anthraquinone, 1,4-dihydroxy-, 1,4-Dioxyanthraquinone, 1,4-Dihydroxyanthra-9,10-quinone, 1,4-Doa, 1,4-Dihydroxy-anthraquinone, 103220-12-8, C.I. 58050, 1,4-DIHYDROXY-9,10-ANTHRACENEDIONE, NSC 15367, NSC 646569, CHEBI:37487, NSC-15367, NSC-646569, CHEMBL17594, 8S496ZV3CS, DTXSID8044464, DIHYDROXYANTHRAQUINONE, 1,4-, MFCD00001209, NSC646569, 9, 1,4-dihydroxy-, 1,4-dihydroxy-9,10-dihydroanthracene-9,10-dione, 1,4-Doa [Russian], WLN: L C666 BV IVJ DQ GQ, CCRIS 3524, HSDB 5242, 1,4-Dioxyanthraquinone [Russian], 1,4-Dihydroxyanthrachinon [Czech], EINECS 201-368-7, UNII-8S496ZV3CS, CI 58050, AI3-17616, 4,9-dihydroxy-1,10-anthraquinone, 9,10-Dihydroxy-1,4-anthraquinone, Quinizarin, 96%, QUINIZARIN [MI], EC 201-368-7, 1,4 Dihydroxy-Anthraquinone, SCHEMBL160038, MEGxp0_001867, SCHEMBL2639287, DTXCID6024464, ACon1_000101, HY-D0226, NSC15367, NSC40899, Tox21_302041, BDBM50240382, CCG-48149, NSC-40899, NSC229036, 1,4-dihydroxy-anthracene-9,10-dione, AKOS001595052, 1,4-Dihydroxy-9,10-anthracene-dione, 1,4-Dihydroxyanthra-9,10-quinone #, NSC-229036, Quinizarin; 1,4-Dihydroxyanthraquinone, CAS-81-64-1, NCGC00160196-01, NCGC00160196-02, NCGC00255951-01, AC-11267, AS-14244, NCI60_001089, CS-0010138, D0243, NS00003772, F87345, EN300-6486266, A840176, AE-641/02529036, Q906609, SR-01000108129, 1,4-DIHYDROXY-9,10-ANTHRACENEDIONE [HSDB], SR-01000108129-1, SR-01000637713-1, W-104202, F1565-0160, 1,4-Dihydroxyanthraquinone, purum, >=98.0% (HPLC), powder, red-brown, 1,4-Dihydroxy-9,10-anthraquinone; 1,4-Dihydroxyanthraquinone; Smoke Orange R; Quinizarine, InChI=1/C14H8O4/c15-9-5-6-10(16)12-11(9)13(17)7-3-1-2-4-8(7)14(12)18/h1-6,15-16" C14H8O4 GUEIZVNYDFNHJU-UHFFFAOYSA-N 1,4-dihydroxyanthracene-9,10-dione n.a. n.a. No No No No No No PMDBD2001133 Quinolin-8-ol Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D0FO2B 1923 n.a. NPC314940 "8-HYDROXYQUINOLINE, quinolin-8-ol, 148-24-3, 8-quinolinol, Oxyquinoline, Oxine, Quinophenol, Oxychinolin, 8-Quinol, 8-Oxyquinoline, Phenopyridine, Oxin, Oxybenzopyridine, Hydroxybenzopyridine, 1-Azanaphthalene-8-ol, 8-Hydroxychinolin, Bioquin, Tumex, 8-Chinolinol, 8-Hydroxy-chinolin, Fennosan H 30, 8-OQ, Fennosan, Oxyquinol, o-Oxychinolin, 8-Oxychinolin, Usaf ek-794, Fennosan HF-15, HYDROXYQUINOLINE, Oxyquinoline [USAN], Caswell No. 719, NCI-C55298, NSC 2039, Quinoline, 8-hydroxy-, 8-hydroxy-quinoline, CCRIS 340, MFCD00006807, Oxoquinoline, Albisal, NSC 615011, HSDB 4073, NSC-2039, EINECS 205-711-1, UNII-5UTX5635HP, 8-hydroxy quinoline, EPA Pesticide Chemical Code 059803, NSC-285166, NSC-402623, NSC-615011, BRN 0114512, 5UTX5635HP, DTXSID5020730, CHEBI:48981, AI3-00483, NSC-48037, NSC-54230, NSC-82404, NSC-82405, NSC-82409, NSC-82410, NSC-82412, NSC285166, J2.960B, DTXCID30730, MLS002702126, CHEMBL310555, quinoline-8-ol, EC 205-711-1, Oxyquinoline (8-Hydroxyquinoline), 5-21-03-00252 (Beilstein Handbook Reference), NSC 82404, NSC615011, Oxyquinoline (USAN), NCGC00090708-03, NCGC00090708-05, OXYQUINOLINE (II), OXYQUINOLINE [II], 8 Hydroxyquinoline, WLN: T66 BNJ JQ, Oxine;8-Hydroxyquinoline;Quinophenol;8-Quinolinone, 8-HYDROXYQUINOLINE (IARC), 8-HYDROXYQUINOLINE [IARC], 8-Chinolinol [Czech], o-Oxychinolin [German], 8 Oxyquinoline, 8 Quinolinol, CAS-148-24-3, Manganese, bis(8-quinolinolato)-, SMR000112313, 8-Hydroxy-chinolin [German], Oxychinoline, 8-Oxyquinolin, 8-Quinolinone, 8-Quinolol, 8-hydroxiquinoline, 8-hydroxychinoline, 8-hydroxylquinoline, HQY, UDDER BALM, 8-Quinolinol, p.a., Spectrum_001053, 3vh9, 8-Hydroxyquinoline Oxine, Spectrum2_000697, Spectrum3_000534, Spectrum4_000465, Spectrum5_001280, 8-Hydroxyquinoline, 99%, NCIMech_000694, OXYQUINOLINE [HSDB], OXYQUINOLINE [INCI], cid_1923, NCIStruc1_000152, NCIStruc2_000240, Oxyquinol Reference Spectrum, NCIOpen2_000962, NCIOpen2_001020, NCIOpen2_001220, NCIOpen2_004264, OXYQUINOLINE [VANDF], Pesticide Code: 059803, SCHEMBL37189, BSPBio_002147, KBioGR_000910, KBioSS_001533, MLS001055492, BIDD:ER0371, DivK1c_000757, SPBio_000853, 8-Hydroxyquinoline, crystalline, HYDROXYQUINOLINE [VANDF], 8-HYDROXYQUINOLINE [MI], BDBM32203, HMS502F19, KBio1_000757, KBio2_001533, KBio2_004101, KBio2_006669, KBio3_001647, HYDROXYQUINOLINE [WHO-DD], NSC2039, NINDS_000757, 8-Quinolinol (7CI,8CI,9CI), HY-B1005, STR00721, Tox21_113083, Tox21_202986, Tox21_400006, 8-Oxychinolin, 8-Quinolinol, Oxine, CCG-35870, NSC 48037, NSC 54230, NSC 82405, NSC 82409, NSC 82410, NSC 82412, NSC402623, s4547, 8-Hydroxyquinoline ACS Reagent Grade, AKOS001061311, AC-5109, CS-4502, DB11145, NSC 285166, NSC 402623, PS-4553, SB40773, 8-Hydroxyquinoline, ACS reagent, 99%, IDI1_000757, NCGC00090708-01, NCGC00090708-02, NCGC00090708-04, NCGC00090708-06, NCGC00090708-07, NCGC00090708-08, NCGC00090708-11, NCGC00260531-01, NCI60_001712, NCI60_002335, SBI-0051472.P003, AM20050821, H0305, NS00010316, 8-Quinolinol, JIS special grade, >=99.0%, 8-Quinolinol, Vetec(TM) reagent grade, 99%, EN300-17403, C19434, D05321, P17615, US9394254, 6, 8-Quinolinol, PESTANAL(R), analytical standard, AB00052065_08, 8-Quinolinol, >=99% (perchloric acid titration), A808745, AP-065/40180076, Q270162, CU-01000012874-2, W-108106, BRD-K66808046-065-01-1, Z56926518, F0001-0526, InChI=1/C9H7NO/c11-8-5-1-3-7-4-2-6-10-9(7)8/h1-6,11, 8-Quinolinol, puriss. p.a., ACS reagent, for the detection and determination of Al, Mg and others, >=99.0% (NT), 8-Quinolinol, puriss. p.a., ACS reagent, reag. Ph. Eur., >=99% (perchloric acid titration)" C9H7NO MCJGNVYPOGVAJF-UHFFFAOYSA-N quinolin-8-ol n.a. n.a. No No No No No No PMDBD2001134 Quinupristin Therapeutic Substance Approved Drug 120138-50-3 DB01369 PA164749647 D00852 D0E2OU 5388937 4470884 n.a. Quinupristin, 120138-50-3, RP 57669, RP-57669, 23OW28RS7P, Quinupristina, Quinupristine, Quinupristinum, Antibiotic RP 57669, Quinupristine [INN-French], Quinupristinum [INN-Latin], Quinupristina [INN-Spanish], N-[(3S,6S,12R,15S,16R,19S,22S,25R)-25-[[(3S)-1-azabicyclo[2.2.2]octan-3-yl]sulfanylmethyl]-3-[[4-(dimethylamino)phenyl]methyl]-12-ethyl-4,16-dimethyl-2,5,11,14,18,21,24-heptaoxo-19-phenyl-17-oxa-1,4,10,13,20-pentazatricyclo[20.4.0.06,10]hexacosan-15-yl]-3-hydroxypyridine-2-carboxamide, UNII-23OW28RS7P, RP 68888, Quinupristin [USAN:INN:BAN], HSDB 8067, QUINUPRISTIN [MI], QUINUPRISTIN [INN], QUINUPRISTIN [JAN], QUINUPRISTIN [USAN], QUINUPRISTIN [VANDF], SCHEMBL40782, N-((6R,9S,10R,13S,15aS,18R,22S,24aS)-22-(p-(Dimethylamino)benzyl)-6-ethyldocosahydro-10,23-dimethyl-5,8,12,15,17,21,24-heptaoxo-13-phenyl-18-(((3S)-3-quinuclidinylthio)methyl)-12H-pyrido(2,1-f)pyrrolo(2,1-l)(1,4,7,10,13,16)oxapentaazacyclononadecin-9-yl)-3-hydroxypicolinamide, QUINUPRISTIN [WHO-DD], CHEMBL1200649, GTPL10798, QUINUPRISTIN [ORANGE BOOK], HY-A0162, SYNERCID COMPONENT QUINUPRISTIN, DB01369, RP57669, QUINUPRISTIN COMPONENT OF SYNERCID, Virginiamycin S1, 4-(4-(dimethylamino)-N-methyl-L-phenylalanine)-5-(5-((1-azabicyclo(2.2.2)oct-3-ylthio)methyl)-4-oxo-L-2-piperidinecarboxylic acid)-, (S)-, CS-0017494, EN300-28266000, Q7272542, N-[(3S,6S,12R,15S,16R,19S,22S,25R)-25-{[(3S)-1-azabicyclo[2.2.2]octan-3-ylsulfanyl]methyl}-3-{[4-(dimethylamino)phenyl]methyl}-12-ethyl-4,16-dimethyl-2,5,11,14,18,21,24-heptaoxo-19-phenyl-17-oxa-1,4,10,13,20-pentaazatricyclo[20.4.0.0,6,10]hexacosan-15-yl]-3-hydroxypyridine-2-carboxamide, VIRGINIAMYCIN S1, 4-(4-(DIMETHYLAMINO)-N-METHYL-L-PHENYLALANINE)-5-(5-(1-AZABICYCLO(2.2.2)OCT-3-YLTHIO)METHYL)-4-OXO-L-2-PIPERIDINECARBOXYLIC ACID)-, (S)- C53H67N9O10S WTHRRGMBUAHGNI-LCYNINFDSA-N N-[(3S,6S,12R,15S,16R,19S,22S,25R)-25-[[(3S)-1-azabicyclo[2.2.2]octan-3-yl]sulfanylmethyl]-3-[[4-(dimethylamino)phenyl]methyl]-12-ethyl-4,16-dimethyl-2,5,11,14,18,21,24-heptaoxo-19-phenyl-17-oxa-1,4,10,13,20-pentazatricyclo[20.4.0.06,10]hexacosan-15-yl]-3-hydroxypyridine-2-carboxamide n.a. Antibiotics No No No No No No PMDBD2001135 Raspberry KAS 434 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001136 Resorcinol Therapeutic Substance Investigational Drug 108-46-3 DB11085 n.a. D00133 D02DBP 5054 4878 NPC270094 "resorcinol, 108-46-3, benzene-1,3-diol, 1,3-Benzenediol, Resorcin, 1,3-Dihydroxybenzene, m-Hydroquinone, m-Hydroxyphenol, m-Dihydroxybenzene, 3-Hydroxyphenol, m-Benzenediol, Resorcine, m-Dioxybenzene, Dihydroxybenzol, Resorzin, Developer O, Developer R, Developer RS, Fouramine RS, Fourrine EW, Pelagol RS, Pelagol Grey RS, Resorcinolum, Fourrine 79, Nako TGG, Durafur developer G, C.I. Oxidation Base 31, Phenol, m-hydroxy-, C.I. Developer 4, Benzene, m-dihydroxy-, Rcra waste number U201, Benzene, 1,3-dihydroxy-, 3-Hydroxycyclohexadien-1-one, FEMA No. 3589, Acnomel, Resorcinum, Rezamid, Sulforcin, Resorcinol (USP), NCI-C05970, NSC 1571, C.I. 76505, CCRIS 4052, HSDB 722, UNII-YUL4LO94HK, YUL4LO94HK, RCRA waste no. U201, NSC-1571, EINECS 203-585-2, .alpha.-Resorcinol, Resorcin (JAN), Resorcin (TN), Resorcinol [USP], EPA Pesticide Chemical Code 071401, BRN 0906905, 1,3-Dihydroxybenzol, DTXSID2021238, CHEBI:27810, AI3-03996, CHEMBL24147, DTXCID601238, C.I.-76505, EC 203-585-2, 4-06-00-05658 (Beilstein Handbook Reference), Resorcinol [UN2876] [Poison], MFCD00002269, NCGC00091501-01, RESORCIN [JAN], BENZENE,1,3-DIHYDROXY RESORCINOL, RESORCINOL (IARC), RESORCINOL [IARC], RESORCINOL (MART.), RESORCINOL [MART.], RESORCINOL (USP-RS), RESORCINOL [USP-RS], RCO, Caswell No. 723, RESORCINOL (EP MONOGRAPH), RESORCINOL [EP MONOGRAPH], RESORCINOL (USP MONOGRAPH), RESORCINOL [USP MONOGRAPH], Rezorsine, m-phenylenediol, Reso, Rodol RS, CAS-108-46-3, FLUORESCEIN IMPURITY A (EP IMPURITY), FLUORESCEIN IMPURITY A [EP IMPURITY], HEXYLRESORCINOL IMPURITY B (EP IMPURITY), HEXYLRESORCINOL IMPURITY B [EP IMPURITY], UN2876, Remazol, RS 11H, RS 11L, m-hydroxy-phenol, 3-hydroxy-phenol, Resorcinol, ACS, 3aqt, 3-Hydroxy phenol, Resorcinol, 8CI, benzen-1,3-diol, Resorcinol, Reagent, 1,3-benzene diol, Resorcine, technical, 1,3-dihyroxybenzene, Acnomel (Salt/Mix), Eskamel (Salt/Mix), Rezamid (Salt/Mix), phenol derivative, 3, 26982-54-7, Benzene,3-dihydroxy-, NAKO-TGG, Sulforcin (Salt/Mix), 1,3-dihydroxy-benzene, Spectrum_000173, M-Dihydroxybenzene,(S), RESORCINOL [MI], Spectrum2_001310, Spectrum3_000895, Spectrum4_000990, Spectrum5_001152, RESORCINOL [FHFI], RESORCINOL [HSDB], RESORCINOL [INCI], RESORCINUM [HPUS], WLN: QR CQ, DURAFOR DEVELOPER G, RESORCINOL [VANDF], bmse000415, 1,3-Dihydroxybenzene, XII, NCIOpen2_003867, RESORCINOL [WHO-DD], SCHEMBL15515, KBioGR_001399, KBioSS_000653, Resorcinol, >=98%, FG, Resorcinol, Flake, Technical, Resorcinol, LR, >=99%, BIDD:ER0285, DivK1c_000041, SPECTRUM1500527, SPBio_001379, Resorcinol, BioXtra, >=99%, BDBM26189, FEMA 3589, HMS500C03, KBio1_000041, KBio2_000653, KBio2_003221, KBio2_005789, KBio3_001810, Resorcinol, reagent grade, 98%, NSC1571, 4e49, NINDS_000041, HMS1920P06, HMS2092G07, Pharmakon1600-01500527, 1,3-Dihydroxybenzene (Resorcinol), Resorcinol (1,3-Dihydroxybenzene), HY-B0907, Resorcinol, ReagentPlus(R), 99%, Tox21_111140, Tox21_202417, Tox21_300140, CCG-39248, NSC757310, Resorcinol 10 microg/mL in Methanol, Resorcinol, Crystalline Powder, USP, AKOS000119813, Resorcinol, ACS reagent, >=99.0%, Tox21_111140_1, DB11085, NSC-757310, UN 2876, IDI1_000041, NCGC00091501-02, NCGC00091501-03, NCGC00091501-04, NCGC00091501-05, NCGC00091501-06, NCGC00253918-01, NCGC00259966-01, Resorcinol, p.a., 99.0-100.5%, Resorcinol, tested according to Ph.Eur., AC-14363, BP-21158, LS-13122, Resorcinol, SAJ first grade, >=98.0%, SBI-0051505.P003, Resorcinol, JIS special grade, >=99.0%, NS00007013, R0008, S4579, 3-Hydroxycyclohexadien-1-one;3-Hydroxyphenol, EN300-19643, 1,3-BENZENEDIOL; 1,3-DIHYDROXYBENZENE, C01751, D00133, AB00052085_03, A801880, Q408865, SR-05000002092, FLUORESCEIN SODIUM IMPURITY A [EP IMPURITY], Q-201666, SR-05000002092-1, BRD-K74190368-001-02-7, F1908-0097, Resorcinol, certified reference material, TraceCERT(R), Z104474576, Resorcinol, European Pharmacopoeia (EP) Reference Standard, Resorcinol, United States Pharmacopeia (USP) Reference Standard, InChI=1/C6H6O2/c7-5-2-1-3-6(8)4-5/h1-4,7-8, Hymecromone impurity A, European Pharmacopoeia (EP) Reference Standard, Resorcinol, Pharmaceutical Secondary Standard; Certified Reference Material" C6H6O2 GHMLBKRAJCXXBS-UHFFFAOYSA-N benzene-1,3-diol n.a. n.a. No No No No No No PMDBD2001137 R-FV-I16 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001138 Rhein Therapeutic Substance Investigational Drug 478-43-3 DB13174 n.a. n.a. D0M2TY 10168 9762 NPC288089 "Rhein, 478-43-3, Monorhein, Rhubarb Yellow, Rheic acid, Cassic acid, 4,5-dihydroxy-9,10-dioxo-9,10-dihydroanthracene-2-carboxylic acid, 4,5-Dihydroxyanthraquinone-2-carboxylic acid, Chrysazin-3-carboxylic acid, 1,8-Dihydroxy-3-carboxyanthraquinone, Rheinic acid, NSC 38629, 1,8-Dihydroxyanthraquinone-3-carboxylic acid, 4,5-dihydroxy-9,10-dioxoanthracene-2-carboxylic acid, 9,10-Dihydro-4,5-dihydroxy-9,10-dioxo-2-anthracenecarboxylic acid, 2-Anthracenecarboxylic acid, 9,10-dihydro-4,5-dihydroxy-9,10-dioxo-, MFCD00009618, Rhein (1,8-dihydroxy-3-carboxyl anthraquinone), YM64C2P6UX, MLS000069639, CHEBI:8825, 2-Anthroic acid, 9,10-dihydro-4,5-dihydroxy-9,10-dioxo-, 4,5-Dihydroxy-2-anthraquinonecarboxylic acid, DTXSID4026000, 4,5-DiOH-anthraquinone-2-COOH, 9,10-Dihydro-4,5-dihydroxy-9,10-dioxoanthracene-2-carboxylic acid, NSC-38629, SMR000058210, dipropionyl rhein, 1,8-DIHYDROXY-3-CARBOXYL ANTHRAQUINONE, 9,10-Dihydro-4,5-dihydroxy-9,10-dioxo-2-anthroic acid, Parietic acid, C15H8O6, Rhein(Monorhein), CCRIS 5129, EINECS 207-521-4, UNII-YM64C2P6UX, BRN 2222155, RHN, Rhein,(S), Rhein; Rhubarb Yellow, Rhein, technical grade, 4ie7, ST057726, regid855879, RHEIN [INCI], RHEIN [MI], Rhein, analytical standard, 1,8-dihydroxy-3-carboxyl-9,10-anthraquinone, SCHEMBL25253, US9238626, Rhein, 4-10-00-04088 (Beilstein Handbook Reference), cid_10168, MLS006011744, CHEMBL418068, DTXCID606000, MEGxp0_001866, 4,5-dihydroxy-9,10-dioxo-anthracene-2-carboxylic acid, ACon1_000217, BDBM32021, BCP28202, HY-N0105, NSC38629, Tox21_201098, 4,5-Dihydroxy-9,10-dioxo-9,10-dihydroanthracene-2-carboxylicacid, LMPK13040015, s2400, AKOS005259272, AC-7978, CS-5239, DB13174, NCGC00018199-01, NCGC00018199-02, NCGC00018199-03, NCGC00018199-04, NCGC00018199-05, NCGC00018199-06, NCGC00018199-07, NCGC00023342-03, NCGC00023342-04, NCGC00258650-01, AM807834, AS-11635, CAS-478-43-3, SY051290, D3986, NS00015851, 4, 5-Dihydroxyanthraquinone-2-carboxylic acid, 2-Anthraquinonecarboxylic acid, 4,5-dihydroxy-, EN300-303248, DIHYDROXY-3-CARBOXYLANTHRAQUINONE, 1,8-, A827360, Q720356, Q-100512, 4,5-dihydroxy-9,10-dioxo-2-anthracenecarboxylic acid, 4,5-dihydroxy-9,10-dioxoanthracene-2-carboxylicacid, BRD-K27335680-001-01-9, 2-Anthroic acid,10-dihydro-4,5-dihydroxy-9,10-dioxo-, 4,5-dihydroxy-9,10-diketo-anthracene-2-carboxylic acid, 2-Anthracenecarboxylic acid,10-dihydro-4,5-dihydroxy-9,10-dioxo-, 4,5-Dihydroxy-9,10-dioxo-9,10-dihydro-2-anthracenecarboxylic acid, 4,5-bis(oxidanyl)-9,10-bis(oxidanylidene)anthracene-2-carboxylic acid, 4,5-Dihydroxy-9,10-dioxo-9,10-dihydro-2-anthracenecarboxylic acid #, 9,10-Dihydro-4,5-dihydroxy-9,10-dioxo-2-anthracene carboxylic acid, 9,10-Dihydro-4,5-dihydroxy-9,10-dioxo-2-anthracenecarboxylic acid, 9CI" C15H8O6 FCDLCPWAQCPTKC-UHFFFAOYSA-N 4,5-dihydroxy-9,10-dioxoanthracene-2-carboxylic acid n.a. n.a. No No No No No No PMDBD2001139 Rhodomyrtone n.a. n.a. n.a. n.a. n.a. n.a. n.a. 12050020 n.a. NPC246654 Rhodomyrtone, (9R)-6,8-dihydroxy-2,2,4,4-tetramethyl-7-(3-methylbutanoyl)-9-(2-methylpropyl)-9H-xanthene-1,3-dione, 468757-69-9, CHEMBL4101406, AKOS040763190, 6,8-dihydroxy-2,2,4,4-tetramethyl-7-(3-methyl-1-oxobutyl)-9-(2-methylpropyl)-4,9-dihydro-1H-xanthene-1,3(2H)-di-one C26H34O6 TYDBFNAOFZIICW-CQSZACIVSA-N (9R)-6,8-dihydroxy-2,2,4,4-tetramethyl-7-(3-methylbutanoyl)-9-(2-methylpropyl)-9H-xanthene-1,3-dione n.a. n.a. No No No No No No PMDBD2001140 RI-19 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001141 Rifalazil Therapeutic Substance Phase 3 129791-92-0 DB04934 n.a. D02550 D0XW9L 135431094 16736451 n.a. "Rifalazil, Benzoxazinorifamycin, KRM-1648, 129791-92-0, Krm 1648, S1976TE8QK, 3''-Hydroxy-5''-(4-isobutylpiperazinyl)benzoxazinorifamycin, (2S,16Z,18E,20S,21S,22R,23R,24R,25S,26R,27S,28E)-5,12,21,23,25-Pentahydroxy-10-(4-isobutyl-1-piperazinyl)-27-methoxy-2,4,16,20,22,24,26-heptamethyl-2,7-(epoxypentadeca(1,11,13)trienimino)-6H-benzofuro(4,5-a)phenoxazine-1(2H),6,15-trione 25-acetate, [(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,6,15,17-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-30-[4-(2-methylpropyl)piperazin-1-yl]-23,32,37-trioxo-8,27,38-trioxa-24,34-diazahexacyclo[23.11.1.14,7.05,36.026,35.028,33]octatriaconta-1,3,5,9,19,21,25,28,30,33,35-undecaen-13-yl] acetate, 3''-hydroxy-5''-(4-isobutyl-1-piperazinyl)benzoxazinorifamycin, (7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,32-Tetrahydroxy-30-(4-isobutyl-1-piperazinyl)-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23,37-trioxo-8,27,38-trioxa-24,34-diazahexacyclo[23.11;.1.14,7.05,36.026,35.028,33]octatriaconta-1(36),2,4,9,19,21,25,28,30,32,34-undecaen-13-yl acetate, Rifamycin viii, 1'',4-didehydro-1-deoxy-1,4-dihydro-3''-hydroxy-5''-(4-(2-methylpropyl)-1-piperazinyl)-1-oxo-, Rifalazil [USAN:INN], [tetrahydroxy-(4-isobutylpiperazin-1-yl)-methoxy-heptamethyl-trioxo-[?]yl] acetate, ABI 1648, Rifamycin VIII, 1'',4-didehydro-1-deoxy-1,4-dihydro-3''-hydroxy-5''-[4-(2-methylpropyl)-1-piperazinyl]-1-oxo-, RLZ, RIFALAZIL [INN], RIFALAZIL [MI], Rifalazil (USAN/INN), RIFALAZIL [USAN], KRM-1648 and Yokuinin, UNII-S1976TE8QK, SCHEMBL76007, CHEMBL236297, KRM-1648 & MBST, ABI1648, CHEBI:188526, ABI-1648, BDBM50491559, KRM-1648 & Mao-Bushi-Saishin-To, DB04934, PA-1648, HY-105099, CS-0024983, D02550, G12816, KRM-1648 & Scretory leukocyte protease inhibitor, Q7333206, (2S,20S,21S,22R,23R,24R,25S,26R,27S)-5,12,21,23-Tetrahydroxy-10-(4-isobutylpiperazin-1-yl)-27-methoxy-2,4,16,20,22,24,26-heptamethyl-1,6,15-trioxo-1,2-dihydro-6H-2,7-(epoxypentadeca[1,11,13]trienoimino)[1]benzofuro[4,5-a]phenoxazin-25-yl acetate, 1'',4-DIDEHYDRO-1-DEOXY-1,4-DIHYDRO-3''-HYDROXY-5''-(4-(2-METHYLPROPYL)-1-PIPERAZINYL)-1-OXORIFAMYCIN VIII, 2,7-(Epoxy[1,11,13]pentadecatrienoimino)-6H-benzofuro[4,5-a]phenoxazine-1,6,15(2H)-trione, 25-(acetyloxy)-5,12,21,23-tetrahydroxy-27-methoxy-2,4,16,20,22,24,26-heptamethyl-10-[4-(2-methylpropyl)-1-piperazinyl]-, (2S,16Z,18E,20S,21S,22R,23R,24R,25S,26R,27S,28E)-" C51H64N4O13 IXSVOCGZBUJEPI-HTQYORAHSA-N [(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,6,15,17-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-30-[4-(2-methylpropyl)piperazin-1-yl]-23,32,37-trioxo-8,27,38-trioxa-24,34-diazahexacyclo[23.11.1.14,7.05,36.026,35.028,33]octatriaconta-1,3,5,9,19,21,25,28,30,33,35-undecaen-13-yl] acetate n.a. n.a. No No No No No No PMDBD2001142 Rifapentine? n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001143 Rilpivirine Therapeutic Substance Approved Drug 500287-72-9 DB08864 n.a. D09720 D0T6WN 6451164 4953643 n.a. "Rilpivirine, 500287-72-9, TMC278, Edurant, Rilpivirine free base, R278474, TMC 278, Rilpivirina, TMC-278, R 278474, UNII-FI96A8X663, CHEBI:68606, HSDB 8153, FI96A8X663, (E)-4-(4-(4-(2-cyanovinyl)-2,6-dimethylphenylamino)pyrimidin-2-ylamino)benzonitrile, Rilpivirine Z-Isomer HCl, 4-{[4-({4-[(E)-2-Cyanoethenyl]-2,6-Dimethylphenyl}amino)pyrimidin-2-Yl]amino}benzonitrile, 4-{[4-({4-[(E)-2-cyanovinyl]-2,6-dimethylphenyl}amino)pyrimidin-2-yl]amino}benzonitrile, DTXSID10198189, R-278474, 500287-72-9 (free base), CABENUVA COMPONENT RILPIVIRINE, 4-[[4-[[4-[(E)-2-Cyanoethenyl]-2,6-dimethyl-phenyl]amino]pyrimidin-2-yl]amino]benzonitrile, DB08864, RILPIVIRINE COMPONENT OF CABENUVA, Rilpivirine(R 278474, TMC 278), (E)-4-((4-((4-(2-cyanovinyl)-2,6-dimethylphenyl)amino)pyrimidin-2-yl)amino)benzonitrile, RILPIVIRINE (MART.), RILPIVIRINE [MART.], 4-((4-((4-((1E)-2-Cyanoethenyl)-2,6-dimethylphenyl)amino)-2-pyrimidinyl)amino)benzonitrile, Benzonitrile, 4-((4-((4-((1E)-2-cyanoethenyl)-2,6-dimethylphenyl)amino)-2-pyrimidinyl)amino)-, Rilpivirine [INN], Rilpivirine [USAN:INN], rilpivirinum, 4-((4-((4-((E)-2-cyanoethenyl)-2,6-dimethylphenyl)amino)pyrimidin-2-yl)amino)benzonitrile, 4-((4-((4-((E)-2-cyanovinyl)-2,6-dimethylphenyl)amino)pyrimidin-2-yl)amino)benzonitrile, 4-[[4-[4-[(E)-2-cyanoethenyl]-2,6-dimethylanilino]pyrimidin-2-yl]amino]benzonitrile, Edurant(TM), 4-((4-((4-((1E)-2-CYANOETHENYL)-2,6-DIMETHYLPHENYL)AMINO)PYRIMIDIN-2-YL)AMINO)BENZONITRILE, 4-[[4-[[4-[(1E)-2-Cyanoethenyl]-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile, 4-{[4-({4-[(1E)-2-Cyanoethenyl]-2,6-dimethylphenyl}amino)pyrimidin-2-yl]amino}benzonitrile, T27, RILPIVIRINE [MI], RILPIVIRINE [JAN], RILPIVIRINE [USAN], RILPIVIRINE [VANDF], RILPIVIRINE [WHO-DD], SCHEMBL384696, SCHEMBL385113, Rilpivirine (JAN/USAN/INN), CHEMBL175691, GTPL11387, DTXCID90120680, EX-A245, J05AG05, RILPIVIRINE [ORANGE BOOK], YIBOMRUWOWDFLG-ONEGZZNKSA-N, BDBM222178, BCP03563, MFCD11046372, s7303, AKOS015901680, BCP9000016, CCG-268241, CS-0440, KE-0036, R278474;TMC278, 4-[[4-[4-[(E)-2-cyanovinyl]-2,6-dimethyl-anilino]pyrimidin-2-yl]amino]benzonitrile, NCGC00319175-03, NCGC00319175-08, AC-30619, HY-10574, BCP0726000192, SW220232-1, D09720, A827939, EN300-21682062, Q421547, W-202888, 4-[[4-[4-[(E)-2-cyanoethenyl]-2,6-dimethylanilino]-2-pyrimidinyl]amino]benzonitrile, 4-{4-[4-((E)-2-Cyano-vinyl)-2,6-dimethyl-phenylamino]-pyrimidin-2-ylamino}-benzonitrile, 4-[[4-[[4-[(E)-2-cyanoethenyl]-2,6-dimethyl-phenyl]amino]pyrimidin-2-yl]amino]benzenecarbonitrile, 4-{[4-({4-[(1E)-2-cyanoeth-1-en-1-yl]-2,6-dimethylphenyl}amino)pyrimidin-2-yl]amino}benzonitrile, BENZONITRILE, 4-((4-((4-((1E)-2-CYANOETHENYL)-2,6-DIMETHYLPHENYL)AMINO)-2- PYRIMIDINYL)AMINO)-" C22H18N6 YIBOMRUWOWDFLG-ONEGZZNKSA-N 4-[[4-[4-[(E)-2-cyanoethenyl]-2,6-dimethylanilino]pyrimidin-2-yl]amino]benzonitrile n.a. n.a. No No No No No No PMDBD2001144 RK-19 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001145 RK-25 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001146 RK-31 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001147 RNAIII-inhibiting Peptide n.a. n.a. n.a. n.a. n.a. n.a. n.a. 134128288 n.a. n.a. "RNAIII-inhibiting peptide(TFA), RNAIII-inhibiting peptide TFA, 2703745-76-8, (2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-3-hydroxypropanoyl]pyrrolidine-2-carbonyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-3-hydroxybutanoyl]amino]-N-[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]butanediamide;2,2,2-trifluoroacetic acid, RNAIII-inhibiting peptide, HY-P1452A, RNAIII-INHIBITING PEPTIDETFA, EX-A8194, AKOS040763999, MS-31876, CS-0043429, G16493, RNAIII-inhibiting peptide TFA(228544-21-6 free base)" C47H57F3N10O13 UFMWBLWECSYAKK-TUPMYQNZSA-N "(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-3-hydroxypropanoyl]pyrrolidine-2-carbonyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-3-hydroxybutanoyl]amino]-N-[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]butanediamide;2,2,2-trifluoroacetic acid" n.a. n.a. No No No No No No PMDBD2001148 Rosmarinic acid Therapeutic Substance Investigational Drug 20283-92-5 DB16865 n.a. n.a. D05PTT 5281792 4445104 NPC61 rosmarinic acid, 20283-92-5, Rosemary acid, Labiatenic acid, Rosmarinicacid, Labiatic acid, (R)-rosmarinic acid, trans-Rosmarinic acid, Rosemaric acid, Rosmarinate, Rosmarinic acid racemate, Rosmarinic-acid, UNII-MQE6XG29YI, MQE6XG29YI, 537-15-5, CCRIS 9361, RM 21A, ORISTRACT ROA, HSDB 7688, NPLC 0542, (R,E)-3-(3,4-dihydroxyphenyl)-2-((3-(3,4-dihydroxyphenyl)acryloyl)oxy)propanoic acid, (2R)-3-(3,4-dihydroxyphenyl)-2-[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxypropanoic acid, CHEMBL324842, RM-21A, CHEBI:50371, NPLC-0542, DTXSID20896987, (R)-O-(3,4-Dihydroxycinnamoyl)-3-(3,4- dihydroxyphenyl)lactic acid, MFCD00017740, Benzenepropanoic acid, alpha-((3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl)oxy)-3,4-dihydroxy-, (R)-O-(3,4-Dihydroxycinnamoyl)-3-(3,4-dihydroxyphenyl)lactic acid, 3,4-Dihydroxycinnamic acid (R)-1-carboxy-2-(3,4-dihydroxyphenyl)ethyl ester, 3,4-Dihydroxycinnamic acid 2-ester with 3-(3,4-dihydroxyphenyl)lactic acid, R-(+)-2-(3,4-Dihydroxycinnamoyloxy)-3-(3,4-dihydroxyphenyl)propionic acid, (2R)-3-(3,4-dihydroxyphenyl)-2-[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyloxy]propanoic acid, (2r)-3-(3,4-Dihydroxyphenyl)-2-{[(2e)-3-(3,4-Dihydroxyphenyl)prop-2-Enoyl]oxy}propanoic Acid, CINNAMIC ACID, 3,4-DIHYDROXY-, 2-ESTER with 3-(3,4-DIHYDROXYPHENYL)LACTIC ACID, Benzenepropanoic acid,a-[[(2E)-3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl]oxy]-3,4-dihydroxy-,(aR)-, ROSMARINIC ACID (USP-RS), ROSMARINIC ACID [USP-RS], (2R)-3-(3,4-dihydroxyphenyl)-2-[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy-propanoic acid, alpha-(((3,4-Dihydroxyphenyl)-1-oxo-2-propenyl)oxy)-3,4-dihydroxybenzenepropanoic acid, Benzenepropanoic acid, alpha-((3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl)oxy)-3,4-dihydroxy-, (R-(E))-, Rosmarimic acid, BENZENEPROPANOIC ACID, .ALPHA.-(((2E)-3-(3,4-DIHYDROXYPHENYL)-1-OXO-2-PROPENYL)OXY)-3,4-DIHYDROXY-, (.ALPHA.R)-, Benzenepropanoic acid, .alpha.-[[(2E)-3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl]oxy]-3,4-dihydroxy-, (.alpha.R)-, Rosmarinic acid, 2, Rosmarinic acid, 96%, bmse000648, ROSMARINIC ACID [MI], MLS000697677, ROSMARINIC ACID [HSDB], ROSMARINIC ACID [INCI], MEGxp0_000163, SCHEMBL1650675, SCHEMBL2028694, ACon1_001068, CHEBI:92370, cid_5281792, 3-(3,4-dihydroxyphenyl)-2-((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyloxy)propanoic acid, DTXCID801326415, HMS2227A13, HMS3266D13, HMS3411K16, HMS3649C22, HMS3675K16, HMS3885I15, HY-N0529, BDBM50133496, s3612, ZB1872, AKOS015892734, CCG-207919, CCG-208268, NCGC00169708-01, 1ST40049, AC-33965, AS-35341, SMR000445579, NS00014042, C01850, EN300-364852, ROSMARINIC ACID (CONSTITUENT OF ROSEMARY), A814378, SR-01000946599, Q-100246, SR-01000946599-1, (2R)-O-caffeoyl-3-(3,4-dihydroxyphenyl)lactic acid, Q50380051, F0001-0715, ROSMARINIC ACID (CONSTITUENT OF HOLY BASIL LEAF), ROSMARINIC ACID (CONSTITUENT OF ROSEMARY) [DSC], 93B6A3BF-927D-4C59-8A49-29BDBC87C194, Rosmarinic acid, primary pharmaceutical reference standard, ROSMARINIC ACID (CONSTITUENT OF HOLY BASIL LEAF) [DSC], Rosmarinic acid, European Pharmacopoeia (EP) Reference Standard, Rosmarinic acid, >=98% (HPLC), from Rosemarinus officinalis L., Rosmarinic acid, United States Pharmacopeia (USP) Reference Standard, (2R)-3-(3,4-dihydroxyphenyl)-2-[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxypropanoicacid, (R,E)-3-(3,4-dihydroxyphenyl)-2-((3-(3,4-dihydroxyphenyl)acryloyl)oxy)propanoicacid, (R,E)-3-(3,4-dihydroxyphenyl)-2-(3-(3,4-dihydroxyphenyl)acryloyloxy)propanoic acid, alpha-(((3,4-Dihydroxyphenyl)-1-oxo-2-propenyl)oxy)-3,4-dihydroxy-benzenepropanoic acid, (2R)-3-(3,4-DIHYDROXYPHENYL)-2-{[3-(3,4-DIHYDROXYPHENYL)PROP-2-ENOYL]OXY}PROPANOIC ACID, [R-(+)]-?-[[3-(3,4-Dihydroxyphenyl)-1-oxo-2-propenyl]oxy]-3,4-dihydroxybenzenepropanoic acid, BENZENEPROPANOIC ACID, .ALPHA.-(((2E)-3-(3,4-DIHYDROXYPHENYL)-1-OXO-2-PROPEN-1-YL)OXY)-3,4-DIHYDROXY-, (.ALPHA.R)-, Benzenepropanoic acid, .alpha.-((3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl)oxy)-3,4-dihydroxy-, (R-(E))-, BENZENEPROPANOIC ACID, alpha-(((2E)-3-(3,4-DIHYDROXYPHENYL)-1-OXO-2-PROPEN-1-YL)OXY)-3,4-DIHYDROXY-, (alphaR)-, BENZENEPROPANOIC ACID, alpha-(((2E)-3-(3,4-DIHYDROXYPHENYL)-1-OXO-2-PROPENYL)OXY)-3,4-DIHYDROXY-, (alphaR)- C18H16O8 DOUMFZQKYFQNTF-WUTVXBCWSA-N (2R)-3-(3,4-dihydroxyphenyl)-2-[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxypropanoic acid n.a. n.a. No No No No No No PMDBD2001149 Rosoxacin Therapeutic Substance Approved Drug 40034-42-2 DB00817 PA164776843 D02305 D07CPU 287180 253208 n.a. ROSOXACIN, Acrosoxacin, 40034-42-2, Eradacil, Winuron, Roxadyl, Eracine, Rosoxacine, Rosoxacinum, Eradacin, Win 35,213, Rosoxacine [INN-French], Rosoxacino [INN-Spanish], 1-Ethyl-4-oxo-7-(4-pyridyl)-1,4-dihydroquinoline-3-carboxylic Acid, 1-Ethyl-1,4-dihydro-4-oxo-7-(4-pyridyl)-3-quinolinecarboxylic acid, 1-ethyl-4-oxo-7-pyridin-4-ylquinoline-3-carboxylic acid, Eradicin, Winoxacin, 1-ethyl-4-oxo-7-(pyridin-4-yl)-1,4-dihydroquinoline-3-carboxylic acid, WIN 35213, 3-Quinolinecarboxylic acid, 1-ethyl-1,4-dihydro-4-oxo-7-(4-pyridinyl)-, NSC-146617, 1-Ethyl-1,4-dihydro-4-oxo-7-(4-pyridinyl)-3-quinolinecarboxylic acid, 3Y1OT3J4NW, Rosoxacino, MFCD00057294, NSC146617, WIN-35213, Rosoxacin Hemisulfate, Rosoxacinum [INN-Latin], Roxadyl (TN), Rosoxacin (USAN/INN), EINECS 254-758-4, UNII-3Y1OT3J4NW, NSC 146617, rosoxacina, Rosoxacin [USAN:INN:BAN], Win-35123, Acrosoxacin Hemisulfate, ROSOXACIN [INN], ROSOXACIN [MI], PD 107522, ROSOXACIN [USAN], ROSOXACIN [MART.], ROSOXACIN [WHO-DD], Oprea1_128096, SCHEMBL135645, CHEMBL291157, GTPL12474, DTXSID90193091, Win-35,213, CHEBI:131715, HY-A0208, AC1324, AKOS027460752, DB00817, CS-12131, SY038205, CS-0017556, NS00011857, D02305, EN300-18536122, Q754690, 1-ethyl-4-oxo-7-(4-pyridyl)quinoline-3-carboxylic acid, 3-Quinolinecarboxylic acid,4-dihydro-4-oxo-7-(4-pyridinyl)-, 1-Ethyl-1,4-dihydro-4-oxo-7-(4-pyridinyl)-3-quinolinecarboxylic Acid Hemisulfate, 1-Ethyl-4-oxo-7-(4-pyridinyl)-1,4-dihydro-3-quinolinecarboxylic acid, AldrichCPR C17H14N2O3 XBPZXDSZHPDXQU-UHFFFAOYSA-N 1-ethyl-4-oxo-7-pyridin-4-ylquinoline-3-carboxylic acid Sanofi-Aventis Antiinfective Agents No No No No No No PMDBD2001150 RT2 n.a. n.a. n.a. n.a. n.a. n.a. n.a. 131632227 n.a. n.a. RT2 C22H26O6 VWVKUNOPTJGDOB-AANPDWTMSA-N (3S,3''S,4''S,5''S,6''R)-5-[(4-ethylphenyl)methyl]-6''-(hydroxymethyl)spiro[1H-2-benzofuran-3,2''-oxane]-3'',4'',5''-triol n.a. n.a. No No No No No No PMDBD2001151 RTA3 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001152 R-Thanatin n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001153 Rutaecarpine n.a. n.a. n.a. n.a. n.a. n.a. n.a. 65752 n.a. NPC21429 "Rutaecarpine, 84-26-4, Rutecarpine, Rutacarpine, Rhetine, Rutaecarpin, 8,13-dihydroindolo[2'',3'':3,4]pyrido[2,1-b]quinazolin-5(7H)-one, Indolo[2'',3'':3,4]pyrido[2,1-b]quinazolin-5(7H)-one, 8,13-dihydro-, MFCD00210551, 8XZV289PRY, CHEMBL85139, CHEBI:8922, 7,8-dihydroindolo[2'',3'':3,4]pyrido[2,1-b]quinazolin-5(13H)-one, 8,13-Dihydro-indolo[2'',3'':3,4]pyrido[2,1-b]quinazolin-5(7H)-one, NSC-258317, Indolo(2'',3'':3,4)pyrido(2,1-b)quinazolin-5(7H)-one, 8,13-dihydro-, C18H13N3O, 8,13-DIHYDROINDOLO(2'',3'':3,4)PYRIDO(2,1-B)QUINAZOLIN-5(7H)-ONE, 3,13,21-triazapentacyclo[11.8.0.0^{2,10}.0^{4,9}.0^{15,20}]henicosa-1(21),2(10),4,6,8,15,17,19-octaen-14-one, 3,13,21-triazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-1(21),2(10),4,6,8,15,17,19-octaen-14-one, SMR001230721, SR-01000076104, UNII-8XZV289PRY, NSC 258317, 8,13-dihydro-Indolo(2'',3'':3,4)pyrido(2,1-b)quinazolin-5(7H)-one, Rutaecarpine,(S), RUTECARPINE [MI], Lopac-R-3277, Rutaecarpine (Rutecarpine), UPCMLD-DP040, Lopac0_001091, Oprea1_313284, cid_65752, MLS002153304, MLS006011796, SCHEMBL288507, Rutaecarpine, >98% (HPLC), UPCMLD-DP040:001, DTXSID00232884, ACVGWSKVRYFWRP-UHFFFAOYSA-N, HMS2233M24, HMS3263K04, HMS3374B10, HMS3656C09, HMS3884P13, BCP21309, HY-N0147, Tox21_501091, BDBM50131046, NSC258317, s2349, AKOS005720935, CCG-205168, CS-6160, GS-3618, LP01091, SDCCGSBI-0051061.P002, SMP2_000103, NCGC00015892-01, NCGC00015892-02, NCGC00015892-03, NCGC00015892-04, NCGC00015892-05, NCGC00015892-06, NCGC00015892-07, NCGC00015892-08, NCGC00015892-13, NCGC00094364-01, NCGC00094364-03, NCGC00094364-04, NCGC00261776-01, 1ST40308, 3,13,21-triazapentacyclo[11.8.0.0^{2,10}.0^{4,9}.0^{15,20}]henicosa-1(21),2(10),4(9),5,7,15(20),16,18-octaen-14-one, AC-34838, NCI60_002069, EU-0101091, NS00115956, R0102, RutaecarpineRutacarpine; Rhetine; Rutaecarpin, SW220226-1, C09238, EN300-302963, H10091, R 3277, A864154, Q-100850, SR-01000076104-2, SR-01000076104-6, Q15424771, Z2768165384, Indolo[2'',4]pyrido[2,1-b]quinazolin-5(7H)-one, 8,13-dihydro-, 8,13-Dihydro-7H-indolo[2'''',3'''':3,4]pyrido[2,1-b]quinazolin-5-one, InChI=1/C18H13N3O/c22-18-13-6-2-4-8-15(13)20-17-16-12(9-10-21(17)18)11-5-1-3-7-14(11)19-16/h1-8,19H,9-10H" C18H13N3O ACVGWSKVRYFWRP-UHFFFAOYSA-N 3,13,21-triazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-1(21),2(10),4,6,8,15,17,19-octaen-14-one n.a. n.a. No No No No No No PMDBD2001154 S-(2-Aminoethyl)-L-cysteine hydrochloride n.a. n.a. n.a. n.a. n.a. n.a. n.a. 16218879 n.a. n.a. "4099-35-8, S-(2-Aminoethyl)-L-cysteine hydrochloride, Thialysine hydrochloride, H-Cys(aminoethyl)-OH HCl, 20662-32-2, Thialysine HCl, S-(2-Aminoethyl)-L-cysteine HCl, S-(2-Aminoethyl)-l-cysteine, HCl, Thialysine (hydrochloride), LJ 226, NSC 186915, NSC-186915, WPH5RH5BID, (R)-2-Amino-3-((2-aminoethyl)thio)propanoic acid hydrochloride, (2R)-2-amino-3-(2-aminoethylsulfanyl)propanoic acid;hydrochloride, S-(2-Aminoethyl)cysteine hydrochloride, (2R)-2-amino-3-[(2-aminoethyl)sulfanyl]propanoic acid hydrochloride, EINECS 243-948-2, S-2-Aminoethyl-L-cysteine hydrochloride, H-Cys(Et-NH2)-OH.HCl, SCHEMBL5494298, DTXSID50942860, MFCD00036385, AKOS015894672, FD21310, L-4-Thialysine HCl;L-Thiosine HCl, S-(aminoethyl)-L-cysteine hydrochloride, AS-49033, HY-122526, S-(2-Aminoethyl)-l-cysteine, hydrochloride, CS-0086292, A-5450, S-(2-Aminoethyl)cysteine--hydrogen chloride (1/1), S-(2-Aminoethyl)-L-cysteine hydrochloride, >=98% (TLC), (R)-2-amino-3-(2-aminoethylthio)propanoic acid hydrochloride, L-CYSTEINE, S-(2-AMINOETHYL)-, HYDROCHLORIDE (1:1)" C5H13ClN2O2S CVHKULVNPGAEQM-WCCKRBBISA-N "(2R)-2-amino-3-(2-aminoethylsulfanyl)propanoic acid;hydrochloride" n.a. n.a. No No No No No No PMDBD2001155 S-(2-thiazoyl)-L-cysteine n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001156 S-(2-thienyl)-L-cysteine n.a. n.a. n.a. n.a. n.a. n.a. n.a. 16218806 n.a. n.a. S-(2-Thienyl)-L-cysteine, 405150-23-4, (2R)-2-amino-3-thiophen-2-ylsulfanylpropanoic acid, (R)-2-Amino-3-(thiophen-2-ylthio)propanoic acid, S-thiophenyl-l-cysteine, S-Thiophen-2-yl-L-cysteine, SCHEMBL503186, DTXSID50585039 C7H9NO2S2 XRPOWEFAFQZLRI-YFKPBYRVSA-N (2R)-2-amino-3-thiophen-2-ylsulfanylpropanoic acid n.a. n.a. No No No No No No PMDBD2001157 S-(4-tolyl)-L-cysteine n.a. n.a. n.a. n.a. n.a. n.a. n.a. 16218551 n.a. n.a. S-(4-Tolyl)-L-cysteine, (R)-2-Amino-3-(p-tolylthio)propionic acid, SCHEMBL503210, CHEMBL4083194, S-(4-Tolyl)-L-cysteine, produced by Wacker Chemie AG, Burghausen, Germany, >=95.0% (HPLC) C10H13NO2S CHRJYKJYNAKSHG-VIFPVBQESA-N (2R)-2-amino-3-(4-methylphenyl)sulfanylpropanoic acid n.a. n.a. No No No No No No PMDBD2001158 S6L3-33 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001159 Sage oil Therapeutic Substance n.a. 8022-56-8 DB11199 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001160 Salicylic Acid Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. D07HBX 338 n.a. NPC100551 salicylic acid, 2-Hydroxybenzoic acid, 69-72-7, o-hydroxybenzoic acid, 2-Carboxyphenol, o-Carboxyphenol, Rutranex, Salonil, Retarder W, Duoplant, Keralyt, Psoriacid-S-stift, Freezone, Saligel, Ionil, Salicylic acid soap, Stri-Dex, Verrugon, Salicylic acid collodion, Benzoic acid, 2-hydroxy-, Acidum salicylicum, Trans-Ver-Sal, 2-Hydroxybenzenecarboxylic acid, Phenol-2-carboxylic acid, Orthohydroxybenzoic acid, Salicyclic acid, Acido salicilico, Kyselina salicylova, Salicylic acid, tech., Duofilm, Ionil-Plus, Dr. Scholl''s callus removers, Clear away wart remover, Duofil wart remover, Domerine, Occlusal, Sebucare, Sebulex, Mediplast pads, Akurza Lotion, Hydrisalic Gel, Kyselina 2-hydroxybenzoova, Akurza Cream, Ionil plus, Salex Lotion, Salex Cream, DuoPlant Gel, Caswell No. 731, Dr. Scholl''s corn removers, Kyselina salicylova [Czech], salicylicum acidum, DHS Sal Shampoo, P&S Shampoo, Dr. Scholl''s wart remover kit, Durasal, Acido salicilico [Italian], NSC 180, Advanced pain relief corn removers, Acido o-idrossibenzoico, 2-hydroxy-benzoic acid, Kyselina 2-hydroxybenzoova [Czech], Benzoic acid, hydroxy-, Advanced pain relief callus removers, CCRIS 6714, HSDB 672, Acido o-idrossibenzoico [Italian], AI3-02407, Propa pH Peel-Off Acne Mask, Salicylic acid & Sulfur Soap, EPA Pesticide Chemical Code 076602, Anti-blemish, CHEBI:16914, BRN 0774890, NSC-180, UNII-O414PZ4LPZ, EINECS 200-712-3, O414PZ4LPZ, MFCD00002439, DTXSID7026368, FEMA NO. 3985, Bazuka Extra Strength Gel, CHEMBL424, Salicylic acid [USP:JAN], MLS000069653, DTXCID206368, NSC180, 29656-58-4, K 537, EC 200-712-3, ATA fraction 10, ammonium salt, NCGC00159447-05, SMR000059163, Acid, Salicylic, ortho-Hydroxybenzoic Acid, Salicylic acid (USP:JAN), SALICYLIC ACID (USP), SALICYLIC ACID [USP], o Hydroxybenzoic Acid, SALICYLIC ACID (MART.), SALICYLIC ACID [MART.], SALICYLIC ACID (USP-RS), Salicylic acid [USAN:JAN], SALICYLIC ACID [USP-RS], 2 Hydroxybenzoic Acid, Acid, o-Hydroxybenzoic, Acid, 2-Hydroxybenzoic, ortho Hydroxybenzoic Acid, SALICYLIC ACID (EP IMPURITY), SALICYLIC ACID [EP IMPURITY], SALICYLIC ACID (EP MONOGRAPH), SALICYLIC ACID [EP MONOGRAPH], Acid, ortho-Hydroxybenzoic, SALICYLIC ACID (USP MONOGRAPH), SALICYLIC ACID [USP MONOGRAPH], CAS-69-72-7, LAMIVUDINE IMPURITY C (EP IMPURITY), LAMIVUDINE IMPURITY C [EP IMPURITY], MESALAZINE IMPURITY H (EP IMPURITY), MESALAZINE IMPURITY H [EP IMPURITY], NSC629474, phenol derivative, 7, Salicylic acid (TN), SULFASALAZINE IMPURITY H (EP IMPURITY), SULFASALAZINE IMPURITY H [EP IMPURITY], ACETYLSALICYLIC ACID IMPURITY C (EP IMPURITY), ACETYLSALICYLIC ACID IMPURITY C [EP IMPURITY], liquid, Aftaseptic, Azurechelin, Klearactil, Neutrogena, Quitacallos, Trulyclear, Acneclir, Acneworx, Acnisal, Bioarpil, Blemfree, Dermoneen, Jinhancho, Kingskin, Mediplast, Noxzema, Nusaderm, pHisoderm, Psoracare, Salicylic acid (6CI,8CI), Stridex, StridexMaximum, Veraciti, Verruguin, Virasal, Acneen, ClearSynergy, salicylic gel, salicylic-acid, Salvax, StrataClear, ApotheCare, Biore, Blackhead scrub, CornStick C7H6O3 YGSDEFSMJLZEOE-UHFFFAOYSA-N 2-hydroxybenzoic acid n.a. Antiinflammatory Agents No No No No No No PMDBD2001161 Sanguinarine Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. D0T3NB 5154 n.a. NPC46451 "SANGUINARINE, 2447-54-3, Pseudochelerythrine, Sanguinarin, sangvinarin, SANGUINARIUM, Veadent, Sangrovit, Dimethylenedioxy benzphenanthridine, UNII-AV9VK043SS, EINECS 219-503-3, AV9VK043SS, [1,3]Benzodioxolo[5,6-c]-1,3-dioxolo[4,5-i]phenanthridinium, 13-methyl-, Pseudochelerythrine;Sanguinarin, BRN 3915507, DTXSID0045204, CHEBI:17183, Benzophenanthridine alkaloid, DTXCID8025204, (1,3)-Benzodioxolo(5,6-c)-1,3-dioxolo(4,5-i)phenanthridinium, 13-methyl-, 24-methyl-5,7,18,20-tetraoxa-24-azoniahexacyclo[11.11.0.02,10.04,8.014,22.017,21]tetracosa-1(24),2,4(8),9,11,13,15,17(21),22-nonaene, NCGC00015959-03, Sanguiritrin, CAS-2447-54-3, 13-Methyl[1,3]benzodioxolo[5,6-C][1,3]dioxolo[4,5-I]phenanthridin-13-Ium, (1,3)BENZODIOXOLO(5,6-C)-1,3-DIOXOLO(4,5-I)PHENANTHRIDINIUM, 13-METHYL-, 13-Methyl-[1,3]dioxolo[4'',5'':4,5]benzo[1,2-c][1,3]dioxolo[4,5-i]phenanthridin-13-ium, pseudo-chelerythrine, UI5, y-Chelerythrine, SR-01000075650, |x-Chelerythrine, 13-methyl(1,3)benzodioxolo(5,6-c)-1,3-dioxolo(4,5-i)phenanthridinium, 13-methyl[1,3]benzodioxolo[5,6-c]-1,3-dioxolo[4,5-i]phenanthridinium, 13-methyl-2H,10H-(1,3)dioxolo(4,5-i)(1,3)dioxolo(4'',5'':4,5)benzo(1,2-c)phenanthridinium, 13-methyl-2H,10H-[1,3]dioxolo[4,5-i][1,3]dioxolo[4'',5'':4,5]benzo[1,2-c]phenanthridinium, sanguinarium-chloride, Spectrum_000259, Prestwick0_000987, Prestwick1_000987, Prestwick2_000987, Prestwick3_000987, Spectrum2_000724, Spectrum3_001148, Spectrum4_001838, Spectrum5_000635, Lopac-S-5890, SANGUINARINE [MI], cid_5154, Lopac0_001108, BSPBio_001053, BSPBio_002675, KBioGR_002542, KBioSS_000739, MLS002154085, DivK1c_000495, SANGUINARINE [WHO-DD], SCHEMBL123241, SPBio_000648, SPBio_002954, BPBio1_001159, CHEMBL417799, SCHEMBL17131945, BDBM25525, GTPL11563, KBio1_000495, KBio2_000739, KBio2_003307, KBio2_005875, KBio3_002175, NINDS_000495, HMS1571E15, HMS2098E15, BCP13614, EX-A5014, HY-N0052, Tox21_110268, NSC765394, s9032, AKOS025311557, Tox21_110268_1, CCG-205184, compound 1 [PMID: 28621943], CS-3818, NSC-765394, SDCCGMLS-0066612.P001, IDI1_000495, NCGC00015959-01, NCGC00015959-02, NCGC00015959-04, NCGC00015959-05, NCGC00015959-09, NCGC00015959-16, NCGC00160289-01, NCGC00160289-02, AC-34836, SMR001233394, SBI-0051077.P003, AB00053789, NS00018310, C06162, E80766, AB00053789_04, Q347392, Q-100313, SR-01000075650-7, BRD-K66898851-001-03-7, 5-Methyl-2,3:7,8-bis(methylenedioxy)benzo[c]phenanthridinium(1+), 13-Methyl[1,3]benzodioxolo[5,6-c]-1,3-dioxolo[4,5-i]phenanthridinium nitrate, 13-Methyl[1,3]benzodioxolo[5,6-c]-1,3-dioxolo[4,5-i]phenanthridinium(1+), 9CI, 24-methyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0^{2,10}.0^{4,8}.0^{14,22}.0^{17,21}]tetracosa-1(13),2,4(8),9,11,14(22),15,17(21),23-nonaen-24-ium, 24-methyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0^{2,10}.0^{4,8}.0^{14,22}.0^{17,21}]tetracosa-1(13),2,4(8),9,11,14,16,21,23-nonaen-24-ium, 24-methyl-5,7,18,20-tetraoxa-24-azoniahexacyclo[11.11.0.0^{2,10.0^{4,8.0^{14,22.0^{17,21]tetracosa-1(24),2,4(8),9,11,13,15,17(21),22-nonaene" C20H14NO4+ INVGWHRKADIJHF-UHFFFAOYSA-N 24-methyl-5,7,18,20-tetraoxa-24-azoniahexacyclo[11.11.0.02,10.04,8.014,22.017,21]tetracosa-1(24),2,4(8),9,11,13,15,17(21),22-nonaene n.a. n.a. No No No No No No PMDBD2001162 Saquinavir Therapeutic Substance Approved Drug 127779-20-8 DB01232 PA451305 D00429 D0WI3T 441243 390016 n.a. "SAQUINAVIR, 127779-20-8, Invirase, Fortovase, Ro 31-8959, Saquinavirum, Ro 318959, CHEBI:63621, Ro-31-8959, UNII-L3JE09KZ2F, L3JE09KZ2F, Ro 31-8959/000, Sch 52852, HSDB 7161, SCH-52852, CHEMBL114, (2S)-N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]-2-(quinoline-2-carbonylamino)butanediamide, DTXSID6044012, Saquinavir [USAN:USP:INN:BAN], (S)-N1-((2S,3R)-4-((3S,4aS,8aS)-3-(tert-butylcarbamoyl)octahydroisoquinolin-2(1H)-yl)-3-hydroxy-1-phenylbutan-2-yl)-2-(quinoline-2-carboxamido)succinamide, Ro-31-8959/000, SAQUINAVIR (MART.), SAQUINAVIR [MART.], ROC, SAQUINAVIR (USP IMPURITY), SAQUINAVIR [USP IMPURITY], Saquinivir, Saquinavir (USAN:USP:INN:BAN), Fortovase(TM), Fortovase (TN), (2S)-N-[(1S,2R)-3-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinolin-2-yl]-1-benzyl-2-hydroxy-propyl]-2-(quinoline-2-carbonylamino)butanediamide, (2S)-N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-decahydroisoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]-2-(quinolin-2-ylformamido)butanediamide, (S)-N-((IS)-I-((1R)-2-((3S,4aS,8aS)-3-(tert-Butylcarbamoyl)octahydro-2(1H)-isoquinolyl)-1-hydroxyethyl)phenethyl)-2-quinaldamidosuccinamide, Butanediamide, N1-((1S,2R)-3-((3S,4aS,8aS)-3-(((1,1-dimethylethyl)amino)carbonyl)octahydro-2(1H)-isoquinolinyl)-2-hydroxy-1-(phenylmethyl)propyl)-2-((2-quinolinylcarbonyl)amino)-, (2S)-, Butanediamide, N1-(3-(3-(((1,1-dimethylethyl)amino)carbonyl)octahydro-2(1H)-isoquinolinyl)-2-hydroxy-1-(phenylmethyl)propyl)-2-((2-quinolinylcarbonyl)amino)-, (3S-(2(1R*(R*),2S*),3alpha,4aalpha,8aalpha))-, Butanediamide, N1-[(1S,2R)-3-[(3S,4aS,8aS)-3-[[(1,1-dimethylethyl)amino]carbonyl]octahydro-2(1H)-isoquinolinyl]-2-hydroxy-1-(phenylmethyl)propyl]-2-[(2-quinolinylcarbonyl)amino]-, (2S)-, N(1)-{(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)octahydroisoquinolin-2(1H)-yl]-3-hydroxy-1-phenylbutan-2-yl}-N(2)-(quinolin-2-ylcarbonyl)-L-aspartamide, SMR000469157, Saquinavir [USAN], Invirase(TM)(monomesylate), Ro 31 8959, Saquinavir (JAN/USP/INN), SQV, 1hxb, 2fgu, 2fgv, saquinaviri mesilas, (2S)-N-[(2S,3R)-4-[(2S,3S,4aS,8aS)-3-(tert-butylcarbamoyl)-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinolin-2-yl]-3-hydroxy-1 -phenyl-butan-2-yl]-2-(quinolin-2-ylcarbonylamino)butanediamide, (S)-N-[(IS)-I-[(1R)-2-[(3S,4aS,8aS)-3-(tert-Butylcarbamoyl)octahydro-2(1H)-isoquinolyl]-1-hydroxyethyl]phenethyl]-2-quinaldamidosuccinamide, N(1)-((2S,3R)-4-((3S,4aS,8aS)-3-(tert-butylcarbamoyl)octahydroisoquinolin-2(1H)-yl)-3-hydroxy-1-phenylbutan-2-yl)-N(2)-(quinolin-2-ylcarbonyl)-L-aspartamide, Saquinavir- Bio-X, PLCG-SQV, NSC722663, NP-SQV, SAQUINAVIR [MI], SAQUINAVIR [INN], SAQUINAVIR [JAN], Prestwick0_001114, Prestwick1_001114, Prestwick2_001114, Prestwick3_001114, SAQUINAVIR [HSDB], SAQUINAVIR [VANDF], SCHEMBL6881, SAQUINAVIR [WHO-DD], SAQUINAVIR [WHO-IP], BIDD:PXR0010, BDBM519, BSPBio_001248, MLS001195635, MLS001304735, BIDD:GT0323, SAQUINAVIR [EMA EPAR], SPBio_003114, BPBio1_001373, GTPL4813, DTXCID4024012, SAQUINAVIR [ORANGE BOOK], J05AE01, QWAXKHKRTORLEM-UGJKXSETSA-N, HMS2232L04, SAQUINAVIRUM [WHO-IP LATIN], (S)-N-, BDBM50213021, MFCD00866925, AKOS000280831, CS-1180, DB01232, MRF-0000273, NCGC00091469-02, NCGC00091469-15, AC-26377, BS164390, Fortovase; SAQUINAVIR; RO 31-8959, HY-17007, Ro-318959000, AB00514056, NS00007140, D00429, EN300-19767269, Q422654, BRD-K09963420-066-03-4, -phenyl-butan-2-yl]-2-(quinolin-2-ylcarbonylamino)butanediamide, (2S)-N-[(2S,3R)-4-[(2S,3S,4aS,8aS)-3-(tert-butylcarbamoyl)-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinolin-2-yl]-3-hydroxy-1, (2S)-N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-decahydroisoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]-2-[(quinolin-2-yl)formamido]butanediamide, (3S-(2(1R*(R*),2S*),3I,4athetav,8athetav))-N(sup 1)-(3-(3-(((1,1-Dimethylethyl)amino)carbonyl)octahydro-2(1H)-isoquinolinyl)-2-hydroxy-1-(phenylmethyl)propyl)-2-((2-quinolinylcarbonyl)amino)butanediamide, (S)-N-((.ALPHA.S)-.ALPHA.-((1R)-2-((3S,4AS,8AS)-3-(TERT-BUTYLCARBAMOYL)OCTAHYDRO-2(1H)-ISOQUINOLYL)-1-HYDROXYETHYL)PHENETHYL)-2-QUINALDAMIDOSUCCINAMIDE, (S)-N-((alphaS)-alpha-((1R)-2-((3S,4AS,8AS)-3-(TERT-BUTYLCARBAMOYL)OCTAHYDRO-2(1H)-ISOQUINOLYL)-1-HYDROXYETHYL)PHENETHYL)-2-QUINALDAMIDOSUCCINAMIDE, BUTANEDIAMIDE, N(SUP 1)-(3-(3-(((1,1-DIMETHYLETHYL)AMINO)CARBONYL)OCTAHYDRO-2(1H)-ISOQUINOLINYL)-2-HYDROXY-1-(PHENYLMETHYL)PROPYL)-2-((2-QUINOLINYLCARBONYL)AMINO)-, (3S-(2(1R*(R*),2S*),3.ALPHA.,4A.BETA.,8A.BETA.))-, BUTANEDIAMIDE, N(SUP 1)-(3-(3-(((1,1-DIMETHYLETHYL)AMINO)CARBONYL)OCTAHYDRO-2(1H)-ISOQUINOLINYL)-2-HYDROXY-1-(PHENYLMETHYL)PROPYL)-2-((2-QUINOLINYLCARBONYL)AMINO)-, (3S-(2(1R*(R*),2S*),3alpha,4Abeta,8Abeta))-, cis-N-tert-Butyldecahydro-2-((2R,3S)-2-hydroxy-4-phenyl-3-((N-(2-quinolylcarbonyl)-L-asparaginyl)amino)butyl)-(3S,4aS,8aS)-isoquinoline-3-carboxamide, N-tert.butyl-decahydro -2- [2(R)-hydroxy-4-phenyl-3(S)-[[N-(2-quinolylcarbonyl) -L-asparaginyl]amino]butyl]-(4aS,8aS)-isoquinoline-3(S)-carboxamide, N-tert.butyl-decahydro-2-[2(R)-hydroxy-4-phenyl-3(S)-[[N-(2-quinolylcarbonyl)-L-asparaginyl]amino]butyl]-(4aS,8aS)-isoquinoline-3(S)-carboxamide, N-tert.butyl-decahydro-2[2(R)-hydroxy-4-phenyl-3-(S)-[[N-(2-quinolylcarbonyl)-L-asparaginyl]amino]butyl]-(4aS,8aS)-isoquinoline-3(S)-carboxamide, N~1~-{(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)octahydroisoquinolin-2(1H)-yl]-3-hydroxy-1-phenylbutan-2-yl}-N~2~-(quinolin-2-ylcarbonyl)-L-aspartamide" C38H50N6O5 QWAXKHKRTORLEM-UGJKXSETSA-N (2S)-N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]-2-(quinoline-2-carbonylamino)butanediamide Hoffmann-La Roche pharmaceutical company Anti-HIV Agents No No No No No No PMDBD2001163 S-carboxylmethyl-L-cysteine Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. D0X5SI 193653 n.a. n.a. carbocysteine, 638-23-3, Carbocisteine, S-Carboxymethyl-L-cysteine, carbocistein, S-(CARBOXYMETHYL)-L-CYSTEINE, Mucodyne, Rhinathiol, Reomucil, Transbronchin, Lisomucil, Muciclar, Mucolase, Mucocis, Siroxyl, Loviscol, Thiodril, Mucofan, Lisil, Bronchokod, Carbocit, Mucotab, Pectox, PectDrill, Carbocisteina, Mucopront, Pulmoclase, Rinatiol, Chilvax, l-carbocysteine, Mucolex, Mucosol, L-Carbocisteine, Superthiol sirup, H-Cys(carboxymethyl)-OH, (R)-S-(Carboxymethyl)cysteine, Carbocisteinum, Methista, Mucotron, S-(Carboxymethyl)-(R)-cysteine, Mucojet sirup, Mucolex sirup, L-3-((Carboxymethyl)thio)alanine, L-(Carboxymethyl)cysteine, LJ 206, (2R)-2-amino-3-[(carboxymethyl)sulfanyl]propanoic acid, 3-(Carboxymethylthio)-L-alanine, (L)-2-Amino-3-(carboxymethylthio)propionic acid, AHR 3053, AHR-3053, DF 1794Y, S-Carboxylmethyl-L-cysteine, 186537-58-6, NSC 14156, UNII-740J2QX53R, Carbocisteine [INN], CHEBI:16163, R05CB03, 740J2QX53R, 3-((Carboxymethyl)thio)-L-alanine, EINECS 211-327-5, LJ-206, NSC-14156, BRN 1725012, Alanine, 3-((carboxymethyl)thio)-, L-, L.J. 206, L-Cysteine, S-(carboxymethyl)-, CHEMBL396416, 3-[(Carboxymethyl)thio]alanine, 1391068-19-1, Cysteine, S-(carboxymethyl)-, MFCD00002614, (2R)-2-amino-3-(carboxymethylsulfanyl)propanoic acid, Carbocysteine [USAN], Broncodeterge, CARBOCISTEINE (MART.), CARBOCISTEINE [MART.], 3-((Carboxymethyl)thio)alanine, (2R)-2-AMINO-3-((CARBOXYMETHYL)THIO)PROPIONIC ACID, Mukinyl, CARBOCISTEINE (EP MONOGRAPH), CARBOCISTEINE [EP MONOGRAPH], SCMC, L-Isomer Carbocysteine, S Carboxymethylcysteine, (R)-2-amino-3-(carboxymethylthio)propanoic acid, Carbocysteine, L Isomer, Carbocysteine, L-Isomer, DTXCID702738, Carbocisteinum [INN-Latin], Carbocisteina [INN-Spanish], Carbocysteine [USAN:INN:BAN], L.J.206, Mucodyne (TN), Carbocistein [JAN], Carbocysteine dl-form, CARBOCYSTEINE [MI], L-Carbocisteine (JP17), CARBOCISTEINE [JAN], CARBOCYSTEINE [INCI], SCHEMBL20854, (2R)-2-amino-3-(carboxymethylthio)propanoic acid, L-CARBOCISTEINE [JAN], HY-D0205A, (Carboxymethyl)cysteine-, (L)-, DTXSID30110060, L-CARBOCISTEINE [WHO-DD], 3-(Carboxymethylthio)alanine, L-, LJ206, S-Carboxymethyl-L-cysteine, 98%, BDBM50213735, s5216, AKOS015922826, 5-Amino-3-thiadihexanoic acid, (L)-, DB04339, AC-11146, AS-57938, CS-0017457, NS00068531, C-1850, C03727, D00175, EN300-312258, H11928, (2R)-2-amino-3-(carboxymethylthio)propionic acid, A813055, A816956, A834542, Q423408, 2-Amino-3-(carboxymethylthio)propionic acid, (L)-, Q-200796, (2R)-3-(carboxythio)-2-(methylamino)propanoic acid, Z1222399234, (2R)-2-azanyl-3-(2-hydroxy-2-oxoethylsulfanyl)propanoic acid, Carbocisteine, European Pharmacopoeia (EP) Reference Standard C5H9NO4S GBFLZEXEOZUWRN-VKHMYHEASA-N (2R)-2-amino-3-(carboxymethylsulfanyl)propanoic acid Sopar Pharma SA n.a. No No No No No No PMDBD2001164 Scopoletin Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D05QOR 5280460 n.a. NPC76336 "scopoletin, 92-61-5, Gelseminic acid, 7-Hydroxy-6-methoxy-2H-chromen-2-one, 6-Methylesculetin, Chrysatropic acid, Murrayetin, Scopoletine, Scopoletol, 7-Hydroxy-6-methoxycoumarin, Escopoletin, 6-O-Methylesculetin, 6-Methoxy-7-hydroxycoumarin, 2H-1-Benzopyran-2-one, 7-hydroxy-6-methoxy-, 7-Hydroxy-6-methoxy-2H-1-benzopyran-2-one, 6-Methoxyumbelliferone, Esculetin 6-methyl ether, beta-Methylesculetin, 7-hydroxy-6-methoxychromen-2-one, Esculetin-6-methyl ether, Buxuletin, .beta.-Methylesculetin, Chrysotropic Acid, Acid, Gelseminic, Acid, Chrysotropic, COUMARIN, 7-HYDROXY-6-METHOXY-, 7-Hydroxy-5-methoxycoumarin, CCRIS 3592, NSC 405647, KLF1HS0SXJ, UNII-KLF1HS0SXJ, Baogongteng B, EINECS 202-171-9, NSC-405647, BRN 0156296, COPOLETIN, CHEBI:17488, 7-hydroxy-6-methoxy-chromen-2-one, MFCD00006872, NSC405647, CHEMBL71851, DTXSID0075368, Gelseminic acid;Chrysatropic acid, 5-18-03-00203 (Beilstein Handbook Reference), TNP00096, SCOPOLETIN (USP-RS), SCOPOLETIN [USP-RS], SMR000112541, SR-01000841273, Scopoletin?, b-Methylaesculetin, |A-Methylaesculetin, beta -methylesculetin, Scopoletin, >=99%, SCOPOLETIN [MI], Prestwick0_000962, Prestwick1_000962, Prestwick2_000962, Prestwick3_000962, Spectrum2_001207, Spectrum3_001532, Spectrum4_001054, Spectrum5_000654, Aesculetin 6-methyl ether, BIDD:PXR0125, BSPBio_000963, BSPBio_002944, KBioGR_001348, 7-hydroxy-6-methoxy-coumarin, MLS002154074, MLS002472878, DivK1c_000720, SCHEMBL147702, SPECTRUM1502242, 7-hydroxy 6-methoxy coumarine, SPBio_000994, SPBio_002884, Scopoletin, analytical standard, BPBio1_001061, MEGxp0_001192, DTXCID5048766, ACon1_000143, HMS502D22, KBio1_000720, KBio3_002444, NINDS_000720, HMS1571A05, HMS1921N16, HMS2098A05, HMS2268G04, HMS3885K10, BCP13342, HY-N0342, 6-methoxy-7-oxidanyl-chromen-2-one, BDBM50156693, CCG-39140, s3881, TD8126, AKOS000277133, CS-5791, CAS-92-61-5, IDI1_000720, 7-hydroxy-6-methoxy-1-benzopyran-2-one, NCGC00016349-01, NCGC00016349-02, NCGC00016349-03, NCGC00016349-04, NCGC00016349-05, NCGC00016349-06, NCGC00016349-07, NCGC00016349-08, NCGC00094973-01, NCGC00094973-02, NCGC00094973-03, 1ST40126, AC-34125, AS-65759, NCI60_003834, 7-Hydroxy-6-methoxy-2H-chromen-2-one #, AB00443525, NS00007731, S0367, C01752, S-2000, A844290, SCOPOLETIN (CONSTITUENT OF STINGING NETTLE), Q2472366, SR-01000841273-3, SR-01000841273-4, BRD-K96163925-001-06-5, BRD-K96163925-001-09-9, 2H-1-Benzopyran-2-one, 7-hydroxy-6-methoxy- (9CI), 0B4B9FAA-686D-4977-AA08-65F8E4F1977C, SCOPOLETIN (CONSTITUENT OF STINGING NETTLE) [DSC], Scopoletin, United States Pharmacopeia (USP) Reference Standard, Scopoletin;6-Methoxyumbelliferone; 7-Hydroxy-6-methoxy-2H-1-benzopyran-2-one, Scopoletin7-Hydroxy-6-methoxy-2H-chromen-2-one; 6-Methylesculetin; Chrysatropic acid, T83" C10H8O4 RODXRVNMMDRFIK-UHFFFAOYSA-N 7-hydroxy-6-methoxychromen-2-one n.a. n.a. No No No No No No PMDBD2001165 Scrambled LL-37 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001166 Seg6D n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001167 Seg6L n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001168 Sennidin A n.a. n.a. n.a. n.a. n.a. n.a. n.a. 92826 n.a. n.a. Sennidin A, 641-12-3, O8793FIM31, (9R,9''R)-4,4'',5,5''-Tetrahydroxy-10,10''-dioxo-9,9'',10,10''-tetrahydro-[9,9''-bianthracene]-2,2''-dicarboxylic acid, Dihydroxydianthrone, SennidinA, UNII-O8793FIM31, (9R)-9-[(9R)-2-carboxy-4,5-dihydroxy-10-oxo-9H-anthracen-9-yl]-4,5-dihydroxy-10-oxo-9H-anthracene-2-carboxylic acid, EINECS 211-371-5, CHEMBL5197294, SCHEMBL17166294, DTXSID601318488, HY-N6936, AKOS030573520, (9,9''-Bianthracene)-2,2''-dicarboxylic acid, 9,9'',10,10''-tetrahydro-4,4'',5,5''-tetrahydroxy-10,10''-dioxo-, (R*,R*)-(+)-, FS-10383, CS-0027785, G71233, Q27285465, (9,9''-Bianthracene)-2,2''-dicarboxylic acid, 9,9'',10,10''-tetrahydro-4,4'',5,5''-tetrahydroxy-10,10''-dioxo-, (R*,R*)-(+)-, (9,9''-BIANTHRACENE)-2,2''-DICARBOXYLIC ACID, 9,9'',10,10''-TETRAHYDRO-4,4'',5,5''-TETRAHYDROXY-10,10''-DIOXO-, (9R,9''R)-REL-(+)-, (R*,R*)-(+)-9,9'',10,10''-Tetrahydro-4,4'',5,5''-tetrahydroxy-10,10''-dioxo(9,9''-bianthracene)-2,2''-dicarboxylic acid, 9,9''-Bianthracene]-2,2''-dicarboxylic acid, 9,9'',10,10''-tetrahydro-4,4'',5,5''-tetrahydroxy-10,10''-dioxo-, (9R,9''R)- C30H18O10 JPMRHWLJLNKRTJ-FGZHOGPDSA-N (9R)-9-[(9R)-2-carboxy-4,5-dihydroxy-10-oxo-9H-anthracen-9-yl]-4,5-dihydroxy-10-oxo-9H-anthracene-2-carboxylic acid n.a. n.a. No No No No No No PMDBD2001169 S-ethyl-L-cysteine n.a. n.a. n.a. n.a. n.a. n.a. n.a. 92185 n.a. n.a. S-Ethyl-L-cysteine, 2629-59-6, S-Ethylcysteine, L-Cysteine, S-ethyl-, (R)-2-Amino-3-(ethylthio)propanoic acid, 3-(Ethylthio)alanine, (2R)-2-amino-3-(ethylsulfanyl)propanoic acid, 2139-90-4, B46YS921BY, (2R)-2-amino-3-ethylsulfanylpropanoic acid, 22196-52-7, EINECS 220-106-2, NSC 49244, UNII-B46YS921BY, s-ethyl cysteine, Cysteine, S-ethyl-, 3-ethylthio-L-alanine, CHEMBL60475, SCHEMBL340835, DTXSID9020588, CHEBI:156209, AKOS016037521, NS00028077, (2R)-2-amino-3-ethylsulfanyl-propanoic acid, (2R)-2-azanyl-3-ethylsulfanyl-propanoic acid, E-6350, EN300-1168621, Q23779747, ECX C5H11NO2S ULXKXLZEOGLCRJ-BYPYZUCNSA-N (2R)-2-amino-3-ethylsulfanylpropanoic acid n.a. n.a. No No No No No No PMDBD2001170 Siamycin I n.a. n.a. n.a. n.a. n.a. n.a. n.a. 16130275 n.a. n.a. Siamycin I, 164802-68-0, CLGVGSCNDFAGCGYAIVCFW, BMY 29304, FR901724, FR 901724, MS 271, DTXSID70167811 C97H131N23O26S4 TXYRKTDGDMHVHR-NEKRQKPVSA-N (2S)-2-[[(2S)-2-[[(1S,4S,7S,13R,19S,22S,25S,28S,31R,36R,39S,45S,51S,54R,60S)-60-(2-amino-2-oxoethyl)-4-benzyl-25-[(2S)-butan-2-yl]-39-(hydroxymethyl)-19-[(4-hydroxyphenyl)methyl]-7,22-dimethyl-51-(2-methylpropyl)-2,5,8,11,14,17,20,23,26,29,38,41,44,47,50,53,56,59,62-nonadecaoxo-28,45-di(propan-2-yl)-33,34,64,65-tetrathia-3,6,9,12,15,18,21,24,27,30,37,40,43,46,49,52,55,58,61-nonadecazatricyclo[34.21.5.413,54]hexahexacontane-31-carbonyl]amino]-3-phenylpropanoyl]amino]-3-(1H-indol-3-yl)propanoic acid n.a. n.a. No No No No No No PMDBD2001171 Silver dihydrogen citrate n.a. n.a. n.a. n.a. n.a. n.a. n.a. 22485758 n.a. n.a. Axenohl, Axen, Silver dihydrogen citrate, UNII-KV00TD5U9T, KV00TD5U9T, 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, silver(1+) salt (1:1), 127694-63-7 C6H7AgO7 QZRSVBDWRWTHMT-UHFFFAOYSA-M "silver;hydron;2-hydroxypropane-1,2,3-tricarboxylate" n.a. n.a. No No No No No No PMDBD2001172 Silver Ion n.a. n.a. n.a. n.a. n.a. n.a. n.a. 104755 n.a. n.a. Silver cation, SILVER ION, silver(1+), Silver, ion (Ag1+), 14701-21-4, Silver ion (1+), Silver, ion, Silver(I), UNII-57N7B0K90A, 57N7B0K90A, Ag(+), CHEBI:49468, silver(I) cation, Ag+, Silver elemental, Silver,ion, Collosol argentum, Col sil, Silver preparation, Argent. nit., Argentum colloidale, Dermazin Crm 1%, Flamazine Crm 1%, silver (I), Silver (I) ion, silver(1+) ion, NANOVER, IONIC SILVER, Silver ion antibacterial, Silver standard for AAS, Silver standard for ICP, Hand Sanitizer Gel(Ag), Pekana - argentum metallicum, Ancos Silver Ion Antibacterial, Silver Liquid (S#107)-Liq, CHEMBL1230866, CHEBI:60253, Argentum Metallicum 4ch - 30ch, DTXSID10892099, FOIXSVOLVBLSDH-UHFFFAOYSA-N, Argentum Mettallicum Gtte 4ch-30ch, DB14521, BP-13466, E174, SSD (1% Silver Sulfadiazine Cream USP), Argentum Metallicum (Silver Metallicum 6x), NANO SILVER ANTIBACTERIAL DISINFECTANT, NS00131574, Argentum Met.Praep.D8(D10 D12 D15 D20 D30), Q27104658 Ag+ FOIXSVOLVBLSDH-UHFFFAOYSA-N silver(1+) n.a. n.a. No No No No No No PMDBD2001173 Silver nanowires n.a. n.a. n.a. n.a. n.a. n.a. n.a. 23954 n.a. n.a. "7440-22-4, Ag, Silver, Colloidal silver, Silver, colloidal, Argentum, Silver atom, Silver metal, Silber, Silver, bullion, Silver, flakes, Silver(II), Nanosilver, Silver nanowires, CI 77820, Silver needles, Silver powder, Silver flake, Silver foil, Silver shot, Silver wire, Silver on alumina, 3M4G523W1G, MFCD00003397, Pb/Ag Alloy, 50g Chips, Silver, elemental, 69011-54-7, Caswell No. 735, argent, plata, Silver Nanowire, Silver Granufoam, Silver nanowires (stored in ethanol), Metz 3000-1, Silver Powder, 99.95% (metal basis) Nano, Silver; Argentum; Silver metal; Silver atom;, HSDB 5034, EINECS 231-131-3, FA 312, LA 113, LS 500, SR 999, Silver Standard: Ag @ 1000 microg/mL in 5% HNO3, Silver Standard: Ag @ 10000 microg/mL in 5% HNO3, EPA Pesticide Chemical Code 072501, Silver AA Standard: Ag @ 1000 microg/mL in 5% HNO3, Theraworx, UNII-3M4G523W1G, Silver Nanofoil, Silver Nanorods, Silver plate, Ag Nanowires, CCRIS 9464, Silver rod, Silver, foil, 0.5m coil, thickness 0.025mm, annealed, 99.95+%, Silver, foil, 0.5m coil, thickness 0.035mm, as rolled, 99.95+%, Silver, foil, 1m coil, thickness 0.025mm, annealed, 99.95+%, Silver, foil, 1m coil, thickness 0.035mm, as rolled, 99.95+%, Sulfur-Free Silver Concentrate: Ag @ approx. 1 wt% in Hydrocarbons, Silver Nanocubes, Silver Nanoflake, Silver Nanostars, Silver Nanotubes, C.I. 77820, Silver, foil, thickness 0.015 mm, size 25 x 25 mm, purity 99.95+%, Silver, foil, thickness 0.015 mm, size 50 x 50 mm, purity 99.95+%, Silver, foil, thickness 0.030 mm, size 260 x 300 mm, purity 99.95+%, Sulfur-Free Cerium Concentrate: Ce @ approx. 12 wt% in Hydrocarbons, Copper Dispersion, Silver Nanoplates, Silver Nanopowder, Silver Nanoprisms, Nanosilver colloid, silber(II)hydride, AgII, Ag nanowire-50, Ag nanowire-60, silver (II), Ag nanowire -90, Conductive Film Ink, Silver Nanoflake Ink, for elemental analysis, Conductive Silver Paste, Conductive Silver Slurry, SILVER [VANDF], Silver, conductive paste, Conductive nanosilver ink, SILVER [HSDB], SILVER [INCI], Ag nanowires - 40 nm, SILVER [WHO-DD], Silver Nanowire Biosensor, SILVER [MI], Silver, 99.9%, SILVER [MART.], Ag nanowire - 120 nm, Silver Nanowire Dispersion, 47Ag, Ag nanowires - 200 nm, Ag++, Ag2+, Silver Colloidal Dispersion, Silver Nanowires Properties, Ultra Thin Silver Nanofoil, UNII-Q3A5NLA4B5, EC 231-131-3, Q3A5NLA4B5, Silver powder, -100 mesh, Silver Nano Water Dispersion, Ag(0), Silver Nanowires Antibacterial, CHEBI:9141, Silver Nanowire Pressure Sensor, COLLOIDAL SILVER [INCI], DTXSID4024305, Nano Silver Colloidal Dispersion, SILVER COLLOIDAL [VANDF], Silver flake, APS 4-8 micron, CHEBI:30512, HSDB 7056, DTXSID80161148, Silver powder, APS 1-3 micron, Silver powder, APS 4-7 micron, Silver rod, 5mm (0.2in) dia, SILVER COLLOIDAL [WHO-DD], Silver flake, 80% <20 micron, XYDQMRVDDPZFMM-UHFFFAOYSA-N, ARGENTUM METALLICUM [HPUS], CI 77820 [INCI], Silver nanopowder, APS 20-40nm, Silver Nanowire Transparent Conductor, Silver, plasma standard solution, Ag, AKOS005259067, Silver powder, spherical, -325 mesh, Silver powder, spherical, -500 mesh, Silver powder, spherical, -635 mesh, DB12965, Silver powder, -22 mesh, Premion(R), Silver powder, APS 0.7-1.3 micron, Silver rod, 6.35mm (0.25in) dia, Silver, colloidal, 65-75% Ag basis, Ag-Doped Antibacterial Agent Nanopowder" Ag BQCADISMDOOEFD-UHFFFAOYSA-N silver n.a. n.a. No No No No No No PMDBD2001174 Silver nitrate Therapeutic Substance Approved Drug 7761-88-8 DB11080 n.a. D01730 D0A2HR 24470 22878 n.a. "SILVER NITRATE, 7761-88-8, silver(I) nitrate, Argenti nitras, Silvernitrate, Silver mononitrate, Silbernitrat, Nitric acid silver(I) salt, Nitrate d''argent, Silver(1+) nitrate, Argerol, AgNO3, Nitrato de plata, Nitric acid silver(1+) salt, Silver nitrate(DOT), Caswell No. 737, HSDB 685, Argentum nitricum, UNII-95IT3W8JZE, EINECS 231-853-9, 95IT3W8JZE, EPA Pesticide Chemical Code 072503, NSC 135800, silver (I) nitrate, CHEBI:32130, NSC-135800, Silver nitrate [USP:JAN], DTXSID3032042, EC 231-853-9, MFCD00003414, Silver nitrate (USP:JAN), SILVER NITRATE (MART.), SILVER NITRATE [MART.], Silver nitrate [JAN], SILVER NITRATE (EP MONOGRAPH), SILVER NITRATE (USP IMPURITY), SILVER NITRATE [EP MONOGRAPH], SILVER NITRATE [USP IMPURITY], Nitrate d''argent [French], Nitrato de plata [Spanish], TOUGHENED SILVER NITRATE (USP MONOGRAPH), TOUGHENED SILVER NITRATE [USP MONOGRAPH], UTS Silverator Water Treatment Unit, UN1493, SILVER NITRATE, ACS, silver;nitrate, silver nitrate-, Nitrato de prata, silver(I)nitrate, Nitric acid, silver (1+) salt, Nitrato d''argento, Arg Nit, Silver Nitrate BP, Silver Nitrate IP, Silver Nitrate USP, silver (1) nitrate, Argentum nitricum 1M, Argentum Nitricum 6x, Caswell No 737, Nitric acid silver(1+) salt (1:1), Silver (1+) salt, Silver nitrate (TN), Silver (1+) nitrate, Argentum Nitricum200ck, Argentum nitricum 200C, Silver nitrate ACS grade, Silver nitrate, Premion?, SILVER NITRATE [MI], Argentum Nitricum Kit Refill, Silver nitrate, ACS reagent, Silver nitrate (JP17/USP), SILVER NITRATE [HSDB], SILVER NITRATE [INCI], Silver nitrate, Ag 63.3%, Ag (N O3), Silver (I) nitrate (1:1), SILVER NITRATE [VANDF], CHEMBL177367, SILVER NITRATE (AGNO3), ARGENTUM NITRICUM [HPUS], DTXCID1012042, For Pesticide Code: 072503, SILVER NITRATE [WHO-DD], SILVER NITRATE [WHO-IP], Avoca Flexible Caustic Applicator, Silver nitrate, AR, >=99.9%, Silver nitrate, LR, >=99.5%, Silver nitrate, 99.9%+ AR grade, AKOS015833341, ARGENTI NITRAS [WHO-IP LATIN], AT27248, DB11080, SILVER(1+) NITRATE [WHO-IP], Silver nitrate [UN1493] [Oxidizer], BP-30056, Silver nitrate, ACS reagent, >=99.0%, NS00075692, Silver nitrate, BioXtra, >99% (titration), Silver nitrate, tested according to Ph.Eur., Silver nitrate, SAJ first grade, >=99.8%, Silver nitrate, Trace metals grade,99.995%, D01730, Silver nitrate, 99.9999% trace metals basis, Silver nitrate, JIS special grade, >=99.8%, Silver nitrate, meets USP testing specifications, Q207442, Silver nitrate, puriss. p.a., >=99.5% (AT), SR-01000944542, SR-01000944542-1, Silver nitrate, anhydrous, 99.999% trace metals basis, Silver nitrate, p.a., ACS reagent, reag. ISO, 99.8%, Silver nitrate, ReagentPlus(R), >=99.0% (titration), Assay-isotopic standard for silver, NIST(R) SRM(R) 978a, Silver standard for ICP, for ICP, ready-to-use, in nitric acid, Silver standard for AAS, ready-to-use, traceable to BAM, in nitric acid, Silver nitrate on silica gel, extent of labeling: ~10 wt. % loading, +230 mesh, Silver nitrate, BioReagent, suitable for plant cell culture, >99% (titration), Silver nitrate, meets analytical specification of Ph. Eur., BP, USP, 99.8-100.5%, Silver nitrate, puriss. p.a., ACS reagent, reag. ISO, reag. Ph. Eur., >=99.8%" AgNO3 SQGYOTSLMSWVJD-UHFFFAOYSA-N "silver;nitrate" n.a. n.a. No No No No No No PMDBD2001175 Silver sulfadiazine Therapeutic Substance Approved Drug 22199-08-2 DB05245 PA164744951 D00433 D08JCA 441244 390017 n.a. "silver sulfadiazine, 22199-08-2, SULFADIAZINE SILVER, Sulfadiazine silver salt, Flamazine, Silver sulphadiazine, Silvadene, Dermazin, Thermazene, Sulfadiazine, silver, Dermazine, Geben, Silbertone, silver sulfadiazinate, Sulfadiazin silber, Silvazine, Altreet-ag, Sulfadiazin, silbersalz, Sildaflo, silver(1+) sulfadiazinate, UNII-W46JY43EJR, W46JY43EJR, CHEBI:9142, DTXSID4048646, Benzenesulfonamide, 4-amino-N-2-pyrimidinyl-, monosilver(1+) salt, 4-Amino-N-(2-pyrimidinyl)benzenesulfonamide silver salt, EINECS 244-834-5, NSC 625324, SSD, N(sup 1)-2-Pyrimidinylsulfanilamide monosilver(1+) salt, DTXCID1028572, Silver, (4-amino-N-2-pyrimidinylbenzenesulfonamidato-NN,O1)-, Sulfadiazine, silver [USAN:USP], Silver(I) sulfadiazine, silver;(4-aminophenyl)sulfonyl-pyrimidin-2-ylazanide, Sulfanilamide, N(sup 1)-2-pyrimidinyl-, monosilver(1+) salt, MFCD00072101, Silver Sulfafdiazine, Sulfafdiazine, Silver, Silver(I) ((4-Aminophenyl)sulfonyl)(pyrimidin-2-yl)amide, silver(1+) [(4-aminophenyl)sulfonyl](pyrimidin-2-yl)azanide, Sulfadiazine, silver (USAN:USP), SULFADIAZINE SILVER (MART.), SULFADIAZINE SILVER [MART.], SILVER SULFADIAZINE (USP-RS), SILVER SULFADIAZINE [USP-RS], Silvadene (TN), SILVER SULFADIAZINE (USP MONOGRAPH), SILVER SULFADIAZINE [USP MONOGRAPH], Sulfadiazine, Silver [USAN], CAS-22199-08-2, SULFADIAZINE, SILVER (USP IMPURITY), SULFADIAZINE, SILVER [USP IMPURITY], NSC625324, NCGC00183137-01, NCGC00188438-01, N1-2-Pyrimidinylsulfanilamide monosilver(1+) salt, Sulfadiazine, silver (USP), Sliverex, silver(1+) ((4-aminophenyl)sulfonyl)(pyrimidin-2-yl)azanide, RayaSore Kit, Ssd Cream, Silver (I) sulfadiazine, 98%, Silver Sulfadiazene, Sulfadiazinum argentum, (4-Amino-N-pyrimidin-2-ylbenzenesulphonamidato-NN,O1)silver, Silver sulfadiazine USP, SILVER, (4-AMINO-N-(2-PYRIMIDINYL-.KAPPA.N1)BENZENESULFONAMIDATO-.KAPPA.O)-, SILVER SULFADAZINE, Silver (I) Sulfadiazine, 1152234-18-8, ThermazeneSilver Sulfadiazine, SCHEMBL15633, Sulfadiazine silver (JP17), Silver sulfadiazine bulk powder, CHEMBL1382627, SULFADIAZINE SILVER [JAN], (4-Amino-N-2-pyrimidinylbenzenesulfonamidato-NN,01)-silver, SILVER SULFADIAZINE [VANDF], Tox21_112998, Tox21_113471, SULFADIAZINE SILVER [WHO-DD], SULFADIAZINE SILVER [WHO-IP], SULFADIAZINE SILVER SALT [MI], AKOS005111099, AC-3535, DB05245, SILVER SULFADIAZINE [GREEN BOOK], SILVER SULFADIAZINE [ORANGE BOOK], AS-13863, SY105573, NS00127432, S0595, SULFADIAZINUM ARGENTUM [WHO-IP LATIN], D00433, Q420984, J-014582, silver (4-aminophenyl)sulfonyl-pyrimidin-2-yl-azanide, 4-amino-N-(2-pyrimidinyl) benzenesulfonamide silver salt, Monosilver 4-amino-N-(pyrimidin-2-yl)benzenesulfonamidate, silver(1+) ion 4-{[(pyrimidin-2-yl)azanidyl]sulfonyl}aniline, BENZENESULFONAMIDE, 4-AMINO-N-2-PYRIMIDINYL-, SILVER(1+) SALT (1:1), SILVER, (4-AMINO-N-(2-PYRIMIDINYL-kappaN1)BENZENESULFONAMIDATO-kappaO)-" C10H9AgN4O2S UEJSSZHHYBHCEL-UHFFFAOYSA-N "silver;(4-aminophenyl)sulfonyl-pyrimidin-2-ylazanide" n.a. Antiinfective Agents No No No No No No PMDBD2001176 Silver sulphate n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001177 Silybin Therapeutic Substance Phase 2/3 n.a. n.a. n.a. n.a. D02ADM 31553 n.a. NPC7154 "silibinin, Silybin, 22888-70-6, Silybin A, Silibinin A, Silymarin I, Flavobin, SILYMARIN, Silibinine, Silymarine I, Silibininum, Silibinina, Silibinin [INN], Silliver, Silybine, Silymarine, Flavobin Spofa, 36804-17-8, (2R,3R)-3,5,7-trihydroxy-2-((2R,3R)-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-2,3-dihydrobenzo[b][1,4]dioxin-6-yl)chroman-4-one, NSC-651520, ( inverted exclamation markA)-SILYBIN, CHEBI:9144, (2R,3R)-3,5,7-trihydroxy-2-[(2R,3R)-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-2,3-dihydro-1,4-benzodioxin-6-yl]-2,3-dihydrochromen-4-one, DTXSID8026018, 33X338MNE4, Silibinin (INN), NSC651520, NCGC00091057-01, (2R,3R)-3,5,7-trihydroxy-2-[(2R,3R)-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-2,3-dihydro-1,4-benzodioxin-6-yl]-3,4-dihydro-2H-1-benzopyran-4-one, 1265089-69-7, DTXCID106018, silybinin, Silibinine [INN-French], Silibininum [INN-Latin], Silibinina [INN-Spanish], 802918-57-6, 7C3MT, (2R,3R)-3,5,7-trihydroxy-2-[(2R,3R)-3-(4-hydroxy-3-methoxy-phenyl)-2-(hydroxymethyl)-2,3-dihydro-1,4-benzodioxin-6-yl]chroman-4-one, (2R,3R)-3,5,7-trihydroxy-2-[(2R,3R)-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-2,3-dihydro-1,4-benzodioxin-6-yl]-2,3-dihydro-4H-chromen-4-one, 2,3-Dihydro-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-6-(3,5,7-trihydroxy-4-oxobenzopyran-2-yl)benzodioxin, 4H-1-Benzopyran-4-one, 2-((2R,3R)-2,3-dihydro-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-1,4-benzodioxin-6-yl)-2,3-dihydro-3,5,7-trihydroxy-, (2R,3R)-, CAS-22888-70-6, EINECS 245-302-5, NSC 651520, Silybin;Silibinin A;Silymarin I, UNII-33X338MNE4, CCRIS 9378, MFCD00872186, 4H-1-Benzopyran-4-one, 2-[(2R,3R)-2,3-dihydro-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-1,4-benzodioxin-6-yl]-2,3-dihydro-3,5,7-trihydroxy-, (2R,3R)-, 65666-07-1, Legalon (TN), Silibinin (Silybin), Spectrum2_001694, Spectrum3_001132, Spectrum4_001978, Spectrum5_001893, SILYBIN A [MI], BSPBio_002623, KBioGR_002481, MLS001304057, SCHEMBL324884, SPECTRUM1505256, SPBio_001648, CHEMBL431701, MEGxp0_001301, GTPL12449, KBio3_002123, HMS1922P05, HMS2232P03, 2-[2R,3R-Dihydro-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-1,4-benzodioxin-6-yl]-2R,3R-dihydro-3,5,7-trihydroxy-4H-1-benzopyran-4-one, AMY28808, Tox21_111070, Tox21_200755, BDBM50084982, CCG-38779, MFCD03225424, s2357, Methanone, cyclohexyl-1-pyrrolidinyl-, AKOS004119918, Tox21_111070_1, DB09298, DS-9661, SDCCGMLS-0066916.P001, SMP2_000323, NCGC00091057-02, NCGC00091057-03, NCGC00091057-05, NCGC00258309-01, Silybin A (constituent of milk thistle), 1ST40325, 3,5,7-Trihydroxy-2-(3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-1,4-benzodioxan-6-yl)-4-chromanone, 4H-1-Benzopyran-4-one, 2,3-dihydro-2-(2,3-dihydro-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-1,4-benzodioxin-6-yl)-3,5,7-trihydroxy-, (2R-(2-alpha,3-beta,6(2R*,3R*)))-, 4H-1-Benzopyran-4-one, 2-(2,3-dihydro-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-1,4-benzodioxin-6-yl)-2,3-dihydro-3,5,7-trihydroxy-, (2R-(2alpha,3beta,6(2R*,3R*)))-, BP-30210, HY-13748, SMR000718776, SBI-0207018.P001, HY-139637, CS-0226432, Silybin ASilibinin A; Silybin A; Silymarin I, D08515, E82516, AB00876265_06, Q425702, SR-01000799140, Q-100291, SR-01000799140-2, BRD-K80353138-001-02-2, BRD-K80353138-001-07-1, SILYBIN A (CONSTITUENT OF MILK THISTLE) [DSC], (2R,3R)-3,5,7-trihydroxy-2-(3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-2,3-dihydrobenzo[b][1,4]dioxin-6-yl)chroman-4-one, (2R,3R)-3,5,7-Trihydroxy-2-[(2R,3R)-3-(4-hydroxy-3-methoxy-phenyl)-2-hydroxymethyl-2,3-dihydro-benzo[1,4]dioxin-6-yl]-chroman-4-one, (2R,3R)-3,5,7-Trihydroxy-2-[3-(4-hydroxy-3-methoxy-phenyl)-2-hydroxymethyl-2,3-dihydro-benzo[1,4]dioxin-6-yl]-chroman-4-one, 3,5,7-Trihydroxy-2-(3-(4-hydroxy-3-methoxyphenyl)- 2-(hydroxymethyl)-1,4-benzodioxan-6-yl)-4-chromanone, 3,5,7-Trihydroxy-2-[3-(4-hydroxy-3-methoxy-phenyl)-2-hydroxymethyl-2,3-dihydro-benzo[1,4]dioxin-6-yl]-chroman-4-one, 3,5,7-trihydroxy-2-[3-(4-hydroxy-3-methoxyphenyl)-2-hydroxymethyl-(2R,3R)-2,3-dihydrobenzo[b][1,4]dioxin-6-yl]-(2R,3R)-3,4-dihydro-2H-4-chromenone, 4H-1-Benzopyran-4-one,2-[(2R,3R)-2,3-dihydro-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-1,4-benzodioxin-6-yl]-2,3-dihydro-3,5,7-trihydroxy-, (2R,3R)-" C25H22O10 SEBFKMXJBCUCAI-HKTJVKLFSA-N (2R,3R)-3,5,7-trihydroxy-2-[(2R,3R)-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-2,3-dihydro-1,4-benzodioxin-6-yl]-2,3-dihydrochromen-4-one Meda Pharmaceuticals Somerset, NJ n.a. No No No No No No PMDBD2001178 Simeprevir Therapeutic Substance Approved Drug 923604-59-5 DB06290 n.a. D10081 D00TLP 24873435 23331536 n.a. SIMEPREVIR, 923604-59-5, TMC-435, TMC 435, TMC435, TMC 435350, TMC-435350, TMC435350, Olysio, Simeprevir sodium, CHEMBL501849, (1R,4R,6S,7Z,15R,17R)-N-cyclopropylsulfonyl-17-[7-methoxy-8-methyl-2-(4-propan-2-yl-1,3-thiazol-2-yl)quinolin-4-yl]oxy-13-methyl-2,14-dioxo-3,13-diazatricyclo[13.3.0.04,6]octadec-7-ene-4-carboxamide, (2R,3aR,10Z,11aS,12aR,14aR)-N-(cyclopropylsulfonyl)-2-({7-methoxy-8-methyl-2-[4-(1-methylethyl)-1,3-thiazol-2-yl]quinolin-4-yl}oxy)-5-methyl-4,14-dioxo-2,3,3a,4,5,6,7,8,9,11a,12,13,14,14a-tetradecahydrocyclopenta[c]cyclopropa[g][1,6]diazacyclotetradecine-12a(1H)-carboxamide, (2R,3aR,11aS,12aR,14aR,Z)-N-(Cyclopropylsulfonyl)-2-((2-(4-isopropylthiazol-2-yl)-7-methoxy-8-methylquinolin-4-yl)oxy)-5-methyl-4,14-dioxo-2,3,3a,4,5,6,7,8,9,11a,12,13,14,14a-tetradecahydrocyclopenta[c]cyclopropa[g][1,6]diazacyclotetradecine-12a(1H)-carboxamide, Simeprevir [USAN], SIMEPREVIR SODIUM [JAN], HCV-PI, SIMEPREVIR [MI], SIMEPREVIR [INN], SIMEPREVIR [JAN], SIMEPREVIR [VANDF], SIMEPREVIR [WHO-DD], SCHEMBL826061, GTPL7367, DTXSID20919221, CHEBI:134743, N-cyclopropylsulfonyl-[[2-(4-isopropylthiazol-2-yl)-7-methoxy-8-methyl-4-quinolyl]oxy]-methyl-dioxo-[?]carboxamide, BDBM50336504, s5015, AKOS025401966, CCG-270435, AC-27651, AS-56205, TMC-00435350, TMC-435, TMC-435350, US8741926, 47, US8754106, 47, Q7517689, (2R,3aR,10Z,11aS,12aR,14aR)-N-(Cyclopropylsulfonyl)-2-({7-methoxy-8-methyl-2-[4-(propan-2-yl)-1,3-thiazol-2-yl]quinolin-4-yl}oxy)-5-methyl-4,14-dioxo-2,3,3a,4,5,6,7,8,9,11a,12,13,14,14a-tetradecahydrocyclopenta[c]cyclopropa[g][1,6]diazacyclotetradecine-12a(1H)-carboxamide, (2R,3aR,11aS,12aR,14aR)-N-(cyclopropylsulfonyl)-2-(2-(4-isopropylthiazol-2-yl)-7-methoxy-8-methylquinolin-4-yloxy)-5-methyl-4,14-dioxo-1,2,3,3a,4,5,6,7,8,9,11a,12,12a,13,14,14a-hexadecahydrocyclopenta[c]cyclopropa[g][1,6]diazacyclotetradecine-12a-carboxamide, (2R,3aR,11aS,12aR,14aR,Z)-N-(cyclopropylsulfonyl)-2-((2-(4-isopropylthiazol-2-yl)-7-methoxy-8-methylquinolin-4-yl)oxy)-5-methyl-4,14-dioxo-1,2,3,3a,4,5,6,7,8,9,11a,12,12a,13,14,14a-hexadecahydrocyclopenta[c]cyclopropa[g][1,6]diazacyclotetradecine-12a-carboxamide, (2R,3aR,11aS,12aR,14aR,Z)-N-(cyclopropylsulfonyl)-2-(2-(4-isopropylthiazol-2-yl)-7-methoxy-8-methylquinolin-4-yloxy)-5-methyl-4,14-dioxo-1,2,3,3a,4,5,6,7,8,9,11a,12,12a,13,14,14a-hexadecahydrocyclopenta[c]cyclopropa[g][1,6]diazacyclotetradecine-12a-carboxamide, N-[17-[2-(4-isopropylthiazole-2-yl)-7-methoxy-8-methylquinolin-4-yloxy]-13-methyl-2,14-dioxo-3,13-diazatricyclo [13.3.0.0''''4,6]octadec-7-ene-4-carbonyl](cyclopropyl)sulfonamide C38H47N5O7S2 JTZZSQYMACOLNN-VDWJNHBNSA-N (1R,4R,6S,7Z,15R,17R)-N-cyclopropylsulfonyl-17-[7-methoxy-8-methyl-2-(4-propan-2-yl-1,3-thiazol-2-yl)quinolin-4-yl]oxy-13-methyl-2,14-dioxo-3,13-diazatricyclo[13.3.0.04,6]octadec-7-ene-4-carboxamide Johnson & Johnson Antiinfective Agents No No No No No No PMDBD2001179 Sinapic acid Therapeutic Substance n.a. 7362-37-0 DB08587 n.a. n.a. n.a. 637775 553361 NPC300326 SINAPIC ACID, Sinapinic acid, 530-59-6, 3,5-Dimethoxy-4-hydroxycinnamic acid, trans-sinapic acid, 7362-37-0, SINAPINATE, (E)-Sinapic acid, Sinapate, Synapoic acid, 4-Hydroxy-3,5-dimethoxycinnamic acid, (2E)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoic acid, (E)-3-(4-hydroxy-3,5-dimethoxyphenyl)acrylic acid, (E)-3-(4-Hydroxy-3,5-dimethoxyphenyl)-2-propenoic acid, (2E)-3-(4-hydroxy-3,5-dimethoxyphenyl)acrylic acid, 2-Propenoic acid, 3-(4-hydroxy-3,5-dimethoxyphenyl)-, Cinnamic acid, 4-hydroxy-3,5-dimethoxy-, (E)-, (E)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoic acid, MFCD00004401, CHEMBL109341, CHEBI:15714, 3-(4-hydroxy-3,5-dimethoxyphenyl)acrylic acid, P0I60993EC, NSC59261, 4-Hydroxy-3,5-dimethoxy-cinnamic acid, (2E)-3-(4-Hydroxy-3,5-dimethoxyphenyl)-2-propenoic acid, 2-propenoic acid, 3-(4-hydroxy-3,5-dimethoxyphenyl)-, (2E)-, 2-Propenoic acid, 3-(4-hydroxy-3,5-dimethoxyphenyl)-, (E)-, trans-3,5-Dimethoxy-4-hydroxycinnamic acid, 3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoic acid, SXX, UNII-P0I60993EC, 3-(4-Hydroxy-3,5-dimethoxyphenyl)-2-Propenoic acid, 3-(4-hydroxy-3,5-dimethoxyphenyl)-(E)-2-propenoic acid, trans-sinapinic acid, sinapic acid, (E)-, CHEBI:77131, Sinapic_acid, NSC-59261, 3,5-dimethoxy-4-hydroxy-trans-cinnamic acid, Sinapic acid, trans-, DEGLY SINA, bmse000318, bmse000594, bmse010209, SCHEMBL37312, MLS001066354, Sinapinic acid (Sinapic acid), Sinapic acid, >=98%, powder, HMS2230P08, BDBM50341142, s3981, AKOS015851820, CCG-214595, CS-W010448, DB08587, HY-W009732, MS-8962, trans-Sinapic acid, analytical standard, NCGC00247028-01, 1ST40176, AC-34343, SMR000471879, Cinnamic acid, 4-hydroxy-3,5-dimethoxy-, SBI-0206696.P002, 4-Hydroxy-3,5-dimethoxy-(E)-Cinnamic acid, NS00015085, EN300-93177, C00482, Q417527, (E)-3-(4-hydroxy-3,5-dimethoxyphenyl)acrylicacid, W-105777, BRD-K95487349-001-04-2, (E)-3-(4-Hydroxy-3,5-dimethoxy-phenyl)-acrylic acid, 3-(4-Hydroxy-3,5-dimethoxyphenyl)-2-propenoic acid #, Z1266855053, 3-(4-Hydroxy-3,5-dimethoxyphenyl)-(2E)-2-Propenoic acid, 7AE78999-D500-492B-9651-46622E8DAA71, Sinapic acid, matrix substance for MALDI-MS, >=99.0% (T), Sinapic acid, matrix substance for MALDI-MS, >=99.5%, Ultra pure, InChI=1/C11H12O5/c1-15-8-5-7(3-4-10(12)13)6-9(16-2)11(8)14/h3-6,14H,1-2H3,(H,12,13)/b4-3 C11H12O5 PCMORTLOPMLEFB-ONEGZZNKSA-N (E)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoic acid n.a. n.a. No No No No No No PMDBD2001180 Sinefungin Therapeutic Substance Investigational Drug 58944-73-3 DB01910 n.a. D05846 D00FLT 65482 58931 n.a. sinefungin, 58944-73-3, ADENOSYL-ORNITHINE, Antibiotic A 9145, Compound 57926, Sinefungina, Sinefungine, Sinefunginum, A 9145, 6,9-Diamino-1-(6-amino-9H-purin-9-yl)-1,5,6,7,8,9-hexadeoxydecofuranuronic acid, 6,9-Diamino-1-(6-amino-9H-purin-9-yl)-1,5,6,7,8,9-hexadeoxy-beta-D-ribo-decofuranuronic acid, W2U467CIIL, CHEBI:45453, LILLY 57926, (2S,5S)-2,5-diamino-6-[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]hexanoic acid, Antibiotic 32232RP, LY-57926, (2S,5S)-2,5-diamino-6-((2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)hexanoic acid, (2S,5S)-2,5-diamino-6-[(2R,3S,R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]hexanoic acid, Antibiotic 32232 RP, Sinefungin [USAN:INN], Sinefungine [INN-French], Sinefunginum [INN-Latin], Sinefungina [INN-Spanish], (5S)-5-amino-6-[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]-L-norleucine, SFG, A-9145, UNII-W2U467CIIL, BRN 3574678, LY 57926, RP 32232, 1aqj, 1qaq, Decofuranuronic acid, 6,9-diamino-1-(6-amino-9H-purin-9-yl)-1,5,6,7,8,9-hexadeoxy-, 2h2j, SINEFUNGIN [MI], SINEFUNGIN [INN], Sinefungin (USAN/INN), SINEFUNGIN [USAN], SINEFUNGIN [MART.], SCHEMBL167609, CHEMBL1214186, DTXSID10207689, BCP28648, Sinefungin, 95% (HPLC), powder, BDBM50378739, AKOS027327588, CCG-208696, DB01910, NCGC00263619-01, NCGC00263619-03, 6,9-Diamino-1-(6-amino-9H-purin-9-yl)-1,5,6,7,8,9-hexadeoxy-D-glycero-alpha-L-talo-decofuranuronic acid, AS-77750, BS162746, D-glycero-alpha-L-talo-Decofuranuronic acid, 6,9-diamino-1-(6-amino-9H-purin-9-yl)-1,5,6,7,8,9-hexadeoxy-, Decofuranuronic acid, 6,9-diamino-1-(6-amino-9H-purin-9-yl)-1,5,6,7,8,9-hexadeoxy-, (beta-D-ribo)-, HY-101938, CS-0022195, NS00018031, D05846, A869317, (2S,5S)-5-(5''-Adenosyl)-2,5-diaminopentanoic acid, BRD-K91100918-001-01-2, Q27093021, TCA-O-PCP?Trichloroacetic acid pentachlorophenyl ester, (2S,5S)-2,5-Diamino-6-[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxy-2-tetrahydrofuryl]hexanoic Acid, (2S,5S)-2,5-diamino-6-[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]hexanoic acid (non-preferred name), 6,9-DIAMINO-1-(6-AMINO-9H-PURIN-9-YL)-1,5,6,7,8,9-HEXADEOXY-.BETA.-D-RIBO-DECOFURANURONIC ACID, 6,9-Diamino-1-(6-amino-9H-purin-9-yl)-1,5,6,7,8,9-hexadeoxy-D-glycero-a-L-talo-decofuranuronic acid, DECOFURANURONIC ACID, 6,9-DIAMINO-1-(6-AMINO-9H-PURIN-9-YL)-1,5,6,7,8,9-HEXADEOXY-, (.BETA.-D-RIBO)- C15H23N7O5 LMXOHSDXUQEUSF-YECHIGJVSA-N (2S,5S)-2,5-diamino-6-[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]hexanoic acid n.a. n.a. No No No No No No PMDBD2001181 Sinensetin n.a. n.a. n.a. n.a. n.a. n.a. n.a. 145659 n.a. NPC215932 "Sinensetin, 2306-27-6, Pedalitin permethyl ether, 5,6,7,3'',4''-Pentamethoxyflavone, 2-(3,4-Dimethoxyphenyl)-5,6,7-trimethoxy-4H-chromen-4-one, 3'',4'',5,6,7-Pentamethoxyflavone, 4H-1-Benzopyran-4-one, 2-(3,4-dimethoxyphenyl)-5,6,7-trimethoxy-, UNII-240LNZ51AT, 240LNZ51AT, CHEBI:9159, 2-(3,4-dimethoxyphenyl)-5,6,7-trimethoxychromen-4-one, CHEMBL226507, DTXSID60177626, 2-(3,4-dimethoxyphenyl)-5,6,7-trimethoxy-4H-1-benzopyran-4-one, FLAVONE, 3'',4'',5,6,7-PENTAMETHOXY-, SR-05000002257, SCHEMBL621101, MEGxp0_000957, DTXCID20100117, HY-N0297, BDBM50338975, LMPK12111250, MFCD00017421, s9227, AKOS016009570, CCG-208419, CS-5907, Flavone, 5,6,7,3'',4''-pentamethoxy, 3'''',4'''',5,6,7-pentamethoxy flavone, 5,6,7,3'''',4'''' -pentamethoxyflavone, NCGC00163623-01, 1ST40172, AC-34822, BS-16575, A816546, Q3484909, SR-05000002257-2, SR-05000002257-3, BRD-K84996949-001-01-5, B0005-407401, 2-(3,4-Dimethoxyphenyl)-5,6,7-trimethoxy-4H-chromen-4-one #, 2-(3,4-dimethoxyphenyl)-5,6,7-trimethoxy-chromen-4-one;Sinensetin" C20H20O7 LKMNXYDUQXAUCZ-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5,6,7-trimethoxychromen-4-one n.a. n.a. No No No No Yes No rxnAddEX12,rxnAdd117 PMDBD2001182 Sm6(L1)2C n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001183 Sm6(L2)B33 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001184 Sm6(L3)2C n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001185 SMAP-29 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001186 S-methyl- L-cysteine n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001187 Sodium ascorbate Therapeutic Substance n.a. 134-03-2 DB14482 PA166163262 D05853 n.a. 23667548 n.a. n.a. "SODIUM ASCORBATE, 134-03-2, Sodium L-ascorbate, L-Ascorbic acid sodium salt, Vitamin C sodium, Monosodium L-ascorbate, Ascorbicin, Ascorbic acid sodium salt, Natrii ascorbas, Vitamin C Sodium Salt, Iskia-C, Natri-C, Ascorbate de sodium, Sodascorbate, (+)-Sodium L-ascorbate, L-Ascorbic acid, monosodium salt, Vitamin C, sodium salt, ascorbate, Ascorbin, Cevalin, L-Ascorbic acid sodium, 3-Oxo-L-gulofuranolactone sodium, MFCD00082340, INS NO.301, L(+)-Ascorbic acid sodium salt, INS-301, S033EH8359, L-Ascorbic acid (sodium salt), DTXSID0020105, E-301, CHEBI:113451, l-Ascorbate, sodium, Sodium (R)-2-((S)-1,2-dihydroxyethyl)-4-hydroxy-5-oxo-2,5-dihydrofuran-3-olate, Cebitate, Aminofenitrooxon, sodium (2R)-2-[(1S)-1,2-dihydroxyethyl]-4-hydroxy-5-oxo-2H-furan-3-olate, sodium (L)-ascorbate, sodium (2R)-2-[(1S)-1,2-dihydroxyethyl]-4-hydroxy-5-oxo-2,5-dihydrofuran-3-olate, SODIUM ASCORBATE (II), SODIUM ASCORBATE [II], SODIUM ASCORBATE (MART.), SODIUM ASCORBATE [MART.], sodiumascorbate, SODIUM ASCORBATE (USP-RS), SODIUM ASCORBATE [USP-RS], Ascorbato sodico, Ascorbato sodico [DCIT], SODIUM ASCORBATE (EP MONOGRAPH), SODIUM ASCORBATE [EP MONOGRAPH], SODIUM ASCORBATE (USP MONOGRAPH), SODIUM ASCORBATE [USP MONOGRAPH], Monosodium Ascorbate, Natrii ascorbas [INN-Latin], Ascorbic acid sodium derivative, CCRIS 3291, HSDB 694, HBL 508, Ascorbate de sodium [INN-French], EINECS 205-126-1, Tianafacacid, Sodium ascorbate [USP:INN], UNII-S033EH8359, Sodium derivative of 3-oxo-L-gulofuranolactone, Ascorbate, Sodium, sodium (2R)-2-((1S)-1,2-dihydroxyethyl)-4-hydroxy-5-oxo-2,5-dihydrofuran-3-olate, Sodium ascorbate; Sodium (2R)-2-[(1S)-1,2-dihydroxyethyl]-4-hydroxy-5-oxo-2,5-dihydrofuran-3-olate, (+)-Sodium L-ascorbate;Vitamin C sodium salt;Sodium L-ascorbate, E301, sodium L-ascorbate salt, VITA-JEC C, EC 205-126-1, SCHEMBL3745, ASK-P 10KR, DTXCID60105, L(+)Ascorbic acid sodium salt, SODIUM ASCORBATE [FCC], SODIUM ASCORBATE [INN], CHEMBL591665, SODIUM ASCORBATE [HSDB], SODIUM ASCORBATE [INCI], SODIUM ASCORBATE [VANDF], HY-B0166A, SODIUM ASCORBATE [WHO-DD], L-Ascorbic Acid Sodium Salt,(S), Tox21_300556, AKOS015895058, L-Ascorbic acid, sodium salt (1:1), SODIUM ASCORBATE [ORANGE BOOK], ASCORBIC ACID SODIUM SALT [MI], CS-6063, DB14482, 3-Keto-L-gulofuranlactone sodium enolate, NCGC00254355-01, BP-30077, CAS-134-03-2, A0539, E80761, EN300-221566, A806721, Q424551, J-006471, 2,3-Didehydro-L-theo-hexono-1,4-lactone sodium enolate, Z1255486556, sodium (2R)-2-[(1S)-1,2-bis(oxidanyl)ethyl]-4-oxidanyl-5-oxidanylidene-2H-furan-3-olate, Sodium(R)-2-((S)-1,2-dihydroxyethyl)-4-hydroxy-5-oxo-2,5-dihydrofuran-3-olate, sodium;(2R)-2-[(1S)-1,2-dihydroxyethyl]-4-hydroxy-5-oxo-2H-furan-3-olate" C6H7NaO6 PPASLZSBLFJQEF-RXSVEWSESA-M "sodium;(2R)-2-[(1S)-1,2-dihydroxyethyl]-4-hydroxy-5-oxo-2H-furan-3-olate" n.a. n.a. No No No No No No PMDBD2001188 Sodium Chloride Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. D04YZL 5234 n.a. n.a. "sodium chloride, 7647-14-5, Salt, Table salt, Halite, Saline, Common salt, Rock salt, Dendritis, Purex, Sodium chloric, Sodium chloride (NaCl), Flexivial, Gingivyl, Hyposaline, Sodium monochloride, Iodized salt, Slow Sodium, Top flake, SS salt, Adsorbanac, Natriumchlorid, Hypersal, Sea salt, NaCl, H.G. blending, Salt (ingredient), sodiumchloride, sodium;chloride, Trisodium trichloride, White crystal, Sodium chloride (Na4Cl4), Natrum Muriaticum, Extra Fine 200 Salt, Extra Fine 325 Salt, Sodium chloride brine, purified, Colyte, Isotonic saline, Broncho saline, Dendritic salt, Caswell No. 754, Normal saline, CCRIS 982, Arm-A-Vial, HSDB 6368, Kochsalz, Mafiron, cloruro sodico, EPA Pesticide Chemical Code 013905, natrii chloridum, Watesal A, chlorure de sodium, EINECS 231-598-3, Brinewate Superfine, NSC 77364, NSC-77364, UNII-451W47IQ8X, LS-1700, 14762-51-7, CHEBI:26710, 451W47IQ8X, Sodium chloride in plastic container, UNII-VR5Y7PDT5W, MFCD00003477, Sodium chloride, hypertonic, Sodium chloride 3% in plastic container, Sodium chloride 5% in plastic container, Sodium chloride [USP:JAN], Sodium chloride 0.9% in plastic container, 10% Sodium Chloride Injection, Sodium chloride 0.45% in plastic container, Sodium chloride 23.4% in plastic container, Ayr, SODIUM CHLORIDE ANHYDROUS, DTXSID3021271, SODIUM CHLORIDE, ANHYDROUS, Sodium chloride, for cell culture, EC 231-598-3, NSC77364, Sodium chloride 0.9% in sterile plastic container, Sodium chloride, for molecular biology, sterling, B1655, Sodium chloride, United States Pharmacopeia (USP) Reference Standard, Sodium chloride, ultra dry, Sodium chloride (USP:JAN), SODIUM CHLORIDE (II), SODIUM CHLORIDE [II], Sodium chloride (Na36Cl), SODIUM CHLORIDE (USP-RS), SODIUM CHLORIDE [USP-RS], Natriumchlorid [German], SODIUM CHLORIDE (EP MONOGRAPH), SODIUM CHLORIDE [EP MONOGRAPH], SODIUM CHLORIDE (USP MONOGRAPH), SODIUM CHLORIDE [USP MONOGRAPH], Halite (NaCl), Sodium chloride, meets analytical specification of Ph. Eur. BP USP, inverted exclamation markU0.00002% Al, Sodium chloride, ACS reagent, >=99.0%, Sodium-36 chloride, Athomer, Cleanoz, Isotonic, Licefreee, Nebusal, Pulmosal, Titrisol, Entsol, NasoxinSpray, sodium-chloride, Solsel, Octiq, Ancient Secrets, for spectroscopy, Sterile Saline, Walgreen Saline, Athomer Baby, Athomer Mini, Mineral Metea, Saline Wipes, Sea water, Athomer Propolis, Beanguard Gargle, Clear Mist, Normal Salt, Saline Mist, Stat trak plus, Walgreens Saline, Saline Nasal2oz, Saline Nasal3oz, Na-zone, Sel Gemme, Bye Zero, Aqua Maris Daily, Uzushio Biryuu M, Cardiovascular Kit, CVS Saline, Licefreee Everyday, Nat Mur, Natrium Muriaticum, TID Clean Align, TID Clean Plant, Adsorbanac (TN), Aqua Maris Strong, MEIJER Saline, TID Clean Care, TID Clean Dent, Amphenol-40, Aquamarine8105, Normal Salt Tablets, sodium chloride salt, Sterile Saline Mist, Saline Nasal1.5oz, Corvatrol 0.9%, 3% Sodium Chloride, Canners 999, Sodium Chloride ACS, sodium chloride spray, NaCl Solution, 1M, Nat Mur 3X, Nat Mur 6X, Extrafine 200 salt, Extrafine 325 salt, Natrum Muriaticum 6C, Saline Nasal1 fl oz, Walgreens Saline Mist, 32343-72-9, Sel Gemme8146, 0.9% saline, AQUA MARINA, Bye Bye (Toc Toc), Natrium Muriaticum 6X, Nat Mur 12X, Nat Mur 30X, SUPRASEL NITRITE, Homeopathic Pediculicide, Natrum muriaticum 30C, Vamousse Lice Treatment, Aqua Maris Daily Clean, Cleansing Wipe / Tube, P-Care K40MX, P-Care K80MX, Saline, sodium chloride, Sodium chloride, tablet, Nat Mur 200X, Natrum Muriaticum8009, TONICPET 9, Aqua Maris Extra Strong, Sodium chloride (8CI), Vamousse Lice Prevention, API AQUARIUM SALT, mono-sodium chloride salt, Muro 128, 0.9% nacl, Sodium chloride, isotonic, Sterile Saline Kids Mist, 7.5% Hypertonic Saline, Hypertonic Saline 7.2%, Sodium chloride 2.65%, Salt (6CI,7CI), Sodium Chloride 0.65%, Sodium ChlorideNormal Salt, VR5Y7PDT5W, API POND POND SALT, Special Salt 100/95, USP SODIUM CHLORIDE, Extra Strenght Saline Mist, Nacl 0.9%, WLN: NA G, Hypertonic Saline 7.2 %, VetivexVeterinary Hypertonic, SDG high level disinfectant, Ancient SecretsBreathe Again, Cardiovascular Accessory Kit, Sterile Saline MistRite Aid, Sterile Saline MistWalgreens, Vamousse Pro Lice Treatment, Natrum Muriaticum Kit Refill, Sodium Chloride Hypertonicity, SODIUM CHLORIDE [MI], SODIUM CHLORIDE1 GRAM, NATRUM MURIATICUM200ck, Sodium chloride, ACS reagent, Sykes 0.9% Sodium Chloride, B1655 [LANGUAL], SODIUM CHLORIDE [JAN], Sodium Chloride for Irrigation, Sodium chloride, 99.999%, 0.9% SODIUM CHLORIDE, RNS60 COMPONENT SALINE, Sodium chloride (JP17/USP), SODIUM CHLORIDE [HSDB], SODIUM CHLORIDE [INCI], Sodium chloride, Optical Grade, Chlorine-containing disinfectant, DTXCID001271, Sykes Hypertonic Saline 7.2%, SinuCleanse Sterile Saline Mist, SODIUM CHLORIDE [VANDF], Bacteriostatic sodium chloride 0.9% in plastic container, CHEMBL1200574, NATRUM MURIATICUM [HPUS], RNS-60 COMPONENT SALINE, HY-Y0344D, HY-Y0344H, HY-Y0344I, HY-Y0344J, Isotonic sodium chloride solution, SODIUM CHLORIDE 23.4%, Sodium chloride biochemical grade, 7647-14-5 (solid), SODIUM CHLORIDE [WHO-DD], SODIUM CHLORIDE [WHO-IP], Sterile Saline Kids MistPediaMeds, Veterinary 0.9% Sodium Chloride, VETIVEXVeterinary Sodium Chloride, Extra Strenght Saline MistRite Aid, Sodium chloride, AR, >=99.9%, Sodium chloride, LR, >=99.5%, Sodium chloride, Spectroscopy Grade, STR02627, Walgreens Saline MistExtra Strength, Haemonetics 0.9 % Sodium Chloride, Sodium chloride, MANAC Incorporated, SODIUM CHLORIDE [GREEN BOOK], Sodium chloride, >=99%, AR grade, Vamousse Lice Treatment Complete Kit, SODIUM CHLORIDE [ORANGE BOOK], AKOS024438089, AKOS024457457, Alfa Veterinary 0.9% Sodium Chloride, SODIUM CHLORIDE, BACTERIOSTATIC, USEPA/OPP Pesticide Code: 13905, DB09153, Sodium chloride, technical grade, 95%, Sodium chloride, technical grade, 97%, Altachlore Sodium Chloride Hypertonicity, NATRII CHLORIDUM [WHO-IP LATIN], Sodium Chloride Hypertonicity Ophthalmic, Sodium chloride, Ph. Eur., USP grade, Sodium chloride, p.a., 99-100.5%, SinuCleanse Sterile Saline Mist Daily Care, Sodium chloride, NIST(R) SRM(R) 919b, Sodium chloride, ReagentPlus(R), >=99%, Sodium chloride, USP, 99.0-100.5%, Sodium chloride, USP, 99.0-101.0%, Sterile Saline Kids MistSinuCleanse Breathe, CS-0376163, CS-0909801, CS-0909802, CS-0909803, NS00076259, Q2314, S0572, Sodium chloride, BioXtra, >=99.5% (AT), Sodium chloride, SAJ first grade, >=99.0%, Sodium chloride, tested according to Ph.Eur., D02056, Sodium chloride, 99.999% trace metals basis, Sodium chloride, JIS special grade, >=99.5%, Sodium chloride, Trace metals grade, 99.99%, Isotopic standard for chlorine, NIST SRM 975a, Sodium chloride, Vetec(TM) reagent grade, 99%, Sodanylium and hydrochloric acid, ion(1-) (1:1), Sodium chloride, puriss. p.a., >=99.5% (AT), Sodium chloride, NIST(R) SRM(R) 2201, ion-selective, Sodium chloride crystal optic disc, 25mm x 5mm, unpolished, Sodium chloride crystal optic disc, 13mm x 1mm, polished both sides, Sodium chloride crystal optic disc, 13mm x 2mm, polished both sides, Sodium chloride crystal optic disc, 22mm x 4mm, polished both sides, Sodium chloride crystal optic disc, 25mm x 2mm, polished both sides, Sodium chloride crystal optic disc, 25mm x 4mm, polished both sides, Sodium chloride crystal optic disc, 32mm x 3mm, polished both sides, Sodium chloride, BioUltra, for molecular biology, >=99.5% (AT), Sodium chloride, puriss. p.a., >=99.5% (AT), powder or crystals, Sodium chloride, reagent grade, >=98%, +80 mesh particle size, Sodium standard for AAS, ready-to-use, traceable to BAM, in H2O, Sodium chloride crystal optic rectangle, 38.5mm x 19.5mm x 4mm, unpolished, Sodium chloride crystal optic rectangle, 41mm x 23mm x 6mm, unpolished, Sodium chloride, anhydrous, beads, -10 mesh, 99.99% trace metals basis, Sodium chloride, anhydrous, beads, -10 mesh, 99.999% trace metals basis, Sodium chloride, p.a., ACS reagent, reag. ISO, reag. Ph. Eur., 99.5%, Sodium chloride, random crystals, optical grade, 99.98% trace metals basis, SODIUM CHLORIDE 0.9% IN PLASTIC THERMOJECT KIT FOR CARDIAC OUTPUT USE, Sodium chloride crystal optic disc, 32mm x 3mm (drilled), polished both sides, Sodium chloride crystal optic rectangle, 30mm x 15mm x 4mm (drilled), polished both sides, Sodium chloride crystal optic rectangle, 30mm x 15mm x 4mm, polished both sides, Sodium chloride crystal optic rectangle, 38.5mm x 19.5mm x 4mm, polished both sides, Sodium chloride, anhydrous, free-flowing, Redi-Dri(TM), ReagentPlus(R), >=99%, Sodium chloride, anhydrous, Redi-Dri(TM), free-flowing, ACS reagent, >=99%, Sodium chloride, BioPerformance Certified, >=99% (titration), Cell Culture Tested, Sodium chloride, meets analytical specification of Ph. Eur., BP, USP, 99.0-100.5%, Sodium chloride, Pharmaceutical Secondary Standard; Certified Reference Material, Sodium chloride, puriss. p.a., ACS reagent, reag. ISO, reag. Ph. Eur., >=99.5%, Sodium chloride crystal optic rectangle, 38.5mm x 19.5mm x 4mm (drilled), polished both sides, Sodium chloride, BioReagent, suitable for cell culture, suitable for insect cell culture, suitable for plant cell culture, >=99%, Sodium chloride, certified reference material for titrimetry, certified by BAM, according to ISO 17025, >=99.5%, Sodium chloride, for molecular biology, DNase, RNase, and protease, none detected, >=98% (titration)" ClNa FAPWRFPIFSIZLT-UHFFFAOYSA-M "sodium;chloride" n.a. n.a. No No No No No No PMDBD2001189 Sodium sulfate Therapeutic Substance n.a. 7757-82-6 DB09472 n.a. D01732 n.a. 24436 n.a. n.a. "SODIUM SULFATE, 7757-82-6, Disodium sulfate, Sodium sulfate, anhydrous, Sodium sulfate anhydrous, Salt cake, Sodium sulphate, Sulfuric acid disodium salt, Disodium sulphate, sodiumsulfate, Sulfuric acid, sodium salt, 15124-09-1, disodium;sulfate, Bisodium sulfate, Sodium sulphate anhydrous, Na sulphate, Sulfate, sodium, Sodium sulfate (Na2SO4), Caswell No. 793, Natriumsulfat, Na2SO4, HSDB 5042, Sodium sulphate, anhydrous, Sodium sulfate, dried [JAN], UNII-36KCS0R750, Sodium sulfate, dried, CHEBI:32149, 36KCS0R750, EINECS 231-820-9, MFCD00003504, EPA Pesticide Chemical Code 005604, NSC 403914, NSC-403914, AI3-02398, DTXSID1021291, INS NO.514(I), EC 231-820-9, INS-514(I), Sulfuric acid disodium salt, anhydrous, E-514(I), 13759-07-4, Sodium sulfate, dried (JAN), Dibasic sodium sulfate, Natriumsulfat (German), SODIUM SULFATE ANHYDROUS (II), SODIUM SULFATE ANHYDROUS [II], ANHYDROUS SODIUM SULFATE (MART.), ANHYDROUS SODIUM SULFATE [MART.], SODIUM SULFATE ANHYDROUS (USP MONOGRAPH), SODIUM SULFATE ANHYDROUS [USP MONOGRAPH], SODIUM SULFATE, ANHYDROUS (EP MONOGRAPH), SODIUM SULFATE, ANHYDROUS [EP MONOGRAPH], Sulfuric acid sodium salt (1:2), Na2O4S, Thenardite (Na2(SO4)), Glaubers salt, EINECS 268-366-6, EINECS 268-773-9, EINECS 270-211-2, Sodium sulfate anyhdrous, SDA 17-062-04, Sulfuric acid sodium salt, SODIUM SULFATE [MI], Sodium sulfate, ACS reagent, Sodium sulfate, dried (TN), SODIUM SULFATE [HSDB], NATRII SULFAS ANHYDRICUS, SAL MIRABILIS ANHYDRICUS, CHEMBL233406, DTXCID601291, Anhydous sodium sulfate (JP17), 7757-82-6 (anhyd.), BCP13313, Tox21_201045, Sodium sulfate sodium salt (Na2SO4), AKOS015833463, ANHYDROUS SODIUM SULFATE [JAN], Sodium sulfate, BioXtra, >=99.0%, DB09472, NCGC00258598-01, Sodium sulfate, LR, anhydrous, >=99%, E514, SODIUM SULFATE ANHYDROUS [USP-RS], SODIUM SULFATE ANHYDROUS [WHO-DD], Sodium Sulfate Anhydrous; Sodium sulphate, CAS-7757-82-6, SODIUM SULFATE, ANHYDROUS [WHO-IP], Sodium sulfate, AR, anhydrous, >=99.5%, NS00081401, S0566, Sodium sulfate, 99.9955% (metals basis), Sodium sulfate, ReagentPlus(R), >=99.0%, SODIUM SULFATE ANHYDROUS [ORANGE BOOK], Sodium sulfate, Trace metals grade, 99.99%, D01732, NATRII SULFAS ANHYDRICUS [WHO-IP LATIN], Sodium sulfate, >=99.99% trace metals basis, Sodium sulfate, JIS special grade, >=99.0%, Sodium sulfate, Vetec(TM) reagent grade, 99%, Sodium sulfate, meets USP testing specifications, Q211737, Sodium sulfate, for HPLC, 99.0-101.0% (T), Sodium sulfate, purum, anhydrous, >=99.0% (T), Sodium sulfate, SAJ first grade, >=99.0%, beads, Sodium sulfate, SAJ first grade, >=99.0%, powder, Sodium sulfate, >=99.0%, plant cell culture tested, Sodium sulfate, BioUltra, anhydrous, >=99.0% (T), Sodium sulfate, p.a., 99.0-101.0%, reag. ISO, Sodium sulfate, tested according to Ph.Eur., anhydrous, SULFURIC ACID DISODIUM SALT, ANHYDROUS [WHO-IP], Sodium sulfate, ACS reagent, >=99.0%, anhydrous, powder, Sodium sulfate, ACS reagent, >=99.0%, anhydrous, granular, Sodium sulfate, anhydrous, free-flowing, Redi-Dri(TM), ACS reagent, >=99%, Sodium sulfate, anhydrous, free-flowing, Redi-Dri(TM), ReagentPlus(R), >=99%, Sodium sulfate, anhydrous, granular, free-flowing, Redi-Dri(TM), ACS reagent, >=99%, Sodium sulfate, puriss. p.a., ACS reagent, reag. ISO, reag. Ph. Eur., anhydrous, >=99.0%" Na2O4S PMZURENOXWZQFD-UHFFFAOYSA-L "disodium;sulfate" n.a. n.a. No No No No No No PMDBD2001190 Sorbitol Therapeutic Substance Approved Drug 50-70-4 DB01638 PA451455 D00096 D09MXS 5780 5576 NPC66052 "D-Sorbitol, sorbitol, D-Glucitol, 50-70-4, glucitol, L-Gulitol, (-)-Sorbitol, Glucarine, D-(-)-Sorbitol, Diakarmon, Sorbilande, Sorbostyl, Esasorb, Multitol, Neosorb, Nivitin, Sorbite, Sorbol, Cholaxine, Sionit, Sionite, Sionon, Siosan, Sorbo, Karion instant, Sorbitol F, Sorbex Rp, Sorbitol FP, D-Sorbol, Sionit K, Sorbex M, Sorbex R, Sorbex S, Sorbex X, Sorbicolan, Sorvilande, Gulitol, D-Sorbite, Neosorb P 60, Foodol D 70, (2R,3R,4R,5S)-Hexane-1,2,3,4,5,6-hexaol, Neosorb 20/60DC, Glucitol, D-, Neosorb 70/70, Neosorb P 20/60, d-Sorbit, Karion, Karion (carbohydrate), Neosorb 70/02, (2R,3R,4R,5S)-hexane-1,2,3,4,5,6-hexol, D-1,2,3,4,5,6-Hexanehexol, FEMA No. 3029, G-ol, CCRIS 1898, Neosorb P 60W, Probilagol, Hexahydric alcohol, iso-sorbide, Sorbit, Glc-ol, AI3-19424, HSDB 801, Sorbitol (e420), NSC 25944, DTXSID5023588, CHEBI:17924, Sorbitol 3% in plastic container, EINECS 200-061-5, Ins-420(i), UNII-506T60A25R, Sorbitol [USP:NF], SORBITOL 3.3% IN PLASTIC CONTAINER, 1,2,3,4,5,6-Hexanehexol, E 420, E-420(i), Ins no.420(i), MFCD00004708, NSC-25944, 506T60A25R, 7B5697N, E420, Resulax, Sorbilax, DTXCID903588, Sorbitol (USP), (2S,3R,4R,5R)-hexane-1,2,3,4,5,6-hexol, D-Sorbit 1000 microg/mL in Methanol, Sorbitol (USP:NF), Medevac, SORBITOL [USP], SORBITOL (II), SORBITOL [II], E-420, SORBITOL (MART.), SORBITOL [MART.], SORBITOL (USP-RS), SORBITOL [USP-RS], Sorbitur, 26566-34-7, SORBITOL (EP MONOGRAPH), SORBITOL [EP MONOGRAPH], Sorbit DP, C*PharmSorbidex, Sorbitol;D-Glucitol, Liponic 70-NC, CAS-50-70-4, ISOMALT IMPURITY C (EP IMPURITY), ISOMALT IMPURITY C [EP IMPURITY], MALTITOL IMPURITY A (EP IMPURITY), MALTITOL IMPURITY A [EP IMPURITY], SMR000112219, WURCS=2.0/1,1,0/[h2122h]/1/, LACTITOL MONOHYDRATE IMPURITY E (EP IMPURITY), LACTITOL MONOHYDRATE IMPURITY E [EP IMPURITY], Sorbitolum, Meritol, Solbitol, Sorbitab, Sorbogem, Sorbitol Instant, Sorbitol S, Sorbitol FK, Sorbit D-Powder, Sorbit S, Sorbit W-Powder, Sorbit WP, Sorbitol (NF), Neosorb P60, Kyowa Powder 50M, Sorbogem 712, Sorbitol (Glucitol), Liponic 76-NC, 99%, high purity, Sorbit D 70, Sorbit DP 50, Sorbit L 70, Sorbit T 70, Sorbit W 70, D-Sorbitol, 99%, Sorbit W-Powder 50, D-sorbitol; D-glucitol, D-Sorbitol (JP17), SORBITOL [HSDB], SORBITOL [INCI], SORBITOL [FCC], SORBITOL [MI], SORBITOL [VANDF], D-Sorbitol, >=98%, D-SORBITOL [JAN], SCHEMBL763, Sorbit Kyowa Powder 50M, bmse000115, bmse000803, bmse001007, D-SORBITOL [FHFI], Epitope ID:114708, SORBITOL [WHO-DD], Isomalt impurity, sorbitol-, D-Sorbitol, NF/FCC grade, CHEMBL1682, MLS001333209, MLS001333210, SORBITOL [ORANGE BOOK], D-Sorbitol, analytical standard, D-Sorbitol, for electrophoresis, CHEBI:30911, D-Sorbitol, BioXtra, >=98%, D-Sorbitol, for synthesis, 99%, HMS2094K21, HMS2270A18, Pharmakon1600-01300028, HY-B0400, Tox21_201937, Tox21_303388, D-Sorbitol, >=98%, FCC, FG, NSC759608, s2393, AKOS015899604, D-Sorbitol, plant cell culture tested, CCG-229392, DB01638, NSC-759608, Sorbitol 3% in plastic container (TN), NCGC00164353-01, NCGC00164353-02, NCGC00164353-03, NCGC00257447-01, NCGC00259486-01, AC-13186, CS-13177, D-Sorbitol, SAJ first grade, >=97.0%, SBI-0206688.P002, SORBITOL-MANNITOL COMPONENT SORBITOL, D-Sorbitol, for molecular biology, >=98%, D-Sorbitol, BioUltra, >=99.5% (HPLC), D-Sorbitol, SAJ special grade, >=99.0%, D-Sorbitol, Vetec(TM) reagent grade, 97%, NS00121242, S0065, SW220289-1, D-Sorbitol, crystallized, >=99.0% (HPLC), SORBITOL COMPONENT OF SORBITOL-MANNITOL, A15606, C00794, D00096, E70384, AB00919085_06, D-Sorbitol, liquid, tested according to Ph.Eur., EN300-7832133, ISOMALT IMPURITY, SORBITOL- [USP IMPURITY], ISOMALT IMPURITY, SORBITOL-(USP IMPURITY), Q245280, 5-(4-Methoxyphenyl)-1,3-Oxazole-4-CarboxylicAcid, rel-(2R,3R,4R,5S)-hexane-1,2,3,4,5,6-hexol, Sorbitol, European Pharmacopoeia (EP) Reference Standard, 75DE42C3-7C3B-4802-95E0-463F02268BDC, Sorbitol, United States Pharmacopeia (USP) Reference Standard, D-Sorbitol, BioReagent, cell culture tested, plant cell culture tested, Sorbitol, Pharmaceutical Secondary Standard; Certified Reference Material" C6H14O6 FBPFZTCFMRRESA-JGWLITMVSA-N (2R,3R,4R,5S)-hexane-1,2,3,4,5,6-hexol Pharmaxis n.a. No No No No No No PMDBD2001191 S-OSIP108 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001192 SP1 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001193 Spermine Therapeutic Substance Terminated 71-44-3 DB00127 PA164781199 n.a. D0LD9S 1103 1072 NPC95589 "spermine, 71-44-3, musculamine, neuridine, gerontine, Spermin, 4,9-Diaza-1,12-dodecanediamine, N,N''-Bis(3-aminopropyl)-1,4-butanediamine, Spermine, puriss, Diaminopropyltetramethylenediamine, N,N''-Bis(3-aminopropyl)butane-1,4-diamine, 1,4-Butanediamine, N,N''-bis(3-aminopropyl)-, 4,9-Diazadodecamethylenediamine, Gerotine, 1,4-Bis(aminopropyl)butanediamine, 68956-56-9, Spermina, 4,9-Diazadodecane-1,12-diamine, NSC 268508, Actilip sp-91, 1,4-Bis(aminopropyl) butanediamine, N1,N1''-(Butane-1,4-diyl)bis(propane-1,3-diamine), 1,4-Diaminobutane, N,N''-bis(3-aminopropyl)-, BRN 1750791, 1,5,10,14-Tetraazatetradecane, UNII-2FZ7Y3VOQX, 2FZ7Y3VOQX, AI3-26633, EINECS 200-754-2, Spermine free base, NSC-268508, CHEBI:15746, MFCD00008215, NSC 268508; Neuridine, CHEMBL23194, DTXSID9058781, N,N''-Bis(3-aminopropyl)-1,4-diaminobutane, N1,N4-bis(3-aminopropyl)-1,4-butanediamine, diaminopropyl-tetramethylenediamine, 4-04-00-01301 (Beilstein Handbook Reference), NSC268508, 71-44-3 (FREE BASE), (3-aminopropyl)({4-[(3-aminopropyl)amino]butyl})amine, spermidine 3HCl, 1,4-Butanediamine, N1,N4-bis(3-aminopropyl)-, 71052-31-8, SPM, MLS002472980, C10H26N4, Spermina [Italian], SMR001397086, Spermine puriss, EINECS 273-309-3, 4,12-diamine, Spermine, >=97%, Tocris-0958, GEROTINE [INCI], SPERMINE [MI], Lopac-S-2876, Biomol-NT_000213, bmse000117, EC 273-309-3, NCIMech_000206, Spermine, min. 98.0%, Lopac0_001077, SCHEMBL14965, WLN: Z3M4M3Z, GTPL710, Spermine, analytical standard, BPBio1_001086, SPERMINETETRAHYDROCHLORIDE, DTXCID8046872, BDBM79403, cid_5351186, 1, N,N''-bis(3-aminopropyl)-, Spermine, >=99.0% (GC), HY-B1777, CCG-35276, HB0588, HSCI1_000212, s3948, AKOS024258603, DB00127, SB38410, SDCCGSBI-0051047.P003, N1,N4-bis(3-aminopropyl)-butanediamine, NCGC00015941-01, NCGC00015941-02, NCGC00015941-03, NCGC00015941-04, NCGC00015941-05, NCGC00015941-10, NCGC00024902-01, NCGC00024902-02, NCGC00024902-03, AS-35114, BP-21388, NCI60_035280, CS-0013806, N,Na?Bis(3-aminopropyl)-1,4-diaminobutane, NS00014922, Spermine, Vetec(TM) reagent grade, >=97%, N,N''''-bis(3-aminopropyl)butane-1,4-diamine, N1,N4-Bis(3-aminopropyl)butane-1,4-diamine, C00750, EN300-175597, S-7400, Z-1049, A866441, L001114, n1,n1''-(butane-1,4-diyl)dipropane-1,3-diamine, Q424597, N,N''-Bis(3-aminopropyl)-1,4-tetramethylenediamine, Z1269219211, 2B445AED-6284-43E4-82FE-39598858D67F, 3-aminopropyl-[4-(3-aminopropylamino)butyl]amine;hydrochloride, N,N''''''''-bis(3-aminopropyl)butane-1,4-diamine;hydrochloride, N,N''''''''-bis(3-azanylpropyl)butane-1,4-diamine;hydrochloride, Spermine, BioReagent, amorphous semi-solid, suitable for cell culture" C10H26N4 PFNFFQXMRSDOHW-UHFFFAOYSA-N N,N''-bis(3-aminopropyl)butane-1,4-diamine n.a. n.a. No No No No No No PMDBD2001194 S-phenyl-L-cysteine n.a. n.a. n.a. n.a. n.a. n.a. n.a. 119462 n.a. n.a. S-Phenyl-L-cysteine, 34317-61-8, (R)-2-Amino-3-(phenylthio)propanoic acid, H-Cys(phenyl)-OH, beta-Phenylcysteine, S-Phenylcysteine, (2R)-2-amino-3-phenylsulfanylpropanoic acid, MFCD01318758, (2R)-2-ammonio-3-(phenylthio)propanoate, L-Cysteine, S-phenyl-, L-S-phenylcysteine, S-Phenyl-L-cysteine, 97%, CHEMBL63062, SCHEMBL342512, DTXSID20187882, XYUBQWNJDIAEES-QMMMGPOBSA-N, AKOS006281414, AKOS007930134, FD21309, HY-W020826, (R)-2-Amino-3-(phenylthio)propanoicacid, AC-10075, AS-49032, CS-0033656, A822168, J-700245 C9H11NO2S XYUBQWNJDIAEES-QMMMGPOBSA-N (2R)-2-amino-3-phenylsulfanylpropanoic acid n.a. n.a. No No No No No No PMDBD2001195 S-phenyl-L-cysteine sulfoxide Therapeutic Substance Preclinical n.a. n.a. n.a. n.a. DB1U9N 101712556 n.a. n.a. S-phenyl-l-cysteine sulfoxide, (2R)-2-Amino-3-(phenylsulfinyl)propanoic acid, 103000-63-1, starbld0008578, SCHEMBL17894423 C9H11NO3S YIYUCMJLQCHZLS-BVVIDWAXSA-N (2R)-2-amino-3-(benzenesulfinyl)propanoic acid n.a. n.a. No No No No No No PMDBD2001196 S-propyl-L-cysteine n.a. n.a. n.a. n.a. n.a. n.a. n.a. 101975 n.a. NPC255467 L-Cysteine, S-propyl-, 1115-93-1, S-Propyl-L-cysteine, (2R)-2-amino-3-propylsulfanylpropanoic acid, (R)-2-Amino-3-(propylthio)propanoic acid, Propylcysteine #, Alanine, 3-(propylthio)-, L-, s-propyl cysteine, S-(n-Propyl)-L-cysteine, SCHEMBL1157633, DTXSID30912187, CHEBI:192026, WAAGBMYUYFBZIW-YFKPBYRVSA-N, (2R)-2-amino-3-propylsulanylpropanoic acid C6H13NO2S WAAGBMYUYFBZIW-YFKPBYRVSA-N (2R)-2-amino-3-propylsulfanylpropanoic acid n.a. n.a. No No No No No No PMDBD2001197 SQ109 Therapeutic Substance Phase 2 n.a. n.a. n.a. n.a. D0K8DI 5274428 n.a. n.a. SQ109, 502487-67-4, SQ-109, SQ 109, N-Geranyl-N''-(2-adamantyl)ethane-1,2-diamine, NSC 722041, 9AU7XUV31A, N''-(2-adamantyl)-N-[(2E)-3,7-dimethylocta-2,6-dienyl]ethane-1,2-diamine, CHEMBL561057, NSC-722041, N-[(2e)-3,7-Dimethylocta-2,6-Dien-1-Yl]-N''-[(1r,3s,5r,7r)-Tricyclo[3.3.1.1~3,7~]dec-2-Yl]ethane-1,2-Diamine, UNII-9AU7XUV31A, (E)-N1-(ADAMANTAN-2-YL)-N2-(3,7-DIMETHYLOCTA-2,6-DIEN-1-YL)ETHANE-1,2-DIAMINE, N1-((1r,5R,7S)-adamantan-2-yl)-N2-((E)-3,7-dimethylocta-2,6-dien-1-yl)ethane-1,2-diamine, SQ 109 Deuterated, 1,2-ETHANEDIAMINE, N-((2E)-3,7-DIMETHYL-2,6-OCTADIENYL)-N''-TRICYCLO(3.3.1.13,7)DEC-2-YL-, 1,2-Ethanediamine, N-[(2E)-3,7-dimethyl-2,6-octadienyl]-N''-tricyclo[3.3.1.13,7]dec-2-yl-, GTPL7997, SCHEMBL1780846, SCHEMBL1780848, SCHEMBL10050752, SCHEMBL19630696, DTXSID30964540, EX-A764, JFIBVDBTCDTBRH-REZTVBANSA-N, CVA48767, BDBM50388398, NSC722041, AKOS030526825, CS-1188, DB05186, AC-31289, HY-14989, MS-24974, PD062226, PD119643, SQ109, >=98% (HPLC), NS00072436, N-ADAMANTANYL-N''-GERANYL-ETHYLENEDIAMINE, A857589, J-690310, Q7392720, Q27454083, N1-(Adamantan-2-yl)-N2-(3,7-dimethylocta-2,6-dien-1-yl)ethane-1,2-diamine, 1,2-Ethanediamine, N1-((2E)-3,7-dimethyl-2,6-octadien-1-yl)-N2-tricyclo(3.3.1.13,7)dec-2-yl-, N-[(2E)-3,7-dimethyl-2,6-octadienyl]-N ?-tricyclo[3.3.1.13,7]dec-2-yl-1,2-ethanediamine, N-[(2E)-3,7-Dimethyl-2,6-octadienyl]-N inverted exclamation marka-tricyclo[3.3.1.13,7]dec-2-yl-1,2-ethanediamine, N-[(2E)-3,7-Dimethyl-2,6-octadienyl]-N''-tricyclo[3.3.1.1(3,7)]dec-2-yl-1,2-ethanediamine, N1-[(2E)-3,7-Dimethyl-2,6-octadien-1-yl]-N2-tricyclo[3.3.1.13,7]dec-2-yl-1,2-ethanediamine C22H38N2 JFIBVDBTCDTBRH-REZTVBANSA-N N''-(2-adamantyl)-N-[(2E)-3,7-dimethylocta-2,6-dienyl]ethane-1,2-diamine Sequella n.a. No No No No No No PMDBD2001198 Ssp (A4K-A11K) n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001199 Stavudine Therapeutic Substance Approved Drug 3056-17-5 DB00649 PA451494 D00445 D0Z8EX 18283 17270 n.a. "stavudine, 3056-17-5, sanilvudine, Zerit, 2'',3''-Didehydro-3''-deoxythymidine, Stavudinum, Zerit Xr, Estavudina, d4T, BMY-27857, Thymidine, 2'',3''-didehydro-3''-deoxy-, Stavudinum [INN-Latin], Estavudina [INN-Spanish], 3''-Deoxy-2''-thymidinene, 2'',3''-Didehydro-3''-deoxythimidine, ddeThd, 1-((2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione, Dideoxydidehydrothymidine, 3''-Deoxy-2'',3''-didehydrothymidine, BMY 27857, Stavudine (d4T), BO9LE4QFZF, 1-(2,3-Dideoxy-beta-D-glycero-pent-2-enofuranosyl)thymine, Stavudine (dt4), STV, NSC 163661, NSC-759897, Sanilvudine (JAN), DTXSID1023819, CHEBI:63581, CHEMBL991, NSC-163661, Zerut XR, MLS000028546, D-4T, DTXCID803819, 1-[(2R,5S)-5-(HYDROXYMETHYL)-2,5-DIHYDROFURAN-2-YL]-5-METHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE, NSC163661, 1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-5-methylpyrimidine-2,4(1H,3H)-dione, 1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-5-methylpyrimidine-2,4-dione, NCGC00023212-07, SMR000058350, D 4T (nucleoside), SANILVUDINE [JAN], STAVUDINE (MART.), STAVUDINE [MART.], STAVUDINE (USP-RS), STAVUDINE [USP-RS], STAVUDINE (EP MONOGRAPH), STAVUDINE [EP MONOGRAPH], Stavudine [USAN:BAN:INN], STAVUDINE (USP MONOGRAPH), STAVUDINE [USP MONOGRAPH], 1-(2,3-Dideoxy-.beta.-D-glycero-pent-2-enofuranosyl)thymine, D 4T, ddeTyd, 1-(cis-5-(Hydroxymethyl)-2,5-dihydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione, 1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-5-methyl-pyrimidine-2,4-dione, 220020-60-0, CAS-3056-17-5, Zerit(TM), Zerit (TN), HSDB 7338, SR-01000075802, UNII-BO9LE4QFZF, BMY27857, Stavudine (USAN/INN), 2'',3'' Didehydro 3'' deoxythymidine, 3''-deoxythymidin-2''-ene, BRN 0618327, D4T & GM-CSF, Stavudin, 2'',3''-Didehydro-2'',3''-dideoxythmidine, 2''-Thymidinene, 3''-deoxy-, MFCD00132921, Stavudine [USAN:USP:INN:BAN], Stavudine- Bio-X, D4TMBY-27857-3, Didehydrodeoxythymidine, STAVUDINE [INN], STAVUDINE [MI], STAVUDINE [HSDB], STAVUDINE [USAN], Opera_ID_1281, D 1413, cid_5155, STAVUDINE [WHO-DD], STAVUDINE [WHO-IP], 1-((2R,5S)-5-Hydroxymethyl-2,5-dihydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione, 3''''-deoxy-2''''-thymidine, Lopac0_000336, SCHEMBL38661, STAVUDINE [EMA EPAR], cid_18283, MLS000759504, MLS001055348, MLS001077292, MLS001424091, MLS006011922, BIDD:GT0082, 2'',3''-Anhydrothymidine; d4T, STAVUDINE [EP IMPURITY], STAVUDINE [ORANGE BOOK], 1-(2,3-dideoxy-beta-glycero-pent-2-enofuranosyl)thymine, GTPL12678, 1-(2,3-Dideoxy-beta-D-glycero-2-pentenofuranosyl)thymine, STAVUDINUM [WHO-IP LATIN], HMS2051O20, HMS2234C10, HMS3039O05, HMS3259L21, HMS3261C13, HMS3428C07, HMS3714N22, Pharmakon1600-01502339, STAVUDINE (D4T) [VANDF], STAVUDINE (DT4) [VANDF], BCP02952, HY-B0116, Tox21_110886, Tox21_201393, Tox21_300583, Tox21_500336, BDBM50013111, NSC759897, AKOS005622554, Tox21_110886_1, AC-5263, CCG-100902, CS-1872, DB00649, KS-1115, LP00336, NC00152, NC00684, SDCCGSBI-0050324.P002, ZIDOVUDINE IMPURITY A [WHO-IP], 2'''',3''''-didehydro-3''''-deoxythymidine, 3''''-deoxy-2'''',3''''-didehydrothymidine, 3''-Deoxy-2'',3''-didehydro-D-thymidine, NCGC00023212-03, NCGC00023212-04, NCGC00023212-05, NCGC00023212-08, NCGC00023212-09, NCGC00023212-10, NCGC00023212-11, NCGC00023212-12, NCGC00023212-13, NCGC00023212-14, NCGC00023212-25, NCGC00023212-30, NCGC00254372-01, NCGC00258944-01, NCGC00261021-01, Stavudine 100 microg/mL in Acetonitrile, 1-[5-(hydroxymethyl)-2,5-dihydro-2-furanyl]-5-methyl-2,4(1H,3H)-pyrimidinedione & Colony-stimulating factor 2, BD164571, SMR000673569, 2'',3''-didehydro-2'',3''-dideoxythymidine, Thymidine, 2'',3''-didehydro-, 3''-deoxy-, ZIDOVUDINE IMPURITY A [EP IMPURITY], D3580, EU-0100336, NS00002353, 2'''',3''''-dideoxy-2'''',3''''-didehydrothymidine, C07312, D00445, EN300-120634, AB00383018_18, Q423984, J-700246, Q-201742, SR-01000075802-1, SR-01000075802-4, 2'',3''-Didehydro-3''-deoxythymidine, >=98% (TLC), Z1530425068, Stavudine, European Pharmacopoeia (EP) Reference Standard, Stavudine, United States Pharmacopeia (USP) Reference Standard, Thymine, 1-(2,3-dideoxy-beta-D-glycero-pent-2-enofuranosyl)-, 1-(5-Hydroxymethyl-2,5-dihydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione, 1-(5-Hydroxymethyl-2,5-dihydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione (ddeThd), 1-[(2R,5S)-2,5-Dihydro-5-(hydroxymethyl)-2-furanyl]-5-methyl-2,4(1H,3H)-pyrimidinedione, 3''- Azido-3''-deoxythymidine & Granulocyte-macrophage colony-stimulating factor, Stavudine for system suitability, European Pharmacopoeia (EP) Reference Standard, 1-[(2R,5S)-5-(Hydroxymethyl)-2,5-dihydrofuran-2-yl]-5-methylpyrimidine-2,4-(1H,3H)-dione" C10H12N2O4 XNKLLVCARDGLGL-JGVFFNPUSA-N 1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-5-methylpyrimidine-2,4-dione Aurobindo Pharma Anti-HIV Agents No No No No No No PMDBD2001200 Stearic acid Therapeutic Substance Investigational Drug 4/11/1957 DB03193 n.a. D00119 D02WFA 5281 5091 NPC209970 "stearic acid, Octadecanoic acid, 57-11-4, n-Octadecanoic acid, Stearophanic acid, Cetylacetic acid, 1-Heptadecanecarboxylic acid, Pearl stearic, Stearex Beads, Octadecansaeure, Stearinsaeure, Vanicol, Hydrofol Acid 150, Century 1240, Glycon DP, Glycon TP, Industrene R, Stearate, Formula 300, Hydrofol 1895, Hystrene 7018, Hystrene 9718, Glycon S-80, Glycon S-90, octadecoic acid, Tegostearic 254, Tegostearic 255, Tegostearic 272, Hystrene 80, Humko Industrene R, Hydrofol acid 1655, Hydrofol acid 1855, Hystrene S-97, Hystrene T-70, Industrene 5016, Dar-chem 14, Emersol 120, Emersol 132, Hystrene 4516, Hystrene 5016, Groco 54, Groco 55, Groco 55L, Groco 58, Groco 59, Glycon S-70, Industrene 8718, Industrene 9018, Emersol 150, Kam 1000, Barolub FTA, FEMA No. 3035, Acidum stearinicul, C18:0, Caswell No. 801D, Oktadekansaeure, HY-Phi 1199, HY-Phi 1205, HY-Phi 1303, HY-Phi 1401, acide stearique, Kam 2000, Kam 3000, Steric acid, Century 1210, acide octadecanoique, Stearic acid, pure, PD 185, NAA 173, CCRIS 2305, Stearic acid 50, HSDB 2000, Emersol 153NF, Dervacid 3155, Purified stearic acid, Adeka sa 300, Century 1220, Century 1230, Emersol 6349, Hydrofol Acid 150 (VAN), NSC 25956, Lunac S 40, Hydrofol Acid 1895, Prifac 2918, Promulsin, EPA Pesticide Chemical Code 079082, Vis-Plus, AI3-00909, UNII-4ELV7Z65AP, EINECS 200-313-4, n-Octadecylic acid, 4ELV7Z65AP, NSC-25956, Pristerene 4900, Hystrene S 97, Hystrene T 70, Stearic Acid Cherry, Edenor C18, Edenor ST 1, Sunfat 18S, BRN 0608585, Emersol 153, Selosol 920, Stearic acid (TN), Hystrene 9718NF, Kortacid 1895, Lunac 30, CH3-[CH2]16-COOH, DTXSID8021642, Loxiol G 20, CHEBI:28842, Lunac S 20, Lunac S 30, Lunac S 90, Lunac S 90KC, Hystrene 9718NFFG, MFCD00002752, NSC-261168, CHEMBL46403, 17FA, DTXCID301642, EC 200-313-4, 4-02-00-01206 (Beilstein Handbook Reference), NSC25956, FA 18:0, NCGC00091596-02, STEARIC ACID (II), STEARIC ACID [II], 400JB9103-88, A 1760, 68937-76-8, STEARIC ACID (MART.), STEARIC ACID [MART.], STEARIC ACID (USP-RS), STEARIC ACID [USP-RS], CH3-(CH2)16-COOH, Oktadekansaure, Stearicacid, Lunac, STEARIC ACID (EP MONOGRAPH), STEARIC ACID [EP MONOGRAPH], CAS-57-11-4, Isostearic acid EX, Haimaric MKH(R), Prisorine 3501, Prisorine 3502, Prisorine 3508, Emersol 871, Emersol 875, Emery 875D, Emery 871, Unimac 5680, C-Lube 10, Stearic acid [JAN:NF], octadecansaure, Stearinsaure, Stearophanate, Stearex, Tsubaki, n-Octadecanoate, Bassinic acid, Lactaric acid, Talgic acid, Doctor Plus, Edenor htict-n, 1hmr, 1hmt, 4fnn, Kiri stearic acid, Obeo Baby Bubble, Jinhwagwangsu Hair, Lunac YA, Palmitostearic acid, Stearic acid 70, Stearic acid, CP, Sterene 60b, Sterene 60r, EINECS 250-178-0, F 3 (lubricant), Industrene 4518, Jinhwagwangsu Bubble, Nonsoul SK 1, Pristerene 4904, Pristerene 4910, Pristerene 4916, Pristerene 4963, Pristerene 4981, Pristerene 9429, Pristerene 9559, Pristerine 4989, CELOZOLE, fatty acid 18:0, Sterene 460, Industrene 5016K, Radiacid 0427, Edenor ST 20, Serfax MT 90, Stearic acid_ravikumar, Unister NAA 180, Century 1224, NORSOREX AP, Edenor HT-JG 60, Stearic acid (8CI), Stearic acid, puriss., Hyfac 410, Hyfac 420, Hyfac 421, Hyfac 422, Hystrene 7018 FG, Lunac S 50, Lunac S 98, Prifac 5905, 3v2p, 875D, 1-Heptadecanecarboxylate, Industrene 7018 FG, AFCO-Chem B 65, Heptadecanecarboxylic acid, Edenor C 18/98, Octadecanoic acid (9CI), Stearic acid, >=98%, SCHEMBL659, Hystrene 9718 NF FG, bmse000485, STEARIC ACID [MI], Emery 400 (Salt/Mix), NEO-FAT 18S, STEARIC ACID [DSC], STEARIC ACID [JAN], Stearic acid (JP15/NF), Stearic acid (JP17/NF), Emersol 110 (Salt/Mix), STEARIC ACID [FHFI], STEARIC ACID [HSDB], STEARIC ACID [INCI], NOPCOCERA LU 6418, Stearic acid (reagent grade), STEARIC ACID [VANDF], WLN: QV17, STEARIC ACID [WHO-DD], GTPL3377, WO 2, UNII-X33R8U0062, CELLBN FIRST CARE CLEANSER, NAA 180, Nonsoul SN 1 (*Sodium salt*), SNA-2000 (*Sodium salt*), Stearic acid, analytical standard, VLZ 200, S 30C, PURIFIED STEARIC ACID [NF], Stearic acid, reagent grade, 95%, HY-B2219, ZENOL POWERFULX RECOVERYCREAM, Tox21_111154, Tox21_201887, Tox21_300562, BDBM50240485, LMFA01010018, s5733, SA 200, Stearic acid, >=95%, FCC, FG, AKOS005716958, Tox21_111154_1, CCG-267314, DB03193, FA 1655, NSC 261168, X33R8U0062, NCGC00091596-01, NCGC00091596-03, NCGC00091596-04, NCGC00091596-05, NCGC00254456-01, NCGC00259436-01, E570, VS-03242, Stearic acid, puriss., >=98.5% (GC), Stearic acid, SAJ first grade, >=90.0%, CS-0021598, G 270, NS00010335, S 300, S0163, EN300-19730, Stearic acid, SAJ special grade, >=95.0%, Stearic acid, Vetec(TM) reagent grade, 94%, C01530, D00119, EC 250-178-0, F70008, Stearic acid 50, tested according to Ph.Eur., Q209685, SR-01000944717, STEARIC ACID (CONSTITUENT OF SAW PALMETTO), Melting Point Standard 69-71C, analytical standard, SR-01000944717-1, Stearic acid, Grade I, >=98.5% (capillary GC), Stearic acid, SAJ first grade, >=90.0%, powder, F0001-1489, STEARIC ACID (CONSTITUENT OF SAW PALMETTO) [DSC], Stearic acid, certified reference material, TraceCERT(R), Z104474964, CD7993EA-AD14-452A-A907-33376CC98790, Stearic acid, European Pharmacopoeia (EP) Reference Standard, Stearic acid, United States Pharmacopeia (USP) Reference Standard, Stearic Acid, Pharmaceutical Secondary Standard; Certified Reference Material, 18639-67-3, InChI=1/C18H36O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h2-17H2,1H3,(H,19,20" C18H36O2 QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid n.a. n.a. No No No No No No PMDBD2001201 Stilbene n.a. n.a. n.a. n.a. n.a. n.a. n.a. 638088 n.a. NPC36357 trans-Stilbene, 103-30-0, (E)-Stilbene, STILBENE, TRANS-1,2-DIPHENYLETHYLENE, Bibenzal, 1,2-Diphenylethylene, (E)-1,2-Diphenylethene, Bibenzylidene, Bibenzylidine, Stilbene, (E)-, (E)-1,2-Diphenylethylene, 588-59-0, trans-1,2-Diphenylethene, alpha,beta-Diphenylethylene, 1,1''-(1,2-Ethenediyl)dibenzene, Benzene, 1,1''-(1E)-1,2-ethenediylbis-, trans-alpha,beta-Diphenylethylene, TRANS-STILBENE-ALPHA,ALPHA''-D2, 1,1''-(1,2-Ethenediyl)bisbenzene, 5284-44-6, Stilben, 1,2-Diphenylethene, MFCD00064300, Benzene, 1,1''-(1,2-ethenediyl)bis-, (E)-, 1,1''-(E)-ethene-1,2-diyldibenzene, [(E)-2-Phenylethenyl]benzene, 3FA7NW80A0, [(1E)-2-phenylethenyl]benzene, DTXSID4026050, CHEBI:36007, NSC-2069, 1,1''-(1,2-Ethenediyl)bis[benzene], Toluylene, TRANS-STILBENE-D10 (RINGS-D10), Stilben [German], Stilbenes, CCRIS 5933, HSDB 5020, NSC 2069, EINECS 203-098-5, EINECS 209-621-3, UNII-W1WNW14Z2I, .alpha.,.beta.-Diphenylethylene, BRN 1616740, BRN 1904445, UNII-3FA7NW80A0, (E)-1,1''-(1,2-Ethenediyl)bisbenzene, trans stilbene, AI3-52677, E-stilbene, E-1,2-diphenylethene, trans-Stilbene, 96%, STILBENE, TRANS-, 1,trans-2-Diphenylethene, STILBENE TRANS-FORM, 1,trans-2-Diphenylethylene, W1WNW14Z2I, 4-05-00-02160 (Beilstein Handbook Reference), BIDD:ER0266, BIDD:ER0595, ghl.PD_Mitscher_leg0.1238, CHEMBL113028, DTXCID106050, Trans-1,2-Diphenylethene (1), CHEBI:26775, 1,1''-ethene-1,2-diyldibenzene, NSC2069, STILBENE TRANS-FORM [MI], BDBM175262, 1,1''-(ethene-1,2-diyl)dibenzene, Tox21_202726, AKOS002312306, trans-.alpha.,.beta.-Diphenylethylene, NCGC00260274-01, AC-20799, CAS-103-30-0, LS-14271, TRANS-1,2-DIPHENYLETHYLENE [HSDB], 1,1''-[(1E)-ethene-1,2-diyl]dibenzene, Benzene,1''-(1,2-ethenediyl)bis-, (E)-, HY-128793, benzene, 1,1''-[(E)-1,2-ethenediyl]bis-, CS-0144621, NS00023216, S0090, D78253, EN300-100505, EN300-303343, S-8000, A832041, Q306338, InChI=1/C14H12/c1-3-7-13(8-4-1)11-12-14-9-5-2-6-10-14/h1-12H/b12-11 C14H12 PJANXHGTPQOBST-VAWYXSNFSA-N (E)-stilbene n.a. n.a. No No No No No No PMDBD2001202 Streptorubin B n.a. n.a. n.a. n.a. n.a. n.a. n.a. 135515502 n.a. n.a. BMCHP, Streptorubin B, Butyl-meta-cycloheptylprodiginine, 56208-07-2, Cyclonona(b)pyrrole, 4-butyl-1,4,5,6,7,8,9,10-octahydro-2-((3-methoxy-5-(1H-pyrrol-2-yl)-2H-pyrrol-2-ylidene)methyl)-, CHEMBL1812867 C25H33N3O TXFXBRICRNFFRR-JLPGSUDCSA-N 2-butyl-11-[(Z)-[3-methoxy-5-(1H-pyrrol-2-yl)pyrrol-2-ylidene]methyl]-10-azabicyclo[7.2.1]dodeca-1(11),9(12)-diene n.a. n.a. No No No No No No PMDBD2001203 Subtilosin n.a. n.a. n.a. n.a. n.a. n.a. n.a. 44227770 n.a. n.a. Subtilosin C152H226N38O45S3 TXVROFQRFWFJGU-UHFFFAOYSA-N 3-[85-(4-aminobutyl)-88-(2-amino-2-oxoethyl)-3a,19-dibenzyl-13,31,64-tri(butan-2-yl)-22,43-bis(carboxymethyl)-1,73-bis(1-hydroxyethyl)-67-(hydroxymethyl)-94-(1H-indol-3-ylmethyl)-4,10,55,58,76-pentamethyl-6a,49,97-tris(2-methylpropyl)-2a,3,5a,6,8a,9,11a,12,15,18,21,24,30,33,39,42,45,48,51,54,57,60,63,66,69,72,75,78,81,84,87,90,93,96,99-pentatriacontaoxo-46-propan-2-yl-12a,14a,17a-trithia-1a,2,4a,5,7a,8,10a,11,14,17,20,23,29,32,38,41,44,47,50,53,56,59,62,65,68,71,74,77,80,83,86,89,92,95,98-pentatriacontazahexacyclo[68.41.2.219,52.279,103.025,29.034,38]heptadecahectan-16-yl]propanoic acid n.a. n.a. No No No No No No PMDBD2001204 Sucrose Therapeutic Substance Investigational Drug 57-50-1 DB02772 PA451525 D00025 D08TCV 5988 5768 NPC130683 "sucrose, 57-50-1, saccharose, sugar, Table sugar, Cane sugar, White sugar, D-Sucrose, Rohrzucker, Saccharum, Microse, Rock candy, Amerfand, Amerfond, Confectioner''s sugar, D-(+)-Saccharose, Sucrose, pure, sacarosa, D(+)-Sucrose, D-Saccharose, Sucrose, dust, D(+)-Saccharose, Sacharose, D-(+)-Sucrose, beta-D-Fructofuranosyl-alpha-D-glucopyranoside, CCRIS 2120, HSDB 500, Sucraloxum [INN-Latin], CHEBI:17992, beta-D-Fructofuranosyl alpha-D-glucopyranoside, NCI-C56597, (+)-Sucrose, AI3-09085, alpha-D-Glucopyranosyl beta-D-fructofuranoside, Sucrose, purified, (alpha-D-Glucosido)-beta-D-fructofuranoside, EINECS 200-334-9, NSC 406942, Fructofuranoside, alpha-D-glucopyranosyl, beta-D, Glucopyranoside, beta-D-fructofuranosyl, alpha-D, DTXSID2021288, UNII-C151H8M554, GNE-410, S-67F, Glc(alpha1->2beta)Fru, alpha-D-Glucopyranoside, beta-D-fructofuranosyl-, C151H8M554, NSC-406942, DTXCID101288, 1-alpha-D-glucopyranosyl-2-beta-D-fructofuranoside, alpha-D-Glucopyranoside, beta-D-fructofuranosyl, MFCD00006626, beta-D-Fruf-(2<->1)-alpha-D-Glcp, NCGC00164248-01, Sucraloxum, Sucraloxum (INN-Latin), SUCROSE (II), SUCROSE [II], SUCROSE (USP-RS), SUCROSE [USP-RS], (2R,3R,4S,5S,6R)-2-[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol, SUCROSE (EP IMPURITY), SUCROSE [EP IMPURITY], SUCROSE (EP MONOGRAPH), SUCROSE [EP MONOGRAPH], Saccarose, Sucrose [USAN:JAN], Compressible sugar, CAS-57-50-1, (2R,3R,4S,5S,6R)-2-{[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol, 92004-84-7, Sucrose [JAN:NF], Beetsugar, GLC-(1-2)FRU, Frost Sugar, Sucrose,ultrapure, Manalox AS, Sucrose, AR, Sucrose, LR, Sucrose, ultrapure, Sucrose, USP, Sucrose ACS grade, Sucrose (TN), Sugar spheres (NF), Sugar,(S), REFINED SUGAR, Sucrose, ACS reagent, Sucrose, reagent grade, 1af6, SUGAR, WHITE, SUCROSE [VANDF], Sucrose (for injection), SUCROSE [HSDB], SUCROSE [INCI], DYSPEPSIA HEADACHE, Sucrose (JP17/NF), SUCROSE [FCC], SUCROSE [JAN], SUGAR [VANDF], SUCROSE [MI], SUCROSE [NF], Sucrose Biochemical grade, SUCROSE [WHO-DD], Sucrose, SAJ first grade, SACCHARUM OFFICINALE, Sugar, compressible (NF), bmse000119, bmse000804, bmse000918, Epitope ID:153236, Sucrose, >=99.5%, Sucrose, JIS special grade, White soft sugar (JP17), Sucrose, analytical standard, Sucrose, cell culture tested, Sugar, confectioner''s (NF), 1-alpha-D-glucopyranosyl-2-beta-D-fructofranoside, Sucrose, p.a., ACS reagent, CHEMBL253582, GTPL5411, CHEBI:65313, Sucrose, Molecular Biology Grade, Sucrose, >=99.5% (GC), alpha-D-Glc-(1-2)-beta-D-Fru, SACCHARUM OFFICINALE [HPUS], HY-B1779, Tox21_112093, Tox21_201397, Tox21_300410, BDBM50108105, s3598, Sucrose, for electrophoresis, >99%, AKOS024306988, alpha-D-Glc-(1-->2)-beta-D-Fru, Sucrose Palmitic Acid (1:1 Mixture), DB02772, Sucrose, BioXtra, >=99.5% (GC), a-D-Glucopyranosyl A-D-fructofuranoside, b -D-Fructofuranosyl a-D-glucopyranoside, NCGC00164248-02, NCGC00164248-03, NCGC00164248-05, NCGC00254237-01, NCGC00258948-01, D-Saccharose 20000 microg/mL in Water, Sucrose, meets USP testing specifications, Sucrose, Vetec(TM) reagent grade, 99%, D-Saccharose 1000 microg/mL in Methanol, alpha-D-Glucopyranosylbeta-D-fructofuranoside, CS-0013810, S0111, Sucrose, Grade I, plant cell culture tested, Sucrose, Grade II, plant cell culture tested, C00089, D00025, D70407, EN300-126630, Sucrose, for molecular biology, >=99.5% (GC), Sucrose|?-D-Fructofuranosyl ?-D-glucopyranoside, SR-01000883983, Sucrose, NIST(R) SRM(R) 17f, optical rotation, J-519846, Q4027534, SR-01000883983-1, Sucrose, for microbiology, ACS reagent, >=99.0%, alpha-D-glucopyranosyl-(1->2)-beta-D-fructofuranoside, Sucrose, British Pharmacopoeia (BP) Reference Standard, Sucrose, European Pharmacopoeia (EP) Reference Standard, Sucrose, Vetec(TM) reagent grade, RNase and DNase free, Z1589255958, .BETA.-D-FRUCTOFURANOSYL-.ALPHA.-D-GLUCOPYRANOSIDE, beta-D-fructofuranosyl-(2↔1)-alpha-D-glucopyranoside, Sucrose, analytical standard, for enzymatic assay kit SCA20, .ALPHA.-D-GLUCOPYRANOSIDE, .BETA.-D-FRUCTOFURANOSYL-, SUCROSE (CONSTITUENT OF CRANBERRY LIQUID PREPARATION), Sucrose, anhydrous, free-flowing, Redi-Dri(TM), ACS reagent, Sucrose, BioUltra, for molecular biology, >=99.5% (HPLC), Sucrose, United States Pharmacopeia (USP) Reference Standard, Carbon isotopes in sucrose, NIST(R) RM 8542, IAEA-CH-6 sucrose, SUCROSE (CONSTITUENT OF CRANBERRY LIQUID PREPARATION) [DSC], Compressible sugar, United States Pharmacopeia (USP) Reference Standard, Sucrose, puriss., meets analytical specification of Ph. Eur., BP, NF, WURCS=2.0/2,2,1/[ha122h-2b_2-5][a2122h-1a_1-5]/1-2/a2-b1, (2R,3R,4S,5S,6R)-2-(((2S,3S,4S,5R)-3,4-Dihydroxy-2,5-bis(hydroxymethyl)tetrahydrofuran-2-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol, (2R,3R,4S,5S,6R)-2-((2S,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)tetrahydrofuran-2-ylhydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol, (2R,3R,4S,5S,6R)-2-((2S,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)tetrahydrofuran-2-yloxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol, (2R,3R,4S,5S,6R)-2-[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)tetrahydrofuran-2-yl]oxy-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol, 8027-47-2, 8030-20-4, 85456-51-5, 86101-30-6, 87430-66-8, A-5, Sucrose, BioReagent, suitable for cell culture, suitable for insect cell culture, >=99.5% (GC)" C12H22O11 CZMRCDWAGMRECN-UGDNZRGBSA-N (2R,3R,4S,5S,6R)-2-[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol n.a. n.a. No No No No Yes No rxnAGORA1365,rxnAGORA1688,rxnAGORA2314,rxnAGORA2315,rxnAGORA3125 PMDBD2001205 Sulfacetamide Therapeutic Substance Approved Drug 144-80-9 DB00634 PA451536 D05947 D0M4VM 5320 n.a. n.a. "sulfacetamide, 144-80-9, Sulphacetamide, Acetosulfamine, N-((4-Aminophenyl)sulfonyl)acetamide, N-Acetylsulfanilamide, N-Sulfanilylacetamide, Acetosulfamin, Albucid, Urosulfon, N-Sulphanilylacetamide, Sulfacetimide, Acetocid, Sulfacet, Sulfanilacetamide, Formosulfacetamide, Sulphasil, Urosulfone, Albamine, Alesten, Oclucid, Sulamyd, Sulfacyl, Region, Sulfanilazetamid, N-(4-aminophenyl)sulfonylacetamide, p-Aminobenzenesulfonacetamide, Sulfacetamidum, Sulphacetamidum, Steramide, Sebizon, Bleph-10, N-Acetyl-4-aminobenzenesulfonamide, Sulf-10, Ophthel-S, Sulfacetamida, p-Aminobenzenesulfonoacetamide, N''-Acetylsulfanilamide, Bleph-10 liquifilm, N-[(4-Aminophenyl)sulfonyl]acetamide, Isopto cetamide, Solfacetamide, OP-Sulfa 30, Sulfacylum, Klaron, Acetamide, N-sulfanilyl-, N1-Acetylsulfanilamide, N-((p-Aminophenyl)sulfonyl)acetamide, N(sup1)-Acetylsulfanilamide, N-Acetylsulfanilamine, A-500, N-(4-Aminophenylsulfonyl)acetamide, Caswell No. 808A, N(sup 1)-Acetylsulfanilamide, N-(4-Aminobenzenesulfonyl)acetamide, Sulfacel-15, Sulfanilamide, N(sup 1)-acetyl-, Sulfacetamidum [INN-Latin], N(sup 1)-Acetyl-4-aminophenylsulfonamide, SULSTER, Sulfacetamida [INN-Spanish], N-[(p-Aminophenyl)sulfonyl]acetamide, NSC 63871, CCRIS 6273, N(1)-acetylsulfanilamide, Acetamide, N-((4-aminophenyl)sulfonyl)-, Acetamide, N-[(4-aminophenyl)sulfonyl]-, N-(p-Aminobenzenesulfonyl)acetamide, EINECS 205-640-6, NSC-63871, EPA Pesticide Chemical Code 077904, BRN 0981718, FML-S, DTXSID8026060, UNII-4965G3J0F5, CHEBI:63845, AI3-26837, MFCD00066501, N(1)-acetyl-4-aminophenylsulfonamide, CHEMBL455, 4965G3J0F5, Triple sulfa (sulfacetamide), MLS000069710, DTXCID406060, Sulfacetamide [USP:INN:BAN], 4-14-00-02662 (Beilstein Handbook Reference), N-acetyl-4-amino-benzenesulfonamide, TRYSUL COMPONENT SULFACETAMIDE, SULTRIN COMPONENT SULFACETAMIDE, VAGILIA COMPONENT SULFACETAMIDE, Sulfacyl (VAN), GYNE-SULF COMPONENT SULFACETAMIDE, SULFACETAMIDE COMPONENT OF TRYSUL, NCGC00018242-04, NCGC00018242-07, SMR000058173, SULFACETAMIDE COMPONENT OF SULTRIN, SULFACETAMIDE COMPONENT OF VAGILIA, SULFACETAMIDE COMPONENT OF GYNE-SULF, NSC63871, Solfacetamide [DCIT], Sulfacetamide 100 microg/mL in Acetonitrile, Sulfacetamidum (INN-Latin), Sulfanilazetamid [German], Sulfacetamida (INN-Spanish), SULFACETAMIDE (MART.), SULFACETAMIDE [MART.], Sulfacetamide (USP:INN:BAN), SULFACETAMIDE (USP IMPURITY), SULFACETAMIDE [USP IMPURITY], CAS-144-80-9, SULFADIMIDINE IMPURITY E (EP IMPURITY), SULFADIMIDINE IMPURITY E [EP IMPURITY], Sulfacetamide (USP/INN), Sulfacetamid, Sulfacetamide, 1, N-[(4-Aminophenyl)sulfonyl]acetamide; Sulfacetamide; Sulfadimidine Imp. E (Pharmeuropa); Sulfadimidine Impurity E, CETAPRED, PREDAMIDE, Spectrum_000984, Opera_ID_1990, Prestwick0_000014, Prestwick1_000014, Prestwick2_000014, Prestwick3_000014, Spectrum2_001318, Spectrum3_001017, Spectrum4_001146, Spectrum5_001230, WLN: ZR DSWMV1, SULFACETAMIDE [MI], CBChromo1_000180, Sulfanilamide, N1-acetyl-, 4-acetylaminosulfonylaniline, SULFACETAMIDE [INN], NCIOpen2_002838, Sulfacetamide, >=98.0%, Oprea1_686524, Oprea1_810285, SCHEMBL40863, BSPBio_000047, BSPBio_002773, CBDivE_013934, KBioGR_001691, KBioSS_001464, SULFACETAMIDE [VANDF], MLS001076499, DivK1c_000227, SPECTRUM1500545, SPBio_001415, SPBio_001968, SULFACETAMIDE [WHO-DD], SULFACETAMIDE [WHO-IP], BPBio1_000053, GTPL12633, HMS500L09, KBio1_000227, KBio2_001464, KBio2_004032, KBio2_006600, KBio3_001993, 4-[(acetylamino)sulfonyl]aniline, D10AF06, S01AB04, NINDS_000227, 4-[(acetylamino) sulfonyl]aniline, HMS1921A11, HMS2092I13, HMS2232K07, HMS3259G06, HMS3374O02, Pharmakon1600-01500545, SULFACETAMIDE [ORANGE BOOK], Sulfacetamide, >=98.0% (NT), HY-N7123, SULFACETAMIDE (TRIPLE SULFA), Tox21_110846, Tox21_201999, Tox21_303100, AC2473, BDBM50316126, CCG-39256, NSC757323, s5546, 4-(ACETYLAMINOSULFONYL)ANILINE, SULFACETAMIDUM [WHO-IP LATIN], AKOS000119729, N-[(4-aminobenzene)sulfonyl]acetamide, Tox21_110846_1, AC-7630, DB00634, KS-5327, NC00538, NSC-757323, IDI1_000227, NCGC00018242-01, NCGC00018242-02, NCGC00018242-03, NCGC00018242-05, NCGC00018242-06, NCGC00018242-08, NCGC00021857-03, NCGC00021857-04, NCGC00021857-05, NCGC00257159-01, NCGC00259548-01, N-(P-AMINOPHENYLSULFONYL)ACETAMIDE, SY014752, SBI-0051519.P003, CS-0013812, NS00010528, S0577, EN300-18138, D05947, AB00052094_14, N-ACETYL-4-AMINOBENZENESULFONIC ACID AMIDE, SR-01000000194, Sulfacetamide, VETRANAL(TM), analytical standard, TRIPLE SULFA (SULFACETAMIDE) [ORANGE BOOK], Q-201757, Q2022983, SR-01000000194-2, Sulfacetamide, Antibiotic for Culture Media Use Only, BRD-K21520694-001-12-3, N-((4-AMINOPHENYL)SULFONYL)ACETAMIDE [WHO-IP], Z57202572, Sulfacetamide, United States Pharmacopeia (USP) Reference Standard" C8H10N2O3S SKIVFJLNDNKQPD-UHFFFAOYSA-N N-(4-aminophenyl)sulfonylacetamide n.a. Antibiotics No No No No No No PMDBD2001206 Sulfacytine Therapeutic Substance Approved Drug 17784-12-2 DB01298 PA164754808 n.a. D0T1GT 5322 5131 n.a. "sulfacytine, 17784-12-2, Sulfacitine, Renoquid, 1-Ethyl-N-sulfanilylcytosine, 1-Ethyl N4-sulfanilylcytosin, CI-636, Sulfacitinum, Sulfacitina, Sulfacitinum [INN-Latin], Sulfacitina [INN-Spanish], Nl-sulfanilyl-1-ethylcytosine, N-Sulfanilyl-l-ethylcytosine, N-Sulfanilyl-1-ethylcytosine, NSC 356717, HSDB 3272, CI 636, CL 636, 4-amino-N-(1-ethyl-2-oxopyrimidin-4-yl)benzenesulfonamide, NSC-356717, Sulfacitine [INN], UNII-T795873AJP, Sulfacytine (USAN), Renoquid; Sulfacitine, 1401-49-6, DTXSID6023606, Sulfanilamide, N1-(1-ethyl-1,2-dihydro-2-oxo-4-pyrimidinyl)-, N(sup 1)-(1-Ethyl-1,2-dihydro-2-oxo-4-pyrimidinyl)sulfanilamide, T795873AJP, Benzenesulfonamide, 4-amino-N-(1-ethyl-1,2-dihydro-2-oxo-4-pyrimidinyl)-, 4-amino-N-(1-ethyl-2-oxo-1,2-dihydropyrimidin-4-yl)benzenesulfonamide, DTXCID903606, Sulfanilamide, N(1)-(1-ethyl-1,2-dihydro-2-oxo-4-pyrimidinyl)-, NSC356717, Sulfacitinum (INN-Latin), SULFACYTINE [USAN], Sulfacitina (INN-Spanish), SULFACYTINE (MART.), SULFACYTINE [MART.], 4-amino-N-(1-ethyl-2-oxo-1,2-dihydropyrimidin-4-yl)benzene-1-sulfonamide, Benzenesulfonamide,4-amino-N-(1-ethyl-1,2-dihydro-2-oxo-4-pyrimidinyl)-, Renoquid (TN), Sulfactin (antibiotic), Sulfacytine [USAN:INN:BAN], starbld0009659, SULFACYTINE [MI], SULFACYTINE [HSDB], SULFACYTINE [VANDF], SCHEMBL49377, SULFACITINE [WHO-DD], CHEMBL1201056, SULFACYTINE [ORANGE BOOK], CHEBI:135230, SIBQAECNSSQUOD-UHFFFAOYSA-N, N(sup1)-(1-Ethyl-1,2-dihydro-2-oxo-4-pyrimidinyl)sulfanilamide, Tox21_113734, AKOS040754107, DB01298, NCGC00253598-01, HY-16472, CAS-17784-12-2, CS-0006353, NS00011875, D02519, G12151, Sulfanilamide,2-dihydro-2-oxo-4-pyrimidinyl)-, EN300-18536155, Benzenesulfonamide,2-dihydro-2-oxo-4-pyrimidinyl)-, Q7636169, N1-(1-Ethyl-1,2-dihydro-2-oxo-4-pyrimidinyl)sulfanilamide, N(1)-(1-ethyl-1,2-dihydro-2-oxo-4-pyrimidinyl)sulfanilamide, 4-Amino-N-(1-ethyl-2-oxo-1,2-dihydro-4-pyrimidinyl)benzenesulfonamide #" C12H14N4O3S SIBQAECNSSQUOD-UHFFFAOYSA-N 4-amino-N-(1-ethyl-2-oxopyrimidin-4-yl)benzenesulfonamide n.a. Antiinfective Agents No No No No No No PMDBD2001207 Sulfadiazine? n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001208 Sulfadoxine Therapeutic Substance Approved Drug 2447-57-6 DB01299 PA451540 D00580 D07PAO 17134 16218 n.a. "SULFADOXINE, 2447-57-6, Sulphadoxine, Sulforthomidine, 4-amino-N-(5,6-dimethoxypyrimidin-4-yl)benzenesulfonamide, Sulfadoxin, Fanasil, Sulphormethoxine, Sulfadoxinum, Sulfadoxina, Fanzil, Ro 4-4393, Benzenesulfonamide, 4-amino-N-(5,6-dimethoxy-4-pyrimidinyl)-, 4-Amino-N-(5,6-dimethoxy-4-pyrimidinyl)benzenesulfonamide, 4-Sulfanilamido-5,6-dimethoxypyrimidine, Sulfadoxine-d3, Fanasulf, Sulfadoxine (Sulphadoxine), N''-(5,6-Dimethoxy-4-pyrimidyl)sulfanilamide, 6-(4-Aminobenzenesulfonamido)-4,5-dimethoxypyrimidine, 4-amino-N-(5,6-dimethoxypyrimidin-4-yl)benzene-1-sulfonamide, MFCD00792890, NSC-759319, Ro-4-4393, CHEBI:9329, Solfadossina, DTXSID6023608, Ro-44393, 88463U4SM5, WR-4073, NCGC00016612-01, Orthosulfin, J21.373J, CAS-2447-57-6, Solfadossina [DCIT], Sulfadoxinum [INN-Latin], Sulfadoxina [INN-Spanish], DTXCID703608, 4-amino-N-[5,6-bis(methyloxy)pyrimidin-4-yl]benzenesulfonamide, WR 4873, SR-05000001523, EINECS 219-504-9, N1-(5,6-Dimethoxy-4-pyrimidinyl)sulfanilamide, BRN 0625453, Sulfadoxine (JAN/USP/INN), UNII-88463U4SM5, Sanasil: Sulfadoxine: Sulformetoxin, N(sup 1)-(5,6-Dimethoxy-4-pyrimidinyl)sulfanilamide, 1173021-35-6, WR 4073, Sulfadoxine [USAN:USP:INN:BAN:JAN], SULFADOXINE [MI], Prestwick0_001094, Prestwick1_001094, Prestwick2_001094, Prestwick3_001094, SULFADOXINE [INN], SULFADOXINE [JAN], SULFADOXINE [USAN], SULFADOXINE [VANDF], CHEMBL1539, SULFADOXINE [MART.], SCHEMBL41069, BSPBio_001168, SULFADOXINE [USP-RS], SULFADOXINE [WHO-DD], SULFADOXINE [WHO-IP], 5-25-13-00306 (Beilstein Handbook Reference), MLS002154150, SPBio_003054, BPBio1_001286, Sulfadoxin, >=95% (TLC), GTPL10173, SULFADOXINE [ORANGE BOOK], HMS1571K10, HMS2090P07, HMS2094C19, HMS2098K10, HMS2230E05, HMS3371I15, HMS3715K10, Pharmakon1600-01506086, SULFADOXINE [EP MONOGRAPH], SULFADOXINE [USP MONOGRAPH], HY-B0439, SULFADOXINUM [WHO-IP LATIN], Tox21_110523, FANSIDAR COMPONENT SULFADOXINE, NSC759319, s2511, AKOS015897281, Tox21_110523_1, AC-8428, CCG-213610, DB01299, KS-5334, NSC 759319, SULFADOXINE COMPONENT OF FANSIDAR, NCGC00016612-02, NCGC00016612-04, NCGC00016612-05, SMR000857259, SY045794, SBI-0206941.P001, Sulfadoxin 1000 microg/mL in Acetonitrile, AB00514044, N1-5,6-Dimethoxy-4-pyrimidinylsulfanilamide, NS00008538, C07630, D00580, EN300-118712, H10765, Sulfadoxin, VETRANAL(TM), analytical standard, AB00514044-06, AB00514044_07, AB00514044_08, A817328, Q411557, SR-05000001523-1, SR-05000001523-3, W-107313, BRD-K55250441-001-03-1, BRD-K55250441-001-06-4, Sulfadoxin, certified reference material, TraceCERT(R), Z1515385080, 4-Amino-N-(5,6-dimethoxy-4-pyrimidinyl)benzenesulfonamide;, 4-azanyl-N-(5,6-dimethoxypyrimidin-4-yl)benzenesulfonamide, Sulfadoxine, European Pharmacopoeia (EP) Reference Standard, Sulfadoxine, United States Pharmacopeia (USP) Reference Standard" C12H14N4O4S PJSFRIWCGOHTNF-UHFFFAOYSA-N 4-amino-N-(5,6-dimethoxypyrimidin-4-yl)benzenesulfonamide n.a. n.a. No No No No No No PMDBD2001209 Sulfalene Therapeutic Substance Withdrawn from market n.a. n.a. n.a. n.a. D0F0OK 9047 n.a. n.a. "SULFALENE, 152-47-6, Sulfamethoxypyrazine, Sulfametopyrazine, Sulfamethopyrazine, Sulfalen, 4-amino-N-(3-methoxypyrazin-2-yl)benzenesulfonamide, Kelfizine, Sulfapyrazinemethoxine, Sulfapyrazinemethoxyne, Kelfizin, Kelfizina, Dalysep, Sulfapyrazinemethoxyine, Kelfizine W, SMP2, 3-Methoxy-2-sulfapyrazine, 2-Sulfanilamido-3-methoxypyrazine, 3-Methoxy-2-sulfanilamidopyrazine, Farmitalia 204/122, 3-Methoxypyrazine sulfanilamide, 2-Methoxy-3-sulfanilamidopyrazine, NSC-110433, N1-(3-Methoxypyrazinyl)sulfanilamide, Benzenesulfonamide, 4-amino-N-(3-methoxypyrazinyl)-, 2-(p-Aminobenzenesulfanamide)-3-methoxypyrazine, 2-(p-Aminobenzenesulfonamido)-3-methoxypyrazine, AS 18908, F.I. 5978, Pyrazine, 2-sulfanilamido-3-methoxy-, 4-Amino-N-(3-methoxypyrazinyl)benzenesulfonamide, AS-18908, N1-(3-Methoxy-2-pyrazinyl)sulfanilamide, N(sup1)-(3-Methoxypyrazinyl)sulfanilamide, N(sup 1)-(3-Methoxypyrazinyl)sulfanilamide, 4-Amino-N-(3-methoxy-2-pyrazinyl)-benzenesulfonamide, Sulfalene(SMPZ), N(sup1)-(3-Methoxy-2-pyrazinyl)sulfanilamide, Sulfalene (USAN), N(sup 1)-(3-Methoxy-2-pyrazinyl)sulfanilamide, Sulfanilamide, N''-(3-methoxypyrazinyl)-, Sulfanilamide, N1-(3-methoxypyrazinyl)-, Sulfamethopyrazine (JAN), Sulfanilamide, N(sup 1)-(3-methoxypyrazinyl)-, Sulfanilamide, N(sup 1)-(3-methoxy-2-pyrazinyl)-, T6BL4ZC15G, Sulfametopyrazine;AS-18908, Sulfalenum, DTXSID2046179, CHEBI:32162, Solfametopirazina, NSC110433, Sulfalene [USAN:INN], 4-amino-N-(3-methoxypyrazin-2-yl)benzene-1-sulfonamide, Sulfalenum [INN-Latin], Solfametopirazina [DCIT], Sulfaleno [INN-Spanish], NCGC00160482-01, Sulfaleno, SULFALENE [USAN], Sulfametoxypyridazin, 2-Sulfanilamide 3-methoxy-pyrazine, SULFAMETHOPYRAZINE [JAN], 4-Amino-N-(3-methoxy-pyrazin-2-yl)-benzenesulfonamide, DTXCID0026179, Kelfizina (TN), CAS-152-47-6, SMR000011031, FI 5978, WR 4629, EINECS 205-804-7, CBMicro_013257, UNII-T6BL4ZC15G, NSC 110433, BRN 0622512, Vetkelfizina, Policydal, N-(3-Methoxypyrazin-2-yl)sulfanilamide, SULFALENE [INN], SULFALENE [MI], SULFALENE [WHO-DD], Oprea1_010520, SCHEMBL28404, 4-Amino-N-(3-methoxypyrazinyl)-benzenesulfonamide, 5-25-12-00574 (Beilstein Handbook Reference), MLS001304101, MLS001304170, Butadiene sulfone;3-Sulfolene, 4-Amino-N-(3-methoxypyrazin-2-yl);benzenesulfonamide, CHEMBL1525826, GTPL10174, SULFAMETOPYRAZINE [MART.], HMS2866D06, HMS3604L11, BCP30869, HY-A0130, SMSF0004129, Tox21_111844, WLN: T6N DNJ BO1 CMSWR DZ, AC-750, MFCD00437754, s4976, AKOS000538590, Tox21_111844_1, CB03172, CCG-112228, CS-8165, DB00664, KS-5333, NCGC00160482-02, Sulfalene 100 microg/mL in Acetonitrile, BIM-0013167.P001, NS00003478, Sulfanilamide, N1-(3-methoxy-2-pyrazinyl)-, A11687, D01216, EN300-124886, Sulfalene Sulfamethoxypyrazine Sulfametopyrazine, A809315, SR-01000817374, Q-201763, Q6577302, SR-01000817374-3, Z277559098, 4-amino-N-(3-methoxypyrazin-2-yl)benzenesulfonamide;Sulfalene, Sulfametopyrazine; AS-18908; Sulfalene; Sulfaleno;Sulfamethoxypyrazine, 5175-55-3" C11H12N4O3S KXRZBTAEDBELFD-UHFFFAOYSA-N 4-amino-N-(3-methoxypyrazin-2-yl)benzenesulfonamide n.a. Antiinfective Agents No No No No No No PMDBD2001210 Sulfamerazine Therapeutic Substance Approved Drug 127-79-7 DB01581 PA164776842 D02435 D0H1GJ 5325 5134 n.a. "sulfamerazine, 127-79-7, Sulphamerazine, Sulfamethyldiazine, Sulfamerazin, Methylsulfazine, Cremomerazine, Sulfameradine, Metilsulfadiazin, Kelamerazine, Methylpyrimal, Metilsulfazin, Sulfamerazina, Sulfamerazinum, Percoccide, Pyralcid, Septacil, Septosyl, Solumedin, Sumedine, Mebacid, Mesulfa, Romezin, 2-Sulfa-4-methylpyrimidine, Veta-Merazine, 4-amino-N-(4-methylpyrimidin-2-yl)benzenesulfonamide, Debenal-M, Pirimal-M, Pyrimal M, Methylsulfazin, Solfamerazina, N-(4-Methyl-2-pyrimidyl)sulfanilamide, Benzenesulfonamide, 4-amino-N-(4-methyl-2-pyrimidinyl)-, 2-(Sulfanilamido)-4-methylpyrimidine, 2-(4-Aminobenzenesulfonamido)-4-methylpyrimidine, 4-Amino-N-(4-methyl-2-pyrimidinyl)-benzenesulfonamide, 2643-RP, RP 2632, (p-Aminobenzolsulfonyl)-2-amino-4-methylpyrimidin, A-310, 2-Sulfanilamido-4-methylpyrimidine, Sulfamerazinum [INN-Latin], N1-(4-Methyl-2-pyrimidinyl)sulfanilamide, Sulfamerazina [INN-Spanish], NSC 27259, Sulfanilamide, N1-(4-methyl-2-pyrimidinyl)-, CHEBI:102130, UNII-UR1SAB295F, 2632 R. P., EINECS 204-866-2, N(1)-(4-Methyl-2-pyrimidinyl)sulfanilamide, UR1SAB295F, NSC-27259, RP2632, Solumedine, 2-(p-Aminobenzolsulfonamido)-4-methylpyrimidine, BRN 0249133, N(sup 1)-(4-Methyl-2-pyrimidinyl)sulfanilamide, Sulfamerazine-13C6, Sulfamerazine (INN), DTXSID0023612, 4-Amino-N-(4-methyl-2-pyrimidinyl)benzenesulfonamide, AI3-08026, Sulfanilamide, N(sup 1)-(4-methyl-2-pyrimidinyl)-, MLS000551747, 4-amino-N-(4-methylpyrimidin-2-yl)benzene-1-sulfonamide, DTXCID603612, Sulfamerazine [USP:INN:BAN], 5-25-10-00167 (Beilstein Handbook Reference), MFCD00023212, SULFOSE COMPONENT SULFAMERAZINE, TERFONYL COMPONENT SULFAMERAZINE, LANTRISUL COMPONENT SULFAMERAZINE, SULFALOID COMPONENT SULFAMERAZINE, NCGC00016386-01, NEOTRIZINE COMPONENT SULFAMERAZINE, CAS-127-79-7, SMR000145672, SULFAMERAZINE COMPONENT OF SULFOSE, SULFAMERAZINE COMPONENT OF TERFONYL, SULFAMERAZINE COMPONENT OF LANTRISUL, SULFAMERAZINE COMPONENT OF SULFALOID, Solfamerazina [DCIT], SULFAMERAZINE COMPONENT OF NEOTRIZINE, Sulfamerazine 100 microg/mL in Acetonitrile, TRIPLE SULFOID COMPONENT SULFAMERAZINE, SULFAMERAZINE [INN], SULFAMERAZINE COMPONENT OF TRIPLE SULFOID, Sulfamerazinum (INN-Latin), Sulfamerazina (INN-Spanish), SULFAMERAZINE (MART.), SULFAMERAZINE [MART.], SULFAMERAZINE (USP-RS), SULFAMERAZINE [USP-RS], Sulfamerazine (USP:INN:BAN), 4-Amino-N-(4-methyl-pyrimidin-2-yl)-benzenesulfonamide, SULFAMERAZINE (EP MONOGRAPH), SULFAMERAZINE [EP MONOGRAPH], 4-amino-N-(4-methylpyrimidin-2-yl), SULFADIMIDINE IMPURITY A (EP IMPURITY), SULFADIMIDINE IMPURITY A [EP IMPURITY], SR-01000684857, ulfamerazine, (p-Aminobenzolsulfonyl)-2-amino-4-methylpyrimidin [German], Prestwick_17, 4-Amino-N-(4-methyl-2-pyrimidyl)benzenesulfonamide; Sulfamerazine; Sulfadimidine Imp. A (Pharmeuropa); Sulfadimidine Impurity A, Monomethylsulfadiazine, Spectrum_000003, N1-(4-Methylpyrimidin-2-yl)sulfanilamide, Opera_ID_988, Prestwick0_000694, Prestwick1_000694, Prestwick2_000694, Prestwick3_000694, Spectrum2_001320, Spectrum3_001363, Spectrum4_000343, Spectrum5_001413, 2(p-Aminobenzolsulfonamido)-4-methylpyrimidin, SULFAMERAZINE [MI], CHEMBL438, Epitope ID:122236, N(sup1)-(4-Methyl-2-pyrimidinyl)sulfanilamide, SCHEMBL33999, BSPBio_000847, BSPBio_002886, KBioGR_000745, KBioSS_000343, SULFAMERAZINE [VANDF], MLS001201765, DivK1c_000563, SPECTRUM1500547, SPBio_001419, SPBio_002768, SULFAMERAZINE [WHO-DD], SULFAMERAZINE FISH GRADE, BPBio1_000933, GTPL12640, HMS501M05, KBio1_000563, KBio2_000343, KBio2_002911, KBio2_005479, KBio3_002106, NINDS_000563, HMS1570K09, HMS1921A15, HMS2092I17, HMS2097K09, HMS2234D16, HMS3374K04, HMS3652I03, HMS3714K09, Pharmakon1600-01500547, SULFAMERAZINE [GREEN BOOK], SULFAMERAZINE [ORANGE BOOK], AMY23374, HY-B0512, NSC27259, Tox21_110411, CCG-39258, NSC757325, s3132, AKOS005143010, Tox21_110411_1, DB01581, KS-5323, NSC-757325, IDI1_000563, NCGC00016386-02, NCGC00016386-03, NCGC00016386-06, NCGC00094787-01, NCGC00094787-02, N''-(4-Methyl-2-pyrimidyl) sulfanilamide, SULFAMERAZINE (TRISULFAPYRIMIDINES), TRISULFAPYRIMIDINES (SULFAMERAZINE), SBI-0051521.P003, Sulfamerazine, ReagentPlus(R), >=99.0%, AB00052096, NS00000004, SW196334-3, Sulfamerazine 1000 microg/mL in Acetonitrile, Sulfamerazine, Vetec(TM) reagent grade, 98%, 2-(p-Aminobenzosulfonamido)-4-methylpyrimidine, D02435, D84140, EN300-202655, AB00052096-13, AB00052096_15, AB00052096_16, A805747, Q415196, Sulfamerazine, VETRANAL(TM), analytical standard, Q-201761, SR-01000684857-2, SR-01000684857-4, BRD-K93524252-001-05-6, BRD-K93524252-001-15-5, F2190-0484, N(SUP 1)-(4-METHYL-2- PYRIMIDINYL)SULFANILAMIDE, TRISULFAPYRIMIDINES (SULFAMERAZINE) [ORANGE BOOK], Z1954804578, Sulfamerazine, European Pharmacopoeia (EP) Reference Standard, Sulfamerazine, United States Pharmacopeia (USP) Reference Standard, Sulfamerazine, Pharmaceutical Secondary Standard; Certified Reference Material" C11H12N4O2S QPPBRPIAZZHUNT-UHFFFAOYSA-N 4-amino-N-(4-methylpyrimidin-2-yl)benzenesulfonamide n.a. Antiinfective Agents No No No No No No PMDBD2001211 Sulfamethazine Therapeutic Substance Approved Drug 57-68-1 DB01582 PA451542 n.a. D0V9YR 5327 5136 n.a. "sulfamethazine, Sulfadimidine, 57-68-1, Sulfadimerazine, Sulfamezathine, Sulphamethazine, Sulfadimethyldiazine, Sulfadimethylpyrimidine, 4-amino-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide, Sulfadimezine, Sulphadimidine, Sulphamezathine, Sulfamethiazine, Sulphadimethylpyrimidine, Sulphamethasine, Sulfadimesin, Sulfadimesine, Sulfadimezin, Sulfadimidin, Sulfadimidinum, Sulfadine, Sulfametazyny, Sulphamidine, Sulphodimezine, Cremomethazine, Kelametazine, Sulfadimidina, Sulfametazina, Sulfodimesin, Sulfodimezine, Azolmetazin, Dimezathine, Pirmazin, Spanbolet, Superseptil, Superseptyl, Vertolan, Diazil, Mermeth, Neasina, Neazina, Sulfa-Isodimerazine, Intradine, Diazyl, Calfspan Tablets, Dimidin-R, Hava-Span, 4,6-Dimethyl-2-sulfanilamidopyrimidine, Sa III, Sulfamidine, SulfaSURE SR Bolus, 2-Sulfanilamido-4,6-dimethylpyrimidine, 4-Amino-N-(4,6-dimethyl-2-pyrimidinyl)benzenesulfonamide, Primazin, N-(4,6-Dimethyl-2-pyrimidyl)sulfanilamide, 4,6-Dimethylsulfadiazine, 2-(p-Aminobenzenesulfonamido)-4,6-dimethylpyrimidine, Diazil (the sulfanilamide), Sulmet, A-502, NCI-C56600, Benzenesulfonamide, 4-amino-N-(4,6-dimethyl-2-pyrimidinyl)-, 6-(4''-Aminobenzol-sulfonamido)-2,4-dimethylpyrimidin, N(1)-(4,6-Dimethyl-2-pyrimidyl)sulfanilamide, N(1)-(4,6-Dimethyl-2-pyrimidinyl)sulfanilamide, 4-Amino-N-(2,6-dimethyl-4-pyrimidinyl)benzenesulfonamide, sulfamethazone, Diazilsulfadine, Calfspan, (p-Aminobenzolsulfonyl)-2-amino-4,6-dimethylpyrimidin, BN 2409, Sulka k boluses, CHEBI:102265, S-Dimidine, N(sup 1)-(4,6-Dimethyl-2-pyrimidinyl)sulfanilamide, 2-(4-Aminobenzenesulfonamido)-4,6-dimethylpyrimidine, Sulfadimidine;Sulfadimerazine, NSC-67457, NSC-683529, Sulfadimidine (INN), DTXSID6021290, Sulfamethazine (USP), Sulfamethazine [USP], Sulfadimezinum, 4-Amino-N-(4,6-dimethyl-pyrimidin-2-yl)-benzenesulfonamide, 4-amino-N-(4,6-dimethylpyrimidin-2-yl)benzene-1-sulfonamide, MFCD00006066, 48U51W007F, BN-2409, N(Sup1)-(4,6-Dimethyl-2-pyrimidinyl)sulfanilamide, Sulfanilamide, N(sup1)-(4,6-dimethyl-2-pyrimidinyl)-, MLS000069711, DTXCID201290, Solfadimidina, n(sup1)-(2,6-Dimethylpyrimid-4-yl)sulfanilamide, N(Sup1)-(4,6-Dimethyl-2-pyrimidyl)sulfanilamide, NSC67457, Sulfanilamide, N1-(4,6-dimethyl-2-pyrimidinyl)-, Sulka S Boluses, NSC683529, SULFOSE COMPONENT SULFAMETHAZINE, SMZ, TERFONYL COMPONENT SULFAMETHAZINE, LANTRISUL COMPONENT SULFAMETHAZINE, NCGC00018243-07, SULFALOID COMPONENT SULFAMETHAZINE, NEOTRIZINE COMPONENT SULFAMETHAZINE, SMR000017409, SULFAMETHAZINE COMPONENT OF SULFOSE, SULFAMETHAZINE COMPONENT OF TERFONYL, TRISULFAPYRIMIDINES (SULFAMETHAZINE), Solfadimidina [DCIT], SULFAMETHAZINE COMPONENT OF LANTRISUL, SULFAMETHAZINE COMPONENT OF SULFALOID, N1-(4,6-Dimethyl-2-pyrimidyl)sulfanilamide, Sulfametazyny [Polish], SULFAMETHAZINE COMPONENT OF NEOTRIZINE, Sulfamethazine 100 microg/mL in Acetonitrile, TRIPLE SULFOID COMPONENT SULFAMETHAZINE, N1-(4,6-Dimethyl-2-pyrimidinyl)sulfanilamide, SULFADIMIDINE [INN], SULFAMETHAZINE COMPONENT OF TRIPLE SULFOID, SULFAMETHAZINE (IARC), SULFAMETHAZINE [IARC], SULFADIMIDINE (MART.), SULFADIMIDINE [MART.], Sulfadimidinum [INN-Latin], Sulfadimidina [INN-Spanish], SULFAMETHAZINE (USP-RS), SULFAMETHAZINE [USP-RS], Sulfametazina [Italian], SULFADIMIDINE (EP IMPURITY), SULFADIMIDINE [EP IMPURITY], HSDB 4157, SULFADIMIDINE (EP MONOGRAPH), SULFADIMIDINE [EP MONOGRAPH], 4-Amino-N-(4,6-dimethyl-pyrimidin-2-yl)-benzene-13C6-sulfon-amide, SULFAMETHAZINE (USP MONOGRAPH), SULFAMETHAZINE [USP MONOGRAPH], Sulfadimidine [INN:BAN], CAS-57-68-1, CCRIS 3701, Sulfamezathine (TN), EINECS 200-346-4, NSC 67457, BRN 0261304, N(sup 1)-(4,6-Dimethyl-2-pyrimidyl)sulfanilamide, ulfamethazine, Panazin, AI3-26817, Sulmet Oblets, Dimidim-R, UNII-48U51W007F, Sustain III, Sulka-S Bolus, (p-Aminobenzolsulfonyl)-2-amino-4,6-dimethylpyrimidin [German], 6-(4''-Aminobenzol-sulfonamido)-2,4-dimethylpyrimidin [German], Supra Sulfa III, Sustain III Calf, Sulfadimidine,(S), SulfaTECH SR, Sulfanilamide, N(1)-(4,6-dimethyl-2-pyrimidinyl)-, AZOLMETAZINE, SULFISOMIDON, 4-Amino-N-(4,6-dimethyl-2-pyrimidyl)benzenesulfonamide, Sentry aq mardel biospheres maracyn plus, Spectrum_000990, Sulfadimidinun (Latin), [(4-Aminophenyl)sulfonyl](4,6-dimethylpyrimidin-2-yl)amine, 4-amino-N-(4, Opera_ID_1374, Prestwick0_000775, Prestwick1_000775, Prestwick2_000775, Prestwick3_000775, Spectrum2_001321, Spectrum3_001700, Spectrum4_000344, Spectrum5_001270, Sulfamethazine, >=99%, Sulmet Solution Injectable, CHEMBL446, Epitope ID:122238, Sulfamethazine Spanbolet II, Cambridge id 5251384, NCIOpen2_003489, BIDD:PXR0093, Oprea1_142608, Oprea1_677935, BSPBio_000850, BSPBio_003260, CBDivE_012932, KBioGR_000747, KBioSS_001470, SULFAMETHAZINE [HSDB], 5-25-10-00250 (Beilstein Handbook Reference), MLS000103403, MLS001077331, MLS002454449, DivK1c_000293, SCHEMBL151305, SPECTRUM1500548, SULFAMETHAZINE [VANDF], SPBio_001441, SPBio_002789, SULFADIMIDINE [WHO-DD], SULFADIMIDINE [WHO-IP], BPBio1_000936, Sulfamethazine Sustained Release, Sulfanilamide, N(sup 1)-(4,6-dimethyl-2-pyrimidinyl)-, ASWVTGNCAZCNNR-UHFFFAOYSA-, GTPL12642, HMS500O15, KBio1_000293, KBio2_001470, KBio2_004038, KBio2_006606, KBio3_002480, J01EB03, NINDS_000293, HMS1921A17, HMS2092I19, HMS3652K03, Pharmakon1600-01500548, SULFAMETHAZINE [GREEN BOOK], BCP28439, HY-B0035, Sulfadimidine for peak identification, SULFAMETHAZINE [ORANGE BOOK], Tox21_110847, Tox21_202221, Tox21_303006, CCG-39259, NSC757326, s3133, Sulfamethazine Sustained Release Calf, SULFADIMIDINUM [WHO-IP LATIN], AKOS000119894, Tox21_110847_1, DB01582, MS-1576, NSC-757326, IDI1_000293, NCGC00018243-01, NCGC00018243-02, NCGC00018243-03, NCGC00018243-04, NCGC00018243-05, NCGC00018243-06, NCGC00018243-08, NCGC00018243-09, NCGC00021490-03, NCGC00021490-04, NCGC00021490-05, NCGC00021490-06, NCGC00256371-01, NCGC00259770-01, Sulmet Drinking Water Solution, 12.5%, WLN: T6N CNJ BMSWR DZ& D1 F1, AC-16126, Sulfanilamide,6-dimethyl-4-pyrimidinyl)-, SBI-0051522.P003, SULFAMETHAZINE (TRISULFAPYRIMIDINES), Sustain III Bolus, Sustain III Calf Bolus, A 502, NS00000199, NS00114258, SW219689-1, Benzenesulfonamide,6-dimethyl-4-pyrimidinyl)-, EN300-16843, C19530, D02436, F85014, Sulfamethazine 1000 microg/mL in Acetonitrile, AB00052097_12, AB00052097_13, A831551, SR-01000000211, Sulfamethazine, Vetec(TM) reagent grade, >=99%, Sulfamethazine, VETRANAL(TM), analytical standard, Q3976823, SR-01000000211-3, W-105450, 4-amino-N-(4,6-dimethyl-2-pyridyl)benzenesulfonamide, BRD-K11640013-001-02-6, BRD-K11640013-236-03-6, Z56791687, 2-(4-Aminobenzenesulfonylamino)-4,6-dimethylpyrimidine, F1443-4796, 2-(P-AMINOBENZENESULFONAMIDO)-4,6-DIMETHYLPYRIDINE, TRISULFAPYRIMIDINES (SULFAMETHAZINE) [ORANGE BOOK], N(1)-(4,6-Dimethyl-2-pyrimidinyl)sulfanilamide sulfadimidine, Sulfadimidine, European Pharmacopoeia (EP) Reference Standard, (4-AMINO-N-(4,6-DIMETHYL-2-PYRIMIDINYL)BENZENE SULFONAMIDE, 4-AMINO-N-(4,6-DIMETHYL-2-PYRIMIDINYL)BENZENESULFONAMINDE, HSDB 4157; HSDB 4157; HSDB 4157;Sulfadimidine;Sulfadimerazine, Sulfamethazine, United States Pharmacopeia (USP) Reference Standard, Sulfadimidine for peak identification, European Pharmacopoeia (EP) Reference Standard, InChI=1/C12H14N4O2S/c1-8-7-9(2)15-12(14-8)16-19(17,18)11-5-3-10(13)4-6-11/h3-7H,13H2,1-2H3,(H,14,15,16)" C12H14N4O2S ASWVTGNCAZCNNR-UHFFFAOYSA-N 4-amino-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide n.a. Antiinfective Agents No No No No No No PMDBD2001212 Sulfamethizole Therapeutic Substance Approved Drug 144-82-1 DB00576 PA164781307 D00870 D07JJS 5328 5137 n.a. sulfamethizole, 144-82-1, Sulfamethizol, Sulphamethizole, Thiosulfil, Rufol, Proklar, Sulfamethylthiadiazole, 4-Amino-N-(5-methyl-1,3,4-thiadiazol-2-yl)benzenesulfonamide, Sulfamethizolum, Sulfametizol, Sulfurine, Ayerlucil, Methazol, Microsul, Sulfapyelon, Sulfstat, Tetracid, Thidicur, Ultrasul, Urocydal, Urodiaton, Urolucosil, Urosulfin, Lucosil, Renasul, Salimol, Famet, Uroz, Sulfa gram, Solfametizolo, Sulfametizol [INN-Spanish], RP 2145, Sulfamethizolum [INN-Latin], 4-Amino-N-(5-Methyl-1,3,4-Thiadiazol-2-Yl)Benzene-1-Sulfonamide, Benzenesulfonamide, 4-amino-N-(5-methyl-1,3,4-thiadiazol-2-yl)-, VK 53, CCRIS 756, sulphamethazole, CHEBI:9331, sulphamethiozole, Sulfamethizole (Proklar), HSDB 4379, 2-(p-Aminobenzenesulfonamido)-5-methylthiadiazole, EINECS 205-641-1, 2-Methyl-5-sulfanilamido-1,3,4-thiadiazole, 2-Sulfanilamido-5-methyl-1,3,4-thiadiazole, 5-Methyl-2-sulfanilamido-1,3,4-thiadiazole, NSC-757327, DTXSID5023615, N1-(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanilamide, AI3-50149, UNII-25W8454H16, N(sup 1)-(5-Methyl-1,3,4-thiadiazol-2-yl)-sulfanilamide, CHEMBL1191, MLS000028603, DTXCID803615, N(sup 1)-(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanilamide, 25W8454H16, Solfametizolo [DCIT], Sulfamethizole [USP:INN:BAN:JAN], N(1)-(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanilamide, NSC 757327, NCGC00016407-05, NCGC00016407-08, CAS-144-82-1, SMR000058666, Sulfanilamide, N(sup 1)-(5-methyl-1,3,4-thiadiazol-2-yl)-, Sulfametizol (INN-Spanish), Sulfamethizolum (INN-Latin), Thiosulfil-A-Forte, SULFAMETHIZOLE (MART.), SULFAMETHIZOLE [MART.], SULFAMETHIZOLE (USP-RS), SULFAMETHIZOLE [USP-RS], SULFAMETHIZOLE (EP IMPURITY), Sulfamethizole (USP:INN:BAN:JAN), SULFAMETHIZOLE [EP IMPURITY], N (SUP 1)-(5-METHYL-1,3,4-THIADIAZOL-2-YL)SULFANILAMIDE, SULFAMETHIZOLE (EP MONOGRAPH), SULFAMETHIZOLE [EP MONOGRAPH], SULFAMETHIZOLE (USP MONOGRAPH), SULFAMETHIZOLE [USP MONOGRAPH], Thiosulfil (TN), SR-01000003158, sulfametizolo, Prestwick_114, Spectrum_000992, Opera_ID_1595, Prestwick0_000742, Prestwick1_000742, Prestwick2_000742, Prestwick3_000742, Spectrum2_001322, Spectrum3_000570, Spectrum4_000640, Spectrum5_001078, Epitope ID:122233, SULFAMETHIZOLE [MI], SULFAMETHIZOLE [INN], SULFAMETHIZOLE [JAN], SCHEMBL26453, BSPBio_000724, BSPBio_001960, KBioGR_001260, KBioSS_001472, SULFAMETHIZOLE [HSDB], MLS002303066, DivK1c_000141, SPECTRUM1500549, SULFAMETHIZOLE [VANDF], SPBio_001443, SPBio_002663, Sulfamethizole-(phenyl-13C6), BPBio1_000798, SULFAMETHIZOLE [WHO-DD], GTPL12683, HMS500H03, KBio1_000141, KBio2_001472, KBio2_004040, KBio2_006608, KBio3_001460, B05CA04, D06BA04, J01EB02, S01AB01, NINDS_000141, Sulfamethizole (JP17/USP/INN), HMS1570E06, HMS1921A19, HMS2092I21, HMS2097E06, HMS2233L09, HMS3371A13, HMS3655F05, HMS3714E06, Pharmakon1600-01500549, HY-B0333, SULFAMETHIZOLE [ORANGE BOOK], Tox21_110425, Tox21_201035, BDBM50295558, CCG-39260, MFCD00053363, NSC757327, s1957, AKOS002666345, Tox21_110425_1, DB00576, IDI1_000141, SMP1_000284, NCGC00016407-01, NCGC00016407-02, NCGC00016407-03, NCGC00016407-04, NCGC00016407-06, NCGC00016407-07, NCGC00016407-09, NCGC00016407-11, NCGC00016407-13, NCGC00024107-03, NCGC00024107-04, NCGC00024107-05, NCGC00258588-01, AS-10177, SBI-0051523.P003, AB00052098, NS00000005, SW196425-3, Sulfamethizol 1000 microg/mL in Acetonitrile, 4-(AMINOMETHYL)-1-N-BOC-PIPERIDINE-HCl, C08050, D00870, D88000, EN300-217740, AB00052098_15, AB00052098_16, A921093, Sulfamethizole, VETRANAL(TM), analytical standard, J-008011, Q3976824, SR-01000003158-2, SR-01000003158-3, Sulfamethizole, analytical standard, >=99% (HPLC), BRD-K31682896-001-05-9, BRD-K31682896-001-15-8, Sulfamethizole, European Pharmacopoeia (EP) Reference Standard, 4-amino-N-(5-methyl[1,3,4]thiadiazol-2-yl)-benzenesulfonamide, N(SUP1)-(5-METHYL-1,3,4-THIADIAZOL-2-YL)SULFANILIMIDE, Sulfamethizole, United States Pharmacopeia (USP) Reference Standard, SULFANILAMIDE, N(1)-(5-METHYL-1,3,4-THIADIAZOL-2-YL)-, 4-AMINO-N-(5-METHYL-1,3,4-THIADIAZOL-2-YL)BENZENESULFONIMIDE C9H10N4O2S2 VACCAVUAMIDAGB-UHFFFAOYSA-N 4-amino-N-(5-methyl-1,3,4-thiadiazol-2-yl)benzenesulfonamide n.a. Antiinfective Agents No No No No No No PMDBD2001213 Sulfamoxole Therapeutic Substance n.a. 729-99-7 DB08798 PA165958417 D02516 n.a. 12894 12361 n.a. SULFAMOXOLE, 729-99-7, Sulfamoxol, Sulphamoxole, Sulfamoxolum, Oxasulfa, Sulfadimethyloxazole, Sulfmidil, Tardamid, Sulfavigor, Justamil, Sulfuno, Tardamide, 4-Amino-N-(4,5-dimethyl-2-oxazolyl)benzenesulfonamide, 4,5-Dimethyl-2-sulfanilamidooxazole, N1-(4,5-Dimethyl-2-oxazolyl)sulfanilamide, NSC 683535, 2-(p-Aminobenzenesulfonamido)-4,5-dimethyloxazole, p-Aminobenzenesulfonyl-2-amino-4,5-dimethyloxazole, 4-amino-N-(4,5-dimethyloxazol-2-yl)benzenesulfonamide, N(sup 1)-(4,5-Dimethyl-2-oxazolyl)sulfanilamide, NSC683535, NSC-683535, 2-(p-Aminobenzolsulfonamido)-4,5-dimethyloxazol, 4-Amino-N-(4,5-dimethyl-1,3-oxazol-2-yl)benzenesulfonamide, CHEBI:55548, 4-amino-N-(dimethyl-1,3-oxazol-2-yl)benzene-1-sulfonamide, Benzenesulfonamide, 4-amino-N-(4,5-dimethyl-2-oxazolyl)-, Oxazole, 2-(p-aminophenylsulfonylamino)-4,5-dimethyl-, HGG82XE020, Solfamossolo, Sulfono, Sulfamoxol 100 microg/mL in Acetonitrile, N1-(4,5-Dimethyloxazol-2-yl)sulfanilamide, N1-(4,5-Dimethyloxazol-2-yl)-sulfanilamide, Solfamossolo [DCIT], Sulfamoxol [INN-Spanish], Sulfamoxolum [INN-Latin], EINECS 211-982-7, UNII-HGG82XE020, Sulfano, Sulfune, Sulfamoxole [USAN:INN:BAN], 2-(p-Aminobenzolsulfonamido)-4,5-dimethyloxazol [German], SULFAMOXOLE [MI], SULFAMOXOLE [INN], Sulfamoxole (USAN/INN), SULFAMOXOLE [USAN], Epitope ID:122242, Sulfanilamide, N1-(4,5-dimethyl-2-oxazolyl)-, SULFAMOXOLE [MART.], SULFAMOXOLE [WHO-DD], SCHEMBL151518, Sulfanilamide, N(sup 1)-(4,5-dimethyl-2-oxazolyl)-, CHEMBL2105399, DTXSID5023617, GTPL12744, HY-B1782, MFCD00005303, (+/-)-BUFURALOLHYDROCHLORIDE, AKOS022507464, DB08798, NS-04235, Sulfamoxole 1000 microg/mL in Acetonitrile, CS-0013814, NS00000006, D02516, G12050, N(1)-(4,5-Dimethyl-2-oxazolyl)sulfanilamide, Sulfamoxole, VETRANAL(TM), analytical standard, SR-01000944561, Q6577297, SR-01000944561-1, 4-Amino-N-(4,5-dimethyl-1,3-oxazol-2-yl)benzenesulfonamide #, 4-amino-N-(4,5-dimethyl-1,3-oxazol-2-yl)benzene-1-sulfonamide, InChI=1/C11H13N3O3S/c1-7-8(2)17-11(13-7)14-18(15,16)10-5-3-9(12)4-6-10/h3-6H,12H2,1-2H3,(H,13,14 C11H13N3O3S CYFLXLSBHQBMFT-UHFFFAOYSA-N 4-amino-N-(4,5-dimethyl-1,3-oxazol-2-yl)benzenesulfonamide n.a. n.a. No No No No No No PMDBD2001214 Sulfaphenazole Therapeutic Substance Approved Drug 526-08-9 DB06729 PA130231310 D01954 D0A4YE 5335 5144 n.a. "sulfaphenazole, 526-08-9, Sulphaphenazole, Sulfabid, Sulfafenazol, Sulfaphenazon, Plisulfan, Raziosulfa, Depocid, Depotsulfonamide, 4-Amino-N-(1-phenyl-1H-pyrazol-5-yl)benzenesulfonamide, Sulfaphenazol, Sulphenazole, Sulfaphenylpyrazole, Sulfaphenylpipazol, Sulfaphenazolum, Sulfafenazolo, Firmazolo, Paidazolo, Eftolon, Inamil, Isarol, Merian, Orisul, Microtan pirazolo, 1-Phenyl-5-sulfanilamidopyrazole, 5-Sulfanilamido-1-phenylpyrazole, Sulfaphenylpyrazol, Phenylsulfapyrazole, N''-(1-Phenylpyrazol-5-yl)sulfanilamide, Solfafenazolo, 3-(p-Aminobenzenesulfonamido)-2-phenylpyrazole, Sulfafenazolo [Italian], Benzenesulfonamide, 4-amino-N-(1-phenyl-1H-pyrazol-5-yl)-, Sulfafenazol [INN-Spanish], Sulfaphenazol [INN-French], Sulfaphenazolum [INN-Latin], 4-amino-N-(2-phenylpyrazol-3-yl)benzenesulfonamide, N1-(1-Phenylpyrazol-5-yl)sulfanilamide, UNII-0J8L4V3F81, N(sup 1)-(1-Phenylpyrazol-5-yl)sulfanilamide, 4-amino-N-(1-phenyl-1H-pyrazol-5-yl)benzene-1-sulfonamide, EINECS 208-384-3, NSC-757859, Sulfaphenazole-d4, BRN 0308518, DTXSID2044131, CHEBI:77780, N(1)-(1-Phenylpyrazol-5-yl)sulfanilamide, 0J8L4V3F81, Sulfanilamide, N(sup 1)-(1-phenylpyrazol-5-yl)-, CHEMBL1109, 1420043-53-3, DTXCID0024131, 5-25-09-00415 (Beilstein Handbook Reference), MFCD00057226, NSC 757859, NCGC00015925-02, CAS-526-08-9, Solfafenazolo [DCIT], Sulfafenazol (INN-Spanish), Sulfaphenazol (INN-French), Sulfaphenazolum (INN-Latin), SULFAPHENAZOLE (MART.), SULFAPHENAZOLE [MART.], Orisulf, 4-Amino-N-(2-phenyl-2H-pyrazol-3-yl)-benze-ne-13C6-sulfonamide, Isarol V, SMR000326684, Prestwick_454, SR-01000075649, Lopac-S-0758, Sulfaphenazole (JAN/INN), Sulfonylpyrazol, Sulfaphenazole [INN:BAN:JAN], Sulfabid (TN), Spectrum_001406, Prestwick0_000021, Prestwick1_000021, Prestwick2_000021, Prestwick3_000021, Spectrum2_001943, Spectrum3_001741, Spectrum4_000443, Spectrum5_001185, Sulfaphenazole, >=98%, Sulfanilamide, N1-(1-phenylpyrazol-5-yl)-, Sulfaphenazole 100 microg/mL in Acetonitrile, SULFAPHENAZOLE [MI], SULFAPHENAZOLE [INN], SULFAPHENAZOLE [JAN], Lopac0_001095, BSPBio_000081, BSPBio_003442, KBioGR_000826, KBioSS_001886, MLS000859612, MLS001056713, DivK1c_000303, SCHEMBL122040, SPECTRUM1501143, SPBio_002002, SPBio_002005, BPBio1_000091, SULFAPHENAZOLE [WHO-DD], GTPL11352, HMS500P05, KBio1_000303, KBio2_001886, KBio2_004454, KBio2_007022, KBio3_002662, 4-Amino-N-(1-phenyl-1H-pyrazol-5-yl)-benzenesulfonamide, 4-Amino-N-(2-phenyl-2H-pyrazol-3-yl)-benzenesulfonamide, J01ED08, NINDS_000303, HMS1568E03, HMS1921J13, HMS2095E03, HMS2235J21, HMS3263K12, HMS3373E16, HMS3712E03, Pharmakon1600-01501143, Sulfaphenazole, >=98% (HPLC), BCP27626, HY-B1218, STR05485, SULFAPHENAZOLE [ORANGE BOOK], Tox21_110262, Tox21_501095, BDBM50090677, CCG-39431, NSC757859, Pyrazole, 1-phenyl-5-sulfanilamido-, s3673, AKOS003348743, Tox21_110262_1, 1ST4057, CS-4843, DB06729, LP01095, SDCCGSBI-0051065.P004, IDI1_000303, NCGC00015925-01, NCGC00015925-03, NCGC00015925-04, NCGC00015925-05, NCGC00015925-06, NCGC00015925-07, NCGC00015925-08, NCGC00015925-09, NCGC00015925-10, NCGC00015925-12, NCGC00015925-13, NCGC00015925-17, NCGC00094368-01, NCGC00094368-02, NCGC00094368-03, NCGC00094368-04, NCGC00094368-05, NCGC00261780-01, SBI-0051065.P003, AB00052218, EU-0101095, NS00006369, BIM-0051065.0001, D01954, D70410, S 0758, AB00052218_10, EN300-7419010, Q6577293, SR-01000075649-2, SR-01000075649-7, SR-01000075649-8, SR-01000075649-9, BRD-K10671814-001-05-6, BRD-K10671814-001-09-8, BRN-0308518; BRN0308518; BRN 0308518;Sulfabid;Sulfaphenylpyrazol;Sulphaphenazole" C15H14N4O2S QWCJHSGMANYXCW-UHFFFAOYSA-N 4-amino-N-(2-phenylpyrazol-3-yl)benzenesulfonamide Pharmaceutical Research Assoc Inc Antiinfective Agents No No No No No No PMDBD2001215 Sulfathiazole Therapeutic Substance n.a. 72-14-0 DB06147 PA165958356 D01047 n.a. 5340 n.a. n.a. "sulfathiazole, 72-14-0, Sulphathiazole, Sulfathiazol, 2-Sulfanilamidothiazole, Thiazamide, Sulfanilamidothiazole, Norsulfazole, Norsulfasol, 2-Sulfonamidothiazole, 4-Amino-N-(thiazol-2-yl)benzenesulfonamide, Neostrepsan, Sulfocerol, Thiozamide, Sulzol, 2-(Sulfanilylamino)thiazole, Formosulfathiazole, Sulfathiazolum, Azoquimiol, Azoseptale, Cerazole, Chemosept, Eleudron, Estafilol, Norsulfazol, Planomide, Poliseptil, Sanotiazol, Septozol, Sulfatiazol, Thiacoccine, Thiasulfol, Wintrazole, 2-Sulfanilamidothiazol, Cibazol, Duatok, Dulana, Coco-Thiazole, 2-(p-Aminobenzenesulfonamido)thiazole, N(1)-2-Thiazolylsulfanilamide, Streptosilthiazole, Sulfamul, 4-Amino-N-2-thiazolylbenzenesulfonamide, Usaf sn-9, Cerazol (suspension), 2-(p-Aminobenzenesulphonamido)thiazole, Norsulfazolum, Ciba 3714, N1-(2-Thiazolyl)sulfanilamide, 4-Amino-N-(1,3-Thiazol-2-Yl)Benzene-1-Sulfonamide, Solfatiazolo, N1-2-Thiazolylsulfanilamide, M&B 760, Caswell No. 809B, 4-Amino-N-(1,3-thiazol-2-yl)benzenesulfonamide, Benzenesulfonamide, 4-amino-N-2-thiazolyl-, Sulfanilamide, N1-2-thiazolyl-, RP 2090, N(sup 1)-2-Thiazolylsulfanilamide, 2090 R.P., CCRIS 765, sulfthiazole, CHEBI:9337, 4-amino-N-1,3-thiazol-2-ylbenzenesulfonamide, 2090 rp, M+B 760, UNII-Y7FKS2XWQH, Y7FKS2XWQH, HSDB 4380, 2-Sulfathiazole, 4-Amino-N-thiazol-2-yl-benzenesulfonamide, Sulfanilamide, N(1)-2-thiazolyl-, Sulfathiazol [INN-French], Sulfatiazol [INN-Spanish], EINECS 200-771-5, Sulfathiazolum [INN-Latin], NSC 31812, NSC-31812, Triple sulfa (sulfathiazole), EPA Pesticide Chemical Code 077903, NSC 683531, NSC-683531, Sulfanilamide, N(sup 1)-2-thiazolyl-, Sulfathiazole-13C6, DTXSID8026068, AI3-01050, Sodium sulfathiazole, CHEMBL437, DTXCID606068, N''-(2-Thiazolyl)sulfanilamide, Sulfathiazole [USP:INN:BAN], N(sup1)-(2-Thiazolyl)sulfanilamide, TRYSUL COMPONENT SULFATHIAZOLE, MFCD00005319, NSC683531, Sulfanilamide, N(sup1)-2-thiazolyl-, SULTRIN COMPONENT SULFATHIAZOLE, VAGILIA COMPONENT SULFATHIAZOLE, CAS-72-14-0, GYNE-SULF COMPONENT SULFATHIAZOLE, SULFATHIAZOLE COMPONENT OF TRYSUL, NCGC00016309-02, NCGC00016309-06, SULFATHIAZOLE COMPONENT OF SULTRIN, SULFATHIAZOLE COMPONENT OF VAGILIA, 4-Amino-N-(2-thiazolyl)benzenesulfonamide, Sulfanilamide, N1-4-thiazolin-2-ylidene-, SULFATHIAZOLE COMPONENT OF GYNE-SULF, Sulfathiazole 100 microg/mL in Acetonitrile, Sulfathiazol (INN-French), Sulfatiazol (INN-Spanish), Sulfathiazolum (INN-Latin), SULFATHIAZOLE (MART.), SULFATHIAZOLE [MART.], SULFATHIAZOLE (USP-RS), SULFATHIAZOLE [USP-RS], Sulfathiazole (USP:INN:BAN), Solfatiazolo [DCIT], SULFATHIAZOLE (EP MONOGRAPH), SULFATHIAZOLE [EP MONOGRAPH], SULFATHIAZOLE (USP MONOGRAPH), SULFATHIAZOLE [USP MONOGRAPH], 2-Sulfanilamidothiazol [German], SR-05000001722, sulfatiazolo, Sulfathiazole; 4-Amino-N-(thiazol-2-yl)benzenesulfonamide, Enterobiocine, Sulfavitina, Cerazol, Sulfaplex, YTZ, Prestwick_430, Spectrum_001000, 4-amino-N-2-thiazolyl Benzenesulfonamide, Benzenesulfonamide, 4 amino N 2 thiazolyl, Benzenesulfonamide, 4-amino-N-2-thiazolyl, Prestwick0_000016, Prestwick1_000016, Prestwick2_000016, Prestwick3_000016, Spectrum2_000841, Spectrum3_001729, Spectrum4_000348, Spectrum5_001441, Sulfathiazole (USP/INN), N-2-Thiazolylsulfanilamide, SULFATHIAZOLE [MI], Epitope ID:122234, SULFATHIAZOLE [INN], Cambridge id 5251400, cid_5340, SULFATHIAZOLE [HSDB], Oprea1_105970, Oprea1_297844, SCHEMBL94165, BSPBio_000051, BSPBio_003378, KBioGR_000755, KBioSS_001480, SULFATHIAZOLE [VANDF], [(4-Aminophenyl)sulfonyl]-1,3-thiazol-2-ylamine, MLS002154174, N-1-2-Thiazolylsulfanilamide, DivK1c_000560, SPECTRUM1500553, SPBio_000821, SPBio_001972, SULFATHIAZOLE [WHO-DD], BPBio1_000057, WLN: T5N CSJ BMSWR DZ, GTPL12699, HMS501L22, KBio1_000560, KBio2_001480, KBio2_004048, KBio2_006616, KBio3_002598, D06BA02, J01EB07, N(sup1)-2-Thiazolylsulfanilamide, NINDS_000560, HMS1568C13, HMS1921C07, HMS2092K09, HMS2095C13, HMS2259A13, HMS3652A03, HMS3712C13, Pharmakon1600-01500553, SULFATHIAZOLE [GREEN BOOK], SULFATHIAZOLE [ORANGE BOOK], AMY33440, HY-B0507, NSC31812, SULFATHIAZOLE (TRIPLE SULFA), Tox21_110363, Tox21_202243, Tox21_303238, BDBM50027796, CCG-40296, NSC757331, s3116, 2-(4-Aminobenzenesulfonamido)thiazole, AKOS000108630, Tox21_110363_1, DB06147, NSC-757331, SDCCGMLS-0065585.P001, IDI1_000560, N(SUP1)-2-THIAZOYLSULFANILAMIDE, NCGC00016309-01, NCGC00016309-03, NCGC00016309-04, NCGC00016309-05, NCGC00016309-07, NCGC00016309-08, NCGC00016309-09, NCGC00016309-10, NCGC00016309-14, NCGC00091133-01, NCGC00091133-02, NCGC00091133-03, NCGC00091133-04, NCGC00257187-01, NCGC00259792-01, AC-12783, DS-17245, NCI60_002730, SMR000017368, Pyridine,2-(chloromethyl)-3,4-dimethoxy-, SBI-0051527.P004, 4-amino-N-(thiazol-2-yl)-benzenesulfonamide, AB00052102, NS00000201, SW149625-4, 4-[(1,3-Thiazol-2-yl)aminosulfonyl]aniline, EN300-18132, Sulfathiazole 1000 microg/mL in Acetonitrile, Sulfathiazole, analytical standard, >=98.0%, D01047, D70411, AB00052102_14, AB00052102_15, Q408427, Sulfathiazole, VETRANAL(TM), analytical standard, TRIPLE SULFA (SULFATHIAZOLE) [ORANGE BOOK], 4-Amino-N-(1,3-thiazol-2-yl)benzenesulfonamide #, Q-201765, SR-05000001722-1, SR-05000001722-3, Sulfathiazole, Antibiotic for Culture Media Use Only, BRD-K14705039-001-05-7, BRD-K14705039-001-08-1, Z57198680, F1443-4816, Sulfathiazole, European Pharmacopoeia (EP) Reference Standard, Sulfathiazole, United States Pharmacopeia (USP) Reference Standard" C9H9N3O2S2 JNMRHUJNCSQMMB-UHFFFAOYSA-N 4-amino-N-(1,3-thiazol-2-yl)benzenesulfonamide n.a. n.a. No No No No No Yes EX_sftz(e),SFTZ_GLC_GLCAASE,SFTZ_GLC_GLCAASEe,SFTZ_GLC_GLCAASEepp,SFTZte,SFTZtepp,SFTZtex PMDBD2001216 Sulfisoxazole Therapeutic Substance Approved Drug 127-69-5 DB00263 PA164748964 D00450 D09TBD 5344 5151 n.a. sulfisoxazole, Sulfafurazole, 127-69-5, Sulphafurazole, Sulfisoxazol, Sulfafurazol, Sulfaisoxazole, Sulfofurazole, Gantrisin, Sulfisoxasole, Sulphaisoxazole, Sulfadimethylisoxazole, Alphazole, Amidoxal, Sulfalar, Sulfoxol, Sulfasoxazole, Sulfisonazole, Sulphafurazolum, Accuzole, Renosulfan, Soxomide, Sulfisoxazole dialamine, Sulfizin, Sulsoxin, Sosol, Roxosul tablets, Cosoxazole, Gantrisona, Gantrosan, Sulphafurazol, Sulphisoxazol, Sulphofurazole, Uritrisin, Chemouag, Entusil, Entusul, Isoxamin, Neazolin, Neoxazol, Soxisol, Stansin, Sulfagan, Sulfasol, Sulfazin, Thiasin, Unisulf, Pancid, Sulbio, Sulphadimethylisoxazole, 4-amino-N-(3,4-dimethylisoxazol-5-yl)benzenesulfonamide, Norilgan-S, SK-Soxazole, Novosaxazole, Sulfafurazolum, Dorsulfan, Gantrisine, Novazolo, Saxosozine, Sodizole, Soxamide, Soxazole, Soxitabs, Sulfapolar, Sulfisin, Sulfizol, Sulfizole, Urisoxin, Roxosul, Urogan, Dorsulfan warthausen, Koro-sulf, Tl-azole, V-Sul, SOXO, Sulfisoxazolum, Sulphisoxazole, Vagilia, Azo Gantrisin, J-Sul, 3,4-Dimethyl-5-sulfonamidoisoxazole, 3,4-Dimethyl-5-sulfanilamidoisoxazole, 5-Sulfanilamido-3,4-dimethylisoxazole, Solfafurazolo, 3,4-Dimethyl-5-sulphonamidoisoxazole, 4-Amino-N-(3,4-dimethyl-5-isoxazolyl)benzenesulfonamide, 3,4-Dimethylisoxazole-5-sulfanilamide, 3,4-Dimethyl-5-sulphanilamidoisoxazole, 3,4-Dimethylisoxazole-5-sulphanilamide, Benzenesulfonamide, 4-amino-N-(3,4-dimethyl-5-isoxazolyl)-, 5-Sulphanilamido-3,4-dimethyl-isoxazole, G-sox, 5-(4-Aminophenylsulfonamido)-3,4-dimethylisoxazole, NCI-C50022, 5-(p-Aminobenzenesulfonamido)-3,4-dimethylisoxazole, N1-(3,4-Dimethyl-5-isoxazolyl)sulfanilamide, 5-(p-Aminobenzenesulphonamido)-3,4-dimethylisoxazole, N''-(3,4)Dimethylisoxazol-5-yl-sulphanilamide, NU 445, U.S.-67, Sulfafurazolum [INN-Latin], 4-Amino-N-(3,4-dimethyl-5-isoxazolyl)benzenesulphonamide, CCRIS 568, Gantrizin, HSDB 797, Pediazole, CHEBI:102484, N(Sup1)-(3,4-Dimethyl-5-isoxazolyl)sulfanilamide, EINECS 204-858-9, NSC 13120, NSC-13120, NSC 683536, NSC-683536, BRN 0263871, Sulfafurazole (INN), Sulfafurazole [INN], DTXSID6021292, UNII-740T4C525W, N(sup 1)-(3,4-Dimethyl-5-isoxazolyl)sulfanilamide, AI3-24003, N(sup 1)-(3,4-Dimethyl-5-isoxazolyl)sulphanilamide, Gantrisin (TN), NSC13120, 4-amino-N-(dimethyl-1,2-oxazol-5-yl)benzene-1-sulfonamide, component of Azo-Sulfizin, 4-amino-N-(3,4-dimethyl-1,2-oxazol-5-yl)benzenesulfonamide, MFCD00003150, component of Azo Gantrisin, Sulfisoxazole [USP:JAN], CHEMBL453, 740T4C525W, DTXCID001292, Sulfasoxizole, NU-445, N(1)-(3,4-dimethyl-5-isoxazolyl)sulfanilamide, N(1)-(3,4-dimethyl-5-isoxazolyl)sulphanilamide, 4-27-00-04747 (Beilstein Handbook Reference), NSC33807, NSC38588, Sulfanilamide, N1-(3,4-dimethyl-5-isoxazolyl)-, 3,4-Dimethylisoxale-5-sulfanilamide, NSC683536, Sulfanilamide, N(sup 1)-(3,4-dimethyl-5-isoxazolyl)-, Sulfazin (VAN), NCGC00016384-03, NCGC00016384-10, Azosulfizin, Sulphafuraz, 4-Amino-N-(3,4-dimethyl-isoxazol-5-yl)-benzenesulfonamide, Astrazolo, Bactesulf, Barazae, CAS-127-69-5, Resoxol, Roxoxol, Sulfagen, Suloxsol, Ganda, AZO GANTRISIN COMPONENT SULFISOXAZOLE, Solfafurazolo [DCIT], Sulfisoxazole (USP:JAN), N1-(3,4-Dimethyl-5-isoxazolyl)sulphanilamide, SULFISOXAZOLE COMPONENT OF AZO GANTRISIN, Sulfafurazolum (INN-Latin), SULFAFURAZOLE (IARC), SULFAFURAZOLE [IARC], 5-(p-Aminobenzenesulfonamido)-3,4-dimethylisooxale, SULFAFURAZOLE (MART.), SULFAFURAZOLE [MART.], SULFISOXAZOLE (USP-RS), SULFISOXAZOLE [USP-RS], 4-amino-N-(3,4-dimethyl-1,2-oxazol-5-yl)benzene-1-sulfonamide, SULFAFURAZOLE (EP MONOGRAPH), SULFAFURAZOLE [EP MONOGRAPH], 4-Amino-N-(3,4-dimethyl-isoxazol-5-yl) benzene-13C6-sulfonamide, SULFISOXAZOLE (USP MONOGRAPH), SULFISOXAZOLE [USP MONOGRAPH], WLN: T5NOJ CMSWR DZ& D1 E1, Sulfanilamide,4-dimethyl-5-isoxazolyl)-, SMR000037657, Benzenesulfonamide,4-dimethyl-5-isoxazolyl)-, US-67, SR-01000003085, Soxisol Tablets, NU445, Component of Azo Gantrisin Accuzole, Prestwick_726, Spectrum_001024, Tocris-0731, Prestwick0_000334, Prestwick1_000334, Prestwick2_000334, Prestwick3_000334, Spectrum2_001325, Spectrum3_001728, Spectrum4_000349, Spectrum5_001222, Azo-Sulfizin (Salt/Mix), SULFISOXAZOLE [MI], Azo Gantrisin (Salt/Mix), Epitope ID:122240, SULFISOXAZOLE [JAN], Sulfisoxazole (JP17/USP), SULFISOXAZOLE [HSDB], Sulfisoxazole, >=99.0%, Oprea1_680668, Oprea1_828173, SCHEMBL23467, BSPBio_000367, BSPBio_003376, KBioGR_000757, KBioSS_001504, SULFISOXAZOLE [VANDF], MLS000028495, MLS000037737, MLS000563718, BIDD:GT0322, DivK1c_000579, SPECTRUM1500555, SPBio_001449, SPBio_002288, SULFAFURAZOLE [WHO-DD], BPBio1_000405, N(sup 1)-(3,4-dimethyl-5-isoxazolyl)-sulfanilamide, GTPL12700, HMS501M21, KBio1_000579, KBio2_001504, KBio2_004072, KBio2_006640, KBio3_002596, [(4-aminophenyl)sulfonyl](3,4-dimethylisoxazol-5-yl)amine, 4-amino-N-(3,4-dimethylisoxazol-5-yl)-benzenesulfonamide, NINDS_000579, HMS1569C09, HMS2092K13, HMS2096C09, HMS2233G23, HMS3259C06, HMS3266N17, HMS3374K11, HMS3411F03, HMS3655B03, HMS3675F03, HMS3713C09, Pharmakon1600-01500555, SULFISOXAZOLE [GREEN BOOK], SULFISOXAZOLE [ORANGE BOOK], HY-B0323, STR04988, Tox21_110409, Tox21_112958, Tox21_202265, Tox21_302851, BDBM50034452, CCG-39263, NSC-33807, NSC-38588, NSC757343, s1916, AKOS000119074, AKOS000310021, Tox21_110409_1, AC-1941, DB00263, NC00536, NSC-757343, IDI1_000579, NCGC00016384-01, NCGC00016384-02, NCGC00016384-04, NCGC00016384-05, NCGC00016384-06, NCGC00016384-07, NCGC00016384-08, NCGC00016384-09, NCGC00016384-11, NCGC00016384-12, NCGC00016384-14, NCGC00016384-15, NCGC00023116-02, NCGC00023116-05, NCGC00023116-06, NCGC00023116-07, NCGC00023116-08, NCGC00256605-01, NCGC00259814-01, SBI-0051529.P003, UPCMLD00X127-69-5:001, AB00052104, NS00002072, SW196872-3, U0098, EN300-35024, Sulfisoxazole 1000 microg/mL in Acetonitrile, 3,4-DIMETHYLISOAXAZOLE-5-SULPHANILIMIDE, C07318, D00450, H10712, AB00052104-14, AB00052104_15, AB00052104_16, Q372598, Sulfisoxazole, VETRANAL(TM), analytical standard, 5-(4-Aminophenylsulphonamido)-3,4-dimethylisoxazole, J-005528, SR-01000003085-2, SR-01000003085-5, SR-01000003085-6, 5-(p-Aminobenzenesulphonamide)-3,4-dimethylisoxazole, BRD-K50859149-001-05-4, BRD-K50859149-001-10-4, Sulfanilamide, N(sup1)-(3,4-dimethyl-5-isoxazolyl)-, Sulfanilamide, N.sup1.-(3,4-dimethyl-5-isoxazolyl)-, Z90124784, 4-Amino-N-(3,4-dimethyl-5-isoxazolyl)benzenesulfonamid, F0848-0391, 4-amino-N-(3,4-dimethyl-5-isoxazolyl)benzene-sulfonamide, 4-Amino-N-(3,4-dimethyl-5-isoxazolyl)benzenesulfonamide #, SULFANILAMIDE, N(1)-(3,4-DIMETHYL-5-ISOXAZOLYL)-, Sulfafurazole, European Pharmacopoeia (EP) Reference Standard, SULFANILAMIDE, N(SUP 1)-(3,4-DIMETHYL-5-ISOXAZOLYL), Sulfisoxazole, United States Pharmacopeia (USP) Reference Standard, 4-amino-N-(3,4-dimethyl-2,5-dihydro-1,2-oxazol-5-ylidene)benzene-1-sulfonamide, InChI=1/C11H13N3O3S/c1-7-8(2)13-17-11(7)14-18(15,16)10-5-3-9(12)4-6-10/h3-6,14H,12H2,1-2H C11H13N3O3S NHUHCSRWZMLRLA-UHFFFAOYSA-N 4-amino-N-(3,4-dimethyl-1,2-oxazol-5-yl)benzenesulfonamide Hoffmann La Roche Inc Antiinfective Agents No No No No No No PMDBD2001217 Syringic acid Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D0Q7DJ 10742 n.a. NPC110899 SYRINGIC ACID, 530-57-4, 4-Hydroxy-3,5-dimethoxybenzoic acid, 3,5-Dimethoxy-4-hydroxybenzoic acid, Cedar acid, Gallic acid 3,5-dimethyl ether, Benzoic acid, 4-hydroxy-3,5-dimethoxy-, NSC 2129, 3,5-Dimethoxy-4-hydroxybenzyl acid, EINECS 208-486-8, BRN 2115262, UNII-E390O181H5, CHEBI:68329, AI3-24376, NSC-2129, MFCD00002552, 4-Hydroxy-3,5-dimethoxy-benzoic acid, E390O181H5, CHEMBL1414, DTXSID0060191, 4-10-00-01995 (Beilstein Handbook Reference), 4-Hydroxy-3,5-dimethoxybenzoicacid, 2,6-DIMETHOXY-4-CARBOXYPHENOL, 3,5-dimethoxy-4-oxidanyl-benzoic acid, Syringlicacid, SYRA, SpecPlus_000485, Spectrum3_001866, Spectrum5_000963, Syringic acid, >=95%, bmse000607, bmse010206, SCHEMBL42751, BSPBio_003312, SYRINGIC ACID [INCI], DivK1c_006581, 3,5-Dimethyl-4-hydroxybenzoate, DTXCID2041337, 3,5-dimethyl ether Gallic Acid, KBio1_001525, KBio3_002814, 3,5-Dimethoxy-4-hydroxybenzoate, NSC2129, HMS3885G17, Syringic acid, analytical standard, HY-N0339, BDBM50187132, s3629, 3,5-dimethoxy-4-hydroxy benzoic acid, AKOS000269664, AC-7975, CCG-214218, PS-8244, NCGC00178148-01, 1ST40130, SY005479, CS-0008899, G0014, NS00001894, EN300-117146, 3 pound not5-DIMETHOXY-4-HYDROXYBENZOICACID, Q408428, Q-100604, BRD-K51980294-001-01-9, F3157-0001, Z1255360342, 3,5-Dimethoxy-4-hydroxybenzoic acid, 4-Hydroxy-3,5-dimethoxy-benzoic acid, IJP, InChI=1/C9H10O5/c1-13-6-3-5(9(11)12)4-7(14-2)8(6)10/h3-4,10H,1-2H3,(H,11,12 C9H10O5 JMSVCTWVEWCHDZ-UHFFFAOYSA-N 4-hydroxy-3,5-dimethoxybenzoic acid n.a. n.a. No No No No Yes No rxnDiet210 PMDBD2001218 Tachyplesin III n.a. n.a. n.a. n.a. n.a. n.a. n.a. 16739289 n.a. n.a. Tachyplesin III, CHEMBL415278 C99H155N33O19S4 HMHANTFVNOFNNZ-CPFWMRGPSA-N (2S)-2,6-diamino-N-[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-1-[[2-[[(2S,3S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2R)-1-[[(2S)-1-amino-5-carbamimidamido-1-oxopentan-2-yl]amino]-1-oxo-3-sulfanylpropan-2-yl]amino]-1-oxohexan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-1-oxo-3-sulfanylpropan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-1-oxo-3-sulfanylpropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1-oxo-3-sulfanylpropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]hexanamide n.a. n.a. No No No No No No PMDBD2001219 Tangeretin n.a. n.a. n.a. n.a. n.a. n.a. n.a. 68077 n.a. NPC40818 "Tangeretin, 481-53-8, Tangeritin, Ponkanetin, Pentamethoxyflavone, 4'',5,6,7,8-Pentamethoxyflavone, 5,6,7,8,4''-Pentamethoxyflavone, 5,6,7,8-tetramethoxy-2-(4-methoxyphenyl)chromen-4-one, 4H-1-Benzopyran-4-one, 5,6,7,8-tetramethoxy-2-(4-methoxyphenyl)-, 5,6,7,8-tetramethoxy-2-(4-methoxyphenyl)-4H-chromen-4-one, UNII-I4TLA1DLX6, I4TLA1DLX6, NSC53909, EINECS 207-570-1, NSC 53909, NSC-53909, BRN 0351695, CHEBI:9400, AI3-23869, 5,6,7,8-Tetramethoxy-2-(4-methoxyphenyl)-4-benzopyrone, 4'',5,6,7,8-pentamethoxy-flavone, NSC618905, NSC-618905, 4H-1-Benzopyran-4-one, 5,6,7,8-tetramethoxy-2-(p-methoxyphenyl)-, Flavone, 4'',5,6,7,8-pentamethoxy-, CHEMBL73930, MLS002667634, DTXSID30197417, 2-(4-Methoxyphenyl)-5,6,7,8-tetramethoxy-4H-1-benzopyran-4-one, 5,6,7,8-tetramethoxy-2-(4-methoxyphenyl)-4H-1-benzopyran-4-one, 5-18-05-00491 (Beilstein Handbook Reference), MFCD00017438, Flavone, 5,6,7,8,4''-pentamethoxy, Tangeritin; NSC53909; NSC618905, 4H-1-Benzopyran-4-one, 2-(4-methoxyphenyl)-5,6,7,8-tetramethoxy-, Tangeretin (6CI), Tangeretin;Tangeratin, Tangeretin (Tangeritin), Spectrum2_001698, Spectrum3_000920, Spectrum4_001019, TANGERITIN [INCI], TANGERETIN [WHO-DD], SCHEMBL19740, KBioGR_001517, Flavone, 4'',5,6,7,8-pentamethoxy- (7CI,8CI), SPECTRUM1505269, SPBio_001656, Tangeretin, analytical standard, MEGxp0_001011, Tangeretin, >=95% (HPLC), ACon1_001263, KBio3_001900, 5,6,7,8,4-pentamethoxyflavone, DTXCID40119908, Flavone,5,6,7,8-pentamethoxy-, HMS3651A22, HY-N0133, 4'''',5,6,7,8-pentamethoxyflavone, 5,6,7,8,4''''-Pentamethoxyflavone, BDBM50209218, CCG-38782, LMPK12111443, s2363, AKOS015895209, AC-1699, CS-5484, SDCCGMLS-0066766.P001, NCGC00095850-01, NCGC00095850-02, NCGC00169520-01, 1ST40174, AS-11637, NCI60_004330, SMR001557394, NS00031773, SW219232-1, T2708, A827490, Flavone, 4'',5,6,7,8-pentamethoxy-(7CI,8CI), SR-05000002625, CU-01000013437-2, Q-100525, Q1748737, SR-05000002625-1, BRD-K25186396-001-02-1, BRD-K25186396-001-04-7, 4H-1-Benzopyran-4-one,6,7,8-tetramethoxy-2-(4-methoxyphenyl)-, 4H-1-Benzopyran-4-one,6,7,8-tetramethoxy-2-(p-methoxyphenyl)-, 4H-1-Benzopyran-4-one, 5,6,7,8-tetra-methoxy-2-(4-methoxyphenyl)-, 5,6,7,8-Tetramethoxy-2-(4-methoxyphenyl)-4H-1-benzopyran-4-one, 9CI, TangeretinPonkanetin; Pentamethoxyflavone; 4'',5,6,7,8-Pentamethoxyflavone" C20H20O7 ULSUXBXHSYSGDT-UHFFFAOYSA-N 5,6,7,8-tetramethoxy-2-(4-methoxyphenyl)chromen-4-one n.a. n.a. No No No No Yes No rxnAddEX13,rxnAdd118 PMDBD2001220 Tangerine oil n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001221 Tannic acid Therapeutic Substance Investigational Drug 1401-55-4 DB09372 n.a. n.a. D0R4WJ 16129778 17288010 NPC149300 TANNIC ACID, 1401-55-4, Gallotannin, Glycerite, Chinese gallotannin, 5424-20-4, Gallotannic acid, MFCD00066397, MLS001335996, CHEBI:81066, [2,3-dihydroxy-5-[[(2R,3R,4S,5R,6S)-3,4,5,6-tetrakis[[3,4-dihydroxy-5-(3,4,5-trihydroxybenzoyl)oxybenzoyl]oxy]oxan-2-yl]methoxycarbonyl]phenyl] 3,4,5-trihydroxybenzoate, SMR000857330, DSSTox_CID_6076, DSSTox_RID_78006, DSSTox_GSID_26076, [2,3-Dihydroxy-5-[[3,4,5,6-tetrakis[[3,4-dihydroxy-5-(3,4,5-trihydroxybenzoyl)oxybenzoyl]oxy]oxan-2-yl]methoxycarbonyl]phenyl] 3,4,5-trihydroxybenzoate, Tannicum acidum, FEMA No. 3042, beta-D-Glucose pentakis(3,4-dihydroxy-5-((3,4,5-trihydroxybenzoyl)oxy)benzoate), BETA-D-GLUCOSE PENTAKIS[3,4-DIHYDROXY-5-[(3,4,5-TRIHYDROXYBENZOYL)OXY]BENZOATE], (2S,3R,4S,5R,6R)-6-(((3,4-Dihydroxy-5-((3,4,5-trihydroxybenzoyl)oxy)benzoyl)oxy)methyl)tetrahydro-2H-pyran-2,3,4,5-tetrayl tetrakis(3,4-dihydroxy-5-((3,4,5-trihydroxybenzoyl)oxy)benzoate), CAS-1401-55-4, tannic-acid, NSC656273, NSC-656273, NSC-758670, NCGC00095101-01, EINECS 226-562-9, TANNICACID, Tannin (Tannic acid), Tannic acid, technical, Asian holly oak nutgall, Tannic acid, ACS reagent, Tannic acid, technical grade, MLS001335995, SCHEMBL409692, Tannic acid, SAJ first grade, CHEMBL506247, GTPL4319, BDBM60986, DTXSID00892987, Tannic acid, puriss., 95.0%, cid_16129778, Tox21_111422, Tox21_300079, BDBM50442879, s3951, AKOS015951319, Tannic acid, Vetec(TM) reagent grade, CCG-270692, NCGC00186054-01, NCGC00186054-02, NCGC00253925-01, Tannic acid, tested according to Ph.Eur., HY-135530, CS-0113395, NS00093444, C17409, Tannic acid, Source: Chinese natural gall nuts, A901485, Q427956, Q-201780, Tannic acid, puriss., meets analytical specification of USP, powder, Tannic acid, United States Pharmacopeia (USP) Reference Standard, .Beta.-D-glucopyranose, pentakis[3,4-dihydroxy-5-[(3,4,5-trihydroxybenzoyl)oxy]benzoate], (2R,3R,4S,5R,6S)-4,5,6-tris({3,4-dihydroxy-5-[(3,4,5-trihydroxyphenyl)carbonyloxy]phenyl}carbonyloxy)-2-[({3,4-dihydroxy-5-[(3,4,5-trihydroxyphenyl)carbonyloxy]phenyl}carbonyloxy)methyl]oxan-3-yl 3,4-dihydroxy-5-[(3,4,5-trihydroxyphenyl)carbonyloxy]benzoate, [2,3-dihydroxy-5-[[(2R,3R,4S,5R,6S)-3,4,5,6-tetrakis[[3,4-dihydroxy-5-(3,4,5-trihydroxybenzoyl)oxy-benzoyl]oxy]tetrahydropyran-2-yl]methoxycarbonyl]phenyl] 3,4,5-trihydroxybenzoate, [2,3-dihydroxy-5-[[(2R,3R,4S,5R,6S)-3,4,5,6-tetrakis[[3,4-dihydroxy-5-(3,4,5-trihydroxybenzoyl)oxybenzoyl]oxy]oxan-2-yl]methoxycarbonyl]phenyl]3,4,5-trihydroxybenzoate C76H52O46 LRBQNJMCXXYXIU-PPKXGCFTSA-N [2,3-dihydroxy-5-[[(2R,3R,4S,5R,6S)-3,4,5,6-tetrakis[[3,4-dihydroxy-5-(3,4,5-trihydroxybenzoyl)oxybenzoyl]oxy]oxan-2-yl]methoxycarbonyl]phenyl] 3,4,5-trihydroxybenzoate n.a. n.a. No No No No No No PMDBD2001222 Taurine Therapeutic Substance Investigational Drug 107-35-7 DB01956 PA451590 D00047 D0C6IE 1123 1091 n.a. "taurine, 2-aminoethanesulfonic acid, 107-35-7, Ethanesulfonic acid, 2-amino-, tauphon, L-Taurine, 2-Aminoethylsulfonic acid, 2-Sulfoethylamine, O-Due, taufon, 2-aminoethane-1-sulfonic acid, aminoethylsulfonic acid, Aminoethanesulfonic acid, beta-Aminoethylsulfonic acid, FEMA No. 3813, Taurinum [Latin], Taurina [Spanish], Taurine [INN], Taurina, Taurinum, C2H7NO3S, CCRIS 4721, NCI-C60606, AI3-18307, Taurineold, Taukard, UNII-1EQV5MLY3D, 1EQV5MLY3D, 2-aminoethane sulfonic acid, EINECS 203-483-8, NSC 32428, NSC-32428, 1-Aminoethane-2-sulfonic acid, DTXSID3021304, CHEBI:15891, 2-aminoethyl sulfonate, HSDB 8167, NSC32428, MFCD00008197, Taurine [USP:INN:BAN], .beta.-Aminoethylsulfonic acid, DTXCID301304, EC 203-483-8, Taurinum (Latin), NCGC00015997-06, TAURINE (MART.), TAURINE [MART.], TAURINE (USP-RS), TAURINE [USP-RS], Taurine (USP:INN:BAN), Aminoethylsulfonic acid (JAN), TAURINE (USP MONOGRAPH), TAURINE [USP MONOGRAPH], 2-amino-ethanesulfonic acid, AMINOETHYLSULFONIC ACID [JAN], CAS-107-35-7, SMR000326743, SR-01000076144, 2-AminoethanesulfonicAcid, Taurate, Aminoethylsulfonate, Taurine,(S), Taurine (TN), b-Aminoethylsulfonate, Taurine (8CI), 2-Aminoethylsulfonate, beta-Aminoethylsulfonate, Tocris-0209, TAURINE [VANDF], 2aminoethanesulfonic acid, TAURINE [FHFI], TAURINE [INCI], Taurine, >=99%, b-Aminoethylsulfonic acid, TAURINE [JAN], TAURINE [MI], Lopac-T-0625, TAURINE [WHO-DD], WLN: Z2SWQ, 1-Aminoethane-2-sulfonate, bmse000120, bmse000805, bmse000863, Lopac0_001134, SCHEMBL23068, Taurine, >=98%, FG, MLS000859681, MLS001332383, MLS001332384, Taurine (JP17/USP/INN), CHEMBL239243, GTPL2379, Taurine, >=99.0% (T), HMS2093L13, HMS2233D19, HMS3263D09, HMS3370J18, Pharmakon1600-01505463, HY-B0351, RKL10149, taurine; 2-aminoethanesulfonic acid, Tox21_110277, Tox21_202520, Tox21_501134, BDBM50357220, HB2658, NSC759150, s2008, AKOS005208848, Tox21_110277_1, CCG-205208, DB01956, Ethanesulfonic acid, 2-amino- (9CI), LP01134, NSC-759150, SDCCGSBI-0051101.P003, Taurine, BioUltra, >=99.5% (T), Taurine, SAJ first grade, >=98.5%, NCGC00015997-01, NCGC00015997-02, NCGC00015997-03, NCGC00015997-04, NCGC00015997-05, NCGC00015997-07, NCGC00015997-08, NCGC00015997-10, NCGC00015997-20, NCGC00024497-01, NCGC00024497-02, NCGC00024497-03, NCGC00024497-04, NCGC00024497-05, NCGC00260069-01, NCGC00261819-01, AS-13587, NCI60_002814, SBI-0051101.P002, Taurine, Vetec(TM) reagent grade, >=99%, A0295, AM20080018, EU-0101134, NS00009343, EN300-28228, C00245, D00047, D78121, T 0625, AB00443712-07, AB00443712_09, AB00443712_10, Q207051, J-508042, SR-01000076144-1, SR-01000076144-3, SR-01000076144-5, Taurine, certified reference material, TraceCERT(R), F2191-0280, Z248489432, Taurine, cell culture tested, meets USP testing specifications, Taurine, United States Pharmacopeia (USP) Reference Standard, Taurine, Pharmaceutical Secondary Standard; Certified Reference Material" C2H7NO3S XOAAWQZATWQOTB-UHFFFAOYSA-N 2-aminoethanesulfonic acid n.a. n.a. No No No No Yes Yes rxnAGORA1366,rxnAGORA2323,rxnAGORA3298,rxnAGORA3299,rxnAGORA4518 EX_taur(e) PMDBD2001224 Tea tree oil Therapeutic Substance n.a. 68647-73-4 DB11218 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001225 Teichoplanin n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001226 Telaprevir Therapeutic Substance Approved Drug 402957-28-2 DB05521 PA165958354 D09012 D0X9CH 3010818 2279948 NPC483795 Telaprevir, 402957-28-2, VX-950, Incivek, Incivo, Telaprevir (VX-950), MP-424, Telavic, VX 950, LY-570310, S-Telaprevir, MP 424, VRT 111950, VRT-111950, VX950 cpd, LY 570310, UNII-655M5O3W0U, CHEBI:68595, HSDB 8125, 655M5O3W0U, CHEMBL231813, (1S,3aR,6aS)-2-((S)-2-((S)-2-cyclohexyl-2-(pyrazine-2-carboxamido)acetamido)-3,3-dimethylbutanoyl)-N-((S)-1-(cyclopropylamino)-1,2-dioxohexan-3-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide, DTXSID40193304, (3S,3aS,6aR)-2-[(2S)-2-[[(2S)-2-cyclohexyl-2-(pyrazine-2-carbonylamino)acetyl]amino]-3,3-dimethylbutanoyl]-N-[(3S)-1-(cyclopropylamino)-1,2-dioxohexan-3-yl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-3-carboxamide, TELAPREVIR (MART.), TELAPREVIR [MART.], (1S,3aR,6aS)-(2S)-2-cyclohexyl-N-(pyrazinylcarbonyl)glycyl-3-methyl-L-valyl-N-((1S)-1-((cyclopropylamino)oxoacetyl)butyl)octahydrocyclopenta(c)pyrrole-1-carboxamide, (1S,3aR,6aS)-2-((S)-2-((S)-2-cyclohexyl-2-(pyrazine-6-carboxamido)acetamido)-3,3-dimethylbutanoyl)-N-((S)-1-(cyclopropylamino)-1,2-dioxohexan-3-yl)-octahydrocyclopenta[c]pyrrole-1-carboxamide, Cyclopenta(c)pyrrole-1-carboxamide, (2S)-2-cyclohexyl-N-(pyrazinylcarbonyl)glycyl-3-methyl-L-valyl-N-((1S)-1-((cyclopropylamino)oxoacetyl)butyl)octahydro-, (1S,3aR,6aS)-, 569364-34-7, Telaprevir [USAN:INN], telaprevirum, Incivek(TM), (1S,3aR,6aS)-2-((2S)-2-(((2S)-2-cyclohexyl-2-((pyrazin-2-ylcarbonyl)amino)acetyl)amino)-3,3-dimethylbutanoyl)-N-((3S)-1-(cyclopropylamino)-1,2-dioxohexan-3-yl)octahydrocyclopenta(c)pyrrole-1-carboxamide, (1S,3AR,6AS)-2-((2S)-2-(((2S)-CYCLOHEXYL((PYRAZINYLCARBONYL)AMINO)ACETYL)AMINO)-3,3-DIMETHYLBUTANOYL)-N-((1S)-1-((CYCLOPROPYLAMINO)OXOACETYL)BUTYL) OCTAHYDROCYCLOPENTA(C)PYRROLE-1-CARBOXAMIDE, (1S,3aR,6aS)-2-[(2S)-2-({(2S)-2-cyclohexyl-2-[(pyrazin-2-ylcarbonyl)amino]acetyl}amino)-3,3-dimethylbutanoyl]-N-[(3S)-1-(cyclopropylamino)-1,2-dioxohexan-3-yl]octahydrocyclopenta[c]pyrrole-1-carboxamide, (1S,3aR,6aS)-2-[(2S)-2-[[(2S)-Cyclohexyl[(pyrazinylcarbonyl)amino]acetyl]amino]-3,3-dimethylbutanoyl]-N-[(1S)-1-[(cyclopropylamino)oxoacetyl]butyl] octahydrocyclopenta[c]pyrrole-1-carboxamide, Incivek (TN), Incivo (TN), Telaprevir,VX-950, TELAPREVIR [MI], TELAPREVIR [INN], TELAPREVIR [JAN], (1S,3aR,6aS)-2-[(2S)-2-[[(2S)-2-cyclohexyl-2-(pyrazine-2-carbonylamino)acetyl]amino]-3,3-dimethylbutanoyl]-N-[(3S)-1-(cyclopropylamino)-1,2-dioxohexan-3-yl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-1-carboxamide, TELAPREVIR [USAN], VX-950 (Telaprevir), TELAPREVIR [VANDF], TELAPREVIR [WHO-DD], SCHEMBL183996, Telaprevir (JAN/USAN/INN), GTPL7871, TELAPREVIR [ORANGE BOOK], DTXCID10115795, EX-A006, J05AP02, (1S,3aR,6aS)-2-, BBAWEDCPNXPBQM-GDEBMMAJSA-N, AIDS213006, AIDS-213006, BDBM50326056, FD7166, MFCD11616089, s1538, VRT111950, AKOS005145815, CCG-270366, CS-0285, DB05521, NCGC00346545-03, (3S,3aS,6aR)-2-[(2S)-2-[[(2S)-2-cyclohexyl-2-(pyrazine-2-carbonylamino)acetyl]amino]-3,3-dimethyl-butanoyl]-N-[(1S)-1-[2-(cyclopropylamino)-2-oxo-acetyl]butyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-3-carboxamide, AS-16995, HY-10235, WO-00218369, D09012, EN300-26212550, Q408557, Q-101417, Z2235802141, (1S,3aR,6aS)-(2S)-2-Cyclohexyl-N-(2-pyrazinylcarbonyl)glycyl-3-methyl-L-valyl-N-[(1S)-1-[2-(cyclopropylamino)-2-oxoacetyl]butyl]octahydrocyclopenta[c]pyrrole-1-carboxamide, (1S,3aR,6aS)-2-((2S)-2-((2S)-2-Cyclohexyl-2-((pyrazin-2-ylcarbonyl)amino)acetylamino)-3,3-dimethylbutanoyl)-N-((3S)-1-cyclopropylamino-1,2-dioxohexan-3-yl)octahydrocyclopenta(c)pyrrole-1-carboxamide, (1S,3aR,6aS)-2-((S)-2-((S)-2-cyclohexyl-2-(pyrazine-2-carboxamido)acetamido)-3,3-dimethylbutanoyl)-N-((S)-1-(cyclopropylamino)-1,2-dioxo-hexan-3-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide, (1S,3aR,6aS)-2-((S)-2-((S)-2-cyclohexyl-2-(pyrazine-2-carboxamido)acetamido)-3,3-dimethylbutanoyl)-N-((S)-1-(cydopropylamino)-1,2-dioxo-hexan-3-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide, (1S,3aR,6aS)-2-((S)-2-((S)-2-cyclohexyl-2-(pyrazine-3-carboxamido)acetamido)-3,3-dimethylbutanoyl)-N-((S)-1-(cyclopropylamino)-1,2-dioxohexan-3-yl)-octahydrocyclopenta[c]pyrrole-1-carboxamide, (1S,3aR,6aS)-N-((S)-2-((S)-2-cyclohexyl-2-(pyrazine-2-carboxamido)acetamido)-3,3-dimethylbutanoyl)-N-((S)-1-(cyclopropylamino)-1,2-dioxohexan-3-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide, (3S)-3-{[(1S,3aR,6aS)-2-[(2S)-2-[(2S)-2-cyclohexyl-2-(pyrazin-2-ylformamido)acetamido]-3,3-dimethylbutanoyl]-octahydrocyclopenta[c]pyrrol-1-yl]formamido}-N-cyclopropyl-2-oxohexanamide, (3S)-3-{[(1S,3aR,6aS)-2-[(2S)-2-[(2S)-2-cyclohexyl-2-[(pyrazin-2-yl)formamido]acetamido]-3,3-dimethylbutanoyl]-octahydrocyclopenta[c]pyrrol-1-yl]formamido}-N-cyclopropyl-2-oxohexanamide, 2-(2-{2-Cyclohexyl-2-[(pyrazine-2-carbonyl)-amino]-acetylamino}-3,3-dimethyl-butyryl)-octahydro-cyclopenta[c]pyrrole-1-carboxylic acid (1-cyclopropylaminooxalyl-butyl)-amide C36H53N7O6 BBAWEDCPNXPBQM-GDEBMMAJSA-N (3S,3aS,6aR)-2-[(2S)-2-[[(2S)-2-cyclohexyl-2-(pyrazine-2-carbonylamino)acetyl]amino]-3,3-dimethylbutanoyl]-N-[(3S)-1-(cyclopropylamino)-1,2-dioxohexan-3-yl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-3-carboxamide n.a. n.a. No No No No No No PMDBD2001228 Telekin n.a. n.a. n.a. n.a. n.a. n.a. n.a. 12443309 n.a. NPC90014 telekin, Eudesmanolide, 6752-90-5, (3aR,4aR,8aR,9aR)-4a-Hydroxy-8a-methyl-3,5-dimethylenedecahydronaphtho[2,3-b]furan-2(3H)-one, (3aR,4aR,8aR,9aR)-4a-hydroxy-8a-methyl-3,5-dimethylidene-4,6,7,8,9,9a-hexahydro-3aH-benzo[f][1]benzofuran-2-one, starbld0028755, Compound NP-009716, CHEMBL406233, CHEBI:181502, HY-N10483, AKOS040739215, NCGC00384720-01, CS-0564736, NS00094043, 5alpha-Hydroxyeudesm-4(15),11(13)-dien-8beta,12-olide, (3aR,4aR,8aR,9aR)-4a-hydroxy-8a-methyl-3,5-dimethylidene-4,6,7,8,9,9a-hexahydro-3aH-benzo[][1]benzouran-2-one, NCGC00384720-01_C15H20O3_(3aR,4aR,8aR,9aR)-4a-Hydroxy-8a-methyl-3,5-bis(methylene)decahydronaphtho[2,3-b]furan-2(3H)-one C15H20O3 LIDPBIULZNRIJE-QHSBEEBCSA-N (3aR,4aR,8aR,9aR)-4a-hydroxy-8a-methyl-3,5-dimethylidene-4,6,7,8,9,9a-hexahydro-3aH-benzo[f][1]benzofuran-2-one n.a. n.a. No No No No No No PMDBD2001229 Tellurite n.a. n.a. n.a. n.a. n.a. n.a. n.a. 115037 n.a. n.a. tellurite, Tellurate (TeO3(2-)), trioxotellurate(IV), 15852-22-9, tellurite ion, trioxotellurate(2-), trioxidotellurate(2-), TeO3(2-), CHEBI:30477, DTXSID10894775, SITVSCPRJNYAGV-UHFFFAOYSA-L, [TeO3](2-), Q7697684 O3Te-2 SITVSCPRJNYAGV-UHFFFAOYSA-L tellurite n.a. n.a. No No No No No No PMDBD2001230 Terconazole Therapeutic Substance Approved Drug 67915-31-5 DB00251 PA164768834 D00888 D01AQT 441383 421966 n.a. "terconazole, 67915-31-5, Triaconazole, Terazol 3, Terazol 7, Fungistat, Gyno-Terazol, Tercospor, termayazole, Terconazolum, Terconazol, DTXSID2045498, R 42470, 1-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-4-propan-2-ylpiperazine, DTXCID0025498, CHEBI:82980, R-42470, R42470, R 42,470, NSC-331942, 1-(4-{[(2R,4S)-2-(2,4-dichlorophenyl)-2-[(1H-1,2,4-triazol-1-yl)methyl]-1,3-dioxolan-4-yl]methoxy}phenyl)-4-(propan-2-yl)piperazine, 1-[4-[[(2R,4S)-2-(2,4-Dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-4-(1-methylethyl)-rel-piperazine, rel-(2S,4S)-Terconazole, TERCONAZOLE (MART.), TERCONAZOLE (USP-RS), R-42,470, terconazolo, Panlomyc, TERCONAZOLE (EP MONOGRAPH), TERCONAZOLE (USP MONOGRAPH), NSC331942, NCGC00016912-01, Terconazole; 1-[4-[[(2RS,4SR)-2-(2,4-Dichlorophenyl)-2-[(1H-1,2,4-triazol-1-yl)methyl]-1,3-dioxolan-4-yl]methoxy]phenyl]-4-(1-methylethyl)piperazine, CAS-67915-31-5, Terazol 3 (TN), (2R,4S)-terconazole, Terconazole (USP/INN), Prestwick3_000495, CHEMBL1306, SCHEMBL23165, BSPBio_000389, 1-(4-((2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)-4-(1-methylethyl)piperazine, MLS002153844, BIDD:GT0705, BPBio1_000429, CHEBI:9451, TerconazoleVaginal Cream 0.8%, G01AG02, BLSQLHNBWJLIBQ-OZXSUGGESA-N, HMS2096D11, HMS2233C22, HMS3713D11, Pharmakon1600-01503847, HY-B1790, PIPERAZINE, 1-(4-((2-(2,4-DICHLOROPHENYL)-2-(1H-1,2,4-TRIAZOL-1-YLMETHYL)-1,3-DIOXOLAN-4-YL)METHOXY)PHENYL)-4-(1-METHYLETHYL)-, CIS, Tox21_110679, BDBM50375318, MFCD05662369, NSC760361, s5033, AKOS016846147, CCG-213216, CS-6456, DB00251, KS-1463, NSC-760361, NCGC00179575-01, AS-14153, Piperazine,1-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-4-(1-methylethyl)-, rel-, SMR001233206, AB00513849, NS00009370, C08080, C76152, D00888, AB00513849_07, A917374, EN300-20600044, SR-01000841196, J-008500, Q7701687, SR-01000841196-2, BRD-K86204871-001-02-2, BRD-K86204871-001-13-9, 1-(4-{[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)-4-(propan-2-yl)piperazine, 1-(4-{[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)-4-isopropylpiperazine, 1-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-4-propan-2-yl-piperazine, 172587-59-6, 1H-Pyrazole-3-acetamide,5-[[7-[3-[ethyl(2-hydroxyethyl)amino]propoxy]-4-quinazolinyl]amino]-N-(3-fluorophenyl)-, rac-1-(4-(((2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)-4-isopropylpiperazine" C26H31Cl2N5O3 BLSQLHNBWJLIBQ-OZXSUGGESA-N 1-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-4-propan-2-ylpiperazine n.a. Antifungal Agents No No No No No No PMDBD2001231 Terpinene-4-ol n.a. n.a. n.a. n.a. n.a. n.a. n.a. 11230 n.a. NPC177112 4-Carvomenthenol, Terpinen-4-ol, 562-74-3, 4-Terpineol, p-Menth-1-en-4-ol, 1-Terpinen-4-ol, Terpinenol-4, 1-p-Menthen-4-ol, Terpene-4-ol, 1-Menthene-4-ol, TERPINENE-4-OL, 1-para-Menthen-4-ol, 3-Cyclohexen-1-ol, 4-methyl-1-(1-methylethyl)-, rac Terpinen-4-ol, (+-)-p-Menth-1-en-4-ol, (+/-)-Terpinen-4-ol, Terpinenolu-4, Terpineol-4, dl-4-Terpineol, FEMA No. 2248, Terpinine-4-ol, (+/-)-4-Terpineol, para-Menth-1-en-4-ol, 4-Carvomenthenol (natural), 1-Methyl-4-isopropyl-1-cyclohexen-4-ol, 4-Methyl-1-isopropyl-3-cyclohexen-1-ol, 4-Methyl-1-(1-methylethyl)-3-cyclohexen-1-ol, Terpin-4-en-1-ol, CCRIS 9067, NSC 147749, 4-Methyl-1-(propan-2-yl)cyclohex-3-en-1-ol, 4-methyl-1-propan-2-ylcyclohex-3-en-1-ol, EINECS 209-235-5, EINECS 248-910-9, UNII-L65MV77ZG6, alpha-terpinen-4-ol, BRN 1906603, L65MV77ZG6, 1-isopropyl-4-methylcyclohex-3-en-1-ol, CHEBI:78884, NSC-147749, DTXSID4044824, HSDB 8264, (1)-1-(Isopropyl)-4-methylcyclohex-3-en-1-ol, 4-06-00-00250 (Beilstein Handbook Reference), 4-TERPINEOL, (+/-)-, TERPINEN-4-OL,(+/-)-, MFCD00001562, 1-(ISOPROPYL)-4-METHYLCYCLOHEX-3-EN-1-OL, METHYL-1-(1-METHYLETHYL)-3-CYCLOHEXEN-1-OL, L-4-terpineneol, L-4-terpineol, L-terpinen-4-ol, Terpinenolu-4 [Czech], (+/-)-1-Isopropyl-4-methyl-3-cyclohexen-1-ol, Origanol, Terpinen 4-ol, 1-isopropyl-4-methylcyclohex-3-enol, (-)-1-Isopropyl-4-methyl-3-cyclohexen-1-ol, alpha -Terpinen-4-ol, 1-Isopropyl-4-methyl-3-cyclohexen-1-ol, (R)-, 1-isopropyl-4-methyl-cyclohex-3-en-1-ol, 4-TERPINEOL [INCI], SCHEMBL22344, TERPINEN-4-OL [FCC], (-)-p-Menth-1-en-4-ol, CHEMBL507795, 4-CARVOMENTHENOL [FHFI], DTXCID2024824, FEMA 2248, (+/-)-p-Menth-1-en-4-ol, Tox21_301785, AC1341, NSC147749, s6118, AKOS015903412, CS-W018032, DB12816, HY-W017316, SB44714, 4-Carvomenthenol, >=95%, FCC, FG, NCGC00256250-01, 1-Isopropyl-4-methyl-3-cyclohexen-1-ol, 4-Carvomenthenol, natural, >=95%, FG, AS-56462, CAS-562-74-3, SY012857, M0319, NS00013199, T1993, C17073, A918559, Q416114, (-)-4-Hydroxy-4-isopropyl-1-methyl-1-cyclohexene, (+/-)-4-Hydroxy-4-isopropyl-1-methyl-1-cyclohexene, Terpinen 4-ol, primary pharmaceutical reference standard C10H18O WRYLYDPHFGVWKC-UHFFFAOYSA-N 4-methyl-1-propan-2-ylcyclohex-3-en-1-ol n.a. n.a. No No No No No No PMDBD2001232 Tert-butanol Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D0Q7LD 6386 n.a. n.a. "tert-Butanol, tert-Butyl alcohol, 2-Methylpropan-2-ol, 2-Methyl-2-propanol, 75-65-0, t-Butanol, T-BUTYL ALCOHOL, 1,1-Dimethylethanol, Trimethylcarbinol, t-Butyl hydroxide, Trimethyl carbinol, Trimethyl methanol, Tertiary-Butyl Alcohol, Trimethylmethanol, tert-butylalcohol, 2-Propanol, 2-methyl-, Butanol tertiaire, Dimethylethanol, tertiary butanol, tertiary-Butanol, Alcool butylique tertiaire, tert- butyl alcohol, Methanol, trimethyl-, tertiary Butyl Alcohol, t-BuOH, NCI-C55367, t-Butyl alchohol, tert-BuOH, tert-Butyl hydroxide, 2-Methyl n-propan-2-ol, 2-Methyl-2-propan-d9-ol, MD83SFE959, CHEBI:45895, MFCD00004464, Arconol, tert-Butyl alcohol, anhydrous, Caswell No. 124A, t-butylalcohol, tert Butanol, tert.-butanol, tBuOH, Butanol tertiaire [French], tert Butyl Alcohol, HSDB 50, TBU, 2-Methylpropanol-2, Alcohol, tert-Butyl, CCRIS 4755, Alcool butylique tertiaire [French], EINECS 200-889-7, BRN 0906698, terbutanol, tertbutanol, tertiarybutanol, UNII-MD83SFE959, ter-butanol, tert.butanol, t-Butylalkohol, t-butyl-alcohol, terbutyl alcohol, AI3-01288, tert -butanol, tertbutyl alcohol, tert. Butanol, t- butanol, HOtBu, ter-butyl alcohol, tert-buyl alcohol, tert-butyl-alcohol, tert.-butylalcohol, tert.butyl alcohol, Trimethyl-Methanol, tert-Butanol, AR, 2methyl-2-propanol, tert. butyl alcohol, HOt-Bu, Tert.-butyl alcohol, tert-C4H9OH, 2-methyl,2-propanol, Methyl-2 propanol-2, t-Bu-OH, 1,1-dimethyl ethanol, 2-methyl propan-2-ol, 2-methyl-propan-2-ol, tert-Butanol HPLC grade, tert-Butanol ACS reagent, Ethanol, 1,1-Dimethyl-, 2-methyl-2-propyl alcohol, EC 200-889-7, BUTYL ALCOHOL, TERT-, (CH3)3COH, 25-65-0, 4-01-00-01609 (Beilstein Handbook Reference), HOC(CH3)3, CHEMBL16502, T-BUTYL ALCOHOL [HSDB], T-BUTYL ALCOHOL [INCI], DTXSID8020204, TERT-BUTYL ALCOHOL [II], TERT-BUTYL ALCOHOL [MI], tert-Butanol, >=99% (GC), tert-Butanol, analytical standard, tert-Butanol, p.a., 99.0%, AMY11058, tert-Butanol, anhydrous, >=99.5%, AKOS009029221, DB03900, tert-Butanol, for HPLC, >=99.5%, tert-Butanol, technical grade, 95.0%, tert-Butanol, ACS reagent, >=99.0%, tert-Butyl alcohol; 1,1-Dimethylethanol, BP-20656, tert-Butanol 100 microg/mL in Acetonitrile, tert-Butanol, SAJ first grade, >=98.0%, B0706, NS00006876, tert-Butanol, TEBOL(R) 99, >=99.3%, EN300-19307, tert-Butanol, SAJ special grade, >=99.0%, C21389, A838477, Q285790, InChI=1/C4H10O/c1-4(2,3)5/h5H,1-3H, J-510082, F0001-1901, tert-Butanol, puriss. p.a., ACS reagent, >=99.7% (GC), tert-Butanol, certified reference material, 5000 mug/mL in methanol" C4H10O DKGAVHZHDRPRBM-UHFFFAOYSA-N 2-methylpropan-2-ol n.a. n.a. No No No No No No PMDBD2001233 Tet-20 n.a. n.a. n.a. n.a. n.a. n.a. n.a. 168510669 n.a. n.a. Tet-20, HY-P5486, CS-0884139 C78H141N31O14S MQADQGRMRXLIPN-NJWXTKLRSA-N (2R)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2,6-diaminohexanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-3-methylpentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-3-methylbutanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-3-methylbutanoyl]amino]-3-methylpentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]hexanoyl]amino]-3-sulfanylpropanoic acid n.a. n.a. No No No No No No PMDBD2001234 Tet-213 n.a. n.a. n.a. n.a. n.a. n.a. n.a. 164886681 n.a. n.a. Tet-213, HY-P3459, CS-0566030 CH4K2W4 ZRGJYDDWDCLLMO-UHFFFAOYSA-N n.a. n.a. n.a. No No No No No No PMDBD2001235 Tet-26 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001236 Tetracycline Therapeutic Substance Approved Drug 60-54-8 DB00759 PA451640 D00201 D08NQZ 54675776 10257122 n.a. tetracycline, 60-54-8, Deschlorobiomycin, Tsiklomitsin, Abramycin, Tetracyclinum, Tsiklomistsin, Tetracyclin, Achromycin, Tetraciclina, Solvocin, Sumycin, Ambramycin, Tetrazyklin, Cyclopar, Liquamycin, Omegamycin, Panmycin, Tetracyn, Tetradecin, Tetrafil, Tetraverine, Vetacyclinum, Tetra-Co, Achromycin V, Abricycline, Agromicina, Ambramicina, Biocycline, Cefracycline, Criseociclina, Democracin, Hostacyclin, Lexacycline, Limecycline, Mericycline, Neocycline, Orlycycline, Purocyclina, Roviciclina, Ciclibion, Copharlan, Micycline, Tetrabon, Veracin, Amycin, Tetracycline base, SK-Tetracycline, Tetracycline II, Cyclomycin, Tetracycl, Tetracycline HCl, Tetracycline I, Bio-tetra, Brodspec, CHEBI:27902, Piracaps (base), Centet (base), Achromycin (naphthacene derivative), Ala-Tet, Tetracyclinehydrate, Tetracyclinum [INN-Latin], Tetraciclina [INN-Spanish], UNII-F8VB5M810T, NSC-108579, Cefracycline suspension, CCRIS 9483, F8VB5M810T, (4S,4aS,5aS,12aS)-4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide, (4S,4aS,5aS,6S,12aS)-4-(dimethylamino)-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide, DTXSID7023645, HSDB 3188, EINECS 200-481-9, 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, (4S,4aS,5aS,6S,12aS)-, Vetquamycin-324 (free base), Liquamycin (Veterinary), DTXCID703645, EC 200-481-9, Tetracycline (internal use), Tetracycline [USP:INN:BAN:JAN], PYLERA COMPONENT TETRACYCLINE, Supramycin, MFCD00151232, NSC108579, 60-54-8 (FREE BASE), 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, (4S-(4alpha,4aalpha,5aalpha,6beta,12aalpha))-, TETRACYCLINE COMPONENT OF PYLERA, E701, T-125, 6-Methyl-1,11-dioxy-2-naphthacenecarboxamide, Tetracyclinum (INN-Latin), Tetraciclina (INN-Spanish), TETRACYCLINE (MART.), TETRACYCLINE [MART.], (4S,4aS,5aS,6S,12aR)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide, 4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,1 0,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide, TETRACYCLINE (EP MONOGRAPH), TETRACYCLINE (USP IMPURITY), Tetracycline (USP:INN:BAN:JAN), TETRACYCLINE [EP MONOGRAPH], TETRACYCLINE [USP IMPURITY], TETRACYCLINE (USP MONOGRAPH), TETRACYCLINE [USP MONOGRAPH], Bristaciclin alpha, (4R,4AS,5AS,6S,12AS)-4-(DIMETHYLAMINO)-3,6,10,12,12A-PENTAHYDROXY-6-METHYL-1,11-DIOXO-1,4,4A,5,5A,6,11,12A-OCTAHYDROTETRACENE-2-CARBOXAMIDE, Sumycin (TN), LYMECYCLINE IMPURITY H (EP IMPURITY), LYMECYCLINE IMPURITY H [EP IMPURITY], 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, 6416-04-2 (3H2O), Economycin, Vetquamycin, Tetracycline (JAN/USP/INN), SR-01000000212, Tetrabid Organon, VETRACYCLINUM, Spectrum_001034, Tetracycline, EP grade, Prestwick0_000140, Prestwick1_000140, Prestwick2_000140, Prestwick3_000140, Spectrum2_001329, Spectrum3_000565, Spectrum4_000352, Spectrum5_001112, TETRACYCLINE [MI], TETRACYCLINE [INN], TETRACYCLINE [JAN], TETRACYCLINE [HSDB], SCHEMBL3098, TETRACYCLINE [VANDF], BSPBio_000220, BSPBio_001950, KBioGR_000783, KBioSS_001514, BIDD:GT0653, DivK1c_000827, SCHEMBL537050, TETRACYCLINE [WHO-DD], Tetracycline Intramuscular Vet, SPBio_001457, SPBio_002159, BPBio1_000242, SCHEMBL2116649, SCHEMBL2116661, SCHEMBL21271987, GTPL10927, KBio1_000827, KBio2_001514, KBio2_004082, KBio2_006650, KBio3_001450, A01AB13, D06AA04, J01AA07, S01AA09, S02AA08, S03AA02, TETRACYCLINE [GREEN BOOK], NINDS_000827, HMS2090B04, TETRACYCLINE [ORANGE BOOK], Tetracycline, >=98.0% (NT), 2-NAPHTHACENECARBOXAMIDE, 4-(DIMETHYLAMINO)-1,4,4A,5,5A,6,11,12A-OCTAHYDRO-3,6,10,12,12A-PENTAHYDROXY-6-METHYL-1,11-DIOXO-, (4S-(4.ALPHA.,4A.ALPHA.,5A.ALPHA.,6.BETA.,12A.ALPHA.))-, 4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide, HY-A0107, RKL10088, Tetracycline, >=88.0% (HPLC), Tox21_300150, BDBM50237605, s4490, AKOS024277860, AKOS026749977, CS-8188, DB00759, Tetracycline dried down 2.5 microg/mL, CAS-60-54-8, IDI1_000827, NCGC00017323-03, NCGC00017323-04, NCGC00017323-05, NCGC00017323-07, NCGC00017323-15, NCGC00142507-02, NCGC00254063-01, BT166207, SBI-0051530.P003, NS00000577, T3971, C06570, D00201, EN300-374118, AB00053550-04, AB00053550_05, AB00053550_06, Q193045, SR-01000000212-3, Z2144222809, OXYTETRACYCLINE HYDROCHLORIDE IMPURITY B [EP IMPURITY], (4S,4aS,5aS,6S,12aS)-4-(dimethylamino)-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide C22H24N2O8 NWXMGUDVXFXRIG-WESIUVDSSA-N (4S,4aS,5aS,6S,12aR)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide Pfizer Inc Antibiotics No No No No No No PMDBD2001237 Tetrameric peptide n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001238 Tetrazol-1-yl n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001239 Thiazolidinedione-8 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001240 Thiophenone TF101 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001241 Thymol Therapeutic Substance Approved Drug 89-83-8 DB02513 n.a. D01039 D06GIP 6989 21105998 NPC259512 "THYMOL, 89-83-8, 2-Isopropyl-5-methylphenol, Thyme camphor, 5-Methyl-2-isopropylphenol, 3-p-Cymenol, 6-Isopropyl-m-cresol, Thymic acid, 5-Methyl-2-(1-methylethyl)phenol, 3-Hydroxy-p-cymene, 6-Isopropyl-3-methylphenol, Isopropyl cresol, m-Thymol, p-Cymen-3-ol, Phenol, 5-methyl-2-(1-methylethyl)-, 5-methyl-2-(propan-2-yl)phenol, Apiguard, p-Cymene, 3-hydroxy-, m-Cresol, 6-isopropyl-, 6-Isopropyl-p-cresol, 5-Methyl-2-isopropyl-1-phenol, 3-Methyl-6-isopropylphenol, 1-Hydroxy-5-methyl-2-isopropylbenzene, 2-Hydroxy-1-isopropyl-4-methylbenzene, 2-isopropyl-5-methyl-phenol, Thymol (natural), Cymophenol, alpha-, FEMA No. 3066, 5-methyl-2-propan-2-ylphenol, THYMOLUM, 1-Methyl-3-hydroxy-4-isopropylbenzene, Caswell No. 856A, FEMA Number 3066, Phenol, 2-isopropyl-5-methyl-, 3-Hydroxy-1-methyl-4-isopropylbenzene, IPMP, NSC 11215, CCRIS 7299, HSDB 866, EINECS 201-944-8, Isopropyl-m-cresol, NSC-11215, NSC-47821, NSC-49142, EPA Pesticide Chemical Code 080402, UNII-3J50XA376E, DTXSID6034972, CHEBI:27607, AI3-00708, 3J50XA376E, CHEMBL29411, DTXCID4014972, EC 201-944-8, MFCD00002309, NCGC00159373-02, NCGC00159373-04, THYMOL (USP-RS), THYMOL [USP-RS], THYMOL (MART.), THYMOL [MART.], 2-iso-Propyl-d7-5-Methyl-d3-phenol--d3, THYMOL (EP MONOGRAPH), THYMOL [EP MONOGRAPH], WLN: QR C1 FY1&1, CAS-89-83-8, Thymol; 5-Methyl-2-(methylethyl)phenol, Thymol [JAN:NF], Thymate, Thergy, Influenza Care, Common Colds, Acne Vanish, Acute Bronchitis, FLE Disinfectant, Thymol, puriss., Chronic Bronchitis, Thymol & propolis, Thymol (TN), Thymol,(S), Common Colds Synergy, thymol crystal puriss, Thymol, FCC, FG, Influenza Care Synergy, THYMOLUM [HPUS], Acute Bronchitis Synergy, Thymol (JP17/NF), THYMOL [VANDF], THYMOL [FHFI], THYMOL [HSDB], THYMOL [INCI], THYMOL [FCC], THYMOL [JAN], THYMOL [WHO-DD], THYMOL [II], THYMOL [MI], Chronic Bronchitis Synergy, FLE Antibacterial Solution, Thymol, analytical standard, Thymol, >=98.5%, SCHEMBL22165, 5-Methyl-2-Isopropyl Phenol, MLS001074692, BIDD:ER0658, Benefect Natural Hand Sanitizer, GTPL2499, 5-methyl-2-propan-2-yl-phenol, 1e06, HMS2267P15, HY-N6810, NSC11215, NSC47821, NSC49142, 5-methyl-2-(1-methylethyl)-phenol, Tox21_111613, Tox21_300358, BDBM50240432, s5157, Thymol, tested according to Ph.Eur., AKOS000119786, Tox21_111613_1, CCG-266209, DB02513, KS-5170, LMPR0102090029, MB00129, Thymol, SAJ first grade, >=98.0%, NCGC00159373-03, NCGC00159373-05, NCGC00254459-01, AC-34742, Acne Vanish Synergyfor treatment of Acnes, SMR000471893, CS-0008421, M0410, NS00006694, EN300-17999, C09908, Cleanwell Natural Orange Vanilla Hand Sanitizer, Cleanwell Natural Original Hand Sanitizer Wipes, D01039, Thymol, primary pharmaceutical reference standard, A845314, A861043, AE-562/43461428, Q408883, SR-01000763796, SR-01000763796-2, W-100357, Cleanwell Natural Orange Vanilla Hand Sanitizing Wipes, Thymol, Standard for quantitative NMR, TraceCERT(R), Z57127464, BENZENE,2-HYDROXY,1-ISOPROPYL,4-METHYL THYMOL, F0001-2201, Thymol, European Pharmacopoeia (EP) Reference Standard, Thymol, United States Pharmacopeia (USP) Reference Standard, Thymol, meets analytical specification of Ph. Eur., BP, NF, 99-101%, Thymol, Pharmaceutical Secondary Standard; Certified Reference Material, InChI=1/C10H14O/c1-7(2)9-5-4-8(3)6-10(9)11/h4-7,11H,1-3H" C10H14O MGSRCZKZVOBKFT-UHFFFAOYSA-N 5-methyl-2-propan-2-ylphenol n.a. n.a. No No No No No No PMDBD2001242 Tigecycline Therapeutic Substance Approved Drug 220620-09-7 DB00560 PA164746412 D01079 D0G4OD 54686904 10482314 n.a. "Tigecycline, 220620-09-7, Tygacil, WAY-GAR-936, GAR-936, TBG-MINO, GAR 936, CHEBI:149836, Tigecycline hydrate, (4S,4aS,5aR,12aS)-9-(2-(tert-butylamino)acetamido)-4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide, 70JE2N95KR, (4S,4aS,5aR,12aS)-9-(2-(tert-butylamino)acetamido)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide, DTXSID2048581, (4S,4aS,5aR,12aS)-9-[(N-tert-butylglycyl)amino]-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide, Tigecycline [USAN], Tigilcycline, GAR-936,Tigecycline, Tygacil(TM), (4S,4aS,5aR,12aR)-9-[[2-(tert-butylamino)acetyl]amino]-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide, (4S,4aS,5aR,12aS)-9-[2-(tert-butylamino)acetamido]-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide, 2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-9-((((1,1-dimethylethyl)amino)acetyl)amino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, (4S,4aS,5aR,12aS)-, 2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-9-((2-((1,1-dimethylethyl)amino)acetyl)amino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, (4S,4aS,5aR,12aS)-, 2-NAPHTHACENECARBOXAMIDE, 4,7-BIS(DIMETHYLAMINO)-9-[[[(1,1-DIMETHYLETHYL)AMINO]ACETYL]AMINO]-1,4,4A,5,5A,6,11,12A-OCTAHYDRO-3,10,12,12A-TETRAHYDROXY-1,11-DIOXO-, (4S,4AS,5AR,12AS)-, 2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-9-[[2-[(1,1-dimethylethyl)amino]acetyl]amino]-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, (4S,4aS,5aR,12aS)-, Tygacil (TN), Tigecyclin, GAR936, MFCD00935753, 9-t-Butylglycylamido minocycline, Haizheng Li Xing, Tigecycline 95%, NCGC00183095-01, (4S,4aS,5aR,12aS)-4,7-Bis(dimethylamino)-9-[[2-[(1,1-dimethylethyl)amino]acetyl]amino]-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide; Tygacil; WAY-GAR 936; Glycylcycline;, (4s,4as,5ar,12as)-9-[2-(tert-butylamino)acetamido]-4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide, T1C, Tigecycline (JAN/USP), TIGECYCLINE [MI], TIGECYCLINE [INN], TIGECYCLINE [JAN], TIGECYCLINE [VANDF], TIGECYCLINE [MART.], UNII-70JE2N95KR, TIGECYCLINE [USP-RS], TIGECYCLINE [WHO-DD], (4S,4aS,5aR,12aS)-9-(2-(tert-Butylamino)acetamido)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1, MLS006010079, SCHEMBL101795, SCHEMBL105082, SCHEMBL237962, TIGECYCLINE [EMA EPAR], Tigecycline [USAN:INN:BAN], CHEMBL376140, 9-t-butylglycylamido-minocycline, DTXCID8028507, GTPL10929, HSDB 8172, TIGECYCLINE [ORANGE BOOK], 9-tert-Butylglycylamidominocycline, BCPP000045, HMS3714I13, TIGECYCLINE [EP MONOGRAPH], TIGECYCLINE [USP MONOGRAPH], BCP01397, HY-B0117, Tox21_112910, BDBM50247905, NSC794945, s1403, AKOS015895663, AKOS025401452, AKOS037643695, AC-1798, CCG-270150, CS-1876, DB00560, NSC-794945, 9-t-Butylglycylamido-minocycline hydrate, 220620-09-7 (anhy.), (4S,12aS)-4,7-Bis(dimethylamino)-9-{2-[(tert-butyl)amino]acetylamino}-3,10,12,12a-tetrahydroxy-1,11-dioxo-4,5,6,12a,4a,5a-hexahydronaphthacene-2-carboxamide, (4S,4AS,5aR,12aS)-9-(2-(tert-butylamino)acetamido)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxa, 121GE002, AS-30703, SMR002530064, AM20090708, CAS-220620-09-7, NS00011897, T3589, D01079, AB01566818_01, A815890, EN300-19769236, Q420595, Tigecycline, Antibiotic for Culture Media Use Only, Q-101396, (4s,4as,5ar,12as)-9-(2-t-butylaminoacetylamino)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydronaphthacene-2-carboxamide, (4S,4aS,5aR,12aS)-9-[[2-(tert-butylamino)acetyl]amino]-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide, 2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-9-((((1,1-dimethylethyl)amino)acetyl)amino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, (4S,4aS,5aR,12aS)-" C29H39N5O8 SOVUOXKZCCAWOJ-HJYUBDRYSA-N (4S,4aS,5aR,12aR)-9-[[2-(tert-butylamino)acetyl]amino]-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide Wyeth Pharmaceuticals Antibiotics No No No No No No PMDBD2001243 Tiliroside Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D0IB3K 5320686 n.a. NPC19240 "Tiliroside, 20316-62-5, Tribuloside, Trans-Tiliroside, 22153-44-2, 15M04TXR9M, CHEMBL266564, [(2R,3S,4S,5R,6S)-6-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-3-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl (E)-3-(4-hydroxyphenyl)prop-2-enoate, CHEBI:80944, 2-Propenoic acid, 3-(4-hydroxyphenyl)-, 6''-ester with 3-(beta-D-glucopyranosyloxy)-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one, ((2R,3S,4S,5R,6S)-6-((5,7-Dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-3-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)methyl (E)-3-(4-hydroxyphenyl)acrylate, ((2R,3S,4S,5R,6S)-6-((5,7-Dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-3-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)methyl 3-(4-hydroxyphenyl)acrylate, [(2R,3S,4S,5R,6S)-6-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-chromen-3-yl]oxy-3,4,5-trihydroxy-tetrahydropyran-2-yl]methyl (E)-3-(4-hydroxyphenyl)prop-2-enoate, UNII-15M04TXR9M, Potengriffioside A, 6''''-O-trans-p-Coumaroylastragalin, RONACARE TILIROSIDE, TILIROSIDE [INCI], SCHEMBL23597, Tiliroside, analytical standard, MEGxp0_000169, DVGGLGXQSFURLP-VWMSDXGPSA-N, DTXSID601021936, GLXC-13144, Kaempferol-3-(p-coumaryl)glucoside, HY-N2443, BDBM50241244, MFCD00017454, AKOS015896718, NCGC00163634-01, ASTRAGALIN-6''''-TRANS-P-COUMARATE, MS-30569, CS-0022668, NS00097257, kaempferol 3-O-(6""-O-p-coumaroyl)-glucoside, C17140, A814433, Q-100248, KAEMPFEROL 3-O-(6''''-O-P-COUMAROYL)GLUCOSIDE, Q23418844, kaempferol-3-beta-D-(6-O-trans-p-coumaroyl)glucopyranoside, Kaempferol-3-O-(6-O-trans-p-coumaroyl)-.beta.-glucopyranoside, kaempferol-3-O-beta-D-(6''''-(E)-p-coumaroyl)-glucopyranoside, 3-O-KAEMPFEROL 6-O-(TRANS-P-COUMAROYL)-.BETA.-D-GLUCOPYRANOSIDE, kaempferol 3-O-(6'''''''' ''''''''-O-E-p-coumaroyl)-beta-D-glucopyranoside, KAEMPFEROL 3-O-(6''''-O-(E)-P-COUMAROYL)-.BETA.-D-GLUCOPYRANOSIDE, KAEMPFEROL 3-O-.BETA.-D-(6-O-TRANS-P-COUMAROYL)GLUCOPYRANOSIDE, KAEMPFEROL-3-O(-6-O-TRANS-P-COUMAROYL-.BETA.-GLUCOPYRANOSIDE, KAEMPFEROL 3-O-(6''''-O-(TRANS-P-COUMAROYL))-.BETA.-D-GLUCOPYRANOSIDE, (E)-((2R,3S,4S,5R,6S)-6-(5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-3-yloxy)-3,4,5-trihydroxy-tetrahydro-2H-pyran-2-yl)methyl 3-(4-hydroxyphenyl)acrylate, (E)-((2R,3S,4S,5R,6S)-6-(5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-3-yloxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)methyl 3-(4-hydroxyphenyl)acrylate, 2-PROPENOIC ACID, 3-(4-HYDROXYPHENYL)-, 6''-ESTER WITH 3-(.BETA.-D-GLUCOPYRANOSYLOXY)-5,7-DIHYDROXY-2-(4-HYDROXYPHENYL)-4H-1-BENZOPYRAN-4-ONE, (E)-, 4H-1-BENZOPYRAN-4-ONE, 5,7-DIHYDROXY-2-(4-HYDROXYPHENYL)-3-((6-O-((2E)-3-(4-HYDROXYPHENYL)-1-OXO-2-PROPEN-1-YL)-.BETA.-D-GLUCOPYRANOSYL)OXY)-, 4H-1-Benzopyran-4-one, 5,7-dihydroxy-2-(4-hydroxyphenyl)-3-[[6-O-[(2E)-3-(4-hydroxyphenyl)-1-oxo-2-propenyl]-.beta.-D-glucopyranosyl]oxy]-, 5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4E-1-benzopyran-3-yl 6-O-[(2E)-3-(4-hydroxyphenyl)prop-2-enoyl]-beta-D-glucopyranoside" C30H26O13 DVGGLGXQSFURLP-VWMSDXGPSA-N [(2R,3S,4S,5R,6S)-6-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-3-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl (E)-3-(4-hydroxyphenyl)prop-2-enoate n.a. n.a. No No No No No No PMDBD2001244 Timolol Therapeutic Substance Approved Drug 26839-75-8 DB00373 PA451690 n.a. D05UVD 33624 n.a. n.a. "timolol, 26839-75-8, (S)-timolol, Timoptic, Timolol GFS, Timolol anhydrous, (2S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol, Timoptic-XE, (S)-timolol (anhydrous), Timololum [INN-Latin], (-)-3-Morpholino-4-(3-tert-butylamino-2-hydroxypropoxy)-1,2,5-thiadiazole, S-(-)-3-(3-tert-Butylamino-2-hydroxypropoxy)-4-morpholino-1,2,5-thiadiazole, Timolol (INN), (S)-1-(1,1-(Dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl)oxy)-2-propanol, (S)-1-(tert-Butylamino)-3-((4-morpholino-1,2,5-thiadiazol-3-yl)oxy)propan-2-ol, Betimol (TN), Timopic, CHEMBL499, 5JKY92S7BR, CHEBI:9599, DTXSID4023674, (2S)-1-((1,1-dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl)oxy)-2-propanol, NCGC00016798-06, Timololum, TIMOLOL [INN], 2-Propanol, 1-((1,1-dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl)oxy)-, (2S)-, DTXCID203674, 2-Propanol, 1-[(1,1-dimethylethyl)amino]-3-[[4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl]oxy]-, (2S)-, Timolol (TN), CAS-26839-75-8, HSDB 6533, Timolol [USAN:INN], EINECS 248-032-6, CAS-26921-17-5, UNII-5JKY92S7BR, (S)-Timolol; Arutimol; L-Timolol, Tocris-0649, TIMOLOL [HSDB], TIMOLOL [MI], Prestwick0_000948, Prestwick1_000948, Prestwick2_000948, Prestwick3_000948, Lopac-T-6394, TIMOLOL [WHO-DD], SCHEMBL4912, Lopac0_001189, Oprea1_640981, BSPBio_000916, GTPL565, 2-Propanol, 1-((1,1-dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl)oxy)-, (S)-, BIDD:GT0073, SPBio_003075, BPBio1_001008, HMS2089I11, HMS3259C20, Tox21_110614, BDBM50292219, AKOS015969764, Tox21_110614_1, DB00373, NC00592, (2S)-3-[(tert-butyl)amino]-1-(4-morpholin-4-yl(1,2,5-thiadiazol-3-yl)oxy)propa n-2-ol, NCGC00016038-01, NCGC00016038-02, NCGC00016798-01, NCGC00016798-02, NCGC00016798-03, NCGC00016798-05, NCGC00016798-07, NCGC00016798-08, NCGC00016798-09, NCGC00016798-11, NCGC00016798-20, NCGC00022033-02, NCGC00022033-04, NCGC00022033-05, (2S)-1-[(1,1-dimethylethyl)amino]-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol, HY-17494, AB00513729, CS-0009238, NS00115928, C07141, D08600, AB00513729-17, EN300-17982937, Q413994, W-107148, BRD-K08806317-050-03-6, BRD-K08806317-103-02-5, (2S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1, 2, 5-thiadiazol-3-yl)oxy]propan-2-ol, (2S)-1-(tert-butylamino)-3-{[4-(morpholin-4-yl)-1,2,5-thiadiazol-3-yl]oxy}propan-2-ol, (S)-1-(TERT-BUTYLAMINO)-3-((4-MORPHOLINO-1,2,5-THIADIAZOL-3-YL)OXY)-2-PROPANOL, (S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol, (S)-1-tert-Butylamino-3-(4-morpholin-4-yl-[1,2,5]thiadiazol-3-yloxy)-propan-2-ol, 1-(tert-butylamino)-3-[4-(1,4-oxazinan-4-yl)-1,2,5-thiadiazol-3-yloxy]-(2S)-propan-2-ol" C13H24N4O3S BLJRIMJGRPQVNF-JTQLQIEISA-N (2S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol Merck Frosst Antiarrhythmic Agents No No No No No No PMDBD2001245 Tipranavir Therapeutic Substance Approved Drug 174484-41-4 DB00932 PA163522473 n.a. D0EV6T 54682461 10482313 n.a. Tipranavir, 174484-41-4, Aptivus, PNU-140690, TPV, CHEBI:63628, U-140690, UNII-ZZT404XD09, Tipranavir (INN), ZZT404XD09, DTXSID6048622, HSDB 8083, 3''-((1R)-1-((6R)-5,6-Dihydro-4-hydroxy-2-oxo-6-phenethyl-6-propyl-2H-pyran-3-yl)propyl)-5-(trifluoromethyl)-2-pyridinesulfonanilide, U 140690, 2-Pyridinesulfonamide, N-[3-[(1R)-1-[(6R)-5,6-dihydro-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-2H-pyran-3-yl]propyl]phenyl]-5-(trifluoromethyl)-, DTXCID9028548, N-(3-{(1R)-1-[(6R)-4-HYDROXY-2-OXO-6-PHENETHYL-6-PROPYL-5,6-DIHYDRO-2H-PYRAN-3-YL]PROPYL}PHENYL)-5-(TRIFLUOROMETHYL)-2-PYRIDINESULFONAMIDE, TIPRANAVIR [INN], TIPRANAVIR (MART.), TIPRANAVIR [MART.], N-(3-{(1R)-1-[(6R)-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-5,6-dihydro-2H-pyran-3-yl]propyl}phenyl)-5-(trifluoromethyl)pyridine-2-sulfonamide, N-[3-[(1R)-1-[(2R)-4-hydroxy-6-oxo-2-(2-phenylethyl)-2-propyl-3H-pyran-5-yl]propyl]phenyl]-5-(trifluoromethyl)pyridine-2-sulfonamide, PNU 140690, Aptivus(TM), 2-Pyridinesulfonamide, N-(3-((1R)-1-((6R)-5,6-dihydro-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-2H-pyran-3-yl)propyl)phenyl)-5-(trifluoromethyl)-, 2-Pyridinesulfonamide, N-(3-(1-(5,6-dihydro-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-2H-pyran-3-yl)propyl)phenyl)-5-(trifluoromethyl)-, (R-(R*,R*))-, N-{3-[(1R)-1-[(6R)-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-5,6-dihydro-2H-pyran-3-yl]propyl]phenyl}-5-(trifluoromethyl)pyridine-2-sulfonamide, Aptivus (TN), Tipranavir [INN:BAN], tipranavirum, Tipranavir?, NCGC00182028-01, N-(3-((1R)-1-((6R)-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-5,6-dihydro-2H-pyran-3-yl)propyl)phenyl)-5-(trifluoromethyl)pyridine-2-sulfonamide, tipranavir, (R-(R*,R*))-isomer, 1d4y, 2o4l, 2o4n, 2o4p, TIPRANAVIR [MI], TIPRANAVIR [VANDF], TIPRANAVIR [WHO-DD], SCHEMBL40629, SCHEMBL40630, N-[3-[(1R)-1-[(2R)-6-hydroxy-4-oxo-2-phenethyl-2-propyl-3H-pyran-5-yl]propyl]phenyl]-5-(trifluoromethyl)pyridine-2-sulfonamide, TIPRANAVIR [EMA EPAR], CHEMBL183041, CHEMBL222559, TIPRANAVIR [ORANGE BOOK], GTPL12685, J05AE09, NZPXPXAGXYTROM-FYBSXPHGSA-N, SUJUHGSWHZTSEU-FYBSXPHGSA-N, EX-A4113, Tox21_112962, BDBM50479982, AKOS030254403, CS-1210, DB00932, NCGC00379087-01, NCGC00379087-02, AS-79082, HY-15148, N-[3-[(1R)-1-[(2R)-6-hydroxy-4-oxo-2-(2-phenylethyl)-2-propyl-3H-pyran-5-yl]propyl]phenyl]-5-(trifluoromethyl)pyridine-2-sulfonamide, N-[3-[(1R)-1-[(6R)-5,6-Dihydro-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-2H-pyran-3-yl]propyl]phenyl]-5-(trifluoromethyl)-2-pyridinesulfonamide, CAS-174484-41-4, NS00015496, D08605, F84910, A811642, EN300-19769351, Q423404, J-010991, N-[3-[(1R)-1-[(2R)-4-hydroxy-6-oxo-2-phenethyl-2-propyl-3H-pyran-5-yl]propyl]phenyl]-5-(trifluoromethyl)pyridine-2-sulfonamide, N-[3-[(1R)-1-[(2R)-6-hydroxy-4-oxo-2-(2-phenylethyl)-2-propyl-3H-pyran-5-yl]propyl]phenyl]-5-(trifluoromethyl)-2-pyridinesulfonamide, N-[3-[(1R)-1-[(2R)-6-oxidanyl-4-oxidanylidene-2-(2-phenylethyl)-2-propyl-3H-pyran-5-yl]propyl]phenyl]-5-(trifluoromethyl)pyridine-2-sulfonamide C31H33F3N2O5S SUJUHGSWHZTSEU-FYBSXPHGSA-N N-[3-[(1R)-1-[(2R)-4-hydroxy-6-oxo-2-(2-phenylethyl)-2-propyl-3H-pyran-5-yl]propyl]phenyl]-5-(trifluoromethyl)pyridine-2-sulfonamide Boehriger Ingelheim Anti-HIV Agents No No No No No No PMDBD2001246 Titanium dioxide Therapeutic Substance n.a. 13463-67-7 DB09536 n.a. n.a. n.a. 26042 n.a. n.a. TITANIUM DIOXIDE, Titanium oxide, 13463-67-7, Titanium(IV) oxide, Rutile, dioxotitanium, Anatase, Titania, 1317-70-0, 1317-80-2, Anatase (TiO2), Rutile (TiO2), Titanium White, Titafrance, Hombitan, Tiofine, Tioxide, Tipaque, Titanox, Rayox, Bayertitan A, Titanic anhydride, Tioxide RHD, Tioxide RSM, Zopaque LDC, Rutiox CR, Titanox RANC, A-Fil Cream, Calcotone White T, Tioxide A-DM, Tioxide AD-M, Levanox White RKB, Flamenco, Titandioxid, A-Fil, Kronos, Tronox, Unitane, Zopaque, Runa rh20, Unitane or-150, Unitane or-340, Unitane or-342, Unitane or-350, Unitane or-540, Unitane or-640, Bayertitan T, Kronos RN 40P, Kronos RN 56, Tiona td, Horse head a-420, Unitane OR 450, Unitane OR 650, Tin dioxide dust, Titanium peroxide, Titanox 2010, Uniwhite AO, Uniwhite KO, Kronos CL 220, Kronos titanium dioxide, Unitane OR, Kronos 2073, Ti-Pure, Bayertitan AN 3, Tioxide R-CR, Tioxide R-SM, Tioxide R.XL, 1700 White, Runa ARH 200, Bayertitan R-U-F, Titanium peroxide (TiO2), Aerosil P 25, Aerosil P 27, Austiox R-CR 3, Bayertitan, Baytitan, Cab-O-Ti, Titandioxid (sweden), Aerolyst 7710, Hombitan R 101D, Hombitan R 610K, Unitane o-110, Unitane o-220, Uniwhite OR 450, Uniwhite OR 650, Horse head a-410, Horse head r-710, Aerosil P 25S6, Aerosil T 805, Atlas white titanium dioxide, Tipaque R 820, Titanium(IV) oxide, rutile, Blend White 9202, 63B1 White, Amperit 780.0, Unitane 0-110, Unitane 0-220, Cosmetic White C47-5175, Runa ARH 20, Titanium oxide (TiO2), P 25 (oxide), RO 2, CG-T, Ti-Pure R 900, Ti-Pure R 901, Bistrater L-NSC 200C, Tiona t.d., C-Weiss 7, Titanium(IV) oxide, anatase, CCRIS 590, Cosmetic White C47-9623, TiO2, KH 360, A-FN 3, HSDB 869, NCI-C0424O, AUF 0015S, AMT 600, JR 600A, Cosmetic Hydrophobic TiO2 9428, 234DA, 500HD, NCI-C04240, Cosmetic Micro Blend TiO2 9228, dioxyde de titane, UNII-15FIX9V2JP, C.I. 77891, dioxido de titanio, E 171, EINECS 215-282-2, EINECS 236-675-5, CL 310, NSC 15204, Orgasol 1002D White 10 Extra Cos, Brookite, CCRIS 9325, CI 77891, oxido de titanio(IV), 1385RN 59, AI3-01334, BR 29-7-2, R 680, Titanium dioxide (USP), Titanium dioxide [USP], 15FIX9V2JP, CHEBI:32234, EC 215-282-2, EC 236-675-5, NSC15204, MFCD00011269, NSC-15204, Octahedrite, Tichlor, Titanic oxide, Titan White, Anatase titanium dioxide, Trioxide(s), (TiO2), [TiO2], Austiox R-CR, Tioxide A-HR, Tioxide R XL, Bayertitan R-U 2, Bayertitan R-FK-D, Bayertitan R-FD 1, Bayertitan R-KB 2, Bayertitan R-KB 3, Bayertitan R-KB 4, Bayertitan R-KB 5, Bayertitan R-KB 6, Tinoc M 6, Octahedrite (mineral), Titandioxid [Swedish], austiox, Bayer R-FD 1, bayeritian, Bayertitan R-FK 21, Titanium oxide (VAN), Kronos 1002, R 830 (mineral), C-Weiss 7 [German], MC 50 (oxide), C 97 (oxide), NT 100 (oxide), Bayertitan R-V-SE 20, S 150 (oxide), Titanium(IV) oxide, catalyst support, 15 wt% Titanium Oxide in Water Nano, unitane or 572, AMT 100, Rutile titanium dioxide, EINECS 215-280-1, TITANIUM DIOXIDE ENAMEL GRADE, Finntitan, CCRIS 9317, Photo Plasma, Dermablend Cover, Titanium-Dioxide, LBelEffet Parfit, Titantium Dioxide, BB Cream Medium, (rutile), Silky Eye Primer, bis(oxido)titanium, BB Cream, KH360, component of A-Fil, Covergirl Aquasmooth, UNID Physical Sun, White Holic 50mL, Complexion Protection, G.M. Collin, SPF 15Medium, spf 30 Lip Balm, KOWET, LOVEA, Natural SPF 30, NUFIL, SPF 15Light, Antibacterial PE film, Natural Sunscreen Tan, oxido de titanio(4), SPF 15Warm Tan, titanium dioxide cream, 98084-96-9, White Holic 100mL O2Ti GWEVSGVZZGPLCZ-UHFFFAOYSA-N dioxotitanium n.a. n.a. No No No No No No PMDBD2001247 TMB-8 Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D01WXA 5494 n.a. n.a. TMB-8, 8-(Diethylamino)octyl 3,4,5-trimethoxybenzoate, 57818-92-5, 8-(N,N-Diethylamino)octyl-3,4,5-trimethoxybenzoate, T9NF33OQ5T, 3,4,5-Trimethoxybenzoic acid, 8-(diethylamino)octyl ester, TMB 8, TM-8, UNII-T9NF33OQ5T, Lopac-861804, Lopac0_000022, BSPBio_001503, CHEMBL258764, GTPL4323, SCHEMBL2173737, DTXSID70206532, CHEBI:107633, HMS1791L05, HMS1989L05, HMS3402L05, EI-110, CCG-204118, SDCCGSBI-0050011.P002, NCGC00014998-01, NCGC00014998-02, NCGC00014998-03, NCGC00014998-04, NCGC00014998-05, NCGC00014998-06, NCGC00014998-07, NCGC00162047-01, NCGC00162047-02, NCGC00162047-03, NCGC00162047-04, BRD-K58220566-001-02-2, Q27089002, Benzoic acid, 3,4,5-trimethoxy-, 8-(diethylamino)octyl ester, TRIMETHOXYBENZOIC ACID, 8-(DIETHYLAMINO)OCTYL ESTER, 3,4,5- C22H37NO5 IBQMHBGFMLHHLE-UHFFFAOYSA-N 8-(diethylamino)octyl 3,4,5-trimethoxybenzoate n.a. n.a. No No No No No No PMDBD2001248 TMC-151s C n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001249 Tobramycin-bismuth-ethanedithiol n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001250 Tomentosin n.a. n.a. n.a. n.a. n.a. n.a. n.a. 155173 n.a. NPC138408 Tomentosin, 33649-15-9, Xanthalongi, CHEBI:9631, 6-Deacetoxybritanlin G, CHEMBL1164483, SCHEMBL12476412, DTXSID10955274, HY-N8284, (3aR,7S,8aR)-7-methyl-3-methylidene-6-(3-oxobutyl)-4,7,8,8a-tetrahydro-3aH-cyclohepta[b]furan-2-one, CS-0142625, NS00094046, C09562, Q27108453, (3aR,7S,8aR)-7-Methyl-3-methylene-6-(3-oxobutyl)-3,3a,4,7,8,8a-hexahydro-2H-cyclohepta[b]furan-2-one, 2H-Cyclohepta(b)furan-2-one, 3,3a,4,7,8,8a-hexahydro-7-methyl-3-methylene-6-(3-oxobutyl)-, (3aR,7S,8aR)-, 7-Methyl-3-methylidene-6-(3-oxobutyl)-3,3a,4,7,8,8a-hexahydro-2H-cyclohepta[b]furan-2-one C15H20O3 AVFIYMSJDDGDBQ-CUOATXAZSA-N (3aR,7S,8aR)-7-methyl-3-methylidene-6-(3-oxobutyl)-4,7,8,8a-tetrahydro-3aH-cyclohepta[b]furan-2-one n.a. n.a. No No No No No No PMDBD2001251 trans-2-dodecenoic acid n.a. n.a. n.a. n.a. n.a. n.a. n.a. 5282729 n.a. NPC28853 Dodec-2-enoic acid, (E)-dodec-2-enoic acid, trans-2-Dodecenoic acid, 32466-54-9, 4412-16-2, 2-Dodecenoic acid, (2E)-dodec-2-enoic acid, (2E)-2-Dodecenoic acid, Dodecenoic acid, trans-dodec-2-enoic acid, 2E-Lauroleic acid, 2E-Dodecenoic acid, 1289-45-8, C12:1n-10, (E)-2-dodecenoic acid, TRANS-2-DODECENOICACID, 2-Dodecensaeure, 2t-Dodecensaeure, Dodec-2-ensaeure, Dodec-2-enoicacid, EINECS 224-569-1, Dodecen-(2t)-saeure, trans-2-lauroleic acid, 12:1, n-10 trans, C12:1, n-10 trans, CHEMBL4281333, CHEBI:37162, CHEBI:38371, DTXSID401343611, AMY37907, LMFA01030788, MFCD00045906, NSC 59856, AKOS008105134, AS-57983, WS-00320, AI3-11152, C12:1, CS-0152270, D5660, EN300-65552, EN300-365600, W16764, A826494, A934942, Q27117056, Q27117632, Z336127680, 3X1 C12H22O2 PAWGRNGPMLVJQH-ZHACJKMWSA-N (E)-dodec-2-enoic acid n.a. n.a. No No No No No No PMDBD2001252 trans-2-Nonenal n.a. n.a. n.a. n.a. n.a. n.a. n.a. 5283335 n.a. NPC33489 trans-2-Nonenal, 2-NONENAL, 18829-56-6, (E)-Non-2-enal, (E)-2-Nonenal, 2-Nonenal, (2E)-, 2463-53-8, 2-Nonenal, (E)-, 2-trans-Nonenal, 3-Hexyl-2-propenal, trans-2-Nonen-1-al, (2E)-non-2-enal, 3-Hexylacrolein, (E)-2-nonen-1-al, 2-Nonen-1-al, (2E)-2-Nonenal, FEMA No. 3213, beta-Hexylacrolein, Heptylideneacetaldehyde, alpha-Nonenyl aldehyde, trans-2-Nonenal-D2, MFCD00007012, DTXSID0047086, 8VEO649985, 213595-54-1, 3-hexyl-acrolein, .beta.-Hexylacrolein, trans-2-Nonenal (natural), trans-Non-2-enal, .alpha.-Nonenyl aldehyde, CCRIS 3326, CCRIS 9203, EINECS 219-562-5, EINECS 242-609-6, NSC 20746, CHEBI:61726, BRN 1722170, AI3-36268, UNII-8VEO649985, t-2-nonenal, (2e)-nonenal, ?2-Nonenal, trans-2-nonealdehyde, heptylidene acetaldehyde, trans-2-Nonenal, 97%, UNII-93C6BZW2TV, 2-NONENAL [FHFI], 2-NONENAL [MI], 2-NONENAL, TRANS-, 93C6BZW2TV, 4-01-00-03502 (Beilstein Handbook Reference), SCHEMBL102464, CHEMBL450072, DTXCID8027086, (E)-2-NONENAL [FCC], CHEBI:142592, trans-2-Nonenal, >=95%, FG, Tox21_300815, LMFA06000041, trans-2-Nonenal, analytical standard, AKOS015902295, NCGC00248181-01, NCGC00254719-01, AS-17376, LS-13683, CAS-18829-56-6, N0430, N0483, NS00083046, EN300-396736, EN300-1664833, J-012128, Q4596912 C9H16O BSAIUMLZVGUGKX-BQYQJAHWSA-N (E)-non-2-enal n.a. n.a. No No No No No No PMDBD2001253 trans-2-Pentenal Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D08MUZ 5364752 n.a. NPC72258 trans-2-Pentenal, 2-PENTENAL, 1576-87-0, (E)-pent-2-enal, (E)-2-Pentenal, 764-39-6, 3-Ethylacrolein, 2-(E)-Pentenal, 2-Pentenal, (E)-, pent-2-enal, 2-Pentenal, (2E)-, (E)-Pent-2-en-1-al, 2-Ethylacrylic aldehyde, trans-2-Penten-1-al, 3-Ethyl-2-propenal, (2E)-2-Pentenal, (2E)-pent-2-enal, gamma-Methylcrotonaldehyde, trans-pent-2-enal, FEMA No. 3218, Pentenal, MFCD00009615, 7A4R3CQA2T, CHEMBL256368, 2-Penten-1-al, Pentenal, (E)-, Propylidenacetaldehyd, beta-Aethyl-acrolein, 3-ethylprop-2-enal, 31424-04-1, CCRIS 3514, CCRIS 4564, (E)-2-penten-1-al, EINECS 212-120-2, EINECS 216-414-1, UNII-7A4R3CQA2T, CHEBI:61722, BRN 1719742, beta-ethylacrolein, e-2-pentenal, ?trans-2-Pentenal, (E)-3-ethylacrolein, 2-TRANS-PENTENAL, (2E)-2-Pentenal #, trans-2-Pentenal, 95%, (E)-3-ethyl-2-propenal, 2-PENTENAL [FHFI], GTPL2417, DTCCTIQRPGSLPT-ONEGZZNKSA-, DTXSID80858788, CHEBI:156100, trans-2-Pentenal, >=95%, FG, .GAMMA.-METHYLCROTONALDEHYDE, BDBM50203069, trans-2-Pentenal, analytical standard, AKOS015836373, HY-W111375, CS-0173472, NS00083236, P1790, EN300-321467, DIETHYL(AMINOMETHYL)PHOSPHONATEOXALATESALT, A809867, A838705, J-009437, Q24705869, InChI=1/C5H8O/c1-2-3-4-5-6/h3-5H,2H2,1H3/b4-3+ C5H8O DTCCTIQRPGSLPT-ONEGZZNKSA-N (E)-pent-2-enal n.a. n.a. No No No No No No PMDBD2001254 trans-Stillbene n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001255 Tricaine Therapeutic Substance n.a. 582-33-2 DB11552 n.a. D08632 n.a. 261501 13860074 n.a. "886-86-2, Ethyl 3-aminobenzoate methanesulfonate, Tricaine methanesulfonate, Tricaine, Finquel, Tricaine mesylate, MS-222, 3-Aminobenzoic acid ethyl ester methanesulfonate, Metacaine, Ethyl m-aminobenzoate methanesulfonate, Tricaine mesilate, metacaine mesylate, Tricaine methane sulfonate, Ethyl 3-aminobenzoate methanesulfonic acid salt, metacaine methanesulfonate, MFCD00013176, NSC-93790, TS-222, Ethyl 3-aminobenzoate, methanesulfonic acid salt, Tricaine (methanesulfonate), 971ZM8IPK1, DTXSID6022133, MS 222, CHEBI:131331, Ethyl m-aminobenzoate, methanesulfonic acid salt, 3-(ethoxycarbonyl)anilinium methanesulfonate, TS 222, Ethyl m-aminobenzoate methane sulfonate, methanesulfonic acid--ethyl 3-aminobenzoate (1/1), DTXCID502133, TRICAINE MESILATE (MART.), TRICAINE MESILATE [MART.], 3-Aminobenzoic acid ethyl ester methanesulfonate salt, CAS-886-86-2, NCGC00166020-01, C10H15NO5S, Benzoic acid, 3-amino-, ethyl ester, methanesulfonate (1:1), ethyl 3-aminobenzoate;methanesulfonic acid, Ethyl 3-aminobenzoate methanesulfonate salt, TRICAINE [MI], MS 222 (veterinary), ETHYL 3-AMINOBENZOATE METHANESULPHONATE SALT, WLN: ZR CVO2 &WSQ1, CHEMBL3184210, HMS3885O19, BCP09224, NSC93790, Tox21_112290, s3682, AKOS015852379, Tox21_112290_1, CCG-267065, CS-W012493, DS-4091, HY-W011777, NCGC00166020-03, SY033468, TRICAINE METHANESULFONATE [WHO-DD], Benzoic acid, ethyl ester, methanesulfonate, Ethyl 3-aminobenzoate methanesulfonate, 98%, T0941, TRICAINE METHANESULFONATE [GREEN BOOK], H11281, A842843, Q3533237, W-100390, Ethyl 3-aminobenzoate methanesulfonate salt, analytical standard, 3-Amino-benzoic acid ethyl ester; compound with methanesulfonic acid" C10H15NO5S FQZJYWMRQDKBQN-UHFFFAOYSA-N "ethyl 3-aminobenzoate;methanesulfonic acid" n.a. n.a. No No No No No No PMDBD2001256 Triclosan? n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001257 Triethyl[2-({10,15,20,24,26,29,31,33,34-nonakis[3-(triethylphosphaniumyl)propoxy]hexacyclo[21.2.2.2,.2,.2,.2]pentatriaconta-1(25),3(35),4,6(34),8,10,13,15,18,20,23,26,28,30,32-pentadecaen-4-yl}oxy)ethyl]phosphanium decabromide n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001258 Triethyl[3-({33-[2-(triethylazaniumyl)ethoxy]-10,15,20,25,27,29,31,34-octakis[3-(triethylazaniumyl)propoxy]hexacyclo[21.2.2.2.2.2.2]pentatriaconta-1(25),3,5,8,10,13,15,18,20,23,26,28,30,32,34-pentadecaen-4-yl}oxy)propyl]azanium decabromide n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001259 Trimethoprim-sulfamethoxazole Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. D0P0VD 358641 n.a. n.a. "sulfamethoxazole & trimethoprim, sulfamethoxazole + trimethoprim, CO-Trimoxazole, Trimosulfa, Cotrimoxazole, 8064-90-2, Septra, Sulfatrim, Trimforte, Cotrim, Trimethoprimsulfa, Sulfamethoxazole-trimethoprim, TMP-SMX, Trimethoprim-sulfamethoxazole, Abactrim, Gantrim, SULFAMETHOXAZOLE AND TRIMETHOPRIM, Septra Grape, Sulfatrim-Ds, Sulfatrim-Ss, Septra Ds, Bactrim Pediatric, Bactrim DS, Uroplus DS, Uroplus SS, Sulfamethoprim-DS, Sulfatrim Pediatric, Sulmeprim Pediatric, Aposulfatrim, Bactoreduct, Cotrimhexal, Cotrimoxazol, Cotrimstada, Jenamoxazol, Sulfotrimin, Supracombin, Agoprim, Alfatrim, Bacteral, Bactilen, Bactiver, Bactrizol, Bactromin, Bactropin, Berlocid, Bibacrim, Chemitrim, Chemotrim, Cotribene, Cotriver, Dibaprim, Duratrimet, Eltrianyl, Escoprim, Esteprim, Fectrim, Gantaprim, Gantaprin, Groprim, Helveprim, Kemoprim, Laratrim, Linaris, Maxtrim, Microtrim, Mikrosid, Momentol, Oecotrim, Oxaprim, Pantoprim, Primazole, Septrim, Servitrim, Sigaprim, Sigaprin, Sulfotrim, Tacumil, Teleprim, Teleprin, Thiocuran, Tribakin, Trigonyl, Trimesulf, Trimetoger, Trimexazol, Uroplus, Abacin, Bacton, Baktar, Ciplin, Imexim, Suprim, Trifen, Bacterial forte, Comox, Microtrim forte, Nopil, Omsat, Duon, Trimetho comp, Bactrim Forte, Co-Trimaxazol, Cotrim Holsen, Cotrimox-Wolff, Trimethoprim-sulfamethoxazole combination, Cotrim-Puren, Cotrimoxazol AL, Strepto-Plus, Cotrim-Hefa, Trimexole-F, Baktrisid-DS, TMP/SMX, TRIMETHOPRIM/SULFAMETHOXAZOLE, Co-trim-tablinen, Cotrim-radiopharm, Sulfa-Tyl, Sulfameth/TMP, Sulfameth/Trimeth, Cotrim Eu Rho, Cotrim_BASF, Cotrimoxazol-Cophar, Trimethoprim and sulphamethoxazole, Cotrim D.S., Sulfamethoxazole Trimethoprim, Cotrim.L.U.T., SMX-TMP, SMX/TMP, Sulfamethoxazole / trimethoprim, Sulfamethoxazole-trimeth, Trimethoprim and sulfamethoxazole, HSDB 6780, TMS 480, A 033, NSC618652, NSC 618652, SULFAMETHOXAZOLE AND TRIMETHOPRIM DOUBLE STRENGTH, SULFAMETHOXAZOLE AND TRIMETHOPRIM SINGLE STRENGTH, CHEBI:3770, DTXSID0032233, Biseptol, Eusaprim, Kepinol, Oriprim, Sulprim, Sumetrolim, Drylin, Kepinol Forte, Cotrimoxazole (Trimethoprim/sulfamethoxazole 1:5), Benzenesulfonamide, 4-a)mino-N-(5-methyl-3-isoxazolyl)-, mixt. with 5-((3,4,5-trimethoxyphenyl)methyl-2,4-pyrimidinediamine, Cotrimoxazole (Trimethoprim/sulfamethoxazole 1:19), Centran, Centrin, Eslectin, Insozalin, Septrin, Trimedin, Trimezole, 4-amino-N-(5-methyl-1,2-oxazol-3-yl)benzenesulfonamide;5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine, 4-amino-N-(5-methylisoxazol-3-yl)benzenesulfonamide compound with 5-(3,4,5-trimethoxybenzyl)pyrimidine-2,4-diamine (1:1), Benzenesulfonamide, 4-amino-N-(5-methyl-3-isoxazolyl)-, mixt. with 5-((3,4,5-trimethoxyphenyl)methyl)-2,4-pyrimidinediamine, Benzenesulfonamide, 4-amino-N-(5-methyl-3-isoxazolyl)-, mixt. with 5-[(3,4,5-trimethoxyphenyl)methyl]-2,4-pyrimidinediamine, Sulfamethoxazole / TMP, SMX / TMP, TMP / SMX, Sulfamethoxazole/Trimethoprim, Co-Trimazole, Bactrim (TN), SULFAMETHOXAZOLE; TRIMETHOPRIM, Septra (TN), Sulfamethox-TMP DS, Sulfamethoxazole/TMP, Sulfameth/Trimeth-DS, Co-Trimoxazole (BAN), sulfamethoxazol/trimetoprim, Epitope ID:141805, TMP & SMX, Trimethoprim, Sulfamethoxazole Drug Combination, Sulfamethoxazole;Trimethoprim, Trimethoprim;Sulfamethoxazole, CHEMBL58061, SCHEMBL870329, Trimethoprim & Sulfamethoxazole, Trimethoprim / Sulfamethoxazole, WZRJTRPJURQBRM-UHFFFAOYSA-N, DTXCID301474601, Sulfamethoxazole and TrimethoprimDS, Sulfamethoxazole and Trimethoprim DS, Sulfamethoxazole-trimethoprim mixture, SULFAMETHOXAZOLE, TRIMETHOPRIM, AKOS030548395, HY-141619A, NSC-618652, HY-141619, CS-0182655, CS-0885981, NS00076153, D00285, Q898623, SULFAMETHOXAZOLE AND TRIMETHOPRIMdouble strength, Benzenesulfonamide, mixt. with 5-[(3,4,5-trimethoxyphenyl)methyl]-2,4- pyrimidinediamine, 4-amino-N-(5-methyl-1,2-oxazol-3-yl)benzenesulfonamide-5-(3,4,5-trimethoxybenzyl)pyrimidine-2,4-diamine (1:1), 4-amino-N-(5-methylisoxazol-3-yl)benzenesulfonamide; 5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine, 50808-41-8, Benzenesulfonamide, 4-amino-N-(5-methyl-3-isoxazolyl)- & 5-((3,4,5-trimethoxyphenyl)methyl)-2,4-pyrimidinediamine, Pyrimidine, 2,4-diamino-5-(3,4,5-trimethoxybenzyl)- and N''-(5-methyl-3-isoxazolyl)sulfanilamide, Pyrimidine, 2,4-diamino-5-(3,4,5-trimethoxybenzyl)-and N''-(5-methyl-3-isoxazolyl)sulfanilamide, SXT" C24H29N7O6S WZRJTRPJURQBRM-UHFFFAOYSA-N "4-amino-N-(5-methyl-1,2-oxazol-3-yl)benzenesulfonamide;5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine" n.a. n.a. No No No No No No PMDBD2001260 Trimethoxyflavone n.a. n.a. n.a. n.a. n.a. n.a. n.a. 53666501 n.a. n.a. Trimethoxyflavone, SCHEMBL1765292 C18H16O5 AWXFHJXPYIPUSS-UHFFFAOYSA-N 3,5,6-trimethoxy-2-phenylchromen-4-one n.a. n.a. No No No No No No PMDBD2001261 Trimethyl(3-{4-[3-(trimethylazaniumyl)propoxy]phenoxy}propyl)azanium dibromide n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001262 Trimethyl(3-{4-[3-(trimethylphosphaniumyl)propoxy]phenoxy}propyl)phosphanium dibromide n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001263 Trimethyl[2-({10,15,20,24,26,29,31,33,34-nonakis[3-(trimethylphosphaniumyl)propoxy]hexacyclo[21.2.2.2,.2,.2,.2]pentatriaconta-1(25),3(35),4,6(34),8,10,13,15,18,20,23,26,28,30,32-pentadecaen-4-yl}oxy)ethyl]phosphanium decabromide n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001264 Trimethyl[3-({33-[2-(trimethylazaniumyl)ethoxy]-10,15,20,25,27,29,31,34-octakis[3-(trimethylazaniumyl)propoxy]hexacyclo[21.2.2.2,.2,.2,.2]pentatriaconta-1(25),3,5,8,10,13,15,18,20,23,26,28,30,32,34-pentadecaen-4-yl}oxy)propyl]azanium decabromide n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001265 Tyrosol Therapeutic Substance n.a. 501-94-0 DB16855 n.a. n.a. n.a. 10393 9964 NPC300017 "2-(4-Hydroxyphenyl)ethanol, Tyrosol, 501-94-0, 4-(2-Hydroxyethyl)phenol, 4-Hydroxyphenethyl alcohol, 4-Hydroxyphenylethanol, 4-Hydroxybenzeneethanol, p-Hydroxyphenethyl alcohol, Benzeneethanol, 4-hydroxy-, p-Tyrosol, 4-Hydroxyphenylethyl alcohol, Tyrosol C, 2-(4-Hydroxyphenyl)ethyl Alcohol, MFCD00002902, NSC 59876, p-Thyrosol, UNII-1AK4MU3SNX, 1AK4MU3SNX, EINECS 207-930-8, beta-(4-Hydroxyphenyl)ethanol, CHEBI:1879, p-HPEA, 2-(P-HYDROXYPHENYL)ETHANOL, Metoprolol IMpurity 07, 4-hydroxy-Benzeneethanol, NSC-59876, p-Hydroxyphenylethyl alcohol, 4-(2-Hydroxy-ethyl)-phenol, CHEMBL53566, DTXSID8060111, HYDROXYPHENETHYL ALCOHOL, P-, p-hydroxyphenylethanol, n-tyrosol, SMR000857159, para-hydroxyphenylethanol, 4-hydroxyphenethylalcohol, METOPROLOL TARTRATE IMPURITY G (EP IMPURITY), METOPROLOL TARTRATE IMPURITY G [EP IMPURITY], METOPROLOL SUCCINATE IMPURITY G (EP IMPURITY), METOPROLOL SUCCINATE IMPURITY G [EP IMPURITY], 4-tyrosol, YRL, Tyrosol ,(S), 2-(4-Hydroxyphenyl)ethanol (Tyrosol), 4-hydroxybenzenethanol, 4-(Hydroxyethyl)phenol, p-Hydroxy-benzeneethanol, TYROSOL [MI], b-(p-Hydroxyphenyl)ethanol, bmse000173, b-(4-Hydroxyphenyl)ethanol, 4-Hydroxyphenylmethylcarbinol, 2-(p-hydroxyphenyl) ethanol, SCHEMBL43838, (4-Hydroxyphenethyl) alcohol, 2-(4-hydroxyphenyl) ethanol, 2-(4-hydroxyphenyl)-ethanol, beta-(p-Hydroxyphenyl)ethanol, MLS001332423, MLS001332424, Phenethyl alcohol, p-hydroxy-, Ethanol, 2-(4-hydroxyphenyl), DTXCID7040780, SCHEMBL10620528, .beta.-(p-Hydroxyphenyl)ethanol, 2-(4-Hydroxyphenyl)-1-ethanol, Ethanol, 2-(4-hydroxyphenyl)-, .beta.-(4-Hydroxyphenyl)ethanol, HMS2230E12, 2-(4-Hydroxyphenyl)ethanol, 98%, BCP34277, HY-N0474, NSC59876, STR02735, BDBM50339585, s3773, AKOS000280287, AC-2493, CCG-266147, CS-W019782, KS-5274, NCGC00246994-01, NCGC00246994-03, SY001653, AM20060146, H0720, NS00014657, C06044, EN300-116733, TYROSOL (CONSTITUENT OF RHODIOLA ROSEA), 2-(4-Hydroxyphenyl)ethanol, analytical standard, NSC 59876; p-HPEA;4-Hydroxyphenethyl alcohol, Q402607, TYROSOL (CONSTITUENT OF RHODIOLA ROSEA) [DSC], F0001-1309, Z1250886919, 947D0361-23C6-4863-8346-22AB05108AC5, 4-hydroxy-Benzeneethanol;4-Hydroxyphenylethanol;beta-(4-Hydroxyphenyl)ethanol, InChI=1/C8H10O2/c9-6-5-7-1-3-8(10)4-2-7/h1-4,9-10H,5-6H" C8H10O2 YCCILVSKPBXVIP-UHFFFAOYSA-N 4-(2-hydroxyethyl)phenol n.a. n.a. No No No No Yes No rxn02996,rxnDiet211 PMDBD2001266 Tyrphostin 9 n.a. n.a. n.a. n.a. n.a. n.a. n.a. 5614 n.a. n.a. "Malonoben, tyrphostin A9, 10537-47-0, Tyrphostin 9, 2-(3,5-Di-tert-butyl-4-hydroxybenzylidene)malononitrile, NSC 242557, GCP 5126, ENT 27910, SF 6847, RG-50872, AG 17, Tyrphostin 9AG-17, (3,5-Di-t-butyl-4-hydroxybenzylidene)malononitrile, Tyrphostin 9 (RG-50872, Malonaben, SF 6847), S-15126, 3,5-di-t-Butyl-4-hydroxy-benzylidenemalononitrile, MLS002702095, 87TE8MRS65, CHEBI:82168, GCP5126, 2-[(3,5-di-tert-butyl-4-hydroxyphenyl)methylidene]propanedinitrile, Propanedinitrile, 2-((3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl)methylene)-, MFCD00209853, NSC242557, NSC-242557, 2-[(3,5-ditert-butyl-4-hydroxyphenyl)methylidene]propanedinitrile, 2,6-Di-tert-butyl-4-(2,2-dicyanovinyl)phenol, Malonoben [ANSI], 3,5-Di-tert-butyl-4-hydroxybenzilidenemalononitrile, (3,5-Di-tert-butyl-4-hydroxy-benzylidene)malononitrile, 3,5-DI-TERT-BUTYL-4-HYDROXYBENZYLIDENEMALONONITRILE, Caswell No. 291AA, [[3,5-bis(1,1-Dimethylethyl)-4-hydroxyphenyl]methylene]propanedinitrile, 2-[[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]methylene]-propanedinitrile, Gulf S-15126, (6S)-2-[(3-Chloro-4-fluorophenyl)methyl]-N,8-diethyl-1,2,6,7,8,9-hexahydro-10-hydroxy-6-methyl-1,9-dioxo-pyrazino[1'',2'':1,5]pyrrolo[2,3-d]pyridazine-4-carboxam, SMR001230759, Malonoben [ANSI:ISO], EPA Pesticide Chemical Code 537200, BRN 2700764, UNII-87TE8MRS65, Malonaben, AI3-27910, tyrphostin-A9, ((3,5-BIS(1,1-DIMETHYLETHYL)-4-HYDROXYPHENYL)METHYLENE)PROPANEDINITRILE, propanedinitrile, 2-[[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]methylene]-, Tyrphostin AG 17, SF-6847, Tyrphostin A9, solid, TYRPHOSTINA9, MALONOBEN [ISO], Lopac-T-182, BiomolKI_000020, 2-((3,5-Bis(1,1-dimethyl)-4-hydroxyphenyl)methylene)propanedinitrile, BiomolKI2_000009, 2-((3,5-bis(1,1-Dimethylethyl)-4-hydroxyphenyl)methylene)propanedinitrile, Propanedinitrile, ((3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl)methylene)-, Neuro_000115, CBiol_001719, Lopac0_001254, Oprea1_168738, BMK1-C8, BSPBio_001200, KBioGR_000540, KBioSS_000540, 4-10-00-02178 (Beilstein Handbook Reference), MLS002153354, CHEMBL78150, SCHEMBL120440, TYRPHOSTIN 9, AG-9, Tyrphostin 9 (SF 6847), AG17, BDBM4325, (3,5-di-tert-butyl-4-hydroxybenzylidene)propanedinitrile, DTXSID1042106, KBio2_000540, KBio2_003108, KBio2_005676, KBio3_000979, KBio3_000980, Malononitrile, (3,5-di-tert-butyl-4-hydroxybenzylidene)-, Bio1_000005, Bio1_000494, Bio1_000983, Bio2_000440, Bio2_000920, HMS1362L21, HMS1792L21, HMS1990L21, HMS2232D08, HMS3263L10, HMS3371F08, HMS3403L21, HMS3651J06, MALONONITRILE, 3,5-DI-tert-BUTYL-4-HYDROXYBENZYLIDENE-, 2-[(3,5-ditert-butyl-4-hydroxy-phenyl)methylene]propanedinitrile, BCP06486, GCP-5126, Tox21_501254, HSCI1_000185, s2895, AKOS024319213, Propanedinitrile,2-[[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]methylene]-, CCG-100624, CS-1033, LP01254, SDCCGSBI-0051221.P002, IDI1_002195, benzylidenemalononitrile (BMN) deriv. 9, NCGC00015992-01, NCGC00015992-02, NCGC00015992-03, NCGC00015992-04, NCGC00015992-05, NCGC00015992-06, NCGC00015992-07, NCGC00094494-01, NCGC00094494-02, NCGC00094494-03, NCGC00094494-04, NCGC00094494-05, NCGC00261939-01, AC-32053, HY-15511, LS-14656, NCI60_001943, SF 6847;RG-50872, EU-0101254, NS00123653, SW219498-1, T-182, T3667, C19039, N10851, AG 17 - CAS 10537-47-0, SR-01000075534, J-001407, J-524054, Malononitrile,5-di-tert-butyl-4-hydroxybenzylidene-, SR-01000075534-1, 3,5-di-tert-butyl-4-hydroxybenzylidene-malononitrile, BRD-K40255344-001-04-4, BRD-K40255344-001-05-1, Q27155778, (3,5-di-tert-butyl-4-hydroxybenzylidene)-Malononitrile, 2-(3,5-Di-tert-butyl-4-hydroxy-benzylidene)-malononitrile, 3,5-DI-TERT-BUTYL-4-HYDROXYBENZYLIDENEMALONITRILE, 2-[[3,1-dimethyl)-4-hydroxyphenyl]methylene]propanedinitrile, 2-[[3,1-dimethylethyl)-4-hydroxyphenyl]methylene]propanedinitrile, [[3,5-bis(1,1-Dimethylethyl)-4-hydroxyphenyl]methylene]-propanedinitrile, Propanedinitrile,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]methylene]-, [[3,5-Bis(1,1-dimethylethyl)-4-hydroxyphenyl]methylene]propanedinitrile, 9CI, Tyrphostin A9, Tyrphostin 9, 2-(3,5-Di-tert-butyl-4-hydroxybenzylidene)malononitrile, Propanedinitrile, 2-((3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl)methylene)-; alpha-Cyano-(3,5-di-t-butyl-4-hydroxy)cinnamonitrile; Malonoben" C18H22N2O MZOPWQKISXCCTP-UHFFFAOYSA-N 2-[(3,5-ditert-butyl-4-hydroxyphenyl)methylidene]propanedinitrile n.a. n.a. No No No No No No PMDBD2001267 Tyrphostin AG1478 Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D0ZH1U 2051 n.a. n.a. "AG-1478, 153436-53-4, Tyrphostin AG 1478, N-(3-chlorophenyl)-6,7-dimethoxyquinazolin-4-amine, Tyrphostin AG-1478, 175178-82-2, 4-(3-Chloroanilino)-6,7-dimethoxyquinazoline, AG1478, AG 1478, 4-Quinazolinamine, N-(3-chlorophenyl)-6,7-dimethoxy-, AG-1478 (Tyrphostin AG-1478), tyrphostin AG1478, AG-1478 free base, SUH0SEZ9HY, NSC-693255, CHEMBL7917, N-(3-Chlorophenyl)-6,7-dimethoxy-4-quinazolinamine, DTXSID0051447, CHEBI:75404, MFCD00270914, Tyrphostin AG-1478;NSC 693255, (3-Chlorophenyl)(6,7-dimethoxyquinazolin-4-yl)amine, BRD6408, BRD-6408, SR-01000076156, NSC693255, Tocris-1276, tyrphostin-AG-1478, UNII-SUH0SEZ9HY, BiomolKI_000018, Maybridge1_004001, Lopac-T-4182, BiomolKI2_000028, CBiol_002058, Lopac0_001127, Oprea1_653581, SCHEMBL93838, BSPBio_001390, KBioGR_000110, KBioSS_000110, MLS006012026, BDBM3532, GTPL4862, N-(3-chlorophenyl)-6,7-dimethoxy-quinazolin-4-amine, DTXCID9030044, BCBcMAP01_000035, HMS552N19, KBio2_000110, KBio2_002678, KBio2_005246, KBio3_000219, KBio3_000220, Bio1_000344, Bio1_000833, Bio1_001322, Bio2_000110, Bio2_000590, HMS1361F12, HMS1791F12, HMS1989F12, HMS3229O03, HMS3263B15, HMS3656B19, HMS3672E11, BCP07988, BCP15152, EX-A1236, Tyrphostin AG 1478, >=98%, Tox21_303781, Tox21_501127, CCG-52663, s2728, AKOS002350880, CS-1606, LP01127, NSC 693255, SB19361, SDCCGSBI-0051095.P003, IDI1_033860, NCGC00016017-01, NCGC00016017-02, NCGC00016017-03, NCGC00016017-04, NCGC00016017-05, NCGC00016017-06, NCGC00016017-07, NCGC00016017-08, NCGC00016017-09, NCGC00016017-20, NCGC00025093-01, NCGC00025093-02, NCGC00025093-03, NCGC00025093-04, NCGC00025093-05, NCGC00261812-01, NCGC00357072-01, AC-32828, GK 03499, HY-13524, NCI60_033425, SMR001456495, CAS-175178-82-2, EU-0101127, NS00017849, SW219714-1, T2944, 6,7-dimethoxy-4-(3''-chloroanilino)quinazoline, A15294, A24890, T 4182, 11N-812, A811809, AG-1478;Tyrphostin AG-1478; NSC 693255, CU-00000000399-1, J-011074, J-519544, SR-01000076156-1, SR-01000076156-4, SR-01000076156-7, AG 1478 - CAS 175178-82-2, BRD-K68336408-001-02-6, BRD-K68336408-003-02-2, Q27074338, COC1=C(OC)C=C2C(NC3=CC(Cl)=CC=C3)=NC=NC2=C1, 0TO" C16H14ClN3O2 GFNNBHLJANVSQV-UHFFFAOYSA-N N-(3-chlorophenyl)-6,7-dimethoxyquinazolin-4-amine n.a. n.a. No No No No No No PMDBD2001268 TZD-C8 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001269 Umbelliferone Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D02JEZ 5281426 n.a. NPC247553 "Umbelliferone, 7-hydroxycoumarin, 93-35-6, 7-Hydroxy-2H-chromen-2-one, Hydrangin, Skimmetin, 7-hydroxycoumarine, Hydrangine, Skimmetine, 7-Oxycoumarin, Umbelliferon, 2H-1-Benzopyran-2-one, 7-hydroxy-, 7-Hydroxy-2H-1-benzopyran-2-one, 7-hydroxy coumarin, beta-Umbelliferone, Coumarin, 7-hydroxy-, 7-hydroxychromen-2-one, 7 HC, NSC 19790, 7-hydroxy-coumarin, 7-hydroxy-1-benzopyran-2-one, CCRIS 3591, EINECS 202-240-3, UNII-60Z60NTL4G, MFCD00006878, 2-Hydroxy-7H-chromen-7-one, BRN 0127683, 60Z60NTL4G, 32922-68-2, CHEBI:27510, AI3-38054, 7 OH COUMARIN, NSC19790, NSC-19790, CHEMBL51628, 7-HC, DTXSID5052626, 5-18-01-00386 (Beilstein Handbook Reference), 7-oxidanylchromen-2-one, 7-hydroxycumarin, 7-hydroxycoumarin, 14C-labeled, Dichrin A, 7-hydroxycournarin, beta -umbelliferone, 07L, 7-hydroxy-coumarine, .beta.-Umbelliferone, Umbelliferone, 99%, 7-Hydroxy-2-chromenone, Coumarin derivative, 3a, Spectrum2_001962, Spectrum3_000751, 7-hydroxy-chromen-2-one, 7-hydroxycoumarin sulphate, UMBELLIFERONE [MI], 7-Hydroxy Coumarin ,(S), BIDD:PXR0126, SCHEMBL22018, BSPBio_002362, SPECTRUM231084, MLS002207035, BIDD:ER0671, SPBio_002083, UMBELLIFERONE [WHO-DD], MEGxp0_000814, DTXCID9031199, ACon1_000219, KBio3_001582, 7-Hydroxy-2H-chromen-2-one #, Umbelliferone, analytical standard, HMS1607M21, HMS2271N09, HMS3741M03, CS-D1186, HY-N0573, STR04824, BDBM50174558, CCG-39436, s3675, Umbelliferone (Hydrangin, Skimmetin), AKOS000120867, NSC-019790, SDCCGMLS-0066941.P001, 7-Hydroxycoumarin;Hydrangin;NSC 19790, NCGC00095801-01, NCGC00095801-02, NCGC00095801-03, NCGC00095801-07, NCGC00178691-01, NCGC00178691-02, 1ST11436, AC-18399, AC-34707, NCI60_001646, SMR000112324, SY001924, H0236, NS00001324, EN300-18075, Umbelliferone, Vetec(TM) reagent grade, 98%, C09315, U-3000, A801734, A844525, Q416196, BRD-K87991767-001-02-0, BRD-K87991767-001-03-8, Z57150899, F0722-0129, Umbelliferone, suitable for fluorescence indicator, >=98.0% (HPLC), InChI=1/C9H6O3/c10-7-3-1-6-2-4-9(11)12-8(6)5-7/h1-5,10, Umbelliferone; 7-Hydroxy-2H-1-benzopyran-2-one; 7-Oxycoumarin; Hydrangin; Skimmetin, 142044-47-1" C9H6O3 ORHBXUUXSCNDEV-UHFFFAOYSA-N 7-hydroxychromen-2-one n.a. n.a. No No No No No No PMDBD2001270 Undecanoic acid Therapeutic Substance Investigational Drug 112-37-8 DB16857 n.a. n.a. D0X0PF 8180 7888 NPC14227 "UNDECANOIC ACID, 112-37-8, Hendecanoic acid, Undecylic acid, undecanoate, n-Undecanoic acid, n-Undecoic acid, n-Undecylic acid, Undecoic acid, 1-Decanecarboxylic acid, FEMA No. 3245, undecanoicacid, Undecanoate [USAN], Undekansaeure, NSC-7885, CHEBI:32368, MFCD00002730, Undecanoate;Hendecanoic acid, 138ON3IIQG, DTXSID8021690, NSC7885, 64118-43-0, 1-decanecarboxylate, C11:0, NSC 7885, EINECS 203-964-2, UNII-138ON3IIQG, BRN 1759287, AI3-02280, undecansäure, Undecanoic acid, 98%, bmse000563, SCHEMBL9266, NCIOpen2_009435, 4-02-00-01068 (Beilstein Handbook Reference), WLN: QV10, CH3-[CH2]9-COOH, UNDECANOIC ACID [FHFI], UNDECANOIC ACID [INCI], CHEMBL108030, DTXCID001690, GTPL5533, QSPL 035, QSPL 155, QSPL 192, Undecanoic acid, >=97%, FG, HMS3740G13, Tox21_201031, Undecanoic acid, analytical standard, BDBM50511006, LMFA01010011, AKOS000276906, AM85321, CS-W004282, DS-6048, FA 11:0, HY-W004282, PB44018, NCGC00248901-01, NCGC00258584-01, BP-27912, CAS-112-37-8, SY007756, NS00014192, S9454, U0004, EN300-19485, C17715, P19940, A802562, Q425988, J-002761, 75EF58E9-1C6B-4875-8B82-D0B7A10FAEA2, F2191-0248, Z104473988" C11H22O2 ZDPHROOEEOARMN-UHFFFAOYSA-N undecanoic acid n.a. n.a. No No No No No No PMDBD2001271 Undecyl beta-maltoside n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001272 Uracil Therapeutic Substance Investigational Drug 66-22-8 DB03419 n.a. D00027 D0Y0DG 1174 1141 NPC27699 "uracil, 66-22-8, 2,4-Dihydroxypyrimidine, 2,4(1H,3H)-Pyrimidinedione, pyrimidine-2,4(1H,3H)-dione, Pyrod, pyrimidine-2,4-diol, 2,4-Pyrimidinediol, 2,4-Dioxopyrimidine, Hybar X, 2,4-Pyrimidinedione, Pirod, 51953-14-1, 1H-Pyrimidine-2,4-dione, URACIL-6-D1, RU 12709, 1,2,3,4-tetrahydropyrimidine-2,4-dione, Uracil [USAN], Urazil, Ura, CCRIS 3077, CHEBI:17568, NSC 3970, NSC-3970, AI3-25470, MFCD00006016, Uracyl, 2-Hydroxy-4(3H)-pyrimidinone, SQ 6201, SQ 7726, SQ 8493, SQ-6201, SQ-7726, SQ-8493, BMS 205603-01, BMS-205603-01, UNII-56HH86ZVCT, 24897-51-6, EINECS 200-621-9, 56HH86ZVCT, Lamivudine impurity e, 2-Hydroxy-4(1H)-pyrimidinone, DTXSID4021424, NSC3970, Lamivudine impurity e rs, URACIL-5-D1, DTXCID101424, 144104-68-7, 4-Hydroxy-2(1H)-pyrimidinone, Fluorouracil specified compound c, NCGC00181030-01, URACIL (USP-RS), URACIL [USP-RS], URACIL (MART.), URACIL [MART.], 24897-50-5, 4-Hydroxyuracil, CAS-66-22-8, CID 5274267, LAMIVUDINE IMPURITY F (EP IMPURITY), LAMIVUDINE IMPURITY F [EP IMPURITY], FLUOROURACIL IMPURITY C (EP IMPURITY), FLUOROURACIL IMPURITY C [EP IMPURITY], LAMIVUDINE IMPURITY E (USP IMPURITY), LAMIVUDINE IMPURITY E [USP IMPURITY], Uracil (8CI), Uracil [USAN:JAN], 66255-05-8, FLUOROURACIL SPECIFIED COMPOUND C (USP IMPURITY), FLUOROURACIL SPECIFIED COMPOUND C [USP IMPURITY], 8h-uracil, hydroxypyrimidinone, 2,6-Dioxypyrimidin, Uracil,(S), 2,4-Dioxypyrimidine, 2,4(1H,3H)-Pyrimidinedione (9CI), pyrimidine-2,4-dione, 2, 4-Dioxopyrimidine, Fluorouracil Impurity C, Uracil, 99%, 1ui0, Uracil (JAN/USAN), 2,3H)-Pyrimidinedione, 2,6-Dihydroxypyrimidine, URACIL [INCI], URACIL [JAN], URACIL [WHO-DD], URACIL [MI], bmse000187, bmse000940, CHEMBL566, Epitope ID:120356, NCIMech_000782, SCHEMBL8235, Uracil, >=99.0%, MLS001304993, GTPL4560, 2,4-(1h,3h)-pyrimidinedione, 2-hydroxy-4-(1H)-pyrimidione, 2-hydroxy-4-(3H)-pyrimidione, 4-hydroxy-2-(1H)-pyrimidione, 1H-pyrimidine-2,4-dione;Uracil, Uracil, >=99.0% (T), HMS2234E19, HMS3264C13, HMS3373E18, HMS3652N05, Pharmakon1600-01502345, BCP26546, HY-I0960, NSC29742, Tox21_112680, Tox21_201023, BDBM50549809, CCG-35866, NSC-29742, NSC759649, s4177, AKOS000119989, AKOS002303991, Tox21_112680_1, 4(3H)-Pyrimidinone,2-hydroxy-(9ci), AM83913, CCG-213042, CS-W020104, DB03419, NSC-759649, PS-5279, SB55489, SB55884, NCGC00181030-02, NCGC00247663-01, NCGC00258576-01, Uracil, Vetec(TM) reagent grade, 98%, NCI60_003718, Pyrimidine-2,4(1H,3H)-dione (Uracil), SMR000752912, SY008943, NS00002070, SW220239-1, U0013, EN300-17138, Uracil, suitable for cell culture, BioReagent, C00106, D00027, AB00171810_03, AB00171810_04, AB00918623-05, A835376, AC-907/30002021, Q182990, Z56889474, F1796-0008, E2FC11E5-1887-46DF-B415-82313CE9B2BD, Uracil, United States Pharmacopeia (USP) Reference Standard, Fluorouracil impurity C, European Pharmacopoeia (EP) Reference Standard, InChI=1/C4H4N2O2/c7-3-1-2-5-4(8)6-3/h1-2H,(H2,5,6,7,8, Uracil, Pharmaceutical Secondary Standard; Certified Reference Material" C4H4N2O2 ISAKRJDGNUQOIC-UHFFFAOYSA-N 1H-pyrimidine-2,4-dione n.a. n.a. No No No No No No PMDBD2001273 Ursolic acid Therapeutic Substance Phase 2 77-52-1 DB15588 n.a. n.a. D07LUJ 64945 58472 NPC51700 "Ursolic acid, 77-52-1, Prunol, Malol, Urson, 3beta-Hydroxyurs-12-en-28-oic acid, Micromerol, (3beta)-3-Hydroxyurs-12-en-28-oic acid, (+)-Ursolic acid, NSC-4060, 3beta-Hydroxy-12-ursen-28-ic acid, CCRIS 7123, CHEBI:9908, NSC 167406, ursolic-acid, NSC 4060, EINECS 201-034-0, NSC-167406, UNII-P3M2575F3F, AI3-03109, HSDB 7685, P3M2575F3F, CHEMBL169, Urs-12-en-28-oic acid, 3beta-hydroxy-, .beta.-Ursolic acid, Bungeolic acid, URSOLIC ACID (USP-RS), URSOLIC ACID [USP-RS], NSC4060, Prunol;Urson;Malol, MFCD00009621, SMR000445681, SR-01000779684, Urs-12-en-28-oic acid, 3-hydroxy-, (3.beta.)-, TNP00103, (3 beta)-3-hydroxyurs-12-en-28-oic acid, 6Q5, Urs-12-en-28-oic acid, 3-hydroxy-, (3beta)-, 3beta-hydroxy-Urs-12-en-28-oic acid, 3B-HYDROXYURS-12-EN-28-OIC ACID, Prestwick3_000089, Ursolic acid, >=90%, URSOLIC ACID [MI], URSOLIC ACID [HSDB], URSOLIC ACID [INCI], SCHEMBL70205, BSPBio_000018, (1S,2R,4aS,6aR,6aS,6bR,8aR,10S,12aR,14bS)-10-hydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydro-1H-picene-4a-carboxylic acid, MLS000728569, MLS002154196, MLS002207073, URSOLIC ACID [WHO-DD], BPBio1_000020, N-Ethylhydroxylaminehydrochloride, DTXSID70883221, Ursolic acid, analytical standard, 3beta-Hydroxyurs-12-en-28-oate, HMS2095A20, HMS2231P19, (1S,2R,4aS,6aS,6bR,8aR,10S,12aR,12bR,14bS)-10-hydroxy-1,2,6a,6b,9,9,12a-heptamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylic acid, 3beta-hydroxy-Urs-12-en-28-oate, HY-N0140, BDBM50148911, 3beta-Hydroxy-12-ursen-28-oic Acid, AKOS005228010, AKOS016023773, 3.beta.-hydroxy-Urs-12-en-28-oate, CCG-208282, CS-3799, DB15588, LMPR0106180007, (3beta)-3-Hydroxyurs-12-en-28-oate, NCGC00017223-06, (3beta)-3-hydroxy-Urs-12-en-28-oate, AS-35119, 3.beta.-hydroxy-Urs-12-en-28-oic acid, 1ST001599, (3beta)-3-hydroxy-Urs-12-en-28-oic acid, AB00513802, NS00006443, U0065, C08988, A839123, Q416260, Q-201916, SR-01000779684-4, SR-01000779684-5, (3.BETA.)-3-HYDROXYURS-12-EN-28-OIC ACID, BRD-K68185022-001-02-3, BRD-K68185022-001-14-8, URSOLIC ACID (CONSTITUENT OF HOLY BASIL LEAF), Ursolic acid, primary pharmaceutical reference standard, AF479D19-631E-48F1-8ABA-FB2A806046FA, URSOLIC ACID (CONSTITUENT OF HOLY BASIL LEAF) [DSC], (3beta,5beta,18alpha,20beta)-3-hydroxyurs-12-en-28-oic acid, Ursolic acid, European Pharmacopoeia (EP) Reference Standard, Ursolic acidMalol; Urson; 3beta-Hydroxyurs-12-en-28-oic acid, Ursolic acid, United States Pharmacopeia (USP) Reference Standard, (1S,2R,4aS,6aR,6aS,6bR,8aR,10S,12aR,14bS)-10-hydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydro-1H-picene-4a-carboxylicacid" C30H48O3 WCGUUGGRBIKTOS-GPOJBZKASA-N (1S,2R,4aS,6aR,6aS,6bR,8aR,10S,12aR,14bS)-10-hydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydro-1H-picene-4a-carboxylic acid n.a. n.a. No No No No No No PMDBD2001274 Usnic acid Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D09JSD 5646 n.a. NPC111201 "usnic acid, 125-46-2, Usno, 1,3(2H,9bH)-Dibenzofurandione, 2,6-diacetyl-7,9-dihydroxy-8,9b-dimethyl-, usnic-acid, L-Usnic acid, NSC 8517, NSC5890, 7-Hydroxy-(S)-usnate, 2,6-Diacetyl-7,9-dihydroxy-8,9b-dimethyldibenzo[b,d]furan-1,3(2H,9bh)-dione, 2,6-Diacetyl-7,9-dihydroxy-8,9b-dimethyl-1,3(2H,9bH)-dibenzofurandione, CHEBI:2264, NSC5889, NSC8517, 2,6-Diacetyl-1,2,3,9b-tetrahydro-7,9-dihydroxy-8,9b-dimethyldibenzofuran-1,3-dione, 4,10-diacetyl-11,13-dihydroxy-2,12-dimethyl-8-oxatricyclo[7.4.0.0^{2,7}]trideca-1(9),6,10,12-tetraene-3,5-dione, Usninsaeure [German], (+-)-Uanic acid, CCRIS 5518, HSDB 7170, EINECS 204-740-7, BRN 1299865, UNII-0W584PFJ77, Usinic acid, AI3-50457, Uanic acid, Spectrum_000177, Spectrum2_000744, Spectrum3_001195, Spectrum4_001811, Spectrum5_000541, USNIC ACID, (D), USNIC ACID, (L), (.+/-.)-Usnic acid, BSPBio_002869, KBioGR_002446, KBioSS_000657, DivK1c_001009, SCHEMBL177774, SPBio_000728, CHEMBL1375951, DTXSID0040123, HMS503I19, KBio1_001009, KBio2_000657, KBio2_003225, KBio2_005793, KBio3_002369, NINDS_001009, 2,6-diacetyl-7,9-dihydroxy-8,9b-dimethyl-dibenzofuran-1,3-dione, 2,6-diacetyl-7,9-dihydroxy-8,9b-dimethyldibenzofuran-1,3-dione, HY-N0656, CCG-40251, s4953, AKOS005613032, SDCCGMLS-0066516.P001, IDI1_001009, NCGC00094823-01, NCGC00094823-02, NCGC00094823-03, AS-18744, NCI60_004436, NCI60_004437, CS-0009679, NS00004156, U0023, EN300-7388062, A805384, Usnic acid, Antibiotic for Culture Media Use Only, Q-100111, BRD-A85739295-001-03-6, Q27105599, WLN: T B656 CV EV HO FU BHT & JB1 DV1 KQ L1 MQ, 1,9bH)-Dibenzofurandione, 2,6-diacetyl-7,9-dihydroxy-8,9b-dimethyl-, Dibenzofuran-1,9bH)-dione, 2,6-diacetyl-7,9-dihydroxy-8,9b-dimethyl-, (+/-)-1,3(2H,9bH)-Dibenzofurandione, 2,6-diacetyl-7,9-dihydroxy-8,9b-dimethyl-, 2,6-diacetyl-7,9-dihydroxy-8,9b-dimethyl-9bh-dibenzofuran-1,3-dione, AldrichCPR, 2,6-diacetyl-7,9-dihydroxy-8,9b-dimethyl-dibenzofuran-1,3-dione;Usnic acid, 2,6-Diacetyl-7,9-dihydroxy-8,9b-dimethyldibenzo[b,d]furan-1,3(2H,9bh)-dione #, 2,6-Diacetyl-1,2,3,9b-tetrahydro-7,9-dihydroxy-8,9b-dimethyldiben- zofuran-1,3-dione/ Usno, 4,10-diacetyl-11,13-dihydroxy-2,12-dimethyl-8-oxatricyclo[7.4.0.0,2,7]trideca-1(13),6,9,11-tetraene-3,5-dione" C18H16O7 CUCUKLJLRRAKFN-UHFFFAOYSA-N 2,6-diacetyl-7,9-dihydroxy-8,9b-dimethyldibenzofuran-1,3-dione n.a. n.a. No No No No No No PMDBD2001275 Vanillic acid Therapeutic Substance n.a. 121-34-6 DB02130 n.a. n.a. n.a. 8468 21708 NPC111888 Vanillic acid, 4-HYDROXY-3-METHOXYBENZOIC ACID, 121-34-6, Acide vanillique, p-Vanillic acid, Benzoic acid, 4-hydroxy-3-methoxy-, 3-Methoxy-4-hydroxybenzoic acid, Vanillate, m-Anisic acid, 4-hydroxy-, VanillicAcid, Protocatechuic acid, 3-methyl ester, NSC 3987, NSC 674322, 4-hydroxy-3-methoxy-Benzoic acid, UNII-GM8Q3JM2Y8, 4-Hydroxy-3-methoxybenzoate, EINECS 204-466-8, GM8Q3JM2Y8, MFCD00002551, BRN 2208364, CHEBI:30816, AI3-19542, NSC-3987, NSC-674322, VA, 4-Hydroxy-3-methoxybenzoicacid, CHEMBL120568, DTXSID6059522, FEMA NO. 3988, DROXIDOPA METABOLITE (VA), 4-hydroxy-3-methoxy benzoic acid, 2-METHOXY-4-CARBOXYPHENOL, NSC674322, M-METHOXY-P-HYDROXY-BENZOIC ACID, Acid, Vanillic, VA (VAN), VNL, 4-hydroxy-m-Anisic acid, Vanillinsaure, p-Vanillate, Vanilic acid, 4 Hydroxy 3 methoxybenzoic Acid, p Hydroxy m methoxy benzoic Acid, p-Hydroxy-m-methoxy-benzoic Acid, Acid, 4-Hydroxy-3-methoxybenzoic, Acid, p-Hydroxy-m-methoxy-benzoic, Vanillic Acid,(S), 4-hydroxy-m-Anisate, Vanillic acid (M2), Vanillic acid, 97%, bmse000486, bmse000614, bmse010205, WLN: QVR DQ CO1, VANILLIC ACID [MI], 3-Methoxy-4-hydroxybenzoate, SCHEMBL26179, VANILLIC ACID [INCI], MLS000574833, 4-hydroxy-3-methoxy-Benzoate, Vanillic acid, >=97%, FG, 4-hydroxy-3methoxy benzoic acid, DTXCID1033668, 4-hydroxyl-3-methoxybenzoic acid, NSC3987, 4- hydroxy-3-methoxybenzoic acid, HMS2197E16, Protocatechuic acid 3-methyl ester, HY-N0708, STR02334, BDBM50337364, CK2172, s5343, AKOS000113195, CCG-266343, NCGC00247610-01, 1ST40128, AC-11841, BP-13246, SMR000156289, SY001450, Vanillic acid, purum, >=97.0% (HPLC), AM20050239, CS-0009728, NS00014581, V0017, 4-HYDROXY-3-METHOXYBENZOIC ACID [FHFI], C06672, EN300-105765, Vanillic acid, Vetec(TM) reagent grade, 97%, A804715, Q419672, Q-201921, Z381356666, Vanillic acid, certified reference material, TraceCERT(R), 3E9555E5-85F5-4FCE-A429-5182E959C6A3, InChI=1/C8H8O4/c1-12-7-4-5(8(10)11)2-3-6(7)9/h2-4,9H,1H3,(H,10,11 C8H8O4 WKOLLVMJNQIZCI-UHFFFAOYSA-N 4-hydroxy-3-methoxybenzoic acid n.a. n.a. No No No No No No PMDBD2001276 Vanillin Therapeutic Substance Patented Drug n.a. n.a. n.a. n.a. D0B5YS 1183 n.a. NPC203719 "vanillin, 4-Hydroxy-3-methoxybenzaldehyde, 121-33-5, Vanillaldehyde, Vanillic aldehyde, p-Vanillin, Lioxin, Vanilline, Vanilla, 3-Methoxy-4-hydroxybenzaldehyde, 4-Hydroxy-m-anisaldehyde, 2-Methoxy-4-formylphenol, Zimco, Benzaldehyde, 4-hydroxy-3-methoxy-, p-Hydroxy-m-methoxybenzaldehyde, 4-Hydroxy-3-methoxy-benzaldehyde, Methylprotocatechuic aldehyde, 4-Formyl-2-methoxyphenol, Vanilin, Vanillin (natural), 4-Hydroxy-5-methoxybenzaldehyde, m-Anisaldehyde, 4-hydroxy-, Protocatechualdehyde, methyl-, FEMA No. 3107, vaniline, Rhovanil, Protocatechualdehyde 3-methyl ether, Vanillin (NF), NSC 15351, m-Methoxy-p-hydroxybenzaldehyde, CCRIS 2687, Vanillin Melting Point Standard, HSDB 1027, Vanillin, natural, EINECS 204-465-2, NSC-15351, NSC-48383, Vanillin [NF], NSC-403658, UNII-CHI530446X, BRN 0472792, Vanillin (Standard), CHEBI:18346, 4-hydroxy-3-methoxy-benzyldehyde, AI3-00093, NPLC-0145, CHI530446X, MFCD00006942, CHEMBL13883, DTXSID0021969, VANILLIN (METHOXY-13C), EC 204-465-2, H-0264, 4-08-00-01763 (Beilstein Handbook Reference), NSC15351, 4-HYDROXY,3-METHOXY-BENZALDEHYDE, NCGC00091645-03, 4-hydroxy-3-methoxybenzaldehyde (vanillin), VANILLIN (II), VANILLIN [II], VANILLIN (MART.), VANILLIN [MART.], WLN: VHR DQ CO1, Vanillin [USAN], DTXCID301969, VANILLIN (EP MONOGRAPH), VANILLIN [EP MONOGRAPH], Vanillinum, Oleoresin vanilla, Vanilla oleoresin, CAS-121-33-5, 3-methoxy-4-hydroxy-benzaldehyde, oleo-Resins vanilla, V55, Vanillin sodium salt, VANILLIN [FHFI], VANILLIN [HSDB], VANILLIN [INCI], FEMA Number 3107, oleo-Resins vanilla-bean, VANILLIN [FCC], 4-Hydroxy-3-methoxybenzaldehyde(Vanilline), VANILLIN [MI], VANILLIN [VANDF], methyl-Protocatechualdehyde, bmse000343, bmse000597, bmse010006, Methylprotcatechuic aldehyde, VANILLIN [USP-RS], VANILLIN [WHO-DD], SCHEMBL1213, MLS002303069, BIDD:ER0330, Vanillin, puriss., 99.5%, GTPL6412, SGCUT00016, 4-hydroxy 3-methoxybenzaldehyde, METHYLPROTOCATECHUALDEHYDE, FEMA 3107, HY-N0098R, Vanilla oleoresin (vanilla SPP), 3-methoxy-4-hydroxy benzaldehyde, 4-hydroxy-3-methoxy benzaldehyde, VANILLIN, NATURAL [FHFI], 3-methoxy-4-hydroxy benzoaldehyde, Vanillin, ReagentPlus(R), 99%, 4-hydroxy-3-(methoxy)benzaldehyde, HMS3651D20, HMS3885K07, Vanillin, >=97%, FCC, FG, 4-hydoxy-3-(methyloxy)benzaldehyde, BCP29943, HY-N0098, NSC48383, STR01001, to_000089, Tox21_113534, Tox21_201925, Tox21_300352, 4-hydoxy-3-(methyloxy)benz aldehyde, BDBM50177405, MFCD08702848, NSC403658, s3071, AKOS000118929, Tox21_113534_1, CCG-266230, CS-W020052, Vanillin, tested according to Ph.Eur., NCGC00091645-01, NCGC00091645-02, NCGC00091645-04, NCGC00091645-05, NCGC00091645-07, NCGC00254468-01, NCGC00259474-01, Vanillin, natural, >=97%, FCC, FG, AC-10370, BP-10602, NCI60_001085, SMR000156285, SY224451, Vanillin 1000 microg/mL in Acetonitrile, Vanillin, JIS special grade, >=98.0%, Vanillin, Vetec(TM) reagent grade, 98%, 3-Methoxy-4-hydroxybenzaldehyde (vanillin), AM20060497, CS-0694801, H0264, NS00009754, SW219190-1, V0080, EN300-18281, vanillin (3-methoxy-4-hydroxy- benzaldehyde), A19444, C00755, D00091, Q33495, 4-Hydroxy-3-methoxybenzaldehyde inclusion complex, Vanillin (83 degrees C) Melting Point Standard, 4-hydroxy-3-methoxy-Benzaldehyde-5-chlorovanillin, 4-hydroxy-3-methoxybenzaldehyde (ACD/Name 4.0), AC-907/21098004, Q-100102, Vanillin, TraceCERT(R), certified reference material, Z57772449, F2190-0587, Vanillin, European Pharmacopoeia (EP) Reference Standard, 1-(AMINOMETHYL)-CYCLOPROPANECARBOXYLICACIDETHYLESTER, Mettler-Toledo Calibration substance ME 51143093, Vanillin, Vanillin, United States Pharmacopeia (USP) Reference Standard, NSC 15351;NSC-15351; NSC15351 pound>>4-Hydroxy-3-methoxybenzaldehyde, Vanillin, Pharmaceutical Secondary Standard; Certified Reference Material, InChI=1/C8H8O3/c1-11-8-4-6(5-9)2-3-7(8)10/h2-5,10H,1H, Vanillin Melting Point Standard, United States Pharmacopeia (USP) Reference Standard, Mettler-Toledo Calibration substance ME 51143093, Vanillin, traceable to primary standards (LGC), Vanillin melting point standard, Pharmaceutical Secondary Standard; Certified Reference Material" C8H8O3 MWOOGOJBHIARFG-UHFFFAOYSA-N 4-hydroxy-3-methoxybenzaldehyde n.a. n.a. No No No No Yes No rxnDiet214,rxnAdd167 PMDBD2001277 Vanillylacetone n.a. n.a. n.a. n.a. n.a. n.a. n.a. 31211 n.a. NPC299406 "ZINGERONE, Vanillylacetone, 122-48-5, 4-(4-Hydroxy-3-methoxyphenyl)butan-2-one, Zingiberone, 4-(4-Hydroxy-3-methoxyphenyl)-2-butanone, Zingherone, Gingerone, Vanillyl acetone, 2-Butanone, 4-(4-hydroxy-3-methoxyphenyl)-, [0]-Paradol, 4-Hydroxy-3-methoxybenzylacetone, (4-Hydroxy-3-methoxyphenyl)ethyl methyl ketone, (0)-Paradol, NSC 15335, 4-(3-Methoxy-4-hydroxyphenyl)-2-butanone, 3-Methoxy-4-hydroxybenzylacetone, FEMA No. 3124, 2-(4-Hydroxy-3-methoxyphenyl)ethyl methyl ketone, UNII-4MMW850892, Vanillylacetone;Gingerone, CHEMBL25894, DTXSID8047420, 4-(4-hydroxy-3-methoxy-phenyl)-butan-2-one, CHEBI:68657, MFCD00048232, NSC-15335, 4MMW850892, 3-Methoxy-4-hydroxy-benzylacetone, (O)-Paradol, CCRIS 2036, HSDB 1064, EINECS 204-548-3, BRN 2051099, vanillylaceton, AI3-31837, [0]Paradol, ZINGERONE [FCC], ZINGERONE [MI], ZINGERONE [FHFI], ZINGERONE [HSDB], ZINGERONE [INCI], 97%,flavors and fragrances, 4-08-00-01866 (Beilstein Handbook Reference), SCHEMBL119051, Vanillylacetone, >=96%, FG, VANILLYLACETON [WHO-DD], DTXCID6027420, FEMA 3124, 4-(4-hydroxy-3-methoxyphenyl)-, HMS3651E22, NSC15335, Tox21_302493, BDBM50304073, s2371, AKOS009462778, CCG-208511, DB15589, Vanillylacetone, >=98%, natural, FG, Zingerone, analytical reference material, NCGC00256663-01, 1ST40217, AC-34331, AS-65368, CAS-122-48-5, HY-14621, SY017980, 4(4-Hydroxy-3-methoxyphenyl)-2-butanone, 4-(3-methoxy-4-hydroxyphenyl)butan-2-one, CS-0003480, H1314, NS00013332, SW219618-1, C17497, EN300-1721864, A891122, SR-05000013705, Q1064625, SR-05000013705-1, W-108429, 4-(4-Hydroxy-3-methoxyphenyl)-2-butanone, 9CI, 8CI, Z1255442373, InChI=1/C11H14O3/c1-8(12)3-4-9-5-6-10(13)11(7-9)14-2/h5-7,13H,3-4H2,1-2H" C11H14O3 OJYLAHXKWMRDGS-UHFFFAOYSA-N 4-(4-hydroxy-3-methoxyphenyl)butan-2-one n.a. n.a. No No No No No No PMDBD2001278 Viomycin Therapeutic Substance n.a. 32988-50-4 DB06827 n.a. n.a. n.a. 135398671 2301596 n.a. Celiomycin, Florimycin, Tuberactinomycin B, VIOMYCIN, Vinacetin A, Vioactane, Viomicina, Viomycine, Viomycinum, 32988-50-4, CHEBI:15782, YVU35998K5, Floromycin, (3S)-3,6-diamino-N-[(3S,6Z,9S,12S,15S)-3-[(4S,6R)-2-amino-4-hydroxy-1,4,5,6-tetrahydropyrimidin-6-yl]-6-[(carbamoylamino)methylidene]-9,12-bis(hydroxymethyl)-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentazacyclohexadec-15-yl]hexanamide, Viomycin [INN], (3S)-3,6-diamino-N-[(3S,6Z,9S,12S,15S)-3-[(4R,6S)-2-amino-6-hydroxy-1,4,5,6-tetrahydropyrimidin-4-yl]-6-[(carbamoylamino)methylidene]-9,12-bis(hydroxymethyl)-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentazacyclohexadec-15-yl]hexanamide, (3S)-3,6-diamino-N-[(3S,6Z,9S,12S,15S)-6-[(carbamoylamino)methylene]-3-[(4R,6S)-6-hydroxy-2-iminohexahydropyrimidin-4-yl]-9,12-bis(hydroxymethyl)-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentaazacyclohexadecan-15-yl]hexanamide, Viomicina [Italian], Viomycin [INN:BAN], Viomycine [INN-French], Viomycinum [INN-Latin], 37883-00-4, Viomicina [INN-Spanish], UNII-YVU35998K5, Viomycin (VM), EINECS 251-323-0, VIOMYCIN [WHO-DD], SCHEMBL34586, TUBERACTINOMYCIN B [MI], CHEMBL3085436, DTXSID0023741, HY-A0155, DB06827, AB00514055, (S)-3,6-Diamino-N-((3S,9S,12S,15S,Z)3((2R,4S)-6-amino-4-hydroxy-1,2,3,4-tetrahydropyridin-2-yl)-9,12-bis(hydroxymethyl)-2,5,8,11,14-pentaoxo-6-(ureidomethylene)-1,4,7,10,13-pentaazacyclohexadecan-15-yl)hexanamide disulfate, C01540, (3S)-3,6-diamino-N-[(3S,6Z,9S,12S,15S)-3-[(4R,6S)-6-hydroxy-2-imino-hexahydropyrimidin-4-yl]-9,12-bis(hydroxymethyl)-2,5,8,11,14-pentaoxo-6-(ureidomethylene)-1,4,7,10,13-pentazacyclohexadec-15-yl]hexanamide, (3S)-3,6-diamino-N-[(3S,6Z,9S,12S,15S)-6-{[(aminocarbonyl)amino]methylidene}-3-[(4R,6S)-2-amino-6-hydroxy-3,4,5,6-tetrahydropyrimidin-4-yl]-9,12-bis(hydroxymethyl)-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentaazacyclohexadecan-15-yl]hexanamide, GLYCINE, 3-AMINO-N-((3S)-3,6-DIAMINO-1-OXOHEXYL)-L-ALANYL-L-SERYL-L-SERYL-(2Z)-3-((AMINOCARBONYL)AMINO)-2,3-DIDEHYDROALANYL-2-((4R,6S)-2-AMINO-1,4,5,6-TETRAHYDRO-6-HYDROXY-4-PYRIMIDINYL)-, (5->13)-LACTAM, (2S)- C25H43N13O10 GXFAIFRPOKBQRV-GHXCTMGLSA-N (3S)-3,6-diamino-N-[(3S,6Z,9S,12S,15S)-3-[(4R,6S)-2-amino-6-hydroxy-1,4,5,6-tetrahydropyrimidin-4-yl]-6-[(carbamoylamino)methylidene]-9,12-bis(hydroxymethyl)-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentazacyclohexadec-15-yl]hexanamide n.a. n.a. No No No No No No PMDBD2001279 Virginiamycin M1 Therapeutic Substance n.a. 21411-53-0 DB01669 n.a. n.a. n.a. 5459319 10222381 NPC58001 virginiamycin m1, Streptogramin A, Ostreogrycin a, Mikamycin A, Pristinamycin IIA, Virginiamycin Factor M1, VERNAMYCIN A, Staphylomycin M1, Antibiotic PA 114A1, 21411-53-0, Antibiotic pa 114a, 8W4UOL59AZ, Virginiamycin M1 (~90%), CHEBI:9997, PA-114A, NSC-87432, NSC-244426, RP-12536, NSC87434, NSC 244426, MIKAMYCIN A [MI], UNII-8W4UOL59AZ, STREPTOGRAMIN A [MI], SCHEMBL673193, PRISTINAMYCIN IIA [MI], VIRGINIAMYCIN M1 [MI], CHEMBL1236670, GTPL12933, Virginiamycin M1-d2 (>90%), (10R,11R,12E,17E,19E,21S)-21-hydroxy-11,19-dimethyl-10-propan-2-yl-9,26-dioxa-3,15,28-triazatricyclo[23.2.1.03,7]octacosa-1(27),6,12,17,19,25(28)-hexaene-2,8,14,23-tetrone, HY-N6686, EINECS 244-376-6, MFCD00869411, NSC 87432, NSC-87434, Vernamycin A & vernamycin B (1:1), DB01669, CS-0019826, NS00011661, E80259, Virginiamycin M1 (200 ug/mL in Methanol) (~90%), (3R,4R,5E,10E,12E,14S)-14-hydroxy-3-isopropyl-4,12-dimethyl-8,9,14,15,24,25-hexahydro-1H,3H,22H-21,18-(azeno)pyrrolo[2,1-c][1,8,4,19]dioxadiazacyclotetracosine-1,7,16,22(4H,17H)-tetrone, (3R,4R,5E,10E,12E,14S)-14-hydroxy-4,12-dimethyl-3-(1-methylethyl)-8,9,14,15,24,25-hexahydro-1H,3H,22H-21,18-(azeno)pyrrolo[2,1-c][1,8,4,19]dioxadiazacyclotetracosine-1,7,16,22(4H,17H)-tetrone, (3R-(3R*,4R*,5E,10E,12E,14S*))-8,9,14,15,24,25-HEXAHYDRO-14-HYDROXY-4,12-DIMETHYL-3-(1-METHYLETHYL)-3H-21,18-NITRILO-1H,22H-PYRROLO(2,1-C)(1,8,4,19)DIOXADIAZACYCLOTETRACOSINE-1,7,16,22(4H,17H)-TETRONE, 3H-21,18-NITRILO-1H,22H-PYRROLO(2,1-C)(1,8,4,19)DIOXADIAZACYCLOTETRACOSINE-1,7,16,22(4H,17H)-TETRONE, 8,9,14,15,24,25-HEXAHYDRO-14-HYDROXY-4,12-DIMETHYL-3-(1-METHYLETHYL)-, (3R,4R,5E,10E,12E,14S)-, 8,9,14,15,24,25-Hexahydro-14-hydroxy-3-isopropyl-4,12-dimethyl-3H-21,18-nitrilo-1H,22H-pyrrolo(2,1-c)(1,8,4,19)dioxadiazacyclotetracosine-1,7,16,22(4H,17H)-tetrone, 8,9,14,15,24,25-Hexahydro-14-hydroxy-4,12-dimethyl-3-(1-methylethyl)-3H-21,18-nitrilo-1H,22H-pyrrolo(2,1-c)(1,8,4,19)dioxadiazacyclotetracosine-1,7,16,22(4H,17H)-tetrone C28H35N3O7 DAIKHDNSXMZDCU-FQTGFAPKSA-N (10R,11R,12E,17E,19E,21S)-21-hydroxy-11,19-dimethyl-10-propan-2-yl-9,26-dioxa-3,15,28-triazatricyclo[23.2.1.03,7]octacosa-1(27),6,12,17,19,25(28)-hexaene-2,8,14,23-tetrone n.a. n.a. No No No No No No PMDBD2001280 Virstatin Therapeutic Substance Preclinical n.a. n.a. n.a. n.a. DL74RO 145949 n.a. n.a. Virstatin, 88909-96-0, Isodibut, 4-(1,3-Dioxo-1H,3H-benzo[de]isoquinolin-2-yl)-butyric acid, 4-NAPHTHALIMIDOBUTYRIC ACID, 4-(1,3-dioxo-1H-benzo[de]isoquinolin-2(3H)-yl)butanoic acid, 4-(N-(1,8-naphthalimide))-n-butyric acid, 4-(1,3-dioxobenzo[de]isoquinolin-2-yl)butanoic acid, 1,3-Dioxo-1H-benz(de)isoquinoline-2(3H)-butanoic acid, 24SR2Q1Y6M, MFCD00181400, 1,3-dioxo-1H-Benz[de]isoquinoline-2(3H)-butanoic acid, 1H-Benz(de)isoquinoline-2(3H)-butanoic acid, 1,3-dioxo-, 4-{2,4-dioxo-3-azatricyclo[7.3.1.0^{5,13}]trideca-1(13),5,7,9,11-pentaen-3-yl}butanoic acid, Izodibut, 4-(1,3-DIOXO-1H,3H-BENZO(DE)ISOQUINOLIN-2-YL)-BUTYRIC ACID, 1,3-Dioxo-1H-benz(de)isoquinoline-2(3H)-butyric acid, H-Phg-NH2 Hcl, SpecPlus_000928, Spectrum2_000449, Spectrum3_001240, CBMicro_014897, CBKinase1_000229, CBKinase1_012629, ISODIBUT [WHO-DD], UNII-24SR2Q1Y6M, BSPBio_002720, CBDivE_001858, CBDivE_003272, MLS001207259, DivK1c_007024, SPBio_000498, CHEMBL403272, SCHEMBL3134908, SCHEMBL3852274, KBio1_001968, KBio3_002220, DTXSID10237406, CHEBI:189759, CCG-39963, AKOS000114634, DG-0077, ALX-430-147, NCGC00178507-01, SMR000504925, HY-127041, CS-0092231, EN300-00247, G37502, AB00053241-05, 4-(N-(1,8-NAPHTHALIMIDO))-N-BUTYRIC ACID, BRD-K60241851-001-02-8, BRD-K60241851-001-06-9, Z56891243, 1h,3H-benzo(de)isoquinoline-2-butyric acid-1,3-dione, F0303-0081, 4-{2,4-Dioxo-3-azatricyclo[7.3.1.0 {5,13}]trideca- 1(13),5,7,9,11-pentaen-3-yl}butanoic acid, 4-{2,4-Dioxo-3-azatricyclo[7.3.1.0,5,13]trideca-1(13),5,7,9,11-pentaen-3-yl}butanoic acid C16H13NO4 ZHXRDXTYPCPBTI-UHFFFAOYSA-N 4-(1,3-dioxobenzo[de]isoquinolin-2-yl)butanoic acid n.a. n.a. No No No No No No PMDBD2001281 Vitamin C Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. D07AHW 54670067 n.a. NPC187770 "l-ascorbic acid, ascorbic acid, vitamin C, 50-81-7, L-ascorbate, Ascoltin, ascorbate, L(+)-Ascorbic acid, Ascorbicap, Cevitamic acid, Laroscorbine, Testascorbic, Allercorb, Ascorbajen, Ascorbutina, Ascorteal, Ascorvit, Cantaxin, Cebicure, Cegiolan, Celaskon, Cenetone, Cenolate, Cescorbat, Cetemican, Cevatine, Cevitamin, Citriscorb, Colascor, Concemin, Lemascorb, Proscorbin, Roscorbic, Secorbate, Viforcit, Viscorin, Vitacimin, Vitamisin, Vitascorbol, Adenex, Ascorb, Ascorin, Cantan, Cebion, Cebione, Ceglion, Cemagyl, Cemill, Cereon, Cergona, Cetamid, Cevimin, Cevital, Cevitan, Cevitex, Ciamin, Hybrin, Redoxon, Ribena, Vicelat, Vitace, Vitacee, Vitacin, Cebid, Cecon, Celin, Cevex, Cipca, Hicee, Xitix, Davitamon C, Arco-cee, Planavit C, Catavin C, Ce lent, Liqui-Cee, Vicomin C, Cee-Vite, Cevi-Bid, Natrascorb, Scorbacid, Scorbu-C, Duoscorb, C-Level, C-Vimin, Cetane-Caps TD, Cewin, C-Long, C-Quin, C-Span, Meri-C, Cee-Caps TD, Cevalin, Antiscorbic vitamin, 3-Oxo-L-gulofuranolactone, L-Lyxoascorbic acid, L-Xyloascorbic acid, Ce-Mi-Lin, Acidum ascorbicum, Antiscorbutic vitamin, Natrascorb injectable, IDO-C, Cetane-Caps TC, Acidum ascorbinicum, CE-VI-Sol, 3-Keto-L-gulofuranolactone, L-(+)-Ascorbic Acid, Kyselina askorbova, Dora-C-500, Ascor-B.I.D., Ascorbicab, (R)-5-((S)-1,2-dihydroxyethyl)-3,4-dihydroxyfuran-2(5H)-one, Acido ascorbico, Acide ascorbique, Cortalex, Ferancee, Stuartinic, Tolfrinic, L-Threoascorbic acid, Caswell No. 061B, Antiscorbutic factor, FEMA No. 2109, L-3-Ketothreohexuronic acid lactone, Ascorbinsaeure, (+)-Ascorbic acid, Chromagen, Kyselina askorbova [Czech], Ascor, NCI-C54808, Ascorbicum acidum, Ferrous ascorbate, Acide ascorbique [INN-French], Acido ascorbico [INN-Spanish], Acidum ascorbicum [INN-Latin], Sodascorbate, CCRIS 57, L-threo-Hex-2-enonic acid, gamma-lactone, L-threo-Ascorbic acid, Chewcee, Citrovit, HSDB 818, Juvamine, 3-Oxo-L-gulofuranolactone (enol form), Vasc, UNII-PQ6CK8PD0R, PQ6CK8PD0R, Rovimix C, Scorbu C, EINECS 200-066-2, NSC 33832, Ascorbic acid, l-, Cetebe, Ascorbin, Ronotec 100, Ascorbyl radical, INS NO.300, DTXSID5020106, Rontex 100, CHEBI:29073, INS-300, Hex-2-enonic acid gamma-lactone, L-threo-, E-300, L-Ascorbic acid (GMP), MFCD00064328, NSC-33832, Iron(II) ascorbate, NSC-218455, component of E and C-Level, component of Endoglobin Forte, E300, DTXCID90106, Vitamin c (as ascorbic acid), (5R)-5-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxy-2,5-dihydrofuran-2-one, Ascorbic acid [USP:INN:BAN:JAN], component of Cortalex, component of Ferancee, NSC 218455, 6730-29-6, cevibid, NCGC00164357-01, Ester-C, (2R)-2-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxy-2H-furan-5-one, (5R)-5-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxyfuran-2(5H)-one, ASCORBIC ACID (II), ASCORBIC ACID [II], L-Ascorbic acid 1000 microg/mL in Acetonitrile, Ascorbinsaure, Kangbingfeng, 53262-66-1, Ceklin, ASCORBIC ACID (MART.), ASCORBIC ACID [MART.], Acide ascorbique (INN-French), Acido ascorbico (INN-Spanish), Acidum ascorbicum (INN-Latin), ASCORBIC ACID (USP-RS), ASCORBIC ACID [USP-RS], Parentrovite, Cell C, NSC33832, Ascorbic acid (USP:INN:BAN:JAN), Viscorin 100M, ASCORBIC ACID (EP MONOGRAPH), ASCORBIC ACID [EP MONOGRAPH], ASCORBIC ACID (USP MONOGRAPH), ASCORBIC ACID [USP MONOGRAPH], Suncoat VC 40, Acid, Ascorbic, (5R)-5-((1S)-1,2-DIHYDROXYETHYL)-3,4-DIHYDROXYFURAN-2(5H)-ONE, Ascorbicap (TN), Xyloascorbic acid, L-, Ascoltin (TN), [14C]ascorbic acid, Ascorbic acid [BAN:INN:JAN], [14C]-ascorbic acid, ascorbic acid (vit C), L-Ascorbic acid, meets USP testing specifications, 2-(1,2-Dihydroxyethyl)-4,5-dihydroxyfuran-3-one, DTXSID7048112, Ascorbinezuur, Cevitamate, Asorbicap, Clairfore, CleanFlex, L-lyxoascorbate, L-xyloascorbate, .Ascorbinsaure, New Clairfore, vitamine C, Vitamina C, 3eka, Ester C, (+)-ascorbate, L(+)-ascorbate, L-threo-hex-2-enono-1,4-lactone, HICELl, L-Ascorbic acid, free radical form, L-(+)-ascorbate, Vitamin C,(S), E 300, Ascorbic Acid1505, NEO-VALDRIN, VITA RICH, Dr Cellapy SR Premium, VIT C, (2R)-2-[(1S)-1,2-dihydroxyethyl]-4,5-dihydroxyfuran-3-one, Prestwick3_000325, L-Ascorbic acid, 99%, ASCOR (TN), SCHEMBL785, hex-1-enofuranos-3-ulose, bmse000182, VITAMIN C [VANDF], Vitamin C (Ascorbic acid), ASCORBIC ACID [MI], SCHEMBL4430, ASCORBIC ACID [FCC], ASCORBIC ACID [INN], ASCORBIC ACID [JAN], L-Ascorbic acid, FCC, FG, L-Ascorbic Acid, Free Acid, ASCORBIC ACID [FHFI], ASCORBIC ACID [HSDB], ASCORBIC ACID [INCI], BSPBio_000329, (r)-5-(1,2-dihydroxy-ethyl)-3,4-dihydroxy-5h-furan-2-one, MLS002153776, AROMACURA SHOWER FILTER, ASCORBIC ACID [VANDF], CHEMBL40274, L-Ascorbic acid, cell culture, BPBio1_000363, GTPL4532, GTPL4781, L-Ascorbic acid, reagent grade, ASCORBIC ACID [WHO-DD], ASCORBIC ACID [WHO-IP], L-Ascorbic acid, >=99.0%, CHEBI:22652, HY-B0166G, DTXCID50820452, DTXSID50986567, Ascorbic acid (JP17/USP/INN), CHEBI:176783, HMS2096A11, HMS2231N16, HMS3713A11, L-Ascorbic acid ACS reagent grade, (2R)-2-[(1S)-1,2-Dihydroxyethyl]-4,5-dihydroxy-furan-3-one, ASCORBIC ACID [ORANGE BOOK], BCP27915, HY-B0166, L-Threoascorbic acid,Antiscorbutic factor,Vitamin C;(R)-5-((S)-1,2-Dihydroxyethyl)-3,4-dihydroxyfuran-2(5H)-one, Tox21_110315, Tox21_112104, Tox21_202127, Tox21_302958, gamma-lactone L-threo-Hex-2-enonate, HB1238, L-Ascorbic acid, analytical standard, L-Ascorbic acid, AR, >=99.5%, s3114, AKOS016843589, Tox21_112104_1, CCG-207946, DB00126, L-Ascorbic acid, mixt. with vitamin B, ACIDUM ASCORBICUM [WHO-IP LATIN], gamma-lactone L-threo-Hex-2-enonic acid, L-Ascorbic acid, ACS reagent, >=99%, NCGC00091517-01, NCGC00091517-02, NCGC00091517-03, NCGC00091517-06, NCGC00188972-01, NCGC00256504-01, NCGC00259676-01, BP-12831, SMR001233160, L-Ascorbic acid, plant cell culture tested, L-Ascorbic acid, reagent grade, crystalline, A0537, AB00376923, Ascorbic Acid (L-Ascorbic Acid; Vitamin C), CS-0626121, NS00001126, SW198791-2, L-Ascorbic acid, BioUltra, >=99.5% (RT), L-Ascorbic acid, tested according to Ph.Eur., C00072, D00018, E80759, EN300-708766, L-Ascorbic acid, p.a., ACS reagent, 99.0%, 2,3-DEHYDRO-L-THREO-HEXONO-1,4-LACTONE, AB00376923_04, AB00376923_05, Celladix C.E.F ADVANCED BRIGHTENING AMPOULE, L-Ascorbic acid, JIS special grade, >=99.0%, L-Ascorbic acid, Vetec(TM) reagent grade, 99%, L-Ascorbic acid, BioXtra, >=99.0%, crystalline, Q199678, 2-(1,2-dihydroxyethyl)-4,5-dihydroxy-furan-3-one, L-Ascorbic acid, puriss. p.a., >=99.0% (RT), Q27101942, 47A605F0-4187-47A8-B0CE-F9E7DA1B0076, L-Ascorbic acid, p.a., ACS reagent, reag. ISO, 99.7%, Ascorbic acid, British Pharmacopoeia (BP) Reference Standard, Ascorbic acid, European Pharmacopoeia (EP) Reference Standard, L-Ascorbic acid, certified reference material, TraceCERT(R), L-Ascorbic acid, powder, cell culture tested, gamma-irradiated, Ascorbic acid, United States Pharmacopeia (USP) Reference Standard, 4-((E)-2-[(2-HYDROXYETHYL)SULFANYL]DIAZENYL)BENZENECARBOXYLICACID, (5R)-5-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxyfuran-2(5H)-one (non-preferred name), L-Ascorbic acid, anhydrous, free-flowing, Redi-Dri(TM), ACS reagent, >=99%, L-Ascorbic acid, suitable for cell culture, suitable for plant cell culture, >=98%, L-Ascorbic acid, puriss. p.a., ACS reagent, reag. ISO, reag. Ph. Eur., 99.7-100.5% (oxidimetric)" C6H8O6 CIWBSHSKHKDKBQ-JLAZNSOCSA-N (2R)-2-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxy-2H-furan-5-one n.a. Vitamins No No No No No No PMDBD2001282 Vitamin E Therapeutic Substance Approved Drug 9/2/1959 DB00163 PA451900 n.a. D02TQO 14985 n.a. NPC242580 "VITAMIN E, alpha-Tocopherol, D-alpha-Tocopherol, 59-02-9, 5,7,8-Trimethyltocol, (+)-alpha-Tocopherol, alpha Tocopherol, TOCOPHEROL, 2074-53-5, Phytogermine, Aquasol E, (R,R,R)-alpha-Tocopherol, Syntopherol, Viteolin, Eprolin, Esorb, (2R,4''R,8''R)-alpha-Tocopherol, Tocopherol alpha, dl-a-Tocopherol, alpha-Vitamin E, Profecundin, Denamone, Epsilan, Tokopharm, Vascuals, Viprimol, Etavit, alpha-Tokoferol, Evion, alpha-Tocopherol, D-, d-a-tocopherol, Eprolin S, Viterra E, E Prolin, E-Vimin, D-alpha tocopherol, Lan-E, Med-E, Tenox GT 1, Vi-E, Rhenogran Ronotec 50, a-Tocopherol, (2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL, Covitol F 1000, E 307 (tocopherol), (R)-2,5,7,8-Tetramethyl-2-((4R,8R)-4,8,12-trimethyltridecyl)chroman-6-ol, Vitamin Ea, a-D-Tocopherol, Tocopherol (R,S), (+)-a-Tocopherol, CCRIS 3588, CHEBI:18145, Vitamin-E, 2,5,7,8-Tetramethyl-2-(4'',8'',12''-trimethyltridecyl)-6-chromanol, HSDB 2556, EINECS 200-412-2, NSC 20812, (+/-)-alpha-Tocopherol, 1406-18-4, Evitaminum, Waynecomycin, Almefrol, E307, Emipherol, Etamican, Vitayonon, Ilitia, (2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydro-2H-chromen-6-ol, H4N855PNZ1, BPBio1_000362, 18920-62-2, Vitaplex E, DTXSID0026339, E 307, Spavit E, EC 200-412-2, ido-E, Endo E, N9PR3490H9, Vita E, Antisterility vitamin, a-Vitamin E, MFCD00072045, (2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-ol, 2H-1-Benzopyran-6-ol, 3,4-dihydro-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-, (2R)-, rel-alpha-Vitamin E, 2H-1-Benzopyran-6-ol, 3,4-dihydro-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-, (2R)-rel-, DTXCID706339, RRR-alpha-tocopherol, Vitamin E alpha, CAS-59-02-9, 2H-1-Benzopyran-6-ol, 3,4-dihydro-2,5,7,8-tetramethyl-2-((4R,8R)-4,8,12-trimethyltridecyl)-, (2R)-, 2H-1-Benzopyran-6-ol, 3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-, (2R-(2R*(4R*,8R*)))-, 2H-1-Benzopyran-6-ol, 3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-, [2R-[2R*(4R*,8R*)]]-, SMR000471844, VIV, alpha-Tocopherol acid, 3,4-Dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-benzopyran-6-ol, (all-R)-alpha-Tocopherol, DTXSID8021355, Phytogermin, Palmvtee, alpha-Tocoferol, (+-)-Med-E, UNII-N9PR3490H9, Vitamin Ealpha, NSC-20812, Alpha-tocopherols, .ALPHA.-TOCOPHEROL, D-, Pheryl-E, DL--Tocopherol, Vita plus E, Acne C-Patch, rel--Vitamin E, -Vitamin E, Vitamin e d-alpha, NCGC00016688-02, Vitamin E, liquid, Prestwick_653, EINECS 215-798-8, EINECS 218-197-9, .alpha.-Vitamin E, Envirose 100, NSC 82623, COVIREL, RRR-alpha-tocopheryl, Vitamin E [USP], ()-alpha-Tocopherol, delta-alpha-tocopherol, alpha-delta-Tocopherol, Tocopherol, d-alpha-, CONTROX VP, EPROLIN-S, Vitamin E (D-form), TENOX GT, CHEMBL47, (R,R,R)-a-Tocopherol, Prestwick3_000404, (+)- alpha -Tocopherol, (+)-.alpha.-Tocopherol, all-rac-alpha-Tocopherolum, bmse000600, R,r,r-.alpha.-tocopherol, alpha-TOCOPHEROL (II), SCHEMBL3097, COVI-OX T 30P, DL-all-rac-alpha-Tocopherol, RIKKI N 70, UNII-H4N855PNZ1, BIDD:PXR0174, COVI-OX T 50, Vita-Jec Essential E-300, BSPBio_000328, E-MIX 40A, MLS001066396, MLS001335981, MLS001335982, BIDD:ER0562, INS NO.307A, T1539_SIGMA, DTXCID201355, INS-307A, (+)-ALPHA-TOCOPHEROL-, ALPHA-TOCOPHEROL [HSDB], (2R,4''R,8''R)-a-Tocopherol, .ALPHA.-TOCOPHEROL [MI], ALPHA TOCOPHEROL (USP-RS), (+)--Tocopherol; D--Tocopherol, HMS2096A10, HMS2231G08, C29H50O2 (D-alpha-tocopherol), D-ALPHA TOCOPHEROL [MART.], HY-N0683, Tox21_110563, Tox21_113208, Tox21_202081, BDBM50458513, E-307A, LMPR02020001, MFCD00006848, AKOS004910417, CS-8161, DB00163, (2R)-2-((4R,8R)-4,8,12-trimethyltridecyl)-2,5,7,8-tetramethylchroman-6-ol, NCGC00142625-01, NCGC00142625-04, NCGC00142625-05, NCGC00142625-06, NCGC00142625-07, NCGC00142625-10, NCGC00142625-17, NCGC00259630-01, (2R)-3,4-Dihydro-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-2H-1-benzopyran-6-ol, (2R*(4R*,8R*))-(1)-3,4-Dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-benzopyran-6-ol, ALPHA-TOCOPHEROL, UNSPECIFIED FORM, AS-13990, J24.260H, rel-(+)--Tocopherol; rel-D--Tocopherol, J203.513H, E-307, NS00069772, T2309, C02477, F82497, EN300-7417123, Q158348, Q-201932, W-107596, W-109164, Z2235811339, 07AA93F0-3339-4EEC-B50B-ADB70F657087, (2R,4''R,8''R)-2,5,7,8-Tetramethyl-2-(4'',8'',12''-trimethyltridecyl)-6-chromanol, 3,4-Dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-1- -benzopyran-6-ol, 3,4-Dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-1--benzopyran-6-ol, (2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydro-2H-1-benzopyran-6-ol, (R)-2,5,7,8-tetramethyl-2-((4R,8R)-4,8,12-trimethyltridecyl)-3,4-dihydro-2H-chromen-6-ol, 2H-1-Benzopyran-6-ol, 3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-, 2R- 2R*(4R*,8R*) -, 2H-1-Benzopyran-6-ol, 3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-, (2R*(4R*,8R*))-(+-)-, rel-(2R)-2,5,7,8-tetramethyl-2-((4R,8R)-4,8,12-trimethyltridecyl)-3,4-dihydro-2H-chromen-6-ol" C29H50O2 GVJHHUAWPYXKBD-IEOSBIPESA-N (2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-ol n.a. n.a. No No No No Yes No rxnDiet28 PMDBD2001283 Vitexin Therapeutic Substance n.a. 3681-93-4 DB16836 n.a. n.a. n.a. 5280441 4444098 NPC209846 Vitexin, 3681-93-4, Apigenin 8-C-glucoside, 8-beta-D-Glucopyranosyl-apigenin, EINECS 222-963-8, UNII-9VP70K75OK, ORIENTOSIDE, VITEXINA, VITEXINE, 9VP70K75OK, Apigenin-8-C-glucoside, CHEBI:16954, Flavone, 8-D-glucosyl-4'',5,7-trihydroxy-, 4H-1-Benzopyran-4-one, 5,7-dihydroxy-8-beta-D-glucopyranosyl-2-(4-hydroxyphenyl)-, DTXSID90190287, MFCD00017456, 8C-hexosyl apigenin, VITEXIN (USP-RS), VITEXIN [USP-RS], 4H-1-Benzopyran-4-one, 8-beta-D-glucopyranosyl-5,7-dihydroxy-2-(4-hydroxyphenyl)-, 5,7-dihydroxy-2-(4-hydroxyphenyl)-8-((2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)-4H-chromen-4-one, Vitxein, 5,7-dihydroxy-2-(4-hydroxyphenyl)-8-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-4-one, 8-glycosylapigenin, (1S)-1,5-anhydro-1-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-8-yl]-D-glucitol, 4H-1-Benzopyran-4-one, 8-.beta.-D-glucopyranosyl-5,7-dihydroxy-2-(4-hydroxyphenyl)-, 8-glycosyl-apigenin, 8-beta-D-Glucopyranosyl-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one, (1S)-1,5-anhydro-1-(5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-8-yl)-D-glucitol, Vitexin,(S), VITEXIN [INCI], VITEXIN [WHO-DD], Vitexin, analytical standard, SCHEMBL25277, CHEMBL487417, DTXCID00112778, SGEWCQFRYRRZDC-VPRICQMDSA-N, Apigenin 8-C-.beta.-D-glucoside, HY-N0013, BDBM50362886, HB4123, s9192, AKOS025311479, AC-6086, CCG-208516, NCGC00163642-01, Vitexin 100 microg/mL in Acetone:Water, 5,7-dihydroxy-2-(4-hydroxyphenyl)-8-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]chromen-4-one, AS-55909, (hydroxymethyl)tetrahydro-2H-pyran-2-yl)-, 1ST158047, CS-0007090, NS00018314, APIGENIN-8-C-.BETA.-D-GLUCOPYRANOSIDE, C01460, Q259075, Vitexin, primary pharmaceutical reference standard, Q-100437, 8-((2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-, 5,7,4''-Trihydroxyflavone 8-C-.beta.-D-glucopyranoside, VITEXIN (CONSTITUENT OF HAWTHORN LEAF WITH FLOWER), FLAVONE, 8-beta-D-GLUCOPYRANOSYL-4'',5,7-TRIHYDROXY-, Vitexin, United States Pharmacopeia (USP) Reference Standard, FLAVONE, 8-.BETA.-D-GLUCOPYRANOSYL-4'',5,7-TRIHYDROXY-, 4H-1-Benzopyran-4-one, 5,7-dihydroxy-8-.beta.-D-glucopyranosyl-2-(4-hydroxyphenyl)- C21H20O10 SGEWCQFRYRRZDC-VPRICQMDSA-N 5,7-dihydroxy-2-(4-hydroxyphenyl)-8-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-4-one n.a. n.a. No No No No No No PMDBD2001284 VS2 n.a. n.a. n.a. n.a. n.a. n.a. n.a. 445490 n.a. n.a. VS2 C35H38N2O5S2 APTUSKZLSSDMBF-XFCANUNOSA-N benzyl N-[(2S)-1-[[(2S,3S)-1-benzylsulfonyl-5-phenyl-2-sulfanylpentan-3-yl]amino]-1-oxo-3-phenylpropan-2-yl]carbamate n.a. n.a. No No No No No No PMDBD2001285 VSL2 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001286 W-7 Hydrochloride n.a. n.a. n.a. n.a. n.a. n.a. n.a. 124887 n.a. n.a. "61714-27-0, W-7 HYDROCHLORIDE, N-(6-Aminohexyl)-5-chloro-1-naphthalenesulfonamide hydrochloride, n-(6-aminohexyl)-5-chloronaphthalene-1-sulfonamide hydrochloride, W-7 HCL, W 7 (hydrochloride), W-7 (hydrochloride), W-7, n-(6-Aminohexyl)-5-chloro-1-naphthalenesulfonamide HCl, N-(6-Aminohexyl)-5-chloro-1-naphthalenesulfonamide monohydrochloride, MFCD00012559, W7, W-7 hydrochloride;NSC 683545;NSC-683545;NSC683545, N-(6-aminohexyl)-5-chloronaphthalene-1-sulfonamide;hydrochloride, SR-01000075532, W7 HCl, 1-Naphthalenesulfonamide, N-(6-aminohexyl)-5-chloro-, monohydrochloride, W 7 HCl, MLS000859986, SCHEMBL897995, SPECTRUM1503627, CHEMBL513116, DTXSID10210719, CCG-39347, NSC683545, AKOS024457749, N-(6-AMINOHEXYL)-5-CHLORO-1-NAPHTHALENESULPHONAMIDE HYDROCHLORIDE, NSC-683545, NCGC00093583-01, NCGC00093583-02, NCGC00093583-03, NCGC00093583-04, NCGC00178278-01, NCGC00178278-02, AS-71717, SMR000326845, HY-100912, CS-0020582, EU-0100075, W-7, Hydrochloride - CAS 61714-27-0, A 3281, C16092, SR-01000075532-1, SR-01000075532-3, N-(6-AMINOHEXYL)-5-CHLORONAPHTHALENE-1-SULFONAMIDE HCL, n-(6-aminohexyl)-5-chloronaphthalene-1-sulfonamidehydrochloride, 1-Naphthalenesulfonamide, N-(6-aminohexyl)-5-chloro-, hydrochloride (1:1), N-AMINOHEXYL-5-CHLORONAPHTHALENE-1-YLSULFONAMIDE HYDROCHLORIDE, N-(6-Aminohexyl)-5-chloro-1-naphthalenesulfonamide hydrochloride, >=99.0% (TLC)" C16H22Cl2N2O2S OMMOSRLIFSCDBL-UHFFFAOYSA-N "N-(6-aminohexyl)-5-chloronaphthalene-1-sulfonamide;hydrochloride" n.a. n.a. No No No No No No PMDBD2001287 Wheat bran Therapeutic Substance n.a. n.a. DB10685 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001288 YC-1 compound Therapeutic Substance Patented Drug n.a. n.a. n.a. n.a. D0L1TA 5712 n.a. n.a. "yc-1, Lificiguat, 170632-47-0, YC 1, (5-(1-benzyl-1H-indazol-3-yl)furan-2-yl)methanol, 3-(5''-Hydroxymethyl-2''-furyl)-1-benzylindazole, 154453-18-6, Lificiguat [INN], C19H16N2O2, [5-(1-benzylindazol-3-yl)furan-2-yl]methanol, 5-[1-(Phenylmethyl)-1H-indazol-3-yl]-2-furanmethanol, 515CC1WPTE, CHEMBL333985, 3-(5''-Hydroxymethyl-2''-furyl)-1-benzyl indazole, 3-(5/''-hydroxymethyl-2/''-furyl)-1-benzylindazole, NSC-728165, YC1, 1-Benzyl-3-(5-hydroxymethyl-2-furyl)indazole, [5-(1-benzyl-1H-indazol-3-yl)furan-2-yl]methanol, [5-[1-(phenylmethyl)indazol-3-yl]furan-2-yl]methanol, YC 1 compound, YC-1 compound, SMR000857214, Lificiguat(YC-1), [5-(1-benzyl-1h-indazol-3-yl)-2-furyl]methanol, SR-01000076202, UNII-515CC1WPTE, lificiguatum, YC-1(Lificiguat), YC-1; Lificiguat, YC-1, powder, 2-Furanmethanol,5-[1-(phenylmethyl)-1H-indazol-3-yl]-, Lopac-Y-102, LIFICIGUAT [WHO-DD], Lopac0_001230, BSPBio_000987, KBioGR_000327, KBioSS_000327, MLS001333257, MLS001333258, MLS002172480, MLS006012048, SCHEMBL187837, GTPL5291, CHEBI:93060, KBio2_000327, KBio2_002895, KBio2_005463, KBio3_000653, KBio3_000654, DTXSID70165635, CHEBI:142430, Bio2_000324, Bio2_000804, HMS1362A09, HMS1792A09, HMS1990A09, HMS2235B17, HMS3263F22, HMS3373B12, HMS3403A09, HMS3649M04, KUC114162N, BCP09072, EX-A2409, VGA63247, Tox21_501230, BDBM50095469, HB3521, MFCD06407798, NSC728165, NSC756879, AKOS022180370, CCG-205304, CS-3363, LP01230, NSC 728165, NSC-756879, SDCCGSBI-0051197.P002, IDI1_002079, QTL1_000091, NCGC00016103-01, NCGC00016103-02, NCGC00016103-03, NCGC00016103-04, NCGC00016103-05, NCGC00016103-06, NCGC00016103-07, NCGC00016103-17, NCGC00094472-01, NCGC00094472-02, NCGC00094472-03, NCGC00094472-04, NCGC00261915-01, AC-29036, AS-55797, HY-14927, KSC-412-005-, EU-0101230, Y-102, 1-Benzyl-3-(5-hydroxymethylfur-2-yl)indazole, 3-(5-hydroxymethyl-2-furyl)-1-benzylindazole, 1-Benzyl-3-(5''-hydroxymethyl-2-furyl)indazole, 3-(5''-hydroxymethyl-2''furyl)-1-benzyl-indazole, A907557, 1-Benzyl-3-(5-hydroxymethyl-2-furyl)-1H-indazole, J-010636, SR-01000076202-1, SR-01000076202-7, BRD-K60476892-001-02-1, BRD-K60476892-001-11-2, Q27089256, [5-(1-Benzyl-1H-indazol-3-yl)-furan-2-yl]-methanol, 1-(1-benzyl-3-(5''''-hydroxymethyl-2''''-furyl)-indazole, 2-Furanmethanol, 5-[1-(phenylmethyl)-1H-indazol-3-yl]-, 5-a[1-a?phenylmethyl)-a?H-aindazol-a?-ayl]-a?-afuranmethanol" C19H16N2O2 OQQVFCKUDYMWGV-UHFFFAOYSA-N [5-(1-benzylindazol-3-yl)furan-2-yl]methanol YUNG SHIN PHARM. IND. CO., LTD n.a. No No No No No No PMDBD2001289 Yohimbine hydrochloride n.a. n.a. n.a. n.a. n.a. n.a. n.a. 6169 n.a. n.a. "YOHIMBINE HYDROCHLORIDE, 65-19-0, Yohimbine HCl, Antagonil, Yohimbe, Aphrodine hydrochloride, Yohimbine monohydrochloride, Yohimbin HCl, Yohimbine (Hydrochloride), Yohimbin hydrochloride, UNII-NB2E1YP49F, EINECS 200-600-4, NB2E1YP49F, NSC 19509, Yohimbin hydrochloride [USP], AI3-60247, NSC-19509, DTXSID40891272, Yohimbine hydrochloride [USP:BAN], Yohimban-16-carboxylic acid, 17-hydroxy-, methyl ester, monohydrochloride, (16alpha,17alpha)-, 17alpha-Hydroxy-20-alpha-yohimban-16-beta-carboxylic acid, methyl ester, hydrochloride, Yohimban-16-alpha-carboxylic acid, 17-alpha-hydroxy-, methyl ester, hydrochloride, Yohimban-16alpha-carboxylic acid, 17alpha-hydroxy-, methyl ester, monohydrochloride, Yohimbin hydrochloride (USP), YOHIMBINE CHLORIDE, Yohimbine hydrochloride (USP:BAN), 17-Hydroxyyohimban-16-carboxylic acid methyl ester hydrochloride, CHEMBL537669, YOHIMBINE HYDROCHLORIDE (MART.), YOHIMBINE HYDROCHLORIDE [MART.], YOHIMBINE HYDROCHLORIDE (USP-RS), YOHIMBINE HYDROCHLORIDE [USP-RS], methyl (1S,15R,18S,19R,20S)-18-hydroxy-3,13-diazapentacyclo[11.8.0.0^{2,10}.0^{4,9}.0^{15,20}]henicosa-2(10),4,6,8-tetraene-19-carboxylate hydrochloride, SMR000058527, YOHIMBINE HYDROCHLORIDE (EP MONOGRAPH), YOHIMBINE HYDROCHLORIDE [EP MONOGRAPH], YOHIMBINE HYDROCHLORIDE (USP MONOGRAPH), YOHIMBINE HYDROCHLORIDE [USP MONOGRAPH], SR-01000597896, Parkimbine, Gynimbine, Menolysin, Tosanpin, Yobinol, Yohydrol, Yocon, SR-01000075297, MFCD00012674, Yobine Injection, Prestwick_961, Yohimbine-Hydrochloride, Hydrochloride, Aphrodine, Hydrochloride, Yohimbine, MLS001306411, MLS001333983, Yohimbine hydrochloride (USP), PIPZGJSEDRMUAW-VJDCAHTMSA-N, DTXCID601030458, HMS1569F10, Yohimbine hydrochloride (Antagonil), BCP19708, HY-N0127, Tox21_501210, YOHIMBINE HYDROCHLORIDE [MI], s2373, AKOS015951349, CCG-208327, CS-5238, LP01210, YOHIMBINE HYDROCHLORIDE [VANDF], YOHIMBINE HYDROCHLORIDE [WHO-DD], NCGC00094457-01, NCGC00261895-01, AC-22571, AS-13939, YOHIMBINE HYDROCHLORIDE [GREEN BOOK], Yohimbine hydrochloride, analytical standard, EU-0101210, NS00078828, SW199050-2, Y0002, D06671, Y 3125, Yohimbine hydrochloride, >=98% (TLC), powder, Q-201938, SR-01000075297-1, SR-01000597896-1, SR-01000597896-4, Q15680050, 17?-Hydroxyyohimban-16?-carboxylic acid methyl ester hydrochloride, Yohimbine hydrochloride, European Pharmacopoeia (EP) Reference Standard, Yohimbine hydrochloride, United States Pharmacopeia (USP) Reference Standard, 17.ALPHA.-HYDROXY-20-.ALPHA.-YOHIMBAN-16-.BETA.-CARBOXYLIC ACID, METHYL ESTER, HYDROCHLORIDE, methyl(1S,15R,18S,19R,20S)-18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate;hydrochloride, Yohimban-16-carboxylic acid, 17-hydroxy-, methyl ester, hydrochloride (1:1), (16alpha,17alpha)-" C21H27ClN2O3 PIPZGJSEDRMUAW-VJDCAHTMSA-N "methyl (1S,15R,18S,19R,20S)-18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate;hydrochloride" n.a. n.a. No No No No No No PMDBD2001290 Zalcitabine Therapeutic Substance Approved Drug 7481-89-2 DB00943 PA451950 D00412 D0Z9QR 24066 22498 NPC487916 "zalcitabine, Dideoxycytidine, 7481-89-2, 2'',3''-DIDEOXYCYTIDINE, ddCyd, HIVID, Cytidine, 2'',3''-dideoxy-, ddC, 4-Amino-1-((2R,5S)-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one, Zalcitibine, NSC 606170, Ro 24-2027/000, Ro-24-2027/000, NSC-606170, CHEMBL853, 6L3XT8CB3I, 4-amino-1-[(2R,5S)-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidin-2(1H)-one, DTXSID0023747, CHEBI:10101, MFCD00012188, NCGC00090705-08, Ro-242027000, Ro-24-2027000, 4-AMINO-1-[(2R,5S)-5-(HYDROXYMETHYL)OXOLAN-2-YL]-1,2-DIHYDROPYRIMIDIN-2-ONE, 2,3-dideoxycytidine, DTXCID703747, NSC606170, 4-amino-1-[(2R,5S)-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidin-2-one, SMR000058253, CCRIS 692, Hivid(TM), Hivid (TN), HSDB 7156, Interferon AD + ddC, ddC & GM-CSF, ddC & sCD4, PC-SOD & ddC, DDC (DDC), UNII-6L3XT8CB3I, BRN 0654956, Zalcitabine (JAN/USP/INN), Zalcitabine?, DS-4152 & ddC, 1-(2,3-Dideoxy-beta-D-ribofuranosyl)cytosine, ddC & NP (from PHCA or HSA), SRI-7707, Zalcitabine [USAN:USP:INN:BAN], 2'',3''-Dideoxycytidine;ddC;Dideoxycytidine, CAS-7481-89-2, Zalcitabine- Bio-X, KS-1130, ddC & IFN.alpha., .beta.-D-DDC, dideoxycytidine (DDC), ZALCITABINE [MI], 4-amino-1-[(2R,5S)-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one, Prestwick0_001037, Prestwick1_001037, Prestwick2_001037, Prestwick3_001037, ddC & Interferon.alpha., ZALCITABINE [INN], ZALCITABINE [JAN], 2'', 3''-dideoxycytidine, ZALCITABINE [HSDB], ZALCITABINE [IARC], ZALCITABINE [USAN], bmse000712, UPCMLD-DP115, D 5782, ZALCITABINE [VANDF], SCHEMBL3598, TimTec1_004969, ZALCITABINE [MART.], Lopac0_000360, BSPBio_001253, ZALCITABINE [USP-RS], ZALCITABINE [WHO-DD], 3''-Azido-3''-deoxythymidine/2'',3''-Dideoxycytidine, 5-25-14-00313 (Beilstein Handbook Reference), MLS000069636, MLS000759540, MLS001055363, MLS001424210, MLS006011951, SPBio_003104, BPBio1_001378, GTPL4828, UPCMLD-DP115:001, 2'',3''-Dideoxycytidine & sCD4(soluble recombinant protein), Zalcitabine (dideoxycytidine,ddc), ZALCITABINE [ORANGE BOOK], HMS1548B19, HMS1571O15, HMS2051H18, HMS2090C12, HMS2098O15, HMS2236N08, HMS3261G21, HMS3715O15, Pharmakon1600-01502360, ZALCITABINE [USP IMPURITY], .beta.-D-2'',3''-Dideoxycytidine, Zalcitabine, 2''3''-Dideoxycytidine, BCP13878, Tox21_113491, Tox21_201655, Tox21_303169, Tox21_500360, AC-824, BDBM50145605, Lecithinized superoxide dismutase & .beta.-D-2'',3''-Dideoxycytidine, NSC759655, s1719, AKOS015854844, AKOS015894505, Tox21_113491_1, CCG-101050, CS-1110, DB00943, LP00360, NC00300, NSC-759655, SDCCGSBI-0050348.P002, SRI-7707-13, SRI-7707-14, SRI-7707_15, SRI-7707_17, NCGC00090705-01, NCGC00090705-02, NCGC00090705-03, NCGC00090705-05, NCGC00090705-06, NCGC00090705-07, NCGC00090705-09, NCGC00090705-10, NCGC00090705-11, NCGC00090705-13, NCGC00090705-15, NCGC00090705-24, NCGC00090705-25, NCGC00179242-01, NCGC00257202-01, NCGC00259204-01, NCGC00261045-01, BD164564, BP-58631, HY-17392, ddC;Dideoxycytidine;2'',3''-Dideoxycytidine, 2'',3''-Dideoxycytidine & Interferon.alpha., 2'',3''-Dideoxycytidine, >=98% (HPLC), D3581, EU-0100360, NS00005543, SW197364-4, 2'',3''-Dideoxycytidine, >=99.0% (HPLC), C07207, C76390, D00412, EN300-120633, Cytidine, 2'',3''-dideoxy- & Interferon.alpha., A838234, SR-01000075822, SR-01000736919, ZALCITABINE (DIDEOXYCYTIDINE,DDC) [VANDF], J-700276, Q-201941, Q2344582, SR-01000075822-1, SR-01000736919-5, Cytidine, 2'',3''-dideoxy- & Colony-stimulating factor, Ro-242027000/Ro-24-2027-000, Z1550648753, Zalcitabine, United States Pharmacopeia (USP) Reference Standard, 4-Amino-1-(5-hydroxymethyl-tetrahydro-furan-2-yl)-1H-pyrimidin-2-one, .beta.-D-2'',3''-Dideoxycytidine & Granulocyte-macrophage colony-stimulating factor" C9H13N3O3 WREGKURFCTUGRC-POYBYMJQSA-N 4-amino-1-[(2R,5S)-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one Hoffmann-La Roche pharmaceutical company Anti-HIV Agents No No No No No No PMDBD2001291 Zanamivir Therapeutic Substance Approved Drug 139110-80-8 DB00558 PA164740891 D00902 D00NPP 60855 54842 n.a. zanamivir, 139110-80-8, Relenza, 4-Guanidino-Neu5Ac2en, GANA, Zanamavir, GG167, GR-121167X, GG-167, GR 121167X, GANA (inhibitor), 4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid, UNII-L6O3XI777I, GG 167, L6O3XI777I, DTXSID0023749, CHEBI:50663, GR-121167, HSDB 7437, 5-Acetamido-2,6-anhydro-3,4,5-trideoxy-4-guanidino-D-glycero-D-galacto-non-2-enonic acid, Relenza (TN), (2R,3R,4S)-3-acetamido-4-(diaminomethylideneamino)-2-[(1R,2R)-1,2,3-trihydroxypropyl]-3,4-dihydro-2H-pyran-6-carboxylic acid, ZMR, CHEMBL222813, DTXCID503749, 139110-80-8 (free base), MFCD00866966, 5-(acetylamino)-2,6-anhydro-4-carbamimidamido-3,4,5-trideoxy-D-glycero-D-galacto-non-2-enonic acid, ZANAMIVIR (MART.), ZANAMIVIR [MART.], ZANAMIVIR (USP-RS), ZANAMIVIR [USP-RS], ZANAMIVIRHYDRATE, ZANAMIVIR (USP MONOGRAPH), ZANAMIVIR [USP MONOGRAPH], (2R,3R,4S)-3-(acetylamino)-4-carbamimidamido-2-[(1R,2R)-1,2,3-trihydroxypropyl]-3,4-dihydro-2H-pyran-6-carboxylic acid, (2R,3R,4S)-3-Acetamido-4-guanidino-2-((1R,2R)-1,2,3-trihydroxypropyl)-3,4-dihydro-2H-pyran-6-carboxylic acid, (2r,3r,4s)-4-[(diaminomethylidene)amino]-3-acetamido-2-[(1r,2r)-1,2,3-trihydroxypropyl]-3,4-dihydro-2h-pyran-6-carboxylic acid, 5-acetamido-2,6-anhydro-4-carbamimidamido-3,4,5-trideoxy-D-glycero-D-galacto-non-2-enonic acid, D-glycero-D-galacto-Non-2-enonic acid, 5-(acetylamino)-4-[(aminoiminomethyl)amino]-2,6-anhydro-3,4,5-trideoxy-, CAS-139110-80-8, 4-Guanidino-NeueAc2en, 4 Guanidino Neu5Ac2en, 551942-41-7, zanamivirum, Dectova, Zanamivi, Zanamivir [USAN:INN:BAN], 2qwe, NCGC00164561-01, (2R,3R,4S)-3-(acetylamino)-4-carbamimidamido-2-((1R,2R)-1,2,3-trihydroxypropyl)-3,4-dihydro-2H-pyran-6-carboxylic acid, (2R,3R,4S)-3-acetamido-4-guanidino-2-[(1R,2R)-1,2,3-trihydroxypropyl]-3,4-dihydro-2H-pyran-6-carboxylic acid, D-GLYCERO-D-GALACTO-NON-2-ENONIC ACID, 5-(ACETYLAMINO)-4-((AMINOIMINOMETHYL)AMINO)-2,6-ANHYDRO-3,4,5-TRIDEOXY-, GR121167X, Zanamivir (Relenza), Zanamivir (Relenza)?, 1a4g, Zanamivir (USP/INN), 5-(Acetylamino)-4-, ZANAMIVIR [INN], ZANAMIVIR [MI], ZANAMIVIR [HSDB], ZANAMIVIR [USAN], ZANAMIVIR [VANDF], SCHEMBL9501, ZANAMIVIR [WHO-DD], GNA, BIDD:GT0349, BDBM4934, ZANAMIVIR [ORANGE BOOK], Zanamivir, >=98% (HPLC), GTPL12307, 4 Guanidino 2 Deoxy 2,3 Didehydro N Acetylneuraminic Acid, 4-guanidino-2-deoxy-2,3-didehydro-N-acetylneuraminic acid, J05AH01, ARAIBEBZBOPLMB-UFGQHTETSA-N, Acid, 4-Guanidino-2-Deoxy-2,3-Didehydro-N-Acetylneuraminic, 2,3-didehydro-2,4-dideoxy-4-guanidinyl-N-acetylneuraminic acid, 4-guanidino-2,4-dideoxy-2,3-didehydro-N-acetylneuraminic acid, Tox21_112190, 2,3-didehydro-2,4-dideoxy-4-guanidino-N-acetyl-D-neuraminic acid, BDBM50330326, s3007, AKOS015841013, AKOS015994539, Tox21_112190_1, BS-1017, CCG-267828, CS-0631, DB00558, 5-acetylamino-2,6-anhydro-4-guanidino-3,4,5-trideoxy-D-galacto-non-enoic acid, 5-acetylamino-4-guanidino-6-(1,2,3-trihydroxypropyl)-5,6-dihydro-4H-pyran-2-carboxylic acid, NCGC00164561-02, NCGC00164561-08, NCGC00164561-11, (2R,3R,4S)-3-acetamido-4-((diaminomethylene)amino)-2-((1R,2R)-1,2,3-trihydroxypropyl)-3,4-dihydro-2H-pyran-6-carboxylic acid, 5-(acetylamino)-4-{[amino(imino)methyl]amino}-2,6-anhydro-3,4,5-trideoxy-D-glycero-D-galacto-non-2-enonic acid, HY-13210, NS00003906, Z0023, C08095, C72554, D00902, AB01566897_01, A807485, EN300-26991905, Q146075, Q-201942, Zanamivir, United States Pharmacopeia (USP) Reference Standard, Zanamivir for assay, EuropePharmacopoeia (EP) Reference Standard, 2,3-Didehydro-2,4-dideoxy-4-guanidine-N-acetyl-acetyl-D-neuraminic acid, 5-acetamido-4-guanidino-2,3,4,5-tetradeoxy-D-glycero-D-galacto-non-2-enopyranosonic acid, 5-Acetamino-2,6-anhydro-4-guanidino-3,4,5-trideoxy-D-galcto-non-enoic acid, Zanamivir for system suitability, European Pharmacopoeia (EP) Reference Standard, (2R,3R,4S)-3-(ACETYLAMINO)-4-{[AMINO(IMINO)METHYL]AMINO}-2-[(1R,2R)-1,2,3-TRIHYDROXYPROPYL]-3,4-DIHYDRO-2H-PYRAN-6-CARBOXYLIC ACID, (2R,3R,4S)-4-[(diaminomethylidene)amino]-3-acetamido-2-[(1R,2R)-1,2,3-trihydroxypropyl]-3,4-dihydro-2H-pyran-6-carboxylic acid hydrate, (2R,3R,4S)-4-carbamimidamido-3-acetamido-2-[(1R,2R)-1,2,3-trihydroxypropyl]-3,4-dihydro-2H-pyran-6-carboxylic acid, (4S,5R,6R)-5-acetamido-4-(diaminomethyleneamino)-6-((1R,2R)-1,2,3-trihydroxypropyl)-5,6-dihydro-4H-pyran-2-carboxylic acid, (4S,5R,6R)-5-acetylamino-4-guanidino-6-((1R,2R)-1,2,3-trihydroxy-propy)-5,6-dihydro-4H-pyran-2-carboxylic acid, (4S,5R,6R)-5-acetylamino-4-guanidino-6-((1R,2R)-1,2,3-trihydroxy-propyl)-5,6-dihydro-4H-pyran-2-carboxylic acid, (4S,5R,6R)-5-Acetylamino-4-guanidino-6-((1R,3R)-1,2,3-trihydroxy-propyl)-5,6-dihydro-4H-pyran-2-carboxylic acid, (4S,5R,6R)-5-Acetylamino-4-guanidino-6-((R)-1,2,3-trihydroxy-propyl)-5,6-dihydro-4H-pyran-2-carboxylic acid, (4S,5R,6R)-5-Acetylamino-4-guanidino-6-(1,2,3-trihydroxy-propyl)-5,6-dihydro-4H-pyran-2-carboxylic acid, 4-diaminomethylamino-3-methylcarboxamido-2-(1,2,3-trihydroxypropyl)-(3R)-3,4-dihydro-2H-6-pyrancarboxylic acid(Zanamivir), 5-Acetylamino-4-guanidino-6-(1,2,3-trihydroxy-propyl)-5,6-dihydro-4H-pyran-2-carboxylic acid, 5-Acetylamino-4-guanidino-6-(1,2,3-trihydroxy-propyl)-5,6-dihydro-4H-pyran-2-carboxylic acid(zanamivir), 5-Formylamino-4-guanidino-6-(1,2,3-trihydroxy-propyl)-5,6-dihydro-4H-pyran-2-carboxylic acid, D-glycero-D-galacto-Non-2-enonic acid, 5-(acetylamino)-4-(aminoiminomethyl)amino)-2,6-anhydro-3,4,5-trideoxy- C12H20N4O7 ARAIBEBZBOPLMB-UFGQHTETSA-N (2R,3R,4S)-3-acetamido-4-(diaminomethylideneamino)-2-[(1R,2R)-1,2,3-trihydroxypropyl]-3,4-dihydro-2H-pyran-6-carboxylic acid GlaxoSmithKline Antiviral Agents No No No No No No PMDBD2001292 Zeaxanthin Therapeutic Substance n.a. 144-68-3 DB11176 n.a. n.a. n.a. 5280899 4444421 NPC45782 "Zeaxanthin, 144-68-3, Anchovyxanthin, all-trans-Zeaxanthin, Zeaxanthol, Xanthophyll 3, Beta,beta-carotene-3,3''-diol, Luteinofta, Optisharp, Zeagold, 3R,3''R-Zeaxanthin, trans-Zeaxanthin, (3R,3''R)-Zeaxanthin, beta-carotene-3,3''-diol, Zeaxanthin, 65%, (3R,3''R)-beta,beta-Carotene-3,3''-diol, UNII-CV0IB81ORO, CV0IB81ORO, EINECS 205-636-4, INS NO.161H(I), DTXSID5046807, CHEBI:27547, INS-161H(I), all-trans-Anchovyxanthin, all-trans-beta-carotene-3,3''-diol, E 161H, E-161H(I), (1R)-4-[(1E,3E,5E,7E,9E,11E,13E,15E,17E)-18-[(4R)-4-hydroxy-2,6,6-trimethylcyclohexen-1-yl]-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaenyl]-3,5,5-trimethylcyclohex-3-en-1-ol, (1R,1''R)-4,4''-((1E,3E,5E,7E,9E,11E,13E,15E,17E)-3,7,12,16-Tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaene-1,18-diyl)bis(3,5,5-trimethylcyclohex-3-enol), DTXCID3026807, MFCD08435940, (3R,3''R)-dihydroxy-beta,beta-carotene, beta,beta-Carotene-3,3''-diol, (3R,3''R)-, ZEAXANTHIN (MART.), ZEAXANTHIN [MART.], Zeaxanthine, Zeaxanthins, 3R,3''R Zeaxanthin, Beta Carotene 3,3'' Diol, Zeaxanthin, tech., NCGC00181020-01, Zeaxanthin - 10%, Zeaxanthin, all-trans-, ZEAXANTHIN [MI], ZEAXANTHIN [INCI], ZEAXANTHIN [VANDF], Anchovyxanthin, all-trans-, ZEAXANTHIN [WHO-DD], SCHEMBL19442, .beta.,.beta.-Carotene-3,3''-diol, (3R,3''R)-, Zeaxanthin, analytical standard, CHEMBL2359248, beta,beta-carotene-3R,3''R-diol, Tox21_112670, LMPR01070261, NSC713073, AKOS016015115, DB11176, DS-5859, NSC-713073, (3R,3''R)-DIHYDROXY-beta-CAROTENE, Zeaxanthin 10 microg/mL in Acetonitrile, 1ST40033, CAS-144-68-3, XZ177654, HY-120318, CS-0077564, NS00019592, (3R,3''R)-DIHYDROXY-.BETA.-CAROTENE, C06098, EN300-7418250, A808258, Q169337, W-108152, .beta.-Carotene-3,3''-diol, (3R,3''R)-all-trans-, beta,beta-carotene-3,3''-diol, (3R,3''R)-all-trans-, 6AB548E1-4B81-4843-8E0E-481DCFC93CA8, Zeaxanthinall-trans-Zeaxanthin; Zeaxanthol; Xanthophyll 3, ZEAXANTHIN/(3R,3''R)-ZEAXANTHIN (CONSTITUENT OF AZTEC MARIGOLD ZEAXANTHIN EXTRACT), (1R)-3,5,5-trimethyl-4-[(1E,3E,5E,7E,9E,11E,13E,15E,17E)-3,7,12,16-tetramethyl-18-[(4R)-2,6,6-trimethyl-4-oxidanyl-cyclohexen-1-yl]octadeca-1,3,5,7,9,11,13,15,17-nonaenyl]cyclohex-3-en-1-ol, (1R)-4-[(1E,3E,5E,7E,9E,11E,13E,15E,17E)-18-[(4R)-4-hydroxy-2,6,6-trimethyl-1-cyclohexenyl]-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaenyl]-3,5,5-trimethyl-1-cyclohex-3-enol, (1R)-4-[(1E,3E,5E,7E,9E,11E,13E,15E,17E)-18-[(4R)-4-hydroxy-2,6,6-trimethylcyclohex-1-en-1-yl]-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaen-1-yl]-3,5,5-trimethylcyclohex-3-en-1-ol, 4-(18-(4-hydroxy-2,6,6-trimethyl-1-cyclohexenyl)-3,7,12,16-tetramethyl-octadeca-1,3,5,7,9,11,13,15,17-nonaenyl)-3,5,5-trimethyl-cyclohex-3-en-1-ol" C40H56O2 JKQXZKUSFCKOGQ-QAYBQHTQSA-N (1R)-4-[(1E,3E,5E,7E,9E,11E,13E,15E,17E)-18-[(4R)-4-hydroxy-2,6,6-trimethylcyclohexen-1-yl]-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaenyl]-3,5,5-trimethylcyclohex-3-en-1-ol n.a. n.a. No No No No Yes No rxn02707,rxn16595,rxnDiet47 PMDBD2001293 Zinc Therapeutic Substance n.a. 7440-66-6 DB01593 PA451956 n.a. n.a. 23994 n.a. n.a. "7440-66-6, Zinc, Zn, Zinc dust, Zinc, elemental, Zinc powder, Zincum metallicum, cinc, Rheinzink, Jasad, Granular zinc, Blue powder, Emanay zinc dust, Zinc (fume or dust), Zinc, ion (Zn1+), Zinc(1+), Zinc(1-), zincide, zincum, CCRIS 1582, LS 2, LS 6, Zink, CHEBI:30185, HSDB 1344, UNII-J41CSQ7QDS, J41CSQ7QDS, Zinc, ion (Zn 1-), EINECS 231-175-3, MFCD00011291, zinc(0), CHEBI:27363, 30Zn, Zinc foil, Zinc shot, Zinc rod, CHEMBL1201279, DTXSID7035012, EC 231-175-3, 14018-82-7, Merrillite, Zinc, SAJ first grade, Zinc powder; Cinc; Merrillite, Zinc, p.a., 99.8%, Asarco L 15, Lead refinery vacuum zinc, Zinc rod, 1.27cm (0.5in) dia, Zinc wire, 1.0mm (0.04in) dia, Zinc (metallic), Zinc wire, 0.25mm (0.01in) dia, Zinc, suitable for arsenic determination, Zinc (dust or fume), ZINC, DUST, Zinc Standard: Zn @ 1000 microg/mL in 5% HNO3, UN1435, UN1436, Zinc Standard: Zn @ 10000 microg/mL in 5% HNO3, Zinc AA Standard: Zn @ 1000 microg/mL in 5% HNO3, zinc anion, zinc atom, Zinc granules, Sulfur-Free Zinc Concentrate: Zn @ approx. 18 wt% in Hydrocarbons, Zinc ashes, Zinc mossy, Zinc, lump, 10 mm max. lump size, weight 100 g, purity 99.99%, Zinc, lump, 10 mm max. lump size, weight 200 g, purity 99.99%, Zinc wire, Zinc, pellets, Zinc Met, zinc(I) cation, Zinc, rods, Zinc, Mossy, zincide(-I), Zinc single crystal disc, 10mm (0.39in) dia, 2-3mm (0.08-0.1in) thick, (0001) orientation, +/-0.5 degrees, zincide(1-), Zinc, purum, powder, zinc(1+) ion, Zinc, dust 44, zinc ion (1+), Zincum Metallicum 12X, Zinc, ion (Zn1-), NEURALGIA HEADACHE, Zincum metallicum 200C, ZINC [VANDF], ZINC [EMA EPAR], Zinc powder or zinc dust, Zinc, JIS special grade, ZINC [INCI], Zinc pieces 2-14 mesh, Zinc powder 6-9 microns, UF (METAL), ZINC [WHO-DD], ECKA 4, Epitope ID:114075, ZINC [MI], LS 2 (ELEMENT), Zinc powder, -100 mesh, Zinc, mossy, >=99%, ZINCUM METALLICUM30c, Zincum Metallicum Kit Refill, Zinc dust, <10 micrometers, Zinc, 99.5%, Zn(+), Zn(-), Zn(0), ZINCUM METALLICUM200CK, DTXCID004384, LS 4, LS 5, Zinc metal, NIST SRM 683, Rieke(R) Zinc 10% in THF, ZINC, ELEMENTAL [HSDB], Zinc, p.a., 99.9%, Zinc rod, 7mm (0.3in) dia, Zinc, LR, dust, >=90%, ZINCUM METALLICUM [HPUS], CHEBI:37254, CHEBI:37255, Zinc powder, median 6-9 micron, Zinc, shot, 99.9999%, F 2000 (METAL), VM 4P16, Zinc powder or zinc dust [UN1436] [Dangerous when wet], Zinc, LR, granular, >=99%, Zinc powder, -140+325 mesh, Zinc rod, 8mm (0.31in) dia, DTXSID101316732, DTXSID201316735, High-purity zinc, NIST SRM 682" Zn HCHKCACWOHOZIP-UHFFFAOYSA-N zinc n.a. n.a. No No No No Yes No rxnAGORA1376,rxnAGORA2412 PMDBD2001294 Zinc Dichloride Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. D05ELV 5727 n.a. n.a. 7646-85-7, zinc chloride, Dichlorozinc, Zinc dichloride, Zinc(II) chloride, Zinkchloride, Zintrace, Zinc chloride fume, Zinkchlorid, Zine dichloride, Chlorure de zinc, Zinc chloride (ZnCl2), Zinc (chlorure de), Zinco (cloruro di), Caswell No. 910, MFCD00011295, CCRIS 3509, HSDB 1050, EINECS 231-592-0, EPA Pesticide Chemical Code 087801, NSC 529648, AI3-04470, UNII-86Q357L16B, Zinc chloride in plastic container, NSC529648, 86Q357L16B, Zinc chloride, ultra dry, EC 231-592-0, Zinc chloride (USP:JAN), Zinc chloride [USP:JAN], Zinkchlorid [German], Zinkchloride [Dutch], Chlorure de zinc [French], Zinc (chlorure de) [French], Zinco (cloruro di) [Italian], UN1840, UN2331, CHLORZINK, ZINCCHLORID, Caswell No 910, Zinc chloride (TN), Zinc chloride in THF, CLOLURO DI ZINCO, WLN: ZN G2, Zinc chloride (JP17/USP), Zinc chloride, LR, >=97%, Zinc chloride, p.a., 97.0%, ZINC CHLORIDE, (ANHYDROUS), Zinc chloride, 1.9M in 2-MeTHF, Zinc chloride, for molecular biology, Zinc Chloride, ACS Grade, anhydrous, AKOS016017250, Zinc chloride, ACS reagent, >=97%, Zinc chloride, reagent grade, >=98%, USEPA/OPP Pesticide Code: 087801, Zinc chloride (99.99%-Zn) PURATREM, Zinc chloride, 99.999% trace metals basis, Zinc chloride, SAJ first grade, >=95.0%, Zinc chloride, JIS special grade, >=98.0%, D02058, Q204714, Zinc chloride, anhydrous [UN2331] [Corrosive], BRD-K46586998-001-01-1, Zinc chloride, BioReagent, for molecular biology, >=97.0%, Zinc chloride, anhydrous, powder, >=99.995% trace metals basis, Zinc chloride, anhydrous, free-flowing, Redi-Dri(TM), ACS reagent, >=97%, Zinc chloride, 1M in diethyl ether, packaged under Argon in resealable ChemSeal bottles, Zinc chloride, anhydrous, beads, amorphous, -10 mesh, 99.99% trace metals basis, Zinc chloride, anhydrous, beads, amorphous, -10 mesh, 99.999% trace metals basis, Zinc chloride, anhydrous, free-flowing, Redi-Dri(TM), reagent grade, >=98%, Zinc chloride, puriss. p.a., ACS reagent, reag. ISO, reag. Ph. Eur., >=98%, Zinc chloride, puriss., meets analytical specification of Ph. Eur., BP, USP, 98-100.5%, Zinc chloride, BioReagent, for molecular biology, suitable for cell culture, suitable for insect cell culture Cl2Zn JIAARYAFYJHUJI-UHFFFAOYSA-L dichlorozinc Hospira Inc n.a. No No No No No No PMDBD2001295 Zinc Nitrate n.a. n.a. n.a. n.a. n.a. n.a. n.a. 24518 n.a. n.a. "ZINC NITRATE, Zinc dinitrate, 7779-88-6, Celloxan, 13778-30-8, zinc;dinitrate, Nitrate de zinc, Nitric acid, zinc salt, X 4 (nitrate), UNII-EDO66F5U49, Zinc nitrate (Zn(NO3)2), EDO66F5U49, zinc(2+) dinitrate, HSDB 1056, ZINC(II) NITRATE, EINECS 231-943-8, Nitric acid, zinc salt (2:1), DTXSID10890636, EC 231-943-8, X 4, ZINC NITRATE (MART.), ZINC NITRATE [MART.], MFCD00011293, Nitrate de zinc [French], UN1514, CATALYST FT, ZINC NITRATE [MI], ZINC NITRATE [HSDB], ZINC NITRATE [INCI], ZINC NITRATE [WHO-DD], DTXCID401030921, AEROTEX ACCELERATOR NUMBER 5, AKOS025294449, Zinc nitrate [UN1514] [Oxidizer], NS00075695, Q204863, Zinc, plasma standard solution, Specpure?, 10?g/ml, Zinc, AAS standard solution, Specpure?, Zn 1000?g/ml, Zinc, plasma standard solution, Specpure?, Zn 10,000?g/ml" N2O6Zn ONDPHDOFVYQSGI-UHFFFAOYSA-N "zinc;dinitrate" n.a. n.a. No No No No No No PMDBD2001296 Zinc oxide Therapeutic Substance n.a. 1314-13-2 DB09321 n.a. D01170 n.a. 14806 n.a. n.a. ZINC OXIDE, 1314-13-2, oxozinc, Zinc White, Zinc Oxide Powder, Chinese White, Snow white, Akro-zinc bar 85, MFCD00011300, Azo-33, Supertah, Zincite, Azodox, Lassars Paste, Flores de zinci, Lassar Paste, Zinci Oxicum, Hubbuck''s White, Blanc de Zinc, Vandem VPC, White seal-7, K-Zinc, 174846-84-5, Akro-zinc bar 90, Azodox-55, Azodox-55TT, Red Seal 9, Electrox 2500, Kadox 15, Zinc oxide [USAN], Protox 166, Protox 168, Protox 169, Caswell No. 920, Electox 2500, Cynku tlenek [Polish], Desitin, Nogenol, C-Weiss 8 [German], zincum oxidatum, Azo-55TT, Azo-66TT, Azo-77TT, Zinc gelatin, RVPaque, Azo 22, Azo-55, Azo-66, Azo-77, No-Genol, Zinc oxide substrate, 10x10x0.5mm, polished one side, 0001 orientation, Zinc oxide, 99.99% trace metals basis, CCRIS 1309, C-Weiss 8, HSDB 5024, A&D Medicated Ointment, EINECS 215-222-5, UNII-SOI2LOH54Z, Zinc oxide [USP:JAN], EPA Pesticide Chemical Code 088502, Leaded zinc oxide, ZN-0401 E 3/16'''', ZnO Quantum Dots, Zinc Oxide Slurry, Zinc oxide, heavy, Zinc oxide (TN), Zinc Oxide Nanowire, Zinc Oxide Nanowires, Zine Oxide ,(S), Zinc Oxide Dispersion, Zinc Oxide Nanopowder, Zinc oxide, Nanotek?, Zinc oxide, Puratronic, Zinc Oxide Quantum Dots, Zinc oxide,99.99%, EC 215-222-5, Zinc oxide (JP17/USP), Zinc oxide, sintered tablets, Zinc oxide, LR, >=99%, Aluminium Doped ZnO Dispersion, Zinc oxide [USAN:USP:JAN], Zinc oxide, analytical standard, Zinc Oxide Nanopowder Dispersion, Zinc Oxide Nanopowder (Type I), Zinc oxide, NanoArc ZN-0605, Zinc oxide, p.a., 99.0%, Zinc Oxide Nanopowder (Type II), Zinc Oxide Dispersion Wood Coating, Zinc Oxide Powder, 99.9% Nano, Yttrium Doped Zinc Oxide Dispersion, Europium Doped Zinc Oxide Dispersion, Zinc oxide, USP, 99-100.5%, AKOS015904168, DB09321, Zinc oxide, ACS reagent, >=99.0%, Zinc oxide, 30nm,20 wt.% isopropanol, Zinc oxide, tested according to Ph.Eur., Zinc oxide, 99.999% trace metals basis, Zinc oxide, SAJ first grade, >=99.0%, Zinc oxide, JIS special grade, >=99.0%, CS-0179846, Antimony Tin Dioxide (ATO) Sputtering Targets, D01170, Zinc oxide, nanopowder, <100 nm particle size, Q190077, Zinc Oxide Nanodispersion Type A-Nonionic (70nm), Zinc Oxide Nanodispersion Type B-Anionic (70nm), Zinc Oxide Nanodispersion Type C-Cationic (70nm), Zinc oxide, nanowires, diam. x L 90 nm x 1 mum, J-005999, Zinc oxide, nanowires, diam. x L 50 nm x 300 nm, Zinc oxide, nanowires, diam. x L 300 nm x 4-5 mum, Zinc oxide, puriss. p.a., ACS reagent, >=99.0% (KT), AZO Powder / AZO MicroPowder / ZnO Doped with Metal Aluminum, Zinc oxide, nanopowder, <50 nm particle size (BET), >97%, Zinc oxide, ReagentPlus(R), powder, <5 mum particle size, 99.9%, Zinc oxide, United States Pharmacopeia (USP) Reference Standard, Zinc oxide substrate, 10x10x0.5mm, polished two sides, 0001 orientation, 20 wt% Zinc Oxide in water, 20 wt% (ZnO) (pale yellow powder), >99% Nano, nanoparticles, inverted exclamation markU50 nm particle size ,40 wt. % in H2O, Zinc oxide sputtering target, 50.8mm (2.0in) dia x 3.18mm (0.125in) thick, Zinc oxide sputtering target, 50.8mm (2.0in) dia x 6.35mm (0.250in) thick, Zinc oxide, NanoTek Z1102PMA, 50% in 1,2-propanediol monomethyl ether acetate, colloidal dispersion, Zinc oxide, sputtering target, diam. x thickness 3.00 in. x 0.125 in., 99.99% trace metals basis OZn XLOMVQKBTHCTTD-UHFFFAOYSA-N oxozinc n.a. n.a. No No No No No No PMDBD2001297 Zinc sulfate Therapeutic Substance Approved Drug 7733-02-0 DB09322 PA451971 n.a. D07CEI 24424 n.a. n.a. "Zinc sulfate, 7733-02-0, Zinc sulphate, Zinc sulfate anhydrous, Zincate, White vitriol, zinc(II) sulfate, Zincomed, Optraex, Zinc vitriol, OP-Thal-zin, Zinc sulfate (1:1), Bufopto zinc sulfate, ZnSO4, Sulfuric acid, zinc salt (1:1), Zinc sulphate anhydrous, Sulfate de zinc, Zinc sulfate, anhydrous, Zinc sulphate, anhydrous, Zinc sulfate (anhydrous), Zincfrin, Zinc (as sulfate), zinc(2+) sulfate, Zinc (as sulphate), 0J6Z13X3WO, Zinc sulphate hydrate, CHEBI:35176, NSC-32677, NSC-135806, DTXSID2040315, Zinc sulfate, unspecified hydrate, Medizinc, Optised, Orazinc, Solvezinc, Zinklet, Neozin, Visine-ac, Zinci Sulfas, Prefrin-Z, Zincum Sulfuricum, Zink-Gro, Zinc vitriol (VAN), Caswell No. 927, White vitriol (VAN), Zincsulphate, Salvazinc, zinc;sulfate, NU-Z, Sulfuric acid, zinc salt, Zinc-200, Sulfate de zinc [French], Sulfate, Zinc, CCRIS 3664, Sulfuric acid zinc salt (VAN), HSDB 1063, EINECS 231-793-3, NSC 32677, EPA Pesticide Chemical Code 089001, NSC 135806, UNII-0J6Z13X3WO, AI3-03967, Sulfato de cinc, zinc(II)sulfate, Sulfato de zinco, Solfato di Zinco, Caswell No 927, O4SZn, HONNY FRESH 10P, ZINC SULFATE (II), ZINC SULFATE [MI], EC 231-793-3, ZINC SULFATE [HSDB], ZINC SULFATE (MART.), ZINC SULFATE (USP-RS), 89DS0H96TB, CHEMBL1200929, DTXCID0020315, Zinc Sulfate (Solution in Water), ZINC SULFATE (USP IMPURITY), EPA Pesticide Chemical Code 08901, AKOS025295737, DB09322, NS00076230, Q204954, J-010404" O4SZn NWONKYPBYAMBJT-UHFFFAOYSA-L "zinc;sulfate" Abraxis Pharmaceutical Products n.a. No No No No No No PMDBD2001298 ZnO nanoparticles n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001299 Alternaria?spp. toxins Environmental Chemicals n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD2001300 polysorbate-80 Environmental Chemicals n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD2001301 As toxicity Environmental Chemicals n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No Yes No No No No PMDBD2001302 Cd detoxification Environmental Chemicals n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001303 Pb and Cd toxicity Environmental Chemicals n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001304 treat Hg toxicity Environmental Chemicals n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001305 Pb toxicity Environmental Chemicals n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001306 Cd toxicity Environmental Chemicals n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001307 t Cr toxicity Environmental Chemicals n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001308 Diazinon n.a. n.a. n.a. n.a. n.a. n.a. n.a. 3017 n.a. n.a. "diazinon, Dimpylate, 333-41-5, Diazinone, Oleodiazinon, Ciazinon, Neocidol, Dassitox, Diazitol, Ektoband, Nedcidol, Spectracide, Antigal, Basudin, Bazuden, Dacutox, Dazzel, Diazide, Diazol, Exodin, Flytrol, Galesan, Nucidol, Sarolex, Dicid, Alfa-tox, Diazajet, Dimpylat, Garden Tox, Bassadinon, Terminator, Compass, Disonex, Dizinon, Drawizon, Kayazinon, Kayazol, Meodinon, Dyzol, Nipsan, Diazinon ag 500, Knox-out, Delzinon, Dimpylatum, Dipofene, Dizictol, Neodinon, Optimizer, Bazudin, Dizinil, Srolex, Basudin 10 G, Geigy 24480, Basudin S, Knox Out 2FM, Diagran, Fezudin, NCI-C08673, AG-500, G-24480, Dimpylate [INN], ENT 19,507, Isopropylmethylpyrimidyl diethyl thiophosphate, Diziktol, O,O-Diethyl 2-isopropyl-4-methylpyrimidyl-6-thiophosphate, New Z Diazinon, G 301, O,O-Diethyl O-(2-isopropyl-6-methyl-4-pyrimidinyl) phosphorothioate, 4-Pyrimidinol, 2-isopropyl-6-methyl-, O-ester with O,O-diethyl phosphorothioate, Diethyl 4-(2-isopropyl-6-methylpyrimidinyl)phosphorothionate, O-2-Isopropyl-4-methylpyrimidyl-O,O-diethyl phosphorothioate, Optimizer Insecticide, O,O-Diethyl O-(2-isopropyl-4-methyl-6-pyrimidyl) thionophosphate, CHEBI:34682, O,O-Diethyl O-6-methyl-2-isopropyl-4-pyrimidinyl phosphorothioate, NSC-8938, Phosphorothioate, O,O-diethyl O-6-(2-isopropyl-4-methylpyrimidyl), Thiophosphate de O,O-diethyle et de O-2-isopropyl-4-methyl-6-pyrimidyle, Diethyl 2-isopropyl-4-methyl-6-pyrimidyl thionophosphate, Phosphorothioic acid, O,O-diethyl O-(6-methyl-2-(1-methylethyl)-4-pyrimidinyl) ester, YUS1M1Q929, Diethyl 2-isopropyl-4-methyl-6-pyrimidinyl phosphorothionate, DTXSID9020407, O,O-Diethyl 2-isopropyl-6-methyl-4-pyrimidinylphosphorothioate, NSC8938, Dimpylate (INN), O,O-Diethyl-O-(2-isopropyl-4-methyl-pyrimidin-6-yl)-monothiofosfaat, Diazinon; Dimpylate, Phosphorothioic acid, O,O-diethyl O-(2-isopropyl-6-methyl-4-pyrimidinyl) ester, NCGC00091073-01, Bazudine, Neotsidol, O,O-Diethyl O-(2-isopropyl-4-methyl-6-pyrimidinyl) phosphorothioate, O,O-diethyl O-[6-methyl-2-(1-methylethyl)pyrimidin-4-yl] thiophosphate, Kleen-Dok, Phosphorothioic acid, O,O-diethylO-[6-methyl-2-(1-methylethyl)-4-pyrimidinyl] ester, Diazinon, analytical standard, DTXCID50407, KFM Blowfly Dressing, Compass (insecticide), Caswell No. 342, gardentox, Dimpilato, Antlak, Diaterr-fos, Dimpylatum [INN-Latin], O,O-Diaethyl-O-(2-isopropyl-4-methyl-pyrinidin-6-yl)-monothiophosphat, O,O-Diethyl O-(2-isopropyl-4-methyl-6-pyrimidyl) phosphorothioate, Cooper''s Flystrike Powder, Dimpilato [INN-Spanish], NSC 8938, Phosphorothioic acid, O,O-diethyl O-[6-methyl-2-(1-methylethyl)-4-pyrimidinyl] ester, Diazinon [ANSI:BSI:ISO], CAS-333-41-5, CCRIS 204, HSDB 303, Knox Out Yellow Jacket Contorl, OMS 469, EINECS 206-373-8, PT 265, EPA Pesticide Chemical Code 057801, BRN 0273790, UNII-YUS1M1Q929, Spertacide, Bazanon, AI3-19507, Diethyl dimpylatum, Dimpylate, INN, Basudin 5G, Spectracide 25EC, G 24480, Agridin 60, Basudin 10G, Spectrum_001777, Dimpylate [INN:BAN], DIAZINON [HSDB], DIAZINON [IARC], New Z Diazinon (TN), SpecPlus_000344, DIAZINON [ISO], DIAZINON [MI], O,O-Diethyl O-(2-isopropyl-6-methyl-4-pyrimidinyl)phosphorothioate, O,O-Diethyl-O-(2-isopropyl-4-methyl-6-pyrimidyl)phosphorothioate, Spectrum2_001226, Spectrum3_000802, Spectrum4_000642, Spectrum5_001929, Thiophosphoric acid 2-isopropyl-4-methyl-6-pyrimidyl diethyl ester, O,O-Diethyl-O-(2-isopropyl-4-methyl-6-pyrimidinyl)-phosphorothioate, Phosphorothioic acid, O,O-diethyl O-(isopropylmethylpyrimidinyl) ester, DIMPYLATE [MART.], O,O-Diaethyl-O-(2-isopropyl-4-methyl)-6-pyrimidyl-thionophosphat [German], O,O-Diaethyl-O-(2-isopropyl-4-methyl-pyrimidin-6-yl)-monothiophosphat [German], O,O-Diethyl O-(6-methyl-2-(1-methylethyl)-4-pyrimidinyl)phosphorothioate, O,O-Diethyl-O-(2-isopropyl-4-methyl-pyrimidin-6-yl)-monothiofosfaat [Dutch], O,O-Dietil-O-(2-isopropil-4-metil-pirimidin-6-il)-monotiofosfato [Italian], DIMPYLATE [WHO-DD], Optimizer Insecticide (TN), Thiophosphate de O,O-diethyle et de O-2-isopropyl-4-methyl-6-pyrimidyle [French], SCHEMBL17453, BSPBio_002263, KBioGR_000983, KBioSS_002258, 5-23-11-00187 (Beilstein Handbook Reference), MLS002207243, BIDD:ER0457, DivK1c_006440, SPBio_001072, CHEMBL388560, FHIVAFMUCKRCQO-UHFFFAOYSA-, KBio1_001384, KBio2_002257, KBio2_004825, KBio2_007393, KBio3_001763, AMY3613, HMS3264I04, Pharmakon1600-00330017, HY-B1113, O,O-Diaethyl-O-(2-isopropyl-4-methyl)-6-pyrimidyl-thionophosphat, o,o-diethyl o-2-isopropyl-6-methylpyrimidin-4-yl phosphorothioate, Diazinon 100 microg/mL in Acetone, Tox21_111077, Tox21_201409, Tox21_300730, BDBM50005409, CCG-39143, ENT 19507, MFCD00036204, NSC755893, O,O-Diaethyl-O-(2-isopropyl-4-methyl-pyrimidin-6-yl)-monothiophosphat, O,O-Dietil-O-(2-isopropil-4-metil-pirimidin-6-il)-monotiofosfato, Diazinon 10 microg/mL in Cyclohexane, Diazinon 1000 microg/mL in Toluene, AKOS025311513, Diazinon 1000 microg/mL in Methanol, diethoxy-(2-isopropyl-6-methyl-pyrimidin-4-yl)oxy-thioxo-$l^{5}-phosphane, O,O-diethyl O-(6-methyl-2-(1-methylethyl)-4-pyrimidinyl) phosphorothioate, Tox21_111077_1, CS-4712, Diazinon 10 microg/mL in Acetonitrile, Diazinon 100 microg/mL in Cyclohexane, NSC-755893, Diazinon 100 microg/mL in Acetonitrile, NCGC00091073-02, NCGC00091073-03, NCGC00091073-04, NCGC00091073-05, NCGC00091073-06, NCGC00091073-07, NCGC00254636-01, NCGC00258960-01, SMR000777921, SBI-0052498.P002, Diazinon, PESTANAL(R), analytical standard, NS00008266, D07856, F88283, AB00053004_04, Q411202, SR-01000872734, Q-200952, SR-01000872734-1, BRD-K60567437-001-04-5, Diazinon, certified reference material, TraceCERT(R), 4-Pyrimidinol, O-ester with O,O-diethyl phosphorothioate, WLN: T6N CNJ BY1 & 1 DOPS & O2 & O2 F1, O, O-Diethyl 2-isopropyl-4-methylpyrimidyl-6-thiophosphate, O,O-Diethyl-O-(2-isopropyl-4-methylpyrimidyl)thiophosphate, o,o-Dietil-o-(2-isopropil-4-metil-pirimidin-il)-monotiofosato, Phosphorothioate,O-diethyl O-6-(2-isopropyl-4-methylpyrimidyl), O,O-Diethyl O-(2-isopropyl-6-methyl-4-primidinyl)phosphorothioate, O,O-Diethyl O-(2-isopropyl-6-methyl-4-pyrimidinyl) thiophosphate, O,O-Diethyl o-(2-isopropyl-6-methyl-4-pyrimidinyl) thiophosphate #, O,O-diethyl O-(2-isopropyl-6-methyl-4-pyrimidinyl)thio-phosphate, o,o-diethyl o-(2-isopropyl-6-methylpyrimidin-4-yl) phosphorothioate, O,O-Diethyl-O-(2-isopropyl-4-methyl-6-pyrimidyl) thiophosphate, diethoxy-(6-methyl-2-propan-2-ylpyrimidin-4-yl)oxy-sulfanylidenephosphorane, O,O-diethyl O-[6-methyl-2-(propan-2-yl)pyrimidin-4-yl] phosphorothioate, o,o-Diethyl-O-(6-methyl-2-(1-methylethyl)-4-pyrimidinyl)phosophorothioate, Phosphorothioic acid, O,O-diethyl 2-isopropyl-6-methyl-4-pyrimidinyl ester, Phosphorothioic acid,O-diethyl O-(2-isopropyl-6-methyl-4-pyrimidinyl) ester, diethoxy-(6-methyl-2-propan-2-ylpyrimidin-4-yl)oxy-sulfanylidene-$l^{5-phosphane, diethoxy-(6-methyl-2-propan-2-ylpyrimidin-4-yl)oxy-sulfanylidene-lambda5-phosphane, ethyl 6-methyl-2-(propan-2-yl)pyrimidin-4-yl ethoxy(sulfanylidene)phosphonite, PHOSPHOROTHIOIC ACID O,O-DIETHYL O-(6-METHYL-2-(1-METHYLETHYL)-4-PYRIMIDINYL) ESTER, Phosphorothioic acid, O,O-diethyl {O-[6-methyl-2-(1-methylethyl)-4-pyrimidinyl]} ester, PHOSPHOROTHIOIC ACID,O-DIETHYL O-[6-METHYL-2-(1-METHYLETHYL)-4-PYRIMIDINYL] ESTER, InChI=1/C12H21N2O3PS/c1-6-15-18(19,16-7-2)17-11-8-10(5)13-12(14-11)9(3)4/h8-9H,6-7H2,1-5H3" C12H21N2O3PS FHIVAFMUCKRCQO-UHFFFAOYSA-N diethoxy-(6-methyl-2-propan-2-ylpyrimidin-4-yl)oxy-sulfanylidene-lambda5-phosphane n.a. n.a. No No No No No No PMDBD2001309 Emulsi?ers (P80 and CMC) n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001310 Malathion Therapeutic Substance Approved Drug 121-75-5 DB00772 PA164748092 D00534 D0K3LW 4004 3864 n.a. malathion, 121-75-5, Carbophos, Carbofos, Mercaptothion, Karbofos, Phosphothion, Carbetox, Ethiolacar, Maldison, Oleophosphothion, Ovide, Chemathion, Prioderm, Sadophos, Cythion, Sadofos, Carbetovur, Fosfothion, Fosfotion, Malaspray, Cimexan, Fyfanon, Malafor, Malagran, Malamar, Malathon, Malatol, Moscarda, Sumitox, Etiol, Ortho Malathion, Siptox I, Extermathion, Forthion, Hilthion, Malacide, Malakill, Malaphos, Malasol, Malatox, Malphos, Taskil, Emmatos extra, Carbethoxy malathion, Kop-thion, Malamar 50, Compound 4049, Detmol MA, Insecticide no. 4049, Malathyl, Malation, Mercaptotion, Emmatos, Kypfos, Malataf, Malathion E50, Malmed, Calmathion, Cleensheen, Malathione, Celthion, Zithiol, Fosfotion 550, American cyanamid 4,049, Malaphele, Malathiozoo, Maltox, Vetiol, Vegfru malatox, Staeubol-Puder, Derbac-M, Hilthion 25wdp, Maltox MLT, SF 60, Mercaptosuccinic acid diethyl ester, Latka 4049, Experimental insecticide 4049, Malathyne, NCI-C00215, diethyl 2-dimethoxyphosphinothioylsulfanylbutanedioate, Fog 3, Four thousand forty-nine, ENT 17,034, Diethyl (dimethoxyphosphinothioylthio)succinate, TM-4049, AC 26691, O,O-Dimethyldithiophosphate diethylmercaptosuccinate, 8059HC, EL 4049, NSC-6524, O,O-Dimethyl S-(1,2-dicarbethoxyethyl) dithiophosphate, Dicarboethoxyethyl O,O-dimethyl phosphorodithioate, U5N7SU872W, DTXSID4020791, MLT, TAK, Butanedioic acid, ((dimethoxyphosphinothioyl)thio)-, diethyl ester, Diethyl(dimethoxythiophosphorylthio)succinate, O,O-Dimethyl S-(1,2-dicarbethoxyethyl)phosphorodithioate, S-1,2-Bis(ethoxycarbonyl)ethyl-O,O-dimethyl thiophosphate, Succinic acid, mercapto-, diethyl ester, S-ester with O,O-dimethyl phosphorodithioate, ENT-17034, S-(1,2-Dicarbethoxyethyl) O,O-dimethyldithiophosphate, DTXCID80791, CHEBI:6651, Malathiazol, Camathion, Carbafos, Dorthion, ((Dimethoxyphosphinothioyl)thio)butanedioic acid diethyl ester, O,O-Dimethyl S-1,2-di(ethoxycarbamyl)ethyl phosphorodithioate, Flair, Diethyl mercaptosuccinate, O,O-dimethyl dithiophosphate, S-ester, NSC6524, S-(1,2-Bis(ethoxycarbonyl)ethyl) O,O-dimethyl phosphorodithioate, S-(1,2-Di(ethoxycarbonyl)ethyl) dimethyl phosphorothiolothionate, O,O-Dimethyl-S-1,2-dikarbetoxylethylditiofosfat, Lice Rid, diethyl 2-[(dimethoxyphosphorothioyl)thio]succinate, Diethyl mercaptosuccinate, O,O-dimethyl thiophosphate, Kill-A-Mite, Succinic acid, mercapto-, diethyl ester, S-ester with O,O-dimethylphosphorodithioate, Malation [Polish], Diethyl mercaptosuccinate, O,O-dimethyl phosphorodithioate, O,O-Dwumetylo-S-1,2-bis(karboetoksyetylo)-dwutiofosforan, S-(1,2-Bis(carbethoxy)ethyl) O,O-dimethyl dithiophosphate, NCGC00091902-05, NCGC00091902-08, 1,2-Di(ethoxycarbonyl)ethyl O,O-dimethyl phosphorodithioate, Diethyl mercaptosuccinic acid O,O-dimethyl phosphorodithioate, Organoderm, S-(1,2-Bis(etossi-carbonil)-etil)-O,O-dimetil-ditiofosfato, S-(1,2-Bis(ethoxy-carbonyl)-ethyl)-O,O-dimethyl-dithiofosfaat, MALATHION (IARC), MALATHION [IARC], Butanedioic acid, [(dimethoxyphosphinothioyl)thio]-, diethyl ester, Dithiophosphate de O,O-dimethyle et de S-(1,2-dicarboethoxyethyle), Mercaptotion [Spanish], O,O-Dimethyl S-1,2-di(ethoxycarbamyl)ethyl, MALATHION (MART.), MALATHION [MART.], MALATHION (USP-RS), MALATHION [USP-RS], Diethyl 2-(dimethoxyphosphinothioylthio)succinate, O,O-Dimethyl S-(1,2-bis(ethoxycarbonyl)ethyl), Malathion 60, Latka 4049 [Czech], Diethyl (dimethoxyphosphinothioylthio) butanedioate, Sadofos 30, MALATHION (EP MONOGRAPH), MALATHION [EP MONOGRAPH], O,O-Dimethyl dithiophosphate of diethyl mercaptosuccinate, Kop-Thionkypfosmalacide, malathine, MALATHION (USP MONOGRAPH), MALATHION [USP MONOGRAPH], O,O-Dimethyl S-(1,2-dicarbethoxyethyl) thiothionophosphate, S-(1,2-Dicarbethoxyethyl) O,O-dimethyl phosphorodithioate, [(dimethoxyphosphinothioyl)thio]butanedioic acid diethyl ester, DIETHYL 2-((DIMETHOXYPHOSPHINOTHIOYL)THIO)BUTANEDIOATE, [(Dimethoxyphosphinothioyl)thio]butanedioic acid, diethyl ester, S-(1,O-dimethyl phosphorodithioate, S-[1,O-dimethyl phosphorodithioate, Diethyl mercaptosuccinate S-ester with O,O-dimethyl phosphorodithioate, Malathion (USP), OMS 1, IFO 13140, CAS-121-75-5, CCRIS 368, HSDB 665, Ovide (TN), Malathion [USP:BAN], EINECS 204-497-7, BRN 1804525, S-[1,2-Bis(carbethoxy)ethyl] O,O-dimethyl dithiophosphate, UNII-U5N7SU872W, Banmite, Celthign, Cromocide, Duramitex, Gammaxine, Radotion, AI3-17034, Detmol malathion, S-[1,2-Bis(ethoxycarbonyl)ethyl] O,O-dimethyl phosphorodithioate, Malathion ULV, PBI crop saver, Suleo M, Diethyl ((dimethoxyphosphinothioyl)thio)butanedioate, Phosphorodithioic acid, O,O-dimethyl ester, S-ester with diethyl mercaptosuccinate, MAVIDAN, Detmol 96%, Greenfly aerosol spray, O,O-Dimethyl-S-1,2-dikarbetoxylethylditiofosfat [Czech], Agrichem greenfly spray, S-(1,2-Dicarbethoxyethyl) O,O-dimethylphosphorodithioate, Detmol MA 96%, Spectrum_001795, SpecPlus_000386, TAK (PESTICIDE), MALATHION [MI], Malathion LB concentrate, O,O-Dimethyl S-(1,2-bis(ethoxycarbonyl)ethyl) dithiophosphate, MALATHION [HSDB], O,O-Dimethyl-S-1,2-(dicarbaethoxyaethyl)-dithiophosphat [German], O,O-Dwumetylo-S-1,2-bis(karboetoksyetylo)-dwutiofosforan [Polish], Spectrum2_001228, Spectrum3_000813, Spectrum4_000653, Spectrum5_001936, CYTHION INSECTICIDE, Eveshield captan/malathion, MALATHION [VANDF], Malathion ULV concentrate, MALATHION E 50, Diethyl mercaptosuccinate S-ester with O,O-dimethylphosphorodithioate, S-(1,2-Bis(ethoxy-carbonyl)-ethyl)-O,O-dimethyl-dithiofosfaat [Dutch], S-(1,2-Bis(etossi-carbonil)-etil)-O,O-dimetil-ditiofosfato [Italian], Dithiophosphate de O,O-dimethyle et de S-(1,2-dicarboethoxyethyle) [French], INSECTICIDE 4049, S-(1,2-Bis(aethoxy-carbonyl)-aethyl)-O,O-dimethyl-dithiophosphat [German], MALATHION [WHO-DD], SCHEMBL27358, BSPBio_002305, KBioGR_001025, KBioSS_002288, Prentox malathion 95% spray, S-(1,O-dimetil-ditiofosfato, S-1,O-dimethyl thiophosphate, All purpose garden insecticide, DivK1c_006482, Malathion, analytical standard, SPBio_001076, S-(1,O-dimethyl-dithiofosfaat, 1,O-dimethyl phosphordithioates, MALATHION [ORANGE BOOK], O,2-dikarbetoxylethylditiofosfat, S-(1,O-dimethyl-dithiophasphat, CHEMBL1200468, O,O-Dimethyl-S-1,2-(dicarbaethoxyaethyl)-dithiophosphat, BDBM85372, JXSJBGJIGXNWCI-UHFFFAOYSA-, KBio1_001426, KBio2_002286, KBio2_004854, KBio2_007422, KBio3_001805, S-[1,O-dimethyl dithiophosphate, O,O-dimethyl-S-(1,2-dicarbethoxyethyl) thiothionophosphate, CHEBI:141474, S-O,O-dimethyl-phosphorodithioate, HMS3264A04, O,O-dimethyl-S-(1,2-bis(ethoxycarbonyl)ethyl)dithiophosphate, Pharmakon1600-00330021, Fisons greenfly and blackfly killer, HY-B0943, S-(1,2-Bis(aethoxy-carbonyl)-aethyl)-O,O-dimethyl-dithiophosphat, S-(1,2-di(ethoxycarbonyl)ethyl) dimethylphosphorothiolothionate, Tox21_111175, Tox21_400048, CCG-39152, NSC755848, STCC 4941156, AKOS015897264, Butanedioic acid, ((dimethoxyphosphinothioyl)-thio)-, diethyl ester, (+-)-, Diethyl (+-)-mercaptosuccinate, S-ester with O,O-dimethyl phosphorodithioate, Diethyl mercaptosuccinic acid, S-ester of O,O-dimethyl phosphorodithioate, Malathion 1000 microg/mL in Acetone, Malathion 1000 microg/mL in Toluene, Malathion organophosphorous insecticide, O,2-dicarbethoxyethyl) dithiophosphate, Tox21_111175_1, CS-4416, DB00772, NSC-755848, TM 4049, Malathion 100 microg/mL in Cyclohexane, USEPA/OPP Pesticide Code: 057701, NCGC00091902-01, NCGC00091902-02, NCGC00091902-03, NCGC00091902-06, NCGC00091902-07, NCGC00091902-09, NCGC00091902-11, O,2-dicarbethoxyethyl) phosphorodithioate, AS-13786, CAS_121-75-5, O,2-dicarbethoxyethyl) thiothionophosphate, Malathyl LV concentrate & ULV concentrate, Dithiophosphate de O,2-dicarboethoxyethyle), Malathion, vial of 1 g, analytical standard, NS00001740, O,2-di(ethoxycarbamyl)ethyl phosphorothioate, 0,2-bis(ethoxycarbonyl)ethyl] dithiophosphate, Malathion, PESTANAL(R), analytical standard, C07497, D00534, diethyl (dimethoxyphosphinothioylthio) succinate, O,O-dimethyl-S-1,2-dikarbetoxyethylditiofosfat, WLN: 2OV1YVO2 & SPS & O1 & O1, AB00053015_02, diethyl 2-(dimethoxyphosphorothioylthio)succinate, EN300-7479313, Dicarboethoxyethyl-O,O-dimethyl phosphorodithioate, Diethyl mercaptosuccinate,O-dimethyl thiophosphate, L001138, Q423005, SR-01000942243, Diethyl (dimethoxyphosphinothiotylthio) butanedioate, Diethyl [(dimethoxyphosphinothoiyl)thio]butanedioate, Diethyl mercaptosuccinate-O,O-dimethyl thiophosphate, J-004630, O,O-Dimethyl dithiophosphate diethylmercaptosuccinate, SR-01000942243-1, 1,2-D.(ethoxycarbonyl)dimethyl phosphorothiolothionate, Diethyl mercaptosuccinate,O-dimethyl phosphorodithioate, Malathion, certified reference material, TraceCERT(R), O,O-dimethyl dithiophosphate diethyl mercaptosuccinate, s-(1,2-dicarbethoxyethyl)-o,o-dimethyldithiophosphate, Diethyl mercaptosuccinate-O,O-dimethyl phosphorodithioate, O,O-dimethyl-S-(1,2-dicarbethoxyethyl) dithiophosphate, O,O-dimethyl-S-(1,2-dicarbethoxyethyl)phosphorodithioate, O,O-Dimethyl-S-1,2-(dicarbaethoxyaethyl)dithiophosphat, 1,2-Di(ethoxycarbonyl)ethyl O,O-dimethyl phosphordithioate, 1,2-di(ethoxycarbonyl)ethyl-O,O-dimethyl phosphorodithioate, diethyl 2-((dimethoxyphosphorothioyl)sulfanyl)butanedioate, Diethyl 2-[(dimethoxyphosphorothioyl)sulfanyl]succinate #, Diethyl mercaptosuccinic acid,O-dimethyl phosphorodithioate, Malathion, European Pharmacopoeia (EP) Reference Standard, O,O-Dimethyl S-(1,2-dicarbethoxyethyl) phosphorodithioate, O,O-Dimethyl S-1,2-di(ethoxycarbamyl)ethyl phosphorothioate, S-(1,2-bis(carbethoxy)ethyl)-O,O-dimethyl dithiophosphate, Diethyl mercaptosuccinate,O-dimethyl dithiophosphate, S-ester, Diethyl mercaptosuccinate-O,O-dimethyl dithiophosphate, S-ester, Diethyl mercaptosuccinic acid-O,O-dimethyl phosphorodithioate, Malathion, United States Pharmacopeia (USP) Reference Standard, Mercaptosuccinic acid diethyl ester,O-dimethyl phosphorothioate, O,O-Dimethyl S-(1,2-bis(ethoxycarbonyl)ethyl)dithiophosphate, O,O-dimethyl S-[1,2-bis(ethoxy carbonyl)ethyl]dithiophosphate, O,O-dimethyl-S-1,2-di(ethoxycarbamyl)ethyl phosphorodithioate, s-1,2-bis(ethoxycarbonyl)ethyl o,o-dimethylphosphorodithioate, Butanedioic Acid,((dimethoxyphosphinothioyl)thio)-, Diethyl Ester, Diethyl mercaptosuccinate-S-ester with O,O-dimethylphosphorodithioate, o,o-Dimethyl-S-(1,2-di(ethoxycarbonyl)ethyl) phosphorodithioate, S-(1,2-Bis(aethoxy-carbonyl)-aethyl)-O,O-dimethyl-dithiophasphat, S-(1,2-BIS(ETHOXYCARBONYL)ETHYL) O,O-DIMETHYL THIOPHOSPHATE, S-(1,2-di(ethoxycarbonyl)-ethyl) dimethyl phosphorothiolothionate, [(DIMETHOXYPHOPHINOTHIOYL)THIO]BUTANEDIOIC ACID, DIETHYL ESTER, S-(1,2-BIS(ETHOXYCARBONYL) ETHYL)O,O-DIMETHYL-PHOSPHORODITHIOATE, S-(1,2-BIS(ETHOXYCARBONYL)ETHYL O,O-DIMETHYLPHOSPHORODITHIOATE, Succinic acid, diethyl ester, S-ester with 0,0-dimethyl phosphorodithioate, Succinic acid, diethyl ester, S-ester with O,O-dimethyl phosphorodithioate, 1,4-diethyl 2-{[dimethoxy(sulfanylidene)-$l^{5}-phosphanyl]sulfanyl}butanedioate, 1,4-diethyl 2-{[dimethoxy(sulfanylidene)-lambda5-phosphanyl]sulfanyl}butanedioate, BUTANEDIOIC ACID, ((DIMETHOXYPHOSPHINOTHIOYL)-THIO)-, DIETHYL ESTER, (+/-)-, DIETHYL (+/-)-MERCAPTOSUCCINATE, S-ESTER WITH O,O-DIMETHYL PHOSPHORODITHIOATE, Mercaptosuccinic acid diethyl ester, S-ester with O,O-dimethyl phosphorothioate, MERCAPTOSUCCINIC ACID, DIETHYL ESTER, S-ESTER WITH O,O-DIMETHYL PHOSPHORO-DITHIOATE, Phosphorodithioic acid,0-dimethyl ester, S-ester with diethyl mercaptosuccinate, Phosphorodithioic acid-O,O-dimethyl ester-S-ester with diethyl mercaptosuccinate, InChI=1/C10H19O6PS2/c1-5-15-9(11)7-8(10(12)16-6-2)19-17(18,13-3)14-4/h8H,5-7H2,1-4H3 C10H19O6PS2 JXSJBGJIGXNWCI-UHFFFAOYSA-N diethyl 2-dimethoxyphosphinothioylsulfanylbutanedioate n.a. Parasympathomimetics No No No No No No PMDBD2001311 Neotame n.a. n.a. n.a. n.a. n.a. n.a. n.a. 9810996 n.a. n.a. Neotame, 165450-17-9, (S)-3-((3,3-Dimethylbutyl)amino)-4-(((S)-1-methoxy-1-oxo-3-phenylpropan-2-yl)amino)-4-oxobutanoic acid, VJ597D52EX, NC 00723, HSDB 7965, NC-00723, L-Phenylalanine, N-(3,3-dimethylbutyl)-L-alpha-aspartyl-, 2-methyl ester, Neotame [NF], N-(N-(3,3-dimethylbutyl)-L-alpha-aspartyl)-L-phenylalanine 1-methyl ester, UNII-VJ597D52EX, MFCD09039056, NEOTAME [FHFI], NEOTAME [INCI], NEOTAME [FCC], NEOTAME [II], NEOTAME [MI], NEOTAME [MART.], NEOTAME [USP-RS], MIRASEE 200, SCHEMBL4311, Neotame, analytical standard, INS NO.961, CHEMBL3718532, CHEBI:83503, DTXSID50167950, INS-961, Neotame 1000 microg/mL in Water, s4442, AKOS016842430, AM84564, BCP9000982, CS-W011769, GS-3213, HY-W011053, (3S)-3-[(3,3-dimethylbutyl)amino]-3-{[(2S)-1-methoxy-1-oxo-3-phenylpropan-2-yl]carbamoyl}propanoic acid, BCP0726000005, E 961, E-961, N1112, A810640, Q415698, J-010204, methyl N-(3,3-dimethylbutyl)-L-alpha-aspartyl-L-phenylalaninate, N-[N-(3,3-dimethylbutyl)-L-alpha-aspartyl]-L-phenylalanine methyl ester, L-PHENYLALANINE, N-(N-(3,3-DIMETHYLBUTYL)-L-.ALPHA.-ASPARTYL)-1-METHYL ESTER, N-(N-(3,3-DIMETHYLBUTYL)-L-.ALPHA.-ASPARTYL)-L-PHENYLALANINE 1-METHYL ESTER, (3S)-3-(3,3-dimethylbutylamino)-4-[[(2S)-1-methoxy-1-oxo-3-phenylpropan-2-yl]amino]-4-oxobutanoic acid, (3S)-4-[[(1S)-1-benzyl-2-methoxy-2-oxo-ethyl]amino]-3-(3,3-dimethylbutylamino)-4-oxo-butanoic acid, (S)-3-((3,3-Dimethylbutyl)amino)-4-(((S)-1-methoxy-1-oxo-3-phenylpropan-2-yl)amino)-4-oxobutanoicacid C20H30N2O5 HLIAVLHNDJUHFG-HOTGVXAUSA-N (3S)-3-(3,3-dimethylbutylamino)-4-[[(2S)-1-methoxy-1-oxo-3-phenylpropan-2-yl]amino]-4-oxobutanoic acid n.a. n.a. No No No No No No PMDBD2001312 Nicotine Therapeutic Substance Approved Drug 5/11/1954 DB00184 PA450626 D03365 D0T8GD 89594 80863 NPC182570 "nicotine, L-Nicotine, 54-11-5, (-)-Nicotine, (S)-Nicotine, (S)-3-(1-methylpyrrolidin-2-yl)pyridine, Habitrol, (S)-(-)-Nicotine, Nicotrol, Nicoderm, 3-[(2S)-1-methylpyrrolidin-2-yl]pyridine, Nicotine polacrilex, Fumetobac, Micotine, Nicocide, Prostep, Tendust, Nico-dust, Nicoderm Cq, Nicotine alkaloid, Emo-nik, Nico-Fume, Mach-Nic, Nic-Sal, Flux MAAG, Nicotina, Nikotyna, Ortho N-4 dust, Ortho N-5 dust, XL All Insecticide, Niagara P.A. dust, Destruxol orchid spray, L(-)-nicotine, 3-(N-Methylpyrollidino)pyridine, 3-(N-Methylpyrrolidino)pyridine, Nicabate, Nicorette, Nicotinum, Niquitin, Tabazur, L-3-(1-Methyl-2-pyrrolidyl)pyridine, Caswell No. 597, Ortho N-4 and N-5 dusts, Nicotin, (-)-3-(1-Methyl-2-pyrrolidyl)pyridine, (S)-3-(1-Methyl-2-pyrrolidinyl)pyridine, RCRA waste number P075, 1-Methyl-2-(3-pyridyl)pyrrolidine, NSC 5065, S-(-)-Nicotine, Nikotin, ENT 3,424, 3-(2-(N-methylpyrrolidinyl))pyridine, CCRIS 1637, fumeto bac, HSDB 1107, Pyridine, 3-(1-methyl-2-pyrrolidinyl)-, (S)-, 3-((2S)-1-methylpyrrolidin-2-yl)pyridine, EINECS 200-193-3, UNII-6M3C89ZY6R, nicotine s(-), (-)-3-(N-Methylpyrrolidino)pyridine, 3-(1-Methyl-2-pyrollidinyl)pyridine, beta-Pyridyl-alpha-N-methylpyrrolidine, EPA Pesticide Chemical Code 056702, beta-Pyridyl-alpha-N-methyl pyrrolidine, 6M3C89ZY6R, Pyrrolidine, 1-methyl-2-(3-pyridal)-, DTXSID1020930, CHEBI:17688, (S)-3-(N-methylpyrrolidin-2-yl)pyridine, AI3-03424, 3-(1-Methyl-2-pyrrolidinyl)pyridine, Nicotine [USP:BAN], Pyridine, 3-(tetrahydro-1-methylpyrrol-2-yl), MFCD00006369, DTXCID50930, EC 200-193-3, Pyridine, 3-((2S)-1-methyl-2-pyrrolidinyl)-, Pyridine, 3-[(2S)-1-methyl-2-pyrrolidinyl]-, NICOTINE COMPONENT OF COMMIT, NSC-5065, 1-Methyl-2-(3-pyridiyl)pyrrolidine, NICOTINE COMPONENT OF NICORETTE, Nikotin [German], Nikotyna [Polish], 104062-50-2, Nicotina [Italian], Pyrrolidine, 1-methyl-2-(3-pyridyl)-, Nicotine (USP:BAN), Nicotrol Inhaler, NICOTINE (MART.), NICOTINE [MART.], Nicotrol NS, Nicotine [for single use], NICOTINE-L (BASE), destruxol, 3-((2S)-1-METHYL-2-PYRROLIDINYL)PYRIDINE, (-)-1-Methyl-2-(3-pyridyl)pyrrolidine, NICOTINE (EP MONOGRAPH), NICOTINE [EP MONOGRAPH], NICOTINE (USP MONOGRAPH), NICOTINE [USP MONOGRAPH], Nicotine [BSI:ISO], Exodus, Nicotine-D salicylate, CAS-54-11-5, DL-tetrahydronicotyrine, Habitrol (TN), Nicotine (USP), Nicotine [ISO], SMR000059074, methyl-2-pyrrolidinyl)pyridine, UN1654, RCRA waste no. P075, CHEBI:18723, blip, Nicorelief, bjwc nicotine, euqate nicotine, NicoretteMint, NicotineMini, nictoine gum, delta-Nicotine, Lucy nicotine, Nicorette gum, Equate Nicotine, Leader Nicotine, Rexall Nicotine, Maxi Nicotine, Mini Nicotine, Nicotine betadex, Nicotine Mini, Nicotinum,, Careone Nicotine, Good Sense, Habitrol Lozenge, NicoretteOriginal, Sunmark Nicotine, Topcare Nicotine, 1-methyl-2-(3-pyridal)-pyrrolidene, HabitrolStep 1, HabitrolStep 2, HabitrolStep 3, Equaline Nicotine, HEB Nicotine, Nicotine polarilex, Nicotinetransdermal, Stop Smoking Aid, nicotinemint flavor, NicotineSugar Free, Care One Nicotine, DG Health nicotine, NicoretteFresh Mint, 3-(1-Methyl-2-pyrrolidyl)pyridine, Basic Care Nicotine, Good Sense Nicotine, NicoretteFruit Chill, Up and Up Nicotine, Health Mart Nicotine, MACHNIC, NICODERMCQ, Topcare Nicotine Gum, a-N-methylpyrrolidine, Campbell''s nico-soap, Caswell No 597, 3-N-methylpyrrolidine, Habitrol LozengeCherry, Members Mark Nicotine, R)-(+)-nicotine, good sense nicotinemint, Harris Teeter Nicotine, a -N-methylpyrrolidine, NicoretteCinnamon Surge, TEN DUST, CHEMBL3, NIAGARA PA DUST, Signature Care Nicotine, 1uw6, exchange select nicotine, family wellness nicotine, NicoretteSpearmint Burst, Nicotine PolacrilexMINT, NicoretteWhite Ice Mint, basic care nicotine mini, NICOTINE [HSDB], up and up mini nicotine, NICOTINE (TPD), alpha-N-methylpyrrolidine, NICOTINE [MI], Nicotine [UN1654], NICOTINE [VANDF], Nicotinetransdermal system, NICOTINUM [HPUS], (S)-(-)--nicotine, foster and thrive nicotine, Nicotine COATED ice mint, Nicotine Polacrilexoriginal, Kirkland Signature Quit 2, Kirkland Signature Quit 4, bmse000105, Kirkland Signature Nicotine, Members Mark Mini Nicotine, NICOTINE [WHO-DD], (2S) 3-(1-Methyl-pyrrolidin-2-yl)-pyridine, Berkley and Jensen Nicotine, NICOTINE, (LIQUID), Nicotine polacrilex [USAN], Pyridine, 3-(1-methyl-2-pyrrolidinyl)-,(S)-, S-()-Nicotine-pyridine-d4, SCHEMBL20192, MLS001055457, MLS001335905, Nicotine Polacrilexcoated mint, BIDD:GT0599, Habitrol LozengeOriginal Flavor, NICOTINE [ORANGE BOOK], Good Neighbor Pharmacy Nicotine, GTPL2585, BDBM82070, l-Nicotine, 1mg/ml in Methanol, Nicotine Polacrilexcoated cinnamon, Nicotine Transdermal System Patch, Nicotinetransdermal system step 2, l-Nicotine, 10mg/ml in Methanol, l-Nicotine, 50mg/ml in Methanol, Nicotine PolacrilexOrigianl Flavor, Nicotine PolacrilexOriginal Flavor, Nicotine Transdermal SystemStep 1, Nicotine Transdermal SystemStep 2, Nicotine Transdermal SystemStep 3, HMS2230H17, HMS3259E16, Nicotine [UN1654] [Poison], Nicotine PolacrilexCoated Ice Mint, good neighbor pharmacy nicotine mini, HY-B0638, l-Nicotine, 100mg/ml in Methanol, Nicotine 10 microg/mL in Methanol, NICOTINETransdermal System Step 1, NICOTINETransdermal System Step 3, Good Sense NicotineStop Smoking Aid, Tox21_201814, Tox21_300174, Nicotine 100 microg/mL in Methanol, PDSP1_000113, PDSP1_000465, PDSP2_000463, PDSP2_000555, 1-methyl-2-(3-pyridal)-Pyrrolidine, AKOS016843798, Nicotac Nicotine PolacrilexCoated Mint, Nicotine 1000 microg/mL in Methanol, 3-(1-methyl-2-pyrrolidinyl)-Pyridine, CCG-204892, CS-3999, DB00184, NC00577, SB12751, SDCCGMLS-0066911.P001, SDCCGSBI-0050785.P004, USEPA/OPP Pesticide Code: 056702, NCGC00090693-01, NCGC00090693-02, NCGC00090693-03, NCGC00090693-04, NCGC00090693-05, NCGC00090693-06, NCGC00090693-07, NCGC00090693-08, NCGC00090693-09, NCGC00254095-01, NCGC00259363-01, (-)-Nicotine, >=99% (GC), liquid, Nicotac Nicotine PolacrilexCoated Cinnamon, NICOTINE COMPOUND, LIQUID, N.O.S., SBI-0050785.P003, CAS_29790-52-1, N0079, NS00010445, NICOTINE PREPARATION, LIQUID, N.O.S., (S)-(-)-Nicotine (1.0 mg/mL in Methanol), C00745, D03365, EN300-304948, LEADER NICOTINE TRANSDERMAL SYSTEMSTEP 1, LEADER NICOTINE TRANSDERMAL SYSTEMSTEP 2, LEADER NICOTINE TRANSDERMAL SYSTEMSTEP 3, P10017, PYRROLIDENE, 1-METHYL-2-(3-PYRIDAL)-, (-)-.beta.-Pyridyl-.alpha.-N-methylpyrrolidine, AB00694322_12, (-)-Nicotine, PESTANAL(R), analytical standard, J-500021, SR-05000001762-5, BRD-K05395900-322-02-1, BRD-K05395900-322-04-7, Pyridine, 3-(tetrahydro-1-methylpyrrol-2-yl), (S)-, Q28086552, PYRIDINE, 3-(TETRAHYDRO-1-METHYL PYRROL-2-YL), Z1198150037, 434F7990-3240-4A43-ACEC-E6CC1E495FA0, (S)-(-)-NICOTINE; 3-[(2S)-1-METHYL-2-PYRROLIDINYL] PYRIDINE" C10H14N2 SNICXCGAKADSCV-JTQLQIEISA-N 3-[(2S)-1-methylpyrrolidin-2-yl]pyridine Upjohn Corporation n.a. No No No No No No PMDBD2001313 Sucralose Therapeutic Substance n.a. 56038-13-2 DB15049 n.a. n.a. n.a. 71485 64561 n.a. "Sucralose, 56038-13-2, Trichlorosucrose, Splenda, Aspasvit, EINECS 259-952-2, 1'',4,6''-Trichlorogalactosucrose, UNII-96K6UQ3ZD4, 96K6UQ3ZD4, Sucrazit, Trichlorogalactosucrose, CHEBI:32159, BRN 3654410, Sansweet su 100, CCRIS 8449, Trichlorogalacto-sucrose, DTXSID1040245, HSDB 7964, San sweet sa 8020, 1,6-Dichloro-1,6-dideoxy-beta-D-fructofuranosyl 4-chloro-4-deoxy-alpha-D-galactopyranoside, 1,6-Dichloro-1,6-dideoxy-beta-D-fructofuranosyl-4-chloro-4-deoxy-alpha-D-galactopyranoside, NSC-759272, E955, INS NO.955, 4,1'',6''-trichlorogalactosucrose, CHEMBL3185084, DTXCID9020245, INS-955, alpha-D-Galactopyranoside, 1,6-dichloro-1,6-dideoxy-beta-D-fructofuranosyl 4-chloro-4-deoxy-, NSC 759272, (2R,3R,4R,5R,6R)-2-[(2R,3S,4S,5S)-2,5-bis(chloromethyl)-3,4-dihydroxyoxolan-2-yl]oxy-5-chloro-6-(hydroxymethyl)oxane-3,4-diol, SUCRALOSE (II), SUCRALOSE [II], 1'',4'',6''-TRICHLORO-GALACTOSUCROSE, Acucar Light, E-955, SUCRALOSE (MART.), SUCRALOSE [MART.], SUCRALOSE (USP-RS), SUCRALOSE [USP-RS], (2R,3R,4R,5R,6R)-2-(((2R,3S,4S,5S)-2,5-Bis(chloromethyl)-3,4-dihydroxytetrahydrofuran-2-yl)oxy)-5-chloro-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4-diol, .alpha.-D-Galactopyranoside, 1,6-dichloro-1,6-dideoxy-.beta.-D-fructofuranosyl 4-chloro-4-deoxy-, SUCRALOSE (EP MONOGRAPH), SUCRALOSE [EP MONOGRAPH], MFCD03648615, 4,1'',6''-Trichloro-4,1'',6''-trideoxy-galacto-sucrose, E955;Trichlorosucrose, CAS-56038-13-2, Sucralose [BAN:NF], Sucralose; 1,6-Dichloro-1,6-dideoxy-beta-d-fructofuranosyl 4-chloro-4-deoxy-alpha-d-galactopyranoside, SUCRALOSE [FCC], SUCRALOSE [MI], SUCRALOSE [INCI], SCHEMBL3686, SUCRALOSE [WHO-DD], 1,6-Dichloro-1,6-dideoxy-beta-D-fructofuranosyl 4-chloro-4-deoxy-alpha-D-galactose, Sucralose, analytical standard, BAQAVOSOZGMPRM-QBMZZYIRSA-N, HMS2093H16, Pharmakon1600-01505953, HY-N0614, Sucralose, >=98.0% (HPLC), Tox21_113658, Tox21_201752, Tox21_303425, BDBM50367128, NSC759272, s4214, AKOS015962432, CCG-213995, CS-8130, a-D-Galactopyranoside, 1,6-dichloro-1,6-dideoxy-b-D-fructofuranosyl4-chloro-4-deoxy-, NCGC00249110-01, NCGC00249110-03, NCGC00249110-04, NCGC00257400-01, NCGC00259301-01, (2R,3R,4R,5R,6R)-2-[(2R,3S,4S,5S)-2,5-bis(chloromethyl)-3,4-dihydroxy-tetrahydrofuran-2-yl]oxy-5-chloro-6-(hydroxymethyl)tetrahydropyran-3,4-diol, 1-(1,6-Dichloro-1,6-dideoxy-beta-D-fructofuranosyl)-4-chloro-4-deoxy-alpha-D-galactopyranoside, SBI-0206860.P001, Sucralose 1000 microg/mL in Acetonitrile, 1'',4'',6''-Trideoxy-trichloro-galactosucrose, NS00000320, A22902, AB01563242_01, AB01563242_02, Q410209, SR-05000001935, SR-05000001935-1, W-203112, BRD-K58968598-001-03-6, Sucralose, European Pharmacopoeia (EP) Reference Standard, Sucralose, United States Pharmacopeia (USP) Reference Standard, Sucralose, Pharmaceutical Secondary Standard; Certified Reference Material, 1,6-Dichloro-1,6-dideoxy-beta-D-fructofuranosyl-4-chloro-4-deoxy-a-D-galactopyranoside, (2R,3R,4R,5R,6R)-2-((2R,3S,4S,5S)-2,5-bis(chloromethyl)-3,4-dihydroxytetrahydrofuran-2-yloxy)-5-chloro-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4-diol, 1'',6''-dichloro-1'',6-dideoxy-beta-D-fructofuranosyl-4-chloro-4-deoxy-alpha-D-galactopyranoside, 1,6-dichloro-1,6-dideoxy-.beta.-d-fructofuranosyl-4-chloro-4-deoxy-.alpha.-d-galactopyranoside" C12H19Cl3O8 BAQAVOSOZGMPRM-QBMZZYIRSA-N (2R,3R,4R,5R,6R)-2-[(2R,3S,4S,5S)-2,5-bis(chloromethyl)-3,4-dihydroxyoxolan-2-yl]oxy-5-chloro-6-(hydroxymethyl)oxane-3,4-diol n.a. n.a. No No No No No No PMDBD2001314 Tau-?uvalinate n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001315 Traffic-related air n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001316 Cefpirome Therapeutic Substance n.a. 84957-29-9 DB13682 n.a. D07649 n.a. 5479539 4586396 n.a. CEFPIROME, 84957-29-9, Cefpiroma, Cefpiromum, Cefrom, Cefir, HR 810, HR-810 FREE BASE, CHEBI:3503, S72Q2F09HY, Cefpirome (INN), (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-(6,7-dihydro-5H-cyclopenta[b]pyridin-1-ium-1-ylmethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate, cefpirome sulphate, CEFPIROME [INN], HR-810, 5H-Cyclopenta[b]pyridinium,1-[[(6R,7R)-7-[[(2Z)-(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-6,7-dihydro-, inner salt, Cefpiromum [Latin], Cefpiroma [Spanish], Cefpirome [INN:BAN], NCGC00181339-01, UNII-S72Q2F09HY, Broact, Keiten, Keiten, Cefpiroma, Cefir (TN), CEFPIROME [MI], CEFPIROME [WHO-DD], SCHEMBL49406, MLS006010792, CHEMBL65794, DTXSID2048244, SCHEMBL22207951, HY-B0699, AKOS016013926, DB13682, (6R,7R)-7-{[(2Z)-2-(2-Amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-(6,7-dihydro-5H-cyclopenta[b]pyridinium-1-ylmethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate, 1-(((6R,7R)-7-(2-(2-Amino-4-thiazolyl)glyoxylamino)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-6,7-dihydro-5H-1-pyridinium hydroxide, inner salt, 5H-1-Pyrindinium, 1-((7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-6,7-dihydro-, hydroxide, inner salt, (6R-(6alpha,7beta(Z)))-, SMR004701476, CS-0009593, D07649, EN300-24767392, (6R,7R)-7-((2-(2-Amino-4-thiazolyl)-2-methoxyiminoacetamido)-8-oxo-3-(2beta-trimethylenpyridinio)methyl)-5-thia-1-azabicyclo(4.2.0)oct-2-en-2-carboxylat, 1-(((6R,7R)-7-(2-(2-AMINO-4-THIAZOLYL)GLYOXYLAMIDO)-2-CARBOXY-8-OXO-5-THIA-1-AZABICYCLO(4.2.0)OCT-2-EN-3-YL)METHYL)-6,7-DIHYDRO-5H-1-PYRINDINIUM HYDROXIDE, INNER SALT, 72-(Z)-(O-METHYLOXIME), 1-{[(6R,7R)-2-carboxylato-7-{[(2Z)-1-hydroxy-2-(2-imino-2,3-dihydro-1,3-thiazol-4-yl)-2-(methoxyimino)ethylidene]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl}-5H,6H,7H-cyclopenta[b]pyridin-1-ium, 1-{[(6R,7R)-7-[(2Z)-2-(2-AMINO-1,3-THIAZOL-4-YL)-2-(METHOXYIMINO)ACETAMIDO]-2-CARBOXYLATO-8-OXO-5-THIA-1-AZABICYCLO[4.2.0]OCT-2-EN-3-YL]METHYL}-5H,6H,7H-CYCLOPENTA[B]PYRIDIN-1-IUM, 5H-1-Pyrindinium, 1-((7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-5,6,7,8-tetrahydro-, hydroxide, inner salt, (6R-(6alpha,7beta(Z)))-, 5H-1-PYRINDINIUM, 1-((7-(((2-AMINO-4-THIAZOLYL)(METHOXYIMINO)ACETYL)AMINO)-2-CARBOXY-8-OXO-5-THIA-1-AZABICYCLO(4.2.0)OCT-2-EN-3-YL)METHYL)-6,7-DIHYDRO-, HYDROXIDE, INNER SALT, (6R-(6.ALPHA.,7.BETA.(Z)))-, 7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-(6,7-dihydro-5H-cyclopenta[b]pyridinium-1-ylmethyl)-3,4-didehydrocepham-4-carboxylic acid C22H22N6O5S2 DKOQGJHPHLTOJR-WHRDSVKCSA-N (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-(6,7-dihydro-5H-cyclopenta[b]pyridin-1-ium-1-ylmethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate n.a. n.a. No No No No No No PMDBD2001317 Polymyxin E n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001318 1-hydroxy S-ibuprofen drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes 1HIBUP_S_GLCAASE,1HIBUP_S_GLCAASEe,1HIBUP_S_GLCAASEepp,1HIBUP_Sabc,1HIBUP_St,1HIBUP_St2,1HIBUP_Ste,1HIBUP_Stepp,1HIBUP_Stex,EX_1hibup_S(e) PMDBD2001319 1-hydroxy S-ibuprofen-glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes 1HIBUP_S_GLCAASE,1HIBUP_S_GLCAASEe,1HIBUP_S_GLCAASEepp,1HIBUPGLU_Sabc,1HIBUPGLU_St,1HIBUPGLU_St2,1HIBUPGLU_St2pp,1HIBUPGLU_Ste,1HIBUPGLU_Stex,EX_1hibupglu_S(e) PMDBD2001320 1''-OH-midazolam-glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes 1HMDGLUC_GLCAASE,1HMDGLUC_GLCAASEe,1HMDGLUC_GLCAASEepp,1HMDGLUCabc,1HMDGLUCt,1HMDGLUCt2,1HMDGLUCt2pp,1HMDGLUCtex,EX_1hmdgluc(e) PMDBD2001321 1''-OH-midazolam drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes 1HMDGLUC_GLCAASE,1HMDGLUC_GLCAASEe,1HMDGLUC_GLCAASEepp,1OHMDZte,EX_1ohmdz(e) PMDBD2001322 2-hydroxy-atorvastatin-acid / ortho-hydroxy-atorvastatin acid drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001323 2-hydroxy-atorvastatin-acyl-glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001324 2-hydroxy-atorvastatin-lactone / ortho-hydroxy-atorvastatin lactone drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001325 2-hydroxy-atorvastatin-lactone-glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001326 2-hydroxy-S-ibuprofen drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes 2HIBUP_S_GLCAASE,2HIBUP_S_GLCAASEe,2HIBUP_S_GLCAASEepp,2HIBUP_Sabc,2HIBUP_St,2HIBUP_St2,2HIBUP_Stepp,2HIBUP_Stex,EX_2hibup_S(e) PMDBD2001327 2-hydroxy S-ibuprofen-glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes 2HIBUP_S_GLCAASE,2HIBUP_S_GLCAASEe,2HIBUP_S_GLCAASEepp,2HIBUPGLU_St2pp,2HIBUPGLU_Ste,2HIBUPGLU_Stex,EX_2hibupglu_S(e) PMDBD2001328 2-Hydroxycarbamazepine drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes 2OH_CBZ_GLC_GLCAASE,2OH_CBZ_GLC_GLCAASEe,2OH_CBZ_GLC_GLCAASEepp,2OH_CBZte,2OH_CBZtepp,2OH_CBZtex,EX_2oh_cbz(e) PMDBD2001329 2-Hydroxy Carbamazepine Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001330 2-Hydroxymetronidazole drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes 2OH_MTZ_GLC_GLCAASE,2OH_MTZ_GLC_GLCAASEe,2OH_MTZ_GLC_GLCAASEepp,2OH_MTZte,2OH_MTZtepp,2OH_MTZtex,EX_2oh_mtz(e) PMDBD2001331 2-Hydroxymetronidazole Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001332 L-dopa n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001333 3-hydroxy S-ibuprofen drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes 3HIBUP_S_GLCAASE,3HIBUP_S_GLCAASEe,3HIBUP_S_GLCAASEepp,3HIBUP_Sabc,3HIBUP_St,3HIBUP_St2,3HIBUP_Stepp,3HIBUP_Stex,EX_3hibup_S(e) PMDBD2001334 3-hydroxy S-ibuprofen-glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes 3HIBUP_S_GLCAASE,3HIBUP_S_GLCAASEe,3HIBUP_S_GLCAASEepp,3HIBUPGLU_St2pp,3HIBUPGLU_Ste,3HIBUPGLU_Stex,EX_3hibupglu_S(e) PMDBD2001335 3-methoxy-acetaminophen drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes 3MEACMPte,3MEACMPtepp,3MEACMPtex,EX_3meacmp(e),GLC3MEACP_GLCAASE,GLC3MEACP_GLCAASEe,GLC3MEACP_GLCAASEepp PMDBD2001336 3-Hydroxycarbamazepine drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes 3OH_CBZ_GLC_GLCAASE,3OH_CBZ_GLC_GLCAASEe,3OH_CBZ_GLC_GLCAASEepp,3OH_CBZte,3OH_CBZtepp,3OH_CBZtex,EX_3oh_cbz(e) PMDBD2001337 3-Hydroxy Carbamazepine Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001338 3-Hydroxydesloratadine drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes 3OH_DLOR_GLC_GLCAASE,3OH_DLOR_GLC_GLCAASEe,3OH_DLOR_GLC_GLCAASEepp,3OH_DLORte,3OH_DLORtepp,3OH_DLORtex,EX_3oh_dlor(e) PMDBD2001339 3-Hydroxydesloratadine Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001340 3-Hydroxy N-Desethylamiodarone (3-Hydroxy_MDEA) (M8) drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001341 3-Hydroxy N-Desethylamiodarone Glucuronide (3-Hydroxy_MDEA_Glc) (M15) drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001342 3-Hydroxymorphinan drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes 3OH_MXN_GLC_GLCAASE,3OH_MXN_GLC_GLCAASEe,3OH_MXN_GLC_GLCAASEepp,3OH_MXNte,3OH_MXNtepp,3OH_MXNtex,EX_3oh_mxn(e) PMDBD2001343 3-Hydroxymorphinan O-Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001344 4-Dehydroxytempol drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes 4DH_TPNO_1GLC_GLCAASE,4DH_TPNO_1GLC_GLCAASEe,4DH_TPNOte,EX_4dh_tpno(e) PMDBD2001345 4-Dehydroxytempol 1-O-Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001346 4-OH-midazolam-glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes 4HMDGLUC_GLCAASE,4HMDGLUC_GLCAASEe,4HMDGLUC_GLCAASEepp,4HMDGLUCabc,4HMDGLUCt,4HMDGLUCt2,4HMDGLUCt2pp,4HMDGLUCtex,EX_4hmdgluc(e) PMDBD2001347 4-Hydroxydiclofenac drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes 4OH_DCF_GLC_GLCAASE,4OH_DCF_GLC_GLCAASEe,4OH_DCF_GLC_GLCAASEepp,4OH_DCFte,4OH_DCFtepp,4OH_DCFtex,EX_4oh_dcf(e) PMDBD2001348 4-Hydroxydiclofenac Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001349 4-Hydroxybenzyl Ketoprofen drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes 4OH_KP_GLC_GLCAASE,4OH_KP_GLC_GLCAASEe,4OH_KP_GLC_GLCAASEepp,4OH_KPte,4OH_KPtepp,4OH_KPtex,EX_4oh_kp(e) PMDBD2001350 4-Hydroxybenzyl Ketoprofen Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001351 4-Hydroxy Levamisole (M1) drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001352 4-Hydroxy Levamisole Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001353 4-Hydroxymethamphetamine drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes 4OH_METH_GLC_GLCAASE,4OH_METH_GLC_GLCAASEe,4OH_METH_GLC_GLCAASEepp,4OH_METHte,4OH_METHtepp,4OH_METHtex,EX_4oh_meth(e) PMDBD2001354 4-Hydroxymethamphetamine Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001355 4-Hydroxypropanolol drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes 4OH_PROPL_GLC_GLCAASE,4OH_PROPL_GLC_GLCAASEe,4OH_PROPL_GLC_GLCAASEepp,4OH_PROPLte,4OH_PROPLtepp,4OH_PROPLtex,EX_4oh_propl(e) PMDBD2001356 4-Hydroxypropranolol Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001357 4-Hydroxytriazolam drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes 4OH_TRZ_GLC_GLCAASE,4OH_TRZ_GLC_GLCAASEe,4OH_TRZ_GLC_GLCAASEepp,4OH_TRZte,4OH_TRZtepp,4OH_TRZtex,EX_4oh_trz(e) PMDBD2001358 4-Hydroxy Triazolam Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001359 4-Hydroxyvoriconazole drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes 4OH_VCZ_GLC_GLCAASE,4OH_VCZ_GLC_GLCAASEe,4OH_VCZ_GLC_GLCAASEepp,4OH_VCZte,4OH_VCZtepp,4OH_VCZtex,EX_4oh_vcz(e) PMDBD2001360 4-Hydroxyvoriconazole Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001361 4-OH-midazolam drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes 4HMDGLUC_GLCAASE,4HMDGLUC_GLCAASEe,4HMDGLUC_GLCAASEepp,4OHMDZte,4OHMDZtepp,4OHMDZtex,EX_4ohmdz(e) PMDBD2001362 5-Aminosalicylic Acid (Mesalamine) drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes 5ASAabc,5ASAt2r,AC5ASAc,AC5ASAe,EX_5asa(e),SSZ_AR_NADi,SSZ_AR_NADPi PMDBD2001364 5-Hydroxy-Sulfapyridine drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes 5OH_SULFP_GLC_GLCAASE,5OH_SULFP_GLC_GLCAASEe,5OH_SULFP_GLC_GLCAASEepp,5OH_SULFPte,5OH_SULFPtepp,5OH_SULFPtex,EX_5oh_sulfp(e) PMDBD2001365 5-Hydroxy-Sulfapyridine-O-Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001366 5-hydroxy-fluvastatin drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001367 5-hydroxy-fluvastatin-glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001368 6-beta-OH-gliclazide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes 6BHGLZGLC_GLCAASE,6BHGLZGLC_GLCAASEe,6BHGLZGLC_GLCAASEepp,6BHGLZte,6BHGLZtepp,6BHGLZtex,EX_6bhglz(e) PMDBD2001369 6-beta-OH-gliclazide-glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001370 6-hydroxy-fluvastatin drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001371 6-hydroxy-fluvastatin-glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001372 7-Aminoclonazepam drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes CZP_NR,CZP_NRe,EX_7a_czp(e),t7ACZPpp PMDBD2001373 7-beta-OH-gliclazide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes 7BHGLZ_GLCAASE,7BHGLZ_GLCAASEe,7BHGLZ_GLCAASEepp,7BHGLZabc,7BHGLZt,7BHGLZt2,7BHGLZtepp,7BHGLZtex,EX_7bhglz(e) PMDBD2001374 7-beta-OH-gliclazide-glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001375 7-hydroxy-Efavirenz drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes 7OH_EFV_GLC_GLCAASE,7OH_EFV_GLC_GLCAASEe,7OH_EFV_GLC_GLCAASEepp,7OH_EFVte,7OH_EFVtepp,7OH_EFVtex,EX_7oh_efv(e) PMDBD2001376 7-hydroxy-Efavirenz Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001377 8,14-Dihydroxyefavirenz drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes 814DIOH_EFV_GLC_GLCAASE,814DIOH_EFV_GLC_GLCAASEe,814DIOH_EFV_GLC_GLCAASEepp,814DIOH_EFVte,814DIOH_EFVtepp,814DIOH_EFVtex,EX_814dioh_efv(e) PMDBD2001378 8,14-Dihydroxyefavirenz Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001379 8-hydroxy-Efavirenz drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes 8OH_EFV_GLC_GLCAASE,8OH_EFV_GLC_GLCAASEe,8OH_EFV_GLC_GLCAASEepp,8OH_EFVte,8OH_EFVtepp,8OH_EFVtex,EX_8oh_efv(e) PMDBD2001380 8-hydroxy-Efavirenz Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001381 4-Aminobenzoyl-Beta-Alanine drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes ABZ_ALA_Bt2r,ABZ_ALA_Bt2rpp,ABZ_ALA_Btex,BZD_AR_NADi,BZD_AR_NADPi,EX_abz_ala_b(e) PMDBD2001382 Acetyl 4-Aminobenzoylglycine drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001383 Acetyl 4-Aminobenzoylglycine Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001384 N-Acetyl-5-Aminosalicylic Acid drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001385 N-Acetylisoniazid drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes ACISNZDabc,ACISNZDabcpp,ACISNZDppp,ACISNZDtex,EX_acisnzd(e),ISNZDAc,ISNZDAe PMDBD2001387 Acetaminophen Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001389 4-Hydroxyalprazolam drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes ALPZ_4OH_GLC_GLCAASE,ALPZ_4OH_GLC_GLCAASEe,ALPZ_4OH_GLC_GLCAASEepp,ALPZ_4OHte,ALPZ_4OHtepp,ALPZ_4OHtex,EX_alpz_4oh(e) PMDBD2001390 4-Hydroxyalprazolam Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001391 Alpha-Hydroxyalprazolam drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes ALPZ_AOH_GLC_GLCAASE,ALPZ_AOH_GLC_GLCAASEe,ALPZ_AOH_GLC_GLCAASEepp,ALPZ_AOHte,ALPZ_AOHtepp,ALPZ_AOHtex,EX_alpz_aoh(e) PMDBD2001392 Alpha-Hydroxyalprazolam Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001393 Desmethylalfentanil (AM14) n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes AM14_GLC_GLCAASE,AM14_GLC_GLCAASEe,AM14_GLC_GLCAASEepp,AM14te,AM14tepp,AM14tex,EX_am14(e) PMDBD2001394 Desmethylalfentanil Glucuronide (AM14 Glucuronide) drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001395 AM1C (Cyclosporine) (M18) n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes AM1CCSte,AM1CCStepp,AM1CCStex,AM1CGLC_GLCAASE,AM1CGLC_GLCAASEe,AM1CGLC_GLCAASEepp,EX_am1ccs(e) PMDBD2001396 AM1C-Glucuronide (Cyclosporine) drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes AM1CGLC_GLCAASE,AM1CGLC_GLCAASEe,AM1CGLC_GLCAASEepp,AM1CGLCabc,AM1CGLCt,AM1CGLCt2,AM1CGLCt2pp,AM1CGLCtex,EX_am1cglc(e) PMDBD2001397 N-(4-Hydroxyphenyl)Propanamide (AM5) drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. 24823586 n.a. n.a. 4-methyl-N~3~-(2-{[4-(4-methylpiperazin-1-yl)phenyl]amino}pyrimidin-5-yl)-N~1~-[3-(trifluoromethyl)phenyl]benzene-1,3-dicarboxamide, 1,3-Benzenedicarboxamide, 4-methyl-N3-[2-[[4-(4-methyl-1-piperazinyl)phenyl]amino]-5-pyrimidinyl]-N1-[3-(trifluoromethyl)phenyl]-, 925898-26-6, Aminopyrimidine amide, 10b, CHEMBL408070, SCHEMBL2951849, BDBM26366, JZLAJYOZJKREKH-UHFFFAOYSA-N, Q27457513, 4-methyl-3-N-(2-{[4-(4-methylpiperazin-1-yl)phenyl]amino}pyrimidin-5-yl)-1-N-[3-(trifluoromethyl)phenyl]benzene-1,3-dicarboxamide, AM5 C31H30F3N7O2 JZLAJYOZJKREKH-UHFFFAOYSA-N 4-methyl-3-N-[2-[4-(4-methylpiperazin-1-yl)anilino]pyrimidin-5-yl]-1-N-[3-(trifluoromethyl)phenyl]benzene-1,3-dicarboxamide n.a. n.a. No No No No No Yes AM5_GLC_GLCAASE,AM5_GLC_GLCAASEe,AM5_GLC_GLCAASEepp,AM5te,AM5tepp,AM5tex,EX_am5(e) PMDBD2001398 N-(4-Hydroxyphenyl)Propanamide Glucuronide (AM5 Glucuronide) drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001399 Desmethylnoralfentanil (AM6) n.a. n.a. n.a. n.a. n.a. n.a. n.a. 24823590 n.a. n.a. 2-methyl-N-{4-methyl-3-[(2-{[4-(4-methylpiperazin-1-yl)phenyl]amino}pyrimidin-5-yl)carbamoyl]phenyl}-3-(trifluoromethyl)benzamide, 925897-25-2, Benzamide, 2-methyl-N-[4-methyl-3-[[[2-[[4-(4-methyl-1-piperazinyl)phenyl]amino]-5-pyrimidinyl]amino]carbonyl]phenyl]-3-(trifluoromethyl)-, Aminopyrimidine amide, 19, CHEMBL271140, SCHEMBL2943475, BDBM26382, YNJXLRWECIJSPA-UHFFFAOYSA-N, Q27457517, 4-methyl-1-N-[2-methyl-3-(trifluoromethyl)benzene]-3-N-(2-{[4-(4-methylpiperazin-1-yl)phenyl]amino}pyrimidin-5-yl)benzene-1,3-dicarboxamide, AM6 C32H32F3N7O2 YNJXLRWECIJSPA-UHFFFAOYSA-N 2-methyl-N-[4-methyl-3-[[2-[4-(4-methylpiperazin-1-yl)anilino]pyrimidin-5-yl]carbamoyl]phenyl]-3-(trifluoromethyl)benzamide n.a. n.a. No No No No No Yes AM6_GLC_GLCAASE,AM6_GLC_GLCAASEe,AM6_GLC_GLCAASEepp,AM6te,AM6tepp,AM6tex,EX_am6(e) PMDBD2001400 Desmethylnoralfentanil Glucuronide (AM6 Glucuronide) drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001402 Carboxylamiodarone (M12) n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001403 Carboxylamiodarone Glucuronide (M19) drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001404 Amiodarone Glucuronide (M16) drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001405 4-Aminobenzoylglycine drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001406 4-Aminobenzoylglycine Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001407 Oxidation Product Of M3 M6 drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes AMNTD_M6_GLC_GLCAASE,AMNTD_M6_GLC_GLCAASEe,AMNTD_M6_GLC_GLCAASEepp,AMNTD_M6te,AMNTD_M6tepp,AMNTD_M6tex,EX_amntd_m6(e) PMDBD2001408 Amantadine M6 Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001409 7-Amino Nitrozepam drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_anzp(e),NZP_NR,NZP_NRe,NZP_Nrei,NZP_NReipp,NZP_NRepp,tANZPpp PMDBD2001410 atorvastatin-acid drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001411 atorvastatin-acyl-glucuronide / G2 drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001412 atorvastatin-ether-glucuronide -G1 drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001413 atorvastatin-lactone drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001414 atorvastatin-lactone-ether-glucuronide / G3 drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001415 (Bis-(P-Hydroxyphenyl)-Pyridyl-2-Methane drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. 69046 n.a. n.a. 603-41-8, deacetylbisacodyl, Dihydroxydiphenyl-pyridyl methane, Desacetyl Bisacodyl, DDPM, Deacetylbisocodyl, p,p''-(2-Pyridylmethylene)bisphenol, 4,4''-(2-Pyridinylmethylene)bisphenol, desacetylbisacodyl, La-96, Phenol, 4,4''-(2-pyridinylmethylene)bis-, 4,4''-(2-Pyridylmethylene)diphenol, 4-[(4-hydroxyphenyl)-pyridin-2-ylmethyl]phenol, C18H15NO2, Deacetyl Bisacodyl, EINECS 210-039-7, 4,4''-(Pyridin-2-ylmethylene)diphenol, BHPM, BRN 0212040, UNII-R09078E41Y, BISACODYL DIPHENOL, R09078E41Y, Bis(4-hydroxyphenyl)(2-pyridyl)methane, Phenol, 4,4''-(2-pyridylmethylene)di-, DTXSID20209053, EC 210-039-7, 4-[(4-hydroxyphenyl)(pyridin-2-yl)methyl]phenol, BIS-(P-HYDROXYPHENYL)PYRIDYL-2-METHANE, desacetyl-bisacodyl, BISACODYL IMPURITY A (EP IMPURITY), BISACODYL IMPURITY A [EP IMPURITY], SODIUM PICOSULFATE IMPURITY B (EP IMPURITY), SODIUM PICOSULFATE IMPURITY B [EP IMPURITY], 4,4''-Dihydroxydiphenyl(2-pyridyl)methane, SCHEMBL3615825, CHEMBL3544537, DTXCID40131544, LJROKJGQSPMTKB-UHFFFAOYSA-N, BP_34, bis(p-hydroxyphenyl)pyridyl-2-methane, 4,4''-(2-Pyridyl-methylen)-diphenol, AKOS024323666, DB14232, 1ST11277, 4,4''-[(Pyridin-2-yl)methylene]diphenol, AS-83080, HY-131637, CS-0137992, NS00003912, C90507, Bis-(p-hydroxyphenyl)-pyridyl-2-methane (BHPM), Q27287600 C18H15NO2 LJROKJGQSPMTKB-UHFFFAOYSA-N 4-[(4-hydroxyphenyl)-pyridin-2-ylmethyl]phenol n.a. n.a. No No No No No Yes BHPM_GLC_GLCAASE,BHPM_GLC_GLCAASEe,BHPM_GLC_GLCAASEepp,BHPMte,BHPMtepp,BHPMtex,EX_bhpm(e) PMDBD2001416 Bis-(P-Hydroxy-Phenyl)-Pyridyl-2-Methane Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001417 BILR 355 drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes BILR_355te,BILR_355tepp,BILR_355tex,BILR_M10_GLCAASE,BILR_M10_GLCAASEe,BILR_M10_GLCAASEepp,BILR_M16_GLCAASE,BILR_M16_GLCAASEe,BILR_M16_GLCAASEepp,EX_bilr_355(e) PMDBD2001418 BILR M10 drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes BILR_M10_GLCAASE,BILR_M10_GLCAASEe,BILR_M10_GLCAASEepp,BILR_M10abc,BILR_M10t,BILR_M10t2,BILR_M10t2pp,BILR_M10tex,EX_bilr_M10(e) PMDBD2001419 BILR M12 drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes BILR_M12_GLCAASE,BILR_M12_GLCAASEe,BILR_M12_GLCAASEepp,BILR_M12abc,BILR_M12t,BILR_M12t2,BILR_M12t2pp,BILR_M12tex,EX_bilr_M12(e) PMDBD2001420 BILR M14 drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes BILR_M14te,BILR_M14tepp,BILR_M14tex,BILR_M15_GLCAASE,BILR_M15_GLCAASEe,BILR_M15_GLCAASEepp,EX_bilr_M14(e) PMDBD2001421 BILR M15 drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes BILR_M15_GLCAASE,BILR_M15_GLCAASEe,BILR_M15_GLCAASEepp,BILR_M15abc,BILR_M15t,BILR_M15t2,BILR_M15t2pp,BILR_M15tex,EX_bilr_M15(e) PMDBD2001422 BILR M16 drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes BILR_M16_GLCAASE,BILR_M16_GLCAASEe,BILR_M16_GLCAASEepp,BILR_M16abc,BILR_M16t,BILR_M16t2,BILR_M16t2pp,BILR_M16tex,EX_bilr_M16(e) PMDBD2001423 BILR M7 drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes BILR_M12_GLCAASE,BILR_M12_GLCAASEe,BILR_M12_GLCAASEepp,BILR_M7te,BILR_M7tepp,BILR_M7tex,EX_bilr_M7(e) PMDBD2001426 Bosentan Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001427 (E)-5-(2-Bromovinyl)Uracil drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes BVUte,BVUtepp,BVUtex,EX_bvu(e),PYNP_SRV PMDBD2001428 Benzoate Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D02VGM 23056 n.a. n.a. 3-Quinuclidinyl benzilate, 6581-06-2, 3-Quinuclidyl benzilate, 3-quinuclidinyl-benzilate, [3H]QNB, (+/-)-Quinuclidinyl benzilate, 1-azabicyclo[2.2.2]octan-3-yl 2-hydroxy-2,2-diphenylacetate, Ro 2-3308, r(-)-quinuclidinyl benzilate, CHEMBL12980, (+-)-3-Quinuclidyl benzilate, (+-)-Oxyquinuclidine benzilate, NIOSH/DD4639000, (+-)-3-Quinuclidinol benzilate, (+-)-3-Quinuclidinyl benzilate, (+-)-beta-Quinuclidinyl benzilate, (+-)-3-Hydroxyquinuclidine benzilate, 3-Chinuclidylbenzilate, BZ, 3-Quinuclidinol benzilate, DD46390000, (+-)-Ro 2-3308, Benzilic acid, 3-quinuclidinyl ester, (+-)-, Buzz, Agent BZ, NSC 173698, CS 4030, EA 2277, QNB, Benzeneacetic acid, alpha-hydroxy-alpha-phenyl-, 1-azabicyclo(2.2.2)oct-3-yl ester, (+-)-, 1-Azabicyclo(2.2.2)octan-3-ol, benzilate, NSC170423, 3-Oxyquinuclidine benzilate, .beta.-Quinuclidinyl benzilate, 3-Hydroxyquinuclidine benzilate, [3H]quinuclidinylbenzilate, 3-Quinuclidinol, benzilate (ester), NSC-173698, Benzeneacetic acid, .alpha.-hydroxy-.alpha.-phenyl-, 1-azabicyclo(2.2.2)oct-3-yl ester, Benzeneacetic acid, .alpha.-hydroxy-.alpha.-phenyl-, 1-azabicyclo[2.2.2]oct-3-yl ester, Substance 78, (+/-)-QNB, SCHEMBL59698, GTPL318, GTPL3260, DTXSID00894168, Benzeneacetic acid, alpha-hydroxy-alpha-phenyl-, 1-azabicyclo[2.2.2]oct-3-yl ester, R-(-)-3-Quinuclidinyl benzilate, BDBM50010096, MFCD00055094, NSC168347, NSC173698, AKOS027321160, (+/-)-Quinuclidinyl benzilate, powder, EA-2277, NSC-168347, NCGC00485298-01, NS00121904, (+/-)-Quinuclidinyl alpha-hydroxydiphenylacetate, quinuclidin-3-yl 2-hydroxy-2,2-diphenyl-acetate, L001186, Q223068, Benzeneacetic acid, 1-azabicyclo[2.2.2]oct-3-yl ester, 1-Azabicyclo[2.2.2]oct-3-yl hydroxy(diphenyl)acetate #, Hydroxy-diphenyl-acetic acid 1-aza-bicyclo[2.2.2]oct-3-yl ester, 1-AZABICYCLO[2.2.2]OCTAN-8-YL 2-HYDROXY-2,2-DI(PHENYL)ACETATE, Hydroxy-diphenyl-acetic acid 1-aza-bicyclo[2.2.2]oct-3-yl ester(QNB), Hydroxy-diphenyl-acetic acid 1-aza-bicyclo[2.2.2]oct-3-yl ester(R)-(-)-(QNB) C21H23NO3 HGMITUYOCPPQLE-UHFFFAOYSA-N 1-azabicyclo[2.2.2]octan-3-yl 2-hydroxy-2,2-diphenylacetate n.a. n.a. No No No No Yes Yes rxnAGORA3455,rxnAGORA3456,rxnAGORA5351,rxnAGORA5352,rxnAdd38 BZ_GLC_GLCAASE,BZ_GLC_GLCAASEe,BZ_GLC_GLCAASEepp,BZte,BZtepp,BZtex,BZtpp,EX_bz(e) PMDBD2001429 Benzoic Acid Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001431 chenodeoxycholate Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. D03ZTE 10133 n.a. NPC34046 chenodeoxycholic acid, Chenodiol, 474-25-9, Chenix, Chenic acid, Cdca, Chenodesoxycholic acid, Chenodeoxycholate, Gallodesoxycholic acid, Chendol, Anthropodeoxycholic acid, Anthropodesoxycholic acid, Anthropododesoxycholic acid, Chenofalk, Chenodesoxycholsaeure, Chenocol, Chenossil, Cholanorm, Xenbilox, Fluibil, Henohol, Chenique Acid, Chenocholic acid, Chenodiol [USAN], 3alpha,7alpha-Dihydroxy-5beta-cholan-24-oic acid, Acido chenodeoxicholico, Acide chenodeoxycholique, Acidum chenodeoxycholicum, 7-alpha-Hydroxylithocholic acid, 3alpha,7alpha-Dihydroxy-5beta-cholanic acid, Sodium chenodeoxycholate, 7alpha-hydroxylithocholic acid, Chenodesoxycholsaeure [German], CCRIS 2195, 3-alpha,7-alpha-Dihydroxycholanic acid, UNII-0GEI24LG0J, EINECS 207-481-8, 0GEI24LG0J, 3-alpha,7-alpha-Dihydroxycholansaeure, Acide chenodeoxycholique [INN-French], Acido chenodeoxicholico [INN-Spanish], Acidum chenodeoxycholicum [INN-Latin], NSC 657949, DTXSID2020260, CHEBI:16755, Acid, Chenic, 3-alpha,7-alpha-Dihydroxy-5-beta-cholan-24-oic acid, 3-alpha,7-alpha-Dihydroxycholansaeure [German], Cholan-24-oic acid, 3,7-dihydroxy-, (3alpha,5beta,7alpha)-, NSC-657949, NSC-757798, Chenodeoxycholic acid [INN], DTXCID40260, (3alpha,5beta,7alpha)-3,7-dihydroxycholan-24-oic acid, 5-beta-Cholan-24-oic acid, 3-alpha,7-alpha-dihydroxy-, (4R)-4-[(3R,5S,7R,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid, EC 207-481-8, Cholan-24-oic acid, 3,7-dihydroxy-, (3-alpha,5-beta,7-alpha)-, Chenodiol (USAN), (3alpha,5beta,7alpha,8xi)-3,7-dihydroxycholan-24-oic acid, Leadiant (formerly Chenodeoxycholic acid sigma-tau), Chenodal, CHENODEOXYCHOLIC ACID (MART.), CHENODEOXYCHOLIC ACID [MART.], Acid, Chenique, Acide chenodeoxycholique (INN-French), Acido chenodeoxicholico (INN-Spanish), Acidum chenodeoxycholicum (INN-Latin), 5beta-Cholanic acid-3alpha,7alpha-diol, Chendeoxycholic Acid, CHENODEOXYCHOLIC ACID (EP IMPURITY), CHENODEOXYCHOLIC ACID [EP IMPURITY], CHENODEOXYCHOLIC ACID (EP MONOGRAPH), CHENODEOXYCHOLIC ACID [EP MONOGRAPH], Acid, Chenodeoxycholic, Acid, Gallodesoxycholic, URSODEOXYCHOLIC ACID IMPURITY A (EP IMPURITY), URSODEOXYCHOLIC ACID IMPURITY A [EP IMPURITY], Chenocedon, Chendal, Chenodex, Chenorm, Hekbilin, Kebilis, MFCD00064142, NSC657949, NCGC00016387-02, (R)-4-((3R,5S,7R,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid, CAS-474-25-9, JN3, chenodeoxycholic-acid, acido quenodeoxicolico, Cholan-24-oic acid, 3,7-dihydroxy-, (3a,5b,7a)-, (+)-chenodeoxycholate, acido chenodesossicolico, acide chenodesoxycholique, CHENODIOL [MI], Prestwick0_000285, Prestwick1_000285, Prestwick2_000285, Prestwick3_000285, Spectrum5_002009, CHENIX (TN), CHENODIOL [VANDF], (+)-chenodeoxycholic acid, bmse000908, 7a-Hydroxy-desoxycholsaeure, chAnodAsoxycholique (acide), BIDD:PXR0056, SCHEMBL25055, BSPBio_000190, GTPL608, MLS002154253, 3a,7a-dihydroxy-5b-cholanate, SPBio_002409, 3,7-Dihydroxy-5-Cholanicacid, BPBio1_000210, CHEMBL240597, Chenodeoxycholic acid, >=97%, CHENODIOL [ORANGE BOOK], 7.alpha.-Hydroxylithocholic acid, BDBM21674, Chenodeoxycholic Acid, Free Acid, A05AA01, 3a,7a-dihydroxy-5b-cholanic acid, HMS1568J12, HMS2095J12, HMS2234I22, HMS3712J12, Chenodeoxycholic acid (JP16/INN), Chenodeoxycholic acid (JP17/INN), CHENODEOXYCHOLIC ACID [JAN], 3alpha,7alpha-Dihydroxycholanic acid, Tox21_110412, Tox21_200491, (3beta,7beta,8xi,9xi,14xi,17alpha)-3,7-dihydroxycholan-24-oic acid, 3a,7a-dihydroxy-5b-cholan-24-oate, Cholan-24-oic acid, 3,7-dihydroxy-, (3.alpha.,5.beta.,7.alpha.)-, HSCI1_000210, LMST04010032, AKOS024280614, CHENODEOXYCHOLIC ACID [WHO-DD], CCG-220285, CS-0834, DB06777, SMP1_000064, 3.alpha.,7.alpha.-Dihydroxycholansaeure, 3a,7a-dihydroxy-5b,14a,17b-cholanate, 3a,7a-dihydroxy-5b-cholan-24-oic acid, NCGC00142400-03, NCGC00142400-04, NCGC00142400-08, NCGC00258045-01, (4R)-4-((1S,2S,7S,11S,5R,9R,10R,14R,15R)-5,9-dihydroxy-2,15-dimethyltetracyclo [8.7.0.0<2,7>.0<11,15>]heptadec-14-yl)pentanoic acid, 24404-86-2, 3.alpha.,7.alpha.-Dihydroxycholanic acid, AS-13636, HY-76847, SMR000857194, 3a,7a-dihydroxy-5b,14a,17b-cholanic acid, AB00513822, NS00069558, S1843, (3a,5b,7a)-3,7-dihydroxy-cholan-24-oate, 3alpha, 7alpha-dihydroxy-5beta-cholanoic acid, EN300-75328, 3alpha, 7alpha,-dihydroxy-5beta-cholanic acid, C-2900, C02528, D00163, (3a,5b,7a)-3,7-dihydroxy-cholan-24-oic acid, AB00513822-06, AB00513822_07, A827222, Q419028, 3.alpha.,7.alpha.-Dihydroxy-5.beta.-cholanic acid, Dihydroxy-3.alpha.,7.alpha.(5.beta.)Cholanic acid, 3.alpha.,7.alpha.-Dihydroxy-5.beta.-cholanoic acid, BRD-K18135438-001-16-7, 0DBBBC66-0CFA-4DB9-97F4-5B1492756A02, Z1172235745, 3.alpha.,7.alpha.-Dihydroxy-5.beta.-cholan-24-oic acid, 5.beta.-Cholan-24-oic acid, 3.alpha.,7.alpha.-dihydroxy-, CHOLAN-24-OIC ACID, 3,7-DIHYDROXY-, (3alpha,5beta,7alpha), (3alpha,5alpha,7beta,8alpha,17alpha)-3,7-dihydroxycholan-24-oic acid, 3,7-Dihydroxycholan-24-oic acid, (3.alpha.,5.beta.,7.alpha.)- #, Chenodeoxycholic acid, 500 mug/mL in methanol, certified reference material, Chenodeoxycholic acid, European Pharmacopoeia (EP) Reference Standard, Cholan-24-oic acid, 3,7-dihydroxy-, (3-.alpha., 5-.beta., 7-.alpha.)-, Cholan-24-oic acid, 3,7-dihydroxy-, (3-alpha,5-beta,7-alpha)- (9CI), CHOLAN-24-OIC ACID, 3,7-DIHYDROXY-, (3.ALPHA.,5.BETA.,7.ALPHA.), (4R)-4-[(1R,3aS,3bR,4R,5aS,7R,9aS,9bS,11aR)-4,7-dihydroxy-9a,11a-dimethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-1-yl]pentanoic acid, (4R)-4-[(1S,2S,5R,7S,9R,10R,11S,14R,15R)-5,9-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0?,?.0??,??]heptadecan-14-yl]pentanoic acid, (4R)-4-[(1S,2S,5R,7S,9R,10R,11S,14R,15R)-5,9-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl]pentanoic acid, (4R)-4-[(3R,5S,7R,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoicacid C24H40O4 RUDATBOHQWOJDD-BSWAIDMHSA-N (4R)-4-[(3R,5S,7R,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid Sigma Tau Pharmaceuticals Inc n.a. No No No No No Yes EX_C02528(e),GCDCHOLBHSe,TCDCHOLBHSe,TCDCHOLBHSepp PMDBD2001432 S-carboxy ibuprofen drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes CARIBUP_S_GLCAASE,CARIBUP_S_GLCAASEe,CARIBUP_S_GLCAASEepp,CARIBUP_Sabc,CARIBUP_St,CARIBUP_St2,CARIBUP_Stepp,CARIBUP_Stex,EX_caribup_s(e) PMDBD2001433 S-carboxy ibuprofen glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes CARIBUP_S_GLCAASE,CARIBUP_S_GLCAASEe,CARIBUP_S_GLCAASEepp,CARIBUPGLU_St2pp,CARIBUPGLU_Ste,CARIBUPGLU_Stex,EX_caribupglu_S(e) PMDBD2001435 Carbamazepine Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001436 CD6168 drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes CD6168_GLC_GLCAASE,CD6168_GLC_GLCAASEe,CD6168_GLC_GLCAASEepp,CD6168te,CD6168tepp,CD6168tex,EX_cd6168(e) PMDBD2001437 CD6168 Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001439 Chloramphenicol 3-Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001440 Cholate Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. D0OR2L 221493 n.a. NPC80089 "cholic acid, 81-25-4, Cholalic acid, cholate, Colalin, Cholalin, Cholsaeure, Cholbam, cholicacid, kolbam, NSC-6135, 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholanic acid, Cholic acid, 5beta-, 3,7,12-Trihydroxycholanic acid, 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholan-24-oic acid, Cholic acid [USAN], HSDB 982, (R)-4-((3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-Trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid, SODIUM CHOLATE, UNII-G1JO7801AE, MFCD00003672, CCRIS 1626, G1JO7801AE, CHEBI:16359, EINECS 201-337-8, (4R)-4-[(3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid, Cholan-24-oic acid, 3,7,12-trihydroxy-, (3a,5b,7a,12a)-, BRN 2822009, TERPENES AND TERPENOIDS, CHEMBL205596, DTXSID6040660, NSC6135, EC 201-337-8, 3-alpha,7-alpha,12-alpha-Trihydroxycholansaeure, 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholanate, 4-10-00-02072 (Beilstein Handbook Reference), 17-beta-(1-Methyl-3-carboxypropyl)etiocholane-3alpha,7alpha,12alpha-triol, 129874-08-4, CHD, Cholic acid (USAN), orphacol, 3-alpha,7-alpha,12-alpha-Trihydroxy-5-beta-cholan-24-oic acid, 5beta-Cholan-24-oic acid, 3alpha,7alpha,12alpha-trihydroxy-, C24H40O5, 3,7,12-Trihydroxycholan-24-oic acid, (3alpha,5beta,7alpha,12alpha)-, 3,7,12-Trihydroxy-cholan-24-oic acid (3-alpha,5-beta,7-alpha,12-alpha), Cholan-24-oic acid, 3,7,12-trihydroxy-, (3alpha,5beta,7alpha,12alpha)-, Cholic acid (sodium), 4-[(3R,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-Trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid, CHOLIC ACID (USP-RS), CHOLIC ACID [USP-RS], CHOLIC ACID (EP IMPURITY), CHOLIC ACID [EP IMPURITY], (3alpha,5beta,7alpha,12alpha)-3,7,12-trihydroxycholan-24-oic acid, (3alpha,5beta,7alpha,8x,12alpha)-3,7,12-trihydroxycholan-24-oic acid, Cholan-24-oic acid, 3,7,12-trihydroxy-, (3-alpha,5-beta,7-alpha,12-alpha)-, (4R)-4-[(1R,3aS,3bR,4R,5aS,7R,9aS,9bS,11S,11aR)-4,7,11-trihydroxy-9a,11a-dimethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-1-yl]pentanoic acid, SMR000112165, Colalin (VAN), Cholsaeure [German], 5beta-Cholanic acid-3alpha,7alpha,12alpha-triol, Cholan-24-oic acid, 3,7,12-trihydroxy-, (3.alpha.,5.beta.,7.alpha.,12.alpha.)-, 361-09-1, URSODEOXYCHOLIC ACID IMPURITY B (EP IMPURITY), URSODEOXYCHOLIC ACID IMPURITY B [EP IMPURITY], Cholalate, OrphacolReg, cholic-acid, Orphacol&Reg;, 5b-Cholate, 5b-Cholic acid, CholsA currencyure, Cholbam (TN), Cholic acid (8CI), 5.beta.-Cholic acid, Spectrum5_002005, CHOLIC ACID [MI], 3alpha,7alpha,12alpha-Trihydroxycholanic acid, bmse000650, CHOLIC ACID [FCC], CHOLIC ACID [JAN], CHOLIC ACID [HSDB], BIDD:PXR0196, SCHEMBL27461, GTPL609, 3.alpha.,7.alpha.,12.alpha.-Trihydroxy-5.beta.-cholanic acid, MLS001066422, MLS002207051, CHOLIC ACID [WHO-DD], 3a,7a,12a-Trihydroxycholanate, 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholanoic acid, CHOLIC ACID [EMA EPAR], DTXCID4020660, BDBM21680, 3-alpha,7-alpha,12-alpha-Trihydroxycholansaeure [German], CHOLIC ACID [ORANGE BOOK], HMS2268L18, 3a,7a,12a-Trihydroxy-b-cholanate, 3a,7a,12a-Trihydroxycholanic acid, HY-N0324, 3a,7a,12a-Trihydroxy-5b-cholanate, 5b-Cholanic acid-3a,7a,12a-triol, LMST04010001, s3742, 3a,7a,12a-Trihydroxy-5b-cholanoate, 3a,7a,12a-Trihydroxy-beta-cholanate, 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholan-24-oic Acid (Cholic Acid), AKOS005622502, 3a,7a,12a-Trihydroxy-b-cholanic acid, CCG-268746, CS-6608, DB02659, 3a,7a,12a-Trihydroxy-5A-cholanic acid, 3a,7a,12a-Trihydroxy-5b-cholanic acid, NCGC00142384-03, 3a,7a,12a-Trihydroxy-5b-cholanoic acid, 3a,7a,12a-Trihydroxy-beta-cholanic acid, 4-((1S,2S,7S,11S,16S,5R,9R,10R,14R,15R)-5,9,16-trihydroxy-2,15-dimethyltetracy clo[8.7.0.0<2,7>.0<11,15>]heptadec-14-yl)pentanoic acid, AS-69849, BP-30084, 3a,7a,12a-Trihydroxy-5b-cholan-24-oate, Cholic acid, Vetec(TM) reagent grade, 98%, NS00010900, Cholic acid, from ox or sheep bile, >=98%, 3a,7a,12a-Trihydroxy-5b-cholan-24-oic acid, C-5900, C00695, D10699, EN300-6766788, A830252, Q287415, SR-01000765698, 3alpha,7alpha,12alpha-Trihydroxy-beta-cholanic acid, SR-01000765698-4, 3.alpha.,12.alpha.-Trihydroxy-5.beta.-cholanic acid, 3-.alpha.,7-.alpha.,12-.alpha.-Trihydroxycholansaeure, 3alpha, 7alpha, 12alpha-trihydroxy-5beta-cholanic acid, 3alpha, 7alpha, 12alpha-trihydroxy-5beta-cholanoic acid, Z1954806455, 3-&alpha,7-&alpha,12-&alpha-trihydroxy-5-&beta-cholanate, Cholic acid, British Pharmacopoeia (BP) Reference Standard, Cholic acid, European Pharmacopoeia (EP) Reference Standard, 17b-[1-Methyl-3-carboxypropyl]etiocholane-3a,7a,12a-triol, 5.beta.-Cholan-24-oic acid,7.alpha.,12.alpha.-trihydroxy-, 5beta-Cholanic acid, 3alpha,7alpha,12alpha-trihydroxy- (7CI), 5beta-Cholanic acid-3alpha,7alpha,12alpha-triol 5beta-Cholic acid, Cholic acid, 500 mug/mL in methanol, certified reference material, Cholic acid, United States Pharmacopeia (USP) Reference Standard, 17beta-[1-Methyl-3-carboxypropyl]etiocholane-3alpha,7alpha,12alpha-triol, 3-.alpha.,7-.alpha.,12-.alpha.-Trihydroxy-5-.beta.-cholan-24-oic acid, 5.beta.-Cholan-24-oic acid, 3.alpha.,7.alpha.,12.alpha.-trihydroxy-, (3.alpha.,5.beta.,7.alpha.,12.alpha.)-3,7,12-Trihydroxycholan-24-oic acid sodium salt, (3alpha,5beta,7alpha,8alpha,12alpha,14beta,17alpha)-3,7,12-trihydroxycholan-24-oic acid, 17.beta.-(1-Methyl-3-carboxypropyl)etiocholane-3.alpha.,7.alpha.,12.alpha.-triol, 3,7,12-Trihydroxy-cholan-24-oic acid, (3.alpha.,5.beta.,7.alpha.,12.alpha.)-, Cholan-24-oic acid, 3,7,12-trihydroxy-, (3alpha,5beta,7alpha,12alpha)- (9CI), Cholan-24-oic acid,7,12-trihydroxy-, (3.alpha.,5.beta.,7.alpha.,12.alpha.)-, (4R)-4-((3R,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid, (4R)-4-[(1S,2S,5R,7S,9R,10R,11S,14R,15R,16S)-5,9,16-trihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl]pentanoic acid, (4R)-4-[(3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoicacid, (R)-4-((3R,5S,7R,8R,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid, 10321-98-9, CHOLAN-24-OIC ACID, 3,7,12-TRIHYDROXY-, (3-.ALPHA.,5-.BETA.,7-.ALPHA.,12-.ALPHA.)-" C24H40O5 BHQCQFFYRZLCQQ-OELDTZBJSA-N (4R)-4-[(3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid n.a. n.a. No No No No No Yes EX_cholate(e),GCHOLBHSe,TCHOLBHSe,TCHOLBHSepp PMDBD2001442 Carboxycelecoxib drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001443 Carboxycelecoxib Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001444 Celecoxib Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001445 Clopidogrel Carboxylic Acid drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes CLOBI_Cte,CLOBI_Ctepp,CLOBI_Ctex,CLOBI_GLC_GLCAASE,CLOBI_GLC_GLCAASEe,CLOBI_GLC_GLCAASEepp,EX_clobi_c(e) PMDBD2001446 Clopidogrel Acyl-Beta-D-Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes CLOBI_GLC_GLCAASE,CLOBI_GLC_GLCAASEe,CLOBI_GLC_GLCAASEepp,CLOBI_GLCabc,CLOBI_GLCt,CLOBI_GLCt2,CLOBI_GLCt2pp,CLOBI_GLCtex,EX_clobi_glc(e) PMDBD2001447 cerivastatin-M1 drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001448 cerivastatin-M23 drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001449 cerivastatin-M1-glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001450 cerivastatin-M23-glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001452 Deaminated Amiodarone (M5) drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes DAA_GLC_GLCAASE,DAA_GLC_GLCAASEe,DAA_GLC_GLCAASEepp,DAAte,DAAtepp,DAAtex,EX_daa(e) PMDBD2001453 Deaminated Amiodarone Glucuronide (M14) drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001455 Diclofenac Acyl Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001456 Di-N-Desethylamiodarone (DDEA) drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. 125134 n.a. n.a. Di-N-desethylamiodarone, Di-N-desethyl Amiodarone, 94317-95-0, DDEA, CHEMBL1598, [4-(2-aminoethoxy)-3,5-diiodophenyl]-(2-butyl-1-benzofuran-3-yl)methanone, Desdiethylamiodarone, N,N-Didesethylamiodarone, N,N-Di-desethyl Amiodarone, SCHEMBL7242769, BDBM18959, DTXSID90241425, L 33530, (2-Butylbenzofuran-3-yl)[4-[2- aminoethoxy]-3,5-diiodophenyl]methanone, 3-{[4-(2-aminoethoxy)-3,5-diiodophenyl]carbonyl}-2-butyl-1-benzofuran, Methanone, (4-(2-aminoethoxy)-3,5-diiodophenyl)(2-butyl-3-benzofuranyl)- C21H21I2NO3 ZOCLVGHDXBVATF-UHFFFAOYSA-N [4-(2-aminoethoxy)-3,5-diiodophenyl]-(2-butyl-1-benzofuran-3-yl)methanone n.a. n.a. No No No No No No PMDBD2001457 Di-N-Desethylamiodarone Glucuronide Conjugate (DDEA_Glc) drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001458 Desmethylastemizole drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes DES_ASTZL_GLC_GLCAASE,DES_ASTZL_GLC_GLCAASEe,DES_ASTZL_GLC_GLCAASEepp,DES_ASTZLte,DES_ASTZLtepp,DES_ASTZLtex,EX_des_astzl(e) PMDBD2001459 Desmethylastemozole Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001460 Gemcitabine (2beta,2beta-difluorodeoxycytidine) drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001461 2'',2''-Difluorodeoxyuridine drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes DFDCYTDD,DFDCYTDDe,DFDCYTDDepp,DFDURIte,DFDURItepp,DFDURItex,EX_dfduri(e) PMDBD2001462 glycochenodeoxycholate drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001463 5,6-Dihydro 5-Fluoro Uracil drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001464 Digoxin 16-Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001465 20,22-Dihydrodigitoxin drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001466 Dihydrodigoxin drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001468 Deleobuvir Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001469 5-O-Desmethyl Donepezil drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes DNPZ_5DESte,DNPZ_5DEStepp,DNPZ_5DEStex,DNPZ_M12_GLCAASE,DNPZ_M12_GLCAASEe,DNPZ_M12_GLCAASEepp,EX_dnpz_5des(e) PMDBD2001470 6-O-Desmethyldonepezil drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes DNPZ_6DESte,DNPZ_6DEStepp,DNPZ_6DEStex,DNPZ_M11_GLCAASE,DNPZ_M11_GLCAASEe,DNPZ_M11_GLCAASEepp,EX_dnpz_6des(e) PMDBD2001471 Donepezil Metabolite M11 drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001472 Donepezil Metabolite M12 drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001473 Donepezil Metabolite M13 drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001474 Donepezil Metabolite M14 drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001475 Donepezil Metabolite M9 drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001476 Etravarine Dihydroxylated (M4, M5, M6) drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes DOH_ETR_GLC_GLCAASE,DOH_ETR_GLC_GLCAASEe,DOH_ETR_GLC_GLCAASEepp,DOH_ETRte,DOH_ETRtepp,DOH_ETRtex,EX_doh_etr(e) PMDBD2001477 Etravarine Dihydroxylated Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001478 Dihydroxyvoriconazole drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes DOH_VCZ_GLC_GLCAASE,DOH_VCZ_GLC_GLCAASEe,DOH_VCZ_GLC_GLCAASEepp,DOH_VCZte,DOH_VCZtepp,DOH_VCZtex,EX_doh_vcz(e) PMDBD2001479 Dihydroxyvoriconazole Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001480 Dopamine Therapeutic Substance Approved Drug 51-61-6 DB00988 PA449396 D07870 D08HVR 6047 661 n.a. "levodopa, L-dopa, 59-92-7, 3,4-dihydroxy-L-phenylalanine, Dopar, 3-Hydroxy-L-tyrosine, Bendopa, Larodopa, 3,4-Dihydroxyphenylalanine, Cidandopa, Dopaidan, Dopalina, Maipedopa, Dopasol, Eldopal, Eldopar, Levopa, Prodopa, Syndopa, Brocadopa, Insulamina, Deadopa, Pardopa, (-)-Dopa, Dihydroxy-L-phenylalanine, Helfo-Dopa, 3-(3,4-Dihydroxyphenyl)-L-alanine, Dopaflex, Doparkine, Dopaston, Dopastral, Eldopatec, Eurodopa, Doparl, Doprin, Veldopa, Dopal-fher, Levodopum, L-3,4-Dihydroxyphenylalanine, (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid, Dopa, Levedopa, Ledopa, L-o-Hydroxytyrosine, L-Tyrosine, 3-hydroxy-, Dopaston SE, (-)-3-(3,4-Dihydroxyphenyl)-L-alanine, Laradopa, Parda, beta-(3,4-Dihydroxyphenyl)-L-alanine, 3,4-Dihydroxyphenyl-L-alanine, L-(o-Dihydroxyphenyl)alanine, L-(-)-Dopa, L-3-Hydroxytyrosine, L-beta-(3,4-Dihydroxyphenyl)alanine, Inbrija, Weldopa, beta-(3,4-Dihydroxyphenyl)alanine, L-Dihydroxyphenylalanine, L-3-(3,4-Dihydroxyphenyl)alanine, (S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid, Ro 4-6316, CVT-301, CCRIS 3766, Levodopum [INN-Latin], CHEBI:15765, HSDB 3348, alanine, 3-(3,4-dihydroxyphenyl)-, L-, dihydroxyphenylalanine, EINECS 200-445-2, component of Sinemet, NSC 118381, NSC-118381, Dopar (TN), DTXSID9023209, beta-(3,4-Dihydroxyphenyl)-alpha-L-alanine, L-beta-(3,4-Dihydroxyphenyl)-alpha-alanine, UNII-46627O600J, Alanine, 3-(3,4-dihydroxyphenyl)-, (-)-, L(-)-Dopa, (-)-(3,4-Dihydroxyphenyl)alanine, MFCD00002598, NSC118381, L-.beta.-(3,4-Dihydroxyphenyl)alanine, CHEMBL1009, .beta.-(3,4-Dihydroxyphenyl)-L-alanine, DHIVY COMPONENT LEVODOPA, DTXCID303209, DUOPA COMPONENT LEVODOPA, RYTARY COMPONENT LEVODOPA, 46627O600J, L-(3,4-Dihydroxyphenyl)alanine, PARCOPA COMPONENT LEVODOPA, STALEVO COMPONENT LEVODOPA, CARBILEV COMPONENT LEVODOPA, CORBILTA COMPONENT LEVODOPA, DOPASNAP COMPONENT LEVODOPA, IPX203 COMPONENT LEVODOPA, V-1512, LEVODOPA COMPONENT OF DHIVY, LEVODOPA COMPONENT OF DUOPA, IPX-203 COMPONENT LEVODOPA, LEVODOPA COMPONENT OF RYTARY, LEVODOPA COMPONENT OF PARCOPA, LEVODOPA COMPONENT OF SINEMET, LEVODOPA COMPONENT OF STALEVO, Inbrija (levodopa inhalation powder), LEVODOPA COMPONENT OF CARBILEV, LEVODOPA COMPONENT OF CORBILTA, LEVODOPA COMPONENT OF DOPASNAP, .beta.-(3,4-Dihydroxyphenyl)alanine, Levodopa [USAN:USP:INN:BAN:JAN], CAS-59-92-7, NCGC00016270-04, Biodopa, Cerepap, Sobiodopa, L-(3,4-Dihydroxyphenyl)-.alpha.-alanine, Levodopum (INN-Latin), LEVODOPA (MART.), LEVODOPA [MART.], LEVODOPA (USP-RS), LEVODOPA [USP-RS], Helfo DOPA, beta-(3,4-Dihydroxyphenyl)-alpha-alanine, LEVODOPA (EP IMPURITY), LEVODOPA [EP IMPURITY], LEVODOPA (EP MONOGRAPH), LEVODOPA [EP MONOGRAPH], LEVODOPA (USP MONOGRAPH), LEVODOPA [USP MONOGRAPH], Atamet, BDBM50130192, L-O-Dihydroxyphenylalanine, Levodopa (USAN:USP:INN:BAN:JAN), L Dopa, L-3, WLN: QVYZ1R CQ DQ, 3,4-Dihydroxyphenylalanine (VAN), SR-01000075384, L-3,4-Dihydrophenylalanine, Dopastone, Dopicar, Prolopa, (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoate, Prestwick_185, Levodopa (Sinemet), L-DOPA; Levodopa, Madopa (Salt/Mix), Spectrum_000454, 4-dihydroxyphenylalanine, LEVODOPA [HSDB], LEVODOPA [USAN], LEVODOPA [INN], LEVODOPA [JAN], LEVODOPA [MI], LEVODOPA [VANDF], Prestwick0_000017, Prestwick1_000017, Prestwick2_000017, Prestwick3_000017, Spectrum2_000496, Spectrum4_000539, Spectrum5_001899, Lopac-D-9628, Levodopa (JP15/USP), bmse000322, Epitope ID:150927, LEVODOPA [WHO-DD], LEVODOPA [WHO-IP], DOPA, L-, 3, 4-Dihydroxyphenylalanine, Alanine,4-dihydroxyphenyl)-, LEVODOPA [EMA EPAR], Lopac0_000454, SCHEMBL22655, BSPBio_000053, BSPBio_002354, KBioGR_001177, KBioSS_000934, L-4-5-Dihydroxyphenylalanine, MLS000028514, BIDD:GT0158, DivK1c_000452, SPECTRUM2300205, Levodopa (JP17/USP/INN), SPBio_000391, SPBio_001974, LEVODOPA [ORANGE BOOK], BPBio1_000059, GTPL3639, b-(3,4-Dihydroxyphenyl)alanine, WLN: QVYZ1R CQ DQ -L, 3, 4-Dihydroxy-L-phenylalanine, BDBM60928, HMS501G14, KBio1_000452, KBio2_000934, KBio2_003502, KBio2_006070, LEVODOPUM [WHO-IP LATIN], N04BA01, Alanine,4-dihydroxyphenyl)-, L-, L-(3, 4-Dihydroxyphenyl)alanine, NINDS_000452, HMS1568C15, HMS1922J14, HMS2090O08, HMS2093N04, HMS2095C15, HMS2230B04, HMS3261K10, HMS3712C15, Pharmakon1600-02300205, H-Phe{3,4-(OH)2}-OH, HY-N0304, Levodopa;3,4-Dihydroxyphenylalanine, b-(3,4-Dihydroxyphenyl)-L-alanine, Tox21_110338, Tox21_500454, CCG-39571, HB1925, L-3-(3,4-dihydroxy-phenyl)alanine, L-3-(3,4-dihydroxyphenyl)-Alanine, NSC759573, PDSP1_001541, PDSP2_001525, s1726, Alanine, 3-(3,4-dihydroxyphenyl)-, Alanine,4-dihydroxyphenyl)-, (-)-, AKOS010396267, b-(3,4-Dihydroxyphenyl)-a-L-alanine, L-b-(3,4-Dihydroxyphenyl)-a-alanine, L-DOPA (3,4-Dihydroxyphenylalanine), .beta.-(3, 4-Dihydroxyphenyl)alanine, AC-8432, AM82124, CS-1945, DB01235, LP00454, NSC-759573, SDCCGMLS-0066924.P001, SDCCGSBI-0050439.P004, IDI1_000452, NCGC00015384-01, NCGC00016270-01, NCGC00016270-06, NCGC00016270-07, NCGC00016270-09, NCGC00016270-10, NCGC00016270-22, NCGC00093869-04, NCGC00261139-01, AS-13287, BP-12850, SMR000058312, SBI-0050439.P003, L-(3, 4-Dihydroxyphenyl)-.alpha.-alanine, D0600, D9628, EU-0100454, NS00068395, EN300-52637, Alanine, 3-(3, 4-dihydroxyphenyl)-, (-)-, C00355, D 9628, D00059, D70595, 3,4-Dihydroxy-L-phenylalanine, >=98% (TLC), AB00052418-06, AB00052418-07, AB00052418_08, AB00052418_09, A832543, Q300989, (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoicacid, Q-201294, SR-01000075384-1, SR-01000075384-4, SR-01000075384-6, SR-01000075384-7, (S)-2-Amino-3-(3,4-dihydroxy-phenyl)-propionic acid, F0347-4695, Levodopa, British Pharmacopoeia (BP) Reference Standard, Levodopa, European Pharmacopoeia (EP) Reference Standard, Z756440064, (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acidL-dopa, 1E83F927-C221-46AA-B90A-81B33C5F3868, 3,4-Dihydroxy-L-phenylalanine, Vetec(TM) reagent grade, 98%, LEVODOPA COMPONENT OF LEVODOPA/CARBIDOPA/ENTACAPONE ORION, Levodopa, United States Pharmacopeia (USP) Reference Standard, LEVODOPA/CARBIDOPA/ENTACAPONE ORION COMPONENT LEVODOPA, 3,4-Dihydroxy-L-phenylalanine, certified reference material, TraceCERT(R), Levodopa, Pharmaceutical Secondary Standard; Certified Reference Material, 122769-74-8, 65170-01-6" C9H11NO4 WTDRDQBEARUVNC-LURJTMIESA-N (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid Orion Corp n.a. No No No No No Yes 3HLYTCL,DOPADH,DOPAt2,EX_dopa(e) PMDBD2001481 Dextrorphan Therapeutic Substance n.a. 125-73-5 DB14682 n.a. n.a. n.a. n.a. 10489895 n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes DXO_GLC_GLCAASE,DXO_GLC_GLCAASEe,DXO_GLC_GLCAASEepp,DXOte,DXOtepp,DXOtex,EX_dxo(e) PMDBD2001482 Dextrorphan O-Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001484 Efavirenz Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001486 Eltrombopag Glucuronide (M2) drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001487 Eltrombopag M3 (Glucuronide Conjugate) drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001488 Eltrombopag M4 (Glucuronide Conjugate) drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001489 Estradiol-17-glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001490 Estriol Therapeutic Substance Approved Drug 50-27-1 DB04573 PA164769104 D00185 D0Z1FX 5756 5553 NPC77569 estriol, 50-27-1, Oestriol, Trihydroxyestrin, Aacifemine, Estratriol, Ovestrion, Destriol, Ovestin, Theelol, Tridestrin, Oestratriol, Orestin, Ortho-Gynest, 16alpha-Hydroxyestradiol, Deuslon-A, Hemostyptanon, Oestriolum, Hormomed, Klimoral, Overstin, Triovex, Thulol, 16alpha,17beta-Estriol, Gynaesan, Orgastyptin, Estriel, Holin, Trihydroxyoestrin, Hormonin, Stiptanon, Synapause, Triodurin, 16alpha-Hydroxyoestradiol, 16-alpha-Hydroxyestradiol, 16alpha,17beta-Oestriol, Colpogyn, Estriolo, Incurin, Estriolo [Italian], Estriol, unconjugated, 16alpha-Hydroxy-17beta-estradiol, (16alpha,17beta)-Estra-1,3,5(10)-triene-3,16,17-triol, 16-alpha,17-beta-Estriol, 3,16alpha,17beta-Estriol, NSC-12169, 16-alpha,17-beta-Oestriol, 16-alpha-Hydroxyoestradiol, Deuslon A, 3,16-alpha,17-beta-Estriol, 3,16-alpha,17-beta-Oestriol, Ovesterin, 16.alpha.-Hydroxyestradiol, Ovo-vinces, 3,16alpha,17beta-Trihydroxy-1,3,5(10)-estratriene, Klimax E, 16.alpha.,17.beta.-Estriol, 16-Hydroxyestradiol, 1,3,5-Estratriene-3beta,16alpha,17beta-triol, 16.alpha.-Estriol, 1,3,5-Oestratriene-3beta,16alpha,17beta-triol, A 13610, CCRIS 284, Estra-1,3,5(10)-trien-3,16alpha,17beta-triol, Chlorapatite, Oestra-1,3,5(10)-triene-3,16alpha,17beta-triol, Gynasan, Trimesta, 3,16alpha,17beta-Trihydroxy-delta-1,3,5-oestratriene, oestriol., CHEBI:27974, HSDB 3590, (16alpha,17beta)-Oestra-1,3,5(10)-triene-3,16,17-triol, Estra-1,3,5(10)-triene-3,16alpha,17beta-triol, EINECS 200-022-2, 16.alpha.-Hydroxyoestradiol, NSC 12169, 3,16alpha,17beta-trihydroxy-Delta(1,3,5)-estratriene, 3,16-alpha,17-beta-Trihydroxy-delta-1,3,5-estratriene, 3,16-alpha,17-beta-Trihydroxy-delta-1,3,5-oestratriene, 3,16-alpha,17-beta-Trihydroxyestra-1,3,5(10)-triene, 3,16-alpha,17-beta-Trihydroxyoestra-1,3,5(10)-triene, Estriol (Standard), UNII-FB33469R8E, BRN 2508172, 1,3,5(10)-Estratriene-3,16alpha,17beta-Triol, 16.alpha.,17.beta.-Oestriol, DTXSID9022366, OE3, 1,3,5(10)-Estratriene-3,16-alpha,17beta-triol, Oestra-1,3,5(10)-triene-3,16-alpha,17-beta-triol, FB33469R8E, Estra-1,3,5(10)-triene-3,16,17-triol, Estra-1,3,5(10)-triene-3,16,17-triol, (16alpha,17beta)-, 16.alpha.-Hydroxy-17.beta.-estradiol, DTXCID002366, Estriol [USP:INN:BAN:JAN], 4-06-00-07550 (Beilstein Handbook Reference), NSC12169, MFCD00003691, (8R,9S,13S,14S,16R,17R)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,16,17-triol, ESTRIOL (MART.), ESTRIOL [MART.], ESTRIOL (USP-RS), ESTRIOL [USP-RS], 1,3,5-ESTRATRIENE-3B,16A,17B-TRIOL, 1306-04-3, ESTRIOL (EP MONOGRAPH), ESTRIOL [EP MONOGRAPH], ESTRIOL (USP MONOGRAPH), Estriol (USP:INN:BAN:JAN), ESTRIOL [USP MONOGRAPH], 3,16.alpha.,17.beta.-Estriol, (16A,17B)-ESTRA-1,3,5(10)-TRIENE-3,16,17-TRIOL, ESTRIOL (EMA EPAR VETERINARY), ESTRIOL [EMA EPAR VETERINARY], 16a-Hydroxyestradiol, (1S,10R,11S,13R,14R,15S)-15-methyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-2(7),3,5-triene-5,13,14-triol, 3,17.beta.-Estriol, Estriel (TN), Oestriol [Steroidal oestrogens], Estra-1,3,5(10)-triene-3,16,17-triol, (16.alpha.,17.beta.)-, SR-01000721851, 16alpha,17beta Estriol, 1,3,5(10)-Estratriene-3,16.alpha.,17.beta.-triol, Estra-1,3,5(10)-trien-3,16.alpha.,17.beta.-triol, Estra-1,3,5(10)-triene-3,16.alpha.,17.beta.-triol, 1,3,5(10)-ESTRATRIENE-3,16,17-TRIOL, 1,3,5-Estratriene-3.beta.,16-.alpha.,17-.beta.-triol, 1,3,5-Oestratriene-3-.beta.,16.alpha.,17.beta.-triol, 3,16.alpha.,17.beta.-Trihydroxy-1,3,5(10)-estratriene, 3,16.alpha.,17.beta.-Trihydroxyestra-1,3,5(10)-triene, Oestra-1,3,5(10)-triene-3,16.alpha., 17.beta.-triol, Trophicreme, 3,16.alpha.,17.beta.-Trihydroxy-.delta.-1,3,5-estratriene, Ostriol, Ovestinon, Gynsan, 3,16.alpha.,17.beta.-Trihydroxy-.delta.-1,3,5-oestratriene, (16.alpha.,17.beta.)-Estra-1,3,5(10)-triene-3,16,17-triol, (16.alpha.,17.beta.)-Oestra-1,3,5(10)-triene-3,16,17-triol, Estro-Life, 16alpha-Estriol, 3,16-.alpha.,17-.beta.-Oestriol, Holin V, CAS-50-27-1, 16a-Estriol, NCGC00166111-01, 16a,17b-Estriol, Estriol 5.0 Cream, Estriol, 98%, Estra-1,3,5(10)-triene-3,16,17-triol, (16a,17b)-, ESTRIOL [HSDB], Estriol, >=97%, ESTRIOL [JAN], ESTRIOL [MI], 3,16a,17b-Estriol, Prestwick0_001096, Prestwick1_001096, Prestwick2_001096, Prestwick3_001096, Estriol (JP17/USP), E0218, ESTRIOL [WHO-DD], Epitope ID:140131, 1,3,5(10)-Estratrien-3,16.alpha.,17.beta.-triol, Advanced Formula Estro-Life, Estra-1,3,5(10)-triene-3,16-.alpha., l7-.beta.-triol, SCHEMBL78033, BSPBio_001172, ESTRIOL [GREEN BOOK], 3,16-.alpha.,17-.beta.-Trihydroxyoestra-1,3,5(10)-triene, MLS000069812, BIDD:ER0124, SPBio_003056, BPBio1_001290, CHEMBL193482, GTPL2821, Estriol 1.0 mg/ml in Methanol, HY-B0412R, HMS1571K14, HMS2090E20, HMS2098K14, HMS2234A18, HMS3715K14, HMS3884P19, BCP23357, HY-B0412, Tox21_112320, Tox21_301604, BDBM50410506, LMST02010003, s2466, AKOS015894926, Tox21_112320_1, BCP9000661, CCG-221096, DB04573, Estriol 100 microg/mL in Acetonitrile, Estriol, purum, >=97.0% (HPLC), FD12050, SMP1_000122, NCGC00166111-02, NCGC00179277-01, NCGC00255193-01, NCGC00274080-01, AS-13735, Estriol, meets USP testing specifications, SMR000059210, BCP0726000219, AB00514045, CS-0694816, Estriol, VETRANAL(TM), analytical standard, NS00009155, WLN: L E5 B666TTT&J E1 FQ GQ OQ, C05141, D00185, Estra-1,3,5(10)-triene-3,16a,17b-triol, 3,16a,17b-Trihydroxyestra-1,3,5(10)-triene, 3,17.beta.-Trihydroxy-1,3,5(10)-estratriene, 3,17.beta.-Trihydroxyestra-1,3,5(10)-triene, AB00514045-08, AB00514045-09, AB00514045_10, EN300-7390799, (16.alpha.,3,5(10)-triene-3,16,17-triol, Q409721, 3,17.beta.-Trihydroxy-.delta.-1,3,5-estratriene, 3,17.beta.-Trihydroxy-.delta.-1,3,5-oestratriene, Q-201072, SR-01000721851-3, SR-01000721851-4, 1,5(10)-Estratriene-3,16.alpha., 17.beta.-triol, 1,5(10)-Estratriene-3,16.alpha.,17.beta.-triol, 3,16alpah,17beta-Trihydroxyestra-1,3,5(10)-triene, 3,16alpha,17beta-Trihydroxyestra-1,3,5(10)-triene, BRD-K17016787-001-03-5, BRD-K17016787-001-16-7, Estra-1,5(10)-trien-3,16.alpha.,17.beta.-triol, Estra-1,5(10)-triene-3,16.alpha.,17.beta.-triol, 1,5-Estratriene-3.beta.,16-.alpha.,17-.beta.-triol, 1,5-Oestratriene-3-.beta.,16.alpha.,17.beta.-triol, 13b-Methyl-1,3,5(10)-gonatriene-3,16a,17b-triol, Estra-1,5(10)-trien-3,16.alpha., 17.beta.-triol, Estra-1,5(10)-triene-3,16.alpha., 17.beta.-triol, Estriol, European Pharmacopoeia (EP) Reference Standard, Oestra-1,5(10)-triene-3,16.alpha., 17.beta.-triol, Oestra-1,5(10)-triene-3,16.alpha.,17.beta.-triol, 6EC6F23B-A991-4606-8BC7-146D915DAB31, Estriol, United States Pharmacopeia (USP) Reference Standard, (S)-1,2,3,4-Tetrahydro-3-isoquinolinecarboxylic acidt-butyl ester, 13beta-METHYL-1,3,5(10)-GONATRIENE-3,16alpha,17beta-TRIOL, estra-1(10),2,4-triene-3,16,17-triol, (16alpha,17beta)-, Estra-1,5(10)-triene-3,16,17-triol, (16.alpha.,17.beta.)-, (9beta,13alpha,16beta,17beta)-estra-1(10),2,4-triene-3,16,17-triol, 13.BETA.-METHYL-1,3,5(10)-GONATRIENE-3,16.ALPHA.,17.BETA.-TRIOL, Estriol for system suitability, European Pharmacopoeia (EP) Reference Standard, (13S,16R,17R)-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,16,17-triol, (1R,2R,3aS,3bR,9bS,11aS)-11a-methyl-1H,2H,3H,3aH,3bH,4H,5H,9bH,10H,11H,11aH-cyclopenta[a]phenanthrene-1,2,7-triol, (8R,13S,16R,17R)-13-Methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,16,17-triol, (8R,9S,13S,14S,16R,17R)-13-methyl-6,7,8,9,11,12,14,15,16, 17-decahydrocyclopenta[a]phenanthrene-3,16,17-triol C18H24O3 PROQIPRRNZUXQM-ZXXIGWHRSA-N (8R,9S,13S,14S,16R,17R)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,16,17-triol Pipex Pharmaceuticals Estrogens No No No No No Yes ESTRIOLGLC_GLCAASE,ESTRIOLGLC_GLCAASEe,ESTRIOLGLC_GLCAASEepp,ESTRIOLte,ESTRIOLtepp,ESTRIOLtex,EX_estriol(e) PMDBD2001491 Estriol-16-Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001492 Estrone-3-glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001494 Ezetimibe Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001497 fluvstatin-glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001498 des-isopropyl-dihydro-fluvastatin-tetranor drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001499 des-isopropyl-dihydro-fluvastatin-tetranor-glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001500 glycocholate drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001501 glucuronide-conjugate of 3-methoxy-acetaminophen drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_glc3meacp(e),GLC3MEACP_GLCAASE,GLC3MEACP_GLCAASEe,GLC3MEACP_GLCAASEepp,GLC3MEACPabc,GLC3MEACPt,GLC3MEACPt2,GLC3MEACPt2pp,GLC3MEACPtex PMDBD2001503 Galantamine Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001504 Glycine Therapeutic Substance Approved Drug 56-40-6 DB00145 PA449789 D00011 D0M8AB 750 730 n.a. "glycine, 56-40-6, 2-Aminoacetic acid, aminoacetic acid, Glycocoll, Aminoethanoic acid, Glycolixir, H-Gly-OH, Glycosthene, Glicoamin, Aciport, Padil, L-Glycine, Hampshire glycine, Amitone, Leimzucker, Aminoazijnzuur, Acetic acid, amino-, Glycine, non-medical, Sucre de gelatine, Glycinum, GLY (IUPAC abbrev), Gyn-hydralin, Corilin, Glicina, Glycine [INN], Glyzin, FEMA No. 3287, Acido aminoacetico, Glycinum [INN-Latin], Acide aminoacetique, Glicina [INN-Spanish], Acidum aminoaceticum, gly, Glykokoll, Aminoessigsaeure, Hgly, CCRIS 5915, HSDB 495, Acide aminoacetique [INN-French], Acido aminoacetico [INN-Spanish], Acidum aminoaceticum [INN-Latin], 25718-94-9, AI3-04085, NSC 25936, GLYCINE 1.5% IN PLASTIC CONTAINER, H2N-CH2-COOH, amino-Acetic acid, EINECS 200-272-2, UNII-TE7660XO1C, MFCD00008131, NSC-25936, [14C]glycine, TE7660XO1C, DTXSID9020667, CHEBI:15428, Glycine [USP:INN], NSC25936, CHEMBL773, DTXCID90667, Glycine iron sulphate (1:1), GLYCINE-1-13C-15N, EC 200-272-2, aminoacetate, GLYCINE-2-13C-15N, Athenon, 2-aminoacetate, Glycine (USP:INN), NCGC00024503-01, Glycinum (INN-Latin), Glicina (INN-Spanish), GLYCINE (II), GLYCINE [II], GLYCINE (MART.), GLYCINE [MART.], Glycine, free base, GLYCINE (USP-RS), GLYCINE [USP-RS], GLYCINE (EP MONOGRAPH), GLYCINE [EP MONOGRAPH], GLYCINE (USP MONOGRAPH), GLYCINE [USP MONOGRAPH], Acide aminoacetique (INN-French), Acido aminoacetico (INN-Spanish), Acidum aminoaceticum (INN-Latin), CAS-56-40-6, Glycine, labeled with carbon-14, AMINOACETIC ACID 1.5% IN PLASTIC CONTAINER, Aminoessigsaure, Aminoethanoate, 18875-39-3, amino-Acetate, Glycine;, 2-aminoaceticacid, [3H]glycine, Glycine USP grade, Glycine, EP/USP, H-Gly, L-Gly, Gly-CO, Gly-OH, L-Glycine,(S), [14C]-glycine, Corilin (Salt/Mix), Tocris-0219, Glycine (H-Gly-OH), GLYCINE [VANDF], NH2CH2COOH, GLYCINE [FHFI], GLYCINE [HSDB], GLYCINE [INCI], Glycine, >=99%, GLYCINE [FCC], GLYCINE [JAN], GLYCINE [MI], Glycine (JP17/USP), Glycine, 99%, FCC, GLYCINE [WHO-DD], Biomol-NT_000195, bmse000089, bmse000977, WLN: Z1VQ, Gly-253, GLYCINE [GREEN BOOK], GTPL727, AB-131/40217813, GLYCINE [ORANGE BOOK], Treating Gingivitis Toothpaste, Glycine, Electrophoresis Grade, BPBio1_001222, GTPL4084, GTPL4635, Repair Cracked Teeth Toothpaste, BDBM18133, AZD4282, Glycine, >=99.0% (NT), Glycine, 98.5-101.5%, Pharmakon1600-01300021, Glycine 1000 microg/mL in Water, 2-Aminoacetic acid;Aminoacetic acid, BCP25965, CS-B1641, HY-Y0966, Glycine, ACS reagent, >=98.5%, Tox21_113575, Glycine, 99%, natural, FCC, FG, HB0299, NSC760120, s4821, Glycine, purum, >=98.5% (NT), Glycine, tested according to Ph.Eur., AKOS000119626, Glycine, for electrophoresis, >=99%, Tox21_113575_1, AM81781, CAREDO Treating Gingivitis Toothpastes, CCG-266010, DB00145, NSC-760120, Glycine - Absolute carbon isotope ratio, Glycine, BioUltra, >=99.0% (NT), Glycine, BioXtra, >=99% (titration), SERINE IMPURITY B [EP IMPURITY], CAREDO Repair Cracked Teeth Toothpastes, Glycine, SAJ special grade, >=99.0%, NCGC00024503-02, NCGC00024503-03, BP-31024, Glycine, Vetec(TM) reagent grade, 98%, CAREDO Treating Gingivitis Toothpastes100g, G0099, G0317, Glycine, ReagentPlus(R), >=99% (HPLC), NS00001575, CAREDO Repair Cracked Teeth Toothpastes100g, EN300-19731, A20662, C00037, D00011, D70890, M03001, L001246, Q620730, SR-01000597729, Glycine, certified reference material, TraceCERT(R), Q-201300, SR-01000597729-1, Q27115084, B72BA06C-60E9-4A83-A24A-A2D7F465BB65, F2191-0197, Glycine, European Pharmacopoeia (EP) Reference Standard, Z955123660, Glycine, BioUltra, for molecular biology, >=99.0% (NT), InChI=1/C2H5NO2/c3-1-2(4)5/h1,3H2,(H,4,5, Glycine, United States Pharmacopeia (USP) Reference Standard, Glycine, Pharmaceutical Secondary Standard; Certified Reference Material, Glycine, analytical standard, for nitrogen determination according to Kjeldahl method, Glycine, from non-animal source, meets EP, JP, USP testing specifications, suitable for cell culture, >=98.5%, Glycine, meets analytical specification of Ph. Eur., BP, USP, 99-101% (based on anhydrous substance)" C2H5NO2 DHMQDGOQFOQNFH-UHFFFAOYSA-N 2-aminoacetic acid n.a. Dietary supplement No No No No Yes Yes rxnAGORA1299,rxnAGORA1727,rxnAGORA1730,rxnAGORA1731,rxnAGORA2028,rxnAGORA2350,rxnAGORA2821,rxnAGORA2849,rxnAGORA2851,rxnAGORA2868,rxnAGORA3241,rxnAGORA3389,rxnAGORA3908 EX_gly(e) PMDBD2001506 Gemfibrozil 1-O-Beta-Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001507 Gemfibrozil M1 (4-Ring Hydroxylated Metabolite) drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001508 M1 Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001509 Gemfibrozil M2 (Benzyl Alcohol Metabolite) drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001510 M2 Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001511 Gemfibrozil M3 (Benzoic Acid Metabolite) drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001512 M3 Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001513 glucuronide-thiomethyl-acetaminophen conjugate drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001515 Hesperetin 3-O-Glucuronide (Aglycone Of Hesperidin) drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001516 Hesperetin 3-O-Sulfate drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001517 Hesperetin 3'',7-Diglucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001518 Hesperetin 3-O-Glucuronide 7-Sulfate drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001519 Hesperetin 7-O-Glucuronide (Aglycone Of Hesperidin) drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001520 Hesperetin 7-O-Sulfate drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001521 Hesperetin 7-O-Glucuronide 3-Sulfate drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001522 ibuprofen-S Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_ibup_S(e),IBUP_Ste,IBUP_Stepp,IBUP_Stex,IBUPGLUC_GLCAASE,IBUPGLUC_GLCAASEe,IBUPGLUC_GLCAASEepp PMDBD2001523 ibuprofen acyl glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_ibupgluc(e),IBUPGLUC_GLCAASE,IBUPGLUC_GLCAASEe,IBUPGLUC_GLCAASEepp,IBUPGLUCabc,IBUPGLUCt,IBUPGLUCt2,IBUPGLUCt2pp,IBUPGLUCtex PMDBD2001525 Indomethacin Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001527 Indanyl Glucuronide M1 drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001528 Isoniazid Therapeutic Substance n.a. 54-85-3 DB00951 PA450112 D00346 n.a. n.a. 3635 n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_isnzd(e),ISNZDabc,ISNZDabcpp,ISNZDAc,ISNZDAe,ISNZDppp,ISNZDtex PMDBD2001529 Isosorbide 5-Mononitrate drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001530 Isosorbide 5-Mononitrate 2-Beta-D-Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001531 Ketoprofen (2-(3-Benzoylphenyl)Propionic Acid) drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_kprofen(e),KPROFEN_GLC_GLCAASE,KPROFEN_GLC_GLCAASEe,KPROFEN_GLC_GLCAASEepp,KPROFENte,KPROFENtepp,KPROFENtex PMDBD2001532 Ketoprofen Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001534 Losartan-E3174/ losartan-M6 drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_lst4exp(e),LST4EXPte,LST4EXPtepp,LST4EXPtex,LSTNM4_GLCAASE,LSTNM4_GLCAASEe,LSTNM4_GLCAASEepp PMDBD2001536 Losartan-N1-glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001537 Losartan-M4 (glucuronide derivative) drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001538 Losartan-N2-glucuronide / Losartan-M7 drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001540 Midazolam Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001541 Midazolam-glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001543 Misonidazole Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001545 Morphine 3-Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001546 Morphine 6-Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001548 Metronidazole Beta-D-Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001549 N-Hydroxylated Phenacetin drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_N_oh_phtn(e),N_OH_PHTN_GLC_GLCAASE,N_OH_PHTN_GLC_GLCAASEe,N_OH_PHTN_GLC_GLCAASEepp,N_OH_PHTNte,N_OH_PHTNtepp,N_OH_PHTNtex,PHTN_GLC_GLCAASE,PHTN_GLC_GLCAASEe,PHTN_GLC_GLCAASEepp PMDBD2001550 N-Hydroxylated Phenacetin Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001551 Nitrosochloramphenicol Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001553 Nisoldipine (M5) drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_nsldp_m5(e),NSLDP_M5_GLC_GLCAASE,NSLDP_M5_GLC_GLCAASEe,NSLDP_M5_GLC_GLCAASEepp,NSLDP_M5te,NSLDP_M5tepp,NSLDP_M5tex PMDBD2001554 Nisoldipine (M5) Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001555 Norverapamil Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_nverp(e),NVERP_GLC_GLCAASE,NVERP_GLC_GLCAASEe,NVERP_GLC_GLCAASEepp,NVERPte,NVERPtepp,NVERPtex PMDBD2001556 Norverapamil Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001557 Nitrazepam, Benzalin, Neozepam Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_nzp(e),NZP_NR,NZP_NRe,NZP_Nrei,NZP_NReipp,NZP_NRepp,NZPtex,tNZPpp PMDBD2001558 O-Desmethylepigalantamine Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001559 O-Desmethylepigalantamine Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001560 O-Desmethylgalantamine Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001561 O-Desmethylgalantamine Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001562 Etravarine Monohydroxylated (M1, M2, M3) drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_oh_etr(e),OH_ETR_GLC_GLCAASE,OH_ETR_GLC_GLCAASEe,OH_ETR_GLC_GLCAASEepp,OH_ETRte,OH_ETRtepp,OH_ETRtex PMDBD2001563 Etravarine Monohydroxylated Glucuronide (M7) drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001564 P-Hydroxyphenobarbital drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_oh_pbl(e),OH_PBL_GLC_GLCAASE,OH_PBL_GLC_GLCAASEe,OH_PBL_GLC_GLCAASEepp,OH_PBLte,OH_PBLtepp,OH_PBLtex PMDBD2001565 Phenobarbital O-Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001567 p-Cresol Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes 4HPHACDC,EX_pcresol(e),PCRESOLt2r PMDBD2001568 3-(3-Hydroxyphenyl)Propionate drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_phppa(e),PHPPA_GLC_GLCAASE,PHPPA_GLC_GLCAASEe,PHPPA_GLC_GLCAASEepp,PHPPAte PMDBD2001569 3-(3-Hydroxyphenyl)Propionate Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001570 Phenacetin Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_phtn_glc(e),PHTN_GLC_GLCAASE,PHTN_GLC_GLCAASEe,PHTN_GLC_GLCAASEepp,PHTN_GLCabc,PHTN_GLCt,PHTN_GLCt2,PHTN_GLCt2pp,PHTN_GLCtex PMDBD2001572 Probenecid Acyl Beta-D-Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001574 Prontosil Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001576 Propranolol Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001577 Paroxetine Mi drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_prx_mI(e),PRX_MI_GLC_GLCAASE,PRX_MI_GLC_GLCAASEe,PRX_MI_GLC_GLCAASEepp,PRX_MIte,PRX_MItepp,PRX_MItex PMDBD2001578 Paroxetine Mi Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001579 Paroxetine Mii drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_prx_mII(e),PRX_MII_GLC_GLCAASE,PRX_MII_GLC_GLCAASEe,PRX_MII_GLC_GLCAASEepp,PRX_MIIte,PRX_MIItepp,PRX_MIItex PMDBD2001580 Paroxetine Mii Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001581 pitavastatin Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001582 pitavastatin-glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001584 pravastatin glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001585 R-6-Hydroxywarfarin drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_R_6oh_warf(e),R_6OH_WARF_GLC_GLCAASE,R_6OH_WARF_GLC_GLCAASEe,R_6OH_WARF_GLC_GLCAASEepp,R_6OH_WARFte,R_6OH_WARFtepp,R_6OH_WARFtex PMDBD2001586 R-6-Hydroxywarfarin Glucuronate drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001587 R-7-Hydroxywarfarin drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_R_7oh_warf(e),R_7OH_WARF_GLC_GLCAASE,R_7OH_WARF_GLC_GLCAASEe,R_7OH_WARF_GLC_GLCAASEepp,R_7OH_WARFte,R_7OH_WARFtepp,R_7OH_WARFtex PMDBD2001588 R-7-Hydroxy Warfarin Glucuronate drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001589 R-8-Hydroxywarfarin drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_R_8oh_warf(e),R_8OH_WARF_GLC_GLCAASE,R_8OH_WARF_GLC_GLCAASEe,R_8OH_WARF_GLC_GLCAASEepp,R_8OH_WARFte,R_8OH_WARFtepp,R_8OH_WARFtex PMDBD2001590 R-8-Hydroxywarfarin Glucuronate drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001591 R406 Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. 11984591 n.a. n.a. "R406, 841290-81-1, R406 Benzenesulfonate, Tamatinib besylate, R406 besylate, R-406 besylate, 6-((5-fluoro-2-((3,4,5-trimethoxyphenyl)amino)pyrimidin-4-yl)amino)-2,2-dimethyl-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one benzenesulfonate, 6-[[5-fluoro-2-[(3,4,5-trimethoxyphenyl)amino]-4-pyrimidinyl]amino]-2,2-dimethyl-2H-pyrido[3,2-b]-1,4-oxazin-3(4H)-one benzenesulfonate, 841290-81-1 (besylate), 6-(5-fluoro-2-(3,4,5-trimethoxyphenylamino)pyrimidin-4-ylamino)-2,2-dimethyl-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one benzenesulfonate, benzenesulfonic acid;6-[[5-fluoro-2-(3,4,5-trimethoxyanilino)pyrimidin-4-yl]amino]-2,2-dimethyl-4H-pyrido[3,2-b][1,4]oxazin-3-one, N4-(2,2-dimethyl-3-oxo-4H-pyrid(1,4)oxazin-6-yl)-5-fluoro-N2-(3,4,5-trimethoxyphenyl)-2,4-pyrimidinediamine, R 406 cpd, N4-(2,2-dimethyl-3-oxo-4H-pyrid[1,4]oxazin-6-yl)-5-fluoro-N2-(3,4,5-trimethoxyphenyl)-2,4-pyrimidinediamine, CS-0229, TAMATINIB (SALT), SCHEMBL1222514, DTXSID80475212, HMS3651M14, BCP14809, EX-A103-1, MFCD18385012, s2194, AKOS027338664, AM81252, CCG-270282, NSC-742317, AC-32803, AS-55802, HY-12067, R406?, SW219254-2, 2H-Pyrido[3,2-b]-1,4-oxazin-3(4H)-one, 6-[[5-fluoro-2-[(3,4,5-trimethoxyphenyl)amino]-4-pyrimidinyl]amino]-2,2-dimethyl-, benzenesulfonate (1:1), 6-({5-fluoro-2-[(3,4,5-trimethoxyphenyl)amino]pyrimidin-4-yl}amino)-2,2-dimethyl-2H,3H,4H-pyrido[3,2-b][1,4]oxazin-3-one; benzenesulfonic acid" C28H29FN6O8S UXDRJPYSTZHIOE-UHFFFAOYSA-N "benzenesulfonic acid;6-[[5-fluoro-2-(3,4,5-trimethoxyanilino)pyrimidin-4-yl]amino]-2,2-dimethyl-4H-pyrido[3,2-b][1,4]oxazin-3-one" n.a. n.a. No No No No No Yes ALKP_R788,ALKP_R788e,ALKP_R788epp,EX_r406(e),R406_GLC_GLCAASE,R406_GLC_GLCAASEe,R406_GLC_GLCAASEepp,R406te,R406tepp,R406tex PMDBD2001592 Lactam N-Glucuronide Of R406 drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001593 R529 Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. 146675097 n.a. n.a. JR1IDX058G, UNII-JR1IDX058G, R529, 1294007-59-2, R 529, R-529, 2H-Pyrido(3,2-b)-1,4-oxazin-3(4H)-one, 6-((5-fluoro-2-((4-hydroxy-3,5-dimethoxyphenyl)amino)-4-pyrimidinyl)amino)-2,2-dimethyl-, 6-((5-Fluoro-2-((4-hydroxy-3,5-dimethoxyphenyl)amino)-4-pyrimidinyl)amino)-2,2-dimethyl-2H-pyrido(3,2-b)-1,4-oxazin-3(4H)-one, 6-((5-fluoro-2-((4-hydroxy-3,5-dimethoxyphenyl)amino)pyrimidin-4-yl)amino)-2,2-dimethyl-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one, C21H21FN6O5, F96265 C21H21FN6O5 RMDPXHNYYYEJFP-UHFFFAOYSA-N 6-[[5-fluoro-2-(4-hydroxy-3,5-dimethoxyanilino)pyrimidin-4-yl]amino]-2,2-dimethyl-4H-pyrido[3,2-b][1,4]oxazin-3-one n.a. n.a. No No No No No Yes EX_r529(e),R529_GLC_GLCAASE,R529_GLC_GLCAASEe,R529_GLC_GLCAASEepp,R529te,R529tepp,R529tex PMDBD2001594 Glucuronide R529 drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001595 R788 (Fostamatinib) Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. D0V8HJ 11671467 n.a. n.a. "Fostamatinib, 901119-35-5, R788, Fostamatinib (R788), Tavlesse, R788 compound, Tavalisse, R-935788 Free acid, Fostamatinib(R788), R-788 Free acid, R935788 FREE ACID, R788 FREE ACID, R 788, R-788, [6-[[5-fluoro-2-(3,4,5-trimethoxyanilino)pyrimidin-4-yl]amino]-2,2-dimethyl-3-oxopyrido[3,2-b][1,4]oxazin-4-yl]methyl dihydrogen phosphate, UNII-SQ8A3S5101, R 788 compound, Fostamatinib [USAN], SQ8A3S5101, R7935788, Fostamatinib (USAN), 2H-Pyrido(3,2-b)-1,4-oxazin-3(4H)-one, 6-((5-fluoro-2-((3,4,5-trimethoxyphenyl)amino)-4-pyrimidinyl)amino)-2,2-dimethyl-4-((phosphonooxy)methyl)-, (6-((5-FLUORO-2-((3,4,5-TRIMETHOXYPHENYL)AMINO)PYRIMIDIN-4-YL)AMINO)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-PYRIDO(3,2-B)(1,4)OXAZIN-4-YL)METHYL DIHYDROGEN PHOSPHATE, [6-({5-Fluoro-2-[(3,4,5-Trimethoxyphenyl)amino]pyrimidin-4-Yl}amino)-2,2-Dimethyl-3-Oxo-2,3-Dihydro-4h-Pyrido[3,2-B][1,4]oxazin-4-Yl]methyl Dihydrogen Phosphate, Fostamatinib [USAN:INN], fostamatinibum, R-935788, 2H-Pyrido[3,2-b]-1,4-oxazin-3(4H)-one, 6-[[5-fluoro-2-[(3,4,5-trimethoxyphenyl)amino]-4-pyrimidinyl]amino]-2,2-dimethyl-4-[(phosphonooxy)methyl]-, R788 (Fostamatinib), FOSTAMATINIB [MI], FOSTAMATINIB [INN], FOSTAMATINIB [WHO-DD], GTPL7796, SCHEMBL1201371, CHEMBL2103830, EX-A108, GKDRMWXFWHEQQT-UHFFFAOYSA-N, BCPP000226, DTXSID401009170, HMS3651H09, BCP01871, BDBM50431381, HY-13038A, MFCD16628163, NSC800102, s2625, AKOS025404920, AM81257, BCP9000704, CCG-270128, DB12010, NSC-800102, PB25570, NCGC00346622-01, NCGC00346622-02, [6-[[5-fluoro-2-(3,4,5-trimethoxyanilino)pyrimidin-4-yl]amino]-2,2-dimethyl-3-oxo-pyrido[3,2-b][1,4]oxazin-4-yl]methyl dihydrogen phosphate, AC-30126, AS-56399, NS00072506, SW219234-1, D09347, A857764, EN300-20332957, J-517972, Q5473550, Z2235801948, R788;R7935788;R 788;R 7935788;R-788;R-7935788, (6-((5-Fluoro-2-((3,4,5-trimethoxyphenyl)amino)pyrimidin-4-yl)amino)-2,2-dimethyl-3-oxo-2H-pyrido[3,2-b][1,4]oxazin-4(3H)-yl)methyl dihydrogen phosphate, (6-(5-fluoro-2-(3,4,5-trimethoxyphenylamino)pyrimidin-4-ylamino)-2,2-dimethyl-3-oxo-2,3-dihydropyrido[3,2-b][1,4]oxazin-4-yl)methyl dihydrogen phosphate, [6-[[5-fluoro-2-[(3,4,5-trimethoxyphenyl)amino]pyrimidin-4-yl]amino]-2,2-dimethyl-3-oxopyrido[2,3-e][1,4]oxazin-4-yl]methyl dihydrogen phosphate, {[6-({5-fluoro-2-[(3,4,5-trimethoxyphenyl)amino]pyrimidin-4-yl}amino)-2,2-dimethyl-3-oxo-2H,3H,4H-pyrido[3,2-b][1,4]oxazin-4-yl]methoxy}phosphonic acid, 2RC, 6-((5-Fluoro-2-((3,4,5-trimethoxyphenyl)amino)-4-pyrimidinyl)amino)-2,2-dimethyl-4-((phosphonooxy)methyl)-2h-pyrido(3,2-b)-1,4-oxazi n-3(4h)-one, 6-[[5-fluoro-2-[(3,4,5-trimethoxyphenyl)amino]-4-pyrimidinyl]amino]-2,2-dimethyl-4-[(phosphonooxy)methyl]-2H-pyrido[3,2-b]-1,4-oxazin-3(4H)-one, R 788; 6-[[5-Fluoro-2-[(3,4,5-trimethoxyphenyl)amino]-4-pyrimidinyl]amino]-2,2-dimethyl-4-[(phosphonooxy)methyl]-2H-pyrido[3,2-b]-1,4-oxazin-3(4H)-one" C23H26FN6O9P GKDRMWXFWHEQQT-UHFFFAOYSA-N [6-[[5-fluoro-2-(3,4,5-trimethoxyanilino)pyrimidin-4-yl]amino]-2,2-dimethyl-3-oxopyrido[3,2-b][1,4]oxazin-4-yl]methyl dihydrogen phosphate Rigel Pharmaceuticals n.a. No No No No No Yes ALKP_R788,ALKP_R788e,ALKP_R788epp,EX_r788(e),R788t2,R788t2pp,R788tex PMDBD2001596 Regorafenib Therapeutic Substance n.a. 755037-03-7 DB08896 n.a. D10138 n.a. n.a. 9342697 n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_regfnb(e),REGFNB_GLC_GLCAASE,REGFNB_GLC_GLCAASEe,REGFNB_GLC_GLCAASEepp,REGFNBte,REGFNBtepp,REGFNBtex PMDBD2001597 regorafenib-N-beta-glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001599 Repaglinide Acyl-Beta-D-Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001600 SKF 104557 (N-Despropyl Ropinirole) drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_rpn_104557(e),RPN_104557_CB_GLC_GLCAASE,RPN_104557_CB_GLC_GLCAASEe,RPN_104557_CB_GLC_GLCAASEepp,RPN_104557te,RPN_104557tepp,RPN_104557tex PMDBD2001601 SKF 104557 Carbamyl Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001602 SKF 96990 drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_rpn_96990(e),RPN_96990_GLC_GLCAASE,RPN_96990_GLC_GLCAASEe,RPN_96990_GLC_GLCAASEepp,RPN_96990te,RPN_96990tepp,RPN_96990tex PMDBD2001603 SKF 96990 Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001604 Hydroxy Ropinirole drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_rpn_oh(e),RPN_OH_GLC_GLCAASE,RPN_OH_GLC_GLCAASEe,RPN_OH_GLC_GLCAASEepp,RPN_OHte,RPN_OHtepp,RPN_OHtex PMDBD2001605 SKF 89124 Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001607 rosuvastatin-glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001608 S-4-Hydroxywarfarin drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_S_4oh_warf(e),S_4OH_WARF_GLC_GLCAASE,S_4OH_WARF_GLC_GLCAASEe,S_4OH_WARF_GLC_GLCAASEepp,S_4OH_WARFte,S_4OH_WARFtepp,S_4OH_WARFtex PMDBD2001609 S-4-Hydroxywarfarin Glucuronate drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001610 S-6-Hydroxywarfarin drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_S_6oh_warf(e),S_6OH_WARF_GLC_GLCAASE,S_6OH_WARF_GLC_GLCAASEe,S_6OH_WARF_GLC_GLCAASEepp,S_6OH_WARFte,S_6OH_WARFtepp,S_6OH_WARFtex PMDBD2001611 S-6-Hydroxywarfarin Glucuronate drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001613 Sb-611855 (Intermediate Of M3) drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes ELTR_M3_GLCAASE,ELTR_M3_GLCAASEe,ELTR_M3_GLCAASEepp,EX_sb_611855(e),SB_611855te,SB_611855tepp,SB_611855tex PMDBD2001614 Sb_Y (Intermediate Of M4) drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes ELTR_M4_GLCAASE,ELTR_M4_GLCAASEe,ELTR_M4_GLCAASEepp,EX_sb_y(e),SB_Yte,SB_Ytepp,SB_Ytex PMDBD2001615 SCH 488128 drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_sch_488128(e),SCH_488128_GLCAASE,SCH_488128_GLCAASEe,SCH_488128_GLCAASEepp,SCH_488128abc,SCH_488128t,SCH_488128t2,SCH_488128t2pp,SCH_488128tex PMDBD2001616 SCH 57871 drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_sch_57871(e),SCH_57871_GLC_GLCAASE,SCH_57871_GLC_GLCAASEe,SCH_57871_GLC_GLCAASEepp,SCH_57871te,SCH_57871tepp,SCH_57871tex PMDBD2001617 SCH 57871 Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001618 Nw 1689 (N-Dealkylated Safinamide) drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_sfnd_1689(e),SFND_1689_GLC_GLCAASE,SFND_1689_GLC_GLCAASEe,SFND_1689_GLC_GLCAASEepp,SFND_1689te,SFND_1689tepp,SFND_1689tex PMDBD2001619 Nw 1689 Acyl Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001621 Sulfathiazole Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001622 simvastatin-acyl-glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001623 2-Sulfamoylacetylphenol drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. 91885558 n.a. n.a. DT-061, 1809427-19-7, SMAP, N-[(1R,2R,3S)-2-hydroxy-3-(10H-phenoxazin-10-yl)cyclohexyl]-4-(trifluoromethoxy)benzene-1-sulfonamide, N-[(1R,2R,3S)-2-hydroxy-3-phenoxazin-10-ylcyclohexyl]-4-(trifluoromethoxy)benzenesulfonamide, 1809427-18-6, DT-061(SMAP), CHEMBL4450419, SCHEMBL18382592, WGKGADVPRVLHHZ-ZHRMCQFGSA-N, EX-A5068, s8774, AKOS040732252, AT33975, MS-29649, HY-112929, CS-0069645, L2J C25H23F3N2O5S WGKGADVPRVLHHZ-ZHRMCQFGSA-N N-[(1R,2R,3S)-2-hydroxy-3-phenoxazin-10-ylcyclohexyl]-4-(trifluoromethoxy)benzenesulfonamide n.a. n.a. No No No No No Yes EX_smap(e),SMAP_GLC_GLCAASE,SMAP_GLC_GLCAASEe,SMAP_GLC_GLCAASEepp,SMAPte,SMAPtepp,SMAPtex PMDBD2001624 2-Sulfamoylacetylphenol Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001625 simvastatin dihydroxy acid form drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001626 SN-38 (active metabolite of irinotecan) Therapeutic Substance Phase 2 n.a. n.a. n.a. n.a. D0B6YB 104842 n.a. NPC276661 "7-Ethyl-10-hydroxycamptothecin, 86639-52-3, SN-38, SN 38, SN 38 lactone, 7-Ethyl-10-hydroxy-camptothecin, (S)-4,11-Diethyl-4,9-dihydroxy-1H-pyrano[3'',4'':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, SN38, 10-Hydroxy-7-ethylcamptothecin, 7-Ethyl-10-hydroxy-20(S)-camptothecin, NK012, NK 012, NK-012, CHEBI:8988, 113015-38-6, IT-141, NSC673596, 0H43101T0J, (19S)-10,19-diethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione, (4S)-4,11-diethyl-4,9-dihydroxy-1H-pyrano[3'',4'':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, CAMPTOTHECIN, 7-ETHYL-10-HYDROXY-, (4S)-4,11-Diethyl-4,9-dihydroxy-1H-pyrano(3'',4'':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione, 7-ethyl-10-hydroxy-20(s)-campthothecin, LE-SN38, Captothecin, 7-ethyl-10-hydroxy-, MFCD00871873, UNII-0H43101T0J, C22H20N2O5, 110714-48-2, 1H-PYRANO(3'',4'':6,7)INDOLIZINO(1,2-B)QUINOLINE-3,14(4H,12H)-DIONE, 4,11-DIETHYL-4,9-DIHYDROXY-, (4S)-, 1H-Pyrano[3'',4'':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4,11-diethyl-4,9-dihydroxy-, (4S)-, AvaChem1025, (+)-7-ETHYL-10-HYDROXYCAMPTOTHECIN, diethyl(dihydroxy)[?]dione, SN 38- Bio-X, SCHEMBL34018, (4S)-4,11-Diethyl-4,9-dihydroxy-1H-pyrano[3'',4'':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)dione, GTPL6925, SN 38 [WHO-DD], DTXSID4040399, 10-hydroxy-7-ethyl camptothecin, 10-hydroxy-7-ethyl-camptothecin, EX-A989, HMS3413B12, HMS3652P12, HMS3677B12, BCP01386, 7-Ethyl-10-hydroxy-20(S)-CPT, BDBM50418088, s4908, AKOS015920433, AC-1357, BCP9000200, CCG-264764, CS-1579, DB05482, NSC-673596, SN-38(NK-012)?, NCGC00167831-01, NCGC00167831-05, AS-13533, BE164132, BP-24513, HY-13704, NCI60_026056, 7-Ethyl-10-hydroxy-20-(S)-camptothecine, E0748, NS00069821, SW219948-1, S-(+)-7-ETHYL-10-HYDROXYCAMPOTHECIN, EN300-122379, A857464, Q-100871, Q1750127, 7-Ethyl-10-hydroxycamptothecin, >=98% (HPLC), powder, Z1541759909, (19S)-10,19-diethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.0^{2,11}.0^{4,9}.0^{15,20}]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaene-14,18-dione, (19S)-10,19-diethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaene-14,18-dione, (4S)-4,11-Diethyl-4,9-dihydroxy-1H-pyrano[3'',4'':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)dione, AldrichCPR, (4S)-4,9-Dihydroxy-4,11-diethyl-1H-pyrano[3'',4'':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione;SN-38, (S)-4,11-Diethyl-4,9-di-OH-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione, 1H-Pyrano[3'',7]indolizino[1,2-b]quinoline- 3,14(4H,12H)-dione, 4,11-diethyl-4,9-dihydroxy-, (4S)-, 7-Ethyl-10-hydroxycamptothecin ((S)-4,11-Diethyl-4,9-dihydroxy-1H-pyrano[3'',4'':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione), H-Pyrano(3'',4'':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione, 4,11-diethyl-4,9-dihydroxy-, (S)-, RS4" C22H20N2O5 FJHBVJOVLFPMQE-QFIPXVFZSA-N (19S)-10,19-diethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione NeoPharm n.a. No No No No No No PMDBD2001627 SN38 glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001629 Sulfinpyrazone Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001630 Sulfinpyrazone Sulfone drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001631 Sulfinpyrazone Sulfone Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001635 Sitagliptin M3 (Ether Glucuronide Conjugate Of A Hydroxylated Derivative) drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001636 Sitagliptin M4 (N-Carbomyl Glucuronide Conjugate) drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001638 1,2,4-Triaminobenzene drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. 449049 n.a. n.a. TAB C23H28ClN7O2 PEOVMXAZBBJGIH-UHFFFAOYSA-N 2-[benzyl-[2-[2-chloro-5-(2,4-diamino-6-ethylpyrimidin-5-yl)phenyl]hydrazinyl]amino]ethyl acetate n.a. n.a. No No No No No Yes EX_tab(e),PRONT_AR_NADi,PRONT_AR_NADPi,TABt2r,TABt2rpp,TABtex PMDBD2001639 N-(2-Methyl-3-Chlorophenyl)-Anthranilic Acid drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_tat(e),TAT_GLCAASE,TAT_GLCAASEe,TAT_GLCAASEepp,TATabc,TATt,TATt2,TATt2pp,TATtex PMDBD2001641 taurocholate drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_tchola(e),TCHOLBHSe,TCHOLBHSepp PMDBD2001642 Taurochenodeoxycholate drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_tdchola(e),TCDCHOLBHSe,TCDCHOLBHSepp PMDBD2001643 Taurodeoxycholic acid drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. 121225588 n.a. n.a. (2~{s},3~{r},4~{s},5~{r},6~{r})-2-[(2~{s},3~{r},4~{s},5~{r},6~{r})-4-[4-(3-Fluorophenyl)-1,2,3-Triazol-1-Yl]-6-(Hydroxymethyl)-3,5-Bis(Oxidanyl)oxan-2-Yl]sulfanyl-6-(Hydroxymethyl)oxane-3,4,5-Triol, TGZ, Q27466284 C20H26FN3O9S PZQVUALSHLQTOK-UYIOFKAJSA-N (2S,3R,4S,5R,6R)-2-[(2S,3R,4S,5R,6R)-4-[4-(3-fluorophenyl)triazol-1-yl]-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl-6-(hydroxymethyl)oxane-3,4,5-triol n.a. n.a. No No No No No No PMDBD2001645 Troglitazone Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001646 thiomethyl-sulphoxide-conjugate-acetaminophen drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001647 Tolfenamic Acid 1A drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001648 Tolfenamic Acid 1B drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001649 Tolfenamic Acid 1X drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001650 Tolfenamic Acid 2 drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001651 Tolfenamic Acid 2A drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001652 Tolfenamic Acid 3 drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001653 Tolfenamic Acid 4 drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001654 N-(2-Hydroxymethyl-3-Chlorophenyl)-Anthranilic Acid drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001655 N-(2-Hydroxymethyl-3-Chloro-4-Hydroxyphenyl)-Anthranilic Acid drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001656 N-(2-Formyl-3-Chlorophenyl) Anthranilic Acid drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001657 N-(2-Methyl-3- Chloro-4-Hydroxyphenyl)-Anthranilic Acid drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001658 Tolfenamic Acid M4A drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001659 N-(2-Methyl-3-Chloro-5-Hydroxyphenyl)-Anthranilic Acid drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001660 Tolfenamic Acid M5A drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001661 Tolfenamic Acid M5B drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001662 N-(2-Carboxy-3-Chlorophenyl)-Anthranilic Acid drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001663 N-(2-Methyl-3-Chloro-4-Metoxyphenyl)-Anthranilic Acid drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001665 Telmisartan Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001666 thiomethyl-conjugate-acetaminophen drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001667 Tolcapone? drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_tolcp(e),TOLCP_GLC_GLCAASE,TOLCP_GLC_GLCAASEe,TOLCP_GLC_GLCAASEepp,TOLCPte,TOLCPtepp,TOLCPtex PMDBD2001668 Tolcapone N-Acetyl Amino Metabolite drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001669 Tolcapone N-Acetyl Amino Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001670 Tolcapone Amine Derivative drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001671 Tolcapone Amine Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001672 Tolcapone 3-Beta-D-Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001673 Tempol 1-O-Glucuronide And 4-O-Glucoside drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_tpno_1glc_4g(e),TPNO_1GLC_4G_GLCAASE,TPNO_1GLC_4G_GLCAASEe,TPNO_1GLC_4G_GLCAASEepp,TPNO_1GLC_4Gabc,TPNO_1GLC_4Gt,TPNO_1GLC_4Gt2,TPNO_1GLC_4Gt2pp,TPNO_1GLC_4Gtex PMDBD2001674 Tempol 4-O-Glucoside drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_tpno_4g(e),TPNO_1GLC_4G_GLCAASE,TPNO_1GLC_4G_GLCAASEe,TPNO_1GLC_4G_GLCAASEepp,TPNO_4Gte,TPNO_4Gtepp,TPNO_4Gtex PMDBD2001675 Tempol 4-O-Glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001676 Tempol Hydroxylamine drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_tpnoh(e),TPNO_4GLC_GLCAASE,TPNO_4GLC_GLCAASEe,TPNO_4GLC_GLCAASEepp,TPNOHte PMDBD2001677 thiomethyl-sulphoxide-acetaminophen-glucuronide drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_tsacmgluc(e),TSACMGLUC_GLCAASE,TSACMGLUC_GLCAASEe,TSACMGLUC_GLCAASEepp,TSACMGLUCabc,TSACMGLUCt,TSACMGLUCt2,TSACMGLUCt2pp,TSACMGLUCtex PMDBD2001678 tym drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. 446202 n.a. n.a. TRYPTOPHANYL-5''AMP, TYM, starbld0044786, AKOS040754272, DB01831, NS00071297, Q27092965, 5''-O-[(R)-{[(2S)-2-amino-3-(1H-indol-3-yl)propanoyl]oxy}(hydroxy)phosphoryl]adenosine C21H24N7O8P IFQVDHDRFCKAAW-SQIXAUHQSA-N [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] (2S)-2-amino-3-(1H-indol-3-yl)propanoate n.a. n.a. No No No No No Yes TYMt2r,TYRCBOX PMDBD2001679 tyr_L drug metabolite n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes TYRCBOX,TYRt2r PMDBD2001680 laurate Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 4149208 n.a. NPC201182 Dodecanoate, laurate, n-Dodecanoate, dodecylate, laurostearate, vulvate, 1-undecanecarboxylate, dodecoate, duodecyclate, duodecylate, Dodecanoate anion, dodecanoate, 3, 2qhd, 3ueu, undecane-1-carboxylate, tin II 2-ethylhexanoate, BDBM23434, CHEBI:18262, POULHZVOKOAJMA-UHFFFAOYSA-M, DTXSID901316267, CH3-[CH2]10-COO(-), AKOS022105929, 115-05-9, Q27102954 C12H23O2- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate n.a. n.a. No No No No Yes No rxnAGORA76,rxnAGORA3396,rxnAGORA3402 PMDBD2001681 L-aspartate(1-) Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 5460294 n.a. n.a. (2S)-2-ammoniobutanedioate, aspartate, L-aspartate(1-), (2S)-2-azaniumylbutanedioate, 2nwl, hydrogen L-aspartate, L-aspartic acid monoanion, (2S)-2-ammoniosuccinate, CHEBI:29991, 2v25, A831202 C4H6NO4- CKLJMWTZIZZHCS-REOHCLBHSA-M (2S)-2-azaniumylbutanedioate n.a. n.a. No No No No Yes No rxnAGORA121,rxnAGORA262,rxnAGORA263,rxnAGORA267,rxnAGORA268,rxnAGORA269,rxnAGORA270,rxnAGORA271,rxnAGORA272,rxnAGORA273,rxnAGORA274,rxnAGORA275,rxnAGORA1258,rxnAGORA2031,rxnAGORA2574,rxnAGORA2576,rxnAGORA2577,rxnAGORA2578,rxnAGORA2939,rxnAGORA3537,rxnAGORA3538,rxnAGORA3792,rxnAGORA3852,rxn00344 PMDBD2001682 L-alanine Dietary Substance, Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. D09PUL 5950 n.a. n.a. "L-alanine, alanine, 56-41-7, (S)-Alanine, L-alpha-alanine, (S)-2-Aminopropanoic acid, H-Ala-OH, L-2-Aminopropionic acid, (2S)-2-Aminopropanoic acid, 2-Aminopropionic acid, L-(+)-Alanine, L-2-Aminopropanoic acid, alpha-Alanine, (L)-Alanine, L-alpha-Aminopropionic acid, alpha-Aminopropionic acid, L-2-Aminopropionsaeure, L-S-Aminopropionic acid, (S)-2-Aminopropionsaeure, 2-Aminopropanoic acid, L-, Alaninum [Latin], (S)-(+)-Alanine, (S)-alpha-Aminopropionsaeure, Alaninum, Alanine (VAN), ALANINE, L-, L-Alanin, Alanine [USAN:INN], Alanina [DCIT,Spanish], (S)-2-Aminopropionic acid, Propanoic acid, 2-amino-, (S)-, L-a-Aminopropionic acid, HSDB 1801, alanina, NSC 206315, 25191-17-7, UNII-OF5P57N2ZX, EINECS 200-273-8, OF5P57N2ZX, L-Ala, CHEBI:16977, MFCD00064410, l alanine, CHEMBL279597, L-Isomer alanine, DTXSID20873899, EC 200-273-8, Alaninum (Latin), Alanine, L isomer, Alanine, L-isomer, ALANINE (II), ALANINE [II], a-Alanine, L-a-Alanine, 6898-94-8, ALANINE (EP MONOGRAPH), ALANINE [EP MONOGRAPH], 14C-L-Alanine, a-Aminopropionic acid, ALANINE (USP MONOGRAPH), ALANINE [USP MONOGRAPH], (C14)L-Alanine, .alpha.-Alanine, L-.alpha.-Alanine, NSC-206315, L-&alpha-alanine, SERINE IMPURITY A (EP IMPURITY), SERINE IMPURITY A [EP IMPURITY], VALINE IMPURITY A (EP IMPURITY), VALINE IMPURITY A [EP IMPURITY], 115967-49-2, Alanine (USP), L-Alanine (9CI), 2-Ammoniopropanoate, Propanoic acid, 2-amino-, .alpha.-Aminopropionic acid, LYSINE ACETATE IMPURITY C (EP IMPURITY), LYSINE ACETATE IMPURITY C [EP IMPURITY], L-Alanine, labeled with carbon-14, L-.alpha.-Aminopropionic acid, Ritalanine, Racemic alanine, a-Aminopropionate, L-Alanine, labeled with tritium, 3h-l-alanine, L-Alanine Powder, Propanoic acid, 2-amino-, (S), [3H]alanine, L-a-Aminopropionate, [14C]alanine, [3H]-alanine, alpha-Aminopropanoate, alpha-Aminopropionate, L-2-Aminopropanoate, L-2-Aminopropionate, L-Alanine,(S), [14C]-alanine, Alanine (L-Alanine), L-alpha-Aminopropionate, Tocris-0205, 2-Ammoniopropanoic acid, ALA-OH, starbld0003382, L-Alanine (JP17), (S)-2-Aminopropanoate, ALANINE [VANDF], ALANINE [HSDB], ALANINE [INCI], ALANINE [USAN], ALANINE [INN], alpha-Aminopropanoic acid, ALANINE [MI], L-Ala-2, L-ALANINE [FCC], L-ALANINE [JAN], (S)-2-amino-Propanoate, ALANINE [WHO-DD], L-Alanine, >=99%, bmse000028, bmse000994, L-CH3CH(NH2)COOH, L-ALANINE [USP-RS], GTPL720, (S)-2-amino-Propanoic acid, 26336-61-8, (2S)-2-azanylpropanoic acid, Alanine, L- (7CI,8CI), GTPL4542, GTPL4543, L-Alanine, >=98% (TLC), L-Alanine, 99%, natural, FG, DTXCID001012092, F4F207FF-8FF8-4789-99A1-147AE0A36673, HY-N0229, STR01663, L-Alanine, >=99.0% (NT), AC-014, BDBM50000099, s5631, (S)-2-aminopropanoic acid;H-Ala-OH, AKOS010367904, AKOS015840030, CCG-266017, CS-W020002, DB00160, L-Alanine, purum, >=98.0% (NT), NCGC00024494-01, 130380-93-7, AC-24031, BP-13281, L-Alanine, BioUltra, >=99.5% (NT), L-Alanine, SAJ special grade, >=99.0%, A0179, AM20100374, NS00100192, EN300-52621, A15652, C00041, D00012, D84362, L-Alanine, Cell Culture Reagent (H-L-Ala-OH), A803529, Q218642, SR-01000597687, J-015860, Q-201274, SR-01000597687-3, L-Alanine, certified reference material, TraceCERT(R), Alanine, European Pharmacopoeia (EP) Reference Standard, F0001-2354, Z756424912, L-Alanine, United States Pharmacopeia (USP) Reference Standard, L-Alanine, Pharmaceutical Secondary Standard; Certified Reference Material, Non-animal origin pound notEP, JP, USP pound>>for cell culture pound not98.5 to 101.0%, 77160-91-9, L-Alanine, from non-animal source, meets EP, USP testing specifications, suitable for cell culture, >=98.5%" C3H7NO2 QNAYBMKLOCPYGJ-REOHCLBHSA-N (2S)-2-aminopropanoic acid n.a. Dietary supplement No No No No Yes No rxnAGORA236,rxnAGORA239,rxnAGORA1244,rxnAGORA2354,rxnAGORA2386,rxnAGORA2561,rxnAGORA2562,rxnAGORA3180,rxnAGORA3317,rxnAGORA3390,rxnAGORA3771,rxnAGORA3908,rxnAGORA3919,rxnAGORA4518 PMDBD2001683 Maltose Dietary Substance, Therapeutic Substance Phase 1/2 69-79-4 DB03323 n.a. D00044 D04RYY 6255 388329 NPC246558 maltose, beta-maltose, 69-79-4, 133-99-3, D-Maltose, Maltobiose, D-(+)-Maltose, 4-O-alpha-D-glucopyranosyl-beta-D-glucopyranose, BETA-D-GLUCOPYRANOSYL(1-4)-D-GLUCOPYRANOSE, Cextromaltose, Finetose, Maltodiose, Sunmalt, Malt sugar, INSULIN, (ARG-INSULIN), Finetose F, Sunmalt S, 120022-04-0, R4B6462NGR, Maltose, pure, CHEBI:18147, beta-D-Cellobiose, beta-D-glucopyranose, 4-O-alpha-D-glucopyranosyl-, 4-O-alpha-D-Glucopyranosyl-D-glucose, NSC-760396, (2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[(2R,3S,4R,5R,6R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxane-3,4,5-triol, 4-(alpha-D-Glucosido)-D-glucose, 4-(alpha-D-Glucopyranosido)-alpha-glucopyranose, beta-D-Maltose, cellobiose, D-Glucose, 4-O-alpha-D-glucopyranosyl-, B-D-GLUCOPYRANOSE, 4-O-A-D-GLUCOPYRANOSYL-, alpha-D-glucopyranosyl-(1->4)-beta-D-glucopyranose, AI3-09089, Maltose anhydrous, Maltose HH, Maltose HHH, Advantose 100, Maltose, beta-, (2R,3R,4R,5R)-2,3,5,6-Tetrahydroxy-4-(((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)hexanal, Maltose beta-anomer, UNII-R4B6462NGR, Maltroise, 1wdr, N9S, Glca1-4Glcb, Glcalpha1-4Glcbeta, Maltose (8CI), SUNMALT-S, 2f5t, .BETA.-MALTOSE, .BETA.-D-MALTOSE, .BETA.-D-CELLOBIOSE, SCHEMBL15064, MALTOSE .BETA.-ANOMER, .beta.-D-Glucopyranose, 4-O-.alpha.-D-glucopyranosyl-, CHEMBL1908365, DTXSID901318570, HMS3264C14, Pharmakon1600-01301024, NSC760396, alpha-D-Glcp-(1->4)-beta-D-Glcp, AKOS016008531, CCG-231520, NCGC00389762-01, BS-10031, NS00069769, C01971, D70315, 4-O-(alpha-D-Glucopyranosyl)-beta-D-glucopyranose, BioReagent, for molecular biology, ~20% in H2O, alpha-D-glucopyranose-(1->4)-beta-D-glucopyranose, 857A38D2-86D7-41F1-BC3C-DADBC19CF9DC, D-Glucose, 4-O-alpha-D-glucopyranosyl- (6CI,9CI), Q26914030, (2R,3R,4R,5S,6R)-6-(Hydroxymethyl)-5-(((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2,3,4-triol, (2R,3R,4R,5S,6R)-6-(Hydroxymethyl)-5-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxane-2,3,4-triol, (2R,3S,4S,5R,6R)-2-methylol-6-[(2R,3S,4R,5R,6R)-4,5,6-trihydroxy-2-methylol-tetrahydropyran-3-yl]oxy-tetrahydropyran-3,4,5-triol C12H22O11 GUBGYTABKSRVRQ-QUYVBRFLSA-N (2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[(2R,3S,4R,5R,6R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxane-3,4,5-triol n.a. n.a. No No No No Yes No rxnAGORA245,rxnAGORA246,rxnAGORA247,rxnAGORA248,rxnAGORA1328,rxnAGORA1867,rxnAGORA1870,rxnAGORA1900,rxnAGORA2944,rxnAGORA5019 PMDBD2001684 Biotin Dietary Substance, Therapeutic Substance Investigational Drug 58-85-5 DB00121 PA448625 D00029 D0P8TJ 171548 149962 NPC199072 "biotin, d-biotin, 58-85-5, vitamin H, Vitamin B7, Bioepiderm, coenzyme R, Bios II, Factor S, D(+)-Biotin, Biodermatin, D-(+)-Biotin, (+)-Biotin, Biotine, Biotinum, Injacom H, Biotina, Meribin, Factor S (vitamin), Lutavit H2, Ritatin, CCRIS 3932, HSDB 346, 3H-Biotin, MFCD00005541, NSC 63865, Biotine [INN-French], Biotinum [INN-Latin], Biotina [INN-Spanish], 5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanoic acid, cis-Hexahydro-2-oxo-1H-thieno(3,4)imidazole-4-valeric acid, cis-Tetrahydro-2-oxothieno(3,4-d)imidazoline-4-valeric acid, AI3-51198, 1swk, 1swn, 1swr, EINECS 200-399-3, Rovimix H 2, D-Biotin Factor S, UNII-6SO6U10H04, 5-[(3aS,4S,6aR)-2-oxo-hexahydro-1H-thieno[3,4-d]imidazolidin-4-yl]pentanoic acid, CHEBI:15956, 6SO6U10H04, 5-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanoic acid, 5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoic acid, Medebiotin, NSC-63865, Biotin [USP:INN:JAN], cis-(+)-Tetrahydro-2-oxothieno[3,4]imidazoline-4-valeric acid, (+)-cis-Hexahydro-2-oxo-1H-thieno[3,4]imidazole-4-valeric acid, MD-1003, 1H-thieno[3,4-d]imidazole-4-pentanoic acid, hexahydro-2-oxo-, (3aS,4S,6aR)-, 1H-Thieno(3,4-d)imidazole-4-pentanoic acid, hexahydro-2-oxo-, (3aS-(3aalpha,4beta,6aalpha))-, DTXCID102679, DTXSID7022679, 2''-Keto-3,4-imidazolido-2-tetrahydrothiophene-N-valeric acid, (3aS,4S,6aR)-Hexahydro-2-oxo-1H-thieno(3,4-d)imidazole-4-valeric acid, (3aS,4S,6aR)-Hexahydro-2-oxo-1H-thieno[3,4-d]imidazole-4-valeric acid, Hexahydro-2-oxo-1H-thieno(3,4-d)imidazole-4-pentanoic acid, (3aS-(3aalpha,4beta,6aalpha))-, D-Biotin 10 microg/mL in Acetonitrile, Biotine (INN-French), Biotinum (INN-Latin), Biotina (INN-Spanish), beta-Biotin, BIOTIN (USP-RS), BIOTIN [USP-RS], BIOTIN (MART.), BIOTIN [MART.], Vitamin Bw, Biotin (USP:INN:JAN), (3aS-(3aalpha,4b,6aalpha))-Hexahydro-2-oxo-1H-thieno(3,4-d)imidaz- ole-4-pentanoic acid, BIOTIN (EP IMPURITY), BIOTIN [EP IMPURITY], BIOTIN (EP MONOGRAPH), BIOTIN [EP MONOGRAPH], BIOTIN (USP MONOGRAPH), BIOTIN [USP MONOGRAPH], Hexahydro-2-oxo-1H-thieno(3,4-d)imidazole-4-pentanoic acid, 1H-Thieno(3,4-d)imidazole-4-pentanoic acid, hexahydro-2-oxo-, (3aS,4S,6aR)-, 5-((3AS,4S,6aR)-rel-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanoic acid, Bios H, SMR000112255, D(+)Biotin, 22377-59-9, Biotitum, hexahydro-2-oxo-1H-thieno[3,4-d]imidazole-4-pentanoic acid, NSC63865, delta-Biotin, Amerix Biotin, Biotin Drops, Hairq-plus, Vitamin-h, Tk-nax, 1avd, 1ndj, 1stp, 1swg, 1swp, 2avi, 4bcs, 4ggz, 4jnj, Bioepiderm (TN), CAS-58-85-5, NCGC00094984-04, 1H-Thieno[3,4-d]imidazole-4-pentanoic acid, hexahydro-2-oxo-, [3as-(3aalpha,4beta,6aalpha)]-, Biotin111In, delta-(+)-Biotin, SUBIR, Biotin Drops2081, Biotin (8CI), delta-biotin factor s, TWINKLE ESSENCE, 1df8, 1n9m, 2gh7, 3t2w, 4bj8, BIOTIN [VANDF], BIOTIN [HSDB], BIOTIN [INCI], SPAI-SONSPROCAPELL, BIOTIN [FCC], BIOTIN [INN], BIOTIN [JAN], BIOTIN [WHO-DD], Prestwick0_000418, Prestwick1_000418, Prestwick2_000418, Prestwick3_000418, BIOTIN [MI], cid_253, D-BIOTIN [VANDF], SPAI-SONSPROLAC-VIT, BDBM12, bmse000227, CHEMBL857, ExoSCRT Scalp Care HRLV, Probes2_000006, SCHEMBL8763, BIOTIN [ORANGE BOOK], Biotin for system suitability, BSPBio_000376, Biotin (JP17/USP/INN), MLS001066402, MLS001074888, MLS001331736, MLS001333089, D-Biotin, analytical standard, SPBio_002315, BPBio1_000414, cid_171548, GTPL4787, HAIRJOY EYEBROW SIGNATURE, HAIRJOY EYELASH SIGNATURE, A11HA05, AMF0005, 1n43, 2f01, Biotin, >=99.0% (T), CIS-TETRAHYDRO-2-OXOTHIENO, HMS1569C18, HMS2096C18, HMS2271O06, HMS3713C18, Bonogen Activatorhair loss treatment, HY-B0511, Tox21_113050, Tox21_302161, AC8089, Biotin, tested according to Ph.Eur., s3130, AKOS001287669, Tox21_113050_1, CCG-220418, CIS-HEXAHYDRO-2-OXO-1H-THIENO, DB00121, 1H-Thieno(3,4-d)imidazole-4-pentanoic acid, hexahydro-2-oxo-, (3aS-(3aalpha,4b,6aalpha))-, Biotin, meets USP testing specifications, Biotin, SAJ special grade, >=98.0%, NCGC00179580-01, NCGC00179580-02, NCGC00179580-04, NCGC00179580-08, NCGC00255377-01, 20 - Potency of multivitamin supplements, 56846-45-8, AC-19998, BP-20441, Biotin, >=99% (TLC), lyophilized powder, Biotin, Vetec(TM) reagent grade, >=99%, AB00374191, B0463, NS00126825, EN300-54173, BIONA-VITCONTROLS AND PREVENTS HAIR LOSS, C00120, D00029, M02926, AB00374191-08, AB00374191_11, A929752, Biotin, plant cell culture tested, >=99% (TLC), Q181354, SR-01000765521, Biotin, certified reference material, TraceCERT(R), Q-200929, SR-01000765521-2, BRD-K89210380-001-03-8, BRD-K89210380-001-13-7, 6AE43AA3-BC3D-4C49-9DB9-5913A2401EB6, Biotin, European Pharmacopoeia (EP) Reference Standard, F2173-0855, Hexahydro-2-oxo-1H-thieno(3,4-d)imidazole-4-pentanoate, Z210803762, Biotin, United States Pharmacopeia (USP) Reference Standard, cis-(+)-Tetrahydro-2-oxothieno[3,4]imidazoline-4-valerate, (+)-cis-Hexahydro-2-oxo-1H-thieno[3,4]imidazole-4-valerate, 5-(2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanoate, Daunorubicin hydrochloride, Antibiotic for Culture Media Use Only, (3aS,4S,6aR)-Hexahydro-2-oxo-1H-thieno[3,4-d]imidazole-4-valerate, Biotin, Pharmaceutical Secondary Standard; Certified Reference Material, 1H-Thieno[3,4-d]imidazole-4-pentanoic acid, hexahydro-2-oxo-, (3aS,4S,6aR)- (9CI), 5-((3aR,6S,6aS)-2-Oxo-hexahydro-thieno[3,4-d]imidazol-6-yl)-pentanoic acid, 5-[(3aR,6S,6aS)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-6-yl]pentanoic acid, Biotin for system suitability, European Pharmacopoeia (EP) Reference Standard, hexahydro-2-oxo-[3aS-(3aa,4b,6aa)]-1H-Thieno[3,4-d]imidazole-4-pentanoate, hexahydro-2-oxo-[3aS-(3aa,4b,6aa)]-1H-Thieno[3,4-d]imidazole-4-pentanoic acid, hexahydro-2-oxo-[3as-(3alpha,4beta,6alpha)]-1H-Thieno[3,4-d]imidazole-4-pentanoate, hexahydro-2-oxo-[3as-(3alpha,4beta,6alpha)]-1H-Thieno[3,4-d]imidazole-4-pentanoic acid, Biotin, powder, BioReagent, suitable for cell culture, suitable for insect cell culture, suitable for plant cell culture, >=99%" C10H16N2O3S YBJHBAHKTGYVGT-ZKWXMUAHSA-N 5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoic acid n.a. n.a. No No No No Yes No rxnAGORA527,rxnAGORA1260,rxnAGORA2589,rxnAGORA2649,rxn00792 PMDBD2001685 Dextrin Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 62698 n.a. NPC139037 Dextrin, 9004-53-9, (3R,4S,5S,6R)-2-[(2R,3S,4R,5R)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2R,3S,4R,5R,6S)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol, Dextrid, Dextrins, Fortodex, Corn dextrin, Dextrina Bianca, Dextrin 3, Caloreen, Dextrine, Nutriose, SCHEMBL1091972, FYGDTMLNYKFZSV-MRCIVHHJSA-N, AKOS037517263, Maltodextrin, dextrose equivalent 16-20, D4657, E80458, A843422, Q177570, (3R,4S,5S,6R)-2-[(2R,3S,4R,5R)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2R,3S,4R,5R,6S)-4,5,6-trihydroxy-2-(hydroxymethyl)tetrahydropyran-3-yl]oxy-tetrahydropyran-3-yl]oxy-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol, (3R,4S,5S,6R)-2-{[(2R,3S,4R,5R)-4,5-dihydroxy-2-(hydroxymethyl)-6-{[(2R,3S,4R,5R,6S)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}oxan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol, all-E)-9-(4-Methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoicacidethylester C18H32O16 FYGDTMLNYKFZSV-MRCIVHHJSA-N (3R,4S,5S,6R)-2-[(2R,3S,4R,5R)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2R,3S,4R,5R,6S)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol n.a. n.a. No No No No Yes No rxnAGORA593,rxnAGORA594,rxnAGORA1281 PMDBD2001686 Menaquinone 8 Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 5376507 n.a. n.a. Menaquinone 8, Vitamin MK 8, 523-38-6, Menaquinone MK8, Vitamin K2(40), menaquinone-8, MK 8, SR2A44CB4U, 2-methyl-3-[(2E,6E,10E,14E,18E,22E,26E)-3,7,11,15,19,23,27,31-octamethyldotriaconta-2,6,10,14,18,22,26,30-octaenyl]naphthalene-1,4-dione, (all-E)-2-Methyl-3-(3,7,11,15,19,23,27,31-octamethyl-2,6,10,14,18,22,26,30-dotriacontaoctaenyl)-1,4-naphthalenedione, 2-methyl-3-[(2E,6E,10E,14E,18E,22E,26E)-3,7,11,15,19,23,27,31-octamethyldotriaconta-2,6,10,14,18,22,26,30-octaen-1-yl]naphthalene-1,4-dione, 1,4-Naphthalenedione, 2-methyl-3-(3,7,11,15,19,23,27,31-octamethyl-2,6,10,14,18,22,26,30-dotriacontaoctaenyl)-, (all-E)-, 1,4-Naphthoquinone, 2-methyl-3-(3,7,11,15,19,23,27,31-octamethyl-2,6,10,14,18,22,26,30-dotriacontaoctaenyl)-, VitaminMK8, trans-menaquinone-8, Vitamin MK-8, UNII-SR2A44CB4U, 2-Methyl-3-[(2E,6E,10E,14E,18E,22E,26E)-3,7,11,15,19,23,27,31-octamethyl-2,6,10,14,18,22,26,30-dotriacontaoctaen-1-yl]-1,4-naphthalenedione, SCHEMBL10055449, SCHEMBL14164340, CHEBI:44027, LXKDFTDVRVLXFY-WQWYCSGDSA-N, 2-methyl-3-[(2E,6E,10E,14E,18Z,22E,26E)-3,7,11,15,19,23,27,31-octamethyldotriaconta-2,6,10,14,18,22,26,30-octaen-1-yl]naphthalene-1,4-dione, A936882, Q27120539, 1,4-Naphthalenedione, 2-methyl-3-((2E,6E,10E,14E,18E,22E,26E)- 3,7,11,15,19,23,27,31-octamethyl-2,6,10,14,18,22,26,30-dotriacontaoctaenyl)-, 1,4-Naphthalenedione, 2-methyl-3-[(2E,6E,10E,14E,18E,22E,26E)-3,7,11,15,19,23,27,31-octamethyl-2,6,10,14,18,22,26,30-dotriacontaoctaen-1-yl]-, 2-Methyl-3-(3,7,11,15,19,23,27,31-octamethyl-2,6,10,14,18,22,26,30-dotriacontaoctaen-1-yl)-1,4-naphthoquinone, 2-Methyl-3-[(2E,6E,10E,14E,18E,22E,26E)-3,7,11,15,19,23,27,31-octamethyl-2,6,10,14,18,22,26,30-dotriacontaoctaenyl]naphthoquinone # C51H72O2 LXKDFTDVRVLXFY-WQWYCSGDSA-N 2-methyl-3-[(2E,6E,10E,14E,18E,22E,26E)-3,7,11,15,19,23,27,31-octamethyldotriaconta-2,6,10,14,18,22,26,30-octaenyl]naphthalene-1,4-dione n.a. n.a. No No No No Yes No rxnAGORA607,rxnAGORA1862,rxnAGORA2313,rxnAGORA2807,rxnAGORA2854,rxnAGORA2985,rxnAGORA2999,rxnAGORA3001,rxnAGORA3346,rxnAGORA3373,rxnAGORA3494,rxnAGORA3633,rxnAGORA3783,rxnAGORA4000,rxnAGORA4494 PMDBD2001687 4-Aminobutanoate Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 5460232 n.a. n.a. 4-aminobutanoate, gamma-aminobutyrate, 4-aminobutyrate, 4-Aminobutylate, 4-Amino-butyrat, CHEBI:30566, gamma-aminobutanoate, gamma-aminobutyrate anion, 4-aminobutanoic acid ion (1-), DTXSID701301246, Butanoic acid, 4-amino-, ion(1-), 60-28-6, Q27104134 C4H8NO2- BTCSSZJGUNDROE-UHFFFAOYSA-M 4-aminobutanoate n.a. n.a. No No No No Yes No rxnAGORA853,rxnAGORA1694,rxnAGORA1695,rxnAGORA2492,rxnAGORA3443 PMDBD2001688 Citrate Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 31348 n.a. NPC328069 126-44-3, Citrate, Citrate ion, 2-hydroxypropane-1,2,3-tricarboxylate, CITRATE ANION, 664CCH53PI, citr, Lithium citrate, 2-Hydroxy-1,2,3-propanetricarboxylate(3-), 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, ion(3-), citrate(3-), ANION STANDARD - CITRATE, citrate trianion, 2qpq, 3itc, 3kgq, citrate(3-) anion, 2yg2, 3ry8, 4eu3, cit(3-), ANIONSTANDARD-CITRATE, UNII-664CCH53PI, CITRIC ACID, ION(3-), BDBM92494, CHEBI:16947, DTXSID30155037, 3r69, AKOS022140114, 2-oxidanylpropane-1,2,3-tricarboxylate, NCGC00164253-02, NCGC00164253-04, AB00443858_02, A839293, 2-hydroxy-1,2,3-propanetricarboxylic acid, ion(3-), Q55503059 C6H5O7-3 KRKNYBCHXYNGOX-UHFFFAOYSA-K 2-hydroxypropane-1,2,3-tricarboxylate n.a. n.a. No No No No Yes No rxnAGORA1266,rxnAGORA1945,rxnAGORA2522,rxnAGORA2523,rxnAGORA2602,rxnAGORA3197,rxnAGORA3735,rxnAGORA3976,rxnAGORA4085,rxnAGORA4536,rxnAGORA5141,rxnAGORA5142 PMDBD2001689 Chloride Dietary Substance, Therapeutic Substance Phase 3 n.a. n.a. n.a. n.a. D07QKK 312 n.a. NPC224259 "16887-00-6, chloride, chloride ion, Chloride anion, Chloride(1-), Chloride (ion), Chlorides, Chloride ions, Perchloride, Chlorine anion, Chlorine, ion, Pls216 protein, UNII-Q32ZN48698, 131500-00-0, Cl-, Q32ZN48698, Hydrochloric acid, ion(1-), Cl(-), Cadmium manganese mercury telluride (Cd0.2Mn0.04Hg0.76Te), DTXSID6043969, CHEBI:17996, Chloride - Cl(-) @1000microg/mL, .beta.-D-Galactopyranoside, 4-hydroxybutyl, 139512-37-1, 147258-25-1, 155522-09-1, Chlorate Standard: ClO3- @ 1000 microg/mL in H2O, Chloride (from KCl) Standard: Cl- @ 100 microg/mL in H2O, Chloride (from NH4Cl) Standard: Cl- @ 10000 microg/mL in H2O, 1,2-bis[4-fluoro-6-{4-sulfo-5-(2-(4-sulfonaphtalene-3-ylazo)-1-hydroxy-3,6-disulfo-8-aminonaphthalen, Chlorid, Chloride (from KCl) Standard: Cl- @ 1000 microg/mL in H2O, Chloride (from KCl) Standard: Cl- @ 10000 microg/mL in H2O, chloride salt, chloride salts, Chlorine ion, Chlorine-, Cl?, Chloride (Cl-), Chlorine(1-), Chlorine ion(1-), Chloride ion (1-), 42 - Milk Powder, CHLORIDE STANDARD, CHLORIDE [VANDF], Chlorine, ion (Cl1-), 3-Carbamoyl-1-ethoxymethylpyridinium chloride, 14 - Anions on Filters, CHLORIDE [WHO-DD], 1-Butoxymethyl-3-carbamoyl-pyridinium; chloride, CHEMBL19429, Chloride (from KCl) Standard, 5,9-bis-dimethylamino-benzo[a]phenoxazinylium, chloride, DTXCID4023969, BDBM26979, CHEBI:23114, 28 - Chemical analysis of soaps, c0884, MFCD00143949, AKOS015903642, Chloride standard solution (8 ppm CI), DB14547, 54071-91-9, 62770-30-3, 01A - Major Ions in High Salinity Water, C00698, Q108200, Chloride Ion Chromatography Standard: Cl- @ 100microg/mL in H2O, Chloride Ion Chromatography Standard: Cl- @ 100microg/mL in H2O" Cl- VEXZGXHMUGYJMC-UHFFFAOYSA-M chloride n.a. n.a. No No No No Yes No rxnAGORA1267,rxnAGORA2425 PMDBD2001690 D-Galactose Dietary Substance, Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. D0A7GX 6036 n.a. NPC176017 "D-Gal, D-Galactopyranose, D-Galactopyranoside, D-Galactose, Gal, Galactopyranose, Galactopyranoside, Galactose, 10257-28-0, Galactose, pure, (3R,4S,5R,6R)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol, CHEBI:4139, brain sugar, (+)-Galactose, EINECS 233-595-2, cerebrose, AI3-18440, D-galacto-hexose, DTXSID001015860, NSC 8102, CHEBI:12936, NSC-8102, D Galactose, D-Glucose-2-13C, 40825-89-6, SMR000857326, UNII-7IOF6H4H77, Galaktose, galacto-hexose, (3R,4S,5R,6R)-6-(Hydroxymethyl)tetrahydro-2H-pyran-2,3,4,5-tetraol, Galactose; D-Galactopyranose; D(+)-Galactose; GSK 620104E; Allopurinol related, D-Galactose (9CI), Galactose, D- (8CI), Epitope ID:141794, D-Galactose 1000 microg/mL in Methanol:Water, SCHEMBL38935, MLS001335983, MLS001335984, CHEMBL195923, DTXCID903088, CHEBI:28260, BDBM228805, DTXCID601437050, HMS2230N07, MFCD00006969, s3849, AKOS030573864, CCG-266426, NCGC00166082-01, AS-46931, CS-0204480, G0008, NS00087175, C00124, EN300-135967, F10950, G-1701, O_FULL_10000000000000_GS_94, Q27106307, Z1665647488, (3R,4S,5R,6R)-6-methyloltetrahydropyran-2,3,4,5-tetrol, WURCS=2.0/1,1,0/(a2112h-1x_1-5)/1/" C6H12O6 WQZGKKKJIJFFOK-SVZMEOIVSA-N (3R,4S,5R,6R)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol Bayer Schering Pharma AG n.a. No No No No Yes No rxnAGORA1293,rxnAGORA1664,rxnAGORA1671,rxnAGORA1807,rxnAGORA3749,rxnAGORA3913,rxnAGORA3942,rxnAGORA4836 PMDBD2001691 D-glucose Dietary Substance, Therapeutic Substance Investigational Drug 50-99-7 DB01914 n.a. n.a. D0C1FY 5793 n.a. NPC289758 D-Glc, D-Glucopyranose, D-Glucopyranoside, D-Glucose, Glc, Glucopyranose, Glucopyranoside, Glucose, dextrose, 2280-44-6, Grape sugar, (3R,4S,5S,6R)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol, D-Glcp, Traubenzucker, 54-17-1, Glucopyranose, D-, Glucosum, anhydrous, CHEBI:4167, GLUCOSE, ALPHA-D-, rel-(3R,4S,5S,6R)-6-(Hydroxymethyl)tetrahydro-2H-pyran-2,3,4,5-tetraol, Corn sugar, DTXSID901015217, (+)-Glucose, (3R,4S,5S,6R)-6-(Hydroxymethyl)tetrahydro-2H-pyran-2,3,4,5-tetraol, Glucodin, Goldsugar, Meritose, Vadex, Clintose L, D-gluco-hexose, CPC hydrate, Roferose ST, Clearsweet 95, a-D-Glucopyranose, Staleydex 95M, Staleydex 111, Cerelose 2001, Tabfine 097(HS), UNII-5J5I9EB41E, 2h-pyran-2,3,4,5-tetraol, D-Glucopyranose, anhydrous, DTXSID30197710, Liquid glucose, glc-ring, EINECS 207-757-8, Cartose Cerelose, D-glucose-ring, Glucose injection, Glucose 40, Staleydex 130, EINECS 218-914-5, Glc-OH, Meritose 200, nchembio867-comp4, Glucose (JP17), starbld0000491, 6-(hydroxymethyl)tetrahydropyran-2,3,4,5-tetraol, Anhydrous Glucose ,(S), Purified glucose (JP17), Epitope ID:142342, D-(+)-DEXTROSE, GTPL4536, CHEMBL1222250, BDBM34103, CHEBI:37661, DTXCID90120201, DTXCID201473543, DTXSID501015215, 26655-34-5, AKOS025147374, NSC 287045, NCGC00166293-01, BS-48662, G0048, (3R,4S,5S,6R)-6-(hydroxymethyl)tetrahydro-, C00031, D00009, F71542, Q37525, Q23905964, N_FULL/O_FULL_10000000000000_GS_656, D-glucose (closed ring structure, complete stereochemistry), WURCS=2.0/1,1,0/(a2122h-1a_1-5)/1/, 1023302-86-4 C6H12O6 WQZGKKKJIJFFOK-GASJEMHNSA-N (3R,4S,5S,6R)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol n.a. n.a. No No No No Yes No rxnAGORA245,rxnAGORA246,rxnAGORA247,rxnAGORA248,rxnAGORA1296,rxnAGORA1689,rxnAGORA1756,rxnAGORA1900,rxnAGORA2408,rxnAGORA2827,rxnAGORA2834,rxnAGORA3687,rxnAGORA3741,rxn40751,rxn41390 PMDBD2001692 L-glutamate(1-) Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 5460299 n.a. n.a. L-glutamate(1-), glutaminic acid, L-Glutamic acid, ion(1-), 1-amino-propane-1,3-dicarboxylic acid, 11070-68-1, 2pyy, 2xxr, 2xxw, 2xxx, 2zns, 3fas, 3fuz, hydrogen L-glutamate, 3ff3, 3s9e, L-glutamic acid monoanion, (2S)-2-ammoniopentanedioate, L-glutamate(1-) zwitterionic, CHEBI:29985, L-Glutamic acid, inner salt, ion(1-), Q41875350 C5H8NO4- WHUUTDBJXJRKMK-VKHMYHEASA-M (2S)-2-azaniumylpentanedioate n.a. n.a. No No No No Yes No rxnAGORA262,rxnAGORA274,rxnAGORA1298,rxnAGORA1677,rxnAGORA1691,rxnAGORA1693,rxnAGORA1695,rxnAGORA1696,rxnAGORA1701,rxnAGORA1783,rxnAGORA1814,rxnAGORA1949,rxnAGORA1961,rxnAGORA2003,rxnAGORA2052,rxnAGORA2370,rxnAGORA2374,rxnAGORA2402,rxnAGORA2485,rxnAGORA2492,rxnAGORA2507,rxnAGORA2634,rxnAGORA2799,rxnAGORA2840,rxnAGORA2841,rxnAGORA2842,rxnAGORA2846,rxnAGORA2847,rxnAGORA3198,rxnAGORA3390,rxnAGORA3407,rxnAGORA3787,rxnAGORA4011,rxnAGORA4099,rxnAGORA4477,rxnAGORA4658,rxnAGORA4664,rxn12216,rxn14123,rxn38875 PMDBD2001694 L-histidine Dietary Substance, Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D07UTZ 6274 n.a. n.a. "L-histidine, histidine, 71-00-1, H-His-OH, glyoxaline-5-alanine, Anti-rheuma, L-(-)-Histidine, Istidina, S-Histidine, (L)-Histidine, histidina, Histidinum, HISTIDINE, L-, (S)-4-(2-Amino-2-carboxyethyl)imidazole, Histidine (VAN), FEMA No. 3694, (2S)-2-amino-3-(1H-imidazol-4-yl)propanoic acid, L-Hisidine, L-Histidin, (S)-alpha-amino-1H-imidazole-4-propanoic acid, Histidine [USAN:INN], Histidinum [INN-Latin], 4-(2-Amino-2-carboxyethyl)imidazole, (S)-Histidine, his, Histidina [INN-Spanish], L-beta-(4-Imidazolyl)alanin, (S)-2-Amino-3-(4-imidazolyl)propionsaeure, L-hystidine, HSDB 1810, 1H-Imidazole-4-alanine, (S)-, AI3-26558, EINECS 200-745-3, L-beta-(4-Imidazolyl)-alpha-alanin, (S)-alpha-Amino-1H-imidazole-4-propionic acid, L-His, L-Alanine, 3-(1H-imidazol-4-yl)-, NSC 137773, UNII-4QD397987E, CHEBI:15971, alpha-Amino-4(or 5)-imidazolepropionic acid, Histidine (L-Histidine), MFCD00064315, 4QD397987E, NSC-137773, alpha-Amino-1H-imidazole-4-propionic acid, (S)-, 1H-Imidazole-4-propanoic acid, alpha-amino-, (S)-, (S)-a-Amino-1H-imidazole-4-propanoic acid, DTXSID9023126, (S)-2-Amino-3-(4-imidazolyl)propionic acid, L-Histidine Base, 7006-35-1, HISTIDINE (II), HISTIDINE [II], Histidinum (INN-Latin), Histidina (INN-Spanish), HISTIDINE (MART.), HISTIDINE [MART.], (2S)-2-amino-3-(imidazol-4-yl)propanoic acid, histidin, HISTIDINE (EP MONOGRAPH), HISTIDINE [EP MONOGRAPH], HISTIDINE (USP MONOGRAPH), HISTIDINE [USP MONOGRAPH], Histidine, monohydrochloride, CHEBI:27570, NSC137773, 1hsl, 1lag, [3H]histidine, Histidine,(S), [3H]-histidine, (2S)-2-amino-3-(1H-imidazol-4-yl)propanoic acid hydrochloride, L-His-OH, Histidine (USP/INN), HISTIDINE [INN], HISTIDINE [MI], L-Histidine (JP17), L-2-Amino-3-(4-imidazolyl)propionic acid, HISTIDINE [HSDB], HISTIDINE [INCI], HISTIDINE [USAN], HISTIDINE [VANDF], Lopac-H-8125, bmse000039, bmse000976, bmse001015, L-HISTIDINE [FCC], L-HISTIDINE [JAN], L-Histidine (H-His-OH), amino-4-imidazoleproprionate, HISTIDINE [WHO-DD], L-HISTIDINE [FHFI], SCHEMBL3259, Lopac0_000566, US9138393, Histidine, US9144538, Histidine, (S)1H-Imidazole-4-alanine, CHEMBL17962, L-HISTIDINE [USP-RS], (2S)-2-amino-3-(1H-imidazol-5-yl)propanoic acid, (S)-1H-Imidazole-4-alanine, BDBM7953, DTXCID503126, GTPL3310, GTPL4670, L-Histidine, non-animal source, Imidazole C-4(5) deriv. 5, amino-4-imidazoleproprionic acid, amino-1H-imidazole-4-propanoate, Treating Periodontitis Toothpaste, L-Histidine, p.a., 98.5%, BDBM181118, 3-(1H-imidazol-4-yl)-L-Alanine, HY-N0832, amino-1H-imidazole-4-propanoic acid, AKOS015854051, AKOS026676613, AM81801, CCG-204656, CS-7781, DB00117, SDCCGSBI-0050549.P002, SERINE IMPURITY C [EP IMPURITY], (S)-a-Amino-1H-imidazole-4-propanoate, NCGC00015518-01, NCGC00162189-01, NCGC00162189-02, NCGC00162189-05, AC-35086, AS-14171, CAREDO Treating Periodontitis Toothpastes, (S)-alpha-Amino-1H-imidazole-4-propanoate, (S)-alpha-Amino-1H-imidazole-4-propionate, L-Histidine, BioUltra, >=99.5% (NT), H0149, L-Histidine, SAJ special grade, >=98.5%, NS00074195, S3989, EN300-57334, (S)-2-Amino-3-(imidazol-4-yl)propanoic acid, C00135, CAREDO Treating Periodontitis Toothpastes100g, D00032, D70843, H-2310, L-Histidine, ReagentPlus(R), >=99% (TLC), M02982, L-Histidine, Vetec(TM) reagent grade, >=99%, (S)-2-amino-3-(1H-imidazol-4-yl)propanoic acid, Q485277, B81AEDB0-EACA-4296-9BAB-52D60F137FFB, 1H-Imidazole-4-propanoic acid, .alpha.-amino-, (S)-, F8881-8926, F8889-0575, L-Histidine, certified reference material, TraceCERT(R), Z359369984, Histidine, European Pharmacopoeia (EP) Reference Standard, L-Histidine, United States Pharmacopeia (USP) Reference Standard, L-Histidine, Pharmaceutical Secondary Standard; Certified Reference Material, L-Histidine, cell culture tested, meets EP, USP testing specifications, from non-animal source" C6H9N3O2 HNDVDQJCIGZPNO-YFKPBYRVSA-N (2S)-2-amino-3-(1H-imidazol-5-yl)propanoic acid n.a. n.a. No No No No Yes No rxnAGORA1319,rxnAGORA1766,rxnAGORA2887,rxnAGORA2888,rxnAGORA3496 PMDBD2001695 L-isoleucine Dietary Substance, Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D0I8SK 6306 n.a. n.a. "l-isoleucine, Isoleucine, 73-32-5, (2S,3S)-2-Amino-3-methylpentanoic acid, H-Ile-OH, 2S,3S-Isoleucine, (S)-Isoleucine, (S,S)-Isoleucine, 2-Amino-3-methylvaleric acid, L-(+)-Isoleucine, erythro-L-Isoleucine, L-Ile, ISOLEUCINE, L-, alpha-Amino-beta-methylvaleric acid, Isoleucine (VAN), Isoleucinum [Latin], Isoleucina [Spanish], Norvaline, 3-methyl-, Valeric acid, 2-amino-3-methyl-, L-Norvaline, 3-methyl-, erythro-, Acetic acid, amino-sec-butyl-, ile, Pentanoic acid, 2-amino-3-methyl-, CCRIS 5229, iso-leucine, (2S,3S)-alpha-Amino-beta-methyl-n-valeric acid, NSC 46708, (2S,3S)-alpha-Amino-beta-merthylvaleric acid, (S-(R*,R*))-2-Amino-3-methylpentanoic acid, FEMA No. 3295, (2S,3S)-alpha-Amino-beta-merthyl-n-valeric acid, 2-Amino-3-methylpentanoic acid, (S-(R*,R*))-, Acetic acid, amino(1-methylpropyl)-, (R*,R*)-, MFCD00064222, Isoleucine (L-Isoleucine), 5HX0BYT4E3, Pentanoic acid, 2-amino-3-methyl-, (S-(R*,R))-, DTXSID2046882, FEMA NO. 4675, CHEBI:17191, [S-(R*,R*)]-2-Amino-3-methylpentanoic acid, 2S-Amino-3S-methylpentanoic acid, Isoleucine, DL-, DL-Allo-isoleucine, MFCD00004268, NSC-46708, 04Y7590D77, (2S,3S)-alpha-Amino-beta-methylvaleric acid, Pentanoic acid, 2-amino-3-methyl-, (2S,3S)-, Isoleucina, Isoleucinum, DTXCID201323037, Isoleucine [USAN:INN], CAS-443-79-8, (2S,3S)-2-amino-3-methylpentanoate, EINECS 200-798-2, UNII-5HX0BYT4E3, (2S,3S)-2-Amino-3-methylpentanoicacid, NSC-9958, NSC46708, L-iso-leucine, HSDB 7798, (L)-Isoleucine, L- iso-Leucine, Isoleucine [USAN:USP:INN:BAN], UNII-04Y7590D77, NCGC00181164-01, Isoleucine (USP), NSC 9958, EINECS 207-139-8, H-Ile, Ile-OH, L-Isoleucine,(S), (+)-L-isoleucine, L-[14C]Isoleucine, (2S,3S)-a-Amino-b-methylvaleric acid, L-Isoleucine, 99%, ISOLEUCINE [II], ISOLEUCINE [MI], (2S,3S)-a-Amino-b-methyl-n-valeric acid, AI3-18474, L-Isoleucine (JP17), ISOLEUCINE [INN], (2S,3S)-2-amino-3-methyl-Pentanoic acid, ISOLEUCINE [HSDB], ISOLEUCINE [INCI], ISOLEUCINE [USAN], ISOLEUCINE DL-FORM, 2-Amino-3-methylvalerate, ISOLEUCINE [VANDF], Isoleucine, L- (8CI), bmse000041, bmse000866, bmse000884, 2-amino-3-methylpentanoate, ISOLEUCINE [MART.], L-Isoleucine (H-lle-OH), L-ISOLEUCINE [FCC], L-ISOLEUCINE [JAN], SCHEMBL8869, DL-ISOLEUCINE [FCC], ISOLEUCINE [WHO-DD], sec-C4H9CH(NH2)COOH, DL-ISOLEUCINE [FHFI], L-Isoleucine (H-L-Ile-OH), L-ISOLEUCINE [USP-RS], GTPL3311, CHEMBL1233584, DTXSID1047441, ISOLEUCINE DL-FORM [MI], L-Isoleucine: D-allo-isoleucine, BDBM18140, Norvaline, 3-methyl-, erythro-, ISOLEUCINE [EP MONOGRAPH], ISOLEUCINE [USP MONOGRAPH], L-Isoleucine, 99%, FCC, FG, Pharmakon1600-01301004, (2S,3S)-a-Amino-b-methylvalerate, HY-N0771, Tox21_112765, LMFA01100047, NSC760109, s3752, L-Isoleucine, Vetec(TM), 98.5%, AKOS015842027, Tox21_112765_1, (2S,3S)-a-Amino-b-methyl-n-valerate, AM81842, CCG-266114, CS-W018502, DB00167, FD20022, NSC-760109, (2S,3S)-2-amino-3-methyl-Pentanoate, VALINE IMPURITY B [EP IMPURITY], (2S,3S)-alph-Amino-beta-methylvalerate, LEUCINE IMPURITY A [EP IMPURITY], NCGC00274084-01, (2S,3S)-alpha-Amino-beta-methylvalerate, AC-34995, AS-11616, BP-20357, (2S,3S)-alpha-Amino-beta-merthylvalerate, [S-(R*,R*)]-2-Amino-3-methylpentanoate, L-Isoleucine, BioUltra, >=99.5% (NT), (2S,3S)-alph-Amino-beta-methylvaleric acid, (2S,3S)-alpha-Amino-beta-methyl-n-valerate, I0181, NS00009745, (2S,3S)-alpha-Amino-beta-merthyl-n-valerate, EN300-52623, L-Isoleucine, SAJ special grade, >=99.0%, (+/-)-erythro-2-Amino-3-methylpentanoic acid, C00407, D00065, L-Isoleucine, reagent grade, >=98% (HPLC), M03002, L-Isoleucine, Vetec(TM) reagent grade, >=98%, L-Isoleucine, Cell Culture Reagent (H-L-Ile-OH), Q484940, Q-201311, (2S,3S)-.alpha.-Amino-.beta.-methyl-n-valeric acid, .alpha.-Amino-.beta.-methylvaleric acid, (2S,3S)-, Pentanoic acid, 2-amino-3-methyl-, [S-(R*,R*)]-, F8880-9085, Z756427442, Isoleucine, European Pharmacopoeia (EP) Reference Standard, L-Isoleucine, certified reference material, TraceCERT(R), E46116A2-987C-4709-9E80-A64DA838D5A1, L-Isoleucine, United States Pharmacopeia (USP) Reference Standard, L-Isoleucine, Pharmaceutical Secondary Standard; Certified Reference Material, (S,S)-2-amino-3-methyl-pentanoicacid;(s,s)-isoleucine;[S-(R*,R*)]-2-Amino-3-methylpentanoic acid, 1160211-67-5, L-Isoleucine, from non-animal source, meets EP, JP, USP testing specifications, suitable for cell culture, 98.5-101.0%" C6H13NO2 AGPKZVBTJJNPAG-WHFBIAKZSA-N (2S,3S)-2-amino-3-methylpentanoic acid n.a. n.a. No No No No Yes No rxnAGORA1321,rxnAGORA1783,rxnAGORA1784,rxnAGORA1785,rxnAGORA3993 PMDBD2001696 potassium Dietary Substance, Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. D0RN2W 5462222 n.a. n.a. "7440-09-7, K, Potassium, Kalium, Potassium, metal, potasio, potassium atom, Potassium metal, Kalium;, CHEBI:26216, MFCD00133776, 19K, Potassium Standard: K+ @ 1000 microg/mL in H2O, Potassium Standard: K @ 1000 microg/mL in 5% HNO3, Potassium Standard: K @ 10000 microg/mL in 5% HNO3, monopotassium, Potassium AA Standard: K @ 1000 microg/mL in 5% HNO3, mono-potassium, HSDB 698, Sulfur-Free Boron Concentrate: B @ approx. 3 wt% in Hydrocarbons, Nabumeton A, Sulfur-Free Potassium Concentrate: K @ approx. 4 wt% in Hydrocarbons, Potassium (NOS), Potassium, 2N+, EINECS 231-119-8, Potassium, elemental, UNII-RWP5GA015D, POTASSIUM, (METAL), Potassium, SAJ first grade, RWP5GA015D, Potassium hydride, in paraffin, DTXSID9049748, DTXCID70820696, Potassium, chunks, in mineral oil, MFCD00011357, AKOS028109834, DB14500, Q703, NS00076466, Potassium, ingot, 99.95% trace metals basis, Potassium - K @ 1000 microg/mL in 5% HNO3, Potassium - K @ 1000 microg/g in Hydrocarbon Oil, Potassium - K @ 5000 microg/g in Hydrocarbon Oil, Potassium Standard: K @ 10 microg/mL in 2% HNO3, Potassium, solid, 99.95% trace metals basis, ampoule, Potassium Standard: K @ 1000 microg/g in Hydrocarbon Oil, Potassium Standard: K @ 5000 microg/g in Hydrocarbon Oil, Potassium, AAS standard solution, Specpure?, K 1000?g/ml, Potassium, plasma standard solution, Specpure?, K 1000?g/ml, Potassium Hollow Cathode Lamp: 1.5"" Diameter, 2-pin, Non-Coded, Potassium Hollow Cathode Lamp: 2.0"" Diameter, 4-pin, Cableless, Potassium Hollow Cathode Lamp: 2.0"" Diameter, 9-pin, Non-Coded, Potassium, plasma standard solution, Specpure?, K 10,000?g/ml, Potassium, Ion chromatography standard solution, Specpure, K+ 1000?g/ml, Sulfur-Free Potassium Standard: K @ 1000 microg/g in Hydrocarbon Oil, Sulfur-Free Potassium Standard: K @ 5000 microg/g in Hydrocarbon Oil" K ZLMJMSJWJFRBEC-UHFFFAOYSA-N potassium n.a. n.a. No No No No Yes No rxnAGORA1322,rxnAGORA1805,rxnAGORA2891,rxnAGORA2924,rxnAGORA3184,rxnAGORA4459 PMDBD2001697 Lactose Dietary Substance, Therapeutic Substance Investigational Drug 63-42-3 DB04465 PA450161 D00046 D0K8XC 6134 389820 NPC58629 (+)-Lactose, .beta.-Lactose, 4-(beta-D-Galactosido)-D-glucose, 4-O-beta-D-Galactopyranosyl-beta-D-glucopyranose, 4-O-beta-D-Galactopyranosyl-D-glucose, beta-D-Glucopyranose, 4-O-beta-D-galactopyranosyl-, beta-D-Lactose, beta-Lactose, D-(+)-Lactose, D-Glucose, 4-O-beta-D-galactopyranosyl, D-Lactose, Lactose, Lactose [JAN], Milk sugar, 5965-66-2, Lactose anhydrous, EINECS 227-751-9, Galbeta1-4Glcbeta, Lactobiose, Galb1-4Glcb, Lactin, UNII-13Q3A43E0S, Saccharum lactin, CHEBI:36218, Fast-flo Lactose, Beta-d-lactose, with 30% alfa, 13Q3A43E0S, (2R,3R,4S,5R,6S)-2-(hydroxymethyl)-6-[(2R,3S,4R,5R,6R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxane-3,4,5-triol, Aletobiose, beta-D-galactopyranosyl-(1->4)-beta-D-glucopyranose, Galactinum, Tablettose, DTXSID2023193, DTXSID5058723, Zeparox EP, Lactose Fast-flo, Pharmatose 21, beta-D-Galp-(1->4)-beta-D-Glcp, Lactin (carbohydrate), beta-D-galactopyranosyl-(1->4)-beta-D-glucose, Osmolactan, (2R,3R,4S,5R,6S)-2-(hydroxymethyl)-6-[(2R,3S,4R,5R,6R)-4,5,6-trihydroxy-2-(hydroxymethyl)tetrahydropyran-3-yl]oxy-tetrahydropyran-3,4,5-triol, (2R,3R,4S,5R,6S)-2-(hydroxymethyl)-6-{[(2R,3S,4R,5R,6R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}oxane-3,4,5-triol, Anhydrous lactose, Super-Tab, Tablettose 70, Tablettose 80, Lactosum anhydricum, Pharmatose 325M, .beta.-D-Lactose, Sorbalac 400, Flowlac 100, Pharmatosa DCL 21, (2R,3R,4R,5S,6R)-6-(Hydroxymethyl)-5-(((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2,3,4-triol, LAT, Saccharum lactis, beta -lactose, Lactose, beta-, 1gwv, 1gzc, 2zgm, Lactose-electricitas, Lactosum, anhydrous, Lactose (8CI), 1ax1, 1z3v, 2nn8, CHEMBL417016, DTXCID403193, DTXCID50196482, Tox21_301866, BDBM50370453, MFCD00064521, beta-D-Gal-(1-->4)-beta-D-Glc, AKOS015950662, HY-W150340, CAS-63-42-3, NCGC00255383-01, .beta.-D-Gal-(1-->4)-.beta.-D-Glc, CS-0206827, NS00083021, 820 - Lactose (low levels) - Food products, C01970, D-Glucose, 4-O-b-D-galactopyranosyl- (9CI), F71297, EN300-7536191, A832404, Q127900, 4-O-(beta-D-Galactopyranosyl)-beta-D-glucopyranose, beta-Lactose, suitable for component for culture media, beta-D-Lactose, contains ca. 70% beta and ca. 30% alpha, 60B85732-763B-4E21-BD67-6163315FD251, beta-Lactose, <=30% alpha-anomer basis, >=99% total lactose basis, WURCS=2.0/2,2,1/(a2122h-1b_1-5)(a2112h-1b_1-5)/1-2/a4-b1, (2R,3R,4R,5S,6R)-6-(hydroxymethyl)-5-((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)tetrahydro-2H-pyran-2,3,4-triol C12H22O11 GUBGYTABKSRVRQ-DCSYEGIMSA-N (2R,3R,4S,5R,6S)-2-(hydroxymethyl)-6-[(2R,3S,4R,5R,6R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxane-3,4,5-triol n.a. n.a. No No No No Yes No rxnAGORA1325,rxnAGORA1807,rxnAGORA1811,rxnAGORA3782,rxnAGORA3855 PMDBD2001698 L-leucine Dietary Substance, Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D0W4MZ 6106 n.a. n.a. "L-leucine, leucine, 61-90-5, (S)-Leucine, (S)-2-Amino-4-methylpentanoic acid, H-Leu-OH, (2S)-2-amino-4-methylpentanoic acid, Leucin, (S)-(+)-Leucine, leu, Leucinum, L-Norvaline, 4-methyl-, LEUCINE, L-, FEMA No. 3297, (S)-2-Amino-4-methylvaleric acid, L-alpha-Aminoisocaproic acid, Leucin [German], Leucine (VAN), Leucina, (2S)-alpha-leucine, L-(+)-Leucine, L-(-)-2-Amino-4-methylpentanoic acid, L-leucin, Leucine [USAN:INN], Leucinum [INN-Latin], Leucina [INN-Spanish], Leucina [Latin,Spanish], Valeric acid, 2-amino-4-methyl-, (S)-, AI3-08899, 2-amino-4-methylvaleric acid, NSC 46709, Pentanoic acid, 2-amino-4-methyl-, (S)-, 2-Amino-4-methylpentanoic acid, (S)-, UNII-GMW67QNF9C, GMW67QNF9C, L-Leuzin, Leucine, l, 2-Amino-4-methylvaleric acid (L), EINECS 200-522-0, 2-Amino-4-methylpentanoic acid (L), NSC-46709, Leucine (L-Leucine), CHEBI:15603, (2S)-alpha-2-amino-4-methylvaleric acid, HSDB 7799, MFCD00002617, CHEMBL291962, DTXSID9023203, L-Leucine, labeled with tritium, EC 200-522-0, Leucinum (INN-Latin), Leucina (INN-Spanish), Leucina (Latin,Spanish), LEUCINE (II), LEUCINE [II], LEUCINE (MART.), LEUCINE [MART.], L-Leu, alpha-Aminoisocaproic acid, Leuzin, Hleu, LEUCINE (EP MONOGRAPH), LEUCINE [EP MONOGRAPH], LEUCINE (USP MONOGRAPH), LEUCINE [USP MONOGRAPH], Norvaline, 4-methyl-, (2S)-2-amino-4-methylpentanoate, L-a-Aminoisocaproic acid, NSC9252, LeuOH, 1lan, 1usk, 3h-l-leucine, L-2-Amino-4-methylpentanoic acid, L-Leucine;, (L)-leucine, .alpha.-Amino-.gamma.-methylvaleric acid, (3H)Leucine, H-Leu, Leucine (USP), L-a-Aminoisocaproate, L-Leucine,(S), Leucine (H-3), 4-methyl-L-Norvaline, L-Leu-OH, (2S)-2-amino-4-methyl-pentanoic acid, H-Leu-OH USP grade, 1f2o, starbld0005460, L-Leucine (JP17), L-alpha-Aminoisocaproate, LEUCINE [VANDF], LEUCINE [HSDB], LEUCINE [INCI], LEUCINE [USAN], LEUCINE [INN], LEUCINE [MI], L-LEUCINE [FCC], L-LEUCINE [JAN], L-LEUCINE [FHFI], LEUCINE [WHO-DD], bmse000042, bmse000920, L-Leucine, 99%, FG, SCHEMBL3889, NCIStruc1_001860, NCIStruc2_000010, iso-C4H9CH(NH2)COOH, L-LEUCINE [USP-RS], 2-Amino-4-methyl-valeric acid, DTXCID903203, GTPL3312, L-.alpha.-Aminoisocaproic acid, (S)-2-Amino-4-methylvalerate, Norvaline, 4-methyl-, (L)-, (S)-2-Amino-4-methylpentanoate, IS_LEUCINE-5,5,5-D3, Pharmakon1600-01301005, HY-N0486, NCI46709, STR01720, L-Leucine, Vetec(TM), 98.5%, BDBM50219348, CCG-37658, NCGC00013565, NSC760100, s3753, Oxirane, 2,3-bis(2-chlorophenyl)-, (S)-2-Amino-4-methyl-pentanoic acid, 2-Amino-4-methylvaleric acid, (L)-, AKOS010373766, AKOS015841779, AM81871, CS-W020705, DB00149, NSC-760100, 2-Amino-4-methylpentanoic acid, (L)-, VALINE IMPURITY C [EP IMPURITY], L-Leucine, tested according to Ph.Eur., NCGC00013565-02, NCGC00096678-01, 71000-80-1, Certified Reference Material of L-leucine, E641, L-Leucine, BioUltra, >=99.5% (NT), L-Leucine, SAJ special grade, >=99.0%, L-Leucine, reagent grade, >=98% (HPLC), L0029, NS00125065, EN300-52627, L-Leucine, Vetec(TM) reagent grade, >=98%, C00123, D00030, F70226, L-2700, M03060, (2S)-2-azaniumyl-4-methyl-pentanoate;H-Leu-OH, L-Leucine, Cell Culture Reagent (H-L-Leu-OH), A821449, A833479, Q483745, Q-201312, (2R)-2-amino-4-methyl-pentanoic acid;D-HOMO-VALINE, L-Leucine, certified reference material, TraceCERT(R), LYSINE HYDROCHLORIDE IMPURITY A [EP IMPURITY], 2B9FF792-3CA1-4BEA-BC63-6D4E1A86714E, F8889-8638, Leucine, European Pharmacopoeia (EP) Reference Standard, Z756437526, L-Leucine, United States Pharmacopeia (USP) Reference Standard, L-Leucine, Pharmaceutical Secondary Standard; Certified Reference Material, L-Leucine, from non-animal source, meets EP, JP, USP testing specifications, suitable for cell culture, 98.5-101.0%" C6H13NO2 ROHFNLRQFUQHCH-YFKPBYRVSA-N (2S)-2-amino-4-methylpentanoic acid n.a. n.a. No No No No Yes No rxnAGORA1326,rxnAGORA1814,rxnAGORA1815,rxnAGORA1816,rxnAGORA3992 PMDBD2001699 L-methionine Dietary Substance, Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D0PO8E 6137 n.a. n.a. "L-methionine, 63-68-3, methionine, h-Met-oh, (S)-2-Amino-4-(methylthio)butanoic acid, Cymethion, L-(-)-Methionine, S-Methionine, Liquimeth, Neo-methidin, L-Methioninum, Methilanin, (L)-Methionine, Acimethin, L-Methionin, (S)-methionine, metionina, Methionine (VAN), Methioninum, Metionina [DCIT], (2S)-2-amino-4-(methylsulfanyl)butanoic acid, L-alpha-Amino-gamma-methylmercaptobutyric acid, h-Met-h, Methioninum [INN-Latin], L-Homocysteine, S-methyl-, met, CCRIS 5528, CCRIS 5536, HSDB 4317, L(-)-Amino-gamma-methylthiobutyric acid, L-Met, L-alpha-Amino-gamma-methylthiobutyric acid, L-gamma-Methylthio-alpha-aminobutyric acid, L-Methionine-35S, METHIONINE, L-, 2-Amino-4-methylthiobutanoic acid (S)-, UNII-AE28F7PNPL, AE28F7PNPL, Toxin WAR (Bacillus thuringiensis strain PS205C), 2-Amino-4-(methylthio)butyric acid, (S)-, EINECS 200-562-9, NSC 22946, Butanoic acid, 2-amino-4-(methylthio)-, (S)-, (S)-2-amino-4-(methylthio)butyric acid, CHEBI:16643, (2S)-2-Amino-4-methylsulfanylbutanoic acid, L-a-Amino-g-methylthiobutyric acid, carbon-11 methionine, S-Methyl-L-homocysteine, (S)-(+)-Methionine, MFCD00063097, NSC-22946, gamma-Methylthio-alpha-aminobutyric acid, L-2-Amino-4-(methylthio)butanoic acid, CHEMBL42336, 3654-96-4, DTXSID5040548, L-2-Amino-4methylthiobutyric acid, Methionine [USAN:USP:INN:BAN], meritonin, METHIONINE (II), METHIONINE [II], Methioninum (INN-Latin), (S)-2-Amino-4-(methylmercapto)butyric acid, METHIONINE (MART.), METHIONINE [MART.], Hmet, METHIONINE (EP MONOGRAPH), METHIONINE [EP MONOGRAPH], METHIONINE (USP MONOGRAPH), METHIONINE [USP MONOGRAPH], Methionine (USAN:USP:INN:BAN), Methionine [USAN:INN], (2S)-2-amino-4-methylsulfanyl-butanoic acid, C-11 Methionine, 1006386-95-3, 58576-49-1, l-2-Amino-4-(methylthio)butyric acid, (2S)-2-amino-4-(methylsulfanyl)butanoate, C-11 Met, L-Lobamine, 3h-l-methionine, g-Methylthio-a-aminobutyric acid, racemic methionine, 1wkm, Toxin WAR, (35S)Methionine, Methionine (USP), L(-)-Methionin, a-Amino-g-methylmercaptobutyric acid, methioninum racemicum, L-Methionine,(S), 1pg2, 1qq9, L-Methionine Z (TN), METHIONINE [MI], L-Methionine (JP17), METHIONINE [INN], METHIONINE [HSDB], METHIONINE [INCI], METHIONINE [USAN], Methionine (L-Methionine), METHIONINE [VANDF], Methionine, L- (8CI), bmse000044, bmse000915, L-METHIONINE [FCC], L-METHIONINE [JAN], SCHEMBL4226, G-methylthio-a-aminobutyrate, L-Methionine (H-Met-OH), METHIONINE [WHO-DD], 2-Amino-4-methylthiobutanoate, L-a-amino-g-methylthiobutyrate, L-METHIONINE [USP-RS], GTPL4814, A-amino-g-methylmercaptobutyrate, IS_METHIONINE-METHYL-D3, 2-Amino-4-(methylthio)butyrate, DTXCID3020548, SCHEMBL15702352, V03AB26, Pharmakon1600-01301006, alpha-amino-alpha-aminobutyric acid, gamma-methylthio-alpha-aminobutyrate, HY-N0326, L-2-Amino-4-methylthiobutyric acid, BDBM50142500, MFCD00801344, NSC760117, s5633, L-alpha-amino-gamma-methylthiobutyrate, L-Methionine, Vetec(TM), 98.5%, (S)-2-Amino-4-(methylthio)butanoate, AKOS000281626, AKOS015852512, L-Methionine, labeled with carbon-11, alpha-amino-gamma-methylmercaptobutyrate, CCG-266196, CS-W020566, DB00134, NSC-760117, (S)-2-amino-4-(methylthio)-Butanoate, LEUCINE IMPURITY B [EP IMPURITY], NCGC00160620-01, NCGC00160620-02, AS-10898, BP-31235, (S)-2-amino-4-(methylthio)-Butanoic acid, L-Methionine, BioUltra, >=99.5% (NT), A5456, AM20100552, M0099, NS00068567, EN300-52631, L-Methionine, SAJ special grade, >=98.5%, C00073, D00019, D70895, L(-)-amino-alpha-amino-alpha-aminobutyric acid, L-Methionine, reagent grade, >=98% (HPLC), M-3100, M02939, M02945, L-Methionine, Vetec(TM) reagent grade, >=98%, A934626, L-Methionine, Cell Culture Reagent (H-L-Met-OH), C6CB5837-2B49-4B25-AAB0-D305DAFE26EB, Q22124685, F1905-8241, Z756440050, L-Methionine, certified reference material, TraceCERT(R), Methionine, European Pharmacopoeia (EP) Reference Standard, N-(2CT Resin)-L-Met-OH (200-400 mesh, > 0.3 mmol/g), L-Methionine, United States Pharmacopeia (USP) Reference Standard, L-Methionine, Pharmaceutical Secondary Standard; Certified Reference Material, Soft tissue sarcoma-associated protein (human clone WO2004048938-SEQID-1139), L-Methionine, from non-animal source, meets EP, JP, USP testing specifications, suitable for cell culture, 99.0-101.0%" C5H11NO2S FFEARJCKVFRZRR-BYPYZUCNSA-N (2S)-2-amino-4-methylsulfanylbutanoic acid n.a. n.a. No No No No Yes No rxnAGORA1333,rxnAGORA1883,rxnAGORA1890,rxnAGORA3372,rxnAGORA3787,rxnAGORA4136,rxn00457 PMDBD2001700 magnesium Dietary Substance, Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. D0B8QB 5462224 n.a. n.a. "7439-95-4, Magnesium, Mg, magnesio, Magnesium metallicum, Magnesium metal, Magnesium turnings, Rieke''s active magnesium, Magnesium powder, HSDB 654, Magnesium ribbon, MFCD00085308, Magnesium, turnings, UNII-I38ZP9992A, DTXSID0049658, Magnesium sheet, I38ZP9992A, Magnesium powdered, Magnesio [Italian], EINECS 231-104-6, UN1418, UN1869, UN2950, Magnesium Standard: Mg+2 @ 1000 microg/mL in H2O, 12Mg, Magnesium Standard: Mg @ 1000 microg/mL in 5% HNO3, Magnesium Standard: Mg @ 10000 microg/mL in 5% HNO3, Magnesium AA Standard: Mg @ 1000 microg/mL in 5% HNO3, magnesium atom, Magnesium rod, Magnesium, foil, thickness 0.0125 mm, size 25 x 25 mm, purity 99.9%, Magnesium, foil, thickness 0.0125 mm, size 50 x 50 mm, purity 99.9%, Magnesium, foil, thickness 0.015 mm, size 100 x 100 mm, purity 99.9%, Magnesium, foil, thickness 0.015 mm, size 25 x 25 mm, purity 99.9%, Magnesium, foil, thickness 0.015 mm, size 50 x 50 mm, purity 99.9%, Magnesium, foil, thickness 0.02 mm, size 100 x 100 mm, purity 99.9%, Magnesium, foil, thickness 0.02 mm, size 25 x 25 mm, purity 99.9%, Magnesium, foil, thickness 0.02 mm, size 50 x 50 mm, purity 99.9%, Magnesium, foil, thickness 0.025 mm, size 100 x 100 mm, purity 99.9%, Magnesium, foil, thickness 0.025 mm, size 50 x 50 mm, purity 99.9%, Magnesium, foil, thickness 1.0 mm, size 100 x 100 mm, purity 99.9%, Magnesium, foil, thickness 1.0 mm, size 25 x 25 mm, purity 99.9%, Magnesium, foil, thickness 1.0 mm, size 50 x 50 mm, purity 99.9%, magnesium(0), Magnesium (0), Magnesium, elemental, Magnesium (Turnings), MAGNESIUM SCRAP, Magnesium, 99.5%, Nmc Magma Mineral Pack, MAGNESIUM ELEMENT, MAGNESIUM [MI], MAGNESIUM [HSDB], MAGNESIUM [VANDF], Magnesium powder 50 mesh, EC 231-104-6, Magnesium, >=99.8%, MAGNESIUM [WHO-DD], Magnesium powder 325 mesh, JIS 1, Magnesium turnings, -4 mesh, PK 31 (MAGNESIUM), Magnesium, powder, >=99%, Magnesium, plate, 99.95%, Magnesium powder, -325 mesh, Magnesium, puriss., 98.0%, Magnesium, puriss., 99.5%, MAGNESIUM POWDER [INCI], Magnesium turnings for Grignards, CHEMBL2146125, CHEBI:25107, HSDB 7065, DTXCID70876310, MAGNESIUM GRANULES, COATED, PK 31, Magnesium granules, -12+50 mesh, MAGNESIUM METALLICUM [HPUS], Magnesium powder, -20+100 mesh, Magnesium powder,-100+200 mesh, Residuals in pure zinc, O50x20mm, Magnesium, granular, 20-230 mesh, UN2010, AKOS015902697, AKOS016017174, AKOS028110047, Magnesium, grit, >=99.0% (KT), DB14513, Magnesium, LR, turnings, >=99.5%, Magnesium hydride, hydrogen-storage grade, Magnesium, ribbon, >=99.5% Mg basis, Magnesium, SAJ first grade, >=98.0%, Magnesium, SAJ first grade, >=99.0%, BP-30179, BP-31186, Magnesium, turnings, reagent grade, 98%, Q660, Rieke Magnesium 2.5g in 100 ml of THF, M3358, Magnesium, ingot, >=99% trace metals basis, Magnesium, ribbon, =99% trace metals basis, NS00076161, Magnesium foil, 1.0mm (0.04in) thick, hard, Magnesium foil, 0.25mm (0.01in) thick, hard, Magnesium, 20-230 mesh, reagent grade, 98%, Magnesium - Mg @ 1000 microg/mL in 5% HNO3, Magnesium foil, 0.05mm (0.002in) thick, hard, 2.5 grams of Rieke Magnesium in 100 mL of THF, 25 grams of Rieke(R) Magnesium in 1000mL of THF, 5.0 grams of Rieke(R) Magnesium in 200mL of THF, Magnesium foil, 0.125mm (0.005in) thick, hard, Magnesium hydride [UN2010] [Dangerous when wet], Magnesium matrix modifier, for graphite furnace-AAS, 2.5 grams of Rieke(R) Magnesium in 100 mL of THF, Magnesium - Mg @ 1000 microg/g in Hydrocarbon Oil, Magnesium - Mg @ 5000 microg/g in Hydrocarbon Oil, Magnesium Standard: Mg @ 10 microg/mL in 2% HNO3, Magnesium turnings, 1cm (0.4in) & down, Puratronic?, Magnesium, NIST(R) SRM(R) 980, isotopic standard, M000000010, Magnesium, ReagentPlus(R), powder, -50 mesh, >=99%, Magnesium granules, coated particle size not <149 microns, Magnesium rod, 3.3cm (1.3in) dia x 30cm (12in) long, Magnesium rod, 7.9mm (0.31in) dia x 25mm (1in) length, Magnesium Standard: Mg @ 1000 microg/g in Hydrocarbon Oil, Magnesium Standard: Mg @ 5000 microg/g in Hydrocarbon Oil, Magnesium, chips 6-35 mesh, 99.98% trace metals basis, Magnesium, chips, 6-35 mesh, 99.98% trace metals basis, Magnesium, rod, diam. 6 mm, >=99.9% trace metals basis, Magnesium, in a Sure/Seal(TM) bottle, turnings, 37.5 mmol, Magnesium, ReagentPlus(R), ribbon, >=99% trace metals basis, Magnesium, turnings, ~1/8 in., 99.95% trace metals basis, Magnesium, wire reel, 1m, diameter 0.4mm, as drawn, 99.9+%, Magnesium, wire reel, 1m, diameter 0.5mm, as drawn, 99.9+%, Magnesium, wire reel, 1m, diameter 1.0mm, as drawn, 99.9+%, Magnesium, wire reel, 1m, diameter 1.1mm, as drawn, 99.9+%, Magnesium, wire reel, 2m, diameter 0.4mm, as drawn, 99.9+%, Magnesium, wire reel, 2m, diameter 0.5mm, as drawn, 99.9+%, Magnesium, wire reel, 2m, diameter 1.0mm, as drawn, 99.9+%, Magnesium, wire reel, 2m, diameter 1.1mm, as drawn, 99.9+%, Magnesium, wire, 127 mum diameter, 99.9% trace metals basis, MAGNESIUM ALLOY, (WITH > 50% MAGNESIUM, PELLETS, TURNINGS), MAGNESIUM GRANULES COATED, (PARTICLE SIZE >= 149 MICRONS), Magnesium Hollow Cathode Lamp: 2.0"" Diameter, 4-pin, Cableless, Magnesium Hollow Cathode Lamp: 2.0"" Diameter, 9-pin, Non-Coded, Magnesium slug, 6.35mm (0.25in) dia x 12.7mm (0.50in) length, Magnesium slug, 6.35mm (0.25in) dia x 6.35mm (0.25in) length, Magnesium, foil, diameter 8 mm, thickness 0.025 mm, purity 99.9%, Magnesium, foil, diameter 8 mm, thickness 0.075 mm, purity 99.9%, Magnesium, foil, diameter 8 mm, thickness 0.25 mm, purity 99.9%, Magnesium, foil, thickness 0.002 mm, 4 mm diameter, purity 99.9%, Magnesium, foil, thickness 0.002 mm, 6 mm diameter, purity 99.9%, Magnesium, foil, thickness 0.002 mm, diameter 8 mm, purity 99.9%, Magnesium, foil, thickness 0.003 mm, 4 mm diameter, purity 99.9%, Magnesium, foil, thickness 0.003 mm, 6 mm diameter, purity 99.9%, Magnesium, foil, thickness 0.003 mm, 8 mm diameter, purity 99.9%, Magnesium, foil, thickness 0.005 mm, 4 mm diameter, purity 99.9%, Magnesium, foil, thickness 0.005 mm, 6 mm diameter, purity 99.9%, Magnesium, foil, thickness 0.005 mm, 8 mm diameter, purity 99.9%, Magnesium, foil, thickness 0.01 mm, 15 mm diameter, purity 99.9%, Magnesium, foil, thickness 0.01 mm, 4 mm diameter, purity 99.9%, Magnesium, foil, thickness 0.01 mm, 8 mm diameter, purity 99.9%, Magnesium, foil, thickness 0.01 mm, diameter 10 mm, purity 99.9%, Magnesium, foil, thickness 0.01 mm, diameter 6 mm, purity 99.9%, Magnesium, foil, thickness 0.015 mm, 6 mm diameter, purity 99.9%, Magnesium, foil, thickness 0.015 mm, diameter 4 mm, purity 99.9%, Magnesium, foil, thickness 0.015 mm, diameter 8 mm, purity 99.9%, Magnesium, foil, thickness 0.02 mm, 15 mm diameter, purity 99.9%, Magnesium, foil, thickness 0.02 mm, 4 mm diameter, purity 99.9%, Magnesium, foil, thickness 0.02 mm, 6 mm diameter, purity 99.9%, Magnesium, foil, thickness 0.02 mm, 8 mm diameter, purity 99.9%, Magnesium, foil, thickness 0.02 mm, diameter 25 mm, purity 99.9%, Magnesium, foil, thickness 0.02 mm, purity 99.9%, diameter 10 mm, Magnesium, foil, thickness 0.025 mm, 4 mm diameter, purity 99.9%, Magnesium, foil, thickness 0.025 mm, diameter 6 mm, purity 99.9%, Magnesium, foil, thickness 0.05 mm, 10 mm diameter, purity 99.9%, Magnesium, foil, thickness 0.05 mm, 15 mm diameter, purity 99.9%, Magnesium, foil, thickness 0.05 mm, 4 mm diameter, purity 99.9%, Magnesium, foil, thickness 0.05 mm, 8 mm diameter, purity 99.9%, Magnesium, foil, thickness 0.05 mm, diameter 25 mm, purity 99.9%, Magnesium, foil, thickness 0.05 mm, diameter 6 mm, purity 99.9%, Magnesium, foil, thickness 0.075 mm, 4 mm diameter, purity 99.9%, Magnesium, foil, thickness 0.075 mm, 6 mm diameter, purity 99.9%, Magnesium, foil, thickness 0.1 mm, 10 mm diameter, purity 99.9%, Magnesium, foil, thickness 0.1 mm, 15 mm diameter, purity 99.9%, Magnesium, foil, thickness 0.1 mm, 25 mm diameter, purity 99.9%, Magnesium, foil, thickness 0.1 mm, 4 mm diameter, purity 99.9%, Magnesium, foil, thickness 0.1 mm, 6 mm diameter, purity 99.9%, Magnesium, foil, thickness 0.1 mm, 8 mm diameter, purity 99.9%, Magnesium, foil, thickness 0.125 mm, 4 mm diameter, purity 99.9%, Magnesium, foil, thickness 0.125 mm, 6 mm diameter, purity 99.9%, Magnesium, foil, thickness 0.125 mm, 8 mm diameter, purity 99.9%, Magnesium, foil, thickness 0.15 mm, 10 mm diameter, purity 99.9%, Magnesium, foil, thickness 0.15 mm, 4 mm diameter, purity 99.9%, Magnesium, foil, thickness 0.15 mm, 8 mm diameter, purity 99.9%, Magnesium, foil, thickness 0.15 mm, diameter 15 mm, purity 99.9%, Magnesium, foil, thickness 0.15 mm, diameter 25 mm, purity 99.9%, Magnesium, foil, thickness 0.15 mm, diameter 6 mm, purity 99.9%, Magnesium, foil, thickness 0.25 mm, 10 mm diameter, purity 99.9%, Magnesium, foil, thickness 0.25 mm, 4 mm diameter, purity 99.9%, Magnesium, foil, thickness 0.25 mm, 6 mm diameter, purity 99.9%, Magnesium, foil, thickness 0.25 mm, diameter 15 mm, purity 99.9%, Magnesium, foil, thickness 0.25 mm, diameter 25 mm, purity 99.9%, Magnesium, foil, thickness 0.5 mm, 10 mm diameter, purity 99.9%, Magnesium, foil, thickness 0.5 mm, 15 mm diameter, purity 99.9%, Magnesium, foil, thickness 0.5 mm, 4 mm diameter, purity 99.9%, Magnesium, foil, thickness 0.5 mm, 6 mm diameter, purity 99.9%, Magnesium, foil, thickness 0.5 mm, diameter 25 mm, purity 99.9%, Magnesium, foil, thickness 0.5 mm, diameter 8 mm, purity 99.9%, Magnesium, foil, thickness 1.0 mm, 10 mm diameter, purity 99.9%, Magnesium, foil, thickness 1.0 mm, 15 mm diameter, purity 99.9%, Magnesium, foil, thickness 1.0 mm, 25 mm diameter, purity 99.9%, Magnesium, foil, thickness 1.0 mm, 6 mm diameter, purity 99.9%, Magnesium, foil, thickness 1.0 mm, 8 mm diameter, purity 99.9%, Magnesium, foil, thickness 1.0 mm, diameter 4 mm, purity 99.9%, Magnesium, foil, thickness 1.5 mm, 15 mm diameter, purity 99.9%, Magnesium, foil, thickness 1.5 mm, 25 mm diameter, purity 99.9%, Magnesium, foil, thickness 1.5 mm, 4 mm diameter, purity 99.9%, Magnesium, foil, thickness 1.5 mm, 6 mm diameter, purity 99.9%, Magnesium, foil, thickness 1.5 mm, 8 mm diameter, purity 99.9%, Magnesium, foil, thickness 1.5 mm, diameter 10 mm, purity 99.9%, Magnesium, rod, 1.6 mm diameter, length 1000 mm, purity 99.9%, Magnesium, rod, 1.6 mm diameter, length 200 mm, purity 99.9%, Magnesium, rod, 1.6 mm diameter, length 500 mm, purity 99.9%, Magnesium, rod, 1.6 mm diameter, purity 99.9%, length 100 mm, Magnesium, rod, 10 mm diameter, length 100 mm, purity 99.97%, Magnesium, rod, 10 mm diameter, length 200 mm, purity 99.97%, Magnesium, rod, 10 mm diameter, length 50 mm, purity 99.97%, Magnesium, rod, 12.7 mm diameter, length 100 mm, purity 99.9%, Magnesium, rod, 12.7 mm diameter, length 500 mm, purity 99.9%, Magnesium, rod, 12.7 mm diameter, purity 99.9%, length 200 mm, Magnesium, rod, 15 mm diameter, length 50 mm, purity 99.97%, Magnesium, rod, 25.4 mm diameter, length 100 mm, purity 99.9%, Magnesium, rod, 25.4 mm diameter, length 1000 mm, purity 99.9%, Magnesium, rod, 25.4 mm diameter, length 200 mm, purity 99.9%, Magnesium, rod, 25.4 mm diameter, length 500 mm, purity 99.9%, Magnesium, rod, 3.2 mm diameter, length 100 mm, purity 99.9%, Magnesium, rod, 3.2 mm diameter, length 1000 mm, purity 99.9%, Magnesium, rod, 3.2 mm diameter, length 200 mm, purity 99.9%, Magnesium, rod, 4.8 mm diameter, length 100 mm, purity 99.9%, Magnesium, rod, 4.8 mm diameter, length 1000 mm, purity 99.9%, Magnesium, rod, 4.8 mm diameter, length 200 mm, purity 99.9%, Magnesium, rod, 4.8 mm diameter, length 500 mm, purity 99.9%, Magnesium, rod, 50 mm diameter, length 100 mm, purity 99.9%, Magnesium, rod, 50 mm diameter, length 200 mm, purity 99.9%, Magnesium, rod, 7.9 mm diameter, length 100 mm, purity 99.9%, Magnesium, rod, 7.9 mm diameter, length 1000 mm, purity 99.9%, Magnesium, rod, 7.9 mm diameter, length 200 mm, purity 99.9%, Magnesium, rod, 7.9 mm diameter, length 500 mm, purity 99.9%, Magnesium, rod, 76 mm diameter, length 150 mm, purity 99.9%, Magnesium, rod, length 100 mm, 15 mm diameter, purity 99.97%, Magnesium, rod, length 1000 mm, 12.7 mm diameter, purity 99.9%, Magnesium, rod, length 500 mm, 3.2 mm diameter, purity 99.9%, Magnesium, rod, length 500 mm, 50 mm diameter, purity 99.9%, Magnesium, wire reel, 0.1m, diameter 0.125mm, as drawn, 99.9+%, Magnesium, wire reel, 0.1m, diameter 0.25mm, as drawn, 99.9+%, Magnesium, wire reel, 0.1m, diameter 0.4mm, as drawn, 99.9+%, Magnesium, wire reel, 0.1m, diameter 0.5mm, as drawn, 99.9+%, Magnesium, wire reel, 0.1m, diameter 1.0mm, as drawn, 99.9+%, Magnesium, wire reel, 0.1m, diameter 1.1mm, as drawn, 99.9+%, Magnesium, wire reel, 0.5m, diameter 0.125mm, as drawn, 99.9+%, Magnesium, wire reel, 0.5m, diameter 0.25mm, as drawn, 99.9+%, Magnesium, wire reel, 0.5m, diameter 0.4mm, as drawn, 99.9+%, Magnesium, wire reel, 0.5m, diameter 0.5mm, as drawn, 99.9+%, Magnesium, wire reel, 0.5m, diameter 1.0mm, as drawn, 99.9+%, Magnesium, wire reel, 0.5m, diameter 1.1mm, as drawn, 99.9+%, Magnesium, wire reel, 1m, diameter 0.125mm, as drawn, 99.9+%, Magnesium, wire reel, 1m, diameter 0.25mm, as drawn, 99.9+%, Magnesium, wire reel, 2m, diameter 0.125mm, as drawn, 99.9+%, Magnesium, wire reel, 2m, diameter 0.25mm, as drawn, 99.9+%, AQUANAL(TM)-plus magnesium (Mg) 100-1500 mg/L, refill pack for 37426, Magnesium cube, 19mm (0.75in) x 19mm (0.75in) x 19mm (0.75in), Magnesium slug, 3.175mm (0.125in) dia x 3.175mm (0.125in) length, Magnesium, foil, diameter 10 mm, thickness 0.003 mm, purity 99.9%, Magnesium, foil, thickness 0.002 mm, 10 mm diameter, purity 99.9%, Magnesium, foil, thickness 0.002 mm, 15 mm diameter, purity 99.9%, Magnesium, foil, thickness 0.002 mm, size 25 x 25 mm, purity 99.9%, Magnesium, foil, thickness 0.002 mm, size 50 x 50 mm, purity 99.9%, Magnesium, foil, thickness 0.003 mm, 15 mm diameter, purity 99.9%, Magnesium, foil, thickness 0.003 mm, size 25 x 25 mm, purity 99.9%, Magnesium, foil, thickness 0.003 mm, size 50 x 50 mm, purity 99.9%, Magnesium, foil, thickness 0.005 mm, diameter 10 mm, purity 99.9%, Magnesium, foil, thickness 0.005 mm, diameter 15 mm, purity 99.9%, Magnesium, foil, thickness 0.005 mm, size 25 x 25 mm, purity 99.9%, Magnesium, foil, thickness 0.005 mm, size 50 x 50 mm, purity 99.9%, Magnesium, foil, thickness 0.01 mm, size 100 x 100 mm, purity 99.9%, Magnesium, foil, thickness 0.01 mm, size 25 x 25 mm, purity 99.9%, Magnesium, foil, thickness 0.01 mm, size 50 x 50 mm, purity 99.9%, Magnesium, foil, thickness 0.0125 mm, 25 mm diameter, purity 99.9%, Magnesium, foil, thickness 0.0125 mm, 8 mm diameter, purity 99.9%, Magnesium, foil, thickness 0.0125 mm, diameter 10 mm, purity 99.9%, Magnesium, foil, thickness 0.0125 mm, diameter 15 mm, purity 99.9%, Magnesium, foil, thickness 0.0125 mm, diameter 4 mm, purity 99.9%, Magnesium, foil, thickness 0.0125 mm, diameter 6 mm, purity 99.9%, Magnesium, foil, thickness 0.0125 mm, size 100 x 100 mm, purity 99.9%, Magnesium, foil, thickness 0.015 mm, 10 mm diameter, purity 99.9%, Magnesium, foil, thickness 0.015 mm, 15 mm diameter, purity 99.9%, Magnesium, foil, thickness 0.015 mm, diameter 25 mm, purity 99.9%, Magnesium, foil, thickness 0.025 mm, 10 mm diameter, purity 99.9%, Magnesium, foil, thickness 0.025 mm, 25 mm diameter, purity 99.9%, Magnesium, foil, thickness 0.025 mm, diameter 15 mm, purity 99.9%, Magnesium, foil, thickness 0.025 mm, size 25 x 25 mm, purity 99.9%, Magnesium, foil, thickness 0.05 mm, size 100 x 100 mm, purity 99.9%, Magnesium, foil, thickness 0.05 mm, size 25 x 25 mm, purity 99.9%, Magnesium, foil, thickness 0.05 mm, size 50 x 50 mm, purity 99.9%, Magnesium, foil, thickness 0.075 mm, 10 mm diameter, purity 99.9%, Magnesium, foil, thickness 0.075 mm, 15 mm diameter, purity 99.9%, Magnesium, foil, thickness 0.075 mm, diameter 25 mm, purity 99.9%, Magnesium, foil, thickness 0.075 mm, size 100 x 100 mm, purity 99.9%, Magnesium, foil, thickness 0.075 mm, size 25 x 25 mm, purity 99.9%, Magnesium, foil, thickness 0.075 mm, size 50 x 50 mm, purity 99.9%, Magnesium, foil, thickness 0.1 mm, size 100 x 100 mm, purity 99.9%, Magnesium, foil, thickness 0.1 mm, size 25 x 25 mm, purity 99.9%, Magnesium, foil, thickness 0.1 mm, size 50 x 50 mm, purity 99.9%, Magnesium, foil, thickness 0.125 mm, 10 mm diameter, purity 99.9%, Magnesium, foil, thickness 0.125 mm, 15 mm diameter, purity 99.9%, Magnesium, foil, thickness 0.125 mm, 25 mm diameter, purity 99.9%, Magnesium, foil, thickness 0.125 mm, size 100 x 100 mm, purity 99.9%, Magnesium, foil, thickness 0.125 mm, size 25 x 25 mm, purity 99.9%, Magnesium, foil, thickness 0.125 mm, size 50 x 50 mm, purity 99.9%, Magnesium, foil, thickness 0.15 mm, size 100 x 100 mm, purity 99.9%, Magnesium, foil, thickness 0.15 mm, size 25 x 25 mm, purity 99.9%, Magnesium, foil, thickness 0.15 mm, size 50 x 50 mm, purity 99.9%, Magnesium, foil, thickness 0.25 mm, size 100 x 100 mm, purity 99.9%, Magnesium, foil, thickness 0.25 mm, size 150 x 150 mm, purity 99.9%, Magnesium, foil, thickness 0.25 mm, size 25 x 25 mm, purity 99.9%, Magnesium, foil, thickness 0.25 mm, size 50 x 50 mm, purity 99.9%, Magnesium, foil, thickness 0.5 mm, size 100 x 100 mm, purity 99.9%, Magnesium, foil, thickness 0.5 mm, size 150 x 150 mm, purity 99.9%, Magnesium, foil, thickness 0.5 mm, size 25 x 25 mm, purity 99.9%, Magnesium, foil, thickness 0.5 mm, size 50 x 50 mm, purity 99.9%, Magnesium, foil, thickness 1.0 mm, size 150 x 150 mm, purity 99.9%, Magnesium, foil, thickness 1.5 mm, size 100 x 100 mm, purity 99.9%, Magnesium, foil, thickness 1.5 mm, size 25 x 25 mm, purity 99.9%, Magnesium, foil, thickness 1.5 mm, size 50 x 50 mm, purity 99.9%, Magnesium, foil, thickness 2.0 mm, size 100 x 100 mm, purity 99.9%, Magnesium, foil, thickness 2.0 mm, size 25 x 25 mm, purity 99.9%, Magnesium, foil, thickness 2.0 mm, size 50 x 50 mm, purity 99.9%, Magnesium, foil, thickness 3.0 mm, size 100 x 100 mm, purity 99.9%, Magnesium, foil, thickness 3.0 mm, size 50 x 50 mm, purity 99.9%, Magnesium, foil, thickness 6.0 mm, size 100 x 100 mm, purity 99.9%, Magnesium, foil, thickness 6.0 mm, size 50 x 50 mm, purity 99.9%, Magnesium, ReagentPlus(R), powder, -325 mesh, 99.5% trace metals basis, Sulfur-Free Magnesium Standard: Mg @ 1000 microg/g in Hydrocarbon Oil, Sulfur-Free Magnesium Standard: Mg @ 5000 microg/g in Hydrocarbon Oil, MAGNESIUM ALLOYS, WITH MORE THAN 50% MAGNESIUM, IN PELLETS, TURNINGS OR RIBBONS, Magnesium granules, coated particle size not <149 microns [UN2950] [Dangerous when wet], Magnesium preparation, Highly Reactive Rieke(R)Metal, suspension, 2.5 g in THF, Magnesium ribbon, approximate dimensions, 3.0mm (0.12in) wide, 0.15mm (0.0059in) thick, Magnesium slug, 3.175mm (0.125in) dia x 6.35mm (0.25in) length, annealed, Magnesium slug, 6.35mm (0.25in) dia x 12.7mm (0.50in) length, 99.95% (metals basis), Magnesium slug, 6.35mm (0.25in) dia x 6.35mm (0.25in) length, 99.95% (metals basis), Magnesium sputtering target, 50.8mm (2.0in) dia x 6.35mm (0.250in) thick, Magnesium sputtering target, 76.2mm (3.0in) dia x 6.35mm (0.250in) thick, Magnesium, dendritic pieces, purified by distillation, 99.99% trace metals basis, Magnesium, dendritic pieces, purified by distillation, 99.998% trace metals basis, Magnesium, in a Sure/Seal(TM) bottle, turnings, anhydrous tetrahydrofuran 37.5 mmol, Magnesium, powder, 250 max. part. size (micron), weight 1000 g, purity 99.8+%, Magnesium, powder, 50 max. part. size (micron), purity 99.8%, weight 1000 g, Magnesium, powder, 50 max. part. size (micron), weight 100 g, purity 99.8%, Magnesium, powder, 50 max. part. size (micron), weight 200 g, purity 99.8%, Magnesium, powder, max. particle size 250 micron, weight 100 g, purity 99.8+%, Magnesium, powder, max. particle size 250 micron, weight 200 g, purity 99.8+%, Magnesium, powder, max. particle size 250 micron, weight 500 g, purity 99.8+%, Magnesium, powder, max. particle size 50 micron, weight 500 g, purity 99.8%, Magnesium slug, 3.175mm (0.125in) dia x 6.35mm (0.25in) length, annealed, 99.95% (metals basis), Magnesium, microfoil, 25x25mm, thinness 1.0mum, specific density 174mug/cm2, 6 micron aluminum permanent support, 99.9%, Magnesium, microfoil, 50x50mm, thinness 1.0mum, specific density 174mug/cm2, 6 micron aluminum permanent support, 99.9%, Magnesium, microleaf, 25x25mm, thinness 1.0mum, specific density 174mug/cm2, removable support, 99.9%, Magnesium, microleaf, 50x50mm, thinness 1.0mum, specific density 174mug/cm2, removable support, 99.9%" Mg FYYHWMGAXLPEAU-UHFFFAOYSA-N magnesium AstraZeneca n.a. No No No No Yes No rxnAGORA1337,rxnAGORA1891,rxnAGORA1893,rxnAGORA4093 PMDBD2001701 Sodium Dietary Substance, Therapeutic Substance Phase 3 n.a. n.a. n.a. n.a. D0K8NR 5360545 n.a. n.a. "7440-23-5, Na, Sodium, Natrium, Sodio, sodium atom, 116001-96-8, 11Na, DTXSID1049774, CHEBI:26708, MFCD00085307, Sodium metal, Natrium; Sodio; Sodium metal;, Sodium 23, HSDB 687, Sodium Standard: Na+ @ 1000 microg/mL in H2O, EINECS 231-132-9, Sodium Standard: Na @ 1000 microg/mL in 5% HNO3, Sodium Standard: Na @ 10000 microg/mL in 5% HNO3, Sodium AA Standard: Na @ 1000 microg/mL in 5% HNO3, monosodium, mono sodium, mono-sodium, UNII-9NEZ333N27, Sodium ingot, AMG 386, Sodium, CP, Sodalite8149, Sodium hydride, CP, Sodium (NOS), Sodium, 3N5, ATOMIC SODIUM, Sodium hydride, 60%, SODIUM, METAL, GMW VITAPET WATER, SODIUM, ELEMENTAL, SODIUM, (METAL), Sodium, ACS reagent, dry, EC 231-132-9, Pentosan [USAN 1990], SODIUM HYDRIDE [MI], Sodium hydride, dry, 95%, UNII-23J3BHR95O, SODIUM HYDRIDE [HSDB], HSDB 745, NAH 80, Sodium, sticks, in mineral oil, DTXCID00876449, 9NEZ333N27, Sodium dispersion, gray suspension, EINECS 231-587-3, MFCD00003471, UN1427, AKOS015833457, Sodium Phyllo-pentaoxodimanganate(III), Sodium, SAJ first grade, >=99.5%, Sodium, 99%, lumps, contains kerosene, 1ST000547C6-25A, Sodium, 40 wt % dispersion in paraffin, Q658, Sodium metal, ingot in a sealed foil pack, Sodium, 99.95% trace metals basis, ingot, D5792, NS00076202, Sodium, 25-35 wt % dispersion in paraffin, EC 231-587-3, AB01566864_01, Sodium - Na @ 1000 microg/mL in 5% HNO3, Sodium hydride [UN1427] [Dangerous when wet], Sodium Standard: Na+ @ 100 microg/mL in H2O, A838715, Sodium - Na @ 1000 microg/g in Hydrocarbon Oil, Sodium - Na @ 5000 microg/g in Hydrocarbon Oil, Sodium Standard: Na @ 10 microg/mL in 2% HNO3, Sodium, solid, 99.95% trace metals basis, ampoule, Sodium standard for AAS, ready-to-use, in nitric acid, Sodium Standard: Na @ 1000 microg/g in Hydrocarbon Oil, Sodium Standard: Na @ 5000 microg/g in Hydrocarbon Oil, Sodium, AAS standard solution, Specpure?, Na 1000?g/ml, Sodium, plasma standard solution, Specpure?, Na 1000?g/ml, U-[13C6]-quinic acid solution in acetonitrile, 25 ug/mL, Sodium Hollow Cathode Lamp: 1.5"" Diameter, 2-pin, Non-Coded, Sodium Hollow Cathode Lamp: 2.0"" Diameter, 4-pin, Cableless, Sodium Hollow Cathode Lamp: 2.0"" Diameter, 9-pin, Non-Coded, Sodium, in kerosene, pieces (large), >=99.8% (sodium basis), Sodium, plasma standard solution, Specpure?, Na 10,000?g/ml, Sodium standard for ICP, for ICP, ready-to-use, in nitric acid, Sulfur-Free Sodium Concentrate: Na @ approx. 3 wt% in Hydrocarbons, Sulfur-Free Sodium Standard: Na @ 1000 microg/g in Hydrocarbon Oil, Sulfur-Free Sodium Standard: Na @ 5000 microg/g in Hydrocarbon Oil, Sodium standard for AAS, analytical standard, 10.00 g/L Na in nitric acid, Sodium, Ion chromatography standard solution, Specpure?, Na+ 1000?g/ml" Na KEAYESYHFKHZAL-UHFFFAOYSA-N sodium Amgen n.a. No No No No Yes No rxnAGORA1340,rxnAGORA2989,rxnAGORA3357,rxnAGORA3370,rxnAGORA3380,rxnAGORA3410,rxnAGORA3504,rxnAGORA3655,rxnAGORA3909,rxnAGORA4020,rxnAGORA4046,rxnAGORA4090,rxnAGORA4094,rxnAGORA4275,rxnAGORA4482,rxnAGORA4697,rxnAGORA4706,rxnAGORA4707,rxnAGORA4900 PMDBD2001702 Nicotinate Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 937 n.a. NPC318336 nicotinate, pyridine-3-carboxylate, 3-pyridinecarboxylate, 3 Pyridinecarboxylic Acid, nico-400-, CHEBI:32544, PVNIIMVLHYAWGP-UHFFFAOYSA-M, AC-907/25004509, Q27104221 C6H4NO2- PVNIIMVLHYAWGP-UHFFFAOYSA-M pyridine-3-carboxylate n.a. n.a. No No No No Yes No rxnAGORA1341,rxnAGORA1908,rxnAGORA1913,rxnAGORA1928,rxnAGORA3646,rxnAGORA4444,rxnAGORA4475 PMDBD2001703 octadecanoate (n-C18:0) Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 3033836 n.a. NPC209971 Stearate, Octadecanoate, 646-29-7, Octadecanoic acid, ion(1-), stearic acid, ion(1-), Stearates, 3uex, Stearic acid ion(1-)salt, octadecanoate (n-C18:0), CHEBI:25629, QIQXTHQIDYTFRH-UHFFFAOYSA-M, DTXSID301020741, CH3-[CH2]16-COO(-), AKOS022105769, NCGC00164255-02, Q28529718 C18H35O2- QIQXTHQIDYTFRH-UHFFFAOYSA-M octadecanoate n.a. n.a. No No No No Yes No rxnAGORA1344,rxnAGORA1380,rxnAGORA1947,rxnAGORA1948,rxnAGORA3265,rxnAGORA3312,rxnAGORA4608 PMDBD2001704 (R)-Pantothenate Dietary Substance, Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. D07SJT 6613 n.a. NPC60151 "pantothenic acid, D-pantothenic acid, 79-83-4, vitamin B5, pantothenate, Chick antidermatitis factor, (R)-pantothenate, (+)-Pantothenic acid, (R)-pantothenic acid, (D)-(+)-Pantothenic acid, PANTOTHENOIC ACID, HSDB 1020, Kyselina pantothenova, Kyselina pantothenova [Czech], Pantothenic acid (d), BRN 1727064, Pantothenic Acid [BAN], D(+)-N-(2,4-Dihydroxy-3,3-dimethylbutyryl)-beta-alanine, beta-Alanine, N-(2,4-dihydroxy-3,3-dimethyl-1-oxobutyl)-, (R)-, EINECS 201-229-0, Vitamin B-5, B 5, Vitamin, UNII-19F5HK2737, CHEBI:46905, Pantothenic acid, D-, 3-[[(2R)-2,4-dihydroxy-3,3-dimethylbutanoyl]amino]propanoic acid, N-(2,4-Dihydroxy-3,3-dimethylbutyryl)-beta-alanine, (D,+)-N(alpha-gamma-Dihydroxy-beta,beta-dimethylbutyryl)-beta-alanine, 19F5HK2737, DTXSID9023417, N-[(2R)-2,4-DIHYDROXY-3,3-DIMETHYLBUTANOYL]-BETA-ALANINE, 4-04-00-02569 (Beilstein Handbook Reference), Pantothenic acid (BAN), (+)-Pantothenate, PANTOTHENIC ACID (MART.), PANTOTHENIC ACID [MART.], (R)-N-(2,4-Dihydroxy-3,3-dimethyl-1-oxobutyl)-beta-alanine, 3-[(2R)-2,4-dihydroxy-3,3-dimethylbutanamido]propanoic acid, N-[(2R)-2,4-Dihydroxy-3,3-dimethyl-1-oxobutyl]-beta-alanine, d-pantothenate, PAU, B5, Vitamin, Vitamin B 5, pantothenic-acid, MFCD00020513, Pantotenico acido, N-((2R)-2,4-DIHYDROXY-3,3-DIMETHYL-1-OXOBUTYL)-beta-ALANINE, delta-Pantothenate, Pantothen Pharmaselect, delta-Pantothenic acid, (R)-3-(2,4-Dihydroxy-3,3-dimethylbutanamido)propanoic acid, D-(+)-pantothenic acid, (D)-(+)-Pantothenate, N-(2,4-dihydroxy-3,3-dimethylbutanoyl)-beta-alanine, bmse000287, SCHEMBL5436, CHEMBL1594, Pantothen Pharmaselect (TN), VITAMIN B5 [VANDF], PANTOTHENIC ACID [MI], (+)-(R)-3-(2,4-Dihydroxy-3,3-dimethylbutanamido)propanoic acid, Pantothenic acid, D- (8CI), DTXCID203417, GTPL4668, Pantothenic acid (pantothenate), PANTOTHENIC ACID [HSDB], PANTOTHENIC ACID [INCI], PANTOTHENIC ACID [VANDF], ()-pantothenate;()-vitamin B5, VITAMIN B5 [GREEN BOOK], PANTOTHENIC ACID [WHO-DD], HMS2090P08, HMS3656K08, HY-B0430, .beta.-Alanine, N-(2,4-dihydroxy-3,3-dimethyl-1-oxobutyl)-, (R)-, AKOS016010488, PANTOTHENIC ACID [ORANGE BOOK], DB01783, NCGC00183031-08, NCGC00346610-01, AS-75446, SBI-0206933.P001, NS00069969, SW220291-1, C00864, D07413, E83797, EN300-113766, Pantothenic Acid (Technical Grade, Contains Lactone), Q63390527, D(+)-N-(2,4-Dihydroxy-3,3-dimethylbutyryl)-b-alanine, 450B5472-A689-4BCA-9BC1-58691B72D00F, N-[(2R)-2,4-Dihydroxy-3,3-dimethyl-1-oxobutyl]-ss-alanine, 3-((R)-2,4-Dihydroxy-3,3-dimethyl-butyrylamino)-propionic acid, 3-[[(2R)-2,4-dihydroxy-3,3-dimethyl-butanoyl]amino]propionic acid, beta-Alanine, N-(2,4-dihydroxy-3,3-dimethyl-1-oxobutyl)-,(R)-, beta-Alanine, N-[(2R)-2,4-dihydroxy-3,3-dimethyl-1-oxobutyl]-, 3-[[(2R)-3,3-dimethyl-2,4-bis(oxidanyl)butanoyl]amino]propanoic acid, b-Alanine, N-[(2R)-2,4-dihydroxy-3,3-dimethyl-1-oxobutyl]- (9CI), beta-Alanine, N-(2,4-dihydroxy-3,3-dimethyl-1-oxobutyl)-, (R)- (9CI), N-((2R)-2,4-DIHYDROXY-3,3-DIMETHYL-1-OXOBUTYL)-.BETA.-ALANINE" C9H17NO5 GHOKWGTUZJEAQD-ZETCQYMHSA-N 3-[[(2R)-2,4-dihydroxy-3,3-dimethylbutanoyl]amino]propanoic acid n.a. n.a. No No No No Yes No rxnAGORA1350,rxnAGORA2010,rxnAGORA2011,rxnAGORA4972 PMDBD2001705 L-proline Dietary Substance, Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. D0DZ3X 145742 n.a. n.a. "L-proline, proline, 147-85-3, L-(-)-Proline, (2S)-pyrrolidine-2-carboxylic acid, (S)-Pyrrolidine-2-carboxylic acid, H-Pro-OH, 2-pyrrolidinecarboxylic acid, (-)-Proline, (-)-(S)-Proline, Prolinum, (S)-2-Pyrrolidinecarboxylic acid, (-)-2-Pyrrolidinecarboxylic acid, prolina, (S)-Proline, L-Pyrrolidine-2-carboxylic acid, L-alpha-Pyrrolidinecarboxylic acid, (S)-2-Carboxypyrrolidine, L-Prolin, Prolinum [Latin], Prolina [Spanish], Proline, L-, Proline (VAN), (L)-PROLINE, FEMA No. 3319, Proline [USAN:INN], FEMA Number 3319, 2-Pyrrolidinecarboxylic acid, (S)-, PRO (IUPAC abbreviation), CB 1707, (S)-(-)-Proline, HSDB 1210, AI3-26710, UNII-9DLQ4CIU6V, 9DLQ4CIU6V, EINECS 205-702-2, NSC 46703, pro, CHEBI:17203, MFCD00064318, NSC-46703, 37159-97-0, CHEMBL54922, L-2-pyrrolidinecarboxylic acid, DTXSID5044021, EC 205-702-2, Prolinum (Latin), prol, 4305-67-3, Proline (L-Proline), PROLINE (II), PROLINE [II], PROLINE (MART.), PROLINE [MART.], PROLINE (EP MONOGRAPH), PROLINE [EP MONOGRAPH], PROLINE (USP MONOGRAPH), PROLINE [USP MONOGRAPH], Carboxypyrrolidine, L-(2,3-3H)Proline, Proline (USP), (2S)-pyrrolidin-1-ium-2-carboxylate, L-Proline, labeled with carbon-14, racemic proline, rac-proline, NSC46703, s-proline, 3h-l-proline, L-Proline;, Proline, (S)-pyrrolidine-2-carboxylic acid, (-)-2-Pyrrolidinecarboxylic acid, (-)-Proline, (S)-(-)-Proline, (S)-2-Carboxypyrrolidine, (S)-2-Pyrrolidinecarboxylic acid, (S)-Proline, 2-Pyrrolidinecarboxylic acid, Carboxypyrrolidine, L-(-)-Proline, L-Pyrrolidine-2-carboxylic acid, L-alpha-Pyrrolidinecarboxylic acid, NSC 46703, H-Pro, (2S)-proline, Pro-OH, L-Proline,(S), L-Pro-OH, (-)-Proline (S)-2-Carboxypyrrolidine, 2-Pyrrolidinecarboxylate, L-Proline (JP17), PROLINE [VANDF], PROLINE [HSDB], PROLINE [INCI], PROLINE [USAN], PROLINE [INN], PROLINE [MI], L-PROLINE [FCC], L-PROLINE [JAN], L-PROLINE [FHFI], PROLINE [WHO-DD], bmse000047, bmse000947, (2S)-2-carboxypyrrolidine, SCHEMBL7792, L-PROLINE [USP-RS], (S)-2-Pyrralidinecarboxylate, (S)-2-Pyrrolidinecarboxylate, (-)-2-Pyrrolidinecarboxylate, (S)-(-)-PROLIN, GTPL3314, DTXCID3024021, L-Proline, 99%, FCC, FG, (S)-2-Pyrralidinecarboxylic acid, pyrrolidin-2-(S)-carboxylic acid, Pharmakon1600-01301007, pyrrolidine-2-(S)-carboxylic acid, BCP25292, HY-Y0252, (S) -pyrrolidine-2-carboxylic acid, L-Proline, >=99.0% (NT), (S)-(-)-Pyrrolidine-2-carboxylate, BDBM50000100, NCGC00014017, NSC760114, s5629, AKOS010372120, AKOS015856025, CCG-214709, CS-W019861, DB00172, NSC-760114, (S)-(-)-Pyrrolidine-2-carboxylic acid, NCGC00014017-02, NCGC00014017-03, NCGC00097126-01, AC-11190, AS-10803, L-Proline, BioUltra, >=99.5% (NT), L-Proline, SAJ special grade, >=99.0%, AM20080359, L-Proline, Vetec(TM), 98.5-101.5%, NS00074201, P0481, EN300-52624, L-Proline, Vetec(TM) reagent grade, >=99%, C00148, D00035, L-Proline, ReagentPlus(R), >=99% (HPLC), M02947, P17692, Q-201327, L-Proline, certified reference material, TraceCERT(R), Q20035886, A01B5B63-CC3D-4796-A7B4-C2DE26A6FA93, F0001-2348, Flavor and Extract Manufacturers'' Association No. 3319, Proline, European Pharmacopoeia (EP) Reference Standard, Z756429958, L-Proline, United States Pharmacopeia (USP) Reference Standard, L-Proline, Pharmaceutical Secondary Standard; Certified Reference Material, L-Proline, from non-animal source, meets EP, USP testing specifications, suitable for cell culture" C5H9NO2 ONIBWKKTOPOVIA-BYPYZUCNSA-N (2S)-pyrrolidine-2-carboxylic acid n.a. Dietary supplement No No No No Yes No rxnAGORA1351,rxnAGORA1963,rxnAGORA2035,rxnAGORA2036,rxnAGORA3074,rxnAGORA3077,rxnAGORA3078,rxnAGORA3079,rxnAGORA3583,rxnAGORA4116 PMDBD2001706 D-ribose Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 10975657 n.a. NPC95006 D-Rib, D-Ribopyranose, D-Ribopyranoside, D-Ribose, Rib, Ribopyranose, Ribopyranoside, Ribose, 10257-32-6, D Ribose, (3R,4R,5R)-Tetrahydro-2H-pyran-2,3,4,5-tetraol, (3R,4R,5R)-Oxane-2,3,4,5-tetrol, Ribopyranose (7CI,8CI,9CI), 10257-33-7, (3R,4R,5R)-tetrahydro-2H-pyran-2,3,4,5-tetrol, Ribiose, ribo-pentose, D-ribo-pentose, EC 700-481-3, Ribopyranose(7ci,8ci,9ci), SCHEMBL339948, CHEBI:16988, CHEBI:33942, CHEBI:47006, CHEBI:47007, DTXSID70450356, SRBFZHDQGSBBOR-SOOFDHNKSA-N, NS00106195, C21057, EN300-1704373, Q27120754, rel-(3R,4R,5R)-tetrahydro-2H-pyran-2,3,4,5-tetrol C5H10O5 SRBFZHDQGSBBOR-SOOFDHNKSA-N (3R,4R,5R)-oxane-2,3,4,5-tetrol n.a. n.a. No No No No Yes No rxnAGORA1354,rxnAGORA2089,rxnAGORA2094,rxnAGORA2096,rxnAGORA2652 PMDBD2001707 Riboflavin Dietary Substance, Therapeutic Substance Approved Drug 83-88-5 DB00140 PA451242 D00050 D04QST 493570 n.a. NPC94167 "riboflavin, vitamin B2, 83-88-5, Riboflavine, Lactoflavin, Vitamin G, Lactoflavine, Flavaxin, (-)-riboflavin, Riboflavinum, Beflavin, Beflavine, Lactobene, Ribocrisina, Riboderm, Riboflavina, Ribotone, Vitaflavine, Flaxain, Ribipca, Ribosyn, Ribovel, Vitamin Bi, Flavin BB, Russupteridine Yellow III, Vitasan B2, HYRE, Bisulase, Riboflavinequinone, 7,8-Dimethyl-10-ribitylisoalloxazine, 6,7-Dimethyl-9-D-ribitylisoalloxazine, E101, Lacto-flavin, Fiboflavin, Dermadram, vitamin-b2, HSDB 817, Aqua-Flave, C.I. Food Yellow 15, Riboflavin (Vit B2), CCRIS 1904, Ins no.101(iii), CHEBI:17015, Ins-101(iii), Riboflavin (Vitamin B2), UNII-TLM2976OFR, 7,8-Dimethyl-10-(D-ribo-2,3,4,5-tetrahydroxypentyl)isoalloxazine, EINECS 201-507-1, E-101(iii), TLM2976OFR, Vitamin b2 (as riboflavin), NSC 33298, Vitamin B-2, DTXSID8021777, AI3-14697, INS NO. 101(I), Isoalloxazine, 7,8-dimethyl-10-D-ribityl-, C.I. 50900, 7,8-dimethyl-10-[(2S,3S,4R)-2,3,4,5-tetrahydroxypentyl]benzo[g]pteridine-2,4-dione, MFCD00005022, NSC-33298, NCI-0033298, 7,8-dimethyl-10-((2S,3S,4R)-2,3,4,5-tetrahydroxypentyl)benzo[g]pteridine-2,4(3H,10H)-dione, D-Ribitol, 1-deoxy-1-(3,4-dihydro-7,8-dimethyl-2,4-dioxobenzo(g)pteridin-10(2H)-yl)-, DTXCID401777, Isoalloxazine, 7,8-dimethyl-10-(D-ribo-2,3,4,5-tetrahydroxypentyl)-, 1-Deoxy-1-(7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2H)-yl)pentitol, RIBOFLAVIN (II), RIBOFLAVIN [II], RIBOFLAVIN (MART.), RIBOFLAVIN [MART.], 1-Deoxy-1-(3,4-dihydro-7,8-dimethyl-2,4-dioxobenzo[g]pteridin-10(2H)-yl)-D-ribitol, 1-deoxy-1-(7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2H)-yl)-D-ribitol, RIBOFLAVIN (USP-RS), RIBOFLAVIN [USP-RS], Riboflavine [INN-French], Riboflavinum [INN-Latin], Riboflavina [INN-Spanish], 7,8-DIMETHYL-10-(1''-D-RIBITYL)ISOALLOXAZINE, RIBOFLAVIN (EP MONOGRAPH), RIBOFLAVIN [EP MONOGRAPH], RIBOFLAVIN (USP MONOGRAPH), RIBOFLAVIN [USP MONOGRAPH], Benzo(g)pteridine-2,4(3H,10H)-dione, 7,8-dimethyl-10-(D-ribo-2,3,4,5-tetrahydroxypentyl)-, 7,8-dimethyl-10-(D-ribo-2,3,4,5-tetrahydroxypentyl)benzo[g]pteridine-2,4(3H,10H)-dione, 7,8-dimethyl-10-[(2S,3S,4R)-2,3,4,5-tetrahydroxypentyl]-2H,3H,4H,10H-benzo[g]pteridine-2,4-dione, Vitamin B 2, Riboflavin [USP:INN:BAN], vitaminum b2, 1kyv, 2ccb, 2vxa, ()-Riboflavin, 1-deoxy-1-(7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo(g)pteridin-10(2H)-yl)-D-ribitol, 1-deoxy-1-(7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo(g)pteridin-10(2H)-yl)pentitol, 5-deoxy-5-(7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo(g)pteridin-10(2H)-yl)-D-ribitol, 5-deoxy-5-(7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2H)-yl)-D-ribitol, 7,8-dimethyl-10-(D-ribo-2,3,4,5-tetrahydroxypentyl)benzo(g)pteridine-2,4(3H,10H)-dione, San Yellow B, CAS-83-88-5, NCGC00017291-05, Bisulase (TN), 7,8-dimethyl-10-((2S,3S,4R)-2,3,4,5-tetrahydroxypentyl)benzo(g)pteridine-2,4(3H,10H)-dione, Food Yellow 15, Prestwick_442, 1217461-14-7, 2fl5, 2vx9, 4d1y, RIBOFLAVIN [MI], RIBOFLAVIN [FCC], RIBOFLAVIN [INN], RIBOFLAVIN [JAN], Vitamin B2; E101, Prestwick3_000634, RIBOFLAVIN [HSDB], RIBOFLAVIN [INCI], LACTOFLAVIN [INCI], RIBOFLAVIN [VANDF], Epitope ID:161730, RIBOFLAVINUM [HPUS], SCHEMBL7706, CHEMBL1534, RIBOFLAVIN [WHO-DD], RIBOFLAVIN [WHO-IP], VITAMIN B2 [VANDF], BSPBio_000628, MLS001066391, BPBio1_000692, GTPL6578, Riboflavin (JP17/USP/INN), RIBOFLAVINE; VITAMIN B2, RIBOFLAVIN [ORANGE BOOK], A11HA04, S01XA26, VITAMIN B2 [GREEN BOOK], (-)-Riboflavin, 97-103%, HMS2096P10, Benzo[g]pteridine riboflavin deriv., HY-B0456, Riboflavin(B2);7,8-Dimethyl-10-((2S,3S,4R)-2,3,4,5-tetrahydroxypentyl)benzo[g]pteridine-2,4(3H,10H)-dione, RIBOFLAVINUM [WHO-IP LATIN], Tox21_110813, Tox21_111714, Tox21_201633, Tox21_302980, 6,7-Dimethyl-9-ribitylisoalloxazine, BDBM50362895, s2540, Riboflavin (B2), analytical standard, Tox21_111714_1, DB00140, NCGC00091288-01, NCGC00091288-02, NCGC00091288-03, NCGC00091288-04, NCGC00091288-05, NCGC00179498-01, NCGC00256408-01, NCGC00259182-01, AS-15936, SMR000112236, R0020, (-)-Riboflavin, tested according to Ph.Eur., C00255, D00050, EN300-6477227, (-)-Riboflavin, meets USP testing specifications, A840676, A934900, Q130365, (-)-Riboflavin, from Eremothecium ashbyii, >=98%, W-104132, Z2216887959, RIBOFLAVIN SODIUM PHOSPHATE IMPURITY D [EP IMPURITY], Riboflavin, European Pharmacopoeia (EP) Reference Standard, Riboflavin, United States Pharmacopeia (USP) Reference Standard, 7,8-Dimethyl-10-(D-ribo-2,3,4,5-tetrahydroxypentyl)-isoalloxazine, Riboflavin, Pharmaceutical Secondary Standard; Certified Reference Material, 3,10-Dihydro-7,8-dimethyl-10-(D-ribo-2,3,4,5-tetrahydroxypentyl)benzopteridine-2,4-dione, 7,8-dimethyl-10-(D-ribo-2,3,4,5-tetrahydroxypentyl)-Benzo[g]pteridine-2,4(3H,10H)-dione, d-ribitol, 1-Deoxy-1-(3,4-dihydro-7,8-dimethyl-2,4-dioxobenzo(g)pteridin-10(-2H)-yl)-, Riboflavin for peak identification, European Pharmacopoeia (EP) Reference Standard, (-)-Riboflavin, 100 mug/mL (1% ammonium acetate in 50:50 methanol:water), certified reference material, ampule of 1 mL, (-)-Riboflavin, BioReagent, suitable for cell culture, suitable for insect cell culture, >=98%, 7,8-dimethyl-10-[(2S,3S,4R)-2,3,4,5-tetrakis(oxidanyl)pentyl]benzo[g]pteridine-2,4-dione, 7,8-dimethyl-2,4-dioxo-10-[(2S,3S,4R)-2,3,4,5-tetrahydroxypentyl](2,4a,10a-C,1,3-)-2H,3H,4H,10H-benzo[g]pteridin-3-yl, InChI=1/C17H20N4O6/c1-7-3-9-10(4-8(7)2)21(5-11(23)14(25)12(24)6-22)15-13(18-9)16(26)20-17(27)19-15/h3-4,11-12,14,22-25H,5-6H2,1-2H3,(H,20,26,27)/t11-,12+,14-/m0/s" C17H20N4O6 AUNGANRZJHBGPY-SCRDCRAPSA-N 7,8-dimethyl-10-[(2S,3S,4R)-2,3,4,5-tetrahydroxypentyl]benzo[g]pteridine-2,4-dione n.a. n.a. No No No No Yes No rxnAGORA1355,rxnAGORA2088,rxnAGORA2095,rxnAGORA4795,rxnAGORA4797,rxnAGORA4916 PMDBD2001708 L-serine Dietary Substance, Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D0T6GM 5951 n.a. n.a. "L-serine, serine, 56-45-1, (S)-2-Amino-3-hydroxypropanoic acid, (S)-Serine, H-Ser-OH, beta-Hydroxyalanine, L-ser, L-(-)-Serine, Serine, L-, (2S)-2-amino-3-hydroxypropanoic acid, L-Serin, L-3-Hydroxy-alanine, 2-Amino-3-hydroxypropionic acid, beta-Hydroxy-L-alanine, Serinum [Latin], SER (IUPAC abbrev), Serina [Spanish], L-2-Amino-3-hydroxypropionic acid, Serine (VAN), Serinum, alpha-Amino-beta-hydroxypropionic acid, Serene, Serina, (-)-Serine, L-3-Hydroxy-2-aminopropionic acid, Serine [USAN:INN], HSDB 680, (S)-(-)-Serine, 2-Amino-3-hydroxypropanoic acid, (S)-, Propanoic acid, 2-amino-3-hydroxy-, (S)-, (S)-2-Amino-3-hydroxypropionic acid, ser, CHEBI:17115, BRN 1721404, (S)-alpha-Amino-beta-hydroxypropionic acid, EINECS 200-274-3, MFCD00064224, NSC 118365, Serine (L-Serine), (2S)-2-amino-3-hydroxy-propanoic acid, 3-Hydroxyalanine, UNII-452VLY9402, 452VLY9402, NSC-118365, (S)-2-amino-3-hydroxy-Propanoic acid, 6898-95-9, Serinum (Latin), DTXSID60883230, EC 200-274-3, 4-04-00-03118 (Beilstein Handbook Reference), SERINE (II), SERINE [II], SERINE (MART.), SERINE [MART.], L-SERINE (USP-RS), L-SERINE [USP-RS], serin, SERINE (EP MONOGRAPH), SERINE [EP MONOGRAPH], SERINE (USP MONOGRAPH), SERINE [USP MONOGRAPH], l serine, .beta.-Hydroxyalanine, b-Hydroxy-L-alanine, rac-serine, Racemic serine, 2-amino-3-hydroxypropanoate, NSC118365, ?-Hydroxyalanine, 3h-l-serine, L-Serine;, H-Ser, (S)-a-Amino-b-hydroxypropionic acid, Serine (USP), 3-hydroxy-L-Alanine, L-Serine,(S), Tocris-0226, Tocris-0227, L-Serine (JP17), SERINE [VANDF], SERINE [HSDB], SERINE [INCI], SERINE [USAN], L-Alanine, 3-hydroxy-, SERINE [INN], (S)-(+)-2-Amino-3-hydroxypropionic acid, Serine (L) [INCI], SERINE [WHO-DD], Lopac-S-4250, SERINE [MI], L-SERINE [FCC], L-SERINE [JAN], (L)-SERINE, bmse000048, bmse000809, bmse000867, bmse000885, Epitope ID:150900, SCHEMBL1775, GTPL726, CHEMBL11298, L-3-Hydroxy-2-aminopropionate, (S)-a-Amino-b-hydroxypropionate, (S)-b-Amino-3-hydroxypropionate, (S)-2-Amino-3-hydroxypropanoate, DTXCID501022779, DTXSID301031857, Pharmakon1600-01301010, L-Serine - CAS 56-45-1, (S)-2-amino-3-hydroxy-Propanoate, HY-N0650, L-Serine, Vetec(TM), 98.5%, STR02557, (S)-beta-Amino-3-hydroxypropionate, Fmoc-(2-aminomethylphenyl)aceticacid, l-2-Amino-3-hydroxy-propanoic acid, L-Serine, >=99.0% (NT), BDBM50357212, NSC760115, (S)-b-Amino-3-hydroxypropionic acid, AKOS015854115, (S)-alpha-Amino-beta-hydroxypropionate, AC-1190, CCG-266038, CS-W020136, DB00133, NSC-760115, (S)-beta-Amino-3-hydroxypropionic acid, L-Serine, tested according to Ph.Eur., NCGC00015952-01, NCGC00024507-01, NCGC00024507-02, BP-13282, L-Serine, BioUltra, >=99.5% (NT), SY002847, 2-Amino-3-hydroxypropanoic acid-, (S)-, Propanoic acid, 2-amino-3-hydroxy-, (S), AM20100375, NS00068389, S0035, S9353, EN300-52635, L-Serine, ReagentPlus(R), >=99% (HPLC), L-Serine, Vetec(TM) reagent grade, >=99%, A20660, C00065, D00016, L-Serine, Cell Culture Reagent (H-L-Ser-OH), Q183290, SR-01000597708, .alpha.-Amino-.beta.-hydroxypropionic acid-, (S)-, SR-01000597708-1, L-Serine, certified reference material, TraceCERT(R), F1905-7047, Serine, European Pharmacopoeia (EP) Reference Standard, Z756440058, 3AB40D3A-043A-488F-8361-D1BF309F842C, L-Serine, United States Pharmacopeia (USP) Reference Standard, (s)-2-amino-3-hydroxypropanoicacid;2-Amion-3-hydroxypropionicacid, L-Serine, Pharmaceutical Secondary Standard; Certified Reference Material, L-Serine, from non-animal source, meets EP, USP testing specifications, suitable for cell culture, 98.5-101.0%" C3H7NO3 MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-amino-3-hydroxypropanoic acid n.a. n.a. No No No No Yes No rxnAGORA1359,rxnAGORA1679,rxnAGORA2054,rxnAGORA2055,rxnAGORA2056,rxnAGORA2057,rxnAGORA2058,rxnAGORA2059,rxnAGORA2060,rxnAGORA2061,rxnAGORA2062,rxnAGORA2063,rxnAGORA2064,rxnAGORA2065,rxnAGORA2066,rxnAGORA2114,rxnAGORA2115,rxnAGORA2367,rxnAGORA2368,rxnAGORA2415,rxnAGORA3325,rxnAGORA3919,rxnAGORA4055,rxnAGORA4072,rxn10228,rxn10229,rxn10230,rxn10231 PMDBD2001709 Thiamin Dietary Substance, Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D07TYL 1130 n.a. NPC150950 "thiamine, thiamin, vitamin B1, Aneurin, Antiberiberi factor, Thiamine ion, 70-16-6, thiaminium, Betaxin, thiamine(1+), Biamine, thiamine(1+) ion, CHEBI:18385, 2-[3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-1,3-thiazol-3-ium-5-yl]ethanol, 3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-5-(2-hydroxyethyl)-4-methyl-1,3-thiazol-3-ium, Thiamine (Vit B1), 3-(4-AMINO-2-METHYL-PYRIMIDIN-5-YLMETHYL)-5-(2-HYDROXY-ETHYL)-4-METHYL-THIAZOL-3-IUM, 4ABT0J945J, VIB, THD, Thiaminum (INN-Latin), Tiamina (INN-Spanish), UNII-X66NSO3N35, CCRIS 5823, HSDB 220, 3-((4-Amino-2-methylpyrimidin-5-yl)methyl)-5-(2-hydroxyethyl)-4-methylthiazol-3-ium, DTXSID2023648, Thiazolium, 3-((4-amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydroxyethyl)-4-methyl-, [3H]thiamine, [3H]-thiamine, Vitamin B 1, NSC36226, [3H]vitamin B1, EINECS 200-425-3, vitaminum b1, 1sbr, 3rlb, 3-((4-amino-2-methylpyrimidin-5-yl)methyl)-5-(2-hydroxyethyl)-4-methyl-1,3-thiazol-3-ium, ThOH, Vit B1, Thiamine HCL 100 mg, Prestwick0_000631, Prestwick1_000631, Prestwick2_000631, Prestwick3_000631, bmse000274, TimTec1_000613, CHEMBL1547, THIAMIN; VITAMIN B1, UNII-4ABT0J945J, SCHEMBL10075, BSPBio_000622, SPBio_002841, BPBio1_000686, DTXCID903648, GTPL4628, GTPL4629, SCHEMBL22129283, A11DA01, DTXSID50220251, BDBM50373877, AKOS000668650, DB00152, 2-[3-[(4-amino-2-methyl-pyrimidin-5-yl)methyl]-4-methyl-thiazol-3-ium-5-yl]ethanol, 3[(4-Amino-2-methyl-5-pyrimidinyl)-methyl]-5-(2-hydroxyethyl)-4-methylthiazolium chloride, SMP1_000084, NCGC00017013-05, NCGC00017013-06, NCGC00188957-01, NCGC00188957-02, NS00002759, C00378, Q83187, 2-(3-((4-amino-2-methyl-pyrimidin-5-yl)methyl)-4-methyl-1-thia-3-azoniacyclopenta-2,4-dien-5-yl)ethanol" C12H17N4OS+ JZRWCGZRTZMZEH-UHFFFAOYSA-N 2-[3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-1,3-thiazol-3-ium-5-yl]ethanol n.a. n.a. No No No No Yes No rxnAGORA1367,rxnAGORA2349,rxnAGORA2359,rxnAGORA3414,rxnAGORA3415,rxnAGORA3587 PMDBD2001710 L-threonine Dietary Substance, Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D0N0GE 6288 n.a. n.a. "L-threonine, threonine, 72-19-5, (2S,3R)-2-amino-3-hydroxybutanoic acid, Threonin, L-(-)-Threonine, (S)-Threonine, DL-Threonine, H-Thr-OH, 2-amino-3-hydroxybutyric acid, 80-68-2, Threonine, L-, Threonine (VAN), Threoninum [Latin], Treonina [Spanish], thre, Threoninum, Treonina, (2S,3R)-2-Amino-3-hydroxybutyric acid, Threonine [USAN:INN], (2S)-threonine, (2S,3R)-(-)-Threonine, L-Threonin, L-thr, EINECS 200-774-1, Threonine, DL-, NSC 16589, NSC 46701, L-alpha-Amino-beta-hydroxybutyric acid, 2-Amino-3-hydroxybutanoic acid, (R-(R*,S*))-, DTXSID2046412, FEMA NO. 4710, UNII-2ZD004190S, CHEBI:16857, Butanoic acid, 2-amino-3-hydroxy-, (R-(R*,S*))-, HSDB 7797, L-2-Amino-3-hydroxybutyric acid, MFCD00064270, NSC-16589, NSC-46701, TFM6DU5S6A, 2ZD004190S, DTXCID0026412, [R-(R*,S*)]-2-Amino-3-hydroxybutanoic acid, thr, Threoninum (Latin), THREONINE (II), THREONINE [II], THREONINE (L), (2S,3R)-rel-2-Amino-3-hydroxybutanoic acid, THREONINE (MART.), THREONINE [MART.], (R-(R*,S*))-2-Amino-3-hydroxybutanoic acid, THREONINE (EP MONOGRAPH), THREONINE [EP MONOGRAPH], Threonine #, THREONINE (USP MONOGRAPH), THREONINE [USP MONOGRAPH], Allothreonine, D-, CAS-72-19-5, (R-(R*,S*))-2-Amino-3-hydroxybutanoate, [R-(R*,S*)]-2-Amino-3-hydroxybutanoate, L-(U-14C)Threonine, NSC46701, beta-methylserine, MFCD00063722, L-Threonine;, NSC-206292, (+/-)-2-Amino-3-hydroxybutyric acid, NCGC00164520-01, NCGC00164520-02, Threonine (USP), L-Threonine,(S), H-Thr, (+/-)-threonine, L-Thr-OH, L-Threonine (9CI), Threonine, labeled with carbon-14, L-, THREONINE [INN], L-Threonine (JP17), THREONINE [MI], Threonine (L-Threonine), THREONINE [HSDB], THREONINE [INCI], THREONINE [USAN], UNII-TFM6DU5S6A, THREONINE [VANDF], Threonine, L- (8CI), 2-Amino-3-hydroxybutyrate, bmse000049, bmse000810, bmse000859, L-THREONINE [FCC], L-THREONINE [JAN], L-Threonine (H-Thr-OH), 2-Amino-3-hydroxybutanoate, SCHEMBL1480, THREONINE [WHO-DD], L-2-Amino-3-hydroxybutyrate, L-THREONINE [USP-RS], L-Threonine non-animal source, CCRIS 8603, CHEMBL291747, GTPL4785, CHEBI:26986, DTXSID70893087, L-alpha-Amino-beta-hydroxybutyrate, Pharmakon1600-01301008, HY-N0658, EINECS 201-300-6, Tox21_112154, AC7878, NSC760118, s4951, (2S,3R)-2-Amino-3-hydroxybutyrate, AKOS006240505, AKOS015840277, Tox21_112154_1, CCG-214540, CS-W020046, DB00156, NSC 206292, NSC-760118, 7013-32-3, AC-11296, AS-12789, L-Threonine, BioXtra, >=99.5% (NT), L-Threonine, p.a., 99.0-101.0%, AI3-18477, (2S,3R)-rel-2-Amino-3-hydroxybutanoicacid, [R-(R*,S*)]-2-amino-3-hydroxy-Butanoate, AM20100684, NS00001961, NS00078877, T0230, EN300-54609, L-Threonine, reagent grade, >=98% (HPLC), C00188, D00041, G76695, M02962, [R-(R*,S*)]-2-amino-3-hydroxy-Butanoic acid, L-Threonine, Vetec(TM) reagent grade, >=98%, Q186521, 3DD2E9AD-DB9A-460E-8A6B-C01B0F67AC4E, Q-201331, LYSINE HYDROCHLORIDE IMPURITY C [EP IMPURITY], 48: PN: WO2004076659 FIGURE: 7 claimed sequence, F8881-8883, L-Threonine, certified reference material, TraceCERT(R), Z813019058, L-Threonine, European Pharmacopoeia (EP) Reference Standard, L-Threonine, United States Pharmacopeia (USP) Reference Standard, from non-animal source,EP,JP,USP pound>>for cell culture,99.0-101.0%, L-Threonine, Pharmaceutical Secondary Standard; Certified Reference Material, L-Threonine, from non-animal source, meets EP, JP, USP testing specifications, suitable for cell culture, 99.0-101.0%" C4H9NO3 AYFVYJQAPQTCCC-GBXIJSLDSA-N (2S,3R)-2-amino-3-hydroxybutanoic acid n.a. n.a. No No No No Yes No rxnAGORA1368,rxnAGORA2350,rxnAGORA2351,rxnAGORA2353,rxnAGORA3146,rxnAGORA4135 PMDBD2001711 L-valine Dietary Substance, Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D0LL5V 6287 n.a. n.a. "L-valine, valine, 72-18-4, (S)-Valine, H-Val-OH, (S)-2-Amino-3-methylbutanoic acid, (2S)-2-amino-3-methylbutanoic acid, 2-Amino-3-methylbutyric acid, (S)-2-Amino-3-methylbutyric acid, L-alpha-Amino-beta-methylbutyric acid, Valinum [Latin], Valina [Spanish], valina, Valine (VAN), Valinum, Butanoic acid, 2-amino-3-methyl-, Valine [USAN:INN], L-valin, VALINE, L-, L(+)-alpha-Aminoisovaleric acid, (S)-alpha-Amino-beta-methylbutyric acid, Butanoic acid, 2-amino-3-methyl-, (S)-, NSC 76038, 2-Amino-3-methylbutyric acid, (S)-, 2-Amino-3-methylbutanoic acid, (S)-, val, CHEBI:16414, UNII-HG18B9YRS7, EINECS 200-773-6, HG18B9YRS7, NSC-76038, (L)-valine, 2-Amino-3-methylbutanoic acid (VAN), Valine (L-Valine), HSDB 7800, L-2-Amino-3-methylbutanoic acid, l-(+)-alpha-Aminoisovaleric acid, L-2-Aminoisovaleric Acid, MFCD00064220, 7004-03-7, (S)-alpha-Aminoisovaleric acid, Valinum (Latin), DTXSID40883233, EC 200-773-6, VALINE (II), VALINE [II], L-Val, VALINE (MART.), VALINE [MART.], valin, 2-aminoisovaleric acid, Hval, VALINE (EP MONOGRAPH), VALINE [EP MONOGRAPH], VALINE (USP MONOGRAPH), VALINE [USP MONOGRAPH], (2S)-2-amino-3-methylbutanoate, alpha-aminoisovaleric acid, 2-Amino-3-methyl-butyric acid, 2-amino-3-methylbutanoate, Racemic valine, L-(+)-a-Aminoisovaleric acid, s-valin, L-(+)-.alpha.-Aminoisovaleric acid, L-a-Amino-b-methylbutyric acid, 3h-l-valine, (S)-a-Amino-b-methylbutyric acid, L-Valine;, L-Valine, FCC, Valine (USP), (+)-valine, L-Valine,(S), 1t4s, L-Valine (JP17), L-Valine, 99%, VALINE [VANDF], VALINE [HSDB], VALINE [INCI], VALINE [USAN], (S)-Val, L-Val-4, L-VAL-OH, VALINE [INN], VALINE [WHO-DD], VALINE [MI], 2-Amino-3-methylbutyrate, L-VALINE [FCC], L-VALINE [JAN], bmse000052, bmse000811, bmse000860, L-(+)-a-Aminoisovalerate, L-a-Amino-b-methylbutyrate, SCHEMBL8516, (S)-A-Aminoisovaleric acid, L-VALINE [USP-RS], (S)-?-Aminoisovaleric acid, 2-Aminoisovaleric acid,(S), CHEMBL43068, (S)-a-Amino-b-methylbutyrate, L-(+)-alpha-Aminoisovalerate, L-iso-C3H7CH(NH2)COOH, GTPL4794, (S)-2-Amino-3-methylbutyrate, (S)-2-Amino-3-methylbutanoate, L-alpha-Amino-beta-methylbutyrate, (S)-2-amino-3-methyl-Butanoate, DTXCID201022782, Pharmakon1600-01301009, HY-N0717, (S)-alpha-Amino-beta-methylbutyrate, (S)-2-amino-3-methyl-butyric acid, BDBM50463208, NSC760111, s5628, (S)-2-amino-3-methyl-Butanoic acid, L-Valine, 98.5-101.5%, AKOS015841564, AM82363, CCG-266067, CS-W020706, DB00161, L-Valine, 99%, natural, FCC, FG, NSC-760111, NCGC00344520-01, AS-12787, L-Valine, BioUltra, >=99.5% (NT), L-Valine, SAJ special grade, >=98.5%, L-Valine, reagent grade, >=98% (HPLC), V0014, EN300-52625, L-Valine, Vetec(TM) reagent grade, >=98%, C00183, D00039, L-Valine, Cell Culture Reagent (H-L-Val-OH), LYSINE ACETATE IMPURITY D [EP IMPURITY], M02950, V-1800, (S)-(+)-2-AMINO-3-METHYLBUTYRIC ACID, Q483752, Q-100919, L-Valine, certified reference material, TraceCERT(R), F8889-8698, Valine, European Pharmacopoeia (EP) Reference Standard, Z756430564, 1B39571B-0AE8-4A9A-AE80-4B898D11A981, L-Valine, dimer, meets the analytical specifications of USP, L-Valine, United States Pharmacopeia (USP) Reference Standard, L-Valine, Pharmaceutical Secondary Standard; Certified Reference Material, InChI=1/C5H11NO2/c1-3(2)4(6)5(7)8/h3-4H,6H2,1-2H3,(H,7,8)/t4-/m0/s, L-Valine, from non-animal source, meets EP, JP, USP testing specifications, suitable for cell culture, 98.5-101.0%" C5H11NO2 KZSNJWFQEVHDMF-BYPYZUCNSA-N (2S)-2-amino-3-methylbutanoic acid n.a. n.a. No No No No Yes No rxnAGORA1374,rxnAGORA2402,rxnAGORA2403,rxnAGORA2404,rxnAGORA3180,rxnAGORA3994 PMDBD2001712 aldehydo-D-xylose Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 644160 n.a. NPC200137 "DL-Xylose, 58-86-6, aldehydo-D-xylose, (2R,3S,4R)-2,3,4,5-tetrahydroxypentanal, 25990-60-7, (D)-XYLOSE, (+)-Xylose, D-xylo-pentose, Xylose (VAN), 41247-05-6, Xylose, D-, A1TA934AKO, CHEBI:15936, (+-)-Xylose, MFCD00151475, D-(+)-Xylose;(+)-Xylose;Wood sugar, ()-Xylos, D-Xylose,(S), XYLOSE [VANDF], XYLOSE [HSDB], XYLOSE [INCI], XYLOSE [WHO-DD], XYLOSE [MI], DL-Xylose, >=99%, SCHEMBL15776, XYLOSE [ORANGE BOOK], GTPL4724, CHEMBL1236821, Pharmakon1600-01300048, HY-N0537, ( inverted exclamation markA)-Xylos, ( inverted exclamation markA)-Xylose, MFCD00198055, NSC760130, s2124, AKOS015893065, AM83959, CCG-231055, CS-4824, D-Xylose 1000 microg/mL in Methanol, DB09419, DS-7921, NSC-760130, (2R,3S,4R)-2,3,4,5-tetrahydroxypentana, NS00071570, SW220286-1, X0019, X0020, (2R,4R,5R)-tetrahydropyran-2,3,4,5-tetrol, C74347, EN300-107152, X-7910, X-7950, AB00375890_02, A832048, SR-05000002382, D-xylose (open structure, complete stereochemistry), J-520430, SR-05000002382-1, W-202083, Q27077130, Z1255438834, 141492-19-5, 25702-75-4" C5H10O5 PYMYPHUHKUWMLA-VPENINKCSA-N (2R,3S,4R)-2,3,4,5-tetrahydroxypentanal n.a. n.a. No No No No Yes No rxnAGORA1375,rxnAGORA2407,rxnAGORA2410,rxnAGORA3183 PMDBD2001713 tetradecanoate (n-C14:0) Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No Yes No rxnAGORA1377,rxnAGORA2778,rxnAGORA3156,rxnAGORA3416,rxnAGORA4601 PMDBD2001714 Hexadecanoate (n-C16:0) Dietary Substance, Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D02TVS 985 n.a. NPC216630 "palmitic acid, Hexadecanoic acid, 57-10-3, Cetylic acid, palmitate, n-Hexadecanoic acid, Hexadecylic acid, 1-Pentadecanecarboxylic acid, Hydrofol, n-Hexadecoic acid, Palmitinic acid, hexaectylic acid, Pentadecanecarboxylic acid, hexadecoic acid, 1-Hexyldecanoic Acid, Industrene 4516, Emersol 140, Emersol 143, Hystrene 8016, Hystrene 9016, Palmitinsaeure, Palmitic acid, pure, Palmitic acid 95%, Kortacid 1698, FEMA No. 2832, Loxiol EP 278, Palmitic acid (natural), Hydrofol Acid 1690, Cetyl acid, Prifac 2960, C16:0, HSDB 5001, Pristerene 4934, Pristerene-4934, Edenor C16, NSC 5030, AI3-01594, Lunac P 95KC, Lunac P 95, Lunac P 98, CCRIS 5443, Prifac-2960, CHEBI:15756, NSC5030, NSC-5030, EINECS 200-312-9, UNII-2V16EO95H1, FA 16:0, BRN 0607489, Palmitic acid (NF), DTXSID2021602, Glycon P-45, IMEX C 1498, 2V16EO95H1, Hexadecanoic acid (9CI), MFCD00002747, 67701-02-4, Palmitic acid (7CI,8CI), CHEMBL82293, DTXCID101602, CH3-[CH2]14-COOH, EC 200-312-9, 4-02-00-01157 (Beilstein Handbook Reference), n-hexadecoate, LMFA01010001, PA 900, EDENOR C 16-98-100, FA 1695, SURFAXIN COMPONENT PALMITIC ACID, 1-hexyldecanoate, NCGC00164358-01, LUCINACTANT COMPONENT PALMITIC ACID, 1219802-61-5, pentadecanecarboxylate, Hexadecanoic acid 10 microg/mL in Acetonitrile, HEXADECANOIC-11,11,12,12-D4 ACID, PALMITIC ACID (II), PALMITIC ACID [II], PALMITIC ACID (MART.), PALMITIC ACID [MART.], CH3-(CH2)14-COOH, Palmitic acid; Hexadecanoic acid, PLM, palmic acid, Hexadecanoate (n-C16:0), PALMITIC ACID (EP MONOGRAPH), PALMITIC ACID [EP MONOGRAPH], Acid, Palmitic, CAS-57-10-3, Acid, Hexadecanoic, SR-01000944716, Palmitic acid [USAN:NF], palmitoate, Hexadecoate, Palmitinate, Palmitinsaure, palmitic-acid, palmitoic acid, Hexadecanoicacid, Aethalic acid, Hexadecanoic acid Palmitic acid, 2hmb, 2hnx, Palmitic acid_jeyam, n-Hexadecyclic Acid, fatty acid 16:0, Palmitic Acid, FCC, Kortacid 1695, Palmitic acid_RaGuSa, Univol U332, Prifrac 2960, Hexadecanoic acid anion, Hexadecanoic--d5 Acid, 3v2q, Palmitic acid, >=99%, bmse000590, Epitope ID:141181, CETYL ACID [VANDF], PALMITIC ACID [MI], SCHEMBL6177, PALMITIC ACID [DSC], PALMITIC ACID [FCC], PALMITIC ACID [FHFI], PALMITIC ACID [HSDB], PALMITIC ACID [INCI], PALMITIC ACID [USAN], FAT, WLN: QV15, P5585_SIGMA, PALMITIC ACID [VANDF], GTPL1055, QSPL 166, PALMITIC ACID [USP-RS], PALMITIC ACID [WHO-DD], (1(1)(3)C)hexadecanoic acid, 1b56, HMS3649N08, Palmitic acid, analytical standard, Palmitic acid, BioXtra, >=99%, Palmitic acid, Grade II, ~95%, HY-N0830, Palmitic acid, natural, 98%, FG, Tox21_112105, Tox21_201671, Tox21_302966, AC9381, BDBM50152850, s3794, Palmitic acid, >=95%, FCC, FG, AKOS005720983, Tox21_112105_1, CCG-267027, CR-0047, DB03796, Palmitic acid, for synthesis, 98.0%, NCGC00164358-02, NCGC00164358-03, NCGC00256424-01, NCGC00259220-01, BP-27917, Palmitic acid, purum, >=98.0% (GC), SY006518, CS-0009861, NS00008548, P0002, P1145, Palmitic acid, SAJ first grade, >=95.0%, EN300-19603, C00249, D05341, Palmitic acid, Vetec(TM) reagent grade, 98%, PALMITIC ACID (CONSTITUENT OF SPIRULINA), Palmitic acid, >=98% palmitic acid basis (GC), A831313, Q209727, PALMITIC ACID (CONSTITUENT OF FLAX SEED OIL), PALMITIC ACID (CONSTITUENT OF SAW PALMETTO), SR-01000944716-1, SR-01000944716-2, BA71C79B-C9B1-451A-A5BE-B480B5CC7D0C, PALMITIC ACID (CONSTITUENT OF BORAGE SEED OIL), PALMITIC ACID (CONSTITUENT OF SPIRULINA) [DSC], F0001-1488, Z104474418, PALMITIC ACID (CONSTITUENT OF EVENING PRIMROSE OIL), PALMITIC ACID (CONSTITUENT OF SAW PALMETTO) [DSC], Palmitic acid, certified reference material, TraceCERT(R), Palmitic acid, European Pharmacopoeia (EP) Reference Standard, Palmitic acid, United States Pharmacopeia (USP) Reference Standard, Palmitic acid, Pharmaceutical Secondary Standard; Certified Reference Material, Sodium Palmitate, Palmitic acid sodium salt, Sodium hexadecanoate, Sodium pentadecanecarboxylate, HSDB 759" C16H32O2 IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid n.a. n.a. No No No No Yes No rxnAGORA1378,rxnAGORA2752,rxnAGORA2876,rxnAGORA3408,rxn33911 PMDBD2001715 octadecenoate (n-C18:1) Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 5460221 n.a. NPC7106 oleate, (Z)-octadec-9-enoate, (9Z)-octadec-9-enoate, 115-06-0, (9Z)-Octadecenoate, cis-9-octadecenoate, 9 Octadecenoic Acid, CHEMBL3122151, Oleat, oleic acid anion, 9-Octadecenoic acid (Z)-, ion(1-), (Z)-9-Octadecenoate, octadecenoate (n-C18:1), CHEBI:30823, DTXSID701027701, BDBM50448437, (Z)-9-octadecenoic acid, ion(1-), AKOS022060681, Q27104153 C18H33O2- ZQPPMHVWECSIRJ-KTKRTIGZSA-M (Z)-octadec-9-enoate n.a. n.a. No No No No Yes No rxnAGORA1381,rxnAGORA3481,rxnAGORA3508,rxnAGORA3967 PMDBD2001716 5,6,7,8-Tetrahydrofolate Dietary Substance, Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. D0H2QO 135444742 n.a. n.a. tetrahydrofolic acid, tetrahydrofolate, 135-16-0, 5,6,7,8-tetrahydrofolic acid, Tetrahydropteroylglutamic acid, (2S)-2-(4-(((2-Amino-4-oxo-3,4,5,6,7,8-hexahydropteridin-6-yl)methyl)amino)benzamido)pentanedioic acid, 5,6,7,8-tetrahydrofolate, (6S)-tetrahydrofolate, CHEBI:20506, 43ZWB253H4, (6S)-Tetrahydrofolic acid, Glutamic acid, N-(p-(((2-amino-3,4,5,6,7,8-hexahydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-, L-, tetrahydrofolyl-(L-Glu)n, (2S)-2-[[4-[(2-amino-4-oxo-5,6,7,8-tetrahydro-3H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid, TETRAHYDROFOLICACID, C19H23N7O6, EINECS 205-181-1, UNII-43ZWB253H4, L-GLUTAMIC ACID, N-(4-(((2-AMINO-1,4,5,6,7,8-HEXAHYDRO-4-OXO-6-PTERIDINYL)METHYL)AMINO)BENZOYL)-, L-glutamic acid, N-[4-[[(2-amino-1,4,5,6,7,8-hexahydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-, 5,6,7,8-Tetrahydropteroyl-L-glutamic acid, L-Tetrahydrofolic Acid (>70% when packaged), SCHEMBL82453, N-(4-(((2-Amino-1,4,5,6,7,8-hexahydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid, CHEMBL91866, GTPL4675, CHEMBL2021342, CHEBI:68512, DTXSID70897520, TETRAHYDROFOLIC ACID [DSC], BDBM50022833, MFCD00135583, AKOS022174895, AKOS040744825, (2S)-5,6,7,8-tetrahydrofolic acid, DB00116, DS-7498, AC-31120, HY-14520, N-[4-{[(2-amino-4-oxo-3,4,5,6,7,8-hexahydropteridin-6-yl)methyl]amino}benzoyl]-L-glutamic acid, CS-0003422, (-)-L-5,6,7,8-TETRAHYDROFOLIC ACID, 5,6,7,8-Tetrahydropteroyl-L-glutamic acid, THF, A910085, J-006656, Q53668656, Tetrahydrofolic acid, >=65% (when packaged), powder, (2S)-2-(4-((2-amino-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl)methylamino)benzamido)pentanedioic acid, (2S)-2-[(4-{[(2-amino-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl)methyl]amino}phenyl)formamido]pentanedioic acid, (S)-2-{4-[(2-Amino-4-oxo-1,4,5,6,7,8-hexahydro-pteridin-6-ylmethyl)-amino]-benzoylamino}-pentanedioic acid, 2-{4-[(2-Amino-4-oxo-1,4,5,6,7,8-hexahydro-pteridin-6-ylmethyl)-amino]-benzoylamino}-pentanedioic acid, L-Glutamic acid, N-(4-(((2-amino-1,4,5,6,7,8-hexahydro-4-oxopteridinyl)methyl)amino)benzoyl)-, L-Glutamic acid, N-[4-[[(2-amino-3,4,5,6,7,8-hexahydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]- C19H23N7O6 MSTNYGQPCMXVAQ-KIYNQFGBSA-N (2S)-2-[[4-[(2-amino-4-oxo-5,6,7,8-tetrahydro-3H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid n.a. Dietary supplement No No No No Yes No rxnAGORA1409,rxnAGORA2822,rxnAGORA2842,rxnAGORA3407,rxnAGORA3923,rxnAGORA4472,rxnAGORA4476,rxn16130,rxn16131 PMDBD2001717 4-hydroxybenzoate Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 54675830 n.a. NPC29884 4-hydroxybenzoate, p-hydroxybenzoate, p-Hydroxybenzoate anion, Benzoic acid, 4-hydroxy-, ion(1-), 456-23-5, 4-Hydroxybenzoate ion, 8MJB9HSC8Q, Benzoic acid, p-hydroxy-, ion(1-), 3pcc, 3pch, Hydroxybenzoic acid, 4-hydroxy-benzoate, Benzoic acid, p-hydroxy, WLN: QVR DQ, CHEMBL1762656, NSC4961, DB04242, NCGC00166040-01, C00156, AE-848/32195059, parahydroxybenzoate, 4-carboxyphenolate, 4-oxidanylbenzoate, para-hydroxybenzoate, 4e3g, PHB, UNII-8MJB9HSC8Q, H20059_ALDRICH, W398608_ALDRICH, p-Hydroxybenzoic acid monoanion, 240141_ALDRICH, p-Hydroxybenzoic acid ion(1-), 54630_FLUKA, CHEBI:17879, 4-hydroxybenzoic acid, ion(1-), DTXSID10196564, FJKROLUGYXJWQN-UHFFFAOYSA-M, AIDS018038, AIDS-018038, BDBM50340074, P-HYDROXYBENZENECARBOXYLIC ACID, ST5210584, NS00134210, A846111, Q27102693 C7H5O3- FJKROLUGYXJWQN-UHFFFAOYSA-M 4-carboxyphenolate n.a. n.a. No No No No Yes No rxnAGORA1751,rxnAGORA2478,rxnAGORA3610,rxnAGORA3622,rxnAGORA3850,rxnAGORA5035 PMDBD2001718 D-Fructose Dietary Substance, Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. D06HZY 2723872 n.a. NPC70756 D-Arabino-Hex-2-ulo-Pyranose, D-Fru, D-Fructopyranose, D-Fructopyranoside, D-Fructose, Fru, Fructopyranose, Fructopyranoside, Fructose, CHEBI:37714, fructosteril, laevoral, laevosan, levugen, UNII-R73GS1TJE0, HSDB 526, Fruchtzucker, Fruktose, Laevulose, Levolose, BRN 1423189, arabino-hex-2-ulose, [14C]-Fructose, 4-01-00-04402 (Beilstein Handbook Reference), SCHEMBL239448, (3S,4R,5R)-2-(hydroxymethyl)oxane-2,3,4,5-tetrol, CHEMBL2325229, CHEBI:15824, CHEBI:28757, LKDRXBCSQODPBY-VRPWFDPXSA-N, AKOS004910390, F0317, C05003, TOPIRAMATE IMPURITY, FRUCTOSE-(USP IMPURITY), Q27117234, EB37038E-44A6-4AF7-B0D8-47A315AD2F74, FRUCTOSE (CONSTITUENT OF CRANBERRY LIQUID PREPARATION), (3S,4R,5R)-2-(hydroxymethyl)tetrahydro-2H-pyran-2,3,4,5-tetraol C6H12O6 LKDRXBCSQODPBY-VRPWFDPXSA-N (3S,4R,5R)-2-(hydroxymethyl)oxane-2,3,4,5-tetrol n.a. n.a. No No No No Yes No rxnAGORA1688,rxnAGORA1757,rxnAGORA2314,rxnAGORA2408,rxnAGORA2741,rxnAGORA2801,rxnAGORA3635,rxnAGORA3714,rxnAGORA3748,rxnAGORA3891 PMDBD2001719 (S)-malate(2-) Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 5459792 n.a. NPC20286 L-malate, (2S)-2-hydroxybutanedioate, (S)-malate(2-), (S)-malate, L-Hydroxysuccinic acid, CHEMBL493556, (2S)-2-oxidanylbutanedioate, CHEBI:15589, BJEPYKJPYRNKOW-REOHCLBHSA-L, BDBM50257204, A836370, Q27098126 C4H4O5-2 BJEPYKJPYRNKOW-REOHCLBHSA-L (2S)-2-hydroxybutanedioate n.a. n.a. No No No No Yes No rxnAGORA1877,rxnAGORA2757,rxnAGORA2848,rxnAGORA2945,rxnAGORA2957,rxnAGORA3246,rxnAGORA3249,rxnAGORA3250,rxnAGORA3371,rxnAGORA3411,rxnAGORA3545,rxnAGORA4976 PMDBD2001720 (3,4-dihydroxyphenyl)acetate Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 5460350 n.a. NPC328376 (3,4-dihydroxyphenyl)acetate, 2-(3,4-dihydroxyphenyl)acetate, (dihydroxyphenyl)acetic acid, CHEBI:17612, Q27102477, 3,4-Dihydroxyphenylacetic acid, homoprotocatechuic acid, homoprotocatechuate C8H7O4- CFFZDZCDUFSOFZ-UHFFFAOYSA-M 2-(3,4-dihydroxyphenyl)acetate n.a. n.a. No No No No Yes No rxnAGORA2448,rxnAGORA2639,rxnAGORA2716,rxnAGORA3838,rxnAGORA4728,rxn02367,rxnAdd32,rxnAdd60 PMDBD2001721 3-hydroxycinnamic acid Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 637541 n.a. NPC257182 "3-Hydroxycinnamic acid, 14755-02-3, M-COUMARIC ACID, 588-30-7, 3-Coumaric acid, m-Hydroxycinnamic acid, (E)-3-(3-Hydroxyphenyl)acrylic acid, trans-3-Hydroxycinnamic acid, 3-(3-Hydroxyphenyl)acrylic acid, trans-m-Coumaric Acid, trans-3-Hydroxycinnamate, Cinnamic acid, m-hydroxy-, trans-3-coumaric acid, (2E)-3-(3-hydroxyphenyl)acrylic acid, (2E)-3-(3-hydroxyphenyl)prop-2-enoic acid, 2-propenoic acid, 3-(3-hydroxyphenyl)-, (2E)-, 3''-Hydroxycinnamic acid, (E)-3-(3-hydroxyphenyl)prop-2-enoic acid, 2-Propenoic acid, 3-(3-hydroxyphenyl)-, 3-(3-hydroxyphenyl)prop-2-enoic acid, m-Coumarate, KWJ2DDJ34H, (E)-3-(3-Hydroxyphenyl)-2-propenoic acid, (2E)-3-(3-Hydroxyphenyl)-2-propenoic acid, MFCD00004390, CHEBI:32357, NSC 28956, NSC 50308, NSC-28956, NSC-50308, 2-Propenoic acid, 3-(3-hydroxyphenyl)-, (E)-, CHEMBL98521, 3-(3-Hydroxyphenyl)acrylsaeure, 3-(3-hydroxyphenyl)-2-propenoic acid, HYDROXYCINNAMIC ACID, TRANS-3-, 3-hydroxycinnamate, (E)-m-Coumaric acid, (2E)-3-(3-hydroxyphenyl)prop-2-enoate, 3-(3-hydroxyphenyl)acrylate, meta-coumaric acid, 3-(3-hydroxyphenyl)prop-2-enoate, trans-m-Cumaric Acid, UNII-KWJ2DDJ34H, m-Hydroxycinnamate, m-hydroxy-Cinnamate, EINECS 209-615-0, 3''-Hydroxycinnamate, m-hydroxy-Cinnamic acid, AI3-32389, bmse000093, Cinnamic acid, 3-hydroxy-, SCHEMBL442408, CHEBI:47925, DTXSID001336224, 3-(3-hydroxyphenyl)-2-Propenoate, AMY14568, NSC28956, NSC50308, m-Coumaric acid, analytical standard, trans-3-Hydroxycinnamic acid, 99%, BDBM50146456, s5586, AKOS000146568, CCG-266308, (E)-3-(3-hydroxyphenyl)-acrylic acid, (E)-3-(3-hydroxy-phenyl)-acrylic acid, (E)-3-(3-hydroxyphenyl)-2-propenoate, (2E)-3-(3-hydroxyphenyl)-2-propenoate, 1ST40362, AC-16619, AS-12450, LS-13594, HY-113357, CS-0062284, NS00076981, EN300-103182, EN300-345689, F15419, G60884, A808663, A832036, J-501891, Q6712039, Z247613734, (E)-3-(3-hydroxyphenyl)prop-2-enoic acid;m-Coumaric acid, 358818FD-674F-4656-96AF-40F17C30F2EE, InChI=1/C9H8O3/c10-8-3-1-2-7(6-8)4-5-9(11)12/h1-6,10H,(H,11,12)/b5-4" C9H8O3 KKSDGJDHHZEWEP-SNAWJCMRSA-N (E)-3-(3-hydroxyphenyl)prop-2-enoic acid n.a. n.a. No No No No Yes No rxnAGORA2459,rxnAGORA2460,rxnAGORA2718,rxnAdd153 PMDBD2001722 beta-carotene Dietary Substance, Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. D0MY8N 5280489 n.a. NPC17810 "beta-carotene, 7235-40-7, beta Carotene, beta,beta-Carotene, Solatene, Betacarotene, Carotaben, Provatene, Provitamin A, Serlabo, all-trans-beta-Carotene, Food orange 5, Lucaratin, BetaVit, KPMK, Provatenol, Karotin, Natural Yellow 26, beta-Karotin, Solatene (caps), C.I. Food Orange 5, Zlut prirodni 26, Betacaroteno, Betacarotenum, CI Food Orange 5, Carotene,beta, b-Carotene, b,b-Carotene, .beta.-Carotene, Lucarotin 30sun, .beta.,.beta.-Carotene, trans-beta-Carotene, beta-Carotene, all-trans-, Beta, beta-carotene, CI 40800, CI 75130, Betacarotenum [Latin], NSC 62794, C.I. 75130, CCRIS 3245, Ins-160a(iii), Ins no.160a(iii), Caroten base 35468, beta-Carotin, HSDB 3264, beta;-Carotene, Diet,beta-carotene supplementation, E-160a(iii), E160A, .beta. Carotene, all-trans-.beta.-Carotene, (all-E)-1,1''-(3,7,12,16-Tetramethyl-1,3,5,7,9,11,13,15,17-octadecanonaene-1,18-diyl)bis(2,6,6-trimethylcyclohexene), EINECS 230-636-6, UNII-01YAE03M7J, Betacarotene [INN], 01YAE03M7J, 116-32-5, DTXSID3020253, CHEBI:17579, Rovimix .beta.-carotene, NSC62794, NSC-62794, 1,3,3-trimethyl-2-[(1E,3E,5E,7E,9E,11E,13E,15E,17E)-3,7,12,16-tetramethyl-18-(2,6,6-trimethylcyclohexen-1-yl)octadeca-1,3,5,7,9,11,13,15,17-nonaenyl]cyclohexene, DTXCID10253, MLS001066383, 1,1''-(3,7,12,16-Tetramethyl-1,3,5,7,9,11,13,15,17-octadecanonaene-1,18-diyl)bis(2,6,6-trimethylcyclohexene), (all E)-, 2,2''-((1E,3E,5E,7E,9E,11E,13E,15E,17E)-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaene-1,18-diyl)bis(1,3,3-trimethylcyclohex-1-ene), C.I.-40800, EC 230-636-6, Betacarotene (INN), Cyclohexene, 1,1''-(3,7,12,16-tetramethyl-1,3,5,7,9,11,13,15,17-octadecanonaene-1,18-diyl)bis(2,6,6-trimethyl-, (all-E)-, Betacarotenum (Latin), CAROTENE, BETA, NCGC00096081-01, SMR000112037, Karotin [Czech], BETACAROTENE (MART.), BETACAROTENE [MART.], .beta.-Carotene, all-trans-, beta carotene [USAN], Betacaroteno [Spanish], BETACAROTENE (EP IMPURITY), BETACAROTENE [EP IMPURITY], BETACAROTENE (EP MONOGRAPH), BETACAROTENE [EP MONOGRAPH], beta -carotene, MFCD00001556, BETA CAROTENE (USP MONOGRAPH), BETA CAROTENE [USP MONOGRAPH], Betacarotenum [INN-Latin], Betacaroteno [INN-Spanish], Zlut prirodni 26 [Czech], 1,1''-[(1E,3E,5E,7E,9E,11E,13E,15E,17E)-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaene-1,18-diyl]bis(2,6,6-trimethylcyclohexene), SR-01000763803, Beta carotene [USAN:USP], Lucarotin, Lumitene, Lurotin, 9-cis--Carotene, all-E-b-Carotene, Rovimix b-carotene, Carotene, .beta., Solatene (TN), 1,1''-((1E,3E,5E,7E,9E,11E,13E,15E,17E)-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaene-1,18-diyl)bis(2,6,6-trimethylcyclohexene), Cyclohexene, 1,1''-(3,7,12,16-tetramethyl-1,3,5,7,9,11,13,15,17-octadecanonaene-1,18-diyl)bis[2,6,6-trimethyl-, (all-E)-, |A,|A-Carotene, I(2)-Carotene, Carotene Base 80S, all-trans-b-Carotene, beta Carotene (USP), trans-.beta.-Carotene, all trans beta-Carotene, b-Carotene - 30%, all-E-.beta.-Carotene, all-epsilon-beta-Carotene, Spectrum5_000505, ROVIMIX beta-CAROTENE, .beta., .beta.-Carotene, bmse000832, C40H56 (beta-carotene), BETA CAROTENE [DSC], BETA-CAROTENE [FCC], CHEMBL1293, BIDD:PXR0110, BETA CAROTENE [HSDB], BETA-CAROTENE [INCI], BSPBio_003404, BETA CAROTENE [VANDF], BETACAROTENE [WHO-DD], CAROTENE,BETA [VANDF], .BETA.-CAROTENE [MI], BETA CAROTENE [USP-RS], BDBM54988, cid_5280489, HMS501A12, .beta.,.beta.-Carotene, neo B, A11CA02, D02BB01, CI 40800 [INCI], CI 75130 [INCI], HMS2091M17, Pharmakon1600-01500143, BETA CAROTENE [ORANGE BOOK], HY-N0411, beta-Carotene, >=97.0% (UV), Tox21_111557, CCG-36062, LMPR01070001, NSC755910, s1767, AKOS015896682, AC-1869, DB06755, NSC-755910, SDCCGMLS-0066579.P001, IDI1_000330, NCGC00096081-02, |A, AS-13354, XC175229, CAS-7235-40-7, SBI-0051295.P003, NS00002019, SW220035-1, C02094, D03101, AB00051925_06, AB00051925_07, BETA-CAROTENE (CONSTITUENT OF SPIRULINA), beta-Carotene, Vetec(TM) reagent grade, >=93%, EN300-21680271, Q306135, Q-200706, SR-01000763803-2, SR-01000763803-3, SR-01000763803-4, BETA-CAROTENE (CONSTITUENT OF SPIRULINA) [DSC], beta-Carotene, Type I, synthetic, >=93% (UV), powder, 89648336-F9B2-44A0-9BF8-62E73369CB9B, Beta Carotene, United States Pharmacopeia (USP) Reference Standard, beta-Carotene, Type II, synthetic, >=95% (HPLC), crystalline, BETA-CAROTENE (CONSTITUENT OF LYCOPENE AND TOMATO EXTRACT CONTAINING LYCOPENE), beta-Carotene, Pharmaceutical Secondary Standard; Certified Reference Material, (all-E)-1,1''-(3,7,12,16-Tetramethyl-1,3,5, 7,9,11,13,15,17-octadecanonaene-1,18-diyl)bis[2,6, 6-trimethylcyclohexene], (all-E)-1,1''-(3,7,12,16-Tetramethyl-1,3,5,7,9,11,13,15,17-octadecanonaene-1,18-diyl)bis, (all-E)-1,1''-(3,7,12,16-tetramethyl-1,3,5,7,9,11,13,15,17-octadecanonaene-1,18-diyl)bis[2,6,6-trimethyl-Cyclohexene, 1,3,3-trimethyl-2-[(1E,3E,5E,7E,9E,11E,13E,15E,17E)-3,7,12,16-tetramethyl-18-(2,6,6-trimethylcyclohex-1-en-1-yl)octadeca-1,3,5,7,9,11,13,15,17-nonaen-1-yl]cyclohex-1-ene, 3,7,12,16-tetramethyl-1,18-bis(2,6,6-trimethyl-1-cyclohexenyl)-octadeca-1,3,5,7,9,11,13,15,17-nonaene" C40H56 OENHQHLEOONYIE-JLTXGRSLSA-N 1,3,3-trimethyl-2-[(1E,3E,5E,7E,9E,11E,13E,15E,17E)-3,7,12,16-tetramethyl-18-(2,6,6-trimethylcyclohexen-1-yl)octadeca-1,3,5,7,9,11,13,15,17-nonaenyl]cyclohexene n.a. n.a. No No No No Yes No rxnAGORA2581,rxnAGORA5331,rxnAGORA5332,rxn02707,rxn06497,rxn07389,rxn16595,rxn38449 PMDBD2001723 Sulfur Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 5362487 n.a. n.a. 231-722-6, 7704-34-9, 9035-99-8, Agri-Sul, AN-Sulfur Colloid Kit, Aquilite, Asulfa-Supra, Atomic sulfur, Bensulfoid, Brimstone, Colloidal sulfur, Colloidal-S, Devisulphur, elemental sulfur, Flour sulfur, Flour sulphur, Flowers of sulfur, Flowers of sulphur, Gofrativ, Ground vocle sulfur, Ground vocle sulphur, Precipitated sulfur, S, Sofril, Solfa, Soufre, Soufre [ISO-French], Sperlox-S, Spersul, Spersul thiovit, Sublimed sulfur, Sublimed sulphur, Suffa, Sufran, Sufran D, Sulfex, Sulfidal, Sulforon, Sulfospor, Sulfur, sulfur (0), Sulfur (JP17), Sulfur (molten), Sulfur [NA1350] [Class 9], Sulfur [UN1350] [Flammable solid], Sulfur 10 microg/mL in Isooctane, Sulfur atom, Sulfur bactericide,fumigant, Sulfur Compounds, Sulfur hydride, Sulfur hydroxide, Sulfur in Isooctane standard solution, Specpure, 100g/g (0.010%), Sulfur in Isooctane standard solution, Specpure, 10g/g (0.001%), Sulfur in Isooctane standard solution, Specpure?, 25?g/g (0.0025%), Sulfur ointment, Sulfur precipitated, Sulfur Soap, Sulfur vapor, Sulfur, 99.998% trace metals basis, SULFUR, 99.999%, Sulfur, colloidal, metastable technetium-99 labeled, Sulfur, elemental, Sulfur, flakes, >=99.99% trace metals basis, Sulfur, LR, >=99%, Sulfur, molten [NA2448] [Class 9], Sulfur, molten [UN2448] [Flammable solid], Sulfur, monoclinic, Sulfur, PESTANAL(R), analytical standard, Sulfur, pharmaceutical, Sulfur, powder, 99.98% trace metals basis, Sulfur, powder, colloidal, Sulfur, precipitated, Sulfur, precipitated (USP), Sulfur, precipitated [USP], Sulfur, prilled, >=99.99 trace metals basis, Sulfur, puriss., 95.0%, Sulfur, puriss., 99.5-100.5%, meets analytical specification of Ph. Eur., BP, USP, precipitated, Sulfur, purum p.a., >=99.5% (T), Sulfur, reagent grade, powder, purified by refining, -100 mesh particle size, Sulfur, reagent grade, purified by sublimation, -100 mesh particle size, powder, Sulfur, rhombic, Sulfur, SAJ first grade, >=98.0%, Sulfur, solid, Sulfur, sublimed, Sulfur, sublimed (USP), Sulfur, sublimed [USP], Sulikol, Sulkol, sulphur, Sulphur [ISO], Sulphur, precipitated, sublimed or colloidal, Sulsol, Sultaf, Super cosan, Super Six, Svovl, TechneColl, TechneScan Sulfur Colloid, Tesuloid, Thiolux, Thion, Thiovit, Thiovit S, Thiozol, Ultra Sulfur, Wettasul, Zolvis, Sulfur (>80per cent), Armarita, Prosacea, Sulfaderm, DermaWash, Motto, NaturasilScabies, Lemaitre Sulfur, Spot Correction, Sulfur Lotion, Amino Mask, Dermaline Sulfur, Madina Acne, NaturasilRingworm, Sulfo lo, sulfur suspension, Malin and Goetz, Dr Berrys, Acne LotionSulfur, PowerSpot Cleanse, Clinicians Complex, DermaWash S2, NaturasilJock Itch, Sulfur 6, Acne Drying Lotion, Acne Sulfur Lotion, Sulfur 3X, Sulfur Facial Wash, Sulphur Kit Refill, Aqua KAVI, CliXit Acne Eraser, Sulphur 12X, Sulphur 30C, Amino MaskBioelements, LIQUIMAT, SULFER, SULPHOR, Sulphur 200C, Sulphur7138, THYLOX, NaturasilAthletes Foot, Sulfur Spot Treatment, EradiKate Facial Mask, DEEP ACNE, Sulfur 3% Soap Bar, ariSulfurAcne Treatment, Acne LotionSulfurSulfur, END-ZIT, SULPHUR200ck, Therapeutic Sulfur Mask, DHC Acne Spot Therapy, caring mill Acne Drying, Sulfur 3 Special Order, SULPHUR 6C, Overnight Spot Treatment, Renu Laboratories Drying, Super-Sulfur Magic Mask, TreeActiv Spot Treatment, Calm Eczema Therapy Wash, Concealing Spot Treatment, Organic Sulfur Suspension, CLIXIT ACNE DRYING, Dermaharmony 10% Sulfur, Sulfur 30 Special Order, Acne Clearing Sulfur Mask, Calm Eczema Therapy Cream, Kate Summerville EradiKate, NaturasilInternal Parasites, MINERAL BLEMISH KIT, NERD ACNE TREATMENT, SULFUR CALMING MASK, Epionce Purifying Spot Gel, SULFUR 3%, UNBLEMISH Clarifying Mask, bareMinerals Blemish Therapy, ELFMineral Blemish Kit Box, EradiKate ACNE TREATMENT, Glytone Acne Treatment Mask, SULFUR ACNE TREATMENT, Acne Control Clarifying Mask, Lemaitre SulfurAcne treatment, Sulfur Acne Foaming Cleanser, Derma E Acne Clarifying Mask, Malin and GoetzAcne Treatment, Kalium Sulfuratum Bath Essence, Rapid Relief Acne Sulfur Mask, Activ O2 Acne Treatment Cream, caring mill Acne Spot Treatment, QUICK DRY ACNE TREATMENT, Sulfur Facial WashAcne Cleanser, DTXCID7014941, DTXSID9034941, Earths Care Acne Spot Treatment, Earths Care Acne Treatment Mask, Game Over Acne Drying Treatment, EradiKate Daily Foaming Cleanser, CLIXIT ACNE SPOT TREATMENT, FEIXBIOAZUFRE / BIOSULPHUR, Matys Organic Baby Eczema Relief, Belli Acne Control Spot Treatment, Get Clarity Foaming Acne Cleanser, MDacne Customized Cream (Sulfur), De La Cruz Sulfur Acne Medication, Naturium Sulfur Spot Treatment 8%, Dr BerrysMulti-purpose sulfur Creme, ACNE AND BLEMISH CONTROL MASK, Neutrogena Stubborn Acne Spot Drying, Proactiv Clean Mineral Acne Cleanser, TreeActiv Cystic Acne Spot Treatment, Treatment 101Acne Clearing Treatment, CLIXIT TINTED BLEMISH CONCEALER, Glovers Dandruff Control Med., Floral, Glytone Acne Clarifying Treatment Mask, 2-(Perfluoroalkyl)ethyl allyl sulphide, CelestyAcne Series Instant Repair Mask, Shaant Spot Hero Drying Acne Treatment, CLIXIT TINTED BLEMISH CONCEALERLight, The INKEY List Acne Clearing Moisturizer, CLIXIT TINTED BLEMISH CONCEALERMedium, Glovers Dandruff Control Medicine, Regular, LIQUIMATACNE TREATMENT AND COVER-UP, Philosophy Clear Days Ahead Acne Treatment, EradiKate Daily Foaming CleanserAcne Treatment, Anna Guanche MD Miracle Cream The Pimple Cream, SUNDAY RILEY SULFUR ACNE TREATMENT MASK, Rodan and FieldsUnblemish 1 Wash Acne Medicated Cleanser, Soft Services CLEARING Clay Multi-Use Breakout Treatment, SUNDAY RILEY SATURN SULFUR ACNE SPOT TREATMENT MASK, Vichy Laboratoires Normaderm SOS Acne Rescue Spot Corrector, Josie Maran-Argan Apothecary Daily Response Calming Treatment, Kiehls Since 1851 Dermatologist Solutions Breakout Control Targeted Acne Spot Treatment, 56996-94-2 S NINIDFKCEFEMDL-UHFFFAOYSA-N sulfur n.a. n.a. No No No No Yes No rxnAGORA2589,rxnAGORA3586,rxnAGORA5325,rxnAGORA5326 PMDBD2001724 butyrate Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 104775 n.a. NPC149193 "butyrate, butanoate, N-Butyrate, n-butanoate, Butanoic acid, ion(1-), 461-55-2, butanate, 1-butanoate, propanecarboxylate, 1-butyrate, 1-propanecarboxylate, CHEMBL62381, NCGC00167555-01, ethyl,acetate, Sodium; butyrate, DTXSID8040432, CHEBI:17968, FERIUCNNQQJTOY-UHFFFAOYSA-M, CH3-[CH2]2-COO(-), BDBM50079401, c0035, PD121533, AB01566831_01, Q55582441" C4H7O2- FERIUCNNQQJTOY-UHFFFAOYSA-M butanoate n.a. n.a. No No No No Yes No rxnAGORA2592,rxnAGORA2733,rxnAGORA3393,rxnAGORA4559 PMDBD2001725 D-Mannitol Dietary Substance, Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. D0P7EK 6251 n.a. NPC86412 "D-mannitol, mannitol, 69-65-8, Mannite, Osmitrol, Manna sugar, 87-78-5, Cordycepic acid, Osmofundin, Resectisol, Diosmol, Mannit, Mannazucker, Mannidex, Mannigen, Mannistol, Invenex, Isotol, Osmosal, Marine Crystal, Maniton-S, D-(-)-Mannitol, Bronchitol, Mannitol, D-, (2R,3R,4R,5R)-hexane-1,2,3,4,5,6-hexol, Mannogem 2080, (2R,3R,4R,5R)-Hexane-1,2,3,4,5,6-hexaol, DL-Mannitol, Mannitol 5%, Mannitol (VAN), Aridol, Mannitol 10%, Mannitol 15%, Mannitol 20%, Osmitrol 5% In Water, Osmitrol 10% In Water, Osmitrol 15% In Water, Osmitrol 20% In Water, SDM No. 35, Hexahydroxyhexane, Resectisol In Plastic Container, Mannitol (USP), Mannitol 5% In Plastic Container, NCI-C50362, Mannitol 10% In Plastic Container, Mannitol 15% In Plastic Container, Mannitol 20% In Plastic Container, CCRIS 369, Mannitolum, HSDB 714, Manitol, CHEBI:16899, BRN 1721898, Maniton s, Mannitol;Mannite, UNII-3OWL53L36A, Mannitol [USP], NSC 407017, 3OWL53L36A, INS NO.421, OSMITROL 5% IN WATER IN PLASTIC CONTAINER, DTXSID1023235, OSMITROL 10% IN WATER IN PLASTIC CONTAINER, OSMITROL 15% IN WATER IN PLASTIC CONTAINER, OSMITROL 20% IN WATER IN PLASTIC CONTAINER, INS-421, E-421, MFCD00064287, NSC-407017, E421, DTXCID603235, 133-43-7, mannitol-d, DTXSID30858955, 4-01-00-02841 (Beilstein Handbook Reference), Mannitol [USAN], 1,2,3,4,5,6-Hexanehexol, manita, NCGC00164246-01, MANNITOL (II), MANNITOL [II], Mannidex 16700, E 421, MANNITOL (MART.), MANNITOL [MART.], MANNITOL (USP-RS), MANNITOL [USP-RS], MTL, MANNITOL 25%, MANNITOL (EP IMPURITY), MANNITOL [EP IMPURITY], rel-(2R,3R,4R,5R)-Hexane-1,2,3,4,5,6-hexaol, MANNITOL (EP MONOGRAPH), MANNITOL [EP MONOGRAPH], MANNITOL (USP MONOGRAPH), MANNITOL [USP MONOGRAPH], D-Mannit, CAS-69-65-8, ISOMALT IMPURITY B (EP IMPURITY), ISOMALT IMPURITY B [EP IMPURITY], Osmitrol (TN), SMR000857324, SR-01000838849, D-Mannitol, EP, USP grade, NSC 9256, EINECS 200-711-8, EINECS 201-770-2, Cordycepate, D-mitobronitol, MANNITOL 10% W/ DEXTROSE 5% IN DISTILLED WATER, AI3-19511, Mannit p, NSC407017, D-?Mannitol, Bronchitol (TN), (D)-mannitol, Mannitol 25, Mannitol 35, Mannitol 60, D(-)Mannitol, Mannitol,(S), Pearlitol 25 c, Pearlitol 50 c, Mannitol m300, Pearlitol 160 c, Mannitol 200, Mannitol 300, Pearlitol 200 sd, Pearlitol 300 dc, Mannitol 2080, D-Mannit 1000 microg/mL in Methanol, ARIDOL KIT, D-Mannitol (Osmitrol), D-Mannitol (JP17), MANNITOL [HSDB], MANNITOL [INCI], MANNITOL [FCC], MANNITOL 15% W/ DEXTROSE 5% IN SODIUM CHLORIDE 0.45%, MANNITOL 5% W/ DEXTROSE 5% IN SODIUM CHLORIDE 0.12%, Crystalline mannitol fine, MANNITOL [MI], MANNITOL [VANDF], D-Mannitol, ACS reagent, D-Mannitol, >=98%, M0044, D-MANNITOL [JAN], SCHEMBL919, bmse000099, CHEMBL689, Epitope ID:114705, MANNITOL [WHO-DD], Isomalt impurity, mannitol-, GD11 Rx SCM C5, Crystalline mannitol standard, D-MANNITOL [WHO-IP], ED1D1E61-FEFB-430A-AFDC-D1F4A957FC3D, MLS001335977, MLS001335978, D-Mannitol, Biochemical grade, Crystalline mannitol extra-fine, MANNITOL [ORANGE BOOK], D-Mannitol, AR, >=99%, D-Mannitol, LR, >=99%, CHEBI:29864, CURESTEM CELL HEALER C20, MANNITOLUM [WHO-IP LATIN], DTXCID001324372, HMS2230N11, 287100-73-6, AMY33410, Aridol Bronchial Challenge Test Kit, HY-N0378, Tox21_112092, Tox21_201487, Tox21_300483, POTASSIUMNONAFLUORO-T-BUTOXIDE, AKOS006280947, D-Mannitol, plant cell culture tested, Tox21_112092_1, BCP9000575, CCG-266445, D-Mannitol, BioXtra, >=98% (GC), DB00742, D-Mannitol, NIST(R) SRM(R) 920, NCGC00164246-03, NCGC00164246-04, NCGC00164246-05, NCGC00164246-18, NCGC00254277-01, NCGC00259038-01, 85085-15-0, AC-12776, AC-14054, AS-30501, D-Mannitol, tested according to Ph.Eur., D-Mannitol, p.a., 96.0-101.5%, D-Mannitol, SAJ first grade, >=99.0%, SORBITOL-MANNITOL COMPONENT MANNITOL, D-Mannitol, SAJ special grade, >=99.0%, NS00068035, S2381, SW220287-1, MANNITOL COMPONENT OF SORBITOL-MANNITOL, C00392, D00062, EN300-212188, AB00443917_06, ISOMALT IMPURITY, MANNITOL- [USP IMPURITY], ISOMALT IMPURITY, MANNITOL-(USP IMPURITY), Q407646, Q-101039, SR-01000838849-3, SR-01000838849-4, D-Mannitol, ACS reagent, for microbiology, >=99.0%, LACTITOL MONOHYDRATE IMPURITY C [EP IMPURITY], D-Mannitol, meets EP, FCC, USP testing specifications, Mannitol, European Pharmacopoeia (EP) Reference Standard, Z1198149813, D-Mannitol, BioUltra, >=99.0% (sum of enantiomers, HPLC), Mannitol, United States Pharmacopeia (USP) Reference Standard, D-Mannitol, >=99.9999% (metals basis), for boron determination, Mannitol, Pharmaceutical Secondary Standard; Certified Reference Material" C6H14O6 FBPFZTCFMRRESA-KVTDHHQDSA-N (2R,3R,4R,5R)-hexane-1,2,3,4,5,6-hexol n.a. Sweetening Agents No No No No Yes No rxnAGORA2759,rxnAGORA2971,rxnAGORA3714,rxnAGORA3845 PMDBD2001726 Nitrite Dietary Substance n.a. 14797-65-0 DB12529 n.a. n.a. n.a. 946 921 n.a. nitrite, Nitrite Ion, 14797-65-0, Nitrite anion, Nitrous acid, ion(1-), Nitrite(1-), Nitrit, Nitrite ion (NO2-), Nitrogen dioxide ion(1-), Nitrogen peroxide ion(1-), dioxonitrate(III), dioxonitrate(1-), dioxidonitrate(1-), NO2-, UNII-J39976L608, DTXSID5024219, J39976L608, CHEBI:16301, NO2(-), Water Supply QC Check Sample: Nitrite, Nitrites, Nitrite as N @ 1000 microg/mL in H2O, NO2?, (NO2)(-), [NO2](-), Nitrite Standard: NO2- @ 1000 microg/mL in H2O, Nitrite Standard: NO2- @ 10000 microg/mL in H2O, Nitrite Standard, ONO-, CHEMBL1361, DTXCID704219, BDBM26989, MFCD00144923, DB12529, NCGC00090737-03, NCGC00090737-04, Nitrite as N @ 10000 microg/mL in H2O, AB01566909_01, Q213788 NO2- IOVCWXUNBOPUCH-UHFFFAOYSA-M nitrite n.a. n.a. No No No No Yes No rxnAGORA2764,rxnAGORA2997,rxnAGORA2998,rxnAGORA3002,rxnAGORA3004,rxnAGORA3010,rxnAGORA3011,rxnAGORA3012,rxnAGORA3013,rxnAGORA3650,rxnAGORA3651,rxnAGORA4146,rxnAGORA4712,rxnAGORA4949 PMDBD2001727 Nitrate Dietary Substance, Therapeutic Substance Investigational Drug 14797-55-8 DB14049 n.a. n.a. D00RJT 943 918 n.a. "nitrate, NITRATE ION, 14797-55-8, Nitrates, Nitrate(1-), trioxonitrate(V), trioxonitrate(1-), NITRATO, trioxidonitrate(1-), NO3-, Nitrate (No3-), NITRATE ANION, UNII-T93E9Y2844, UN3218, T93E9Y2844, NITRATE ION (NO3-), CHEMBL186200, NO3, DTXSID5024217, NITRIC ACID, ION(1-), CHEBI:17632, Nitrate (6CI,7CI,8CI,9CI), NO3(-), UN1447, Nitrate as N @ 1000 microg/mL in H2O, Nitrate as N @ 10000 microg/mL in H2O, Nitrate(1-); Nitrato; Nitric acid, ion(1-), NO3?, Nitrate(6CI,7CI,8CI,9CI), (NO3)(-), [NO3](-), Nitrate Standard: NO3- @ 1000 microg/mL in H2O, Nitrate Standard: NO3- @ 10000 microg/mL in H2O, nitrooxidane, trioxidonitrate, trioxonitrate, ISOSORBIDE DINITRATE, DILUTED IMPURITY A (EP IMPURITY), ISOSORBIDE DINITRATE, DILUTED IMPURITY A [EP IMPURITY], ISOSORBIDE MONONITRATE, DILUTED IMPURITY A (EP IMPURITY), ISOSORBIDE MONONITRATE, DILUTED IMPURITY A [EP IMPURITY], Nitrate Standard, INORGANIC NITRATES, 732 - Meat Based Sample, Nitrates, inorganic, n.o.s., DTXCID904217, Fresh water-Nitrate, low level, Nitrate Anion Standard Solution, Fresh water-Nitrate, high level, BDBM26988, MFCD00144920, AKOS015904030, 65 -Nitrate & Nitrite in milk powder, DB14049, N511, Nitrate standard solution (100 ppm NO3), 787 - Nitrate analysis of vegetable leaves, NS00114192, 798 - Nitrate in infant vegetable food puree, Q182168, Nitrates, inorganic, n.o.s. [UN1447] [Oxidizer], 718 - Nitrate and nitrite analysis of fish and fish products" NO3- NHNBFGGVMKEFGY-UHFFFAOYSA-N nitrate n.a. n.a. No No No No Yes No rxnAGORA2765,rxnAGORA2998,rxnAGORA2999,rxnAGORA3000,rxnAGORA3001,rxnAGORA3002,rxnAGORA3003,rxnAGORA3010,rxnAGORA3011 PMDBD2001728 D-glucitol Dietary Substance, Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. D09MXS 5780 n.a. NPC66052 "D-Sorbitol, sorbitol, D-Glucitol, 50-70-4, glucitol, L-Gulitol, (-)-Sorbitol, Glucarine, D-(-)-Sorbitol, Diakarmon, Sorbilande, Sorbostyl, Esasorb, Multitol, Neosorb, Nivitin, Sorbite, Sorbol, Cholaxine, Sionit, Sionite, Sionon, Siosan, Sorbo, Karion instant, Sorbitol F, Sorbex Rp, Sorbitol FP, D-Sorbol, Sionit K, Sorbex M, Sorbex R, Sorbex S, Sorbex X, Sorbicolan, Sorvilande, Gulitol, D-Sorbite, Neosorb P 60, Foodol D 70, (2R,3R,4R,5S)-Hexane-1,2,3,4,5,6-hexaol, Neosorb 20/60DC, Glucitol, D-, Neosorb 70/70, Neosorb P 20/60, d-Sorbit, Karion, Karion (carbohydrate), Neosorb 70/02, (2R,3R,4R,5S)-hexane-1,2,3,4,5,6-hexol, D-1,2,3,4,5,6-Hexanehexol, FEMA No. 3029, G-ol, CCRIS 1898, Neosorb P 60W, Probilagol, Hexahydric alcohol, iso-sorbide, Sorbit, Glc-ol, AI3-19424, HSDB 801, Sorbitol (e420), NSC 25944, DTXSID5023588, CHEBI:17924, Sorbitol 3% in plastic container, EINECS 200-061-5, Ins-420(i), UNII-506T60A25R, Sorbitol [USP:NF], SORBITOL 3.3% IN PLASTIC CONTAINER, 1,2,3,4,5,6-Hexanehexol, E 420, E-420(i), Ins no.420(i), MFCD00004708, NSC-25944, 506T60A25R, 7B5697N, E420, Resulax, Sorbilax, DTXCID903588, Sorbitol (USP), (2S,3R,4R,5R)-hexane-1,2,3,4,5,6-hexol, D-Sorbit 1000 microg/mL in Methanol, Sorbitol (USP:NF), Medevac, SORBITOL [USP], SORBITOL (II), SORBITOL [II], E-420, SORBITOL (MART.), SORBITOL [MART.], SORBITOL (USP-RS), SORBITOL [USP-RS], Sorbitur, 26566-34-7, SORBITOL (EP MONOGRAPH), SORBITOL [EP MONOGRAPH], Sorbit DP, C*PharmSorbidex, Sorbitol;D-Glucitol, Liponic 70-NC, CAS-50-70-4, ISOMALT IMPURITY C (EP IMPURITY), ISOMALT IMPURITY C [EP IMPURITY], MALTITOL IMPURITY A (EP IMPURITY), MALTITOL IMPURITY A [EP IMPURITY], SMR000112219, WURCS=2.0/1,1,0/[h2122h]/1/, LACTITOL MONOHYDRATE IMPURITY E (EP IMPURITY), LACTITOL MONOHYDRATE IMPURITY E [EP IMPURITY], Sorbitolum, Meritol, Solbitol, Sorbitab, Sorbogem, Sorbitol Instant, Sorbitol S, Sorbitol FK, Sorbit D-Powder, Sorbit S, Sorbit W-Powder, Sorbit WP, Sorbitol (NF), Neosorb P60, Kyowa Powder 50M, Sorbogem 712, Sorbitol (Glucitol), Liponic 76-NC, 99%, high purity, Sorbit D 70, Sorbit DP 50, Sorbit L 70, Sorbit T 70, Sorbit W 70, D-Sorbitol, 99%, Sorbit W-Powder 50, D-sorbitol; D-glucitol, D-Sorbitol (JP17), SORBITOL [HSDB], SORBITOL [INCI], SORBITOL [FCC], SORBITOL [MI], SORBITOL [VANDF], D-Sorbitol, >=98%, D-SORBITOL [JAN], SCHEMBL763, Sorbit Kyowa Powder 50M, bmse000115, bmse000803, bmse001007, D-SORBITOL [FHFI], Epitope ID:114708, SORBITOL [WHO-DD], Isomalt impurity, sorbitol-, D-Sorbitol, NF/FCC grade, CHEMBL1682, MLS001333209, MLS001333210, SORBITOL [ORANGE BOOK], D-Sorbitol, analytical standard, D-Sorbitol, for electrophoresis, CHEBI:30911, D-Sorbitol, BioXtra, >=98%, D-Sorbitol, for synthesis, 99%, HMS2094K21, HMS2270A18, Pharmakon1600-01300028, HY-B0400, Tox21_201937, Tox21_303388, D-Sorbitol, >=98%, FCC, FG, NSC759608, s2393, AKOS015899604, D-Sorbitol, plant cell culture tested, CCG-229392, DB01638, NSC-759608, Sorbitol 3% in plastic container (TN), NCGC00164353-01, NCGC00164353-02, NCGC00164353-03, NCGC00257447-01, NCGC00259486-01, AC-13186, CS-13177, D-Sorbitol, SAJ first grade, >=97.0%, SBI-0206688.P002, SORBITOL-MANNITOL COMPONENT SORBITOL, D-Sorbitol, for molecular biology, >=98%, D-Sorbitol, BioUltra, >=99.5% (HPLC), D-Sorbitol, SAJ special grade, >=99.0%, D-Sorbitol, Vetec(TM) reagent grade, 97%, NS00121242, S0065, SW220289-1, D-Sorbitol, crystallized, >=99.0% (HPLC), SORBITOL COMPONENT OF SORBITOL-MANNITOL, A15606, C00794, D00096, E70384, AB00919085_06, D-Sorbitol, liquid, tested according to Ph.Eur., EN300-7832133, ISOMALT IMPURITY, SORBITOL- [USP IMPURITY], ISOMALT IMPURITY, SORBITOL-(USP IMPURITY), Q245280, 5-(4-Methoxyphenyl)-1,3-Oxazole-4-CarboxylicAcid, rel-(2R,3R,4R,5S)-hexane-1,2,3,4,5,6-hexol, Sorbitol, European Pharmacopoeia (EP) Reference Standard, 75DE42C3-7C3B-4802-95E0-463F02268BDC, Sorbitol, United States Pharmacopeia (USP) Reference Standard, D-Sorbitol, BioReagent, cell culture tested, plant cell culture tested, Sorbitol, Pharmaceutical Secondary Standard; Certified Reference Material" C6H14O6 FBPFZTCFMRRESA-JGWLITMVSA-N (2R,3R,4R,5S)-hexane-1,2,3,4,5,6-hexol Pharmaxis n.a. No No No No Yes No rxnAGORA2773,rxnAGORA3103,rxnAGORA3891,rxnAGORA4106 PMDBD2001729 hydrogen cyanide Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 768 n.a. NPC163076 hydrogen cyanide, hydrocyanic acid, Formonitrile, Prussic acid, Cyanwasserstoff, Blausaeure, Formic anammonide, Zaclondiscoids, Evercyn, Cyclon, 74-90-8, Cyclone B, Aero Liquid HCN, Agent AC, Cyaanwaterstof, Blauwzuur, Cyjanowodor, Acido cianidrico, Acide cyanhydrique, methanenitrile, Caswell No. 483, Hydrogen cyanide [ISO], hydridonitridocarbon, RCRA waste number P063, Blausaeure [German], Carbon hydride nitride (CHN), HSDB 165, HCN, UN 1051, hydrogen(nitridocarbonate), EINECS 200-821-6, [CHN], UNII-2WTB3V159F, AC [Cyanide], EPA Pesticide Chemical Code 045801, AI3-31100-X, BRN 1718793, 2WTB3V159F, CHEBI:18407, Acide cyanhydrique [ISO-French], Carbon nitride (C3N4), 143334-20-7, HYDROCYANICUM ACIDUM, Zyklon B, CHEMBL183419, DTXSID9024148, EC 200-821-6, AC (CHEMICAL WARFARE AGENT), AC (Cyanide), Blausaeure (German), (CHN), Blauwzuur [Dutch], Cyjanowodor [Polish], Acide cyanhydrique (ISO-French), Cyaanwaterstof [Dutch], Cyanwasserstoff [German], Acido cianidrico [Italian], Acid, Hydrocyanic, Cyanide, Hydrogen, Acide cyanhydrique [French], Graphitic Carbon Nitride, NA1613, UN1051, UN1613, UN1614, UN3294, RCRA waste no. P063, Zootic acid, Nitrilomethane #, Prussic acid, anhydrous, stabilized, Carbon hydride nitride, Hydrocyanic acid, anhydrous, stabilized, Hydrogen cyanide, anhydrous, stabilized, Prussic acid, unstabilized, UN 1613 (Salt/Mix), UN 1614 (Salt/Mix), HYDROGEN CYANIDE [MI], Hydrocyanic acid (prussic), unstabilized [Forbidden], DTXCID004148, HYDROGEN CYANIDE [HSDB], HYDROGEN CYANIDE [WHO-DD], HYDROCYANICUM ACIDUM [HPUS], BDBM50152968, Hydrocyanic acid, anhydrous, stabilized, absorbed in a porous inert material, Hydrogen cyanide, anhydrous, stabilized, absorbed in a porous inert material, Prussic acid, anhydrous, stabilized, absorbed in a porous inert material, NA 1051, Hydrocyanic acid (prussic), unstabilized, CHN, Hydrogen cyanide, stabilized with <3% water, NS00077168, C01326, Q3416481, Graphitic carbon nitride, 99%, length: 1 - 10 mum, hydridonitridocarbonhydrogen(nitridocarbonate)methanenitrile, Hydrogen cyanide, stabilized with <3% water [UN1051] [Poison], Hydrogen cyanide, stabilized, with <3% water and absorbed in a porous inert material, Hydrogen cyanide, stabilized, with <3% water and absorbed in a porous inert material [UN1614] [Poison] CHN LELOWRISYMNNSU-UHFFFAOYSA-N formonitrile n.a. n.a. No No No No Yes No rxnAGORA2955,rxnAGORA3662 PMDBD2001730 retinol Dietary Substance, Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. D0S7WX 445354 n.a. NPC55412 "retinol, Vitamin A, all-trans-Retinol, 68-26-8, Vitamin A1, Alphalin, Chocola A, Alphasterol, Apostavit, Aquasynth, Axerophthol, Epiteliol, Prepalin, Testavol, Veroftal, Afaxin, Agiolan, Agoncal, Anatola, Apexol, Dofsol, Myvpack, Vaflol, Vitpex, Aoral, trans-retinol, Vitamin A alcohol, Disatabs Tabs, Oleovitamin A, Bentavit A, Dohyfral A, Alcovit A, Anatola A, Vogan-Neu, all-trans-Retinyl alcohol, A-Mulsal, Biosterol, Ophthalamin, Plivit A, Vi-Alpha, A-Vitan, All-trans retinol, Atars, Avibon, Avitol, Axerol, Vafol, Vogan, Retrovitamin A, Lard Factor, all-trans-Vitamin A alcohol, Homagenets Aoral, Sehkraft A, Hi-A-Vita, Vitamin A1 alcohol, A-Sol, all-trans-Vitamin A, A-Vi-Pel, ACON, ATAV, Super A, Solu-A, 11103-57-4, Nio-A-Let, Vio-A, Vi-Dom-A, Anti-infective vitamin, Antixerophthalmic vitamin, Vitavel A, Del-VI-A, Wachstumsvitamin, Vitamine A, Vitavel-A, Retinolo, Retinolum, Thalasphere, beta-Retinol, Vitamin A1, all-trans-, Vitamin A alcohol, all-trans-, Hydrovit A, trans-Vitamin A alcohol, Vi-alpha; Vi-alpha, Retinol, all trans-, Antixerophthalmisches Vitamin, Rovimix A 500, all-trans-Vitamin A1, Vitamin A1 alcohol, all trans, Retinol (Vit A), (2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol, CCRIS 5444, HSDB 815, UNII-G2SH0XKK91, .beta.-Retinol, (2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraen-1-ol, EINECS 200-683-7, G2SH0XKK91, NSC 122759, NSC-122759, UNII-81G40H8B0T, BRN 0403040, (all-E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol, DTXSID3023556, Vitamin A [Natural], Vitamin A1 alcohol, all-trans-, 2,4,6,8-Nonatetraen-1-ol, 3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-, (all-E)-, EINECS 234-328-2, MFCD00001552, CHEMBL986, 3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclchexen-1-yl)-2,4,6,8-nonatetraen-1-ol, DTXCID203556, Axerophtholum, CHEBI:17336, EC 200-683-7, all-trans-13,14-Dihydro retinol, Vitaminum A, 4-06-00-04133 (Beilstein Handbook Reference), VITAMINA, 3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol, (all-E)-, Retinolo [DCIT], Vitamin A (Natural), NCGC00017343-07, Cylasphere, Retinol [INN:BAN], Retinolum [INN-Latin], 3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol, All Trans Retinol, Ro-a-vit, tROL, Vitamin A alcohol (VAN), Aquasol A Parenteral, Vitamin-A, CAS-68-26-8, all-trans-Retinol;(2E,4E,6E,8E)-3,7-Dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol, SMR000112036, [11,12-3H]-Retinol, 9-cis,13-cis-Retinol, Vitamin A (USP), ophthalamin (obsolete), SR-01000763813, Retin-11,12-t2-ol (9CI), CHEBI:50211, Tegosphere VitA, vitamins A, .alpha.sterol, b-Retinol, .alpha.lin, Retinyl A, trans-Retinol acid (Vitamin A), 1rbp, vitamin A vitamer, vitamin A vitamers, Vi-.alpha., LUTAVIT A, MICROVIT A, VIATMIN A, 1gx8, Retinol-(cellular-retinol-binding-protein), RETINOL [HSDB], RETINOL [INCI], RETINOL [INN], retinolum densatum oleosum, Spectrum5_000993, Spectrum5_001997, VITAMIN A [MI], RETINOL [WHO-DD], Retinol, 95%, synthetic, all-trans vitamin A alcohol, SCHEMBL3112, VITAMIN A (MART.), 3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonate-traen-1-ol, 3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol, (all-E)-Isomer, Alcohol 9,13-dimethyl-7-(1,1,5-trimethyl-6-cyclohexen-5-yl)-7,9,11,13-nonatetraen-15-ol, all-trans-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol, VITAMIN A CONCENTRATE, BIDD:PXR0102, MLS001066379, MLS001074751, MLS006010008, Retinol, all-trans- (8CI), SPECTRUM1501203, (ALL-E)-, GTPL4053, HMS501I08, A11CA01, D10AD02, R01AX02, S01XA02, VITAMIN A (EP MONOGRAPH), 3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol, VITAMIN A (USP MONOGRAPH), 81G40H8B0T, DTXSID301014459, HMS1921B04, HMS2092L13, HMS2270C05, Pharmakon1600-01501203, VITAMIN A, UNSPECIFIED FORM, (2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-enyl)nona-2,4,6,8-tetraen-1-ol, BCP06593, HY-B1342, Tox21_110818, Tox21_202441, Tox21_300287, BDBM50092056, CCG-38864, LMPR01090001, NSC122759, NSC758150, s5592, 3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)-nona-2,4,6,8-tetraen-1-ol, AKOS015902578, 1ST1502, DB00162, NSC-758150, SDCCGMLS-0066724.P001, (2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-enyl)nona-2,4,6,8-tetr aen-1-ol, IDI1_000486, SMP2_000102, NCGC00017343-02, NCGC00017343-03, NCGC00017343-04, NCGC00017343-05, NCGC00017343-06, NCGC00017343-08, NCGC00017343-09, NCGC00017343-10, NCGC00017343-11, NCGC00091784-01, NCGC00091784-02, NCGC00091784-03, NCGC00091784-04, NCGC00091784-05, NCGC00091784-06, NCGC00254024-01, NCGC00259990-01, AC-11701, BS-17906, SBI-0051690.P002, CS-0013091, NS00003017, C00473, C17276, D06543, AB00052248_05, EN300-6733268, A836068, Q424976, Retinol, >=95.0% (HPLC), ~2700 U/mg, Retinol, synthetic, >=95% (HPLC), crystalline, J-014834, J-017515, Q-201926, SR-01000763813-2, SR-01000763813-4, W-104683, BRD-K22429181-001-06-8, BRD-K64634304-001-01-5, WLN: L6UTJ A1 B1U1Y1&U2U1Y1&U2Q C1 C1, Retinol, BioXtra, >=97.5% (HPLC), ~3100 U/mg, Z2315574891, 3,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol, 2,4,6,8-NONATETRAEN-1-OL, 3,7-DIMETHYL-9-(2,6,6-TRIMETHYL-1-CYCLOHEXEN-1-YL)-, 2,6,8-Nonatetraen-1-ol, 3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-, (all-E)-, 3,7-Dimethyl-9-(2,6, 6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol, 3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol, all (E)-, (2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)-1-nona-2,4,6,8-tetraenol, (2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)nona-2,4,6,8-tetraen-1-ol" C20H30O FPIPGXGPPPQFEQ-OVSJKPMPSA-N (2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraen-1-ol n.a. Vitamins No No No No Yes No rxnAGORA3092,rxnAGORA5327,rxnAGORA5328 PMDBD2001731 Salicylic acid, o-Hydroxybenzoic acid Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No Yes No rxnAGORA3296,rxnAGORA5343,rxnAGORA5344,rxn07524,rxnAdd31 PMDBD2001733 4-hydroxyphenylacetate Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 127 n.a. NPC52472 4-hydroxyphenylacetic acid, 156-38-7, 2-(4-hydroxyphenyl)acetic acid, p-hydroxyphenylacetic acid, (4-Hydroxyphenyl)acetic acid, benzeneacetic acid, 4-hydroxy-, 4-Hydroxybenzeneacetic acid, 4-hydroxyphenylacetate, (p-Hydroxyphenyl)acetic acid, Parahydroxy phenylacetic acid, 4-Carboxymethylphenol, Acetic acid, (p-hydroxyphenyl)-, p-hydroxyphenylacetate, MFCD00004347, Parahydroxy phenylacetate, 3J9SHG0RCN, p-Hydroxyphenyl acetic acid, 4-hydroxyphenyl-acetic acid, CHEMBL1772, (4-hydroxy-phenyl)-acetic acid, CHEBI:18101, NSC-25066, NSC-27460, 4-hydroxybenzeneacetate, 4HP, (p-hydroxyphenyl)acetate, 2-[4-(hydroxy)phenyl)acetic acid, 4-HPA, 4-Hydroxyphenyl acetic acid, 2-(4-(HYDROXY)PHENYL)ACETIC ACID, 4-(Carboxymethyl)phenol, EINECS 205-851-3, UNII-3J9SHG0RCN, NSC 25066, BRN 1448766, 4-hydroxy phenyl acetic acid, AI3-17755, 3pcg, HPAA, Parahydroxyphenylacetate, 1ai6, 4-Hydroxy-Benzeneacetate, 4-hydroxyphenyacetic acid, 4-hydroxyphenylactic acid, 4-hyroxyphenylacetic acid, (p-hydroxyphenyl)-Acetate, ChemDiv3_005483, bmse000455, 4- hydroxyphenylacetic acid, 4-hydroxy-phenylacetic acid, 4-hydroxyphenylethanoic acid, (4-hydroxy-phenyl)-acetate, p-hydroxy phenyl acetic acid, 4-Hydroxy-Benzeneacetic acid, 4-Hydroxybenzene acetic acid, SCHEMBL75700, 4-hydroxy-phenyl acetic acid, 4-10-00-00543 (Beilstein Handbook Reference), MLS001066398, (p-hydroxyphenyl)-Acetic acid, (4-hydroxyphenyl) acetic acid, (4-hydroxyphenyl)-acetic acid, (4-hydroxyphenyl)ethanoic acid, Acetic acid, 4-hydroxyphenyl-, (4-Hydroxy-phenyl)-essigsaeure, 4-Hydroxyphenylacetic Acid,(S), DTXSID5059745, 4-Hydroxyphenylacetic acid, 98%, HMS1488J05, HMS2760I07, CS-D1503, HY-N1902, NSC25066, NSC27460, AC7824, BDBM50339586, s4863, AKOS000277614, AM84511, CCG-266227, PS-5568, IDI1_023393, AC-10104, SMR000020068, SY004128, EU-0016214, H0290, NS00006155, EN300-18714, C00642, H-7100, A809742, AM-814/41090691, Q4637160, Z89269462, 2-(4-Hydroxyphenyl)acetic acidP-hydroxybenzeneacetic acid, 4-Hydroxyphenylacetic acid, Vetec(TM) reagent grade, 98%, B977C251-72C6-4D13-AD85-937DCA3E6AF2, InChI=1/C8H8O3/c9-7-3-1-6(2-4-7)5-8(10)11/h1-4,9H,5H2,(H,10,11 C8H8O3 XQXPVVBIMDBYFF-UHFFFAOYSA-N 2-(4-hydroxyphenyl)acetic acid n.a. n.a. No No No No Yes Yes rxnAGORA3469,rxnAGORA3497,rxnAGORA3510,rxnAGORA3838,rxnAGORA4727,rxnAdd37 EX_4hphac(e) PMDBD2001734 Urate Dietary Substance, Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D0D3CS 1175 n.a. NPC5707 "uric acid, 69-93-2, urate, Lithic acid, 2,6,8-trioxypurine, 2,6,8-trihydroxypurine, 8-hydroxyxanthine, 2,6,8-Trioxopurine, 7,9-Dihydro-1H-purine-2,6,8(3H)-trione, 1H-Purine-2,6,8(3H)-trione, 7,9-dihydro-, 1H-Purine-2,6,8-triol, Purine-2,6,8(1H,3H,9H)-trione, trioxopurine, Uricum acidum, 2,3,6,7,8,9-hexahydro-1H-purine-2,6,8-trione, 7,9-dihydro-3H-purine-2,6,8-trione, NSC 3975, AI3-15432, 1H-purine-2,6,8(3H,7H,9H)-trione, Idelalisib metabolite m54, NSC-3975, EINECS 200-720-7, DTXSID3042508, UNII-268B43MJ25, CHEBI:17775, MFCD00005712, CHEMBL792, 268B43MJ25, 9H-purine-2,6,8-triol, DTXCID1022508, CHEBI:46823, 2,6-dihydroxy-7,9-dihydropurin-8-one, NCGC00181032-01, 8-Hydroxy-3,9-Dihydro-1h-Purine-2,6-Dione, 6,8-Dioxo-6,7,8,9-tetrahydro-1H-purin-2-olate, Acid, Uric, URC, Lithate, hypoxanthinediol, uric acids, uric-acid, 2,8-Trioxopurine, 2,8-Trioxypurine, 8HX, Uric acid (8CI), 2,8-Trihydroxypurine, Uric Acid1547, 1l5s, 2,6,8-trihydroxypurin, Purine-2,6,8-triol, 1H-Purine-2,8-triol, Uric acid, 99.0%, URIC ACID [MI], URIC ACID [INCI], bmse000126, H-Purine-2,6,8-triol, SCHEMBL7933, 7H-purine-2,6,8-triol, URICUM ACIDUM [HPUS], (S)-3-Aminoquinuclidine HCl, GTPL4731, SCHEMBL15777793, SCHEMBL17081907, CHEBI:27226, CHEBI:46811, CHEBI:46814, CHEBI:46817, CHEBI:62589, NSC3975, Uric acid, >=99%, crystalline, HMS3604N17, AMY23430, BCP28980, HY-B2130, Purine-2,8(1H,3H,9H)-trione, Tox21_113563, BDBM50325824, s3955, AKOS000118731, Purine-3,6,8(1H,3H,9H)-trione, CCG-339700, DB08844, Uric acid, NIST(R) SRM(R) 913b, CAS-69-93-2, purine-2,6,8-(1H,3H,9H)-trione, Uric acid, BioXtra, >=99% (HPLC), AS-56119, SY057305, 6-hydroxy-1H-purine-2,8(7H,9H)-dione, 2,6,8-Trioxypurine;2,6,8-Trihydroxypurine, 2,6-dihydroxy-7,9-dihydro-8H-purin-8-one, CS-0020287, NS00009325, U0018, 1H-Purine-2,8(3H)-trione, 7,9-dihydro-, EN300-19268, 7,9-Dihydro-3H-purine-2,6,8-trione(Urate), C00366, U-6050, 1H-Purine-2,6,8-triol 2,6,8-Trihydroxypurine, 7,9-Dihydro-3H-purine-2,6,8-trione(uric acid), A866713, Q105522, SR-01000945208, SR-01000945208-1, 565FF3AF-8AFA-4EE9-9FC4-6B119784A5BB, 1H-Purine-2,6,8(3H)-trione, 7,9-dihydro- (9CI), Z104473370, InChI=1/C5H4N4O3/c10-3-1-2(7-4(11)6-1)8-5(12)9-3/h(H4,6,7,8,9,10,11,12" C5H4N4O3 LEHOTFFKMJEONL-UHFFFAOYSA-N 7,9-dihydro-3H-purine-2,6,8-trione n.a. n.a. No No No No Yes No rxnAGORA3531,rxnAGORA5321,rxnAGORA5322 PMDBD2001735 oxalate(2-) Dietary Substance, Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D01FAR 71081 n.a. NPC315615 oxalate, Oxalate Ion, ethanedioate, oxalate(2-), Oxalic acid, ion(2-), Ethanedioic acid, ion(2-), 338-70-5, PQ7QG47K6T, oxalate2-, oxalate dianion, 3mof, 2rk7, OXALATE ION(2-), UNII-PQ7QG47K6T, OXALATE (C2O42-), GTPL4538, BDBM92964, CHEBI:30623, OXALATE ION (C2O42-), MUBZPKHOEPUJKR-UHFFFAOYSA-L, DTXSID901047254, NS00007765, A808245, Q27088221 C2O4-2 MUBZPKHOEPUJKR-UHFFFAOYSA-L oxalate n.a. n.a. No No No No Yes No rxnAGORA3572,rxnAGORA3581,rxnAGORA4530,rxnAGORA5075,rxnAGORA5076 PMDBD2001736 trans-Cinnamate Dietary Substance, Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D0T2QL 444539 n.a. NPC206800 "CINNAMIC ACID, TRANS-CINNAMIC ACID, 140-10-3, 621-82-9, 3-Phenylacrylic acid, (E)-Cinnamic acid, trans-3-Phenylacrylic acid, Phenylacrylic acid, Zimtsaeure, (E)-3-phenylprop-2-enoic acid, E-Cinnamic Acid, 3-Phenylpropenoic acid, trans-Cinnamate, (2E)-3-phenylprop-2-enoic acid, 2-Propenoic acid, 3-phenyl-, (2E)-, 3-phenylprop-2-enoic acid, Cinnamic acid, (E)-, Cinnamylic acid, trans-beta-Carboxystyrene, (2E)-3-Phenyl-2-propenoic acid, beta-Phenylacrylic acid, (E)-cinnamate, Benzeneacrylic acid, trans-3-Phenyl-2-propenoic acid, 3-Phenyl-2-propenoic acid, Heparin, lithium salt, Benzenepropenoic acid, FEMA No. 2288, CCRIS 3190, 2-Propenoic acid, 3-phenyl-, (E)-, (E)-3-Phenyl-2-propenoic acid, t-Cinnamic acid, EINECS 205-398-1, MFCD00004369, NSC 44010, Benzylideneacetic acid, UNII-U14A832J8D, BRN 1905952, CINNAMIC ACIDUM, AI3-23709, Cinnamic acid, trans-, Kyselina skoricove, PhCH=CHCO2H, TRANS-CINNAMIC-D5 ACID, Acidum cinnamylicum, U14A832J8D, (2E)-2-Phenyl-2-propenoic acid, PHENYLETHYLENECARBOXYLIC ACID, NSC-9189, NSC-44010, Cinnamic acid(only trans), NSC-623441, (2E)-3-phenylacrylic acid, CHEMBL27246, Cinnamic acid (natural), DTXSID5022489, CHEBI:27386, CHEBI:35697, NSC 9189, cinnamate, 4-09-00-02002 (Beilstein Handbook Reference), NCGC00165979-01, 352431-48-2, EINECS 210-708-3, BRN 0507757, AI3-00891, CINNAMIC ACID (MART.), CINNAMIC ACID [MART.], DTXCID002489, CINNAMIC ACID (USP-RS), CINNAMIC ACID [USP-RS], (E)-3-phenylprop-2-enoate, (2E)-3-phenylprop-2-enoate, CAS-140-10-3, .beta.-Phenylacrylic acid, 343338-31-8, (E)-3-Phenylacrylic acid, DTXSID40110056, trans-Zimtsaeure, NSC 623441, trans cinnamic acid, cinnamic acid, (trans)-(E)-isomer, 5-Thiazolamine?HCl, b-Phenylacrylic acid, Cinnamic acid, E-, Cinnamic Acid Natural, Cinnamic Acid1511, trans-b-Carboxystyrene, Cinnamicacid(onlytrans), trans-3-Phenylacrylate, (E)-3-Phenylacrylate, E-3-phenylpropenoic acid, Trans-Cinnamic Acid,(S), bmse000124, CINNAMIC ACID [MI], SCHEMBL1332, trans-.beta.-Carboxystyrene, trans-Cinnamic acid, 97%, trans-Cinnamic acid, 99%, WLN: QV1U1R, (E)-3-phenyl-acrylic acid, 3-phenyl-2E-propenoic acid, CINNAMIC ACID [FCC], Zimtsaeure | trans-Cinnamate, CINNAMIC ACID [FHFI], CINNAMIC ACID [INCI], trans-3-Phenyl-2-propenoate, BIDD:ER0586, tert-.beta.-Phenylacrylic acid, trans-Cinnamic acid, >=99%, (2E)-2-Phenyl-2-propenoate, (2E)-3-Phenyl-2-propenoate, GTPL3203, CINNAMIC ACID [WHO-DD], DTXCID9065316, BDBM16430, HY-N0610A, NSC9189, NSC44010, STR00363, trans-Cinnamic acid, >=99%, FG, Tox21_112279, Tox21_302137, NSC623441, s3677, AKOS000118871, CCG-214473, CS-W020005, trans-Cinnamic acid, analytical standard, NCGC00165979-04, NCGC00165979-06, NCGC00255114-01, 1ST40140, AC-34658, AS-75479, BP-20203, 3-Phenylacrylic acid; -Phenylacrylic acid, C3412, NS00001286, EN300-19599, trans-Cinnamic acid, purum, >=99.0% (T), C00423, D70605, EN300-306004, AB00374254-03, trans-cinnamic acid (trans-3-phenylacrylic acid), trans-Cinnamic Acid [Matrix for MALDI-TOF/MS], A833631, Q164785, SR-05000002380, trans-Cinnamic acid, natural, >=99%, FCC, FG, Q-100150, SR-05000002380-1, W-105037, F2191-0134, trans-Cinnamic Acid Zone Refined (number of passes:40), trans-Cinnamic acid; Phenylacrylic acid;Cinnamylic acid, Z104474406, 1BE36587-A165-4142-9340-18FFE3E03426, CINNAMIC ACID (CONSTITUENT OF CINNAMOMUM VERUM BARK) [DSC], Cinnamic acid, United States Pharmacopeia (USP) Reference Standard, TRANS-CINNAMIC ACID (CONSTITUENT OF CINNAMOMUM CASSIA BARK) [DSC], InChI=1/C9H8O2/c10-9(11)7-6-8-4-2-1-3-5-8/h1-7H,(H,10,11)/b7-6" C9H8O2 WBYWAXJHAXSJNI-VOTSOKGWSA-N (E)-3-phenylprop-2-enoic acid n.a. n.a. No No No No Yes No rxnAGORA3594,rxnAGORA4660,rxnAGORA4661,rxnAGORA4731,rxn01614,rxnAdd158 PMDBD2001737 myo-inositol Dietary Substance, Therapeutic Substance Phase 2 n.a. n.a. n.a. n.a. D03SHD 892 n.a. NPC113212 "inositol, myo-inositol, Scyllo-inositol, epi-Inositol, Muco-Inositol, Allo-inositol, i-Inositol, 87-89-8, meso-Inositol, D-chiro-Inositol, Neo-inositol, 643-12-9, 1L-Chiro-inositol, D-(+)-chiro-Inositol, cis-Inositol, 488-59-5, 1D-Chiro-inositol, Myoinositol, Scyllitol, Cyclohexane-1,2,3,4,5,6-hexaol, 6917-35-7, 488-58-4, cyclohexane-1,2,3,4,5,6-hexol, Quercinitol, 551-72-4, mesoinositol, Cocositol, Meat sugar, Myoinosite, Dambose, chiro-inositol, 41546-34-3, Inositene, Inositina, L-chiro-Inositol, Phaseomannite, Inosital, Inosite, Inositol, myo-, Iso-inositol, Cyclohexitol, Phaseomannitol, 643-10-7, Mesoinosit, Mesoinosite, Scyllite, Mesovit, Nucite, Mesol, 488-55-1, Cyclohexanehexol, D-chiro Inositol, Inositol, meso-, cis-1,2,3,5-trans-4,6-Cyclohexanehexol, D-myo-Inositol, 488-54-0, Bios I, Insitolum, Isoinositol, L-(-)-chiro-Inositol, (-)-Inositol, 576-63-6, d-Inositol, L-Inositol, L-myo-Inositol, Inositol, allo-, Inositol, muco-, Inositol, i-, Inositol, scyllo-, Inositol (VAN), alloinositol, neoinositol, Hexahydroxycyclohexane, Levoinositol, scyllo-Cyclohexanehexol, 1D-myo-Inositol, 1L-myo-Inositol, Inositol, cis-, Inositol, epi-, Inositol, neo-, epi-Cyclohexanehexol, (+)-Inositol, 1,2,3,4,5,6-Cyclohexanehexol, 38876-99-2, (-)-chiro-Inositol, ELND005, Rat antispectacled eye factor, (1R,2R,3S,4R,5r,6S)-cyclohexane-1,2,3,4,5,6-hexaol, CCRIS 6745, 1,2,3,5-trans-4,6-Cyclohexanehexol, cis-, AZD 103, Chiro-inositol, (-)-, Inositol, myo, (1R,2R,3S,4S,5S,6S)-Cyclohexane-1,2,3,4,5,6-hexaol, MFCD00077932, (1r,2r,3r,4r,5r,6r)-cyclohexane-1,2,3,4,5,6-hexol, (1r,2R,3S,4r,5R,6S)-cyclohexane-1,2,3,4,5,6-hexol, 1,3,5/2,4,6-Hexahydroxycyclohexane, (1R,2R,3R,4R,5S,6S)-Cyclohexane-1,2,3,4,5,6-hexaol, 1-L-chiro-Inositol, Inositol, D-chiro-, (+)-Chiro-Inositol, CHEBI:17268, AI3-16111, NSC8101, 1,3,5/2,4,6-cyclohexanehexol, 1,2,3,5/4,6-Cyclohexanehexol, NSC 8101, NSC-8101, Chiro-inositol, (+)-, (1R,2R,3R,4S,5S,6s)-cyclohexane-1,2,3,4,5,6-hexaol, (1R,2R,3S,4S,5S,6S)-cyclohexane-1,2,3,4,5,6-hexol, 1,2,3,4,5,6-HEXAHYDROXY-CYCLOHEXANE, MFCD00065455, NSC-25142, NSC-55551, NSC404118, myo-Inositol;meso-Inositol, 1,2,3,4,5,6-Hexahydroxycyclohexane, NSC 404118, NSC-404118, J101.890F, J101.891D, (1s,2s,3s,4s,5s,6s)-cyclohexane-1,2,3,4,5,6-hexol, 63GQX5QW03, 8LQ63P85IC, 9O6Y5O4P9W, ELND-005, R1Y9F3N15A, (1R,2R,3R,4R,5S,6S)-cyclohexane-1,2,3,4,5,6-hexol, (1r,2R,3R,4s,5S,6S)-cyclohexane-1,2,3,4,5,6-hexol, (1s,2R,3R,4s,5S,6S)-cyclohexane-1,2,3,4,5,6-hexol, DTXSID7023146, CHEBI:10642, CHEBI:23927, CHEBI:27372, CHEBI:27987, AZD-103, 4661D3JP8D, 6R79WV4R10, M94176HJ2F, Inositol (VAN8C, NSC45517, NSC55551, NSC55552, NSC-55552, NSC-55558, 1VS4X81277, NSC-103959, NSC-127230, INS, NCGC00159409-02, (1R,2R,3S,4R,5S,6S)-cyclohexane-1,2,3,4,5,6-hexaol, (1R,2R,3S,4R,5S,6S)-cyclohexane-1,2,3,4,5,6-hexol, (1r,2R,3S,4s,5R,6S)-cyclohexane-1,2,3,4,5,6-hexol, 4L6452S749, 587A93P465, Inositol, myo- (8CI), MYO-INOSITOL-1,2,3,4,5,6-D6, 1,3,4,5,6-Cyclohexanehexol, 1,3,5/4,6-Cyclohexanehexol, DTXCID2065254, (1R,2S,3r,4R,5S,6s)-cyclohexane-1,2,3,4,5,6-hexol, 1,2,4/3,5,6-cyclohexanehexol, (1R,2R,3S,4S,5S,6R)-CYCLOHEXANE-1,2,3,4,5,6-HEXOL, rel-(1r,2r,3r,4r,5r,6r)-Cyclohexane-1,2,3,4,5,6-hexaol, rel-(1R,2r,3S,4R,5s,6S)-Cyclohexane-1,2,3,4,5,6-hexaol, Mouse antialopecia factor, 1,2,3,4,5,6-Cyclohexanehexol #, cis-1,2,3,4,5,6-cyclohexanehexol, CAS-87-89-8, cis-1,3,5-trans-4,6-Cyclohexanehexol, SMR000857145, SMR000857319, SMR000857320, ELND 005, SR-05000001655, EINECS 201-781-2, inositols, UNII-63GQX5QW03, UNII-8LQ63P85IC, UNII-9O6Y5O4P9W, UNII-R1Y9F3N15A, Matezodambose, an inositol, Inositol [Nonspecific isomer], UNII-4661D3JP8D, UNII-6R79WV4R10, UNII-M94176HJ2F, Muscle sugar, inositol myo-, UNII-1VS4X81277, 4irx, Inositol, chiro-, rac-chiro-inositol, UNII-4L6452S749, UNII-587A93P465, Inosital (TN), Inositol (NF), CBU, EINECS 207-681-5, EINECS 207-682-0, EINECS 209-000-7, EINECS 211-393-5, EINECS 211-394-0, EINECS 230-024-9, NSC 25142, EPIINOSITOL, (+)-Epi-Inositol, CHIRO-INOSITOLS, allo-Inositol, 97%, Inositol [USAN:NF], INOSITOL, MESO, Spectrum_001595, 2os9, INOSITOL [INCI], INOSITOL [USAN], INOSITOL [FCC], INOSITOL [INN], orthorhombic myo-inositol, D-(+)-Chiro Inositol, DL-CHIRO-INOSITOL, INOSITOL [MI], INOSITOL (D), INOSITOL (L), INOSITOL [VANDF], Spectrum3_001053, Spectrum4_001193, Spectrum5_000961, myo-Inositol, >=99%, INOSITOL [MART.], bmse000102, bmse000103, bmse000113, bmse000901, bmse000922, Epitope ID:144993, INOSITOL [USP-RS], INOSITOL [WHO-DD], scyllo-Inositol, >=98%, SCHEMBL5831, SCHEMBL5832, SCHEMBL5969, NCIOpen2_008191, BSPBio_002606, KBioGR_001885, KBioSS_002075, MLS001332377, MLS001332378, MLS001335965, MLS001335966, MLS001335967, MLS001335968, SCHEMBL187278, SCHEMBL187397, SCHEMBL187796, SCHEMBL188106, SCHEMBL188237, SCHEMBL491333, SCHEMBL959404, SCHEMBL959405, CHEMBL278373, CHEMBL468154, GTPL4495, GTPL4645, GTPL4648, GTPL4649, MEGxp0_001817, SCHEMBL1055883, SCHEMBL4748543, SCHEMBL6378921, SCHEMBL6468882, SCHEMBL6791918, CHEMBL1222251, CHEMBL1231671, CHEMBL1950780, CHEMBL3976780, SCHEMBL12371461, SCHEMBL12377889, SCHEMBL12411898, SCHEMBL12711208, SCHEMBL12735687, SCHEMBL13058696, SCHEMBL13114115, SCHEMBL13114116, SCHEMBL13114128, SCHEMBL13207905, SCHEMBL13580047, SCHEMBL14542470, SCHEMBL21388397, ACon1_002457, CHEBI:22357, CHEBI:23311, CHEBI:24848, CHEBI:25492, CHEBI:27374, D-(+)-chiro-Inositol, 95%, KBio2_002075, KBio2_004643, KBio2_007211, KBio3_001826, L-(-)-chiro-Inositol, 95%, DTXSID30110000, DTXSID50905091, myo-Inositol, p.a., 98.0%, CDAISMWEOUEBRE-GNIYUCBRSA-N, CDAISMWEOUEBRE-GPIVLXJGSA-N, CDAISMWEOUEBRE-LOLGQZEGSA-N, CDAISMWEOUEBRE-NIPYSYMMSA-N, CDAISMWEOUEBRE-OQYPVSDDSA-N, 1,2,3,4,5/6-cyclohexanehexol, 1,2,3,4/5,6-cyclohexanehexol, 1,2,3/4,5,6-cyclohexanehexol, 1,2,4,5/3,6-cyclohexanehexol, DTXSID101028818, DTXSID101028820, DTXSID201028823, DTXSID301028826, DTXSID601028825, DTXSID901028824, HMS2091N13, HMS2230N03, HMS2235H05, HMS2235M23, HMS3369B06, HMS3369F20, HMS3373E05, Pharmakon1600-01500352, D-CHIRO-INOSITOL [USP-RS], D-CHIRO-INOSITOL [WHO-DD], BCP25172, HY-B1411, HY-N3021, MYO-INOSITOL [EP MONOGRAPH], NSC25142, NSC55558, Tox21_111642, Tox21_302035, CCG-36096, cis-Inositol, >=98.0% (TLC), MFCD00003863, MFCD00272608, MFCD00799555, MFCD00799556, MFCD01321249, NSC 55552, NSC 55558, NSC-45517, NSC103959, NSC127230, NSC757076, s4530, epi-Inositol, >=98.0% (HPLC), 1,2,3,4,5,6/0-cyclohexanetetrol, AKOS006240678, AKOS006332036, AKOS015895894, AKOS015912905, AKOS015912934, AKOS015960429, AKOS015960633, AKOS015994742, AKOS024318869, AKOS027320475, AKOS027327401, Tox21_111642_1, CS-4782, CS-W010757, CS-W017225, DB03106, DB13178, DB15350, HY-W010041, HY-W016509, HY-W021265, HY-W127726, J9.771C, KS-1284, KS-1420, NSC 103959, NSC 127230, NSC-757076, SB44732, SB45039, SB46764, SB46855, D-chiro-Inositol, >=98.0% (HPLC), NCGC00159409-03, NCGC00159409-04, NCGC00159409-07, NCGC00159409-08, NCGC00169828-01, NCGC00178580-01, NCGC00178580-03, NCGC00255362-01, AC-11070, AS-10616, AS-68396, AS-68424, cyclohexane-1R,2R,3S,4S,5R,6S-hexol, LS-13189, NCI60_041778, SY060836, myo-Inositol, purum, >=98.0% (HPLC), rac-chiro-1,2,3,4,5,6-cyclohexanehexol, SBI-0051369.P003, cis-1,2,4-trans-3,5,6-Cyclohexanehexol, HY-121962, J101.888D, J101.889B, J101.892B, myo-Inositol, for microbiology, >=99.0%, CS-0023004, CS-0039882, CS-0083766, CS-0185922, CS-0369552, I0040, I0628, I0629, I0630, I0631, I0632, I0633, NS00007581, NS00074234, NS00079417, NS00079658, NS00080052, NS00080101, NS00080335, S6176, EN300-82941, myo-Inositol, BioUltra, >=99.5% (HPLC), myo-Inositol, SAJ special grade, >=99.0%, myo-Inositol, Vetec(TM) reagent grade, 99%, C00137, C06151, C06152, C06153, C19891, D08079, D78450, D91187, D91188, D91189, E78671, EN300-658805, F19572, I-6500, M01914, T72516, AB00051982_13, EN300-7361851, EN300-7411506, A834712, A836375, A866896, EN300-19631206, EN300-19632288, EN300-25914216, Q407997, Q743661, Q-201583, Q2838375, Q2974313, Q3011024, Q3023527, Q3205874, Q3331426, Q3347078, Q3589114, SR-05000001655-1, SR-05000001655-5, W-202861, W-202862, W-203081, W-203168, W-203392, 1,2,4/3,5,6-Cyclohexane-1,2,3,4,5,6-hexol, 7B0CEF84-D9CE-4A88-AA7D-EC50C89387A5, 1D7A27BF-6060-4FA9-AC46-3BD18DBA406E, 220128F1-89BF-442D-AD6D-E6D1EA7BA625, Z1486007281, (1r,2r,3r,4r,5r,6r)-cyclohexane-1,2,3,4,5,6-hexaol, (1R,2S,3r,4R,5S,6r)-cyclohexane-1,2,3,4,5,6-hexol, (1R,2S,3s,4R,5S,6s)-cyclohexane-1,2,3,4,5,6-hexol, Inositol, United States Pharmacopeia (USP) Reference Standard, myo-Inositol, European Pharmacopoeia (EP) Reference Standard, rel-(1S,2s,3s,4s,5s,6s)-cyclohexane-1,2,3,4,5,6-hexaol, 1,2,3,4,5,6-Cyclohexanehexol, (cis,cis,cis,trans,cis,trans)- #, 1,2,3,4,5,6-cyclohexanehexol, (1alpha,2alpha,3alpha,4beta,5alpha,6beta), Inositol, Pharmaceutical Secondary Standard; Certified Reference Material, 1.ALPHA.,2.ALPHA.,3.BETA.,4.ALPHA.,5.BETA.,6.BETA.-CYCLOHEXANEHEXOL, 2H3, myo-Inositol, BioReagent, suitable for cell culture, suitable for insect cell culture, suitable for plant cell culture" C6H12O6 CDAISMWEOUEBRE-UHFFFAOYSA-N cyclohexane-1,2,3,4,5,6-hexol n.a. n.a. No No No No Yes No rxnAGORA3686,rxnAGORA3688,rxnAGORA3713,rxnAGORA5191,rxn05038 PMDBD2001738 4-Hydroxybenzaldehyde (iJN746) Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No Yes No rxnAGORA3850,rxnAGORA5035,rxnAGORA5349,rxnAGORA5350 PMDBD2001739 Phenol Dietary Substance, Therapeutic Substance Phase 2/3 108-95-2 DB03255 PA450913 D00033 D0L6HN 996 971 n.a. "phenol, 108-95-2, carbolic acid, Hydroxybenzene, Phenic acid, Oxybenzene, Benzenol, Phenylic acid, Phenylic alcohol, Monophenol, Phenyl hydrate, Phenyl hydroxide, PhOH, Monohydroxybenzene, Paoscle, Phenole, Izal, Phenyl alcohol, Phenol alcohol, Acide carbolique, Phenol, liquefied, Fenolo, Carbolsaure, Phenosmolin, Fenol, Liquid phenol, Phenol, pure, Benzene, hydroxy-, Rcra waste number U188, Liquefied phenol, Liquified Phenol, Carbolicum acidum, Fenolo [Italian], NCI-C50124, Phenole [German], Campho-Phenique Gel, phenylalcohol, UN 2312 (molten), Phenol [JAN], UN 1671 (solid), Phenic, Carbolsaure [German], Caswell No. 649, Campho-Phenique Liquid, Phenol, molten, 2-allphenol, Baker''s P & S liquid & Ointment, Fenol [Dutch, Polish], NSC 36808, Phenol, liquified, Baker''s P and S Liquid and Ointment, Monohydroxy benzene, Acide carbolique [French], CCRIS 504, Campho-Phenique Cold Sore Gel, Carbolsaeure, FEMA No. 3223, Karbolsaeure, HSDB 113, acide phenique, DTXSID5021124, Phenic alcohol, Phenol,liquified, Synthetic phenol, Phenol, dimer, AI3-01814, RCRA waste no. U188, EINECS 203-632-7, UNII-339NCG44TV, MFCD00002143, NSC-36808, UN1671, UN2312, UN2821, EPA Pesticide Chemical Code 064001, 339NCG44TV, CHEBI:15882, Phenol [USP:JAN], ENT-1814, Phenol-3,5-d2, 27073-41-2, CHEMBL14060, DTXCID501124, EC 203-632-7, NSC36808, Phenol, Glass Distilled Under Argon, 65996-83-0, Phenol, solid [UN1671] [Poison], Phenol (USP:JAN), Phenol, molten [UN2312] [Poison], NCGC00091454-04, Fenosmoline, Fenosmolin, PHENOL (IARC), PHENOL [IARC], PHENOL (USP-RS), PHENOL [USP-RS], PHENOL (II), PHENOL [II], PHENOL (MART.), PHENOL [MART.], Phenol, >=99.0%, 17442-59-0, PHENOL (EP MONOGRAPH), PHENOL [EP MONOGRAPH], PHENOL (USP MONOGRAPH), PHENOL [USP MONOGRAPH], Carbol, hydroxy benzene, Phenol 100 microg/mL in Methanol, Phenol, liquid, Phenol, solid, Baker''s p and s, Phenol, sulfurated, CAS-108-95-2, METACRESOL IMPURITY A (EP IMPURITY), METACRESOL IMPURITY A [EP IMPURITY], (14C)Phenol, HEXYLRESORCINOL IMPURITY A (EP IMPURITY), HEXYLRESORCINOL IMPURITY A [EP IMPURITY], PHENOL (2,3,4,5,6-D5), arenols, Benzophenol, Karbolsaure, Phylorinol, Ulcerease, Hydroxy-benzene, Phenol liquid, Phenol molten, Fungus Fighte, Phenol synthetic, Pandy''s reagent, Cepastat lozenges, Fortinia ID, Phenol, labeled with carbon-14, Acidum Carbolicum, Phenol (liquid), 2-phenyl alcohol, Sore ThroatCherry, Phenol, synthetic, Phenol, ultrapure, ABC Sore Throat, HEB Sore Throat, Phenol ACS grade, RugbyCherry Flavor, Sore ThroatMenthol, Sore Throat Spray, Meijer Sore Throat, Sore Throat Cherry, Sore Throat Relief, Liquefied phenol BP, Paoscle (TN), Topcare Sore Throat, Carbolic acid liquid, Phenol (TN), Phenol,(S), TopCareCherry Flavor, Phenol, ACS reagent, PUBLIX Sore Throat, Carbolic acid, liquid, CepastatExtra Strength, Walgreens Sore Throat, 63496-48-0, Sore ThroatReadyInCase, Vortex Moisturizer Oral, 1ai7, 1li2, 4i7l, Liquefied phenol (TN), DRx Choice Sore Throat, PHENOL [VANDF], Wild Horse 777 Oral, PHENOL [FHFI], PHENOL [HSDB], PHENOL [INCI], Sore Throat ReliefCherry, Castellani Paint 1.5%, Phenol (JP17/USP), PHENOL [WHO-DD], Phenol, detached crystals, Pain RelievingPetro Carbo, PHENOL [MI], Phenol, >=99%, Sore Throat ReliefMenthol, WLN: QR, Good Neighbor Sore Throat, Liquefied phenol (JP17), bmse000290, bmse010026, C6H5OH, Fenol(DUTCH, POLISH), NICE SORE THROAT Cherry, PHENOL, 80% in ethanol, Phenol, LR, >=99%, Phen-2,4,6-d3-ol-d, HEB Sore ThroatCherry Flavor, MLS001065591, Phenol (CGA 73330), Phenol, for molecular biology, BIDD:ER0293, Phenol for disinfection (TN), ABC Sore ThroatMenthol Flavor, HEB Sore ThroatMenthol Flavor, NICE SORE THROAT Spearmint, Phenol, natural, 97%, FG, CHLORASEPTIC SORE THROAT, Chloraseptic Sore Throat Cherry, Chloraseptic Sore Throat Citrus, Cuticura pain relieving ointment, Sore Throat ReliefCherry Flavor, CARBOLICUM ACIDUM [HPUS], Phenol, AR, >=99.5%, PHENOL,LIQUIFIED [VANDF], BDBM26187, CHEBI:33853, Phenol for disinfection (JP17), Topcare Sore ThroatMenthol Flavor, 3f39, Phenol 10 microg/mL in Methanol, PUBLIX Sore ThroatMenthol Flavor, Walgreens Sore ThroatCherry Flavor, phenol 0.6% anesthetic oral rinse, Tox21_113463, Tox21_201639, Tox21_300042, DRx Choice Sore ThroatMenthol Flavor, Phenol 5000 microg/mL in Methanol, AKOS000119025, Eos Medicated Pain Relieving Lip Balm, Tox21_113463_1, DB03255, Good Neighbor Sore ThroatCherry Flavor, NA 2821, Phenol, BioXtra, >=99.5% (GC), Phenol, SAJ first grade, >=98.0%, UN 1671, UN 2312, UN 2821, USEPA/OPP Pesticide Code: 064001, NCGC00091454-01, NCGC00091454-02, NCGC00091454-03, NCGC00091454-05, NCGC00091454-06, NCGC00091454-07, NCGC00254019-01, NCGC00259188-01, Phenol, JIS special grade, >=99.0%, 61788-41-8, 73607-76-8, AM802906, BP-30160, METHYL SALICYLATE IMPURITY B [EP], SMR000568492, Phenol 1000 microg/mL in Dichloromethane, Phenol, PESTANAL(R), analytical standard, Liquified Phenol (contains 7-10 % water), NS00010045, P1610, P2771, EN300-19432, C00146, D00033, Phenol, unstabilized, ReagentPlus(R), >=99%, SALICYLIC ACID IMPURITY C [EP IMPURITY], Phenol, p.a., ACS reagent, 99.5-100.5%, PUBLIX Sore Throat Fast Relief Oral Anesthetic, Q130336, CVS Health Sore Throat Fast Relief Oral Anesthetic, J-610001, Phenol, for molecular biology, ~90% (T), liquid, A13-01814, F1908-0106, Phenol, unstabilized, purified by redistillation, >=99%, Z104473830, InChI=1/C6H6O/c7-6-4-2-1-3-5-6/h1-5,7, Phenol, BioUltra, for molecular biology, >=99.5% (GC), Phenol, United States Pharmacopeia (USP) Reference Standard, Liquified Phenol, meets USP testing specifications, >=89.0%, Phenol, BioUltra, for molecular biology, TE-saturated, ~73% (T), phenol;phenol [jan];phenol, pure;phenol phenol [jan] phenol, pure, Phenol, puriss. p.a., ACS reagent, reag. Ph. Eur., 99.0-100.5%, Phenol, contains hypophosphorous as stabilizer, loose crystals, ACS reagent, >=99.0%, Phenol, puriss., meets analytical specification of Ph. Eur., BP, USP, 99.5-100.5% (GC), Phenol, puriss., meets analytical specification of Ph. Eur., BP, USP, >=99.5% (GC), crystalline (detached)" C6H6O ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol n.a. n.a. No No No No Yes No rxnAGORA2478,rxnAGORA3856,rxnAGORA3973,rxnAGORA3974,rxnAdd231 PMDBD2001740 L-ascorbate Dietary Substance, Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. D07AHW 54670067 n.a. NPC187770 "l-ascorbic acid, ascorbic acid, vitamin C, 50-81-7, L-ascorbate, Ascoltin, ascorbate, L(+)-Ascorbic acid, Ascorbicap, Cevitamic acid, Laroscorbine, Testascorbic, Allercorb, Ascorbajen, Ascorbutina, Ascorteal, Ascorvit, Cantaxin, Cebicure, Cegiolan, Celaskon, Cenetone, Cenolate, Cescorbat, Cetemican, Cevatine, Cevitamin, Citriscorb, Colascor, Concemin, Lemascorb, Proscorbin, Roscorbic, Secorbate, Viforcit, Viscorin, Vitacimin, Vitamisin, Vitascorbol, Adenex, Ascorb, Ascorin, Cantan, Cebion, Cebione, Ceglion, Cemagyl, Cemill, Cereon, Cergona, Cetamid, Cevimin, Cevital, Cevitan, Cevitex, Ciamin, Hybrin, Redoxon, Ribena, Vicelat, Vitace, Vitacee, Vitacin, Cebid, Cecon, Celin, Cevex, Cipca, Hicee, Xitix, Davitamon C, Arco-cee, Planavit C, Catavin C, Ce lent, Liqui-Cee, Vicomin C, Cee-Vite, Cevi-Bid, Natrascorb, Scorbacid, Scorbu-C, Duoscorb, C-Level, C-Vimin, Cetane-Caps TD, Cewin, C-Long, C-Quin, C-Span, Meri-C, Cee-Caps TD, Cevalin, Antiscorbic vitamin, 3-Oxo-L-gulofuranolactone, L-Lyxoascorbic acid, L-Xyloascorbic acid, Ce-Mi-Lin, Acidum ascorbicum, Antiscorbutic vitamin, Natrascorb injectable, IDO-C, Cetane-Caps TC, Acidum ascorbinicum, CE-VI-Sol, 3-Keto-L-gulofuranolactone, L-(+)-Ascorbic Acid, Kyselina askorbova, Dora-C-500, Ascor-B.I.D., Ascorbicab, (R)-5-((S)-1,2-dihydroxyethyl)-3,4-dihydroxyfuran-2(5H)-one, Acido ascorbico, Acide ascorbique, Cortalex, Ferancee, Stuartinic, Tolfrinic, L-Threoascorbic acid, Caswell No. 061B, Antiscorbutic factor, FEMA No. 2109, L-3-Ketothreohexuronic acid lactone, Ascorbinsaeure, (+)-Ascorbic acid, Chromagen, Kyselina askorbova [Czech], Ascor, NCI-C54808, Ascorbicum acidum, Ferrous ascorbate, Acide ascorbique [INN-French], Acido ascorbico [INN-Spanish], Acidum ascorbicum [INN-Latin], Sodascorbate, CCRIS 57, L-threo-Hex-2-enonic acid, gamma-lactone, L-threo-Ascorbic acid, Chewcee, Citrovit, HSDB 818, Juvamine, 3-Oxo-L-gulofuranolactone (enol form), Vasc, UNII-PQ6CK8PD0R, PQ6CK8PD0R, Rovimix C, Scorbu C, EINECS 200-066-2, NSC 33832, Ascorbic acid, l-, Cetebe, Ascorbin, Ronotec 100, Ascorbyl radical, INS NO.300, DTXSID5020106, Rontex 100, CHEBI:29073, INS-300, Hex-2-enonic acid gamma-lactone, L-threo-, E-300, L-Ascorbic acid (GMP), MFCD00064328, NSC-33832, Iron(II) ascorbate, NSC-218455, component of E and C-Level, component of Endoglobin Forte, E300, DTXCID90106, Vitamin c (as ascorbic acid), (5R)-5-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxy-2,5-dihydrofuran-2-one, Ascorbic acid [USP:INN:BAN:JAN], component of Cortalex, component of Ferancee, NSC 218455, 6730-29-6, cevibid, NCGC00164357-01, Ester-C, (2R)-2-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxy-2H-furan-5-one, (5R)-5-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxyfuran-2(5H)-one, ASCORBIC ACID (II), ASCORBIC ACID [II], L-Ascorbic acid 1000 microg/mL in Acetonitrile, Ascorbinsaure, Kangbingfeng, 53262-66-1, Ceklin, ASCORBIC ACID (MART.), ASCORBIC ACID [MART.], Acide ascorbique (INN-French), Acido ascorbico (INN-Spanish), Acidum ascorbicum (INN-Latin), ASCORBIC ACID (USP-RS), ASCORBIC ACID [USP-RS], Parentrovite, Cell C, NSC33832, Ascorbic acid (USP:INN:BAN:JAN), Viscorin 100M, ASCORBIC ACID (EP MONOGRAPH), ASCORBIC ACID [EP MONOGRAPH], ASCORBIC ACID (USP MONOGRAPH), ASCORBIC ACID [USP MONOGRAPH], Suncoat VC 40, Acid, Ascorbic, (5R)-5-((1S)-1,2-DIHYDROXYETHYL)-3,4-DIHYDROXYFURAN-2(5H)-ONE, Ascorbicap (TN), Xyloascorbic acid, L-, Ascoltin (TN), [14C]ascorbic acid, Ascorbic acid [BAN:INN:JAN], [14C]-ascorbic acid, ascorbic acid (vit C), L-Ascorbic acid, meets USP testing specifications, 2-(1,2-Dihydroxyethyl)-4,5-dihydroxyfuran-3-one, DTXSID7048112, Ascorbinezuur, Cevitamate, Asorbicap, Clairfore, CleanFlex, L-lyxoascorbate, L-xyloascorbate, .Ascorbinsaure, New Clairfore, vitamine C, Vitamina C, 3eka, Ester C, (+)-ascorbate, L(+)-ascorbate, L-threo-hex-2-enono-1,4-lactone, HICELl, L-Ascorbic acid, free radical form, L-(+)-ascorbate, Vitamin C,(S), E 300, Ascorbic Acid1505, NEO-VALDRIN, VITA RICH, Dr Cellapy SR Premium, VIT C, (2R)-2-[(1S)-1,2-dihydroxyethyl]-4,5-dihydroxyfuran-3-one, Prestwick3_000325, L-Ascorbic acid, 99%, ASCOR (TN), SCHEMBL785, hex-1-enofuranos-3-ulose, bmse000182, VITAMIN C [VANDF], Vitamin C (Ascorbic acid), ASCORBIC ACID [MI], SCHEMBL4430, ASCORBIC ACID [FCC], ASCORBIC ACID [INN], ASCORBIC ACID [JAN], L-Ascorbic acid, FCC, FG, L-Ascorbic Acid, Free Acid, ASCORBIC ACID [FHFI], ASCORBIC ACID [HSDB], ASCORBIC ACID [INCI], BSPBio_000329, (r)-5-(1,2-dihydroxy-ethyl)-3,4-dihydroxy-5h-furan-2-one, MLS002153776, AROMACURA SHOWER FILTER, ASCORBIC ACID [VANDF], CHEMBL40274, L-Ascorbic acid, cell culture, BPBio1_000363, GTPL4532, GTPL4781, L-Ascorbic acid, reagent grade, ASCORBIC ACID [WHO-DD], ASCORBIC ACID [WHO-IP], L-Ascorbic acid, >=99.0%, CHEBI:22652, HY-B0166G, DTXCID50820452, DTXSID50986567, Ascorbic acid (JP17/USP/INN), CHEBI:176783, HMS2096A11, HMS2231N16, HMS3713A11, L-Ascorbic acid ACS reagent grade, (2R)-2-[(1S)-1,2-Dihydroxyethyl]-4,5-dihydroxy-furan-3-one, ASCORBIC ACID [ORANGE BOOK], BCP27915, HY-B0166, L-Threoascorbic acid,Antiscorbutic factor,Vitamin C;(R)-5-((S)-1,2-Dihydroxyethyl)-3,4-dihydroxyfuran-2(5H)-one, Tox21_110315, Tox21_112104, Tox21_202127, Tox21_302958, gamma-lactone L-threo-Hex-2-enonate, HB1238, L-Ascorbic acid, analytical standard, L-Ascorbic acid, AR, >=99.5%, s3114, AKOS016843589, Tox21_112104_1, CCG-207946, DB00126, L-Ascorbic acid, mixt. with vitamin B, ACIDUM ASCORBICUM [WHO-IP LATIN], gamma-lactone L-threo-Hex-2-enonic acid, L-Ascorbic acid, ACS reagent, >=99%, NCGC00091517-01, NCGC00091517-02, NCGC00091517-03, NCGC00091517-06, NCGC00188972-01, NCGC00256504-01, NCGC00259676-01, BP-12831, SMR001233160, L-Ascorbic acid, plant cell culture tested, L-Ascorbic acid, reagent grade, crystalline, A0537, AB00376923, Ascorbic Acid (L-Ascorbic Acid; Vitamin C), CS-0626121, NS00001126, SW198791-2, L-Ascorbic acid, BioUltra, >=99.5% (RT), L-Ascorbic acid, tested according to Ph.Eur., C00072, D00018, E80759, EN300-708766, L-Ascorbic acid, p.a., ACS reagent, 99.0%, 2,3-DEHYDRO-L-THREO-HEXONO-1,4-LACTONE, AB00376923_04, AB00376923_05, Celladix C.E.F ADVANCED BRIGHTENING AMPOULE, L-Ascorbic acid, JIS special grade, >=99.0%, L-Ascorbic acid, Vetec(TM) reagent grade, 99%, L-Ascorbic acid, BioXtra, >=99.0%, crystalline, Q199678, 2-(1,2-dihydroxyethyl)-4,5-dihydroxy-furan-3-one, L-Ascorbic acid, puriss. p.a., >=99.0% (RT), Q27101942, 47A605F0-4187-47A8-B0CE-F9E7DA1B0076, L-Ascorbic acid, p.a., ACS reagent, reag. ISO, 99.7%, Ascorbic acid, British Pharmacopoeia (BP) Reference Standard, Ascorbic acid, European Pharmacopoeia (EP) Reference Standard, L-Ascorbic acid, certified reference material, TraceCERT(R), L-Ascorbic acid, powder, cell culture tested, gamma-irradiated, Ascorbic acid, United States Pharmacopeia (USP) Reference Standard, 4-((E)-2-[(2-HYDROXYETHYL)SULFANYL]DIAZENYL)BENZENECARBOXYLICACID, (5R)-5-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxyfuran-2(5H)-one (non-preferred name), L-Ascorbic acid, anhydrous, free-flowing, Redi-Dri(TM), ACS reagent, >=99%, L-Ascorbic acid, suitable for cell culture, suitable for plant cell culture, >=98%, L-Ascorbic acid, puriss. p.a., ACS reagent, reag. ISO, reag. Ph. Eur., 99.7-100.5% (oxidimetric)" C6H8O6 CIWBSHSKHKDKBQ-JLAZNSOCSA-N (2R)-2-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxy-2H-furan-5-one n.a. Vitamins No No No No Yes No rxnAGORA4114,rxnAGORA5333,rxnAGORA5334 PMDBD2001741 Cellulose, chain length 500 glc_D assumed, DOI: 10.1002/anie.200460587 Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No No PMDBD2001742 4-Methylcatechol Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 9958 n.a. NPC107522 4-Methylcatechol, 452-86-8, 4-methylbenzene-1,2-diol, 3,4-Dihydroxytoluene, Homocatechol, p-Methylcatechol, 4-Methyl-1,2-benzenediol, Homopyrocatechol, 4-METHYLPYROCATECHOL, Toluene-3,4-diol, 1,2-Dihydroxy-4-methylbenzene, p-Methylpyrocatechol, 1,2-Benzenediol, 4-methyl-, 4-Methyl-1,2-dihydroxybenzene, Pyrocatechol, 4-methyl-, 2-Hydroxy-4-methylphenol, CHEBI:17254, NSC 17489, CCRIS 3333, 1-Methyl-3,4-dihydroxybenzene, UNII-12GLI7JGB3, EINECS 207-214-5, 12GLI7JGB3, BRN 0636512, DTXSID5020861, NSC-17489, METHYL CATECHOL, 4-, DTXCID30861, CHEMBL158766, HMDB00873, 4-METHYL-D3-CATECHOL, MFCD00002205, 1219803-18-5, 5-methylcatechol, DROXIDOPA METABOLITE (3,4-DIHYDROXYTOLUENE), MCT, 83719-41-9, 1,1-Ferrocenedimethanol, 4-Methylcatehol, 4-Metylcatechol, 4-methyl catechol, 4-methyl-catechol, 4-methyl pyrocatechol, 4-methyl-Pyrocatechol, 4k7n, bmse000475, Epitope ID:150928, 4-methyl-benzene-1,2-diol, SCHEMBL12388, 4-Methylcatechol, >=95%, MLS001066329, 4-Methylbenzene-1,2-diol #, 1,2-dihydroxy-5-methylbenzene, 4-methyl-1,2-dihydroxy benzene, HMS3886M12, AMY25678, NSC17489, Tox21_200632, BDBM50548723, c0126, s5616, AKOS000121479, CCG-266087, CS-W013530, DB04120, HY-W012814, NCGC00248773-01, NCGC00258186-01, AC-12438, AS-11944, CAS-452-86-8, SMR000471857, SY012747, M0413, NS00015292, EN300-21094, C06730, D70562, A872403, W-106144, Q15303189, F0001-1227, Z104490128, InChI=1/C7H8O2/c1-5-2-3-6(8)7(9)4-5/h2-4,8-9H,1H C7H8O2 ZBCATMYQYDCTIZ-UHFFFAOYSA-N 4-methylbenzene-1,2-diol n.a. n.a. No No No No Yes No rxnAGORA4728,rxnAGORA4729,rxnAGORA4733,rxnAdd228 PMDBD2001743 L-cystine Dietary Substance, Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D0V1CP 67678 n.a. n.a. "L-cystine, 56-89-3, cystine, L-Cystin, L-Dicysteine, beta,beta''-Dithiodialanine, L-Cysteine disulfide, 1-Cystine, 3,3''-Dithiodialanine, Cystine, L-, Dicysteine, Cystine (L)-, Cystine acid, (H-Cys-OH)2, Cysteine disulfide, Cystin, Alanine, 3,3''-dithiodi-, Alanine, 3,3''-dithiobis-, beta,beta''-Dithioalanine, L-, L-Alanine, 3,3''-dithiobis-, 3,3''-Dithiobis(2-aminopropanoic acid), L-(-)-Cystine, (-)-Cystine, Gelucystine, CCRIS 5822, L-alpha-Diamino-beta-dithiolactic acid, Bis(beta-amino-beta-carboxyethyl)disulfide, UNII-48TCX9A1VT, 3,3''-Dithiobis-L-alanine, EINECS 200-296-3, (R-(R*,R*))-3,3''-Dithiobis(2-aminopropanoic acid), 48TCX9A1VT, NSC 13203, beta,beta''-Diamino-beta,beta''-dicarboxydiethyl disulfide, (2R,2''R)-3,3''-disulfanediylbis(2-aminopropanoic acid), BRN 1728094, DTXSID2046418, CHEBI:16283, AI3-09064, beta,beta''-Diamino-beta,beta''-dicarboxydiethyldisulfide, 3,3''-Dithiobis(2-aminopropanoic acid), (R-(R*,R*))-, Propanoic acid, 3,3''-dithiobis(2-amino-, (R-(R*,R*))-, NSC-13203, S-CYSTEINYL CYSTEINE, Bis(beta-amino-beta-carboxyethyl) disulfide, DTXCID0026418, EC 200-296-3, (2R)-2-amino-3-{[(2R)-2-amino-2-carboxyethyl]disulfanyl}propanoic acid, 4-04-00-03155 (Beilstein Handbook Reference), C6H12N2O4S2, E921, CYSTINE (MART.), CYSTINE [MART.], CYSTINE (USP-RS), CYSTINE [USP-RS], (R,R)-3,3''-dithiobis(2-aminopropanoic acid), S-(((R)-2-amino-2-carboxyethyl)thio)cysteine, cistina, Zystin, Cystine (VAN), Cystine [USAN], Cystin (VAN), CYSTINE (EP MONOGRAPH), CYSTINE [EP MONOGRAPH], 3,3-DISULFANEDIYLBIS((2R)-2-AMINOPROPANOIC ACID), 2-amino-3-(2-amino-2-carboxy-ethyl)disulfanyl-propanoic acid, alpha-Diamino-beta-dithiolactic acid, 24645-67-8, Cystine,d, (R-(R*,R*))-3,3''-Dithiobis, [R-(R*,R*)]-3,3''-Dithiobis, MFCD00064228, L Cystine, CAS-56-89-3, 2079930-29-1, TYROSINE IMPURITY C (EP IMPURITY), TYROSINE IMPURITY C [EP IMPURITY], (H-Cys-OH), ACETYLCYSTEINE IMPURITY A (EP IMPURITY), ACETYLCYSTEINE IMPURITY A [EP IMPURITY], Cystine [USAN:INN], [R-(R*,R*)]-3,3''-dithiobis[2-aminopropanoic acid], cystinum, DTXSID50859005, NCGC00164531-01, IYY, 3,3''-Dithiobis, b,b''-Dithiodialanine, (R,R)-3,3''-Dithiobis(2-aminopropionicacid), L-Cystine (9CI), Cystine (USAN/INN), L-Cystine (JP17), CYSTINE [VANDF], CYSTINE [INCI], CYSTINE [INN], CYSTINE [MI], L-CYSTINE [FCC], L-CYSTINE [JAN], Cystine, L- (8CI), CYSTINE [WHO-DD], bmse000035, (2R)-2-amino-3-[[(2R)-2-amino-2-carboxy-ethyl]disulfanyl]propanoic acid, beta,beta''-Dithiobisalanine, SCHEMBL10226, L-Cystine, non-animal source, CHEMBL590540, GTPL5413, (H-Cys-OH)2 (Disulfide bond), DTXCID60210087, HY-N0394, Tox21_112162, CCG-36355, L-Cystine, >=99.7% (TLC), s4808, Bis(b-amino-b-carboxyethyl) disulfide, Cystine, NIST(R) SRM(R) 143d, AKOS015898645, Tox21_112162_1, AM81644, DB00138, (2R)-2-azanyl-3-[[(2R)-2-azanyl-3-oxidanyl-3-oxidanylidene-propyl]disulfanyl]propanoic acid, Bis(b-amino-beta-carboxyethyl) disulfide, NCGC00166006-01, NCGC00166006-02, AC-11189, AS-12654, D(+)-3,3''-Dithiobis(2-aminopropanoate, L-Cystine, >=98% (TLC), crystalline, L-Cystine, BioUltra, >=99.5% (T), L-Cystine, SAJ special grade, >=99.0%, L-Cystine, Vetec(TM) reagent grade, 98%, ACETYLCYSTEINE IMPURITY A (L-CYSTINE), b,b''-Diamino-b,b''-dicarboxydiethyl disulfide, CS-0008930, D(+)-3,3''-Dithiobis(2-aminopropanoic acid, NS00007403, C00491, D03636, EN300-174654, M06021, Q408626, 3,3''-Disulfanediylbis((2R)-2-aminopropanoic acid), 3,3''-dithiobis[2-amino-[R-(R*,R*)]-Propanoate, 2-Amino-3-[(2-amino-2-carboxyethyl)dithio]propanoate, L-Cystine, certified reference material, TraceCERT(R), 3,3''-dithiobis[2-amino-[R-(R*,R*)]-Propanoic acid, Cystine, European Pharmacopoeia (EP) Reference Standard, Z1269145231, 2-amino-3-(2-amino-2-carboxy-ethyl)disulfanyl-propanoate, 2-Amino-3-[(2-amino-2-carboxyethyl)dithio]propanoic acid, DD82F461-3F8F-4624-9E2C-0272A9FA79ED, Cystine, United States Pharmacopeia (USP) Reference Standard, L-Cystine, Cell Culture Reagent (H-L-Cys(1)-OH.H-L-Cys(1)-OH), L-Cystine, Pharmaceutical Secondary Standard; Certified Reference Material, L-Cystine, produced by Wacker Chemie AG, Burghausen, Germany, >=98.5%, L-Cystine, from non-animal source, meets EP testing specifications, suitable for cell culture, 98.5-101.0%" C6H12N2O4S2 LEVWYRKDKASIDU-IMJSIDKUSA-N (2R)-2-amino-3-[[(2R)-2-amino-2-carboxyethyl]disulfanyl]propanoic acid n.a. n.a. No No No No Yes No rxnAGORA4795,rxnAGORA4799 PMDBD2001744 cholesterol Dietary Substance, Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D02DLW 5997 n.a. NPC28657 "cholesterol, 57-88-5, Cholesterin, Cholest-5-en-3beta-ol, Cholesteryl alcohol, Dythol, Cholestrin, Cordulan, Dusoline, Dusoran, Cholesterine, Cholestrol, Hydrocerin, Lidinite, Kathro, Lanol, Super hartolan, Lidinit, Cholesterol base H, Provitamin D, Nimco cholesterol base H, (-)-Cholesterol, Cholesterinum, Tegolan, 5:6-Cholesten-3beta-ol, 3beta-Hydroxycholest-5-ene, (3beta)-cholest-5-en-3-ol, Tegolan (VAN), Cholest-5-en-3-beta-ol, 5-Cholesten-3beta-ol, CCRIS 2834, Cholest-5-en-3-ol (3beta)-, HSDB 7106, Cholest-5-en-3-ol, 3beta-Hydroxy-5-cholestene, NSC 8798, (3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol, 3-beta-Hydroxycholest-5-ene, 5-Cholesten-3B-ol, Cholest-5-en-3-ol (3.beta.)-, Dastar, CHEBI:16113, Provitamin-d, Cholest-5-en-3-ol, (3beta)-, AI3-03112, delta(sup 5)-Cholesten-3-beta-ol, Fancol CH, NSC-8798, 3h-cholesterol, EINECS 200-353-2, UNII-97C5T2UQ7J, 97C5T2UQ7J, DTXSID3022401, Nimco cholesterol base No. 712, NSC8798, 5-cholestene-3beta-ol, 5:6-Cholesten-3-ol, (3beta,14beta,17alpha)-cholest-5-en-3-ol, 5-Cholesten-3.beta.-ol, Cholest-5-en-3.beta.-ol, 5,6-Cholesten-3.beta.-ol, 3.beta.-Hydroxycholest-5-ene, DTXCID402401, EC 200-353-2, MFCD00003646, 129111-15-5, NCGC00159351-02, CHOLESTEROL (II), CHOLESTEROL [II], CHOLESTEROL (IARC), CHOLESTEROL [IARC], CHOLESTEROL (MART.), CHOLESTEROL [MART.], CHOLESTEROL (USP-RS), CHOLESTEROL [USP-RS], CHOLESTEROL (EP MONOGRAPH), CHOLESTEROL [EP MONOGRAPH], Cholesterol-t, (3S,8S,9S,10R,13R,14S,17R)-17-[(1R)-1,5-dimethylhexyl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol, (3H)-Cholesterol, epicholesterin, Cholesterol [BAN:JAN:NF], ?Cholesterol, .DELTA.5-Cholesten-3-.beta.-ol, 80356-14-5, 1zhy, Cholesterol,(S), Cholest-5-en-3-ol, (3.beta.)- #, Cholesterol1551, Cholesterol (TN), 20-epi-cholesterol, 20-iso-cholesterol, Cholesterol, 94%, Liquid crystal CN/9, (+)-ent-Cholesterol, cholest-5-en-3b-ol, 5-Cholesten-3ss--ol, Cholesterol (>99%), Cholesterol, 99.0%, CHOLESTEROL [MI], ALF component cholesterol, CHOLESTEROL [JAN], ALFQ component cholesterol, Cholesterol (JP17/NF), CHOLESTEROL [HSDB], CHOLESTEROL [INCI], Phospholipon & Cholesterol, Delta5-Cholesten-3beta-ol, Epitope ID:150761, CHOLESTEROL [VANDF], 3beta-cholest-5-en-3-ol, 3ss--Hydroxy-5-cholestene, CHOLESTERINUM [HPUS], BIDD:PXR0095, (3b)-cholest-5-en-3-ol, CHOLESTEROL [WHO-DD], 5:6-Cholesten-3.beta.-ol, 20bFH-cholest-5-en-3b-ol, BIDD:ER0548, Cholest-5-en-3-ol (3beta)-, labeled with tritium, CHEMBL112570, Cholest-5-en-3-ol (3beta), GTPL2718, BDBM20192, (20bFH)-cholest-5-en-3b-ol, CHEBI:140435, (3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-((R)-6-methylheptan-2-yl)-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol, 10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol, Cholesterol, Sigma Grade, >=99%, HY-N0322, Tox21_111595, Analytical Reagent,>95.0%(HPLC), CMC_13392, LMST01010001, s4154, AKOS005267135, Cholest-5-en-3-ol, (3-.beta.)-, CS-5106, DB04540, GS-6857, CAS-57-88-5, Cholesterol, NIST(R) SRM(R) 911c, SMP1_000069, NCGC00159351-03, 22243-67-0, BP-26125, Cholesterol 10 microg/mL in Acetonitrile, Cholesterol, tested according to Ph.Eur., C3624, Cholesterol, from lanolin, >=95.0% (GC), Cholesterol, from lanolin, >=99.0% (GC), NS00005787, Army Liposome Formulation component cholesterol, C00187, D00040, EN300-323186, F70214, Q43656, AB00443913_03, Cholesterol, >=95% (GC), powder, Ash, free, Cholesterol, Vetec(TM) reagent grade, >=92.5%, Soya phospholipon & Cholesterol (2:1 molar ratio), W-105431, 5BBA213B-ECF4-44AF-8AAF-8A0120F2F886, WLN: L E5 B666 LUTJ A1 E1 FY1&3Y1&1 OQ, Z2033589790, Cholesterol, European Pharmacopoeia (EP) Reference Standard, Cholesterol, powder, BioReagent, suitable for cell culture, >=99%, Cholesterol, United States Pharmacopeia (USP) Reference Standard, Cholesterol, Pharmaceutical Secondary Standard; Certified Reference Material, (1R,3aS,3bS,7S,9aR,9bS,11aR)-9a,11a-dimethyl-1-[(2R)-6-methylheptan-2-yl]-1H,2H,3H,3aH,3bH,4H,6H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-ol, (1S,2R,5S,10S,11S,14R,15R)-2,15-dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0;{2,7}.0;{11,15}]heptadec-7-en-5-ol" C27H46O HVYWMOMLDIMFJA-DPAQBDIFSA-N (3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol n.a. n.a. No No No No Yes No rxnAGORA4961,rxnAGORA4962,rxnAGORA4963,rxnAGORA4965 PMDBD2001745 octanoate (n-C8:0) Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 119389 n.a. NPC315459 octanoate, Caprylate, n-octanoate, 74-81-7, capryloate, n-octic acid, Octanoic acid, ion(1-), n-caprylate, n-octoate, n-octylate, 1-heptanecarboxylate, caprilate, Caprylates, octanoate, 1, 3nq9, octanoate (n-C8:0), BDBM23432, CHEBI:25646, DTXSID70995277, CH3-[CH2]6-COO(-), A805133, Q27109891 C8H15O2- WWZKQHOCKIZLMA-UHFFFAOYSA-M octanoate n.a. n.a. No No No No Yes No rxnAGORA5313,rxnAGORA5314 PMDBD2001746 tetradecenoate (n-C14:1) Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No Yes No rxnAGORA5317,rxnAGORA5318,rxn08015,rxn09146 PMDBD2001747 Hexadecenoate (n-C16:1) Dietary Substance, Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D02TRN 445638 n.a. NPC36061 "palmitoleic acid, 373-49-9, (Z)-Hexadec-9-enoic acid, cis-9-Hexadecenoic acid, 9-cis-Hexadecenoic acid, zoomaric acid, (Z)-9-hexadecenoic acid, Zoomeric acid, cis-Palmitoleic acid, Oleopalmitic acid, (9Z)-hexadec-9-enoic acid, cis-9-palmitoleic acid, (9Z)-Hexadecenoic acid, 9Z-hexadecenoic acid, Palmitolinoleic acid, 9Z-palmitoleic acid, cis-delta-9-Hexadecenoic acid, Hexadecenoate, Oleopalmitate, Zoomerate, cis-Delta(9)-hexadecenoic acid, 16:1Delta9, cis-Palmitoleate, 9-Hexadecenoate, 9-Hexadecenoic acid, (9Z)-, UNII-209B6YPZ4I, 9-Hexadecenoic acid, (Z)-, 9-cis-hexadecenoate, 209B6YPZ4I, (Z)-9-hexadecenoate, (Z)-Palmitoleic acid, CHEBI:28716, EINECS 206-765-9, cis-9-hexadecenoate, cis-delta-9-Hexadecenoate, (Z)-Hexadec-9-enoicacid, NSC 277452, AI3-36443, CHEMBL453509, DTXSID0041197, MFCD00004437, NSC-277452, FA 16:1, 16:1(N-7), C16:1n-7, cis-.delta.9-Hexadecenoic acid, palmitoleic-acid, Physetoleic acid, NSC277452, cis-Palmitoleicacid, (Z)-9-hexadecenic acid, bmse000926, Fatty Acid 16:1 n-7, Hexadecenoate (n-C16:1), SCHEMBL33310, GTPL5547, DTXCID8021197, PALMITOLEIC ACID [WHO-DD], C16:1n7, Tox21_300950, BDBM50269531, LMFA01030056, Palmitoleic acid, analytical standard, AKOS015843187, CS-W012589, DB04257, FS-6301, HY-W011873, NCGC00248225-01, NCGC00248225-03, NCGC00254852-01, AC-33786, BP-29012, CAS-373-49-9, FA(16:1(9Z)), H0072, NS00015112, Palmitoleic acid, >=98.5% (GC), liquid, S3341, C08362, Palmetoleic acid; Palmetoleic acid (C16:1 cis), PALMITOLEIC ACID (CONSTITUENT OF SPIRULINA), Q412366, PALMITOLEIC ACID (CONSTITUENT OF SAW PALMETTO), ED9A824A-5CB7-476E-884E-4216DD38386E, PALMITOLEIC ACID (CONSTITUENT OF SPIRULINA) [DSC], PALMITOLEIC ACID (C16:1) (CONSTITUENT OF KRILL OIL), PALMITOLEIC ACID (CONSTITUENT OF SAW PALMETTO) [DSC]" C16H30O2 SECPZKHBENQXJG-FPLPWBNLSA-N (Z)-hexadec-9-enoic acid n.a. n.a. No No No No Yes No rxnAGORA5319,rxnAGORA5320,rxn08017,rxn09148 PMDBD2001748 retinal Dietary Substance, Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D05SOU 638015 n.a. NPC281986 "all-trans-Retinal, retinal, 116-31-4, retinaldehyde, vitamin A aldehyde, trans-Retinal, retinene, axerophthal, all-E-Retinal, all trans-Retinal, E-Retinal, all-trans-Vitamin A aldehyde, Retinene 1, all-trans-Retinaldehyde, Vitamin A1 aldehyde, all-trans retinal, all-trans-Retinene, Retinal, all-trans-, Retinal, all-trans, (2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal, trans-Vitamin A aldehyde, (2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenal, CHEBI:17898, DTXSID5025998, RR725D715M, MFCD00001550, NSC626581, NSC-122757, NSC-626581, Retinyl aldehyde, Retinaldehyde (VAN), TOCOPHEROL, ALPHA, Retinal, 9-cis-, Retinal, 13-cis-, EINECS 204-135-8, NSC 122757, NSC 626581, BRN 1914183, retinaldehyd, Retinin, epsilon-Retinal, UNII-RR725D715M, Retinene1, retinal all-trans, tocopherol alpha-, NSC-122756, all-trans Retinal-14,15-13C2, all-epsilon-Retinal, RETINAL [INCI], RETINAL [MI], RETINAL TRANS-ISOMER, 4-07-00-01253 (Beilstein Handbook Reference), All-trans-Vitamin-A-Aldehyde, CHEMBL81379, RETINALDEHYD [WHO-DD], RETINALDEHYDE [MART.], SCHEMBL106993, DTXCID205998, GTPL2350, SCHEMBL22261821, 2g79, AMY27005, BCP14368, NSC20811, trans-Retinal (Vitamin A aldehyde), Tox21_201005, all trans-Retinal, powder, >=98%, BDBM50553255, LMPR01090002, NSC-20811, NSC122756, NSC122757, s6132, 3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-Nonatetraenal, AKOS024463375, CS-W004500, DS-8008, HY-W004500, NCGC00090821-02, NCGC00090821-03, NCGC00090821-04, NCGC00090821-05, NCGC00090821-06, NCGC00090821-07, NCGC00258558-01, CAS-116-31-4, LS-14807, Retinaldehyde;Vitamin A aldehyde;Retinene, NS00015353, C00376, F20593, M02447, EN300-6493898, A893585, Q28529715, Z2315585275, 3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)nona-2,4,6,8-tetraenal, (2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-enyl)nona-2,4,6,8-tetraenal, 2,4,6,8-Nonatetraenal, 3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-, (all-E)-, 2,6,8-Nonatetraenal, 3,7-dimethyl-9-(2,6,6-trimethyl-1- cyclohexen-1-yl)-, (all-E)-, 2,6,8-Nonatetraenal, 3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-, (all-E)-, InChI=1/C20H28O/c1-16(8-6-9-17(2)13-15-21)11-12-19-18(3)10-7-14-20(19,4)5/h6,8-9,11-13,15H,7,10,14H2,1-5H3/b9-6+,12-11+,16-8+,17-13" C20H28O NCYCYZXNIZJOKI-OVSJKPMPSA-N (2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenal n.a. n.a. No No No No Yes No rxnAGORA3092,rxnAGORA5329,rxnAGORA5330 PMDBD2001749 phylloquinone Dietary Substance, Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. D00FSV 5284607 n.a. NPC188844 "Phylloquinone, Vitamin K1, phytonadione, 84-80-0, Phytomenadione, Phytylmenadione, 3-Phytylmenadione, Aquamephyton, Phyllochinon, Konakion, Mephyton, Monodion, Synthex P, 2-Methyl-3-phytyl-1,4-naphthoquinone, Mono-Kay, Fitomenadiona, Phyllochinonum, Phytomenadionum, Phytonadionum, trans-Phylloquinone, Kinadion, VitaminK1, Combinal K1, Kativ N, alpha-Phylloquinone, K-Ject, Aqua mephyton, Antihemorrhagic vitamin, Vitamin K 1, 79083-00-4, Fitomenadione, Aqua-Mephytin, Phythyl-menadion, Kephton, 2-Methyl-3-phytyl-1,4-naphthochinon, 2'',3''-trans-Vitamin K1, 11104-38-4, CHEBI:18067, Phylloquinone e-form, VITAMIN K, Vitamin K1(20), DTXSID8023472, 2-Methyl-3-(3,7,11,15-tetramethyl-2-hexadecenyl)-1,4-naphthalenedione, 2-methyl-3-[(2E,7R,11R)-3,7,11,15-tetramethylhexadec-2-en-1-yl]naphthalene-1,4-dione, NSC 270681, NSC-270681, S5Z3U87QHF, 1,4-Naphthoquinone, 2-methyl-3-phytyl-, 2-methyl-3-[(E,7R,11R)-3,7,11,15-tetramethylhexadec-2-enyl]naphthalene-1,4-dione, DTXCID003472, MLF3D1712D, Phytonadione, (E)-(+/-)-, MFCD00214063, 1,4-Naphthalenedione,2-methyl-3-[(2E,7R,11R)-3,7,11,15-tetramethyl-2-hexadecen-1-yl]-, 1,4-Naphthalenedione, 2-methyl-3-(3,7,11,15-tetramethyl-2-hexadecenyl)-, (R-(R*,R*-(E)))-, 2-Methyl-3-((7R,11R,E)-3,7,11,15-tetramethylhexadec-2-en-1-yl)naphthalene-1,4-dione, Orakay, 1,4-Naphthalenedione, 2-methyl-3-(3,7,11,15-tetramethyl-2-hexadecenyl)-, 2-Methyl-3-[(2E)-3,7,11,15-tetramethyl-2-hexadecenyl]naphthoquinone, 2-Methyl-3-phythyl-1,4-naphthochinon, CAS-84-80-0, rel-2-Methyl-3-((7R,11R,E)-3,7,11,15-tetramethylhexadec-2-en-1-yl)naphthalene-1,4-dione, Phytonadione, K1, 1,4-Naphthalenedione, 2-methyl-3-(3,7,11,15-tetramethyl-2-hexadecenyl)-, [R-[R*,R*-(E)]]-, 2-methyl-3-[(2E,7R,11R)-3,7,11,15-tetramethylhexadec-2-en-1-yl]-1,4-dihydronaphthalene-1,4-dione, Phyllochinon [German], Fitomenadione [DCIT], Vitamin K1 (VAN), Phytonadione [USP:JAN], UNII-S5Z3U87QHF, Fitomenadiona [INN-Spanish], Phytomenadionum [INN-Latin], Kanavit, Neokay, a-Phylloquinone, Konakion mm, NSC270681, vitaminum k1, 2-Methyl-3-((2E)-3,7,11,15-tetramethyl-2-hexadecenyl)naphthoquinone, Konakion mm paed, HSDB 3162, (E)-phytonadione, 2-methyl-3-((2E,7R,11R)-3,7,11,15-tetramethylhexadec-2-en-1-yl)naphthalene-1,4-dione, 2-methyl-3-((7R,11R,E)-3,7,11,15-tetramethylhexadec-2-enyl)naphthalene-1,4-dione, NCGC00159423-02, EINECS 201-564-2, EINECS 234-330-3, EINECS 279-052-3, Vitamin K1 (contains up to 20% cis isomer), vitamin K1, 11, Vitamin K1 (generic), Vitamin K1 ,(S), VEDA-K1, VETA-K1, PHYTONADIONE [JAN], 98%(sum of Cis-trans), 2-Methyl-3-phytyl-1,4-naphthochinon [German], phylloquinone;2-METHYL-3-PHYTYL-1,4-NAPHTHOQUINONE, Phylloquinone;Phytomenadione, SCHEMBL3882, 2'',3''-trans-phylloquinone, Vitamin K1 (Phylloquinone), Vitamin K1, viscous liquid, CHEMBL1550, UNII-MLF3D1712D, 5VET002 Veta K-1, PHYTONADIONE, (E)-, PHYLLOQUINONE, (E)-, MLS001074732, PHYTONADIONEPHYTONADIONE, BIDD:GT0793, PHYTOMENADIONE, (E)-, PHYTONADIONE (USP-RS), SCHEMBL351365, PHYTOMENADIONE (MART.), 2-Methyl-3-[(2E)-3,7,11,15-tetramethyl-2-hexadecenyl]naphthoquinone #, -2-enyl)naphthalene-1,4-dione, BDBM24782, B02BA01, [r-[r*,R*-(E)]]-2-Methyl-3-(3,7,11,15-tetramethyl-2-hexadecenyl)-1,4-napthalenedione, [r-[r*,R*-(E)]]-2-Methyl-3-(3-7,11,15-tetramethyl-2-hexadecenyl)-1,4-naphthalenedione, PHYLLOQUINONE E-FORM [MI], HMS2094G09, HMS2270J10, Pharmakon1600-01505485, HY-N0684, PHYTOMENADIONE (EP IMPURITY), PHYTONADIONE (USP MONOGRAPH), Tox21_111655, BDBM50553259, LMPR02030028, NSC760373, s4698, 2-Methyl-3-phytyl-1,4-napthoquinone, AKOS015841892, Tox21_111655_1, A034SE7857, CCG-213568, CS-6376, DB01022, NSC-760373, (R*,R*-(E))-(1)-2-Methyl-3-(3,7,11,15-tetramethylhexadec-2-enyl)-1,4-naphthoquinone, NCGC00159423-03, Phylloquinone (K1), analytical standard, AC-34846, AS-13734, SMR000112043, SBI-0206926.P001, trans-Phytomenadione 100 microg/mL in Ethanol, AB00698065_04, A840928, EN300-22411510, Q186093, SR-05000001941, C31H46O2 (2-methyl-3-phytyl-1,4-naphthoquinone), Q-201934, SR-05000001941-1, W-108488, Z2568644345, 2-methyl-3-((7R,11R,E)-3,7,11,15-tetramethylhexadec, 84C51B31-3CE2-476B-BE66-A84BDD46A513, VITAMIN K1; 2-METHYL-3-PHYTYL-1,4-NAPHTHOQUINONE, Phytomenadione, European Pharmacopoeia (EP) Reference Standard, Phytonadione, United States Pharmacopeia (USP) Reference Standard, 2-Methyl-3-(3,7,11,15-tetramethyl-2-hexadecenyl)-1,4-naphthalened- ione, Vitamin K1, BioXtra, >=99.0% (sum of isomers, HPLC), mixtur of isomers, 1,4-Naphthalenedione, 2-methyl-3-((2E,7R,11R)-3,7,11,15-tetramethyl-2-hexadecen-1-yl)-, 1,4-Naphthalenedione, 2-methyl-3-((2E,7R,11R)-3,7,11,15-tetramethyl-2-hexadecenyl)-, 2-Methyl-3-((2E,7R,11R)-3,7,11,15-tetramethylhexadec-2-en-1-yl)-1,4-naphthoquinone, Phytonadione, Pharmaceutical Secondary Standard; Certified Reference Material, 1,4-NAPHTHALENEDIONE, 2-METHYL-3-((2E,7R,11R)-3,7,11,15-TETRAMETHYL-2-HEXADECEN-1-YL)-, REL-, 2-METHYL-3-((2E,7R,11R)-3,7,11,15-TETRAMETHYL-2-HEXADECENYL)-1,4-NAPHTHALENEDIONE, 2-methyl-3-[(E,7R,11R)-3,7,11,15-tetramethylhexadec-2-enyl]naphthalene-1,4-dione;Vitamin K1, MIXTURE OF THE TRANS (E) AND CIS (Z) ISOMERS CONTAINING NOT LESS THAN 75% OF TRANS-PHYTOMENADIONE" C31H46O2 MBWXNTAXLNYFJB-NKFFZRIASA-N 2-methyl-3-[(E,7R,11R)-3,7,11,15-tetramethylhexadec-2-enyl]naphthalene-1,4-dione n.a. Vitamins No No No No Yes No rxnAGORA5335,rxnAGORA5336 PMDBD2001750 2,3-Dihydroxybenzoate Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 54675818 n.a. n.a. 2,3-dihydroxybenzoate, 2-pyrocatechuate, 3-Hydroxysalicylate, Catechol-3-carboxylate, CHEBI:36654, Q27104375 C7H5O4- GLDQAMYCGOIJDV-UHFFFAOYSA-M 2-carboxy-6-hydroxyphenolate n.a. n.a. No No No No Yes No rxnAGORA5341,rxnAGORA5342,rxnAdd29 PMDBD2001751 3,4-Dihydroxyphenylethyleneglycol Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 91528 n.a. NPC84225 28822-73-3, 3,4-Dihydroxyphenylglycol, 4-(1,2-dihydroxyethyl)benzene-1,2-diol, DOPEG, 3343-19-9, 3,4-Dihydroxyphenylethyleneglycol, dl-3,4-Dihydroxyphenylglycol, 1,2-Benzenediol, 4-(1,2-dihydroxyethyl)-, Dihydroxyphenylethylene glycol, DL-3,4-Dihydroxyphenyl glycol, rac 3,4-Dihydroxyphenylethylene Glycol, UEH9K539KJ, (3,4-Dihydroxyphenyl)glycol, 3,4-dihydroxyphenethyl glycol, 4-(1,2-Dihydroxyethyl)-1,2-benzenediol, 3,4-dihydroxyphenylethyl glycol, (+/-)-3,4-Dihydroxyphenylglycol, (3,4-dihydroxyphenyl)ethylene glycol, NSC 92532, NSC-92532, 1-(3,4-dihydroxyphenyl)-1,2-ethanediol, rac 3,4-Dihydroxyphenylethylene Glycol-d3, EINECS 249-260-9, 1,2-Benzenediol, 4-(1,2-dihydroxyethyl)-, (-)-, (1)-4-(1,2-Dihydroxyethyl)pyrocatechol, 1-(3,4-Dihydroxyphenyl)ethane-1,2-diol, UNII-UEH9K539KJ, SCHEMBL141609, Phenylglycol, 3,4-dihydroxy-, CHEBI:1387, 3,4-Dihydroxyphenylglycol, DL-, DTXSID20865451, (+-)-3,4-Dihydroxyphenylglycol, Ba 2775, NSC92532, AKOS003368780, AKOS016843225, beta,3,4-trihydroxy phenethyl alcohol, BA-2775, CS-W010782, HY-W010066, DHPG (3,4-DIHYDROXYPHENYLGLYCOL), MS-22923, 2-hydroxy-2-(3,4-dihydroxy)phenylethanol, NS00014708, 3,4-DIHYDROXYPHENYLGLYCOL, (+/-)-, C05576, F85606, EN300-1855459, A819617, Q262270, 1,2-Benzenediol, 4-(1,2-dihydroxyethyl)-, (.+/-.)-, 1,2-Ethanediol, 1-(3,4-dihydroxyphenyl)-, (.+/-.)-, 4740838A-79C1-450B-827D-A3B2F61834F4 C8H10O4 MTVWFVDWRVYDOR-UHFFFAOYSA-N 4-(1,2-dihydroxyethyl)benzene-1,2-diol n.a. n.a. No No No No Yes No rxnAGORA5345,rxnAGORA5346,rxnAdd33 PMDBD2001752 Catechol Dietary Substance, Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D07QJJ 289 n.a. NPC204932 "pyrocatechol, catechol, 120-80-9, 1,2-dihydroxybenzene, 1,2-benzenediol, benzene-1,2-diol, pyrocatechin, 2-hydroxyphenol, o-Benzenediol, o-Dihydroxybenzene, o-Dioxybenzene, o-Hydroquinone, o-Hydroxyphenol, Phthalhydroquinone, Pyrocatechine, o-Phenylenediol, Oxyphenic acid, Fouramine PCH, benzenediol, Durafur developer C, Pelagol Grey C, Catechin (phenol), Fourrine 68, Benzene, o-dihydroxy-, Catechol (phenol), o-Diphenol, C.I. Oxidation Base 26, Pyrokatechin, Pyrokatechol, Katechol, ortho-Dihydroxybenzene, NCI-C55856, NSC 1573, C.I. 76500, Catechol-pyrocatechol, 12385-08-9, DTXSID3020257, MFCD00002188, LF3AJ089DQ, 1,2-Dihydroxybenzene-d6, CHEMBL280998, CHEBI:18135, NSC-1573, ortho-Hydroxyphenol, CAQ, 1,?2-?Benzenediol, 1,2-Benzenediol-1,2,3,4,5,6-13C6, ortho-Benzenediol, ortho-Dioxybenzene, ortho-Hydroquinone, Katechol [Czech], ortho-Phenylenediol, Pyrocatechinic acid, 26982-53-6, DTXCID30257, Pyrokatechin [Czech], Pyrokatechol [Czech], Benzene-1,2-diol (Pyrocatechol), CI Oxidation Base 26, Phthalic alcohol, CAS-120-80-9, SMR000326660, CCRIS 741, HSDB 1436, EINECS 204-427-5, UNII-LF3AJ089DQ, BRN 0471401, Oxyphenate, CI 76500, Kachin, ortho-diphenol, benzene diol, ortho-Quinol, AI3-03995, 4oow, alpha-hydroxyphenol, 1,2-benzenedio, o-dihydroxy-benzene, phenol derivative, 2, 3fw4, 4k7i, CATECHOL [HSDB], CATECHOL [IARC], Pyrocatechol, >=99%, CATECHOL [VANDF], Lopac-C-9510, PYROCATECHOL [MI], WLN: QR BQ, bmse000385, EC 204-427-5, PYROCATECHOL [INCI], 1,2-Dihydroxybenzene, XI, 1,2-Benzenediol; Catechol, Lopac0_000280, SCHEMBL18351, MLS002153385, MLS002303022, BIDD:ER0327, Pyrocatechinic acidPyrocatechol, Pyrocatechol, p.a., 99.0%, BDBM26188, Durafur Developer CFouramine PCH, NSC1573, HMS2233A17, HMS3260H22, HMS3373K16, Tox21_202317, Tox21_300153, Tox21_500280, s6305, AKOS000119002, CCG-204375, DB02232, LP00280, SDCCGSBI-0050268.P002, NCGC00015283-01, NCGC00015283-02, NCGC00015283-03, NCGC00015283-04, NCGC00015283-05, NCGC00015283-06, NCGC00015283-07, NCGC00015283-08, NCGC00015283-10, NCGC00091262-01, NCGC00091262-02, NCGC00091262-03, NCGC00253952-01, NCGC00259866-01, NCGC00260965-01, AC-34196, BP-21156, BS-20054, Catechol (Pyrocatechol; Benzene-1,2-diol), C.I.-76500, EU-0100280, NS00007130, P0317, P0567, EN300-19426, C 9510, C00090, C01785, D91943, 1,2-Dihydroxybenzene, ReagentPlus(R), >=99%, Pyrocatechol, purified by sublimation, >=99.5%, A804599, AB-131/40235236, Q282440, SR-01000075791, SR-01000075791-1, W-109068, 1,2-Dihydroxybenzene 1000 microg/mL in Dichloromethane, F0001-0332, Pyrocatechol, certified reference material, TraceCERT(R), Z104473810, InChI=1/C6H6O2/c7-5-3-1-2-4-6(5)8/h1-4,7-8, Pyrocatechol, plant cell culture tested, BioReagent, >=99%, powder, 2H-1-Benzopyran-3,5,7-triol, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-,(2R-trans)-" C6H6O2 YCIMNLLNPGFGHC-UHFFFAOYSA-N benzene-1,2-diol n.a. n.a. No No No No Yes No rxnAGORA3296,rxnAGORA5353,rxnAGORA5354,rxn00596,rxnAdd231 PMDBD2001753 Protocatechuate Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 72 n.a. NPC156654 "3,4-DIHYDROXYBENZOIC ACID, protocatechuic acid, 99-50-3, Protocatehuic acid, 4-Carboxy-1,2-dihydroxybenzene, protocatechuate, 4,5-Dihydroxybenzoic acid, Benzoic acid, 3,4-dihydroxy-, 3,4-dihydroxybenzoate, CCRIS 6291, protocatechuicacid, EINECS 202-760-0, UNII-36R5QJ8L4B, MFCD00002509, NSC 16631, BRN 1448841, 36R5QJ8L4B, DTXSID4021212, CHEBI:36062, PROTOCATECHOIC ACID, NSC-16631, Catechol-4-carboxylic Acid, 3, 4-Dihydroxybenzoic acid, CHEMBL37537, MLS000737807, DTXCID601212, FEMA NO. 4430, PROTOCATECHUIC ACID (PCA), DIHYDROXYBENZOIC ACID, 3,4-, 1ykp, DROXIDOPA METABOLITE (PROTOCATECHOIC ACID), 3,4-Dihydroxy Benzoic Acid, NSC16631, DB03946, SMR000528167, C00230, D-3487, Hypogallic acid, b-Resorcylate, beta-Resorcylate, ProtocatechicAcid, b-resorcylic acid, 4fht, Protacatechuic Acid, ZINCSELENITE, Carbohydroquinonic acid, cid_72, Protocatechuic Acid,(S), Protocatechuic acid (M1), bmse000328, 3,4-dihydroxy-benzoic acid, 3,4-dihydroxybenzoic acid (protocatechuic acid), SCHEMBL39435, 3,4-Dihydroxybenzoate, VIII, Pyrocatechol-4-carboxylic Acid, PROTOCATECHUIC ACID [MI], HMS2270A17, KUC104409N, HY-N0294, Tox21_200167, BDBM50100861, s3975, AKOS000119632, AC-9617, CCG-207950, CS-6092, KSC-10-128, CAS-99-50-3, NCGC00246757-01, NCGC00246757-02, NCGC00257721-01, 3,4-DIHYDROXYBENZOIC ACID [INCI], AS-10808, SY014104, AM20060767, NS00014667, 3,4-Dihydroxybenzoic acid, >=97.0% (T), EN300-21544, 3,4-Dihydroxybenzoic acid, analytical standard, F11285, 3,4-dihydroxybenzoate;3,4-Dihydroxybenzoic acid, A846038, AE-562/40524392, Q418599, 976C8CCE-B25D-4E0A-9A6F-3CEEA7A6964F, Z104501142, 3,4-Dihydroxybenzoic acid, Vetec(TM) reagent grade, 97%, PROTOCATECHOIC ACID (CONSTITUENT OF MARITIME PINE), Protocatechuic acid, primary pharmaceutical reference standard, PROTOCATECHOIC ACID (CONSTITUENT OF MARITIME PINE) [DSC], Protocatechuic acid, United States Pharmacopeia (USP) Reference Standard, InChI=1/C7H6O4/c8-5-2-1-4(7(10)11)3-6(5)9/h1-3,8-9H,(H,10,11, 1225528-47-1" C7H6O4 YQUVCSBJEUQKSH-UHFFFAOYSA-N 3,4-dihydroxybenzoic acid n.a. n.a. No No No No Yes No rxnAGORA5355,rxnAGORA5356,rxnAdd39 PMDBD2001754 4-Coumarate Dietary Substance, Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D0AU0M 637542 n.a. NPC81010 "p-coumaric acid, 4-Hydroxycinnamic acid, 501-98-4, p-Hydroxycinnamic acid, trans-4-Hydroxycinnamic acid, 4-Coumaric acid, 7400-08-0, trans-p-Coumaric acid, p-Cumaric acid, p-Hydroxy-cinnamic acid, Para-Coumaric acid, Naringeninic acid, Hydroxycinnamic acid, (E)-p-Coumaric acid, trans-4-coumaric acid, 3-(4-hydroxyphenyl)acrylic acid, trans-p-Coumarinic acid, (E)-3-(4-Hydroxyphenyl)acrylic acid, Cinnamic acid, p-hydroxy-, (E)-p-Hydroxycinnamic acid, 4''-hydroxycinnamic acid, trans-p-Hydroxycinnamic acid, 2-propenoic acid, 3-(4-hydroxyphenyl)-, (2E)-, p-Hydroxyphenylacrylic acid, (2E)-3-(4-hydroxyphenyl)prop-2-enoic acid, 3-(4-Hydroxyphenyl)-2-propenoic acid, 4-coumarate, Cinnamic acid, p-hydroxy-, (E)-, trans-p-Hydroxycinnamate, 2-Propenoic acid, 3-(4-hydroxyphenyl)-, (E)-3-(4-Hydroxyphenyl)-2-propenoic acid, (E)-3-(4-hydroxyphenyl)prop-2-enoic acid, 4-Hydroxycinnamate, (2E)-3-(4-hydroxyphenyl)acrylic acid, beta-(4-Hydroxyphenyl)acrylic acid, NSC 59260, trans-4-hydroxycinnamate, UNII-IBS9D1EU3J, IBS9D1EU3J, EINECS 231-000-0, Para coumaric acid, (E)-4-hydroxycinnamic acid, 3-(4-hydroxyphenyl)prop-2-enoic acid, NSC 674321, p-coumarate, 2-Propenoic acid, 3-(4-hydroxyphenyl)-, (E)-, BRN 2207381, BRN 2207383, CHEBI:32374, ORISTAR PCA, parahydroxycinnamic acid, MFCD00004399, NSC-59260, NSC-674321, 4-hydroxy cinnamic acid, CHEMBL66879, PARA HYDROXYCINNAMIC ACID, 1261170-80-2, beta-[4-Hydroxyphenyl]acrylic acid, 0-10-00-00297 (Beilstein Handbook Reference), 4-10-00-01005 (Beilstein Handbook Reference), NSC674321, trans-p-coumarate, Dehydroepiandrosterone-[D6] (CertiMass solution), 3-(4-hydroxyphenyl)acrylate, .beta.-[4-Hydroxyphenyl]acrylic acid, trans-HPPA, (E)-3-[4-hydroxyphenyl]-2-propenoic acid, 4-coumaric acid, (E)-isomer, 4-Hydroxycinnamicacid, trans-p-Cumaric Acid, 4-Hydroxycinamic acid, .BETA.-(4-HYDROXYPHENYL)ACRYLIC ACID, 2-Propenoic acid, 3-(4-hydroxyphenyl)-, (Z)-, CHEBI:36090, hydroxycinnamate, Para coumarate, p-coumaric-acid, Para-Coumarate, p-Cumarate, naringeninic-acid, p-Hydroxycinnamate, 4qem, Coumaric acid, p-, 4''-Hydroxycinnamate, 4-Hydroxy cinnamate, p-Coumaric acid,trans, p-Coumaric acid 98%, 4f8j, p-Coumaric acid, trans, 4-Hydroxyphenylpropenoate, (2E)-3-(4-Hydroxyphenyl)-2-propenoic acid, trans-3-(4''-hydroxyphenyl)-2-propenoic acid, bmse000150, bmse000591, bmse010208, trans-4-HydroxycinnamicAcid, b-[4-Hydroxyphenyl]acrylate, SCHEMBL39106, p-hydroxycinnamic acid (M4), MLS001066419, p-Hydroxycinnamic acid, trans, P-COUMARIC ACID [MI], beta-[4-Hydroxyphenyl]acrylate, BDBM4374, GTPL5787, SODIUM2,4-PENTANEDIONATE, b-[4-Hydroxyphenyl]acrylic acid, trans-p-HydroxyzimtsA currencyure, DTXSID30901076, P-COUMARIC ACID [WHO-DD], HMS1409E10, 3-(4-Hydroxyphenyl)-2-propenoate, HYDROXYCINNAMIC ACID [INCI], BCP22803, HY-N2391, NSC59260, STR06515, 4-HYDROXYPHENYLPROPENOIC ACID, Cinnamic acid, 4-hydroxy-, trans-, AC7957, CK2547, s4759, s9564, AKOS000120685, p-Coumaric acid;p-Hydroxycinnamic acid, BCP9001042, CCG-266309, CS-W020394, DB04066, p-Coumaric acid, >=98.0% (HPLC), (E)-3-(4-hydroxyphenyl)prop-2-enoate, NCGC00246974-01, 1ST40051, 50940-26-6, AC-10318, AC-34130, AC-34133, AS-12000, BP-13278, SMR000112201, (E)-3-(4-hydroxyphenyl)prop-2-enoicacid, trans-p-Coumaric acid, analytical standard, AM20050138, NS00068187, EN300-17292, A19490, C00811, Q99374, (2E)-3-(4-Hydroxyphenyl)-2-propenoic acid #, A828008, AE-562/40414679, trans-p-Coumaric acid 1000 microg/mL in Acetone, Q-100560, W-104438, Z56911963, 0C1BFF2D-2CF7-4FC1-9F76-3268C2C7F783, F2191-0188, p-Coumaric acid, primary pharmaceutical reference standard, (E)-3-(4-hydroxyphenyl)prop-2-enoate;Trans-4-Hydroxycinnamic Acid, InChI=1/C9H8O3/c10-8-4-1-7(2-5-8)3-6-9(11)12/h1-6,10H,(H,11,12)/b6-3" C9H8O3 NGSWKAQJJWESNS-ZZXKWVIFSA-N (E)-3-(4-hydroxyphenyl)prop-2-enoic acid n.a. n.a. No No No No Yes No rxn01182,rxn02118,rxn12175,rxnDiet219,rxnAdd170 PMDBD2001755 Caffeate Dietary Substance, Therapeutic Substance Phase 4 n.a. n.a. n.a. n.a. D0V9EN 689043 n.a. NPC294902 caffeic acid, 3,4-Dihydroxycinnamic acid, 331-39-5, trans-caffeic acid, 501-16-6, 3-(3,4-dihydroxyphenyl)acrylic acid, 3,4-Dihydroxybenzeneacrylic acid, (E)-3-(3,4-dihydroxyphenyl)acrylic acid, (2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid, 3-(3,4-Dihydroxyphenyl)-2-propenoic acid, (E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid, Caffeicacid, Cinnamic acid, 3,4-dihydroxy-, 2-Propenoic acid, 3-(3,4-dihydroxyphenyl)-, 4-(2-Carboxyethenyl)-1,2-dihydroxybenzene, trans-Caffeate, CCRIS 847, NSC 57197, 3,4-Dihydroxy-trans-cinnamate, 3-(3,4-Dihydroxyphenyl)propenoic acid, (E)-3,4-dihydroxycinnamic acid, HSDB 7088, UNII-U2S3A33KVM, 4-(2''-Carboxyvinyl)-1,2-dihydroxybenzene, 2-Propenoic acid, 3-(3,4-dihydroxyphenyl)-, (E)-, 71693-97-5, EINECS 206-361-2, U2S3A33KVM, NSC-57197, Caffeate, NSC-623438, CHEBI:16433, AI3-63211, trans-3,4-Dihydroxycinnamic Acid, 3-(3,4-Dihydroxy phenyl)-2-propenoic acid, NSC57197, 331-89-5, CHEMBL145, 3-(3,4-dihydroxyphenyl)prop-2-enoic acid, MLS000069738, CHEBI:36281, MFCD00004392, NSC623438, 2-Propenoic acid, 3-(3,4-dihydroxyphenyl)-, (2E)-, SMR000058214, (2E)-3-(3,4-dihydroxyphenyl)acrylic acid, CAFFEIC ACID (IARC), CAFFEIC ACID [IARC], Caffeic acid - Natural, SR-01000000203, caffeic acid, (E)-isomer, DTXSID5020231, caffeic-acid, Caffeic acid pure, Caffeic acid, 1, Caffeic acid 1000 microg/mL in Acetone, 3,4-dihydroxycinnamic acid (caffeic acid), Caffeic Acid,(S), Caffeic Acid1507, Caffeic acid, trans-, 3,4-dihydroxycinnamate, CAFFEIC ACID natural, Opera_ID_1700, CAFFEIC ACID [MI], CAFFEIC ACID [DSC], Cinnamic acid,4-dihydroxy-, 3,4-Dihydroxycinnamic acid, predominantly trans, CAFFEIC ACID [HSDB], CAFFEIC ACID [INCI], 3,4-Dihydroxybenzeneacrylate, SCHEMBL23358, MLS001076493, MLS002207132, MLS002222302, MLS006011849, BIDD:ER0456, DTXCID10231, SPECTRUM1503987, CAFFEIC ACID [WHO-DD], 2-Propenoic acid,3-(3,4-dihydroxyphenyl)-, (2E)-, 3,4-Dihydroxycinnamate, XVII, BDBM4375, cid_689043, GTPL5155, AMY3943, Trans 3,4-Dihydroxycinnamic acid, DTXSID901316055, HMS2235G09, HMS3260J17, HMS3649O17, BCP28271, HY-N0172, Tox21_200648, Tox21_500208, Caffeic Acid - CAS 331-39-5, CCG-38895, s2277, Caffeic acid, >=98.0% (HPLC), 2-Propenoic acid,4-dihydroxyphenyl)-, AKOS000144463, AC-8006, CS-8205, DB01880, LP00208, SDCCGMLS-0002982.P003, SDCCGSBI-0050196.P004, NCGC00017364-04, NCGC00017364-05, NCGC00017364-06, NCGC00017364-07, NCGC00017364-08, NCGC00017364-09, NCGC00017364-10, NCGC00017364-11, NCGC00017364-12, NCGC00017364-13, NCGC00017364-22, NCGC00022654-03, NCGC00022654-04, NCGC00022654-05, NCGC00022654-06, NCGC00022654-07, NCGC00022654-08, NCGC00022654-09, NCGC00258202-01, NCGC00260893-01, NCGC00263641-01, (E)-3-(3,4-dihydroxyphenyl)acrylicacid, AS-10895, BP-30112, CAS-331-39-5, SMR004703501, XC164210, 4-(2''Carboxyvinyl)-1,2-dihydroxybenzene, Caffeic acid, purum, >=95.0% (HPLC), HY-121231, AB00490047, CS-0081280, EU-0100208, NS00010313, SW197202-3, 2-Morpholin-4-yl-isonicotinicacidhydrochloride, 2-Propenoic acid, 3-(3,4-dihdroxyphenyl)-, (E)-3-(3,4-dihydroxyphenyl)prop-2-enoicacid, C 0625, C-1500, C01197, C01481, EN300-1067793, (2E)-3-(3,4-Dihydroxyphenyl)-2-propenoic acid, A851723, CAFFEIC ACID (CONSTITUENT OF BLACK COHOSH), Q414116, SR-01000000203-2, SR-01000000203-6, SR-01000000203-7, SR-01000000203-8, BRD-K09900591-001-06-9, SR-01000000203-13, CAFFEIC ACID (CONSTITUENT OF BLACK COHOSH) [DSC], F3096-1708, Z240113804, 8B3E4DA7-F3B0-4972-A315-2E387071737F, trans-Caffeic acid, certified reference material, TraceCERT(R), Caffeic acid, matrix substance for MALDI-MS, >=99.0% (HPLC), Caffeic acid, United States Pharmacopeia (USP) Reference Standard, Caffeic acid, matrix substance for MALDI-MS, >=99.0% (HPLC), powder, light beige, InChI=1/C9H8O4/c10-7-3-1-6(5-8(7)11)2-4-9(12)13/h1-5,10-11H,(H,12,13)/b4-2 C9H8O4 QAIPRVGONGVQAS-DUXPYHPUSA-N (E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid n.a. n.a. No No No No Yes No rxn01427,rxn02149,rxnDiet90,rxnAdd156,rxnAdd168 PMDBD2001756 Gentisate Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 3469 n.a. NPC312800 "2,5-DIHYDROXYBENZOIC ACID, gentisic acid, 490-79-9, Hydroquinonecarboxylic acid, Benzoic acid, 2,5-dihydroxy-, 5-Hydroxysalicylic acid, Gentisate, Gensigen, Gensigon, 2,5-Dioxybenzoic acid, 2,5-Dhba, Gentisinic acid, Salicylic acid, 5-hydroxy-, Carboxyhydroquinone, Kyselina gentisinova, Gentisic acid [INN], Gentisinate, MFCD00002460, NSC 27224, Kyselina 2,5-dihydroxybenzoova, 3,6-dihydroxybenzoic acid, CHEMBL1461, VP36V95O3T, CHEBI:17189, BENZOIC ACID,2,5-DIHYDROXY, Gentinatre, Gentalpin, Gentasol, Gentidol, Gentisan, Gentisod, Legential, Nagentis, Casate, Gabail, Nagent, Casate sodium, NSC-27224, Gensalate sodium, Sodium-Gent, WLN: QVR BQ EQ, GENTISATE SODIUM, Acido gentisico, Acide gentisique, Acidum gentisicum, Kyselina gentisinova [Czech], NSC8512, Acide gentisique [INN-French], Acido gentisico [INN-Spanish], Acidum gentisicum [INN-Latin], EINECS 207-718-5, Acido 2,5-diidrossibenzoico [Italian], 2,5-Dihydroxy benzoic acid, BRN 2209119, gentisicacid, Kyselina 2,5-dihydroxybenzoova [Czech], Acido 2,5-diidrossibenzoico, UNII-VP36V95O3T, AI3-60431, Dihydroxybenzoicacid, GTQ, 2,5-Dioxybenzoate, GENOP, 5-hydroxy-Salicylate, 3,6-Dihydroxybenzoate, Spectrum_001241, 2,5dihydroxybenzoic acid, 5-hydroxy-Salicylic acid, Spectrum2_000773, Spectrum3_001326, Spectrum4_001821, Spectrum5_000581, 2,5,dihydroxybenzoic acid, bmse000326, GENTISIC ACID [II], GENTISIC ACID [MI], SCHEMBL3690, 2,5-dihydroxy-benzoic acid, 2,5-Dihydroxybenzoate, VI, NCIOpen2_000913, Oprea1_039290, BSPBio_003051, KBioGR_002487, KBioSS_001721, 4-10-00-01441 (Beilstein Handbook Reference), MLS002207134, DivK1c_000538, SPBio_000846, GENTISIC ACID [WHO-DD], DTXSID4060078, HMS501K20, KBio1_000538, KBio2_001721, KBio2_004289, KBio2_006857, KBio3_002271, 2,5-Dihydroxybenzoic acid, tech, NINDS_000538, 2,5-Dihydroxybenzoic acid, 98%, AMY18270, NSC27224, NSC49098, BDBM50335808, CCG-40154, CK2181, NSC-49098, s3799, AKOS003267857, CS-W001179, HY-W001179, PS-6232, IDI1_000538, NCGC00178325-01, 1ST40048, 2,5-DIHYDROXYBENZOIC ACID [INCI], AC-23625, SMR000393742, SY014321, gentisic acid (2,5-dihydroxybenzoic acid), MESALAZINE IMPURITY G [EP IMPURITY], D0569, D2933, NS00007790, EN300-81715, 2,5-Dihydroxybenzoic acid, analytical standard, C00628, Gentisic acid; Hydroquinonecarboxylic acid; DHB, AE-562/40605400, Q417831, Resorcyllic acid, alphaodium 2,5-dihydroxybenzoate, W-106033, 26A2CD0F-7EBD-431F-8BDA-168766205AE1, Z275164274, 2,5-Dihydroxybenzoic acid, matrix substance for MALDI-MS, >99.0% (HPLC), 2,5-Dihydroxybenzoic acid, matrix substance for MALDI-MS, >=99.5% (HPLC), Ultra pure, InChI=1/C7H6O4/c8-4-1-2-6(9)5(3-4)7(10)11/h1-3,8-9H,(H,10,11" C7H6O4 WXTMDXOMEHJXQO-UHFFFAOYSA-N 2,5-dihydroxybenzoic acid n.a. n.a. No No No No Yes No rxn01919,rxn07524,rxnDiet134 PMDBD2001757 Chlorogenate Dietary Substance, Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D02HCQ 1794427 n.a. NPC302857 CHLOROGENIC ACID, 327-97-9, 3-O-Caffeoylquinic acid, Heriguard, Chlorogenate, 3-(3,4-Dihydroxycinnamoyl)quinic acid, 3-Caffeoylquinic acid, Hlorogenic acid, trans-Chlorogenic acid, CP chlorogenic acid, Caffeoyl quinic acid, Chlorogenicacid, NSC-407296, 5-CQA, (+)-Chlorogenic acid, CCRIS 1400, Chlorogenic acid [MI], 5-O-(3,4-Dihydroxycinnamoyl)-L-quinic acid, trans-Caffeic acid 5-o-D-quinate, 202650-88-2, EINECS 206-325-6, Chlorogenic acid [WHO-DD], UNII-318ADP12RI, NSC 70861, NSC-70861, NSC 407296, 318ADP12RI, CHEBI:16112, trans-5-O-Caffeoylquinic acid, MFCD00003862, (1S,3R,4R,5R)-3-[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy-1,4,5-trihydroxycyclohexane-1-carboxylic acid, CHEMBL284616, DTXCID604786, Cyclohexanecarboxylic acid, 3-((3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl)oxy)-1,4,5-trihydroxy-, (1S-(1-alpha,3-beta,4-alpha,5-alpha))-, DTXSID3024786, 1,3,4,5-tetrahydroxycyclohexanecarboxylic acid 3-(3,4-dihydroxycinnamate), (1S,3R,4R,5R)-3-{[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-1,4,5-trihydroxycyclohexane-1-carboxylic acid, Cyclohexanecarboxylic acid, 3-(((2E)-3-(3,4-dihydroxyphenyl)-1-oxo-2-propen-1-yl)oxy)-1,4,5-trihydroxy-, (1S,3R,4R,5R)-, Cyclohexanecarboxylic acid, 3-((3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl)oxy)-1,4,5-trihydroxy-, (1S,3R,4R,5R)-, Chlorogenic acid (constituent of st. john''s wort) [DSC], 3-O-(3,4-Dihydroxycinnamoyl)-D-quinic acid, (1S,3R,4R,5R)-3-(((E)-3-(3,4-dihydroxyphenyl)acryloyl)oxy)-1,4,5-trihydroxycyclohexane-1-carboxylic acid, Cyclohexanecarboxylic acid, 3-((3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl)oxy)-1,4,5-trihydroxy-, (1S-(1alpha,3beta,4alpha,5alpha))-, Cyclohexanecarboxylic acid, 3-[[3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl]oxy]-1,4,5-trihydroxy-, (1S,3R,4R,5R)-, caffeoylquinic acid, CHLOROGENIC ACID (USP-RS), CHLOROGENIC ACID [USP-RS], Chlorogenic acid hemihydrate, 3-O-caffeoyl-D-quinic acid, Caffetannic acid, 1,3,4,5-Tetrahydroxycyclohexanecarboxylic acid 3-(3,4-dihydroxycinnamate, 3-Caffeoylquinate, Acid, Chlorogenic, 3-[[3-(3,4-Dihydroxyphenyl)-1-oxo-2-propenyl]oxy] 1,4,5-trihydroxycyclohexanecarboxylic acid, (1S,3R,4R,5R)-3-(((3-(3,4-dihydroxyphenyl)acryloyl)oxy)-1,4,5-trihydroxycyclohexanecarboxylic acid, [1S-(1alpha,3beta,4alpha,5alpha)]-3-[[3-(3,4-Dihydroxyphenyl)-1-oxo-2-propenyl]oxy]-1,4,5-trihydroxycyclohexanecarboxylic acid, [1S-(1alpha,3beta,4alpha,5alpha)]3-[[3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl]oxy]-1,4,5-trihydroxycyclohexanecarboxylic acid, cyclohexanecarboxylic acid, 3-[[(2E)-3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl]oxy]-1,4,5-trihydroxy-, (1S,3R,4R,5R)-, Cyclohexanecarboxylic acid, 3-[[3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl]oxy]-1,4,5-trihydroxy-, [1S-(1alpha,3beta,4alpha,5alpha)]-, 3 Caffeoylquinic Acid, Acid, 3-Caffeoylquinic, 3-trans-Caffeoylquinic acid, Hlorogenate, Helianthic acid, Igasuric acid, NSC70861, Chlorogenic-acid, NSC407296, Caffeylquinic acid, Chlorogenic acid,, (1S-(1alpha,3beta,4alpha,5alpha))3-((3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl)oxy)-1,4,5-trihydroxycyclohexanecarboxylic acid, 3-(3,4-Dihydroxycinnamoyl)quinate, CAS-327-97-9, edit(1S,3R,4R,5R)-3-(((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl)oxy)-1,4,5-trihydroxycyclohexane-1-carboxylic acid, edit(1S,3R,4R,5R)-3-{[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-1,4,5-trihydroxycyclohexane-1-carboxylic acid, Prestwick_112, (E)-chlorogenic acid, 5-caffeoyl quinic acid, Chlorogenic Acid1510, Chlorogenic acid (8CI), Prestwick2_000427, Prestwick3_000427, Spectrum5_000733, bmse000387, Quinic acid, 5-caffeoyl-, SCHEMBL19466, BSPBio_000414, BSPBio_003353, SPECTRUM210800, MLS002153805, BIDD:ER0453, BPBio1_000456, Quinic acid, 3-caffeoyl-, E-, ACon1_000581, CHEBI:95271, GTPL12477, BDBM513080, DTXSID101318952, HMS1569E16, HMS1923C11, HMS2096E16, HMS2235F03, HMS3649E06, HY-N0055, Tox21_202495, BDBM50327036, CCG-38471, s2280, AKOS015955866, AC-6032, Chlorogenic acid, >=95% (titration), CS-3766, DB12029, SDCCGMLS-0066467.P001, NCGC00168941-01, NCGC00168941-02, NCGC00168941-03, NCGC00168941-05, NCGC00260044-01, (1S,3R,4R,5R)-3-[(E)-3-(3,4-DIHYDROXY-PHENYL)-ACRYLOYLOXY]-1,4,5-TRIHYDROXY-CYCLOHEXANECARBOXYLIC ACID, (1S,3R,4R,5R)-3-[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy-1,4,5-trihydroxycyclohexane-1-carboxylicacid, 1ST40089, AS-12284, SMR000857273, Chlorogenic acid 1000 microg/mL in Acetone, NS00015066, Chlorogenic acid 10 microg/mL in Acetonitrile, C00852, F16266, Chlorogenic acid (constituent of st. john''s wort), Q421964, SR-01000841185, SR-01000946600, D54CAE3D-CDDA-455D-A28E-77FC9EFE4A43, SR-01000841185-4, SR-01000946600-1, BRD-K47114202-001-06-2, 32CF6D13-8F08-485F-B79E-F8A6AC318E07, Chlorogenic acid, primary pharmaceutical reference standard, Chlorogenic acid, European Pharmacopoeia (EP) Reference Standard, Chlorogenic acid, United States Pharmacopeia (USP) Reference Standard, 3-[(E)-3-(3,4-Dihydroxy-phenyl)-acryloyloxy]-1,4,5-trihydroxy-cyclohexanecarboxylic acid, 3-[3-(3,4-Dihydroxy-phenyl)-acryloyloxy]-1,4,5-trihydroxy-cyclohexanecarboxylic acid, (1R,3S,4S,5S)-3-[(E)-3-(3,4-Dihydroxy-phenyl)-acryloyloxy]-1,4,5-trihydroxy-cyclohexanecarboxylic acid, (1S,3R,4R,5R)-3-(((3-(3,4-dihydroxyphenyl)acryloyl)oxy)-1,4,5-trihydroxycyclohexanecarboxylicacid, (1S,3R,4R,5R)-3-((E)-3-(3,4-dihydroxyphenyl)acryloyloxy)-1,4,5-trihydroxycyclohexanecarboxylic acid, (1S,3R,4R,5R)-3-[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy-1,4,5-trihydroxy-cyclohexanecarboxylic acid, (1S,3R,4R,5R)-3-[3-(3,4-dihydroxyphenyl)prop-2-enoyloxy]-1,4,5-trihydroxycyclohexanecarboxylic acid, (1S,3R,4R,5R,E)-3-(3-(3,4-dihydroxyphenyl)acryloyloxy)-1,4,5-trihydroxycyclohexanecarboxylic acid, Chlorogenic acid (constituent of echinacea angustifolia root, echinacea pallida root, echinacea purpurea root and echinacea purpurea aerial parts), CYCLOHEXANECARBOXYLIC ACID, 3-((3-(3,4-DIHYDROXYPHENYL)-1-OXO-2-PROPENYL)OXY)-1,4,5-TRIHYDROXY-, (1S-(1-.ALPHA.,3-.BETA.,4-.ALPHA.,5-.ALPHA.))-, Cyclohexanecarboxylic acid,3-[[3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl]oxy]-1,4,5-trihydroxy-,(1S,3R,4R,5R)- C16H18O9 CWVRJTMFETXNAD-JUHZACGLSA-N (1S,3R,4R,5R)-3-[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy-1,4,5-trihydroxycyclohexane-1-carboxylic acid n.a. n.a. No No No No Yes No rxn02149,rxnDiet66 PMDBD2001758 Selenium Dietary Substance n.a. 7782-49-2 DB11135 n.a. n.a. n.a. 6326970 n.a. n.a. "7782-49-2, Se, Selenium, Selenium hydride, SELENIUM ATOM, Elemental selenium, Selenium elemental, Selenium, elemental, Selen, Selenium dihydride, Selenium metallicum, SELENIUM POWDER, CI 77805, Dihydrogen monoselenide, C.I. 77805, SELENIUM78, MFCD00134090, Hydrogen selenide, anhydrous, H6241UJ22B, Vandex, Gray selenium, Selenium base, Selenium dust, Colloidal selenium, Selen [Polish], elenium, elemental; Vandex;, Selenium, metallic, Selenium, colloidal, Caswell No. 732, selenio, Selenium anhydride, Electronic E-2, CCRIS 4250, HSDB 4493, EINECS 231-957-4, UN2658, Hydrogen selenide (H2Se), EPA Pesticide Chemical Code 072001, Selenium Standard: Se @ 1000 microg/mL in 5% HNO3, Selenium Standard: Se @ 10000 microg/mL in 5% HNO3, Selenium AA Standard: Se @ 1000 microg/mL in 5% HNO3, Selenium metal, UNII-H6241UJ22B, HSDB 548, Selenium, powder, Selenium (Powder), EINECS 231-978-9, Selenium shot, 4N, selenium (hexagonal), UN2202, UN3283, selenium (iv) hydride, HYDROGEN SELENID, B-TRAXIM SE, SELENIUM [MI], SELENIUM [VANDF], Selenium hydride (SeH2), SELENIUM [MART.], 34Se, SELENIUM [WHO-DD], UNII-V91P54KPAM, EC 231-957-4, Selenium, powder, 99+%, Selenium compound, n.o.s., Selenium powder, -200 mesh, Selenium powder, -325 mesh, SELSAF 2000, HYDROGEN SELENIDE [MI], Selenium, p.a., 99.5%, CHEMBL1235891, DTXSID9021261, CHEBI:27568, HSDB 6909, Selenium Nanopowder in aq. media, SELENIUM METALLICUM [HPUS], SELENIUM, ELEMENTAL [HSDB], powder,99.9% metals basis,200mesh, DB11135, NSC-605850, NSC-605851, NSC-605852, N725, Q876, Selenium, pellets, < 5mm, >=99.999%, E1457, NS00099723, Selenium ingot/button, ~38mm (1.5in) dia, C01529, Selenium - Se @ 1000 microg/mL in 5% HNO3, Selenium - Se @ 1000 microg/g in Hydrocarbon Oil, Selenium powder [UN2658] [Keep away from food], Selenium shot, amorphous, 1-5mm (0.04-0.20in), Selenium Standard: Se @ 10 microg/mL in 2% HNO3, Selenium, foil, 25x25mm, thickness 3mm, 99.95%, Hydrogen selenide, anhydrous [UN2202] [Poison gas], S008000000, Selenium, shots, 99.99999% (7N), diameter 2-4 mm, Selenium Standard: Se @ 1000 microg/g in Hydrocarbon Oil, Selenium, pellets, <5 mm, >=99.99% trace metals basis, Selenium, powder, -100 mesh, >=99.5% trace metals basis, Selenium, powder, -100 mesh, 99.99% trace metals basis, Selenium Hollow Cathode Lamp: 2.0"" Diameter, 4-pin, Cableless, Selenium Hollow Cathode Lamp: 1.5"" Diameter, 2-pin, Non-Coded, Selenium Hollow Cathode Lamp: 2.0"" Diameter, 9-pin, Non-Coded, Selenium compound, n.o.s. [UN3283] [Poison, Keep away from food], Selenium, lump, 3 mm max. lump size, weight 100 g, high purity 99.999%, Selenium, lump, 3 mm max. lump size, weight 20 g, high purity 99.999%, Selenium, lump, 3 mm max. lump size, weight 50 g, high purity 99.999%, Selenium, pellets, <5 mm particle size, >=99.999% trace metals basis, Sulfur-Free Selenium Standard: Se @ 1000 microg/g in Hydrocarbon Oil, Selenium shot, amorphous, 2-6mm (0.08-0.2in), Puratronic(R), 99.999% (metals basis), Selenium, powder, 250 max. part. size (micron), purity 99.95%, weight 100 g, Selenium, powder, 250 max. part. size (micron), weight 50 g, purity 99.95%, Selenium, powder, max. particle size 250 micron, weight 200 g, purity 99.95%, Selenium, rod, 99.9999% (6N), diameter 20 mm, length 55 mm, approx. 74g, Selenium, rod, 99.99999% (7N), diameter 20 mm, length 55 mm, approx. 74 g, Se0" Se BUGBHKTXTAQXES-UHFFFAOYSA-N selenium n.a. n.a. No No No No Yes No rxn02572,rxnDiet21 PMDBD2001759 Sinapaldehyde Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 5280802 n.a. NPC271985 Sinapaldehyde, 4206-58-0, Sinapinaldehyde, Sinapyl aldehyde, Sinapoyl aldehyde, (E)-3-(4-Hydroxy-3,5-dimethoxyphenyl)acrylaldehyde, 20649-43-8, Sinapic aldehyde, trans-Sinapaldehyde, (E)-3-(4-Hydroxy-3,5-dimethoxyphenyl)-2-propenal, Trans-3,5-Dimethoxy-4-Hydroxy Cinnamaldehyde, 3,5-Dimethoxy-4-hydroxycinnamaldehyde, 2-Propenal, 3-(4-hydroxy-3,5-dimethoxyphenyl)-, (2E)-, (E)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enal, (2E)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enal, (2E)-3-(4-hydroxy-3,5-dimethoxyphenyl)acrylaldehyde, 4VB87UV6WG, CHEBI:27949, (2E)-3-(4-Hydroxy-3,5-dimethoxyphenyl)-2-propenal, 2-Propenal, 3-(4-hydroxy-3,5-dimethoxyphenyl)-, (E)-, Cinnamaldehyde, 4-hydroxy-3,5-dimethoxy-, (E)-3,5-Dimethoxy-4-hydroxyphenylpropenaldehyde, trans-3,5-Dimethoxy-4-hydroxycinnamaldehyde, (E)-sinapaldehyde, (E)-sinapoaldehyde, 3,5 Dimethoxy-4-hydroxycinnamaldehyde, (E)-sinapoyl aldehyde, 3,5-Dimethoxy-4-hydroxycinnamaldehyde (E), bmse000606, bmse010085, UNII-4VB87UV6WG, SCHEMBL197270, CHEMBL225067, MEGxp0_001085, ACon1_001103, DTXSID10863340, HY-N1312, MFCD00075980, 3,4-dimethoxy-4-hydroxycinnamaldehyde, AKOS015999009, NCGC00169673-01, BS-42317, 1ST168185, CS-0016716, 3-(4-Hydroxy-3,5-dimethoxyphenyl)-2-propenal, C05610, G12202, 3-(4-Hydroxy-3,5-dimethoxyphenyl)acrylaldehyde, EN300-1860016, trans-3,5-Dimethoxy-4-hydroxycinnamaldehyde, 98%, (E)-3-(4-hydroxy-3,5-dimethoxy-phenyl)prop-2-enal, BRD-K19027245-001-01-0, Q63392287, 072ADBB5-241A-428F-B856-9EF1F076A5A6, Retention index: SEE J. Agric. Food Chem. 2009, 57, 3217-3227, SNY C11H12O4 CDICDSOGTRCHMG-ONEGZZNKSA-N (E)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enal n.a. n.a. No No No No Yes No rxn02758,rxn05142,rxn05143,rxnDiet207 PMDBD2001760 Ferulaldehyde Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 5280536 n.a. NPC39793 "Coniferaldehyde, Coniferyl aldehyde, 4-HYDROXY-3-METHOXYCINNAMALDEHYDE, 458-36-6, 20649-42-7, Ferulaldehyde, 3-(4-Hydroxy-3-methoxyphenyl)acrylaldehyde, Ferulyl aldehyde, coniferylaldehyde, p-Coniferaldehyde, trans-coniferyl aldehyde, (E)-Ferulaldehyde, 3-Methoxy-4-hydroxycinnamaldehyde, trans-Coniferaldehyde, 3-(4-Hydroxy-3-methoxyphenyl)prop-2-enal, trans-Ferulaldehyde, 2-Propenal, 3-(4-hydroxy-3-methoxyphenyl)-, (2E)-, Cinnamaldehyde, 4-hydroxy-3-methoxy-, (E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enal, (E)-3-(4-Hydroxy-3-methoxyphenyl)acrylaldehyde, (2e)-3-(4-Hydroxy-3-Methoxyphenyl)prop-2-Enal, 2-Methoxy-4-(3-oxo-1-propenyl)phenol, 4-Hydroxy-3-methoxy-trans-cinnamaldehyde, 3-(4-Hydroxy-3-methoxyphenyl)-2-propenal, 06TPT01AD5, CHEMBL242529, CHEBI:16547, 2-Propenal, 3-(4-hydroxy-3-methoxyphenyl), (E)-, UNII-06TPT01AD5, Ferulic Aldehyde, Coniferylic aldehyde, (E)-coniferaldehyde, Trans-Coniferylaldehyde, bmse000422, bmse000601, bmse010076, SCHEMBL167835, E-Coniferyl aldehyde; trans-Coniferaldehyde; trans-Coniferyl aldehyde, DTXSID10174685, 4-Hydroxy3-Methoxy Cinnamaldehyde, AMY25249, HY-N2535, HY-N3616, STR05037, 4-hydroxy-3-methoxycinnamic aldehyde, BDBM50211193, MFCD00075811, s9221, 3-BIPHENYL-3-AMINO-ACETICACID, AKOS015916118, CCG-266411, 4-Hydroxy-3-methoxycinnamaldehyde, 98%, AC-34773, CS-0022807, CS-0023941, NS00066975, C02666, (2E)-3-(4-Hydroxy-3-methoxyphenyl)-2-propenal, (E)-3-(4-hydroxy-3-methoxy-phenyl)prop-2-enal, Q63390505, Z1255419416, 5DF06912-B0DD-4C76-B493-29D29F746430, InChI=1/C10H10O3/c1-13-10-7-8(3-2-6-11)4-5-9(10)12/h2-7,12H,1H3/b3-2" C10H10O3 DKZBBWMURDFHNE-NSCUHMNNSA-N (E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enal n.a. n.a. No No No No Yes No rxn03971,rxnDiet125 PMDBD2001761 Vitamin D3 Dietary Substance, Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. D0K5WS 5280795 n.a. NPC269877 "Vitamin D3, cholecalciferol, 67-97-0, Colecalciferol, Calciol, Ricketon, Oleovitamin D3, Deparal, Arachitol, Delsterol, Trivitan, Ebivit, Vigantol, Vigorsan, vitamin d-3, Colecalcipherol, Colecalciferolum, Cholecalciferolum, D3-Vicotrat, D3-Vigantol, Vi-de-3-hydrosol, NEO Dohyfral D3, Provitina, Quintox, Rampage, 1406-16-2, Vitinc Dan-Dee-3, (+)-Vitamin D3, Cholecalciferol, D3, Colecalciferolo, Vi-De3, Duphafral D3 1000, Delta-D, Colecalciferol D3, Irradiated 7-dehydrocholesterol, CCRIS 6286, HSDB 820, Videkhol, 7-Dehydrocholesterol, irradiated, FeraCol, CHEBI:28940, Granuvit D3, CC, EINECS 200-673-2, Colecalciferolum [INN-Latin], EPA Pesticide Chemical Code 202901, NSC 375571, NSC-375571, UNII-1C6V77QF41, VIGANTOLETTEN, Colecalciferol [INN], 1C6V77QF41, (3beta,5Z,7E)-9,10-secocholesta-5,7,10(19)-trien-3-ol, MFCD00078131, (1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol, Vitamin d (cholecalciferol), 9,10-Secocholesta-5,7,10(19)-trien-3-beta-ol, AK R215 COMPONENT COLECALCIFEROL, AK-R215 COMPONENT COLECALCIFEROL, 9,10-Seco(5Z,7E)-5,7,10(19)-cholestatrien-3-ol, Micro-dee, DTXSID6026294, Vitamin d3 (as cholecalciferol), (5Z,7E)-(3S)-9,10-secocholesta-5,7,10(19)-trien-3-ol, 9,10-Secocholesta-5,7,10(19)-trien-3-ol, (3beta,5Z,7E)-, Vitamin d assay system suitability, VidDe-3-hydrosol, Cholecalciferol [USP:BAN:JAN:ISO], NSC375571, Colecalciferol (INN), (3S,5Z,7E)-9,10-secocholesta-5,7,10(19)-trien-3-ol, Vitamin D3 10 microg/mL in Acetonitrile, (5Z,7E)-(3S)-9,10-seco-5,7,10(19)-cholestatrien-3-ol, 9,10-Secocholestra-5,7,10(19)-trien-3-ol, (3beta,5Z,7E)-, 9,10-Secocholesta-5,7,10(19)-trien-3-ol, Colecalciferolum (INN-Latin), COLECALCIFEROL (MART.), COLECALCIFEROL [MART.], CHOLECALCIFEROL (USP-RS), CHOLECALCIFEROL [USP-RS], 9,10-Seco(5Z,7E)-5,7,10(19)-cholestatrien-3beta-ol, Colecalciferolo [DCIT], 9,10-Secocholesta-5(Z),7(E),10(19)-trien-3(.beta.)-ol, 9,10-Secocholesta-5,7,10(19)-trien-3-ol, (3.beta.,5Z,7E)-, CHOLECALCIFEROL (EP MONOGRAPH), Cholecalciferol (USP:BAN:JAN:ISO), CHOLECALCIFEROL [EP MONOGRAPH], CHOLECALCIFEROL (USP MONOGRAPH), CHOLECALCIFEROL [USP MONOGRAPH], (1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-1-[(1R)-1,5-dimethylhexyl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylene-cyclohexanol, (S,Z)-3-(2-((1R,3aS,7aR,E)-7a-methyl-1-((R)-6-methylheptan-2-yl)octahydro-4H-inden-4-ylidene)ethylidene)-4-methylenecyclohexan-1-ol, Cyclohexanol, 3-[(2E)-2-[(1R,3aS,7aR)-1-[(1R)-1,5-dimethylhexyl]octahydro-7a-methyl-4H-inden-4-ylidene]ethylidene]-4-methylene-, (1S,3Z)-, Vitamin D 3, CCRIS 5813, Vitamin D3 emulsifiable, EINECS 215-797-2, DTXCID306294, UNII-9VU1KI44GP, Vitamin D3; Cholecalciferol, Devaron, Vitamin D3 (Cholecalciferol), (3.beta.,5Z,7E)-9,10-secocholesta-5,7,10(19)-trien-3-ol, vitaminum d3, DP-R206, Osteo-Vit3, Prestwick_63, Cholecalciferol D3, NCGC00159331-02, Cyclohexanol, 3-((2E)-2-((1R,3aS,7aR)-1-((1R)-1,5-dimethylhexyl)octahydro-7a-methyl-4H-inden-4-ylidene)ethylidene)-4-methylene-, (1S,3Z)-, 9,10-secocholesta-5,7,10-trien-3-ol, Novel-D3, DECALCITROL, ()-Vitamin D3, Cholecalciferol (D3), Delta-D (TN), VITA-DESIC, CHOLECALCIFEROL IMPURITY A (EP IMPURITY), Prestwick3_000429, bmse000507, UPCMLD-DP152, VITAMIN D3 [MI], VITAMIN D3 [FCC], SCHEMBL3126, 9VU1KI44GP, CHEMBL1042, BSPBio_000418, CHOLECALCIFEROL [ISO], CHOLECALCIFEROL [JAN], 9,10-Secocholesta-5,7,10(19)-trien-3beta-ol, Cholecalciferol; 67-97-0, Cholecalciferol (JP17/USP), CHOLECALCIFEROL [HSDB], CHOLECALCIFEROL [INCI], CHOLECALCIFEROL [VANDF], BPBio1_000460, MEGxm0_000458, COLECALCIFEROL [WHO-DD], COLECALCIFEROL [WHO-IP], UPCMLD-DP152:001, ACon1_001997, A11CC05, COLECALCIFEROL [EMA EPAR], HMS2096E20, Cholecalciferol, >=98% (HPLC), (1S,3Z)-3-((2E)-2-((1R,3AR,7AS)-7A-METHYL-1-((2R)-6-METHYLHEPTAN-2-YL)-2,3,3A,5,6,7-HEXAHYDRO-1H-INDEN-4-YLIDENE)ETHYLIDENE)-4-METHYLIDENE-CYCLOHEXAN-1-OL, (1S,3Z)-3-[(2E)-2-[(1R,3AR,7AS)-7A-METHYL-1-[(2R)-6-METHYLHEPTAN-2-YL]-2,3,3A,5,6,7-HEXAHYDRO-1H-INDEN-4-YLIDENE]ETHYLIDENE]-4-METHYLIDENE-CYCLOHEXAN-1-OL, Cholecalciferol, analytical standard, GROWTH SUPPORTPATCH, HAUTUKI, BDBM50030475, CHOLECALCIFEROL [ORANGE BOOK], LMST03020001, s4063, Cholecalciferol for system suitability, 5,7-CHOLESTADIEN-3-BETAL-OL, AKOS015950641, AC-8884, CCG-268466, COLECALCIFEROLUM [WHO-IP LATIN], CS-1179, DB00169, DP-R206 COMPONENT VITAMIN D3, SMP1_000068, USEPA/OPP Pesticide Code: 202901, NCGC00091072-01, NCGC00159331-04, BS-42465, HY-15398, Cholecalciferol (D3), analytical standard, NS00008889, C05443, D00188, FOSAMAX PLUS D COMPONENT CHOLECALCIFEROL, Cholecalciferol, meets USP testing specifications, 9,10-Secocholesta-5,7,10(19)-trien-3?-ol, CHOLECALCIFEROL COMPONENT OF FOSAMAX PLUS D, Q139347, (5E,7E)-9,10-Secocholesta-5,7,10-trien-3-ol, Q-201931, VITAMIN D ASSAY SYSTEM SUITABILITY [USP-RS], 3-beta,Z,7E-9,10-Secocholestr-5,7,10(19)-trien-3-ol, (3beta,Z,7E)-9,10-Secocholesta-5,7,10(19)-trien-3-ol, 9,10-Secocholesta-5,7,10(19)-trien-3-ol, (3b,5Z,7E)-, Cholecalciferol, European Pharmacopoeia (EP) Reference Standard, Colecalciferol, British Pharmacopoeia (BP) Reference Standard, (5E,7E)-9,10-SECOCHOLESTA-5,7,10(19)-TRIEN-3beta-OL, Cholecalciferol, United States Pharmacopeia (USP) Reference Standard, Cholecalciferol for system suitability, European Pharmacopoeia (EP) Reference Standard, (1S,3Z)-3-[(2E)-2-[7a-Methyl-1-(6-methylheptan-2-yl)-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol, Cholecalciferol (Vitamin D3), Pharmaceutical Secondary Standard; Certified Reference Material" C27H44O QYSXJUFSXHHAJI-YRZJJWOYSA-N (1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol n.a. Vitamins No No No No Yes No rxn06424,rxnDiet27 PMDBD2001762 Theobromine Dietary Substance, Therapeutic Substance Approved Drug 83-67-0 DB01412 PA451646 n.a. D0I0DS 5429 5236 NPC119133 "theobromine, 83-67-0, 3,7-Dimethylxanthine, Diurobromine, Theosalvose, Santheose, Teobromin, Theostene, Thesodate, Thesal, 3,7-dimethylpurine-2,6-dione, 3,7-Dimethyl-3,7-dihydro-1H-purine-2,6-dione, Theobromin, Xantheose, Xanthine, 3,7-dimethyl-, 3,7-Dihydro-3,7-dimethyl-1H-purine-2,6-dione, FEMA No. 3591, Theobrominum, Theobromine (natural), 2,6-Dihydroxy-3,7-dimethylpurine, SC 15090, 1H-Purine-2,6-dione, 3,7-dihydro-3,7-dimethyl-, NSC 5039, CCRIS 2350, BRN 0016464, HSDB 7332, UNII-OBD445WZ5P, NSC-5039, 519-41-5, EINECS 201-494-2, 2,6-Dihydroxy-3,7-dimethyl-purine, OBD445WZ5P, MFCD00022830, DTXSID9026132, CHEBI:28946, 3,7-dimethyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione, CHEMBL1114, SC-15090, DTXCID506132, NSC5039, 5-26-13-00553 (Beilstein Handbook Reference), Theobromine (3,7-Dimethylxanthine), 3,7-dimethyl-1H-purine-2,6-dione, CAS-83-67-0, NCGC00016023-11, THEOBROMINE (IARC), THEOBROMINE [IARC], 3,7-Dimethyl-1H-purine-2,6(3H,7H)-dione, THEOBROMINE (MART.), THEOBROMINE [MART.], THEOBROMINE (EP IMPURITY), THEOBROMINE [EP IMPURITY], 7-Dimethylxanthine, PENTOXIFYLLINE IMPURITY A (EP IMPURITY), PENTOXIFYLLINE IMPURITY A [EP IMPURITY], SR-01000000069, Theobromine [INN:BAN:NF], Theobromine;, 37T, Prestwick_1054, Theobromine(20%), 3,7-dimethylxanthin, Spectrum_000053, 3, 7-Dimethylxanthine, Caffeine EP impurity D, THEOBROMINE [MI], Prestwick0_000874, Prestwick1_000874, Prestwick2_000874, Prestwick3_000874, Spectrum2_000985, Spectrum3_000279, Spectrum4_000403, Spectrum5_001387, Lopac-T-4500, THEOBROMINE [FHFI], THEOBROMINE [HSDB], THEOBROMINE [INCI], THEOBROMINE [VANDF], THEOBROMINUM [HPUS], SCHEMBL3184, Theobromine, >=98.0%, 3,7-dimethyl-1,3,7-trihydropurine-2,6-dione, Lopac0_001187, BSPBio_000947, BSPBio_001758, KBioGR_000666, KBioSS_000433, THEOBROMINE [WHO-DD], MLS000028407, DivK1c_000611, SPECTRUM1500649, SPBio_001049, SPBio_002868, BPBio1_001043, Theobromine, analytical standard, HMS501O13, KBio1_000611, KBio2_000433, KBio2_003001, KBio2_005569, KBio3_001258, YAPQBXQYLJRXSA-UHFFFAOYSA-, NINDS_000611, HMS1570P09, HMS1921O13, HMS2092G04, HMS2097P09, HMS3263N15, HMS3714P09, Pharmakon1600-01500649, HY-N0138, Theobromine 0.1 mg/ml in Methanol, Theobromine, >=98.0% (HPLC), Tox21_110284, Tox21_300016, Tox21_501187, BDBM50014260, CCG-40078, NSC757407, PDSP1_001017, PDSP2_001001, s2368, AKOS000121558, Tox21_110284_1, 5-26-13-00553 (Beilstein), CS-7972, DB01412, LP01187, NSC-757407, SDCCGMLS-0002875.P003, SDCCGSBI-0051154.P004, IDI1_000611, NCGC00016023-01, NCGC00016023-02, NCGC00016023-03, NCGC00016023-04, NCGC00016023-05, NCGC00016023-06, NCGC00016023-07, NCGC00016023-08, NCGC00016023-09, NCGC00016023-10, NCGC00016023-12, NCGC00016023-13, NCGC00016023-14, NCGC00016023-15, NCGC00016023-17, NCGC00016023-18, NCGC00016023-26, NCGC00024123-03, NCGC00024123-04, NCGC00024123-05, NCGC00024123-06, NCGC00024123-07, NCGC00024123-08, NCGC00179030-01, NCGC00179030-02, NCGC00253943-01, NCGC00261872-01, WLN: T56 BN DN FNVMVJ B1 F1, AC-11381, AC-34381, AS-13904, SMR000058357, SY048379, SBI-0051154.P003, 1H-Purine-2, 3,7-dihydro-3,7-dimethyl-, AB00052141, EU-0101187, NS00009946, T0178, EN300-16609, C07480, D71206, T 4500, AB00052141_12, Q206844, 3,7-Dimethyl-3,7-dihydro-1H-purine-2,6-dione #, Q-100848, SR-01000000069-2, SR-01000000069-4, SR-01000000069-7, SR-01000000069-8, SR-01000000069-9, BRD-K34888156-001-08-8, CAFFEINE MONOHYDRATE IMPURITY D [EP IMPURITY], CEC63CCA-3B4B-4F4F-92C1-1789DF3C880A, SR-01000000069-10, Z56347209, 1H-purine-2,6-dione,3,7-dihydro-3,7- dimethyl- (9CI), Theobromine, European Pharmacopoeia (EP) Reference Standard, 3,7-DIMETHYLXANTHINE; 3,7-DIMETHYLPURINE-2,6-DIONE, Theobromine, Pharmaceutical Secondary Standard; Certified Reference Material, InChI=1/C7H8N4O2/c1-10-3-8-5-4(10)6(12)9-7(13)11(5)2/h3H,1-2H3,(H,9,12,13)" C7H8N4O2 YAPQBXQYLJRXSA-UHFFFAOYSA-N 3,7-dimethylpurine-2,6-dione n.a. n.a. No No No No Yes No rxn07752,rxnDiet14 PMDBD2001763 Decanoate Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 4678093 n.a. NPC279028 decanoate, caprate, caprinate, n-decanoate, caprynate, decoate, decylate, n-caprate, n-decoate, n-decylate, 1-nonanecarboxylate, Decanoic acid anion, decanoate, 2, nC9H19CO2 anion, 3nq3, 3u9q, Decanoic acid, ion(1-), BDBM23433, CHEBI:27689, GHVNFZFCNZKVNT-UHFFFAOYSA-M, DTXSID401314266, CH3-[CH2]8-COO(-), 3398-75-2, Q27103266 C10H19O2- GHVNFZFCNZKVNT-UHFFFAOYSA-M decanoate n.a. n.a. No No No No Yes No rxn08448,rxnDiet2 PMDBD2001764 Hexanoate Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 4398339 n.a. NPC332988 Hexanoate, caproate, butylacetate, hexoate, n-hexanoate, Hexanoate anion, 151-33-7, Hexanoic acid, ion(1-), capronate, hexylate, pentylformate, n-caproate, n-hexoate, n-hexylate, 1-hexanoate, 1-pentanecarboxylate, Bi(OHex)3, a hexonic acid, pentanecarboxylate, 1-pentacarboxylate, nPnCO2 anion, Hexanoate (n-C6:0), BDBM36174, CHEBI:17120, CH3-[CH2]4-COO(-), AKOS015907975, A807936, Q27102218 C6H11O2- FUZZWVXGSFPDMH-UHFFFAOYSA-M hexanoate n.a. n.a. No No No No Yes No rxn08733,rxnDiet1 PMDBD2001765 (S,S)-Tartaric acid Dietary Substance, Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D0K2BZ 439655 n.a. NPC100742 "d-Tartaric acid, 147-71-7, D-(-)-Tartaric acid, (2S,3S)-2,3-Dihydroxysuccinic acid, D(-)-TARTARIC ACID, (2S,3S)-2,3-dihydroxybutanedioic acid, (-)-Tartaric acid, D-threaric acid, DL-Tartaric acid, (-)-D-Tartaric acid, (2S,3S)-(-)-Tartaric acid, (S,S)-Tartaric acid, (-)-(S,S)-Tartaric acid, (S,S)-(-)-Tartaric acid, Butanedioic acid, 2,3-dihydroxy-, (2S,3S)-, (2S,3S)-Tartaric acid, S-Bacampicillin, RRX6A4PL3C, tartaric acid, CHEBI:15672, MFCD00004238, C4H6O6, 133-37-9, 106449-07-4, tartrate, levo-Tartaric acid, unusual tartaric acid, D-(-)-tartaricacid, UNII-RRX6A4PL3C, DTXSID5046986, Linksweinsaeure, MFCD00071626, 1rpa, levo tartaric acid, (-)-Weinsaeure, EINECS 205-695-6, D-()-Tartaric acid, E-7050 (2S,3S)-2,3-dihydroxysuccinic acid, (+)-D-tartaric acid, NSC-155080, Butanedioic acid, 2,3-dihydroxy-, (S-(R*,R*))-, (2s, 3s)-tartaric acid, TARTARIC ACID, D-, Tartaric acid, D-(-)-, NCIStruc1_000172, NCIStruc2_000222, MLS001076664, D-TARTARIC ACID [MI], DL-Tartaric acid, >=99%, SCHEMBL116846, UNNATURAL TARTARIC ACID, CHEMBL1200861, D-(-)-Tartaric acid, 99%, DTXSID4043775, (2S,3S) (-) tartaric acid, HMS2231C23, 1007601-97-9, CCG-38066, NCGC00014424, NCI155080, s3134, AKOS005067832, DB01694, DS-3383, D-(-)-Tartaric acid, LR, >=98%, NCGC00014424-02, NCGC00097529-01, BP-13000, BP-31023, DL-Tartaric acid, ReagentPlus(R), 99%, E334, SMR000499572, AM20080237, CS-0017144, NS00074105, T0026, D-(-)-Tartaric acid, ReagentPlus(R), 99%, EN300-72270, (2R/S,3R/S)-dihydroxy-1,4-butanedioic acid, A22830, C02107, D78024, DL-Tartaric acid, Vetec(TM) reagent grade, 99%, J-006363, J-501029, D-(-)-Tartaric acid, Vetec(TM) reagent grade, 99%, Q23034947, (S,S)-Tartaric acid;Tartaric acid;D-(-)-Tartaric acid, Butanedioic acid, 2,3-dihydroxy-, (S-(theta,theta))-, Z1147451575, D-(-)-Tartaric acid, puriss., unnatural form, >=99.0% (T), DL-Tartaric acid, anhydrous, for ion chromatography, >=99.5% (T)" C4H6O6 FEWJPZIEWOKRBE-LWMBPPNESA-N (2S,3S)-2,3-dihydroxybutanedioic acid n.a. n.a. No No No No Yes No rxn15040,rxnDiet221 PMDBD2001766 alpha-Cryptoxanthin Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 70678559 n.a. NPC2584 alpha-Cryptoxanthin, (3''R,6''R)-beta,epsilon-Caroten-3''-ol, CHEBI:10223, Q27108604 C40H56O ORAKUVXRZWMARG-XBBNTEQGSA-N (1R,4R)-3,5,5-trimethyl-4-[(1E,3E,5E,7E,9E,11E,13E,15E,17E)-3,7,12,16-tetramethyl-18-(2,6,6-trimethylcyclohexen-1-yl)octadeca-1,3,5,7,9,11,13,15,17-nonaenyl]cyclohex-2-en-1-ol n.a. n.a. No No No No Yes No rxn15706,rxnDiet39 PMDBD2001767 Neurosporene Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 5280789 n.a. n.a. Neurosporene, 502-64-7, all-trans-Neurosporene, 7,8-dihydro-psi,psi-carotene, (6E,8E,10E,12E,14E,16E,18E,20E,22E,26E)-2,6,10,14,19,23,27,31-octamethyldotriaconta-2,6,8,10,12,14,16,18,20,22,26,30-dodecaene, FVN22YW634, psi,psi-Carotene, 7,8-dihydro-, 7,9,9''-cis-neurosporene, Neurosporin, all-trans neurosporene, UNII-FVN22YW634, CHEBI:16833, ATCICVFRSJQYDV-XILUKMICSA-N, DTXSID901045315, LMPR01070086, Lycopene, 7,8-dihydro-, all-trans-, C05431, Q15269719, 2,6,8,10,12,14,16,18,20,22,26,30-Dotriacontadodecaene, 2,6,10,14,19,23,27,31-octamethyl- C40H58 ATCICVFRSJQYDV-XILUKMICSA-N (6E,8E,10E,12E,14E,16E,18E,20E,22E,26E)-2,6,10,14,19,23,27,31-octamethyldotriaconta-2,6,8,10,12,14,16,18,20,22,26,30-dodecaene n.a. n.a. No No No No Yes No rxn16537,rxn22878,rxnDiet45 PMDBD2001768 Lycopene Dietary Substance n.a. 502-65-8 DB11231 n.a. n.a. n.a. 446925 394156 NPC99088 "LYCOPENE, 502-65-8, all-trans-Lycopene, Psi,psi-carotene, trans-Lycopene, Lycopene 7, lycored, Redivivo, Mexoryl SAQ, Tomat-O-Red, TOMATO LYCOPENE, (6E,8E,10E,12E,14E,16E,18E,20E,22E,24E,26E)-2,6,10,14,19,23,27,31-octamethyldotriaconta-2,6,8,10,12,14,16,18,20,22,24,26,30-tridecaene, (all-trans)-lycopene, Lycopene, all-trans-, Aec lycopene, y,y-Carotene, (all-e)-lycopene, CI 75125, Solanorubin, Ateronon, CCRIS 7925, NSC 407322, UNII-SB0N2N0WV6, Blakeslea trispora, C.I. 75125, EINECS 207-949-1, SB0N2N0WV6, INS-160D(III), INS NO.160D(III), Lycopene from blakeslea trispora, DTXSID2046593, FEMA NO. 4110, CHEBI:15948, E-160D(III), NSC-407322, LYC-O-MATO, DTXCID0026593, All trans Lycopene, MFCD00017350, NSC407322, (all-E)-2,6,10,14,19,23,27,31-Octamethyl-2,6,8,10,12,14,16,18,20,22,24,26,30-dotriacontatridecaene, NCGC00166291-01, .psi.,.psi.-Carotene, LYCOPENE (MART.), LYCOPENE [MART.], Lycopene (VAN), cis-Lycopene, LYCOPENE PREPARATION (USP-RS), LYCOPENE PREPARATION [USP-RS], psi, psi-Carotene, LYC, LyocpenePowder, psi-psi-carotene, Lyco Vit, Lycopene preparation, Lycopene all-trans-, Lycopene, dispersion, Lycopene (>80%), LYCOPENE [INCI], LYCOPENE [MI], LYCOPENE [VANDF], LYCOPENE [WHO-DD], BSPBio_003389, Lycopene, analytical standard, E160d, TOMATO LYCOPENE [FHFI], CHEMBL501174, Lycopene, >=90%, from tomato, CI 75125 [INCI], HY-N0287, Tox21_112395, LMPR01070257, s3943, AKOS015961276, CS-6378, DB11231, FD10111, NCGC00166291-02, NCGC00166291-03, NCGC00166291-04, 2,6,10,14,19,23,27,31-octamethyldotriaconta-2,6,8,10,12,14,16,18,20,22,24,26,30-tridecaene, AC-13571, AC-33932, CAS-502-65-8, LS-15428, Lycopene, >=98% (HPLC), from tomato, L0257, NS00013534, LYCOPENE FROM BLAKESLEA TRISPORA [FCC], C05432, Q208130, Q-100561, Lycopene, United States Pharmacopeia (USP) Reference Standard, Lycopene, Pharmaceutical Secondary Standard; Certified Reference Material, (ALL-E)-LYCOPENE (CONSTITUENT OF LYCOPENE AND TOMATO EXTRACT CONTAINING LYCOPENE), (6E,8E,10E,12E,14E,16E,18E,20E,22E,24E,26E)-2,6,10,14,19,23,27,31-Octamethyl-2,6,8,10,12,14,16,18,20,22,24,26,30-dotriacontatridecaene, 2,6,10,14,19,23,27,31-Octamethyl-dotriaconta-2,6,8,10,12,14,16,18,20,22,24,26,30-tridecaene, 2,6,8,10,12,14,16,18,20,22,24,26,30-Dotriacontatridecaene, 2,6,10,14,19,23,27,31-octamethyl-, (6E,8E,10E,12E,14E,16E,18E,20E,22E,24E,26E)-, 2,6,8,10,12,14,16,18,20,22,24,26,30-Dotriacontatridecaene, 2,6,10,14,19,23,27,31-Octamethyl-, (all-E)-" C40H56 OAIJSZIZWZSQBC-GYZMGTAESA-N (6E,8E,10E,12E,14E,16E,18E,20E,22E,24E,26E)-2,6,10,14,19,23,27,31-octamethyldotriaconta-2,6,8,10,12,14,16,18,20,22,24,26,30-tridecaene n.a. n.a. No No No No Yes No rxn06497,rxn16562,rxnDiet44 PMDBD2001769 Pinoresinol Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 73399 n.a. NPC228346 Pinoresinol, (+)-Pinoresinol, 487-36-5, D-PINORESINOL, UNII-V4N1UDY811, V4N1UDY811, NSC 35444, NSC-35444, CHEBI:40, PINORESINOL, (+)-, 4,4''-(1s,3ar,4s,6ar)-tetrahydro-1h,3h-furo[3,4-c]furan-1,4-diylbis(2-methoxyphenol), ( inverted exclamation markA)-Pinoresinol, pino-resinol, (7alpha,7''alpha,8alpha,8''alpha)-3,3''-dimethoxy-7,9'':7'',9-diepoxylignane-4,4''-diol, 4,4''-((1S,3aR,4S,6aR)-Hexahydrofuro[3,4-c]furan-1,4-diyl)bis(2-methoxyphenol), 4-[(3S,3aR,6S,6aR)-6-(3-methoxy-4-oxidanyl-phenyl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-3-yl]-2-methoxy-phenol, PHENOL, 4,4''-((1S,3AR,4S,6AR)-TETRAHYDRO-1H,3H-FURO(3,4-C)FURAN-1,4-DIYL)BIS(2-METHOXY-, Phenol, 4,4''-(tetrahydro-1H,3H-furo(3,4-c)furan-1,4-diylbis(2-methoxy-, (1S-(1alpha,3aalpha,4alpha,6aalpha))-, 4-[(3S,3aR,6S,6aR)-6-(4-hydroxy-3-methoxy-phenyl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-3-yl]-2-methoxy-phenol, SCHEMBL122105, CHEBI:8225, CHEMBL260183, MEGxp0_000829, ACon1_001809, Pinoresinol, >=95% (HPLC), (+)-Pinoresinol (>80% ee), DTXSID20964099, HGXBRUKMWQGOIE-AFHBHXEDSA-N, HY-N0957, HY-N6253, Pinoresinol, >=95.0% (HPLC), MFCD07784516, AKOS037514981, Phenol,4,4''-[(1S,3aR,4R,6aS)-tetrahydro-1H,3H-furo[3,4-c]furan-1,4-diyl]bis[2-methoxy-, NCGC00180117-01, BS-16858, Pinoresinol, analytical reference material, CS-0016092, CS-0032788, P2568, C05366, D82113, Q3388802, BRD-K78515374-001-01-5, PHENOL, 4,4''-(TETRAHYDRO-1H,3H-FURO(3,4-C)FURAN-1,4-DIYLBIS(2-METHOXY-, (1S-(1.ALPHA.,3A.ALPHA.,4.ALPHA.,6A.ALPHA.))-, Phenol, 4,4''-[(1S,3aR,4R,6aS)-tetrahydro-1H,3H-furo[3,4-c]furan-1,4-diyl]bis[2-methoxy- C20H22O6 HGXBRUKMWQGOIE-AFHBHXEDSA-N 4-[(3S,3aR,6S,6aR)-6-(4-hydroxy-3-methoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-3-yl]-2-methoxyphenol n.a. n.a. No No No No Yes No rxn22914,rxn25077,rxnDiet182,rxnAdd198,rxnAdd199 PMDBD2001770 Malonyldaidzin Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 9913968 n.a. NPC95495 "Malonyldaidzin, Daidzin 6''''-O-Malonate, 124590-31-4, 6""-O-Malonyldaidzin, 6''''-O-MALONYLDAIDZIN, Malonyldaidzin, (-)-, 54CE6OWE7A, CHEBI:80371, Malonyl daidzin (constituent of soy isoflavones) [DSC], 3-Oxo-3-(((2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-((3-(4-hydroxyphenyl)-4-oxo-4H-chromen-7-yl)oxy)tetrahydro-2H-pyran-2-yl)methoxy)propanoic acid, 3-oxo-3-[[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[3-(4-hydroxyphenyl)-4-oxochromen-7-yl]oxyoxan-2-yl]methoxy]propanoic acid, malonyl daidzin, Malonyl-daidzin, UNII-54CE6OWE7A, CHEMBL3426719, DTXSID201319060, HY-N4073, AKOS040760360, MS-29327, PD165367, CS-0030648, NS00094569, E88875, Q27149376, 3-(4-hydroxyphenyl)-4-oxo-4H-1-benzopyran-7-yl 6-O-(carboxyacetyl)-beta-D-glucopyranoside, 3-(4-Hydroxyphenyl)-4-oxo-4H-chromen-8-yl 6-O-(carboxyacetyl)-beta-D-glucopyranoside, 3-(4-HYDROXYPHENYL)-4-OXO-4H-CHROMEN-8-YL 6-O-(CARBOXYACETYL)-.BETA.-D-GLUCOPYRANOSIDE, 4H-1-Benzopyran-4-one, 7-[[6-O-(2-carboxyacetyl)-.beta.-D-glucopyranosyl]oxy]-3-(4-hydroxyphenyl)-" C24H22O12 MTXMHWSVSZKYBT-ASDZUOGYSA-N 3-oxo-3-[[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[3-(4-hydroxyphenyl)-4-oxochromen-7-yl]oxyoxan-2-yl]methoxy]propanoic acid n.a. n.a. No No No No Yes No rxn23865,rxnDiet74,rxnAdd172 PMDBD2001771 Malonylgenistin Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 15934091 n.a. NPC176259 "Malonylgenistin, 6''''-O-MALONYLGENISTIN, 51011-05-3, Genistin Malonate, Genistin 6''''-O-Malonate, 6-O-Malonylgenistin"", 7-O-Glucosyl-6''''-malonyl Genistein, 2AUB85VT2K, CHEBI:80372, 3-oxo-3-[[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[5-hydroxy-3-(4-hydroxyphenyl)-4-oxochromen-7-yl]oxyoxan-2-yl]methoxy]propanoic acid, Malonyl genistin (constituent of soy isoflavones) [DSC], malonyl genistin, 6''''-Malonylgenistin, 5-Hydroxy-3-(4-hydroxyphenyl)-4-oxo-4H-chromen-7-yl 6-O-(carboxylatoacetyl)hexopyranoside, Malonyl-genistin, 6-O-Malonylgenistin, UNII-2AUB85VT2K, MEGxp0_000226, CHEMBL3426722, ACon0_001356, 6""-O-Malonylgenistin, Free Acid, DTXSID201316854, HY-N0917, AKOS030526829, CS-4241, MS-29612, NS00094571, Genistein-7-o-beta-D-glucosyl-6''''-o-malonate, genistein 7-O-beta-D-glucoside 6''''-O-malonate, Genistein 7-O-beta-d-glucoside-6''''-O-malonate, Q27149379, GENISTEIN-7-O-.BETA.-D-GLUCOSYL-6''''-O-MALONATE, 5-hydroxy-3-(4-hydroxyphenyl)-4-oxo-4H-1-benzopyran-7-yl 6-O-(carboxyacetyl)-beta-D-glucopyranoside, PROPANEDIOIC ACID, 6''-ESTER WITH 7-(.BETA.-D-GLUCOPYRANOSYLOXY)-5-HYDROXY-3-(4-HYDROXYPHENYL)-4H-1-BENZOPYRAN-4-ONE, Propanedioic acid, 6''-ester with 7-(beta-D-glucopyranosyloxy)-5-hydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one" C24H22O13 FRAUJUKWSKMNJY-RSEYPYQYSA-N 3-oxo-3-[[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[5-hydroxy-3-(4-hydroxyphenyl)-4-oxochromen-7-yl]oxyoxan-2-yl]methoxy]propanoic acid n.a. n.a. No No No No Yes No rxn23868,rxnDiet75,rxnAdd173 PMDBD2001772 Sitosterol Dietary Substance, Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. D0Y7LD 222284 n.a. NPC230301 "BETA-SITOSTEROL, Sitosterol, 83-46-5, Cupreol, Azuprostat, 22,23-Dihydrostigmasterol, Quebrachol, Cinchol, Triastonal, Rhamnol, beta-Sitosterin, Nimbosterol, Prostasal, alpha-Dihydrofucosterol, Harzol, B-Sitosterol, (-)-beta-Sitosterol, Sito-Lande, 24alpha-Ethylcholesterol, Betaprost, beta Sitosterol, Stigmast-5-en-3beta-ol, (24R)-Ethylcholest-5-en-3beta-ol, alpha-Phytosterol, Angelicin (steroid), sitosterin, (3beta)-Stigmast-5-en-3-ol, Sobatum, (24R)-Stigmast-5-en-3beta-ol, Beta-sistosterol, SKF 14463, SITOSTEROL, BETA-, SITOSTEROL, BETA, CHEBI:27693, NSC8096, 24-alpha-Ethylcholesterol, Stigmast-5-en-3-ol, (3beta)-, a-Dihydrofucosterol, UNII-S347WMO6M4, Phytosterol, delta5-Stigmasten-3-beta-ol, CCRIS 5529, S347WMO6M4, DTXSID5022481, Stigmasterol, 22,23-dihydro-, (3-beta)-Stigmast-5-en-3-ol, NSC 8096, NSC-8096, .alpha.-Dihydrofucosterol, EINECS 201-480-6, NSC 18173, NSC-18173, NSC-49083, AI3-26020, CHEMBL221542, DTXCID802481, .beta.-Sitosterol, NSC18173, NSC49083, .alpha.-Phytosterol, Sitosterol, .beta., Stigmasterol,23-dihydro-, SITOSTEROL (MART.), SITOSTEROL [MART.], BETA-SITOSTEROL (USP-RS), BETA-SITOSTEROL [USP-RS], .beta.-Sitosterin, MFCD00003631, Stigmast-5-en-3-ol, (3.beta.)-, 5-Stigmasten-3beta-ol, (3S,8S,9S,10R,13R,14S,17R)-17-[(2R,5R)-5-ethyl-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol, 24.alpha.-Ethylcholesterol, Stigmast-5-en-3-ol, (3b)-, Stigmast-5-en-3.beta.-ol, SR-05000002307, Beta-Sitosterol (purity>98%), Stigmast-5-en-3-beta-ol, Sitosterol beta, a-Phytosterol, b-Sitosterin, beta-Phytosterol, ss--Sitosterol, I2-sitosterol, .beta.Sitosterin, .beta.Sitosterol, beta -Sitosterol, CAS-83-46-5, NCGC00095716-01, Beta-Sitosterol-2, (3S,8S,9S,10R,13R,14S,17R)-17-((2R,5R)-5-ethyl-6-methylheptan-2-yl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol, (3S,8S,9S,10R,13R,14S,17R)-17-[(1R,4R)-4-ethyl-1,5-dimethyl-hexyl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol, (-)-b-Sitosterol, Harzol (TN), 24a-Ethylcholesterol, alpha.Dihydrofucosterol, D5-Stigmasten-3b-ol, Stigmast-5-en-3b-ol, Prestwick0_000985, Prestwick1_000985, Prestwick2_000985, Prestwick3_000985, b-Sitosterol (Synthetic), Delta5-Stigmasten-3b-ol, beta-Sitosterol, >=70%, Beta-sitosterol [WHO-DD], BIDD:PXR0121, SCHEMBL16105, 22,23-dihydro-Stigmasterol, BSPBio_001049, 3 beta-stigmast-5-en-3-ol, 5-cholesten-24-ethyl-3-ol, BIDD:ER0636, SPBio_002950, BETA-SITOSTEROL [INCI], BPBio1_001155, MEGxp0_001710, BETA SITOSTEROL [VANDF], .BETA.-SITOSTEROL [MI], (24R)-Stigmast-5-en-3b-ol, ACon1_000287, CHEBI:176889, HMS1571E11, HMS2098E11, (24R)-Ethylcholest-5-en-3b-ol, 24-Ethylcholest-5-en-3.beta.-ol, beta-Sitosterol, analytical standard, Tox21_111514, BDBM50218197, beta-Sitosterol, synthetic, >=95%, LMST01040129, NSC821067, s2273, AKOS005267194, delta(SUP 5)-STIGMASTEN-3beta-OL, AT37227, BETA-SITOSTEROL, 40% (HPLC), CCG-208334, DB14038, NSC-821067, beta-Sitosterol, from soybean, >=96%, SMP1_000274, NCGC00142598-02, NCGC00142598-03, NCGC00142598-08, (3.BETA.)-STIGMAST-5-EN-3-OL, 14-((1S,4R)-4-ethyl-1,5-dimethylhexyl)(1S,5S,10S,11S,2R,14R,15R)-2,15-dimethyl tetracyclo[8.7.0.0<2,7>.0<11,15>]heptadec-7-en-5-ol, 1ST40101, AC-24183, NCI60_041777, AB00513984, NS00078818, S0040, beta-SITOSTEROL (CONSTITUENT OF PYGEUM), .DELTA.(SUP 5)-STIGMASTEN-3.BETA.-OL, C01753, D08518, 24beta-ETHYL-delta(SUP 5)-CHOLESTEN-3beta-OL, A840577, alpha-Dihydrofucosterol, 22,23-Dihydrostigmasterol, Q-200712, SR-05000002307-2, SR-05000002307-3, BETA-SITOSTEROL (CONSTITUENT OF SAW PALMETTO), Corn sterilized quantitative extract (beta sitosterol), Q63409374, .BETA.-SITOSTEROL (CONSTITUENT OF PYGEUM) [DSC], BETA-SITOSTEROL (CONSTITUENT OF STINGING NETTLE), BETA-SITOSTEROL (CONSTITUENT OF SAW PALMETTO) [DSC], BETA-SITOSTEROL, inverted exclamation markY 98% (HPLC), beta-Sitosterol, analytical standard, from soybean, >=40%, beta-Sitosterol, primary pharmaceutical reference standard, 24.BETA.-ETHYL-.DELTA.(SUP 5)-CHOLESTEN-3.BETA.-OL, BETA-SITOSTEROL (CONSTITUENT OF STINGING NETTLE) [DSC], Beta-sitosterol, European Pharmacopoeia (EP) Reference Standard, -Sitosterol (purity>98%);22,23-Dihydrostigmasterol (purity>98%), beta-Sitosterol, United States Pharmacopeia (USP) Reference Standard, beta-Sitosterol, certified reference material, 100 mug/mL in chloroform, (3S,9S,10R,13R,14S,17R)-17-((2R,5R)-5-ethyl-6-methylheptan-2-yl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol, 17-(5-ethyl-6-methyl-heptan-2-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol, 76772-70-8, beta-SITOSTEROL (CONSTITUENT OF ECHINACEA ANGUSTIFOLIA ROOT, ECHINACEA PALLIDA ROOT, ECHINACEA PURPUREA ROOT AND ECHINACEA PURPUREA AERIAL PARTS)" C29H50O KZJWDPNRJALLNS-VJSFXXLFSA-N (3S,8S,9S,10R,13R,14S,17R)-17-[(2R,5R)-5-ethyl-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol n.a. n.a. No No No No Yes No rxn23911,rxnDiet35 PMDBD2001773 Ferulate Dietary Substance, Therapeutic Substance Patented Drug n.a. n.a. n.a. n.a. D03SLR 445858 n.a. NPC70744 "ferulic acid, trans-Ferulic Acid, 1135-24-6, 537-98-4, 4-Hydroxy-3-methoxycinnamic acid, trans-4-Hydroxy-3-methoxycinnamic acid, 3-(4-Hydroxy-3-methoxyphenyl)acrylic acid, (E)-Ferulic acid, Coniferic acid, ferulate, 2-Propenoic acid, 3-(4-hydroxy-3-methoxyphenyl)-, Ferulic acid, trans-, 3-(4-Hydroxy-3-methoxyphenyl)-2-propenoic acid, (E)-3-(4-Hydroxy-3-methoxyphenyl)-2-propenoic acid, (2E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoic acid, Cinnamic acid, 4-hydroxy-3-methoxy-, 3-methoxy-4-hydroxycinnamic acid, Fumalic acid, Cinnamic acid, 4-hydroxy-3-methoxy-, (E)-, (E)-4-Hydroxy-3-methoxycinnamic acid, UNII-AVM951ZWST, (E)-4''-Hydroxy-3''-methoxycinnamic acid, 2-Propenoic acid, 3-(4-hydroxy-3-methoxyphenyl)-, (2E)-, AVM951ZWST, 4-Hydroxy-3-methoxy cinnamic acid, EINECS 208-679-7, Cinnamic acid, 4-hydroxy-3-methoxy-, trans-, MFCD00004400, 2-Propenoic acid, 3-(4-hydroxy-3-methoxyphenyl)-, (E)-, (E)-3-(4-hydroxy-3-methoxyphenyl)acrylic acid, CCRIS 3256, CCRIS 7127, CIS-FERULICACID, CHEBI:17620, (E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoic acid, HSDB 7663, NSC 2821, NSC-2821, EINECS 214-490-0, NSC 51986, NSC-51986, (2E)-3-(4-Hydroxy-3-methoxyphenyl)acrylic acid, NSC 674320, Fumalic acid (Ferulic acid), 4-Hydroxy-3-methoxycinnamate, (2E)-3-(4-Hydroxy-3-methoxyphenyl)-2-propenoic acid, (E)-3-(4-hydroxy-3-methoxy-phenyl)prop-2-enoic acid, CHEMBL32749, 3-(4-Hydroxy-3-methoxyphenyl)propenoic acid, NSC2821, 3-Methoxy-4-hydroxy-trans-cinnamate, NSC-674320, 97274-61-8, 3-methoxy-4-hydroxy-trans-cinnamic acid, (E)-Ferulate, trans-Ferulic Acid (purified by sublimation), Trans-3-(4-hydroxy-3-methoxyphenyl)acrylic acid, 4-HYDROXY-3-METHOXY-D3-CINNAMIC ACID, FERULIC ACID (USP-RS), FERULIC ACID [USP-RS], CINNAMIC ACID,4-HYDROXY,3-METHOXY FERULIC ACID, caffeic acid 3-methyl ether, ferulic acid, (E)-isomer, SMR000112202, 3-(4-hydroxy-3-methoxyphenyl)prop-2-enoic acid, DTXSID5040673, ferulasaure, Ferulicacid, trans-Ferulate, (E)-3-(4-Hydroxy-3-methoxyphenyl)-2-propenoate, CCRIS 7575, trans-FerulicAcid, Ferulic acid, E-, (E)-Coniferic acid, trans-4-Hydroxy-3-methoxycinnamicacid, Ferulic acid (M5), Ferulic Acid ,(S), FERULIC-ACID, Spectrum5_000554, bmse000459, bmse000587, bmse010211, FERULIC ACID [MI], trans-Ferulic acid, 99%, FERULIC ACID [HSDB], FERULIC ACID [INCI], SCHEMBL15673, BSPBio_003168, MLS001066385, MLS001332483, MLS001332484, MLS002207079, MLS006011435, SPECTRUM1501017, trans-Ferulic acid, >=99%, FERULIC ACID [WHO-DD], DTXCID3020673, DTXSID70892035, HMS1921D05, HMS2269P04, (E)-4-Hydroxy-3-methoxycinnamate, trans-4-Hydroxy-3-methoxycinnamate, BCP21231, BCP21789, HY-N0060, NSC51986, STR00961, (E)-4-hydroxy-3-methoxy-Cinnamate, TRANS-FERULIC ACID [WHO-DD], (E)4-hydroxy-3-methoxycinnamic acid, AC7905, BDBM50214744, CCG-38860, s2300, AKOS000263735, AC-7965, BCP9000163, DB07767, PS-3435, SDCCGMLS-0066667.P001, trans-3-methoxy-4-hydroxycinnamic acid, (E)-4-hydroxy-3-methoxy-Cinnamic acid, 3-(4-Hydroxy-3-methoxyphenyl)propenoate, 4-Hydroxy-3-methoxycinnamic acid, trans, NCGC00094889-01, NCGC00094889-02, NCGC00094889-03, NCGC00094889-04, 1ST40035, AC-10321, BS-17543, SMR004703246, AM20060784, CS-0007108, F1257, H0267, NS00068201, SW219616-1, EN300-16798, C01494, F-2000, A829775, FERULIC ACID (CONSTITUENT OF BLACK COHOSH), Q417362, SR-01000765539, (2E)-3-(4-Hydroxy-3-methoxyphenyl)-2-propenoate, (E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoicacid, J-002980, SR-01000765539-3, Z56782558, (E)-3-(3-methoxy-4-oxidanyl-phenyl)prop-2-enoic acid, FERULIC ACID (CONSTITUENT OF BLACK COHOSH) [DSC], 055E203F-B305-4B7F-8CE7-F9C0C03AB609, 3986A1BE-A670-4B06-833B-E17253079FD8, Ferulic acid, European Pharmacopoeia (EP) Reference Standard, trans-Ferulic acid, certified reference material, TraceCERT(R), Diethyl2-(acetamido)-2-(2-(bromomethyl)-5-nitrobenzyl)malonate, Ferulic acid, United States Pharmacopeia (USP) Reference Standard, trans-Ferulic acid, matrix substance for MALDI-MS, >=99.0% (HPLC), Ferulic Acid, Pharmaceutical Secondary Standard; Certified Reference Material, InChI=1/C10H10O4/c1-14-9-6-7(2-4-8(9)11)3-5-10(12)13/h2-6,11H,1H3,(H,12,13" C10H10O4 KSEBMYQBYZTDHS-HWKANZROSA-N (E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoic acid n.a. n.a. No No No No Yes No rxn03971,rxn24563,rxnDiet126,rxnAdd161,rxnAdd162,rxnAdd163 PMDBD2001774 1,4-Naphthoquinone Dietary Substance, Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D0DQ6Z 8530 n.a. NPC215008 1,4-NAPHTHOQUINONE, 130-15-4, naphthalene-1,4-dione, 1,4-Naphthalenedione, p-Naphthoquinone, NAPHTHOQUINONE, alpha-Naphthoquinone, a-naphthoquinone, 1,4-Naphthylquinone, 1,4-Dihydro-1,4-diketonaphthalene, 1,4-Naphthaquinone, USAF CY-10, 1,4-Naftochinon, RCRA waste number U166, 1,4-dihydronaphthalene-1,4-dione, .alpha.-Naphthoquinone, NSC 9583, RBF5ZU7R7K, CHEMBL55934, NQ-1, DTXSID5040704, CHEBI:27418, NSC9583, NSC-9583, MFCD00001676, 1,4-Naftochinon [Czech], 1,4 naphthoquinone, CCRIS 5424, 1,4-naphtho-quinone, HSDB 2037, Naphthoquinone, 1,4-, EINECS 204-977-6, UNII-RBF5ZU7R7K, RCRA waste no. U166, napthoquinone, AI3-24292, naphthalene-1, Naphthoquinone #, Naphthoquinone 1, 1,4naphtaquinone, para-naphthoquinone, 1,4-naphtoquinone, 1,4-diketonaphthalene, 1,4-naphthalene-dione, Dithianon metabolite NQ, Spectrum2_000481, Spectrum3_000754, Spectrum4_001245, 1,4-naphtho-quinone, 3, WLN: L66 BV EVJ, SCHEMBL42139, 1,4-Naphthoquinone, 97%, BSPBio_002368, KBioGR_001770, MLS000069814, SPBio_000341, DTXCID3020704, BDBM24776, KBio3_001588, 1,4-NAPHTHOQUINONE [MI], 1,4-NAPHTHOQUINONE [HSDB], Tox21_303967, CCG-39519, s9342, AKOS004907201, AKOS025243281, CS-W016206, FS-2704, HY-W015490, NCGC00164067-01, NCGC00164067-02, NCGC00357275-01, AC-34538, CAS-130-15-4, SMR000059173, N0040, NS00014590, EN300-21246, C02617, D70977, 1,4-Naphthoquinone, purum, >=96.5% (HPLC), Q161542, Q-200085, Z104494806, 1,4-Naphthoquinone, 97% (dry wt.), cont. up to 5% water, InChI=1/C10H6O2/c11-9-5-6-10(12)8-4-2-1-3-7(8)9/h1-6 C10H6O2 FRASJONUBLZVQX-UHFFFAOYSA-N naphthalene-1,4-dione n.a. n.a. No No No No Yes No rxn25369,rxnDiet64 PMDBD2001775 4-Vinylguaiacol Dietary Substance n.a. 7786-61-0 DB03514 n.a. n.a. n.a. 332 325 NPC246358 2-Methoxy-4-vinylphenol, 7786-61-0, 4-vinylguaiacol, p-Vinylguaiacol, 4-ETHENYL-2-METHOXYPHENOL, 4-Hydroxy-3-methoxystyrene, Phenol, 4-ethenyl-2-methoxy-, o-methoxy-p-vinylphenol, para-vinylguaiacol, Guaiacol, 4-vinyl-, p-Vinyl guaiacol, 4-vinyl-2-methoxyphenol, Phenol, 2-methoxy-4-vinyl-, 4-Hydroxy-3-methoxyvinylbenzene, FEMA No. 2675, 2-METHOXY-4-VINYL-PHENOL, 3-Methoxy-4-hydroxystyrene, Varamol 106, CCRIS 548, CHEBI:42438, Vinylcatechol-O-methyl ether, P-, UNII-DA069CTH0O, EINECS 232-101-2, 2M4VP, DA069CTH0O, Guaiacol, 4-vinyl, BRN 2044521, 4-hydroxy-3-methoxyphenylethene, DTXSID7052529, 2-(4-hydroxy-3-methoxyphenyl)ethene, 2-Methoxy-4-ethenylphenol, Phenol, 2-methoxy-4-ethenyl, Phenol, 4-vinyl, 2-methoxy, CHEMBL1232595, DTXCID8031102, (4-Hydroxy-3-methoxyphenyl)ethene, 3-06-00-04981 (Beilstein Handbook Reference), 4-vinyl guaiacol, EUG, Vinyl guaiacol, p-Vinyl guaicol, 4-vinylguaiacole, 4-Ethenylguaiacol, 4-Vinyl-O-guaiacol, 2-Methoxy-vinylphenol, 31853-85-7, 2-Metoxy-4-vinyl-phenol, bmse010071, 4-ethenyl-2-methoxy-phenol, SCHEMBL54199, 2-?Methoxy-?4-?vinylphenol, BCP27800, Tox21_304024, BDBM50548720, MFCD00015437, AKOS015890494, DB03514, FS-3782, HY-W019940, 2-methoxy-4-vinylphenol (vinylguaiacol), 2-METHOXY-4-VINYLPHENOL [FHFI], 2-Methoxy-4-vinylphenol, >=98%, FG, NCGC00357234-01, Vinylguaiacol (4-vinyl-2-methoxyphenol), BP-11167, PD006849, CAS-7786-61-0, 2-Methoxy-4-vinylphenol (4-vinylguaiacol), 4-Vinyl-2-methoxyphenol (4-vinylguaiacol), 2-Methoxy-4-vinylphenol, analytical standard, 4-Vinyl-2-methoxyphenol ( p-vinylguaiacol), AM20041169, CS-0031749, NS00005168, C17883, EN300-1832370, A839253, Q4596898, W-104295, 2-METHOXY-4-VINYLPHENOL (STABILIZED WITH TBC), 4M4 C9H10O2 YOMSJEATGXXYPX-UHFFFAOYSA-N 4-ethenyl-2-methoxyphenol n.a. n.a. No No No No Yes No rxn24563,rxn25875,rxnDiet71,rxnAdd229 PMDBD2001776 4-Vinylphenol Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 62453 n.a. NPC265146 4-Vinylphenol, 4-Hydroxystyrene, 2628-17-3, 4-ETHENYLPHENOL, p-Vinylphenol, Phenol, 4-ethenyl-, p-Hydroxystyrene, 4-Vinylphenol, 10 wt.% In propylene glycol, Phenol, P-vinyl-, FEMA No. 3739, MFCD00017593, OA7V1SM8YL, CHEBI:1883, CHEMBL349881, 4-vinyl phenol, EINECS 220-103-6, UNII-OA7V1SM8YL, BRN 0506844, paravinyl phenol, 4-VP, p-vinyl phenol, Para-vinylphenol, 4-Ethenyl-phenol, 4-Vinyl-Phenol, 4-Hydroxy styrene, VINYLPHENOL, P-, SCHEMBL59328, P-VINYLPHENOL [FHFI], 4-06-00-03775 (Beilstein Handbook Reference), DTXSID7073301, SCHEMBL13341430, AMY18684, BDBM50017833, NSC114470, AKOS015891246, CS-W005288, DS-6347, HY-W005288, NSC-114470, SY062083, 4-Vinylphenol 10 wt.% In propylene glycol, NS00005416, C05627, EN300-252561, Q4637201, W-107182 C8H8O FUGYGGDSWSUORM-UHFFFAOYSA-N 4-ethenylphenol n.a. n.a. No No No No Yes No rxn02118,rxn25876,rxnDiet72 PMDBD2001777 Stearidonic acid Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 5312508 n.a. NPC149821 Stearidonic acid, 20290-75-9, Moroctic acid, (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoic acid, (6Z,9Z,12Z,15Z)-Octadecatetraenoic acid, 6,9,12,15-Octadecatetraenoic acid, (6Z,9Z,12Z,15Z)-, 6,9,12,15-Octadecatetraenoic acid, 6Z,9Z,12Z,15Z-octadecatetraenoic acid, P4CEK3495O, CHEBI:32389, FA 18:4, 111174-40-4, C18:4n-3,6,9,12, all-cis-octadeca-6,9,12,15-tetraenoic acid, UNII-P4CEK3495O, Morotic acid, 6cis Stearidonic acid, stearidonic acid C18:4, all-cis-6,9,12,15-Octadecatetraenoic acid, Stearidonic acid, >=99%, SCHEMBL29226, STEARIDONIC ACID [MI], CHEMBL484430, 6,9,12,15-octadecatetraenoate, DTXSID20920493, STEARIDONIC ACID [WHO-DD], HMS3649J17, LMFA01030357, MOROCTIC ACID (C18:4 N3), AKOS040735398, NCGC00344331-01, AS-80602, NS00010575, 6Z, 9Z, 12Z, 15Z- octadecatetraenoic acid, FA(18:4(6Z,9Z,12Z,15Z)), SR-01000946667, .DELTA.6,9,12,15-OCTADECATETRAENOIC ACID, 6(Z),9(Z),12(Z),15(Z)-Octadecatetraenoic acid, Q2739877, SR-01000946667-1, (6Z, 9Z, 12Z, 15Z)-octadeca-6, 9, 12, 15-tetraenoic acid C18H28O2 JIWBIWFOSCKQMA-LTKCOYKYSA-N (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoic acid n.a. n.a. No No No No Yes No rxn33921,rxnDiet9 PMDBD2001778 Pentadecylic acid Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 13849 n.a. NPC154186 "PENTADECANOIC ACID, 1002-84-2, Pentadecylic acid, n-Pentadecanoic acid, Pentadecyclic acid, n-Pentadecylic acid, NSC 28486, C15:0, MFCD00002745, Pentadecanoic acid, 99%, 2,2-DIDEUTEROPENTADECANOIC ACID, CCW02D961F, CHEMBL460025, DTXSID2021652, CHEBI:42504, 64118-45-2, NSC-28486, F15, EINECS 213-693-1, BRN 1773831, UNII-CCW02D961F, Pentadecyclate, n-Pentadecylate, AI3-36441, n-Pentadecanoate, pentadecanoic''acid, n-Pentadecanoicacid, pentadecansäure, tetradecylcarboxylic acid, tetradecyl carboxylic acid, bmse000558, SCHEMBL6311, Pentadecanoic acid, >=99%, 4-02-00-01147 (Beilstein Handbook Reference), WLN: QV14, DTXCID601652, FA 15:0a, FEMA NO. 4334, AMY5935, PENTADECANOIC ACID [FHFI], NSC28486, Tox21_201197, BDBM50242348, LMFA01010015, s6234, AKOS015903762, CS-W004283, FA 15:0, HY-W004283, Pentadecanoic acid, analytical standard, NCGC00248954-01, NCGC00258749-01, AS-57005, BP-27916, SY009985, CAS-1002-84-2, Pentadecanoic acid, ~99% (capillary GC), NS00015703, P0035, EN300-176407, H10804, Pentadecanoic acid; n-Caprylic Acid Sodium Salt, 9B1C70C0-EF6E-4FCF-A3D3-DACCDCCF791C, A897509, Q418951, J-000083" C15H30O2 WQEPLUUGTLDZJY-UHFFFAOYSA-N pentadecanoic acid n.a. n.a. No No No No Yes No rxn36510,rxnDiet3 PMDBD2001779 beta-Tocopherol Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 6857447 n.a. NPC128410 BETA-TOCOPHEROL, 16698-35-4, 148-03-8, d-beta-Tocopherol, 5,8-Dimethyltocol, Cumotocopherol, Neotocopherol, beta Tocopherol, p-Xylotocopherol, (R)-2,5,8-Trimethyl-2-((4R,8R)-4,8,12-trimethyltridecyl)chroman-6-ol, .beta.-Tocopherol, 2H-1-Benzopyran-6-ol, 3,4-dihydro-2,5,8-trimethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-, (2R)-, (2R)-2,5,8-trimethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-ol, 8K9365K9PX, 9U6A490501, beta-D-Tocopherol, [2R[2R*(4R*,8R*)]]-3,4-dihydro-2,5,8-trimethyl-2-(4,8,12-trimethyltridecyl)-2H-benzopyran-6-ol, 2H-1-Benzopyran-6-ol, 3,4-dihydro-2,5,8-trimethyl-2-((4R,8R)-4,8,12-trimethyltridecyl)-, (2R)-, 2H-1-Benzopyran-6-ol, 3,4-dihydro-2,5,8-trimethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-, (2R)-rel-, DL-beta-Tocopherol, rel-(R)-2,5,8-Trimethyl-2-((4R,8R)-4,8,12-trimethyltridecyl)chroman-6-ol, (2R)-2,5,8-trimethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydro-2H-1-benzopyran-6-ol, (2R)-3,4-dihydro-2,5,8-trimethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-2H-1-benzopyran-6-ol, 2H-1-Benzopyran-6-ol, 3,4-dihydro-2,5,8-trimethyl-2-((4R,8R)-4,8,12-trimethyltridecyl)-, (2R)-rel-, UNII-8K9365K9PX, (2R)-2,5,8-trimethyl-2-(4,8,12-trimethyltridecyl)chroman-6-ol, beta -Tocopherol, -Tocopherol-d3, Tocopherol, beta-, UNII-9U6A490501, (2R(2R*(4R*,8R*)))-3,4-Dihydro-2,5,8-trimethyl-2-(4,8,12-trimethyltridecyl)-2H-benzopyran-6-ol, (2R)-3,4-DIHYDRO-2,5,8-TRIMETHYL-2-((4R,8R)-4,8,12-TRIMETHYLTRIDECYL)-2H-1-BENZOPYRAN-6-OL, 48223-98-9, EINECS 205-708-5, EINECS 240-747-1, (+/-)-beta-Tocopherol, DL-BETA TOCOPHEROL, (R,R,R)-beta-Tocopherol, D-.BETA.-TOCOPHEROL, BIDD:PXR0140, SCHEMBL39202, DL-.BETA.-TOCOPHEROL, 6-Chromanol, 2,5,8-trimethyl-2-(4,8,12-trimethyltridecyl)-, RRR-.BETA.-TOCOPHEROL, rac- beta -Tocopherol solution, b-Tocopherol (Racemic Mixture), .BETA.-TOCOPHEROL [MI], .BETA.-TOCOPHEROL, DL-, CHEBI:47771, BETA TOCOPHEROL [WHO-DD], DTXSID10873424, DTXSID30884931, 2H-1-Benzopyran-6-ol, 3,4-dihydro-2,5,8-trimethyl-2-(4,8,12-trimethyltridecyl)-, (+)-2,5,8-trimethyl-2-(4,8,12-trimethyltridecyl)-6-chromanol, VITAMIN E (BETA TOCOTRIENOL), AKOS022171754, 3,4-Dihydro-2,5,8-trimethyl-2-(4,8,12-trimethyltridecyl)-2H-benzopyran-6-ol, AS-74577, HY-133680, J236.825K, CS-0128997, NS00076596, J1.282.204I, J1.604.281A, E76237, Q155667, J-010328, RRR-.ALPHA.-TOCOPHEROL IMPURITY B [EP IMPURITY], FA7BA838-41F9-4B85-947D-F3A920942587, (2R)-2,5,8-trimethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydro-2H-chromen-6-ol, ?[2R[2R*(4R*,8R*)]]-3,4-dihydro-2,5,8-trimethyl-2-(4,8,12-trimethyltridecyl)-2H-benzopyran-6-ol, 2H-1-BENZOPYRAN-6-OL, 3,4-DIHYDRO-2,5,8-TRIMETHYL-2-(4,8,12-TRIMETHYLTRIDECYL)-, (2R*(4R*,8R*))- 6-CHROMANOL, 2,5,8-TRIMETHYL-2-(4,8,12-TRIMETHYLTRIDECYL)-, RAC-(2R*)-3,4-DIHYDRO-2,5,8-TRIMETHYL-2-((4R*,8R*)-4,8,12-TRIMETHYLTRIDECYL)-2H-1-BENZOPYRAN-6-OL, REL-(2R*)-2,5,8-TRIMETHYL-2-((4R*,8R*)-4,8,12-TRIMETHYLTRIDECYL)-3,4-DIHYDRO-2H-1-BENZOPYRAN-6-OL C28H48O2 WGVKWNUPNGFDFJ-DQCZWYHMSA-N (2R)-2,5,8-trimethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-ol n.a. n.a. No No No No Yes No rxn36787,rxn38869,rxnDiet29 PMDBD2001780 delta-Tocopherol Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 92094 n.a. NPC187993 "delta-Tocopherol, 119-13-1, (+)-delta-Tocopherol, D-delta-TOCOPHEROL, 8-Methyltocol, .delta.-Tocopherol, JU84X1II0N, DTXSID1046263, CHEBI:47772, (2R)-2,8-dimethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydro-2H-chromen-6-ol, (2R)-3,4-dihydro-2,8-dimethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-2H-1-benzopyran-6-ol, NCGC00160622-01, E309, DTXCID9026263, delta-Vitamin E, delta-D-Tocopherol, (2R(2R*(4R*,8R*)))-3,4-Dihydro-2,8-dimethyl-2-(4,8,12-trimethyltridecyl)-2H-benzopyran-6-ol, [2R[2R*(4R*,8R*)]]-3,4-dihydro-2,8-dimethyl-2-(4,8,12-trimethyltridecyl)-2H-benzopyran-6-ol, 251562-63-7, 2H-1-Benzopyran-6-ol, 3,4-dihydro-2,8-dimethyl-2-((4R,8R)-4,8,12-trimethyltridecyl)-, (2R)-, 2H-1-Benzopyran-6-ol, 3,4-dihydro-2,8-dimethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-, (2R)-, CAS-119-13-1, Rel-(2R)-3,4-Dihydro-2,8-dimethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-2H-1-benzopyran-6-ol, UNII-JU84X1II0N, (R,R,R)-delta-Tocopherol, Vitamine E, (2R)-3,4-DIHYDRO-2,8-DIMETHYL-2-((4R,8R)-4,8,12-TRIMETHYLTRIDECYL)-2H-1-BENZOPYRAN-6-OL, (2R,4''R,8''R)-delta-Tocopherol, EINECS 204-299-0, .delta.-Vitamin E, ()-delta-Tocopherol, (+)-|A-Tocopherol, (+)- delta -Tocopherol, bmse000547, ?-Tocopherol (>90%), delta-Tocopherol (>90%), DELTA-TOCOPHEROL, D-, SCHEMBL886921, RRR-.DELTA.-TOCOPHEROL, CHEMBL1451395, .DELTA.-TOCOPHEROL [MI], DELTA-TOCOPHEROL [WHO-DD], (+)-delta-Tocopherol, >=90%, AMY25540, Tox21_111941, delta-Tocopherol, analytical standard, LMPR02020066, s6348, AKOS040758846, Tox21_111941_1, |A-Tocopherol (>90%);8-Methyltocol, J5.309K, NCGC00160622-02, NCGC00160622-03, NCGC00160622-04, HY-113026, CS-0059380, NS00015095, E80733, Q155751, J-004070, D94B2EA5-AEC1-47F2-94D1-A1F978E6C436, RRR-.ALPHA.-TOCOPHEROL IMPURITY A [EP IMPURITY], (R)-2,8-Dimethyl-2-((4R,8R)-4,8,12-trimethyltridecyl)chroman-6-ol" C27H46O2 GZIFEOYASATJEH-VHFRWLAGSA-N (2R)-2,8-dimethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-ol n.a. n.a. No No No No Yes No rxn36844,rxn38872,rxnDiet30 PMDBD2001781 gamma-Tocopherol Dietary Substance n.a. 54-28-4 DB15394 n.a. n.a. n.a. 92729 83708 NPC48623 "gamma-Tocopherol, 54-28-4, D-gamma-Tocopherol, (+)-gamma-Tocopherol, 7,8-Dimethyltocol, o-Xylotocopherol, Gamma tocopherol, (R,R,R)-gamma-Tocopherol, .gamma.-Tocopherol, Rrr-.gamma.-tocopherol, (r,r,r)-.gamma.-tocopherol, DTXSID9049031, CHEBI:18185, 8EF1Z1238F, (2R)-2,7,8-trimethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-ol, NCGC00185764-01, J213.540J, (R)-2,7,8-trimethyl-2-((4R,8R)-4,8,12-trimethyltridecyl)chroman-6-ol, (2R)-2,7,8-trimethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydro-2H-chromen-6-ol, (2R)-3,4-dihydro-2,7,8-trimethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-2H-1-benzopyran-6-ol, Methyltocols, -Tocopherol, 2H-1-Benzopyran-6-ol, 3,4-dihydro-2,7,8-trimethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-, (2R)-, gamma-Tocopherol, d-, Vitamin E succinate (calcium), 7,8-Dimethyltocolo-xylotocopherol, UNII-8EF1Z1238F, tocopherol gamma, Vitamin E gamma, gamma -Tocopherol, ??-Tocopherol, 3,4-Dihydro-2,7,8-trimethyl-2-(4,8,12-trimethyltridecyl)-2H-1-benzopyran-6-ol, (2R)-3,4-DIHYDRO-2,7,8-TRIMETHYL-2-((4R,8R)-4,8,12-TRIMETHYLTRIDECYL)-2H-1-BENZOPYRAN-6-OL, 2H-1-Benzopyran-6-ol, 3,4-dihydro-2,7,8-trimethyl-2-((4R,8R)-4,8,12-trimethyltridecyl)-, (2R)-, EINECS 200-201-5, (+)-y-Tocopherol, MFCD00066529, (+)-.gamma.-Tocopherol, SCHEMBL120346, CHEMBL2151591, DTXCID0028957, D--Tocopherol;(+)--Tocopherol, .GAMMA.-TOCOPHEROL [MI], GAMMA-TOCOPHEROL [WHO-DD], (+)-2,7,8-trimethyl-2-(4,8,12-trimethyltridecyl)-6-chromanol, HY-N7148, Tox21_113559, LMPR02020065, AKOS040759356, DB15394, CAS-54-28-4, NCGC00185764-03, BS-48945, (+)-gamma-Tocopherol, >=96% (HPLC), (+)-gamma-Tocopherol, analytical standard, CS-0103047, NS00074161, C02483, F75916, Q155753, RRR-.ALPHA.-TOCOPHEROL IMPURITY C [EP IMPURITY], 2,7,8-Trimethyl-2-(4,8,12-trimethyltridecyl)-6-chromanol, DL-alpha-Tocopherol succinate calcium;-Tocopherol succinate calcium, (2R(2R*(4R*,8R*)))-3,4-Dihydro-2,7,8-trimethyl-2-(4,8,12-trimethyltridecyl)-2H-benzopyran-6-ol, 2H-1-Benzopyran-6-ol,3,4-dihydro-2,7,8-trimethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-, (2R)-" C28H48O2 QUEDXNHFTDJVIY-DQCZWYHMSA-N (2R)-2,7,8-trimethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-ol n.a. n.a. No No No No Yes No rxn05004,rxn36846,rxn38873,rxnDiet31 PMDBD2001782 Taxifolin Dietary Substance n.a. 480-18-2 DB02224 n.a. n.a. n.a. 439533 388626 NPC246162 "TAXIFOLIN, (+)-Taxifolin, dihydroquercetin, 480-18-2, Distylin, Taxifoliol, (+)-Dihydroquercetin, 24198-97-8, (2R,3R)-Dihydroquercetin, Lavitol, (+/-)-Taxifolin, Diquertin, Lariksin, 2,3-Dihydroquercetin, Flamena D, TAXIFOLIN-(+), 17654-26-1, (2R,3R)-3,3'',4'',5,7-Pentahydroxyflavanone, trans-Dihydroquercetin, (2R,3R)-(+)-Taxifolin, 3,5,7,3'',4''-Pentahydroxyflavanone, (2R,3R)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxychroman-4-one, (+/-)-dihydroquercetin, 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-2,3-dihydro-3,5,7-trihydroxy-, (2R,3R)-, taxifolin (dihydroquercetin), (2R,3R)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-2,3-dihydrochromen-4-one, UNII-9SOB9E3987, FLAMENA, CCRIS 9292, (2R,3R)-2-(3,4-DIHYDROXYPHENYL)-3,5,7-TRIHYDROXY-2,3-DIHYDRO-4H-CHROMEN-4-ONE, (+)-trans Taxifolin, CHEBI:17948, Flavanone, 3,3'',4'',5,7-pentahydroxy-, (+)-(2R,3R)-dihydroquercetin, 9SOB9E3987, (2R-trans)-2-(3,4-Dihydroxyphenyl)-2,3-dihydro-3,5,7-trihydroxy-4-benzopyrone, Taxifolin, (+/-)-, (+/-)-trans Taxifolin, EINECS 207-543-4, EAS93SC1VS, (+/-)-Taxifolin hydrate, 3,3'',4'',5,7-Pentahydroxyflavanone, BRN 0093548, Dihydroquercetin, (+/-)-, DTXSID8022450, 5-18-05-00451 (Beilstein Handbook Reference), 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-2,3-dihydro-3,5,7-trihydroxy-, Flavone, 2,3-dihydro-3,3'',4'',5,7-pentahydroxy-, MFCD00006845, DIHYDROQUERCETIN, (+)-(2R,3R)-, trans dihydroquercetin, (2R,3R)-2-(3,4-dihydroxyphenyl)-2,3-dihydro-3,5,7-trihydroxy-4H-1-benzopyran-4-one, 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-2,3-dihydro-3,5,7-trihydroxy-, (2R-trans)-, (?)-Taxifolin, (2R,3R)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-chroman-4-one, rel-(2R,3R)-2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxychroman-4-one, 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-2,3-dihydro-3,5,7-trihydroxy-, trans-(+/-)-, DQH, SMR000466389, (+)-trans-Taxifolin, Dihydroquercetin hydrate, a cis or trans dihydroquercetin, (+)-Dihydroquercetin; (+)-Taxifolin, Taxifolin (Tax), ()-Taxifolin, (2R,3R)-TRANS-DIHYDROQUERCETIN, (+)-3,3'',4'',5,7-Pentahydroxyflavanone, UNII-EAS93SC1VS, SCHEMBL39786, MLS000759539, MLS001066341, MLS001074712, MLS001424044, MLS002153142, BIDD:ER0483, Taxifolin, analytical standard, DIHYDROQUERCETIN [INCI], DTXCID502450, MEGxp0_000741, ACon1_000239, DIHYDROQUERCETIN [WHO-DD], rel-(2R,3R)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-2,3-dihydro-4H-chromen-4-one, BDBM212435, DTXSID301017215, HMS2051M22, HMS2234L14, HY-N0136, AC-935, MFCD11044454, s2366, AKOS015965399, CCG-100909, CS-3365, DB02224, KS-1312, NC00159, NCGC00016024-08, NCGC00180750-01, 20254-28-8, AS-17723, 3,3'',4'',5,7-Pentahydroxyflavanone hydrate, NS00015857, SW197539-2, T3666, C01617, G12170, (2R,3R)-3,5,7,3'',4''-Pentahydroxyflavanone, Q412191, SR-01000759385, (+)-TAXIFOLIN (CONSTITUENT OF MILK THISTLE), Flavanone, 3,3'',4'',5,7-pentahydroxy-, (R,R)-, J-011205, SR-01000759385-6, Taxifolin, primary pharmaceutical reference standard, (+)-TAXIFOLIN (CONSTITUENT OF MARITIME PINE), F40AB773-26FA-4112-A46D-DC970AF64BC1, Flavanone, 3,3'',4'',5,7-pentahydroxy-, (2R)-trans-, Flavanone, 3,3'',4'',5,7-pentahydroxy-, trans-(+)-, (+)-TAXIFOLIN (CONSTITUENT OF MARITIME PINE) [DSC], (+)-TAXIFOLIN (CONSTITUENT OF MILK THISTLE) [DSC], Flavanone, 3,3'',4'',5,7-pentahydroxy-, (2R,3R)-(+)-, 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-2,3-dihydro-4H-chromen-4-one, (2R-trans)-, 4H-1-Benzopyran-4-one,2-(3,4-dihydroxyphenyl)-2,3-dihydro-3,5,7-trihydroxy-,(2R,3R)-rel-" C15H12O7 CXQWRCVTCMQVQX-LSDHHAIUSA-N (2R,3R)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-2,3-dihydrochromen-4-one n.a. n.a. No No No No Yes No rxn38395,rxnDiet118,rxnAdd59,rxnAdd60,rxnAdd61,rxnAdd62,rxnAdd64 PMDBD2001783 Linoleate Dietary Substance, Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D03LOG 5280450 n.a. NPC85813 "linoleic acid, 60-33-3, Linolic acid, (9Z,12Z)-octadeca-9,12-dienoic acid, Telfairic acid, cis,cis-Linoleic acid, Linoleate, 9,12-Linoleic acid, Emersol 315, cis,cis-9,12-Octadecadienoic acid, Unifac 6550, 9Z,12Z-Linoleic acid, cis-9,cis-12-Octadecadienoic acid, Emersol 310, (Z,Z)-9,12-Octadecadienoic acid, Extra Linoleic 90, 9Z,12Z-octadecadienoic acid, 9-cis,12-cis-Linoleic acid, all-cis-9,12-Octadecadienoic acid, acide linoleique, Linoleic, acido linoleico, Leinoleic acid, 9,12-Octadecadienoic acid (9Z,12Z)-, 9-cis,12-cis-Octadecadienoic acid, alpha-Linoleic acid, Ronacare asc 3, (9Z,12Z)-Octadecadienoic acid, acide cis-linoleique, Linoleic acid, pure, CCRIS 650, 9,12-Octadecadienoic acid (Z,Z)-, 9,12-Octadecadienoic acid, CHEBI:17351, HSDB 5200, UNII-9KJL21T0QJ, cis-delta9,12-Octadecadienoic acid, EINECS 200-470-9, 9KJL21T0QJ, cis-Delta(9,12)-octadecadienoic acid, 9,12-Octadecadienoic acid, (Z,Z)-, NSC 281243, NSC-281243, 8024-22-4, DTXSID2025505, AI3-11132, cis-9, cis-12-octadecadienoic acid, C18:2 (n-6), FEMA NO. 3380, LINOLEIC ACID-, CHEMBL267476, DTXCID505505, 9-cis,12-cis-Octadecadienoate, 8016-21-5, delta9,12-Octadecadienoic acid, C18:2, C18:2, n-6,9 all-cis, MFCD00064241, NSC281243, cis,cis-linoleate, NCGC00091049-04, VITAMIN F COMPONENT LINOLEIC ACID, VESPULA PENSYLVANICA B708568K063, LINOLEIC ACID (MART.), LINOLEIC ACID [MART.], C18:2 9c, 12c omega6 todos cis-9,12-octadienoico, CAS-60-33-3, 14C-Linoleic acid, (9Z,12Z)-9,12-octadecadienoic acid, (14C)-Linoleic acid, octadeca-9,12-dienoic acid, SR-01000944790, (14C)alpha-Linolenic acid, 9,12 Octadecadienoic Acid, acidelinoleique, 7552P0K6PN, Linolate, Acid, 9,12-Octadecadienoic, linoleic-acid, Leinolic acid, trans-9,trans-12-Octadecadienoic acid, 85594-37-2, 9Z,12Z-Linoleate, 80969-37-5, n-6,9 all-cis, Linoleic acid, 95%, 9Z,12Z-Octadecadienoate, 9-cis,12-cis-Linoleate, Linoleic acid, >=95%, Linoleic acid, >=99%, bmse000497, bmse000604, Epitope ID:117705, POLYLIN NO 515, LINOLEIC ACID [MI], SCHEMBL7067, (9Z,12Z)-9,12-Octadecadienoic-1-13C Acid, Fatty Acid 18:2 n-6, POLYIN NO.515, cis,12-Octadecadienoic acid, LINOLEIC ACID [FCC], Pamolyn 125 (Salt/Mix), cis-D9,12-Octadecadienoate, BSPBio_001374, LINOLEIC ACID [HSDB], LINOLEIC ACID [INCI], CCRIS 652, LINOLEIC ACID [VANDF], UNII-7552P0K6PN, all-cis-9,12-Octadecadienoate, BML3-C03, cis-9,cis-12-Octadecadienoate, GTPL1052, Linoleic acid, >=95%, FG, Linoleic acid, puriss., 90%, LINOLEIC ACID [WHO-DD], (Z,Z)-9,12-Octadecadienoate, ACon1_000270, BDBM22231, cis-D9,12-Octadecadienoic acid, Linoleic acid, >=93% (GC), CHEBI:137735, 9,12-Octadecadienoic acid, (Z,Z)-, labeled with carbon-14, HMS1361E16, HMS1791E16, HMS1989E16, HMS3402E16, HMS3649F07, HMS3886F05, Linoleic acid, analytical standard, 9,12-Octadecadienoic acid (VAN), cis,cis,9,12-Octadecadienoic acid, HY-N0729, 9,12-Octadecadienoic acid, (Z)-, Tox21_111067, Tox21_202171, Tox21_303080, (9Z,12Z)-9,12-Octadecadienoate, C18:2 9c, cis,cis-octadeca-9,12-dienoic acid, cis-9,cis-12-Octadecadienoic acid,, LMFA01030120, s5821, (Z,Z)-Octadeca-9, 12-dienoic acid, 9,12-Octadecadienoic acid, (E,E)-, 9,12-Octadecadienoic acid, cis,cis-, AKOS015951293, Cis, cis-octadeca-9,12-dienoic acid, DB14104, (Z)-9,12-OCTADECADIENOIC ACID, 9-(Z), 12-(Z)-Octadecadienoic acid, cis-.DELTA.9,12-Octadecadienoic acid, IDI1_033844, NCGC00091049-01, NCGC00091049-02, NCGC00091049-03, NCGC00091049-05, NCGC00091049-06, NCGC00091049-07, NCGC00257024-01, NCGC00259720-01, 12c omega6 todos cis-9,12-octadienoico, AC-33770, AS-12672, BP-31121, FA(18:2(9Z,12Z)), Linoleic acid, technical, 60-74% (GC), Octadeca-9,12-dienoic acid, (cis,cis)-, AI3-36448, 9,Z)-, CS-0009742, L0053, L0124, NS00010521, C01595, EN300-383983, LINOLEIC ACID (CONSTITUENT OF SPIRULINA), 9, (Z)-, A832696, Q407426, LINOLEIC ACID (CONSTITUENT OF FLAX SEED OIL), LINOLEIC ACID (CONSTITUENT OF SAW PALMETTO), SR-01000944790-1, SR-01000944790-3, BRD-K08973992-001-03-9, LINOLEIC ACID (CONSTITUENT OF BORAGE SEED OIL), LINOLEIC ACID (CONSTITUENT OF SPIRULINA) [DSC], 5CE5E1F3-8859-4C5B-9AFE-E44A7076DF6E, LINOLEIC ACID (C18:2) (CONSTITUENT OF KRILL OIL), LINOLEIC ACID (CONSTITUENT OF SAW PALMETTO) [DSC], Linoleic acid, liquid, BioReagent, suitable for cell culture, Linoleic acid, 2.0 mg/mL in ethanol, certified reference material, cis,cis-9,12-octadecadienoic acid; LINOLEATE; emersol315; Linoleic; unifac6550;, 30175-49-6, LIN" C18H32O2 OYHQOLUKZRVURQ-HZJYTTRNSA-N (9Z,12Z)-octadeca-9,12-dienoic acid n.a. n.a. No No No No Yes No rxn38975,rxnDiet7 PMDBD2001784 Linolenate Dietary Substance, Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D0C5SV 5280934 n.a. NPC294548 "linolenic acid, alpha-Linolenic acid, 463-40-1, linolenate, (9Z,12Z,15Z)-octadeca-9,12,15-trienoic acid, a-Linolenic acid, cis,cis,cis-9,12,15-Octadecatrienoic acid, all-cis-9,12,15-Octadecatrienoic acid, (Z,Z,Z)-9,12,15-Octadecatrienoic acid, 9-cis,12-cis,15-cis-Octadecatrienoic acid, alpha-Lnn, alpha-LA, (9,12,15)-linolenic acid, (9Z,12Z,15Z)-Octadecatrienoic acid, 9,12,15-Octadecatrienoic acid, (Z,Z,Z)-, alpha Linolenic Acid, Linolenic acid, crude, CCRIS 656, .alpha.-Linolenic acid, 9Z,12Z,15Z-Octadecatrienoic acid, Industrene 120, UNII-0RBV727H71, cis-delta9,12,15-Octadecatrienoic acid, DTXSID7025506, CHEBI:27432, Prifrac 2942, AI3-23986, cis-Delta(9,12,15)-octadecatrienoic acid, (Z,Z,Z)-Octadeca-9,12,15-trienoic acid, 0RBV727H71, 9,12,15-Octadecatrienoic acid, NSC 2042, NSC-2042, EINECS 207-334-8, 68424-45-3, FA 18:3, CHEMBL8739, 9,12,15-all-cis-Octadecatrienoic acid, DTXCID905506, cis-9,cis-12,cis-15-Octadecatrienoic acid, C18:3, NSC2042, cis-9,12,15-octadecatrienoic acid, 9,12,15-Octadecatrienoic acid, (9Z,12Z,15Z)-, MFCD00065720, LINOLENIC ACID (18:3 n-3), NCGC00091058-04, Linolenic acid 10 microg/mL in Methanol, FEMA NO. 3380, LINOLENIC ACID-, ALPHA-LINOLENIC ACID (C18:3 N3), C18:3 (N-3), cis-9, cis-12, cis-15-octadecatrienoic acid, VITAMIN F COMPONENT ALPHA LINOLENIC ACID, 18:3(N-3), LINOLENIC ACID (MART.), LINOLENIC ACID [MART.], Octadeca-9,12,15-trienoic acid, C18H30O2, 29857-63-4, CAS-463-40-1, SMR000857336, C18:3n-3,6,9, (9Z,12Z,15Z)-Octadecatrienoate, Linolenic acid (8CI), cis,cis,cis-9,12,15-octadecatrienoate, alpha-Linolenic acid; ALA; cis-alpha-Linolenic acid, Linolensaeure, a-Linolenate, cis,cis-9,12,15-Octadecatrienoic acid, (9Z,12Z,15Z)-9,12,15-Octadecatrienoic acid, LNL, alpha-linolenic-acid, Octadeca-9Z,12Z,15Z-trienoic acid, alpha -linolenic acid, Linolenic acid, >=99%, Linolenic acid, tech grade, alpha-Linolenic Acid tech., Linolenic Acid (~90%), LINOLENIC ACID [MI], (9Z,12Z,15Z)octadeca-9,12,15-trienoic acid, SCHEMBL15282, 806 - Fish oil supplement, 9,12,15-Octadecatrienoate, BSPBio_001376, MLS001336029, MLS001336030, MLS002454413, LINOLENIC ACID [INCI], LINOLENIC ACID [VANDF], BML3-B05, GTPL1049, Linolenic acid, ~70% (GC), LINOLENIC ACID [WHO-DD], CHEBI:25048, cid_5280934, cis-9,12,15-octadecatrienoate, LINOLENIC ACID AND ISOMERS, FA005, HMS1361E18, HMS1791E18, HMS1989E18, HMS2233C13, HMS3402E18, HMS3649H05, Linolenic acid, analytical standard, CMC_7371, HY-N0728, all-cis-9,15-Octadecatrienoic acid, Tox21_111071, Tox21_201727, Tox21_303322, all-cis-9,12,15-Octadecatrienoate, BDBM50240347, LMFA01030152, AKOS016008598, DB00132, (Z,Z,Z)-9,12,15-Octadecatrienoate, 9-cis,12-cis,15-cis-octadecatrienoate, Fatty Acid cis, cis, cis 18:3 n-3, IDI1_033846, NCGC00091058-01, NCGC00091058-02, NCGC00091058-05, NCGC00091058-06, NCGC00091058-07, NCGC00091058-08, NCGC00091058-09, NCGC00091058-10, NCGC00257192-01, NCGC00259276-01, (all-Z)-9,12,15-Octadecatrienoic acid, 9,15-Octadecatrienoic acid, (Z,Z,Z)-, AC-33768, AS-57338, 9(Z),12(Z),15(Z)-Octadecatrienoic acid, CS-0009741, L0050, cis,cis,cis-octadeca-9,12,15-trienoic acid, FA(18:3(9Z,12Z,15Z)), Octadecatrienoic acid, 9,12,15-(Z,Z,Z)-, C06427, Linolenic acid, Vetec(TM) reagent grade, 98%, EN300-6734316, CIS-DELTA-9,12,15-OCTADECATRIENOIC ACID, L000707, Q256502, SR-01000838327, LINOLENIC ACID (CONSTITUENT OF SAW PALMETTO), SR-01000838327-2, 2DCD0473-E5CC-47BB-A0A4-95899AFF6C4B, BRD-K33396764-001-02-0, 9,12,15-Octadecatrienoic acid, (9Z,12Z,15Z)- (9CI), alpha-LINOLENIC ACID (CONSTITUENT OF FLAX SEED OIL), LINOLENIC ACID (CONSTITUENT OF EVENING PRIMROSE OIL), LINOLENIC ACID (CONSTITUENT OF SAW PALMETTO) [DSC], alpha-LINOLENIC ACID (C18:3) (CONSTITUENT OF KRILL OIL), alpha-Linolenic acid, 1.0 mg/mL in ethanol, certified reference material" C18H30O2 DTOSIQBPPRVQHS-PDBXOOCHSA-N (9Z,12Z,15Z)-octadeca-9,12,15-trienoic acid n.a. n.a. No No No No Yes No rxn38976,rxnDiet8 PMDBD2001785 IdB 1027 Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 68247 n.a. NPC226331 "Cyanidin chloride, 528-58-5, Cyanidol chloride, Gastrotelos, 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxychromenylium chloride, Cyanidin (Chloride), Idb 1027, IdB-1027, 1-Benzopyrylium, 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-, chloride, 3,3'',4'',5,7-Pentahydroxyflavylium chloride, EINECS 208-438-6, 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-1-benzopyrylium chloride, NSC 407291, UNII-2G4283G96U, 3,3''4'',5,7-Pentahydroxyflavylium chloride, 3,3'',4'',5,7-Pentahydroxy-2-phenylbenzopyrylium chloride, 2G4283G96U, NSC-407291, 2-(3,4-dihydroxyphenyl)chromenylium-3,5,7-triol chloride, CHEMBL511367, Flavylium, 3,3''4'',5,7-pentahydroxy-, chloride, Cyanidol, MFCD00017582, NSC407291, 2-(3,4-dihydroxyphenyl)chromenylium-3,5,7-triol;chloride, Flavylium, 3,3'',4'',5,7-pentahydroxy-, chloride, CYANIDIN CHLORIDE (USP-RS), CYANIDIN CHLORIDE [USP-RS], CyanidinChloride, 1-benzopyrylium, 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-, chloride (1:1), 3,3'',4,5,7-Pentahydroxyflavylium chloride, Cyanidin-Chloride, Cyanidin hydrochloride, SCHEMBL156277, CYANIDIN CHLORIDE [MI], DTXSID80967263, BCP24007, HY-N0499, BDBM50462423, Cyanidin chloride, >=95% (HPLC), Cyanidin chloride, analytical standard, AKOS016010264, 3,4'',5,7-Pentahydroxyflavylium chloride, AC-34419, AS-71153, 1ST000592, CS-0009023, NS00080093, Flavylium,3'',4'',5,7-pentahydroxy-, chloride, Q-100600, 3,4'',5,7-Pentahydroxy-2-phenylbenzopyrylium chloride, Q27254696, 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxychromenyliumchloride, 1-Benzopyrylium,4-dihydroxyphenyl)-3,5,7-trihydroxy-, chloride, Cyanidin chloride, European Pharmacopoeia (EP) Reference Standard, 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-1??-chromen-1-ylium chloride, Cyanidin chloride, United States Pharmacopeia (USP) Reference Standard, 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-1$l^{4}-chromen-1-ylium chloride" C15H11ClO6 COAWNPJQKJEHPG-UHFFFAOYSA-N "2-(3,4-dihydroxyphenyl)chromenylium-3,5,7-triol;chloride" n.a. n.a. No No No No Yes No rxn04390,rxn07698,rxn40097,rxnDiet99,rxnAdd12 PMDBD2001786 gamma-Tocotrienol Dietary Substance, Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D09YBF 5282349 n.a. NPC45663 gamma-Tocotrienol, 14101-61-2, D-gamma-Tocotrienol, Plastochromanol, 7,8-Dimethyltocotrienol, Plastochromanol 3, .gamma.-Tocotrienol, D-.gamma.-Tocotrienol, (R)-.gamma.-Tocotrienol, 185QAE24TR, CHEBI:33277, (2R)-2,7,8-trimethyl-2-[(3E,7E)-4,8,12-trimethyltrideca-3,7,11-trienyl]-3,4-dihydrochromen-6-ol, (R)-2,7,8-Trimethyl-2-((3E,7E)-4,8,12-trimethyltrideca-3,7,11-trien-1-yl)chroman-6-ol, (R-(E,E))-3,4-Dihydro-2,7,8-trimethyl-2-(4,8,12-trimethyl-3,7,11-tridecatrienyl)-2H-1-benzopyran-6-ol, 2H-1-Benzopyran-6-ol, 3,4-dihydro-2,7,8-trimethyl-2-(4,8,12-trimethyl-3,7,11-tridecatrienyl)-, (R-(E,E))-, Gama-Tocotrienol, 2H-1-Benzopyran-6-ol, 3,4-dihydro-2,7,8-trimethyl-2-(4,8,12-trimethyl-3,7,11-tridecatrienyl)-, [R-(E,E)]-, 2H-1-benzopyran-6-ol, 3,4-dihydro-2,7,8-trimethyl-2-[(3E,7E)-4,8,12-trimethyl-3,7,11-tridecatrienyl]-, (2R)-, 2R,7,8-trimethyl-2-[(3E,7E)-4,8,12-trimethyltrideca-3,7,11-trien-1-yl]-3,4-dihydro-2H-chromen-6-ol, UNII-185QAE24TR, gammaTocotrienol, gamma Tocotrienol, D-?-Tocotrienol, gamma -Tocotrienol, 2H-1-BENZOPYRAN-6-OL, 3,4-DIHYDRO-2,7,8-TRIMETHYL-2-((3E,7E)-4,8,12-TRIMETHYL-3,7,11-TRIDECATRIEN-1-YL)-, (2R)-, 2H-1-BENZOPYRAN-6-OL, 3,4-DIHYDRO-2,7,8-TRIMETHYL-2-((3E,7E)-4,8,12-TRIMETHYL-3,7,11-TRIDECATRIENYL)-, (2R)-, 2H-1-Benzopyran-6-ol, 3,4-dihydro-2,7,8-trimethyl-2-[(3E,7E)-4,8,12-trimethyl-3,7,11-tridecatrien-1-yl]-, (2R)-, 2R-gamma-tocotrienol, (R)-gamma-Tocotrienol, BIDD:PXR0016, gammaTocotrienolPlastochromanol, CHEMBL120697, SCHEMBL3272929, SCHEMBL16430897, DTXSID101019984, HMS3650C14, GAMMA TOCOTRIENOL [WHO-DD], 3,4-Dihydro-2,7,8-trimethyl-2-[(3E,7E)-4,8,12-trimethyl-3,7,11-tridecatrienyl]-2H-1-benzopyran-6-ol, LMPR02020057, gamma-Tocotrienol, analytical standard, AKOS040744431, J13.903C, HY-108694, CS-0029988, G13332, D-gamma-Tocotrienol, analytical reference material, SR-01000946268, SR-01000946268-1, Q15633932, 6-Chromanol, 2,7,8-trimethyl-2-(4,8,12-trimethyl-3,7,11-tridecatrienyl)-, 6-Chromanol, 2,7,8-trimethyl-2-(4,8,12-trimethyl-3,7,11-tridecatrienyl)- (7CI,8CI), (2R)-2,7,8-trimethyl-2-(4'',8'',12''-trimethyl-trideca-3'',7'',11''-trienyl)-6-hydroxychroman, (2R)-2,7,8-trimethyl-2-[(3E,7E)-4,8,12-trimethyltrideca-3,7,11-trien-1-yl]-3,4-dihydro-2H-chromen-6-ol, (r)-2,7,8-trimethyl-2-((3e,7e)-4,8,12-trimethyltrideca-3,7,11-trien-1-yl) chroman-6-ol, 2,7,8-TRIMETHYL-2-[(3E,7E,11E,15E,19E,23E,27E)-4,8,12,16,20,24,28,32-O CTAMETHYL-3,7,11,15,19,23,27,31-TRITRIACONTAOCTAENYL]-6-CHROMANOL, 2H-1-Benzopyran-6-ol, 3,4-dihydro-2,7,8-trimethyl-2-[(3E,7E)-4,8,12-trimethyl-3,7,11-tridecatrienyl]-, (2R)- (9CI) C28H42O2 OTXNTMVVOOBZCV-WAZJVIJMSA-N (2R)-2,7,8-trimethyl-2-[(3E,7E)-4,8,12-trimethyltrideca-3,7,11-trienyl]-3,4-dihydrochromen-6-ol Davos Life Science Pte Ltd n.a. No No No No Yes No rxn40276,rxnDiet33 PMDBD2001787 Isotrifoliin Dietary Substance, Therapeutic Substance Phase 2/3 n.a. n.a. n.a. n.a. D04PBH 5280804 n.a. NPC179950 Isoquercetin, Isoquercitrin, 482-35-9, Hirsutrin, 3-Glucosylquercetin, Quercetin 3-glucoside, Quercetin 3-o-glucopyranoside, Quercetin 3-D-glucoside, Quercetol 3-monoglucoside, Quercetin 3-O-glucoside, Quercetol 3-glucoside, CONTIGOSIDE B, Quercetin-3-O-glucopyranoside, Quercetin 3-monoglucoside, Glucosyl 3-quercetin, Quercetin 3-beta-glucoside, quercetin-3-O-glucoside, Isotrifoliin, Quercetin 3-beta-O-glucoside, quercetin glucoside, Quercetin-3-glucose, quercetin-3-glucoside, Ronacare isoquercetin, Glucosyl-3-quercetin, Isoquercetin, (-)-, 3-beta-D-Glucosylquercetin, UNII-6HN2PC637T, NSC 115918, BRN 0100989, 6HN2PC637T, CCRIS 9340, CHEBI:68352, quercetin 3-O-beta-D-glucopyranoside, NSC-115918, Quercetin 3.beta.-glucoside, CHEMBL250450, 4-18-00-03493 (Beilstein Handbook Reference), 3,3'',4'',5,7-Pentahydroxyflavone 3-beta-glucoside, MFCD00017746, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-4H-chromen-4-one, Q 5, Quercetin 3-O-.beta.-D-glucopyranoside, 2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4H-chromen-3-yl beta-D-glucopyranoside, 4H-1-Benzopyran-4-one, 5,7-dihydroxy-2-(3,4-dihydroxyphenyl)-3-(beta-D-glucopyranosyloxy)-, NSC-407304, quercetin 3-O-beta-D-glucoside, 2-(3,4-Dihidroxyphenyl)-3-(beta-D-glucofuranosyloxy)-5,7-dihydroxy-4H-1-benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-3-(beta-D-glucopyranosyloxy)-5,7-dihydroxy-4H-1-benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)-4H-chromen-4-one, SMR000466391, Quercetin 3-beta-D-glucoside, hydroside, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-chromen-4-one, Isoquercitrin (6), ISOQUERCITRIN?, 3-glucoside isoquercitrin, ISOQUERCITRIN [MI], Quercetin 3-b-D-glucoside, ISOQUERCETIN [INCI], Quercetin 3-glucopyranoside, Quercetin 3-ss-D-glucoside, 4H-1-benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-3-(beta-D-glucopyranosyloxy)-5,7-dihydroxy-, IQC-950AN, MLS000759532, MLS001424096, Quercetin 3-O-b-D Glucoside, SCHEMBL181306, QUERCETIN 3beta-GLUCOSIDE, quercetin-3-beta-glucopyranoside, ACon1_002134, cid_5280804, cid_5378597, Quercetin 3- beta -D-glucoside, 3-o-beta-d-glucopyranosylquercetin, BDBM153265, HMS2051B17, quercetin-3-o-beta-glucopyranoside, HY-N1445, BDBM50241354, PDSP1_001363, PDSP2_001347, s3842, AKOS015896729, CCG-100967, DB12665, NC00217, Quercetin-3-O-beta-D-galactopyranoside, 4H-1-Benzopyran-4-one,2-(3,4-dihydroxyphenyl)-3-(b-D-glucopyranosyloxy)-5,7-dihydroxy-, quercetin -3-O-beta-D-galactopyranoside, AS-35335, QUERCETIN-3-O-.BETA.-D-GLUCOSIDE, Quercetin 3-glucoside, analytical standard, QUERCETIN-3-.BETA.-GLUCOPYRANOSIDE, 3-O-.BETA.-D-GLUCOPYRANOSYLQUERCETIN, CS-0016884, NS00069794, C05623, QUERCETIN 3-O-GLUCOPYRANOSIDE [WHO-DD], AB00639942-06, Quercetin 3-beta-D-glucoside, >=90% (HPLC), 3,3'',4'',5,7-Pentahydroxyflavone 3-A-glucoside, A871939, 3-Glucopyranosyloxy-3'',4'',5,7-tetrahydroxyflavone, Q-100268, Q6086296, BRD-K73991644-001-01-7, 3,3'''',4'''',5,7-pentahydroxyflavone-3-beta-O-glucoside, Isoquercitrin, primary pharmaceutical reference standard, QUERCETIN 3-O-GLUCOSIDE (CONSTITUENT OF GINKGO), 3'',4'',5,7-TETRAHYDROXYFLAVONE-3-beta-D-GLUCOPYRANOSIDE, QUERCETIN 3-O-GLUCOSIDE (CONSTITUENT OF GINKGO) [DSC], 3'',4'',5,7-TETRAHYDROXYFLAVONE-3-.BETA.-D-GLUCOPYRANOSIDE, 2-(3,4-Dihydroxy-phenyl)-5,7-dihydroxy-3-(3,4,5-trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-chromen-4-one, 2-(3,4-Dihydroxyphenyl)-3-(b-D-glucopyranosyloxy)-5,7-dihydroxy-4H-1-benzopyran-4-one, 9CI, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-tetrahydro-2H-pyran-2-yloxy)-4H-chromen-4-one, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-tetrahydro-2H-pyran-2-yloxy)-4H-chromen-4-one, 4H-1-BENZOPYRAN-4-ONE, 2- (3,4-DIHYDROXYPHENYL)-3- (SS-D-GLUCOFURANOSYLOXY)-5,7-DIHYDROXY-, 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxy-phenyl)-3-(.beta.-D-glucofuranosyloxy)-5,7-dihydroxy-, 4H-1-BENZOPYRAN-4-ONE, 2-(3,4-DIHYDROXYPHENYL)-3-(.BETA.-D-GLUCOPYRANOSYLOXY)-5,7-DIHYDROXY-, 4H-1-BENZOPYRAN-4-ONE, 2-(3,4-DIHYDROXYPHENYL)-3-(SS-D-GLUCOFURANOSYLOXY)-5,7-DIHYDROXY-, HW2 C21H20O12 OVSQVDMCBVZWGM-QSOFNFLRSA-N 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one n.a. n.a. No No No No Yes No rxn04627,rxn40751,rxn42983,rxn43970,rxnDiet192 PMDBD2001788 Matairesinol Dietary Substance n.a. 580-72-3 DB04200 n.a. n.a. n.a. 119205 106491 NPC68779 "Matairesinol, (-)-Matairesinol, 580-72-3, Artigenin congener, Matai-resinol, (3R,4R)-3,4-bis(4-hydroxy-3-methoxybenzyl)dihydrofuran-2(3H)-one, XLW63P8WUA, (3R,4R)-3,4-bis[(4-hydroxy-3-methoxyphenyl)methyl]oxolan-2-one, 3R,4R-Bis((4-hydroxy-3-methoxyphenyl)methyl)dihydro-2(3H)-furanone, CHEBI:6698, (8R,8''R)-(-)-Matairesinol, UNII-XLW63P8WUA, CHEMBL425148, FEMA NO. 4762, DTXSID40920490, 2(3H)-Furanone, dihydro-3,4-bis((4-hydroxy-3-methoxyphenyl)methyl)-, (3R-trans)-, 2(3H)-FURANONE, DIHYDRO-3,4-BIS((4-HYDROXY-3-METHOXYPHENYL)METHYL)-, (3R,4R)-, (3R,4R)-3,4-bis((4-hydroxy-3-methoxyphenyl)methyl)oxolan-2-one, 2(3H)-Furanone, dihydro-3,4-bis[(4-hydroxy-3-methoxyphenyl)methyl]-, (3R-trans)-, (alphaR,betaR)-alpha,beta-Bis(4-hydroxy-3-methoxybenzyl)butyrolactone, SCHEMBL120499, MEGxp0_001689, 2(3H)-Furanone, dihydro-3,4-bis[(4-hydroxy-3-methoxyphenyl)methyl]-, ACon1_001075, Matairesinol, analytical standard, Matairesinol, >=85% (HPLC), DTXCID301349397, HMS3649D06, (3R,4R)-Dihydro-3,4-bis[(4-hydroxy-3-methoxyphenyl)methyl]-2(3H)-furanone; (-)-Matairesinol; (8R,8''R)-(-)-Matairesinol, HY-N3312, BDBM50240921, MFCD03453216, AKOS040760547, DB04200, 2(3H)-Furanone, dihydro-3,4-bis[(4-hydroxy-3-methoxyphenyl)methyl]-,(3R,4R)-, NCGC00169701-01, NCGC00169701-03, MS-25629, 2(3H)-Furanone, dihydro-3,4-divanillyl-, CS-0023873, NS00066976, A831721, SR-01000946700, Q4284467, SR-01000946700-1, BRD-K66216249-001-01-7, (2R,3R)-2,3-Bis(4-hydroxy-3-methoxybenzyl)-4-butanolide, ARTIGENIN CONGENER; DIBENZYLBUTYROLACTONE LIGNANOLIDE, 3,4-Bis(4-hydroxy-3-methoxybenzyl)dihydro-2(3H)-furanone #, (3R,4R)-3,4-Bis-(4-hydroxy-3-methoxy-benzyl)-dihydro-furan-2-one, (3R,4R)-3,4-bis[(4-hydroxy-3-methoxy-phenyl)methyl]tetrahydrofuran-2-one, Dihydro-3,4-bis[(4-hydroxy-3-methoxyphenyl)methyl]-(3R,4R)-2(3H)-Furanone, Dihydro-3,4-bis[(4-hydroxy-3-methoxyphenyl)methyl]-(3R-trans)-2(3H)-Furanone" C20H22O6 MATGKVZWFZHCLI-LSDHHAIUSA-N (3R,4R)-3,4-bis[(4-hydroxy-3-methoxyphenyl)methyl]oxolan-2-one n.a. n.a. No No No No Yes No rxn44005,rxnDiet160,rxnAdd194,rxnAdd195 PMDBD2001789 Ciratin Dietary Substance, Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. D0I9HF 10621 n.a. NPC79056 "hesperidin, 520-26-3, Cirantin, Hesperidoside, Hesper bitabs, Hesperetin 7-rhamnoglucoside, Hesperetin 7-rutinoside, Hesperetin-rutinosid, Hesperidine, Ciratin, (S)-(-)-Hesperidin, CCRIS 3940, EINECS 208-288-1, (2S)-Hesperidin, NSC 44184, UNII-E750O06Y6O, BRN 0075140, DIOSVEIN, Hesperetin-7-O-rhamnoglucoside, Hesperidin, (2S)-, DTXSID9044328, Hesperetin-7-rutinoside, CHEBI:28775, E750O06Y6O, Hesperetin 7-O-rutinoside, USAF CF-3, Hesperitin-7-rhamnoglucoside, Hesperidin, (S)-(-)-, 3'',5''-Dihydroxy-4''-methoxy-7-rutinosyloxyflavan-4-on, MLS001304066, (2S)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxy-2,3-dihydrochromen-4-one, DTXCID7024328, EC 208-288-1, 5-18-05-00218 (Beilstein Handbook Reference), Hesperidin (JAN), Hesperetin, 7-(6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoside), NSC-44184, (2S)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4-oxo-3,4-dihydro-2H-chromen-7-yl 6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoside, (2S)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-3,4-dihydro-2H-1-benzopyran-4-one, (S)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-((((2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)methyl)tetrahydro-2H-pyran-2-yl)oxy)chroman-4-one, 4H-1-Benzopyran-4-one, 7-((6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl)oxy)-2,3-dihydo-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-, (S)-, 5-Hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-((6-O-alpha-L-rhamnopyranosyl-beta-D-glucopyranosyl)oxy)-4-chromanon, 7-((6-O-(6-Deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl)oxy)-2,3-dihydro-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-one, (S)-, 7-(6-O-Desoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyloxy)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4-chromanon, SMR000718775, HESPERIDIN [JAN], MFCD00075663, HESPERIDIN (MART.), HESPERIDIN [MART.], HESPERIDIN (USP-RS), HESPERIDIN [USP-RS], (s)-7-[[6-o-(6-deoxy-alpha-l-mannopyranosyl)-beta-d-glucopyranosyl]oxy]-2,3-dihydro-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4h-1-benzopyran-4-one, Aurantiamarin (Methyl Hesperidin), 3'',5''-DIHYDROXY-4''-METHOXY-7-RUTINOSYLOXYFLAVAN-4-ONE, hesperetin 7-(6-O-alpha-L-rhamnopyranosyl)-beta-D-glucopyranoside, NSC44184, Hesperidin 2S, 2S, Hesperidin, (2S)-5-hydroxy-2-(3-hydroxy-4-methoxy-phenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl]oxymethyl]tetrahydropyran-2-yl]oxy-chroman-4-one, Hesperetin 7 Rutinoside, SR-01000799145, Hesperetin 7 Rhamnoglucoside, Hesperidina, Cirmtin, 7-Rhamnoglucoside, Hesperetin, Hesperidin,(S), NCGC00016481-01, (2S)-7-[[6-O-(6-Deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl]oxy]-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-2,3-dihydro-4H-1-benzopyran-4-one (Hesperidin), (S)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(((2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yloxy)methyl)tetrahydro-2H-pyran-2-yloxy)chroman-4-one, CAS-520-26-3, Hesperetin Glycoside, Hesperitin-7-rutinoside, Hesperidin, >=80%, HESPERIDIN [MI], DIOSMIN [NDI], Prestwick3_000400, HESPERIDIN [INCI], HESPERIDIN [VANDF], Glucopyranoside, hesperetin-7 6-O-(6-deoxy-alpha-L-mannopyranosyl)-, beta-D-, HESPERIDIN [WHO-DD], SCHEMBL94586, BSPBio_000619, 4H-1-Benzopyran-4-one, 7-((6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl)oxy)-2,3-dihydro-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-, (S)-, cid_10621, Hesperidin, analytical standard, BPBio1_000681, CHEMBL449317, NDI 590 [FDMS], BCBcMAP01_000136, BDBM61776, NDI 590, 2H-pyran-2-yloxy)chroman-4-one, HMS2096O21, HMS2233I03, HMS3713O21, Tox21_110448, s2309, AKOS015895450, CCG-208580, CS-5631, DB04703, KS-5308, SMP1_000149, NCGC00179501-01, 1ST40133, 4H-1-Benzopyran-4-one, 7-((6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl)oxy)-2,3-dihydro-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-, (2S)-, HY-15337, AB00513829, H0049, NS00008545, C09755, D01038, (S)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-, EN300-7419024, Q385937, Hesperidin, primary pharmaceutical reference standard, methyltetrahydro-2H-pyran-2-yloxy)methyl)tetrahydro-, SR-01000799145-4, SR-01000799145-5, SR-01000799145-7, 7-((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-, BRD-K38903228-001-02-8, BRD-K38903228-001-13-5, Hesperidin, European Pharmacopoeia (EP) Reference Standard, Hesperidin, Pharmaceutical Secondary Standard; Certified Reference Material, Flavanone, 3'',5,7-trihydroxy-4''-methoxy-, 7-(6-O-alpha-L-rhamnosyl-D-glucoside), (2S)-2-(4-methoxy-3-oxidanyl-phenyl)-7-[(2S,3R,4S,5S,6R)-6-[[(2R,3R,4R,5R,6S)-6-methyl-3,4,5-tris(oxidanyl)oxan-2-yl]oxymethyl]-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-5-oxidanyl-2,3-dihydrochromen-4-one, (2S)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-2-oxanyl]oxymethyl]-2-oxanyl]oxy]-3,4-dihydro-2H-1-benzopyran-4-one, (2S)-7-((6-O-(6-DEOXY-.ALPHA.-L-MANNOPYRANOSYL)-.BETA.-D-GLUCOPYRANOSYL)OXY)-2,3-DIHYDRO-5-HYDROXY-2-(3-HYDROXY-4-METHOXYPHENYL)-4H-1-BENZOPYRAN-4-ONE, (2S)-7-((6-O-(6-DEOXY-alpha-L-MANNOPYRANOSYL)-beta-D-GLUCOPYRANOSYL)OXY)-2,3-DIHYDRO-5-HYDROXY-2-(3-HYDROXY-4-METHOXYPHENYL)-4H-1-BENZOPYRAN-4-ONE, (S)-7-[[6-O-(6-Deoxy-.alpha.-L-mannopyranosyl)-.beta.-D-glucopyranosyl]oxy]-2,3-dihydro-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-one, 4H-1-BENZOPYRAN-4-ONE, 7-((6-O-(6-DEOXY-.ALPHA.-L-MANNOPYRANOSYL)-.BETA.-D-GLUCOPYRANOSYL)OXY)-2,3-DIHYDO-5-HYDROXY-2-(3-HYDROXY-4-METHOXYPHENYL)-, (S)-, 5-HYDROXY-2-(3-HYDROXY-4-METHOXYPHENYL)-7-((6-O-.ALPHA.-L-RHAMNOPYRANOSYL-.BETA.-D-GLUCOPYRANOSYL)OXY)-4-CHROMANON" C28H34O15 QUQPHWDTPGMPEX-QJBIFVCTSA-N (2S)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxy-2,3-dihydrochromen-4-one n.a. n.a. No No No No Yes No rxn46354,rxnDiet139,rxnAdd76 PMDBD2001790 Luteolin 7-O-beta-D-diglucuronide Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 5282153 n.a. NPC128988 Luteolin 7-diglucuronide, 96400-45-2, Luteolin 7-O-beta-D-diglucuronide, luteolin-7-O-[beta-D-glucuronosyl-(1->2)-beta-D-glucuronide], (2S,3S,4S,5R,6R)-6-[(2S,3R,4S,5S,6S)-6-carboxy-2-[2-(3,4-dihydroxyphenyl)-5-hydroxy-4-oxochromen-7-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid, luteolin-7-O-[beta-glucuronosyl-(1->2)-beta-glucuronide], (2S,3S,4S,5R,6R)-6-(((2S,3R,4S,5S,6S)-6-Carboxy-2-((2-(3,4-dihydroxyphenyl)-5-hydroxy-4-oxo-4H-chromen-7-yl)oxy)-4,5-dihydroxytetrahydro-2H-pyran-3-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid, CHEBI:60077, HY-N7269, C27H26O18, AKOS040740834, MS-30898, CS-0111085, E87152, Q27127061 C27H26O18 PBBVWJQPAZYQDB-DBFWEQBMSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4S,5S,6S)-6-carboxy-2-[2-(3,4-dihydroxyphenyl)-5-hydroxy-4-oxochromen-7-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid n.a. n.a. No No No No Yes No rxn46905,rxnDiet156,rxnAdd87 PMDBD2001791 HMF Dietary Substance, Therapeutic Substance Phase 2 n.a. n.a. n.a. n.a. D0E9BF 237332 n.a. NPC107482 "5-HYDROXYMETHYLFURFURAL, 67-47-0, 5-Hydroxymethyl-2-furaldehyde, 5-(hydroxymethyl)furan-2-carbaldehyde, 5-(Hydroxymethyl)furfural, 5-(Hydroxymethyl)-2-furaldehyde, Hydroxymethylfurfural, 5-(Hydroxymethyl)-2-furfural, 5-Oxymethylfurfurole, 5-Hydroxymethylfuraldehyde, Hydroxymethylfurfurole, 5-(Hydroxymethyl)-2-furancarbonal, 2-Hydroxymethyl-5-furfural, 5-Hydroxymethylfuran-2-aldehyde, Hydroxymethylfurfuraldehyde, 5-Hydroxymethyl-2-formylfuran, Hydroxymethylfurfuralaldehyde, 5-Hydroxymethyl-2-furfural, 2-Furancarboxaldehyde, 5-(hydroxymethyl)-, 5-(Hydroxymethyl)-2-furfuraldehyde, 5-Hydroxymethylfurfuraldehyde, 5-(Hydroxymethyl)-2-furancarboxaldehyde, 5-(Hyddroxymethyl)furfurole, Aes-103, HMF, NSC-40738, 5-Hydroxymethyl-2-furancarboxaldehyde, 5-HYDROXYMETHYL-FURFURAL, 5-HMF, 2-Furaldehyde, 5-(hydroxymethyl)-, 5-Hydroxymethyl-2-furfuraldehyde, CHEBI:412516, 5-(Hydroxymethyl)furan-2-aldehyde, 5-Hydroxymethyl-2-furancarbaldehyde, MFCD00003234, NSC 40738, 5-(Hydroxymethyl)furfurole, 2-formyl-5-hydroxymethylfuran, 70ETD81LF0, DTXSID3030428, 5-(Hydroxymethyl)-2-formylfuran, 5-Hydroxymethyl-furan-2-carbaldehyde, 5-hydroxymethyl furfural, DTXCID1010428, CAS-67-47-0, CCRIS 3160, EINECS 200-654-9, Aes 103, BRN 0110889, UNII-70ETD81LF0, HSDB 7982, 5-methylolfurfural, 5-(Hydroxymethyl)furan-2-carboxaldehyde, 5hydroxymethyl_furfural, 5-Hydrxoymethylfurfural, 5-formylfurfuryl alcohol, 5HMF, 5-hydroxy methyl furfural, Epitope ID:136033, 5-Hydroxymethyl furaldehyde, CBiol_000485, SCHEMBL19176, 5-18-01-00130 (Beilstein Handbook Reference), MLS002454379, CHEMBL185885, QSPL 022, GTPL10939, HYDROXYMETHYLFURFURAL, 5-, 5-hydroxymethylfuran-2-carbaldehyde, BCP31207, CS-D1116, HY-Y0051, NSC40738, Tox21_201892, Tox21_303551, BDBM50487911, GEO-01528, ICCB3_000133, s3772, 5-Hydroxymethyl-2-furaldehyde, 99%, 5-(hydroxymethyl)-2-furfural (HMF), AKOS005166879, AC-1262, CCG-266098, DB12298, GS-3074, 5-(hydroxymethyl)-furan-2-carbaldehyde, NCGC00091513-01, NCGC00091513-02, NCGC00257266-01, NCGC00259441-01, 5-(hydroxymethyl)-2-furan-carboxaldehyde, 5-(Hydroxymethyl)furfural, >=99%, FG, SMR000393981, SY010869, 5-(hydroxy methyl) 2-furan-carboxaldehyde, A9037, AM20100616, H0269, NS00014938, 5-(HYDROXYMETHYL)-2-FURALDEHYDE [MI], EN300-82764, 5-(Hydroxymethyl)furfural, analytical standard, Q414606, Q-200545, 801 - Honey essential composition and quality factors, 5-hydroxymethylfurfural; 5-(hydroxymethyl)-2-furaldehyde, F2191-0155, Z1238542812, 5-(hydroxymethyl)furan-2-carbaldehyde;5-(Hydroxymethyl)furfural, InChI=1/C6H6O3/c7-3-5-1-2-6(4-8)9-5/h1-3,8H,4H, FC-801-QC sample 801 - Essential composition and quality factors - Honey, GLUCOSAMINE SULFATE POTASSIUM CHLORIDE IMPURITY E [ EP IMPURITY]" C6H6O3 NOEGNKMFWQHSLB-UHFFFAOYSA-N 5-(hydroxymethyl)furan-2-carbaldehyde Aesrx n.a. No No No No Yes No rxn47004,rxnDiet48 PMDBD2001792 Docosanoate Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 5460660 n.a. NPC184924 behenate, Docosanoate, CHEBI:23858, UKMSUNONTOPOIO-UHFFFAOYSA-M, CH3-[CH2]20-COO(-), Q28487669 C22H43O2- UKMSUNONTOPOIO-UHFFFAOYSA-M docosanoate n.a. n.a. No No No No Yes No rxnDiet4 PMDBD2001793 Erucic acid Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 5281116 n.a. NPC290563 ERUCIC ACID, (Z)-Docos-13-enoic acid, 112-86-7, cis-13-Docosenoic acid, 13-Docosenoic acid, (Z)-, 13-cis-Docosenoic acid, Hystrene 2290, 13Z-docosenoic acid, 13-Docosenoic acid, (13Z)-, Prifrac 2990, cis-erucic acid, Z-13-Docosenoic acid, 13-Docosenoic acid, (Z)-13-Docosenoic acid, delta13-cis-Docosenoic acid, delta13:14-Docosenoic acid, (13Z)-13-Docosenoic acid, Erucasaeure, CHEBI:28792, cis-eruic acid, HSDB 5015, (13Z)-Docosenoic acid, 13(Z)-Docosenoic Acid, NSC 6814, EINECS 204-011-3, C22:1n-9, (13Z)-docos-13-enoic acid, .delta.13-cis-Docosenoic acid, Erucic acid, 85%, UNII-075441GMF2, docos-13c-enoic acid, AI3-18180, Prifac 2990, 22:1omega9, NSC-6814, MFCD00063188, NOURACID RE 07, 075441GMF2, JARIC 22:1, cis-Delta(13)-docosenoic acid, DTXSID8026931, FA 22:1, 13-Docosenoic acid, (13Z)-, dimer, (Z)-13-docosenoate, 22:1(N-9), 63541-50-4, 1072-39-5, docosensaure, erucasaure, NSC6814, 13-docosenoate, 13-Docosensaure, C22-fatty acid, cis-13-Docosenoate, Edenor C 22 Eruca, Docosensaure, 13-cic, Edenor U 122, Cis 13-docosaenoic Acid, Erucic acid, >=99%, delta 13-cis-Docosenoate, delta.13-cis-Docosenoate, Cis-docos-13-enoic Acid, ERUCIC ACID [MI], (Z)-Docos-13-enoicacid, (13Z)-13-Docosenoate, ERUCIC ACID [HSDB], ERUCIC ACID [INCI], SCHEMBL5987, 13-Docosenoic acid, (Z), C22:1,n-9 cis, delta 13-cis-Docosenoic acid, delta.13-cis-Docosenoic acid, Docosenoic acid, 13-(Z)-, Fatty Acid 22:1 n-9 cis, Fatty Acid cis 22:1 n-9, DTXCID706931, CHEMBL1173380, Erucic acid, analytical standard, HY-N7109A, (13Z)-13-Docosenoic acid #, 13-DOCOSENsaure (ALTSTOFF), HMS3649F15, HY-N7109, 13-DOCOSENSAEURE (ALTSTOFF), Tox21_200242, BDBM50463967, LMFA01030089, AKOS015961814, DELTA 13:14-DOCOSENOIC ACID, Erucic acid, >=99% (capillary GC), Erucic acid, technical, ~90% (GC), 13-docosenoic acid (ACD/Name 4.0), CCG-267904, DELTA(13)-CIS-DOCOSENOIC ACID, NCGC00166073-01, NCGC00166073-02, NCGC00166073-04, NCGC00257796-01, CAS-112-86-7, FA(22:1(13Z)), 22:1 n-9, CS-0014094, CS-0203830, D0965, NS00005003, S5383, C08316, F17010, Q413531, SR-01000946653, ERUCIC ACID (CONSTITUENT OF BORAGE SEED OIL), SR-01000946653-1, W-108635, 084C86E4-C0FF-45E5-9F1D-09913C9193BE C22H42O2 DPUOLQHDNGRHBS-KTKRTIGZSA-N (Z)-docos-13-enoic acid n.a. n.a. No No No No Yes No rxnDiet6 PMDBD2001794 Arachidonate Dietary Substance, Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D0HD9P 444899 n.a. NPC91495 arachidonic acid, 506-32-1, arachidonate, (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoic acid, Immunocytophyte, (all-Z)-5,8,11,14-Eicosatetraenoic acid, cis-5,8,11,14-Eicosatetraenoic acid, 5,8,11,14-Eicosatetraenoic acid, (all-Z)-, all-cis-5,8,11,14-eicosatetraenoic acid, Arachidonsaeure, 5Z,8Z,11Z,14Z-eicosatetraenoic acid, (5Z,8Z,11Z,14Z)-5,8,11,14-Eicosatetraenoic Acid, UNII-27YG812J1I, CCRIS 6312, CHEBI:15843, 27YG812J1I, EINECS 208-033-4, CHEMBL15594, AI3-09613, DTXSID4040420, Icosa-5,8,11,14-tetraenoic acid, MFCD00004417, (5Z,8Z,11Z,14Z)-5,8,11,14-Eikosatetraensaeure, 5Z,8Z,11Z,14Z-icosatetraenoic acid, FA 20:4, ARACHIDONIC ACID (20:4, n-6), (5Z,8Z,11Z,14Z)-Icosatetraenoic acid, 5,8,11,14-Eicosatetraenoic acid, C20:4, cis-Delta(5,8,11,14)-eicosatetraenoic acid, [1-14C]Arachidonic acid, 93444-49-6, (5Z,8Z,11Z,14Z)-5,8,11,14-Icosatetraenoic acid, ARACHIDONIC ACID (MART.), ARACHIDONIC ACID [MART.], (14C)Arachidonic acid, Arachidonic Acid, 99%, Arachidonic Acid, >97%, Immunocytophyt, Vevodar, 5,8,11,14-Icosatetraenoic Acid, arachidonic-acid, 1adl, 1gnj, 1vyg, cis,cis,cis,cis-5,8,11,14-Eicosatetraenoic acid, (14C)-arachidonic acid, Spectrum5_001910, Fatty Acid 20:4 n-6, SCHEMBL16162, BSPBio_001539, MLS001361328, ARACHIDONIC ACID [MI], AA-[d8], BML3-B03, GTPL2391, ARACHIDONIC ACID [INCI], 5,8,11,14-Eicosatetraenoate, DTXCID2020420, BDBM22319, ARACHIDONIC ACID [WHO-DD], CHEBI:137828, HMS1361M21, HMS1791M21, HMS1989M21, HMS3402M21, HMS3649B05, 5Z,8Z,11Z,14Z-Eicosatetraenoate, Arachidonic acid, >95.0% (GC), 5,8,11,14-Eicosatetraenoic acid, labeled with carbon-14, (all-Z)-, Arachidonic acid, analytical standard, cis-D5,8,11,14-Eicosatetraenoate, LMFA01030001, s6185, AKOS015950830, CCG-214838, DB04557, FS-5880, 5,8,11,14-all-cis-Eicosatetraenoate, all-cis-5,8,11,14-Eicosatetraenoate, ARACHIDONIC ACID (20:4 n-6), IDI1_034009, cis-D5,8,11,14-Eicosatetraenoic acid, NCGC00094608-01, NCGC00094608-02, NCGC00094608-03, NCGC00094608-04, NCGC00094608-05, NCGC00094608-06, (all-Z)-5,8,11,14-Eicosatetraenoate, AC-14348, AC-33769, BP-29803, Eicosa-5Z,8Z,11Z,14Z-tetraenoic acid, SMR000857374, 5,8,11,14-all-cis-Eicosatetraenoic acid, All-cis-icosa-5,8,11,14-tetraenoic acid, HY-109590, A0781, all-cis-eicosa-5,8,11,14-tetraenoic acid, CS-0032762, >95.0% (GC), 5-cis,8-cis,11-cis,14-cis-Eicosatetraenoate, Arachidonic acid (in Tocrisolvetrade mark100), C00219, W15452, FA(20:4(5Z,8Z,11Z,14Z)), 5-cis,8-cis,11-cis,14-cis-Eicosatetraenoic acid, A929392, Q407699, SR-01000838311, SR-01000838311-2, BRD-K03070961-001-02-8, BRD-K03070961-001-04-4, (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoicacid, Arachidonic Acid-d8 (Major, 10mg/ml in Methyl Acetate), (5Z,8Z,11Z,14Z)-5,8,11,14-Icosatetraenoic acid #, Arachidonic acid, from non-animal source, >=98.5% (GC), Arachidonic acid, from porcine liver, >=99% (GC), liquid, D18DBC10-379C-4E78-9A50-8B791A2F4E68, Arachidonic acid, from porcine liver, >=85% (capillary GC), liquid, Arachidonic acid, 1.0 mg/mL in ethanol, certified reference material, Arachidonic acid, from porcine liver, BioReagent, suitable for cell culture, >=99% (GC) C20H32O2 YZXBAPSDXZZRGB-DOFZRALJSA-N (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoic acid n.a. n.a. No No No No Yes No rxnDiet10 PMDBD2001795 Eicosapentaenoic acid Dietary Substance, Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. D0G2MW 446284 n.a. NPC117572 "Eicosapentaenoic acid, Timnodonic acid, Icosapent, 10417-94-4, Icosapentaenoic acid, EPA, cis-5,8,11,14,17-Eicosapentaenoic acid, Icosapento, Icosapentum, (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoic acid, Miraxion, 5,8,11,14,17-EICOSAPENTAENOIC ACID, eicosapentaenoate, 5Z,8Z,11Z,14Z,17Z-Eicosapentaenoic acid, (all-Z)-5,8,11,14,17-Eicosapentaenoic acid, Icosapent [INN], Eicosapentanoic acid, (5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-eicosapentaenoic acid, Eye Q, Eye-Q, Ropufa 70, Incromega e 7010sr, CCRIS 3279, AAN7QOV9EA, UNII-AAN7QOV9EA, EPA 45G, (5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid, 5,8,11,14,17-Icosapentaenoic acid, EPA [drug], CHEBI:28364, (5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate, (5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid, Icosapentum [INN-Latin], Icosapento [INN-Spanish], C20:5n-3,6,9,12,15, C20:5 (n-3), CHEMBL460026, DTXSID9041023, all-cis-5,8,11,14,17-icosapentaenoic acid, all-cis-5,8,11,14,17-eicosapentaenoic acid, all-cis-icosa-5,8,11,14,17-pentaenoic acid, Icosapent (INN), cis-Delta(5,8,11,14,17)-eicosapentaenoic acid, 5,8,11,14,17-Eicosapentaenoic acid, (all-Z)-, Eicosapentaenoic acid (c20:5 n3), EPA;Timnodonic acid, Icosapentaenoate, (all-Z)-delta5,8,11,14,17-Eicosapentaenoic acid, MFCD00065716, EPA (drug), cis-5,8,11,14,17-EPA, FA 20:5, NCGC00161344-03, 5,8,11,14,17-Eicosapentaenoic acid, (5Z,8Z,11Z,14Z,17Z)-, EICOSAPENTAENOIC ACID (20:5 n-3), Icosapentum (INN-Latin), Icosapento (INN-Spanish), all cis-5,8,11,14,17-Eicosapentaenoic Acid, Eicosa-5Z,8Z,11Z,14Z,17Z-pentaenoic Acid (20:5, n-3), (5Z,8Z,11Z,14Z,17Z)-icosapentaenoate, Timnodonate, 3gwx, RELIVEN, EPA-FFA, all-cis-icosapentaenoate, ICOSAPENT (EPA), all-cis-icosapentaenoic acid, SCHEMBL20469, BSPBio_001328, BML3-B01, GTPL3362, DTXCID7021023, EICOSAPENTAENOIC ACID [MI], HMS1361C10, HMS1791C10, HMS1989C10, HMS3402C10, HMS3649D19, HY-B0660, 5,8,11,14,17-Icosapentaenoate, EICOSAPENTAENOIC ACID [INCI], Tox21_111991, 5,8,11,14,17-Eicosapentaenoate, BDBM50242349, EICOSAPENTAENOIC ACID [VANDF], LMFA01030759, s6476, EICOSAPENTAENOIC ACID [MART.], AKOS027470327, EICOSAPENTAENOIC ACID [USP-RS], EICOSAPENTAENOIC ACID [WHO-DD], CCG-207957, CCG-208136, DB00159, cis-5,8,11,14,17-eicosapentaenoate, IDI1_033798, NCGC00161344-01, NCGC00161344-02, NCGC00161344-04, NCGC00161344-07, 5Z,8Z,11Z,14Z,17Z-Eicosapentaenoate, AC-31072, AS-53730, CAS-10417-94-4, E0441, NS00010730, 5,8,11,14,17-Eicosapentaenoic acid (6CI), all cis-5,8,11,14,17-Icosapentaenoic Acid, C06428, D08061, P16966, EN300-7403855, (all-cis)-5,8,11,14,17-Eicosapentaenoic acid, EICOSAPENTAENOIC ACID (EPA) (C20:5 N3), L001256, Q409990, SR-01000946647, FA(20:5(5Z,8Z,11Z,14Z,17Z)), J-001125, SR-01000946647-1, z,z,z,z,z-eicosa-5,8,11,14,17-pentaenoic acid, (Z,Z,Z,Z,Z)-5,8,11,14,17-eicosapentaenoic acid, BRD-K47192521-001-02-1, cis-5,8,11,14,17-Eicosapentaenoic acid, >=99%, 7F8BF016-B146-4F72-A52E-B9298BA3A9AB, C20H30O2 (cis-5,8,11,14,17-eicosapentaenoic acid), Eicosapentaenoic acid, 5,8,11,14,17-(Z,Z,Z,Z,Z)-, 5,8,11,14,17-Eicosapentaenoic acid, (all-Z)- (8CI), cis-5,8,11,14,17-Eicosapentaenoic acid, >=85%, liquid, cis-5,8,11,14,17-Eicosapentaenoic acid, analytical standard, (5Z,8Z,11 Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoic acid, (5Z,8Z,11Z,14Z,17Z)-eicosa-5,8,11,14,17-pentaenoic acid, cis, cis, cis, cis, cis-eicosa-5,8,11,14,17-pentaenoic acid, 5,8,11,14,17-Eicosapentaenoic acid, (5Z,8Z,11Z,14Z,17Z)- (9CI), 25377-48-4, cis-5,8,11,14,17-Eicosapentaenoic acid, 500 mug/mL in ethanol, certified reference material" C20H30O2 JAZBEHYOTPTENJ-JLNKQSITSA-N (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoic acid n.a. Dietary supplement No No No No Yes No rxnDiet11 PMDBD2001796 Docosahexaenoic acid Dietary Substance, Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. D0Q5XX 445580 n.a. NPC270796 Docosahexaenoic acid, Doconexent, 6217-54-5, Cervonic acid, cis-4,7,10,13,16,19-Docosahexaenoic acid, Docosahexaenoate, Doconexentum, Doconexento, Doxonexent, (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoic acid, all-cis-DHA, AquaGrow Advantage, Martek DHA HM, Ropufa 60, Monolife 50, all-Z-Docosahexaenoic acid, Doconexent [INN], CCRIS 7670, UNII-ZAD9OKH9JC, ZAD9OKH9JC, all-cis-4,7,10,13,16,19-Docosahexaenoic acid, (4Z,7Z,10Z,13Z,16Z,19Z)-Docosahexaenoic acid, Algal DHA, Docosaheaenoic-acid, Docosahexaenoic acid (all-Z), all-cis-docosa-4,7,10,13,16,19-hexaenoic acid, DTXSID5040465, (all-Z)-4,7,10,13,16,19-Docosahexaenoic acid, CHEBI:28125, DOCOSAHEXANOIC ACID, Doconexentum [INN-Latin], Doconexento [INN-Spanish], FA 22:6, DOCOSA-4,7,10,13,16,19-HEXAENOIC ACID, (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,16,19-Docosahexaenoic acid, 4,7,10,13,16,19-Docosahexaenoic acid, (all-Z)-, C22:6 (n-3), CHEMBL367149, 22:6 n-3, docosahexaenoic acid(DHA), Retriacyl (proposed trade name), delta4,7,10,13,16,19-Docosahexaenoic acid, 4-cis,7-cis,10-cis,13-cis,16-cis,19-cis-Docosahexaenoic acid, 4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoic acid, Docosahexaenoic acid (c22:6 n3), OMEGA-3 MARINE TRIGLYCERIDES, MFCD00065722, efalex, NCGC00161345-04, DOCOSAHEXAENOIC ACID (22:6 n-3), 22:6(n-3), Doconexentum (INN-Latin), cis-4,7,10,13,16,19-Docosahexanoic acid, Doconexento (INN-Spanish), A320050000, C22:6n-3,6,9,12,15,18, Marinol D 50TG, 4,7,10,13,16,19-Docosahexaenoic acid, (4Z,7Z,10Z,13Z,16Z,19Z)-, SR-05000002130, Cervonate, 1fdq, Docohexanenoic Acid, Complete Natal DHA, Docosahexanenoic acid, all-Z-Docosahexaenoate, WesNatal DHA Complete, Spectrum5_002062, OBTREX DHA Combo Pack, Obstetrix DHA Combo Pack, Docosahexaenoic acid (6CI), SCHEMBL19577, BSPBio_001298, MLS004773950, BML3-B02, GTPL1051, DTXCID3020465, BCBcMAP01_000145, CHEBI:36005, DOCOSAHEXAENOIC ACID [MI], DTXSID401018161, HMS1361A20, HMS1791A20, HMS1989A20, HMS3402A20, HMS3649J15, DOCOSAHEXAENOIC ACID [INCI], HXA, HY-B2167, DOCOSAHEXAENOIC ACID [VANDF], Tox21_111992, BDBM50210259, DOCOSAHEXAENOIC ACID [MART.], LMFA01030185, DOCOSAHEXAENOIC ACID [USP-RS], DOCOSAHEXAENOIC ACID [WHO-DD], AKOS015962159, AC-1010, CCG-207958, CCG-208135, CS-6261, DB03756, KL-0761, IDI1_033768, 4,7,10,13,16,19-Docosahexaenoate, NCGC00161345-01, NCGC00161345-02, NCGC00161345-03, NCGC00161345-05, NCGC00161345-07, all cis- Docosahexaenoic acid (cis-DHA), BP-29833, SMR001881493, CAS-6217-54-5, cis-4,7,10,13,16,19-Docosahexanoate, D2226, S6454, C06429, H10987, AB01563379_01, DOCOSAHEXAENOIC ACID (DHA) (C22:6 N3), Select-OB Plus DHAPrenatal Supplement Plus DHA, Vitafol-OB Plus DHAPrenatal Supplement Plus DHA, Q423345, DHA-[21,21,22,22,22-d5], SR-05000002130-1, SR-05000002130-4, BRD-K39965020-001-02-6, 4,7,10,13,16,19-Docosahexaenoic acid, (all cis)-, cis-4,7,10,13,16,19-Docosahexaenoic acid, >=98%, FA(22:6(4Z,7Z,10Z,13Z,16Z,19Z)), z,z,z,z,z,z-docosa-4,7,10,13,16,19-hexaenoic acid, 800E8E72-BBF4-46F7-A60B-B8F2B54669C7, C22H32O2 (cis-4,7,10,13,16,19-docosahexaenoic acid), 4,7,10,13,16,19-Docosahexaenoic acid, (all-Z)- (8CI), cis-4,7,10,13,16,19-Docosahexaenoic acid, analytical standard, Docosa-4Z,7Z,10Z,13Z,16Z,19Z-hexaenoic Acid (22:6, n-3), (4Z,7Z,10Z,13Z,16Z, 19Z)-docosa-4,7,10,13,16,19-hexaenoic acid, (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4, 7,10,13,16,19-hexaenoic acid, (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19- hexaenoic acid, cis-4,7,13,16,19-Docosahexaenoic acid (stabilized with vitamine E), 4,7,10,13,16,19-Docosahexaenoic acid, (4Z,7Z,10Z,13Z,16Z,19Z)- (9CI), 1024594-51-1, cis-4,7,10,13,16,19-Docosahexaenoic acid, 500 mug/mL in ethanol, certified reference material C22H32O2 MBMBGCFOFBJSGT-KUBAVDMBSA-N (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoic acid Omthera Pharmaceutials n.a. No No No No Yes No rxnDiet13 PMDBD2001797 Lignin Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 175586 n.a. NPC491236 94113-57-2, LIGNIN, Disodium 4-(acetylamino)-5-hydroxy-6-(phenylazo)naphthalene-1,7-disulphonate, EINECS 302-591-3, NS00063733 C18H13N3Na2O8S2 RLLNZXVKBYGKIP-UHFFFAOYSA-L "disodium;4-acetamido-5-hydroxy-6-phenyldiazenylnaphthalene-1,7-disulfonate" n.a. n.a. No No No No Yes No rxnDiet15 PMDBD2001798 F- Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 28179 n.a. n.a. fluoride, fluoride ion, 16984-48-8, Fluoride ion(1-), Perfluoride, Fluorine ion, Fluoride(1-), Fluoride ion(F-), Fluorine ion(1-), FLUORIDE STANDARD, Drinking water, fluoride treated, Fluorine anion, UNII-Q80VPU408O, Q80VPU408O, FLURORIDE-ION, F-, FLUORINE ION(F1-), DTXSID9049617, CHEBI:17051, F(-), Fluoride dust, Fluoride Standard: F- @ 1000 microg/mL in H2O, Fluorides, Fluoride as dust, Fluorine-, F?, FLUORIDE [VANDF], CHEMBL1362, Fluoride Standard: F- @ 100 microg/mL in H2O, Fluoride Standard: F- @ 10000 microg/mL in H2O, Topex Neutral pH Fluoride Gel, DTXCID3029576, BDBM26978, Topex Neutral pH Fluoride GelMint, MFCD00144315, AKOS015903717, DB11257, Topex Neutral pH Fluoride GelStrawberry, NS00075546, C00742, Q407350, Fluoride Ion Chromatography Standard: F- @ 100microg/mL in H2O F- KRHYYFGTRYWZRS-UHFFFAOYSA-M fluoride n.a. n.a. No No No No Yes No rxnDiet19 PMDBD2001799 Calcidiol Dietary Substance, Therapeutic Substance Approved Drug n.a. n.a. n.a. n.a. D02VPX 5283731 n.a. NPC27395 Calcifediol, Calcidiol, 25-hydroxyvitamin D3, 19356-17-3, 25-Hydroxycholecalciferol, Calcifediol anhydrous, Hidroferol, Calderol, Didrogyl, Calcifediolum, Rayaldee, Ro 8-8892, Vitamin D, 25-hydroxy-, 5,6-cis-25-Hydroxyvitamin D3, Calcifediol [INN], Cholecalciferol, 25-hydroxy-, CHEBI:17933, T0WXW8F54E, 64719-49-9, (3S,5Z,7E)-9,10-secocholesta-5,7,10-triene-3,25-diol, (3beta,5Z,7E)-9,10-secocholesta-5,7,10(19)-triene-3,25-diol, MFCD00867077, (1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol, (1S,3Z)-3-{2-[(1R,3aS,4E,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-octahydro-1H-inden-4-ylidene]ethylidene}-4-methylidenecyclohexan-1-ol, 3-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-4-METHYLENE-CYCLOHEXANOL, Calcifidiol, Delakmin, 25-Hydroxy vitamin D3, (5Z,7E)-(3S)-9,10-secocholesta-5,7,10(19)-triene-3,25-diol, U-32070E, U 32070 E, 25-hydroxyvitamin D3 / 25-hydroxycholecalciferol / calcidiol, 25-Hydroxycholescalciferol, Calcifediolum [INN-Latin], Rovimix Hy-D, U 32070E, Hy-D, 25-(OH)Vitamin D3, 5,6-trans-25-Hydroxycholescalciferol, UNII-T0WXW8F54E, DTXSID0022721, Ryaldee, BML2-E02, (5Z,7E)-(3S)-9,10-seco-5,7,10(19)-cholestatriene-3,25-diol, NCGC00161326-04, 25(OH)D3, EINECS 242-990-9, CALCIFEDIOL [MI], (5Z,7E)-9,10-Seco-5,7,10(19)-cholestatrien-3beta,25-diol, 5,6-trans-9,10-Seco-5,7,10(19)-cholestatrien-3beta,25-diol, Spectrum5_001931, 25-hydroxy-cholecalciferol, CALCIFEDIOL,ANHYDROUS, SCHEMBL3296, CHEMBL1040, BSPBio_001411, CALCIFEDIOL, ANHYDROUS, (3S,5Z,7E)-9,10-seco-5,7,10(19)-cholestatriene-3,25-diol, GTPL6921, CHEBI:94743, AMY2863, BCPP000306, DM100, HMS1361G13, HMS1791G13, HMS1989G13, HMS2089L21, HMS3402G13, (3S,5Z,7E)-9,10-secocholesta-5,7,10(19)-triene-3,25-diol, 9,10-Secocholesta-5,7,10(19)-triene-3,25-diol, (3beta,5Z,7E)-, BDBM50521013, CALCIFEDIOL,ANHYDROUS [VANDF], LMST03020246, s1469, AKOS015965097, BCP9000472, CCG-268657, CS-0800, DB00146, IDI1_033881, NCGC00161326-01, AC-31367, HY-32351, 25-Hydroxycholecalciferol, >=98% (HPLC), NS00026306, C01561, AB01275461-01, AB01275461_02, EN300-7413489, A923587, Q139307, SR-05000001468, SR-05000001468-1, W-201718, 25-Hydroxyvitamin D3 monohydrate, >=99.0% (HPLC), 9,10-Secocholesta-5,7,10(19)-triene-3b,25-diol, BRD-K77175907-001-01-5, B91135EC-8937-4D8B-A533-CCD82F33C1B0, Calcifediol, European Pharmacopoeia (EP) Reference Standard, Calcifediol, United States Pharmacopeia (USP) Reference Standard, (3S,5Z,14beta,17alpha)-9,10-secocholesta-5,7,10-triene-3,25-diol, (5Z,7E)-9,10-Secocholesta-5,7,10(19)-triene-3b,25-diol monohydrate, 9,10-Secocholesta-5,7,10(19)-triene-1,25-diol, (3.beta,.5Z,7E)-, (?R,1R,3aS,4E,7aR)-4-[(2Z)-2-[(5S)-5-hydroxy-2-methylenecyclohexylidene]ethylidene]octahydro-?,?,?,7a-tetramethyl-1H-indene-1-pentanol, (1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-1-[(1R)-5-hydroxy-1,5-dimethyl-hexyl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylene-cyclohexanol, (S,Z)-3-((E)-2-((1R,3aS,7aR)-1-((R)-6-hydroxy-6-methylheptan-2-yl)-7a-methylhexahydro-1H-inden-4(2H)-ylidene)ethylidene)-4-methylenecyclohexanol, 1H-Indene-1-pentanol, octahydro-4-[(2Z)-2-[(5S)-5-hydroxy-2-methylenecyclohexylidene]ethylidene]-.alpha.,.alpha.,.epsilon.,7a-tetramethyl-, (.epsilon.R,1R,3aS,4E,7aR)- C27H44O2 JWUBBDSIWDLEOM-DTOXIADCSA-N (1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol United Research Laboratories Vitamins No No No No Yes No rxn06424,rxnDiet26 PMDBD2001800 alpha-Tocotrienol Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 5282347 n.a. NPC139047 alpha-Tocotrienol, 58864-81-6, D-alpha-Tocotrienol, zeta1-Tocopherol, D-|A-Tocotrienol, (R)-alpha-Tocotrienol, (2R,3''E,7''E)-alpha-Tocotrienol, 1721-51-3, Tocotrienol, alpha, B6LXL1832Y, (2R)-2,5,7,8-tetramethyl-2-[(3E,7E)-4,8,12-trimethyltrideca-3,7,11-trienyl]-3,4-dihydrochromen-6-ol, CHEBI:33270, (2R)-2,5,7,8-tetramethyl-2-[(3E,7E)-4,8,12-trimethyltrideca-3,7,11-trienyl]chroman-6-ol, (2R)-2,5,7,8-Tetramethyl-2-((3E,7E)-4,8,12-trimethyltrideca-3,7,11-trienyl)chroman-6-ol, 2H-1-Benzopyran-6-ol, 3,4-dihydro-2,5,7,8-tetramethyl-2-((3E,7E)-4,8,12-trimethyl-3,7,11-tridecatrienyl)-, (2R)-, 2H-1-Benzopyran-6-ol, 3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyl-3,7,11-tridecatrienyl)-, (R-(E,E))-, 2R,5,7,8-tetramethyl-2-[(3E,7E)-4,8,12-trimethyltrideca-3,7,11-trien-1-yl]-3,4-dihydro-2H-chromen-6-ol, alpha-Tocotrienol [MI], UNII-B6LXL1832Y, alpha -Tocotrienol, 2H-1-Benzopyran-6-ol, 3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyl-3,7,11-tridecatrienyl)-, [R-(E,E)]-, 2H-1-benzopyran-6-ol, 3,4-dihydro-2,5,7,8-tetramethyl-2-[(3E,7E)-4,8,12-trimethyl-3,7,11-tridecatrienyl]-, (2R)-, .alpha.-Tocotrienol, delta-alpha-tocotrienol, D-ALPHA TOCOTRIENOL, D-.ALPHA.-TOCOTRIENOL, SCHEMBL242672, CHEMBL120276, Tocotrienol, 5,7,8-trimethyl, SCHEMBL16430461, (R)-.ALPHA.-TOCOTRIENOL, .ALPHA.-TOCOTRIENOL [MI], DTXSID901019976, HMS3650C04, ALPHA-TOCOTRIENOL [WHO-DD], D-a-Tocotrienol (Rice) (>75%), LMPR02020054, MFCD11045308, alpha-Tocotrienol, analytical standard, VITAMIN E (ALPHA-TOCOTRIENOL), AKOS027326801, NCGC00253538-02, AS-78670, HY-129459, CS-0105636, NS00125196, (2R,3''E,7''E)-.ALPHA.-TOCOTRIENOL, D-alpha-Tocotrienol, analytical reference material, Q171833, SR-01000946263, J-010798, SR-01000946263-1, (2R)-2,5,7,8-tetramethyl-2-[(3E,7E)-4,8,12-trimethyltrideca-3,7,11-trien-1-yl]-3,4-dihydro-2H-chromen-6-ol, 2H-1-Benzopyran-6-ol, 3,4-dihydro-2,5,7,8-tetramethyl-2-[(3E,7E)-4,8,12-trimethyl-3,7,11-tridecatrienyl]-, (2R)- (9CI) C29H44O2 RZFHLOLGZPDCHJ-XZXLULOTSA-N (2R)-2,5,7,8-tetramethyl-2-[(3E,7E)-4,8,12-trimethyltrideca-3,7,11-trienyl]-3,4-dihydrochromen-6-ol n.a. n.a. No No No No Yes No rxn40276,rxnDiet32 PMDBD2001801 Brassicasterol Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 5281327 n.a. NPC35699 BRASSICASTEROL, 474-67-9, Brassicasterin, Ergosta-5,22(E)-dien-3beta-ol, Ergosta-5,22-dien-3-ol, (3b,22E)-, Ergosta-5,22E-dien-3beta-ol, 2B0KG2XFOF, (3S,8S,9S,10R,13R,14S,17R)-17-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol, 5,22-Cholestadien-24beta-methyl-3beta-ol, 24(R)-Methylcholesta-5,22E-dien-3beta-ol, UNII-2B0KG2XFOF, 24-Methylcholesta-5,22-dien-3beta-ol, EINECS 207-486-5, 5,22-Ergostadienol, (3beta,22E)-ergosta-5,22-dien-3-ol, 5,22-Ergostadien-3beta-ol, SCHEMBL165980, CHEBI:3168, BRASSICASTEROL [WHO-DD], DTXSID80197124, Brassicasterol, from semisynthetic, LMST01030098, MFCD00201659, AKOS040760305, (22E)-ergosta-5,22-dien-3beta-ol, 24-methyl cholest-5,22-dien-3beta-ol, AS-78829, HY-113289, CS-0059521, Ergosta-5,22-dien-3-ol, (3beta,22E)-, NS00031693, C08813, E80559, (3.BETA.,22E)-ERGOSTA-5,22-DIEN-3-OL, 24-METHYL CHOLEST-5,22-DIEN-3.BETA.-OL, Q2700587, (22E,24R)-24-methylcholesta-5,22-dien-3beta-ol C28H46O OILXMJHPFNGGTO-ZAUYPBDWSA-N (3S,8S,9S,10R,13R,14S,17R)-17-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol n.a. n.a. No No No No Yes No rxnDiet36 PMDBD2001802 Campesterol Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 173183 n.a. NPC162742 CAMPESTEROL, 474-62-4, Campesterin, Campest-5-en-3beta-ol, 24(R)-methylcholesterol, Campasterol, Ergost-5-en-3-ol, (3beta,24R)-, NSC 224330, CHEBI:28623, 24alpha-Methylcholesterol, Ergost-5-en-3beta-ol, (24R)-, (24R)-5-Ergosten-3b-ol, (24R)ergost-5-en-3beta-ol, (24R)-5-Ergosten-3beta-ol, (3S,8S,9S,10R,13R,14S,17R)-17-[(2R,5R)-5,6-dimethylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol, 5L5O665639, delta5-24-Isoergosten-3beta-ol, cholest 5-en-3-ol, 24-methyl, DTXSID801009891, UNII-5L5O665639, (3beta,24R)-ergost-5-en-3-ol, EINECS 207-484-4, NSC-224330, .DELTA.5-24-Isoergosten-3.beta.-ol, (24R)-24-methylcholest-5-en-3beta-ol, 24.alpha.-Methylcholesterol, Ergost-5-en-3-beta-ol, (24S)-beta-Methyl cholesterol, Ergost-5-en-3-ol, (3b,24R)-, Mieyajunsu A, MFCD28143670, (24R)-Methylcholest-5-en-3.beta.-ol, (8R,9S,10S,13R,14S,17R)-17-((2R,5R)-5,6-Dimethylheptan-2-yl)-10,13-dimethyl-4,5,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol, 24.alpha.-Methyl-5-cholesten-3.beta.-ol, Ergost-5-en-3-ol-, (24R, 3.beta.)-, 24a-Methylcholesterol, Campest-5-en-3-ol, CAMPESTEROL [MI], 24-alpha-Methylcholesterol, SCHEMBL94161, CAMPESTEROL [WHO-DD], 24-methyl-5-Cholestene-3-ol, CHEMBL520535, (24R)-Ergost-5-en-3b-ol, (3-beta)-Ergost-5-en-3-ol, 24a-Methyl-5-cholesten-3b-ol, DTXCID1020988, (24R)-5-Ergosten-3-beta-ol, (24R)-Ergost-5-en-3beta-ol, 24-Methylcholest-5-en-3beta-ol, (24R)-Ergost-5-en-3-beta-ol, (3b,24R)-Ergost-5-en-3-ol, (24R)-Methylcholest-5-en-3b-ol, 290299-12-6, 3 beta, 24R-ergost-5-en-3-ol, HY-N1459, LMST01030097, (3-beta-24R)-Ergost-5-en-3-ol, CS-6302, NCGC00522517-01, AC-34100, MS-26818, CAMPESTEROL (CONSTITUENT OF PYGEUM), 1ST000522, NS00009246, NS00077009, (3.BETA.,24R)-ERGOST-5-EN-3-OL, C01789, CAMPESTEROL (CONSTITUENT OF SAW PALMETTO), CAMPESTEROL (CONSTITUENT OF PYGEUM) [DSC], Q2756479, CAMPESTEROL (CONSTITUENT OF SAW PALMETTO) [DSC], BF0849B6-7A25-4057-93A9-EB053E920C49 C28H48O SGNBVLSWZMBQTH-PODYLUTMSA-N (3S,8S,9S,10R,13R,14S,17R)-17-[(2R,5R)-5,6-dimethylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol n.a. n.a. No No No No Yes No rxnDiet38 PMDBD2001803 beta-Cryptoxanthin Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 5281235 n.a. NPC164487 beta-Cryptoxanthin, Cryptoxanthin, 472-70-8, Caricaxanthin, Cryptoxanthine, Cryptoxanthol, beta-Caroten-3-ol, Kryptoxanthin, Neocryptoxanthin, Xanthrophyll 1, (3R)-Cryptoxanthin, Neo-beta-cryptoxanthin, (3R)-beta,beta-caroten-3-ol, 3-Hydroxy-beta-carotene, UNII-6ZIB13GI33, 6ZIB13GI33, E 161c, beta,beta-Caroten-3-ol, (3R)-, BETA-CRYPTOXANTHINE, CRYPTOXANTHIN (E 161C), DTXSID30912309, (1R)-3,5,5-trimethyl-4-[(1E,3E,5E,7E,9E,11E,13E,15E,17E)-3,7,12,16-tetramethyl-18-(2,6,6-trimethylcyclohexen-1-yl)octadeca-1,3,5,7,9,11,13,15,17-nonaenyl]cyclohex-3-en-1-ol, B-CRYPTOXANTHIN, Cryptoxanthins, Hydroxy-beta-carotene, all-trans-beta-Cryptoxanthin, b-Krypoxanthin, ??-Cryptoxanthin, beta -Cryptoxanthin, b,b-Caroten-3-ol, 3-Hydroxy-b-carotene, .beta.,.beta.-Caroten-3-ol, (3R)-, (3R)-?-Cryptoxanthin, beta,beta-carotene-3-ol, CRYPTOXANTHIN [MI], beta-Cryptoxanthin - 97%, .BETA.-CRYPTOXANTHIN, SCHEMBL24469, .BETA.-CAROTEN-3-OL, CRYPTOXANTHIN [WHO-DD], NEO-.BETA.-CRYPTOXANTHIN, CHEBI:10362, DTXCID301341331, 3-HYDROXY-.BETA.-CAROTENE, beta-Cryptoxanthin, >=97% (TLC), LMPR01070269, AKOS030567999, ALL-TRANS-.BETA.-CRYPTOXANTHIN, beta-CAROTEN-3-OL, (R)-ALL-TRANS-, HY-108059, CS-0027251, NS00121052, .BETA.-CAROTEN-3-OL, (R)-ALL-TRANS-, C08591, Q392062, 5-AMINOMETHYL-2-HYDROXY-BENZOICACIDMETHYLESTER, BETA-CRYPTOXANTHINE (CONSTITUENT OF SPIRULINA), BETA-CRYPTOXANTHINE (CONSTITUENT OF SPIRULINA) [DSC] C40H56O DMASLKHVQRHNES-FKKUPVFPSA-N (1R)-3,5,5-trimethyl-4-[(1E,3E,5E,7E,9E,11E,13E,15E,17E)-3,7,12,16-tetramethyl-18-(2,6,6-trimethylcyclohexen-1-yl)octadeca-1,3,5,7,9,11,13,15,17-nonaenyl]cyclohex-3-en-1-ol n.a. n.a. No No No No Yes No rxn38449,rxnDiet40 PMDBD2001804 Lutein Dietary Substance n.a. 127-40-2 DB00137 PA164748318 n.a. n.a. 5281243 4444655 NPC313179 "Lutein, XANTHOPHYLL, 127-40-2, Bo-Xan, Vegetable lutein, all-trans-Lutein, Vegetable luteol, trans-Lutein, Xantofyl, Lutein ester, all-trans-(+)-Xanthophyll, FloraGLO, FloraGLO Lutein, Lutein A, Lutein, all-trans-, all-trans-Xanthophyll, Lutamax, Oro Glo 7, beta,epsilon-Carotene-3,3''-diol, (3R,3''R,6''R)-, E 161b, Xanthophyll, all-trans-(+)-, Leutein, Lutein from tagetes erecta, OS 24, UNII-X72A60C9MT, (3R,3''R,6''R)-Lutein, INS NO.161B(I), X72A60C9MT, DTXSID8046749, CHEBI:28838, INS-161B(I), beta,epsilon-Carotene-3,3''-diol, Xanthophyll (~80%), E 161, EINECS 204-840-0, E-161B, E-161B(I), NSC 59193, NSC-59193, DTXCID6026749, (3R,3''R,6''R)-beta,epsilon-carotene-3,3''-diol, 180580-60-3, .beta.,.epsilon.-Carotene-3,3''-diol, .beta.,.epsilon.-Carotene-3,3''-diol, (3R,3''R,6''R)-, LUTEIN (USP-RS), LUTEIN [USP-RS], LUTEIN (MART.), LUTEIN [MART.], (1R)-4-[(1E,3E,5E,7E,9E,11E,13E,15E,17E)-18-[(1R,4R)-4-hydroxy-2,6,6-trimethylcyclohex-2-en-1-yl]-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaenyl]-3,5,5-trimethylcyclohex-3-en-1-ol, (1R,4R)-4-((1E,3E,5E,7E,9E,11E,13E,15E,17E)-18-((R)-4-hydroxy-2,6,6-trimethylcyclohex-1-en-1-yl)-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaen-1-yl)-3,5,5-trimethylcyclohex-2-enol, NSC59193, gamma Lutein, Lutein, gamma, (1R,4R)-4-((1E,3E,5E,7E,9E,11E,13E,15E,17E)-18-((4R)-4-HYDROXY-2,6,6-TRIMETHYL-1-CYCLOHEXEN-1-YL)-3,7,12,16-TETRAMETHYL-1,3,5,7,9,11,13,15,17-OCTADECANONAEN-1-YL)-3,5,5-TRIMETHYL-2-CYCLOHEXEN-1-OL, Leutin, Noon for Kids, Lutein; Xantofyl, (3R,3''R,6S)-4,5-DIDEHYDRO-5,6-DIHYDRO-BETA,BETA-CAROTENE-3,3''-DIOL, NCGC00167965-01, ()-Lutein, Lutein (Xanthophyll), Lutein - 5%, Xanthophyll, tech grade, LEUTEIN [VANDF], LUTEIN [VANDF], e-carotene-3,3''-diol, Lutein - 10%, Lutein - 20%, LUTEIN [DSC], LUTEIN [FCC], XANTHOPHYLL [MI], Xanthophyll, from marigold, XANTOFYL [WHO-DD], Lutein, analytical standard, SCHEMBL19342, |A,|A-carotene-3,3''-diol, 3,3''-Dihydroxy-alpha-carotene, CHEMBL173929, (invertedexclamationmarkA)-Lutein, BCBcMAP01_000190, HMS3886I13, HY-N6947, (3R,3''R)-dihydroxy-alpha-carotene, Tox21_112594, ( inverted exclamation markA)-Lutein, LMPR01070274, MFCD08435941, s5103, (3R,3''R,6R)-4,5-didehydro-5,6-dihydro-beta,beta-carotene-3,3''-diol, AKOS008901394, CCG-270087, DB00137, SMP1_000317, AS-63011, CAS-127-40-2, XL176941, XL176947, XL176948, CS-0015250, NS00019507, C08601, Q63409232, 4'',5''-Didehydro-6''-hydro-.beta.-carotene-3,3''-diol #, AB972DAC-E626-49F1-898D-598AF7729FD0, (3R,3''R,6R)-4,5-DIDEHYDRO-5,6-DIHYDRO-beta,beta-CAROTIN-3,3''-DIOL, Lutein, Pharmaceutical Secondary Standard; Certified Reference Material, (3R,3''R,6R)-4,5-DIDEHYDRO-5,6-DIHYDRO-.BETA.,.BETA.-CAROTENE-3,3''-DIOL, (3R,3''R,6R)-4,5-DIDEHYDRO-5,6-DIHYDRO-.BETA.,.BETA.-CAROTIN-3,3''-DIOL, .BETA.,.BETA.-CAROTENE-3,3''-DIOL, 4,5-DIDEHYDRO-5,6-DIHYDRO-, (3R,3''R,6R)-, beta,beta-CAROTENE-3,3''-DIOL, 4,5-DIDEHYDRO-5,6-DIHYDRO-, (3R,3''R,6R)-, 4-(18-(4-hydroxy-2,6,6-trimethyl-1-cyclohex-2-enyl)-3,7,12,16-tetramethyl-octadeca-1,3,5,7,9,11,13,15,17-nonaenyl)-3,5,5-trimethyl-cyclohex-3-en-1-ol" C40H56O2 KBPHJBAIARWVSC-RGZFRNHPSA-N (1R)-4-[(1E,3E,5E,7E,9E,11E,13E,15E,17E)-18-[(1R,4R)-4-hydroxy-2,6,6-trimethylcyclohex-2-en-1-yl]-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaenyl]-3,5,5-trimethylcyclohex-3-en-1-ol n.a. n.a. No No No No Yes No rxn15706,rxnDiet43 PMDBD2001805 Stigmasterol Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 5280794 n.a. NPC113733 STIGMASTEROL, 83-48-7, Stigmasterin, beta-Stigmasterol, Stigmasta-5,22-dien-3beta-ol, Stigmasta-5,22-dien-3-ol, (3b,22E)-, (24S)-5,22-Stigmastadien-3beta-ol, Stigmasta-5,22-dien-3-beta-ol, UNII-99WUK5D0Y8, Stigmasta-5,22-dien-3-ol, (3beta,22E)-, Delta5-Stigmasterol, .beta.-Stigmasterol, STIMASTEROL, 99WUK5D0Y8, CCRIS 7476, CHEBI:28824, HSDB 7683, (3beta,22E)-Stigmasta-5,22-dien-3-ol, NSC 8095, NSC-8095, EINECS 201-482-7, Wulzen anti-stiffness factor, Stigmasta-5,22-dien-3-ol, (3beta)-, Stigmasta-5,22-dien-3-ol, Stigmasta-5,22E-dien-3beta-ol, DTXSID801015733, Delta5,22-Stigmastadien-3beta-ol, MFCD00003630, 5,22-Cholestadien-24-ethyl-3beta-ol, GUINEA-PIG-ANTI-STIFFNESS FACTOR, (22E)-stigmasta-5,22-dien-3beta-ol, .delta.5,22-Stigmastadien-3.beta.-ol, 3beta-Hydroxy-24-ethyl-5,22-cholestadiene, (3.beta.,22E)-Stigmasta-5,22-dien-3-ol, (3S,8S,9S,10R,13R,14S,17R)-17-[(E,1R,4S)-4-ethyl-1,5-dimethyl-hex-2-enyl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol, 5,22-Stigmastadien-3beta-ol, Serposterol, b-stigmasterol, Stigmasta-5,22-dien-3.beta.-ol, D5-Stigmasterol, Stigmasterol, ~95%, STIGMASTEROL [MI], STIGMASTEROL [HSDB], SCHEMBL23999, .DELTA.5-STIGMASTEROL, STIGMASTEROL [WHO-DD], stigmasta-5,22t-dien-3b-ol, CHEMBL400247, stigmasta-5,22-dien-3-b-ol, DTXCID601473919, GLXC-13540, HY-N0131, (24S)-5,22-stigmastadien-3b-ol, BDBM50376364, HB4095, LMST01040123, s2361, 24aFH-stigmasta-5,22t-dien-3b-ol, AKOS022168193, 1ST7509, CS-7746, (24S)-Stigmast-5,22-dien-3beta-ol, (24xH)-stigmasta-5,22t-dien-3b-ol, 24-Ethyl-5,22-cholestadien-3beta-ol, (24aFH)-stigmasta-5,22t-dien-3b-ol, (24x)-ethylcholesta-5,22-dien-3b-ol, NCGC00142599-03, (3b,22E)-stigmasta-5,22-dien-3-ol, (3S,8S,9S,10R,13R,14S,17R)-17-((2R,5S,E)-5-ethyl-6-methylhept-3-en-2-yl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol, (3S,8S,9S,10R,13R,14S,17R)-17-[(E,2R,5S)-5-ethyl-6-methylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol, 14-((2E)(4S,1R)-4-ethyl-1,5-dimethylhex-2-enyl)(1S,5S,10S,11S,2R,14R,15R)-2,15 -dimethyltetracyclo[8.7.0.0<2,7>.0<11,15>]heptadec-7-en-5-ol, 24x-24-ethylcholest-5,22-dien-3b-ol, AS-15473, 24-Ethyl-5,22-cholestadien-3.beta.-ol, 5,22-Cholestadien-24beta-ethyl-3beta-ol, rac-(24xH)-stigmasta-5,22t-dien-3b-ol, STIGMASTEROL (CONSTITUENT OF PYGEUM), (24S)-24-Ethylcholesta-5,22-dien-3beta-ol, C05442, Q425004, STIGMASTEROL (CONSTITUENT OF PYGEUM) [DSC], STIGMASTEROL (CONSTITUENT OF SAW PALMETTO), Q-201746, STIGMASTEROL (CONSTITUENT OF SAW PALMETTO) [DSC], 3beta-HYDROXY-24-ETHYL-delta(SUP 5,22)-CHOLESTADIENE, 3.BETA.-HYDROXY-24-ETHYL-.DELTA.(SUP 5,22)-CHOLESTADIENE, Stigmasterol, certified reference material, 10 mg/mL in chloroform, 17-(4-ethyl-1,5-dimethyl-hex-2-enyl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol C29H48O HCXVJBMSMIARIN-PHZDYDNGSA-N (3S,8S,9S,10R,13R,14S,17R)-17-[(E,2R,5S)-5-ethyl-6-methylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol n.a. n.a. No No No No Yes No rxn23911,rxnDiet46 PMDBD2001806 (-)-gallocatechin gallate Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 199472 n.a. NPC300845 (-)-Gallocatechin gallate, 4233-96-9, (-)-Gallocatechol gallate, (2S,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl 3,4,5-trihydroxybenzoate, Gallocatechin gallate, (-)-, (-)-gallocatechin-3-O-gallate, (2S,3R)-2-(3,4,5-Trihydroxyphenyl)-3,4-dihydro-1(2H)-benzopyran-3,5,7-triol 3-(3,4,5-trihydroxybenzoate), [(2S,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl] 3,4,5-trihydroxybenzoate, IRW3C4Y31Q, (-)-Gallocatechin 3-gallate, CHEMBL264938, MFCD00214298, (2S,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl 3,4,5-trihydroxybenzoate, Gallocatechol, 3-gallate, (-)-, UNII-IRW3C4Y31Q, (-)-Gallocatechin 3-O-gallate, Gallocatechin gallate (Gcg), CCRIS 9286, GCG, L-GCG, Gallocatechingallate(-GCG), ent-Gallocatechin 3-gallate, SCHEMBL49461, Benzoic acid, 3,4,5-trihydroxy-, 3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl ester, (2S-trans)-, NVP-XAA 225, CHEBI:95002, DTXSID20195144, CHEBI:156271, WMBWREPUVVBILR-NQIIRXRSSA-N, HY-N0522, BDBM50236531, s9058, AKOS015901852, AC-6044, CCG-269313, CS-7698, NCGC00390250-01, 1ST40201, BS-50638, (-)-Gallocatechin gallate, analytical standard, A11681, Q-100471, BRD-K19216856-001-01-9, Q27166763, (-)-Gallocatechin gallate, from green tea, >=98% (HPLC), (2S,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl3,4,5-trihydroxybenzoate, (2S,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate, BENZOIC ACID, 3,4,5-TRIHYDROXY-, (2S,3R)-3,4-DIHYDRO-5,7-DIHYDROXY-2-(3,4,5-TRIHYDROXYPHENYL)-2H-1-BENZOPYRAN-3-YL ESTER C22H18O11 WMBWREPUVVBILR-NQIIRXRSSA-N [(2S,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl] 3,4,5-trihydroxybenzoate n.a. n.a. No No No No Yes No rxnDiet59,rxnAdd52 PMDBD2001807 (-)-Epicatechin Dietary Substance, Therapeutic Substance Phase 1/2 n.a. n.a. n.a. n.a. D05TPI 72276 n.a. NPC126029 "(-)-Epicatechin, Epicatechin, 490-46-0, L-Epicatechin, (-)-Epicatechol, Epicatechol, l-Acacatechin, epi-Catechin, epi-Catechol, (2R,3R)-2-(3,4-Dihydroxyphenyl)chroman-3,5,7-triol, l-Epicatechol, (-)epicatechin, (2R,3R)-(-)-Epicatechin, (2R,3R)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol, (-)-epi catechin, CCRIS 7097, CHEBI:90, EINECS 207-710-1, UNII-34PHS7TU43, NSC 81161, Epicatechol, (-)-, 34PHS7TU43, 2,3-cis-epicatechin, DTXSID4045133, (-)-(2R:3R)-5,7,3'',4''-Tetrahydroxyflavan-3-ol, C15H14O6, NSC-81161, (2R,3R)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3,5,7-triol, 2H-1-Benzopyran-3,5,7-triol, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-, (2R,3R)-, DTXCID2025133, 2-(3,4-Dihydroxyphenyl)-2,3,4-trihydro-3,5,7-trihydroxychromene, 2H-1-Benzopyran-3,5,7-triol, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-, (2R-cis)-, (-)-cis-Epicatechin, 2H-1-Benzopyran-3,5,7-triol, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-,(2R,3R)-, (2R,3R)-2-(3,4-dihydroxyphenyl)chromane-3,5,7-triol, Epicatechin-(-), (-)-EPICATECHIN (USP-RS), (-)-EPICATECHIN [USP-RS], CAS-490-46-0, SMR000156230, Acacatechin, Colatein, alpha-catechin, Kakaol, NSC81161, Teacatechin I, .alpha. Catechin, NCGC00015215-02, 28E, L(-)-Epicatechin, Prestwick_203, (-)-cis-3,3'',4'',5,7-Pentahydroxyflavane, L-Epicatechin ,(S), Spectrum_000159, SpecPlus_000267, Spectrum2_000675, Spectrum3_000243, Spectrum4_000949, Spectrum5_000929, Lopac-C-1251, Oprea1_209947, SCHEMBL19412, BSPBio_001626, KBioGR_001538, KBioSS_000639, SPECTRUM210206, cid_72276, MLS001304012, MLS001304152, DivK1c_006363, SPBio_000769, CHEMBL583912, L-EPICATECHIN [WHO-DD], ACon1_001106, BCBcMAP01_000224, BDBM23417, GTPL12497, KBio1_001307, KBio2_000639, KBio2_003207, KBio2_005775, KBio3_001126, HMS1923M05, KUC104404N, HY-N0001, Tox21_110101, 3,3'',4'',5,7-Pentahydroxyflavane, CCG-38571, LMPK12020003, s4723, (-)-Epicatechin, analytical standard, AKOS015895981, Tox21_110101_1, (-)-Epicatechin, >=90% (HPLC), CS-3760, DB12039, DS-3358, KSC-10-144, SDCCGMLS-0066927.P001, SMP1_000115, NCGC00015215-01, NCGC00016415-01, NCGC00016415-02, NCGC00016415-03, NCGC00016415-04, NCGC00017331-08, AC-14586, BP-30203, CAS-154-23-4, CAS-7295-85-4, 1ST000539, E1226, NS00093637, (-)-Epicatechin 1000 microg/mL in Acetone, C09727, O10053, (-)-Epicatechin 1000 microg/mL in Acetonitrile, A871843, (-)-Epicatechin, >=98% (HPLC), from green tea, Q-200001, CF3BA0C2-DE1B-44AB-A4D3-800F017221BA, Epicatechin, primary pharmaceutical reference standard, Q23050136, (-)-EPICATECHIN (CONSTITUENT OF MARITIME PINE), (2R,3R)-2-(3,4-Dihydroxyphenyl)-3,5,7-chromanetriol, (-)-EPICATECHIN (CONSTITUENT OF MARITIME PINE) [DSC], (-)-EPICATECHIN (CONSTITUENT OF GRAPE SEEDS OLIGOMERIC PROANTHOCYANIDINS), (-)-EPICATECHIN(EG) (CONSTITUENT OF POWDERED DECAFFEINATED GREEN TEA EXTRACT), (2R-cis)-2-(3,4-Dihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3,5,7-triol, 2-(3,4-dihydroxyphenyl)-2,3,4-trihydro-3,5,7-trihydroxychromene;L-Epicatechin" C15H14O6 PFTAWBLQPZVEMU-UKRRQHHQSA-N (2R,3R)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol n.a. n.a. No No No No Yes No rxn43189,rxnDiet60,rxnAdd53,rxnAdd54 PMDBD2001808 (-)-epicatechin-3-O-gallate Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 107905 n.a. NPC160512 (-)-Epicatechin gallate, 1257-08-5, Epicatechin gallate, (-)-epicatechingallate, (-)-Epicatechin-3-O-gallate, L-Epicatechin gallate, epicatechin monogallate, (-)-Epicatechin-3-gallate, Teatannin, (-)-Epicatechin 3-O-gallate, ECG, Epicatechol, gallate, 3-O-Galloylepicatechin, epicatechin-3-O-gallate, (-)-cis-3,3'',4'',5,7-Pentahydroxyflavane 3-gallate, 3-Gallate(-)-Epicatechol, CHEMBL36327, [(2R,3R)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3,4-dihydro-2H-chromen-3-yl] 3,4,5-trihydroxybenzoate, CHEBI:70255, 92587OVD8Z, MFCD00075936, (2R,3R)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxychroman-3-yl 3,4,5-trihydroxybenzoate, Epicatechin-3-galloyl ester, Benzoic acid, 3,4,5-trihydroxy-, (2R,3R)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-5,7-dihydroxy-2H-1-benzopyran-3-yl ester, Epicatechin 3-gallate, epi-Catechin 3-O-gallate, epicatechin gallate, (2R-cis)-isomer, NSC 636594, UNII-92587OVD8Z, NSC636594, (2R,3R)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3,4-dihydro-2H-chromen-3-yl 3,4,5-trihydroxybenzoate, Epicatechol, 3-gallate, (-)-, NSC-636594, (-)epicatechingallate, Spectrum_000314, L-ECG, SpecPlus_000275, (-) epicatechin gallate, epicatechin-gallate-(-), Spectrum2_000165, Spectrum3_000246, Spectrum4_001540, Spectrum5_000080, epicatechin gallate (ECG), (-)-Epicatechin 3-gallate, (?)-Epicatechin 3-gallate, SCHEMBL39047, BSPBio_001632, EPICATECHOL 3-GALLATE, KBioGR_001980, KBioSS_000794, SPECTRUM210238, Benzoic acid, 3,4,5-trihydroxy-, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-5,7-dihydroxy-2H-1-benzopyran-3-yl ester, (2R-cis)-, DivK1c_006371, EPICATECHINGALLATE, L-, SPBio_000029, (-)EPICATECHIN GALLATE, MEGxp0_000810, EPICATECHIN 3-O-GALLATE, GTPL12462, KBio1_001315, KBio2_000794, KBio2_003362, KBio2_005930, KBio3_001132, DTXSID70925231, 3,4,5-Trihydroxy-benzoic acid 2-(3,4-dihydroxy-phenyl)-5,7-dihydroxy-chroman-3-yl ester, HY-N0002, BDBM50153015, CCG-38376, LMPK12020090, s3925, AKOS015965216, AC-6037, AM84365, CS-3761, SDCCGMLS-0066549.P001, (-)-cis-2-(3,4-Dihydroxyphenyl)-3,4-dihydro-1(2H)-benzopyran-3,5,7-triol 3-gallate, (-)-EPI CATECHIN-3-O-GALLATE, [(2R,3R)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-chroman-3-yl] 3,4,5-trihydroxybenzoate, NCGC00179135-01, NCGC00179135-02, 1ST40120, AS-15722, E0890, NS00094557, SR-05000002675, Q-200002, Q5382492, SR-05000002675-1, BRD-K50660797-001-01-0, BRD-K50660797-001-03-6, (-)-Epicatechin gallate, >=98% (HPLC), from green tea, Epicatechin gallate, primary pharmaceutical reference standard, rel-(2R,3R)-2-(3,4-Dihydroxyphenyl)-5,7-dihydroxychroman-3-yl 3,4,5-trihydroxybenzoate, (2R,3R)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3,4-dihydro-2H-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate, 3,4,5-Trihydroxy-benzoic acid (2R,3R)-2-(3,4-dihydroxy-phenyl)-5,7-dihydroxy-chroman-3-yl ester, Benzoic acid, 3,4,5-trihydroxy-, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-5,7- dihydroxy-2H-1-benzopyran-3-yl ester, (-)-cis- C22H18O10 LSHVYAFMTMFKBA-TZIWHRDSSA-N [(2R,3R)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3,4-dihydro-2H-chromen-3-yl] 3,4,5-trihydroxybenzoate n.a. n.a. No No No No Yes No rxnDiet61,rxnAdd55 PMDBD2001809 (-)-Epigallocatechin Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 72277 n.a. NPC220825 "(-)-Epigallocatechin, Epigallocatechin, 970-74-1, Epigallocatechol, L-Epigallocatechin, epi-Gallocatechin, Antiscurvy factor C2, (-)-Epigallocatechol, l-Epigallocatechol, Galloepicatechin, 3,3'',4'',5,5'',7-Flavanhexol, (-)-epi-Gallocatechin, Sunphenon EGC, Factor C2 (antiscurvy), (-)-3,3'',4'',5,5'',7-Flavanhexol, 2,3-cis-epigallocatechin, Antiscurvy factor C(sub 2), EGC, (2R,3R)-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol, CCRIS 5441, UNII-7Z197MG6QL, 7Z197MG6QL, CHEBI:42255, 1-epi-3'',4'',5,5'',7-Pentahydroxy-3-Flavan, NSC 674039, NSC-674039, CHEMBL47386, (2R,3R)-2-(3,4,5-trihydroxyphenyl)chromane-3,5,7-triol, (-)-EGC, DTXSID40891550, (-)-cis-3,3'',4'',5,5'',7-Hexahydroxyflavane, MFCD00075939, 2H-1-Benzopyran-3,5,7-triol, 3,4-dihydro-2-(3,4,5-trihydroxyphenyl)-, (2R-cis)-, 2-(3,4,5-TRIHYDROXY-PHENYL)-CHROMAN-3,5,7-TRIOL, (-)-cis-2-(3,4,5-Trihydroxyphenyl)-3,4-dihydro-1(2H)-benzopyran-3,5,7-triol, (-)EPIGALLOCATECHIN, (2R,3R)-2-(3,4,5-trihydroxyphenyl)chroman-3,5,7-triol, 2H-1-BENZOPYRAN-3,5,7-TRIOL, 3,4-DIHYDRO-2-(3,4,5-TRIHYDROXYPHENYL)-, (2R,3R)-, Teacatechin II, NSC674039, Epigallocatechin;EGC;L-Epigallocatechin, (-) epigallocatechin, epigallocatechin-(-), epigallocatechin (egc), Spectrum_000806, SpecPlus_000269, Spectrum2_000703, Spectrum3_000248, Spectrum4_000950, Spectrum5_000889, (-)-Epigallocatechin/EGC, (-)-Epigallocatechin(EGC), SCHEMBL19553, BSPBio_001636, KBioGR_001540, KBioSS_001286, SPECTRUM205113, DivK1c_006365, SPBio_000885, BCBcMAP01_000207, GTPL12461, KBio1_001309, KBio2_001286, KBio2_003854, KBio2_006422, KBio3_001136, DTXCID501030643, GLXC-13576, EGC, (-)-EPIGALLOCATECHIN, HY-N0225, (-)-Epigallocatechin from green tea, AC-394, BDBM50187665, CCG-38353, LMPK12020004, s3922, AKOS015965244, CS-3762, DB03823, DS-5807, SDCCGMLS-0066479.P001, (2R,3R)-3,4-Dihydro-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3,5,7-triol, SMP1_000114, NCGC00179131-01, NCGC00179131-02, (-)-Epigallocatechin, analytical standard, 124107-38-6, 1ST40119, NCI60_026204, (3,3'',4'',5,5'',7-Hexahydroxyflavan), E1084, NS00014558, (-)-3,5,7,3'',4'',5''-Hexahydroxylflavan, (-)-cis-3,3'',4'',5,5'',7-Hexahydroxyflavan, Epigallocatechin 1000 microg/mL in Acetonitrile, A846754, SR-05000002564, Q-200003, Q3044728, SR-05000002564-1, Q51617505, (-)-Epigallocatechin, >=95% (HPLC), from green tea, 3beta-Hydroxy-5alpha-pregnan-20-one Sulfate Pyridine Salt, C24E9F59-8F06-44E2-B2DE-FF132A8774F3, Epigallocatechin, primary pharmaceutical reference standard, rel-(2R,3R)-2-(3,4,5-Trihydroxyphenyl)chromane-3,5,7-triol, cis-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-1(2H)-benzopyran-3,5,7-triol, (-)-EPIGALLOCATECHIN(EGC) (CONSTITUENT OF POWDERED DECAFFEINATED GREEN TEA EXTRACT), (-)cis-2-(3,4,5-Trihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3,5,7-triol, 2H-1-Benzopyran-3,7-triol, 3,4-dihydro-2-(3,4,5-trihydroxyphenyl)-, (2R-cis)-, 5,7-triol,3,4-dihydro-2-(3,4,5-trihydroxyphenyl)-2h-1-benzopyran-(2r-cis, (-)-epigallocatechol;3,3?,4?,5,5?,7-flavanhexol;5,7-triol,3,4-dihydro-2-(3,4,5-trihydroxyphenyl)-2h-1-benzopyran-(2r-cis, 188819-07-0" C15H14O7 XMOCLSLCDHWDHP-IUODEOHRSA-N (2R,3R)-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol n.a. n.a. No No No No Yes No rxnDiet62,rxnAdd56,rxnAdd57 PMDBD2001810 Epigallocatechin 3-gallate Dietary Substance n.a. n.a. n.a. n.a. n.a. D0U2BH 65064 n.a. NPC250436 "(-)-Epigallocatechin gallate, EGCG, 989-51-5, Epigallocatechin gallate, Epigallocatechin 3-gallate, Tea catechin, Epigallocatechin-3-gallate, Teavigo, Epigallocatechin-3-monogallate, (-)-Epigallocatechin-3-o-gallate, (-)-epigallocatechin 3-gallate, PF-EGCg 90, (-)-Epigallocatechol gallate, NVP-XAA 723, CCRIS 3729, (2R,3R)-5,7-Dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl 3,4,5-trihydroxybenzoate, Catechin deriv., UNII-BQM438CTEL, BQM438CTEL, epigallocatechin-3-O-gallate, CHEBI:4806, Epigallocatechingallate, Epigallocatechin-gallate, Epigallocatechol, 3-gallate, (-)-, (2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl 3,4,5-trihydroxybenzoate, CHEMBL297453, [(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl] 3,4,5-trihydroxybenzoate, DTXSID1029889, [(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl] 3,4,5-trihydroxybenzoate, Benzoic acid, 3,4,5-trihydroxy-, (2R,3R)-3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl ester, EGCG cpd, (-)-Epigallocatechin Gallate (Standard), (2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate, Gallic acid, 3-ester with epigallocatechol, (-)-, DTXCID80567, (-)-cis-3,3'',4'',5,5'',7-Hexahydroxy-flavane-3-gallate, epigallo-catechin gallate, (-)-cis-2-(3,4,5-Trihydroxyphenyl)-3,4-dihydro-1(2H)-benzopyran-3,5,7-triol 3-gallate, Benzoic acid, 3,4,5-trihydroxy-, 3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl ester, (2R-cis)-, CAS-989-51-5, SMR000449288, SR-01000759328, (-)-EPIGALLOCATECHIN-3-O-GALLATE (USP-RS), (-)-EPIGALLOCATECHIN-3-O-GALLATE [USP-RS], L-Epigallocatechin gallate, Epigallocate, Sunphenon, EPIGALOCATECHIN GALLATE, (-)-EGCG, Epigallocic acid, Teatannin II, 2kdh, 3oob, 4awm, (-)-epigallocatechin 3-O-gallate, KDH, Epigallocatcchin Gallate, Epigallocatechol Gallate, Spectrum_000316, SpecPlus_000277, Spectrum2_000168, Spectrum3_000244, Spectrum4_001541, Spectrum5_000102, Galloyl-L-epigallocatechol, EGCG [WHO-DD], EGCG [MI], 3-O-Galloylepigallocatechin, (-)-Epigallocatechin gallat, (-)-Epigallocatehin gallate, SCHEMBL35258, BSPBio_001628, epigallocatechin-gallate-(-), KBioGR_002002, KBioSS_000796, SPECTRUM210239, cid_65064, MLS000758300, MLS001424000, DivK1c_006373, SPBio_000035, Epigallocatechin monogallate, B, GTPL7002, MEGxp0_001166, (-)-Epigallocatechin-3-gallate, ACon1_001054, KBio1_001317, KBio2_000796, KBio2_003364, KBio2_005932, KBio3_001128, HMS2051K21, HMS3649E08, 3-O-Galloyl-(-)-epigallocatechin, EPIGALLOCATECHIN 3-O-GALLATE, Tox21_201468, Tox21_303457, BDBM50070942, CCG-38378, FR-109, HY-13653R, LMPK12030005, MFCD00075940, s2250, AKOS015918182, CS-1258, DB12116, DS-9030, EPIGALLOCATECHIN GALLATE [INCI], NC00078, SDCCGMLS-0066550.P001, (-)-Epigallocatechin gallate, >=95%, (-)-Epigallocatechin-3-gallate; EGCG, NCGC00164319-01, NCGC00164319-02, NCGC00164319-03, NCGC00164319-04, NCGC00164319-06, NCGC00257243-01, NCGC00259019-01, (-)-Epigallocatechin gallate (85% (-)-epigallocatechin gallate, 10% (-)-epigallocatechin, 5% (-)- epicatechin gallate), 1ST40118, AC-34075, BP-30205, HY-13653, CS-0694875, E0694, NS00015163, SW197458-3, C09731, M01719, (-)-Epigallocatechin gallate, >=97.0% (HPLC), (-)-Epigallocatechin gallate, analytical standard, A845931, Q393339, SR-01000946601, Q-100914, SR-01000759328-5, SR-01000759328-6, SR-01000946601-1, Epigallocatechin-3-gallate 1000 microg/mL in Acetonitrile, (-)-Epigallocatechin gallate, >=80% (HPLC), from green tea, Epigallocatechin gallate, primary pharmaceutical reference standard, ((2R,3R)-2-(3,4,5-trihydroxyphenyl)-5,7-dihydroxy-chroman-3-yl) 3,4,5-trihydroxybenzoate, (-)-Epigallocatechin-3-O-gallate, United States Pharmacopeia (USP) Reference Standard, (2R,3R)-5,7-Dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl3,4,5-trihydroxybenzoate, [5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl] 2,3,4-trihydroxybenzoate, Epigallocatechin gallate, Pharmaceutical Secondary Standard; Certified Reference Material, (-)-cis-3,4-Dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-1(2H)-benzopyran-3-yl Gallate, (-)-EPIGALLOCATECHIN GALLATE (85% (-)-EPIGALLOCATECHIN GALLATE, 10% (-)-EPIGALLOCATECHIN, 5% (-)-EPICATECHIN GALLATE), (-)-EPIGALLOCATECHIN-3-O-GALLATE (EGCG) (CONSTITUENT OF POWDERED DECAFFEINATED GREEN TEA EXTRACT), (2R,3R)-5,7-Dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl-3,4,5-trihydroxybenzoate, (2R-cis)-3,4-Dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl 3,4,5-Trihydroxybenzoate, [(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl]3,4,5-trihydroxybenzoate, 2041570-28-7, 3,4,5-Trihydroxybenzoic acid (2R,3R)-3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl ester, 3,4-Dihydro-5,7-dihydroxy-2R-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3R-yl-3,4,5-trihydroxybenzoate, Benzoic acid, 3,4,5-trihydroxy-,(2R,3R)-3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl ester" C22H18O11 WMBWREPUVVBILR-WIYYLYMNSA-N [(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl] 3,4,5-trihydroxybenzoate Anagen Therapeutics Inc n.a. No No No No Yes No rxnDiet63,rxnAdd58 PMDBD2001811 3,7-Di-O-methylquercetin Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 5280417 n.a. NPC188871 3,7-Di-O-methylquercetin, 2068-02-2, Quercetin 3,7-dimethyl ether, 3,7-Dimethylquercetin, 2-(3,4-Dihydroxyphenyl)-5-hydroxy-3,7-dimethoxy-4-benzopyrone, 3,7-O-dimethylquercetin, 3'',4'',5-Trihydroxy-3,7-dimethoxyflavone, 5,3'',4''-Trihydroxy-3,7-dimethoxyflavone, Quercetin 3,7-di-O-methyl ether, V8R92XSR1M, 3,7-Dimethoxy-5,3'',4''-trihydroxyflavone, CHEMBL164861, 2-(3,4-dihydroxyphenyl)-5-hydroxy-3,7-dimethoxychromen-4-one, CHEBI:18010, 2-(3,4-Dihydroxyphenyl)-5-hydroxy-3,7-dimethoxy-4H-chromen-4-one, 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-5-hydroxy-3,7-dimethoxy-, Flavone, 3'',4'',5-trihydroxy-3,7-dimethoxy-, UNII-V8R92XSR1M, C01265, Quercetin-3,7-dimethylether, FENOFIBRICACIDETHYLESTER, SCHEMBL828941, DTXSID40174734, HY-N1798, EINECS 218-187-4, BDBM50240897, LMPK12112731, AKOS025288164, FS-8747, PD119377, CS-0017651, NS00045988, 3'''',4'''',5-trihydroxy-3,7-dimethoxyflavone, Q27102757, 2-(3, 4-dihydroxyphenyl)-5-hydroxy-3, 7-dimethoxychromen-4-one, 2-(3,4-dihydroxyphenyl)-5-hydroxy-3,7-dimethoxy-chromen-4-one, 2-(3,4-Dihydroxyphenyl)-5-hydroxy-3,7-dimethoxy-4H-chromen-4-one # C17H14O7 LUJAXSNNYBCFEE-UHFFFAOYSA-N 2-(3,4-dihydroxyphenyl)-5-hydroxy-3,7-dimethoxychromen-4-one n.a. n.a. No No No No Yes No rxnDiet65,rxnAdd120 PMDBD2001812 3-Hydroxybenzoate Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 54675842 n.a. NPC187911 3-Hydroxybenzoate, Benzoic acid, 3-hydroxy-, ion(1-), 10476-50-3, CHEBI:16193, DTXSID501299499, Q27098580 C7H5O3- IJFXRHURBJZNAO-UHFFFAOYSA-M 3-carboxyphenolate n.a. n.a. No No No No Yes No rxnDiet67,rxnAdd35 PMDBD2001813 p-Ethylphenol Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 31242 n.a. NPC197783 4-ETHYLPHENOL, 123-07-9, p-Ethylphenol, Phenol, 4-ethyl-, Phenol, p-ethyl-, 1-Ethyl-4-hydroxybenzene, 1-Hydroxy-4-ethylbenzene, para-Ethylphenol, 4-Hydroxyphenylethane, 4-ethyl-phenol, FEMA No. 3156, Paraethylphenol, Phenol, 3(or 4)-ethyl-, MFCD00002393, AGG7E6G0ZC, 29471-88-3, DTXSID4021977, CHEBI:49584, BENZENE,1-ETHYL,4-HYDROXY, NSC-62012, 4-ETHYLPHENOL-2,3,5,6-D4, OD, DTXCID801977, 4-Hydroxyethylbenzene, Hydroxyphenylethane, p-, 4-ethyl phenol, CAS-123-07-9, HSDB 5598, EINECS 204-598-6, UNII-AGG7E6G0ZC, NSC 62012, BRN 1363317, 4-ethylphenole, AI3-26063, p-ethyl phenol, 4-ethyl- phenol, 4-ethyl-phenyl alcohol, 2ra6, 4-ETILFENOL, (4-hydroxyphenyl)ethane, 4-Ethylphenol, 99%, bmse000681, P-HYDROXYETHYLBENZENE, SCHEMBL28713, P-ETHYLPHENOL [FHFI], 4-06-00-03020 (Beilstein Handbook Reference), 4-ETHYLPHENOL [HSDB], BIDD:ER0028, (P-HYDROXYPHENYL)ETHANE, CHEMBL108475, SGCUT00257, 4-Ethylphenol, >=98%, FG, AMY8780, NSC62012, P-ETHYLPHENOL [EP IMPURITY], to_000047, Tox21_201533, Tox21_302986, p-Ethylphenol, 4-Hydroxyphenylethane, s6308, 4-Ethylphenol, >=97.0% (GC), AKOS000120205, CCG-356389, CS-W013552, HY-W012836, NCGC00249062-01, NCGC00256558-01, NCGC00259083-01, BS-14729, 4-Ethylphenol 10 microg/mL in Acetonitrile, 4-Ethylphenol 1000 microg/mL in Methanol, METACRESOL IMPURITY K [EP IMPURITY], E0159, NS00010739, EN300-20678, D70486, 4-Ethylphenol, PESTANAL(R), analytical standard, Q409853, W-108417, F1908-0166, Z104479728, InChI=1/C8H10O/c1-2-7-3-5-8(9)6-4-7/h3-6,9H,2H2,1H, 152399-67-2, ETY C8H10O HXDOZKJGKXYMEW-UHFFFAOYSA-N 4-ethylphenol n.a. n.a. No No No No Yes No rxn25876,rxnDiet69,rxnAdd227 PMDBD2001814 O-Feruloylquinate Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 10177048 n.a. NPC112704 4-Feruloylquinic acid, 4-O-feruloyl-D-quinic acid, 2613-86-7, 4-O-Feruloylquinic acid, (3R,5R)-1,3,5-trihydroxy-4-[(E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxycyclohexane-1-carboxylic acid, (1S,3R,4S,5R)-1,3,5-trihydroxy-4-{[(2E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxy}cyclohexanecarboxylic acid, O-Feruloylquinate, CHEBI:18013, CHEBI:176888, CHEBI:189458, HY-N6598, AKOS040760225, NCGC00380877-01, 4-O-(E)-Feruloylquinic Acid (~90%), 96646-16-1, MS-25895, PD166562, CS-0034325, NS00097304, E88717, Q27102761, (3r,5r)-1,3,5-trihydroxy-4-{[(2e)-3-(4-hydroxy-3-methoxyphenyl)-2-propenoyl]oxy}cyclohexanecarboxylic acid, NCGC00380877-01_C17H20O9_Cyclohexanecarboxylic acid, 1,3,5-trihydroxy-4-[[(2E)-3-(4-hydroxy-3-methoxyphenyl)-1-oxo-2-propen-1-yl]oxy]-, (1alpha,3alpha,4alpha,5beta)- C17H20O9 VTMFDSJJVNQXLT-XQCMRRNBSA-N (3R,5R)-1,3,5-trihydroxy-4-[(E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxycyclohexane-1-carboxylic acid n.a. n.a. No No No No Yes No rxnDiet73,rxnAdd151 PMDBD2001815 Malonylglycitin Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 23724657 n.a. NPC273687 6''''-O-MALONYLGLYCITIN, Malonylglycitin, Glycitin 6''''-O-Malonate, Glycitein 6''''-O-Malonylglucoside, 7625LXB9M8, UNII-7625LXB9M8, 3-oxo-3-[[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[3-(4-hydroxyphenyl)-6-methoxy-4-oxochromen-7-yl]oxyoxan-2-yl]methoxy]propanoic acid, 3-(4-Hydroxyphenyl)-6-methoxy-4-oxo-4H-chromen-8-yl 6-O-(carboxyacetyl)-beta-D-glucopyranoside, 4H-1-Benzopyran-4-one, 7-((6-O-(2-carboxyacetyl)-beta-D-glucopyranosyl)oxy)-3-(4-hydroxyphenyl)-6-methoxy-, malonyl glycitin, Malonyl-glycitin, 4H-1-BENZOPYRAN-4-ONE, 7-((6-O-(2-CARBOXYACETYL)-.BETA.-D-GLUCOPYRANOSYL)OXY)-3-(4-HYDROXYPHENYL)-6-METHOXY-, 4H-1-Benzopyran-4-one, 7-[[6-O-(2-carboxyacetyl)-.beta.-D-glucopyranosyl]oxy]-3-(4-hydroxyphenyl)-6-methoxy-, CHEBI:80374, DTXSID701314722, NS00094570, Q27149386, MALONYL GLYCITIN (CONSTITUENT OF SOY ISOFLAVONES) [DSC], 3-(4-hydroxyphenyl)-6-methoxy-4-oxo-4H-1-benzopyran-7-yl 6-O-(carboxyacetyl)-beta-D-glucopyranoside, 3-(4-HYDROXYPHENYL)-6-METHOXY-4-OXO-4H-CHROMEN-8-YL 6-O-(CARBOXYACETYL)-.BETA.-D-GLUCOPYRANOSIDE, 3-oxo-3-{[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-{[3-(4-hydroxyphenyl)-6-methoxy-4-oxo-4H-chromen-7-yl]oxy}oxan-2-yl]methoxy}propanoic acid C25H24O13 OWMHCYFEIJPHFB-GOZZSVHWSA-N 3-oxo-3-[[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[3-(4-hydroxyphenyl)-6-methoxy-4-oxochromen-7-yl]oxyoxan-2-yl]methoxy]propanoic acid n.a. n.a. No No No No Yes No rxnDiet76,rxnAdd174 PMDBD2001816 Flavaprenin Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 480764 n.a. NPC32739 8-Prenylnaringenin, 53846-50-7, Sophoraflavanone B, Flavaprenin, (-)-8-Prenylnaringenin, (S)-8-dimethylallylnaringenin, 8-?Prenylnaringenin, (2S)-5,7-dihydroxy-2-(4-hydroxyphenyl)-8-(3-methylbut-2-enyl)-2,3-dihydrochromen-4-one, (-)-(2S)-8-dimethylallylnaringenin, 5L872SZR8X, CHEMBL376915, YS04, CHEBI:50207, (-)-(2S)-5,7-dihydroxy-2-(4-hydroxyphenyl)-8-(3-methylbut-2-enyl)chroman-4-one, (S)-5,7-DIHYDROXY-2-(4-HYDROXYPHENYL)-8-(3-METHYLBUT-2-EN-1-YL)CHROMAN-4-ONE, (2S)-5,7-dihydroxy-2-(4-hydroxyphenyl)-8-(3-methylbut-2-en-1-yl)-2,3-dihydro-4H-chromen-4-one, 8-prenyl-naringenin, (2S)-5,7-dihydroxy-2-(4-hydroxyphenyl)-8-(3-methylbut-2-en-1-yl)-3,4-dihydro-2H-1-benzopyran-4-one, HOPEIN, (s)-8-prenylnaringenin, 8-dimethylallylnaringenin, UNII-5L872SZR8X, 8-prenylnaringenin (8-PN), BIDD:ER0149, cid_509245, SCHEMBL1171435, BDBM19460, DTXSID60333083, LPEPZZAVFJPLNZ-SFHVURJKSA-N, AIDS095901, GLXC-09019, HY-N2787, AKOS032948436, 8-Prenylnaringenin, analytical standard, AT10700, 8-Prenylnaringenin (Sophoraflavanone B), AC-35053, AS-82967, PD017477, CS-0023305, NS00067003, C18023, A936797, EN300-19006927, Q4644281, (2S)-5,7-dihydroxy-2-(4-hydroxyphenyl)-8-(3-methylbut-2-enyl)chroman-4-one, 5,7-Dihydroxy-2-(4-hydroxy-phenyl)-8-(3-methyl-but-2-enyl)-1-benzopyran-4-one, 4H-1-BENZOPYRAN-4-ONE, 2,3-DIHYDRO-5,7-DIHYDROXY-2-(4-HYDROXYPHENYL)-8-(3-METHYL-2-BUTEN-1-YL)-, (2S)- C20H20O5 LPEPZZAVFJPLNZ-SFHVURJKSA-N (2S)-5,7-dihydroxy-2-(4-hydroxyphenyl)-8-(3-methylbut-2-enyl)-2,3-dihydrochromen-4-one n.a. n.a. No No No No Yes No rxnDiet78 PMDBD2001817 Vicenin-2 Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 442664 n.a. NPC112701 "23666-13-9, Vicenin 2, Vicenin II, Vicenin, Vicenin-2, Vicenin -2, Violantin, CHEBI:69814, MLS000575019, 6,8-di-c-glucosylapigenin, 5,7,4''-Trihydroxyflavone-6,8-di-C-glucoside, ViceninII, isovitexin 8-C-beta-glucoside, AC1L9D6K, Apigenin-6,8-di-C-glycoside, apigenin-6,8-di-C-glycopyranoside, SureCN5826175, 5,7-dihydroxy-2-(4-hydroxyphenyl)-6,8-bis[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-4-one, SCHEMBL5826175, CHEMBL1442950, DTXSID80904219, HMS2210F06, HY-N2165, MFCD08458851, AKOS015896841, Vicenin-II; 6,8-Di-C-glucosylapigenin, NCGC00247567-01, AC-34904, MS-30565, SMR000232371, 1ST163797, CS-0019465, Vicenin 2, primary pharmaceutical reference standard, 5,7-Dihydroxy-2-(4-hydroxyphenyl)-6,8-bis((2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)-4H-chromen-4-one, 5,7-dihydroxy-2-(4-hydroxyphenyl)-6,8-bis[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]chromen-4-one" C27H30O15 FIAAVMJLAGNUKW-VQVVXJKKSA-N 5,7-dihydroxy-2-(4-hydroxyphenyl)-6,8-bis[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-4-one n.a. n.a. No No No No Yes No rxnDiet81,rxnAdd86 PMDBD2001818 Isovitexin Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 162350 n.a. NPC289774 "Isovitexin, 38953-85-4, Saponaretin, Homovitexin, 29702-25-8, 6-Glucosylapigenin, Apigenin-6-C-glucoside, 6-C-Glucosylapigenin, Isoavroside, Avroside, Apigenin 6-C-glucoside, CHEBI:18330, UNII-KTQ9R9MS0Q, KTQ9R9MS0Q, beta-D-isovitexin, Apigenin 6-C-beta-glucopyranoside, 5,7-dihydroxy-2-(4-hydroxyphenyl)-6-((2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)-4H-chromen-4-one, 5,7-dihydroxy-2-(4-hydroxyphenyl)-6-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-4-one, 6-C-beta-D-Glucopyranosylapigenin, Flavone, 6-beta-D-glucopyranosyl-4'',5,7-trihydroxy-, 6C-hexosyl apigenin, 4H-1-Benzopyran-4-one, 6-beta-D-glucopyranosyl-5,7-dihydroxy-2-(4-hydroxyphenyl)-, 6-C-glucosyl-apigenin, (1S)-1,5-anhydro-1-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-6-yl]-D-glucitol, 4H-1-Benzopyran-4-one, 6-.beta.-D-glucopyranosyl-5,7-dihydroxy-2-(4-hydroxyphenyl)-, Saponaretin;Homovitexin, SMR001215816, 6-glucosyl-apigenin, ISOVITEXIN WITH, 6-C-glucosyl-4'',5,7-trihydroxyflavone, 6-(beta-D-glucopyranosyl)-2-hydroxynaringenin, CCRIS 9341, (1S)-1,5-anhydro-1-(5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-6-yl)-D-glucitol, Isovitexin with HPLC, ISOVITEXIN?, Saponaretin; Homovitexin, C01714, ISOVITEXIN [WHO-DD], MLS000563041, MLS002473147, SCHEMBL513620, Isovitexin, analytical standard, CHEMBL465360, DTXSID60952152, HMS2268O04, HMS3886D14, HY-N0773, Isovitexin, >=98.0% (HPLC), BDBM50486938, MFCD00076044, s9035, AKOS032948364, CCG-208397, 6-beta-D-Glucopyranosyl-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one, NCGC00163578-01, AC-34970, AS-56231, 6-C-.BETA.-D-GLUCOPYRANOSYLAPIGENIN, CS-0009796, Isovitexin 100 microg/mL in Acetonitrile:Methanol, Isovitexin, primary pharmaceutical reference standard, Q3155636, Flavone, 6-.beta.-D-glucopyranosyl-4'',5,7-trihydroxy-, Ethyl6-amino-5-cyano-2-methyl-4-phenyl-4H-pyran-3-carboxylate, ISOVITEXIN (CONSTITUENT OF HAWTHORN LEAF WITH FLOWER), 4H-1-Benzopyran-4-one, 6-beta-D-glucopyranosyl-5,7-dihydroxy-2-(4-hydroxyphenyl)- (VAN), 5,7-dihydroxy-2-(4-hydroxyphenyl)-6-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]chromen-4-one" C21H20O10 MYXNWGACZJSMBT-VJXVFPJBSA-N 5,7-dihydroxy-2-(4-hydroxyphenyl)-6-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-4-one n.a. n.a. No No No No Yes No rxnDiet82,rxnAdd99 PMDBD2001819 Cosmetin Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 5280704 n.a. NPC210003 "578-74-5, Apigetrin, COSMOSIIN, Apigenin 7-glucoside, Cosmosioside, Cosmosiine, APIGENIN-7-GLUCOSIDE, Apigenin 7-O-beta-D-glucoside, Cosmetin, Cosemetin, Cosmoside, Apigenin 7-O-glucoside, Apigenin-7-O-glucoside, UNII-7OF2S66PCH, Apigenin 7-O-beta-D-glucopyranoside, 7OF2S66PCH, apigenin 7-O-beta-glucoside, NSC-407303, 7-O-(beta-D-Glucosyl)apigenin, CHEBI:16778, Apigenin, 7-beta-D-glucopyranoside, EINECS 209-430-5, 7-O-beta-D-Glucosyl-5,7,4''-trihydroxyflavone, NSC 407303, 7-O-beta-D-glucosyl-apigenin, 7-(beta-D-Glucopyranosyloxy)-5-hydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one, 5-Hydroxy-2-(4-hydroxyphenyl)-7-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-4H-chromen-4-one, 5-hydroxy-2-(4-hydroxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one, 4'',5,7-TRIHYDROXYFLAVONE 7-GLUCOSIDE, 5-hydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-7-yl beta-D-glucopyranoside, Apigenin 7-beta-D-glucoside, APIGENIN-7-GLUCOSIDE (USP-RS), APIGENIN-7-GLUCOSIDE [USP-RS], 4H-1-Benzopyran-4-one, 7-(beta-D-glucopyranosyloxy)-5-hydroxy-2-(4-hydroxyphenyl)-, Apigenin 7-O-.beta.-D-glucoside, Cosmociin, 7-O-(.beta.-D-Glucosyl)apigenin, MFCD00016787, Apigenin 7-O-.beta.-D-glucopyranoside, Apigenin-7-O-|A-D-glucopyranoside, Spectrum_000176, SpecPlus_000927, APIGETRIN [MI], Spectrum2_001752, Spectrum3_001249, Spectrum4_001741, Spectrum5_000562, 4-ethynyl-1,1-biphenyl, 7-O-beta-D-Glucosylapigenin, BSPBio_002758, KBioGR_002182, KBioSS_000656, SPECTRUM211950, DivK1c_007023, SCHEMBL146404, SPBio_001884, Apigenin-7-O-|A-D-glucoside, Apigenin 7-beta-glucopyranoside, CHEMBL487017, MEGxp0_001431, KBio1_001967, KBio2_000656, KBio2_003224, KBio2_005792, KBio3_002258, 4H-1-Benzopyran-4-one, 7-(.beta.-D-glucopyranosyloxy)-5-hydroxy-2-(4-hydroxyphenyl)-, Apigenin 7-O-beta-glucopyranoside, Apigenin-7-O-b-D-glucopyranoside, KMOUJOKENFFTPU-QNDFHXLGSA-N, 7-O-beta-D-Glucopyranosylapigenin, DTXSID401028774, HMS1923E03, Apigetrin(Apigenin-7-O-glucoside), HY-N0578, BDBM50378582, CCG-38803, s9125, AKOS025117305, Apigenin-7-O-.beta.-D-glucopyranoside, CS-5931, 4H-1-Benzopyran-4-one, 7-(b-D-glucopyranosyloxy)-5-hydroxy-2-(4-hydroxyphenyl)-, NCGC00178486-01, 5-hydroxy-2-(4-hydroxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-chromen-4-one, Apigenin 7-glucoside, analytical standard, AS-75174, NS00079827, 4'',5,7-Trihydroxyflavone 7-beta-D-glucoside, C04608, A831652, Q2858304, BRD-K13642330-001-01-8, APIGENIN 7-O-GLUCOSIDE (CONSTITUENT OF CHAMOMILE), Apigenin 7-glucoside, primary pharmaceutical reference standard, APIGENIN 7-O-GLUCOSIDE (CONSTITUENT OF CHAMOMILE) [DSC], Apigenin 7-glucoside, EuropePharmacopoeia (EP) Reference Standard, Apigenin-7-O-glucoside 1000 microg/mL in Acetone:Dimethyl sulfoxide, Apigenin 7-glucoside, United States Pharmacopeia (USP) Reference Standard, 7-(.BETA.-D-GLUCOPYRANOSYLOXY)-5-HYDROXY-2-(4-HYDROXYPHENYL)-4H-1-BENZOPYRAN-4-ONE, 4H-1-Benzopyran-4-one, 7-(.beta.-D-glucopyranosyloxy)-5-hydroxy-2-(4-hydroxyphenyl)-, Apigenin 7-O-glucoside, 5-hydroxy-2-(4-hydroxyphenyl)-7-((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)-4H-chromen-4-one, 5-hydroxy-2-(4-hydroxyphenyl)-7-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-chromen-4-one;Apigenin 7-Glucoside, 5-hydroxy-2-(4-hydroxyphenyl)-7-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4H-chromen-4-one" C21H20O10 KMOUJOKENFFTPU-QNDFHXLGSA-N 5-hydroxy-2-(4-hydroxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one n.a. n.a. No No No No Yes No rxn04641,rxnDiet83,rxnAdd100 PMDBD2001820 (-)-Arctigenin Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 64981 n.a. NPC176814 "Arctigenin, (-)-Arctigenin, 7770-78-7, (+/-)-Arctigenin, Arctigenin, (+/-)-, UNII-U76MR9VS6M, U76MR9VS6M, Arctigenin, trans-((+/-)-, C21H24O6, (3R,4R)-4-(3,4-dimethoxybenzyl)-3-(4-hydroxy-3-methoxybenzyl)dihydrofuran-2(3H)-one, 2(3H)-Furanone, 4-((3,4-dimethoxyphenyl)methyl)dihydro-3-((4-hydroxy-3-methoxyphenyl)methyl)-, (3R-trans)-, CHEBI:79, ARCTIGENIN, (-)-, (3R,4R)-4-[(3,4-dimethoxyphenyl)methyl]-3-[(4-hydroxy-3-methoxyphenyl)methyl]oxolan-2-one, 2(3H)-Furanone, 4-((3,4-dimethoxyphenyl)methyl)dihydro-3-((4-hydroxy-3-methoxyphenyl)methyl)-, (3R,4R)-, ARCTIGENIN, TRANS-(-)-, 2FD8L150E7, 144901-91-7, (3R,4R)-4-[(3,4-Dimethoxyphenyl)methyl]dihydro-3-[(4-hydroxy-3-methoxyphenyl)methyl]-2(3H)-furanone, 2(3H)-Furanone, 4-((3,4-dimethoxyphenyl)methyl)dihydro-3-((4-hydroxy-3-methoxyphenyl)methyl)-, (3R,4R)-rel-, 2(3H)-Furanone, 4-((3,4-dimethoxyphenyl)methyl)dihydro-3-((4-hydroxy-3-methoxyphenyl)methyl)-, trans-, (3R,4R)-4-[(3,4-dimethoxyphenyl)methyl]-3- [(4-hydroxy-3-methoxyphenyl)methyl]-2-tetrahydrofuranone, Arctigenen, UNII-2FD8L150E7, Arctigenin?, MFCD00870597, 2(3H)-Furanone, 4-[(3,4-dimethoxyphenyl)methyl]dihydro-3-[(4-hydroxy-3-methoxyphenyl)methyl]-, (3R,4R)-, Tocris-1777, ARCTIGENIN [INCI], SCHEMBL381820, CHEMBL435734, MEGxp0_001799, ACon1_000416, DTXSID60998919, HMS3268E18, HMS3412H04, HMS3676H04, HY-N0035, BDBM50375656, HB0119, s3897, AKOS015897121, CCG-268327, NCGC00025291-01, NCGC00025291-02, NCGC00025291-03, NCGC00025291-04, AC-33952, AS-56162, (-)-Arctigenin, >=95% (LC/MS-ELSD), NS00123849, A865172, SR-01000597504, Q-100825, Q4787603, SR-01000597504-1, BRD-K53523901-001-01-0, (3R,4R)-4-[(3,4-dimethoxyphenyl)methyl]-3-[(3-methoxy-4-oxidanyl-phenyl)methyl]oxolan-2-one, (3R,4R)-4-[(3,4-dimethoxyphenyl)methyl]-3-[(4-hydroxy-3-methoxy-phenyl)methyl]tetrahydrofuran-2-one, (3R,4R)-4-[(3,4-DIMETHOXYPHENYL)METHYL]DIHYDRO-3-[(4-HYDROXY-3-METHOXYPHENYL)METHYL]-2(3H)-FURANONE;2(3H)-FURANONE,4-[(3,4-DIMETHOXYPHENYL)METHYL]DIHYDRO-3-[(4-HYDROXY-3-METHOXYPHENYL)METHYL]-,(3R,4R);(-)-ARCTIGENIN;ARCTIGENIN;ARCTIGENIN(P), (3R-trans)-4-[(3,4-dimethoxyphenyl)methyl]-3-[(4-hydroxy- 3-methoxyphenyl)methyl]-4,5-dihydrofuran-2(3H)-one, 4-[(3,4-Dimethoxyphenyl)methyl]dihydro-3-[(4-hydroxy-3-methoxyphenyl)methyl]-(3R,4R)-2(3H)-Furanone, 4-[(3,4-Dimethoxyphenyl)methyl]dihydro-3-[(4-hydroxy-3-methoxyphenyl)methyl]-(3R-trans)-2(3H)-Furanone, EQC" C21H24O6 NQWVSMVXKMHKTF-JKSUJKDBSA-N (3R,4R)-4-[(3,4-dimethoxyphenyl)methyl]-3-[(4-hydroxy-3-methoxyphenyl)methyl]oxolan-2-one n.a. n.a. No No No No Yes No rxn44005,rxnDiet84,rxnAdd188,rxnAdd189 PMDBD2001821 Biochanin A Dietary Substance, Therapeutic Substance Investigational Drug 491-80-5 DB15334 n.a. n.a. D0S9YX 5280373 4444068 NPC294409 biochanin A, 491-80-5, Biochanin, 4''-Methylgenistein, 5,7-Dihydroxy-4''-methoxyisoflavone, 5,7-Dihydroxy-3-(4-methoxyphenyl)-4H-chromen-4-one, olmelin, Pratensol, Biochanine A, Genistein 4-methyl ether, 5,7-dihydroxy-3-(4-methoxyphenyl)chromen-4-one, Biochanin-A, 4-Methylgenistein, 4H-1-Benzopyran-4-one, 5,7-dihydroxy-3-(4-methoxyphenyl)-, 5,7-Dihydrox -4''-methoxyisoflavone, NSC 123538, CCRIS 5449, NSC-123538, Isoflavone, 5,7-dihydroxy-4''-methoxy-, Genistein 4''-methyl ether, EINECS 207-744-7, MFCD00006839, NSC123538, UNII-U13J6U390T, 5,7-Dihydroxy-3-p-methoxyphenyl-4H-chromen-4-one, DTXSID1022394, CHEBI:17574, U13J6U390T, MLS000069443, CHEMBL131921, DTXCID102394, 4''-Methoxy-5,7-dihydroxy isoflavone, 5,7-dihydroxy-3-(4-methoxyphenyl)-4H-1-benzopyran-4-one, SMR000059116, BIOCHANIN A (USP-RS), BIOCHANIN A [USP-RS], CAS-491-80-5, SR-01000003021, BiochaninA, QSO, Biochanin A, 9, 5,7-dihydroxy-4''-methoxy-Isoflavone, Biochanin A (BCA), Biochanin A (BIO), Spectrum_000195, Genistein 4-Methylether, Opera_ID_621, Spectrum2_000047, Spectrum3_001098, Spectrum4_001927, Spectrum5_001624, BIOCHANIN A [MI], Oprea1_038096, SCHEMBL61258, BSPBio_002776, KBioGR_002274, KBioSS_000675, MLS001148446, MLS006011785, BIDD:ER0123, DivK1c_001027, SPBio_000173, BDBM9461, GTPL2829, SPECTRUM10100003, Biochanin A (4-Methylgenistein), cid_5280373, HMS503M15, KBio1_001027, KBio2_000675, KBio2_003243, KBio2_005811, KBio3_001996, NINDS_001027, HMS2232N19, HMS3369A02, HMS3656A13, TNP00319, Isoflavone,7-dihydroxy-4''-methoxy-, Tox21_202097, Tox21_302901, CCG-38351, LMPK12050229, s2377, AKOS002163860, DB15334, IDI1_001027, SMP1_000045, NCGC00017369-01, NCGC00017369-02, NCGC00017369-03, NCGC00017369-04, NCGC00017369-05, NCGC00017369-06, NCGC00017369-07, NCGC00017369-08, NCGC00017369-09, NCGC00017369-10, NCGC00022428-03, NCGC00022428-04, NCGC00022428-05, NCGC00178478-01, NCGC00256458-01, NCGC00259646-01, AC-22309, AS-17474, HY-14595, NCI60_000558, SY048226, Biochanin A, analytical reference material, B4098, NS00001869, SW219333-1, 5,7-dihydroxy-4''-methoxy-Isoflavone (8CI), BIOCHANIN A (CONSTITUENT OF RED CLOVER), C00814, Q864222, Q-100552, SR-01000003021-4, SR-01000003021-5, BIOCHANIN A (CONSTITUENT OF RED CLOVER) [DSC], BRD-K73303757-001-02-6, BRD-K73303757-001-12-5, 5,7-Dihydroxy-3-(4-methoxyphenyl)-4H-chromen-4-one #, F1190-0491, 4H-1-Benzopyran-4-one,7-dihydroxy-3-(4-methoxyphenyl)-, 2AA2D226-B323-4AE2-B576-2D47D15F9845, Biochanin A, United States Pharmacopeia (USP) Reference Standard C16H12O5 WUADCCWRTIWANL-UHFFFAOYSA-N 5,7-dihydroxy-3-(4-methoxyphenyl)chromen-4-one n.a. n.a. No No No No Yes No rxnDiet87,rxnAdd175 PMDBD2001822 Bisdemethoxycurcumin Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 5315472 n.a. NPC68269 "Bisdemethoxycurcumin, 33171-05-0, 24939-16-0, Curcumin III, Didemethoxycurcumin, (1E,6E)-1,7-bis(4-hydroxyphenyl)hepta-1,6-diene-3,5-dione, Bis(4-hydroxycinnamoyl)methane, Bis-demethoxycurcumin, Bisdemethoxycucurmin, bisdesmethoxycurcumin, (E,E)-Bisdemethoxycurcumin, 1,6-Heptadiene-3,5-dione, 1,7-bis(4-hydroxyphenyl)-, Bis(p-hydroxycinnamoyl)methane, NSC687839, 2EFO1BP34R, 1,7-Bis(4-hydroxyphenyl)-1,6-heptadiene-3,5-dione, CHEMBL105350, CHEBI:71045, C19H16O4, 1,7-bis(4-hydroxyphenyl)hepta-1,6-diene-3,5-dione, 22608-12-4, 1,6-Heptadiene-3,5-dione, 1,7-bis(4-hydroxyphenyl)-, (1E,6E)-, BHCMT, p,p''-Dihydroxydicinnamoylmethane, UNII-2EFO1BP34R, Curcumin III;Didemethoxycurcumin, Curcumin Lll, Curcuminoid A, Bisdemethoxy Curcumin, di-p-coumaroylmethane, Dide Methoxycurcu Min, BDMC;(E,E)-Curcumin III, INS NO.100(III), SCHEMBL428638, INS-100(III), SCHEMBL13521971, cid_5324473, HY-N0007A, DTXSID00872663, E-100(III), (1E,6E)-1,7-Bis(4-hydroxyphenyl)-hepta-1,6-diene-3,5-dione, ZAA93916, BIS-DEMETHOXYCURCUMIN [INCI], BDBM50059989, MFCD03419284, BISDESMETHOXYCURCUMIN [USP-RS], AKOS015902102, CCG-207959, CCG-208635, NSC-687839, Bisdemethoxycurcumin, analytical standard, 1ST40222, AC-24239, AC-34720, ADAMANTAN-1-YL-ACETICACIDHYDRAZIDE, AS-57295, AS-68737, B3347, Bisdemethoxycurcumin, >=98% (HPLC), solid, CS-0018287, NS00116324, S3938, A875406, Q-100322, Q4917168, BRD-K37445107-001-01-9, 1,7-bis(4-hydroxyphenyl)-1,6-Heptadiene-3,5-dione(E,E), (1E,6E)-1,7-Bis(4-hydroxyphenyl)-1,6-heptadiene-3,5-dione, 1,7-bis(4-hydroxyphenyl)-3-hydroxy-1,3,6-heptatrien-5-one, 1,7-BIS-(4-HYDROXYPHENYL)-HEPTA-1,6-DIENE-3,5-DIONE, (1E,6E)-1,7-Bis-(4-hydroxy-phenyl)-hepta-1,6-diene-3,5-dione, 1,6-Heptadiene-3,5-dione, 1,7-bis(4-hydroxyphenyl)-, (E,E)-, 5-Hydroxy-1,7-bis-(4-hydroxy-phenyl)-hepta-1,4,6-trien-3-one, (1E,4Z,6E)-5-Hydroxy-1,7-bis-(4-hydroxy-phenyl)-hepta-1,4,6-trien-3-one" C19H16O4 PREBVFJICNPEKM-YDWXAUTNSA-N (1E,6E)-1,7-bis(4-hydroxyphenyl)hepta-1,6-diene-3,5-dione n.a. n.a. No No No No Yes No rxnDiet88 PMDBD2001823 trans-Cinnamoyl beta-D-glucoside Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 5280653 n.a. NPC268631 1-O-trans-Cinnamoyl-beta-D-glucopyranose, 40004-96-4, CHEBI:16279, trans-Cinnamoyl beta-D-glucoside, [(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (E)-3-phenylprop-2-enoate, 1-O-trans-Cinnamoyl-|A-D-glucopyranose, 1-O-[(2E)-3-phenylprop-2-enoyl]-beta-D-glucopyranose, 1-O-Cinnamoylglucose, (2S,3R,4S,5S,6R)-3,4,5-Trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl cinnamate, cinnamoyl-beta-D-glucoside, C04164, MEGxp0_001981, SCHEMBL2335653, CHEMBL1215106, trans-cinnamoyl-beta-D-glucoside, ACon1_001938, DTXSID301286331, 1-O-cinnamoyl-beta-D-glucopyranose, HY-N11631, AKOS040734954, 1-O-(trans-cinnamoyl)-beta-D-glucose, NCGC00179985-01, CS-0674793, BRD-K79011636-001-01-8, Q27101829 C15H18O7 CJGRGYBLAHPYOM-HOLMNUNMSA-N [(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (E)-3-phenylprop-2-enoate n.a. n.a. No No No No Yes No rxn01614,rxnDiet93,rxnAdd152 PMDBD2001824 Cirsilineol Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 162464 n.a. NPC47781 Cirsilineol, 41365-32-6, Eupatrin, Fastigenin, Anisomelin, 4'',5-Dihydroxy-3'',6,7-trimethoxyflavone, Cirsileneol, UNII-08DZZ529FE, 08DZZ529FE, CHEBI:3718, 5,4''-Dihydroxy-6,7,3''-trimethoxyflavone, NSC-633556, 4,5-Dihydroxy-3,6,7-trimethoxyflavone, 4H-1-Benzopyran-4-one, 5-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-6,7-dimethoxy-, 4'',5-dihydroxy-3'',6,7-trimethoxy-flavone, DTXSID20194314, NSC633556, 5-Hydroxy-2-(4-hydroxy-3-methoxyphenyl)-6,7-dimethoxy-4H-chromen-4-one, 5-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-6,7-dimethoxy-4H-1-benzopyran-4-one, 5-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-6,7-dimethoxychromen-4-one, CHEMBL487213, SCHEMBL2045672, Cirsilineol, analytical standard, DTXCID30116805, VKOSQMWSWLZQPA-UHFFFAOYSA-N, BDBM50412272, LMPK12111249, AKOS040744460, MS-25276, HY-119347, CS-0067567, C10032, G12957, Q15634189, Cirsilineol (5,4''-dihydroxy-6,7,3''-trimethoxyflavone), 5-hydroxy-2-(4-hydroxy-3-methoxy-phenyl)-6,7-dimethoxy-chromen-4-one, 5-Hydroxy-2-(4-hydroxy-3-methoxyphenyl)-6,7-dimethoxy-4H-chromen-4-one # C18H16O7 VKOSQMWSWLZQPA-UHFFFAOYSA-N 5-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-6,7-dimethoxychromen-4-one n.a. n.a. No No No No Yes No rxnDiet94,rxnAdd103 PMDBD2001825 Scrophulein Dietary Substance, Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D06NRZ 188323 n.a. NPC120163 "Cirsimaritin, 6601-62-3, Scrophulein, Skrofulein, 7-Methylcapillarisin, 4'',5-Dihydroxy-6,7-dimethoxyflavone, 6-Methoxygenkwanin, cirsimartin, 6,7-Dimethoxyscutellarein, F59VJ7UX6B, CIRCIMARITIN, CIRSITAKAOGENIN, CIRSUMARITIN, CHEBI:81337, 5-hydroxy-2-(4-hydroxyphenyl)-6,7-dimethoxychromen-4-one, 5-Hydroxy-2-(4-hydroxyphenyl)-6,7-dimethoxy-4H-chromen-4-one, 4H-1-Benzopyran-4-one, 5-hydroxy-2-(4-hydroxyphenyl)-6,7-dimethoxy-, CHEMBL348436, 5-hydroxy-2-(4-hydroxyphenyl)-6,7-dimethoxy-chromen-4-one, DTXSID00216220, 4'',5-dihydroxy-6,7-dimethoxy-flavone, SCUTELLAREIN 6,7-DIMETHYL ETHER, 5-hydroxy-2-(4-hydroxyphenyl)-6,7-dimethoxy-4H-1-benzopyran-4-one, Flavone, 4'',5-dihydroxy-6,7-dimethoxy-, UNII-F59VJ7UX6B, MLS000876998, cid_188323, MEGxp0_000498, SCHEMBL1663486, ACon1_000850, DTXCID00138711, PubChem SID: 26725076, ZIIAJIWLQUVGHB-UHFFFAOYSA-N, HMS2271M05, BCP28927, HY-N6648, BDBM50049394, LMPK12111163, AKOS030556306, 5,4''''-Dihydroxy-6,7-dimethoxyflavone, Cirsimaritin, >=90% (LC/MS-ELSD), (5,4''-Dihydroxy-6,7-dimethoxyflavone), NCGC00169297-01, MS-24601, SMR000440660, CS-0067284, NS00097247, C17785, E80636, BRD-K58305393-001-01-2, Q27155276, 5-Hydroxy-2-(4-hydroxy-phenyl)-6,7-dimethoxy-chromen-4-one, 5-Hydroxy-2-(4-hydroxyphenyl)-6,7-dimethoxy-4H-chromen-4-one #, Skrofulein;Scrophulein;5-hydroxy-2-(4-hydroxyphenyl)-6,7-dimethoxychromen-4-one" C17H14O6 ZIIAJIWLQUVGHB-UHFFFAOYSA-N 5-hydroxy-2-(4-hydroxyphenyl)-6,7-dimethoxychromen-4-one n.a. n.a. No No No No Yes No rxnDiet95,rxnAdd104 PMDBD2001826 Rattex Dietary Substance, Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D03ZMQ 323 n.a. NPC139891 "coumarin, 91-64-5, 2H-Chromen-2-one, 2H-1-Benzopyran-2-one, cumarin, 1,2-Benzopyrone, chromen-2-one, Rattex, Coumarinic anhydride, Tonka bean camphor, Coumarine, cis-o-Coumarinic acid lactone, Coumarinic lactone, o-Hydroxycinnamic acid lactone, Benzo-alpha-pyrone, o-Hydroxycinnamic lactone, 2-Oxo-1,2-benzopyran, Kumarin, Benzo-a-pyrone, 2H-Benzo(b)pyran-2-one, 5,6-Benzo-2-pyrone, 2H-1-Benzopyran, 2-oxo-, Kumarin [Czech], o-Hydroxyzimtsaure-lacton, 5,6-Benzo-alpha-pyrone, 2H-Benzo[b]pyran-2-one, Coumarinum, 1-Benzopyran-2-one, NCI C07103, Caswell No. 259C, o-Coumaric acid lactone, 103802-83-1, NSC 8774, CCRIS 181, cis-o-Coumaric acid anhydride, chromenone, EPA Pesticide Chemical Code 127301, DTXSID7020348, CHEBI:28794, BRN 0383644, HSDB 1623, 2-oxo-2H-1-benzopyran, o-Hydroxyzimtsaure-lacton [German], AI3-00753, UNII-A4VZ22K1WT, NSC-8774, EINECS 202-086-7, A4VZ22K1WT, Nci-c07103, 2-Propenoic acid, 3-(2-hydroxyphenyl)-, delta-lactone, 3-(2-Hydroxyphenyl)-2-propenoic delta-lactone, Benzo-.alpha.-pyrone, Cinnamic acid, o-hydroxy-, delta-lactone, Coumarin (prohibited), NSC8774, o-hydroxycinnamic acid delta-lactone, MFCD00006850, CHEMBL6466, 2-Propenoic acid, 3-(2-hydroxyphenyl)-delta-lactone, DTXCID50348, MLS000028741, EC 202-086-7, 5-17-10-00143 (Beilstein Handbook Reference), NCGC00091502-01, Coumarin, >=98%, SMR000059040, COUMARIN (IARC), COUMARIN [IARC], COUMARIN (MART.), COUMARIN [MART.], 2h-chromene-2-one, 2-Propenoic acid, 3-(2-hydroxyphenyl)-, d-lactone, 2-Propenoic acid, 3-(2-hydroxyphenyl)-, .delta.-lactone, benzopyranone, coumarinac lactone, CAS-91-64-5, Coumarin [NF], COU, 2H-Benzopyran-2-one, SR-01000721887, chromen-one, a coumarin, coumarin-, d-lactone, Venalot mono, alpha-benzopyrone, Coumarin Phenolic, Rattex Rodenticide, benzopyrylium olate, Coumarin (DCF), Coumarin1513, 1, 2-Benzopyrone, a 1,2-benzopyrone, Venalot mono (TN), Spectrum_001336, ST023509, COUMARIN [HSDB], COUMARIN [INCI], Opera_ID_268, 2H-Chromen-2-one #, 3-(2-hydroxyphenyl)-, COUMARIN [MI], 2H-1-benzopyran-2-on, Spectrum2_000303, Spectrum3_001772, Spectrum4_001818, Spectrum5_000555, COUMARINUM [HPUS], bmse000077, COUMARIN [WHO-DD], Epitope ID:114082, SCHEMBL6252, WLN: T66 BOVJ, BSPBio_003263, KBioGR_002460, KBioSS_001816, MLS001148422, MLS002454395, {2H-Benzo[b]pyran-2-one}, BIDD:ER0667, SPECTRUM1400208, SPBio_000266, Cinnamic acid, .delta.-lactone, Coumarin, >=99% (HPLC), BDBM12342, KBio2_001816, KBio2_004384, KBio2_006952, KBio3_002764, GLXC-19130, HMS1923M11, HMS2091E19, HMS2232H18, HMS3369L08, HMS3652B05, HMS3885D09, Pharmakon1600-01400208, AMY37188, HY-N0709, Tox21_111141, Tox21_202427, Tox21_300057, CCG-38580, NSC755852, s4170, COUMARIN (PROHIBITED) [FHFI], AKOS000120175, Tox21_111141_1, 2H-chromen-2-one (ACD/Name 4.0), CR-0048, CS-8148, DB04665, NSC-755852, SDCCGMLS-0066912.P001, USEPA/OPP Pesticide Code: 127301, NCGC00091502-02, NCGC00091502-03, NCGC00091502-04, NCGC00091502-05, NCGC00091502-06, NCGC00091502-07, NCGC00091502-08, NCGC00091502-09, NCGC00091502-11, NCGC00091502-12, NCGC00091502-16, NCGC00254092-01, NCGC00259976-01, Coumarin 1000 microg/mL in Acetonitrile, NCI60_041938, SBI-0061760.P002, Cinnamic acid, o-hydroxy-, .delta.-lactone, Coumarin, Vetec(TM) reagent grade, >=99%, NS00002381, SW220278-1, EN300-18115, BIM-0061760.0001, C05851, D07751, D81844, AB00375898_11, AB00375898_12, Coumarin, primary pharmaceutical reference standard, Q111812, CU-01000013121-2, Q-100890, SR-01000721887-2, SR-01000721887-3, BRD-K23913458-001-02-5, BRD-K23913458-001-13-2, Coumarin, certified reference material, TraceCERT(R), Z57169486, Coumarin, European Pharmacopoeia (EP) Reference Standard, F3096-1712, COUMARIN (CONSTITUENT OF CINNAMOMUM CASSIA BARK) [DSC], COUMARIN (CONSTITUENT OF CINNAMOMUM VERUM BARK) [DSC], D3E956C4-9541-4F57-9435-7D915C38E19E, InChI=1/C9H6O2/c10-9-6-5-7-3-1-2-4-8(7)11-9/h1-6, 2h-1-benzopyran-2-one;coumarin;2h-chromen-2-one;coumarin ;coumarin (2h-1-benzopyran-2-one) (chromen-2-one);2h-1-benzopyran-2-one coumarin 2h-chromen-2-one coumarin coumarin (2h-1-benzopyran-2-one) (chromen-2-one)" C9H6O2 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N chromen-2-one n.a. n.a. No No No No Yes No rxn24720,rxn45944,rxnDiet96 PMDBD2001827 Cyanin Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 441688 n.a. NPC280945 Cyanin, 20905-74-2, Cyanidin 3,5-diglucoside ion, CHEBI:3978, Cyanidin 3,5-diglucoside cation, Cyanidin-3,5-di-O-glucoside, Cyanidin 3-O-glucoside-5-O-glucoside, Cyanidin 3,5-O-diglucoside, Cyanidin 3,5-di-O-glucoside, 2U0001Z916, UNII-2U0001Z916, Cyanidin 3,5-beta-D-o-diglucoside, (2S,3R,4S,5S,6R)-2-[2-(3,4-dihydroxyphenyl)-7-hydroxy-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromenylium-5-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol, Cyanidin 3,5-diglucoside, cyanidin-3,5-diglucoside, Flavylium, 3,5-bis(beta-D-glucopyranosyloxy)-3'',4'',7-trihydroxy-, 1-Benzopyrylium, 2-(3,4-dihydroxyphenyl)-3,5-bis(beta-D-glucopyranosyloxy)-7-hydroxy-, 2-(3,4-Dihydroxyphenyl)-3,5-bis(beta-D-glucopyranosyloxy)-7-hydroxy-1-benzopyrylium, Cyanidin-3,5-O-diglucoside, SCHEMBL6138846, CHEMBL2425137, DTXSID70331611, 3,5-bis(beta-D-glucopyranosyloxy)-3'',4'',7-trihydroxyflavylium, BDBM50005093, CYANIDIN 3,5-.BETA.-D-O-DIGLUCOSIDE, C08639, Q21099632, FLAVYLIUM, 3,5-BIS(.BETA.-D-GLUCOPYRANOSYLOXY)-3'',4'',7-TRIHYDROXY-, 1-BENZOPYRYLIUM, 2-(3,4-DIHYDROXYPHENYL)-3,5-BIS(.BETA.-D-GLUCOPYRANOSYLOXY)-7-HYDROXY-, 2-(3,4-DIHYDROXYPHENYL)-3,5-BIS(.BETA.-D-GLUCOPYRANOSYLOXY)-7-HYDROXY-1-BENZOPYRYLIUM, 2-(3,4-dihydroxyphenyl)-3-(beta-D-glucopyranosyloxy)-7-hydroxychromenylium-5-yl beta-D-glucopyranoside C27H31O16+ RDFLLVCQYHQOBU-ZOTFFYTFSA-O (2S,3R,4S,5S,6R)-2-[2-(3,4-dihydroxyphenyl)-7-hydroxy-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromenylium-5-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol n.a. n.a. No No No No Yes No rxnDiet100,rxnAdd13 PMDBD2001828 Cyanidin 3-(6-p-caffeoyl)glucoside Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 23724734 n.a. n.a. Cyanidin 3-(6-p-caffeoyl)glucoside, CHEBI:80476, DTXSID201341526, Cyanidin 3-O-(6''''-caffeoyl-glucoside), Q27149527, [(2R,3S,4S,5R,6S)-6-[2-(3,4-dihydroxyphenyl)-5,7-dihydroxychromenylium-3-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate C30H27O14+ RTVUMLBJQCCROY-SHPGVJHPSA-O [(2R,3S,4S,5R,6S)-6-[2-(3,4-dihydroxyphenyl)-5,7-dihydroxychromenylium-3-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate n.a. n.a. No No No No Yes No rxnDiet101 PMDBD2001829 Cyanidin-3-(6''-malonylglucoside) Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 443915 n.a. NPC245789 "171828-62-9, Cyanidin 3-O-(6-O-malonyl-beta-D-glucoside), Cyanidin-3-(6''-malonylglucoside), Cyanidin 3-O-(6''-O-malonylglucoside), Cyanidin 3-(6""-malonylglucoside), 3-[[(2R,3S,4S,5R,6S)-6-[2-(3,4-dihydroxyphenyl)-5,7-dihydroxychromenylium-3-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methoxy]-3-oxopropanoic acid, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxychromenium-3-yl 6-O-(carboxyacetyl)-beta-D-glucopyranoside, CHEBI:31442, DTXSID80332139, Cyanidin 3-(6''''-malonyl)glucoside, AKOS040763594, Q27114312, 1-BENZOPYRYLIUM,3-[[6-O-(2-CARBOXYACETYL)-B-D-GLUCOPYRANOSYL]OXY]-2-(3,4-DIHYDROXYPHENYL)-5,7-DIHYDROXY-" C24H23O14+ ROQLTZUOXIQBDO-JZWLZXDTSA-O 3-[[(2R,3S,4S,5R,6S)-6-[2-(3,4-dihydroxyphenyl)-5,7-dihydroxychromenylium-3-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methoxy]-3-oxopropanoic acid n.a. n.a. No No No No Yes No rxnDiet102,rxnAdd2 PMDBD2001830 Cyanidin 3-O-(6-O-p-coumaroyl)glucoside Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 5282067 n.a. NPC259293 Cyanidin 3-O-(6-O-p-coumaroyl)glucoside, [(2R,3S,4S,5R,6S)-6-[2-(3,4-dihydroxyphenyl)-5,7-dihydroxychromenylium-3-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl (E)-3-(4-hydroxyphenyl)prop-2-enoate, CHEMBL4211858, CHEBI:29560, cyanidin 3-O-(6-O-(E)-4-coumaroyl-beta-D-glucoside), cyanidin 3-O-(6-O-(E)-p-coumaroyl-beta-D-glucoside), 2-(3,4-dihydroxyphenyl)-5,7-dihydroxychromenium-3-yl 6-O-[(2E)-3-(4-hydroxyphenyl)prop-2-enoyl]-beta-D-glucopyranoside C30H27O13+ QAOBEOXFSUJDJL-SHPGVJHPSA-O [(2R,3S,4S,5R,6S)-6-[2-(3,4-dihydroxyphenyl)-5,7-dihydroxychromenylium-3-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl (E)-3-(4-hydroxyphenyl)prop-2-enoate n.a. n.a. No No No No Yes No rxnDiet103,rxnAdd3 PMDBD2001831 Cyanidin 3-O-galactoside Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 441699 n.a. NPC159451 Cyanidin 3-O-galactoside, 142506-26-1, Cyanidin 3-galactoside cation, Cyanidin 3-o-galactoside cation, YM35G4AYEY, (2S,3R,4S,5R,6R)-2-[2-(3,4-dihydroxyphenyl)-5,7-dihydroxychromenylium-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol, CHEBI:27475, Idaein, Cyanidin 3-galactoside, UNII-YM35G4AYEY, Cyanidin 3-O-beta-galactopyranoside, SCHEMBL1097555, CHEMBL1197952, Cyanidin 3-O- galactopyranoside, DTXSID80950312, Cyanidin 3-O-beta-D-galactopyranoside, 1-Benzopyrylium, 2-(3,4-dihydroxyphenyl)-3-(beta-D-galactopyranosyloxy)-5,7-dihydroxy-, C08647, E87173, Q63399308, 3-(beta-D-galactopyranosyloxy)-3'',4'',5,7-tetrahydroxyflavylium, 2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-1-benzopyran-1-ium-3-yl hexopyranoside, 1-BENZOPYRYLIUM, 2-(3,4-DIHYDROXYPHENYL)-3-(.BETA.-D-GALACTOPYRANOSYLOXY)-5,7-DIHYDROXY- C21H21O11+ RKWHWFONKJEUEF-WVXKDWSHSA-O (2S,3R,4S,5R,6R)-2-[2-(3,4-dihydroxyphenyl)-5,7-dihydroxychromenylium-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol n.a. n.a. No No No No Yes No rxn40097,rxnDiet104,rxnAdd14 PMDBD2001832 Cyanidin 3-O-glucoside Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 197081 n.a. NPC77916 "7084-24-4, Chrysontemin, Kuromanin chloride, Glucocyanidin, Kuromanine, Cyanidin 3-O-glucoside, Cyanidol 3-glucoside, Cyanidine 3-glucoside, Asterin, Cyanidin 3-monoglucoside, Cyanidin-3-glucoside chloride, Cyanidin 3 glucoside, Kuromanin (chloride), CYANIDIN 3-GLUCOSIDE CHLORIDE, Chrysanthemin, EINECS 230-384-7, UNII-8X15R84UEM, Glucocyanidin chloride, cyanidin-3-o-glucoside chloride, Cyanidin 3-glucoside, Cyanidin 3-O-glucoside chloride, 8X15R84UEM, CYANIDIN CHLORIDE 3-GLUCOSIDE, CYANIDIN-3-GLUCOSIDE-CHLORIDE, 2-(3,4-Dihydroxyphenyl)-3-(beta-D-glucopyranosyloxy)-5,7-dihydroxy-1-benzopyrylium chloride, cyanidin-3-O-glucoside, 47705-70-4, cyanidin-3-glucoside, 1-Benzopyrylium, 2-(3,4-dihydroxyphenyl)-3-(beta-D-glucopyranosyloxy)-5,7-dihydroxy-, chloride, 1-Benzopyrylium, 5,7-dihydroxy-2-(3,4-dihydroxyphenyl)-3-(beta-D-glucopyranosyloxy)-, chloride, 2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-3-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)chromenylium, 2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-3-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)chromenylium chloride, CYANIDIN-3-O-GLUCOSIDE CHLORIDE (USP-RS), CYANIDIN-3-O-GLUCOSIDE CHLORIDE [USP-RS], (2S,3R,4S,5S,6R)-2-[2-(3,4-dihydroxyphenyl)-5,7-dihydroxychromenylium-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol;chloride, Chrysontemin chloride, SCHEMBL158216, DTXSID401028798, HY-N0640, MFCD27665410, Cyanidin 3-O-glucopyranoside chloride, cyanidin-3-O-beta-d-galactopyranoside, AKOS022185309, CS-5203, AC-33936, AS-56225, 1ST000906, CYANIDIN CHLORIDE 3-GLUCOSIDE [MI], Cyanidin-3-glucoside chloride; Chrysanthemin, NS00080449, CYANIDIN 3-GLUCOSIDE CHLORIDE [WHO-DD], EN300-26217066, Q-100788, Q5114535, 2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-3-chromeniumyl beta-D-glucopyranoside chloride, 1-BENZOPYRYLIUM, 2-(3,4-DIHYDROXYPHENYL)-3-(.BETA.-D-GLUCOPYRANOSYLOXY)-5,7-DIHYDROXY-, CHLORIDE (1:1), 1-BENZOPYRYLIUM, 2-(3,4-DIHYDROXYPHENYL)-3-(beta-D-GLUCOPYRANOSYLOXY)-5,7-DIHYDROXY-, CHLORIDE (1:1), 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1lambda4-chromen-1-ylium chloride" C21H21ClO11 YTMNONATNXDQJF-UBNZBFALSA-N "(2S,3R,4S,5S,6R)-2-[2-(3,4-dihydroxyphenyl)-5,7-dihydroxychromenylium-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol;chloride" n.a. n.a. No No No No Yes No rxn04399,rxn04632,rxn04633,rxn07668,rxn07718,rxn40131,rxn44863,rxnDiet105,rxnAdd15 PMDBD2001833 Cyanidin 3-O-rutinoside Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 441674 n.a. NPC34241 Cyanidin 3-O-rutinoside, Cyanidin 3-rutinoside, keracyanin cation, Keracyanin ion, 28338-59-2, Cyanidin-3-rutinoside, UNII-OR49FC491X, OR49FC491X, Cyanidin 3-O-rhamnosylglucoside, Cyanidin 3-beta-D-O-rutinoside, CHEBI:28064, Cyanidin 3-rhamnoglucoside, 1-Benzopyrylium, 3-((6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl)oxy)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-, 1-Benzopyrylium, 3-[[6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl]oxy]-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-, Ceracyanin, Oleocyanin, Noctilux, Nyctalux, Sambucine, Keracyanin, INN, SCHEMBL410529, CHEMBL505251, DTXSID401313656, (2R,3R,4R,5R,6S)-2-[[(2R,3S,4S,5R,6S)-6-[2-(3,4-dihydroxyphenyl)-5,7-dihydroxychromenylium-3-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methoxy]-6-methyloxane-3,4,5-triol, CYANIDIN 3-.BETA.-D-O-RUTINOSIDE, C08620, Q27103483, (2R, 3R, 4R, 5R, 6S)-2-[[(2R, 3S, 4S, 5R, 6S)-6-[2-(3, 4-dihydroxyphenyl)-5, 7-dihydroxychromenylium-3-yl]oxy-3, 4, 5-trihydroxyoxan-2-yl]methoxy]-6-methyloxane-3, 4, 5-triol, 1-BENZOPYRYLIUM, 3-((6-O-(6-DEOXY-.ALPHA.-L-MANNOPYRANOSYL)-.BETA.-D-GLUCOPYRANOSYL)OXY)-2-(3,4-DIHYDROXYPHENYL)-5,7-DIHYDROXY-, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxychromenium-3-yl 6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoside, FLAVYLIUM, 3-((6-O-(6-DEOXY-.ALPHA.-L-MANNOPYRANOSYL)-.BETA.-D-GLUCOPYRANOSYL)OXY)-3'',4'',5,7-TETRAHYDROXY-, FLAVYLIUM, 3-((6-O-(6-DEOXY-alpha-L-MANNOPYRANOSYL)-beta-D-GLUCOPYRANOSYL)OXY)-3'',4'',5,7-TETRAHYDROXY- C27H31O15+ USNPULRDBDVJAO-FXCAAIILSA-O (2R,3R,4R,5R,6S)-2-[[(2R,3S,4S,5R,6S)-6-[2-(3,4-dihydroxyphenyl)-5,7-dihydroxychromenylium-3-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methoxy]-6-methyloxane-3,4,5-triol n.a. n.a. No No No No Yes No rxnDiet106 PMDBD2001834 Cyanidin 3-O-beta-D-sambubioside Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 6602304 n.a. NPC59673 Cyanidin 3-O-beta-D-sambubioside, 63535-17-1, 7RKF71MYMB, Cyanidin 3-o-sambubioside ion, UNII-7RKF71MYMB, Cyanidin 3-O-sambubioside, (2S,3R,4S,5R)-2-[(2S,3R,4S,5S,6R)-2-[2-(3,4-dihydroxyphenyl)-5,7-dihydroxychromenylium-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxyoxane-3,4,5-triol, cyanidin 3-O-(2-O-xylopyranosylglycopyranoside), Cy 3-Samb, SCHEMBL4266827, CHEBI:74811, DTXSID801346479, PD161370, C20490, Q23465648, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxychromenium-3-yl beta-D-xylopyranosyl-(1->2)-beta-D-glucopyranoside C26H29O15+ ZPPQIOUITZSYAO-AOBOYTTNSA-O (2S,3R,4S,5R)-2-[(2S,3R,4S,5S,6R)-2-[2-(3,4-dihydroxyphenyl)-5,7-dihydroxychromenylium-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxyoxane-3,4,5-triol n.a. n.a. No No No No Yes No rxnDiet107,rxnAdd4 PMDBD2001835 cyanidin 3-sambubioside 5-glucoside Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 10197243 n.a. n.a. Cyanidin 3-sambubioside 5-glucoside, SCHEMBL6391417, CHEBI:138860, 73036-94-9, C20493, Q63398355, (2S,3R,4S,5S,6R)-2-[3-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxy-2-(3,4-dihydroxyphenyl)-7-hydroxychromenylium-5-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol C32H39O20+ OLBLWNPOURNBCY-MRBLLYQQSA-O (2S,3R,4S,5S,6R)-2-[3-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxy-2-(3,4-dihydroxyphenyl)-7-hydroxychromenylium-5-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol n.a. n.a. No No No No Yes No rxnDiet108,rxnAdd5 PMDBD2001836 Cyanidin 3-O-sophoroside Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 11169452 n.a. NPC19973 Cyanidin 3-O-sophoroside, 38820-68-7, (2S,3R,4S,5S,6R)-2-[(2S,3R,4S,5S,6R)-2-[2-(3,4-dihydroxyphenyl)-5,7-dihydroxychromenylium-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol, CHEBI:80438, Cyanidin 3-O-sophoroside chloride, Q23048908 C27H31O16+ SXYMMDGPXYVCER-WGNLCONDSA-O (2S,3R,4S,5S,6R)-2-[(2S,3R,4S,5S,6R)-2-[2-(3,4-dihydroxyphenyl)-5,7-dihydroxychromenylium-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol n.a. n.a. No No No No Yes No rxnDiet109,rxnAdd17 PMDBD2001837 Delphinidin 3-(6-p-coumaroyl)glucoside Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 15922818 n.a. NPC119866 Delphinidin-3-O-(6-p-coumaroyl)glucoside, Delphinidin 3-(6-p-coumaroyl)glucoside, [(2R,3S,4S,5R,6S)-6-[5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chromenylium-3-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl (E)-3-(4-hydroxyphenyl)prop-2-enoate, Delphinidin 3-O-beta-D-(6-O-(E)-p-coumaryl)galactopyranoside, CHEBI:75677, Q5254433, delfinidin 3-O-(6-O-(E)-4-coumaroyl-beta-D-glucoside), delfinidin 3-O-(6-O-(E)-p-coumaroyl-beta-D-glucoside), delphinidin 3-O-(6-O-(E)-4-coumaroyl-beta-D-glucoside), 5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chromenium-3-yl 6-O-[(2E)-3-(4-hydroxyphenyl)prop-2-enoyl]-beta-D-glucopyranoside C30H27O14+ DHTPVCYNNWQRMN-LHRGPQAGSA-O [(2R,3S,4S,5R,6S)-6-[5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chromenylium-3-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl (E)-3-(4-hydroxyphenyl)prop-2-enoate n.a. n.a. No No No No Yes No rxnDiet112 PMDBD2001838 Mirtillin Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 165558 n.a. NPC119952 "Myrtillin, 6906-38-3, Mirtillin, DELPHINIDIN-3-GLUCOSIDE, Delphinidin 3-monoglucoside, Delphinidol 3-glucoside, DELPHINIDIN 3-GLUCOSIDE CHLORIDE, Delphinidine 3-monoglucoside, Delphinidin-3-glucoside chloride, Delphinin, Delphinidin 3-O-glucoside chloride, UNII-474A9U89JS, 474A9U89JS, Delphinidin-3-O-glucoside chloride, Delphinidin 3-O-beta-D-glucopyranoside, Delphinidin 3-glucoside (chloride), (2S,3R,4S,5S,6R)-2-[5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chromenylium-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol;chloride, Delphinidin 3-O-beta-glucopyranoside chloride, Flavylium, 3-(beta-D-glucopyranosyloxy)-3'',4'',5,5'',7-pentahydroxy-, chloride, 1-Benzopyrylium, 5,7-dihydroxy-3-(beta-D-glucopyranosyloxy)-2-(3,4,5-trihydroxyphenyl)-, chloride, delphinidin 3-O-beta-glucoside, Delphinidin 3-monoglucoside (chloride), Delphinidin-3-O-glucoside, Delphinidin 3-D-Glucoside, SCHEMBL675415, CHEBI:189576, Delphinidin 3- beta -D-Glucoside, DTXSID901028800, MFCD01762899, AKOS030573521, DELPHINIDIN 3-BETA-D-GLUCOSIDE, Delphinidin 3-O-beta-D-glucoside chloride, 1ST157006, HY-108052, CS-0027237, Delphinidin-3-glucoside chloride , HPLC Grade, Q945655, DELPHINIDIN 3-O-GLUCOSIDE CHLORIDE [WHO-DD], Delphinidin 3-O-beta-D-glucoside chloride, analytical standard, 3,3'',4'',5,5'',7-Hexahydroxyflavylium chloride, mono-beta-D-glucopyranoside, Delphinidin glucoside (chloride); Delphinidin-3-O--D-glucoside (chloride), 1-BENZOPYRYLIUM, 3-(.BETA.-D-GLUCOPYRANOSYLOXY)-5,7-DIHYDROXY-2-(3,4,5-TRIHYDROXYPHENYL)-, CHLORIDE (1:1), 1-BENZOPYRYLIUM, 3-(beta-D-GLUCOPYRANOSYLOXY)-5,7-DIHYDROXY-2-(3,4,5-TRIHYDROXYPHENYL)-, CHLORIDE (1:1), 5,7-Dihydroxy-3-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-2-(3,4,5-trihydroxyphenyl)chromenylium chloride, 5,7-Dihydroxy-3-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-2-(3,4,5-trihydroxyphenyl)chromenyliumchloride, 5,7-dihydroxy-3-((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)-2-(3,4,5-trihydroxyphenyl)chromenylium chloride" C21H21ClO12 ZJWIIMLSNZOCBP-BTTVDUMLSA-N "(2S,3R,4S,5S,6R)-2-[5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chromenylium-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol;chloride" n.a. n.a. No No No No Yes No rxn07693,rxn07719,rxn40132,rxnDiet113 PMDBD2001839 Tulipanin Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 5492231 n.a. NPC84955 Tulipanin, delphinidin 3-rutinoside, Delphinidin-3-rutinoside, CHEBI:80441, Delphinidin 3-rhamnosyl-glucoside, Q7852090, 5,7-Dihydroxy-3-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-((((2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)methyl)tetrahydro-2H-pyran-2-yl)oxy)-2-(3,4,5-trihydroxyphenyl)chromenylium, 5,7-dihydroxy-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-2-(3,4,5-trihydroxyphenyl)-1$l^{4}-chromen-1-ylium C27H31O16+ PLKUTZNSKRWCCA-LTSKFBHWSA-O (2R,3R,4R,5R,6S)-2-[[(2R,3S,4S,5R,6S)-6-[5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chromenylium-3-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methoxy]-6-methyloxane-3,4,5-triol n.a. n.a. No No No No Yes No rxnDiet114 PMDBD2001840 Delphinidin 3-O-beta-D-sambubioside Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 10196837 n.a. n.a. Delphinidin 3-O-beta-D-sambubioside, Delphinidin 3-sambubioside, 53158-73-9, (2S,3R,4S,5R)-2-[(2S,3R,4S,5S,6R)-2-[5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chromenylium-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxyoxane-3,4,5-triol, CHEBI:74810, DTXSID301343044, PD161372, C20491, Q27144921, 178275-92-8, 5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chromenium-3-yl beta-D-xylopyranosyl-(1->2)-beta-D-glucopyranoside C26H29O16+ TWYYVOVDSNRIJM-AFAGGVQESA-O (2S,3R,4S,5R)-2-[(2S,3R,4S,5S,6R)-2-[5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chromenylium-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxyoxane-3,4,5-triol n.a. n.a. No No No No Yes No rxnDiet115 PMDBD2001841 Demethoxycurcumin Dietary Substance, Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D03EDF 5469424 n.a. NPC71941 "Demethoxycurcumin, 22608-11-3, 24939-17-1, curcumin II, monodemethoxycurcumin, desmethoxycurcumin, BHCFM, 33171-16-3, 4-Hydroxycinnamoyl(feroyl)methane, (1E,6E)-1-(4-hydroxy-3-methoxyphenyl)-7-(4-hydroxyphenyl)hepta-1,6-diene-3,5-dione, Demethoxy Curcumin, (2E)-Demethoxy Curcumin, Feruloyl-P-hydroxycinnnamoylmethane, curcuminII, (E/Z)-Demethoxycurcumin, 1-(4-hydroxy-3-methoxyphenyl)-7-(4-hydroxyphenyl)hepta-1,6-diene-3,5-dione, 1,6-Heptadiene-3,5-dione, 1-(4-hydroxy-3-methoxyphenyl)-7-(4-hydroxyphenyl)-, p-Hydroxycinnamoylferuloylmethane, CHEBI:65737, 4-hydroxycinnamoyl(feruloyl)methane, MFCD03427310, NSC687841, (1E,6E)-1-(4-HYDROXY-3-METHOXY-PHENYL)-7-(4-HYDROXYPHENYL)HEPTA-1,6-DI ENE-3,5-DIONE, W2F8059T80, (1E,6E)-1-(4-hydroxy-3-methoxyphenyl)-7-(4-hydroxyphenyl)-1,6-heptadiene-3,5-dione, (E,E)-1-(4-Hydroxy-3-methoxyphenyl)-7-(4-hydroxyphenyl)-1,6-heptadiene-3,5-dione, p-Hydroxycinnamoyl-feruloylmethane, demethoxy-curcumin, (1E,6E)-1-(4-hydroxy-3-methoxyphenyl)-7-(4-hydroxyphenyl)-hepta-1,6-diene-3,5-dione, 1,6-Heptadiene-3,5-dione, 1-(4-hydroxy-3-methoxyphenyl)-7-(4-hydroxyphenyl)-, (1E,6E)-, UNII-W2F8059T80, Curcumin II;Desmethoxycurcumin;Monodemethoxycurcumin, feruloyl-p-coumaroylmethane, SCHEMBL431246, CHEMBL105360, INS NO.100(II), SCHEMBL2553051, DEMETHOXYCURCUMIN [INCI], SCHEMBL13521973, SCHEMBL23884878, SCHEMBL23884879, cid_5324476, HY-N0006A, INS-100(II), DTXSID00873751, HJTVQHVGMGKONQ-LUZURFALSA-N, DESMETHOXYCURCUMIN [USP-RS], Demethoxycurcumin, >=98% (HPLC), BDBM50163744, E-100(II), s9280, Demethoxycurcumin, analytical standard, AKOS015903509, CCG-267896, NSC-687841, 1ST40221, AC-34584, BS-48948, LS-14764, CS-0009120, NS00116352, A910179, 6-Bromo-2-pyridin-4-yl-quinoline-4-carboxylicacid, Q-100287, Q5264607, (1E,6E)-1-(4-Hydroxy-3-methoxy-phenyl)-7-(4-hydroxy-phenyl)-hepta-1,6-diene-3,5-dione, 1,6-Heptadiene-3,5-dione, 1-(4-hydroxy-3-methoxyphenyl)-7-(4-hydroxyphenyl)- (VAN), 1-(4-Hydroxy-3-methoxyphenyl)-7-(4-hydroxyphenyl)-1,6-heptadiene-3,5-dione, 9CI, 1-(4-hydroxyphenyl)-7-(4-hydroxy-3-methoxyphenyl)-hepta-1,6-diene-3,5-dione, 5-hydroxy-7-(4-hydroxy-3-methoxyphenyl)-1-(4-hydroxyphenyl)hepta-1,4,6-trien-3-one, (1E,4Z,6E)-5-Hydroxy-1-(4-hydroxy-3-methoxy-phenyl)-7-(4-hydroxy-phenyl)-hepta-1,4,6-trien-3-one, (1E,6E)-1-(4-HYDROXY-3-METHOXY-PHENYL)-7-(4-HYDROXYPHENYL)HEPTA-1,6-DIENE-3,5-DIONE" C20H18O5 HJTVQHVGMGKONQ-LUZURFALSA-N (1E,6E)-1-(4-hydroxy-3-methoxyphenyl)-7-(4-hydroxyphenyl)hepta-1,6-diene-3,5-dione n.a. n.a. No No No No Yes No rxnDiet116 PMDBD2001842 Dihydrocaffeic acid Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 348154 n.a. NPC222084 Dihydrocaffeic acid, 1078-61-1, 3-(3,4-Dihydroxyphenyl)propionic acid, 3-(3,4-Dihydroxyphenyl)propanoic acid, 3,4-Dihydroxyhydrocinnamic acid, Hydrocaffeic acid, 3,4-Dihydroxyphenylpropionic acid, Benzenepropanoic acid, 3,4-dihydroxy-, 3,4-Dihydroxybenzenepropanoic acid, 3,4-Dihydroxybenzenepropionic acid, HYKOP, 3,4-Dihydroxy-benzenepropanoic acid, Hydrocinnamic acid, 3,4-dihydroxy-, 3,4-Dihydroxydihydrocinnamic acid, 3,4-dihydroxyhydrocinnamate, MSW0228VUB, 3-(3,4-dihydroxyphenyl)propanoate, CHEBI:48400, Hydrocaffeate, MFCD00002776, NSC624007, NSC 624007, NSC-407275, NSC-624007, 71693-95-3, 3,4-Dihydroxy-beta-phenylpropionic acid, 3-(3,4-dihydroxyphenyl) propionic acid, 3,4-Dihydroxyphenylpropanoate, Dihydrocafeate, Dihydrocaffeate, EINECS 214-083-8, NSC 407275, BRN 2213449, 3-(3,4-DIHYDROXYPHENYL)PROPIONICACID, bmse000680, UNII-MSW0228VUB, 3,4-Dihydroxydihydrocinnamate, 3,4-Dihydroxyphenylpropionate, 3-10-00-01517 (Beilstein Handbook Reference), SCHEMBL245530, 3,4-Dihydroxybenzenepropionate, CHEMBL136927, cid_348154, Hydrocinnamic acid,4-dihydroxy-, BDBM41957, 3,4-Dihydroxy-b-phenylpropionate, 3,4-dihydroxyhydro cinnamic acid, 3,4-HPA, AMY3775, DTXSID40221919, 3-(3,4-Dihydroxyphenyl)propionate, HY-N2406, 3,4-Dihydroxy-beta-phenylpropionate, NSC407275, s6338, 3,4-Dihydroxy-b-phenylpropionic acid, AKOS015856196, 3,4-Dihydroxyhydrocinnamic acid, 98%, 3 pound not4-Dihydroxyhydrocinnamic acid, AC-34200, AS-63093, SY101000, 3-(3,4-Dihydroxyphenyl)propanoic acid #, 3-[3,4-bis(oxidanyl)phenyl]propanoic acid, CS-0022607, D5901, NS00014665, 3,4-dihydroxy-(6CI,7CI,8CI)Hydrocinnamate, A50643, EN300-111272, 3,4-dihydroxy-(6CI,7CI,8CI)Hydrocinnamic acid, 3,4-DIHYDROXY-.BETA.-PHENYLPROPIONIC ACID, A801769, J-510568, BF0C7A6D-A5FC-4B39-819E-5ECC037C0C39, Q10395580, Z1255449981, InChI=1/C9H10O4/c10-7-3-1-6(5-8(7)11)2-4-9(12)13/h1,3,5,10-11H,2,4H2,(H,12,13 C9H10O4 DZAUWHJDUNRCTF-UHFFFAOYSA-N 3-(3,4-dihydroxyphenyl)propanoic acid n.a. n.a. No No No No Yes No rxnDiet117,rxnAdd62,rxnAdd159 PMDBD2001843 Eriodictyol Dietary Substance, Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D08AIJ 440735 n.a. NPC294852 ERIODICTYOL, 552-58-9, Eriodictiol, Huazhongilexone, (+)-Eriodictyol, (S)-2-(3,4-Dihydroxyphenyl)-2,3-dihydro-5,7-dihydroxy-4-benzopyrone, (S)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxychroman-4-one, CHEMBL8996, CHEBI:28412, (2S)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-2,3-dihydrochromen-4-one, (2S)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-2,3-dihydro-4H-chromen-4-one, Q520486B8Y, (S)-Eriodictyol, (2S)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3,4-dihydro-2H-1-benzopyran-4-one, eriodicryol, eryodictiol, UNII-Q520486B8Y, NSC-649412, ERD, EINECS 209-016-4, NSC 649412, Eriodictyol - 98%, Eriodictyol with HPLC, ERIODICTYOL [MI], ERIODICTYOL [INCI], SCHEMBL19180, Eriodictyol, analytical standard, DTXSID70877706, 5,7,3'''',4''''-tetrahydroxyflavon, BCP13401, HY-N0637, Eriodictyol, >=95.0% (HPLC), BDBM50325671, LMPK12140002, MFCD00135890, s9123, 5,7,3'''',4''''-tetrahydroxyflavanone, AKOS025311577, AC-6043, CCG-267356, (2S)-2-(3,4-Dihydroxyphenyl)-2,3-dihydro-5,7-dihydroxy-4H-1-benzopyran-4-one, (S)-3'',4'',5,7-Tetrahydroxyflavanone, AS-72316, 1ST158874, CS-0009666, NS00014833, C05631, A830557, EN300-18546823, Q-100627, Q3459685, (S)-2-(3,4-Dihydroxy-phenyl)-5,7-dihydroxy-chroman-4-one, (S)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-2,3-dihydrochromen-4-one C15H12O6 SBHXYTNGIZCORC-ZDUSSCGKSA-N (2S)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-2,3-dihydrochromen-4-one n.a. n.a. No No No No Yes No rxn02602,rxn24424,rxnDiet120,rxnAdd73 PMDBD2001844 Formononetin Dietary Substance, Therapeutic Substance Investigational Drug 485-72-3 DB15335 n.a. n.a. D0M7BR 5280378 4444070 NPC209560 "formononetin, 485-72-3, Biochanin B, Formononetol, 7-hydroxy-3-(4-methoxyphenyl)-4H-chromen-4-one, 7-Hydroxy-4''-methoxyisoflavone, 7-hydroxy-3-(4-methoxyphenyl)chromen-4-one, Flavosil, Neochanin, Myconate, Mycotech, 4''-O-methyldaidzein, 4H-1-Benzopyran-4-one, 7-hydroxy-3-(4-methoxyphenyl)-, Isoflavone, 7-hydroxy-4''-methoxy-, NSC-93360, 7-Hydroxy-3-(4-methoxyphenyl)-4-benzopyrone, CHEBI:18088, EINECS 207-623-9, UNII-295DQC67BJ, MFCD00016948, NSC 93360, 7-Hydroxy-3-(4-methoxyphenyl)chromone, 295DQC67BJ, DTXSID4022311, 7-hydroxy-4''-methoxy-isoflavone, DTXCID502311, NSC93360, 7-hydroxy-3-(4-methoxyphenyl)-4H-benzopyran-4-one, 7-Hydroxy-3-(4-methoxyphenyl)-4H-1-benzopyran-4-one, FORMONONETIN (USP-RS), FORMONONETIN [USP-RS], SMR000470932, SR-01000765510, formononetine, Formoononetin, Formononetin,(S), Formononetin (FOR), Spectrum_000373, SpecPlus_000223, Daidzein 4-methyl ether, Spectrum2_000560, Spectrum3_000660, Spectrum4_001429, Spectrum5_000258, FORMONONETIN [MI], Formononetin (Formononetol), FORMONONETIN [INCI], NCIOpen2_005983, Oprea1_139748, Oprea1_815287, SCHEMBL62915, BSPBio_002299, KBioGR_001878, KBioSS_000853, SPECTRUM102007, MLS000697593, MLS006011897, BIDD:ER0119, DivK1c_006319, SPBio_000639, CHEMBL242341, Formononetin, analytical standard, KBio1_001263, KBio2_000853, KBio2_003421, KBio2_005989, KBio3_001519, HMS1922N18, HMS2231I04, HMS3369C07, HMS3655N22, BCP29929, Formononetin, >=99.0% (TLC), HY-N0183, TNP00176, Tox21_301848, BDBM50021398, CCG-38727, LMPK12050037, s2299, AKOS000270811, AC-8001, DB15335, SDCCGMLS-0066428.P001, 7-hydroxy-4''-methoxy-Isoflavone (8CI), NCGC00017269-01, NCGC00017269-02, NCGC00017269-03, NCGC00017269-04, NCGC00017269-05, NCGC00017269-06, NCGC00017269-07, NCGC00095207-01, NCGC00095207-02, NCGC00095207-03, NCGC00178715-01, NCGC00255167-01, 1ST40259, AS-11642, CAS-485-72-3, NCI60_042081, F0868, K-080, NS00002004, SW219915-1, C00858, EN300-116214, FORMONONETIN (CONSTITUENT OF ASTRAGALUS), AB00052676-07, FORMONONETIN (CONSTITUENT OF RED CLOVER), A827555, AE-641/01968055, Q408859, 7-hydroxy-3-(4-methoxyphenyl)-1-benzopyran-4-one, Q-100540, SR-01000765510-3, SR-01000765510-4, 7-Hydroxy-3-(4''-methoxyphenyl)-4H-benzopyran-4-one, BRD-K55567017-001-02-4, BRD-K55567017-001-06-5, FORMONONETIN (CONSTITUENT OF ASTRAGALUS) [DSC], FORMONONETIN (CONSTITUENT OF RED CLOVER) [DSC], F3139-1207, Z374511822, 7-hydroxy-3-(4-methoxyphenyl)-4H-benzopyran-4-one(9CI), Formononetin, United States Pharmacopeia (USP) Reference Standard, Biochanin B; Flavosil; Formononetol; NSC 93360; NSC93360; NSC-93360" C16H12O4 HKQYGTCOTHHOMP-UHFFFAOYSA-N 7-hydroxy-3-(4-methoxyphenyl)chromen-4-one n.a. n.a. No No No No Yes No rxnDiet127,rxnAdd179 PMDBD2001845 Galangin Dietary Substance, Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D0Y7HG 5281616 n.a. NPC187432 "Galangin, 548-83-4, Norizalpinin, 3,5,7-Trihydroxyflavone, 3,5,7-Trihydroxy-2-phenyl-4H-chromen-4-one, 3,5,7-triOH-Flavone, 4H-1-Benzopyran-4-one, 3,5,7-trihydroxy-2-phenyl-, 3,5,7-Trihydroxy-2-phenyl-4-benzopyrone, FLAVONE, 3,5,7-TRIHYDROXY-, NSC-407229, 3,5,7-trihydroxy-2-phenylchromen-4-one, 4H-Benzopyran-4-one, 3,5,7-trihydroxy-2-phenyl-, MFCD00006833, NSC407229, 142FWE6ECS, CHEBI:5262, CHEMBL309490, 3,5,7-trihydroxy-2-phenyl-4H-benzopyran-4-one, TNP00099, 3,5,7-Trihydroxy-2-phenyl-4H-1-benzopyran-4-one, Norizalpinin;3,5,7-Trihydroxyflavone, 3,5,7-tris(oxidanyl)-2-phenyl-chromen-4-one, EINECS 208-960-4, UNII-142FWE6ECS, NSC 407229, BRN 0272179, teptochrysin, CCRIS 8471, Galangin,(S), 3,7-Trihydroxyflavone, 5,7-Dihydroxyflavonol, GALANGIN [INCI], 3,5,7-trihydroxy-2-phenyl-chromen-4-one, GALANGIN [MI], 3,5,7-Trihydroxy-Flavone, GTPL410, 5-18-04-00567 (Beilstein Handbook Reference), MLS002473087, SCHEMBL117225, MEGxp0_000533, ACon1_000977, cid_5281616, DTXSID70203288, HMS2268D24, EX-A4261, HY-N0382, BDBM50049391, LMPK12111653, s5529, Galangin, autophagy inducing flavonoid, AKOS003672546, 1ST7408, AC-6383, AM85813, CCG-208629, CS-5619, NCGC00017220-01, NCGC00017220-02, NCGC00017220-03, NCGC00142457-01, NCGC00169794-01, AS-14766, SMR000112582, G0370, NS00018339, 3,5,7-trihydroxy-2-phenyl-1-benzopyran-4-one, 3,5,7-Trihydroxy-2-phenyl-4H-chromen-4-one #, 4H-1-Benzopyran-4-one,5,7-trihydroxy-2-phenyl-, A830393, SR-05000002165, Q-100620, Q2456591, SR-05000002165-2, BRD-K16503581-001-01-5, BRD-K16503581-001-04-9, Z1980554245, 3,5,7-Trihydroxy-2-phenyl-4H-1-benzopyran-4-one, 9CI, 4H-1-Benzopyran-4-one, 3,5,7-trihydroxy-2-phenyl- (9CI)" C15H10O5 VCCRNZQBSJXYJD-UHFFFAOYSA-N 3,5,7-trihydroxy-2-phenylchromen-4-one n.a. n.a. No No No No Yes No rxnDiet128,rxnAdd121 PMDBD2001846 Gallate Dietary Substance, Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D0Y3TZ 370 n.a. NPC225710 "Gallic acid, 3,4,5-Trihydroxybenzoic acid, 149-91-7, gallate, Benzoic acid, 3,4,5-trihydroxy-, Gallic acid, tech., Kyselina gallova, Pyrogallol-5-carboxylic acid, GALOP, HSDB 2117, CCRIS 5523, 3,4,5-Trihydroxybenzoate, MFCD00002510, NSC 674319, CHEBI:30778, Kyselina 3,4,5-trihydroxybenzoova, AI3-16412, EINECS 205-749-9, NSC 20103, NSC-20103, NSC-674319, UNII-632XD903SP, BRN 2050274, DTXSID0020650, 632XD903SP, NSC20103, 3,4,5-Trihydroxybenzoic acid, anhydrous, DTXCID60650, CHEMBL288114, 3,4,5-trihydroxy-Benzoic acid, 3-10-00-02070 (Beilstein Handbook Reference), NSC674319, NCGC00091125-01, GALLIC ACID ANHYDROUS, Kyselina gallova [Czech], Acid, Gallic, CAS-149-91-7, Gallic acid [NF], SR-05000001537, gallic-acid, Kyselina 3,4,5-trihydroxybenzoova [Czech], Gallic acid tech., Gallic Acid, F, GDE, Gallic Acid1520, Spectrum_000342, SpecPlus_000307, 5-Trihydroxybenzoic acid, Spectrum2_000399, Spectrum3_000254, Spectrum4_001544, Spectrum5_000108, GALLIC ACID [MI], bmse000389, 3,5-Trihydroxybenzoic acid, GALLIC ACID [HSDB], GALLIC ACID [INCI], 3,4,5-hydroxybenzoic acid, WLN: QVR CQ DQ EQ, 3,4,5-trihydroxy-Benzoate, Oprea1_087792, SCHEMBL15012, 3,4,5-Trihydroxybenzoicacid, BSPBio_001668, KBioGR_002008, KBioSS_000822, SPECTRUM210369, BIDD:ER0374, DivK1c_006403, GALLIC ACID [WHO-DD], SPBio_000617, 3,4,5-Trihydroxybenzoate, X, Benzoic acid,4,5-trihydroxy-, GTPL5549, 3,4,5-Trihydroxybenzoic acid;, KBio1_001347, KBio2_000822, KBio2_003390, KBio2_005958, KBio3_001168, CPD-183, Gallic acid, puriss., 98.0%, HMS1923K07, HMS2091A07, Pharmakon1600-00210369, BCP18127, HY-N0523, NSC36997, Tox21_111089, Tox21_202515, BDBM50085536, CCG-38670, NSC-36997, NSC755825, s4603, AKOS000119625, Tox21_111089_1, AC-1206, CS-8191, NSC-755825, PS-8710, SDCCGMLS-0066503.P001, NCGC00091125-02, NCGC00091125-03, NCGC00091125-04, NCGC00091125-05, NCGC00091125-07, NCGC00091125-13, NCGC00260064-01, SY038078, SBI-0052184.P002, Gallic acid, 97.5-102.5% (titration), G0011, NS00013682, EN300-21542, C01424, D85056, 3,4,5-trihydroxybenzoic acid (ACD/Name 4.0), AB00052697_03, Q375837, Q-201146, SR-05000001537-1, SR-05000001537-2, SR-05000001537-3, BRD-K77345217-001-01-9, F1908-0156, Gallic acid, certified reference material, TraceCERT(R), Z104501122, 78563C7D-0E2D-4766-A8EA-670A03C78FCF, GALLIC ACID (CONSTITUENT OF GRAPE SEEDS OLIGOMERIC PROANTHOCYANIDINS), InChI=1/C7H6O5/c8-4-1-3(7(11)12)2-5(9)6(4)10/h1-2,8-10H,(H,11,12, 137657-43-3" C7H6O5 LNTHITQWFMADLM-UHFFFAOYSA-N 3,4,5-trihydroxybenzoic acid n.a. n.a. No No No No Yes No rxn16131,rxnDiet129,rxnAdd46,rxnAdd47,rxnAdd232 PMDBD2001847 beta-Glucogallin Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 124021 n.a. NPC108455 beta-Glucogallin, 13405-60-2, 1-O-Galloyl-beta-D-glucose, 1-Galloyl-beta-glucose, galloyl glucose, 554-37-0, .beta.-Glucogallin, b-glucogallin, .beta.-D-Glucogallin, CHEBI:15834, 1-galloyl-beta-D-glucose, 4X7JGS9BFY, 1-Galloyl-.beta.-glucose, [(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] 3,4,5-trihydroxybenzoate, CHEMBL480283, .beta.-D-Glucopyranose, 1-(3,4,5-trihydroxybenzoate), 1-O-(3,4,5-trihydroxybenzoyl)-beta-D-glucopyranose, 1-Galloylglucose, UNII-4X7JGS9BFY, |A-Glucogalin, D-Glucose 1-(3,4,5-trihydroxybenzoate), Glucopyranose, 1-gallate, .beta.-D-, gaillic acid |?-D-glucopyranosyl ester, GALLIC GLUCOSIDE, GALLOTANNIN 1, beta-D-Glucopyranose, 1-(3,4,5-trihydroxybenzoate), .beta.-D-Glucose, 1-gallate, SCHEMBL1263104, 1-O-Galloyl-.beta.-D-glucose, .BETA.-GLUCOGALLIN [MI], DTXSID00928396, GALLYL GLUCOSIDE, .BETA.-, AMY41547, 1(.BETA.)-O-GALLOYLGLUCOSE, .BETA.-GLUCOGALLIN, (-)-, BDBM50260536, AKOS027439204, 1-O-(3,4,5-Trihydroxybenzoyl)hexopyranose, HY-133708, CS-0129906, C01158, G76777, 1-O-Galloyl-beta-D-glucose, analytical standard, .BETA.-D-GLUCOSE 1-(3,4,5-TRIHYDROXYBENZOATE), (2S,3R,4S,5S,6R)-3,4,5-Trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl 3,4,5-trihydroxybenzoate, [(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl] 3,4,5-trihydroxybenzoate C13H16O10 GDVRUDXLQBVIKP-HQHREHCSSA-N [(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] 3,4,5-trihydroxybenzoate n.a. n.a. No No No No Yes No rxnDiet130,rxnAdd42 PMDBD2001848 Gardenin B Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 96539 n.a. NPC176775 Gardenin B, 2798-20-1, Demethyltangeretin, 5-demethyltangeretin, 5-Hydroxy-4'',6,7,8-tetramethoxyflavone, 5-hydroxy-6,7,8-trimethoxy-2-(4-methoxyphenyl)chromen-4-one, CHEBI:79628, MLS002701917, 313E89KN5E, C19H18O7, NSC79093, NSC-79093, NSC-618926, 5-Hydroxy-6,7,8,4''-tetramethoxyflavone, 5-Hydroxy-6,7,8-trimethoxy-2-(4-methoxyphenyl)-4H-chromen-4-one, 5-Hydroxy-2-(4-methoxyphenyl)-6,7,8-trimethoxy-4H-1-benzopyran-4-one, 5-Hydroxy-6,7,8-trimethoxy-2-(4-methoxyphenyl)-4H-1-benzopyran-4-one, 5-o-desmethyltangeretin, 4H-1-Benzopyran-4-one, 5-hydroxy-6,7,8-trimethoxy-2-(4-methoxyphenyl)-, GardeninB, UNII-313E89KN5E, NSC 79093, 5-Desmethyltangeretin, 5-O-Demethyltangeretin, GARDENIN B [MI], SPECTRUM1505031, Flavone,6,7,8-tetramethoxy-, CHEMBL226512, SCHEMBL1764516, DTXSID10182260, HMS1923M21, BCP33595, HY-N6037, BDBM50060925, LMPK12111451, NSC618926, AKOS032962784, 5-Hydroxy-4'',7,8-tetramethoxyflavone, 5-Hydroxy-6,8,4''-tetramethoxyflavone, CCG-214611, 5-Hydroxy-4''6,7,8-tetramethoxyflavone, NCGC00095006-01, MS-25625, NCI60_041745, SMR001565501, XG161759, CS-0032215, Flavone, 5-hydroxy-4'',6,7,8-tetramethoxy-, E87197, Q-100922, Q27148750, 4H-1-Benzopyran-4-one,7,8-trimethoxy-2-(4-methoxyphenyl)- C19H18O7 LXEVSYZNYDZSOB-UHFFFAOYSA-N 5-hydroxy-6,7,8-trimethoxy-2-(4-methoxyphenyl)chromen-4-one n.a. n.a. No No No No Yes No rxnDiet131 PMDBD2001849 Glycitein Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 5317750 n.a. NPC100971 "Glycitein, 40957-83-3, 7,4''-Dihydroxy-6-methoxyisoflavone, 4H-1-Benzopyran-4-one, 7-hydroxy-3-(4-hydroxyphenyl)-6-methoxy-, 4'',7-Dihydroxy-6-methoxyisoflavone, 7-hydroxy-3-(4-hydroxyphenyl)-6-methoxy-4H-chromen-4-one, 7-hydroxy-3-(4-hydroxyphenyl)-6-methoxychromen-4-one, 7-Hydroxy-3-(4-hydroxyphenyl)-6-methoxy-4H-1-benzopyran-4-one, 92M5F28TVF, CHEMBL513024, CHEBI:34778, MFCD00016679, UNII-92M5F28TVF, GLYCITEIN [USP-RS], SCHEMBL19720, BIDD:ER0470, Glycitein, analytical standard, 7-hydroxy-3-(4-hydroxyphenyl)-6-methoxy-chromen-4-one, Glycitein, >=97% (HPLC), DTXSID40193960, HMS3886N16, BCP13270, HY-N0016, AC-998, BDBM50241530, LMPK12050104, s9107, AKOS015892762, CCG-267294, 1ST40160, AS-71538, NS00014840, A825364, Q-100465, Q3109347, 4-hydroxy-3-(4-hydroxyphenyl)-6-methoxy-chromen-7-one, 7-hydroxy-3-(4-hydroxyphenyl)-6-methoxychromen-4H-one, GLYCITEIN (CONSTITUENT OF SOY ISOFLAVONES) [DSC], Glycitein, United States Pharmacopeia (USP) Reference Standard, 7-Hydroxy-3-(4-hydroxyphenyl)-6-methoxy-4H-1-benzopyran-4-one; 7,4 inverted exclamation mark -Dihydroxy-6 methoxyisoflavone;Glycetein, 7-Hydroxy-3-(4-hydroxyphenyl)-6-methoxy-4H-1-benzopyran-4-one; 7,4''-Dihydroxy-6-methoxyisoflavone; Glycetein; Glycitein; Glycitin aglycon" C16H12O5 DXYUAIFZCFRPTH-UHFFFAOYSA-N 7-hydroxy-3-(4-hydroxyphenyl)-6-methoxychromen-4-one n.a. n.a. No No No No Yes No rxn07532,rxnDiet135,rxnAdd182 PMDBD2001850 Glycitin Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 187808 n.a. NPC74119 "Glycitin, 40246-10-4, Glycitein 7-O-glucoside, Glycitein 7-O-beta-glucoside, 3-(4-hydroxyphenyl)-6-methoxy-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one, G2S44P62XC, 3-(4-hydroxyphenyl)-6-methoxy-7-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-4H-chromen-4-one, 3-(4-hydroxyphenyl)-6-methoxy-4-oxo-4H-chromen-7-yl beta-D-glucopyranoside, 3-(4-hydroxyphenyl)-6-methoxy-4-oxo-4H-chromen-7-yl .beta.-D-glucopyranoside, UNII-G2S44P62XC, Glycitein-7-beta-O-glucoside, BIDD:ER0468, 4'',7-dihydroxy-6-methoxyisoflavone-7-d-glucoside, Glycitein 7-O-b-glucoside, Glycitein-7-b-O-glucoside, GLYCITIN [USP-RS], 4H-1-Benzopyran-4-one, 7-(beta-D-glucopyranosyloxy)-3-(4-hydroxyphenyl)-6-methoxy-, SCHEMBL62443, CHEBI:80373, DTXSID80193227, HY-N0012, MFCD00800711, s3825, AKOS015892761, AC-6047, CCG-269194, 4H-1-Benzopyran-4-one, 7-(.beta.-D-glucopyranosyloxy)-3-(4-hydroxyphenyl)-6-methoxy-, GLYCITEIN 7-O-.BETA.-GLUCOSIDE, GLYCITEIN-7-.BETA.-O-GLUCOSIDE, 1ST40143, 4'',7-Dihydroxy 6-methoxyisoflavone 7-O-glucoside, A825006, Q27149383, GLYCITIN (CONSTITUENT OF SOY ISOFLAVONES) [DSC], Glycitin, United States Pharmacopeia (USP) Reference Standard, 3-(4-hydroxyphenyl)-6-methoxy-7-((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)-4H-chromen-4-one, 3-(4-hydroxyphenyl)-6-methoxy-7-[3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-chromen-4-one, 7-(?-D-Glucopyranosyloxy)-3-(4-hydroxyphenyl)-6-methoxy-4H-1-benzopyran-4-one; Glycitein 7-O-glucoside; Glycitein 7-O-?-glucoside; Glycitein-7-?-O-glucoside; Glycitin" C22H22O10 OZBAVEKZGSOMOJ-MIUGBVLSSA-N 3-(4-hydroxyphenyl)-6-methoxy-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one n.a. n.a. No No No No Yes No rxnDiet136,rxnAdd183 PMDBD2001851 Homovanillate Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 1738 n.a. NPC281020 "Homovanillic acid, 306-08-1, 4-Hydroxy-3-methoxyphenylacetic acid, 2-(4-hydroxy-3-methoxyphenyl)acetic acid, Vanillacetic acid, Benzeneacetic acid, 4-hydroxy-3-methoxy-, Vanilacetic acid, 3-Methoxy-4-hydroxyphenylacetic acid, Homovanillate, 4-Hydroxy-3-methoxybenzeneacetic acid, (4-HYDROXY-3-METHOXYPHENYL)ACETIC ACID, Homovaniuic acid, HVA, Homovanilic acid, Acetic acid, (4-hydroxy-3-methoxyphenyl)-, 53587-33-0, Homovanillinic acid, UNII-X77S6GMS36, MFCD00004350, NSC 16682, X77S6GMS36, 3-Methoxy-4-hydroxyphenylacetate, CHEBI:545959, EINECS 206-176-7, NSC-16682, 4-HYDROXY-3-METHOXYPHENYLACETIC-2,2-D2 ACID, DTXSID5059791, HMDB00118, 4-hydroxy-3-methoxy-benzeneacetic acid, 2-(3-Methoxy-4-Oxidanyl-Phenyl)ethanoic Acid, 4-hydroxy-3-methoxyphenylacetic acid (homovanillic acid), Acid, Homovanillic, Homovanilate, Vanilacetate, homovanillic-acid, 4-HYDROXY-3-METHOXYPHENYLACETIC ACID (2,5,6-D3,ALPHA,ALPHA-D2), YTX, 3 Methoxy 4 Hydroxyphenylacetic Acid, 4 Hydroxy 3 Methoxyphenylacetic Acid, Acid, 3-Methoxy-4-Hydroxyphenylacetic, Acid, 4-Hydroxy-3-Methoxyphenylacetic, Homovanillic acid; HVA, Homovanillic acid, 98%, Lopac-H-1252, bmse000132, SCHEMBL8792, CHEMBL1562, Lopac0_000632, Oprea1_505423, MLS001056771, HOMOVANILLIC ACID [MI], DTXCID4038219, QRMZSPFSDQBLIX-UHFFFAOYSA-, 4-Hydroxy-3-methoxybenzeneacetate, HMS2233B24, HMS3261P06, HMS3886C14, 4-hydroxy-3-methoxyphenyacetic acid, AMY18047, BCP33265, HY-N0384, NSC16682, STR09131, Tox21_500632, 4-hydroxy 3-methoxyphenylacetic acid, HB1902, s5642, Homovanillic acid, analytical standard, 3-methoxy-4-hydroxy-phenylacetic acid, 4-hydroxy-3-methoxy-phenylacetic acid, 4-hydroxy-3-methoxyphenyl-acetic acid, AKOS005447065, CCG-204720, Homovanillic acid, Fluorimetric reagent, LP00632, PS-3625, SDCCGSBI-0050613.P002, NCGC00015497-01, NCGC00015497-02, NCGC00015497-03, NCGC00015497-04, NCGC00015497-05, NCGC00015497-08, NCGC00093999-01, NCGC00093999-02, NCGC00093999-03, NCGC00261317-01, 1ST40053, 4-HYDROXY-3-METHOXY BENZENEACETIC, SMR000326729, SY017698, (4-Hydroxy-3-methoxy-phenyl)-acetic acid, (4-hydroxy-3-methyoxy-phenyl)-acetic acid, 4-HYDROXY-3-METHOXY-alpha-TOLUIC ACID, CS-0008924, EU-0100632, H0339, NS00015133, C05582, EN300-179380, H 1252, H-3200, 4-HYDROXY-3-METHOXY-.ALPHA.-TOLUIC ACID, Q903566, SR-01000075364, Acetic acid, (4-hydroxy-3-methoxyphenyl)- (8CI), J-610010, SR-01000075364-1, 4-Hydroxy-3-methoxyphenylacetic acid Homovanillic acid, 562F45C3-F314-46F6-8FC2-74D84EBB9CBC, Z1203162033, 4-Hydroxy-3-methoxyphenylacetic acid;Vanillacetic acid;2-(4-Hydroxy-3-methoxyphenyl)acetic acid, InChI=1/C9H10O4/c1-13-8-4-6(5-9(11)12)2-3-7(8)10/h2-4,10H,5H2,1H3,(H,11,12)" C9H10O4 QRMZSPFSDQBLIX-UHFFFAOYSA-N 2-(4-hydroxy-3-methoxyphenyl)acetic acid n.a. n.a. No No No No Yes No rxn02367,rxnDiet140 PMDBD2001852 3-hydroxytyrosol Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 82755 n.a. NPC12278 "Hydroxytyrosol, 10597-60-1, 3,4-Dihydroxyphenylethanol, 4-(2-hydroxyethyl)benzene-1,2-diol, 2-(3,4-Dihydroxyphenyl)ethanol, 3,4-Dihydroxyphenethyl Alcohol, dopet, 3-Hydroxytyrosol, 1,2-Benzenediol, 4-(2-hydroxyethyl)-, 2-(3,4-Dihydroxyphenyl)ethyl Alcohol, 4-(2-hydroxyethyl)-1,2-Benzenediol, beta-3,4-Dihydroxyphenylethyl alcohol, Dihydroxyphenylethanol, MFCD01320529, QEU0NE4O90, CHEBI:68889, 3,4-Dihydroxyphenethylalcohol, UNII-QEU0NE4O90, Dopaol, hydroxy tyrosol, 3,4-dihydroxy-1-benzeneethanol, 4-(2-Hydroxy-ethyl)-benzene-1,2-diol, HYDROXYTYROSOL [MI], SCHEMBL44363, HYDROXYTYROSOL [INCI], Hydroxy Tyrosol (>85%), HYDROXYTYROSOL [WHO-DD], CHEMBL1950045, JUUBCHWRXWPFFH-UHFFFAOYSA-, DTXSID70147451, Ba 2774, BCP31094, HY-N0570, 2-(3,4-Di-hydroxyphenyl)-ethanol, s3826, 3-Hydroxytyrosol, >=98% (HPLC), 3-Hydroxytyrosol, analytical standard, AKOS003368868, AC-5308, CCG-266246, DB12771, AS-10017, SY017402, AM20020163, CS-0009107, D2756, NS00023400, EN300-117537, A801346, Q744577, Q-100040, BRD-K04809113-001-01-7, 3,4-Dihydroxyphenethyl Alcohol;3,4-Dihydroxyphenyl ethanol, InChI=1/C8H10O3/c9-4-3-6-1-2-7(10)8(11)5-6/h1-2,5,9-11H,3-4H2" C8H10O3 JUUBCHWRXWPFFH-UHFFFAOYSA-N 4-(2-hydroxyethyl)benzene-1,2-diol n.a. n.a. No No No No Yes No rxnDiet141,rxnAdd224 PMDBD2001853 Isorhamnetin Dietary Substance, Therapeutic Substance Investigational Drug 480-19-3 DB16767 n.a. n.a. D07YDN 5281654 4444973 NPC125062 Isorhamnetin, 480-19-3, 3-Methylquercetin, Isorhamnetol, Quercetin 3''-methyl ether, 3''-Methoxyquercetin, 3''-O-Methylquercetin, isorhamnetine, iso-rhamnetin, 3''-Methoxy-3,4'',5,7-tetrahydroxyflavone, 3''-Methylquercetin, 3,5,7-Trihydroxy-2-(4-hydroxy-3-methoxyphenyl)-4H-chromen-4-one, C.I. 75680, 3,4'',5,7-Tetrahydroxy-3''-methoxyflavone, CCRIS 3791, 3-Methylquercetine, EINECS 207-545-5, UNII-07X3IB4R4Z, Flavone, 3''-methoxy-3,4'',5,7-tetrahydroxy-, BRN 0044723, 07X3IB4R4Z, CHEBI:6052, 3,5,7-trihydroxy-2-(4-hydroxy-3-methoxyphenyl)chromen-4-one, 3,5,7,4''-Tetrahydroxy-3''-methoxyflavone, FLAVONE, 3,4'',5,7-TETRAHYDROXY-3''-METHOXY-, 4H-1-Benzopyran-4-one, 3,5,7-trihydroxy-2-(4-hydroxy-3-methoxyphenyl)-, 3,5,7-Trihydroxy-2-(4-hydroxy-3-methoxyphenyl)-4-benzopyrone, 4H-1-Benzopyran-4-one, 2-(3-methoxy-4-hydroxyphenyl)-3,5,7-trihydroxy-, CHEMBL379064, 3,4'',5,7-tetrahydroxy-3''-methoxy-flavone, METHYLQUERCETIN, 3''-O-, DTXSID10197379, MFCD00017310, ISORHAMNETIN (USP-RS), ISORHAMNETIN [USP-RS], 3''-O-Methyl Quercetin, 3,5,7-trihydroxy-2-(4-hydroxy-3-methoxyphenyl)-4H-benzopyran-4-one, 3-methyl-quercetin, SR-05000002256, Isorhanetin,(S), IRH, -4H-chromen-4-one, 3,5,7-Trihydroxy-2-(4-hydroxy-3-metoxyphenyl)benzopyran-4-one, 3,5,7-Trihydroxy-2-(4-hydroxy-3-methoxyphenyl)-4H-1-benzopyran-4-one, quercetin-3''-methyl ether, ISORHAMNETIN [INCI], Oprea1_145406, SCHEMBL19235, MEGxp0_001863, ACon1_000275, BDBM23409, Isorhamnetin, analytical standard, 3-Methylquercetin (Isorhamnetin), DTXCID70119870, 3,5,7-trihydroxy-2-(4-hydroxy-3-methoxy-phenyl)chromen-4-one, BCP11534, EX-A6804, HY-N0776, Isorhamnetin, >=95.0% (HPLC), LMPK12110002, s9111, AKOS015905141, CCG-208422, CCG-208453, CS-5945, NCGC00163572-01, NCGC00163572-02, NCGC00163572-03, NCGC00180719-01, AC-20263, AS-71136, ISORHAMNETIN (CONSTITUENT OF GINKGO), I1068, NS00003531, 3,5,7-trihydroxy-2-(4-hydroxy-3-methoxyphenyl), ISORHAMNETIN (CONSTITUENT OF GINKGO) [DSC], Q416138, Q-100518, SR-05000002256-2, SR-05000002256-3, BRD-K83977206-001-01-4, Isorhamnetin, primary pharmaceutical reference standard, Isorhamnetin, United States Pharmacopeia (USP) Reference Standard, 3,5,7-Trihydroxy-2-(4-hydroxy-3-methoxyphenyl)-4H-chromen-4-one # C16H12O7 IZQSVPBOUDKVDZ-UHFFFAOYSA-N 3,5,7-trihydroxy-2-(4-hydroxy-3-methoxyphenyl)chromen-4-one n.a. n.a. No No No No Yes No rxn48472,rxnDiet143,rxnAdd65 PMDBD2001854 isorhamnetin 3-O-glucoside Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 5318645 n.a. NPC225434 isorhamnetin-3-O-glucoside, 5041-82-7, isorhamnetin 3-O-glucoside, Isorhamnetin-3-O-beta-D-Glucoside, Isorhamnetin 3-glucoside, isorhamnetin-3-Glu, UNII-BI252A6EPL, BI252A6EPL, isorhamnetin 3-O-beta-D-glucopyranoside, Isorhamnetin 3-O-beta-D-glucoside, CHEMBL234316, 5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one, CHEBI:75750, Isorhamnetin-3-O-|A-D-Glucoside, 4H-1-Benzopyran-4-one, 3-(beta-D-glucopyranosyloxy)-5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-, 4H-1-Benzopyran-4-one, 3-(.beta.-D-glucopyranosyloxy)-5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-, Isorhamnetin-3-O-galactoside, Isorhamnetin-3-O-b-D-Glucoside, 3-Glucosylisorhamnetin, Isorhamnetin-3-Oglucoside, SCHEMBL2025447, Isorhamnetin 3-beta-D-glucoside, CQLRUIIRRZYHHS-LFXZADKFSA-N, DTXSID601311218, HY-N0777, BDBM50379283, MFCD00017689, AKOS032948993, CCG-208394, CS-5409, Isorhamnetin-3-O-beta-D-glucopyranoside, NCGC00163573-01, AC-34958, AS-82867, NS00134343, A918376, ISORHAMNETIN 3-O-.BETA.-D-GLUCOPYRANOSIDE, SR-05000002275, SR-05000002275-2, Q27145528, ISORHAMNETIN-3-O-GLUCOSIDE (CONSTITUENT OF GINKGO), ISORHAMNETIN-3-O-GLUCOSIDE (CONSTITUENT OF GINKGO) [DSC], 3,4'',5,7-TETRAHYDROXY-3''-METHOXYFLAVONE 3-.BETA.-D-GLUCOPYRANOSIDE, 3,4'',5,7-TETRAHYDROXY-3''-METHOXYFLAVONE 3-beta-D-GLUCOPYRANOSIDE, 5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-4-oxo-4H-chromen-3-yl beta-D-glucopyranoside, 1085711-35-8, 5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-3-((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)-4H-chromen-4-one, 5,7-Dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-4-oxo-4H-chromen-3-yl .beta.-D-glucopyranoside C22H22O12 CQLRUIIRRZYHHS-LFXZADKFSA-N 5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one n.a. n.a. No No No No Yes No rxnDiet144,rxnAdd66 PMDBD2001855 Juglone Dietary Substance, Therapeutic Substance Phase 3 n.a. n.a. n.a. n.a. D0C0NH 3806 n.a. NPC108288 juglone, 481-39-0, 5-Hydroxy-1,4-naphthoquinone, 5-Hydroxy-1,4-naphthalenedione, 5-Hydroxynaphthalene-1,4-dione, Regianin, Nucin, Juglon, Akhnot, Yuglon, C.I. Natural Brown 7, 8-Hydroxy-1,4-naphthoquinone, 5-Hydroxynaphthoquinone, 1,4-NAPHTHALENEDIONE, 5-HYDROXY-, 5-Hydroxy-p-naphthoquinone, C.I. 75500, 1,4-Naphthoquinone, 5-hydroxy-, Juglane, Jugnlon, Iuglon, 1,4-Naphthoquinone, 8-hydroxy-, 5-Hydroxy-1,4-naphthosemiquinone, 5-Hydroxy-1,4-naftochinon, NSC 153189, NSC 622948, 5-hydroxy-1,4-dihydronaphthalene-1,4-dione, MFCD00001684, CHEMBL43612, W6Q80SK9L6, 5-Hydroxy-[1,4]Naphthoquinone, 8-Hydroxy-1,4-naphthalenedione, CHEBI:15794, NCI 2323, NSC34266, NSC153189, NSC622948, NSC-153189, NSC-622948, 1, 8-hydroxy-, WLN: L66 BV EVJ GQ, Caswell No. 515AA, CCRIS 5423, EINECS 207-567-5, 5-Hydroxy-1,4-naftochinon [Czech], JUGLONE CRYSTALLIZED, BRN 1909764, UNII-W6Q80SK9L6, Antibiotic PD7, 481-13-0, Spectrum_000415, 3b7j, JUGLONE [MI], Spectrum2_000778, Spectrum3_001228, Spectrum4_001769, Spectrum5_000357, 5-HNQ, SCHEMBL34185, BSPBio_001157, BSPBio_002676, KBioGR_000497, KBioGR_002257, KBioGR_002470, KBioSS_000497, KBioSS_000895, KBioSS_002477, SPECTRUM300038, 4-08-00-02368 (Beilstein Handbook Reference), DivK1c_001026, SPBio_000856, -Hydroxy-1,4-naphthalenedione, DTXSID0031504, BDBM24777, HMS503M13, KBio1_001026, KBio2_000497, KBio2_000895, KBio2_002470, KBio2_003065, KBio2_003463, KBio2_005038, KBio2_005633, KBio2_006031, KBio2_007606, KBio3_000913, KBio3_000914, KBio3_002176, KBio3_002948, 5-hydroxy-naphthalene-1,4-dione, cMAP_000058, NINDS_001026, Bio1_000441, Bio1_000930, Bio1_001419, Bio2_000409, Bio2_000889, HMS1362I19, HMS1792I19, HMS1923G07, HMS1990I19, HMS3403I19, Juglone - CAS 481-39-0, 5-hydroxy-1,4-naphthoquinone, 4, HY-N6949, CCG-40256, NSC-34266, s5512, ZB1862, 5-Hydroxy-1,4-naphthoquinone, 97%, AKOS001576598, 5-Hydroxy-1,4-naphthalenedione, 9CI, CS-W017516, SDCCGMLS-0066542.P001, IDI1_001026, IDI1_002164, SMP1_000168, NCGC00095247-01, NCGC00095247-02, NCGC00095247-03, NCGC00095247-04, NCGC00095247-05, CI 75500, CI-75500, SY051453, 5-Hydroxy-1,4-naphthalenedione(Juglone)?, 1,4-dihydro-1,4-dioxo-5-hydroxynaphthalene, AM20040546, H0286, NS00021169, C03840, EN300-160375, F17689, A827478, A936425, Q900912, SR-05000002406, J-650071, Q-100522, SR-05000002406-1, F0451-0746, InChI=1/C10H6O3/c11-7-4-5-9(13)10-6(7)2-1-3-8(10)12/h1-5,12 C10H6O3 KQPYUDDGWXQXHS-UHFFFAOYSA-N 5-hydroxynaphthalene-1,4-dione Genentech n.a. No No No No Yes No rxn25369,rxnDiet145 PMDBD2001856 Kaempferide Dietary Substance, Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D04DYO 5281666 n.a. NPC241838 Kaempferide, 491-54-3, Kaempferid, 4''-Methylkaempferol, 4''-O-Methylkaempferol, Kaempferol 4''-methyl ether, 3,5,7-Trihydroxy-2-(4-methoxyphenyl)-4H-chromen-4-one, 3,5,7-trihydroxy-2-(4-methoxyphenyl)chromen-4-one, Campheride, Kaempferol 4''-O-methyl ether, Kaemperide, Kampheride, 4H-1-Benzopyran-4-one, 3,5,7-trihydroxy-2-(4-methoxyphenyl)-, 5,7-Dihydroxy-4''-methoxyflavonol, 4''-Methoxy-3,5,7-trihydroxyflavone, NSC 407294, KAMPFERIDE, NSC-407294, 3,5,7-Trihydroxy-2-(4-methoxyphenyl)-4-benzopyrone, CHEMBL40919, 508XL61MPD, CHEBI:6099, FLAVANONE, 4''-METHOXY-3,5,7-TRIHYDROXY-, NSC407294, Kempferide, 4''-Methoxykaempferol, EINECS 207-738-4, BRN 0305378, UNII-508XL61MPD, Kaemferide, Flavone, 3,5,7-trihydroxy-4''-methoxy-, Kaempferide (AS), 3 5 7-trihydroxy-4''-methoxyflavone, 3,5,7-Trihydroxy-4''-methoxyflavone, 4''-Methoxy-3'',5,7-trihydroxyflavone, Kaempferol 4''''-methyl ether, 5-18-05-00253 (Beilstein Handbook Reference), SCHEMBL426774, Kaempferide, analytical standard, DTXSID9034155, AMY5862, HMS3746E09, BCP20573, BDBM50084978, LMPK12110563, MFCD00016771, s3879, Flavone,5,7-trihydroxy-4''-methoxy-, AKOS015903441, 3,5,7-Trihydroxy-4''-methoxy-Flavone, CCG-267464, CS-0957, 4''-Methoxy-3,5,7-trihydroxy-Flavanone, NCGC00379085-03, 1ST40132, AC-30805, BS-16895, HY-15449, K0057, NS00031862, WLN: T66 BO EVJ CR DO1& DQ GQ IQ, A827662, Q3116775, 1.3,5,7-Trihydroxy-2-(4-methoxyphenyl)-4-benzopyrone, 3,5,7-Trihydroxy-2-(4-methoxyphenyl)-4H-chromen-4-one #, 3,5,7-Trihydroxy-2-(4-methoxyphenyl)-4H-1-benzopyran-4-one, 4H-1-Benzopyran-4-one,5,7-trihydroxy-2-(4-methoxyphenyl)-, 3,5,7-Trihydroxy-2-(4-methoxyphenyl)-4H-1-benzopyran-4-one, 9CI C16H12O6 SQFSKOYWJBQGKQ-UHFFFAOYSA-N 3,5,7-trihydroxy-2-(4-methoxyphenyl)chromen-4-one n.a. n.a. No No No No Yes No rxnDiet146,rxnAdd122,rxnAdd123 PMDBD2001857 Kaempferol Dietary Substance, Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D0G3TK 5280863 n.a. NPC116775 "kaempferol, 520-18-3, Robigenin, Kaempherol, Kempferol, Populnetin, Rhamnolutein, Trifolitin, Swartziol, 3,4'',5,7-Tetrahydroxyflavone, Pelargidenolon, Rhamnolutin, Indigo Yellow, Kampherol, Campherol, Kampferol, Nimbecetin, 3,5,7-Trihydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-one, Kaemferol, 5,7,4''-Trihydroxyflavonol, Pelargidenolon 1497, 3,5,7-Trihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one, C.I. 75640, 3,5,7-trihydroxy-2-(4-hydroxyphenyl)chromen-4-one, Pelargidenon, Kampcetin, CCRIS 41, 4H-1-Benzopyran-4-one, 3,5,7-trihydroxy-2-(4-hydroxyphenyl)-, Flavone, 3,4'',5,7-tetrahydroxy-, NSC 407289, NSC 656277, EINECS 208-287-6, Kempferol;Robigenin, NSC-407289, NSC-656277, UNII-731P2LE49E, BRN 0304401, 3,5,7,4''-Tetrahydroxyflavone, DTXSID7020768, CHEBI:28499, AI3-36096, HSDB 7703, 731P2LE49E, 3''-DEOXYQUERCETIN, MFCD00016938, CHEMBL150, DTXCID30768, 5-18-05-00251 (Beilstein Handbook Reference), NSC656277, CAS-520-18-3, CI 75640, KAEMPFEROL (IARC), KAEMPFEROL [IARC], SMR000112585, 4det, Kaempferol,(S), KAEMPFEROL [MI], 5,4''-Trihydroxyflavonol, Prestwick0_001098, Prestwick1_001098, Prestwick2_001098, Prestwick3_001098, KAEMPFEROL [HSDB], KAEMPFEROL [INCI], 3,5,7-Tetrahydroxyflavone, KAEMPFEROL [USP-RS], BIDD:PXR0073, Oprea1_650954, SCHEMBL18817, BSPBio_001176, MLS000697730, MLS001055391, MLS001074884, MLS006010737, BIDD:ER0134, SPBio_003058, Kaempferol, analytical standard, BDBM7462, BPBio1_001294, MEGxp0_001283, Flavone,4'',5,7-tetrahydroxy-, ACon1_001867, cid_5280863, GTPL11052, CHEBI: 28499, HMS1571K18, HMS2098K18, HMS2267I09, HMS3414C03, HMS3656M03, HMS3678C03, HMS3884B13, 4H-1-Benzopyran-4-one,3,5,7-trihydroxy-2-(4-hydroxyphenyl)-, Kaempferol, >=97.0% (HPLC), TNP00039, Tox21_201165, Tox21_303363, AC-544, HSCI1_000027, LMPK12110003, NSC407289, s2314, AKOS015895240, Kaempferol, >=90% (HPLC), powder, CCG-202823, CS-1273, DB01852, GS-3570, NCGC00016480-01, NCGC00016480-02, NCGC00016480-03, NCGC00016480-04, NCGC00016480-05, NCGC00016480-06, NCGC00016480-07, NCGC00016480-08, NCGC00016480-09, NCGC00091036-01, NCGC00091036-02, NCGC00164322-01, NCGC00179275-01, NCGC00179275-02, NCGC00257464-01, NCGC00258717-01, BP-25390, HY-14590, KAEMPFEROL (CONSTITUENT OF GINKGO), Kaempferol 100 microg/mL in Acetonitrile, SY023424, AB00514046, K0018, NS00001605, SW197199-2, 3,4'',5,7-tetrahydroxy-Flavone (7CI,8CI), C05903, EN300-205764, H10428, S00111, Flavone, 3,4'',5,7-tetrahydroxy- (7CI,8CI), KAEMPFEROL (CONSTITUENT OF GINKGO) [DSC], A828886, Q393336, SR-01000765646, Kaempferol, primary pharmaceutical reference standard, Q-100584, SR-01000765646-3, 3,5,7-trihydroxy-2-(4-hydroxyphenyl)-chromen-4-one, BRD-K12807006-001-05-2, BRD-K12807006-001-10-2, Z57183373, 2-(4-hydroxyphenyl)-3,5,7-tris(oxidanyl)chromen-4-one, 3,5,7-trihydroxy-2-(4-hydroxyphenyl)chromen-4-one??, A91A6666-86C8-4B33-B3EF-F74CD3CD7F47, 3,5,7-trihydroxy-2-(4-hydroxyphenyl)-1-benzopyran-4-one, 3,5,7-Trihydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-one #, 4H-1-Benzopyran-4-one,5,7-trihydroxy-2-(4-hydroxyphenyl)-, Kaempferol, United States Pharmacopeia (USP) Reference Standard, 4H-1-Benzopyran-4-one, 3,5,7-trihydroxy-2-(4-hydroxyphenyl)- (9CI), 3,4'',5,7-Tetrahydroxyflavone, 3,5,7-Trihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one, 4H-1-Benzopyran-4-one, 3,5,7-trihydroxy-2-(4-hydroxyphenyl)-5,7,4''-Trihydroxyflavonol" C15H10O6 IYRMWMYZSQPJKC-UHFFFAOYSA-N 3,5,7-trihydroxy-2-(4-hydroxyphenyl)chromen-4-one n.a. n.a. No No No No Yes No rxn16643,rxn24727,rxn26526,rxn39775,rxnDiet147,rxnAdd124,rxnAdd125 PMDBD2001858 kaempferol 3,7-O-diglucoside Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No Yes No rxnDiet148,rxnAdd126 PMDBD2001859 Trifolin Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 5282149 n.a. NPC78263 "Trifolin, Kaempferol-3-O-galactoside, 23627-87-4, Trifolioside, Kaempferol 3-galactoside, Kaempferol 3-O-beta-D-galactoside, CHEMBL453290, CHEBI:31742, KAEMPFEROL 3-O-GALACTOSIDE, Kaempferol 3-O-|A-D-galactopyranoside, 5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-3-yl beta-D-galactopyranoside, 4H-1-Benzopyran-4-one, 3-(beta-D-galactopyranosyloxy)-5,7-dihydroxy-2-(4-hydroxyphenyl)-, 5,7-dihydroxy-2-(4-hydroxyphenyl)-3-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one, 7CKD5ET5SP, trifoliin, KAEMPFEROL 3-O-D-GALACTOSIDE, 5,7-DIHYDROXY-2-(4-HYDROXYPHENYL)-3-((2S,3R,4S,5R,6R)-3,4,5-TRIHYDROXY-6-(HYDROXYMETHYL)OXAN-2-YL)OXYCHROMEN-4-ONE, SCHEMBL572365, MEGxp0_000499, ACon1_000322, DTXSID30946447, GLXC-14095, Kaempferol-3-O-beta-D-galactoside, HY-N6605, BDBM50313764, kaempferol-3-o-beta-galactopyranoside, AKOS032962714, Kaempferol 3-O-beta-D-galactopyranoside, KAEMPFEROL 3-O-GALACTOPYRANOSIDE, KAEMPFEROL-3-O-D-GALACTOPYRANOSIDE, MS-28113, KAEMPFEROL 3-.BETA.-D-GALACTOSIDE, KAEMPFEROL 3-O-.BETA.-GALACTOSIDE, 1ST158858, CS-0034340, KAEMPFEROL 3-.BETA.-D-GALACTOPYRANOSIDE, KAEMPFEROL 3-O-.BETA.-D-GALACTOPYRANOSIDE, Q7841515, 3-O-b-D-Galactopyranosyloxy-4'',5,7-trihydroxyflavone, BRD-K09085848-001-01-1, 3-(.BETA.-D-GALACTOPYRANOSYLOXY)-5,7-DIHYDROXY-2-(4-HYDROXYPHENYL)-4H-1-BENZOPYRAN-4-ONE, 4H-1-BENZOPYRAN-4-ONE, 3-(.BETA.-D-GALACTOPYRANOSYLOXY)-5,7-DIHYDROXY-2-(4-HYDROXYPHENYL)-, 5,7-dihydroxy-2-(4-hydroxyphenyl)-3-((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)-4H-chromen-4-one, Kaempferol-3-O-galactosideTrifolioside; Kaempferol 3-galactoside; Kaempferol 3-O-beta-D-galactoside" C21H20O11 JPUKWEQWGBDDQB-DTGCRPNFSA-N 5,7-dihydroxy-2-(4-hydroxyphenyl)-3-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one n.a. n.a. No No No No Yes No rxnDiet149,rxnAdd127 PMDBD2001860 Kaempferol 3-O-glucoside Dietary Substance, Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D08BFU 5282102 n.a. NPC133671 "Astragalin, 480-10-4, Astragaline, Kaempferol 3-O-glucoside, kaempferol-3-glucoside, Kaempferol 3-glucoside, Kaempferol-3-O-glucoside, 3-Glucosylkaempferol, asragalin, Kaempferol-3-beta-monoglucoside, Kaempferol-3-beta-glucopyranoside, 3,4'',5,7-Tetrahydroxyflavone-3-glucoside, Kaempferol 3-O-beta-D-glucopyranoside, Kaempferol 3-O-beta-D-glucoside, UNII-APM8UQ3Z9O, APM8UQ3Z9O, 4H-1-Benzopyran-4-one, 3-(beta-D-glucopyranosyloxy)-5,7-dihydroxy-2-(4-hydroxyphenyl)-, CHEBI:30200, Kaempferol 3-beta-D-glucopyranoside, CHEMBL233930, DTXSID801017739, kaempferol-3-O-beta-glucopyranoside, MFCD00075932, KAEMPFEROL 3-O-GLUCOPYRANOSIDE, 5,7-dihydroxy-2-(4-hydroxyphenyl)-3-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-4H-chromen-4-one, Kaempferol 3-O-.beta.-D-glucopyranoside, 5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-3-yl beta-D-glucopyranoside, 3-(beta-D-glucopyranosyloxy)-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-one, Kaempferol-3-D-glucoside, 5,7-dihydroxy-2-(4-hydroxyphenyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one, kaempferol-3-O-D-glucoside, 5,7-dihydroxy-2-(4-hydroxyphenyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-chromen-4-one, Kaempferol 3-beta-D-glucopyranoside, >=97.0% (HPLC), Astraglin, Astragalin?, Kaempferol 3-D-glucoside, 3-O-b-D-Glucopyranoside, SCHEMBL23897, K5, MLS002473092, MEGxp0_000168, ACon1_001224, cid_5282102, Kaempferol 3-b-D-glucopyranoside, BDBM226182, DTXCID101475934, GLXC-13293, HMS2227A14, HY-N0015, KAEMPFEROL 3-beta-D-GLUCOSIDE, KAEMPFEROL 3-O-beta-GLUCOSIDE, BDBM50241243, s9289, ZB1884, AKOS015896779, CCG-269212, CS-3720, Kaempferol 3-O-beta-D-glucoside (6), KAEMPFEROL 3-.BETA.-D-GLUCOSIDE, KAEMPFEROL 3-O-.BETA.-GLUCOSIDE, Kaempferol-3-O-.beta.-D-glucopyranoside, NCGC00163580-01, NCGC00163580-02, AC-35088, SMR001397194, KAEMPFEROL 3-O-.BETA.-D-GLUCOSIDE, Kaempferol 3-glucoside, analytical standard, 3,4'''',5,7-Tetrahydroxyflavone-3-glucoside, NS00097613, 3-((2S,3R,4S,5S,6R)-, KAEMPFEROL 3-.BETA.-D-GLUCOPYRANOSIDE, 3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-, A827420, SR-05000002271, Q-100517, Q4811191, SR-05000002271-2, (2S,3S)-DIHYROKAEMPFEROL 3-O-beta-D-GLUCOSIDE, 3-O-b-D-Glucopyranosyloxy-4'',5,7-trihydroxyflavone, BRD-K44487476-001-01-5, KAEMPFEROL 3-O-GLUCOSIDE (CONSTITUENT OF GINKGO), (2S,3S)-DIHYROKAEMPFEROL 3-O-.BETA.-D-GLUCOSIDE, 4'',5,7-TRIHYDROXYFLAVONE 3-beta-D-GLUCOPYRANOSIDE, 4'',5,7-TRIHYDROXYFLAVONE 3-.BETA.-D-GLUCOPYRANOSIDE, KAEMPFEROL 3-O-GLUCOSIDE (CONSTITUENT OF GINKGO) [DSC], Astragaline;3-Glucosylkaempferol;Kaempferol 3--D-glucopyranoside, Kaempferol 3-glucoside, primary pharmaceutical reference standard, 3-(beta-D-Glucopyranosyloxy)-5,7-dihydroxy-2-(4-methoxyphenyl)-4H-1-benzopyran-4-one, 5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-3-yl .beta.-D-glucopyranoside, 4H-1-BENZOPYRAN-4-ONE, 3-(.BETA.-D-GLUCOPYRANOSYLOXY)-5,7-DIHYDROXY-2-(4-HYDROXYPHENYL)-, 5,7-dihydroxy-2-(4-hydroxyphenyl)-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4H-chromen-4-one" C21H20O11 JPUKWEQWGBDDQB-QSOFNFLRSA-N 5,7-dihydroxy-2-(4-hydroxyphenyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one n.a. n.a. No No No No Yes No rxn04619,rxn24737,rxnDiet150,rxnAdd128 PMDBD2001861 Sophoraflavonoloside Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 5282155 n.a. NPC135846 "Sophoraflavonoloside, Kaempferol 3-O-sophoroside, 19895-95-5, Kaempferol-3-O-sophoroside, Kaempferol-3-sophoroside, Kaempferol-3-o-sophroside, Kaempferol 3-O-beta-sophoroside, CHEBI:31743, Kaempferol 3-O-beta-D-sophoroside, 3-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one, K3S, 3C1196Z645, Kaempferol 3-O-beta-D-glucosyl-(1->2)-beta-D-glucoside, kaempferol-3-o-diglucoside, UNII-3C1196Z645, Kaempferol 3-diglucoside, 4H-1-Benzopyran-4-one, 3-((2-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)oxy)-5,7-dihydroxy-2-(4-hydroxyphenyl)-, SCHEMBL6423194, CHEMBL2032411, DTXSID20941769, Flavone, 3,4'',5,7-tetrahydroxy-, 3-(glucosylglucoside), Kaempferol-3-O-beta-D-sophoroside, HY-N2055, MFCD01662713, AKOS030530341, Flavone, 3,4'',5,7-tetrahydroxy-, 3-(2-O-beta-D-glucopyranosyl-beta-glucopyranoside), 30373-88-7, 4H-1-Benzopyran-4-one, 3-((2-O-beta-D-glucopyranosyl-beta-diglucopyranosyl)oxy)-5,7-dihydroxy-2-(4-hydroxyphenyl)-, AC-34783, MS-30700, 1ST158863, CS-0018544, Q27114674, 3-((2-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)oxy)-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one, 3-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-tetrahydropyran-2-yl]oxy-5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one, 4H-1-BENZOPYRAN-4-ONE, 3-((2-O-.BETA.-D-GLUCOPYRANOSYL-.BETA.-D-GLUCOPYRANOSYL)OXY)-5,7-DIHYDROXY-2-(4-HYDROXYPHENYL)-, 4H-1-BENZOPYRAN-4-ONE, 3-((2-O-.BETA.-D-GLUCOPYRANOSYL-.BETA.-DIGLUCOPYRANOSYL)OXY)-5,7-DIHYDROXY-2-(4-HYDROXYPHENYL)-, 5,7-Dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-1-benzopyran-3-yl 2-O-hexopyranosylhexopyranoside, 5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-3-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside, FLAVONE, 3,4'',5,7-TETRAHYDROXY-, 3-(2-O-BETA-D-GLUCOPYRANOSYL-.BETA.-GLUCOPYRANOSIDE), Kaempferol 3-O-Beta-sophorosideKaempferol-3-O-sophoroside; Kaempferol-3-sophoroside; Kaempferol-3-o-sophroside" C27H30O16 LKZDFKLGDGSGEO-UJECXLDQSA-N 3-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one n.a. n.a. No No No No Yes No rxnDiet151,rxnAdd129 PMDBD2001862 kaempferol 7-O-glucoside Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 10095180 n.a. NPC203500 "16290-07-6, kaempferol 7-O-glucoside, Kaempferol-7-o-D-glucopyranoside, Kaempferol-7-o-beta-D-glucopyranoside, Populnin, Kaempferol-7-O-|A-D-glucopyranoside, UNII-RZF1QN1Z8R, RZF1QN1Z8R, kaempferol 7-O-beta-glucoside, KAEMPFEROL-7-GLUCOPYRANOSIDE, Kaempferol 7-o-beta-D-glucopyranoside, CHEBI:75790, 3,5-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-7-yl beta-D-glucopyranoside, 3,5-dihydroxy-2-(4-hydroxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one, Kaempferol-7-glucoside; Kaempferol-7-O-beta-D-glucopyranoside, 4H-1-Benzopyran-4-one, 7-(beta-D-glucopyranosyloxy)-3,5-dihydroxy-2-(4-hydroxyphenyl)-, Kaempferol 7-glucoside, Kaempferol 7-O-|A -D-glucopyranoside, CHEMBL469441, SCHEMBL3462759, kaempferol-7-o-beta-d-glucoside, BDBM226180, DTXSID301029781, Kaempferol-7-O--D-glucopyranoside, HY-N0627, MFCD08459623, AKOS016004615, Kaempferol 7-O-beta-D-glucoside (4), Kaempferol 7-O-beta -D-glucopyranoside, AC-34756, inverted exclamation markY90.0% (HPLC), MS-28115, XK171016, CS-0009619, KAEMPFEROL 7-O-.BETA.-D-GLUCOPYRANOSIDE, KAEMPFEROL-7-O-.BETA.-D-GLUCOPYRANOSIDE, Q3266683, KAEMPFEROL 7-O-GLUCOSIDE (CONSTITUENT OF GINKGO), Kaempferol 7-O-beta -D-glucopyranoside, >=90.0% (HPLC), KAEMPFEROL 7-O-GLUCOSIDE (CONSTITUENT OF GINKGO) [DSC], 3,5-Dihydroxy-2-(4-hydroxyphenyl)-7-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-4H-chromen-4-one" C21H20O11 YPWHZCPMOQGCDQ-HMGRVEAOSA-N 3,5-dihydroxy-2-(4-hydroxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one n.a. n.a. No No No No Yes No rxnDiet152,rxnAdd130 PMDBD2001863 Lariciresinol Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 332427 n.a. NPC257582 "Lariciresinol, (+)-Lariciresinol, 27003-73-2, NSC-329247, UNII-73XCE5OZB0, 73XCE5OZB0, CHEBI:67246, CHEMBL518421, 3-Furanmethanol, tetrahydro-2-(4-hydroxy-3-methoxyphenyl)-4-((4-hydroxy-3-methoxyphenyl)methyl)-, (2S,3R,4R)-, DTXSID30318362, 3-Furanmethanol, tetrahydro-2-(4-hydroxy-3-methoxyphenyl)-4-vanillyl-, 4-((2S,3R,4R)-4-(4-hydroxy-3-methoxybenzyl)-3-(hydroxymethyl)tetrahydrofuran-2-yl)-2-methoxyphenol, larici-resinol, Lariciresinol, (+)-, 4-[(2S,3R,4R)-4-(4-hydroxy-3-methoxybenzyl)-3-(hydroxymethyl)tetrahydrofuran-2-yl]-2-methoxyphenol, 4-[[(3R,4R,5S)-4-(hydroxymethyl)-5-(3-methoxy-4-oxidanyl-phenyl)oxolan-3-yl]methyl]-2-methoxy-phenol, 4-[[(3R,4R,5S)-5-(4-hydroxy-3-methoxyphenyl)-4-(hydroxymethyl)oxolan-3-yl]methyl]-2-methoxyphenol, SCHEMBL121881, DTXCID70269485, (2S,3R,4R)-Tetrahydro-2-(4-hydroxy-3-methoxyphenyl)-4-[(4-hydroxy-3-methoxyphenyl)methyl]-3-furanmethanol; (+)-Lariciresinol, 3-Furanmethanol, tetrahydro-2-(4-hydroxy-3-methoxyphenyl)-4-((4-hydroxy-3-methoxyphenyl)methyl)-, (2R-(2alpha,3beta,4beta))-, BDBM50335920, NSC329247, AKOS032948405, FS-9698, (+)-Lariciresinol, >=95.0% (HPLC), E87137, Q6489358, (+)-4-[[(3S,4R,5S)-5-(4-hydroxy-3-methoxyphenyl)-4-(hydroxymethyl)oxolan-3-yl]methyl]-2-methoxyphenol, 3-Furanmethanol,tetrahydro-2-(4-hydroxy-3-methoxyphenyl)-4-[(4-hydroxy-3-methoxyphenyl)methyl]-, (2S,3R,4R)-, 4-[(2S,3R,4R)-4-(4-Hydroxy-3-methoxybenzyl)-3-(hydroxymethyl)tetrahydro-2-furanyl]-2-methoxyphenol, 4-[[(3R,4R,5S)-5-(4-hydroxy-3-methoxy-phenyl)-4-(hydroxymethyl)tetrahydrofuran-3-yl]methyl]-2-methoxy-phenol" C20H24O6 MHXCIKYXNYCMHY-AUSJPIAWSA-N 4-[[(3R,4R,5S)-5-(4-hydroxy-3-methoxyphenyl)-4-(hydroxymethyl)oxolan-3-yl]methyl]-2-methoxyphenol n.a. n.a. No No No No Yes No rxn22914,rxn25064,rxnDiet153,rxnAdd190,rxnAdd191 PMDBD2001864 Orientin Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 5281675 n.a. NPC117418 Orientin, 28608-75-5, Lutexin, Luteolin-8-glucoside, Luteolin 8-C-glucoside, Orientine, Orientin (Flavone), Luteolin 8-glucoside, UNII-IAX93XCW6C, 8-beta-D-glucosylluteolin, IAX93XCW6C, 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-8-beta-D-glucopyranosyl-5,7-dihydroxy-, CHEBI:7781, Luteolin-8-C-glucoside, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-8-((2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)-4H-chromen-4-one, 2-(3,4-Dihydroxyphenyl)-8-beta-D-glucopyranosyl-5,7-dihydroxy-4H-1-benzopyran-4-one, MASSBANK PR020063, DTXSID60182790, 8-glucosylluteolin, C10114, MFCD00017432, J17.734B, Luteolin 8-C-beta-D-glucopyranoside, 8C-hexosyl luteolin, 2-(3,4-dihydroxyphenyl)-8-beta-D-glucopyranosyl-5,7-dihydroxy-4H-chromen-4-one, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-8-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-4-one, 8-beta-D-Glucopyranosyl-3'',4'',5,7-tetrahydroxyflavone, 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-8-.beta.-D-glucopyranosyl-5,7-dihydroxy-, (1S)-1,5-ANHYDRO-1-(2-(3,4-DIHYDROXYPHENYL)-5,7-DIHYDROXY-4-OXO-4H-CHROMEN-8-YL)-D-GLUCITOL, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-8-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-4H-chromen-4-one, D-GLUCITOL, 1,5-ANHYDRO-1-C-(2-(3,4-DIHYDROXYPHENYL)-5,7-DIHYDROXY-4-OXO-4H-1-BENZOPYRAN-8-YL)-, (1S)-, NSC-133101, USE, 8-.beta.-D-Glucopyranosyl-3'',4'',5,7-tetrahydroxyflavone, SCHEMBL25942, Orientin, analytical standard, CHEMBL520866, Orientin, >=97% (HPLC), BDBM84982, DTXCID00105281, Luteolin 8-C-b-D-glucopyranoside, NIAID AIDS# 026706, GLXC-13194, HMS3886J16, HY-N0405, 8-.BETA.-D-GLUCOSYLLUTEOLIN, s9099, AKOS015896746, CCG-269214, 4H-1-benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-8-beta-D-glucopyranosyl-5,7-dihydroxy, LUTEOLIN 8-C-beta-GLUCOPYRANOSIDE, NCGC00482848-01, 1ST14011, AC-34280, AS-73888, LUTEOLIN 8-C-.BETA.-GLUCOPYRANOSIDE, CS-0008937, O0503, LUTEOLIN 8-C-.BETA.-D-GLUCOPYRANOSIDE, Orientin 100 microg/mL in Acetonitrile:Water, A819507, EN300-19631775, Orientin, primary pharmaceutical reference standard, Q421676, 8-b-D-Glucopyranosyl-3'',4'',7''-tetrahydroxyflavone, Q-100362, 2-(3,4-DIHYDROXYPHENYL)-8-.BETA.-D-GLUCOPYRANOSYL-5,7-DIHYDROXY-4H-CHROMEN-4-ONE, 2-(3,4-DIHYDROXYPHENYL)-5,7-DIHYDROXY-8-(.BETA.-D-GLUCOPYRANOSYL)-4H-1-BENZOPYRAN-4-ONE, 2-(3,4-DIHYDROXYPHENYL)-5,7-DIHYDROXY-8-(beta-D-GLUCOPYRANOSYL)-4H-1-BENZOPYRAN-4-ONE, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-8-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]chromen-4-one, 2-(3,4-DIHYDROXYPHENYL)-8-.BETA.-D-GLUCOPYRANOSYL-5,7-DIHYDROXY-4H-1-BENZOPYRAN-4-ONE, 8-(.BETA.-D-GLUCOPYRANOSYL)-2-(3,4-DIHYDROXYPHENYL)-5,7-DIHYDROXY-4H-1-BENZOPYRAN-4-ONE, 8-(beta-D-GLUCOPYRANOSYL)-2-(3,4-DIHYDROXYPHENYL)-5,7-DIHYDROXY-4H-1-BENZOPYRAN-4-ONE C21H20O11 PLAPMLGJVGLZOV-VPRICQMDSA-N 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-8-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-4-one n.a. n.a. No No No No Yes No rxnDiet155,rxnAdd111 PMDBD2001865 Luteolin 7-O-glucoside Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 5280637 n.a. NPC189142 "Cynaroside, Luteoloside, 5373-11-5, Luteolin 7-glucoside, Cinaroside, Luteolin-7-glucoside, Luteolin 7-O-glucoside, Luteolin-7-O-glucoside, Glucoluteolin, 7-Glucoluteolin, 7-Glucosylluteolin, Luteolin 7-O-beta-D-glucoside, Luteolin 7-monoglucoside, Luteolin 7-O-glucopyranoside, nephrocizin, NEPHROCIZINE, Flavopurposide, Daphneflavonoloside, 98J6XDS46I, 26811-41-6, CHEBI:27994, 7-O-beta-D-Glucosyl-5,7,3'',4''-tetrahydroxyflavone, EINECS 226-365-8, UNII-98J6XDS46I, MLS002473222, CHEMBL233929, Luteolin-7-O-D-glucopyranoside, 2-(3,4-dihydroxyphenyl)-5-hydroxy-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one, Luteolin 7-.beta.-D-glucoside, MFCD06799436, 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-7-(beta-D-glucopyranosyloxy)-5-hydroxy-, NSC 724451, NSC-724451, SMR000232358, 2-(3,4-dihydroxyphenyl)-5-hydroxy-4-oxo-4H-chromen-7-yl beta-D-glucopyranoside, 2-(3,4-Dihydroxyphenyl)-7-(beta-D-glucopyranosyloxy)-5-hydroxy-4H-1-benzopyran-4-one, 7-(beta-D-glucopyranosyloxy)-5-hydroxy-2-(3,4-dihydroxyphenyl)-4H-chromen-4-one, 2-(3,4-dihydroxyphenyl)-5-hydroxy-7-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-4H-chromen-4-one, luteolin glucoside, 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-7-(.beta.-D-glucopyranosyloxy)-5-hydroxy-, LUTEOLIN 7-O-GLUCOSIDE (USP-RS), LUTEOLIN 7-O-GLUCOSIDE [USP-RS], 2-(3,4-dihydroxyphenyl)-5-hydroxy-7-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4H-chromen-4-one, Luteolin, glucoside, Luteolin monoglucoside, SR-01000867987, luteolin-7-O-monoglucoside, luteolin-7-beta-D-glucoside, luteolin 7-O-beta-d-glucopyranoside, 2-(3,4-dihydroxyphenyl)-5-hydroxy-7-((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)-4H-chromen-4-one, Luteolin 7-beta-glucoside, Luteolin 7-O-D-glucoside, Flavon, 3'',4'',5,7-tetrahydroxy-, glucoside, luteolin-7-O-beta-glucoside, Luteolin 7-beta-D-glucoside, Luteolin 7-O-b-D-glucoside, Luteolin-7-D-glucopyranoside, SCHEMBL149118, Luteolin 7-b-D-Glucopyranoside, MEGxp0_000619, 7-beta-D-GLUCOSYLLUTEOLIN, Luteolin-7-O-Glucoside ,(S), REGID_for_CID_657946, cid_5280637, DTXSID50949617, LUTEOLIN 7-O-beta-GLUCOSIDE, REGID_for_CID_5280637, HMS2224O21, LUTEOLIN 7-GLUCOSIDE [MI], Flavone, 3'',4'',5,7-tetrahydroxy-, mono-beta-D-glucopyranoside, HY-N0540, 7-.BETA.-D-GLUCOSYLLUTEOLIN, BDBM50241242, Luteolin 7-.beta.-D-glucopyranoside, s9018, AKOS015903261, AC-6054, CCG-269211, CS-5712, LUTEOLIN 7-O-.BETA.-GLUCOSIDE, 4H-1-Benzopyran-4-one,2-(3,4-dihydroxyphenyl)-7-(b-D-glucopyranosyloxy)-5-hydroxy-, LUTEOLIN 5-O-beta-GLUCOPYRANOSIDE, LUTEOLIN 7-O-beta-GLUCOPYRANOSIDE, LUTEOLIN 7-O-.BETA.-D-GLUCOSIDE, NCGC00163589-01, NCGC00163589-02, AS-73889, Luteolin 7-glucoside, analytical standard, LUTEOLIN, 7-beta-D-GLUCOPYRANOSIDE, LUTEOLIN-7-O-4C1-beta-D-GLUCOSIDE, 1ST000007, LUTEOLIN 5-O-.BETA.-GLUCOPYRANOSIDE, LUTEOLIN 7-O-.BETA.-GLUCOPYRANOSIDE, NS00043563, LUTEOLIN 7-O-.BETA.-D-GLUCOPYRANOSIDE, LUTEOLIN, 7-.BETA.-D-GLUCOPYRANOSIDE, LUTEOLIN-7-O-4C1-.BETA.-D-GLUCOSIDE, C03951, Luteolin 7-glucoside;Luteolin 7-O--D-glucoside, Luteolin 7-O-beta-D-glucoside, >=98.0% (HPLC), Luteolin-7-O-glucoside 1000 microg/mL in Ethanol, Q2317288, SR-01000867987-2, SR-01000867987-3, 7-(beta-D-GLUCOSYLOXY)-3'',4'',5-TRIHYDROXYFLAVONE, 3'',4'',5,7-TETRAHYDROXYFLAVONE 7-beta-D-GLUCOPYRANOSIDE, 3'',4'',5-TRIHYDROXYFLAVONE 7-O-beta-D-GLUCOPYRANOSIDE, 7-(.BETA.-D-GLUCOSYLOXY)-3'',4'',5-TRIHYDROXYFLAVONE, Luteolin 7-glucoside, primary pharmaceutical reference standard, 3'',4'',5,7-TETRAHYDROXYFLAVONE 7-.BETA.-D-GLUCOPYRANOSIDE, 3'',4'',5-TRIHYDROXYFLAVONE 7-O-.BETA.-D-GLUCOPYRANOSIDE, 2-(3,4-Dihydroxyphenyl)-5-hydroxy-4-oxo-4H-chromen-7-yl hexopyranoside #, Luteolin 7-O-Glucoside, United States Pharmacopeia (USP) Reference Standard, 2-(3,4-dihydroxyphenyl)-5-hydroxy-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-chromen-4-one, 2-(3,4-DIHYDROXYPHENYL)-7-(.BETA.-D-GLUCOPYRANOSYLOXY)-5-HYDROXY-4H-1-BENZOPYRAN-4-ONE, 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-, mono-beta-D-glucopyranoside" C21H20O11 PEFNSGRTCBGNAN-QNDFHXLGSA-N 2-(3,4-dihydroxyphenyl)-5-hydroxy-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one n.a. n.a. No No No No Yes No rxnDiet157,rxnAdd112 PMDBD2001866 Luteolin 7-O-glucuronide Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 5280601 n.a. NPC20505 Luteolin 7-glucuronide, 29741-10-4, Luteolin-7-glucuronide, Luteolin 7-O-glucuronide, Luteolin-7-O-glucuronside, Cyanidenon-7-O-beta-D-glucuronic acid, Luteolin 7-O-beta-D-glucuronopyranoside, (2S,3S,4S,5R,6S)-6-[2-(3,4-dihydroxyphenyl)-5-hydroxy-4-oxochromen-7-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid, CHEBI:18128, R4346D0X7P, luteolin 7-O-beta-D-glucosiduronic acid, 2-(3,4-dihydroxyphenyl)-5-hydroxy-4-oxo-4H-chromen-7-yl beta-D-glucopyranosiduronic acid, Luteolin 7-O-beta-D-Glucuronide, C03515, Luteolin- 7-?O-Glucuronide, UNII-R4346D0X7P, CHEMBL464224, MEGxp0_000794, SCHEMBL1279040, Luteolin-7-O-|A-D-glucuronide, DTXSID50952181, BDBM226184, HY-N1463, AKOS032946035, Luteolin 7-O-beta-D-glucuronide (14), LUTEOLIN-7-.BETA.-D-GLUCURONIDE, MS-28490, CS-0016910, CYANIDENON-7-O-.BETA.-D-GLUCURONIC ACID, Luteolin 7-O-glucuronide (Luteolin 7-glucuronide4)?, FLAVONE, 3'',4'',5,7-TETRAHYDROXY-, 7-.BETA.-D-GLUCOPYRANURONOSIDE, (2S,3S,4S,5R,6S)-6-((2-(3,4-Dihydroxyphenyl)-5-hydroxy-4-oxo-4H-chromen-7-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid, (2S,3S,4S,5R,6S)-6-[2-(3,4-dihydroxyphenyl)-5-hydroxy-4-oxo-chromen-7-yl]oxy-3,4,5-trihydroxy-tetrahydropyran-2-carboxylic acid, .BETA.-D-GLUCOPYRANOSIDURONIC ACID, 2-(3,4-DIHYDROXYPHENYL)-5-HYDROXY-4-OXO-4H-1-BENZOPYRAN-7-YL, 2-(3,4-DIHYDROXYPHENYL)-5-HYDROXY-4-OXO-4H-1-BENZOPYRAN-7-YL .BETA.-D-GLUCOPYRANOSIDURONIC ACID, 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-7-(.beta.-D-glucopyranuronosyloxy)-5-hydroxy-, beta-D-Glucopyranosiduronic acid, 2-(3,4-dihydroxyphenyl)-5-hydroxy-4-oxo-4H-1-benzopyran-7-yl, GLUCOPYRANOSIDURONIC ACID, 2-(3,4-DIHYDROXYPHENYL)-5-HYDROXY-4-OXO-4H-1-BENZOPYRAN-7-YL, .BETA.-D- C21H18O12 VSUOKLTVXQRUSG-ZFORQUDYSA-N (2S,3S,4S,5R,6S)-6-[2-(3,4-dihydroxyphenyl)-5-hydroxy-4-oxochromen-7-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid n.a. n.a. No No No No Yes No rxn46905,rxnDiet158,rxnAdd113 PMDBD2001867 Enin Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 443652 n.a. NPC277867 Oenin, Malvidin 3-O-glucoside, Malvidin-3-glucoside, 18470-06-9, Enin, Malvidin 3-Glucoside, malvidin 3-O-beta-D-glucoside, (2S,3R,4S,5S,6R)-2-[5,7-dihydroxy-2-(4-hydroxy-3,5-dimethoxyphenyl)chromenylium-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol, CHEBI:31799, Enoside, Ligulin, 1-Benzopyrylium, 3-(beta-D-glucopyranosyloxy)-5,7-dihydroxy-2-(4-hydroxy-3,5-dimethoxyphenyl)-, (3''-O-methyl-(3)H)malvidin-3-glucoside, Malvidin 3-O-beta-D-glucopyranoside, malvidin glucoside, CHEMBL403236, SCHEMBL6139047, GTPL12427, DTXSID30332124, 1ST162121, Q137147, 5,7-dihydroxy-2-(4-hydroxy-3,5-dimethoxyphenyl)chromenium-3-yl beta-D-glucopyranoside, 5,7-dihydroxy-2-(4-hydroxy-3,5-dimethoxyphenyl)-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1$l^{4}-chromen-1-ylium C23H25O12+ PXUQTDZNOHRWLI-OXUVVOBNSA-O (2S,3R,4S,5S,6R)-2-[5,7-dihydroxy-2-(4-hydroxy-3,5-dimethoxyphenyl)chromenylium-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol n.a. n.a. No No No No Yes No rxnDiet159 PMDBD2001868 Prunin Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 92794 n.a. NPC39351 Prunin, 529-55-5, Naringenin-7-O-glucoside, Naringenin 7-O-beta-D-glucoside, CHEBI:28327, Naringenin 7-O-glucoside, Naringenin 7-0-glucoside, LSB8HDX4E5, (S)-7-(beta-D-Glucopyranosyloxy)-2,3-dihydro-5-hydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one, (2S)-5-hydroxy-2-(4-hydroxyphenyl)-4-oxo-3,4-dihydro-2H-chromen-7-yl beta-D-glucopyranoside, (S)-5-Hydroxy-2-(4-hydroxyphenyl)-7-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)chroman-4-one, PRUNIN PROTEIN, PRUNUS, MFCD00210548, NSC-135064, EINECS 208-464-8, NSC 135064, Pru1 protein, Prunus, Pru2 protein, Prunus, UNII-LSB8HDX4E5, Pru du 6 protein, Prunus, 4'',5,7-Trihydroxyflavanone 7-O-.beta.-D-glucopyranoside, NARINGENIN 7-GLUCOSIDE, SCHEMBL318229, CHEMBL469654, Pru du 6.01 protein, Prunus, Pru du 6.02 protein, Prunus, DTXSID40967365, GLXC-14478, 4H-1-Benzopyran-4-one, 7-(.beta.-D-glucopyranosyloxy)-2,3-dihydro-5-hydroxy-2-(4-hydroxyphenyl)-, (2S)-, HY-N1549, BDBM50249470, Prunin, >=95% (LC/MS-ELSD), AKOS037515151, CCG-208407, (2S)-naringenin 7-O-beta-D-glucoside, NCGC00163599-01, AC-35062, NARINGENIN 7-O-.BETA.-D-GLUCOSIDE, 1ST175404, CS-0017098, NS00015840, C09099, NARINGENIN 7-.BETA.-D-GLUCOSIDE, (-)-, NARINGENIN 7-O-.BETA.-D-GLUCOPYRANOSIDE, SR-05000013703, SR-05000013703-1, Q15424791, (2S)-5-HYDROXY-2-(4-HYDROXYPHENYL)-7-((2S,3R,4S,5S,6R)-3,4,5-TRIHYDROXY-6-(HYDROXYMETHYL)OXAN-2-YL)OXY-2,3-DIHYDROCHROMEN-4-ONE, (2S)-7-(.BETA.-D-GLUCOPYRANOSYLOXY)-2,3-DIHYDRO-5-HYDROXY-2-(4-HYDROXYPHENYL)-4H-1-BENZOPYRAN-4-ONE, (S)-5-hydroxy-2-(4-hydroxyphenyl)-7-((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)chroman-4-one, 4H-1-BENZOPYRAN-4-ONE, 7-(.BETA.-D-GLUCOPYRANOSYLOXY)-2,3-DIHYDRO-5-HYDROXY-2-(4-HYDROXYPHENYL)-, (S)- C21H22O10 DLIKSSGEMUFQOK-SFTVRKLSSA-N (2S)-5-hydroxy-2-(4-hydroxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3-dihydrochromen-4-one n.a. n.a. No No No No Yes No rxn24413,rxn41673,rxnDiet163,rxnAdd67 PMDBD2001869 Narirutin Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 442431 n.a. NPC271270 Narirutin, 14259-46-2, Isonaringenin, Isonaringin, Naringenin-7-O-rutinoside, (2S)-Narirutin, Naringenin 7-O-rutinoside, CHEBI:28705, 06M5EAT0YC, Naringenin 7-beta-rutinoside, FEMA No. 2769, EINECS 238-138-0, UNII-06M5EAT0YC, (2S)-5-hydroxy-2-(4-hydroxyphenyl)-4-oxo-3,4-dihydro-2H-chromen-7-yl 6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoside, (S)-5-hydroxy-2-(4-hydroxyphenyl)-7-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-((((2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)methyl)tetrahydro-2H-pyran-2-yl)oxy)chroman-4-one, ISONARINGIN (USP-RS), ISONARINGIN [USP-RS], Flavanone, 4'',5,7-trihydroxy-, 7-beta-rutinoside, 4H-1-Benzopyran-4-one, 7-((6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoxyl)oxy)-2,3-dihydro-5-hydroxy-2-(4-hydroxyphenyl)-, (S)-, 4H-1-Benzopyran-4-one,7-[[6-O-(6-deoxy-a-L-mannopyranosyl)-b-D-glucopyranosyl]oxy]-2,3-dihydro-5-hydroxy-2-(4-hydroxyphenyl)-, (2S)-, BrovincamineFumarte, NARIRUTIN [INCI], SCHEMBL669946, CHEMBL446246, Narirutin, >=98% (HPLC), NARINGENIN 7beta-RUTINOSIDE, DTXSID30931535, HXTFHSYLYXVTHC-AJHDJQPGSA-N, HY-N0804, BDBM50249471, MFCD00017316, s9242, NARINGENIN 7.BETA.-RUTINOSIDE, AKOS030530132, CCG-270129, (2S)-5-hydroxy-2-(4-hydroxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxy-2,3-dihydrochromen-4-one, 1ST40165, AS-75180, CS-0009810, NS00053810, C09793, Q-100159, Q13569061, FLAVANONE, 4'',5,7-TRIHYDROXY-, 7beta-RUTINOSIDE, FLAVANONE, 4'',5,7-TRIHYDROXY-, 7.BETA.-RUTINOSIDE, (2S)-5-hydroxy-2-(4-hydroxyphenyl)-7-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-3,4-dihydro-2H-1-benzopyran-4-one, (2S)-7-((6-O-(6-DEOXY-.ALPHA.-L-MANNOPYRANOSYL)-.BETA.-D-GLUCOPYRANOSYL)OXY)-2,3-DIHYDRO-5-HYDROXY-2-(4-HYDROXYPHENYL)-4H-1-BENZOPYRAN-4-ONE, (2S)-7-((6-O-(6-DEOXY-alpha-L-MANNOPYRANOSYL)-beta-D-GLUCOPYRANOSYL)OXY)-2,3-DIHYDRO-5-HYDROXY-2-(4-HYDROXYPHENYL)-4H-1-BENZOPYRAN-4-ONE, (S)-5-hydroxy-2-(4-hydroxyphenyl)-7-((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(((2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yloxy)methyl)tetrahydro-2H-pyran-2-yloxy)chroman-4-one, (S)-7-((6-O-(6-Deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl)oxy)-2,3-dihydro-5-hydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one, 4H-1-BENZOPYRAN-4-ONE, 7-((6-O-(6-DEOXY-.ALPHA.-L-MANNOPYRANOSYL)-.BETA.-D-GLUCOPYRANOSYL)OXY)-2,3-DIHYDRO-5-HYDROXY-2-(4-HYDROXYPHENYL)-, (2S)-, 4H-1-Benzopyran-4-one, 7-((6-O-(6-deoxy-alpa-L-mannopyranosyl)-beta-D-glucopyranosyl)oxy)-2,3-dihydro-5-hydroxy-2-(4-hydroxyphenyl)-, (2S)-, 4H-1-BENZOPYRAN-4-ONE, 7-((6-O-(6-DEOXY-alpha-L-MANNOPYRANOSYL)-beta-D-GLUCOPYRANOSYL)OXY)-2,3-DIHYDRO-5-HYDROXY-2-(4-HYDROXYPHENYL)-, (2S)- C27H32O14 HXTFHSYLYXVTHC-AJHDJQPGSA-N (2S)-5-hydroxy-2-(4-hydroxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxy-2,3-dihydrochromen-4-one n.a. n.a. No No No No Yes No rxnDiet165 PMDBD2001870 methyl (2S,3E,4S)-4-{2-[2-(3,4-dihydroxyphenyl)ethoxy]-2-oxoethyl}-3-ethylidene-2-hydroxy-3,4-dihydro-2H-pyran-5-carboxylate Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 101723007 n.a. n.a. methyl (2S,3E,4S)-4-{2-[2-(3,4-dihydroxyphenyl)ethoxy]-2-oxoethyl}-3-ethylidene-2-hydroxy-3,4-dihydro-2H-pyran-5-carboxylate C19H22O8 BIWKXNFEOZXNLX-HWHRUHDTSA-N methyl (4S,5E,6S)-4-[2-[2-(3,4-dihydroxyphenyl)ethoxy]-2-oxoethyl]-5-ethylidene-6-hydroxy-4H-pyran-3-carboxylate n.a. n.a. No No No No Yes No rxnDiet167,rxnAdd217 PMDBD2001871 pelargonidin-3,5-diglucoside Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 167642 n.a. n.a. Pelargonin chloride, 17334-58-6, Pelargonin (glycoside), Pelargonidin-3,5-O-diglucoside chloride, Pelargonidin 3,5-diglucoside, 4OJV6238UJ, Pelargonin, Pelargonidin 3,5-diglucoside (chloride), Pelargonin (VAN), 1-Benzopyrylium, 3,5-bis(beta-D-glucopyranosyloxy)-7-hydroxy-2-(4-hydroxyphenyl)-, chloride, UNII-4OJV6238UJ, EINECS 241-360-0, Pelargonidin 3,5-di-O-glucoside, NSC 87526, Pelargonidin, 3,5-di-beta-D-glucopyranoside, Glucopyranoside, pelargonidin-3,5 di-, beta-D-, Pelargonidin-3,5-diglucoside, SCHEMBL350109, DTXSID601341528, AKOS040760619, Pelargonin chloride, >=90% (HPLC), FS-7561, 3,5-Bis(beta-D-glucopyranosyloxy)-7-hydroxy-2-(4-hydroxyphenyl)-1-benzopyrylium chloride, Pelargonin chloride, analytical standard, 1-Benzopyrylium, 3,5-bis(.beta.-D-glucopyranosyloxy)-7-hydroxy-2-(4-hydroxyphenyl)-, chloride, PELARGONIDIN 3,5-DIGLUCOSIDE [MI], HY-123894, CS-0086770, NS00052402, PELARGONIDIN 3,5-DI-.BETA.-D-GLUCOSIDE, PELARGONIDIN 3-O-GLUCOSIDE-5-O-GLUCOSIDE, J-010897, PELARGONIDIN 3,5-DI-.BETA.-D-GLUCOPYRANOSIDE, 3,4'',5,7-TETRAHYDROXYFLAVYLIUM, CHLORIDE, 3,5-DIGLUCOSIDE, 3,5-BIS(.BETA.-D-GLUCOPYRANOSYLOXY)-4'',7-DIHYDROXYFLAVYLIUM CHLORIDE C27H31ClO15 DIRROHKULXIUCB-DHJOXOLYSA-N "(2S,3R,4S,5S,6R)-2-[7-hydroxy-2-(4-hydroxyphenyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromenylium-5-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol;chloride" n.a. n.a. No No No No Yes No rxnDiet169 PMDBD2001872 Pelargonidin 3-O-(6-O-malonyl-beta-D-glucoside) Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 443913 n.a. n.a. Pelargonidin 3-O-(6-O-malonyl-beta-D-glucoside), 165070-68-8, 3-[[(2R,3S,4S,5R,6S)-6-[5,7-dihydroxy-2-(4-hydroxyphenyl)chromenylium-3-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methoxy]-3-oxopropanoic acid, 5,7-dihydroxy-2-(4-hydroxyphenyl)chromenium-3-yl 6-O-(carboxyacetyl)-beta-D-glucopyranoside, 1-Benzopyrylium, 3-[[6-O-(carboxyacetyl)-beta-D-glucopyranosyl]oxy]-5,7-dihydroxy-2-(4-hydroxyphenyl)-, CHEBI:31965, DTXSID20332138, Q27114738 C24H23O13+ XLZUBCUKXQFBKB-JZWLZXDTSA-O 3-[[(2R,3S,4S,5R,6S)-6-[5,7-dihydroxy-2-(4-hydroxyphenyl)chromenylium-3-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methoxy]-3-oxopropanoic acid n.a. n.a. No No No No Yes No rxnDiet170,rxnAdd9 PMDBD2001873 Pelargonidin 3-glucoside Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 3080714 n.a. n.a. "18466-51-8, Pelargonidin 3-glucoside, Callistephin chloride, Pelargonidin-3-glucoside, PELARGONIDIN-3-GLUCOSIDE CHLORIDE, Pelargonidin-3-O-glucoside chloride, Callistephin (chloride), UNII-8H1WZY9R6P, 8H1WZY9R6P, Pelargonidin-3-glucopyranoside, MFCD00017578, (2S,3R,4S,5S,6R)-2-[5,7-dihydroxy-2-(4-hydroxyphenyl)chromenylium-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol;chloride, 1-Benzopyrylium, 3-(beta-D-glucopyranosyloxy)-5,7-dihydroxy-2-(4-hydroxyphenyl)-, chloride, pelargonidin-3-O-glucoside, Pelargonidin monoglucoside, SCHEMBL316939, CHEBI:36122, DTXSID00939866, Pelargonidin 3-Glucoside (>90%), PELARGONIDIN 3-MONOGLUCOSIDE, Pelargonidin 3-O-glucoside chloride, Callistephin (chloride), HPLC Grade, AKOS030573523, PELARGONIDIN 3-GLUCOSIDE [MI], CS-W020785, HY-W040045, PELARGONIDIN 3-.BETA.-GLUCOSIDE, PELARGONIDIN 3-GLUCOSIDE CHLORIDE, 1ST40267, AS-78470, Callistephin chloride, >=95.0% (HPLC), Callistephin chloride, >=97.0% (HPLC), pelargonidin 3-O-beta-D-glucoside chloride, PELARGONIDIN 3-.BETA.-D-GLUCOPYRANOSIDE, PELARGONIDIN 3-O-.BETA.-D-GLUCOPYRANOSIDE, 3-(Glucosyloxy)-4'',5,7-trihydroxyflavylium chloride, Q27116710, 3,4'',5,7-TETRAHYDROXYFLAVYLIUM CHLORIDE 3-GLUCOSIDE, 3-(beta-D-glucopyranosyloxy)-4'',5,7-trihydroxyflavylium chloride, 3,4'',5,7-TETRAHYDROXYFLAVYLIUM CHLORIDE 3-.BETA.-D-GLUCOPYRANOSIDE, 3-(.BETA.-D-GLUCOPYRANOSYLOXY)-4'',5,7-TRIHYDROXYFLAVYLIUM CHLORIDE, 1-BENZOPYRYLIUM, 3-(.BETA.-D-GLUCOPYRANOSYLOXY)-5,7-DIHYDROXY-2-(4-HYDROXYPHENYL)-, CHLORIDE, 5,7-dihydroxy-2-(4-hydroxyphenyl)-3-((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)chromenylium chloride" C21H21ClO10 CAHGSEFWVUVGGL-UBNZBFALSA-N "(2S,3R,4S,5S,6R)-2-[5,7-dihydroxy-2-(4-hydroxyphenyl)chromenylium-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol;chloride" n.a. n.a. No No No No Yes No rxn04617,rxn07667,rxn24466,rxn40130,rxnDiet171,rxnAdd23 PMDBD2001874 Pelargonidin 3-O-rutinoside Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 443917 n.a. NPC11119 Pelargonidin 3-O-rutinoside, (2R,3R,4R,5R,6S)-2-[[(2R,3S,4S,5R,6S)-6-[5,7-dihydroxy-2-(4-hydroxyphenyl)chromenylium-3-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methoxy]-6-methyloxane-3,4,5-triol, CHEBI:31968, DTXSID501341470, Q27114740, 5,7-dihydroxy-2-(4-hydroxyphenyl)chromenium-3-yl 6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoside C27H31O14+ IFYOHQQBIKDHFT-ASZXTAQUSA-O (2R,3R,4R,5R,6S)-2-[[(2R,3S,4S,5R,6S)-6-[5,7-dihydroxy-2-(4-hydroxyphenyl)chromenylium-3-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methoxy]-6-methyloxane-3,4,5-triol n.a. n.a. No No No No Yes No rxnDiet172 PMDBD2001875 Pelargonidin 3-O-beta-D-sambubioside Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 71627264 n.a. n.a. Pelargonidin 3-O-beta-D-sambubioside, CHEBI:74809, C20489, Q27144920, 5,7-dihydroxy-2-(4-hydroxyphenyl)chromenium-3-yl beta-D-xylopyranosyl-(1->2)-beta-D-glucopyranoside C26H29O14+ NKUOSFBSKVBOJC-AOBOYTTNSA-O (2S,3R,4S,5R)-2-[(2S,3R,4S,5S,6R)-2-[5,7-dihydroxy-2-(4-hydroxyphenyl)chromenylium-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxyoxane-3,4,5-triol n.a. n.a. No No No No Yes No rxnDiet173 PMDBD2001876 Pelargonidin 3-O-sophoroside Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 23724704 n.a. NPC115872 Pelargonidin 3-O-sophoroside, Pelargonidin 3-sophoroside, CHEBI:134007, DTXSID601341473, Q27149488, (2S,3R,4S,5S,6R)-2-[(2S,3R,4S,5S,6R)-2-[5,7-dihydroxy-2-(4-hydroxyphenyl)chromenylium-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol, 34365-81-6, 5,7-dihydroxy-2-(4-hydroxyphenyl)-1-benzopyran-1-ium-3-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside C27H31O15+ HASVPNDDKSXPGU-WGNLCONDSA-O (2S,3R,4S,5S,6R)-2-[(2S,3R,4S,5S,6R)-2-[5,7-dihydroxy-2-(4-hydroxyphenyl)chromenylium-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol n.a. n.a. No No No No Yes No rxnDiet174,rxnAdd25 PMDBD2001877 Peonidin Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 441773 n.a. NPC86655 Peonidin, CHEBI:75314, 2-(4-hydroxy-3-methoxyphenyl)chromenylium-3,5,7-triol, peonidin cation, peonidin(1+), 3,4'',5,7-tetrahydroxy-3''-methoxyflavylium, SCHEMBL20017, CHEMBL1277324, DTXSID80861792, BDBM50347140, LMPK12010006, Q3072948, 3,5,7-Trihydroxy-2-(4-hydroxy-3-methoxyphenyl)-1-benzopyrylium C16H13O6+ XFDQJKDGGOEYPI-UHFFFAOYSA-O 2-(4-hydroxy-3-methoxyphenyl)chromenylium-3,5,7-triol n.a. n.a. No No No No Yes No rxnDiet175,rxnAdd26 PMDBD2001878 Peonidin-3-glucoside Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 443654 n.a. NPC125755 Peonidin-3-glucoside, 68795-37-9, peonidin 3-O-beta-D-glucoside, CHEBI:74793, (2S,3R,4S,5S,6R)-2-[5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)chromenylium-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol, 3''-O-methylcyanidin 3-O-beta-D-glucoside, D5ZBS8SDA7, Peonidin 3-beta-D-glucoside, CHEMBL1784263, DTXSID70988503, Q6625055, 3-(beta-D-Glucopyranosyloxy)-5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-1-benzopyrylium, 5,7-Dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-1-benzopyran-1-ium-3-yl hexopyranoside, 5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)chromenium-3-yl beta-D-glucopyranoside, (2S,3S,4R,5S,6R)-2-(Hydroxymethyl)-6-(2-(3-methoxy-4-oxidanyl-phenyl)-5,7-bis(oxidanyl)chromenylium-3-yl)oxy-oxane-3,4,5-triol, 5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1$l^{4}-chromen-1-ylium, 5,7-Dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1lambda4-benzopyran-1-ylium C22H23O11+ ZZWPMFROUHHAKY-OUUKCGNVSA-O (2S,3R,4S,5S,6R)-2-[5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)chromenylium-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol n.a. n.a. No No No No Yes No rxnDiet176,rxnAdd27 PMDBD2001879 Petunidin 3-glucoside Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 443651 n.a. NPC161700 Petunidin 3-glucoside, Petunidin 3-O-glucoside, Petunidin-3-glucoside, 71991-88-3, CHEBI:31985, Petunidin 3-O-beta-D-glucopyranoside, (2S,3R,4S,5S,6R)-2-[2-(3,4-dihydroxy-5-methoxyphenyl)-5,7-dihydroxychromenylium-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol, petunidin-3-monoglucoside, petunidin-3-O-beta-D-glucoside, CHEMBL1784264, DTXSID40990158, petunidin-3-O-beta-D-glucopyranoside, E88956, Q7179425, 2-(3,4-Dihydroxy-5-methoxyphenyl)-5,7-dihydroxy-1-benzopyran-1-ium-3-yl hexopyranoside, 2-(3,4-dihydroxy-5-methoxyphenyl)-5,7-dihydroxychromenium-3-yl beta-D-glucopyranoside, 2-(3,4-dihydroxy-5-methoxyphenyl)-5,7-dihydroxy-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1$l^{4}-chromen-1-ylium C22H23O12+ CCQDWIRWKWIUKK-QKYBYQKWSA-O (2S,3R,4S,5S,6R)-2-[2-(3,4-dihydroxy-5-methoxyphenyl)-5,7-dihydroxychromenylium-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol n.a. n.a. No No No No Yes No rxnDiet177,rxnAdd28 PMDBD2001880 Phlorizin Dietary Substance, Therapeutic Substance Investigational Drug 60-81-1 DB16771 n.a. n.a. D06WAL 6072 16498836 NPC259182 "Phlorizin, Phloridzin, 60-81-1, Phlorhizin, Phlorizoside, Floridzin, Phlorrhizin, Phloretin 2''-glucoside, Phloridzinum, Phloridzosid, Phlorrhizen, Phlorizine, NSC 2833, Phloretin-2''-O-beta-glucoside, AI3-19835, EINECS 200-487-1, UNII-CU9S17279X, CHEBI:8113, Phlorizin hydrate, CU9S17279X, NSC-2833, Phloridzin dihydrate, phloretin 2''-O-glucoside, 1-(2,4-dihydroxy-6-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)phenyl)-3-(4-hydroxyphenyl)propan-1-one, 7061-54-3, Phloretin-2''-beta-glucoside, 1-[2-(beta-D-Glucopyranosyloxy)-4,6-dihydroxyphenyl]-3-(4-hydroxyphenyl)-1-propanone, CHEMBL245067, DTXSID3075339, Phloretin-2''-O-.beta.-glucoside, 2''-(beta-D-Glucopyranosyloxy)-4'',6''-dihydroxy-3-(4-hydroxyphenyl)propiophenone, 1-Propanone, 1-(2-(beta-D-glucopyranosyloxy)-4,6-dihydroxyphenyl)-3-(4-hydroxyphenyl)-, 1-(2,4-dihydroxy-6-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)-3-(4-hydroxyphenyl)propan-1-one, Phlorizin (dihydrate), 1-Propanone, 1-[2-(beta-D-glucopyranosyloxy)-4,6-dihydroxyphenyl]-3-(4-hydroxyphenyl)-, 2''-(.beta.-D-glucopyranosyloxy)-4'',6''-dihydroxy-3-(4-hydroxyphenyl)propiophenone, 1-[2-[(2S,3R,4S,5S,6R)-6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-4,6-bis(oxidanyl)phenyl]-3-(4-hydroxyphenyl)propan-1-one, Phloretin-2''-O-glucoside, SR-01000781913, Lopin, 1-Propanone, 1-[2-(.beta.-D-glucopyranosyloxy)-4,6-dihydroxyphenyl]-3-(4-hydroxyphenyl)-, Phloridzin Phenolic, O-glucoside, 1, Phloridzin1535, 1-PROPANONE, 1-(2-(.BETA.-D-GLUCOPYRANOSYLOXY)-4,6-DIHYDROXYPHENYL)-3-(4-HYDROXYPHENYL)-, Phlorizin (Phloridzin), Spectrum_001291, PHLORIDZIN [MI], SpecPlus_000325, Spectrum2_000701, Spectrum3_001227, Spectrum4_001651, Spectrum5_000521, PHLORIDZIN [INCI], PHLORIDZINUM [HPUS], PHLORIDZIN [WHO-DD], SCHEMBL17290, BSPBio_002674, KBioGR_002141, KBioSS_001771, SPECTRUM300547, JMC511145 Compound 1, DivK1c_006421, SPBio_000881, GTPL4757, DTXCID1042738, BDBM20875, KBio1_001365, KBio2_001771, KBio2_004339, KBio2_006907, KBio3_002174, HMS2090P10, Phloretin 2''-ss-D-glucopyranoside, HY-N0143, CCG-38341, s2343, 4,6-dihydroxy-2-(beta-D-glucosido)-beta-(p-hydroxyphenyl)propiophenone, AKOS015920054, AC-7976, CS-2013, SDCCGMLS-0066626.P001, 1-Propanone,1-[2-(b-D-glucopyranosyloxy)-4,6-dihydroxyphenyl]-3-(4-hydroxyphenyl)-, NCGC00142423-01, NCGC00142423-02, NCGC00142423-06, 1-[2,4-dihydroxy-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-3-(4-hydroxyphenyl)propan-1-one, 1-[2,4-dihydroxy-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-phenyl]-3-(4-hydroxyphenyl)propan-1-one, 1-{6-[(2S,4S,5S,3R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)(2H-3,4,5,6-tetrahydr opyran-2-yloxy)]-2,4-dihydroxyphenyl}-3-(4-hydroxyphenyl)propan-1-one, 1ST40016, AS-15724, NS00002475, P0248, C01604, A836937, A868885, Q413105, Q-100699, SR-01000781913-2, SR-01000781913-4, SR-01000781913-5, BRD-K73756878-001-02-9, 1-[2-(.beta.-D-Glucopyranosyloxy)-4,6-dihydroxyphenyl]-3-(4-hydroxyphenyl)-1-propanone, 1-[2-(?-D-Glucopyranosyloxy)-4,6-dihydroxyphenyl]-3-(4-hydroxyphenyl)-1-propanone, 1-[2-(ss-D-Glucopyranosyloxy)-4,6-dihydroxyphenyl]-3-(4-hydroxyphenyl)-1-propanone, 3,5-dihydroxy-2-[3-(4-hydroxyphenyl)propanoyl]phenyl beta-D-glucopyranoside, 1-(2,4-dihydroxy-6-((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)phenyl)-3-(4-hydroxyphenyl)propan-1-one, 1-[2,4-dihydroxy-6-[3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-phenyl]-3-(4-hydroxyphenyl)propan-1-one dihydrate;Phlorizin dihydrate, 112318-65-7, LN9" C21H24O10 IOUVKUPGCMBWBT-QNDFHXLGSA-N 1-[2,4-dihydroxy-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-3-(4-hydroxyphenyl)propan-1-one n.a. n.a. No No No No Yes No rxnDiet179 PMDBD2001881 Piceatannol Dietary Substance, Therapeutic Substance Investigational Drug 10083-24-6 DB08399 n.a. n.a. D0O0VZ 667639 581006 NPC34864 "piceatannol, 10083-24-6, 3-Hydroxyresveratol, trans-Piceatannol, (E)-4-(3,5-dihydroxystyryl)benzene-1,2-diol, Astringenin, 3,5,3'',4''-Tetrahydroxystilbene, 3,3'',4''5-Tetrahydroxystilbene, 4-[(E)-2-(3,5-dihydroxyphenyl)ethenyl]benzene-1,2-diol, (E)-Piceatannol, 3,3'',4,5''-Tetrahydroxystilbene, 4339-71-3, NSC-365798, 4-[(E)-2-(3,5-dihydroxyphenyl)vinyl]benzene-1,2-diol, C14H12O4, 6KS3LS0D4F, 3,3'',4,5''-Tetrahydroxy-trans-stilbene, CHEBI:28814, NSC-622471, DB08399, trans-3,3'',4,5''-Tetrahydroxystilbene, CHEMBL69863, 4-(3,5-dihydroxystyryl)benzene-1,2-diol, astringinin, 1,2-Benzenediol, 4-(2-(3,5-dihydroxyphenyl)ethenyl)-, (E)-, C05901, MFCD00221715, NSC365798, NSC622471, piceatanol, 3,4,3'',5''-tetrahydroxy-trans-stilbene, 4-[(1E)-2-(3,5-Dihydroxyphenyl)ethenyl]-1,2-benzenediol, J61.264B, 3,3'',4,5''-STILBENETETROL, (E)-, 3,3'',4,5''-Stilbenetetrol, 1,2-Benzenediol, 4-[(1E)-2-(3,5-dihydroxyphenyl)ethenyl]-, 4-((E)-2-(3,5-DIHYDROXYPHENYL)ETHENYL)BENZENE-1,2-DIOL, 4-((E)-2-(3,5-DIHYDROXYPHENYL)VINYL)-1,2-BENZENEDIOL, SMR001230734, Astringenin;trans-Piceatannol, SR-01000076056, MLS003171221, UNII-6KS3LS0D4F, 4-((E)-2-(3,5-dihydroxyphenyl)vinyl)benzene-1,2-diol, NSC 365798, NSC 622471, 4-((1E)-2-(3,5-dihydroxyphenyl)ethenyl)benzene-1,2-diol, 4-[(1E)-2-(3,5-dihydroxyphenyl)ethenyl]benzene-1,2-diol, Astringinine, 1,2-Benzenediol, 4-[2-(3,5-dihydroxyphenyl)ethenyl]-, (E)-, CCRIS 9289, 1,2-BENZENEDIOL, 4-((1E)-2-(3,5-DIHYDROXYPHENYL)ETHENYL)-, Piceatannol, powder, 1,2-Benzenediol, 4-(2-(3,5-dihydroxyphenyl)ethenyl)-, BiomolKI_000023, PICEATANNOL [INCI], BiomolKI2_000031, Lopac0_000915, SCHEMBL43541, BSPBio_001120, MLS002153321, MLS006010974, BIDD:ER0001, SCHEMBL505561, BMK1-C11, cid_667639, MEGxp0_000245, DTXSID6040587, REGID_for_CID_667639, CHEBI:92460, HMS1362H21, HMS1792H21, HMS1990H21, HMS2236B03, HMS3262H12, HMS3403H21, HMS3412J21, HMS3676J21, ML027, Tox21_500915, 3,3'''',4,5''''-tetrahydroxystilbene, BDBM50045936, HB0505, LMPK13090006, s3026, 3,4,3'''',5''''-tetrahydroxystillbene, AKOS015914951, AC-5281, CCG-100627, CS-5657, FD18005, LP00915, SDCCGSBI-0050890.P002, IDI1_002155, SMP2_000263, NCGC00094226-01, NCGC00094226-02, NCGC00094226-03, NCGC00094226-04, NCGC00094226-05, NCGC00094226-06, NCGC00094226-07, NCGC00094226-20, NCGC00261600-01, AS-18099, HY-13518, trans-3,3'''',4,5''''-tetrahydroxystilbene, 3,4,3'''',5''''-tetrahydroxy-trans-stilbene, EU-0100915, NS00014902, P1928, SW219501-1, K00089, P 0453, A800279, EN300-23569528, 1, 4-[2-(3,5-dihydroxyphenyl)ethenyl]-, (E)-, CU-00000000400-1, J-000228, Q7190608, SR-01000076056-1, SR-01000076056-6, SR-01000076056-9, BRD-K91509126-001-04-6, BRD-K91509126-001-05-3, (E)-4-[2-(3,5Dihydroxyphenyl)ethenyl]1,2-benzenediol, F13BE9BB-B7D7-4D40-B31A-C15B953E033D, (E)-4-[2-(3,5-Dihydroxyphenyl)ethenyl]1,2-benzenediol, 5-[(E)-2-(3,4-dihydroxyphenyl)ethenyl]benzene-1,3-diol, 5-[(E)-2-(3,4-Dihydroxyphenyl)vinyl]benzene-1,3-diol, 1,2-Benzenediol, 4-[(E)-2-(3,5-dihydroxyphenyl)ethenyl]-, 4-[2-(3,5-dihydroxyphenyl)-(E)-1-ethenyl]-1,2-benzenediol, 4-[(E)-2-(3,5-dihydroxyphenyl)vinyl]benzene-1,2-diol(Piceatannol), 4-[2-(3,5-dihydroxyphenyl)-(E)-1-ethenyl]-1,2-benzenediol(Piceatannol), (E)-4-[2-(3,5Dihydroxyphenyl)ethenyl]1,2-benzenediol, 3,3'',4,5''-Tetrahydroxy-trans-stilbene, (E)-4-[2-(3,5Dihydroxyphenyl)ethenyl]1,2-benzenediol, 3,3a?4,5a?Tetrahydroxy-trans-stilbene" C14H12O4 CDRPUGZCRXZLFL-OWOJBTEDSA-N 4-[(E)-2-(3,5-dihydroxyphenyl)ethenyl]benzene-1,2-diol n.a. n.a. No No No No Yes No rxn02968,rxnDiet180 PMDBD2001882 Pinocembrin Dietary Substance, Therapeutic Substance Phase 2 n.a. n.a. n.a. n.a. D0G5CS 68071 n.a. NPC243083 Pinocembrin, 480-39-7, Dihydrochrysin, Galangin flavanone, (+)-Pinocembrin, 5,7-Dihydroxyflavanone, (S)-5,7-dihydroxy-2-phenylchroman-4-one, (2S)-pinocembrin, (S)-5,7-dihydroxyflavanone, 4H-1-Benzopyran-4-one, 2,3-dihydro-5,7-dihydroxy-2-phenyl-, (2S)-, CHEMBL399910, (s)-pinocembrin, CHEBI:28157, (S)-2,3-Dihydro-5,7-dihydroxy-2-phenyl-4H-1-benzopyran-4-one, 8T7C8CH791, NSC-279005, (+)-pinocoembrin, SMR000232372, Pinocembrin (6CI), 4H-1-Benzopyran-4-one, 2,3-dihydro-5,7-dihydroxy-2-phenyl-, (-)-, (2s)-5,7-dihydroxy-2-phenyl-2,3-dihydro-4h-chromen-4-one, NSC 43318, NSC 279005, NSC 661207, NSC43318, UNII-8T7C8CH791, 4H-1-Benzopyran-4-one, 2,3-dihydro-5,7-dihydroxy-2-phenyl-, (S)-, NSC-43318, NSC661207, Spectrum_001879, SpecPlus_000896, Spectrum2_001670, Spectrum3_001635, Spectrum4_001765, Spectrum5_000349, Oprea1_508274, BSPBio_003329, KBioGR_002249, KBioSS_002406, MLS000697595, MLS000728654, DivK1c_006992, SPBio_001859, (2S)-5,7-dihydroxy-2-phenyl-2,3-dihydrochromen-4-one, DTXSID3075412, SCHEMBL10026578, BDBM26667, KBio1_001936, KBio2_002401, KBio2_004969, KBio2_007537, KBio3_002549, HMS2205J20, HY-N0575, CCG-39668, LMPK12140214, s3941, AKOS004111068, SDCCGMLS-0066749.P001, NCGC00178137-01, AC-34601, AS-56293, XP162085, CS-0009111, (2S)-5,7-dihydroxy-2-phenyl-chroman-4-one, C09827, SR-01000762561, SR-01000762561-3, BRD-K94689771-001-02-5, Pinocembrin, analytical standard, 95% (TLC), solid, (2~{S})-5,7-bis(oxidanyl)-2-phenyl-2,3-dihydrochromen-4-one, (2S)-5,7-dihydroxy-2-phenyl-3,4-dihydro-2H-1-benzopyran-4-one, 4H-1-Benzopyran-4-one, 2,3-dihydro-5,7-dihydroxy-2-phenyl-, (S)-(-)- C15H12O4 URFCJEUYXNAHFI-ZDUSSCGKSA-N (2S)-5,7-dihydroxy-2-phenyl-2,3-dihydrochromen-4-one n.a. n.a. No No No No Yes No rxnDiet181,rxnAdd84 PMDBD2001883 2,3-trans-proanthocyanidin Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 146798 n.a. NPC58190 Procyanidin B3, 23567-23-9, Proanthocyanidin B3, CHEBI:75630, 2TC1A0KEAQ, Catechin(4a->8)catechin, 2,3-trans-proanthocyanidin, CHEMBL501490, catechin-(4alpha->8)-catechin, C-(4a,8)-C, (2R,3S)-2-(3,4-dihydroxyphenyl)-8-[(2R,3S,4S)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2H-chromen-4-yl]-3,4-dihydro-2H-chromene-3,5,7-triol, Procyanidin B-3, (4,8''-Bi-2H-1-benzopyran)-3,3'',5,5'',7,7''-hexol, 2,2''-bis(3,4-dihydroxyphenyl)-3,3'',4,4''-tetrahydro-, (2R,2''R,3S,3''S,4S)-, [4,8''-Bi-2H-1-benzopyran]-3,3'',5,5'',7,7''-hexol, 2,2''-bis(3,4-dihydroxyphenyl)-3,3'',4,4''-tetrahydro-, (2R,2''R,3S,3''S,4S)-, (2R,2''R,3S,3''S,4S)-2,2''-Bis(3,4-dihydroxyphenyl)-[4,8''-bichromane]-3,3'',5,5'',7,7''-hexaol, UNII-2TC1A0KEAQ, PROCYANIDINB3, PROCYANIDOL B3S, (-)-PROCYANIDIN B3, SCHEMBL677697, DTXSID60178193, XFZJEEAOWLFHDH-AVFWISQGSA-N, Catechin-(4.alpha.-->8)catechin, HY-N2345, BDBM50447858, LMPK12030003, AKOS016009332, (2R-(2alpha,3beta,4alpha(2''R*,3''S*)))-2,2''-Bis(3,4-dihydroxyphenyl)-3,3'',4,4''-tetrahydro-(4,8''-Bi-2H-1-benzopyran)-3,3'',5,5'',7,7''-hexol, (4,8''-Bi-2H-1-benzopyran)-3,3'',5,5'',7,7''-hexol, 2,2''-bis(3,4-dihydroxyphenyl)-3,3'',4,4''-tetrahydro-, (2R-(2alpha,3beta,4alpha(2''R*,3''S*)))-, AC-35059, MS-30396, 1ST169527, CS-0021307, NS00094744, Q7247553, (2R,2''R,3S,3''S,4S)-2,2''-bis(3,4-dihydroxyphenyl)-3,3'',4,4''-tetrahydro-2H,2''H-4,8''-bichromene-3,3'',5,5'',7,7''-hexol, (2R,3S,4S)-2-(3,4-dihydroxyphenyl)-4-[(2R,3S)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-chroman-8-yl]chromane-3,5,7-triol C30H26O12 XFZJEEAOWLFHDH-AVFWISQGSA-N (2R,3S)-2-(3,4-dihydroxyphenyl)-8-[(2R,3S,4S)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2H-chromen-4-yl]-3,4-dihydro-2H-chromene-3,5,7-triol n.a. n.a. No No No No Yes No rxnDiet184,rxnAdd211 PMDBD2001884 quercetin 3,4''-O-diglucoside Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 5320835 n.a. NPC60735 Quercetin 3,4''-diglucoside, 29125-80-2, quercetin 3,4''-O-diglucoside, Quercetin-3,4-di-O-glucoside, QUERCETIN DIHYDRATE(RG), Quercetin-3,4''-diglucoside, SCHEMBL934200, CHEMBL1098352, CHEBI:131498, DTXSID301045305, HY-N8685, AKOS040762259, FS-6824, quercetin 3,4''-di-O-beta-D-glucoside, CS-0148914, Quercetin 3,4''-di-O-beta-D-glucopyranoside, J-017401, Q7271320, Quercetin 3,4''-diglucoside, >=85% (LC/MS-UV), 4-[3-(beta-D-glucopyranosyloxy)-5,7-dihydroxy-4-oxo-4H-1-benzopyran-2-yl]-2-hydroxyphenyl beta-D-glucopyranoside, 5, 7-dihydroxy-2-[3-hydroxy-4-[(2S, 3R, 4S, 5S, 6R)-3, 4, 5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-3-[(2S, 3R, 4S, 5S, 6R)-3, 4, 5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one C27H30O17 RPVIQWDFJPYNJM-DEFKTLOSSA-N 5,7-dihydroxy-2-[3-hydroxy-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one n.a. n.a. No No No No Yes No rxnDiet190,rxnAdd141 PMDBD2001885 Hyperin Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 5281643 n.a. NPC281131 Hyperoside, 482-36-0, Hyperin, Hyperosid, Quercetin 3-galactoside, Hyperozide, Quercetin-3-O-galactoside, Quercetin-3-galactoside, quercetin galactoside, Quercetin 3-D-galactoside, Quercetin 3-O-beta-D-galactopyranoside, Hyperasid, Jyperin, quercetin 3-O-galactoside, QUERCETIN 3-B-D-GALACTOSIDE, Quercetin 3-beta-D-galactopyranoside, NSC 407304, UNII-8O1CR18L82, CCRIS 9339, CHEBI:67486, 8O1CR18L82, EINECS 207-580-6, MFCD00016933, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-(((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-4H-chromen-4-one, CHEMBL251254, Quercetin 3-O-beta-D-galactoside, 2-(3,4-Dihydroxyphenyl)-3-(beta-D-galactopyranosyloxy)-5,7-dihydroxy-4H-1-benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one, Quercetin 3-.beta.-D-galactopyranoside, HYPEROSIDE (USP-RS), HYPEROSIDE [USP-RS], Isoquercitrin, 3,3'',4'',5,7-Pentahydroxyflavone 3-D-galactoside, 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-3-(.beta.-D-galactopyranosyloxy)-5,7-dihydroxy-, NSC-407304, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4H-chromen-3-yl beta-D-galactopyranoside, 2-[3,4-bis(oxidanyl)phenyl]-3-[(2S,3R,4S,5R,6R)-6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-5,7-bis(oxidanyl)chromen-4-one, 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-3-(beta-D-galactopyranosyloxy)-5,7-dihydroxy-, p Hyperin, Quercetin 3-O-.beta.-D-galactopyranoside, Hyperin,(S), BIDD:PXR0057, MLS000759538, 2-yloxy)-4H-chromen-4-one, jm5b01461, Compound 84, MEGxp0_000392, SCHEMBL1250514, ACon1_000623, BDBM429266, DTXSID501028789, HMS2051H17, HY-N0452, BDBM50241367, s5453, AKOS015896780, 6-(hydroxymethyl)tetrahydro-2H-pyran-, CCG-100970, NC00220, NCGC00168902-03, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-chromen-4-one, AS-56199, SMR000466394, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-, 1ST000529, QUERCETIN 3-O-.BETA.-D-GALACTOSIDE, CS-0008982, NS00079301, Quercetin 3-D-galactoside, >=97.0% (HPLC), AB00639910-03, 3-((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-, HYPEROSIDE (CONSTITUENT OF ST. JOHN''S WORT), Hyperoside, primary pharmaceutical reference standard, Q-100530, Q5242815, BRD-K84955386-001-01-1, 3-O-b-D-Galactopyranosyloxy-3'',4'',5,7-tetrahydroxyflavone, HYPEROSIDE (CONSTITUENT OF ST. JOHN''S WORT) [DSC], HYPEROSIDE (CONSTITUENT OF HAWTHORN LEAF WITH FLOWER), Hyperoside, United States Pharmacopeia (USP) Reference Standard, 2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4H-chromen-3-yl hexopyranoside #, 2-(3,4-Dihydroxy-phenyl)-5,7-dihydroxy-3-((2S,4R,5R)-3,4,5-trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-chromen-4-one, 2-(3,4-DIHYDROXYPHENYL)-3-(.BETA.-D-GALACTOPYRANOSYLOXY)-5,7-DIHYDROXY-4H-1-BENZOPYRAN-4-ONE, 2-(3,4-dihydroxyphenyl)-3-(alpha-D-galactopyranosyloxy)-5,7-dihydroxy-4H-1-benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)-4H-chromen-4-one, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4H-chromen-4-one, J6O C21H20O12 OVSQVDMCBVZWGM-DTGCRPNFSA-N 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one n.a. n.a. No No No No Yes No rxnDiet191,rxnAdd142 PMDBD2001886 Quercitrin Dietary Substance, Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D07DJS 5280459 n.a. NPC173637 quercitrin, 522-12-3, Quercetin 3-rhamnoside, Quercitroside, Quercetrin, Quercimelin, Thujin, Quercetin 3-O-rhamnoside, Quercetin 3-L-rhamnoside, Quercetin-3-L-rhamnoside, Quercitronic acid, Quercetin-3-rhamnoside, Quercetin 3-O-alpha-L-rhamnoside, Usaf cf-2, Quercetin 3-O-L-rhamnoside, Quercetrin-3-O-rham, Rhamnosyl-3-quercitin, Quercitin-3-rhamnoside, Quercetin 3-O-rhamnopyranoside, Rhamnoside, quercetin-3, CHEBI:17558, C.I. 75720, Quercetin 3-O-alpha-rhamnopyranoside, UNII-2Y8906LC5P, Quercetin 3-O-alpha-L-rhamnopyranoside, 3,3'',4'',5,7-Pentahydroxyflavone-3-L-rhamnoside, HSDB 4339, 2Y8906LC5P, NCI-C60102, QUERCETIN 3-RHAMNOPYRANOSIDE, EINECS 208-322-5, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-(((2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4H-chromen-4-one, Quercetin, 3-(6-deoxy-alpha-L-mannopyranoside), Mannopyranoside, quercetin-3 6-deoxy-, alpha-L-, BRN 0068135, luteolin 6-deoxy-alpha-L-mannopyranoside, CI 75720, 3-O-RHAMNOSYLQUERCETIN, AI3-36095, Quercetin-3-O-rhamnoside, DTXSID50200230, NSC9221, 5-18-05-00514 (Beilstein Handbook Reference), NSC-9221, Flavone, 3,3'',4'',5,7-pentahydroxy-, 3-rhamnoside, MFCD00016932, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4H-chromen-3-yl 6-deoxy-alpha-L-mannopyranoside, WA 17779, Flavone, 3,3'',4'',5,7-pentahydroxy-, 3-(6-deoxy-alpha-L-mannopyranoside), 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxychromen-4-one, 3-((6-Deoxy-alpha-L-mannopyranosyl)-oxy)-2-(3,4-dihydr oxyphenyl)-5,7-dihydroxy-4H-1-benzopyran-4-one, 4H-1-Benzopyran-4-one, 3-((6-deoxy-alpha-L-mannopyranosyl)oxy)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-, 5,7,3'',4''-TETRAHYDROXYFLAVONOL 3-O-RHAMNOSIDE, 3,3'',4'',5,7-PENTAHYDROXYFLAVONE 3-L-RHAMNOSIDE, 3-((6-Deoxy-alpha-L-mannopyranosyl)-oxy)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4H-1-benzopyran-4-one, 3-((6-Deoxy-alpha-L-mannopyranosyl)oxy)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4H-benzopyran-4-one, 4H-1-Benzopyran-4-one, 3-((6-deoxy-.alpha.-L-mannopyranosyl)oxy)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-, CHEMBL82242, quercetin-3-O-alpha-rhamnoside, Quercetin 3-O-.alpha.-L-rhamnoside, 4gue, Quercitroside,(S), 4H-1-Benzopyran-4-one, 3-[(6-deoxy-.alpha.-L-mannopyranosyl)oxy]-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-, QCT, 3-rhamnosyl quercetin, 5,7-dihydroxy-3-, QUERCITRIN [MI], QUERCITRIN [HSDB], BIDD:PXR0076, 2-(3,4-dihydroxyphenyl)-, MLS002472998, SCHEMBL147092, MEGxp0_000185, ACon1_000189, BDBM84978, cid_5280459, 5-trihydroxy-6-methyltetrahydro-, DTXCID50122721, OXGUCUVFOIWWQJ-HQBVPOQASA-N, HMS2219D24, QUERCETIN 3-A-L-RHAMNOSIDE, HY-N0418, BDBM50056315, s3824, AKOS000278033, CCG-269215, CS-5408, SMP1_000253, 1ST40260, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-chromen-4-one, AC-20295, AC-34266, BS-16996, QUERCETIN-3-O-.ALPHA.-RHAMNOSIDE, SMR001397103, 3-O-alpha-L-RHAMNOPYRANOSYLQUERCETIN, NS00006156, 3-O-.ALPHA.-L-RHAMNOPYRANOSYLQUERCETIN, C01750, QUERCETIN 3-O-.ALPHA.-RHAMNOPYRANOSIDE, QUERCETIN 3-O-.ALPHA.-L-RHAMNOPYRANOSIDE, ((2S,3R,4R,5R,6S)-3,4,, Q-100588, Q-100945, Q1649777, Quercitrin, primary pharmaceutical reference standard, BRD-K98601533-001-01-7, Flavone, 3,3'',4'',5, 7-pentahydroxy-, 3-rhamnoside, 3-O-a-L-Rhamnopyranosyloxy-3'',4'',5,7-tetrahydroxyflavone, QUERCITRIN (QUERCETIN-3-O-RHAMNOSIDE) (CONSTITUENT OF GINKGO), QUERCITRIN (QUERCETIN-3-O- RHAMNOSIDE) (CONSTITUENT OF GINKGO) [DSC], 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-((2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yloxy)-4H-chromen-4-one, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-{[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-4H-chromen-4-one, 2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4H-chromen-3-yl 6-deoxy-.alpha.-L-mannopyranoside, 3-((6-DEOXY-.ALPHA.-L-MANNOPYRANOSYL)OXY)-2-(3,4-DIHYDROXYPHENYL)-5,7-DIHYDROXY-4H-1-BENZOPYRAN-4-ONE, 3-((6-DEOXY-alpha-L-MANNOPYRANOSYL)OXY)-2-(3,4-DIHYDROXYPHENYL)-5,7-DIHYDROXY-4H-1-BENZOPYRAN-4-ONE C21H20O11 OXGUCUVFOIWWQJ-HQBVPOQASA-N 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxychromen-4-one n.a. n.a. No No No No Yes No rxnDiet193,rxnAdd144 PMDBD2001887 QUOSP Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 5282166 n.a. NPC94610 Baimaside, QUOSP, 18609-17-1, Quercetin-3-O-sophoroside, Quercetin 3-O-sophoroside, Quercetin 3-beta-D-sophoroside, Quercetin 3-O-beta-D-glucosyl-(1->2)-beta-D-glucoside, QUERCETIN-3-SOPHOROSIDE, 3-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-2-(3,4-dihydroxyphenyl)-5,7-dihydroxychromen-4-one, 27459-71-8, 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-3-((2-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)oxy)-5,7-dihydroxy-, Quercetin 3-glucobioside, quercetin diglucoside, Quercetin, 3-(O-glucosylglucoside), quercetin 3-O-beta-D-, CHEMBL3979974, CHEBI:32082, DTXSID60940039, GLXC-13117, HY-N2183, MFCD02259431, AKOS032946006, MS-30826, CS-0019491, F17657, Q27114777, 2-(3,4-dihydroxyphenyl)-3-((2-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)oxy)-5,7-dihydroxy-4H-1-benzopyran-4-one, 2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4H-1-benzopyran-3-yl 2-O-hexopyranosylhexopyranoside, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4H-chromen-3-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside, 3-(((2S,3R,4S,5S,6R)-4,5-Dihydroxy-6-(hydroxymethyl)-3-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4H-chromen-4-one C27H30O17 RDUAJIJVNHKTQC-UJECXLDQSA-N 3-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-2-(3,4-dihydroxyphenyl)-5,7-dihydroxychromen-4-one n.a. n.a. No No No No Yes No rxnDiet195,rxnAdd146 PMDBD2001888 quercetin 4''-O-glucoside Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 5320844 n.a. NPC21100 Spiraeoside, 20229-56-5, Spiraein, Spiraeosid, Spireoside, Quercetin 4''-O-glucoside, Spiraein (Acacia), Quercetin 4''-glucoside, Quercetin-4''-glucoside, EINECS 243-614-6, UNII-K2B74751XI, K2B74751XI, CHEMBL402947, CHEBI:75839, DTXSID00174078, QUERCETIN 4''-MONOGLUCOSIDE, quercetin 4''-O-beta-D-glucopyranoside, 3,5,7-trihydroxy-2-[3-hydroxy-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]chromen-4-one, 4H-1-Benzopyran-4-one, 2-(4-(beta-D-glucopyranosyloxy)-3-hydroxyphenyl)-3,5,7-trihydroxy-, Quercetin 4''-O-beta-D-glucoside, Quercetin 4''-b-D-glucoside, 4H-1-Benzopyran-4-one, 2-[4-(beta-D-glucopyranosyloxy)-3-hydroxyphenyl]-3,5,7-trihydroxy-, 4H-1-BENZOPYRAN-4-ONE, 2-(4-(.BETA.-D-GLUCOPYRANOSYLOXY)-3-HYDROXYPHENYL)-3,5,7-TRIHYDROXY-, 4H-1-Benzopyran-4-one, 2-[4-(.beta.-D-glucopyranosyloxy)-3-hydroxyphenyl]-3,5,7-trihydroxy-, SPIRAEOSIDE [INCI], 2-(4-(beta-D-Glucopyranosyloxy)-3-hydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one, SPIRAEOSIDE [WHO-DD], Spireoside (6CI,7CI,8CI), SCHEMBL1155660, Spiraeoside, analytical standard, DTXCID5096569, HY-N8253, LUTEOLIN 4''-beta-D-GLUCOSIDE, BDBM50362884, MFCD00221723, AKOS025146959, LUTEOLIN 4''-.BETA.-D-GLUCOSIDE, NCGC00163625-01, MS-28545, QUERCETIN 4''-beta-D-GLUCOPYRANOSIDE, CS-0141978, NS00026552, QUERCETIN 4''-.BETA.-D-GLUCOPYRANOSIDE, D85150, J-013135, Q7577713, SPIRAEOSIDE (CONSTITUENT OF HAWTHORN LEAF WITH FLOWER), 2-hydroxy-4-(3,5,7-trihydroxy-4-oxo-4H-chromen-2-yl)phenyl beta-D-glucopyranoside, 3,5,7-trihydroxy-2-(3-hydroxy-4-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)-4H-chromen-4-one C21H20O12 OIUBYZLTFSLSBY-HMGRVEAOSA-N 3,5,7-trihydroxy-2-[3-hydroxy-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]chromen-4-one n.a. n.a. No No No No Yes No rxnDiet196,rxnAdd147 PMDBD2001889 Rhamnetin Dietary Substance n.a. 90-19-7 DB16772 n.a. n.a. n.a. 5281691 4445008 NPC87125 Rhamnetin, 90-19-7, beta-Rhamnocitrin, 7-Methoxyquercetin, 7-O-Methylquercetin, Quercetin 7-methyl ether, 7-Methylquercetin, 3,5,3'',4''-Tetrahydroxy-7-methoxyflavone, 3,3'',4'',5-Tetrahydroxy-7-methoxyflavone, .beta.-Rhamnocitrin, C.I. 75690, 2-(3,4-dihydroxyphenyl)-3,5-dihydroxy-7-methoxy-4H-chromen-4-one, 2-(3,4-Dihydroxyphenyl)-3,5-dihydroxy-7-methoxy-4H-1-benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-3,5-dihydroxy-7-methoxychromen-4-one, NSC19802, NSC-19802, 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-3,5-dihydroxy-7-methoxy-, 3,5,3'',4''-Tetrahydroxy-7-methoxyflaone, CHEMBL312163, CHEBI:74992, Flavone, 3,3'',4'',5-tetrahydroxy-7-methoxy-, MFCD00016931, FLAVONE, 7-METHOXY-3,3'',4'',5-TETRAHYDROXY-, 71803L5F4S, 2-(3,4-dihydroxyphenyl)-3,5-dihydroxy-7-methoxy-chromen-4-one, 7-O-Methyl Quercetin, NSC 19802, CCRIS 3792, EINECS 201-974-1, BRN 0047741, UNII-71803L5F4S, Spectrum_001185, SpecPlus_000463, RHAMNETIN [MI], Spectrum2_000642, Spectrum3_001343, Spectrum4_001872, Spectrum5_000464, BSPBio_003125, KBioGR_002367, KBioSS_001665, SPECTRUM310031, 5-18-05-00495 (Beilstein Handbook Reference), DivK1c_006559, Rhamnetin, analytical standard, SCHEMBL555118, SPBio_000643, BDBM23410, KBio1_001503, KBio2_001665, KBio2_004233, KBio2_006801, KBio3_002345, DTXSID40237979, Rhamnetin - Tech grade ca 50%, HY-N7036, CCG-38555, LMPK12112624, AKOS027320587, 3,4'',5-Tetrahydroxy-7-methoxyflavone, CS-W014522, SDCCGMLS-0066624.P001, NCGC00095624-01, NCGC00095624-02, NCGC00095624-03, NCGC00178254-01, AS-78315, NCI60_001648, Flavone,3'',4'',5-tetrahydroxy-7-methoxy-, NS00015848, E87178, Q288988, SR-05000002269, SR-05000002269-2, W-100338, BRD-K37206356-001-01-3, 4H-1-Benzopyran-4-one,4-dihydroxyphenyl)-3,5-dihydroxy-7-methoxy-, J8G C16H12O7 JGUZGNYPMHHYRK-UHFFFAOYSA-N 2-(3,4-dihydroxyphenyl)-3,5-dihydroxy-7-methoxychromen-4-one n.a. n.a. No No No No Yes No rxn48225,rxnDiet198,rxnAdd148 PMDBD2001890 Rhoifolin Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 5282150 n.a. NPC65003 Rhoifolin, 17306-46-6, Rhoifoloside, Apigenin 7-O-neohesperidoside, Apigenin-7-O-rhamnoglucoside, Apigenin-7-Neohesperidoside, CHEBI:31227, Apigenin-7-O-neohesperidoside, K86F9AKS2A, MFCD00016773, 7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)chromen-4-one, 7-((2-O-(6-Deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl)oxy)-5-hydroxy-2-(4-hydroxyphenyl)-4H-benzopyran-4-one, 7-[[2-O-(6-Deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl]oxy]-5-hydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one, 5-hydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-7-yl 2-O-(alpha-L-rhamnopyranosyl)-beta-D-glucopyranoside, 7-[[2-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl]oxy]-5-hydroxy-2-(4-hydroxyphenyl)-4H-benzopyran-4-one, NSC-649413, EINECS 241-335-4, Rhoifolin, 90%, RHIOFOLEN, NSC 649413, Spectrum_001547, SpecPlus_000505, Spectrum2_001641, Spectrum3_001920, Spectrum4_001919, Spectrum5_000638, UNII-K86F9AKS2A, RHOIFOLIN [USP-RS], BSPBio_003520, KBioGR_002545, KBioSS_002027, DivK1c_006601, SCHEMBL118911, SPECTRUM1504075, SPBio_001761, CHEMBL395990, Apigenin 7-O-beta-D-rutinoside, KBio1_001545, KBio2_002027, KBio2_004595, KBio2_007163, KBio3_003025, DTXSID10938284, RPMNUQRUHXIGHK-PYXJVEIZSA-N, HY-N0755, BDBM50587668, CCG-38761, s9084, AKOS037514818, SDCCGMLS-0066828.P001, NCGC00178013-01, 1ST40167, 4H-1-Benzopyran-4-one, 7-((2-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl)oxy)-5-hydroxy-2-(4-hydroxyphenyl)-, AC-34965, AS-74974, CS-0009783, APIGENIN 7-O-.BETA.-D-NEOHESPERIDOSIDE, A811485, Apigenin 7-O-neohesperidoside, >=99.0% (HPLC), Q-100207, Q3429675, BRD-K23327891-001-02-3, BRD-K23327891-001-03-1, 4H-1-BENZOPYRAN-4-ONE, 7-((2-O-(6-DEOXY-.ALPHA.-L-MANNOPYRANOSYL)-.BETA.-D-GLUCOPYRANOSYL)OXY)-5-HYDROXY-2-(4-HYDROXYPHENYL)-, 4H-1-Benzopyran-4-one, 7-[[2-O-(6-deoxy-.alpha.-L-mannopyranosyl)-.beta.-D-glucopyranosyl]-oxy]-5-hydroxy-2-(4-hydroxyphenyl)-, 7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-tetrahydropyran-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)chromen-4-one, 7-{[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-5-hydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-one C27H30O14 RPMNUQRUHXIGHK-PYXJVEIZSA-N 7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)chromen-4-one n.a. n.a. No No No No Yes No rxnDiet199 PMDBD2001891 Rosmarinate Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 639655 n.a. NPC18074 Rosmarinate, (S)-rosmarinic acid, CHEBI:50372, 537-15-5, (2S)-3-(3,4-dihydroxyphenyl)-2-[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyloxy]propanoic acid, (-)-Rosmarinic acid, CHEMBL3098862, SCHEMBL15263386, SCHEMBL15263387, DTXSID20897055, AC-1823, 179188-11-5, Q27122042 C18H16O8 DOUMFZQKYFQNTF-GIZXNFQBSA-N (2S)-3-(3,4-dihydroxyphenyl)-2-[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxypropanoic acid n.a. n.a. No No No No Yes No rxnDiet200,rxnAdd168 PMDBD2001892 Sakuranetin Dietary Substance, Therapeutic Substance Investigational Drug 2957-21-3 DB08517 n.a. n.a. D0B7OW 73571 66249 NPC222342 Sakuranetin, 2957-21-3, (2S)-sakuranetin, (S)-5-hydroxy-2-(4-hydroxyphenyl)-7-methoxychroman-4-one, 4'',5-Dihydroxy-7-methoxyflavanone, Naringenin 7-methyl ether, 7-O-Methylnaringenin, 5,4''-Dihydroxy-7-methoxyflavanone, 4H-1-Benzopyran-4-one, 2,3-dihydro-5-hydroxy-2-(4-hydroxyphenyl)-7-methoxy-, (2S)-, CHEMBL448297, (S)-(-)-4'',5-dihydroxy-7-methoxyflavanone, CHEBI:28927, (2S)-5-hydroxy-2-(4-hydroxyphenyl)-7-methoxy-2,3-dihydro-4H-chromen-4-one, 5-hydroxy-2-(4-hydroxyphenyl)-7-methoxy-chroman-4-one, 3O38P61299, 4H-1-Benzopyran-4-one, 2,3-dihydro-5-hydroxy-2-(4-hydroxyphenyl)-7-methoxy-, (S)-, UNII-3O38P61299, EINECS 220-980-5, NSC 407228, SAKURANETIN [MI], GTPL412, SCHEMBL555542, Flavanone, 4'',5-dihydroxy-7-methoxy-, (S)-(-)-, Sakuranetin, analytical standard, 3d04, HY-N3006, 5,4''''-dihydroxy-7-methoxyflavanone, BDBM50312648, LMPK12140571, AKOS027321114, DB08517, (2S)-4'',5-dihydroxy-7-methoxyflavanone, AS-79385, CS-0022916, (2S)-5,4''-dihydroxy-7-methoxyflavan-4-one, C09833, Q3459689, (2S)-5-hydroxy-2-(4-hydroxyphenyl)-7-methoxy-chroman-4-one, (2S)-5-hydroxy-2-(4-hydroxyphenyl)-7-methoxychroman-4-one, (2S)--5-hydroxy-2-(4-hydroxyphenyl)-7-methoxy-2,3-dihydrochromen-4-one, (S)-2,3-dihydro-5-hydroxy-2-(4-hydroxyphenyl)-7-methoxy-4H-1-benzopyran-4-one C16H14O5 DJOJDHGQRNZXQQ-AWEZNQCLSA-N (2S)-5-hydroxy-2-(4-hydroxyphenyl)-7-methoxy-2,3-dihydrochromen-4-one n.a. n.a. No No No No Yes No rxnDiet201,rxnAdd85 PMDBD2001893 Scutellarein Dietary Substance, Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D00LMG 5281697 n.a. NPC130230 "Scutellarein, 529-53-3, 6-Hydroxyapigenin, 5,6,7,4''-Tetrahydroxyflavone, 4'',5,6,7-tetrahydroxyflavone, 5,6,7-trihydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-one, 5,6,7-trihydroxy-2-(4-hydroxyphenyl)chromen-4-one, 4'',5,6,7-Tetrahydroxyflavanone, SCUTELLARTLN, 5,6,7-Trihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one, CHEBI:9062, P460GTI853, MFCD00017692, 4H-1-Benzopyran-4-one, 5,6,7-trihydroxy-2-(4-hydroxyphenyl)-, 6-Hydroxyapigenin;4'',5,6,7-Tetrahydroxyflavone, Scutellartln?, UNII-P460GTI853, SCUTELLAREIN [MI], CHEMBL55415, SCHEMBL142093, SCUTELLAREIN [WHO-DD], BDBM23411, GTPL12463, DTXSID40200946, Scutellarein, >=98% (HPLC), BCP07597, HY-N0752, 6-HYDROXYPELARGIDENON-1465, LMPK12111160, s9120, AKOS015960467, CCG-267330, CS-5596, NCGC00482644-02, AC-11200, AC-34252, AS-19541, C3507, NS00116303, A829325, EN300-23012033, Q-100602, Q2058351, 5,6,7-trihydroxy-2-(4-hydroxyphenyl)-1-benzopyran-4-one" C15H10O6 JVXZRQGOGOXCEC-UHFFFAOYSA-N 5,6,7-trihydroxy-2-(4-hydroxyphenyl)chromen-4-one n.a. n.a. No No No No Yes No rxnDiet203,rxnAdd116 PMDBD2001894 Sinapate Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 637775 n.a. NPC300326 SINAPIC ACID, Sinapinic acid, 530-59-6, 3,5-Dimethoxy-4-hydroxycinnamic acid, trans-sinapic acid, 7362-37-0, SINAPINATE, (E)-Sinapic acid, Sinapate, Synapoic acid, 4-Hydroxy-3,5-dimethoxycinnamic acid, (2E)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoic acid, (E)-3-(4-hydroxy-3,5-dimethoxyphenyl)acrylic acid, (E)-3-(4-Hydroxy-3,5-dimethoxyphenyl)-2-propenoic acid, (2E)-3-(4-hydroxy-3,5-dimethoxyphenyl)acrylic acid, 2-Propenoic acid, 3-(4-hydroxy-3,5-dimethoxyphenyl)-, Cinnamic acid, 4-hydroxy-3,5-dimethoxy-, (E)-, (E)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoic acid, MFCD00004401, CHEMBL109341, CHEBI:15714, 3-(4-hydroxy-3,5-dimethoxyphenyl)acrylic acid, P0I60993EC, NSC59261, 4-Hydroxy-3,5-dimethoxy-cinnamic acid, (2E)-3-(4-Hydroxy-3,5-dimethoxyphenyl)-2-propenoic acid, 2-propenoic acid, 3-(4-hydroxy-3,5-dimethoxyphenyl)-, (2E)-, 2-Propenoic acid, 3-(4-hydroxy-3,5-dimethoxyphenyl)-, (E)-, trans-3,5-Dimethoxy-4-hydroxycinnamic acid, 3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoic acid, SXX, UNII-P0I60993EC, 3-(4-Hydroxy-3,5-dimethoxyphenyl)-2-Propenoic acid, 3-(4-hydroxy-3,5-dimethoxyphenyl)-(E)-2-propenoic acid, trans-sinapinic acid, sinapic acid, (E)-, CHEBI:77131, Sinapic_acid, NSC-59261, 3,5-dimethoxy-4-hydroxy-trans-cinnamic acid, Sinapic acid, trans-, DEGLY SINA, bmse000318, bmse000594, bmse010209, SCHEMBL37312, MLS001066354, Sinapinic acid (Sinapic acid), Sinapic acid, >=98%, powder, HMS2230P08, BDBM50341142, s3981, AKOS015851820, CCG-214595, CS-W010448, DB08587, HY-W009732, MS-8962, trans-Sinapic acid, analytical standard, NCGC00247028-01, 1ST40176, AC-34343, SMR000471879, Cinnamic acid, 4-hydroxy-3,5-dimethoxy-, SBI-0206696.P002, 4-Hydroxy-3,5-dimethoxy-(E)-Cinnamic acid, NS00015085, EN300-93177, C00482, Q417527, (E)-3-(4-hydroxy-3,5-dimethoxyphenyl)acrylicacid, W-105777, BRD-K95487349-001-04-2, (E)-3-(4-Hydroxy-3,5-dimethoxy-phenyl)-acrylic acid, 3-(4-Hydroxy-3,5-dimethoxyphenyl)-2-propenoic acid #, Z1266855053, 3-(4-Hydroxy-3,5-dimethoxyphenyl)-(2E)-2-Propenoic acid, 7AE78999-D500-492B-9651-46622E8DAA71, Sinapic acid, matrix substance for MALDI-MS, >=99.0% (T), Sinapic acid, matrix substance for MALDI-MS, >=99.5%, Ultra pure, InChI=1/C11H12O5/c1-15-8-5-7(3-4-10(12)13)6-9(16-2)11(8)14/h3-6,14H,1-2H3,(H,12,13)/b4-3 C11H12O5 PCMORTLOPMLEFB-ONEGZZNKSA-N (E)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoic acid n.a. n.a. No No No No Yes No rxn05142,rxnDiet208 PMDBD2001895 Vanillate Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 54675858 n.a. NPC227211 Vanillate, 4-Hydroxy-3-methoxybenzoate, VA, 4-carboxy-2-methoxyphenolate, CHEBI:16632, WKOLLVMJNQIZCI-UHFFFAOYSA-M, DB02130 C8H7O4- WKOLLVMJNQIZCI-UHFFFAOYSA-M 4-carboxy-2-methoxyphenolate n.a. n.a. No No No No Yes No rxnDiet213,rxnAdd40 PMDBD2001896 Xanthohumol Dietary Substance n.a. 6754-58-1 DB15359 n.a. n.a. n.a. 639665 555077 NPC249606 Xanthohumol, 6754-58-1, 569-83-5, 1-(2,4-Dihydroxy-6-methoxy-3-(3-methylbut-2-en-1-yl)phenyl)-3-(4-hydroxyphenyl)prop-2-en-1-one, Xantho-flav, (E/Z)-Xanthohumol, (E)-1-[2,4-dihydroxy-6-methoxy-3-(3-methylbut-2-enyl)phenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one, T4467YT1NT, CHEBI:66331, Xanthohumol(Random Configuration), 2'',4,4''-trihydroxy-6''-methoxy-3''-prenylchalcone, 1-(2,4-Dihydroxy-6-methoxy-3-(3-methyl-2-butenyl)phenyl)-3-(4-hydroxyphenyl)-2-propen-1-one, (2E)-1-[2,4-dihydroxy-6-methoxy-3-(3-methylbut-2-en-1-yl)phenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one, (E)-1-(2,4-Dihydroxy-6-methoxy-3-(3-methylbut-2-en-1-yl)phenyl)-3-(4-hydroxyphenyl)prop-2-en-1-one, (2E)-1-(2,4-DIHYDROXY-6-METHOXY-3-(3-METHYL-2-BUTEN-1-YL)PHENYL)-3-(4-HYDROXYPHENYL)-2-PROPEN-1-ONE, (E)-1-(2,4-dihydroxy-6-methoxy-3-(3-methylbut-2-enyl)phenyl)-3-(4-hydroxyphenyl)prop-2-en-1-one, 2-Propen-1-one, 1-(2,4-hydroxy-6-methoxy-3-(3-methyl-2-butenyl)phenyl)-3-(4-hydroxyphenyl)-, (E)-, UNII-T4467YT1NT, MFCD00210576, (2E)-1-[2,4-Dihydroxy-6-methoxy-3-(3-methyl-2-buten-1-yl)phenyl]-3-(4-hydroxyphenyl)-2-propen-1-one, Xanthohumol from hop (Humulus lupulus), XANTHOHUMOL [INCI], SCHEMBL143683, CHEMBL253896, MEGxp0_000104, Xanthohumol(RandomConfiguration), ACon1_001634, CHEBI:94745, HY-N1067A, DTXSID00893171, HMS3886H19, BCP18498, BDBM50384998, LMPK12120294, s7889, AKOS016010098, AKOS040762512, CCG-268086, DB15359, (E)-1-[2,4-Dihydroxy-6-methoxy-3-(3-methyl-2-butenyl)phenyl]-3-(4-hydroxyphenyl)propenone, SMP2_000278, NCGC00180304-01, AC-31276, BS-17392, TS-10147, 1ST166072, CS-0159153, X0068, A867246, Q408088, BRD-K77390737-001-01-6, Q27166535, Xanthohumol, primary pharmaceutical reference standard, Xanthohumol from hop (Humulus lupulus), >=96% (HPLC), 1-[2,4-dihydroxy-6-methoxy-3-(3-methylbut-2-enyl)phenyl]-3-(4-hydroxyphenyl)-2-propen-1-one, 2-Propen-1-one, 1-[2,4-dihydroxy-6-methoxy-3-(3-methyl-2-buten-1-yl)phenyl]-3-(4-hydroxyphenyl)-, (2E)-, InChI=1/C21H22O5/c1-13(2)4-10-16-18(24)12-19(26-3)20(21(16)25)17(23)11-7-14-5-8-15(22)9-6-14/h4-9,11-12,22,24-25H,10H2,1-3H3/b11-7 C21H22O5 ORXQGKIUCDPEAJ-YRNVUSSQSA-N (E)-1-[2,4-dihydroxy-6-methoxy-3-(3-methylbut-2-enyl)phenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one n.a. n.a. No No No No Yes No rxnDiet215 PMDBD2001897 trans-2-Hydroxycinnamate Dietary Substance, Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D05WQF 637540 n.a. NPC246679 "2-Hydroxycinnamic acid, 614-60-8, trans-2-Hydroxycinnamic acid, o-Coumaric acid, 2-Coumaric acid, trans-o-Hydroxycinnamic acid, 583-17-5, trans-o-Coumaric acid, 3-(2-hydroxyphenyl)acrylic acid, (E)-o-Hydroxycinnamic acid, 2-Coumarate, 2-Hydroxycinnamate, (2E)-3-(2-hydroxyphenyl)prop-2-enoic acid, trans-2-Hydroxycinnamate, o-Hydroxy-trans-cinnamic acid, (E)-3-(2-Hydroxyphenyl)-2-propenoic acid, 2-Hydroxycinnamic acid, (E)-, (2E)-3-(2-HYDROXYPHENYL)ACRYLIC ACID, CINNAMIC ACID, o-HYDROXY-, (E)-, (E)-3-(2-hydroxyphenyl)prop-2-enoic acid, (E)-2-hydroxycinnamic acid, 2-Propenoic acid, 3-(2-hydroxyphenyl)-, (E)-, trans-2-coumaric acid, (E)-3-(2-hydroxyphenyl)acrylic acid, CCRIS 5834, o-coumarate, 2-Propenoic acid, 3-(2-hydroxyphenyl)-, (2E)-, UNII-23AU5FZB9C, EINECS 210-386-4, 23AU5FZB9C, (2E)-3-(2-Hydroxyphenyl)-2-propenoic acid, NSC 32952, 3-(2-hydroxyphenyl)prop-2-enoic acid, O-Hydroxycinnamic acid, BRN 1100900, 2-Propenoic acid, 3-(2-hydroxyphenyl)-, CHEBI:18125, 2-Hydroxycinnamic acid, (2E)-, NSC-32952, O-TRANS-COUMARIC ACID, CHEMBL52564, 2-Hydroxycinnamic acid, predominantly trans, FEMA NO. 4700, (E)-3-(2-HYDROXY-PHENYL)-ACRYLIC ACID, MFCD00004379, 2-HYDROXYCINNAMIC ACID, TRANS-, 2-Hydroxycinamic acid, 3-(2-hydroxyphenyl)prop-2-enoate, o-Hydroxycinnamate, 3-(2-Hydroxyphenyl)-2-propenoic acid, trans-o-Coumarate, ortho-Hydroxycinnamate, trans-o-Cumaric Acid, (E)-Coumarinic Acid, trans-o-Hydroxycinnamate, O- COUMARIC ACID, o-Hydroxy-trans-cinnamate, (E)-o-Hydroxycinnamicacid, bmse000347, Cinnamic acid, o-hydroxy-, WLN: QV1U1R BQ, SCHEMBL64885, (2E)-2-hydroxycinnamic acid, 3-(2-hydroxyphenyl)acrylicacid, QSPL 150, CHEBI:18176, trans-o-HydroxyzimtsA currencyure, AMY4052, DTXSID10883240, NSC32952, BDBM50146462, AKOS003790794, CS-W013247, DB01650, HY-W012531, (E)-3-(2-hydroxyphenyl)-acrylic acid, CINNAMIC ACID,2-HYDROXY (TRANS), trans-3-(2-hydroxyphenyl)propenoic acid, AS-12449, NS00014689, C01772, 2-Hydroxycinnamic acid, predominantly trans, 97%, A833239, A869477, Q7072006, TRANS-2-HYDROXYCINNAMIC ACID; O-COUMARIC ACID, F2191-0203, (2E)-3-(2-hydroxyphenyl)acrylic acid predominately trans-, 90E8F55A-AB69-4720-95AF-747C2DCA5471, 2-Hydroxycinnamic acid = o-Hydroxycinnamic acid = o-Coumaric acid" C9H8O3 PMOWTIHVNWZYFI-AATRIKPKSA-N (E)-3-(2-hydroxyphenyl)prop-2-enoic acid n.a. n.a. No No No No Yes No rxnDiet218,rxnAdd169 PMDBD2001898 p-Coumaroyl-D-glucose Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 21039417 n.a. n.a. p-Coumaroyl-D-glucose, CHEBI:190396, (E,5R,6S,7R,8R)-5,6,7,8,9-pentahydroxy-1-(4-hydroxyphenyl)non-1-ene-3,4-dione C15H18O8 MBXDFASBTUWDHK-MFFVXOFNSA-N (E,5R,6S,7R,8R)-5,6,7,8,9-pentahydroxy-1-(4-hydroxyphenyl)non-1-ene-3,4-dione n.a. n.a. No No No No Yes No rxn12175,rxnDiet220,rxnAdd154 PMDBD2001899 p-Coumaroyl quinic acid Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 6441280 n.a. NPC68517 2-Coumaroylquinic acid, trans-5-O-(4-coumaroyl)-D-quinic acid, 1899-30-5, 5746-55-4, 5-p-coumaroylquinic acid, p-Coumaroyl quinic acid, o-Coumaroylquinic acid, (1S,3R,4R,5R)-1,3,4-trihydroxy-5-[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]oxycyclohexane-1-carboxylic acid, CHEBI:15937, 5-O-(E)-p-Coumaroylquinic acid, 4C4BU5688G, 3-p-coumaroylquinic acid, trans-5-O-(4-Coumaroyl)-D-quinate, (1S,3R,4R,5R)-1,3,4-Trihydroxy-5-(((E)-3-(4-hydroxyphenyl)acryloyl)oxy)cyclohexanecarboxylic acid, (1S,3R,4R,5R)-1,3,4-trihydroxy-5-[(2E)-3-(4-hydroxyphenyl)prop-2-enoyloxy]cyclohexanecarboxylic acid, p-Coumaroylquinic acid, 3-O-p-Coumaroylquinic acid, UNII-4C4BU5688G, Coumaroylquinic acid, 5-P-COQA, CHEMBL284243, SCHEMBL10307372, CHEBI:75500, HY-N10543A, HY-N10543, 5-P-TRANS-COUMAROYLQUINIC ACID, 5-P-COUMAROYLQUINIC ACID, (E)-, Cyclohexanecarboxylic acid, 1,3,4-trihydroxy-5-((3-(4-hydroxyphenyl)-1-oxo-2-propenyl)oxy)-, (1S-(1alpha,3alpha,4alpha,5beta))-, TS-10189, 21600YP321, CS-0610713, CS-0895414, TRANS-P-COUMARIC ACID 5-O-D-QUINATE, Q27098307, (1S,3R,4R,5R)-1,3,4-trihydroxy-5-{[3-(4-hydroxyphenyl)prop-2-enoyl]oxy}cyclohexanecarboxylic acid, CINNAMIC ACID, P-HYDROXY-, 5-ESTER WITH 1,3,4,5-TETRAHYDROXYCYCLOHEXANECARBOXYLIC ACID, (E)-, CYCLOHEXANECARBOXYLIC ACID, 1,3,4-TRIHYDROXY-5-(((2E)-3-(4-HYDROXYPHENYL)-1-OXO-2-PROPEN-1-YL)OXY)-, (1S,3R,4R,5R)-, CYCLOHEXANECARBOXYLIC ACID, 1,3,4-TRIHYDROXY-5-(((2E)-3-(4-HYDROXYPHENYL)-1-OXO-2-PROPENYL)OXY)-, (1S,3R,4R,5R)-, CYCLOHEXANECARBOXYLIC ACID, 1,3,4-TRIHYDROXY-5-((3-(4-HYDROXYPHENYL)-1-OXO-2-PROPENYL)OXY)-, (1S-(1.ALPHA.,3.ALPHA.,4.ALPHA.,5.BETA.(E)))-, Cyclohexanecarboxylic acid, 1,3,4-trihydroxy-5-((3-(4-hydroxyphenyl)-1-oxo-2-propenyl)oxy)-, (1S-(1alpha,3alpha,4alpha,5beta(E)))- C16H18O8 BMRSEYFENKXDIS-OTCYKTEZSA-N (1S,3R,4R,5R)-1,3,4-trihydroxy-5-[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]oxycyclohexane-1-carboxylic acid n.a. n.a. No No No No Yes No rxnDiet222,rxnAdd171 PMDBD2001900 Eriocitrin Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 83489 n.a. NPC43587 Eriocitrin, Eriodictioside, 13463-28-0, Eriodictyol-7-O-rutinoside, Eriodictyol 7-O-rutinoside, CHEBI:28709, eriodictyol 7-rutinoside, AS293HR5XQ, (2S)-2-(3,4-dihydroxyphenyl)-5-hydroxy-4-oxo-3,4-dihydro-2H-chromen-7-yl 6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoside, (S)-2-(3,4-dihydroxyphenyl)-5-hydroxy-7-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-((((2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)methyl)tetrahydro-2H-pyran-2-yl)oxy)chroman-4-one, UNII-AS293HR5XQ, Eriodictyol 7-O-beta-rutinoside, (S)-3'',4'',5,7-Tetrahydroxyflavanone-7-[6-O-(alpha-L-rhamnopyranosyl)-beta-D-glucopyranoside], EINECS 236-668-7, Eriodictyol glycoside, ERIOCITRIN [WHO-DD], SCHEMBL750974, Eriocitrin, analytical standard, CHEMBL2165586, DTXSID60864408, Eriocitrin, >=98.0% (HPLC), EX-A6774, HY-N0636, BDBM50462417, s9211, Eriocitrin (Mixture of Diastereomers), AKOS030573687, CCG-208387, NCGC00163549-01, (S)-7-((6-O-(6-Deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl)oxy)-2-(3,4-dihydroxyphenyl)-2,3-dihydro-5-hydroxy-4H-benzopyran-4-one, 4H-1-Benzopyran-4-one, 7-((6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl)oxy)-2-(3,4-dihydroxyphenyl)-2,3-dihydro-5-hydroxy-, (S)-, AS-75208, CS-0009665, C09732, A910366, SR-05000002278, Eriocitrin, primary pharmaceutical reference standard, SR-05000002278-2, Q13567664, Glucopyranoside, eriodictyol-7 6-O-(6-deoxy-alpha-L-mannopyranosyl)-, beta-D-, (2S)-2-(3,4-dihydroxyphenyl)-5-hydroxy-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-oxan-2-yl]oxymethyl]oxan-2-yl]oxy-chroman-4-one, (2S)-2-(3,4-dihydroxyphenyl)-5-hydroxy-7-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-3,4-dihydro-2H-1-benzopyran-4-one, 4H-1-Benzopyran-4-one, 7-[[6-O-(6-deoxy-.alpha.-L-mannopyranosyl)-.beta.-D-glucopyranosyl]oxy]-2-(3,4-dihydroxyphenyl)-2,3-dihydro-5-hydroxy-, (2S)-, 4H-1-Benzopyran-4-one,7-[[6-O-(6-deoxy-a-L-mannopyranosyl)-b-D-glucopyranosyl]oxy]-2-(3,4-dihydroxyphenyl)-2,3-dihydro-5-hydroxy-, (2S)-, Flavanone, 3'',4'',5,7-tetrahydroxy-, 7-(6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoside) C27H32O15 OMQADRGFMLGFJF-MNPJBKLOSA-N (2S)-2-(3,4-dihydroxyphenyl)-5-hydroxy-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxy-2,3-dihydrochromen-4-one n.a. n.a. No No No No Yes No rxnAddEX1,rxnAdd72 PMDBD2001901 Oleuropein Dietary Substance, Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D08TZZ 5281544 n.a. NPC296643 Oleuropein, 32619-42-4, Oleoeuropein, oleoeuropeine, 2-(3,4-Dihydroxyphenyl)ethyl (2S-(2alpha,3E,4beta))-3-ethylidene-2-(beta-D-glucopyranosyloxy)-3,4-dihydro-5-(methoxycarbonyl)-2H-pyran-4-acetate, 2O4553545L, methyl (4S,5E,6S)-4-[2-[2-(3,4-dihydroxyphenyl)ethoxy]-2-oxoethyl]-5-ethylidene-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4H-pyran-3-carboxylate, 2H-Pyran-4-acetic acid, 3-ethylidene-2-(.beta.-D-glucopyranosyloxy)-3,4-dihydro-5-(methoxycarbonyl)-, 2-(3,4-dihydroxyphenyl)ethyl ester, (2S,3E,4S)-, methyl (2S,3E,4S)-4-{2-[2-(3,4-dihydroxyphenyl)ethoxy]-2-oxoethyl}-3-ethylidene-2-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4-dihydro-2H-pyran-5-carboxylate, Methyl (2S,4S,E)-4-(2-(3,4-dihydroxyphenethoxy)-2-oxoethyl)-3-ethylidene-2-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-3,4-dihydro-2H-pyran-5-carboxylate, EINECS 251-129-6, Oleuropeine, Oleuroperin, UNII-2O4553545L, Oleuropein, 75%, Oleuropein, >95%, OLEUROPEIN [MI], OLEUROPEIN [INCI], OLEUROPEIN [VANDF], Oleuropein, >=98.0%, OLEUROPEIN [USP-RS], OLEUROPEIN [WHO-DD], Oleuropein, analytical standard, CHEBI:7747, MEGxp0_000369, SCHEMBL4306969, CHEMBL1911053, Oleuropein, >=80% (HPLC), ACon1_000443, GTPL11027, DTXSID60905103, HY-N0292, methyl(4S,5E,6S)-4-[2-[2-(3,4-dihydroxyphenyl)ethoxy]-2-oxoethyl]-5-ethylidene-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4H-pyran-3-carboxylate, AKOS015900702, CCG-269961, NCGC00169074-01, NCGC00169074-02, NCGC00169074-03, AS-56230, 1ST164391, CS-0008800, O0420, S7867, Q402625, Oleuropein, primary pharmaceutical reference standard, BRD-K08037284-001-01-4, Oleuropein, European Pharmacopoeia (EP) Reference Standard, Oleuropein, United States Pharmacopeia (USP) Reference Standard, [2S-(2alpha,3E,4beta)]-3-ethylidene-2-(beta-D-glucopyranosyloxy)-3,4-dihydro-5-(methoxycarbonyl)-2H-pyran-4-acetic acid 2-(3,4-dihydroxyphenyl)ethyl ester, 2H-PYRAN-4-ACETIC ACID, 3-ETHYLIDENE-2-(.BETA.-D-GLUCOPYRANOSYLOXY)-3,4-DIHYDRO-5-(METHOXYCARBONYL)-, 2-(3,4-DIHYDROXYPHENYL)ETHYL ESTER, (2S-(2.ALPHA.,3E,4.BETA.))-, 2H-PYRAN-4-ACETIC ACID, 5-CARBOXY-3-ETHYLIDENE-2-(.BETA.-D-GLUCOSYLOXY)-3,4-DIHYDRO-, 3,4-DIHYDROXYPHENETHYL 5-METHYL ESTER, methyl (2S,3E,4S)-4-{2-[2-(3,4-dihydroxyphenyl)ethoxy]-2-oxoethyl}-3-ethylidene-2-(beta-D-glucopyranosyloxy)-3,4-dihydro-2H-pyran-5-carboxylate, methyl (4S,5E,6S)-4-[2-[2-(3,4-dihydroxyphenyl)ethoxy]-2-oxo-ethyl]-5-ethylidene-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-4H-pyran-3-carboxylate C25H32O13 RFWGABANNQMHMZ-ZCHJGGQASA-N methyl (4S,5E,6S)-4-[2-[2-(3,4-dihydroxyphenyl)ethoxy]-2-oxoethyl]-5-ethylidene-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4H-pyran-3-carboxylate Biopharm Technology Corp n.a. No No No No Yes No rxnAddEX2,rxnAdd216 PMDBD2001902 6-Prenylnaringenin Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 155094 n.a. NPC231949 6-Prenylnaringenin, 68236-13-5, (2S)-6-Prenylnaringenin, (2S)-5,7-dihydroxy-2-(4-hydroxyphenyl)-6-(3-methylbut-2-enyl)-2,3-dihydrochromen-4-one, 7342WYG80Y, 4H-1-Benzopyran-4-one, 2,3-dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-6-(3-methyl-2-butenyl)-, (2S)-, (S)-4'',5,7-Trihydroxy-6-prenylflavanone, (S)-5,7-Dihydroxy-2-(4-hydroxyphenyl)-6-(3-methylbut-2-en-1-yl)chroman-4-one, 5,7,4''-Trihydroxy-6-prenylflavanone, SCHEMBL145714, UNII-7342WYG80Y, YS03, CHEBI:27566, GTPL12585, DTXSID80218409, YHWNASRGLKJRJJ-KRWDZBQOSA-N, LMPK12140277, AKOS037515358, 6-Prenylnaringenin, analytical standard, MS-25193, HY-107198, CS-0027603, NS00126925, C09832, G14141, K-07047, Q27103198, (2S)-5,7-dihydroxy-2-(4-hydroxyphenyl)-6-(3-methylbut-2-enyl)chroman-4-one, 5,7-Dihydroxy-2-(4-hydroxy-phenyl)-6-(3-methyl-but-2-enyl)-1-benzopyran-4-one, (2S)-2,3-DIHYDRO-5,7-DIHYDROXY-2-(4-HYDROXYPHENYL)-6-(3-METHYL-2-BUTEN-1-YL)-4H-1-BENZOPYRAN-4-ONE, (2S)-2,3-dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-6-(3-methyl-2-butenyl)-4H-1-benzopyran-4-one, 2,3-Dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-6-(3-methyl-2-butenyl)-4h-1-benzopyran-4-one, 4H-1-BENZOPYRAN-4-ONE, 2,3-DIHYDRO-5,7-DIHYDROXY-2-(4-HYDROXYPHENYL)-6-(3-METHYL-2-BUTEN-1-YL)-, (2S)- C20H20O5 YHWNASRGLKJRJJ-KRWDZBQOSA-N (2S)-5,7-dihydroxy-2-(4-hydroxyphenyl)-6-(3-methylbut-2-enyl)-2,3-dihydrochromen-4-one n.a. n.a. No No No No Yes No rxnAddEX4 PMDBD2001903 Diosmetin Dietary Substance, Therapeutic Substance Patented Drug 520-34-3 DB11259 n.a. n.a. D0EV5U 5281612 4444931 NPC52005 Diosmetin, 520-34-3, Luteolin 4''-methyl ether, 5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-chromen-4-one, 4''-Methylluteolin, Salinigricoflavonol, Diosmetine, Pillon, 3'',5,7-trihydroxy-4''-methoxyflavone, Luteolin 4-methyl ether, 5,7,3''-Trihydroxy-4''-methoxyflavone, 5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chromen-4-one, UNII-TWZ37241OT, 4H-1-Benzopyran-4-one, 5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-, 5,7-Dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-4-benzopyrone, DIOSMETOL, CHEBI:4630, TWZ37241OT, 5,7-Dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-one, HSDB 8101, EINECS 208-291-8, MFCD00017425, Flavone, 3'',5,7-trihydroxy-4''-methoxy-, LUTEOLIN-4''-METHYL ETHER, DTXSID80199966, CYANIDENON-4''-METHYL ETHER 1479, SR-05000002196, 5,7-Dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-one (Diosmetin), 3'',5,7-trihydroxy-4''-methoxy flavone, Spectrum_001505, SpecPlus_000435, DIOSMETIN [MI], DIOSMETIN [INCI], Spectrum2_001638, Spectrum3_000987, Spectrum4_001113, Spectrum5_001707, DIOSMETIN [WHO-DD], BSPBio_002653, KBioGR_001586, KBioSS_001985, MLS006011843, CHEMBL90568, Diosmetin, analytical standard, DivK1c_006531, SCHEMBL289337, SPBio_001735, BDBM23414, KBio1_001475, KBio2_001985, KBio2_004553, KBio2_007121, KBio3_001873, DTXCID40122457, 5,7-dihydroxy-2-(3-hydroxy-4-methoxy-phenyl)chromen-4-one, HMS3656G13, BCP28283, HY-N0125, CCG-38758, Diosmetin (Luteolin 4-methyl ether), LMPK12110824, s2380, AKOS005720974, CS-5455, DB11259, SDCCGMLS-0066783.P001, NCGC00163540-01, NCGC00163540-02, NCGC00163540-03, NCGC00178549-01, AC-34868, BS-17174, SMR002044787, SY066981, D4441, NS00014641, SW219332-1, Whoo Gongjinhyang Seol Whitening Jin Essence, ISAKNOX X202 WHITENING SECRET ESSENCE, C10038, A828902, A871094, ISA KNOX WXII PLUS WHITENING REVOLUTION SERUM, Q1649664, SR-05000002196-2, SR-05000002196-3, BRD-K26862302-001-02-9, BRD-K26862302-001-03-7, 2-(4-methoxy-3-oxidanyl-phenyl)-5,7-bis(oxidanyl)chromen-4-one, 5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-1-benzopyran-4-one, J8D C16H12O6 MBNGWHIJMBWFHU-UHFFFAOYSA-N 5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chromen-4-one UNIVERSITY OF SOUTH FLORIDA TAN, Jun LUO, Deyan n.a. No No No No Yes No rxnAddEX5 PMDBD2001904 Dinatin Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 5281628 n.a. NPC241498 Hispidulin, 1447-88-7, Dinatin, Scutellarein 6-methyl ether, 4'',5,7-Trihydroxy-6-methoxyflavone, 4H-1-BENZOPYRAN-4-ONE, 5,7-DIHYDROXY-2-(4-HYDROXYPHENYL)-6-METHOXY-, Salvitin, 5,7-Dihydroxy-2-(4-hydroxyphenyl)-6-methoxy-4H-chromen-4-one, 6-O-Methylapigenin, NSC 122415, NSC-122415, TCMDC-123942, 5,7-dihydroxy-2-(4-hydroxyphenyl)-6-methoxychromen-4-one, HISPEDULIN, CCRIS 8484, CHEBI:75902, NSC122415, N7F61604C2, Flavone, 4'',5,7-trihydroxy-6-methoxy-, CHEMBL293776, UNII-N7F61604C2, DTXSID30162786, MFCD00143504, 5,7-Dihydroxy-2-(4-hydroxyphenyl)-6-methoxy-4H-1-benzopyran-4-one, methoxyapigenin, 6-methoxyapigenin, Hispidulin?, 6-methoxy apigenin, 4'',5,7-trihydroxy-6-methoxy-flavone, M-3-GHYDRATE, Oprea1_873387, MLS000728540, SCHEMBL514926, MEGxp0_000683, DTXCID7085277, Hispidulin, >=98% (HPLC), ACon1_000933, cid_5281628, PubChem SID: 26725244, IHFBPDAQLQOCBX-UHFFFAOYSA-N, 4'',7-Trihydroxy-6-methoxyflavone, 5,7-dihydroxy-2-(4-hydroxyphenyl)-6-methoxy-chromen-4-one, HMS2223A03, HMS3344G13, HMS3868N13, HY-N1950, Flavone,5,7-trihydroxy-6-methoxy-, BDBM50049395, LMPK12111159, s3296, ZB1763, 4?,5,7-Trihydroxy-6-methoxyflavone, AKOS004110694, 5,7,4''''-Trihydroxy-6-methoxyflavone, CS-6502, DB14008, NCGC00167728-01, NCGC00167728-02, NCGC00169216-01, AC-34245, AS-78830, NCI60_000530, SMR000445653, SY121814, NS00069992, Q-100165, BRD-K72066874-001-01-0, Q15410994, 5,7-Dihydroxy-2-(4-hydroxy-phenyl)-6-methoxy-chromen-4-one, 4H-1-Benzopyran-4-one,7-dihydroxy-2-(4-hydroxyphenyl)-6-methoxy-, 5,7-Dihydroxy-2-(4-hydroxyphenyl)-6-methoxy-4H-chromen-4-one #, 4H-1-Benzopyran-4-one, 5, 7-dihydroxy-2-(4-hydroxyphenyl)-6-methoxy-, HUL C16H12O6 IHFBPDAQLQOCBX-UHFFFAOYSA-N 5,7-dihydroxy-2-(4-hydroxyphenyl)-6-methoxychromen-4-one n.a. n.a. No No No No Yes No rxnAddEX7,rxnAdd106 PMDBD2001905 6-Hydroxyluteolin Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 5281642 n.a. NPC275772 6-Hydroxyluteolin, 18003-33-3, 5,6,7,3'',4''-Pentahydroxyflavone, 6-OH-Luteolin, Demethylpedalitin, 3'',4'',5,6,7-Pentahydroxyflavone, 2-(3,4-dihydroxyphenyl)-5,6,7-trihydroxychromen-4-one, CHEBI:2197, CHEMBL464107, T1XT53489D, 2-(3,4-dihydroxyphenyl)-5,6,7-trihydroxy-4H-1-benzopyran-4-one, 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-5,6,7-trihydroxy-, 2-(3,4-dihydroxyphenyl)-5,6,7-trihydroxy-4H-chromen-4-one, UNII-T1XT53489D, NORNEPETIN, NORNEPITIN, 6-HYDROXYLUTEOLOL, SCHEMBL1155724, DTXSID10170900, BDBM50412291, LMPK12111229, HY-151231, CS-0610540, E87163, FLAVONE, 3'',4'',5,6,7-PENTAHYDROXY-, Q23055354 C15H10O7 VYAKIUWQLHRZGK-UHFFFAOYSA-N 2-(3,4-dihydroxyphenyl)-5,6,7-trihydroxychromen-4-one n.a. n.a. No No No No Yes No rxnAddEX8,rxnAdd93 PMDBD2001906 Morin Dietary Substance, Therapeutic Substance Investigational Drug 480-16-0 DB16770 n.a. n.a. D0NJ4H 5281670 4444989 NPC216361 morin, 480-16-0, Aurantica, Calico Yellow, 2'',3,4'',5,7-Pentahydroxyflavone, 2-(2,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one, Al-Morin, Toxylon Pomiferum, Bois d,Arc, Bois d''arc, C.I. Natural Yellow 8, C.I. Natural Yellow 11, Osage Orange Crystals, 2''-Hydroxypelargidenolon 1522, 3,5,7,2'',4''-Pentahydroxyflavone, 3,5,7,2'',4''-Pentahydroxyflavonol, C.I. 75660, 2'',4'',3,5,7-Pentahydroxyflavone, 2'',4'',5,7-Tetrahydroxyflavan-3-ol, Zlut prirodni 11, 2-(2,4-dihydroxyphenyl)-3,5,7-trihydroxychromen-4-one, 4H-1-Benzopyran-4-one, 2-(2,4-dihydroxyphenyl)-3,5,7-trihydroxy-, NSC 19801, 2-(2,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one, C.I.Natural Yellow 8, NSC19801, NSC-19801, 8NFQ3F76WR, Flavone, 2'',3,4'',5,7-pentahydroxy-, CHEMBL28626, MLS000069618, CHEBI:75092, 3,5 7 2 4-Pentahydroxyflavone, 2'',4'',5,7-Tetrahydroxyflavonol, 4H-1-Benzopyran-4-one, 2-2-(2,4-dihydroxyphenyl)-3,5,7-trihydroxy-, SMR000058259, 2-[2,4-bis(oxidanyl)phenyl]-3,5,7-tris(oxidanyl)chromen-4-one, Bois d''arc [French], Zlut prirodni 11 [Czech], MORIN, REAG, SR-01000000157, EINECS 207-542-9, UNII-8NFQ3F76WR, BRN 0327474, Morin anhydrous, AI3-38057, CCRIS 8680, Aluminum Ionophore I, Spectrum_001234, regid855692, Spectrum2_000715, Spectrum3_001941, Spectrum4_001924, Spectrum5_000737, MORIN [MI], Lopac0_000776, SCHEMBL19984, BSPBio_003541, GTPL411, KBioGR_002268, KBioSS_001714, 5-18-05-00492 (Beilstein Handbook Reference), MLS006012034, BIDD:ER0115, DivK1c_000958, SPECTRUM1502259, SPBio_000929, MEGxp0_001864, Morin, p.a., 97.0%, 2'',3,5,7-Pentahydroxyflavone, DTXSID1022398, ACon1_000260, BDBM26658, cid_5281670, HMS502P20, KBio1_000958, KBio2_001714, KBio2_004282, KBio2_006850, KBio3_002824, 2-(2,4-dihydroxyphenyl)-3,5,7-trihydroxy-chromen-4-one, 2'',4'',5,7-Pentahydroxyflavone, 3,7,2'',4''-Pentahydroxyflavone, NINDS_000958, 2'',5,7-Tetrahydroxyflavan-3-ol, HMS1921P12, HMS3262K14, Flavone,3,4'',5,7-pentahydroxy-, HY-N0621, Tox21_500776, CCG-39036, LMPK12112517, MFCD00006826, s9110, 2'',3,4'',5,7-pentahydroxy flavone, 2'',3,4'',5,7-Pentahydroxy-Flavone, AKOS001582671, LP00776, SDCCGMLS-0003296.P003, SDCCGSBI-0050754.P003, 2'',4'',5, 7-Tetrahydroxyflavan-3-ol, IDI1_000958, s10675, SMP1_000199, NCGC00015672-01, NCGC00015672-02, NCGC00015672-03, NCGC00015672-04, NCGC00015672-05, NCGC00015672-06, NCGC00015672-07, NCGC00015672-08, NCGC00015672-09, NCGC00015672-10, NCGC00015672-11, NCGC00015672-12, NCGC00015672-13, NCGC00015672-14, NCGC00015672-24, NCGC00015672-25, NCGC00022214-03, NCGC00022214-04, NCGC00022214-05, NCGC00022214-06, NCGC00022214-07, NCGC00178000-01, NCGC00178000-02, NCGC00261461-01, AC-34723, BS-32477, NCI60_001647, CS-0009616, EU-0100776, NS00015830, P0041, M 4008, M-8200, EN300-7400825, A871995, Q418224, 2-(2,4-dihydroxyphenyl)-3,5,7-trihydroxy-chromone, 91A9D69E-FAB0-45CD-90E5-DEEFBADE86C1, SR-01000000157-2, SR-01000000157-6, SR-01000000157-7, BRD-K11590034-001-01-0, Aluminum Ionophore I, Selectophore(TM), function tested, 2-(2,4-dihydroxyphenyl)-3,5,7-trihydroxy-1-benzopyran-4-one, 2-(2,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one #, 2-(2,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one, 9CI C15H10O7 YXOLAZRVSSWPPT-UHFFFAOYSA-N 2-(2,4-dihydroxyphenyl)-3,5,7-trihydroxychromen-4-one n.a. n.a. No No No No Yes No rxnAddEX9,rxnAdd131 PMDBD2001907 Procyanidin B1 Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 11250133 n.a. NPC108811 Procyanidin B1, 20315-25-7, Proanthocyanidin B1, Procyanidin dimer B1, Endotelon, CHEBI:75633, UNII-0566J48E7X, EC-(4b,8)-C, PROCYANIDOL B1, 0566J48E7X, Epicatechin-(4beta->8)-ent-epicatechin, (+)-PROCYANIDIN B1, Epicatechin(4beta->8)catechin, PROCYANIDIN B1, (+)-, C30H26O12, MFCD01861512, (2R,3S)-2-(3,4-dihydroxyphenyl)-8-[(2R,3R,4R)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2H-chromen-4-yl]-3,4-dihydro-2H-chromene-3,5,7-triol, (4,8-Bi-2H-1-benzopyran)-3,3'',5,5'',7,7''-hexol, 2,2''-bis(3,4-dihydroxyphenyl)-3,3'',4,4''-tetrahydro-, 2,2''-Bis(3,4-dihydroxyphenyl)-3,3'',4,4''-tetrahydro-(4,8-Bi-2H-1-benzopyran)-3,3'',5,5'',7,7''-hexol, [4,8''-Bi-2H-1-benzopyran]-3,3'',5,5'',7,7''-hexol, 2,2''-bis(3,4-dihydroxyphenyl)-3,3'',4,4''-tetrahydro-, (2R,2''R,3R,3''S,4R)-, Procyanidin D, Procyanidol D, cis,trans''''-4,8''''-Bi-(3,3'',4'',5,7-Pentahydroxyflavane), (2R,2''R,3R,3''S,4R)-2,2''-Bis(3,4-dihydroxyphenyl)-[4,8''-bichromane]-3,3'',5,5'',7,7''-hexaol, (2R,2''R,3R,3''S,4R)-2,2''-bis(3,4-dihydroxyphenyl)-3,3'',4,4''-tetrahydro-2H,2''H-4,8''-bichromene-3,3'',5,5'',7,7''-hexol, (4,8''-BI-2H-1-BENZOPYRAN)-3,3'',5,5'',7,7''-HEXOL, 2,2''-BIS(3,4-DIHYDROXYPHENYL)-3,3'',4,4''-TETRAHYDRO-, (2R,2''R,3R,3''S,4R)-, ProcyanidinB1, Procyanidin-B1, procyanidin-B-2, Epicatechin(4b->8)catechin, SCHEMBL676745, CHEMBL504937, DTXSID401030238, 71328-22-8, HY-N0795, Procyanidin B1, analytical standard, BDBM50553252, LMPK12030001, AKOS030530133, CS-5955, AC-34943, AS-78072, 4,8-Bi-(3,3'',4'',5,7-Pentahydroxyflavane), (-)-EPICATECHIN-(4beta-8)-(+)-CATECHIN, Q-100247, Q7247551, (-)-EPICATECHIN-(4.BETA.-8)-(+)-CATECHIN, PROCYANIDIN B1 (CONSTITUENT OF MARITIME PINE), PROCYANIDIN B1 (CONSTITUENT OF MARITIME PINE) [DSC], PROCYANIDIN B1 (CONSTITUENT OF GRAPE SEEDS OLIGOMERIC PROANTHOCYANIDINS), (2R,2''R,3R,3''S,4R)-2,2''-Bis(3,4-dihydroxyphenyl)-[4,8''-bichroman]-3,3'',5,5'',7,7''-hexaol, (2R,3R,4R)-2-(3,4-dihydroxyphenyl)-4-[(2R,3S)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-chroman-8-yl]chromane-3,5,7-triol, (4,8''-BI-2H-1-BENZOPYRAN)-3,3'',5,5'',7,7''-HEXOL, 2,2''-BIS(3,4-DIHYDROXYPHENYL)-3,3'',4,4''-TETRAHYDRO-, (2R-(2.ALPHA.,3.ALPHA.,4.BETA.(2''R*,3''S*)))-, (4,8''-BI-2H-1-BENZOPYRAN)-3,3'',5,5'',7,7''-HEXOL, 2,2''-BIS(3,4-DIHYDROXYPHENYL)-3,3'',4,4''-TETRAHYDRO-, (2R-(2alpha,3alpha,4beta(2''R*,3''S*)))- C30H26O12 XFZJEEAOWLFHDH-UKWJTHFESA-N (2R,3S)-2-(3,4-dihydroxyphenyl)-8-[(2R,3R,4R)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2H-chromen-4-yl]-3,4-dihydro-2H-chromene-3,5,7-triol n.a. n.a. No No No No Yes No rxnAddEX14,rxnAdd11 PMDBD2001908 Procyanidin B4 Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 147299 n.a. NPC202742 Procyanidin B4, 29106-51-2, Procyanidol B4, (-)-procyanidin B4, Catechin-(4alpha->8)-epicatechin, Procyanidin B4, (-)-, (2R,2''R,3S,3''R,4S)-2,2''-Bis(3,4-dihydroxyphenyl)-[4,8''-bichroman]-3,3'',5,5'',7,7''-hexaol, CHEBI:27589, 2OP8987K2X, (2R,3R)-2-(3,4-dihydroxyphenyl)-8-[(2R,3S,4S)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2H-chromen-4-yl]-3,4-dihydro-2H-chromene-3,5,7-triol, UNII-2OP8987K2X, SCHEMBL718738, CHEMBL447373, DTXSID50183357, XFZJEEAOWLFHDH-VUGKQVTMSA-N, LMPK12030004, ZB1882, Catechin-(4.alpha.-->8)epicatechin, AKOS027326530, (4,8''-Bi-2H-1-benzopyran)-3,3'',5,5'',7,7''-hexol, 2,2''-bis(3,4-dihydroxyphenyl)-3,3''4,4''-tetrahydro-, (2R-(2alpha,3beta,4alpha(2''R*,3''R*)))-, MS-30397, HY-107208, CATECHIN-(4.ALPHA.->8)-EPICATECHIN, CS-0027644, NS00094718, Q7247555, (+)-CATECHIN-(4.ALPHA.->8)-(-)-EPICATECHIN, (2R,2''R,3S,3''R,4S)-2,2''-bis(3,4-dihydroxyphenyl)-3,3'',4,4''-tetrahydro-2H,2''H-4,8''-bichromene-3,3'',5,5'',7,7''-hexol, (2R,3S,4S)-2-(3,4-dihydroxyphenyl)-4-[(2R,3R)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-chroman-8-yl]chromane-3,5,7-triol, (4,8''-BI-2H-1-BENZOPYRAN)-3,3'',5,5'',7,7''-HEXOL, 2,2''-BIS(3,4-DIHYDROXYPHENYL)-3,3'',4,4''-TETRAHYDRO-, (2R,2''R,3S,3''R,4S)-, (4,8''-BI-2H-1-BENZOPYRAN)-3,3'',5,5'',7,7''-HEXOL, 2,2''-BIS(3,4-DIHYDROXYPHENYL)-3,3''4,4''-TETRAHYDRO-, (2R-(2.ALPHA.,3.BETA.,4.ALPHA.(2''R*,3''R*)))- C30H26O12 XFZJEEAOWLFHDH-VUGKQVTMSA-N (2R,3R)-2-(3,4-dihydroxyphenyl)-8-[(2R,3S,4S)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2H-chromen-4-yl]-3,4-dihydro-2H-chromene-3,5,7-triol n.a. n.a. No No No No Yes No rxnAddEX15,rxnAdd212 PMDBD2001909 Chicoric acid Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 5281764 n.a. NPC217052 "Chicoric acid, Cichoric Acid, L-Chicoric acid, 70831-56-0, 6537-80-0, (-)-Chicoric acid, dicaffeoyltartaric acid, (2R,3R)-2,3-bis[[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy]butanedioic acid, (-)-L-Chicoric acid, L-Cichoric acid, NSC 699173, L-DCTA, Chicoric acid, (-)-, NSC699173, S4YY3V8YHD, Dicaffeoyl-L-tartaric acid, trans-Caffeoyltartaric acid, CHEBI:3594, CHEMBL282731, DTXSID0033332, (2R,3R)-2,3-bis(((E)-3-(3,4-dihydroxyphenyl)acryloyl)oxy)succinic acid, 2,3-Bis((3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl)oxy)butanedioic acid, (R-(R*,R*-(E,E)))-2,3-Bis((3-(3,4-dihydroxphenyl)-1-oxo-2-propenyl)oxy)butanedioic acid, NSC-699173, (2R,3R)-2,3-Bis[[(E)-3-(3,4-dihydroxyphenyl)acryloyl]oxy]succinic Acid, ChicoricAcid, (2R,3R)-2,3-bis{[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}butanedioic acid, Butanedioic acid, 2,3-bis[[(2E)-3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl]oxy]-, (2R,3R)-, UNII-S4YY3V8YHD, L-Chicoricacid, 1-chicoricacid, Cichoric-Acid, l-Chicoric-acid, GKP, (-)-Chicoric acid;trans-Caffeoyltartaric acid, L-CA, (-)-CICHORIC ACID, 2,3-bis[3-(3,4-dihydroxyphenyl)prop-2-enoyloxy]butanedioic acid, CHICORIC ACID [USP-RS], DTXCID8013332, SCHEMBL15532218, 2,3-Dicaffeoyl-L-tartaric acid, YDDGKXBLOXEEMN-IABMMNSOSA-N, Chicoric Acid, >=95% (HPLC), HY-N0457, Tox21_201055, BDBM50076273, MFCD00189418, s9133, AKOS000278435, CCG-269487, CS-4262, Butanedioic acid, 2,3-bis(((2E)-3-(3,4-dihydroxphenyl)-1-oxo-2-propenyl)oxy)-, (2R,3R)-, ( -)-Chicoric acid, analytical standard, NCGC00091914-01, NCGC00091914-02, NCGC00091914-04, NCGC00258608-01, 1ST40121, AC-34315, AC-36990, AS-56447, Butanedioic acid, 2,3-bis((3-(3,4-dihydroxphenyl)-1-oxo-2-propenyl)oxy)-, (R-(R*,R*-(E,E)))-, CAS-70831-56-0, C3450, NS00037116, D78144, A914269, Q5119402, TARTARIC ACID, BIS(3,4-DIHYDROXYCINNAMATE), Chicoric Acid, United States Pharmacopeia (USP) Reference Standard, (2R,3R)-2,3-Bis((3-(3,4-dihydroxyphenyl)acryloyl)oxy)succinic acid, (2R,3R)-2,3-bis((E)-3-(3,4-dihydroxyphenyl)acryloyloxy)succinic acid, (2R,3R)-2,3-Bis-[(E)-3-(3,4-dihydroxy-phenyl)-acryloyloxy]-succinic acid, (2R,3R)-2,3-Bis[[3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl]oxy]butanedioic acid, (2R,3R)-2,3-bis{[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}succinic acid, (2R,3R)-2,3-bis{[3-(3,4-Dihydroxyphenyl)prop-2-enoyl]oxy}butanedioic acid, [S-(R*,R*)]-2,3-Bis[[3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl]oxy]butanedioic acid, butanedioic acid, 2,3-bis(((2E)-3-(3,4-dihydroxyphenyl)-1-oxo-2-propen-1-yl)oxy)-, (2R,3R)-, Butanedioic acid, 2,3-bis((3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl)oxy)-, (R-(R*,R*))-, Butanedioic acid, 2,3-bis[[(2E)-3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl]oxy]-, (2R,3R)- (9CI), Butanedioic acid, 2,3-bis[[3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl]oxy]-, [R-[R*,R*-(E,E)]]-, NCGC00091914-04!(2R,3R)-2,3-bis[[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy]butanedioic acid" C22H18O12 YDDGKXBLOXEEMN-IABMMNSOSA-N (2R,3R)-2,3-bis[[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy]butanedioic acid n.a. n.a. No No No No Yes No rxnAddEX16,rxnAdd157 PMDBD2001910 4-p-Coumaroylquinic acid Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 5281766 n.a. NPC200561 4-p-Coumaroylquinic acid, 4-O-p-Coumaroylquinic acid, 4-o-Coumaroylquinic acid, 1108200-72-1, 4-Coumaroylquinic acid, 4-p-Cqa, K4772MBI5O, UNII-K4772MBI5O, (3R,5R)-1,3,5-trihydroxy-4-[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]oxycyclohexane-1-carboxylic acid, 53539-37-0, Cyclohexanecarboxylic acid, 1,3,5-trihydroxy-4-(((2E)-3-(4-hydroxyphenyl)-1-oxo-2-propen-1-yl)oxy)-, (1alpha,3R,4alpha,5R)-, 93451-44-6, CHEBI:1945, MEGxp0_000071, SCHEMBL21381742, CHEBI:176887, DTXSID701341733, AKOS040734777, FS-8566, NCGC00380946-01, (1S,3R,4S,5R)-1,3,5-trihydroxy-4-{[3-(4-hydroxyphenyl)prop-2-enoyl]oxy}cyclohexanecarboxylic acid, (3R,5R)-1,3,5-trihydroxy-4-(((E)-3-(4-hydroxyphenyl)acryloyl)oxy)cyclohexane-1-carboxylic acid, CYCLOHEXANECARBOXYLIC ACID, 1,3,5-TRIHYDROXY-4-(((2E)-3-(4-HYDROXYPHENYL)-1-OXO-2-PROPEN-1-YL)OXY)-, (1.ALPHA.,3R,4.ALPHA.,5R)-, NCGC00380946-01_C16H18O8_(1S,3R,4S,5R)-1,3,5-Trihydroxy-4-{[(2E)-3-(4-hydroxyphenyl)-2-propenoyl]oxy}cyclohexanecarboxylic acid C16H18O8 XWRHBGVVCOSNKO-OPGYGNEESA-N (3R,5R)-1,3,5-trihydroxy-4-[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]oxycyclohexane-1-carboxylic acid n.a. n.a. No No No No Yes No rxnAddEX17,rxnAdd155 PMDBD2001911 Isochlorogenic acid B Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 5281780 n.a. NPC224389 3,4-Dicaffeoylquinic acid, Isochlorogenic acid b, 14534-61-3, 4,5-Dicqa, (1S,3R,4R,5R)-3,4-bis[[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy]-1,5-dihydroxycyclohexane-1-carboxylic acid, 3,4-Di-O-Caffeoylquinic acid, 45777W94HK, CHEBI:5995, CHEMBL249448, 89886-31-7, UNII-45777W94HK, Cyclohexanecarboxylic acid, 3,4-bis(((2E)-3-(3,4-dihydroxyphenyl)-1-oxo-2-propen-1-yl)oxy)-1,5-dihydroxy-, (1S,3R,4R,5R)-, Cyclohexanecarboxylic acid, 3,4-bis((3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl)oxy)-1,5-dihydroxy-, (1S,3R,4R,5R)-, Cyclohexanecarboxylic acid, 3,4-bis[[3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl]oxy]-1,5-dihydroxy-, (1S,3R,4R,5R)-, 102851-07-0, IsochlorogenicacidB, Cyclohexanecarboxylic acid, 3,4-bis[[3-(3,4-dihydroxyphenyl)-1-oxo-2-propen-1-yl]oxy]-1,5-dihydroxy-, (1R,3S,4S,5S)-rel-, Isochlorogenic-acid-B, 3,4-dicaffeoylquinate, Rel-3,4-Dicaffeoylquinic Acid, 4,5-Di-O-caffeoylquinic acid?, Quinic acid 3,4-di-O-caffeate, SCHEMBL12246115, ACon1_002212, GTPL12549, HY-N0057, BDBM50362838, s9274, AKOS026673963, CCG-269822, CS-3769, NCGC00179718-01, 1ST15168, AS-74985, NS00097363, Q-100168, Q27106970, 3,4-Di-O-caffeoylquinic acid, >=90% (LC/MS-ELSD), (1S,3R,4R,5R)-3,4-bis({[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy})-1,5-dihydroxycyclohexane-1-carboxylic acid, (1S,3R,4R,5R)-3,4-bis({[3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy})-1,5-dihydroxycyclohexane-1-carboxylic acid, (1S,3R,4R,5R)-3,4-bis[[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy]-1,5-dihydroxy-cyclohexanecarboxylic acid C25H24O12 UFCLZKMFXSILNL-PSEXTPKNSA-N (1S,3R,4R,5R)-3,4-bis[[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy]-1,5-dihydroxycyclohexane-1-carboxylic acid n.a. n.a. No No No No Yes No rxnAddEX18,rxnAdd149 PMDBD2001912 Isoferulic acid Dietary Substance, Therapeutic Substance Investigational Drug 537-73-5 DB07109 n.a. n.a. D04EWW 736186 643318 NPC164706 Isoferulic acid, 3-Hydroxy-4-methoxycinnamic acid, 537-73-5, Hesperetic acid, 25522-33-2, 3-(3-Hydroxy-4-methoxyphenyl)acrylic acid, trans-Isoferulic acid, (2E)-3-(3-hydroxy-4-methoxyphenyl)prop-2-enoic acid, Isoferulate, (E)-3-(3-hydroxy-4-methoxyphenyl)acrylic acid, 2-Propenoic acid, 3-(3-hydroxy-4-methoxyphenyl)-, Cinnamic acid, 3-hydroxy-4-methoxy-, Hesperetate, 3-(3-hydroxy-4-methoxyphenyl)prop-2-enoic acid, UNII-XSQ2K2G7MC, XSQ2K2G7MC, 3-(3-Hydroxy-4-methoxyphenyl)-2-propenoic acid, (E)-3''-Hydroxy-4''-methoxycinnamic acid, CHEBI:27794, (E)-3-(3-hydroxy-4-methoxyphenyl)prop-2-enoic acid, EINECS 208-676-0, NSC 51987, NSC-51987, BRN 2212760, 4-O-METHYLCAFFEIC ACID, CHEMBL233295, 4-10-00-01777 (Beilstein Handbook Reference), (E)-3-(3-hydroxy-4-methoxy-phenyl)-acrylic acid, trans-3-Hydroxy-4-methoxycinnamic acid, 3-Hydroxy-4-methoxycinnamic acid (isoferulic acid), (2E)-3-(3-HYDROXY-4-METHOXYPHENYL)ACRYLIC ACID, 3-[3-Hydroxy-4-(methoxy-d3)phenyl]-2-propenoic Acid, cis-Isoferulic acid, 3-Hydroxy-4-methoxycinnamate, 3-hydroxy-4-methoxy-cinnamic acid, Isoferulasaure, DTXSID501009309, Hesperetinic acid, EINECS 247-071-6, Isoferulic Acid ,(S), bmse000618, MLS000563054, SCHEMBL249041, SCHEMBL249042, 3-hydroxy-4-methoxy-Cinnamate, 3-Hydroxy-4-methoxycinnamic acid, predominantly trans, GTPL7980, 3-Hydroxy-4-methoxycinnamic-acid, DTXCID90908460, DTXSID901314847, HMS2268G06, HY-N0761, NSC51987, STR05122, BDBM50241245, MFCD00004391, s3764, AKOS000141174, CCG-266533, CS-W020120, DB07109, NCGC00247490-01, NCGC00247490-02, 1ST40364, AC-34927, LS-13768, MS-11465, SMR001215828, trans-Isoferulic acid, analytical standard, 3-(3-hydroxy-4-methoxyphenyl)-2-Propenoate, AM20040660, H0524, NS00014666, EN300-50983, (E)-3-(3-hydroxy-4-methoxyphenyl)acrylicacid, EN300-331979, Q-100609, ISOFERULIC ACID (CONSTITUENT OF BLACK COHOSH), Q27096447, Z2693271860, (2E)-3-(3-Hydroxy-4-methoxyphenyl)-2-propenoic acid #, 3-Hydroxy-4-methoxycinnamic acid, predominantly trans, 97%, ISOFERULIC ACID (CONSTITUENT OF BLACK COHOSH) [DSC], (E)-4-Hydroxy-4-(6-methoxynaphthalen-2-yl)but-3-en-2-one, 4FE C10H10O4 QURCVMIEKCOAJU-HWKANZROSA-N (E)-3-(3-hydroxy-4-methoxyphenyl)prop-2-enoic acid n.a. n.a. No No No No Yes No rxnAddEX19,rxnAdd165,rxnAdd166,rxnAdd167 PMDBD2001913 Nortrachelogenin Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 394846 n.a. NPC33090 "Nortrachelogenin, 34444-37-6, Pinopalustrin, (-)-Wikstromol, (-)-Wikstromol; NSC 271296, NSC698802, (3S,4S)-3-hydroxy-3,4-bis[(4-hydroxy-3-methoxyphenyl)methyl]oxolan-2-one, SCHEMBL874637, CHEBI:7639, GLXC-17522, EX-A7963, HY-N3171, AKOS032948713, NSC-698802, MS-26049, (-)-Nortrachelogenin, >=95.0% (HPLC), CS-0023487, G13050, Q27107549" C20H22O7 ZITBJWXLODLDRH-XOBRGWDASA-N (3S,4S)-3-hydroxy-3,4-bis[(4-hydroxy-3-methoxyphenyl)methyl]oxolan-2-one n.a. n.a. No No No No Yes No rxnAddEX20,rxnAdd196,rxnAdd197 PMDBD2001914 Theogallin Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 442988 n.a. NPC50221 Theogallin, 17365-11-6, 3-Galloylquinic acid, 3-O-Galloylquinic acid, Gallotannin 20, 3-Galloyl quinate, Quinic acid, 3-gallate, Benzoic acid, 3,4,5-trihydroxy-, (1R,2R,3R,5S)-5-carboxy-2,3,5-trihydroxycyclohexyl ester, (1S,3R,4R,5R)-1,3,4-trihydroxy-5-(3,4,5-trihydroxybenzoyl)oxycyclohexane-1-carboxylic acid, CHEBI:9522, N8GTS57R32, (1S,3R,4R,5R)-1,3,4-trihydroxy-5-(3,4,5-trihydroxybenzoyloxy)cyclohexanecarboxylic acid, (1S,3R,4R,5R)-1,3,4-Trihydroxy-5-((3,4,5-trihydroxybenzoyl)oxy)cyclohexane-1-carboxylic acid, UNII-N8GTS57R32, CHEMBL3233512, SCHEMBL21176646, DTXSID60332031, AKOS040740246, MS-25271, HY-122924, CS-0090456, G16405, Q5931666, (1S,3R,4R,5R)-1,3,4-trihydroxy-5-(3,4,5-trihydroxybenzoyl)oxy-cyclohexanecarboxylic acid, (1S,3R,4R,5R)-1,3,4-Trihydroxy-5-(3,4,5-trihydroxyphenylcarbonyloxy)cyclohexanecarboxylic acid, BENZOIC ACID, 3,4,5-TRIHYDROXY-, 5-CARBOXY-2,3,5-TRIHYDROXYCYCLOHEXYL ESTER, (1R-(1.ALPHA.,2.BETA.,3.BETA.,5.BETA.))-, Benzoic acid, 3,4,5-trihydroxy-, 5-carboxy-2,3,5-trihydroxycyclohexyl ester, (1R-(1alpha,2beta,3beta,5beta))- C14H16O10 LDPLFHGGZNSKDS-FTBFGRRBSA-N (1S,3R,4R,5R)-1,3,4-trihydroxy-5-(3,4,5-trihydroxybenzoyl)oxycyclohexane-1-carboxylic acid n.a. n.a. No No No No Yes No rxnAddEX21,rxnAdd222 PMDBD2001915 Sesamin Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 72307 n.a. NPC171928 "sesamin, 607-80-7, Fagarol, Sezamin, (+)-Sesamin, D-(+)-Sesamin, d-Sesamin, Asarinin, Episesamin, (+/-)-Sesamin, Sesamin dl-form [MI], CHEBI:66470, Sesamin, (+/-)-, pseudocubebin, NSC 36403, (+)-Segamin, UNII-S7946O4P76, AI3-00811, S7946O4P76, FY3S29JVC9, 81602-22-4, MFCD00216134, NSC-36403, 1H,3H-Furo(3,4-c)furan, tetrahydro-1,4-bis(3,4-(methylenedioxy)phenyl)-, (1S,3aR,4S,6aR)-, 5-[(3S,3aR,6S,6aR)-3-(1,3-benzodioxol-5-yl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-6-yl]-1,3-benzodioxole, PSEUDO CUBEBIN, Sesamin, (+)-, 1,3-Benzodioxole, 5,5''-((1R,3as,4R,6as)-tetrahydro-1H,3h-furo(3,4-c)furan-1,4-diyl)bis-, rel-, 1,3-Benzodioxole, 5,5''-(tetrahydro-1H,3H-furo(3,4-c)furan-1,4-diyl)bis-, (1S-(1alpha,3a alpha,4alpha,6a alpha))-, l-sesamin, (1S,3aR,4S,6aR)-1,4-Bis(benzo[d][1,3]dioxol-5-yl)hexahydrofuro[3,4-c]furan, 5,5''-(TETRAHYDRO-1H,3H-FURO(3,4-C)FURAN-1,4-DIYL)BIS-1,3-BENZODIOXOLE, TETRAHYDRO-1,4-BIS(3,4-(METHYLENEDIOXY)PHENYL)-1H,3H-FURO(3,4-C)FURAN, SMR000445559, SR-01000777562, UNII-FY3S29JVC9, Fsesamin, 5,5''-(1S,3aR,4S,6aR)-tetrahydro-1H,3H-furo(3,4-c)furan-1,4-diylbis(1,3-benzodioxole), 5,5''-(1S,3aR,4S,6aR)-tetrahydro-1H,3H-furo[3,4-c]furan-1,4-diylbis(1,3-benzodioxole), Sesamin (Fagarol), 5-[(3S,3aR,6S,6aR)-6-(1,3-benzodioxol-5-yl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-3-yl]-1,3-benzodioxole, Sesamin,(S), Rel-(7S,7''S8R,8''R)-Sesamin, SESAMIN D-FORM, SESAMIN [MI], SESAMIN [WHO-DD], Sesamin, analytical standard, SCHEMBL94517, SESAMIN D-FORM [MI], MLS000728578, MLS002473316, CHEMBL252915, Sesamin, >=95%, crystalline, Sesamin, >=98% (HPLC), ACon0_000323, ACon1_002421, GTPL11372, PEYUIKBAABKQKQ-AFHBHXEDSA-N, DTXSID301030528, HMS2232F11, HY-N0121, BDBM50542904, s2392, AKOS022168195, 1ST5401, CCG-268081, (1S,3aR,4S,6aR)-1,4-bis(benzo[d][1,3]dioxol-5-yl)tetrahydro-1H,3H-furo[3,4-c]furan, dioxol-5-yl)hexahydrofuro[3,4-c]furan, NCGC00169864-01, NCGC00169864-02, 1,3-Benzodioxole, 5,5''-(tetrahydro-1H,3h-furo(3,4-c)furan-1,4-diyl)bis-, (1alpha,3aalpha,4alpha,6aalpha)-, 1,3-Benzodioxole, 5,5''-(tetrahydro-1H,3h-furo(3,4-c)furan-1,4-diyl)bis-, (1alpha,3aalpha,4alpha,6aalpha)-(+/-)-, 1,3-Benzodioxole, 5,5''-(tetrahydro-1H,3H-furo[3,4-c]furan-1,4-diyl)bis-, (1S,3aR,4S,6aR)-, AS-13527, REL-(7S,7''S,8R,8''R)-SESAMIN, CS-0007831, NS00096653, SesaminSezamin; (+)-Sesamin; D-(+)-Sesamin, (1S,3aR,4S,6aR)-1,4-di(benzo[d][1,3], A832882, Q-100697, Q3511416, SR-01000777562-3, SR-01000777562-4, (1S,3aR,4S,6aR)-1,4-di(benzo[d][1,3]dioxol-5-yl)hexahydrofuro[3,4-c]furan, 5,5''-(1S,3aR,4S,6aR)-Tetrahydro-1H,3H-furo[3,4-c]furan-1,4-diylbis(1,3-benzodioxol), 1,3-BENZODIOXOLE, 5,5''-(TETRAHYDRO-1H,3H-FURO(3,4-C)FURAN-1,4-DIYL)BIS-, (1.ALPHA.,3A.ALPHA.,4.ALPHA.,6A.ALPHA.)-, 1,3-BENZODIOXOLE, 5,5''-(TETRAHYDRO-1H,3H-FURO(3,4-C)FURAN-1,4-DIYL)BIS-, (1.ALPHA.,3A.ALPHA.,4.ALPHA.,6A.ALPHA.)-(+/-)-, 1,3-BENZODIOXOLE, 5,5''-(TETRAHYDRO-1H,3H-FURO(3,4-C)FURAN-1,4-DIYL)BIS-, (1S-(1.ALPHA.,3A .ALPHA.,4.ALPHA.,6A .ALPHA.))-" C20H18O6 PEYUIKBAABKQKQ-AFHBHXEDSA-N 5-[(3S,3aR,6S,6aR)-3-(1,3-benzodioxol-5-yl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-6-yl]-1,3-benzodioxole n.a. n.a. No No No No Yes No rxnAddEX22,rxnAdd202,rxnAdd203 PMDBD2001916 Sesamolinol Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 443019 n.a. NPC303181 Sesamolinol, 100016-94-2, C10883, 4-[[(3S,3aR,6R,6aR)-3-(1,3-benzodioxol-5-yl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-6-yl]oxy]-2-methoxyphenol, AC1L9DVK, (+)-sesamolinol, CHEBI:9127, DTXSID10332041, Q27108282, 4-[[(3S,3aR,6R,6aR)-3-(1,3-benzodioxol-5-yl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-6-yl]oxy]-2-methoxy-phenol, 4-[[3-(1,3-benzodioxol-5-yl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-6-yl]oxy]-2-methoxyphenol C20H20O7 OJVGWDJIYBTWDS-AFHBHXEDSA-N 4-[[(3S,3aR,6R,6aR)-3-(1,3-benzodioxol-5-yl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-6-yl]oxy]-2-methoxyphenol n.a. n.a. No No No No Yes No rxnAddEX23,rxnAdd204,rxnAdd205 PMDBD2001917 Trachelogenin Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 452855 n.a. NPC31751 Trachelogenin, 34209-69-3, (-)-Trachelogenin, 2(3H)-Furanone, dihydro-3-hydroxy-3-vanillyl-4-veratryl-, 379VHZ3K1I, CHEBI:9647, (3S,4S)-4-[(3,4-dimethoxyphenyl)methyl]-3-hydroxy-3-[(4-hydroxy-3-methoxyphenyl)methyl]oxolan-2-one, 2(3H)-Furanone, 4-[(3,4-dimethoxyphenyl)methyl]dihydro-3-hydroxy-3-[(4-hydroxy-3-methoxyphenyl)methyl]-, (3S,4S)-, 2(3H)-Furanone, 4-((3,4-dimethoxyphenyl)methyl)dihydro-3-hydroxy-3-((4-hydroxy-3-methoxyphenyl)methyl)-, (3S,4S)-, (3S,4S)-4-[(3,4-dimethoxyphenyl)methyl]-3-hydroxy-3-[(4-hydroxy-3-methoxy-phenyl)methyl]tetrahydrofuran-2-one, UNII-379VHZ3K1I, TRACHELOGENIN, (-)-, CHEMBL491178, MEGxp0_001798, SCHEMBL3980011, ACon1_002414, DTXSID50187799, HY-N7934, AKOS030573612, NCGC00169870-01, MS-26437, CS-0138835, BRD-K17107446-001-01-9, Q26359226, 2(3H)-FURANONE, 4-((3,4-DIMETHOXYPHENYL)METHYL)DIHYDRO-3-HYDROXY-3-((4-HYDROXY-3-METHOXYPHENYL)METHYL)-, (3S-CIS)- C21H24O7 YFVZKLQNMNKWSB-BTYIYWSLSA-N (3S,4S)-4-[(3,4-dimethoxyphenyl)methyl]-3-hydroxy-3-[(4-hydroxy-3-methoxyphenyl)methyl]oxolan-2-one n.a. n.a. No No No No Yes No rxnAddEX24,rxnAdd208,rxnAdd209 PMDBD2001918 3-Methylgalangin Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 5281946 n.a. NPC184536 "Galangin 3-methyl ether, 3-O-Methylgalangin, 6665-74-3, 3-Methylgalangin, GALANGIN-3-METHYLETHER, 5,7-Dihydroxy-3-methoxyflavone, 5,7-dihydroxy-3-methoxy-2-phenylchromen-4-one, 5,7-Dihydroxy-3-methoxy-2-phenyl-4H-1-benzopyran-4-one, 4H-1-Benzopyran-4-one, 5,7-dihydroxy-3-methoxy-2-phenyl-, Galangin 3-O-methyl ether, CHEBI:1602, CHEMBL1822221, 02887TX99X, Galangin 3-methyl ether;3-Methylgalangin, 5,7-dihydroxy-3-methoxy-2-phenyl-4H-chromen-4-one, UNII-02887TX99X, Galangin3-O-methylether, SCHEMBL4631662, DTXSID20216823, BCP33596, HY-N4167, BDBM50423814, LMPK12111654, s3307, AKOS015906503, CCG-214442, AC-34262, MS-24038, FLAVONE, 5,7-DIHYDROXY-3-METHOXY-, CS-0032292, G13252, Q27105478" C16H12O5 LYISDADPVOHJBJ-UHFFFAOYSA-N 5,7-dihydroxy-3-methoxy-2-phenylchromen-4-one n.a. n.a. No No No No Yes No rxnAddEX25,rxnAdd119 PMDBD2001919 Tetra-O-methylscutellarein Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 96118 n.a. NPC14958 Scutellarein tetramethyl ether, 4'',5,6,7-Tetramethoxyflavone, 1168-42-9, Tetramethyl-O-scutellarin, Tetra-O-methylscutellarein, Tetramethylscutellarein, Flavone, 4'',5,6,7-tetramethoxy-, 5,6,7,4''-Tetramethoxyflavone, NSC-53908, Scutellarein tetramethylether, 5,6,7-trimethoxy-2-(4-methoxyphenyl)chromen-4-one, 5,6,7-Trimethoxy-2-(4-methoxyphenyl)-4H-chromen-4-one, NSC53908, 4H-1-Benzopyran-4-one, 5,6,7-trimethoxy-2-(4-methoxyphenyl)-, DWN851IYG6, 5,6,7-Trimethoxy-2-(4-methoxyphenyl)-4H-1-benzopyran-4-one, CHEBI:34357, NSC 53908, 5-METHOXYSALVIGENIN, Scutellareintetramethylether, UNII-DWN851IYG6, Scutellarein 5,6,7,4''-tetramethyl ether, 4'', 5,6,7-Tetramethoxyflavone, DTXSID60151522, Flavone, 5,6,7,4''-tetramethoxy, PECTOLINARIGENIN DIMETHYL ETHER, Tetrametlglscutellarein, NCIMech_000290, Oprea1_070007, 4'',6,7-Tetramethoxyflavone, MLS001048998, CHEMBL75349, SCHEMBL739115, Flavone,5,6,7-tetramethoxy-, DTXCID4074013, ACon1_001966, 4'',5,6,7-tetramethoxy flavone, 4'',5,6,7-Tetramethoxy-Flavone, HMS2271J05, BCP10002, HY-N4314, BDBM50451668, CCG-35304, LMPK12111167, MFCD00017442, AKOS015969703, NCGC00179960-01, MS-25233, NCI60_004329, SMR000387012, CS-0032724, Flavone, 4'',5,6,7-tetramethoxy- (8CI), NS00134226, T3970, E80724, BRD-K36475601-001-01-8, Q27116014, 5,6,7-Trimethoxy-2-(4-methoxyphenyl)-4H-chromen-4-one #, 4H-1-Benzopyran-4-one,6,7-trimethoxy-2-(4-methoxyphenyl)-, 4H-1-Benzopyran-4-one, 5,6, 7-trimethoxy-2-(4-methoxyphenyl)-, NCGC00179960-02!5,6,7-trimethoxy-2-(4-methoxyphenyl)chromen-4-one C19H18O6 URSUMOWUGDXZHU-UHFFFAOYSA-N 5,6,7-trimethoxy-2-(4-methoxyphenyl)chromen-4-one n.a. n.a. No No No No Yes No rxnAddEX27,rxnAdd89,rxnAdd90,rxnAdd92 PMDBD2001920 Procyanidin C1 Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 169853 n.a. NPC279406 "Procyanidin C1, 37064-30-5, Procyanidol C1, Proanthocyanidin C1, Cinnamtannin A1, (2R,2''R,2''''R,3R,3''R,3''''R,4R,4''S)-2,2'',2''''-Tris(3,4-dihydroxyphenyl)-[4,8'':4'',8''''-terchroman]-3,3'',3'''',5,5'',5'''',7,7'',7''''-nonaol, UNII-33516LCW4F, CHEBI:75643, Procyanidin trimer C1, 33516LCW4F, EC-(4b,8)-EC-(4b,8)-EC, CHEMBL290632, (2r,2''r,2''''r,3r,3''r,3''''r,4r,4''s)-2,2'',2''''-tris(3,4-dihydroxyphenyl)-3,3'',3'''',4,4'',4''''-hexahydro-2h,2''h,2''''h-4,8'':4'',8''''-terchromene-3,3'',3'''',5,5'',5'''',7,7'',7''''-nonol, Epicatechin-(4beta->8)-epicatechin-(4beta->8)-epicatechin, PROCYANIDIN C1, (+)-, DTXSID10190562, [Epicatechin(4b->8)]2-epicatechin, (2R,3R,4S)-2-(3,4-dihydroxyphenyl)-4-[(2R,3R)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2H-chromen-8-yl]-8-[(2R,3R,4R)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2H-chromen-4-yl]-3,4-dihydro-2H-chromene-3,5,7-triol, (4,8'':4'',8''''-Ter-2H-1-benzopyran)-3,3'',3'''',5,5'',5'''',7,7'',7''''-nonol, 2,2'',2''''-tris(3,4-dihydroxyphenyl)-3,3'',3'''',4,4'',4''''-hexahydro-, stereoisomer, [Epicatechin-(4beta->8)]2-epicatechin, (Epicatechin(4b->8))2-epicatechin, Procyanidin C-1, (Epicatechin-(4beta->8))2-epicatechin, Proanthocyanidin C1;, PCC1, SCHEMBL678609, DTXCID50113053, HY-N2342, BDBM50240460, AKOS027321198, AC-35069, MS-31600, 1ST166802, CS-0021304, C17624, Q7247556, PROCYANIDIN C1 (CONSTITUENT OF MARITIME PINE), epicatechin-(4beta-8)-epicatechin-(4beta-8)-epicatechin, PROCYANIDIN C1 (CONSTITUENT OF MARITIME PINE) [DSC], Epicatechin-(4.beta.-->8)epicatechin-(4.beta.-->8)epicatechin, EPICATECHIN-(4.BETA.->8)-EPICATECHIN-(4.BETA.->8)-EPICATECHIN, (2R,3R,4R,2''''R,3''''R,4''''S,2''''''''R,3''''''''R)-2,2'''',2''''''''-Tris-(3,4-dihydroxy-phenyl)-3,4,3'''',4'''',3'''''''',4''''''''-hexahydro-2H,2''''H,2''''''''H-[4,8'''';4'''',8'''''''']terchromene-3,5,7,3'''',5'''',7'''',3'''''''',5'''''''',7''''''''-nonaol, (2R,3R,4S)-2-(3,4-dihydroxyphenyl)-4-[(2R,3R)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-chroman-8-yl]-8-[(2R,3R,4R)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-chroman-4-yl]chromane-3,5,7-triol, (2R,3R,4S)-2-(3,4-dihydroxyphenyl)-8-[(2R,3R,4R)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2H-1-benzopyran-4-yl]-4-[(2R,3R)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2H-1-benzopyran-8-yl]-3,4-dihydro-2H-1-benzopyran-3,5,7-triol" C45H38O18 MOJZMWJRUKIQGL-XILRTYJMSA-N (2R,3R,4S)-2-(3,4-dihydroxyphenyl)-4-[(2R,3R)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2H-chromen-8-yl]-8-[(2R,3R,4R)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2H-chromen-4-yl]-3,4-dihydro-2H-chromene-3,5,7-triol n.a. n.a. No No No No Yes No rxnAddEX28,rxnAdd214 PMDBD2001921 Cinnamtannin A2 Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 16130899 n.a. NPC224161 Cinnamtannin A2, 86631-38-1, CHEBI:81227, Procyanidin tetramer, (2R,3R,4R)-2-(3,4-dihydroxyphenyl)-4-[(2R,3R,4S)-2-(3,4-dihydroxyphenyl)-4-[(2R,3R)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2H-chromen-8-yl]-3,5,7-trihydroxy-3,4-dihydro-2H-chromen-8-yl]-8-[(2R,3R,4R)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2H-chromen-4-yl]-3,4-dihydro-2H-chromene-3,5,7-triol, [4,8'':4'',8'''':4'''',8''''''-Quater-2H-1-benzopyran]-3,3'',3'''',3'''''',5,5'',5'''',5'''''',7,7'',7'''',7''''''-dodecol, 2,2'',2'''',2''''''-tetrakis(3,4-dihydroxyphenyl)-3,3'',3'''',3'''''',4,4'',4'''',4''''''-octahydro-, (2R,2''R,2''''R,2''''''R,3R,3''R,3''''R,3''''''R,4R,4''R,4''''S)-, Cinnamtannin I, Epicatechin tetramer, Tetrameric proanthocyanidin, SCHEMBL6861829, CHEMBL3409094, DTXSID201317088, HY-N9536, [Epicatechin(4b->8)]3-epicatechin, AKOS040758406, CS-0198420, C17625, E88997, Q23048725, (1(2)R,1(3)R,1(4)R,2(2)R,2(3)R,2(4)R,3(2)R,3(3)R,3(4)S,4(2)R,4(3)R)-1(2),2(2),3(2),4(2)-tetrakis(3,4-dihydroxyphenyl)-1(3),1(4),2(3),2(4),3(3),3(4),4(3),4(4)-octahydro-1(2)H,2(2)H,3(2)H,4(2)2H-[1(4),2(8):2(4),3(8):3(4),4(8)-quater-1-benzopyran]-1(3),1(5),1(7),2(3),2(5),2(7),3(3),3(5),3(7),4(3),4(5),4(7)-dodecol, (2R,2''R,2''''R,2''''''R,3R,3''R,3''''R,3''''''R,4R,4''S,4''''S)-2,2'',2'''',2''''''-Tetrakis(3,4-dihydroxyphenyl)-3,3'',3'''',3'''''',4,4'',4'''',4''''''-octahydro-2H,2''H,2''''H,2''''''H-4,8'':4'',8'''':4'''',8''''''-quaterchromene-3,3'',3'''',3'''''',5,5'',5'''',5'''''',7,7'',7'''',7''''''-dodecol, (2R,3R,4R)-2-(3,4-dihydroxyphenyl)-4-[(2R,3R,4S)-2-(3,4-dihydroxyphenyl)-4-[(2R,3R)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-chroman-8-yl]-3,5,7-trihydroxy-chroman-8-yl]-8-[(2R,3R,4R)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-chroman-4-yl]chromane-3,5,7-triol, (2R,3R,4R)-2-(3,4-dihydroxyphenyl)-8-[(2R,3R,4R)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2H-1-benzopyran-4-yl]-4-[(2R,3R,4S)-2-(3,4-dihydroxyphenyl)-4-[(2R,3R)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2H-1-benzopyran-8-yl]-3,5,7-trihydroxy-3,4-dihydro-2H-1-benzopyran-8-yl]-3,4-dihydro-2H-1-benzopyran-3,5,7-triol C60H50O24 QFLMUASKTWGRQE-JNIIMKSASA-N (2R,3R,4R)-2-(3,4-dihydroxyphenyl)-4-[(2R,3R,4S)-2-(3,4-dihydroxyphenyl)-4-[(2R,3R)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2H-chromen-8-yl]-3,5,7-trihydroxy-3,4-dihydro-2H-chromen-8-yl]-8-[(2R,3R,4R)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2H-chromen-4-yl]-3,4-dihydro-2H-chromene-3,5,7-triol n.a. n.a. No No No No Yes No rxnAddEX29,rxnAdd223 PMDBD2001922 Procyanidin B2 Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 122738 n.a. NPC236202 "Procyanidin B2, 29106-49-8, Procyanidol B2, Proanthocyanidin B2, (+)-Procyanidin B2, Procyanidin B-2, CHEBI:75632, 2,3-cis-proanthocyanidin, UNII-L88HKE854X, L88HKE854X, EC-(4b,8)-EC, Epicathechin-(4beta->8)-epicathechin, NSC 623097, PROCYANIDIN B2 DIMER, CHEMBL38714, PROCYANIDIN B2, (+)-, NSC-623097, (2R,3R)-2-(3,4-dihydroxyphenyl)-8-[(2R,3R,4R)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2H-chromen-4-yl]-3,4-dihydro-2H-chromene-3,5,7-triol, [4,8''-Bi-2H-1-benzopyran]-3,3'',5,5'',7,7''-hexol, 2,2''-bis(3,4-dihydroxyphenyl)-3,3'',4,4''-tetrahydro-, (2R,2''R,3R,3''R,4R)-, (2R-(2alpha,3alpha,4beta(2''R*,3''R*)))-2,2''-Bis(3,4-dihydroxyphenyl)-3,3'',4,4''-tetrahydro-(4,8''-Bi-2H-1-benzopyran)-3,3'',5,5'',7,7''-hexol, (4,8''-Bi-2H-1-benzopyran)-3,3'',5,5'',7,7''-hexol, 2,2''-bis(3,4-dihydroxyphenyl)-3,3'',4,4''-tetrahydro-, (2R-(2alpha,3alpha,4beta(2''R*,3''R*)))-, PROCYANIDIN B2 (USP-RS), PROCYANIDIN B2 [USP-RS], (2R,2''R,3R,3''R,4R)-2,2''-Bis(3,4-dihydroxyphenyl)-[4,8''-bichromane]-3,3'',5,5'',7,7''-hexaol, (2R,2''R,3R,3''R,4R)-2,2''-bis(3,4-dihydroxyphenyl)-3,3'',4,4''-tetrahydro-2H,2''H-4,8''-bichromene-3,3'',5,5'',7,7''-hexol, (4,8''-BI-2H-1-BENZOPYRAN)-3,3'',5,5'',7,7''-HEXOL, 2,2''-BIS(3,4-DIHYDROXYPHENYL)-3,3'',4,4''-TETRAHYDRO-, (2R,2''R,3R,3''R,4R)-, PROCYANIDINB2, Procyanidin-B2, Procyanidin dimer B2, SCHEMBL288579, DTXSID701028797, HY-N0796, Procyanidin B2, analytical standard, BDBM50553253, LMPK12030002, MFCD01861513, AKOS008901339, CS-5982, BS-49221, 4,8″-Bi-[(+)-epicatechin], cis, C17639, (-)-Epicatechin-(4.beta.-8)-(-)-epicatechin, A912693, J-017393, Q7247552, (-)-EPICATECHIN-(4beta->8)-(-)-EPICATECHIN, (-)-EPICATECHIN-(4.BETA.->8)-(-)-EPICATECHIN, cis,cis""-4,8""-Bi(3,3'',4'',5,7-pentahydroxyflavane), cis″-4,8″-Bi(3,3'',4'',5,7-pentahydroxyflavane), PROCYANIDIN B2 (CONSTITUENT OF GRAPE SEEDS OLIGOMERIC PROANTHOCYANIDINS), (2R,2''R,3R,3''R,4R)-2,2''-Bis(3,4-dihydroxyphenyl)-4,8''-bichroman-3,3'',5,5'',7,7''-hexol, (2R,3R,4R)-2-(3,4-dihydroxyphenyl)-4-[(2R,3R)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-chroman-8-yl]chromane-3,5,7-triol, (2R-(2.ALPHA.,3.ALPHA.,4.BETA.(2''R*,3''R*)))-2,2''-BIS(3,4-DIHYDROXYPHENYL)-3,3'',4,4''-TETRAHYDRO-(4,8''-BI-2H-1-BENZOPYRAN)-3,3'',5,5'',7,7''-HEXOL, (4,8''-BI-2H-1-BENZOPYRAN)-3,3'',5,5'',7,7''-HEXOL, 2,2''-BIS(3,4-DIHYDROXYPHENYL)-3,3'',4,4''-TETRAHYDRO-, (2R-(2.ALPHA.,3.ALPHA.,4.BETA.(2''R*,3''R*)))-" C30H26O12 XFZJEEAOWLFHDH-NFJBMHMQSA-N (2R,3R)-2-(3,4-dihydroxyphenyl)-8-[(2R,3R,4R)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2H-chromen-4-yl]-3,4-dihydro-2H-chromene-3,5,7-triol n.a. n.a. No No No No Yes No rxnAddEX30,rxnAdd210 PMDBD2001923 Procyanidin B5 Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 124017 n.a. NPC294558 Procyanidin B5, Procyanidol B5, 12798-57-1, Proanthocyanidin B5, UNII-W51N19H6K6, BRN 3586526, Procyanidin dimer B5, PROCYANIDINB5, CHEBI:75621, W51N19H6K6, Epicatechin(4b->6)epicatechin, (2R,3R)-2-(3,4-dihydroxyphenyl)-6-[(2R,3R,4S)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2H-chromen-4-yl]-3,4-dihydro-2H-chromene-3,5,7-triol, (4,6''-Bi-2H-1-benzopyran)-3,3'',5,5'',7,7''-hexol, 2,2''-bis(3,4-dihydroxyphenyl)-3,3'',4,4''-tetrahydro-, (2R-(2-alpha,3-alpha,4-beta(2''R*,3''R*)))-, EC-(4b,6)-EC, DTXSID00155761, 5-19-03-00736 (Beilstein Handbook Reference), epicatechin-(4beta->6)-epicatechin, (2R,2''R,3R,3''R,4S)-2,2''-bis(3,4-dihydroxyphenyl)-3,3'',4,4''-tetrahydro-2H,2''H-4,6''-bichromene-3,3'',5,5'',7,7''-hexol, (2R,2''R,3R,3''R,4S)-2,2''-bis(3,4-Dihydroxyphenyl)-[4,6''-bichromane]-3,3'',5,5'',7,7''-hexaol, CHEMBL506487, DTXCID9078252, SCHEMBL13610158, HY-N7935, AKOS040762696, Epicatechin-(4.beta.-->6)epicatechin, CS-0138836, C17640, (-)-EPICATECHIN-(4beta-6)-(-)-EPICATECHIN, Q7247557, PROCYANIDIN B5 (CONSTITUENT OF MARITIME PINE), (-)-EPICATECHIN-(4.BETA.-6)-(-)-EPICATECHIN, PROCYANIDIN B5 (CONSTITUENT OF MARITIME PINE) [DSC], (2R,3R,4S)-2-(3,4-dihydroxyphenyl)-4-[(2R,3R)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-chroman-6-yl]chromane-3,5,7-triol C30H26O12 GMISZFQPFDAPGI-CVJZBMGUSA-N (2R,3R)-2-(3,4-dihydroxyphenyl)-6-[(2R,3R,4S)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2H-chromen-4-yl]-3,4-dihydro-2H-chromene-3,5,7-triol n.a. n.a. No No No No Yes No rxnAddEX31,rxnAdd213 PMDBD2001924 Isoxanthohumol Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 513197 n.a. NPC76338 Isoxanthohumol, 521-48-2, Isoxanthohumol(Sophora), (2S)-Isoxanthohumol, 7-hydroxy-2-(4-hydroxyphenyl)-5-methoxy-8-(3-methylbut-2-enyl)-2,3-dihydrochromen-4-one, CHEMBL492828, 7-Hydroxy-2-(4-hydroxyphenyl)-5-methoxy-8-(3-methylbut-2-en-1-yl)chroman-4-one, (+/-)-Isoxanthohumol, UNII-B3BXQ4EZD6, Isoxanthohumol, HPLC Grade, SCHEMBL904557, HY-N2584A, CHEBI:171798, Isoxanthohumol, >=99% (HPLC), Isoxanthohumol, analytical standard, BCP23864, BDBM50252521, LMPK12140553, MFCD00238718, SMP2_000215, NCGC00390429-01, MS-25527, 4'',7-dihydroxy-5-methoxy-8-prenylflavanone, CS-0064440, 4'',7-dihydroxy-5-methoxy-8-c-prenylflavanone, Q6086616, Isoxanthohumol, primary pharmaceutical reference standard, 7-hydroxy-2-(4-hydroxy-phenyl)-5-methoxy-8-(3-methyl-but-2-enyl)-chroman-4-one, 7-hydroxy-2-(4-hydroxyphenyl)-5-methoxy-8-(3-methylbut-2-enyl)chroman-4-one, 2,3-Dihydro-7-hydroxy-2-(4-hydroxyphenyl)-5-methoxy-8-(3-methyl-2-butenyl)-4h-1-benzopyran-4-one, 4H-1-Benzopyran-4-one, 2,3-dihydro-7-hydroxy-2-(4-hydroxyphenyl)-5-methoxy-8-(3-methyl-2-butenyl)-, 7-Hydroxy-2-(4-hydroxyphenyl)-5-methoxy-8-(3-methyl-2-butenyl)-2,3-dihydro-4H-chromen-4-one # C21H22O5 YKGCBLWILMDSAV-UHFFFAOYSA-N 7-hydroxy-2-(4-hydroxyphenyl)-5-methoxy-8-(3-methylbut-2-enyl)-2,3-dihydrochromen-4-one n.a. n.a. No No No No Yes No rxnAddEX32,rxnAdd77 PMDBD2001925 3,5-Dihydroxybenzoate Dietary Substance, Therapeutic Substance Investigational Drug n.a. n.a. n.a. n.a. D0W1OR 7424 n.a. NPC98543 3,5-DIHYDROXYBENZOIC ACID, 99-10-5, alpha-Resorcylic acid, 5-Carboxyresorcinol, Benzoic acid, 3,5-dihydroxy-, 3,5-Dihydroxybenzoicacid, 3,5-Dihydroxy-benzoic acid, 3,5-DIHYDROXYBENZOATE, NSC 22948, .alpha.-Resorcylic acid, a-resorcylic acid, 3,5-Dihydroxy benzoic acid, MFCD00002512, 2WC5LMO6L1, CHEMBL95308, CHEBI:39912, 3,5-Dihydroxybenzoic acid, 97%, NSC-22948, 3,5-dihydroxybenzoic acid (alpha-resorcylic acid), 3,5-DHBA, UNII-2WC5LMO6L1, EINECS 202-730-7, BRN 2207864, AI3-52338, |A-Resorcylic acid, 3,5-dihyroxybenzoic acid, 3_5_dihydroxybenzoic_acid, 3,5-Dihydroxybenzoate, IX, SCHEMBL28106, 4-10-00-01501 (Beilstein Handbook Reference), GTPL5783, DTXSID8059184, NSC22948, STR02341, BDBM50336490, s6160, AKOS005721135, AB00234, AC-1166, CS-W016276, HY-W015560, PS-4051, 34D, AC-10253, SY003472, 3,5-Dihydroxybenzoic acid (ACD/Name 4.0), D0570, D2554, NS00001748, 3,5-Dihydroxybenzoic Acid (?-Resorcylic Acid), EN300-112021, P16552, AE-562/40806860, alpha-Resorcylic Acid (3,5-Dihydroxybenzoic Acid), Q-200348, Q4634089, TERBUTALINE SULFATE IMPURITY A [EP IMPURITY], F0001-2331, Z1255485190, 3,5-Dihydroxybenzoic acid, Vetec(TM) reagent grade, 97%, InChI=1/C7H6O4/c8-5-1-4(7(10)11)2-6(9)3-5/h1-3,8-9H,(H,10,11, 145639-71-0, 19991-00-5 C7H6O4 UYEMGAFJOZZIFP-UHFFFAOYSA-N 3,5-dihydroxybenzoic acid n.a. n.a. No No No No Yes No rxnAddEX33,rxnAdd34 PMDBD2001926 2,6-Dihydroxybenzoate Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 54676638 n.a. n.a. "2,6-Dihydroxybenzoate, gamma-resorcylate, 935-71-7, Benzoic acid, 2,6-dihydroxy-, ion(1-), 2-carboxy-3-hydroxyphenolate, 6-hydroxysalicylate, 4e3f, DTXSID80239457, AKEUNCKRJATALU-UHFFFAOYSA-M, CHEBI:131450, 2,6-dihydroxybenzoate;2,6-Dihydroxybenzoic acid, A820312, Q27225137" C7H5O4- AKEUNCKRJATALU-UHFFFAOYSA-M 2-carboxy-3-hydroxyphenolate n.a. n.a. No No No No Yes No rxnAddEX34,rxnAdd30 PMDBD2001927 (-)-syringaresinol Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 11604108 n.a. NPC34103 "(-)-syringaresinol, 6216-81-5, (-)-Lirioresinol B, Syringaresinol - 93%, Syringaresinol, (-)-, DL-Syringaresinol, QD6NNG8CM5, UNII-QD6NNG8CM5, CHEBI:49212, 4,4''-((1R,3aS,4R,6aS)-Tetrahydro-1H,3H-furo(3,4-C)furan-1,4-diyl)bis(2,6-dimethoxyphenol), 4-[(3R,3aS,6R,6aS)-6-(4-hydroxy-3,5-dimethoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-3-yl]-2,6-dimethoxyphenol, Phenol, 4,4''-((1R,3aS,4R,6aS)-tetrahydro-1H,3H-furo(3,4-C)furan-1,4-diyl)bis(2,6-dimethoxy-, (7beta,7''beta,8beta,8''beta)-3,3'',5,5''-tetramethoxy-7,9'':7'',9-diepoxylignane-4,4''-diol, Phenol, 4,4''-(tetrahydro-1H,3H-furo(3,4-C)furan-1,4-diyl)bis(2,6-dimethoxy-, (1R-(1alpha,3aalpha,4alpha,6aalpha))-, Lirioresinol b, minus Syringaresinol, ()-Syringaresinol;, CHEMBL402653, SCHEMBL16562875, KOWMJRJXZMEZLD-WRMVBYCNSA-N, DTXSID901316029, AKOS030231411, MS-27314, XS164035, HY-126066, CS-0090357, Q27121535, 4,4''-(1R,3aS,4R,6aS)-Tetrahydro-1H,3H-furo[3,4-c]furan-1,4-diylbis(2,6-dimethoxyphenol), 4-[(3R,3aS,6R,6aS)-6-(4-hydroxy-3,5-dimethoxy-phenyl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-3-yl]-2,6-dimethoxy-phenol, PHENOL, 4,4''-(TETRAHYDRO-1H,3H-FURO(3,4-C)FURAN-1,4-DIYL)BIS(2,6-DIMETHOXY-, (1R-(1.ALPHA.,3A.ALPHA.,4.ALPHA.,6A.ALPHA.))-" C22H26O8 KOWMJRJXZMEZLD-WRMVBYCNSA-N 4-[(3R,3aS,6R,6aS)-6-(4-hydroxy-3,5-dimethoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-3-yl]-2,6-dimethoxyphenol n.a. n.a. No No No No Yes No rxnAddEX36,rxnAdd206,rxnAdd207 PMDBD2001928 demethyloleuropein Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 6450302 n.a. n.a. Demethyloleuropein, Oleoeuropein acid, Demethyloleoeuropein, Demethyloleoeuropeine, 52077-55-1, (4S,5E,6S)-4-[2-[2-(3,4-dihydroxyphenyl)ethoxy]-2-oxoethyl]-5-ethylidene-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4H-pyran-3-carboxylic acid, (2S-(2alpha,3E,4beta))-2-(3,4-Dihydroxyphenyl)ethyl 5-carboxy-3-ethylidene-2-(beta-D-glucopyranosyloxy)-3,4-dihydro-2H-pyran-4-acetate, 2H-Pyran-4-acetic acid, 5-carboxy-3-ethylidene-2-(beta-D-glucopyranosyloxy)-3,4-dihydro-, 2-(3,4-dihydroxyphenyl)ethyl ester, (2S-(2alpha,3E,4beta))-, SCHEMBL569830, CHEBI:180799, DTXSID301315942, (4s,5e,6s)-4-[2-[2-(3,4-dihydroxyphenyl)ethoxy]-2-oxoethyl]-5-ethylidene-6-[[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]-4h-pyran-3-carboxylic acid C24H30O13 HKVGJQVJNQRJPO-VTDDDATNSA-N (4S,5E,6S)-4-[2-[2-(3,4-dihydroxyphenyl)ethoxy]-2-oxoethyl]-5-ethylidene-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4H-pyran-3-carboxylic acid n.a. n.a. No No No No Yes No rxnAddEX37,rxnAdd215 PMDBD2001929 ligstroside Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 14136859 n.a. NPC169398 Ligustroside, ligstroside, 35897-92-8, Ligusroside, 83S9SA69C5, UNII-83S9SA69C5, (-)-ligstroside, MEGxp0_000487, CHEMBL1086877, ACon1_000577, CHEBI:149585, DTXSID701318124, HY-N3383, methyl (4S,5E,6S)-5-ethylidene-4-[2-[2-(4-hydroxyphenyl)ethoxy]-2-oxoethyl]-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4H-pyran-3-carboxylate, AKOS040760521, NCGC00168945-01, MS-29709, CS-0024058, NS00093976, BRD-K49137267-001-01-4, Q27269447, 2H-PYRAN-4-ACETIC ACID, 3-ETHYLIDENE-2-(.BETA.-D-GLUCOPYRANOSYLOXY)-3,4-DIHYDRO-5-(METHOXYCARBONYL)-, 2-(4-HYDROXYPHENYL)ETHYL ESTER, (2S,3E,4S)-, methyl (2S,3E,4S)-3-ethylidene-4-{2-[2-(4-hydroxyphenyl)ethoxy]-2-oxoethyl}-2-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4-dihydro-2H-pyran-5-carboxylate C25H32O12 GMQXOLRKJQWPNB-MVVLSVRYSA-N methyl (4S,5E,6S)-5-ethylidene-4-[2-[2-(4-hydroxyphenyl)ethoxy]-2-oxoethyl]-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4H-pyran-3-carboxylate n.a. n.a. No No No No Yes No rxnAddEX38,rxnAdd192,rxnAdd193 PMDBD2001930 Vinylphenol Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 135442 n.a. n.a. 2-Ethenylphenol, 2-vinylphenol, 695-84-1, Vinylphenol, 2-HYDROXYSTYRENE, Phenol, 2-ethenyl-, Phenol, ethenyl-, 31257-96-2, 2-ethenyl-phenol, I4M2EJN11W, o-Vinylphenol, o-Hydroxystyrene, UNII-I4M2EJN11W, 2-vinyl-phenol, 2-ethenyl phenol, 2-hydroxy styrene, EINECS 250-539-2, SCHEMBL20076, DTXSID50873443, AKOS015995591, HS-5574, DB-261448, CS-0136689, FT-0675825, NS00022038, EN300-50361, E91838, Q27280437 C8H8O JESXATFQYMPTNL-UHFFFAOYSA-N 2-ethenylphenol n.a. n.a. No No No No Yes No rxnAdd230 PMDBD2001931 Naringenin + Neohesperidin Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No Yes No rxnAdd79 PMDBD2001932 Cyanidin 5-O-glucoside Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 15126294 n.a. n.a. Cyanidin 5-O-glucoside, CHEBI:80434, Q27149486, (2S,3R,4S,5S,6R)-2-[2-(3,4-dihydroxyphenyl)-3,7-dihydroxychromenylium-5-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol C21H21O11+ PWORRIQTGXEXBH-GQUPQBGVSA-O (2S,3R,4S,5S,6R)-2-[2-(3,4-dihydroxyphenyl)-3,7-dihydroxychromenylium-5-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol n.a. n.a. No No No No Yes No rxn07699 PMDBD2001933 3-Methylcatechol Dietary Substance n.a. n.a. n.a. n.a. n.a. n.a. 340 n.a. n.a. "3-methylcatechol, 488-17-5, 3-methylbenzene-1,2-diol, 2,3-dihydroxytoluene, 3-Methylpyrocatechol, 1,2-Benzenediol, 3-methyl-, 2,3-Toluenediol, 1,2-Dihydroxy-3-methylbenzene, Pyrocatechol, 3-methyl-, Catechol, 3-methyl-, 3-Methyl-1,2-benzenediol, Dihydroxytoluene, 3-Methyl-1,2-dihydroxybenzene, 3-METHYL CATECHOL, 3-METHYL-BENZENE-1,2-DIOL, NSC 66523, CHEBI:18404, UNII-0HUZ4Q9R8C, EINECS 207-672-6, 0HUZ4Q9R8C, BRN 0774602, AI3-61047, NSC-66523, CHEMBL1173328, NSC 66523-d3, 4-06-00-05860 (Beilstein Handbook Reference), MFCD00016435, 1,2-Dihydroxy-3-methylbenzene; 2,3-Dihydroxytoluene; 2,3-Toulenediol; 3-Methyl-1,2-benzenediol; 3-Methylpyrocatechol, 2, 3-Toluenediol, 3-Methylcatechol, 98%, 2-Hydroxy-3-methylphenol, bmse000334, WLN: QR BQ C1, SCHEMBL67369, DTXSID9060071, SCHEMBL10526382, 1, 2-Dihydroxy-3-methylbenzene, 3-Methyl-1, 2-dihydroxybenzene, 3-methyl-1,2-dihydroxy benzene, HMS1789D12, NSC66523, STR09012, BDBM50548725, AKOS000121356, CS-W013531, DB03454, HY-W012815, AC-22587, AM808211, PD007518, SY034740, DB-028549, FT-0612043, FT-0671610, M0184, NS00031826, EN300-16625, C02923, A827610, W-106038, Q15303191, Z56347229, F0001-1277, 2,3-Dihydroxytoluene; 3-Methylbenzene-1,2-diol;3-Methylbenzene-1,2-diol, InChI=1/C7H8O2/c1-5-3-2-4-6(8)7(5)9/h2-4,8-9H,1H" C7H8O2 PGSWEKYNAOWQDF-UHFFFAOYSA-N 3-methylbenzene-1,2-diol n.a. n.a. No No No No Yes No rxnAdd225 PMDBD2001934 Sulfinpyrazone_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_spz_glc(e),SPZ_GLC_GLCAASE,SPZ_GLC_GLCAASEe,SPZ_GLC_GLCAASEepp,SPZ_GLCabc,SPZ_GLCt,SPZ_GLCt2,SPZ_GLCt2pp,SPZ_GLCtex PMDBD2001935 5-Hydroxy-Sulfapyridine_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes 5OH_SULFP_GLC_GLCAASE,5OH_SULFP_GLC_GLCAASEe,5OH_SULFP_GLC_GLCAASEepp,5OH_SULFP_GLCabc,5OH_SULFP_GLCt,5OH_SULFP_GLCt2,5OH_SULFP_GLCt2pp,5OH_SULFP_GLCtex,EX_5oh_sulfp_glc(e) PMDBD2001936 Amiodarone_c_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes AMIO_C_GLC_GLCAASE,AMIO_C_GLC_GLCAASEe,AMIO_C_GLC_GLCAASEepp,AMIO_C_GLCabc,AMIO_C_GLCt,AMIO_C_GLCt2,AMIO_C_GLCt2pp,AMIO_C_GLCtex,EX_amio_c_glc(e) PMDBD2001937 Tolfenamic Acid_m3 Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_tlf_a_m3(e),TLF_A_M3_GLCAASE,TLF_A_M3_GLCAASEe,TLF_A_M3_GLCAASEepp,TLF_A_M3abc,TLF_A_M3t,TLF_A_M3t2,TLF_A_M3t2pp,TLF_A_M3tex PMDBD2001938 4-AminobenzoylGlycinecine Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes AMN_B_GLY_GLC_GLCAASE,AMN_B_GLY_GLC_GLCAASEe,AMN_B_GLY_GLC_GLCAASEepp,AMN_B_GLYte,AMN_B_GLYtepp,AMN_B_GLYtex,EX_amn_b_gly(e) PMDBD2001939 SCH 57871_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_sch_57871_glc(e),SCH_57871_GLC_GLCAASE,SCH_57871_GLC_GLCAASEe,SCH_57871_GLC_GLCAASEepp,SCH_57871_GLCabc,SCH_57871_GLCt,SCH_57871_GLCt2,SCH_57871_GLCt2pp,SCH_57871_GLCtex PMDBD2001940 Di-N-Desethylamiodarone (DDEA) _glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes DDEA_GLC_GLCAASE,DDEA_GLC_GLCAASEe,DDEA_GLC_GLCAASEepp,DDEA_GLCabc,DDEA_GLCt,DDEA_GLCt2,DDEA_GLCt2pp,DDEA_GLCtex,EX_ddea_glc(e) PMDBD2001941 Acetaminophenglu Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes ACMPGLU_GLCAASE,ACMPGLU_GLCAASEe,ACMPGLU_GLCAASEepp,ACMPGLUabc,ACMPGLUt,ACMPGLUt2,ACMPGLUt2pp,ACMPGLUtex,EX_acmpglu(e) PMDBD2001942 Galactose Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. 6036 n.a. n.a. "D-Gal, D-Galactopyranose, D-Galactopyranoside, D-Galactose, Gal, Galactopyranose, Galactopyranoside, Galactose, 10257-28-0, Galactose, pure, (3R,4S,5R,6R)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol, CHEBI:4139, brain sugar, (+)-Galactose, EINECS 233-595-2, cerebrose, AI3-18440, D-galacto-hexose, DTXSID001015860, NSC 8102, CHEBI:12936, NSC-8102, D Galactose, D-Glucose-2-13C, SMR000857326, UNII-7IOF6H4H77, Galaktose, galacto-hexose, D-aGalactopyranose, Galactose; D-Galactopyranose; D(+)-Galactose; GSK 620104E; Allopurinol related, 40825-89-6, D-Galactose (9CI), Galactose, D- (8CI), Epitope ID:141794, D-Galactose 1000 microg/mL in Methanol:Water, SCHEMBL38935, MLS001335983, MLS001335984, CHEMBL195923, DTXCID903088, CHEBI:28260, BDBM228805, DTXCID601437050, HMS2230N07, MFCD00006969, s3849, AKOS030573864, CCG-266426, NCGC00166082-01, AS-46931, CS-0204480, G0008, NS00087175, C00124, EN300-135967, F10950, G-1701, O_FULL_10000000000000_GS_94, Q27106307, Z1665647488, (3R,4S,5R,6R)-6-methyloltetrahydropyran-2,3,4,5-tetrol, WURCS=2.0/1,1,0/(a2112h-1x_1-5)/1/" C6H12O6 WQZGKKKJIJFFOK-SVZMEOIVSA-N (3R,4S,5R,6R)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol n.a. n.a. No No No No No Yes GALt1r PMDBD2001943 atorvasN-(2-Methyl-3-Chlorophenyl)-Anthranilic Acidin-ether-glucuronide -G1 Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes ATVETHGLUC_GLCAASE,ATVETHGLUC_GLCAASEe,ATVETHGLUC_GLCAASEepp,ATVETHGLUCabc,ATVETHGLUCt,ATVETHGLUCt2,ATVETHGLUCt2pp,ATVETHGLUCtex,EX_atvethgluc(e) PMDBD2001944 Sitagliptin_m3 Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_stg_m3(e),STG_M3_GLCAASE,STG_M3_GLCAASEe,STG_M3_GLCAASEepp,STG_M3abc,STG_M3t,STG_M3t2,STG_M3t2pp,STG_M3tex PMDBD2001945 cerivasN-(2-Methyl-3-Chlorophenyl)-Anthranilic Acidin-M1-glucuronide Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes CVM1GLUC_GLCAASE,CVM1GLUC_GLCAASEe,CVM1GLUC_GLCAASEepp,CVM1GLUCabc,CVM1GLUCt,CVM1GLUCt2,CVM1GLUCt2pp,CVM1GLUCtex,EX_cvm1gluc(e) PMDBD2001946 Tolfenamic Acid_m5b Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_tlf_a_m5b(e),TLF_A_M5B_GLCAASE,TLF_A_M5B_GLCAASEe,TLF_A_M5B_GLCAASEepp,TLF_A_M5Babc,TLF_A_M5Bt,TLF_A_M5Bt2,TLF_A_M5Bt2pp,TLF_A_M5Btex PMDBD2001947 S-4-Hydroxywarfarin_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_S_4oh_warf_glc(e),S_4OH_WARF_GLC_GLCAASE,S_4OH_WARF_GLC_GLCAASEe,S_4OH_WARF_GLC_GLCAASEepp,S_4OH_WARF_GLCabc,S_4OH_WARF_GLCt,S_4OH_WARF_GLCt2,S_4OH_WARF_GLCt2pp,S_4OH_WARF_GLCtex PMDBD2001948 4-AminobenzoylGlycinecine_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes AMN_B_GLY_GLC_GLCAASE,AMN_B_GLY_GLC_GLCAASEe,AMN_B_GLY_GLC_GLCAASEepp,AMN_B_GLY_GLCabc,AMN_B_GLY_GLCt,AMN_B_GLY_GLCt2,AMN_B_GLY_GLCt2pp,AMN_B_GLY_GLCtex,EX_amn_b_gly_glc(e) PMDBD2001949 dihydro_Digoxin Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes DIHYDRO_DIGOXINc,DIHYDRO_DIGOXINt2r,EX_dihydro_digoxin(e) PMDBD2001950 Tolcapone?_ac_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_tolcp_ac_glc(e),TOLCP_AC_GLC_GLCAASE,TOLCP_AC_GLC_GLCAASEe,TOLCP_AC_GLC_GLCAASEepp,TOLCP_AC_GLCabc,TOLCP_AC_GLCt,TOLCP_AC_GLCt2,TOLCP_AC_GLCt2pp,TOLCP_AC_GLCtex PMDBD2001951 4-Hydroxydiclofenac_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes 4OH_DCF_GLC_GLCAASE,4OH_DCF_GLC_GLCAASEe,4OH_DCF_GLC_GLCAASEepp,4OH_DCF_GLCabc,4OH_DCF_GLCt,4OH_DCF_GLCt2,4OH_DCF_GLCt2pp,4OH_DCF_GLCtex,EX_4oh_dcf_glc(e) PMDBD2001952 Proline Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. 145742 n.a. n.a. "L-proline, 147-85-3, proline, L-(-)-Proline, (2S)-pyrrolidine-2-carboxylic acid, (S)-Pyrrolidine-2-carboxylic acid, 2-pyrrolidinecarboxylic acid, H-Pro-OH, (-)-Proline, (-)-(S)-Proline, Prolinum, (S)-2-Pyrrolidinecarboxylic acid, (-)-2-Pyrrolidinecarboxylic acid, prolina, (S)-Proline, L-Pyrrolidine-2-carboxylic acid, L-alpha-Pyrrolidinecarboxylic acid, (S)-2-Carboxypyrrolidine, L-Prolin, Prolinum [Latin], Prolina [Spanish], Proline, L-, Proline (VAN), (L)-PROLINE, FEMA No. 3319, Proline [USAN:INN], FEMA Number 3319, 2-Pyrrolidinecarboxylic acid, (S)-, PRO (IUPAC abbreviation), CB 1707, (S)-(-)-Proline, HSDB 1210, AI3-26710, UNII-9DLQ4CIU6V, 9DLQ4CIU6V, EINECS 205-702-2, NSC 46703, pro, CHEBI:17203, MFCD00064318, NSC-46703, 37159-97-0, CHEMBL54922, L-2-pyrrolidinecarboxylic acid, DTXSID5044021, EC 205-702-2, Prolinum (Latin), prol, 4305-67-3, Proline (L-Proline), PROLINE (II), PROLINE [II], PROLINE (MART.), PROLINE [MART.], PROLINE (EP MONOGRAPH), PROLINE [EP MONOGRAPH], PROLINE (USP MONOGRAPH), PROLINE [USP MONOGRAPH], Carboxypyrrolidine, L-(2,3-3H)Proline, Proline (USP), (2S)-pyrrolidin-1-ium-2-carboxylate, L-Proline, labeled with carbon-14, racemic proline, rac-proline, NSC46703, s-proline, 3h-l-proline, L-Proline;, Proline, (S)-pyrrolidine-2-carboxylic acid, (-)-2-Pyrrolidinecarboxylic acid, (-)-Proline, (S)-(-)-Proline, (S)-2-Carboxypyrrolidine, (S)-2-Pyrrolidinecarboxylic acid, (S)-Proline, 2-Pyrrolidinecarboxylic acid, Carboxypyrrolidine, L-(-)-Proline, L-Pyrrolidine-2-carboxylic acid, L-alpha-Pyrrolidinecarboxylic acid, NSC 46703, H-Pro, (2S)-proline, Pro-OH, L-Proline,(S), L-Pro-OH, (-)-Proline (S)-2-Carboxypyrrolidine, 2-Pyrrolidinecarboxylate, L-Proline (JP17), PROLINE [VANDF], PROLINE [HSDB], PROLINE [USAN], PROLINE [INN], PROLINE [MI], L-PROLINE [FCC], L-PROLINE [JAN], L-PROLINE [FHFI], PROLINE [WHO-DD], bmse000047, bmse000947, (2S)-2-carboxypyrrolidine, SCHEMBL7792, L-PROLINE [USP-RS], (S)-2-Pyrralidinecarboxylate, (S)-2-Pyrrolidinecarboxylate, (-)-2-Pyrrolidinecarboxylate, (S)-(-)-PROLIN, GTPL3314, DTXCID3024021, L-Proline, 99%, FCC, FG, (S)-2-Pyrralidinecarboxylic acid, pyrrolidin-2-(S)-carboxylic acid, Pharmakon1600-01301007, pyrrolidine-2-(S)-carboxylic acid, BCP25292, HY-Y0252, (S) -pyrrolidine-2-carboxylic acid, L-Proline, >=99.0% (NT), (S)-(-)-Pyrrolidine-2-carboxylate, BDBM50000100, NCGC00014017, NSC760114, s5629, AKOS010372120, AKOS015856025, CCG-214709, CS-W019861, DB00172, NSC-760114, (S)-(-)-Pyrrolidine-2-carboxylic acid, NCGC00014017-02, NCGC00014017-03, NCGC00097126-01, AC-11190, AS-10803, L-Proline, BioUltra, >=99.5% (NT), DB-029981, L-Proline, SAJ special grade, >=99.0%, AM20080359, L-Proline, Vetec(TM), 98.5-101.5%, NS00074201, P0481, EN300-52624, L-Proline, Vetec(TM) reagent grade, >=99%, C00148, D00035, L-Proline, ReagentPlus(R), >=99% (HPLC), M02947, P17692, Q-201327, L-Proline, certified reference material, TraceCERT(R), Q20035886, A01B5B63-CC3D-4796-A7B4-C2DE26A6FA93, F0001-2348, Flavor and Extract Manufacturers' Association No. 3319, Proline, European Pharmacopoeia (EP) Reference Standard, Z756429958, L-Proline, United States Pharmacopeia (USP) Reference Standard, L-Proline, Pharmaceutical Secondary Standard; Certified Reference Material, L-Proline, from non-animal source, meets EP, USP testing specifications, suitable for cell culture" C5H9NO2 ONIBWKKTOPOVIA-BYPYZUCNSA-N (2S)-pyrrolidine-2-carboxylic acid n.a. n.a. No No No No No Yes PROPAT4tepp PMDBD2001953 atorvasN-(2-Methyl-3-Chlorophenyl)-Anthranilic Acidin-lactonegluc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes ATVLACGLUC_GLCAASE,ATVLACGLUC_GLCAASEe,ATVLACGLUC_GLCAASEepp,ATVLACGLUCabc,ATVLACGLUCt,ATVLACGLUCt2,ATVLACGLUCt2pp,ATVLACGLUCtex,EX_atvlacgluc(e) PMDBD2001954 Desmethylnoralfentanil (AM6)_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes AM6_GLC_GLCAASE,AM6_GLC_GLCAASEe,AM6_GLC_GLCAASEepp,AM6_GLCabc,AM6_GLCt,AM6_GLCt2,AM6_GLCt2pp,AM6_GLCtex,EX_am6_glc(e) PMDBD2001955 Gemfibrozil_mI Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_gmfl_mI(e),GMFL_MI_GLC_GLCAASE,GMFL_MI_GLC_GLCAASEe,GMFL_MI_GLC_GLCAASEepp,GMFL_MIte,GMFL_MItepp,GMFL_MItex PMDBD2001956 rosuvasN-(2-Methyl-3-Chlorophenyl)-Anthranilic Acidin Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_rsv(e),RSVGLUC_GLCAASE,RSVGLUC_GLCAASEe,RSVGLUC_GLCAASEepp,RSVte,RSVtepp,RSVtex PMDBD2001957 Acetyl 4-AminobenzoylGlycinecine Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes AC_AMN_B_GLY_GLC_GLCAASE,AC_AMN_B_GLY_GLC_GLCAASEe,AC_AMN_B_GLY_GLC_GLCAASEepp,AC_AMN_B_GLYte,AC_AMN_B_GLYtepp,AC_AMN_B_GLYtex,EX_ac_amn_b_gly(e) PMDBD2001958 Dextrorphan_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes DXO_GLC_GLCAASE,DXO_GLC_GLCAASEe,DXO_GLC_GLCAASEepp,DXO_GLCabc,DXO_GLCt,DXO_GLCt2,DXO_GLCt2pp,DXO_GLCtex,EX_dxo_glc(e) PMDBD2001959 atorvasN-(2-Methyl-3-Chlorophenyl)-Anthranilic Acidin-acid Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes ATVACIDte,ATVACIDtepp,ATVACIDtex,ATVETHGLUC_GLCAASE,ATVETHGLUC_GLCAASEe,ATVETHGLUC_GLCAASEepp,EX_atvacid(e) PMDBD2001960 Gemfibrozil_mII_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_gmfl_mII_glc(e),GMFL_MII_GLC_GLCAASE,GMFL_MII_GLC_GLCAASEe,GMFL_MII_GLC_GLCAASEepp,GMFL_MII_GLCabc,GMFL_MII_GLCt,GMFL_MII_GLCt2,GMFL_MII_GLCt2pp,GMFL_MII_GLCtex PMDBD2001961 simvasN-(2-Methyl-3-Chlorophenyl)-Anthranilic Acidin dihydroxy acid form Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_smvacid(e),SIMVGLUC_GLCAASE,SIMVGLUC_GLCAASEe,SIMVGLUC_GLCAASEepp,SMVACIDte,SMVACIDtepp,SMVACIDtex PMDBD2001962 Gemfibrozil_mII Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_gmfl_mII(e),GMFL_MII_GLC_GLCAASE,GMFL_MII_GLC_GLCAASEe,GMFL_MII_GLC_GLCAASEepp,GMFL_MIIte,GMFL_MIItepp,GMFL_MIItex PMDBD2001963 pravasN-(2-Methyl-3-Chlorophenyl)-Anthranilic Acidin Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_pvs(e),PVSGLUC_GLCAASE,PVSGLUC_GLCAASEe,PVSGLUC_GLCAASEepp,PVSte,PVStepp,PVStex PMDBD2001964 Propranolol_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_propl_glc(e),PROPL_GLC_GLCAASE,PROPL_GLC_GLCAASEe,PROPL_GLC_GLCAASEepp,PROPL_GLCabc,PROPL_GLCt,PROPL_GLCt2,PROPL_GLCt2pp,PROPL_GLCtex PMDBD2001965 Morphine_3glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_mrphn_3glc(e),MRPHN_3GLC_GLCAASE,MRPHN_3GLC_GLCAASEe,MRPHN_3GLC_GLCAASEepp,MRPHN_3GLCabc,MRPHN_3GLCt,MRPHN_3GLCt2,MRPHN_3GLCt2pp,MRPHN_3GLCtex PMDBD2001966 atorvasN-(2-Methyl-3-Chlorophenyl)-Anthranilic Acidin-lactone Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes ATVACYLGLUC_GLCAASE,ATVACYLGLUC_GLCAASEe,ATVACYLGLUC_GLCAASEepp,ATVLACGLUC_GLCAASE,ATVLACGLUC_GLCAASEe,ATVLACGLUC_GLCAASEepp,ATVLACte,ATVLACtepp,ATVLACtex,EX_atvlac(e) PMDBD2001967 Estriolglc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes ESTRIOLGLC_GLCAASE,ESTRIOLGLC_GLCAASEe,ESTRIOLGLC_GLCAASEepp,ESTRIOLGLCabc,ESTRIOLGLCt2,ESTRIOLGLCt2pp,ESTRIOLGLCtex,estriolup,EX_estriolglc(e) PMDBD2001968 (Bis-(P-Hydroxyphenyl)-Pyridyl-2-Methane_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes BHPM_GLC_GLCAASE,BHPM_GLC_GLCAASEe,BHPM_GLC_GLCAASEepp,BHPM_GLCabc,BHPM_GLCt,BHPM_GLCt2,BHPM_GLCt2pp,BHPM_GLCtex,EX_bhpm_glc(e) PMDBD2001969 fluvasN-(2-Methyl-3-Chlorophenyl)-Anthranilic Acidintet Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_fvstet(e),FVSTETGLU_GLCAASE,FVSTETGLU_GLCAASEe,FVSTETGLU_GLCAASEepp,FVSTETte,FVSTETtepp,FVSTETtex PMDBD2001970 Etravarine Monohydroxylated (M1, M2, M3)_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_oh_etr_glc(e),OH_ETR_GLC_GLCAASE,OH_ETR_GLC_GLCAASEe,OH_ETR_GLC_GLCAASEepp,OH_ETR_GLCabc,OH_ETR_GLCt,OH_ETR_GLCt2,OH_ETR_GLCt2pp,OH_ETR_GLCtex PMDBD2001971 Tolfenamic Acid_m5 Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_tlf_a_m5(e),TLF_A_M5_GLCAASE,TLF_A_M5_GLCAASEe,TLF_A_M5_GLCAASEepp,TLF_A_M5abc,TLF_A_M5B_GLCAASE,TLF_A_M5B_GLCAASEe,TLF_A_M5B_GLCAASEepp,TLF_A_M5t,TLF_A_M5t2,TLF_A_M5t2pp,TLF_A_M5te,TLF_A_M5tepp,TLF_A_M5tex PMDBD2001972 cerivasN-(2-Methyl-3-Chlorophenyl)-Anthranilic Acidin-M23 Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes CRVSM23te,CVM23GLUC_GLCAASE,CVM23GLUC_GLCAASEe,CVM23GLUC_GLCAASEepp,EX_crvsm23(e) PMDBD2001973 Probenecid_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_prob_glc(e),PROB_GLC_GLCAASE,PROB_GLC_GLCAASEe,PROB_GLC_GLCAASEepp,PROB_GLCabc,PROB_GLCt,PROB_GLCt2,PROB_GLCt2pp,PROB_GLCtex PMDBD2001974 Oxidation Product Of M3 M6_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes AMNTD_M6_GLC_GLCAASE,AMNTD_M6_GLC_GLCAASEe,AMNTD_M6_GLC_GLCAASEepp,AMNTD_M6_GLCabc,AMNTD_M6_GLCt,AMNTD_M6_GLCt2,AMNTD_M6_GLCt2pp,AMNTD_M6_GLCtex,EX_amntd_m6_glc(e) PMDBD2001975 5-hydroxy-fluvasN-(2-Methyl-3-Chlorophenyl)-Anthranilic Acidin Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes 5OHFVSGLU_GLCAASE,5OHFVSGLU_GLCAASEe,5OHFVSGLU_GLCAASEepp,5OHFVSte,5OHFVStepp,5OHFVStex,EX_5ohfvs(e) PMDBD2001976 Tolfenamic Acid_m4a Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_tlf_a_m4a(e),TLF_A_M4A_GLCAASE,TLF_A_M4A_GLCAASEe,TLF_A_M4A_GLCAASEepp,TLF_A_M4Aabc,TLF_A_M4At,TLF_A_M4At2,TLF_A_M4At2pp,TLF_A_M4Atex PMDBD2001977 Indinavir_m1 Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_inv_m1(e),INV_M1_GLCAASE,INV_M1_GLCAASEe,INV_M1abc,INV_M1t,INV_M1t2,INV_M1t2pp,INV_M1tex PMDBD2001978 4-Hydroxyvoriconazole_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes 4OH_VCZ_GLC_GLCAASE,4OH_VCZ_GLC_GLCAASEe,4OH_VCZ_GLC_GLCAASEepp,4OH_VCZ_GLCabc,4OH_VCZ_GLCt,4OH_VCZ_GLCt2,4OH_VCZ_GLCt2pp,4OH_VCZ_GLCtex,EX_4oh_vcz_glc(e) PMDBD2001979 simvasN-(2-Methyl-3-Chlorophenyl)-Anthranilic Acidin-acyl-glucuronide Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_simvgluc(e),SIMVGLUC_GLCAASE,SIMVGLUC_GLCAASEe,SIMVGLUC_GLCAASEepp,SIMVGLUCabc,SIMVGLUCt,SIMVGLUCt2,SIMVGLUCt2pp,SIMVGLUCtex PMDBD2001980 Bosentan_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes BSN_GLC_GLCAASE,BSN_GLC_GLCAASEe,BSN_GLC_GLCAASEepp,BSN_GLCabc,BSN_GLCt,BSN_GLCt2,BSN_GLCt2pp,BSN_GLCtex,EX_bsn_glc(e) PMDBD2001981 Tolfenamic Acid_1x Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_tlf_a_1x(e),TLF_A_1Xte,TLF_A_1Xtepp,TLF_A_1Xtex,TLF_A_M9_GLCAASE,TLF_A_M9_GLCAASEe,TLF_A_M9_GLCAASEepp PMDBD2001982 Indomethacin_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_imn_glc(e),IMN_GLC_GLCAASE,IMN_GLC_GLCAASEe,IMN_GLC_GLCAASEepp,IMN_GLCabc,IMN_GLCt,IMN_GLCt2,IMN_GLCt2pp,IMN_GLCtex PMDBD2001983 Midazolam_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_mdz_glc(e),MDZ_GLC_GLCAASE,MDZ_GLC_GLCAASEe,MDZ_GLC_GLCAASEepp,MDZ_GLCabc,MDZ_GLCt,MDZ_GLCt2,MDZ_GLCt2pp,MDZ_GLCtex PMDBD2001984 Isosorbide 5-Mononitrate _glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_isosorbide_5mn_glc(e),ISOSORBIDE_5MN_GLC_GLCAASE,ISOSORBIDE_5MN_GLC_GLCAASEe,ISOSORBIDE_5MN_GLC_GLCAASEepp,ISOSORBIDE_5MN_GLCabc,ISOSORBIDE_5MN_GLCt,ISOSORBIDE_5MN_GLCt2,ISOSORBIDE_5MN_GLCt2pp,ISOSORBIDE_5MN_GLCtex PMDBD2001985 Tolfenamic Acid_m1 Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_tlf_a_m1(e),TLF_A_M1_GLCAASE,TLF_A_M1_GLCAASEe,TLF_A_M1_GLCAASEepp,TLF_A_M1abc,TLF_A_M1t,TLF_A_M1t2,TLF_A_M1t2pp,TLF_A_M1tex PMDBD2001986 R-8-Hydroxywarfarin_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_R_8oh_warf_glc(e),R_8OH_WARF_GLC_GLCAASE,R_8OH_WARF_GLC_GLCAASEe,R_8OH_WARF_GLC_GLCAASEepp,R_8OH_WARF_GLCabc,R_8OH_WARF_GLCt,R_8OH_WARF_GLCt2,R_8OH_WARF_GLCt2pp,R_8OH_WARF_GLCtex PMDBD2001987 Deleobuvir_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes DLB_GLC_GLCAASE,DLB_GLC_GLCAASEe,DLB_GLC_GLCAASEepp,DLB_GLCabc,DLB_GLCt,DLB_GLCt2,DLB_GLCt2pp,DLB_GLCtex,EX_dlb_glc(e) PMDBD2001988 Tolfenamic Acid_1a Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_tlf_a_1a(e),TLF_A_1Ate,TLF_A_1Atepp,TLF_A_1Atex,TLF_A_M4_GLCAASE,TLF_A_M4_GLCAASEe,TLF_A_M4_GLCAASEepp,TLF_A_M4A_GLCAASE,TLF_A_M4A_GLCAASEe,TLF_A_M4A_GLCAASEepp PMDBD2001989 7-beta-OH-gliclazideglc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes 7BHGLZ_GLCAASE,7BHGLZ_GLCAASEe,7BHGLZ_GLCAASEepp,7BHGLZGLCt2pp,7BHGLZGLCte,7BHGLZGLCtex,EX_7bhglzglc(e) PMDBD2001990 Acetaminophen_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes ACMP_GLC_GLCAASE,ACMP_GLC_GLCAASEe,ACMP_GLC_GLCAASEepp,ACMP_GLCabc,ACMP_GLCt,ACMP_GLCt2,ACMP_GLCt2pp,ACMP_GLCtex,EX_acmp_glc(e) PMDBD2001991 Estradiolglc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes ESTRAABCtc,ESTRADIOLGLC_GLCAASE,ESTRADIOLGLC_GLCAASEe,ESTRADIOLGLC_GLCAASEepp,ESTRADIOLGLCt2i,ESTRADIOLGLCt2ipp,ESTRADIOLGLCtex,ESTRADIOLup,EX_estradiolglc(e) PMDBD2001992 cBenzoate_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes CBZ_GLC_GLCAASE,CBZ_GLC_GLCAASEe,CBZ_GLCabc,CBZ_GLCt,CBZ_GLCt2,EX_cbz_glc(e) PMDBD2001993 Sitagliptin_m4 Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_stg_m4(e),STG_M4_GLCAASE,STG_M4_GLCAASEe,STG_M4_GLCAASEepp,STG_M4abc,STG_M4t,STG_M4t2,STG_M4t2pp,STG_M4tex PMDBD2001994 L-Dopamine Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. 681 n.a. n.a. "dopamine, 4-(2-Aminoethyl)benzene-1,2-diol, 51-61-6, 3-Hydroxytyramine, Oxytyramine, Hydroxytyramin, Dopamin, 3,4-dihydroxyphenethylamine, hydroxytyramine, intropin, 4-(2-Aminoethyl)catechol, 2-(3,4-dihydroxyphenyl)ethylamine, Dopaminum, Dophamine, 4-(2-Aminoethyl)pyrocatechol, Dopamina, 3,4-Dihydroxyphenylethylamine, 4-(2-Aminoethyl)-1,2-benzenediol, L-DOPAMINE, ASL 279, Pyrocatechol, 4-(2-aminoethyl)-, 1,2-Benzenediol, 4-(2-aminoethyl)-, Dopaminum [INN-Latin], Dopamina [INN-Spanish], Dobutamine a, A-dopamine, 3-Hydroxtyramine, KW-3-060, alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane, 4-(2-aminoethyl)-pyrocatechol, NSC 173182, HSDB 3068, UNII-VTD58H1Z2X, EINECS 200-110-0, VTD58H1Z2X, Dopamine (INN), NSC-173182, a-(3,4-Dihydroxyphenyl)-b-aminoethane, DTXSID6022420, CHEBI:18243, 4-(2-Aminoethyl)-1,2-bezenediol, DTXCID602420, 50444-17-2, Revimine, 3,4 Dihydroxyphenethylamine, LDP, NCGC00015519-05, Dopaminum (INN-Latin), Pyrocatechol, 4-(2-aminoethyl)- (8CI), DOPAMINE [INN], Dopamina (INN-Spanish), Dopamine [INN:BAN], .alpha.-(3,4-Dihydroxyphenyl)-.beta.-aminoethane, (3H)-Dopamine, Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride, 62-31-7 (HYDROCHLORIDE), CAS-51-61-6, Medopa (TN), NSC169105, NSC173182, 1,2-Benzenediol, 4-(2-aminoethyl)- (9CI), NORADRENALINE TARTRATE IMPURITY C (EP IMPURITY), NORADRENALINE TARTRATE IMPURITY C [EP IMPURITY], Intropin [*hydrochloride*], 4-(2-Aminoethyl)-1,2-benzenediol hydrochloride, 4-(2-aminoethyl)benzene-1,2-diol;hydrochloride, DOBUTAMINE HYDROCHLORIDESPECIFIED IMPURITY A (EP IMPURITY), DOBUTAMINE HYDROCHLORIDESPECIFIED IMPURITY A [EP IMPURITY], SR-01000075366, .beta.-(3,4-Dihydroxyphenyl)ethylamine hydrochloride, m-Hydroxytyramine-, Dopamine (USAN)(*hydrochloride*), Dopamine1515, IP 498, Intropin (Salt/Mix), Spectrum_001012, 1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium, DOPAMINE [HSDB], DOPAMINE [MI], CHEMBL59, DOPAMINE [VANDF], Spectrum2_001023, Spectrum3_000406, Spectrum4_000525, Spectrum5_000945, Lopac-H-8502, Biomol-NT_000001, bmse000909, bmse000933, DOPAMINE [WHO-DD], SCHEMBL8505, 1, 4-(2-aminoethyl)-, Lopac0_000586, Oprea1_088821, BSPBio_001932, GTPL940, KBioGR_001129, KBioGR_002388, KBioGR_002484, KBioSS_001492, KBioSS_002393, KBioSS_002491, cid_65340, BIDD:ER0506, DivK1c_000780, SPECTRUM1505155, SPBio_001205, BPBio1_001123, 153C5321-5FEE-4B0B-8925-F388F0EEEBD1, BDBM55121, KBio1_000780, KBio2_001492, KBio2_002388, KBio2_002484, KBio2_004060, KBio2_004956, KBio2_005052, KBio2_006628, KBio2_007524, KBio2_007620, KBio3_001152, KBio3_002867, KBio3_002962, cMAP_000036, cMAP_000065, NINDS_000780, HMS3743I03, AMY40803, BCP34189, Tox21_110167, 2-(3, 4-Dihydroxyphenyl)ethylamine, 2-(3,4-dihydroxyphenyl) ethylamine, BBL013043, MFCD00130258, STK301601, 3,4-DihydroxyphenylA currencythylamin, AKOS003790978, Tox21_110167_1, CCG-204675, DB00988, FS-5341, SDCCGSBI-0050568.P005, 2-(3,4-Dihydroxyphenyl)-1-ethanamine, 4-(2-Amino-ethyl)-benzene-1,2-diol, 4-(2-Aminoethyl)-1,2-benzenediol #, IDI1_000780, UPCMLD0ENAT5885989:001, NCGC00015519-01, NCGC00015519-02, NCGC00015519-03, NCGC00015519-04, NCGC00015519-07, NCGC00015519-08, NCGC00015519-09, NCGC00015519-10, NCGC00015519-11, NCGC00015519-25, NCGC00096050-01, NCGC00096050-02, NCGC00096050-03, NCGC00096050-04, NCGC00096050-05, BP-23276, 4-(2-aminoethyl)pyrocatechol;hydrochloride, SBI-0050568.P004, benzene, 1-(2-amino)ethyl-3,4-dihydroxy-, FT-0698513, NS00000608, EN300-35022, C03758, D07870, F21485, 4-(2-azanylethyl)benzene-1,2-diol;hydrochloride, AB00053463-12, AB00053463_13, AB00053463_14, L000232, Q170304, SR-01000075366-7, DOBUTAMINE HYDROCHLORIDE IMPURITY A [EP IMPURITY], Oseltamivir-d3;Hydroxytyramin;4-(2-Aminoethyl)benzene-1,2-diol, 86389-83-5" C8H11NO2 VYFYYTLLBUKUHU-UHFFFAOYSA-N 4-(2-aminoethyl)benzene-1,2-diol n.a. n.a. No No No No No Yes 34DHPHEt2,3HLYTCL,DOPA34DHPHEt,DOPA34DHPHEt6,EX_34dhphe(e) PMDBD2001995 SN-38 (active me1,2,4-Triaminobenzeneolite of irinotecan) Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_sn38(e),SN38G_GLCAASE,SN38G_GLCAASEe,SN38G_GLCAASEepp,SN38te,SN38tepp,SN38tex PMDBD2001996 Hesperetin_3_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_hst_3_glc(e),HST_3_GLC_GLCAASE,HST_3_GLC_GLCAASEe,HST_3_GLC_GLCAASEepp,HST_3_GLCabc,HST_3_GLCt,HST_3_GLCt2,HST_3_GLCt2pp,HST_3_GLCte,HST_3_GLCtepp,HST_3_GLCtex,HST_37_DIGLC_GLCAASE2,HST_37_DIGLC_GLCAASEe2,HST_37_DIGLC_GLCAASEe2pp PMDBD2001997 odsm_eGalantamine_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_odsm_egltmn_glc(e),ODSM_EGLTMN_GLC_GLCAASE,ODSM_EGLTMN_GLC_GLCAASEe,ODSM_EGLTMN_GLC_GLCAASEepp,ODSM_EGLTMN_GLCabc,ODSM_EGLTMN_GLCt,ODSM_EGLTMN_GLCt2,ODSM_EGLTMN_GLCt2pp,ODSM_EGLTMN_GLCtex PMDBD2001998 Eltrombopag_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes ELTR_GLC_GLCAASE,ELTR_GLC_GLCAASEe,ELTR_GLC_GLCAASEepp,ELTR_GLCabc,ELTR_GLCt,ELTR_GLCt2,ELTR_GLCt2pp,ELTR_GLCtex,EX_eltr_glc(e) PMDBD2001999 Sulfathiazole_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_sftz_glc(e),SFTZ_GLC_GLCAASE,SFTZ_GLC_GLCAASEe,SFTZ_GLC_GLCAASEepp,SFTZ_GLCabc,SFTZ_GLCt,SFTZ_GLCt2,SFTZ_GLCt2pp,SFTZ_GLCtex PMDBD2002000 Donepezil Me1,2,4-Triaminobenzeneolite M9 Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes DNPZ_M13_GLCAASE,DNPZ_M13_GLCAASEe,DNPZ_M13_GLCAASEepp,DNPZ_M14_GLCAASE,DNPZ_M14_GLCAASEe,DNPZ_M14_GLCAASEepp,DNPZ_M9te,DNPZ_M9tepp,DNPZ_M9tex,EX_dnpz_m9(e) PMDBD2002001 Alpha-Hydroxyalprazolam_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes ALPZ_AOH_GLC_GLCAASE,ALPZ_AOH_GLC_GLCAASEe,ALPZ_AOH_GLC_GLCAASEepp,ALPZ_AOH_GLCabc,ALPZ_AOH_GLCt,ALPZ_AOH_GLCt2,ALPZ_AOH_GLCt2pp,ALPZ_AOH_GLCtex,EX_alpz_aoh_glc(e) PMDBD2002002 6-beta-OH-gliclazideglc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes 6BHGLZGLC_GLCAASE,6BHGLZGLC_GLCAASEe,6BHGLZGLC_GLCAASEepp,6BHGLZGLCabc,6BHGLZGLCt,6BHGLZGLCt2,6BHGLZGLCt2pp,6BHGLZGLCtex,EX_6bhglzglc(e) PMDBD2002003 cerivasN-(2-Methyl-3-Chlorophenyl)-Anthranilic Acidin-M1 Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes CRVSM1te,CVM1GLUC_GLCAASE,CVM1GLUC_GLCAASEe,CVM1GLUC_GLCAASEepp,EX_crvsm1(e) PMDBD2002004 Tolcapone?_am_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_tolcp_am_glc(e),TOLCP_AM_GLC_GLCAASE,TOLCP_AM_GLC_GLCAASEe,TOLCP_AM_GLC_GLCAASEepp,TOLCP_AM_GLCabc,TOLCP_AM_GLCt,TOLCP_AM_GLCt2,TOLCP_AM_GLCt2pp,TOLCP_AM_GLCtex PMDBD2002005 2 (E)-5-(2-Bromovinyl)Uracil Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes PYNP_BRV PMDBD2002006 Nisoldipine (M5)_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_nsldp_m5_glc(e),NSLDP_M5_GLC_GLCAASE,NSLDP_M5_GLC_GLCAASEe,NSLDP_M5_GLC_GLCAASEepp,NSLDP_M5_GLCabc,NSLDP_M5_GLCt,NSLDP_M5_GLCt2,NSLDP_M5_GLCt2pp,NSLDP_M5_GLCtex PMDBD2002007 Amiodarone_c Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes AMIO_C_GLC_GLCAASE,AMIO_C_GLC_GLCAASEe,AMIO_C_GLC_GLCAASEepp,AMIO_Cte,AMIO_Ctepp,AMIO_Ctex,EX_amio_c(e) PMDBD2002008 nChloramphenicol Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes CAP_NR,CAP_NRe,EX_nchlphncl(e),NCHLPHNCLtex,tNCAPpp PMDBD2002009 Donepezil Me1,2,4-Triaminobenzeneolite M14 Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes DNPZ_M14_GLCAASE,DNPZ_M14_GLCAASEe,DNPZ_M14_GLCAASEepp,DNPZ_M14abc,DNPZ_M14t,DNPZ_M14t2,DNPZ_M14t2pp,DNPZ_M14tex,EX_dnpz_m14(e) PMDBD2002010 Tolfenamic Acid_m5a Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_tlf_a_m5a(e),TLF_A_M5A_GLCAASE,TLF_A_M5A_GLCAASEe,TLF_A_M5A_GLCAASEepp,TLF_A_M5Aabc,TLF_A_M5At,TLF_A_M5At2,TLF_A_M5At2pp,TLF_A_M5Atex PMDBD2002011 Sulfinpyrazone_sfn_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_spz_sfn_glc(e),SPZ_SFN_GLC_GLCAASE,SPZ_SFN_GLC_GLCAASEe,SPZ_SFN_GLC_GLCAASEepp,SPZ_SFN_GLCabc,SPZ_SFN_GLCt,SPZ_SFN_GLCt2,SPZ_SFN_GLCt2pp,SPZ_SFN_GLCtex PMDBD2002012 Deaminated Amiodarone (M5)_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes DAA_GLC_GLCAASE,DAA_GLC_GLCAASEe,DAA_GLC_GLCAASEepp,DAA_GLCabc,DAA_GLCt,DAA_GLCt2,DAA_GLCt2pp,DAA_GLCtex,EX_daa_glc(e) PMDBD2002013 pitavasN-(2-Methyl-3-Chlorophenyl)-Anthranilic Acidin Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_ptvst(e),PTVSTGLUC_GLCAASEepp,PTVSTte,PTVSTtepp,PTVSTtex PMDBD2002014 Donepezil Me1,2,4-Triaminobenzeneolite M11 Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes DNPZ_M11_GLCAASE,DNPZ_M11_GLCAASEe,DNPZ_M11_GLCAASEepp,DNPZ_M11abc,DNPZ_M11t,DNPZ_M11t2,DNPZ_M11t2pp,DNPZ_M11tex,EX_dnpz_m11(e) PMDBD2002015 Gemfibrozil_mI_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_gmfl_mI_glc(e),GMFL_MI_GLC_GLCAASE,GMFL_MI_GLC_GLCAASEe,GMFL_MI_GLC_GLCAASEepp,GMFL_MI_GLCabc,GMFL_MI_GLCt,GMFL_MI_GLCt2,GMFL_MI_GLCt2pp,GMFL_MI_GLCtex PMDBD2002016 N-Hydroxylated Phenacetin_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_N_oh_phtn_glc(e),N_OH_PHTN_GLC_GLCAASE,N_OH_PHTN_GLC_GLCAASEe,N_OH_PHTN_GLC_GLCAASEepp,N_OH_PHTN_GLCabc,N_OH_PHTN_GLCt,N_OH_PHTN_GLCt2,N_OH_PHTN_GLCt2pp,N_OH_PHTN_GLCtex PMDBD2002017 5-hydroxy-fluvasN-(2-Methyl-3-Chlorophenyl)-Anthranilic Acidinglu Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes 5OHFVSGLU_GLCAASE,5OHFVSGLU_GLCAASEe,5OHFVSGLU_GLCAASEepp,5OHFVSGLUabc,5OHFVSGLUt,5OHFVSGLUt2,5OHFVSGLUt2pp,5OHFVSGLUtex,EX_5ohfvsglu(e) PMDBD2002018 Gemci1,2,4-Triaminobenzeneine (2',2'-difluorodeoxycytidine) Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes DFDCYTDabc,DFDCYTDabcpp,DFDCYTDD,DFDCYTDDe,DFDCYTDDepp,DFDCYTDtex,EX_dfdcytd(e) PMDBD2002019 Nw 1689 (N-Dealkylated Safinamide)_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_sfnd_1689_glc(e),SFND_1689_GLC_GLCAASE,SFND_1689_GLC_GLCAASEe,SFND_1689_GLC_GLCAASEepp,SFND_1689_GLCabc,SFND_1689_GLCt,SFND_1689_GLCt2,SFND_1689_GLCt2pp,SFND_1689_GLCtex PMDBD2002020 Estroneglc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes ESTRONEGLC_GLCAASE,ESTRONEGLC_GLCAASEe,ESTRONEGLC_GLCAASEepp,ESTRONEGLCabc,ESTRONEGLCt2,ESTRONEGLCt2pp,ESTRONEGLCtex,ESTRONEup,EX_estroneglc(e) PMDBD2002021 Digoxin_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes DIGOXIN_GLC_GLCAASE,DIGOXIN_GLC_GLCAASEe,DIGOXIN_GLC_GLCAASEepp,DIGOXIN_GLCabc,DIGOXIN_GLCt,DIGOXIN_GLCt2,DIGOXIN_GLCt2pp,DIGOXIN_GLCtex,EX_digoxin_glc(e) PMDBD2002022 Sulfinpyrazone_sfn Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_spz_sfn(e),SPZ_SFN_GLC_GLCAASE,SPZ_SFN_GLC_GLCAASEe,SPZ_SFN_GLC_GLCAASEepp,SPZ_SFNte,SPZ_SFNtepp,SPZ_SFNtex PMDBD2002023 Glycinecochenodeoxycholate Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes DGCHOLtex,EX_dgchol(e),GCDCHOLBHSe PMDBD2002024 P-Hydroxyphenobarbital_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_oh_pbl_glc(e),OH_PBL_GLC_GLCAASE,OH_PBL_GLC_GLCAASEe,OH_PBL_GLC_GLCAASEepp,OH_PBL_GLCabc,OH_PBL_GLCt,OH_PBL_GLCt2,OH_PBL_GLCt2pp,OH_PBL_GLCtex PMDBD2002025 8-hydroxy-Efavirenz_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes 8OH_EFV_GLC_GLCAASE,8OH_EFV_GLC_GLCAASEe,8OH_EFV_GLC_GLCAASEepp,8OH_EFV_GLCabc,8OH_EFV_GLCt,8OH_EFV_GLCt2,8OH_EFV_GLCt2pp,8OH_EFV_GLCtex,EX_8oh_efv_glc(e) PMDBD2002026 6-hydroxy-fluvasN-(2-Methyl-3-Chlorophenyl)-Anthranilic Acidin Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes 6OHFVSGLU_GLCAASE,6OHFVSGLU_GLCAASEe,6OHFVSGLU_GLCAASEepp,6OHFVSte,6OHFVStepp,6OHFVStex,EX_6ohfvs(e) PMDBD2002027 Ketoprofen (2-(3-Benzoylphenyl)Propionic Acid)_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_kprofen_glc(e),KPROFEN_GLC_GLCAASE,KPROFEN_GLC_GLCAASEe,KPROFEN_GLC_GLCAASEepp,KPROFEN_GLCabc,KPROFEN_GLCt,KPROFEN_GLCt2,KPROFEN_GLCt2pp,KPROFEN_GLCtex PMDBD2002028 m-Tyramine Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. 11492 n.a. n.a. m-Tyramine, 3-(2-AMINOETHYL)PHENOL, 588-05-6, 3-(2-Amino-ethyl)-phenol, 2-(3-HYDROXYPHENYL)ETHYLAMINE, 3-Tyramine, meta-Tyramine, 3-Hydroxyphenylethylamine, Metatyramine, 3-Hydroxyphenethylamine, Phenol, 3-(2-aminoethyl)-, m-Hydroxyphenethylamine, K1OA38R0EZ, Phenol, m-(2-aminoethyl)-, CHEMBL145584, CHEBI:89626, UNII-K1OA38R0EZ, Spectrum_001586, SpecPlus_000940, TYRAMINE, M-, Spectrum5_001880, 3-(2-aminoethyl)-phenol, Biomol-NT_000076, SCHEMBL43719, KBioSS_002066, DivK1c_007036, BPBio1_001396, METATYRAMINE HYDROCHLORIDE, KBio1_001980, KBio2_002066, KBio2_004634, KBio2_007202, DTXSID50207522, BCP26746, BDBM50020502, MFCD06654561, 2-(3-Hydroxy-phenyl)-ethyl-ammonium, 3-(2-aminoethyl)phenol,hydrochloride, AKOS000153827, SB37807, 3-(2-Amino-ethyl)-phenol, AldrichCPR, benzene, 1-(2-aminoethyl)-3-hydroxy-, NCGC00163167-01, NCGC00163167-02, AS-35809, HY-113356, CS-0062283, FT-0632451, EN300-145171, Q6553277, BRD-K26842203-001-01-3 C8H11NO GHFGJTVYMNRGBY-UHFFFAOYSA-N 3-(2-aminoethyl)phenol n.a. n.a. No No No No No Yes EX_mtym(e),MTYMt2r PMDBD2002029 Hesperetin_3_s Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_hst_3_s(e),HST_3_Ste,HST_3_Stepp,HST_3_Stex,HST_7GLC_3S_GLCAASE,HST_7GLC_3S_GLCAASEe,HST_7GLC_3S_GLCAASEepp PMDBD2002030 R-6-Hydroxywarfarin_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_R_6oh_warf_glc(e),R_6OH_WARF_GLC_GLCAASE,R_6OH_WARF_GLC_GLCAASEe,R_6OH_WARF_GLC_GLCAASEepp,R_6OH_WARF_GLCabc,R_6OH_WARF_GLCt,R_6OH_WARF_GLCt2,R_6OH_WARF_GLCt2pp,R_6OH_WARF_GLCtex PMDBD2002031 Tolfenamic Acid_m4 Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_tlf_a_m4(e),TLF_A_M4_GLCAASE,TLF_A_M4_GLCAASEe,TLF_A_M4_GLCAASEepp,TLF_A_M4abc,TLF_A_M4t,TLF_A_M4t2,TLF_A_M4t2pp,TLF_A_M4tex PMDBD2002032 Tolfenamic Acid_m2 Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_tlf_a_m2(e),TLF_A_M2_GLCAASE,TLF_A_M2_GLCAASEe,TLF_A_M2_GLCAASEepp,TLF_A_M2abc,TLF_A_M2t,TLF_A_M2t2,TLF_A_M2t2pp,TLF_A_M2tex PMDBD2002033 7-hydroxy-Efavirenz_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes 7OH_EFV_GLC_GLCAASE,7OH_EFV_GLC_GLCAASEe,7OH_EFV_GLC_GLCAASEepp,7OH_EFV_GLCabc,7OH_EFV_GLCt,7OH_EFV_GLCt2,7OH_EFV_GLCt2pp,7OH_EFV_GLCtex,EX_7oh_efv_glc(e) PMDBD2002034 4-Hydroxybenzyl Ketoprofen_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes 4OH_KP_GLC_GLCAASE,4OH_KP_GLC_GLCAASEe,4OH_KP_GLC_GLCAASEepp,4OH_KP_GLCabc,4OH_KP_GLCt,4OH_KP_GLCt2,4OH_KP_GLCt2pp,4OH_KP_GLCtex,EX_4oh_kp_glc(e) PMDBD2002035 Benzoated Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes BZD_AR_NADi,BZD_AR_NADPi,BZDt2r,BZDt2rpp,BZDtex,EX_bzd(e) PMDBD2002036 tmAcetaminophen Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_tmacmp(e),GTACMP_GLCAASE,GTACMP_GLCAASEe,GTACMP_GLCAASEepp,TMACMPte PMDBD2002037 Losartanm4 Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_lstnm4(e),LSTNM4_GLCAASE,LSTNM4_GLCAASEe,LSTNM4_GLCAASEepp,LSTNM4abc,LSTNM4t,LSTNM4t2,LSTNM4t2pp,LSTNM4tex PMDBD2002038 Hesperetin_7_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_hst_7_glc(e),HST_37_DIGLC_GLCAASE,HST_37_DIGLC_GLCAASEe,HST_37_DIGLC_GLCAASEepp,HST_7_GLC_GLCAASE,HST_7_GLC_GLCAASEe,HST_7_GLC_GLCAASEepp,HST_7_GLCabc,HST_7_GLCt,HST_7_GLCt2,HST_7_GLCt2pp,HST_7_GLCte,HST_7_GLCtepp,HST_7_GLCtex PMDBD2002039 Repaglinide_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_rep_glc(e),REP_GLC_GLCAASE,REP_GLC_GLCAASEe,REP_GLC_GLCAASEepp,REP_GLCabc,REP_GLCt,REP_GLCt2,REP_GLCt2pp,REP_GLCtex PMDBD2002040 S-6-Hydroxywarfarin_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_S_6oh_warf_glc(e),S_6OH_WARF_GLC_GLCAASE,S_6OH_WARF_GLC_GLCAASEe,S_6OH_WARF_GLC_GLCAASEepp,S_6OH_WARF_GLCabc,S_6OH_WARF_GLCt,S_6OH_WARF_GLCt2,S_6OH_WARF_GLCt2pp,S_6OH_WARF_GLCtex PMDBD2002041 Tolfenamic Acid_m6 Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_tlf_a_m6(e),TLF_A_M6_GLCAASE,TLF_A_M6_GLCAASEe,TLF_A_M6_GLCAASEepp,TLF_A_M6abc,TLF_A_M6t,TLF_A_M6t2,TLF_A_M6t2pp,TLF_A_M6tex PMDBD2002042 Eltrombopag_m3 Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes ELTR_M3_GLCAASE,ELTR_M3_GLCAASEepp,ELTR_M3abc,ELTR_M3t,ELTR_M3t2,ELTR_M3t2pp,ELTR_M3tex,EX_eltr_m3(e) PMDBD2002043 rosuvasN-(2-Methyl-3-Chlorophenyl)-Anthranilic Acidingluc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_rsvgluc(e),RSVGLUC_GLCAASE,RSVGLUC_GLCAASEe,RSVGLUC_GLCAASEepp,RSVGLUCabc,RSVGLUCt,RSVGLUCt2,RSVGLUCt2pp,RSVGLUCtex PMDBD2002044 4-Hydroxyalprazolam_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes ALPZ_4OH_GLC_GLCAASE,ALPZ_4OH_GLC_GLCAASEe,ALPZ_4OH_GLC_GLCAASEepp,ALPZ_4OH_GLCabc,ALPZ_4OH_GLCt,ALPZ_4OH_GLCt2,ALPZ_4OH_GLCt2pp,ALPZ_4OH_GLCtex,EX_alpz_4oh_glc(e) PMDBD2002045 Metronidazole_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_mtz_glc(e),MTZ_GLC_GLCAASE,MTZ_GLC_GLCAASEe,MTZ_GLC_GLCAASEepp,MTZ_GLCabc,MTZ_GLCt,MTZ_GLCt2,MTZ_GLCt2pp,MTZ_GLCtex PMDBD2002046 Gemfibrozil_mIII Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_gmfl_mIII(e),GMFL_MIII_GLC_GLCAASE,GMFL_MIII_GLC_GLCAASEe,GMFL_MIII_GLC_GLCAASEepp,GMFL_MIIIte,GMFL_MIIItepp,GMFL_MIIItex PMDBD2002047 Celecoxib_c_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes CLCXB_C_GLC_GLCAASE,CLCXB_C_GLC_GLCAASEe,CLCXB_C_GLC_GLCAASEepp,CLCXB_C_GLCabc,CLCXB_C_GLCt,CLCXB_C_GLCt2,CLCXB_C_GLCt2pp,CLCXB_C_GLCtex,EX_clcxb_c_glc(e) PMDBD2002048 R-7-Hydroxywarfarin_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_R_7oh_warf_glc(e),R_7OH_WARF_GLC_GLCAASE,R_7OH_WARF_GLC_GLCAASEe,R_7OH_WARF_GLC_GLCAASEepp,R_7OH_WARF_GLCabc,R_7OH_WARF_GLCt,R_7OH_WARF_GLCt2,R_7OH_WARF_GLCt2pp,R_7OH_WARF_GLCtex PMDBD2002049 Efavirenz_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EFV_GLC_GLCAASE,EFV_GLC_GLCAASEe,EFV_GLC_GLCAASEepp,EFV_GLCabc,EFV_GLCt,EFV_GLCt2,EFV_GLCt2pp,EFV_GLCtex,EX_efv_glc(e) PMDBD2002050 odsm_Galantamine Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_odsm_gltmn(e),ODSM_GLTMN_GLC_GLCAASE,ODSM_GLTMN_GLC_GLCAASEe,ODSM_GLTMN_GLC_GLCAASEepp,ODSM_GLTMNte,ODSM_GLTMNtepp,ODSM_GLTMNtex PMDBD2002051 4-Hydroxytriazolam_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes 4OH_TRZ_GLC_GLCAASE,4OH_TRZ_GLC_GLCAASEe,4OH_TRZ_GLC_GLCAASEepp,4OH_TRZ_GLCabc,4OH_TRZ_GLCt,4OH_TRZ_GLCt2,4OH_TRZ_GLCt2pp,4OH_TRZ_GLCtex,EX_4oh_trz_glc(e) PMDBD2002052 3-(3-Hydroxyphenyl)Propionate_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_phppa_glc(e),PHPPA_GLC_GLCAASE,PHPPA_GLC_GLCAASEe,PHPPA_GLC_GLCAASEepp,PHPPA_GLCabc,PHPPA_GLCt,PHPPA_GLCt2,PHPPA_GLCt2pp,PHPPA_GLCtex PMDBD2002053 Etravarine Dihydroxylated (M4, M5, M6)_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes DOH_ETR_GLC_GLCAASE,DOH_ETR_GLC_GLCAASEe,DOH_ETR_GLC_GLCAASEepp,DOH_ETR_GLCabc,DOH_ETR_GLCt,DOH_ETR_GLCt2,DOH_ETR_GLCt2pp,DOH_ETR_GLCtex,EX_doh_etr_glc(e) PMDBD2002054 3-Hydroxycarbamazepine_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes 3OH_CBZ_GLC_GLCAASE,3OH_CBZ_GLC_GLCAASEe,3OH_CBZ_GLC_GLCAASEepp,3OH_CBZ_GLCabc,3OH_CBZ_GLCt,3OH_CBZ_GLCt2,3OH_CBZ_GLCt2pp,3OH_CBZ_GLCtex,EX_3oh_cbz_glc(e) PMDBD2002055 sulfoacetate Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. 31257 n.a. n.a. SULFOACETIC ACID, 2-sulfoacetic acid, 123-43-3, Acetic acid, sulfo-, Sulfoethanoic acid, Sulphoacetic acid, Acetic acid, 2-sulfo-, Sulfoacetate, Y4XC05H603, Disodium sulfonoacetate, Kyselina sulfooctova [Czech], Kyselina sulfooctova, SAT, NSC19191, HSDB 2706, EINECS 204-627-2, BRN 1764390, Sulfoessigsaure, Sulfonoacetate, UNII-Y4XC05H603, AI3-28536, Sulfo-aceticacid, 2-sulfoaceticacid, bmse000632, SCHEMBL71944, 4-04-00-00102 (Beilstein Handbook Reference), DTXSID8059556, CHEBI:50519, 2-SULFOACETIC ACID [MI], Sulfoacetic acid, technical grade, STR10351, AKOS006223972, DB-041731, FT-0601929, NS00020376, A805074, J-004940, Q27104770 C2H4O5S AGGIJOLULBJGTQ-UHFFFAOYSA-N 2-sulfoacetic acid n.a. n.a. No No No No No Yes SULFACabcpp,SULFACtex,SULFACtr PMDBD2002056 fluvasN-(2-Methyl-3-Chlorophenyl)-Anthranilic Acidin Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_fvs(e),FVSGLUC_GLCAASE,FVSGLUC_GLCAASEe,FVSGLUC_GLCAASEepp,FVSte,FVStepp,FVStex PMDBD2002057 Tolcapone?_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_tolcp_glc(e),TOLCP_GLC_GLCAASE,TOLCP_GLC_GLCAASEe,TOLCP_GLC_GLCAASEepp,TOLCP_GLCabc,TOLCP_GLCt,TOLCP_GLCt2,TOLCP_GLCt2pp,TOLCP_GLCtex PMDBD2002058 propionate Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. 104745 n.a. n.a. propionate, propanoate, 72-03-7, Propanoic acid, ion(1-), Propanoic acid anion, Propionate ion, EtCO2 anion, AKW5EM890C, ANION STANDARD - PROPIONATE, metacetonate, propanate, pseudoacetate, ethanecarboxylate, Sentry Grain Preservative, CHEMBL500826, NCGC00159468-02, carboxylatoethane, PROPANOATE ION, UNII-AKW5EM890C, CH3-CH2-COO(-), CHEBI:17272, DTXSID90222279, BDBM50257201, STL483862, AKOS015901051, NCGC00159468-03, NCGC00159468-04, A839578, Q862450 C3H5O2- XBDQKXXYIPTUBI-UHFFFAOYSA-M propanoate n.a. n.a. No No No No No Yes 3HPPPNtex PMDBD2002059 Regorafenib_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_regfnb_glc(e),REGFNB_GLC_GLCAASE,REGFNB_GLC_GLCAASEe,REGFNB_GLC_GLCAASEepp,REGFNB_GLCabc,REGFNB_GLCt,REGFNB_GLCt2,REGFNB_GLCt2pp,REGFNB_GLCtex PMDBD2002060 dh5-Fluorouracil Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes 56DFURADH,56DFURADHe,56DFURADHepp,5FURADH,DH5FURAt,EX_dh5fura(e) PMDBD2002061 R406_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_r406_glc(e),R406_GLC_GLCAASE,R406_GLC_GLCAASEe,R406_GLC_GLCAASEepp,R406_GLCabc,R406_GLCt,R406_GLCt2,R406_GLCt2pp,R406_GLCtex PMDBD2002062 CD6168_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes CD6168_GLC_GLCAASE,CD6168_GLC_GLCAASEe,CD6168_GLC_GLCAASEepp,CD6168_GLCabc,CD6168_GLCt,CD6168_GLCt2,CD6168_GLCt2pp,CD6168_GLCtex,EX_cd6168_glc(e) PMDBD2002063 fluvasN-(2-Methyl-3-Chlorophenyl)-Anthranilic Acidintetglu Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_fvstetglu(e),FVSTETGLU_GLCAASE,FVSTETGLU_GLCAASEe,FVSTETGLU_GLCAASEepp,FVSTETGLUabc,FVSTETGLUt,FVSTETGLUt2,FVSTETGLUt2pp,FVSTETGLUtex PMDBD2002064 3-Hydroxy N-DesethylAmiodaronedarone (3-Hydroxy_MDEA) (M8)_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes 3OH_MDEA_GLC_GLCAASE,3OH_MDEA_GLC_GLCAASEe,3OH_MDEA_GLC_GLCAASEepp,3OH_MDEA_GLCabc,3OH_MDEA_GLCt,3OH_MDEA_GLCt2,3OH_MDEA_GLCt2pp,3OH_MDEA_GLCtex,EX_3oh_mdea_glc(e) PMDBD2002065 ac5-Aminosalicylic Acid (Mesalamine) Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes AC5ASAabc,AC5ASAabcpp,AC5ASAc,AC5ASAe,AC5ASAppp,AC5ASAtex,EX_ac5asa(e) PMDBD2002066 pravasN-(2-Methyl-3-Chlorophenyl)-Anthranilic Acidingluc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_pvsgluc(e),PVSGLUC_GLCAASE,PVSGLUC_GLCAASEe,PVSGLUC_GLCAASEepp,PVSGLUCabc,PVSGLUCt,PVSGLUCt2,PVSGLUCt2pp,PVSGLUCtex PMDBD2002067 Tolfenamic Acid_3 Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_tlf_a_3(e),TLF_A_3te,TLF_A_3tepp,TLF_A_3tex,TLF_A_M3_GLCAASE,TLF_A_M3_GLCAASEe,TLF_A_M3_GLCAASEepp PMDBD2002068 Celecoxib_c Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes CLCXB_C_GLC_GLCAASE,CLCXB_C_GLC_GLCAASEe,CLCXB_C_GLC_GLCAASEepp,CLCXB_Cte,CLCXB_Ctepp,CLCXB_Ctex,EX_clcxb_c(e) PMDBD2002069 2-Hydroxycarbamazepine_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes 2OH_CBZ_GLC_GLCAASE,2OH_CBZ_GLC_GLCAASEe,2OH_CBZ_GLC_GLCAASEepp,2OH_CBZ_GLCabc,2OH_CBZ_GLCt,2OH_CBZ_GLCt2,2OH_CBZ_GLCt2pp,2OH_CBZ_GLCtex,EX_2oh_cbz_glc(e) PMDBD2002070 4-Hydroxy LevaMisonidazolele (M1) Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes 4OH_LEVOLE_GLC_GLCAASE,4OH_LEVOLE_GLC_GLCAASEe,4OH_LEVOLE_GLC_GLCAASEepp,4OH_LEVOLEte,4OH_LEVOLEtepp,4OH_LEVOLEtex,EX_4oh_levole(e) PMDBD2002071 Donepezil Me1,2,4-Triaminobenzeneolite M13 Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes DNPZ_M13_GLCAASE,DNPZ_M13_GLCAASEe,DNPZ_M13_GLCAASEepp,DNPZ_M13abc,DNPZ_M13t,DNPZ_M13t2,DNPZ_M13t2pp,DNPZ_M13tex,EX_dnpz_m13(e) PMDBD2002072 3-Hydroxyphenylacetate Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. 12122 n.a. n.a. "3-Hydroxyphenylacetic acid, 621-37-4, 2-(3-hydroxyphenyl)acetic acid, (3-Hydroxyphenyl)acetic acid, 3-Hydroxybenzeneacetic acid, (m-Hydroxyphenyl)acetic acid, Benzeneacetic acid, 3-hydroxy-, M-HYDROXYPHENYLACETIC ACID, 3-Hydroxyphenylacetate, Acetic acid, (m-hydroxyphenyl)-, Metahydroxy phenylacetic acid, (3-Hydroxy-phenyl)-acetic acid, MFCD00004337, K59Z6Z8REF, CHEMBL190035, CHEBI:17445, NSC-14360, m-hydroxyphenylacetate, 3-Hydroxyphenylaceticacid, 3HP, EINECS 210-684-4, NSC 14360, UNII-K59Z6Z8REF, 3pce, 3-hydroxy-benzeneacetate, bmse000339, 3-hydroxy phenylacetic acid, 3-hydroxy-phenylacetic acid, 3-hydroxyphenyl acetic acid, (3-hydroxy-phenyl)-acetate, 3-hydroxy-benzeneacetic acid, (3-hydroxy)phenylacetic acid, 3-hydroxy phenyl acetic acid, 3-hydroxy-phenyl acetic acid, 3-Hydroxy-phenyl-acetic acid, SCHEMBL337470, Acetic acid, 3-hydroxyphenyl-, HMDB00440, 2-(3-hydroxyphenyl)-acetic acid, DTXSID90211148, 3'-HYDROXYPHENYLACETIC ACID, NSC14360, 3-Hydroxyphenylacetic acid, >=99%, AB3840, BDBM50168283, s3364, AKOS005259462, CS-W001083, HY-W001083, PS-3166, Benzeneacetic acid, 3-hydroxy- (9CI), Acetic acid, (m-hydroxyphenyl)- (8CI), AC-23554, BP-30187, PD098600, SY013505, DB-002809, A8594, AM20061198, FT-0615854, H0356, NS00014720, EN300-54805, C05593, AE-562/43460507, W-105043, Q10395566, Z816000338, 2-(3-hydroxyphenyl)acetic acid;3-Hydroxyphenylacetic acid, 91827D95-20B5-4654-B5F1-90598A532D49, InChI=1/C8H8O3/c9-7-3-1-2-6(4-7)5-8(10)11/h1-4,9H,5H2,(H,10,11" C8H8O3 FVMDYYGIDFPZAX-UHFFFAOYSA-N 2-(3-hydroxyphenyl)acetic acid n.a. n.a. No No No No No Yes 3HPHACtex PMDBD2002073 Eltrombopag_m4 Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes ELTR_M4_GLCAASE,ELTR_M4_GLCAASEe,ELTR_M4_GLCAASEepp,ELTR_M4abc,ELTR_M4t,ELTR_M4t2,ELTR_M4t2pp,ELTR_M4tex,EX_eltr_m4(e) PMDBD2002074 pitavasN-(2-Methyl-3-Chlorophenyl)-Anthranilic Acidingluc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_ptvstgluc(e),PTVSTGLUC_GLCAASE,PTVSTGLUC_GLCAASEe,PTVSTGLUC_GLCAASEepp,PTVSTGLUCabc,PTVSTGLUCt,PTVSTGLUCt2,PTVSTGLUCt2pp,PTVSTGLUCtex PMDBD2002075 Ezetimibe_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_eztmb_glc(e),EZTMB_GLC_GLCAASE,EZTMB_GLC_GLCAASEe,EZTMB_GLC_GLCAASEepp,EZTMB_GLCabc,EZTMB_GLCt,EZTMB_GLCt2,EZTMB_GLCt2pp,EZTMB_GLCtex PMDBD2002076 Tyramine Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. 5610 n.a. n.a. tyramine, 51-67-2, 4-(2-Aminoethyl)phenol, p-Tyramine, 4-Hydroxyphenethylamine, Uteramine, 2-(4-Hydroxyphenyl)ethylamine, Tyrosamine, Tocosine, Tyramin, Systogene, Phenol, 4-(2-aminoethyl)-, 4-Hydroxyphenylethylamine, p-(2-Aminoethyl)phenol, p-Hydroxyphenethylamine, Tenosin-wirkstoff, p-Hydroxyphenylethylamine, 2-(p-Hydroxyphenyl)ethylamine, Phenethylamine, p-hydroxy-, p-beta-Aminoethylphenol, Phenol, p-(2-aminoethyl)-, Benzeneethanamine, 4-hydroxy-, Tyramine base, beta-Hydroxyphenylethylamine, alpha-(4-Hydroxyphenyl)-beta-aminoethane, MFCD00008193, NSC 249188, BRN 1099914, HSDB 2132, 2-p-hydroxyphenylethylamine, UNII-X8ZC7V0OX3, EINECS 200-115-8, X8ZC7V0OX3, NSC-249188, Tyramine, free base, 4-Hydroxy-beta-phenylethylamine, DTXSID2043874, FEMA NO. 4215, beta-(4-Hydroxyphenyl)ethylamine, CHEBI:15760, p-.beta.-Aminoethylphenol, 4-(2-aminoethyl)-Phenol, 4 Hydroxyphenethylamine, CHEMBL11608, MLS000079096, p-Hydroxy-.beta.-phenethylamine, 2-(4'-Hydroxyphenyl)ethylamine, DTXCID0023874, 4-Hydroxy-.beta.-phenylethylamine, .beta.-(4-Hydroxyphenyl)ethylamine, 4-13-00-01788 (Beilstein Handbook Reference), NSC249188, NCGC00016011-08, SMR000059295, .alpha.-(4-Hydroxyphenyl)-.beta.-aminoethane, CAS-51-67-2, [3H]tyramine, [3H]-Tyramine, SR-01000075365, L-Tyramine, 4-aminoethylphenol, AEF, Tyramine, 99%, Spectrum_001213, Opera_ID_887, TYRAMINE [FHFI], TYRAMINE [HSDB], TYRAMINE [MI], TYRAMINE [VANDF], Tyramine, 98%, FG, p-hydroxy-phenylethylamine, Spectrum2_000738, Spectrum3_000693, Spectrum4_001801, Spectrum5_000501, Lopac-T-2879, 4-hydroxy-benzeneethanamin, p-(2-aminoethyl)-Phenol, P-hydroxy-b-phenethylamine, Biomol-NT_000075, bmse000243, bmse000870, bmse000891, TYRAMINE [WHO-DD], 4-hydroxy-Benzeneethanamine, (4-hydroxyphenyl)ethylamine, cid_5610, SCHEMBL4111, WLN: Z2R DQ, 4-(2-amino-ethyl)-phenol, P-hydroxy-b-phenylethylamine, 4- (2-aminoethyl)-Phenol, 4-Hydroxy-b-phenylethylamine, Lopac0_001136, Oprea1_294339, BSPBio_002445, KBioGR_002405, KBioSS_001693, p-Hydroxy-beta-phenethylamine, SPECTRUM210400, Tyramine, analytical standard, b-(4-Hydroxyphenyl)ethylamine, BIDD:ER0507, DivK1c_000918, 2-(4-hydroxyphenyl)ethanamine, SPBio_000696, p-Hydroxy-beta-phenylethylamine, BPBio1_001394, GTPL2148, GTPL2150, SGCUT00017, 2-(4-hydroxy-phenyl)ethylamine, 2-(4-Hydroxyphenyl)-ethylamine, BDBM29135, HMS502N20, KBio1_000918, KBio2_001693, KBio2_004261, KBio2_006829, KBio3_001665, NINDS_000918, p-Hydroxy-.beta.-phenylethylamine, HMS1923C19, HMS2235J05, HMS3885C17, a-(4-Hydroxyphenyl)-b-aminoethane, to_000085, 4-(2-Aminoethyl)-phenol(thyramin), Tox21_110282, BBL027695, CCG-39684, MFCD00149002, s3625, STK531130, AKOS000156022, Tox21_110282_1, CS-W007606, DB08841, HY-W007606, SDCCGSBI-0051103.P003, benzene, 1-(2-amino)ethyl-4-hydroxy-, benzene, 1-(2-aminoethyl)-4-hydroxy-, IDI1_000918, NCGC00016011-01, NCGC00016011-02, NCGC00016011-03, NCGC00016011-04, NCGC00016011-05, NCGC00016011-06, NCGC00016011-07, NCGC00016011-09, NCGC00016011-10, NCGC00016011-11, NCGC00016011-12, NCGC00016011-14, NCGC00016011-16, NCGC00016011-20, NCGC00063825-04, NCGC00063825-05, NCGC00063825-06, NCGC00063825-07, NCGC00063825-08, 1ST40050, AS-11671, SY002127, Tyramine, Vetec(TM) reagent grade, 99%, alpha.-(4-Hydroxyphenyl)-beta-aminoethane, A0302, AM20060645, FT-0651978, NS00000072, EN300-51746, C00483, T-8910, T-8911, AB00051887-15, Q165930, SR-01000075365-5, BRD-K53893978-001-03-1, Ractopamine hydrochloride suspension impurity, tyramine-, InChI=1/C8H11NO/c9-6-5-7-1-3-8(10)4-2-7/h1-4,10H,5-6,9H, RACTOPAMINE HYDROCHLORIDE SUSPENSION IMPURITY, TYRAMINE- [USP IMPURITY] C8H11NO DZGWFCGJZKJUFP-UHFFFAOYSA-N 4-(2-aminoethyl)phenol n.a. n.a. No No No No No Yes EX_tym(e) PMDBD2002078 Chloramphenicol_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes CHLPHNCL_GLC_GLCAASE,CHLPHNCL_GLC_GLCAASEe,CHLPHNCL_GLC_GLCAASEepp,CHLPHNCL_GLCabc,CHLPHNCL_GLCt,CHLPHNCL_GLCt2,CHLPHNCL_GLCt2pp,CHLPHNCL_GLCtex,EX_chlphncl_glc(e) PMDBD2002079 Tolfenamic Acid_m9 Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_tlf_a_m9(e),TLF_A_M9_GLCAASE,TLF_A_M9_GLCAASEe,TLF_A_M9_GLCAASEepp,TLF_A_M9abc,TLF_A_M9t,TLF_A_M9t2,TLF_A_M9t2pp,TLF_A_M9tex PMDBD2002080 Losartanm7 Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_lstnm7(e),LSTNM7_GLCAASE,LSTNM7_GLCAASEe,LSTNM7_GLCAASEepp,LSTNM7abc,LSTNM7t,LSTNM7t2,LSTNM7t2pp,LSTNM7tex PMDBD2002081 Troglitazone_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_tgz_glc(e),TGZ_GLC_GLCAASE,TGZ_GLC_GLCAASEe,TGZ_GLC_GLCAASEepp,TGZ_GLCabc,TGZ_GLCt,TGZ_GLCt2,TGZ_GLCt2pp,TGZ_GLCtex PMDBD2002082 3-Hydroxy N-DesethylAmiodaronedarone (3-Hydroxy_MDEA) (M8) Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes 3OH_MDEA_GLC_GLCAASE,3OH_MDEA_GLC_GLCAASEe,3OH_MDEA_GLC_GLCAASEepp,3OH_MDEAte,3OH_MDEAtepp,3OH_MDEAtex,EX_3oh_mdea(e) PMDBD2002083 Galantamine_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_gltmn_glc(e),GLTMN_GLC_GLCAASE,GLTMN_GLC_GLCAASEe,GLTMN_GLC_GLCAASEepp,GLTMN_GLCabc,GLTMN_GLCt,GLTMN_GLCt2,GLTMN_GLCt2pp,GLTMN_GLCtex PMDBD2002084 2-Sulfamoylacetylphenol_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_smap_glc(e),SMAP_GLC_GLCAASE,SMAP_GLC_GLCAASEe,SMAP_GLC_GLCAASEepp,SMAP_GLCabc,SMAP_GLCt,SMAP_GLCt2,SMAP_GLCt2pp,SMAP_GLCtex PMDBD2002085 Desmethylastemizole_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes DES_ASTZL_GLC_GLCAASE,DES_ASTZL_GLC_GLCAASEe,DES_ASTZL_GLC_GLCAASEepp,DES_ASTZL_GLCabc,DES_ASTZL_GLCt,DES_ASTZL_GLCt2,DES_ASTZL_GLCt2pp,DES_ASTZL_GLCtex,EX_des_astzl_glc(e) PMDBD2002086 Glycinecocholate Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_gchola(e),GCHOLBHSe PMDBD2002087 Hesperetin_3glc_7s Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_hst_3glc_7s(e),HST_3GLC_7S_GLCAASE,HST_3GLC_7S_GLCAASEe,HST_3GLC_7S_GLCAASEepp,HST_3GLC_7Sabc,HST_3GLC_7St,HST_3GLC_7St2,HST_3GLC_7St2pp,HST_3GLC_7Stex PMDBD2002088 4-Hydroxymethamphetamine_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes 4OH_METH_GLC_GLCAASE,4OH_METH_GLC_GLCAASEe,4OH_METH_GLC_GLCAASEepp,4OH_METH_GLCabc,4OH_METH_GLCt,4OH_METH_GLCt2,4OH_METH_GLCt2pp,4OH_METH_GLCtex,EX_4oh_meth_glc(e) PMDBD2002089 Midazolamglc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_mdzglc(e),MDZGLC_GLCAASE,MDZGLC_GLCAASEe,MDZGLC_GLCAASEepp,MDZGLCabc,MDZGLCt,MDZGLCt2,MDZGLCt2pp,MDZGLCtex PMDBD2002090 Gemfibrozil_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_gmfl_glc(e),GMFL_GLC_GLCAASE,GMFL_GLC_GLCAASEe,GMFL_GLC_GLCAASEepp,GMFL_GLCabc,GMFL_GLCt,GMFL_GLCt2,GMFL_GLCt2pp,GMFL_GLCtex PMDBD2002091 Donepezil Me1,2,4-Triaminobenzeneolite M12 Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes DNPZ_M12_GLCAASE,DNPZ_M12_GLCAASEe,DNPZ_M12_GLCAASEepp,DNPZ_M12abc,DNPZ_M12t,DNPZ_M12t2,DNPZ_M12t2pp,DNPZ_M12tex,EX_dnpz_m12(e) PMDBD2002092 cBenzoate Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes CBZ_GLC_GLCAASE,CBZ_GLC_GLCAASEe,CBZte,EX_cbz(e) PMDBD2002093 Tempol 4-O-Glucosidelc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_tpno_4glc(e),TPNO_4GLC_GLCAASE,TPNO_4GLC_GLCAASEe,TPNO_4GLC_GLCAASEepp,TPNO_4GLCabc,TPNO_4GLCt,TPNO_4GLCt2,TPNO_4GLCt2pp,TPNO_4GLCtex PMDBD2002094 Acetyl 4-AminobenzoylGlycinecine_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes AC_AMN_B_GLY_GLC_GLCAASE,AC_AMN_B_GLY_GLC_GLCAASEe,AC_AMN_B_GLY_GLC_GLCAASEepp,AC_AMN_B_GLY_GLCabc,AC_AMN_B_GLY_GLCt,AC_AMN_B_GLY_GLCt2,AC_AMN_B_GLY_GLCt2pp,AC_AMN_B_GLY_GLCtex,EX_ac_amn_b_gly_glc(e) PMDBD2002095 Tolfenamic Acid_4 Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_tlf_a_4(e),TLF_A_4te,TLF_A_4tepp,TLF_A_4tex,TLF_A_M6_GLCAASE,TLF_A_M6_GLCAASEe,TLF_A_M6_GLCAASEepp PMDBD2002096 cerivasN-(2-Methyl-3-Chlorophenyl)-Anthranilic Acidin-M23-glucuronide Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes CVM23GLUC_GLCAASE,CVM23GLUC_GLCAASEe,CVM23GLUC_GLCAASEepp,CVM23GLUCabc,CVM23GLUCt,CVM23GLUCt2,CVM23GLUCt2pp,CVM23GLUCtex,EX_cvm23gluc(e) PMDBD2002097 R529_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_r529_glc(e),R529_GLC_GLCAASE,R529_GLC_GLCAASEe,R529_GLC_GLCAASEepp,R529_GLCabc,R529_GLCt,R529_GLCt2,R529_GLCt2pp,R529_GLCtex PMDBD2002098 Losartan1gluc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_lstn1gluc(e),LSTN1GLUC_GLCAASE,LSTN1GLUC_GLCAASEe,LSTN1GLUC_GLCAASEepp,LSTN1GLUCabc,LSTN1GLUCt,LSTN1GLUCt2,LSTN1GLUCt2pp,LSTN1GLUCtex PMDBD2002099 Gemfibrozil_mIII_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_gmfl_mIII_glc(e),GMFL_MIII_GLC_GLCAASE,GMFL_MIII_GLC_GLCAASEe,GMFL_MIII_GLC_GLCAASEepp,GMFL_MIII_GLCabc,GMFL_MIII_GLCt,GMFL_MIII_GLCt2,GMFL_MIII_GLCt2pp,GMFL_MIII_GLCtex PMDBD2002100 Paroxetine Mi_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_prx_mI_glc(e),PRX_MI_GLC_GLCAASE,PRX_MI_GLC_GLCAASEe,PRX_MI_GLC_GLCAASEepp,PRX_MI_GLCabc,PRX_MI_GLCt,PRX_MI_GLCt2,PRX_MI_GLCt2pp,PRX_MI_GLCtex PMDBD2002101 Amiodarone_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes AMIO_GLC_GLCAASE,AMIO_GLC_GLCAASEe,AMIO_GLC_GLCAASEepp,AMIO_GLCabc,AMIO_GLCt,AMIO_GLCt2,AMIO_GLCt2pp,AMIO_GLCtex,EX_amio_glc(e) PMDBD2002102 SKF 96990_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_rpn_96990_glc(e),RPN_96990_GLC_GLCAASE,RPN_96990_GLC_GLCAASEe,RPN_96990_GLC_GLCAASEepp,RPN_96990_GLCabc,RPN_96990_GLCt,RPN_96990_GLCt2,RPN_96990_GLCt2pp,RPN_96990_GLCtex PMDBD2002103 SN-38 (active me1,2,4-Triaminobenzeneolite of irinotecan)g Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_sn38g(e),SN38G_GLCAASE,SN38G_GLCAASEe,SN38G_GLCAASEepp,SN38Gabc,SN38Gt,SN38Gt2,SN38Gt2pp,SN38Gtex PMDBD2002104 4-Hydroxy LevaMisonidazolele (M1)_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes 4OH_LEVOLE_GLC_GLCAASE,4OH_LEVOLE_GLC_GLCAASEe,4OH_LEVOLE_GLC_GLCAASEepp,4OH_LEVOLE_GLCabc,4OH_LEVOLE_GLCt,4OH_LEVOLE_GLCt2,4OH_LEVOLE_GLCt2pp,4OH_LEVOLE_GLCtex,EX_4oh_levole_glc(e) PMDBD2002105 Dihydroxyvoriconazole_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes DOH_VCZ_GLC_GLCAASE,DOH_VCZ_GLC_GLCAASEe,DOH_VCZ_GLC_GLCAASEepp,DOH_VCZ_GLCabc,DOH_VCZ_GLCt,DOH_VCZ_GLCt2,DOH_VCZ_GLCt2pp,DOH_VCZ_GLCtex,EX_doh_vcz_glc(e) PMDBD2002106 Tolfenamic Acid_2a Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_tlf_a_2a(e),TLF_A_2Ate,TLF_A_2Atepp,TLF_A_2Atex,TLF_A_M2_GLCAASE,TLF_A_M2_GLCAASEe,TLF_A_M2_GLCAASEepp PMDBD2002107 Hesperetin_37_diglc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_hst_37_diglc(e),HST_37_DIGLC_GLCAASE,HST_37_DIGLC_GLCAASE2,HST_37_DIGLC_GLCAASEe,HST_37_DIGLC_GLCAASEe2,HST_37_DIGLC_GLCAASEe2pp,HST_37_DIGLC_GLCAASEepp,HST_37_DIGLCabc,HST_37_DIGLCt,HST_37_DIGLCt2,HST_37_DIGLCt2pp,HST_37_DIGLCtex PMDBD2002108 Morphine_6glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_mrphn_6glc(e),MRPHN_6GLC_GLCAASE,MRPHN_6GLC_GLCAASEe,MRPHN_6GLC_GLCAASEepp,MRPHN_6GLCabc,MRPHN_6GLCt,MRPHN_6GLCt2,MRPHN_6GLCt2pp,MRPHN_6GLCtex PMDBD2002109 Hydroxy Ropinirole_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_rpn_oh_glc(e),RPN_OH_GLC_GLCAASE,RPN_OH_GLC_GLCAASEe,RPN_OH_GLC_GLCAASEepp,RPN_OH_GLCabc,RPN_OH_GLCt,RPN_OH_GLCt2,RPN_OH_GLCt2pp,RPN_OH_GLCtex PMDBD2002110 Tolcapone?_am Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_tolcp_am(e),TOLCP_AM_GLC_GLCAASE,TOLCP_AM_GLC_GLCAASEe,TOLCP_AM_GLC_GLCAASEepp,TOLCP_AMte,TOLCP_AMtepp,TOLCP_AMtex PMDBD2002111 8,14-Dihydroxyefavirenz_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes 814DIOH_EFV_GLC_GLCAASE,814DIOH_EFV_GLC_GLCAASEe,814DIOH_EFV_GLC_GLCAASEepp,814DIOH_EFV_GLCabc,814DIOH_EFV_GLCt,814DIOH_EFV_GLCt2,814DIOH_EFV_GLCt2pp,814DIOH_EFV_GLCtex,EX_814dioh_efv_glc(e) PMDBD2002112 SKF 104557 (N-Despropyl Ropinirole)_cb_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_rpn_104557_cb_glc(e),RPN_104557_CB_GLC_GLCAASE,RPN_104557_CB_GLC_GLCAASEe,RPN_104557_CB_GLC_GLCAASEepp,RPN_104557_CB_GLCabc,RPN_104557_CB_GLCt,RPN_104557_CB_GLCt2,RPN_104557_CB_GLCt2pp,RPN_104557_CB_GLCtex PMDBD2002113 Paroxetine MiI_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_prx_mII_glc(e),PRX_MII_GLC_GLCAASE,PRX_MII_GLC_GLCAASEe,PRX_MII_GLC_GLCAASEepp,PRX_MII_GLCabc,PRX_MII_GLCt,PRX_MII_GLCt2,PRX_MII_GLCt2pp,PRX_MII_GLCtex PMDBD2002114 fluvasN-(2-Methyl-3-Chlorophenyl)-Anthranilic Acidingluc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_fvsgluc(e),FVSGLUC_GLCAASE,FVSGLUC_GLCAASEe,FVSGLUC_GLCAASEepp,FVSGLUCabc,FVSGLUCt,FVSGLUCt2,FVSGLUCt2pp,FVSGLUCtex PMDBD2002115 Hydroxyphenylacetate Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. 11970 n.a. n.a. "2-Hydroxyphenylacetic acid, 614-75-5, 2-(2-hydroxyphenyl)acetic acid, (2-Hydroxyphenyl)acetic acid, 2-Hydroxybenzeneacetic acid, Benzeneacetic acid, 2-hydroxy-, O-HYDROXYPHENYLACETIC ACID, 2-Hydroxyphenylacetate, Acetic acid, (o-hydroxyphenyl)-, (o-Hydroxyphenyl)acetic acid, ortho-Hydroxyphenylacetic acid, Hydroxyphenylacetic acid, o-Hydroxy phenylacetic acid, MFCD00004323, 2-HPAA, UK3R9Q59AV, CHEMBL240714, CHEBI:28478, NSC-62000, (2-HYDROXYPHENYL)-ACETIC ACID, 2-Hydroxyphenylaceticacid, (o-Hydroxyphenyl)acetate, UNII-UK3R9Q59AV, 2-hydroxy phenylacetic acid, Hydroxyphenylacetate, OHP, EINECS 210-393-2, NSC 62000, 2-Hydroxybenzeneacetate, (o-hydroxyphenyl)-Acetate, bmse000715, 2'-hydroxyphenylacetic acid, 2-hydroxy-phenylacetic acid, 2-hydroxy-benzeneacetic acid, SCHEMBL72309, 2-(Hydroxyphenyl)acetic acid, (o-hydroxyphenyl)-Acetic acid, Acetic acid, 2-hydroxyphenyl-, (2-hydroxy-phenyl)-acetic acid, DTXSID1060633, BDBM16426, NSC62000, HYDROXYPHENYLACETIC ACID, O-, s6154, STL301502, AKOS004909470, AC-2695, CS-W016306, FS-2587, HY-W015590, BP-13099, PD099467, DB-013545, AM20060692, FT-0612632, H0340, NS00014664, EN300-50865, A26509, C05852, H-7080, 2-hydroxy-benzeneaceticaci;2-hydroxyphenylacetate, 2-Hydroxyphenylacetic acid, ReagentPlus(R), 99%, Q27103728, 7C10F5F6-7BF6-48EE-85EE-22D3FA4D62B1, Z608061328, 2-Hydroxyphenylacetic acid, Vetec(TM) reagent grade, 98%, InChI=1/C8H8O3/c9-7-4-2-1-3-6(7)5-8(10)11/h1-4,9H,5H2,(H,10,11" C8H8O3 CCVYRRGZDBSHFU-UHFFFAOYSA-N 2-(2-hydroxyphenyl)acetic acid n.a. n.a. No No No No No Yes HPACt2r PMDBD2002116 Benzoate_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes BZ_GLC_GLCAASE,BZ_GLC_GLCAASEe,BZ_GLC_GLCAASEepp,BZ_GLCabc,BZ_GLCt,BZ_GLCt2,BZ_GLCt2pp,BZ_GLCtex,EX_bz_glc(e) PMDBD2002117 Misonidazole_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_miso_glc(e),MISO_GLC_GLCAASE,MISO_GLC_GLCAASEe,MISO_GLC_GLCAASEepp,MISO_GLCabc,MISO_GLCt,MISO_GLCt2,MISO_GLCt2pp,MISO_GLCtex PMDBD2002118 drug_substrate Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes Reaction ID PMDBD2002119 3-Hydroxydesloratadine_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes 3OH_DLOR_GLC_GLCAASE,3OH_DLOR_GLC_GLCAASEe,3OH_DLOR_GLC_GLCAASEepp,3OH_DLOR_GLCabc,3OH_DLOR_GLCt,3OH_DLOR_GLCt2,3OH_DLOR_GLCt2pp,3OH_DLOR_GLCtex,EX_3oh_dlor_glc(e) PMDBD2002120 odsm_Galantamine_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_odsm_gltmn_glc(e),ODSM_GLTMN_GLC_GLCAASE,ODSM_GLTMN_GLC_GLCAASEe,ODSM_GLTMN_GLC_GLCAASEepp,ODSM_GLTMN_GLCabc,ODSM_GLTMN_GLCt,ODSM_GLTMN_GLCt2,ODSM_GLTMN_GLCt2pp,ODSM_GLTMN_GLCtex PMDBD2002122 Celecoxib_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes CLCXB_GLC_GLCAASE,CLCXB_GLC_GLCAASEe,CLCXB_GLC_GLCAASEepp,CLCXB_GLCabc,CLCXB_GLCt,CLCXB_GLCt2,CLCXB_GLCt2pp,CLCXB_GLCtex,EX_clcxb_glc(e) PMDBD2002123 Hesperetin_7glc_3s Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_hst_7glc_3s(e),HST_7GLC_3S_GLCAASE,HST_7GLC_3S_GLCAASEe,HST_7GLC_3S_GLCAASEepp,HST_7GLC_3Sabc,HST_7GLC_3St,HST_7GLC_3St2,HST_7GLC_3St2pp,HST_7GLC_3Stex PMDBD2002124 Diclofenac_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes DCF_GLC_GLCAASE,DCF_GLC_GLCAASEe,DCF_GLC_GLCAASEepp,DCF_GLCabc,DCF_GLCt,DCF_GLCt2,DCF_GLCt2pp,DCF_GLCtex,EX_dcf_glc(e) PMDBD2002125 Telmisartan_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_tlms_glc(e),TLMS_GLC_GLCAASE,TLMS_GLC_GLCAASEe,TLMS_GLC_GLCAASEepp,TLMS_GLCabc,TLMS_GLCt,TLMS_GLCt2,TLMS_GLCt2pp,TLMS_GLCtex PMDBD2002126 2-Hydroxymetronidazole_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes 2OH_MTZ_GLC_GLCAASE,2OH_MTZ_GLC_GLCAASEe,2OH_MTZ_GLC_GLCAASEepp,2OH_MTZ_GLCabc,2OH_MTZ_GLCt,2OH_MTZ_GLCt2,2OH_MTZ_GLCt2pp,2OH_MTZ_GLCtex,EX_2oh_mtz_glc(e) PMDBD2002127 4-Hydroxypropanolol_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes 4OH_PROPL_GLC_GLCAASE,4OH_PROPL_GLC_GLCAASEe,4OH_PROPL_GLC_GLCAASEepp,4OH_PROPL_GLCabc,4OH_PROPL_GLCt,4OH_PROPL_GLCt2,4OH_PROPL_GLCt2pp,4OH_PROPL_GLCtex,EX_4oh_propl_glc(e) PMDBD2002128 gtAcetaminophen Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_gtacmp(e),GTACMP_GLCAASE,GTACMP_GLCAASEe,GTACMP_GLCAASEepp,GTACMPabc,GTACMPt,GTACMPt2,GTACMPt2pp,GTACMPtex PMDBD2002129 Norverapamil_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_nverp_glc(e),NVERP_GLC_GLCAASE,NVERP_GLC_GLCAASEe,NVERP_GLC_GLCAASEepp,NVERP_GLCabc,NVERP_GLCt,NVERP_GLCt2,NVERP_GLCt2pp,NVERP_GLCtex PMDBD2002130 thsAcetaminophen Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_thsacmp(e),THSACMPte,TSACMGLUC_GLCAASE,TSACMGLUC_GLCAASEe,TSACMGLUC_GLCAASEepp PMDBD2002131 Hesperetin_7_s Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_hst_7_s(e),HST_3GLC_7S_GLCAASE,HST_3GLC_7S_GLCAASEe,HST_3GLC_7S_GLCAASEepp,HST_7_Ste,HST_7_Stepp,HST_7_Stex PMDBD2002132 Tolcapone?_ac Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_tolcp_ac(e),TOLCP_AC_GLC_GLCAASE,TOLCP_AC_GLC_GLCAASEe,TOLCP_AC_GLC_GLCAASEepp,TOLCP_ACte,TOLCP_ACtepp,TOLCP_ACtex PMDBD2002133 Desmethylalfentanil (AM14)_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes AM14_GLC_GLCAASE,AM14_GLC_GLCAASEe,AM14_GLC_GLCAASEepp,AM14_GLCabc,AM14_GLCt,AM14_GLCt2,AM14_GLCt2pp,AM14_GLCtex,EX_am14_glc(e) PMDBD2002134 Tolfenamic Acid_1b Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_tlf_a_1b(e),TLF_A_1Bte,TLF_A_1Btepp,TLF_A_1Btex,TLF_A_M5_GLCAASE,TLF_A_M5_GLCAASEe,TLF_A_M5_GLCAASEepp,TLF_A_M5A_GLCAASE,TLF_A_M5A_GLCAASEe,TLF_A_M5A_GLCAASEepp PMDBD2002135 Prontosil_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_pront_glc(e),PRONT_GLC_GLCAASE,PRONT_GLC_GLCAASEe,PRONT_GLC_GLCAASEepp,PRONT_GLCabc,PRONT_GLCt,PRONT_GLCt2,PRONT_GLCt2pp,PRONT_GLCtex PMDBD2002136 drug_metabolite Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes Reaction ID PMDBD2002137 dihydro_Digitoxin Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes DIHYDRO_DIGITOXINc,DIHYDRO_DIGITOXINt2r,EX_dihydro_digitoxin(e) PMDBD2002138 3-Hydroxymorphinan_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes 3OH_MXN_GLC_GLCAASE,3OH_MXN_GLC_GLCAASEe,3OH_MXN_GLC_GLCAASEepp,3OH_MXN_GLCabc,3OH_MXN_GLCt,3OH_MXN_GLCt2,3OH_MXN_GLCt2pp,3OH_MXN_GLCtex,EX_3oh_mxn_glc(e) PMDBD2002139 6-hydroxy-fluvasN-(2-Methyl-3-Chlorophenyl)-Anthranilic Acidinglu Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes 6OHFVSGLU_GLCAASE,6OHFVSGLU_GLCAASEe,6OHFVSGLU_GLCAASEepp,6OHFVSGLUabc,6OHFVSGLUt,6OHFVSGLUt2,6OHFVSGLUt2pp,6OHFVSGLUtex,EX_6ohfvsglu(e) PMDBD2002140 4-Dehydroxytempol_1glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes 4DH_TPNO_1GLC_GLCAASE,4DH_TPNO_1GLC_GLCAASEe,4DH_TPNO_1GLCabc,4DH_TPNO_1GLCt,4DH_TPNO_1GLCt2,EX_4dh_tpno_1glc(e) PMDBD2002141 NeoProntosilosil Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_neopront(e),NEOPRONT_AR_NADi,NEOPRONT_AR_NADPi,NEOPRONTt2r,NEOPRONTt2rpp,NEOPRONTtex PMDBD2002142 Tolfenamic Acid_2 Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_tlf_a_2(e),TLF_A_2te,TLF_A_2tepp,TLF_A_2tex,TLF_A_M1_GLCAASE,TLF_A_M1_GLCAASEe,TLF_A_M1_GLCAASEepp PMDBD2002143 odsm_eGalantamine Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes EX_odsm_egltmn(e),ODSM_EGLTMN_GLC_GLCAASE,ODSM_EGLTMN_GLC_GLCAASEe,ODSM_EGLTMN_GLC_GLCAASEepp,ODSM_EGLTMNte,ODSM_EGLTMNtepp,ODSM_EGLTMNtex PMDBD2002144 N-(4-Hydroxyphenyl)Propanamide (AM5)_glc Therapeutic Substance n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. No No No No No Yes AM5_GLC_GLCAASE,AM5_GLC_GLCAASEe,AM5_GLC_GLCAASEepp,AM5_GLCabc,AM5_GLCt,AM5_GLCt2,AM5_GLCt2pp,AM5_GLCtex,EX_am5_glc(e)